Chromosome	Approved_Gene_Symbol	OMIM_INFO
chr1	ALPQTL2	612367.0 | ALPQTL2 | Alkaline phosphatase, plasma level of, QTL 2 | 100196914.0 | nan | linkage with rs1780324 | {Alkaline phosphatase, plasma level of, QTL 2}, 612367 (2)
chr1	ANON1	606788.0 | ANON1 | Anorexia nervosa, susceptibility to, 1 | 171514.0 | nan | nan | {Anorexia nervosa, susceptibility to, 1}, 606788 (2)
chr1	BCC1	605462.0 | BCC1 | Basal cell carcinoma, susceptibility to, 1 | 100307118.0 | nan | associated with rs7538876 | {Basal cell carcinoma, susceptibility to, 1}, 605462 (2)
chr1	BMND3	606928.0 | BMND3 | Bone mineral density QTL 3 | 246259.0 | nan | ?another locus at 3p21 | [Bone mineral density QTL 3], 606928 (2)
chr1		618815.0 | C1DUPp36.33, DUP1p36.33 | Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster | nan | nan | nan | Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster, 618815 (4), Autosomal dominant
chr1	CMM	155600.0 | CMM, MLM, DNS | Cutaneous malignant melanoma/dysplastic nevus | 1243.0 | nan | some linkage studies negative; see 9p | {Melanoma, cutaneous malignant, 1}, 155600 (2), Autosomal dominant
chr1	CCV	115665.0 | CTRCT8, CCV | Cataract, congenital, Volkmann type | 7792.0 | nan | linked to Rh in Scottish family | Cataract 8, multiple types, 115665 (2), Autosomal dominant
chr1		607872.0 | DEL1p36, C1DELp36 | Chromosome 1p36 deletion syndrome, distal | nan | nan | contiguous gene deletion syndrome | Chromosome 1p36 deletion syndrome, distal, 607872 (4), Isolated cases
chr1		619343.0 | DEL1p36, C1DELp36 | Chromosome 1p36 deletion syndrome, proximal | nan | nan | nan | Chromosome 1p36 deletion syndrome, proximal, 619343 (4), Autosomal dominant
chr1	DYX8	608995.0 | DYX8 | Dyslexia, susceptibility to, 8 | 406874.0 | nan | between D1S552 and D1S1622 | {Dyslexia, susceptibility to, 8}, 608995 (2), Multifactorial, Autosomal dominant
chr1		131190.0 | ERPL1, HLM2 | Endogenous retroviral pol gene-like sequence 1 (oncogene HLM2) | nan | nan | nan | nan
chr1	IBD7	605225.0 | IBD7 | Inflammatory bowel disease 7 | 57042.0 | nan | associated with rs6426833 | {Inflammatory bowel disease 7}, 605225 (2)
chr1	MS4	612596.0 | MS4 | Multiple sclerosis, susceptibility to, 4 | 100271696.0 | nan | associated with rs10492972 | {Multiple sclerosis, susceptibility to, 4}, 612596 (2)
chr1	MYP14	610320.0 | MYP14 | Myopia 14 | 100359407.0 | nan | between D1S552 and D1S1622 | Myopia 14, 610320 (2), Autosomal dominant
chr1		605606.0 | PSORS7 | Psoriasis susceptibility 7 | nan | nan | nan | {Psoriasis susceptibility 7}, 605606 (2)
chr1	PTPRZ2	604008.0 | PTPRZ2 | Protein-tyrosine phosphatase, receptor-type, zeta-2 | 5804.0 | nan | nan | nan
chr1	SAI1	154280.0 | SAI1, MTS1, TFS1 | Suppression of anchorage independence-1 (malignant transformation suppression-1) | 6298.0 | nan | nan | nan
chr1	ZBTB40-IT1	618485.0 | ZBTB40IT1 | ZBTB40 intronic transcript 1, noncoding | 100874345.0 | nan | nan | nan
chr1	SAMD11	616765.0 | SAMD11, MRS | Sterile alpha motif domain-containing protein 11 | 148398.0 | ENSG00000187634 | nan | nan
chr1	NOC2L	610770.0 | NOC2L, NIR | NOC2-like nucleolar-associated transcriptional repressor | 26155.0 | ENSG00000188976 | nan | nan
chr1	KLHL17	619262.0 | KLHL17, AF | Kelch-like 17 | 339451.0 | ENSG00000187961 | nan | nan
chr1	PERM1	615921.0 | PERM1, C1orf170 | PPARGC1-and ESRR-induced regulator, muscle, 1 | 84808.0 | ENSG00000187642 | nan | nan
chr1	HES4	608060.0 | HES4 | Hes family bHLH transcription factor 4 | 57801.0 | ENSG00000188290 | nan | nan
chr1	ISG15	147571.0 | ISG15, G1P2, IFI15, IMD38 | ISG15 ubiquitin-like modifier | 9636.0 | ENSG00000187608 | nan | Immunodeficiency 38, 616126 (3), Autosomal recessive
chr1	AGRN	103320.0 | AGRN, CMS8 | Agrin | 375790.0 | ENSG00000188157 | nan | Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive
chr1	MIR200B	612091.0 | MIR200B, MIRN200B | Micro RNA 200B | 406984.0 | ENSG00000207730 | nan | nan
chr1	MIR200A	612090.0 | MIR200A, MIRN200A | Micro RNA 200A | 406983.0 | ENSG00000207607 | nan | nan
chr1	MIR429	612094.0 | MIR429, MIRN429 | Micro RNA 429 | 554210.0 | ENSG00000198976 | nan | nan
chr1	TNFRSF18	603905.0 | TNFRSF18, AITR, GITR | Tumor necrosis factor receptor superfamily, member 18 | 8784.0 | ENSG00000186891 | nan | nan
chr1	TNFRSF4	600315.0 | TNFRSF4, TXGP1L, OX40, ACT35, IMD16 | Tumor necrosis factor receptor superfamily, member 4 | 7293.0 | ENSG00000186827 | mutation identified in 1 IMD16 family | ?Immunodeficiency 16, 615593 (3), Autosomal recessive
chr1	SDF4	614282.0 | SDF4, CAB45 | Stromal cell-derived factor 4 | 51150.0 | ENSG00000078808 | nan | nan
chr1	B3GALT6	615291.0 | B3GALT6, SEMDJL1, EDSSPD2, ALGAZ | UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6 | 126792.0 | ENSG00000176022 | nan | Ehlers-Danlos syndrome, spondylodysplastic type, 2, 615349 (3), Autosomal recessive; Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3), Autosomal recessive; Al-Gazali syndrome, 609465 (3), Autosomal recessive
chr1	C1QTNF12	616593.0 | FAM132A, C1QDC2, C1QTNF12 | Family with sequence similarity 132, member A | 388581.0 | ENSG00000184163 | nan | nan
chr1	UBE2J2	619756.0 | UBE2J2, NCUBE2, UBC6 | Ubiquitin-conjugating enzyme E2 J2 | 118424.0 | ENSG00000160087 | nan | nan
chr1	SCNN1D	601328.0 | SCNN1D | Sodium channel epithelial 1, subunit delta | 6339.0 | ENSG00000162572 | nan | nan
chr1	INTS11	611354.0 | INTS11, PSF3L, RC68, NEDMLOB | Integrator complex subunit 11 | 54973.0 | ENSG00000127054 | nan | Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities, 620428 (3), Autosomal recessive
chr1	CPTP	615467.0 | GLTPD1, CPTP | Glycolipid transfer protein domain-containing protein 1 | 80772.0 | ENSG00000224051 | nan | nan
chr1	TAS1R3	605865.0 | TAS1R3, T1R3 | Taste receptor type 1, member 3 | 83756.0 | ENSG00000169962 | nan | nan
chr1	DVL1	601365.0 | DVL1, DRS2 | Dishevelled segment polarity protein 1 | 1855.0 | ENSG00000107404 | nan | Robinow syndrome, autosomal dominant 2, 616331 (3), Autosomal dominant
chr1	MXRA8	617293.0 | MXRA8, ASP3 | Matrix remodeling-associated protein 8 | 54587.0 | ENSG00000162576 | nan | nan
chr1	AURKAIP1	609183.0 | AURKAIP1, AKIP, AIP | Aurora kinase A-interacting protein 1 | 54998.0 | ENSG00000175756 | nan | nan
chr1	CCNL2	613482.0 | CCNL2 | Cyclin L2 | 81669.0 | ENSG00000221978 | nan | nan
chr1	MRPL20	611833.0 | MRPL20 | Mitochondrial ribosomal protein L20 | 55052.0 | ENSG00000242485 | nan | nan
chr1	VWA1	611901.0 | VWA1, WARP, HMNR7 | von Willebrand factor A domain-containing protein 1 | 64856.0 | ENSG00000179403 | nan | Neuronopathy, distal hereditary motor, autosomal recessive 7, 619216 (3), Autosomal recessive
chr1	ATAD3C	617227.0 | ATAD3C | ATPase family, AAA domain-containing, member 3C | 219293.0 | ENSG00000215915 | nan | nan
chr1	ATAD3B	612317.0 | ATAD3B, TOB3, KIAA1273 | ATPase family, AAA domain-containing, member 3B | 83858.0 | ENSG00000160072 | nan | nan
chr1	ATAD3A	612316.0 | ATAD3A, HAYOS, PHRINL | ATPase family, AAA domain-containing, member 3A | 55210.0 | ENSG00000197785 | nan | Harel-Yoon syndrome, 617183 (3), Autosomal recessive, Autosomal dominant; Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal, 618810 (3), Autosomal recessive
chr1	TMEM240	616101.0 | TMEM240, C1orf70, SCA21 | Transmembrane protein 240 | 339453.0 | ENSG00000205090 | nan | Spinocerebellar ataxia 21, 607454 (3), Autosomal dominant
chr1	SSU72	617680.0 | SSU72 | SSU72 homolog, RNA polymerase II CTD phosphatase | 29101.0 | ENSG00000160075 | nan | nan
chr1	MIB2	611141.0 | MIB2 | Mindbomb E3 ubiquitin protein ligase 2 | 142678.0 | ENSG00000197530 | nan | nan
chr1	MMP23B	603321.0 | MMP23B, MMP22 | Matrix metalloproteinase 23B | 8510.0 | ENSG00000189409 | nan | nan
chr1	CDK11B	176873.0 | CDK11B, CDC2L1, P58, CDK11 | Cyclin-dependent kinase 11B | 984.0 | ENSG00000248333 | nan | nan
chr1	SLC35E2B	619315.0 | SLC35E2B, KIAA0447 | Solute carrier family 35, member E2B | 728661.0 | ENSG00000189339 | nan | nan
chr1	MMP23A	603320.0 | MMP23A, MMP21, MIFR | Matrix metalloproteinase 23A | 8511.0 | ENSG00000310190 | nan | nan
chr1	CDK11A	116951.0 | CDK11A, CDC2L2 | Cyclin-dependent kinase 11A | 728642.0 | ENSG00000008128 | nan | nan
chr1	NADK	611616.0 | NADK | NAD kinase | 65220.0 | ENSG00000008130 | nan | nan
chr1	GNB1	139380.0 | GNB1, MRD42, MDS | Guanine nucleotide-binding protein, beta polypeptide-1 | 2782.0 | ENSG00000078369 | nan | Myelodysplastic syndrome, somatic, 614286 (3); Leukemia, acute lymphoblastic, somatic, 613065 (3); Intellectual developmental disorder, autosomal dominant 42, 616973 (3), Autosomal dominant
chr1	CALML6	610171.0 | CALML6, CAGLP | Calmodulin-like 6 | 163688.0 | ENSG00000169885 | nan | nan
chr1	CFAP74	620187.0 | CFAP74, KIAA1751, C1orf222, CILD49 | Cilia- and flagella-associated protein 74 | 85452.0 | ENSG00000142609 | nan | Ciliary dyskinesia, primary, 49, without situs inversus, 620197 (3), Autosomal recessive
chr1	GABRD	137163.0 | GABRD, GEFSP5 | Gamma-aminobutyric acid (GABA) A receptor, delta | 2563.0 | ENSG00000187730 | mutation identified in 1 GEFSP5 family | {?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant
chr1	PRKCZ	176982.0 | PRKCZ, PKC2 | Protein kinase C, zeta form | 5590.0 | ENSG00000067606 | nan | nan
chr1	FAAP20	615183.0 | C1orf86, FAAP20 | Chromosome 1 open reading frame 86 | 199990.0 | ENSG00000162585 | nan | nan
chr1	SKI	164780.0 | SKI, SGS | SKI protooncogene | 6497.0 | ENSG00000157933 | formerly mapped to 1q22-q24 | Shprintzen-Goldberg syndrome, 182212 (3), Autosomal dominant
chr1	DYT13	607671.0 | DYT13 | Dystonia 13, torsion | 93983.0 | nan | nan | Dystonia 13, torsion, 607671 (2), Autosomal dominant
chr1	KONDS	606242.0 | KONDS | Kondoh syndrome | 100653373.0 | nan | linked to rs966321 and rs1441834 | Kondoh syndrome, 606242 (2), Autosomal recessive
chr1	RER1	620048.0 | RER1 | Retention in endoplasmic reticulum sorting receptor 1 | 11079.0 | ENSG00000157916 | nan | nan
chr1	PEX10	602859.0 | PEX10, NALD, PBD6A, PBD6B | Peroxisome biogenesis factor 10 | 5192.0 | ENSG00000157911 | nan | Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive
chr1	PLCH2	612836.0 | PLCH2, PLCL4 | Phospholipase C, eta-2 | 9651.0 | ENSG00000149527 | nan | nan
chr1	PANK4	606162.0 | PANK4, CTRCT49 | Pantothenate kinase 4 | 55229.0 | ENSG00000157881 | mutation identified in 1 CTRCT49 family | ?Cataract 49, 619593 (3), Autosomal dominant
chr1	HES5	607348.0 | HES5 | Hes family bHLH transcription factor 5 | 388585.0 | ENSG00000197921 | nan | nan
chr1	TNFRSF14	602746.0 | TNFRSF14, HVEM, TR2 | Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 8764.0 | ENSG00000157873 | nan | nan
chr1	MMEL1	618104.0 | MMEL1, NEPII, NEP2, NL1, SEP | Membrane metalloendopeptidase-like 1 | 79258.0 | ENSG00000142606 | nan | nan
chr1	ACTRT2	608535.0 | ACTRT2, ARPT2, ARPM2 | Actin-related protein T2 | 140625.0 | ENSG00000169717 | nan | nan
chr1	PRDM16	605557.0 | PRDM16, MEL1, LVNC8, CMD1LL | PR domain-containing protein 16 | 63976.0 | ENSG00000142611 | nan | Left ventricular noncompaction 8, 615373 (3), Autosomal dominant; Cardiomyopathy, dilated, 1LL, 615373 (3), Autosomal dominant
chr1	ARHGEF16	618871.0 | ARHGEF16 | RHO guanine nucleotide exchange factor 16 | 27237.0 | ENSG00000130762 | nan | nan
chr1	MEGF6	604266.0 | MEGF6, EGFL3 | Multiple epidermal growth factor-like domains 6 | 1953.0 | ENSG00000162591 | nan | nan
chr1	MIR551A	615148.0 | MIR551A | Micro RNA 551A | 693135.0 | ENSG00000207776 | nan | nan
chr1	TPRG1L	611460.0 | TPRG1L, FAM79A | Tumor protein p63 regulated 1-like | 127262.0 | ENSG00000158109 | nan | nan
chr1	WRAP73	606040.0 | WDR8 | WD repeat-containing protein 8 | 49856.0 | ENSG00000116213 | nan | nan
chr1	TP73	601990.0 | TP73, CILD47 | p53-related protein | 7161.0 | ENSG00000078900 | imprinted | Ciliary dyskinesia, primary, 47, and lissencephaly, 619466 (3), Autosomal recessive
chr1	SMIM1	615242.0 | SMIM1, VEL | Small integral membrane protein 1 | 388588.0 | ENSG00000235169 | nan | [Blood group, Vel system], 615264 (3), Autosomal recessive
chr1	LRRC47	619154.0 | LRRC47, KIAA1185 | Leucine-rich repeat-containing protein 47 | 57470.0 | ENSG00000130764 | nan | nan
chr1	CEP104	616690.0 | CEP104, GLYBP, KIAA0562, JBTS25, MRT77 | Centrosomal protein, 104kD | 9731.0 | ENSG00000116198 | nan | Joubert syndrome 25, 616781 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 77, 619988 (3), Autosomal recessive
chr1	DFFB	601883.0 | DFFB, CAD, DFF2 | DNA fragmentation factor, 40kD, beta subunit | 1677.0 | ENSG00000169598 | nan | nan
chr1	AJAP1	610972.0 | AJAP1, SHREW1 | Adherens junction-associated protein 1 | 55966.0 | ENSG00000196581 | nan | nan
chr1	DFNB96	614414.0 | DFNB96 | Deafness, autosomal recessive 96 | 100861440.0 | nan | between rs3817914 and rs477558 | Deafness, autosomal recessive 96, 614414 (2), Autosomal recessive
chr1	NPHP4	607215.0 | NPHP4, SLSN4 | Nephrocystin 4 | 261734.0 | ENSG00000131697 | nan | Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive
chr1	KCNAB2	601142.0 | KCNAB2, KCNA2B | Potassium voltage-gated channel, shaker-related subfamily, beta member 2 | 8514.0 | ENSG00000069424 | nan | nan
chr1	CHD5	610771.0 | CHD5, PMNDS | Chromodomain helicase DNA-binding protein 5 | 26038.0 | ENSG00000116254 | nan | Parenti-Mignot neurodevelopmental syndrome, 619873 (3), Autosomal dominant
chr1	RPL22	180474.0 | RPL22, EAP | Ribosomal protein L22 | 6146.0 | ENSG00000116251 | fused with AML1 in t(3;21) | nan
chr1	RNF207	616923.0 | RNF207, C1orf188 | RING finger protein 207 | 388591.0 | ENSG00000158286 | nan | nan
chr1	ICMT	605851.0 | ICMT | Isoprenylcysteine carboxylmethyltransferase | 23463.0 | ENSG00000116237 | nan | nan
chr1	HES3	609971.0 | HES3 | Hes family bHLH transcription factor 3 | 390992.0 | ENSG00000173673 | nan | nan
chr1	GPR153	614269.0 | GPR153 | G protein-coupled receptor 153 | 387509.0 | ENSG00000158292 | nan | nan
chr1	ACOT7	602587.0 | ACOT7, BACH, LACH | Acyl-CoA thioesterase 7 | 11332.0 | ENSG00000097021 | nan | nan
chr1	HES2	609970.0 | HES2 | Hes family bHLH transcription factor 2 | 54626.0 | ENSG00000069812 | nan | nan
chr1	ESPN	606351.0 | ESPN, USH1M | Espin | 83715.0 | ENSG00000187017 | mutation identified in 1 USH1M family | Deafness, neurosensory, without vestibular involvement, autosomal dominant, 609006 (3), Autosomal recessive; Deafness, autosomal recessive 36, 609006 (3), Autosomal recessive; ?Usher syndrome, type 1M, 618632 (3), Autosomal recessive
chr1	TNFRSF25	603366.0 | TNFRSF25, TNFRSF12, DR3, LARD | Tumor necrosis factor receptor superfamily, member 25 | 8718.0 | ENSG00000215788 | nan | nan
chr1	PLEKHG5	611101.0 | PLEKHG5, KIAA0720, HMNR4, CMTRIC | Pleckstrin homology domain- and RhoGEF domain-containing protein G5 | 57449.0 | ENSG00000171680 | nan | Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive
chr1	NOL9	620304.0 | NOL9 | Nucleolar protein 9 | 79707.0 | ENSG00000162408 | nan | nan
chr1	TAS1R1	606225.0 | TAS1R1, T1R1 | Taste receptor type 1, member 1 | 80835.0 | ENSG00000173662 | nan | nan
chr1	ZBTB48	165270.0 | ZBTB48, HKR3 | Zinc finger- and BTB domain-containing protein 48 | 3104.0 | ENSG00000204859 | nan | nan
chr1	KLHL21	616262.0 | KLHL21, KIAA0469 | Kelch-like 21 | 9903.0 | ENSG00000162413 | nan | nan
chr1	PHF13	620054.0 | PHF13, SPOC1 | PHD finger protein 13 | 148479.0 | ENSG00000116273 | nan | nan
chr1	THAP3	612532.0 | THAP3 | THAP domain-containing protein 3 | 90326.0 | ENSG00000041988 | nan | nan
chr1	DNAJC11	614827.0 | DNAJC11 | DNAJ/HSP40 homolog, subfamily C, member 11 | 55735.0 | ENSG00000007923 | nan | nan
chr1	CAMTA1	611501.0 | CAMTA1, KIAA0833, CECBA | Calmodulin-binding transcription activator 1 | 23261.0 | ENSG00000171735 | nan | Cerebellar dysfunction with variable cognitive and behavioral abnormalities, 614756 (3), Autosomal dominant
chr1	GLC3B	600975.0 | GLC3B | Glaucoma 3, primary infantile, B | 2728.0 | nan | nan | Glaucoma 3, primary infantile, B, 600975 (2), Autosomal recessive
chr1	SCZD12	608543.0 | SCZD12 | Schizophrenia 12 | 619488.0 | nan | max lod at D1S1612 | {Schizophrenia 12}, 181500 (2), Autosomal dominant
chr1	VAMP3	603657.0 | VAMP3 | Vesicle-associated membrane protein 3 | 9341.0 | ENSG00000049245 | nan | nan
chr1	PER3	603427.0 | PER3, FASPS3 | Period circadian regulator 3 | 8863.0 | ENSG00000049246 | mutation identified in 1 FASPS3 family | ?Advanced sleep phase syndrome, familial, 3, 616882 (3), Autosomal dominant
chr1	UTS2	604097.0 | UTS2 | Urotensin II | 10911.0 | ENSG00000049247 | nan | nan
chr1	TNFRSF9	602250.0 | TNFRSF9, ILA, CD137, IMD109 | Tumor necrosis factor receptor superfamily, member 9 (interleukin-activated receptor; Ly63, mouse, homolog of) | 3604.0 | ENSG00000049249 | nan | Immunodeficiency 109 with lymphoproliferation, 620282 (3), Autosomal recessive
chr1	PARK7	602533.0 | DJ1, PARK7 | Oncogene DJ-1 | 11315.0 | ENSG00000116288 | nan | Parkinson disease 7, autosomal recessive early-onset, 606324 (3), Autosomal recessive
chr1	ERRFI1	608069.0 | MIG6, RALT | Mitogen-inducible gene 6 | 54206.0 | ENSG00000116285 | nan | nan
chr1	SLC45A1	605763.0 | SLC45A1, DNB5, IDDNPF | Solute carrier family 45, member 1 | 50651.0 | ENSG00000162426 | nan | Intellectual developmental disorder with neuropsychiatric features, 617532 (3), Autosomal recessive
chr1	RERE	605226.0 | RERE, NEDBEH | Arginine-glutamic acid dipeptide repeats | 473.0 | ENSG00000142599 | nan | Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3), Autosomal dominant
chr1	ENO1	172430.0 | ENO1, PPH, MPB1 | Enolase-1, alpha | 2023.0 | ENSG00000074800 | nan | nan
chr1	CA6	114780.0 | CA6 | Carbonic anhydrase VI | 765.0 | ENSG00000131686 | nan | nan
chr1	SLC2A7	610371.0 | SLC2A7, GLUT7 | Solute carrier family 2 (facilitated glucose transporter), member 7 | 155184.0 | ENSG00000197241 | nan | nan
chr1	SLC2A5	138230.0 | SLC2A5, GLUT5 | Solute carrier family 2 (facilitated glucose transporter), member 5 | 6518.0 | ENSG00000142583 | nan | nan
chr1	GPR157	620860.0 | GPR157 | G protein-coupled receptor 157 | 80045.0 | ENSG00000180758 | nan | nan
chr1	MIR34A	611172.0 | MIR34A, MIRN34A | Micro RNA 34A | 407040.0 | ENSG00000284357 | nan | nan
chr1	H6PD	138090.0 | H6PD, GDH, G6PDH, CORTRD1 | Hexose-6-phosphate dehydrogenase | 9563.0 | ENSG00000049239 | digenic triallelic mutations with HSD11B1 | Cortisone reductase deficiency 1, 604931 (3), Autosomal recessive
chr1	SPSB1	611657.0 | SPSB, SSB1 | SPRY domain- and SOCS box-containing 1 | 80176.0 | ENSG00000171621 | nan | nan
chr1	SLC25A33	610816.0 | SLC25A33 | Solute carrier family 25 (mitochondrial carrier), member 33 | 84275.0 | ENSG00000171612 | nan | nan
chr1	PIK3CD	602839.0 | PIK3CD, APDS, IMD14A, IMD14B, ROCHIS | Phosphatidylinositol 3-kinase, catalytic, 110kD, delta | 5293.0 | ENSG00000171608 | mutation identified in 1 ROCHIS family | Immunodeficiency 14A, autosomal dominant, 615513 (3), Autosomal dominant; Immunodeficiency 14B, autosomal recessive, 619281 (3), Autosomal recessive; ?Roifman-Chitayat syndrome, digenic, 613328 (3), Digenic recessive
chr1	CLSTN1	611321.0 | CLSTN1, KIAA0911 | Calsyntenin 1 | 22883.0 | ENSG00000171603 | nan | nan
chr1	CTNNBIP1	607758.0 | CTNNBIP1, ICAT | Catenin, beta-interacting protein 1 | 56998.0 | ENSG00000178585 | nan | nan
chr1	LZIC	610458.0 | LZIC | Leucine zipper and CTNNBIP1 domains-containing protein | 84328.0 | ENSG00000162441 | nan | nan
chr1	NMNAT1	608700.0 | NMNAT1, NMNAT, PNAT1, LCA9, SHILCA | Nicotinamide nucleotide adenylyltransferase 1 | 64802.0 | ENSG00000173614 | nan | Spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis, 619260 (3), Autosomal recessive; Leber congenital amaurosis 9, 608553 (3), Autosomal recessive
chr1	RBP7	608604.0 | RBP7, CRBP4 | Retinol-binding protein 7 | 116362.0 | ENSG00000162444 | nan | nan
chr1	UBE4B	613565.0 | UBE4B, UFD2A, KIAA0684 | Ubiquitination factor E4B | 10277.0 | ENSG00000130939 | nan | nan
chr1	KIF1B	605995.0 | KIF1B, CMT2A, CMT2A1, NBLST1 | Kinesin family member 1B | 23095.0 | ENSG00000054523 | nan | {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant
chr1	PGD	172200.0 | PGD | 6-phosphogluconate dehydrogenase | 5226.0 | ENSG00000142657 | nan | nan
chr1	CENPS	609130.0 | CENPS, APITD1, MHF1 | Centromeric protein S | 378708.0 | ENSG00000175279 | nan | nan
chr1	CORT	602784.0 | CORT | Cortistatin | 1325.0 | ENSG00000241563 | nan | nan
chr1	DFFA	601882.0 | DFFA, DFF1 | DNA fragmentation factor, 45kD, alpha subunit | 1676.0 | ENSG00000160049 | nan | nan
chr1	PEX14	601791.0 | PEX14, PBD13A | Peroxisome biogenesis factor 14 | 5195.0 | ENSG00000142655 | nan | Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3), Autosomal recessive
chr1	CASZ1	609895.0 | CASZ1, SRG | Castor zinc finger protein 1 | 54897.0 | ENSG00000130940 | nan | nan
chr1	C1orf127	619700.0 | C1orf127 | Chromosome 1 open reading frame 127 | 148345.0 | ENSG00000175262 | nan | nan
chr1	TARDBP	605078.0 | TARDBP, TDP43, ALS10 | TAR DNA-binding protein | 23435.0 | ENSG00000120948 | pseudogenes on 2, 6, 8, 13, 20 | Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant
chr1	MASP2	605102.0 | MASP2 | Mannan-binding lectin serine protease 2 | 10747.0 | ENSG00000009724 | nan | MASP2 deficiency, 613791 (3), Autosomal recessive
chr1	SRM	182891.0 | SRM, SPS1 | Spermidine synthase-1 | 6723.0 | ENSG00000116649 | ?pseudogene on 3p14-q21 | nan
chr1	EXOSC10	605960.0 | EXOSC10, PMSCL2 | Exosome component 10 | 5394.0 | ENSG00000171824 | nan | nan
chr1	MTOR	601231.0 | MTOR, FRAP1, SKS | Mechanistic target of rapamycin | 2475.0 | ENSG00000198793 | nan | Focal cortical dysplasia, type II, somatic, 607341 (3); Smith-Kingsmore syndrome, 616638 (3), Autosomal dominant
chr1	ANGPTL7	618517.0 | ANGPTL7, CDT6 | Angiopoietin-like 7 | 10218.0 | ENSG00000171819 | nan | nan
chr1	UBIAD1	611632.0 | UBIAD1, TERE1, SCCD | UbiA prenyltransferase domain-containing protein 1 | 29914.0 | ENSG00000120942 | nan | Corneal dystrophy, Schnyder type, 121800 (3), Autosomal dominant
chr1	DISP3	611251.0 | DISP3, PTCHD2, KIAA1337 | Dispatched RND transporter family, member 3 | 57540.0 | ENSG00000204624 | nan | nan
chr1	FBXO2	607112.0 | FBXO2, FBX2, FBG1, NFB42 | F-box protein 2 | 26232.0 | ENSG00000116661 | nan | nan
chr1	FBXO44	609111.0 | FBXO44, FBX44, FBX6A, FBG3 | F-box protein 44 | 93611.0 | ENSG00000132879 | nan | nan
chr1	FBXO6	605647.0 | FBXO6, FBX6, FBG2 | F-box protein 6 | 26270.0 | ENSG00000116663 | nan | nan
chr1	MAD2L2	604094.0 | MAD2L2, MAD2B, FANCV | Mitotic arrest-deficient 2 like 2 | 10459.0 | ENSG00000116670 | mutation identified in 1 FANCV patient; pseudogene on 14q21-q23 | ?Fanconi anemia, complementation group V, 617243 (3), Autosomal recessive
chr1	DRAXIN	612682.0 | DRAXIN, C1orf187 | Dorsal inhibitory axon guidance protein | 374946.0 | ENSG00000162490 | nan | nan
chr1	AGTRAP	608729.0 | AGTRAP | Angiotensin II receptor-associated protein | 57085.0 | ENSG00000177674 | nan | nan
chr1	MTHFR	607093.0 | MTHFR | Methylenetetrahydrofolate reductase | 4524.0 | ENSG00000177000 | nan | {Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive
chr1	CLCN6	602726.0 | CLCN6, CLCN6 | Chloride channel 6 | 1185.0 | ENSG00000011021 | nan | Ceroid lipofuscinosis, neuronal, 15, 619173 (3), Autosomal dominant
chr1	NPPA	108780.0 | NPPA, PND, ANP, ATFB6, ATRST2 | Natriuretic peptide precursor A | 4878.0 | ENSG00000175206 | nan | Atrial standstill 2, 615745 (3), Autosomal recessive; Atrial fibrillation, familial, 6, 612201 (3), Autosomal dominant
chr1	NPPB	600295.0 | NPPB, BNP | Natriuretic peptide precursor B | 4879.0 | ENSG00000120937 | nan | nan
chr1	RNU5E-1	620362.0 | RNU5E-1, RNU5E | RNA, U5E small nuclear 1 | 26829.0 | ENSG00000199347 | nan | nan
chr1	PLOD1	153454.0 | PLOD1, LH1, LLH, EDSKCL1 | Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) | 5351.0 | ENSG00000083444 | nan | Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive
chr1	MFN2	608507.0 | MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B, MSL | Mitofusin 2 | 9927.0 | ENSG00000116688 | nan | Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant
chr1	MIIP	608772.0 | MIIP, IIP45 | Migration and invasion inhibitory protein | 60672.0 | ENSG00000116691 | nan | nan
chr1	TNFRSF8	153243.0 | TNFRSF8, CD30, D1S166E | Tumor necrosis factor receptor superfamily, member 8 (CD30 antigen; Ki-1 antigen) | 943.0 | ENSG00000120949 | nan | nan
chr1	TNFRSF1B	191191.0 | TNFRSF1B, TNFR2, TNFBR | Tumor necrosis factor receptor superfamily, member 1B | 7133.0 | ENSG00000028137 | nan | nan
chr1	VPS13D	608877.0 | VPS13D, SCAR4 | Vacuolar protein sorting 13 homolog D | 55187.0 | ENSG00000048707 | nan | Spinocerebellar ataxia, autosomal recessive 4, 607317 (3), Autosomal recessive
chr1	GBD2	609918.0 | GBD2 | Gallbladder disease 2 | 100048905.0 | nan | between D1S1597 and D1S47 | Gallbladder disease 2, 609918 (2)
chr1	DHRS3	612830.0 | DHRS3, RETSDR1 | Short-chain dehydrogenase/reductase family, member 3 | 9249.0 | ENSG00000162496 | nan | nan
chr1	LRRC38	615212.0 | LRRC38 | Leucine-rich repeat-containing protein 38 | 126755.0 | ENSG00000162494 | nan | nan
chr1	PDPN	608863.0 | PDPN, TI1A, T1A2, GP36, OTS8, AGGRUS | Podoplanin | 10630.0 | ENSG00000162493 | nan | nan
chr1	PRDM2	601196.0 | PRDM2, RIZ | PR domain-containing protein 2 (retinoblastoma protein-binding zinc-finger protein RIZ) | 7799.0 | ENSG00000116731 | nan | nan
chr1	KAZN	618301.0 | KAZN | Kazrin, periplakin-interacting protein | 23254.0 | ENSG00000189337 | nan | nan
chr1	FHAD1	620889.0 | FHAD1 | Forkhead-associated phosphopeptide-binding domain-containing protein | 114827.0 | ENSG00000142621 | nan | nan
chr1	EFHD2	616450.0 | EFHD2, SWS1 | EF-hand domain family, member D2 | 79180.0 | ENSG00000142634 | nan | nan
chr1	CTRC	601405.0 | CTRC, CLCR | Chymotrypsin | 11330.0 | ENSG00000162438 | nan | {Pancreatitis, chronic, susceptibility to}, 167800 (3), Autosomal dominant
chr1	CELA2A	609443.0 | CELA2A, ELA2A, AOMS4 | Chymotrypsin-like elastase family, member 2A | 63036.0 | ENSG00000142615 | nan | Abdominal obesity-metabolic syndrome 4, 618620 (3), Autosomal dominant
chr1	CELA2B	609444.0 | CELA2B, ELA2B | Chymotrypsin-like elastase family, member 2B | 51032.0 | ENSG00000215704 | nan | nan
chr1	CASP9	602234.0 | CASP9, APAF3 | Caspase 9, apoptosis-related cysteine protease | 842.0 | ENSG00000132906 | nan | nan
chr1	DNAJC16	619973.0 | DNAJC16, ERDJ8, KIAA0962 | DNAJ/HSP40 heat-shock protein family, member C16 | 23341.0 | ENSG00000116138 | nan | nan
chr1	AGMAT	617887.0 | AGMAT, AUH | Agmatinase | 79814.0 | ENSG00000116771 | nan | nan
chr1	DDI2	620871.0 | DDI2 | DNA damage-inducible 1 homolog 2 | 84301.0 | ENSG00000197312 | nan | nan
chr1	RSC1A1	601966.0 | RSC1A1, RS1 | Regulatory solute carrier protein, family 1, member 1 | 6248.0 | ENSG00000215695 | nan | nan
chr1	PLEKHM2	609613.0 | PLEKHM2, SKIP, KIAA0842 | Pleckstrin homology domain-containing protein, family M, member 2 | 23207.0 | ENSG00000116786 | nan | nan
chr1	SLC25A34	610817.0 | SLC25A34 | Solute carrier family 25, member 34 | 284723.0 | ENSG00000162461 | nan | nan
chr1	FBLIM1	607747.0 | FBLIM1, FBLP1, MIGFILIN | Filamin-binding LIM protein 1 | 54751.0 | ENSG00000162458 | nan | nan
chr1	SPEN	613484.0 | SPEN, MINT, SHARP, HIAA0929, RATARS | Spen family transcriptional repressor | 23013.0 | ENSG00000065526 | nan | Radio-Tartaglia syndrome, 619312 (3), Autosomal dominant
chr1	ANIB3	609122.0 | ANIB3 | Aneurysm, intracranial berry, 3 | 497657.0 | nan | nan | Aneurysm, intracranial berry, 3, 609122 (2), Autosomal dominant
chr1	EA8	616055.0 | EA8 | Episodic ataxia, type 8 | 104326187.0 | nan | between rs2743201 and rs215791 | Episodic ataxia, type 8, 616055 (2), Autosomal dominant
chr1	LOC7795	601201.0 | MEMO1 | Methylation modifier for class I HLA | 7795.0 | nan | nan | nan
chr1	ZBTB17	604084.0 | ZBTB17, ZNF151, MIZ1 | Zinc finger- and BTB domain-containing protein 17 | 7709.0 | ENSG00000116809 | nan | nan
chr1	SRARP	619448.0 | SRARP, ERRF, C1orf64 | Steroid receptor-associated and -regulated protein | 149563.0 | ENSG00000183888 | nan | nan
chr1	HSPB7	610692.0 | HSPB7, CVHSP | Heat-shock 27kD protein 7 | 27129.0 | ENSG00000173641 | nan | nan
chr1	CLCNKA	602024.0 | CLCNKA | Chloride channel, kidney, A | 1187.0 | ENSG00000186510 | 11kb from CLCNKB; simultaneous mutation in CLCNKA and CLCNKB | Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive
chr1	CLCNKB	602023.0 | CLCNKB | Chloride channel, kidney, B | 1188.0 | ENSG00000184908 | unequal crossingover with CLCNKA | Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive
chr1	EPHA2	176946.0 | EPHA2, ECK, CTPP1, CTPA, ARCC2, CTRCT6 | Ephrin receptor EphA2 | 1969.0 | ENSG00000142627 | nan | Cataract 6, multiple types, 116600 (3), Autosomal dominant
chr1	ARHGEF19	612496.0 | ARHGEF19, WGEF | RHO guanine nucleotide exchange factor 19 | 128272.0 | ENSG00000142632 | nan | nan
chr1	CPLANE2	620487.0 | CPLANE2, RSG1 | Ciliogenesis and planar polarity effector complex, subunit 2 | 79363.0 | ENSG00000132881 | nan | nan
chr1	FBXO42	609109.0 | FBXO42, FBX42, KIAA1332 | F-box protein 42 | 54455.0 | ENSG00000037637 | nan | nan
chr1	SZRD1	620682.0 | SZRD1, C1orf144 | SUZ RNA-binding domain-containing protein 1 | 26099.0 | ENSG00000055070 | nan | nan
chr1	NECAP2	611624.0 | NECAP2 | NECAP endocytosis-associated protein 2 | 55707.0 | ENSG00000157191 | nan | nan
chr1	TRG-CCC1-1	189911.0 | TRG-CCC1-1, TRNAG1, TRG1 | tRNA glycine 1 (anticodon CCC) 1-1 | 7195.0 | nan | nan | nan
chr1	NBPF1	610501.0 | NBPF1, KIAA1693 | Neuroblastoma breakpoint family, member 1 | 55672.0 | ENSG00000219481 | pseudogenes on 3 and 5 | nan
chr1	RNU1-4	180680.0 | RNU1A, RNU1 | RNA, U1A small nuclear | 6060.0 | ENSG00000207389 | ?same as A12M2 | nan
chr1	TRE-TTC3-1	180640.0 | TRE-TTC3-1, TRNAE1, TRNE, TRE | tRNA glutamic acid (anticodon TTC) 3-1 | 7193.0 | nan | nan | nan
chr1	CROCC	615776.0 | CROCC, ROOTLETIN, KIAA0445 | Ciliary rootlet coiled-coil protein | 9696.0 | ENSG00000058453 | nan | nan
chr1	MFAP2	156790.0 | MFAP2, MAGP, MAGP1 | Microfibrillar-associated protein-2 | 4237.0 | ENSG00000117122 | nan | nan
chr1	ATP13A2	610513.0 | ATP13A2, PARK9, KRPPD, SPG78 | ATPase 13A2 | 23400.0 | ENSG00000159363 | mutation identified in 1 family with CLN12 | Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive
chr1	SDHB	185470.0 | SDHB, SDH2, SDHIP, PPGL4, MC2DN4 | Succinate dehydrogenase complex, iron-sulfur subunit B | 6390.0 | ENSG00000117118 | 1 of 2 polypeptides | Pheochromocytoma/paraganglioma syndrome 4, 115310 (3), Autosomal dominant; Mitochondrial complex II deficiency, nuclear type 4, 619224 (3), Autosomal recessive; Gastrointestinal stromal tumor, 606764 (3), Isolated cases, Autosomal dominant; Paraganglioma and gastric stromal sarcoma, 606864 (3)
chr1	PADI2	607935.0 | PADI2 | Peptidylarginine deiminase, type II | 11240.0 | ENSG00000117115 | nan | nan
chr1	PADI1	607934.0 | PADI1 | Peptidylarginine deiminase, type I | 29943.0 | ENSG00000142623 | nan | nan
chr1	PADI3	606755.0 | PADI3, UHS1 | Peptidylarginine deiminase, type III | 51702.0 | ENSG00000142619 | nan | Uncombable hair syndrome, 191480 (3), Autosomal recessive
chr1	PADI4	605347.0 | PADI4, PADI5, PAD | Peptidylarginine deiminase, type IV | 23569.0 | ENSG00000159339 | nan | nan
chr1	PADI6	610363.0 | PADI6, OZEMA16 | Peptidylarginine deiminase, type VI | 353238.0 | ENSG00000276747 | nan | Oocyte/zygote/embryo maturation arrest 16, 617234 (3), Autosomal recessive
chr1	RCC2	609587.0 | RCC2, KIAA1470 | Regulator of chromosome condensation 2 | 55920.0 | ENSG00000179051 | nan | nan
chr1	ARHGEF10L	612494.0 | ARHGEF10L, GRINCHGEF, KIAA1626 | RHO guanine nucleotide exchange factor 10-like protein | 55160.0 | ENSG00000074964 | nan | nan
chr1	PAX7	167410.0 | PAX7, RMS2, CMYO19 | Paired box gene 7 | 5081.0 | ENSG00000009709 | fused with FKHR in rhabdomyosarcoma | Congenital myopathy 19, 618578 (3), Autosomal recessive; Rhabdomyosarcoma 2, alveolar, 268220 (3), Somatic mutation
chr1	TAS1R2	606226.0 | TAS1R2, T1R2 | Taste receptor type 1, member 2 | 80834.0 | ENSG00000179002 | nan | nan
chr1	ALDH4A1	606811.0 | ALDH4A1, ALDH4, P5CDH | Aldehyde dehydrogenase 4 family, member A1 (delta-1-pyrroline 5-carboxylate dehydrogenase) | 8659.0 | ENSG00000159423 | nan | Hyperprolinemia, type II, 239510 (3), Autosomal recessive
chr1	UBR4	609890.0 | UBR4, ZUBR1, RBAF600, KIAA1307 | Ubiquitin protein ligase E3 component n-recognin 4 | 23352.0 | ENSG00000127481 | nan | nan
chr1	EMC1	616846.0 | EMC1, KIAA0090, CAVIPMR | Endoplasmic reticulum membrane protein complex, subunit 1 | 23065.0 | ENSG00000127463 | nan | Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3), Autosomal recessive
chr1	MRTO4	620476.0 | MRTO4, MRT4 | MRT4 homolog, ribosome maturation factor | 51154.0 | ENSG00000053372 | nan | nan
chr1	AKR7L	608478.0 | AKR7A4, AFAR3 | Aldo-keto reductase family 7, member A4 | 246181.0 | ENSG00000211454 | nan | nan
chr1	AKR7A3	608477.0 | AKR7A3, AFAR2 | Aldo-keto reductase family 7, member A3 | 22977.0 | ENSG00000162482 | nan | nan
chr1	AKR7A2	603418.0 | AKR7A2, AKR7, AFAR | Aldo-keto reductase family 7, member A2 | 8574.0 | ENSG00000053371 | pseudogenes on Xq25 and 1p12 | nan
chr1	SLC66A1	614760.0 | SLC66A2, PQLC2 | Solute carrier family 66 member 1 | 54896.0 | ENSG00000040487 | nan | nan
chr1	CAPZB	601572.0 | CAPZB, CAPPB | Capping protein (actin filament) muscle Z-line, beta | 832.0 | ENSG00000077549 | nan | nan
chr1	MICOS10	616574.0 | MICOS10, MINOS1, MIO10, MIC10 | Mitochondrial contact site and cristae organizing system, 10kD subunit | 440574.0 | ENSG00000173436 | nan | nan
chr1	NBL1	600613.0 | D1S1733E, DAN | Differential-screening-selected gene aberrant in neuroblastoma | 4681.0 | ENSG00000158747 | aberrant in some neuroblastomas | nan
chr1	HTR6	601109.0 | HTR6 | 5-hydroxytryptamine (serotonin) receptor-6 | 3362.0 | ENSG00000158748 | nan | nan
chr1	RNF186	617163.0 | RNF186 | Ring finger protein 186 | 54546.0 | ENSG00000178828 | nan | nan
chr1	OTUD3	611758.0 | OTUD3, KIAA0459 | OTU domain-containing protein 3 | 23252.0 | ENSG00000169914 | nan | nan
chr1	PLA2G2E	618320.0 | PLA2G2E | Secretory phospholipase A2, group IIE | 30814.0 | ENSG00000188784 | nan | nan
chr1	PLA2G2A	172411.0 | PLA2G2A, PLA2B, PLA2L, MOM1 | Phospholipase A2, group IIA, platelets, synovial fluid | 5320.0 | ENSG00000188257 | germline mutation identified in 1 CRC patient | {?Colorectal cancer, susceptibility to}, 114500 (3), Somatic mutation, Autosomal dominant
chr1	PLA2G5	601192.0 | PLA2G5, FRFB | Phospholipase A2, group V | 5322.0 | ENSG00000127472 | nan | [Fleck retina, familial benign], 228980 (3), Autosomal recessive
chr1	B6QTL1	612957.0 | B6QTL1 | Vitamin B6 plasma level QTL 1 | 100302718.0 | nan | associated with rs4654748 | {Vitamin B6 plasma level QTL 1}, 612957 (2)
chr1	BFIS4	612627.0 | BFIS4, BFIC4 | Seizures, benign familial infantile, 4 | 100271922.0 | nan | between D1S2864 and D1S2830 | Seizures, benign familial infantile, 4, 612627 (2)
chr1	PLA2G2D	605630.0 | PLA2G2D, SPLASH | Phospholipase A2, group IID | 26279.0 | ENSG00000117215 | nan | nan
chr1	PLA2G2F	616793.0 | PLA2G2F | Phospholipase A2, group IIf | 64600.0 | ENSG00000158786 | nan | nan
chr1	UBXN10	616783.0 | UBXN10 | UBX domain protein 10 | 127733.0 | ENSG00000162543 | nan | nan
chr1	CAMK2N1	614986.0 | CAMK2N1 | Calcium/calmodulin-dependent protein kinase II inhibitor 1 | 55450.0 | ENSG00000162545 | nan | nan
chr1	MUL1	612037.0 | MUL1, MULAN, C1orf166 | Mitochondrial ubiquitin ligase activator of NFKB1 | 79594.0 | ENSG00000090432 | nan | nan
chr1	CDA	123920.0 | CDA | Cytidine deaminase | 978.0 | ENSG00000158825 | nan | nan
chr1	PINK1	608309.0 | PINK1, PARK6 | PTEN-induced putative kinase 1 | 65018.0 | ENSG00000158828 | nan | Parkinson disease 6, early onset, 605909 (3), Autosomal recessive
chr1	DDOST	602202.0 | DDOST, OST, OST48, CDG1R | Dolichyl-diphosphooligosaccharide-protein glycosyltransferase | 1650.0 | ENSG00000244038 | nan | Congenital disorder of glycosylation, type Ir, 614507 (3), Autosomal recessive
chr1	KIF17	605037.0 | KIF17, KIAA1405 | Kinesin family member 17 | 57576.0 | ENSG00000117245 | nan | nan
chr1	HP1BP3	616072.0 | HP1BP3, HP1BP74 | Heterochromatin protein 1-binding protein 3 | 50809.0 | ENSG00000127483 | nan | nan
chr1	EIF4G3	603929.0 | EIF4G3, EIF4GII | Eukaryotic translation initiation factor 4-gamma, 3 | 8672.0 | ENSG00000075151 | nan | nan
chr1	ECE1	600423.0 | ECE1 | Endothelin converting enzyme 1 | 1889.0 | ENSG00000117298 | mutation identified in 1 HCAD patient | {Hypertension, essential, susceptibility to}, 145500 (3), Multifactorial; ?Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 (3), Autosomal dominant
chr1	NBPF3	612992.0 | NBPF3 | Neuroblastoma breakpoint family, member 3 | 84224.0 | ENSG00000142794 | nan | nan
chr1	ALPL	171760.0 | ALPL, HOPS, TNSALP, HPPA, HPPO, HPPI, HPPC | Alkaline phosphatase, liver/bone/kidney | 249.0 | ENSG00000162551 | nan | Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant
chr1	RAP1GAP	600278.0 | RAP1GA1 | RAP1, GTPase activating protein 1 | 5909.0 | ENSG00000076864 | nan | nan
chr1	USP48	617445.0 | USP48, USP31, DFNA85 | Ubiquitin-specific peptidase 48 | 84196.0 | ENSG00000090686 | nan | Deafness, autosomal dominant 85, 620227 (3), Autosomal dominant
chr1	HSPG2	142461.0 | HSPG2, PLC, SJS, SJA, SJS1 | Heparan sulfate proteoglycan of basement membrane (perlecan) | 3339.0 | ENSG00000142798 | nan | Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive
chr1	CELA3B	618694.0 | CELA3B | Chymotrypsin-like elastase 3A | 23436.0 | ENSG00000219073 | distal to CELA3A | nan
chr1	CELA3A	618693.0 | CELA3A | Chymotrypsin-like elastase 3A | 10136.0 | ENSG00000142789 | proximal to CELA3B | nan
chr1	CDC42	116952.0 | CDC42, TKS | Cell division cycle 42 (GTP-binding protein, 25kD) | 998.0 | ENSG00000070831 | nan | Takenouchi-Kosaki syndrome, 616737 (3), Autosomal dominant
chr1	WNT4	603490.0 | WNT4, SERKAL | Wingless-type MMTV integration site family, member 4 | 54361.0 | ENSG00000162552 | mutation identified in 1 SERKAL family | ?SERKAL syndrome, 611812 (3), Autosomal recessive; Mullerian aplasia and hyperandrogenism, 158330 (3), Autosomal dominant
chr1	ZBTB40	612106.0 | ZBTB40, KIAA0478 | Zinc finger- and BTB domain-containing protein 40 | 9923.0 | ENSG00000184677 | nan | nan
chr1	EPHA8	176945.0 | EPHA8, EEK, HEK3 | Ephrin receptor EphA8 (eph- and elk-related kinase) | 2046.0 | ENSG00000070886 | nan | nan
chr1	C1QA	120550.0 | C1QA, C1QD1 | Complement component 1, q subcomponent, A chain | 712.0 | ENSG00000173372 | nan | C1q deficiency 1, 613652 (3), Autosomal recessive
chr1	C1QC	120575.0 | C1QC, C1QG, C1QD3 | Complement component 1, q subcomponent, C chain | 714.0 | ENSG00000159189 | nan | C1q deficiency 3, 620322 (3), Autosomal recessive
chr1	C1QB	120570.0 | C1QB, C1QD2 | Complement component 1, q subcomponent, B chain | 713.0 | ENSG00000173369 | nan | C1q deficiency 2, 620321 (3), Autosomal recessive
chr1	EPHB2	600997.0 | EPHB2, EPHT3, DRT, ERK, PCBC, CAPB, BDPLT22 | eph tyrosine kinase 3 (ephrin receptor EphB2) | 2048.0 | ENSG00000133216 | mutation identified in 1 BDPLT22 family | ?Bleeding disorder, platelet-type, 22, 618462 (3), Autosomal recessive; {Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)
chr1	KDM1A	609132.0 | KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF, AIMAH3 | Lysine demethylase 1A | 23028.0 | ENSG00000004487 | nan | Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3), Autosomal dominant; {ACTH-independent macronodular adrenal hyperplasia 3}, 620990 (3), Autosomal dominant
chr1	LUZP1	601422.0 | LUZP1 | Leucine zipper protein 1 | 7798.0 | ENSG00000169641 | nan | nan
chr1	HTR1D	182133.0 | HTR1D | 5-hydroxytryptamine (serotonin) receptor-1D | 3352.0 | ENSG00000179546 | nan | nan
chr1	HNRNPR	607201.0 | HNRPR, HNRNPR, NEDDFSB | Heterogeneous nuclear ribonucleoprotein R | 10236.0 | ENSG00000125944 | nan | Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities, 620073 (3), Autosomal dominant
chr1	ZNF436	611703.0 | ZNF436, KIAA1710 | Zinc finger protein 436 | 80818.0 | ENSG00000125945 | nan | nan
chr1	TCEA3	604128.0 | TCEA3 | Transcription elongation factor A, 3 | 6920.0 | ENSG00000204219 | nan | nan
chr1	ASAP3	616594.0 | ASAP3, UPLC1, CENTB6, DDEFL1, ACAP4 | ARF GTPase-activating protein with SH3 domain, ankyrin repeat, and PH domain 3 | 55616.0 | ENSG00000088280 | nan | nan
chr1	E2F2	600426.0 | E2F2 | E2F transcription factor 2 | 1870.0 | ENSG00000007968 | nan | nan
chr1	ID3	600277.0 | ID3 | Inhibitor of DNA binding 3, dominant negative, helix-loop-helix protein | 3399.0 | ENSG00000117318 | nan | nan
chr1	MDS2	607305.0 | MDS2 | Myelodysplasia syndrome gene 2 | 259283.0 | ENSG00000197880 | fused with ETV6 in myelodysplastic syndrome | nan
chr1	RPL11	604175.0 | RPL11, DBA7 | Ribosomal protein L11 | 6135.0 | ENSG00000142676 | nan | Diamond-Blackfan anemia 7, 612562 (3), Autosomal dominant
chr1	ELOA	600786.0 | TCEB3 | Transcription elongation factor B (SIII), polypeptide 3 (110kD, elongin A) | 6924.0 | ENSG00000011007 | nan | nan
chr1	PITHD1	618784.0 | PITHD1, C1orf128 | PITH domain containing 1 | 57095.0 | ENSG00000057757 | nan | nan
chr1	LYPLA2	616143.0 | LYPLA2, APT2 | Lysophospholipase II | 11313.0 | ENSG00000011009 | nan | nan
chr1	GALE	606953.0 | GALE, THC13 | UDP galactose-4-epimerase | 2582.0 | ENSG00000117308 | nan | Thrombocytopenia 13, syndromic, 620776 (3), Autosomal recessive; Galactose epimerase deficiency, 230350 (3), Autosomal recessive
chr1	HMGCL	613898.0 | HMGCL | 3-hydroxy-3-methylglutaryl-Coenzyme A lyase | 3155.0 | ENSG00000117305 | nan | HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive
chr1	FUCA1	612280.0 | FUCA1 | Fucosidase, alpha-L- 1, tissue | 2517.0 | ENSG00000179163 | 8cM distal to RH; pseudogene on 2q31-q32 | Fucosidosis, 230000 (3), Autosomal recessive
chr1	CNR2	605051.0 | CNR2, CB2, CX5 | Cannabinoid receptor 2 | 1269.0 | ENSG00000188822 | nan | nan
chr1	PNRC2	611882.0 | PNRC2 | Proline-rich nuclear receptor coactivator 2 | 55629.0 | ENSG00000189266 | nan | nan
chr1	SRSF10	605221.0 | SRSF10, FUSIP1, TASR, TASR1, TASR2 | Splicine factor, serine/arginine-rich, 10 | 10772.0 | ENSG00000188529 | pseudogenes on chr. 9, 12, 20 | nan
chr1	MYOM3	616832.0 | MYOM3 | Myomesin 3 | 127294.0 | ENSG00000142661 | nan | nan
chr1	IL22RA1	605457.0 | IL22RA1, IL22R1 | Interleukin 22 receptor, alpha-1 | 58985.0 | ENSG00000142677 | nan | nan
chr1	IFNLR1	607404.0 | IFNLR1, IL28RA | Interferon, lambda receptor 1 | 163702.0 | ENSG00000185436 | nan | nan
chr1	GRHL3	608317.0 | GRHL3, SOM, TFCP2L4, VWS2 | Grainyhead-like 3 | 57822.0 | ENSG00000158055 | nan | van der Woude syndrome 2, 606713 (3), Autosomal dominant
chr1	STPG1	615826.0 | STPG1, MAPO2, C1orf201 | Sperm-tail PG-rich repeat-containing protein 1 | 90529.0 | ENSG00000001460 | nan | nan
chr1	NIPAL3	620034.0 | NIPAL3, NPAL3 | NIPA-like domain-containing protein 3 | 57185.0 | ENSG00000001461 | nan | nan
chr1	RCAN3	605860.0 | RCAN3, DSCR1L2, MCIP3 | Regulator of calcineurin 3 | 11123.0 | ENSG00000117602 | nan | nan
chr1	SRRM1	605975.0 | SRRM1, SRM160 | Serine/arginine repetitive matrix 1 (ser/arg-related nuclear matrix protein, 160kD) | 10250.0 | ENSG00000133226 | nan | nan
chr1	CLIC4	606536.0 | CLIC4, MTCLIC | Chloride intracellular channel 4 | 25932.0 | ENSG00000169504 | nan | nan
chr1	RUNX3	600210.0 | RUNX3, CBFA3, PEBP2A3, AML2 | Runt-related transcription factor 3 | 864.0 | ENSG00000020633 | nan | nan
chr1	SYF2	607090.0 | SYF2, P29 | SYF2 pre-mRNA splicing factor | 25949.0 | ENSG00000117614 | nan | nan
chr1	RSRP1	620030.0 | RSRP1, C1orf63 | Arginine- and serine-rich protein 1 | 57035.0 | ENSG00000117616 | nan | nan
chr1	RHD	111680.0 | RHD, HDFNRH | Rhesus system D polypeptide | 6007.0 | ENSG00000187010 | nan | {Hemolytic disease of fetus and newborn, RH-induced}, 619462 (3), Isolated cases; [Blood group, RH system], 111690 (3)
chr1	TMEM50A	605348.0 | TMEM50A, SMP1 | Transmembrane protein 50A | 23585.0 | ENSG00000183726 | between RHD and RHCE | nan
chr1	RHCE	111700.0 | RHCE, RHNA | Rhesus system C and E polypeptides | 6006.0 | ENSG00000188672 | nan | Rh-null disease, amorph type, 617970 (3), Autosomal recessive
chr1	MACO1	610301.0 | TMEM57, FLJ10747 | Transmembrane protein 57 | 55219.0 | ENSG00000204178 | nan | nan
chr1	LDLRAP1	605747.0 | LDLRAP1, ARH, FHCB2, FHCB1, FHCL4 | Low density lipoprotein receptor adaptor protein 1 | 26119.0 | ENSG00000157978 | nan | Hypercholesterolemia, familial, 4, 603813 (3), Autosomal recessive
chr1	MAN1C1	616772.0 | MAN1C1 | Mannosidase, alpha, class 1C, member 1 | 57134.0 | ENSG00000117643 | nan | nan
chr1	SELENON	606210.0 | SELENON, SEPN1, SELN, CMYO3 | Selenoprotein N | 57190.0 | ENSG00000162430 | nan | Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive
chr1	MTFR1L	620765.0 | MTFR1L | Mitochondrial fission regulator 1-like protein | 56181.0 | ENSG00000117640 | nan | nan
chr1	AUNIP	620397.0 | AUNIP, AIBP, C1orf135 | Aurora kinase A- and ninein-interacting protein | 79000.0 | ENSG00000127423 | nan | nan
chr1	PAQR7	607779.0 | PAQR7, MPRA, PGLP | Progestin and ADIPOQ receptor family, member 7 | 164091.0 | ENSG00000182749 | nan | nan
chr1	STMN1	151442.0 | STMN1, LAP18, SMN | Stathmin | 3925.0 | ENSG00000117632 | nan | nan
chr1	PAFAH2	602344.0 | PAFAH2 | Platelet-activating factor acetylhydrolase 2 | 5051.0 | ENSG00000158006 | nan | nan
chr1	EXTL1	601738.0 | EXTL1 | Exostosin-like 1 | 2134.0 | ENSG00000158008 | nan | nan
chr1	SLC30A2	609617.0 | SLC30A2, ZNT2, TNZD | Solute carrier family 30 (zinc transporter), member 2 | 7780.0 | ENSG00000158014 | nan | Zinc deficiency, transient neonatal, 608118 (3), Autosomal dominant
chr1	TRIM63	606131.0 | TRIM63, RNF28, SMRZ, MURF1 | Tripartite motif containing 63 | 84676.0 | ENSG00000158022 | nan | nan
chr1	PDIK1L	610785.0 | PDIK1L | PDLIM1-interacting kinase 1-like | 149420.0 | ENSG00000175087 | nan | nan
chr1	ZNF593	616698.0 | ZNF593, ZT86 | Zinc finger protein 593 | 51042.0 | ENSG00000142684 | nan | nan
chr1	CNKSR1	603272.0 | CNKSR1, CNK1 | Connector enhancer of KSR 1 | 10256.0 | ENSG00000142675 | nan | nan
chr1	CATSPER4	609121.0 | CATSPER4 | Cation channel, sperm-associated, 4 | 378807.0 | ENSG00000188782 | nan | nan
chr1	CEP85	618898.0 | CEP85, CCDC21 | Centrosomal protein, 85kD | 64793.0 | ENSG00000130695 | nan | nan
chr1	SH3BGRL3	615679.0 | SH3BGRL3 | SH3 domain-binding glutamic acid-rich protein-like protein 3 | 83442.0 | ENSG00000142669 | nan | nan
chr1	UBXN11	609151.0 | UBXN11, SOC | UBX domain protein 11 | 91544.0 | ENSG00000158062 | nan | nan
chr1	CD52	114280.0 | CD52, CDW52 | CD52 molecule | 1043.0 | ENSG00000169442 | nan | nan
chr1	CRYBG2	619765.0 | CRYBG2, AIM1L | Crystallin beta-gamma domain-containing protein 2 | 55057.0 | ENSG00000176092 | nan | nan
chr1	ZNF683	616775.0 | ZNF683, HOBIT | Zinc finger protein 683 | 257101.0 | ENSG00000176083 | nan | nan
chr1	LIN28A	611043.0 | LIN28A | lin-28 homolog A | 79727.0 | ENSG00000131914 | nan | nan
chr1	DHDDS	608172.0 | DHDDS, HDS, RP59, DEDSM | Dehydrodolichyl diphosphate synthase | 79947.0 | ENSG00000117682 | mutation identified in 1 CDG1BB patient | Developmental delay and seizures with or without movement abnormalities, 617836 (3), Autosomal dominant; ?Congenital disorder of glycosylation, type 1bb, 613861 (3), Autosomal recessive; Retinitis pigmentosa 59, 613861 (3), Autosomal recessive
chr1	HMGN2	163910.0 | HMGN2, HMG17 | High-mobility group nucleosomal binding protein 2 | 3151.0 | ENSG00000198830 | nan | nan
chr1	RPS6KA1	601684.0 | RPS6KA1, RSK1 | Ribosomal protein S6 kinase A1 | 6195.0 | ENSG00000117676 | nan | nan
chr1	ARID1A	603024.0 | ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2 | AT rich interactive domain 1A, SWI-like | 8289.0 | ENSG00000117713 | nan | Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant
chr1	PIGV	610274.0 | PIGV, HPMRS1 | Phosphatidylinositol glycan, class V | 55650.0 | ENSG00000060642 | nan | Hyperphosphatasia with impaired intellectual development syndrome 1, 239300 (3), Autosomal recessive
chr1	ZDHHC18	620963.0 | ZDHHC18, DHHC18 | Zinc finger DHHC-type palmitoyltransferase 18 | 84243.0 | ENSG00000204160 | nan | nan
chr1	SFN	601290.0 | SFN | Stratifin | 2810.0 | ENSG00000175793 | nan | nan
chr1	GPATCH3	617486.0 | GPATCH3 | G-patch domain-containing protein 3 | 63906.0 | ENSG00000198746 | nan | nan
chr1	NUDC	610325.0 | NUDC | Nuclear distribution C, dynein complex regulator | 10726.0 | ENSG00000090273 | nan | nan
chr1	NR0B2	604630.0 | NR0B2, SHP | Nuclear receptor subfamily 0, group B, member 2 | 8431.0 | ENSG00000131910 | nan | Obesity, mild, early-onset, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant
chr1	KDF1	616758.0 | KDF1, C1orf172, ECTD12 | Keratinocyte differentiation factor 1 | 126695.0 | ENSG00000175707 | mutation identified in 1 ECTD12 family | ?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type, 617337 (3), Autosomal dominant
chr1	TRNP1	616824.0 | TRNP1 | TMF1-regulated nuclear protein 1 | 388610.0 | ENSG00000253368 | nan | nan
chr1	TENT5B	619069.0 | TENT5B, FAM46 | Terminal nucleotidyltransferase 5B | 115572.0 | ENSG00000158246 | nan | nan
chr1	SLC9A1	107310.0 | SLC9A1, NHE1, APNH, LIKNS | Solute carrier family 9 (sodium/hydrogen exchanger), member 1 (antiporter, Na+/H+, amiloride sensitive) | 6548.0 | ENSG00000090020 | nan | Lichtenstein-Knorr syndrome, 616291 (3), Autosomal recessive
chr1	WDTC1	619763.0 | WDTC1, ADP | WD and tetratricopeptide repeats protein 1 | 23038.0 | ENSG00000142784 | nan | nan
chr1	TMEM222	619469.0 | TMEM222, C1orf160, NEDMOSBA | Transmembrane protein 222 | 84065.0 | ENSG00000186501 | nan | Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities, 619470 (3), Autosomal recessive
chr1	SYTL1	608042.0 | SYTL1, SLP1, JFC1 | Synaptotagmin-like protein 1 | 84958.0 | ENSG00000142765 | nan | nan
chr1	MAP3K6	604468.0 | MAP3K6, MAPKKK6, ASK2 | Mitogen-activated protein kinase kinase kinase 6 | 9064.0 | ENSG00000142733 | nan | nan
chr1	FCN3	604973.0 | FCN3, HAKA1 | Ficolin 3 | 8547.0 | ENSG00000142748 | nan | Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive
chr1	GPR3	600241.0 | GPR3 | G protein-coupled receptor-3 | 2827.0 | ENSG00000181773 | nan | nan
chr1	WASF2	605875.0 | WASF2, WAVE2, SCAR2 | WAS protein family member 2 | 10163.0 | ENSG00000158195 | ?pseudogene on Xp11.21 | nan
chr1	AHDC1	615790.0 | AHDC1, XIGIS, MRD25 | AT-hook DNA-binding motif-containing protein 1 | 27245.0 | ENSG00000126705 | nan | Xia-Gibbs syndrome, 615829 (3), Autosomal dominant
chr1		617930.0 | C1DELp35, DEL1p35 | Chromosome 1p35 deletion syndrome | nan | nan | SRO 1.03 Mb containing 23 genes | Chromosome 1p35 deletion syndrome, 617930 (4), Autosomal dominant
chr1	EBVS1	132850.0 | EBVS1 | Epstein-Barr virus integration site | 1888.0 | nan | nan | nan
chr1	FGR	164940.0 | FGR, SRC2 | Oncogene FGR | 2268.0 | ENSG00000000938 | same as SRC2 | nan
chr1	IFI6	147572.0 | G1P3, IFI616 | Interferon, alpha-inducible protein (clone IFI-6-16) | 2537.0 | ENSG00000126709 | nan | nan
chr1	STX12	606892.0 | STX12, STX13 | Syntaxin 12 | 23673.0 | ENSG00000117758 | nan | nan
chr1	PPP1R8	602636.0 | PPP1R8, NIPP1, ARD1 | Protein phosphatase-1, regulatory subunit-8 | 5511.0 | ENSG00000117751 | nan | nan
chr1	SCARNA1	620811.0 | SCARNA1 | Small cajal body-specific RNA 1 | 677774.0 | ENSG00000252947 | nan | nan
chr1	THEMIS2	617856.0 | THEMIS2, C1orf38, ICB1 | Thymocyte selection-associated protein family, member 2 | 9473.0 | ENSG00000130775 | nan | nan
chr1	RPA2	179836.0 | RPA2 | Replication protein A2, 32kD | 6118.0 | ENSG00000117748 | nan | nan
chr1	SMPDL3B	617737.0 | SMPDL3B, ASML3B | Sphingolyelin phosphodiesterase, acid-like, 3B | 27293.0 | ENSG00000130768 | nan | nan
chr1	XKR8	619940.0 | XKR8 | XK-related protein 8 | 55113.0 | ENSG00000158156 | nan | nan
chr1	EYA3	601655.0 | EYA3 | EYA transcriptional coactivator and phosphatase 3 | 2140.0 | ENSG00000158161 | nan | nan
chr1	PTAFR	173393.0 | PTAFR | Platelet-activating factor receptor | 5724.0 | ENSG00000169403 | nan | nan
chr1	ATP5IF1	614981.0 | ATP1F1, IF1 | ATPase inhibitory factor 1 | 93974.0 | ENSG00000130770 | nan | nan
chr1	SESN2	607767.0 | SEST2, HI95 | Sestrin 2 | 83667.0 | ENSG00000130766 | nan | nan
chr1	MED18	612384.0 | MED18 | Mediator complex subunit 18 | 54797.0 | ENSG00000130772 | nan | nan
chr1	PHACTR4	608726.0 | PHACTR4 | Phosphatase and actin regulator 4 | 65979.0 | ENSG00000204138 | nan | nan
chr1	SNHG3	603238.0 | RNU17D, U17HG | RNA, U17d small nucleolar | 8420.0 | ENSG00000242125 | nan | nan
chr1	RCC1	179710.0 | CHC1, RCC1 | Regulator of chromosome condensation | 1104.0 | ENSG00000180198 | nan | nan
chr1	SNORA73A	180645.0 | RNU17A, RNE1 | RNA, U17a small nucleolar | 6080.0 | ENSG00000274266 | in IVS1 of CHC1 | nan
chr1	SNORA73B	603239.0 | RNU17B | RNA, U17b small nucleolar | 26768.0 | ENSG00000200087 | nan | nan
chr1	TRNAU1AP	619597.0 | TRNAU1AP | tRNA selenocysteine 1-associated protein 1 | 54952.0 | ENSG00000180098 | nan | nan
chr1	TAF12	600773.0 | TAF12 | TAF12 RNA polymerase II, TATA box-binding protein-associated factor, 20kD | 6883.0 | ENSG00000120656 | nan | nan
chr1	GMEB1	604409.0 | GMEB1 | Glucocorticoid modulatory element-binding protein 1 | 10691.0 | ENSG00000162419 | nan | nan
chr1	YTHDF2	610640.0 | YTHDF2 | YTH N6-methyladenosine RNA-binding protein 2 | 51441.0 | ENSG00000198492 | fused with AML1 in t(1;21) | nan
chr1	OPRD1	165195.0 | OPRD1 | Opioid receptor, delta-1 | 4985.0 | ENSG00000116329 | nan | nan
chr1	EPB41	130500.0 | EPB41, EL1 | Erythrocyte surface protein band 4.1 | 2035.0 | ENSG00000159023 | nan | Elliptocytosis-1, 611804 (3), Autosomal recessive, Autosomal dominant
chr1	SRSF4	601940.0 | SRSF4, SFRS4, SRp75 | Splicing factor, serine/arginine-rich, 4 | 6429.0 | ENSG00000116350 | nan | nan
chr1	MECR	608205.0 | MECR, NRBF1, DYTOABG, OPA16 | Mitochondrial trans-2-enoyl-CoA reductase | 51102.0 | ENSG00000116353 | mutation identified in 1 OPA16 family | Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, 617282 (3), Autosomal recessive; Optic atrophy 16, 620629 (3), Autosomal recessive
chr1	PTPRU	602454.0 | PTPRU, GLEPP1, PTPU2 | Protein tyrosine phosphatase, receptor type, U | 10076.0 | ENSG00000060656 | nan | nan
chr1	MATN1	115437.0 | MATN1, CRTM, CMP | Matrilin 1, cartilage matrix protein | 4146.0 | ENSG00000162510 | nan | nan
chr1	LAPTM5	601476.0 | LAPTM5 | Lysosomal-associated multispanning membrane protein-5 | 7805.0 | ENSG00000162511 | nan | nan
chr1	SDC3	186357.0 | SDC3, SYND3, SDCN | Syndecan 3 | 9672.0 | ENSG00000162512 | nan | {Obesity, association with}, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant
chr1	PUM1	607204.0 | PUM1, KIAA0099, SCA47, NEDMSF | Pumilio RNA binding family member 1 | 9698.0 | ENSG00000134644 | nan | Spinocerebellar ataxia 47, 617931 (3), Autosomal dominant; Neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphism, 620719 (3), Autosomal dominant
chr1	NKAIN1	612871.0 | NKAIN1 | Na+/K+ transporting ATPase-interacting 1 | 79570.0 | ENSG00000084628 | nan | nan
chr1	SNRNP40	607797.0 | SNRNP40, SPF38, PRPF8BP | Small nuclear ribonucleoprotein 40kDa (U5) | 9410.0 | ENSG00000060688 | nan | nan
chr1	ZCCHC17	619744.0 | ZCCHC17, PS1D | Zinc finger CCHC domain-containing protein 17 | 51538.0 | ENSG00000121766 | nan | nan
chr1	FABP3	134651.0 | FABP3 | Fatty acid-binding protein 3, muscle | 2170.0 | ENSG00000121769 | nan | nan
chr1	SERINC2	614549.0 | SERINC2 | Serine incorporator 2 | 347735.0 | ENSG00000168528 | nan | nan
chr1	TINAGL1	616064.0 | TINAGL1, TINAGRP | Tubulointerstitial nephritis antigen-like protein 1 | 64129.0 | ENSG00000142910 | nan | nan
chr1	HCRTR1	602392.0 | HCRTR1, OX1R | Hypocretin receptor 1 | 3061.0 | ENSG00000121764 | nan | nan
chr1	PEF1	610033.0 | PEF1 | Peflin | 553115.0 | ENSG00000162517 | nan | nan
chr1	COL16A1	120326.0 | COL16A1 | Collagen XVI, alpha-1 polypeptide | 1307.0 | ENSG00000084636 | nan | nan
chr1	ADGRB2	602683.0 | ADGRB2, BAI2 | Adhesion G protein-coupled receptor B2 | 576.0 | ENSG00000121753 | nan | nan
chr1	SPOCD1	619038.0 | SPOCD1 | SPOC domain-containing protein 1 | 90853.0 | ENSG00000134668 | nan | nan
chr1	PTP4A2	601584.0 | PTP4A2, PTP4A, PRL2, HH13 | Protein tyrosine phosphatase, type 4A, 2 | 8073.0 | ENSG00000184007 | nan | nan
chr1	KHDRBS1	602489.0 | KHDRBS1, SAM68 | KH domain-containing, RNA-binding, signal transduction-associated protein 1 | 10657.0 | ENSG00000121774 | nan | nan
chr1	KPNA6	610563.0 | KPNA6 | Karyopherin alpha-6 | 23633.0 | ENSG00000025800 | nan | nan
chr1	TXLNA	608676.0 | TXLNA, IL14 | Taxilin, alpha | 200081.0 | ENSG00000084652 | nan | nan
chr1	CCDC28B	610162.0 | CCDC28B, MGC1203 | Coiled-coil domain-containing protein 28B | 79140.0 | ENSG00000160050 | nan | {Bardet-Biedl syndrome 1, modifier of}, 209900 (3), Autosomal recessive, Digenic recessive
chr1	TMEM234	620289.0 | TMEM234 | Transmembrane protein 234 | 56063.0 | ENSG00000160055 | nan | nan
chr1	EIF3I	603911.0 | EIF3I, EIF3S2, TRIP1 | Eukaryotic translation initiation factor 3, subunit I | 8668.0 | ENSG00000084623 | pseudogene on 7q32 | nan
chr1	LCK	153390.0 | LCK, IMD22 | Lymphocyte-specific protein tyrosine kinase | 3932.0 | ENSG00000182866 | LCK/TCRB fusion in leukemia | Immunodeficiency 22, 615758 (3), Autosomal recessive
chr1	HDAC1	601241.0 | HDAC1, RPD3L1 | Histone deacetylase-1 | 3065.0 | ENSG00000116478 | nan | nan
chr1	MARCKSL1	602940.0 | MARCKSL1, MLP, MRP | MARCKS-like protein 1 | 65108.0 | ENSG00000175130 | nan | nan
chr1	TSSK3	607660.0 | TSSK3, STK22C, STK22D | Testis-specific serine/threonine kinase 3 | 81629.0 | ENSG00000162526 | nan | nan
chr1	BSDC1	617518.0 | BSDC1 | BSD domain-containing protein 1 | 55108.0 | ENSG00000160058 | nan | nan
chr1	ZBTB8A	618742.0 | ZBTB8A, BOZF1 | Zinc finger- and BTB domain-containing protein 8A | 653121.0 | ENSG00000160062 | nan | nan
chr1	ZBTB8OS	615891.0 | ZBTB8OS, ARCH | Zinc finger- and BTB domain-containing protein 8, opposite strand | 339487.0 | ENSG00000176261 | nan | nan
chr1	RBBP4	602923.0 | RBBP4, RBAP48 | Retinoblastoma-binding protein 4 | 5928.0 | ENSG00000162521 | nan | nan
chr1	SYNC	611750.0 | SYNC1 | Syncoilin 1 | 81493.0 | ENSG00000162520 | nan | nan
chr1	YARS1	603623.0 | YARS1, YARS, CMTDIC, TYRRS, YTS, YRS, IMNEPD2 | Tyrosyl-tRNA synthetase 1 | 8565.0 | ENSG00000134684 | nan | Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant
chr1	S100PBP	611889.0 | S100PBP, S100PBPR | S100P-binding protein | 64766.0 | ENSG00000116497 | nan | nan
chr1	FNDC5	611906.0 | FNDC5, FRCP2 | Fibronectin type III domain-containing protein 5 | 252995.0 | ENSG00000160097 | nan | nan
chr1	HPCA	142622.0 | HPCA, DYT2 | Hippocalcin, 23kD, Ca2+-binding protein | 3208.0 | ENSG00000121905 | nan | Dystonia 2, torsion, autosomal recessive, 224500 (3), Autosomal recessive
chr1	RNF19B	610872.0 | IBRDC3, NKLAM | IBR domain-containing protein 3 | 127544.0 | ENSG00000116514 | nan | nan
chr1	AK2	103020.0 | AK2 | Adenylate kinase-2, mitochondrial | 204.0 | ENSG00000004455 | nan | Reticular dysgenesis, 267500 (3), Autosomal recessive
chr1	AZIN2	608353.0 | AZIN2, ODC1L, KIAA1945 | Antizyme inhibitor 2 | 113451.0 | ENSG00000142920 | nan | nan
chr1	TRIM62	616755.0 | TRIM62, DEAR1 | Tripartite motif-containing protein 62 | 55223.0 | ENSG00000116525 | nan | nan
chr1	A3GALT2	619850.0 | A3GALT2, IGB3S | Alpha-1,3-galactosyltransferase 2 | 127550.0 | ENSG00000184389 | nan | nan
chr1	PHC2	602979.0 | PHC2 | Polyhomeotic homolog 2 | 1912.0 | ENSG00000134686 | nan | nan
chr1	ZSCAN20	611315.0 | ZSCAN20, ZNF31, KOX29 | Zinc finger- and SCAN domain-containing protein 20 | 7579.0 | ENSG00000121903 | nan | nan
chr1	CSMD2	608398.0 | CSMD2, KIAA1884 | Cub and Sushi multiple domains 2 | 114784.0 | ENSG00000121904 | nan | nan
chr1	HMGB4	617285.0 | HMGB4 | High mobility group box 4 | 127540.0 | ENSG00000176256 | nan | nan
chr1	GBD3	609919.0 | GBD3 | Gallbladder disease 3 | 100048906.0 | nan | new D2S255 | Gallbladder disease 3, 609919 (2)
chr1	MACST	613545.0 | MACST | Macrostomia | 100529231.0 | nan | max lod at D1S2797 | Macrostomia, 613545 (2)
chr1	GJB5	604493.0 | GJB5, CX31.1 | Gap junction protein, beta-5 | 2709.0 | ENSG00000189280 | nan | nan
chr1	GJB4	605425.0 | GJB4, CX30.3, EKVP2 | Gap junction protein, beta-4 | 127534.0 | ENSG00000189433 | nan | Erythrokeratodermia variabilis et progressiva 2, 617524 (3), Autosomal dominant
chr1	GJB3	603324.0 | GJB3, CX31, DFNA2B, EKVP1 | Gap junction protein, beta-3 | 2707.0 | ENSG00000188910 | same YAC as GJA4 | Deafness, digenic, GJB2/GJB3, 220290 (3), Autosomal recessive, Digenic dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal recessive, Autosomal dominant; Deafness, autosomal dominant 2B, with or without peripheral neuropathy, 612644 (3), Autosomal dominant
chr1	GJA4	121012.0 | GJA4, CX37 | Gap junction protein, alpha-4, 37kD (connexin 37) | 2701.0 | ENSG00000187513 | nan | nan
chr1	DLGAP3	611413.0 | DLGAP3, SPAPA3 | Discs large-associated protein 3 | 58512.0 | ENSG00000116544 | nan | nan
chr1	ZMYM6	613567.0 | ZMYM6, ZNF258 | Zinc finger, MYM-type 6 | 9204.0 | ENSG00000163867 | nan | nan
chr1	SFPQ	605199.0 | SFPQ, PSF | Splicing factor, proline- and glutamine-rich | 6421.0 | ENSG00000116560 | fusion gene with TFE3 in RCC | nan
chr1	ZMYM4	613568.0 | ZMYM4, ZNF262, KIAA0425 | Zinc finger, MYM-type 4 | 9202.0 | ENSG00000146463 | nan | nan
chr1	KIAA0319L	613535.0 | KIAA0319L, KIAA1837 | KIAA0319-like | 79932.0 | ENSG00000142687 | nan | nan
chr1	NCDN	608458.0 | NCDN, KIAA0607, NEDIES | Neurochondrin | 23154.0 | ENSG00000020129 | nan | Neurodevelopmental disorder with infantile epileptic spasms, 619373 (3), Autosomal dominant
chr1	TFAP2E	614428.0 | TFAP2E | Transcription factor AP2-epsilon | 339488.0 | ENSG00000116819 | nan | nan
chr1	PSMB2	602175.0 | PSMB2 | Proteasome subunit, beta type, 2 | 5690.0 | ENSG00000126067 | nan | nan
chr1	CLSPN	605434.0 | CLSPN | Claspin | 63967.0 | ENSG00000092853 | nan | nan
chr1	AGO4	607356.0 | AGO4, EIF2C4, KIAA1567 | Argonaute RISC component 4 | 192670.0 | ENSG00000134698 | nan | nan
chr1	AGO1	606228.0 | AGO1, EIF2C1, GERP95, EIF2C, NEDLBAS | Argonaute RISC component 1 | 26523.0 | ENSG00000092847 | nan | Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures, 620292 (3), Autosomal dominant
chr1	AGO3	607355.0 | AGO3, EIF2C3 | Argonaute RISC component 3 | 192669.0 | ENSG00000126070 | nan | nan
chr1	TEKT2	608953.0 | TEKT2, TEKTB1 | Tektin 2 | 27285.0 | ENSG00000092850 | nan | nan
chr1	ADPRS	610624.0 | ADPRHL2, ARH3, CONDSIAS | ADP-ribosylhydrolase-like 2 | 54936.0 | ENSG00000116863 | nan | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures, 618170 (3), Autosomal recessive
chr1	COL8A2	120252.0 | COL8A2, FECD1, PPCD2 | Collagen VIII, alpha-2 polypeptide | 1296.0 | ENSG00000171812 | nan | Corneal dystrophy, posterior polymorphous 2, 609140 (3), Autosomal dominant; Corneal dystrophy, Fuchs endothelial, 1, 136800 (3), Autosomal dominant
chr1	TRAPPC3	610955.0 | TRAPPC3, BET3 | Trafficking protein particle complex, subunit 3 | 27095.0 | ENSG00000054116 | nan | nan
chr1	THRAP3	603809.0 | THRAP3, TRAP150 | Thyroid hormone receptor-associated protein 3 | 9967.0 | ENSG00000054118 | nan | nan
chr1	STK40	609437.0 | STK40, SHIK | Serine/threonine protein kinase 40 | 83931.0 | ENSG00000196182 | nan | nan
chr1	LSM10	617909.0 | LSM10 | LSM10, U7 small nuclear RNA-associated protein | 84967.0 | ENSG00000181817 | nan | nan
chr1	OSCP1	608854.0 | NOR1 | Oxidored-nitro domain-containing protein 1 | 127700.0 | ENSG00000116885 | nan | nan
chr1	MRPS15	611979.0 | MRPS15 | Mitochondrial ribosomal protein S15 | 64960.0 | ENSG00000116898 | nan | nan
chr1	CSF3R	138971.0 | CSF3R, GCSFR, SCN7 | Colony-stimulating factor-3 receptor (granulocyte) | 1441.0 | ENSG00000119535 | mutation identified in 1 HNTP family | Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3), Autosomal recessive; ?Neutrophilia, hereditary, 162830 (3), Autosomal dominant
chr1	GRIK3	138243.0 | GRIK3, GLUR7 | Glutamate receptor, ionotropic, kainate 3 | 2899.0 | ENSG00000163873 | nan | nan
chr1	ZC3H12A	610562.0 | ZC3H12A, MCPIP, MCPIP1 | Zinc finger CCCH domain-containing protein 12A | 80149.0 | ENSG00000163874 | nan | nan
chr1	MEAF6	611001.0 | MEAF6, C1orf149, EAF6 | MYST/ESA1-associated factor 6 | 64769.0 | ENSG00000163875 | nan | nan
chr1	SNIP1	608241.0 | SNIP1, NEDHCS | SMAD nuclear interacting protein 1 | 79753.0 | ENSG00000163877 | nan | Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures, 614501 (3), Autosomal recessive
chr1	DNALI1	602135.0 | DNALI1, P28, SPGF83 | Dynein, axonemal, light intermediate polypeptide 1 | 7802.0 | ENSG00000163879 | nan | Spermatogenic failure 83, 620354 (3), Autosomal recessive
chr1	GNL2	609365.0 | GNL2, NGP1 | Guanine nucleotide-binding protein-like 2 | 29889.0 | ENSG00000134697 | nan | nan
chr1	RSPO1	609595.0 | RSPO1, FLJ40906 | R-spondin 1 | 284654.0 | ENSG00000169218 | nan | Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3), Autosomal recessive; Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3), Autosomal recessive
chr1	AIRIM	614799.0 | AIRIM, C1orf109 | AFG2 interacting ribosome maturation factor | 54955.0 | ENSG00000116922 | nan | nan
chr1	CDCA8	609977.0 | CDCA8 | Cell division cycle-associated protein 8 | 55143.0 | ENSG00000134690 | possible pseudogene on chr.7 | nan
chr1	EPHA10	611123.0 | EPHA10, DFNA88 | Ephrin receptor EphA10 | 284656.0 | ENSG00000183317 | mutation identified in 1 DFNA88 family | ?Deafness, autosomal dominant 88, 620283 (3), Autosomal dominant
chr1	MANEAL	620919.0 | MANEAL | Mannosidase, endo-alpha-like | 149175.0 | ENSG00000185090 | nan | nan
chr1	YRDC	612276.0 | YRDC, IRIP, GAMOS10 | YRDC domain-containing protein | 79693.0 | ENSG00000196449 | nan | Galloway-Mowat syndrome 10, 619609 (3), Autosomal recessive
chr1	MTF1	600172.0 | MTF1 | Metal-regulatory transcription factor 1 | 4520.0 | ENSG00000188786 | nan | nan
chr1	INPP5B	147264.0 | INPP5B | Inositol polyphosphate-5-phosphatase, 75kD | 3633.0 | ENSG00000204084 | nan | nan
chr1	SF3A3	605596.0 | SF3A3, SF3A60, SAP61, PRP9 | Splicing factor 3A, subunit 3 | 10946.0 | ENSG00000183431 | nan | nan
chr1	FHL3	602790.0 | FHL3, SLIM2 | Four-and-a-half LIM domains-3 | 2275.0 | ENSG00000183386 | nan | nan
chr1	UTP11	609440.0 | UTP11L, CGI94 | UTP11-like protein | 51118.0 | ENSG00000183520 | nan | nan
chr1	POU3F1	602479.0 | POU3F1 | POU domain, class 3, transcription factor-1 | 5453.0 | ENSG00000185668 | nan | nan
chr1	RRAGC	608267.0 | RRAGC, RAGC, LNGODS | RAS-related GTP-binding protein C | 64121.0 | ENSG00000116954 | nan | Long-Olsen-Distelmaier syndrome, 620609 (3), Autosomal dominant
chr1	MYCBP	606535.0 | MYCBP | MYC-binding protein | 26292.0 | ENSG00000214114 | nan | nan
chr1	GJA9	611923.0 | GJA9, CX59 | Gap junction protein, alpha-9 | 81025.0 | ENSG00000131233 | nan | nan
chr1	RHBDL2	608962.0 | RHBDL2 | Rhomboid-like 2 | 54933.0 | ENSG00000158315 | nan | nan
chr1	AKIRIN1	615164.0 | AKIRIN1 | Akirin 1 | 79647.0 | ENSG00000174574 | nan | nan
chr1	NDUFS5	603847.0 | NDUFS5 | NADH-ubiquinone oxidoreductase subunit S5 | 4725.0 | ENSG00000168653 | nan | nan
chr1	MACF1	608271.0 | MACF1, ACF7, KIAA1251, LIS9 | Microtubule-actin cross-linking factor 1 | 23499.0 | ENSG00000127603 | nan | Lissencephaly 9 with complex brainstem malformation, 618325 (3), Autosomal dominant
chr1	BMP8A	620847.0 | BMP8A | Bone morphogenetic protein 8A | 353500.0 | ENSG00000183682 | nan | nan
chr1	PABPC4	603407.0 | PABPC4, PABP4, IPABP, APP1 | Polyadenylate-binding protein, cytoplasmic, 4 | 8761.0 | ENSG00000090621 | nan | nan
chr1	HEYL	609034.0 | HEYL | HES-related bHLH transcription factor with YRPW motif-like protein | 26508.0 | ENSG00000163909 | nan | nan
chr1	NT5C1A	610525.0 | NT5C1A, CN1A, CNI, CN1 | 5'-nucleotidase, cytosolic, IA | 84618.0 | ENSG00000116981 | nan | nan
chr1	HPCAL4	619211.0 | HPCAL4, HLP4 | Hippocalcin-like 4 | 51440.0 | ENSG00000116983 | nan | nan
chr1	PPIE	602435.0 | PPIE, CYP33 | Peptidyl-prolyl isomerase E | 10450.0 | ENSG00000084072 | nan | nan
chr1	BMP8B	602284.0 | BMP8B, OP2 | Bone morphogenetic protein-8b (osteogenic protein 2) | 656.0 | ENSG00000116985 | nan | nan
chr1	OXCT2	610289.0 | OXCT2, FLJ0030 | 3-oxoacid CoA transferase 2 | 64064.0 | ENSG00000198754 | nan | nan
chr1	TRIT1	617840.0 | TRIT1, IPT, COXPD35 | tRNA isopentenyltransferase 1 | 54802.0 | ENSG00000043514 | nan | Combined oxidative phosphorylation deficiency 35, 617873 (3), Autosomal recessive
chr1	MYCL	164850.0 | MYCL, LMYC | MYCL protooncogene, bHLH transcription factor | 4610.0 | ENSG00000116990 | nan | nan
chr1	MFSD2A	614397.0 | MFSD2A, NEDMISBA | Major facilitator superfamily domain-containing protein 2A | 84879.0 | ENSG00000168389 | nan | Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain abnormalities, 616486 (3), Autosomal recessive
chr1	CAP1	617801.0 | CAP1 | Cyclase-associated actin cytoskeleton regulatory protein 1 | 10487.0 | ENSG00000131236 | nan | nan
chr1	PPT1	600722.0 | PPT1, CLN1 | Palmitoyl-protein thioesterase 1 | 5538.0 | ENSG00000131238 | nan | Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive
chr1	RLF	180610.0 | RLF | Rearranged L-myc fusion sequence | 6018.0 | ENSG00000117000 | <800kb from MYCL1 | nan
chr1	ZMPSTE24	606480.0 | ZMPSTE24, FACE1, STE24, MADB, RSDM1 | Zinc metalloproteinase STE24 | 10269.0 | ENSG00000084073 | nan | Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy 1, 275210 (3), Autosomal recessive
chr1	COL9A2	120260.0 | COL9A2, EDM2, STL5 | Collagen IX, alpha-2 polypeptide | 1298.0 | ENSG00000049089 | mutation identified in1 STL5 family | Epiphyseal dysplasia, multiple, 2, 600204 (3), Autosomal dominant; ?Stickler syndrome, type V, 614284 (3), Autosomal recessive
chr1	SMAP2	616916.0 | SMAP2, SMAP1L | Small ADP-ribosylation factor GTPase-activating protein 2 | 64744.0 | ENSG00000084070 | nan | nan
chr1	ZFP69	617939.0 | ZFP69, ZNF642 | Zinc finger protein 69 | 339559.0 | ENSG00000187815 | nan | nan
chr1	EXO5	618601.0 | EXO5, C1orf176 | Exonuclease 5 | 64789.0 | ENSG00000164002 | nan | nan
chr1	RIMS3	611600.0 | RIMS3, NIM3, KIAA0137 | Protein regulating synaptic membrane exocytosis 3 | 9783.0 | ENSG00000117016 | nan | nan
chr1	NFYC	605344.0 | NFYC, CBFC | Nuclear transcription factor Y, gamma | 4802.0 | ENSG00000066136 | nan | nan
chr1	MIR30E	619105.0 | MIR30E, MIR30E* | Micro RNA 30E | 407034.0 | ENSG00000198974 | nan | nan
chr1	MIR30C1	615151.0 | MIR30C1 | Micro RNA 30C-1 | 407031.0 | ENSG00000207962 | nan | nan
chr1	KCNQ4	603537.0 | KCNQ4, DFNA2A | Potassium voltage-gated channel, KQT-like subfamily, member 4 | 9132.0 | ENSG00000117013 | nan | Deafness, autosomal dominant 2A, 600101 (3), Autosomal dominant
chr1	CITED4	606815.0 | CITED4 | CBP/P300-interacting transactivator, with glu/asp-rich carboxy terminal domain, 4 | 163732.0 | ENSG00000179862 | nan | nan
chr1	CTPS1	123860.0 | CTPS1, CTPS, IMD24 | Cytidine 5'-triphosphate synthetase 1 | 1503.0 | ENSG00000171793 | nan | Immunodeficiency 24, 615897 (3), Autosomal recessive
chr1	SCMH1	616396.0 | SCMH1 | Scm polycomb group protein homolog 1 | 22955.0 | ENSG00000010803 | nan | nan
chr1	FOXO6	611457.0 | FOXO6 | Forkhead box O6 | 100132074.0 | ENSG00000204060 | nan | nan
chr1	EDN2	131241.0 | EDN2 | Endothelin-2 | 1907.0 | ENSG00000127129 | vasoactive intestinal contractor (VIC) = mouse and rat equivalent | nan
chr1	HIVEP3	606649.0 | HIVEP3, KRC | Human immunodeficiency virus type 1 enhancer-binding protein 3 | 59269.0 | ENSG00000127124 | nan | nan
chr1	GUCA2B	601271.0 | GUCA2B, UGN | Guanylate cyclase activator 2B (uroguanylin) | 2981.0 | ENSG00000044012 | nan | nan
chr1	GUCA2A	139392.0 | GUCA2A, GUCA2 | Guanylate cyclase activator 2A (guanylin 2, intestinal, heat-stable) | 2980.0 | ENSG00000197273 | nan | nan
chr1	FOXJ3	616035.0 | FOXJ3, KIAA1041 | Forkhead box J3 | 22887.0 | ENSG00000198815 | nan | nan
chr1	RIMKLA	618949.0 | RIMKLA, NAAGS2 | Ribosomal modification protein RimK-like family, member A | 284716.0 | ENSG00000177181 | nan | nan
chr1	PPCS	609853.0 | PPCS, CMD2C | Phosphopantothenoylcysteine synthetase | 79717.0 | ENSG00000127125 | nan | Cardiomyopathy, dilated, 2C, 618189 (3), Autosomal recessive
chr1	PPIH	606095.0 | PPIH | Peptidyl-prolyl isomerase H | 10465.0 | ENSG00000171960 | nan | nan
chr1	YBX1	154030.0 | YBX1, NSEP1, YB1, DBPB | Y box binding protein 1 (major histocompatibility complex, class II, Y box-binding protein I) | 4904.0 | ENSG00000065978 | nan | nan
chr1	CLDN19	610036.0 | CLDN19, HOMG5 | Claudin 19 | 149461.0 | ENSG00000164007 | nan | Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive
chr1	P3H1	610339.0 | P3H1, LEPRE1, GROS1, OI8 | Prolyl 3-hydroxylase 1 | 64175.0 | ENSG00000117385 | nan | Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive
chr1	SVBP	617853.0 | SVBP, CCDC23, NEDAHM | Small vasohibin-binding protein | 374969.0 | ENSG00000177868 | nan | Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly, 618569 (3), Autosomal recessive
chr1	ERMAP	609017.0 | ERMAP, SC, RD | Erythroblast membrane-associated protein | 114625.0 | ENSG00000164010 | nan | [Blood group, Scianna system], 111750 (3); [Blood group, Radin], 111620 (3)
chr1	SLC2A1	138140.0 | SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN | Solute carrier family 2 (facilitated glucose transporter), member 1 | 6513.0 | ENSG00000117394 | probably in 1p33 | Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant
chr1	EBNA1BP2	614443.0 | EBNA1BP2, EBP2 | EBNA1-binding protein 2 | 10969.0 | ENSG00000117395 | nan | nan
chr1	CFAP57	614259.0 | CFAP57, WDR65, SPGF95 | Cilia- and flagella-associated protein 57 | 149465.0 | ENSG00000243710 | nan | Spermatogenic failure 95, 620917 (3), Autosomal recessive
chr1	C1orf210	620582.0 | C1orf210, TEMP | Chromosome 1 open reading frame 210 | 149466.0 | ENSG00000253313 | nan | nan
chr1	TIE1	600222.0 | TIE, JTK14, TIE1, LMPHM11 | Tyrosine kinase with immunoglobulin and epidermal growth factor homology domains | 7075.0 | ENSG00000066056 | nan | Lymphatic malformation 11, 619401 (3), Autosomal dominant
chr1	MPL	159530.0 | MPL, TPOR, MPLV, THCYT2 | MPL protooncogene, thrombopoietin receptor | 4352.0 | ENSG00000117400 | nan | Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Amegakaryocytic thrombocytopenia, congenital, 1, 604498 (3), Autosomal recessive; Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant
chr1	CDC20	603618.0 | CDC20, OZEMA14 | Cell division cycle 20 | 991.0 | ENSG00000117399 | pseudogene on 9q13-q21 | Oocyte/zygote/embryo maturation arrest 14, 620276 (3), Autosomal recessive
chr1	ELOVL1	611813.0 | ELOVL1, SSC1, IKSHD | Elongation of very long chain fatty acids-like 1 | 64834.0 | ENSG00000066322 | nan | Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies, 618527 (3), Autosomal recessive, Autosomal dominant
chr1	MED8	607956.0 | MED8 | Mediator complex subunit 8 | 112950.0 | ENSG00000159479 | nan | nan
chr1	SZT2	615463.0 | SZT2, KIAA0467, DEE18 | SZT2 subunit of KICSTOR complex | 23334.0 | ENSG00000198198 | nan | Developmental and epileptic encephalopathy 18, 615476 (3), Autosomal recessive
chr1	HYI	619128.0 | HYI | Hydroxypyruvate isomerase | 81888.0 | ENSG00000178922 | nan | nan
chr1	PTPRF	179590.0 | PTPRF, LAR, BNAH2 | Protein tyrosine phosphatase, receptor type, f polypeptide | 5792.0 | ENSG00000142949 | mutation identified in 1 BNAH2 family | ?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3), Autosomal recessive
chr1	KDM4A	609764.0 | KDM4A, JMJD2A, JHDM3A, KIAA0677 | Lysine demethylase 4A | 9682.0 | ENSG00000066135 | nan | nan
chr1	PTOS1	178300.0 | PTOS1 | Ptosis, congenital 1, autosomal dominant | 5765.0 | nan | nan | Ptosis, hereditary congenital, 1, 178300 (2), Autosomal dominant
chr1	ST3GAL3	606494.0 | ST3GAL3, SIAT6, ST3GALII, MRT12, DEE15 | ST3 beta-galactoside alpha-2,3-sialyltransferase 3 | 6487.0 | ENSG00000126091 | nan | Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive
chr1	ARTN	603886.0 | ARTN | Artemin | 9048.0 | ENSG00000117407 | nan | nan
chr1	IPO13	610411.0 | IPO13, IMP13, KIAA0724, RANBP13 | Importin 13 | 9670.0 | ENSG00000117408 | nan | nan
chr1	DPH2	603456.0 | DPH2, DPH2L2, DEDSSH2 | Diphthamide biosynthesis protein 2 | 1802.0 | ENSG00000132768 | nan | Developmental delay with short stature, dysmorphic facial features, and sparse hair 2, 620062 (3), Autosomal recessive
chr1	ATP6V0B	603717.0 | ATP6V0B, ATP6F | ATPase, H+ transporting, V0 subunit b | 533.0 | ENSG00000117410 | nan | nan
chr1	B4GALT2	604013.0 | B4GALT2 | Beta-1,4-galactosyltransferase 2 | 8704.0 | ENSG00000117411 | nan | nan
chr1	SLC6A9	601019.0 | SLC6A9, GLYT1, GCENSG | Solute carrier family 6 (neurotransmitter transporter, glycine), member 9 | 6536.0 | ENSG00000196517 | nan | Glycine encephalopathy with normal serum glycine, 617301 (3), Autosomal recessive
chr1	KLF17	609602.0 | KLF717, ZLF393 | Kruppel-like factor 17 | 128209.0 | ENSG00000171872 | nan | nan
chr1	DMAP1	605077.0 | DNMAP1, DMAP1 | DNMT1-associated protein 1 | 55929.0 | ENSG00000178028 | nan | nan
chr1	ERI3	609917.0 | PRNPIP, PINT1 | Prion protein-interacting protein | 79033.0 | ENSG00000117419 | nan | nan
chr1	RNF220	616136.0 | RNF220, HLD23 | RING finger protein 220 | 55182.0 | ENSG00000187147 | nan | Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy, 619688 (3), Autosomal recessive
chr1	TMEM53	619722.0 | TMEM53, NET4, CTDI | Transmembrane protein 53 | 79639.0 | ENSG00000126106 | nan | Craniotubular dysplasia, Ikegawa type, 619727 (3), Autosomal recessive
chr1	RNU5F-1	620363.0 | RNU5F-1, RNU5F | RNA, U5F small nuclear 1 | 26828.0 | ENSG00000199377 | nan | nan
chr1	RNU5D-1	620361.0 | RNU5D-1, RNU5D | RNA, U5D small nuclear 1 | 26830.0 | ENSG00000200169 | nan | nan
chr1	KIF2C	604538.0 | KIF2C, KNSL6, MCAK | Kinesin family, member 2C | 11004.0 | ENSG00000142945 | nan | nan
chr1	RPS8	600357.0 | RPS8 | Ribosomal protein S8 | 6202.0 | ENSG00000142937 | nan | nan
chr1	BEST4	607336.0 | BEST4, VMD2L2 | Bestrophin 4 | 266675.0 | ENSG00000142959 | nan | nan
chr1	PLK3	602913.0 | PLK3, CNK, PRK | Polo-like kinase 3 | 1263.0 | ENSG00000173846 | previously assigned to 8p21 by FISH | nan
chr1	DYNLT4	611713.0 | DYNLT4, TCTEX1D4 | Dynein light chain Tctex-type 4 | 343521.0 | ENSG00000188396 | nan | nan
chr1	PTCH2	603673.0 | PTCH2 | Patched 2 | 8643.0 | ENSG00000117425 | nan | Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)
chr1	EIF2B3	606273.0 | EIF2B3, VWM3 | Eukaryotic translation initiation factor 2B, subunit 3 | 8891.0 | ENSG00000070785 | nan | Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3), Autosomal recessive
chr1	HECTD3	618638.0 | HECTD3 | HECT domain-containing E3 ubiquitin protein ligase 3 | 79654.0 | ENSG00000126107 | nan | nan
chr1	UROD	613521.0 | UROD | Uroporphyrinogen decarboxylase | 7389.0 | ENSG00000126088 | nan | Porphyria, hepatoerythropoietic, 176100 (3), Autosomal recessive, Autosomal dominant; Porphyria cutanea tarda, 176100 (3), Autosomal recessive, Autosomal dominant
chr1	ZSWIM5	620132.0 | ZSWIM5, KIAA1511 | Zinc finger SWIM domain-containing protein 5 | 57643.0 | ENSG00000162415 | nan | nan
chr1	HPDL	618994.0 | HPDL, NEDSWMA, SPG83 | 4-hydroxyphenylpyruvate dioxygenase-like | 84842.0 | ENSG00000186603 | nan | Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive
chr1	MUTYH	604933.0 | MUTYH, MYH | mutY DNA glycosylase | 4595.0 | ENSG00000132781 | nan | Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)
chr1	TOE1	613931.0 | TOE1, PCH7 | Target of EGR1 | 114034.0 | ENSG00000132773 | nan | Pontocerebellar hypoplasia, type 7, 614969 (3), Autosomal recessive
chr1	TESK2	604746.0 | TESK2 | Testis-associated actin-modeling kinase 2 | 10420.0 | ENSG00000070759 | nan | nan
chr1	MMACHC	609831.0 | MMACHC | Metabolism of cobalamin associated C | 25974.0 | ENSG00000132763 | nan | Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive
chr1	PRDX1	176763.0 | PRDX1, PRXI, PAGA, NKEFA | Peroxiredoxin 1 | 5052.0 | ENSG00000117450 | pseudogene PAGB on 9p22 | Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive
chr1	AKR1A1	103830.0 | AKR1A1, ALR | Aldo-keto reductase family 1, member A1 (aldehyde reductase) | 10327.0 | ENSG00000117448 | nan | nan
chr1	NASP	603185.0 | NASP | Nuclear autoantigenic sperm protein | 4678.0 | ENSG00000132780 | nan | nan
chr1	IPP	147485.0 | IPP | Intracisternal A particle-promoted polypeptide | 3652.0 | ENSG00000197429 | nan | nan
chr1	MAST2	612257.0 | MAST2, MAST205, KIAA0807 | Microtubule-associated serine/threonine kinase 2 | 23139.0 | ENSG00000086015 | nan | nan
chr1	PIK3R3	606076.0 | PIK3R3 | Phosphatidylinositol 3-kinase, regulatory, 3 | 8503.0 | ENSG00000117461 | nan | nan
chr1	TSPAN1	613170.0 | TSPAN1, NET1 | Tetraspanin 1 | 10103.0 | ENSG00000117472 | nan | nan
chr1	POMGNT1	606822.0 | POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15 | Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase | 55624.0 | ENSG00000085998 | nan | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive
chr1	LURAP1	616129.0 | LURAP1, LRAP35A | Leucine-rich adaptor protein 1 | 541468.0 | ENSG00000171357 | nan | nan
chr1	RAD54L	603615.0 | RAD54L, HR54, HRAD54 | RAD54 like | 8438.0 | ENSG00000085999 | nan | {Breast cancer, invasive ductal}, 114480 (3), Somatic mutation, Autosomal dominant; Adenocarcinoma, colonic, somatic (3); Lymphoma, non-Hodgkin, somatic, 605027 (3)
chr1	LRRC41	618753.0 | LRRC41, MUF1 | Leucine-rich repeat-containing protein 41 | 10489.0 | ENSG00000132128 | nan | nan
chr1	BMND14	612728.0 | BMND14 | Bone mineral density quantitative trait locus 14 | 100294718.0 | nan | associated with rs17131547 | [Bone mineral density QTL 14], 612728 (2)
chr1	CYP4Z2P	618954.0 | CYP4Z2P | Cytochrome P450, family 4, subfamily Z, member 2, pseudogene | 163720.0 | ENSG00000290456 | nan | nan
chr1	FWS	613606.0 | FWS | Forsythe-Wakeling syndrome | 100529224.0 | nan | between rs2354462 and rs718883 | Forsythe-Wakeling syndrome, 613606 (2), Autosomal recessive
chr1	OFC13	613857.0 | OFC13 | Orofacial cleft 13 | 100653367.0 | nan | associated with rs3827730 | Orofacial cleft 13, 613857 (2), Autosomal dominant
chr1		618377.0 | PAINQTL1 | Pain sensitivity quantitative trait locus 1 | nan | nan | deletion identified in 1 PAINQTL1 family | ?Pain sensitivity QTL1, 618377 (4), Autosomal dominant
chr1	SKINT1L	616392.0 | SKINTL, SKINTP | SKINT1-like pseudogene | 391037.0 | nan | nan | nan
chr1	UQCRH	613844.0 | UQCRH, MC3DN11 | Ubiquinol-cytochrome c reductase hinge protein | 7388.0 | ENSG00000173660 | mutation identified in 1 MC3DN11 family | ?Mitochondrial complex III deficiency, nuclear type 11, 620137 (3), Autosomal recessive
chr1	NSUN4	615394.0 | NSUN4 | NOP2/SUN RNA methyltransferase family, member 4 | 387338.0 | ENSG00000117481 | nan | nan
chr1	FAAH	602935.0 | FAAH | Fatty acid amide hydrolase | 2166.0 | ENSG00000117480 | nan | {Drug addiction, susceptibility to}, 606581 (3)
chr1	FAAHP1	618375.0 | FAAHP1, FAAHOUT, LINC00505 | Fatty acid amide hydrolase pseudogene 1 | 729041.0 | nan | nan | nan
chr1	DMBX1	607410.0 | DMBX1, OTX3 | Diencephalon/mesencephalon homeobox 1 | 127343.0 | ENSG00000197587 | nan | nan
chr1	KNCN	611455.0 | KNCN, KINO, L5 | Kinocilin | 148930.0 | ENSG00000162456 | nan | nan
chr1	MKNK1	606724.0 | MKNK1, MNK1 | Mitogen-activated protein kinase-interacting serine/threonine kinase 1 | 8569.0 | ENSG00000079277 | nan | nan
chr1	MOB3C	620804.0 | MOB3C | MOB kinase activator 3C | 148932.0 | ENSG00000142961 | nan | nan
chr1	ATPAF1	608917.0 | ATPAF1, ATP11 | ATP synthase, mitochondrial F1 complex, assembly factor 1 | 64756.0 | ENSG00000123472 | nan | nan
chr1	EFCAB14	619559.0 | EFCAB14, KIAA0464 | EF-hand calcium-binding domain-containing protein 14 | 9813.0 | ENSG00000159658 | nan | nan
chr1	CYP4B1	124075.0 | CYP4B1 | Cytochrome P450, subfamily IVB, polypeptide 1 | 1580.0 | ENSG00000142973 | nan | nan
chr1	CYP4A11	601310.0 | CYP4A11 | Cytochrome P450, subfamily IVA, polypeptide 11 | 1579.0 | ENSG00000187048 | nan | nan
chr1	CYP4X1	614999.0 | CYP4X1, CYPIVX1 | Cytochrome P450, family 4, subfamily X, polypeptide 1 | 260293.0 | ENSG00000186377 | nan | nan
chr1	CYP4Z1	618953.0 | CYP4Z1 | Cytochrome P450, family 4, subfamily Z, member 1 | 199974.0 | ENSG00000186160 | nan | nan
chr1	CYP4A22	615341.0 | CYP4A22 | Cytochrome P450, family 4, subfamily A, polypeptide 22 | 284541.0 | ENSG00000162365 | nan | nan
chr1	PDZK1IP1	607178.0 | PDZK1IP1, MAP17 | PDZK1-interacting protein 1 | 10158.0 | ENSG00000162366 | near SLC in human, mouse, chicken, zebrafish | nan
chr1	TAL1	187040.0 | TAL1, TCL5, SCL | T-cell acute lymphocytic leukemia-1 | 6886.0 | ENSG00000162367 | proximal to MYCL1 | Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)
chr1	STIL	181590.0 | STIL, SIL, MCPH7 | SCL/TAL1-interrupting locus | 6491.0 | ENSG00000123473 | within about 250kb of SCL | Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive
chr1	CMPK1	191710.0 | CMPK1, CMPK, UMPK, UMK, CMK | Cytidine monophosphate (UMP-CMP) kinase 1, cytosolic | 51727.0 | ENSG00000162368 | nan | nan
chr1	FOXE3	601094.0 | FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11 | Forkhead box E3 | 2301.0 | ENSG00000186790 | nan | Anterior segment dysgenesis 2, multiple subtypes, 610256 (3), Autosomal recessive; {Aortic aneurysm, familial thoracic 11, susceptibility to}, 617349 (3), Autosomal dominant; Cataract 34, multiple types, 612968 (3)
chr1	FOXD2	602211.0 | FOXD2, FKHL17, FREAC9 | Forkhead box D2 | 2306.0 | ENSG00000186564 | nan | nan
chr1	TRABD2B	614913.0 | TRABD2B, TIKI2 | TRAB domain-containing protein 2B | 388630.0 | ENSG00000269113 | nan | nan
chr1	SLC5A9	620216.0 | SLC5A9, SGLT4 | Solute carrier family 5 (sodium/glucose cotransporter), member 9 | 200010.0 | ENSG00000117834 | nan | nan
chr1	SPATA6	613947.0 | SPATA6, SRF1, HASH | Spermatogenesis-associated protein 6 | 54558.0 | ENSG00000132122 | nan | nan
chr1	AGBL4	616476.0 | AGBL4, CCP6 | ATP/GTP-binding protein-like 4 | 84871.0 | ENSG00000186094 | nan | nan
chr1	ELAVL4	168360.0 | ELAVL4, HUD, PNEM | ELAV-like RNA binding protein 4 (Hu antigen D) | 1996.0 | ENSG00000162374 | nan | nan
chr1	PARK10	606852.0 | PARK10, AAOPD | Parkinson disease 10 | 170534.0 | nan | max lod at D1S2652; ?associated with CDCP2 | {Parkinson disease 10}, 606852 (2)
chr1	STQTL23	613548.0 | STQTL23 | Stature quantitative trait locus 23 | 100529222.0 | nan | linked to rs628667 | {Stature QTL 23}, 613548 (2)
chr1	DMRTA2	614804.0 | DMRTA2 | Doublesex- and MAB3-related transcription factor A2 | 63950.0 | ENSG00000142700 | nan | nan
chr1	FAF1	604460.0 | FAF1, HFAF1 | Fas-associated factor 1 | 11124.0 | ENSG00000185104 | nan | nan
chr1	CDKN2C	603369.0 | CDKN2C, INK4C | Cyclin-dependent kinase inhibitor 2C | 1031.0 | ENSG00000123080 | nan | nan
chr1	RNF11	612598.0 | RNF11 | Ring finger protein 11 | 26994.0 | ENSG00000123091 | nan | nan
chr1	TTC39A	619885.0 | TTC39A, C1orf34, KIAA0452 | Tetratricopeptide repeat domain-contining protein 39A | 22996.0 | ENSG00000085831 | nan | nan
chr1	EPS15	600051.0 | EPS15 | Epidermal growth factor receptor pathway substrate-15 | 2060.0 | ENSG00000085832 | nan | nan
chr1	OSBPL9	606737.0 | OSBPL9, ORP9 | Oxysterol-binding protein-like protein 9 | 114883.0 | ENSG00000117859 | nan | nan
chr1	NRDC	602651.0 | NRD1 | Nardilysin (N-arginine dibasic convertase) | 4898.0 | ENSG00000078618 | nan | nan
chr1	RAB3B	179510.0 | RAB3B | Brain antigen RAB3B | 5865.0 | ENSG00000169213 | nan | nan
chr1	TXNDC12	609448.0 | TXNDC12, TLP19, ERP18 | Thioredoxin domain-containing protein 12 | 51060.0 | ENSG00000117862 | nan | nan
chr1	ZFYVE9	603755.0 | ZFYVE9, MADHIP, SARA | Zinc finger, FYVE domain containing 9 | 9372.0 | ENSG00000157077 | nan | nan
chr1	ORC1	601902.0 | ORC1, ORC1L | Origin recognition complex, subunit 1 | 4998.0 | ENSG00000085840 | nan | Meier-Gorlin syndrome 1, 224690 (3), Autosomal recessive
chr1	PRPF38A	617031.0 | PRPF38A, PRP38A | Pre-mRNA processing factor 38A | 84950.0 | ENSG00000134748 | nan | nan
chr1	TUT4	613692.0 | TUT4, ZCCHC11, KIAA0191 | Terminal uridylyl transferase 4 | 23318.0 | ENSG00000134744 | nan | nan
chr1	GPX7	615784.0 | GPX7, NPGPX | Glutathione peroxidase 7 | 2882.0 | ENSG00000116157 | nan | nan
chr1	SHISAL2A	620218.0 | SHISAL2A, FAM159A | SHISA-like 2A | 348378.0 | ENSG00000182183 | nan | nan
chr1	COA7	615623.0 | COA7, RESA1, SELRC1, C1orf163, SCAN3 | Cytochrome C oxidase assembly factor | 65260.0 | ENSG00000162377 | nan | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3, 618387 (3), Autosomal recessive
chr1	ZYG11B	618673.0 | ZYG11B | ZYG11 family, member B, cell cycle regulator | 79699.0 | ENSG00000162378 | nan | nan
chr1	ZYG11A	618675.0 | ZYG11A | ZYG11 family, member A, cell cycle regulator | 440590.0 | ENSG00000203995 | nan | nan
chr1	ECHDC2	620724.0 | ECHDC | Enoyl coenzyme A hydratase domain-containing protein 2 | 55268.0 | ENSG00000121310 | nan | nan
chr1	SCP2	184755.0 | SCP2 | Sterol carrier protein-2 | 6342.0 | ENSG00000116171 | mutation identified in 1 LKDMN patient | ?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3), Autosomal recessive
chr1	PODN	608661.0 | PODN | Podocan | 127435.0 | ENSG00000174348 | nan | nan
chr1	SLC1A7	604471.0 | SLC1A7 | Solute carrier family 1 (glutamate transporter), member 7 | 6512.0 | ENSG00000162383 | nan | nan
chr1	CPT2	600650.0 | CPT2, IIAE4 | Carnitine palmitoyltransferase II | 1376.0 | ENSG00000157184 | formerly at 1p13 | {Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant
chr1	MAGOH	602603.0 | MAGOH | Mago homolog, exon junction complex subunit | 4116.0 | ENSG00000162385 | nan | nan
chr1	LRP8	602600.0 | LRP8, APOER2, MCI1 | Low density lipoprotein receptor-related protein 8 (Apolipoprotein E receptor 2) | 7804.0 | ENSG00000157193 | nan | {Myocardial infarction, susceptibility to}, 608446 (3)
chr1	DMRTB1	614805.0 | DMRTB1 | Doublesex- and MAB3-related transcription factor B1 | 63948.0 | ENSG00000143006 | nan | nan
chr1	GLIS1	610378.0 | GLIS1 | Glis family zinc finger protein 1 | 148979.0 | ENSG00000174332 | nan | nan
chr1	NDC1	610115.0 | TMEM48, NDC1 | Transmembrane protein 48 | 55706.0 | ENSG00000058804 | nan | nan
chr1	YIPF1	617521.0 | YIPF1 | YIP1 domain family, member 1 | 54432.0 | ENSG00000058799 | nan | nan
chr1	DIO1	147892.0 | DIO1, TXDI1, THMA2 | Deiodinase, iodothyronine, type I | 1733.0 | ENSG00000211452 | nan | Thyroid hormone metabolism, abnormal, 2, 619855 (3), Autosomal dominant
chr1	IFT25	620841.0 | IFT25, C1orf41 | Intraflagellar transport 25 | 51668.0 | ENSG00000081870 | nan | nan
chr1	LRRC42	620896.0 | LRRC42 | Leucine-rich repeat-containing protein 42 | 115353.0 | ENSG00000116212 | nan | nan
chr1	TMEM59	617084.0 | TMEM59, DCF1 | Transmembrane protein 59 | 9528.0 | ENSG00000116209 | nan | nan
chr1	CDCP2	612320.0 | CDCP2 | Cub domain-containing protein 2 | 200008.0 | ENSG00000157211 | ?associated with PARK10 | nan
chr1	MRPL37	611843.0 | MRPL37 | Mitochondrial ribosomal protein L37 | 51253.0 | ENSG00000116221 | nan | nan
chr1	SSBP3	607390.0 | SSBP3 | Single-stranded DNA-binding protein 3 | 23648.0 | ENSG00000157216 | nan | nan
chr1	ACOT11	606803.0 | ACOT11, THEA, BFIT, BFIT1, BFIT2, KIAA0707 | Acyl-CoA thioesterase 11 | 26027.0 | ENSG00000162390 | nan | nan
chr1	TTC4	606753.0 | TTC4 | Tetratricopeptide repeat domain 4 | 7268.0 | ENSG00000243725 | pseudogene on 7p14-p13 | nan
chr1	PARS2	612036.0 | PARS2, DEE75 | Prolyl-tRNA synthetase 2 | 25973.0 | ENSG00000162396 | nan | Developmental and epileptic encephalopathy 75, 618437 (3), Autosomal recessive
chr1	CIMAP2	616446.0 | LEXM, C1orf177, LEM | Lymphocyte expansion molecule | 163747.0 | ENSG00000162398 | nan | nan
chr1	DHCR24	606418.0 | DHCR24, KIAA0018 | 24-dehydrocholesterol reductase | 1718.0 | ENSG00000116133 | nan | Desmosterolosis, 602398 (3), Autosomal recessive
chr1	BSND	606412.0 | BSND | Barttin | 7809.0 | ENSG00000162399 | nan | Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive
chr1	PCSK9	607786.0 | PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1, FHCL3 | Proprotein convertase, subtilisin/kexin-type, 9 | 255738.0 | ENSG00000169174 | nan | {Low density lipoprotein cholesterol level QTL 1}, 603776 (3), Autosomal dominant; Hypercholesterolemia, familial, 3, 603776 (3), Autosomal dominant
chr1	USP24	610569.0 | USP24, KIAA1057 | Ubiquitin-specific protease 24 | 23358.0 | ENSG00000162402 | nan | nan
chr1	PLPP3	607125.0 | PLPP3, PPAP2B | Phospholipid phosphatase 3 | 8613.0 | ENSG00000162407 | nan | nan
chr1	PRKAA2	600497.0 | PRKAA2, AMPK | Protein kinase, AMP-activated, alpha-2 catalytic subunit | 5563.0 | ENSG00000162409 | nan | nan
chr1	FYB2	618478.0 | FYB2, ARAP, C1orf168 | FYN-binding protein 2 | 199920.0 | ENSG00000187889 | nan | nan
chr1	C8A	120950.0 | C8A | Complement component-8, alpha polypeptide | 731.0 | ENSG00000157131 | nan | C8 deficiency, type I, 613790 (3), Autosomal recessive
chr1	C8B	120960.0 | C8B | Complement component-8, beta polypeptide | 732.0 | ENSG00000021852 | nan | C8 deficiency, type II, 613789 (3), Autosomal recessive
chr1	DAB1	603448.0 | DAB1, SCA37 | DAB adaptor protein 1 | 1600.0 | ENSG00000173406 | nan | Spinocerebellar ataxia 37, 615945 (3), Autosomal dominant
chr1	OMA1	617081.0 | OMA1, MPRP1 | OMA1 zinc metallopeptidase | 115209.0 | ENSG00000162600 | nan | nan
chr1	TACSTD2	137290.0 | TACSTD2, TROP2, M1S1 | Tumor-associated calcium signal transducer 2 | 4070.0 | ENSG00000184292 | nan | Corneal dystrophy, gelatinous drop-like, 204870 (3), Autosomal recessive
chr1	MYSM1	612176.0 | MYSM1, 2ADUB, KIAA1915, BMFS4 | MYB-like, SWIRM, and MPN domains-containing protein 1 | 114803.0 | ENSG00000162601 | nan | Bone marrow failure syndrome 4, 618116 (3), Autosomal recessive
chr1	JUN	165160.0 | JUN | Jun protooncogene, AP-1 transcription factor subunit | 3725.0 | ENSG00000177606 | nan | nan
chr1	FGGY	611370.0 | FGGY, FLJ10986 | FGGY carbohydrate kinase domain-containing protein | 55277.0 | ENSG00000172456 | nan | nan
chr1	HOOK1	607820.0 | HOOK1, HK1 | Hook microtubule tethering protein 1 | 51361.0 | ENSG00000134709 | nan | nan
chr1	CYP2J2	601258.0 | CYP2J2 | Cytochrome P450, subfamily IIJ (arachidonic acid epoxygenase), polypeptide 2 | 1573.0 | ENSG00000134716 | nan | nan
chr1	C1orf87	618860.0 | C1orf87, CREF | Chromosome 1 open reading frame 87 | 127795.0 | ENSG00000162598 | nan | nan
chr1	AIR	601676.0 | AIR | Acute insulin response | 7808.0 | nan | nan | Acute insulin response, 601676 (2)
chr1	ASRT4	610906.0 | ASRT4 | Asthma-related traits, susceptibility to, 4 | 100188823.0 | nan | max lod at D1S2890 | {Asthma-related traits, susceptibility to, 4}, 610906 (2)
chr1	AVSD1	606215.0 | AVSD1, AVCD | Atrioventricular septal defect, susceptibility to, 1 | 7446.0 | nan | nan | {Atrioventricular septal defect, susceptibility to, 1}, 606215 (2)
chr1	OFC14	615892.0 | OFC14 | Orofacial cleft 14 | 103581096.0 | nan | nan | Orofacial cleft 14, 615892 (2), Autosomal recessive
chr1		164750.0 | OPHLC, C1DUPp31.3, DUP1p31.3 | Omphalocele due to duplication of 1p31.3 | nan | nan | duplication of 710kb at 1p31.3 | Omphalocele due to duplication of 1p31.3, 164750 (4), Isolated cases
chr1	PAOD1	606787.0 | PAOD1 | Peripheral arterial occlusive disease 1 | 171513.0 | nan | nan | Peripheral arterial occlusive disease 1, 606787 (2)
chr1	POROK5	612293.0 | POROK5, DSAP3 | Porokeratosis 5, disseminated superficial actinic | 100190982.0 | nan | between D1S438 and D1S464 | Porokeratosis 5, disseminated superficial actinic, 612293 (2)
chr1	NFIA	600727.0 | NFIA, BRMUTD | Nuclear factor I/A | 4774.0 | ENSG00000162599 | nan | Brain malformations with or without urinary tract defects, 613735 (3), Autosomal dominant
chr1	TM2D1	610080.0 | TM2D1, BBP | TM2 domain-containing protein 1 | 83941.0 | ENSG00000162604 | nan | nan
chr1	PATJ	603199.0 | PATJ, INADL | PALS1-associated tight junction protein | 10207.0 | ENSG00000132849 | nan | nan
chr1	KANK4	614612.0 | KANK4 | KN motif- and ankyrin repeat domain-containing protein 4 | 163782.0 | ENSG00000132854 | nan | nan
chr1	USP1	603478.0 | USP1 | Ubiquitin-specific protease 1 | 7398.0 | ENSG00000162607 | nan | nan
chr1	DOCK7	615730.0 | DOCK7, KIAA1771, DEE23 | Dedicator of cytokinesis 7 | 85440.0 | ENSG00000116641 | nan | Developmental and epileptic encephalopathy 23, 615859 (3), Autosomal recessive
chr1	ANGPTL3	604774.0 | ANGPTL3, ANGPT5, FHBL2 | Angiopoietin-like 3 | 27329.0 | ENSG00000132855 | nan | Hypobetalipoproteinemia, familial, 2, 605019 (3), Autosomal recessive
chr1	ATG4C	611339.0 | ATG4C, APG4C | Autophagy related 4C cysteine peptidase | 84938.0 | ENSG00000125703 | nan | nan
chr1	FOXD3	611539.0 | FOXD3, AIS1, VAMAS2 | Forkhead box D3 | 27022.0 | ENSG00000187140 | nan | {Autoimmune disease, susceptibility to, 1}, 607836 (3), Autosomal dominant
chr1	ALG6	604566.0 | ALG6, CDG1C | ALG6 alpha-1,3-glucosyltransferase | 29929.0 | ENSG00000088035 | nan | Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive
chr1	ITGB3BP	605494.0 | ITGB3BP, NRIF3 | Integrin, beta-3, binding protein of | 23421.0 | ENSG00000142856 | nan | nan
chr1	EFCAB7	617632.0 | EFCAB7, KIAA1799 | EF-hand calcium-binding domain-containing protein 7 | 84455.0 | ENSG00000203965 | nan | nan
chr1	PGM1	171900.0 | PGM1, GSD14, CDG1T | Phosphoglucomutase-1 | 5236.0 | ENSG00000079739 | distal to ACADM; formerly 1p22.1 | Congenital disorder of glycosylation, type It, 614921 (3), Autosomal recessive
chr1	ROR1	602336.0 | ROR1, NTRKR1 | Receptor tyrosine kinase-like orphan receptor 1 | 4919.0 | ENSG00000185483 | mutation identified in 1 DFNB108 family | ?Deafness, autosomal recessive 108, 617654 (3), Autosomal recessive
chr1	CACHD1	620144.0 | CACHD1, KIAA1573 | CACHE domain-containing protein 1 | 57685.0 | ENSG00000158966 | nan | nan
chr1	RAVER2	609953.0 | RAVER2, KIAA1579 | Ribonucleoprotein, PTB binding 2 | 55225.0 | ENSG00000162437 | nan | nan
chr1	JAK1	147795.0 | JAK1, AIIDE | Janus kinase 1 (a protein-tyrosine kinase) | 3716.0 | ENSG00000162434 | related gene on 9p24 | Autoinflammation, immune dysregulation, and eosinophilia, 618999 (3), Autosomal dominant
chr1	MIR101-1	612511.0 | MIR101-1, MIRN101-1 | Micro RNA 101-1 | 406893.0 | ENSG00000199135 | another locus, MIRN101-2, on 9p24 | nan
chr1	AK4	103030.0 | AK4, AK3 | Adenylate kinase 4 | 205.0 | ENSG00000162433 | nan | nan
chr1	DNAJC6	608375.0 | DNAJC6, DJC6, KIAA0473, PARK19 | DNAJ heat shock protein family (Hsp40) member C6 | 9829.0 | ENSG00000116675 | nan | Parkinson disease 19a, juvenile-onset, 615528 (3), Autosomal recessive; Parkinson disease 19b, early-onset, 615528 (3), Autosomal recessive
chr1	LEPR	601007.0 | LEPR, OBR, LEPRD | Leptin receptor | 3953.0 | ENSG00000116678 | nan | Obesity, morbid, due to leptin receptor deficiency, 614963 (3), Autosomal recessive
chr1	LEPROT	613461.0 | LEPROT, OBRGRP | Leptin receptor overlapping transcript | 54741.0 | ENSG00000213625 | transcribed in same direction as LEPR | nan
chr1	PDE4B	600127.0 | PDE4B, DPDE4 | Phosphodiesterase-4B, cAMP-specific (dunce-like phosphodiesterase E4) | 5142.0 | ENSG00000184588 | nan | nan
chr1	SGIP1	611540.0 | SGIP1 | SH3-domain GRB2-like (endophilin)-interacting protein 1 | 84251.0 | ENSG00000118473 | nan | nan
chr1	DYNLT5	619994.0 | DYNLT6, TCTEX1D1 | Dynein light chain, TCTEX-type family, member 5 | 200132.0 | ENSG00000152760 | nan | nan
chr1	INSL5	606413.0 | INSL5 | Insulin-like 5 | 10022.0 | ENSG00000172410 | nan | nan
chr1	DNAI4	619156.0 | DNAI4, WDR78 | Dynein, axonemal, intermediate chain 4 | 79819.0 | ENSG00000152763 | nan | nan
chr1	MIER1	616848.0 | MIER1, KIAA1610 | MIER1 transcriptional regulator | 57708.0 | ENSG00000198160 | nan | nan
chr1	SLC35D1	610804.0 | SLC35D1, UGTREL7, KIAA0260, SHNKND | Solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 | 23169.0 | ENSG00000116704 | nan | Schneckenbecken dysplasia, 269250 (3), Autosomal recessive
chr1	IL23R	607562.0 | IL23R, IBD17 | Interleukin 23 receptor | 149233.0 | ENSG00000162594 | nan | {Inflammatory bowel disease 17, protection against}, 612261 (3); {Psoriasis, protection against}, 605606 (3)
chr1	IL12RB2	601642.0 | IL12RB2 | Interleukin 12 receptor, beta-2 | 3595.0 | ENSG00000081985 | nan | nan
chr1	SERBP1	607378.0 | SERBP1, PAIRBP1 | Serpine1 mRNA-binding protein 1 | 26135.0 | ENSG00000142864 | nan | nan
chr1	GADD45A	126335.0 | DDIT1, GADD45 | DNA damage-inducible transcript-1 | 1647.0 | ENSG00000116717 | nan | nan
chr1	GNG12	615405.0 | GNG12 | Guanine nucleotide-binding protein, gamma 12 | 55970.0 | ENSG00000172380 | nan | nan
chr1	GNG12-AS1	615406.0 | GNG12AS1 | GNG12 antisense RNA 1 | 100289178.0 | ENSG00000232284 | nan | nan
chr1	DIRAS3	605193.0 | DIRAS3, ARHI | DIRAS family, GTP-binding RAS-like protein 3 | 9077.0 | ENSG00000162595 | nan | nan
chr1	WLS	611514.0 | WLS, GPR177, EVI, ZKS | WNT ligand secretion mediator | 79971.0 | ENSG00000116729 | nan | Zaki syndrome, 619648 (3), Autosomal recessive
chr1	RPE65	180069.0 | RPE65, RP20, LCA2 | RPE65 retinoid isomerohydrolase | 6121.0 | ENSG00000116745 | nan | Retinitis pigmentosa 20, 613794 (3), Autosomal recessive; Retinitis pigmentosa 87 with choroidal involvement, 618697 (3), Autosomal dominant; Leber congenital amaurosis 2, 204100 (3), Autosomal recessive
chr1	DEPDC1	612002.0 | DEPDC1 | DEP domain-containing 1 | 55635.0 | ENSG00000024526 | nan | nan
chr1	PBC3	613008.0 | PBC3 | Biliary cirrhosis, primary, 3 | 100303717.0 | nan | associated with rs3790567 | {Biliary cirrhosis, primary, 3}, 613008 (2)
chr1	SPG29	609727.0 | SPG29 | Spastic paraplegia 29, autosomal dominant | 619379.0 | nan | max lod at D1S2865 | Spastic paraplegia 29, autosomal dominant, 609727 (2), Autosomal dominant
chr1	LRRC7	614453.0 | LRRC7, DENSIN, KIAA1365 | Leucine-rich repeat-containing protein 7 | 57554.0 | ENSG00000033122 | nan | nan
chr1	PIN1P1	602051.0 | PIN1L | Peptidyl-prolyl cis/trans isomerase, NIMA-interacting-like | 5301.0 | ENSG00000293134 | ?transcribed pseudogene | nan
chr1	SRSF11	602010.0 | SRSF11, SFRS11 | Splicing factor, serine/arginine-rich, 11 | 9295.0 | ENSG00000116754 | nan | nan
chr1	ANKRD13C	615125.0 | ANKRD13C | Ankyrin repeat domain-containing protein 13C | 81573.0 | ENSG00000118454 | nan | nan
chr1	ANKRD13C-DT	604372.0 | HHLA3 | Human endogenous retrovirus-H long terminal repeat-associating 3 | 11147.0 | ENSG00000197568 | nan | nan
chr1	CTH	607657.0 | CTH | Cystathionine gamma-lyase | 1491.0 | ENSG00000116761 | previously assigned to chr.16 | Cystathioninuria, 219500 (3), Autosomal recessive
chr1	PTGER3	176806.0 | PTGER3, EP3 | Prostaglandin E receptor 3, EP3 subtype | 5733.0 | ENSG00000050628 | nan | nan
chr1	ZRANB2	604347.0 | ZRANB2, ZNF265, ZIS | Zinc finger RANBP2-type domain-containing protein 2 | 9406.0 | ENSG00000132485 | nan | nan
chr1	NEGR1	613173.0 | NEGR1, KILON | Neuronal growth regulator 1 | 257194.0 | ENSG00000172260 | nan | nan
chr1	LRRIQ3	617957.0 | LRRIQ3, LRRC44 | Leucine rich repeats- and IQ motif-containing protein 3 | 127255.0 | ENSG00000162620 | nan | nan
chr1	FPGT	603609.0 | FPGT, GFPP | Fucose-1-phosphate guanylyltransferase | 8790.0 | ENSG00000254685 | nan | nan
chr1	TNNI3K	613932.0 | TNNI3K, CCDD | TNNI3-interacting kinase | 51086.0 | ENSG00000116783 | nan | Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3), Autosomal dominant
chr1	ERICH3	620866.0 | ERICH3, C1orf173 | Glutamate-rich protein 3 | 127254.0 | ENSG00000178965 | nan | nan
chr1	CRYZ	123691.0 | CRYZ | Crystallin, zeta (quinone reductase) | 1429.0 | ENSG00000116791 | nan | nan
chr1	TYW3	611245.0 | TYW3 | tRNA-yW synthesizing protein 3 homolog | 127253.0 | ENSG00000162623 | nan | nan
chr1	LHX8	604425.0 | LHX8 | LIM homeobox 8 | 431707.0 | ENSG00000162624 | nan | nan
chr1	SLC44A5	620329.0 | SLC44A5, CTL5 | Solute carrier family 44, member 5 | 204962.0 | ENSG00000137968 | nan | nan
chr1	ACADM	607008.0 | ACADM, MCAD | Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain | 34.0 | ENSG00000117054 | nan | Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive
chr1	RABGGTB	179080.0 | RABGGTB | Rab geranylgeranyltransferase, beta subunit | 5876.0 | ENSG00000137955 | nan | nan
chr1	MSH4	602105.0 | MSH4, POF20, SPGF2 | mutS homolog 4 | 4438.0 | ENSG00000057468 | nan | Premature ovarian failure 20, 619938 (3), Autosomal recessive; Spermatogenic failure 2, 108420 (3), Autosomal recessive
chr1	ASB17	619936.0 | ASB17 | Ankyrin repeat- and SOCS box-containing protein 17 | 127247.0 | ENSG00000154007 | nan | nan
chr1	ST6GALNAC3	610133.0 | ST6GALNAC3, SIAT7C | ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | 256435.0 | ENSG00000184005 | nan | nan
chr1	ST6GALNAC5	610134.0 | ST6GALNAC5, SIAT7E | ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6 sialyltransferase 5 | 81849.0 | ENSG00000117069 | nan | nan
chr1	PIGK	605087.0 | PIGK, GPI8, NEDHCAS | Phosphatidylinositol glycan, class K | 10026.0 | ENSG00000142892 | nan | Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures, 618879 (3), Autosomal recessive
chr1	AK5	608009.0 | AK5 | Adenylate kinase 5 | 26289.0 | ENSG00000154027 | nan | nan
chr1	ZZZ3	619892.0 | ZZZ3 | Zinc finger ZZ-type domain-containing protein 3 | 26009.0 | ENSG00000036549 | nan | nan
chr1	USP33	615146.0 | USP33, VDU1 | Ubiquitin-specific protease 33 | 23032.0 | ENSG00000077254 | nan | nan
chr1	MIGA1	616773.0 | MIGA1, FAM73A | Mitoguardin 1 | 374986.0 | ENSG00000180488 | nan | nan
chr1	NEXN-AS1	618370.0 | NEXAS1 | NEXN antisense RNA 1 | 374987.0 | ENSG00000235927 | nan | nan
chr1	NEXN	613121.0 | NEXN, NELIN, CMD1CC, CMH20 | Nexilin F-actin binding protein | 91624.0 | ENSG00000162614 | nan | Cardiomyopathy, dilated, 1CC, 613122 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 20, 613876 (3), Autosomal dominant
chr1	FUBP1	603444.0 | FUBP1, FUBP, FBP | Far upstream element-binding protein 1 | 8880.0 | ENSG00000162613 | nan | nan
chr1	DNAJB4	611327.0 | DNAJB4, HLJ1, CMYO21 | DNAJ/HSP40 homolog, subfamily B, member 4 | 11080.0 | ENSG00000162616 | nan | Congenital myopathy 21 with early respiratory failure, 620326 (3), Autosomal recessive
chr1	GIPC2	619089.0 | GIPC2 | GIPC PDZ domain-containing family, member 2 | 54810.0 | ENSG00000137960 | nan | nan
chr1	PTGFR	600563.0 | PTGFR | Prostaglandin F receptor (FP) | 5737.0 | ENSG00000122420 | nan | nan
chr1	IFI44L	613975.0 | IFI44L | Interferon-induced protein 44-like | 10964.0 | ENSG00000137959 | nan | nan
chr1	IFI44	610468.0 | IFI44, P44 | Interferon-induced protein 44 | 10561.0 | ENSG00000137965 | nan | nan
chr1	ADGRL4	616419.0 | ADGRL4, ETL, ELTD1 | Adhesion G protein-coupled receptor L4 | 64123.0 | ENSG00000162618 | nan | nan
chr1	ADGRL2	607018.0 | ADGRL2, LPHN2, LPHH1, CIRL2, CL2, KIAA0786 | Adhesion G protein-coupled receptor L2 | 23266.0 | ENSG00000117114 | nan | nan
chr1	TTLL7	618813.0 | TTLL7 | Tubulin tyrosine ligase-like 7 | 79739.0 | ENSG00000137941 | nan | nan
chr1	PRKACB	176892.0 | PRKACB, CAFD2 | Protein kinase, cAMP-dependent, catalytic, beta | 5567.0 | ENSG00000142875 | nan | Cardioacrofacial dysplasia 2, 619143 (3), Autosomal dominant, Somatic mosaicism
chr1	SAMD13	620800.0 | SAMD13, DJL | Sterile alpha motif domain-containing protein 13 | 148418.0 | ENSG00000203943 | nan | nan
chr1	DNASE2B	608057.0 | DNASE2B, DLAD | Deoxyribonuclease II beta | 58511.0 | ENSG00000137976 | nan | nan
chr1	CMM4	608035.0 | CMM4 | Melanoma, cutaneous malignant, 4 | 474388.0 | nan | between D1S430 and D1S2664 | {Melanoma, cutaneous malignant, 4}, 608035 (2), Autosomal dominant
chr1	KAZA2	611381.0 | KAZA2 | Kala-azar, susceptibility to, 2 | 101241898.0 | nan | nan | {Kala-azar, susceptibility to, 2}, 611381 (2)
chr1	UOX	191540.0 | UOX | Urate oxidase, pseudogene | 391051.0 | nan | nonsense mutations responsible for absence of enzyme in man and hominoid primates | [Urate oxidase deficiency] (1)
chr1	GNG5	600874.0 | GNG5 | Guanine nucleotide-binding protein (G protein), gamma 5 | 2787.0 | ENSG00000174021 | nan | nan
chr1	CTBS	600873.0 | CTBS, CTB | Chitobiase, di-N-acetyl- | 1486.0 | ENSG00000117151 | nan | nan
chr1	SSX2IP	608690.0 | SSX2IP, ADIP, KIAA0923 | SSX2-interacting protein | 117178.0 | ENSG00000117155 | nan | nan
chr1	LPAR3	605106.0 | LPAR3, EDG7, LPA3 | Lysophosphatidic acid receptor 3 | 23566.0 | ENSG00000171517 | nan | nan
chr1	MCOLN2	607399.0 | MCOLN2 | Mucolipin 2 | 255231.0 | ENSG00000153898 | incorrectly assigned to chr.3 | nan
chr1	MCOLN3	607400.0 | MCOLN3 | Mucolipin 3 | 55283.0 | ENSG00000055732 | nan | nan
chr1	DNAI3	617968.0 | WDR63 | WD repeat-containing protein 63 | 126820.0 | ENSG00000162643 | nan | nan
chr1	SYDE2	620834.0 | SYDE2 | Synapse defective Rho GTPase homolog 2 | 84144.0 | ENSG00000097096 | nan | nan
chr1	BCL10	603517.0 | BCL10, IMD37 | B-cell leukemia/lymphoma 10 | 8915.0 | ENSG00000142867 | mutation identified in 1 IMD37 patient | {Lymphoma, follicular, somatic}, 605027 (3); ?Immunodeficiency 37, 616098 (3), Autosomal recessive; {Sezary syndrome, somatic} (3); {Male germ cell tumor, somatic}, 273300 (3); Lymphoma, MALT, somatic, 137245 (3); {Mesothelioma, somatic}, 156240 (3)
chr1	DDAH1	604743.0 | DDAH1 | Dimethylarginine dimethylaminohydrolase-1 | 23576.0 | ENSG00000153904 | nan | nan
chr1	CCN1	602369.0 | CCN1, CYR61, IGFBP10 | Cellular communication network factor 1 | 3491.0 | ENSG00000142871 | nan | nan
chr1	ZNHIT6	620473.0 | ZNHIT6, BCD1 | Zinc finger HIT domain-containing protein 6 | 54680.0 | ENSG00000117174 | nan | nan
chr1	COL24A1	610025.0 | COL24A1 | Collagen, type XXIV, alpha-1 | 255631.0 | ENSG00000171502 | nan | nan
chr1	ODF2L	620130.0 | ODF2L, KIAA1229 | Outer dense fiber of sperm tails 2-like protein | 57489.0 | ENSG00000122417 | nan | nan
chr1	CLCA2	604003.0 | CLCA2 | Chloride channel accessory 2 | 9635.0 | ENSG00000137975 | nan | nan
chr1	CLCA1	603906.0 | CLCA1, CACC1 | Chloride channel accessory 1 | 1179.0 | ENSG00000016490 | nan | nan
chr1	CLCA4	616857.0 | CLCA4, CACC2 | Chloride channel accessory 4 | 22802.0 | ENSG00000016602 | nan | nan
chr1	CLCA3P	604337.0 | CLCA3 | Chloride channel accessory 3 | 9629.0 | ENSG00000291014 | nan | nan
chr1	SH3GLB1	609287.0 | SH3GLB1, KIAA0491 | SH3 domain, GRB2-like, endophilin B1 | 51100.0 | ENSG00000097033 | nan | nan
chr1	SELENOF	606254.0 | SELENOF, SEP15 | Selenoprotein F | 9403.0 | ENSG00000183291 | nan | nan
chr1	HS2ST1	604844.0 | HS2ST1, NFSRA | Heparan sulfate 2-O-sulfotransferase 1 | 9653.0 | ENSG00000153936 | nan | Neurofacioskeletal syndrome with or without renal agenesis, 619194 (3), Autosomal recessive
chr1	LMO4	603129.0 | LMO4 | LIM domain only 4 | 8543.0 | ENSG00000143013 | nan | nan
chr1	PKN2	602549.0 | PKN2, PRKCL2, PRK2, PAK2 | Protein kinase N2 | 5586.0 | ENSG00000065243 | nan | nan
chr1	GTF2B	189963.0 | GTF2B, TFIIB, TF2B | General transcription factor IIb | 2959.0 | ENSG00000137947 | nan | nan
chr1	KYAT3	610656.0 | CCBL2, KAT3 | Cysteine conjugate beta-lyase 2 | 56267.0 | ENSG00000137944 | nan | nan
chr1	GBP3	600413.0 | GBP3 | Guanylate-binding protein 3 | 2635.0 | ENSG00000117226 | nan | nan
chr1	GBP1	600411.0 | GBP1 | Guanylate binding protein 1, interferon-inducible, 67kD | 2633.0 | ENSG00000117228 | nan | nan
chr1	GBP2	600412.0 | GBP2 | Guanylate-binding protein 2, interferon-inducible | 2634.0 | ENSG00000162645 | nan | nan
chr1	GBP7	612468.0 | GBP7 | Guanylate-binding protein 7 | 388646.0 | ENSG00000213512 | nan | nan
chr1	GBP4	612466.0 | GBP4 | Guanylate-binding protein 4 | 115361.0 | ENSG00000162654 | nan | nan
chr1	GBP5	611467.0 | GBP5 | Guanylate-binding protein 5 | 115362.0 | ENSG00000154451 | nan | nan
chr1	GBP6	612467.0 | GBP6 | Guanylate-binding protein 6 | 163351.0 | ENSG00000183347 | nan | nan
chr1	LRRC8B	612888.0 | LRRC8B, TALRRP, KIAA0231 | Leucine-rich repeat-containing protein 8B | 23507.0 | ENSG00000197147 | nan | nan
chr1	LRRC8C	612889.0 | LRRC8C, FAD158, AD158 | Leucine-rich repeat-containing protein 8C | 84230.0 | ENSG00000171488 | nan | nan
chr1	LRRC8D	612890.0 | LRRC8D, LRRC5 | Leucine-rich repeat-containing protein 8D | 55144.0 | ENSG00000171492 | nan | nan
chr1	ZNF326	614601.0 | ZNF326, ZIRD | Zinc finger protein 326 | 284695.0 | ENSG00000162664 | nan | nan
chr1	BARHL2	605212.0 | BARHL2 | BARH-like 2 | 343472.0 | ENSG00000143032 | nan | nan
chr1	ZNF644	614159.0 | ZNF644, MYP21 | Zinc finger protein 644 | 84146.0 | ENSG00000122482 | nan | Myopia 21, autosomal dominant, 614167 (3), Autosomal dominant
chr1	HFM1	615684.0 | HFM1, MER3, POF9 | Helicase for meiosis 1 | 164045.0 | ENSG00000162669 | nan | Premature ovarian failure 9, 615724 (3), Autosomal recessive
chr1	CDC7	603311.0 | CDC7, CDC7L1 | Cell division cycle 7 | 8317.0 | ENSG00000097046 | nan | nan
chr1	TGFBR3	600742.0 | TGFBR3 | Transforming growth factor, beta receptor III (betaglycan, 300kD) | 7049.0 | ENSG00000069702 | nan | nan
chr1	BRDT	602144.0 | BRDT, SPGF21 | Bromodomain, testis-specific | 676.0 | ENSG00000137948 | mutation identified in 1 SPGF21 patient | ?Spermatogenic failure 21, 617644 (3), Autosomal recessive
chr1	EPHX4	617401.0 | EPHX4, ABHD7 | Epoxide hydrolase 4 | 253152.0 | ENSG00000172031 | nan | nan
chr1	BTBD8	617945.0 | BTBD8, KIAA1107, APACHE | BTB domain-containing protein 8 | 284697.0 | ENSG00000189195 | nan | nan
chr1	C1orf146	618968.0 | C1orf146, SPO16, SCRE | Chromosome 1 open reading frame 146 | 388649.0 | ENSG00000203910 | nan | nan
chr1	GLMN	601749.0 | GLMN, GVM, VMGLOM | Glomulin | 11146.0 | ENSG00000174842 | nan | Glomuvenous malformations, 138000 (3), Autosomal dominant
chr1	RPAP2	611476.0 | RPAP2, C1orf82 | RNA polymerase II-associated protein 2 | 79871.0 | ENSG00000122484 | nan | nan
chr1	GFI1	600871.0 | GFI1, ZNF163, SCN2 | Growth factor independent 1 | 2672.0 | ENSG00000162676 | mutation identified in 1 NICINA patient | ?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant
chr1	EVI5	602942.0 | EVI5, NB4S | Ecotropic viral integration site 5 | 7813.0 | ENSG00000067208 | nan | nan
chr1	RPL5	603634.0 | RPL5, DBA6 | Ribosomal protein L5 | 6125.0 | ENSG00000122406 | nan | Diamond-Blackfan anemia 6, 612561 (3), Autosomal dominant
chr1	DIPK1A	614542.0 | DIPK1A, FAM69A | Divergent protein kinase domain 1A | 388650.0 | ENSG00000154511 | nan | nan
chr1	SNORD21	603635.0 | SNORD21, RNU21 | Small nucleolar RNA, C/D box 21 | 6083.0 | ENSG00000206680 | nan | nan
chr1	MTF2	609882.0 | MTF2, PCL2, M96 | Metal-regulatory transcription factor 2 | 22823.0 | ENSG00000143033 | nan | nan
chr1	TMED5	616876.0 | TMED5 | Transmembrane p24 trafficking protein 5 | 50999.0 | ENSG00000117500 | nan | nan
chr1	DR1	601482.0 | DR1 | Down-regulator of transcription 1, TBP-binding (negative cofactor 2) | 1810.0 | ENSG00000117505 | nan | nan
chr1	FNBP1L	608848.0 | FNBP1L, TOCA1, C1orf39 | Formin binding protein 1-like | 54874.0 | ENSG00000137942 | nan | nan
chr1	BCAR3	604704.0 | BCAR3, SH2D3B, NSP2 | Breast cancer antiestrogen resistance 3 | 8412.0 | ENSG00000137936 | nan | nan
chr1	DNTTIP2	611199.0 | DNTTIP2, ERBP, FCF2 | DNTT-interacting protein 2 | 30836.0 | ENSG00000067334 | nan | nan
chr1	GCLM	601176.0 | GCLM, GLCLR | Glutamate-cysteine ligase, modifier subunit | 2730.0 | ENSG00000023909 | nan | {Myocardial infarction, susceptibility to}, 608446 (3)
chr1	ABCA4	601691.0 | ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2 | ATP-binding transporter, retina-specific | 24.0 | ENSG00000198691 | nan | Retinal dystrophy, early-onset severe, 248200 (3), Autosomal recessive; Retinitis pigmentosa 19, 601718 (3), Autosomal recessive; {Macular degeneration, age-related, 2}, 153800 (3), Autosomal dominant; Cone-rod dystrophy 3, 604116 (3), Autosomal recessive; Fundus flavimaculatus, 248200 (3), Autosomal recessive; Stargardt disease 1, 248200 (3), Autosomal recessive
chr1	ARHGAP29	610496.0 | ARHGAP29, PARG1 | RHO GTPase-activating protein 29 | 9411.0 | ENSG00000137962 | nan | nan
chr1	STQTL7	609822.0 | STQTL7 | Stature quantitative trait locus 7 | 100037265.0 | nan | max lod at D1S1631 | {Stature QTL 7}, 609822 (2)
chr1	WS2B	600193.0 | WS2B | Waardenburg syndrome, type 2B | 7488.0 | nan | nan | Waardenburg syndrome, type 2B, 600193 (2), Autosomal dominant
chr1	ABCD3	170995.0 | ABCD3, PXMP1, PMP70, CBAS5 | ATP-binding cassette, subfamily D, member 3 (peroxisomal membrane protein 1, 70kD) | 5825.0 | ENSG00000117528 | mutation identified in 1 CBAS5 family | ?Bile acid synthesis defect, congenital, 5, 616278 (3), Autosomal recessive
chr1	F3	134390.0 | F3, TFA | Coagulation factor III | 2152.0 | ENSG00000117525 | nan | nan
chr1	SLC44A3	620328.0 | SLC44A3, CTL3 | Solute carrier family 44, member 3 | 126969.0 | ENSG00000143036 | nan | nan
chr1	CNN3	602374.0 | CNN3 | Calponin 3, acidic | 1266.0 | ENSG00000117519 | nan | nan
chr1	ALG14	612866.0 | ALG14, CMS15, IDDEBF, MEPCA | ALG14 UDP-N-acetylglucosaminyltransferase subunit | 199857.0 | ENSG00000172339 | mutation identified in 1 CMSWTA family | Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies, 619031 (3), Autosomal recessive; Myopathy, epilepsy, and progressive cerebral atrophy, 619036 (3), Autosomal recessive; ?Myasthenic syndrome, congenital, 15, without tubular aggregates, 616227 (3), Autosomal recessive
chr1	RWDD3	615875.0 | RWDD3, RSUME | RWD domain-containing protein 3 | 25950.0 | ENSG00000122481 | nan | nan
chr1	PTBP2	608449.0 | PTBP2, NPTB | Polypyrimidine tract-binding protein 2 | 58155.0 | ENSG00000117569 | nan | nan
chr1	DPYD	612779.0 | DPYD, DPD | Dihydropyrimidine dehydrogenase | 1806.0 | ENSG00000188641 | nan | Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive
chr1	MIR137	614304.0 | MIR137, MIRN137 | Micro RNA 137 | 406928.0 | ENSG00000284202 | nan | nan
chr1	SNX7	614904.0 | SNX7 | Sorting nexin 7 | 51375.0 | ENSG00000162627 | nan | nan
chr1	PLPPR5	617287.0 | PLPPR5, LPPR5, PAP2D, PAP2 | Phospholipid phosphatase-related protein 5 | 163404.0 | ENSG00000117598 | nan | nan
chr1	PLPPR4	607813.0 | PLPPR4, LPPR4, PRG1, KIAA0455 | Phospholipid phosphatase-related protein 4 | 9890.0 | ENSG00000117600 | nan | nan
chr1	PALMD	610182.0 | PALMD, PALML | Palmdelphin | 54873.0 | ENSG00000099260 | nan | nan
chr1	FRRS1	611578.0 | FRRS1, SDR2 | Ferric chelate reductase 1 | 391059.0 | ENSG00000156869 | nan | nan
chr1	AGL	610860.0 | AGL, GDE | Amylo-1,6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme) | 178.0 | ENSG00000162688 | nan | Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive
chr1	SLC35A3	605632.0 | SLC35A3, AMRS | Solute carrier family 35 (UDP-GlcNAc transporter), member 3 | 23443.0 | ENSG00000117620 | nan | Arthrogryposis, impaired intellectual development, and seizures, 615553 (3), Autosomal recessive
chr1	MFSD14A	620347.0 | MFSD14A, HAIT1 | Major facilitator superfamily domain-containing protein 14A | 64645.0 | ENSG00000156875 | nan | nan
chr1	SASS6	609321.0 | SASS6, SAS6, MCPH14 | SAS-6 centriolar assembly protein | 163786.0 | ENSG00000156876 | nan | Microcephaly 14, primary, autosomal recessive, 616402 (3), Autosomal recessive
chr1	DBT	248610.0 | DBT, BCATE2, MSUD2 | Dihydrolipoamide branched chain transacylase (E2 component of branched chain keto acid dehydrogenase complex) | 1629.0 | ENSG00000137992 | pseudogene on 3q24 | Maple syrup urine disease, type II, 620699 (3), Autosomal recessive
chr1	RTCA	611286.0 | RTCD1, RPC | RNA terminal phosphate cyclase domain-containing protein 1 | 8634.0 | ENSG00000137996 | nan | nan
chr1	CDC14A	603504.0 | CDC14A, DFNB32 | Cell division cycle 14A | 8556.0 | ENSG00000079335 | nan | Deafness, autosomal recessive 32, with or without immotile sperm, 608653 (3), Autosomal recessive
chr1	GPR88	607468.0 | GPR88, STRG, COCPMR | G protein-coupled receptor 88 | 54112.0 | ENSG00000181656 | mutation identified in 1 COCPMR family | ?Chorea, childhood-onset, with psychomotor retardation, 616939 (3), Autosomal recessive
chr1	VCAM1	192225.0 | VCAM1 | Vascular cell adhesion molecule-1 | 7412.0 | ENSG00000162692 | nan | nan
chr1	EXTL2	602411.0 | EXTL2 | Exostosin-like 2 | 2135.0 | ENSG00000162694 | nan | nan
chr1	SLC30A7	611149.0 | SLC30A7, ZNT7, ZHS | Solute carrier family 30 (zinc transporter), member 7 | 148867.0 | ENSG00000162695 | nan | Ziegler-Huang syndrome, 620501 (3), Autosomal recessive
chr1	DPH5	611075.0 | DPH5, HSPC143, NEDSFF | Diphthamide biosynthesis protein 5 | 51611.0 | ENSG00000117543 | nan | Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties, 620070 (3), Autosomal recessive
chr1	S1PR1	601974.0 | S1PR1, EDG1, S1P1 | Sphingosine-1-phosphate receptor 1 | 1901.0 | ENSG00000170989 | nan | nan
chr1		612841.0 | HYPT5, MUHH2 | Hypotrichosis 5 | nan | nan | max lod at D1S2881 | Hypotrichosis 5, 612841 (2), Autosomal dominant
chr1	MRT4	611107.0 | MRT4 | Intellectual developmental disorder, autosomal recessive 4 | 100009675.0 | nan | between D2S429 and D1S187 | Intellectual developmental disorder, autosomal recessive 4, 611107 (2), Autosomal recessive
chr1	OLFM3	607567.0 | OLFM3, NOE3 | Olfactomedin 3 | 118427.0 | ENSG00000118733 | nan | nan
chr1	COL11A1	120280.0 | COL11A1, STL2, DFNA37 | Collagen XI, alpha-1 polypeptide | 1301.0 | ENSG00000060718 | nan | Fibrochondrogenesis 1, 228520 (3), Autosomal recessive; Stickler syndrome, type II, 604841 (3), Autosomal dominant; Marshall syndrome, 154780 (3), Autosomal dominant; Deafness, autosomal dominant 37, 618533 (3), Autosomal dominant; {Lumbar disc herniation, susceptibility to}, 603932 (3)
chr1	RNPC3	618016.0 | RNPC3, SNRNP65, KIAA1839, CPHD7 | RNA-binding region-containing protein 3 | 55599.0 | ENSG00000185946 | nan | Pituitary hormone deficiency, combined or isolated, 7, 618160 (3), Autosomal recessive
chr1	AMY2B	104660.0 | AMY2B | Amylase, pancreatic, alpha-2B | 280.0 | ENSG00000240038 | distal to NGFB | nan
chr1	AMY2A	104650.0 | AMY2A | Amylase, pancreatic, alpha-2A | 279.0 | ENSG00000243480 | nan | nan
chr1	AMY1A	104700.0 | AMY1A | Amylase, salivary, alpha-1A | 276.0 | ENSG00000237763 | multiple amylase genes | nan
chr1	AMY1B	104701.0 | AMY1B | Amylase, salivary, alpha-1B | 277.0 | ENSG00000174876 | nan | nan
chr1	AMY1C	104702.0 | AMY1C | Amylase, salivary, alpha-1C | 278.0 | ENSG00000187733 | nan | nan
chr1	CYMP	118943.0 | CYMP | Chymosin pseudogene | 643160.0 | ENSG00000240194 | nan | nan
chr1	VUR	193000.0 | VUR1 | Vesicoureteral reflux | 54113.0 | nan | nan | Vesicoureteral reflux 1, 193000 (2), Autosomal dominant
chr1	PRMT6	608274.0 | PRMT6 | Protein arginine N-methyltransferase 6 | 55170.0 | ENSG00000198890 | nan | nan
chr1	NTNG1	608818.0 | NTNG1, LMNT1, KIAA0976 | Netrin G1 | 22854.0 | ENSG00000162631 | nan | nan
chr1	VAV3	605541.0 | VAV3 | VAV guanine nucleotide exchange factor 3 | 10451.0 | ENSG00000134215 | nan | nan
chr1	SLC25A24	608744.0 | SLC25A24, SCAMC1 | Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24 | 29957.0 | ENSG00000085491 | nan | Fontaine progeroid syndrome, 612289 (3), Autosomal dominant
chr1	NBPF4	613994.0 | NBPF4 | Neuroblastoma breakpoint family, member 4 | 148545.0 | ENSG00000196427 | nan | nan
chr1	NBPF5P	613995.0 | NBPF5P | NBPF member 5, pseudogene | 100507044.0 | nan | nan | nan
chr1	NBPF6	613996.0 | NBPF6 | Neuroblastoma breakpoint family, member 6 | 653149.0 | ENSG00000186086 | nan | nan
chr1	HENMT1	612178.0 | HENMT1, C1orf59, HEN1 | HEN methyltransferase 1 | 113802.0 | ENSG00000162639 | nan | nan
chr1	STXBP3	608339.0 | STXBP3, MUNC18C, PSP | Syntaxin-binding protein 3 | 6814.0 | ENSG00000116266 | nan | nan
chr1	GPSM2	609245.0 | GPSM2, LGN, PINS, DFNB82, CMCS | G-protein signaling modulator 2 | 29899.0 | ENSG00000121957 | nan | Chudley-McCullough syndrome, 604213 (3), Autosomal recessive
chr1	CLCC1	617539.0 | CLCC1, MCLC, RP32 | Chloride channel CLIC-like 1 | 23155.0 | ENSG00000121940 | nan | Retinitis pigmentosa 32, 609913 (3), Autosomal recessive
chr1	WDR47	615734.0 | WDR47, NEMITIN, KIAA0893 | WD repeat-containing protein 47 | 22911.0 | ENSG00000085433 | nan | nan
chr1	TAF13	600774.0 | TAF13, TAF2K, MRT60 | TAF13 RNA polymerase II, TATA box-binding protein-associated factor, 18kD | 6884.0 | ENSG00000197780 | nan | Intellectual developmental disorder, autosomal recessive 60, 617432 (3), Autosomal recessive
chr1	CFAP276	618682.0 | CFAP276, C10orf194 | Cilia- and flagella-associated protein 276 | 127003.0 | ENSG00000179902 | nan | nan
chr1	ELAPOR1	611298.0 | ELAPOR1, KIAA1324, EIG121 | Endosome-lysosome-associated apoptosis and autophagy regulator 1 | 57535.0 | ENSG00000116299 | nan | nan
chr1	SARS1	607529.0 | SARS1, SARS, SERS, NEDMAS | Seryl-tRNA synthetase 1 | 6301.0 | ENSG00000031698 | nan | Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive
chr1	CELSR2	604265.0 | CELSR2, EGFL2, MEGF3 | Cadherin EGF LAG seven-pass G-type receptor 3 (epidermal growth factor-like 2) | 1952.0 | ENSG00000143126 | nan | nan
chr1	PSRC1	613126.0 | PSRC1, DDA3 | Proline/serine-rich coiled-coil protein 1 | 84722.0 | ENSG00000134222 | nan | nan
chr1	MYBPHL	619807.0 | MYBPHL | Myosin-binding protein H-like | 343263.0 | ENSG00000221986 | nan | nan
chr1	SORT1	602458.0 | SORT1, NT3, LDLCQ6 | Sortilin | 6272.0 | ENSG00000134243 | nan | [Low density lipoprotein cholesterol level QTL6], 613589 (3), Autosomal dominant
chr1	PSMA5	176844.0 | PSMA5, PSC5 | Proteasome component 5 | 5686.0 | ENSG00000143106 | nan | nan
chr1	AMIGO1	615689.0 | AMIGO1, ALI2, KIAA1163 | Adhesion molecule with Ig-like domain 1 | 57463.0 | ENSG00000181754 | nan | nan
chr1	GPR61	606916.0 | GPR61 | G protein-coupled receptor 61 | 83873.0 | ENSG00000156097 | nan | nan
chr1	GNAI3	139370.0 | GNAI3, ARCND1 | Guanine nucleotide-binding protein (G-protein), alpha-inhibiting activity polypeptide-3 | 2773.0 | ENSG00000065135 | nan | Auriculocondylar syndrome 1, 602483 (3), Autosomal dominant
chr1	MIR197	611189.0 | MIR197 | Micro rNA 197 | 406974.0 | ENSG00000284443 | nan | nan
chr1	GNAT2	139340.0 | GNAT2, ACHM4 | Guanine nucleotide-binding protein (G-protein), alpha-transducing (transducin) activity polypeptide-2 | 2780.0 | ENSG00000134183 | nan | Achromatopsia 4, 613856 (3)
chr1	AMPD2	102771.0 | AMPD2, SPG63, PCH9 | Adenosine monophosphate deaminase-2, isoform L | 271.0 | ENSG00000116337 | mutation identified in 1 SPG63 family | Pontocerebellar hypoplasia, type 9, 615809 (3), Autosomal recessive; ?Spastic paraplegia 63, autosomal recessive, 615686 (3), Autosomal recessive
chr1	GSTM4	138333.0 | GSTM4 | Glutathione S-transferase M4 | 2948.0 | ENSG00000168765 | nan | nan
chr1	GSTM2	138380.0 | GSTM2, GST4 | Glutathione S-transferase M2, muscle | 2946.0 | ENSG00000213366 | nan | nan
chr1	GSTM1	138350.0 | GSTM1 | Glutathione S-transferase M1 | 2944.0 | ENSG00000134184 | nan | nan
chr1	GSTM5	138385.0 | GSTM5 | Glutathione S-transferase M5 | 2949.0 | ENSG00000134201 | pseudogene on chr.3 | nan
chr1	GSTM3	138390.0 | GSTM3, GST5 | Glutathione S-transferase M3, brain | 2947.0 | ENSG00000134202 | nan | nan
chr1	EPS8L3	614989.0 | EPS8L3, EPS8R3, HYPT5 | EPS8-like protein 3 | 79574.0 | ENSG00000198758 | mutation identified in 1 HYPT5 family | ?Hypotrichosis 5, 612841 (3), Autosomal dominant
chr1	CSF1	120420.0 | CSF1, MCSF | Colony-stimulating factor-1 (macrophage) | 1435.0 | ENSG00000184371 | incorrectly assigned to chr.5 | nan
chr1	AHCYL1	607826.0 | AHCYL1, DCAL, IRBIT | Adenosylhomocysteine-like 1 | 10768.0 | ENSG00000168710 | nan | nan
chr1	STRIP1	617918.0 | STRIP1, FAR11A, FAM40A | Striatin-interacting protein 1 | 85369.0 | ENSG00000143093 | nan | nan
chr1	ALX3	606014.0 | ALX3, FND1 | Aristaless-like homeobox 3 | 257.0 | ENSG00000156150 | nan | Frontonasal dysplasia 1, 136760 (3), Autosomal recessive
chr1	UBL4B	611127.0 | UBL4B | Ubiquitin-like 4B | 164153.0 | ENSG00000186150 | nan | nan
chr1	SLC6A17	610299.0 | SLC6A17, NTT4, MRT48 | Solute carrier family 6 (neurotransmitter transporter), member 17 | 388662.0 | ENSG00000197106 | nan | Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive
chr1	KCNC4	176265.0 | KCNC4 | Potassium voltage-gated channel, Shaw-related subfamily, member 4 | 3749.0 | ENSG00000116396 | nan | nan
chr1	RBM15	606077.0 | RBM15, SPEN, OTT | One-twenty two protein (RNA binding motif protein 15; Spen, Drosophila, homolog of) | 64783.0 | ENSG00000162775 | nan | nan
chr1	SLC16A4	603878.0 | SLC16A4, MCT5 | Solute carrier family 16 (monocarboxylic acid transporter) member 4 | 9122.0 | ENSG00000168679 | nan | nan
chr1	LAMTOR5	608521.0 | LAMTOR5, HBXIP, XIP | Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 5 | 10542.0 | ENSG00000134248 | nan | nan
chr1	PROK1	606233.0 | PROK1, PK1, PRK1, EGVEGF | Prokineticin 1 | 84432.0 | ENSG00000143125 | nan | nan
chr1	KCNA10	602420.0 | KCNA10 | Potassium voltage-gated channel, shaker-related subfamily, member 10 | 3744.0 | ENSG00000143105 | nan | nan
chr1	KCNA2	176262.0 | KCNA2, DEE32 | Potassium channel, voltage-gated, Shaker-related subfamily, member 2 | 3737.0 | ENSG00000177301 | nan | Developmental and epileptic encephalopathy 32, 616366 (3), Autosomal dominant
chr1	KCNA3	176263.0 | KCNA3 | Potassium voltage-gated channel, shaker-related subfamily, member 3 | 3738.0 | ENSG00000177272 | mapped probably in error to chr.13 | nan
chr1	CD53	151525.0 | CD53, MOX44 | CD53 antigen | 963.0 | ENSG00000143119 | nan | nan
chr1	LRIF1	615354.0 | LRIF1, RIF1, FSHD3 | Ligand-dependent nuclear receptor-interacting factor 1 | 55791.0 | ENSG00000121931 | mutation identified in 1 FSHD3 patient | ?Facioscapulohumeral muscular dystrophy 3, digenic, 619477 (3), Digenic recessive
chr1	DRAM2	613360.0 | DRAM2, TMEM77, CORD21 | Damage-regulated autophagy modulator 2 | 128338.0 | ENSG00000156171 | nan | Cone-rod dystrophy 21, 616502 (3), Autosomal recessive
chr1	CEPT1	616751.0 | CEPT1 | Choline/ethanolamine phosphotransferase 1 | 10390.0 | ENSG00000134255 | nan | nan
chr1	DENND2D	615111.0 | DENND2D | DENN/MADD domain-containing protein 2D | 79961.0 | ENSG00000162777 | nan | nan
chr1	NR1H5P	617386.0 | NR1H5P, FXRB | Nuclear receptor subfamily 1, group H, member 5, pseudogene | 643609.0 | ENSG00000227970 | nan | nan
chr1	CHI3L2	601526.0 | CHI3L2, YKL39 | Chitinase 3-like 2 | 1117.0 | ENSG00000064886 | nan | nan
chr1	CHIA	606080.0 | CHIA, TSA1902, CHIT2 | Chitinase, acidic | 27159.0 | ENSG00000134216 | nan | nan
chr1	CIMAP3	614234.0 | C1orf88, PIFO | Chromosome 1 open reading frame 88 (pitchfork, mouse, homolog of) | 128344.0 | ENSG00000173947 | nan | nan
chr1	OVGP1	603578.0 | OVGP1 | Oviductal glycoprotein 1 | 5016.0 | ENSG00000085465 | nan | nan
chr1	WDR77	611734.0 | WDR77, MEP50 | WD repeat-containing protein 77 | 79084.0 | ENSG00000116455 | nan | nan
chr1	ATP5PB	603270.0 | ATP5PB, ATP5F1 | ATP synthase peripheral stalk membrane, subunit B | 515.0 | ENSG00000116459 | nan | nan
chr1	ADORA3	600445.0 | ADORA3 | Adenosine A3 receptor | 140.0 | ENSG00000282608 | nan | nan
chr1	RAP1A	179520.0 | RAP1A, KREV1 | RAS-related protein RAP1A | 5906.0 | ENSG00000116473 | pseudogene on 14q24.3 | nan
chr1	INKA2	620403.0 | INKA2, FAM212B | INKA-box actin regulator 2 | 55924.0 | ENSG00000197852 | nan | nan
chr1	DDX20	606168.0 | DDX20 | DEAD-box helicase 20 | 11218.0 | ENSG00000064703 | nan | nan
chr1	KCND3	605411.0 | KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9 | Potassium voltage-gated channel, Shal-related subfamily, member 3 | 3752.0 | ENSG00000171385 | nan | Spinocerebellar ataxia 19, 607346 (3), Autosomal dominant; Brugada syndrome 9, 616399 (3), Autosomal dominant
chr1	CTTNBP2NL	615100.0 | CTTNBP2NL | CTTNBP2 N terminus-like protein | 55917.0 | ENSG00000143079 | nan | nan
chr1	WNT2B	601968.0 | WNT2B, WNT13, XWNT2 | Wingless-type MMTV integration site family, member 2B | 7482.0 | ENSG00000134245 | nan | Diarrhea 9, 618168 (3), Autosomal recessive
chr1	ST7L	617640.0 | ST7L, ST7R | Suppressor of tumorigenicity 7-like protein | 54879.0 | ENSG00000007341 | nan | nan
chr1	CAPZA1	601580.0 | CAPZA1, CAPPA1 | Capping protein, muscle Z-line, alpha-1 | 829.0 | ENSG00000116489 | nan | nan
chr1	MOV10	610742.0 | MOV10, KIAA1631 | Mov10 RISC complex RNA helicase | 4343.0 | ENSG00000155363 | nan | nan
chr1	RHOC	165380.0 | RHOC, ARHC, ARH9, RHOH9 | RAS homolog gene family, member C (oncogene RHO H9) | 389.0 | ENSG00000155366 | incorrectly assigned to chr.5 | nan
chr1	PPM1J	609957.0 | PPM1J, PP2CZ, PPP2CZ | Protein phosphatase, magnesium-dependent, 1J | 333926.0 | ENSG00000155367 | nan | nan
chr1	TAFA3	617497.0 | FAM19A3, TAFA3 | Family with sequence similarity 19, member A3, CC motif chemokine-like | 284467.0 | ENSG00000184599 | nan | nan
chr1	SLC16A1	600682.0 | SLC16A1, MCT1, HHF7, MCT1D | Solute carrier family 16 (monocarboxylic acid transporters), member 1 | 6566.0 | ENSG00000155380 | nan | Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3), Autosomal dominant; Erythrocyte lactate transporter defect, 245340 (3), Autosomal dominant; Monocarboxylate transporter 1 deficiency, 616095 (3), Autosomal recessive, Autosomal dominant
chr1	LRIG2	608869.0 | LRIG2, LIG2, KIAA0806, UFS2 | Leucine-rich repeats- and immunoglobulin-like domains-containing protein 2 | 9860.0 | ENSG00000198799 | nan | Urofacial syndrome 2, 615112 (3), Autosomal recessive
chr1	MAGI3	615943.0 | MAGI3, KIAA1634 | Membrane-associated guanylate kinase, WW and PDZ domains-containing, 3 | 260425.0 | ENSG00000081026 | nan | nan
chr1	PHTF1	604950.0 | PHTF1 | Putative homeodomain transcription factor 1 | 10745.0 | ENSG00000116793 | nan | nan
chr1	RSBN1	615858.0 | RSBN1, ROSBIN | Round spermatid basic protein 1 | 54665.0 | ENSG00000081019 | nan | nan
chr1	PTPN22	600716.0 | PTPN22, PEP, PTPN8, LYP | Protein tyrosine phosphatase, nonreceptor-type 22 | 26191.0 | ENSG00000134242 | nan | {Rheumatoid arthritis, susceptibility to}, 180300 (3); {Systemic lupus erythematosus susceptibility to}, 152700 (3), Autosomal dominant; {Diabetes, type 1, susceptibility to}, 222100 (3), Autosomal recessive
chr1	BCL2L15	619660.0 | BCL2L15, BFK | BCL2-like 15 | 440603.0 | ENSG00000188761 | nan | nan
chr1	AP4B1	607245.0 | AP4B1, SPG47, CPSQ5 | Adaptor-related protein complex 4, beta-1 subunit | 10717.0 | ENSG00000134262 | nan | Spastic paraplegia 47, autosomal recessive, 614066 (3), Autosomal recessive
chr1	DCLRE1B	609683.0 | DCLRE1B, SNM1B, APOLLO, DKCB8 | DNA cross-link repair protein 1B | 64858.0 | ENSG00000118655 | nan | Dyskeratosis congenita, autosomal recessive 8, 620133 (3), Autosomal recessive
chr1	HIPK1	608003.0 | HIPK1 | Homeodomain-interacting protein kinase 1 | 204851.0 | ENSG00000163349 | nan | nan
chr1	OLFML3	610088.0 | OLFML3, OLF44 | Olfactomedin-like 3 | 56944.0 | ENSG00000116774 | nan | nan
chr1	SYT6	607718.0 | SYT6 | Synaptotagmin 6 | 148281.0 | ENSG00000134207 | nan | nan
chr1	TRIM33	605769.0 | TRIM33, TIF1G, RFG7, PTC7 | Tripartite motif-containing protein 33 | 51592.0 | ENSG00000197323 | fused with RET to form PTC7 | nan
chr1	BCAS2	605783.0 | BCAS2, DAM1 | BCAS2 pre-mRNA processing factor | 10286.0 | ENSG00000116752 | nan | nan
chr1	AMPD1	102770.0 | AMPD1, MMDD | Adenosine monophosphate deaminase-1, muscle | 270.0 | ENSG00000116748 | nan | Myopathy due to myoadenylate deaminase deficiency, 615511 (3), Autosomal recessive
chr1	NRAS	164790.0 | NRAS, ALPS4, NS6, CMNS, NCMS | NRAS protooncogene, GTPase | 4893.0 | ENSG00000213281 | cen-CD2-NGFB-NRAS | Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)
chr1	CSDE1	191510.0 | CSDE1, D1S155E, UNR | Cold-shock domain-containing E1, RNA-binding | 7812.0 | ENSG00000009307 | 130bp 5' to NRAS | nan
chr1	SIKE1	611656.0 | SIKE | Suppressor of IKK-epsilon | 80143.0 | ENSG00000052723 | nan | nan
chr1	SYCP1	602162.0 | SYCP1, SCP1 | Synaptonemal complex protein-1 | 6847.0 | ENSG00000198765 | nan | nan
chr1	TSHB	188540.0 | TSHB, CHNG4 | Thyroid-stimulating hormone, beta polypeptide | 7252.0 | ENSG00000134200 | centromeric to NGFB | Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive
chr1	TSPAN2	613133.0 | TSPAN2, NET3 | Tetraspanin 2 | 10100.0 | ENSG00000134198 | nan | nan
chr1	NGF	162030.0 | NGF, NGFB, HSAN5 | Nerve growth factor, beta | 4803.0 | ENSG00000134259 | same 310kb fragment as TSHB; order: cen-CD2-CD58-ATP1A1-NGF-TSHB-NRAS-tel | Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive
chr1	VANGL1	610132.0 | VANGL1, STBM2 | Vang-like 1 | 81839.0 | ENSG00000173218 | nan | {Neural tube defects, susceptibility to}, 182940 (3), Autosomal dominant; Caudal regression syndrome, 600145 (3), Autosomal dominant
chr1	CASQ2	114251.0 | CASQ2 | Calsequestrin, fast-twitch, skeletal muscle-2 | 845.0 | ENSG00000118729 | nan | Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3), Autosomal recessive
chr1	NHLH2	162361.0 | NHLH2, HEN2, HH27 | Nescient helix loop helix 2 | 4808.0 | ENSG00000177551 | mutation identified in 1 HH27 patient | ?Hypogonadotropic hypogonadism 27 without anosmia, 619755 (3), Autosomal recessive
chr1	SLC22A15	608275.0 | SLC22A15, FLIPT1 | Solute carrier family 22 (organic cation transporter), member 15 | 55356.0 | ENSG00000163393 | nan | nan
chr1	ATP1A1	182310.0 | ATP1A1, CMT2DD, HOMGSMR2 | ATPase, Na+K+ transporting, alpha-1 polypeptide | 476.0 | ENSG00000163399 | nan | Hypomagnesemia, seizures, and impaired intellectual development 2, 618314 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2DD, 618036 (3), Autosomal dominant
chr1	ATP1A1-AS1	618305.0 | ATP1A1AS1 | ATP1A1 antisense RNA 1 | 84852.0 | ENSG00000203865 | nan | nan
chr1	CD58	153420.0 | CD58, LFA3 | CD58 antigen (lymphocyte function-associated antigen 3) | 965.0 | ENSG00000116815 | ?same as MSK1; gene cloned | nan
chr1	IGSF3	603491.0 | IGSF3, LCDD | Immunoglobulin superfamily, member 3 | 3321.0 | ENSG00000143061 | mutation identified in 1 LCDD family | ?Lacrimal duct defect, 149700 (3), Autosomal recessive
chr1	CD2	186990.0 | CD2 | CD2 antigen (p50), sheep red blood cell receptor | 914.0 | ENSG00000116824 | nan | nan
chr1	PTGFRN	601204.0 | PTGFRN, FPRP | Prostaglandin F2 receptor negative regulator | 5738.0 | ENSG00000134247 | nan | nan
chr1	CD101	604516.0 | CD101, IGSF2 | CD101 antigen | 9398.0 | ENSG00000134256 | nan | nan
chr1	TTF2	604718.0 | TTF2 | Transcription termination factor 2 | 8458.0 | ENSG00000116830 | nan | nan
chr1	TRIM45	609318.0 | TRIM45 | Tripartite motif-containing protein 45 | 80263.0 | ENSG00000134253 | nan | nan
chr1	VTCN1	608162.0 | VCTN1, B7H4, B7X, B7S1 | V-set domain containing T cell activation inhibitor 1 | 79679.0 | ENSG00000134258 | nan | nan
chr1	NOTCH2NLR	618026.0 | NOTCH2NLR | NOTCH2 N-terminal-like-related, pseudogene | 101929796.0 | ENSG00000286106 | nan | nan
chr1	MAN1A2	604345.0 | MAN1A2 | Mannosidase, alpha, class 1A, member 2 | 10905.0 | ENSG00000198162 | nan | nan
chr1	TENT5C	613952.0 | TENT5C, FAM46C | Terminal nucleotidyltransferase 5C | 54855.0 | ENSG00000183508 | nan | nan
chr1	GDAP2	618128.0 | GDAP2, SCAR27 | Ganglioside-induced differentiation-associated protein 2 | 54834.0 | ENSG00000196505 | nan | Spinocerebellar ataxia, autosomal recessive 27, 618369 (3), Autosomal recessive
chr1	WDR3	604737.0 | WDR3 | WD repeat-containing protein 3 | 10885.0 | ENSG00000065183 | nan | nan
chr1	SPAG17	616554.0 | SPAG17, PF6, SPGF55 | Sperm-associated antigen 17 | 200162.0 | ENSG00000155761 | mutation identified in 1 SPGF55 family | ?Spermatogenic failure 55, 619380 (3), Autosomal recessive
chr1	TBX15	604127.0 | TBX15 | T-box 15 | 6913.0 | ENSG00000092607 | nan | Cousin syndrome, 260660 (3), Autosomal recessive
chr1	WARS2	604733.0 | WARS2, NEMMLAS, PKDYS3 | Tryptophanyl-tRNA synthetase 2 | 10352.0 | ENSG00000116874 | nan | Parkinsonism-dystonia 3, childhood-onset, 619738 (3), Autosomal recessive; Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, 617710 (3), Autosomal recessive
chr1	HAO2	605176.0 | HAO2, HAOX2 | Hydroxyacid oxidase 2 | 51179.0 | ENSG00000116882 | nan | nan
chr1	HSD3B2	613890.0 | HSD3B2 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 2 (adrenal, gonadal) | 3284.0 | ENSG00000203859 | nan | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive
chr1	HSD3B1	109715.0 | HSD3B1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 1 (placental, peripheral) | 3283.0 | ENSG00000203857 | nan | nan
chr1	ZNF697	620981.0 | ZNF697, ZFP697 | Zinc finger protein 697 | 90874.0 | ENSG00000143067 | nan | nan
chr1	PHGDH	606879.0 | PHGDH, NLS1, PHGDHD | Phosphoglycerate dehydrogenase | 26227.0 | ENSG00000092621 | nan | Neu-Laxova syndrome 1, 256520 (3), Autosomal recessive; Phosphoglycerate dehydrogenase deficiency, 601815 (3), Autosomal recessive
chr1	HMGCS2	600234.0 | HMGCS2 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2, mitochondrial | 3158.0 | ENSG00000134240 | nan | HMG-CoA synthase-2 deficiency, 605911 (3), Autosomal recessive
chr1	REG4	609846.0 | REG4 | Regenerating islet-derived family, member 4 | 83998.0 | ENSG00000134193 | nan | nan
chr1	NBPF7P	613997.0 | NBPF7 | Neuroblastoma breakpoint family, member 7 | 343505.0 | nan | nan | nan
chr1	ADAM30	604779.0 | ADAM30 | ADAM metallopeptidase domain 30 | 11085.0 | ENSG00000134249 | nan | nan
chr1	NOTCH2	600275.0 | NOTCH2, AGS2, HJCYS | Notch receptor 2 | 4853.0 | ENSG00000134250 | nan | Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant
chr1	SEC22B	604029.0 | SEC22B, SEC22L1 | SEC22 homolog B, vesicle trafficking protein | 9554.0 | ENSG00000265808 | nan | nan
chr1	MNRI	606190.0 | MNRI | Meningioma, radiation-induced | 117192.0 | nan | nan | Meningioma, radiation-induced, 606190 (2)
chr1	NBPF8	613998.0 | NBPF8 | Neuroblastoma breakpoint family, member 8 | 728841.0 | ENSG00000270231 | nan | nan
chr1	PFN1P2	608609.0 | C1orf152, COAS3 | Chromosome 1 open reading frame 152 | 767846.0 | ENSG00000293296 | nan | nan
chr1	FCGR1BP	601502.0 | FCGR1B, CD34 | Fc fragment of IgG receptor Ib | 2210.0 | ENSG00000291135 | nan | nan
chr1	FAM72B	614711.0 | FAM72B | Family with sequence similarity 72, member B | 653820.0 | ENSG00000188610 | nan | nan
chr1	SRGAP2C	614704.0 | SRGAP2C | SLIT-ROBO Rho GTPase-activating protein 2C | 653464.0 | ENSG00000171943 | nan | nan
chr1		151628.0 | LRE2 | LINE retrotransposable element-2 | nan | nan | inserted in DMD gene | nan
chr1	CORD8	605549.0 | CORD8 | Cone-rod dystrophy 8 | 54109.0 | nan | nan | Cone-rod dystrophy 8, 605549 (2), Autosomal recessive
chr1	GNRHR2	612875.0 | GNRHR2 | Gonadotropin-releasing hormone receptor 2 | 114814.0 | ENSG00000293505 | ?processed pseudogene | nan
chr1		189890.0 | TRNL | tRNA asparagine-like | nan | nan | nan | nan
chr1	AD13	611152.0 | AD13 | Alzheimer disease-13 | 100188837.0 | nan | max lod D1S498 | {Alzheimer disease-13}, 611152 (2)
chr1	ASPG3	608781.0 | ASPG3 | Asperger syndrome, susceptibility to, 3 | 449015.0 | nan | max lod at D1S484 | {Asperger syndrome susceptibility 3}, 608781 (2)
chr1	BMND2	605833.0 | BMND2 | Bone mineral density QTL 2 | 338027.0 | nan | nan | [Bone mineral density QTL 2], 605833 (2)
chr1		612474.0 | DEL1q21, C1DELq21 | Chromosome 1q21.1 deletion syndrome | nan | nan | contiguous gene deletion syndrome | Chromosome 1q21.1 deletion syndrome, 612474 (4), Isolated cases, Autosomal dominant
chr1	DFNA49	608372.0 | DFNA49 | Deafness, autosomal dominant 49 | 317664.0 | nan | max lod at D1S3784 and D1S3786 | Deafness, autosomal dominant 49, 608372 (2), Autosomal dominant
chr1		612475.0 | DUP1q21, C1DUPq21 | Chromosome 1q21.1 duplication syndrome | nan | nan | contiguous gene duplication syndrome | Chromosome 1q21.1 duplication syndrome, 612475 (4), Isolated cases, Autosomal dominant
chr1	ERVK-7	614013.0 | ERVK-7, HERV-KIII, HERV-K102 | Endogenous retrovirus group K, member 7 | 449619.0 | nan | nan | nan
chr1	NBLST6	613017.0 | NBLST6 | Neuroblastoma, susceptibility to, 6 | 100306939.0 | nan | ?contiguous gene deletion or duplication disease | {Neuroblastoma, susceptibility to, 6}, 613017 (2)
chr1	NBPF17P	612970.0 | NBPF17P, NBPF23 | Neuroblastoma breakpoint family, member 17, pseudogene | 401967.0 | ENSG00000179571 | nan | nan
chr1	PSORS4	603935.0 | PSORS4 | Psoriasis susceptibility 4 | 10547.0 | nan | nan | {Psoriasis susceptibility 4}, 603935 (2)
chr1	PTCPRN	605642.0 | PTCPRN, PRN1 | Papillary thyroid carcinoma with papillary renal neoplasia | 79052.0 | nan | nan | Thyroid carcinoma, papillary, with papillary renal neoplasia, 605642 (2)
chr1	RFH1	161900.0 | RFH1, AORF | Renal failure, progressive, with hypertension | 59331.0 | nan | nan | Nephropathy-hypertension, 161900 (2), Autosomal dominant
chr1	SLEB14	613145.0 | SLEB14 | Systemic lupus erythematosus, susceptibility to, 14 | 100322878.0 | nan | associated with rs3093061 | {Systemic lupus erythematosus, susceptibility to, 14}, 613145 (2)
chr1	SPRR2C	182269.0 | SPRR2C | Small proline-rich protein 2C | 6702.0 | ENSG00000301592 | prob. pseudogene | nan
chr1	UAQTL6	614747.0 | UAQTL6 | Uric acid concentration, serum, quantitative trait locus 6 | 100996935.0 | nan | associated with C/T variant at chr1_142697422 | [Uric acid concentration, serum, QTL6], 614747 (2)
chr1	FCGR1CP	601503.0 | FCGR1C, CD64 | Fc fragment of IgG receptor Ic, pseudogene | 100132417.0 | ENSG00000265531 | nan | nan
chr1	FAM72C	616853.0 | FAM72C | Family with sequence similarity 72, member C | 554282.0 | ENSG00000263513 | nan | nan
chr1	SRGAP2D	614705.0 | SRGAP2D | SLIT-ROBO Rho GTPase-activating protein 2D | 100996712.0 | nan | nan | nan
chr1	PPIAL4E	608608.0 | PPIAL4A, COAS2 | Peptidylprolyl isomerase A (cyclophilin A)-like 4A | 730262.0 | ENSG00000271567 | nan | nan
chr1	NBPF15	610414.0 | NBPF15, MGC8902 | Neuroblastoma breakpoint family, member 15 | 284565.0 | ENSG00000266338 | contains 6 copies of DUF1220 domain | nan
chr1	SRGAP2B	614703.0 | SRGAP2B | SLIT-ROBO Rho GTPase-activating protein 2B | 647135.0 | ENSG00000196369 | nan | nan
chr1	FAM72D	614712.0 | FAM72D | Family with sequence similarity 72, member D | 728833.0 | ENSG00000215784 | nan | nan
chr1	TRN-GTT2-7	189880.0 | TRNAN1, TRN1, TRN | tRNA asparagine | 7214.0 | nan | nan | nan
chr1	NBPF20	614007.0 | NBPF20 | Neuroblastoma breakpoint family, member 20 | 100288142.0 | ENSG00000162825 | nan | nan
chr1	GPR89A	612821.0 | GPR89A | G protein-coupled receptor 89A | 653519.0 | ENSG00000117262 | nan | nan
chr1	PDZK1	603831.0 | PDZK1 | PDZ domain-containing 1 | 5174.0 | ENSG00000174827 | nan | nan
chr1	CD160	604463.0 | CD160, BY55 | CD160 antigen | 11126.0 | ENSG00000117281 | nan | nan
chr1	RNF115	619535.0 | RNF115, BCA2, RABRING7, ZFP364 | RING finger protein 115 | 27246.0 | ENSG00000265491 | nan | nan
chr1	POLR3C	617454.0 | POLR3C, RPC62, RPC3 | Polymerase III, RNA, subunit C | 10623.0 | ENSG00000186141 | nan | nan
chr1	PIAS3	605987.0 | PIAS3 | Protein inhibitor of activated STAT3 | 10401.0 | ENSG00000131788 | nan | nan
chr1	ITGA10	604042.0 | ITGA10 | Integrin, alpha-10 | 8515.0 | ENSG00000143127 | nan | nan
chr1	PEX11B	603867.0 | PEX11B, PEX14B | Peroxisome biogenesis 11B | 8799.0 | ENSG00000131779 | nan | Peroxisome biogenesis disorder 14B, 614920 (3), Autosomal recessive
chr1	RBM8A	605313.0 | RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1 | RNA-binding motif protein 8A | 9939.0 | ENSG00000265241 | pseudogene on chr.14 | Thrombocytopenia-absent radius syndrome, 274000 (3), Autosomal recessive
chr1	POLR3GL	617457.0 | POLR3GL, SOFM | Polymerase III, RNA, subunit G-like | 84265.0 | ENSG00000121851 | nan | Short stature, oligodontia, dysmorphic facies, and motor delay, 619234 (3), Autosomal recessive
chr1	TXNIP	606599.0 | TXNIP, VDUP1 | Thioredoxin-interacting protein | 10628.0 | ENSG00000265972 | nan | nan
chr1	HJV	608374.0 | HJV, HFE2A | Hemojuvelin | 148738.0 | ENSG00000168509 | between D1S442 and D1S2347 | Hemochromatosis, type 2A, 602390 (3), Autosomal recessive
chr1	NBPF10	614000.0 | NBPF10 | Neuroblastoma breakpoint family, member 10 | 100132406.0 | ENSG00000271425 | nan | nan
chr1	NOTCH2NLA	618023.0 | NOTCH2NLA | NOTCH2 N-terminal-like protein A | 388677.0 | ENSG00000264343 | nan | nan
chr1	HYDIN2	610813.0 | HYDIN2, KIAA1864 | HYDIN axonemal central pair apparatus protein 2 | 100288805.0 | nan | duplicated copy 16q22.2 | nan
chr1	NBPF12	608607.0 | NBPF12, COAS1, KIAA1245 | Neuroblastoma breakpoint family, member 12 | 149013.0 | ENSG00000268043 | nan | nan
chr1	PRKAB2	602741.0 | PRKAB2 | Protein kinase, AMP-activated, noncatalytic, beta-2 | 5565.0 | ENSG00000131791 | nan | nan
chr1	CHD1L	613039.0 | CHD1L, ALC1 | Chromodomain helicase DNA-binding protein 1-like | 9557.0 | ENSG00000131778 | nan | nan
chr1	FMO5	603957.0 | FMO5 | Flavin-containing monooxygenase 5 | 2330.0 | ENSG00000131781 | nan | nan
chr1	BCL9	602597.0 | BCL9 | B-cell CLL/lymphoma-9 | 607.0 | ENSG00000116128 | nan | nan
chr1	ACP6	611471.0 | ACP6, LPAP, ACPL1 | Acid phosphatase 6, lysophosphatide | 51205.0 | ENSG00000162836 | nan | nan
chr1	GJA5	121013.0 | GJA5, CX40, ATFB11 | Gap junction protein, alpha-5, 40kD (connexin 40) | 2702.0 | ENSG00000265107 | nan | Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant
chr1	GJA8	600897.0 | GJA8, CX50, CTRCT1, CZP1, CAE1 | Gap junction membrane channel protein alpha-8 (connexin 50) | 2703.0 | ENSG00000121634 | nan | Cataract 1, multiple types, 116200 (3), Autosomal dominant
chr1	GPR89B	612806.0 | GPR89B, GPHR | G protein-coupled receptor 89B | 51463.0 | ENSG00000188092 | nan | nan
chr1	NBPF11	614001.0 | NBPF11 | Neuroblastoma breakpoint family, member 11 | 200030.0 | ENSG00000263956 | nan | nan
chr1	NBPF14	614003.0 | NBPF14 | Neuroblastoma breakpoint, member 14 | 25832.0 | ENSG00000270629 | nan | nan
chr1	NOTCH2NLB	618024.0 | NOTCH2NLB | NOTCH2 N-terminal-like protein B | 100996763.0 | ENSG00000286019 | nan | nan
chr1	PDE4DIP	608117.0 | PDE4DIP, MMGL, KIAA0454, KIAA0477 | Phosphodiesterase 4D-interacting protein | 9659.0 | ENSG00000178104 | nan | nan
chr1	NBPF9	613999.0 | NBPF9 | Neuroblastoma breakpoint family, member 9 | 400818.0 | ENSG00000269713 | nan | nan
chr1	NOTCH2NLC	618025.0 | NOTCH2NLC, NIID, ETM6, OPDM3 | NOTCH2 N-terminal-like protein C | 100996717.0 | ENSG00000286219 | nan | Tremor, hereditary essential, 6, 618866 (3), Autosomal dominant; Oculopharyngodistal myopathy 3, 619473 (3), Autosomal dominant; Neuronal intranuclear inclusion disease, 603472 (3), Autosomal dominant
chr1	NBPF19	614006.0 | NBPF19 | Neuroblastoma breakpoint family, member 19 | 101060226.0 | ENSG00000271383 | nan | nan
chr1	FCGR1A	146760.0 | FCGR1A, IGFR1, CD64 | Fc fragment of IgG receptor Ia | 2209.0 | ENSG00000150337 | nan | [IgG receptor I, phagocytic, familial deficiency of] (3)
chr1	H4C14	142750.0 | H4C14, H4FN, H4F2 | H4 clustered histone 14 | 8370.0 | ENSG00000270882 | 100-200 histone genes; some on chromosome 6 and 12, as well as perhaps 7 | nan
chr1	H3C14	142780.0 | H3C14, HIST2H3C, H3F2 | H3 clustered histone 14 | 126961.0 | ENSG00000203811 | nan | nan
chr1	H2AC18	142720.0 | H2AC18, HIST2H2AA, H2AFO, H2A | H2A clustered histone 18 | 8337.0 | ENSG00000288825 | nan | nan
chr1	H2BC21	601831.0 | H2BC21, HIST2H2BE, H2B | H2B clustered histone 21 | 8349.0 | ENSG00000184678 | nan | nan
chr1	H2AC20	602797.0 | H2AC20, HIST2H2AC, H2AFQ | H2A clustered histone 20 | 8338.0 | ENSG00000184260 | nan | nan
chr1	H2AC21	615014.0 | H2AC21, HIST2H2AB, H2AB | H2A clustered histone 21 | 317772.0 | ENSG00000184270 | nan | nan
chr1	BOLA1	613181.0 | BOLA1 | bolA family member 1 | 51027.0 | ENSG00000178096 | nan | nan
chr1	SV2A	185860.0 | SV2A, SV2, DEE113 | Synaptic vesicle glycoprotein 2A | 9900.0 | ENSG00000159164 | nan | Developmental and epileptic encephalopathy 113, 620772 (3), Autosomal recessive
chr1	SF3B4	605593.0 | SF3B4, SF3B49, SAP49, AFD1 | Splicing factor 3B, subunit 4 | 10262.0 | ENSG00000143368 | nan | Acrofacial dysostosis 1, Nager type, 154400 (3), Autosomal dominant
chr1	OTUD7B	611748.0 | OTUD7B, CEZANNE | OTU domain-containing protein 7B | 56957.0 | ENSG00000264522 | nan | nan
chr1	VPS45	610035.0 | VPS45, VPS45A, SCN5 | Vacuolar protein sorting 45 homolog | 11311.0 | ENSG00000136631 | nan | Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3), Autosomal recessive
chr1	PLEKHO1	608335.0 | PLEKHO1, CKIP1 | Pleckstrin homology domain-containing protein, family O, member 1 | 51177.0 | ENSG00000023902 | nan | nan
chr1	ANP32E	609611.0 | ANP32E, LANPL | Acidic leucine-rich nuclear phosphoprotein 32 family, member E | 81611.0 | ENSG00000143401 | nan | nan
chr1	CA14	604832.0 | CA14 | Carbonic anhydrase XIV | 23632.0 | ENSG00000118298 | nan | nan
chr1	APH1A	607629.0 | APH1A | APH1 homolog A, gamma secretase subunit | 51107.0 | ENSG00000117362 | nan | nan
chr1	CIART	615782.0 | CIART, CHRONO, GM129 | Circadian-associated repressor of transcription | 148523.0 | ENSG00000159208 | nan | nan
chr1	MRPS21	611984.0 | MRPS21 | Mitochondrial ribosomal protein S21 | 54460.0 | ENSG00000266472 | 9 pseudogenes | nan
chr1	PRPF3	607301.0 | PRPF3, HPRP3, RP18 | Pre-mRNA processing factor 3 | 9129.0 | ENSG00000117360 | nan | Retinitis pigmentosa 18, 601414 (3), Autosomal dominant
chr1	RPRD2	614695.0 | RPRD2 | Regulation of nuclear pre-mRNA domain-containing 2 | 23248.0 | ENSG00000163125 | nan | nan
chr1	TARS2	612805.0 | TARS2, COXPD21 | Threonyl-tRNA synthetase 2 | 80222.0 | ENSG00000143374 | nan | Combined oxidative phosphorylation deficiency 21, 615918 (3), Autosomal recessive
chr1	ECM1	602201.0 | ECM1, URBWD | Extracellular matrix protein-1 | 1893.0 | ENSG00000143369 | nan | Urbach-Wiethe disease, 247100 (3), Autosomal recessive
chr1	FALEC	616092.0 | FALEC, FAL1 | Focally amplified long noncoding RNA in epithelial cancer | 100874054.0 | ENSG00000228126 | nan | nan
chr1	ADAMTSL4	610113.0 | ADAMTSL4, TSRC1, ECTOL2 | ADAMTS-like 4 | 54507.0 | ENSG00000143382 | nan | Ectopia lentis et pupillae, 225200 (3), Autosomal recessive; Ectopia lentis, isolated, autosomal recessive, 225100 (3), Autosomal recessive
chr1	MCL1	159552.0 | MCL1 | Myeloid cell leukemia sequence 1 (BCL2-related) | 4170.0 | ENSG00000143384 | nan | nan
chr1	HRM2	139450.0 | HRM2 | Hair morphology 2 (curly hair) | 100379199.0 | nan | associated with rs11803731 | Hair, curly, 139450 (2), Autosomal dominant
chr1	ENSA	603061.0 | ENSA | Endosulfine, alpha | 2029.0 | ENSG00000143420 | nan | nan
chr1	GOLPH3L	612208.0 | GOLPH3L, GPP34R | Golgi phosphoprotein 3-like | 55204.0 | ENSG00000143457 | nan | nan
chr1	HORMAD1	609824.0 | HORMAD1, NOHMA | HORMA domain-containing 1 | 84072.0 | ENSG00000143452 | nan | nan
chr1	CTSS	116845.0 | CTSS | Cathepsin S | 1520.0 | ENSG00000163131 | nan | nan
chr1	CTSK	601105.0 | CTSK | Cathepsin K | 1513.0 | ENSG00000143387 | nan | Pycnodysostosis, 265800 (3), Autosomal recessive
chr1	ARNT	126110.0 | ARNT | Aryl hydrocarbon receptor nuclear translocator | 405.0 | ENSG00000143437 | nan | nan
chr1	SETDB1	604396.0 | SETDB1 | SET domain protein, bifurcated, 1 | 9869.0 | ENSG00000143379 | nan | nan
chr1	CERS2	606920.0 | CERS2, LASS2 | Ceramide synthase 2 | 29956.0 | ENSG00000143418 | nan | nan
chr1	ANXA9	603319.0 | ANXA9, ANX31 | Annexin A9 (annexin XXXI) | 8416.0 | ENSG00000143412 | nan | nan
chr1	MINDY1	618407.0 | MINDY1, FAM63A | MINDY lysine-48 deubiquitinase 1 | 55793.0 | ENSG00000143409 | nan | nan
chr1	PRUNE1	617413.0 | PRUNE1, DRES17, NMIHBA | Prune exopolyphosphatase 1 | 58497.0 | ENSG00000143363 | nan | Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, 617481 (3), Autosomal recessive
chr1	BNIPL	611275.0 | BNIPL, BNIPS, BNIPL1, BNIPL2 | BCL2/adenovirus E1B 19kD protein-interacting protein 2-like | 149428.0 | ENSG00000163141 | nan | nan
chr1	CDC42SE1	619456.0 | CDC42SE1, SPEC1 | CDC42 small effector 1 | 56882.0 | ENSG00000197622 | nan | nan
chr1	MLLT11	604684.0 | MLLT11, AF1Q | Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 11 | 10962.0 | ENSG00000213190 | nan | nan
chr1	SEMA6C	609294.0 | SEMA6C, KIAA1869 | Semaphorin 6C | 10500.0 | ENSG00000143434 | nan | nan
chr1	TNFAIP8L2	612112.0 | TNFAIP8L2, TIPE2 | Tumor necrosis factor-alpha-induced protein 8-like 2 | 79626.0 | ENSG00000163154 | nan | nan
chr1	SCNM1	608095.0 | SCNM1, MGC3180, OFD19 | Sodium channel modifier 1 | 79005.0 | ENSG00000163156 | nan | Orofaciodigital syndrome XIX, 620107 (3), Autosomal recessive
chr1	TMOD4	605834.0 | TMOD4 | Tropomodulin 4, muscle | 29765.0 | ENSG00000163157 | nan | nan
chr1	VPS72	600607.0 | VPS72, CFL1, YL1 | Vacuolar protein sorting 72 homolog | 6944.0 | ENSG00000163159 | nan | nan
chr1	PIP5K1A	603275.0 | PIP5K1A | Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha | 8394.0 | ENSG00000143398 | nan | nan
chr1	PSMD4	601648.0 | PSMD4, S5A, RPN10 | Proteasome 26S subunit, non-ATPase, 4 | 5710.0 | ENSG00000159352 | nan | nan
chr1	ZNF687	610568.0 | ZNF687, KIAA1441, PDB6 | Zinc finger protein 687 | 57592.0 | ENSG00000143373 | fused with AML1 in t(1;21) | Paget disease of bone 6, 616833 (3), Autosomal dominant
chr1	PI4KB	602758.0 | PI4KB, PIK4CB, DFNA87 | Phosphatidylinositol 4-kinase, beta | 5298.0 | ENSG00000143393 | nan | Deafness, autosomal dominant 87, 620281 (3), Autosomal dominant
chr1	RFX5	601863.0 | RFX5, MHC2D3, MHC2D5 | Regulatory factor X, 5 (influences HLA class II expression) | 5993.0 | ENSG00000143390 | mutation identified in 1 MHC2D5 family | ?MHC class II deficiency 5, 620818 (3), Autosomal recessive; MHC class II deficiency 3, 620816 (3), Autosomal recessive
chr1	SELENBP1	604188.0 | SELENBP1, SP56, EHMTO | Selenium-binding protein 1 | 8991.0 | ENSG00000143416 | nan | Extraoral halitosis due to MTO deficiency, 618148 (3), Autosomal recessive
chr1	PSMB4	602177.0 | PSMB4, PRAAS3 | Proteasome subunit, beta type, 4 | 5692.0 | ENSG00000159377 | mutation identified in 1 PRAAS3 patient and 1 digenic family | ?Proteasome-associated autoinflammatory syndrome 3 and digenic forms, 617591 (3), Autosomal recessive
chr1	POGZ	614787.0 | POGZ, KIAA0461, MRD37, WHSUS | POGO transposable-element derived protein with ZNF domain | 23126.0 | ENSG00000143442 | nan | White-Sutton syndrome, 616364 (3), Autosomal dominant
chr1	CGN	609473.0 | CGN, KIAA1319 | Cingulin | 57530.0 | ENSG00000143375 | nan | nan
chr1	TUFT1	600087.0 | TUFT1, WHSF | Tuftelin 1 | 7286.0 | ENSG00000143367 | nan | Woolly hair-skin fragility syndrome, 620415 (3), Autosomal recessive
chr1	SNX27	611541.0 | SNX27, MRT1 | Sorting nexin 27 | 81609.0 | ENSG00000143376 | nan | nan
chr1	CELF3	612678.0 | CELF3, TNRC4, BRUNOL1 | CUGbp- and ELAV-like family, member 3 | 11189.0 | ENSG00000159409 | nan | nan
chr1	MRPL9	611824.0 | MRPL9 | Mitochondrial ribosomal protein L9 | 65005.0 | ENSG00000143436 | nan | nan
chr1	OAZ3	605138.0 | OAZ3, AZ3 | Ornithine decarboxylase antizyme 3 | 51686.0 | ENSG00000143450 | nan | nan
chr1	TDRKH	609501.0 | TDRKH | Tudor and KH domains-containing protein | 11022.0 | ENSG00000182134 | nan | nan
chr1	LINGO4	609794.0 | LINGO4, LRRN6D | Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 4 | 339398.0 | ENSG00000213171 | nan | nan
chr1	RORC	602943.0 | RORC, RORG, RZRG, IMD42 | RAR-related orphan receptor C | 6097.0 | ENSG00000143365 | nan | Immunodeficiency 42, 616622 (3), Autosomal recessive
chr1	THEM5	615653.0 | THEM5, ACOT15 | Thioesterase superfamily member 5 | 284486.0 | ENSG00000196407 | nan | nan
chr1	THEM4	606388.0 | CTMP | C-terminal modulator protein | 117145.0 | ENSG00000159445 | nan | nan
chr1	S100A10	114085.0 | S100A10, CAL1L | S100 calcium-binding protein A10 (annexin II ligand, calpactin I, light polypeptide (p11)) | 6281.0 | ENSG00000197747 | on chr.3 in mouse | nan
chr1	S100A11	603114.0 | S100A11 | S100 calcium-binding protein A11 | 6282.0 | ENSG00000163191 | nan | nan
chr1	TCHH	190370.0 | TCHH, THH, THL, TRHY, UHS3 | Trichohyalin | 7062.0 | ENSG00000159450 | mutation identified in 1 UHS3 patient | ?Uncombable hair syndrome 3, 617252 (3), Autosomal recessive
chr1	RPTN	613259.0 | RPTN | Repetin | 126638.0 | ENSG00000215853 | nan | nan
chr1	HRNR	616293.0 | HRNR | Hornerin | 388697.0 | ENSG00000197915 | nan | nan
chr1	FLG	135940.0 | FLG, ATOD2 | Filaggrin | 2312.0 | ENSG00000143631 | nan | Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)
chr1	FLG2	616284.0 | FLG2, IFPS, PSS6 | Filaggrin family, member 2 | 388698.0 | ENSG00000143520 | nan | Peeling skin syndrome 6, 618084 (3), Autosomal recessive
chr1	CRNN	611312.0 | CRNN, C1orf10, PDRC1 | Cornulin | 49860.0 | ENSG00000143536 | nan | nan
chr1	LCE5A	612619.0 | LCE5A, LEP18 | Late cornified envelope protein 5A | 254910.0 | ENSG00000186207 | nan | nan
chr1	CRCT1	617426.0 | CRCT1, NICE1, C1orf42 | Cysteine-rich c-terminal 1 | 54544.0 | ENSG00000169509 | nan | nan
chr1	LCE3E	612617.0 | LCE3E, LEP17 | Late cornified envelope protein 3E | 353145.0 | ENSG00000185966 | nan | nan
chr1	LCE3D	612616.0 | LCE3D, LEP16 | Late cornified envelope protein 3D | 84648.0 | ENSG00000163202 | within intron 2 of LCE3C | nan
chr1	LCE3C	612615.0 | LCE3C, LEP15 | Late cornified envelope protein 3C | 353144.0 | ENSG00000244057 | nan | nan
chr1	LCE3B	612614.0 | LCE3B, LEP14 | Late cornified envelope protein 3B | 353143.0 | ENSG00000187238 | nan | nan
chr1	LCE3A	612613.0 | LCE3A, LEP13 | Late cornified envelope protein 3A | 353142.0 | ENSG00000185962 | nan | nan
chr1	LCE2D	612612.0 | LCE2D, LEP12 | Late cornified envelope protein 2D | 353141.0 | ENSG00000187223 | nan | nan
chr1	LCE2C	612611.0 | LCE2C, LEP11 | Late cornified envelope protein 2C | 353140.0 | ENSG00000187180 | nan | nan
chr1	LCE2B	612610.0 | LCE2B, LEP10, XP5 | Late cornified envelope protein 2B | 26239.0 | ENSG00000159455 | nan | nan
chr1	LCE2A	612609.0 | LCE2A, LEP9 | Late cornified envelope protein 2A | 353139.0 | ENSG00000187173 | nan | nan
chr1	LCE4A	612618.0 | LCE4A, LEP8 | Late cornified envelope protein 4A | 199834.0 | ENSG00000187170 | nan | nan
chr1	KPRP	613260.0 | KPRP | Keratinocyte proline-rich protein | 448834.0 | ENSG00000203786 | nan | nan
chr1	LCE1F	612608.0 | LCE1F, LEP6 | Late cornified envelope protein 1F | 353137.0 | ENSG00000240386 | nan | nan
chr1	LCE1E	612607.0 | LCE1E | Late cornified envelope protein 1E | 353135.0 | ENSG00000186226 | nan | nan
chr1	LCE1D	612606.0 | LCE1D, LEP4 | Late cornified envelope protein 1D | 353134.0 | ENSG00000172155 | nan | nan
chr1	LCE1C	612605.0 | LCE1C, LEP3 | Late cornified envelope 1C | 353133.0 | ENSG00000197084 | nan | nan
chr1	LCE1B	612604.0 | LCE1B, LEP2 | Late cornified envelope protein 1B | 353132.0 | ENSG00000196734 | nan | nan
chr1	LCE1A	612603.0 | LCE1A, LEP1 | Late cornified envelope protein 1A | 353131.0 | ENSG00000186844 | nan | nan
chr1	SMCP	601148.0 | SMCP, MCSP, MCS | Sperm mitochondria-associated cysteine-rich protein | 4184.0 | ENSG00000163206 | nan | nan
chr1	IVL	147360.0 | IVL | Involucrin | 3713.0 | ENSG00000163207 | nan | nan
chr1	SPRR4	616363.0 | SPRR4 | Small proline-rich protein 4 | 163778.0 | ENSG00000184148 | nan | nan
chr1	SPRR1A	182265.0 | SPRR1A | Small proline-rich protein 1A | 6698.0 | ENSG00000169474 | nan | nan
chr1	SPRR3	182271.0 | SPRR3 | Small proline-rich protein 3 | 6707.0 | ENSG00000163209 | nan | nan
chr1	SPRR1B	182266.0 | SPRR1B | Small proline-rich protein 1B | 6699.0 | ENSG00000169469 | nan | nan
chr1	SPRR2D	617587.0 | SPRR2D | Small proline-rich protein 2D | 6703.0 | ENSG00000163216 | nan | nan
chr1	SPRR2A	182267.0 | SPRR2A | Small proline-rich protein 2A | 6700.0 | ENSG00000241794 | about 7 SPRR2 genes | nan
chr1	SPRR2B	182268.0 | SPRR2B | Small proline-rich protein 2B | 6701.0 | ENSG00000196805 | nan | nan
chr1	SPRR2E	617588.0 | SPRR2E | Small proline-rich protein 2E | 6704.0 | ENSG00000203785 | nan | nan
chr1	SPRR2F	617589.0 | SPRR2F | Small proline-rich protein 2F | 6705.0 | ENSG00000244094 | nan | nan
chr1	SPRR2G	617590.0 | SPRR2G | Small proline-rich protein 2G | 6706.0 | ENSG00000159516 | nan | nan
chr1	LELP1	611042.0 | LELP1 | Late cornified envelope-like proline-rich 1 | 149018.0 | ENSG00000203784 | nan | nan
chr1	LORICRIN	152445.0 | LOR | Loricrin | 4014.0 | ENSG00000203782 | nan | Vohwinkel syndrome with ichthyosis, 604117 (3), Autosomal dominant
chr1	PGLYRP3	608197.0 | PGRPIA | Peptidoglycan recognition protein, intermediate, alpha | 114771.0 | ENSG00000159527 | nan | nan
chr1	PGLYRP4	608198.0 | PGRPIB | Peptidoglycan recognition protein, intermediate, beta | 57115.0 | ENSG00000163218 | nan | nan
chr1	S100A9	123886.0 | S100A9, CAGB, CFAG | S100 calcium-binding protein A9 (calgranulin B) | 6280.0 | ENSG00000163220 | nan | nan
chr1	S100A12	603112.0 | S100A12, CAAF1, CGRP | S100 calcium-binding protein A12 | 6283.0 | ENSG00000163221 | between S100A8 and S100A9 | nan
chr1	S100A8	123885.0 | S100A8, CAGA, CFAG | S100 calcium-binding protein A8 (calgranulin A) | 6279.0 | ENSG00000143546 | over-expressed in 1q21-linked psoriasis | nan
chr1	S100A7A	617427.0 | S100A7A, S100A15, NICE2 | S100 calcium-binding protein A7A | 338324.0 | ENSG00000184330 | nan | nan
chr1	S100A7	600353.0 | S100A7 | S100 calcium-binding protein A7 | 6278.0 | ENSG00000143556 | nan | nan
chr1	S100A6	114110.0 | S100A6, CACY | S100 calcium-binding protein A6 (calcyclin) | 6277.0 | ENSG00000197956 | nan | nan
chr1	S100A5	176991.0 | S100A5, S100D | S100 calcium-binding protein A5 | 6276.0 | ENSG00000196420 | nan | nan
chr1	S100A4	114210.0 | S100A4, CAPL | S100 calcium-binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog) | 6275.0 | ENSG00000196154 | nan | nan
chr1	S100A3	176992.0 | S100A3, S100E | S100 calcium-binding protein A3 | 6274.0 | ENSG00000188015 | nan | nan
chr1	S100A2	176993.0 | S100A2, S100L | S100 calcium-binding protein A2 | 6273.0 | ENSG00000196754 | nan | nan
chr1	S100A16	617437.0 | S100A16, AAG13 | S100 calcium-binding protein A16 | 140576.0 | ENSG00000188643 | nan | nan
chr1	S100A14	607986.0 | S100A14, BCMP84 | S100 Calcium-binding protein A14 | 57402.0 | ENSG00000189334 | nan | nan
chr1	S100A13	601989.0 | S100A13 | S100 calcium-binding protein A13 | 6284.0 | ENSG00000189171 | nan | nan
chr1	S100A1	176940.0 | S100A1 | S100 protein, alpha polypeptide | 6271.0 | ENSG00000160678 | nan | nan
chr1	CHTOP	614206.0 | CHTOP, C10orf77, SRAG, FOP | Chromatin target of PRMT1 | 26097.0 | ENSG00000160679 | nan | nan
chr1	SNAPIN	607007.0 | SNAPIN, SNAPAP, BLOC1S7, BLOS7 | SNAP-associated protein | 23557.0 | ENSG00000143553 | nan | nan
chr1	ILF2	603181.0 | ILF2, NF45 | Interleukin enhancer-binding factor 2 | 3608.0 | ENSG00000143621 | nan | nan
chr1	NPR1	108960.0 | NPR1, ANPRA | Natriuretic peptide receptor A/guanylate cyclase A | 4881.0 | ENSG00000169418 | nan | nan
chr1	INTS3	611347.0 | INTS3, INT3, SOSSA | Integrator complex subunit 3 | 65123.0 | ENSG00000143624 | nan | nan
chr1	SLC27A3	604193.0 | SLC27A3, FATP3 | Solute carrier family 27 (fatty acid transporter), member 3 | 11000.0 | ENSG00000143554 | nan | nan
chr1	GATAD2B	614998.0 | GATAD2B, KIAA1150, p68, GANDS | GATA zinc finger domain-containing protein 2B | 57459.0 | ENSG00000143614 | nan | GAND syndrome, 615074 (3), Autosomal dominant
chr1	DENND4B	619843.0 | DENND4B | DENN domain-containing protein 4B | 9909.0 | ENSG00000198837 | nan | nan
chr1	CRTC2	608972.0 | CRTC2, TORC2 | CREB-regulated transcription coactivator 2 | 200186.0 | ENSG00000160741 | nan | nan
chr1	SLC39A1	604740.0 | SLC39A1, ZIRTL | Solute carrier family 39 (zinc transporter), member 3 (zinc/iron-regulated transporter-like) | 27173.0 | ENSG00000143570 | REc | nan
chr1	CREB3L4	607138.0 | CREB3L4, CREB4, AIBZIP | cAMP responsive element binding protein 3-like 4 | 148327.0 | ENSG00000143578 | nan | nan
chr1	JTB	604671.0 | JTB, PAR | Jumping translocation breakpoint | 10899.0 | ENSG00000143543 | nan | nan
chr1	RAB13	602672.0 | RAB13 | RAB13, member RAS oncogene family | 5872.0 | ENSG00000143545 | previously assigned to 12q13 by in situ hybridization | nan
chr1	RPS27	603702.0 | RPS27, MPS1, DBA17 | Ribosomal protein S27 | 6232.0 | ENSG00000177954 | mutation identified in 1 DBA17 patient | ?Diamond-Blackfan anemia 17, 617409 (3), Autosomal dominant
chr1	TPM3	191030.0 | TPM3, NEM1, CMYO4A, CMYO4B | Tropomyosin 3 | 7170.0 | ENSG00000143549 | nan | Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant; Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive
chr1	C1orf43	617428.0 | C1orf43, NS5ATP4, NICE3 | Chromosome 1 open reading frame 43 | 25912.0 | ENSG00000143612 | nan | nan
chr1	UBAP2L	616472.0 | UBAP2L, NICE4, NEDLBF | Ubiquitin-associated protein 2-like | 9898.0 | ENSG00000143569 | nan | Neurodevelopmental disorder with impaired language, behavioral abnormalities, and dysmorphic facies, 620494 (3), Autosomal dominant
chr1	HAX1	605998.0 | HAX1, SCN3 | HCLS1-associated protein X1 | 10456.0 | ENSG00000143575 | nan | Neutropenia, severe congenital 3, autosomal recessive, 610738 (3), Autosomal recessive
chr1	AQP10	606578.0 | AQP10 | Aquaporin 10 | 89872.0 | ENSG00000143595 | nan | nan
chr1	ATP8B2	605867.0 | ATP8B2, ATPID | ATPase, class I, type 8B, member 2 | 57198.0 | ENSG00000143515 | nan | nan
chr1	IL6R	147880.0 | IL6R, IL6RQ, IL6QTL, HIES5 | Interleukin-6 receptor | 3570.0 | ENSG00000160712 | IL6R-like gene on chr.9 | [Interleukin 6, serum level of, QTL], 614752 (3); Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections, 618944 (3), Autosomal recessive; [Interleukin-6 receptor, soluble, serum level of, QTL], 614689 (3)
chr1	SHE	610482.0 | SHE | SH2 domain-containing protein E | 126669.0 | ENSG00000169291 | nan | nan
chr1	UBE2Q1	617429.0 | UBE2Q1, GTAP, NICE5 | Ubiquitin-conjugating enzyme E2 Q1 | 55585.0 | ENSG00000160714 | nan | nan
chr1	CHRNB2	118507.0 | CHRNB2, EFNL3 | Cholinergic receptor, nicotinic, beta polypeptide-2 | 1141.0 | ENSG00000160716 | linked to AMY in mouse | Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
chr1	ADAR	146920.0 | ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6 | Adenosine deaminase, RNA-specific | 103.0 | ENSG00000160710 | nan | Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive
chr1	KCNN3	602983.0 | KCNN3, SK3, SKCA3, ZLS3 | Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 3 | 3782.0 | ENSG00000143603 | nan | Zimmermann-Laband syndrome 3, 618658 (3), Autosomal dominant
chr1	PMVK	607622.0 | PMVK, PMK, POROK1 | Phosphomevalonate kinase | 10654.0 | ENSG00000163344 | nan | Porokeratosis 1, multiple types, 175800 (3), Autosomal dominant
chr1	PBXIP1	618819.0 | PBXIP1, HPIP | PBX homeobox-interacting protein 1 | 57326.0 | ENSG00000163346 | nan | nan
chr1	PYGO2	606903.0 | PYGO2 | Pygopus family PHD finger 2 | 90780.0 | ENSG00000163348 | nan | nan
chr1	SHC1	600560.0 | SHC1 | SHC (Src homology 2 domain-containing) transforming protein-1 | 6464.0 | ENSG00000160691 | nan | nan
chr1	CKS1B	116900.0 | CKS1B, CKS1 | CDC28 protein kinase 1B | 1163.0 | ENSG00000173207 | previously to 8q21 by FISH | nan
chr1	FLAD1	610595.0 | FLAD1, FADS, LSMFLAD | Flavin adenine dinucleotide synthetase 1 | 80308.0 | ENSG00000160688 | nan | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3), Autosomal recessive
chr1	LENEP	607377.0 | LENEP, LEP503 | Lens epithelial protein | 55891.0 | ENSG00000163352 | nan | nan
chr1	ZBTB7B	607646.0 | ZBTB7B, ZFP67, CKROX, THPOK | Zinc finger- and BTB domain-containing protein 7B | 51043.0 | ENSG00000160685 | nan | nan
chr1	DCST2	619861.0 | DCST2, SPE42 | DCSTAMP domain-containing protein 1 | 127579.0 | ENSG00000163354 | nan | nan
chr1	DCST1	619860.0 | DCST1, SNKY, SPE49 | DCSTAMP domain-containing protein 1 | 149095.0 | ENSG00000163357 | nan | nan
chr1	ADAM15	605548.0 | ADAM15, MDC15 | ADAM metallopeptidase domain 15 | 8751.0 | ENSG00000143537 | nan | nan
chr1	EFNA4	601380.0 | EFNA4, EPLG4 | eph-related receptor tyrosine kinase ligand 4 (ephrin-A4) | 1945.0 | ENSG00000243364 | nan | nan
chr1	EFNA3	601381.0 | EFNA3, EPLG3 | eph-related receptor tyrosine kinase ligand 3 (ephrin A3) | 1944.0 | ENSG00000143590 | nan | nan
chr1	EFNA1	191164.0 | EFNA1, EPLG1, TNFAIP4 | eph-related receptor tyrosine kinase ligand 1 (tumor necrosis factor, alpha-induced protein 4) | 1942.0 | ENSG00000169242 | nan | nan
chr1	SLC50A1	613683.0 | SLC50A1, RAG1AP1 | Solute carrier family 50 (sugar transporter), member 1 | 55974.0 | ENSG00000169241 | nan | nan
chr1	DPM3	605951.0 | DPM3, MDDGC15, MDDGB15 | Dolichyl-phosphate mannosyltransferase 3 | 54344.0 | ENSG00000179085 | mutation identified in 1 MDDGB15 patient | ?Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 15, 618992 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15, 612937 (3), Autosomal recessive
chr1	KRTCAP2	619029.0 | KRTCAP2, KCP2 | Keratinocyte-associated protein 2 | 200185.0 | ENSG00000163463 | nan | nan
chr1	TRIM46	600986.0 | GENEY | Gene Y | 80128.0 | ENSG00000163462 | nan | nan
chr1	MUC1	158340.0 | MUC1, PUM, ADTKD2 | Mucin 1, cell surface associated | 4582.0 | ENSG00000185499 | 5cM proximal to SPTA1 | Tubulointerstitial kidney disease, autosomal dominant, 2, 174000 (3), Autosomal dominant
chr1	THBS3	188062.0 | THBS3, TSP3 | Thrombospondin 3 | 7059.0 | ENSG00000169231 | nan | nan
chr1	MTX1	600605.0 | MTX1, MTXN | Metaxin 1 | 4580.0 | ENSG00000173171 | between GBA and TSP3 | nan
chr1	GBA1	606463.0 | GBA | Glucosidase, acid beta | 2629.0 | ENSG00000177628 | pseudogene GBAP ~16kb 3' to GBA | {Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant
chr1	ENTREP3	619447.0 | FAM189B, COTE1 | Family with sequence similarity 189, member B | 10712.0 | ENSG00000160767 | nan | nan
chr1	SCAMP3	606913.0 | SCAMP3, PROPIN1 | Secretory carrier membrane protein 3 | 10067.0 | ENSG00000116521 | nan | nan
chr1	CLK2	602989.0 | CLK2 | CDC-like kinase 2 | 1196.0 | ENSG00000176444 | near GDLD and PRKAA2; conflicting assignment 1q21 | nan
chr1	HCN3	609973.0 | HCN3, KIAA1535 | Hyperpolarization-activated cyclic nucleotide-gated potassium channel 3 | 57657.0 | ENSG00000143630 | nan | nan
chr1	PKLR	609712.0 | PKLR, PK1, CNSHA2 | Pyruvate kinase, liver and RBC type | 5313.0 | ENSG00000143627 | nan | Anemia, congenital, nonspherocytic hemolytic, 2, pyruvate kinase deficient, 266200 (3), Autosomal recessive; [Adenosine triphosphate, elevated, of erythrocytes], 102900 (3), Autosomal dominant
chr1	FDPS	134629.0 | FDPS, FPS, POROK9 | Farnesyl diphosphate synthase | 2224.0 | ENSG00000160752 | nan | Porokeratosis 9, multiple types, 616631 (3), Autosomal dominant
chr1	RUSC1	617318.0 | RUSC1, NESCA | RUN domain- and SH3 domain-containing protein 1 | 23623.0 | ENSG00000160753 | nan | nan
chr1	ASH1L	607999.0 | ASH1L, KIAA1420, ASH1, MRD52 | ASH1-like histone lysine methyltransferase | 55870.0 | ENSG00000116539 | nan | Intellectual developmental disorder, autosomal dominant 52, 617796 (3), Autosomal dominant
chr1	MSTO1	617619.0 | MSTO1, MMYAT | Misato 1, mitochondrial distribution and morphology regulator | 55154.0 | ENSG00000125459 | nan | Myopathy, mitochondrial, and ataxia, 617675 (3), Autosomal recessive, Autosomal dominant
chr1	YY1AP1	607860.0 | YY1AP1, YAP, HCCA2, GRNG | YY1 associated protein 1 | 55249.0 | ENSG00000163374 | nan | Grange syndrome, 602531 (3), Autosomal recessive
chr1	DAP3	602074.0 | DAP3 | Death associated protein 3 | 7818.0 | ENSG00000132676 | nan | nan
chr1	GON4L	610393.0 | GON4L, KIAA1606 | GON4-like protein | 54856.0 | ENSG00000116580 | nan | nan
chr1	SYT11	608741.0 | SYT11, KIAA0080 | Synaptotagmin 11 | 23208.0 | ENSG00000132718 | nan | nan
chr1	RIT1	609591.0 | RIT1, RIT, ROC1, NS8 | Ric-like protein without CAAX motif 1 | 6016.0 | ENSG00000143622 | nan | Noonan syndrome 8, 615355 (3), Autosomal dominant
chr1	KHDC4	619370.0 | KHDC4, KIAA0907, BLOM7 | KH domain-containing protein 4, pre-mRNA splicing factor | 22889.0 | ENSG00000132680 | nan | nan
chr1	RXFP4	609043.0 | RXFP4, RLN3R2, GPR100, GPCR142 | Relaxin/insulin-like family peptide receptor 4 | 339403.0 | ENSG00000173080 | nan | nan
chr1	ARHGEF2	607560.0 | ARHGEF2, GEFH1, KIAA0651, NEDMHM | RHO guanine nucleotide exchange factor 2 | 9181.0 | ENSG00000116584 | mutation identified in 1 NEDMHM family | ?Neurodevelopmental disorder with midbrain and hindbrain malformations, 617523 (3), Autosomal recessive
chr1	SSR2	600867.0 | SSR2 | Signal sequence receptor, beta | 6746.0 | ENSG00000163479 | nan | nan
chr1	UBQLN4	605440.0 | UBQLN4, A1U, C1orf6 | Ubiquitin 4 | 56893.0 | ENSG00000160803 | nan | nan
chr1	LAMTOR2	610389.0 | LAMTOR2, MAPBPIP, p14, | Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 | 28956.0 | ENSG00000116586 | mutation identified in 1 family | Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3), Autosomal recessive
chr1	RAB25	612942.0 | RAB25, RAB11C | Ras-associated protein RAB25 | 57111.0 | ENSG00000132698 | nan | nan
chr1	MEX3A	611007.0 | MEX3A | mex-3 RNA binding family member A | 92312.0 | ENSG00000254726 | nan | nan
chr1	LMNA	150330.0 | LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS | Lamin A/C | 4000.0 | ENSG00000160789 | nan | Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant
chr1	SEMA4A	607292.0 | SEMA4A, SEMB, RP35, CORD10 | Semaphorin 4A | 64218.0 | ENSG00000196189 | nan | Retinitis pigmentosa 35, 610282 (3), Autosomal recessive; Cone-rod dystrophy 10, 610283 (3), Autosomal recessive
chr1	SLC25A44	610824.0 | SLC25A44 | Solute carrier family 25, member 44 | 9673.0 | ENSG00000160785 | nan | nan
chr1	PMF1	609176.0 | PMF1 | Polyamine-modulated factor 1 | 11243.0 | ENSG00000160783 | nan | nan
chr1	BGLAP	112260.0 | BGLAP | Bone gamma-carboxyglutamic acid protein | 632.0 | ENSG00000242252 | nan | nan
chr1	PAQR6	614579.0 | PAQR6 | Progestin and ADIPOQ receptor family, member 6 | 79957.0 | ENSG00000160781 | nan | nan
chr1	SMG5	610962.0 | SMG5, EST1B, KIAA1089 | SMG5 nonsense-mediated nRNA decay factor | 23381.0 | ENSG00000198952 | nan | nan
chr1	TMEM79	615531.0 | TMEM79, MATT | Transmembrane protein 79 | 84283.0 | ENSG00000163472 | nan | nan
chr1	GLMP	619958.0 | GLMP, C1orf85 | Glycosylated lysosomal membrane protein | 112770.0 | ENSG00000198715 | nan | nan
chr1	VHLL	619650.0 | VHLL, VLP | VHL-like protein | 391104.0 | ENSG00000189030 | nan | nan
chr1	CCT3	600114.0 | CCT3, TRIC5 | Chaperonin-containing TCP1, subunit 3, gamma (TCP1 (t-complex-1) ring complex, polypeptide 5) | 7203.0 | ENSG00000163468 | nan | nan
chr1	TSACC	619679.0 | TSACC, SIP | TSSK6-activating cochaperone | 128229.0 | ENSG00000163467 | nan | nan
chr1	RHBG	607079.0 | RHBG | Rhesus blood group, B glycoprotein | 57127.0 | ENSG00000132677 | nan | nan
chr1	MIR9-1HG	618747.0 | C1orf61, CROC4 | Chromosome 1 open reading frame 61 | 10485.0 | ENSG00000125462 | nan | nan
chr1	MIR9-1	611186.0 | MIR9-1, MIRN9-1 | Micro RNA 9-1 | 407046.0 | ENSG00000207933 | nan | nan
chr1	MEF2D	600663.0 | MEF2D | MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D) | 4209.0 | ENSG00000116604 | nan | nan
chr1	NAXE	608862.0 | NAXE, APOA1BP, AIBP, PEBEL | NAD(P)HX epimerase | 128240.0 | ENSG00000163382 | nan | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 617186 (3), Autosomal recessive
chr1	BDET	605913.0 | BDET | Bleeding disorder, east Texas type | 85504.0 | nan | nan | Bleeding disorder, east Texas type, 605913 (2)
chr1		157560.0 | D1S61, D1S111, MS336 | Minisatellite 33.6 | 7824.0 | nan | nan | nan
chr1	HAPLN2	619726.0 | HAPLN2, BRAL1 | Hyaluronan and proteoglycan link protein 2 | 60484.0 | ENSG00000132702 | nan | nan
chr1	BCAN	600347.0 | BCAN | Brevican | 63827.0 | ENSG00000132692 | nan | nan
chr1	NES	600915.0 | NES | Nestin | 10763.0 | ENSG00000132688 | nan | nan
chr1	CRABP2	180231.0 | CRABP2, RBP6 | Cellular retinoic acid-binding protein-2 | 1382.0 | ENSG00000143320 | nan | nan
chr1	ISG20L2	611930.0 | ISG20L2 | Interferon-stimulated exonuclease gene 20-kD-like 2 | 81875.0 | ENSG00000143319 | nan | nan
chr1	MRPL24	611836.0 | MRPL24 | Mitochondrial ribosomal protein L24 | 79590.0 | ENSG00000143314 | nan | nan
chr1	HDGF	600339.0 | HDGF | Hepatoma-derived growth factor | 3068.0 | ENSG00000143321 | previously assigned to Chr.X | nan
chr1	PRCC	179755.0 | PRCC, RCCP1 | Proline-rich mitotic checkpoint control factor | 5546.0 | ENSG00000143294 | t(X;1)(p11;q21); fuses with TFE3 in RCCP | Renal cell carcinoma, papillary, 605074 (3)
chr1	SH2D2A	604514.0 | SH2D2A, TSAD | SH2 domain protein 2A | 9047.0 | ENSG00000027869 | nan | nan
chr1	NTRK1	191315.0 | NTRK1, TRKA | Neurotrophic tyrosine kinase, receptor, type 1 | 4914.0 | ENSG00000198400 | TRK = chimera of TPM3 and NTRK1 | Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive
chr1	INSRR	147671.0 | INSRR, IRR | Insulin receptor-related receptor | 3645.0 | ENSG00000027644 | nan | nan
chr1	PEAR1	610278.0 | PEAR1 | Platelet endothelial aggregation receptor 1 | 375033.0 | ENSG00000187800 | nan | nan
chr1	ARHGEF11	605708.0 | ARHGEF11, GTRAP48, KIAA0380 | Rho guanine nucleotide exchange factor 11 | 9826.0 | ENSG00000132694 | nan | nan
chr1	ETV3	164873.0 | ETV3, PE1 | ETS variant transcription factor 3 | 2117.0 | ENSG00000117036 | nan | nan
chr1	FCRL5	605877.0 | IRTA2 | Immunoglobulin superfamily receptor translocation-associated gene 2 | 83416.0 | ENSG00000143297 | nan | nan
chr1	FCRL4	605876.0 | IRTA1 | Immunoglobulin superfamily receptor translocation-associated gene 1 | 83417.0 | ENSG00000163518 | fused with IGHA1 in multiple myeloma | nan
chr1	FCRL3	606510.0 | FCRH3 | Fc receptor-like protein 3 | 115352.0 | ENSG00000160856 | nan | nan
chr1	FCRL2	606509.0 | SPAP1, SPAP1A, SPAP1B, SPAP1C | SH2 domain-containing phosphatase anchor protein 1 | 79368.0 | ENSG00000132704 | nan | nan
chr1	FCRL1	606508.0 | FCRL1, FCRH1 | Fc receptor-like protein 1 | 115350.0 | ENSG00000163534 | nan | nan
chr1	CD5L	602592.0 | CD5L | CD5 antigen-like (scavenger receptor cysteine rich family) | 922.0 | ENSG00000073754 | nan | nan
chr1	KIRREL1	607428.0 | KIRREL1, NEPH1, NPHS23 | Kirre-like nephrin family adhesion molecule 1 | 55243.0 | ENSG00000183853 | nan | Nephrotic syndrome, type 23, 619201 (3), Autosomal recessive
chr1	CD1D	188410.0 | CD1D | Thymocyte antigen CD1D | 912.0 | ENSG00000158473 | nan | nan
chr1	CD1A	188370.0 | CD1A | Thymocyte antigen CD1A | 909.0 | ENSG00000158477 | genes A, B, C, D in cluster | nan
chr1	CD1B	188360.0 | CD1B | Thymocyte antigen CD1B | 910.0 | ENSG00000158485 | nan | nan
chr1	CD1C	188340.0 | CD1C | Thymocyte antigen CD1C | 911.0 | ENSG00000158481 | nan | nan
chr1	CD1E	188411.0 | CD1E | Thymocyte antigen CD1E | 913.0 | ENSG00000158488 | nan | nan
chr1	SPTA1	182860.0 | SPTA1, EL2, SPH3, HS3, HPP | Spectrin, alpha, erythrocytic-1 | 6708.0 | ENSG00000163554 | 17cM proximal to FY | Spherocytosis, type 3, 270970 (3), Autosomal recessive; Elliptocytosis-2, 130600 (3), Autosomal dominant; Pyropoikilocytosis, 266140 (3), Autosomal recessive
chr1	MNDA	159553.0 | MNDA | Myeloid cell nuclear differentiation antigen | 4332.0 | ENSG00000163563 | nan | nan
chr1	PYHIN1	612677.0 | PYHIN1, IFIX | Pyrin and Hin domain family, member 1 | 149628.0 | ENSG00000163564 | nan | nan
chr1	IFI16	147586.0 | IFI16 | Interferon, gamma-inducible protein 16 | 3428.0 | ENSG00000163565 | nan | nan
chr1	AIM2	604578.0 | AIM2 | Absent in melanoma 2 | 9447.0 | ENSG00000163568 | nan | nan
chr1	CADM3	609743.0 | CADM3, IGSF4B, TSLL1, NECL1, SYNCAM3, CMT2FF | Cell adhesion molecule 3 | 57863.0 | ENSG00000162706 | nan | Charcot-Marie-Tooth disease, axonal, type 2FF, 619519 (3), Autosomal dominant
chr1	ACKR1	613665.0 | ACKR1, DARC, FY, GPD, WBCQ1 | Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines) | 2532.0 | ENSG00000213088 | by A, 1q22-q23 | [Blood group, Duffy system], 110700 (3), Autosomal recessive, Autosomal dominant; [White blood cell count QTL], 611862 (3), Autosomal recessive; {Malaria, vivax, protection against}, 611162 (3)
chr1	FCER1A	147140.0 | FCER1A | Fc IgE receptor, alpha polypeptide | 2205.0 | ENSG00000179639 | nan | nan
chr1	OR10J5	619546.0 | OR10J5, OLFR16, MOR23 | Olfactory receptor, family 10, subfamily J, member 5 | 127385.0 | ENSG00000184155 | nan | nan
chr1	APCS	104770.0 | APCS, SAP | Amyloid P component, serum | 325.0 | ENSG00000132703 | probably close to CRP | nan
chr1	CRP	123260.0 | CRP | C-reactive protein | 1401.0 | ENSG00000132693 | nan | nan
chr1	DUSP23	618361.0 | DUSP23, DUSP25, LDP3, VHZ | Dual-specificity phosphatase 23 | 54935.0 | ENSG00000158716 | nan | nan
chr1	FCRL6	613562.0 | FCRL6 | Fc receptor-like protein 6 | 343413.0 | ENSG00000181036 | nan | nan
chr1	SLAMF8	606620.0 | SLAMF8, BLAME | SLAM family, member 8 | 56833.0 | ENSG00000158714 | nan | nan
chr1	CFAP45	605152.0 | CFAP45, CCDC19, NESG1, HTX11 | Cilia- and flagella-associated protein 45 | 25790.0 | ENSG00000213085 | nan | Heterotaxy, visceral, 11, autosomal, with male infertility, 619608 (3), Autosomal recessive
chr1	TAGLN2	604634.0 | TAGLN2 | Transgelin 2 | 8407.0 | ENSG00000158710 | nan | nan
chr1	IGSF9	609738.0 | IGSF9, KIAA1355 | Immunoglobulin superfamily, member 9 | 57549.0 | ENSG00000085552 | nan | nan
chr1	SLAMF9	608589.0 | SLAMF9, CD2F10 | SLAM family, member 9 | 89886.0 | ENSG00000162723 | nan | nan
chr1	PIGM	610273.0 | PIGM | Phosphatidylinositol glycan, class M | 93183.0 | ENSG00000143315 | nan | Glycosylphosphatidylinositol deficiency, 610293 (3), Autosomal recessive
chr1	KCNJ10	602208.0 | KCNJ10, SESAME | Potassium inwardly-rectifying channel, subfamily J, member 10 | 3766.0 | ENSG00000177807 | nan | Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive
chr1	KCNJ9	600932.0 | KCNJ9, GIRK3 | Potassium inwardly-rectifying channel, subfamily J, member 9 | 3765.0 | ENSG00000162728 | nan | nan
chr1	IGSF8	606644.0 | IGSF8, PGRL, CD81P3 | Immunoglobulin superfamily, member 8 | 93185.0 | ENSG00000162729 | nan | nan
chr1	ATP1A2	182340.0 | ATP1A2, FHM2, MHP2, FARIMPD, DEE98 | ATPase, Na+K+ transporting, alpha-2 polypeptide | 477.0 | ENSG00000018625 | nan | Developmental and epileptic encephalopathy 98, 619605 (3), Autosomal dominant; Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies, 619602 (3), Autosomal recessive; Alternating hemiplegia of childhood 1, 104290 (3), Autosomal dominant; Migraine, familial basilar, 602481 (3), Autosomal dominant; Migraine, familial hemiplegic, 2, 602481 (3), Autosomal dominant
chr1	ATP1A4	607321.0 | ATP1A4, ATP1AL2 | ATPase, Na+/K+ transporting, alpha-4 polypeptide | 480.0 | ENSG00000132681 | nan | nan
chr1	CASQ1	114250.0 | CASQ1, VMCQA | Calsequestrin, fast-twitch, skeletal muscle-1 | 844.0 | ENSG00000143318 | nan | Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3), Autosomal dominant
chr1	PEA15	603434.0 | PEA15, HMAT1, PED | Proliferation and apoptosis adaptor protein 15 | 8682.0 | ENSG00000162734 | nan | nan
chr1	DCAF8	615820.0 | DCAF8, WDR42A, GAN2 | DDB1- and CUL4-associated factor 8 | 50717.0 | ENSG00000132716 | mutation identified in 1 GAN2 family | ?Giant axonal neuropathy 2, autosomal dominant, 610100 (3), Autosomal dominant
chr1	PEX19	600279.0 | PEX19, PXF, HK33, D1S2223E, PBD12A | Peroxisome biogenesis factor 19 (peroxisomal farnesylated protein) | 5824.0 | ENSG00000162735 | nan | Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive
chr1	COPA	601924.0 | COPA, AIAISD | Coatomer protein complex, subunit alpha | 1314.0 | ENSG00000122218 | nan | {Autoinflammation and autoimmunity, systemic, with immune dysregulation}, 616414 (3), Autosomal dominant
chr1	NCSTN	605254.0 | NCSTN | Nicastrin | 23385.0 | ENSG00000162736 | nan | Acne inversa, familial, 1, 142690 (3), Autosomal dominant
chr1	NHLH1	162360.0 | NHLH1, HEN1 | Nescient helix loop helix 1 | 4807.0 | ENSG00000171786 | closely linked to Sap in mouse | nan
chr1	VANGL2	600533.0 | VANGL2, LTAP | VANGL planar cell polarity protein 2 | 57216.0 | ENSG00000162738 | nan | Neural tube defects, 182940 (3), Autosomal dominant
chr1	SLAMF6	606446.0 | SLAMF6, NTBA | SLAM family, member 6 | 114836.0 | ENSG00000162739 | nan | nan
chr1	QTV	610141.0 | QTV | QT interval, variation in | 100379215.0 | nan | associated with rs12143842 | [QT interval, variation in], 610141 (2)
chr1	CD84	604513.0 | CD84, SLAMF5 | CD84 antigen | 8832.0 | ENSG00000066294 | nan | nan
chr1	SLAMF1	603492.0 | SLAMF1, SLAM, CDW150, CD150 | SLAM family, member 1 | 6504.0 | ENSG00000117090 | nan | nan
chr1	CD48	109530.0 | CD48, BCM1, BLAST1 | CD48 antigen (B-cell membrane protein) | 962.0 | ENSG00000117091 | nan | nan
chr1	SLAMF7	606625.0 | SLAMF7, CRACC, CS1 | SLAM family, member 7 | 57823.0 | ENSG00000026751 | nan | nan
chr1	LY9	600684.0 | LY9 | T-lymphocyte surface antigen Ly-9 | 4063.0 | ENSG00000122224 | within 410kb of CD48 | nan
chr1	CD244	605554.0 | CD244, NAIL, NKR2B4, SLAMF4 | CD244 antigen | 51744.0 | ENSG00000122223 | nan | {Rheumatoid arthritis, susceptibility to}, 180300 (3)
chr1	ITLN1	609873.0 | ITLN1, INTL, LFR, HL1 | Intelectin 1 | 55600.0 | ENSG00000179914 | nan | nan
chr1	ITLN2	609874.0 | ITLN2, HL2 | Intelectin 2 | 142683.0 | ENSG00000158764 | nan | nan
chr1	F11R	605721.0 | F11R, JAM1 | F11 receptor (junctional adhesion molecule 1) | 50848.0 | ENSG00000158769 | nan | nan
chr1	TSTD1	616041.0 | TSTD1, KAT | Thiosulfate sulfurtransferase (rhodanese)-like domain-containing protein 1 | 100131187.0 | ENSG00000215845 | nan | nan
chr1	USF1	191523.0 | USF1, HYPLIP1 | Upstream transcription factor 1 | 7391.0 | ENSG00000158773 | nan | {Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)
chr1	ARHGAP30	614264.0 | ARHGAP30 | RHO GTPase-activating protein 30 | 257106.0 | ENSG00000186517 | nan | nan
chr1	NECTIN4	609607.0 | NECTIN4, PVRL4, PRR4, EDSS1 | Nectin 4 | 81607.0 | ENSG00000143217 | nan | Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3), Autosomal recessive
chr1	KLHDC9	617375.0 | KLHDC9, KARCA1 | Kelch domain-containing protein 9 | 126823.0 | ENSG00000162755 | nan | nan
chr1	PFDN2	613466.0 | PFDN2 | Prefoldin 2 | 5202.0 | ENSG00000143256 | nan | nan
chr1	NIT1	604618.0 | NIT1 | Nitrilase 1 | 4817.0 | ENSG00000158793 | nan | nan
chr1	DEDD	606841.0 | DEDD, DEFT | Death effector domain-containing protein | 9191.0 | ENSG00000158796 | nan | nan
chr1	UFC1	610554.0 | UFC1, NEDSG | Ubiquitin-fold modifier-conjugating enzyme 1 | 51506.0 | ENSG00000143222 | nan | Neurodevelopmental disorder with spasticity and poor growth, 618076 (3), Autosomal recessive
chr1	USP21	604729.0 | USP21, USP23 | Ubiquitin-specific protease 21 | 27005.0 | ENSG00000143258 | nan | nan
chr1	PPOX	600923.0 | PPOX, VP, VPCO | Protoporphyrinogen oxidase | 5498.0 | ENSG00000143224 | nan | Variegate porphyria, childhood-onset, 620483 (3), Autosomal recessive; Variegate porphyria, 176200 (3), Autosomal dominant
chr1	B4GALT3	604014.0 | B4GALT3 | Beta-1,4-galactosyltransferase 3 | 8703.0 | ENSG00000158850 | nan | nan
chr1	ADAMTS4	603876.0 | ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif 4 (aggrecanase 1) | 9507.0 | ENSG00000158859 | nan | nan
chr1	NDUFS2	602985.0 | NDUFS2, MC1DN6, LHONAR2 | NADH-ubiquinone oxidoreductase core subunit S2 | 4720.0 | ENSG00000158864 | mutation identified in 1 LHONAR2 family | ?Leber-like hereditary optic neuropathy, autosomal recessive 2, 620569 (3), Autosomal recessive; Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive
chr1	FCER1G	147139.0 | FCER1G | Fc fragment of IgE, high affinity I, receptor for, gamma polypeptide | 2207.0 | ENSG00000158869 | probably on 1q close to CD32 | nan
chr1	APOA2	107670.0 | APOA2 | Apolipoprotein A-II | 336.0 | ENSG00000158874 | nan | Apolipoprotein A-II deficiency (3); {Hypercholesterolemia, familial, modifier of}, 143890 (3), Autosomal recessive, Autosomal dominant
chr1	NR1I3	603881.0 | NR1I3, CAR, MB67 | Nuclear receptor subfamily 1, group I, member 3 | 9970.0 | ENSG00000143257 | nan | nan
chr1	MPZ	159440.0 | MPZ, CMT1B, CMTDID, DSS, CHN2 | Myelin protein zero | 4359.0 | ENSG00000158887 | nan | Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant
chr1	SDHC	602413.0 | SDHC, PPGL3 | Succinate dehydrogenase complex, subunit C | 6391.0 | ENSG00000143252 | nan | Pheochromocytoma/paraganglioma syndrome 3, 605373 (3), Autosomal dominant; Paraganglioma and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606764 (3), Isolated cases, Autosomal dominant
chr1	CFAP126	616119.0 | CFAP126, FLTP | Cilia- and flagella-associated protein 126 | 257177.0 | ENSG00000188931 | nan | nan
chr1	FCGR2A	146790.0 | FCGR2A, IGFR2, CD32 | Fc fragment of IgG receptor IIa | 2212.0 | ENSG00000143226 | FCG2 and FCG3 within 250kb | {Malaria, severe, susceptibility to}, 611162 (3); {Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}, 219700 (3), Autosomal recessive; {Lupus nephritis, susceptibility to}, 152700 (3), Autosomal dominant
chr1	HSPA6	140555.0 | HSPA6 | Heat-shock 70kD protein-6 (HSP70B') | 3310.0 | ENSG00000173110 | nan | nan
chr1	FCGR3A	146740.0 | FCGR3A, CD16, IGFR3, IMD20 | Fc fragment of IgG receptor IIIa | 2214.0 | ENSG00000203747 | FCGR2A and FCGR3A within 250kb antigen | Immunodeficiency 20, 615707 (3), Autosomal recessive
chr1	FCGR2C	612169.0 | FCGR2C, CD32C | Fc fragment of IgG receptor IIc | 9103.0 | nan | ?pseudogene | nan
chr1	HSPA7	140556.0 | HSPA7 | Heat-shock protein family A (Hsp70) member 7, pseudogene | 3311.0 | ENSG00000225217 | nan | nan
chr1	FCGR3B	610665.0 | FCGR3B | Fc fragment of IgG receptor IIIb | 2215.0 | ENSG00000162747 | nan | nan
chr1	FCGR2B	604590.0 | FCGR2B, CD32 | Fc fragment of IgG receptor Ia | 2213.0 | ENSG00000072694 | nan | {Systemic lupus erythematosus, susceptibility to}, 152700 (3), Autosomal dominant; {Malaria, resistance to}, 611162 (3)
chr1	FCRLA	606891.0 | FREB | Fc receptor homolog expressed in B cells | 84824.0 | ENSG00000132185 | nan | nan
chr1	FCRLB	609251.0 | FCRLB, FCRL2, FREB2, FCRY | Fc receptor-like protein B | 127943.0 | ENSG00000162746 | nan | nan
chr1	DUSP12	604835.0 | DUSP1, YVH1 | Dual-specificity phosphatase 12 | 11266.0 | ENSG00000081721 | nan | nan
chr1	ATF6	605537.0 | ATF6, ACHM7 | Activating transcription factor-6 | 22926.0 | ENSG00000118217 | nan | Achromatopsia 7, 616517 (3), Autosomal recessive
chr1	NOS1AP	605551.0 | NOS1AP, CAPON, KIAA0464, NPHS22 | Nitric oxide synthase 1 (neuronal) adaptor protein | 9722.0 | ENSG00000198929 | nan | Nephrotic syndrome, type 22, 619155 (3), Autosomal recessive
chr1	SPATA46	617257.0 | SPATA46 | Spermatogenesis-associated protein 46 | 284680.0 | ENSG00000171722 | nan | nan
chr1	SH2D1B	608510.0 | SH2D1B, EAT2 | SH2 domain-containing 1B | 117157.0 | ENSG00000198574 | nan | nan
chr1	UHMK1	608849.0 | KIS | Kinase-interacting stathmin | 127933.0 | ENSG00000152332 | nan | nan
chr1	UAP1	602862.0 | UAP1, SPAG2 | ADP-N-acetylglucosamine pyrophosphorylase 1 | 6675.0 | ENSG00000117143 | nan | nan
chr1	DDR2	191311.0 | DDR2, NTRKR3, TKT, WRCN | Discoidin domain receptor family, member 2 | 4921.0 | ENSG00000162733 | nan | Warburg-Cinotti syndrome, 618175 (3), Autosomal dominant; Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3), Autosomal recessive
chr1	HSD17B7	606756.0 | HSD17B7 | 17-beta-hydroxysteroid dehydrogenase VII | 51478.0 | ENSG00000132196 | nan | nan
chr1	RGS4	602516.0 | RGS4 | Regulator of G protein signaling 4 | 5999.0 | ENSG00000117152 | nan | nan
chr1	RGS5	603276.0 | RGS5 | Regulator of G protein signaling-5 | 8490.0 | ENSG00000143248 | nan | [Blood pressure regulation QTL], 145500 (2), Multifactorial
chr1	NUF2	611772.0 | NUF2, NUF2R, CDCA1 | NUF2 component of NDC80 kinetochore complex | 83540.0 | ENSG00000143228 | nan | nan
chr1	PBX1	176310.0 | PBX1, CAKUHED | Pre-B cell leukemia transcription factor-1 | 5087.0 | ENSG00000185630 | pseudogene PBXP1 on chr.3 | Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, 617641 (3), Autosomal dominant
chr1	LMX1A	600298.0 | LMX1A, LMX1, DFNA7 | LIM homeobox transcription factor-1, alpha | 4009.0 | ENSG00000162761 | nan | Deafness, autosomal dominant 7, 601412 (3), Autosomal dominant
chr1	RXRG	180247.0 | RXRG | Retinoid X receptor, gamma | 6258.0 | ENSG00000143171 | nan | nan
chr1		605429.0 | DFNM1 | Deafness, nonsyndromic, modifier 1 | nan | nan | nan | {Deafness, nonsyndromic, modifier 1}, 605429 (2), Autosomal dominant
chr1	LRRC52	615218.0 | LRRC52 | Leucine-rich repeat-containing protein 52 | 440699.0 | ENSG00000162763 | nan | nan
chr1	MGST3	604564.0 | MGST3 | Glutatione S-transferase, microsomal, 3 | 4259.0 | ENSG00000143198 | nan | nan
chr1	ALDH9A1	602733.0 | ALDH9A1, ALDH9, E3 | Aldehyde dehydrogenase 9 family, member A1 | 223.0 | ENSG00000143149 | nan | nan
chr1	TMCO1	614123.0 | TMCO1, CFSMR1 | Transmembrane and coiled-coil domains protein 1 | 54499.0 | ENSG00000143183 | nan | Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1, 213980 (3), Autosomal recessive
chr1	UCK2	609329.0 | UCK2, TSA903 | Uridine/cytidine kinase 2 | 7371.0 | ENSG00000143179 | nan | nan
chr1	POGK	620039.0 | POGK, BASS2 | POGO transposable element-derived protein with KRAB domain | 57645.0 | ENSG00000143157 | nan | nan
chr1	TADA1	612763.0 | TADA1L, STAF42 | Transcriptional adaptor 1-like | 117143.0 | ENSG00000152382 | nan | nan
chr1	ILDR2	618081.0 | ILDR2 | Immunoglobulin-like domain-containing receptor 2 | 387597.0 | ENSG00000143195 | nan | nan
chr1	MAEL	611368.0 | MAEL | Maelstrom spermatogenic transposon silencer | 84944.0 | ENSG00000143194 | nan | nan
chr1	GPA33	602171.0 | GPA33 | Glycoprotein A33 | 10223.0 | ENSG00000143167 | nan | nan
chr1	POU2F1	164175.0 | OTF1, OCT1 | Octamer-binding transcription factor-1 | 5451.0 | ENSG00000143190 | nan | nan
chr1	CD247	186780.0 | CD247, CD3Z, TCRZ, IMD25 | CD247 antigen | 919.0 | ENSG00000198821 | mutation identified in one IMD25 patient | ?Immunodeficiency 25, 610163 (3), Autosomal recessive
chr1	CREG1	618055.0 | CREG1 | Cellular repressor of E1A-stimulated genes 1 | 8804.0 | ENSG00000143162 | nan | nan
chr1	RCSD1	610579.0 | RCSD1, CAPZIP | RCSD domain-containing protein 1 | 92241.0 | ENSG00000198771 | nan | nan
chr1	MPZL1	604376.0 | MPZL1, PZR | Myelin protein zero-like 1 | 9019.0 | ENSG00000197965 | nan | nan
chr1	ADCY10	605205.0 | ADCY10, SAC, HCA2 | Adenylyl cyclase 10, soluble | 55811.0 | ENSG00000143199 | nan | {Hypercalciuria, absorptive, susceptibility to}, 143870 (3), Autosomal dominant
chr1	DCAF6	610494.0 | DCAF6, IQWD1, NRIP | DDB1 and CUL4 associated factor 6 | 55827.0 | ENSG00000143164 | nan | nan
chr1	MPC2	614737.0 | MPC2, BRP44 | Mitochondrial pyruvate carrier 2 | 25874.0 | ENSG00000143158 | nan | nan
chr1	GPR161	612250.0 | GPR161 | G protein-coupled receptor 161 | 23432.0 | ENSG00000143147 | nan | {Medulloblastoma predisposition syndrome}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation
chr1	TIPRL	611807.0 | TIPRL, TIP41, TIP | TIP41-like protein | 261726.0 | ENSG00000143155 | nan | nan
chr1	TBX19	604614.0 | TBX19 | T-box 19 | 9095.0 | ENSG00000143178 | nan | Adrenocorticotropic hormone deficiency, 201400 (3), Autosomal recessive
chr1	XCL2	604828.0 | XCL2, SCYC2, SCM1B | Chemokine, C motif, ligand 2 | 6846.0 | ENSG00000143185 | nan | nan
chr1	XCL1	600250.0 | XCL1, SCYC1, SCM1, LTN, LPTN | Chemokine, C motif, ligand 1 (lymphotactin) | 6375.0 | ENSG00000143184 | nan | nan
chr1	DPT	125597.0 | DPT | Dermatopontin | 1805.0 | ENSG00000143196 | nan | nan
chr1	ATP1B1	182330.0 | ATP1B1 | ATPase, Na+K+ transporting, beta-1 polypeptide | 481.0 | ENSG00000143153 | nan | [Blood pressure regulation QTL], 145500 (2), Multifactorial
chr1	NME7	613465.0 | NME7, MN23H7 | NME/NM23 family, member 7 | 29922.0 | ENSG00000143156 | nan | nan
chr1	BLZF1	608692.0 | BLZF1, JEM1 | Basic leucine zipper nuclear factor 1 | 8548.0 | ENSG00000117475 | nan | nan
chr1	CCDC181	620891.0 | CCDC181 | Coiled-coil domain-containing protein 181 | 57821.0 | ENSG00000117477 | nan | nan
chr1	SLC19A2	603941.0 | SLC19A2, THTR1, TRMA, THMD1 | Solute carrier family 19 (thiamine transporter), member 2 | 10560.0 | ENSG00000117479 | nan | Thiamine-responsive megaloblastic anemia syndrome, 249270 (3), Autosomal recessive
chr1	F5	612309.0 | F5, THPH2, RPRGL1 | Coagulation factor V (proaccelerin, labile factor) | 2153.0 | ENSG00000198734 | Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment | Thrombophilia 2 due to activated protein C resistance, 188055 (3), Autosomal dominant; {Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3), Autosomal dominant; {Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3), Autosomal dominant; {Budd-Chiari syndrome}, 600880 (3), Autosomal recessive; {Stroke, ischemic, susceptibility to}, 601367 (3), Multifactorial; Factor V deficiency, 227400 (3), Autosomal recessive
chr1	SELP	173610.0 | SELP, GRMP | Selectin P (granulocyte membrane protein, 140kD; antigen CD62) | 6403.0 | ENSG00000174175 | in same 300kb segment as LYAM1, ELAM1 | nan
chr1	SELL	153240.0 | SELL, LYAM1, LAM1, LNHR | Selectin L (lymphocyte adhesion molecule 1) | 6402.0 | ENSG00000188404 | nan | nan
chr1	SELE	131210.0 | SELE, ELAM1 | Selectin E (endothelial leukocyte adhesion molecule-1) | 6401.0 | ENSG00000007908 | nan | nan
chr1	METTL18	615255.0 | METTL18, C1orf156 | Methyltransferase-like 18 | 92342.0 | ENSG00000171806 | nan | nan
chr1	SCYL3	608192.0 | SCYL3, PACE1 | SCY1-like pseudokinase 3 | 57147.0 | ENSG00000000457 | nan | nan
chr1	KIFAP3	601836.0 | KIFAP3, SMAP | Kinesin-associated protein 3 | 22920.0 | ENSG00000075945 | nan | nan
chr1	GORAB	607983.0 | GORAB, SCYL1BP1, NTKLBP1, GO | Golgin, RAB6-interacting | 92344.0 | ENSG00000120370 | nan | Geroderma osteodysplasticum, 231070 (3), Autosomal recessive
chr1	PRRX1	167420.0 | PRRX1, PMX1, PHOX1, AGOTC | Paired-related homeobox gene 1 | 5396.0 | ENSG00000116132 | nan | Agnathia-otocephaly complex, 202650 (3), Autosomal recessive, Autosomal dominant
chr1	FMO3	136132.0 | FMO3, TMAU | Flavin-containing monooxygenase 3 | 2328.0 | ENSG00000007933 | nan | Trimethylaminuria, 602079 (3), Autosomal recessive
chr1	FMO2	603955.0 | FMO2 | Flavin-containing monooxygenase 2, pulmonary | 2327.0 | ENSG00000094963 | probably cluster of FMO genes at 1q23-q25 | nan
chr1	FMO1	136130.0 | FMO1 | Flavin-containing monooxygenase 1, fetal liver | 2326.0 | ENSG00000010932 | nan | nan
chr1	FMO4	136131.0 | FMO4 | Flavin-containing monooxygenase 2, adult liver | 2329.0 | ENSG00000076258 | nan | nan
chr1	PRRC2C	617373.0 | PRRC2C, KIAA1096 | Proline-rich coiled-coil protein 3C | 23215.0 | ENSG00000117523 | nan | nan
chr1	MYOC	601652.0 | MYOC, TIGR, GLC1A, JOAG, GPOA | Myocilin (trabecular meshwork-induced glucocorticoid response protein) | 4653.0 | ENSG00000034971 | nan | Glaucoma 1A, primary open angle, 137750 (3), Autosomal dominant
chr1	VAMP4	606909.0 | VAMP24 | Vesicle-associated membrane protein 4 | 8674.0 | ENSG00000117533 | nan | nan
chr1	METTL13	617987.0 | EEF1AKNMT, METTL13, FEAT, KIAA0859, DFNB26M | EEF1A lysine and N-terminal methyltransferase | 51603.0 | ENSG00000010165 | mutation identified in 1 family | {?Deafness, autosomal recessive 26, modifier of}, 605429 (3), Autosomal dominant
chr1	DNM3	611445.0 | DNM3, KIAA0820 | Dynamin 3 | 26052.0 | ENSG00000197959 | nan | nan
chr1	MIR214	610721.0 | MIR214, MIRN214 | Micro RNA 214 | 406996.0 | ENSG00000283844 | nan | nan
chr1	MIR3120	614722.0 | MIR3120 | Micro RNA 3120 | 100422882.0 | ENSG00000283152 | in intron 13 of DNM3 in sense orientation | nan
chr1	MIR199A2	610720.0 | MIR199A2, MIRN199A2 | Micro RNA 199A2 | 406977.0 | ENSG00000208024 | nan | nan
chr1	PIGC	601730.0 | PIGC, GPI2, GPIBD16, MRT62 | Phosphatidylinositol glycan, class C | 5279.0 | ENSG00000135845 | nan | Glycosylphosphatidylinositol biosynthesis defect 16, 617816 (3), Autosomal recessive
chr1	SUCO	619434.0 | SUCO, C1orf9 | SUN domain-containing ossification factor | 51430.0 | ENSG00000094975 | nan | nan
chr1	FASLG	134638.0 | FASLG, TNFSF6, APT1LG1, FASL, ALPS1B | Fas ligand (TNF superfamily, member 6) | 356.0 | ENSG00000117560 | nan | Autoimmune lymphoproliferative syndrome, type IB, 601859 (3), Autosomal dominant; {Lung cancer, susceptibility to}, 211980 (3), Somatic mutation, Autosomal dominant
chr1	AD14	611154.0 | AD14 | Alzheimer disease 14 | 100188754.0 | nan | max lod at D1S218 | {Alzheimer disease-14}, 611154 (2)
chr1	PDON2	608526.0 | PDON2 | Periodontitis, aggressive, 2 | 406237.0 | nan | between D1S196 and D1S533 | Periodontitis, aggressive, 2, 608526 (2)
chr1		611013.0 | RGSL2 | Regulator of G protein signaling-like 2 | nan | nan | related to AD linked to 1q25 | nan
chr1	TNFSF18	603898.0 | TNFSF18, AITRL, GITRL | Tumor necrosis factor ligand superfamily, member 18 | 8995.0 | ENSG00000120337 | nan | nan
chr1	TNFSF4	603594.0 | TNFSF4, GP34, OX4OL | Tumor necrosis factor ligand superfamily, member 4 | 7292.0 | ENSG00000117586 | nan | {Myocardial infarction, susceptibility to}, 608446 (3)
chr1	PRDX6	602316.0 | PRDX6 | Peroxiredoxin 6 | 9588.0 | ENSG00000117592 | nan | nan
chr1	SLC9C2	620338.0 | SLC9C2, NHE11 | Solute carrier family 9, member C2 | 284525.0 | ENSG00000162753 | nan | nan
chr1	ANKRD45	618712.0 | ANKRD45 | Ankyrin repeat domain-containing protein 45 | 339416.0 | ENSG00000183831 | nan | nan
chr1	KLHL20	617679.0 | KLHL20, KLEIP, KLHLX | Kelch-like 20 | 27252.0 | ENSG00000076321 | nan | nan
chr1	CENPL	611503.0 | CENPL | Centromeric protein L | 91687.0 | ENSG00000120334 | nan | nan
chr1	DARS2	610956.0 | DARS2, ASPRS. LBSL | Aspartyl-tRNA synthetase 2 | 55157.0 | ENSG00000117593 | nan | Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive
chr1	GAS5	608280.0 | GAS5 | Growth arrest-specific 5 | 60674.0 | ENSG00000234741 | nan | nan
chr1	SERPINC1	107300.0 | SERPINC1, AT3, AT3D, THPH7 | Antithrombin III | 462.0 | ENSG00000117601 | ~17cM distal to FY | Thrombophilia 7 due to antithrombin III deficiency, 613118 (3), Autosomal recessive, Autosomal dominant
chr1	RC3H1	609424.0 | RC3H1, KIAA2025, IMDSHY | Roquin | 149041.0 | ENSG00000135870 | mutation identified in 1 IMDSHY patient | ?Immune dysregulation and systemic hyperinflammation syndrome, 618998 (3), Autosomal recessive
chr1	RABGAP1L	609238.0 | RABGAP1L, TBC1D18, KIAA0471 | RAB GTPase-activating protein 1-like | 9910.0 | ENSG00000152061 | nan | nan
chr1	GPR52	604106.0 | GPR52 | G protein-coupled receptor 52 | 9293.0 | ENSG00000203737 | nan | nan
chr1	CACYBP	606186.0 | SIP | SIAH1-interacting protein | 27101.0 | ENSG00000116161 | nan | nan
chr1	MRPS14	611978.0 | MRPS14, COXPD38 | Mitochondrial ribosomal protein S14 | 63931.0 | ENSG00000120333 | mutation identified in 1 COXPD38 patient | ?Combined oxidative phosphorylation deficiency 38, 618378 (3), Autosomal recessive
chr1	TNN	617472.0 | TNN | Tenascin N | 63923.0 | ENSG00000120332 | nan | nan
chr1	KIAA0040	616696.0 | KIAA0040 | KIAA0040 gene | 9674.0 | ENSG00000235750 | nan | nan
chr1	TNR	601995.0 | TNR, NEDSTO | Tenascin R (restrictin, janusin) | 7143.0 | ENSG00000116147 | nan | Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus, 619653 (3), Autosomal recessive
chr1	COP1	608067.0 | RFWD2, COP1 | Ring finger- and WD repeat domain-containing protein 2 | 64326.0 | ENSG00000143207 | pseudogenes on chr. 3, 9, 18 | nan
chr1		615492.0 | LINC-COX2 | Long intergenic noncoding RNA COX2 | nan | nan | nan | nan
chr1	PAPPA2	619485.0 | PAPPA2, PAPPE, SSDA | Pappalysin 2 | 60676.0 | ENSG00000116183 | nan | Short stature, Dauber-Argente type, 619489 (3), Autosomal recessive
chr1	ASTN1	600904.0 | ASTN1, ASTN | Astrotactin 1 | 460.0 | ENSG00000152092 | nan | nan
chr1	BRINP2	619359.0 | BRINP2 | Bone morphogenetic protein/retinoic acid-inducible neural-specific protein 2 | 57795.0 | ENSG00000198797 | nan | nan
chr1	SEC16B	612855.0 | SEC16B, LZTR2, RGPR, SEC16S | SEC16 homolog B, endoplasmic reticulum export factor | 89866.0 | ENSG00000120341 | nan | nan
chr1	RASAL2	606136.0 | RASAL2, NGAP | Ras protein activator-like 2 | 9462.0 | ENSG00000075391 | nan | nan
chr1	RALGPS2	617819.0 | RALGPS2, FLJ10244 | RAL guanine nucleotide exchange factor with PH domain and SH3 domain-binding motif 2 | 55103.0 | ENSG00000116191 | nan | nan
chr1	ANGPTL1	603874.0 | ANGPTL1 | Angiopoietin-like 1 | 9068.0 | ENSG00000116194 | nan | nan
chr1	FAM20B	611063.0 | FAM20B | Family with sequence similarity 20, member B | 9917.0 | ENSG00000116199 | nan | nan
chr1	TOR3A	607555.0 | TOR3A, ADIR | Torsin family 3, member A (ATP-dependent interferon-responsive protein) | 64222.0 | ENSG00000186283 | nan | nan
chr1	ABL2	164690.0 | ABL2, ABLL, ARG | ABL protooncogene 2, nonreceptor tyrosine kinase | 27.0 | ENSG00000143322 | fused with ETV6 in AML | nan
chr1	SOAT1	102642.0 | SOAT1, STAT, ACAT | Sterol O-acyltransferase 1 (acyl-Coenzyme A: cholesterol acyltransferase 1) | 6646.0 | ENSG00000057252 | nan | nan
chr1	NPHS2	604766.0 | PDCN, NPHS2, SRN1 | Podocin | 7827.0 | ENSG00000116218 | modifies phenotype of NPHS1 mutations to FSGS | Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive
chr1	TDRD5	617748.0 | TDRD5, TUDOR3 | Tudor domain-containing protein 5 | 163589.0 | ENSG00000162782 | nan | nan
chr1	FAM163A	611727.0 | C1orf76, NDSP | Neuroblastoma-derived secretory protein | 148753.0 | ENSG00000143340 | nan | nan
chr1	TOR1AIP2	614513.0 | TOR1AIP2, LULL1 | Torsin A-interacting protein 2 | 163590.0 | ENSG00000169905 | nan | nan
chr1	TOR1AIP1	614512.0 | TOR1AIP1, LAP1, LAP1B, LGMD2Y | Torsin 1A-interacting protein 1 | 26092.0 | ENSG00000143337 | mutation identified in 1 MRRSDC family | ?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures, 617072 (3), Autosomal recessive
chr1	CEP350	617870.0 | CEP350, CAP350, KIAA0480 | Centrosomal protein 350 | 9857.0 | ENSG00000135837 | nan | nan
chr1	QSOX1	603120.0 | QSOX1 | Quiescin Q6 sulfhydryl oxidase 1 | 5768.0 | ENSG00000116260 | nan | nan
chr1	LHX4	602146.0 | LHX4, CPHD4 | LIM homeobox gene 4 | 89884.0 | ENSG00000121454 | fused to IGH in ALL | Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant
chr1	ACBD6	616352.0 | ACBD6, NEDPM | Acyl-CoA-binding domain-containing protein 6 | 84320.0 | ENSG00000230124 | nan | Neurodevelopmental disorder with progressive movement abnormalities, 620785 (3), Autosomal recessive
chr1	VDAC1P4	610030.0 | VDAC1P4 | Voltage-dependent anion channel 1 pseudogene 4 | 7418.0 | nan | nan | nan
chr1	XPR1	605237.0 | XPR1, SYG1, IBGC6 | Xenotropic and polytropic retrovirus receptor | 9213.0 | ENSG00000143324 | nan | Basal ganglia calcification, idiopathic, 6, 616413 (3), Autosomal dominant
chr1	STX6	603944.0 | STX6 | Syntaxin 6 | 10228.0 | ENSG00000135823 | nan | nan
chr1	MR1	600764.0 | MR1, HLALS | Major histocompatibility complex, class I-related | 3140.0 | ENSG00000153029 | nan | nan
chr1	IER5	607177.0 | IER5 | Immediate-early response gene 5 | 51278.0 | ENSG00000162783 | nan | nan
chr1	CACNA1E	601013.0 | CACNA1E, CACNL1A6, DEE69 | Calcium channel, voltage-dependent, alpha 1E subunit | 777.0 | ENSG00000198216 | nan | Developmental and epileptic encephalopathy 69, 618285 (3), Autosomal dominant
chr1	GLUL	138290.0 | GLUL, GLNS, DEE116 | Glutamate-ammonia ligase (glutamine synthase) | 2752.0 | ENSG00000135821 | pseudogene on chr.9 | Glutamine deficiency, congenital, 610015 (3), Autosomal recessive; Developmental and epileptic encephalopathy 116, 620806 (3), Autosomal dominant
chr1	TEDDM1	620288.0 | TEDDM1 | Transmembrane epididymal protein 1 | 127670.0 | ENSG00000203730 | nan | nan
chr1	RGSL1	611012.0 | RGSL1 | Regulator of G protein signaling-like 1 | 353299.0 | ENSG00000121446 | nan | nan
chr1	RNASEL	180435.0 | RNASEL, RNS4, PRCA1, HPC1 | Ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) | 6041.0 | ENSG00000135828 | nan | Prostate cancer 1, 601518 (3), Autosomal dominant
chr1	RGS16	602514.0 | RGS16 | Regulator of G protein signaling-16 | 6004.0 | ENSG00000143333 | nan | nan
chr1	RGS8	607189.0 | RGS8 | Regulator of G protein signaling 8 | 85397.0 | ENSG00000135824 | nan | nan
chr1	NPL	611412.0 | NPL, C1orf13, C112 | N-acetylneuraminate pyruvate lyase | 80896.0 | ENSG00000135838 | nan | nan
chr1	DHX9	603115.0 | DHX9, DDX9, NDHII, MRD75 | DExH-box helicase 9 | 1660.0 | ENSG00000135829 | nan | Intellectual developmental disorder, autosomal dominant 75, 620988 (3), Autosomal dominant
chr1	SHCBP1L	619514.0 | SHCBP1L, C1orf14 | SHC-binding and spindle-associated protein 1-like | 81626.0 | ENSG00000157060 | nan | nan
chr1	LAMC1	150290.0 | LAMC1, LAMB2 | Laminin, gamma-1 (formerly LAMB2) | 3915.0 | ENSG00000135862 | at least 3 genes, ?linked | nan
chr1	LAMC2	150292.0 | LAMC2, LAMNB2, LAMB2T, JEB3A, JEB3B | Laminin, gamma-2 (nicein, 100kD; kalinin, 105kD; BM600, 100kD) | 3918.0 | ENSG00000058085 | nan | Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive
chr1	NMNAT2	608701.0 | NMNAT2, PNAT2, KIAA0479 | Nicotinamide nucleotide adenylyltransferase 2 | 23057.0 | ENSG00000157064 | nan | nan
chr1	SMG7	610964.0 | SMG7, EST1C, KIAA0250 | SMG7 nonsense-mediated mRNA decay factor | 9887.0 | ENSG00000116698 | nan | nan
chr1	NCF2	608515.0 | NCF2 | Neutrophil cytosolic factor-2, 65kD | 4688.0 | ENSG00000116701 | nan | Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive
chr1	ARPC5	604227.0 | ARPC5, ARC16, IMD113 | Actin-related protein 2/3 complex, subunit 5 | 10092.0 | ENSG00000162704 | nan | Immunodeficiency 133 with autoimmunity and autoinflammation, 620565 (3), Autosomal recessive
chr1	RGL1	605667.0 | RGL1, RGL | Ral guanine nucleotide dissociation stimulator-like 1 | 23179.0 | ENSG00000143344 | nan | nan
chr1	APOBEC4	609908.0 | APOBEC4 | Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 4 | 403314.0 | ENSG00000173627 | nan | nan
chr1	COLGALT2	617533.0 | COLGALT2, GLT25D2, KIAA0584 | Collagen beta(1-0)galactosyltransferase 2 | 23127.0 | ENSG00000198756 | nan | nan
chr1	TSEN15	608756.0 | TSEN15, SEN15, C1orf19, PCH2F | tRNA splicing endonuclease, subunit 15 | 116461.0 | ENSG00000198860 | nan | Pontocerebellar hypoplasia, type 2F, 617026 (3), Autosomal recessive
chr1	EDEM3	610214.0 | EDEM3, C1orf22, CDG2V | Endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 3 | 80267.0 | ENSG00000116406 | nan | Congenital disorder of glycosylation, type IIv, 619493 (3), Autosomal recessive
chr1	NIBAN1	619294.0 | NIBAN1, C1orf24 | Niban apoptosis regulator 1 | 116496.0 | ENSG00000135842 | nan | nan
chr1	RNF2	608985.0 | RNF2, RING2, RING1B, HIPI3, DING, BAP1, LUSYAM | RING finger protein 2 | 6045.0 | ENSG00000121481 | nan | Luo-Schoch-Yamamoto syndrome, 619460 (3), Autosomal dominant
chr1	TRMT1L	611673.0 | TRMT1L, C1orf25, TRM1L | tRNA methyltransferase 1-like | 81627.0 | ENSG00000121486 | nan | nan
chr1	SWT1	619513.0 | SWT1, C1orf26 | SWT1 RNA endoribonuclease homolog | 54823.0 | ENSG00000116668 | nan | nan
chr1	IVNS1ABP	609209.0 | IVNS1ABP, NS1BP, ND1, IMD70 | Influenza virus NS1A protein-binding protein | 10625.0 | ENSG00000116679 | nan | Immunodeficiency 70, 618969 (3), Autosomal dominant
chr1	HMCN1	608548.0 | HMCN1, FBLN6, FIBL6, ARMD1 | Hemicentin (fibulin 6) | 83872.0 | ENSG00000143341 | nan | {Macular degeneration, age-related, 1}, 603075 (3), Autosomal dominant
chr1	BOS2	120502.0 | BOS2 | Branchiootic syndrome 2 | 64585.0 | nan | nan | Branchiootic syndrome 2, 120502 (2), Autosomal dominant
chr1	CELIAC7	612005.0 | CELIAC7 | Celiac disease, susceptibility to, 7 | 100301522.0 | nan | associated with rs2816316 | {Celiac disease, susceptibility to, 7}, 612005 (2)
chr1	MGR6	607516.0 | MGR6, FHM3 | Migraine, several forms | 317773.0 | nan | nan | {Migraine with or without aura, susceptibility to, 6}, 607516 (2), Autosomal dominant; {Migraine, familial hemiplegic, 4}, 607516 (2), Autosomal dominant
chr1	PHA2A	145260.0 | PHA2A, PHA2 | Pseudohypoaldosteronism type IIA | 7830.0 | nan | nan | Pseudohypoaldosteronism, type IIA, 145260 (2), Autosomal dominant
chr1	PSNP2	609454.0 | PSNP2 | Supranuclear palsy, progressive, 2 | 619408.0 | nan | between D1S238 and D1S2823 | Supranuclear palsy, progressive, 2, 609454 (2), Autosomal dominant
chr1	PVOP1	176780.0 | PVOP1 | Pelvic organ prolapse, susceptibility to, 1 | 100312952.0 | nan | associated with rs10911193 | {Pelvic organ prolapse, susceptibility to, 1}, 176780 (2), Autosomal dominant
chr1	PRG4	604283.0 | PRG4, CACP, MSF, SZP, HAPO | Proteoglycan 4 (megakaryocyte stimulating factor; hemangiopoietin) | 10216.0 | ENSG00000116690 | nan | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3), Autosomal recessive
chr1	TPR	189940.0 | TPR, MRT79 | Tumor potentiating region (translocated promoter region) | 7175.0 | ENSG00000047410 | mutation identified in 1 MRT79 family | ?Intellectual developmental disorder, autosomal recessive 79, 620393 (3), Autosomal recessive
chr1	ODR4	609335.0 | ODR4, C1orf27 | odr-4 GPCR localization factor homolog | 54953.0 | ENSG00000157181 | nan | nan
chr1	PDC	171490.0 | PDC | Phosducin, pineal gland | 5132.0 | ENSG00000116703 | nan | nan
chr1	PTGS2	600262.0 | PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 5743.0 | ENSG00000073756 | nan | nan
chr1	PACERR	617650.0 | PACERR, PTGS2AS1 | PTGS2 antisense NFKB1 complex-mediated expression regulator RNA, noncoding | 103752588.0 | nan | nan | nan
chr1	PLA2G4A	600522.0 | PLA2G4A, PLA2G4, GURDP | Phospholipase A2, group IVA, cytosolic | 5321.0 | ENSG00000116711 | nan | Gastrointestinal ulceration, recurrent, with dysfunctional platelets, 618372 (3), Autosomal recessive
chr1	BRINP3	618390.0 | BRINP3, FAM5C | Bone morphogenetic protein/retionoic acid-inducible neural-specific protein 3 | 339479.0 | ENSG00000162670 | nan | nan
chr1	RGS18	607192.0 | RGS18 | Regulator of G protein signaling 18 | 64407.0 | ENSG00000150681 | nan | nan
chr1	RGS21	612407.0 | RGS21 | Regulator of G protein signaling 21 | 431704.0 | ENSG00000253148 | nan | nan
chr1	RGS1	600323.0 | RGS1, IER1, IR20 | Regulator of G-protein signaling 1 | 5996.0 | ENSG00000090104 | nan | nan
chr1	RGS13	607190.0 | RGS13 | Regulator of G protein signaling 13 | 6003.0 | ENSG00000127074 | nan | nan
chr1	RGS2	600861.0 | RGS2, G0S8 | G0 to G1 switch regulatory 8, 24kD | 5997.0 | ENSG00000116741 | nan | nan
chr1	UCHL5	610667.0 | UCHL5, UCH37 | Ubiquitin carboxyl-terminal hydrolase L5 | 51377.0 | ENSG00000116750 | nan | nan
chr1	RO60	600063.0 | TROVE2, RO60, SSA2 | TROVE domain family, member 2 | 6738.0 | ENSG00000116747 | nan | nan
chr1	GLRX2	606820.0 | GLRX2, GRX2 | Glutaredoxin 2 | 51022.0 | ENSG00000023572 | nan | nan
chr1	CDC73	607393.0 | CDC73, HRPT2, C1orf28 | Cell division cycle 73 | 79577.0 | ENSG00000134371 | nan | Hyperparathyroidism, familial primary, 145000 (3), Autosomal dominant; Parathyroid adenoma with cystic changes, 145001 (3), Autosomal dominant; Parathyroid carcinoma, 608266 (3); Hyperparathyroidism-jaw tumor syndrome, 145001 (3), Autosomal dominant
chr1	B3GALT2	603018.0 | B3GALT2, GLCT2 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 2 | 8707.0 | ENSG00000162630 | nan | nan
chr1	KCNT2	610044.0 | KCNT2, SLICK, DEE57 | Potassium channel, subfamily T, member 2 | 343450.0 | ENSG00000162687 | nan | Developmental and epileptic encephalopathy 57, 617771 (3), Autosomal dominant
chr1	CFH	134370.0 | CFH, HF1, HUS, ARMD4, AHUS1 | Complement factor H | 3075.0 | ENSG00000000971 | nan | {Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant
chr1	CFHR3	605336.0 | CFHR3, FHR3, HLF4, CFHL3 | Complement factor H-related 3 | 10878.0 | ENSG00000116785 | nan | {Macular degeneration, age-related, reduced risk of}, 603075 (3), Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3), Autosomal recessive, Autosomal dominant
chr1	CFHR1	134371.0 | CFHR1, FHR1, HFL1, CFHL1 | Complement factor H-related 1 | 3078.0 | ENSG00000244414 | nan | {Macular degeneration, age-related, reduced risk of}, 603075 (3), Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3), Autosomal recessive, Autosomal dominant
chr1	CFHR4	605337.0 | CFHR4, FHR4, CFHL4 | Complement factor H-related 4 | 10877.0 | ENSG00000134365 | nan | nan
chr1	CFHR2	600889.0 | CFHR2, FHR2, HFL3, CFHL2 | Complement factor H-related 2 | 3080.0 | ENSG00000080910 | in same 165kb YAC as F13B | nan
chr1	CFHR5	608593.0 | CFHR5, CFHL5, FHR5, CFHR5D | Complement factor H-related 5 | 81494.0 | ENSG00000134389 | nan | Nephropathy due to CFHR5 deficiency, 614809 (3), Autosomal dominant
chr1	F13B	134580.0 | F13B | Coagulation factor XIII, B polypeptide | 2165.0 | ENSG00000143278 | nan | Factor XIIIB deficiency, 613235 (3), Autosomal recessive
chr1	ASPM	605481.0 | ASPM, MCPH5 | Abnormal spindle-like, microcephaly-associated | 259266.0 | ENSG00000066279 | nan | Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive
chr1	CRB1	604210.0 | CRB1, RP12, LCA8 | Crumbs cell polarity complex component 1 | 23418.0 | ENSG00000134376 | nan | Leber congenital amaurosis 8, 613835 (3), Autosomal recessive; Retinitis pigmentosa-12, 600105 (3), Autosomal recessive; Pigmented paravenous chorioretinal atrophy, 172870 (3), Autosomal dominant
chr1	DENND1B	613292.0 | DENND1B, FAM31B, C1orf18 | DENN/MADD domain-containing 1B | 163486.0 | ENSG00000213047 | nan | nan
chr1	LHX9	606066.0 | LHX9 | LIM homeobox gene 9 | 56956.0 | ENSG00000143355 | nan | nan
chr1	NEK7	606848.0 | NEK7 | NIMA-related kinase 7 | 140609.0 | ENSG00000151414 | nan | nan
chr1	ATP6V1G3	618071.0 | ATP6V1G3 | ATPase, H+ transporting, V1 subunit G3 | 127124.0 | ENSG00000151418 | nan | nan
chr1	PTPRC	151460.0 | PTPRC, CD45, LCA, IMD105 | Protein tyrosine phosphatase, receptor type, c polypeptide | 5788.0 | ENSG00000081237 | nan | Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive
chr1	GFND1	137950.0 | GFND1 | Glomerulopathy with fibronectin deposits 1 | 100689213.0 | nan | max lod at D1S2782 | Glomerulopathy with fibronectin deposits 1, 137950 (2), Autosomal dominant
chr1	GUK2	139280.0 | GUK2 | Guanylate kinase-2 | 2988.0 | nan | genetic independence of GUK1 and GUK2 unproved | nan
chr1	IBD23	612381.0 | IBD23 | Inflammatory bowel disease 23 | 100240733.0 | nan | associated with rs3024505 | {Inflammatory bowel disease 23}, 612381 (2)
chr1		614826.0 | NYS7 | Nystagmus 7, congenital, autosomal dominant | nan | nan | disruption of TADs on 1q32 | Nystagmus 7, congenital, autosomal dominant, 614826 (4), Autosomal dominant
chr1	PARK16	613164.0 | PARK16 | Parkinson disease 16 | 100359403.0 | nan | associated with rs823128 | {Parkinson disease 16}, 613164 (2)
chr1	PFHB2	140400.0 | PFHB2 | Progressive familial heart block, type II | 105463127.0 | nan | between D1S70 and D1S505 | Progressive familial heart block, type II, 140400 (2), Autosomal dominant
chr1	MIR181B1	612744.0 | MIR181B1, MIRN181B1 | Micro RNA 181B1 | 406955.0 | ENSG00000207975 | nan | nan
chr1	MIR181A1	612742.0 | MIR181A1, MIR213, MIRN181A1 | Micro RNA 181A1 | 406995.0 | ENSG00000207759 | nan | nan
chr1	NR5A2	604453.0 | NR5A2, FTF, HB1F | Nuclear receptor subfamily 5, group A, member 2 (fetoprotein transcription factor) | 2494.0 | ENSG00000116833 | nan | nan
chr1	ZNF281	618703.0 | ZNF281, ZBP99, GZP1 | Zinc finger ptoein 281 | 23528.0 | ENSG00000162702 | nan | nan
chr1	KIF14	611279.0 | KIF14, KIAA0042, MKS12, MCPH20 | Kinesin family member 14 | 9928.0 | ENSG00000118193 | mutation identified in 1 MKS12 family | Microcephaly 20, primary, autosomal recessive, 617914 (3), Autosomal recessive; ?Meckel syndrome 12, 616258 (3), Autosomal recessive
chr1	DDX59	615464.0 | DDX59, OFD5 | DEAD-box helicase 59 | 83479.0 | ENSG00000118197 | nan | Orofaciodigital syndrome V, 174300 (3), Autosomal recessive
chr1	CAMSAP2	613775.0 | CAMSAP1L, CAMSAP2, KIAA1078 | Calmodulin-regulated spectrin-associated protein 1-like 1 | 23271.0 | ENSG00000118200 | nan | nan
chr1	GPR25	602174.0 | GPR25 | G protein-coupled receptor-25 | 2848.0 | ENSG00000170128 | nan | nan
chr1	INAVA	618051.0 | INAVA, C1orf106, IBD29 | Innate immunity activator | 55765.0 | ENSG00000163362 | nan | {Inflammatory bowel disease 29}, 618077 (3), Autosomal dominant
chr1	KIF21B	608322.0 | KIF21B, KIAA0449 | Kinesin family member 21B | 23046.0 | ENSG00000116852 | nan | nan
chr1	CACNA1S	114208.0 | CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1, MHS5, CMYO18 | Calcium channel, voltage-dependent, L type, alpha 1S subunit | 779.0 | ENSG00000081248 | nan | {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant
chr1	ASCL5	620809.0 | ASCL5, AMELOD | Achaete-scute family bHLH transcription factor 5 | 647219.0 | ENSG00000232237 | nan | nan
chr1	TMEM9	616877.0 | TMEM9, TMEM9A, DERM4 | Transmembrane protein 9 | 252839.0 | ENSG00000116857 | nan | nan
chr1	IGFN1	617309.0 | IGFN1, EEF1A2BP1 | Immunoglobulin-like and fibronectin type III domains-containing protein 1 | 91156.0 | ENSG00000163395 | nan | nan
chr1	PKP1	601975.0 | PKP1, EDSFS | Plakophilin-1 | 5317.0 | ENSG00000081277 | nan | Ectodermal dysplasia/skin fragility syndrome, 604536 (3), Autosomal recessive
chr1	TNNT2	191045.0 | TNNT2, CMH2, CMD1D, RCM3, LVNC6 | Troponin-T2, cardiac | 7139.0 | ENSG00000118194 | nan | Cardiomyopathy, dilated, 1D, 601494 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 2, 115195 (3), Autosomal dominant; Cardiomyopathy, familial restrictive, 3, 612422 (3), Autosomal dominant; Left ventricular noncompaction 6, 601494 (3), Autosomal dominant
chr1	LAD1	602314.0 | LAD1 | Ladinin | 3898.0 | ENSG00000159166 | nan | nan
chr1	TNNI1	191042.0 | TNNI1 | Troponin-I, skeletal, slow | 7135.0 | ENSG00000159173 | nan | nan
chr1	PHLDA3	607054.0 | PHLDA3, TIH1 | Pleckstrin homology-like domain, family A, member 3 | 23612.0 | ENSG00000174307 | nan | nan
chr1	CSRP1	123876.0 | CSRP1, CSRP | Cysteine and glycine-rich protein-1 | 1465.0 | ENSG00000159176 | nan | nan
chr1	NAV1	611628.0 | NAV1, POMFIL3, KIAA1151 | Neuron navigator 1 | 89796.0 | ENSG00000134369 | nan | nan
chr1	MIR1231	617040.0 | MIR1231 | Micro RNA 1231 | 100302158.0 | ENSG00000221028 | nan | nan
chr1	IPO9	620893.0 | IPO9, IMP9, RANBP9 | Importin 9 | 55705.0 | ENSG00000198700 | nan | nan
chr1	SHISA4	617326.0 | SHISA4, C1orf40, TMEM58 | Shisa family, member 4 | 149345.0 | ENSG00000198892 | nan | nan
chr1	LMOD1	602715.0 | LMOD1, SMLMOD, 1D, MMIHS3 | Leiomodin 1 | 25802.0 | ENSG00000163431 | mutation identified in 1 MMIHD3 patient | ?Megacystis-microcolon-intestinal hypoperistalsis syndrome 3, 619362 (3), Autosomal recessive
chr1	TIMM17A	605057.0 | TIMM17A, TIM17A | Translocase of inner mitochondrial membrane 17A | 10440.0 | ENSG00000134375 | nan | nan
chr1	RNPEP	602675.0 | RNPEP | Arginyl aminopeptidase (aminopeptidase B) | 6051.0 | ENSG00000176393 | nan | nan
chr1	ELF3	602191.0 | ELF3, ESX | E74-like factor 3 (ETS domain transcription factor, serine box, epithelial-specific) | 1999.0 | ENSG00000163435 | nan | nan
chr1	GPR37L1	617630.0 | GPR37L1, ETBRLP2 | G protein-coupled receptor 37-like 1 | 9283.0 | ENSG00000170075 | nan | nan
chr1	ARL8A	616597.0 | ARL8A, GIE2 | ADP ribosylation factor-like GTPase 8A | 127829.0 | ENSG00000143862 | nan | nan
chr1	PTPN7	176889.0 | PTPN7 | Protein tyrosine phosphatase, nonreceptor-type, 7 | 5778.0 | ENSG00000143851 | nan | nan
chr1	LGR6	606653.0 | LGR6 | Leucine-rich repeat-containing G protein-coupled receptor-6 | 59352.0 | ENSG00000133067 | nan | nan
chr1	UBE2T	610538.0 | UBE2T, HSPC150, FANCT | Ubiquitin-conjugating enzyme E2 T | 29089.0 | ENSG00000077152 | nan | Fanconi anemia, complementation group T, 616435 (3), Autosomal recessive
chr1	PPP1R12B	603768.0 | PPP1R12B, MYPT2 | Protein phosphatase 1, regulatory subunit 12B (myosin phosphatase target subunit 2) | 4660.0 | ENSG00000077157 | nan | nan
chr1	SYT2	600104.0 | SYT2, CMS7A, MYSPC, CMS7B | Synaptotagmin-2 | 127833.0 | ENSG00000143858 | nan | Myasthenic syndrome, congenital, 7A, presynaptic, and distal motor neuropathy, autosomal dominant, 616040 (3), Autosomal dominant; Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive, 619461 (3), Autosomal recessive
chr1	KDM5B	605393.0 | KDM5B, JARID1B, PUT1, PLU1, RBBP2H1A, MRT65 | Lysine-specific demethylase 5B | 10765.0 | ENSG00000117139 | nan | Intellectual developmental disorder, autosomal recessive 65, 618109 (3), Autosomal recessive
chr1	RABIF	603417.0 | RABIF, RASGFR3, MSS4 | Rab-interacting factor (Ras-specific guanine-releasing factor-3; mammalian suppressor of SEC4) | 5877.0 | ENSG00000183155 | nan | nan
chr1	KLHL12	614522.0 | KLHL12, DKIR | Kelch-like 12 | 59349.0 | ENSG00000117153 | nan | nan
chr1	ADIPOR1	607945.0 | ADIPOR1, CGI45 | Adiponectin receptor 1 | 51094.0 | ENSG00000159346 | nan | nan
chr1	CYB5R1	608341.0 | CYB5BR1, NQO3A2, B5R.1 | Cytochrome b5 reductase 1 | 51706.0 | ENSG00000159348 | nan | nan
chr1	PPFIA4	603145.0 | PPFIA4 | PTPRF-interacting protein alpha-4 | 8497.0 | ENSG00000143847 | nan | nan
chr1	MYOG	159980.0 | MYOG, MYF4 | Myogenic factor-4; myogenin | 4656.0 | ENSG00000122180 | nan | nan
chr1	ADORA1	102775.0 | ADORA1, RDC7 | Adenosine A1 receptor | 134.0 | ENSG00000163485 | nan | nan
chr1	MYBPH	160795.0 | MYBPH | Myosin-binding protein H | 4608.0 | ENSG00000133055 | nan | nan
chr1	CHI3L1	601525.0 | CHI3L1, GP39, YKL40, ASRT7 | Chitinase 3-like 1 (cartilage glycoprotein-39) | 1116.0 | ENSG00000133048 | nan | {Asthma-related traits, susceptibility to, 7}, 611960 (3); {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant
chr1	CHIT1	600031.0 | CHIT, CHITD | Chitotriosidase | 1118.0 | ENSG00000133063 | nan | [Chitotriosidase deficiency], 614122 (3), Autosomal recessive
chr1	BTG2	601597.0 | BTG2, PC3 | BTG antiproliferation factor 2 | 7832.0 | ENSG00000159388 | nan | nan
chr1	FMOD	600245.0 | FMOD | Fibromodulin | 2331.0 | ENSG00000122176 | nan | nan
chr1	BMNCR	618553.0 | BMNCR | Bone marrow associated noncoding RNA | 107985249.0 | nan | nan | nan
chr1	PRELP	601914.0 | PRELP | Proline arginine-rich end leucine-rich repeat protein | 5549.0 | ENSG00000188783 | nan | nan
chr1	OPTC	605127.0 | OPTC | Opticin | 26254.0 | ENSG00000188770 | nan | nan
chr1	ATP2B4	108732.0 | ATP2B4, ATP2B2, PMCA4 | ATPase, Ca++ transporting, plasma membrane, 4 | 493.0 | ENSG00000058668 | nan | nan
chr1	LAX1	619622.0 | LAX1, LAX | Lymphocyte transmembrane adaptor 1 | 54900.0 | ENSG00000122188 | nan | nan
chr1	ZBED6	613512.0 | ZBED6 | Zinc finger BED domain-containing protein 6 | 100381270.0 | ENSG00000257315 | in intron 1 of ZC3H11A | nan
chr1	ZC3H11A	613513.0 | ZC3H11A, KIAA0663 | Zinc finger CCCH domain-containing protein 11A | 9877.0 | ENSG00000058673 | nan | nan
chr1	SNRPE	128260.0 | SNRPE, HYPT11 | Small nuclear ribonucleoprotein polypeptide E | 6635.0 | ENSG00000182004 | nan | Hypotrichosis 11, 615059 (3), Autosomal dominant
chr1	SOX13	604748.0 | SOX13, ICA12 | SRY-box 13 | 9580.0 | ENSG00000143842 | nan | nan
chr1	ETNK2	609859.0 | ETNK2, EKI2 | Ethanolamine kinase 2 | 55224.0 | ENSG00000143845 | nan | nan
chr1	REN	179820.0 | REN, RTD, ADTKD4 | Renin | 5972.0 | ENSG00000143839 | ~24cM distal to AT3 | Renal tubular dysgenesis, 267430 (3), Autosomal recessive; [Hyperproreninemia] (3); Tubulointerstitial kidney disease, autosomal dominant, 4, 613092 (3), Autosomal dominant
chr1	KISS1	603286.0 | KISS1, HH13 | KISS1 metastasis suppressor | 3814.0 | ENSG00000170498 | mutation identified in 1 HH13 family | ?Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 (3), Autosomal recessive
chr1	GOLT1A	620633.0 | GOLT1A, GOT1B | Golbi transport 1A | 127845.0 | ENSG00000174567 | nan | nan
chr1	PLEKHA6	607771.0 | PEPP3, KIAA0969 | Phosphatidylinositol 3-phosphate-binding PH domain protein 3 | 22874.0 | ENSG00000143850 | nan | nan
chr1	PPP1R15B	613257.0 | PPP1R15B, CREP, MSSGM2 | Protein phosphatase 1, regulatory subunit 15B | 84919.0 | ENSG00000158615 | nan | Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3), Autosomal recessive
chr1	PIK3C2B	602838.0 | PIK3C2B | Phosphatidylinositol 3-kinase, class 2, beta polypeptide | 5287.0 | ENSG00000133056 | nan | nan
chr1	MDM4	602704.0 | MDM4, BMFS6 | MDM4 regulator of p53 | 4194.0 | ENSG00000198625 | mutation identified in 1 BMFS6 family | ?Bone marrow failure syndrome 6, 618849 (3), Autosomal dominant
chr1	LRRN2	605492.0 | LRRN2, GAC1, LRANK1 | Leucine-rich repeat protein, neuronal, 2 | 10446.0 | ENSG00000170382 | nan | nan
chr1	NFASC	609145.0 | NFASC, KIAA0756, NEDCPMD | Neurofascin | 23114.0 | ENSG00000163531 | nan | Neurodevelopmental disorder with central and peripheral motor dysfunction, 618356 (3), Autosomal recessive
chr1	CNTN2	190197.0 | CNTN2, TAX, TAX1, EPEO5 | Contactin 2 (transiently-expressed axonal glycoprotein) | 6900.0 | ENSG00000184144 | 1 family identified with mutation | Epilepsy, early-onset, 5, with or without developmental delay, 615400 (3), Autosomal recessive
chr1	RBBP5	600697.0 | RBBP5, RBQ3 | Retinoblastoma-binding protein-5 | 5929.0 | ENSG00000117222 | nan | nan
chr1	DSTYK	612666.0 | DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23 | Dual serine/threonine and tyrosine protein kinase | 25778.0 | ENSG00000133059 | nan | Spastic paraplegia 23, autosomal recessive, 270750 (3), Autosomal recessive; Congenital anomalies of kidney and urinary tract 1, 610805 (3), Autosomal dominant
chr1	TMCC2	619429.0 | TMCC2 | Transmembrane and coiled-coil domain family, member 2 | 9911.0 | ENSG00000133069 | nan | nan
chr1	NUAK2	608131.0 | NUAK2, SNARK, ANPH2 | NUAK family, SNF1-like kinase, 2 | 81788.0 | ENSG00000163545 | mutation identified in 1 ANPH2 family | ?Anencephaly 2, 619452 (3), Autosomal recessive
chr1	KLHDC8A	614503.0 | KLHDC8A | Kelch domain-containing protein 8A | 55220.0 | ENSG00000162873 | nan | nan
chr1	LEMD1	610480.0 | LEMD1 | LEM domain-containing protein 1 | 93273.0 | ENSG00000186007 | nan | nan
chr1	BLACAT1	615480.0 | BLACAT1, LINC00912 | Bladder cancer-associated transcript 1, noncoding | 101669762.0 | ENSG00000281406 | nan | nan
chr1	MIR135B	619560.0 | MIR135B | Micro RNA 135B | 442891.0 | ENSG00000199059 | nan | nan
chr1	CDK18	169190.0 | CDK18, PCTK3 | Cyclin-dependent kinase 18 | 5129.0 | ENSG00000117266 | nan | nan
chr1	MFSD4A	620299.0 | MFSD4A | Major facilitator superfamily domain-containing protein 4A | 148808.0 | ENSG00000174514 | nan | nan
chr1	ELK4	600246.0 | ELK4, SAP1 | ELK4, ETS-domain protein (SRF accessory protein 1) | 2005.0 | ENSG00000158711 | nan | nan
chr1	SLC45A3	605097.0 | SLC45A3, PRST, PCANAP6, IPCA6 | Solute carrier family 45, member 3 (prostein) | 85414.0 | ENSG00000158715 | nan | nan
chr1	NUCKS1	611912.0 | NUCKS1, NUCKS | Nuclear casein kinase and cyclin-dependent kinase substrate 1 | 64710.0 | ENSG00000069275 | nan | nan
chr1	RAB29	603949.0 | RAB7L1 | RAB7-like 1 | 8934.0 | ENSG00000117280 | nan | nan
chr1	SLC41A1	610801.0 | SLC41A1, NPHPL2 | Solute carrier family 41, member 1 | 254428.0 | ENSG00000133065 | mutation identified in 1 NPHPL2 family | ?Nephronophthisis-like nephropathy 2, 619468 (3), Autosomal recessive
chr1	PM20D1	617124.0 | PM20D1 | Peptidase M20 domain-containing protein 1 | 148811.0 | ENSG00000162877 | nan | nan
chr1	SLC26A9	608481.0 | SLC26A9 | Solute carrier family 26 (sulfate transporter), member 9 | 115019.0 | ENSG00000174502 | nan | nan
chr1	CTSE	116890.0 | CTSE | Cathepsin E | 1510.0 | ENSG00000196188 | closely linked to REN | nan
chr1	RHEX	616088.0 | RHEX, C1orf186, RHEX | Regulator of hemoglobinization and erythroid cell expansion | 440712.0 | ENSG00000263961 | nan | nan
chr1	AVPR1B	600264.0 | AVPR1B, AVPR3 | Arginine vasopressin receptor-1B | 553.0 | ENSG00000198049 | nan | nan
chr1	FAM72A	614710.0 | FAM72A, LMPIP, UGENE | Family with sequence similarity 72, member A | 729533.0 | ENSG00000196550 | nan | nan
chr1	SRGAP2	606524.0 | SRGAP2, KIAA0456 | Slit-robo GTPase-activating protein, rho, 2 | 23380.0 | ENSG00000266028 | nan | nan
chr1	IKBKE	605048.0 | IKBKE | Inhibitor of nuclear factor kappa-B kinase, subunit epsilon | 9641.0 | ENSG00000263528 | nan | nan
chr1	RASSF5	607020.0 | RASSF5, NORE1 | Ras association (RalGDS/AF-6) domain family 5 (Nore1, mouse, homolog of) | 83593.0 | ENSG00000266094 | nan | nan
chr1	EIF2D	613709.0 | EIF2D, HCA56 | Eukaryotic translation initiation factor 2D | 1939.0 | ENSG00000143486 | nan | nan
chr1	DYRK3	603497.0 | DYRK3 | Dual-specificity tyrosine phosphorylation-regulated kinase 3 | 8444.0 | ENSG00000143479 | nan | nan
chr1	MAPKAPK2	602006.0 | MAPKAPK2, MK2 | Mitogen-activated protein kinase-activated protein kinase 2 | 9261.0 | ENSG00000162889 | nan | nan
chr1	IL10	124092.0 | IL10, CSIF, GVHDS | Interleukin-10 | 3586.0 | ENSG00000136634 | nan | {Rheumatoid arthritis, progression of}, 180300 (3); {Graft-versus-host disease, protection against}, 614395 (3); {HIV-1, susceptibility to}, 609423 (3)
chr1	IL19	605687.0 | IL19 | Interleukin 19 | 29949.0 | ENSG00000142224 | nan | nan
chr1	IL20	605619.0 | IL20 | Interleukin 20 | 50604.0 | ENSG00000162891 | nan | nan
chr1	IL24	604136.0 | IL24, ST16, MDA7 | Interleukin 24 (suppression of tumorigenicity 16) | 11009.0 | ENSG00000162892 | nan | nan
chr1	FCMR	606015.0 | FAIM3, TOSO, FCMR | Fas apoptotic inhibitory molecule 3 | 9214.0 | ENSG00000162894 | nan | nan
chr1	PIGR	173880.0 | PIGR | Polymeric immunoglobulin receptor | 5284.0 | ENSG00000162896 | nan | nan
chr1	FCAMR	605484.0 | FCAMR | Fc fragment of IgA and IgM, receptor for | 83953.0 | ENSG00000162897 | nan | nan
chr1	C1orf116	611680.0 | SARG, C1orf116 | Specifically androgen-regulated gene | 79098.0 | ENSG00000182795 | nan | nan
chr1	PFKFB2	171835.0 | PFKFB2 | Fructose-2,6-bisphosphatase, cardiac isozyme | 5208.0 | ENSG00000123836 | nan | nan
chr1	YOD1	612023.0 | YOD1, OTUD2, DUBA8 | YOD1 deubiquitinase | 55432.0 | ENSG00000180667 | nan | nan
chr1	C4BPB	120831.0 | C4BPB | Complement component 4-binding protein, beta polypeptide | 725.0 | ENSG00000123843 | nan | nan
chr1	C4BPA	120830.0 | C4BPA | Complement component 4-binding protein, alpha polypeptide | 722.0 | ENSG00000123838 | same RE fragment as C4BPB | nan
chr1	CD55	125240.0 | CD55, DAF, CROM, CHAPLE | CD55 antigen (blood group Cromer) | 1604.0 | ENSG00000196352 | nan | [Blood group Cromer], 613793 (3), Autosomal recessive; Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy, 226300 (3), Autosomal recessive
chr1	CR2	120650.0 | CR2, C3DR, SLEB9, CVID7 | Complement component (3d/Epstein-Barr virus) receptor-2 | 1380.0 | ENSG00000117322 | mutation identified in CVID7 patient | {Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3); ?Immunodeficiency, common variable, 7, 614699 (3), Autosomal recessive
chr1	CR1	120620.0 | CR1, C3BR | Complement component (3b/4b) receptor-1 | 1378.0 | ENSG00000203710 | nan | [Blood group, Knops system], 607486 (3); {Malaria, severe, resistance to}, 611162 (3)
chr1	CR1L	605886.0 | CR1L | Complement component receptor 1-like | 1379.0 | ENSG00000197721 | nan | nan
chr1	CD46	120920.0 | MCP, CD46, AHUS2 | Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen) | 4179.0 | ENSG00000117335 | nan | {Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3), Autosomal recessive, Autosomal dominant
chr1	MIR29C	610784.0 | MIR29C, MIRN29C | Micro RNA 29C | 407026.0 | ENSG00000284214 | nan | nan
chr1	MIR29B2	619035.0 | MIR29B2 | Micro RNA 29B2 | 407025.0 | ENSG00000284203 | nan | nan
chr1	CD34	142230.0 | CD34 | CD34 antigen | 947.0 | ENSG00000174059 | nan | nan
chr1	PLXNA2	601054.0 | PLXNA2, OCT, PLXN2 | Plexin A2 (OCT transmembrane protein) | 5362.0 | ENSG00000076356 | nan | nan
chr1	MIR205	613147.0 | MIR205, MIRN205 | Micro RNA 205 | 406988.0 | ENSG00000284485 | nan | nan
chr1	CAMK1G	614994.0 | CAMK1G, CLICK3 | Calcium/calmodulin-dependent protein kinase IG | 57172.0 | ENSG00000008118 | nan | nan
chr1	LAMB3	150310.0 | LAMB3, AI1A, JEB1B, JEB1A | Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD) | 3914.0 | ENSG00000196878 | nan | Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant
chr1	G0S2	614447.0 | G0S2 | G0/G1 switch gene 2 | 50486.0 | ENSG00000123689 | nan | nan
chr1	HSD11B1	600713.0 | HSD11B1, HSD11, HSD11L, CORTRD2 | Hydroxysteroid, 11-beta, dehydrogenase 1 | 3290.0 | ENSG00000117594 | digenic triallelic mutations with H6PD | Cortisone reductase deficiency 2, 614662 (3), Autosomal dominant
chr1	TRAF3IP3	608255.0 | TRAF3IP3, T3JAM | TRAF3-interacting protein 3 | 80342.0 | ENSG00000009790 | nan | nan
chr1	IRF6	607199.0 | IRF6, VWS1, LPS, PIT, PPS1, OFC6 | Interferon regulatory factor 6 | 3664.0 | ENSG00000117595 | OFC6 in enhancer 5' of IRF6 | {Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant
chr1	UTP25	619663.0 | UTP25 | UTP25 small subunit processor component | 27042.0 | ENSG00000117597 | nan | nan
chr1	SYT14	610949.0 | SYT14, SCAR11 | Synaptotagmin 14 | 255928.0 | ENSG00000143469 | mutation identified in 1 SCAR11 family | ?Spinocerebellar ataxia, autosomal recessive 11, 614229 (3), Autosomal recessive
chr1	HHAT	605743.0 | HHAT, MART2, SKI1, NNMS | Hedgehog acyltransferase | 55733.0 | ENSG00000054392 | nan | Nivelon-Nivelon-Mabille syndrome, 600092 (3), Autosomal recessive
chr1	KCNH1	603305.0 | KCNH1, EAG, TMBTS, ZLS1 | Potassium voltage-gated channel, subfamily H, member 1 (ether-a-go-go, drosophila, homolog of) | 3756.0 | ENSG00000143473 | nan | Zimmermann-Laband syndrome 1, 135500 (3), Autosomal dominant; Temple-Baraitser syndrome, 611816 (3), Autosomal dominant
chr1	RCOR3	620464.0 | RCOR3 | REST corepressor 3 | 55758.0 | ENSG00000117625 | nan | nan
chr1	TRAF5	602356.0 | TRAF5 | TNF receptor-associated factor 5 | 7188.0 | ENSG00000082512 | nan | nan
chr1	LINC00467	620079.0 | LINC00467, ASAP | Long intergenic noncoding RNA 467 | 84791.0 | ENSG00000153363 | nan | nan
chr1	RD3	180040.0 | RD3, LCA12, C1orf36 | RD3 regulator of GUCY2D | 343035.0 | ENSG00000198570 | nan | Leber congenital amaurosis 12, 610612 (3), Autosomal recessive
chr1	SLC30A1	609521.0 | SLC30A1, ZNT1 | Solute carrier family 30 (zinc transporter), member 1 | 7779.0 | ENSG00000170385 | nan | nan
chr1	NEK2	604043.0 | NEK2, RP67 | NIMA-related kinase 2 | 4751.0 | ENSG00000117650 | pseudogenes on chr. 2, 14, and 22; mutation identified in 1 family | ?Retinitis pigmentosa 67, 615565 (3), Autosomal recessive
chr1	LPGAT1	610473.0 | LPGAT1 | Lysophosphatidylglycerol acyltransferase 1 | 9926.0 | ENSG00000123684 | nan | nan
chr1	INTS7	611350.0 | INTS7, INT7 | Integrator complex subunit 7 | 25896.0 | ENSG00000143493 | nan | nan
chr1	DTL	610617.0 | DTL, RAMP, DCAF2, CDT2 | Denticleless E3 ubiquitin protein ligase homolog | 51514.0 | ENSG00000143476 | nan | nan
chr1	PPP2R5A	601643.0 | PPP2R5A | Protein phosphatase-2, regulatory subunit B (B56), alpha isoform | 5525.0 | ENSG00000066027 | nan | nan
chr1	PACC1	618427.0 | PACC1, TMEM206 | Proton-activated chloride channel 1 | 55248.0 | ENSG00000065600 | nan | nan
chr1	NENF	611874.0 | NENF, CIR2 | Neuron-derived neurotrophic factor | 29937.0 | ENSG00000117691 | nan | nan
chr1	ATF3	603148.0 | ATF3 | Activating transcription factor 3 | 467.0 | ENSG00000162772 | nan | nan
chr1	GARIN4	619852.0 | GARIN4, GARIL4 | Golgi-associated RAB2 interactor family, member 4 | 149647.0 | ENSG00000162771 | nan | nan
chr1	BATF3	612470.0 | BATF3 | Basic leucine zipper transcription factor, ATF-like, 3 | 55509.0 | ENSG00000123685 | nan | nan
chr1	NSL1	609174.0 | NSL1, DC8, C1orf48 | NSL1, MIS12 kinetochore complex component | 25936.0 | ENSG00000117697 | nan | nan
chr1	FLVCR1-DT	610864.0 | FLVCR1-DT, LQK1 | FLVCR1 divergent transcript | 642946.0 | ENSG00000198468 | nan | nan
chr1	FLVCR1	609144.0 | FLVCR1, AXPC1, PCARP | FLVCR heme transporter 1 | 28982.0 | ENSG00000162769 | nan | Ataxia, posterior column, with retinitis pigmentosa, 609033 (3), Autosomal recessive
chr1	VASH2	610471.0 | VASH2 | Vasohibin 2 | 79805.0 | ENSG00000143494 | nan | nan
chr1	ANGEL2	619001.0 | ANGEL2, CCR4D | Angel homolog 2 | 90806.0 | ENSG00000174606 | nan | nan
chr1	RPS6KC1	617517.0 | RPS6KC1, RPK118 | Ribosomal protein S6 kinase C1 | 26750.0 | ENSG00000136643 | nan | nan
chr1	LINC00538	614635.0 | LINC00538, YIYA | Long intergenic noncoding RNA 538 | 100861504.0 | nan | nan | nan
chr1	PROX1	601546.0 | PROX1 | Prospero homeobox 1 | 5629.0 | ENSG00000117707 | nan | nan
chr1	SMYD2	610663.0 | SMYD2 | SET and MYND domain-containing protein 2 | 56950.0 | ENSG00000143499 | nan | nan
chr1	PTPN14	603155.0 | PTPN14, PEZ, CATLPH | Protein tyrosine phosphatase, nonreceptor-type, 14 | 5784.0 | ENSG00000152104 | nan | Choanal atresia and lymphedema, 613611 (3), Autosomal recessive
chr1	AUTS11	610836.0 | AUTS11 | Autism, susceptibility to, 11 | 100188820.0 | nan | associated with rs12740310, rs3737296, and rs12310279 | {Autism susceptibility 11}, 610836 (2)
chr1		612530.0 | DEL1q41q42, C1DELq41q42 | Chromosome 1q41-q42 deletion syndrome | nan | nan | contiguous gene deletion of 1.7Mb | Chromosome 1q41-q42 deletion syndrome, 612530 (4), Isolated cases
chr1	OTSC10	615589.0 | OTSC10 | Otosclerosis 10 | 102723100.0 | nan | nan | Otosclerosis 10, 615589 (2), Autosomal dominant
chr1	RMD1	600332.0 | RMD1 | Rippling muscle disease 1 | 6022.0 | nan | nan | Rippling muscle disease-1, 600332 (2), Autosomal dominant
chr1	CENPF	600236.0 | CENPF, CILD31, STROMS | Centromere autoantigen F, 400kD | 1063.0 | ENSG00000117724 | nan | Stromme syndrome, 243605 (3), Autosomal recessive
chr1	KCNK2	603219.0 | KCNK2, TREK | Potassium channel, subfamily K, member 2 | 3776.0 | ENSG00000082482 | nan | nan
chr1	KCTD3	613272.0 | KCTD3 | Potassium channel tetramerization domain-containing protein 3 | 51133.0 | ENSG00000136636 | nan | nan
chr1	USH2A	608400.0 | USH2A, RP39 | Usherin | 7399.0 | ENSG00000042781 | nan | Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive
chr1	ESRRG	602969.0 | ESRRG | Estrogen-related receptor, gamma | 2104.0 | ENSG00000196482 | nan | nan
chr1	GPATCH2	616836.0 | GPATCH2, GPATC2 | G-patch domain-containing protein 2 | 55105.0 | ENSG00000092978 | nan | nan
chr1	SPATA17	611032.0 | SPATA17, MSRG11 | Spermatogenesis-associated protein 17 | 128153.0 | ENSG00000162814 | nan | nan
chr1	RRP15	611193.0 | RRP15 | Ribosomal RNA-processing 15 homolog | 51018.0 | ENSG00000067533 | nan | nan
chr1	TGFB2	190220.0 | TGFB2, LDS4 | Transforming growth factor, beta-2 | 7042.0 | ENSG00000092969 | nan | Loeys-Dietz syndrome 4, 614816 (3), Autosomal dominant
chr1	LYPLAL1	616548.0 | LYPLAL1 | Lysophospholipase-like 1 | 127018.0 | ENSG00000143353 | nan | nan
chr1	SLC30A10	611146.0 | SLC30A10, ZNT10, HMNDYT1 | Solute carrier family 30 (zinc transporter), member 10 | 55532.0 | ENSG00000196660 | nan | Hypermanganesemia with dystonia 1, 613280 (3), Autosomal recessive
chr1	EPRS1	138295.0 | EPRS, PARS, HLD15 | Glutamyl-prolyl-tRNA synthetase | 2058.0 | ENSG00000136628 | nan | Leukodystrophy, hypomyelinating, 15, 617951 (3), Autosomal recessive
chr1	BPNT1	604053.0 | BPNT1 | 3'(2'),5'-bisphosphate nucleotidase 1 | 10380.0 | ENSG00000162813 | nan | nan
chr1	IARS2	612801.0 | IARS2, CAGSSS | Isoleucyl-tRNA synthetase 2 | 55699.0 | ENSG00000067704 | nan | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive
chr1	MIR215	610943.0 | MIR215, MIRN215 | Micro RNA 215 | 406997.0 | ENSG00000207590 | nan | nan
chr1	MIR194-1	610940.0 | MIR194-1, MIRN194-1 | Micro RNA 194-1 | 406969.0 | ENSG00000207624 | nan | nan
chr1	RAB3GAP2	609275.0 | RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2, MARTS1 | RAB3 GTPase-activating protein (noncatalytic) subunit 2 | 25782.0 | ENSG00000118873 | nan | Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive
chr1	MARK1	606511.0 | MARK1, KIAA1477 | MAP/microtubule affinity-regulating kinase 1 | 4139.0 | ENSG00000116141 | nan | nan
chr1	MTARC2	614127.0 | MTARC2, MOSC2, MARC2 | Mitochondrial amidoxime-reducing component 2 | 54996.0 | ENSG00000117791 | nan | nan
chr1	MTARC1	614126.0 | MTARC1, MOSC1, MARC1 | Mitochondrial amidoxime-reducing component 1 | 64757.0 | ENSG00000186205 | nan | nan
chr1	HLX	142995.0 | HLX1 | H.20-like homeobox | 3142.0 | ENSG00000136630 | nan | nan
chr1	DUSP10	608867.0 | DUSP10, MKP5 | Dual-specificity phosphatase 10 | 11221.0 | ENSG00000143507 | nan | nan
chr1	HHIPL2	620214.0 | HHIPL2, KIAA1822L | HHIP-like 2 | 79802.0 | ENSG00000143512 | nan | nan
chr1	TAF1A	604903.0 | TAF1A, RAFI48, SL1 | TATA box-binding protein-associated factor 1A | 9015.0 | ENSG00000143498 | nan | nan
chr1	MIA3	613455.0 | MIA3, TANGO1, TANGO, KIAA0268, ODCD2 | MIA SH3 domain ER export factor 3 | 375056.0 | ENSG00000154305 | mutation identified in 1 ODCD2 family | ?Ondontochondrodysplasia 2 with hearing loss and diabetes, 619269 (3), Autosomal recessive
chr1	AIDA	612375.0 | AIDA | Axin interactor, dorsalization-associated | 64853.0 | ENSG00000186063 | nan | nan
chr1	DISP1	607502.0 | DISP1, DISPA | Dispatched RND transporter family, member 1 | 84976.0 | ENSG00000154309 | nan | nan
chr1	TLR5	603031.0 | TLR5, TIL3, SLEB1, MELIOS | Toll-like receptor-5 | 7100.0 | ENSG00000187554 | nan | {Melioidosis, susceptibility to}, 615557 (3), Autosomal dominant; {Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3); {Systemic lupus erythematosus, resistance to}, 601744 (3); {Legionnaire disease, susceptibility to}, 608556 (3)
chr1	SUSD4	615827.0 | SUSD4 | Sushi domain-containing protein 4 | 55061.0 | ENSG00000143502 | nan | nan
chr1	CAPN8	618777.0 | CAPN8 | Calpain 8 | 388743.0 | ENSG00000203697 | nan | nan
chr1	CAPN2	114230.0 | CAPN2 | Calpain, large polypeptide L2 | 824.0 | ENSG00000162909 | nan | nan
chr1	TP53BP2	602143.0 | TP53BP2, ASPP2 | Tumor protein p53-binding protein-2 | 7159.0 | ENSG00000143514 | nan | nan
chr1	BCC2	613058.0 | BCC2 | Basal cell carcinoma, susceptibility to, 2 | 100307119.0 | nan | associated with rs801114 | {Basal cell carcinoma, susceptibility to, 2}, 613058 (2)
chr1	EA3	606554.0 | EA3 | Episodic ataxia, type 3 | 780905.0 | nan | max lod at D1S235 | Episodic ataxia, type 3, 606554 (2), Autosomal dominant
chr1	HRES1	143025.0 | HRES1 | HTLV-1 related endogenous sequence | 3272.0 | nan | nan | nan
chr1	MDC1B	604801.0 | MDC1B | Muscular dystrophy, congenital, 1B | 53368.0 | nan | nan | Muscular dystrophy, congenital, 1B, 604801 (2), Autosomal recessive
chr1	PEPC	170000.0 | PEPC | Peptidase C | 5183.0 | nan | 1q25, 1q32 = conflicting localizations | nan
chr1		180420.0 | RN5S1@ | RNA, 5S cluster 1 | nan | nan | 25-30% at 1q31 (RN5S3@) | nan
chr1	FBXO28	609100.0 | FBXO28, FBX28, KIAA0483, DEE100 | F-box protein 28 | 23219.0 | ENSG00000143756 | nan | Developmental and epileptic encephalopathy 100, 619777 (3), Autosomal dominant
chr1	DEGS1	615843.0 | DEGS1, DES1, MLD, HLD18 | Delta(4)-desaturase, sphingolipid, 1 | 8560.0 | ENSG00000143753 | nan | Leukodystrophy, hypomyelinating, 18, 618404 (3), Autosomal recessive
chr1	NVL	602426.0 | NVL | Nuclear valosin-containing protein-like | 4931.0 | ENSG00000143748 | nan | nan
chr1	CNIH4	617483.0 | CNIH4, CNIH2 | Cornichon family AMPA receptor auxiliary protein 4 | 29097.0 | ENSG00000143771 | nan | nan
chr1	WDR26	617424.0 | WDR26, SKDEAS | WD repeat-containing protein 26 | 80232.0 | ENSG00000162923 | nan | Skraban-Deardorff syndrome, 617616 (3), Autosomal dominant
chr1	DNAH14	603341.0 | DNAH14, HL18 | Dynein, axonemal, heavy chain 14 | 127602.0 | ENSG00000185842 | nan | nan
chr1	LBR	600024.0 | LBR, PHA, PHASK | Lamin B receptor | 3930.0 | ENSG00000143815 | nan | Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive
chr1	ENAH	609061.0 | ENAH, ENA, MENA, NDPP1 | ENAH actin regulator | 55740.0 | ENSG00000154380 | nan | nan
chr1	SRP9	600707.0 | SRP9, ALURBP | Signal recognition particle, 9kD | 6726.0 | ENSG00000143742 | nan | nan
chr1	EPHX1	132810.0 | EPHX1 | Epoxide hydroxylase 1, microsomal xenobiotic | 2052.0 | ENSG00000143819 | nan | nan
chr1	TMEM63A	618685.0 | TMEM63A, KIAA0792, HLD19 | Transmembrane protein 63A | 9725.0 | ENSG00000196187 | nan | Leukodystrophy, hypomyelinating, 19, transient infantile, 618688 (3), Autosomal dominant
chr1	LEFTY1	603037.0 | LEFTB, LEFTY1 | Left-right determination, factor B | 10637.0 | ENSG00000243709 | nan | nan
chr1	PYCR2	616406.0 | PYCR2, HLD10 | Pyrroline-5-carboxylate reductase 2 | 29920.0 | ENSG00000143811 | nan | Leukodystrophy, hypomyelinating, 10, 616420 (3), Autosomal recessive
chr1	LEFTY2	601877.0 | LEFTY2, EBAF, TGFB4, LEFTA, LEFTYA | Left-right determination factor 2 | 7044.0 | ENSG00000143768 | nan | nan
chr1	SDE2	620743.0 | SDE2 | SDE2 telomere maintenance homolog | 163859.0 | ENSG00000143751 | nan | nan
chr1	H3-3A	601128.0 | H3-3A, H3F3A, H3F3, BRYLIB1 | H3.3 histone A | 3020.0 | ENSG00000163041 | nan | Bryant-Li-Bhoj neurodevelopmental syndrome 1, 619720 (3), Autosomal dominant
chr1	ACBD3	606809.0 | ACBD3, GOCAP1, GOLPH1, GCP60 | Acyl-Coenzyme A binding domain containing 3 | 64746.0 | ENSG00000182827 | nan | nan
chr1	MIXL1	609852.0 | MIXL1, MIXL, MIX | MIX1 homeobox-like protein 1 | 83881.0 | ENSG00000185155 | nan | nan
chr1	LIN9	609375.0 | LIN9 | lin-9 DREAM MuvB core complex component | 286826.0 | ENSG00000183814 | nan | nan
chr1	PARP1	173870.0 | PARP1, ADPRT, PPOL, PARP | Poly(ADP-ribose) polymerase 1 | 142.0 | ENSG00000143799 | ?processed pseudogenes on chr.13 and 14 | nan
chr1	ITPKB	147522.0 | ITPKB | Inositol 1,4,5-trisphosphate 3-kinase B | 3707.0 | ENSG00000143772 | nan | nan
chr1	PSEN2	600759.0 | PSEN2, AD4, STM2, CMD1V | Presenilin 2 | 5664.0 | ENSG00000143801 | nan | Alzheimer disease-4, 606889 (3), Autosomal dominant; Cardiomyopathy, dilated, 1V, 613697 (3), Autosomal dominant
chr1	COQ8A	606980.0 | ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4 | AARF domain-containing kinase 3 | 56997.0 | ENSG00000163050 | nan | Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive
chr1	CDC42BPA	603412.0 | CDC42BPA, PK428, MRCKA | CDC42-binding protein kinase alpha | 8476.0 | ENSG00000143776 | nan | nan
chr1	SNAP47	619659.0 | SNAP47 | Synaptosome-associated protein 47 | 116841.0 | ENSG00000143740 | nan | nan
chr1	JMJD4	620928.0 | JMJD4 | Jumonji domain-containing protein 4 | 65094.0 | ENSG00000081692 | nan | nan
chr1	WNT9A	602863.0 | WNT14 | Wingless-type MMTV integration site family, member 14 | 7483.0 | ENSG00000143816 | nan | nan
chr1	WNT3A	606359.0 | WNT3A | Wingless-type MMTV integration site family, member 3A | 89780.0 | ENSG00000154342 | nan | nan
chr1	ARF1	103180.0 | ARF1, PVNH8 | ADP-ribosylation factor-1 | 375.0 | ENSG00000143761 | nan | Periventricular nodular heterotopia 8, 618185 (3), Autosomal dominant
chr1	MRPL55	611859.0 | MRPL55 | Mitochondrial ribosomal protein L55 | 128308.0 | ENSG00000162910 | nan | nan
chr1	GUK1	139270.0 | GUK1 | Guanylate kinase-1 | 2987.0 | ENSG00000143774 | nan | nan
chr1	GJC2	608803.0 | GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPHM3 | Gap junction protein, gamma-2 (47kD) | 57165.0 | ENSG00000198835 | mutation identified in 1 SPG44 family | Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive
chr1	IBA57	615316.0 | IBA57, C1orf69, MMDS3, SPG74 | Iron-sulfur cluster assembly factor IBA57 | 200205.0 | ENSG00000181873 | nan | Multiple mitochondrial dysfunctions syndrome 3, 615330 (3), Autosomal recessive; ?Spastic paraplegia 74, autosomal recessive, 616451 (3), Autosomal recessive
chr1	OBSCN	608616.0 | OBSCN, KIAA1556, KIAA1639, RHABDO1 | Obscurin | 84033.0 | ENSG00000154358 | nan | {Rhabdomyolysis, susceptibility to, 1}, 620235 (3), Autosomal recessive
chr1	TRIM11	607868.0 | TRIM11 | Tripartite motif-containing protein 11 | 81559.0 | ENSG00000154370 | nan | nan
chr1	TRIM17	606123.0 | RNF16 | RING finger protein-16 | 51127.0 | ENSG00000162931 | nan | nan
chr1	H3-4	602820.0 | H3-4, HIST3H3, H3FT, H3T | H3.4 histone | 8290.0 | ENSG00000168148 | nan | nan
chr1	H2AC25	615015.0 | H2AW, HIST3H2A | H2A.W histone | 92815.0 | ENSG00000181218 | nan | nan
chr1	H2BC26	615046.0 | H2BU1, HIST3H2BB, H2Bb | H2B.U histone 1 | 128312.0 | ENSG00000196890 | nan | nan
chr1	RNF187	613754.0 | RNF186, RACO1 | Ring finger protein 187 | 149603.0 | ENSG00000168159 | nan | nan
chr1	RHOU	606366.0 | RHOU, WRCH1 | Ras homolog gene family, member U | 58480.0 | ENSG00000116574 | nan | nan
chr1	RAB4A	179511.0 | RAB4A, RAB4 | Ras-associated protein RAB4A | 5867.0 | ENSG00000168118 | nan | nan
chr1	CCSAP	616762.0 | CCSAP, CSAP, C1orf96 | Centriole-, cilia-, and spindle-associated protein | 126731.0 | ENSG00000154429 | nan | nan
chr1	ACTA1	102610.0 | ACTA1, ASMA, NEM3, CMYO2A, CMYO2B, SHPM, CMYO2C | Actin, alpha-1, skeletal muscle | 58.0 | ENSG00000143632 | mutation identified in 1 SHPM family | Congenital myopathy 2B, severe infantile, autosomal recessive, 620265 (3), Autosomal recessive; ?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Congenital myopathy 2C, severe infantile, autosomal dominant, 620278 (3), Autosomal dominant; Congenital myopathy 2A, typical, autosomal dominant, 161800 (3), Autosomal dominant
chr1	NUP133	607613.0 | NUP133, NPHS18, GAMOS8 | Nucleoporin, 133kD | 55746.0 | ENSG00000069248 | mutation identified in 1 GAMOS8 family | ?Galloway-Mowat syndrome 8, 618349 (3), Autosomal recessive; Nephrotic syndrome, type 18, 618177 (3), Autosomal recessive
chr1	ABCB10	605454.0 | ABCB10, MTABC2 | ATP-binding cassette, subfamily B, member 10 | 23456.0 | ENSG00000135776 | pseudogene on 15q13-q14 | nan
chr1	URB2	619372.0 | URB2, KIAA0133 | URB2 ribosome biogenesis homolog | 9816.0 | ENSG00000135763 | nan | nan
chr1	GALNT2	602274.0 | GALNT2, CDG2T | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 | 2590.0 | ENSG00000143641 | nan | Congenital disorder of glycosylation, type IIt, 618885 (3), Autosomal recessive
chr1	PGBD5	616791.0 | PGBD5 | Piggybac transposable element-derived 5 | 79605.0 | ENSG00000177614 | nan | nan
chr1	PCAP	602759.0 | PCAP | Predisposing for prostate cancer | 7834.0 | nan | nan | {Prostate cancer, susceptibility to}, 602759 (2)
chr1	SHFL1	119100.0 | SHFL1, SHFLD | Split-hand/foot malformation with long bone deficiency 1 | 791121.0 | nan | between rs1124110 and rs535043 | Split-hand/foot malformation with long bone deficiency 1, 119100 (2), Autosomal dominant
chr1	COG2	606974.0 | COG2, LDLC, CDG2Q | Component of oligomeric golgi complex 2 | 22796.0 | ENSG00000135775 | mutation identified in 1 CDG2Q patient | ?Congenital disorder of glycosylation, type IIq, 617395 (3), Autosomal recessive
chr1	AGT	106150.0 | AGT, SERPINA8 | Angiotensinogen | 183.0 | ENSG00000135744 | nan | Renal tubular dysgenesis, 267430 (3), Autosomal recessive
chr1	CAPN9	606401.0 | CAPN9 | Calpain 9 | 10753.0 | ENSG00000135773 | nan | nan
chr1	ARV1	611647.0 | ARV1, DEE38 | ARV1 homolog, fatty acid homeostasis modulator | 64801.0 | ENSG00000173409 | nan | Developmental and epileptic encephalopathy 38, 617020 (3), Autosomal recessive
chr1	TRIM67	610584.0 | TRIM67 | Tripartite motif-containing protein 67 | 440730.0 | ENSG00000119283 | nan | nan
chr1	GNPAT	602744.0 | GNPAT, DHAPAT, RCDP2 | Glyceronephosphate O-acyltransferase | 8443.0 | ENSG00000116906 | nan | Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive
chr1	EXOC8	615283.0 | EXOC8, EXO84, SEC84, NEDMISB | Exocyst complex component 8 | 149371.0 | ENSG00000116903 | mutation identified in 1 NEDMISB family | ?Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy, 619076 (3), Autosomal recessive
chr1	SPRTN	616086.0 | SPRTN, DVC1, C1orf124, RJALS | SprT-like N-terminal domain protein | 83932.0 | ENSG00000010072 | nan | Ruijs-Aalfs syndrome, 616200 (3), Autosomal recessive
chr1	EGLN1	606425.0 | EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH | egl-9 family hypoxia inducible factor 1 | 54583.0 | ENSG00000135766 | nan | Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; [Hemoglobin, high altitude adaptation], 609070 (3), Autosomal dominant
chr1	TSNAX	602964.0 | TSNAX, TRAX | Translin-associated factor X | 7257.0 | ENSG00000116918 | nan | nan
chr1	DISC1	605210.0 | DISC1, SCZD9 | Disrupted in schizophrenia 1 | 27185.0 | ENSG00000162946 | nan | {Schizophrenia 9, susceptibility to}, 604906 (3)
chr1	DISC2	606271.0 | DISC2 | Disrupted in schizophrenia 2 | 27184.0 | nan | noncoding antisense RAN | Schizophrenia, 181500 (2), Autosomal dominant
chr1	SIPA1L2	611609.0 | SIPA1L2, KIAA1389 | SIPA1-like protein 2 | 57568.0 | ENSG00000116991 | nan | nan
chr1	MAP10	618551.0 | MAP10, KIAA1383, MTR120 | Microtubule-associated protein 10 | 54627.0 | ENSG00000212916 | nan | nan
chr1	PCNX2	617656.0 | PCNX2, KIAA0435 | Pecanex 2 | 80003.0 | ENSG00000135749 | nan | nan
chr1	MAP3K21	614793.0 | MAP3K21, MLK4, KIAA1804 | Mitogen-activated protein kinase kinase kinase 21 | 84451.0 | ENSG00000143674 | nan | nan
chr1	KCNK1	601745.0 | KCNK1, TWIK1 | Potassium channel, subfamily K, member 1 | 3775.0 | ENSG00000135750 | nan | nan
chr1	COA6	614772.0 | COA6, C1orf31, MC4DN13 | Cytochrome c oxidase assembly factor 6 | 388753.0 | ENSG00000168275 | nan | Mitochondrial complex IV deficiency, nuclear type 13, 616501 (3), Autosomal recessive
chr1	TARBP1	605052.0 | TARBP1, TRP185 | TAR RNA-binding protein 1 | 6894.0 | ENSG00000059588 | nan | nan
chr1	IRF2BP2	615332.0 | IRF2BP2, CVID14 | Interferon regulatory factor 2-binding protein 2 | 359948.0 | ENSG00000168264 | mutation identified in 1 CVID14 family | ?Immunodeficiency, common variable, 14, 617765 (3), Autosomal dominant
chr1	TOMM20	601848.0 | TOMM20, MAS20, KIAA0016 | Translocase of outer mitochondrial membrane 20 | 9804.0 | ENSG00000173726 | nan | nan
chr1	RBM34	619915.0 | RBM34, KIAA0117 | RNA-binding motif protein 34 | 23029.0 | ENSG00000188739 | nan | nan
chr1	ARID4B	609696.0 | ARID4B, SAP180, RBP1L1, RBBP1L1, BRCAA1 | AT-rich interactive domain-containing protein 4B | 51742.0 | ENSG00000054267 | nan | nan
chr1	GGPS1	606982.0 | GGPS1, GGPPS1, MDHLO | Geranylgeranyl diphosphate synthase 1 | 9453.0 | ENSG00000152904 | nan | Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome, 619518 (3), Autosomal recessive
chr1	TBCE	604934.0 | TBCE, KCS, KCS1, HRD, PEAMO | Tubulin-specific chaperone E | 6905.0 | ENSG00000284770 | nan | Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive
chr1	B3GALNT2	610194.0 | B3GALNT2, MGC39558, MDDGA11 | Beta-1,3-N-acetylgalactosaminyltransferase 2 | 148789.0 | ENSG00000162885 | nan | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 11, 615181 (3), Autosomal recessive
chr1	GNG4	604388.0 | GNG4 | Guanine nucleotide-binding protein, gamma 4 | 2786.0 | ENSG00000168243 | nan | nan
chr1	LYST	606897.0 | LYST, CHS1 | Lysosomal trafficking regulator | 1130.0 | ENSG00000143669 | nan | Chediak-Higashi syndrome, 214500 (3), Autosomal recessive
chr1	NID1	131390.0 | NID | Nidogen | 4811.0 | ENSG00000116962 | nan | nan
chr1	GPR137B	604658.0 | TM7SF1 | Transmembrane 7 superfamily, member 1 | 7107.0 | ENSG00000077585 | nan | nan
chr1	ERO1B	615437.0 | ERO1LB | Endoplasmic reticulum oxidoreduction 1-like beta | 56605.0 | ENSG00000086619 | nan | nan
chr1	EDARADD	606603.0 | EDARADD, ED3, EDA3, ECTD11B, ECTD11A | EDAR-associated death domain | 128178.0 | ENSG00000186197 | nan | Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant
chr1	DFNB45	612433.0 | DFNB45 | Deafness, autosomal recessive 45 | 449483.0 | nan | between D1S547 and D1S2836 | Deafness, autosomal recessive 45, 612433 (2), Autosomal recessive
chr1	LGALS8	606099.0 | LGALS8, PCTA1 | Lectin, galactoside-binding, soluble, 8 | 3964.0 | ENSG00000116977 | nan | nan
chr1	HEATR1	620390.0 | HEATR1, UTP10 | HEAT repeat-containing protein 1 | 55127.0 | ENSG00000119285 | nan | nan
chr1	ACTN2	102573.0 | ACTN2, CMD1AA, CMH23, CMYO8, MPD6 | Actinin, alpha-2 | 88.0 | ENSG00000077522 | nan | Myopathy, distal, 6, adult onset, 618655 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3), Autosomal dominant; Congenital myopathy 8, 618654 (3), Autosomal dominant; Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3), Autosomal dominant
chr1	MTR	156570.0 | MTR, HMAG | 5-methyltetrahydrofolate-homocysteine methyltransferase 1 | 4548.0 | ENSG00000116984 | nan | {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive
chr1	RYR2	180902.0 | RYR2, VTSIP, ARVC2, VACRDS | Ryanodine receptor-2 (cardiac) | 6262.0 | ENSG00000198626 | nan | Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3), Autosomal dominant; Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome, 115000 (3), Autosomal dominant
chr1	ZP4	613514.0 | ZP4, ZPB | Zona pellucida glycoprotein 4 | 57829.0 | ENSG00000116996 | nan | nan
chr1	CHRM3	118494.0 | CHRM3, PBS, EGBRS | Cholinergic receptor, muscarinic, 3 | 1131.0 | ENSG00000133019 | nan | Prune belly syndrome, 100100 (3), Autosomal recessive
chr1	FMN2	606373.0 | FMN2, MRT47 | Formin 2 | 56776.0 | ENSG00000155816 | nan | Intellectual developmental disorder, autosomal recessive 47, 616193 (3), Autosomal recessive
chr1	GREM2	608832.0 | GREM2, PRDC, STHAG9 | Gremlin 2, DAN family BMP antagonist | 64388.0 | ENSG00000180875 | nan | Tooth agenesis, selective, 9, 617275 (3), Autosomal dominant
chr1	RGS7	602517.0 | RGS7 | Regulator of G protein signaling 7 | 6000.0 | ENSG00000182901 | nan | nan
chr1	FH	136850.0 | FH, HLRCC, MCUL1, FMRD | Fumarate hydratase | 2271.0 | ENSG00000091483 | nan | Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive
chr1	KMO	603538.0 | KMO | Kynurenine 3-monooxygenase | 8564.0 | ENSG00000117009 | nan | nan
chr1	OPN3	606695.0 | OPN3, ECPN | Opsin 3 | 23596.0 | ENSG00000054277 | nan | nan
chr1	CHML	118825.0 | CHML, REP2 | Choroideremia-like | 1122.0 | ENSG00000203668 | nan | nan
chr1	EXO1	606063.0 | EXO1, HEX1 | Exonuclease 1 | 9156.0 | ENSG00000174371 | nan | nan
chr1	BECN2	615687.0 | BECN2, BECN1L1 | Beclin 2 | 441925.0 | ENSG00000196289 | nan | nan
chr1	MAP1LC3C	609605.0 | MAP1LC3C, LC3C | Microtubule-associated protein 1, light chain 3, gamma | 440738.0 | ENSG00000197769 | nan | nan
chr1	CEP170	613023.0 | CEP170, KIAA0470 | Centrosomal protein, 170kD | 9859.0 | ENSG00000143702 | nan | nan
chr1	SDCCAG8	613524.0 | SDCCAG8, CCCAP, SLSN7, BBS16 | SHH signaling and ciliogenesis regulator SDCCAG8 | 10806.0 | ENSG00000054282 | nan | Senior-Loken syndrome 7, 613615 (3), Autosomal recessive; Bardet-Biedl syndrome 16, 615993 (3), Autosomal recessive
chr1	AKT3	611223.0 | AKT3, PKBG, MPPH2 | AKT serine/threonine kinase 3 | 10000.0 | ENSG00000117020 | nan | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3), Autosomal dominant
chr1	ZBTB18	608433.0 | ZBTB18, ZNF238, RP58, MRD22 | Zinc finger and BTB domain containing 18 | 10472.0 | ENSG00000179456 | nan | Intellectual developmental disorder, autosomal dominant 22, 612337 (3), Autosomal dominant
chr1	ADSS2	103060.0 | ADSS | Adenylosuccinate synthetase (Ade(-)H-complementing) | 159.0 | ENSG00000035687 | nan | nan
chr1	CATSPERE	617510.0 | CATSPERE, C10orf101 | Cation channel, sprem-associated, auxiliary subunit epsilon | 257044.0 | ENSG00000179397 | nan | nan
chr1	DESI2	614638.0 | DESI2, PPPDE1 | Desumoylating isopeptidase 2 | 51029.0 | ENSG00000121644 | nan | nan
chr1	COX20	614698.0 | COX20, FAM36A, MC4DN11 | Cytochrome c oxidase assembly factor COX20 | 116228.0 | ENSG00000203667 | nan | Mitochondrial complex IV deficiency, nuclear type 11, 619054 (3), Autosomal recessive
chr1	HNRNPU	602869.0 | HNRNPU, HNRPU, SAFA, DEE54 | Heterogeneous nuclear ribonucleoprotein U | 3192.0 | ENSG00000153187 | nan | Developmental and epileptic encephalopathy 54, 617391 (3), Autosomal dominant
chr1	EFCAB2	619617.0 | EFCAB2, DRC8 | EF-hand calcium-binding domain-containing protein 2 | 84288.0 | ENSG00000203666 | nan | nan
chr1	KIF26B	614026.0 | KIF26B | Kinesin family member 26B | 55083.0 | ENSG00000162849 | nan | nan
chr1	SMYD3	608783.0 | SMYD3 | SET and MYND domain-containing protein 3 | 64754.0 | ENSG00000185420 | nan | nan
chr1	TFB2M	607055.0 | TFB2M | Transcription factor B2, mitochondrial | 64216.0 | ENSG00000162851 | nan | nan
chr1	CNST	613439.0 | CNST | Consortin | 163882.0 | ENSG00000162852 | nan | nan
chr1	SCCPDH	620831.0 | SCCPDH, CGI49 | Saccharopine dehydrogenase, putative | 51097.0 | ENSG00000143653 | nan | nan
chr1	AHCTF1	610853.0 | AHCTF1, ELYS | AT hook containing transcription factor 1 | 25909.0 | ENSG00000153207 | nan | nan
chr1	ZNF695	616348.0 | ZNF695, SBZF3 | Zinc finger protein 695 | 57116.0 | ENSG00000197472 | nan | nan
chr1	ZNF124	194631.0 | ZNF124 | Zinc finger protein-124 (HZF-16) | 7678.0 | ENSG00000196418 | nan | nan
chr1	ZNF496	613911.0 | ZNF496, NIZP1, ZFP496 | Zinc finger protein 496 | 84838.0 | ENSG00000162714 | nan | nan
chr1	NLRP3	606416.0 | NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH | NLR family, pyrin domain containing 3 | 114548.0 | ENSG00000162711 | nan | CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant
chr1	OR13G1	611677.0 | OR13G1 | Olfactory receptor, family 13, subfamily G, member 1 | 441933.0 | ENSG00000197437 | nan | nan
chr1	TRIM58	620527.0 | TRIM58 | Tripartite motif-containing protein 58 | 25893.0 | ENSG00000162722 | nan | nan
chr1	OR2W3	616729.0 | OR2W3 | Olfactory receptor family 2 subfamily W member 3 | 343171.0 | ENSG00000238243 | nan | nan
chr1	OR2M7	618509.0 | OR2M7 | Olfactory receptor, family 2, subfamily M, member 7 | 391196.0 | ENSG00000177186 | nan | nan
chr1	OR14I1	618516.0 | OR14I1 | Olfactory receptor, family 14, subfamily I, member 1 | 401994.0 | ENSG00000189181 | nan | nan
chr1	LYPD8	617067.0 | LYPD8 | LY6/PLAUR domain-containing protein 8 | 646627.0 | ENSG00000259823 | nan | nan
chr1	SH3BP5L	620652.0 | SH3BP5L | SH3 domain-binding protein 5-like | 80851.0 | ENSG00000175137 | nan | nan
chr1	ZNF692	617758.0 | ZNF692, AREBP | Zinc finger protein 692 | 55657.0 | ENSG00000171163 | nan | nan
chr2	ALLC	612396.0 | ALLC | Allantoicase | 55821.0 | ENSG00000151360 | nonfunctional in humans | nan
chr2	CTRCT29	115800.0 | CTRCT29 | Cataract 29, coralliform | 101867602.0 | nan | between D2S297 and D2S2269 | Cataract 29, coralliform, 115800 (2), Autosomal dominant
chr2	ETM2	602134.0 | ETM2, ETM | Tremor, hereditary essential, 2 | 2112.0 | nan | max lod at D2S272 | Essential tremor, hereditary, 2, 602134 (2), Autosomal dominant
chr2	HYT3	607329.0 | HYT3 | Hypertension, essential, susceptibility to, 3 | 387575.0 | nan | nan | {Hypertension, essential, susceptibility to, 3}, 145500 (2), Multifactorial
chr2	PEE2	609402.0 | PEE2 | Preeclampsia/eclampsia 2 | 780908.0 | nan | nan | Preeclampsia/eclampsia 2, 609402 (2)
chr2		101850.0 | PPKP3 | Keratoderma, palmoplantar, punctate type III | nan | nan | max lod at ACP1 and IGKC | ?Keratoderma, palmoplantar, punctate type 3, 101850 (2), Autosomal dominant
chr2	FAM110C	611395.0 | FAM110C | Family with sequence similarity 110, member C | 642273.0 | ENSG00000184731 | nan | nan
chr2	SH3YL1	617314.0 | SH3YL1 | SH3 domain- and SYLF domain-containing protein 1 | 26751.0 | ENSG00000035115 | nan | nan
chr2	ACP1	171500.0 | ACP1 | Acid phosphatase 1, soluble | 52.0 | ENSG00000143727 | nan | nan
chr2	ALKAL2	619671.0 | ALKAL2, FAM150B, AUGA | ALK and LTK ligand 2 | 285016.0 | ENSG00000189292 | nan | nan
chr2	TMEM18	613220.0 | TMEM18 | Transmembrane protein 18 | 129787.0 | ENSG00000151353 | nan | nan
chr2	SNTG2	608715.0 | SNTG2, SYN5 | Syntrophin, gamma-2 | 54221.0 | ENSG00000172554 | nan | nan
chr2	TPO	606765.0 | TPO, TPX, TDH2A | Thyroid peroxidase | 7173.0 | ENSG00000115705 | nan | Thyroid dyshormonogenesis 2A, 274500 (3), Autosomal recessive
chr2	PXDN	605158.0 | PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA, ASGD7 | Peroxidasin | 7837.0 | ENSG00000130508 | nan | Anterior segment dysgenesis 7, with sclerocornea, 269400 (3), Autosomal recessive
chr2	MYT1L	613084.0 | MYT1L, KIAA1106, MRD39 | Myelin transcription factor 1-like | 23040.0 | ENSG00000186487 | nan | Intellectual developmental disorder, autosomal dominant 39, 616521 (3), Autosomal dominant
chr2	EIPR1	608998.0 | EIPR1, TSSC1 | EARP complex and GARP complex interacting protein 1 | 7260.0 | ENSG00000032389 | nan | nan
chr2	TRAPPC12	614139.0 | TRAPPC12, TTC15, PEBAS | Trafficking protein particle complex, subunit 12 | 51112.0 | ENSG00000171853 | nan | Encephalopathy, progressive, early-onset, with brain atrophy and spasticity, 617669 (3), Autosomal recessive
chr2	ADI1	613400.0 | ADI1, SIPL | Acireductone dioxygenase 1 | 55256.0 | ENSG00000182551 | nan | nan
chr2	RNASEH1	604123.0 | RNASEH1, PEOB2 | Ribonuclease H1 | 246243.0 | ENSG00000171865 | pseudogenes on chr. 17 and chr.1 | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3), Autosomal recessive
chr2	RPS7	603658.0 | RPS7, DBA8 | Ribosomal protein S7 | 6201.0 | ENSG00000171863 | nan | Diamond-Blackfan anemia 8, 612563 (3), Autosomal dominant
chr2	COLEC11	612502.0 | COLEC11, CLK1, 3MC2 | Collectin 11 | 78989.0 | ENSG00000118004 | nan | 3MC syndrome 2, 265050 (3), Autosomal recessive
chr2	SOX11	600898.0 | SOX11, MRD27, IDDMOH | SRY-box 11 | 6664.0 | ENSG00000176887 | nan | Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism, 615866 (3), Autosomal dominant
chr2	NRIR	620418.0 | NRIR | Negative regulator of interferon response, noncoding | 104326052.0 | nan | nan | nan
chr2	CMPK2	611787.0 | CMPK2 | Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial | 129607.0 | ENSG00000134326 | nan | nan
chr2	RSAD2	607810.0 | RSAD2, VIPERIN | Radical S-adenosyl methionine domain containing 2 | 91543.0 | ENSG00000134321 | nan | nan
chr2	DFNB47	609946.0 | DFNB47 | Deafness, neurosensory, autosomal recessive 47 | 449489.0 | nan | max lod at D2S1400 and D2S262 | Deafness, neurosensory, autosomal recessive 47, 609946 (2), Autosomal recessive
chr2	RNF144A	619454.0 | RNF144A, UIP4, KIAA0161 | Ring finger protein 144A | 9781.0 | ENSG00000151692 | nan | nan
chr2	ID2	600386.0 | ID2 | Inhibitor of DNA binding 2, dominant negative | 3398.0 | ENSG00000115738 | nan | nan
chr2	KIDINS220	615759.0 | KIDINS220, ARMS, SINO, VENARG | Kinase D-interacting substrate, 220kD | 57498.0 | ENSG00000134313 | nan | Spastic paraplegia, intellectual disability, nystagmus, and obesity, 617296 (3), Autosomal dominant; Ventriculomegaly and arthrogryposis, 619501 (3), Autosomal recessive
chr2	MBOAT2	611949.0 | MBOAT2, LPCAT4 | Membrane-bound O-acyltransferase domain-containing 2 | 129642.0 | ENSG00000143797 | nan | nan
chr2	ASAP2	603817.0 | DDEF2, PAP | Development- and differentiation-enhancing factor 2 | 8853.0 | ENSG00000151693 | nan | nan
chr2	ITGB1BP1	607153.0 | ITGB1BP1, ICAP1, ICAP1A, ICAP1B | Integrin cytoplasmic domain-associated protein 1 beta | 9270.0 | ENSG00000119185 | nan | nan
chr2	CPSF3	606029.0 | CPSF3, CPSF73, NEDMHSN | Cleavage and polyadenylation specificity factor 3 | 51692.0 | ENSG00000119203 | nan | Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures, 619876 (3), Autosomal recessive
chr2	ADAM17	603639.0 | ADAM17, TACE, NISBD1 | ADAM metallopeptidase domain 17 | 6868.0 | ENSG00000151694 | mutation identified in 1 NISBD1 family | ?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3), Autosomal recessive
chr2	YWHAQ	609009.0 | TYHAQ | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta isoform | 10971.0 | ENSG00000134308 | pseudogene on chr.22 | nan
chr2	TAF1B	604904.0 | RAF1B, RAFI63, SL1 | TATA box-binding protein-associated factor 1B | 9014.0 | ENSG00000115750 | nan | nan
chr2	GRHL1	609786.0 | GRHL1, LBP32, MGR | Grainyhead-like 1 | 29841.0 | ENSG00000134317 | nan | nan
chr2	KLF11	603301.0 | KLF11, TIEG2, FKLF1, FKLF, MODY7 | Kruppel-like factor 11 | 8462.0 | ENSG00000172059 | nan | Maturity-onset diabetes of the young, type VII, 610508 (3)
chr2	CYS1	618713.0 | CYS1 | Cystin 1 | 192668.0 | ENSG00000205795 | nan | nan
chr2	RRM2	180390.0 | RRM2 | Ribonucleotide reductase, M2 polypeptide | 6241.0 | ENSG00000171848 | pseudogenes on 1p, 1q, Xp | nan
chr2	HPCAL1	600207.0 | HPCAL1 | Hippocalcin-like 1 | 3241.0 | ENSG00000115756 | nan | nan
chr2	ODC1	165640.0 | ODC1, BABS | Ornithine decarboxylase-1 | 4953.0 | ENSG00000115758 | pseudogene ODCP on 7q31-qter | Bachmann-Bupp syndrome, 619075 (3), Autosomal dominant
chr2	NOL10	616197.0 | NOL10, PQBP5 | Nucleolar protein 10 | 79954.0 | ENSG00000115761 | nan | nan
chr2	ATP6V1C2	618070.0 | ATP6V1C2 | ATPase, H+ transporting, V1 subunit C2 | 245973.0 | ENSG00000143882 | nan | nan
chr2	PDIA6	611099.0 | PDIA6, ERP5 | Protein disulfide isomerase, family A, member 6 | 10130.0 | ENSG00000143870 | nan | nan
chr2	KCNF1	603787.0 | KCNF1, KH1 | Potassium voltage-gated channel, subfamily F, member 1 | 3754.0 | ENSG00000162975 | nan | nan
chr2	ROCK2	604002.0 | ROCK2 | RHO-associated coiled-coil-containing protein kinase 2 | 9475.0 | ENSG00000134318 | nan | nan
chr2	E2F6	602944.0 | E2F6 | E2F transcription factor 6 | 1876.0 | ENSG00000169016 | nan | nan
chr2	GREB1	611736.0 | GREB1 | GREB1 protein | 9687.0 | ENSG00000196208 | nan | nan
chr2	NTSR2	605538.0 | NTSR2 | Neurotensin receptor 2 | 23620.0 | ENSG00000169006 | nan | nan
chr2	LPIN1	605518.0 | LPIN1 | Lipin 1 | 23175.0 | ENSG00000134324 | related to LSL | Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3), Autosomal recessive
chr2	CLQTL2	610760.0 | CLQTL2 | Cholesterol level quantitative trait locus 2 | 100188817.0 | nan | max lod at D2S1360 | [Cholesterol level QTL 2], 610760 (2)
chr2	GEFSP4	609800.0 | GEFSP4 | Generalized epilepsy with febrile seizures plus, type 4 | 100188796.0 | nan | max lod at D2S305 | Generalized epilepsy with febrile seizures plus, type 4, 609800 (2), Autosomal dominant
chr2	KTCN4	609271.0 | KTCN4 | Keratoconus 4 | 550624.0 | nan | between D2S305 and D2S2373 | Keratoconus 4, 609271 (2)
chr2	TRIB2	609462.0 | TRIB2, TRB2 | Tribbles pseudokinase 2 | 28951.0 | ENSG00000071575 | nan | nan
chr2	LRATD1	611234.0 | LRATD1, FAM84A, NSE1 | LRAT domain containing 1 gene | 151354.0 | ENSG00000162981 | nan | nan
chr2	NBAS	608025.0 | NBAS, NAG, SOPH, ILFS2 | NBAS subunit of NRZ tethering complex | 51594.0 | ENSG00000151779 | nan | Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3), Autosomal recessive; Infantile liver failure syndrome 2, 616483 (3), Autosomal recessive
chr2	DDX1	601257.0 | DDX1 | DEAD-box helicase 1 | 1653.0 | ENSG00000079785 | nan | nan
chr2	MYCNUT	615968.0 | MYCNUT | MYCN upstream transcript, noncoding | 103752554.0 | ENSG00000223850 | nan | nan
chr2	MYCNOS	605374.0 | MYCNOS, NCYM | Oncogene NCYM, opposite strand | 10408.0 | ENSG00000233718 | nan | nan
chr2	MYCN	164840.0 | MYCN, NMYC, FGLDS1, MPAPA | Oncogene NMYC | 4613.0 | ENSG00000134323 | proximal to APOB | Feingold syndrome 1, 164280 (3), Autosomal dominant; Megalencephaly-polydactyly syndrome, 620748 (3), Autosomal dominant
chr2	GACAT3	616132.0 | GACAT3, LINC01458 | Gastric cancer-associated transcript 3, noncoding | 104797537.0 | ENSG00000236289 | nan | nan
chr2	VSNL1	600817.0 | VSNL1, VILIP, HLP3 | Visinin-like 1 | 7447.0 | ENSG00000163032 | nan | nan
chr2	SMC6	609387.0 | SMC6L1, SMC6 | Structural maintenance of chromosomes 6-like 1 | 79677.0 | ENSG00000163029 | nan | nan
chr2	GEN1	612449.0 | GEN1 | GEN1 Holliday junction 5' flap endonuclease | 348654.0 | ENSG00000178295 | nan | nan
chr2	MSGN1	612209.0 | MSGN1 | Mesogenin 1 | 343930.0 | ENSG00000151379 | nan | nan
chr2	KCNS3	603888.0 | KCNS3, KV9.3 | Potassium voltate-gated channel, delayed-rectifier, subfamily S, member 3 | 3790.0 | ENSG00000170745 | nan | nan
chr2	RDH14	616796.0 | RDH14, SDR7C4, PAN2 | Retinol dehydrogenase 14 | 57665.0 | ENSG00000240857 | nan | nan
chr2	NT5C1B	610526.0 | NT5C1B, CN1B, AIRP | 5'-nucleotidase, cytosolic, Ib | 93034.0 | ENSG00000185013 | nan | nan
chr2	OSR1	608891.0 | ODD, OSR1 | ODD-skipped-related transcription factor 1 | 130497.0 | ENSG00000143867 | nan | nan
chr2	WDR35	613602.0 | WDR35, NAOFEN, KIAA1336, CED2, SRTD7 | WD repeat-containing protein 35 | 57539.0 | ENSG00000118965 | nan | Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3), Autosomal recessive; Cranioectodermal dysplasia 2, 613610 (3), Autosomal recessive
chr2	MATN3	602109.0 | MATN3, EDM5, HOA, OS2, SEMDBCD | Matrilin 3 | 4148.0 | ENSG00000132031 | nan | {Osteoarthritis susceptibility 2}, 140600 (3), Autosomal dominant; Spondyloepimetaphyseal dysplasia, Borochowitz-Cormier-Daire type, 608728 (3), Autosomal recessive; Epiphyseal dysplasia, multiple, 5, 607078 (3), Autosomal dominant
chr2	LAPTM4A	618837.0 | LAPTM4A | Lysosome-associated protein, transmembrane 4, alpha | 9741.0 | ENSG00000068697 | nan | nan
chr2	SDC1	186355.0 | SDC1 | Syndecan 1 | 6382.0 | ENSG00000115884 | close to NMYC in mouse | nan
chr2	PUM2	607205.0 | PUM2, KIAA0235 | Pumilio RNA binding family member 2 | 23369.0 | ENSG00000055917 | nan | nan
chr2	RHOB	165370.0 | RHOB, ARHB, ARH6, RHOH6 | RAS homolog gene family, member B (oncogene RHO H6) | 388.0 | ENSG00000143878 | nan | nan
chr2	HS1BP3	609359.0 | HS1BP3, FLJ14249, ETM2 | HS1-binding protein 3 | 64342.0 | ENSG00000118960 | nan | nan
chr2	GDF7	604651.0 | GDF7 | Growth/differentiation factor 7 | 151449.0 | ENSG00000143869 | nan | nan
chr2	LDAH	613570.0 | LDAH, C2orf43 | Lipid droplet associated hydrolase | 60526.0 | ENSG00000118961 | nan | nan
chr2	APOB	107730.0 | APOB, FLDB, LDLCQ4, FCHL2 | Apolipoprotein B (including Ag(x) antigen) | 338.0 | ENSG00000084674 | 1 gene for liver apo-B100 and gut apo-B48; Ag linked | Hypercholesterolemia, familial, 2, 144010 (3), Autosomal dominant; Hypobetalipoproteinemia, 615558 (3), Autosomal recessive
chr2	ATAD2B	615347.0 | ATAD2B, KIAA1240 | ATPase family, AAA domain-containing, member 2B | 54454.0 | ENSG00000119778 | nan | nan
chr2	GINGF3	609955.0 | GINGF3, HGF3, GGF3 | Fibromatosis, gingival, 3 | 780916.0 | nan | between D2S2221 and D2S1788 | Fibromatosis, gingival, 3, 609955 (2)
chr2	MFSD2B	617845.0 | MFSD2B | Major facilitator superfamily domain-containing protein 2B | 388931.0 | ENSG00000205639 | nan | nan
chr2	WDCP	616234.0 | C2orf44, WDCP | WD repeat- and coiled-coil-containing protein | 80304.0 | ENSG00000163026 | nan | nan
chr2	FKBP1B	600620.0 | FKBP1B, PKBP1L | FK506-binding protein 1B | 2281.0 | ENSG00000119782 | nan | nan
chr2	SF3B6	607835.0 | SF3B6, SAP14, SF3B14, P14 | Splicing factor 3B, subunit 6 | 51639.0 | ENSG00000115128 | nan | nan
chr2	TP53I3	605171.0 | TP53I3, PIG3 | Tumor protein p53-inducible protein 3 | 9540.0 | ENSG00000115129 | nan | nan
chr2	PFN4	620046.0 | PFN4 | Profilin family, member 4 | 375189.0 | ENSG00000176732 | nan | nan
chr2	ITSN2	604464.0 | ITSN2, SH3D1B, SWAP, KIAA1256 | Intersectin 2 | 50618.0 | ENSG00000198399 | nan | nan
chr2	NCOA1	602691.0 | NCOA1, SRC1 | Nuclear receptor coactivator 1 | 8648.0 | ENSG00000084676 | nan | nan
chr2	PTRHD1	617342.0 | PRTHD1, C2orf79, NEDPBA | Peptidyl-tRNA hydrolase domain-containing 1 | 391356.0 | ENSG00000184924 | nan | Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities, 620747 (3), Autosomal recessive
chr2	CENPO	611504.0 | CENPO | Centromeric protein O | 79172.0 | ENSG00000138092 | nan | nan
chr2	ADCY3	600291.0 | ADCY3, BMIQ19 | Adenylate cyclase-3 | 109.0 | ENSG00000138031 | nan | {Obesity, susceptibility to, BMIQ19}, 617885 (3), Autosomal recessive
chr2	DNAJC27	613527.0 | DNAJC27, RBJ | DNAJ/HSP40 homolog, subfamily, C, member 27 | 51277.0 | ENSG00000115137 | nan | nan
chr2	EFR3B	616797.0 | EFR3B, KIAA0953 | EFR3 homolog B | 22979.0 | ENSG00000084710 | nan | nan
chr2	POMC	176830.0 | POMC, OBAIRH | Proopiomelanocortin (adrenocorticotropin/beta-lipotropin) | 5443.0 | ENSG00000115138 | nan | {Obesity, early-onset, susceptibility to}, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant; Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3), Autosomal recessive
chr2	DNMT3A	602769.0 | DNMT3A, TBRS, HESJAS | DNA methyltransferase 3A | 1788.0 | ENSG00000119772 | nan | Tatton-Brown-Rahman syndrome, 615879 (3), Autosomal dominant; Acute myeloid leukemia, somatic, 601626 (3); Heyn-Sproul-Jackson syndrome, 618724 (3), Autosomal dominant
chr2	DTNB	602415.0 | DTNB | Dystrobrevin, beta | 1838.0 | ENSG00000138101 | nan | nan
chr2	ASXL2	612991.0 | ASXL2, KIAA1685, SHAPNS | ASXL transcriptional regulator 2 | 55252.0 | ENSG00000143970 | nan | Shashi-Pena syndrome, 617190 (3), Autosomal dominant
chr2	KIF3C	602845.0 | KIF3C | Kinesin family member 3C | 3797.0 | ENSG00000084731 | nan | nan
chr2	RAB10	612672.0 | RAB10 | Ras-associated protein | 10890.0 | ENSG00000084733 | nan | nan
chr2	GAREM2	617999.0 | GAREM2 | GRB2-associated regulator of MAPK1, subtype 2 | 150946.0 | ENSG00000157833 | nan | nan
chr2	HADHA	600890.0 | HADHA, MTPA | Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit | 3030.0 | ENSG00000084754 | nan | HELLP syndrome, maternal, of pregnancy, 609016 (3), Autosomal recessive; LCHAD deficiency, 609016 (3), Autosomal recessive; Mitochondrial trifunctional protein deficiency 1, 609015 (3), Autosomal recessive; Fatty liver, acute, of pregnancy, 609016 (3), Autosomal recessive
chr2	HADHB	143450.0 | HADHB, MTPD2 | Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase /enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit | 3032.0 | ENSG00000138029 | nan | Mitochondrial trifunctional protein deficiency 2, 620300 (3)
chr2	ADGRF3	620873.0 | ADGRF3, GPR113 | Adhesion G protein-coupled recetpor F3 | 165082.0 | ENSG00000173567 | nan | nan
chr2	SELENOI	607915.0 | SELENOI, SELI, SPG81 | Selenoprotein I | 85465.0 | ENSG00000138018 | nan | Spastic paraplegia 81, autosomal recessive, 618768 (3), Autosomal recessive
chr2	DRC1	615288.0 | DRC1, CCDC164, C2orf39, CILD21, SPGF80 | Dynein regulatory complex, subunit 1 | 92749.0 | ENSG00000157856 | nan | Spermatogenic failure 80, 620222 (3), Autosomal recessive; Ciliary dyskinesia, primary, 21, 615294 (3), Autosomal recessive
chr2	OTOF	603681.0 | OTOF, DFNB9, NSRD9, AUNB1 | Otoferlin | 9381.0 | ENSG00000115155 | symbolized DFNB6 by authors | Auditory neuropathy, autosomal recessive, 1, 601071 (3), Autosomal recessive; Deafness, autosomal recessive 9, 601071 (3), Autosomal recessive
chr2	CIB4	610646.0 | CIB4, KIP4 | Calcium- and integrin-binding protein 4 | 130106.0 | ENSG00000157884 | nan | nan
chr2	KCNK3	603220.0 | KCNK3, TASK, PPH4 | Potassium channel, subfamily K, member 3 | 3777.0 | ENSG00000171303 | nan | Pulmonary hypertension, primary, 4, 615344 (3), Autosomal dominant
chr2	SLC35F6	619667.0 | SLC35F6, ANT2BP, C2orf18 | Solute carrier family 35, member F6 | 54978.0 | ENSG00000213699 | nan | nan
chr2	CENPA	117139.0 | CENPA | Centromere protein A, 17kD | 1058.0 | ENSG00000115163 | nan | nan
chr2	DPYSL5	608383.0 | DPYSL5, CRMP5, CRAM, RTSC4 | Dihydropyrimidinase-like 5 | 56896.0 | ENSG00000157851 | nan | Ritscher-Schinzel syndrome 4, 619435 (3), Autosomal dominant
chr2	MAPRE3	605788.0 | MAPRE3, EB3, RP3, EBF3 | Microtubule-associated protein, RP/EB family, member 3 | 22924.0 | ENSG00000084764 | nan | nan
chr2	TMEM214	615301.0 | TMEM214 | Transmembrane protein 214 | 54867.0 | ENSG00000119777 | nan | nan
chr2	AGBL5	615900.0 | AGBL5, CCP5, RP75 | AATP/GTP-binding protein-like 5 | 60509.0 | ENSG00000084693 | nan | Retinitis pigmentosa 75, 617023 (3), Autosomal recessive
chr2	OST4	618932.0 | OST4 | Oligosaccharyltransferase complex, noncatalytic subunit 4 | 100128731.0 | ENSG00000228474 | nan | nan
chr2	EMILIN1	130660.0 | EMILIN1, EMILIN, HMND10, ATBFS | Elastin microfibril interfacer 1 | 11117.0 | ENSG00000138080 | nan | Neuronopathy, distal hereditary motor, autosomal dominant 10, 620080 (3), Autosomal dominant; Arterial tortuosity-bone fragility syndrome, 620908 (3), Autosomal recessive
chr2	KHK	614058.0 | KHK, FRUCTU | Ketohexokinase (fructokinase) | 3795.0 | ENSG00000138030 | mutation identified in 1 FRUCTU family | ?[Fructosuria, essential], 229800 (3), Autosomal recessive
chr2	CGREF1	606137.0 | CGREF1, CGR11 | Cell growth regulator with EF-hand domain 1 | 10669.0 | ENSG00000138028 | nan | nan
chr2	ABHD1	612195.0 | ABHD1, LABH1 | Abhydrolase domain-containing 1 | 84696.0 | ENSG00000143994 | nan | nan
chr2	PREB	606395.0 | PREB | Prolactin regulatory element-binding protein | 10113.0 | ENSG00000138073 | nan | nan
chr2	TCF23	609635.0 | TCF23 | Transcription factor 23 | 150921.0 | ENSG00000163792 | nan | nan
chr2	SLC5A6	604024.0 | SLC5A6, SMVT, NERIB, SMVTD, COMNB | Solute carrier family 5 (sodium dependent vitamin transporter), member 6 | 8884.0 | ENSG00000138074 | nan | Sodium-dependent multivitamin transporter deficiency, 618973 (3), Autosomal recessive; Peripheral motor neuropathy, childhood-onset, biotin-responsive, 619903 (3), Autosomal recessive
chr2	ATRAID	619682.0 | ATRAID, APR3 | All-trans retinoic acid-induced differentiation factor | 51374.0 | ENSG00000138085 | nan | nan
chr2	CAD	114010.0 | CAD, CDG1Z, DEE50 | CAD trifunctional protein of pyrimidine biosynthesis | 790.0 | ENSG00000084774 | nan | Developmental and epileptic encephalopathy 50, 616457 (3), Autosomal recessive
chr2	SLC30A3	602878.0 | SLC30A3, ZNT3 | Solute carrier family 30 (zinc transporter), member 3 | 7781.0 | ENSG00000115194 | nan | nan
chr2	DNAJC5G	613946.0 | DNAJC5G | DNAJ/HSP40 homolog, subfamily C, member 5, gamma | 285126.0 | ENSG00000163793 | nan | nan
chr2	TRIM54	606474.0 | TRIM54, RNF30, MURF3 | Tripartite motif containing 54 | 57159.0 | ENSG00000138100 | nan | nan
chr2	UCN	600945.0 | UCN, UROC | Urocortin | 7349.0 | ENSG00000163794 | nan | nan
chr2	MPV17	137960.0 | MPV17, MTDPS6, CMT2EE | Mitochondrial inner membrane protein MPV17 | 4358.0 | ENSG00000115204 | nan | Charcot-Marie-Tooth disease, axonal, type 2EE, 618400 (3), Autosomal recessive; Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3), Autosomal recessive
chr2	GTF3C2	604883.0 | GTF3C2 | General transcription factor 3C, polypeptide 2 | 2976.0 | ENSG00000115207 | nan | nan
chr2	EIF2B4	606687.0 | EIF2B4, VWM4 | Eukaryotic translation initiation factor 2B, subunit 4 | 8890.0 | ENSG00000115211 | nan | Leukoencephalopathy with vanishing white matter 4, with or without ovarian failure, 620314 (3), Autosomal recessive
chr2	SNX17	605963.0 | SNX17 | Sorting nexin 17 | 9784.0 | ENSG00000115234 | nan | nan
chr2	ZNF513	613598.0 | ZNF513, RP58 | Zinc finger protein 513 | 130557.0 | ENSG00000163795 | mutation identified in 1 RP58 family | ?Retinitis pigmentosa 58, 613617 (3), Autosomal recessive
chr2	PPM1G	605119.0 | PPM1G, PP2CG | Protein phosphatase, magnesium/manganese-dependent, 1G | 5496.0 | ENSG00000115241 | nan | nan
chr2	NRBP1	606010.0 | NRBP | Nuclear receptor-binding protein | 29959.0 | ENSG00000115216 | nan | nan
chr2	KRTCAP3	619261.0 | KRTCAP3, KCP3 | Keratinocyte-associated protein 3 | 200634.0 | ENSG00000157992 | nan | nan
chr2	IFT172	607386.0 | IFT172, SLB, KIAA1179, SRTD10, RP71, BBS20 | Intraflagellar transport 172 | 26160.0 | ENSG00000138002 | nan | Retinitis pigmentosa 71, 616394 (3), Autosomal recessive; Bardet-Biedl syndrome 20, 619471 (3), Autosomal recessive; Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3), Autosomal recessive
chr2	FNDC4	611905.0 | FNDC4, FRCP1 | Fibronectin type III domain-containing protein 4 | 64838.0 | ENSG00000115226 | nan | nan
chr2	GCKR	600842.0 | GCKR, GKRP, FGQTL5 | Glucokinase (hexokinase 4) regulatory protein | 2646.0 | ENSG00000084734 | nan | [Fasting plasma glucose level QTL 5], 613463 (3)
chr2	ZNF512	620921.0 | ZNF512 | Zinc finger protein 512 | 84450.0 | ENSG00000243943 | nan | nan
chr2	GPN1	611479.0 | XAB1, MBDIN | XPA-binding protein | 11321.0 | ENSG00000198522 | nan | nan
chr2	SUPT7L	612762.0 | SUPT7L, SUPT7H, SPT7l, KIAA0764, STAF65G | SPTY7-like, STAGA complex subunit gamma | 9913.0 | ENSG00000119760 | nan | nan
chr2	SLC4A1AP	602655.0 | SLC4A1AP | Solute carrier family 4 (anion exchanger), member 1, adaptor protein | 22950.0 | ENSG00000163798 | nan | nan
chr2	MRPL33	610059.0 | MRPL33 | Mitochondrial ribosomal protein L33 | 9553.0 | ENSG00000243147 | nan | nan
chr2	RBKS	611132.0 | RBKS | Ribokinase | 64080.0 | ENSG00000171174 | nan | nan
chr2	BABAM2	610497.0 | BRE, BRCC4, BRCC45 | Brain and reproductive organ-expressed protein | 9577.0 | ENSG00000158019 | nan | nan
chr2	FOSL2	601575.0 | FOSL2, ACED | FOS-like 2, AP-1 transcription factor subunit | 2355.0 | ENSG00000075426 | nan | Aplasia cutis-enamel dysplasia syndrome, 620789 (3), Autosomal dominant
chr2	PLB1	610179.0 | PLB1, PLB, FLJ30866 | Phospholipase B1 | 151056.0 | ENSG00000163803 | nan | nan
chr2	PPP1CB	600590.0 | PPP1CB, NSLH2 | Protein phosphatase-1, catalytic subunit, beta isoform | 5500.0 | ENSG00000213639 | nan | Noonan syndrome-like disorder with loose anagen hair 2, 617506 (3), Autosomal dominant
chr2	SPDYA	614029.0 | SPDYA, SPY1, RINGOA | Speedy/RINGO cell cycle regulator family, member A | 245711.0 | ENSG00000163806 | nan | nan
chr2	TRMT61B	619404.0 | TRMT61B | tRNA methyltransferase 61B | 55006.0 | ENSG00000171103 | nan | nan
chr2	WDR43	616195.0 | WDR43, UTP5, KIAA0007 | WD repeat-containing protein 43 | 23160.0 | ENSG00000163811 | nan | nan
chr2	TOGARAM2	620949.0 | TOGARAM2, FAM179A | TOG array regulator of axonemal microtubules 2 | 165186.0 | ENSG00000189350 | nan | nan
chr2	PCARE	613425.0 | PCARE, C2orf71, RP54 | Photoreceptor cilium actin regulator | 388939.0 | ENSG00000179270 | nan | Retinitis pigmentosa 54, 613428 (3), Autosomal recessive
chr2	ALK	105590.0 | ALK, NBLST3 | ALK receptor tyrosine kinase | 238.0 | ENSG00000171094 | nan | {Neuroblastoma, susceptibility to, 3}, 613014 (3)
chr2	YPEL5	609726.0 | YPEL5 | Yippee-like 5 | 51646.0 | ENSG00000119801 | nan | nan
chr2	LBH	611763.0 | LBH | LBH regulator of WNT signaling pathway | 81606.0 | ENSG00000213626 | nan | nan
chr2	LCLAT1	614241.0 | LCLAT1, ALCAT1, AGPAT8 | Lysocardiolipin acyltransferase 1 | 253558.0 | ENSG00000172954 | nan | nan
chr2	CAPN13	610228.0 | CAPN13, FLJ23523 | Calpain 13 | 92291.0 | ENSG00000162949 | nan | nan
chr2	GALNT14	608225.0 | GALNT14 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 | 79623.0 | ENSG00000158089 | nan | nan
chr2	CAPN14	610229.0 | CAPN14 | Calpain 14 | 440854.0 | ENSG00000214711 | nan | nan
chr2	EHD3	605891.0 | EHD3 | EH domain-containing 3 | 30845.0 | ENSG00000013016 | nan | nan
chr2	XDH	607633.0 | XDH, XAN1 | Xanthine dehydrogenase (xanthine oxidase) | 7498.0 | ENSG00000158125 | nan | Xanthinuria, type I, 278300 (3), Autosomal recessive
chr2	SRD5A2	607306.0 | SRD5A2 | Steroid-5-alpha-reductase, alpha polypeptide-2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha-2) | 6716.0 | ENSG00000277893 | nan | Pseudovaginal perineoscrotal hypospadias, 264600 (3), Autosomal recessive
chr2	CANDF1	114580.0 | CANDF1, CMCT | Candidiasis, familial, 1 | 117084.0 | nan | between D2S367 and D2S2240 | Candidiasis, familial, 1, autosomal dominant, 114580 (2), Autosomal dominant
chr2	MEMO1	611786.0 | MEMO1, MEMO, C2orf4 | Mediator of cell motility 1 | 51072.0 | ENSG00000162959 | nan | nan
chr2	DPY30	612032.0 | DPY30 | DPY30 histone methyltransferase complex regulatory subunit | 84661.0 | ENSG00000162961 | nan | nan
chr2	SPAST	604277.0 | SPAST, SPG4 | Spastin | 6683.0 | ENSG00000021574 | nan | Spastic paraplegia 4, autosomal dominant, 182601 (3), Autosomal dominant
chr2	SLC30A6	611148.0 | SLC30A6, ZNT6 | Solute carrier family 30 (zinc transporter), member 6 | 55676.0 | ENSG00000152683 | nan | nan
chr2	NLRC4	606831.0 | NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4 | NLR family, caspase recruitment domain-containing 4 | 58484.0 | ENSG00000091106 | mutation identified in 1 FCAS4 family | ?Familial cold autoinflammatory syndrome 4, 616115 (3), Autosomal dominant; Autoinflammation with infantile enterocolitis, 616050 (3), Autosomal dominant
chr2	YIPF4	617534.0 | YIPF4 | Yip1 domain family, member 4 | 84272.0 | ENSG00000119820 | nan | nan
chr2	BIRC6	605638.0 | BIRC6, KIAA1289 | Baculoviral IAP repeat-containing protein-6 | 57448.0 | ENSG00000115760 | nan | nan
chr2	MIR558	616473.0 | MIR558 | Micro RNA 558 | 693143.0 | ENSG00000207653 | BIRC6 is host gene | nan
chr2	LTBP1	150390.0 | LTBP1, ARCL2E | Latent transforming growth factor beta binding protein 1 | 4052.0 | ENSG00000049323 | nan | Cutis laxa, autosomal recessive, type IIE, 619451 (3), Autosomal recessive
chr2	RASGRP3	609531.0 | RASGRP3, KIAA0846 | Ras guanyl nucleotide-releasing protein 3 | 25780.0 | ENSG00000152689 | nan | nan
chr2	FAM98A	620904.0 | FAM98A | Family with sequence similarity 98, member A | 25940.0 | ENSG00000119812 | nan | nan
chr2		602499.0 | MACOM | Macrophthalmia, colobomatous, with microcornea | nan | nan | nan | Macrophthalmia, colobomatous, with microcornea, 602499 (4), Autosomal dominant
chr2	CRIM1	606189.0 | CRIM1 | Cysteine-rich motor neuron protein 1 | 51232.0 | ENSG00000150938 | nan | nan
chr2	FEZ2	604826.0 | FEZ2 | Fasciculation and elongation protein zeta 2 | 9637.0 | ENSG00000171055 | nan | nan
chr2	VIT	617693.0 | VIT, VIT1 | Vitrin | 5212.0 | ENSG00000205221 | nan | nan
chr2	STRN	614765.0 | STRN | Striatin, calmodulin-binding protein | 6801.0 | ENSG00000115808 | nan | nan
chr2	HEATR5B	619627.0 | HEATR5B | HEAT repeat-containing protein 5B | 54497.0 | ENSG00000008869 | nan | nan
chr2	EIF2AK2	176871.0 | EIF2AK2, PRKR, LEUDEN, DYT33 | Eurkaryotic translation initiation factor 2-alpha kinase 2 | 5610.0 | ENSG00000055332 | mutation identified in 1 DYT33 patient | Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome, 618877 (3), Autosomal dominant; Dystonia 33, 619687 (3), Autosomal recessive, Autosomal dominant
chr2	SULT6B1	617152.0 | SULT6B1 | Sulfotransferase family 6B, member 1 | 391365.0 | ENSG00000138068 | nan | nan
chr2	CEBPZ	612828.0 | CEBPZ, CBF, NOC1 | CCAAT/enhancer-binding protein, zeta | 10153.0 | ENSG00000115816 | nan | nan
chr2	NDUFAF7	615898.0 | NDUFAF7, MIDA | NADH-ubiquinone oxidoreductase complex assembly factor 7 | 55471.0 | ENSG00000003509 | nan | nan
chr2	PRKD3	607077.0 | PRKCN | Protein kinase C, nu | 23683.0 | ENSG00000115825 | nan | nan
chr2	QPCT	607065.0 | QPCT, QC | Glutaminyl-peptide cyclotransferase | 25797.0 | ENSG00000115828 | nan | nan
chr2	CDC42EP3	606133.0 | CDC42EP3, CEP3, BORG2 | CDC42 effector protein 3 | 10602.0 | ENSG00000163171 | nan | nan
chr2	RMDN2	611872.0 | RMDN1, FAM82A1, FAM82A, RMD2 | Regulator of microtubule dynamics 2 | 151393.0 | ENSG00000115841 | nan | nan
chr2	CYP1B1	601771.0 | CYP1B1, GLC3A, ASGD6 | Cytochrome P450, subfamily I, dioxin-inducible, polypeptide 1 | 1545.0 | ENSG00000138061 | nan | Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3), Autosomal recessive; Anterior segment dysgenesis 6, multiple subtypes, 617315 (3), Autosomal recessive
chr2	ATL2	609368.0 | ATL2, ARL3IP2 | Atlastin GTPase 2 | 64225.0 | ENSG00000119787 | nan | nan
chr2	HNFJ3	614227.0 | HNFJ3 | Hyperuricemic nephropathy, familial juvenile, 3 | 100689490.0 | nan | between rs372139 and rs896986 | Hyperuricemic nephropathy, familial juvenile, 3, 614227 (2), Autosomal dominant
chr2	HNRNPLL	611208.0 | HNRNPLL, HNRPLL, SRRF | Heterogeneous nuclear ribonucleoprotein L-like | 92906.0 | ENSG00000143889 | nan | nan
chr2	GALM	137030.0 | GALM, GLAT, GALAC4 | Galactose mutarotase | 130589.0 | ENSG00000143891 | nan | Galactosemia IV, 618881 (3), Autosomal recessive
chr2	SRSF7	600572.0 | SRSF7, SFRS7 | Splicing factor, arginine/serine-rich 7, 35kD | 6432.0 | ENSG00000115875 | nan | nan
chr2	GEMIN6	607006.0 | GEMIN6 | GEM-associated protein 6 | 79833.0 | ENSG00000152147 | nan | nan
chr2	SOS1	182530.0 | SOS1, GINGF, GF1, HGF, NS4 | SOS Ras/Rac guanine nucleotide exchange factor 1 | 6654.0 | ENSG00000115904 | mutation identified in 1 GINGF1 family | Noonan syndrome 4, 610733 (3), Autosomal dominant; ?Fibromatosis, gingival, 1, 135300 (3), Autosomal dominant
chr2	MAP4K3	604921.0 | MAP4K3, GLK | Mitogen-activated protein kinase kinase kinase kinase 3 | 8491.0 | ENSG00000011566 | nan | nan
chr2	THUMPD2	611751.0 | THUMPD2, C2orf8 | THUMP domain-containing 2 | 80745.0 | ENSG00000138050 | nan | nan
chr2	SLC8A1	182305.0 | SLC8A1, NCX1 | Solute carrier family 8, member 1 (sodium-calcium exchanger-1) | 6546.0 | ENSG00000183023 | nan | nan
chr2		606407.0 | DEL2p21, C2DELp21 | Homozygous 2p21 deletion syndrome | nan | nan | contiguous gene syndrome disrupting SLC3A1 and PREPL genes | Hypotonia-cystinuria syndrome, 606407 (4), Autosomal recessive
chr2		615654.0 | DFNA58 | Deafness, autosomal dominant 58 | nan | nan | duplication of 200kb | Deafness, autosomal dominant 58, 615654 (4), Autosomal dominant
chr2	LEPQTL1	601694.0 | LEPQTL1, LSL | Leptin serum levels quantitative trait locus 1 | 7839.0 | nan | nan | [Leptin serum levels QTL1], 601694 (2)
chr2	PKDCC	614150.0 | PKDCC, VLK, SGK493, RLSDF | Protein kinase domain-containing, cytoplasmic | 91461.0 | ENSG00000162878 | nan | Rhizomelic limb shortening with dysmorphic features, 618821 (3), Autosomal recessive
chr2	EML4	607442.0 | EML4, ROPP120 | Echinoderm microtubule associated protein like-4 | 27436.0 | ENSG00000143924 | nan | nan
chr2	COX7A2L	605771.0 | COX7A2L, COX7RP, EB1 | Cytochrome c oxidase subunit VIIA, polypeptide 2-like | 9167.0 | ENSG00000115944 | nan | nan
chr2	KCNG3	606767.0 | KCNG3, KV6.3 | Potassium voltage-gated channel, subfamily G, member 3 | 170850.0 | ENSG00000171126 | nan | nan
chr2	MTA3	609050.0 | MTA3, KIAA1266 | Mtastasis-associated 1 family member 3 | 57504.0 | ENSG00000057935 | nan | nan
chr2	OXER1	620064.0 | OXER1, TG1019 | Oxoeicosanoid receptor 1 | 165140.0 | ENSG00000162881 | nan | nan
chr2	HAAO	604521.0 | HAAO, VCRL1 | 3-hydroxyanthranilate 3,4-dioxygenase | 23498.0 | ENSG00000162882 | nan | Vertebral, cardiac, renal, and limb defects syndrome 1, 617660 (3), Autosomal recessive
chr2	ZFP36L2	612053.0 | ZFP36L2, ERF2, TIS11D, OZEMA13 | Zinc finger protein 36-like 2 | 678.0 | ENSG00000152518 | nan | Oocyte/zygote/embryo maturation arrest 13, 620154 (3), Autosomal recessive
chr2	THADA	611800.0 | THADA, KIAA1767 | THADA armadillo repeat containing | 63892.0 | ENSG00000115970 | nan | nan
chr2	PLEKHH2	612723.0 | PLEKHH2 | Pleckstrin homology domain-containing protein, family H, member 2 | 130271.0 | ENSG00000152527 | nan | nan
chr2	DYNC2LI1	617083.0 | DYNC2LI1, D2LIC, LIC3, SRTD15 | Dynein, cytoplasmic 2, light intermediate chain 1 | 51626.0 | ENSG00000138036 | nan | Short-rib thoracic dysplasia 15 with polydactyly, 617088 (3), Autosomal recessive
chr2	ABCG5	605459.0 | ABCG5, STSL2 | ATP-binding cassette, subfamily G, member 5 | 64240.0 | ENSG00000138075 | nan | Sitosterolemia 2, 618666 (3), Autosomal recessive
chr2	ABCG8	605460.0 | ABCG8, GBD4, STSL1 | ATP-binding cassette, subfamily G, member 8 | 64241.0 | ENSG00000143921 | nan | Sitosterolemia 1, 210250 (3), Autosomal recessive; {Gallbladder disease 4}, 611465 (3)
chr2	LRPPRC	607544.0 | LRPPRC, LRP130, LSFC, MC4DN5 | Leucine-rich PPR motif-containing protein | 10128.0 | ENSG00000138095 | nan | Mitochondrial complex IV deficiency, nuclear type 5, (French-Canadian), 220111 (3), Autosomal recessive
chr2	PPM1B	603770.0 | PPM1B | Protein phosphatase, magnesium-dependent, 1, beta isoform | 5495.0 | ENSG00000138032 | formerly PP2CB | nan
chr2	SLC3A1	104614.0 | SLC3A1, ATR1, D2H, NBAT | Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters), member 1 | 6519.0 | ENSG00000138079 | nan | Cystinuria, 220100 (3), Autosomal recessive, Autosomal dominant
chr2	PREPL	609557.0 | PREPL, KIAA0436, CMS22 | Prolyl endopeptidase-like | 9581.0 | ENSG00000138078 | nan | Myasthenic syndrome, congenital, 22, 616224 (3), Autosomal recessive
chr2	CAMKMT	609559.0 | CAMKMT, C2orf34 | Calmodulin lysine N-methyltransferase | 79823.0 | ENSG00000143919 | nan | nan
chr2	SIX3	603714.0 | SIX3, HPE2 | SIX homeobox 3 | 6496.0 | ENSG00000138083 | nan | Schizencephaly, 269160 (3); Holoprosencephaly 2, 157170 (3), Autosomal dominant
chr2	SIX2	604994.0 | SIX2 | SIX homeobox 2 | 10736.0 | ENSG00000170577 | nan | nan
chr2	PRKCE	176975.0 | PRKCE, PKCE | Protein kinase C, epsilon | 5581.0 | ENSG00000171132 | nan | nan
chr2	EPAS1	603349.0 | EPAS1, MOP2, HIF2A, ECYT4 | Endothelial PAS domain protein 1 | 2034.0 | ENSG00000116016 | nan | Erythrocytosis, familial, 4, 611783 (3), Autosomal dominant
chr2	ATP6V1E2	617385.0 | ATP6V1E2, ATP6E1 | ATPase, H+ transporting, V1 subunit E1 | 90423.0 | ENSG00000250565 | nan | nan
chr2	RHOQ	605857.0 | RHOQ, ARHQ, TC10 | Ras-homolog gene family, member Q | 23433.0 | ENSG00000119729 | nan | nan
chr2	PIGF	600153.0 | PIGF, OORS | Phosphatidylinositol glycan, class F | 5281.0 | ENSG00000151665 | pseudogene on 5 | Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome, 619356 (3), Autosomal recessive
chr2	CRIPT	604594.0 | CRIPT, RTS3 | Cystine-rich PDZ binding protein | 9419.0 | ENSG00000119878 | nan | Rothmund-Thomson syndrome, type 3, 615789 (3), Autosomal recessive
chr2	SOCS5	607094.0 | SOCS5, CIS6, KIAA0671 | Suppressor of cytokine signaling 5 | 9655.0 | ENSG00000171150 | also signals at 3p22 | nan
chr2	MCFD2	607788.0 | MCFD2, F5F8D2 | Multiple coagulation factor deficiency protein 2 | 90411.0 | ENSG00000180398 | nan | Factor V and factor VIII, combined deficiency of, 613625 (3)
chr2	TTC7A	609332.0 | TTC7A, TTC7, KIAA1140, MINAT, GIDID | Tetratricopeptide repeat domain 7A | 57217.0 | ENSG00000068724 | nan | Gastrointestinal defects and immunodeficiency syndrome, 243150 (3), Autosomal recessive
chr2	CALM2	114182.0 | CALM2, LQT15 | Calmodulin-2 | 805.0 | ENSG00000143933 | nan | Long QT syndrome 15, 616249 (3), Autosomal dominant
chr2	BCYRN1	606089.0 | BCYRN1, BC200 | Brain cytoplasmic RNA 1 | 618.0 | ENSG00000236824 | nan | nan
chr2	EPCAM	185535.0 | EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, LYNCH8 | Epithelial cellular adhesion molecule | 4072.0 | ENSG00000119888 | previously assigned to 4q | Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant
chr2	MSH2	609309.0 | MSH2, COCA1, FCC1, LYNCH1, MMRCS2 | mutS homolog 2 | 4436.0 | ENSG00000095002 | nan | Lynch syndrome 1, 120435 (3), Autosomal dominant; Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 2, 619096 (3), Autosomal recessive
chr2	ASRT3	609958.0 | ASRT3 | Asthma-related traits, susceptibility to, 3 | 100188801.0 | nan | max lod at rs2063871 | {Asthma-related traits, susceptibility to, 3}, 609958 (2)
chr2	CNC2	605244.0 | CNC2 | Carney complex, type II | 1257.0 | nan | nan | Carney complex, type II, 605244 (2)
chr2	DYX3	604254.0 | DYX3 | Dyslexia, susceptibility to, 3 | 11192.0 | nan | nan | {Dyslexia, susceptibility to, 3}, 604254 (2)
chr2	STQTL24	613549.0 | STQTL24 | Stature quantitative trait locus 24 | 100529223.0 | nan | linked to rs1520446 | {Stature QTL 24}, 613549 (2)
chr2	KCNK12	607366.0 | KCNK12, THIK2 | Potassium channel, subfamily K, member 12 | 56660.0 | ENSG00000184261 | nan | nan
chr2	MSH6	600678.0 | MSH6, GTBP, LYNCH5, MMRCS3 | mutS homolog 6 | 2956.0 | ENSG00000116062 | 0.5 Mb from MSH2 | Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant
chr2	FBXO11	607871.0 | FBXO11, FBX11, VIT1, PRMT9, IDDFBA | F-box only protein 11 | 80204.0 | ENSG00000138081 | ?2p16 | Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant
chr2	FOXN2	143089.0 | FOXN2, HTLF | Forkhead box N2 | 3344.0 | ENSG00000170802 | nan | nan
chr2	PPP1R21	618159.0 | PPP1R21, CCDC128, KLRAQ1, NEDHFBA | Protein phosphatase 1, regulatory subunit 21 | 129285.0 | ENSG00000162869 | nan | Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities, 619383 (3), Autosomal recessive
chr2	STON1	605357.0 | STON1, STN1, SBLF, SALF | Stonin 1 | 11037.0 | ENSG00000243244 | nan | nan
chr2	GTF2A1L	605358.0 | GTF2A1L, ALF | General transcription factor IIA, 1-like | 11036.0 | ENSG00000242441 | nan | nan
chr2	LHCGR	152790.0 | LHCGR, LHR, LCGR | Luteinizing hormone/choriogonadotropin receptor | 3973.0 | ENSG00000138039 | nan | Leydig cell adenoma, somatic, with precocious puberty, 176410 (3); Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3), Autosomal recessive; Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3), Autosomal recessive; Luteinizing hormone resistance, female, 238320 (3), Autosomal recessive; Precocious puberty, male, 176410 (3), Autosomal dominant
chr2	FSHR	136435.0 | FSHR, ODG1 | Follicle stimulating hormone receptor | 2492.0 | ENSG00000170820 | nan | Ovarian hyperstimulation syndrome, 608115 (3), Autosomal dominant; Ovarian dysgenesis 1, 233300 (3), Autosomal recessive
chr2	NRXN1	600565.0 | NRXN1, PTHSL2, SCZD17 | Neurexin 1 | 9378.0 | ENSG00000179915 | nan | Pitt-Hopkins-like syndrome 2, 614325 (3), Autosomal recessive; {Schizophrenia, susceptibility to, 17}, 614332 (3)
chr2	ASB3	605760.0 | ASB3 | Ankyrin repeat-containing SOCS box protein 3 | 51130.0 | ENSG00000115239 | nan | nan
chr2	CHAC2	617446.0 | CHAC2 | CHAC cation transport regulator homolog 2 | 494143.0 | ENSG00000143942 | nan | nan
chr2	ERLEC1	611229.0 | ERLEC1, C2orf30 | Erlectin (endoplasmic reticulum lectin 1) | 27248.0 | ENSG00000068912 | nan | nan
chr2	GPR75	606704.0 | GPR75 | G protein-coupled receptor 75 | 10936.0 | ENSG00000119737 | nan | nan
chr2	PSME4	607705.0 | PSME4, PA200, KIAA0077 | Proteasome activator subunit 4 | 23198.0 | ENSG00000068878 | nan | nan
chr2	ACYP2	102595.0 | ACYP2, ACYP | Acylphosphatase 2, muscle type | 98.0 | ENSG00000170634 | nan | nan
chr2	SPTBN1	182790.0 | SPTBN1, DDISBA | Spectrin, beta, nonerythrocytic-1 (beta-fodrin) | 6711.0 | ENSG00000115306 | nan | Developmental delay, impaired speech, and behavioral abnormalities, 619475 (3), Autosomal dominant
chr2		612513.0 | DEL2p16.1-p15, C2DELp161-p15 | Chromosome 2p16.1-p15 deletion syndrome | nan | nan | contiguous gene deletion syndrome | Chromosome 2p16.1-p15 deletion syndrome, 612513 (4), Isolated cases
chr2	HPFH2	142335.0 | HBFQTL5 | Fetal hemoglobin quantitative trait locus 5 | 3247.0 | nan | associated with rs11886868 | [Fetal hemoglobin QTL5], 142335 (2), Autosomal dominant
chr2	RTN4	604475.0 | RTN4, NOGO | Neurite outgrowth inhibitor (reticulon 4) | 57142.0 | ENSG00000115310 | nan | nan
chr2	RPS27A	191343.0 | RPS27A, UBA80, HUBCEP80, CEP80, UBCEP1 | Ribosomal protein S27a | 6233.0 | ENSG00000143947 | nan | nan
chr2	MTIF2	603766.0 | MTIF2 | Mitochondrial translational initiation factor 2 | 4528.0 | ENSG00000085760 | nan | nan
chr2	CCDC88A	609736.0 | CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHOL | Coiled-coil domain-containing protein 88A | 55704.0 | ENSG00000115355 | mutation identified in 1 PEHOL family | ?PEHO syndrome-like, 617507 (3), Autosomal recessive
chr2	PPP4R3B	610352.0 | PPP4R3B, PP4R3B, SMEK2, KIAA1387 | Protein phosphatase 4, regulatory subunit 3, beta | 57223.0 | ENSG00000275052 | nan | nan
chr2	PNPT1	610316.0 | PNPT1, OLD35, COXPD13, DFNB70, SCA25 | Polyribonucleotide nucleotidyltransferase 1 | 87178.0 | ENSG00000138035 | nan | Spinocerebellar ataxia 25, 608703 (3), Autosomal dominant; Deafness, autosomal recessive 70, with or without adult-onset neurodegeneration, 614934 (3), Autosomal recessive; Combined oxidative phosphorylation deficiency 13, 614932 (3), Autosomal recessive
chr2	EFEMP1	601548.0 | EFEMP1, FBNL, DHRD, GLC1H, ARCL1D | EGF-containing fibulin-like extracellular matrix protein 1 (fibrillin-like) | 2202.0 | ENSG00000115380 | nan | Doyne honeycomb degeneration of retina, 126600 (3), Autosomal dominant; Cutis laxa, autosomal recessive, type ID, 620780 (3), Autosomal recessive; Glaucoma 1, open angle, H, 611276 (3), Autosomal dominant
chr2	MIR217	615096.0 | MIR217 | Micro RNA 217 | 406999.0 | ENSG00000207548 | nan | nan
chr2	MIR216A	610944.0 | MIR216, MIRN216 | Micro RNA 216 | 406998.0 | ENSG00000207798 | nan | nan
chr2	VRK2	602169.0 | VRK2 | VRK serine/threonine kinase 2 | 7444.0 | ENSG00000028116 | nan | nan
chr2	FANCL	608111.0 | PHF9, FANCL | PHD finger protein 9 | 55120.0 | ENSG00000115392 | nan | Fanconi anemia, complementation group L, 614083 (3), Autosomal recessive
chr2	BCL11A	606557.0 | BCL11A, CTIP1, EVI9, KIAA1809, DILOS | B-cell CLL/lymphoma 11A | 53335.0 | ENSG00000119866 | nan | Dias-Logan syndrome, 617101 (3), Autosomal dominant
chr2	PAPOLG	616865.0 | PAPOLG | Poly(A) polymerase, gamma | 64895.0 | ENSG00000115421 | nan | nan
chr2	REL	164910.0 | REL, IMD92 | REL protooncogene, NF-kappa-B subunit | 5966.0 | ENSG00000162924 | nan | Immunodeficiency 92, 619652 (3), Autosomal recessive
chr2	PUS10	612787.0 | PUS10, DOBI | Pseudouridylate synthase 10 | 150962.0 | ENSG00000162927 | nan | nan
chr2	PEX13	601789.0 | PEX13, ZWS, NALD, PBD11A, PBD11B | Peroxisome biogenesis factor 13 (peroxin 13) | 5194.0 | ENSG00000162928 | nan | Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3), Autosomal recessive; Peroxisome biogenesis disorder 11B, 614885 (3), Autosomal recessive
chr2	SANBR	620213.0 | SANBR, KIAA1841 | SANT and BTB domain regulator of CSR | 84542.0 | ENSG00000162929 | nan | nan
chr2	USP34	615295.0 | USP34, KIAA0570 | Ubiquitin-specific protease 34 | 9736.0 | ENSG00000115464 | nan | nan
chr2	XPO1	602559.0 | XPO1, CRM1 | Exportin-1 (required for chromosome region maintenance) | 7514.0 | ENSG00000082898 | nan | nan
chr2	FAM161A	613596.0 | FAM161A, RP28 | Family with sequence similarity 161, member A | 84140.0 | ENSG00000170264 | nan | Retinitis pigmentosa 28, 606068 (3), Autosomal recessive
chr2	CCT4	605142.0 | CCT4, CCTD, SRB | Chaperonin containing T-complex polypeptide 1, subunit 4 | 10575.0 | ENSG00000115484 | nan | nan
chr2	COMMD1	607238.0 | COMMD1, MURR1 | Copper metabolism Murr1 domain-containing 1 | 150684.0 | ENSG00000173163 | nan | nan
chr2	B3GNT2	605581.0 | B3GNT2, B3GNT1, B3GNT | Beta-1,3-N-acetylglucosyaminyltransferase 2 | 10678.0 | ENSG00000170340 | nan | nan
chr2	TMEM17	614950.0 | TMEM17 | Transmembrane protein 17 | 200728.0 | ENSG00000186889 | nan | nan
chr2	EHBP1	609922.0 | EHBP1, KIAA0903, HPC12 | EH domain-binding protein 1 | 23301.0 | ENSG00000115504 | nan | {Prostate cancer, hereditary, 12}, 611868 (3)
chr2	OTX1	600036.0 | OTX1 | Orthodenticle homeobox 1 | 5013.0 | ENSG00000115507 | nan | nan
chr2	WDPCP	613580.0 | WDPCP, C2orf86, BBS15, CHDTHP | WD repeat-containing planar cell polarity effector | 51057.0 | ENSG00000143951 | nan | Bardet-Biedl syndrome 15, 615992 (3), Autosomal recessive; Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3), Autosomal recessive
chr2	MDH1	154200.0 | MDH1, DEE88, KAR | Malate dehydrogenase 1 | 4190.0 | ENSG00000014641 | proximal to APOB; mutation identified in 1 DEE88 family | ?Developmental and epileptic encephalopathy 88, 618959 (3), Autosomal recessive
chr2	UGP2	191760.0 | UGP2, UGPP2, DEE83 | Uridyl diphosphate glucose pyrophosphorylase-2 | 7360.0 | ENSG00000169764 | nan | Developmental and epileptic encephalopathy 83, 618744 (3), Autosomal recessive
chr2	VPS54	614633.0 | VPS54, VPS54L, WR | VPS54 subunit of GARP complex | 51542.0 | ENSG00000143952 | nan | nan
chr2	HRPT3	610071.0 | HRPT3 | Hyperparathyroidism 3 | 780919.0 | nan | between D2S2368 and D2S358 | Hyperparathyroidism 3, 610071 (2)
chr2	RLS7	612853.0 | RLS7 | Restless legs syndrome, susceptibility to, 7 | 100302561.0 | nan | associated with rs2300478 | {Restless legs syndrome 7}, 612853 (2)
chr2	PELI1	614797.0 | PELI1 | Pellino E3 ubiquitin protein ligase 1 | 57162.0 | ENSG00000197329 | nan | nan
chr2	LGALSL	617902.0 | LGALSL | Galectin-like protein | 29094.0 | ENSG00000119862 | nan | nan
chr2	AFTPH	619628.0 | AFTPH | Aftiphilin | 54812.0 | ENSG00000119844 | nan | nan
chr2	SERTAD2	617851.0 | SERTAD2, TRIPBR2, KIAA0127 | SERTA domain-containing protein 2 | 9792.0 | ENSG00000179833 | nan | nan
chr2	SLC1A4	600229.0 | SLC1A4, SATT, ASCT1, SPATCCM | Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | 6509.0 | ENSG00000115902 | nan | Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3), Autosomal recessive
chr2	CEP68	616889.0 | CEP68, KIAA0582 | Centrosomal protein, 68kD | 23177.0 | ENSG00000011523 | nan | nan
chr2	RAB1A	179508.0 | RAB1A, RAB1 | RAB1A member RAS oncogene family | 5861.0 | ENSG00000138069 | nan | nan
chr2	ACTR2	604221.0 | ACTR2, ARP2 | Actin-related protein 2 | 10097.0 | ENSG00000138071 | nan | nan
chr2	SPRED2	609292.0 | SPRED2, NS14 | Sprouty-related EVH1 domain-containing protein 2 | 200734.0 | ENSG00000198369 | nan | Noonan syndrome 14, 619745 (3), Autosomal recessive
chr2	MEIS1	601739.0 | MEIS1 | Meis homeobox 1 | 4211.0 | ENSG00000143995 | nan | nan
chr2	ETAA1	613196.0 | ETAA1, ETAA16 | Ewing tumor-associated antigen 1 | 54465.0 | ENSG00000143971 | nan | nan
chr2	C1D	606997.0 | C1D, SUNCOR | Nuclear DNA-binding protein C1D | 10438.0 | ENSG00000197223 | pseudogene on chr.10 | nan
chr2	DNAAF10	610729.0 | WDR92, LOC116143, MONAD | WD repeat-containing protein 92 | 116143.0 | ENSG00000243667 | nan | nan
chr2	PNO1	618710.0 | PNO1 | Partner of NOB1 | 56902.0 | ENSG00000115946 | nan | nan
chr2	PPP3R1	601302.0 | PPP3R1, CALNB1 | Protein phosphatase-3 (formerly 2B), regulatory subunit B (19kD), alpha isoform (calcineurin B, type I) | 5534.0 | ENSG00000221823 | nan | nan
chr2	CNRIP1	618538.0 | CNRIP1, CRIP1 | Cannabinoid receptor-interacting protein 1 | 25927.0 | ENSG00000119865 | nan | nan
chr2	PLEK	173570.0 | PLEK | Pleckstrin | 5341.0 | ENSG00000115956 | nan | nan
chr2	OFC2	602966.0 | OFC2 | Orofacial cleft 2 | 4964.0 | nan | ?relation to TGFA | Orofacial cleft 2, 602966 (2), Autosomal dominant
chr2	PARK3	602404.0 | PARK3 | Parkinson disease 3 | 5072.0 | nan | nan | {Parkinson disease 3}, 602404 (2)
chr2	PEE1	189800.0 | PEE1, PREG1 | Preeclampsia/eclampsia 1 | 5177.0 | nan | ?distinct loci at 2p25 and 9p13 | Preeclampsia/eclampsia 1, 189800 (2), Autosomal dominant
chr2	FBXO48	620549.0 | FBXO48 | F-box protein 48 | 554251.0 | ENSG00000204923 | nan | nan
chr2	APLF	611035.0 | AFPL, C2orf13 | Aprataxin- and PNK-like factor | 200558.0 | ENSG00000169621 | nan | nan
chr2	PROKR1	607122.0 | PROKR1, PKR1, GPR73 | Prokineticin receptor 1 | 10887.0 | ENSG00000169618 | nan | nan
chr2	ARHGAP25	610587.0 | ARHGAP25, KAIA0053 | RHO GTPase-activating protein 25 | 9938.0 | ENSG00000163219 | nan | nan
chr2	BMP10	608748.0 | BMP10 | Bone morphogenetic protein 10 | 27302.0 | ENSG00000163217 | nan | nan
chr2	GKN2	618589.0 | GKN2, GDDR | Gastrokine 2 | 200504.0 | ENSG00000183607 | nan | nan
chr2	GKN1	606402.0 | GKN1, CA11 | Gastrokine 1 | 56287.0 | ENSG00000169605 | nan | nan
chr2	ANTXR1	606410.0 | ANTXR1, TEM8, ATR, GAPO | Anthrax toxin receptor 1 | 84168.0 | ENSG00000169604 | mutation identified in 1 HCI patient | GAPO syndrome, 230740 (3), Autosomal recessive; {?Hemangioma, capillary infantile, susceptibility to}, 602089 (3), Autosomal dominant
chr2	GFPT1	138292.0 | GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1 | Glutamine-fructose-6-phosphate transaminase | 2673.0 | ENSG00000198380 | nan | Myasthenia, congenital, 12, with tubular aggregates, 610542 (3), Autosomal recessive
chr2	NFU1	608100.0 | NFU1, HIRIP, MMDS1, SPG93 | NFU1 iron-sulfur cluster scaffold | 27247.0 | ENSG00000169599 | nan | Spastic paraplegia 93, autosomal recessive, 620938 (3), Autosomal recessive; Multiple mitochondrial dysfunctions syndrome 1, 605711 (3), Autosomal recessive
chr2	AAK1	616405.0 | AAK1, KIAA1048 | Adaptor protein 2-associated kinase 1 | 22848.0 | ENSG00000115977 | nan | nan
chr2	ANXA4	106491.0 | ANXA4, ANX4 | Annexin A4 (placental anticoagulant protein II) | 307.0 | ENSG00000196975 | nan | nan
chr2	GMCL1	618627.0 | GMCL1, SPATA29, BTBD13 | Germ cell-less 1, spermatogenesis-associated | 64395.0 | ENSG00000087338 | nan | nan
chr2	SNRNP27	619629.0 | SNRNP27, RY1 | Small nuclear ribonucleoprotein U4/U6.U5, subunit 27 | 11017.0 | ENSG00000124380 | nan | nan
chr2	MXD1	600021.0 | MAD | MAD protein (MAX-binding protein) | 4084.0 | ENSG00000059728 | nan | nan
chr2	ASPRV1	611765.0 | ASPRV1, SASP, TAPS, MUNO, ADLI | Aspartic peptidase, retroviral-like 1 | 151516.0 | ENSG00000293615 | nan | Ichthyosis, lamellar, autosomal dominant, 146750 (3), Autosomal dominant
chr2	PCBP1	601209.0 | PCBP1 | Poly(rC)-binding protein-1 | 5093.0 | ENSG00000169564 | nan | nan
chr2	TIA1	603518.0 | TIA1, WDM, ALS26 | TIA1 cytotoxic granule-associated RNA-binding protein | 7072.0 | ENSG00000116001 | nan | Welander distal myopathy, 604454 (3), Autosomal recessive, Autosomal dominant; Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia, 619133 (3), Autosomal dominant
chr2	PCYOX1	610995.0 | PCYOX1, PCL1, KIAA0908 | Prenylcysteine oxidase 1 | 51449.0 | ENSG00000116005 | nan | nan
chr2	SNRPG	603542.0 | SNRPG | Small nuclear ribonucleoprotein polypeptide G | 6637.0 | ENSG00000143977 | nan | nan
chr2	FAM136A	616275.0 | FAM136A | Family with sequence similarity 136, member A | 84908.0 | ENSG00000035141 | nan | nan
chr2	TGFA	190170.0 | TGFA | Transforming growth factor, alpha | 7039.0 | ENSG00000163235 | nan | nan
chr2	ADD2	102681.0 | ADD2 | Adducin-2, beta | 119.0 | ENSG00000075340 | nan | nan
chr2	FIGLA	608697.0 | FIGLA, POF6 | Folliculogenesis specific bHLH transcription factor | 344018.0 | ENSG00000183733 | nan | Premature ovarian failure 6, 612310 (3), Autosomal recessive, Autosomal dominant
chr2	CLEC4F	620105.0 | CLEC4F, KCR, KCLR | C-type lectin domain family 4, member F | 165530.0 | ENSG00000152672 | nan | nan
chr2	CD207	604862.0 | CD207, LANGERIN, CLEC4K | CD207 antigen | 50489.0 | ENSG00000116031 | mutation identified in 1 patient | [?Birbeck granule deficiency], 613393 (3)
chr2	VAX2	604295.0 | VAX2 | Ventral anterior homeobox 2 | 25806.0 | ENSG00000116035 | nan | nan
chr2	ATP6V1B1	192132.0 | ATP6V1B1, ATP6B1, VPP3, DRTA2 | ATPase, H+ transporting, V1 subunit B1 | 525.0 | ENSG00000116039 | nan | Distal renal tubular acidosis 2 with progressive sensorineural hearing loss, 267300 (3), Autosomal recessive
chr2	ANKRD53	617009.0 | ANKRD53 | Ankyrin repeat domain-containing protein 53 | 79998.0 | ENSG00000144031 | nan | nan
chr2	TEX261	618562.0 | TEX261 | Testis-expressed gene 261 | 113419.0 | ENSG00000144043 | nan | nan
chr2	NAGK	606828.0 | NAGK, GNK | N-acetylglucosamine kinase | 55577.0 | ENSG00000124357 | nan | nan
chr2	MCEE	608419.0 | MCEE | Methylmalonyl-CoA epimerase | 84693.0 | ENSG00000124370 | nan | Methylmalonyl-CoA epimerase deficiency, 251120 (3), Autosomal recessive
chr2	MPHOSPH10	605503.0 | MPHOSPH10, MPP10 | M-phase phosphoprotein 10 | 10199.0 | ENSG00000124383 | nan | nan
chr2	PAIP2B	611018.0 | PAIP2B | Polyadenylate-binding protein-interacting protein 2B | 400961.0 | ENSG00000124374 | nan | nan
chr2	ZNF638	614349.0 | ZNF638, NP220 | Zinc finger protein 638 | 27332.0 | ENSG00000075292 | nan | nan
chr2	DYSF	603009.0 | DYSF, LGMDR2, MMD1 | Dysferlin | 8291.0 | ENSG00000135636 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 2, 253601 (3), Autosomal recessive; Miyoshi muscular dystrophy 1, 254130 (3), Autosomal recessive; Myopathy, distal, with anterior tibial onset, 606768 (3), Autosomal recessive
chr2	CYP26B1	605207.0 | CYP26B1, CYP26A2, P450RAI2, RHFCA | Cytochrome P450, subfamily XXVIB, polypeptide 1 | 56603.0 | ENSG00000003137 | nan | Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)
chr2	EXOC6B	607880.0 | EXOC6B, SEC15B, KIAA0919, SEMDJL3 | Exocyst complex component 6B | 23233.0 | ENSG00000144036 | nan | Spondyloepimetaphyseal dysplasia with joint laxity, type 3, 618395 (3), Autosomal recessive
chr2	SPR	182125.0 | SPR | Sepiapterin reductase | 6697.0 | ENSG00000116096 | nan | Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3), Autosomal recessive, ?Autosomal dominant
chr2	EMX1	600034.0 | EMX1 | Empty spiracles homeobox 1 | 2016.0 | ENSG00000135638 | close to VAX2 | nan
chr2	SFXN5	615572.0 | SFXN5 | Sideroflexin 5 | 94097.0 | ENSG00000144040 | nan | nan
chr2	RAB11FIP5	605536.0 | RAB11RIP5, RIP11, KIAA0857 | Rab11 family-interacting protein 5 | 26056.0 | ENSG00000135631 | nan | nan
chr2	NOTO	620695.0 | NOTO | Notochord homeobox | 344022.0 | ENSG00000214513 | nan | nan
chr2	SMYD5	619114.0 | SMYD5 | SET and MYND domain-containing protein 5 | 10322.0 | ENSG00000135632 | nan | nan
chr2	PRADC1	619674.0 | PRADC1, PAP21, C2orf7 | Protease-associated domain-containing protein 1 | 84279.0 | ENSG00000135617 | nan | nan
chr2	CCT7	605140.0 | CCT7 | Chaperonin containing T-complex polypeptide 1, subunit 7 | 10574.0 | ENSG00000135624 | nan | nan
chr2	FBXO41	609108.0 | FBXO41, FBX41, KIAA1940 | F-box only protein 41 | 150726.0 | ENSG00000163013 | nan | nan
chr2	EGR4	128992.0 | EGR4, NGFIC | Early growth response-4 | 1961.0 | ENSG00000135625 | nan | nan
chr2	ALMS1	606844.0 | ALMS1, ALSS, KIAA0328 | ALMS1 centrosome and basal body associated protein | 7840.0 | ENSG00000116127 | nan | Alstrom syndrome, 203800 (3), Autosomal recessive
chr2	NAT8	606716.0 | NAT8, TSC510 | N-acetyltransferase 8 | 9027.0 | ENSG00000144035 | nan | nan
chr2	NAT8B	608190.0 | NAT8B, CML2 | N-acetyltransferase 8B | 51471.0 | nan | nan | nan
chr2	TPRKB	608680.0 | TPRKB, GAMOS5 | TP53RK-binding protein | 51002.0 | ENSG00000144034 | nan | Galloway-Mowat syndrome 5, 617731 (3), Autosomal recessive
chr2	DUSP11	603092.0 | DUSP11, PIR1 | Dual specificity phosphatase-11, RNA/RNP complex-interacting | 8446.0 | ENSG00000144048 | nan | nan
chr2	STAMBP	606247.0 | STAMBP, AMSH, MICCAP | STAM binding protein | 10617.0 | ENSG00000124356 | nan | Microcephaly-capillary malformation syndrome, 614261 (3), Autosomal recessive
chr2	ACTG2	102545.0 | ACTG2, ACTA3, VSCM1, MMIHS5 | Actin, gamma-2, smooth muscle, enteric | 72.0 | ENSG00000163017 | nan | Megacystis-microcolon-intestinal hypoperistalsis syndrome 5, 619431 (3), Autosomal dominant; Visceral myopathy 1, 155310 (3), Autosomal dominant
chr2	DGUOK	601465.0 | DGUOK, DGK, MTDPS3, PEOB4, NCPH1 | Deoxyguanosine kinase, mitochondrial | 1716.0 | ENSG00000114956 | nan | Portal hypertension, noncirrhotic, 1, 617068 (3), Autosomal recessive; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, 617070 (3), Autosomal recessive; Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3), Autosomal recessive
chr2	TET3	613555.0 | TET3, KIAA0401, BEFAHRS | tet methylcytosine dioxygenase 3 | 200424.0 | ENSG00000187605 | nan | Beck-Fahrner syndrome, 618798 (3), Autosomal recessive, Autosomal dominant
chr2	BOLA3	613183.0 | BOLA3, MMDS2 | bolA family member 3 | 388962.0 | ENSG00000163170 | nan | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3), Autosomal recessive
chr2	MOB1A	609281.0 | MOB1A, MABKL1B, MATS1, C2orf6 | MOB kinase activator 1A | 55233.0 | ENSG00000114978 | nan | nan
chr2	MTHFD2	604887.0 | MTHFD2 | Methylenetetrahydrofolate dehydrogenase 2 | 10797.0 | ENSG00000065911 | nan | nan
chr2	SLC4A5	606757.0 | SLC4A5, NBC4 | Solute carrier family 4, sodium bicarbonate cotransporter, member 5 | 57835.0 | ENSG00000188687 | nan | nan
chr2	DCTN1	601143.0 | DCTN1, HMND14 | Dynactin 1 | 1639.0 | ENSG00000204843 | nan | Perry syndrome, 168605 (3), Autosomal dominant; {Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3), Autosomal recessive, Autosomal dominant; Neuronopathy, distal hereditary motor, autosomal dominant 14, 607641 (3), Autosomal dominant
chr2	WDR54	620826.0 | WDR54 | WD repeat-containing protein 54 | 84058.0 | ENSG00000005448 | nan | nan
chr2	RTKN	602288.0 | RTKN | Rhotekin | 6242.0 | ENSG00000114993 | nan | nan
chr2	INO80B	616456.0 | INO80B, PAPA1, HMGA1L4 | INO80 complex, subunit B | 83444.0 | ENSG00000115274 | nan | nan
chr2	WBP1	606961.0 | WBP1 | WW domain-binding protein 1 | 23559.0 | ENSG00000239779 | nan | nan
chr2	MOGS	601336.0 | MOGS, GCS1, CDG2B | Mannosyl-oligosaccharide glucosidase | 7841.0 | ENSG00000115275 | nan | Congenital disorder of glycosylation, type IIb, 606056 (3), Autosomal recessive
chr2	MRPL53	611857.0 | MRPL53 | Mitochondrial ribosomal protein L53 | 116540.0 | ENSG00000204822 | pseudogene on 1 | nan
chr2	LBX2	607164.0 | LBX2 | Lady bird-like homeobox 2 | 85474.0 | ENSG00000179528 | nan | nan
chr2	PCGF1	610231.0 | PCGF1, NSPC1 | Polycomb group RING finger protein 1 | 84759.0 | ENSG00000115289 | nan | nan
chr2	TLX2	604240.0 | TLX2, HOX11L1 | T-cell leukemia, homeobox 2 | 3196.0 | ENSG00000115297 | nan | nan
chr2	DQX1	620580.0 | DQX1 | DEAQ-box RNA-dependent ATPase 1 | 165545.0 | ENSG00000144045 | nan | nan
chr2	AUP1	602434.0 | AUP1 | Ancient ubiquitous protein 1 | 550.0 | ENSG00000115307 | nan | nan
chr2	HTRA2	606441.0 | HTRA2, OMI, PARK13, PRSS25, MGCA8 | HTRA serine peptidase 2 | 27429.0 | ENSG00000115317 | nan | {Parkinson disease 13}, 610297 (3); 3-methylglutaconic aciduria, type VIII, 617248 (3), Autosomal recessive
chr2	LOXL3	607163.0 | LOXL3, MYP28 | Lysyl oxidase-like 3 | 84695.0 | ENSG00000115318 | nan | Myopia 28, autosomal recessive, 619781 (3), Autosomal recessive
chr2	DOK1	602919.0 | DOK1 | Downstream of tyrosine kinase 1 | 1796.0 | ENSG00000115325 | nan | nan
chr2	M1AP	619098.0 | M1AP, SPATA37, C2orf65, SPGF48 | Meiosis 1-associated protein | 130951.0 | ENSG00000159374 | nan | Spermatogenic failure 48, 619108 (3), Autosomal recessive
chr2	SEMA4F	603706.0 | SEMAW | Semaphorin W | 10505.0 | ENSG00000135622 | nan | nan
chr2	CTRCT27	607304.0 | CTRCT27, CCNP | Cataract 27, nuclear progressive | 266979.0 | nan | near D2S2333 | Cataract 27, nuclear progressive, 607304 (2)
chr2		613564.0 | DEL2p12p11.2, C2DELp12p11.2 | Chromosome 2p12-p11.2 deletion syndrome | nan | nan | contiguous gene deletion syndrome | Chromosome 2p12-p11.2 deletion syndrome, 613564 (4), Isolated cases
chr2	DFNA43	608394.0 | DFNA43 | Deafness, autosomal dominant 43 | 192676.0 | nan | max lod at D2S139 | Deafness, autosomal dominant 43, 608394 (2), Autosomal dominant
chr2	HSR	139900.0 | HSR | Hand skill, relative | 338386.0 | nan | nan | [Handedness], 139900 (2), Autosomal dominant
chr2		146970.0 | IGKJ@ | Immunoglobulin kappa light chain joining gene cluster | 7842.0 | nan | 5 genes | nan
chr2		146980.0 | IGKV@ | Immunoglobulin kappa light chain variable gene cluster | 3519.0 | nan | 25+ genes in 4 classes; orphon gene 1.5Mb telomeric of IGKC | nan
chr2	HK2	601125.0 | HK2 | Hexokinase-2, muscle | 3099.0 | ENSG00000159399 | no recombination with TGFA | nan
chr2	POLE4	607269.0 | POLE4 | Polymerase, DNA, epsilon-4 | 56655.0 | ENSG00000115350 | nan | nan
chr2	TACR1	162323.0 | TACR1, TAC1R, NK1R | Tachykinin receptor 1 (substance P receptor; neurokinin-1 receptor) | 6869.0 | ENSG00000115353 | nan | nan
chr2	EVA1A	618990.0 | EVA1A, TMEM166, FAM176A | EVA1 homolog A, regulator of programmed cell death | 84141.0 | ENSG00000115363 | nan | nan
chr2	MRPL19	611832.0 | MRPL19, MRPL15, KIAA0104 | Mitochondrial ribosomal protein L19 | 9801.0 | ENSG00000115364 | nan | nan
chr2	GCFC2	189901.0 | C2orf3, TCF9, GCF | GC factor | 6936.0 | ENSG00000005436 | nan | nan
chr2	LRRTM4	610870.0 | LRRTM4 | Leucine-rich repeat transmembrane protein 4 | 80059.0 | ENSG00000176204 | nan | nan
chr2	REG3G	609933.0 | REG3G, PAP1B | Regenerating islet-derived 3-gamma | 130120.0 | ENSG00000143954 | nan | nan
chr2	REG1B	167771.0 | REG1B, REGL, PSPS2 | Regenerating family member 1 beta | 5968.0 | ENSG00000172023 | nan | nan
chr2	REG1A	167770.0 | REG1A, PSPS1, REG | Regenerating islet-derived 1 alpha (pancreatic stone protein, pancreatic thread protein) | 5967.0 | ENSG00000115386 | nan | nan
chr2	REG3A	167805.0 | PAP | Pancreatitis-associated protein | 5068.0 | ENSG00000172016 | nan | nan
chr2	CTNNA2	114025.0 | CTNNA2, CAPR, CTNR, CDCBM9 | Catenin, alpha-2 (cadherin-associated protein, related) | 1496.0 | ENSG00000066032 | nan | Cortical dysplasia, complex, with other brain malformations 9, 618174 (3), Autosomal recessive
chr2	LRRTM1	610867.0 | LRRTM1 | Leucine-rich repeat transmembrane protein 1 | 347730.0 | ENSG00000162951 | nan | nan
chr2	SUCLG1	611224.0 | SUCLG1, SUCLA1, MTDPS9 | Succinate-CoA ligase, GDP/ADP-forming, subunit alpha | 8802.0 | ENSG00000163541 | nan | Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3), Autosomal recessive
chr2	DNAH6	603336.0 | DNAH6, HL2 | Dynein, axonemal, heavy chain 6 | 1768.0 | ENSG00000115423 | nan | nan
chr2	TRABD2A	614912.0 | TRABD2A, TIKI1 | TRAB domain-containing protein 2A | 129293.0 | ENSG00000186854 | nan | nan
chr2	TMSB10	188399.0 | TMSB10 | Thymosin, beta-10 | 9168.0 | ENSG00000034510 | nan | nan
chr2	KCMF1	614719.0 | KCMF1, DEBT91, FIGC | Potassium channel modulatory factor 1 | 56888.0 | ENSG00000176407 | nan | nan
chr2	TCF7L1	604652.0 | TCF7L1 | Transcription factor 7-like 1 | 83439.0 | ENSG00000152284 | nan | nan
chr2	TGOLN2	603062.0 | TGOLN2, TGN46, TGN38 | Trans-golgi network protein 2, 46kD | 10618.0 | ENSG00000152291 | nan | nan
chr2	RETSAT	617597.0 | RETSAT | Retinol saturase | 54884.0 | ENSG00000042445 | nan | nan
chr2	ELMOD3	615427.0 | ELMOD3, RBED1, DFNB88, DFNA81 | ELMO/CED12 domain-containing protein 3 | 84173.0 | ENSG00000115459 | mutation identified in 1 DFNB88 and 1 DFNA81 family | ?Deafness, autosomal recessive 88, 615429 (3), Autosomal recessive; ?Deafness, autosomal dominant 81, 619500 (3), Autosomal dominant
chr2	CAPG	153615.0 | CAPG | Capping protein, gelsolin-like | 822.0 | ENSG00000042493 | nan | nan
chr2	PARTICL	616350.0 | PARTICL | Promoter of MAT2A antisense radiation-induced circulating long noncoding RNA | 100630918.0 | ENSG00000286532 | overlaps promoter of MAT2A on opposite strand | nan
chr2	MAT2A	601468.0 | MAT2A, MATA2, SAMS2 | Methionine adenosyltransferase II, alpha | 4144.0 | ENSG00000168906 | nan | nan
chr2	GGCX	137167.0 | GGCX, VKCFD1 | Gamma-glutamyl carboxylase | 2677.0 | ENSG00000115486 | nan | Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3), Autosomal recessive; Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)
chr2	VAMP8	603177.0 | VAMP8 | Vesicle-associated membrane protein 8 | 8673.0 | ENSG00000118640 | nan | nan
chr2	VAMP5	607029.0 | VAMP5 | Vesicle-associated membrane protein 5 (myobrevin) | 10791.0 | ENSG00000168899 | nan | nan
chr2	RNF181	612490.0 | RNF181 | Ring finger protein 181 | 51255.0 | ENSG00000168894 | nan | nan
chr2	TMEM150A	616757.0 | TMEM150A, TMEM150 | Transmembrane protein 150A | 129303.0 | ENSG00000168890 | nan | nan
chr2	USP39	611594.0 | USP39, SAD1 | Ubiquitin-specific protease 39 | 10713.0 | ENSG00000168883 | nan | nan
chr2	C2orf68	618519.0 | C2orf68, HCRCN81 | Chromosome 2 open reading frame 68 | 388969.0 | ENSG00000168887 | nan | nan
chr2	SFTPB	178640.0 | SFTPB, SFTB3, SMDP1 | Pulmonary surfactant-associated protein B, 18kD | 6439.0 | ENSG00000168878 | nan | Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3), Autosomal recessive
chr2	GNLY	188855.0 | GNLY, D2S69E, TLA519 | Granulysin (T-lymphocyte activation gene 519) | 10578.0 | ENSG00000115523 | nan | nan
chr2	ATOH8	619820.0 | ATOH8 | Atonal bHLH transcription factor 8 | 84913.0 | ENSG00000168874 | nan | nan
chr2	ST3GAL5	604402.0 | SIAT9, ST3GALV, SPDRS | Sialyltransferase 9 | 8869.0 | ENSG00000115525 | nan | Salt and pepper developmental regression syndrome, 609056 (3), Autosomal recessive
chr2	POLR1A	616404.0 | POLR1A, RPA194, AFDCIN, HLD27 | Polymerase I, RNA, subunit A | 25885.0 | ENSG00000068654 | nan | Leukodystrophy, hypomyelinating, 27, 620675 (3), Autosomal recessive; Acrofacial dysostosis, Cincinnati type, 616462 (3), Autosomal dominant
chr2	PTCD3	614918.0 | PTCD3, COXPD51 | Pentatricopeptide repeat domain-containing protein 3 | 55037.0 | ENSG00000132300 | nan | Combined oxidative phosphorylation deficiency 51, 619057 (3), Autosomal recessive
chr2	SNORD94	620810.0 | SNORD94 | Small nucleolar RNA, C/D box, 94 | 692225.0 | ENSG00000208772 | nan | nan
chr2	IMMT	600378.0 | IMMT, HMP | Inner membrane protein, mitochondrial (mitofilin) | 10989.0 | ENSG00000132305 | pseudogene on chr.21 | nan
chr2	MRPL35	611841.0 | MRPL35 | Mitochondrial ribosomal protein L35 | 51318.0 | ENSG00000132313 | pseudogenes on 6, 10, and X | nan
chr2	REEP1	609139.0 | REEP1, C2orf23, SPG31, HMND12, HMNR6 | Receptor expression-enhancing protein 1 | 65055.0 | ENSG00000068615 | mutation identified in 1 HMND12 family | Neuronopathy, distal hereditary motor, autosomal recessive 6, 620011 (3), Autosomal recessive; Spastic paraplegia 31, autosomal dominant, 610250 (3), Autosomal dominant; ?Neuronopathy, distal hereditary motor, autosomal dominant 12, 614751 (3), Autosomal dominant
chr2	KDM3A	611512.0 | KDM3A, JMJD1A, JHDM2A, TSGA, KIAA0742 | Lysine demethylase 3A | 55818.0 | ENSG00000115548 | nan | nan
chr2	CHMP3	610052.0 | CHMP3, VPS24, NEDF | Charged multivesicular body protein 3 | 51652.0 | ENSG00000115561 | nan | nan
chr2	RNF103	602507.0 | RNF103, ZFP103, KF1 | RING finger protein 103 | 7844.0 | ENSG00000239305 | nan | nan
chr2	RMND5A	618964.0 | RMND5A, RMD5, GID2 | Required for meiotic nuclear division 5 homolog A | 64795.0 | ENSG00000153561 | nan | nan
chr2	CD8A	186910.0 | CD8A, IMD116 | CD8 antigen, alpha polypeptide  (p32) | 925.0 | ENSG00000153563 | distal to IGK | Immunodeficiency 116, 608957 (3), Autosomal recessive
chr2	CD8B	186730.0 | CD8B1, CD8B | CD8 antigen, beta polypeptide 1 (p37) | 926.0 | ENSG00000172116 | pseudogene, CD8B2, on 2q12 | nan
chr2	RGPD1	612704.0 | RGPD1, RGP1 | RANBP2-like and GRIP domain-containing protein 1 | 400966.0 | ENSG00000187627 | nan | nan
chr2	PLGLB1	173340.0 | PLGLB1, PLGL, PRGB | Plasminogen-like B1 | 5343.0 | ENSG00000183281 | nan | nan
chr2	RGPD2	612705.0 | RGPD2, RGP2 | RANBP2-like and GRIP domain-containing protein 2 | 729857.0 | ENSG00000185304 | nan | nan
chr2	SMYD1	606846.0 | SMYD1, BOP, ZMYND18 | SET and MYND domain-containing protein 1 | 150572.0 | ENSG00000115593 | nan | nan
chr2	FABP1	134650.0 | FABP1 | Fatty acid-binding protein, liver | 2168.0 | ENSG00000163586 | nan | nan
chr2	THNSL2	611261.0 | THNSL2, THS2 | Threonine synthase-like 2 | 55258.0 | ENSG00000144115 | nan | nan
chr2	FOXI3	612351.0 | FOXI3, CFM2 | Forkhead box I3 | 344167.0 | ENSG00000214336 | nan | Craniofacial microsomia 2, 620444 (3), Autosomal recessive, Autosomal dominant
chr2	SPMIP9	619676.0 | SPMIP9, TEX37, TSC21 | Sperm microtubule inner protein 9 | 200523.0 | ENSG00000172073 | nan | nan
chr2	EIF2AK3	604032.0 | EIF2AK3, PEK, PERK, WRS | Eukaryotic translation initiation factor 2-alpha kinase 3 | 9451.0 | ENSG00000172071 | nan | Wolcott-Rallison syndrome, 226980 (3), Autosomal recessive
chr2	RPIA	180430.0 | RPIA, RPI, RPIAD | Ribose 5-phosphate isomerase A | 22934.0 | ENSG00000153574 | nan | Ribose 5-phosphate isomerase deficiency, 608611 (3), Autosomal recessive
chr2	IGKDEL	146780.0 | IGKDEL | Immunoglobulin kappa polypeptide deleting element | 3515.0 | nan | nan | nan
chr2	IGKC	147200.0 | IGKC, IGKCD | Immunoglobulin kappa constant region | 3514.0 | ENSG00000211592 | nan | Kappa light chain deficiency, 614102 (3), Autosomal recessive
chr2	CELIAC8	612006.0 | CELIAC8 | Celiac disease, susceptibility to, 8 | 100188870.0 | nan | associated with rs917997 and rs13015714 | {Celiac disease, susceptibility to, 8}, 612006 (2)
chr2	COPD	606963.0 | COPD | Pulmonary disease, chronic obstructive, severe early-onset | 260431.0 | nan | ?SERPINE2 | Pulmonary disease, chronic obstructive, severe early-onset, 606963 (2)
chr2	GLC1B	606689.0 | GLC1B | Glaucoma 1, open angle, B (adult-onset) | 2722.0 | nan | nan | Glaucoma 1B, primary open angle, adult onset, 606689 (2)
chr2	NNO3	611897.0 | NNO3 | Nanophthalmos 3 | 100187717.0 | nan | max lod at D2S2265 | Nanophthalmos 3, 611897 (2)
chr2	MAL	188860.0 | MAL, HLD28 | T-lymphocyte maturation-associated protein | 4118.0 | ENSG00000172005 | mutation identified in 1 HLD28 family | ?Leukodystrophy, hypomyelinating, 28, 620978 (3), Autosomal recessive
chr2	MRPS5	611972.0 | MRPS5 | Mitochondrial ribosomal protein S5 | 64969.0 | ENSG00000144029 | nan | nan
chr2	ZNF2	194500.0 | ZNF2 | Zinc finger protein-2 | 7549.0 | ENSG00000275111 | nan | nan
chr2	PROM2	617160.0 | PROM2, PROML2 | Prominin 2 | 150696.0 | ENSG00000155066 | nan | nan
chr2	KCNIP3	604662.0 | KCNIP3, KCHIP3, CSEN, DREAM | Potassium channel-interacting protein 3 | 30818.0 | ENSG00000115041 | nan | nan
chr2	GPAT2	616431.0 | GPAT2 | Glycerol-3-phosphate acyltransferase 2, mitochondrial | 150763.0 | ENSG00000186281 | nan | nan
chr2	ADRA2B	104260.0 | ADRA2B, ADRA2L1 | Adrenergic, alpha-2B-, receptor | 151.0 | ENSG00000274286 | nan | nan
chr2	ASTL	608860.0 | ASTL, OZEMA11 | Astacin-like metalloendopeptidase | 431705.0 | ENSG00000188886 | mutation identified in 1 OZEMA11 family | ?Oocyte/zygote/embryo maturation arrest 11, 619643 (3), Autosomal recessive
chr2	DUSP2	603068.0 | DUSP2, PAC1 | Dual-specificity phosphatase-2 | 1844.0 | ENSG00000158050 | nan | nan
chr2	STARD7	616712.0 | STARD7, GTT1, FAME2 | START domain-containing protein 4 | 56910.0 | ENSG00000084090 | nan | Epilepsy, familial adult myoclonic, 2, 607876 (3), Autosomal dominant
chr2	TMEM127	613403.0 | TMEM127 | Transmembrane protein 127 | 55654.0 | ENSG00000135956 | nan | {Pheochromocytoma, susceptibility to}, 171300 (3), Autosomal dominant
chr2	CIAO1	604333.0 | CIAO1, WDR39, MMDS10 | WD repeat-containing protein CIAO1 | 9391.0 | ENSG00000144021 | nan | Multiple mitochondrial dysfunctions syndrome 10, 620960 (3), Autosomal recessive
chr2	SNRNP200	601664.0 | SNRNP200, ASCC3L1, KIAA0788, RP33 | Small nuclear ribonucleoprotein 200kD (U5) | 23020.0 | ENSG00000144028 | nan | Retinitis pigmentosa 33, 610359 (3), Autosomal dominant
chr2	ITPRIPL1	620821.0 | ITPRIPL1 | ITPRIPL1-like protein 1 | 150771.0 | ENSG00000198885 | nan | nan
chr2	NCAPH	602332.0 | NCAPH, CAPH, BRRN1, MCPH23 | Non-SMC condensin I complex subunit H | 23397.0 | ENSG00000121152 | mutation identified in 1 MCPH23 patient | ?Microcephaly 23, primary, autosomal recessive, 617985 (3), Autosomal recessive
chr2	NEURL3	617206.0 | NEURL3, LINCR | Neuralized E3 ubiquitin protein ligase 3 | 93082.0 | ENSG00000163121 | nan | nan
chr2	ARID5A	611583.0 | ARID5A, MRF1 | AT-rich interactive domain-containing protein 5A | 10865.0 | ENSG00000196843 | nan | nan
chr2	KANSL3	617742.0 | KANSL3, NSL3, KIAA1310 | Kat8 regulatory NSL complex, subunit 3 | 55683.0 | ENSG00000114982 | nan | nan
chr2	FER1L5	620883.0 | FER1L5 | FER1-like family, member 5 | 90342.0 | ENSG00000249715 | nan | nan
chr2	LMAN2L	609552.0 | LMAN2L, VIPL, MRT52, MRD69 | Lectin, mannose binding 2-like | 81562.0 | ENSG00000114988 | mutation identified in 1 MRT52 family and in 1 MRD69 family | ?Intellectual developmental disorder, autosomal dominant 69, 617863 (3), Autosomal dominant; ?Intellectual developmental disorder, autosomal recessive 52, 616887 (3), Autosomal recessive
chr2	CNNM4	607805.0 | CNNM4, ACDP4 | Cyclin M4 | 26504.0 | ENSG00000158158 | nan | Jalili syndrome, 217080 (3), Autosomal recessive
chr2	CNNM3	607804.0 | CNNM3, ACDP3 | Cyclin M3 | 26505.0 | ENSG00000168763 | previously assigned to 2p12-p11.2 | nan
chr2	ANKRD23	610736.0 | ANKRD23, DARP | Ankyrin repeat domain-containing protein 23 | 200539.0 | ENSG00000163126 | nan | nan
chr2	SEMA4C	604462.0 | SEMA4C, SEMAF, KIAA1739 | Semaphorin 4C | 54910.0 | ENSG00000168758 | nan | nan
chr2	ANKRD36	620262.0 | ANKRD36, KIAA1641 | Ankyrin repeat domain-containing protein 36 | 375248.0 | ENSG00000135976 | nan | nan
chr2	COX5B	123866.0 | COX5B | Cytochrome c oxidase, subunit Vb | 1329.0 | ENSG00000135940 | 7 pseudogenes on 4, 6, 7, 11, 12, 13, and 22 | nan
chr2	ACTR1B	605144.0 | ACTR1B, ARP1B, CTRN2 | Actin-related protein 1B | 10120.0 | ENSG00000115073 | nan | nan
chr2	ZAP70	176947.0 | ZAP70, SRK, ADMIO2, IMD48 | Zeta-chain associated protein kinase, 70kD (syk-related tyrosine kinase) | 7535.0 | ENSG00000115085 | nan | Immunodeficiency 48, 269840 (3), Autosomal recessive; Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3), Autosomal recessive
chr2	TMEM131	615659.0 | TMEM131, KIAA0257, CC28 | Transmembrane protein 131 | 23505.0 | ENSG00000075568 | nan | nan
chr2	VWA3B	614884.0 | VWA3B, SCAR22 | von Willebrand factor A domain-containing protein 3B | 200403.0 | ENSG00000168658 | mutation identified in 1 SCAR22 family | ?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3), Autosomal recessive
chr2	CNGA3	600053.0 | CNGA3, CNG3, ACHM2 | Cyclic nucleotide-gated channel, alpha-3 | 1261.0 | ENSG00000144191 | nan | Achromatopsia 2, 216900 (3), Autosomal recessive
chr2	INPP4A	600916.0 | INPP4A, INPP4 | Inositol polyphosphate-4-phosphatase, type I, 107kD | 3631.0 | ENSG00000040933 | nan | nan
chr2	COA5	613920.0 | COA5, C2orf64, PET191, MC4DN9 | Cytochrome c oxidase assembly factor 5 | 493753.0 | ENSG00000183513 | mutation identified in 1 MC4DN9 family | ?Mitochondrial complex IV, deficiency, nuclear type 9, 616500 (3), Autosomal recessive
chr2	UNC50	617826.0 | UNC50, UNCL, GMH1 | Unc50 inner nuclear membrane RNA-binding protein | 25972.0 | ENSG00000115446 | nan | nan
chr2	MGAT4A	604623.0 | MGAT4A | Alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A | 11320.0 | ENSG00000071073 | nan | nan
chr2	TSGA10	607166.0 | TSGA10, SPGF26 | Testis-specific protein 10 | 80705.0 | ENSG00000135951 | mutation identified in 1 SPGF26 | ?Spermatogenic failure 26, 617961 (3), Autosomal recessive
chr2	LIPT1	610284.0 | LIPT1, LIPT1D | Lipoyltransferase 1 | 51601.0 | ENSG00000144182 | nan | Lipoyltransferase 1 deficiency, 616299 (3), Autosomal recessive
chr2	MRPL30	611838.0 | MRPL30, MRPL28 | Mitochondrial ribosomal protein L30 | 51263.0 | ENSG00000185414 | nan | nan
chr2	LYG2	616547.0 | LYG2, LYSG2 | Lysozyme G-like 2 | 254773.0 | ENSG00000185674 | nan | nan
chr2	TXNDC9	612564.0 | TXNDC9, PHLP3 | Thioredoxin domain-containing protein 9 | 10190.0 | ENSG00000115514 | nan | nan
chr2	EIF5B	606086.0 | EIF5B, IF2, KIAA0741 | Eukaryotic translation initiation factor 5B | 9669.0 | ENSG00000158417 | nan | nan
chr2	REV1	606134.0 | REV1L, REV1 | REV1 DNA directed polymerase | 51455.0 | ENSG00000135945 | nan | nan
chr2	AFF3	601464.0 | AFF3, LAF4, KINS | AF4/FMR2 family, member 3 | 3899.0 | ENSG00000144218 | nan | KINSSHIP syndrome, 619297 (3), Autosomal dominant
chr2	CHST10	606376.0 | CHST10, HNK1ST | Carbohydrate sulfotransferase 10 | 9486.0 | ENSG00000115526 | nan | nan
chr2	NMS	619337.0 | NMS | Neuromedin S | 129521.0 | ENSG00000204640 | nan | nan
chr2	PDCL3	611678.0 | PDCL3, PHLP3, VIAF | Phosducin-like 3 | 79031.0 | ENSG00000115539 | nan | nan
chr2	NPAS2	603347.0 | NPAS2, MOP4 | Neuronal PAS domain protein 2 | 4862.0 | ENSG00000170485 | nan | nan
chr2	RPL31	617415.0 | RPL31 | Ribosomal protein L31 | 6160.0 | ENSG00000071082 | nan | nan
chr2	CNOT11	620509.0 | CNOT11, C2orf29 | CCR4-NOT transcription complex, subunit 11 | 55571.0 | ENSG00000158435 | nan | nan
chr2	CREG2	618540.0 | CREG2 | Cellular repressor of E1A-stimulated genes 2 | 200407.0 | ENSG00000175874 | nan | nan
chr2	MAP4K4	604666.0 | MAP4K4, HGK, NIK, KIAA0687 | Mitogen-activated protein kinase kinase kinase kinase 4 | 9448.0 | ENSG00000071054 | nan | nan
chr2	IL1R2	147811.0 | IL1R2, IL1RB | Interleukin-1 receptor, type II | 7850.0 | ENSG00000115590 | nan | nan
chr2	IL1R1	147810.0 | IL1R1, IL1RA, CRMO3 | Interleukin-1 receptor, type I | 3554.0 | ENSG00000115594 | mutation identified in 1 CRMO3 patient | ?Chronic recurrent multifocal osteomyelitis 3, 259680 (3), Autosomal dominant
chr2	IGKV1OR2-108	147185.0 | IGKV1OR2-108, IGO1 | Immunoglobulin orphon (transposed element) 1 | 28862.0 | nan | nan | nan
chr2		617071.0 | LNC13 | Long noncoding RNA 13 | nan | nan | nan | nan
chr2	IL1RL2	604512.0 | IL1RL2, IL1RRP2 | Interleukin 1 receptor-like 2 | 8808.0 | ENSG00000115598 | nan | nan
chr2	IL1RL1	601203.0 | IL1RL1 | Interleukin 1 receptor-like 1 | 9173.0 | ENSG00000115602 | nan | nan
chr2	IL18R1	604494.0 | IL18R1, IL1RRP | Interleukin 18 receptor 1 | 8809.0 | ENSG00000115604 | nan | nan
chr2	IL18RAP	604509.0 | IL18RAP, ACPL | Interleukin 18 receptor accessory protein | 8807.0 | ENSG00000115607 | nan | nan
chr2	SLC9A4	600531.0 | SLC9A4, NHE4 | Solute carrier family 9 (sodium/hydrogen exchanger), member 4 | 389015.0 | ENSG00000180251 | nan | nan
chr2	SLC9A2	600530.0 | SLC9A2 | Solute carrier family 9 (sodium/hydrogen exchanger), member 2 | 6549.0 | ENSG00000115616 | nan | nan
chr2	MFSD9	620301.0 | MFSD9 | Major facilitator superfamily domain-containing protein 9 | 84804.0 | ENSG00000135953 | nan | nan
chr2	PANTR1	618169.0 | PANTR1, LINC01158 | POU3F3-adjacent noncoding transcript 1 | 100506421.0 | ENSG00000233639 | nan | nan
chr2	POU3F3	602480.0 | POU3F3, SNIBFIS | POU domain, class 3, transcription factor-3 | 5455.0 | ENSG00000198914 | nan | Snijders Blok-Fisher syndrome, 618604 (3), Autosomal dominant
chr2	LINC01159	618208.0 | LINC01159, LINC-BRN1B | Long intergenic noncoding RNA 1159 | 102682016.0 | ENSG00000229743 | nan | nan
chr2	MRPS9	611975.0 | MRPS9 | Mitochondrial ribosomal protein S9 | 64965.0 | ENSG00000135972 | nan | nan
chr2	GPR45	604838.0 | GPR45 | G protein-coupled receptor 45 | 11250.0 | ENSG00000135973 | nan | nan
chr2	TGFBRAP1	606237.0 | TGFBRAP1, TRAP1 | Transforming growth factor-beta receptor-associated protein 1 | 9392.0 | ENSG00000135966 | nan | nan
chr2	FHL2	602633.0 | FHL2, DRAL | Four and a half LIM domains-2 (Down-regulated in rhabdomyosarcoma LIM protein) | 2274.0 | ENSG00000115641 | nan | nan
chr2	NCK2	604930.0 | NCK2 | NCK adaptor protein 2 | 8440.0 | ENSG00000071051 | nan | nan
chr2	ECRG4	611752.0 | ECRG4, C2orf40 | ECRG4 augurin precursor | 84417.0 | ENSG00000119147 | nan | nan
chr2	UXS1	609749.0 | UXS1, UGD | UDP-glucuronate decarboxylase 1 | 80146.0 | ENSG00000115652 | nan | nan
chr2	PLGLA	612212.0 | PLGLA, PRGA | Plasminogen-like A | 285189.0 | nan | nan | nan
chr2	RGPD3	612706.0 | RGPD3, RGP3 | RANBP2-like and GRIP domain-containing protein 3 | 653489.0 | ENSG00000153165 | nan | nan
chr2		612710.0 | RGPD7, RGP7 | RANBP2-like and GRIP domain-containing protein 7 | nan | nan | nan | nan
chr2	ST6GAL2	608472.0 | ST6GALII, KIAA1877 | Beta-galactoside alpha-2,6-sialyltransferase II | 84620.0 | ENSG00000144057 | nan | nan
chr2	RGPD4	612707.0 | RGPD4, RGP4 | RANBP2-like and GRIP domain-containing protein 4 | 285190.0 | ENSG00000196862 | nan | nan
chr2	SLC5A7	608761.0 | SLC5A7, CHT1, HMND7, CMS20 | Solute carrier family 5 (choline transporter), member 7 | 60482.0 | ENSG00000115665 | nan | Neuronopathy, distal hereditary motor, autosomal dominant 7, 158580 (3), Autosomal dominant; Myasthenic syndrome, congenital, 20, presynaptic, 617143 (3), Autosomal recessive
chr2	SULT1C3	617151.0 | SULT1C3 | Sulfotransferase family 1C, member 3 | 442038.0 | ENSG00000196228 | nan | nan
chr2	SULT1C2	602385.0 | SULT1C1 | Sulfotransferase 1C1 | 6819.0 | ENSG00000198203 | nan | nan
chr2	SULT1C4	608357.0 | SULT1C2 | Sulfotransferase family 1C, member 2 | 27233.0 | ENSG00000198075 | nan | nan
chr2	GCC2	612711.0 | GCC2, GCC185, KIAA0336 | GRIP and coiled-coil domains-containing protein 2 | 9648.0 | ENSG00000135968 | nan | nan
chr2	LIMS1	602567.0 | LIMS1, PINCH1 | LIM zinc finger-containing protein 1 | 3987.0 | ENSG00000169756 | nan | nan
chr2	COMA	257550.0 | COMA | Cogan-type congenital oculomotor apraxia | 266710.0 | nan | independent gene or feature of nephronophthisis | Oculomotor apraxia, congenital, Cogan-type, 257550 (2), Autosomal recessive
chr2	RANBP2	601181.0 | RANBP2, NUP358, ANE1, IIAE3 | RAN-binding protein 2 | 5903.0 | ENSG00000153201 | nan | {Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3), Autosomal dominant
chr2	EDAR	604095.0 | EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B | Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of) | 10913.0 | ENSG00000135960 | nan | [Hair morphology 1, hair thickness], 612630 (3); Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3), Autosomal dominant; Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3), Autosomal recessive
chr2	SH3RF3	618933.0 | SH3RF3, POSH2 | SH3 domain-containing RING finger protein 3 | 344558.0 | ENSG00000172985 | nan | nan
chr2	SEPTIN10	611737.0 | SEPT10 | Septin 10 | 151011.0 | ENSG00000186522 | pseudogene on 8q22.1-q12 | nan
chr2	RGPD5	612708.0 | RGPD5, RGP5, BS63 | RANBP2-like and GRIP domain-containing protein 5 | 84220.0 | ENSG00000015568 | nan | nan
chr2	MALL	602022.0 | MALL, BENE | mal, T-cell differentiation protein-like | 7851.0 | ENSG00000144063 | nan | nan
chr2	NPHP1	607100.0 | NPHP1, NPH1, SLSN1, JBTS4 | Nephrocystin | 4867.0 | ENSG00000144061 | nan | Joubert syndrome 4, 609583 (3), Autosomal recessive; Nephronophthisis 1, juvenile, 256100 (3), Autosomal recessive; Senior-Loken syndrome-1, 266900 (3), Autosomal recessive
chr2	MTLN	620770.0 | MTLN, MOXI, TILR | Mitoregulin | 205251.0 | ENSG00000175701 | nan | nan
chr2	RGPD6	612709.0 | RGPD6, RGP6 | RANBP2-like and GRIP domain-containing protein 6 | 729540.0 | ENSG00000183054 | nan | nan
chr2	BUB1	602452.0 | BUB1, MCPH30 | BUB1 mitotic checkpoint serine/threonine kinase | 699.0 | ENSG00000169679 | nan | Colorectal cancer with chromosomal instability, somatic, 114500 (3); Microcephaly 30, primary, autosomal recessive, 620183 (3), Autosomal recessive
chr2	BCL2L11	603827.0 | BCL2L11, BIM | BCL2-like 11 | 10018.0 | ENSG00000153094 | nan | nan
chr2	MIR4435-2HG	617144.0 | MIR4435-2HG, MORRBID | MIR4435-2 host gene (long noncoding RNA MORRBID) | 541471.0 | ENSG00000172965 | nan | nan
chr2	ANAPC1	608473.0 | ANAPC1, APC1 | Anaphase-promoting complex, subunit 1 | 64682.0 | ENSG00000153107 | nan | Rothmund-Thomson syndrome, type 1, 618625 (3), Autosomal recessive
chr2	MERTK	604705.0 | MERTK, RP38 | Mer tyrosine kinase protooncogene | 10461.0 | ENSG00000153208 | nan | Retinitis pigmentosa 38, 613862 (3), Autosomal recessive
chr2	TMEM87B	617203.0 | TMEM87B | Transmembrane protein 87B | 84910.0 | ENSG00000153214 | nan | nan
chr2	FBLN7	611551.0 | FBLN7, TM14 | Fibulin 7 | 129804.0 | ENSG00000144152 | nan | nan
chr2	BMIQ13	612459.0 | BMIQ13 | Body mass index quantitative trait locus 13 | 100233157.0 | nan | associated with rs7566605 | [Body mass index QTL13], 612459 (2)
chr2	CMD1H	604288.0 | CMD1H | Cardiomyopathy, dilated, 1H | 23459.0 | nan | nan | Cardiomyopathy, dilated, 1H, 604288 (2)
chr2		619217.0 | ENDOVESL | ENDOVE syndrome, limb-only type | nan | nan | nan | ENDOVE syndrome, limb-only type, 619217 (4), Autosomal recessive
chr2		165320.0 | LCO | Liver cancer oncogene | nan | nan | nan | nan
chr2	VIS1	164755.0 | VIS1, HIS1 | Viral integration site 1 | 7435.0 | nan | nan | nan
chr2	RGPD8	602752.0 | RGPD8, RGP8, RANBP2L1 | RANBP2-like and GRIP domain-containing protein 8 | 727851.0 | ENSG00000169629 | nan | nan
chr2	TTL	608291.0 | TTL | Tubulin-tyrosine ligase | 150465.0 | ENSG00000114999 | nan | nan
chr2	POLR1B	602000.0 | POLR1B, TCS4 | Polymerase I, RNA, subunit B | 84172.0 | ENSG00000125630 | nan | Treacher-Collins syndrome 4, 618939 (3), Autosomal dominant
chr2	CHCHD5	616978.0 | CHCHD5, MIC14 | Coiled coil-helix-coiled coil-helix domain-containing protein 5 | 84269.0 | ENSG00000125611 | nan | nan
chr2	SLC20A1	137570.0 | SLC20A1, GLVR1 | Solute carrier family 20, phosphate transporter, member 1 (Gibbon ape leukemia virus receptor-1) | 6574.0 | ENSG00000144136 | nan | nan
chr2	CKAP2L	616174.0 | CKAP2L, RADMIS | Cytoskeleton-associated protein 2-like | 150468.0 | ENSG00000169607 | nan | Filippi syndrome, 272440 (3), Autosomal recessive
chr2	IL1A	147760.0 | IL1A | Interleukin-1, alpha | 3552.0 | ENSG00000115008 | within 430kb of IL1B, IL1RN | nan
chr2	IL1B	147720.0 | IL1B | Interleukin-1, beta | 3553.0 | ENSG00000125538 | within 430kb of IL1RN, IL1A | {Gastric cancer risk after H. pylori infection}, 613659 (3)
chr2	IL37	605510.0 | IL37, IL1F7, FIL1Z, IL1H4, IL1RP1, IBD31 | Interleukin 37 | 27178.0 | ENSG00000125571 | mutation identified in 1 IBD31 patient | ?Inflammatory bowel disease (infantile ulcerative colitis) 31, 619398 (3), Autosomal recessive
chr2	IL36G	605542.0 | IL36G, IL1F9, IL1H1, IL1RP2 | Interleukin 36, gamma | 56300.0 | ENSG00000136688 | nan | nan
chr2	IL36A	605509.0 | IL36A, IL1F6, FIL1E | Interleukin 36, alpha | 27179.0 | ENSG00000136694 | nan | nan
chr2	IL36B	605508.0 | IL36B, IL1F8, IL1H2, FIL1H | Interleukin 36, beta | 27177.0 | ENSG00000136696 | nan | nan
chr2	IL36RN	605507.0 | IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14 | Interleukin 36 receptor antagonist | 26525.0 | ENSG00000136695 | nan | Psoriasis 14, pustular, 614204 (3), Autosomal recessive
chr2	IL1F10	615296.0 | IL1F10, IL1HY2 | Interleukin 1 family, member 10 | 84639.0 | ENSG00000136697 | nan | nan
chr2	IL1RN	147679.0 | IL1RN, MVCD4, DIRA, CRMO2 | Interleukin-1 receptor antagonist | 3557.0 | ENSG00000136689 | nan | Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis, 612852 (3), Autosomal recessive; {Gastric cancer risk after H. pylori infection}, 613659 (3); {Microvascular complications of diabetes 4}, 612628 (3); Interleukin 1 receptor antagonist deficiency, 612852 (3), Autosomal recessive
chr2	PSD4	614442.0 | PSD4, EFA6B, TIC | Pleckstrin and Sec7 domains-containing protein 4 | 23550.0 | ENSG00000125637 | nan | nan
chr2	PAX8	167415.0 | PAX8 | Paired box homeotic gene-8 | 7849.0 | ENSG00000125618 | nan | Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3), Autosomal dominant
chr2	ZNG1B	611079.0 | CBWD2 | Cobalamin synthetase W domain-containing protein 2 | 150472.0 | ENSG00000136682 | nan | nan
chr2	FOXD4L1	611084.0 | FOXD4L1 | Forkhead box D4-like 1 | 200350.0 | ENSG00000184492 | nan | nan
chr2	RABL2A	605412.0 | RABL2A | RAB-like 2A | 11159.0 | ENSG00000144134 | nan | nan
chr2	SLC35F5	619997.0 | SLC35F5 | Solute carrier family 35, member F5 | 80255.0 | ENSG00000115084 | nan | nan
chr2	ACTR3	604222.0 | ACTR3, ARP3 | Actin-related protein 3 | 10096.0 | ENSG00000115091 | nan | nan
chr2	DPP10	608209.0 | DPP10, DPRP3, KIAA1492 | Dipeptidyl peptidase X | 57628.0 | ENSG00000175497 | nan | nan
chr2	DDX18	606355.0 | DDX18 | DEAD-box helicase 18 | 8886.0 | ENSG00000088205 | nan | nan
chr2	CCDC93	620553.0 | CCDC93 | Coiled-coil domain-containing protein 93 | 54520.0 | ENSG00000125633 | nan | nan
chr2	INSIG2	608660.0 | INSIG2 | Insulin-induced gene 2 | 51141.0 | ENSG00000125629 | nan | nan
chr2	THORLNC	619296.0 | THORLNC | Testis-associated oncogenic long noncoding RNA | 100506797.0 | ENSG00000226856 | nan | nan
chr2	EN1	131290.0 | EN1, ENDOVESLB | Engrailed-1 | 2019.0 | ENSG00000163064 | mutation identified in 1 ENDOVESLB patient | ?ENDOVE syndrome, limb-brain type, 619218 (3), Autosomal recessive
chr2	MARCO	604870.0 | MARCO | Macrophage receptor with collagenous structure | 8685.0 | ENSG00000019169 | nan | nan
chr2	C1QL2	614330.0 | C1QL2, CTRP10, C1QTNF10 | Complement component 1, q subcomponent-like 2 | 165257.0 | ENSG00000144119 | nan | nan
chr2	STEAP3	609671.0 | STEAP3, TSAP6, AHMIO2 | STEAP3 metalloreductase | 55240.0 | ENSG00000115107 | mutation identified in 1 AHMIO2 family | ?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3), Autosomal dominant
chr2	DBI	125950.0 | DBI | Diazepam-binding inhibitor | 1622.0 | ENSG00000155368 | ?on 6q21-qter | nan
chr2	TMEM37	618831.0 | TMEM37 | Transmembrane protein 37 | 140738.0 | ENSG00000171227 | nan | nan
chr2	SCTR	182098.0 | SCTR | Secretin receptor | 6344.0 | ENSG00000080293 | nan | nan
chr2	CFAP221	618704.0 | CFAP221, PCDP1 | Cilia- and flagella-associated protein 221 | 200373.0 | ENSG00000163075 | nan | nan
chr2	TMEM177	620752.0 | TMEM177 | Transmembrane protein 177 | 80775.0 | ENSG00000144120 | nan | nan
chr2	PTPN4	176878.0 | PTPN4, PTPMEG1 | Protein-tyrosine phosphatase, nonreceptor-type, 4 | 5775.0 | ENSG00000088179 | nan | nan
chr2	EPB41L5	611730.0 | EPB41L5, KIAA1548 | Erythrocyte membrane protein band 4.1-like 5 | 57669.0 | ENSG00000115109 | nan | nan
chr2	RALB	179551.0 | RALB | RAS-like protooncogene B | 5899.0 | ENSG00000144118 | nan | nan
chr2	INHBB	147390.0 | INHBB | Inhibin, beta-2 | 3625.0 | ENSG00000163083 | nan | nan
chr2	GLI2	165230.0 | GLI2, HPE9, CJS | GLI-Kruppel family member GLI2 (oncogene GLI2) | 2736.0 | ENSG00000074047 | nan | Culler-Jones syndrome, 615849 (3), Autosomal dominant; Holoprosencephaly 9, 610829 (3), Autosomal dominant
chr2	TFCP2L1	609785.0 | TFCP2L1, CRTR1, LBP9 | Transcription factor CP2-like 1 | 29842.0 | ENSG00000115112 | nan | nan
chr2	CLASP1	605852.0 | CLASP1, KIAA0622 | CLIP-associated protein 1 | 23332.0 | ENSG00000074054 | nan | nan
chr2	RNU4ATAC	601428.0 | RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN, LWS | RNA, U4ATAC small nuclear | 100151683.0 | ENSG00000264229 | nan | Roifman syndrome, 616651 (3), Autosomal recessive; Lowry-Wood syndrome, 226960 (3), Autosomal recessive; Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3), Autosomal recessive
chr2	DYT21	614588.0 | DYT21 | Dystonia 21 | 100885773.0 | nan | nan | Dystonia 21, 614588 (2), Autosomal dominant
chr2	NIFK	611970.0 | NIFK, MKI67IP, NOPP34 | Nucleolar protein interacting with the FHA domain of MKI67 | 84365.0 | ENSG00000155438 | nan | nan
chr2	TSN	600575.0 | TSN | Translin | 7247.0 | ENSG00000211460 | nan | nan
chr2	CNTNAP5	610519.0 | CNTNAP5, CASPR5 | Contactin-associated protein-like 5 | 129684.0 | ENSG00000155052 | nan | nan
chr2	GYPC	110750.0 | GYPC, GE, GPC | Glycophorin C | 2995.0 | ENSG00000136732 | nan | [Blood group, Gerbich], 616089 (3); {Malaria, resistance to}, 611162 (3)
chr2	BIN1	601248.0 | BIN1, AMPHL, CNM2 | Box-dependent MYC-interacting protein-1 (amphiphysin-like) | 274.0 | ENSG00000136717 | nan | Centronuclear myopathy 2, 255200 (3), Autosomal recessive
chr2	CYP27C1	620605.0 | CYP27C1 | Cytochrome P450, family 2, subfamily C, member 1 | 339761.0 | ENSG00000186684 | nan | nan
chr2	ERCC3	133510.0 | ERCC3, XPB, TTD2 | ERCC excision repair 3, TFIIH core complex helicase subunit | 2071.0 | ENSG00000163161 | nan | Trichothiodystrophy 2, photosensitive, 616390 (3), Autosomal recessive; Xeroderma pigmentosum, group B, 610651 (3), Autosomal recessive
chr2	MAP3K2	609487.0 | MAP3K2, MEKK2 | Mitogen-activated protein kinase kinase kinase 2 | 10746.0 | ENSG00000169967 | nan | nan
chr2	PROC	612283.0 | PROC, PC, THPH3, THPH4 | Protein C (inactivator of coagulation factors Va and VIIIa) | 5624.0 | ENSG00000115718 | nan | Thrombophilia 3 due to protein C deficiency, autosomal dominant, 176860 (3), Autosomal dominant; Thrombophilia 3 due to protein C deficiency, autosomal recessive, 612304 (3), Autosomal recessive
chr2	MYO7B	606541.0 | MYO7B | Myosin VIIb | 4648.0 | ENSG00000169994 | nan | nan
chr2	LIMS2	607908.0 | LIMS2, PINCH2, MDRCMTT | LIM zinc finger domain-containing protein 2 | 55679.0 | ENSG00000072163 | mutation identified in 1 LGMD2W family | ?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue, 616827 (3), Autosomal recessive
chr2	GPR17	603071.0 | GPR17 | G protein-coupled receptor-17 | 2840.0 | ENSG00000144230 | nan | nan
chr2	WDR33	618082.0 | WDR33, WDC146 | WD repeat-containing protein 33 | 55339.0 | ENSG00000136709 | nan | nan
chr2	POLR2D	606017.0 | POLR2D | Polymerase II, RNA, subunit D | 5433.0 | ENSG00000144231 | nan | nan
chr2	SAP130	609697.0 | SAP130 | Sin3A-associated protein, 130kD | 79595.0 | ENSG00000136715 | nan | nan
chr2	UGGT1	605897.0 | UGGT1, HUGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | 56886.0 | ENSG00000136731 | nan | nan
chr2	HS6ST1	604846.0 | HS6ST1, HS6ST, HH15 | Heparan sulfate 6-O-sulfotransferase 1 | 9394.0 | ENSG00000136720 | nan | {Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3), Autosomal dominant
chr2	ADHD5	612311.0 | ADHD5 | Attention deficit-hyperactivity disorder, susceptibility to, 5 | 100190790.0 | nan | max lod at rs985162 | {Attention deficit-hyperactivity disorder, susceptibility to, 5}, 612311 (2)
chr2	CHDS2	608316.0 | CHDS2 | Coronary heart disease, susceptibility to, 2 | 387584.0 | nan | nan | {Coronary heart disease, susceptibility to, 2}, 608316 (2)
chr2	NMTC3	606240.0 | NMTC3 | Nonmedullary thyroid carcinoma 3 | 114568.0 | nan | nan | {Thyroid carcinoma, nonmedullary, 3}, 606240 (2), Autosomal dominant
chr2	RAB6C	612909.0 | RAB6C, WTH3 | Ras-associated protein RAB6C | 84084.0 | ENSG00000222014 | nan | nan
chr2	SMPD4	610457.0 | SMPD4, NSMASE3, KIAA1418, NEDMABA | Sphingomyelin phosphodiesterase 4, neutral membrane | 55627.0 | ENSG00000136699 | nan | Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies, 618622 (3), Autosomal recessive
chr2	MZT2B	613450.0 | MZT2B, FAM128B, MOZART2B | Mitotic spindle organizing protein 2B | 80097.0 | ENSG00000152082 | nan | nan
chr2	TUBA3E	619918.0 | TUBA3E | Tubulin, alpha-3E | 112714.0 | ENSG00000152086 | nan | nan
chr2	CCDC115	613734.0 | CCDC115, CCP1, CDG2O | Coiled-coil domain-containing protein 115 | 84317.0 | ENSG00000136710 | nan | Congenital disorder of glycosylation, type IIo, 616828 (3), Autosomal recessive
chr2	IMP4	612981.0 | IMP4, BXDC4 | IMP U3 small nucleolar ribonucleoprotein 4 | 92856.0 | ENSG00000136718 | nan | nan
chr2	PTPN18	606587.0 | PTPN18, BDP1 | Protein-tyrosine phosphatase, nonreceptor-type, 18 | 26469.0 | ENSG00000072135 | nan | nan
chr2	CFC1	605194.0 | CFC1, CRYPTIC, HTX2 | Cryptic protein | 55997.0 | ENSG00000136698 | nan | Heterotaxy, visceral, 2, autosomal, 605376 (3), Autosomal dominant
chr2	ARHGEF4	605216.0 | ARHGEF4, ASEF | RHO guanine nucleotide exchange factor 4 | 50649.0 | ENSG00000136002 | nan | nan
chr2	FAM168B	620078.0 | FAM168B, MANI | Family with sequence similarity 168, member B | 130074.0 | ENSG00000152102 | nan | nan
chr2	PLEKHB2	618452.0 | PLEKHB2, EVT2 | Pleckstrin homology domain-containing protein, family B, member 2 | 55041.0 | ENSG00000115762 | nan | nan
chr2	POTEE	608914.0 | POTEE, POTE2 | POTE ankyrin domain family, member E | 445582.0 | ENSG00000188219 | 5 POTE2 genes within 2Mb segment | nan
chr2	MZT2A	613449.0 | FAM128A, MOZART2A | Family with sequence similarity 128, member A | 653784.0 | ENSG00000173272 | nan | nan
chr2	TUBA3D	617878.0 | TUBA3D, KTCN9 | Tubulin, alpha-3D | 113457.0 | ENSG00000075886 | nan | Keratoconus 9, 617928 (3), Autosomal dominant
chr2	POTEKP	611266.0 | POTEKP, ACT, ACTBL3, POTEK, FKSG30 | POTE ankyrin domain family, member K, pseudogene | 440915.0 | nan | nan | nan
chr2	GPR39	602886.0 | GPR39 | G protein-coupled receptor-39 | 2863.0 | ENSG00000183840 | nan | nan
chr2	LYPD1	610450.0 | LYPD1, PHTS | LY6/PLAUR domain-containing protein 1 | 116372.0 | ENSG00000150551 | nan | nan
chr2	NCKAP5	608789.0 | NCKAP5, NAP5 | NCK-associated protein 5 | 344148.0 | ENSG00000176771 | nan | nan
chr2	MGAT5	601774.0 | MGAT5 | Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl- glucosaminyltransferase | 4249.0 | ENSG00000152127 | nan | nan
chr2	TMEM163	618978.0 | TMEM163, SV31, HLD25 | Transmembrane protein 163 | 81615.0 | ENSG00000152128 | REc | Leukodystrophy, hypomyelinating, 25, 620243 (3), Autosomal dominant
chr2	ACMSD	608889.0 | ACMSD | Aminocarboxymuconate semialdehyde decarboxylase | 130013.0 | ENSG00000153086 | nan | nan
chr2	CCNT2	603862.0 | CCNT2 | Cyclin T2 | 905.0 | ENSG00000082258 | nan | nan
chr2	RAB3GAP1	602536.0 | RAB3GAP1, WARBM1, P130, MARTS2 | RAB3 GTPase-activating protein, catalytic subunit | 22930.0 | ENSG00000115839 | nan | Martsolf syndrome 2, 619420 (3), Autosomal recessive; Warburg micro syndrome 1, 600118 (3), Autosomal recessive
chr2	ZRANB3	615655.0 | ZRANB3 | Zinc finger RANBP2-type domain-containing protein 3 | 84083.0 | ENSG00000121988 | nan | nan
chr2	R3HDM1	619474.0 | R3HDM1, KIAA0029 | R3H domain-containing protein 1 | 23518.0 | ENSG00000048991 | nan | nan
chr2	MIR128-1	611774.0 | MIR128-1, MIRN128-1, MIR128A | Micro RNA 128-1 | 406915.0 | ENSG00000207654 | nan | nan
chr2	UBXN4	611216.0 | UBXN4, UBXD2, KIAA2042, ERASIN | UBX domain protein 4 | 23190.0 | ENSG00000144224 | nan | nan
chr2	LCT	603202.0 | LCT, LAC, LPH | Lactase (lactase-phlorizin hydrolase) | 3938.0 | ENSG00000115850 | nan | Lactase deficiency, congenital, 223000 (3), Autosomal recessive
chr2	MCM6	601806.0 | MCM6 | Minichromosome maintenance complex component 6 | 4175.0 | ENSG00000076003 | mutations in introns 9 and 13 | Lactase persistence/nonpersistence, 223100 (3), Autosomal dominant
chr2	DARS1	603084.0 | DARS1, DARS, HBSL | Aspartyl tRNA synthetase 1 | 1615.0 | ENSG00000115866 | nan | Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3), Autosomal recessive
chr2	MAFD5	611535.0 | MAFD5 | Major affective disorder 5 | 100188843.0 | nan | nan | {Major affective disorder 5}, 611535 (2)
chr2	CXCR4	162643.0 | CXCR4, D2S201E, NPY3R, WHIMS1 | Chemokine (C-X-C motif) receptor 4 (neuropeptide Y receptor Y3) | 7852.0 | ENSG00000121966 | nan | WHIM syndrome 1, 193670 (3), Autosomal dominant; Myelokathexis, isolated, 193670 (3), Autosomal dominant
chr2	HNMT	605238.0 | HNMT, MRT51 | Histamine N-methyltransferase | 3176.0 | ENSG00000150540 | nan | Intellectual developmental disorder, autosomal recessive 51, 616739 (3), Autosomal recessive; {Asthma, susceptibility to}, 600807 (3), Autosomal dominant
chr2	NXPH2	604635.0 | NXPH2, NPH2 | Neuroxophilin 2 | 11249.0 | ENSG00000144227 | nan | nan
chr2	LRP1B	608766.0 | LRP1B | Low density lipoprotein receptor-related protein 1B | 53353.0 | ENSG00000168702 | nan | nan
chr2	KYNU	605197.0 | KYNU, KYNUU, VCRL2 | Kynureninase | 8942.0 | ENSG00000115919 | mutation identified in 1 KYNUU family | ?Hydroxykynureninuria, 236800 (3), Autosomal recessive; Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3), Autosomal recessive
chr2	ARHGAP15	610578.0 | ARHGAP15, BM046 | Rho GTPase-activating protein 15 | 55843.0 | ENSG00000075884 | nan | nan
chr2	GTDC1	610165.0 | GTDC1 | Glycosyltransferase-like domain containing 1 | 79712.0 | ENSG00000121964 | nan | nan
chr2	ZEB2	605802.0 | ZEB2, ZFHX1B, SMADIP1, SIP1 | Zinc finger E box-binding homeobox 2 | 9839.0 | ENSG00000169554 | nan | Mowat-Wilson syndrome, 235730 (3), Autosomal dominant
chr2	ACVR2A	102581.0 | ACVR2A, ACVR2 | Activin A receptor, type IIA | 92.0 | ENSG00000121989 | nan | nan
chr2	DFNA16	603964.0 | DFNA16 | Deafness, autosomal dominant 16 | 1694.0 | nan | nan | Deafness, autosomal dominant 16, 603964 (2), Autosomal dominant
chr2	DFNB27	605818.0 | DFNB27 | Deafness, autosomal recessive 27 | 23713.0 | nan | nan | Deafness, autosomal recessive 27, 605818 (2), Autosomal recessive
chr2	GEFSP7	613863.0 | GEFSP7, FEB3B | Generalized epilepsy with febrile seizures plus, type 7 | 120325367.0 | nan | max lod at D2S2330 | Generalized epilepsy with febrile seizures plus, type 7, 613863 (2), Autosomal dominant
chr2	ORC4	603056.0 | ORC4, ORC4L | Origin recognition complex, subunit 4 | 5000.0 | ENSG00000115947 | nan | Meier-Gorlin syndrome 2, 613800 (3), Autosomal recessive
chr2	MBD5	611472.0 | MBD5, KIAA1461, MRD1 | Methyl-CpG-binding domain protein 5 | 55777.0 | ENSG00000204406 | nan | Intellectual developmental disorder, autosomal dominant 1, 156200 (3), Autosomal dominant
chr2	EPC2	611000.0 | EPC2 | Enhancer of polycomb homolog 2 | 26122.0 | ENSG00000135999 | nan | nan
chr2	KIF5C	604593.0 | KIF5C, NKHC2, CDCBM2 | Kinesin family member 5C | 3800.0 | ENSG00000168280 | nan | Cortical dysplasia, complex, with other brain malformations 2, 615282 (3), Autosomal dominant
chr2	LYPD6	613359.0 | LYPD6 | LY6/PLAUR domain-containing protein 6 | 130574.0 | ENSG00000187123 | nan | nan
chr2	MMADHC	611935.0 | MMADHC, C2orf25, MAHCD, MACD, HMAD | Metabolism of cobalamin associated D | 27249.0 | ENSG00000168288 | nan | Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3), Autosomal recessive; Methylmalonic aciduria, cblD type, 620953 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblD type, 620952 (3), Autosomal recessive
chr2	RND3	602924.0 | RND3, RHOE, ARHE | RHO family GTPase 3 | 390.0 | ENSG00000115963 | nan | nan
chr2	NMI	603525.0 | NMI | NMYC interactor | 9111.0 | ENSG00000123609 | previously assigned to 22q13.3 | nan
chr2	TNFAIP6	600410.0 | TNFAIP6 | Tumor necrosis factor, alpha-induced protein-6 | 7130.0 | ENSG00000123610 | nan | nan
chr2	RIF1	608952.0 | RIF1 | Replication timing regulatory factor 1 | 55183.0 | ENSG00000080345 | nan | nan
chr2	NEB	161650.0 | NEB, NEM2, AMC6 | Nebulin | 4703.0 | ENSG00000183091 | nan | Nemaline myopathy 2, autosomal recessive, 256030 (3), Autosomal recessive; Arthrogryposis multiplex congenita 6, 619334 (3), Autosomal recessive
chr2	ARL5A	608960.0 | ARL5A | ADP ribosylation factor-like GTPase 5A | 26225.0 | ENSG00000162980 | nan | nan
chr2	CACNB4	601949.0 | CACNB4, EJM6, EA5, EIG9 | Calcium channel, voltage-dependent, beta 4 subunit | 785.0 | ENSG00000182389 | mutation identified in 1 EA5 family | {Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3), Autosomal dominant; ?Episodic ataxia, type 5, 613855 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3), Autosomal dominant
chr2	STAM2	606244.0 | STAM2 | Signal-transducing adaptor molecule 2 | 10254.0 | ENSG00000115145 | nan | nan
chr2	FMNL2	616285.0 | FMNL2, KIAA1902 | Formin-like 2 | 114793.0 | ENSG00000157827 | nan | nan
chr2	PRPF40A	612941.0 | PRPF40A, HYPA, FNBP3, FBP11 | Pre-mRNA processing factor 40A | 55660.0 | ENSG00000196504 | nan | nan
chr2	ARL6IP6	616495.0 | ARL6IP6, AIP6 | ADP ribosylation factor-like GTPase 6 interacting protein 6 | 151188.0 | ENSG00000177917 | nan | nan
chr2	GALNT13	608369.0 | GALNT13, KIAA1918 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 | 114805.0 | ENSG00000144278 | nan | nan
chr2	RPRM	612171.0 | RPRM | Reprimo | 56475.0 | ENSG00000177519 | nan | nan
chr2	FGQTL1	612108.0 | FGQTL1 | Fasting plasma glucose level QTL 1 | 100499165.0 | nan | associated with rs560887 | [Fasting plasma glucose level QTL 1], 612108 (2)
chr2	INTLQ2	610295.0 | INTLQ2 | Intelligence quantitative trait locus 3 | 100462723.0 | nan | nan | {Intelligence QTL3}, 610295 (2)
chr2		156232.0 | MMDK, MDK | Mesomelic dysplasia, Kantaputra type | nan | nan | caused by disruption of the HOXD gene cluster | Mesomelic dysplasia, Kantaputra type, 156232 (4), Autosomal dominant
chr2	SYNSTH	612759.0 | SYNSTH | Synesthesia | 100301527.0 | nan | max lod at D2S142 | Synesthesia, 612759 (2)
chr2	KCNJ3	601534.0 | KCNJ3, GIRK1 | Potassium inwardly-rectifying channel, subfamily J, member 3 | 3760.0 | ENSG00000162989 | nan | nan
chr2	NR4A2	601828.0 | NR4A2, NURR1, NOT, TINUR, IDLDP | Nuclear receptor subfamily 4, group A, member 2 | 4929.0 | ENSG00000153234 | nan | Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism, 619911 (3), Autosomal dominant
chr2	GPD2	138430.0 | GPD2 | Glycerol-3-phosphate dehydrogenase 2 (mitochondrial) | 2820.0 | ENSG00000115159 | pseudogene on 19 | {Type 2 diabetes mellitus, susceptibility to}, 125853 (3), Autosomal dominant
chr2	GALNT5	615129.0 | GALNT5, GALNACT5 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 | 11227.0 | ENSG00000136542 | nan | nan
chr2	ERMN	610072.0 | ERMN, JN, KIAA1189 | Ermin | 57471.0 | ENSG00000136541 | nan | nan
chr2	CYTIP	604448.0 | CYTIP, PSCDBP, HE | Cytohesin 1 interacting protein | 9595.0 | ENSG00000115165 | nan | nan
chr2	ACVR1C	608981.0 | ACVR1C, ALK7 | Activin A receptor, type IC | 130399.0 | ENSG00000123612 | nan | nan
chr2	ACVR1	102576.0 | ACVR1, ACVRLK2, ALK2, FOP | Activin A receptor, type I | 90.0 | ENSG00000115170 | nan | Fibrodysplasia ossificans progressiva, 135100 (3), Autosomal dominant
chr2	UPP2	617340.0 | UPP2 | Uridine phosphorylase 2 | 151531.0 | ENSG00000007001 | nan | nan
chr2	PKP4	604276.0 | PKP4 | Plakophilin-4 | 8502.0 | ENSG00000144283 | nan | nan
chr2	TANC1	611397.0 | TANC1, KIAA1728 | Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 1 | 85461.0 | ENSG00000115183 | nan | nan
chr2	WDSUB1	620802.0 | WDSUB1 | WD repeat-, sterile alpha motif-, and U-box domain-containing protein 1 | 151525.0 | ENSG00000196151 | nan | nan
chr2	BAZ2B	605683.0 | BAZ2B | Bromodomain adjacent to zinc finger domain, 2B | 29994.0 | ENSG00000123636 | nan | nan
chr2	MARCHF7	613334.0 | MARCH7 | Membrane-associated RING-CH finger protein 7 | 64844.0 | ENSG00000136536 | nan | nan
chr2	CD302	612246.0 | CD302, DCL1, KIAA0022 | CD302 antigen | 9936.0 | ENSG00000241399 | nan | nan
chr2	LY75	604524.0 | LY75 | Lymphocyte antigen 75 | 4065.0 | ENSG00000054219 | nan | nan
chr2	PLA2R1	604939.0 | PLA2R1, PLA2R | Phospholipase A2 receptor 1 | 22925.0 | ENSG00000153246 | nan | nan
chr2	ITGB6	147558.0 | ITGB6, AI1H | Integrin, beta-6 | 3694.0 | ENSG00000115221 | nan | Amelogenesis imperfecta, type IH, 616221 (3), Autosomal recessive
chr2	RBMS1	602310.0 | RBMS1, MSSP, SCR2 | RNA-binding motif protein, single strand-interacting, 1 | 5937.0 | ENSG00000153250 | nan | nan
chr2	TANK	603893.0 | TANK, ITRAF | TRAF family member-associated NF-Kappa-B activator | 10010.0 | ENSG00000136560 | nan | nan
chr2	PSMD14	607173.0 | PSMD14, POH1, PAD1 | Proteasome 26S subunit, non-ATPase, 14 | 10213.0 | ENSG00000115233 | nan | nan
chr2	TBR1	604616.0 | TBR1, IDDAS | T-box, brain, 1 | 10716.0 | ENSG00000136535 | nan | Intellectual developmental disorder with autism and speech delay, 606053 (3), Autosomal dominant
chr2	SLC4A10	605556.0 | SLC4A10, 620746 | Solute carrier family 4 (sodium bicarbonate cotransporter-like), member 10 | 57282.0 | ENSG00000144290 | nan | Neurodevelopmental disorder with hypotonia and characteristic brain abnormalities, 620746 (3), Autosomal recessive
chr2	DPP4	102720.0 | DPP4, CD26, ADCP2 | Dipeptidylpeptidase IV (CD26; adenosine deaminase complexing protein-2) | 1803.0 | ENSG00000197635 | nan | nan
chr2	GCG	138030.0 | GCG | Glucagon | 2641.0 | ENSG00000115263 | nan | nan
chr2	FAP	600403.0 | FAP, FAPA | Fibroblast activation protein, alpha subunit | 2191.0 | ENSG00000078098 | nan | nan
chr2	IFIH1	606951.0 | IFIH1, MDA5, AGS7, SGMRT1, IMD95 | Interferon induced with helicase C domain 1 | 64135.0 | ENSG00000115267 | nan | Immunodeficiency 95, 619773 (3), Autosomal recessive; Aicardi-Goutieres syndrome 7, 615846 (3), Autosomal dominant; Singleton-Merten syndrome 1, 182250 (3), Autosomal dominant
chr2	GCA	607030.0 | GCA | Grancalcin | 25801.0 | ENSG00000115271 | nan | nan
chr2	KCNH7	608169.0 | KCNH7, ERG3, HERG3, Kv11.3 | Potassium channel, voltage-gated, subfamily H, member 7 | 90134.0 | ENSG00000184611 | nan | nan
chr2		610155.0 | IDDM19 | Diabetes mellitus, insulin-dependent, 19 | nan | nan | associated with rs1990760 | {Diabetes mellitus, insulin-dependent, 19}, 610155 (2)
chr2	FIGN	605295.0 | FIGN | Fidgetin | 55137.0 | ENSG00000182263 | nan | nan
chr2	GRB14	601524.0 | GRB14 | Growth factor receptor-bound protein 14 | 2888.0 | ENSG00000115290 | nan | nan
chr2	COBLL1	610318.0 | COBLL1, COBLR1, KIAA0977 | COBL-like protein 1 | 22837.0 | ENSG00000082438 | nan | nan
chr2	SLC38A11	616526.0 | SLC38A11 | Solute carrier family 38 (amino acid transporter), member 11 | 151258.0 | ENSG00000169507 | nan | nan
chr2	SCN3A	182391.0 | SCN3A, FFEVF4, DEE62 | Sodium voltage-gated channel, alpha subunit 3 | 6328.0 | ENSG00000153253 | nan | Epilepsy, familial focal, with variable foci 4, 617935 (3), Autosomal dominant; Developmental and epileptic encephalopathy 62, 617938 (3), Autosomal dominant
chr2	SCN2A	182390.0 | SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9 | Sodium voltage-gated channel, alpha subunit 2 | 6326.0 | ENSG00000136531 | 4 related genes on chr.2 | Seizures, benign familial infantile, 3, 607745 (3), Autosomal dominant; Developmental and epileptic encephalopathy 11, 613721 (3), Autosomal dominant; Episodic ataxia, type 9, 618924 (3), Autosomal dominant
chr2	CSRNP3	620405.0 | CSRNP3, TAIP2, MBU1 | Cysteine- and serine-rich nuclear protein 3 | 80034.0 | ENSG00000178662 | nan | nan
chr2	GALNT3	601756.0 | GALNT3, HHS, HFTC1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 | 2591.0 | ENSG00000115339 | nan | Tumoral calcinosis, hyperphosphatemic, familial, 1, 211900 (3), Autosomal recessive
chr2	TTC21B	612014.0 | TTC21B, THM1, NPHP12, SRTD4, ATD4 | Tetratricopeptide repeat domain 21B | 79809.0 | ENSG00000123607 | nan | Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3), Autosomal recessive; Nephronophthisis 12, 613820 (3), Autosomal recessive, Autosomal dominant
chr2	SCN1A	182389.0 | SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B | Sodium voltage-gated channel, alpha subunit 1 | 6323.0 | ENSG00000144285 | nan | Developmental and epileptic encephalopathy 6B, non-Dravet, 619317 (3), Autosomal dominant; Migraine, familial hemiplegic, 3, 609634 (3), Autosomal dominant; Dravet syndrome, 607208 (3), Autosomal dominant; Febrile seizures, familial, 3A, 604403 (3), Autosomal dominant; Generalized epilepsy with febrile seizures plus, type 2, 604403 (3), Autosomal dominant
chr2	SCN9A	603415.0 | SCN9A, NENA, PN1, SFNP, HSAN2D | Sodium voltage-gated channel, alpha subunit 9 | 6335.0 | ENSG00000169432 | nan | Erythermalgia, primary, 133020 (3), Autosomal dominant; Insensitivity to pain, congenital, 243000 (3), Autosomal recessive; Small fiber neuropathy, 133020 (3), Autosomal dominant; Paroxysmal extreme pain disorder, 167400 (3), Autosomal dominant; Neuropathy, hereditary sensory and autonomic, type IID, 243000 (3), Autosomal recessive
chr2	SCN7A	182392.0 | SCN7A, SCN6A | Sodium voltage-gated channel, alpha subunit 7 | 6332.0 | ENSG00000136546 | nan | nan
chr2	XIRP2	609778.0 | XIRP2, CMYA3, XIRP2 | XIN actin-binding repeat-containing protein 2 | 129446.0 | ENSG00000163092 | nan | nan
chr2	B3GALT1	603093.0 | B3GALT1 | UDP-GAL:beta-GlcNAc beta-1,3-galactosyltransferase, polypeptide 1 | 8708.0 | ENSG00000172318 | nan | nan
chr2	STK39	607648.0 | STK39, SPAK | Serine/threonine protein kinase 39 | 27347.0 | ENSG00000198648 | nan | nan
chr2	CERS6	615336.0 | CERS6, LASS6 | Ceramide synthase 6 | 253782.0 | ENSG00000172292 | nan | nan
chr2	NOSTRIN	607496.0 | NOSTRIN | Nitric oxide synthase trafficker | 115677.0 | ENSG00000163072 | nan | nan
chr2	SPC25	609395.0 | SPC25, SPBC25 | SPC25, NDC80 kinetochore complex component | 57405.0 | ENSG00000152253 | nan | nan
chr2		613681.0 | DUP2q31.1, C2DUPq31.1 | Chromosome 2q31.1 duplication syndrome | nan | nan | duplication of 9 HOXD genes and MTX2 | Chromosome 2q31.1 duplication syndrome, 613681 (4), Autosomal dominant
chr2	IDDM7	600321.0 | IDDM7 | Insulin-dependent diabetes mellitus-7 | 3406.0 | nan | nan | {Diabetes mellitus, insulin-dependent, 7}, 600321 (2)
chr2	PNKD2	611147.0 | PNKD2 | Paroxysmal nonkinesigenic dyskinesia 2 | 100188328.0 | nan | between D2S2188 and D2S364 | Paroxysmal nonkinesigenic dyskinesia 2, 611147 (2), Autosomal dominant
chr2	SHFM5	606708.0 | SHFM5 | Split-hand/foot malformation 5 | 171157.0 | nan | between EVX2 and D2S294 | Split-hand/foot malformation 5, 606708 (2)
chr2	G6PC2	608058.0 | G6PC2, IGRP | Glucose-6-phosphatase, catalytic, 2 | 57818.0 | ENSG00000152254 | nan | nan
chr2	ABCB11	603201.0 | ABCB11, BSEP, SPGP, PFIC2, BRIC2 | ATP-binding cassette, subfamily B, member 11 (bile salt export pump) | 8647.0 | ENSG00000073734 | nan | Cholestasis, benign recurrent intrahepatic, 2, 605479 (3), Autosomal recessive; Cholestasis, progressive familial intrahepatic 2, 601847 (3), Autosomal recessive
chr2	DHRS9	612131.0 | DHRS9, RDHTBE | Short-chain dehydrogenase/reductase family, member 9 | 10170.0 | ENSG00000073737 | nan | nan
chr2	LRP2	600073.0 | LRP2, DBS | Low density lipoprotein-related protein 2 | 4036.0 | ENSG00000081479 | nan | Donnai-Barrow syndrome, 222448 (3), Autosomal recessive
chr2	BBS5	603650.0 | BBS5 | BBS gene 5 | 129880.0 | ENSG00000163093 | nan | Bardet-Biedl syndrome 5, 615983 (3), Autosomal recessive
chr2	KLHL41	607701.0 | KLHL41, KBTBD10, SARCOSIN, NEM9 | Kelch-like family member 41 | 10324.0 | ENSG00000239474 | nan | Nemaline myopathy 9, 615731 (3), Autosomal recessive
chr2	FASTKD1	617529.0 | FASTKD1, KIAA1800 | Fast kinase domains 1 | 79675.0 | ENSG00000138399 | nan | nan
chr2	PPIG	606093.0 | PPIG | Peptidyl-prolyl isomerase G (cyclophilin G) | 9360.0 | ENSG00000138398 | nan | nan
chr2	SSB	109090.0 | SSB, LARP3 | Small RNA-binding exonuclease protection factor La | 6741.0 | ENSG00000138385 | nan | nan
chr2	METTL5	618628.0 | METTL5, HSPC133, MRT72 | Methyltransferase 5, N6-adenosine | 29081.0 | ENSG00000138382 | nan | Intellectual developmental disorder, autosomal recessive 72, 618665 (3), Autosomal recessive
chr2	UBR3	613831.0 | UBR3 | Ubiquitin protein ligase E3 component N-recognin 3 | 130507.0 | ENSG00000144357 | nan | nan
chr2	MYO3B	610040.0 | MYO3B | Myosin IIIB | 140469.0 | ENSG00000071909 | nan | nan
chr2	SP5	609391.0 | SP5 | Transcription factor Sp5 | 389058.0 | ENSG00000204335 | nan | nan
chr2	ERICH2	620858.0 | ERICH2 | Glutamate-rich protein 2 | 285141.0 | ENSG00000204334 | nan | nan
chr2	GAD1	605363.0 | GAD1, SCP, DEE89 | Glutamate decarboxylase-1, brain, 67kD | 2571.0 | ENSG00000128683 | nan | Developmental and epileptic encephalopathy 89, 619124 (3), Autosomal recessive
chr2	GORASP2	608693.0 | GORASP2, GRASP55 | Golgi reassembly stacking protein 2 | 26003.0 | ENSG00000115806 | nan | nan
chr2	TLK1	608438.0 | TLK1, KIAA0137 | Tousled-like kinase 1 | 9874.0 | ENSG00000198586 | nan | nan
chr2	METTL8	609525.0 | METTL8, TIP | Methyltransferase 8, methylcytidine | 79828.0 | ENSG00000123600 | nan | nan
chr2	DCAF17	612515.0 | DCAF17, C20orf37 | DDB1- and CUL4-associated factor 17 | 80067.0 | ENSG00000115827 | nan | Woodhouse-Sakati syndrome, 241080 (3), Autosomal recessive
chr2	CYBRD1	605745.0 | CYBD1, DCYTB | Cytochrome b reductase 1 | 79901.0 | ENSG00000071967 | nan | nan
chr2	DYNC1I2	603331.0 | DYNC1I2, DNCI2, IC2, NEDMIBA | Dynein, cytoplasmic-1, intermediate chain-2 | 1781.0 | ENSG00000077380 | nan | Neurodevelopmental disorder with microcephaly and structural brain anomalies, 618492 (3), Autosomal recessive
chr2	SLC25A12	603667.0 | SLC25A12, ARALAR, DEE39 | Solute carrier family 25 (mitochondrial carrier, Aralar), member 12 | 8604.0 | ENSG00000115840 | nan | Developmental and epileptic encephalopathy 39, 612949 (3), Autosomal recessive
chr2	HAT1	603053.0 | HAT1 | Histone acetyltransferase-1 | 8520.0 | ENSG00000128708 | nan | nan
chr2	METAP1D	610267.0 | METAP1D, MAP1D | Methionyl aminopeptidase type 1D (mitochondrial) | 254042.0 | ENSG00000172878 | nan | nan
chr2	DLX1	600029.0 | DLX1 | Distal-less homeobox 1 | 1745.0 | ENSG00000144355 | nan | nan
chr2	DLX2	126255.0 | DLX2, TES1 | Distal-less homeobox 2 | 1746.0 | ENSG00000115844 | nan | nan
chr2	ITGA6	147556.0 | ITGA6, JEB6 | Integrin, alpha-6 | 3655.0 | ENSG00000091409 | nan | Epidermolysis bullosa, junctional 6, with pyloric atresia, 619817 (3), Autosomal recessive
chr2	PDK1	602524.0 | PDK1 | Pyruvate dehydrogenase kinase, isoenzyme 1 | 5163.0 | ENSG00000152256 | nan | nan
chr2	RAPGEF4	606058.0 | RAPGEF4, EPAC2 | Rap guanine nucleotide exchange factor | 11069.0 | ENSG00000091428 | nan | nan
chr2	MAP3K20	609479.0 | MAP3K20, ZAK, MLTK, MRK, SFMMP, CNM6 | Mitogen-activated protein kinase kinase kinase 20 | 51776.0 | ENSG00000091436 | nan | Centronuclear myopathy 6 with fiber-type disproportion, 617760 (3), Autosomal recessive; Split-foot malformation with mesoaxial polydactyly, 616890 (3), Autosomal recessive
chr2	CDCA7	609937.0 | CDCA7, JPO1, ICF3 | Cell division cycle-associated 7 | 83879.0 | ENSG00000144354 | nan | Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3), Autosomal recessive
chr2	SP3	601804.0 | SP3 | Sp3 transcription factor | 6670.0 | ENSG00000172845 | nan | nan
chr2	OLA1	611175.0 | OLA1, GTBP9 | OBG-like ATPase 1 | 29789.0 | ENSG00000138430 | nan | nan
chr2	CIR1	605228.0 | CIR1 | CBF1-interacting corepressor | 9541.0 | ENSG00000138433 | nan | nan
chr2	SCRN3	614967.0 | SCRN3, SES3 | Secernin 3 | 79634.0 | ENSG00000144306 | nan | nan
chr2	GPR155	620855.0 | GPR155, PGR22, LYCHOS | G protein-coupled receptor 155 | 151556.0 | ENSG00000163328 | nan | nan
chr2	WIPF1	602357.0 | WIPF1, WASPIP, WIP, WAS2 | WAS/WASL-interacting protein family, member 1 | 7456.0 | ENSG00000115935 | nan | Wiskott-Aldrich syndrome 2, 614493 (3), Autosomal recessive
chr2	CHRNA1	100690.0 | CHRNA1, ACHRD, CMS1B, CMS1A | Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle | 1134.0 | ENSG00000138435 | nan | Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3), Autosomal recessive, Autosomal dominant; Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3), Autosomal dominant; Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessive
chr2	CHN1	118423.0 | CHN1, CHN, ARHGAP2, RHOGAP2, DURS2 | Chimerin 1 (GTPase-activating protein, rho, 2) | 1123.0 | ENSG00000128656 | nan | Duane retraction syndrome 2, 604356 (3), Autosomal dominant
chr2	ATF2	123811.0 | ATF2, CREB2 | Activating transcription factor 2 | 1386.0 | ENSG00000115966 | nan | nan
chr2	ATP5MC3	602736.0 | ATP5MC3, ATP5G3, DYTSPG | ATP synthase membrane subunit c locus 3 | 518.0 | ENSG00000154518 | nan | Dystonia, early-onset, and/or spastic paraplegia, 619681 (3), Autosomal dominant
chr2	LNPK	610236.0 | LNPK, KIAA1715, NEDEHCC | Lunapark | 80856.0 | ENSG00000144320 | nan | Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, 618090 (3), Autosomal recessive
chr2	EVX2	142991.0 | EVX2 | Even-skipped homeobox 2 | 344191.0 | ENSG00000174279 | 13kb 5' to HOX4I | nan
chr2	HOXD13	142989.0 | HOXD13, HOX4I, SPD1, BDSD | Homeobox D13 | 3239.0 | ENSG00000128714 | mutation identified in 1 BDSD family | Syndactyly, type V, 186300 (3), Autosomal dominant; Synpolydactyly 1, 186000 (3), Autosomal dominant; Brachydactyly, type E, 113300 (3), Autosomal dominant; Brachydactyly, type D, 113200 (3), Autosomal dominant; ?Brachydactyly-syndactyly syndrome, 610713 (3)
chr2	HOXD12	142988.0 | HOXD12, HOX4H | Homeobox D12 | 3238.0 | ENSG00000170178 | upstream from HOX4A-G | nan
chr2	HOXD11	142986.0 | HOXD11, HOX4F | Homeobox D11 | 3237.0 | ENSG00000128713 | nan | nan
chr2	HOXD10	142984.0 | HOXD10, HOX4D | Homeobox D10 | 3236.0 | ENSG00000128710 | nan | Vertical talus, congenital, 192950 (3), Autosomal dominant; Charcot-Marie-Tooth disease, foot deformity of, 192950 (3), Autosomal dominant
chr2	HOXD9	142982.0 | HOXD9, HOX4C | Homeobox D9 | 3235.0 | ENSG00000128709 | nan | nan
chr2	HOXD8	142985.0 | HOXD8, HOX4E | Homeobox D8 | 3234.0 | ENSG00000175879 | nan | nan
chr2	MIR10B	611576.0 | MIR10B, MIRN10B | Micro RNA 10B | 406903.0 | ENSG00000207744 | nan | nan
chr2	HOXD4	142981.0 | HOXD4, HOX4B | Homeobox D4 | 3233.0 | ENSG00000170166 | nan | nan
chr2	HOXD3	142980.0 | HOXD3, HOX4A | Homeobox D3 | 3232.0 | ENSG00000128652 | nan | nan
chr2	HAGLR	618209.0 | HAGLR, MDGT | HOXD antisense growth-associated long noncoding RNA | 401022.0 | ENSG00000224189 | nan | nan
chr2	HOXD1	142987.0 | HOXD1, HOX4G | Homeobox D1 | 3231.0 | ENSG00000128645 | nan | nan
chr2	MTX2	608555.0 | MTX2, MDPS | Metaxin 2 | 10651.0 | ENSG00000128654 | nan | Mandibuloacral dysplasia progeroid syndrome, 619127 (3), Autosomal recessive
chr2		612345.0 | DEL2q31 | Chromosome 2q31.2 deletion syndrome | nan | nan | contiguous gene deletion syndrome | Chromosome 2q31.2 deletion syndrome, 612345 (4)
chr2	HNRNPA3	605372.0 | HNRPA3, D10S102, FBRNP | Heterogeneous nuclear ribonucleoprotein A3 | 220988.0 | ENSG00000170144 | nan | nan
chr2	NFE2L2	600492.0 | NFE2L2, NRF2, IMDDHH | Nuclear factor, erythroid-derived 2-like 2 | 4780.0 | ENSG00000116044 | nan | Immunodeficiency, developmental delay, and hypohomocysteinemia, 617744 (3), Autosomal dominant
chr2	AGPS	603051.0 | AGPS, ADHAPS, RCDP3 | Alkylglycerone-phosphate synthase | 8540.0 | ENSG00000018510 | nan | Rhizomelic chondrodysplasia punctata, type 3, 600121 (3), Autosomal recessive
chr2	IFT70B	620742.0 | IFT70B, TTC30B | Intraflagellar transport 70B | 150737.0 | ENSG00000196659 | nan | nan
chr2	IFT70A	620741.0 | IFT70A, TTC30A | Intraflagellar transport 70A | 92104.0 | ENSG00000197557 | nan | nan
chr2	PDE11A	604961.0 | PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2 | Phosphodiesterase 11A | 50940.0 | ENSG00000128655 | nan | Pigmented nodular adrenocortical disease, primary, 2, 610475 (3), Autosomal dominant
chr2	RBM45	608888.0 | RBM45, DRB1 | RNA binding motif protein 45 | 129831.0 | ENSG00000155636 | nan | nan
chr2	OSBPL6	606734.0 | OSBPL6, ORP6 | Oxysterol-binding protein-like protein 6 | 114880.0 | ENSG00000079156 | nan | nan
chr2	PRKRA	603424.0 | PRKRA, PACT, RAX, DYT16 | Protein kinase, interferon-inducible double-stranded RNA-dependent activator | 8575.0 | ENSG00000180228 | nan | Dystonia 16, 612067 (3), Autosomal recessive
chr2	PJVK	610219.0 | PJVK, DFNB59 | Pejvakin | 494513.0 | ENSG00000204311 | nan | Deafness, autosomal recessive 59, 610220 (3), Autosomal recessive
chr2	FKBP7	607062.0 | FKBP7, FKBP23 | FK506-binding protein 7 | 51661.0 | ENSG00000079150 | nan | nan
chr2	PLEKHA3	607774.0 | PLEKHA3, FAPP1 | Pleckstrin homology domain-containing protein, family A, member 3 | 65977.0 | ENSG00000116095 | nan | nan
chr2	TTN	188840.0 | TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYO5 | Titin | 7273.0 | ENSG00000155657 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3), Autosomal recessive; Cardiomyopathy, familial hypertrophic, 9, 613765 (3), Autosomal dominant; Congenital myopathy 5 with cardiomyopathy, 611705 (3), Autosomal recessive; Tibial muscular dystrophy, tardive, 600334 (3), Autosomal dominant; Cardiomyopathy, dilated, 1G, 604145 (3), Autosomal dominant; Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3), Autosomal dominant
chr2	CCDC141	616031.0 | CCDC141, CAMDI | Coiled-coil domain-containing protein 141 | 285025.0 | ENSG00000163492 | nan | nan
chr2	ZNF385B	612344.0 | ZNF385B, ZFN533 | Zinc finger protein 385B | 151126.0 | ENSG00000144331 | nan | nan
chr2		187370.0 | DA10 | Arthrogryposis, distal, type 10 | nan | nan | max lod at D2S364 | Arthrogryposis, distal, type 10, 187370 (2), Autosomal dominant
chr2	MIR1258	614488.0 | MIR1258 | Micro RNA 1258 | 100302172.0 | ENSG00000221240 | on opposite strand from ZNF385B | nan
chr2	CWC22	615186.0 | CWC22, KIAA1604, NCM | CWC22 spliceosome-associated protein homolog | 57703.0 | ENSG00000163510 | nan | nan
chr2	SCHLAP1	615568.0 | SCHLAP1, PCAT114, LINC00913 | SWI/SNF complex antagonist associated with prostate cancer 1, noncoding | 101669767.0 | ENSG00000281131 | nan | nan
chr2	UBE2E3	604151.0 | UBE2E3, UBCH9 | Ubiquitin-conjugating enzyme E2 E3 | 10477.0 | ENSG00000170035 | nan | nan
chr2	ITGA4	192975.0 | ITGA4, CD49D | Integrin, alpha-4 (antigen CD49D, alpha-4 subunit of VLA-4 receptor) | 3676.0 | ENSG00000115232 | nan | nan
chr2	CERKL	608381.0 | CERKL, RP26 | Ceramide kinase-like | 375298.0 | ENSG00000188452 | nan | Retinitis pigmentosa 26, 608380 (3), Autosomal recessive
chr2	NEUROD1	601724.0 | NEUROD1, T2D | Neurogenic differentiation 1 | 4760.0 | ENSG00000162992 | nan | {Type 2 diabetes mellitus, susceptibility to}, 125853 (3), Autosomal dominant; Maturity-onset diabetes of the young 6, 606394 (3)
chr2	ITPRID2	118990.0 | ITPRID2, SSFA2, CS1 | ITPR-interacting domain-containing protein 2 | 6744.0 | ENSG00000138434 | nan | nan
chr2	PPP1R1C	613240.0 | PPP1R1C, IPP5 | Protein phosphatase 1, regulatory subunit 1C | 151242.0 | ENSG00000150722 | nan | nan
chr2	ARVD4	602087.0 | ARVD4 | Arrhythmogenic right ventricular dysplasia 4 | 425.0 | nan | nan | Arrhythmogenic right ventricular dysplasia 4, 602087 (2), Autosomal dominant
chr2	SCZD14	612361.0 | SCZD14 | Schizophrenia 14 | 100196913.0 | nan | associated with rs1344706 | {Schizophrenia, susceptibility to, 14}, 612361 (2)
chr2	PDE1A	171890.0 | PDE1A | Phosphodiesterase-1A | 5136.0 | ENSG00000115252 | nan | nan
chr2	DNAJC10	607987.0 | DNAJC10, ERDJ5, JPDI | DNAJ/HSP40 homolog, subfamily C, member 10 | 54431.0 | ENSG00000077232 | nan | nan
chr2	FRZB	605083.0 | FRZB, FRZB1, SRFP3, OS1 | Frizzled-related protein | 2487.0 | ENSG00000162998 | nan | {Osteoarthritis susceptibility 1}, 165720 (3), Multifactorial
chr2	NCKAP1	604891.0 | NCKAP1, NAP1 | NCK-associated protein 1 | 10787.0 | ENSG00000061676 | nan | nan
chr2	DUSP19	611437.0 | DUSP19, SKRP1, DUSP17 | Dual-specificity phosphatase 19 | 142679.0 | ENSG00000162999 | nan | nan
chr2	NUP35	608140.0 | NUP35, NP44 | Nucleoporin, 35kD | 129401.0 | ENSG00000163002 | nan | nan
chr2	ZNF804A	612282.0 | ZNF804A, C2orf10 | Zinc finger protein 804A | 91752.0 | ENSG00000170396 | nan | nan
chr2	FSIP2	615796.0 | FSIP2, SPGF34 | Fibrous sheath-interacting protein 2 | 401024.0 | ENSG00000188738 | nan | Spermatogenic failure 34, 618153 (3), Autosomal recessive
chr2	ZC3H15	619704.0 | ZC3H15, DFRP1, LEREPO4 | Zinc finger CCCH domain-containing protein 15 | 55854.0 | ENSG00000065548 | nan | nan
chr2	ITGAV	193210.0 | ITGAV, VNRA | Integrin, alpha-V (vitronectin receptor, alpha polypeptide) | 3685.0 | ENSG00000138448 | nan | nan
chr2	FAM171B	620309.0 | FAM171B, KIAA1946 | Family with sequence similarity 171, member B | 165215.0 | ENSG00000144369 | nan | nan
chr2	CALCRL	114190.0 | CALCRL, CGRPR, CRLR, LMPHM8 | Calcitonin receptor-like | 10203.0 | ENSG00000064989 | mutation identified in 1 LMPHM8 family | ?Lymphatic malformation 8, 618773 (3), Autosomal recessive
chr2	TFPI	152310.0 | TFPI, LACI | Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 7035.0 | ENSG00000003436 | nan | nan
chr2	GULP1	608165.0 | GULP1, CED6 | PTB domain-containing engulfment adaptor protein 1 | 51454.0 | ENSG00000144366 | nan | nan
chr2	DIRC1	606423.0 | DIRC1 | Disrupted in renal cancer 1 | 116093.0 | nan | nan | nan
chr2	COL3A1	120180.0 | COL3A1, EDSVASC, PMGEDSV | Collagen III, alpha-1 polypeptide | 1281.0 | ENSG00000168542 | in same 35kb segment as COL5A2 | Ehlers-Danlos syndrome, vascular type, 130050 (3), Autosomal dominant; Polymicrogyria with or without vascular-type EDS, 618343 (3), Autosomal recessive
chr2	COL5A2	120190.0 | COL5A2, EDSCL2 | Collagen V, alpha-2 polypeptide | 1290.0 | ENSG00000204262 | very close to COL3A1 | Ehlers-Danlos syndrome, classic type, 2, 130010 (3), Autosomal dominant
chr2	WDR75	620341.0 | WDR75, UTP17, NET16 | WD repeat-containing protein 75 | 84128.0 | ENSG00000115368 | nan | nan
chr2	SLC40A1	604653.0 | SLC40A1, SLC11A3, FPN1, IREG1, HFE4 | Solute carrier family 40 (iron-regulated transporter), member 1 | 30061.0 | ENSG00000138449 | nan | Hemochromatosis, type 4, 606069 (3), Autosomal dominant
chr2	ASDURF	619740.0 | ASDURF | ASNSD1 upstream open reading frame | 110599588.0 | ENSG00000286053 | nan | nan
chr2	ASNSD1	619739.0 | ASNSD1 | Asparagine synthetase domain-containing protein 1 | 54529.0 | ENSG00000138381 | nan | nan
chr2	ANKAR	609803.0 | FLJ25415 | FLJ25415 gene | 150709.0 | ENSG00000151687 | nan | nan
chr2	OSGEPL1	619634.0 | OSGEPL1, QRI7 | O-sialoglycoprotein endopeptidase-like 1 | 64172.0 | ENSG00000128694 | nan | nan
chr2	ORMDL1	610073.0 | ORMDL1 | ORM1-like protein 1 | 94101.0 | ENSG00000128699 | pseudogene on 10p14 | nan
chr2	PMS1	600258.0 | PMS1, PMSL1, HNPCC3 | PMS1 homolog 1, mismatch repair system component | 5378.0 | ENSG00000064933 | nan | nan
chr2	C2orf88	615117.0 | C2orf88, SMAKAP | Small membrane protein kinase A-anchoring protein | 84281.0 | ENSG00000187699 | nan | nan
chr2	MSTN	601788.0 | MSTN, GDF8, MSLHP | Myostatin | 2660.0 | ENSG00000138379 | mutation identified in 1 MSLHP patient | ?Muscle hypertrophy, 614160 (3), Autosomal recessive
chr2	HIBCH	610690.0 | HIBCH | 3-hydroxyisobutyryl-CoA hydrolase | 26275.0 | ENSG00000198130 | nan | 3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3), Autosomal recessive
chr2	INPP1	147263.0 | INPP1 | Inositol polyphosphate-1-phosphatase | 3628.0 | ENSG00000151689 | nan | nan
chr2	MFSD6	613476.0 | MFSD6, MMR2 | Major facilitator superfamily domain-containing protein 6 | 54842.0 | ENSG00000151690 | nan | nan
chr2	NEMP2	616497.0 | NEMP2, TMEM194B | Nuclear envelope integral membrane protein 2 | 100131211.0 | ENSG00000189362 | nan | nan
chr2	NAB1	600800.0 | NAB1 | NGFI-A-binding protein, ERG1-binding protein | 4664.0 | ENSG00000138386 | nan | nan
chr2	GLS	138280.0 | GLS, GLS1, DEE71, CASGID, GDPAG | Glutaminase | 2744.0 | ENSG00000115419 | mutation identified in 1 CASGID patient | Global developmental delay, progressive ataxia, and elevated glutamine, 618412 (3), Autosomal recessive; ?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development, 618339 (3), Autosomal dominant; Developmental and epileptic encephalopathy 71, 618328 (3), Autosomal recessive
chr2	STAT1	600555.0 | STAT1, CANDF7, IMD31A, IMD31B, IMD31C | Signal transducer and activator of transcription-1 | 6772.0 | ENSG00000115415 | nan | Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant, 614162 (3), Autosomal dominant; Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3), Autosomal dominant; Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3), Autosomal recessive
chr2	STAT4	600558.0 | STAT4, SLEB11, DPMC | Signal transducer and activator of transcription-4 | 6775.0 | ENSG00000138378 | nan | Disabling pansclerotic morphea of childhood, 620443 (3), Autosomal dominant; {Systemic lupus erythematosus, susceptibility to, 11}, 612253 (3)
chr2	MYO1B	606537.0 | MYO1B | Myosin IB | 4430.0 | ENSG00000128641 | nan | nan
chr2	NABP1	612103.0 | NABP1, OBFC2A, SSB2 | Nucleic acid-binding protein 1 | 64859.0 | ENSG00000173559 | nan | nan
chr2	CAVIN2	606728.0 | CAVIN2, SDPR, SDR | Caveolae-associated protein 2 | 8436.0 | ENSG00000168497 | nan | nan
chr2	TMEFF2	605734.0 | TMEFF2, HPP1, TR | Transmembrane protein with EGF-like and 2 follistatin-like domains 2 | 23671.0 | ENSG00000144339 | nan | nan
chr2	PCGEM1	605443.0 | PCGEM1 | Prostate-specific gene PCGEM1 | 64002.0 | ENSG00000227418 | nan | nan
chr2	SLC39A10	608733.0 | SLC39A10, KIAA1265 | Solute carrier family 39 (zinc transporter), member 10 | 57181.0 | ENSG00000196950 | nan | nan
chr2	DNAH7	610061.0 | DNAH7, KIAA0944, CILD50 | Dynein, axonemal, heavy chain 7 | 56171.0 | ENSG00000118997 | nan | Ciliary dyskinesia, primary, 50, 620356 (3), Autosomal recessive
chr2	STK17B	604727.0 | STK17B, DRAK2 | Serine/threonine protein kinase 17b | 9262.0 | ENSG00000081320 | nan | nan
chr2	HECW2	617245.0 | HECW2, NEDL2, KIAA1301, NDHSAL | HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 2 | 57520.0 | ENSG00000138411 | nan | Neurodevelopmental disorder with hypotonia, seizures, and absent language, 617268 (3), Autosomal dominant
chr2	ANIB9	612586.0 | ANIB9 | Aneurysm, intracranial berry, 9 | 100271688.0 | nan | associated with rs700651 | {Aneurysm, intracranial berry, 9}, 612586 (2)
chr2	EJM9	614280.0 | EJM9 | Epilepsy, juvenile myoclonic, susceptibility to, 9 | 100750238.0 | nan | max lod at D2S2248 | {Epilepsy, juvenile myoclonic, susceptibility to, 9}, 614280 (2), Autosomal dominant
chr2	RLS4	610439.0 | RLS4 | Restless legs syndrome, susceptibility to, 4 | 100188813.0 | nan | between D2S311 and D2S317 | {Restless legs syndrome 4}, 610439 (2)
chr2	GTF3C3	604888.0 | GTF3C3, TFIIIC102 | General transcription factor 3C, polypeptide 3 | 9330.0 | ENSG00000119041 | nan | nan
chr2	PGAP1	611655.0 | PGAP1, NEDDSBA | Post-GPI attachment to proteins 1 | 80055.0 | ENSG00000197121 | nan | Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities, 615802 (3), Autosomal recessive
chr2	ANKRD44	620861.0 | ANKRD44, ARSB | Ankyrin repeat domain-containing protein 44 | 91526.0 | ENSG00000065413 | nan | nan
chr2	SF3B1	605590.0 | SF3B1, SF3B155, SAP155, MDS | Splicing factor 3B, subunit 1 | 23451.0 | ENSG00000115524 | nan | Myelodysplastic syndrome, somatic, 614286 (3)
chr2	COQ10B	620737.0 | COQ10B | Coenzyme Q10B | 80219.0 | ENSG00000115520 | nan | nan
chr2	HSPD1	118190.0 | HSPD1, SPG13, HSP60, HLD4 | Heat-shock 60kD protein 1 | 3329.0 | ENSG00000144381 | nan | Spastic paraplegia 13, autosomal dominant, 605280 (3), Autosomal dominant; Leukodystrophy, hypomyelinating, 4, 612233 (3), Autosomal recessive
chr2	HSPE1	600141.0 | HSPE1, HSP10 | Heat-shock 10kD protein | 3336.0 | ENSG00000115541 | nan | nan
chr2	MOB4	609361.0 | MOB4, MOBKL3, PREI3, MOB1, MOB3 | MOB family, member 4 | 25843.0 | ENSG00000115540 | nan | nan
chr2	RFTN2	618215.0 | RFTN2 | Lipid raft linking protein 2 | 130132.0 | ENSG00000162944 | nan | nan
chr2	MARS2	609728.0 | MARS2, SPAX3, COXPD25 | Methionyl-tRNA synthetase 2 | 92935.0 | ENSG00000247626 | mutation identified in 1 COXPD25 family | ?Combined oxidative phosphorylation deficiency 25, 616430 (3), Autosomal recessive; Spastic ataxia 3, autosomal recessive, 611390 (3), Autosomal recessive
chr2	BOLL	606165.0 | BOLL, BOULE | BOL-like (Boule, Drosophila, homolog of) | 66037.0 | ENSG00000152430 | nan | nan
chr2	PLCL1	600597.0 | PLDL1, PLCE, PLCL | Phospholipase C-like 1 | 5334.0 | ENSG00000115896 | nan | nan
chr2	SATB2	608148.0 | SATB2, KIAA1034, GLSS | Special AT-rich sequence-binding protein 2 | 23314.0 | ENSG00000119042 | nan | Glass syndrome, 612313 (3), Autosomal dominant
chr2	FTCDNL1	614308.0 | FTCDNL1, FONG | Formiminotransferase cyclodeaminase N-terminal like | 348751.0 | ENSG00000226124 | nan | nan
chr2	C2orf69	619219.0 | C2orf69, COXPD53 | Chromosome 2 open reading frame 69 | 205327.0 | ENSG00000178074 | nan | Combined oxidative phosphorylation deficiency 53, 619423 (3), Autosomal recessive
chr2	TYW5	619882.0 | TYW5 | tRNA yW-synthesizing protein 5 | 129450.0 | ENSG00000162971 | nan | nan
chr2	MAIP1	617267.0 | MAIP1, C2orf47 | Matrix AAA peptidase-interacting protein 1 | 79568.0 | ENSG00000162972 | nan | nan
chr2	SPATS2L	613817.0 | SPATS2L, SGNP | Spermatogenesis-associated serine-rich protein 2-like | 26010.0 | ENSG00000196141 | nan | nan
chr2	SGO2	612425.0 | SGOL2, SGO2, TRIPIN | Shugoshin-like 2 | 151246.0 | ENSG00000163535 | nan | nan
chr2	AOX1	602841.0 | AOX1 | Aldehyde oxidase-1 | 316.0 | ENSG00000138356 | nan | nan
chr2	BZW1	619252.0 | BZW1, BZAP45, KIAA0005 | Basic leucine zipper domain- and W2 domain-containing protein 1 | 9689.0 | ENSG00000082153 | nan | nan
chr2	CLK1	601951.0 | CLK1, CLK, STY | CDC-like kinase 1 | 1195.0 | ENSG00000013441 | nan | nan
chr2	PPIL3	615811.0 | PPIL3 | Peptidyl-prolyl isomerase-like 3 | 53938.0 | ENSG00000240344 | nan | nan
chr2	NIF3L1	605778.0 | NIF3L1 | NGG1 interacting factor 3-like 1 | 60491.0 | ENSG00000196290 | nan | nan
chr2	ORC2	601182.0 | ORC2, ORC2L | Origin recognition complex, subunit 2 | 4999.0 | ENSG00000115942 | nan | nan
chr2	NDUFB3	603839.0 | NDUFB3, MC1DN25 | NADH-ubiquinone oxidoreductase subunit B3 | 4709.0 | ENSG00000119013 | pseudogenes on chr. 1, 9, and 14 | Mitochondrial complex I deficiency, nuclear type 25, 618246 (3), Autosomal recessive
chr2	CFLAR	603599.0 | CFLAR, FLIP, CASPER, FLAME1, CASH | CASP8- and FADD-like apoptosis regulator | 8837.0 | ENSG00000003402 | nan | nan
chr2	CASP10	601762.0 | CASP10, MCH4, ALPS2 | Caspase 10, apoptosis-related cysteine protease | 843.0 | ENSG00000003400 | nan | Autoimmune lymphoproliferative syndrome, type II, 603909 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3)
chr2	CASP8	601763.0 | CASP8, MCH5, ALPS2B | Caspase 8, apoptosis-related cysteine protease | 841.0 | ENSG00000064012 | mutation identified in 1 CEDS family | {Breast cancer, protection against}, 114480 (3), Somatic mutation, Autosomal dominant; ?Caspase 8 lymphadenopathy syndrome, 607271 (3), Autosomal recessive; Hepatocellular carcinoma, somatic, 114550 (3); {Lung cancer, protection against}, 211980 (3), Somatic mutation, Autosomal dominant
chr2	FLACC1	619796.0 | FLACC1, ALS2CR12 | Flagellum-associated protein containing coiled-coil domains 1 | 130540.0 | ENSG00000155749 | nan | nan
chr2	TRAK2	607334.0 | TRAK2, GRIF1, ALS2CR3, KIAA0549, OIP98 | Gamma-aminobutyric acid receptor-interacting factor 1 | 66008.0 | ENSG00000115993 | nan | nan
chr2	STRADB	607333.0 | STRADB, ILPIP, ALS2CR2 | STE20-related kinase adaptor beta | 55437.0 | ENSG00000082146 | pseudogenes on chromosomes 1 and 9 | nan
chr2	C2CD6	619776.0 | C2CD6, ALS2CR11, SPGF68 | C2 calcium-dependent domain-containing protein 6 | 151254.0 | ENSG00000155754 | mutation identified in 1 SPGF68 patient | ?Spermatogenic failure 68, 619805 (3), Autosomal recessive
chr2	TMEM237	614423.0 | TMEM237, ALS2CR4, JBTS14 | Transmembrane protein 237 | 65062.0 | ENSG00000155755 | nan | Joubert syndrome 14, 614424 (3), Autosomal recessive
chr2	MPP4	606575.0 | MPP4, DLG6 | Membrane protein, palmitoylated 4 | 58538.0 | ENSG00000082126 | nan | nan
chr2	ALS2	606352.0 | ALS2, ALSJ, PLSJ, IAHSP | Alsin Rho guanine nucleotide exchange factor ALS2 | 57679.0 | ENSG00000003393 | nan | Primary lateral sclerosis, juvenile, 606353 (3), Autosomal recessive; Spastic paralysis, infantile onset ascending, 607225 (3), Autosomal recessive; Amyotrophic lateral sclerosis 2, juvenile, 205100 (3), Autosomal recessive
chr2	CDK15	616147.0 | CDK15, PFTAIRE2, ALS2CR7 | Cyclin-dependent kinase 15 | 65061.0 | ENSG00000138395 | nan | nan
chr2	FZD7	603410.0 | FZD7 | Frizzled class receptor 7 | 8324.0 | ENSG00000155760 | nan | nan
chr2	SUMO1	601912.0 | SUMO1, UBL1, SMT3, OFC10 | Small ubiquitin-like modifier 1 | 7341.0 | ENSG00000116030 | mutation identified in 1 OFC10 patient | ?Orofacial cleft 10, 613705 (3), Isolated cases
chr2	NOP58	616742.0 | NOP58, NOP5 | NOP58 ribonucleoprotein | 51602.0 | ENSG00000055044 | nan | nan
chr2	BMPR2	600799.0 | BMPR2, PPH1, POVD1 | Bone morphogenetic receptor, type II | 659.0 | ENSG00000204217 | nan | Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3), Autosomal dominant; Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3), Autosomal dominant; Pulmonary venoocclusive disease 1, 265450 (3), Autosomal dominant
chr2	WDR12	616620.0 | WDR12 | WD repeat-containing protein 12 | 55759.0 | ENSG00000138442 | nan | nan
chr2	CARF	607586.0 | ALS2CR8, CARF | Amyotrophic lateral sclerosis 2 chromosome region, candidate 8 (calcium response factor) | 79800.0 | ENSG00000138380 | nan | nan
chr2	NBEAL1	609816.0 | NBEAL1, ALS2CR17 | Neurobeachin-like 1 | 65065.0 | ENSG00000144426 | nan | nan
chr2	ABI2	606442.0 | ABI2, AIP1 | ABL interactor 2 | 10152.0 | ENSG00000138443 | nan | nan
chr2	RAPH1	609035.0 | RAPH1, KIAA1681, LPD | RAS association and pleckstrin homology domains-containing protein 1 | 65059.0 | ENSG00000173166 | nan | nan
chr2	CD28	186760.0 | CD28, IMD123 | CD28 antigen (Tp44) | 940.0 | ENSG00000178562 | mutation identified in 1 IMD123 family | ?Immunodeficiency 123 with HPV-related verrucosis, 620901 (3), Autosomal recessive
chr2	CTLA4	123890.0 | CTLA4, IDDM12, CELIAC3, ALPS5 | Cytotoxic T-lymphocyte-associated serine esterase-4 | 1493.0 | ENSG00000163599 | nan | Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation, 616100 (3), Autosomal dominant; {Diabetes mellitus, insulin-dependent, 12}, 601388 (3); {Celiac disease, susceptibility to, 3}, 609755 (3); {Hashimoto thyroiditis}, 140300 (3), Autosomal dominant; {Systemic lupus erythematosus, susceptibility to}, 152700 (3), Autosomal dominant
chr2	ICOS	604558.0 | ICOS, AILIM, CVID1 | Inducible costimulator | 29851.0 | ENSG00000163600 | nan | Immunodeficiency, common variable, 1, 607594 (3), Autosomal recessive
chr2	OS4	610839.0 | OS4, GOA1 | Osteoarthritis susceptibility 4 | 100188821.0 | nan | max lod at D2S2358 | {Osteoarthritis susceptibility 4}, 610839 (2)
chr2	PARD3B	619353.0 | PARD3B | PAR3 family cell polarity regulator, beta | 117583.0 | ENSG00000116117 | nan | nan
chr2	NRP2	602070.0 | NRP2, VEGF1265R2, NPN2 | Neuropilin 2 | 8828.0 | ENSG00000118257 | nan | nan
chr2	INO80D	619207.0 | INO80D | INO80 complex, subunit D | 54891.0 | ENSG00000114933 | nan | nan
chr2	NDUFS1	157655.0 | NDUFS1, MC1DN5 | NADH-ubiquinone oxidoreductase core subunit S1 | 4719.0 | ENSG00000023228 | nan | Mitochondrial complex I deficiency, nuclear type 5, 618226 (3), Autosomal recessive
chr2	EEF1B2	600655.0 | EEF1B2, EEF1B1 | Eukaryotic translation elongation factor-1, beta-2 | 1933.0 | ENSG00000114942 | pseudogene on chr.15 | nan
chr2	CMKLR2	600239.0 | CMKLR2, GPR1 | Chemerin chemokine-like receptor 2 | 2825.0 | ENSG00000183671 | nan | nan
chr2	CMKLR2-AS	617636.0 | CMKLR2-AS, GPR1AS | CMKLR2 antisense RNA | 101669764.0 | nan | nan | nan
chr2	ZDBF2	617059.0 | ZDBF2, KIAA1571 | Zinc finger DBF domain-containing protein 2 | 57683.0 | ENSG00000204186 | nan | nan
chr2	ADAM23	603710.0 | ADAM23, MDC3 | ADAM metallopeptidase domain 23 | 8745.0 | ENSG00000114948 | nan | nan
chr2	DYTN	618510.0 | DYTN | Dystrotelin | 391475.0 | ENSG00000232125 | nan | nan
chr2	FASTKD2	612322.0 | FASTKD2, KIAA0971, COXPD44 | FAST kinase domains 2 | 22868.0 | ENSG00000118246 | nan | Combined oxidative phosphorylation deficiency 44, 618855 (3), Autosomal recessive
chr2	CPO	609563.0 | CPO | Carboxypeptidase O | 130749.0 | ENSG00000144410 | nan | nan
chr2	KLF7	604865.0 | KLF7, UKLF | Kruppel-like factor 7 | 8609.0 | ENSG00000118263 | nan | nan
chr2	MYOSLID	618976.0 | MYOSLID | Myocardin-induced smooth muscle long noncoding RNA, inducer of differentiation | 105373853.0 | nan | overlaps with 3 other lncRNAs in the opposite direction | nan
chr2	CREB1	123810.0 | CREB1 | cAMP-response element-binding protein-1 | 1385.0 | ENSG00000118260 | fusion gene with EWSR1 | Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)
chr2	METTL21A	615257.0 | METTL21A, FAM119A | Methyltransferase 21A, HSPA lysine | 151194.0 | ENSG00000144401 | nan | nan
chr2	CCNYL1	620559.0 | CCNYL1 | Cyclin Y-like 1 | 151195.0 | ENSG00000163249 | nan | nan
chr2	FZD5	601723.0 | FZD5, MCOPCB11 | Frizzled class receptor 5 | 7855.0 | ENSG00000163251 | nan | Microphthalmia/coloboma 11, 620731 (3), Autosomal dominant
chr2	PLEKHM3	619186.0 | PLEKHM3, DAPR | Pleckstrin homology domain-containing protein, family M, member 3 | 389072.0 | ENSG00000178385 | nan | nan
chr2	CRYGD	123690.0 | CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC | Crystallin, gamma D | 1421.0 | ENSG00000118231 | nan | Cataract 4, multiple types, 115700 (3), Autosomal dominant
chr2	CRYGC	123680.0 | CRYGC, CRYG3, CTRCT2, CCL | Crystallin, gamma C | 1420.0 | ENSG00000163254 | nan | Cataract 2, multiple types, 604307 (3), Autosomal dominant
chr2	CRYGB	123670.0 | CRYGB, CRYG2, CTRCT39 | Crystallin, gamma B | 1419.0 | ENSG00000182187 | nan | Cataract 39, multiple types, autosomal dominant, 615188 (3), Autosomal dominant
chr2	CRYGA	123660.0 | CRYGA, CRYG1 | Crystallin, gamma A | 1418.0 | ENSG00000168582 | nan | nan
chr2	C2orf80	615536.0 | C2orf80, GONDA1 | Chromosome 2 open reading frame 80 | 389073.0 | ENSG00000188674 | nan | nan
chr2		185900.0 | DUP2q35, C2DUPq35, SDTY1, SD1 | Chromosome 2q35 duplication syndrome (syndactyly, type I) | nan | nan | phenotypes due to different-sized duplications of 2q35 | Craniosynostosis, Philadelphia type, with syndactyly, 185900 (4), Autosomal dominant; Syndactyly, type 1, 185900 (4), Autosomal dominant
chr2	IDDM13	601318.0 | IDDM13 | Insulin-dependent diabetes mellitus-13 | 3412.0 | nan | nan | {Diabetes mellitus, insulin-dependent, 13}, 601318 (2)
chr2	SLEN2	607966.0 | SLEN2 | Systemic lupus erythematosus with nephritis, susceptibility to, 2 | 192679.0 | nan | nan | {Systemic lupus erythematosus with nephritis, susceptibility to, 2}, 607966 (2)
chr2		186860.0 | TCL4 | T-cell leukemia/lymphoma-4 | 6946.0 | nan | nan | Leukemia/lymphoma, T-cell, 186860 (2)
chr2	IDH1	147700.0 | IDH1 | Isocitrate dehydrogenase (NADP+) 1 | 3417.0 | ENSG00000138413 | nan | {Glioma, susceptibility to, somatic}, 137800 (3)
chr2	PIKFYVE	609414.0 | PIKFYVE, PIP5K3 | Phosphatidylinositol kinase, FYVE-finger containing | 200576.0 | ENSG00000115020 | nan | Corneal fleck dystrophy, 121850 (3), Autosomal dominant
chr2	PTH2R	601469.0 | PTHR2 | Parathyroid hormone receptor 2 | 5746.0 | ENSG00000144407 | nan | nan
chr2	MAP2	157130.0 | MAP2 | Microtubule-associated protein-2 | 4133.0 | ENSG00000078018 | nan | nan
chr2	UNC80	612636.0 | UNC80, C2orf21, KIAA1843 | Unc-80 homolog, NALCN channel complex subunit | 285175.0 | ENSG00000144406 | nan | Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3), Autosomal recessive
chr2	RPE	180480.0 | RPE | Ribulose 5-phosphate 3-epimerase | 6120.0 | ENSG00000197713 | nan | nan
chr2	KANSL1L	613833.0 | KANSL1L, C2orf67, MSL1V2 | KAT8 regulatory NSL complex subunit 1-like | 151050.0 | ENSG00000144445 | nan | nan
chr2	ACADL	609576.0 | ACADL, LCAD | Acyl-Coenzyme A dehydrogenase, long chain | 33.0 | ENSG00000115361 | nan | nan
chr2	MYL1	160780.0 | MYL1, CMYO14 | Myosin, light polypeptide-1, alkali, skeletal, fast | 4632.0 | ENSG00000168530 | nan | Congenital myopathy 14, 618414 (3), Autosomal recessive
chr2	LANCL1	604155.0 | LANCL1, GPR69A | LanC-like 1 (G protein-coupled receptor 69A) | 10314.0 | ENSG00000115365 | nan | nan
chr2	CPS1	608307.0 | CPS1, PHN | Carbamoyl-phosphate synthetase 1, mitochondrial | 1373.0 | ENSG00000021826 | urea cycle enzyme | Carbamoylphosphate synthetase I deficiency, 237300 (3), Autosomal recessive; {Pulmonary hypertension, neonatal, susceptibility to}, 615371 (3)
chr2	ERBB4	600543.0 | ERBB4, HER4, ALS19 | Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4 | 2066.0 | ENSG00000178568 | nan | Amyotrophic lateral sclerosis 19, 615515 (3), Autosomal dominant
chr2	IKZF2	606234.0 | IKZF2, ANF1A2, HELIOS | Ikaros family zinc finger 2 | 22807.0 | ENSG00000030419 | nan | nan
chr2	SPAG16	612173.0 | SPAG16, PF20 | Sperm-associated antigen 16 | 79582.0 | ENSG00000144451 | nan | nan
chr2	VWC2L	619794.0 | VWC2L | von Willebrand factor C domain-containing protein 2-like | 402117.0 | ENSG00000174453 | nan | nan
chr2	MTBS1	607949.0 | MTBS1 | Mycobacterium tuberculosis, susceptibility to infection by | 404716.0 | nan | nan | {Tuberculosis, susceptibility to}, 607949 (2)
chr2	NBLST5	613016.0 | NBLST5 | Neuroblastoma, susceptibility to, 5 | 100306938.0 | nan | associated with rs6435862, rs3768716 | {Neuroblastoma, susceptibility to, 5}, 613016 (2)
chr2	BARD1	601593.0 | BARD1 | BRCA1-associated RING domain 1 | 580.0 | ENSG00000138376 | nan | {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant
chr2	ABCA12	607800.0 | ABCA12, ARCI4A, ARCI4B, ICR2B, LI2 | ATP-binding cassette, subfamily A, member 12 | 26154.0 | ENSG00000144452 | nan | Ichthyosis, congenital, autosomal recessive 4B (harlequin), 242500 (3), Autosomal recessive; Ichthyosis, congenital, autosomal recessive 4A, 601277 (3), Autosomal recessive
chr2	ATIC	601731.0 | ATIC, PURH, AICAR | 5-aminoimidazole-4-carboxyamide ribonucleotide formyltransferase/IMP cyclohydrolase | 471.0 | ENSG00000138363 | nan | AICA-ribosiduria due to ATIC deficiency, 608688 (3), Autosomal recessive
chr2	FN1	135600.0 | FN1, FN, LETS, FNZ, GFND2, SMDCF | Fibronectin-1 | 2335.0 | ENSG00000115414 | nan | Spondylometaphyseal dysplasia, corner fracture type, 184255 (3), Autosomal dominant; Glomerulopathy with fibronectin deposits 2, 601894 (3), Autosomal dominant
chr2	MREG	609207.0 | MREG, DSU | Melanoregulin | 55686.0 | ENSG00000118242 | nan | nan
chr2	PECR	605843.0 | PECR, TERP | Peroxisomal trans-2-enoyl-CoA reductase | 55825.0 | ENSG00000115425 | nan | nan
chr2	XRCC5	194364.0 | XRCC5 | X-ray repair cross complementing 5 | 7520.0 | ENSG00000079246 | included in YAC contig spanning 2q33-q34 | nan
chr2	MARCHF4	608208.0 | MARCH4, RNF174, KIAA1399 | Membrane-associated RING-CH finger protein 4 | 57574.0 | ENSG00000144583 | nan | nan
chr2	SMARCAL1	606622.0 | SMARCAL1, HARP, SIOD | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A-like | 50485.0 | ENSG00000138375 | nan | Schimke immunoosseous dysplasia, 242900 (3), Autosomal recessive
chr2	RPL37A	613314.0 | RPL37A | Ribosomal protein L37A | 6168.0 | ENSG00000197756 | nan | nan
chr2	IGFBP2	146731.0 | IGFBP2 | Insulin-like growth factor-binding protein-2, 36kD | 3485.0 | ENSG00000115457 | nan | nan
chr2	IGFBP5	146734.0 | IGFBP5, IBP5 | Insulin-like growth factor-binding protein 5 | 3488.0 | ENSG00000115461 | nan | nan
chr2	TNP1	190231.0 | TNP1 | Transition protein-1 | 7141.0 | ENSG00000118245 | nan | nan
chr2	DIRC3	608262.0 | DIRC3 | Disrupted in renal carcinoma 3 | 729582.0 | ENSG00000231672 | nan | nan
chr2	TNS1	600076.0 | TNS1, TNS | Tensin 1 | 7145.0 | ENSG00000079308 | nan | nan
chr2	RUFY4	620994.0 | RUFY4 | RUN and FYVE domains-containing protein 4 | 285180.0 | ENSG00000188282 | nan | nan
chr2	CXCR2	146928.0 | CXCR2, IL8RB, IL8R2, WHIMS2 | Chemokine, CXC motif, receptor 2 | 3579.0 | ENSG00000180871 | mutation identified in 1 WHIMS2 family | ?WHIM syndrome 2, 619407 (3), Autosomal recessive
chr2	CXCR1	146929.0 | CXCR1, IL8RA | Chemokine, CXC motif, receptor 1 | 3577.0 | ENSG00000163464 | nan | {AIDS, slow progression to}, 609423 (3)
chr2	ARPC2	604224.0 | ARPC2, ARC34 | Actin-related protein 2/3 complex, subunit 2 | 10109.0 | ENSG00000163466 | nan | nan
chr2	GPBAR1	610147.0 | GPBAR1, BG37 | G protein-coupled bile acid receptor 1 | 151306.0 | ENSG00000179921 | nan | nan
chr2	AAMP	603488.0 | AAMP | Angio-associated migratory cell protein | 14.0 | ENSG00000127837 | nan | nan
chr2	PNKD	609023.0 | PNKD, R1, TAHCCP2, KIPP1184, BRP17, FPD1, PDC, DYT8 | PNKD metallo-beta-lactamase domain-containing protein | 25953.0 | ENSG00000127838 | nan | Paroxysmal nonkinesigenic dyskinesia 1, 118800 (3), Autosomal dominant
chr2	TMBIM1	610364.0 | TMBIM1, RECS1 | Transmembrane BAX inhibitor motif-containing protein 1 | 64114.0 | ENSG00000135926 | nan | nan
chr2	CATIP	619387.0 | CATIP, C2orf62 | Ciliogenesis-associated TTC17-interacting protein | 375307.0 | ENSG00000158428 | mutation identifed in 1 SPGF54 family | ?Spermatogenic failure 54, 619379 (3), Autosomal recessive
chr2	SLC11A1	600266.0 | NRAMP1, NRAMP, SLC11A1 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 | 6556.0 | ENSG00000018280 | within 220 kb of VIL1 | {Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3); {Buruli ulcer, susceptibility to}, 610446 (3)
chr2	CTDSP1	605323.0 | CTDSP1, NLIIF, SCP1 | C-terminal domain of RNA polymerase II polypeptide A, small phosphatase of, 1 | 58190.0 | ENSG00000144579 | nan | nan
chr2	MIR26B	612152.0 | MIR26B, MIRN26B | Micro RNA 26B | 407017.0 | ENSG00000199121 | nan | nan
chr2	VIL1	193040.0 | VIL1 | Villin-1 | 7429.0 | ENSG00000127831 | nan | nan
chr2	USP37	620226.0 | USP37 | Ubiquitin-specific peptidase 37 | 57695.0 | ENSG00000135913 | nan | nan
chr2	CNOT9	612054.0 | CNOT9, RQCD1, RCD1 | CCR4-NOT transcription complex subunit 9 | 9125.0 | ENSG00000144580 | nan | nan
chr2	PLCD4	605939.0 | PLCD4 | Phospholipase C, delta-4 | 84812.0 | ENSG00000115556 | nan | nan
chr2	ZNF142	604083.0 | ZNF142, NEDISHM | Zinc finger protein-142 | 7701.0 | ENSG00000115568 | nan | Neurodevelopmental disorder with impaired speech and hyperkinetic movements, 618425 (3), Autosomal recessive
chr2	BCS1L	603647.0 | BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1 | BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone | 617.0 | ENSG00000074582 | nan | GRACILE syndrome, 603358 (3), Autosomal recessive; Mitochondrial complex III deficiency, nuclear type 1, 124000 (3), Autosomal recessive; Bjornstad syndrome, 262000 (3), Autosomal recessive
chr2	RNF25	616014.0 | RNF25, AO7 | Ring finger protein 25 | 64320.0 | ENSG00000163481 | nan | nan
chr2	STK36	607652.0 | STK36, FU, KIAA1278, CILD46 | Serine/threonine protein kinase 36 | 27148.0 | ENSG00000163482 | mutation identified in 1 CILD46 patient | ?Ciliary dyskinesia, primary, 46, 619436 (3), Autosomal recessive
chr2	TTLL4	618738.0 | TTLL4 | Tubulin tyrosine ligase-like 4 | 9654.0 | ENSG00000135912 | nan | nan
chr2	CYP27A1	606530.0 | CYP27A1, CYP27, CTX | Cytochrome P450, subfamily XXVIIA, polypeptide 1 (sterol 27-hydroxylase) | 1593.0 | ENSG00000135929 | nan | Cerebrotendinous xanthomatosis, 213700 (3), Autosomal recessive
chr2	PRKAG3	604976.0 | PRKAG3, SMGMQTL | Protein kinase, AMP-activated, noncatalytic, gamma 3 | 53632.0 | ENSG00000115592 | nan | [Skeletal muscle glycogen content and metabolism QTL], 619030 (3), Autosomal recessive
chr2	WNT6	604663.0 | WNT6 | Wingless-type MMTV integration site family, member 6 | 7475.0 | ENSG00000115596 | nan | nan
chr2	WNT10A	606268.0 | WNT10A, SSPS, STHAG4, ECTD16, OODD | Wingless-type MMTV integration site family, member 10A | 80326.0 | ENSG00000135925 | nan | Schopf-Schulz-Passarge syndrome, 224750 (3), Autosomal recessive; Tooth agenesis, selective, 4, 150400 (3), Autosomal recessive, Autosomal dominant; Ectodermal dysplasia 16 (odontoonychodermal dysplasia), 257980 (3), Autosomal recessive
chr2	CDK5R2	603764.0 | CDK5R2, NCK5AI | Cyclin-dependent kinase 5, regulatory subunit 2 | 8941.0 | ENSG00000171450 | nan | nan
chr2	FEV	607150.0 | FEV | FEV transcription factor, ETS family member | 54738.0 | ENSG00000163497 | fused with EWS in tumors | nan
chr2	CRYBA2	600836.0 | CRYBA2, CTRCT42 | Crystallin, beta A2 | 1412.0 | ENSG00000163499 | mutation identified in 1 CTRCT42 family | ?Cataract 42, 115900 (3), Autosomal dominant
chr2	MIR375	611173.0 | MIR375, MIRN375 | Micro RNA 375 | 494324.0 | ENSG00000198973 | nan | nan
chr2	CFAP65	614270.0 | CFAP65, CCDC108, SPGF40 | Cilia- and flagella-associated protein 65 | 255101.0 | ENSG00000181378 | nan | Spermatogenic failure 40, 618664 (3), Autosomal recessive
chr2	IHH	600726.0 | IHH, BDA1 | Indian hedgehog | 3549.0 | ENSG00000163501 | nan | Acrocapitofemoral dysplasia, 607778 (3), Autosomal recessive; Brachydactyly, type A1, 112500 (3), Autosomal dominant
chr2	NHEJ1	611290.0 | NHEJ1, XLF, IMD124, MCOPCB13 | Nonhomologous end-joining factor 1 | 79840.0 | ENSG00000187736 | nan | Microphthalmia/coloboma 13, 620968 (3), Autosomal recessive; Immunodeficiency 124, severe combined, 611291 (3), Autosomal recessive
chr2	SLC23A3	620339.0 | SLC23A3, YSPL1 | Solute carrier family 23, member 3 | 151295.0 | ENSG00000213901 | nan | nan
chr2	ZFAND2B	613474.0 | ZFAND2B, AIRAPL | Zinc finger AN1 domain-containing protein 2B | 130617.0 | ENSG00000158552 | nan | nan
chr2	ABCB6	605452.0 | ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2 | ATP-binding cassette, subfamily B, member 6 | 10058.0 | ENSG00000115657 | nan | Dyschromatosis universalis hereditaria 3, 615402 (3), Autosomal dominant; [Blood group, Langereis system], 111600 (3); Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3), Autosomal dominant; Microphthalmia/coloboma 7, 614497 (3), Autosomal dominant
chr2	ATG9A	612204.0 | ATG9A, APG9L1 | Autophagy related 9A | 79065.0 | ENSG00000198925 | nan | nan
chr2	ANKZF1	617541.0 | ANKZF1, ZNF744 | Ankyrin repeat- and zinc finger domain-containing 1 | 55139.0 | ENSG00000163516 | nan | nan
chr2	STK16	604719.0 | STK16, TSF1 | Serine/threonine protein kinase 16 | 8576.0 | ENSG00000115661 | nan | nan
chr2	TUBA4A	191110.0 | TUBA4A, TUBA1, ALS22 | Tubulin, alpha-4A | 7277.0 | ENSG00000127824 | nan | Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia, 616208 (3), Autosomal dominant
chr2	DNAJB2	604139.0 | DNAJB2, HSJ1, HSPF3, HMNR5 | DNAJ/HSP40 homolog, subfamily B, member 2 | 3300.0 | ENSG00000135924 | nan | Neuronopathy, distal hereditary motor, autosomal recessive 5, 614881 (3), Autosomal recessive
chr2	PTPRN	601773.0 | PTPRN, IA2 | Protein tyrosine phosphatase, receptor type N (islet cell antigen 2) | 5798.0 | ENSG00000054356 | nan | nan
chr2	RESP18	612721.0 | RESP18 | Regulated endocrine-specific protein 18 | 389075.0 | ENSG00000182698 | nan | nan
chr2	DNPEP	611367.0 | DNPEP, ASPEP, DAP | Aspartyl aminopeptidase | 23549.0 | ENSG00000123992 | nan | nan
chr2	DES	125660.0 | DES, CMD1I, MFM1, SCPNK | Desmin | 1674.0 | ENSG00000175084 | nan | Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3), Autosomal dominant; Cardiomyopathy, dilated, 1I, 604765 (3), Autosomal dominant; Myopathy, myofibrillar, 1, 601419 (3), Autosomal recessive, Autosomal dominant
chr2	SPEG	615950.0 | SPEG, APEG1, CNM5 | SPEG complex locus | 10290.0 | ENSG00000072195 | nan | Centronuclear myopathy 5, 615959 (3), Autosomal recessive
chr2	GMPPA	615495.0 | GMPPA, AAMR | GDP-mannose pyrophosphorylase A | 29926.0 | ENSG00000144591 | nan | Alacrima, achalasia, and impaired intellectual development syndrome, 615510 (3), Autosomal recessive
chr2	ASIC4	606715.0 | ACCN4, ASIC4, BNAC4 | Cation channel, amiloride-sensitive, neuronal, 4 | 55515.0 | ENSG00000072182 | nan | nan
chr2	CHPF	610405.0 | CHPF, CSS2 | Chondroitin polymerizing factor | 79586.0 | ENSG00000123989 | nan | nan
chr2	OBSL1	610991.0 | OBSL1, KIAA0657, 3M2 | Obscurin-like 1 | 23363.0 | ENSG00000124006 | nan | 3-M syndrome 2, 612921 (3), Autosomal recessive
chr2	INHA	147380.0 | INHA | Inhibin, alpha | 3623.0 | ENSG00000123999 | proximal to PAX3 | nan
chr2	STK11IP	607172.0 | STK11IP, KIAA1898, LIP1 | Serine/threonine kinase 11 interacting protein | 114790.0 | ENSG00000144589 | nan | nan
chr2	SLC4A3	106195.0 | SLC4A3, SLC2C, AE3, SQT7 | Solute carrier family 4 (anion exchanger), member 3 | 6508.0 | ENSG00000114923 | nan | Short QT syndrome 7, 620231 (3), Autosomal dominant
chr2	ACRPV	102510.0 | ACRPV | Acropectorovertebral dysplasia (F syndrome) | 414058.0 | nan | nan | Acropectorovertebral dysplasia, 102510 (2), Autosomal dominant
chr2	IGAN2	613944.0 | IGAN2 | IgA nephropathy, susceptibility to, 2 | 100653384.0 | nan | between D2S1323 and D2S362 | {IgA nephropathy, susceptibility to, 2}, 613944 (2), ?Autosomal dominant
chr2	SPDA3	613238.0 | SPDA3 | Spondyloarthropathy, susceptibility to, 3 | 100379218.0 | nan | max lod at D2S2228 | {Spondyloarthropathy, susceptibility to, 3}, 613238 (2)
chr2	EPHA4	602188.0 | EPHA4, HEK8, TYRO1 | Ephrin receptor EphA4 | 2043.0 | ENSG00000116106 | nan | nan
chr2	PAX3	606597.0 | PAX3, WS1, HUP2, CDHS, WS3 | Paired box homeotic gene-3 | 5077.0 | ENSG00000135903 | nan | Craniofacial-deafness-hand syndrome, 122880 (3), Autosomal dominant; Waardenburg syndrome, type 3, 148820 (3), Autosomal recessive, Autosomal dominant; Waardenburg syndrome, type 1, 193500 (3), Autosomal dominant; Rhabdomyosarcoma 2, alveolar, 268220 (3), Somatic mutation
chr2	SGPP2	612827.0 | SGPP2, SPP2 | Sphingosine-1-phosphate phosphatase 2 | 130367.0 | ENSG00000163082 | nan | nan
chr2	FARSB	609690.0 | FARSB, FARSLB, RILDBC1 | Phenylalanine-tRNA synthetase-like, beta subunit | 10056.0 | ENSG00000116120 | nan | Rajab interstitial lung disease with brain calcifications 1, 613658 (3), Autosomal recessive
chr2	MOGAT1	610268.0 | MOGAT1, MGAT1, DGAT2L1 | Monoacylglycerol O-acyltransferase 1 | 116255.0 | ENSG00000124003 | nan | nan
chr2	ACSL3	602371.0 | ACSL3, FACL3, ACS3 | Acyl-CoA synthetase long-chain family member 3 | 2181.0 | ENSG00000123983 | nan | nan
chr2	KCNE4	607775.0 | KCNE4, MIRP3 | Potassium channel, voltage-gated, ISK-related subfamily, member 4 | 23704.0 | ENSG00000152049 | nan | nan
chr2	SCG2	118930.0 | SCG2, CHGC | Secretogranin II (chromogranin C) | 7857.0 | ENSG00000171951 | nan | nan
chr2	AP1S3	615781.0 | AP1S3, PSORS15 | Adaptor-related protein complex 1, sigma-3 subunit | 130340.0 | ENSG00000152056 | nan | {Psoriasis 15, pustular, susceptibility to}, 616106 (3), Autosomal dominant
chr2	WDFY1	618080.0 | WDFY1, FENS1 | WD repeat-and FYVE domain-containing protein 1 | 57590.0 | ENSG00000085449 | nan | nan
chr2	MRPL44	611849.0 | MRPL44, COXPD16 | Mitochondrial ribosomal protein L44 | 65080.0 | ENSG00000135900 | nan | Combined oxidative phosphorylation deficiency 16, 615395 (3), Autosomal recessive
chr2	SERPINE2	177010.0 | PI7, PN1, SERPINE2 | Protease inhibitor 7 (protease nexin I) | 5270.0 | ENSG00000135919 | near MYL1; ?COPD susceptibility | nan
chr2	FAM124B	618403.0 | FAM124B | Family with sequence similarity 124, member B | 79843.0 | ENSG00000124019 | nan | nan
chr2	CUL3	603136.0 | CUL3, PHA2E, NEDAUS | Cullin 3 | 8452.0 | ENSG00000036257 | nan | Neurodevelopmental disorder with or without autism or seizures, 619239 (3), Autosomal dominant; Pseudohypoaldosteronism, type IIE, 614496 (3), Autosomal dominant
chr2	DOCK10	611518.0 | DOCK10, KIAA0694, ZIZ3 | Dedicator of cytokinesis 10 | 55619.0 | ENSG00000135905 | nan | nan
chr2	NYAP2	615478.0 | NYPA2, KIAA1486 | Neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 2 | 57624.0 | ENSG00000144460 | nan | nan
chr2	IRS1	147545.0 | IRS1 | Insulin receptor substrate-1 | 3667.0 | ENSG00000169047 | nan | {Type 2 diabetes mellitus, susceptibility to}, 125853 (3), Autosomal dominant
chr2	RHBDD1	617515.0 | RHBDD1, RRP4, RHBDL4 | Rhomboid domain-containing 1 | 84236.0 | ENSG00000144468 | nan | nan
chr2	COL4A4	120131.0 | COL4A4, ATS2, BFH1 | Collagen IV, alpha-4 polypeptide | 1286.0 | ENSG00000081052 | head-to-head with COL4A4 in same YAC | Hematuria, familial benign, 1, 141200 (3), Autosomal dominant; Alport syndrome 2, autosomal recessive, 203780 (3), Autosomal recessive
chr2	COL4A3	120070.0 | COL4A3, ATS3A, ATS3B, BFH2 | Collagen IV, alpha-3 polypeptide (Goodpasture antigen) | 1285.0 | ENSG00000169031 | noncollagenous domain = Goodpasture antigen | Alport syndrome 3A, autosomal dominant, 104200 (3), Autosomal dominant; Hematuria, benign familial, 2, 620320 (3), Autosomal dominant; Alport syndrome 3B, autosomal recessive, 620536 (3)
chr2	MFF	614785.0 | MFF, C2orf33, EMPF2 | Mitochondrial fission factor | 56947.0 | ENSG00000168958 | nan | Encephalopathy due to defective mitochondrial and peroxisomal fission 2, 617086 (3), Autosomal recessive
chr2	TM4SF20	615404.0 | TM4SF20, SLI5 | Transmembrane 4 L6 family, member 20 | 79853.0 | ENSG00000168955 | nan | {Specific language impairment 5}, 615432 (3), Autosomal dominant
chr2	AGFG1	600862.0 | AGFG1, HRB, RIP, RAB | ADP-ribosylation factor GTPase-activating protein with FG repeats 1 | 3267.0 | ENSG00000173744 | nan | nan
chr2	SLC19A3	606152.0 | SLC19A3, THMD2, BBGD | Solute carrier family 19 (folate transporter), member 3 | 80704.0 | ENSG00000135917 | nan | Thiamine metabolism dysfunction syndrome 2 (biotin/thiamine-responsive basal ganglia disease type), 607483 (3), Autosomal recessive
chr2	CCL20	601960.0 | CCL20, SCYA20, MIP3A, LARC | Chemokine, C-C motif, ligand 20 | 6364.0 | ENSG00000115009 | nan | nan
chr2	DAW1	620279.0 | DAW1, WDR69, ODA16, CILD52 | Dynein assembly factor with WD repeats 1 | 164781.0 | ENSG00000123977 | nan | Ciliary dyskinesia, primary, 52, 620570 (3), Autosomal recessive
chr2	SPHKAP	611646.0 | SPHKAP, SKIP, KIAA1678 | SPHK1 interactor, AKAP domain containing | 80309.0 | ENSG00000153820 | nan | nan
chr2	PID1	612930.0 | PID1, NYGGF4 | Phosphotyrosine interaction domain-containing 1 | 55022.0 | ENSG00000153823 | nan | nan
chr2	DNER	607299.0 | DNER | Delta-and notch-like egf-related receptor | 92737.0 | ENSG00000187957 | nan | nan
chr2	TRIP12	604506.0 | TRIP12, MRD49 | Thyroid hormone receptor interactor 12 | 9320.0 | ENSG00000153827 | nan | Intellectual developmental disorder, autosomal dominant 49, 617752 (3), Autosomal dominant
chr2	FBXO36	609105.0 | FBXO36, FBX36 | F-box only protein 36 | 130888.0 | ENSG00000153832 | nan | nan
chr2		600430.0 | BDMR, C2DELq37, DEL2q37 | Chromosome 2q37 deletion syndrome | nan | nan | nan | Chromosome 2q37 deletion syndrome, 600430 (4), Autosomal dominant
chr2	HPE6	605934.0 | HPE6 | Holoprosencephaly 6 | 117190.0 | nan | nan | Holoprosencephaly 6, 605934 (2)
chr2	MYP12	609995.0 | MYP12 | Myopia 12 | 664780.0 | nan | max lod at D2S2344 | Myopia 12, 609995 (2)
chr2	STQTL21	613440.0 | STQTL21 | Stature quantitative trait locus 21 | 100502568.0 | nan | associated with rs6717918 | {Stature QTL 21}, 613440 (2)
chr2	SP110	604457.0 | SP110, IFI41, IFI75, VODI | SP110 nuclear body protein (interferon-induced protein 41, 30kD; interferon-induced protein 75, 52kD) | 3431.0 | ENSG00000135899 | nan | {Mycobacterium tuberculosis, susceptibility to}, 607948 (3); Hepatic venoocclusive disease with immunodeficiency, 235550 (3), Autosomal recessive
chr2	SP140	608602.0 | SP140, LYSP100 | Nuclear body protein sp140 | 11262.0 | ENSG00000079263 | nan | nan
chr2	SP140L	617747.0 | SP140L | Nuclear body protein SP140-like | 93349.0 | ENSG00000185404 | nan | nan
chr2	SP100	604585.0 | SP100 | Nuclear antigen SP100 | 6672.0 | ENSG00000067066 | nan | nan
chr2	CAB39	612174.0 | CAB39 | Calcium-binding protein 39 | 51719.0 | ENSG00000135932 | nan | nan
chr2	ITM2C	609554.0 | ITM2C, BRI3 | Integral membrane protein 2C | 81618.0 | ENSG00000135916 | nan | nan
chr2	GPR55	604107.0 | GPR55 | G protein-coupled receptor 55 | 9290.0 | ENSG00000135898 | nan | nan
chr2	SPATA3	619857.0 | SPATA3, TSARG1 | Spermatogenesis-associated protein 3 | 130560.0 | ENSG00000173699 | nan | nan
chr2	PSMD1	617842.0 | PSMD1 | Proteasome 26S subunit, non-ATPase, 1 | 5707.0 | ENSG00000173692 | nan | nan
chr2	HTR2B	601122.0 | HTR2B | 5-hydroxytryptamine (serotonin) receptor-2B | 3357.0 | ENSG00000135914 | nan | nan
chr2	ARMC9	617612.0 | ARMC9, KIAA1868, JBTS30 | Armadillo repeat-containing protein 9 | 80210.0 | ENSG00000135931 | nan | Joubert syndrome 30, 617622 (3), Autosomal recessive
chr2	B3GNT7	615313.0 | B3GNT7 | Beta-1,3-N-acetylglucosaminyltransferase 7 | 93010.0 | ENSG00000156966 | nan | nan
chr2	NCL	164035.0 | NCL | Nucleolin | 4691.0 | ENSG00000115053 | nan | nan
chr2	SNORD20	604012.0 | RNU20 | RNA, U20 small nucleolar | 6082.0 | ENSG00000207280 | nan | nan
chr2	SNORD82	611133.0 | SNORD82, RNU82 | Small nucleolar RNA, C/D box, 82 | 25826.0 | ENSG00000202400 | nan | nan
chr2	NMUR1	604153.0 | NMUR1, GPR66, FM3 | Neuromedin U receptor 1 | 10316.0 | ENSG00000171596 | nan | nan
chr2	PTMA	188390.0 | PTMA, TMSA | Prothymosin, alpha (gene sequence 28) | 5757.0 | ENSG00000187514 | nan | nan
chr2	PDE6D	602676.0 | PDE6D, JBTS22 | Phosphodiesterase 6D | 5147.0 | ENSG00000156973 | nan | Joubert syndrome 22, 615665 (3), Autosomal recessive
chr2	COPS7B	616010.0 | COPS7B | COP9 signalosome, subunit 7B | 64708.0 | ENSG00000144524 | nan | nan
chr2	NPPC	600296.0 | NPPC | Natriuretic peptide precursor C | 4880.0 | ENSG00000163273 | nan | nan
chr2	DIS3L2	614184.0 | DIS3L2, PRLMNS | DIS3 like exosome 3'-5' exoribonuclease 2 | 129563.0 | ENSG00000144535 | nan | Perlman syndrome, 267000 (3), Autosomal recessive
chr2	ALPP	171800.0 | ALPP | Alkaline phosphatase, placental (Regan isozyme) | 250.0 | ENSG00000163283 | nan | nan
chr2	ALPG	171810.0 | ALPPL2 | Alkaline phosphatase, placental-like 2 | 251.0 | ENSG00000163286 | nan | nan
chr2	ALPI	171740.0 | ALPI | Alkaline phosphatase, intestinal | 248.0 | ENSG00000163295 | close to ALPP; proximal to PAX3 | nan
chr2	ECEL1	605896.0 | ECEL1, XCE, DA5D | Endothelin-converting enzyme-like 1 | 9427.0 | ENSG00000171551 | nan | Arthrogryposis, distal, type 5D, 615065 (3), Autosomal recessive
chr2	PRSS56	613858.0 | PRSS56, MCOP6 | Protease, serine, 56 | 646960.0 | ENSG00000237412 | nan | Microphthalmia, isolated 6, 613517 (3), Autosomal recessive
chr2	CHRND	100720.0 | CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C | Cholinergic receptor, nicotinic, delta polypeptide | 1144.0 | ENSG00000135902 | mutation identified in 1 CMS3A patient and 1 CMS3C family | ?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3), Autosomal recessive; Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessive; Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3), Autosomal recessive; ?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3), Autosomal dominant
chr2	CHRNG	100730.0 | CHRNG, ACHRG | Cholinergic receptor, nicotinic, gamma polypeptide | 1146.0 | ENSG00000196811 | tightly linked to CHRND by RE | Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessive; Escobar syndrome, 265000 (3), Autosomal recessive
chr2	TIGD1	612972.0 | TIGD1 | TIGGER transposable element-derived gene 1 | 200765.0 | ENSG00000221944 | nan | nan
chr2	EIF4E2	605895.0 | EIF4E2, EIF4EL3, 4EHP | Eukaryotic translation initiation factor 4E family, member 2 | 9470.0 | ENSG00000135930 | nan | nan
chr2	EFHD1	611617.0 | EFHD1 | EF-hand domain family, member D1 | 80303.0 | ENSG00000115468 | nan | nan
chr2	GIGYF2	612003.0 | GIGYF2, KIAA0642, PARK11 | GRB10-interacting GYF protein 2 | 26058.0 | ENSG00000204120 | nan | {Parkinson disease 11}, 607688 (3)
chr2	KCNJ13	603208.0 | KCNJ13, SVD, LCA16 | Potassium inwardly-rectifying channel, subfamily J, member 13 | 3769.0 | ENSG00000115474 | nan | Snowflake vitreoretinal degeneration, 193230 (3), Autosomal dominant; Leber congenital amaurosis 16, 614186 (3), Autosomal recessive
chr2	SNORC	620882.0 | SNORC | Secondary ossification center-associated regulator of chondrocyte maturation | 389084.0 | ENSG00000182600 | nan | nan
chr2	NGEF	605991.0 | NGEF | Neuronal guanine nucleotide exchange factor | 25791.0 | ENSG00000066248 | nan | nan
chr2	NEU2	605528.0 | NEU2, SIAL2 | Neuraminidase 2 | 4759.0 | ENSG00000115488 | nan | nan
chr2	INPP5D	601582.0 | INPP5D, SHIP | Inositol polyphosphate-5-phosphatase, 145kD | 3635.0 | ENSG00000168918 | nan | nan
chr2	ATG16L1	610767.0 | ATG16L1, APG16L, IBD10 | Autophagy related 16 like 1 | 55054.0 | ENSG00000085978 | nan | {Inflammatory bowel disease (Crohn disease) 10}, 611081 (3)
chr2	SCARNA5	615640.0 | SCARNA5 | Small Cajal body-specific RNA 5 | 677775.0 | ENSG00000252010 | within intron 9 of ATG16L1 | nan
chr2	SCARNA6	615641.0 | SCARNA6 | Small Cajal body-specific RNA 6 | 677772.0 | ENSG00000251791 | within intron 12 of ATG16L1 | nan
chr2	SAG	181031.0 | SAG, RP47, RP96 | S-antigen; retina and pineal gland (arrestin) | 6295.0 | ENSG00000130561 | nan | Retinitis pigmentosa 47, autosomal recessive, 613758 (3), Autosomal recessive; Retinitis pigmentosa 96, autosomal dominant, 620228 (3), Autosomal dominant; Oguchi disease-1, 258100 (3), Autosomal recessive
chr2	DGKD	601826.0 | DGKD | Diacylglycerol kinase, delta, 130kD | 8527.0 | ENSG00000077044 | nan | nan
chr2	USP40	610570.0 | USP40 | Ubiquitin-specific protease 40 | 55230.0 | ENSG00000085982 | nan | nan
chr2	UGT1A8	606433.0 | UGT1A8 | UDP-glycosyltransferase 1 family, polypeptide A8 | 54576.0 | ENSG00000242366 | nan | nan
chr2	UGT1A10	606435.0 | UGT1A10 | UDP-glycosyltransferase 1 family, polypeptide A10 | 54575.0 | ENSG00000242515 | nan | nan
chr2	UGT1A9	606434.0 | UGT1A9 | UDP-glycosyltransferase 1 family, polypeptide A9 | 54600.0 | ENSG00000241119 | nan | nan
chr2	UGT1A7	606432.0 | UGT1A7 | UDP-glycosyltransferase 1 family, polypeptide A7 | 54577.0 | ENSG00000244122 | nan | nan
chr2	UGT1A6	606431.0 | UGT1A6 | UDP-glycosyltransferase 1 family, polypeptide A6 | 54578.0 | ENSG00000167165 | nan | nan
chr2	UGT1A5	606430.0 | UGT1A5 | UDP-glycosyltransferase 1 family, polypeptide A5 | 54579.0 | ENSG00000288705 | nan | nan
chr2	UGT1A4	606429.0 | UGT1A4, UGT1D | UDP-glycosyltransferase 1 family, polypeptide A4 | 54657.0 | ENSG00000244474 | nan | nan
chr2	UGT1A3	606428.0 | UGT1A3, UGT1C | UDP-glycosyltransferase 1 family, polypeptide A3 | 54659.0 | ENSG00000288702 | nan | nan
chr2	UGT1A1	191740.0 | UGT1A1, UGT1, GNT1, BILIQTL1 | UDP glycosyltransferase 1 family, polypeptide A1 | 54658.0 | ENSG00000241635 | nan | Crigler-Najjar syndrome, type I, 218800 (3), Autosomal recessive; [Bilirubin, serum level of, QTL1], 601816 (3); Hyperbilirubinemia, familial transient neonatal, 237900 (3), Autosomal recessive, Autosomal dominant; Crigler-Najjar syndrome, type II, 606785 (3), Autosomal recessive; [Gilbert syndrome], 143500 (3), Autosomal recessive
chr2	HJURP	612667.0 | HJURP | Holliday junction recognition protein | 55355.0 | ENSG00000123485 | nan | nan
chr2	TRPM8	606678.0 | TRPM8, TRPP8 | Transient receptor potential cation channel, subfamily M, member 8 | 79054.0 | ENSG00000144481 | nan | nan
chr2	SPP2	602637.0 | SPP2 | Secreted phosphoprotein-2, 24kD | 6694.0 | ENSG00000072080 | nan | nan
chr2	ARL4C	604787.0 | ARL4C, ARL7 | ADP ribosylation factor-like GTPase 4C | 10123.0 | ENSG00000188042 | nan | nan
chr2	SH3BP4	605611.0 | SH3BP4, BOG25 | SH3 domain-binding protein 4 | 23677.0 | ENSG00000130147 | nan | nan
chr2	AGAP1	608651.0 | AGAP1, CENTG2, KIAA1099 | Arf GTPase-activating protein with GTPase domain, ankyrin repeat, and pleckstrin homology domain 1 | 116987.0 | ENSG00000157985 | nan | nan
chr2	GBX2	601135.0 | GBX2 | Gastrulation brain homeobox 2 | 2637.0 | ENSG00000168505 | nan | nan
chr2	ACKR3	610376.0 | ACKR3, CXCR7, CMKOR1, GPR159, RDC1 | Atypical chemokine receptor 3 | 57007.0 | ENSG00000144476 | mutation identified in 1 OCABSN family | ?Oculomotor-abducens synkinesis, 619215 (3), Autosomal recessive
chr2	COPS8	616011.0 | COPS8, CSN8 | COP9 signalosome, subunit 8 | 10920.0 | ENSG00000198612 | nan | nan
chr2	COL6A3	120250.0 | COL6A3, DYT27, BTHLM1C, UCMD1C | Collagen VI, alpha-3 polypeptide | 1293.0 | ENSG00000163359 | close to CRBP1 | Bethlem myopathy 1C, 620726 (3), Autosomal recessive, Autosomal dominant; Ullrich congenital muscular dystrophy 1C, 620728 (3), Autosomal recessive, Autosomal dominant; Dystonia 27, 616411 (3), Autosomal recessive
chr2	MLPH	606526.0 | MLPH | Melanophilin | 79083.0 | ENSG00000115648 | nan | Griscelli syndrome, type 3, 609227 (3), Autosomal recessive
chr2	PRLH	602663.0 | PRLH, PRRP | Prolactin-releasing hormone | 51052.0 | ENSG00000071677 | nan | nan
chr2	RAB17	602206.0 | RAB17 | Ras-associated protein | 64284.0 | ENSG00000124839 | nan | nan
chr2	LRRFIP1	603256.0 | LRRFIP1, GCF2, TRIP, FLAP1 | Leucine-rich repeat in FLII-interacting protein 1 | 9208.0 | ENSG00000124831 | nan | nan
chr2	RAMP1	605153.0 | RAMP1 | Receptor activity-modifying protein 1 | 10267.0 | ENSG00000132329 | nan | nan
chr2	UBE2F	617700.0 | UBE2F, NCE2 | Ubiquitin-conjugating enzyme E2 F (putative) | 140739.0 | ENSG00000184182 | nan | nan
chr2	SCLY	611056.0 | SCLY, SCL | Selenocysteine lyase | 51540.0 | ENSG00000132330 | nan | nan
chr2	ESPNL	619974.0 | ESPNL | Espin-like protein | 339768.0 | ENSG00000144488 | nan | nan
chr2	ERFE	615099.0 | ERFE, FAM132B, CTRP15 | Erythroferrone | 151176.0 | ENSG00000178752 | nan | nan
chr2	ILKAP	618909.0 | ILKAP, PP2CD | ILK-associated serine/threonine phosphatase | 80895.0 | ENSG00000132323 | nan | nan
chr2	HES6	610331.0 | HES6 | Hes family bHLH transcription factor 6 | 55502.0 | ENSG00000144485 | nan | nan
chr2	PER2	603426.0 | PER2, FASPS1, KIAA0347 | Period circadian regulator 2 | 8864.0 | ENSG00000132326 | mutation identified in 1 FASPS1 family | ?Advanced sleep phase syndrome, familial, 1, 604348 (3), Autosomal dominant
chr2	TRAF3IP1	607380.0 | TRAF3IP1, MIPT3, SLSN9 | TNF receptor-associated factor 3-interacting protein 1 | 26146.0 | ENSG00000204104 | nan | Senior-Loken syndrome 9, 616629 (3), Autosomal recessive
chr2	ASB1	605758.0 | ASB1 | Ankyrin repeat-containing SOCS box protein 1 | 51665.0 | ENSG00000065802 | nan | nan
chr2	TWIST2	607556.0 | TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS | Twist family bHLH transcription factor 2 | 117581.0 | ENSG00000233608 | nan | Ablepharon-macrostomia syndrome, 200110 (3), Autosomal dominant; Barber-Say syndrome, 209885 (3), Autosomal dominant; Focal facial dermal dysplasia 3, Setleis type, 227260 (3), Autosomal recessive
chr2	HDAC4	605314.0 | HDAC4, HDACA, NEDCHF | Histone deacetylase 4 | 9759.0 | ENSG00000068024 | nan | Neurodevelopmental disorder with central hypotonia and dysmorphic facies, 619797 (3), Autosomal dominant
chr2	NDUFA10	603835.0 | NDUFA10, MC1DN22 | NADH-ubiquinone oxidoreductase subunit A10 | 4705.0 | ENSG00000130414 | nan | Mitochondrial complex I deficiency, nuclear type 22, 618243 (3), Autosomal recessive
chr2	COPS9	619349.0 | COPS9, CSNAP, MYEOV2 | COP9 signalosome, subunit 9 | 150678.0 | ENSG00000172428 | nan | nan
chr2	OTOS	607877.0 | OTOSP | Otospiralin | 150677.0 | ENSG00000178602 | nan | nan
chr2	GPC1	600395.0 | GPC1 | Glypican 1 | 2817.0 | ENSG00000063660 | nan | nan
chr2	MIR149	615209.0 | MIR149 | Micro RNA 149 | 406941.0 | ENSG00000207611 | nan | nan
chr2	ANKMY1	620842.0 | ANKMY1, ZMYND13 | Ankyrin repeat- and MYND domain-containing protein 1 | 51281.0 | ENSG00000144504 | nan | nan
chr2	RNPEPL1	605287.0 | RNPEPL1 | Arginyl aminopeptidase-like 1 (aminopeptidase B-like) | 57140.0 | ENSG00000142327 | nan | nan
chr2	CAPN10	605286.0 | CAPN10, NIDDM1 | Calpain-10 | 11132.0 | ENSG00000142330 | nan | {Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)
chr2	GPR35	602646.0 | GPR35 | G protein-coupled receptor-35 | 2859.0 | ENSG00000178623 | nan | nan
chr2	AQP12A	609789.0 | AQP12A, AQPX2, AQP12 | Aquaporin 12A | 375318.0 | ENSG00000184945 | nan | nan
chr2	KIF1A	601255.0 | KIF1A, ATSV, UNC104, SPG30A, SPG30B, HSN2C, MRD9 | Kinesin family member 1A | 547.0 | ENSG00000130294 | incorrectly assigned to chr.9 | NESCAV syndrome, 614255 (3), Autosomal dominant; Neuropathy, hereditary sensory, type IIC, 614213 (3), Autosomal recessive; Spastic paraplegia 30, autosomal dominant, 610357 (3), Autosomal dominant; Spastic paraplegia 30, autosomal recessive, 620607 (3), Autosomal recessive
chr2	AGXT	604285.0 | AGXT, SPAT | Alanine-glyoxylate aminotransferase, liver-specific peroxisomal | 189.0 | ENSG00000172482 | nan | Hyperoxaluria, primary, type 1, 259900 (3), Autosomal recessive
chr2	SNED1	616634.0 | SNED1, SNEP | SUSHI, NIDOGEN, and EGF-like domains protein 1 | 25992.0 | ENSG00000162804 | nan | nan
chr2	MTERF4	615393.0 | MTERF4, MTERFD2 | Mitochondrial transcription termination factor 4 | 130916.0 | ENSG00000122085 | nan | nan
chr2	PASK	607505.0 | PASK, KIAA0135 | Pas domain-containing serine-threonine kinase | 23178.0 | ENSG00000115687 | nan | nan
chr2	PPP1R7	602877.0 | PPP1R7, SDS22 | Protein phosphatase 1, regulatory subunit 7 | 5510.0 | ENSG00000115685 | nan | nan
chr2	ANO7	605096.0 | TMEM16G, PCANAP5, IPCA5, DTMPP, NGEP | Transmembrane protein 16G | 50636.0 | ENSG00000146205 | nan | nan
chr2	HDLBP	142695.0 | HDLBP, VGL | High-density lipoprotein-binding protein | 3069.0 | ENSG00000115677 | nan | nan
chr2	SEPTIN2	601506.0 | SEPT2, NEDD5, DIFF6 | Septin 2 | 4735.0 | ENSG00000168385 | nan | nan
chr2	FARP2	617586.0 | FARP2, FRG, FIR | FERM, ARHGEF, and pleckstrin domain-containing protein 2 | 9855.0 | ENSG00000006607 | nan | nan
chr2	STK25	602255.0 | STK25, SOK1, YSK1 | Serine/threonine protein kinase 25 | 10494.0 | ENSG00000115694 | nan | nan
chr2	BOK	605404.0 | BOK, BCL2L9 | BCL2-related ovarian killer | 666.0 | ENSG00000176720 | nan | nan
chr2	THAP4	612533.0 | THAP4 | THAP domain-containing protein 4 | 51078.0 | ENSG00000176946 | nan | nan
chr2	ATG4B	611338.0 | ATG4B, APG4B, KIAA0943 | Autophagy related 4B cysteine peptidase | 23192.0 | ENSG00000168397 | nan | nan
chr2	DTYMK	188345.0 | DTYMK, TYMK, CDC8, CONPM | Deoxythymidylate kinase | 1841.0 | ENSG00000168393 | nan | Neurodegeneration, childhood-onset, with progressive microcephaly, 619847 (3), Autosomal recessive
chr2	ING5	608525.0 | ING5 | Inhibitor of growth-5 | 84289.0 | ENSG00000168395 | nan | nan
chr2	D2HGDH	609186.0 | D2HGDH, D2HGD | D-2-hydroxyglutarate dehydrogenase | 728294.0 | ENSG00000180902 | nan | D-2-hydroxyglutaric aciduria, 600721 (3), Autosomal recessive
chr2	GAL3ST2	608237.0 | GAL3ST2, GP3ST | Galactose-3-O-sulfotransferase 2 | 64090.0 | ENSG00000154252 | nan | nan
chr2	NEU4	608527.0 | NEU4 | Neuraminidase 4 | 129807.0 | ENSG00000204099 | nan | nan
chr2	PDCD1	600244.0 | PDCD1, SLEB2 | Programmed cell death 1 | 5133.0 | ENSG00000188389 | nan | {Multiple sclerosis, disease progression, modifier of}, 126200 (3), Multifactorial; {Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3)
chr2		601136.0 | TSE2 | Transsuppressor of expression 2 | 57324.0 | nan | nan | nan
chr3	CRCL	607135.0 | CRCL | Creatinine clearance QTL | 261727.0 | nan | in African Americans | Creatinine clearance QTL, 607135 (2)
chr3		613792.0 | DEL3pterp25, C3DELpterp25 | 3p- syndrome (chromosome 3pter-p25 deletion syndrome) | nan | nan | contiguous gene deletion syndrome | 3p- syndrome, 613792 (4), Autosomal dominant
chr3	HPC5	609299.0 | HPC5 | Prostate cancer, hereditary, 5 | 619402.0 | nan | between D3S1270 and D3S4559 | {Prostate cancer, hereditary, 5}, 609299 (2)
chr3	IBD9	608448.0 | IBD9 | Inflammatory bowel disease 9 | 317669.0 | nan | nan | {Inflammatory bowel disease 9}, 608448 (2)
chr3	MYMY1	252350.0 | MYMY1, MYMY | Moyamoya disease | 50960.0 | nan | max lod at D3S3050 | Moyamoya disease, 252350 (2), Autosomal recessive
chr3	STQTL5	608982.0 | STQTL5 | Stature quantitative trait locus 5 | 619479.0 | nan | max lod between D3S1297 and D3S1304 | {Stature QTL 5}, 608982 (2)
chr3	CHL1	607416.0 | CHL1, CALL, L1CAM2 | Cell adhesion molecule L1-like | 10752.0 | ENSG00000134121 | nan | nan
chr3	CNTN6	607220.0 | CNTN6, NB3 | Contactin 6 | 27255.0 | ENSG00000134115 | nan | nan
chr3	CNTN4	607280.0 | CNTN4 | Contactin 4 | 152330.0 | ENSG00000144619 | nan | nan
chr3	IL5RA	147851.0 | IL5RA | Interleukin-5 receptor, alpha | 3568.0 | ENSG00000091181 | nan | nan
chr3	TRNT1	612907.0 | TRNT1, SIFD, RPEM | tRNA nucleotidyltransferase, CCA-adding, 1 | 51095.0 | ENSG00000072756 | pseudogenes on chromosomes 1 and 22 | Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3), Autosomal recessive; Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3), Autosomal recessive
chr3	CRBN	609262.0 | CRBN, MRT2 | Cereblon | 51185.0 | ENSG00000113851 | between D3S3525 and D3S1560 | Intellectual developmental disorder, autosomal recessive 2, 607417 (3), Autosomal recessive
chr3	LRRN1	619623.0 | LRRN1, NLRR1 | Leucine-rich repeat neuronal protein 1 | 57633.0 | ENSG00000175928 | nan | nan
chr3	ARHI2	612976.0 | ARHI2 | Age-related hearing impairment 2 | 100302721.0 | nan | associated with rs11928865, rs779701, and rs779706 | {Age-related hearing impairment 2}, 612976 (2)
chr3	SUMF1	607939.0 | SUMF1, FGE | Sulfatase-modifying factor-1 | 285362.0 | ENSG00000144455 | nan | Multiple sulfatase deficiency, 272200 (3), Autosomal recessive
chr3	SETMAR	609834.0 | SETMAR, METNASE | SET and Mariner transposase domains-containing protein | 6419.0 | ENSG00000170364 | nan | nan
chr3	ITPR1	147265.0 | ITPR1, SCA15, SCA16, SCA29 | Inositol 1,4,5-triphosphate receptor, type 1 | 3708.0 | ENSG00000150995 | nan | Gillespie syndrome, 206700 (3), Autosomal recessive, Autosomal dominant; Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3), Autosomal dominant; Spinocerebellar ataxia 15, 606658 (3), Autosomal dominant
chr3	EGOT	611662.0 | EGOT, EGO | Eosinophil granule ontogeny transcript | 100126791.0 | ENSG00000235947 | nan | nan
chr3	BHLHE40	604256.0 | BHLHE40, HLHB2, STRA13, DEC1 | Basic helix-loop-helix family, member E40 | 8553.0 | ENSG00000134107 | nan | nan
chr3	ARL8B	616596.0 | ARL8B, GIE1 | ADP ribosylation factor-like GTPase 8B | 55207.0 | ENSG00000134108 | nan | nan
chr3	EDEM1	607673.0 | EDEM, KIAA0212 | ER degradation-enhancing alpha-mannosidase-like protein | 9695.0 | ENSG00000134109 | nan | nan
chr3	GRM7	604101.0 | GRM7, MGLUR7, NEDSHBA | Glutamate receptor, metabotropic, 7 | 2917.0 | ENSG00000196277 | nan | Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities, 618922 (3), Autosomal recessive
chr3	OVCAS1	607893.0 | OVCAS1 | Ovarian cancer, susceptibility to, 1 | 574048.0 | nan | between D3S1597 and D3S3611 | {Ovarian cancer, susceptibility to}, 607893 (2)
chr3	LMCD1	604859.0 | LMCD1 | LIM and cysteine-rich domains 1 | 29995.0 | ENSG00000071282 | nan | nan
chr3	LINC00312	610485.0 | LINC00312, LOH3CR2A | Long intergenic non-protein coding RNA 312 | 29931.0 | nan | nan | nan
chr3	SSUH2	617479.0 | SSUH2, C3orf32, FLS485 | Ssu-2 homolog | 51066.0 | ENSG00000125046 | nan | nan
chr3	CAV3	601253.0 | CAV3, LQT9, MPDT, RMD2 | Caveolin-3 | 859.0 | ENSG00000182533 | within 7-10kb of OXTR | Myopathy, distal, Tateyama type, 614321 (3), Autosomal dominant; Creatine phosphokinase, elevated serum, 123320 (3), Autosomal dominant; Cardiomyopathy, familial hypertrophic, 192600 (3), Digenic dominant, Autosomal dominant; Rippling muscle disease 2, 606072 (3), Autosomal dominant; Long QT syndrome 9, 611818 (3), Autosomal dominant
chr3	OXTR	167055.0 | OXTR | Oxytocin receptor | 5021.0 | ENSG00000180914 | 3p25 by others; within 7-10kb of CAV3 | nan
chr3	RAD18	605256.0 | RAD18 | RAD18 E3 ubiquitin protein ligase | 56852.0 | ENSG00000070950 | nan | nan
chr3	SRGAP3	606525.0 | SRGAP3, KIAA0411, MEGAP | Slit-robo GTPase-activating protein, rho, 3 | 9901.0 | ENSG00000196220 | nan | nan
chr3	SETD5	615743.0 | SETD5, KIAA1757, MRD23 | SET domain-containing protein 5 | 55209.0 | ENSG00000168137 | nan | Intellectual developmental disorder, autosomal dominant 23, 615761 (3), Autosomal dominant
chr3	LHFPL4	610240.0 | LHFPL4 | LHFP tetraspan subfamily, member 4 | 375323.0 | ENSG00000156959 | nan | nan
chr3	MTMR14	611089.0 | MTMR14, C3orf29, HJUMPY | Myotubularin-related protein 14 | 64419.0 | ENSG00000163719 | nan | {Centronuclear myopathy, autosomal, modifier of}, 160150 (3), Autosomal dominant
chr3	BRPF1	602410.0 | BRPF1, BR140, IDDDFP | Bromodomain- and PHD finger-containing protein 1, 140kD | 7862.0 | ENSG00000156983 | nan | Intellectual developmental disorder with dysmorphic facies and ptosis, 617333 (3), Autosomal dominant
chr3	OGG1	601982.0 | OGG1 | 8-hydroxyguanine DNA glycosylase | 4968.0 | ENSG00000114026 | nan | Renal cell carcinoma, clear cell, somatic, 144700 (3)
chr3	CAMK1	604998.0 | CAMK1, CAMKI | Calcium/calmodulin-dependent protein kinase I | 8536.0 | ENSG00000134072 | nan | nan
chr3	TADA3	602945.0 | TADA3, TADA3L, ADA3 | Transcriptional adaptor 3 | 10474.0 | ENSG00000171148 | nan | nan
chr3	ARPC4	604226.0 | ARPC4, ARC20, DEVLO | Actin-related protein 2/3 complex, subunit 4 | 10093.0 | ENSG00000241553 | nan | Developmental delay, language impairment, and ocular abnormalities, 620141 (3), Autosomal dominant
chr3	TTLL3	619195.0 | TTLL3 | Tubulin tyrosine ligase-like 3 | 26140.0 | ENSG00000214021 | nan | nan
chr3	RPUSD3	617759.0 | RPUSD3 | RNA pseudouridylate synthase domain-containing protein 3 | 285367.0 | ENSG00000156990 | nan | nan
chr3	CIDEC	612120.0 | CIDEC, FSP27, CIDE3, FPLD5 | Cell death-inducing DFFA-like effector C | 63924.0 | ENSG00000187288 | 1 patient identified with mutation | ?Lipodystrophy, familial partial, type 5, 615238 (3), Autosomal recessive
chr3	JAGN1	616012.0 | JAGN1, SCN6 | Jagunal homolog 1 | 84522.0 | ENSG00000171135 | nan | Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3), Autosomal recessive
chr3	IL17RE	614995.0 | IL17RE | Interleukin 17 receptor E | 132014.0 | ENSG00000163701 | nan | nan
chr3	IL17RC	610925.0 | IL17RC, IL17RL, CANDF9 | Interleukin 17 receptor C | 84818.0 | ENSG00000163702 | nan | Candidiasis, familial, 9, 616445 (3), Autosomal recessive
chr3	CRELD1	607170.0 | CRELD1, AVSD2, JELANS | Cysteine-rich protein with EGF-like domains 1 | 78987.0 | ENSG00000163703 | nan | Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3), Autosomal dominant; Jeffries-Lakhani neurodevelopmental syndrome, 620771 (3), Autosomal recessive; {Atrioventricular septal defect, susceptibility to, 2}, 606217 (3), Autosomal dominant
chr3	PRRT3	619993.0 | PRRT3 | Proline-rich transmembrane protein 3 | 285368.0 | ENSG00000163704 | nan | nan
chr3	PRRT3-AS1	619106.0 | PRRT3AS1 | PRRT3 antisense RNA 1, noncoding | 100874032.0 | ENSG00000230082 | nan | nan
chr3	EMC3	620273.0 | EMC3 | Endoplasmic reticulum membrane protein complex, subunit 3 | 55831.0 | ENSG00000125037 | nan | nan
chr3	FANCD2	613984.0 | FANCD2, FANCD, FACD, FAD | Fanconi anemia, complementation group D2 | 2177.0 | ENSG00000144554 | nan | Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive
chr3	BRK1	611183.0 | BRK1, C3orf10, HSPC300 | BRICK1, SCAR/WAVE actin-nucleating complex subunit | 55845.0 | ENSG00000254999 | nan | nan
chr3	VHL	608537.0 | VHL | von Hippel-Lindau tumor suppressor | 7428.0 | ENSG00000134086 | nan | Hemangioblastoma, cerebellar, somatic (3); Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive; von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant; Renal cell carcinoma, somatic, 144700 (3); Pheochromocytoma, 171300 (3), Autosomal dominant
chr3	IRAK2	603304.0 | IRAK2 | Interleukin 1 receptor-associated kinase 2 | 3656.0 | ENSG00000134070 | nan | nan
chr3	TATDN2	619330.0 | TATDN2, KIAA0218 | TatD DNase domain-containing protein 2 | 9797.0 | ENSG00000157014 | nan | nan
chr3	GHRLOS	618445.0 | GHRLOS | Ghrelin opposite strand, noncoding | 100126793.0 | ENSG00000240288 | nan | nan
chr3	GHRL	605353.0 | GHRL | Ghrelin | 51738.0 | ENSG00000157017 | nan | {Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant
chr3	SEC13	600152.0 | SEC13, SEC13L1, D3S1231E, SEC13R | SEC13 homolog, nuclear pore and COPII coat complex component | 6396.0 | ENSG00000157020 | nan | nan
chr3	ATP2B2	108733.0 | ATP2B2, PMCA2, DFNA82 | ATPase, Ca++ transporting, plasma membrane, 2 | 491.0 | ENSG00000157087 | nan | Deafness, autosomal dominant 82, 619804 (3), Autosomal dominant; {Deafness, autosomal recessive 12, modifier of}, 601386 (3), Autosomal recessive
chr3	SLC6A11	607952.0 | SLC6A11, GAT3, GAT4 | Solute carrier family 6 (neurotransmitter transporter, GABA), member 11 | 6538.0 | ENSG00000132164 | nan | nan
chr3	SLC6A1	137165.0 | SLC6A1, GABATR, MAE | Solute carrier family 6 (neurotransmitter transporter, GABA), member 1 | 6529.0 | ENSG00000157103 | nan | Myoclonic-atonic epilepsy, 616421 (3), Autosomal dominant
chr3	HRH1	600167.0 | HRH1 | Histamine receptor, subclass H1 | 3269.0 | ENSG00000196639 | nan | nan
chr3	ATG7	608760.0 | ATG7, APG7L, GSA7, SCAR31 | Autophagy related 7 | 10533.0 | ENSG00000197548 | nan | Spinocerebellar ataxia, autosomal recessive 31, 619422 (3), Autosomal recessive
chr3	VGLL4	618692.0 | VGLL4, KIAA0121 | Vestigial-like family member 4 | 9686.0 | ENSG00000144560 | nan | nan
chr3		606661.0 | UVM2 | Melanoma, uveal, susceptibility to, 2 | nan | nan | nan | {Melanoma, uveal, susceptibility to, 2}, 606661 (2), Autosomal dominant
chr3	TAMM41	614948.0 | TAMM41, RAM41, C3orf31, COXPD56 | TAM41 mitochondrial translocator assembly and maintenance homolog | 132001.0 | ENSG00000144559 | nan | Combined oxidative phosphorylation deficiency 56, 620139 (3), Autosomal recessive
chr3	SYN2	600755.0 | SYN2 | Synapsin II | 6854.0 | ENSG00000157152 | nan | {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant
chr3	TIMP4	601915.0 | TIMP4 | Tissue inhibitor of metalloproteinase 4 | 7079.0 | ENSG00000157150 | nan | nan
chr3	PPARG	601487.0 | PPARG, PPARG1, PPARG2, CIMT1, GLM1 | Peroxisome proliferator activated receptor, gamma | 5468.0 | ENSG00000132170 | PPARG1, PPARG2 from same gene | {Diabetes, type 2}, 125853 (3), Autosomal dominant; Insulin resistance, severe, digenic, 604367 (3), Autosomal dominant; Lipodystrophy, familial partial, type 3, 604367 (3), Autosomal dominant; [Obesity, resistance to] (3); Obesity, severe, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant; Carotid intimal medial thickness 1, 609338 (3)
chr3	TSEN2	608753.0 | TSEN2, SEN2, PCH2B | tRNA splicing endonuclease, subunit 2 | 80746.0 | ENSG00000154743 | nan | Pontocerebellar hypoplasia type 2B, 612389 (3), Autosomal recessive
chr3	MKRN2	608426.0 | MKRN2 | Makorin 2 | 23609.0 | ENSG00000075975 | nan | nan
chr3	RAF1	164760.0 | RAF1, CRAF, NS5, CMD1NN | Oncogene RAF1 | 5894.0 | ENSG00000132155 | nan | Cardiomyopathy, dilated, 1NN, 615916 (3), Autosomal dominant; Noonan syndrome 5, 611553 (3), Autosomal dominant; LEOPARD syndrome 2, 611554 (3), Autosomal dominant
chr3	CAND2	610403.0 | CAND2, TIP120B, KIAA0667 | Cullin-associated neddylation -dissociated 2 | 23066.0 | ENSG00000144712 | nan | nan
chr3	IQSEC1	610166.0 | IQSEC1, KIAA0763, IDDSSBA | IQ motif- and Sec7 domain-containing protein 1 | 9922.0 | ENSG00000144711 | nan | Intellectual developmental disorder with short stature and behavioral abnormalities, 618687 (3), Autosomal recessive
chr3	LGMD1H	613530.0 | LGMD1H | Muscular dystrophy, limb-girdle, type 1H | 100529230.0 | nan | between D3S1263 and D3S1277 | Muscular dystrophy, limb-girdle, type 1H, 613530 (2), Autosomal dominant
chr3	NUP210	607703.0 | NUP210, GP210, KIAA0906 | Nucleoporin, 210kD | 23225.0 | ENSG00000132182 | nan | nan
chr3	HDAC11	607226.0 | HDAC11 | Histone deacetylase 11 | 79885.0 | ENSG00000163517 | nan | nan
chr3	FBLN2	135821.0 | FBLN2 | Fibulin-2 | 2199.0 | ENSG00000163520 | nan | nan
chr3	WNT7A	601570.0 | WNT7A | Wingless-type MMTV integration site family, member 7A | 7476.0 | ENSG00000154764 | nan | Fuhrmann syndrome, 228930 (3), Autosomal recessive; Ulna and fibula, absence of, with severe limb deficiency, 276820 (3), Autosomal recessive
chr3	TPRXL	611167.0 | TPRXL | Tetrapeptide repeat homeobox-like | 348825.0 | ENSG00000292995 | nan | nan
chr3	CHCHD4	611077.0 | CHDH4, MIA40 | Coiled-coil-helix-coiled-coil-helix domain-containing protein 4 | 131474.0 | ENSG00000163528 | nan | nan
chr3	TMEM43	612048.0 | TMEM43, ARVD5, ARVC5, EDMD7, AUNA3 | Transmembrane protein 43 | 79188.0 | ENSG00000170876 | nan | Arrhythmogenic right ventricular dysplasia 5, 604400 (3), Autosomal dominant; Auditory neuropathy, autosomal dominant 3, 619832 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3), Autosomal dominant
chr3	XPC	613208.0 | XPC, XPCC | XPC complex subunit, DNA damage recognition and repair factor | 7508.0 | ENSG00000154767 | nan | Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessive
chr3	LSM3	607283.0 | LSM3 | LSM3 protein | 27258.0 | ENSG00000170860 | nan | nan
chr3	SLC6A6	186854.0 | SLC6A6, TAUT, HTRDC | Solute carrier family 6 (neurotransmitter transporter, taurine), member 6 | 6533.0 | ENSG00000131389 | nan | Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive
chr3	CCDC174	616735.0 | CCDC174, HSPC212, IHPM | Coiled-coil domain-containing protein 174 | 51244.0 | ENSG00000154781 | nan | Hypotonia, infantile, with psychomotor retardation, 616816 (3), Autosomal recessive
chr3	C3orf20	619992.0 | C3orf20 | Chromosome 3 open reading frame 20 | 84077.0 | ENSG00000131379 | nan | nan
chr3	FGD5	614788.0 | FGD5 | FYVE, RhoGEF, and PH domain-containing protein 5 | 152273.0 | ENSG00000154783 | nan | nan
chr3	NR2C2	601426.0 | NR2C2, TR4, TAK1 | Nuclear receptor subfamily 2, group C, member 2 | 7182.0 | ENSG00000177463 | nan | nan
chr3	MRPS25	611987.0 | MRPS25, COXPD50 | Mitochondrial ribosomal protein S25 | 64432.0 | ENSG00000131368 | mutation identified in 1 COXPD50 patient | ?Combined oxidative phosphorylation deficiency 50, 619025 (3), Autosomal recessive
chr3	RBSN	609511.0 | RBSN, ZFYVE20, KAREVS, MFANDO | Rabenosyn 5 | 64145.0 | ENSG00000131381 | nan | Myelofibrosis, congenital, with anemia, neutropenia, developmental delay, and ocular abnormalities, 620939 (3), Autosomal recessive; Kariminejad-Reversade neurodevelopmental syndrome, 620937 (3), Autosomal recessive
chr3	COL6A4P1	612397.0 | COL6A4P1, DVWA, DIVA, LOC344875 | Collagen, type VI, alpha 4, pseudogene 1 | 344875.0 | ENSG00000291281 | nan | nan
chr3	CAPN7	606400.0 | CAPN7, PALBH | Calpain 7 | 23473.0 | ENSG00000131375 | nan | nan
chr3	SH3BP5	605612.0 | SH3BP5, SAB | SH3 domain-binding protein 5 | 9467.0 | ENSG00000131370 | previously mapped to 1q431 | nan
chr3	METTL6	618903.0 | METTL6 | Methyltransferase 6, methylcytidine | 131965.0 | ENSG00000206562 | nan | nan
chr3	EAF1	608315.0 | EAF1 | ELL-associated factor 1 | 85403.0 | ENSG00000144597 | nan | nan
chr3	COLQ	603033.0 | COLQ, EAD, CMS5 | Collagenic tail of endplate acetylcholinesterase | 8292.0 | ENSG00000206561 | nan | Myasthenic syndrome, congenital, 5, 603034 (3), Autosomal recessive
chr3	HACL1	604300.0 | HACL1, HPCL2 | 2-hydroxyacyl-CoA lyase 1 | 26061.0 | ENSG00000131373 | nan | nan
chr3	BTD	609019.0 | BTD | Biotinidase | 686.0 | ENSG00000169814 | nan | Biotinidase deficiency, 253260 (3), Autosomal recessive
chr3	ANKRD28	611122.0 | ANKRD28, PITK, KIAA0379 | Ankyrin repeat domain-containing protein 28 | 23243.0 | ENSG00000206560 | nan | nan
chr3	GALNT15	615131.0 | GALNT15, GALNACT15 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 | 117248.0 | ENSG00000131386 | nan | nan
chr3	DPH3	608959.0 | DPH3, KTI11, ZCSL2, DELGIP1 | Diphthamide biosynthesis protein 3 | 285381.0 | ENSG00000154813 | nan | nan
chr3	OXNAD1	620581.0 | OXNAD1 | Oxidoreductase NAD-binding domain-contining protein 1 | 92106.0 | ENSG00000154814 | nan | nan
chr3	ASPG4	609954.0 | ASPG4 | Asperger syndrome, susceptibility to, 4 | 100188800.0 | nan | max lod at D3S2432 | {Asperger syndrome susceptibility 4}, 609954 (2)
chr3	ATOD9	613519.0 | ATOD9 | Dermatitis, atopic, 9 | 105463126.0 | nan | max lod at D3S1768 | {Dermatitis, atopic, susceptibility to, 9}, 613519 (2)
chr3	HSN1B	608088.0 | HSN1B | Hereditary sensory neuropathy, type IB | 378888.0 | nan | max lod at D3S2338 | Neuropathy, hereditary sensory, type IB, 608088 (2), Autosomal dominant
chr3	OS6	612401.0 | OS6 | Osteoarthritis susceptibility 6 | 100286836.0 | nan | associated with rs11718863 and rs7639618 | {Osteoarthritis susceptibility 6}, 612401 (2)
chr3	TRICY1	609649.0 | TRICY1 | Trichilemmal cyst 1 | 94014.0 | nan | max lod at D3S1277 | Trichilemmal cyst 1, 609649 (2), Autosomal dominant
chr3	RFTN1	618210.0 | RFTN1, KIAA0084 | Lipid raft linking protein 1 | 23180.0 | ENSG00000131378 | nan | nan
chr3	DAZL	601486.0 | DAZL, DAZH, SPGYLA | Deleted in azoospermia-like | 1618.0 | ENSG00000092345 | ?founding member of DAZ gene family | {Spermatogenic failure, susceptibility to} (3)
chr3	PLCL2	614276.0 | PLCL2, KIAA1092 | Phospholipase C-like 2 | 23228.0 | ENSG00000154822 | nan | nan
chr3	TBC1D5	615740.0 | TBC1D5, KIAA0210 | TBC1 domain family, member 5 | 9779.0 | ENSG00000131374 | nan | nan
chr3	SATB1	602075.0 | SATB1, DEFDA, DHDBV | Special AT-rich sequence binding protein-1 | 6304.0 | ENSG00000182568 | nan | den Hoed-de Boer-Voisin syndrome, 619229 (3), Autosomal dominant; Developmental delay with dysmorphic facies and dental anomalies, 619228 (3), Autosomal dominant
chr3	KCNH8	608260.0 | KCNH8, ELK1 | Potassium channel, voltage-gated, subfamily H, member 8 | 131096.0 | ENSG00000183960 | nan | nan
chr3	RAB5A	179512.0 | RAB5A, RAB5 | RAS-associated protein RAB5A | 5868.0 | ENSG00000144566 | nan | nan
chr3	KAT2B	602303.0 | CAF | CREBBP-associated factor | 8850.0 | ENSG00000114166 | nan | nan
chr3	SGO1	609168.0 | SGOL1, SGO, SGO1, CAID | Shugoshin-like 1 | 151648.0 | ENSG00000129810 | nan | Chronic atrial and intestinal dysrhythmia, 616201 (3), Autosomal recessive
chr3	UBE2E2	602163.0 | UBE2E2 | Ubiquitin-conjugating enzyme E2 E2 | 7325.0 | ENSG00000182247 | nan | nan
chr3	FEB9	611634.0 | FEB9 | Febrile seizures, familial, 9 | 100188849.0 | nan | between D3S3727 and D3S3567 | Febrile seizures, familial, 9, 611634 (2), Autosomal dominant
chr3	UBE2E1	602916.0 | UBE2E1, UBCH6 | Ubiquitin-conjugating enzyme E2 E1 | 7324.0 | ENSG00000170142 | nan | nan
chr3	NKIRAS1	604496.0 | NKIRAS1, KBRAS1 | NFKB inhibitor-interacting Ras-like protein 1 | 28512.0 | ENSG00000197885 | nan | nan
chr3	RPL15	604174.0 | RPL15, DBA12 | Ribosomal protein L15 | 6138.0 | ENSG00000174748 | nan | Diamond-Blackfan anemia 12, 615550 (3), Autosomal dominant
chr3	NR1D2	602304.0 | NR1D2, RVR, BD73 | Nuclear receptor subfamily 1, group D, member 2 | 9975.0 | ENSG00000174738 | nan | nan
chr3	THRB	190160.0 | THRB, ERBA2, THR1, PRTH | Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2) | 7068.0 | ENSG00000151090 | nan | Thyroid hormone resistance, autosomal recessive, 274300 (3), Autosomal recessive; Thyroid hormone resistance, 188570 (3), Autosomal dominant; Thyroid hormone resistance, selective pituitary, 145650 (3), Autosomal dominant
chr3	RARB	180220.0 | RARB, HAP, MCOPS12 | Retinoic acid receptor, beta polypeptide | 5915.0 | ENSG00000077092 | = HAP = HBV-activated protein | Microphthalmia, syndromic 12, 615524 (3), Autosomal recessive, Autosomal dominant
chr3	TOP2B	126431.0 | TOP2B, BILU | Topoisomerase (DNA) II, beta, 180kD | 7155.0 | ENSG00000077097 | nan | B-cell immunodeficiency, distal limb anomalies, and urogenital malformations, 609296 (3), Autosomal dominant
chr3	NGLY1	610661.0 | NGLY1, PNG1, CDDG, CDG1V | N-glycanase 1 | 55768.0 | ENSG00000151092 | nan | Congenital disorder of deglycosylation 1, 615273 (3), Autosomal recessive
chr3	OXSM	610324.0 | OXSM, KS | 3-oxoacyl-ACP synthase, mitochondrial | 54995.0 | ENSG00000151093 | nan | nan
chr3	LRRC3B	618996.0 | LRRC3B, LRP15 | Leucine-rich repeat-containing protein 3B | 116135.0 | ENSG00000179796 | nan | nan
chr3	NEK10	618726.0 | NEK10, CILD44 | NIMA-related kinase 10 | 152110.0 | ENSG00000163491 | nan | Ciliary dyskinesia, primary, 44, 618781 (3), Autosomal recessive
chr3	SLC4A7	603353.0 | SLC4A7, NBC2, NBC3 | Solute carrier family 4, sodium bicarbonate cotransporter, member 7 | 9497.0 | ENSG00000033867 | nan | nan
chr3	EOMES	604615.0 | EOMES, TBR2 | Eomesodermin | 8320.0 | ENSG00000163508 | ?translocation separating regulatory element from promoter | nan
chr3	CMC1	615166.0 | CMC1, C3orf68 | C-X9-C motif-containing 1 | 152100.0 | ENSG00000187118 | nan | nan
chr3	AZI2	609916.0 | AZI2, AZ2, NAP1, TILP | 5-azacytidine-induced protein 2 | 64343.0 | ENSG00000163512 | nan | nan
chr3	RBMS3	605786.0 | RBMS3 | RNA-binding motif protein, single strand-interacting, 3 | 27303.0 | ENSG00000144642 | nan | nan
chr3	TGFBR2	190182.0 | TGFBR2, HNPCC6, AAT3, MFS2, LDS2 | Transforming growth factor, beta receptor II, 70-80kD | 7048.0 | ENSG00000163513 | nan | Loeys-Dietz syndrome 2, 610168 (3), Autosomal dominant; Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3); Esophageal cancer, somatic, 133239 (3)
chr3	GADL1	615601.0 | GADL1 | Glutamate decarboxylase-like 1 | 339896.0 | ENSG00000144644 | nan | nan
chr3	SCLC1	182280.0 | SCLC1 | Small-cell cancer of lung | 7864.0 | nan | centromeric to ERBA2 | Small-cell cancer of lung, 182280 (2), Autosomal dominant
chr3	STT3B	608605.0 | STT3B, SIMP, CDG1X | STT3B, subunit of the oligosaccharyltransferase complex (catalytic) | 201595.0 | ENSG00000163527 | nan | Congenital disorder of glycosylation, type Ix, 615597 (3), Autosomal recessive
chr3	OSBPL10	606738.0 | OSBPL10, ORP10 | Oxysterol-binding protein-like protein 10 | 114884.0 | ENSG00000144645 | nan | nan
chr3	HHV8S	614836.0 | HHV8S | Human herpesvirus 8, susceptibility to | 101056702.0 | nan | nan | {Human herpesvirus 8, susceptibility to}, 614836 (2)
chr3	GPD1L	611778.0 | GPD1L, KIAA0089 | Glycerol-3-phosphate dehydrogenase 1-like | 23171.0 | ENSG00000152642 | nan | Brugada syndrome 2, 611777 (3), Autosomal dominant
chr3	CMTM8	607891.0 | CMTM8, CKLFSF8 | CKLF-like marvel transmembrane domain-containing 8 | 152189.0 | ENSG00000170293 | nan | nan
chr3	CMTM7	607890.0 | CMTM7, CKLFSF7 | CKLF-like marvel transmembrane domain-containing 7 | 112616.0 | ENSG00000153551 | nan | nan
chr3	CMTM6	607889.0 | CMTM6, CKLFSF6 | CKLF-like marvel transmembrane domain-containing 6 | 54918.0 | ENSG00000091317 | nan | nan
chr3	DYNC1LI1	615890.0 | DYNC1LI1, LIC1 | Dynein, cytoplasmic 1, light intermediate chain 1 | 51143.0 | ENSG00000144635 | nan | nan
chr3	CNOT10	620508.0 | CNOT10 | CCR4-NOT transcription complex, subunit 10 | 25904.0 | ENSG00000182973 | nan | nan
chr3	TRIM71	618570.0 | TRIM71, LIN41, HYC4 | Tripartite motif-containing protein 71 | 131405.0 | ENSG00000206557 | nan | Hydrocephalus, congenital, 4, 618667 (3), Autosomal dominant
chr3	CCR4	604836.0 | CCR4, CKR4, CMKBR4 | Chemokine (C-C) receptor-4 | 1233.0 | ENSG00000183813 | nan | nan
chr3	GLB1	611458.0 | GLB1, MPS4B | Galactosidase, beta-1 | 2720.0 | ENSG00000170266 | 3p14.2-p11 excluded | GM1-gangliosidosis, type I, 230500 (3), Autosomal recessive; GM1-gangliosidosis, type III, 230650 (3), Autosomal recessive; Mucopolysaccharidosis type IVB (Morquio), 253010 (3), Autosomal recessive; GM1-gangliosidosis, type II, 230600 (3), Autosomal recessive
chr3	CRTAP	605497.0 | CRTAP, CASP, OI7 | Cartilage-associated protein | 10491.0 | ENSG00000170275 | nan | Osteogenesis imperfecta, type VII, 610682 (3), Autosomal recessive
chr3	SUSD5	619917.0 | SUSD5, KIAA0527 | Sushi domain-containing protein 5 | 26032.0 | ENSG00000173705 | nan | nan
chr3	FBXL2	605652.0 | FBXL2, FBL2 | F-box and leucine-rich repeat protein 2 | 25827.0 | ENSG00000153558 | nan | nan
chr3	UBP1	609784.0 | UBP1, LBP1A, LBP1B | Upstream binding protein 1 | 7342.0 | ENSG00000153560 | nan | nan
chr3	CLASP2	605853.0 | CLASP2 | CLIP-associated protein 2 | 23122.0 | ENSG00000163539 | nan | nan
chr3	PDCD6IP	608074.0 | PDCD6IP, AIP1, ALIX, KIAA1375, MCPH29 | Programmed cell death 6-interacting protein | 10015.0 | ENSG00000170248 | mutation identified in 1 MCPH29 family | ?Microcephaly 29, primary, autosomal recessive, 620047 (3), Autosomal recessive
chr3	ARPP21	605488.0 | ARPP21, RCS | cAMP-regulated phosphoprotein 21 | 10777.0 | ENSG00000172995 | nan | nan
chr3	MIR128-2	611769.0 | MIR128-2, MIR128B, MIRN128-2 | Micro RNA 128-2 | 406916.0 | ENSG00000207625 | nan | nan
chr3	STAC	602317.0 | STAC | SRC homology three (SH3) and cysteine-rich domain | 6769.0 | ENSG00000144681 | nan | nan
chr3	DDH2	615612.0 | DDH2 | Developmental dysplasia of the hip 2 | 102775567.0 | nan | between rs4481097 and rs4626072 | Developmental dysplasia of the hip 2, 615612 (2), Autosomal dominant
chr3	DCLK3	613167.0 | DCLK3, DCK3, CLR | Doublecortin-like kinase 3 | 85443.0 | ENSG00000163673 | nan | nan
chr3	TRANK1	619316.0 | TRANK1, KIAA0342 | Tetratricopeptide repeat- and ankyrin repeat-containing protein 1 | 9881.0 | ENSG00000168016 | nan | nan
chr3	EPM2AIP1	607911.0 | EPM2AIP1, KIAA0766 | EPM2A-interacting protein 1 | 9852.0 | ENSG00000178567 | nan | nan
chr3	MLH1	120436.0 | MLH1, COCA2, LYNCH2, MMRCS1 | DNA mismatch repair protein MLH1 | 4292.0 | ENSG00000076242 | nan | Lynch syndrome 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive
chr3	LRRFIP2	614043.0 | LRRFIP2 | Leucine-rich repeat in FLII-interacting protein 2 | 9209.0 | ENSG00000093167 | nan | nan
chr3	GOLGA4	602509.0 | GOLGA4 | Golgin A4 | 2803.0 | ENSG00000144674 | nan | nan
chr3	APRG1	611429.0 | APRG1, C3orf35 | APRG1 tumor suppressor candidate | 339883.0 | ENSG00000198590 | nan | nan
chr3	ITGA9	603963.0 | ITGA9 | Integrin, alpha-9 | 3680.0 | ENSG00000144668 | nan | nan
chr3	CTDSPL	608592.0 | CTDSPL, SCP3, HYA22 | CTD small phosphatase-like | 10217.0 | ENSG00000144677 | nan | nan
chr3	MIR26A1	612151.0 | MIR26A, MIRN26A1 | Micro RNA 26A1 | 407015.0 | ENSG00000199075 | nan | nan
chr3	VILL	619666.0 | VILL | Villin-like protein | 50853.0 | ENSG00000136059 | nan | nan
chr3	PLCD1	602142.0 | PLCD1, NDNC3 | Phospholipase C, delta-1 | 5333.0 | ENSG00000187091 | nan | Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3), Autosomal recessive, Autosomal dominant
chr3	DLEC1	604050.0 | DLEC1, DLC1 | Deleted in lung and esophageal cancer 1 | 9940.0 | ENSG00000008226 | nan | nan
chr3	ACAA1	604054.0 | ACAA1 | Acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiolase) | 30.0 | ENSG00000060971 | nan | nan
chr3	MYD88	602170.0 | MYD88, MYD88D, IMD68 | MYD88 innate immune signal transduction adaptor | 4615.0 | ENSG00000172936 | nan | Macroglobulinemia, Waldenstrom, somatic, 153600 (3); Immunodeficiency 68, 612260 (3), Autosomal recessive
chr3	OXSR1	604046.0 | OSR1 | Oxidative stress-responsive 1 | 9943.0 | ENSG00000172939 | nan | nan
chr3	SLC22A13	604047.0 | SLC22A13, ORCTL3, OCTL1 | Solute carrier family 22 (organic anion/urate transporter), member 13 | 9390.0 | ENSG00000172940 | nan | nan
chr3	SLC22A14	604048.0 | SLC22A14, ORCTL4, OCTL2 | Solute carrier family 22, member 14 | 9389.0 | ENSG00000144671 | nan | nan
chr3	XYLB	604049.0 | XYLB | Xylulokinase | 9942.0 | ENSG00000093217 | nan | nan
chr3	ACVR2B	602730.0 | ACVR2B, ACTRIIB, HTX4 | Activin A receptor, type IIB | 93.0 | ENSG00000114739 | nan | Heterotaxy, visceral, 4, autosomal, 613751 (3)
chr3	EXOG	604051.0 | EXOG, ENDOGL1, ENGL | Endo/exonuclease, ENDOG-like | 9941.0 | ENSG00000157036 | nan | nan
chr3	SCN5A	600163.0 | SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2 | Sodium channel, voltage-gated, type V, alpha polypeptide | 6331.0 | ENSG00000183873 | nan | Ventricular fibrillation, familial, 1, 603829 (3); Heart block, progressive, type IA, 113900 (3), Autosomal dominant; Cardiomyopathy, dilated, 1E, 601154 (3), Autosomal dominant; Heart block, nonprogressive, 113900 (3), Autosomal dominant; Long QT syndrome 3, 603830 (3), Autosomal dominant; Sick sinus syndrome 1, 608567 (3), Autosomal recessive; Brugada syndrome 1, 601144 (3), Autosomal dominant; Atrial fibrillation, familial, 10, 614022 (3), Autosomal dominant; {Sudden infant death syndrome, susceptibility to}, 272120 (3), Autosomal recessive
chr3	SCN10A	604427.0 | SCN10A, FEPS2 | Sodium voltage-gated channel, alpha subunit 10 | 6336.0 | ENSG00000185313 | nan | Episodic pain syndrome, familial, 2, 615551 (3), Autosomal dominant
chr3	SCN11A	604385.0 | SCN11A, HSAN7, FEPS3 | Sodium voltage-gated channel, alpha subunit 11 | 11280.0 | ENSG00000168356 | nan | Episodic pain syndrome, familial, 3, 615552 (3), Autosomal dominant; Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3), Autosomal dominant
chr3	WDR48	612167.0 | WDR48, KIAA1449 | WD repeat-containing protein 48 | 57599.0 | ENSG00000114742 | nan | nan
chr3	GORASP1	606867.0 | GORASP1, GOLPH5, GRASP65, P65 | Golgi reassembly stacking protein 1, 65kD | 64689.0 | ENSG00000114745 | nan | nan
chr3	TTC21A	611430.0 | TTC21A, STI2, SPGF37 | Tetratricopeptide repeat domain-containing protein 21A | 199223.0 | ENSG00000168026 | nan | Spermatogenic failure 37, 618429 (3), Autosomal recessive
chr3	CSRNP1	606458.0 | CSRNP1, AXUD1 | Cysteine- and serine-rich nuclear protein 1 | 64651.0 | ENSG00000144655 | nan | nan
chr3	XIRP1	609777.0 | XIRP1, CMYA1, XIN | xin actin-binding repeat containing 1 | 165904.0 | ENSG00000168334 | nan | nan
chr3	CX3CR1	601470.0 | CX3CR1, GPR13, V28 | Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13) | 1524.0 | ENSG00000168329 | nan | {Rapid progression to AIDS from HIV1 infection}, 609423 (3); {Macular degeneration, age-related, 12}, 613784 (3); {Coronary artery disease, resistance to}, 607339 (3)
chr3	CCR8	601834.0 | CCR8, CMKBR8, CMKBRL2, CKRL1 | Chemokine (C-C) receptor 8 | 1237.0 | ENSG00000179934 | nan | nan
chr3	SLC25A38	610819.0 | SLC25A38, SIDBA2 | Solute carrier family 25, member 38 | 54977.0 | ENSG00000144659 | nan | Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3), Autosomal recessive
chr3	RPSA	150370.0 | RPSA, LAMR1, LAMBR, ICAS | Ribosomal protein SA | 3921.0 | ENSG00000168028 | nan | Asplenia, isolated congenital, 271400 (3), Autosomal dominant
chr3	SNORA62	180646.0 | SNORA62, RNU108, RNE2 | Small nucleolar RNA, H/ACA box, 62 | 6044.0 | ENSG00000202363 | nan | nan
chr3	MOBP	600948.0 | MOBP | Myelin-associated oligodendrocyte basic protein | 4336.0 | ENSG00000168314 | nan | nan
chr3	MYRIP	611790.0 | MYRIP, SLAC2C | Myosin VIIA- and RAB-interacting protein | 25924.0 | ENSG00000170011 | nan | nan
chr3	ENTPD3	603161.0 | ENTPD3, CD39L3 | Ectonucleoside triphosphate diphosphohydrolase 3 | 956.0 | ENSG00000168032 | nan | nan
chr3	RPL14	617414.0 | RPL14 | Ribosomal protein L14 | 9045.0 | ENSG00000188846 | nan | nan
chr3	CTNNB1	116806.0 | CTNNB1, NEDSDV, EVR7 | Catenin (cadherin-associated protein), beta 1, 88kD | 1499.0 | ENSG00000168036 | nan | Exudative vitreoretinopathy 7, 617572 (3), Autosomal dominant; Pilomatricoma, somatic, 132600 (3); Colorectal cancer, somatic, 114500 (3); Neurodevelopmental disorder with spastic diplegia and visual defects, 615075 (3), Autosomal dominant; Medulloblastoma, somatic, 155255 (3); Ovarian cancer, somatic, 167000 (3); Hepatocellular carcinoma, somatic, 114550 (3)
chr3	ULK4	617010.0 | ULK4, FAM7C1 | Unc51-like kinase 4 | 54986.0 | ENSG00000168038 | nan | nan
chr3	TRAK1	608112.0 | TRAK1, OIP106, KIAA1042, DEE68 | Trafficking protein, kinesin-binding 1 | 22906.0 | ENSG00000182606 | nan | Developmental and epileptic encephalopathy 68, 618201 (3), Autosomal recessive
chr3	CCK	118440.0 | CCK | Cholecystokinin | 885.0 | ENSG00000187094 | nan | nan
chr3	LYZL4	612750.0 | LYZL4 | Lysozyme-like 4 | 131375.0 | ENSG00000157093 | nan | nan
chr3	VIPR1	192321.0 | VIPR1 | Vasoactive intestinal peptide receptor 1 | 7433.0 | ENSG00000114812 | incorrectly assigned to 2q37 | nan
chr3	SEC22C	604028.0 | SEC22C | SEC22 homolog C, vesicle trafficking protein | 9117.0 | ENSG00000093183 | nan | nan
chr3	SS18L2	606473.0 | SS18L2 | SS18-like gene 2 | 51188.0 | ENSG00000008324 | nan | nan
chr3	NKTR	161565.0 | NKTR | Natural tumor-killer recognition sequence | 4820.0 | ENSG00000114857 | mouse gene close to Cck | nan
chr3	ZBTB47	619969.0 | ZBTB47, ZNF651, KIAA1190 | Zinc finger- and BTB domain-containing protein 47 | 92999.0 | ENSG00000114853 | nan | nan
chr3	KLHL40	615340.0 | KLHL40, SYRP, KBTBD5, NEM8 | Kelch-like 40 | 131377.0 | ENSG00000157119 | nan | Nemaline myopathy 8, autosomal recessive, 615348 (3), Autosomal recessive
chr3	HHATL	608116.0 | HHATL, MBOAT3, C3orf3, KIAA1173 | Hedgehog acyltransferase-like protein | 57467.0 | ENSG00000010282 | nan | nan
chr3	HIGD1A	618623.0 | HIGD1A, HIG1, RCF1A | HIG1 hypoxia-inducivle domain family, member 1A | 25994.0 | ENSG00000181061 | nan | nan
chr3	ACKR2	602648.0 | ACKR2, CCBP2, CMKBR9, D6, CCR9, CCR10 | Atypical chemokine receptor 2 | 1238.0 | ENSG00000144648 | nan | nan
chr3	CYP8B1	602172.0 | CYP8B1, CYP12 | Cytochrome P450, subfamily VIIIB, polypeptide 1 | 1582.0 | ENSG00000180432 | nan | nan
chr3	GASK1A	620413.0 | GSK1A, FAM198A | Golgi-associated kinase 1A | 729085.0 | ENSG00000144649 | nan | nan
chr3	POMGNT2	614828.0 | POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8, MDDGC8 | Protein O-mannose beta-1,2-N-acetylglucosaminyltransferase 2 | 84892.0 | ENSG00000144647 | nan | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 8, 614830 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8, 618135 (3), Autosomal recessive
chr3	SNRK	612760.0 | SNRK, KIAA0096 | SNF-related kinase | 54861.0 | ENSG00000163788 | nan | nan
chr3	ANO10	613726.0 | ANO10, TMEM16K, SCAR10 | Anoctamin 10 | 55129.0 | ENSG00000160746 | nan | Spinocerebellar ataxia, autosomal recessive 10, 613728 (3), Autosomal recessive
chr3	CELIAC9	612007.0 | CELIAC9 | Celiac disease, susceptibility to, 9 | 100188871.0 | nan | associated with rs6441961 | {Celiac disease, susceptibility to, 9}, 612007 (2)
chr3	HSCR6	606874.0 | HSCR6 | Hirschsprung disease, susceptibility to, 6 | 246321.0 | nan | nan | {Hirschsprung disease, susceptibility to, 6}, 606874 (2)
chr3	IBD12	612241.0 | IBD12 | Inflammatory bowel disease 12 | 100188952.0 | nan | nan | {Inflammatory bowel disease 12}, 612241 (2)
chr3	MPVQTL2	612574.0 | MPVQTL2 | Mean platelet volume quantitative trait locus 2 | 100271868.0 | nan | associated with rs12485738 | [Mean platelet volume QTL2], 612574 (2)
chr3	PSC	613806.0 | PSC | Cholangitis, primary sclerosing | 100653366.0 | nan | nan | Cholangitis, primary sclerosing, 613806 (2)
chr3		601994.0 | TRR | Transfer RNA arginine | nan | nan | nan | nan
chr3	ABHD5	604780.0 | ABHD5, CGI58, IECN2, NCIE2 | Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase | 51099.0 | ENSG00000011198 | nan | Chanarin-Dorfman syndrome, 275630 (3), Autosomal recessive
chr3	MIR138-1	613394.0 | MIR138-1, MIRN138-1 | Micro RNA 138-1 | 406929.0 | ENSG00000207954 | nan | nan
chr3	ZD1	609815.0 | ZD1 | Zygodactyly 1 | 780914.0 | nan | max lod at D3S2409 | Zygodactyly 1, 609815 (2)
chr3	TOPAZ1	614412.0 | TOPAZ1, C3orf77 | Testis- and ovary-specific PAZ domain protein 1 | 375337.0 | ENSG00000173769 | nan | nan
chr3	TCAIM	620787.0 | TCAIM, TOAG1 | T-cell activation inhibitor, mitochondrial | 285343.0 | ENSG00000179152 | nan | nan
chr3	ZNF445	619508.0 | ZNF445, ZFP445 | Zinc finger protein 445 | 353274.0 | ENSG00000185219 | nan | nan
chr3	ZNF197	618359.0 | ZNF197, ZNF20, VHLAK | Zinc finger protein 197 | 10168.0 | ENSG00000186448 | nan | nan
chr3	ZNF35	194533.0 | ZNF35, HF10 | Zinc finger protein-35 (HF.10) | 7584.0 | ENSG00000169981 | nan | nan
chr3	KIF15	617569.0 | KIF15, KLP2, KNSL7, BRDCS2 | Kinesin family, member 15 | 56992.0 | ENSG00000163808 | mutation identified in 1 BRDCS2 patient | ?Braddock-Carey syndrome 2, 619981 (3), Autosomal recessive
chr3	TGM4	600585.0 | TGM4 | Transglutaminase-4, prostate | 7047.0 | ENSG00000163810 | nan | nan
chr3	ZDHHC3	617150.0 | ZDHHC3, DHHC3, GODZ | Zinc finger DHHC domain-containing protein 3 | 51304.0 | ENSG00000163812 | nan | nan
chr3	EXOSC7	606488.0 | EXOSC7, RRP42 | Exosome component 7 | 23016.0 | ENSG00000075914 | nan | nan
chr3	CLEC3B	187520.0 | CLEC3B, TNA, MCDR4 | C-type lectin domain family 3, member B | 7123.0 | ENSG00000163815 | nan | Macular dystrophy, retinal, 4, 619977 (3), Autosomal dominant
chr3	CDCP1	611735.0 | CDCP1, SIMA135 | CUB domain-containing protein 1 | 64866.0 | ENSG00000163814 | nan | nan
chr3	TMEM158	620257.0 | TMEM158, RIS1 | Transmembrane protein 158 | 25907.0 | ENSG00000249992 | nan | nan
chr3	LARS2	604544.0 | LARS2, PRLTS4, HLASA | Leucyl-tRNA synthetase, mitochondrial | 23395.0 | ENSG00000011376 | nan | Perrault syndrome 4, 615300 (3), Autosomal recessive; Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3), Autosomal recessive
chr3	LIMD1	604543.0 | LIMD1 | LIM domain-containing protein 1 | 8994.0 | ENSG00000144791 | nan | nan
chr3	SACM1L	606569.0 | SACM1L, SAC1, KIAA0851 | SAC1 suppressor of actin mutations 1-like | 22908.0 | ENSG00000211456 | nan | nan
chr3	SLC6A20	605616.0 | SLC6A20, XT3 | X transporter protein 3 | 54716.0 | ENSG00000163817 | nan | nan
chr3	LZTFL1	606568.0 | LZTFL1, BBS17 | Leucine zipper transcription factor-like 1 | 54585.0 | ENSG00000163818 | nan | Bardet-Biedl syndrome 17, 615994 (3), Autosomal recessive
chr3	CCR9	604738.0 | CCR9 | Chemokine, CC motif, receptor 9 | 10803.0 | ENSG00000173585 | nan | nan
chr3	FYCO1	607182.0 | FYCO1, CATC2, CTRCT18 | FYVE and coiled-coil domain containing 1 | 79443.0 | ENSG00000163820 | nan | Cataract 18, autosomal recessive, 610019 (3), Autosomal recessive
chr3	CXCR6	605163.0 | CXCR6, STRL33, BONZO | Chemokine, CXC motif, receptor 6 | 10663.0 | ENSG00000172215 | nan | nan
chr3	XCR1	600552.0 | XCR1, CCXCR1, GPR5 | Chemokine, C motif, receptor 1 (G protein-coupled receptor-5) | 2829.0 | ENSG00000173578 | nan | nan
chr3	CCR1	601159.0 | CCR1, CMKBR1, CKR1, HM145 | Chemokine (C-C) receptor 1 | 1230.0 | ENSG00000163823 | nan | nan
chr3	CCR3	601268.0 | CCR3, CKR3, CMKBR3 | Chemokine (C-C) receptor 3 | 1232.0 | ENSG00000183625 | nan | nan
chr3	CCR2	601267.0 | CCR2, CMKBR2, PCLUD | Chemokine (C-C) receptor 2 | 729230.0 | ENSG00000121807 | nan | {HIV infection, susceptibility/resistance to}, 609423 (3); Polycystic lung disease, 219600 (3), Autosomal recessive
chr3	CCR5	601373.0 | CCR5, CMKBR5, CCCKR5, IDDM22 | Chemokine (C-C) receptor 5 | 1234.0 | ENSG00000160791 | nan | {HIV infection, susceptibility/resistance to}, 609423 (3); {Diabetes mellitus, insulin-dependent, 22}, 612522 (3); {Hepatitis C virus, resistance to}, 609532 (3); {West nile virus, susceptibility to}, 610379 (3)
chr3	CCRL2	608379.0 | CCRL2 | Chemokine, CC motif, receptor-like protein 2 | 9034.0 | ENSG00000121797 | nan | nan
chr3	LTF	150210.0 | LTF | Lactotransferrin | 4057.0 | ENSG00000012223 | nan | nan
chr3	RTP3	607181.0 | RTP3, TMEM7 | Receptor-transporting protein 3 | 83597.0 | ENSG00000163825 | nan | nan
chr3	LRRC2	607180.0 | LRRC2 | Leucine-rich repeat-containing 2 | 79442.0 | ENSG00000163827 | nan | nan
chr3	CRIPTO	187395.0 | CRIPTO, TDGF1, CRGF | CRIPTO, EGF-CFC family member | 6997.0 | ENSG00000241186 | nan | nan
chr3	ALS2CL	612402.0 | ALS2CL | ALS2 C-terminal-like protein | 259173.0 | ENSG00000178038 | nan | nan
chr3	TMIE	607237.0 | TMIE, DFNB6 | Transmembrane inner ear-expressed gene | 259236.0 | ENSG00000181585 | nan | Deafness, autosomal recessive 6, 600971 (3), Autosomal recessive
chr3	PRSS50	607950.0 | PRSS50 | Protease, serine, 50 | 29122.0 | ENSG00000283706 | nan | nan
chr3	MYL3	160790.0 | MYL3, CMH8 | Myosin, light polypeptide-3, alkali; ventricular, skeletal, slow | 4634.0 | ENSG00000160808 | nan | Cardiomyopathy, hypertrophic, 8, 608751 (3), Autosomal recessive, Autosomal dominant
chr3	PTH1R	168468.0 | PTH1R, PTHR1, PTHR, PFE, EKNS | Parathyroid hormone 1 receptor | 5745.0 | ENSG00000160801 | nan | Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3), Autosomal dominant; Eiken syndrome, 600002 (3), Autosomal recessive; Failure of tooth eruption, primary, 125350 (3), Autosomal dominant; Chondrodysplasia, Blomstrand type, 215045 (3), Autosomal recessive
chr3	NBEAL2	614169.0 | NBEAL2, KIAA0540, GPS, BDPLT4 | Neurobeachin-like 2 | 23218.0 | ENSG00000160796 | nan | Gray platelet syndrome, 139090 (3), Autosomal recessive
chr3	SETD2	612778.0 | SETD2, SET2, HYPB, HBP231, KIAA1732, LLS, RAPAS, MRD70 | SET domain-containing protein 2 | 29072.0 | ENSG00000181555 | nan | Luscan-Lumish syndrome, 616831 (3), Autosomal dominant; Intellectual developmental disorder, autosomal dominant 70, 620157 (3), Autosomal dominant; Rabin-Pappas syndrome, 620155 (3), Autosomal dominant
chr3	KIF9	607910.0 | KIF9 | Kinesin family member 9 | 64147.0 | ENSG00000088727 | nan | nan
chr3	KLHL18	619926.0 | KLHL18, KIAA0795 | Kelch-like family, member 18 | 23276.0 | ENSG00000114648 | nan | nan
chr3	PTPN23	606584.0 | PTPN23, KIAA1471, HDPTP, NEDBASS | Protein-tyrosine phosphatase, nonreceptor-type, 23 | 25930.0 | ENSG00000076201 | nan | Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, 618890 (3), Autosomal recessive
chr3	SCAP	601510.0 | SCAP | SREBP cleavage-activating protein | 22937.0 | ENSG00000114650 | nan | nan
chr3	ELP6	615020.0 | ELP6, TMEM103, C3orf75 | Elongator acetyltransferase complex, subunit 6 | 54859.0 | ENSG00000163832 | nan | nan
chr3	CSPG5	606775.0 | CSPG5, NGC | Chondroitin sulfate proteoglycan 5 | 10675.0 | ENSG00000114646 | nan | nan
chr3	SMARCC1	601732.0 | SMARCC1, BAF155, HYC5 | SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily C, member 1 | 6599.0 | ENSG00000173473 | nan | {Hydrocephalus, congenital, 5, susceptibility to}, 620241 (3), Autosomal dominant
chr3	DHX30	616423.0 | DHX30, DDX30, RETCOR, KIAA0890, NEDMIAL | DExH-box helicase 30 | 22907.0 | ENSG00000132153 | nan | Neurodevelopmental disorder with variable motor and speech impairment, 617804 (3), Autosomal dominant
chr3	MAP4	157132.0 | MAP4 | Microtubule-associated protein 4 | 4134.0 | ENSG00000047849 | nan | nan
chr3	CDC25A	116947.0 | CDC25A | Cell division cycle 25A | 993.0 | ENSG00000164045 | nan | nan
chr3	CAMP	600474.0 | CAMP, FALL39 | Cathelicidin antimicrobial peptide | 820.0 | ENSG00000164047 | nan | nan
chr3	ZNF589	616702.0 | ZNF589, SZF1 | Zinc finger protein 589 | 51385.0 | ENSG00000164048 | nan | nan
chr3	NME6	608294.0 | NME6 | NME/NM23 nucleoside diphosphate kinase 6 | 10201.0 | ENSG00000172113 | nan | nan
chr3	FBXW12	609075.0 | FBXW12, FBW12, FBXO35, FBXO12 | F-box and WD40 domain protein 12 | 285231.0 | ENSG00000164049 | nan | nan
chr3	PLXNB1	601053.0 | PLXNB1, SEP | Plexin B1 | 5364.0 | ENSG00000164050 | nan | nan
chr3	CCDC51	618585.0 | CCDC51, MITOK | Coiled-coil domain-containing protein 51 | 79714.0 | ENSG00000164051 | nan | nan
chr3	TMA7	615808.0 | TMA7, HSPC016 | Translation machinery-associated 7 homolog | 51372.0 | ENSG00000232112 | nan | nan
chr3	ATRIP	606605.0 | ATRIP | ATR-interacting protein | 84126.0 | ENSG00000164053 | nan | nan
chr3	TREX1	606609.0 | TREX1, AGS1, CRV, HERNS, RVCLS | 3' repair exonuclease 1 | 11277.0 | ENSG00000213689 | nan | Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations, 192315 (3), Autosomal dominant; Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3), Autosomal recessive, Autosomal dominant; {Systemic lupus erythematosus, susceptibility to}, 152700 (3), Autosomal dominant; Chilblain lupus, 610448 (3), Autosomal dominant
chr3	SHISA5	607290.0 | SHISA5, SCOTIN | Shisa family, member 5 | 51246.0 | ENSG00000164054 | pseudogene on Xq13.1-q13.3 | nan
chr3	PFKFB4	605320.0 | PFKFB4 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 | 5210.0 | ENSG00000114268 | nan | nan
chr3	UCN2	605902.0 | UCN2, SRP, UR | Urocortin II | 90226.0 | ENSG00000145040 | nan | nan
chr3	COL7A1	120120.0 | COL7A1, NDNC8 | Collagen VII, alpha-1 polypeptide | 1294.0 | ENSG00000114270 | nan | Nail disorder, nonsyndromic congenital, 8, 607523 (3), Autosomal dominant; Epidermolysis bullosa dystrophica, Bart type, 132000 (3), Autosomal dominant; Epidermolysis bullosa dystrophica inversa, 226600 (3), Autosomal recessive; Epidermolysis bullosa dystrophica, autosomal recessive, 226600 (3), Autosomal recessive; Epidermolysis bullosa, pretibial, 131850 (3), Autosomal recessive, Autosomal dominant; Epidermolysis bullosa dystrophica, autosomal dominant, 131750 (3), Autosomal dominant; Transient bullous of the newborn, 131705 (3), Autosomal recessive, Autosomal dominant; Epidermolysis bullosa pruriginosa, 604129 (3), Autosomal recessive, Autosomal dominant; Epidermolysis bullosa dystrophica, localisata variant, 226600 (3), Autosomal recessive
chr3	UQCRC1	191328.0 | UQCRC1, PKNPY | Ubiquinol-cytochrome c reductase core protein I | 7384.0 | ENSG00000010256 | close upstream of COL7A1 | Parkinsonism with polyneuropathy, 619279 (3), Autosomal dominant
chr3	SLC26A6	610068.0 | SLC26A6 | Solute carrier family 26 (anion transporter), member 6 | 65010.0 | ENSG00000225697 | nan | nan
chr3	CELSR3	604264.0 | CELSR3, EGFL1, MEGF2 | Cadherin EGF LAG seven-pass G-type receptor 3 (epidermal growth factor-like 1) | 1951.0 | ENSG00000008300 | nan | nan
chr3	NCKIPSD	606671.0 | NCKIPSD, AF3P21, SPIN90 | NCK-interacting protein with SH3 domain | 51517.0 | ENSG00000213672 | nan | nan
chr3	IP6K2	606992.0 | IP6K2, IHPK2 | Inositol hexaphosphate kinase 2 | 51447.0 | ENSG00000068745 | nan | nan
chr3	PRKAR2A	176910.0 | PRKAR2A | Protein kinase, cAMP-dependent, regulatory, type II, alpha | 5576.0 | ENSG00000114302 | nan | nan
chr3	SLC25A20	613698.0 | SLC25A20, CACT, CAC | Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (carnitine-acylcarnitine translocase) | 788.0 | ENSG00000178537 | pseudogene on 6p12 | Carnitine-acylcarnitine translocase deficiency, 212138 (3), Autosomal recessive
chr3	ARIH2	605615.0 | ARIH2, ARI2, TRIAD1 | Ariadne RBR E3 ubiquitin protein ligase 2 | 10425.0 | ENSG00000177479 | nan | nan
chr3	P4HTM	614584.0 | P4HTM, PH4, HIDEA | Prolyl 4-hydroxylase, transmembrane | 54681.0 | ENSG00000178467 | nan | Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities, 618493 (3), Autosomal recessive
chr3	WDR6	606031.0 | WDR6 | WD repeat-containing protein 6 | 11180.0 | ENSG00000178252 | previously assigned to 15q21 by FISH | nan
chr3	DALRD3	618904.0 | DALRD3, DEE86 | DALR anticodon-binding domain-containing protein 3 | 55152.0 | ENSG00000178149 | mutation identified in 1 DEE86 family | ?Developmental and epileptic encephalopathy 86, 618910 (3), Autosomal recessive
chr3	NDUFAF3	612911.0 | NDUFAF3, MC1DN18 | NADH-ubiquinone oxidoreductase complex assembly factor 3 | 25915.0 | ENSG00000178057 | nan | Mitochondrial complex I deficiency, nuclear type 18, 618240 (3), Autosomal recessive
chr3	MIR191	615150.0 | MIR191 | Micro RNA 191 | 406966.0 | ENSG00000207605 | nan | nan
chr3	IMPDH2	146691.0 | IMPDH2, IMPD2 | Inosine-5'-monophosphate dehydrogenase, type II | 3615.0 | ENSG00000178035 | nan | [IMPDH2 enzyme activity, variation in], 617995 (3)
chr3	QRICH1	617387.0 | QRICH1, VERBRAS | Glutamine-rich protein 1 | 54870.0 | ENSG00000198218 | nan | Ververi-Brady syndrome, 617982 (3), Autosomal dominant
chr3	QARS1	603727.0 | QARS1, QARS, GLNRS, MSCCA | Glutaminyl-tRNA synthetase 1 | 5859.0 | ENSG00000172053 | nan | Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3), Autosomal recessive
chr3	USP19	614471.0 | USP19, KIAA0891 | Ubiquitin-specific protease 19 | 10869.0 | ENSG00000172046 | nan | nan
chr3	LAMB2	150325.0 | LAMB2, LAMS, NPHS5, PIERS | Laminin, beta-2 (laminin S) | 3913.0 | ENSG00000172037 | nan | Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3), Autosomal recessive; Pierson syndrome, 609049 (3), Autosomal recessive
chr3	KLHDC8B	613169.0 | KLHDC8B, CHL | Kelch domain-containing protein 8B | 200942.0 | ENSG00000185909 | nan | {Hodgkin lymphoma, susceptibility to}, 236000 (3), Autosomal recessive
chr3	IHO1	619190.0 | IHO1, CCDC36 | Interactor of HORMAD1 1 | 339834.0 | ENSG00000173421 | nan | nan
chr3	MIR4271	617176.0 | MIR4271 | Micro RNA 4271 | 100422952.0 | ENSG00000264633 | nan | nan
chr3	USP4	603486.0 | USP4, UNP | Ubiquitin-specific protease-4 | 7375.0 | ENSG00000114316 | nan | nan
chr3	GPX1	138320.0 | GPX1, GPXD | Glutathione peroxidase-1 | 2876.0 | ENSG00000233276 | ?pseudogene on 3p11-p12 | Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1), Autosomal recessive
chr3	RHOA	165390.0 | RHOA, ARHA, ARH12, RHOH12, EDFAOB | Ras homolog gene family, member A (oncogene RHO H12) | 387.0 | ENSG00000067560 | nan | Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic, 618727 (3)
chr3	TCTA	600690.0 | TCTA | T-cell leukemia translocation altered gene | 6988.0 | ENSG00000145022 | nan | nan
chr3	AMT	238310.0 | AMT, NKH, GCE2 | Aminomethyltransferase (glycine cleavage system protein T) | 275.0 | ENSG00000145020 | nan | Glycine encephalopathy 2, 620398 (3)
chr3	NICN1	611516.0 | NICN1 | Nicolin 1 | 84276.0 | ENSG00000145029 | processed pseudogene on X | nan
chr3	DAG1	128239.0 | DAG1, DAG, MDDGC9, MDDGA9, LGMDR16 | Dystrophin-associated glycoprotein-1 | 1605.0 | ENSG00000173402 | nan | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3), Autosomal recessive
chr3	BSN	604020.0 | BSN, ZNF231 | Bassoon presynaptic cytomatrix protein | 8927.0 | ENSG00000164061 | nan | nan
chr3	APEH	102645.0 | APEH, D3S48E | N-acylaminoacyl-peptide hydrolase | 327.0 | ENSG00000164062 | nan | nan
chr3	MST1	142408.0 | MST1, HGFL | Macrophage-stimulating-1 (hepatocyte growth factor-like) | 4485.0 | ENSG00000173531 | nan | nan
chr3	RNF123	614472.0 | RNF123, KPC1 | Ring finger protein 123 | 63891.0 | ENSG00000164068 | nan | nan
chr3	AMIGO3	615691.0 | AMIGO3, ALI3 | Adhesion molecule with Ig-like domain 3 | 386724.0 | ENSG00000176020 | nan | nan
chr3	GMPPB	615320.0 | GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19 | GDP-mannose pyrophosphorylase B | 29925.0 | ENSG00000173540 | nan | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 14, 615351 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3), Autosomal recessive
chr3	IP6K1	606991.0 | IP6K1, IHPK1, KIAA0263 | Inositol hexaphosphate kinase 1 | 9807.0 | ENSG00000176095 | nan | nan
chr3	INKA1	620426.0 | INKA1, INCA | INKA box actin regulator 1 | 389119.0 | ENSG00000185614 | nan | nan
chr3	UBA7	191325.0 | UBA7, UBE7, UBE1L | Ubiquitin-like modifier activating enzyme 7 | 7318.0 | ENSG00000182179 | nan | nan
chr3	TRAIP	605958.0 | TRAIP, TRIP, RNF206, SCKL9 | TRAF-interacting protein | 10293.0 | ENSG00000183763 | nan | Seckel syndrome 9, 616777 (3), Autosomal recessive
chr3	CAMKV	614993.0 | CAMKV, 1G5 | CAM kinase-like vesicle-associated | 79012.0 | ENSG00000164076 | nan | nan
chr3	MST1R	600168.0 | MST1R, RON, NPCA3 | Macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | 4486.0 | ENSG00000164078 | nan | {Nasopharyngeal carcinoma, susceptibility to, 3}, 617075 (3), Autosomal dominant
chr3	MON1A	611464.0 | MON1A, SAND1 | MON1 homolog B, secretory trafficking associated | 84315.0 | ENSG00000164077 | nan | nan
chr3	RBM6	606886.0 | RBM6, DEF3 | RNA-binding motif protein 6 | 10180.0 | ENSG00000004534 | nan | nan
chr3	RBM5	606884.0 | RMB5, LUCA15 | RNA-binding motif protein 5 | 10181.0 | ENSG00000003756 | nan | nan
chr3	SEMA3F	601124.0 | SEMA3F, SEMA4 | Semaphorin III/F | 6405.0 | ENSG00000001617 | nan | nan
chr3	GNAT1	139330.0 | GNAT1, CSNBAD3, CSNB1G | Guanine nucleotide-binding protein (G protein), alpha-transducing (transducin) activity polypeptide-1 | 2779.0 | ENSG00000114349 | nan | Night blindness, congenital stationary, autosomal dominant 3, 610444 (3), Autosomal dominant; Night blindness, congenital stationary, type 1G, 616389 (3), Autosomal recessive
chr3	SLC38A3	604437.0 | SLC38A3, SN1, G17, DEE102 | Solute carrier family 38, member 3 | 10991.0 | ENSG00000188338 | nan | Developmental and epileptic encephalopathy 102, 619881 (3), Autosomal recessive
chr3	GNAI2	139360.0 | GNAI2, GNAI2B, GIP | Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-2 | 2771.0 | ENSG00000114353 | on 12p13-p12, GNAI2L | Ventricular tachycardia, idiopathic, 192605 (3), Autosomal dominant; Pituitary adenoma, ACTH-secreting, somatic (3)
chr3	SEMA3B	601281.0 | SEMA5 | Semaphorin A(V) | 7869.0 | ENSG00000012171 | nan | nan
chr3	IFRD2	602725.0 | IFRD2 | Interferon-related developmental regulator-2 | 7866.0 | ENSG00000214706 | nan | nan
chr3	HYAL3	604038.0 | HYAL3, LUCA3 | Hyaluronoglucosaminidase 3 | 8372.0 | ENSG00000186792 | nan | nan
chr3	NAA80	607073.0 | NAA80, FUS2, ANDS | N-alpha-acetyltransferase 80, NatH catalytic subunit | 24142.0 | ENSG00000243477 | mutation identified in 1 ANDS family | ?Auroneurodental syndrome, 620830 (3), Autosomal recessive
chr3	HYAL1	607071.0 | HYAL1, MPS9 | Hyaluronoglucosaminidase 1 | 3373.0 | ENSG00000114378 | nan | Mucopolysaccharidosis type IX, 601492 (3), Autosomal recessive
chr3	HYAL2	603551.0 | HYAL2, LUCA2 | Hyaluronoglucosaminidase 2 | 8692.0 | ENSG00000068001 | nan | nan
chr3	TUSC2	607052.0 | FUS1 | FUS1 gene | 11334.0 | ENSG00000114383 | nan | nan
chr3	RASSF1	605082.0 | RASSF1 | Ras association domain family protein 1 | 11186.0 | ENSG00000068028 | epigenetically inactivated | nan
chr3	ZMYND10	607070.0 | ZMYND10, BLU | Zinc finger MYND domain-containing protein 10 | 51364.0 | ENSG00000004838 | nan | Ciliary dyskinesia, primary, 22, 615444 (3), Autosomal recessive
chr3	NPRL2	607072.0 | NPRL2, FFEVF2 | NPR2-like protein, GATOR1 complex subunit | 10641.0 | ENSG00000114388 | nan | Epilepsy, familial focal, with variable foci 2, 617116 (3), Autosomal dominant
chr3	CYB561D2	607068.0 | CYB561D2, 101F6 | Cytochrome b-561 domain containing 2 | 11068.0 | ENSG00000114395 | nan | nan
chr3	TMEM115	607069.0 | TMEM115, PL6 | Transmembrane protein 115 | 11070.0 | ENSG00000126062 | nan | nan
chr3	CACNA2D2	607082.0 | CACNA2D2, KIAA0558, CASVDD | Calcium channel, voltage-dependent, alpha-2/delta subunit 2 | 9254.0 | ENSG00000007402 | nan | Cerebellar atrophy with seizures and variable developmental delay, 618501 (3), Autosomal recessive
chr3	HEMK1	618609.0 | HEMK1, MTQ1, MPRMC | HemK methyltransferase family, member 1 | 51409.0 | ENSG00000114735 | nan | nan
chr3	CISH	602441.0 | CISH, BACTS2 | Cytokine inducible SH2-containing protein | 1154.0 | ENSG00000114737 | nan | {Malaria, susceptibility to}, 611162 (3); {Bacteremia, susceptibility to}, 614383 (3); {Tuberculosis, susceptibility to}, 607948 (3)
chr3	MAPKAPK3	602130.0 | MAPKAP3, 3PK, MDPT3 | Mitogen-activated protein kinase-activated protein kinase-3 | 7867.0 | ENSG00000114738 | mutation identified in 1 MDPT3 family | ?Macular dystrophy, patterned, 3, 617111 (3), Autosomal dominant
chr3	DOCK3	603123.0 | DOCK3, NEDIDHA | Dedicator of cytokinesis 3 | 1795.0 | ENSG00000088538 | nan | Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia, 618292 (3), Autosomal recessive
chr3	MANF	601916.0 | MANF, ARMET, ARP, DDDS | Mesencephalic astrocyte derived neurotrophic factor | 7873.0 | ENSG00000145050 | nan | Diabetes, deafness, developmental delay, and short stature syndrome, 620651 (3), Autosomal recessive
chr3	RBM15B	612602.0 | RBM15B, OTT3, HUMAGCGB | RNA-binding motif protein 15B | 29890.0 | ENSG00000259956 | nan | nan
chr3	DCAF1	617259.0 | DCAF1, RIP, VPRBP, KIAA0800 | DDB1- and CUL4-associated factor 1 | 9730.0 | ENSG00000145041 | nan | nan
chr3	RAD54L2	620006.0 | RAD54L2, ARIP4 | RAD54-like 2 | 23132.0 | ENSG00000164080 | nan | nan
chr3	TEX264	620608.0 | TEX64 | Testis-expressed gene 264 | 51368.0 | ENSG00000164081 | nan | nan
chr3	GRM2	604099.0 | GRM2, MGLUR2 | Glutamate receptor, metabotropic, 2 | 2912.0 | ENSG00000164082 | nan | nan
chr3	RRP9	620013.0 | RRP9 | Ribosomal RNA-processing 9, U3 small nucleolar RNA-binding protein | 9136.0 | ENSG00000114767 | nan | nan
chr3	PARP3	607726.0 | PARP3, ADPRTL3 | Poly(ADP-ribose) polymerase 3 | 10039.0 | ENSG00000041880 | nan | nan
chr3	GPR62	606917.0 | GPR62 | G protein-coupled receptor 62 | 118442.0 | ENSG00000180929 | nan | nan
chr3	PCBP4	608503.0 | PCBP4, MGC10 | Poly(rC)-binding protein 4 | 57060.0 | ENSG00000090097 | nan | nan
chr3	ABHD14A	618771.0 | ABHD14A, DORZ1 | Abhydrolase domain-containing protein 14A | 25864.0 | ENSG00000248487 | nan | nan
chr3	ACY1	104620.0 | ACY1, ACY1D | Aminoacylase-1 | 95.0 | ENSG00000243989 | nan | Aminoacylase 1 deficiency, 609924 (3), Autosomal recessive
chr3	RPL29	601832.0 | RPL29, HIP | Ribosomal protein L29 | 6159.0 | ENSG00000162244 | nan | nan
chr3	DUSP7	602749.0 | DUSP7, MKPX, PYST2 | Dual-specificity phosphatase-7 | 1849.0 | ENSG00000164086 | nan | nan
chr3	POC1A	614783.0 | POC1A, PIX2, SOFT | POC1 centriolar protein A | 25886.0 | ENSG00000164087 | nan | Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3), Autosomal recessive
chr3	ALAS1	125290.0 | ALAS1 | Aminolevulinate, delta-, synthase-1 | 211.0 | ENSG00000023330 | nan | nan
chr3	TLR9	605474.0 | TLR9 | Toll-like receptor 9 | 54106.0 | ENSG00000239732 | nan | nan
chr3	TWF2	607433.0 | TWF2, PTK9L, A6RP | Twinfilin actin-binding protein 2 | 11344.0 | ENSG00000247596 | nan | nan
chr3	PPM1M	608979.0 | PPM1M, PP2CE | Protein phosphatase 1M (protein phosphatase 2C, eta isoform) | 132160.0 | ENSG00000164088 | nan | nan
chr3	WDR82	611059.0 | WDR82, TMEM113 | WD repeat-containing protein 82 | 80335.0 | ENSG00000164091 | nan | nan
chr3	MIRLET7G	612102.0 | MIRLET7G, LET7G, MIRNLET7G | Micro RNA Let7G | 406890.0 | ENSG00000199150 | nan | nan
chr3	GLYCTK	610516.0 | GLYCTK, GLYCTK1 | Glycerate kinase | 132158.0 | ENSG00000168237 | nan | D-glyceric aciduria, 220120 (3), Autosomal recessive
chr3		620997.0 | SEMA3G | Semaphorin 3G | nan | nan | nan | nan
chr3	DNAH1	603332.0 | DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37 | Dynein, axonemal, heavy chain-1 | 25981.0 | ENSG00000114841 | nan | Spermatogenic failure 18, 617576 (3), Autosomal recessive; Ciliary dyskinesia, primary, 37, 617577 (3), Autosomal recessive
chr3	BAP1	603089.0 | BAP1, TPDS1, KURIS, UVM2 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | 8314.0 | ENSG00000163930 | nan | Kury-Isidor syndrome, 619762 (3), Autosomal dominant; Tumor predisposition syndrome 1, 614327 (3), Autosomal dominant; {Uveal melanoma, susceptibility to, 2}, 606661 (3), Autosomal dominant
chr3	PHF7	620057.0 | PHF7 | PHD finger protein 7 | 51533.0 | ENSG00000010318 | nan | nan
chr3	TNNC1	191040.0 | TNNC1, CMD1Z, CMH13 | Troponin-C1, slow | 7134.0 | ENSG00000114854 | nan | Cardiomyopathy, dilated, 1Z, 611879 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 13, 613243 (3), Autosomal dominant
chr3	NISCH	615507.0 | NISCH, IRAS, KIAA0975 | Nischarin | 11188.0 | ENSG00000010322 | nan | nan
chr3	STAB1	608560.0 | STAB1, FEEL1, KIAA0246, HRFT | Stabilin 1 | 23166.0 | ENSG00000010327 | nan | [Hyperferritinemia], 620729 (3), Autosomal recessive
chr3	UQCC5	620435.0 | UQCC5, SMIM4 | Ubiquinol-cytochrome c reductase complex assembly factor 5 | 440957.0 | ENSG00000168273 | nan | nan
chr3	PBRM1	606083.0 | PBRM1, PB1, BAF180, RCC | Polybromo 1 | 55193.0 | ENSG00000163939 | mutation identified in 1 ccRCC family | ?Renal cell carcinoma, clear cell, 144700 (3)
chr3	GNL3	608011.0 | GNL3, NS, E2IG3 | Guanine nucleotide-binding protein-like 3 | 26354.0 | ENSG00000163938 | nan | nan
chr3	GLT8D1	618399.0 | GLT8D1 | Glycosyltransferase 8 domain-containing protein 1 | 55830.0 | ENSG00000016864 | nan | nan
chr3	SPCS1	610358.0 | SPCS1, SPC12 | Signal peptidase complex, subunit 1 | 28972.0 | ENSG00000114902 | nan | nan
chr3	NEK4	601959.0 | NEK4, STK2, NRK2 | NIMA (never in mitosis gene a)-related kinase 4 (serine/threonine protein kinase-2) | 6787.0 | ENSG00000114904 | nan | nan
chr3	ITIH1	147270.0 | ITIH1 | Inter-alpha (globulin) inhibitor, H1 polypeptide | 3697.0 | ENSG00000055957 | nan | nan
chr3	ITIH3	146650.0 | ITIH3 | Inter-alpha (globulin) inhibitor, H3 polypeptide | 3699.0 | ENSG00000162267 | nan | nan
chr3	ITIH4	600564.0 | ITIH4, PK120, ITIHL1 | Inter-alpha (globulin) inhibitor, H4 polypeptide | 3700.0 | ENSG00000055955 | nan | nan
chr3	MUSTN1	617195.0 | MUSTN1, MUSTANG | Musculoskeletal embryonic nuclear protein 1 | 389125.0 | ENSG00000272573 | nan | nan
chr3	STIMATE	617189.0 | TMEM110, STIMATE | Transmembrane protein 110 | 375346.0 | ENSG00000213533 | nan | nan
chr3	SFMBT1	607319.0 | SFMBT1, RU1 | SCM-like protein with 4 MBT domains 1 | 51460.0 | ENSG00000163935 | nan | nan
chr3	RFT1	611908.0 | RFT1, CDG1N | RFT1 homolog | 91869.0 | ENSG00000163933 | nan | Congenital disorder of glycosylation, type In, 612015 (3), Autosomal recessive
chr3	PRKCD	176977.0 | PRKCD, CVID9, ALPS3 | Protein kinase C, delta | 5580.0 | ENSG00000163932 | mutation identified in 1 family | Autoimmune lymphoproliferative syndrome, type III, 615559 (3), Autosomal recessive
chr3	TKT	606781.0 | TKT, SDDHD | Transketolase | 7086.0 | ENSG00000163931 | nan | Short stature, developmental delay, and congenital heart defects, 617044 (3), Autosomal recessive
chr3	DCP1A	607010.0 | DCP1A, SMIF | Decapping mRNA 1A | 55802.0 | ENSG00000272886 | nan | nan
chr3	CACNA1D	114206.0 | CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA | Calcium channel, voltage-dependent, L type, alpha 1D subunit | 776.0 | ENSG00000157388 | nan | Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3), Autosomal dominant; Sinoatrial node dysfunction and deafness, 614896 (3), Autosomal recessive
chr3	IL17RB	605458.0 | IL17RB, IL17BR, IL17RH1 | Interleukin 17, receptor B | 55540.0 | ENSG00000056736 | nan | nan
chr3	ACTR8	619716.0 | ACTR8, ARP8 | Actin-related protein 8 | 93973.0 | ENSG00000113812 | nan | nan
chr3	SELENOK	607916.0 | SELENOK, SELK, HSPC030 | Selenoprotein K | 58515.0 | ENSG00000113811 | nan | nan
chr3	CACNA2D3	606399.0 | CACNA2D3 | Calcium channel, voltage-dependent, alpha-2/delta subunit 3 | 55799.0 | ENSG00000157445 | nan | nan
chr3	KTCN3	608586.0 | KTCN3 | Keratoconus 3 | 406215.0 | nan | nan | Keratoconus 3, 608586 (2), Autosomal dominant
chr3	ESRG	611473.0 | ESRG, HESRG | Embryonic stem cell-related protein | 790952.0 | ENSG00000265992 | nan | nan
chr3	WNT5A	164975.0 | WNT5A | Wingless-type MMTV integration site family, member 5A | 7474.0 | ENSG00000114251 | nan | Robinow syndrome, autosomal dominant 1, 180700 (3), Autosomal dominant
chr3	ERC2	617250.0 | ERC2, CAST, KIAA0378 | ELKS/RAB6-interacting/CAST family, member 2 | 26059.0 | ENSG00000187672 | nan | nan
chr3	CCDC66	619287.0 | CCDC66 | Coiled-coil domain-containing protein 66 | 285331.0 | ENSG00000180376 | nan | nan
chr3	TASOR	616493.0 | FAM208A, RAP140, C3orf63, KIAA1105 | Family with sequence similarity 208, member A | 23272.0 | ENSG00000163946 | nan | nan
chr3	ARHGEF3	612115.0 | ARHGEF3, XPLN | RHO guanine nucleotide exchange factor 3 | 50650.0 | ENSG00000163947 | nan | nan
chr3	SPATA12	609869.0 | SPATA12, SRG5 | Spermatogenesis-associated protein 12 | 353324.0 | ENSG00000186451 | nan | nan
chr3	IL17RD	606807.0 | IL17RD, SEF, HH18 | Interleukin 17, receptor D (Sef, zebrafish, homolog of) | 54756.0 | ENSG00000144730 | nan | Hypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3), Autosomal recessive, Autosomal dominant, Digenic dominant
chr3	HESX1	601802.0 | HESX1, RPX, CPHD5 | Homeobox gene expressed in ES cells | 8820.0 | ENSG00000163666 | nan | Pituitary hormone deficiency, combined, 5, 182230 (3), Autosomal recessive, Autosomal dominant; Septooptic dysplasia, 182230 (3), Autosomal recessive, Autosomal dominant; Growth hormone deficiency with pituitary anomalies, 182230 (3), Autosomal recessive, Autosomal dominant
chr3	APPL1	604299.0 | APPL1, APPL, MODY14 | Adaptor protein containing PH domain, PTB domain, and leucine zipper motif 1 | 26060.0 | ENSG00000157500 | nan | {Maturity-onset diabetes of the young, type 14}, 616511 (3), Autosomal dominant
chr3	DNAH12	603340.0 | DNAH12, DNAHC3, HL19 | Dynein, heavy chain-5 | 201625.0 | ENSG00000174844 | nan | nan
chr3	PDE12	616519.0 | PDE12 | Phosphodiesterase 12 | 201626.0 | ENSG00000174840 | nan | nan
chr3	ARF4	601177.0 | ARF4, ARF2 | ADP-ribosylation factor 4 | 378.0 | ENSG00000168374 | nan | nan
chr3	DENND6A	620561.0 | DENND6A, FAM116A | DENN domain-containing protein 6A | 201627.0 | ENSG00000174839 | nan | nan
chr3	SLMAP	602701.0 | SLAP | Sarcolemmal-associated protein | 7871.0 | ENSG00000163681 | nan | nan
chr3	FLNB	603381.0 | FLNB, SCT, AOI, LRS1 | Filamin B | 2317.0 | ENSG00000136068 | nan | Larsen syndrome, 150250 (3), Autosomal dominant; Atelosteogenesis, type I, 108720 (3), Autosomal dominant; Atelosteogenesis, type III, 108721 (3), Autosomal dominant; Spondylocarpotarsal synostosis syndrome, 272460 (3), Autosomal recessive; Boomerang dysplasia, 112310 (3), Autosomal dominant
chr3	DNASE1L3	602244.0 | DNASE1L3, SLEB16 | Deoxyribonuclease I-like 3 | 1776.0 | ENSG00000163687 | nan | Systemic lupus erythematosus 16, 614420 (3), Autosomal recessive
chr3	ABHD6	616966.0 | ADHB6 | Abhydrolase domain-containing protein 6, acylglycerol lipase | 57406.0 | ENSG00000163686 | nan | nan
chr3	HTD2	620769.0 | HTD2 | Hydroxyacyl-thioester dehydratase, type 2 | 109703458.0 | ENSG00000255154 | nan | nan
chr3	RPP14	606112.0 | RPP14 | Ribonuclease P/MRP subunit p14 | 11102.0 | ENSG00000163684 | nan | nan
chr3	PXK	611450.0 | PXK, MONAKA | PXK domain-containing serine/threonine kinase | 54899.0 | ENSG00000168297 | nan | nan
chr3	PDHB	179060.0 | PDHB, PDHBD | Pyruvate dehydrogenase E1, subunit beta | 5162.0 | ENSG00000168291 | nan | Pyruvate dehydrogenase E1-beta deficiency, 614111 (3), Autosomal recessive
chr3	KCTD6	618791.0 | KCTD6, KCASH3 | Potassium channel tetramerization domain-containing protein 6 | 200845.0 | ENSG00000168301 | nan | nan
chr3	ACOX2	601641.0 | ACOX2, BRCACOX, CBAS6 | Acyl-Coenzyme A oxidase 2, branched chain | 8309.0 | ENSG00000168306 | nan | Bile acid synthesis defect, congenital, 6, 617308 (3), Autosomal recessive
chr3	FAM107A	608295.0 | FAM107A, DRR1, TU3A | Family with sequence similarity 107, member A (downregulated in renal cell carcinoma 1) | 11170.0 | ENSG00000168309 | nan | nan
chr3	FAM3D	608619.0 | FAM3D | Family with sequence similarity 3, member D | 131177.0 | ENSG00000198643 | nan | nan
chr3	FHIT	601153.0 | FRA3B, FHIT | Fragile histidine triad gene | 2272.0 | ENSG00000189283 | deleted in RCC | nan
chr3	PTPRG	176886.0 | PTPRG, PTPG | Protein tyrosine phosphatase, receptor type, gamma polypeptide | 5793.0 | ENSG00000144724 | nan | nan
chr3	FEZF2	607414.0 | FEZF2, ZNF312, FEZL, TOF | FEZ family zinc finger 2 | 55079.0 | ENSG00000153266 | nan | nan
chr3	CADPS	604667.0 | CADPS, CAPS | Ca(2+)-dependent activator protein for secretion | 8618.0 | ENSG00000163618 | nan | nan
chr3	SNTN	617832.0 | SNTN, S100AL, S100A1L | Sentan, cilia apical structural protein | 132203.0 | ENSG00000188817 | nan | nan
chr3	HYT7	610948.0 | HYT7 | Hypertension, essential, susceptibility to, 7 | 100188825.0 | nan | nan | {Hypertension, essential, susceptibility to, 7}, 610948 (2)
chr3	THOC7	611965.0 | THOC7, NIF3L1BP1 | THO complex, subunit 7 | 80145.0 | ENSG00000163634 | nan | nan
chr3	ATXN7	607640.0 | ATXN7, SCA7, OPCA3 | Ataxin 7 | 6314.0 | ENSG00000163635 | nan | Spinocerebellar ataxia 7, 164500 (3), Autosomal dominant
chr3	SCAANT1	614481.0 | ATXN7AS1, SCAANT1 | ATXN7 antisense noncoding transcript 1 | 100861563.0 | ENSG00000280620 | nan | nan
chr3	PSMD6	617857.0 | PSMD6, KIAA0107 | Proteasome 26S subunit, non-ATPase, 6 | 9861.0 | ENSG00000163636 | nan | nan
chr3	PRICKLE2	608501.0 | PRICKLE2 | Prickle-like 2 | 166336.0 | ENSG00000163637 | nan | nan
chr3	ADAMTS9	605421.0 | ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif 9 | 56999.0 | ENSG00000163638 | nan | nan
chr3	MAGI1	602625.0 | MAGI1, BAIAP1, WWP3, TNRC19 | Membrane-associated guanylate kinase, WW and PDZ domains-containing, 1 | 9223.0 | ENSG00000151276 | nan | nan
chr3	SLC25A26	611037.0 | SLC25A26, SAMC, COXPD28 | Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26 | 115286.0 | ENSG00000144741 | nan | Combined oxidative phosphorylation deficiency 28, 616794 (3), Autosomal recessive
chr3	LRIG1	608868.0 | LRIG1, LIG1 | Leucine-rich repeats- and immunoglobulin-like domains-containing protein 1 | 26018.0 | ENSG00000144749 | nan | nan
chr3	KBTBD8	616607.0 | KBTBD8, TAKRP, KIAA1842 | Kelch repeat- and BTB/POZ domain-containing protein 8 | 84541.0 | ENSG00000163376 | nan | nan
chr3	SUCLG2	603922.0 | SUCLG2 | Succinate-CoA ligase, GDP-forming, beta subunit | 8801.0 | ENSG00000172340 | nan | nan
chr3	TAFA1	617495.0 | TAFA1, FAM19A1 | TAFA chemokine-like family member 1 | 407738.0 | ENSG00000183662 | nan | nan
chr3	TAFA4	617498.0 | FAM19A4, TAFA4 | Family with sequence similarity 19, member A4, CC motif chemokine-like | 151647.0 | ENSG00000163377 | nan | nan
chr3	EOGT	614789.0 | EOGT, EOGT1, C3orf64, AOS4 | EGF domain-specific O-linked N-acetylglucosamine transferase | 285203.0 | ENSG00000163378 | nan | Adams-Oliver syndrome 4, 615297 (3), Autosomal recessive
chr3	TMF1	601126.0 | TMF1 | TATA element modulatory factor 1 | 7110.0 | ENSG00000144747 | nan | nan
chr3	UBA3	603172.0 | UBA3, UBE1C | Ubiquitin-like modifier activating enzyme 3 | 9039.0 | ENSG00000144744 | nan | nan
chr3	ARL6IP5	605709.0 | ARL6IP5 | ADP ribosylation factor-like GTPase 6 interacting protein 5 | 10550.0 | ENSG00000144746 | nan | nan
chr3	LMOD3	616112.0 | LMOD3, NEM10 | Leiomodin 3 | 56203.0 | ENSG00000163380 | nan | Nemaline myopathy 10, 616165 (3), Autosomal recessive
chr3	FRMD4B	617467.0 | FRMD4B, GRSP1, KIAA1013 | FERM domain-containing protein 4B | 23150.0 | ENSG00000114541 | nan | nan
chr3	MITF	156845.0 | MITF, WS2A, CMM8, COMMAD | Microphthalmia-associated transcription factor | 4286.0 | ENSG00000187098 | nan | Waardenburg syndrome, type 2A, 193510 (3), Autosomal dominant; {Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3); Tietz albinism-deafness syndrome, 103500 (3), Autosomal dominant; COMMAD syndrome, 617306 (3), Autosomal recessive
chr3	SAMMSON	616895.0 | SAMMSON, LINC01212 | Survival-associated mitochondrial melanoma-specific oncogenic noncoding RNA | 101927152.0 | ENSG00000240405 | nan | nan
chr3	FOXP1	605515.0 | FOXP1, QRF1 | Forkhead box P1 | 27086.0 | ENSG00000114861 | nan | Intellectual developmental disorder with language impairment with or without autistic features, 613670 (3), Autosomal dominant
chr3	EIF4E3	609896.0 | EIF4E3 | Eukaryotic translation initiation factor 4E family, member 3 | 317649.0 | ENSG00000163412 | nan | nan
chr3	GPR27	605187.0 | GPR27, SREB1 | G protein-coupled receptor 27 | 2850.0 | ENSG00000170837 | nan | nan
chr3	PROK2	607002.0 | PROK2, PK2, BV8, HH4 | Prokineticin 2 | 60675.0 | ENSG00000163421 | nan | Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3), Autosomal dominant
chr3	RYBP	607535.0 | RYBP, YEAF1 | Ring1- and YY1-binding protein | 23429.0 | ENSG00000163602 | nan | nan
chr3	SHQ1	613663.0 | SHQ1, DYT35, NEDDS | SHQ1, H/ACA ribonucleoprotein assembly factor | 55164.0 | ENSG00000144736 | mutation identified in 1 DYT35 family | Neurodevelopmental disorder with dystonia and seizures, 619922 (3), Autosomal recessive; ?Dystonia 35, childhood-onset, 619921 (3), Autosomal recessive
chr3	GXYLT2	613322.0 | GXYLT2, GLT8D4 | Glucoside xylosyltransferase 2 | 727936.0 | ENSG00000172986 | nan | nan
chr3	PPP4R2	613822.0 | PPP4R2, PP4R2 | Protein phosphatase 4, regulatory subunit 2 | 151987.0 | ENSG00000163605 | nan | nan
chr3	EBLN2	613250.0 | EBLN2 | Endogenous Borna-like N element-containing protein 2 | 55096.0 | ENSG00000255423 | nan | nan
chr3	PDZRN3	609729.0 | PDZRN3, KIAA1095 | PDZ domain-containing ring finger protein 3 | 23024.0 | ENSG00000121440 | nan | nan
chr3	DYX5	606896.0 | DYX5 | Dyslexia, susceptibility to, 5 | 171089.0 | nan | ?same locus as SSD | {Dyslexia, susceptibility to, 5}, 606896 (2)
chr3	SSD	608445.0 | SSD | Speech-sound disorder | 404713.0 | nan | ?same locus as DYX5 | {Speech-sound disorder}, 608445 (2)
chr3	CNTN3	601325.0 | CNTN3, PANG | Contactin 3 (plasmocytoma-associated neuronal glycoprotein) | 5067.0 | ENSG00000113805 | nan | nan
chr3	ZNF717	618405.0 | ZNF717, OB1 | Zinc finger protein 717 | 100131827.0 | ENSG00000227124 | nan | nan
chr3	ROBO2	602431.0 | ROBO2, SAX3, KIAA1568 | Roundabout guidance receptor 2 | 6092.0 | ENSG00000185008 | nan | Vesicoureteral reflux 2, 610878 (3), Autosomal dominant
chr3	ROBO1	602430.0 | ROBO1, DUTT1, SAX3, CPHD8, NYS8, NORS | Roundabout guidance receptor 1 | 6091.0 | ENSG00000169855 | mutation identified in 1 NYS8 family | Pituitary hormone deficiency, combined or isolated, 8, 620303 (3), Autosomal dominant; Neurooculorenal syndrome, 620305 (3), Autosomal recessive; ?Nystagmus 8, congenital, autosomal recessive, 257400 (3), Autosomal recessive
chr3	GBE1	607839.0 | GBE1, GSD4, APBD | Glycogen branching enzyme | 2632.0 | ENSG00000114480 | nan | Glycogen storage disease IV, 232500 (3), Autosomal recessive; Polyglucosan body disease, adult form, 263570 (3), Autosomal recessive
chr3	CADM2	609938.0 | CADM2, IGSF4D, SYNCAM2, NECL3 | Cell adhesion molecule 2 | 253559.0 | ENSG00000175161 | nan | nan
chr3	VGLL3	609980.0 | VGLL3, VGL3 | Vestigial-like 3 | 389136.0 | ENSG00000206538 | nan | nan
chr3	CHMP2B	609512.0 | CHMP2B, DMT1, VPS2B, FTDALS7 | Charged multivesicular body protein 2B | 25978.0 | ENSG00000083937 | nan | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7, 600795 (3), Autosomal dominant
chr3	POU1F1	173110.0 | POU1F1, PIT1, CPHD1 | POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1) | 5449.0 | ENSG00000064835 | nan | Pituitary hormone deficiency, combined or isolated, 1, 613038 (3), Autosomal recessive, Autosomal dominant
chr3	HTR1F	182134.0 | HTR1F, HTR1EL, MR77 | 5-hydroxytryptamine receptor 1F | 3355.0 | ENSG00000179097 | nan | nan
chr3	CGGBP1	603363.0 | CGGBP1 | CGG triplet repeat binding protein 1 | 8545.0 | ENSG00000163320 | nan | nan
chr3	EPHA3	179611.0 | EPHA3, ETK1, HEK | Ephrin receptor EphA3 (human embryo kinase 1) | 2042.0 | ENSG00000044524 | nan | nan
chr3	ERVK-5	614012.0 | ERVK-5, HERV-KII | Endogenous retrovirus group K, member 5 | 60358.0 | nan | nan | nan
chr3	PROS1	176880.0 | PROS1, THPH5, THPH6 | Protein S, alpha | 5627.0 | ENSG00000184500 | pseudogene PROSP contiguous on chr.3 | Thrombophilia 5 due to protein S deficiency, autosomal recessive, 614514 (3), Autosomal recessive; Thrombophilia 5 due to protein S deficiency, autosomal dominant, 612336 (3), Autosomal dominant
chr3	ARL13B	608922.0 | ARL13B, ARL2L1, JBTS8 | ADP ribosylation factor-like GTPase 13B | 200894.0 | ENSG00000169379 | nan | Joubert syndrome 8, 612291 (3), Autosomal recessive
chr3	CAMPD1	114200.0 | CAMPD1 | Camptodactyly 1 | 100381210.0 | nan | between D3S2465 and D3S3044 | Camptodactyly 1, 114200 (2), Autosomal dominant
chr3		620119.0 | LNC-CRYBG3 | Long noncoding RNA downstream of crystallin beta-gamma domain containing 3 | nan | nan | nan | nan
chr3	DHFR2	616588.0 | DHFRL1 | Dihydrofolate reductase-like 1 | 200895.0 | ENSG00000178700 | nan | nan
chr3	NSUN3	617491.0 | NSUN3, COXPD48 | NOP2/SUN RNA methyltransferase family, member 3 | 63899.0 | ENSG00000178694 | nan | Combined oxidative phosphorylation deficiency 48, 619012 (3), Autosomal recessive
chr3	EPHA6	600066.0 | EPHA6, HEK12, EHK2 | Ephrin receptor EphA6 | 285220.0 | ENSG00000080224 | nan | nan
chr3	ARL6	608845.0 | ARL6, BBS3, RP55 | ADP ribosylation factor-like GTPase 6 | 84100.0 | ENSG00000113966 | nan | Retinitis pigmentosa 55, 613575 (3), Autosomal recessive; {Bardet-Biedl syndrome 1, modifier of}, 209900 (3), Autosomal recessive, Digenic recessive; Bardet-Biedl syndrome 3, 600151 (3), Autosomal recessive
chr3	CRYBG3	620146.0 | CRYBG3 | Crystallin beta-gamma domain-containing protein 3 | 131544.0 | ENSG00000080200 | nan | nan
chr3	RIOX2	612049.0 | RIOX2, MINA, MINA53, MDIG | Ribosomal oxygenase 2 | 84864.0 | ENSG00000170854 | nan | nan
chr3	GABRR3	618668.0 | GABRR3 | Gamma-aminobutyric acid receptor, RHO-3 | 200959.0 | ENSG00000183185 | nan | nan
chr3	CLDND1	619677.0 | CLDND1, C3orf4 | Claudin domain-containing protein 1 | 56650.0 | ENSG00000080822 | nan | nan
chr3	GPR15	601166.0 | GPR15 | G protein-coupled receptor-15 | 2838.0 | ENSG00000154165 | nan | nan
chr3	CPOX	612732.0 | CPOX, HARPO | Coproporphyrinogen oxidase | 1371.0 | ENSG00000080819 | nan | Coproporphyria, 121300 (3), Autosomal recessive, Autosomal dominant; Harderoporphyria, 618892 (3), Autosomal recessive
chr3	ST3GAL6	607156.0 | ST3GAL6, ST3GALVI | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | 10402.0 | ENSG00000064225 | nan | nan
chr3	DCBLD2	608698.0 | DCBLD2, ESDN | Discoidin, CUB, and LCCL domain-containing protein 2 | 131566.0 | ENSG00000057019 | nan | nan
chr3	COL8A1	120251.0 | COL8A1 | Collagen VIII, alpha-1 polypeptide | 1295.0 | ENSG00000144810 | nan | nan
chr3	FILIP1L	612993.0 | FILIP1L | Filamin A-interacting protein 1-like | 11259.0 | ENSG00000168386 | nan | nan
chr3	TMEM30CP	611030.0 | TMEM30C, CDC50C | Transmembrane protein 30C | 644444.0 | ENSG00000293379 | nan | nan
chr3	TBC1D23	617687.0 | TBC1D23, PCH11 | TBC1 domain family, member 23 | 55773.0 | ENSG00000036054 | nan | Pontocerebellar hypoplasia, type 11, 617695 (3), Autosomal recessive
chr3	NIT2	616769.0 | NIT2 | Nitrilase family member 2 | 56954.0 | ENSG00000114021 | nan | nan
chr3	TOMM70	606081.0 | TOMM70 | Translocase of outer mitochondrial membrane 70 | 9868.0 | ENSG00000154174 | nan | nan
chr3	TMEM45A	616928.0 | TMEM45A, DERP7, DNAPTP4 | Transmembrane protein 45A | 55076.0 | ENSG00000181458 | nan | nan
chr3	ADGRG7	612307.0 | ADGRG7, GPR128 | Adhesion G protein-coupled receptor G7 | 84873.0 | ENSG00000144820 | nan | nan
chr3	TFG	602498.0 | TFG, HMSNP, SPG57 | Trafficking from ER to Golgi regulator | 10342.0 | ENSG00000114354 | fused with NR4A3 or NTRK1; mutation identified in 1 SPG57 family | ?Spastic paraplegia 57, autosomal recessive, 615658 (3), Autosomal recessive; Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3), Autosomal dominant
chr3	ABI3BP	606279.0 | TARSH | Target of Nesh-SH3 | 25890.0 | ENSG00000154175 | nan | nan
chr3	IMPG2	607056.0 | IMPG2, IPM200, RP56, VMD5 | Interphotoreceptor matrix proteoglycan 2 | 50939.0 | ENSG00000081148 | nan | Retinitis pigmentosa 56, 613581 (3), Autosomal recessive; Macular dystrophy, vitelliform, 5, 616152 (3), Autosomal dominant
chr3	SENP7	612846.0 | SENP7, KIAA1707 | Sentrin-specific protease family, member 7 | 57337.0 | ENSG00000138468 | nan | nan
chr3	TRMT10C	615423.0 | TRMT10C, RG9MTD1, MRPP1, COXPD30 | tRNA methyltransferase 10C, mitochondrial RNase P subunit | 54931.0 | ENSG00000174173 | nan | Combined oxidative phosphorylation deficiency 30, 616974 (3), Autosomal recessive
chr3	PCNP	615210.0 | PCNP | PEST-containing nuclear protein | 57092.0 | ENSG00000081154 | nan | nan
chr3	ZBTB11	618181.0 | ZBTB11, MRT69 | Zinc finger- and BTB domain-containing protein 11 | 27107.0 | ENSG00000066422 | nan | Intellectual developmental disorder, autosomal recessive 69, 618383 (3), Autosomal recessive
chr3	RPL24	604180.0 | RPL24 | Ribosomal protein L24 | 6152.0 | ENSG00000114391 | nan | nan
chr3	CEP97	615864.0 | CEP97 | Centrosomal protein, 97kD | 79598.0 | ENSG00000182504 | nan | nan
chr3	NFKBIZ	608004.0 | NFKBIZ, INAP, MAIL, IKBZ | Nuclear factor kappa-B inhibitor, zeta | 64332.0 | ENSG00000144802 | nan | nan
chr3	ZPLD1	615915.0 | ZPLD1 | Zona pellucida-like domain-containing protein 1 | 131368.0 | ENSG00000170044 | nan | nan
chr3		608901.0 | CHDS5 | Coronary heart disease, susceptibility to, 5 | nan | nan | nan | {Coronary heart disease, susceptibility to, 5}, 608901 (2)
chr3	MHS4	600467.0 | MHS4 | Malignant hyperthermia susceptibility 4 | 4265.0 | nan | nan | {Malignant hyperthermia susceptibility 4}, 600467 (2), Autosomal dominant
chr3	ALCAM	601662.0 | ALCAM | Activated leukocyte cell adhesion molecule | 214.0 | ENSG00000170017 | nan | nan
chr3	CBLB	604491.0 | CBLB, ADMIO3 | CAS-BR-M murine ecotropic retroviral transforming sequence B | 868.0 | ENSG00000114423 | nan | Autoimmune disease, multisystem, infantile-onset, 3, 620430 (3), Autosomal recessive
chr3	DUBR	616619.0 | DUBR, DUM, LINC0883 | DPPA2 upstream-binding RNA, noncoding | 344595.0 | ENSG00000243701 | nan | nan
chr3	CD47	601028.0 | CD47, MER6, IAP | CD47 antigen (Rh-related antigen; integrin-associated protein) | 961.0 | ENSG00000196776 | nan | nan
chr3	IFT57	606621.0 | IFT57, ESRRBL1, HIPPI, OFD18 | Intraflagellar transport 57 (HIP1 protein interactor) | 55081.0 | ENSG00000114446 | mutation identified in 1 OFD18 family | ?Orofaciodigital syndrome XVIII, 617927 (3), Autosomal recessive
chr3	HHLA2	604371.0 | HHLA2 | Human endogenous retrovirus-H long terminal repeat-associating 2 | 11148.0 | ENSG00000114455 | nan | nan
chr3	MYH15	609929.0 | MYH15 | Myosin, heavy chain 15 | 22989.0 | ENSG00000144821 | nan | nan
chr3	CIP2A	610643.0 | CIP2A, KIAA1524, p90 | Cell proliferation-regulating inhibitor of protein phosphatase 2A | 57650.0 | ENSG00000163507 | nan | nan
chr3	DZIP3	608672.0 | DZIP3, KIAA0675 | DAZ-interacting zinc finger protein 3 | 9666.0 | ENSG00000198919 | nan | nan
chr3	RETNLB	605645.0 | RETNLB, RELMB, FIZZ2 | Resistin-like protein, beta | 84666.0 | ENSG00000163515 | nan | nan
chr3	TRAT1	604962.0 | TRAT1, TRIM | T-cell receptor-associated transmembrane adaptor 1 | 50852.0 | ENSG00000163519 | nan | nan
chr3	GUCA1C	605128.0 | GUCA1C, GCAP3 | Guanylate cyclase activator 1C | 9626.0 | ENSG00000138472 | nan | nan
chr3	MORC1	603205.0 | MORC1 | MORC family CW-type zinc finger 1 (microrchidia, mouse, homolog of) | 27136.0 | ENSG00000114487 | nan | nan
chr3	DPPA2	614445.0 | DPPA2, PESCRG1, ECAT15-2 | Developmental pluripotency-associated gene 2 | 151871.0 | ENSG00000163530 | nan | nan
chr3	DPPA4	614125.0 | DPPA4 | Developmental pluripotency-associated gene 4 | 55211.0 | ENSG00000121570 | nan | nan
chr3	NECTIN3	607147.0 | NECTIN3, PVRL3, PRR3 | Nectin 3 | 25945.0 | ENSG00000177707 | nan | nan
chr3	CD96	606037.0 | CD96, TACTILE | CD96 antigen | 10225.0 | ENSG00000153283 | nan | C syndrome, 211750 (3), Autosomal dominant
chr3	ZBED2	615246.0 | ZBED2 | Zinc finger BED domain-containing protein 2 | 79413.0 | ENSG00000177494 | nan | nan
chr3	STUT3	614655.0 | STUT3 | Stuttering, familial persistent, 3 | 100909386.0 | nan | max lod at D3S1310 | Stuttering, familial persistent, 3, 614655 (2)
chr3	PLCXD2	617015.0 | PLCXD1 | Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 2 | 257068.0 | ENSG00000240891 | nan | nan
chr3	PHLDB2	610298.0 | PHLDB2 | Pleckstrin homology-like domain, family B, member 2 | 90102.0 | ENSG00000144824 | nan | nan
chr3	ABHD10	618756.0 | ABHD10 | Abhydrolase domain-containing protein 10, depalmitoylase | 55347.0 | ENSG00000144827 | nan | nan
chr3	TAGLN3	607953.0 | TAGLN3, NP24, NP22 | Transgelin 3 | 29114.0 | ENSG00000144834 | nan | nan
chr3	C3orf52	611956.0 | C3orf52, TTMP, HYPT15 | Chromosome 3 open reading frame 52 | 79669.0 | ENSG00000114529 | nan | Hypotrichosis 15, 620177 (3), Autosomal recessive
chr3	GCSAM	607792.0 | GCET2, HGAL | Germinal center-expressed transcript 2 | 257144.0 | ENSG00000174500 | nan | nan
chr3	SLC9C1	612738.0 | SLC9A10 | Solute carrier family 9, member 10 | 285335.0 | ENSG00000172139 | nan | nan
chr3	CD200	155970.0 | MOX2 | MRC OX-2 antigen | 4345.0 | ENSG00000091972 | nan | nan
chr3	BTLA	607925.0 | BTLA | B- and T-lymphocyte attenuator | 151888.0 | ENSG00000186265 | nan | nan
chr3	ATG3	609606.0 | ATG3, APG3 | Autophagy-related 3 | 64422.0 | ENSG00000144848 | nan | nan
chr3	SLC35A5	620298.0 | SLC35A5 | Solute carrier family 35, member A5 | 55032.0 | ENSG00000138459 | nan | nan
chr3	CCDC80	608298.0 | CCDS80, URB, SSG1 | Coiled-coil domain-containing protein 80 | 151887.0 | ENSG00000091986 | nan | nan
chr3	CD200R1	607546.0 | CD200R1, MOX2R, OX2R | CD200 receptor 1 | 131450.0 | ENSG00000163606 | nan | nan
chr3	NEPRO	617089.0 | NEPRO, C3orf17, ANXD3 | Nucleolus and neural progenitor protein | 25871.0 | ENSG00000163608 | nan | Anauxetic dysplasia 3, 618853 (3), Autosomal recessive
chr3	BOC	608708.0 | BOC | Brother of CDON | 91653.0 | ENSG00000144857 | nan | nan
chr3	CFAP44	617559.0 | CFAP44, WDR52, SPGF20 | Cilia- and flagella-associated protein 44 | 55779.0 | ENSG00000206530 | nan | Spermatogenic failure 20, 617593 (3), Autosomal recessive
chr3	SPICE1	613447.0 | SPICE1, CCDC52 | Spindle- and centriole-associated protein 1 | 152185.0 | ENSG00000163611 | nan | nan
chr3	SIDT1	606816.0 | SIDT1 | SID1 transmembrane family, member 1 | 54847.0 | ENSG00000072858 | nan | nan
chr3	USF3	617568.0 | USF3 | Upstream transcription factor family, member 3 | 205717.0 | ENSG00000176542 | nan | nan
chr3		615433.0 | DEL3q13.31, C13DELq13.31 | Chromosome 3q13.31 deletion syndrome | nan | nan | nan | Chromosome 3q13.31 deletion syndrome, 615433 (4), Autosomal dominant
chr3	NAA50	610834.0 | NAA50, NAT13, NAT5, SAN | N-alpha-acetyltransferase 50, NatE catalytic subunit | 80218.0 | ENSG00000121579 | nan | nan
chr3	ATP6V1A	607027.0 | ATP6V1A, HO68, ARCL2D, DEE93 | ATPase, H+ transporting, V1 subunit A | 523.0 | ENSG00000114573 | nan | Cutis laxa, autosomal recessive, type IID, 617403 (3), Autosomal recessive; Developmental and epileptic encephalopathy 93, 618012 (3), Autosomal dominant
chr3	GRAMD1C	620180.0 | GRAMD1C | GRAM domain-containing protein 1C | 54762.0 | ENSG00000178075 | nan | nan
chr3	ZDHHC23	617334.0 | ZDHHC23, NIDD | Zinc finger DHHC-type containing 23 | 254887.0 | ENSG00000184307 | nan | nan
chr3	DRD3	126451.0 | DRD3, ETM1, FET1 | Dopamine receptor D3 | 1814.0 | ENSG00000151577 | nan | {Essential tremor, hereditary, 1}, 190300 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant
chr3	ZNF80	194553.0 | ZNF80 | Zinc finger protein-80 (pT17) | 7634.0 | ENSG00000174255 | nan | nan
chr3	TIGIT	612859.0 | TIGIT | T-cell immunoreceptor with immunoglobulin and ITIM domains | 201633.0 | ENSG00000181847 | nan | nan
chr3	ZBTB20	606025.0 | ZBTB20, ZNF288, DPZF, PRIMS | Zinc finger and BTB-domain containing 20 | 26137.0 | ENSG00000181722 | nan | Primrose syndrome, 259050 (3), Autosomal dominant
chr3	GAP43	162060.0 | GAP43 | Neuron growth-associated protein 43 | 2596.0 | ENSG00000172020 | nan | nan
chr3	LSAMP	603241.0 | LSAMP, LAMP | Limbic system-associated membrane protein | 4045.0 | ENSG00000185565 | nan | nan
chr3	TUSC7	616057.0 | TUSC7, LSAMPAS3, LOC285194 | Tumor suppressor candidate 7, noncoding | 285194.0 | ENSG00000243197 | nan | nan
chr3	IGSF11	608351.0 | IGSF11, BTIGSF, VSIG3 | Immunoglobulin superfamily, member 11 | 152404.0 | ENSG00000144847 | nan | nan
chr3	UPK1B	602380.0 | UPK1B | Uroplakin 1B | 7348.0 | ENSG00000114638 | nan | nan
chr3	B4GALT4	604015.0 | B4GALT4 | Beta-1,4-galactosyltransferase 4 | 8702.0 | ENSG00000121578 | nan | nan
chr3	ARHGAP31	610911.0 | ARHGAP31, CDGAP, KIAA1204, AOS1 | Rho GTPase-activating protein 31 | 57514.0 | ENSG00000031081 | nan | Adams-Oliver syndrome 1, 100300 (3), Autosomal dominant
chr3	POGLUT1	615618.0 | POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMDR21 | Protein O-glucosyltransferase 1 | 56983.0 | ENSG00000163389 | nan | Dowling-Degos disease 4, 615696 (3), Autosomal dominant; Muscular dystrophy, limb-girdle, autosomal recessive 21, 617232 (3), Autosomal recessive
chr3	TIMMDC1	615534.0 | TIMMDC1, C3orf1, MC1DN31 | Translocase of inner mitochondrial membrane domain-containing protein 1 | 51300.0 | ENSG00000113845 | nan | Mitochondrial complex I deficiency, nuclear type 31, 618251 (3), Autosomal recessive
chr3	CD80	112203.0 | CD80, CD28LG, LAB7 | CD80 antigen (CD28 antigen ligand 1, B7-1 antigen) | 941.0 | ENSG00000121594 | nan | nan
chr3	ADPRH	603081.0 | ADPRH | ADP-ribosylarginine hydrolase | 141.0 | ENSG00000144843 | nan | nan
chr3	PLA1A	607460.0 | PLA1A, PSPLA1 | Phosphatidylserine-specific phospholipase A1-alpha | 51365.0 | ENSG00000144837 | nan | nan
chr3	POPDC2	605823.0 | POPDC2, POP2 | Popeye domain-containing protein 2 | 64091.0 | ENSG00000121577 | nan | nan
chr3	COX17	604813.0 | COX17 | Cytochrome c oxidase assembly protein COX17 | 10063.0 | ENSG00000138495 | pseudogene on chr. 13? | nan
chr3	CFAP91	609910.0 | CFAP91, MAATS1, AAT1, C3orf15, SPGF51 | Cilia- and flagella-associated protein 91 | 89876.0 | ENSG00000183833 | nan | Spermatogenic failure 51, 619177 (3), Autosomal recessive
chr3	NR1I2	603065.0 | NR1I2, PXR, SXR, PARq | Nuclear receptor subfamily 1, group I, member 2 | 8856.0 | ENSG00000144852 | nan | nan
chr3	GSK3B	605004.0 | GSK3B | Glycogen synthase kinase 3-beta | 2932.0 | ENSG00000082701 | nan | nan
chr3	GPR156	610464.0 | GPR156, GABABL, DFNB121 | G protein-coupled receptor 156 | 165829.0 | ENSG00000175697 | nan | Deafness, autosomal recessive 121, 620551 (3), Autosomal recessive
chr3	FSTL1	605547.0 | FSTL1, FRP, MIR198 | Follistatin-like 1 | 11167.0 | ENSG00000163430 | FSTL1 mRNA can encode a protein or produce an micoRNA | nan
chr3	NDUFB4	603840.0 | NDUFB4 | NADH-ubiquinone oxidoreductase subunit B4 | 4710.0 | ENSG00000065518 | nan | nan
chr3	HGD	607474.0 | HGD, AKU | Homogentisate 1,2-dioxygenase (homogentisate oxidase) | 3081.0 | ENSG00000113924 | nan | Alkaptonuria, 203500 (3), Autosomal recessive
chr3	RABL3	618542.0 | RABL3, PNCA5 | RAB, member of RAS oncogene family-like 3 | 285282.0 | ENSG00000144840 | mutation identified in 1 PNCA5 family | {?Pancreatic cancer, susceptibility to, 5}, 618680 (3), Autosomal dominant
chr3	GTF2E1	189962.0 | GTF2E1, TF2E1 | General transcription factor IIE, polypeptide 1 | 2960.0 | ENSG00000153767 | nan | nan
chr3	STXBP5L	609381.0 | STXBP5L, LLGL4 | Syntaxin-binding protein 5-like | 9515.0 | ENSG00000145087 | nan | nan
chr3	POLQ	604419.0 | POLQ | Polymerase, DNA, theta | 10721.0 | ENSG00000051341 | nan | nan
chr3	ARGFX	611164.0 | ARGFX | Arginine-fifty homeobox | 503582.0 | ENSG00000186103 | pseudogenes on 5q23.2 and 17q11.2 | nan
chr3	FBXO40	609107.0 | FBXO40, FBX40, KIAA1195 | F-box only protein 40 | 51725.0 | ENSG00000163833 | nan | nan
chr3	HCLS1	601306.0 | HCLS1 | Hematopoietic cell-specific Lyn substrate 1 | 3059.0 | ENSG00000180353 | nan | nan
chr3	GOLGB1	602500.0 | GOLGB1, GCP372 | Golgin B1 | 2804.0 | ENSG00000173230 | nan | nan
chr3	IQCB1	609237.0 | IQCB1, NPHP5, KIAA0036 | IQ motif-containing protein B1 | 9657.0 | ENSG00000173226 | nan | Senior-Loken syndrome 5, 609254 (3), Autosomal recessive
chr3	EAF2	607659.0 | EAF2 | ELL-associated factor 2 | 55840.0 | ENSG00000145088 | nan | nan
chr3	SLC15A2	602339.0 | SLC15A2, PEPT2 | Solute carrier family 15 (H+/peptide transporter), member 2 | 6565.0 | ENSG00000163406 | nan | nan
chr3	ILDR1	609739.0 | ILDR1, DFNB42 | Immunoglobulin-like domain-containing receptor 1 | 286676.0 | ENSG00000145103 | nan | Deafness, autosomal recessive 42, 609646 (3), Autosomal recessive
chr3	CD86	601020.0 | CD86, CD28LG2, LAB72 | CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) | 942.0 | ENSG00000114013 | nan | nan
chr3	CASR	601199.0 | CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1 | Calcium-sensing receptor | 846.0 | ENSG00000036828 | mutation identified in 1 EIG8 family | Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3), Autosomal dominant; Hyperparathyroidism, neonatal, 239200 (3), Autosomal recessive, Autosomal dominant; Hypocalcemia, autosomal dominant, 601198 (3), Autosomal dominant; Hypocalciuric hypercalcemia, type I, 145980 (3), Autosomal dominant; {?Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3), Autosomal dominant
chr3	ATOD1	603165.0 | ATOD1 | Dermatitis, atopic, 1 | 64069.0 | nan | max lod at D3S3606 | {Dermatitis, atopic, susceptibility to, 1}, 603165 (2), Autosomal dominant
chr3	ERVK-4	614011.0 | ERVK-4, HERV-KI | Endogenous retrovirus group K, member 4 | 60359.0 | nan | nan | nan
chr3	FGQTL6	613460.0 | FGQTL6, BWQTL3 | Fasting plasma glucose level QTL 6; Birth weight QTL 3 | 100499168.0 | nan | associated with rs11708067 and rs11708067 | [Birth weight QTL 3], 613460 (2); [Fasting plasma glucose level QTL 6], 613460 (2)
chr3	GLC1C	601682.0 | GLC1C | Glaucoma 1, open angle, C | 2723.0 | nan | nan | Glaucoma 1C, primary open angle, 601682 (2), Autosomal dominant
chr3	MBS2	601471.0 | HCFP1, MBS2 | Facial paresis, hereditary congenital, 1 | 7880.0 | nan | nan | Facial paresis, hereditary congenital, 1, 601471 (2), Autosomal dominant
chr3	PSORS5	604316.0 | PSORS5 | Psoriasis susceptibility 5 | 63870.0 | nan | nan | {Psoriasis susceptibility 5}, 604316 (2)
chr3	CSTA	184600.0 | CSTA, STFA, STF1, AREI, PSS4 | Cystatin A (stefin A) | 1475.0 | ENSG00000121552 | nan | Peeling skin syndrome 4, 607936 (3), Autosomal recessive
chr3	MIX23	620713.0 | MIX23 | Mitochondrial matrix import factor 23 | 131076.0 | ENSG00000160124 | nan | nan
chr3	FAM162A	608017.0 | FAM162A, ,C3orf28, E2IG5 | Family with sequence similarity 162, member A | 26355.0 | ENSG00000114023 | nan | nan
chr3	KPNA1	600686.0 | KPNA1, RCH2, SRP1 | Karyopherin, alpha-1 | 3836.0 | ENSG00000114030 | nan | nan
chr3	PARP9	612065.0 | PARP9, BAL1, BAL | Poly(ADP-ribose) polymerase 9 | 83666.0 | ENSG00000138496 | nan | nan
chr3	DTX3L	613143.0 | DTX3L, BBAP | Deltex E3 ubiquitin liase 3L | 151636.0 | ENSG00000163840 | head-to-head with PARP9 | nan
chr3	PARP15	612066.0 | PARP15, BAL3 | Poly(ADP-ribose) polymerase 15 | 165631.0 | ENSG00000173200 | nan | nan
chr3	PARP14	610028.0 | PARP14, KIAA1268 | Poly(ADP-ribose) polymerase 14 | 54625.0 | ENSG00000173193 | nan | nan
chr3	HSPBAP1	608263.0 | HSPBAP1, PASS1 | Heat-shock 27kD protein-associated protein 1 | 79663.0 | ENSG00000169087 | nan | nan
chr3	SLC49A4	602773.0 | SLC49A4, DIRC2, RCC4 | Solute carrier family 48, member 4 | 84925.0 | ENSG00000138463 | t(2;3)(q35;q21) in renal cell carcinoma | nan
chr3	SEMA5B	609298.0 | SEMA5B, SEMG, KIAA1445 | Semaphorin 5B | 54437.0 | ENSG00000082684 | nan | nan
chr3	PDIA5	616942.0 | PDIA5, PDIR | Protein disulfide isomerase, family A, member 5 | 10954.0 | ENSG00000065485 | nan | nan
chr3	SEC22A	612442.0 | SEC22A, SEC22L2 | SEC22 homolog A, vesicle trafficking protein | 26984.0 | ENSG00000121542 | nan | nan
chr3	ADCY5	600293.0 | ADCY5, FDFM, DSKOD | Adenylate cyclase-5 | 111.0 | ENSG00000173175 | nan | Dyskinesia with orofacial involvement, autosomal dominant, 606703 (3), Autosomal dominant; Neurodevelopmental disorder with hyperkinetic movements and dyskinesia, 619651 (3), Autosomal recessive; Dyskinesia with orofacial involvement, autosomal recessive, 619647 (3), Autosomal recessive
chr3	HACD2	615939.0 | PTPLB, HACD2 | Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member B | 201562.0 | ENSG00000206527 | nan | nan
chr3	MYLK	600922.0 | MYLK, MLCK, AAT7, MMIHS1 | Myosin-light-polypeptide kinase | 4638.0 | ENSG00000065534 | pseudogene on 3p13 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 1, 249210 (3), Autosomal recessive; Aortic aneurysm, familial thoracic 7, 613780 (3), Autosomal dominant
chr3	CCDC14	617147.0 | CCDC14 | Coiled-coil domain-containing protein 14 | 64770.0 | ENSG00000175455 | nan | nan
chr3	ROPN1	611757.0 | ROPN1, ODF6 | Rhophilin-associated tail protein 1 | 54763.0 | ENSG00000065371 | nan | nan
chr3	KALRN	604605.0 | KALRN, HAPIP, DUO | Kalirin | 8997.0 | ENSG00000160145 | nan | nan
chr3	UMPS	613891.0 | UMPS, OPRT | Uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase) | 7372.0 | ENSG00000114491 | nan | Orotic aciduria, 258900 (3), Autosomal recessive
chr3	ITGB5	147561.0 | ITGB5 | Integrin, beta-5 | 3693.0 | ENSG00000082781 | nan | nan
chr3	MUC13	612181.0 | MUC13 | Mucin 13, cell surface-associated | 56667.0 | ENSG00000173702 | nan | nan
chr3	HEG1	614182.0 | HEG1, KIAA1237 | Heart development protein with EGF-like domains 1 | 57493.0 | ENSG00000173706 | nan | nan
chr3	SLC12A8	611316.0 | SLC12A8 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 8 | 84561.0 | ENSG00000221955 | nan | nan
chr3	ZNF148	601897.0 | ZNF148, ZFP148, GDACCF | Zinc finger protein-148 | 7707.0 | ENSG00000163848 | nan | Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies, 617260 (3), Autosomal dominant
chr3	SNX4	605931.0 | SNX4 | Sorting nexin 4 | 8723.0 | ENSG00000114520 | nan | nan
chr3	OSBPL11	606739.0 | OSBPL11, ORP11 | Oxysterol-binding protein-like protein 11 | 114885.0 | ENSG00000144909 | previously assigned to chr.8 | nan
chr3	SLC41A3	610803.0 | SLC41A3 | Solute carrier family 41, member 3 | 54946.0 | ENSG00000114544 | nan | nan
chr3	ALDH1L1	600249.0 | ALDH1L1, FTHFD | Aldehyde dehydrogenase 1 family, member L1 | 10840.0 | ENSG00000144908 | nan | nan
chr3	KLF15	606465.0 | KLF15, KKLF | Kruppel-like factor 15 | 28999.0 | ENSG00000163884 | nan | nan
chr3	ZXDC	615746.0 | ZXDC | ZCD family zinc finger protein C | 79364.0 | ENSG00000070476 | nan | nan
chr3	UROC1	613012.0 | UROC1, UROCD | Urocanase domain-containing protein 1 | 131669.0 | ENSG00000159650 | mutation identified in 1 UROCD patient | ?Urocanase deficiency, 276880 (3), Autosomal recessive
chr3	CHST13	610124.0 | CHST13, C4ST3 | Carbohydrate sulfotransferase 13 | 166012.0 | ENSG00000180767 | nan | nan
chr3	TXNRD3	606235.0 | TXNRD3, TRXR3, TR2 | Thioredoxin reductase 3 | 114112.0 | ENSG00000197763 | nan | nan
chr3	CHCHD6	615634.0 | CHCHD6, CHCM1 | Coiled-coil-helix-coiled-coil-helix domain-containing protein 6 | 84303.0 | ENSG00000159685 | nan | nan
chr3	PLXNA1	601055.0 | PLXNA1, NOVP, NOV, PLXN1, DWOPNED | Plexin A1 (NOV transmembrane protein) | 5361.0 | ENSG00000114554 | nan | Dworschak-Punetha neurodevelopmental syndrome, 619955 (3), Autosomal recessive
chr3	TPRA1	608336.0 | TPRA1, TPRA40, GPR175 | Transmembrane protein, adipocyte associated 1 | 131601.0 | ENSG00000163870 | nan | nan
chr3	MCM2	116945.0 | MCM2, CDCL1, DFNA70 | Minichromosome maintenance complex component 2 (mitotin) | 4171.0 | ENSG00000073111 | mutation identified in 1 DFNA70 family | ?Deafness, autosomal dominant 70, 616968 (3), Autosomal dominant
chr3	PODXL2	616627.0 | PODXL2, EG | Podocalyxin-like 2 | 50512.0 | ENSG00000114631 | nan | nan
chr3	ABTB1	608308.0 | ABTB1, BPOZ | Ankyrin repeat and BTB/POZ domain containing 1 | 80325.0 | ENSG00000114626 | nan | nan
chr3	MGLL	609699.0 | MGLL, MGL, HUK5 | Monoglyceride lipase | 11343.0 | ENSG00000074416 | nan | nan
chr3	SEC61A1	609213.0 | SEC61A1, SEC61, ADTKD5, CVID15 | SEC61 translocon, alpha-1 subunit | 29927.0 | ENSG00000058262 | mutation identified in 1 SCN11 patient | Immunodeficiency, common variable, 15, 620670 (3), Autosomal dominant; ?Neutropenia, severe congenital, 11, autosomal dominant, 620674 (3), Autosomal dominant; Tubulointerstitial kidney disease, autosomal dominant, 5, 617056 (3), Autosomal dominant
chr3	RUVBL1	603449.0 | RUVBL1, NMP238, TIP49 | RuvB-like AAA ATPase 1 | 8607.0 | ENSG00000175792 | nan | nan
chr3	EEFSEC	607695.0 | EEFSEC, SELB, EFSEC | Eukaryotic elongation factor, selenocysteine-tRNA-specific | 60678.0 | ENSG00000132394 | nan | nan
chr3	DNAJB8	611337.0 | DNAJB8, DJ6 | DNAJ/HSP40 homolog, subfamily B, member 8 | 165721.0 | ENSG00000179407 | nan | nan
chr3	GATA2	137295.0 | GATA2, DCML, MONOMAC, IMD21 | GATA-binding protein-2 | 2624.0 | ENSG00000179348 | nan | {Leukemia, acute myeloid, susceptibility to}, 601626 (3), Somatic mutation, Autosomal dominant; Emberger syndrome, 614038 (3), Autosomal dominant; Immunodeficiency 21, 614172 (3), Autosomal dominant; {Myelodysplastic syndrome, susceptibility to}, 614286 (3)
chr3	LINC01565	618259.0 | LINC01565 | Long intergenic noncoding RNA 1565 | 23434.0 | ENSG00000198685 | nan | nan
chr3	RPN1	180470.0 | RPN1 | Ribophorin I | 6184.0 | ENSG00000163902 | nan | nan
chr3	RAB7A	602298.0 | RAB7, CMT2B, PSN | Ras-associated protein RAB7 | 7879.0 | ENSG00000075785 | nan | Charcot-Marie-Tooth disease, type 2B, 600882 (3), Autosomal dominant
chr3	ACAD9	611103.0 | ACAD9, MC1DN20 | Acyl-CoA dehydrogenase family, member 9 | 28976.0 | ENSG00000177646 | nan | Mitochondrial complex I deficiency, nuclear type 20, 611126 (3), Autosomal recessive
chr3	GP9	173515.0 | GP9 | Glycoprotein IX, platelet | 2815.0 | ENSG00000169704 | nan | Bernard-Soulier syndrome, type C, 231200 (3), Autosomal recessive
chr3	ISY1	612764.0 | ISY1, KIAA1160 | ISY1 splicing factor homolog | 57461.0 | ENSG00000240682 | nan | nan
chr3	CNBP	116955.0 | CNBP, ZNF9, CNBP1, DM2, PROMM | CCHC-type zinc finger nucleic acid-binding protein | 7555.0 | ENSG00000169714 | nan | Myotonic dystrophy 2, 602668 (3), Autosomal dominant
chr3	COPG1	615525.0 | COPG1, IMD128 | Coatomer protein complex, subunit gamma-1 | 22820.0 | ENSG00000181789 | mutation identified in 1 IMD128 family | ?Immunodeficiency 128, 620983 (3), Autosomal recessive
chr3	HMCES	618288.0 | HMCES | 5-hydroxymethylcytosine-binding protein, embryonic stem cell-specific | 56941.0 | ENSG00000183624 | nan | nan
chr3	H1-10	602785.0 | H1-10, H1FX, H1X | H1.10 linker histone | 8971.0 | ENSG00000184897 | nan | nan
chr3	MBD4	603574.0 | MBD4, MED1, TPDS2 | Methyl-CpG-binding domain protein 4 | 8930.0 | ENSG00000129071 | nan | {Uveal melanoma, susceptibility to, 1}, 606660 (3), Autosomal dominant; Tumor predisposition syndrome 2, 619975 (3), Autosomal recessive
chr3	IFT122	606045.0 | IFT122, WDR10, CED1 | Intraflagellar transport 122 | 55764.0 | ENSG00000163913 | nan | Cranioectodermal dysplasia 1, 218330 (3), Autosomal recessive
chr3	AD15	604154.0 | AD15 | Alzheimer disease 15 | 100188838.0 | nan | max lod at D3S1579 | {Alzheimer disease-15}, 604154 (2)
chr3	DFNA18	606012.0 | DFNA18 | Deafness, autosomal dominant 18 | 85507.0 | nan | nan | Deafness, autosomal dominant 18, 606012 (2), Autosomal dominant
chr3	DWS	220200.0 | DWS, C3DELq22q24, DEL3q22q24 | Dandy-Walker syndrome | 1858.0 | nan | ZIC1 and ZIC4 good candidate genes | Dandy-Walker syndrome, 220200 (4), Isolated cases
chr3	OTSC5	608787.0 | OTSC5 | Otosclerosis 5 | 317682.0 | nan | max lod at D3S1569 | Otosclerosis 5, 608787 (2), Autosomal dominant
chr3	PARK21	616361.0 | PARK21 | Parkinson disease 21 | 108353827.0 | nan | conflicting mapping on 20pter-p12 | Parkinson disease 21, 616361 (2), Autosomal dominant
chr3	SLSN3	606995.0 | SLSN3 | Senior-Loken syndrome 3 | 260432.0 | nan | ?allelic with NPHP3 | Senior-Loken syndrome 3, 606995 (2), Autosomal recessive
chr3	RHO	180380.0 | RHO, RP4, OPN2, CSNBAD1 | Rhodopsin (opsin 2) | 6010.0 | ENSG00000163914 | nan | Night blindness, congenital stationary, autosomal dominant 1, 610445 (3), Autosomal dominant; Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3), Autosomal recessive, Autosomal dominant; Retinitis punctata albescens, 136880 (3), Autosomal recessive, Autosomal dominant
chr3	PLXND1	604282.0 | PLXND1, CHTD9 | Plexin D1 | 23129.0 | ENSG00000004399 | nan | Congenital heart defects, multiple types, 9, 620294 (3), Autosomal recessive
chr3	TMCC1	616242.0 | TMCC1, KIAA0779 | Transmembrane and coiled-coil domain family 1 | 23023.0 | ENSG00000172765 | nan | nan
chr3	TRH	613879.0 | TRH | Thyrotropin-releasing hormone | 7200.0 | ENSG00000170893 | nan | Thyrotropin-releasing hormone deficiency, 275120 (1), Autosomal recessive
chr3	COL6A4P2	616612.0 | COL6A4P2 | Collagen, type VI, alpha-4, pseudogene 2 | 646300.0 | nan | nan | nan
chr3	COL6A5	611916.0 | COL6A5, COL29A1 | Collagen, type VI, alpha-5 | 256076.0 | ENSG00000172752 | nan | nan
chr3	COL6A6	616613.0 | COL6A6 | Collagen, type VI, alpha-6 | 131873.0 | ENSG00000206384 | nan | nan
chr3	PIK3R4	602610.0 | PIK3R4 | Phosphatidylinositol 3-kinase, regulatory subunit 4 | 30849.0 | ENSG00000196455 | nan | nan
chr3	ATP2C1	604384.0 | ATP2C1, BCPM, HHD | ATPase, Ca(2+)-sequestering | 27032.0 | ENSG00000017260 | nan | Hailey-Hailey disease, 169600 (3), Autosomal dominant
chr3	ASTE1	620693.0 | ASTE1 | Asteroid homolog 1 | 28990.0 | ENSG00000034533 | nan | nan
chr3	NEK11	609779.0 | NEK11 | NIMA-related kinase 11 | 79858.0 | ENSG00000114670 | nan | nan
chr3	NUDT16	617381.0 | NUDT16 | Nudix hydrolase 16 | 131870.0 | ENSG00000198585 | nan | nan
chr3	MRPL3	607118.0 | MRPL3, MRL3, COXPD9 | Mitochondrial ribosomal protein L3 | 11222.0 | ENSG00000114686 | nan | Combined oxidative phosphorylation deficiency 9, 614582 (3), Autosomal recessive
chr3	CPNE4	604208.0 | CPNE4, CPN4 | Copine IV | 131034.0 | ENSG00000196353 | nan | nan
chr3	ACP3	171790.0 | ACPP | Acid phosphatase, prostate | 55.0 | ENSG00000014257 | nan | nan
chr3	DNAJC13	614334.0 | DNAJC13, RME8, KIAA0678 | DNAJ/HSP40 homolog, subfamily C, member 13 | 23317.0 | ENSG00000138246 | nan | nan
chr3	ACAD11	614288.0 | ACAD11 | Acyl-CoA dehydrogenase family, member 11 | 84129.0 | ENSG00000240303 | nan | nan
chr3	ACKR4	606065.0 | ACKR4, CCRL1, PPR1 | Atypical chemokine receptor 4 | 51554.0 | ENSG00000129048 | nan | nan
chr3	UBA5	610552.0 | UBA5, UBE1DC1, DEE44, SCAR24 | Ubiquitin-like modifier activating enzyme 5 | 79876.0 | ENSG00000081307 | mutation identified in 1 SCAR24 family | ?Spinocerebellar ataxia, autosomal recessive 24, 617133 (3), Autosomal recessive; Developmental and epileptic encephalopathy 44, 617132 (3), Autosomal recessive
chr3	NPHP3	608002.0 | NPHP3, NPH3, RHPD1, MKS7 | Nephrocystin 3 | 27031.0 | ENSG00000113971 | nan | Nephronophthisis 3, 604387 (3), Autosomal recessive; Renal-hepatic-pancreatic dysplasia 1, 208540 (3), Autosomal recessive; Meckel syndrome 7, 267010 (3), Autosomal recessive
chr3	TMEM108	617361.0 | TMEM108, RTLN, KIAA1690 | Transmembrane protein 108 | 66000.0 | ENSG00000144868 | nan | nan
chr3	BFSP2	603212.0 | BFSP2, CP49, CP47, CTRCT12 | Beaded filament structural protein 2 (cytoskeletal protein, 49 kD) | 8419.0 | ENSG00000170819 | nan | Cataract 12, multiple types, 611597 (3), Autosomal dominant
chr3	CDV3	618789.0 | CDV3, H41 | CDV3 homolog | 55573.0 | ENSG00000091527 | nan | nan
chr3	TOPBP1	607760.0 | TOPBP1, KIAA0259 | DNA topoisomerase II-binding protein 1 | 11073.0 | ENSG00000163781 | nan | nan
chr3	TF	190000.0 | TF, TFQTL1 | Transferrin | 7018.0 | ENSG00000091513 | nan | Atransferrinemia, 209300 (3), Autosomal recessive
chr3	SRPRB	616883.0 | SRPRB, APMCF1 | SRP receptor subunit, beta | 58477.0 | ENSG00000144867 | nan | nan
chr3	RAB6B	615852.0 | RAB6B | Ras-associated protein RAB6B | 51560.0 | ENSG00000154917 | nan | nan
chr3	SLCO2A1	601460.0 | SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2, PHOAD | Solute carrier organic anion transporter family, member 2A1 | 6578.0 | ENSG00000174640 | nan | Hypertrophic osteoarthropathy, primary, autosomal dominant, 167100 (3), Autosomal dominant; PHOAR2-enteropathy syndrome, 614441 (3), Autosomal recessive
chr3	RYK	600524.0 | RYK, RYK1 | RYK receptor-like tyrosine kinase | 6259.0 | ENSG00000163785 | nan | nan
chr3	AMOTL2	614658.0 | AMOTL2, KIAA0989 | Angiomotin-like 2 | 51421.0 | ENSG00000114019 | nan | nan
chr3	ANAPC13	614484.0 | ANAPC13, APC13, SWM1 | Anaphase-promoting complex, subunit 13 | 25847.0 | ENSG00000129055 | nan | nan
chr3	CEP63	614724.0 | CEP63, SCKL6 | Centrosomal protein, 63kD | 80254.0 | ENSG00000182923 | mutation identified in 1 family | ?Seckel syndrome 6, 614728 (3), Autosomal recessive
chr3	KY	605739.0 | KY, MFM7 | Kyphoscoliosis peptidase | 339855.0 | ENSG00000174611 | nan | Myopathy, myofibrillar, 7, 617114 (3), Autosomal recessive
chr3	EPHB1	600600.0 | EPHB1, EPHT2, NET | eph tyrosine kinase 2 (ephrin receptor EphB1) | 2047.0 | ENSG00000154928 | nan | nan
chr3	PPP2R3A	604944.0 | PP2R3A, PR72, PR130 | Protein phosphatase 2, regulatory subunit B'', alpha | 5523.0 | ENSG00000073711 | nan | nan
chr3	MSL2	614802.0 | MSL2, KIAA1585, KBHS | MSL complex subunit 2 | 55167.0 | ENSG00000174579 | nan | Karayol-Borroto-Haghshenas neurodevelopmental syndrome, 620985 (3), Autosomal dominant
chr3	PCCB	232050.0 | PCCB | Propionyl Coenzyme A carboxylase, beta polypeptide | 5096.0 | ENSG00000114054 | pccB complementation group | Propionicacidemia, 606054 (3), Autosomal recessive
chr3	STAG1	604358.0 | STAG1, MRD47 | Stromal antigen 1 | 10274.0 | ENSG00000118007 | nan | Intellectual developmental disorder, autosomal dominant 47, 617635 (3), Autosomal dominant
chr3	SLC35G2	617812.0 | SLC35G2, TMEM22 | Solute carrier family 35, member G2 | 80723.0 | ENSG00000168917 | nan | nan
chr3	NCK1	600508.0 | NCK | Non-catalytic region of tyrosine kinase | 4690.0 | ENSG00000158092 | nan | nan
chr3	IL20RB	605621.0 | IL20RB, DIRS1 | Interleukin 20 receptor, beta | 53833.0 | ENSG00000174564 | nan | nan
chr3	SOX14	604747.0 | SOX14 | SRY-box 14 | 8403.0 | ENSG00000168875 | nan | nan
chr3	CLDN18	609210.0 | CLDN18 | Claudin 18 | 51208.0 | ENSG00000066405 | nan | nan
chr3	DZIP1L	617570.0 | DZIP1L, DZIP2, PKD5 | DAZ-interacting zinc finger protein 1-like | 199221.0 | ENSG00000158163 | nan | Polycystic kidney disease 5, 617610 (3), Autosomal recessive
chr3	A4GNT	616709.0 | A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | 51146.0 | ENSG00000118017 | nan | nan
chr3	DBR1	607024.0 | DBR1, XGIP | Debranching RNA lariats 1 | 51163.0 | ENSG00000138231 | nan | Xerosis and growth failure with immune and pulmonary dysfunction syndrome, 620510 (3), Autosomal recessive; {Encephalitis, acute, infection (viral)-induced, susceptibility to, 11}, 619441 (3), Autosomal recessive
chr3	ARMC8	618521.0 | ARMC8 | Armadillo repeat-containing protein 8 | 25852.0 | ENSG00000114098 | nan | nan
chr3	NME9	618584.0 | NME9, NXL2, TXNDC6 | NME/NM23 family, member 9 | 347736.0 | ENSG00000181322 | nan | nan
chr3	MRAS	608435.0 | MRAS, RRAS3, NS11 | Muscle Ras viral oncogene homolog | 22808.0 | ENSG00000158186 | nan | Noonan syndrome 11, 618499 (3), Autosomal dominant
chr3	ESYT3	616692.0 | ESYT3, FAM62C | Extended synaptotagmin-like protein 3 | 83850.0 | ENSG00000158220 | nan | nan
chr3	CEP70	614310.0 | CEP70 | Centrosomal protein, 70kD | 80321.0 | ENSG00000114107 | nan | nan
chr3	FAIM	617535.0 | FAIM | Fax apoptotic inhibitory molecule | 55179.0 | ENSG00000158234 | nan | nan
chr3	PIK3CB	602925.0 | PIK3CB, PI3KCB | Phosphatidylinositol 3-kinase, catalytic, beta | 5291.0 | ENSG00000051382 | nan | nan
chr3	FOXL2	605597.0 | FOXL2, BPES, BPES1, PFRK, POF3 | Forkhead transcription factor FOXL2 | 668.0 | ENSG00000183770 | nan | Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3), Autosomal recessive, Autosomal dominant; Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3), Autosomal recessive, Autosomal dominant; Premature ovarian failure 3, 608996 (3), Autosomal dominant
chr3	STQTL10	612221.0 | STQTL10 | Stature quantitative trait locus 10 | 100270794.0 | nan | associated with rs6440003 | {Stature QTL 10}, 612221 (2)
chr3	BPESC1	618995.0 | BPESC1 | Blepharophimosis, ptosis, and epicanthus inversus candidate gene 1 | 60467.0 | ENSG00000232416 | nan | nan
chr3	MRPS22	605810.0 | MRPS22, C3orf5, COXPD5, ODG7 | Mitochondrial ribosomal protein S22 | 56945.0 | ENSG00000175110 | nan | Ovarian dysgenesis 7, 618117 (3), Autosomal recessive; Combined oxidative phosphorylation deficiency 5, 611719 (3), Autosomal recessive
chr3	COPB2	606990.0 | COPB2, MCPH19, OPDD | Coatomer protein complex, subunit beta-2 | 9276.0 | ENSG00000184432 | mutation identified in 1 MCPH19 family | Osteoporosis, childhood- or juvenile-onset, with developmental delay, 619884 (3), Autosomal dominant; ?Microcephaly 19, primary, autosomal recessive, 617800 (3), Autosomal recessive
chr3	RBP2	180280.0 | RBP2, CRBP2 | Retinol-binding protein-2, cellular | 5948.0 | ENSG00000114113 | close to CRBP1 | nan
chr3	RBP1	180260.0 | RBP1, CRBP1 | Retinol-binding protein-1, cellular | 5947.0 | ENSG00000114115 | close to CRBP2 | nan
chr3	NMNAT3	608702.0 | NMNAT3, PNAT3 | Nicotinamide nucleotide adenylyltransferase 3 | 349565.0 | ENSG00000163864 | nan | nan
chr3	CLSTN2	611323.0 | CLSTN2 | Calsyntenin 2 | 64084.0 | ENSG00000158258 | nan | nan
chr3	TRIM42	620334.0 | TRIM42 | Tripartite motif-containing protein 42 | 287015.0 | ENSG00000155890 | nan | nan
chr3	SLC25A36	616149.0 | SLC25A36, PNC2, HHF8 | Solute carrier family 25 (mitochondrial carrier, pyrimidine nucleotide transporter), member 36 | 55186.0 | ENSG00000114120 | nan | Hyperinsulinemic hypoglycemia, familial, 8, 620211 (3), Autosomal recessive
chr3	SPSB4	611660.0 | SPSB4, SSB4 | SPRY domain- and SOCS box-containing 4 | 92369.0 | ENSG00000175093 | nan | nan
chr3	PXYLP1	619732.0 | PXYLP1, XYLP, ACPL2 | 2-phosphoxylose phosphatase 1 | 92370.0 | ENSG00000155893 | nan | nan
chr3	ZBTB38	612218.0 | ZBTB38 | Zinc finger- and BTB domain-containing protein 38 | 253461.0 | ENSG00000177311 | nan | nan
chr3	RASA2	601589.0 | RASA2, GAP1M | RAS p21 protein activator 2 | 5922.0 | ENSG00000155903 | nan | nan
chr3	RNF7	603863.0 | RNF7, ROC2, SAG | RING finger protein-7 (regulator of cullins 2; sensitive to apoptosis gene) | 9616.0 | ENSG00000114125 | nan | nan
chr3	GRK7	606987.0 | GRK7, GPRK7 | G protein-coupled receptor kinase 7 | 131890.0 | ENSG00000114124 | nan | nan
chr3	ATP1B3	601867.0 | ATP1B3 | ATPase, Na+/K+ transporting, beta 3 polypeptide | 483.0 | ENSG00000069849 | nan | nan
chr3	TFDP2	602160.0 | TFDP2, DP2 | Transcription factor Dp-2 (E2F dimerization partner 2) | 7029.0 | ENSG00000114126 | nan | nan
chr3	GK5	620801.0 | GK5 | Glycerol kinase 5 | 256356.0 | ENSG00000175066 | nan | nan
chr3	XRN1	607994.0 | XRN1, SEP1 | Exoribonuclease 1 | 54464.0 | ENSG00000114127 | nan | nan
chr3	ATR	601215.0 | ATR, FRP1, SCKL1, FCTCS | ATR serine/threonine kinase | 545.0 | ENSG00000175054 | mutation identified in 1 FCTCS family | Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant
chr3	PLS1	602734.0 | PLS1, DFNA76 | Plastin-1 | 5357.0 | ENSG00000120756 | nan | Deafness, autosomal dominant 76, 618787 (3), Autosomal dominant
chr3	TRPC1	602343.0 | TRPC1, TRP1 | Transient receptor potential channel 1 | 7220.0 | ENSG00000144935 | also called Htrp-1 | nan
chr3	PCOLCE2	607064.0 | PCOLCE2 | Procollagen C-endopeptidase enhancer-2 | 26577.0 | ENSG00000163710 | nan | nan
chr3	PAQR9	614580.0 | PAQR9 | Progestin and ADIPOQ receptor family, member 9 | 344838.0 | ENSG00000188582 | nan | nan
chr3	U2SURP	617849.0 | U2SURP, SR140, KIAA0332 | U2 small nuclear ribonucleoprotein-associated SURP domain-containing protein | 23350.0 | ENSG00000163714 | nan | nan
chr3	HDLCQ5	610761.0 | HDLCQ5 | High density lipoprotein cholesterol level QTL 5 | 100188818.0 | nan | max lod at D3S3053 | [High density lipoprotein cholesterol level QTL 5], 610761 (2)
chr3	CHST2	603798.0 | CHST2 | Carbohydrate sulfotransferase-2 (GlcNAc-6-O-sulfotransferase; N-acetylglucosamine-6-O-sulfotransferase) | 9435.0 | ENSG00000175040 | mapped by FISH to 7q31 | nan
chr3	SLC9A9	608396.0 | SLC9A9, AUTS16 | Solute carrier family 9 (sodium/hydrogen exchanger), member A9 | 285195.0 | ENSG00000181804 | mutation identified in 1 family | {?Autism susceptibility 16}, 613410 (3)
chr3	DIPK2A	612200.0 | DIPK2A, C3orf58, DIA1 | Divergent protein kinase domain 2A | 205428.0 | ENSG00000181744 | nan | nan
chr3	PLOD2	601865.0 | PLOD2, LH2, TLH, BRKS2 | Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2 | 5352.0 | ENSG00000152952 | nan | Bruck syndrome 2, 609220 (3), Autosomal recessive
chr3	PLSCR4	607612.0 | PLSCR4 | Phospholipid scramblase 4 | 57088.0 | ENSG00000114698 | nan | nan
chr3	PLSCR2	607610.0 | PLSCR2 | Phospholipid scramblase 2 | 57047.0 | ENSG00000163746 | nan | nan
chr3	PLSCR1	604170.0 | PLSCR1, MMTRA1B | Phospholipid scramblase 1 | 5359.0 | ENSG00000188313 | nan | nan
chr3	ZIC4	608948.0 | ZIC4 | Zic family, member 4 | 84107.0 | ENSG00000174963 | nan | nan
chr3	ZIC1	600470.0 | ZIC1, CRS6, BAIDCS | Zic family, member 1 | 7545.0 | ENSG00000152977 | mutation identified in 1 CRS6 family | ?Craniosynostosis 6, 616602 (3), Autosomal dominant; Structural brain anomalies with impaired intellectual development and craniosynostosis, 618736 (3), Autosomal dominant
chr3	AGTR1	106165.0 | AGTR1, AGTR1A, AT2R1 | Angiotensin receptor 1 | 185.0 | ENSG00000144891 | nan | {Hypertension, essential}, 145500 (3), Multifactorial; Renal tubular dysgenesis, 267430 (3), Autosomal recessive
chr3	CPB1	114852.0 | CPB1, PCPB, PASP | Carboxypeptidase B1, tissue | 1360.0 | ENSG00000153002 | nan | nan
chr3	CPA3	114851.0 | CPA3 | Carboxypeptidase A3, mast cell | 1359.0 | ENSG00000163751 | nan | nan
chr3	GYG1	603942.0 | GYG1, GSD15 | Glycogenin 1 | 2992.0 | ENSG00000163754 | mutation identified in 1 GSD15 patient | ?Glycogen storage disease XV, 613507 (3), Autosomal recessive; Polyglucosan body myopathy 2, 616199 (3), Autosomal recessive
chr3	HLTF	603257.0 | SMARCA3, SNF2L3, HIP116 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3 | 6596.0 | ENSG00000071794 | nan | nan
chr3	HPS3	606118.0 | HPS3 | HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 | 84343.0 | ENSG00000163755 | nan | Hermansky-Pudlak syndrome 3, 614072 (3), Autosomal recessive
chr3	CP	117700.0 | CP | Ceruloplasmin | 1356.0 | ENSG00000047457 | ~15cM from TF | Aceruloplasminemia, 604290 (3), Autosomal recessive
chr3	ASPG1	608638.0 | ASPG1 | Asperger syndrome, susceptibility to, 1 | 431710.0 | nan | max lod with D3S3037 | {Asperger syndrome susceptibility 1}, 608638 (2), Isolated cases, Multifactorial
chr3	AUTS8	607373.0 | AUTS8 | Autism, susceptibility to, 8 | 282553.0 | nan | nan | {Autism susceptibility 8}, 607373 (2), Isolated cases, Multifactorial
chr3	CELIAC10	612008.0 | CELIAC10 | Celiac disease, susceptibility to, 10 | 100188872.0 | nan | associated with rs17810546 | {Celiac disease, susceptibility to, 10}, 612008 (2)
chr3	ETL6	615697.0 | ETL6 | Epilepsy, familial temporal lobe, 6 | 103106902.0 | nan | between D3S1584 and D3S3520 | Epilepsy, familial temporal lobe, 6, 615697 (2), Autosomal dominant
chr3	TM4SF1	191155.0 | TM4SF1, M3S1, TAAL6 | Transmembrane-4 superfamily, member 1 | 4071.0 | ENSG00000169908 | nan | nan
chr3	TM4SF4	606567.0 | TM4SF4, ILTMP | Transmembrane 4 superfamily, member 4 | 7104.0 | ENSG00000169903 | nan | nan
chr3	WWTR1	607392.0 | WWTR1, TAZ | WW domain-containing transcription regulator 1 | 25937.0 | ENSG00000018408 | nan | nan
chr3	COMMD2	616699.0 | COMMD2 | COMM domain-containing protein 2 | 51122.0 | ENSG00000114744 | nan | nan
chr3	RNF13	609247.0 | RNF13, DEE73 | RING finger protein 13 | 11342.0 | ENSG00000082996 | nan | Developmental and epileptic encephalopathy 73, 618379 (3), Autosomal dominant
chr3	PFN2	176590.0 | PFN2, PFL, D3S1319E | Profilin-2 | 5217.0 | ENSG00000070087 | mapped previously to chr.1 | nan
chr3	TMEM183BP	611365.0 | TMEM183B, C1orf37DUP | Transmembrane protein 183B | 653659.0 | ENSG00000224831 | nan | nan
chr3	TSC22D2	617724.0 | TSC22D2, KIAA0669 | TSC22 domain family, member 2 | 9819.0 | ENSG00000196428 | nan | nan
chr3	SERP1	617674.0 | SERP1, RAMP4 | Stress-associated endoplasmic reticulum protein 1 | 27230.0 | ENSG00000120742 | nan | nan
chr3	EIF2A	609234.0 | EIF2A | Eukaryotic translation initiation factor 2A | 83939.0 | ENSG00000144895 | nan | nan
chr3	SELENOT	607912.0 | SELENOT, SELT | Selenoprotein T | 51714.0 | ENSG00000198843 | nan | nan
chr3	SIAH2	602213.0 | SIAH2 | SIAH E3 ubiquitin protein ligase family, member 2 | 6478.0 | ENSG00000181788 | nan | nan
chr3	CLRN1	606397.0 | CLRN1, USH3A, USH3, RP61 | Clarin 1 | 7401.0 | ENSG00000163646 | frequent in Finland; ?digenic interaction with MYO7A | Usher syndrome, type 3A, 276902 (3), Autosomal recessive; Retinitis pigmentosa 61, 614180 (3)
chr3	MED12L	611318.0 | MED12L, NOPAR, KIAA1635, NIZIDS | Mediator complex subunit 12-like | 116931.0 | ENSG00000144893 | nan | Nizon-Isidor syndrome, 618872 (3), Autosomal dominant
chr3	GPR171	618925.0 | GPR171 | G protein-coupled receptor 171 | 29909.0 | ENSG00000174946 | nan | nan
chr3	P2RY14	610116.0 | P2RY14, BPR105, KIAA0001 | Purinergic receptor P2Y, G protein-coupled, 14 | 9934.0 | ENSG00000174944 | nan | nan
chr3	GPR87	606379.0 | GPR87 | G protein-coupled receptor 87 | 53836.0 | ENSG00000138271 | nan | nan
chr3	P2RY13	606380.0 | P2RY13, GPR86 | Purinergic receptor P2Y13 | 53829.0 | ENSG00000181631 | nan | nan
chr3	P2RY12	600515.0 | P2RY12, P2Y12, BDPLT8 | Purinergic receptor P2Y, G protein-coupled, 12 | 64805.0 | ENSG00000169313 | nan | Bleeding disorder, platelet-type, 8, 609821 (3), Autosomal recessive
chr3	IGSF10	617351.0 | IGSF10 | Immunoglobulin superfamily, member 10 | 285313.0 | ENSG00000152580 | nan | nan
chr3	AADAC	600338.0 | AADAC, DAC | Arylacetamide deacetylase (esterase) | 13.0 | ENSG00000114771 | nan | nan
chr3	SUCNR1	606381.0 | SUCNR1, GPR91 | Succinate receptor 1 | 56670.0 | ENSG00000198829 | nan | nan
chr3	MBNL1	606516.0 | MBNL1, KIAA0428, EXP | Muscleblind-like protein | 4154.0 | ENSG00000152601 | nan | nan
chr3	P2RY1	601167.0 | P2RY1, P2Y1 | Purinergic receptor P2Y, G-protein coupled, 1 | 5028.0 | ENSG00000169860 | nan | nan
chr3	RAP2B	179541.0 | RAP2B | Ras-related protein 2B | 5912.0 | ENSG00000181467 | nan | nan
chr3	ARHGEF26	617552.0 | ARHGEF26, SGEF | Rho guanine nucleotide exchange factor 26 | 26084.0 | ENSG00000114790 | nan | nan
chr3	DHX36	612767.0 | DHX36, G4R1, RHAU, KIAA1488 | DEAH-box helicase 36 | 170506.0 | ENSG00000174953 | nan | nan
chr3	MME	120520.0 | MME, CD10, CALLA, NEP, CMT2T, SCA43 | Membrane metallo-endopeptidase (common acute lymphocytic leukemia antigen) | 4311.0 | ENSG00000196549 | mutation identified in 1 SCA43 family | ?Spinocerebellar ataxia 43, 617018 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3), Autosomal recessive, Autosomal dominant
chr3	STRIT1	616891.0 | DWORF, LOC100507537 | Dwarf open reading frame | 100507537.0 | ENSG00000240045 | nan | nan
chr3	BWQTL2	613459.0 | BWQTL2 | Birth weight quantitative trait locus 2 | 100502569.0 | nan | associated with rs900400 | [Birth weight QTL 2], 613459 (2)
chr3	PLCH1	612835.0 | PLCH1, PLCL3, KIAA1069, HPE14 | Phospholipase C, eta-1 | 23007.0 | ENSG00000114805 | nan | Holoprosencephaly 14, 619895 (3), Autosomal recessive
chr3	C3orf33	619654.0 | C3orf33 | Chromosome 3 open reading frame 33 | 285315.0 | ENSG00000174928 | nan | nan
chr3	SLC33A1	603690.0 | SLC33A1, ACATN, AT1, SPG42, HPBDS | Solute carrier family 33 (acetyl-CoA transporter), member 1 | 9197.0 | ENSG00000169359 | nan | Spastic paraplegia 42, autosomal dominant, 612539 (3), Autosomal dominant; Huppke-Brendel syndrome, 614482 (3), Autosomal recessive
chr3	GMPS	600358.0 | GMPS | Guanine monophosphate synthetase | 8833.0 | ENSG00000163655 | fusion gene with MLL in AML | nan
chr3	KCNAB1	601141.0 | KCNAB1, KCNA1B | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | 7881.0 | ENSG00000169282 | nan | nan
chr3	SSR3	606213.0 | SSR3, TRAPG | Signal sequence receptor, gamma | 6747.0 | ENSG00000114850 | nan | nan
chr3	TIPARP	612480.0 | TIPARP | TCDD-inducible poly(ADP-ribose) polymerase | 25976.0 | ENSG00000163659 | nan | nan
chr3	LEKR1	613536.0 | LEKR1 | Leucine-, glutamate-, and lysine-rich protein 1 | 389170.0 | ENSG00000197980 | nan | nan
chr3	CCNL1	613384.0 | CCNL1, ANIA6A | Cyclin L1 | 57018.0 | ENSG00000163660 | nan | nan
chr3	VEPH1	609594.0 | VEPH1, MELT, KIAA1692 | Ventricular zone-expressed PH domain-containing protein, zebrafish, homolog of, 1 | 79674.0 | ENSG00000197415 | nan | nan
chr3	PTX3	602492.0 | PTX3 | Pentraxin-3 | 5806.0 | ENSG00000163661 | nan | nan
chr3	SHOX2	602504.0 | SHOX2, SHOT, OG12 | Short stature homeobox 2 | 6474.0 | ENSG00000168779 | nan | nan
chr3	RSRC1	613352.0 | RSRC1, SRRP53, MRT70 | Arginine/serine-rich coiled-coil protein 1 | 51319.0 | ENSG00000174891 | nan | Intellectual developmental disorder, autosomal recessive 70, 618402 (3), Autosomal recessive
chr3	MLF1	601402.0 | MLF1 | Myeloid leukemia factor-1 | 4291.0 | ENSG00000178053 | nan | nan
chr3	GFM1	606639.0 | GFM1, EFG1, GFM, COXPD1 | Mitochondrial elongation factor G1 | 85476.0 | ENSG00000168827 | nan | Combined oxidative phosphorylation deficiency 1, 609060 (3), Autosomal recessive
chr3	LXN	609305.0 | LXN, ECI, TCI | Latexin | 56925.0 | ENSG00000079257 | nan | nan
chr3	RARRES1	605090.0 | RARRES1, TIG1 | Retinoic acid receptor responder 1 | 5918.0 | ENSG00000118849 | nan | nan
chr3	MFSD1	619976.0 | MFSD1 | Major facilitator superfamily domain-containing protein 1 | 64747.0 | ENSG00000118855 | nan | nan
chr3	IQCJ	611622.0 | IQCJ | IQ motif-containing protein J | 654502.0 | ENSG00000214216 | nan | nan
chr3	SCHIP1	619206.0 | SCHIP1 | Schwannomin-interacting protein 1 | 29970.0 | ENSG00000151967 | nan | nan
chr3		109720.0 | PBC1 | Biliary cirrhosis, primary, 1 | nan | nan | associated with rs6441286 and rs574808 | Biliary cirrhosis, primary, 1, 109720 (2), Autosomal dominant
chr3	IL12A	161560.0 | IL12A | Interleukin-12A (natural killer cell stimulatory factor-1, cytotoxic lymphocyte maturation factor-1, p35) | 3592.0 | ENSG00000168811 | nan | nan
chr3	IFT80	611177.0 | IFT80, KIAA1374, WDR56, SRTD2, ATD2 | Intraflagellar transport 80 | 57560.0 | ENSG00000068885 | nan | Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3), Autosomal recessive
chr3	SMC4	605575.0 | CAPC | Chromosome-associated protein C | 10051.0 | ENSG00000113810 | nan | nan
chr3	MIR15B	619572.0 | MIR15B | Micro RNA 15B | 406949.0 | ENSG00000207779 | nan | nan
chr3	TRIM59	616148.0 | TRIM59, RNF104, MRF1, IFT80L | Tripartite motif-containing protein 59 | 286827.0 | ENSG00000213186 | nan | nan
chr3	KPNA4	602970.0 | KPNA4, QIP1 | Karyopherin alpha-4 | 3840.0 | ENSG00000186432 | nan | nan
chr3	SCARNA7	615644.0 | SCARNA7 | Small Cajal body-specific RNA 7 | 677767.0 | ENSG00000238741 | nan | nan
chr3	ARL14	614439.0 | ARL14, ARF7 | ADP ribosylation factor-like GTPase 14 | 80117.0 | ENSG00000179674 | nan | nan
chr3	PPM1L	611931.0 | PPM1L, PP2CE | Protein phosphatase 1-like | 151742.0 | ENSG00000163590 | nan | nan
chr3	AFA1	109200.0 | AGA1, MPB | Alopecia, androgenetic, 1 | 100188784.0 | nan | nan | Alopecia, androgenetic, 1, 109200 (2), Autosomal dominant
chr3		600049.0 | MDS1 | Myelodysplasia syndrome-1 | nan | nan | cen--EVI1--MDS1--EAP--tel | nan
chr3	MNG3	606082.0 | MNG3 | Multinodular goiter-3 | 94337.0 | nan | nan | Goiter, multinodular, 3, 606082 (2)
chr3	MYP8	609257.0 | MYP8 | Myopia 8 | 553192.0 | nan | nan | Myopia 8, 609257 (2), Multifactorial
chr3	B3GALNT1	603094.0 | B3GALT3, GLCT3, GLOB | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 3 | 8706.0 | ENSG00000169255 | nan | [Blood group, P1PK system, P(k) phenotype], 111400 (3); [Blood group, globoside system], 615021 (3)
chr3	NMD3	611021.0 | NMD3 | NMD3 ribosome export adaptor | 51068.0 | ENSG00000169251 | nan | nan
chr3	SPTSSB	610412.0 | SPTSSB, C3orf57, SSSPTB, ADMP | Serine palmitoyltransferase, small subunit B | 165679.0 | ENSG00000196542 | nan | nan
chr3	SI	609845.0 | SI | Sucrase-isomaltase | 6476.0 | ENSG00000090402 | nan | Sucrase-isomaltase deficiency, congenital, 222900 (3), Autosomal recessive
chr3	SLITRK3	609679.0 | SLITRK3, KIAA0848 | SLIT- and NTRK-like family, member 3 | 22865.0 | ENSG00000121871 | nan | nan
chr3	BCHE	177400.0 | BCHE, CHE1, BCHED | Butyrylcholinesterase | 590.0 | ENSG00000114200 | distal to CP, TF | Butyrylcholinesterase deficiency, 617936 (3), Autosomal recessive; {Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}, 617936 (3), Autosomal recessive
chr3	SERPINI2	605587.0 | SERPIN12, PI14, MEPI | Protease inhibitor 14 | 5276.0 | ENSG00000114204 | nan | nan
chr3	PDCD10	609118.0 | PDCD10, TFAR15, CCM3 | Programmed cell death 10 | 11235.0 | ENSG00000114209 | nan | Cerebral cavernous malformations-3, 603285 (3), Autosomal dominant
chr3	SERPINI1	602445.0 | SERPINI1, PI12 | Protease inhibitor 12 | 5274.0 | ENSG00000163536 | nan | Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3), Autosomal dominant
chr3	APMR2	610422.0 | APMR2 | Alopecia-intellectual disability syndrome 2 | 100049544.0 | nan | between D3S1564 and D3S2427 | Alopecia-intellectual disability syndrome 2, 610422 (2), Autosomal recessive
chr3	FEB10	612637.0 | FEB10 | Febrile seizures, familial, 10 | 100271923.0 | nan | between D3S3656 and D3S1232 | Febrile seizures, familial, 10, 612637 (2)
chr3	GOLIM4	606805.0 | GOLIM4, GOLPH4, GPP130 | Golgi integral membrane protein 4 | 27333.0 | ENSG00000173905 | nan | nan
chr3	MECOM	165215.0 | MECOM, EVI1, RUSAT2 | MDS1 and EVS1 complex locus | 2122.0 | ENSG00000085276 | nan | Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3), Autosomal dominant
chr3	TERC	602322.0 | TERC, TRC3, TR, DKCA1, PFBMFT2 | Telomerase RNA component | 7012.0 | ENSG00000277925 | nan | Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 2, 614743 (3), Autosomal dominant; Dyskeratosis congenita, autosomal dominant 1, 127550 (3), Autosomal dominant
chr3	ACTRT3	608534.0 | ARPM1 | Actin-related protein M1 | 84517.0 | ENSG00000184378 | nan | nan
chr3	TRV-AAC1-1	615310.0 | TRV-AAC1-1, TRNAV24 | Transfer RNA valine (AAC) 1-1 | 100189318.0 | nan | nan | nan
chr3	MYNN	606042.0 | MYNN | Myoneurin | 55892.0 | ENSG00000085274 | nan | nan
chr3	LRRC34	619037.0 | LRRC34 | Leucine-rich repeat-containing protein 34 | 151827.0 | ENSG00000171757 | nan | nan
chr3	LRRC31	620925.0 | LRRC31 | Leucine-rich repeat-containing protein 31 | 79782.0 | ENSG00000114248 | nan | nan
chr3	SAMD7	620493.0 | SAMD7, MDCD | Sterile alpha motif domain-containing protein 7 | 344658.0 | ENSG00000187033 | nan | Macular dystrophy with or without cone dysfunction, 620762 (3), Autosomal recessive
chr3	SEC62	602173.0 | SEC62, TLOC1, HTP1 | SEC62 homolog, preprotein translocation factor | 7095.0 | ENSG00000008952 | nan | nan
chr3	PHC3	620031.0 | PHC3, HPH3 | Polyhomeotic homolog 3 | 80012.0 | ENSG00000173889 | nan | nan
chr3	PRKCI	600539.0 | PRKCI | Protein kinase C, iota | 5584.0 | ENSG00000163558 | pseudogene on X | nan
chr3	SKIL	165340.0 | SKIL, SNO | SKI-like | 6498.0 | ENSG00000136603 | nan | nan
chr3	CLDN11	601326.0 | CLDN11, OTM, OSP, HLD22 | Claudin 11 (oligodendrocyte transmembrane protein) | 5010.0 | ENSG00000013297 | nan | Leukodystrophy, hypomyelinating, 22, 619328 (3), Autosomal dominant
chr3	SLC7A14	615720.0 | SLC7A14, KIAA1613, RP68 | Solute carrier family 7, member 14 | 57709.0 | ENSG00000013293 | nan | Retinitis pigmentosa 68, 615725 (3), Autosomal recessive
chr3	EIF5A2	605782.0 | EIF5A2 | Eukaryotic translation initiation factor 5A2 | 56648.0 | ENSG00000163577 | nan | nan
chr3	SLC2A2	138160.0 | SLC2A2, GLUT2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | 6514.0 | ENSG00000163581 | nan | Fanconi-Bickel syndrome, 227810 (3), Autosomal recessive; {Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant
chr3	TNIK	610005.0 | TNIK, KIAA0551, MRT54 | TRAF2-and NCK-interacting kinase | 23043.0 | ENSG00000154310 | nan | Intellectual developmental disorder, autosomal recessive 54, 617028 (3), Autosomal recessive
chr3	PLD1	602382.0 | PLD1, CVDP1 | Phospholipase D1, phosphatidylcholine-specific | 5337.0 | ENSG00000075651 | nan | Cardiac valvular dysplasia 1, 212093 (3), Autosomal recessive
chr3	FNDC3B	611909.0 | FNDC3B, FAD104 | Fibronectin domain III-containing protein 3B | 64778.0 | ENSG00000075420 | nan | nan
chr3	GHSR	601898.0 | GHSR, GHDP | Growth hormone secretagogue receptor | 2693.0 | ENSG00000121853 | nan | Growth hormone deficiency, isolated partial, 615925 (3), Autosomal recessive, Autosomal dominant
chr3	TNFSF10	603598.0 | TNFSF10, TRAIL, APO2L | Tumor necrosis factor ligand superfamily, member 10 | 8743.0 | ENSG00000121858 | nan | nan
chr3	NCEH1	613234.0 | NCEH1, NCEH, KIAA1363 | Neutral cholesterol ester hydrolase 1 | 57552.0 | ENSG00000144959 | nan | nan
chr3	ECT2	600586.0 | ECT2 | Epithelial cell transforming sequence 2 oncogene | 1894.0 | ENSG00000114346 | nan | nan
chr3	SPATA16	609856.0 | SPATA16, SPGF6 | Spermatogenesis-associated protein 16 | 83893.0 | ENSG00000144962 | mutation identified in 1 SPGF6 family | ?Spermatogenic failure 6, 102530 (3), Autosomal recessive
chr3	NLGN1	600568.0 | NLGN1 | Neuroligin 1 | 22871.0 | ENSG00000169760 | nan | {Autism, susceptibility to, 20}, 618830 (3), Autosomal dominant
chr3	NAALADL2	608806.0 | NAALADL2 | N-acetylated alpha-linked acidic dipeptidase-like 2 | 254827.0 | ENSG00000177694 | ?involved in Cornelia de Lange syndrome | nan
chr3	TBL1XR1	608628.0 | TBL1XR1, TBLR1, IRA1, C21, MRD41 | Transducin-beta-like 1 receptor 1 | 79718.0 | ENSG00000177565 | nan | Intellectual developmental disorder, autosomal dominant 41, 616944 (3), Autosomal dominant; Pierpont syndrome, 602342 (3), Autosomal dominant
chr3	KCNMB2	605214.0 | KCNMB2 | Potassium channel, calcium-activated, large conductance, subfamily M, beta member 2 | 10242.0 | ENSG00000197584 | nan | nan
chr3	ZMAT3	606452.0 | WIG1 | Wildtype p53-induced gene | 64393.0 | ENSG00000172667 | nan | nan
chr3	PIK3CA	171834.0 | PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4, HMH | Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide | 5290.0 | ENSG00000121879 | nan | Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)
chr3	KCNMB3	605222.0 | KCNMB3 | Potassium large conductance calcium-activated channel, subfamily M, beta member 3 | 27094.0 | ENSG00000171121 | nan | nan
chr3	ZNF639	619214.0 | ZNF639, ZASC1 | Zinc finger protein 639 | 51193.0 | ENSG00000121864 | nan | nan
chr3	MFN1	608506.0 | MFN1 | Mitofusin 1 | 55669.0 | ENSG00000171109 | nan | nan
chr3	GNB4	610863.0 | GNB4, CMTD1F | Guanine nucleotide-binding protein, beta-4 | 59345.0 | ENSG00000114450 | nan | Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3), Autosomal dominant
chr3	ACTL6A	604958.0 | ACTL6A, BAF53, BAF53A | Actin-like 6A | 86.0 | ENSG00000136518 | nan | nan
chr3	MRPL47	611852.0 | MRPL47 | Mitochondrial ribosomal protein L47 | 57129.0 | ENSG00000136522 | nan | nan
chr3	NDUFB5	603841.0 | NDUFB5 | NADH-ubiquinone oxidoreductase subunit B5 | 4711.0 | ENSG00000136521 | nan | nan
chr3	USP13	603591.0 | USP13, ISOT3 | Ubiquitin-specific protease-13 | 8975.0 | ENSG00000058056 | nan | nan
chr3	PEX5L	611058.0 | PEX5L, PEX5R, PXR2B | Peroxisome biogenesis factor 5-like | 51555.0 | ENSG00000114757 | nan | nan
chr3	CCDC39	613798.0 | CCDC39 | Coiled-coil domain-containing protein 39 | 339829.0 | ENSG00000284862 | nan | Ciliary dyskinesia, primary, 14, 613807 (3), Autosomal recessive
chr3	FXR1	600819.0 | FXR1, MYORIBF, CMYO9A, CMYO9B | FMR1 autosomal homolog 1 | 8087.0 | ENSG00000114416 | mutation identified in 1 CMYP9A family | Congenital myopathy 9B, proximal, with minicore lesions, 618823 (3), Autosomal recessive; ?Congenital myopathy 9A with respiratory insufficiency and bone fractures, 618822 (3), Autosomal recessive
chr3	DNAJC19	608977.0 | DNAJC19, TIM14 | DnaJ (Hsp40) homolog, subfamily C, member 19 (translocase of inner mitochondrial membrane 14, yeast, homolog of) | 131118.0 | ENSG00000205981 | nan | 3-methylglutaconic aciduria, type V, 610198 (3), Autosomal recessive
chr3	SOX2-OT	616338.0 | SOX2OT, NCRNA00043 | SOX2 overlapping transcript, noncoding | 347689.0 | ENSG00000242808 | nan | nan
chr3	SOX2	184429.0 | SOX2, MCOPS3 | SRY (sex determining region Y)-box 2 | 6657.0 | ENSG00000181449 | nan | Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3), Autosomal dominant; Microphthalmia, syndromic 3, 206900 (3), Autosomal dominant
chr3	ATP11B	605869.0 | ATP11B, ATPIR | ATPase, class VI, type 11B | 23200.0 | ENSG00000058063 | nan | nan
chr3	DCUN1D1	605905.0 | DCUN1D1, RP42 | DCN1 domain-containing protein 1 | 54165.0 | ENSG00000043093 | previously mapped to 6q16 | nan
chr3	AOMS1	605552.0 | AOMS1, SYNX | Abdominal obesity-metabolic syndrome QTL1 | 65076.0 | nan | epistatic gene on 17p12 | Abdominal obesity-metabolic syndrome 1, 605552 (2), Autosomal dominant
chr3	SPG14	605229.0 | SPG14 | Spastic paraplegia 14, autosomal recessive | 57309.0 | nan | nan | Spastic paraplegia 14, autosomal recessive, 605229 (2), Autosomal recessive
chr3	MCCC1	609010.0 | MCCC1, MCCA | 3-Methylcrotonyl-CoA carboxylase 1 | 56922.0 | ENSG00000078070 | nan | 3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3), Autosomal recessive
chr3	LAMP3	605883.0 | DCLAMP | Lysosome-associated membrane glycoprotein, dendritic cell-specific | 27074.0 | ENSG00000078081 | nan | nan
chr3	MCF2L2	619946.0 | MCF2L2, ARHGEF22, KIAA0861 | MCF.2 cell line-derived transforming sequence-like 2 | 23101.0 | ENSG00000053524 | nan | nan
chr3	B3GNT5	615333.0 | B3GNT5 | Beta-1,3-N-acetylglucosaminyltransferase 5 | 84002.0 | ENSG00000176597 | nan | nan
chr3	KLHL6	614214.0 | KLHL6, FLJ00029 | Kelch-like 6 | 89857.0 | ENSG00000172578 | nan | nan
chr3	KLHL24	611295.0 | KLHL24, KRIP6, EBS6, CMH29 | Kelch-like 24 | 54800.0 | ENSG00000114796 | nan | Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies, 620236 (3), Autosomal recessive; Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy, 617294 (3), Autosomal dominant
chr3	YEATS2	613373.0 | YEATS2, KIAA1197, FAME4 | YEATS domain-containing protein 2 | 55689.0 | ENSG00000163872 | mutation identifed in 1 FAME4 family | ?Epilepsy, myoclonic, familial adult, 4, 615127 (3), Autosomal dominant
chr3	MAP6D1	610593.0 | MAPO6D1, SL21 | MAP6 domain-containing protein 1 | 79929.0 | ENSG00000180834 | nan | nan
chr3	PARL	607858.0 | PARL | Presenilin-associated rhomboid-like protein | 55486.0 | ENSG00000175193 | nan | nan
chr3	ABCC5	605251.0 | ABCC5, MRP5, MOATC | ATP-binding cassette, subfamily C, member 5 | 10057.0 | ENSG00000114770 | nan | nan
chr3	HTR3D	610122.0 | HTR3D | 5-hydroxytryptamine receptor 3, subunit D | 200909.0 | ENSG00000186090 | nan | nan
chr3	HTR3C	610121.0 | HTR3C | 5-hydroxytryptamine receptor 3C | 170572.0 | ENSG00000178084 | nan | nan
chr3	HTR3E	610123.0 | HTR3E | 5-hydroxytryptamine receptor 3, subunit E | 285242.0 | ENSG00000186038 | nan | nan
chr3	EIF2B5	603945.0 | EIF2B5, CACH, CLE, VWM5 | Eukaryotic translation initiation factor 2B, subunit 5 | 8893.0 | ENSG00000145191 | nan | Leukoencephalopathy with vanishing white matter 5, with or without ovarian failure, 620315 (3), Autosomal recessive
chr3	DVL3	601368.0 | DVL3, DRS3 | Dishevelled 3 (homologous to Drosophila dsh) | 1857.0 | ENSG00000161202 | nan | Robinow syndrome, autosomal dominant 3, 616894 (3), Autosomal dominant
chr3	AP2M1	601024.0 | AP2M1, CLAPM1, MRD60 | Adaptor-related protein complex 2, mu 1 subunit | 1173.0 | ENSG00000161203 | nan | Intellectual developmental disorder 60 with seizures, 618587 (3), Autosomal dominant
chr3	ABCF3	618967.0 | ABCF3 | ATP-binding cassette, subfamily F, member 3 | 55324.0 | ENSG00000161204 | nan | nan
chr3	MIR1224	611620.0 | MIR1224, MIRN1224 | Micro RNA 1224 | 100187716.0 | ENSG00000221120 | nan | nan
chr3	ALG3	608750.0 | ALG3, NOT56L, CDGS4, CDG1D | ALG3 alpha-1,3-mannosyltransferase | 10195.0 | ENSG00000214160 | nan | Congenital disorder of glycosylation, type Id, 601110 (3), Autosomal recessive
chr3	CAMK2N2	608721.0 | CAMK2N2, CAMKIIN | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | 94032.0 | ENSG00000163888 | nan | nan
chr3	ECE2	610145.0 | ECE2, KIAA0604 | Endothelin-converting enzyme 2 | 9718.0 | ENSG00000145194 | nan | nan
chr3	PSMD2	606223.0 | PSMD2, S2, TRAP2 | Proteasome 26S subunit, non-APTase, 2 | 5708.0 | ENSG00000175166 | nan | nan
chr3	EIF4G1	600495.0 | EIF4G1, EIF4G, PARK18 | Eukaryotic translation initiation factor 4 gamma, 1 | 1981.0 | ENSG00000114867 | amplified in squamous cell lung cancer | {Parkinson disease 18}, 614251 (3), Autosomal dominant
chr3	CLCN2	600570.0 | CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2 | Chloride channel-2 | 1181.0 | ENSG00000114859 | nan | Leukoencephalopathy with ataxia, 615651 (3), Autosomal recessive; Hyperaldosteronism, familial, type II, 605635 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3), Autosomal dominant; {Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3), Autosomal dominant
chr3	POLR2H	606023.0 | POLR2H, RPB8 | Polymerase II, RNA, subunit H | 5437.0 | ENSG00000163882 | nan | nan
chr3	THPO	600044.0 | THPO, MGDF, MPLLG, TPO, THCYT1, THC9, CAMT2 | Thrombopoietin (megakaryocyte growth and development factor) | 7066.0 | ENSG00000090534 | nan | Thrombocythemia 1, 187950 (3), Autosomal dominant; Thrombocytopenia 9, 620478 (3), Autosomal dominant; Amegakaryocytic thrombocytopenia, congenital, 2, 620481 (3), Autosomal recessive
chr3	CHRD	603475.0 | CHRD | Chordin | 8646.0 | ENSG00000090539 | near THPO, CLCN2, EIF4G1 | nan
chr3	EPHB3	601839.0 | EPHB3, ETK2 | EPH-like tyrosine kinase-2 | 2049.0 | ENSG00000182580 | nan | nan
chr3	MAGEF1	609267.0 | MAGEF1 | Melanoma antigen, family F, 1 | 64110.0 | ENSG00000177383 | nan | nan
chr3	VPS8	618366.0 | VPS8 | VPS8, corvet complex subunit | 23355.0 | ENSG00000156931 | nan | nan
chr3	EHHADH	607037.0 | EHHADH, PBFE, LBFP, FRTS3 | Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase | 1962.0 | ENSG00000113790 | mutation identified in 1 family | ?Fanconi renotubular syndrome 3, 615605 (3), Autosomal dominant
chr3	MAP3K13	604915.0 | MAP3K13, LZK | Mitogen-activated protein kinase kinase kinase 13 (leucine zipper-bearing kinase) | 9175.0 | ENSG00000073803 | nan | nan
chr3	LIPH	607365.0 | LIPH, LAH2, ARWH2, HYPT7 | Lipase H | 200879.0 | ENSG00000163898 | nan | Hypotrichosis 7, 604379 (3), Autosomal recessive; Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3), Autosomal recessive
chr3	SENP2	608261.0 | SENP2, SMT3IP2, AXAM2, KIAA1331 | Sentrin-specific protease family, member 2 | 59343.0 | ENSG00000163904 | nan | nan
chr3	IGF2BP2	608289.0 | IGF2BP2, IMP2 | Insulin-like growth factor 2 mRNA-binding protein 2 | 10644.0 | ENSG00000073792 | nan | {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant
chr3	TRA2B	602719.0 | TRA2B, SFRS10 | Transformer 2 beta homolog | 6434.0 | ENSG00000136527 | nan | nan
chr3	ETV5	601600.0 | ETV5, ERM | ETS variant transcription factor 5 | 2119.0 | ENSG00000244405 | nan | nan
chr3	DGKG	601854.0 | DGKG, DAGK3 | Diacylglycerol kinase, gamma, 90-kD | 1608.0 | ENSG00000058866 | nan | nan
chr3	CRYGS	123730.0 | CRYGS, CRYG8, CTRCT20 | Crystallin, gamma S | 1427.0 | ENSG00000213139 | nan | Cataract 20, multiple types, 116100 (3), Autosomal dominant
chr3	TBCCD1	619848.0 | TBCCD1 | TBCC domain-containing protein 1 | 55171.0 | ENSG00000113838 | nan | nan
chr3	DNAJB11	611341.0 | DNAJB11, HEDJ, DJ9, ABBP2, PKD6 | DNAJ/HSP40 homolog, subfamily B, member 11 | 51726.0 | ENSG00000090520 | nan | Polycystic kidney disease 6 with or without polycystic liver disease, 618061 (3), Autosomal dominant
chr3	AHSG	138680.0 | AHSG, APMR1 | Alpha-2HS-glycoprotein | 197.0 | ENSG00000145192 | mutation identified in 1 APMR1 family | ?Alopecia-intellectual disability syndrome 1, 203650 (3), Autosomal recessive
chr3	FETUB	605954.0 | FETUB | Fetuin B | 26998.0 | ENSG00000090512 | nan | nan
chr3	HRG	142640.0 | HRG, THPH11 | Histidine-rich glycoprotein | 3273.0 | ENSG00000113905 | nan | Thrombophilia 11 due to HRG deficiency, 613116 (3), Autosomal dominant
chr3	KNG1	612358.0 | KNG1, KNG, HAE6 | Kininogen 1 | 3827.0 | ENSG00000113889 | nan | [Kininogen deficiency], 228960 (3), Autosomal recessive; Angioedema, hereditary, 6, 619363 (3), Autosomal dominant; [High molecular weight kininogen deficiency], 228960 (3), Autosomal recessive
chr3	EIF4A2	601102.0 | EIF4A2, NEDHSS | Eukaryotic translation initiation factor-4A, isoform 2 | 1974.0 | ENSG00000156976 | nan | Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures, 620455 (3), Autosomal recessive, Autosomal dominant
chr3	SNORA81	611334.0 | SNORA81 | Small nucleolar RNA, H/ACA box, 81 | 677847.0 | ENSG00000221420 | in intron 3 of EIF2A | nan
chr3	SNORA63	180647.0 | SNORA63, RNU107, RNE3 | Small nucleolar RNA, H/ACA box, 63 | 6043.0 | ENSG00000200320 | nan | nan
chr3	RFC4	102577.0 | RFC4 | Replication factor C4, 37kD (activator 1, 37kD) | 5984.0 | ENSG00000163918 | nan | nan
chr3	ADIPOQ	605441.0 | ADIPOQ, APM1, GBP28, ADIPQTL1 | Adipocyte-, C1q-, and collagen domain-containing | 9370.0 | ENSG00000181092 | nan | Adiponectin deficiency, 612556 (3), Autosomal dominant
chr3	ST6GAL1	109675.0 | SIAT1 | Sialyltransferase-1 (beta-galactoside alpha-2,6-sialyltransferase) | 6480.0 | ENSG00000073849 | nan | nan
chr3	RPL39L	607547.0 | RPL39L | Ribosomal protein L39-like | 116832.0 | ENSG00000163923 | nan | nan
chr3	RTP1	609137.0 | RTP1 | Receptor-transporting protein 1 | 132112.0 | ENSG00000175077 | nan | nan
chr3	MASP1	600521.0 | MASP1, CRARF, 3MC1 | Mannan-binding lectin serine protease-1 (C4/C2 activating component of Ra-reactive factor) | 5648.0 | ENSG00000127241 | nan | 3MC syndrome 1, 257920 (3), Autosomal recessive
chr3	RTP4	609350.0 | RTP4 | Receptor-transporting protein 4 | 64108.0 | ENSG00000136514 | nan | nan
chr3	SST	182450.0 | SST | Somatostatin | 6750.0 | ENSG00000157005 | nan | nan
chr3	RTP2	609138.0 | RTP2 | Receptor-transporting protein 2 | 344892.0 | ENSG00000198471 | nan | nan
chr3	BCL6	109565.0 | BCL6 | BCL6 transcription repressor | 604.0 | ENSG00000113916 | nan | nan
chr3	LPP	600700.0 | LPP | Lipoma-preferred-partner gene | 4026.0 | ENSG00000145012 | fused with HMGIC in lipoma; fused with MLL in leukemia | Lipoma (3); Leukemia, acute myeloid, 601626 (3), Somatic mutation, Autosomal dominant
chr3	CELIAC11	612009.0 | CELIAC11 | Celiac disease, susceptibility to, 11 | 100188873.0 | nan | associated with rs1464510 | {Celiac disease, susceptibility to, 11}, 612009 (2)
chr3	LNCR5	614210.0 | LNCR5 | Lung cancer susceptibility 5 | 100682395.0 | nan | associated with rs4488809 | {Lung cancer susceptibility 5}, 614210 (2)
chr3	MIR28	612154.0 | MIR28, MIRN28 | Micro RNA 28 | 407020.0 | ENSG00000207651 | nan | nan
chr3	TP63	603273.0 | TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8 | Tumor protein p63 (tumor protein p73-like) | 8626.0 | ENSG00000073282 | nan | Premature ovarian failure 21, 620311 (3), Autosomal dominant; Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3), Autosomal dominant; Hay-Wells syndrome, 106260 (3), Autosomal dominant; Split-hand/foot malformation 4, 605289 (3), Autosomal dominant; Orofacial cleft 8, 618149 (3); Rapp-Hodgkin syndrome, 129400 (3), Autosomal dominant; ADULT syndrome, 103285 (3), Autosomal dominant; Limb-mammary syndrome, 603543 (3), Autosomal dominant
chr3	P3H2	610341.0 | P3H2, LEPREL1, MCVD | Prolyl 3-hydroxylase 2 | 55214.0 | ENSG00000090530 | nan | Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3), Autosomal recessive
chr3	CLDN16	603959.0 | CLDN16, PCLN1, HOMG3 | Claudin 16 (paracellin 1) | 10686.0 | ENSG00000113946 | nan | Hypomagnesemia 3, renal, 248250 (3), Autosomal recessive
chr3	CLDN1	603718.0 | CLDN1, SEMP1, ILVASC | Claudin 1 | 9076.0 | ENSG00000163347 | nan | Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3), Autosomal recessive
chr3	TMEM207	614786.0 | TMEM207 | Transmembrane protein 207 | 131920.0 | ENSG00000198398 | nan | nan
chr3	IL1RAP	602626.0 | IL1RAP | Interleukin 1 receptor accessory protein | 3556.0 | ENSG00000196083 | nan | nan
chr3	GMNC	614448.0 | GMNC, GEMC1 | Geminin coiled-coil domain-containing protein | 647309.0 | ENSG00000205835 | nan | nan
chr3	OSTN	610280.0 | OSTN | Osteocrin | 344901.0 | ENSG00000188729 | nan | nan
chr3	UTS2B	618134.0 | UTS2B, URP | Urotensin 2B | 257313.0 | ENSG00000188958 | nan | nan
chr3	CCDC50	611051.0 | CCDC50, C3orf6, DFNA44 | Coiled-coil domain-containing protein 50 | 152137.0 | ENSG00000152492 | mutation identified in 1 DFNA44 family | ?Deafness, autosomal dominant 44, 607453 (3), Autosomal dominant
chr3	PYDC2	615701.0 | PYDC2, POP2 | Pyrin domain-containing protein 2 | 152138.0 | ENSG00000253548 | nan | nan
chr3	FGF12	601513.0 | FGF12, FHF1, DEE47 | Fibroblast growth factor-12 | 2257.0 | ENSG00000114279 | nan | Developmental and epileptic encephalopathy 47, 617166 (3), Autosomal dominant
chr3		609425.0 | DEL3q29, MICRODEL3q29 | Chromosome 3q29 microdeletion syndrome | nan | nan | contiguous gene deletion syndrome | Chromosome 3q29 microdeletion syndrome, 609425 (4), Isolated cases
chr3		611936.0 | DUP3q29, MICRODUP3q29 | Chromosome 3q29 microduplication syndrome | nan | nan | contiguous gene duplication syndrome | Chromosome 3q29 microduplication syndrome, 611936 (4), Autosomal dominant
chr3	MB21D2	620914.0 | MB21D2 | MAB21 domain-containing protein 2 | 151963.0 | ENSG00000180611 | nan | nan
chr3	PLAAT1	606487.0 | PLAAT1, HRASLS | Phospholipase A and acetyltransferase 1 | 57110.0 | ENSG00000127252 | nan | nan
chr3	ATP13A5	619119.0 | ATP13A5 | ATPase 13A5 | 344905.0 | ENSG00000187527 | nan | nan
chr3	ATP13A4	609556.0 | ATP13A4 | ATPase 13A4 | 84239.0 | ENSG00000127249 | nan | nan
chr3	OPA1	605290.0 | OPA1, NTG, NPG, BERHS, MTDPS14 | OPA1 mitochondrial dynamin-like GTPase | 4976.0 | ENSG00000198836 | mutation identified in 1 MTDPS14 family | Optic atrophy plus syndrome, 125250 (3), Autosomal dominant; {Glaucoma, normal tension, susceptibility to}, 606657 (3); Optic atrophy 1, 165500 (3), Autosomal dominant; Behr syndrome, 210000 (3), Autosomal recessive; ?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3), Autosomal recessive
chr3	HES1	139605.0 | HES1, HRY | Hes family bHLH transcription factor 1 | 3280.0 | ENSG00000114315 | nan | nan
chr3	CPN2	603104.0 | CPN2 | Carboxypeptidase N, polypeptide 2, 83-KD | 1370.0 | ENSG00000178772 | conflicting assignment to chr.8 | nan
chr3	LRRC15	619327.0 | LRRC15, LIB | Leucine-rich repeat-containing protein 15 | 131578.0 | ENSG00000172061 | nan | nan
chr3	GP5	173511.0 | GP5 | Glycoprotein V, platelet | 2814.0 | ENSG00000178732 | nan | nan
chr3	ATP13A3	610232.0 | ATP13A3, AFURS1, PPH5 | ATPase 13A3 | 79572.0 | ENSG00000133657 | nan | Pulmonary hypertension, primary, 5, 265400 (3), Autosomal recessive
chr3	LSG1	610780.0 | LSG1 | Large 60S subunit nuclear export GTPase 1 | 55341.0 | ENSG00000041802 | nan | nan
chr3	XXYLT1	614552.0 | XXYLT1, C3orf21 | Xyloside xylosyltransferase 1 | 152002.0 | ENSG00000173950 | nan | nan
chr3	ACAP2	607766.0 | CENTB2, KIAA0041, ACAP2 | Centaurin, beta-2 | 23527.0 | ENSG00000114331 | nan | nan
chr3	PPP1R2	601792.0 | PPP1R2, IPP2 | Protein phosphatase-1, regulatory (inhibitor) subunit 2 | 5504.0 | ENSG00000184203 | pseudogenes on chr. 5 and 6 | nan
chr3	APOD	107740.0 | APOD | Apolipoprotein D | 347.0 | ENSG00000189058 | nan | nan
chr3	MIR570	614538.0 | MIR570 | Micro RNA 570 | 693155.0 | ENSG00000207650 | nan | nan
chr3	MUC20	610360.0 | MUC20 | Mucin 20, cell surface-associated | 200958.0 | ENSG00000176945 | nan | nan
chr3	MUC4	158372.0 | MUC4 | Mucin 4, tracheobronchial | 4585.0 | ENSG00000145113 | nan | nan
chr3	TNK2	606994.0 | TNK2, ACK, ACK1 | Tyrosine kinase, non-receptor, 2 | 10188.0 | ENSG00000061938 | nan | nan
chr3	TFRC	190010.0 | TFRC, TFR, CD71, IMD46 | Transferrin receptor | 7037.0 | ENSG00000072274 | nan | Immunodeficiency 46, 616740 (3), Autosomal recessive
chr3	ZDHHC19	618671.0 | DHHC19 | Zinc finger DHHC domain-containing palmitoyltransferase 19 | 131540.0 | ENSG00000163958 | nan | nan
chr3	SLC51A	612084.0 | SLC51A, OSTA, PFIC6 | Solute carrier family 51, alpha subunit (organic solute transporter, alpha) | 200931.0 | ENSG00000163959 | mutation identified in 1 PFIC6 patient | ?Cholestasis, progressive familial intrahepatic, 6, 619484 (3), Autosomal recessive
chr3	PCYT1A	123695.0 | PCYT1A, CTPCT, PCYT1, SMDCRD, CGL5 | Phosphate cytidylyltransferase 1, choline, alpha isoform | 5130.0 | ENSG00000161217 | nan | Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3), Autosomal recessive; Lipodystrophy, congenital generalized, type 5, 620680 (3), Autosomal recessive
chr3	DYNLT2B	617353.0 | DYNLT2B, TCTEX1D2, SRTD17 | Dynein light chain Tctex-type 2B | 255758.0 | ENSG00000213123 | nan | Short-rib thoracic dysplasia 17 with or without polydactyly, 617405 (3), Autosomal recessive
chr3	TM4SF19	620845.0 | TM4SF19 | Transmembrane 4 L6 family, member 19 | 116211.0 | ENSG00000145107 | nan | nan
chr3	UBXN7	616379.0 | UBXN7, KIAA0794 | UBX domain protein 7 | 26043.0 | ENSG00000163960 | nan | nan
chr3	RNF168	612688.0 | RNF168, RIDL | RING finger protein 168 | 165918.0 | ENSG00000163961 | nan | RIDDLE syndrome, 611943 (3), Autosomal recessive
chr3	WDR53	615110.0 | WDR53 | WD repeat-containing protein 53 | 348793.0 | ENSG00000185798 | nan | nan
chr3	FBXO45	609112.0 | FBXO45, FBX45 | F-box only protein 45 | 200933.0 | ENSG00000174013 | nan | nan
chr3	NRROS	615322.0 | NRROS, LRRC33, SENEBAC | Negative regulator of oxygen species | 375387.0 | ENSG00000174004 | nan | Seizures, early-onset, with neurodegeneration and brain calcification, 618875 (3), Autosomal recessive
chr3	CEP19	615586.0 | CEP19, C3orf34, MOSPGF | Centrosomal protein, 19kD | 84984.0 | ENSG00000174007 | mutation identified in 1 family | Morbid obesity and spermatogenic failure, 615703 (3), Autosomal recessive
chr3	PIGX	610276.0 | PIGX | Phosphatidylinositol glycan, class X | 54965.0 | ENSG00000163964 | nan | nan
chr3	PAK2	605022.0 | PAK2, PAK65, KNO2 | p21-activated kinase 2 | 5062.0 | ENSG00000180370 | deleted in 3q29 microdeletion syndrome; mutation identified in 1 KNO2 family | ?Knobloch syndrome 2, 618458 (3), Autosomal dominant
chr3	SENP5	612845.0 | SENP5 | Sentrin-specific protease family, member 5 | 205564.0 | ENSG00000119231 | nan | nan
chr3	NCBP2	605133.0 | NCBP2, CBP20, NIP1 | Nuclear CAP-binding protein 2 | 22916.0 | ENSG00000114503 | nan | nan
chr3	PIGZ	611671.0 | PIGZ, SMP3 | Phosphatidylinositol glycan, class Z | 80235.0 | ENSG00000119227 | nan | nan
chr3	MELTF	155750.0 | MFI2, MAP97 | Melanoma-associated antigen p97 | 4241.0 | ENSG00000163975 | nan | nan
chr3	DLG1	601014.0 | DLG1 | Discs large MAGUK scaffold protein 1 | 1739.0 | ENSG00000075711 | deleted in 3q29 microdeletion syndrome | nan
chr3	BDH1	603063.0 | BDH1, BDH | 3-hydroxybutyrate dehydrogenase 1 | 622.0 | ENSG00000161267 | nan | nan
chr3	RUBCN	613516.0 | RUBCN, RUBICON, KIAA0226, SCAR15 | RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein | 9711.0 | ENSG00000145016 | nan | Spinocerebellar ataxia, autosomal recessive 15, 615705 (3), Autosomal recessive
chr3	FYTTD1	616933.0 | FYTTD1, UIF | Forty-two-three domain-containing protein 1 | 84248.0 | ENSG00000122068 | nan | nan
chr3	IQCG	612477.0 | IQCG | IQ motif-containing protein G | 84223.0 | ENSG00000114473 | nan | nan
chr3	RPL35A	180468.0 | RPL35A, DBA5 | Ribosomal protein L35A | 6165.0 | ENSG00000182899 | previous assignment to chr.18 in error | Diamond-Blackfan anemia 5, 612528 (3), Autosomal dominant
chr3	LMLN	609380.0 | LMLN | Leishmanolysin-like | 89782.0 | ENSG00000185621 | nan | nan
chr4		610203.0 | CRIPAK, FLJ3443 | Cysteine-rich inhibitor of PAK1 | nan | nan | nan | nan
chr4	CRSA	600593.0 | CRSA, CRS3 | Craniosynostosis, Adelaide type | 7885.0 | nan | nan | Craniosynostosis, Adelaide type, 600593 (2), ?Autosomal dominant
chr4	INTLQ1	603783.0 | INTLQ1 | Intelligence quantitative trait locus 1 | 100462721.0 | nan | associated with D4S2943, MSX1, and D4S1607 | {Intelligence QTL1}, 603783 (2)
chr4	MHW1	603663.0 | MHW1 | Mental health wellness 1 | 10386.0 | nan | at D4S2949 | {Mental health wellness-1}, 603663 (2)
chr4	MNDEC	611863.0 | MNDEC | Microtia with nasolacrimal duct imperforation and eye coloboma | 100188855.0 | nan | copy number variant (CNV) association | Microtia with nasolacrimal duct imperforation and eye coloboma, 611863 (4)
chr4	PLSA1	611637.0 | PLSA1, PLSA | Primary lateral sclerosis, adult, 1 | 100240702.0 | nan | max lod at D4S2936 | Primary lateral sclerosis, adult, 1, 611637 (2), Autosomal dominant
chr4	SLEB3	605480.0 | SLEB3 | Systemic lupus erythematosus, susceptibility to, 3 | 64695.0 | nan | nan | {Systemic lupus erythematosus, susceptibility to, 3}, 605480 (2)
chr4	SPG38	612335.0 | SPG38 | Spastic paraplegia 38, autosomal dominant | 100049707.0 | nan | between D4S432 and D4S1599 | Spastic paraplegia 38, autosomal dominant, 612335 (2), Autosomal dominant
chr4		194190.0 | WHS | Wolf-Hirschhorn syndrome | nan | nan | contiguous gene syndrome; critical region 200kb region 1.9Mb from telomere | Wolf-Hirschhorn syndrome, 194190 (4), Isolated cases
chr4	ZNF141	194648.0 | ZNF141, D4S90, PAPA6 | Zinc finger protein-141 (clone pHZ-44) | 7700.0 | ENSG00000131127 | 1 family identified with mutation | ?Polydactyly, postaxial, type A6, 615226 (3), Autosomal recessive
chr4	PIGG	616918.0 | PIGG, GPI7, NEDHSCA, EMM | Phosphatidylinositol glycan anchor biosynthesis class G protein | 54872.0 | ENSG00000174227 | nan | [Blood group, EMM system], 619812 (3), Autosomal recessive; Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy, 616917 (3), Autosomal recessive
chr4	PDE6B	180072.0 | PDE6B, PDEB, RP40, CSNBAD2 | Phosphodiesterase 6B | 5158.0 | ENSG00000133256 | nan | Retinitis pigmentosa-40, 613801 (3), Autosomal recessive; Night blindness, congenital stationary, autosomal dominant 2, 163500 (3), Autosomal dominant
chr4	ATP5ME	601519.0 | ATP5I, ATP5K | ATP synthase, H+ transporting, mitochondrial FO complex, subunit E | 521.0 | ENSG00000169020 | nan | nan
chr4	MYL5	160782.0 | MYL5 | Myosin, light polypeptide-5, regulatory | 4636.0 | ENSG00000215375 | nan | nan
chr4	SLC49A3	620318.0 | SLC49A3, MFSD7 | Solute carrier family 49, member 3 | 84179.0 | ENSG00000169026 | nan | nan
chr4	PCGF3	617543.0 | PCGF3, RNF3, RNF3A | Polycomb group RING finger protein 3 | 10336.0 | ENSG00000185619 | nan | nan
chr4	CPLX1	605032.0 | CPLX1, CPX1, DEE63 | Complexin 1 | 10815.0 | ENSG00000168993 | nan | Developmental and epileptic encephalopathy 63, 617976 (3), Autosomal recessive
chr4	GAK	602052.0 | GAK | Cyclin G associated kinase | 2580.0 | ENSG00000178950 | nan | nan
chr4	TMEM175	616660.0 | TMEM175 | Transmembrane protein 175 | 84286.0 | ENSG00000127419 | nan | nan
chr4	DGKQ	601207.0 | DGKQ, DAGK4 | Diacylglycerol kinase, theta, 110kD | 1609.0 | ENSG00000145214 | nan | nan
chr4	SLC26A1	610130.0 | SLC26A1, SAT1, CAON1, HYSULF | Solute carrier family 26 (sulfate transporter), member 1 | 10861.0 | ENSG00000145217 | mutation identified in 1 CAON1 patient and 1 HYSULF patient | ?Hypersulfaturia, 620372 (3), Autosomal recessive; ?Nephrolithiasis, calcium oxalate, 1, 167030 (3), Autosomal recessive
chr4	IDUA	252800.0 | IDUA, IDA | Iduronidase, alpha-L- | 3425.0 | ENSG00000127415 | nan | Mucopolysaccharidosis Is, 607016 (3), Autosomal recessive; Mucopolysaccharidosis Ih/s, 607015 (3), Autosomal recessive; Mucopolysaccharidosis Ih, 607014 (3), Autosomal recessive
chr4	FGFRL1	605830.0 | FGFRL1 | Fibroblast growth factor receptor-like 1 | 53834.0 | ENSG00000127418 | nan | nan
chr4	RNF212	612041.0 | RNF212, ZHP3, SPGF62 | Ring finger protein 212 | 285498.0 | ENSG00000178222 | mutation identified in 1 SPGF62 family | ?Spermatogenic failure 62, 619673 (3), Autosomal recessive; Recombination rate QTL 1, 612042 (3)
chr4	SPON2	605918.0 | SPON2 | Spondin 2 | 10417.0 | ENSG00000159674 | nan | nan
chr4	CTBP1	602618.0 | CTBP1, HADDTS | C-terminal binding protein 1 | 1487.0 | ENSG00000159692 | nan | Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3), Autosomal dominant
chr4	MAEA	606801.0 | MAEA, EMP | Macrophage erythroblast attacher | 10296.0 | ENSG00000090316 | nan | nan
chr4	UVSSA	614632.0 | UVSSA, KIAA1530, UVSS3 | UV-stimulated scaffold protein A | 57654.0 | ENSG00000163945 | nan | UV-sensitive syndrome 3, 614640 (3), Autosomal recessive
chr4	NKX1-1	617869.0 | NKX1-1, SAX2 | NK1 homeobox 1 | 54729.0 | ENSG00000235608 | nan | nan
chr4	FAM53A	617229.0 | FAM53A, DNTNP | Family with sequence similarity 53, member A | 152877.0 | ENSG00000174137 | nan | nan
chr4	SLBP	602422.0 | SLBP, HBP | Stem-loop binding protein | 7884.0 | ENSG00000163950 | nan | nan
chr4	TMEM129	615975.0 | TMEM129 | Transmembrane protein 129 | 92305.0 | ENSG00000168936 | nan | nan
chr4	TACC3	605303.0 | TACC3 | Transforming, acidic, coiled-coil-containing protein 3 | 10460.0 | ENSG00000013810 | nan | nan
chr4	FGFR3	134934.0 | FGFR3, ACH | Fibroblast growth factor receptor-3 | 2261.0 | ENSG00000068078 | nan | Muenke syndrome, 602849 (3), Autosomal dominant; SADDAN, 616482 (3), Autosomal dominant; Hypochondroplasia, 146000 (3), Autosomal dominant; Thanatophoric dysplasia, type II, 187601 (3), Autosomal dominant; Nevus, epidermal, somatic, 162900 (3); CATSHL syndrome, 610474 (3), Autosomal recessive, Autosomal dominant; Thanatophoric dysplasia, type I, 187600 (3), Autosomal dominant; Spermatocytic seminoma, somatic, 273300 (3); Bladder cancer, somatic, 109800 (3); LADD syndrome 2, 620192 (3), Autosomal dominant; Achondroplasia, 100800 (3), Autosomal dominant; Cervical cancer, somatic, 603956 (3); Colorectal cancer, somatic, 114500 (3); Crouzon syndrome with acanthosis nigricans, 612247 (3), Autosomal dominant
chr4	LETM1	604407.0 | LETM1, CONDMIM | Leucine zipper/EF-hand-containing transmembrane protein 1 | 3954.0 | ENSG00000168924 | nan | Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction, 620089 (3), Autosomal recessive
chr4	NSD2	602952.0 | NSD2, WHSC1, MMSET, RAUST | Nuclear receptor-binding SET domain protein 2 | 7468.0 | ENSG00000109685 | nan | Rauch-Steindl syndrome, 619695 (3), Autosomal dominant
chr4	NELFA	606026.0 | NELFA, WHSC2 | Negative elongation factor complex member A | 7469.0 | ENSG00000185049 | nan | nan
chr4	NICOL1	614690.0 | C4orf48 | chromosome 4 open reading frame 48 | 401115.0 | ENSG00000243449 | nan | nan
chr4	NAT8L	610647.0 | NAT8L, CML3, NACED | N-acetyltransferase 8-like | 339983.0 | ENSG00000185818 | mutation identified in 1 patient | ?N-acetylaspartate deficiency, 614063 (3), Autosomal recessive
chr4	POLN	610887.0 | POLN | Polymerase, DNA, nu | 353497.0 | ENSG00000130997 | nan | nan
chr4	HAUS3	613430.0 | HAUS3, DGT3, C4orf15 | HAUS augmin-like complex, subunit 3 | 79441.0 | ENSG00000214367 | nan | nan
chr4	MXD4	620016.0 | MXD4, MAD4 | Max dimerization protein 4 | 10608.0 | ENSG00000123933 | nan | nan
chr4	ZFYVE28	614176.0 | ZFYVE28, LST2, KIAA1643 | Zinc finger FYVE domain-containing protein 28 | 57732.0 | ENSG00000159733 | nan | nan
chr4	RNF4	602850.0 | RNF4 | RING finger protein-4 | 6047.0 | ENSG00000063978 | nan | nan
chr4	FAM193A	620037.0 | FAM193A | Family with sequence similarity 193, member A | 8603.0 | ENSG00000125386 | nan | nan
chr4	TNIP2	610669.0 | TNIP2, ABIN2, FLIP1 | TNFAIP3-interacting protein 2 | 79155.0 | ENSG00000168884 | nan | nan
chr4	SH3BP2	602104.0 | SH3BP2, CRPM | SH3-domain binding protein 2 | 6452.0 | ENSG00000087266 | nan | Cherubism, 118400 (3), Autosomal dominant
chr4	ADD1	102680.0 | ADD1 | Adducin-1, alpha | 118.0 | ENSG00000087274 | nan | {Hypertension, essential, salt-sensitive}, 145500 (3), Multifactorial
chr4	MFSD10	610977.0 | TETRAN, TPO1 | Tetracycline transporter-like protein | 10227.0 | ENSG00000109736 | nan | nan
chr4	NOP14	611526.0 | NOP14, NOL14, RES425 | NOP14 nucleolar protein | 8602.0 | ENSG00000087269 | nan | nan
chr4	GRK4	137026.0 | GRK4, GPRK2L, GPRK4 | G protein-coupled receptor kinase 4 | 2868.0 | ENSG00000125388 | nan | nan
chr4	HTT	613004.0 | HTT, HD, IT15, LOMARS | Huntingtin | 3064.0 | ENSG00000197386 | distal to D4S10 | Lopes-Maciel-Rodan syndrome, 617435 (3), Autosomal recessive; Huntington disease, 143100 (3), Autosomal dominant
chr4	RGS12	602512.0 | RGS12 | Regulator of G protein signaling 12 | 6002.0 | ENSG00000159788 | nan | nan
chr4	HGFAC	604552.0 | HGFAC, HGFA | Hepatocyte growth factor activator | 3083.0 | ENSG00000109758 | nan | nan
chr4	DOK7	610285.0 | DOK7, C4orf25, CMS10, FADS3 | Downstream of tyrosine kinase 7 | 285489.0 | ENSG00000175920 | mutation identified in 1 FADS3 family | Fetal akinesia deformation sequence 3, 618389 (3), Autosomal recessive; Myasthenic syndrome, congenital, 10, 254300 (3), Autosomal recessive
chr4	LRPAP1	104225.0 | LRPAP1, A2MRAP, MYP23 | Low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1) | 4043.0 | ENSG00000163956 | nan | Myopia 23, autosomal recessive, 615431 (3), Autosomal recessive
chr4	ADRA2C	104250.0 | ADRA2C, ADRA2L2 | Adrenergic, alpha-2C-, receptor | 152.0 | ENSG00000184160 | linked to D4S10 | nan
chr4	OTOP1	607806.0 | OTOP1 | Otopetrin 1 | 133060.0 | ENSG00000163982 | nan | nan
chr4	LYAR	617684.0 | LYAR | Ly1 antibody-reactive protein | 55646.0 | ENSG00000145220 | nan | nan
chr4	ZBTB49	616238.0 | ZBTB49, ZNF509 | Zinc finger- and BTB domain-containing protein 49 | 166793.0 | ENSG00000168826 | nan | nan
chr4	NSG1	607645.0 | NSG1, D4S234E, D4S234 | Neuronal vesicle trafficking associated 1 | 27065.0 | ENSG00000168824 | nan | nan
chr4	STX18	606046.0 | STX18 | Syntaxin 18 | 53407.0 | ENSG00000168818 | nan | nan
chr4	MSX1	142983.0 | MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3 | MSH homeobox 1 | 4487.0 | ENSG00000163132 | nan | Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3), Autosomal dominant; Ectodermal dysplasia 3, Witkop type, 189500 (3), Autosomal dominant; Orofacial cleft 5, 608874 (3), Autosomal dominant
chr4	CYTL1	607930.0 | CYTL1, C17 | Cytokine-like protein 1 | 54360.0 | ENSG00000170891 | nan | nan
chr4	EVC2	607261.0 | EVC2, LBN, WAD | EvC ciliary complex subunit 2 (limbin) | 132884.0 | ENSG00000173040 | nan | Ellis-van Creveld syndrome, 225500 (3), Autosomal recessive; Weyers acrofacial dysostosis, 193530 (3), Autosomal dominant
chr4	EVC	604831.0 | EVC | EvC ciliary complex subunit 1 | 2121.0 | ENSG00000072840 | mutation identified in 1 WAD patient | Ellis-van Creveld syndrome, 225500 (3), Autosomal recessive; ?Weyers acrofacial dysostosis, 193530 (3), Autosomal dominant
chr4	CRMP1	602462.0 | CRMP1, DPYSL1, DRP1 | Collapsin response mediator protein-1 | 1400.0 | ENSG00000072832 | nan | nan
chr4	JAKMIP1	611195.0 | JAKMIP1, JAMIP1, MARLIN1 | Janus kinase and microtubule-interacting protein 1 | 152789.0 | ENSG00000152969 | nan | nan
chr4	WFS1	606201.0 | WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41 | Wolframin ER transmembrane glycoprotein | 7466.0 | ENSG00000109501 | mutation identified in 1 CTRCT41 family | Deafness, autosomal dominant 6/14/38, 600965 (3), Autosomal dominant; ?Cataract 41, 116400 (3), Autosomal dominant; Wolfram-like syndrome, autosomal dominant, 614296 (3), Autosomal dominant; {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3), Autosomal dominant; Wolfram syndrome 1, 222300 (3), Autosomal recessive
chr4	PPP2R2C	605997.0 | PPP2R2C, PR52 | Protein phosphatase 2A, regulatory subunit B, gamma isoform | 5522.0 | ENSG00000074211 | nan | nan
chr4	MAN2B2	618899.0 | MAN2B2 | Mannosidase, alpha, class 2B, member 2 | 23324.0 | ENSG00000013288 | nan | nan
chr4	MRFAP1	616905.0 | MRFAP1, PAM14, PGR1` | MORF4 family- associated protein 1 | 93621.0 | ENSG00000179010 | nan | nan
chr4	S100P	600614.0 | S100P | S100 calcium-binding protein P | 6286.0 | ENSG00000163993 | nan | nan
chr4	BLOC1S4	605695.0 | BLOC1S4, BLOS4, CNO | Biogenesis of lysosome-related organelles complex 1, subunit 4 | 55330.0 | ENSG00000186222 | nan | nan
chr4	KIAA0232	619237.0 | KIAA0232 | KIAA0232 gene | 9778.0 | ENSG00000170871 | nan | nan
chr4	TBC1D14	614855.0 | TBC1D14, KIAA1322 | TBC1 domain family, member 14 | 57533.0 | ENSG00000132405 | nan | nan
chr4	CFAP184	619347.0 | CCDC96 | Coiled-coil domain-containing protein 96 | 257236.0 | ENSG00000173013 | nan | nan
chr4	TADA2B	608790.0 | TADA2B, ADA2B | Transcriptional adaptor 2B | 93624.0 | ENSG00000173011 | nan | nan
chr4	GRPEL1	606173.0 | GRPEL1, HMGE | GrpE-like 1, mitochondrial | 80273.0 | ENSG00000109519 | nan | nan
chr4	SORCS2	606284.0 | SORCS2, KIAA1329 | Sortilin-related VPS10 domain-containing receptor 2 | 57537.0 | ENSG00000184985 | nan | nan
chr4	AFAP1-AS1	619779.0 | AFAP1AS1 | AFAP1 antisense RNA 1, noncoding | 84740.0 | ENSG00000272620 | nan | nan
chr4	AFAP1	608252.0 | AFAP1, AFAP, AFAP110 | Actin filament-associated protein 1 | 60312.0 | ENSG00000196526 | nan | nan
chr4	ABLIM2	612544.0 | ABLIM2, KIAA1808 | Actin-binding LIM protein family, member 2 | 84448.0 | ENSG00000163995 | nan | nan
chr4	MIR95	613185.0 | MIR95, MIRN95 | Micro RNA 95 | 407052.0 | ENSG00000207807 | nan | nan
chr4	HTRA3	608785.0 | HTRA3, PRSP | HTRA serine peptidase 3 | 94031.0 | ENSG00000170801 | nan | nan
chr4	ACOX3	603402.0 | ACOX3 | Acyl-coenzyme A oxidase 3, pristanoyl | 8310.0 | ENSG00000087008 | nan | nan
chr4	TRMT44	614309.0 | TRMT44, METTL19 | tRNA methyltransferase 44 homolog | 152992.0 | ENSG00000155275 | nan | nan
chr4	GPR78	606921.0 | GPR78 | G protein-coupled receptor 78 | 27201.0 | ENSG00000155269 | nan | nan
chr4	CPZ	603105.0 | CPZ | Carboxypeptidase Z | 8532.0 | ENSG00000109625 | nan | nan
chr4	HMX1	142992.0 | HMX1, H6 | Homeobox (H6 family) 1 | 3166.0 | ENSG00000215612 | nan | Oculoauricular syndrome, 612109 (3), Autosomal recessive
chr4	USP17L9P	607011.0 | USP17L9P, USP17 | Ubiquitin-specific protease 17-like family member 9, pseudogene | 391627.0 | ENSG00000251694 | nan | nan
chr4	SLC2A9	606142.0 | SLC2A9, GLUT9, UAQTL2 | Solute carrier family 2 (facilitated glucose transporter), member 9 | 56606.0 | ENSG00000109667 | nan | {Uric acid concentration, serum, QTL 2}, 612076 (3), Autosomal recessive, Autosomal dominant; Hypouricemia, renal, 2, 612076 (3), Autosomal recessive, Autosomal dominant
chr4	DRD5	126453.0 | DRD5, DRD1B, DRD1L2 | Dopamine receptor D5 | 1816.0 | ENSG00000169676 | pseudogenes on 2p11 and 1q21 | {Blepharospasm, primary benign}, 606798 (3), Autosomal dominant; {Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3), Autosomal dominant
chr4	WDR1	604734.0 | WDR1, PFITS | WD repeat-containing protein 1 | 9948.0 | ENSG00000071127 | nan | Periodic fever, immunodeficiency, and thrombocytopenia syndrome, 150550 (3), Autosomal recessive
chr4	ZNF518B	617734.0 | ZNF518B, KIAA1729 | Zinc finger protein 518B | 85460.0 | ENSG00000178163 | nan | nan
chr4	CLNK	611434.0 | CLNK, MIST | Cytokine-dependent hematopoietic cell linker | 116449.0 | ENSG00000109684 | nan | nan
chr4	BMIQ7	608410.0 | BMIQ7 | Body mass index quantitative trait locus 7 | 404683.0 | nan | nan | {Obesity, susceptibility to, BMIQ7}, 608410 (2)
chr4	EPPS	607221.0 | EPPS | Epilepsy, partial, with pericentral spikes | 266789.0 | nan | nan | Epilepsy, partial, with pericentral spikes, 607221 (2)
chr4	HDL3	604802.0 | HDL3, HLN2 | Huntington disease-like 3 | 53369.0 | nan | nan | Huntington disease-like 3, 604802 (2), Autosomal recessive
chr4	STQTL13	612226.0 | STQTL13 | Stature quantitative trait locus 13 | 100270796.0 | nan | associated with rs16896068 | {Stature QTL 13}, 612226 (2)
chr4	HS3ST1	603244.0 | HS3ST1, 3OST, 3OST1 | Heparan sulfate-glucosamine 3-sulfotransferase 1 | 9957.0 | ENSG00000002587 | nan | nan
chr4	RAB28	612994.0 | RAB28, CORD18 | Ras-associated protein 28 | 9364.0 | ENSG00000157869 | nan | Cone-rod dystrophy 18, 615374 (3), Autosomal recessive
chr4	NKX3-2	602183.0 | NKX3-2, BAPX1, SMMD | NK3 homeobox 1 | 579.0 | ENSG00000109705 | nan | Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3), Autosomal recessive
chr4	BOD1L1	616746.0 | BOD1L1, FAM44A | BOD1-like protein 1 | 259282.0 | ENSG00000038219 | nan | nan
chr4	CPEB2	610605.0 | CPEB2 | Cytoplasmic polyadenylation element-binding protein 2 | 132864.0 | ENSG00000137449 | nan | nan
chr4	CC2D2A	612013.0 | CC2D2A, KIAA1345, MKS6, COACH2, RP93 | Coiled-coil and C2 domains-containing protein 2A | 57545.0 | ENSG00000048342 | nan | COACH syndrome 2, 619111 (3), Autosomal recessive; Retinitis pigmentosa 93, 619845 (3), Autosomal recessive; Meckel syndrome 6, 612284 (3), Autosomal recessive; Joubert syndrome 9, 612285 (3), Autosomal recessive
chr4	FBXL5	605655.0 | FBXL5, FBL5 | F-box and leucine-rich repeat protein 5 | 26234.0 | ENSG00000118564 | nan | nan
chr4	BST1	600387.0 | BST1 | Bone marrow stromal cell antigen 1 | 683.0 | ENSG00000109743 | previously assigned to 14q32.3 | nan
chr4	CD38	107270.0 | CD38 | CD38 antigen (p45); ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase | 952.0 | ENSG00000004468 | nan | nan
chr4	FGFBP1	607737.0 | FGFBP1, FGFBP, HBP17 | Fibroblast growth factor-binding protein 1 | 9982.0 | ENSG00000137440 | nan | nan
chr4	FGFBP2	607713.0 | FGFBP2, KSP37 | Fibroblast growth factor-binding protein 2 | 83888.0 | ENSG00000137441 | nan | nan
chr4	PROM1	604365.0 | PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4 | Prominin 1 | 8842.0 | ENSG00000007062 | nan | Macular dystrophy, retinal, 2, 608051 (3), Autosomal dominant; Retinitis pigmentosa 41, 612095 (3), Autosomal recessive; Stargardt disease 4, 603786 (3), Autosomal dominant; Cone-rod dystrophy 12, 612657 (3), Autosomal recessive, Autosomal dominant
chr4	TAPT1	612758.0 | TAPT1, CMVFR, OCLSBG | Transmembrane anterior posterior transformation 1 | 202018.0 | ENSG00000169762 | nan | Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3), Autosomal recessive
chr4	LDB2	603450.0 | LDB2, CLIM1 | LIM domain-binding factor-2 | 9079.0 | ENSG00000169744 | nan | nan
chr4	QDPR	612676.0 | QDPR, DHPR | Quinoid dihydropteridine reductase | 5860.0 | ENSG00000151552 | nan | Hyperphenylalaninemia, BH4-deficient, C, 261630 (3), Autosomal recessive
chr4	CLRN2	618988.0 | CLRN2, DFNB117 | Clarin 2 | 645104.0 | ENSG00000249581 | nan | Deafness, autosomal recessive 117, 619174 (3), Autosomal recessive
chr4	LAP3	170250.0 | PEPS | Peptidase S | 51056.0 | ENSG00000002549 | nan | nan
chr4	MED28	610311.0 | MED28, EG1, MAGICIN | Mediator complex subunit 28 | 80306.0 | ENSG00000118579 | nan | nan
chr4	FAM184B	619945.0 | FAM184B, KIAA1276 | Family with sequence similarity 184, member B | 27146.0 | ENSG00000047662 | nan | nan
chr4	DCAF16	620524.0 | DCAF16 | DDB1- and CUL4-associated factor 16 | 54876.0 | ENSG00000163257 | nan | nan
chr4	NCAPG	606280.0 | NCAPG, CAPG | Non-SMC condensin I complex subunit G | 64151.0 | ENSG00000109805 | nan | nan
chr4	LCORL	611799.0 | LCORL, MLR1 | Ligand-dependent nuclear receptor corepressor-like protein | 254251.0 | ENSG00000178177 | nan | nan
chr4	SLIT2	603746.0 | SLIT2 | SLIT guidance ligand 2 | 9353.0 | ENSG00000145147 | nan | nan
chr4	MIR218-1	616770.0 | MIR218-1 | Micro RNA 218-1 | 407000.0 | ENSG00000207732 | within intron of SLIT2 | nan
chr4	KCNIP4	608182.0 | KCNIP4, KCHIP4 | Kv channel-interacting protein 4 | 80333.0 | ENSG00000185774 | nan | nan
chr4	ADGRA3	612303.0 | ADGRA3, GPR125 | Adhesion G protein-coupled receptor A3 | 166647.0 | ENSG00000152990 | nan | nan
chr4	GBA3	606619.0 | GBA3, CBGL1 | Glucosidase, beta, acid 3 | 57733.0 | ENSG00000249948 | nan | nan
chr4	PPARGC1A	604517.0 | PPARGC1A, PPARGC1 | Peroxisome proliferator-activated receptor-gamma, coactivator 1, alpha | 10891.0 | ENSG00000109819 | nan | nan
chr4	DHX15	603403.0 | DHX15, DDX15, DBP1, HRH2 | DEAH-box helicase 15 | 1665.0 | ENSG00000109606 | nan | nan
chr4	SOD3	185490.0 | SOD3 | Superoxide dismutase-3, extracellular | 6649.0 | ENSG00000109610 | nan | [Superoxide dismutase, elevated extracellular] (3)
chr4	LGI2	608301.0 | LGI2, KIAA1916 | Leucine-rich gene, glioma-inactivated, 2 | 55203.0 | ENSG00000153012 | nan | nan
chr4	SEPSECS	613009.0 | SEPSECS, SLA, LP, PCH2D | O-phosphoserine tRNA-selenocysteine tRNA synthase | 51091.0 | ENSG00000109618 | nan | Pontocerebellar hypoplasia type 2D, 613811 (3), Autosomal recessive
chr4	PI4K2B	612101.0 | PI4K2B | Phosphatidylinositol 4-kinase, type 2, beta | 55300.0 | ENSG00000038210 | nan | nan
chr4	ZCCHC4	611792.0 | ZCCHC4 | Zinc finger CCHC domain-containing protein 4 | 29063.0 | ENSG00000168228 | nan | nan
chr4	ANAPC4	606947.0 | ANAPC4, APC4 | Anaphase-promoting complex, subunit 4 | 29945.0 | ENSG00000053900 | nan | nan
chr4	SLC34A2	604217.0 | SLC34A2, PULAM | Solute carrier family 34 (sodium/phosphate cotransporter), member 2 | 10568.0 | ENSG00000157765 | nan | Pulmonary alveolar microlithiasis, 265100 (3), Autosomal recessive
chr4	SEL1L3	619914.0 | SEL1L3, KIAA0746 | SEL1L family, member 3 | 23231.0 | ENSG00000091490 | nan | nan
chr4	SMIM20	617465.0 | SMIM20, MITRAC7, C4orf52 | Small integral membrane protein 20 | 389203.0 | ENSG00000250317 | nan | nan
chr4	RBPJ	147183.0 | RBPJ, RBPSUH, IGKJRB1, AOS3 | Recombination signal-binding protein 1 for kappa J region | 3516.0 | ENSG00000168214 | pseudogenes at 9q13, 9p13, and 3q25 | Adams-Oliver syndrome 3, 614814 (3), Autosomal dominant
chr4	CCKAR	118444.0 | CCKAR | Cholecystokinin A receptor | 886.0 | ENSG00000163394 | nan | nan
chr4	STIM2	610841.0 | STIM2, KIAA1482 | Stromal interaction molecule 2 | 57620.0 | ENSG00000109689 | nan | nan
chr4	NPCA1	607107.0 | NPC1, NPCA1 | Nasopharyngeal carcinoma 1 | 257641.0 | nan | ?associated with acyl-CoA thioesterase 7-like | {Nasopharyngeal carcinoma 1}, 607107 (2)
chr4	PCDH7	602988.0 | PCDH7, BHPCDH | Protocadherin-7 | 5099.0 | ENSG00000169851 | nan | nan
chr4	ARAP2	606645.0 | ARAP2, CENTD1, KIAA0580 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 | 116984.0 | ENSG00000047365 | nan | nan
chr4	DTHD1	616979.0 | DTHD1 | Death domain-containing protein 1 | 401124.0 | ENSG00000197057 | nan | nan
chr4	NWD2	620172.0 | NWD2, KIAA1239 | NACHT domain- and WD repeat-containing protein 2 | 57495.0 | ENSG00000174145 | nan | nan
chr4	RELL1	611212.0 | RELL1 | Relt-like 1 | 768211.0 | ENSG00000181826 | nan | nan
chr4	PGM2	172000.0 | PGM2 | Phosphoglucomutase-2 | 55276.0 | ENSG00000169299 | nan | nan
chr4	TBC1D1	609850.0 | TBC1D1, KIAA1108 | TBC1 domain family, member 1 | 23216.0 | ENSG00000065882 | nan | nan
chr4	PTTG2	604231.0 | PTTG2 | Pituitary tumor-transforming gene 2 | 10744.0 | ENSG00000250254 | nan | nan
chr4	KLF3	609392.0 | KLF3, BKLF | Kruppel-like factor 3 | 51274.0 | ENSG00000109787 | nan | nan
chr4	TLR10	606270.0 | TLR10 | Toll-like receptor 10 | 81793.0 | ENSG00000174123 | nan | nan
chr4	TLR1	601194.0 | TLR1, TIL. LPRS5 | Toll-like receptor-1 | 7096.0 | ENSG00000174125 | nan | {Leprosy, susceptibility to, 5}, 613223 (3); {Leprosy, protection against}, 613223 (3)
chr4	TLR6	605403.0 | TLR6 | Toll-like receptor 6 | 10333.0 | ENSG00000174130 | nan | nan
chr4	MIR574	615469.0 | MIR574, MIR574-3p | Micro RNA 574 | 693159.0 | ENSG00000207944 | nan | nan
chr4	KLHL5	608064.0 | KLHL5 | Kelch-like 5 | 51088.0 | ENSG00000109790 | nan | nan
chr4	WDR19	608151.0 | WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72 | WD repeat-containing protein 19 | 57728.0 | ENSG00000157796 | mutation identified in 1 CED4 family and 1 SRTD5 family | Nephronophthisis 13, 614377 (3), Autosomal recessive; Cranioectodermal dysplasia 4, 614378 (3), Autosomal recessive; Senior-Loken syndrome 8, 616307 (3), Autosomal recessive; Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3), Autosomal recessive; ?Spermatogenic failure 72, 619867 (3), Autosomal recessive
chr4	RFC1	102579.0 | RFC1, RECC1, CANVAS | Replication factor C1, 145kD (activator 1, 145kD) | 5981.0 | ENSG00000035928 | nan | Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome, 614575 (3), Autosomal recessive
chr4	KLB	611135.0 | KLB, BKL | Klotho, beta | 152831.0 | ENSG00000134962 | nan | nan
chr4	RPL9	603686.0 | RPL9 | Ribosomal protein L9 | 6133.0 | ENSG00000163682 | pseudogene on Xpter-p21 | nan
chr4	LIAS	607031.0 | LIAS, PDHLD, HGCLAS | Lipoic acid synthase | 11019.0 | ENSG00000121897 | nan | Hyperglycinemia, lactic acidosis, and seizures, 614462 (3), Autosomal recessive
chr4	UGDH	603370.0 | UGDH, UDPGDH, DEE84 | UDP-glucose dehydrogenase | 7358.0 | ENSG00000109814 | nan | Developmental and epileptic encephalopathy 84, 618792 (3), Autosomal recessive
chr4	UBE2K	602846.0 | UBE2K, HIP2 | Ubiquitin-conjugating enzyme E2 K | 3093.0 | ENSG00000078140 | nan | nan
chr4	PDS5A	613200.0 | PDS5A, KIAA0648, SCC112 | PDS5 cohesin-associated factor A | 23244.0 | ENSG00000121892 | nan | nan
chr4		611963.0 | LOC344967 | Acyl-CoA thioesterase 7-like | 344967.0 | ENSG00000293349 | ?associated with nasopharyngeal carcinoma | nan
chr4	N4BP2	619139.0 | N4BP2, KIAA1413 | NEDD4-binding protein 2 | 55728.0 | ENSG00000078177 | nan | nan
chr4	RHOH	602037.0 | RHOH, ARHH, TTF | Ras homolog gene family, member H | 399.0 | ENSG00000168421 | mutation identified in 1 EV4 family | {?Epidermodysplasia verruciformis, susceptibility to, 4}, 618307 (3), Autosomal recessive
chr4	CHRNA9	605116.0 | CHRNA9 | Cholinergic receptor, neuronal nicotinic, alpha polypeptide 9 | 55584.0 | ENSG00000174343 | nan | nan
chr4	RBM47	619104.0 | RBM7 | RNA-binding motif protein 47 | 54502.0 | ENSG00000163694 | nan | nan
chr4	NSUN7	617185.0 | NSUN7 | NOP2/SUN RNA methyltransferase family, member 7 | 79730.0 | ENSG00000179299 | nan | nan
chr4	APBB2	602710.0 | APBB2, FE65L1 | Amyloid beta A4 precursor protein-binding, family B, member 2 (Fe65-like 1) | 323.0 | ENSG00000163697 | nan | nan
chr4	NRCLP2	605841.0 | NRCLP2 | Narcolepsy 2 | 100918.0 | nan | max lod at D4S2987 | Narcolepsy 2, 605841 (2)
chr4	UCHL1-DT	614991.0 | UCH1LAS | Ubiquitin carboxyl-terminal esterase L1, antisense | 101410542.0 | ENSG00000251173 | nan | nan
chr4	UCHL1	191342.0 | UCHL1, PARK5, SPG79, NDGOA, SPG79A | Ubiquitin C-terminal esterase L1 | 7345.0 | ENSG00000154277 | mutation identified in 1 PARK5 family | {?Parkinson disease 5, susceptibility to}, 613643 (3), Autosomal dominant; Spastic paraplegia 79A, autosomal dominant, 620221 (3), Autosomal dominant; Spastic paraplegia 79B, autosomal recessive, 615491 (3), Autosomal recessive
chr4	LIMCH1	617750.0 | LIMCH1, LMO7B | LIM and calponin homology domains-containing protein 1 | 22998.0 | ENSG00000064042 | nan | nan
chr4	PHOX2B	603851.0 | PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS | Paired mesoderm homeobox 2B | 8929.0 | ENSG00000109132 | nan | {Neuroblastoma, susceptibility to, 2}, 613013 (3); Neuroblastoma with Hirschsprung disease, 613013 (3); Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease, 209880 (3), Autosomal dominant
chr4	TMEM33	618515.0 | TMEM33 | Transmembrane protein 33 | 55161.0 | ENSG00000109133 | nan | nan
chr4	SLC30A9	604604.0 | SLC30A9, C4orf1, HUEL, BILAPES | Solute carrier family 30 (zinc transporter), member 9 | 10463.0 | ENSG00000014824 | nan | Birk-Landau-Perez syndrome, 617595 (3), Autosomal recessive
chr4	SHISA3	617325.0 | SHISA3 | Shisa family, member 3 | 152573.0 | ENSG00000178343 | nan | nan
chr4	ATP8A1	609542.0 | ATP8A1 | ATPase, class I, type 8A, member 1 | 10396.0 | ENSG00000124406 | nan | nan
chr4	GRXCR1	613283.0 | GRXCR1 | Glutaredoxin, cysteine-rich, 1 | 389207.0 | ENSG00000215203 | nan | Deafness, autosomal recessive 25, 613285 (3), Autosomal recessive
chr4	KCTD8	618442.0 | KCTD8 | Potassium channel tetramerization domain-containing protein 8 | 386617.0 | ENSG00000183783 | nan | nan
chr4	YIPF7	619754.0 | YIPF7 | YIP1 domain family, member 7 | 285525.0 | ENSG00000177752 | nan | nan
chr4	GUF1	617064.0 | GUF1, EF4, DEE40 | GUF1 homolog, GTPase | 60558.0 | ENSG00000151806 | mutation identified in 1 DEE40 family | ?Developmental and epileptic encephalopathy 40, 617065 (3), Autosomal recessive
chr4	GNPDA2	613222.0 | GNPDA2, GNP2 | Glucosamine-6-phosphate deaminase 2 | 132789.0 | ENSG00000163281 | nan | nan
chr4	GABRG1	137166.0 | GABRG1 | Gamma-aminobutyric acid (GABA) A receptor, gamma-1 | 2565.0 | ENSG00000163285 | nan | nan
chr4	GABRA2	137140.0 | GABRA2, DEE78 | Gamma-aminobutyric acid (GABA) A receptor, alpha-2 | 2555.0 | ENSG00000151834 | nan | Developmental and epileptic encephalopathy 78, 618557 (3), Autosomal dominant; {Alcohol dependence, susceptibility to}, 103780 (3), Multifactorial
chr4	COX7B2	609811.0 | COX7B2 | Cytochrome C oxidase subunit VIIb2 | 170712.0 | ENSG00000170516 | nan | nan
chr4	GABRA4	137141.0 | GABRA4 | Gamma-aminobutyric acid (GABA) A receptor, alpha-4 | 2557.0 | ENSG00000109158 | cluster with GABRA2, B1, G1; ?involved in autism | nan
chr4	GABRB1	137190.0 | GABRB1, DEE45 | Gamma-aminobutyric acid (GABA) A receptor, beta-1 | 2560.0 | ENSG00000163288 | nan | Developmental and epileptic encephalopathy 45, 617153 (3), Autosomal dominant
chr4	COMMD8	616656.0 | COMMD8 | COMM domain-containing protein 8 | 54951.0 | ENSG00000169019 | nan | nan
chr4	ATP10D	619815.0 | ATP10D, KIAA1487 | ATPase, phospholipid-transporting, 10D | 57205.0 | ENSG00000145246 | nan | nan
chr4	CORIN	605236.0 | CORIN, CRN, TMPRSS10, ATC2, PEE5, CMH30 | Corin, serine peptidase | 10699.0 | ENSG00000145244 | mutation identified in 1 CMH30 family | ?Cardiomyopathy, familial hypertrophic, 30, atrial, 620734 (3), Autosomal recessive; Preeclampsia/eclampsia 5, 614595 (3), Autosomal dominant
chr4	NFXL1	620488.0 | NFXL1, CDZFP | Nuclear transcription factor, X box-binding-like 1 | 152518.0 | ENSG00000170448 | nan | nan
chr4	CNGA1	123825.0 | CNGA1, CNCG1, RP49 | Cyclic nucleotide gated channel, alpha 1 | 1259.0 | ENSG00000198515 | nan | Retinitis pigmentosa 49, 613756 (3), Autosomal recessive
chr4	NIPAL1	620340.0 | NIPAL1, NIPA3 | NIPA-like domain-containing protein 1 | 152519.0 | ENSG00000163293 | nan | nan
chr4	TXK	600058.0 | TXK, BTKL | TXK tyrosine kinase | 7294.0 | ENSG00000074966 | nan | nan
chr4	TEC	600583.0 | TEC | tec protein tyrosine kinase | 7006.0 | ENSG00000135605 | nan | nan
chr4	SLAIN2	610492.0 | SLAIN2, KIAA1458 | SLAIN motif family, member 2 | 57606.0 | ENSG00000109171 | nan | nan
chr4	SLC10A4	618563.0 | SLC10A4 | Solute carrier family 10 (sodium/bile acid cotransporter family), member 4 | 201780.0 | ENSG00000145248 | nan | nan
chr4	ZAR1	607520.0 | ZAR1 | Zygote arrest 1 | 326340.0 | ENSG00000182223 | nan | nan
chr4	FRYL	620798.0 | FRYL, KIAA0826 | FRY-like transcription coactivator | 285527.0 | ENSG00000075539 | nan | nan
chr4	OCIAD1	619596.0 | OCIAD1, ASRIJ | OCIA domain-containing protein 1 | 54940.0 | ENSG00000109180 | nan | nan
chr4	OCIAD2	619633.0 | OCIAD2 | OCIA domain-containing protein 2 | 132299.0 | ENSG00000145247 | tail-to-tail orientation with OCIAD1 | nan
chr4	CWH43	618561.0 | CWH43, PGAP2IP | Cell wall biogenesis protein 43 C-terminal homolog | 80157.0 | ENSG00000109182 | nan | nan
chr4	MHW2	603664.0 | MHW2 | Mental health wellness 2 | 50979.0 | nan | at D4S397 | {Mental health wellness-2}, 603664 (2)
chr4	PSORS3	601454.0 | PSORS3 | Psoriasis susceptibility 3 | 7889.0 | nan | nan | {Psoriasis susceptibility 3}, 601454 (2)
chr4	WM2	610430.0 | WM2 | Macroglobulinemia, Waldenstrom, susceptibility to, 2 | 100188811.0 | nan | between D4S2910 and D4S1539 | {Macroglobulinemia, Waldenstrom, susceptibility to, 2}, 610430 (2)
chr4	DFNB55	609952.0 | DFNB55 | Deafness, autosomal recessive 55 | 494148.0 | nan | max lod at D4S2638 | Deafness, autosomal recessive 55, 609952 (2), Autosomal recessive
chr4	MRT31	614329.0 | MRT31 | Intellectual developmental disorder, autosomal recessive 31 | 100852399.0 | nan | between rs11944876 and rs6551838 | Intellectual developmental disorder, autosomal recessive 31, 614329 (2), Autosomal recessive
chr4	MYP9	609258.0 | MYP9 | Myopia 9 | 553194.0 | nan | nan | Myopia 9, 609258 (2), Multifactorial
chr4	TAPVR1	106700.0 | TAPVR1 | Total anomalous pulmonary venous return 1 | 6893.0 | nan | between D4S1630 and D4S3019; ?mutation in KDR | Total anomalous pulmonary venous return, 106700 (2), Autosomal dominant
chr4	DCUN1D4	612977.0 | DCUN1D4, KIAA0276 | DCN1 domain-containing protein 4 | 23142.0 | ENSG00000109184 | nan | nan
chr4	SGCB	600900.0 | SGCB, LGMDR4 | Sarcoglycan, beta (43kD dystrophin-associated glycoprotein) | 6443.0 | ENSG00000163069 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 4, 604286 (3), Autosomal recessive
chr4	SPATA18	612814.0 | SPATA18, SPETEX1 | Spermatogenesis-associated protein 18 | 132671.0 | ENSG00000163071 | nan | nan
chr4	USP46	612849.0 | USP46 | Ubiquitin-specific peptidase 46 | 64854.0 | ENSG00000109189 | nan | nan
chr4	DANCR	614625.0 | DANCR, ANCR, KIAA0114 | Differentiation-antagonizing noncoding RNA | 57291.0 | ENSG00000226950 | nan | nan
chr4	MIR4449	614627.0 | MIR4449 | Micro RNA 4449 | 100616436.0 | ENSG00000264585 | nan | nan
chr4	SNORA26	614626.0 | SNORA26 | Small nucleolar RNA, H/ACA box, 26 | 677810.0 | ENSG00000212588 | nan | nan
chr4	RASL11B	612404.0 | RASL11B | RAS-like, family 11, member B | 65997.0 | ENSG00000128045 | nan | nan
chr4	FIP1L1	607686.0 | FIP1L1 | Fip1-like 1 | 81608.0 | ENSG00000145216 | fused to PDGFRA in hypereosinophilic syndrome | nan
chr4	LNX1	609732.0 | LNX1, LNX, PDZRN2 | Ligand of numb protein X1 | 84708.0 | ENSG00000072201 | nan | nan
chr4	CHIC2	604332.0 | CHIC2, BTL | Cysteine-rich hydrophobic domain 2 (Brx-like gene translocated in leukemia) | 26511.0 | ENSG00000109220 | nan | {Leukemia, acute myeloid}, 601626 (3), Somatic mutation, Autosomal dominant
chr4	GSX2	616253.0 | GSX2, GSH2, DMJDS2 | GS homeobox 2 | 170825.0 | ENSG00000180613 | nan | Diencephalic-mesencephalic junction dysplasia syndrome 2, 618646 (3), Autosomal recessive
chr4	PDGFRA	173490.0 | PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | 5156.0 | ENSG00000134853 | same 700bp segment as KIT; fused to BCR or FIP1L1 | Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial, 175510 (3); Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation
chr4	KIT	164920.0 | KIT, PBT, MASTC | Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene | 3815.0 | ENSG00000157404 | same 700bp segment as PDGFRA | Gastrointestinal stromal tumor, familial, 606764 (3), Isolated cases, Autosomal dominant; Mastocytosis, cutaneous, 154800 (3), Autosomal dominant; Piebaldism, 172800 (3), Autosomal dominant; Germ cell tumors, somatic, 273300 (3); Mastocytosis, systemic, somatic, 154800 (3); Leukemia, acute myeloid, somatic, 601626 (3)
chr4	KDR	191306.0 | KDR | Kinase insert domain receptor | 3791.0 | ENSG00000128052 | ?mutant in TAPVR1 | {Hemangioma, capillary infantile, susceptibility to}, 602089 (3), Autosomal dominant; Hemangioma, capillary infantile, somatic, 602089 (3)
chr4	SRD5A3	611715.0 | SRD5A3, SRD5A2L, CDG1Q, KRIZI | Steroid 5-alpha-reductase 3 | 79644.0 | ENSG00000128039 | nan | Kahrizi syndrome, 612713 (3), Autosomal recessive; Congenital disorder of glycosylation, type Iq, 612379 (3), Autosomal recessive
chr4	TMEM165	614726.0 | TMEM165, FT27, CDG2K | Transmembrane protein 165 | 55858.0 | ENSG00000134851 | nan | Congenital disorder of glycosylation, type IIk, 614727 (3), Autosomal recessive
chr4	CLOCK	601851.0 | CLOCK | Circadian locomotor output cycles kaput | 9575.0 | ENSG00000134852 | nan | nan
chr4	PDCL2	611676.0 | PDCL2 | Phosducin-like 2 | 132954.0 | ENSG00000163440 | nan | nan
chr4	NMU	605103.0 | NMU | Neuromedin U | 10874.0 | ENSG00000109255 | nan | nan
chr4	EXOC1	607879.0 | EXOC1, SEC3 | Exocyst complex component 1 | 55763.0 | ENSG00000090989 | nan | nan
chr4	CEP135	611423.0 | CEP135, KIAA0635, MCPH8 | Centrosomal protein, 135kD | 9662.0 | ENSG00000174799 | nan | Microcephaly 8, primary, autosomal recessive, 614673 (3), Autosomal recessive
chr4	CRACD	618327.0 | CRACD, KIAA1211 | Capping protein inhibiting regulator of actin dynamics | 57482.0 | ENSG00000109265 | nan | nan
chr4	AASDH	614365.0 | AASDH, ACSF4 | Aminoadipate-semialdehyde dehydrogenase | 132949.0 | ENSG00000157426 | nan | nan
chr4	PPAT	172450.0 | PPAT, GPAT | Phosphoribosylpyrophosphate amidotransferase | 5471.0 | ENSG00000128059 | nan | nan
chr4	PAICS	172439.0 | PAICS, AIRC, PAICSD | Phosphoribosylaminoimidazole carboxylase | 10606.0 | ENSG00000128050 | bifunctional enzyme; mutation identified in 1 PAICSD family | ?Phosphoribosylaminoimidazole carboxylase deficiency, 619859 (3), Autosomal recessive
chr4	SRP72	602122.0 | SRP72, BMFS1 | Signal recognition particle, 72kD | 6731.0 | ENSG00000174780 | nan | Bone marrow failure syndrome 1, 614675 (3), Autosomal dominant
chr4	ARL9	612405.0 | ARL9 | ADP ribosylation factor-like GTPase 9 | 132946.0 | ENSG00000196503 | nan | nan
chr4	HOPX	607275.0 | HOPX, HOP | HOP homeobox | 84525.0 | ENSG00000171476 | nan | nan
chr4	SPINK2	605753.0 | SPINK2, SPGF29 | Serine protease inhibitor, Kazal-type, 2 | 6691.0 | ENSG00000128040 | mutation identified in 1 SPGF29 family | ?Spermatogenic failure 29, 618091 (3), Autosomal recessive
chr4	REST	600571.0 | REST, NRSF, WT6, GINGF5, HGF5, DFNA27 | RE1-silencing transcription factor | 5978.0 | ENSG00000084093 | nan | Deafness, autosomal dominant 27, 612431 (3), Autosomal dominant; {Wilms tumor 6, susceptibility to}, 616806 (3), Autosomal dominant; Fibromatosis, gingival, 5, 617626 (3), Autosomal dominant
chr4	NOA1	614919.0 | NOA1, C4orf14 | Nitric oxide-associated protein 1 | 84273.0 | ENSG00000084092 | nan | nan
chr4	POLR2B	180661.0 | POL2RB | Polymerase (RNA) II (DNA directed) polypeptide B, 140kD | 5431.0 | ENSG00000047315 | nan | nan
chr4	IGFBP7	602867.0 | IGFBP7, MAC25, RAMSVPS | Insulin-like growth factor-binding protein-7 | 3490.0 | ENSG00000163453 | nan | Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3), Autosomal recessive
chr4	AIS4	609400.0 | AIS4, VAMAS5 | Autoimmune disease, susceptibility to, 4 | 619405.0 | nan | between D4S392 and D4S3042 | {Autoimmune disease, susceptibility to, 4}, 609400 (2)
chr4	ADGRL3	616417.0 | ADGRL3, LPHN3, CIRL3, CL3, LEC3, KIAA0768 | Adhesion G protein-coupled receptor L3 | 23284.0 | ENSG00000150471 | nan | nan
chr4	TECRL	617242.0 | TECRL, TERL, SRD5A2L2, GPSN2L, CPVT3 | Trans-2,3-enoyl-CoA reductase-like protein | 253017.0 | ENSG00000205678 | nan | Ventricular tachycardia, catecholaminergic polymorphic, 3, 614021 (3), Autosomal recessive
chr4	EPHA5	600004.0 | EPHA5, TYRO4, HEK7 | Ephrin receptor EphA5 | 2044.0 | ENSG00000145242 | nan | nan
chr4	FMTLE	611630.0 | ETL3, FMTLE | Epilepsy, familial temporal lobe, 3 | 100188848.0 | nan | max lod at D4S1517 | Epilepsy, familial temporal lobe, 3, 611630 (2), Autosomal dominant
chr4	CENPC	117141.0 | CENPC1, CENPC | Centromere autoantigen C1 | 1060.0 | ENSG00000145241 | ?pseudogene on chr.12 | nan
chr4	STAP1	604298.0 | STAP1, BRDG1 | Signal transducing adaptor family member 1 | 26228.0 | ENSG00000035720 | nan | nan
chr4	UBA6	611361.0 | UBA6, UBE1L2 | Ubiquitin-like modifier activating enzyme 6 | 55236.0 | ENSG00000033178 | nan | nan
chr4	GNRHR	138850.0 | GNRHR, LHRHR, HH7 | Gonadotropin-releasing hormone receptor | 2798.0 | ENSG00000109163 | placed at 4q12 or 4q13 by some | Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3), Autosomal recessive
chr4	TMPRSS11D	605369.0 | TMPRSS11D, HAT | Transmembrane protease, serine 11D | 9407.0 | ENSG00000153802 | nan | nan
chr4	TMPRSS11A	611704.0 | TMPRSS11A, ECRG1 | Transmembrane protease, serine 11A | 339967.0 | ENSG00000187054 | nan | nan
chr4	POLR2MP1	608311.0 | GCOM2, GRINL1B | GRINL1B complex locus 2 | 339970.0 | nan | nan | nan
chr4	SYT14P1	610892.0 | SYT14L, SYTDEP, CHR415SYT | Synaptotagmin 14-like protein | 401135.0 | nan | nan | nan
chr4	YTHDC1	617283.0 | YTHDC1, KIAA1966 | TYH domain-containing protein 1 | 91746.0 | ENSG00000083896 | nan | nan
chr4	TMPRSS11E	610399.0 | TMPRSS11E, DESC1 | Transmembrane protease, serine 11E | 28983.0 | ENSG00000087128 | nan | nan
chr4	UGT2B17	601903.0 | UGT2B17, BMND12 | UDP-glucuronyltransferase, family 2, beta-17 | 7367.0 | ENSG00000197888 | nan | {Bone mineral density QTL 12, osteoporosis}, 612560 (3)
chr4	UGT2B15	600069.0 | UGT2B15, UGT2B8 | UDP-glucuronyltransferase, family 2, beta-15 | 7366.0 | ENSG00000196620 | nan | nan
chr4	UGT2B10	600070.0 | UGT2B10 | Uridine diphosphate glycosyltransferase 2 family, member B10 | 7365.0 | ENSG00000109181 | nan | nan
chr4	UGT2A3	616382.0 | UGT2A3 | UDP glucuronosyltransferase 2 family, member A3 | 79799.0 | ENSG00000135220 | nan | nan
chr4	UGT2B7	600068.0 | UGT2B7, UGT2B9 | UDP-glucuronyltransferase, family 2, beta-7 | 7364.0 | ENSG00000171234 | nan | nan
chr4	UGT2B11	603064.0 | UGT2B11 | Uridine diphosphate glycosyltransferase 2 family, member B11 | 10720.0 | ENSG00000213759 | nan | nan
chr4	UGT2B28	606497.0 | UGT2B28 | Uridine diphosphate glycosyltransferase 2 family, member B28 | 54490.0 | ENSG00000135226 | nan | nan
chr4	UGT2B4	600067.0 | UGT2B4, UGT2B11 | UDP-glucuronyltransferase, family 2, beta-4 | 7363.0 | ENSG00000156096 | cluster in order B7--B4--B15 in 195kb | nan
chr4	UGT2A1	604716.0 | UGT2A1 | Uridine diphosphate glycosyltransferase 2 family, member A1 | 10941.0 | ENSG00000173610 | nan | nan
chr4	UGT2A2	619809.0 | UGT2A2 | UDP glucuronosyltransferase family 2, member A2 | 574537.0 | ENSG00000271271 | nan | nan
chr4	SULT1B1	608436.0 | SULT1B1, ST1B2 | Sulfotransferase family 1B, member 1 | 27284.0 | ENSG00000173597 | nan | nan
chr4	SULT1E1	600043.0 | STE, EST | Sulfotransferase, estrogen-preferring | 6783.0 | ENSG00000109193 | nan | nan
chr4	CSN1S1	115450.0 | CSN1 | Casein, alpha | 1446.0 | ENSG00000126545 | nan | nan
chr4	CSN2	115460.0 | CSN2 | Casein, beta | 1447.0 | ENSG00000135222 | nan | nan
chr4	STATH	184470.0 | STATH | Statherin | 6779.0 | ENSG00000126549 | nan | nan
chr4	HTN3	142702.0 | HTN3, HTN2, HIS2 | Histatin-3 | 3347.0 | ENSG00000205649 | nan | nan
chr4	HTN1	142701.0 | HTN1 | Histatin-1 | 3346.0 | ENSG00000126550 | 3 genes in a 15kb segment | nan
chr4	ODAM	614843.0 | ODAM, APIN | Odontogenic ameloblast-associated protein | 54959.0 | ENSG00000109205 | nan | nan
chr4	FDCSP	607241.0 | FDCSP, C4orf7 | Follicular dendritic cell secreted protein | 260436.0 | ENSG00000181617 | nan | nan
chr4	CSN3	601695.0 | CSN3, CNS10, CSNK | Casein, kappa | 1448.0 | ENSG00000171209 | nan | nan
chr4	CABS1	618600.0 | CABS1, CLPH, C4orf35 | Calcium-binding protein, spermatid-associated 1 | 85438.0 | ENSG00000145309 | nan | nan
chr4	SMR3A	618340.0 | SMR3A, PBI | Submaxillary gland androgen-regulated protein 3A | 26952.0 | ENSG00000109208 | nan | nan
chr4	SMR3B	611593.0 | SMR3B, SMR1B, PRL3, PBII | Submaxillary gland androgen-regulated protein 3B | 10879.0 | ENSG00000171201 | nan | nan
chr4	OPRPN	608936.0 | OPRPN, PROL1, PRL1, BPLP | Opiorphin prepropeptide | 58503.0 | ENSG00000171199 | nan | nan
chr4	MUC7	158375.0 | MUC7 | Mucin 7, salivary | 4589.0 | ENSG00000171195 | nan | {Asthma, protection against}, 600807 (3), Autosomal dominant
chr4	AMTN	610912.0 | AMTN, AI3B | Amelotin | 401138.0 | ENSG00000187689 | mutation identified in 1 AI3B family | ?Amelogenesis imperfecta, type IIIB, 617607 (3), Autosomal dominant
chr4	AMBN	601259.0 | AMBN, AI1F | Ameloblastin | 258.0 | ENSG00000178522 | mutation identified in 1 AI1F family | Amelogenesis imperfecta, type IF, 616270 (3), Autosomal recessive
chr4	ENAM	606585.0 | ENAM, AIH2, AI1C | Enamelin | 10117.0 | ENSG00000132464 | nan | Amelogenesis imperfecta, type IC, 204650 (3), Autosomal recessive; Amelogenesis imperfecta, type IB, 104500 (3), Autosomal dominant
chr4	JCHAIN	147790.0 | JCHAIN, IGJ | Joining chain of multimeric IgA and IgM | 3512.0 | ENSG00000132465 | nan | nan
chr4	UTP3	611614.0 | UTP3, CRL1, CRLZ1 | UTP3 small subunit processome component | 57050.0 | ENSG00000132467 | nan | nan
chr4	RUFY3	611194.0 | RUFY3, SINGAR1, RIPX | FUN and FYVE domains-containing protein 3 | 22902.0 | ENSG00000018189 | nan | nan
chr4	GRSF1	604851.0 | GRSF1 | G-rich RNA sequence-binding factor 1 | 2926.0 | ENSG00000132463 | nan | nan
chr4	MOB1B	609282.0 | MOB1B, MOBKL1A, MATS2 | MOB kinase activator 1B | 92597.0 | ENSG00000173542 | nan | nan
chr4	DCK	125450.0 | DCK | Deoxycytidine kinase | 1633.0 | ENSG00000156136 | nan | nan
chr4	SLC4A4	603345.0 | SLC4A4, NBC1, KNBC, PRTAO | Solute carrier family 4, sodium bicarbonate cotransporter, member 4 | 8671.0 | ENSG00000080493 | nan | Proximal renal tubular acidosis-ocular anomaly syndrome, 604278 (3), Autosomal recessive
chr4	GC	139200.0 | GC, DBP | Group-specific component (vitamin D-binding protein) | 2638.0 | ENSG00000145321 | 4q13-q21.1 by in situ hybridization | nan
chr4	NPFFR2	607449.0 | NPFFR2, GPR74, NPFF2, NPGPR | Neuropeptide FF receptor 2 | 10886.0 | ENSG00000056291 | nan | nan
chr4	ADAMTS3	605011.0 | ADAMTS3, HKLLS3 | ADAM metallopeptidase with thrombospondin type 1 motif, 3 | 9508.0 | ENSG00000156140 | nan | Hennekam lymphangiectasia-lymphedema syndrome 3, 618154 (3), Autosomal recessive
chr4	COX18	610428.0 | COX18 | Cytochrome c oxidase assembly protein COX18 | 285521.0 | ENSG00000163626 | nan | nan
chr4	ANKRD17	615929.0 | ANKRD17, GTAR, CAGS | Ankyrin repeat domain-containing protein 17 | 26057.0 | ENSG00000132466 | nan | Chopra-Amiel-Gordon syndrome, 619504 (3), Autosomal dominant
chr4	ALB	103600.0 | ALB, ANALBA, FDAH, FDAHT | Albumin | 213.0 | ENSG00000163631 | mutation identified in 1 FDAHT family | ?[Dysalbuminemic hypertriiodothyroninemia], 615999 (3), Autosomal recessive, Autosomal dominant; Analbuminemia, 616000 (3), Autosomal recessive; [Dysalbuminemic hyperthyroxinemia], 615999 (3), Autosomal recessive, Autosomal dominant
chr4	AFP	104150.0 | AFP, HPAFP, AFPD | Alpha-fetoprotein | 174.0 | ENSG00000081051 | order: 5'-ALB-3'--5'-AFP-3' | [Hereditary persistence of alpha-fetoprotein], 615970 (3), Autosomal dominant; Alpha-fetoprotein deficiency, 615969 (3), Autosomal recessive
chr4	AFM	104145.0 | AFM, ALBA, ALB2 | Afamin | 173.0 | ENSG00000079557 | 10kb 3' of AFP | nan
chr4	RASSF6	612620.0 | RASSF6 | Ras association domain family, member 6 | 166824.0 | ENSG00000169435 | nan | nan
chr4	CXCL8	146930.0 | CXCL8, IL8, SCYB8, NAP1, GCP1 | Chemokine, CXC motif, ligand 8 | 3576.0 | ENSG00000169429 | nan | nan
chr4	CXCL6	138965.0 | CXCL6, SCYB6, GCP2 | Chemokine, C-X-C motif, ligand 6 (granulocyte chemotactic protein-2) | 6372.0 | ENSG00000124875 | nan | nan
chr4	PPBPP1	188035.0 | PPBPP1, PPBPL1, TGB2 | Pro-platelet basic protein pseudogene 1 | 728045.0 | nan | nan | nan
chr4	PF4V1	173461.0 | PF4V1 | Platelet factor 4, variant 1 (PF4-like) | 5197.0 | ENSG00000109272 | same region as PF4 and IP10 | nan
chr4	CXCL1	155730.0 | CXCL1, GRO1, MGSA | Chemokine, C-X-C, ligand 1 (GRO1 oncogene; melanoma growth stimulating activity, alpha) | 2919.0 | ENSG00000163739 | apparently cluster of 3 GRO genes | nan
chr4	PF4	173460.0 | PF4 | Platelet factor 4 | 5196.0 | ENSG00000163737 | 6kb from PF4V1 | nan
chr4	PPBP	121010.0 | PPBP, CXCL7, SCYB7, CTAP3, TGB | Pro-platelet basic protein | 5473.0 | ENSG00000163736 | less than 7kb from PF4 | nan
chr4	CXCL5	600324.0 | CXCL5, SCYB5, ENA78 | Chemokine, C-X-C motif, ligand 5 (epithelial-derived neutrophil-activating peptide 78) | 6374.0 | ENSG00000163735 | nan | nan
chr4	CXCL3	139111.0 | CXCL3, GRO3, MIP2B | Chemokine, C-X-C motif, ligand 3 (GRO3 oncogene) | 2921.0 | ENSG00000163734 | nan | nan
chr4	PPBPP2	611591.0 | PPBPP2, PPBPL2 | Pro-platelet basic protein pseudogene 2 | 10895.0 | ENSG00000290910 | nan | nan
chr4	CXCL2	139110.0 | CXCL2, GRO2, MIP2A | Chemokine, C-X-C motif, ligand 2 (GRO2 oncogene) | 2920.0 | ENSG00000081041 | nan | nan
chr4	MTHFD2L	614047.0 | MTHFD2L | Methylenetetrahydrofolate dehydrogenase 2-like, NADP(+)-dependent | 441024.0 | ENSG00000163738 | nan | nan
chr4	EPGN	618717.0 | EPGN, EPG | Epithelial mitogen | 255324.0 | ENSG00000182585 | nan | nan
chr4	EREG	602061.0 | EREG | Epiregulin | 2069.0 | ENSG00000124882 | nan | nan
chr4	AREG	104640.0 | AREG | Amphiregulin | 374.0 | ENSG00000109321 | nan | nan
chr4	BTC	600345.0 | BTC | Betacellulin | 685.0 | ENSG00000174808 | tightly linked to Areg in mouse | nan
chr4	PARM1	617688.0 | PARM1, CIPAR1 | Prostate androgen-regulated mucin-like protein 1 | 25849.0 | ENSG00000169116 | nan | nan
chr4		613509.0 | DEL4q21, C4DELq21 | Chromosome 4q21 deletion syndrome | nan | nan | contiguous gene deletion if at least 30 genes | Chromosome 4q21 deletion syndrome, 613509 (4), Isolated cases
chr4	FECB	134720.0 | FECB | Fecundity gene, Boorla, of sheep, homolog of | 7892.0 | nan | sheep chr.6 | nan
chr4	OFC4	608371.0 | OFC4 | Orofacial cleft 4 | 474387.0 | nan | nan | Orofacial cleft 4, 608371 (2)
chr4	PFM3	609566.0 | PFM3 | Parietal foramina 3 | 619475.0 | nan | maximum lod between D4S2986 and D4S421 | Parietal foramina 3, 609566 (2), Autosomal dominant
chr4	RCHY1	607680.0 | RCHY1, ZNF363, PIRH2, ARNIP | Ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase | 25898.0 | ENSG00000163743 | nan | nan
chr4	THAP6	612535.0 | THAP6 | THAP domain-containing protein 6 | 152815.0 | ENSG00000174796 | nan | nan
chr4	ODAPH	614829.0 | ODAPH, C4orf26 | Odontogenesis-associated phosphoprotein | 152816.0 | ENSG00000174792 | nan | Amelogenesis imperfecta, type IIA4, 614832 (3), Autosomal recessive
chr4	CDKL2	603442.0 | CDKL2, KKIAMRE, P56 | Cyclin-dependent kinase-like 2 | 8999.0 | ENSG00000138769 | nan | nan
chr4	G3BP2	620020.0 | G3BP2 | G3BP stress granule assembly factor 2 | 9908.0 | ENSG00000138757 | nan | nan
chr4	USO1	603344.0 | USO1, TAP, p115 | USO1 vesicle transport factor | 8615.0 | ENSG00000138768 | nan | nan
chr4	PPEF2	602256.0 | PPEF2 | Protein phosphatase, EF hand calcium-binding domain-2 | 5470.0 | ENSG00000156194 | nan | nan
chr4	NAAA	607469.0 | NAAA, ASAHL | N-acylethanolamine acid amidase | 27163.0 | ENSG00000138744 | nan | nan
chr4	CXCL9	601704.0 | CXCL9, MIG, SCYB9 | Chemokine, C-X-C motif, ligand 9 | 4283.0 | ENSG00000138755 | close to INP10 | nan
chr4	ART3	603086.0 | ART3 | ADP-ribosyltransferase 3 | 419.0 | ENSG00000156219 | nan | nan
chr4	CXCL10	147310.0 | CXCL10, INP10 | Chemokine, C-X-C motif, ligand 10 (interferon-inducible cytokine IP-10) | 3627.0 | ENSG00000169245 | ?involved in monocytic leukemia with t(4;11)(q21;q23) | nan
chr4	CXCL11	604852.0 | CXCL11, SCYB11, IP9, SCYB9B | Chemokine, C-X-C motif, ligand 11 | 6373.0 | ENSG00000169248 | nan | nan
chr4	NUP54	607607.0 | NUP54, DYT37 | Nucleoporin, 54kD | 53371.0 | ENSG00000138750 | nan | Dystonia 37, early-onset, with striatal lesions, 620427 (3), Autosomal recessive
chr4	SCARB2	602257.0 | SCARB2, CD36L2, LIMPII, AMRF, EPM4 | Scavenger receptor class B, member 2 | 950.0 | ENSG00000138760 | nan | Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3), Autosomal recessive
chr4	STBD1	607406.0 | GENEX3414 | Genethonin 1 | 8987.0 | ENSG00000118804 | nan | nan
chr4	SHROOM3	604570.0 | SHROOM3, SHRM, KIAA1481 | Shroom family member 3 | 57619.0 | ENSG00000138771 | nan | nan
chr4	SEPTIN11	612887.0 | SEPT11 | Septin 11 | 55752.0 | ENSG00000138758 | nan | nan
chr4	CCNI	618783.0 | CCNI | Cyclin I | 10983.0 | ENSG00000118816 | nan | nan
chr4	CCNG2	603203.0 | CCNG2 | Cyclin G2 | 901.0 | ENSG00000138764 | nan | nan
chr4	CXCL13	605149.0 | CXCL13, SCYB13, BCA1, BLC | Chemokine, C-X-C motif, ligand 13 | 10563.0 | ENSG00000156234 | nan | nan
chr4	CNOT6L	618069.0 | CNOT6L, CCR4B | CCR4-NOT transcription complex, subunit 6-like | 246175.0 | ENSG00000138767 | nan | nan
chr4	MRPL1	611821.0 | MRPL1 | Mitochondrial ribosomal protein L1 | 65008.0 | ENSG00000169288 | nan | nan
chr4	FRAS1	607830.0 | FRAS1, FRASRS1 | Fraser extracellular matrix complex subunit 1 | 80144.0 | ENSG00000138759 | nan | Fraser syndrome 1, 219000 (3), Autosomal recessive
chr4	ANXA3	106490.0 | ANXA3, ANX3 | Annexin A3 (lipocortin III) | 306.0 | ENSG00000138772 | nan | nan
chr4	BMP2K	617648.0 | BMP2K, BIKE | BMP2-inducible kinase | 55589.0 | ENSG00000138756 | nan | nan
chr4	PAQR3	614577.0 | PAQR3, RKTG | Progestin and ADIPOQ receptor family, member 3 | 152559.0 | ENSG00000163291 | nan | nan
chr4	NAA11	619432.0 | NAA11, ARD2, ARD1B | N-alpha-acetyltransferase 11, NatA catalytic subunit | 84779.0 | ENSG00000156269 | nan | nan
chr4	GK2	600148.0 | GK2, GKTA, GKP2 | Glycerol kinase 2 | 2712.0 | ENSG00000196475 | nan | nan
chr4	PCAT4	609717.0 | PCAT4, GDEP | Prostate cancer-associated transcript 4 | 118425.0 | ENSG00000251321 | nan | nan
chr4	ANTXR2	608041.0 | ANTXR2, CMG2, HFS | Anthrax toxin receptor 2 | 118429.0 | ENSG00000163297 | nan | Hyaline fibromatosis syndrome, 228600 (3), Autosomal recessive
chr4	PRDM8	616639.0 | PRDM8, EPM10 | PR domain-containing protein 8 | 56978.0 | ENSG00000152784 | mutation identified in 1 EPM10 family | ?Epilepsy, progressive myoclonic, 10, 616640 (3), Autosomal recessive
chr4	FGF5	165190.0 | FGF5, TCMGLY | Fibroblast growth factor-5 | 2250.0 | ENSG00000138675 | nan | Trichomegaly, 190330 (3), Autosomal recessive
chr4	BMP3	112263.0 | BMP3 | Bone morphogenetic protein-3 | 651.0 | ENSG00000152785 | nan | nan
chr4	PRKG2	601591.0 | PRKG2, PRKGR2, AMD4, SMDP | Protein kinase, cGMP-dependent, type II | 5593.0 | ENSG00000138669 | mutation identified in 1 SMDP family | Spondylometaphyseal dysplasia, Pagnamenta type, 619638 (3), Autosomal recessive; Acromesomelic dysplasia 4, 619636 (3), Autosomal recessive
chr4	RASGEF1B	614532.0 | RASGEF1B, GPIG4 | RASGEF domain family, member 1B | 153020.0 | ENSG00000138670 | nan | nan
chr4	HNRNPD	601324.0 | HNRPD, AUF1, AUF1A | Heterogeneous nuclear ribonucleoprotein D | 3184.0 | ENSG00000138668 | nan | nan
chr4	HNRNPDL	607137.0 | HNRNPDL, HNRPDL, JKTBP, LGMDD3 | Heterogeneous nuclear ribonucleoprotein D-like protein | 9987.0 | ENSG00000152795 | nan | Muscular dystrophy, limb-girdle, autosomal dominant 3, 609115 (3), Autosomal dominant
chr4	TMEM150C	617292.0 | TMEM150C, TTN3 | Transmembrane protein 150C | 441027.0 | ENSG00000249242 | nan | nan
chr4	SCD5	608370.0 | SCD5, ACOD4, DFNA79 | Stearoyl-CoA desaturase 5 | 79966.0 | ENSG00000145284 | mutation identified in 1 DFNA79 family | ?Deafness, autosomal dominant 79, 619086 (3), Autosomal dominant
chr4	SEC31A	610257.0 | SEC31A, SEC31L1, KIAA0905, NEDSOSB, HPBKS | SEC31 homolog A, COPII coat complex component | 22872.0 | ENSG00000138674 | mutation identified in 1 NEDSOSB family | ?Halperin-Birk syndrome, 618651 (3), Autosomal recessive
chr4	THAP9	612537.0 | THAP9 | THAP domain-containing protein 9 | 79725.0 | ENSG00000168152 | nan | nan
chr4	LIN54	613367.0 | LIN54 | lin-54 DREAM MuvB core complex component | 132660.0 | ENSG00000189308 | nan | nan
chr4	COPS4	616008.0 | COPS4, CSN4 | COP9 signalosome, subunit 4 | 51138.0 | ENSG00000138663 | nan | nan
chr4	PLAC8	607515.0 | PLAC8 | Placenta-specific gene 8 | 51316.0 | ENSG00000145287 | nan | nan
chr4	COQ2	609825.0 | COQ2, COQ10D1, MSA1 | Coenzyme Q2, polyprenyltransferase | 27235.0 | ENSG00000173085 | nan | {Multiple system atrophy, susceptibility to}, 146500 (3), Autosomal recessive, Autosomal dominant; Coenzyme Q10 deficiency, primary, 1, 607426 (3), Autosomal recessive
chr4	HPSE	604724.0 | HPSE, HSE1, HPA | Heparanase | 10855.0 | ENSG00000173083 | nan | nan
chr4	HELQ	606769.0 | HELQ, HEL308 | Helicase, POLQ-like | 113510.0 | ENSG00000163312 | nan | nan
chr4	MRPS18C	611983.0 | MRPS18C, MRPS18-1 | Mitochondrial ribosomal protein S18C | 51023.0 | ENSG00000163319 | 6 pseudogenes | nan
chr4	ABRAXAS1	611143.0 | ABRASAS1, FAM175A, CCDC98, ABRA1 | Abraxas 1, BRCA1 A complex subunit | 84142.0 | ENSG00000163322 | nan | nan
chr4	GPAT3	610958.0 | AGPAT9, GPAT3, MAG1 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | 84803.0 | ENSG00000138678 | nan | nan
chr4	NKX6-1	602563.0 | NKX6-1, NKX6A | NK6 homeobox 1 | 4825.0 | ENSG00000163623 | nan | nan
chr4	CDS1	603548.0 | CDS1 | CDP-diacylglycerol synthase 1 | 1040.0 | ENSG00000163624 | nan | nan
chr4	WDFY3	617485.0 | WDFY3, ALFY, BCHS, MCPH18 | WD repeat- and FYVE domain-containing protein 3 | 23001.0 | ENSG00000163625 | mutation identified in 1 MCPH18 family | ?Microcephaly 18, primary, autosomal dominant, 617520 (3), Autosomal dominant
chr4	ARHGAP24	610586.0 | ARHGAP24, RCGAP72, FILGAP | RHO GTPase-activating protein 24 | 83478.0 | ENSG00000138639 | nan | nan
chr4	MAPK10	602897.0 | MAPK10, PRKM10, JNK3 | Mitogen-activated protein kinase 10 | 5602.0 | ENSG00000109339 | nan | nan
chr4	PTPN13	600267.0 | PTPN13 | Protein tyrosine phosphatase, nonreceptor-type, 13 (APO-1/CD95 (Fas)-associated phosphatase) | 5783.0 | ENSG00000163629 | 633bp upstream of JNK3 | nan
chr4	SLC10A6	613366.0 | SLC10A6, SOAT | Solute carrier family 10 (sodium/bile acid cotransporter family), member 6 | 345274.0 | ENSG00000145283 | nan | nan
chr4	AFF1	159557.0 | AFF1, MLLT2, AF4 | AF4/FMR2 family, member 1 | 4299.0 | ENSG00000172493 | fuses with ALL1 | nan
chr4	ATOD8	613518.0 | ATOD8 | Dermatitis, atopic, 8 | 105463125.0 | nan | nan | {Dermatitis, atopic, susceptibility to, 8}, 613518 (2)
chr4	MUSQTL1	612343.0 | MUSQTL1 | Musical aptitude quantitative trait locus 1 | 100192307.0 | nan | near D4S423 and D4S2460 | [Musical aptitude QTL 1], 612343 (2)
chr4	MYP11	609994.0 | MYP11 | Myopia 11 | 594832.0 | nan | max lod at D4S1564 | Myopia 11, 609994 (2)
chr4	KLHL8	611967.0 | KLHL8, KIAA1378 | Kelch-like 8 | 57563.0 | ENSG00000145332 | nan | nan
chr4	HSD17B13	612127.0 | HSD17B13, SCDR9, FLDP | 17-beta-hydroxysteroid dehydrogenase XIII | 345275.0 | ENSG00000170509 | nan | {Fatty liver disease, protection from}, 620116 (3), Autosomal dominant
chr4	HSD17B11	612831.0 | HSD17B11, RETSDR2, PAN1B | 17-beta-hydroxysteroid dehydrogenase XI | 51170.0 | ENSG00000198189 | nan | nan
chr4	NUDT9	606022.0 | NUDT9 | Nudix hydrolase 9 | 53343.0 | ENSG00000170502 | nan | nan
chr4	SPARCL1	606041.0 | SPARCL1, HEVIN | SPARC-like protein 1 | 8404.0 | ENSG00000152583 | nan | nan
chr4	DSPP	125485.0 | DSPP, DPP, DGI1, DFNA39, DTDP2 | Dentin sialophosphoprotein | 1834.0 | ENSG00000152591 | nan | Dentinogenesis imperfecta, Shields type III, 125500 (3), Autosomal dominant; Dentinogenesis imperfecta, Shields type II, 125490 (3), Autosomal dominant; Dentin dysplasia, type II, 125420 (3), Autosomal dominant; Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3), Autosomal dominant
chr4	DMP1	600980.0 | DMP1, ARHR, ARHP | Dentin matrix acidic phosphoprotein | 1758.0 | ENSG00000152592 | nan | Hypophosphatemic rickets, AR, 241520 (3), Autosomal recessive
chr4	IBSP	147563.0 | IBSP | Integrin-binding sialoprotein (bone sialoprotein II) | 3381.0 | ENSG00000029559 | nan | nan
chr4	MEPE	605912.0 | MEPE | Matrix, extracellular, phosphoglycoprotein | 56955.0 | ENSG00000152595 | nan | nan
chr4	SPP1	166490.0 | SPP1, OPN | Secreted phosphoprotein-1 (osteopontin, bone sialoprotein) | 6696.0 | ENSG00000118785 | nan | nan
chr4	PKD2	173910.0 | PKD2 | Polycystin-2 | 5311.0 | ENSG00000118762 | nan | Polycystic kidney disease 2, 613095 (3), Autosomal dominant
chr4	ABCG2	603756.0 | ABCG2, BCRP, ABCP, UAQTL1, GOUT1 | ATP-binding cassette, subfamily G, member 2 | 9429.0 | ENSG00000118777 | nan | [Junior blood group system], 614490 (3); [Uric acid concentration, serum, QTL1], 138900 (3), ?Autosomal dominant
chr4	PPM1K	611065.0 | PPM1K, PP2CM, PTMP, MSUDMV | Protein phosphatase, PP2C domain-containing, 1K | 152926.0 | ENSG00000163644 | nan | Maple syrup urine disease, mild variant, 615135 (3), Autosomal recessive
chr4	HERC6	609249.0 | HERC6 | HECT domain and RCC1-like domain 6 | 55008.0 | ENSG00000138642 | nan | nan
chr4	HERC5	608242.0 | HERC5, CEB1 | HECT domain and RCC1-like domain 5 | 51191.0 | ENSG00000138646 | nan | nan
chr4	PIGY	610662.0 | PIGY, HPMRS6 | Phosphatidylinositol glycan, class Y | 84992.0 | ENSG00000255072 | nan | Hyperphosphatasia with impaired intellectual development syndrome 6, 616809 (3), Autosomal recessive
chr4	PYURF	619956.0 | PYURF, PREY, NDUFAFQ | PIGY upstream open reading frame | 100996939.0 | ENSG00000145337 | nan | nan
chr4	HERC3	605200.0 | HERC3 | HECT domain and RCC1-like domain 3 | 8916.0 | ENSG00000138641 | nan | nan
chr4	NAP1L5	612203.0 | NAP1L5, DRLM | Nucleosome assembly protein 1-like 5 | 266812.0 | ENSG00000177432 | nan | nan
chr4	FAM13A-AS1	613300.0 | FAM13AOS, FAM13A1OS | FAM13A opposite strand | 285512.0 | nan | overlaps with FAM13A | nan
chr4	FAM13A	613299.0 | FAM13A, FAM13A1, KIAA0914 | Family with sequence similarity 13, member A | 10144.0 | ENSG00000138640 | overlaps with FAM13AOS | nan
chr4	TIGD2	612973.0 | TIGD2 | TIGGER transposable element-derived gene 2 | 166815.0 | ENSG00000180346 | nan | nan
chr4	GPRIN3	611241.0 | GPRIN3, GRIN3 | GPRIN family, member 3 | 285513.0 | ENSG00000185477 | nan | nan
chr4	SNCA	163890.0 | SNCA, NACP, PARK1, PARK4 | Synuclein, alpha (non A4 component of amyloid precursor) | 6622.0 | ENSG00000145335 | nan | Dementia, Lewy body, 127750 (3), Autosomal dominant; Parkinson disease 1, 168601 (3), Autosomal dominant; Parkinson disease 4, 605543 (3), Autosomal dominant
chr4	MMRN1	601456.0 | MMRN1, ECM | Multimerin 1 | 22915.0 | ENSG00000138722 | nan | nan
chr4	CCSER1	618934.0 | CCSER1, FAM190A | Coiled-coil serine-rich protein 1 | 401145.0 | ENSG00000184305 | nan | nan
chr4	GRID2	602368.0 | GRID2, SCAR18 | Glutamate receptor, ionotropic, delta-2 | 2895.0 | ENSG00000152208 | nan | Spinocerebellar ataxia, autosomal recessive 18, 616204 (3), Autosomal recessive
chr4	ATOH1	601461.0 | ATOH1, ATH1, DFNA89 | Atonal bHLH transcription factor 1 | 474.0 | ENSG00000172238 | mutation identified in DFNA89 family | ?Deafness, autosomal dominant 89, 620284 (3), Autosomal dominant
chr4	SMARCAD1	612761.0 | SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS, HRZ | SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1 | 56916.0 | ENSG00000163104 | nan | Basan syndrome, 129200 (3), Autosomal dominant; Huriez syndrome, 181600 (3), Autosomal dominant; Adermatoglyphia, 136000 (3), Autosomal dominant
chr4	HPGDS	602598.0 | HPGDS, PGDS | Prostaglandin D2 synthase, hematopoietic | 27306.0 | ENSG00000163106 | nan | nan
chr4	PDLIM5	605904.0 | ENH | Enigma-like LIM domain protein | 10611.0 | ENSG00000163110 | nan | nan
chr4	BMPR1B	603248.0 | BMPR1B, ALK6, AMD3, BDA2, BDA1D | Bone morphogenetic protein receptor, type IB | 658.0 | ENSG00000138696 | nan | Acromesomelic dysplasia 3, 609441 (3), Autosomal recessive; Brachydactyly, type A2, 112600 (3), Autosomal dominant; Brachydactyly, type A1, D, 616849 (3), Autosomal dominant
chr4	UNC5C	603610.0 | UNC5C, UNC5H3 | unc-5 netrin receptor C | 8633.0 | ENSG00000182168 | nan | nan
chr4	PDHA2	179061.0 | PDHA2, SPGF70 | Pyruvate dehydrogenase E1, subunit alpha-2 | 5161.0 | ENSG00000163114 | nan | Spermatogenic failure 70, 619828 (3), Autosomal recessive
chr4	BTF3P13	603739.0 | BTF3P13, BTF3L3 | Basic transcription factor 3 pseudogene 13 | 132556.0 | nan | nan | nan
chr4	RAP1GDS1	179502.0 | RAP1GDS1 | RAP1, GTP-GDP dissociation stimulator 1 | 5910.0 | ENSG00000138698 | fusion partner with NUP98 in ALL | Alfadhel syndrome, 620655 (3), Autosomal recessive
chr4	TSPAN5	613136.0 | TSPAN5, NET4 | Tetraspanin 5 | 10098.0 | ENSG00000168785 | nan | nan
chr4	EIF4E	133440.0 | EIF4E, EIF4EL1, AUTS19 | Eukaryotic translation initiation factor 4E | 1977.0 | ENSG00000151247 | pseudogene on 20 | {Autism, susceptibility to, 19}, 615091 (3)
chr4	METAP1	610151.0 | METAP1, KIAA0094 | Methionyl aminopeptidase 1 | 23173.0 | ENSG00000164024 | nan | nan
chr4	ADH5	103710.0 | ADH5, FDH, AMEDS, BMFS7 | Alcohol dehydrogenase (class III), chi polypeptide | 128.0 | ENSG00000197894 | AMEDS is digenic with ALDH2 | AMED syndrome, digenic, 619151 (3), Digenic recessive
chr4	ADH4	103740.0 | ADH4 | Alcohol dehydrogenase (class II), pi polypeptide | 127.0 | ENSG00000198099 | nan | nan
chr4	ADH6	103735.0 | ADH6 | Alcohol dehydrogenase 6 (aldehyde reductase) | 130.0 | ENSG00000172955 | nan | nan
chr4	ADH1A	103700.0 | ADH1A, ADH1 | Alcohol dehydrogenase IA (class I), alpha polypeptide | 124.0 | ENSG00000187758 | nan | nan
chr4	ADH1B	103720.0 | ADH1B, ADH2 | Alcohol dehydrogenase IB (class I), beta polypeptide | 125.0 | ENSG00000196616 | nan | {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}, 103780 (3), Multifactorial; {Alcohol dependence, protection against}, 103780 (3), Multifactorial
chr4	ADH1C	103730.0 | ADH1C, ADH3 | Alcohol dehydrogenase IC (class I), gamma polypeptide | 126.0 | ENSG00000248144 | nan | {Alcohol dependence, protection against}, 103780 (3), Multifactorial; {Parkinson disease, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant
chr4	ADH7	600086.0 | ADH7 | Alcohol dehydrogenase-7 | 131.0 | ENSG00000196344 | nan | nan
chr4	TRMT10A	616013.0 | TRMT10A, RG9MTD2, MSSGM1 | tRNA methyltransferase 10A | 93587.0 | ENSG00000145331 | nan | Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3), Autosomal recessive
chr4	MTTP	157147.0 | MTTP | Microsomal triglyceride transfer protein, 88kD | 4547.0 | ENSG00000138823 | nan | Abetalipoproteinemia, 200100 (3), Autosomal recessive
chr4	C4orf54	617881.0 | C4orf54, LOC285556, FOPV | Chromosome 4 open reading frame 54 | 285556.0 | ENSG00000248713 | nan | nan
chr4	DAPP1	605768.0 | DAPP1, BAM32 | Dual adaptor of phosphotyrosine and 3-phosphoinositides 1 | 27071.0 | ENSG00000070190 | nan | nan
chr4	LAMTOR3	603296.0 | LAMTOR3, MP1, MAPBP | Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 3 | 8649.0 | ENSG00000109270 | nan | nan
chr4	DNAJB14	617487.0 | DNAJB14 | DNAJ/HSP40 homolog, subfamily B, member 14 | 79982.0 | ENSG00000164031 | nan | nan
chr4	H2AZ1	142763.0 | H2AZ1, H2AZ | H2A.Z variante histone 1 | 3015.0 | ENSG00000164032 | nan | nan
chr4	HWE2	613340.0 | HWE2 | Epilepsy, hot water, 2 | 100415904.0 | nan | between D4S1572 and D4S2277 | Epilepsy, hot water, 2, 613340 (2)
chr4	MGR1	157300.0 | MGR1, MA | Migraine with or without aura, susceptibility to, 1 | 192115.0 | nan | nan | {Migraine with or without aura, susceptibility to, 1}, 157300 (2), Autosomal dominant
chr4	OCA5	615312.0 | OCA5 | Albinism, oculocutaneous, type V | 101926885.0 | nan | max lod at D4S961 | Albinism, oculocutaneous, type V, 615312 (2), Autosomal recessive
chr4	DDIT4L	607730.0 | DDIT4L, REDD2 | DNA damage-inducible transcript 4-like | 115265.0 | ENSG00000145358 | nan | nan
chr4	EMCN	608350.0 | EMCN, EMCN2 | Endomucin | 51705.0 | ENSG00000164035 | nan | nan
chr4	PPP3CA	114105.0 | PPP3CA, PPP2B, CALNA, CNA1, DEE91, ACCIID | Protein phosphatase 3, catalytic subunit, alpha isoform (calcineurin A alpha) | 5530.0 | ENSG00000138814 | nan | Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development, 618265 (3), Autosomal dominant; Developmental and epileptic encephalopathy 91, 617711 (3), Autosomal dominant
chr4	BANK1	610292.0 | BANK1, FLJ20706, BANK | B-cell scaffold protein with ankyrin repeats 1 | 55024.0 | ENSG00000153064 | nan | nan
chr4	SLC39A8	608732.0 | SLC39A8, BIGM103, CDG2N | Solute carrier family 39 (zinc transporter), member 8 | 64116.0 | ENSG00000138821 | nan | Congenital disorder of glycosylation, type IIn, 616721 (3), Autosomal recessive
chr4	NFKB1	164011.0 | NFKB1, CVID12 | Nuclear factor kappa-B, subunit 1 (p105, p50) | 4790.0 | ENSG00000109320 | nan | Immunodeficiency, common variable, 12, 616576 (3), Autosomal dominant
chr4	MANBA	609489.0 | MANBA, MANB1 | Mannosidase, beta A, lysosomal | 4126.0 | ENSG00000109323 | linked in mouse to Adl-3 | Mannosidosis, beta, 248510 (3), Autosomal recessive
chr4	UBE2D3	602963.0 | UBE2D3, UBCH5C | Ubiquitin-conjugating enzyme E2 D3 | 7323.0 | ENSG00000109332 | nan | nan
chr4	CISD2	611507.0 | CISD2, WFS2, ZCD2, ERIS | CDGSH iron sulfur domain protein 2 | 493856.0 | ENSG00000145354 | nan | Wolfram syndrome 2, 604928 (3), Autosomal recessive
chr4	SLC9B1	611527.0 | NHEDC1 | Na+/H+ exchanger domain-containing protein 1 | 150159.0 | ENSG00000164037 | nan | nan
chr4	SLC9B2	611789.0 | NHEDC2, NHA2 | NA+/H+ exchanger domain-containing protein 2 | 133308.0 | ENSG00000164038 | nan | nan
chr4	CENPE	117143.0 | CENPE, MCPH13 | Centromere autoantigen E, 312kD | 1062.0 | ENSG00000138778 | mutation identified in 1 MCPH13 family | ?Microcephaly 13, primary, autosomal recessive, 616051 (3), Autosomal recessive
chr4	TACR3	162332.0 | TACR3, NK3R, HH11 | Tachykinin receptor 3 | 6870.0 | ENSG00000169836 | nan | Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3), Autosomal recessive
chr4	CXXC4	611645.0 | CXXC4, IDAX | CXXC finger protein 4 | 80319.0 | ENSG00000168772 | nan | nan
chr4	TET2	612839.0 | TET2, KIAA1546, MDS, IMD75 | tet methylcytosine dioxygenase 2 | 54790.0 | ENSG00000168769 | nan | Myelodysplastic syndrome, somatic, 614286 (3); Immunodeficiency 75, 619126 (3), Autosomal recessive
chr4	PPA2	609988.0 | PPA2, SCFI, SCFAI | Pyrophosphatase, inorganic, 2 | 27068.0 | ENSG00000138777 | mutation identified in 1 SCFAI family | ?Sudden cardiac failure, alcohol-induced, 617223 (3), Autosomal recessive; Sudden cardiac failure, infantile, 617222 (3), Autosomal recessive
chr4	ARHGEF38	619919.0 | ARHGEF38 | Rho guanine nucleotide exchange factor 38 | 54848.0 | ENSG00000236699 | nan | nan
chr4	INTS12	611355.0 | INTS12, INT12 | Integrator complex subunit 12 | 57117.0 | ENSG00000138785 | nan | nan
chr4	GSTCD	615912.0 | GSTCD | Glutathione S-transferase C-terminal domain-containing protein | 79807.0 | ENSG00000138780 | nan | nan
chr4	NPNT	610306.0 | NPNT, POEM | Nephronectin | 255743.0 | ENSG00000168743 | nan | nan
chr4	TBCK	616899.0 | TBCK, IHPRF3 | TBC1 domain-containing kinase | 93627.0 | ENSG00000145348 | nan | Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3), Autosomal recessive
chr4	AIMP1	603605.0 | AIMP1, SCYE1, EMAP2, EMAPII, HLD3 | ARS-interacting multifunctional protein 1 | 9255.0 | ENSG00000164022 | nan | Leukodystrophy, hypomyelinating, 3, 260600 (3), Autosomal recessive
chr4	ATFB5	611494.0 | ATFB5 | Atrial fibrillation, familial, 5 | 100188842.0 | nan | association with rs2200733 and rs10033464 | {Atrial fibrillation, familial, 5}, 611494 (2)
chr4	LGV1	152430.0 | LGV1 | Longevity 1, QTL | 140802.0 | nan | maximum lod at D4S1564 | [Longevity 1], 152430 (2)
chr4	DKK2	605415.0 | DKK2 | Dickkopf WNT signaling pathway inhibitor 2 | 27123.0 | ENSG00000155011 | nan | nan
chr4	PAPSS1	603262.0 | PAPSS1, ATPSK1 | 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (ATP sulfurylase/APS kinase-1) | 9061.0 | ENSG00000138801 | nan | nan
chr4	SGMS2	611574.0 | SGMS2, SMS2, CDL | Sphingomyelin synthase 2 | 166929.0 | ENSG00000164023 | nan | Calvarial doughnut lesions with bone fragility with or without spondylometaphyseal dysplasia, 126550 (3), Autosomal dominant
chr4	CYP2U1	610670.0 | CYP2U1, SPG56 | Cytochrome P450, family 2, subfamily U, polypeptide 1 | 113612.0 | ENSG00000155016 | nan | Spastic paraplegia 56, autosomal recessive, 615030 (3), Autosomal recessive
chr4	HADH	601609.0 | HADHSC, SCHAD, HHF4 | L-3-hydroxyacyl-CoA dehydrogenase, short chain | 3033.0 | ENSG00000138796 | nan | Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3), Autosomal recessive; 3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3), Autosomal recessive
chr4	LEF1	153245.0 | LEF1 | Lymphoid enhancer-binding factor-1 | 51176.0 | ENSG00000138795 | nan | nan
chr4	RPL34	616862.0 | RPL34 | Ribosomal protein L34 | 6164.0 | ENSG00000109475 | nan | nan
chr4	OSTC	619023.0 | OSTC | Oligosaccharyltransferase complex, noncatalytic subunit | 58505.0 | ENSG00000198856 | nan | nan
chr4	ETNPPL	614682.0 | AGXT2L1 | Alanine-glyoxylate aminotransferase 2-like 1 | 64850.0 | ENSG00000164089 | nan | nan
chr4	COL25A1	610004.0 | COL25A1, CLAC, CFEOM5 | Collagen, type XXV, alpha-1 polypeptide | 84570.0 | ENSG00000188517 | nan | Fibrosis of extraocular muscles, congenital, 5, 616219 (3), Autosomal recessive
chr4	SEC24B	607184.0 | SEC24B | SEC24-related gene family, member B | 10427.0 | ENSG00000138802 | nan | nan
chr4	MCUB	620702.0 | MCUB, CCDC109B | Mitochondrial calcium uniporter, dominant-negative subunit beta | 55013.0 | ENSG00000005059 | nan | nan
chr4	CASP6	601532.0 | CASP6, MCH2 | Caspase 6, apoptosis-related cysteine protease | 839.0 | ENSG00000138794 | nan | nan
chr4	PLA2G12A	611652.0 | PLA2G12A, GXII, ROSSY | Phospholipase A2, Group XIIA | 81579.0 | ENSG00000123739 | nan | nan
chr4	CFI	217030.0 | CFI, FI, AHUS3, ARMD13 | Complement factor I | 3426.0 | ENSG00000205403 | 40kb distal to EGF | {Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3), Autosomal dominant; {Macular degeneration, age-related, 13, susceptibility to}, 615439 (3), Autosomal dominant; Complement factor I deficiency, 610984 (3), Autosomal recessive
chr4	GAR1	606468.0 | GAR1, NOLA1 | GAR1 ribonucleoprotein | 54433.0 | ENSG00000109534 | nan | nan
chr4	RRH	605224.0 | RRH | Rhodopsin homolog, retinal pigment epithelium-derived (peropsin) | 10692.0 | ENSG00000180245 | nan | nan
chr4	LRIT3	615004.0 | LRIT3, FIGLER4, CSNB1F | Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 3 | 345193.0 | ENSG00000183423 | nan | Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3), Autosomal recessive
chr4	EGF	131530.0 | EGF, URG, HOMG4 | Epidermal growth factor (urogastrone) | 1950.0 | ENSG00000138798 | mutation identified in 1 HOMG4 family | ?Hypomagnesemia 4, renal, 611718 (3), Autosomal recessive
chr4	ELOVL6	611546.0 | ELOVL6, LCE, FACE | Elongation of very long chain fatty acids-like 6 | 79071.0 | ENSG00000170522 | nan | nan
chr4	ENPEP	138297.0 | ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | 2028.0 | ENSG00000138792 | nan | nan
chr4	PANCR	617286.0 | PANCR | PITX2 adjacent noncoding RNA | 110231149.0 | nan | nan | nan
chr4	PITX2	601542.0 | PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4 | Paired-like homeodomain transcription factor-2 | 5308.0 | ENSG00000164093 | nan | Ring dermoid of cornea, 180550 (3), Autosomal dominant; Axenfeld-Rieger syndrome, type 1, 180500 (3), Autosomal dominant; Anterior segment dysgenesis 4, 137600 (3), Autosomal dominant
chr4	MIR297	615520.0 | MIR297 | Micro RNA 297 | 100126354.0 | ENSG00000215961 | nan | nan
chr4	AP1AR	610851.0 | AP1AR, C4orf16, GBAR, 2C18 | Adaptor-related protein complex 1-associated regulatory protein | 55435.0 | ENSG00000138660 | nan | nan
chr4	TIFA	609028.0 | TIFA, T2BP | TRAF-interacting protein with forkhead-associated domain | 92610.0 | ENSG00000145365 | nan | nan
chr4	ALPK1	607347.0 | ALPK1, LAK, KIAA1527, ROSAH | Alpha-kinase 1 | 80216.0 | ENSG00000073331 | nan | ROSAH syndrome, 614979 (3), Autosomal dominant
chr4	NEUROG2	606624.0 | NEUROG2, NGN2, ATOH4 | Neurogenin 2 | 63973.0 | ENSG00000178403 | nan | nan
chr4	LARP7	612026.0 | LARP7, PIP7S, ALAZS | La ribonucleoprotein 7, transcriptional regulator | 51574.0 | ENSG00000174720 | nan | Alazami syndrome, 615071 (3), Autosomal recessive
chr4	MIR367	614600.0 | MIR367 | Micro RNA 367 | 442912.0 | ENSG00000199169 | nan | nan
chr4	MIR302D	614599.0 | MIR302D | Micro RNA 302D | 442896.0 | ENSG00000199145 | nan | nan
chr4	MIR302A	614596.0 | MIR302A | Micro RNA 302A | 407028.0 | ENSG00000207927 | nan | nan
chr4	MIR302C	614598.0 | MIR302C | Micro RNA 302C | 442895.0 | ENSG00000199102 | nan | nan
chr4	MIR302B	614597.0 | MIR302B | Micro RNA 302B | 442894.0 | ENSG00000284463 | nan | nan
chr4	ANK2	106410.0 | ANK2, LQT4 | Ankyrin-2, nonerythrocytic | 287.0 | ENSG00000145362 | nan | Long QT syndrome 4, 600919 (3), Autosomal dominant; Cardiac arrhythmia, ankyrin-B-related, 600919 (3), Autosomal dominant
chr4		620942.0 | SYISL | SYNPO2 intron sense-overlapping long noncoding RNA | nan | nan | nan | nan
chr4	CAMK2D	607708.0 | CAMK2D | Calcium/calmodulin-dependent protein kinase II-delta | 817.0 | ENSG00000145349 | nan | nan
chr4	ARSJ	610010.0 | ARSJ | Arylsulfatase J | 79642.0 | ENSG00000180801 | nan | nan
chr4	UGT8	601291.0 | UGT8, CGT | UDP glycosyltransferase 8 (cerebroside synthase) | 7368.0 | ENSG00000174607 | nan | nan
chr4	NDST4	615039.0 | NDST4 | N-deacetylase/N-sulfotransferase 4 | 64579.0 | ENSG00000138653 | nan | nan
chr4	TRAM1L1	617505.0 | TRAM1L1 | Translocation-associated membrane protein 1-like 1 | 133022.0 | ENSG00000174599 | nan | nan
chr4	NDST3	603950.0 | NDST3 | N-deacetylase/N-sulfotransferase 3 | 9348.0 | ENSG00000164100 | nan | nan
chr4	PRSS12	606709.0 | PRSS12, BSSP3, MRT1 | Protease, serine, 12 | 8492.0 | ENSG00000164099 | nan | Intellectual developmental disorder, autosomal recessive 1, 249500 (3), Autosomal recessive
chr4	METTL14	616504.0 | METTL14, KIAA1627 | Methyltransferase 14, N6-adenosine-methyltransferase subunit | 57721.0 | ENSG00000145388 | nan | nan
chr4	SEC24D	607186.0 | SEC24D, KIAA0755, CLCRP2 | SEC24-related gene family, member D | 9871.0 | ENSG00000150961 | nan | Cole-Carpenter syndrome 2, 616294 (3), Autosomal recessive
chr4	SYNPO2	620941.0 | SYNPO2 | Synaptopodin 2 | 171024.0 | ENSG00000172403 | nan | nan
chr4	MYOZ2	605602.0 | MYOZ2, CMH16 | Myozenin 2 | 51778.0 | ENSG00000172399 | nan | Cardiomyopathy, hypertrophic, 16, 613838 (3), Autosomal dominant
chr4	USP53	617431.0 | USP53, KIAA1350, PFIC7 | Ubiquitin-specific peptidase 53 | 54532.0 | ENSG00000145390 | nan | Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss, 619658 (3), Autosomal recessive
chr4	ARLN	620530.0 | C4orf3, ALN | Chromosome 4 open reading frame 3 | 401152.0 | ENSG00000164096 | nan | nan
chr4	FABP2	134640.0 | FABP2 | Fatty acid-binding protein, intestinal | 2169.0 | ENSG00000145384 | nan | nan
chr4	PDE5A	603310.0 | PDE5A | Phosphodiesterase 5A | 8654.0 | ENSG00000138735 | nan | nan
chr4	CELIAC6	611598.0 | CELIAC6, AIS5 | Celiac disease, susceptibility to, 6 | 100188846.0 | nan | nan | {Autoimmune disease, susceptibility to, 5}, 611598 (2); {Celiac disease, susceptibility to, 6}, 611598 (2)
chr4	IDDM23	612622.0 | IDDM23 | Diabetes mellitus, insulin-dependent, 23 | 100271697.0 | nan | associated with rs6534347 | {Diabetes mellitus, insulin-dependent, 23}, 612622 (2)
chr4	MRT29	614333.0 | MRT29 | Intellectual developmental disorder, autosomal recessive 29 | 100852393.0 | nan | between rs10518325 and rs10518608 | Intellectual developmental disorder, autosomal recessive 29, 614333 (2), Autosomal recessive
chr4	MAD2L1	601467.0 | MAD2L1 | Mitotic arrest-deficient 2-like 1 | 4085.0 | ENSG00000164109 | previously mapped to 5q23-q31 | nan
chr4	PRDM5	614161.0 | PRDM5, BCS2 | PR domain-containing protein 5 | 11107.0 | ENSG00000138738 | nan | Brittle cornea syndrome 2, 614170 (3), Autosomal recessive
chr4	NDNF	616506.0 | NDNF, C4orf31, NORD, HH25 | Neuron-derived neurotrophic factor | 79625.0 | ENSG00000173376 | nan | Hypogonadotropic hypogonadism 25 with anosmia, 618841 (3), Autosomal dominant
chr4	TNIP3	608019.0 | TNIP3, LIND | TNFAIP3-interacting protein 3 | 79931.0 | ENSG00000050730 | nan | nan
chr4	QRFPR	606925.0 | QRFPR, GPR103 | Pyroglutamylated RFamide peptide receptor | 84109.0 | ENSG00000186867 | nan | nan
chr4	ANXA5	131230.0 | ANXA5, ENX2, RPRGL3 | Annexin A5 (endonexin II) | 308.0 | ENSG00000164111 | nan | {Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3), Autosomal dominant
chr4	EXOSC9	606180.0 | EXOSC9, PMSCL1, PCH1D | Exosome component 9 | 5393.0 | ENSG00000123737 | nan | Pontocerebellar hypoplasia, type 1D, 618065 (3), Autosomal recessive
chr4	CCNA2	123835.0 | CCNA, CCN1 | Cyclin A | 890.0 | ENSG00000145386 | nan | nan
chr4	BBS7	607590.0 | BBS7 | BBS7 gene | 55212.0 | ENSG00000138686 | nan | Bardet-Biedl syndrome 7, 615984 (3), Autosomal recessive
chr4	TRPC3	602345.0 | TRPC3, TRP3, SCA41 | Transient receptor potential cation channel, subfamily C, member 3 | 7222.0 | ENSG00000138741 | mutation identified in one SCA41 patient | ?Spinocerebellar ataxia 41, 616410 (3), Autosomal dominant
chr4	BLTP1	611565.0 | BLTP1, KIAA1109, ALKKUCS | Bridge-like lipid transfer protein family, member 1 | 84162.0 | ENSG00000138688 | nan | Alkuraya-Kucinskas syndrome, 617822 (3), Autosomal recessive
chr4	ADAD1	614130.0 | ADAD1, TENR | Adenosine deaminase domain-containing protein 1, testis-specific | 132612.0 | ENSG00000164113 | nan | nan
chr4	IL2	147680.0 | IL2 | Interleukin-2 | 3558.0 | ENSG00000109471 | nan | nan
chr4	IL21	605384.0 | IL21, CVID11 | Interleukin 21 | 59067.0 | ENSG00000138684 | mutation identified in 1 CVID11 patient | ?Immunodeficiency, common variable, 11, 615767 (3), Autosomal recessive
chr4	BBS12	610683.0 | BBS12, FLJ35630, C4orf24 | BBS12 gene | 166379.0 | ENSG00000181004 | 1Mb centromeric to BBS | Bardet-Biedl syndrome 12, 615989 (3), Autosomal recessive
chr4	SF	111800.0 | SF | Stoltzfus blood group | 6420.0 | nan | ~25cM from MNSs | [Blood group, Stoltzfus system], 111800 (2)
chr4	FGF2	134920.0 | FGF2, FGFB | Fibroblast growth factor-2 (basic) | 2247.0 | ENSG00000138685 | many alternate names | nan
chr4	NUDT6	606261.0 | NUDT6, ASFGF2 | Nudix hydrolase 6 | 11162.0 | ENSG00000170917 | nan | nan
chr4	AFG2A	613940.0 | AFG2A, SPATA5, SPAF, NEDHSB | AFG2 AAA ATPase homolog A | 166378.0 | ENSG00000145375 | nan | Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities, 616577 (3), Autosomal recessive
chr4	SPRY1	602465.0 | SPRY1 | Sprouty RTK signaling antagonist 1 | 10252.0 | ENSG00000164056 | nan | nan
chr4	ANKRD50	619856.0 | ANKRD50 | Ankyrin repeat domain-containing protein 50 | 57182.0 | ENSG00000151458 | nan | nan
chr4	FAT4	612411.0 | FAT4, VMLDS2, HKLLS2 | FAT atypical cadherin 4 | 79633.0 | ENSG00000196159 | nan | Van Maldergem syndrome 2, 615546 (3), Autosomal recessive; Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3), Autosomal recessive
chr4	INTU	610621.0 | INTU, KIAA1284, PDZK6, SRTD20, OFD17 | Inturned planar cell polarity protein | 27152.0 | ENSG00000164066 | mutation identified in 1 SRTD20 patient and 1 OFD17 patient | ?Orofaciodigital syndrome XVII, 617926 (3), Autosomal recessive; ?Short-rib thoracic dysplasia 20 with polydactyly, 617925 (3), Autosomal recessive
chr4	SLC25A31	610796.0 | SLC25A31, ANT4, AAC4 | Solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 31 | 83447.0 | ENSG00000151475 | nan | nan
chr4	HSPA4L	619077.0 | HSPA4L, APG1 | Heat-shock protein family A (HSP70) member 4-like protein | 22824.0 | ENSG00000164070 | nan | nan
chr4	PLK4	605031.0 | PLK4, STK18, SAK, MCCRP2 | Polo-like kinase 4 (serine/threonine protein kinase-18) | 10733.0 | ENSG00000142731 | nan | Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3), Autosomal recessive
chr4	MFSD8	611124.0 | MFSD8, MGC33302, CLN7, CCMD | Major facilitator superfamily domain-containing protein 8 | 256471.0 | ENSG00000164073 | nan | Macular dystrophy with central cone involvement, 616170 (3), Autosomal recessive; Ceroid lipofuscinosis, neuronal, 7, 610951 (3), Autosomal recessive
chr4	LARP1B	620467.0 | LARP1B, LARP2 | La ribonucleoprotein 1B | 55132.0 | ENSG00000138709 | nan | nan
chr4	PGRMC2	607735.0 | PGRMC2 | Progesterone receptor membrane component 2 | 10424.0 | ENSG00000164040 | nan | nan
chr4	JADE1	610514.0 | PHF17, JADE1 | PHD finger protein 17 | 79960.0 | ENSG00000077684 | nan | nan
chr4	SCLT1	611399.0 | SCLT1, CAP1A | Sodium channel and clathrin linker 1 | 132320.0 | ENSG00000151466 | nan | nan
chr4	PCDH10	608286.0 | PCDH10, KIAA1400 | Protocadherin 10 | 57575.0 | ENSG00000138650 | nan | nan
chr4	PCDH18	608287.0 | PCDH18, KIAA1562 | Protocadherin 18 | 54510.0 | ENSG00000189184 | nan | nan
chr4	SLC7A11	607933.0 | SLC7A11, XCT | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 | 23657.0 | ENSG00000151012 | nan | nan
chr4	AAA2	609782.0 | AAA2 | Aortic aneurysm, familial abdominal 2 | 100505390.0 | nan | max lod at D4S1644 | Aortic aneurysm, familial abdominal 2, 609782 (2)
chr4	PAND3	609985.0 | PAND3 | Panic disorder 3 | 677663.0 | nan | max lod at D4S413 | Panic disorder 3, 609985 (2)
chr4	PSORS9	607857.0 | PSORS9 | Psoriasis susceptibility 9 | 359825.0 | nan | max lod at D4S1597 | {Psoriasis susceptibility 9}, 607857 (2)
chr4	STQTL12	612224.0 | STQTL12 | Stature quantitative trait locus 12 | 100301523.0 | nan | associated with rs6854783 | {Stature QTL 12}, 612224 (2)
chr4	NOCT	608468.0 | NOCT, CCRN4L, CCR4L, CCR4 | Nocturnin | 25819.0 | ENSG00000151014 | nan | nan
chr4	ELF2	619798.0 | ELF2, NERF | E74-like ETS transcription factor 2 | 1998.0 | ENSG00000109381 | nan | nan
chr4	MGARP	619684.0 | MGARP, OSAP, HUMMR | Mitochondria-localized glutamic acid-rich protein | 84709.0 | ENSG00000137463 | nan | nan
chr4	NDUFC1	603844.0 | NDUFC1 | NADH-ubiquinone oxidoreductase subunit C1 | 4717.0 | ENSG00000109390 | nan | nan
chr4	NAA15	608000.0 | NAA15, NARG1, NATH, MRD50 | N-alpha-acetyltransferase 15, NatA auxiliary subunit | 80155.0 | ENSG00000164134 | nan | Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities, 617787 (3), Autosomal dominant
chr4	RAB33B	605950.0 | RAB33B, SMC2 | Ras-associated protein RAB33B | 83452.0 | ENSG00000172007 | nan | Smith-McCort dysplasia 2, 615222 (3), Autosomal recessive
chr4	SETD7	606594.0 | SETD7, SET7, KIAA1717 | SET domain-containing protein 7 | 80854.0 | ENSG00000145391 | nan | nan
chr4	MGST2	601733.0 | MGST2, GST2 | Microsomal glutathione S-transferase 2 | 4258.0 | ENSG00000085871 | nan | nan
chr4	MAML3	608991.0 | MAML3, MAM2, KIAA1816 | Mastermind-like 3 | 55534.0 | ENSG00000196782 | nan | nan
chr4	CLGN	601858.0 | CLGN | Calmegin | 1047.0 | ENSG00000153132 | nan | nan
chr4	MGAT4D	610310.0 | MGAT4D, LOC152586 | MGAT4 family member D | 152586.0 | ENSG00000205301 | nan | nan
chr4	ELMOD2	610196.0 | ELMOD2 | ELMO domain-containing protein 2 | 255520.0 | ENSG00000179387 | nan | nan
chr4	UCP1	113730.0 | UCP1 | Uncoupling protein 1 (mitochondrial, proton carrier) | 7350.0 | ENSG00000109424 | nan | nan
chr4	TBC1D9	618035.0 | TBC1D9, KIAA0882 | TBC1 domain family member 9 | 23158.0 | ENSG00000109436 | nan | nan
chr4	ZNF330	609550.0 | ZNF330, NOA36 | Zinc finger protein 330 | 27309.0 | ENSG00000109445 | nan | nan
chr4	IL15	600554.0 | IL15 | Interleukin-15 | 3600.0 | ENSG00000164136 | nan | nan
chr4	INPP4B	607494.0 | INPP4B | Inositol polyphosphatase-4-phosphatase, type II, 105kD | 8821.0 | ENSG00000109452 | nan | nan
chr4	USP38	618322.0 | USP38 | Ubiquitin-specific protease 38 | 84640.0 | ENSG00000170185 | nan | nan
chr4	GAB1	604439.0 | GAB1, DFNB26 | Grb2-associated binding protein 1 | 2549.0 | ENSG00000109458 | mutation identified in 1 family | ?Deafness, autosomal recessive 26, 605428 (3), Autosomal recessive
chr4	SMARCA5	603375.0 | SMARCA5, SNF2H | SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 5 | 8467.0 | ENSG00000153147 | nan | nan
chr4	FREM3	608946.0 | FREM3 | FRAS1-related extracellular matrix protein 3 | 166752.0 | ENSG00000183090 | nan | nan
chr4	GYPE	138590.0 | GYPE, GPE | Glycophorin E | 2996.0 | ENSG00000197465 | tandem: 5'-GYPA-GYPB-GYPE-3'; ?4q31.1 | nan
chr4	GYPB	617923.0 | GYPB, SS | Glycophorin B | 2994.0 | ENSG00000250361 | nan | [Blood group, Ss], 111740 (3); {Malaria, resistance to}, 611162 (3)
chr4	GYPA	617922.0 | GYPA, MN, GPA | Glycophorin A | 2993.0 | ENSG00000170180 | nan | {Malaria, resistance to}, 611162 (3); [Blood group, MNSs system], 111300 (3)
chr4	HHIP	606178.0 | HHIP, HIP | Hedgehog-interacting protein | 64399.0 | ENSG00000164161 | nan | nan
chr4	ANAPC10	613745.0 | ANAPC10, DOC1, APC10 | Anaphase-promoting complex, subunit 10 | 10393.0 | ENSG00000164162 | nan | nan
chr4	ABCE1	601213.0 | ABCE1, RNASELI, RNS4I | ATP-binding cassette, subfamily E, member 1 (ribonuclease L inhibitor) | 6059.0 | ENSG00000164163 | nan | nan
chr4	OTUD4	611744.0 | OTUD4, KIAA1046, HIN1 | OTD domain-containing protein 4 | 54726.0 | ENSG00000164164 | nan | nan
chr4	SMAD1	601595.0 | SMAD1, MADH1, MADR1, BSP1 | SMAD family member 1 | 4086.0 | ENSG00000170365 | nan | nan
chr4	MMAA	607481.0 | MMAA | Metabolism of cobalamin associated A | 166785.0 | ENSG00000151611 | nan | Methylmalonic aciduria, vitamin B12-responsive, cblA type, 251100 (3), Autosomal recessive
chr4	ZNF827	617962.0 | ZNF827 | Zinc finger protein 827 | 152485.0 | ENSG00000151612 | nan | nan
chr4	LSM6	607286.0 | LSM6 | LSM6 protein | 11157.0 | ENSG00000164167 | nan | nan
chr4	SLC10A7	611459.0 | SLC10A7, SSASKS | Solute carrier family 10 (sodium/bile acid cotransporter family), member 7 | 84068.0 | ENSG00000120519 | nan | Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis, 618363 (3), Autosomal recessive
chr4	POU4F2	113725.0 | POU4F2, BRN3B | POU domain, class 4, transcription factor 2 | 5458.0 | ENSG00000151615 | nan | nan
chr4	TTC29	618735.0 | TTC29, SPGF42 | Tetratricopeptide repeat domain-containing protein 29 | 83894.0 | ENSG00000137473 | nan | Spermatogenic failure 42, 618745 (3), Autosomal recessive
chr4	EDNRA	131243.0 | EDNRA, MFDA | Endothelin receptor type A | 1909.0 | ENSG00000151617 | nan | {Migraine, resistance to}, 157300 (3), Autosomal dominant; Mandibulofacial dysostosis with alopecia, 616367 (3), Autosomal dominant
chr4	TMEM184C	613937.0 | TMEM184C, TMEM34 | Transmembrane protein 184C | 55751.0 | ENSG00000164168 | nan | nan
chr4	PRMT9	616125.0 | PRMT9, PRMT10 | Protein arginine methyltransferase 9 | 90826.0 | ENSG00000164169 | nan | nan
chr4	ARHGAP10	609746.0 | ARHGAP10, GRAF2, PSGAP | RHO GTPase-activating protein 10 | 79658.0 | ENSG00000071205 | nan | nan
chr4	NR3C2	600983.0 | NR3C2, MLR, MCR | Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor; aldosterone receptor) | 4306.0 | ENSG00000151623 | nan | Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3), Autosomal dominant; Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)
chr4	DCLK2	613166.0 | DCLK2, DCK2, CLIK2, CL2 | Doublecortin-like kinase 2 | 166614.0 | ENSG00000170390 | nan | nan
chr4	HSCR9	611644.0 | HSCR9 | Hirschsprung disease, susceptibility to, 9 | 100188850.0 | nan | between D4S3049 and D4S1566 | {Hirschsprung disease, susceptibility to, 9}, 611644 (2)
chr4	LRBA	606453.0 | LRBA, LBA, CDC4L, CVID8 | Lipopolysaccharide-responsive, beige-like anchor protein | 987.0 | ENSG00000198589 | nan | Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3), Autosomal recessive
chr4	MAB21L2	604357.0 | MAB21L2, MCSKS14 | mab-21 like 2 | 10586.0 | ENSG00000181541 | nan | Microphthalmia/coloboma and skeletal dysplasia syndrome, 615877 (3), Autosomal recessive, Autosomal dominant
chr4	RPS3A	180478.0 | RPS3A | Ribosomal protein S3a | 6189.0 | ENSG00000145425 | nan | nan
chr4	SNORD73A	603568.0 | SNORD73A, RNU73 | Small nucleolar RNA, C/D box 73A | 8944.0 | ENSG00000208797 | nan | nan
chr4	SH3D19	608674.0 | SH3D19, EBP | SH3 domain protein 19 | 152503.0 | ENSG00000109686 | fused with AML1 in t(4;21) | nan
chr4	GATB	603645.0 | GATB, PET112, COXPD41 | Glutamyl-tRNA amidotransferase, subunit B | 5188.0 | ENSG00000059691 | mutation identified in 1 COXPD41 family | ?Combined oxidative phosphorylation deficiency 41, 618838 (3), Autosomal recessive
chr4	FBXW7	606278.0 | FBXW7, AGO, CDC4, DEDHIL | F-box and WD40 domain protein 7 | 55294.0 | ENSG00000109670 | nan | Developmental delay, hypotonia, and impaired language, 620012 (3), Autosomal dominant
chr4	ARFIP1	605928.0 | ARFIP1 | ADP-ribosylation factor-interacting protein 1 | 27236.0 | ENSG00000164144 | nan | nan
chr4	FHDC1	620268.0 | FHDC1 | FH2 domain-containing protein 1 | 85462.0 | ENSG00000137460 | nan | nan
chr4	TRIM2	614141.0 | TRIM2, KIAA0517, CMT2R | Tripartite motif-containing protein 2 | 23321.0 | ENSG00000109654 | nan | Charcot-Marie-Tooth disease, type 2R, 615490 (3), Autosomal recessive
chr4	MND1	611422.0 | MND1 | Meiotic nuclear divisions 1 | 84057.0 | ENSG00000121211 | nan | nan
chr4	TMEM131L	616243.0 | TMEM131L, KIAA0922 | Transmembrane protein 131-like | 23240.0 | ENSG00000121210 | nan | nan
chr4	TLR2	603028.0 | TLR2, TIL4 | Toll-like receptor-2 | 7097.0 | ENSG00000137462 | nan | {Colorectal cancer, susceptibility to}, 114500 (3), Somatic mutation, Autosomal dominant; {Leprosy, susceptibility to}, 246300 (3), Autosomal dominant; {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)
chr4	SFRP2	604157.0 | SFRP2, SARP1 | Secreted frizzled-related protein 2 | 6423.0 | ENSG00000145423 | nan | nan
chr4	DCHS2	612486.0 | DCHS2, CDHJ, PCDHJ | Dachsous cadherin-related 2 | 54798.0 | ENSG00000197410 | nan | nan
chr4	PLRG1	605961.0 | PLRG1, PRL1 | Pleiotropic regulator 1 | 5356.0 | ENSG00000171566 | nan | nan
chr4	FGB	134830.0 | FGB | Fibrinogen, beta polypeptide | 2244.0 | ENSG00000171564 | 4q31 by A; proximal to GYPB/GYPA | Hypofibrinogenemia, congenital, 202400 (3), Autosomal recessive; Dysfibrinogenemia, congenital, 616004 (3), Autosomal dominant; Afibrinogenemia, congenital, 202400 (3), Autosomal recessive
chr4	FGA	134820.0 | FGA, AMYLD2 | Fibrinogen, alpha polypeptide | 2243.0 | ENSG00000171560 | nan | Amyloidosis, hereditary systemic 2, 105200 (3), Autosomal dominant; Hypodysfibrinogenemia, congenital, 616004 (3), Autosomal dominant; Dysfibrinogenemia, congenital, 616004 (3), Autosomal dominant; Afibrinogenemia, congenital, 202400 (3), Autosomal recessive
chr4	RP29	612165.0 | RP29 | Retinitis pigmentosa 29 | 54110.0 | nan | maximum lod at D4S415 | Retinitis pigmentosa 29, 612165 (2), Autosomal recessive
chr4		613603.0 | TRIP4q32.1q32.2, C4TRIPq32.1q32.2 | Chromosome 4q32.1-q32.2 triplication syndrome | nan | nan | nan | Chromosome 4q32.1-q32.2 triplication syndrome, 613603 (4), Autosomal dominant
chr4	FGG	134850.0 | FGG | Fibrinogen, gamma polypeptide | 2266.0 | ENSG00000171557 | linked to MN | Dysfibrinogenemia, congenital, 616004 (3), Autosomal dominant; Hypodysfibrinogenemia, 616004 (3), Autosomal dominant; Hypofibrinogenemia, congenital, 202400 (3), Autosomal recessive; Afibrinogenemia, congenital, 202400 (3), Autosomal recessive
chr4	LRAT	604863.0 | LRAT, LCA14 | Lecithin retinol acyltransferase | 9227.0 | ENSG00000121207 | nan | Leber congenital amaurosis 14, 613341 (3), Autosomal recessive; Retinal dystrophy, early-onset severe, 613341 (3), Autosomal recessive; Retinitis pigmentosa, juvenile, 613341 (3), Autosomal recessive
chr4	RBM46	620147.0 | RBM46 | RNA-binding motif protein 46 | 166863.0 | ENSG00000151962 | nan | nan
chr4	NPY2R	162642.0 | NPY2R | Neuropeptide Y receptor Y2 | 4887.0 | ENSG00000185149 | nan | nan
chr4	MAP9	610070.0 | ASAP | Aster-associated protein | 79884.0 | ENSG00000164114 | nan | nan
chr4	GUCY1A1	139396.0 | GUCY1A3, GUC1A3, GUCSA3, MYMY6 | Guanylate cyclase 1, soluble, alpha 3 | 2982.0 | ENSG00000164116 | nan | Moyamoya 6 with achalasia, 615750 (3), Autosomal recessive
chr4	GUCY1B1	139397.0 | GUCY1B3, GUC1B3, GUCSB3 | Guanylate cyclase 1, soluble, beta 3 | 2983.0 | ENSG00000061918 | nan | nan
chr4	ASIC5	616693.0 | ASIC5, HINAC | Acid-sensing ion channel family member 5 | 51802.0 | ENSG00000256394 | nan | nan
chr4	TDO2	191070.0 | TDO2, TPH2, TRPO, HYPTRP | Tryptophan oxygenase | 6999.0 | ENSG00000151790 | mutation identified in 1 HYPTRP patient | [?Hypertryptophanemia], 600627 (3), Autosomal recessive
chr4	CTSO	600550.0 | CTSO | Cathepsin O | 1519.0 | ENSG00000256043 | nan | nan
chr4	PDGFC	608452.0 | PDGFC | Platelet-derived growth factor C | 56034.0 | ENSG00000145431 | nan | nan
chr4	GLRB	138492.0 | GLRB, HKPX2 | Glycine receptor, beta subunit | 2743.0 | ENSG00000109738 | nan | Hyperekplexia 2, 614619 (3), Autosomal recessive
chr4	GRIA2	138247.0 | GRIA2, GLUR2, NEDLIB | Glutamate receptor, ionotropic, AMPA 2 | 2891.0 | ENSG00000120251 | nan | Neurodevelopmental disorder with language impairment and behavioral abnormalities, 618917 (3), Autosomal dominant
chr4	TMEM144	620325.0 | TMEM144 | Transmembrane protein 144 | 55314.0 | ENSG00000164124 | nan | nan
chr4	RXFP1	606654.0 | RXFP1, LGR7 | Relaxin/insulin-like family peptide receptor 1 | 59350.0 | ENSG00000171509 | nan | nan
chr4	C4orf46	616210.0 | C4orf46, RCDG1 | Chromosome 4 open reading frame 46 | 201725.0 | ENSG00000205208 | nan | nan
chr4	ETFDH	231675.0 | ETFDH, MADD | Electron transfer flavoprotein:ubiquinone oxidoreductase | 2110.0 | ENSG00000171503 | nan | Glutaric acidemia IIC, 231680 (3), Autosomal recessive
chr4	PPID	601753.0 | PPID | Peptidylprolyl isomerase D (cyclophilin D) | 5481.0 | ENSG00000171497 | nan | nan
chr4	FNIP2	612768.0 | FNIP2, FNIPL, KIAA1450 | Folliculin-interacting protein 2 | 57600.0 | ENSG00000052795 | nan | nan
chr4	RAPGEF2	609530.0 | RAPGEF2, NRAPGEP, RAGEF, KIAA0313 | Rap guanine nucleotide exchange factor 2 | 9693.0 | ENSG00000109756 | mutation identified in 1 FAME7 patient | ?Epilepsy, familial adult myoclonic, 7, 618075 (3), Autosomal dominant
chr4	FSTL5	620128.0 | FSTL5 | Follistatin-like 5 | 56884.0 | ENSG00000168843 | nan | nan
chr4	NAF1	617868.0 | NAF1, PFBMFT7 | Nuclear assembly factor 1 ribonucleoprotein | 92345.0 | ENSG00000145414 | nan | Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7, 620365 (3), Autosomal dominant
chr4	NPY1R	162641.0 | NPY1R | Neuropeptide Y receptor | 4886.0 | ENSG00000164128 | nan | nan
chr4	NPY5R	602001.0 | NPY5R | Neuropeptide Y receptor Y5 | 4889.0 | ENSG00000164129 | nan | nan
chr4	MARCHF1	613331.0 | MARCH1 | Membrane-associated RING-CH finger protein 1 | 55016.0 | ENSG00000145416 | nan | nan
chr4	CINN	611109.0 | CINN | Cinnamon odor, pleasantness of | 100188835.0 | nan | max lod at AFM295YES | [Cinnamon odor, pleasantness of], 611109 (2)
chr4	HDLCQ4	610239.0 | HDLCQ4 | High density lipoprotein cholesterol level QTL 4 | 100188806.0 | nan | between D4S1597 and D4S1539 | [High density lipoprotein cholesterol level QTL 4], 610239 (2)
chr4	ANP32CP	606877.0 | ANP32C, PP32R1 | Acidic leucine-rich nuclear phosphoprotein 32 family, member C | 23520.0 | nan | nan | nan
chr4	APELA	615594.0 | ELA, LOC100506013 | Elabela | 100506013.0 | ENSG00000248329 | nan | nan
chr4	TRIM61	619417.0 | TRIM61, RNF35 | Tripartite motif-containing protein 61 | 391712.0 | ENSG00000183439 | nan | nan
chr4	TRIM60	619416.0 | TRIM60, RNF33 | Tripartite motif-containing protein 60 | 166655.0 | ENSG00000176979 | nan | nan
chr4	TMEM192	620677.0 | TMEM192 | Transmembrane protein 192 | 201931.0 | ENSG00000170088 | nan | nan
chr4	KLHL2	605774.0 | KLHL2, MAYVEN | Kelch-like 2 | 11275.0 | ENSG00000109466 | nan | nan
chr4	MSMO1	607545.0 | MSMO1, SC4MOL, ERG25, MCCPD | Methylsterol monooxygenase 1 | 6307.0 | ENSG00000052802 | nan | Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3), Autosomal recessive
chr4	CPE	114855.0 | CPE, BDVS | Carboxypeptidase E | 1363.0 | ENSG00000109472 | nan | BDV syndrome, 619326 (3), Autosomal recessive
chr4	TLL1	606742.0 | TLL1, TLL, ASD6 | Tolloid-like 1 | 7092.0 | ENSG00000038295 | nan | Atrial septal defect 6, 613087 (3), Autosomal dominant
chr4	SPOCK3	607989.0 | SPOCK3 | SPARC/osteonectin, CWCV, and KAZAL-like domains proteoglycan 3 | 50859.0 | ENSG00000196104 | nan | nan
chr4	ANXA10	608008.0 | ANXA10 | Annexin A10 | 11199.0 | ENSG00000109511 | nan | nan
chr4	DDX60	613974.0 | DDX60 | DExD/H-box helicase 60 | 55601.0 | ENSG00000137628 | nan | nan
chr4	DDX60L	616725.0 | DDX60L | DExD/H-box 60 like | 91351.0 | ENSG00000181381 | nan | nan
chr4	PALLD	608092.0 | PALLD, KIAA0992, PNCA1 | Palladin, cytoskeletal-associated protein | 23022.0 | ENSG00000129116 | nan | {Pancreatic cancer, susceptibility to, 1}, 606856 (3), Autosomal dominant
chr4	CBR4	619394.0 | CBR4 | Carbonyl reductase 4 | 84869.0 | ENSG00000145439 | nan | nan
chr4	SH3RF1	618642.0 | SH3RF1, POSH, RNF142 | SH3 domain-containing RING finger protein 1 | 57630.0 | ENSG00000154447 | nan | nan
chr4	HCA1	607258.0 | HCA1 | Hypercalciuria, absorptive, 1 | 266790.0 | nan | nan | Hypercalciuria, absorptive, 607258 (2)
chr4	NEK1	604588.0 | NEK1, SRTD6, SRPS2A, ALS24, OFD2 | NIMA-related kinase 1 | 4750.0 | ENSG00000137601 | 1 patient showed heterozygous NEK2 and DYNC2H1 mutations; mutation identified in 1 OFD2 family | Short-rib thoracic dysplasia 6 with or without polydactyly, 263520 (3), Autosomal recessive, Digenic recessive; ?Orofaciodigital syndrome II, 252100 (3), Autosomal recessive; {Amyotrophic lateral sclerosis, susceptibility to, 24}, 617892 (3), Autosomal dominant
chr4	CLCN3	600580.0 | CLCN3, NEDHYBA, NEDSBA | Chloride channel-3 | 1182.0 | ENSG00000109572 | mutation identified in 1 NEDSBA family | Neurodevelopmental disorder with seizures and brain abnormalities, 619517 (3), Autosomal recessive; Neurodevelopmental disorder with hypotonia and brain abnormalities, 619512 (3), Autosomal dominant
chr4	HPF1	616614.0 | HPF1, C4orf27 | Histone PARylation factor 1 | 54969.0 | ENSG00000056050 | nan | nan
chr4	MFAP3L	616523.0 | MFAP3L, KIAA0626 | Microfibrillar-associated protein 3-like | 9848.0 | ENSG00000198948 | nan | nan
chr4	AADAT	611754.0 | AADAT, KAT2 | Alpha-aminoadipate aminotransferase | 51166.0 | ENSG00000109576 | nan | nan
chr4	GALNTL6	615138.0 | GALNTL6, GALNACT20 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 | 442117.0 | ENSG00000174473 | nan | nan
chr4	GALNT7	605005.0 | GALNT7 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 | 51809.0 | ENSG00000109586 | nan | nan
chr4	HMGB2	163906.0 | HMGB2, HMG2 | High-mobility group box 2 (high-mobility group (nonhistone chromosomal) protein 2) | 3148.0 | ENSG00000164104 | nan | nan
chr4	SAP30	603378.0 | SAP30 | SIN3-associated polypeptide, 30kD | 8819.0 | ENSG00000164105 | nan | nan
chr4	SCRG1	603163.0 | SCRG1 | Scraptie-responsive gene 1 | 11341.0 | ENSG00000164106 | nan | nan
chr4	HAND2	602407.0 | HAND2, DHAND2, DHAND | Heart- and neural crest derivative-expressed 2 | 9464.0 | ENSG00000164107 | nan | nan
chr4	HAND2-AS1	617240.0 | HAND2AS1, UPH, DEIN | HAND2 antisense RNA 1, noncoding (Upperhand) | 79804.0 | ENSG00000237125 | nan | nan
chr4	MORF4	116960.0 | MORF4, SEN1, CSRB | Mortality factor 4, pseudogene | 10934.0 | nan | nan | nan
chr4	FBXO8	605649.0 | FBXO8, FBX8, FBS | F-box only protein 8 | 26269.0 | ENSG00000164117 | nan | nan
chr4	CEP44	620217.0 | CEP44 | Centrosomal protein, 44kD | 80817.0 | ENSG00000164118 | nan | nan
chr4	MIR4276	616274.0 | MIR4276 | Micro RNA 4276 | 100423042.0 | ENSG00000265846 | nan | nan
chr4	HPGD	601688.0 | HPGD, PGDH1, PHOAR1 | Hydroxyprostaglandin dehydrogenase 15-(NAD) | 3248.0 | ENSG00000164120 | mutation identified in 1 DIGC family | ?Digital clubbing, isolated congenital, 119900 (3), Autosomal recessive; Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3), Autosomal recessive; Cranioosteoarthropathy, 259100 (3), Autosomal recessive
chr4	GLRA3	600421.0 | GLRA3 | Glycine receptor, alpha-3 polypeptide | 8001.0 | ENSG00000145451 | nan | nan
chr4	ADAM29	604778.0 | ADAM29 | ADAM metallopeptidase domain 29 | 11086.0 | ENSG00000168594 | nan | nan
chr4	GPM6A	601275.0 | GPM6A, M6A | Glycoprotein M6A | 2823.0 | ENSG00000150625 | nan | nan
chr4	WDR17	609005.0 | WDR17 | WD repeat-containing protein 17 | 116966.0 | ENSG00000150627 | nan | nan
chr4	SPATA4	609879.0 | SPATA4, TSARG2 | Spermatogenesis-associated protein 4 | 132851.0 | ENSG00000150628 | nan | nan
chr4	ASB5	615050.0 | ASB5 | Ankyrin repeat- and SOCS box-containing protein 5 | 140458.0 | ENSG00000164122 | nan | nan
chr4	SPCS3	618854.0 | SPCS3, SPC3, SPC22, SPC23 | Signal peptidase complex, subunit 3 | 60559.0 | ENSG00000129128 | nan | nan
chr4	HMSN5	600361.0 | HMSN5 | Hereditary motor and sensory neuropathy V | 101059903.0 | nan | D4S1552 and D4S2930 | Hereditary motor and sensory neuropathy V, 600361 (2), Autosomal dominant
chr4	SCA30	613371.0 | SCA30 | Spinocerebellar ataxia 30 | 100359393.0 | nan | between rs1397413 and rs2175476; max lod 3.0 | ?Spinocerebellar ataxia 30, 613371 (2), Autosomal dominant
chr4	VEGFC	601528.0 | VEGFC, VRP, LMPHM4 | Vascular endothelial growth factor C | 7424.0 | ENSG00000150630 | nan | Lymphatic malformation 4, 615907 (3), Autosomal dominant
chr4	NEIL3	608934.0 | NEIL3, NEI3, FGP2 | Endonuclease VIII-like 3 | 55247.0 | ENSG00000109674 | nan | nan
chr4	AGA	613228.0 | AGA | Aspartylglucosaminidase | 175.0 | ENSG00000038002 | nan | Aspartylglucosaminuria, 208400 (3), Autosomal recessive
chr4	TENM3	610083.0 | TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9, MCOPS15 | Teneurin transmembrane protein 3 | 55714.0 | ENSG00000218336 | mutation identified in 1 MCOPCB9 family | Microphthalmia, syndromic 15, 615145 (3), Autosomal recessive; ?Microphthalmia/coloboma 9, 615145 (3), Autosomal recessive
chr4	DFNA24	606282.0 | DFNA24 | Deafness, autosomal dominant 24 | 23723.0 | nan | nan | Deafness, autosomal dominant 24, 606282 (2), Autosomal dominant
chr4	DKBI	127600.0 | DKBI | Dyskeratosis, hereditary benign intraepithelial | 80870.0 | nan | nan | Dyskeratosis, hereditary benign intraepithelial, 127600 (2), Autosomal dominant
chr4		158900.0 | FSHD1, FSHD1A | Facioscapulohumeral muscular dystrophy 1 | nan | nan | due to D4Z4 macrosatellite repeat on 4q35 | Facioscapulohumeral muscular dystrophy 1, 158900 (4), Autosomal dominant
chr4	DCTD	607638.0 | DCTD | Deoxycytidylate deaminase | 1635.0 | ENSG00000129187 | nan | nan
chr4	WWC2	620110.0 | WWC2 | WW and C2 domains-containing protein 2 | 80014.0 | ENSG00000151718 | nan | nan
chr4	WWC2-AS1	620088.0 | WWC2AS1 | WWC2 antisense RNA 1, noncoding | 101928734.0 | ENSG00000251128 | nan | nan
chr4	CLDN22	620566.0 | CLDN22 | Claudin 22 | 53842.0 | ENSG00000177300 | nan | nan
chr4	CDKN2AIP	615914.0 | CDKN2AIP, CARF | Cyclin-dependent kinase inhibitor 2A-interacting protein | 55602.0 | ENSG00000168564 | nan | nan
chr4	ING2	604215.0 | ING2, ING1L | Inhibitor of growth 2 | 3622.0 | ENSG00000168556 | nan | nan
chr4	TRAPPC11	614138.0 | TRAPPC11, C4orf41, LGMDR18 | Trafficking protein particle complex, subunit 11 | 60684.0 | ENSG00000168538 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 18, 615356 (3), Autosomal recessive
chr4	STOX2	617359.0 | STOX2, KIAA1392 | Storkhead box 2 | 56977.0 | ENSG00000173320 | nan | nan
chr4	ENPP6	616983.0 | ENPP6 | Ectonucleotide pyrophosphatase/phosphodiesterase 6 | 133121.0 | ENSG00000164303 | nan | nan
chr4	IRF2	147576.0 | IRF2 | Interferon regulatory factor-2 | 3660.0 | ENSG00000168310 | nan | nan
chr4	CASP3	600636.0 | CASP3, CPP32 | Caspase 3, apoptosis-related cysteine protease | 836.0 | ENSG00000164305 | nan | nan
chr4	PRIMPOL	615421.0 | CCDC111, MYP22 | Coiled-coil domain containing 111 | 201973.0 | ENSG00000164306 | nan | Myopia 22, autosomal dominant, 615420 (3), Autosomal dominant
chr4	CENPU	611511.0 | MLF1IP, CENPU, CENP50 | MLF1-interacting protein (centromere protein U) | 79682.0 | ENSG00000151725 | nan | nan
chr4	ACSL1	152425.0 | ACSL1, FACL2, FACL1, LACS, ACS1 | Acyl-CoA synthetase long-chain family member 1 | 2180.0 | ENSG00000151726 | nan | nan
chr4	HELT	617546.0 | HELT, HESL, MGN | HELT basic helix-loop-helix transcription factor | 391723.0 | ENSG00000187821 | nan | nan
chr4	SLC25A4	103220.0 | SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2 | Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle) | 291.0 | ENSG00000151729 | nan | Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR, 615418 (3), Autosomal recessive; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3), Autosomal dominant; Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD, 617184 (3), Autosomal dominant
chr4	CFAP97	616047.0 | CFAP97, HMW, KIAA1430 | Cilia- and flagella-associated protein 97 | 57587.0 | ENSG00000164323 | nan | nan
chr4	SNX25	620961.0 | SNX25 | Sorting nexin 25 | 83891.0 | ENSG00000109762 | nan | nan
chr4	LRP2BP	619020.0 | LRP2BP, MEGBP | LRP2-binding protein | 55805.0 | ENSG00000109771 | nan | nan
chr4	ANKRD37	619021.0 | ANKRD37 | Ankyrin repeat domain-containing protein 37 | 353322.0 | ENSG00000186352 | nan | nan
chr4	UFSP2	611482.0 | UFSP2, C4orf20, BHD, SEMDDR, DEE106 | UFM1-specific peptidase 2 | 55325.0 | ENSG00000109775 | mutation identified in 1 BHD family | ?Hip dysplasia, Beukes type, 142669 (3), Autosomal dominant; Spondyloepimetaphyseal dysplasia, Di Rocco type, 617974 (3), Autosomal dominant; Developmental and epileptic encephalopathy 106, 620028 (3), Autosomal recessive
chr4	CCDC110	609488.0 | KMHN1 | Cancer/testis antigen KM-HN-1 | 256309.0 | ENSG00000168491 | nan | nan
chr4	PDLIM3	605889.0 | ALP | Actinin-associated LIM protein | 27295.0 | ENSG00000154553 | nan | nan
chr4	SORBS2	616349.0 | SORBS2, ARGBP2, KIAA0777 | Sorbin and SH3 domains-containing protein 2 | 8470.0 | ENSG00000154556 | nan | nan
chr4	TLR3	603029.0 | TLR3, IMD83 | Toll-like receptor-3 | 7098.0 | ENSG00000164342 | nan | {HIV1 infection, resistance to}, 609423 (3); {Immunodeficiency 83, susceptibility to viral infections}, 613002 (3), Autosomal recessive, Autosomal dominant
chr4	CYP4V2	608614.0 | CYP4V2, BCD | Cytochrome P450, family 4, subfamily V, polypeptide 2 | 285440.0 | ENSG00000145476 | nan | Bietti crystalline corneoretinal dystrophy, 210370 (3), Autosomal recessive
chr4	KLKB1	229000.0 | KLKB1, KLK3, PKKD | Kallikrein B plasma 1 (Fletcher factor) | 3818.0 | ENSG00000164344 | similar to F11 | Fletcher factor (prekallikrein) deficiency, 612423 (3), Autosomal recessive
chr4	F11	264900.0 | F11 | Coagulation factor XI (plasma thromboplastin antecedent) | 2160.0 | ENSG00000088926 | not closely linked to MNS | Factor XI deficiency, autosomal dominant, 612416 (3); Factor XI deficiency, autosomal recessive, 612416 (3)
chr4	MTNR1A	600665.0 | MTNR1A | Melatonin receptor 1A | 4543.0 | ENSG00000168412 | nan | nan
chr4	FAT1	600976.0 | FAT1, FAT | FAT atypical cadherin 1 | 2195.0 | ENSG00000083857 | nan | nan
chr4	ZFP42	614572.0 | ZFP42, REX1 | Zinc finger protein 42 | 132625.0 | ENSG00000179059 | nan | nan
chr4	TRIML2	620480.0 | TRIML2 | Tripartite motif family like-protein 2 | 205860.0 | ENSG00000179046 | nan | nan
chr4	TRIML1	620979.0 | TRIML1 | Tripartite motif family-like protein 1 | 339976.0 | ENSG00000184108 | nan | nan
chr4	FRG1	601278.0 | FRG1, FSG1 | Facioscapulohumeral muscular dystrophy region gene-1 | 2483.0 | ENSG00000109536 | nan | nan
chr4	DUX4L9	615581.0 | DUX4L9, DUX4C | Double homeobox 4-like 9 | 100288711.0 | ENSG00000224807 | nan | nan
chr4	FRG2	609032.0 | FRG2 | Facioscapulohumeral muscular dystrophy region gene 2 | 448831.0 | ENSG00000205097 | nan | nan
chr4	DBET	614865.0 | DBET | D4A4 binding element transcript, noncoding | 100419743.0 | ENSG00000281591 | nan | nan
chr4	DUX4L8	611442.0 | DUX2 | Double homeobox protein 2 | 26583.0 | ENSG00000281720 | ?10q26.3 | nan
chr4	DUX4	606009.0 | DUX4 | Double homeobox protein 4 | 100288687.0 | ENSG00000260596 | nan | nan
chr4	TS13	187320.0 | TS13 | Temperature sensitivity complementation, ts13 | 7896.0 | nan | nan | nan
chr5	ASD1	108800.0 | ASD1 | Atrial septal defect 1 | 431.0 | nan | max lod at D5S406 | Atrial septal defect 1, 108800 (2), Autosomal dominant
chr5	BCC3	613059.0 | BCC3 | Basal cell carcinoma, susceptibility to, 3 | 100307120.0 | nan | nan | {Basal cell carcinoma, susceptibility to, 3}, 613059 (2)
chr5	GLM8	613033.0 | GLM8 | Glioma susceptibility 8 | 100316847.0 | nan | associated with rs2736100 | {Glioma susceptibility 8}, 613033 (2)
chr5	LNCR3	612571.0 | LNCR3 | Lung cancer susceptibility 3 | 100271687.0 | nan | associated with rs402710 and rs2736100 | {Lung cancer susceptibility 3}, 612571 (2)
chr5	MHS6	601888.0 | MHS6 | Malignant hyperthermia susceptibility 6 | 4266.0 | nan | nan | {Malignant hyperthermia susceptibility 6}, 601888 (2)
chr5	MYP16	612554.0 | MYP16 | Myopia 16 | 100270641.0 | nan | max lod at D5S2505 | Myopia 16, 612554 (2)
chr5	TST2	613637.0 | TST2 | Tuberculin skin test reactivity quantitative trait locus | 100526823.0 | nan | max lod at 16:2.70Mb | [Tuberculin skin test reactivity QTL], 613637 (2)
chr5	PLEKHG4B	620665.0 | PLEKHG4B | Pleckstrin homology domain- and RhoGEF domain-containing protein G4B | 153478.0 | ENSG00000153404 | nan | nan
chr5	SDHA	600857.0 | SDHA, SDH1, SDHF, CMD1GG, PPGL5, MC2DN1, NDAXOA | Succinate dehydrogenase complex, flavoprotein subunit A | 6389.0 | ENSG00000073578 | copy on 3q29 | Cardiomyopathy, dilated, 1GG, 613642 (3), Autosomal recessive; Mitochondrial complex II deficiency, nuclear type 1, 252011 (3), Autosomal recessive; Neurodegeneration with ataxia and late-onset optic atrophy, 619259 (3), Autosomal dominant; Pheochromocytoma/paraganglioma syndrome 5, 614165 (3), Autosomal dominant
chr5	PDCD6	601057.0 | PDCD6, ALG2 | Programmed cell death 6 | 10016.0 | ENSG00000249915 | nan | nan
chr5	AHRR	606517.0 | AHRR, KIAA1234 | Arylhydrocarbon receptor repressor | 57491.0 | ENSG00000063438 | nan | nan
chr5	EXOC3	608186.0 | EXOC3, SEC6 | Exocyst complex component 3 | 11336.0 | ENSG00000180104 | nan | nan
chr5	SLC9A3	182307.0 | SLC9A3, NHE3, DIAR8 | Solute carrier family 9 (sodium/hydrogen exchanger), member 3 | 6550.0 | ENSG00000066230 | pseudogene on chr.10 | Diarrhea 8, secretory sodium, congenital, 616868 (3), Autosomal recessive
chr5	CEP72	616475.0 | CEP72, KIAA1519 | Centrosomal protein, 72kD | 55722.0 | ENSG00000112877 | nan | nan
chr5	TPPP	608773.0 | TPPP, P25, P24 | Tubulin polymerization-promoting protein | 11076.0 | ENSG00000171368 | nan | nan
chr5	BRD9	618465.0 | BRD9 | Bromodomain-containing protein 9 | 65980.0 | ENSG00000028310 | nan | nan
chr5	TRIP13	604507.0 | TRIP13, 16E1BP, MVA3, OZEMA9 | Thyroid hormone receptor interactor 13 | 9319.0 | ENSG00000071539 | nan | Oocyte/zygote/embryo maturation arrest 9, 619011 (3), Autosomal recessive; Mosaic variegated aneuploidy syndrome 3, 617598 (3), Autosomal recessive
chr5	NKD2	607852.0 | NKD2 | NKD inhibitor of WNT signaling pathway 2 | 85409.0 | ENSG00000145506 | nan | nan
chr5	SLC12A7	604879.0 | SLC12A7, KCC4 | Solute carrier family 12 (potassium/chloride transporters), member 7 | 10723.0 | ENSG00000113504 | nan | nan
chr5	SLC6A19	608893.0 | SLC6A19, HND | Solute carrier family 6 (neurotransmitter transporter), member 19 | 340024.0 | ENSG00000174358 | nan | Hartnup disorder, 234500 (3), Autosomal recessive
chr5	SLC6A18	610300.0 | SLC6A18, XTRP2 | Solute carrier family 6 (neurotransmitter transporter), member 18 | 348932.0 | ENSG00000164363 | nan | nan
chr5	TERT	187270.0 | TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9 | Telomerase reverse transcriptase | 7015.0 | ENSG00000164362 | deleted in cri du chat | Dyskeratosis congenita, autosomal dominant 2, 613989 (3), Autosomal recessive, Autosomal dominant; Dyskeratosis congenita, autosomal recessive 4, 613989 (3), Autosomal recessive, Autosomal dominant; Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 1, 614742 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 9}, 615134 (3), Autosomal dominant; {Leukemia, acute myeloid}, 601626 (3), Somatic mutation, Autosomal dominant
chr5	CLPTM1L	612585.0 | CLPTM1L, CRR9 | CLPTM1-like protein | 81037.0 | ENSG00000049656 | nan | nan
chr5	SLC6A3	126455.0 | SLC6A3, DAT1, PKDYS1 | Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 6531.0 | ENSG00000142319 | nan | Parkinsonism-dystonia, infantile, 1, 613135 (3), Autosomal recessive; {Nicotine dependence, protection against}, 188890 (3)
chr5	LPCAT1	610472.0 | AYTL2, LPCAT, LPCAT1 | Acyltransferase-like 2 | 79888.0 | ENSG00000153395 | nan | nan
chr5	MRPL36	611842.0 | MRPL36 | Mitochondrial ribosomal protein L36 | 64979.0 | ENSG00000171421 | nan | nan
chr5	NDUFS6	603848.0 | NDUFS6, MC1DN9 | NADH-ubiquinone oxidoreductase subunit S6 | 4726.0 | ENSG00000145494 | nan | Mitochondrial complex I deficiency, nuclear type 9, 618232 (3), Autosomal recessive
chr5	IRX4	606199.0 | IRX4 | Iroquois homeobox protein 4 | 50805.0 | ENSG00000113430 | nan | nan
chr5	LSINCT5	615764.0 | LSINCT5 | Long stress-induced noncoding transcript 5 | 101234261.0 | ENSG00000281560 | nan | nan
chr5	IRX2	606198.0 | IRX2 | Iroquois homeobox protein 2 | 153572.0 | ENSG00000170561 | nan | nan
chr5	IRX2-DT	610522.0 | CEI | Coordinated expression to IRXA2 | 153571.0 | nan | nan | nan
chr5	IRX1	606197.0 | IRX1 | Iroquois homeobox protein 1 | 79192.0 | ENSG00000170549 | nan | nan
chr5		608850.0 | MCDR3 | Macular dystrophy, retinal, 3 | nan | nan | duplication of cis regulatory element cCRE10 downstream of IRX1 | Macular dystrophy, retinal, 3, 608850 (4), Autosomal dominant
chr5	ADAMTS16	607510.0 | ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | 170690.0 | ENSG00000145536 | nan | nan
chr5	ICE1	617958.0 | ICE1, KIAA0947 | Interactor of little elongation complex ELL subunit 1 | 23379.0 | ENSG00000164151 | nan | nan
chr5	MED10	612382.0 | MED10, NUT2 | Mediator complex subunit 10 | 84246.0 | ENSG00000133398 | nan | nan
chr5	UBE2QL1	615832.0 | UBE2QL1 | Ubiquitin-conjugating enzyme E2Q family-like protein 1 | 134111.0 | ENSG00000215218 | nan | nan
chr5	LINC01018	616385.0 | LINC01018, SRHC | Long intergenic noncoding RNA 1018 | 255167.0 | ENSG00000250056 | nan | nan
chr5	NSUN2	610916.0 | NSUN2, TRM4, SAKI, MISU, MRT5 | NOP2/SUN RNA methyltransferase family, member 2 | 54888.0 | ENSG00000037474 | nan | Intellectual developmental disorder, autosomal recessive 5, 611091 (3), Autosomal recessive
chr5	SRD5A1	184753.0 | SRD5A1 | Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) | 6715.0 | ENSG00000145545 | pseudogene on X | nan
chr5	TENT4A	605198.0 | TENT4A, POLS, TRF4, POLK | Terminal nucleotidyltransferase 4A | 11044.0 | ENSG00000112941 | nan | nan
chr5	ADCY2	103071.0 | ADCY2 | Adenylyl cyclase-2, brain | 108.0 | ENSG00000078295 | nan | nan
chr5	MTRR	602568.0 | MTRR | Methionine synthase reductase | 4552.0 | ENSG00000124275 | nan | Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3), Autosomal recessive; {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive
chr5	FASTKD3	617530.0 | FASTKD3 | Fast kinase domains 3 | 79072.0 | ENSG00000124279 | nan | nan
chr5	SEMA5A	609297.0 | SEMA5A, SEMF | Semaphorin 5a | 9037.0 | ENSG00000112902 | nan | nan
chr5	TAS2R1	604796.0 | TRB7, T2R1 | Taste receptor, family B, member 7 | 50834.0 | ENSG00000169777 | nan | nan
chr5	ADIPQTL2	606770.0 | ADIPQTL2, CAQ5 | Adiponectin, serum level of, QTL 2 | 171511.0 | nan | near D5S817 | {Adiponectin, serum level of, QTL2}, 606770 (2)
chr5	ANIB4	610213.0 | ANIB4 | Aneurysm, intracranial berry, 4 | 724058.0 | nan | max lod at D5S1954 | Aneurysm, intracranial berry, 4, 610213 (2)
chr5	ATPSCKMT	618568.0 | ATPSCKMT, FAM173B | ATP synthase C subunit lysine N-methyltransferase | 134145.0 | ENSG00000150756 | nan | nan
chr5	CCT5	610150.0 | CCT5, KIAA0098, CCTE, HSNSP | chaperonin containing TCP1, subunit 5 (epsilon) | 22948.0 | ENSG00000150753 | mutation identified in 1 HSNSP family | ?Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3), Autosomal recessive
chr5	CMBL	613379.0 | CMBL | Carboxymethylenebutenolidase-like protein | 134147.0 | ENSG00000164237 | nan | nan
chr5	MARCHF6	613297.0 | MARCH6, TEB4, DOA10, KIAA0597, FAME3 | Membrane-associated RING-CH finger protein 6 | 10299.0 | ENSG00000145495 | nan | Epilepsy, familial adult myoclonic, 3, 613608 (3), Autosomal dominant
chr5	ROPN1L	611756.0 | ROPN1L, ASP | ROPN1-like protein | 83853.0 | ENSG00000145491 | nan | nan
chr5	DAP	600954.0 | DAP | Death-associated protein | 1611.0 | ENSG00000112977 | nan | nan
chr5	CTNND2	604275.0 | CTNND2, NPRAP | Catenin, delta-2 | 1501.0 | ENSG00000169862 | nan | nan
chr5	LINC01194	617097.0 | LINC01194, TAG | Long intergenic noncoding RNA 1194 | 404663.0 | ENSG00000248131 | nan | nan
chr5	DNAH5	603335.0 | DNAH5, HL1, PCD, CILD3 | Dynein, axonemal, heavy chain 5 | 1767.0 | ENSG00000039139 | nan | Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3), Autosomal recessive
chr5	TRIO	601893.0 | TRIO, MRD44, MRD63 | Triple functional domain | 7204.0 | ENSG00000038382 | nan | Intellectual developmental disorder, autosomal dominant 44, with microcephaly, 617061 (3), Autosomal dominant; Intellectual developmental disorder, autosomal dominant 63, with macrocephaly, 618825 (3), Autosomal dominant
chr5	OTULIN	615712.0 | OTULIN, FAM105B, GUM, AIPDS, IMD107 | OTU deubiquitinase with linear linkage specificity | 90268.0 | ENSG00000154124 | nan | Autoinflammation, panniculitis, and dermatosis syndrome, 617099 (3), Autosomal recessive; {Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection}, 619986 (3), Autosomal dominant
chr5	ANKH	605145.0 | ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD | ANKH inorganic pyrophosphate transport regulator | 56172.0 | ENSG00000154122 | nan | Chondrocalcinosis 2, 118600 (3), Autosomal dominant; Craniometaphyseal dysplasia, 123000 (3), Autosomal dominant
chr5	MYP19	613969.0 | MYP19 | Myopia 19, autosomal dominant | 100653370.0 | nan | highest lod at D5S419 | Myopia 19, 613969 (2), Autosomal dominant
chr5	PVNH3	608098.0 | PVNH3 | Periventricular nodular heterotopia 3 | 100302681.0 | nan | nan | Periventricular nodular heterotopia 3, 608098 (2)
chr5	FBXL7	605656.0 | FBXL7, FBL7 | F-box and leucine-rich repeat protein 7 | 23194.0 | ENSG00000183580 | nan | nan
chr5	MIR887	620117.0 | MIR887 | Micro RNA 887 | 100126347.0 | ENSG00000216077 | nan | nan
chr5	MARCHF11	613338.0 | MARCH11 | Membrane-associated RING-CH finger protein 11 | 441061.0 | ENSG00000183654 | nan | nan
chr5	ZNF622	608694.0 | ZNF622, ZPR9 | Zinc finger protein 622 | 90441.0 | ENSG00000173545 | nan | nan
chr5	RETREG1	613114.0 | RETREG1, FAM134B, HSAN2B | Reticulophagy regulator 1 | 54463.0 | ENSG00000154153 | nan | Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3), Autosomal recessive
chr5	MYO10	601481.0 | MYO10 | Myosin X | 4651.0 | ENSG00000145555 | nan | nan
chr5	BASP1	605940.0 | BASP1, CAP23, NAP22 | Brain-abundant signal protein, membrane-attached, 1 | 10409.0 | ENSG00000176788 | nan | nan
chr5		157960.0 | MLVI2 | Moloney leukemia virus integration site-2 | 4309.0 | nan | nan | nan
chr5	CDH18	603019.0 | CDH18, CDH14 | Cadherin 18 | 1016.0 | ENSG00000145526 | nan | nan
chr5	CDH12	600562.0 | CDH12, CDHB | Cadherin-12 (N-cadherin 2) | 1010.0 | ENSG00000154162 | pseudogene on 5q13 in SMA region | nan
chr5	PMCHL1	176793.0 | PMCHL1 | Pro-melanin-concentrating hormone-like 1 | 5369.0 | ENSG00000290530 | nan | nan
chr5	PRDM9	609760.0 | PRDM9 | PR domain-containing protein 9 | 56979.0 | ENSG00000164256 | nan | nan
chr5	CDH10	604555.0 | CDH10 | Cadherin 10 | 1008.0 | ENSG00000040731 | nan | nan
chr5	LINC02228	620525.0 | LINC02228, HIKER | Long intergenic noncoding RNA 2228 | 105374694.0 | nan | nan | nan
chr5	CDH9	609974.0 | CDH9 | Cadherin 9 | 1007.0 | ENSG00000113100 | nan | nan
chr5	ADHD4	608906.0 | ADHD4 | Attention deficit-hyperactivity disorder, susceptibility to, 4 | 450090.0 | nan | nan | {Attention deficit-hyperactivity disorder, susceptibility to, 4}, 608906 (2)
chr5	BDA1B	607004.0 | BDA1B | Brachydactyly, type A1, locus B | 246260.0 | nan | nan | Brachydactyly, type A1, B, 607004 (2), Autosomal dominant
chr5		613174.0 | DUP5p13, C5DUPp13 | Chromosome 5p13 duplication syndrome | nan | nan | nan | Chromosome 5p13 duplication syndrome, 613174 (4), Isolated cases
chr5	HYT6	610262.0 | HYT6 | Hypertension, essential, susceptibility to, 6 | 100188808.0 | nan | nan | {Hypertension, essential, susceptibility to, 6}, 145500 (2), Multifactorial
chr5	KYPSC1	610170.0 | KYPSC1 | Kyphoscoliosis 1 | 780921.0 | nan | nan | Kyphoscoliosis 1, 610170 (2)
chr5	CDH6	603007.0 | CDH6 | Cadherin 6 | 1004.0 | ENSG00000113361 | nan | nan
chr5	DROSHA	608828.0 | DROSHA, RNASEN, RANSE3L, RN3 | Drosha ribonuclease III | 29102.0 | ENSG00000113360 | nan | nan
chr5	PDZD2	610697.0 | PDZD2, PAPIN, PIN1, AIPC | PDZ domain containing 2 | 23037.0 | ENSG00000133401 | nan | nan
chr5	GOLPH3	612207.0 | GOLPH3, GPP34, MIDAS | Golgi phosphoprotein 3 | 64083.0 | ENSG00000113384 | nan | nan
chr5	MTMR12	606501.0 | MTMR12, 3PAP, KIAA1682 | Myotubularin-related protein 12 | 54545.0 | ENSG00000150712 | nan | nan
chr5	ZFR	615635.0 | ZFR | Zinc finger RNA-binding protein | 51663.0 | ENSG00000056097 | nan | nan
chr5	SUB1	600503.0 | SUB1, PC4, p15 | SUB1 regulator of transcription | 10923.0 | ENSG00000113387 | nan | nan
chr5	NPR3	108962.0 | NPR3, ANPRC, BOMOS | Natriuretic peptide receptor C | 4883.0 | ENSG00000113389 | nan | Boudin-Mortier syndrome, 619543 (3), Autosomal recessive
chr5	TARS1	187790.0 | TARS1, TARS, TTD7 | Threonyl-tRNA synthetase 1 | 6897.0 | ENSG00000113407 | linked to LARS | Trichothiodystrophy 7, nonphotosensitive, 618546 (3), Autosomal recessive
chr5	ADAMTS12	606184.0 | ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 81792.0 | ENSG00000151388 | nan | nan
chr5	MS3	612595.0 | MS3 | Multiple sclerosis, susceptibility to, 3 | 100271695.0 | nan | associated with rs6897932 | {Multiple sclerosis, susceptibility to, 3}, 612595 (2)
chr5	RXFP3	609445.0 | RXFP3, RLN3R1, SALPR, GPCR135 | Relaxin/insulin-like family peptide receptor 3 | 51289.0 | ENSG00000182631 | nan | nan
chr5	SLC45A2	606202.0 | SLC45A2, MATP, AIM1, SHEP5, OCA4 | Solute carrier family 45, member 2 | 51151.0 | ENSG00000164175 | nan | [Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3), Autosomal recessive; [Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3), Autosomal recessive; Albinism, oculocutaneous, type IV, 606574 (3), Autosomal recessive; [Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3), Autosomal recessive
chr5	AMACR	604489.0 | AMACR, CBAS4, AMACRD | Alpha-methylacyl-CoA racemase | 23600.0 | ENSG00000242110 | nan | Alpha-methylacyl-CoA racemase deficiency, 614307 (3), Autosomal recessive; Bile acid synthesis defect, congenital, 4, 214950 (3), Autosomal recessive
chr5	C1QTNF3	612045.0 | C1ATNF3, CTRP3, CORS26 | C1q- and tumor necrosis factor-related protein 3 | 114899.0 | ENSG00000082196 | nan | nan
chr5	RAI14	606586.0 | RAI14, KIAA1334 | Retinoic acid-induced 14 | 26064.0 | ENSG00000039560 | nan | nan
chr5	TTC23L	616344.0 | TTC23L | Tetratricopeptide repeat domain-containing protein 23-like | 153657.0 | ENSG00000205838 | nan | nan
chr5	RAD1	603153.0 | RAD1 | RAD1 checkpoint DNA exonuclease | 5810.0 | ENSG00000113456 | nan | nan
chr5	BRIX1	618466.0 | BRIX1 | Biogenesis of ribosomes BRIX1 | 55299.0 | ENSG00000113460 | nan | nan
chr5	DNAJC21	617048.0 | DNAJC21, DNAJA5, BMFS3 | DNAJ/HSP40 homolog, subfamily C, member 21 | 134218.0 | ENSG00000168724 | nan | Bone marrow failure syndrome 3, 617052 (3), Autosomal recessive
chr5	AGXT2	612471.0 | AGXT2, AGT2, BAIBA | Alanine-glyoxylate aminotransferase 2 | 64902.0 | ENSG00000113492 | nan | [Beta-aminoisobutyric acid, urinary excretion of], 210100 (3), Autosomal recessive
chr5	PRLR	176761.0 | PRLR, MFAB, HPRL | Prolactin receptor | 5618.0 | ENSG00000113494 | nan | Multiple fibroadenomas of the breast, 615554 (3), Autosomal dominant; Hyperprolactinemia, 615555 (3), Autosomal recessive, Autosomal dominant
chr5	SPEF2	610172.0 | SPEF2, KPL2, KIAA1770, SPGF43 | Sperm flagellar protein 2 | 79925.0 | ENSG00000152582 | nan | Spermatogenic failure 43, 618751 (3), Autosomal recessive
chr5	IL7R	146661.0 | IL7R, IL7RA, CD127, IMD104 | Interleukin-7 receptor | 3575.0 | ENSG00000168685 | nan | Immunodeficiency 104, severe combined, 608971 (3), Autosomal recessive
chr5	CAPSL	618799.0 | CAPSL | Calcyphosine-like protein | 133690.0 | ENSG00000152611 | nan | nan
chr5	UGT3A1	616383.0 | UGT3A1 | Uridine diphosphate glucuronosyltransferase 3 family, member A1 | 133688.0 | ENSG00000145626 | nan | nan
chr5	UGT3A2	616384.0 | UGT3A2 | Uridine diphosphate glucuronosyltransferase 3 family, member A2 | 167127.0 | ENSG00000168671 | nan | nan
chr5	LMBRD2	619490.0 | LMBRD2, DENBA | LMBR1 domain-containing protein 2 | 92255.0 | ENSG00000164187 | nan | Developmental delay with variable neurologic and brain abnormalities, 619694 (3), Autosomal dominant
chr5	SKP2	601436.0 | SKP2 | S-phase kinase-associated protein 2 (p45) | 6502.0 | ENSG00000145604 | nan | nan
chr5	NADK2	615787.0 | NADK2, C5orf33, DECRD | NAD kinase 2, mitochondrial | 133686.0 | ENSG00000152620 | nan | 2,4-dienoyl-CoA reductase deficiency, 616034 (3), Autosomal recessive
chr5	RANBP3L	616391.0 | RANBP3L | RAN-binding protein 3-like | 202151.0 | ENSG00000164188 | nan | nan
chr5	SLC1A3	600111.0 | SLC1A3, EAAT1, EA6 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | 6507.0 | ENSG00000079215 | nan | Episodic ataxia, type 6, 612656 (3), Autosomal dominant
chr5	NIPBL	608667.0 | NIPBL, CDLS1 | Nipped-B-like (delangin) | 25836.0 | ENSG00000164190 | nan | Cornelia de Lange syndrome 1, 122470 (3), Autosomal dominant
chr5	CPLANE1	614571.0 | CPLANE1, C5orf42, JBTS17, OFD6 | Ciliogenesis and planar polarity effector complex, subunit 1 | 65250.0 | ENSG00000197603 | nan | Orofaciodigital syndrome VI, 277170 (3), Autosomal recessive; Joubert syndrome 17, 614615 (3), Autosomal recessive
chr5	NUP155	606694.0 | NUP155, KIAA0791, ATFB15 | Nucleoporin, 155kD | 9631.0 | ENSG00000113569 | mutation identified in 1 ATFB15 family | ?Atrial fibrillation 15, 615770 (3), Autosomal recessive
chr5	WDR70	617233.0 | WDR70 | WD repeat-containing protein 70 | 55100.0 | ENSG00000082068 | nan | nan
chr5	GDNF	600837.0 | GDNF, HSCR3 | Glial cell line derived neurotrophic factor | 2668.0 | ENSG00000168621 | nan | {Hirschsprung disease, susceptibility to, 3}, 613711 (3), Autosomal dominant
chr5	EGFLAM	617683.0 | EGFLAM, PIKA, AGRINL | EGF-like, fibronectin type III, and laminin G domains-containing protein | 133584.0 | ENSG00000164318 | nan | nan
chr5	IBD18	612262.0 | IBD18 | Inflammatory bowel disease 18 | 100190931.0 | nan | associated with rs1373692 | {Inflammatory bowel disease 18}, 612262 (2)
chr5	LIFR	151443.0 | LIFR, STWS, SWS, SJS2 | Leukemia inhibitory factor receptor | 3977.0 | ENSG00000113594 | nan | Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3), Autosomal recessive
chr5	OSMR	601743.0 | OSMR, OSMRB, PLCA1 | Oncostatin M receptor | 9180.0 | ENSG00000145623 | nan | Amyloidosis, primary localized cutaneous, 1, 105250 (3), Autosomal dominant
chr5	RICTOR	609022.0 | RICTOR, AVO3, KIAA1999 | Rapamycin-insensitive campion of mTOR | 253260.0 | ENSG00000164327 | nan | nan
chr5	FYB1	602731.0 | FYB1, SLAP130, ADAP, THC3 | FYN-binding protein 1 | 2533.0 | ENSG00000082074 | nan | Thrombocytopenia 3, 273900 (3), Autosomal recessive
chr5	C9	120940.0 | C9, C9D, ARMD15 | Complement component-9 | 735.0 | ENSG00000113600 | nan | C9 deficiency, 613825 (3); {Macular degeneration, age-related, 15, susceptibility to}, 615591 (3), Autosomal dominant
chr5	DAB2	601236.0 | DAB2, DOC2 | DAB adaptor protein 2 | 1601.0 | ENSG00000153071 | nan | nan
chr5	PTGER4	601586.0 | PTGER4 | Prostaglandin E receptor 4, EP4 subtype | 5734.0 | ENSG00000171522 | nan | nan
chr5	PRKAA1	602739.0 | PRKAA1 | Protein kinase, AMP-activated, catalytic, alpha-1 | 5562.0 | ENSG00000132356 | nan | nan
chr5	RPL37	604181.0 | RPL37 | Ribosomal protein L37 | 6167.0 | ENSG00000145592 | nan | nan
chr5	CARD6	609986.0 | CARD6, CINCIN1 | Caspase recruitment domain-containing protein 6 | 84674.0 | ENSG00000132357 | nan | nan
chr5	C7	217070.0 | C7 | Complement component-7 | 730.0 | ENSG00000112936 | nan | C7 deficiency, 610102 (3)
chr5	MROH2B	620930.0 | MROH2B, SPIF | Maestro HEAT-like repeat family, member 2B | 133558.0 | ENSG00000171495 | nan | nan
chr5	C6	217050.0 | C6 | Complement component-6 | 729.0 | ENSG00000039537 | nan | C6 deficiency, 612446 (3), Autosomal recessive
chr5	PLCXD3	617016.0 | PLCXD3 | Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 3 | 345557.0 | ENSG00000182836 | nan | nan
chr5	OXCT1	601424.0 | OXCT1, OXCT, SCOT | 3-oxoacid CoA transferase 1 | 5019.0 | ENSG00000083720 | nan | Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3), Autosomal recessive
chr5	RIMOC1	620266.0 | RIMOC1, C5orf51 | RAB7A-interacting MON1-CCZ1 complex subunit 1 | 285636.0 | ENSG00000205765 | nan | nan
chr5	FBXO4	609090.0 | FBXO4, FBX4 | F-box only protein 4 | 26272.0 | ENSG00000151876 | nan | nan
chr5	GHR	600946.0 | GHR, GHIP | Growth hormone receptor | 2690.0 | ENSG00000112964 | nan | Laron dwarfism, 262500 (3), Autosomal recessive; Increased responsiveness to growth hormone, 604271 (3), Autosomal dominant; Growth hormone insensitivity, partial, 604271 (3), Autosomal dominant; {Hypercholesterolemia, familial, modifier of}, 143890 (3), Autosomal recessive, Autosomal dominant
chr5	SELENOP	601484.0 | SELENOP, SEPP1 | Selenoprotein P | 6414.0 | ENSG00000250722 | nan | nan
chr5	ANXA2R	611296.0 | ANXA2R, C5orf39, AX2R, AXIIR | Annexin A2 receptor | 389289.0 | ENSG00000177721 | nan | nan
chr5	ZNF131	604073.0 | ZNF131 | Zinc finger protein -31 | 7690.0 | ENSG00000172262 | nan | nan
chr5	HMGCS1	142940.0 | HMGCS1 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 | 3157.0 | ENSG00000112972 | like HMGCR, regulated transcriptionally by steroid | nan
chr5	CCL28	605240.0 | CCL28 | Chemokine, C-C motif, ligand 28 | 56477.0 | ENSG00000151882 | nan | nan
chr5	PAIP1	605184.0 | PAIP1 | Polyadenylate-binding protein-interacting protein 1 | 10605.0 | ENSG00000172239 | nan | nan
chr5	NNT	607878.0 | NNT, GCCD4 | Nicotinamide nucleotide transhydrogenase | 23530.0 | ENSG00000112992 | nan | Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency, 614736 (3), Autosomal recessive
chr5	FGF10	602115.0 | FGF10, LADD3 | Fibroblast growth factor-10 | 2255.0 | ENSG00000070193 | nan | LADD syndrome 3, 620193 (3), Autosomal dominant; Aplasia of lacrimal and salivary glands, 180920 (3), Autosomal dominant
chr5	MRPS30	611991.0 | MRPS30 | Mitochondrial ribosomal protein S30 | 10884.0 | ENSG00000112996 | nan | nan
chr5	HCN1	602780.0 | HCN1, BCNG1, DEE24, GEFSP10 | Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 | 348980.0 | ENSG00000164588 | nan | Developmental and epileptic encephalopathy 24, 615871 (3), Autosomal dominant; Generalized epilepsy with febrile seizures plus, type 10, 618482 (3), Autosomal dominant
chr5	BSZQTL2	609657.0 | BSZQTL2 | Bone size quantitative trait locus 2 | 100188794.0 | nan | nan | {Bone size QTL}, 609657 (2)
chr5	EMB	615669.0 | EMB, GP70 | Embigin | 133418.0 | ENSG00000170571 | nan | nan
chr5	ISL1	600366.0 | ISL1 | ISL1 transcription factor, LIM/homeodomain (islet-1) | 3670.0 | ENSG00000016082 | between D5S395 and D5S407; proximal 5q | nan
chr5	BDPLT9	614200.0 | BDPLT9 | Bleeding disorder, platelet-type, 9 | 116814567.0 | nan | nan | Bleeding disorder, platelet-type, 9, 614200 (2), Autosomal dominant
chr5	ITGA1	192968.0 | ITGA1, VLA1 | Integrin, alpha-1 | 3672.0 | ENSG00000213949 | nan | nan
chr5	PELO	605757.0 | PELO | Pelota mRNA surveillance and ribosome rescue factor | 53918.0 | ENSG00000152684 | nan | nan
chr5	ITGA2	192974.0 | ITGA2, CD49B, BR | Integrin, alpha-2 (CD49B; alpha-2 subunit of VLA-2 receptor; platelet antigen Br) | 3673.0 | ENSG00000164171 | nan | nan
chr5	MOCS2	603708.0 | MOCS2, MPTS, MOCODB | Molybdenum cofactor synthesis-2 | 4338.0 | ENSG00000164172 | nan | Molybdenum cofactor deficiency B, 252160 (3), Autosomal recessive
chr5	FST	136470.0 | FST, FS | Follistatin | 10468.0 | ENSG00000134363 | nan | nan
chr5	NDUFS4	602694.0 | NDUFS4, AQDQ, MC1DN1 | NADH-ubiquinone oxidoreductase subunit S4 | 4724.0 | ENSG00000164258 | nan | Mitochondrial complex I deficiency, nuclear type 1, 252010 (3), Autosomal recessive
chr5	HSPB3	604624.0 | HSPB3, HSPL27, HMND4 | Heat-shock 27kD protein 3 | 8988.0 | ENSG00000169271 | mutation identified in 1 HMND4 family | ?Neuronopathy, distal hereditary motor, autosomal dominant 4, 613376 (3), Autosomal dominant
chr5	ESM1	601521.0 | ESM1 | Endothelial cell-specific molecule 1 | 11082.0 | ENSG00000164283 | nan | nan
chr5	GZMK	600784.0 | GZMK, TRYP2 | Granzyme K | 3003.0 | ENSG00000113088 | nan | nan
chr5	GZMA	140050.0 | GZMA, CTLA3, HFSP | Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3; Hanukah factor serine protease) | 3001.0 | ENSG00000145649 | nan | nan
chr5	CDC20B	620335.0 | CDC20B | Cell division cycle 20B | 166979.0 | ENSG00000164287 | nan | nan
chr5	GPX8	617172.0 | GPX8 | Glutathione peroxidase 8 | 493869.0 | ENSG00000164294 | nan | nan
chr5	MIR449A	613131.0 | MIR449A, MIRN449A | Micro RNA 449A | 554213.0 | ENSG00000198983 | nan | nan
chr5	MIR449B	613132.0 | MIR449B, MIRN449B | Micro RNA 449B | 693123.0 | ENSG00000207728 | nan | nan
chr5	MCIDAS	614086.0 | MCIDAS, IDAS, CILD42 | IDAS | 345643.0 | ENSG00000234602 | nan | Ciliary dyskinesia, primary, 42, 618695 (3), Autosomal recessive
chr5	CCNO	607752.0 | CCNO, UNG2, CILD29 | Cyclin O | 10309.0 | ENSG00000152669 | nan | Ciliary dyskinesia, primary, 29, 615872 (3), Autosomal recessive
chr5	DHX29	612720.0 | DHX29 | DExH-box helicase 29 | 54505.0 | ENSG00000067248 | nan | nan
chr5	MTREX	618122.0 | MTREX, MTR4, SKIV2L2 | MTR4 exosome RNA helicase | 23517.0 | ENSG00000039123 | nan | nan
chr5	PLPP1	607124.0 | PLPP1, PPAP2A | Phopshplipid phosphatase 1 | 8611.0 | ENSG00000067113 | nan | nan
chr5	SLC38A9	616203.0 | SLC38A9, URLC11 | Solute carrier family 38, member 9 | 153129.0 | ENSG00000177058 | nan | nan
chr5	DDX4	605281.0 | DDX4, VASA | DEAD-box helicase 4 | 54514.0 | ENSG00000152670 | nan | nan
chr5	IL31RA	609510.0 | IL31RA, GLMR, GPL, PLCA2 | Interleukin 31 receptor A | 133396.0 | ENSG00000164509 | mutation identified in 1 PLCA2 patient | ?Amyloidosis, primary localized cutaneous, 2, 613955 (3), Autosomal dominant
chr5	IL6ST	600694.0 | IL6ST, HIES4A, HIES4B, STWS2, IMD94 | Interleukin 6 cytokine family signal transducer | 3572.0 | ENSG00000134352 | mutation identified in one IMD94 patient | Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections, 619752 (3), Autosomal dominant; Stuve-Wiedemann syndrome 2, 619751 (3), Autosomal recessive; Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections, 618523 (3), Autosomal recessive; ?Immunodeficiency 94 with autoinflammation and dysmorphic facies, 619750 (3), Autosomal dominant
chr5	ANKRD55	615189.0 | ANKRD55 | Ankyrin repeat domain-containing protein 55 | 79722.0 | ENSG00000164512 | nan | nan
chr5	MAP3K1	600982.0 | MAP3K1, MEKK1, MEKK, SRXY6 | Mitogen-activated protein kinase kinase kinase 1 | 4214.0 | ENSG00000095015 | nan | 46XY sex reversal 6, 613762 (3), Autosomal dominant
chr5	MIER3	620100.0 | MIER3 | MIER family, member 3 | 166968.0 | ENSG00000155545 | nan | nan
chr5	GPBP1	608412.0 | GPBP1, GPBP | GC-rich promoter-binding protein 1 | 65056.0 | ENSG00000062194 | nan | nan
chr5	ACTBL2	614835.0 | ACTBL2 | Actin, beta-like, 2 | 345651.0 | ENSG00000169067 | nan | nan
chr5	PLK2	607023.0 | PLK2, SNK | Polo-like kinase 2 | 10769.0 | ENSG00000145632 | nan | nan
chr5	GAPT	620440.0 | GAPT | GRB2-binding adaptor protein, transmembrane | 202309.0 | ENSG00000175857 | nan | nan
chr5	RAB3C	612829.0 | RAB3C | Ras-associated protein RAB3C | 115827.0 | ENSG00000152932 | nan | nan
chr5	PDE4D	600129.0 | PDE4D, DPDE3, ACRDYS2 | Phosphodiesterase-4D, cAMP-specific (dunce, Drosophila, homolog of, phosphodiesterase-E3) | 5144.0 | ENSG00000113448 | nan | Acrodysostosis 2, with or without hormone resistance, 614613 (3), Autosomal dominant
chr5		615668.0 | DEL5q12, C5DELq12 | Chromosome 5q12 deletion syndrome | nan | nan | nan | Chromosome 5q12 deletion syndrome, 615668 (4), Autosomal dominant
chr5	EJM4	611364.0 | EJM4 | Myoclonic epilepsy, juvenile, 4 | 100126594.0 | nan | max lod at D5S459 | Myoclonic epilepsy, juvenile, 4, 611364 (2), Autosomal dominant
chr5		606799.0 | STRK1 | Stroke, susceptibility to, 1 | nan | nan | association with PDE4D | {Stroke, susceptibility to, 1}, 606799 (2)
chr5	PART1	604991.0 | PART1 | Prostate androgen-regulated transcript 1 | 25859.0 | ENSG00000152931 | nan | nan
chr5	DEPDC1B	616073.0 | DEPDC1B | DEP domain-containing protein 1B | 55789.0 | ENSG00000035499 | nan | nan
chr5	ELOVL7	614451.0 | ELOVL7 | Elongation of very long chain fatty acids-like 6 | 79993.0 | ENSG00000164181 | nan | nan
chr5	ERCC8	609412.0 | ERCC8, CKN1, CSA, UVSS2 | ERCC excision repair 8, CSA ubiquitin ligase complex subunit | 1161.0 | ENSG00000049167 | nan | UV-sensitive syndrome 2, 614621 (3), Autosomal recessive; Cockayne syndrome, type A, 216400 (3), Autosomal recessive
chr5	NDUFAF2	609653.0 | NDUFAF2, NDUFA12L, MMTN, B17.2L, MC1DN10 | NADH-ubiquinone oxidoreductase complex assembly factor 2 | 91942.0 | ENSG00000164182 | pseudogene on chr.2 | Mitochondrial complex I deficiency, nuclear type 10, 618233 (3), Autosomal recessive
chr5	ZSWIM6	615951.0 | ZSWIM6, KIAA1577, AFND, NEDMAGA | Zinc finger SWIM domain-containing protein 6 | 57688.0 | ENSG00000130449 | nan | Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features, 617865 (3), Autosomal dominant; Acromelic frontonasal dysostosis, 603671 (3), Autosomal dominant
chr5	KIF2A	602591.0 | KIF2A, CDCBM3 | Kinesin, heavy chain, 2 | 3796.0 | ENSG00000068796 | nan | Cortical dysplasia, complex, with other brain malformations 3, 615411 (3), Autosomal dominant
chr5	DIMT1	612499.0 | DIMT1L, DIM1, HUSSY5 | DIMT1 rRNA methyltransferase and ribosome maturation factor | 27292.0 | ENSG00000086189 | previously assigned to 8p12 | nan
chr5	IPO11	610889.0 | IPO11, RANBP11, SLRN | Importin 11 | 51194.0 | ENSG00000086200 | nan | nan
chr5	HTR1A	109760.0 | HTR1A, ADRB2RL1, PFMCD | 5-hydroxytryptamine (serotonin) receptor-1A | 3350.0 | ENSG00000178394 | mutation identified in 1 PFMCD patient | ?Periodic fever, menstrual cycle dependent, 614674 (3), Autosomal dominant
chr5	RNF180	616015.0 | RNF180, RINES | RING finger protein 180 | 285671.0 | ENSG00000164197 | nan | nan
chr5	RGS7BP	610890.0 | RGS7BP, R7BP | Regulator of G protein signaling 7-binding protein | 401190.0 | ENSG00000186479 | nan | nan
chr5	SHISAL2B	620219.0 | SHISAL2B, FAM159B | SHISH-like 2B | 100132916.0 | ENSG00000145642 | nan | nan
chr5	CWC27	617170.0 | CWC27, SDCCAG10, RPSKA | CWC27 spliceosome-associated cyclophilin | 10283.0 | ENSG00000153015 | nan | Retinitis pigmentosa with or without skeletal anomalies, 250410 (3), Autosomal recessive
chr5	ADAMTS6	605008.0 | ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | 11174.0 | ENSG00000049192 | nan | nan
chr5	CENPK	611502.0 | CEMPK, SOLT | Centromeric protein K | 64105.0 | ENSG00000123219 | nan | nan
chr5	PPWD1	618274.0 | PPWD1 | Peptidylprolyl isomerase domain- and WD40 repeat-containing protein 1 | 23398.0 | ENSG00000113593 | nan | nan
chr5	TRIM23	601747.0 | TRIM23, ARD1 | Tripartite motif-containing protein 23 | 373.0 | ENSG00000113595 | nan | nan
chr5	SHLD3	618030.0 | SHLD3, RINN1 | Shield complex, subunit 3 | 112441434.0 | ENSG00000253251 | nan | nan
chr5	SGTB	620526.0 | SGTB | Small glutamine-rich tetratricopaptide repeat cochaperone, beta | 54557.0 | ENSG00000197860 | nan | nan
chr5	NLN	611530.0 | NLN, KIAA1226, AGTBP | Neurolysin | 57486.0 | ENSG00000123213 | nan | nan
chr5	ERBIN	606944.0 | ERBB2IP, ERBIN | ERBB2 interacting protein | 55914.0 | ENSG00000112851 | nan | nan
chr5	SREK1	609268.0 | SREK1, SFRS12, SRRp508 | Splicing regulatory glutamine/lysine-rich protein 1 | 140890.0 | ENSG00000153914 | nan | nan
chr5	MAST4	618002.0 | MAST4 | Microtubule-associated serine-threonine kinase 4 | 375449.0 | ENSG00000069020 | nan | nan
chr5	CD180	602226.0 | CD180, LY64, RP105 | CD180 antigen | 4064.0 | ENSG00000134061 | nan | nan
chr5	AAT2	607087.0 | AAT2, FAA2 | Aortic aneurysm, familial thoracic 2 | 252843.0 | nan | nan | Aortic aneurysm, familial thoracic 2, 607087 (2)
chr5	GINGF2	605544.0 | GINGF2, GGF2, HGF2 | Fibromatosis, gingival, 2 | 64644.0 | nan | formerly GINGF2 used for a locus on 2p16-p13 | Fibromatosis, gingival, 2, 605544 (2)
chr5	TSHQTL1	612306.0 | TSHQTL1 | Thyroid-stimulating hormone level QTL 1 | 100190789.0 | nan | associated with rs4704397 | [Thyroid-stimulating hormone level QTL 1], 612306 (2)
chr5	PIK3R1	171833.0 | PIK3R1, GRB1, AGM7, SHORT, IMD36 | Phosphatidylinositol 3-kinase, regulatory, 1 | 5295.0 | ENSG00000145675 | mutation identified in 1 AGM7 family | Immunodeficiency 36, 616005 (3), Autosomal dominant; ?Agammaglobulinemia 7, autosomal recessive, 615214 (3), Autosomal recessive; SHORT syndrome, 269880 (3), Autosomal dominant
chr5	SLC30A5	607819.0 | SLC30A5, ZNT5, ZTL1 | Solute carrier family 30 (zinc transporter), member 5 | 64924.0 | ENSG00000145740 | nan | nan
chr5	CCNB1	123836.0 | CCNB1 | Cyclin B1 | 891.0 | ENSG00000134057 | nan | nan
chr5	CENPH	605607.0 | CENPH | Centromeric protein H | 64946.0 | ENSG00000153044 | nan | nan
chr5	KGD4	611996.0 | MRPS36 | Mitochondrial ribosomal protein S36 | 92259.0 | ENSG00000134056 | 6 pseudogenes | nan
chr5	CDK7	601955.0 | CDK7, STK1, CAK1 | Cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase) | 1022.0 | ENSG00000134058 | previously mapped to 2p15-cen | nan
chr5	CCDC125	613781.0 | CCDC125, KENAE | Coiled-coil domain-containing protein 125 | 202243.0 | ENSG00000183323 | nan | nan
chr5	AK6	619357.0 | AK6, CINAP | Adenylate kinase 6 | 102157402.0 | ENSG00000085231 | nan | nan
chr5	TAF9	600822.0 | TAF9, TAF2G, TAFII32 | TATA box-binding protein-associated factor 9 | 6880.0 | ENSG00000273841 | nan | nan
chr5	RAD17	603139.0 | RAD17 | RAD17 checkpoint clamp loader component | 5884.0 | ENSG00000152942 | nan | nan
chr5	MARVELD2	610572.0 | MARVELD2, MARVD2, TRIC, DFNB49 | Marvel domain-containing protein 2 (tricellulin) | 153562.0 | ENSG00000152939 | nan | Deafness, autosomal recessive 49, 610153 (3), Autosomal recessive
chr5	OCLN	602876.0 | OCLN, BLCPMG, PTORCH1 | Occludin | 100506658.0 | ENSG00000197822 | nan | Pseudo-TORCH syndrome 1, 251290 (3), Autosomal recessive
chr5	SMN2	601627.0 | SMN2 | Survival of motor neuron 2, centromeric | 6607.0 | ENSG00000205571 | nan | {Spinal muscular atrophy, type III, modifier of}, 253400 (3), Autosomal recessive
chr5	SERF1A	603011.0 | SERF1A, H4F5, SMAM1 | Small EDRK-rich factor 1A | 8293.0 | ENSG00000172058 | nan | nan
chr5	SMN1	600354.0 | SMN1, SMA1, SMA2, SMA3, SMA4 | Survival of motor neuron 1, telomeric | 6606.0 | ENSG00000172062 | nan | Spinal muscular atrophy-2, 253550 (3), Autosomal recessive; Spinal muscular atrophy-4, 271150 (3), Autosomal recessive; Spinal muscular atrophy-3, 253400 (3), Autosomal recessive; Spinal muscular atrophy-1, 253300 (3), Autosomal recessive
chr5	NAIP	600355.0 | BIRC1, NAIP | Baculoviral IAP repeat-containing 1 (neuronal apoptosis inhibitory protein) | 4671.0 | ENSG00000249437 | ?involved in SMA | nan
chr5	GTF2H2	601748.0 | GTF2H2 | General transcription factor IIH, polypeptide 2 (44kD subunit) | 2966.0 | ENSG00000145736 | 2 copies | nan
chr5	PMCHL2	176794.0 | PMCHL2 | Pro-melanin-concentrating hormone-like 2 | 5370.0 | ENSG00000290836 | nan | nan
chr5	BDP1	607012.0 | BDP1, TFNR, DFNB112 | B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB | 55814.0 | ENSG00000145734 | mutation identified in 1 DFNB112 family | ?Deafness, autosomal recessive 112, 618257 (3), Autosomal recessive
chr5	MCCC2	609014.0 | MCCC2, MCCB | 3-Methylcrotonyl-CoA carboxylase 2 | 64087.0 | ENSG00000131844 | nan | 3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3), Autosomal recessive
chr5	CARTPT	602606.0 | CARTPT, CART | Cocaine- and amphetamine-regulated transcript prepropeptide | 9607.0 | ENSG00000164326 | mutation identified in 1 family | {?Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant
chr5	MAP1B	157129.0 | MAP1B, PVNH9, DFNA83 | Microtubule-associated protein-1B | 4131.0 | ENSG00000131711 | mutation identified in 1 DFNA83 family | ?Deafness, autosomal dominant 83, 619808 (3), Autosomal dominant; Periventricular nodular heterotopia 9, 618918 (3), Autosomal dominant
chr5	MRPS27	611989.0 | MRPS27, KIAA0264 | Mitochondrial ribosomal protein S27 | 23107.0 | ENSG00000113048 | nan | nan
chr5	PTCD2	615484.0 | PTCD2 | Pentatricopeptide repeat domain-containing protein 2 | 79810.0 | ENSG00000049883 | nan | nan
chr5	ZNF366	610159.0 | ZNF366, DCSCRIPT | Zinc finger protein 366 | 167465.0 | ENSG00000178175 | nan | nan
chr5	TNPO1	602901.0 | TNPO1, KPNB2, MIP1 | Transportin 1 | 3842.0 | ENSG00000083312 | nan | nan
chr5	FCHO2	613438.0 | FCHO2 | FCH domain-only protein 2 | 115548.0 | ENSG00000157107 | nan | nan
chr5	TMEM174	614909.0 | TMEM174 | Transmembrane protein 174 | 134288.0 | ENSG00000164325 | nan | nan
chr5	FOXD1	601091.0 | FOXD1, FKHL8 | Forkhead box D1 | 2297.0 | ENSG00000251493 | nan | nan
chr5	BTF3	602542.0 | BTF3, NACB | Basic transcription factor 3 | 689.0 | ENSG00000145741 | nan | nan
chr5	ANKRA2	605787.0 | ANKRA2, ANKRA | Ankyrin repeat-containing protein, family A, member 2 | 57763.0 | ENSG00000164331 | nan | nan
chr5	UTP15	616194.0 | UTP15 | UTP15 small subunit processome component                            of | 84135.0 | ENSG00000164338 | nan | nan
chr5	ARHGEF28	612790.0 | RGNEF, p190RHOGEF | Rgnef, mouse, homolog of | 64283.0 | ENSG00000214944 | nan | nan
chr5	LINC01157	618214.0 | LINC01157 | Long intergenic noncoding RNA 1157 | 105379037.0 | nan | nan | nan
chr5	ENC1	605173.0 | ENC1, PIG10 | Ectodermal-neural cortex 1 | 8507.0 | ENSG00000171617 | nan | nan
chr5	HEXB	606873.0 | HEXB | Hexosaminidase B, beta polypeptide | 3074.0 | ENSG00000049860 | nan | Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3), Autosomal recessive
chr5	GFM2	606544.0 | GFM2, EFG2, RRF | Mitochondrial elongation factor G2 | 84340.0 | ENSG00000164347 | nan | Combined oxidative phosphorylation deficiency 39, 618397 (3), Autosomal recessive
chr5	NSA2	612497.0 | TINP1, NSA2, HUSSY29 | Transforming growth factor-beta-inducible nuclear protein 1 | 10412.0 | ENSG00000164346 | nan | nan
chr5	FAM169A	615769.0 | FAM169A, SLAP75, KIAA0888 | Family with sequence similarity 169, member A | 26049.0 | ENSG00000198780 | nan | nan
chr5	GCNT4	616782.0 | GCNT4 | Glucosaminyl (N-acetyl) transferase 4, core 2 | 51301.0 | ENSG00000176928 | nan | nan
chr5	ANKRD31	618423.0 | ANKRD31 | Ankyrin repeat domain-containing protein 31 | 256006.0 | ENSG00000145700 | nan | nan
chr5	HMGCR	142910.0 | HMGCR, LDLCQ3, LGMDR28 | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase; HMG CoA reductase | 3156.0 | ENSG00000113161 | mutation identified in 1 MYPLG family | Muscular dystrophy, limb-girdle, autosomal recessive 28, 620375 (3), Autosomal recessive; [Statins, response to], 620410 (3); [Low density lipoprotein cholesterol level QTL 3], 620410 (3)
chr5	CERT1	604677.0 | CERT1, COL4A3BP, GPBP, CERT, MRD34 | Ceramide transporter 1 | 10087.0 | ENSG00000113163 | nan | Intellectual developmental disorder, autosomal dominant 34, 616351 (3), Autosomal dominant
chr5	POLK	605650.0 | POLK, POLQ, DINB1 | Polymerase, DNA, kappa | 51426.0 | ENSG00000122008 | nan | nan
chr5	ANKDD1B	619920.0 | ANKDD1B | Ankyrin repeat- and death domain-containing protein 1B | 728780.0 | ENSG00000189045 | nan | nan
chr5	POC5	617880.0 | POC5, C5orf37 | POC5 centriolar protein | 134359.0 | ENSG00000152359 | nan | nan
chr5	SV2C	610291.0 | SV2C | Synaptic vesicle glycoprotein 2C | 22987.0 | ENSG00000122012 | nan | nan
chr5	IQGAP2	605401.0 | IQGAP2 | IQ motif-containing GTPase-activating protein-2 | 10788.0 | ENSG00000145703 | nan | nan
chr5	F2RL2	601919.0 | F2RL2, PAR3 | Coagulation factor II receptor-like 2 (protease-activated receptor 3) | 2151.0 | ENSG00000164220 | order: PAR2-PAR1-PAR3 | nan
chr5	F2R	187930.0 | F2R, CF2R, PAR1 | Coagulation factor II (thrombin) receptor | 2149.0 | ENSG00000181104 | within 900kb of GPR11 | nan
chr5	F2RL1	600933.0 | F2RL1, GPR11, PAR2 | Coagulation factor II, thrombin, receptor-like 1 (G protein-coupled receptor-11) | 2150.0 | ENSG00000164251 | within 900kb of F2R | nan
chr5	S100Z	610103.0 | S100Z | S100 calcium-binding protein, zeta | 170591.0 | ENSG00000171643 | nan | nan
chr5	CRHBP	122559.0 | CRHBP | Corticotropin releasing hormone-binding protein | 1393.0 | ENSG00000145708 | nan | nan
chr5	AGGF1	608464.0 | AGGF1, VG5Q, HUS84971, FLJ10283 | Angiogenic factor with G patch and FHA domains 1 | 55109.0 | ENSG00000164252 | nan | nan
chr5	ZBED3	615250.0 | ZBED3 | Zinc finger BED domain-containing protein 3 | 84327.0 | ENSG00000132846 | nan | nan
chr5	PDE8B	603390.0 | PDE8B, PPNAD3, ADSD | Phosphodiesterase 8B | 8622.0 | ENSG00000113231 | nan | Pigmented nodular adrenocortical disease, primary, 3, 614190 (3); Striatal degeneration, autosomal dominant, 609161 (3), Autosomal dominant
chr5	WDR41	617502.0 | WDR41 | WD repeat-containing protein 41 | 55255.0 | ENSG00000164253 | nan | nan
chr5	TELAB1	187260.0 | HBT | Telangiectasia, hereditary benign | 338411.0 | nan | max lod at D5S641 | Telangiectasia, hereditary benign, 187260 (2), Autosomal dominant
chr5	KTCN5	614622.0 | KTCN5 | Keratoconus 5 | 100885801.0 | nan | between D5S2499 and D5S495 | Keratoconus 5, 614622 (2), Autosomal dominant
chr5	OTP	604529.0 | OTP | Orthopedia homeobox | 23440.0 | ENSG00000171540 | nan | nan
chr5	TBCA	610058.0 | TBCA | Tubulin-specific chaperone A | 6902.0 | ENSG00000171530 | nan | nan
chr5	AP3B1	603401.0 | AP3B1, ADTB3A, HPS2 | Adaptor-related protein complex 3, beta 1 subunit (adaptin, beta-3a) | 8546.0 | ENSG00000132842 | nan | Hermansky-Pudlak syndrome 2, 608233 (3), Autosomal recessive
chr5	SCAMP1	606911.0 | SCAMP1, SCAMP37 | Secretory carrier membrane protein 1 | 9522.0 | ENSG00000085365 | nan | nan
chr5	LHFPL2	609718.0 | LHFPL2, KIAA0206 | LHFP tetraspan subfamily, member 2 | 10184.0 | ENSG00000145685 | nan | nan
chr5	ARSB	611542.0 | ARSB, MPS6 | Arylsulfatase B | 411.0 | ENSG00000113273 | nan | Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3), Autosomal recessive
chr5	DMGDH	605849.0 | DMGDH, DMGDHD | Dimethylglycine dehydrogenase | 29958.0 | ENSG00000132837 | nan | Dimethylglycine dehydrogenase deficiency, 605850 (3), Autosomal recessive
chr5	BHMT2	605932.0 | BHMT2 | Betaine-homocysteine methyltransferase 2 | 23743.0 | ENSG00000132840 | nan | nan
chr5	BHMT	602888.0 | BHMT | Betaine-homocysteine methyltransferase | 635.0 | ENSG00000145692 | nan | nan
chr5	JMY	604279.0 | JMY | Junction-mediating and regulatory protein | 133746.0 | ENSG00000152409 | nan | nan
chr5	HOMER1	604798.0 | HOMER1, HOMER1B, HOMER1C, HOMER1A | Homer scaffold protein 1 | 9456.0 | ENSG00000152413 | nan | nan
chr5	TENT2	614121.0 | TENT2, APD4, GLD2 | Terminal nucleotidyltransferase 1 | 167153.0 | ENSG00000164329 | nan | nan
chr5	CMYA5	612193.0 | CMYA5, MYOSPRYN, TRIM76 | Cardiomyopathy-associated protein 5 | 202333.0 | ENSG00000164309 | nan | nan
chr5	MTX3	619336.0 | MTX3 | Metaxin 3 | 345778.0 | ENSG00000177034 | nan | nan
chr5	THBS4	600715.0 | THBS4 | Thrombospondin IV | 7060.0 | ENSG00000113296 | nan | nan
chr5	SERINC5	614551.0 | SERINC5, C5orf12, TPO1 | Serine incorporator 5 | 256987.0 | ENSG00000164300 | nan | nan
chr5	SPZ1	618068.0 | SPZ1, PPP1R148 | Spermatogenic leucine zipper protein 1 | 84654.0 | ENSG00000164299 | nan | nan
chr5	ZFYVE16	608880.0 | ZFYVE16, ENDOFIN, KIAA0305 | Zinc finger FYVE domain-containing protein 16 | 9765.0 | ENSG00000039319 | nan | nan
chr5	ANKRD34B	618581.0 | ANKRD34B, DP58 | Ankyrin repeat domain-containing protein 34B | 340120.0 | ENSG00000189127 | nan | nan
chr5	DHFR	126060.0 | DHFR | Dihydrofolate reductase | 1719.0 | ENSG00000228716 | nan | Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive
chr5	MSH3	600887.0 | MSH3, FAP4 | mutS homolog 3 | 4437.0 | ENSG00000113318 | 5' to DHFR | Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)
chr5	RASGRF2	606614.0 | RASGRF2 | Ras protein-specific guanine nucleotide-releasing factor 2 | 5924.0 | ENSG00000113319 | nan | nan
chr5	CKMT2	123295.0 | CKMT2 | Creatine kinase, mitochondrial-2 (sarcomeric) | 1160.0 | ENSG00000131730 | nan | nan
chr5	ZCCHC9	620382.0 | ZCCHC9 | Zinc finger CCHC domain-containing protein 9 | 84240.0 | ENSG00000131732 | nan | nan
chr5	ACOT12	614315.0 | ACOT12, CACH | Acyl-CoA thioesterase 12 | 134526.0 | ENSG00000172497 | nan | nan
chr5	SSBP2	607389.0 | SSBP2 | Single-stranded DNA-binding protein 2 | 23635.0 | ENSG00000145687 | nan | nan
chr5	ATG10	610800.0 | ATG10, APG10 | Autophagy related 10 | 83734.0 | ENSG00000152348 | nan | nan
chr5	VUR4	614317.0 | VUR4 | Vesicoureteral reflux 4 | 100820757.0 | nan | closest marker rs1501656 | Vesicoureteral reflux 4, 614317 (2)
chr5	RPS23	603683.0 | RPS23, BTDD, MCINS | Ribosomal protein S23 | 6228.0 | ENSG00000186468 | nan | Brachycephaly, trichomegaly, and developmental delay, 617412 (3), Autosomal dominant
chr5	TMEM167A	620000.0 | TMEM167A | Transmembrane protein 167A | 153339.0 | ENSG00000174695 | nan | nan
chr5	SCARNA18	611329.0 | SCARNA18 | Small cajal body-specific RNA 18 | 677765.0 | ENSG00000238835 | in intron 1 of TMEM167 | nan
chr5	XRCC4	194363.0 | XRCC4, SSMED | X-ray repair cross complementing 4 | 7518.0 | ENSG00000152422 | between D5S427 and D5S401 | Short stature, microcephaly, and endocrine dysfunction, 616541 (3), Autosomal recessive
chr5	VCAN	118661.0 | VCAN, CSPG2, WGN, WGN1, ERVR | Versican (chondroitin sulfate proteoglycan-2) | 1462.0 | ENSG00000038427 | nan | Wagner syndrome 1, 143200 (3), Autosomal dominant
chr5		612881.0 | PVNH5 | Periventricular nodular heterotopia 5 | nan | nan | deletion range 6.3-17Mb, common range 5.8Mb | Periventricular nodular heterotopia 5, 612881 (4)
chr5	HAPLN1	115435.0 | HAPLN1, CRTL1 | Hyaluronan and proteoglycan link protein 1 | 1404.0 | ENSG00000145681 | nan | nan
chr5	EDIL3	606018.0 | EDIL3, DEL1 | Egf-like repeats- and discoidin I-like domains-containing protein 3 | 10085.0 | ENSG00000164176 | nan | nan
chr5	COX7C	603774.0 | COX7C | Cytochrome C oxidase, subunit VII C | 1350.0 | ENSG00000127184 | pseudogene on 13q14-q21 | nan
chr5	RASA1	139150.0 | RASA1, GAP, CMAVM1, PKWS | RAS p21 protein activator 1 (GTPase activating protein) | 5921.0 | ENSG00000145715 | nan | Capillary malformation-arteriovenous malformation 1, 608354 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)
chr5	CCNH	601953.0 | CCNH, CAK | Cyclin H | 902.0 | ENSG00000134480 | nan | nan
chr5	MIR9-2HG	616611.0 | LINC00461, VISC | Long intergenic noncoding RNA 461 | 645323.0 | ENSG00000245526 | nan | nan
chr5	MIR9-2	611187.0 | MIR9-2, MIRN9-2 | Micro RNA 9-2 | 407047.0 | ENSG00000284447 | nan | nan
chr5	MEF2C	600662.0 | MEF2C, C5DELq14.3, DEL5q14.3, NEDHSIL | MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) | 4208.0 | ENSG00000081189 | nan | Chromosome 5q14.3 deletion syndrome, 613443 (4), Autosomal dominant; Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language, 613443 (3), Autosomal dominant
chr5	CETN3	602907.0 | CETN3, CDC31 | Centrin 3 | 1070.0 | ENSG00000153140 | nan | nan
chr5	MBLAC2	620907.0 | MBLAC2 | Metallo-beta-lactamase domain-containing protein 2 | 153364.0 | ENSG00000176055 | nan | nan
chr5	POLR3G	617456.0 | POLR3G, RPC32, RPC7 | Polymerase III, RNA, subunit G | 10622.0 | ENSG00000113356 | nan | nan
chr5	ADGRV1	602851.0 | ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C | Adhesion G protein-coupled receptor V1 | 84059.0 | ENSG00000164199 | mutation identified in 1 FEB4 family | Usher syndrome, type 2C, 605472 (3), Autosomal recessive, Digenic dominant; Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3), Autosomal recessive, Digenic dominant; ?Febrile seizures, familial, 4, 604352 (3), Autosomal dominant
chr5	LUCAT1	618190.0 | LUCAT1, SCAL1 | Lung cancer-associated transcript 1, noncoding | 100505994.0 | ENSG00000248323 | nan | nan
chr5	ARRDC3	612464.0 | ARRDC3, TLIMP, KIAA1376 | Arrestin domain-containing 3 | 57561.0 | ENSG00000113369 | nan | nan
chr5	NR2F1	132890.0 | NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS | Nuclear receptor subfamily 2, group F, member 1 (transcription factor COUP 1) | 7025.0 | ENSG00000175745 | nan | Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3), Autosomal dominant
chr5	KIAA0825	617266.0 | KIAA0825, PAPA10 | KIAA0825 gene | 285600.0 | ENSG00000185261 | nan | Polydactyly, postaxial, type A10, 618498 (3), Autosomal recessive
chr5	SLF1	618467.0 | SLF1, BRCTX | SMC5-SMC6 complex localization factor 1 | 84250.0 | ENSG00000133302 | nan | nan
chr5	MCTP1	616296.0 | MCTP1 | Multiple C2 domains-containing transmembrane protein 1 | 79772.0 | ENSG00000175471 | nan | nan
chr5	SKIC3	614589.0 | SKIC3, TTC37, KIAA0372 | SKI3 subunit of superkiller complex | 9652.0 | ENSG00000198677 | nan | Trichohepatoenteric syndrome 1, 222470 (3), Autosomal recessive
chr5	ARSK	610011.0 | ARSK, MPS10 | Arylsulfatase K | 153642.0 | ENSG00000164291 | nan | Mucopolysaccharidosis, type X, 619698 (3), Autosomal recessive
chr5	SPATA9	608039.0 | SPATA9 | Spermatogenesis associated 9 | 83890.0 | ENSG00000145757 | nan | nan
chr5	RHOBTB3	607353.0 | RHOBTB3, KIAA0878 | Rho-related BTB domain-containing protein 3 | 22836.0 | ENSG00000164292 | nan | nan
chr5	GLRX	600443.0 | GLRX, GRX | Glutaredoxin (thioltransferase) | 2745.0 | ENSG00000173221 | nan | nan
chr5	ELL2	601874.0 | ELL2 | Elongation factor, RNA polymerase II, 2 | 22936.0 | ENSG00000118985 | nan | nan
chr5	CAST	114090.0 | CAST, PLACK | Calpastatin | 831.0 | ENSG00000310517 | nan | Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3), Autosomal recessive
chr5	PCSK1	162150.0 | PCSK1, NEC1, PC1, PC3, BMIQ12 | Proprotein convertase subtilisin/kexin type 1 | 5122.0 | ENSG00000175426 | nan | {Obesity, susceptibility to, BMIQ12}, 612362 (3); Endocrinopathy due to proprotein convertase 1/3 deficiency, 600955 (3), Autosomal recessive
chr5	ERAP1	606832.0 | ERAP1, ALAP, ARTS1, PILSAP, KIAA0525 | Endoplasmic reticulum aminopeptidase 1 | 51752.0 | ENSG00000164307 | nan | nan
chr5	ERAP2	609497.0 | ERAP2, LRAP | Endoplasmic reticulum aminopeptidase 2 | 64167.0 | ENSG00000164308 | nan | nan
chr5	LNPEP	151300.0 | LNPEP | Leucyl-cystinyl aminopeptidase | 4012.0 | ENSG00000113441 | nan | nan
chr5	LIX1	610466.0 | LIX1 | Limb and CNS expressed 1 | 167410.0 | ENSG00000145721 | nan | nan
chr5	RIOK2	617754.0 | RIOK2, RIO2 | RIO kianse 2 | 55781.0 | ENSG00000058729 | nan | nan
chr5	RGMB	612687.0 | RGMB, DRAGON | RGM domain family, member B | 285704.0 | ENSG00000174136 | nan | nan
chr5	CHD1	602118.0 | CHD1, PILBOS | Chromodomain helicase DNA binding protein-1 | 1105.0 | ENSG00000153922 | nan | Pilarowski-Bjornsson syndrome, 617682 (3), Autosomal dominant
chr5	MGR8	609570.0 | MGR8 | Migraine, susceptibility to, 8 | 100188790.0 | nan | nan | {Migraine, susceptibility to, 8}, 609570 (2)
chr5	ST8SIA4	602547.0 | PST, PST1 | Polysialyltransferase | 7903.0 | ENSG00000113532 | nan | nan
chr5	SLCO4C1	609013.0 | SLCO4C1, OATP4C1 | Solute carrier organic anion transporter family, member 4C1 | 353189.0 | ENSG00000173930 | nan | nan
chr5	SLCO6A1	613365.0 | SLCO6A1, GST | Solute carrier organic anion transporter family, member 6A1 | 133482.0 | ENSG00000205359 | nan | nan
chr5	PAM	170270.0 | PAM | Peptidylglycine alpha-amidating monooxygenase | 5066.0 | ENSG00000145730 | nan | nan
chr5	PPIP5K2	611648.0 | PPIP5K2, HISPPD1, VIP2, KIAA0433, DFNB100 | Histidine acid phosphatase domain-containing protein 1 | 23262.0 | ENSG00000145725 | nan | Deafness, autosomal recessive 100, 618422 (3), Autosomal recessive
chr5	MACIR	616608.0 | MACIR, C5orf30 | Macrophage immunometabolism regulator | 90355.0 | ENSG00000181751 | nan | nan
chr5	NUDT12	609232.0 | NUDT12 | Nudix hydrolase 12 | 83594.0 | ENSG00000112874 | nan | nan
chr5		608970.0 | MDBS2 | Macular dystrophy, butterfly-shaped pigmentary, 2 | nan | nan | between D5S433 and D5S410 | Macular dystrophy, butterfly-shaped pigmentary, 2, 608970 (2), Autosomal dominant
chr5	EFNA5	601535.0 | EFNA5, EPLG7, LERK7 | Ephrin A5 | 1946.0 | ENSG00000184349 | nan | nan
chr5	FBXL17	609083.0 | FBXL17, FBL17, FBX13, FBXO13 | F-box and leucine-rich repeat protein 17 | 64839.0 | ENSG00000145743 | nan | nan
chr5	RPS20P3	180463.0 | RPS20A | Ribosomal protein S20A | 6225.0 | nan | ?pseudogene | nan
chr5	FER	176942.0 | FER, TYK3 | fer (fps/fes related) tyrosine kinase | 2241.0 | ENSG00000151422 | nan | nan
chr5	PJA2	619341.0 | PJA2, NEURODAP1 | Praja RING finger ubiquitin ligase 2 | 9867.0 | ENSG00000198961 | nan | nan
chr5	MAN2A1	154582.0 | MAN2A1, MANA2 | Mannosidase, alpha, class 2A, member 1 | 4124.0 | ENSG00000112893 | nan | nan
chr5	EOE2	613412.0 | EOE2 | Esophagitis, eosinophilic, 2 | 100499167.0 | nan | association with rs3806932 | {Esophagitis, eosinophilic, 2}, 613412 (2), Multifactorial
chr5	GLC1M	610535.0 | GLC1M | Glaucoma 1, open angle, M | 777643.0 | nan | between D5S2051 and D5S2090 | Glaucoma 1, open angle, M, 610535 (2), Autosomal dominant
chr5	ZRSR2P1	601079.0 | ZRSR2P1, ZRSR1, U2AF1RS1 | ZRSR2 pseudogene 1 | 7310.0 | ENSG00000212643 | nan | nan
chr5	TMEM232	620143.0 | TMEM232 | Transmembrane protein 232 | 642987.0 | ENSG00000186952 | nan | nan
chr5	SLC25A46	610826.0 | SLC25A46, HMSN6B, PCH1E | Solute carrier family 25, member 46 | 91137.0 | ENSG00000164209 | nan | Neuropathy, hereditary motor and sensory, type VIB, 616505 (3), Autosomal recessive; Pontocerebellar hypoplasia, type 1E, 619303 (3), Autosomal recessive
chr5	TSLP	607003.0 | TSLP | Thymic stromal lymphopoietin | 85480.0 | ENSG00000145777 | nan | nan
chr5	WDR36	609669.0 | WDR36, TAWDRP, GLC1G | WD repeat-containing protein 36 | 134430.0 | ENSG00000134987 | nan | Glaucoma 1, open angle, G, 609887 (3)
chr5	CAMK4	114080.0 | CAMK4 | Ca(2+)-calmodulin-dependent protein kinase type IV of brain | 814.0 | ENSG00000152495 | nan | nan
chr5	STARD4	607049.0 | STARD4 | Start domain-containing protein 4 | 134429.0 | ENSG00000164211 | nan | nan
chr5	NREP	607332.0 | NREP, C5orf13, P311, PTZ17 | Neuronal regeneration-related protein | 9315.0 | ENSG00000134986 | nan | nan
chr5	EPB41L4A	612141.0 | EPB41L4A, EPB41L4, NBL4 | Erythrocyte membrane protein band 4.1-like 4A | 64097.0 | ENSG00000129595 | nan | nan
chr5	APC	611731.0 | APC, GS, FPC, BTPS2, DESMD | APC regulator of WNT signaling pathway | 324.0 | ENSG00000134982 | 150kb distal to MCC | Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant
chr5	SRP19	182175.0 | SRP19 | Signal recognition particle, 19kD | 6728.0 | ENSG00000153037 | within 100kb of APC | nan
chr5	REEP5	125265.0 | REEP5, D5S346, DP1, C5orf18 | Receptor expression-enhancing protein 5 | 7905.0 | ENSG00000129625 | nan | nan
chr5	DCP2	609844.0 | DCP2 | Decapping mRNA 2 | 167227.0 | ENSG00000172795 | nan | nan
chr5	MCC	159350.0 | MCC | MCC regulator of WNT signaling pathway | 4163.0 | ENSG00000171444 | nan | Colorectal cancer, somatic, 114500 (3)
chr5	TSSK1B	610709.0 | TSSK1, STK22D | Testis-specific serine/threonine kinase 1 | 83942.0 | ENSG00000212122 | pseudogene on chr22 | nan
chr5	YTHDC2	616530.0 | YTHDC2, CAHL | YTH domain-containing protein 2 | 64848.0 | ENSG00000047188 | nan | nan
chr5	KCNN2	605879.0 | KCNN2, SK2, DYT34, NEDMAB | Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 2 | 3781.0 | ENSG00000080709 | nan | ?Dystonia 34, myoclonic, 619724 (3), Autosomal dominant; Neurodevelopmental disorder with or without variable movement or behavioral abnormalities, 619725 (3), Autosomal dominant
chr5	TRIM36	609317.0 | TRIM36, RBCC728, ANPH1 | Tripartite motif-containing protein 36 | 55521.0 | ENSG00000152503 | mutation identified in 1 ANPH1 patient | ?Anencephaly 1, 206500 (3), Autosomal recessive
chr5	PGGT1B	602031.0 | PGGT1B | Protein geranylgeranyltransferase type I, beta subunit | 5229.0 | ENSG00000164219 | nan | nan
chr5	FEM1C	608767.0 | FEM1C, KIAA1785 | Fem-1 homolog C | 56929.0 | ENSG00000145780 | nan | nan
chr5	TICAM2	608321.0 | TIRP, TRAM | Toll/interleukin-1 receptor domain-containing protein | 353376.0 | ENSG00000243414 | nan | nan
chr5	TMED7	619990.0 | TMED7, TAG | Transmembrane p24 trafficking protein 7 | 51014.0 | ENSG00000134970 | nan | nan
chr5	CDO1	603943.0 | CDO1 | Cysteine dioxygenase, type 1 | 1036.0 | ENSG00000129596 | nan | nan
chr5	ATG12	609608.0 | ATG12, APG12, FBR93 | Autophagy-related 12 | 9140.0 | ENSG00000145782 | nan | nan
chr5	AP3S1	601507.0 | AP3S1, CLAPS3 | Adaptor-related protein complex 3, sigma 1 subunit | 1176.0 | ENSG00000177879 | previously assigned to chr. 12 by FISH | nan
chr5	SCZD1	181510.0 | SCZD1 | Schizophrenia susceptibility locus, chromosome 5-related | 6377.0 | nan | max lod at D5S820 | {Schizophrenia}, 181500 (2), Autosomal dominant
chr5	LVRN	610046.0 | LVRN | Laeverin | 206338.0 | ENSG00000172901 | nan | nan
chr5	COMMD10	616704.0 | COMMD10 | COMM domain-containing protein 10 | 51397.0 | ENSG00000145781 | nan | nan
chr5	SEMA6A	605885.0 | SEMA6A | Semaphorin 6A | 57556.0 | ENSG00000092421 | nan | nan
chr5	DMXL1	605671.0 | DMXL1 | DMX-like 1 | 1657.0 | ENSG00000172869 | nan | nan
chr5	TNFAIP8	612111.0 | TNFAIP8, SCCS2 | Tumor necrosis factor-alpha-induced protein 8 | 25816.0 | ENSG00000145779 | nan | nan
chr5	HSD17B4	601860.0 | HSD17B4, PRLTS1 | Hydroxysteroid (17-beta) dehydrogenase 4 | 3295.0 | ENSG00000133835 | nan | D-bifunctional protein deficiency, 261515 (3), Autosomal recessive; Perrault syndrome 1, 233400 (3), Autosomal recessive
chr5	FAM170A	618401.0 | FAM170A, ZNFD | Family with sequence similarity 170, member A | 340069.0 | ENSG00000164334 | nan | nan
chr5	PRR16	615931.0 | PRR16, LARGEN | Proline-rich protein 16 | 51334.0 | ENSG00000184838 | nan | nan
chr5	FTMT	608847.0 | FTMT | Ferritin, mitochondrial | 94033.0 | ENSG00000181867 | nan | nan
chr5	SRFBP1	610479.0 | SRFBP1, P49 | Serum response factor binding protein 1 | 153443.0 | ENSG00000151304 | nan | nan
chr5	LOX	153455.0 | LOX, AAT10 | Lysyl oxidase | 4015.0 | ENSG00000113083 | nan | Aortic aneurysm, familial thoracic 10, 617168 (3), Autosomal dominant
chr5	SNCAIP	603779.0 | SNCAIP | Synuclein-alpha-interacting protein (synphilin 1) | 9627.0 | ENSG00000064692 | nan | nan
chr5	SNX2	605929.0 | SNX2 | Sorting nexin 2 | 6643.0 | ENSG00000205302 | nan | nan
chr5	PPIC	123842.0 | PPIC | Peptidyl-prolyl isomerase C | 5480.0 | ENSG00000168938 | nan | nan
chr5	PRDM6	616982.0 | PRDM6, PRISM, PDA3 | PR domain-containing protein 6 | 93166.0 | ENSG00000061455 | nan | Patent ductus arteriosus 3, 617039 (3), Autosomal dominant
chr5	CEP120	613446.0 | CEP120, CCDC100, SRTD13, JBTS31 | Centrosomal protein, 120kD | 153241.0 | ENSG00000168944 | nan | Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3), Autosomal recessive; Joubert syndrome 31, 617761 (3), Autosomal recessive
chr5	CSNK1G3	604253.0 | CSNK1G3 | Casein kinase I, gamma-3 | 1456.0 | ENSG00000151292 | nan | nan
chr5	ZNF608	620972.0 | ZNF608 | Zinc finger protein 608 | 57507.0 | ENSG00000168916 | nan | nan
chr5	GRAMD2B	620182.0 | GRAMD2B | GRAM domain-containing protein 2B | 65983.0 | ENSG00000155324 | nan | nan
chr5	ALDH7A1	107323.0 | ALDH7A1, ATQ1, EPD, PDE, EPEO4 | Aldehyde dehydrogenase 7 family, member A1 (antiquitin 1) | 501.0 | ENSG00000164904 | nan | Epilepsy, early-onset, 4, vitamin B6-dependent, 266100 (3), Autosomal recessive
chr5	PHAX	604924.0 | RNUXA, PHAX | RNA, U small nuclear, export adaptor | 51808.0 | ENSG00000164902 | nan | nan
chr5	LMNB1	150340.0 | LMNB1, ADLD, MCPH26 | Lamin B1 | 4001.0 | ENSG00000113368 | nan | Leukodystrophy, adult-onset, autosomal dominant, 169500 (3), Autosomal dominant; Microcephaly 26, primary, autosomal dominant, 619179 (3), Autosomal dominant
chr5	MARCHF3	613333.0 | MARCH3 | Membrane-associated RING-CH finger protein 3 | 115123.0 | ENSG00000173926 | nan | nan
chr5	MEGF10	612453.0 | MEGF10, KIAA1780, CMYO10A, CMYO10B | Multiple epidermal growth factor-like domains 10 | 84466.0 | ENSG00000145794 | nan | Congenital myopathy 10A, severe variant, 614399 (3), Autosomal recessive; Congenital myopathy 10B, mild variant, 620249 (3), Autosomal recessive
chr5	CTXN3	618746.0 | KABE | Cortexin 3 | 613212.0 | ENSG00000205279 | nan | nan
chr5	SLC12A2	600840.0 | SLC12A2, NKCC1, KILQS | Solute carrier family 12 (sodium/potassium/chloride transporters), member 2 | 6558.0 | ENSG00000064651 | nan | Kilquist syndrome, 619080 (3), Autosomal recessive; Delpire-McNeill syndrome, 619083 (3), Autosomal dominant; Deafness, autosomal dominant 78, 619081 (3), Autosomal dominant
chr5	FBN2	612570.0 | FBN2, CCA, EOMD | Fibrillin-2 | 2201.0 | ENSG00000138829 | nan | Macular degeneration, early-onset, 616118 (3), Autosomal dominant; Contractural arachnodactyly, congenital, 121050 (3), Autosomal dominant
chr5	SLC27A6	604196.0 | SLC27A6, FATP6, VLCSH1 | Solute carrier family 27 (fatty acid transporter), member 6 | 28965.0 | ENSG00000113396 | nan | nan
chr5	ISOC1	620805.0 | ISOC1 | Isochorismatase domain-containing protein 1 | 51015.0 | ENSG00000066583 | nan | nan
chr5	ADAMTS19	607513.0 | ADAMTS19, CVDP2 | ADAM metallopeptidase domain with thrombospondin type 1 motif, 19 | 171019.0 | ENSG00000145808 | nan | Cardiac valvular dysplasia 2, 620067 (3), Autosomal recessive
chr5	MINAR2	620215.0 | MINAR2, KIAA1024L, DFNB120 | Membrane integral NOTCH2-associated receptor 2 | 100127206.0 | ENSG00000186367 | nan | Deafness, autosomal recessive 120, 620238 (3), Autosomal recessive
chr5	CHSY3	609963.0 | CHSY3, CSS3 | Chondroitin sulfate synthase 3 | 337876.0 | ENSG00000198108 | nan | nan
chr5	HINT1	601314.0 | HINT1, PRKCNH1, NMAN | Histidine triad nucleotide-binding protein 1 (protein kinase C inhibitor 1) | 3094.0 | ENSG00000169567 | nan | Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3), Autosomal recessive
chr5	LYRM7	615831.0 | LYRM7, MZM1L, MC3DN8 | LYR motif-containing protein 7 | 90624.0 | ENSG00000186687 | nan | Mitochondrial complex III deficiency, nuclear type 8, 615838 (3), Autosomal recessive
chr5	AITD2	608174.0 | AITD2 | Autoimmune thyroid disease, susceptibility to, 2 | 387579.0 | nan | nan | {Autoimmune thyroid disease, susceptibility to, 2}, 608174 (2)
chr5	ATOD6	605845.0 | ATOD6 | Dermatitis, atopic, 6 | 114477.0 | nan | between D5S436 and D5S643 | {Dermatitis, atopic, susceptibility to, 6}, 605845 (2)
chr5	CELIAC2	609754.0 | CELIAC2 | Celiac disease, susceptibility to, 2 | 317782.0 | nan | nan | {Celiac disease, susceptibility to, 2}, 609754 (2)
chr5	DFNA54	615649.0 | DFNA54 | Deafness, autosomal dominant 54 | 448962.0 | nan | between D5S1972 and D5S410 | Deafness, autosomal dominant 54, 615649 (2), Autosomal dominant
chr5	EOS	131400.0 | EOS | Eosinophilia, familial | 7908.0 | nan | nan | Eosinophilia, familial, 131400 (2), Autosomal dominant
chr5	IBD5	606348.0 | IBD5 | Inflammatory bowel disease 5 | 50941.0 | nan | nan | {Inflammatory bowel disease 5}, 606348 (2)
chr5	IDDM18	605598.0 | IDDM18 | Insulin-dependent diabetes mellitus-18 | 57044.0 | nan | close to IL12B | {Diabetes mellitus, insulin-dependent, 18}, 605598 (2)
chr5	IGES	147061.0 | IGES | Immunoglobulin E concentration, serum | 3478.0 | nan | nan | {?Allergy and asthma susceptibility}, 147061 (2)
chr5		186550.0 | LBNBG | Liebenberg syndrome | nan | nan | nan | Liebenberg syndrome, 186550 (4), Autosomal dominant
chr5	PCDHA@	604966.0 | PCDHA@ | Protocadherin-alpha gene cluster | 56117.0 | nan | nan | nan
chr5	PCDHB@	604967.0 | PCDHB@ | Protocadherin-beta gene cluster | 56116.0 | nan | nan | nan
chr5	PCDHG@	604968.0 | PCDHG | Protocadherin-gamma gene cluster | 56115.0 | nan | nan | nan
chr5	PDB4	606263.0 | PDB4 | Paget disease of bone 4 | 94003.0 | nan | nan | Paget disease of bone 4, 606263 (2), Autosomal dominant
chr5	PFBI	248310.0 | PFBI | Plasmodium falciparum blood infection levels | 7910.0 | nan | nan | {Malaria, intensity of infection}, 248310 (2), Autosomal recessive
chr5	PSORS11	612599.0 | PSORS11 | Psoriasis susceptibility 11 | 100271719.0 | nan | associated with rs10045431 | {Psoriasis susceptibility 11}, 612599 (2)
chr5	RLS8	615197.0 | RLS8 | Restless legs syndrome, susceptibility to, 8 | 101448072.0 | nan | nan | {Restless legs syndrome 8}, 615197 (2)
chr5	SM1	181460.0 | SM1 | Schistosoma mansoni infection, susceptibility/resistance to | 7911.0 | nan | nan | {Schistosoma mansoni infection, susceptibility/resistance to}, 181460 (2), Autosomal dominant
chr5	CDC42SE2	619457.0 | CDC42SE2, SPEC2 | CDC42 small effector 2 | 56990.0 | ENSG00000158985 | nan | nan
chr5	RAPGEF6	610499.0 | RAPGEF6, RAGEF2, PDZGEF2 | RAP guanine nucleotide exchange factor 6 | 51735.0 | ENSG00000158987 | nan | nan
chr5	FNIP1	610594.0 | FNIP1, KIAA1961, IMD93 | Folliculin-interacting protein 1 | 96459.0 | ENSG00000217128 | nan | Immunodeficiency 93 and hypertrophic cardiomyopathy, 619705 (3), Autosomal recessive
chr5	MEIKIN	616232.0 | MEIKIN | Meiotic kinetochore factor | 728637.0 | ENSG00000239642 | nan | nan
chr5	ACSL6	604443.0 | ACSL6, FACL6, ACS2 | Acyl-CoA synthetase long-chain family member 6 | 23305.0 | ENSG00000164398 | nan | nan
chr5	IL3	147740.0 | IL3 | Interleukin-3 | 3562.0 | ENSG00000164399 | 9kb from CSF2; order: cen-5'IL3-5'CF2-qter | nan
chr5	CSF2	138960.0 | CSF2, GMCSF | Colony-stimulating factor-2 (granulocyte-macrophage) | 1437.0 | ENSG00000164400 | order: cen-CSF2-CSF1-FMS-qter | nan
chr5	P4HA2	600608.0 | P4HA2, MYP25 | Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 2 | 8974.0 | ENSG00000072682 | nan | Myopia 25, autosomal dominant, 617238 (3), Autosomal dominant
chr5	PDLIM4	603422.0 | RIL | LIM domain protein ril | 8572.0 | ENSG00000131435 | nan | {Osteoporosis, susceptibility to}, 166710 (3), Autosomal dominant
chr5	SLC22A4	604190.0 | SLC22A4, OCTN1 | Solute carrier family 22 (organic cation transporter), member 4 | 6583.0 | ENSG00000197208 | nan | {Rheumatoid arthritis, susceptibility to}, 180300 (3)
chr5	SLC22A5	603377.0 | SLC22A5, OCTN2, CDSP, SCD | Solute carrier, family 22 (organic cation transporter), member 5 | 6584.0 | ENSG00000197375 | nan | Carnitine deficiency, systemic primary, 212140 (3), Autosomal recessive
chr5	IRF1	147575.0 | IRF1, MAR, IMD117 | Interferon regulatory factor-1 | 3659.0 | ENSG00000125347 | nan | Nonsmall cell lung cancer, somatic, 211980 (3); Gastric cancer, somatic, 613659 (3); Immunodeficiency 117, mycobacteriosis, autosomal recessive, 620668 (3), Autosomal recessive
chr5	IL5	147850.0 | IL5 | Interleukin-5 | 3567.0 | ENSG00000113525 | < 310kb from IL4 | nan
chr5	RAD50	604040.0 | RAD50, NBSLD | RAD50 double strand break repair protein | 10111.0 | ENSG00000113522 | nan | Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive
chr5	IL13	147683.0 | IL13, ALRH, BHR1 | Interleukin-13 | 3596.0 | ENSG00000169194 | nan | {Asthma, susceptibility to}, 600807 (3), Autosomal dominant; {Allergic rhinitis, susceptibility to}, 607154 (3)
chr5	IL4	147780.0 | IL4 | Interleukin-4 | 3565.0 | ENSG00000113520 | nan | nan
chr5	KIF3A	604683.0 | KIF3A | Kinesin family member 3A | 11127.0 | ENSG00000131437 | nan | nan
chr5	CCNI2	620419.0 | CCNI2 | Cyclin I family, member 2 | 645121.0 | ENSG00000205089 | nan | nan
chr5	SEPTIN8	608418.0 | SEPT8, KIAA0202 | Septin 8 | 23176.0 | ENSG00000164402 | nan | nan
chr5	SHROOM1	611179.0 | SHROOM1, APXL2, KIAA1960 | SHROOM family member 1 | 134549.0 | ENSG00000164403 | nan | nan
chr5	GDF9	601918.0 | GDF9, POF14 | Growth/differentiation factor 9 | 2661.0 | ENSG00000164404 | nan | Premature ovarian failure 14, 618014 (3), Autosomal recessive
chr5	UQCRQ	612080.0 | UQCRQ, QPC, MC3DN4 | Ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kD | 27089.0 | ENSG00000164405 | nan | Mitochondrial complex III deficiency, nuclear type 4, 615159 (3), Autosomal recessive
chr5	LEAP2	611373.0 | LEAP2 | Liver-expressed antimicrobial peptide 2 | 116842.0 | ENSG00000164406 | nan | nan
chr5	AFF4	604417.0 | AFF4, AF5Q31, CHOPS | AF4/FMR2 family, member 4 | 27125.0 | ENSG00000072364 | nan | CHOPS syndrome, 616368 (3), Autosomal dominant
chr5	HSPA4	601113.0 | HSPA4 | Heat-shock protein family A (HSP70), member 4 | 3308.0 | ENSG00000170606 | nan | nan
chr5	WSPAR	616333.0 | WSPAR, lncTCF7 | WNT signaling pathway activating noncoding RNA | 105664404.0 | ENSG00000249073 | nan | nan
chr5	VDAC1	604492.0 | VDAC1 | Voltage-dependent anion channel 1 | 7416.0 | ENSG00000213585 | nan | nan
chr5	TCF7	189908.0 | TCF7 | Transcription factor-7, T-cell specific | 6932.0 | ENSG00000081059 | originally called TCF-1 | nan
chr5	SKP1	601434.0 | SKP1, SKP1A, TCEB1L, OCP2 | S-phase kinase-associated protein 1 (p19A) | 6500.0 | ENSG00000113558 | pseudogene on chr.7 | nan
chr5	PPP2CA	176915.0 | PPP2CA, NEDLBA, HJS3 | Protein phosphatase-2 (formerly 2A), catalytic subunit, alpha isoform | 5515.0 | ENSG00000113575 | nan | Houge-Janssens syndrome 3, 618354 (3), Autosomal dominant
chr5	CDKL3	608459.0 | CDKL3, NKIAMRE | Cyclin-dependent kinase-like 3 | 51265.0 | ENSG00000006837 | nan | nan
chr5	UBE2B	179095.0 | UBE2B, RAD6B | Ubiquitin-conjugating enzyme E2 B | 7320.0 | ENSG00000119048 | nan | nan
chr5	JADE2	610515.0 | PHF15, JADE2, KIAA0239 | PHD finger protein 15 | 23338.0 | ENSG00000043143 | nan | nan
chr5	SAR1B	607690.0 | SAR1B, CMRD, SARA2, ANDD | Secretion-associated Ras-related GTPase 1B | 51128.0 | ENSG00000152700 | nan | Chylomicron retention disease, 246700 (3), Autosomal recessive
chr5	SEC24A	607183.0 | SEC24A | SEC24-related gene family, member A | 10802.0 | ENSG00000113615 | nan | nan
chr5	CAMLG	601118.0 | CAMLG, CDG2Z | Calcium-modulating cyclophilin ligand | 819.0 | ENSG00000164615 | mutation identified in 1 CDG2Z patient | ?Congenital disorder of glycosylation, type IIz, 620201 (3), Autosomal recessive
chr5	DDX46	617848.0 | DDX46, PRP5, KIAA0801 | DEAD-box helicase 46 | 9879.0 | ENSG00000145833 | nan | nan
chr5	TXNDC15	617778.0 | TXNDC15, C5orf14, BUG, MKS14 | Thioredoxin domain-containing protein 15 | 79770.0 | ENSG00000113621 | nan | Meckel syndrome 14, 619879 (3), Autosomal recessive
chr5	PCBD2	609836.0 | PCBD2, DCOH2, DCOHM | Pterin-4-alpha-carbinolamine dehydratase 2 | 84105.0 | ENSG00000132570 | nan | nan
chr5	CATSPER3	609120.0 | CATSPER3, CACRC | Cation channel, sperm-associated, 3 | 347732.0 | ENSG00000152705 | nan | nan
chr5	PITX1	602149.0 | PITX1, PTX1, BFT, POTX, CCF | Paired-like homeodomain transcription factor-1 | 5307.0 | ENSG00000069011 | nan | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3), Autosomal dominant
chr5	MACROH2A1	610054.0 | MACROH2A1, H2AFY, MH2A1 | MacroH2A.1 histone | 9555.0 | ENSG00000113648 | nan | nan
chr5	DCANP1	609710.0 | C5orf20, DCNP1 | Dendritic cell nuclear protein 1 | 140947.0 | ENSG00000251380 | nan | nan
chr5	TIFAB	612663.0 | TIFAB | TRAF-interacting protein with forkhead-associated domain, family member B | 497189.0 | ENSG00000255833 | nan | nan
chr5	NEUROG1	601726.0 | NEUROG1, NEUROD3, CCDDRD | Neurogenin 1 | 4762.0 | ENSG00000181965 | nan | Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay, 620469 (3), Autosomal recessive
chr5	CXCL14	604186.0 | CXCL14, SCYB14, BRAK | Chemokine, C-X-C motif, ligand 14 | 9547.0 | ENSG00000145824 | nan | nan
chr5	SLC25A48	616150.0 | SLC25A48 | Solute carrier family 25, member 48 | 153328.0 | ENSG00000145832 | nan | nan
chr5	IL9	146931.0 | IL9 | Interleukin-9 | 3578.0 | ENSG00000145839 | nan | nan
chr5	FBXL21P	609087.0 | FBXL21, FBL21, FBXL3B, FBL3B | F-box and leucine-rich repeat protein 21 | 26223.0 | nan | nan | nan
chr5	LECT2	602882.0 | LECT2 | Leukocyte cell-derived chemotaxin 2 | 3950.0 | ENSG00000145826 | nan | nan
chr5	TGFBI	601692.0 | TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD | Transforming growth factor, beta-induced, 68kD | 7045.0 | ENSG00000120708 | nan | Corneal dystrophy, Avellino type, 607541 (3), Autosomal dominant; Corneal dystrophy, Reis-Bucklers type, 608470 (3), Autosomal dominant; Corneal dystrophy, Thiel-Behnke type, 602082 (3), Autosomal dominant; Corneal dystrophy, Groenouw type I, 121900 (3), Autosomal dominant; Corneal dystrophy, epithelial basement membrane, 121820 (3), Autosomal dominant; Corneal dystrophy, lattice type I, 122200 (3), Autosomal dominant; Corneal dystrophy, lattice type IIIA, 608471 (3), Autosomal dominant
chr5	VTRNA2-1	614938.0 | VTRNA2-1, NC886, CBL3, VTRNA2 | Vault RNA 2-1 | 100126299.0 | ENSG00000270123 | nan | nan
chr5	SMAD5-AS1	620035.0 | SMAD5AS1, DAMS | SMAD5 antisense RNA1, noncoding | 9597.0 | ENSG00000164621 | nan | nan
chr5	SMAD5	603110.0 | MADH5, SMAD5 | Mothers against decapentaplegic, Drosophila, homolog of, 5 | 4090.0 | ENSG00000113658 | nan | nan
chr5	SPOCK1	602264.0 | SPOCK | Testican | 6695.0 | ENSG00000152377 | previously mapped to chr.21 | nan
chr5	KLHL3	605775.0 | KLHL3, PHA2D | Kelch-like 3 | 26249.0 | ENSG00000146021 | nan | Pseudohypoaldosteronism, type IID, 614495 (3), Autosomal recessive, Autosomal dominant
chr5	MIR874	619450.0 | MIR874 | Micro RNA 874 | 100126343.0 | ENSG00000216009 | nan | nan
chr5	HNRNPA0	609409.0 | HNRPA0 | Heterogeneous nuclear ribonucleoprotein A0 | 10949.0 | ENSG00000177733 | nan | nan
chr5	NPY6R	601770.0 | NPY6R, PP2 | Neuropeptide Y receptor Y6 | 4888.0 | ENSG00000293504 | ?nonfunctional pseudogene | nan
chr5	MYOT	604103.0 | MYOT, TTOD, MFM3 | Myotilin (titin immunoglobulin domain protein) | 9499.0 | ENSG00000120729 | nan | Myopathy, myofibrillar, 3, 609200 (3), Autosomal dominant
chr5	PKD2L2	604669.0 | PKD2L2 | Polycystin 2-like 2 | 27039.0 | ENSG00000078795 | nan | nan
chr5	FAM13B	609371.0 | FAM13B, C5orf5 | Family with sequence similarity 13, member B | 51306.0 | ENSG00000031003 | nan | nan
chr5	WNT8A	606360.0 | WNT8A | Wingless-type MMTV integration site family, member 8A | 7478.0 | ENSG00000061492 | nan | nan
chr5	NME5	603575.0 | NME5, NM23H5, CILD48 | NME/NM23 family, member 5 | 8382.0 | ENSG00000112981 | nan | Ciliary dyskinesia, primary, 48, without situs inversus, 620032 (3), Autosomal recessive
chr5	BRD8	602848.0 | BRD8, SMAP | Bromodomain-containing protein 8 | 10902.0 | ENSG00000112983 | nan | nan
chr5	KIF20A	605664.0 | KIF20A, RAB6KIFL, RCM6 | Kinesin family member 20A | 10112.0 | ENSG00000112984 | mutation identified in 1 RCM6 family | ?Cardiomyopathy, familial restrictive, 6, 619433 (3), Autosomal recessive
chr5	CDC23	603462.0 | CDC23, APC8 | Cell division cycle 23 (anaphase-promoting complex 8) | 8697.0 | ENSG00000094880 | nan | nan
chr5	GFRA3	605710.0 | GFRA3 | GDNF family receptor alpha-3 | 2676.0 | ENSG00000146013 | nan | nan
chr5	CDC25C	157680.0 | CDC25C | Cell division cycle 25C | 995.0 | ENSG00000158402 | nan | nan
chr5	FAM53C	609372.0 | FAM53C, C5orf6 | Family with sequence similarity 53, member C | 51307.0 | ENSG00000120709 | nan | nan
chr5	KDM3B	609373.0 | KDM3B, C5orf7, KIAA1082, JMJD1B, DIJOS | Lysine demethylase 3B | 51780.0 | ENSG00000120733 | nan | Diets-Jongmans syndrome, 618846 (3), Autosomal dominant
chr5	REEP2	609347.0 | REEP2, C5orf19, SPG72A, SPG72B | Receptor expression-enhancing protein 2 | 51308.0 | ENSG00000132563 | mutation identified in 1 SPG72B family | Spastic paraplegia 72A, autosomal dominant, 615625 (3), Autosomal dominant; ?Spastic paraplegia 72B, autosomal recessive, 620606 (3), Autosomal recessive
chr5	EGR1	128990.0 | EGR1 | Early growth response-1 | 1958.0 | ENSG00000120738 | nan | nan
chr5	ETF1	600285.0 | ETF1, RF1, ERF1 | Eukaryotic translation termination factor-1 | 2107.0 | ENSG00000120705 | nan | nan
chr5	HSPA9	600548.0 | HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4 | Heat-shock 70kD protein-9 (mortalin) | 3313.0 | ENSG00000113013 | nan | Even-plus syndrome, 616854 (3), Autosomal recessive; Anemia, sideroblastic, 4, 182170 (3), Autosomal dominant
chr5	CTNNA1	116805.0 | CTNNA1, MDPT2 | Catenin (cadherin-associated protein), alpha 1, 102kD | 1495.0 | ENSG00000044115 | nan | Macular dystrophy, patterned, 2, 608970 (3), Autosomal dominant
chr5	LRRTM2	610868.0 | LRRTM2, KIAA0416 | Leucine-rich repeat transmembrane protein 2 | 26045.0 | ENSG00000146006 | nan | nan
chr5	SIL1	608005.0 | SIL1, BAP, MSS | SIL1 nucleotide exchange factor | 64374.0 | ENSG00000120725 | nan | Marinesco-Sjogren syndrome, 248800 (3), Autosomal recessive
chr5	MATR3	164015.0 | MATR3, MPD2, ALS21 | Matrin 3 | 9782.0 | ENSG00000015479 | nan | Amyotrophic lateral sclerosis 21, 606070 (3), Autosomal dominant
chr5	PAIP2	605604.0 | PAIP2, PAIP2A | Polyadenylate-binding protein-interacting protein 2 | 51247.0 | ENSG00000120727 | nan | nan
chr5	SLC23A1	603790.0 | SLC23A1, SVCT1 | Solute carrier family 23 (nucleobase transporter), member 1 (sodium-dependent vitamin C transporter 1) | 9963.0 | ENSG00000170482 | opposite orientation to MATR3 | nan
chr5	MZB1	609447.0 | MZB1, PACAP, MGC29506 | Marginal zone B and B1 cell-specific protein | 51237.0 | ENSG00000170476 | nan | nan
chr5	ECSCR	615736.0 | ECSCR, ECSM2, ARIA | Endothelial cell surface-expressed chemotaxis and apoptosis regulator | 641700.0 | ENSG00000249751 | nan | nan
chr5	STING1	612374.0 | STING1, TMEM173, MPYS, SAVI | Stimulator of interferon response cGAMP interactor 1 | 340061.0 | ENSG00000184584 | nan | STING-associated vasculopathy, infantile-onset, 615934 (3), Autosomal dominant
chr5	UBE2D2	602962.0 | UBE2D2, UBCH5B, UBC4 | Ubiquitin-conjugating enzyme E2 D2 | 7322.0 | ENSG00000131508 | nan | nan
chr5	CXXC5	612752.0 | CXXC5 | CXXC finger protein 5 | 51523.0 | ENSG00000171604 | nan | nan
chr5	PSD2	620656.0 | PSD2, EFA6C | Pleckstrin and Sec7 domains-containing protein 2 | 84249.0 | ENSG00000146005 | nan | nan
chr5	NRG2	603818.0 | NRG2 | Neuregulin 2 | 9542.0 | ENSG00000158458 | nan | nan
chr5	HHT3	601101.0 | HHT3, ORW3 | Hereditary hemorrhagic telangiectasia, type 3 | 780903.0 | nan | nan | Telangiectasia, hereditary hemorrhagic, type 3, 601101 (2)
chr5	PURA	600473.0 | PURA, PUR1, NEDRIHF | Purine-rich element binding protein A | 5813.0 | ENSG00000185129 | nan | Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties, 616158 (3), Autosomal dominant
chr5	PFDN1	604897.0 | PFDN1 | Prefoldin 1 | 5201.0 | ENSG00000113068 | nan | nan
chr5	HBEGF	126150.0 | HBEGF, DTR, DTSF, HEGFL | Heparin-binding EGF-like growth factor (diphtheria toxin receptor) | 1839.0 | ENSG00000113070 | nan | {Diphtheria, susceptibility to} (1)
chr5	SLC4A9	610207.0 | SLC4A9, AE4 | Solute carrier family 4 (anion exchanger), member 9 | 83697.0 | ENSG00000113073 | nan | nan
chr5	ANKHD1	610500.0 | ANKHD1, MASK, KIAA1085, VBARP | Ankyrin repeat and KH domain-containing protein 1 | 54882.0 | ENSG00000131503 | nan | nan
chr5	EIF4EBP3	603483.0 | EIF4EBP3 | Eukaryotic translation initiation factor 4E-binding protein 3 | 8637.0 | ENSG00000243056 | nan | nan
chr5	SRA1	603819.0 | SRA1 | Steroid receptor RNA activator 1 | 10011.0 | ENSG00000213523 | nan | nan
chr5	APBB3	602711.0 | APBB3, FE65L2 | Amyloid beta (A4) precursor protein-binding, family B, member 3 | 10307.0 | ENSG00000113108 | nan | nan
chr5	SLC35A4	620297.0 | SLC35A4 | Solute carrier family 35, member A4 | 113829.0 | ENSG00000176087 | nan | nan
chr5	CD14	158120.0 | CD14 | CD14 antigen | 929.0 | ENSG00000170458 | nan | nan
chr5	NDUFA2	602137.0 | NDUFA2, MC1DN13 | NADH-ubiquinone oxidoreductase subunit A2 | 4695.0 | ENSG00000131495 | nan | Mitochondrial complex I deficiency, nuclear type 13, 618235 (3), Autosomal recessive
chr5	IK	600549.0 | IK, RED | IK cytokine, downregulator of HLA II | 3550.0 | ENSG00000113141 | nan | nan
chr5	WDR55	620832.0 | WDR55 | WD repeat-containing protein 55 | 54853.0 | ENSG00000120314 | nan | nan
chr5	DND1	609385.0 | DND1 | DND micro RNA-mediated repression inhibitor 1 | 373863.0 | ENSG00000256453 | nan | nan
chr5	HARS1	142810.0 | HARS1, HARS, USH3B, CMT2W | Histidyl-tRNA synthetase 1 | 3035.0 | ENSG00000170445 | nan | Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3), Autosomal dominant; Usher syndrome type 3B, 614504 (3), Autosomal recessive
chr5	HARS2	600783.0 | HARS2, HARSL, HARSR, HO3, PRLTS2 | Histidyl-tRNA synthetase 2 | 23438.0 | ENSG00000112855 | nan | Perrault syndrome 2, 614926 (3), Autosomal recessive
chr5	ZMAT2	619930.0 | ZMAT2, SNU23 | Zinc finger, matrin-type 2 | 153527.0 | ENSG00000146007 | nan | nan
chr5	VTRNA1-1	612695.0 | VTRNA1-1, HVG1, VAULTRC1 | Vault RNA 1-1 | 56664.0 | ENSG00000199990 | nan | nan
chr5	VTRNA1-2	612696.0 | VTRNA1-2, HVG2, VAULTRC2 | Vault RNA 1-2 | 56663.0 | ENSG00000202111 | nan | nan
chr5	VTRNA1-3	612697.0 | VTRNA1-3, HVG3, VAULTRC3 | Vault RNA 1-3 | 56662.0 | ENSG00000202515 | nan | nan
chr5	PCDHA1	606307.0 | PCDHA1 | Protocadherin-alpha 1 | 56147.0 | ENSG00000204970 | nan | nan
chr5	PCDHA2	606308.0 | PCDHA2 | Protocadherin-alpha 2 | 56146.0 | ENSG00000204969 | nan | nan
chr5	PCDHA3	606309.0 | PCDHA3 | Protocadherin-alpha 3 | 56145.0 | ENSG00000255408 | nan | nan
chr5	PCDHA4	606310.0 | PCDHA4 | Protocadherin-alpha 4 | 56144.0 | ENSG00000204967 | nan | nan
chr5	PCDHA5	606311.0 | PCDHA5 | Protocadherin-alpha 5 | 56143.0 | ENSG00000204965 | nan | nan
chr5	PCDHA6	606312.0 | PCDHA6 | Protocadherin-alpha 6 | 56142.0 | ENSG00000081842 | nan | nan
chr5	PCDHA7	606313.0 | PCDHA7 | Protocadherin-alpha 7 | 56141.0 | ENSG00000204963 | nan | nan
chr5	PCDHA8	606314.0 | PCDHA8 | Protocadherin-alpha 8 | 56140.0 | ENSG00000204962 | nan | nan
chr5	PCDHA9	606315.0 | PCDHA9 | Protocadherin-alpha 9 | 9752.0 | ENSG00000204961 | nan | nan
chr5	PCDHA10	606316.0 | PCDHA10 | Protocadherin-alpha 10 | 56139.0 | ENSG00000250120 | nan | nan
chr5	PCDHA11	606317.0 | PCDHA11 | Protocadherin-alpha 11 | 56138.0 | ENSG00000249158 | nan | nan
chr5	PCDHA12	606318.0 | PCDHA12 | Protocadherin-alpha 12 | 56137.0 | ENSG00000251664 | nan | nan
chr5	PCDHA13	606319.0 | PCDHA13 | Protocadherin-alpha 13 | 56136.0 | ENSG00000239389 | nan | nan
chr5	PCDHAC1	606320.0 | PCDHAC1 | Protocadherin-alpha, subfamily C, member 1 | 56135.0 | ENSG00000248383 | nan | nan
chr5	PCDHAC2	606321.0 | PCDHAC2 | Protocadherin-alpha, subfamily C, member 2 | 56134.0 | ENSG00000243232 | nan | nan
chr5	PCDHB1	606327.0 | PCDHB1 | Protocadherin-beta 1 | 29930.0 | ENSG00000171815 | nan | nan
chr5	PCDHB2	606328.0 | PCDHB2 | Protocadherin-beta 2 | 56133.0 | ENSG00000112852 | nan | nan
chr5	PCDHB3	606329.0 | PCDHB3 | Protocadherin-beta 3 | 56132.0 | ENSG00000113205 | nan | nan
chr5	PCDHB4	606330.0 | PCDHB4 | Protocadherin-beta 4 | 56131.0 | ENSG00000081818 | nan | nan
chr5	PCDHB5	606331.0 | PCDHB5 | Protocadherin-beta 5 | 26167.0 | ENSG00000113209 | nan | nan
chr5	PCDHB6	606332.0 | PCDHB6 | Protocadherin-beta 6 | 56130.0 | ENSG00000113211 | nan | nan
chr5	PCDHB7	606333.0 | PCDHB7 | Protocadherin-beta 7 | 56129.0 | ENSG00000113212 | nan | nan
chr5	PCDHB8	606334.0 | PCDHB8 | Protocadherin-beta 8 | 56128.0 | ENSG00000120322 | nan | nan
chr5	PCDHB16	606345.0 | PCDHB16 | Protocadherin-beta 16 | 57717.0 | ENSG00000272674 | nan | nan
chr5	PCDHB9	606335.0 | PCDHB9 | Protocadherin-beta 9 | 56127.0 | ENSG00000177839 | nan | nan
chr5	PCDHB10	606336.0 | PCHB10 | Protocadherin-beta 10 | 56126.0 | ENSG00000120324 | nan | nan
chr5	PCDHB11	606337.0 | PCDHB11 | Protocadherin-beta 11 | 56125.0 | ENSG00000197479 | nan | nan
chr5	PCDHB12	606338.0 | PCDHB12 | Protocadherin-beta 12 | 56124.0 | ENSG00000120328 | nan | nan
chr5	PCDHB13	606339.0 | PCDHB13 | Protocadherin-beta 13 | 56123.0 | ENSG00000187372 | nan | nan
chr5	PCDHB14	606340.0 | PCDHB14 | Protocadherin-beta 14 | 56122.0 | ENSG00000120327 | nan | nan
chr5	PCDHB15	606341.0 | PCDHB15 | Protocadherin-beta 15 | 56121.0 | ENSG00000113248 | nan | nan
chr5	SLC25A2	608157.0 | SLC25A2, ORNT2 | Solute carrier family 25 (mitochondrial carrier, ornithine transporter), member 2 | 83884.0 | ENSG00000120329 | nan | nan
chr5	TAF7	600573.0 | TAF7, TAF2F, TAFII55 | TAF7 RNA polymerase II, TATA box-binding protein-associated factor, 55kD | 6879.0 | ENSG00000178913 | nan | nan
chr5	PCDHGA1	606288.0 | PCDHGA1 | Protocadherin-gamma, subfamily A, member 1 | 56114.0 | ENSG00000204956 | nan | nan
chr5	PCDHGA2	606289.0 | PCDHGA2 | Protocadherin-gamma, subfamily A, member 2 | 56113.0 | ENSG00000081853 | nan | nan
chr5	PCDHGA3	606290.0 | PCDHGA3 | Protocadherin-gamma, subfamily A, member 3 | 56112.0 | ENSG00000254245 | nan | nan
chr5	PCDHGB1	606299.0 | PCDHGB1 | Protocadherin-gamma, subfamily B, member 1 | 56104.0 | ENSG00000254221 | nan | nan
chr5	PCDHGA4	606291.0 | PCDHGA4 | Protocadherin-gamma, subfamily A, member 4 | 56111.0 | ENSG00000262576 | nan | nan
chr5	PCDHGB2	606300.0 | PCDHGB2 | Protocadherin-gamma, subfamily B, member 2 | 56103.0 | ENSG00000253910 | nan | nan
chr5	PCDHGA5	606292.0 | PCDHGA5 | Protocadherin-gamma, subfamily A, member 5 | 56110.0 | ENSG00000253485 | nan | nan
chr5	PCDHGB3	606301.0 | PCDHGB3 | Protocadherin-gamma, subfamily B, member 3 | 56102.0 | ENSG00000262209 | nan | nan
chr5	PCDHGA6	606293.0 | PCDHGA6 | Protocadherin-gamma, subfamily A, member 6 | 56109.0 | ENSG00000253731 | nan | nan
chr5	PCDHGA7	606294.0 | PCDHGA7 | Protocadherin-gamma, subfamily A, member 7 | 56108.0 | ENSG00000253537 | nan | nan
chr5	PCDHGB4	603058.0 | PCDHGB4 | Protocadherin-gamma, subfamily B, member 4 | 8641.0 | ENSG00000253953 | nan | nan
chr5	PCDHGA8	606295.0 | PCDHGA8 | Protocadherin-gamma, subfamily A, member 8 | 9708.0 | ENSG00000253767 | nan | nan
chr5	PCDHGB5	606302.0 | PCDHGB5 | Protocadherin-gamma, subfamily B, member 5 | 56101.0 | ENSG00000276547 | nan | nan
chr5	PCDHGA9	606296.0 | PCDHGA9 | Protocadherin-gamma, subfamily A, member 9 | 56107.0 | ENSG00000261934 | nan | nan
chr5	PCDHGB6	606303.0 | PCDHGB6 | Protocadherin-gamma, subfamily B, member 6 | 56100.0 | ENSG00000253305 | nan | nan
chr5	PCDHGA10	606297.0 | PCDHGA10 | Protocadherin-gamma, subfamily A, member 10 | 56106.0 | ENSG00000253846 | nan | nan
chr5	PCDHGB7	606304.0 | PCDHGB7 | Protocadherin-gamma, subfamily B, member 7 | 56099.0 | ENSG00000254122 | nan | nan
chr5	PCDHGA11	606298.0 | PCDHGA11 | Protocadherin-gamma, subfamily A, member 11 | 56105.0 | ENSG00000253873 | nan | nan
chr5	PCDHGA12	603059.0 | PCDHGA12 | Protocadherin-gamma, subfamily A, member 12 | 26025.0 | ENSG00000253159 | nan | nan
chr5	PCDHGC3	603627.0 | PCDHGC3 | Protocadherin-gamma, subfamily C, member 3 | 5098.0 | ENSG00000240184 | nan | nan
chr5	PCDHGC4	606305.0 | PCDHGC4, NEDGS | Protocadherin-gamma, subfamily C, member 4 | 56098.0 | ENSG00000242419 | nan | Neurodevelopmental disorder with poor growth and skeletal anomalies, 619880 (3), Autosomal recessive
chr5	PCDHGC5	606306.0 | PCDHGC5 | Protocadherin-gamma, subfamily C, member 5 | 56097.0 | ENSG00000240764 | nan | nan
chr5	DIAPH1	602121.0 | DIAPH1, DFNA1, LFHL1, SCBMS | Diaphanous-related formin 1 | 1729.0 | ENSG00000131504 | nan | Deafness, autosomal dominant 1, with or without thrombocytopenia, 124900 (3), Autosomal dominant; Seizures, cortical blindness, microcephaly syndrome, 616632 (3), Autosomal recessive
chr5	HDAC3	605166.0 | HDAC3 | Histone deacetylase 3 | 8841.0 | ENSG00000171720 | nan | nan
chr5	RELL2	611213.0 | RELL2 | Relt-like 2 | 285613.0 | ENSG00000164620 | nan | nan
chr5	FCHSD1	617555.0 | FCHSD1, NWK2 | FCH and double SH3 domains protein 1 | 89848.0 | ENSG00000197948 | nan | nan
chr5	ARAP3	606647.0 | ARAP3, CENTD3 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 | 64411.0 | ENSG00000120318 | nan | nan
chr5	PCDH1	603626.0 | PCDH1, PC42 | Protocadherin 1 (cadherin-like 1) | 5097.0 | ENSG00000156453 | nan | nan
chr5	DELE1	615741.0 | DELE1, KIAA0141 | DAP3 binding cell death enhancer 1 | 9812.0 | ENSG00000081791 | nan | nan
chr5	PCDH12	605622.0 | PCDH12, VECAD2, DMJDS1 | Protocadherin 12 (cadherin, vascular endothelial, 2) | 51294.0 | ENSG00000113555 | nan | Diencephalic-mesencephalic junction dysplasia syndrome 1, 251280 (3), Autosomal recessive
chr5	RNF14	605675.0 | RNF14, ARA54 | RING finger protein-14 | 9604.0 | ENSG00000013561 | nan | nan
chr5	GNPDA1	601798.0 | GNPDA1, GNP1, GNPI, KIAA0060 | Glucosamine 6-phosphate deaminase 1 | 10007.0 | ENSG00000113552 | nan | nan
chr5	NDFIP1	612050.0 | NDFIP1, N4WBP5 | NEDD4 family-interacting protein 1 | 80762.0 | ENSG00000131507 | nan | nan
chr5	SPRY4	607984.0 | SPRY4, HH17 | SPRY domain containing 4 | 81848.0 | ENSG00000187678 | nan | Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3), Autosomal dominant
chr5	SPRY4-IT1	617617.0 | SPRY4IT1 | SPRY4 intronic transcript 1 | 100642175.0 | nan | in intron 2 of SPRY4 | nan
chr5	FGF1	131220.0 | FGF1, FGFA | Fibroblast growth factor-1 (acidic) | 2246.0 | ENSG00000113578 | nan | nan
chr5	ARHGAP26	605370.0 | ARHGAP26, GRAF | RHO GTPase-activating protein 26 | 23092.0 | ENSG00000145819 | nan | Leukemia, juvenile myelomonocytic, somatic, 607785 (3)
chr5	NR3C1	138040.0 | NR3C1, GCR, GRL, GCRST | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 2908.0 | ENSG00000113580 | nan | Glucocorticoid resistance, 615962 (3), Autosomal dominant
chr5	HMHB1	609961.0 | HLA-HB1 | Minor histocompatibility antigen HB-1 | 57824.0 | ENSG00000158497 | nan | nan
chr5	YIPF5	611483.0 | YIPF5, SMAP5, YIP1A, MEDS2 | Yip1 domain family, member 5 | 81555.0 | ENSG00000145817 | nan | Microcephaly, epilepsy, and diabetes syndrome 2, 619278 (3), Autosomal recessive
chr5	KCTD16	613423.0 | KCTD16, KIAA1317 | Potassium channel tetramerization domain-containing 16 | 57528.0 | ENSG00000183775 | nan | nan
chr5	PRELID2	620750.0 | PRELID2 | PRELI domain-containing protein 2 | 153768.0 | ENSG00000186314 | nan | nan
chr5	GRXCR2	615762.0 | GRXCR2, DFNB101 | Glutaredoxin, cysteine-rich, 2 | 643226.0 | ENSG00000204928 | mutation identified in 1 DFNB101 family | ?Deafness, autosomal recessive 101, 615837 (3), Autosomal recessive
chr5	SH3RF2	613377.0 | SH3RF2, HEPP1 | SH3 domain-containing RING finger protein 2 | 153769.0 | ENSG00000156463 | nan | nan
chr5	LARS1	151350.0 | LARS1, LARS, LFIS, ILFS1 | Leucyl-tRNA synthetase 1 | 51520.0 | ENSG00000133706 | mutation identified in 1 family | ?Infantile liver failure syndrome 1, 615438 (3), Autosomal recessive
chr5	RBM27	620082.0 | RBM27, KIAA1311, PSC1 | RNA-binding motif protein 27 | 54439.0 | ENSG00000091009 | nan | nan
chr5	POU4F3	602460.0 | POU4F3, BRN3C, DFNA15, DFNA52 | POU domain, class 4, transcription factor-3 | 5459.0 | ENSG00000091010 | nan | Deafness, autosomal dominant 15/52, 602459 (3), Autosomal dominant
chr5	TCERG1	605409.0 | TCERG1, TAF2S, CA150 | Transcription elongation regulator 1 (transcription factor CA150) | 10915.0 | ENSG00000113649 | nan | nan
chr5	GPR151	618487.0 | GPR151, GALRL, GALR4 | G protein -coupled receptor 151 | 134391.0 | ENSG00000173250 | nan | nan
chr5	PPP2R2B	604325.0 | PPP2R2B | Protein phosphatase 2, regulatory subunit B, beta | 5521.0 | ENSG00000156475 | nan | Spinocerebellar ataxia 12, 604326 (3), Autosomal dominant
chr5	DPYSL3	601168.0 | DPYSL3, ULIP, DRP3 | Dihydropyrimidinase-like 3 | 1809.0 | ENSG00000113657 | nan | nan
chr5	JAKMIP2	611197.0 | JAKMIP2, JAMIP2, NECC1, KIAA0555 | Janus kinase and microtubule-interacting protein 2 | 9832.0 | ENSG00000176049 | nan | nan
chr5	SPINK1	167790.0 | SPINK1, PSTI, PCTT, TATI, TCP | Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor) | 6690.0 | ENSG00000164266 | nan | Tropical calcific pancreatitis, 608189 (3), Autosomal recessive, Autosomal dominant; Pancreatitis, hereditary, 167800 (3), Autosomal dominant; {Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3), Autosomal recessive, Autosomal dominant
chr5	SCGB3A2	606531.0 | SCGB3A2, UGRP1 | Secretoglobin, family 3A, member 2 (uteroglobin-related protein 1) | 117156.0 | ENSG00000164265 | nan | {Asthma, susceptibility to}, 600807 (3), Autosomal dominant
chr5	SPINK5	605010.0 | SPINK5, LEKTI | Serine protease inhibitor, Kazal type, 5 | 11005.0 | ENSG00000133710 | nan | Netherton syndrome, 256500 (3), Autosomal recessive
chr5	SPINK6	615868.0 | SPINK6 | Serine peptidase inhibitor, KAZAL-type, 6 | 404203.0 | ENSG00000178172 | nan | nan
chr5	SPINK13	615205.0 | SPINK13 | Serine protease inhibitor, Kazal-type, 13 | 153218.0 | ENSG00000214510 | nan | nan
chr5	SPINK7	617288.0 | SPINK7, ECRG2 | Serine peptidase inhibitor, Kazal-type, 7 | 84651.0 | ENSG00000145879 | nan | nan
chr5	SPINK9	613511.0 | SPINK9, LEKTI2 | Serine protease inhibitor, Kazal-type, 9 | 643394.0 | ENSG00000204909 | nan | nan
chr5	FBXO38	608533.0 | FBXO38, FBX38, MOKA, HMND6 | F-box only protein 38 | 81545.0 | ENSG00000145868 | nan | Neuronopathy, distal hereditary motor, autosomal dominant 6, 615575 (3), Autosomal dominant
chr5	HTR4	602164.0 | HTR4 | 5-hydroxytryptamine (serotonin) receptor-4 | 3360.0 | ENSG00000164270 | nan | nan
chr5	ADRB2	109690.0 | ADRB2 | Adrenergic, beta-2-, receptor, surface | 154.0 | ENSG00000169252 | nan | Beta-2-adrenoreceptor agonist, reduced response to (3)
chr5	SH3TC2	608206.0 | SH3TC2, KIAA1985, MNMN | SH3 domain and tetratricopeptide repeat domain 2 | 79628.0 | ENSG00000169247 | nan | Charcot-Marie-Tooth disease, type 4C, 601596 (3), Autosomal recessive; Mononeuropathy of the median nerve, mild, 613353 (3), Autosomal dominant
chr5	ABLIM3	611305.0 | ABLIM3, KIAA0843 | Actin-binding LIM protein family, member 3 | 22885.0 | ENSG00000173210 | nan | nan
chr5	AFAP1L1	614410.0 | AFAP1L1 | Actin filament-associated protein 1-like 1 | 134265.0 | ENSG00000157510 | nan | nan
chr5	GRPEL2	618545.0 | GRPEL2 | GrpE-like 2, mitochondrial | 134266.0 | ENSG00000164284 | nan | nan
chr5	IL17B	604627.0 | IL17B | Interleukin 17B | 27190.0 | ENSG00000127743 | nan | nan
chr5	MIR143	612117.0 | MIR143, MIRN143 | Micro RNA 143 | 406935.0 | ENSG00000284182 | nan | nan
chr5	MIR145	611795.0 | MIR145, MIRN145 | Micro RNA 145 | 406937.0 | ENSG00000276365 | nan | nan
chr5	CSNK1A1	600505.0 | CSNK1A1 | Casein kinase-1, alpha-1 polypeptide | 1452.0 | ENSG00000113712 | previously assigned to 13q13 | nan
chr5	ARHGEF37	620664.0 | ARHGEF37 | Rho guanine nucleotide exchange factor 37 | 389337.0 | ENSG00000183111 | nan | nan
chr5	PPARGC1B	608886.0 | PPARGC1B, PGC1B, PERC | Peroxisome proliferator-activated receptor-gamma, coactivator 1, beta | 133522.0 | ENSG00000155846 | nan | nan
chr5	MIR378A	611957.0 | MIR378, MIRN378 | Micro RNA 378 | 494327.0 | ENSG00000199047 | nan | nan
chr5	PDE6A	180071.0 | PDE6A, PDEA, RP43 | Phosphodiesterase 6A | 5145.0 | ENSG00000132915 | nan | Retinitis pigmentosa 43, 613810 (3), Autosomal recessive
chr5	SLC26A2	606718.0 | SLC26A2, DTD, DTDST, D5S1708, EDM4 | Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter) | 1836.0 | ENSG00000155850 | distal to APC | Epiphyseal dysplasia, multiple, 4, 226900 (3), Autosomal recessive; De la Chapelle dysplasia, 256050 (3), Autosomal recessive; Diastrophic dysplasia, 222600 (3), Autosomal recessive; Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3), Autosomal recessive; Achondrogenesis Ib, 600972 (3), Autosomal recessive; Atelosteogenesis, type II, 256050 (3), Autosomal recessive
chr5	HMGXB3	619800.0 | HMGXB3, KIAA0194 | HMG box-containing protein 3 | 22993.0 | ENSG00000113716 | nan | nan
chr5	RPS20P4	180464.0 | RPS20B | Ribosomal protein S20B | 6226.0 | nan | ?pseudogene | nan
chr5	CSF1R	164770.0 | CSF1R, FMS, HDLS1, BANDDOS | Colony-stimulating factor-1 receptor; oncogene FMS (McDonough feline sarcoma) | 1436.0 | ENSG00000182578 | FMS2 is 5' end | Brain abnormalities, neurodegeneration, and dysosteosclerosis, 618476 (3), Autosomal recessive; Leukoencephalopathy, diffuse hereditary, with spheroids 1, 221820 (3), Autosomal dominant
chr5	PDGFRB	173410.0 | PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS | Platelet-derived growth factor receptor, beta polypeptide | 5159.0 | ENSG00000113721 | fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders | Premature aging syndrome, Penttinen type, 601812 (3), Autosomal dominant; Kosaki overgrowth syndrome, 616592 (3), Autosomal dominant; Myofibromatosis, infantile, 1, 228550 (3), Autosomal dominant; Basal ganglia calcification, idiopathic, 4, 615007 (3), Autosomal dominant; Myeloproliferative disorder with eosinophilia, 131440 (4), Autosomal dominant
chr5	CDX1	600746.0 | CDX1 | Caudal type homeobox transcription factor 1 | 1044.0 | ENSG00000113722 | 100kb distal to CSF1R | nan
chr5	SLC6A7	606205.0 | SLC6A7, PROT | Solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 | 6534.0 | ENSG00000011083 | nan | nan
chr5	CAMK2A	114078.0 | CAMK2A, KIAA0968, CAMKA, MRD53, MRT63 | Calcium/calmodulin-dependent protein kinase II-alpha | 815.0 | ENSG00000070808 | mutation identified in 1 MRT63 family | Intellectual developmental disorder, autosomal dominant 53, 617798 (3), Autosomal dominant; ?Intellectual developmental disorder, autosomal recessive 63, 618095 (3), Autosomal recessive
chr5	ARSI	610009.0 | ARSI | Arylsulfatase I | 340075.0 | ENSG00000183876 | nan | nan
chr5	TCOF1	606847.0 | TCOF1, MFD1, TCS1 | Treacle | 6949.0 | ENSG00000070814 | prox. to SPARC | Treacher Collins syndrome 1, 154500 (3), Autosomal dominant
chr5	FECD5	613269.0 | FECD5, FCD3 | Corneal dystrophy, Fuchs endothelial, 5 | 100380874.0 | nan | flanked by D5S470 and D5S2108 | Corneal dystrophy, Fuchs endothelial, 5, 613269 (2)
chr5	CD74	142790.0 | CD74, DHLAG | CD74 antigen (invariant polypeptide of major histocompatibility class II antigen-associated) | 972.0 | ENSG00000019582 | nan | nan
chr5	RPS14	130620.0 | RPS14, EMTB | Ribosomal protein S14 | 6208.0 | ENSG00000164587 | nan | Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)
chr5	NDST1	600853.0 | NDST1, HSST, MRT46 | N-deacetylase/N-sulfotransferase (heparan sulfate-N-deacetylase/N-sulfotransferase) | 3340.0 | ENSG00000070614 | nan | Intellectual developmental disorder, autosomal recessive 46, 616116 (3), Autosomal recessive
chr5	SYNPO	608155.0 | SYNPO | Synaptopodin | 11346.0 | ENSG00000171992 | nan | nan
chr5	MYOZ3	610735.0 | MYOZ3, FRP3 | Myozenin 3 | 91977.0 | ENSG00000164591 | nan | nan
chr5	RBM22	612430.0 | RBM22 | RNA-binding motif protein 22 | 55696.0 | ENSG00000086589 | nan | nan
chr5	DCTN4	614758.0 | DCTN4, P62, DYN4 | Dynactin 4 | 51164.0 | ENSG00000132912 | nan | nan
chr5	SMIM3	608324.0 | SMIM3, NID67 | Small integral membrane protein 3 | 85027.0 | ENSG00000256235 | nan | nan
chr5	IRGM	608212.0 | IRGM, LRG47, IFI1, IBD19 | Immunity-related GTPase family, M | 345611.0 | ENSG00000237693 | nan | {Mycobacterium tuberculosis, protection against}, 607948 (3); {Inflammatory bowel disease (Crohn disease) 19}, 612278 (3)
chr5	ZNF300	612429.0 | ZNF300 | Zinc finger protein 300 | 91975.0 | ENSG00000145908 | nan | nan
chr5	GPX3	138321.0 | GPX3 | Glutathione peroxidase-3, plasma | 2878.0 | ENSG00000211445 | nan | nan
chr5	TNIP1	607714.0 | TNIP1, NAF1, KIAA0113 | TNFAIP3-interacting protein 1 | 10318.0 | ENSG00000145901 | nan | nan
chr5	ANXA6	114070.0 | ANXA6, CBP68 | Annexin A6 (calcium-binding protein p68) | 309.0 | ENSG00000197043 | nan | nan
chr5	CCDC69	619288.0 | CCDC69 | Coiled-coil domain-containing protein 69 | 26112.0 | ENSG00000198624 | nan | nan
chr5	GM2A	613109.0 | GM2A | GM2 ganglioside activator protein | 2760.0 | ENSG00000196743 | pseudogene on chr.3 | GM2-gangliosidosis, AB variant, 272750 (3), Autosomal recessive
chr5	SLC36A3	608332.0 | SLC36A3, PAT3 | Solute carrier family 36 (proton/amino acid symporter), member 3 | 285641.0 | ENSG00000186334 | nan | nan
chr5	SLC36A2	608331.0 | SLC36A2, PAT2 | Solute carrier family 36 (proton/amino acid symporter), member 2 | 153201.0 | ENSG00000186335 | nan | [Iminoglycinuria], 242600 (3), Autosomal recessive, Digenic recessive; [Hyperglycinuria], 138500 (3), Autosomal dominant
chr5	SLC36A1	606561.0 | SLC36A1, LYAAT1, PAT1 | Solute carrier family 36 (proton/amino acid symporter), member 1 (lysosomal amino acid transporter 1) | 206358.0 | ENSG00000123643 | nan | nan
chr5	FAT2	604269.0 | FAT2, MEGF1, SCA45 | FAT atypical cadherin 2 | 2196.0 | ENSG00000086570 | nan | Spinocerebellar ataxia 45, 617769 (3), Autosomal dominant
chr5	SPARC	182120.0 | SPARC, ON, OI17 | Osteonectin (secreted protein, acidic, cysteine-rich) | 6678.0 | ENSG00000113140 | nan | Osteogenesis imperfecta, type XVII, 616507 (3), Autosomal recessive
chr5	ATOX1	602270.0 | ATOX1, HAH1 | Antioxidant protein 1 (ATX, yeast, homolog of) | 475.0 | ENSG00000177556 | nan | nan
chr5	G3BP1	608431.0 | G3BP1, G3BP | G3BP stress granule assembly factor 1 | 10146.0 | ENSG00000145907 | nan | nan
chr5	GLRA1	138491.0 | GLRA1, STHE, HKPX1 | Glycine receptor, alpha-1 polypeptide | 2741.0 | ENSG00000145888 | nan | Hyperekplexia 1, 149400 (3), Autosomal recessive, Autosomal dominant
chr5	NMUR2	605108.0 | NMUR2, NMU2R, FM4 | Neuromedin U receptor 2 | 56923.0 | ENSG00000132911 | nan | nan
chr5	GRIA1	138248.0 | GRIA1, GLUR1, MRD67, MRT76 | Glutamate receptor, ionotropic, AMPA 1 | 2890.0 | ENSG00000155511 | mutation identified in 1 MRT76 patient | ?Intellectual developmental disorder, autosomal recessive 76, 619931 (3), Autosomal recessive; Intellectual developmental disorder, autosomal dominant 67, 619927 (3), Autosomal dominant
chr5	MFAP3	600491.0 | MFAP3 | Microfibrillar-associated protein-3 | 4238.0 | ENSG00000037749 | nan | nan
chr5	GALNT10	608043.0 | GALNT10, GalNAcT10 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 | 55568.0 | ENSG00000164574 | nan | nan
chr5	SAP30L	610398.0 | SAP30L | SAP30-like protein | 79685.0 | ENSG00000164576 | nan | nan
chr5	HAND1	602406.0 | HAND1, EHAND | Heart- and neural crest derivatives-expressed 1 | 9421.0 | ENSG00000113196 | nan | nan
chr5	LARP1	612059.0 | LARP1, LARP, KIAA0731 | La ribonucleoprotein 1, translational regulator | 23367.0 | ENSG00000155506 | incorrectly mapped to chromosome 10 | nan
chr5	FAXDC2	619853.0 | FAXDC2 | Fatty acid hydroxylase domain-containing protein 2 | 10826.0 | ENSG00000170271 | nan | nan
chr5	CNOT8	603731.0 | CNOT8, CALIF, POP2 | CCR4-NOT transcription complex, subunit 8 | 9337.0 | ENSG00000155508 | nan | nan
chr5	GEMIN5	607005.0 | GEMIN5, NEDCAM | GEM-associated protein 5 | 25929.0 | ENSG00000082516 | nan | Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction, 619333 (3), Autosomal recessive
chr5	MRPL22	611835.0 | MRPL22 | Mitochondrial ribosomal protein L22 | 29093.0 | ENSG00000082515 | nan | nan
chr5	KIF4B	609184.0 | KIF4B | Kinesin family member 4B | 285643.0 | ENSG00000226650 | nan | nan
chr5	SGCD	601411.0 | SGCD, SGD, LGMDR6, CMD1L | Sarcoglycan, delta (35kD dystrophin-associated glycoprotein) | 6444.0 | ENSG00000170624 | mutant in Syrian hamster cardiomyopathy | Cardiomyopathy, dilated, 1L, 606685 (3); Muscular dystrophy, limb-girdle, autosomal recessive 6, 601287 (3), Autosomal recessive
chr5	TIMD4	610096.0 | TIMED4, TIM4, SMUCKLER | T-cell immunoglobulin and mucin domains-containing protein 4 | 91937.0 | ENSG00000145850 | nan | nan
chr5	HAVCR1	606518.0 | HAVCR1, HAVCR | Hepatitis A virus cellular receptor 1 | 26762.0 | ENSG00000113249 | nan | nan
chr5	HAVCR2	606652.0 | HAVCR2, TIM3, SPTCL | Hepatitis A virus cellular receptor 2 | 84868.0 | ENSG00000135077 | nan | T-cell lymphoma, subcutaneous panniculitis-like, 618398 (3), Autosomal recessive
chr5	MED7	605045.0 | MED7, CRSP9, CRSP33 | Mediator complex subunit 7 | 9443.0 | ENSG00000155868 | nan | nan
chr5	GARIN3	619883.0 | GARIN3, FAM71B | Golgi-associated RAB2B interactor family, member 3 | 153745.0 | ENSG00000170613 | nan | nan
chr5	ITK	186973.0 | ITK, EMT, LPFS1 | T-cell-specific tyrosine kinase; homolog of mouse T-cell itk/tsk tyrosine kinase | 3702.0 | ENSG00000113263 | nan | Lymphoproliferative syndrome 1, 613011 (3), Autosomal recessive
chr5	CYFIP2	606323.0 | CYFIP2, DEE65 | Cytoplasmic FMRP interacting protein 2 | 26999.0 | ENSG00000055163 | nan | Developmental and epileptic encephalopathy 65, 618008 (3), Autosomal dominant
chr5	NIPAL4	609383.0 | NIPAL4, ICHYN, ARCI6 | NIPA-like domain-containing 4 | 348938.0 | ENSG00000172548 | nan | Ichthyosis, congenital, autosomal recessive 6, 612281 (3), Autosomal recessive
chr5	ADAM19	603640.0 | ADAM19, MLTNB | ADAM metallopeptidase domain 19 | 8728.0 | ENSG00000135074 | nan | nan
chr5	SOX30	606698.0 | SOX30 | SRY-box 30 | 11063.0 | ENSG00000039600 | nan | nan
chr5	THG1L	618802.0 | THG1L, THG1, ICF45, IHG1, SCAR28 | tRNA-histidine guanylyltransferase 1-like protein | 54974.0 | ENSG00000113272 | nan | Spinocerebellar ataxia, autosomal recessive 28, 618800 (3), Autosomal recessive
chr5	LSM11	617910.0 | LSM11, AGS8 | Lsm11, U7 small nuclear RNA-associated protein | 134353.0 | ENSG00000155858 | mutation identified in 1 AGS8 family | ?Aicardi-Goutieres syndrome 8, 619486 (3), Autosomal recessive
chr5	CLINT1	607265.0 | CLINT1, EPN4, EPNR, KIAA0171 | Clathrin interactor 1 (epsin 4) | 9685.0 | ENSG00000113282 | nan | nan
chr5	EBF1	164343.0 | EBF, OLF1 | Early B-cell factor (olfactory neuronal transcription factor 1) | 1879.0 | ENSG00000164330 | nan | nan
chr5	RNF145	620640.0 | RNF145 | RING finger protein 145 | 153830.0 | ENSG00000145860 | nan | nan
chr5	UBLCP1	609867.0 | UBLCP1 | Ubiquitin-like domain-containing CTD phosphatase 1 | 134510.0 | ENSG00000164332 | nan | nan
chr5	IL12B	161561.0 | IL12B, NKSF2, IMD29 | Interleukin-12B (natural killer cell stimulatory factor-2, cytotoxic lymphocyte maturation factor-2, p40) | 3593.0 | ENSG00000113302 | between GLR1 and GABRA1 | Immunodeficiency 29, mycobacteriosis, 614890 (3), Autosomal recessive
chr5	ADRA1B	104220.0 | ADRA1B | Adrenergic, alpha-1B-, receptor | 147.0 | ENSG00000170214 | nan | nan
chr5	TTC1	601963.0 | TTC1, TPR1 | Tetratricopeptide repeat domain-1 | 7265.0 | ENSG00000113312 | nan | nan
chr5	PWWP2A	617823.0 | PWWP2A | PWWP domain-containing protein 2A | 114825.0 | ENSG00000170234 | nan | nan
chr5	FABP6	600422.0 | FABP6, ILLBP | Fatty acid-binding protein 6, ileal (gastrotropin) | 2172.0 | ENSG00000170231 | nan | nan
chr5	C1QTNF2	618647.0 | C1QTNF2, CTRP2 | C1q- and TNF-related protein 2 | 114898.0 | ENSG00000145861 | nan | nan
chr5	FAM200C	615253.0 | ZBED8, C5orf54, BUSTER3 | Zinc finger BED-type containing 8 | 63920.0 | ENSG00000221886 | nan | nan
chr5	SLU7	605974.0 | SLU7 | SLU7 homolog, splicing factor | 10569.0 | ENSG00000164609 | nan | nan
chr5	PTTG1	604147.0 | PTTG1, EAP1, TUTR1 | PITG1 regulator of sister chromatid separation, securin | 9232.0 | ENSG00000164611 | nan | nan
chr5	MIR146A	610566.0 | MIR146A, MIRN146A | Micro RNA 146A | 406938.0 | ENSG00000283733 | nan | nan
chr5	NIDDM4	608036.0 | NIDDM4 | Diabetes mellitus, noninsulin-dependent, 4 | 100188782.0 | nan | nan | {Diabetes mellitus, noninsulin-dependent}, 125853 (2), Autosomal dominant
chr5	ATP10B	619791.0 | ATP10B, KIAA0715 | ATPase, phospholipid-transporting, 10B | 23120.0 | ENSG00000118322 | nan | nan
chr5	GABRB2	600232.0 | GABRB2, DEE92 | Gamma-aminobutyric acid (GABA) A receptor, beta-2 | 2561.0 | ENSG00000145864 | nan | Developmental and epileptic encephalopathy 92, 617829 (3), Autosomal dominant
chr5	GABRA6	137143.0 | GABRA6 | Gamma-aminobutyric acid (GABA) A receptor, alpha-6 | 2559.0 | ENSG00000145863 | nan | nan
chr5	GABRA1	137160.0 | GABRA1, EJM5, ECA4, DEE19 | Gamma-aminobutyric acid (GABA) A receptor, alpha-1 | 2554.0 | ENSG00000022355 | in same 200kb as GABRG2 | {Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3); Developmental and epileptic encephalopathy 19, 615744 (3), Autosomal dominant; {Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)
chr5	GABRG2	137164.0 | GABRG2, DEE74, FEB8, ECA2, GEFSP3 | Gamma-aminobutyric acid (GABA) A receptor, gamma-2 | 2566.0 | ENSG00000113327 | in alpha/beta/gamma cluster | Developmental and epileptic encephalopathy 74, 618396 (3), Autosomal dominant; Febrile seizures, familial, 8, 607681 (3), Autosomal dominant; Generalized epilepsy with febrile seizures plus, type 3, 607681 (3), Autosomal dominant
chr5	CCNG1	601578.0 | CCNG1 | Cyclin G1 | 900.0 | ENSG00000113328 | nan | nan
chr5	NUDCD2	620136.0 | NUDCD2, NUDCL2 | NUDC domain-containing protein 2 | 134492.0 | ENSG00000170584 | nan | nan
chr5	HMMR	600936.0 | HMMR | Hyaluronan-mediated motility receptor (RHAMM) | 3161.0 | ENSG00000072571 | nan | {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant
chr5	MAT2B	605527.0 | MAT2B | Methionine adenosyltransferase II, beta | 27430.0 | ENSG00000038274 | nan | nan
chr5	TENM2	610119.0 | TENM2, ODZ2, TNM2, KIAA1127 | Teneurin transmembrane protein 2 | 57451.0 | ENSG00000145934 | nan | nan
chr5	WWC1	610533.0 | WWC1, KIBRA, KIAA0869, MEMRYQTL | WW and C2 domains-containing protein 1 | 23286.0 | ENSG00000113645 | nan | [Memory, enhanced, QTL], 615602 (3)
chr5	RARS1	107820.0 | RARS1, RARS, HLD9 | Arginyl-tRNA synthetase 1 | 5917.0 | ENSG00000113643 | nan | Leukodystrophy, hypomyelinating, 9, 616140 (3), Autosomal recessive
chr5	PANK3	606161.0 | PANK3 | Pantothenate kinase 3 | 79646.0 | ENSG00000120137 | nan | nan
chr5	MIR103A1	613187.0 | MIR103-1, MIRN103-1 | Micro RNA 103-1 | 406895.0 | ENSG00000199035 | nan | nan
chr5	SLIT3	603745.0 | SLIT3, SLIL2, MEGF5 | SLIT guidance ligand 3 | 6586.0 | ENSG00000184347 | nan | nan
chr5	MIR218-2	616771.0 | MIR218-2 | Micro RNA 218-2 | 407001.0 | ENSG00000207739 | in intron of SLIT3 | nan
chr5		118840.0 | CHR | Chromate resistance (sulfate transport) | nan | nan | nan | nan
chr5	SPDL1	616401.0 | SPDL1, CCDC99, SPINDLY | Spindly apparatus coiled-coil protein 1 | 54908.0 | ENSG00000040275 | nan | nan
chr5	DOCK2	603122.0 | DOCK2, IMD40 | Dedicator of cytokinesis 2 | 1794.0 | ENSG00000134516 | nan | Immunodeficiency 40, 616433 (3), Autosomal recessive
chr5	FOXI1	601093.0 | FOXI1, FKHL10, FREAC6 | Forkhead box I1 | 2299.0 | ENSG00000168269 | some patients have digenic mutations with SLC26A4 | Enlarged vestibular aqueduct, 600791 (3), Autosomal recessive
chr5	LCP2	601603.0 | LCP2, SLP76, IMD81 | Lymphocyte cytosolic protein-2 (SH2 domain-containing leukocyte protein of 76kD) | 3937.0 | ENSG00000043462 | nan | Immunodeficiency 81, 619374 (3), Autosomal recessive
chr5	KCNIP1	604660.0 | KCNIP1, KCHIP1 | Potassium channel-interacting protein 1 | 30820.0 | ENSG00000182132 | nan | nan
chr5	KCNMB1	603951.0 | KCNMB1 | Potassium large conductance calcium-activated channel, subfamily M, beta member 1 | 3779.0 | ENSG00000145936 | nan | {Hypertension, diastolic, resistance to}, 608622 (3), Autosomal dominant
chr5	GABRP	602729.0 | GABRP | Gamma-aminobutyric acid receptor, pi | 2568.0 | ENSG00000094755 | nan | nan
chr5	RANBP17	606141.0 | RANBP17 | RAN-binding protein 17 | 64901.0 | ENSG00000204764 | nan | nan
chr5	TLX3	604640.0 | TLX3, HOX11L2, RNX | T-cell leukemia, homeobox 3 | 30012.0 | ENSG00000164438 | activated in T-cell ALL | nan
chr5	NPM1	164040.0 | NPM1 | Nucleophosmin 1 (nucleolar phosphoprotein B23, numatrin) | 4869.0 | ENSG00000181163 | fused with RARA in APL | Leukemia, acute myeloid, somatic, 601626 (3)
chr5	FGF18	603726.0 | FGF18 | Fibroblast growth factor-18 | 8817.0 | ENSG00000156427 | nan | nan
chr5	FBXW11	605651.0 | FBXW11, FBXW1B, BTRC2, BTRCP2, NEDJED | F-box and WD40 domain protein 11 | 23291.0 | ENSG00000072803 | nan | Neurodevelopmental, jaw, eye, and digital syndrome, 618914 (3), Autosomal dominant
chr5	STK10	603919.0 | STK10, LOK | Serine/threonine protein kinase-10 | 6793.0 | ENSG00000072786 | nan | nan
chr5	EFCAB9	618520.0 | EFCAB9 | EF-hand calcium-binding domain 9 | 285588.0 | ENSG00000214360 | nan | nan
chr5	UBTD2	610174.0 | UBTD2, DCUBP, MGC30022 | Ubiquitin domain-containing protein 2 | 92181.0 | ENSG00000168246 | nan | nan
chr5	SH3PXD2B	613293.0 | SH3PXD2B, TKS4, KIAA1295, FTHS | SH3 and PX domains-containing protein 2B | 285590.0 | ENSG00000174705 | nan | Frank-ter Haar syndrome, 249420 (3), Autosomal recessive
chr5	NEURL1B	615893.0 | NEURL1B, NEUR2 | Neuralized E3 ubiquitin protein ligase 1B | 54492.0 | ENSG00000214357 | nan | nan
chr5	DUSP1	600714.0 | DUSP1, CL100, PTPN10 | Dual specificity phosphatase-1 | 1843.0 | ENSG00000120129 | nan | nan
chr5	ERGIC1	617946.0 | ERGIC1, ERGIC32, KIAA1181, AMC2 | Endoplasmic reticulum-golgi intermediate compartment protein 1 | 57222.0 | ENSG00000113719 | mutation identified in 1 AMCN family | ?Arthrogryposis multiplex congenita 2, neurogenic type, 208100 (3), Autosomal recessive
chr5	ATP6V0E1	603931.0 | ATP6V0E1, ATP6H | ATPase, H+ transporting, V0 subunit E1 | 8992.0 | ENSG00000113732 | previously mapped to Chr.2 | nan
chr5	SNORA74B	611331.0 | SNORA74B | Small nucleolar RNA, H/ACA box, 74B | 677841.0 | ENSG00000212402 | in intron 3 of ATP6V0E1 | nan
chr5	CREBRF	617109.0 | CREBRF, LRF, C5orf41 | CREB3 recruitment factor | 153222.0 | ENSG00000164463 | nan | nan
chr5	BNIP1	603291.0 | BNIP1, NIP1 | BCL2/adenovirus E1B 19kD protein-interacting protein 1 | 662.0 | ENSG00000113734 | nan | nan
chr5	NKX2-5	600584.0 | NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2 | NK2 homeobox-5 gene | 1482.0 | ENSG00000183072 | near border with 5q35 | Hypoplastic left heart syndrome 2, 614435 (3), Autosomal dominant; Tetralogy of Fallot, 187500 (3), Autosomal dominant; Hypothyroidism, congenital nongoitrous, 5, 225250 (3), Autosomal dominant; Conotruncal heart malformations, variable, 217095 (3); Ventricular septal defect 3, 614432 (3), Autosomal dominant; Atrial septal defect 7, with or without AV conduction defects, 108900 (3), Autosomal dominant
chr5	MENOQ4	612886.0 | MENOQ4 | Menopause, natural, age at, QTL4 | 100302519.0 | nan | associated with rs365132, rs7718874, rs402511, rs691141, rs2278493 | {Menopause, natural, age at, QTL4}, 612886 (2)
chr5	STC2	603665.0 | STC2, STCRP | Stanniocalcin 2 | 8614.0 | ENSG00000113739 | nan | nan
chr5	BOD1	616745.0 | BOD1, FAM44B | Biorientation of chromosomes in cell division 1 | 91272.0 | ENSG00000145919 | nan | nan
chr5	CPEB4	610607.0 | CPEB4, KIAA1673 | Cytoplasmic polyadenylation element-binding protein 4 | 80315.0 | ENSG00000113742 | nan | nan
chr5	C5orf47	620002.0 | C5orf47 | Chromsome 5 open reading frame 47 | 133491.0 | ENSG00000185056 | nan | nan
chr5	NSG2	616752.0 | NSG2, HMP19 | Neuronal vesicle trafficking-associated protein 2 | 51617.0 | ENSG00000170091 | nan | nan
chr5	MSX2	123101.0 | MSX2, CRS2, HOX8 | msh homeobox 2 | 4488.0 | ENSG00000120149 | nan | Parietal foramina with cleidocranial dysplasia, 168550 (3), Autosomal dominant; Craniosynostosis 2, 604757 (3), Autosomal dominant; Parietal foramina 1, 168500 (3), Autosomal dominant
chr5	DRD1	126449.0 | DRD1 | Dopamine receptor D1 | 1812.0 | ENSG00000184845 | same 300kb fragment as GRL | nan
chr5	SFXN1	615569.0 | SFXN1 | Sideroflexin 1 | 94081.0 | ENSG00000164466 | nan | nan
chr5	HRH2	142703.0 | HRH2 | Histamine receptor H2 | 3274.0 | ENSG00000113749 | nan | nan
chr5	CPLX2	605033.0 | CPLX2, CPX2 | Complexin 2 | 10814.0 | ENSG00000145920 | nan | nan
chr5	THOC3	606929.0 | THOC3, TEX1 | THO complex 3 (Tex1, yeast, homolog of) | 84321.0 | ENSG00000051596 | nan | nan
chr5	SIMC1	618102.0 | SIMC1, PLEIAD | SUMO-interacting motifs-containing protein 1 | 375484.0 | ENSG00000170085 | nan | nan
chr5	NOP16	612861.0 | NOP16, HSPC111 | Nop16 nucleolar protein | 51491.0 | ENSG00000048162 | nan | nan
chr5	HIGD2A	620788.0 | HIGD2A, HIG2A, RCF1B | HIG1 hypoxia-inducible domain family, member 2A | 192286.0 | ENSG00000146066 | nan | nan
chr5	CLTB	118970.0 | CLTB | Clathrin, light polypeptide (Lcb) | 1212.0 | ENSG00000175416 | previously mapped to chr. 4 | nan
chr5	FAF2	616935.0 | FAF2, ETEA, UBXD8, KIAA0887 | Fas-associated factor family, member 2 | 23197.0 | ENSG00000113194 | nan | nan
chr5	RNF44	619283.0 | RNF44, KIAA1100 | RING finger protein 44 | 22838.0 | ENSG00000146083 | nan | nan
chr5	CDHR2	619713.0 | CDHR2, PCDH24, PCLCK | Cadherin-related family, member 2 | 54825.0 | ENSG00000074276 | nan | nan
chr5	GPRIN1	611239.0 | GPRIN1, GRIN1, KIAA1893 | GPRIN family, member 1 | 114787.0 | ENSG00000169258 | nan | nan
chr5	SNCB	602569.0 | SNCB | Synuclein, beta | 6620.0 | ENSG00000074317 | nan | Dementia, Lewy body, 127750 (3), Autosomal dominant
chr5	TSPAN17	620446.0 | TSPAN17, FBXO23, FBX23 | Tetraspanin 17 | 26262.0 | ENSG00000048140 | nan | nan
chr5	UNC5A	607869.0 | UNC5A, UNC5H1 | unc-5 netrin receptor A | 90249.0 | ENSG00000113763 | nan | nan
chr5	HK3	142570.0 | HK3 | Hexokinase-3, white cell | 3101.0 | ENSG00000160883 | nan | nan
chr5	UIMC1	609433.0 | UIMC1, RAP80 | Ubiquitin interaction motif containing 1 | 51720.0 | ENSG00000087206 | nan | nan
chr5	ZNF346	605308.0 | ZNF346, JAZ | Zinc finger protein 346 | 23567.0 | ENSG00000113761 | nan | nan
chr5	FGFR4	134935.0 | FGFR4 | Fibroblast growth factor receptor-4 | 2264.0 | ENSG00000160867 | distal to DRD1 | {Cancer progression/metastasis} (3)
chr5	NSD1	606681.0 | NSD1, ARA267, STO, SOTOS | Nuclear receptor binding SET domain protein 1 | 64324.0 | ENSG00000165671 | fusion gene with NUP98 in AML | Sotos syndrome, 117550 (3), Autosomal dominant
chr5	RAB24	612415.0 | RAB24 | Ras-associated protein 24 | 53917.0 | ENSG00000169228 | nan | nan
chr5	PRELID1	605733.0 | PRELID1, PRELI, PX19 | PRELI domain-containing protein 1 | 27166.0 | ENSG00000169230 | nan | nan
chr5	MXD3	609450.0 | MXD3, MAD3 | MAX dimerization protein 3 | 83463.0 | ENSG00000213347 | nan | nan
chr5	LMAN2	609551.0 | LMAN2, VIP36, GP36B | Lectin, mannose-binding 2 | 10960.0 | ENSG00000169223 | nan | nan
chr5	RGS14	602513.0 | RGS14 | Regulator of G protein signaling 14 | 10636.0 | ENSG00000169220 | nan | nan
chr5	SLC34A1	182309.0 | SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2 | Solute carrier family 34 (sodium phosphate cotransporter), member 1 | 6569.0 | ENSG00000131183 | mutation identified in 1 FRTS2 family | ?Fanconi renotubular syndrome 2, 613388 (3), Autosomal recessive; Hypercalcemia, infantile, 2, 616963 (3), Autosomal recessive; Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3), Autosomal dominant
chr5	PFN3	612812.0 | PFN3 | Profilin 3 | 345456.0 | ENSG00000196570 | nan | nan
chr5	F12	610619.0 | F12, HAF, HAE3 | Coagulation factor XII (Hageman factor) | 2161.0 | ENSG00000131187 | nan | Angioedema, hereditary, 3, 610618 (3), Autosomal dominant; Factor XII deficiency, 234000 (3), Autosomal recessive
chr5	GRK6	600869.0 | GRK6, GPRK6 | G protein-coupled receptor kinase 6 | 2870.0 | ENSG00000198055 | nan | nan
chr5	PRR7	618306.0 | PRR7 | Proline-rich protein 7 | 80758.0 | ENSG00000131188 | nan | nan
chr5	DBN1	126660.0 | DBN1 | Drebrin-1 | 1627.0 | ENSG00000113758 | nan | nan
chr5	PDLIM7	605903.0 | PDLIM7, ENIGMA | PDZ and LIM domain 7 (enigma) | 9260.0 | ENSG00000196923 | nan | nan
chr5	DOK3	611435.0 | DOK3, DOKL | Docking protein 3 | 79930.0 | ENSG00000146094 | nan | nan
chr5	DDX41	608170.0 | DDX41, ABS, MPLPF | DEAD-box helicase 41 | 51428.0 | ENSG00000183258 | nan | {Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3), Autosomal dominant
chr5	FAM193B	615813.0 | FAM193B, IRIZIO, KIAA1931 | Family with sequence similarity 193, member B | 54540.0 | ENSG00000146067 | nan | nan
chr5	TMED9	620436.0 | TMED9, GMP25 | Transmembrane p24 trafficking protein 9 | 54732.0 | ENSG00000184840 | nan | nan
chr5	B4GALT7	604327.0 | B4GALT7, XGALT1, XGPT1, EDSSPD1 | Beta-1,4-galactosyltransferase 7 | 11285.0 | ENSG00000027847 | nan | Ehlers-Danlos syndrome, spondylodysplastic type, 1, 130070 (3), Autosomal recessive
chr5	PROP1	601538.0 | PROP1, CPHD2 | Prophet of Pit1, paired-like homeodomain transcription factor | 5626.0 | ENSG00000175325 | nan | Pituitary hormone deficiency, combined, 2, 262600 (3), Autosomal recessive
chr5	N4BP3	619140.0 | N4BP3, KIAA0341 | NEDD4-binding protein 3 | 23138.0 | ENSG00000145911 | nan | nan
chr5	NHP2	606470.0 | NHP2, NOLA2, DKCB2 | NHP2 ribonucleoprotein | 55651.0 | ENSG00000145912 | nan | Dyskeratosis congenita, autosomal recessive 2, 613987 (3), Autosomal recessive
chr5	GMCL2	618629.0 | GMCL2 | Germ cell-less 2, spermatogenesis associated | 64396.0 | ENSG00000244234 | nan | nan
chr5	HNRNPAB	602688.0 | HNRNPAB, ABBP1 | Heterogeneous nuclear ribonucleoprotein A/B | 3182.0 | ENSG00000197451 | nan | nan
chr5	PHYKPL	614683.0 | PHYKPL, AGXT2L2, PHLU | 5-phosphohydroxy-L-lysine phospho-lyase | 85007.0 | ENSG00000175309 | mutation identified in 1 PHLU patient | [?Phosphohydroxylysinuria], 615011 (3), Autosomal recessive
chr5	COL23A1	610043.0 | COL23A1 | Collagen, type XXIII, alpha-1 | 91522.0 | ENSG00000050767 | nan | nan
chr5	CLK4	607969.0 | CLK4 | CDC-like kinase 4 | 57396.0 | ENSG00000113240 | nan | nan
chr5	ZNF354A	602444.0 | ZNF354A, TCF17, KID1 | Zinc finger protein 354A | 6940.0 | ENSG00000169131 | nan | nan
chr5	GRM6	604096.0 | GRM6, MGLUR6, CSNB1B | Glutamate receptor, metabotropic, 6 | 2916.0 | ENSG00000113262 | nan | Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3), Autosomal recessive
chr5	ZNF354C	619511.0 | ZNF354C, KID3 | Zinc finger protein 354C | 30832.0 | ENSG00000177932 | nan | nan
chr5	ADAMTS2	604539.0 | ADAMTS2, NPI, EDSDERMS | ADAM metallopeptidase with thrombospondin type 1 motif, 2 (procollagen I N-proteinase) | 9509.0 | ENSG00000087116 | nan | Ehlers-Danlos syndrome, dermatosparaxis type, 225410 (3), Autosomal recessive
chr5	RUFY1	610327.0 | RUFY1 | RUN and FYVE domains-containing protein 1 | 80230.0 | ENSG00000176783 | nan | nan
chr5	HNRNPH1	601035.0 | HNRPH1, NEDCDS | Heterogeneous nuclear ribonucleoprotein H | 3187.0 | ENSG00000169045 | nan | Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects, 620083 (3), Autosomal dominant
chr5	CBY3	620892.0 | CBY3 | Chibby family, member 3 | 646019.0 | ENSG00000204659 | nan | nan
chr5	CANX	114217.0 | CANX | Calnexin | 821.0 | ENSG00000127022 | nan | nan
chr5	MAML1	605424.0 | MAML1 | Mastermind, Drosophila, homolog of, 1 | 9794.0 | ENSG00000161021 | nan | nan
chr5	LTC4S	246530.0 | LTC4S | Leukotriene C4 synthase | 4056.0 | ENSG00000213316 | nan | Leukotriene C4 synthase deficiency, 614037 (1), Autosomal recessive
chr5	MGAT4B	604561.0 | MGAT4B | Alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B | 11282.0 | ENSG00000161013 | nan | nan
chr5	SQSTM1	601530.0 | SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV | Sequestosome 1 | 8878.0 | ENSG00000161011 | nan | Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset, 617145 (3), Autosomal recessive; Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3), Autosomal dominant; Myopathy, distal, with rimmed vacuoles, 617158 (3), Autosomal dominant; Paget disease of bone 3, 167250 (3), Autosomal dominant
chr5	MRNIP	617154.0 | MRNIP, C5orf45 | MRN complex-interacting protein | 51149.0 | ENSG00000161010 | nan | nan
chr5	TBC1D9B	618039.0 | TBC1D9B, KIAA0676 | TBC domain family, member 9B | 23061.0 | ENSG00000197226 | nan | nan
chr5	RNF130	619163.0 | RNF130, GOLIATH, G1RP | RING finger protein 130 | 55819.0 | ENSG00000113269 | nan | nan
chr5	MAPK9	602896.0 | MAPK9, PRKM9, JNK2 | Mitogen-activated protein kinase 9 | 5601.0 | ENSG00000050748 | nan | nan
chr5	GFPT2	603865.0 | GFPT2, GFAT2 | Glutamine: fructose-6-phosphate amidotransferase 2 | 9945.0 | ENSG00000131459 | nan | nan
chr5	CNOT6	608951.0 | CNOT6, CCR4, KIAA1194 | CCR4-NOT transcription complex, subunit 6 | 57472.0 | ENSG00000113300 | nan | nan
chr5	SCGB3A1	606500.0 | SCGB3A1, HIN1 | Secretoglobin, family 3A, member 1 | 92304.0 | ENSG00000161055 | nan | nan
chr5	FLT4	136352.0 | FLT4, VEGFR3, PCL, LMPHM1, CHTD7 | fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3) | 2324.0 | ENSG00000037280 | nan | Hemangioma, capillary infantile, somatic, 602089 (3); Lymphatic malformation 1, 153100 (3), Autosomal dominant; Congenital heart defects, multiple types, 7, 618780 (3), Autosomal dominant
chr5	MGAT1	160995.0 | MGAT1, GLYT1 | Mannosyl (alpha-1,3-)-glycoprotein beta-1,2, N-acetylglucosaminyltransferase | 4245.0 | ENSG00000131446 | nan | nan
chr5	ZFP62	610281.0 | ZFP62 | Zinc finger protein 62 | 643836.0 | ENSG00000196670 | nan | nan
chr5	HEIH	618615.0 | HEIH, LINC00848 | Hepatocellular carcinoma-upregulated EZH2-associated long noncoding RNA | 100859930.0 | ENSG00000278970 | nan | nan
chr5	BTNL8	615606.0 | BTNL8, BTN9.2 | Butyrophilin-like protein 8 | 79908.0 | ENSG00000113303 | nan | nan
chr5	BTNL3	606192.0 | BTNL3 | Butyrophilin-like protein 3 | 10917.0 | ENSG00000168903 | nan | nan
chr5	BTNL9	620648.0 | BRNL9, BTN3 | Butyrophilin-like protein 9 | 153579.0 | ENSG00000165810 | nan | nan
chr5	TRV-CAC1-2	612995.0 | TRV-CAC1-2, TRNAV2, TRV2 | tRNA valine (anticodon CAC) 1-2 | 7240.0 | nan | nan | nan
chr5	TRP-TGG3-1	189912.0 | TRP-TGG3-5, TRNAP3, TRP3 | Transfer RNA-Pro (TGG) 3-5 | 7219.0 | nan | nan | nan
chr5	TRT-TGT6-1	189913.0 | TRT-TGT6-1, TRNAT1, TRT1 | tRNA threonine (anticodon TGT) 6-1 | 7236.0 | nan | nan | nan
chr5	TRIM7	609315.0 | TRIM7, GNIP | Tripartite motif-containing protein 7 | 81786.0 | ENSG00000146054 | nan | nan
chr5	TRV-AAC1-4	189921.0 | TRV-AAC1-4, TRNAV1, TRV1 | tRNA valine (anticodon AAC) 1-4 | 7239.0 | nan | nan | nan
chr5	TRK-CTT2-3	612996.0 | TRK-CTT2-4, TRNAK2, TRK2 | Transfer RNA lysine (CTT) 2-4 | 790966.0 | nan | nan | nan
chr5	TRIM41	610530.0 | TRIM41 | Tripartite motif-containing 41 | 90933.0 | ENSG00000146063 | nan | nan
chr5	RACK1	176981.0 | GNB2L1, RACK1 | Guanine nucleotide-binding protein, beta-2-like 1 | 10399.0 | ENSG00000204628 | nan | nan
chr5	TRIM52	619265.0 | TRIM52 | Tripartite motif-containing protein 52 | 84851.0 | ENSG00000183718 | nan | nan
chr5	TRIM52-AS1	619266.0 | TRIM52AS1 | TRIM52 antisense RNA 1, noncoding | 100507602.0 | ENSG00000248275 | nan | nan
chr6	CLLS4	612558.0 | CLLS4 | Leukemia, chronic lymphocytic susceptibility to, 4 | 100270643.0 | nan | associated with rs872071 | {Leukemia, chronic lymphocytic susceptibility to, 4}, 612558 (2)
chr6		122550.0 | CSCI | Corticosterone side-chain isomerase | nan | nan | ?linked to MHC | nan
chr6		612582.0 | DEL6pter, C6DELpter | Chromosome 6pter-p24 deletion syndrome | nan | nan | nan | Chromosome 6pter-p24 deletion syndrome, 612582 (4), Isolated cases
chr6	INTLQ3	610294.0 | INTLQ3 | Intelligence quantitative trait locus 3 | 100462722.0 | nan | nan | {Intelligence QTL3}, 610294 (2)
chr6	LRSL	608545.0 | LRSL | Larsen-like syndrome | 406214.0 | nan | nan | Larsen-like syndrome, 608545 (2), Isolated cases
chr6	DUSP22	616778.0 | DUSP22, LMWDSP2, MKPX, VHX, JKAP, JSP1 | Dual-specificity phosphatase 22 | 56940.0 | ENSG00000112679 | nan | nan
chr6	IRF4	601900.0 | IRF4, LSIRF, SHEP8 | Interferon regulatory factor-4 | 3662.0 | ENSG00000137265 | dysregulated in t(6;14) | [Skin/hair/eye pigmentation, variation in, 8], 611724 (3)
chr6	EXOC2	615329.0 | EXOC2, SEC5L1, SEC5, NEDFACH | Exocyst complex component 2 | 55770.0 | ENSG00000112685 | nan | Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia, 619306 (3), Autosomal recessive
chr6	HUS1B	609713.0 | HUS1B | HUS1 checkpoint clamp component B | 135458.0 | ENSG00000188996 | nan | nan
chr6	FOXQ1	612788.0 | FOXQ1, HFH1 | Forkhead box Q1 | 94234.0 | ENSG00000164379 | nan | nan
chr6	FOXF2	603250.0 | FOXF2, FKHL6, FREAC2 | Forkhead box F2 | 2295.0 | ENSG00000137273 | nan | nan
chr6	FOXCUT	615976.0 | FOXCUT, LINC01379 | FOXC1 upstream transcript, noncoding | 101927703.0 | nan | nan | nan
chr6	FOXC1	601090.0 | FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3 | Forkhead, Drosophila, homolog-like 7 | 2296.0 | ENSG00000054598 | nan | Axenfeld-Rieger syndrome, type 3, 602482 (3), Autosomal dominant; Anterior segment dysgenesis 3, multiple subtypes, 601631 (3), Autosomal dominant
chr6	GMDS	602884.0 | GMDS | GDP-mannose 4,6-dehydratase | 2762.0 | ENSG00000112699 | nan | nan
chr6	WRNIP1	608196.0 | WRNIP1, WHIP | Werner helicase-interacting protein 1 | 56897.0 | ENSG00000124535 | nan | nan
chr6	SERPINB1	130135.0 | ELANH2, EI | Protease inhibitor 2 (anti-elastase), monocyte/neutrophil derived | 1992.0 | ENSG00000021355 | nan | nan
chr6	SERPINB9	601799.0 | PI9, CAP3, SERPINB9 | Protease inhibitor 9, ovalbumin type | 5272.0 | ENSG00000170542 | nan | nan
chr6	SERPINB6	173321.0 | SERPINB6, PI6, PTI, SPI3, DFNB91 | Protease inhibitor 6 (placental thrombin inhibitor) | 5269.0 | ENSG00000124570 | mutation identified in 1 DFNB91 family | ?Deafness, autosomal recessive 91, 613453 (3), Autosomal recessive
chr6	NQO2	160998.0 | NQO2, NMOR2 | NAD(P)H dehydrogenase, quinone 2 (NAD(P)H menadione oxidoreductase-1, dioxin-inducible-2) | 4835.0 | ENSG00000124588 | nan | {?Breast cancer susceptibility}, 114480 (1), Somatic mutation, Autosomal dominant
chr6	RIPK1	603453.0 | RIPK1, RIP1, RIP, IMD57, AIEFL | Receptor-interacting serine/threonine kinase 1 | 8737.0 | ENSG00000137275 | nan | Immunodeficiency 57 with autoinflammation, 618108 (3), Autosomal recessive; Autoinflammation with episodic fever and lymphadenopathy, 618852 (3), Autosomal dominant
chr6	BPHL	603156.0 | BPHL | Biphenyl hydrolase-like | 670.0 | ENSG00000137274 | nan | nan
chr6	TUBB2A	615101.0 | TUBB2A, CDCBM5 | Tubulin, beta-2A | 7280.0 | ENSG00000137267 | nan | Cortical dysplasia, complex, with other brain malformations 5, 615763 (3), Autosomal dominant
chr6	TUBB2B	612850.0 | TUBB2B, CDCBM7 | Tubulin, beta-2B | 347733.0 | ENSG00000137285 | TUBB2A is 70kb telomeric to TUBB2B | Cortical dysplasia, complex, with other brain malformations 7, 610031 (3), Autosomal dominant
chr6	PSMG4	617550.0 | PSMG4, PAC4, C6orf86 | Proteasome assembly chaperone 4 | 389362.0 | ENSG00000180822 | nan | nan
chr6	SLC22A23	611697.0 | SLC22A23, C6orf85 | Solute carrier family 22, member 23 | 63027.0 | ENSG00000137266 | nan | nan
chr6	FAM50B	614686.0 | FAM60B, X5L | Family with sequence similarity 50, member B | 26240.0 | ENSG00000145945 | nan | nan
chr6	PRP4K	602338.0 | PRP4K, PRPF4B, PRP4 | Pre-mRNA processing factor kinase PRP4K | 8899.0 | ENSG00000112739 | nan | nan
chr6	ECI2	608024.0 | ECI2, PECI, DRS1 | Enoyl-CoA delta isomerase 2 | 10455.0 | ENSG00000198721 | nan | nan
chr6	CDYL	603778.0 | CDYL | Chromodomain protein on Y chromosome-like | 9425.0 | ENSG00000153046 | nan | nan
chr6	RPP40	606117.0 | RPP40 | Ribonuclease P/MRP subunit p40 | 10799.0 | ENSG00000124787 | nan | nan
chr6	LYRM4	613311.0 | LYRM4, ISD11, C6orf149, COXPD19 | LYR motif-containing protein 4 | 57128.0 | ENSG00000214113 | mutation identified in 1 family | ?Combined oxidative phosphorylation deficiency 19, 615595 (3), Autosomal recessive
chr6	PPP1R3G	619541.0 | PPP1R3G | Protein phosphatase 1, regulatory subunit 3G | 648791.0 | ENSG00000219607 | nan | nan
chr6	FARS2	611592.0 | FARS2, FARS1, COXPD14, SPG77 | Phenylalanyl-tRNA synthetase 2, mitochondrial | 10667.0 | ENSG00000145982 | nan | Combined oxidative phosphorylation deficiency 14, 614946 (3), Autosomal recessive; Spastic paraplegia 77, autosomal recessive, 617046 (3), Autosomal recessive
chr6	NRN1	607409.0 | NRN1, NRN | Neuritin 1 | 51299.0 | ENSG00000124785 | nan | nan
chr6	F13A1	134570.0 | F13A1, F13A | Coagulation factor XIII, A polypeptide | 2162.0 | ENSG00000124491 | nan | Factor XIIIA deficiency, 613225 (3), Autosomal recessive; {Myocardial infarction, protection against}, 608446 (3); {Venous thrombosis, protection against}, 188050 (3), Autosomal dominant
chr6	LY86	605241.0 | LY86, MD1 | Lymphocyte antigen 86 | 9450.0 | ENSG00000112799 | nan | nan
chr6	OFC1	119530.0 | OFC1, CL | Orofacial cleft-1 (cleft lip with or without cleft palate; isolated cleft palate) | 4963.0 | nan | probable heterogeneity | Orofacial cleft-1, 119530 (2), Autosomal dominant
chr6	RREB1	602209.0 | RREB1 | RAS-responsive element binding protein-1 | 6239.0 | ENSG00000124782 | nan | nan
chr6	SSR1	600868.0 | SSR1 | Signal sequence receptor, alpha | 6745.0 | ENSG00000124783 | nan | nan
chr6	CAGE1	608304.0 | CTAG3, CAGE1 | Cancer/testis antigen 3 | 285782.0 | ENSG00000164304 | nan | nan
chr6	RIOK1	617753.0 | RIOK1, RIO1 | RIO kinase 1 | 83732.0 | ENSG00000124784 | nan | nan
chr6	DSP	125647.0 | DSP, KPPS2, PPKS2, DCWHKTA | Desmoplakin | 1832.0 | ENSG00000096696 | splice variants result in DP I and DP II | Arrhythmogenic right ventricular dysplasia 8, 607450 (3), Autosomal dominant; Epidermolysis bullosa, lethal acantholytic, 609638 (3), Autosomal recessive; Keratosis palmoplantaris striata II, 612908 (3), Autosomal dominant; Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3), Autosomal dominant; Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3), Autosomal recessive
chr6	BMP6	112266.0 | BMP6, IO | Bone morphogenetic protein-6 | 654.0 | ENSG00000153162 | nan | {Iron overload, susceptibility to}, 620121 (3), Autosomal dominant
chr6	TXNDC5	616412.0 | TXNDC5, ERP46, ENDOPDI, HCC2 | Thioredoxin domain-containing protein 5 | 81567.0 | ENSG00000239264 | nan | nan
chr6	BLOC1S5	607289.0 | BLOC1S5, BLOS5, MUTED, HPS11 | Biogenesis of lysosome-related organelles complex 1, subunit 5 | 63915.0 | ENSG00000188428 | nan | Hermansky-Pudlak syndrome 11, 619172 (3), Autosomal recessive
chr6	EEF1E1	609206.0 | EEF1E1 | Eukaryotic translation elongation factor 1, epsilon-1 | 9521.0 | ENSG00000124802 | nan | nan
chr6	SLC35B3	610845.0 | SLC35B3, PAPST2 | Solute carrier family 25 (3'-phosphoadenosine 5'-phosphosulfate transporter), member B3 | 51000.0 | ENSG00000124786 | nan | nan
chr6	HULC	612210.0 | HULC | Hepatocellular carcinoma-upregulated long noncoding RNA | 728655.0 | nan | nan | nan
chr6	OFCC1	614287.0 | OFCC1, MRDS1 | OFC1 candidate gene 1 | 266553.0 | nan | nan | nan
chr6	TFAP2A	107580.0 | TFAP2A, AP2TF, BOFS | Transcription factor AP-2 alpha (activating enhancer-binding protein 2 alpha) | 7020.0 | ENSG00000137203 | nan | Branchiooculofacial syndrome, 113620 (3), Autosomal dominant
chr6	TFAP2A-AS2	617136.0 | TFAP2AAS2, HIPSTR | TFAP2A antisense RNA 2 | 109729173.0 | ENSG00000285278 | overlaps TFAP2A | nan
chr6	GCNT2	600429.0 | GCNT2, Ii, CTRCT13 | Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme | 2651.0 | ENSG00000111846 | previously assigned to 9q21 | [Blood group, Ii], 110800 (3), Autosomal dominant; Adult i phenotype without cataract, 110800 (3), Autosomal dominant; Cataract 13 with adult i phenotype, 116700 (3), Autosomal recessive
chr6	PAK1IP1	607811.0 | PAK1IP1, PIP1 | PAK1-interacting protein | 55003.0 | ENSG00000111845 | nan | nan
chr6	TMEM14C	615318.0 | TMEM14C | Transmembrane protein 14C | 51522.0 | ENSG00000111843 | nan | nan
chr6	TMEM14B	619865.0 | TMEM14B | Transmembrane protein 14B | 81853.0 | ENSG00000137210 | nan | nan
chr6	MAK	154235.0 | MAK, RP62 | Male germ cell-associated kinase | 4117.0 | ENSG00000111837 | nan | Retinitis pigmentosa 62, 614181 (3), Autosomal recessive
chr6	GCM2	603716.0 | GCM2, GCMB, HRPT4, FIH2 | Glial cells missing transcription factor 2 | 9247.0 | ENSG00000124827 | nan | Hypoparathyroidism, familial isolated 2, 618883 (3), Autosomal recessive, Autosomal dominant; Hyperparathyroidism 4, 617343 (3), Autosomal dominant
chr6	SYCP2L	616799.0 | SYCP2L, C6orf177, POF24 | Synaptonemal complex protein 2-like | 221711.0 | ENSG00000153157 | nan | Premature ovarian failure 24, 620840 (3), Autosomal recessive
chr6	ELOVL2	611814.0 | ELOVL2, SSC2 | Elongation of very long chain fatty acids-like 2 | 54898.0 | ENSG00000197977 | nan | nan
chr6	ERVFRD-1	610524.0 | ERVFRD-1 | Endogenous retrovirus group FRD, member 1 | 405754.0 | ENSG00000244476 | nan | nan
chr6	NEDD9	602265.0 | NEDD9, HEF1, CASL | Neural precursor cell expressed, developmentally downregulated 9 | 4739.0 | ENSG00000111859 | nan | nan
chr6	HDLCQ7	618979.0 | HDLCQ7 | High density lipoprotein cholesterol level QTL7 | 131341973.0 | nan | nan | [High density lipoprotein cholesterol level QTL7], 618979 (2)
chr6	ADTRP	614348.0 | ADTRP, C6orf105 | Androgen-dependent TFPI-regulating protein | 84830.0 | ENSG00000111863 | nan | nan
chr6	HIVEP1	194540.0 | HIVEP1, ZNF40 | Human immunodeficiency virus type I enhancer-binding protein-1 | 3096.0 | ENSG00000095951 | nan | nan
chr6	EDN1	131240.0 | EDN1, ARCND3, QME | Endothelin-1 | 1906.0 | ENSG00000078401 | nan | Question mark ears, isolated, 612798 (3), Autosomal dominant; Auriculocondylar syndrome 3, 615706 (3), Autosomal recessive
chr6	PHACTR1	608723.0 | PHACTR1, KIAA1733, DEE70 | Phosphatase and actin regulator 1 | 221692.0 | ENSG00000112137 | nan | Developmental and epileptic encephalopathy 70, 618298 (3), Autosomal dominant
chr6	TBC1D7	612655.0 | TBC1D7, PIG51, TBC7, MGCPH | TBC1 domain family, member 7 | 51256.0 | ENSG00000145979 | nan | Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3), Autosomal recessive
chr6	GFOD1	619932.0 | GFOD1 | Glucose-fructose oxidoreductase domain-containing protein 1 | 54438.0 | ENSG00000145990 | nan | nan
chr6	ETM3	611456.0 | ETM3 | Tremor, hereditary essential, 3 | 101027378.0 | nan | max lod at D6S1630 and D6S1605 | Essential tremor, hereditary, 3, 611456 (2)
chr6	SCAR3	271250.0 | SCAR3, SCABD | Spinocerebellar ataxia, autosomal recessive 3 | 85502.0 | nan | nan | Spinocerebellar ataxia, autosomal recessive 3, 271250 (2), Autosomal recessive
chr6	SCZD3	600511.0 | SCZD3 | Schizophrenia susceptibility locus, chromosome 6-related | 6365.0 | nan | ?same as DTNBP1; cognitive deficit type | {Schizophrenia}, 181500 (2), Autosomal dominant
chr6	TRX-CAT2-1	180620.0 | TRNAM2, TRNAMI2, RNTMI2 | tRNA methionine-2 | 7212.0 | nan | 2 of 12+ RNTMI genes are on chr. 6 | nan
chr6	SIRT5	604483.0 | SIRT5 | Sirtuin 5 | 23408.0 | ENSG00000124523 | nan | nan
chr6	NOL7	611533.0 | NOL7 | Nucleolar protein 7 | 51406.0 | ENSG00000225921 | nan | nan
chr6	RANBP9	603854.0 | RANBP9, RANBPM | RAN-binding protein 9 | 10048.0 | ENSG00000010017 | nan | nan
chr6	MCUR1	616952.0 | MCUR1, CCDC90A, FMP32 | Mitochondrial calcium uniporter regulator 1 | 63933.0 | ENSG00000050393 | nan | nan
chr6	CD83	604534.0 | CD83, HB15, BL11 | CD83 antigen | 9308.0 | ENSG00000112149 | nan | nan
chr6	ALPQTL3	612368.0 | ALPQTL3 | Alkaline phosphatase, plasma level of, QTL 3 | 100196915.0 | nan | linkage with rs9467160 | {Alkaline phosphatase, plasma level of, QTL3}, 612368 (2)
chr6	BWQTL4	615192.0 | BWQTL4 | Birth weight quantitative trait locus 4 | 101448071.0 | nan | associated with rs7756992 | [Birth weight QTL4], 615192 (2)
chr6	CIHL	613290.0 | CIHL | Hearing loss, cisplatin-induced, susceptibility to | 100381207.0 | nan | associated with rs12201199 | {?Hearing loss, cisplatin-induced, susceptibility to}, 613290 (2)
chr6	CMAHP	603209.0 | CMAHP, CMAH | Cytidine monophospho-N-acetylneuraminic acid hydroxylase pseudogene | 8418.0 | ENSG00000293489 | mutation inactivates gene in humans | nan
chr6		600202.0 | DYX2 | Dyslexia, susceptibility to, 2 | nan | nan | ?between D6S105 and TNFB | {Dyslexia, susceptibility to, 2}, 600202 (2), Autosomal dominant
chr6	NBLST4	613015.0 | NBLST4 | Neuroblastoma, susceptibility to, 4 | 100306937.0 | nan | associated with rs6939340, rs4712653, rs9295536 | {Neuroblastoma, susceptibility to, 4}, 613015 (2)
chr6	OTSC3	608244.0 | OTSC3 | Otosclerosis 3 | 170532.0 | nan | nan | Otosclerosis 3, 608244 (2), Autosomal dominant
chr6	JARID2	601594.0 | JARID2, JMJ, DIDDF | Jumonji and AT-rich interaction domain containing 2 | 3720.0 | ENSG00000008083 | nan | Developmental delay with variable intellectual disability and dysmorphic facies, 620098 (3), Autosomal dominant
chr6	DTNBP1	607145.0 | DTNBP1, HPS7 | Dystrobrevin-binding protein 1 (dysbindin) | 84062.0 | ENSG00000047579 | nan | Hermansky-Pudlak syndrome 7, 614076 (3), Autosomal recessive
chr6	MYLIP	610082.0 | MYLIP, MIR | Myosin regulatory light chain-interacting protein | 29116.0 | ENSG00000007944 | nan | nan
chr6	GMPR	139265.0 | GMPR, GMPR1 | Guanosine monophosphate reductase | 2766.0 | ENSG00000137198 | nan | nan
chr6	ATXN1	601556.0 | ATXN1, ATX1, SCA1 | Ataxin-1 | 6310.0 | ENSG00000124788 | nan | Spinocerebellar ataxia 1, 164400 (3), Autosomal dominant
chr6	RBM24	617603.0 | RBM24, RNPC6 | RNA-binding motif protein 24 | 221662.0 | ENSG00000112183 | nan | nan
chr6	CAP2	618385.0 | CAP2, CMD2I | Cyclase-associated actin cytoskeleton regulatory protein 2 | 10486.0 | ENSG00000112186 | nan | Cardiomyopathy, dilated, 2I, 620462 (3), Autosomal recessive
chr6	FAM8A1	618409.0 | FAM8A1 | Family with sequence similarity 8, member A1 | 51439.0 | ENSG00000137414 | nan | nan
chr6	NUP153	603948.0 | NUP153 | Nucleoporin, 153kD | 9972.0 | ENSG00000124789 | nan | nan
chr6	KIF13A	605433.0 | KIF13A | Kinesin family member 13A | 63971.0 | ENSG00000137177 | nan | nan
chr6	NHLRC1	608072.0 | NHLRC1, MELF2 | NHL repeat-containing 1 gene (malin) | 378884.0 | ENSG00000187566 | nan | Myoclonic epilepsy of Lafora 2, 620681 (3), Autosomal recessive
chr6	TPMT	187680.0 | TPMT, TPMTD | Thiopurine S-methyltransferase | 7172.0 | ENSG00000137364 | nan | {Thiopurines, poor metabolism of, 1}, 610460 (3), Autosomal recessive
chr6	KDM1B	613081.0 | KDM1B, LSD2, AOF1 | Lysine demethylase 1B | 221656.0 | ENSG00000165097 | nan | nan
chr6	DEK	125264.0 | DEK, D6S231E | DEK oncogene | 7913.0 | ENSG00000124795 | fused with CAN in t(6;9) | Leukemia, acute nonlymphocytic, 125264 (2)
chr6	RNF144B	618869.0 | RNF144B | RING finger protein 144B | 255488.0 | ENSG00000137393 | nan | nan
chr6	ID4	600581.0 | ID4 | Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 3400.0 | ENSG00000172201 | nan | nan
chr6	MBOAT1	611732.0 | MBOAT1 | Membrane-bound O-acetyltransferase domain-containing 1 | 154141.0 | ENSG00000172197 | nan | nan
chr6	E2F3	600427.0 | E2F3 | E2F transcription factor 3 | 1871.0 | ENSG00000112242 | nan | nan
chr6	CDKAL1	611259.0 | CDKAL1 | CDK5 regulatory subunit-associated protein 1-like 1 | 54901.0 | ENSG00000145996 | nan | nan
chr6	SOX4	184430.0 | SOX4, CSS10 | SRY (sex determining region Y)-box 4 | 6659.0 | ENSG00000124766 | nan | Coffin-Siris syndrome 10, 618506 (3), Autosomal dominant
chr6	CASC15	616610.0 | CASC15, LINC00340 | Cancer susceptibility candidate 15, noncoding | 401237.0 | nan | nan | nan
chr6	NBAT1	616206.0 | NBAT1 | Neuroblastoma-associated transcript 1, noncoding | 729177.0 | nan | nan | nan
chr6	PRL	176760.0 | PRL | Prolactin | 5617.0 | ENSG00000172179 | ?between 6cen and GLO1 | nan
chr6	NRSN1	616630.0 | NRSN1, VMP | Neurensin 1 | 140767.0 | ENSG00000152954 | nan | nan
chr6	DCDC2	605755.0 | DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC | Doublecortin domain-containing protein 2 | 51473.0 | ENSG00000146038 | mutation identified in 1 DFNB66 family | Nephronophthisis 19, 616217 (3), Autosomal recessive; ?Deafness, autosomal recessive 66, 610212 (3), Autosomal recessive; Sclerosing cholangitis, neonatal, 617394 (3), Autosomal recessive
chr6	KAAG1	608211.0 | KAAG1, RU2AS | Kidney-associated antigen 1 | 353219.0 | ENSG00000146049 | nan | nan
chr6	MRS2	619307.0 | MRS2 | Magnesium transporter MRS2 | 57380.0 | ENSG00000124532 | nan | nan
chr6	GPLD1	602515.0 | GPLD1, PIGPLD, GPIPLD | Phospholipase D1, glycosylphosphatidylinositol-specific | 2822.0 | ENSG00000112293 | nan | nan
chr6	ALDH5A1	610045.0 | ALDH5A1, SSADH | Succinic semialdehyde dehydrogenase | 7915.0 | ENSG00000112294 | nan | Succinic semialdehyde dehydrogenase deficiency, 271980 (3), Autosomal recessive
chr6	KIAA0319	609269.0 | KIAA0319 | KIAA0319 gene | 9856.0 | ENSG00000137261 | nan | nan
chr6	TDP2	605764.0 | TDP2, TTRAP | Tyrosyl-DNA phosphodiesterase 2 | 51567.0 | ENSG00000111802 | nan | Spinocerebellar ataxia, autosomal recessive 23, 616949 (3), Autosomal recessive
chr6	ACOT13	615652.0 | ACOT13, THEM2 | Acyl-CoA thioesterase 13 | 55856.0 | ENSG00000112304 | nan | nan
chr6	GMNN	602842.0 | GMNN, MGORS6 | Geminin DNA replication inhibitor | 51053.0 | ENSG00000112312 | nan | Meier-Gorlin syndrome 6, 616835 (3), Autosomal dominant
chr6	RIPOR2	611410.0 | RIPOR2, FAM65B, C6orf32, KIAA0386, PL48, DFNB104, DFNA21 | RHO family interacting cell polarization regulator 2 | 9750.0 | ENSG00000111913 | mutation identified in 1 DFNB104 family | Deafness, autosomal dominant 21, 607017 (3), Autosomal dominant; ?Deafness, autosomal recessive 104, 616515 (3), Autosomal recessive
chr6	MVCD7	612635.0 | MVCD7 | Microvascular complications of diabetes, susceptibility to, 7 | 131554433.0 | nan | nan | {Microvascular complications of diabetes, susceptibility to, 7}, 612635 (2)
chr6	TFQTL2	614193.0 | TFQTL2 | Transferring serum level quantitative trait locus 2 | 131554434.0 | nan | nan | [Transferrin serum level quantitative trait locus 2], 614193 (2)
chr6	CARMIL1	609593.0 | CARMIL1, LRRC16A, LRRC16 | Capping protein regulator and myosin 1 linker 1 | 55604.0 | ENSG00000079691 | nan | nan
chr6	SCGN	609202.0 | SCGN | Secretagogin | 10590.0 | ENSG00000079689 | nan | nan
chr6	SLC17A1	182308.0 | SLC17A1, NPT1 | Solute carrier family 17, sodium phosphate, member-1 (Sodium phosphate transport 1, kidney) | 6568.0 | ENSG00000124568 | nan | nan
chr6	H2AC1	613499.0 | H2AC1, HISTH2AA, H2AFR, H2AA | H2A clustered histone 1 | 221613.0 | ENSG00000164508 | nan | nan
chr6	H2BC1	609904.0 | H2BC1, HIST1H2BA, TSH2B | H2B clustered histone 1 | 255626.0 | ENSG00000146047 | nan | nan
chr6	SLC17A4	604216.0 | SLC17A4 | Solute carrier family 17 (sodium phosphate), member 4 | 10050.0 | ENSG00000146039 | nan | nan
chr6	SLC17A3	611034.0 | SLC17A3, NPT4, UAQTL4, GOUT4 | Solute carrier family 17 (sodium phosphate cotransporter), member 3 | 10786.0 | ENSG00000124564 | nan | [Uric acid concentration, serum, QTL4], 612671 (3), Autosomal dominant; {Gout susceptibility 4}, 612671 (3), Autosomal dominant
chr6	SLC17A2	611049.0 | SLC17A2, NPT3 | Solute carrier family 17 (sodium phosphate cotransporter), member 2 | 10246.0 | ENSG00000112337 | nan | nan
chr6	H1-1	142709.0 | H1-1, HIST1H1A, H1F1 | H1.1 linker histone, cluster member | 3024.0 | ENSG00000124610 | nan | nan
chr6	H3C1	602810.0 | H3C1, HIST1H3A, H3FA | H3 clustered histone 1 | 8350.0 | ENSG00000275714 | nan | nan
chr6	H4C1	602822.0 | H4C1, HIST1H4A, H4FA | H4 clustered histone 1 | 8359.0 | ENSG00000278637 | nan | nan
chr6	H4C2	602829.0 | H4C2, HIST1H4B, H4FI | H4 clustered histone 2 | 8366.0 | ENSG00000278705 | nan | nan
chr6	H3C2	602819.0 | H3C2, HIST1H3B, H3FL | H3 clustered histone 2 | 8358.0 | ENSG00000286522 | in major cluster on 6p | nan
chr6	H2AC4	602795.0 | H2AC4, HIST1H2AB, H2AFM | H2A clustered histone 4 | 8335.0 | ENSG00000278463 | nan | nan
chr6	H2BC3	602803.0 | H2BC3, HIST1H2BB, H2BFF | H2B clustered histone 3 | 3018.0 | ENSG00000276410 | nan | nan
chr6	H3C3	602812.0 | H3C3, HIST1H3C, H3FC | H3 clustered histone 3 | 8352.0 | ENSG00000287080 | nan | nan
chr6	H1-2	142710.0 | H1-2, HIST1H1C, H1F2 | H1.2 linker histone, cluster member | 3006.0 | ENSG00000187837 | nan | nan
chr6	HFE	613609.0 | HFE, HLA-H, HFE1 | Homeostatic iron regulator | 3077.0 | ENSG00000010704 | nan | Hemochromatosis, type 1, 235200 (3), Autosomal recessive
chr6	H4C3	602827.0 | H4C3, HIST1H4C, H4FG, TEBIVANED1 | H4 clustered histone 3 | 8364.0 | ENSG00000197061 | nan | Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 1, 619758 (3), Autosomal dominant
chr6	H1-6	142712.0 | H1-6, HIST1H1T, H1FT | H1.6 linker histone, cluster member | 3010.0 | ENSG00000187475 | nan | nan
chr6	H2BC4	602847.0 | H2BC4, HIST1H2BC, H2BFL | H2B clustered histone 4 | 8347.0 | ENSG00000180596 | nan | nan
chr6	H2AC6	602794.0 | H2AC6, HIST1H2AC, H2AFL | H2A clustered histone 6 | 8334.0 | ENSG00000180573 | nan | nan
chr6	H1-4	142220.0 | H1-4, HIST1H1E, H1F4, RMNS | H1.4 linker histone, cluster member | 3008.0 | ENSG00000168298 | nan | Rahman syndrome, 617537 (3), Autosomal dominant
chr6	H2BC5	602799.0 | H2BC5, HIST1H2BD, H2BFB | H2B clustered histone 5 | 3017.0 | ENSG00000158373 | nan | nan
chr6	H2BC6	602805.0 | H2BC6, HIST1H2BE, H2BFH | H2B clustered histone 6 | 8344.0 | ENSG00000274290 | nan | nan
chr6	H4C4	602823.0 | H4C4, HIST1H4D, H4FB | H4 clustered histone 4 | 8360.0 | ENSG00000277157 | nan | nan
chr6	H3C4	602811.0 | H3C4, HIST1H3D, H3FB | H3 clustered histone 4 | 8351.0 | ENSG00000197409 | nan | nan
chr6	H2AC7	602792.0 | H2AC7, HIST1H2AD, H2AFG | H2A clustered histone 7 | 3013.0 | ENSG00000196866 | nan | nan
chr6	H2BC7	602804.0 | H2BC7, HIST1H2BF, H2BFG | H2B clustered histone 7 | 8343.0 | ENSG00000277224 | nan | nan
chr6	H4C5	602830.0 | H4C5, HIST1H4E, H4FJ, TEBIVANED3 | H4 clustered histone 5 | 8367.0 | ENSG00000276966 | nan | Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 3, 619950 (3), Autosomal dominant
chr6	H2BC8	602798.0 | H2BC8, HIST1H2BG, H2BFA | H2B clustered histone 8 | 8339.0 | ENSG00000273802 | nan | nan
chr6	H2AC8	602786.0 | H2AC8, HIST1H2AE, H2AFA | H2A clustered histone 8 | 3012.0 | ENSG00000277075 | nan | nan
chr6	H3C6	602813.0 | H3C6, HIST1H3E, H3FD, H3.1 | H3 clustered histone 6 | 8353.0 | ENSG00000274750 | in cluster of 35 histone genes | nan
chr6	H1-3	142210.0 | H1-3, HIST1H1D, H1F3 | H1.3 linker histone, cluster member | 3007.0 | ENSG00000124575 | nan | nan
chr6	H4C6	602824.0 | H4C6, HIST1H4F, H4FC | H4 clustered histone 6 | 8361.0 | ENSG00000274618 | nan | nan
chr6	H4C7	602832.0 | H4C7, HIST1H4G, H4FL | H4 clustered histone 7 | 8369.0 | ENSG00000275663 | nan | nan
chr6	H3C7	602816.0 | H3C7, HIST1H3F | H3 clustered histone 7 | 8968.0 | ENSG00000277775 | nan | nan
chr6	H2BC9	602806.0 | H2BC9, HIST1H2BH, H2BFJ | H2B clustered histone 9 | 8345.0 | ENSG00000275713 | nan | nan
chr6	H3C8	602815.0 | H3C8, HIST1H3G, H3FH | H3 clustered histone 8 | 8355.0 | ENSG00000273983 | nan | nan
chr6	H2BC10	602807.0 | H2BC10, HIST1H2BI, H2BFK | H2B clustered histone 10 | 8346.0 | ENSG00000278588 | nan | nan
chr6	H4C8	602828.0 | H4C8, HIST1H4H, H4FH | H4 clustered histone 8 | 8365.0 | ENSG00000158406 | nan | nan
chr6	TRX-CAT1-2	180621.0 | TRNAM1, TRMI2, TRM2, RNTMT1 | tRNA methionine-1 | 7210.0 | nan | nan | nan
chr6	TRR-TCG4-1	601432.0 | TRR-TCG4-1, TRNAR3, TRR3 | tRNA arginine (anticodon TCG) 4-1 | 7232.0 | nan | nan | nan
chr6	BTN3A2	613594.0 | BTN3A2, BTF4 | Butyrophilin, subfamily 3, member A2 | 11118.0 | ENSG00000186470 | nan | nan
chr6	BTN2A2	613591.0 | BTN2A2, BTF2 | Butyrophilin, subfamily 2, member A2 | 10385.0 | ENSG00000124508 | nan | nan
chr6	BTN3A1	613593.0 | BTN3A1, BTF5, CD277 | Butyrophilin, subfamily 3, member A1 | 11119.0 | ENSG00000026950 | nan | nan
chr6	BTN2A3P	613592.0 | BTN2A3 | Butyrophilin, subfamily 2, member A3 | 54718.0 | ENSG00000291104 | nan | nan
chr6	BTN3A3	613595.0 | BTN3A3, BTF3 | Butyrophilin, subfamily 3, member A3 | 10384.0 | ENSG00000111801 | nan | nan
chr6	BTN2A1	613590.0 | BTN2A1, BTF1 | Butyrophilin, subfamily 2, member A1 | 11120.0 | ENSG00000112763 | nan | nan
chr6	BTN1A1	601610.0 | BTN1A1, BTN | Butyrophilin | 696.0 | ENSG00000124557 | nan | nan
chr6	TRR-ACG1-2	615305.0 | TRNAR2 | Transfer RNA arginine 2 | 7231.0 | nan | nan | nan
chr6	TRV-CAC1-6	615306.0 | TRNAV21 | Transfer RNA valine 21 | 100189227.0 | nan | nan | nan
chr6	ABT1	618750.0 | ABT1 | Activator of basal transcription 1 | 29777.0 | ENSG00000146109 | nan | nan
chr6	ZNF322	610847.0 | ZNF322, ZNF489 | Zinc finger protein 322 | 79692.0 | ENSG00000181315 | nan | nan
chr6	STQTL18	612892.0 | STQTL18 | Stature quantitative trait locus 18 | 100302683.0 | nan | associated with rs10946808 | {Stature QTL 18}, 612892 (2)
chr6	H2BC11	615044.0 | H2BC11, HIST1H2BJ, H2BJ | H2B clustered histone 11 | 8970.0 | ENSG00000124635 | nan | nan
chr6	H2AC11	615012.0 | H2AC11, HIST1H2AG, H2AG, H2AFP | H2A clustered histone 11 | 8969.0 | ENSG00000196787 | nan | nan
chr6	H2BC12	615045.0 | H2BC12, HIST1H2BK, H2BK | H2B clustered histone 12 | 85236.0 | ENSG00000197903 | nan | nan
chr6	H4C9	602833.0 | H4C9, HIST1H4I, H4FM, H4M, TEBIVANED4 | H4 clustered histone 9 | 8294.0 | ENSG00000276180 | nan | Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 4, 619951 (3), Autosomal dominant
chr6	H2AC12	615013.0 | H2AC12, HIST1H2AH, H2AH | H2A clustered histone 12 | 85235.0 | ENSG00000274997 | nan | nan
chr6	TRV-AAC5-1	615307.0 | TRNAV12 | Transfer RNA valine 12 | 100189014.0 | nan | nan | nan
chr6	PRSS16	607169.0 | PRSS16, TSSP | Protease, serine, 16 | 10279.0 | ENSG00000112812 | nan | nan
chr6	ZNF184	602277.0 | ZNF184 | Zinc finger protein-184 | 7738.0 | ENSG00000096654 | nan | nan
chr6	TRS-AGA2-3	189910.0 | TRS-AGA2-3, TRNAS2, TRS2, TRNS | tRNA serine (anticodon AGA) 2-3 | 23437.0 | nan | nan | nan
chr6	TRS-TGA4-1	606172.0 | TRS-TGA4-1, TRNAS3, TRS3 | tRNA serine (anticodon TGA) 4-1 | 23540.0 | nan | nan | nan
chr6	TRS-TGA2-1	606171.0 | TRS-TGA2-1, TRNAS1, TRS1 | tRNA serine (anticodon TGA) 2-1 | 94017.0 | nan | nan | nan
chr6	TRV-AAC4-1	615308.0 | TRNAV17 | Transfer RNA valine 17 | 100189161.0 | nan | nan | nan
chr6	TRT-AGT2-2	615309.0 | TRNAT15 | Transfer RNA threonine 15 | 100189340.0 | nan | nan | nan
chr6	H2BC13	602800.0 | H2BC13, HIST1H2BL, H2BFC | H2B clustered histone 13 | 8340.0 | ENSG00000185130 | nan | nan
chr6	H2AC13	602787.0 | H2AC13, HIST1H2AI, H2AFC | H2A clustered histone 13 | 8329.0 | ENSG00000196747 | nan | nan
chr6	H3C10	602818.0 | H3C10, HIST1H3H, H3FK | H3 clustered histone 10 | 8357.0 | ENSG00000278828 | in minor cluster on 6p | nan
chr6	H2AC14	602791.0 | H2AC14, HIST1H2AJ, HIST1H2AK, H2AFE | H2A clustered histone 14 | 8331.0 | ENSG00000276368 | nan | nan
chr6	H2BC14	602802.0 | H2BC14, HIST1H2BM, H2BFE | H2B clustered histone 14 | 8342.0 | ENSG00000273703 | nan | nan
chr6	H4C11	602826.0 | H4C11, HIST1H4J, H4FE, TEBIVANED2 | H4 clustered histone 11 | 8363.0 | ENSG00000197238 | mutation identified in 1 TEBIVANED2 patient | ?Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 2, 619759 (3), Autosomal dominant
chr6	H4C12	602825.0 | H4C12, HIST1H4K, H4FD | H4 clustered histone 12 | 8362.0 | ENSG00000273542 | nan | nan
chr6	H2AC15	602788.0 | H2AC15, HIST1H2AK, HIST1H2AI, H2AFD | H2A clustered histone 15 | 8330.0 | ENSG00000275221 | nan | nan
chr6	H2BC15	602801.0 | H2BC15, HIST1H2BN, H2BFD | H2B clustered histone 15 | 8341.0 | ENSG00000233822 | nan | nan
chr6	H2AC16	602793.0 | H2AC16, HIST1H2AL, H2AFI | H2A clustered histone 16 | 8332.0 | ENSG00000276903 | nan | nan
chr6	H1-5	142711.0 | H1-5, HIST1H1B, H1F5 | H1.4 linker histone, cluster member | 3009.0 | ENSG00000184357 | ~2Mb centromeric of H1F1 cluster | nan
chr6	H3C11	602814.0 | H3C11, HIST1H3I, H3FF | H3 clustered histone 11 | 8354.0 | ENSG00000275379 | in cluster of 16 histone genes centromeric of major cluster | nan
chr6	H4C13	602831.0 | H4C13, HIST1H4L, H4FK | H4 clustered histone 13 | 8368.0 | ENSG00000275126 | nan | nan
chr6	H3C12	602817.0 | H3C12, HIST1H3J, H3FJ | H3 clustered histone 12 | 8356.0 | ENSG00000197153 | in 2nd cluster on 6p | nan
chr6	H2AC17	602796.0 | H2AC17, HIST1H2AM, H2AFN | H2A clustered histone 17 | 8336.0 | ENSG00000278677 | nan | nan
chr6	H2BC17	602808.0 | H2BC17, HIST1H2BO, H2BFN | H2B clustered histone 17 | 8348.0 | ENSG00000274641 | nan | nan
chr6	ZNF165	600834.0 | ZNF165, LD65 | Zinc finger protein-165 | 7718.0 | ENSG00000197279 | nan | nan
chr6	ZSCAN16	618544.0 | ZSCAN16, ZNF435 | Zinc finger- and SCAN domain-containing protein 16 | 80345.0 | ENSG00000196812 | nan | nan
chr6	ZKSCAN8	602240.0 | ZNF192 | Zinc finger protein-192 | 7745.0 | ENSG00000198315 | nan | nan
chr6	ZSCAN9	602246.0 | ZNF193 | Zinc finger protein-193 | 7746.0 | ENSG00000137185 | nan | nan
chr6	ZKSCAN4	611643.0 | ZKSCAN4, ZNF307 | Zinc finger with KRAB and SCAN domains 4 | 387032.0 | ENSG00000187626 | nan | nan
chr6	ZSCAN26	616474.0 | ZSCAN26, SREZBP | Zinc finger- and SCAN domain-containing protein 26 | 7741.0 | ENSG00000197062 | nan | nan
chr6	ZSCAN31	610794.0 | ZNF323 | Zinc finger protein 323 | 64288.0 | ENSG00000235109 | nan | nan
chr6	ZKSCAN3	612791.0 | ZKSCAN3, ZNF306 | Zinc finger protein with KRAB and SCAN domains 3 | 80317.0 | ENSG00000189298 | nan | nan
chr6	ZSCAN12	603978.0 | ZSCAN12, ZNF96, KIAA0426 | Zinc finger- and SCAN domain-containing protein 12 | 9753.0 | ENSG00000158691 | nan | nan
chr6	GPX6	607913.0 | GPX6 | Glutathione peroxidase 6 | 257202.0 | ENSG00000198704 | nan | nan
chr6	GPX5	603435.0 | GPX5 | Glutathione peroxidase 5 (epididymal) | 2880.0 | ENSG00000224586 | nan | nan
chr6	SCAND3	615254.0 | SCAND3, ZBED9, BUSTER4, KIAA1925 | SCAN domain-containing protein 3 | 114821.0 | ENSG00000232040 | nan | nan
chr6	TRA-TGC7-1	601431.0 | TRA-TGC7-1, TRNAA1 | tRNA alanine (anticodon TGC) 7-1 | 7154.0 | nan | nan | nan
chr6	TRIM27	602165.0 | TRIM27, RFP | Tripartite motif-containing 27 | 5987.0 | ENSG00000204713 | nan | nan
chr6	OR2J3	615016.0 | OR2J3, C3HEXS | Olfactory receptor, family 2, subfamily J, member 3 | 442186.0 | ENSG00000204701 | nan | [C3HEX, ability to smell], 615082 (3), Autosomal dominant
chr6	MAS1L	607235.0 | MAS1L, MRG | MAS1 oncogene-like | 116511.0 | ENSG00000204687 | nan | nan
chr6	UBD	606050.0 | UBD, FAT10 | Ubiquitin D | 10537.0 | ENSG00000213886 | nan | nan
chr6	OR2H2	600578.0 | OR2H3, OLFR2 | Olfactory receptor, family 2, subfamily H, member 3 (olfactory receptor 2) | 7932.0 | ENSG00000204657 | in class I MHC region | nan
chr6	GABBR1	603540.0 | GABBR1, GABABR1, NEDLC | Gamma-aminobutyric acid B receptor 1 | 2550.0 | ENSG00000204681 | nan | Neurodevelopmental disorder with language delay and variable cognitive abnormalities, 620502 (3), Autosomal dominant
chr6	MOG	159465.0 | MOG, NRCLP7 | Myelin-oligodendrocyte glycoprotein | 4340.0 | ENSG00000204655 | 60kb telomeric to HLA-F; mutation identified in 1 NRCLP7 family | ?Narcolepsy 7, 614250 (3), Autosomal dominant
chr6	ZFP57	612192.0 | ZFP57, TNDM1 | ZFP57 zinc finger protein | 346171.0 | ENSG00000204644 | nan | Diabetes mellitus, transient neonatal 1, 601410 (3), Autosomal recessive, Autosomal dominant
chr6	HLA-F	143110.0 | HLA-F, HLA-CDA12, HLAF | Major histocompatibility complex, class I, F | 3134.0 | ENSG00000204642 | nan | nan
chr6	HLA-G	142871.0 | HLA-G | HLA-G histocompatibility antigen, class I | 3135.0 | ENSG00000204632 | nan | {Asthma, susceptibility to}, 600807 (2), Autosomal dominant
chr6	HLA-A	142800.0 | HLA-A | Major histocompatibility complex, class I, A | 3105.0 | ENSG00000206503 | nan | {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)
chr6	HCG9	615797.0 | HCG9, HCGIX, HCGIX4 | HLA complex group 9, noncoding | 10255.0 | ENSG00000204625 | nan | nan
chr6	POLR1HASP	615714.0 | ZNRD1AS1, TCTEX4, HTEX4 | ZNRD1 antisense RNA 1 | 80862.0 | ENSG00000293508 | nan | nan
chr6	POLR1H	607525.0 | POLR1H, ZNRD1, TCTEX6, HTEX6 | Polymerase I, RNA, subunit H | 30834.0 | ENSG00000066379 | nan | nan
chr6	PPP1R11	606670.0 | PPP1R11, TCTEX5 | Protein phosphatase 1, regulatory subunit 11 | 6992.0 | ENSG00000204619 | nan | nan
chr6	RNF39	607524.0 | RNF39, HZFW, HZF, LIRF | Ring finger protein 39 | 80352.0 | ENSG00000204618 | nan | nan
chr6	TRIM31	609316.0 | TRIM31, HCGI | Tripartite motif-containing protein 31 | 11074.0 | ENSG00000204616 | nan | nan
chr6	TRIM40	616976.0 | TRIM40, RNF35 | Tripartite motif-containing protein 40 | 135644.0 | ENSG00000204614 | nan | nan
chr6	TRIM10	605701.0 | RNF9, RFB30, HERF1 | RING finger protein-9 | 10107.0 | ENSG00000204613 | nan | nan
chr6	TRIM26	600830.0 | ZNF173 | Zinc finger protein-173 | 7726.0 | ENSG00000234127 | nan | nan
chr6	TRIM39	605700.0 | TRIM39, RNF23, TFP | Tripartite motif-containing 39 | 56658.0 | ENSG00000204599 | nan | nan
chr6	RPP21	612524.0 | RPP21 | Ribonuclease P/MRP subunit p21 | 79897.0 | ENSG00000241370 | nan | nan
chr6	HLA-E	143010.0 | HLA-E | Major histocompatibility complex, class I, E | 3133.0 | ENSG00000204592 | nan | nan
chr6	ATPLS	107320.0 | ATPLS | Antiphospholipid syndrome, familial | 100499532.0 | nan | possible linkage with HLA-DRB1*14 | ?Antiphospholipid syndrome, familial, 107320 (2), Autosomal dominant
chr6		153380.0 | CP20 | Lymphocyte cytosolic protein, molecular weight 20kD | 7938.0 | nan | nan | nan
chr6	CTEPH1	612862.0 | CTEPH1 | Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to | 100302516.0 | nan | associated with DPB1*0202 | {Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}, 612862 (2)
chr6	DFNA31	608645.0 | DFNA31 | Deafness, autosomal dominant 31 | 347737.0 | nan | between D6S276 and D6S273 | Deafness, autosomal dominant 31, 608645 (2), Autosomal dominant
chr6	EJM3	608816.0 | EJM3 | Epilepsy, juvenile myoclonic 3 | 449018.0 | nan | nan | Epilepsy, juvenile myoclonic 3, 608816 (2)
chr6	FL1	613024.0 | FL1 | Follicular lymphoma, susceptibility to, 1 | 100306940.0 | nan | associated with rs6457327 | {Follicular lymphoma, susceptibility to, 1}, 613024 (2)
chr6	WG	608710.0 | GPA, WG | Granulomatosis with polyangiitis | 474168.0 | nan | nan | Granulomatosis with polyangiitis, 608710 (2)
chr6	HLA-DRB3	612735.0 | HLA-DRB3, HLA-DR52 | Major histocompatibility complex, class II, DR beta-3 | 3125.0 | nan | nan | nan
chr6	IBD3	604519.0 | IBD3 | Inflammatory bowel disease 3 | 30829.0 | nan | nan | {Inflammatory bowel disease 3}, 604519 (2), Autosomal dominant
chr6		222100.0 | IDDM1 | Insulin-dependent diabetes mellitus-1 | nan | nan | linkage or association, with HLA | {Diabetes mellitus, insulin-dependent-1}, 222100 (2), Autosomal recessive
chr6	IGAD1	137100.0 | IGAD1 | Immunoglobulin A deficiency | 10986.0 | nan | nan | Immunoglobulin A deficiency, 137100 (2), Autosomal recessive, Isolated cases, Autosomal dominant
chr6	IGAT	146820.0 | IGAT | Immune response to synthetic polypeptide--IRGAT | 7927.0 | nan | in B/D segment | nan
chr6	IGLP1	147080.0 | IGLP1 | Immune response to synthetic polypeptides-1 | 7925.0 | nan | nan | nan
chr6	IGLP2	147090.0 | IGLP2 | Immune response to synthetic polypeptides-2 | 7926.0 | nan | nan | nan
chr6	ISCW	146850.0 | ISCW | Immune suppression to streptococcal antigen | 7928.0 | nan | HLA-linked | nan
chr6	LAP	150270.0 | LAP | Laryngeal adductor paralysis | 7939.0 | nan | ?linkage to HLA and GLO1 | ?Laryngeal adductor paralysis, 150270 (2), Autosomal dominant
chr6	LATD	601086.0 | LATD | Laterality defects, autosomal dominant | 207115.0 | nan | max lod 2.95 at theta = 0 | nan
chr6	LNCR4	612593.0 | LNCR4 | Lung cancer susceptibility 4 | 100271693.0 | nan | associated with rs3117582 and rs3131379 | {Lung cancer susceptibility 4}, 612593 (2)
chr6	MBNP	614692.0 | MBNP | Membranous nephropathy, susceptibility to | 101154649.0 | nan | nan | {?Membranous nephropathy, susceptibility to}, 614692 (2)
chr6	MPVQTL4	614644.0 | MPVQTL4 | Mean platelet volume quantitative trait locus 4 | 100887753.0 | nan | associated with rs210134 | Mean platelet volume QTL4, 614644 (2)
chr6	MYAS1	607085.0 | MYAS1 | Myasthenia gravis with thymus hyperplasia | 246750.0 | nan | nan | Myasthenia gravis with thymus hyperplasia, 607085 (2)
chr6	NKS1	272370.0 | NKS1, EC1 | Susceptibility to lysis by alloreactive natural killer cells | 4819.0 | nan | nan | {Lysis by alloreactive natural killer cells, susceptibility to}, 272370 (2), Autosomal recessive
chr6	NPCA2	161550.0 | NPCA2 | Nasopharyngeal carcinoma, susceptibility to, 2 | 100312951.0 | nan | associated with rs2517713 and rs2975042 | {Nasopharyngeal carcinoma, susceptibility to, 2}, 161550 (2)
chr6	PBC2	613007.0 | PBC2 | Biliary cirrhosis, primary, 2 | 100303716.0 | nan | associated with rs2856683 | {Biliary cirrhosis, primary, 2}, 613007 (2)
chr6	PBCA	600089.0 | PBCA | Pancreatic beta cell, agenesis of | 7962.0 | nan | uniparental disomy | ?Diabetes mellitus, insulin-dependent, neonatal, 600089 (2), Autosomal recessive
chr6		604809.0 | PBLT | Panbronchiolitis, diffuse | nan | nan | nan | Panbronchiolitis, diffuse, 604809 (2), Multifactorial
chr6	PDCOS	614590.0 | PDCOS | Podoconiosis, susceptibility to | 100885774.0 | nan | nan | {Podoconiosis, susceptibility to}, 614590 (2)
chr6	RLS6	611185.0 | RLS6 | Restless legs syndrome, susceptibility to, 6 | 100302512.0 | nan | associated with rs9296249 and rs9357271 | {Restless legs syndrome 6}, 611185 (2)
chr6	RWS	179450.0 | RWS | Ragweed sensitivity | 7937.0 | nan | ?linkage or association, with HLA | ?Ragweed sensitivity, 179450 (2), Autosomal dominant
chr6	VAMAS6	193200.0 | VAMAS6 | Vitiligo-associated multiple autoimmune disease susceptibility 6 | 246319.0 | nan | possible second locus on 1p31.3-p32.2 | {Vitiligo-associated multiple autoimmune disease susceptibility 6}, 193200 (2), Autosomal recessive
chr6	ZNF204P	603282.0 | ZNF204 | Zinc finger protein-204 | 7754.0 | ENSG00000291112 | ?pseudogene | nan
chr6	GNL1	143024.0 | GNL1, HSR1 | Guanine nucleotide-binding protein-like 1 | 2794.0 | ENSG00000204590 | nan | nan
chr6	ABCF1	603429.0 | ABCF1, ABC50 | ATP-binding cassette 50, TNF-alpha stimulated | 23.0 | ENSG00000204574 | nan | nan
chr6	MIR877	611619.0 | MIR877, MIRN877 | Micro RNA 877 | 100126314.0 | ENSG00000216101 | nan | nan
chr6	PPP1R10	603771.0 | PPP1R10, PNUTS | Protein phosphatase 1, regulatory subunit 10 | 5514.0 | ENSG00000204569 | nan | nan
chr6	MRPS18B	611982.0 | MRPS18B, MRPS18-2 | Mitochondrial ribosomal protein S18B | 28973.0 | ENSG00000204568 | pseudogenes on chromosomes 1 and 2 | nan
chr6	ATAT1	615556.0 | ATAT1, MEC17, C6orf134 | Alpha-tubulin acetyltransferase 1 | 79969.0 | ENSG00000137343 | nan | nan
chr6	DHX16	603405.0 | DHX16, DDX16, DBP2, PRP8, NMOAS | DEAH-box helicase 16 | 8449.0 | ENSG00000204560 | nan | Neuromuscular disease and ocular or auditory anomalies with or without seizures, 618733 (3), Autosomal dominant
chr6	PPP1R18	610990.0 | PPP1R18, KIAA1949 | Protein phosphatase 1 regulatory subunit 18 | 170954.0 | ENSG00000146112 | nan | nan
chr6	NRM	620017.0 | NRM | Nurim | 11270.0 | ENSG00000137404 | nan | nan
chr6	MDC1	607593.0 | MDC1, NFBD1, KIAA0170 | Mediator of DNA damage checkpoint protein 1 | 9656.0 | ENSG00000137337 | nan | nan
chr6	TUBB	191130.0 | TUBB, TUBB5, M40, CDCBM6, CSCSC1 | Tubulin, beta polypeptide | 203068.0 | ENSG00000196230 | nan | Symmetric circumferential skin creases, congenital, 1, 156610 (3), Autosomal dominant; Cortical dysplasia, complex, with other brain malformations 6, 615771 (3), Autosomal dominant
chr6	FLOT1	606998.0 | FLOT1 | Flotillin 1 | 10211.0 | ENSG00000137312 | nan | nan
chr6	IER3	602996.0 | IER3, DIF2, IEX1, PRG1, GLY96 | Immediate early response-3 | 8870.0 | ENSG00000137331 | nan | nan
chr6	DDR1	600408.0 | NEP, EDDR1, NTRK4, TRKE | Neuroepithelial tyrosine kinase | 780.0 | ENSG00000204580 | nan | nan
chr6	GTF2H4	601760.0 | GTF2H4 | General transcription factor IIH, polypeptide 4 | 2968.0 | ENSG00000213780 | nan | nan
chr6	VARS2	612802.0 | VARS2, KIAA1885, COXPD20 | Valyl-tRNA synthetase 2 | 57176.0 | ENSG00000137411 | nan | Combined oxidative phosphorylation deficiency 20, 615917 (3), Autosomal recessive
chr6	MUCL3	613928.0 | MUCL3, DPCR1, C6orf37 | Mucin-like 3 | 135656.0 | ENSG00000168631 | nan | nan
chr6	MUC21	616991.0 | MUC21, C6orf205 | Mucin 21, cell surface-associated | 394263.0 | ENSG00000204544 | nan | nan
chr6	MUC22	613917.0 | MUC22, PBMUCL1 | Mucin 22 | 100507679.0 | ENSG00000261272 | nan | nan
chr6	HCG22	613918.0 | HCG22, PBMUCL2 | HLA complex group 22 | 285834.0 | ENSG00000228789 | nan | nan
chr6	C6orf15	611401.0 | C6orf15, STG | Chromosome 6 open reading frame 15 | 29113.0 | ENSG00000204542 | nan | nan
chr6	PSORS1C1	613525.0 | SEEK1, C6orf16, PSORS1C1 | SEEK1 gene | 170679.0 | ENSG00000204540 | nan | nan
chr6	CDSN	602593.0 | CDSN, HTSS1, HYPT2, PSS1 | Corneodesmosin | 1041.0 | ENSG00000204539 | nan | Hypotrichosis 2, 146520 (3), Autosomal dominant; Peeling skin syndrome 1, 270300 (3), Autosomal recessive
chr6	PSORS1C2	613526.0 | SPR1, C6orf17 | SPR1 gene | 170680.0 | ENSG00000204538 | nan | nan
chr6	CCHCR1	605310.0 | CCHCR1, HCR, C6orf18 | Coiled-coil alpha-helical rod protein 1 | 54535.0 | ENSG00000204536 | ?role in psoriasis | nan
chr6	TCF19	600912.0 | TCF19, SC1 | Transcription factor-19 (SC1) | 6941.0 | ENSG00000137310 | nan | nan
chr6	POU5F1	164177.0 | POU5F1, OTF3, OCT3 | Pou domain, class 5, transcription factor 1 (octamer-binding transcription factor 3) | 5460.0 | ENSG00000204531 | OTF3L on 12; ?related pseudogene on chr.8 | nan
chr6	PSORS1C3	618690.0 | PSORS1C3 | Psoriasis susceptibility 1 candidate 3, noncoding | 100130889.0 | nan | nan | nan
chr6	HLA-C	142840.0 | HLA-C, PSORS1 | Major histocompatibility complex, class I, C | 3107.0 | ENSG00000204525 | nan | {Psoriasis susceptibility 1}, 177900 (3), Multifactorial; {HIV-1 viremia, susceptibility to}, 609423 (3)
chr6	HLA-B	142830.0 | HLA-B, SPDA1 | Major histocompatibility complex, class I, B | 3106.0 | ENSG00000234745 | nan | {Synovitis, chronic, susceptibility to} (3); {Abacavir hypersensitivity, susceptibility to} (3); {Spondyloarthropathy, susceptibility to, 1}, 106300 (3), Multifactorial; {Stevens-Johnson syndrome, susceptibility to}, 608579 (3); {Drug-induced liver injury due to flucloxacillin} (3); {Toxic epidermal necrolysis, susceptibility to}, 608579 (3)
chr6	MICA	600169.0 | MICA | MHC class I polypeptide-related sequence A | 100507436.0 | ENSG00000204520 | nan | nan
chr6	HCP5	604676.0 | HCP5, 6S2650E | Major histocompatibility complex, class I, gene P5-1 | 10866.0 | ENSG00000206337 | nan | nan
chr6	MICB	602436.0 | MICB | MHC class I polypeptide-related sequence B | 4277.0 | ENSG00000204516 | nan | nan
chr6	MCCD1	609624.0 | MCCD1 | Mitochondrial coiled-coil domain 1 | 401250.0 | ENSG00000204511 | nan | nan
chr6	DDX39B	142560.0 | DDX39B, BAT1, D6S81E | DExD-box helicase 39B | 7919.0 | ENSG00000198563 | 5 BATs in 160kb segment including also TNFA, TNFB | nan
chr6	ATP6V1G2	606853.0 | ATP6V1G2, ATP6G | ATPase, H+ transporting, V1 subunit G2 | 534.0 | ENSG00000213760 | nan | nan
chr6	NFKBIL1	601022.0 | NFKBIL1 | Nuclear factor-kappa-B inhibitor-like protein 1 | 4795.0 | ENSG00000204498 | nan | {Rheumatoid arthritis, susceptibility to}, 180300 (3)
chr6	LTA	153440.0 | LTA, TNFB | Lymphotoxin alpha (formerly tumor necrosis factor beta) | 4049.0 | ENSG00000226979 | cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B | {Psoriatic arthritis, susceptibility to}, 607507 (3); {Myocardial infarction, susceptibility to}, 608446 (3); {Leprosy, susceptibility to, 4}, 610988 (3)
chr6	TNF	191160.0 | TNF, TNFA, IMD127 | Tumor necrosis factor (cachectin) | 7124.0 | ENSG00000232810 | mutation identified in 1 IMD127 family | {Migraine without aura, susceptibility to}, 157300 (3), Autosomal dominant; {Dementia, vascular, susceptibility to} (3); ?Immunodeficiency 127, 620977 (3), Autosomal recessive; {Asthma, susceptibility to}, 600807 (3), Autosomal dominant; {Septic shock, susceptibility to} (3); {Malaria, cerebral, susceptibility to}, 611162 (3)
chr6	LTB	600978.0 | LTB, TNFC | Lymphotoxin B | 4050.0 | ENSG00000227507 | nan | nan
chr6	LST1	109170.0 | LST1, D6S49E, B144 | Leukocyte-specific transcript 1 (B144 protein) | 7940.0 | ENSG00000204482 | 10kb 3' from TNFA | nan
chr6	NCR3	611550.0 | NCR3, 1C7, NKP30, CD337, MALS | Natural cytotoxicity triggering receptor 3 | 259197.0 | ENSG00000204475 | nan | {Malaria, mild, susceptibility to}, 609148 (3)
chr6	AIF1	601833.0 | AIF1, IRT1 | Allograft inflammatory factor 1 | 199.0 | ENSG00000204472 | part of TNF block | nan
chr6	PRRC2A	142580.0 | PRRC2A, BAT2, D6S51E | Proline-rich coiled-coil protein 2A | 7916.0 | ENSG00000204469 | nan | nan
chr6	BAG6	142590.0 | BAG6, BAT3, D6S52E | BAG cochaperone 6 | 7917.0 | ENSG00000204463 | nan | nan
chr6	APOM	606907.0 | APOM, NG20 | Apolipoprotein M | 55937.0 | ENSG00000204444 | nan | nan
chr6	GPANK1	142610.0 | GPANK1, BAT4, D6S54E | G patch domain- and ankyrin repeats-containing protein 1 | 7918.0 | ENSG00000204438 | nan | nan
chr6	CSNK2B	115441.0 | CSNK2B, POBINDS | Casein kinase-2, beta polypeptide | 1460.0 | ENSG00000204435 | nan | Poirier-Bienvenu neurodevelopmental syndrome, 618732 (3), Autosomal dominant
chr6	LY6G5B	610433.0 | LY6G5B, G5B | Lymphocyte antigen 6 complex, locus G5B | 58496.0 | ENSG00000240053 | nan | nan
chr6	LY6G5C	610434.0 | LY6G5C, G5C | Lymphocyte antigen 6 complex, locus G5C | 80741.0 | ENSG00000204428 | nan | nan
chr6	ABHD16A	142620.0 | ABHD16A, BAT5, D6S82E, SPG86 | Abhydrolase domain-containing 16A, phospholipase | 7920.0 | ENSG00000204427 | nan | Spastic paraplegia 86, autosomal recessive, 619735 (3), Autosomal recessive
chr6	LY6G6F	611404.0 | LY6G6F, C6orf21 | Lymphocyte antigen 6 family, member G6F | 259215.0 | ENSG00000204424 | nan | nan
chr6	LY6G6E	610437.0 | LY6G6E, G6E | Lymphocyte antigen 6 family member G6E, pseudogene | 79136.0 | nan | nan | nan
chr6	LY6G6D	606038.0 | LY6G6D, MEGT1, G6D, C6orf23 | Lymphocyte antigen 6 complex, locus G6D | 58530.0 | ENSG00000244355 | nan | nan
chr6	LY6G6C	610435.0 | LY6G6C, G6C | Lymphocyte antigen 6 complex, locus G6C | 80740.0 | ENSG00000204421 | nan | nan
chr6	MPIG6B	606520.0 | MPIG6B, G6B, C6orf25, THAMY | Megakaryocyte and platelet inhibitory receptor G6B | 80739.0 | ENSG00000204420 | mutation identified in 1 THAMY family | ?Thrombocytopenia, anemia, and myelofibrosis, 617441 (3), Autosomal recessive
chr6	DDAH2	604744.0 | DDAH2 | Dimethylarginine dimethylaminohydrolase-2 | 23564.0 | ENSG00000213722 | nan | nan
chr6	CLIC1	602872.0 | CLIC1 | Chloride intracellular channel 1 | 1192.0 | ENSG00000213719 | nan | nan
chr6	MSH5	603382.0 | MSH5, POF13, SPGF74 | mutS homolog 5 | 4439.0 | ENSG00000204410 | mutation identified in POF13 family | ?Premature ovarian failure 13, 617442 (3), Autosomal recessive; Spermatogenic failure 74, 619937 (3), Autosomal recessive
chr6	VWA7	609693.0 | VWA7, C6orf27, G7C | von Willebrand factor A domain-containing protein 7 | 80737.0 | ENSG00000204396 | nan | nan
chr6	VARS1	192150.0 | VARS1, VARS, G7A, VARS2, NDMSCA | Valyl-tRNA synthetase 1 | 7407.0 | ENSG00000204394 | nan | Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy, 617802 (3), Autosomal recessive
chr6	LSM2	607282.0 | LSM2, C6orf28 | LSM2 protein | 57819.0 | ENSG00000204392 | nan | nan
chr6	HSPA1L	140559.0 | HSPA1L | Heat-shock 70kD protein-like-1 | 3305.0 | ENSG00000204390 | nan | nan
chr6	HSPA1A	140550.0 | HSPA1A | Heat-shock 70kD protein-1A | 3303.0 | ENSG00000204389 | also 14q22-q24, chr.21, and at least 1 other chromosome | nan
chr6	HSPA1B	603012.0 | HSPA1B | Heat-shock 70kD protein-1B | 3304.0 | ENSG00000204388 | nan | nan
chr6	SNHG32	605447.0 | SNHG32, C6orf48, G8 | Small nucleolar RNA host gene 32 | 50854.0 | ENSG00000204387 | nan | nan
chr6	NEU1	608272.0 | NEU1, NEU, SIAL1 | Neuraminidase 1 (lysosomal sialidase; sialidase 1) | 4758.0 | ENSG00000204386 | nan | Sialidosis, type II, 256550 (3), Autosomal recessive; Sialidosis, type I, 256550 (3), Autosomal recessive
chr6	SLC44A4	606107.0 | SLC44A4, CTL4, C6orf29, DFNA72 | Solute carrier family 44, member 4 | 80736.0 | ENSG00000204385 | mutation identified in 1 DFNA72 family | ?Deafness, autosomal dominant 72, 617606 (3), Autosomal dominant
chr6	EHMT2	604599.0 | EHMT2, GAT8, G9A, NG36 | Euchromatic histone-lysine N-methyltransferase 2 | 10919.0 | ENSG00000204371 | nan | nan
chr6	C2	613927.0 | C2, ARMD14 | Complement component-2 | 717.0 | ENSG00000166278 | no crossover with BF | C2 deficiency, 217000 (3), Autosomal recessive; {Macular degeneration, age-related, 14, reduced risk of}, 615489 (3), Digenic dominant
chr6	CFB	138470.0 | CFB, BF, GBG, AHUS4, ARMD14, CFBD | Complement factor B | 629.0 | ENSG00000243649 | mutation identified in 1 CFBD family | ?Complement factor B deficiency, 615561 (3), Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3), Autosomal dominant; {Macular degeneration, age-related, 14, reduced risk of}, 615489 (3), Digenic dominant
chr6	NELFE	154040.0 | NELFE, RDBP | Negative elongation factor complex, member E | 7936.0 | ENSG00000204356 | nan | nan
chr6	SKIC2	600478.0 | SKIC2, SKIV2L, SKI2, SKI2W, THES2 | SKI2 subunit of superkiller complex | 6499.0 | ENSG00000204351 | nan | Trichohepatoenteric syndrome 2, 614602 (3), Autosomal recessive
chr6	DXO	605996.0 | DXO, DOM3Z | Decapping exoribonuclease | 1797.0 | ENSG00000204348 | nan | nan
chr6	STK19	604977.0 | STK19 | Serine/threonine protein kinase 19 | 8859.0 | ENSG00000204344 | nan | nan
chr6	C4A	120810.0 | C4A, C4S, C4AD | Complement component-4A | 720.0 | ENSG00000244731 | order:  HLA-B, C2, BF, C4A, C4B, CYP21, DR | [Blood group, Rodgers], 614374 (3); C4a deficiency, 614380 (3), Autosomal recessive
chr6	C4B	120820.0 | C4B, C4F, C4BD | Complement component-4B | 721.0 | ENSG00000224389 | 10kb from C4S | C4B deficiency, 614379 (3)
chr6	CYP21A2	613815.0 | CYP21A2, CYP21, CA21H | Cytochrome P450, subfamily XXIA, polypeptide 2 (steroid 21-hydroxylase) | 1589.0 | ENSG00000231852 | linked to C2, C4, BF; 2 loci, A and B; only B active; pseudogene CYP21P contiguous on 6p | Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3), Autosomal recessive; Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3), Autosomal recessive
chr6	TNXB	600985.0 | TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL1, VUR8 | Tenascin XB | 7148.0 | ENSG00000168477 | nan | Ehlers-Danlos syndrome, classic-like, 1, 606408 (3), Autosomal recessive; Vesicoureteral reflux 8, 615963 (3), Autosomal dominant
chr6	ATF6B	600984.0 | ATF6B, CREBL1 | Activating transcription factor 6 beta | 1388.0 | ENSG00000213676 | nan | nan
chr6	FKBPL	617076.0 | FKBPL, DIR1, WISP39 | FK506-binding protein-like | 63943.0 | ENSG00000204315 | nan | nan
chr6	PRRT1	618297.0 | PRRT1, DSPD1 | Proline-rich transmembrane protein 1 | 80863.0 | ENSG00000204314 | nan | nan
chr6	PPT2	603298.0 | PPT2 | Palmitoyl-protein thioesterase-2 | 9374.0 | ENSG00000221988 | nan | nan
chr6	EGFL8	609897.0 | EGFL8 | Epidermal growth factor-like 8 | 80864.0 | ENSG00000241404 | nan | nan
chr6	AGPAT1	603099.0 | AGPAT1, LPAATA | 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase-alpha) | 10554.0 | ENSG00000204310 | nan | nan
chr6	RNF5	602677.0 | RNF5, RING5 | RING finger protein-5 | 6048.0 | ENSG00000204308 | nan | nan
chr6	AGER	600214.0 | AGER, RAGE | Advanced glycosylation end product-specific receptor | 177.0 | ENSG00000204305 | at junction of classes II, III MHC | nan
chr6	PBX2	176311.0 | PBX2, HOX12, G17 | Pre-B-cell leukemia transcription factor-2 | 5089.0 | ENSG00000204304 | nan | nan
chr6	GPSM3	618558.0 | GPSM3, AGS4 | G-protein signaling modulator 3 | 63940.0 | ENSG00000213654 | nan | nan
chr6	NOTCH4	164951.0 | NOTCH4, INT3 | Notch, Drosophila, homolog of, 4 | 4855.0 | ENSG00000204301 | nan | nan
chr6	TSBP1	618151.0 | TSBP1, TSBP, C6orf10 | Testis-expressed basic protein 1 | 10665.0 | ENSG00000204296 | nan | nan
chr6	BTNL2	606000.0 | BTNL2, SS2 | Butyrophilin-like protein 2 | 56244.0 | ENSG00000204290 | nan | {Sarcoidosis, susceptibility to, 2}, 612387 (3), Autosomal dominant
chr6	HLA-DRA	142860.0 | HLA-DRA | Major histocompatibility complex, class II, DR alpha | 3122.0 | ENSG00000204287 | 1 alpha, 3 different beta chains | nan
chr6	HLA-DRB5	604776.0 | HLA-DRB5 | Major histocompatibility complex, class II, DR beta-5 | 3127.0 | ENSG00000198502 | nan | nan
chr6	HLA-DRB1	142857.0 | HLA-DRB1, SS1 | Major histocompatibility complex, class II, DR beta-1 | 3123.0 | ENSG00000196126 | nan | {Multiple sclerosis, susceptibility to, 1}, 126200 (3), Multifactorial; {Sarcoidosis, susceptibility to, 1}, 181000 (3), Autosomal dominant
chr6	HLA-DQA1	146880.0 | HLA-DQA1, CELIAC1 | Major histocompatibility complex, class II, DQ alpha-1 | 3117.0 | ENSG00000196735 | nan | {Celiac disease, susceptibility to}, 212750 (3), Autosomal recessive, Multifactorial
chr6	HLA-DQB1	604305.0 | HLA-DQB1, CELIAC1 | Major histocompatibility complex, class II, DQ beta-1 | 3119.0 | ENSG00000179344 | nan | {Celiac disease, susceptibility to}, 212750 (3), Autosomal recessive, Multifactorial; {Multiple sclerosis, susceptibility to, 1}, 126200 (3), Multifactorial; {Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3), Autosomal dominant
chr6	HLA-DQA2	613503.0 | HLA-DQA2, HLA-DXA | Major histocompatibility complex, class II, DQ alpha-2 | 3118.0 | ENSG00000237541 | nan | nan
chr6	HLA-DQB2	615161.0 | HLA-DQB2, HLA-DXB | Major histocompatibility complex, class II, DQ beta-2 | 3120.0 | ENSG00000232629 | nan | nan
chr6	HLA-DOB	600629.0 | HLA-DOB | Major histocompatibility complex, class II, DO beta | 3112.0 | ENSG00000241106 | nan | nan
chr6	TAP2	170261.0 | TAP2, ABCB3, PSF2, RING11, MHC1D2 | Transporter 2, ATP-binding cassette, subfamily B | 6891.0 | ENSG00000204267 | tel-TAP1-LMP2-LMP1-TAP2-cen | MHC class I deficiency 2, 620813 (3), Autosomal recessive
chr6	PSMB8	177046.0 | PSMB8, LMP7, RING10, JMP, NKJO, ALDD, PRAAS1 | Proteasome subunit, beta type, 8 (large multifunctional protease-7) | 5696.0 | ENSG00000204264 | between TAP1 and TAP2 | Proteasome-associated autoinflammatory syndrome 1 and digenic forms, 256040 (3), Autosomal recessive
chr6	TAP1	170260.0 | TAP1, ABCB2, RING4, PSF1, MHC1D1 | Transporter 1, ATP-binding cassette, subfamily B | 6890.0 | ENSG00000168394 | ~7kb telomeric to TAP2 | MHC class I deficiency 1, 604571 (3), Autosomal recessive
chr6	PSMB9	177045.0 | PSMB9, LMP2, RING12, PRAAS6 | Proteasome subunit, beta type, 9 | 5698.0 | ENSG00000240065 | nan | Proteasome-associated autoinflammatory syndrome 6, 620796 (3), Autosomal dominant
chr6	HLA-DMB	142856.0 | HLA-DMB, RING7 | Major histocompatibility complex, class II, DM beta | 3109.0 | ENSG00000242574 | nan | nan
chr6	HLA-DMA	142855.0 | HLA-DMA, RING6 | Major histocompatibility complex, class II, DM alpha | 3108.0 | ENSG00000204257 | nan | nan
chr6	BRD2	601540.0 | BRD2, RING3, FSRG1 | Bromodomain-containing protein 2 | 6046.0 | ENSG00000204256 | between HLA-DNA and HLA-DMA | nan
chr6	HLA-DOA	142930.0 | HLA-DNA | Major histocompatibility complex, class II, DN alpha | 3111.0 | ENSG00000204252 | nan | nan
chr6	HLA-DPA1	142880.0 | HLA-DPA1, HLADP | Major histocompatibility complex, class II, DP alpha-1 | 3113.0 | ENSG00000231389 | 2 different alpha, 2 different beta chains | nan
chr6	HLA-DPB1	142858.0 | HLA-DPB1 | Major histocompatibility complex, class II, DP beta-1 | 3115.0 | ENSG00000223865 | nan | {Beryllium disease, chronic, susceptibility to} (3)
chr6	COL11A2	120290.0 | COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB | Collagen XI, alpha-2 polypeptide | 1302.0 | ENSG00000204248 | 45kb centromeric of HLA-DPB2; 3'--5'-cen | Deafness, autosomal dominant 13, 601868 (3), Autosomal dominant; Otospondylomegaepiphyseal dysplasia, autosomal recessive, 215150 (3), Autosomal recessive; Fibrochondrogenesis 2, 614524 (3), Autosomal recessive, Autosomal dominant; Deafness, autosomal recessive 53, 609706 (3), Autosomal recessive; Otospondylomegaepiphyseal dysplasia, autosomal dominant, 184840 (3), Autosomal dominant
chr6	RXRB	180246.0 | RXRB | Retinoid X receptor, beta | 6257.0 | ENSG00000204231 | nan | nan
chr6	SLC39A7	601416.0 | SLC39A7, D6S2244E, HKE4, AGM9 | Solute carrier family 39 (zinc transporter), member 7 (Ke4 gene, mouse, homolog of) | 7922.0 | ENSG00000112473 | nan | Agammaglobulinemia 9, autosomal recessive, 619693 (3), Autosomal recessive
chr6	HSD17B8	601417.0 | HSD17B8, FABGL, D6S2245E, HKE6 | Hydroxysteroid (17-beta) dehydrogenase 8 (Ke6 gene, mouse, homolog of) | 7923.0 | ENSG00000204228 | nan | nan
chr6	MIR219A1	611500.0 | MRI219-1, MIRN219-1 | Micro RNA 219-1 | 407002.0 | ENSG00000199036 | nan | nan
chr6	RING1	602045.0 | RING1, RNF1 | RING finger protein-1 | 6015.0 | ENSG00000204227 | nan | nan
chr6	VPS52	603443.0 | VPS52, SACM2L | VPS52 subunit of GARP complex | 6293.0 | ENSG00000223501 | nan | nan
chr6	RPS18	180473.0 | RPS18 | Ribosomal protein S18 | 6222.0 | ENSG00000231500 | nan | nan
chr6	B3GALT4	603095.0 | B3GALT4 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 4 | 8705.0 | ENSG00000235863 | nan | nan
chr6	WDR46	611440.0 | WDR46, BING4 | WD repeat-containing protein 46 | 9277.0 | ENSG00000227057 | nan | nan
chr6	PFDN6	605660.0 | PFDN6, HKE2 | Prefoldin 6 | 10471.0 | ENSG00000204220 | nan | nan
chr6	RGL2	602306.0 | RAB2L | RAB2, member RAS oncogene family-like | 5863.0 | ENSG00000237441 | nan | nan
chr6	TAPBP	601962.0 | TAPBP, TPSN, MHC1D3 | TAP-binding protein (tapasin) | 6892.0 | ENSG00000231925 | mutation identified in 1 MCH1D3 patient | ?MHC class I deficiency 3, 620814 (3), Autosomal recessive
chr6	ZBTB22	611439.0 | ZBTB22, BING1 | Zinc finger- and BTB domain-containing protein 22 | 9278.0 | ENSG00000236104 | nan | nan
chr6	DAXX	603186.0 | DAXX | Death-associated protein 6 | 1616.0 | ENSG00000204209 | nan | nan
chr6	KIFC1	603763.0 | KIFC1, KNSL2, HSET | Kinesin family member C1 | 3833.0 | ENSG00000237649 | nan | nan
chr6	PHF1	602881.0 | PHF1 | PHD finger protein-1 | 5252.0 | ENSG00000112511 | nan | nan
chr6	CUTA	616953.0 | CUTA, ACHAP, C6orf82 | CutA divalent cation tolerance homolog | 51596.0 | ENSG00000112514 | nan | nan
chr6	SYNGAP1	603384.0 | SYNGAP1, MRD5 | Synaptic Ras GTPase activating protein 1 | 8831.0 | ENSG00000197283 | nan | Intellectual developmental disorder, autosomal dominant 5, 612621 (3), Autosomal dominant
chr6	STQTL19	612893.0 | STQTL19 | Stature quantitative trait locus 19 | 100302684.0 | nan | associated with rs1776897 | {Stature QTL 19}, 612893 (2)
chr6	BAK1	600516.0 | BAK1 | BCL2-antagonist/killer 1 | 578.0 | ENSG00000030110 | centromeric to MHC region | nan
chr6	GGNBP1	609495.0 | GGNBP1 | Gametogenetin-binding protein 1 | 449520.0 | nan | nan | nan
chr6	ITPR3	147267.0 | ITPR3, CMT1J | Inositol 1,4,5-triphosphate receptor, type 3 | 3710.0 | ENSG00000096433 | nan | Charcot-Marie-Tooth disease, demyelinating, type 1J, 620111 (3), Autosomal dominant; {Diabetes, type 1, susceptibility to}, 222100 (2), Autosomal recessive
chr6	UQCC2	614461.0 | UQCC2, C6orf126, M19, MC3DN7 | Ubiquinol-cytochrome c reductase complex assembly factor 2 | 84300.0 | ENSG00000137288 | nan | Mitochondrial complex III deficiency, nuclear type 7, 615824 (3), Autosomal recessive
chr6	IP6K3	606993.0 | IP6K3, IHPK3, INSP6K3 | Inositol hexaphosphate kinase 3 | 117283.0 | ENSG00000161896 | pseudogene on 6p24.1 | nan
chr6	LEMD2	616312.0 | LEMD2, NET25, CTRCT42, MARUPS | LEM domain-containing protein 2 | 221496.0 | ENSG00000161904 | nan | Marbach-Rustad progeroid syndrome, 619322 (3), Autosomal dominant; Cataract 46, juvenile-onset, 212500 (3), Autosomal recessive
chr6	MLN	158270.0 | MLN | Motilin | 4295.0 | ENSG00000096395 | nan | nan
chr6	GRM4	604100.0 | GRM4, MGLUR4 | Glutamate receptor, metabotropic, 4 | 2914.0 | ENSG00000124493 | nan | nan
chr6	HMGA1	600701.0 | HMGA1, HMGIY | High-mobility group AT-hook 1 | 3159.0 | ENSG00000137309 | nan | {Type 2 diabetes mellitus, susceptibility to}, 125853 (3), Autosomal dominant
chr6	SMIM29	611419.0 | SMIM29, C6orf1, LBH | Small integral membrane protein 29 | 221491.0 | ENSG00000186577 | opposite strand, tail-to-tail with HMGA1 | nan
chr6	NUDT3	609228.0 | NUDT3, DIPP, DIPP1 | Nudix hydrolase 3 | 11165.0 | ENSG00000272325 | nan | nan
chr6	RPS10	603632.0 | RPS10, DBA9 | Ribosomal protein S10 | 6204.0 | ENSG00000124614 | nan | Diamond-Blackfan anemia 9, 613308 (3), Autosomal dominant
chr6	PACSIN1	606512.0 | PACSIN1, KIAA1379 | Protein kinase C and casein kinase substrate in neurons 1 | 29993.0 | ENSG00000124507 | nan | nan
chr6	SPDEF	608144.0 | SPDEF, PDEF | SAM pointed domain-containing ETS transcription factor | 25803.0 | ENSG00000124664 | nan | nan
chr6	ILRUN	612217.0 | C6orf106 | Chromosome 6 open reading frame 106 | 64771.0 | ENSG00000196821 | nan | nan
chr6	SNRPC	603522.0 | SNRPC | Small nuclear ribonucleoprotein polypeptide C | 6631.0 | ENSG00000124562 | nan | nan
chr6	BLTP3A	619570.0 | UHRF1BP1 | UHRF1-binding protein 1 | 54887.0 | ENSG00000065060 | nan | nan
chr6	TAF11	600772.0 | TAF11, TAF2I, TAFII28 | TAF11 RNA polymerase II, TATA box-binding protein-associated factor, 28kD | 6882.0 | ENSG00000064995 | nan | nan
chr6	ANKS1A	608994.0 | ANKS1, ODIN, KIAA0229 | Ankyrin repeat and sterile alpha motif domains-containing protein 1 | 23294.0 | ENSG00000064999 | nan | nan
chr6	TCP11	186982.0 | TCP11, D6S230E | T-complex protein 11 | 6954.0 | ENSG00000124678 | expressed only in testis at same time as ZNF76 (day 20 after birth) | nan
chr6	SCUBE3	614708.0 | SCUBE3, SSFSC2 | Signal peptide-, CUB domain-,  and EGF-like domains-containing protein 3 | 222663.0 | ENSG00000146197 | nan | Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies, 619184 (3), Autosomal recessive
chr6	ZNF76	194549.0 | ZNF76, D6S229E | Zinc finger protein-76 (expressed in testis) | 7629.0 | ENSG00000065029 | same 300kb fragment as TCP11 | nan
chr6	DEF6	610094.0 | DEF6, IBP, SLAT, IMD87 | DEF6 guanine nucleotide exchange factor | 50619.0 | ENSG00000023892 | nan | Immunodeficiency 87 and autoimmunity, 619573 (3), Autosomal recessive
chr6	PPARD	600409.0 | PPARD, NUC1 | Peroxisome proliferative activated receptor, delta | 5467.0 | ENSG00000112033 | nan | nan
chr6	FANCE	613976.0 | FANCE, FACE | Fanconi anemia, complementation group E gene | 2178.0 | ENSG00000112039 | nan | Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive
chr6	RPL10A	615660.0 | RPL10A, CSA19 | Ribosomal protein L10A | 4736.0 | ENSG00000198755 | nan | nan
chr6	TEAD3	603170.0 | TEAD3, TEF5, TEAD5 | TEA domain family member 3 (transcriptional enhancer factor 5) | 7005.0 | ENSG00000007866 | nan | nan
chr6	TULP1	602280.0 | TULP1, RP14, LCA15 | TUB-like protein 1 | 7287.0 | ENSG00000112041 | nan | Leber congenital amaurosis 15, 613843 (3), Autosomal recessive; Retinitis pigmentosa 14, 600132 (3), Autosomal recessive
chr6	FKBP5	602623.0 | FKBP5, FKBP51 | FK506-binding protein 5 | 2289.0 | ENSG00000096060 | nan | {Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)
chr6	ARMC12	620377.0 | ARMC12, SPGF90 | Armadillo repeat-containing protein 12 | 221481.0 | ENSG00000157343 | nan | Spermatogenic failure 90, 620744 (3), Autosomal recessive
chr6	CLPS	120105.0 | CLPS | Colipase, pancreatic | 1208.0 | ENSG00000137392 | nan | nan
chr6	LHFPL5	609427.0 | LHFPL5, TMHS, DFNB67 | LHFPL tetraspan subfamily, member 5 | 222662.0 | ENSG00000197753 | nan | Deafness, autosomal recessive 67, 610265 (3), Autosomal recessive
chr6	SRPK1	601939.0 | SRPK1 | SRSF protein kinase 1 | 6732.0 | ENSG00000096063 | nan | nan
chr6	SLC26A8	608480.0 | SLC26A8, TAT1, SPGF3 | Solute carrier family 26 (sulfate transporter), member 8 | 116369.0 | ENSG00000112053 | nan | Spermatogenic failure 3, 606766 (3), Autosomal recessive, Autosomal dominant
chr6	MAPK14	600289.0 | MAPK14, CSBP1 | Mitogen-activated protein kinase 14 (cytokine suppressive anti-inflammatory drug binding protein 1) | 1432.0 | ENSG00000112062 | nan | nan
chr6	MAPK13	602899.0 | MAPK13 | Mitogen-activated protein kinase 13 | 5603.0 | ENSG00000156711 | nan | nan
chr6	BRPF3	616856.0 | BRPF3, KIAA1286 | Bromodomain- and PHD finger-containing protein 3 | 27154.0 | ENSG00000096070 | nan | nan
chr6	PNPLA1	612121.0 | PNPLA1, ARCI10 | Patatin-like phospholipase domain-containing protein 1 | 285848.0 | ENSG00000180316 | nan | Ichthyosis, congenital, autosomal recessive 10, 615024 (3), Autosomal recessive
chr6	ETV7	605255.0 | ETV7, TEL2, TELB | ETS variant transcription factor 7 | 51513.0 | ENSG00000010030 | nan | nan
chr6	KCTD20	615932.0 | KCTD20 | Potassium channel tetramerization domain-containing protein 20 | 222658.0 | ENSG00000112078 | nan | nan
chr6	STK38	606964.0 | STK38, NDR | Serine/threonine protein kinase 38 | 11329.0 | ENSG00000112079 | nan | nan
chr6	SRSF3	603364.0 | SRSF3, SFRS3, SRP20 | Splicing factor, arginine/serine-rich, 3 | 6428.0 | ENSG00000112081 | nan | nan
chr6	TP53COR1	616343.0 | TP53COR1 | Tumor protein p53 pathway corepressor 1, noncoding | 102800311.0 | nan | nan | nan
chr6	PANDAR	617179.0 | PANDAR | Promoter of CDKN1A antisense DNA damage-activated RNA | 101154753.0 | ENSG00000281450 | nan | nan
chr6	CDKN1A	116899.0 | CDKN1A, WAF1, CIP1, CDKN1 | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 1026.0 | ENSG00000124762 | nan | nan
chr6	CPNE5	604209.0 | CPNE5, CPN5 | Copine V | 57699.0 | ENSG00000124772 | nan | nan
chr6	PPIL1	601301.0 | PPIL1, CYPL1, PCH14 | Peptidylprolyl isomerase (cyclophilin)-like 1 | 51645.0 | ENSG00000137168 | previously assigned to chr.2 | Pontocerebellar hypoplasia, type 14, 619301 (3), Autosomal recessive
chr6	C6orf89	616642.0 | C6orf89, BRAP, AMFION | Bombesin receptor-activated protein | 221477.0 | ENSG00000198663 | nan | nan
chr6	MTCH1	610449.0 | MTCH1, PSAP | Mitochondrial carrier homolog 1 | 23787.0 | ENSG00000137409 | nan | nan
chr6	FGD2	605091.0 | FGD2 | FYVE, RhoGEF, and PH domain-containing protein 2 | 221472.0 | ENSG00000146192 | nan | nan
chr6	PIM1	164960.0 | PIM1 | Oncogene PIM1 | 5292.0 | ENSG00000137193 | nan | nan
chr6	TBC1D22B	616880.0 | TBC1D22B, C6orf197 | TBC1 domain family, member 22B | 55633.0 | ENSG00000065491 | nan | nan
chr6	RNF8	611685.0 | RNF8, KIAA0646 | Ring finger protein 8 | 9025.0 | ENSG00000112130 | nan | nan
chr6	CMTR1	616189.0 | CMTR1, MTR1, ISG95, FTSJD2, KIAA0082 | CAP methyltransferase 1 | 23070.0 | ENSG00000137200 | nan | nan
chr6	MDGA1	609626.0 | MDGA1, GPIM | MAM domain-containing glycosylphosphatidylinositol anchor 1 | 266727.0 | ENSG00000112139 | nan | nan
chr6	ZFAND3	607455.0 | ZFAND3, TEX27 | Zinc finger AN1 domain-containing protein 3 | 60685.0 | ENSG00000156639 | nan | nan
chr6	BTBD9	611237.0 | BTBD9, KIAA1880 | BTB/POZ domain-containing protein 9 | 114781.0 | ENSG00000183826 | nan | nan
chr6	GLO1	138750.0 | GLO1 | Glyoxalase I | 2739.0 | ENSG00000124767 | ~3cM proximal to HLA | nan
chr6	DNAH8	603337.0 | DNAH8, HDHC9, SPGF46 | Dynein, axonemal, heavy chain 8 | 1769.0 | ENSG00000124721 | nan | Spermatogenic failure 46, 619095 (3), Autosomal recessive
chr6	GLP1R	138032.0 | GLP1R | Glucagon-like peptide 1 receptor | 2740.0 | ENSG00000112164 | nan | nan
chr6	KCNK5	603493.0 | KCNK5, TASK2 | Potassium channel, subfamily K, member 5 | 8645.0 | ENSG00000164626 | nan | nan
chr6	KCNK17	607370.0 | KCNK17, TASK4, TALK2 | Potassium channel, subfamily K, member 17 | 89822.0 | ENSG00000124780 | nan | nan
chr6	KCNK16	607369.0 | KCNK16, TALK1 | Potassium channel, subfamily K, member 16 | 83795.0 | ENSG00000095981 | nan | nan
chr6	KIF6	613919.0 | KIF6 | Kinesin family member 6 | 221458.0 | ENSG00000164627 | nan | nan
chr6	DAAM2	606627.0 | DAAM2, KIAA0381, NPHS24 | Dishevelled-associated activator of morphogenesis 2 | 23500.0 | ENSG00000146122 | nan | Nephrotic syndrome, type 24, 619263 (3), Autosomal recessive
chr6	MOCS1	603707.0 | MOCS1, MOCODA | Molybdenum cofactor synthesis-1 | 4337.0 | ENSG00000124615 | nan | Molybdenum cofactor deficiency A, 252150 (3), Autosomal recessive
chr6	TDRG1	615676.0 | TDRG1, LINC00532 | Testis development-related gene 1, noncoding | 732253.0 | ENSG00000204091 | nan | nan
chr6	LRFN2	612808.0 | LRFN2, SALM1, KIAA1246 | Leucine-rich repeat and fibronectin type III domain-containing protein 2 | 57497.0 | ENSG00000156564 | nan | nan
chr6	MGR3	607498.0 | MGR3 | Migraine with or without aura, susceptibility to, 3 | 337892.0 | nan | lod 5.78 at D6S452 | {Migraine with or without aura, susceptibility to, 3}, 607498 (2), Autosomal dominant
chr6	PPR1	132100.0 | PPR1 | Photoparoxysmal response 1 | 100528023.0 | nan | max lod at D6S2427 | Photoparoxysmal response 1, 132100 (2), Autosomal dominant
chr6	UNC5CL	617464.0 | UNC5CL, ZUD | unc-5 family C-terminal like protein | 222643.0 | ENSG00000124602 | nan | nan
chr6	TSPO2	619409.0 | TSPO2 | Translocator protein 2 | 222642.0 | ENSG00000112212 | nan | nan
chr6	APOBEC2	604797.0 | APOBEC2 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 | 10930.0 | ENSG00000124701 | nan | nan
chr6	OARD1	614393.0 | OARD1, C6orf130 | O-acyl-ADP-ribose deacylase 1 | 221443.0 | ENSG00000124596 | nan | nan
chr6	NFYA	189903.0 | NFYA | Transcription factor NF-Y, A subunit | 4800.0 | ENSG00000001167 | nan | nan
chr6	TREML1	609714.0 | TREML1, TLT1 | Triggering receptor expressed on myeloid cells-like protein 1 | 340205.0 | ENSG00000161911 | nan | nan
chr6	TREM2	605086.0 | TREM2, PLOSL2, AD17 | Triggering receptor expressed on myeloid cells 2 | 54209.0 | ENSG00000095970 | nan | {Alzhieimer disease 17, susceptibility to}, 615080 (3), Autosomal recessive; Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2, 618193 (3), Autosomal recessive
chr6	TREML2	609715.0 | TREML2, TLT2 | Triggering receptor expressed on myeloid cells-like protein 2 | 79865.0 | ENSG00000112195 | nan | nan
chr6	TREML3P	609716.0 | TREML3, TLT3 | Triggering receptor expressed on myeloid cells-like protein 3 | 340206.0 | ENSG00000290563 | nan | nan
chr6	TREML4	614664.0 | TREML4, TLT4 | Triggering receptor expressed on myeloid cells-like protein 4 | 285852.0 | ENSG00000188056 | nan | nan
chr6	TREM1	605085.0 | TREM1 | Triggering receptor expressed on myeloid cells 1 | 54210.0 | ENSG00000124731 | nan | nan
chr6	NCR2	604531.0 | NCR2, LY95, NKP44 | Natural cytotoxicity triggering receptor 2 (lymphocyte antigen 95, mouse, homolog of) | 9436.0 | ENSG00000096264 | nan | nan
chr6	FOXP4	608924.0 | FOXP4 | Forkhead box P4 | 116113.0 | ENSG00000137166 | nan | nan
chr6	MDFI	604971.0 | MDFI | MYOD family inhibitor | 4188.0 | ENSG00000112559 | nan | nan
chr6	TFEB	600744.0 | TFEB, TCFEB | Transcription factor EB | 7942.0 | ENSG00000112561 | nan | nan
chr6	PGC	169740.0 | PGC | Preprogastricsin | 5225.0 | ENSG00000096088 | cen-PGG-GLO1-HLA | nan
chr6	FRS3	607744.0 | FRS3, FRS2B, SNT2 | Fibroblast growth factor receptor substrate 3 | 10817.0 | ENSG00000137218 | nan | nan
chr6	PRICKLE4	611389.0 | PRICKLE4, C6orf49, OBTP | Prickle, Drosophila, homolog of, 4 | 29964.0 | ENSG00000278224 | nan | nan
chr6	TOMM6	616168.0 | TOMM6, TOM6 | Translocase of outer mitochondrial membrane 6 | 100188893.0 | ENSG00000214736 | nan | nan
chr6	MED20	612915.0 | MED20, TRFP | Mediator complex subunit 20 | 9477.0 | ENSG00000124641 | nan | nan
chr6	BYSL	603871.0 | BYSL | By the ribosomal protein S6 gene, Drosophila, homolog-like (bystin) | 705.0 | ENSG00000112578 | nan | nan
chr6	CCND3	123834.0 | CCND3 | Cyclin D3 | 896.0 | ENSG00000112576 | pseudogene also on 6p21 | nan
chr6	TAF8	609514.0 | TAF8, TBN, NEDMLHB | TATA-box binding protein-associated factor 8 | 129685.0 | ENSG00000137413 | nan | Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy, 619972 (3), Autosomal recessive
chr6	C6orf132	620839.0 | C6orf132, lncCCLM | Chromosome 6 open reading frame 132 | 647024.0 | ENSG00000188112 | nan | nan
chr6	GUCA1A	600364.0 | GUCA1A, GCAP, COD3, CORD14 | Guanylate cyclase activator 1A, retina | 2978.0 | ENSG00000048545 | nan | Cone-rod dystrophy 14, 602093 (3), Autosomal dominant; Cone dystrophy-3, 602093 (3), Autosomal dominant
chr6	GUCA1B	602275.0 | GUCA1B, GCAP2, GUCA2, RP48 | Guanylate cyclase activator 1B, retina | 2979.0 | ENSG00000112599 | nan | Retinitis pigmentosa 48, 613827 (3), Autosomal dominant
chr6	MRPS10	611976.0 | MRPS10 | Mitochondrial ribosomal protein S10 | 55173.0 | ENSG00000048544 | 5 pseudogenes on chromosomes 1, 3, and 9 | nan
chr6	TRERF1	610322.0 | TRERF1, TREP132 | Transcriptional regulating factor 1 | 55809.0 | ENSG00000124496 | nan | nan
chr6	UBR2	609134.0 | UBR2, C6orf133, KIAA0349 | Ubiquitin-protein ligase E3 component N-recognin 2 | 23304.0 | ENSG00000024048 | nan | nan
chr6	PRPH2	179605.0 | PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1 | Peripherin 2 | 5961.0 | ENSG00000112619 | digenic RP with ROM1 | Macular dystrophy, patterned, 1, 169150 (3), Autosomal dominant; Choroidal dystrophy, central areolar 2, 613105 (3), Autosomal dominant; Retinitis punctata albescens, 136880 (3), Autosomal recessive, Autosomal dominant; Leber congenital amaurosis 18, 608133 (3), Autosomal recessive, Autosomal dominant, Digenic dominant; Macular dystrophy, vitelliform, 3, 608161 (3), Autosomal dominant; Retinitis pigmentosa 7 and digenic form, 608133 (3), Autosomal recessive, Autosomal dominant, Digenic dominant
chr6	TBCC	602971.0 | TBCC, CFC | Tubulin-specific chaperone C | 6903.0 | ENSG00000124659 | nan | nan
chr6	BICRAL	618502.0 | BICRAL, GLTSCR1L, KIAA0240 | BRD4-interacting chromatin remodeling complex-associated protein-like | 23506.0 | ENSG00000112624 | nan | nan
chr6	RPL7L1	617417.0 | RPL7L1 | Ribosomal protein L7-like 1 | 285855.0 | ENSG00000146223 | nan | nan
chr6	PTCRA	606817.0 | PTCRA, IMD126 | Pre-T-cell receptor, alpha-chain precursor | 171558.0 | ENSG00000171611 | nan | Immunodeficiency 126, 620931 (3), Autosomal recessive
chr6	CNPY3	610774.0 | CNPY3, TNRC5, PRAT4A, ERDA5, DEE60 | Canopy 3, zebrafish, homolog of | 10695.0 | ENSG00000137161 | nan | Developmental and epileptic encephalopathy 60, 617929 (3), Autosomal recessive
chr6	GNMT	606628.0 | GNMT | Glycine N-methyltransferase | 27232.0 | ENSG00000124713 | nan | Glycine N-methyltransferase deficiency, 606664 (3), Autosomal recessive
chr6	PEX6	601498.0 | PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2 | Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1) | 5190.0 | ENSG00000124587 | nan | Peroxisome biogenesis disorder 4B, 614863 (3), Autosomal recessive, Autosomal dominant; Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3), Autosomal recessive; Heimler syndrome 2, 616617 (3), Autosomal recessive
chr6	PPP2R5D	601646.0 | PPP2R5D, MRD35, HJS1 | Protein phosphatase-2, regulatory subunit B (B56), delta isoform | 5528.0 | ENSG00000112640 | nan | Houge-Janssens syndrome 1, 616355 (3), Autosomal dominant
chr6	MEA1	143170.0 | MEA1, MEA | Male-enhanced antigen 1 | 4201.0 | ENSG00000124733 | nan | nan
chr6	KLHDC3	611248.0 | KLHDC3, PEAS | Kelch domain-containing protein 3 | 116138.0 | ENSG00000124702 | nan | nan
chr6	RRP36	613475.0 | RRP36, C6orf153 | Ribosomal RNA-processing factor, 36 | 88745.0 | ENSG00000124541 | nan | nan
chr6	CUL7	609577.0 | CUL7, 3M1 | Cullin 7 | 9820.0 | ENSG00000044090 | nan | 3-M syndrome 1, 273750 (3), Autosomal recessive
chr6	MRPL2	611822.0 | MRPL2 | Mitochondrial ribosomal protein L2 | 51069.0 | ENSG00000112651 | nan | nan
chr6	KLC4	620909.0 | KLC4 | Kinesin light chain 4 | 89953.0 | ENSG00000137171 | nan | nan
chr6	PTK7	601890.0 | PTK7 | PTK7 protein tyrosine kinase 7 | 5754.0 | ENSG00000112655 | nan | nan
chr6	SRF	600589.0 | SRF | Serum response factor | 6722.0 | ENSG00000112658 | nan | nan
chr6	CUL9	607489.0 | CUL9, PARC, KIAA0708 | Cullin 9 | 23113.0 | ENSG00000112659 | nan | nan
chr6	DNPH1	618762.0 | DNPH1 | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 10591.0 | ENSG00000112667 | nan | nan
chr6	TTBK1	619415.0 | TTBK1, BDTK | Tau tubulin kinase 1 | 84630.0 | ENSG00000146216 | nan | nan
chr6	SLC22A7	604995.0 | SLC22A7, OAT2 | Solute carrier family 22 (organic anion transporter), member 7 | 10864.0 | ENSG00000137204 | nan | nan
chr6	ZNF318	617512.0 | ZNF318, TZF, ZFP318 | Zinc finger protein 318 | 24149.0 | ENSG00000171467 | nan | nan
chr6	ABCC10	612509.0 | ABCC10, MRP7 | ATP-binding cassette, subfamily C, member 10 | 89845.0 | ENSG00000124574 | nan | nan
chr6	TJAP1	612658.0 | TJAP1, PILT, TJP4 | Tight junction-associated protein 1 | 93643.0 | ENSG00000137221 | nan | nan
chr6	YIPF3	609775.0 | YIPF3, KLIP1 | YIP1 domain family, member 3 | 25844.0 | ENSG00000137207 | nan | nan
chr6	POLR1C	610060.0 | POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11 | Polymerase I, RNA, subunit C | 9533.0 | ENSG00000171453 | nan | Leukodystrophy, hypomyelinating, 11, 616494 (3), Autosomal recessive; Treacher Collins syndrome 3, 248390 (3), Autosomal recessive
chr6	XPO5	607845.0 | XPO5, KIAA1291 | Exportin 5 | 57510.0 | ENSG00000124571 | nan | nan
chr6	POLH	603968.0 | POLH, XPV | Polymerase, DNA, eta | 5429.0 | ENSG00000170734 | nan | Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive
chr6	GTPBP2	607434.0 | GTPBP2, JABELS | GTP-binding protein 2 | 54676.0 | ENSG00000172432 | nan | Jaberi-Elahi syndrome, 617988 (3), Autosomal recessive
chr6	MAD2L1BP	618136.0 | MAD2L1BP | MAD2L1-binding protein | 9587.0 | ENSG00000124688 | nan | nan
chr6	RSPH9	612648.0 | RSPH9, CILD12 | Radial spoke head 9 homolog | 221421.0 | ENSG00000172426 | nan | Ciliary dyskinesia, primary, 12, 612650 (3), Autosomal recessive
chr6	MRPS18A	611981.0 | MRPS18A, MRPS18-3 | Mitochondrial ribosomal protein S18A | 55168.0 | ENSG00000096080 | nan | nan
chr6	VEGFA	192240.0 | VEGF, MVCD1 | Vascular endothelial growth factor | 7422.0 | ENSG00000112715 | nan | {Microvascular complications of diabetes 1}, 603933 (3)
chr6	MRPL14	611827.0 | MRPL14, MRPL32 | Mitochondrial ribosomal protein L14 | 64928.0 | ENSG00000180992 | nan | nan
chr6	TMEM63B	619952.0 | TMEM64B | Transmembrane protein 63B | 55362.0 | ENSG00000137216 | nan | nan
chr6	CAPN11	604822.0 | CAPN11 | Calpain 11 | 11131.0 | ENSG00000137225 | nan | nan
chr6	MYMX	619912.0 | MYMX, CFZS2 | Myomixer | 101929726.0 | ENSG00000262179 | mutation identified in 1 CFZS2 family | ?Carey-Fineman-Ziter syndrome 2, 619941 (3), Autosomal recessive
chr6	SLC29A1	602193.0 | SLC29A1, ENT1 | Solute carrier family 29 (nucleoside transporters), member 1 (equilibrative nucleoside transporter-1) | 2030.0 | ENSG00000112759 | nan | nan
chr6	HSP90AB1	140572.0 | HSP90AB1, HSPCB, HSPC2, HSP90B | Heas-shock protein, 90kD, alpha, class B, member 1 | 3326.0 | ENSG00000096384 | nan | nan
chr6	SLC35B2	610788.0 | SLC35B2, PAPST1, SLL, HLD26 | Solute carrier family 35 (3'-phosphoadenosine 5'-phosphosulfate transporter), member B2 | 347734.0 | ENSG00000157593 | nan | Leukodystrophy, hypomyelinating, 26, with chondrodysplasia, 620269 (3), Autosomal recessive
chr6	NFKBIE	604548.0 | NFKBIE, IKBE | Nuclear factor kappa-B inhibitor, epsilon | 4794.0 | ENSG00000146232 | nan | nan
chr6	TCTE1	186975.0 | TCTE1 | T-complex-associated-testis-expressed-1 | 202500.0 | ENSG00000146221 | nan | nan
chr6	AARS2	612035.0 | AARS2, KIAA1270, MTALARS, COXPD8, LKENP | Alanyl-tRNA synthetase 2 | 57505.0 | ENSG00000124608 | nan | Leukoencephalopathy, progressive, with ovarian failure, 615889 (3), Autosomal recessive; Combined oxidative phosphorylation deficiency 8, 614096 (3), Autosomal recessive
chr6	CDC5L	602868.0 | CDC5L | Cell division cycle 5-like | 988.0 | ENSG00000096401 | nan | nan
chr6	SUPT3H	602947.0 | SUPT3H, SPT3 | SPT3 homolog, SAGA and STAGA complex component | 8464.0 | ENSG00000196284 | nan | nan
chr6	RUNX2	600211.0 | RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD | Runt-related transcription factor 2 | 860.0 | ENSG00000124813 | nan | Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3), Autosomal dominant; Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3), Autosomal dominant; Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3), Autosomal dominant; Cleidocranial dysplasia, 119600 (3), Autosomal dominant
chr6	CLIC5	607293.0 | CLIC5, DFNB103 | Chloride intracellular channel 5 | 53405.0 | ENSG00000112782 | mutation identified in 1 DFNB103 family | ?Deafness, autosomal recessive 103, 616042 (3), Autosomal recessive
chr6	ENPP4	617000.0 | ENPP4, NPP4, KIAA0879 | Ectonucleotide pyrophosphatase/phosphodiesterase 4 | 22875.0 | ENSG00000001561 | nan | nan
chr6	ENPP5	617001.0 | ENPP5, NPP5 | Ectonucleotide pyrophosphatase/phosphodiesterase 5 | 59084.0 | ENSG00000112796 | nan | nan
chr6	CTRCT28	609026.0 | CTRCT28, ARCC1 | Cataract 28 | 493862.0 | nan | nan | {Cataract 28, age-related cortical, susceptibility to}, 609026 (2)
chr6	NYS2	164100.0 | NYS2, NYSA | Nystagmus 2, congenital, autosomal dominant | 4933.0 | nan | nan | Nystagmus 2, congenital, autosomal dominant, 164100 (2), Autosomal dominant
chr6	RCAN2	604876.0 | RCAN2, ZAKI4, DSCR1L1, MCIP2, CSP2 | Regulator of calcineurin 2 | 10231.0 | ENSG00000172348 | nan | nan
chr6	CYP39A1	605994.0 | CYP39A1 | Cytochrome P450, subfamily XXXIXA (oxysterol 7-alpha-hydroxylase), polypeptide 1 | 51302.0 | ENSG00000146233 | nan | nan
chr6	SLC25A27	613725.0 | SLC25A27, UCP4 | Solute carrier family 25, member 17 | 9481.0 | ENSG00000153291 | nan | nan
chr6	TDRD6	611200.0 | TDRD6 | TUDOR domain-containing protein 6 | 221400.0 | ENSG00000180113 | nan | nan
chr6	PLA2G7	601690.0 | PLA2G7, PAFAH, PAFAD | Phospholipase A2, group VII (platelet-activating factor acetylhydrolase) | 7941.0 | ENSG00000146070 | nan | Platelet-activating factor acetylhydrolase deficiency, 614278 (3), Autosomal recessive
chr6	MEP1A	600388.0 | MEP1A | Meprin A, alpha | 4224.0 | ENSG00000112818 | nan | nan
chr6	ADGRF5	620874.0 | ADGRF5, GPR116 | Adhesion G protein-coupled receptor F5 | 221395.0 | ENSG00000069122 | nan | nan
chr6	ADGRF1	617430.0 | ADGRF1, GPR110 | Adhesion G protein-coupled receptor F1 | 266977.0 | ENSG00000153292 | nan | nan
chr6	TNFRSF21	605732.0 | TNFRSF21, DR6 | Tumor necrosis factor receptor superfamily, member 21 | 27242.0 | ENSG00000146072 | nan | nan
chr6	CD2AP	604241.0 | CD2AP, CMS | CD2-associated protein | 23607.0 | ENSG00000198087 | nan | Glomerulosclerosis, focal segmental, 3, 607832 (3)
chr6	ADGRF2P	620872.0 | ADGRF2, GPR111 | Adhesion G protein-coupled receptor F2 | 222611.0 | nan | nan | nan
chr6	ADGRF4	614268.0 | ADGRF4, GPR115 | Adhesion G protein-coupled receptor F4 | 221393.0 | ENSG00000153294 | nan | nan
chr6	OPN5	609042.0 | OPN5, GRP136, PGR12 | Opsin 5 | 221391.0 | ENSG00000124818 | nan | nan
chr6	PTCHD4	616908.0 | PTCHD4, PTCH53, C6orf138 | Patched domain-containing protein 4 | 442213.0 | ENSG00000244694 | nan | nan
chr6	MMUT	609058.0 | MMUT, MUT, MCM | Methylmalonyl-CoA mutase | 4594.0 | ENSG00000146085 | nan | Methylmalonic aciduria, mut(0) type, 251000 (3), Autosomal recessive
chr6	CENPQ	611506.0 | CENPQ | Centromeric protein Q | 55166.0 | ENSG00000031691 | nan | nan
chr6	GLYATL3	614763.0 | GLYATL3 | Glycine N-acyltransferase-like 3 | 389396.0 | ENSG00000203972 | nan | nan
chr6	RHAG	180297.0 | RHAG, RH50A, OHST, RHNR | Rhesus blood group-associated glycoprotein | 6005.0 | ENSG00000112077 | nan | Overhydrated hereditary stomatocytosis, 185000 (3), Autosomal dominant; Anemia, hemolytic, Rh-null, regulator type, 268150 (3), Autosomal recessive
chr6	CRISP2	187430.0 | CRISP2, TPX1, TSP1 | Cysteine-rich secretory protein 2 | 7180.0 | ENSG00000124490 | nan | nan
chr6	CRISP3	618062.0 | CRISP3, SGP28 | Cysteine-rich secretory protein 3 | 10321.0 | ENSG00000096006 | nan | nan
chr6	PGK2	172270.0 | PGK2 | Phosphoglycerate kinase-2 (testicular PGK) | 5232.0 | ENSG00000170950 | pseudogene on chr.12 | nan
chr6	CRISP1	601193.0 | CRISP1, AEGL1 | Cysteine-rich secretory protein 1 | 167.0 | ENSG00000124812 | nan | nan
chr6	DEFB114	615243.0 | DEFB114, DEFB14 | Defensin, beta, 114 | 245928.0 | ENSG00000177684 | nan | nan
chr6	TFAP2D	610161.0 | TFAP2D, TFAP2BL1 | Transcription factor AP2-delta | 83741.0 | ENSG00000008197 | nan | nan
chr6	TFAP2B	601601.0 | TFAP2B, CHAR, PDA2 | Transcription factor AP-2 beta (activating enhancer-binding protein 2 beta) | 7021.0 | ENSG00000008196 | nan | Patent ductus arteriosus 2, 617035 (3), Autosomal dominant; Char syndrome, 169100 (3), Autosomal dominant
chr6	PKHD1	606702.0 | PKHD1, PCYT, ARPKD, PKD4 | PKHD1 ciliary IPT domain containing fibrocystin/polyductin | 5314.0 | ENSG00000170927 | nan | Polycystic kidney disease 4, with or without hepatic disease, 263200 (3), Autosomal recessive
chr6	MRT24	614345.0 | MRT24 | Intellectual developmental disorder, autosomal recessive 24 | 100852402.0 | nan | between rs651733 and rs1508668 | Intellectual developmental disorder, autosomal recessive 24, 614345 (2), Autosomal recessive
chr6	MIR206	611599.0 | MIR206, MIRN206 | Micro RNA 206 | 406989.0 | ENSG00000207604 | nan | nan
chr6	LINCMD1	614933.0 | LINCMD1 | Long intergenic noncoding RNA, muscle differentiation 1 | 101154644.0 | nan | nan | nan
chr6	MIR133B	610946.0 | MIR133B, MIRN133B | Micro RNA 133B | 442890.0 | ENSG00000199080 | nan | nan
chr6	IL17A	603149.0 | IL17A, IL17, CTLA8 | Interleukin-17a | 3605.0 | ENSG00000112115 | previously mapped to 2q31 | nan
chr6	IL17F	606496.0 | IL17F, ML1, CANDF6 | Interleukin 17F | 112744.0 | ENSG00000112116 | mutation identified in 1 CANDF6 family | ?Candidiasis, familial, 6, autosomal dominant, 613956 (3)
chr6	MCM3	602693.0 | MCM3 | Minichromosome maintenance complex component 3 | 4172.0 | ENSG00000112118 | nan | nan
chr6	PAQR8	607780.0 | PAQR8, C6orf33, LMPB1, MPRB | Progestin and ADIPOQ receptor family, member 8 | 85315.0 | ENSG00000170915 | nan | nan
chr6	EFHC1	608815.0 | EFHC1, FLJ10466, EJM1, JAE, EJA1 | EF hand domain (C-terminal)-containing 1 | 114327.0 | ENSG00000096093 | nan | {Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3), Autosomal dominant; {Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3), Autosomal dominant
chr6	TRAM2	608485.0 | TRAM2, KIAA0057 | Translocation-associated membrane protein 2 | 9697.0 | ENSG00000065308 | nan | nan
chr6	TMEM14A	616870.0 | TMEM14A | Transmembrane protein 14A | 28978.0 | ENSG00000096092 | nan | nan
chr6	GSTA2	138360.0 | GSTA2, GST2 | Glutathione S-transferase A2 | 2939.0 | ENSG00000244067 | nan | nan
chr6	GSTA1	138359.0 | GSTA1 | Glutathione S-transferase A1 | 2938.0 | ENSG00000243955 | nan | nan
chr6	GSTA5	607605.0 | GSTA5 | Glutathione S-transferase, alpha-5 | 221357.0 | ENSG00000182793 | nan | nan
chr6	GSTA3	605449.0 | GSTA3 | Glutathione S-transferase, alpha-3 | 2940.0 | ENSG00000174156 | nan | nan
chr6	GSTA4	605450.0 | GSTA4 | Glutathione S-transferase, alpha-4 | 2941.0 | ENSG00000170899 | nan | nan
chr6	RN7SK	606515.0 | RN7SK, 7SK | RNA, 7SK small nuclear | 125050.0 | ENSG00000202198 | nan | nan
chr6	CILK1	612325.0 | ICK, MRK, KIAA0936, ECO, EJM10 | Intestinal cell kinase | 22858.0 | ENSG00000112144 | nan | {Epilepsy, juvenile myoclonic, susceptibility to, 10}, 617924 (3), Autosomal dominant; Endocrine-cerebroosteodysplasia, 612651 (3), Autosomal recessive
chr6	FBXO9	609091.0 | FBXO9, FBX9 | F-box only protein 9 | 26268.0 | ENSG00000112146 | nan | nan
chr6	GCM1	603715.0 | GCM1, GCMA | Glial cells missing transcription factor 1 | 8521.0 | ENSG00000137270 | nan | nan
chr6	ELOVL5	611805.0 | ELOVL5, HELO1, SCA38 | Elongation of very long chain fatty acids-like 5 | 60481.0 | ENSG00000012660 | nan | Spinocerebellar ataxia 38, 615957 (3), Autosomal dominant
chr6	GCLC	606857.0 | GCLC, GLCLC, CNSHA7 | Glutamate-cysteine ligase, catalytic subunit | 2729.0 | ENSG00000001084 | nan | {Myocardial infarction, susceptibility to}, 608446 (3); Anemia, congenital, nonspherocytic hemolytic, 7, 230450 (3), Autosomal recessive
chr6	KLHL31	610749.0 | KLHL31, KLHL | Kelch-like 31 | 401265.0 | ENSG00000124743 | nan | nan
chr6	LRRC1	608195.0 | LRRC1, LANO | Leucine-rich repeat-containing protein 1 | 55227.0 | ENSG00000137269 | nan | nan
chr6	MLIP	614106.0 | MLIP, C6orf142, MMCKR | Muscular LMNA-interating protein | 90523.0 | ENSG00000146147 | nan | Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis, 620138 (3), Autosomal recessive
chr6	TINAG	606749.0 | TINAG, TIN1, TIN2 | Tubulointerstitial nephritis antigen | 27283.0 | ENSG00000137251 | nan | nan
chr6	HCRTR2	602393.0 | HCRTR2, OX2R | Hypocretin receptor 2 | 3062.0 | ENSG00000137252 | nan | nan
chr6	GFRAL	617837.0 | GFRAL, GRAL | GDNF family receptor alpha-like protein | 389400.0 | ENSG00000187871 | nan | nan
chr6	HMGCLL1	619050.0 | HMGCLL1, ERCHL | 3-hydroxy-3-methylglutaryl-CoA lyase-like protein 1 | 54511.0 | ENSG00000146151 | nan | nan
chr6	BMP5	112265.0 | BMP5 | Bone morphogenetic protein-5 | 653.0 | ENSG00000112175 | nan | nan
chr6	COL21A1	610002.0 | COL21A1 | Collagen, type XXI, alpha-1 polypeptide | 81578.0 | ENSG00000124749 | nan | nan
chr6	DST	113810.0 | DST, BPAG1, DMH, D6S1101, HSAN6, EBS3 | Dystonin (bullous pemphigoid antigen 1) | 667.0 | ENSG00000151914 | nan | Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3), Autosomal recessive; Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency, 615425 (3), Autosomal recessive
chr6	ZNF451	615708.0 | ZNF451, COASTER | Zinc finger protein 451 | 26036.0 | ENSG00000112200 | nan | nan
chr6	BAG2	603882.0 | BAG2 | BAG cochaperone 2 | 9532.0 | ENSG00000112208 | nan | nan
chr6	RAB23	606144.0 | RAB23 | Ras-associated protein RAB23 | 51715.0 | ENSG00000112210 | nan | Carpenter syndrome, 201000 (3), Autosomal recessive
chr6	AITD1	608173.0 | AITD1 | Autoimmune thyroid disease, susceptibility to, 1 | 387578.0 | nan | nan | {Autoimmune thyroid disease, susceptibility to, 1}, 608173 (2)
chr6	PRIM2	176636.0 | PRIM2A | Primase polypeptide 2A, 58kD | 5558.0 | ENSG00000146143 | nan | nan
chr6	BPPV	193007.0 | BPPV | Vertigo, benign paroxysmal positional | 619536.0 | nan | max lod at D6S1556 | Vestibulopathy, familial, 193007 (2), Autosomal dominant
chr6		613544.0 | DEL6q11q14, C6DELq11q14 | Chromosome 6q11-q14 deletion syndrome | nan | nan | contiguous gene deletion syndrome | Chromosome 6q11-q14 deletion syndrome, 613544 (4), Isolated cases
chr6	KHDRBS2	610487.0 | KHDRBS2, SLM1 | KH domain-containing, RNA-binding, signal transduction-associated protein 2 | 202559.0 | ENSG00000112232 | nan | nan
chr6	ADHD3	608905.0 | ADHD3 | Attention deficit-hyperactivity disorder, susceptibility to, 3 | 450089.0 | nan | nan | {Attention deficit-hyperactivity disorder, susceptibility to, 3}, 608905 (2)
chr6	CMD1K	605582.0 | CMD1K | Cardiomyopathy, dilated, 1K | 65014.0 | nan | nan | Cardiomyopathy, dilated, 1K, 605582 (2)
chr6	MRT30	614342.0 | MRT30 | Intellectual developmental disorder, autosomal recessive 30 | 100852401.0 | nan | between rs4612125 and rs285651 | Intellectual developmental disorder, autosomal recessive 30, 614342 (2), Autosomal recessive
chr6	LGSN	611470.0 | GLULD1, LGS | Glutamate-ammonia ligase (glutamine synthetase) domain-containing 1 | 51557.0 | ENSG00000146166 | nan | nan
chr6	PTP4A1	601585.0 | PTP4A1, HH72, PRL1 | Protein tyrosine phosphatase, type 4A, 1 | 7803.0 | ENSG00000112245 | nan | nan
chr6	PHF3	607789.0 | PHF3, KIAA0244 | PHD finger protein 3 | 23469.0 | ENSG00000118482 | nan | nan
chr6	EYS	612424.0 | EYS, RP25 | Eyes shut, Drosophila, homolog of | 346007.0 | ENSG00000188107 | nan | Retinitis pigmentosa 25, 602772 (3), Autosomal recessive
chr6	ADGRB3	602684.0 | ADGRB3, BAI3 | Adhesion G protein-coupled receptor B3 | 577.0 | ENSG00000135298 | nan | nan
chr6	OTSC7	611572.0 | OTSC7 | Otosclerosis 7 | 399516.0 | nan | between D6S1036 and D6S300 | Otosclerosis 7, 611572 (2), Autosomal dominant
chr6		603175.0 | SCZD5 | Schizophrenia susceptibility locus, chromosome 6q-related | nan | nan | max lod at D6S1626 and D6S292 | {Schizophrenia}, 181500 (2), Autosomal dominant
chr6	LMBRD1	612625.0 | LMBRD1, LMBD1, NESI, MAHCF | LMBR1 domain-containing protein 1 | 55788.0 | ENSG00000168216 | nan | Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3), Autosomal recessive
chr6	COL19A1	120165.0 | COL19A1, D6S228E, COL9A1L | Collagen XIX, alpha-1 polypeptide | 1310.0 | ENSG00000082293 | nan | nan
chr6	COL9A1	120210.0 | COL9A1, EDM6, STL4 | Collagen IX, alpha-1 polypeptide | 1297.0 | ENSG00000112280 | mutation identified in 1 EDM6 family | Stickler syndrome, type IV, 614134 (3), Autosomal recessive; ?Epiphyseal dysplasia, multiple, 6, 614135 (3), Autosomal dominant
chr6	SDHAF4	619198.0 | SDHAF4, SDH8, C6orf57 | Succinate dehydrogenase complex assembly factor 4 | 135154.0 | ENSG00000154079 | nan | nan
chr6	SMAP1	611372.0 | SMAP1 | Small ADP-ribosylation factor GTPase-activating protein 1 | 60682.0 | ENSG00000112305 | nan | nan
chr6	B3GAT2	607497.0 | GLCATS, KIAA1963 | UDP-glucuronyltransferase S | 135152.0 | ENSG00000112309 | nan | nan
chr6	MIR30A	612329.0 | MIR30A, MIRN30A | Micro RNA 30A | 407029.0 | ENSG00000207827 | nan | nan
chr6	LINC00472	620059.0 | LINC0472, P53RRA | Long intergenic noncoding RNA 472 | 79940.0 | ENSG00000233237 | nan | nan
chr6	RIMS1	606629.0 | RIMS1, RIM1, RIM, KIAA0340 | Regulating synaptic membrane exocytosis 1 | 22999.0 | ENSG00000079841 | nan | nan
chr6	KCNQ5	607357.0 | KCNQ5, MRD46 | Potassium channel, voltage-gated, KQT-like subfamily, member 5 | 56479.0 | ENSG00000185760 | nan | Intellectual developmental disorder, autosomal dominant 46, 617601 (3), Autosomal dominant
chr6	KHDC1	611688.0 | KHDC1 | KH domain-containing protein 1 | 80759.0 | ENSG00000135314 | nan | nan
chr6	DPPA5	611111.0 | DPPA5, ESG1 | Developmental pluripotency-associated gene 5 | 340168.0 | ENSG00000203909 | nan | nan
chr6	KHDC3L	611687.0 | KHDC3L, C6orf221, ECAT1, HYDM2 | KH domain containing 3-like, subcortical maternal complex member | 154288.0 | ENSG00000203908 | nan | Hydatidiform mole, recurrent, 2, 614293 (3), Autosomal recessive
chr6	OOEP	611689.0 | OOEP, KHDC2 | Oocyte-expressed protein | 441161.0 | ENSG00000203907 | nan | nan
chr6	DDX43	606286.0 | DDX43, HAGE | DEAD-box helicase 43 | 55510.0 | ENSG00000080007 | nan | nan
chr6	CGAS	613973.0 | CGAS, MB21D1, C6orf150 | Cyclic GMP-AMP synthase | 115004.0 | ENSG00000164430 | nan | nan
chr6	MTO1	614667.0 | MTO1, COXPD10 | Mitochondrial tRNA translation optimization 1 | 25821.0 | ENSG00000135297 | nan | Combined oxidative phosphorylation deficiency 10, 614702 (3), Autosomal recessive
chr6	EEF1A1	130590.0 | EEF1A1, EF1A | Eukaryotic translation elongation factor-1, alpha-1 | 1915.0 | ENSG00000156508 | nan | nan
chr6	SLC17A5	604322.0 | SLC17A5, SIASD, SLD | Solute carrier family 17 (sodium phosphate), member 5 | 26503.0 | ENSG00000119899 | nan | Salla disease, 604369 (3), Autosomal recessive; Sialic acid storage disorder, infantile, 269920 (3), Autosomal recessive
chr6	CD109	608859.0 | CD109 | CD109 antigen | 135228.0 | ENSG00000156535 | nan | nan
chr6	COL12A1	120320.0 | COL12A1, UCMD2, BTHLM2, EDSMYP | Collagen, type XII, alpha-1 | 1303.0 | ENSG00000111799 | mutation identified in 1 UCMD2 family | Bethlem myopathy 2, 616471 (3), Autosomal dominant; ?Ullrich congenital muscular dystrophy 2, 616470 (3), Autosomal recessive
chr6	ATFB2	608988.0 | ATFB2 | Atrial fibrillation, familial, 2 | 619478.0 | nan | max lod between  D6S286 and D6S1021 | Atrial fibrillation, familial, 2, 608988 (2)
chr6		603649.0 | CORD7 | Cone-rod dystrophy 7 | nan | nan | maximum LOD at D6S280 | Cone-rod dystrophy 7, 603649 (2), Autosomal dominant
chr6	SHFLD2	610685.0 | SHFLD2 | Split-hand/foot malformation with long bone deficiency 2 | 791123.0 | nan | between rs623155 and rs1547251 | Split-hand/foot malformation with long bone deficiency 2, 610685 (2)
chr6	COX7A2	123996.0 | COX7A2 | Cytochrome c oxidase, subunit VIIa, polypeptide-2, liver | 1347.0 | ENSG00000112695 | previously thought to be on chr.4 | nan
chr6	TMEM30A	611028.0 | TMEM30A, CDC50A | Transmembrane protein 30A | 55754.0 | ENSG00000112697 | nan | nan
chr6	FILIP1	607307.0 | FILIP1, KIAA1275, NMDF | Filamin A-interacting protein | 27145.0 | ENSG00000118407 | nan | Neuromuscular disorder, congenital, with dysmorphic facies, 620775 (3), Autosomal recessive
chr6	SENP6	605003.0 | SENP6, SSP1, SUSP1 | Sentrin-specific protease family, member 6 | 26054.0 | ENSG00000112701 | nan | nan
chr6	MYO6	600970.0 | MYO6, DFNA22, DFNB37 | Myosin VI | 4646.0 | ENSG00000196586 | nan | Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3), Autosomal dominant; Deafness, autosomal dominant 22, 606346 (3), Autosomal dominant; Deafness, autosomal recessive 37, 607821 (3), Autosomal recessive
chr6	IMPG1	602870.0 | IMPG1, IPM150, VMD4, RP91 | Interphotoreceptor matrix proteoglycan-1 | 3617.0 | ENSG00000112706 | nan | Macular dystrophy, vitelliform, 4, 616151 (3), Autosomal recessive, Autosomal dominant; Retinitis pigmentosa 91, 153870 (3), Autosomal dominant
chr6	HTR1B	182131.0 | HTR1B | 5-hydroxytryptamine (serotonin) receptor-1B | 3351.0 | ENSG00000135312 | nan | nan
chr6	MEI4	618417.0 | MEI4 | Meiotic double-stranded break formation protein 4 | 101928601.0 | ENSG00000269964 | nan | nan
chr6	IRAK1BP1	615375.0 | IRAK1BP1, SIMPL | Interleukin 1 receptor-associated kinase 1-binding protein 1 | 134728.0 | ENSG00000146243 | nan | nan
chr6	PHIP	612870.0 | PHIP, CHUJANS, DIDOD | Pleckstrin homology domain-interacting protein | 55023.0 | ENSG00000146247 | nan | Chung-Jansen syndrome, 617991 (3), Autosomal dominant
chr6	HMGN3	604502.0 | HMGN3, TRIP7 | High-mobility group nucleosomal binding protein 3 (thyroid hormone receptor interactor 7) | 9324.0 | ENSG00000118418 | nan | nan
chr6	LCA5	611408.0 | LCA5, C6orf152 | Lebercilin | 167691.0 | ENSG00000135338 | nan | Leber congenital amaurosis 5, 604537 (3), Autosomal recessive
chr6	SH3BGRL2	615678.0 | SH3BGRL2 | SH3 domain-binding glutamic acid-rich protein-like protein 2 | 83699.0 | ENSG00000198478 | nan | nan
chr6	ELOVL4	605512.0 | ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34 | Elongation of very long chain fatty acids 4 | 6785.0 | ENSG00000118402 | nan | Spinocerebellar ataxia 34, 133190 (3), Autosomal dominant; Stargardt disease 3, 600110 (3), Autosomal dominant; Ichthyosis, spastic quadriplegia, and impaired intellectual development, 614457 (3), Autosomal recessive
chr6	TTK	604092.0 | TTK, MPS1L1, PYT | TTK protein kinase | 7272.0 | ENSG00000112742 | nan | nan
chr6	BCKDHB	248611.0 | BCKDHB, E1B, MSUD1B | Branched chain keto acid dehydrogenase E1, beta polypeptide | 594.0 | ENSG00000083123 | nan | Maple syrup urine disease, type Ib, 620698 (3), Autosomal recessive
chr6	TENT5A	611357.0 | TENT5A, FAM46A, C6orf37, OI18 | Terminal nucleotidyltransferase 5A | 55603.0 | ENSG00000112773 | nan | Osteogenesis imperfecta, type XVIII, 617952 (3), Autosomal recessive
chr6	IBTK	606457.0 | IBTK | Inhibitor of Bruton agammaglobulinemia tyrosine kinase | 25998.0 | ENSG00000005700 | nan | nan
chr6	TPBG	190920.0 | TPBG | Trophoblast glycoprotein | 7162.0 | ENSG00000146242 | nan | nan
chr6	UBE3D	612495.0 | UBE3D, UBE2CBP, H10BH | Ubiquitin protein ligase E3D | 90025.0 | ENSG00000118420 | nan | nan
chr6	DOP1A	616823.0 | DOP1A, DOPEY1, DOP1, KIAA1117 | DOP1 leucine zipper-like protein A | 23033.0 | ENSG00000083097 | nan | nan
chr6	PGM3	172100.0 | PGM3, AGM1, IMD23 | Phosphoglucomutase-3 (N-acetylglucosamine-phosphate mutase 1) | 5238.0 | ENSG00000013375 | nan | Immunodeficiency 23, 615816 (3), Autosomal recessive
chr6	ME1	154250.0 | ME1 | Malic enzyme, cytoplasmic | 4199.0 | ENSG00000065833 | nan | nan
chr6	SNAP91	607923.0 | SNAP91, AP180, KIAA0656 | Synaptosomal-associated protein, 91kD | 9892.0 | ENSG00000065609 | nan | nan
chr6	RIPPLY2	609891.0 | RIPPLY2, C6orf59, SCDO6 | Ripply transcriptional repressor 2 | 134701.0 | ENSG00000203877 | mutation identified in 1 SCDO6 family | ?Spondylocostal dysostosis 6, 616566 (3), Autosomal recessive
chr6	CYB5R4	608343.0 | CYB5R4, NCB5OR | Cytochrome b5 reductase 4 | 51167.0 | ENSG00000065615 | nan | nan
chr6	MRAP2	615410.0 | MRAP2, C6orf117, BMIQ18 | Melanocortin 2 receptor accessory protein 2 | 112609.0 | ENSG00000135324 | mutation identified in 1 BMIQ18 individual | {?Obesity, susceptibility to, BMIQ18}, 615457 (3), Autosomal dominant
chr6	CEP162	610201.0 | CEP162, KIAA1009 | Centrosomal protein, 162kD | 22832.0 | ENSG00000135315 | nan | nan
chr6	TBX18	604613.0 | TBX18, CAKUT2 | T-box 18 | 9096.0 | ENSG00000112837 | nan | Congenital anomalies of kidney and urinary tract 2, 143400 (3), Autosomal dominant
chr6	NT5E	129190.0 | NT5E, NT5 | 5' nucleotidase, ecto (CD73) | 4907.0 | ENSG00000135318 | nan | Calcification of joints and arteries, 211800 (3), Autosomal recessive
chr6	SNX14	616105.0 | SNX14, SCAR20 | Sorting nexin 14 | 57231.0 | ENSG00000135317 | nan | Spinocerebellar ataxia, autosomal recessive 20, 616354 (3), Autosomal recessive
chr6	SYNCRIP	616686.0 | SYNCRIP, NSAP1, GRYRBP, HNRNPQ | Synaptotagmin-binding cytoplasmic RNA-interacting protein | 10492.0 | ENSG00000135316 | nan | nan
chr6	SNHG5	613263.0 | SNHG5, U50HG | Small nucleolar RNA host gene 5 | 387066.0 | ENSG00000203875 | nan | nan
chr6	SNORD50A	613117.0 | SNORD50A, RNU50 | Small nucleolar RNA, C/D box, 50A | 26799.0 | nan | nan | nan
chr6	SNORD50B	613264.0 | SNORD50B | Small nucleolar RNA, C/D box | 692088.0 | ENSG00000275072 | nan | nan
chr6	HTR1E	182132.0 | HTR1E | 5-hydroxytryptamine (serotonin) receptor-1E | 3354.0 | ENSG00000168830 | nan | nan
chr6	CGA	118850.0 | CGA | Chorionic gonadotropin, alpha polypeptide | 1081.0 | ENSG00000135346 | shared with LH, FSH, TSH | nan
chr6	ZNF292	616213.0 | ZNF292, ZFP292, KIAA0530, MRD64 | Zinc finger protein 292 | 23036.0 | ENSG00000188994 | nan | Intellectual developmental disorder, autosomal dominant 64, 619188 (3), Autosomal dominant
chr6	GJB7	611921.0 | GJB7, CX25 | Gap junction protein, beta-7 | 375519.0 | ENSG00000164411 | nan | nan
chr6	SLC35A1	605634.0 | SLC35A1, CST, CDG2F | Solute carrier family 35 (CMP-sialic acid transporter), member 1 | 10559.0 | ENSG00000164414 | nan | Congenital disorder of glycosylation, type IIf, 603585 (3), Autosomal recessive
chr6	RARS2	611524.0 | RARS2, RARSL, PCH6 | Arginyl-tRNA synthetase 2 | 57038.0 | ENSG00000146282 | nan | Pontocerebellar hypoplasia, type 6, 611523 (3), Autosomal recessive
chr6	ORC3	604972.0 | ORC3, ORC3L, LAT | Origin recognition complex, subunit 3 | 23595.0 | ENSG00000135336 | nan | nan
chr6	AKIRIN2	615165.0 | AKIRIN2 | Akirin 2 | 55122.0 | ENSG00000135334 | nan | nan
chr6	SPACA1	612739.0 | SPACA1, SAMP32, SPGF85 | Sperm acrosome-associated 1 | 81833.0 | ENSG00000118434 | mutation identified in 1 SPGF85 family | ?Spermatogenic failure 85, 620490 (3), Autosomal recessive
chr6	CNR1	114610.0 | CNR1 | Cannabinoid receptor-1, brain | 1268.0 | ENSG00000118432 | nan | nan
chr6	RNGTT	603512.0 | RNGTT, HCE1, CAP1A | RNA guanylyltransferase and 5'-phosphatase | 8732.0 | ENSG00000111880 | nan | nan
chr6	PNRC1	606714.0 | PNRC1, PROL2 | Proline-rich nuclear receptor coactivator 1 | 10957.0 | ENSG00000146278 | nan | nan
chr6	PM20D2	615913.0 | PM20D2, ACY1L2 | Peptidase M20 domain-containing 2 | 135293.0 | ENSG00000146281 | nan | nan
chr6	GABRR1	137161.0 | GABRR1 | Gamma-aminobutyric acid (GABA) A receptor, rho-1 | 2569.0 | ENSG00000146276 | nan | nan
chr6	GABRR2	137162.0 | GABRR2 | Gamma-aminobutyric acid (GABA) A receptor, rho-2 | 2570.0 | ENSG00000111886 | nan | nan
chr6	UBE2J1	616175.0 | UBE2J1, UBC6E | Ubiquitin-conjugating enzyme E2 J1 | 51465.0 | ENSG00000198833 | nan | nan
chr6	RRAGD	608268.0 | RRAGD, RAGD, HOMG7 | RAS-related GTP-binding protein D | 58528.0 | ENSG00000025039 | nan | Hypomagnesemia 7, renal, with or without dilated cardiomyopathy, 620152 (3), Autosomal dominant
chr6	ANKRD6	610583.0 | ANKRD6, KIAA0957 | Ankyrin repeat domain-containing protein 6 | 22881.0 | ENSG00000135299 | nan | nan
chr6	MDN1	618200.0 | MDN1 | Midasin AAA Atpase 1 | 23195.0 | ENSG00000112159 | nan | nan
chr6	CASP8AP2	606880.0 | CASP8AP2, FLASH | Caspase 8-associated protein 2 | 9994.0 | ENSG00000118412 | nan | nan
chr6	GJA10	611924.0 | GJA10, CX62 | Gap junction protein, alpha-10 | 84694.0 | ENSG00000135355 | nan | nan
chr6	BACH2	605394.0 | BACH2, IMD60 | BTB and CNC homology 2 | 60468.0 | ENSG00000112182 | nan | Immunodeficiency 60 and autoimmunity, 618394 (3), Autosomal dominant
chr6	MAP3K7	602614.0 | MAP3K7, TAK1, CSCF, FMD2 | Mitogen-activated protein kinase kinase kinase 7 | 6885.0 | ENSG00000135341 | nan | Frontometaphyseal dysplasia 2, 617137 (3), Autosomal dominant; Cardiospondylocarpofacial syndrome, 157800 (3), Autosomal dominant
chr6	EPHA7	602190.0 | EPHA7, HEK11 | Ephrin receptor EphA7 | 2045.0 | ENSG00000135333 | nan | nan
chr6	MANEA	612327.0 | MANEA, ENDO | Mannosidase, endo-alpha | 79694.0 | ENSG00000172469 | nan | nan
chr6	FUT9	606865.0 | FUT9 | Fucosyltransferase 9 | 10690.0 | ENSG00000172461 | nan | nan
chr6	UFL1	613372.0 | UFL1, KIAA0776, NLBP | UFM1-specific ligase 1 | 23376.0 | ENSG00000014123 | nan | nan
chr6	FHL5	605126.0 | FHL5, ACT | Four-and-a-half LIM domains 5 | 9457.0 | ENSG00000112214 | nan | nan
chr6	GPR63	606915.0 | GPR63 | G protein-coupled receptor 63 | 81491.0 | ENSG00000112218 | nan | nan
chr6	NDUFAF4	611776.0 | NDUFAF4, HRPAP20, C6orf66, MC1DN15 | NADH-ubiquinone oxidoreductase complex assembly factor 4 | 29078.0 | ENSG00000123545 | nan | Mitochondrial complex I deficiency, nuclear type 15, 618237 (3), Autosomal recessive
chr6	MMS22L	615614.0 | MMS22L, C6orf167 | MMS22-like protein | 253714.0 | ENSG00000146263 | nan | nan
chr6		616328.0 | PNKY | Long intergenic noncoding RNA Pinky | 105447646.0 | nan | nan | nan
chr6	POU3F2	600494.0 | POU3F2, OCT7 | POU domain, class 3, transcription factor 2 | 5454.0 | ENSG00000184486 | nan | nan
chr6	FBXL4	605654.0 | FBXL4, FBL4, MTDPS13 | F-box and leucine-rich repeat protein 4 | 26235.0 | ENSG00000112234 | nan | Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3), Autosomal recessive
chr6	LMPH1B	611944.0 | LMPHM2 | Lymphatic malformation 2 | 100188865.0 | nan | max lod at D6S1671 | Lymphatic malformation 2, 611944 (2), Autosomal dominant
chr6	COQ3	605196.0 | COQ3 | Coenzyme Q3, methyltransferase | 51805.0 | ENSG00000132423 | nan | nan
chr6	PNISR	616653.0 | PNISR, SRRP130, SFRS18 | PNN-interacting serine/arginine-rich protein | 25957.0 | ENSG00000132424 | nan | nan
chr6	USP45	618439.0 | USP45, LCA19 | Ubiquitin-specific protease 45 | 85015.0 | ENSG00000123552 | mutation identified in 1 LCA19 patient | ?Leber congenital amaurosis 19, 618513 (3), Autosomal recessive
chr6	CCNC	123838.0 | CCNC | Cyclin C | 892.0 | ENSG00000112237 | nan | nan
chr6		616842.0 | DHS6S1, MCDR1, PBCRA | DNase1 hypersensitivity, chromosome 6, site 1 | 111365204.0 | nan | upstream of PRDM13 and CCNC | Macular dystrophy 1, 136550 (3), Autosomal dominant; Chorioretinal atrophy, progressive bifocal, 600790 (3), Autosomal dominant
chr6	PRDM13	616741.0 | PRDM13, CDIDHH, PCH17 | PR domain-containing protein 13 | 59336.0 | ENSG00000112238 | nan | Pontocerebellar hypoplasia, type 17, 619909 (3), Autosomal recessive; Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism, 619761 (3), Autosomal recessive
chr6	MCHR2	606111.0 | MCHR2, MCH2R, SLT, MCH2 | Melanin-concentrating hormone receptor 2 | 84539.0 | ENSG00000152034 | nan | nan
chr6	GEFSP8	613828.0 | GEFSP8 | Generalized epilepsy with febrile seizures plus, type 8 | 100653381.0 | nan | between D6S962 and D6S287 | Generalized epilepsy with febrile seizures plus, type 8, 613828 (2)
chr6	SIM1	603128.0 | SIM1 | Single-minded, Drosophila, homolog of, 1 | 6492.0 | ENSG00000112246 | nan | nan
chr6	ASCC3	614217.0 | ASCC3, p200, MRT81 | Activating signal cointegrator 1 complex, subunit 3 | 10973.0 | ENSG00000112249 | nan | Intellectual developmental disorder, autosomal recessive 81, 620700 (3), Autosomal recessive
chr6	GRIK2	138244.0 | GRIK2, GLUR6, MRT6, NEDLAS | Glutamate receptor, ionotropic, kainate 2 | 2898.0 | ENSG00000164418 | nan | Neurodevelopmental disorder with impaired language and ataxia and with or without seizures, 619580 (3), Autosomal dominant; Intellectual developmental disorder, autosomal recessive 6, 611092 (3), Autosomal recessive
chr6	HACE1	610876.0 | HACE1, KIAA1320, SPPRS | HECT domain- and ankyrin repeat-containing E3 ubiquitin protein ligase 1 | 57531.0 | ENSG00000085382 | nan | Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3), Autosomal recessive
chr6	LIN28B	611044.0 | LIN28B | lin-28 homolog B | 389421.0 | ENSG00000187772 | nan | nan
chr6	HTX3	606325.0 | HTX3 | Heterotaxy, visceral, 3, autosomal | 116629.0 | nan | nan | ?Heterotaxy, visceral, 3, autosomal, 606325 (2)
chr6	IDDM15	601666.0 | IDDM15 | Insulin-dependent diabetes mellitus-15 | 3414.0 | nan | nan | {Diabetes mellitus, insulin-dependent, 15}, 601666 (2)
chr6	LGV2	606460.0 | LGV2 | Longevity 2 | 100329168.0 | nan | associated with rs2802292 | [Longevity 2], 606460 (2)
chr6		601349.0 | MCOPS8, MMEP | Microphthalmia, syndromic 8 | nan | nan | translocation with 13q12 | Microphthalmia, syndromic 8, 601349 (2), ?Autosomal dominant
chr6	MENAQ2	612882.0 | MENAQ2 | Menarche, age at, QTL2 | 100302562.0 | nan | associated with rs7759938 | {Menarche, age at, QTL2}, 612882 (2)
chr6	PLF	608852.0 | PLF | Pulmonary function | 450095.0 | nan | close to D6S281 | {Pulmonary function}, 608852 (2)
chr6	POPDC1	604577.0 | BVES, HBVES, POPDC1, LGMDR25 | Blood vessel epicardial substance | 11149.0 | ENSG00000112276 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 25, 616812 (3), Autosomal recessive
chr6	POPDC3	605824.0 | POPDC3, POP3, LGMDR26 | Popeye domain-containing protein 3 | 64208.0 | ENSG00000132429 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 26, 618848 (3), Autosomal recessive
chr6	PREP	600400.0 | PREP | Prolyl endopeptidase | 5550.0 | ENSG00000085377 | nan | nan
chr6	PRDM1	603423.0 | PRDM1, BLIMP1 | PR domain-containing protein 1 (B-lymphocyte-induced maturation protein 1) | 639.0 | ENSG00000057657 | nan | nan
chr6	ATG5	604261.0 | ATG5, APG5, APG5L, ASP, SCAR25 | Autophagy related 5 | 9474.0 | ENSG00000057663 | mutation identified in one SCAR25 family | ?Spinocerebellar ataxia, autosomal recessive 25, 617584 (3), Autosomal recessive
chr6	CRYBG1	601797.0 | CRYBG1, AIM1, ST4 | Crystallin beta-gamma domain-containing 1 | 202.0 | ENSG00000112297 | nan | nan
chr6	RTN4IP1	610502.0 | RTN4IP1, NIMP, OPA10 | Reticulon 4-interacting protein 1 | 84816.0 | ENSG00000130347 | nan | Optic atrophy 10 with or without ataxia, impaired intellectual development and seizures, 616732 (3), Autosomal recessive
chr6	QRSL1	617209.0 | QRSL1, GATA, COXPD40 | Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like protein 1 | 55278.0 | ENSG00000130348 | nan | Combined oxidative phosphorylation deficiency 40, 618835 (3), Autosomal recessive
chr6	CD24	600074.0 | CD24 | CD24 antigen | 100133941.0 | ENSG00000272398 | pseudogenes at 15q21-q22; Yq11 | nan
chr6	MTRES1	618583.0 | MTRES1, C6orf203, HSPC230 | Mitochondrial transcription rescue factor 1 | 51250.0 | ENSG00000130349 | nan | nan
chr6	BEND3	616374.0 | BEND3, KIAA1553 | BEN domain-containing protein 3 | 57673.0 | ENSG00000178409 | nan | nan
chr6	PDSS2	610564.0 | PDSS2, DLP1, C6orf210, COQ10D3 | Prenyl diphosphate synthase, subunit 2 | 57107.0 | ENSG00000164494 | nan | Coenzyme Q10 deficiency, primary, 3, 614652 (3), Autosomal recessive
chr6	SOBP	613667.0 | SOBP, JXC1, MRAMS | Sine oculis-binding protein homolog | 55084.0 | ENSG00000112320 | mutation identified in 1 MRAMS family | ?Impaired intellectual development, anterior maxillary protrusion, and strabismus, 613671 (3), Autosomal recessive
chr6	SEC63	608648.0 | SEC63, PCLD2 | SEC63 homolog, protein translocation regulator | 11231.0 | ENSG00000025796 | nan | Polycystic liver disease 2, 617004 (3), Autosomal dominant
chr6	OSTM1	607649.0 | OSTM1, GL, OPTB5 | Osteopetrosis associated transmembrane protein 1 (grey-lethal, mouse, homolog of) | 28962.0 | ENSG00000081087 | nan | Osteopetrosis, autosomal recessive 5, 259720 (3), Autosomal recessive
chr6	NR2E1	603849.0 | NR2E1, TLX | Nuclear receptor subfamily 2, group E, member 1 (tailless, Drosophila, homolog of) | 7101.0 | ENSG00000112333 | nan | nan
chr6	SNX3	605930.0 | SNX3 | Sorting nexin 3 | 8724.0 | ENSG00000112335 | t(6;13)(q21;q12) | nan
chr6	AFG1L	617469.0 | AFG1L, AFG1, LACE1 | AFG1-like ATPase | 246269.0 | ENSG00000135537 | nan | nan
chr6	FOXO3	602681.0 | FOXO3A, FOXO3, FKHRL1 | Forkhead box O3A | 2309.0 | ENSG00000118689 | nan | nan
chr6	ARMC2	618424.0 | ARMC2, SPGF38 | Armadillo repeat-containing protein 2 | 84071.0 | ENSG00000118690 | nan | Spermatogenic failure 38, 618433 (3), Autosomal recessive
chr6	SESN1	606103.0 | SESN1, SEST1, PA26 | Sestrin 1 | 27244.0 | ENSG00000080546 | nan | nan
chr6	CD164	603356.0 | CD164, DFNA66 | CD164 antigen | 8763.0 | ENSG00000135535 | mutation identified in 1 DFNA66 family | ?Deafness, autosomal dominant 66, 616969 (3), Autosomal dominant
chr6	SMPD2	603498.0 | SMPD2, NSMASE1 | Sphingomyelin phosphodiesterase 2 | 6610.0 | ENSG00000135587 | nan | nan
chr6	MICAL1	607129.0 | MICAL1, NICAL, MICAL | Microtubule-associated monooxygenase, calponin and LIM domains-containing 1 | 64780.0 | ENSG00000135596 | nan | nan
chr6	ZBTB24	614064.0 | ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2 | Zinc finger- and BTB domain-containing protein 24 | 9841.0 | ENSG00000112365 | nan | Immunodeficiency-centromeric instability-facial anomalies syndrome 2, 614069 (3), Autosomal recessive
chr6	AK9	615358.0 | AK9, SPGF89 | Adenylate kinase 9 | 221264.0 | ENSG00000155085 | nan | Spermatogenic failure 89, 620705 (3), Autosomal recessive
chr6	FIG4	609390.0 | FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP | FIG4 phosphoinositide 5-phosphatase | 9896.0 | ENSG00000112367 | mutation identified in 1 BTOP family | Yunis-Varon syndrome, 216340 (3), Autosomal recessive; ?Polymicrogyria, bilateral temporooccipital, 612691 (3), Autosomal recessive; Amyotrophic lateral sclerosis 11, 612577 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 4J, 611228 (3), Autosomal recessive
chr6	GPR6	600553.0 | GPR6 | G protein-coupled receptor-6 | 2830.0 | ENSG00000146360 | nan | nan
chr6	WASF1	605035.0 | WASF1, WAVE, WAVE1, SCAR1, NEDALVS | WAS protein family member 1 | 8936.0 | ENSG00000112290 | nan | Neurodevelopmental disorder with absent language and variable seizures, 618707 (3), Autosomal dominant
chr6	CDC40	605585.0 | CDC40, PRP17, PCH15 | Cell division cycle 40 | 51362.0 | ENSG00000168438 | mutation identified in 1 PCH15 patient | ?Pontocerebellar hypoplasia, type 15, 619302 (3), Autosomal recessive
chr6	DDO	124450.0 | DDO, DASOX | D-aspartate oxidase | 8528.0 | ENSG00000203797 | nan | nan
chr6	SLC22A16	608276.0 | SLC22A16, FLIPT2, CT2 | Solute carrier family 22 (organic cation transporter), member 16 | 85413.0 | ENSG00000004809 | nan | nan
chr6	CDK19	614720.0 | CDK19, KIAA1028, DEE87 | Cyclin-dependent kinase 19 | 23097.0 | ENSG00000155111 | nan | Developmental and epileptic encephalopathy 87, 618916 (3), Autosomal dominant
chr6	AMD1	180980.0 | AMD1 | S-adenosylmethionine decarboxylase-1 | 262.0 | ENSG00000123505 | pseudogene AMD2 on Xq28 | nan
chr6	GTF3C6	611784.0 | GTF3C6, C6orf51 | General transcription factor 3C, polypeptide 6 | 112495.0 | ENSG00000155115 | nan | nan
chr6	RPF2	618471.0 | RPF2, BXDC1 | Ribosome production factor 2 homolog | 84154.0 | ENSG00000197498 | nan | nan
chr6	SLC16A10	607550.0 | SLC16A10, TAT1 | Solute carrier family 16 (monocarboxylic acid transporter), member 10 | 117247.0 | ENSG00000112394 | nan | nan
chr6	MFSD4B	617331.0 | MFSD4B, NAGLT1, Kiaa1919 | Major facilitator superfamily domain-containing protein 4B | 91749.0 | ENSG00000173214 | nan | nan
chr6	REV3L	602776.0 | REV3L, POLZ, REV3 | Rev-3, yeast, homolog-like (polymerase, DNA, zeta) | 5980.0 | ENSG00000009413 | nan | nan
chr6	TRAF3IP2	607043.0 | TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8 | TRAF3-interacting protein 2 | 10758.0 | ENSG00000056972 | mutation identified in 1 family with CANDF8 | ?Candidiasis, familial, 8, 615527 (3), Autosomal recessive; {Psoriasis susceptibility 13}, 614070 (3)
chr6	FYN	137025.0 | FYN | FYN protooncogene, SRC family tyrosine kinase | 2534.0 | ENSG00000010810 | proximal 6q21 | nan
chr6	CCN6	603400.0 | CCN6, WISP3, PPAC, PPRD | Cellular communication network factor 6 | 8838.0 | ENSG00000112761 | nan | Progressive pseudorheumatoid dysplasia, 208230 (3), Autosomal recessive
chr6	TUBE1	607345.0 | TUBE1, TUBE | Tubulin, epsilon-1 | 51175.0 | ENSG00000074935 | nan | nan
chr6	LAMA4	600133.0 | LAMA4, LAMA3, CMD1JJ | Laminin, alpha-4 | 3910.0 | ENSG00000112769 | nan | Cardiomyopathy, dilated, 1JJ, 615235 (3), Autosomal dominant
chr6	MARCKS	177061.0 | MRACKS, MACS, PKCSL | Myristoylated alanine-rich protein kinase C substrate (MARCKS, 80K-L) | 4082.0 | ENSG00000277443 | monomorphic | nan
chr6	HDAC2	605164.0 | HDAC2 | Histone deacetylase 2 | 3066.0 | ENSG00000196591 | nan | nan
chr6	HS3ST5	609407.0 | HS3ST5, 3OST5 | Heparan sulfate-glucosamine 3-sulfotransferase 5 | 222537.0 | ENSG00000249853 | nan | nan
chr6	FEB5	609255.0 | FEB5 | Febrile seizures, familial, 5 | 619398.0 | nan | between D6S1572 and D6S472 | Febrile seizures, familial, 5, 609255 (2), Autosomal dominant
chr6	FIQTL1	606035.0 | FIQTL1 | Fasting insulin level quantitative trait locus 1 | 619503.0 | nan | max lod at D6S1569 | [Fasting insulin level quantitative trait locus 1], 606035 (2)
chr6	IGAN1	161950.0 | IGAN1 | IgA nephropathy, susceptibility to, 1 | 60498.0 | nan | nan | {IgA nephropathy, susceptibility to, 1}, 161950 (2), ?Autosomal dominant
chr6	SM2	604201.0 | SM2 | Hepatic fibrosis susceptibility due to Schistosoma mansoni infection | 53366.0 | nan | ?polymorphism of INFGR1 | {Hepatic fibrosis susceptibility due to Schistosoma mansoni infection}, 604201 (2)
chr6	FRK	606573.0 | FRK, RAK, GTK | FYN-related kinase | 2444.0 | ENSG00000111816 | nan | nan
chr6	COL10A1	120110.0 | COL10A1 | Collagen X, alpha-1 polypeptide | 1300.0 | ENSG00000123500 | nan | Metaphyseal chondrodysplasia, Schmid type, 156500 (3), Autosomal dominant
chr6	TSPYL4	619586.0 | TSPYL4, KIAA0721 | TSPY-like 4 | 23270.0 | ENSG00000187189 | nan | nan
chr6	DSE	605942.0 | DSE, SART2, EDSMC2 | Dermatan sulfate epimerase | 29940.0 | ENSG00000111817 | nan | Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3), Autosomal recessive
chr6	TSPYL1	604714.0 | TSPYL1, TSPYL, SIDDT | Y-encoded testis-specific protein-like | 7259.0 | ENSG00000189241 | nan | Sudden infant death with dysgenesis of the testes syndrome, 608800 (3), Autosomal recessive
chr6	CALHM6	617305.0 | FAM26F, INAM | Family with sequence similarity 26, member F | 441168.0 | ENSG00000188820 | nan | nan
chr6	TRAPPC3L	614137.0 | TRAPPC3L, BET3L | Trafficking protein particle complex, subunit 3-like | 100128327.0 | ENSG00000173626 | nan | nan
chr6	RWDD1	620844.0 | RWDD1 | RWD domain-containing protein 1 | 51389.0 | ENSG00000111832 | nan | nan
chr6	RSPH4A	612647.0 | RSPH4A, CILD11 | Radial spoke head component 4A | 345895.0 | ENSG00000111834 | nan | Ciliary dyskinesia, primary, 11, 612649 (3), Autosomal recessive
chr6	ZUP1	620543.0 | ZUP1, ZUFSP | Zinc finger containing ubiquitin peptidase 1 | 221302.0 | ENSG00000153975 | nan | nan
chr6	KPNA5	604545.0 | KPNA5 | Karyopherin alpha-5 | 3841.0 | ENSG00000196911 | nan | nan
chr6	GPRC6A	613572.0 | GPRC6A | G protein-coupled receptor, family C, group 6, member A | 222545.0 | ENSG00000173612 | nan | nan
chr6	RFX6	612659.0 | RFX6, RFXDC1, MTCHRS | Regulatory factor X, 6 | 222546.0 | ENSG00000185002 | nan | Mitchell-Riley syndrome, 615710 (3), Autosomal recessive
chr6	VGLL2	609979.0 | VGLL2, VGL2, VITO1 | Vestigial-like 2 | 245806.0 | ENSG00000170162 | nan | nan
chr6	ROS1	165020.0 | ROS1, MCF3 | Avian UR2 sarcoma virus oncogene (v-ros) homolog 1 | 6098.0 | ENSG00000047936 | nan | nan
chr6	GOPC	606845.0 | GOPC, PIST, FIG, CAL | Golgi-associated PDZ and coiled-coil domains-containing protein | 57120.0 | ENSG00000047932 | nan | nan
chr6	NUS1	610463.0 | NUS1, NGBR, C6orf68, CDG1AA, MRD55 | NUS1 dehydrodolichyl diphosphate synthase subunit | 116150.0 | ENSG00000153989 | mutation identified in 1 CDG1AA family | Intellectual developmental disorder, autosomal dominant 55, with seizures, 617831 (3), Autosomal dominant; ?Congenital disorder of glycosylation, type 1aa, 617082 (3), Autosomal recessive
chr6	SLC35F1	620349.0 | SLC35F1 | Solute carrier family 35, member F1 | 222553.0 | ENSG00000196376 | nan | nan
chr6	HBFQTL2	142470.0 | HBFQTL2, FCP | Fetal hemoglobin quantitative trait locus 2 | 7954.0 | nan | nan | Fetal hemoglobin quantitative trait locus 2, 142470 (2), Autosomal dominant
chr6	CEP85L	618865.0 | CEP85L, C6orf204, LIS10 | CEP85-like protein | 387119.0 | ENSG00000111860 | nan | Lissencephaly 10, 618873 (3), Autosomal dominant
chr6	PLN	172405.0 | PLN, PLB, CMD1P, CMH18 | Phospholamban | 5350.0 | ENSG00000198523 | nan | Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, hypertrophic, 18, 613874 (3), Autosomal dominant
chr6	MCM9	610098.0 | MCM9, MCMDC1, ODG4 | Minichromosome maintenance complex component 9 | 254394.0 | ENSG00000111877 | nan | Ovarian dysgenesis 4, 616185 (3), Autosomal recessive
chr6	ASF1A	609189.0 | ASF1A, CIA | Anti-silencing function 1A histone chaperone | 25842.0 | ENSG00000111875 | nan | nan
chr6	MAN1A1	604344.0 | MAN1A1 | Mannosidase, alpha, class 1A, member 1 | 4121.0 | ENSG00000111885 | nan | nan
chr6	TBC1D32	615867.0 | TBC1D32, BROMI | TBC1 domain family, member 32 | 221322.0 | ENSG00000146350 | nan | nan
chr6	GJA1	121014.0 | GJA1, CX43, ODDD, SDTY3, ODOD, HSS, CMDR, EKVP3 | Gap junction protein, alpha-1, 43kD (connexin 43) | 2697.0 | ENSG00000152661 | pseudogene on chr.5 | Erythrokeratodermia variabilis et progressiva 3, 617525 (3), Autosomal dominant; Craniometaphyseal dysplasia, autosomal recessive, 218400 (3), Autosomal recessive; Oculodentodigital dysplasia, 164200 (3), Autosomal dominant; Palmoplantar keratoderma with congenital alopecia, 104100 (3), Autosomal dominant; Syndactyly, type III, 186100 (3), Autosomal dominant; Oculodentodigital dysplasia, autosomal recessive, 257850 (3), Autosomal recessive
chr6	HSF2	140581.0 | HSF2 | Heat-shock transcription factor 2 | 3298.0 | ENSG00000025156 | nan | nan
chr6	SERINC1	614548.0 | SERINC1, TMS2, KIAA1253 | Serine incorporator 1 | 57515.0 | ENSG00000111897 | nan | nan
chr6	PKIB	606914.0 | PKIB | Protein kinase, cAMP-dependent catalytic, inhibitor beta | 5570.0 | ENSG00000135549 | nan | nan
chr6	FABP7	602965.0 | FABP7, FABPB, BLBP | Fatty acid-binding protein 7 | 2173.0 | ENSG00000164434 | nan | nan
chr6	SMPDL3A	610728.0 | SMPDL3A, ASML3A | Sphingomyelin phosphodiesterase, acid-like, 3A | 10924.0 | ENSG00000172594 | nan | nan
chr6	CLVS2	616945.0 | CLVS2 | Clavesin 2 | 134829.0 | ENSG00000146352 | nan | nan
chr6	TRDN	603283.0 | TRDN, TDN, CARDAR | Triadin | 10345.0 | ENSG00000186439 | nan | Cardiac arrhythmia syndrome, with or without skeletal muscle weakness, 615441 (3), Autosomal recessive
chr6	NKAIN2	609758.0 | NKAIN2, TCBA | Na+/K+ transporting ATPase interacting 2 | 154215.0 | ENSG00000188580 | fused with SUSP1 in T-cell lymphoma/leukemia | nan
chr6	RNF217-AS1	602532.0 | RNF217AS1, STL | RNF217 antisense RNA 1 | 7955.0 | ENSG00000236548 | nan | nan
chr6	RNF217	618592.0 | RNF217, OSTL, IBRDC1, C6orf172 | Ring finger potein 217 | 154214.0 | ENSG00000146373 | overlaps STL in opposite orientation | nan
chr6	TPD52L1	604069.0 | TPD52L1, D53 | Tumor protein D52-like 1 | 7164.0 | ENSG00000111907 | nan | nan
chr6	HEY2	604674.0 | HEY2, HERP1, GRL | HES-related family bHLH transcription factor with YRPW motif 2 | 23493.0 | ENSG00000135547 | nan | nan
chr6	NCOA7	609752.0 | NCOA7, ERAP140 | Nuclear receptor coactivator 7 | 135112.0 | ENSG00000111912 | nan | nan
chr6	HINT3	609998.0 | HINT3 | Histidine triad nucleotide-binding protein 3 | 135114.0 | ENSG00000111911 | nan | nan
chr6	CENPW	611264.0 | CEMPW, C6orf173, CUG2 | Centromeric protein W | 387103.0 | ENSG00000203760 | nan | nan
chr6	RSPO3	610574.0 | RSPO3, PWTSR, CRISTIN1 | R-spondin 3 | 84870.0 | ENSG00000146374 | nan | nan
chr6	RNF146	612137.0 | RNF146 | Ring finger protein 146 | 81847.0 | ENSG00000118518 | nan | nan
chr6	ECHDC1	612136.0 | ECHDC1 | Enoyl coenzyme A hydratase domain-containing protein 1 | 55862.0 | ENSG00000093144 | nan | nan
chr6	KIAA0408	619236.0 | KIAA0408 | KIAA0408 gene | 9729.0 | ENSG00000189367 | nan | nan
chr6	THEMIS	613607.0 | THEMIS, GASP, SPOT, C6orf190 | Thymocyte-expressed molecule involved in selection | 387357.0 | ENSG00000172673 | nan | nan
chr6	PTPRK	602545.0 | PTPRK | Protein-tyrosine phosphatase, receptor type, kappa | 5796.0 | ENSG00000152894 | nan | nan
chr6	LAMA2	156225.0 | LAMA2, LAMM, MDC1A | Laminin, alpha-2 (merosin) | 3908.0 | ENSG00000196569 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 23, 618138 (3), Autosomal recessive; Muscular dystrophy, congenital, merosin deficient or partially deficient, 607855 (3), Autosomal recessive
chr6	ARHGAP18	613351.0 | ARHGAP18 | RHO GTPase-activating protein 18 | 93663.0 | ENSG00000146376 | nan | nan
chr6	BMIQ3	607446.0 | BMIQ3 | Body mass index quantitative trait locus 3 | 337895.0 | nan | max lod at D6S305 | [Body mass index QTL3], 607446 (2)
chr6	HCHGQ1	609319.0 | HCHGQ1 | Hematocrit/hemoglobin quantitative trait locus 1 | 100381204.0 | nan | nan | [Hematocrit/hemoglobin quantitative trait locus 1], 609319 (2)
chr6	LNCR1	608935.0 | LNCR1 | Lung cancer 1 | 450093.0 | nan | max hlod at D6S2436 | {Lung cancer susceptibility}, 608935 (2)
chr6	MAFD6	611536.0 | MAFD6, BPAD | Major affective disorder 6 | 100188844.0 | nan | nan | {Major affective disorder 6}, 611536 (2)
chr6		602154.0 | NTT | Noncoding transcript in T cells | 7956.0 | nan | nan | nan
chr6		180300.0 | RA | Rheumatoid arthritis, susceptibility to | nan | nan | associated with SNP rs10499194 and rs6920220 | {Rheumatoid arthritis, susceptibility to}, 180300 (2)
chr6	RP63	614494.0 | RP63 | Retinitis pigmentosa 63 | 100862681.0 | nan | between D6S457 and D6S1656 | Retinitis pigmentosa 63, 614494 (2), Autosomal dominant
chr6	SLEB13	612378.0 | SLEB13 | Systemic lupus erythematosus, susceptibility to, 13 | 100196918.0 | nan | associated with rs5029939 | {Systemic lupus erythematosus, susceptibility to, 13}, 612378 (2)
chr6	SPG25	608220.0 | SPG25 | Spastic paraplegia 25, autosomal recessive, with disc herniation | 387583.0 | nan | nan | Spastic paraplegia 25, autosomal recessive, 608220 (2), Autosomal recessive
chr6	L3MBTL3	618844.0 | L3MGTL3, MBT1, KIAA1798 | L3MBTL histone methyl-lysine-binding protein 3 | 84456.0 | ENSG00000198945 | nan | nan
chr6	SAMD3	620516.0 | SAMD3 | Sterile alpha motif domain-containing 3 | 154075.0 | ENSG00000164483 | nan | nan
chr6	EPB41L2	603237.0 | EPB41L2 | Erythrocyte membrane protein band 4.1-like 2 | 2037.0 | ENSG00000079819 | nan | nan
chr6	AKAP7	604693.0 | AKAP7, AKAP18 | A-kinase anchor protein 7 | 9465.0 | ENSG00000118507 | nan | nan
chr6	ARG1	608313.0 | ARG1 | Arginase, liver | 383.0 | ENSG00000118520 | nan | Argininemia, 207800 (3), Autosomal recessive
chr6	MED23	605042.0 | MED23, MRT18 | Mediator complex subunit 23 | 9439.0 | ENSG00000112282 | nan | Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy, 614249 (3), Autosomal recessive
chr6	ENPP3	602182.0 | ENPP3, PDNP3 | Ectonucleotide pyrophosphatase/phosphodiesterase 3 | 5169.0 | ENSG00000154269 | nan | nan
chr6	ENPP1	173335.0 | ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED | Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of) | 5167.0 | ENSG00000197594 | nan | {Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant; Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3), Autosomal recessive; {Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant; Arterial calcification, generalized, of infancy, 1, 208000 (3), Autosomal recessive; Cole disease, 615522 (3), Autosomal dominant
chr6	CCN2	121009.0 | CCN2, CTGF, NOV2 | Cellular communcation network factor 2 | 1490.0 | ENSG00000118523 | proximal to MYB | nan
chr6	MOXD1	609000.0 | MOXD1, MOX | Monooxygenase, DBH-like, 1 | 26002.0 | ENSG00000079931 | nan | nan
chr6	STX7	603217.0 | STX7 | Syntaxin 7 | 8417.0 | ENSG00000079950 | nan | nan
chr6	TAAR9	608282.0 | TAR3, TA3 | Trace amine receptor 3 | 134860.0 | ENSG00000237110 | nan | nan
chr6	TAAR8	606927.0 | GPR102, TA5 | G protein-coupled receptor 102 | 83551.0 | ENSG00000146385 | nan | nan
chr6	TAAR6	608923.0 | TAAR6, TRAR4 | Trace amine-associated receptor 6 | 319100.0 | ENSG00000146383 | nan | nan
chr6	TAAR5	607405.0 | PNR | Putative neurotransmitter receptor | 9038.0 | ENSG00000135569 | nan | nan
chr6	TAAR2	604849.0 | TAAR2, GPR58 | Trace amine-associated receptor 2 | 9287.0 | ENSG00000146378 | nan | nan
chr6	TAAR1	609333.0 | TAAR1, TA1 | Trace amine-associated receptor 1 | 134864.0 | ENSG00000146399 | nan | nan
chr6	VNN1	603570.0 | VNN1 | Vanin 1 | 8876.0 | ENSG00000112299 | nan | nan
chr6	VNN3P	606592.0 | VNN3 | Vanin 3 | 55350.0 | ENSG00000293493 | nan | nan
chr6	VNN2	603571.0 | VNN2 | Vanin 2 | 8875.0 | ENSG00000112303 | nan | nan
chr6	SLC18B1	613361.0 | C6orf192 | Chromosome 6 open reading frame 192 | 116843.0 | ENSG00000146409 | nan | nan
chr6	RPS12	603660.0 | RPS12 | Ribosomal protein S12 | 6206.0 | ENSG00000112306 | nan | nan
chr6	EYA4	603550.0 | EYA4, DFNA10, CMD1J | EYA transcriptional coactivator and phosphatase 4 | 2070.0 | ENSG00000112319 | mutation identified in 1 CMD1J family | ?Cardiomyopathy, dilated, 1J, 605362 (3), Autosomal dominant; Deafness, autosomal dominant 10, 601316 (3), Autosomal dominant
chr6	TARID	616058.0 | TARID | TCF21 antisense RNA inducing promoter demethylation | 100507308.0 | ENSG00000227954 | nan | nan
chr6	TCF21	603306.0 | TCF21, POD1 | Transcription factor-21 (epicardin; podocyte-expressed 1) | 6943.0 | ENSG00000118526 | nan | nan
chr6	TBPL1	605521.0 | TBPL1, TRF2, TLF | TATA box-binding protein-like protein 1 | 9519.0 | ENSG00000028839 | nan | nan
chr6	SLC2A12	610372.0 | SLC2A12, GLUT12 | Solute carrier family 2 (facilitated glucose transporter), member 12 | 154091.0 | ENSG00000146411 | nan | nan
chr6	SGK1	602958.0 | SGK1 | Serum/glucocorticoid-regulated kinase 1 | 6446.0 | ENSG00000118515 | nan | nan
chr6	MPVQTL5	614645.0 | MPVQTL5 | Mean platelet volume quantitative trait locus 5 | 100887752.0 | nan | associated with rs9399137 | Mean platelet volume QTL5, 614645 (2)
chr6	ALDH8A1	606467.0 | ALDH8A1, ALDH12 | Aldehyde dehydrogenase 8 family, member A1 | 64577.0 | ENSG00000118514 | nan | nan
chr6	HBS1L	612450.0 | HBS1L, KIAA1038, ERFS | HBS1-like protein | 10767.0 | ENSG00000112339 | nan | nan
chr6	MYB	189990.0 | MYB | Avian myeloblastosis viral (v-myb) oncogene homolog | 4602.0 | ENSG00000118513 | nan | {T-cell acute lymphoblastic leukemia} (3)
chr6	AHI1	608894.0 | AHI1 | Abelson helper integration site 1 | 54806.0 | ENSG00000135541 | nan | Joubert syndrome 3, 608629 (3), Autosomal recessive
chr6	PDE7B	604645.0 | PDE7B | Phosphodiesterase 7B, cAMP-specific, high-affinity | 27115.0 | ENSG00000171408 | nan | nan
chr6	BCLAF1	612588.0 | BCLAF1, BTF, KIAA0164 | BCL2-associated transcription factor 1 | 9774.0 | ENSG00000029363 | nan | nan
chr6	MAP7	604108.0 | MAP7, EMAP115 | Microtubule-associated protein-7 | 9053.0 | ENSG00000135525 | nan | nan
chr6	MAP3K5	602448.0 | MAP3K5, MEKK5, MAPKKK5, ASK1 | Mitogen-activated protein kinase kinase kinase 5 | 4217.0 | ENSG00000197442 | nan | nan
chr6	PEX7	601757.0 | PEX7, RCDP1, PBD9B | Peroxisomal biogenesis factor-7 | 5191.0 | ENSG00000112357 | nan | Rhizomelic chondrodysplasia punctata, type 1, 215100 (3), Autosomal recessive; Peroxisome biogenesis disorder 9B, 614879 (3), Autosomal recessive
chr6	SLC35D3	612519.0 | SLC35D3 | Solute carrier family 35, member D3 | 340146.0 | ENSG00000182747 | nan | nan
chr6	IL20RA	605620.0 | IL20RA | Interleukin 20 receptor, alpha | 53832.0 | ENSG00000016402 | nan | nan
chr6	IL22RA2	606648.0 | IL22BP, IL22RA2 | Interleukin 22-binding protein | 116379.0 | ENSG00000164485 | nan | nan
chr6	IFNGR1	107470.0 | IFNGR1, IMD27A, IMD27B | Immune interferon, receptor for | 3459.0 | ENSG00000027697 | nan | {H. pylori infection, susceptibility to}, 600263 (3); Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3), Autosomal recessive; Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3), Autosomal dominant; {Tuberculosis infection, protection against}, 607948 (3); {Tuberculosis, susceptibility to}, 607948 (3); {Hepatitis B virus infection, susceptibility to}, 610424 (3)
chr6	OLIG3	609323.0 | OLIG3, BHLHB7 | Oligodendrocyte lineage transcription factor 3 | 167826.0 | ENSG00000177468 | nan | nan
chr6	WAKMAR2	618508.0 | WAKMAR2 | Wound- and keratinocyte migration-associated long noncoding RNA 2 | 100130476.0 | nan | partially overlaps TNFAIP on opposite strand | nan
chr6	TNFAIP3	191163.0 | TNFAIP3, A20, OTUD7C, AIFBL1 | Tumor necrosis factor-alpha-induced protein 3 | 7128.0 | ENSG00000118503 | nan | Autoinflammatory syndrome, familial, Behcet-like 1, 616744 (3), Autosomal dominant
chr6	PERP	609301.0 | PERP, OLMS2, EKVP7 | p53 effector related to PMP22 | 64065.0 | ENSG00000112378 | nan | Erythrokeratodermia variabilis et progressiva 7, 619209 (3), Autosomal recessive; Olmsted syndrome 2, 619208 (3), Autosomal dominant
chr6	ARFGEF3	617411.0 | ARFGEF3, BIG3, KIAA1244 | ADP-ribosylation factor guanine nucleotide exchange factor 3 | 57221.0 | ENSG00000112379 | nan | nan
chr6	PBOV1	605669.0 | PBOV1, UROC28, UC28 | Prostate and breast cancer overexpressed 1 | 59351.0 | ENSG00000254440 | nan | nan
chr6		612863.0 | DEL6q24q25, C6DELq25q25 | Chromosome 6q24-q25 deletion syndrome | nan | nan | nan | Chromosome 6q25-q25 deletion syndrome, 612863 (4), Autosomal dominant
chr6		606255.0 | STQTL1 | Stature quantitative trait locus 1 | nan | nan | associated with rs4896582 and rs3748069 | {Stature QTL 1}, 606255 (2)
chr6		601410.0 | TNDM1 | Transient neonatal diabetes mellitus 1 | nan | nan | disordered imprinting of PLAGL1 and HYMAI | {Diabetes mellitus, transient neonatal 1}, 601410 (4), Autosomal recessive, Autosomal dominant
chr6	HEBP2	605825.0 | C6orf34, SOUL | Soul, chicken, homolog of | 23593.0 | ENSG00000051620 | nan | nan
chr6	NHSL1	620171.0 | NHSL1 | NHS-like protien 1 | 57224.0 | ENSG00000135540 | nan | nan
chr6	CCDC28A	615353.0 | CCDC28A, C6orf80 | Coiled-coil domain-containing 28A | 25901.0 | ENSG00000024862 | nan | nan
chr6	REPS1	614825.0 | REPS1, NBIA7 | RALBP1-associated EPS domain-containing protein 1 | 85021.0 | ENSG00000135597 | mutation identified in 1 NBIA7 family | ?Neurodegeneration with brain iron accumulation 7, 617916 (3), Autosomal recessive
chr6	HECA	607977.0 | HECA, HDC | HDC homolog, cell cycle regulator | 51696.0 | ENSG00000112406 | nan | nan
chr6	TXLNB	611438.0 | TXLNB | Taxilin, beta | 167838.0 | ENSG00000164440 | nan | nan
chr6	CITED2	602937.0 | CITED2, MRG1, P35SRJ, VSD2, ASD8 | CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2 | 10370.0 | ENSG00000164442 | ?pseudogene on 1q22 | Atrial septal defect 8, 614433 (3), Autosomal dominant; Ventricular septal defect 2, 614431 (3), Autosomal dominant
chr6	NMBR	162341.0 | NMBR | Neuromedin B receptor | 4829.0 | ENSG00000135577 | nan | nan
chr6	VTA1	610902.0 | VTA1, 6orf55, SBP1, LIP5, DRG1 | Vessicle trafficking 1 | 51534.0 | ENSG00000009844 | nan | nan
chr6		127500.0 | DUH1, DUH | Dyschromatosis universalis hereditaria 1 | nan | nan | max lod at D6S1553 | Dyschromatosis universalis hereditaria 1, 127500 (2), Autosomal dominant
chr6	ADGRG6	612243.0 | ADGRG6, PR126, VIGR, LCCS9 | Adhesion G protein-coupled receptor G6 | 57211.0 | ENSG00000112414 | nan | Lethal congenital contracture syndrome 9, 616503 (3), Autosomal recessive
chr6	HIVEP2	143054.0 | HIVEP2, MRD43 | Human immunodeficiency virus type I enhancer-binding protein-2 | 3097.0 | ENSG00000010818 | nan | Intellectual developmental disorder, autosomal dominant 43, 616977 (3), Autosomal dominant
chr6	AIG1	608514.0 | AIG1 | Androgen-induced gene 1 | 51390.0 | ENSG00000146416 | nan | nan
chr6	ADAT2	615388.0 | ADAT2, TAD2 | Adenosine deaminase, tRNA-specific, 2 | 134637.0 | ENSG00000189007 | nan | nan
chr6	PEX3	603164.0 | PEX3, PBD10A, PBD10B | Peroxisomal biogenesis factor-3 | 8504.0 | ENSG00000034693 | mutation identified in 1 PBD10B patient | Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3), Autosomal recessive; ?Peroxisome biogenesis disorder 10B, 617370 (3), Autosomal recessive
chr6	FUCA2	136820.0 | FUCA2 | Fucosidase, alpha-L- 2, plasma | 2519.0 | ENSG00000001036 | linked to PLG | nan
chr6	PHACTR2	608724.0 | PHACTR2, KIAA0680 | Phosphatase and actin regulator 2 | 9749.0 | ENSG00000112419 | nan | nan
chr6	LTV1	620074.0 | LTV1, IPHAK | LTV1 ribosome biogenesis factor | 84946.0 | ENSG00000135521 | nan | Inflammatory poikiloderma with hair abnormalities and acral keratoses, 620199 (3), Autosomal recessive
chr6	PLAGL1	603044.0 | PLAGL1, ZAC, LOT1 | Pleomorphic adenoma gene-like 1 (ZAC tumor suppressor) | 5325.0 | ENSG00000118495 | relaxed imprinting in TNDM | nan
chr6	HYMAI	606546.0 | HYMAI | Hydatidiform mole-associated and imprinted transcript | 57061.0 | ENSG00000283122 | relaxed imprinting in TNDM | nan
chr6	SF3B5	617847.0 | SF3B5, SF3B10 | Splicing factor 3B, subunit 5 | 83443.0 | ENSG00000169976 | nan | nan
chr6	STX11	605014.0 | STX11, FHL4, HPLH4, HLH4 | Syntaxin-11 | 8676.0 | ENSG00000135604 | nan | Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3), Autosomal recessive
chr6	UTRN	128240.0 | UTRN, DMDL, DRP1 | Utrophin (homologous to dystrophin) | 7402.0 | ENSG00000152818 | near dy in mouse | nan
chr6	EPM2A	607566.0 | EPM2A, MELF2 | EPM2A glucan phosphatase, laforin | 7957.0 | ENSG00000112425 | nan | Myoclonic epilepsy of Lafora 1, 254780 (3), Autosomal recessive
chr6	FBXO30	609101.0 | FBXO30, FBX30 | F-box only protein 30 | 84085.0 | ENSG00000118496 | nan | nan
chr6	SHPRH	608048.0 | SHPRH, RAD5 | SNF2 histone linker PHD RING helicase | 257218.0 | ENSG00000146414 | nan | nan
chr6	GRM1	604473.0 | GRM1, MGLUR1, GRM1A, SCAR13, SCA44 | Glutamate receptor, metabotropic, 1 | 2911.0 | ENSG00000152822 | nan | Spinocerebellar ataxia, autosomal recessive 13, 614831 (3), Autosomal recessive; Spinocerebellar ataxia 44, 617691 (3), Autosomal dominant
chr6	RAB32	612906.0 | RAB32, PARK26 | Ras-associated protein RAB32 | 10981.0 | ENSG00000118508 | nan | {Parkinson disease 26, autosomal dominant, susceptibility to}, 620923 (3), Autosomal dominant
chr6	ADGB	614630.0 | ADGB | Androglobin | 79747.0 | ENSG00000118492 | nan | nan
chr6	STXBP5	604586.0 | STXBP5 | Syntaxin-binding protein 5 (tomosyn) | 134957.0 | ENSG00000164506 | nan | nan
chr6	SAMD5	620517.0 | SAMD5 | Sterile alpha motif domain-containing 5 | 389432.0 | ENSG00000203727 | nan | nan
chr6	SASH1	607955.0 | SASH1, KIAA0790, CAPOK, DUH1 | Sterile alpha motifs- and SH3 domain-containing protein 1 | 23328.0 | ENSG00000111961 | mutation identified in 1 CAPOK family | Dyschromatosis universalis hereditaria 1, 127500 (3), Autosomal dominant; ?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma, 618373 (3), Autosomal recessive
chr6	BMND11	612114.0 | BMND11 | Bone mineral density quantitative trait locus 11 | 100188884.0 | nan | associated with rs4870044, rs1038304, and rs1999805 | [Bone mineral density QTL 11], 612114 (2)
chr6		612521.0 | IDDM21 | Diabetes mellitus, insulin-dependent, 21 | nan | nan | associated with rs1738074 | {Diabetes mellitus, insulin-dependent, 21}, 612521 (2)
chr6	IDDM8	600883.0 | IDDM8 | Insulin-dependent diabetes mellitus-8 | 3407.0 | nan | nan | {Diabetes mellitus, insulin-dependent, 8}, 600883 (2)
chr6		607572.0 | LPRS2 | Leprosy, susceptibility to, 2 | nan | nan | association with PARK2 | {Leprosy, susceptibility to, 2}, 607572 (2)
chr6	RCD1	180020.0 | RCD1 | Retinal cone dystrophy-1 | 5953.0 | nan | nan | ?Retinal cone dystrophy-1, 180020 (2), Autosomal dominant
chr6	UST	610752.0 | UST | Uronyl 2-sulfotransferase | 10090.0 | ENSG00000111962 | nan | nan
chr6	TAB2	605101.0 | TAB2, MAP3K7IP2, KIAA0733, CHTD2 | Tak1 (MAP3K7) binding protein 2 | 23118.0 | ENSG00000055208 | nan | Congenital heart defects, nonsyndromic, 2, 614980 (3), Autosomal dominant
chr6	SUMO4	608829.0 | SUMO4, IDDM5 | Small ubiquitin-like modifier 4 | 387082.0 | ENSG00000177688 | nan | {Diabetes mellitus, insulin-dependent, 5}, 600320 (3)
chr6	ZC3H12D	611106.0 | ZC3H12D, p34, C6orf95 | Zinc finger CCCH domain-containing protein 12D | 340152.0 | ENSG00000178199 | nan | nan
chr6	PPIL4	607609.0 | PPIL4 | Peptidyl-prolyl isomerase-like 4 | 85313.0 | ENSG00000131013 | nan | nan
chr6	KATNA1	606696.0 | KATNA1 | Katanin, p60 subunit, A1 | 11104.0 | ENSG00000186625 | nan | nan
chr6	LATS1	603473.0 | LATS1 | Large tumor suppressor kinase 1 | 9113.0 | ENSG00000131023 | nan | nan
chr6	NUP43	608141.0 | NUP43 | Nucleoporin, 43kD | 348995.0 | ENSG00000120253 | nan | nan
chr6	PCMT1	176851.0 | PCMT1, PIMT | Protein-L-isoaspartate (D-aspartate) O-methyltransferase | 5110.0 | ENSG00000120265 | nan | nan
chr6	RAET1E	609243.0 | RAET1E, LETAL, ULBP4 | Retinoic acid early transcript 1E | 135250.0 | ENSG00000164520 | nan | nan
chr6	RAET1G	609244.0 | RAET1G | Retinoic acid early transcript 1G | 353091.0 | ENSG00000203722 | nan | nan
chr6	ULBP2	605698.0 | ULBP2 | UL16-binding protein 2 | 80328.0 | ENSG00000131015 | nan | nan
chr6	ULBP1	605697.0 | ULBP1 | UL16-binding protein 1 | 80329.0 | ENSG00000111981 | nan | nan
chr6	RAET1L	611047.0 | RAET1L | Retinoic acid early transcript 1L | 154064.0 | ENSG00000155918 | nan | nan
chr6	ULBP3	605699.0 | ULBP3 | UL16-binding protein 3 | 79465.0 | ENSG00000131019 | nan | nan
chr6	PPP1R14C	613242.0 | PPP1R14C, KEPI | Protein phosphatase 1, regulatory subunit 14C | 81706.0 | ENSG00000198729 | nan | nan
chr6	IYD	612025.0 | IYD, DEHAL1, TDH4 | Iodotyrosine deiodinase | 389434.0 | ENSG00000009765 | nan | Thyroid dyshormonogenesis 4, 274800 (3), Autosomal recessive
chr6	PLEKHG1	620134.0 | PLEKHG1, KIAA1209 | Pleckstrin homology domain-and RhoGEF domain-containing protein G1 | 57480.0 | ENSG00000120278 | nan | nan
chr6	MTHFD1L	611427.0 | MTHFD1L, MTC1THFS | Methylenetetrahydrofolate dehydrogenase 1-like, NADP(+)-dependent | 25902.0 | ENSG00000120254 | nan | nan
chr6	AKAP12	604698.0 | AKAP12, AKAP250, GRAVIN | A-kinase anchor protein 12 | 9590.0 | ENSG00000131016 | nan | nan
chr6	ZBTB2	616595.0 | ZBTB2, ZNF437, KIAA1483 | Zinc finger- and BTB domain-containing protein 2 | 57621.0 | ENSG00000181472 | nan | nan
chr6	RMND1	614917.0 | RMND1, COXPD11 | Required for meiotic nuclear division 1 homolog | 55005.0 | ENSG00000155906 | nan | Combined oxidative phosphorylation deficiency 11, 614922 (3), Autosomal recessive
chr6	ARMT1	616332.0 | ARMT1, C6orf211 | Acidic residue methyltransferase 1 | 79624.0 | ENSG00000146476 | nan | nan
chr6	ESR1	133430.0 | ESR1, ESR, ESTRR | Estrogen receptor 1 | 2099.0 | ENSG00000091831 | nan | Breast cancer, somatic, 114480 (3); {Migraine, susceptibility to}, 157300 (3), Autosomal dominant; Estrogen resistance, 615363 (3), Autosomal recessive; {Myocardial infarction, susceptibility to}, 608446 (3)
chr6	SYNE1	608441.0 | SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4, AMC3 | Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1) | 23345.0 | ENSG00000131018 | nan | Arthrogryposis multiplex congenita 3, myogenic type, 618484 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3), Autosomal dominant; Spinocerebellar ataxia, autosomal recessive 8, 610743 (3), Autosomal recessive
chr6	MYCT1	616805.0 | MYCT1, MTLC | MYC target in myeloid cells 1 | 80177.0 | ENSG00000120279 | nan | nan
chr6	VIP	192320.0 | VIP | Vasoactive intestinal peptide | 7432.0 | ENSG00000146469 | nan | nan
chr6	FBXO5	606013.0 | FBXO5, FBX5, EMI1 | F-box only protein 5 | 26271.0 | ENSG00000112029 | nan | nan
chr6	MTRF1L	613542.0 | MTRF1L | Mitochondrial translational release factor 1-like | 54516.0 | ENSG00000112031 | nan | nan
chr6	RGS17	607191.0 | RGS17, RGSZ2 | Regulator of G protein signaling 17 | 26575.0 | ENSG00000091844 | nan | nan
chr6	OPRM1	600018.0 | OPRM1 | Opioid receptor, mu-1 | 4988.0 | ENSG00000112038 | nan | nan
chr6	IPCEF1	619948.0 | IPCEF1, PIP3E, KIAA0403 | Interaction protein for cytohesin exchange factors 1 | 26034.0 | ENSG00000074706 | nan | nan
chr6	CNKSR3	617476.0 | CNKSR3, CNK3 | CNKSR family, member 3 | 154043.0 | ENSG00000153721 | nan | nan
chr6	SCAF8	616024.0 | SCAF8, KIAA1116 | SR-related C-terminal domain-associated factor 8 | 22828.0 | ENSG00000213079 | nan | nan
chr6	TIAM2	604709.0 | TIAM2 | T-cell lymphoma invasion and metastasis 2 | 26230.0 | ENSG00000146426 | nan | nan
chr6	CELIAC12	612010.0 | CELIAC12 | Celiac disease, susceptibility to, 12 | 100188874.0 | nan | in LD block containing TAGAP | {Celiac disease, susceptibility to, 12}, 612010 (2)
chr6	TFB1M	607033.0 | TFB1M, CGI75 | Transcription factor B1, mitochondrial | 51106.0 | ENSG00000029639 | nan | nan
chr6	NOX3	607105.0 | NOX3 | NADPH oxidase 3 | 50508.0 | ENSG00000074771 | nan | nan
chr6	ARID1B	614556.0 | ARID1B, BAF250B, KIAA1235, MRD12, CSS1 | AT-rich interaction domain-containing protein 1B | 57492.0 | ENSG00000049618 | nan | Coffin-Siris syndrome 1, 135900 (3), Autosomal dominant
chr6	TMEM242	620721.0 | TMEM242 | Transmembrane protein 242 | 729515.0 | ENSG00000215712 | nan | nan
chr6	ZDHHC14	619295.0 | ZDHHC14 | Zinc finger DHHC-type palmitoyltransferase 14 | 79683.0 | ENSG00000175048 | nan | nan
chr6	SNX9	605952.0 | SNX9, SH3PX1 | Sorting nexin 9 | 51429.0 | ENSG00000130340 | nan | nan
chr6	SYNJ2	609410.0 | SYNJ2, KIAA0348 | Synaptojanin 2 | 8871.0 | ENSG00000078269 | nan | nan
chr6	SERAC1	614725.0 | SERAC1, MEGDEL | Serine active site-containing protein 1 | 84947.0 | ENSG00000122335 | nan | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3), Autosomal recessive
chr6	GTF2H5	608780.0 | GTF2H5, TTD3, TFB5, C6orf175, TTDA | General transcription factor IIH, polypeptide 5 | 404672.0 | ENSG00000272047 | nan | Trichothiodystrophy 3, photosensitive, 616395 (3), Autosomal recessive
chr6	TULP4	619442.0 | TULP4, TUSP | TUB-like protein 4 | 56995.0 | ENSG00000130338 | nan | nan
chr6	TMEM181	613209.0 | TMEM181, GPR178, KIAA1423 | Transmembrane protein 181 | 57583.0 | ENSG00000146433 | nan | nan
chr6	DYNLT1	601554.0 | DYNLT1, TCTEL1 | Dynein light chain Tctex-type 1 | 6993.0 | ENSG00000146425 | nan | nan
chr6	SYTL3	620973.0 | SYTL3, SLP3 | Synaptotagmin-like 3 | 94120.0 | ENSG00000164674 | nan | nan
chr6	EZR	123900.0 | EZR, VIL2, CVL | Ezrin | 7430.0 | ENSG00000092820 | coamplified with MYB | nan
chr6	RSPH3	615876.0 | RSPH3, RSHL2, RSP3, CILD32 | Radial spoke head 3 | 83861.0 | ENSG00000130363 | nan | Ciliary dyskinesia, primary, 32, 616481 (3), Autosomal recessive
chr6	TAGAP	609667.0 | TAGAP | T-cell activation GTPase-activating protein | 117289.0 | ENSG00000164691 | nan | nan
chr6	FNDC1	609991.0 | FNDC1, AGS8, KIAA1866 | Fibronectin type III domain-containing protein 1 | 84624.0 | ENSG00000164694 | nan | nan
chr6	SOD2	147460.0 | SOD2, MNSOD, MVCD6 | Superoxide dismutase-2, mitochondrial | 6648.0 | ENSG00000291237 | nan | {Microvascular complications of diabetes 6}, 612634 (3)
chr6	WTAP	605442.0 | WTAP | Wilms tumor 1-associating protein | 9589.0 | ENSG00000146457 | nan | nan
chr6	ACAT2	100678.0 | ACAT2 | Acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase) | 39.0 | ENSG00000120437 | encoded on strand opposite TCP1 | ?ACAT2 deficiency, 614055 (1), Isolated cases
chr6	TCP1	186980.0 | TCP1, CCT1 | T-complex 1 | 6950.0 | ENSG00000120438 | nan | nan
chr6	MRPL18	611831.0 | MRPL18 | Mitochondrial ribosomal protein L18 | 29074.0 | ENSG00000112110 | nan | nan
chr6	PNLDC1	619529.0 | PNLDC1, TRIMMER, SPGF57 | PARN-like ribonuclease domain-containing exonuclease 1 | 154197.0 | ENSG00000146453 | nan | Spermatogenic failure 57, 619528 (3), Autosomal recessive
chr6	MAS1	165180.0 | MAS1 | Oncogene MAS1 | 4142.0 | ENSG00000130368 | nan | nan
chr6	IGF2R	147280.0 | IGF2R, MPRI | Insulin-like growth factor-2 receptor (mannose-6-phosphate receptor, cation-independent) | 3482.0 | ENSG00000197081 | behaves as a tumor suppressor | Hepatocellular carcinoma, somatic, 114550 (3)
chr6	AIRN	604893.0 | AIRN, AIR | Antisense IGF2R RNA, noncoding | 100271873.0 | ENSG00000268257 | nan | nan
chr6	SLC22A1	602607.0 | SLC22A1, OCT1 | Solute carrier family 22 (organic cation transporter), member 1 | 6580.0 | ENSG00000175003 | nan | nan
chr6	SLC22A2	602608.0 | SLC22A2, OCT2 | Solute carrier family 22 (organic cation transporter), member 2 | 6582.0 | ENSG00000112499 | nan | nan
chr6	SLC22A3	604842.0 | SLC22A3, EMT | Solute carrier family 22 (extraneuronal monoamine transporter), member 3 | 6581.0 | ENSG00000146477 | nan | nan
chr6	LPAL2	611682.0 | LPAL2, APOARGC | Lipoprotein(a)-like 2 | 80350.0 | ENSG00000290613 | nan | nan
chr6	LPA	152200.0 | LPA | Apolipoprotein Lp(a) | 4018.0 | ENSG00000198670 | absent in mice | [LPA deficiency, congenital], 618807 (3), Autosomal dominant; {Coronary artery disease, susceptibility to}, 618807 (3), Autosomal dominant
chr6	DFNB38	608219.0 | DFNB38 | Deafness, autosomal recessive 38 | 337991.0 | nan | nan | Deafness, autosomal recessive 38, 608219 (2), Autosomal recessive
chr6	MRT28	614347.0 | MRT28 | Intellectual developmental disorder, autosomal recessive 28 | 100852396.0 | nan | between rs6935718 and rs3886091 | Intellectual developmental disorder, autosomal recessive 28, 614347 (2), Autosomal recessive
chr6	PLG	173350.0 | PLG, HAE4 | Plasminogen | 5340.0 | ENSG00000122194 | 20cM from TCP10A | Dysplasminogenemia, 217090 (3), Autosomal recessive; Angioedema, hereditary, 4, 619360 (3), Autosomal dominant; Plasminogen deficiency, type I, 217090 (3), Autosomal recessive
chr6	MAP3K4	602425.0 | MAP3K4, MEKK4, MTK1, MAPKKK4 | Mitogen-activated protein kinase kinase kinase 4 | 4216.0 | ENSG00000085511 | nan | nan
chr6	AGPAT4	614795.0 | AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | 56895.0 | ENSG00000026652 | nan | nan
chr6	PRKN	602544.0 | PRKN, PARK2, PDJ | Parkin RBR E3 ubiquitin protein ligase | 5071.0 | ENSG00000185345 | shares 5' regulatory region and both 3' UTRs with PACRG | Adenocarcinoma of lung, somatic, 211980 (3); Parkinson disease, juvenile, type 2, 600116 (3), Autosomal recessive; Ovarian cancer, somatic, 167000 (3)
chr6	PACRG	608427.0 | PACRG | Parkin coregulated gene | 135138.0 | ENSG00000112530 | shares 5' regulatory region and both 3' UTRs with PARK2 | nan
chr6	CAHM	615930.0 | CAHM, LINC00468 | Colorectal adenocarcinoma hypermethylated gene, noncoding | 100526820.0 | nan | nan | nan
chr6	QKI	609590.0 | QKI, QK1 | QKI, KH domain-containing RNA-binding protein | 9444.0 | ENSG00000112531 | nan | nan
chr6		215400.0 | CHDM | Chordoma | nan | nan | associated with duplication of the T gene | {Chordoma, susceptibility to}, 215400 (4), Autosomal dominant
chr6	KAZA3	611382.0 | KAZA3 | Kala-azar, susceptibility to, 3 | 101241899.0 | nan | nan | {Kala-azar, susceptibility to, 3}, 611382 (2)
chr6	PDE10A	610652.0 | PDE10A, IOLOD, ADSD2 | Phosphodiesterase 10A | 10846.0 | ENSG00000112541 | nan | Striatal degeneration, autosomal dominant, 616922 (3), Autosomal dominant; Dyskinesia, limb and orofacial, infantile-onset, 616921 (3), Autosomal recessive
chr6	TBXT	601397.0 | TBXT, T, TFT, SAVA | T-box transcription factor T | 6862.0 | ENSG00000164458 | nan | Sacral agenesis with vertebral anomalies, 615709 (3), Autosomal recessive; {Neural tube defects, susceptibility to}, 182940 (3), Autosomal dominant
chr6	MPC1	614738.0 | MPC1, BRP44L, MPYCD | Mitochondrial pyruvate carrier 1 | 51660.0 | ENSG00000060762 | nan | Mitochondrial pyruvate carrier deficiency, 614741 (3), Autosomal recessive
chr6	RPS6KA2	601685.0 | RPS6KA2, RSK3 | Ribosomal protein S6 kinase A2 | 6196.0 | ENSG00000071242 | nan | nan
chr6	RNASET2	612944.0 | RNASET2, RNASE6PL | Ribonuclease T2 | 8635.0 | ENSG00000026297 | nan | Leukoencephalopathy, cystic, without megalencephaly, 612951 (3), Autosomal recessive
chr6	CEP43	605392.0 | FGFR1OP, FOP | Fibroblast growth factor receptor-1 oncogene partner | 11116.0 | ENSG00000213066 | fusion gene with ZNF198, CEP1, and FGFR1 | Myeloproliferative disorder, 605392 (2)
chr6	CCR6	601835.0 | CCR6, CMKBR6, CKRL3, GPR29, GPRCY4 | Chemokine (C-C) receptor 6 | 1235.0 | ENSG00000112486 | nan | nan
chr6	GPR31	602043.0 | GPR31 | G protein-coupled receptor-31 | 2853.0 | ENSG00000120436 | nan | nan
chr6		616837.0 | HPAT5 | Human pluripotency-associated transcript 5, noncoding | 112590798.0 | ENSG00000280707 | nan | nan
chr6	UNC93A	607995.0 | UNC93A | unc-93 homolog A | 54346.0 | ENSG00000112494 | nan | nan
chr6	TCP10L3	187020.0 | TCP10 | T-complex 10 (a murine tcp homolog) | 6953.0 | ENSG00000290751 | nan | nan
chr6	AFDN	159559.0 | AFDN, MLLT4, AF6 | Afadin | 4301.0 | ENSG00000130396 | nan | nan
chr6	KIF25	603815.0 | KIF25, KNSL3 | Kinesin family member 25 | 3834.0 | ENSG00000125337 | nan | nan
chr6	DACT2	608966.0 | DACT2, DPR2, DAPPER2 | Dapper, antagonist of beta-catenin, 2 | 168002.0 | ENSG00000164488 | nan | nan
chr6	SMOC2	607223.0 | SMOC2, SMAP2, DTDP1 | Secreted modular calcium-binding protein 2 | 64094.0 | ENSG00000112562 | nan | Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3), Autosomal recessive
chr6	THBS2	188061.0 | THBS2, EDSCLL3 | Thrombospondin 2 | 7058.0 | ENSG00000186340 | mutation identifed in 1 EDSCL3 family | ?Ehlers-Danlos syndrome, classic-like, 3, 620865 (3), Autosomal dominant; {Lumbar disc herniation, susceptibility to}, 603932 (3)
chr6	WDR27	620936.0 | WDR27 | WD repeat-containing protein 27 | 253769.0 | ENSG00000184465 | nan | nan
chr6	C6orf120	616987.0 | C6orf120 | Chromosome 6 open reading frame 120 | 387263.0 | ENSG00000185127 | nan | nan
chr6	PHF10	613069.0 | PHF10, BAF45A | PHD finger protein 10 | 55274.0 | ENSG00000130024 | nan | nan
chr6	DYNLT2	186977.0 | DYNLT2, TCTE3 | Dynein light chain Tctex-type 2 | 6991.0 | ENSG00000184786 | nan | nan
chr6	ERMARD	615532.0 | ERMARD, C6orf70, PVNH6 | Endoplasmic reticulum membrane-associated RNA degradation protein | 55780.0 | ENSG00000130023 | nan | ?Periventricular nodular heterotopia 6, 615544 (3), Autosomal dominant
chr6	DLL1	606582.0 | DLL1, DELTA1, NEDBAS | Delta-like canonical Notch ligand 1 | 28514.0 | ENSG00000198719 | nan | Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, 618709 (3), Autosomal dominant
chr6	FAM120B	612266.0 | FAM120B, PGCC1, CCPG, KIAA1838 | Family with sequence similarity 120, member B | 84498.0 | ENSG00000112584 | nan | nan
chr6	PSMB1	602017.0 | PSMB1, NEDMHAL | Proteasome subunit, beta type, 1 | 5689.0 | ENSG00000008018 | mutation identified in 1 NEDNHAL family | ?Neurodevelopmental disorder with microcephaly, hypotonia, and absent language, 620038 (3), Autosomal recessive
chr6	TBP	600075.0 | TBP, SCA17, HDL4 | TATA box binding protein | 6908.0 | ENSG00000112592 | nan | Spinocerebellar ataxia 17, 607136 (3), Autosomal dominant; {Parkinson disease, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant
chr6	PDCD2	600866.0 | PDCD2 | Programmed cell death 2 | 5134.0 | ENSG00000071994 | nan | nan
chr6	BEVI	109180.0 | BEVI | Baboon M7 virus replication | 628.0 | nan | nan | nan
chr6		137010.0 | FEA | F9 embryonic antigen | 7959.0 | nan | nan | nan
chr6	LAKLG	153435.0 | LAKLG, LAKL | Lymphokine-activated killer cell ligand | 3905.0 | nan | nan | nan
chr6		158050.0 | MRBC | Monkey RBC receptor | 7960.0 | nan | nan | nan
chr6	TS546	187330.0 | TS546 | Temperature sensitivity complementation, cell cycle specific, ts546 cells | 7963.0 | nan | nan | nan
chr7	ERVK-6	605626.0 | ERVK-6 | Endogenous retroviral group K, member 6 | 64006.0 | nan | nan | nan
chr7	HYP10	614238.0 | HYPT10 | Hypotrichosis 10 | 100736251.0 | nan | between D7S1532 and D7S3047 | Hypotrichosis 10, 614238 (2), Autosomal recessive
chr7	FAM20C	611061.0 | FAM20C, DMP4 | Family with sequence similarity 20, member C | 56975.0 | ENSG00000177706 | nan | Raine syndrome, 259775 (3), Autosomal recessive
chr7	PDGFA	173430.0 | PDGFA | Platelet-derived growth factor, alpha polypeptide | 5154.0 | ENSG00000197461 | nan | nan
chr7	PRKAR1B	176911.0 | PRKAR1B, MASNS | Protein kinase, cAMP-dependent, regulatory, type I, beta | 5575.0 | ENSG00000188191 | nan | Marbach-Schaaf neurodevelopmental syndrome, 619680 (3), Autosomal dominant
chr7	DNAAF5	614864.0 | DNAAF5, HEATR2, CILD18 | Dynein axonemal assembly factor 5 | 54919.0 | ENSG00000164818 | nan | Ciliary dyskinesia, primary, 18, 614874 (3), Autosomal recessive
chr7	SUN1	607723.0 | SUN1, UNC84A, KIAA0810 | SAD1 and UNC84 domain-containing protein 1 | 23353.0 | ENSG00000164828 | nan | nan
chr7	GET4	612056.0 | GET4, C7orf20, CEE, CDG2Y | Guided entry of tail-anchored proteins factor 4 | 51608.0 | ENSG00000239857 | mutation identified in 1 CDG2Y patient | ?Congenital disorder of glycosylation, type IIy, 620200 (3), Autosomal recessive
chr7	ADAP1	608114.0 | CENTA1 | Centaurin, alpha-1 | 11033.0 | ENSG00000105963 | nan | nan
chr7	COX19	610429.0 | COX19 | Cytochrome c oxidase assembly protein Cox19 | 90639.0 | ENSG00000240230 | nan | nan
chr7	CYP2W1	615967.0 | CYP2W1 | Cytochrome P450, family 2, subfamily W, polypeptide 1 | 54905.0 | ENSG00000073067 | nan | nan
chr7	MIR339	615977.0 | MIR339 | Micro RNA 339 | 442907.0 | ENSG00000199023 | nan | nan
chr7	GPER1	601805.0 | GPER1, CMKRL2, GPR30 | G protein-coupled estrogen receptor 1 | 2852.0 | ENSG00000164850 | nan | nan
chr7	ZFAND2A	610699.0 | ZFAND2A, AIRAP | Zinc finger AN1 domain-containing protein 2A | 90637.0 | ENSG00000178381 | nan | nan
chr7	MICALL2	620912.0 | MICALL2, JRAB | MICAL-like protein 2 | 79778.0 | ENSG00000164877 | nan | nan
chr7	INTS1	611345.0 | INTS1, INT1, KIAA1440, NDCAGF | Integrator complex subunit 1 | 26173.0 | ENSG00000164880 | nan | Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies, 618571 (3), Autosomal recessive
chr7	MAFK	600197.0 | MAFK, NFE2U | MAF bZIP transcription factor K | 7975.0 | ENSG00000198517 | nan | nan
chr7	PSMG3	617528.0 | PSMG3, PAC3 | Proteasome assembly chaperone 3 | 84262.0 | ENSG00000157778 | nan | nan
chr7	ELFN1	614964.0 | ELFN1, PPP1R28 | Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1 | 392617.0 | ENSG00000225968 | nan | nan
chr7	MAD1L1	602686.0 | MAD1L1, TXBP181, MVA7 | Mitotic arrest-deficient 1, yeast, homolog-like 1 | 8379.0 | ENSG00000002822 | nan | Prostate cancer, somatic, 176807 (3); Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition, 620189 (3), Autosomal recessive; Lymphoma, B-cell, somatic (3)
chr7	MRM2	606906.0 | MRM2, FTSJ2, FJH1, MTDPS17 | Mitochondrial ribosomal RNA methyltransferase 2 | 29960.0 | ENSG00000122687 | nan | Mitochondrial DNA depletion syndrome 17, 618567 (3), Autosomal recessive
chr7	NUDT1	600312.0 | NUDT1, MTH1 | Nudix hydrolase 1 | 4521.0 | ENSG00000106268 | nan | nan
chr7	SNX8	614905.0 | SNX8 | Sorting nexin 8 | 29886.0 | ENSG00000106266 | nan | nan
chr7	EIF3B	603917.0 | EIF3B, EIF3S9, PRT1 | Eukaryotic translation initiation factor 3, subunit B | 8662.0 | ENSG00000106263 | nan | nan
chr7	CHST12	610129.0 | CHST12, C4ST2 | Carbohydrate sulfotransferase 12 | 55501.0 | ENSG00000136213 | nan | nan
chr7	GRIFIN	619187.0 | GRIFIN | Galectin-related interfiber protein | 402635.0 | ENSG00000275572 | nan | nan
chr7	LFNG	602576.0 | LFNG, SCDO3 | LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | 3955.0 | ENSG00000106003 | nan | Spondylocostal dysostosis 3, autosomal recessive, 609813 (3), Autosomal recessive
chr7	BRAT1	614506.0 | BRAT1, BAAT1, C7orf27, RMFSL, NEDCAS | BRCA1-associated ATM activator 1 | 221927.0 | ENSG00000106009 | nan | Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, 618056 (3), Autosomal recessive; Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3), Autosomal recessive
chr7	IQCE	617631.0 | IQCE, KIAA1023, PAPA7 | IQ domain-containing protein E | 23288.0 | ENSG00000106012 | nan | Polydactyly, postaxial, type A7, 617642 (3), Autosomal recessive
chr7	TTYH3	608919.0 | TTYH3, KIAA1691 | Tweety family member 3 | 80727.0 | ENSG00000136295 | nan | nan
chr7	AMZ1	615168.0 | AMZ1, KIAA1950 | Archaelysin family metallopeptidase 1 | 155185.0 | ENSG00000174945 | nan | nan
chr7	GNA12	604394.0 | GNA12 | Guanine nucleotide-binding protein, alpha-12 | 2768.0 | ENSG00000146535 | nan | nan
chr7	CARD11	607210.0 | CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A | Caspase recruitment domain-containing protein 11 | 84433.0 | ENSG00000198286 | nan | B-cell expansion with NFKB and T-cell anergy, 616452 (3), Autosomal dominant; Immunodeficiency 11B with atopic dermatitis, 617638 (3), Autosomal dominant; Immunodeficiency 11A, 615206 (3), Autosomal recessive
chr7	SDK1	607216.0 | SDK1 | Sidekick cell adhesion molecule 1 | 221935.0 | ENSG00000146555 | nan | nan
chr7	STBMS1	185100.0 | STBMS1 | Strabismus, susceptibility to, 1 | 100188805.0 | nan | max lod at marker 1911/1912 | {Strabismus, susceptibility to, 1}, 185100 (2)
chr7	FOXK1	616302.0 | FOXK1, MNF | Forkhead box K1 | 221937.0 | ENSG00000164916 | nan | nan
chr7	AP5Z1	613653.0 | AP5Z1, KIAA0415, SPG48 | Adaptor-related protein complex 5, zeta-1 subunit | 9907.0 | ENSG00000242802 | nan | Spastic paraplegia 48, autosomal recessive, 613647 (3), Autosomal recessive
chr7	RADIL	611491.0 | RADIL, KIAA1849 | RAP GTPase interactor | 55698.0 | ENSG00000157927 | nan | nan
chr7	PAPOLB	607436.0 | PAPOLB, TPAP | Poly(A) polymerase, beta | 56903.0 | ENSG00000218823 | nan | nan
chr7	MMD2	614581.0 | MMD2, PAQR10 | Monocyte-to-macrophage differentiation-associated protein 2 | 221938.0 | ENSG00000136297 | nan | nan
chr7	RBAK	608191.0 | RBAK | RB-associated KRAB zinc finger | 57786.0 | ENSG00000146587 | nan | nan
chr7	WIPI2	609225.0 | WIPI2, IDDSSA | WD40 repeat protein interacting with phosphoinositides 2 | 26100.0 | ENSG00000157954 | mutation identified in 1 IDDSSA family | ?Intellectual developmental disorder with short stature and variable skeletal anomalies, 618453 (3), Autosomal recessive
chr7	SLC29A4	609149.0 | SLC29A4, PMAT, ENT4 | Solute carrier family 29 (monoamine transporter), member 4 | 222962.0 | ENSG00000164638 | nan | nan
chr7	TNRC18	620902.0 | TNRC18 | Trinucleotide repeat-containing gene 18 | 84629.0 | ENSG00000182095 | nan | nan
chr7	FBXL18	609084.0 | FBXL18, FBL18 | F-box and leucine-rich repeat protein 18 | 80028.0 | ENSG00000155034 | nan | nan
chr7	ACTB	102630.0 | ACTB, BRWS1, BNS, CSMH, DDS1, BRWS1, THC8 | Actin, beta | 60.0 | ENSG00000075624 | nan | Baraitser-Winter syndrome 1, 243310 (3), Autosomal dominant; Becker nevus, syndromic or isolated, somatic mosaic, 604919 (3); Thrombocytopenia 8, with dysmorphic features and developmental delay, 620475 (3), Autosomal dominant; Dystonia-deafness syndrome 1, 607371 (3), Autosomal dominant; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic, 620479 (3)
chr7	FSCN1	602689.0 | FSCN1, SNL | Fascin homolog 1, actin-bundling protein (singed, Drosophila, homolog-like) | 6624.0 | ENSG00000075618 | nan | nan
chr7	RNF216	609948.0 | RNF216, TRIAD3, ZIN, CAHH | RING finger protein 216 | 54476.0 | ENSG00000011275 | nan | Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3), Autosomal recessive
chr7	OCM	164795.0 | OCM | Oncomodulin | 654231.0 | ENSG00000122543 | nan | nan
chr7	CCZ1	620660.0 | CCZ1, C7orf28A | CCZ1 homolog, vacuolar protein trafficking- and biogenesis-associated protein | 51622.0 | ENSG00000122674 | nan | nan
chr7	PMS2	600259.0 | PMS2, PMSL2, HNPCC4, LYNCH4 | PMS1 homolog 2, mismatch repair system component | 5395.0 | ENSG00000122512 | nan | Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive
chr7	AIMP2	600859.0 | AIMP2, JTV1, HLD17 | Aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 | 7965.0 | ENSG00000106305 | nan | Leukodystrophy, hypomyelinating, 17, 618006 (3), Autosomal recessive
chr7	EIF2AK1	613635.0 | EIF2AK1, HRI, LEMSPAD | Eukaryotic translation initiation factor 2-alpha kinase 1 | 27102.0 | ENSG00000086232 | mutation identified in 1 LEMSPAD patient | ?Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome, 618878 (3), Autosomal dominant
chr7	USP42	620946.0 | USP42 | Ubiquitin-specific peptidase 42 | 84132.0 | ENSG00000106346 | nan | nan
chr7	CYTH3	605081.0 | CYTH3, PSCD3, ARNO3, GRP1 | Cytohesin 3 | 9265.0 | ENSG00000008256 | nan | nan
chr7	FAM220A	616628.0 | FAM220A, SIPAR, ACPIN1, C7orf70 | Family with sequence similarity 220, member A | 84792.0 | ENSG00000178397 | nan | nan
chr7	RAC1	602048.0 | RAC1, MRD48 | Rac family small GTPase 1 | 5879.0 | ENSG00000136238 | nan | Intellectual developmental disorder, autosomal dominant 48, 617751 (3), Autosomal dominant
chr7	DAGLB	614016.0 | DAGLB | Diacylglycerol lipase, beta | 221955.0 | ENSG00000164535 | nan | nan
chr7	KDELR2	609024.0 | KDELR2, ELP1, OI21 | KDEL endoplasmic reticulum protein retention receptor 2 | 11014.0 | ENSG00000136240 | nan | Osteogenesis imperfecta, type XXI, 619131 (3), Autosomal recessive
chr7	GRID2IP	610639.0 | GRID2IP1 | GRID2-interacting protein 1 | 392862.0 | ENSG00000215045 | nan | nan
chr7	ZNF12	194536.0 | ZNF12 | Zinc finger protein-12 (KOX3) | 7559.0 | ENSG00000164631 | nan | nan
chr7	C1GALT1	610555.0 | C1GALT1 | Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 | 56913.0 | ENSG00000106392 | nan | nan
chr7		616986.0 | LOC105375159 | Long intergenic noncoding RNA AC011288.2 | nan | nan | nan | nan
chr7	CYMD	153880.0 | MDDC | Macular dystrophy, dominant cystoid | 1541.0 | nan | ?allelic to RP9 | Macular dystrophy, dominant cystoid, 153880 (2), Autosomal dominant
chr7	COL28A1	609996.0 | COL28A1 | Collagen, type XXVIII, alpha-1 polypeptide | 340267.0 | ENSG00000215018 | nan | nan
chr7	MIOS	615359.0 | MIOS | Missing oocyte/meiosis regulator, Drosophila, homolog of | 54468.0 | ENSG00000164654 | nan | nan
chr7	RPA3	179837.0 | RPA3 | Replication protein A3, 14kD | 6119.0 | ENSG00000106399 | nan | nan
chr7	GLCCI1	614283.0 | GLCCI1, TSSN1, GCTR | Glucocorticoid-induced transcript 1 | 113263.0 | ENSG00000106415 | nan | {Glucocorticoid therapy, response to}, 614400 (3)
chr7	ICA1	147625.0 | ICA1 | Islet cell autoantigen 1, 69kD | 3382.0 | ENSG00000003147 | nan | nan
chr7	NXPH1	604639.0 | NXPH1, NPH1 | Neurexophilin 1 | 30010.0 | ENSG00000122584 | nan | nan
chr7	NDUFA4	603833.0 | COXFA4, NDUFA4, MC4DN21 | Cytochrome c oxidase subunit FA4 | 4697.0 | ENSG00000189043 | mutation identified in 1 MC4DN21 family | ?Mitochondrial complex IV deficiency, nuclear type 21, 619065 (3), Autosomal recessive
chr7	PHF14	619907.0 | PHF14, KIAA0783 | PHD finger protein 14 | 9678.0 | ENSG00000106443 | nan | nan
chr7	THSD7A	612249.0 | THSD7A, KIAA0960 | Thrombospondin type-1 domain-containing protein 7A | 221981.0 | ENSG00000005108 | nan | nan
chr7	TMEM106B	613413.0 | TMEM106B, HLD16 | Transmembrane protein 106B | 54664.0 | ENSG00000106460 | nan | Leukodystrophy, hypomyelinating, 16, 617964 (3), Autosomal dominant
chr7	SCIN	613416.0 | SCIN, KIAA1905 | Scinderin | 85477.0 | ENSG00000006747 | nan | nan
chr7	ARL4A	604786.0 | ARL4A, ARL4 | ADP ribosylation factor-like GTPase 4A | 10124.0 | ENSG00000122644 | nan | nan
chr7	EDSS2	613576.0 | EDSS2 | Ectodermal dysplasia-syndactyly syndrome 2 | 100505394.0 | nan | between D7S488 and D7S817 | Ectodermal dysplasia-syndactyly syndrome 2, 613576 (2), Autosomal recessive
chr7	FGQTL4	613462.0 | FGQTL4 | Fasting plasma glucose level QTL 4 | 100499169.0 | nan | associated with rs2191349 | [Fasting plasma glucose level QTL 4], 613462 (2)
chr7	ETV1	600541.0 | ETV1 | ETS variant transcription factor 1 | 2115.0 | ENSG00000006468 | fused with EWS in some Ewing sarcoma | nan
chr7	DGKB	604070.0 | DGKB, DGK, KIAA0718 | Diacylglycerol kinase, beta, 90kD | 1607.0 | ENSG00000136267 | nan | nan
chr7	AGMO	613738.0 | AGMO, TMEM195 | Alkylglycerol monooxygenase | 392636.0 | ENSG00000187546 | nan | nan
chr7	MEOX2	600535.0 | MEOX2 | Mesenchyme homeobox 2 | 4223.0 | ENSG00000106511 | nan | nan
chr7	CRPPA	614631.0 | CRPPA, ISPD, MDDGA7, MDDGC7, LGMDR20 | CDP-L-ribitol pyrophosphorylase A | 729920.0 | ENSG00000214960 | nan | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3), Autosomal recessive
chr7	SOSTDC1	609675.0 | SOSTDC1, ECTODIN, USAG1 | Sclerostin domain-containing protein 1 | 25928.0 | ENSG00000171243 | nan | nan
chr7	BZW2	619275.0 | BZW2, 5MP1 | Basic leucine zipper domain- and W2 domain-containing protein 2 | 28969.0 | ENSG00000136261 | nan | nan
chr7	TSPAN13	613139.0 | TSPAN13, NET6 | Tetraspanin 13 | 27075.0 | ENSG00000106537 | nan | nan
chr7	AGR2	606358.0 | AGR2, AG2, RIFTD | Anterior gradient 2, protein disulphide isomerase family member | 10551.0 | ENSG00000106541 | nan | Respiratory infections, recurrent, and failure to thrive with or without diarrhea, 620233 (3), Autosomal recessive
chr7	AGR3	609482.0 | AGR3, BCMP11 | Anterior gradient 3, Xenopus, homolog of | 155465.0 | ENSG00000173467 | nan | nan
chr7	AHR	600253.0 | AHR, RP85, FVH3 | Aryl hydrocarbon receptor | 196.0 | ENSG00000106546 | mutation identified in 1 RP85 family | Foveal hypoplasia 3, 620958 (3), Autosomal recessive; ?Retinitis pigmentosa 85, 618345 (3), Autosomal recessive
chr7	SNX13	606589.0 | SNX13, KIAA0713 | Sorting nexin 13 | 23161.0 | ENSG00000071189 | nan | nan
chr7	PRPS1L1	611566.0 | PRPS1L1, PRPS3 | Phosphoribosylpyrophosphate synthetase 1-like 1 | 221823.0 | ENSG00000229937 | nan | nan
chr7	HDAC9	606543.0 | HDAC9, MITR, HDAC7B, KIAA0744, ARCND4 | Histone deacetylase 9 | 9734.0 | ENSG00000048052 | mutation identified in 1 ARCND4 family | ?Auriculocondylar syndrome 4, 620457 (3), Autosomal dominant
chr7	TWIST1	601622.0 | TWIST1, ACS3, SCS, CRS1, SWCOS | TWIST, Drosophila, homolog of, 1 | 7291.0 | ENSG00000122691 | nan | Craniosynostosis 1, 123100 (3), Autosomal dominant; Robinow-Sorauf syndrome, 180750 (3), Autosomal dominant; Sweeney-Cox syndrome, 617746 (3), Autosomal dominant; Saethre-Chotzen syndrome with or without eyelid anomalies, 101400 (3), Autosomal dominant
chr7	FERD3L	617578.0 | FERD3L, NTWIST, NATO3, PTFB | FER3-like bHLH transcription factor | 222894.0 | ENSG00000146618 | nan | nan
chr7	POLR1F	608312.0 | POLR1F, TWISTNB | Polymerase I, RNA, subunit F | 221830.0 | ENSG00000105849 | pseudogene on 6q14.3 | nan
chr7	MACC1	612646.0 | MACC1 | MET transcriptional regulator MACC1 | 346389.0 | ENSG00000183742 | nan | nan
chr7	ITGB8	604160.0 | ITGB8 | Integrin, beta-8 | 3696.0 | ENSG00000105855 | nan | nan
chr7	ABCB5	611785.0 | ABCB5 | ATP-binding cassette, subfamily B, member 5 | 340273.0 | ENSG00000004846 | nan | nan
chr7	SP8	608306.0 | SP8, BTD | Transcription factor Sp8 | 221833.0 | ENSG00000164651 | nan | nan
chr7	FGQTL2	613219.0 | FGQTL2, BWQTL1 | Fasting plasma glucose level QTL 2; Birth weight QTL 1 | 100379216.0 | nan | associated with rs4607517 | [Fasting plasma glucose level QTL 2], 613219 (2); [Birth weight QTL 1], 613219 (2)
chr7		164865.0 | MYCLK1 | Avian myelocytomatosis viral (v-myc) oncogene homolog like 1 | nan | nan | nan | nan
chr7	MYP17	608367.0 | MYP17, MYP4 | Myopia 17 | 100359401.0 | nan | previously assigned to 7q36 (MYP4) | Myopia 17, 608367 (2), Autosomal dominant
chr7	STQTL17	612737.0 | STQTL17 | Stature quantitative trait locus 17 | 100301526.0 | nan | associated with rs1635852 and rs849140 | {Stature QTL 17}, 612737 (2)
chr7	SP4	600540.0 | SP4 | Sp4 transcription factor | 6671.0 | ENSG00000105866 | nan | nan
chr7	DNAH11	603339.0 | DNAH11, DNAHC11, CILD7, DNAHBL | Dynein, axonemal, heavy chain-11 | 8701.0 | ENSG00000105877 | nan | Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3), Autosomal recessive
chr7	CDCA7L	609685.0 | CDCA7L, R1, JPO2 | Cell division cycle-associated protein 7-like | 55536.0 | ENSG00000164649 | nan | nan
chr7	RAPGEF5	609527.0 | RAPGEF5, GFR, MRGEF, KIAA0277 | RAP guanine nucleotide exchange factor 5 | 9771.0 | ENSG00000136237 | nan | nan
chr7	IL6	147620.0 | IL6, IFNB2, BSF2, HSF, HGF | Interleukin-6 (interferon, beta-2) | 3569.0 | ENSG00000136244 | nan | {Type 2 diabetes mellitus}, 125853 (3), Autosomal dominant; {Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3), Somatic mutation; {Type 1 diabetes mellitus}, 222100 (3), Autosomal recessive; {Kaposi sarcoma in HIV+, susceptibility to}, 148000 (3), Autosomal dominant; {Crohn disease-associated growth failure}, 266600 (3), Multifactorial
chr7	TOMM7	607980.0 | TOMM7, GMPGS | Translocase of outer mitochondrial membrane 7 | 54543.0 | ENSG00000196683 | nan | Garg-Mishra progeroid syndrome, 620601 (3), Autosomal recessive
chr7	HYCC1	610531.0 | HYCC1, FAM126A, DRCTNNB1A, HLD5 | Hyccin, PI4KA lipid kinase complex, subunit 1 | 84668.0 | ENSG00000122591 | nan | Leukodystrophy, hypomyelinating, 5, 610532 (3), Autosomal recessive
chr7	KLHL7	611119.0 | KLHL7, RP42, PERCHING | Kelch-like 7 | 55975.0 | ENSG00000122550 | nan | Retinitis pigmentosa 42, 612943 (3), Autosomal dominant; PERCHING syndrome, 617055 (3), Autosomal recessive
chr7	NUP42	619998.0 | NUP42, NLP1, UIP1 | Nucleoporin 42 | 11097.0 | ENSG00000136243 | nan | nan
chr7	GPNMB	604368.0 | GPNMB, PLCA3 | Glycoprotein NMB | 10457.0 | ENSG00000136235 | nan | Amyloidosis, primary localized cutaneous, 3, 617920 (3), Autosomal recessive
chr7	MALSU1	614624.0 | MALSU1, C7orf30 | Mitochondrial assembly of ribosomal large subunit 1 | 115416.0 | ENSG00000156928 | nan | nan
chr7	IGF2BP3	608259.0 | IGF2BP3, IMP3, KOC1, VICKZ3 | Insulin-like growth factor 2 mRNA-binding protein 3 | 10643.0 | ENSG00000136231 | nan | nan
chr7	TRA2A	602718.0 | TRA2A | Transformer 2 alpha homolog | 29896.0 | ENSG00000164548 | nan | nan
chr7	STK31	605790.0 | STK31 | Serine/threonine kinase 31 | 56164.0 | ENSG00000196335 | nan | nan
chr7	NPY	162640.0 | NPY | Neuropeptide Y | 4852.0 | ENSG00000122585 | nan | nan
chr7	PALS2	606959.0 | MPP6, VAM1, PALS2 | Membrane protein, palmitoylated 6 | 51678.0 | ENSG00000105926 | nan | nan
chr7	GSDME	608798.0 | GSDME, DFNA5 | Gasdermin E | 1687.0 | ENSG00000105928 | nan | Deafness, autosomal dominant 5, 600994 (3), Autosomal dominant
chr7	OSBPL3	606732.0 | OSBPL3, ORP3, KIAA0704 | Oxysterol-binding protein-like protein 3 | 26031.0 | ENSG00000070882 | nan | nan
chr7	CYCS	123970.0 | CYCS, CYC, THC4 | Cytochrome C, somatic | 54205.0 | ENSG00000172115 | nan | Thrombocytopenia 4, 612004 (3), Autosomal dominant
chr7	SPMIP4	616071.0 | C7orf31 | Chromosome 7 open reading frame 31 | 136895.0 | ENSG00000153790 | nan | nan
chr7	NPVF	616984.0 | NPVF, RFRP, C7orf9 | Neuropeptide VF precursor | 64111.0 | ENSG00000105954 | nan | nan
chr7	MIR148A	613786.0 | MIR148A, MIRN148A | Micro RNA 148A | 406940.0 | ENSG00000199085 | nan | nan
chr7	NFE2L3	604135.0 | NFE2L3, NRF3 | Nuclear factor erythroid 2-like 3 | 9603.0 | ENSG00000050344 | nan | nan
chr7	HNRNPA2B1	600124.0 | HNRPA2B1, IBMPFD2, OPMD2 | Heterogeneous nuclear ribonucleoprotein A2/B1 | 3181.0 | ENSG00000122566 | mutation identified in 1 IBMPFD2 family | Oculopharyngeal muscular dystrophy 2, 620460 (3), Autosomal dominant; ?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, 615422 (3), Autosomal dominant
chr7	CBX3	604477.0 | CBX3 | Chromobox homolog 3 | 11335.0 | ENSG00000122565 | nan | nan
chr7	SNX10	614780.0 | SNX10, OPTB8 | Sorting nexin 10 | 29887.0 | ENSG00000086300 | nan | Osteopetrosis, autosomal recessive 8, 615085 (3), Autosomal recessive
chr7	SKAP2	605215.0 | SKAP2, SCAP2, SKAP55R | src kinase associated phosphoprotein 2 | 8935.0 | ENSG00000005020 | nan | nan
chr7	HOXA1	142955.0 | HOXA1, HOX1F, BSAS | Homeobox A1 | 3198.0 | ENSG00000105991 | nan | Bosley-Salih-Alorainy syndrome, 601536 (3), Autosomal recessive; Athabaskan brainstem dysgenesis syndrome, 601536 (3), Autosomal recessive
chr7	HOXA2	604685.0 | HOXA2, MCOHI | Homeobox A2 | 3199.0 | ENSG00000105996 | mutation identified in 1 MCOHICP family | Microtia with or without hearing impairment (AD), 612290 (3), Autosomal recessive, Autosomal dominant; ?Microtia, hearing impairment, and cleft palate (AR), 612290 (3), Autosomal recessive, Autosomal dominant
chr7	HOXA3	142954.0 | HOXA3, HOX1E | Homeobox-A3 | 3200.0 | ENSG00000105997 | homolog of Drosophila zen1, zen2 | nan
chr7	HOXA-AS2	616068.0 | HOXAAS2 | HOXA cluster antisense RNA 2 | 285943.0 | nan | nan | nan
chr7	HOXA4	142953.0 | HOXA4, HOX1D | Homeobox-A4 | 3201.0 | ENSG00000197576 | homolog of Drosophila Dfd | nan
chr7	HOXA-AS3	618706.0 | HOXAAS3 | HOXA cluster antisense RNA 3, noncoding | 100133311.0 | ENSG00000254369 | nan | nan
chr7	HOXA5	142952.0 | HOXA5, HOX1C | Homeobox A5 | 3202.0 | ENSG00000106004 | nan | nan
chr7	HOXA6	142951.0 | HOXA6, HOX1B | Homeobox A6 | 3203.0 | ENSG00000106006 | nan | nan
chr7	HOXA7	142950.0 | HOXA7, HOX1A | Homeobox A7 | 3204.0 | ENSG00000122592 | homolog of Drosophila Antp | nan
chr7	HOXA9	142956.0 | HOXA9, HOX1G | Homeobox A9 | 3205.0 | ENSG00000078399 | homolog of Drosophila Abd-B; fused to NUP98 in myeloid leukemia | nan
chr7	MIR196B	609688.0 | MIR196B, MIRN196B | Micro RNA 196B | 442920.0 | ENSG00000283745 | nan | nan
chr7	HOXA10	142957.0 | HOXA10, HOX1H | Homeobox A10 | 3206.0 | ENSG00000253293 | nan | nan
chr7	HOXA11	142958.0 | HOXA11, HOX1I, RUSAT1 | Homeobox A11 | 3207.0 | ENSG00000005073 | nan | Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3), Autosomal dominant
chr7	HOXA11-AS	607530.0 | HOXA11AS | Homeobox A11, antisense | 221883.0 | ENSG00000240990 | nan | nan
chr7	HOXA13	142959.0 | HOXA13, HOX1J | Homeobox A13 | 3209.0 | ENSG00000106031 | mutation identified in 1 GTMS family | Hand-foot-genital syndrome, 140000 (3), Autosomal dominant; ?Guttmacher syndrome, 176305 (3), Autosomal dominant
chr7	HOTTIP	614060.0 | HOTTIP, NCRNA00213 | HOXA distal transcript antisense RNA | 100316868.0 | nan | nan | nan
chr7	EVX1	142996.0 | EVX1 | Even-skipped homeobox 1 | 2128.0 | ENSG00000106038 | at 5' end of HOX1 cluster | nan
chr7	HIBADH	608475.0 | HIBADH | 3-hydroxyisobutyrate dehydrogenase | 11112.0 | ENSG00000106049 | nan | nan
chr7	TAX1BP1	605326.0 | TAX1BP1, TXBP151 | TAX1-binding protein 1 | 8887.0 | ENSG00000106052 | nan | nan
chr7	JAZF1	606246.0 | JAZF1, TIP27 | JAZF zinc finger 1 | 221895.0 | ENSG00000153814 | fused with JJAZ1 | nan
chr7	CREB5	618262.0 | CREB5, CREBPA | cAMP response element-binding protein 5 | 9586.0 | ENSG00000146592 | nan | nan
chr7	HHT4	610655.0 | HHT4 | Telangiectasia, hereditary hemorrhagic, type 4 | 791087.0 | nan | between D7S2252 and D7S510 | Telangiectasia, hereditary hemorrhagic, type 4, 610655 (2), Autosomal dominant
chr7	TRIL	613356.0 | TRIL, KIAA0644 | TLR4 interactor with leucine-rich repeats | 9865.0 | ENSG00000255690 | nan | nan
chr7	CPVL	609780.0 | CPVL, HVLP | Carboxypeptidase, vitellogenic-like | 54504.0 | ENSG00000106066 | nan | nan
chr7	CHN2	602857.0 | CHN2, ARHGAP3, RHOGAP3 | Chimerin 2 (GTPase-activating protein, rho, 3) | 1124.0 | ENSG00000106069 | nan | nan
chr7	PRR15	618344.0 | PRR15 | Proline-rich protein 15 | 222171.0 | ENSG00000176532 | nan | nan
chr7	WIPF3	612432.0 | WIPF3, CR16 | WAS/WASL-interacting protein family, member 3 | 644150.0 | ENSG00000122574 | nan | nan
chr7	SCRN1	614965.0 | SCRN1, SES1, KIAA0193 | Secernin 1 | 9805.0 | ENSG00000136193 | nan | nan
chr7	FKBP14	614505.0 | FKBP14, EDSKSCL2 | FK506-binding protein 14 | 55033.0 | ENSG00000106080 | nan | Ehlers-Danlos syndrome, kyphoscoliotic type, 2, 614557 (3), Autosomal recessive
chr7	PLEKHA8	608639.0 | FAPP2 | Phosphatidylinositol 4-phosphate adaptor protein 2 | 84725.0 | ENSG00000106086 | nan | nan
chr7	MTURN	620491.0 | MTURN, C7orf41 | Maturin, neural protenitor differentiation regulator homolog | 222166.0 | ENSG00000180354 | nan | nan
chr7	ZNRF2	612061.0 | ZNRF2 | Zinc finger and ring finger protein 2 | 223082.0 | ENSG00000180233 | nan | nan
chr7	NOD1	605980.0 | NOD1, CARD4 | Nucleotide-binding oligomerization domain protein 1 | 10392.0 | ENSG00000106100 | nan | nan
chr7	GGCT	137170.0 | GGCT, GCTG, C7orf24 | Gamma-glutamylcyclotransferase | 79017.0 | ENSG00000006625 | nan | nan
chr7	GARS1	600287.0 | GARS1, GARS, SMAD1, CMT2D, HMND5, SMAJI | Glycyl-tRNA synthetase 1 | 2617.0 | ENSG00000106105 | nan | Spinal muscular atrophy, infantile, James type, 619042 (3), Autosomal dominant; Neuronopathy, distal hereditary motor, autosomal dominant 5, 600794 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2D, 601472 (3), Autosomal dominant
chr7	CRHR2	602034.0 | CRHR2, CRFR2 | Corticotropin releasing hormone receptor-2 | 1395.0 | ENSG00000106113 | nan | nan
chr7	INMT	604854.0 | INMT | Indolethylamine N-methyltransferase | 11185.0 | ENSG00000241644 | nan | nan
chr7	AQP1	107776.0 | AQP1, CHIP28, CO | Aquaporin-1 (channel-forming integral protein, 28kD) | 358.0 | ENSG00000240583 | nan | [Aquaporin-1 deficiency], 110450 (3); [Blood group, Colton], 110450 (3)
chr7	GHRHR	139191.0 | GHRHR, GHRFR, IGHD4 | Growth hormone releasing hormone receptor | 2692.0 | ENSG00000106128 | nan | Growth hormone deficiency, isolated, type IV, 618157 (3), Autosomal recessive
chr7	ADCYAP1R1	102981.0 | ADCYAP1R1, PACAPR | ADCYAP receptor, type I | 117.0 | ENSG00000078549 | nan | nan
chr7	NEUROD6	611513.0 | NEUROD6, ATOH2, MATH2 | Neurogenic differentiation 6 | 63974.0 | ENSG00000164600 | nan | nan
chr7	PDE1C	602987.0 | PDE1C, HCAM3, DFNA74 | Phosphodiesterase 1C | 5137.0 | ENSG00000154678 | mutation identified in 1 DFNA74 family | ?Deafness, autosomal dominant 74, 618140 (3), Autosomal dominant
chr7	PPP1R17	604088.0 | GSBS | G-substrate | 10842.0 | ENSG00000106341 | nan | {Hypercholesterolemia, susceptibility to}, 143890 (3), Autosomal recessive, Autosomal dominant
chr7	LSM5	607285.0 | LSM5 | LSM5 protein | 23658.0 | ENSG00000106355 | nan | nan
chr7	AVL9	612927.0 | AVL9, KIAA0241 | AVL9 cell migration-associated protein | 23080.0 | ENSG00000105778 | nan | nan
chr7	KBTBD2	619393.0 | KBTBD2 | Kelch repeat- and BTB domain-containing protein 2 | 25948.0 | ENSG00000170852 | nan | nan
chr7	FKBP9	616257.0 | FKBP9, FKBP60, FKBP63 | FK506-binding protein 9 | 11328.0 | ENSG00000122642 | nan | nan
chr7	NT5C3A	606224.0 | NT5C3A, NT5C3, UMPH1, PSN1, CNSHA8 | 5' nucleotidase, cytosolic IIIA (uridine 5' monophosphate hydrolase 1) | 51251.0 | ENSG00000122643 | pseudogenes on chr.4 and chr.7 | Anemia, congenital, nonspherocytic hemolytic, 8, 266120 (3), Autosomal recessive
chr7	RP9	607331.0 | RP9, PAP1 | RP9 pre-mRNA splicing factor | 6100.0 | ENSG00000164610 | mutation identified in 1 patient | ?Retinitis pigmentosa 9, 180104 (3), Autosomal dominant
chr7	BBS9	607968.0 | PTHB1, BBS9 | Parathyroid hormone-responsive B1 gene | 27241.0 | ENSG00000122507 | nan | Bardet-Biedl syndrome 9, 615986 (3), Autosomal recessive
chr7	BMPER	608699.0 | BMPER, CV2 | BMP binding endothelial regulator | 168667.0 | ENSG00000164619 | nan | Diaphanospondylodysostosis, 608022 (3), Autosomal recessive
chr7	NPSR1-AS1	608596.0 | NPSRAS1, AAA1 | NPSR1 antisenase RNA 1 | 404744.0 | ENSG00000197085 | nan | nan
chr7	NPSR1	608595.0 | NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2 | Neuropeptide S receptor 1 | 387129.0 | ENSG00000187258 | nan | {Asthma, susceptibility to, 2}, 608584 (3)
chr7	DPY19L1	613892.0 | DPY19L1, KIAA0877 | DPY19-like 1 | 23333.0 | ENSG00000173852 | nan | nan
chr7	TBX20	606061.0 | TBX20, ASD4 | T-box 20 | 57057.0 | ENSG00000164532 | nan | Atrial septal defect 4, 611363 (3)
chr7	HERPUD2	620829.0 | HERPUD2 | HERPUD family member 2 | 64224.0 | ENSG00000122557 | nan | nan
chr7	SEPTIN7	603151.0 | SEPT7, CDC10 | Septin 7 | 989.0 | ENSG00000122545 | nan | nan
chr7	EEPD1	617192.0 | EEPD1, KIAA1706 | Endonuclease/exonuclease/phosphatase family domain-containing protein 1 | 80820.0 | ENSG00000122547 | nan | nan
chr7	MATCAP2	619896.0 | MATCAP2, KIAA0895 | Microtubule-associated tyrosine carboxypeptidase 2 | 23366.0 | ENSG00000164542 | nan | nan
chr7	ANLN	616027.0 | ANLN, FSFS8 | Actin-binding protein anillin | 54443.0 | ENSG00000011426 | nan | Focal segmental glomerulosclerosis 8, 616032 (3), Autosomal dominant
chr7	AOAH	102593.0 | AOAH | Acyloxyacyl hydrolase (neutrophil) | 313.0 | ENSG00000136250 | nan | nan
chr7	ELMO1	606420.0 | ELMO1, CED12 | Engulfment and cell motility gene 1 | 9844.0 | ENSG00000155849 | nan | nan
chr7		615455.0 | TRGJ@ | T-cell receptor gamma chain joining gene cluster | nan | nan | nan | nan
chr7		615454.0 | TRGV@ | T-cell receptor gamma chain variable gene cluster | nan | nan | nan | nan
chr7	GPR141	609045.0 | GPR141, PGR13 | G protein -coupled receptor 141 | 353345.0 | ENSG00000187037 | nan | nan
chr7	NME8	607421.0 | NME8, TXNDC3, SPTRX2, CILD6 | NME/NM23 family member 8 | 51314.0 | ENSG00000086288 | mutation identified in 1 CILD6 patient | ?Ciliary dyskinesia, primary, 6, 610852 (3), Autosomal recessive
chr7	SFRP4	606570.0 | SFRP4, FRPHE, PYL | Secreted frizzled-related protein 4 | 6424.0 | ENSG00000106483 | nan | Pyle disease, 265900 (3), Autosomal recessive
chr7	EPDR1	619734.0 | EPDR1, UCC1, MERP1 | Ependymin-related protein 1 | 54749.0 | ENSG00000086289 | nan | nan
chr7	STARD3NL	611759.0 | STARD3NL, MENTHO | STARD3 N-terminal like | 83930.0 | ENSG00000010270 | nan | nan
chr7	TRGC2	615450.0 | TRGC2 | T-cell receptor gamma chain constant region 2 | 6967.0 | ENSG00000227191 | nan | nan
chr7		609642.0 | TARP | T-cell antigen receptor, gamma subunit, alternate reading frame protein | 445347.0 | ENSG00000289746 | nan | nan
chr7	TRGC1	186970.0 | TRGC1 | T-cell receptor gamma chain constant region 1 | 6966.0 | ENSG00000211689 | nan | nan
chr7	AMPH	600418.0 | AMPH | Amphiphysin | 273.0 | ENSG00000078053 | nan | nan
chr7	VPS41	605485.0 | VPS41, SCAR29 | VPS41 subunit of HOPS complex | 27072.0 | ENSG00000006715 | nan | Spinocerebellar ataxia, autosomal recessive 29, 619389 (3), Autosomal recessive
chr7	POU6F2	609062.0 | POU6F2, WTSL, WT5 | POU domain, class 6, transcription factor 2 | 11281.0 | ENSG00000106536 | nan | {Wilms tumor susceptibility-5}, 601583 (3), Somatic mutation, Autosomal dominant
chr7	RALA	179550.0 | RALA, HINCONS | RAS-like protooncogene A | 5898.0 | ENSG00000006451 | nan | Hiatt-Neu-Cooper neurodevelopmental syndrome, 619311 (3), Autosomal dominant
chr7	CDK13	603309.0 | CDK13, CDC2L5, CHED, CHDFIDD | Cyclin-dependent kinase 13 | 8621.0 | ENSG00000065883 | nan | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder, 617360 (3), Autosomal dominant
chr7	MPLKIP	609188.0 | MPLKIP, C7orf11, ABHS, TTDN1, TTD4 | M-phase specific PLK1 interacting protein | 136647.0 | ENSG00000168303 | nan | Trichothiodystrophy 4, nonphotosensitive, 234050 (3), Autosomal recessive
chr7	SUGCT	609187.0 | C7orf10, GA3 | Chromosome 7 open reading frame 10 | 79783.0 | ENSG00000175600 | nan | Glutaric aciduria III, 231690 (3), Autosomal recessive
chr7	INHBA	147290.0 | INHBA | Inhibin, beta-1 | 3624.0 | ENSG00000122641 | nan | nan
chr7	GLI3	165240.0 | GLI3, PAPA, PAPB | GLI-Kruppel family member GLI3 (oncogene GLI3) | 2737.0 | ENSG00000106571 | amplified in glioblastoma | Greig cephalopolysyndactyly syndrome, 175700 (3), Autosomal dominant; Polydactyly, postaxial, types A1 and B, 174200 (3), Autosomal dominant; Pallister-Hall syndrome, 146510 (3), Autosomal dominant; Polydactyly, preaxial, type IV, 174700 (3), Autosomal dominant
chr7	PSMA2	176842.0 | PSMA2, PSC2, HC3 | Proteasome (prosome, macropain) subunit, alpha type, 2 | 5683.0 | ENSG00000106588 | incorrectly assigned to 6q | nan
chr7	MRPL32	611839.0 | MRPL32 | Mitochondrial ribosomal protein L32 | 64983.0 | ENSG00000106591 | nan | nan
chr7	HECW1	610384.0 | HECW1, NEDL1, KIAA0322 | HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 1 | 23072.0 | ENSG00000002746 | nan | nan
chr7		619520.0 | SLERT | Box H/ACA small nucleolar RNA-ended long noncoding RNA that enhances pre-rRNA transcription | nan | nan | nan | nan
chr7		618905.0 | SRS2 | Silver-Russell syndrome | nan | nan | maternal uniparental disomy of chromosome 7; 7p13-p11.2 and 7q32 have been implicated | Silver-Russell syndrome 2, 618905 (4), Autosomal dominant
chr7	LUARIS	618172.0 | LUARIS, lncRNA32 | Long noncoding RNA upregulator of antiviral response interferon signaling | 100506895.0 | ENSG00000231638 | overlaps in antisense orientation with HECW1 gene | nan
chr7	STK17A	604726.0 | STK17A, DRAK1 | Serine/threonine protein kinase 17A | 9263.0 | ENSG00000164543 | nan | nan
chr7	COA1	614769.0 | COA1, C7orf44 | Cytochrome c oxidase assembly factor 1 homolog | 55744.0 | ENSG00000106603 | nan | nan
chr7	BLVRA	109750.0 | BLVRA | Biliverdin reductase A | 644.0 | ENSG00000106605 | nan | Hyperbiliverdinemia, 614156 (3), Autosomal recessive, Autosomal dominant
chr7	MRPS24	611986.0 | MRPS24 | Mitochondrial ribosomal protein S24 | 64951.0 | ENSG00000062582 | nan | nan
chr7	URGCP	610337.0 | URGCP, URG4 | Upregulator of cell proliferation | 55665.0 | ENSG00000106608 | nan | nan
chr7	SPDYE1	617623.0 | SPDYE1, SPDYB2L2, RINGO1 | Speedy/RINGO cell cycle regulator family, member E1 | 285955.0 | ENSG00000136206 | nan | nan
chr7	DBNL	610106.0 | DBNL, HIP55 | Drebrin-like | 28988.0 | ENSG00000136279 | nan | nan
chr7	PGAM2	612931.0 | PGAM2, PGAMM, GSD10 | Phosphoglycerate mutase, muscle form | 5224.0 | ENSG00000164708 | nan | Glycogen storage disease X, 261670 (3), Autosomal recessive
chr7	POLM	606344.0 | POLM | Polymerase, DNA, mu | 27434.0 | ENSG00000122678 | nan | nan
chr7	AEBP1	602981.0 | AEBP1, ACLP | AE-binding protein 1 | 165.0 | ENSG00000106624 | nan | Ehlers-Danlos syndrome, classic-like, 2, 618000 (3), Autosomal recessive
chr7	POLD2	600815.0 | POLD2 | Polymerase (DNA directed), delta 2, regulatory subunit, 50kD | 5425.0 | ENSG00000106628 | nan | nan
chr7	MYL7	613993.0 | MYL7, MYL2A, MLC2A, MYLC2A | Myosin, light chain 7, regulatory | 58498.0 | ENSG00000106631 | nan | nan
chr7	GCK	138079.0 | GCK, HHF3, PNDM1 | Glucokinase (hexokinase-4) | 2645.0 | ENSG00000106633 | proximal to TCRB | MODY, type II, 125851 (3), Autosomal dominant; Diabetes mellitus, permanent neonatal 1, 606176 (3), Autosomal recessive; Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3), Autosomal dominant; Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3), Autosomal dominant
chr7	YKT6	606209.0 | YKT6 | YKT6 v-SNARE homolog | 10652.0 | ENSG00000106636 | nan | nan
chr7	CAMK2B	607707.0 | CAMK2B, MRD54 | Calcium/calmodulin-dependent protein kinase II-beta | 816.0 | ENSG00000058404 | nan | Intellectual developmental disorder, autosomal dominant 54, 617799 (3), Autosomal dominant
chr7	NUDCD3	610296.0 | NUDCD3, KIAA1068, NUDCL | NUDC domain-containing protein 3 | 23386.0 | ENSG00000015676 | nan | nan
chr7	NPC1L1	608010.0 | NPC1L1, LDLCQ7 | NPC1-like intracellular cholesterol transporter 1 | 29881.0 | ENSG00000015520 | nan | [Ezetimibe, nonresponse to], 617966 (3); [Low density lipoprotein cholesterol level QTL 7], 617966 (3)
chr7	DDX56	608023.0 | DDX56, NOH61 | DEAD-box helicase 56 | 54606.0 | ENSG00000136271 | nan | nan
chr7	TMED4	612038.0 | TMED4 | Transmembrane p24 trafficking protein 4 | 222068.0 | ENSG00000158604 | nan | nan
chr7	OGDH	613022.0 | OGDH, OGDHD | Oxoglutarate dehydrogenase, lipoamide (alpha-ketoglutarate dehydrogenase) | 4967.0 | ENSG00000105953 | nan | Oxoglutarate dehydrogenase deficiency, 203740 (3), Autosomal recessive
chr7	ZMIZ2	611196.0 | ZMIZ2, KIAA1886, ZIMP7 | Zinc finger MIZ-domain containing 2 | 83637.0 | ENSG00000122515 | nan | nan
chr7	PPIA	123840.0 | PPIA | Peptidylprolyl isomerase A (cyclophilin A) | 5478.0 | ENSG00000196262 | nan | nan
chr7	H2AZ2	620008.0 | H2AZ2, H2AV, H2AFV | H2A.Z variant histone 2 | 94239.0 | ENSG00000105968 | nan | nan
chr7	PURB	608887.0 | PURB | Purine-rich element-binding protein B | 5814.0 | ENSG00000146676 | nan | nan
chr7	MYO1G	600642.0 | MYO1G, HA2, HLA-HA2 | Myosin IG | 64005.0 | ENSG00000136286 | nan | nan
chr7	CCM2	607929.0 | CCM2, C7orf22, MGC4067 | CCM2 scaffold protein | 83605.0 | ENSG00000136280 | nan | Cerebral cavernous malformations-2, 603284 (3), Autosomal dominant
chr7	NACAD	619419.0 | NACAD, KIAA0363 | NAC-alpha domain-containing protein | 23148.0 | ENSG00000136274 | nan | nan
chr7	TBRG4	611325.0 | TBRG4, KIAA0948, CPR2 | Transforming growth factor-beta regulator 4 | 9238.0 | ENSG00000136270 | nan | nan
chr7	SNORA5C	611335.0 | SNORA5C | Small nucleolar RNA, H/ACA box, 5C | 677796.0 | ENSG00000201772 | in intron 3 of TBRG4 | nan
chr7	RAMP3	605155.0 | RAMP3 | Receptor activity-modifying protein 3 | 10268.0 | ENSG00000122679 | nan | nan
chr7		147830.0 | TTIM1 | T-cell tumor invasion and metastasis-1 (invasion-metastasis of neoplasms, chromosome 7 determined) | nan | nan | nan | nan
chr7	ADCY1	103072.0 | ADCY1, DFNB44 | Adenylate cyclase-1, brain | 107.0 | ENSG00000164742 | mutation identified in 1 DFNB44 family | ?Deafness, autosomal recessive 44, 610154 (3), Autosomal recessive
chr7	SEPTIN7P2	611563.0 | SEPT13 | Septin 13 | 641977.0 | ENSG00000291207 | nan | nan
chr7	IGFBP1	146730.0 | IGFBP1 | Insulin-like growth factor-binding protein-1 | 3484.0 | ENSG00000146678 | nan | nan
chr7	IGFBP3	146732.0 | IGFBP3 | Insulin-like growth factor-binding protein-3 | 3486.0 | ENSG00000146674 | tail-to-tail 20kb from IGFBP1 | nan
chr7	TNS3	606825.0 | TNS3, TEM6 | Tensin 3 | 64759.0 | ENSG00000136205 | nan | nan
chr7	PKD1L1	609721.0 | PKD1L1, HTX8 | Polycystin 1L1 | 168507.0 | ENSG00000158683 | nan | Heterotaxy, visceral, 8, autosomal, 617205 (3), Autosomal recessive
chr7	HUS1	603760.0 | HUS1 | HUS1 checkpoint clamp component | 3364.0 | ENSG00000136273 | nan | nan
chr7	SUN3	618984.0 | SUN3, SUNC1 | SAD1 and UNC84 domain-containing protein 3 | 256979.0 | ENSG00000164744 | nan | nan
chr7	UPP1	191730.0 | UPP1, UP | Uridine phosphorylase 1 | 7378.0 | ENSG00000183696 | nan | nan
chr7	ABCA13	607807.0 | ABCA13 | ATP-binding cassette, subfamily A, member 13 | 154664.0 | ENSG00000179869 | nan | nan
chr7	ALL2	613067.0 | ALL2 | Leukemia, acute lymphoblastic, susceptibility to, 2 | 100310786.0 | nan | associated with rs11978267 | {Leukemia, acute lymphoblastic, susceptibility to, 2}, 613067 (2)
chr7	VWC2	611108.0 | VWC2, BRORIN | von Willebrand factor C domain-containing protein 2 | 375567.0 | ENSG00000188730 | nan | nan
chr7	ZPBP	608498.0 | ZPBP, SP38, SPGF66 | Zona pellucida-binding protein | 11055.0 | ENSG00000042813 | mutation identified in 1 SPGF66 patient | ?Spermatogenic failure 66, 619799 (3), Autosomal recessive
chr7	IKZF1	603023.0 | IKZF1, ZNFN1A1, IK1, LYF1, CVID13 | Ikaros family zinc finger 1 | 10320.0 | ENSG00000185811 | fused with BCL6 in DLBL | Immunodeficiency, common variable, 13, 616873 (3), Autosomal dominant
chr7	FIGNL1	615383.0 | FIGNL1 | Fidgetin-like protein 1 | 63979.0 | ENSG00000132436 | nan | nan
chr7	DDC	107930.0 | DDC | DOPA decarboxylase (aromatic L-amino acid decarboxylase) | 1644.0 | ENSG00000132437 | nan | Aromatic L-amino acid decarboxylase deficiency, 608643 (3), Autosomal recessive
chr7	CMH21	614676.0 | CMH21 | Cardiomyopathy, familial hypertrophic, 21 | 100909387.0 | nan | max lod at D7S669 | Cardiomyopathy, hypertrophic, 21, 614676 (2), Autosomal dominant
chr7	GRB10	601523.0 | GRB10, RSS | Growth factor receptor-bound protein-10 | 2887.0 | ENSG00000106070 | nan | nan
chr7	COBL	610317.0 | COBL, KIAA0633 | Cordon-bleu, mouse, homolog of | 23242.0 | ENSG00000106078 | nan | nan
chr7	HPC4	608658.0 | HPC4 | Prostate cancer, hereditary, 4 | 408260.0 | nan | nan | {Prostate cancer, susceptibility to, 4}, 608658 (2)
chr7	NYS3	608345.0 | NYS3 | Nystagmus 3, congenital, autosomal dominant | 4934.0 | nan | translocation t(7;15)(p11.2;q11.2) | Nystagmus 3, congenital, autosomal dominant, 608345 (2), Autosomal dominant
chr7	SEC61G	609215.0 | SEC61G | SEC61 translocon, gamma subunit | 23480.0 | ENSG00000132432 | nan | nan
chr7	EGFR	131550.0 | EGFR, NNCIS | Epidermal growth factor receptor | 1956.0 | ENSG00000146648 | same as oncogene ERBB | Neonatal nephrocutaneous inflammatory syndrome, 616069 (3), Autosomal recessive; Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Somatic mutation, Autosomal dominant; Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Somatic mutation, Autosomal dominant; {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Somatic mutation, Autosomal dominant
chr7	ELDR	618217.0 | ELDR, LINC01156, FABL | EGFR long noncoding downstream RNA | 102725541.0 | nan | nan | nan
chr7	LANCL2	612919.0 | LANCL2, TASP | LanC-like 2 | 55915.0 | ENSG00000132434 | nan | nan
chr7	VOPP1	611915.0 | VOPP1, ECOP, GASP | Vesicular, overexpressed in cancer, prosurvival protein 1 | 81552.0 | ENSG00000154978 | nan | nan
chr7	PSPHP1	604239.0 | PSPHP1, PSPHL, CO9 | Phosphoserine phosphatase pseudogene 1 | 8781.0 | ENSG00000226278 | nan | nan
chr7	SEPTIN14	612140.0 | SEPT14 | Septin 14 | 346288.0 | ENSG00000154997 | nan | nan
chr7	ZNF713	616181.0 | ZNF713 | Zinc finger protein 713 | 349075.0 | ENSG00000178665 | nan | nan
chr7	MRPS17	611980.0 | MRPS17 | Mitochondrial ribosomal protein S17 | 51373.0 | ENSG00000239789 | 9 pseudogenes | nan
chr7	NIPSNAP2	603004.0 | NIPSNAP2, GBAS | Nipsnap homolog 2 | 2631.0 | ENSG00000146729 | nan | nan
chr7	PSPH	172480.0 | PSPH, PSP, PSPHD | Phosphoserine phosphatase | 5723.0 | ENSG00000146733 | nan | Phosphoserine phosphatase deficiency, 614023 (3), Autosomal recessive
chr7	CCT6A	104613.0 | CCT6A, CCT6, HTR3, TCP20 | Chaperonin containing T-complex polypeptide 1, subunit 6A | 908.0 | ENSG00000146731 | nan | nan
chr7	SUMF2	607940.0 | SUMF2 | Sulfatase-modifying factor 2 | 25870.0 | ENSG00000129103 | nan | nan
chr7	PHKG1	172470.0 | PHKG1 | Phosphorylase kinase, gamma 1, muscle | 5260.0 | ENSG00000164776 | presumed pseudogene on 11 | nan
chr7	CHCHD2	616244.0 | CHCHD2, PARK22 | Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 | 51142.0 | ENSG00000106153 | nan | Parkinson disease 22, autosomal dominant, 616710 (3), Autosomal dominant
chr7	ZNF479	617444.0 | ZNF479, KR19 | Zinc finger protein 479 | 90827.0 | ENSG00000185177 | nan | nan
chr7	HRX	145290.0 | HRX | Hyperreflexia | 7974.0 | nan | linked to KEL | nan
chr7	ANIB1	105800.0 | ANIB1 | Aneurysm, intracranial berry, 1 | 116833.0 | nan | in or near ELN | Aneurysm, intracranial berry, 1, 105800 (2), Autosomal dominant
chr7	EEC1	129900.0 | EEC1 | Ectrodactyly, ectodermal dysplasia, cleft lip/palate, 1 | 1913.0 | nan | nan | ?EEC syndrome-1, 129900 (2), Autosomal dominant
chr7	EOE1	610247.0 | EOE1, EE | Esophagitis, eosinophilic, 1 | 100302511.0 | nan | associated with rs2302009 | {Esophagitis, eosinophilic, 1}, 610247 (2), Multifactorial
chr7	ZNF107	603989.0 | ZNF107 | Zinc finger protein-107 | 51427.0 | ENSG00000196247 | nan | nan
chr7	ZNF138	604080.0 | ZNF138 | Zinc finger protein-138 | 7697.0 | ENSG00000197008 | nan | nan
chr7	ZNF273	604756.0 | ZNF273, HZF9 | Zinc finger protein 273 | 10793.0 | ENSG00000198039 | nan | nan
chr7	ZNF117	194624.0 | ZNF117 | Zinc finger protein-117 | 51351.0 | ENSG00000152926 | nan | nan
chr7	ERV3-1	131170.0 | ERV3 | Endogenous retroviral sequence-3 (includes zinc finger protein H-plk) | 2086.0 | ENSG00000213462 | nan | nan
chr7	ZNF92	603974.0 | ZNF92 | Zinc finger protein-92 | 168374.0 | ENSG00000146757 | sequence aligns with sequence on 19p13.1-p12 | nan
chr7	VKORC1L1	608838.0 | VKORC1L1 | Vitamin K epoxide reductase complex, subunit 1-like 1 | 154807.0 | ENSG00000196715 | nan | nan
chr7	GUSB	611499.0 | GUSB, MPS7 | Glucuronidase, beta- | 2990.0 | ENSG00000169919 | nan | Mucopolysaccharidosis VII, 253220 (3), Autosomal recessive
chr7	ASL	608310.0 | ASL | Argininosuccinate lyase | 435.0 | ENSG00000126522 | nan | Argininosuccinic aciduria, 207900 (3), Autosomal recessive
chr7	CRCP	606121.0 | CRCP, CGRPRCP, RCP | CGRP receptor component | 27297.0 | ENSG00000241258 | nan | nan
chr7	TPST1	603125.0 | TPST1 | Tyrosylprotein sulfotransferase 1 | 8460.0 | ENSG00000169902 | nan | nan
chr7	KCTD7	611725.0 | KCTD7, EPM3, CLN14 | Potassium channel tetramerization domain containing 7 | 154881.0 | ENSG00000243335 | nan | Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3), Autosomal recessive
chr7	RABGEF1	609700.0 | RABGEF1, RABEX5 | RAB guanine nucleotide exchange factor 1 | 27342.0 | ENSG00000154710 | nan | nan
chr7	SBDS	607444.0 | SBDS, SDS | SBDS ribosome maturation factor | 51119.0 | ENSG00000126524 | nan | {Aplastic anemia, susceptibility to}, 609135 (3); Shwachman-Diamond syndrome 1, 260400 (3), Autosomal recessive
chr7	TYW1	611243.0 | TYW1 | tRNA yW-synthesizing protein 1 homolog | 55253.0 | ENSG00000198874 | nan | nan
chr7	AUTS2	607270.0 | KIAA0442, MRD26, AUTS2 | KIAA0442 gene | 26053.0 | ENSG00000158321 | translocation break at 7q11.2 | Intellectual developmental disorder, autosomal dominant 26, 615834 (3), Autosomal dominant
chr7	GALNT17	615137.0 | GALNACT17, GALNTL3, WBSCR17 | Polypeptide N-acetylgalactosaminyltransferase 17 | 64409.0 | ENSG00000185274 | nan | nan
chr7	CALN1	607176.0 | CALN1 | Calneuron 1 | 83698.0 | ENSG00000183166 | nan | nan
chr7		613729.0 | DEL7q11.23, C7DELq11.23 | Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb | nan | nan | contiguous gene deletion syndrome | Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb, 613729 (4)
chr7		609757.0 | DUP7q11.23, C7DUPq11.23 | Chromosome 7q11.23 duplication syndrome | nan | nan | nan | Chromosome 7q11.23 duplication syndrome, 609757 (4), Autosomal dominant
chr7		194050.0 | WBS, WMS, WS, DEL7q11, C7DELq11 | Williams-Beuren syndrome (chromosome 7q11.23 deletion syndrome) | nan | nan | contiguous gene syndrome | Williams-Beuren syndrome, 194050 (4), Autosomal dominant
chr7	POM121	615753.0 | POM121, POM121A, KIAA0618 | POM121 transmembrane nucleoporin | 9883.0 | ENSG00000196313 | nan | nan
chr7	TRIM74	612550.0 | TRIM74, TRIM50C | Tripartite motif-containing protein 74 | 378108.0 | ENSG00000155428 | nan | nan
chr7	NSUN5	615732.0 | NSUN5, WBSCR20, WBSCR20A | NOP2/SUN RNA methyltransferase family, member 5 | 55695.0 | ENSG00000130305 | nan | nan
chr7	TRIM50	612548.0 | TRIM50, TRIM50A | Tripartite motif-containing protein 50 | 135892.0 | ENSG00000146755 | nan | nan
chr7	FKBP6	604839.0 | FKBP6, SPGF77 | FK506-binding protein 6 | 8468.0 | ENSG00000077800 | nan | Spermatogenic failure 77, 620103 (3), Autosomal recessive
chr7	FZD9	601766.0 | FZD9, FZD3 | Frizzled class receptor 9 | 8326.0 | ENSG00000188763 | nan | nan
chr7	BAZ1B	605681.0 | BAZ1B, WSTF, WBSCR9 | Bromodomain adjacent to zinc finger domain, 1B | 9031.0 | ENSG00000009954 | nan | nan
chr7	BCL7B	605846.0 | BCL7B | BAF chromatin remodeling complex subunit BCL7B | 9275.0 | ENSG00000106635 | nan | nan
chr7	TBL2	605842.0 | TBL2 | Transducin-beta-like 2 | 26608.0 | ENSG00000106638 | nan | nan
chr7	MLXIPL	605678.0 | MLXIPL, WBSCR14, MONDOB, CHREBP | MLX interacting protein-like | 51085.0 | ENSG00000009950 | nan | nan
chr7	VPS37D	610039.0 | VPS37D, WBSCR24 | VPS37D subunit of ESCRT-I | 155382.0 | ENSG00000176428 | nan | nan
chr7	DNAJC30	618202.0 | DNAJC30, WBSCR18, LHONAR1, MC1DN38 | DNAJ/HSP40 homolog, subfamily C, member 30 | 84277.0 | ENSG00000176410 | nan | Leber-like hereditary optic neuropathy, autosomal recessive 1, 619382 (3), Autosomal recessive
chr7	BUD23	615733.0 | BUD23, WBSCR22, MERM1 | rRNA methyltransferase and ribosome maturation factor Bud23 | 114049.0 | ENSG00000071462 | nan | nan
chr7	STX1A	186590.0 | STX1A, STX1 | Syntaxin 1A, brain | 6804.0 | ENSG00000106089 | nan | nan
chr7	BICDL3P	612545.0 | WBSCR26 | Williams-Beuren syndrome chromosome region 26 | 171022.0 | nan | nan | nan
chr7	CLDN3	602910.0 | CLDN3, CPETR2 | Claudin-3 (Clostridium perfringens enterotoxin receptor 2) | 1365.0 | ENSG00000165215 | nan | nan
chr7	CLDN4	602909.0 | CLDN4, CPETR1, CPER | Claudin 4 | 1364.0 | ENSG00000189143 | nan | nan
chr7	METTL27	612546.0 | WBSCR27 | Williams-Beuren syndrome chromosome region 27 | 155368.0 | ENSG00000165171 | nan | nan
chr7	TMEM270	612547.0 | WBSCR28 | Williams-Beuren syndrome chromosome region 28 | 135886.0 | ENSG00000175877 | nan | nan
chr7	ELN	130160.0 | ELN, SVAS, ADCL1 | Elastin | 2006.0 | ENSG00000049540 | nan | Cutis laxa, autosomal dominant, 123700 (3), Autosomal dominant; Supravalvar aortic stenosis, 185500 (3), Autosomal dominant
chr7	LIMK1	601329.0 | LIMK1 | LIM domain kinase 1 | 3984.0 | ENSG00000106683 | nan | nan
chr7	EIF4H	603431.0 | EIF4H, WBSCR1, WSCR1 | Eukaryotic translation initiation factor 4H | 7458.0 | ENSG00000106682 | nan | nan
chr7	MIR590	615070.0 | MIR590 | Micro RNA 590 | 693175.0 | ENSG00000207741 | nan | nan
chr7	LAT2	605719.0 | LAT2, WBSCR5, LAB, NTAL | Linker for activation of T cells family, member 2 | 7462.0 | ENSG00000086730 | nan | nan
chr7	RFC2	600404.0 | RFC2 | Replication factor C2, 40kD (activator 1, 40kD) | 5982.0 | ENSG00000049541 | nan | nan
chr7	CLIP2	603432.0 | CLIP2, CYLN2, WBSCR4, WSCR4 | CAP-GLY domain-containing linker protein 2 | 7461.0 | ENSG00000106665 | ?neurodevelopmental defect of Williams syndrome | nan
chr7	GTF2IRD1	604318.0 | GTF2IRD1, GTF3, MUSTRD1, WBS | GTF21 repeat domain-containing protein 1 | 9569.0 | ENSG00000006704 | nan | nan
chr7	GTF2I	601679.0 | GTF2I, BAP135, WBS | General transcription factor II-I (BTK-associated protein, 135kD) | 2969.0 | ENSG00000263001 | nan | nan
chr7	NCF1	608512.0 | NCF1, CGD1 | Neutrophil cytosolic factor-1, 47kD | 653361.0 | ENSG00000158517 | nan | Chronic granulomatous disease 1, autosomal recessive, 233700 (3), Autosomal recessive
chr7	GTF2IRD2	608899.0 | GTF2IRD2 | GTF2I repeat domain-containing protein 2 | 84163.0 | ENSG00000196275 | nan | nan
chr7	CASTOR2	617033.0 | CASTOR2, GATSL2 | Cytosolic arginine sensor for mTORC1 subunit 2 | 729438.0 | ENSG00000274070 | nan | nan
chr7	RCC1L	620739.0 | RCC1L, WBSCR16 | RCC1-like protein | 81554.0 | ENSG00000274523 | nan | nan
chr7	GTF2IRD2B	608900.0 | GTF2IRD1B | GTF2I repeat domain-containing protein 2 | 389524.0 | ENSG00000174428 | nan | nan
chr7	TRIM73	612549.0 | TRIM73, TRIM50B | Tripartite motif-containing protein 73 | 375593.0 | ENSG00000178809 | nan | nan
chr7	POM121C	615754.0 | POM121C, POM121-2 | POM121 Transmembrane nucleoporin C | 100101267.0 | ENSG00000272391 | nan | nan
chr7	HIP1	601767.0 | HIP1 | Huntingtin interacting protein-1 | 3092.0 | ENSG00000127946 | nan | nan
chr7	CCL26	604697.0 | CCL26, SCYA26 | Chemokine, C-C motif, ligand 26 | 10344.0 | ENSG00000006606 | nan | nan
chr7	CCL24	602495.0 | CCL24, SCYA24, MPIF2 | Chemokine, C-C motif, ligand 24 | 6369.0 | ENSG00000106178 | nan | nan
chr7	RHBDD2	615203.0 | RHBDD2 | Rhomboid domain-containing protein 2 | 57414.0 | ENSG00000005486 | nan | nan
chr7	POR	124015.0 | POR | Cytochrome P450 oxidoreductase | 5447.0 | ENSG00000127948 | nan | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3), Autosomal recessive; Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)
chr7	TMEM120A	616550.0 | TMEM120A, TMPIT, NET29 | Transmembrane protein 120A | 83862.0 | ENSG00000189077 | nan | nan
chr7	STYXL1	616695.0 | STYXL1, MKSTYX, DUSP24 | Serine/threonine/tyrosine-interacting protein-like 1 | 51657.0 | ENSG00000127952 | nan | nan
chr7	MDH2	154100.0 | MDH2, DEE51 | Malate dehydrogenase 2 | 4191.0 | ENSG00000146701 | nan | Developmental and epileptic encephalopathy 51, 617339 (3), Autosomal recessive
chr7	HSPB1	602195.0 | HSPB1, HSP27, CMT2F, HMND3 | Heat-shock 27kD protein-1 | 3315.0 | ENSG00000106211 | nan | Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3), Autosomal dominant; Neuronopathy, distal hereditary motor, autosomal dominant 3, 608634 (3), Autosomal dominant
chr7	YWHAG	605356.0 | YWHAG, DEE56 | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma isoform | 7532.0 | ENSG00000170027 | nan | Developmental and epileptic encephalopathy 56, 617665 (3), Autosomal dominant
chr7	SSC4D	607639.0 | SSC4D, SRCRB4D | Scavenger receptor cysteine-rich family member with 4 domains | 136853.0 | ENSG00000146700 | nan | nan
chr7	ZP3	182889.0 | ZP3, ZP3A, ZP3B, OZEMA3 | Zona pellucida glycoprotein-3 (sperm receptor) | 7784.0 | ENSG00000188372 | nan | Oocyte/zygote/embryo maturation arrest 3, 617712 (3), Autosomal dominant
chr7	DTX2	613141.0 | DTX2, KIAA1528 | Deltex E3 ubiquitin ligase 2 | 113878.0 | ENSG00000091073 | nan | nan
chr7	UPK3B	611887.0 | UPK3B, UPIIIB, P35 | Uroplakin 3B | 105375355.0 | ENSG00000243566 | nan | nan
chr7	POMZP3	600587.0 | POMZP3 | POM121/ZP3 fusion protein | 22932.0 | ENSG00000146707 | nan | nan
chr7	CCDC146	619829.0 | CCDC146, KIAA1505, SPGF94 | Coiled-coil domain-containing protein 146 | 57639.0 | ENSG00000135205 | nan | Spermatogenic failure 94, 620850 (3), Autosomal recessive
chr7	FGL2	605351.0 | FGL2 | Fibrinogen-like 2 | 10875.0 | ENSG00000127951 | nan | nan
chr7	GSAP	613552.0 | GSAP, PION | Gamma-secretase-activating protein | 54103.0 | ENSG00000186088 | nan | nan
chr7	PTPN12	600079.0 | PTPN12, PTPG1 | Protein tyrosine phosphatase, nonreceptor-type, 12 | 5782.0 | ENSG00000127947 | nan | Colon cancer, somatic, 114500 (3)
chr7	APTR	616048.0 | APTR | Alu-mediated CDKN1A/p21 transcriptional regulator, noncoding | 100505854.0 | ENSG00000214293 | nan | nan
chr7	PHTF2	616785.0 | PHTF2 | Putative homeodomain transcription factor 2 | 57157.0 | ENSG00000006576 | nan | nan
chr7		608950.0 | MAGI2IT, PR47 | MAGI2 intronic transcript | nan | nan | nan | nan
chr7	MHS3	154276.0 | MHS3 | Malignant hyperthermia susceptibility 3 | 7977.0 | nan | ?mutation in CACNA2 | {Malignant hyperthermia susceptibility 3}, 154276 (2), Autosomal dominant
chr7	STQTL11	612223.0 | STQTL11 | Stature quantitative trait locus 11 | 100270795.0 | nan | associated with rs2282978 | {Stature QTL 11}, 612223 (2)
chr7	MAGI2	606382.0 | MAGI2, AIP1, KIAA0705, NPHS15 | Membrane-associated guanylate kinase, WW and PDZ domains-containing, 2 | 9863.0 | ENSG00000187391 | nan | Nephrotic syndrome, type 15, 617609 (3), Autosomal recessive
chr7	GNAI1	139310.0 | GNAI1, NEDHISB | Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-1 | 2770.0 | ENSG00000127955 | nan | Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities, 619854 (3), Autosomal dominant
chr7	GNAT3	139395.0 | GNAT3, GDCA | Guanine nucleotide-binding protein, alpha-transducing activity polypeptide 3 | 346562.0 | ENSG00000214415 | nan | nan
chr7	CD36	173510.0 | CD36, CHDS7, BDPLT10 | CD36 antigen (collagen type I) | 948.0 | ENSG00000135218 | nan | Platelet glycoprotein IV deficiency, 608404 (3), Autosomal recessive; {Coronary heart disease, susceptibility to, 7}, 610938 (3); {Malaria, cerebral, susceptibility to}, 611162 (3); {Malaria, cerebral, reduced risk of}, 611162 (3)
chr7	SEMA3C	602645.0 | SEMA3C | Semaphorin 3C | 10512.0 | ENSG00000075223 | nan | nan
chr7	HGF	142409.0 | HGF, DFNB39 | Hepatic growth factor | 3082.0 | ENSG00000019991 | nan | Deafness, autosomal recessive 39, 608265 (3), Autosomal recessive
chr7	CACNA2D1	114204.0 | CACNA2, CACNL2A, DEE110 | Calcium channel, voltage-dependent, L type, alpha 2/delta subunit | 781.0 | ENSG00000153956 | nan | Developmental and epileptic encephalopathy 110, 620149 (3), Autosomal recessive
chr7	PCLO	604918.0 | PCLO, PCH3 | Piccolo, mouse, homolog of | 27445.0 | ENSG00000186472 | mutation identified in 1 PCHD3 family | ?Pontocerebellar hypoplasia, type 3, 608027 (3), Autosomal recessive
chr7	SEMA3E	608166.0 | SEMA3E, SEMAH, KIAA0331 | Semaphorin 3E | 9723.0 | ENSG00000170381 | nan | nan
chr7	SEMA3A	603961.0 | SEMA3A, SEMAD, COLL1, HH16 | Semaphorin 3A | 10371.0 | ENSG00000075213 | nan | {Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3), Autosomal dominant
chr7	SEMA3D	609907.0 | SEMA3D | Semaphorin 3D | 223117.0 | ENSG00000153993 | nan | nan
chr7	GRM3	601115.0 | GRM3 | Glutamate receptor, metabotropic-3 | 2913.0 | ENSG00000198822 | nan | nan
chr7	ELAPOR2	614048.0 | ELAPOR2, KIAA1324L, EIG121L | Endosome-lysosome-associated apoptosis and autophagy regulator 2 | 222223.0 | ENSG00000164659 | nan | nan
chr7	DMTF1	608491.0 | DMTF1, DMP1 | Cyclin D-binding MYB-like transcription factor 1 | 9988.0 | ENSG00000135164 | nan | nan
chr7	TMEM243	616993.0 | TMEM243, C7orf23, MMTRAG | Transmembrane protein 243 | 79161.0 | ENSG00000135185 | nan | nan
chr7	TP53TG1	616403.0 | TP53TG1 | TP53 target gene 1 | 11257.0 | ENSG00000182165 | nan | nan
chr7	CROT	606090.0 | CROT, COT | Carnitine octanoyltransferase | 54677.0 | ENSG00000005469 | nan | nan
chr7	ABCB4	171060.0 | ABCB4, PGY3, MDR3, ICP3 | ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3) | 5244.0 | ENSG00000005471 | within 500kb of MDR1 | Gallbladder disease 1, 600803 (3), Autosomal recessive, Autosomal dominant; Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3), Autosomal recessive, Autosomal dominant; Cholestasis, progressive familial intrahepatic 3, 602347 (3), Autosomal recessive
chr7	ABCB1	171050.0 | ABCB1, PGY1, MDR1, IBD13, ENPAT | ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1) | 5243.0 | ENSG00000085563 | nan | Encephalopathy, acute transient, 620950 (3), Autosomal recessive; {Inflammatory bowel disease 13}, 612244 (3); {Colchicine resistance}, 120080 (3)
chr7	RUNDC3B	617295.0 | RUNDC3B, RPIP9 | RUN domain-containing protein 3B | 154661.0 | ENSG00000105784 | nan | nan
chr7	SLC25A40	610821.0 | SLC25A40 | Solute carrier family 25, member 40 | 55972.0 | ENSG00000075303 | nan | nan
chr7	DBF4	604281.0 | DBF4, ASK | DBF4 zinc finger | 10926.0 | ENSG00000006634 | nan | nan
chr7	ADAM22	603709.0 | ADAM22, DEE61 | ADAM metallopeptidase domain 22 | 53616.0 | ENSG00000008277 | nan | Developmental and epileptic encephalopathy 61, 617933 (3), Autosomal recessive
chr7	SRI	182520.0 | SRI, SCN | Sorcin (class 4 gene) | 6717.0 | ENSG00000075142 | nan | nan
chr7	STEAP4	611098.0 | STEAP4, STAMP2, TIARP | STEAP4 metalloreductase | 79689.0 | ENSG00000127954 | nan | nan
chr7	STEAP1	604415.0 | STEAP1 | STEAP family member 1 | 26872.0 | ENSG00000164647 | nan | nan
chr7	STEAP2	605094.0 | STEAP2, STAMP1, IPCA1, PCANAP1 | STEAP2 metalloreductase | 261729.0 | ENSG00000157214 | nan | nan
chr7	CFAP69	617949.0 | CFAP69, C7orf63, SPGF24 | Cilia- and flagella-associated protein 69 | 79846.0 | ENSG00000105792 | nan | Spermatogenic failure 24, 617959 (3), Autosomal recessive
chr7	GTPBP10	610920.0 | GTPBP10, OBGH2 | GTP-binding protein 10 | 85865.0 | ENSG00000105793 | nan | nan
chr7	CLDN12	611232.0 | CLKDN12 | Claudin 12 | 9069.0 | ENSG00000157224 | nan | nan
chr7	CDK14	610679.0 | CDK14, PFTK1, PFTAIRE1, KIAA0834 | Cyclin-dependent kinase 14 | 5218.0 | ENSG00000058091 | nan | nan
chr7	FZD1	603408.0 | FZD1 | Frizzled class receptor 1 | 8321.0 | ENSG00000157240 | nan | nan
chr7	MTERF1	602318.0 | MTERF | Transcription termination factor, mitochondrial | 7978.0 | ENSG00000127989 | nan | nan
chr7	AKAP9	604001.0 | AKAP9, YOTIAO, AKAP450, LQT11 | A-kinase anchor protein 9 | 10142.0 | ENSG00000127914 | mutation identified in 1 LQT11 family | ?Long QT syndrome 11, 611820 (3), Autosomal dominant
chr7	CYP51A1	601637.0 | CYP51A1, CYP51 | Cytochrome P450, family 51, subfamily A, polypeptide 1 (lanosterol 14-alpha-demethylase) | 1595.0 | ENSG00000001630 | nan | nan
chr7	KRIT1	604214.0 | KRIT1, CCM1, CAM | KRIT1 ankyrin repeat-containing protein 1 | 889.0 | ENSG00000001631 | nan | Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3), Autosomal dominant; Cerebral cavernous malformations-1, 116860 (3), Autosomal dominant; Cavernous malformations of CNS and retina, 116860 (3), Autosomal dominant
chr7	ANKIB1	620069.0 | ANKIB1, KIAA1386 | Ankyrin repeat- and IBR domain-containing protein 1 | 54467.0 | ENSG00000001629 | nan | nan
chr7	GATAD1	614518.0 | GATAD1, ODAG, CMD2B | GATA zinc finger domain-containing protein 1 | 57798.0 | ENSG00000157259 | mutation identified in 1 GATAD1 family | ?Cardiomyopathy, dilated, 2B, 614672 (3), Autosomal recessive
chr7	ERVW-1	604659.0 | ERVW1, ERVWE1, HERVW | Endogenous retroviral family W, member 1 (syncytin) | 30816.0 | ENSG00000242950 | nan | nan
chr7	PEX1	602136.0 | PEX1, ZWS1, PBD1A, PBD1B, HMLR1 | Peroxisome biogenesis factor-1 | 5189.0 | ENSG00000127980 | nan | Heimler syndrome 1, 234580 (3), Autosomal recessive; Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3), Autosomal recessive; Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3), Autosomal recessive
chr7	CDK6	603368.0 | CDK6, PLSTIRE, MCPH12 | Cyclin-dependent kinase 6 | 1021.0 | ENSG00000105810 | mutation identified in 1 MCPH12 family | ?Microcephaly 12, primary, autosomal recessive, 616080 (3), Autosomal recessive
chr7	SAMD9	610456.0 | SAMD9, NFTC, MIRAGE, M7MLS2 | Sterile alpha motif domain-containing protein 9 | 54809.0 | ENSG00000205413 | nan | Tumoral calcinosis, familial, normophosphatemic, 610455 (3), Autosomal recessive; Monosomy 7 myelodysplasia and leukemia syndrome 2, 619041 (3), Autosomal dominant; MIRAGE syndrome, 617053 (3), Autosomal dominant
chr7	SAMD9L	611170.0 | SAMD9L, ATXPC, M7MLS1, SCA49 | Sterile alpha motif domain-containing 9-like | 219285.0 | ENSG00000177409 | mutation identified in 1 SCA49 family | Ataxia-pancytopenia syndrome, 159550 (3), Autosomal dominant; ?Spinocerebellar ataxia 49, 619806 (3), Autosomal dominant; Monosomy 7 myelodysplasia and leukemia syndrome 1, 252270 (3), Autosomal dominant
chr7	HEPACAM2	614133.0 | HEPACAM2, MIKI | Hepacam family member 2 | 253012.0 | ENSG00000188175 | nan | nan
chr7	VPS50	616465.0 | VPS50, CCDC132, KIAA1861, NEDMSC | VPS50, EARP/GARPII complex subunit | 55610.0 | ENSG00000004766 | nan | Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis, 619685 (3), Autosomal recessive
chr7	CALCR	114131.0 | CALCR, CRT | Calcitonin receptor | 799.0 | ENSG00000004948 | not deleted in Williams syndrome | {Osteoporosis, postmenopausal, susceptibility}, 166710 (3), Autosomal dominant
chr7	MIR489	614523.0 | MIR489 | Micro RNA 489 | 574442.0 | ENSG00000207656 | in intron 4 of CALCR | nan
chr7	TFPI2	600033.0 | TFPI2 | Tissue factor pathway inhibitor-2 | 7980.0 | ENSG00000105825 | nan | nan
chr7	GNGT1	189970.0 | GNGT1 | Guanine nucleotide-binding protein, gamma-transducing activity polypeptide 1 | 2792.0 | ENSG00000127928 | nan | nan
chr7	GNG11	604390.0 | GNG11 | Guanine nucleotide-binding protein, gamma 11 | 2791.0 | ENSG00000127920 | nan | nan
chr7	BET1	605456.0 | BET1, MDRP | Bet1 golgi vesicular membrane-trafficking protein | 10282.0 | ENSG00000105829 | nan | Muscular dystrophy, congenital, with rapid progression, 254100 (3), Autosomal recessive
chr7	COL1A2	120160.0 | COL1A2, EDSCV, EDSARTH2 | Collagen I, alpha-2 polypeptide | 1278.0 | ENSG00000164692 | ~17cM from CF | Osteogenesis imperfecta, type III, 259420 (3), Autosomal dominant; {Osteoporosis, postmenopausal}, 166710 (3), Autosomal dominant; Ehlers-Danlos syndrome, arthrochalasia type, 2, 617821 (3), Autosomal dominant; Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2, 619120 (3), Autosomal dominant; Ehlers-Danlos syndrome, cardiac valvular type, 225320 (3), Autosomal recessive; Osteogenesis imperfecta, type IV, 166220 (3), Autosomal dominant; Osteogenesis imperfecta, type II, 166210 (3), Autosomal dominant
chr7	CASD1	611686.0 | CASD1, C7orf12 | CAS1 domain-containing protein 1 | 64921.0 | ENSG00000127995 | nan | nan
chr7	SGCE	604149.0 | SGCE, DYT11 | Sarcoglycan, epsilon | 8910.0 | ENSG00000127990 | pseudogene on 2q21; maternally imprinted | Dystonia-11, myoclonic, 159900 (3), Autosomal dominant
chr7	PEG10	609810.0 | PEG10, KIAA1051 | Paternally expressed gene 10 | 23089.0 | ENSG00000242265 | nan | nan
chr7	PPP1R9A	602468.0 | PPP1R9A, NRBI, NRB1, KIAA1222 | Protein phosphatase 1, regulatory subunit 9A (neurabin I) | 55607.0 | ENSG00000158528 | nan | nan
chr7	PON1	168820.0 | PON1, PON, ESA, MVCD5 | Paraoxonase-1 | 5444.0 | ENSG00000005421 | nan | {Coronary artery spasm 2, susceptibility to} (3); {Organophosphate poisoning, sensitivity to} (3); {Coronary artery disease, susceptibility to} (3); {Microvascular complications of diabetes 5}, 612633 (3)
chr7	PON3	602720.0 | PON3 | Paraoxonase-3 | 5446.0 | ENSG00000105852 | nan | nan
chr7	PON2	602447.0 | PON2 | Paraoxonase-2 | 5445.0 | ENSG00000105854 | nan | {Coronary artery disease, susceptibility to} (3)
chr7	ASB4	605761.0 | ASB4 | Ankyrin repeat-containing SOCS box protein 4 | 51666.0 | ENSG00000005981 | nan | nan
chr7	PDK4	602527.0 | PDK4 | Pyruvate dehydrogenase kinase, isoenzyme 4 | 5166.0 | ENSG00000004799 | nan | nan
chr7	DYNC1I1	603772.0 | DNCI1 | Dynein, cytoplasmic, intermediate chain 1 | 1780.0 | ENSG00000158560 | nan | nan
chr7	SLC25A13	603859.0 | SLC25A13, CTLN2, NICCD | Solute carrier family 25 (mitochondrial carrier, citrin), member 13 | 10165.0 | ENSG00000004864 | nan | Citrullinemia, type II, neonatal-onset, 605814 (3), Autosomal recessive; Citrullinemia, adult-onset type II, 603471 (3), Autosomal recessive
chr7	SEM1	601285.0 | SEM!, DSS1 | Proteasome 26S subunit SEM1 | 7979.0 | ENSG00000127922 | ?gene mutant in SHFM1 | nan
chr7	DLX6	600030.0 | DLX6 | Distal-less homeobox 6 | 1750.0 | ENSG00000006377 | nan | nan
chr7	DLX5	600028.0 | DLX5, SHFM1D, SHFM1 | Distal-less homeobox 5 | 1749.0 | ENSG00000105880 | mutation identified in 1 SHFM1D family | Split-hand/foot malformation 1, 183600 (3), Autosomal dominant; ?Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3), Autosomal recessive
chr7	SDHAF3	615773.0 | SDHAF3, ACN9 | Succinate dehydrogenase complex assembly factor 3 | 57001.0 | ENSG00000196636 | nan | nan
chr7	TAC1	162320.0 | TAC1, TAC2, NKNA | Tachykinin 1 (substance K; neurokinin A; neurokinin 2; neuromedin L; neuropeptide gamma; tachykinin 2) | 6863.0 | ENSG00000006128 | nan | nan
chr7	ASNS	108370.0 | ASNS, ASNSD | Asparagine synthetase | 440.0 | ENSG00000070669 | temperature sensitive G1 mutant | Asparagine synthetase deficiency, 615574 (3), Autosomal recessive
chr7	OCM2	620522.0 | OCM2 | Oncomodulin 2 | 4951.0 | ENSG00000135175 | nan | nan
chr7	LMTK2	610989.0 | LMTK2, KPI2, BREK, KIAA1079 | Lemur tyrosine kinase 2 | 22853.0 | ENSG00000164715 | nan | nan
chr7	BHLHA15	608606.0 | BHLHA15, MIST1 | Basic helix-loop-helix family, member A15 | 168620.0 | ENSG00000180535 | nan | nan
chr7	TECPR1	614781.0 | TECPR1, KIAA1358 | Tectonin beta-propeller repeat-containing 1 | 25851.0 | ENSG00000205356 | nan | nan
chr7	BRI3	615628.0 | BRI3 | Brain protein I3 | 25798.0 | ENSG00000164713 | nan | nan
chr7	BAIAP2L1	611877.0 | BAIAP2L1, IRTKS | BAI1-associated protein 2-like 1 | 55971.0 | ENSG00000006453 | nan | nan
chr7	AUTS1	209850.0 | AUTS1 | Autism, susceptibility to, 1 | 100188832.0 | nan | nan | {Autism susceptibility 1}, 209850 (2), Isolated cases, Multifactorial
chr7		148750.0 | G7P1 | Kinase-like protein | nan | nan | nan | nan
chr7		612130.0 | GAEC1 | Gene amplified in esophageal cancer 1 | 100126794.0 | nan | nan | nan
chr7	IBD11	191390.0 | IBD11 | Inflammatory bowel disease 11 | 100529151.0 | nan | associated with MUC3A | {Inflammatory bowel disease 11}, 191390 (2), Multifactorial
chr7	MUC3B	605633.0 | MUC3B | Mucin 3B, intestinal | 57876.0 | nan | nan | nan
chr7	MYH16	608580.0 | MYH16 | Myosin, heavy chain 16, skeletal muscle | 84176.0 | ENSG00000002079 | inactivated in humans; expressed in masticatory muscles in nonhuman primates | nan
chr7	PAPA4	608562.0 | PAPA4 | Polydactyly, postaxial, type A4 | 450096.0 | nan | highest lod with D7S1799 | Polydactyly, postaxial, type A4, 608562 (2)
chr7	SCA18	607458.0 | SCA18, SMNA | Spinal cerebellar ataxia 18 | 94008.0 | nan | between D7S2418 and D7S1804 | Spinocerebellar ataxia 18, 607458 (2), Autosomal dominant
chr7		617677.0 | ZASP | ZO2-associated speckle protein | nan | nan | nan | nan
chr7	NPTX2	600750.0 | NPTX2 | Neuronal pentraxin 2 | 4885.0 | ENSG00000106236 | nan | nan
chr7	TRRAP	603015.0 | TRRAP, DEDDFA, DFNA75 | Transformation/transcription domain-associated protein | 8295.0 | ENSG00000196367 | ?mutation identified in 1 DFNA75 family | ?Deafness, autosomal dominant 75, 618778 (3), Autosomal dominant; Developmental delay with or without dysmorphic facies and autism, 618454 (3), Autosomal dominant
chr7	SMURF1	605568.0 | SMURF1 | SMAD ubiquitination regulatory factor 1 | 57154.0 | ENSG00000198742 | nan | nan
chr7	KPNA7	614107.0 | KPNA7, OZEMA17 | Karyopherin alpha 7 | 402569.0 | ENSG00000185467 | nan | Oocyte/zygote/embryo maturation arrest 17, 620319 (3), Autosomal recessive
chr7	ARPC1A	604220.0 | ARPC1A, SOP2L | Actin-related protein 2/3 complex, subunit 1A | 10552.0 | ENSG00000241685 | nan | nan
chr7	ARPC1B	604223.0 | ARPC1B, ARC41, IMD71 | Actin-related protein 2/3 complex, subunit 1B | 10095.0 | ENSG00000130429 | nan | Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia, 617718 (3), Autosomal recessive
chr7	PDAP1	607075.0 | PDAP1, PAP1, PAP | PDGFA-associated protein 1 | 11333.0 | ENSG00000106244 | nan | nan
chr7	BUD31	603477.0 | BUD31, G10 | BUD31 homolog | 8896.0 | ENSG00000106245 | nan | nan
chr7	PTCD1	614774.0 | PTCD1, KIAA0632 | Pentatricopeptide repeat domain 1 | 26024.0 | ENSG00000106246 | nan | nan
chr7	CPSF4	603052.0 | CPSF4, CPSF30, NEB1 | Cleavage-polyadenylation specificity factor 4, 30kD | 10898.0 | ENSG00000160917 | nan | nan
chr7	ATP5MF	619792.0 | ATP5MF, ATP5JL, ATP5J2 | ATP synthase membrane subunit F | 9551.0 | ENSG00000241468 | nan | nan
chr7	ZNF394	619300.0 | ZNF394 | Zinc finger protein 394 | 84124.0 | ENSG00000160908 | nan | nan
chr7	ZKSCAN5	611272.0 | ZKSCAN5, ZFP95, KIAA1015 | Zinc finger protein with KRAB and SCAN domains 5 | 23660.0 | ENSG00000196652 | nan | nan
chr7	ZNF655	617891.0 | ZNF655, VIK | Zinc finger protein 655 | 79027.0 | ENSG00000197343 | nan | nan
chr7	CYP3A5	605325.0 | CYP3A5, P450PCN3 | Cytochrome P450, subfamily IIIA, polypeptide 5 | 1577.0 | ENSG00000106258 | nan | {Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3), Multifactorial
chr7	CYP3A7	605340.0 | CYP3A7 | Cytochrome P450, subfamily IIIA, polypeptide 7 | 1551.0 | ENSG00000160870 | nan | nan
chr7	CYP3A4	124010.0 | CYP3A4, VDDR3 | Cytochrome P450, subfamily IIIA (nifedipine oxidase) polypeptide 4 | 1576.0 | ENSG00000160868 | nan | Vitamin D-dependent rickets, type 3, 619073 (3), Autosomal dominant
chr7	CYP3A43	606534.0 | CYP3A43 | Cytochrome P450, subfamily IIIa, polypeptide 43 | 64816.0 | ENSG00000021461 | nan | nan
chr7	GJC3	611925.0 | GJC3, CX30.2, CX31.3 | Gap junction protein, gamma-3 | 349149.0 | ENSG00000176402 | nan | nan
chr7	AZGP1	194460.0 | AZGP1, ZAG | Alpha-2-glycoprotein, zinc | 563.0 | ENSG00000160862 | nan | nan
chr7	ZKSCAN1	601260.0 | ZNF36, KOX18 | Zinc finger protein-36 (KOX 18) | 7586.0 | ENSG00000106261 | nan | nan
chr7	ZSCAN21	601261.0 | ZNF38, KOX25 | Zinc finger protein-38 (KOX 25) | 7589.0 | ENSG00000166529 | nan | nan
chr7	ZNF3	194510.0 | ZNF3 | Zinc finger protein-3 | 7551.0 | ENSG00000166526 | ?relation to ZNF4, ZNF5; previous assignment to Chr.5 | nan
chr7	COPS6	614729.0 | COPS6, CSN6 | COP9 signalosome, subunit 6 | 10980.0 | ENSG00000168090 | nan | nan
chr7	MCM7	600592.0 | MCM7, MCM2 | Minichromosome maintenance complex component 7 | 4176.0 | ENSG00000166508 | nan | nan
chr7	MIR25	612150.0 | MIR25, MIRN25 | Micro RNA 25 | 407014.0 | ENSG00000207547 | nan | nan
chr7	MIR93	612984.0 | MIR93, MIRN9 | Micro RNA 93 | 407050.0 | ENSG00000207757 | nan | nan
chr7	MIR106B	612983.0 | MIR106B, MIRN106B | Micro RNA 106B | 406900.0 | ENSG00000208036 | nan | nan
chr7	AP4M1	602296.0 | AP4M1, SPG50, CPSQ3 | Adaptor-related protein complex 4, mu-1 subunit | 9179.0 | ENSG00000221838 | nan | Spastic paraplegia 50, autosomal recessive, 612936 (3), Autosomal recessive
chr7	TAF6	602955.0 | TAF6, TAF2E, TAFII80, ALYUS | TAF6 RNA polymerase II, TATA box-binding protein-associated factor, 80kD | 6878.0 | ENSG00000106290 | nan | Alazami-Yuan syndrome, 617126 (3), Autosomal recessive
chr7	CNPY4	610047.0 | CNPY4, PRAT4B, MGC40499 | Canopy 4, zebrafish, homolog of | 245812.0 | ENSG00000166997 | nan | nan
chr7	MBLAC1	620906.0 | MBLAC1 | Metallo-beta-lactamase domain-containing protein 1 | 255374.0 | ENSG00000214309 | nan | nan
chr7	LAMTOR4	618834.0 | LAMTOR4, C7orf59 | Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 4 | 389541.0 | ENSG00000188186 | nan | nan
chr7	TRAPPC14	618350.0 | MAP11, C7orf43, MCPH25 | Microtubule-associated protein 11 | 55262.0 | ENSG00000146826 | mutation identified in 1 MCHP25 family | ?Microcephaly 25, primary, autosomal recessive, 618351 (3), Autosomal recessive
chr7	GAL3ST4	608235.0 | GAL3ST4 | Galactose-3-O-sulfotransferase 4 | 79690.0 | ENSG00000197093 | nan | nan
chr7	GPC2	618446.0 | GPC2 | Glypican 2 | 221914.0 | ENSG00000213420 | nan | nan
chr7	STAG3	608489.0 | STAG3, POF8, SPGF61 | Stromalin 3 | 10734.0 | ENSG00000066923 | nan | Spermatogenic failure 61, 619672 (3), Autosomal recessive; Premature ovarian failure 8, 615723 (3), Autosomal recessive
chr7	PVRIG	617012.0 | PVRIG, CD112R, C7orf15 | Poliovirus receptor-related immunoglobulin domain-containing protein | 79037.0 | ENSG00000213413 | nan | nan
chr7	SPDYE3	617625.0 | SPDYE3, SPDYB2 | Speedy/RINGO cell cycle regulator family, member E3 | 441272.0 | ENSG00000214300 | nan | nan
chr7	PMS2P1	605038.0 | PMS2P1, PMS2L1, PMS3 | Postmeiotic segregation increased 2 pseudogene 1 | 5379.0 | ENSG00000291178 | nan | nan
chr7	PILRB	605342.0 | PILRB | Paired immunoglobulin-like receptor, beta | 29990.0 | ENSG00000121716 | nan | nan
chr7	PILRA	605341.0 | PILRA | Paired immunoglobulin-like receptor, alpha | 29992.0 | ENSG00000085514 | nan | nan
chr7	ZCWPW1	618900.0 | ZCWPW1 | Zinc finger CW-type domain- and PWWP domain-containing protein 1 | 55063.0 | ENSG00000078487 | nan | nan
chr7	MEPCE	611478.0 | MEPCE, BCDIN3 | Methylphosphate capping enzyme | 56257.0 | ENSG00000146834 | nan | nan
chr7	PPP1R35	618937.0 | PPP1R35, C7orf47 | Protein phosphatase 1, regulatory subunit 35 | 221908.0 | ENSG00000160813 | nan | nan
chr7	SPACDR	619782.0 | SPACDR, C7orf61 | Sperm acrosome developmental regulator | 402573.0 | ENSG00000185955 | nan | nan
chr7	TSC22D4	611914.0 | TSC22D4, THG1 | TSC22 domain family, member 4 | 81628.0 | ENSG00000166925 | nan | nan
chr7	NYAP1	615477.0 | NYPA1 | Neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 | 222950.0 | ENSG00000166924 | nan | nan
chr7	AGFG2	604019.0 | AGFG2, HRBL, RABR | ADP-ribosylation factor GTPase-activating protein with FG repeats 2 | 3268.0 | ENSG00000106351 | nan | nan
chr7	SAP25	619230.0 | SAP25 | SIN3A-associated protein, 25kD | 100316904.0 | ENSG00000205307 | nan | nan
chr7	LRCH4	620165.0 | LRCH4 | Leucine-rich repeats- and calponin homology domain-containing protein 4 | 4034.0 | ENSG00000077454 | nan | nan
chr7	FBXO24	609097.0 | FBXO24, FBX24 | F-box only protein 24 | 26261.0 | ENSG00000106336 | nan | nan
chr7	PCOLCE	600270.0 | PCOLCE | Procollagen C-endopeptidase enhancer | 5118.0 | ENSG00000106333 | nan | nan
chr7	MOSPD3	609125.0 | MOSPD3 | Motile sperm domain-containing protein 3 | 64598.0 | ENSG00000106330 | nan | nan
chr7	TFR2	604720.0 | TFR2, HFE3 | Transferrin receptor 2 | 7036.0 | ENSG00000106327 | nan | Hemochromatosis, type 3, 604250 (3), Autosomal recessive
chr7	ACTL6B	612458.0 | ACTL6B, BAF53B, IDDSSAD, DEE76 | Actin-like 6B | 51412.0 | ENSG00000077080 | nan | Developmental and epileptic encephalopathy 76, 618468 (3), Autosomal recessive; Intellectual developmental disorder with severe speech and ambulation defects, 618470 (3), Autosomal dominant
chr7	GNB2	139390.0 | GNB2, SSS4; NEDHYDF | Guanine nucleotide-binding protein, beta polypeptide-2 | 2783.0 | ENSG00000172354 | mutation identified in 1 SSS4 family | Neurodevelopmental disorder with hypotonia and dysmorphic facies, 619503 (3), Autosomal dominant; ?Sick sinus syndrome 4, 619464 (3), Autosomal dominant
chr7	GIGYF1	612064.0 | GIGYF1 | GRB10-interacting GYF protein 1 | 64599.0 | ENSG00000146830 | nan | nan
chr7	POP7	606113.0 | POP7, RPP20 | POP7 homolog, ribonuclease P/MRP subunit | 10248.0 | ENSG00000172336 | nan | nan
chr7	EPO	133170.0 | EPO, MVCD2, ECYT5, DBAL | Erythropoietin | 2056.0 | ENSG00000130427 | mutation identified in 1 DBAL family | {Microvascular complications of diabetes 2}, 612623 (3); Erythrocytosis, familial, 5, 617907 (3), Autosomal dominant; ?Diamond-Blackfan anemia-like, 617911 (3), Autosomal recessive
chr7	ZAN	602372.0 | ZAN | Zonadhesin | 7455.0 | ENSG00000146839 | nan | nan
chr7	EPHB4	600011.0 | EPHB4, HTK, MYK1, HFASD, CMAVM2, LMPHM7 | Ephrin receptor EphB4 (hepatoma transmembrane kinase) | 2050.0 | ENSG00000196411 | nan | Capillary malformation-arteriovenous malformation 2, 618196 (3), Autosomal dominant; Lymphatic malformation 7, 617300 (3), Autosomal dominant
chr7	SLC12A9	616861.0 | SLC12A9, CIP1, CCC6 | Solute carrier family 12 (potassium/chloride transporter), member 9 | 56996.0 | ENSG00000146828 | nan | nan
chr7	TRIP6	602933.0 | TRIP6, OIP1 | Thyroid hormone receptor interactor-6 | 7205.0 | ENSG00000087077 | nan | nan
chr7	SRRT	614469.0 | SRRT, ARS2 | Serrate RNA effector molecule | 51593.0 | ENSG00000087087 | nan | nan
chr7	UFSP1	611481.0 | UFSP1 | UFM1-specific peptidase 1 | 402682.0 | ENSG00000176125 | nan | nan
chr7	ACHE	100740.0 | ACHE, YT | Acetylcholinesterase (YT blood group) | 43.0 | ENSG00000087085 | blood group YT (112100) = epitope of ACHE | [Blood group, Yt system], 112100 (3)
chr7	MUC3A	158371.0 | MUC3A | Mucin 3A, intestinal | 4584.0 | ENSG00000169894 | nan | nan
chr7	MUC12	604609.0 | MUC12, MUC11 | Mucin 12 | 10071.0 | ENSG00000205277 | nan | nan
chr7	MUC17	608424.0 | MUC17 | Mucin 17 | 140453.0 | ENSG00000169876 | nan | nan
chr7	TRIM56	616996.0 | TRIM56 | Tripartite motif-containing protein 56 | 81844.0 | ENSG00000169871 | nan | nan
chr7	SERPINE1	173360.0 | PAI1, PLANH1, SERPINE1 | Plasminogen activator inhibitor, type I | 5054.0 | ENSG00000106366 | nan | Plasminogen activator inhibitor-1 deficiency, 613329 (3), Autosomal recessive, Autosomal dominant; {Transcription of plasminogen activator inhibitor, modulator of} (3)
chr7	AP1S1	603531.0 | AP1S1, CLAPS1, AP19, MEDNIK | Adaptor-related protein complex 1, sigma 1 subunit | 1174.0 | ENSG00000106367 | nan | MEDNIK syndrome, 609313 (3), Autosomal recessive
chr7	VGF	602186.0 | VGF | VGF nerve growth factor inducible | 7425.0 | ENSG00000128564 | nan | nan
chr7	NAT16	615783.0 | NAT16 | N-acetyltransferase 16 | 375607.0 | ENSG00000167011 | nan | nan
chr7	MOGAT3	610184.0 | MOGAT3, MGAT3 | Monoacylglycerol O-acyltransferase 3 | 346606.0 | ENSG00000106384 | nan | nan
chr7	PLOD3	603066.0 | PLOD3, LH3, BCARD | Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (lysyl hydroxylase 3) | 8985.0 | ENSG00000106397 | nan | BCARD syndrome (lysyl hydroxylase 3 deficiency), 612394 (3), Autosomal recessive
chr7	ZNHIT1	618617.0 | ZNHIT1, ZNFN4A1 | Zinc finger HIT domain-containing protein 1 | 10467.0 | ENSG00000106400 | nan | nan
chr7	CLDN15	615778.0 | CLDN15 | Claudin 15 | 24146.0 | ENSG00000106404 | nan | nan
chr7	FIS1	609003.0 | FIS1, TTC11 | Fission, mitochondrial 1 | 51024.0 | ENSG00000214253 | nan | nan
chr7	EMSLR	618575.0 | EMSLR, EMS | E2F1 mRNA stabilizing long noncoding RNA | 101927746.0 | nan | nan | nan
chr7	IFT22	620505.0 | IFT22, RABL5 | Intraflagellar transport 22 | 64792.0 | ENSG00000128581 | nan | nan
chr7	COL26A1	608927.0 | EMID2, EMU2, COL26A1 | EMI domain-containing protein 2 | 136227.0 | ENSG00000160963 | nan | nan
chr7	MYL10	617177.0 | MYL10, PLRLC | Myosin light chain 10 | 93408.0 | ENSG00000106436 | nan | nan
chr7	CUX1	116896.0 | CUX1, CUTL1, CDP, GDDI | Cut-like homeobox 1 | 1523.0 | ENSG00000257923 | nan | Global developmental delay with or without impaired intellectual development, 618330 (3), Autosomal dominant
chr7	SH2B2	605300.0 | APS | Adaptor protein containing PH and SH2 domains | 10603.0 | ENSG00000160999 | nan | nan
chr7	PRKRIP1	617458.0 | PRKRIP1, C114 | PRKR-interacting protein 1, IL11-inducible | 79706.0 | ENSG00000128563 | nan | nan
chr7	ORAI2	610929.0 | ORAI2, MEM142B, C7orf19 | ORAI calcium release-activated calcium modulator 2 | 80228.0 | ENSG00000160991 | nan | nan
chr7	ALKBH4	613302.0 | ALKBH4, ABH4 | AlkB homolog 4, lysine demethylase | 54784.0 | ENSG00000160993 | nan | nan
chr7	LRWD1	615167.0 | LRWD1, ORCA | Leucine-rich repeats- and WD repeat domain-containing protein 1 | 222229.0 | ENSG00000161036 | nan | nan
chr7	POLR2J	604150.0 | POLR2J | Polymerase II, RNA, subunit J | 5439.0 | ENSG00000005075 | nan | nan
chr7	SPDYE2	617624.0 | SPDYE2, SPDYB2L1 | Speedy/RINGO cell cycle regulator family, member E2 | 441273.0 | ENSG00000205238 | nan | nan
chr7	RASA4	607943.0 | RASA4, CAPRI, GAPL, KIAA0538 | Ras p21 protein activator 4 | 10156.0 | ENSG00000105808 | nan | nan
chr7	POLR2J2	609881.0 | POLR2J2, RPB11 | RNA polymerase II, subunit J2 | 246721.0 | ENSG00000228049 | nan | nan
chr7	FBXL13	609080.0 | EBXL13, FBL13 | F-box and leucine-rich repeat protein 13 | 222235.0 | ENSG00000161040 | nan | nan
chr7	LRRC17	618749.0 | LRRC17 | Leucine-rich repeat-containing protein 17 | 10234.0 | ENSG00000128606 | nan | nan
chr7	NFE4	612133.0 | NFE4 | Transcription factor NFE4 | 58160.0 | ENSG00000230257 | nan | nan
chr7	ARMC10	611864.0 | ARMC10, SVH | Armadillo repeat-containing protein 10 | 83787.0 | ENSG00000170632 | nan | nan
chr7	NAPEPLD	612334.0 | NAPEPLD | N-acyl phosphatidylethanolamine-hydrolyzing phospholipase D | 222236.0 | ENSG00000161048 | nan | nan
chr7	PMPCB	603131.0 | PMPCB, MPPB | Peptidase, mitochondrial processing, beta | 9512.0 | ENSG00000105819 | nan | Multiple mitochondrial dysfunctions syndrome 6, 617954 (3), Autosomal recessive
chr7	DNAJC2	605502.0 | DNAJC2, ZRF1, MPP11 | DnaJ (Hsp40) homolog, subfamily C, member 2 | 27000.0 | ENSG00000105821 | nan | nan
chr7	PSMC2	154365.0 | PSMC2, MSS1, S7 | Proteasome 26S subunit, ATPase, 2 | 5701.0 | ENSG00000161057 | nan | nan
chr7	SLC26A5	604943.0 | SLC26A5, PRES, DFNB61 | Solute carrier family 26, member 5 | 375611.0 | ENSG00000170615 | mutation identified in 1 DFNB61 family | ?Deafness, autosomal recessive 61, 613865 (3), Autosomal recessive
chr7	RELN	600514.0 | RELN, RL, LIS2, ETL7 | Reelin | 5649.0 | ENSG00000189056 | nan | {Epilepsy, familial temporal lobe, 7}, 616436 (3), Autosomal dominant; Lissencephaly 2 (Norman-Roberts type), 257320 (3), Autosomal recessive
chr7	ORC5	602331.0 | ORC5, ORC5L | Origin recognition complex, subunit 5 | 5001.0 | ENSG00000164815 | nan | nan
chr7	LHFPL3	609719.0 | LHFPL3 | LHFP tetraspan subfamily, member 3 | 375612.0 | ENSG00000187416 | nan | nan
chr7	CMD1Q	609915.0 | CMD1Q | Cardiomyopathy, dilated, 1Q | 664728.0 | nan | between D7S2545 and D7S2554 | Cardiomyopathy, dilated, 1Q, 609915 (2)
chr7	MPVQTL6	614646.0 | MPVQTL6 | Mean platelet volume quantitative trait locus 6 | 100887751.0 | nan | associated with rs342293 | Mean platelet volume QTL6, 614646 (2)
chr7	KMT2E	608444.0 | KMT2E, MLL5, ODLURO | Lysine (K)-specific methyltransferase 2E | 55904.0 | ENSG00000005483 | nan | O'Donnell-Luria-Rodan syndrome, 618512 (3), Autosomal dominant
chr7	SRPK2	602980.0 | SRPK2 | SRSF protein kinase 2 | 6733.0 | ENSG00000135250 | nan | nan
chr7	PUS7	616261.0 | PUS7, KIAA1897, IDDABS | Pseudouridylate synthase 7, putative | 54517.0 | ENSG00000091127 | nan | Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature, 618342 (3), Autosomal recessive
chr7	RINT1	610089.0 | RINT1, ILFS3 | RAD50-interacting protein 1 | 60561.0 | ENSG00000135249 | nan | Infantile liver failure syndrome 3, 618641 (3), Autosomal recessive
chr7	CDHR3	615610.0 | CDHR3 | Cadherin-related family, member 3 | 222256.0 | ENSG00000128536 | nan | nan
chr7	SYPL1	616665.0 | SYPL1, SYPL | Synaptophysin-like 1 | 6856.0 | ENSG00000008282 | nan | nan
chr7	NAMPT	608764.0 | NAMPT, PBEF1, VF, PBEF | Nicotinamide phosphoribosyltransferase | 10135.0 | ENSG00000105835 | nan | nan
chr7	PIK3CG	601232.0 | PIK3CG, IMD97 | Phosphatidylinositol 3-kinase, catalytic, gamma | 5294.0 | ENSG00000105851 | nan | Immunodeficiency 97 with autoinflammation, 619802 (3), Autosomal recessive
chr7	PRKAR2B	176912.0 | PRKAR2B | Protein kinase, cAMP-dependent, regulatory, type II, beta | 5577.0 | ENSG00000005249 | nan | nan
chr7	HBP1	616714.0 | HBP1 | HMG-box transcription factor 1 | 26959.0 | ENSG00000105856 | nan | nan
chr7	COG5	606821.0 | COG5, GOLTC1, GTC90, CDG2I | Component of oligomeric golgi complex 5 | 10466.0 | ENSG00000164597 | nan | Congenital disorder of glycosylation, type IIi, 613612 (3), Autosomal recessive
chr7	GPR22	601910.0 | GPR22 | G protein-coupled receptor-22 | 2845.0 | ENSG00000172209 | nan | nan
chr7	BCAP29	619612.0 | BCAP29, BAP29, B29 | B-cell receptor-associated protein 29 | 55973.0 | ENSG00000075790 | nan | nan
chr7	SLC26A4	605646.0 | SLC26A4, PDS, DFNB4, EVA, TDH2B | Solute carrier family 26 (sulfate transporter), member 4 | 5172.0 | ENSG00000091137 | some patients have digenic mutations with FOXI1 | Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3), Autosomal recessive; Pendred syndrome, 274600 (3), Autosomal recessive
chr7	CBLL1	606872.0 | CBLL1, HAKAI, RNF188 | Cas-Br-M murine ectopic retroviral transforming sequence like-1 | 79872.0 | ENSG00000105879 | nan | nan
chr7	SLC26A3	126650.0 | SLC26A3, DRA, CLD | Solute carrier family 26 (sulfate transporter), member 3 | 1811.0 | ENSG00000091138 | 5' and close to PDS | Diarrhea 1, secretory chloride, congenital, 214700 (3), Autosomal recessive
chr7		611015.0 | AUTS9 | Autism, susceptibility to, 9 | nan | nan | max lod near D7S530 | {Autism, susceptibility to, 9}, 611015 (2)
chr7	DFNB14	603678.0 | DFNB14 | Deafness, autosomal recessive 14 | 1706.0 | nan | ?same as DFNB17 | Deafness, autosomal recessive 14, 603678 (2), Autosomal recessive
chr7	DFNB17	603010.0 | DFNB17 | Deafness, autosomal recessive 17 | 1709.0 | nan | nan | Deafness, autosomal recessive 17, 603010 (2), Autosomal recessive
chr7	DLD	238331.0 | DLD, LAD, PHE3, DLDD | Dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex) | 1738.0 | ENSG00000091140 | nan | Dihydrolipoamide dehydrogenase deficiency, 246900 (3), Autosomal recessive
chr7	LAMB1	150240.0 | LAMB1, LIS5 | Laminin, beta-1 | 3912.0 | ENSG00000091136 | nan | Lissencephaly 5, 615191 (3), Autosomal recessive
chr7	LAMB4	616380.0 | LAMB4 | Laminin, beta-4 | 22798.0 | ENSG00000091128 | nan | nan
chr7	NRCAM	601581.0 | NRCAM, NEDNMS | Neuronal cell adhesion molecule | 4897.0 | ENSG00000091129 | nan | Neurodevelopmental disorder with neuromuscular and skeletal abnormalities, 619833 (3), Autosomal recessive
chr7	PNPLA8	612123.0 | PNPLA8, MMLA | Patatin-like phospholipase domain-containing protein 8 | 50640.0 | ENSG00000135241 | mutation identified in 1 MMLA family | ?Mitochondrial myopathy with lactic acidosis, 251950 (3), Autosomal recessive
chr7	THAP5	612534.0 | THAP5 | THAP domain-containing protein 5 | 168451.0 | ENSG00000177683 | nan | nan
chr7	DNAJB9	602634.0 | DNAJB9, MDG1 | DnaJ, E. coli, homolog of, subfamily B, member 9 (microvascular endothelial differentiation gene-1) | 4189.0 | ENSG00000128590 | previously assigned to chr.14 by FISH | nan
chr7	IMMP2L	605977.0 | IMMP2L, IMP2 | Inner mitochondrial membrane peptidase, subunit 2 | 83943.0 | ENSG00000184903 | nan | nan
chr7	LRRN3	619748.0 | LRRN3, NLRR3 | Leucine-rich repeat neuronal protein 3 | 54674.0 | ENSG00000173114 | nan | nan
chr7	DOCK4	607679.0 | DOCK4, KIAA0716 | Dedicator of cytokinesis 4 | 9732.0 | ENSG00000128512 | nan | nan
chr7	ZNF277	605465.0 | ZNF277 | Zinc finger protein-277 | 11179.0 | ENSG00000198839 | nan | nan
chr7	IFRD1	603502.0 | IFRD1 | Interferon-related developmental regulator 1 | 3475.0 | ENSG00000006652 | nan | nan
chr7	SAMTOR	617855.0 | BMT2, SAMTOR, C7orf60 | Base methyltransferase of 25S rRNA 2 homolog | 154743.0 | ENSG00000164603 | nan | nan
chr7	GPR85	605188.0 | GPR85, SREB2 | G protein-coupled receptor-85 | 54329.0 | ENSG00000164604 | nan | nan
chr7	PPP1R3A	600917.0 | PPP1R3A, PPP1R3 | Protein phosphatase 1, regulatory subunit 3A | 5506.0 | ENSG00000154415 | nan | Insulin resistance, severe, digenic, 125853 (3), Autosomal dominant
chr7	FOXP2	605317.0 | FOXP2, SPCH1, TNRC10, CAGH44 | Forkhead box P2 | 93986.0 | ENSG00000128573 | nan | Speech-language disorder-1, 602081 (3), Autosomal dominant
chr7	MDFIC	614511.0 | MDFIC, HIC, LMPHM12 | MYOD family inhibitor domain-containing protein | 29969.0 | ENSG00000135272 | nan | Lymphatic malformation 12, 620014 (3), Autosomal recessive
chr7	TFEC	604732.0 | TFEC, TFECL | Transcription factor EC | 22797.0 | ENSG00000105967 | nan | nan
chr7	TES	606085.0 | TES | Testin | 26136.0 | ENSG00000135269 | nan | nan
chr7	CAV2	601048.0 | CAV2 | Caveolin-2 | 858.0 | ENSG00000105971 | nan | nan
chr7	CAV1	601047.0 | CAV1, BSCL3, CGL3, PPH3, LCCNS | Caveolin-1 | 857.0 | ENSG00000105974 | nan | Lipodystrophy, congenital generalized, type 3, 612526 (3), Autosomal recessive; Pulmonary hypertension, primary, 3, 615343 (3), Autosomal dominant; Lipodystrophy, familial partial, type 7, 606721 (3), Autosomal dominant
chr7	MET	164860.0 | MET, DFNB97, OSFD, DA11 | MET protooncogene, receptor tyrosine kinase | 4233.0 | ENSG00000105976 | mutation identified in 1 DFNB97 family and 1 DA11 family | Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3); ?Arthrogryposis, distal, type 11, 620019 (3), Autosomal dominant; Hepatocellular carcinoma, childhood type, somatic, 114550 (3); {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant; ?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive
chr7	CAPZA2	601571.0 | CAPZA2, CAPPA2 | Capping protein (actin filament) muscle Z-line, alpha 2 | 830.0 | ENSG00000198898 | nan | nan
chr7	ST7	600833.0 | ST7, TSG7, RAY1, FAM4A1 | Suppressor of tumorigenicity 7 (breast) | 7982.0 | ENSG00000004866 | nan | nan
chr7	WNT2	147870.0 | WNT2, INT1L1 | Wingless-type MMTV integration site family, member 2 | 7472.0 | ENSG00000105989 | isolated by CMGT with MET | nan
chr7	ASZ1	605797.0 | ASZ1, ALP1, ANKL1, GASZ | Ankyrin repeat, SAM, and basic leucine zipper domain-containing 1 | 136991.0 | ENSG00000154438 | nan | nan
chr7	CFTR	602421.0 | CFTR, ABCC7, CF, MRP7 | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7) | 1080.0 | ENSG00000001626 | distal and 5' to MET | Cystic fibrosis, 219700 (3), Autosomal recessive; Sweat chloride elevation without CF (3); Congenital bilateral absence of vas deferens, 277180 (3), Autosomal recessive; {Pancreatitis, hereditary}, 167800 (3), Autosomal dominant; {Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3), Autosomal dominant; {Hypertrypsinemia, neonatal} (3)
chr7	STQTL2	606256.0 | STQTL2 | Stature quantitative trait locus 2 | 192143.0 | nan | max lod at D7S195 | {Stature QTL 2}, 606256 (2)
chr7	CTTNBP2	609772.0 | CTTNBP2, CORTBP2, KIAA1758 | Cortactin-binding protein 2 | 83992.0 | ENSG00000077063 | nan | nan
chr7	LSM8	607288.0 | LSM8 | LSM8 homolog, U6 small nuclear RNA associated | 51691.0 | ENSG00000128534 | nan | nan
chr7	ANKRD7	610731.0 | ANKRD7 | Ankyrin repeat domain-containing protein 7 | 56311.0 | ENSG00000106013 | nan | nan
chr7	KCND2	605410.0 | KCND2, KIAA1044 | Potassium voltage-gated channel, Shal-related subfamily, member 2 | 3751.0 | ENSG00000184408 | nan | nan
chr7	TSPAN12	613138.0 | TSPAN12, NET2, EVR5 | Tetraspanin 12 | 23554.0 | ENSG00000106025 | nan | Exudative vitreoretinopathy 5, 613310 (3), Autosomal dominant
chr7	ING3	607493.0 | ING3, P47ING3 | Inhibitor of growth family, member 3 | 54556.0 | ENSG00000071243 | nan | nan
chr7	CPED1	620637.0 | CPED1, C7orf58 | Cadherin-like domain- and PC-esterase domain-containing protein 1 | 79974.0 | ENSG00000106034 | nan | nan
chr7	WNT16	606267.0 | WNT16 | Wingless-type MMTV integration site family, member 16 | 51384.0 | ENSG00000002745 | nan | nan
chr7	FAM3C	608618.0 | FAM3C | Family with sequence similarity 3, member C | 10447.0 | ENSG00000196937 | nan | nan
chr7	PTPRZ1	176891.0 | PTPRZ1, PTP18 | Protein-tyrosine phosphatase, receptor-type, zeta-1, polypeptide | 5803.0 | ENSG00000106278 | nan | nan
chr7	AASS	605113.0 | AASS | Alpha-aminoadipic semialdehyde synthase | 10157.0 | ENSG00000008311 | nan | Hyperlysinemia, 238700 (3), Autosomal recessive
chr7	FEZF1	613301.0 | FEZF1, FEZ, ZNF312B, HH22 | FEZ family zinc finger protein 1 | 389549.0 | ENSG00000128610 | nan | Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3), Autosomal recessive
chr7	CADPS2	609978.0 | CADPS2, KIAA1591 | Calcium-dependent activator protein for secretion 2 | 93664.0 | ENSG00000081803 | nan | nan
chr7	RNF133	620556.0 | RNF133 | RING finger protein 133 | 168433.0 | ENSG00000188050 | nan | nan
chr7	TAS2R16	604867.0 | TAS2R16, T2R16, BGLPT | Taste receptor type 2, member 16 | 50833.0 | ENSG00000128519 | nan | {Alcohol dependence, susceptibility to}, 103780 (3), Multifactorial; [Beta-glycopyranoside tasting], 617956 (3), Autosomal dominant
chr7	SLC13A1	606193.0 | SLC13A1, NAS1 | Solute carrier family 13 (sodium/sulfate symporters), member 1 | 6561.0 | ENSG00000081800 | nan | nan
chr7	IQUB	620557.0 | IQUB, TRS4 | IQ motif- and ubiquitin domain-containing protein | 154865.0 | ENSG00000164675 | nan | nan
chr7	NDUFA5	601677.0 | NDUFA5, UQOR13 | NADH-ubiquinone oxidoreductase subunit A5 | 4698.0 | ENSG00000128609 | nan | nan
chr7	ASB15	619757.0 | ASB15 | Ankyrin repeat- and SOCS box-containing protein 15 | 142685.0 | ENSG00000146809 | nan | nan
chr7	LMOD2	608006.0 | LMOD2, CLMOD, CMD2G | Leiomodin 2 | 442721.0 | ENSG00000170807 | nan | Cardiomyopathy, dilated, 2G, 619897 (3), Autosomal recessive
chr7	WASL	605056.0 | WASL, NWASP | WASP-like actin nucleation-promoting factor | 8976.0 | ENSG00000106299 | nan | nan
chr7	HYAL4	604510.0 | HYAL4 | Hyaluronoglucosaminidase 4 | 23553.0 | ENSG00000106302 | nan | nan
chr7	SPAM1	600930.0 | SPAM1 | Sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding) | 6677.0 | ENSG00000106304 | nan | nan
chr7	GPR37	602583.0 | GPR37 | G protein-coupled receptor-37 | 2861.0 | ENSG00000170775 | nan | nan
chr7	POT1	606478.0 | POT1, PFBMFT8, CRMCC3, TPDS3 | Protection of telomeres 1 | 25913.0 | ENSG00000128513 | mutation identified in 1 PFBMFT8 family and 1 CRMCC3 family | Tumor predisposition syndrome 3, 615848 (3), Autosomal dominant; ?Cerebroretinal microangiopathy with calcifications and cysts 3, 620368 (3), Autosomal recessive; ?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8, 620367 (3), Autosomal dominant
chr7	GRM8	601116.0 | GRM8 | Glutamate receptor, metabotropic-8 | 2918.0 | ENSG00000179603 | nan | nan
chr7	BCC6	613063.0 | BCC6 | Basal cell carcinoma, susceptibility to, 6 | 100307123.0 | nan | associated with rs157935 | {Basal cell carcinoma, susceptibility to, 6}, 613063 (2)
chr7	CATR1	600676.0 | CATR1 | CATR tumorigenic conversion 1 | 856.0 | nan | nan | nan
chr7	PBC4	614220.0 | PBC4 | Biliary cirrhosis, primary, 4 | 100689215.0 | nan | associated with rs10488631 | Biliary cirrhosis, primary, 4, 614220 (2)
chr7	PPR3	609573.0 | PPR3 | Photoparoxysmal response 3 | 619471.0 | nan | max lod at D7S1804 | Photoparoxysmal response 3, 609573 (2)
chr7		613909.0 | SCA32 | Spinocerebellar ataxia 32 | nan | nan | between rs3847110 and rs2241728 | Spinocerebellar ataxia 32, 613909 (2), Autosomal dominant
chr7	GCC1	607418.0 | GCC1, GCC88 | GRIP and coiled-coil domains-containing protein 1 | 79571.0 | ENSG00000179562 | nan | nan
chr7	ARF5	103188.0 | ARF5 | ADP-ribosylation factor 5 | 381.0 | ENSG00000004059 | nan | nan
chr7	FSCN3	615800.0 | FSCN3 | Fascin actin-bundling protein 3, testicular | 29999.0 | ENSG00000106328 | nan | nan
chr7	PAX4	167413.0 | PAX4, MODY9, KPD | Paired box homeotic gene-4 | 5078.0 | ENSG00000106331 | nan | {Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3), Autosomal recessive, Autosomal dominant; Maturity-onset diabetes of the young, type IX, 612225 (3); Diabetes mellitus, type 2, 125853 (3), Autosomal dominant
chr7	SND1	602181.0 | P100, SND1 | EBNA-2 coactivator p100 | 27044.0 | ENSG00000197157 | nan | nan
chr7	LRRC4	610486.0 | LRRC4 | Leucine-rich repeat-containing protein 4 | 64101.0 | ENSG00000128594 | nan | nan
chr7	LEP	164160.0 | LEP, OB, LEPD | Leptin (murine obesity homolog) | 3952.0 | ENSG00000174697 | in mouse cen-Cola-2-Met-ob-Cpa-Tcrb-tel | Obesity, morbid, due to leptin deficiency, 614962 (3), Autosomal recessive
chr7	RBM28	612074.0 | RBM28, ANES | RNA-binding motif protein 28 | 55131.0 | ENSG00000106344 | mutation identified in 1 ANES family | ?Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3), Autosomal recessive
chr7	IMPDH1	146690.0 | IMPDH1, RP10, LCA11 | Inosine-5'-monophosphate dehydrogenase, type I | 3614.0 | ENSG00000106348 | pseudogene on 16p13.13 | Retinitis pigmentosa 10, 180105 (3), Autosomal dominant; Leber congenital amaurosis 11, 613837 (3), Autosomal dominant
chr7	HILPDA	617905.0 | HILPDA, HIG2 | Hypoxia-inducible lipid droplet-associated protein | 29923.0 | ENSG00000135245 | nan | nan
chr7	METTL2B	607846.0 | METTL2B, METL | Methyltransferase 2B, methylcytidine | 55798.0 | ENSG00000165055 | nan | nan
chr7	GARIN1A	619904.0 | GARIN1A, GARI, FAM71F2 | Golgi-associated Rab2 interactor 1A | 346653.0 | ENSG00000205085 | nan | nan
chr7	GARIN1B	619905.0 | GARIN1B, GARIL1, FAM71F1 | Golgi-associated Rab2 interactor 1B | 84691.0 | ENSG00000135248 | nan | nan
chr7	CALU	603420.0 | CALU | Calumenin | 813.0 | ENSG00000128595 | nan | nan
chr7	OPN1SW	613522.0 | OPN1SW, BCP, CBT | Blue cone pigment (opsin 1, short-wave-sensitive) | 611.0 | ENSG00000128617 | nan | Colorblindness, tritan, 190900 (3), Autosomal dominant
chr7	CCDC136	611902.0 | CCDC136, NAG6, KIAA1793 | Coiled-coil domain-containing protein 136 | 64753.0 | ENSG00000128596 | nan | nan
chr7	FLNC	102565.0 | FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5, ARVC15 | Filamin C (actin-binding protein-280) | 2318.0 | ENSG00000128591 | nan | Cardiomyopathy, familial hypertrophic, 26, 617047 (3), Autosomal dominant; Arrhythmogenic right ventricular dysplasia, familial, 617047 (3), Autosomal dominant; Cardiomyopathy, familial restrictive 5, 617047 (3), Autosomal dominant; Myopathy, distal, 4, 614065 (3), Autosomal dominant; Myopathy, myofibrillar, 5, 609524 (3), Autosomal dominant
chr7	ATP6V1F	607160.0 | ATP6V1F | ATPase, H+ transporting, lysosomal, 14kD, V1 subunit F | 9296.0 | ENSG00000128524 | nan | nan
chr7	KCP	609344.0 | KCP | Kielin/chordin-like protein | 375616.0 | ENSG00000135253 | nan | nan
chr7	IRF5	607218.0 | IRF5, IBD14, SLEB10 | Interferon regulatory factor 5 | 3663.0 | ENSG00000128604 | nan | {Inflammatory bowel disease 14}, 612245 (3); {Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)
chr7	TNPO3	610032.0 | TNPO3, TRNSR, LGMDD2 | Transportin 3 | 23534.0 | ENSG00000064419 | nan | Muscular dystrophy, limb-girdle, autosomal dominant 2, 608423 (3), Autosomal dominant
chr7	TSPAN33	610120.0 | TSPAN33, PEN | Tetraspanin 33 | 340348.0 | ENSG00000158457 | nan | nan
chr7	SMO	601500.0 | SMO, SMOH, CRJS, PHLS | Smoothened, frizzled class receptor | 6608.0 | ENSG00000128602 | nan | Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)
chr7	AHCYL2	616520.0 | AHCYL2 | Adenosylhomocysteinase-like 2 | 23382.0 | ENSG00000158467 | nan | nan
chr7	STRIP2	617919.0 | STRIP2, FAR11B, FAM40B | Striatin-interacting protein 2 | 57464.0 | ENSG00000128578 | nan | nan
chr7	HYSP3	146450.0 | HYSP3 | Hypospadias 3, autosomal | 100689211.0 | nan | between D7S2519 and D7S2442. | Hypospadias 3, autosomal, 146450 (2), Multifactorial, Autosomal dominant
chr7	NRF1	600879.0 | NRF1 | Nuclear respiratory factor 1 | 4899.0 | ENSG00000106459 | earlier location = 7q31 | nan
chr7	MIR182	611607.0 | MIR182, MIRN182 | Micro RNA 182 | 406958.0 | ENSG00000207990 | nan | nan
chr7	MIR96	611606.0 | MIR96, MIRN96, DFNA50 | Micro RNA 96 | 407053.0 | ENSG00000199158 | nan | Deafness, autosomal dominant 50, 613074 (3), Autosomal dominant
chr7	MIR183	611608.0 | MIR183, MIRN183 | Micro RNA 183 | 406959.0 | ENSG00000207691 | nan | nan
chr7	UBE2H	601082.0 | UBE2H, UBCH2, UBC8 | Ubiquitin-conjugating enzyme E2 H | 7328.0 | ENSG00000186591 | nan | nan
chr7	ZC3HC1	619746.0 | ZC3HC1, NIPA | Zinc finger C3HC-type domain-containing protein 1 | 51530.0 | ENSG00000091732 | nan | nan
chr7	KLHDC10	615152.0 | KLHDC10, SLIM | Kelch domain-containing protein 10 | 23008.0 | ENSG00000128607 | nan | nan
chr7	CPA2	600688.0 | CPA2 | Carboxypeptidase A2, pancreatic | 1358.0 | ENSG00000158516 | nan | nan
chr7	CPA4	607635.0 | CPA4, CPA3 | Carboxypeptidase A4 | 51200.0 | ENSG00000128510 | nan | nan
chr7	CPA5	609561.0 | CPA5 | Carboxypeptidase A5 | 93979.0 | ENSG00000158525 | nan | nan
chr7	CPA1	114850.0 | CPA1 | Carboxypeptidase A | 1357.0 | ENSG00000091704 | both CPA and TRY1 = serine proteases | nan
chr7	CEP41	610523.0 | CEP41, TSGA14, JBTS15 | Centrosomal protein, 41kD | 95681.0 | ENSG00000106477 | nan | Joubert syndrome 15, 614464 (3), Autosomal recessive
chr7	MESTIT1	607794.0 | MESTIT1 | MEST intronic transcript 1 | 317751.0 | ENSG00000272701 | nan | nan
chr7	MEST	601029.0 | MEST, PEG1 | Mesoderm specific transcript, mouse, homolog of | 4232.0 | ENSG00000106484 | imprinted maternally | nan
chr7	MIR335	611768.0 | MIR335 | Micro RNA 335 | 442904.0 | ENSG00000199043 | nan | nan
chr7	COPG2	604355.0 | COPG2 | Coatomer protein complex, subunit gamma-2 | 26958.0 | ENSG00000158623 | nan | nan
chr7	COPG2IT1	610581.0 | COPG2IT1, CIT1 | Coatomer protein complex, subunit gamma-2, intronic transcript 1 | 53844.0 | nan | nan | nan
chr7	KLF14	609393.0 | LKF14, BTEB5 | Kruppel-like factor 14 | 136259.0 | ENSG00000266265 | nan | nan
chr7	BMIQ1	606641.0 | BMIQ1 | Body mass index quantitative trait locus 1 | 170815.0 | nan | max lod at D7S1804 | [Body mass index QTL1], 606641 (2)
chr7	MIR29A	610782.0 | MIR29A, MIRN29A | Micro RNA 29A | 407021.0 | ENSG00000284032 | nan | nan
chr7	MIR29B1	610783.0 | MIR29B1, MIRN29B1 | Micro RNA 29B1 | 407024.0 | ENSG00000283797 | nan | nan
chr7	LINC-PINT	618212.0 | LINC-PINT, PINT | Long intergenic noncoding RNA, p53-induced transcript | 378805.0 | ENSG00000231721 | nan | nan
chr7	MKLN1	605623.0 | MKLN1 | Muskelin 1 | 4289.0 | ENSG00000128585 | nan | nan
chr7	PODXL	602632.0 | PODXL, PCLP | Podocalyxin-like | 5420.0 | ENSG00000128567 | nan | nan
chr7	PLXNA4	604280.0 | PLXNA4 | Plexin A4 | 91584.0 | ENSG00000221866 | nan | nan
chr7	CHCHD3	613748.0 | CHCHD3 | Coiled-coil-helix-coiled-coil-helix domain-containing protein 3 | 54927.0 | ENSG00000106554 | nan | nan
chr7	LUZP6	611050.0 | LUZP6, MPD6 | Leucine zipper protein 6 | 767558.0 | nan | nan | nan
chr7	EXOC4	608185.0 | EXOC4, SEC8, KIAA1699 | Exocyst complex component 4 | 60412.0 | ENSG00000131558 | nan | nan
chr7	LRGUK	616478.0 | LRGUK | Leucine-rich repeats- and guanylate kinase domain-containing protein | 136332.0 | ENSG00000155530 | nan | nan
chr7	SLC35B4	610923.0 | SLC35B4 | Solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine transporter), member B4 | 84912.0 | ENSG00000205060 | nan | nan
chr7	AKR1B1	103880.0 | AKR1B1, ALDR1 | Aldo-keto reductase family 1, member B1 | 231.0 | ENSG00000085662 | nan | nan
chr7	AKR1B10	604707.0 | AKR1B10, ARL1 | Aldo-keto reductase family 1, member B10 | 57016.0 | ENSG00000198074 | nan | nan
chr7	AKR1B15	616336.0 | AKR1B15, AKR1B10L, AKR1R1B7 | Aldo-keto reductase family 1, member B15 | 441282.0 | ENSG00000227471 | nan | nan
chr7	BPGM	613896.0 | BPGM, ECYT8 | 2,3-bisphosphoglycerate mutase | 669.0 | ENSG00000172331 | nan | Erythrocytosis, familial, 8, 222800 (3), Autosomal recessive
chr7	CALD1	114213.0 | CALD1, CDM | Caldesmon-1 | 800.0 | ENSG00000122786 | nan | nan
chr7	AGBL3	617346.0 | AGBL3, CCP3 | ATP/GTP-binding protein-like 3 | 340351.0 | ENSG00000146856 | nan | nan
chr7	CYREN	616980.0 | CYREN, C7orf49, MRI | Cell cycle regulator of nonhomologous end joining | 78996.0 | ENSG00000122783 | nan | nan
chr7	WDR91	616303.0 | WDR91, SORF1 | WD repeat-containing protein 91 | 29062.0 | ENSG00000105875 | nan | nan
chr7	STRA8	609987.0 | STRA8 | Stimulated by retinoic acid 8, mouse, homolog of | 346673.0 | ENSG00000146857 | nan | nan
chr7	CNOT4	604911.0 | CNOT4, NOT4 | CCR4-NOT transcription complex, subunit 4 | 4850.0 | ENSG00000080802 | nan | nan
chr7	NUP205	614352.0 | NUP205, C7orf14, KIAA0225, NPHS13 | Nucleoporin, 205kD | 23165.0 | ENSG00000155561 | mutation identified in 1 NPHS13 family | ?Nephrotic syndrome, type 13, 616893 (3), Autosomal recessive
chr7	STMP1	618755.0 | STMP1, C7orf73, MM47 | Short transmembrane mitochondrial protein 1 | 647087.0 | ENSG00000243317 | nan | nan
chr7	SLC13A4	604309.0 | SLC13A4, SUT1 | Solute carrier family 13 (sodium/sulfate symporters), member 4 (sulfate transporter 1) | 26266.0 | ENSG00000164707 | nan | nan
chr7	MTPN	606484.0 | MTPN | Myotrophin | 136319.0 | ENSG00000105887 | nan | nan
chr7	CHRM2	118493.0 | CHRM2 | Cholinergic receptor, muscarinic, 2 | 1129.0 | ENSG00000181072 | nan | nan
chr7	MIR490	616972.0 | MIR490 | Micro RNA 490 | 574443.0 | ENSG00000207597 | nan | nan
chr7	PTN	162095.0 | PTN, NEGF1 | Pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) | 5764.0 | ENSG00000105894 | nan | nan
chr7	DGKI	604072.0 | DGKI | Diacylglycerol kinase, iota, 130-kD | 9162.0 | ENSG00000157680 | nan | nan
chr7	CREB3L2	608834.0 | CREB3L2, BBF2H7 | cAMP response element-binding protein 3-like 2 | 64764.0 | ENSG00000182158 | nan | nan
chr7	AKR1D1	604741.0 | AKR1D1, SRD5B1, CBAS2 | Bile acid synthesis defect, congenital, 2 | 6718.0 | ENSG00000122787 | nan | Bile acid synthesis defect, congenital, 2, 235555 (3), Autosomal recessive
chr7	TRIM24	603406.0 | TRIM24, TIF1, TIF1A, PTC6 | Tripartite motif-containing protein 24 (Transcriptional intermediary factor 1) | 8805.0 | ENSG00000122779 | fused with RET to form PTC6 | nan
chr7	BDPLT14	614158.0 | BDPLT14 | Bleeding disorder, platelet-type, 14 | 116814566.0 | nan | nan | Bleeding disorder, platelet-type, 14, 614158 (2), Autosomal dominant
chr7	DFNB13	603098.0 | DFNB13 | Deafness, autosomal recessive 13 | 1705.0 | nan | nan | Deafness, autosomal recessive 13, 603098 (2), Autosomal recessive
chr7		182960.0 | HMND1, DHMN1 | Neuronopathy, distal hereditary motor, autosomal dominant 1 | nan | nan | nan | Neuronopathy, distal hereditary motor, autosomal dominant 1, 182960 (4), Autosomal dominant
chr7	OTSC2	605727.0 | OTSC2 | Otosclerosis 2 | 93999.0 | nan | nan | Otosclerosis 2, 605727 (2), Autosomal dominant
chr7		615449.0 | TRBJ@ | T-cell receptor beta chain joining gene cluster | nan | nan | nan | nan
chr7		615446.0 | TRBV@ | T-cell receptor beta chain variable gene cluster | nan | nan | nan | nan
chr7	SVOPL	611700.0 | SVOPL | SV2-related protein-like | 136306.0 | ENSG00000157703 | nan | nan
chr7	ATP6V0A4	605239.0 | ATP6V0A4, ATP6N1B, VPP2, RTA1C, DRTA3 | ATPase, H+ transporting, V0 subunit A4 | 50617.0 | ENSG00000105929 | nan | Distal renal tubular acidosis 3, with or without sensorineural hearing loss, 602722 (3), Autosomal recessive
chr7	KIAA1549	613344.0 | KIAA1549, RP86 | KIAA1549 gene | 57670.0 | ENSG00000122778 | nan | Retinitis pigmentosa 86, 618613 (3), Autosomal recessive
chr7	ZC3HAV1	607312.0 | ZC3HAV1, ZAP, FLJ13288, FLB6421 | Zinc finger CCCH domain-containing antiviral protein 1 | 56829.0 | ENSG00000105939 | nan | nan
chr7	IFT56	617453.0 | TTC26, IFT56, BRENS | Tetratricopeptide repeat domain-containing protein 26 | 79989.0 | ENSG00000105948 | nan | Biliary, renal, neurologic, and skeletal syndrome, 619534 (3), Autosomal recessive
chr7	UBN2	613841.0 | UBN2 | Ubinuclein 2 | 254048.0 | ENSG00000157741 | nan | nan
chr7	FMC1	620766.0 | FMC1 | Formation of mitochondrial complex V assembly factor 1 homolog | 154791.0 | ENSG00000164898 | nan | nan
chr7	LUC7L2	613056.0 | LUC7L2 | LUC7-like 2 pre-mRNA splicing factor | 51631.0 | ENSG00000146963 | nan | nan
chr7	HIPK2	606868.0 | HIPK2 | Homeodomain-interacting protein kinase 2 | 28996.0 | ENSG00000064393 | nan | nan
chr7	TBXAS1	274180.0 | TBXAS1, GHOSAL, CYP5 | Thromboxane A synthase 1, platelet | 6916.0 | ENSG00000059377 | nan | Ghosal hematodiaphyseal syndrome, 231095 (3), Autosomal recessive
chr7	PARP12	612481.0 | PARP12, ZC3HDC1, FLJ22693 | Poly(ADP-ribose) polymerase family, member 12 | 64761.0 | ENSG00000059378 | nan | nan
chr7	KDM7A	619640.0 | KDM7A, JHDM1D, KIAA1718 | Lysine demethylase 7A | 80853.0 | ENSG00000006459 | nan | nan
chr7	SLC37A3	619137.0 | SLC37A3, SPX3 | Solute carrier family 37, member A3 | 84255.0 | ENSG00000157800 | nan | nan
chr7	MKRN1	607754.0 | MKRN1 | Makorin 1 | 23608.0 | ENSG00000133606 | nan | nan
chr7	DENND2A	620120.0 | DENND2A | DENN domain-containing protein 2A | 27147.0 | ENSG00000146966 | nan | nan
chr7	NDUFB2	603838.0 | NDUFB2 | NADH-ubiquinone oxidoreductase subunit B2 | 4708.0 | ENSG00000090266 | nan | nan
chr7	BRAF	164757.0 | BRAF, NS7 | B-Raf protooncogene, serine/threonine kinase | 673.0 | ENSG00000157764 | pseudogene BRAF2 on Xq13 or 7q | Melanoma, malignant, somatic, 155600 (3); LEOPARD syndrome 3, 613707 (3), Autosomal dominant; Cardiofaciocutaneous syndrome, 115150 (3), Autosomal dominant; Adenocarcinoma of lung, somatic, 211980 (3); Noonan syndrome 7, 613706 (3), Autosomal dominant; Colorectal cancer, somatic, 114500 (3); Nonsmall cell lung cancer, somatic, 211980 (3)
chr7	MRPS33	611993.0 | MRPS33 | Mitochondrial ribosomal protein S33 | 51650.0 | ENSG00000090263 | 4 pseudogenes | nan
chr7	AGK	610345.0 | AGK, MULK, MTDPS10, CATC5, CTRCT38 | Acylglycerol kinase | 55750.0 | ENSG00000006530 | nan | Cataract 38, autosomal recessive, 614691 (3), Autosomal recessive; Sengers syndrome, 212350 (3), Autosomal recessive
chr7	DENND11	620122.0 | DENND11, KIAA1147 | DENN domain-containing protein 11 | 57189.0 | ENSG00000257093 | nan | nan
chr7	WEE2	614084.0 | WEE2, WEE1B, OZEMA5 | Wee1 homolog 2 | 494551.0 | ENSG00000214102 | nan | Oocyte/zygote/embryo maturation arrest 5, 617996 (3), Autosomal recessive
chr7	SSBP1	600439.0 | SSBP1, SSBP, OPA13 | Single-stranded DNA-binding protein 1 | 6742.0 | ENSG00000106028 | nan | Optic atrophy 13 with retinal and foveal abnormalities, 165510 (3), Autosomal dominant
chr7	TAS2R3	604868.0 | TAS2R3, T2R3 | Taste receptor type 2, member 3 | 50831.0 | ENSG00000127362 | nan | nan
chr7	TAS2R4	604869.0 | TAS2R4, T2R4 | Taste receptor type 2, member 4 | 50832.0 | ENSG00000127364 | nan | nan
chr7	TAS2R5	605062.0 | TAS2R5, T2R5 | Taste receptor type 2, member 5 | 54429.0 | ENSG00000127366 | nan | nan
chr7	CLEC5A	604987.0 | CLEC5A, CLECSF5, MDL1 | C-type lectin domain family 5, member A | 23601.0 | ENSG00000258227 | nan | nan
chr7	TAS2R38	607751.0 | TAS2R38, T2R61, PTC, THIOT | Taste receptor, type 2, member 38 | 5726.0 | ENSG00000257138 | nan | [Phenylthiocarbamide tasting], 171200 (3), Autosomal dominant
chr7	MGAM	154360.0 | MGAM, MGA | Maltase-glucoamylase | 8972.0 | ENSG00000257335 | similar to EST GS1365 | nan
chr7	PRSS1	276000.0 | PRSS1, TRY1 | Protease, serine, 1 (trypsin 1) | 5644.0 | ENSG00000204983 | 8 trypsinogen genes embedded in TCRB locus | Pancreatitis, hereditary, 167800 (3), Autosomal dominant
chr7	PRSS2	601564.0 | PRSS2, TRY2 | Protease, serine, 2 (trypsin 2) | 5645.0 | ENSG00000275896 | nan | {Pancreatitis, chronic, protection against}, 167800 (3), Autosomal dominant
chr7	TRBD1	615447.0 | TRBD1 | T-cell receptor beta chain diversity gene 1 | 28637.0 | ENSG00000282431 | nan | nan
chr7	TRBC1	186930.0 | TRBC1 | T-cell receptor beta chain constant region 1 | 28639.0 | ENSG00000211751 | nan | nan
chr7	TRBD2	615448.0 | TRBD2 | T-cell receptor beta chain diversity gene 2 | 28636.0 | ENSG00000292271 | nan | nan
chr7	TRBC2	615445.0 | TRBC2 | T-cell receptor beta chain constant region 2 | 28638.0 | ENSG00000211772 | nan | nan
chr7	EPHB6	602757.0 | EPHB6, HEP | Ephrin receptor EPHB6 | 2051.0 | ENSG00000106123 | nan | nan
chr7	TRPV6	606680.0 | TRPV6, ECAC2, CAT1, CATL, HRPTTN | Transient receptor potential cation channel, subfamily V, member 6 | 55503.0 | ENSG00000165125 | nan | Hyperparathyroidism, transient neonatal, 618188 (3), Autosomal recessive
chr7	TRPV5	606679.0 | TRPV5, ECAC1, CAT2 | Transient receptor potential cation channel, subfamily V, member 5 | 56302.0 | ENSG00000127412 | nan | nan
chr7	LLCFC1	618946.0 | LLCFC1, C7orf34, SOF1 | LLLL motif- and CFNLAS motif-containing protein 1 | 135927.0 | ENSG00000165131 | nan | nan
chr7	KEL	613883.0 | KEL | Kell blood group | 3792.0 | ENSG00000197993 | nan | [Blood group, Kell], 110900 (3)
chr7	PIP	176720.0 | PIP | Prolactin-inducible protein | 5304.0 | ENSG00000159763 | nan | nan
chr7	TAS2R40	613964.0 | TAS2R40, T2R40 | Taste receptor, type 2, member 40 | 259286.0 | ENSG00000221937 | nan | nan
chr7	GSTK1	602321.0 | GSTK1 | Glutathione S-transferase, kappa-1 | 373156.0 | ENSG00000197448 | nan | nan
chr7	TMEM139	616524.0 | TMEM139 | Transmembrane protein 139 | 135932.0 | ENSG00000178826 | nan | nan
chr7	CASP2	600639.0 | CASP2, NEDD2, ICH1, MRT80 | Caspase 2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2) | 835.0 | ENSG00000106144 | nan | Intellectual developmental disorder, autosomal recessive 80, with variant lissencephaly, 620653 (3), Autosomal recessive
chr7	CLCN1	118425.0 | CLCN1 | Chloride channel-1, skeletal muscle | 1180.0 | ENSG00000188037 | nan | Myotonia congenita, recessive, 255700 (3), Autosomal recessive; Myotonia congenita, dominant, 160800 (3), Autosomal dominant; Myotonia levior, 160800 (3), Autosomal dominant
chr7	FAM131B	619282.0 | FAM131B, KIAA0773 | Family with sequence similarity 131, member B | 9715.0 | ENSG00000159784 | nan | nan
chr7	ZYX	602002.0 | ZYX | Zyxin | 7791.0 | ENSG00000159840 | nan | nan
chr7	EPHA1	179610.0 | EPHA1, EPHT1 | eph tyrosine kinase 1 (erythropoietin-producing hepatoma amplified sequence; oncogene EPH; ephrin receptor EphA1) | 2041.0 | ENSG00000146904 | nan | nan
chr7	GPDS1	600510.0 | OPDG, GPDS1, PDS1 | Ocular pigment dispersion with or without glaucoma | 7986.0 | nan | nan | Ocular pigment dispersion with or without glaucoma, 600510 (2), Autosomal dominant
chr7	SLI4	612514.0 | SLI4 | Specific language impairment 4 | 100233227.0 | nan | associated with rs1723629 | {Specific language impairment 4}, 612514 (2)
chr7	TAS2R60	613968.0 | TAS2R60, T2R60 | Taste receptor, type 2, member 60 | 338398.0 | ENSG00000185899 | nan | nan
chr7	TAS2R41	613965.0 | TAS2R41, T2R59 | Taste receptor, type 2, member 41 | 259287.0 | ENSG00000221855 | nan | nan
chr7	TCAF2	616252.0 | TCAF2, FAM115C, FAM139A | TRPM8 channel-associated factor 2 | 285966.0 | ENSG00000170379 | nan | nan
chr7	TCAF1	616251.0 | TCAF1, FAM115A, KIAA0738 | TRPM8 channel-associated factor 1 | 9747.0 | ENSG00000198420 | nan | nan
chr7	OR2F1	608497.0 | OR2F1, OLF3 | Olfactory receptor, family 2, subfamily F, member 1 | 26211.0 | ENSG00000213215 | nan | nan
chr7	CTAGE4	608910.0 | CTAGE4 | Cutaneous T-cell lymphoma-associated antigen 4 | 100128553.0 | ENSG00000288784 | nan | nan
chr7	ARHGEF5	600888.0 | ARHGEF5, TIM | Rho guanine nucleotide exchange factor-5 (oncogene TIM) | 7984.0 | ENSG00000050327 | nan | nan
chr7	NOBOX	610934.0 | NOBOX, POF5 | NOBOX oogenesis homeobox | 135935.0 | ENSG00000106410 | nan | Premature ovarian failure 5, 611548 (3), Autosomal dominant
chr7	TPK1	606370.0 | TPK1, THMD5 | Thiamine pyrophosphokinase | 27010.0 | ENSG00000196511 | nan | Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3), Autosomal recessive
chr7	CNTNAP2	604569.0 | CNTNAP2, CASPR2, NRXN4, AUTS15, PTHSL1 | Contactin-associated protein-like 2 | 26047.0 | ENSG00000174469 | nan | Pitt-Hopkins like syndrome 1, 610042 (3), Autosomal recessive; {Autism susceptibility 15}, 612100 (3)
chr7	ACRPS	605967.0 | ACRPS | Acropectoral syndrome | 85505.0 | nan | nan | Acropectoral syndrome, 605967 (2), Autosomal dominant
chr7	AD10	609636.0 | AD10 | Alzheimer disease-10 | 780912.0 | nan | max lod with D7S798 | Alzheimer disease-10, 609636 (2), Autosomal dominant
chr7		611016.0 | AUTS10 | Autism, susceptibility to, 10 | nan | nan | max lod at D7S483 | {Autism, susceptibility to, 10}, 611016 (2)
chr7	CUL1	603134.0 | CUL1 | Cullin 1 | 8454.0 | ENSG00000055130 | nan | nan
chr7	EZH2	601573.0 | EZH2, EZH1, WVS | Enhancer of zeste, Drosophila, homolog of, 2 | 2146.0 | ENSG00000106462 | pseudogene on 21q22 | Weaver syndrome, 277590 (3), Autosomal dominant
chr7	RNY5	601824.0 | RNY5, Y5 | RNA, Y5 small cytoplasmic | 6090.0 | nan | nan | nan
chr7	RNY4	601823.0 | RNY4, Y4 | RNA, Y4 small cytoplasmic | 6086.0 | ENSG00000252316 | nan | nan
chr7	RNY3	601822.0 | RNY3, Y3 | RNA, Y3 small cytoplasmic | 6085.0 | ENSG00000202354 | nan | nan
chr7	RNY1	601821.0 | RNY1, Y1 | RNA, Y1 small cytoplasmic | 6084.0 | ENSG00000201098 | nan | nan
chr7	GHET1	619888.0 | GHET1 | Gastric carcinoma proliferation-enhancing transcript 1, noncoding | 102723099.0 | ENSG00000281189 | nan | nan
chr7	PDIA4	620018.0 | PDIA4 | Protein disulfide isomerase, family A, member 4 | 9601.0 | ENSG00000155660 | nan | nan
chr7	ZNF425	619507.0 | ZNF425 | Zinc finger protein 425 | 155054.0 | ENSG00000204947 | nan | nan
chr7	ZNF398	618593.0 | ZNF398, ZER6 | Zinc finger protein 398 | 57541.0 | ENSG00000197024 | nan | nan
chr7	ZNF282	603397.0 | ZNF282, HUB1 | Zinc finger protein 282 | 8427.0 | ENSG00000170265 | nan | nan
chr7	ZNF212	602386.0 | ZNF212, ZNFC150, ZNF182 | Zinc finger protein 212 | 7988.0 | ENSG00000170260 | nan | nan
chr7	ZNF777	619298.0 | ZNF777 | Zinc finger protein 777 | 27153.0 | ENSG00000196453 | nan | nan
chr7	ZNF746	613914.0 | ZNF746, PARIS | Zinc finger protein 746 | 155061.0 | ENSG00000181220 | nan | nan
chr7	ZNF467	614040.0 | ZNF467, EZI, ZFP467 | Zinc finger protein 467 | 168544.0 | ENSG00000181444 | nan | nan
chr7	SSPOP	617356.0 | SSPOP, SSPO | SCO-spondin, pseudogene | 23145.0 | ENSG00000197558 | nan | nan
chr7	ZNF862	620974.0 | ZNF862 | Zinc finger protein 862 | 643641.0 | ENSG00000106479 | nan | nan
chr7	ATP6V0E2	611019.0 | ATP6V0E2 | ATPase, H+ transporting, V0 subunit E2 | 155066.0 | ENSG00000171130 | nan | nan
chr7		615171.0 | LOC100134040 | LOC100134040 gene | 100134040.0 | nan | nan | nan
chr7	ZBED10P	615252.0 | ZBED10P, ZBED6CL, C7orf29 | Zinc finger BED-type containing 10, pseudogene | 113763.0 | nan | nan | nan
chr7	RARRES2	601973.0 | RARRES2, TIG2 | Retinoic acid receptor responder 2 | 5919.0 | ENSG00000106538 | nan | nan
chr7	REPIN1	619039.0 | REPIN1, RIP60, AP4 | Replication initiator 1 | 29803.0 | ENSG00000214022 | nan | nan
chr7	GIMAP8	616962.0 | GIMAP8 | GTPase, IMAP family, member 8 | 155038.0 | ENSG00000171115 | nan | nan
chr7	GIMAP7	616961.0 | GIMAP7 | GTPase IMAP family, member 7 | 168537.0 | ENSG00000179144 | nan | nan
chr7	GIMAP4	608087.0 | GIMAP4, IMAP4, IAN1 | GTPase, IMAP family, member 4 | 55303.0 | ENSG00000133574 | nan | nan
chr7	GIMAP6	616960.0 | GIMAP6 | GTPase, IMAP family, member 6 | 474344.0 | ENSG00000133561 | nan | nan
chr7	GIMAP2	608085.0 | GIMAP2, IMAP2 | GTPase, IMAP family, member 2 | 26157.0 | ENSG00000106560 | nan | nan
chr7	GIMAP1	608084.0 | GIMAP1, IMAP1 | GTPase, IMAP family, member 1 | 170575.0 | ENSG00000213203 | nan | nan
chr7	GIMAP5	608086.0 | GIMAP5, IAN4L1, IMAP3, NCPH2 | GTPase, IMAP family, member 5 | 55340.0 | ENSG00000196329 | nan | Portal hypertension, noncirrhotic, 2, 619463 (3), Autosomal recessive
chr7	TMEM176B	610385.0 | LR8 | LR8 protein | 28959.0 | ENSG00000106565 | nan | nan
chr7	TMEM176A	610334.0 | TEM176A, HCA112, GS188 | Transmembrane protein 176A | 55365.0 | ENSG00000002933 | nan | nan
chr7	AOC1	104610.0 | AOC1, ABP1, DAO1 | Amine oxidase, copper-containing, 1 | 26.0 | ENSG00000002726 | nan | nan
chr7	KCNH2	152427.0 | KCNH2, LQT2, HERG, SQT1 | Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene) | 3757.0 | ENSG00000055118 | nan | Short QT syndrome 1, 609620 (3); Long QT syndrome 2, 613688 (3), Autosomal dominant
chr7	NOS3	163729.0 | NOS3 | Nitric oxide synthase 3, endothelial cell | 4846.0 | ENSG00000164867 | nan | {Coronary artery spasm 1, susceptibility to} (3); {Hypertension, susceptibility to}, 145500 (3), Multifactorial; {Placental abruption} (3); {Alzheimer disease, late-onset, susceptibility to}, 104300 (3), Autosomal dominant; {Hypertension, pregnancy-induced}, 189800 (3), Autosomal dominant; {Ischemic stroke, susceptibility to}, 601367 (3), Multifactorial
chr7	ATG9B	612205.0 | ATG9B, NOS3AS, APG9L2, SONE | Autophagy related 9B | 285973.0 | ENSG00000181652 | nan | nan
chr7	ABCB8	605464.0 | ABCB8, MABC1 | ATP-binding cassette, subfamily B, member 8 | 11194.0 | ENSG00000197150 | nan | nan
chr7	ASIC3	611741.0 | ACCN3, ASIC3, TNAC1, DRASIC | Cation channel, amiloride-sensitive, neuronal 3 | 9311.0 | ENSG00000213199 | nan | nan
chr7	CDK5	123831.0 | CDK5, LIS7 | Cyclin-dependent kinase 5 | 1020.0 | ENSG00000164885 | mutation identified in 1 LIS7 family | ?Lissencephaly 7 with cerebellar hypoplasia, 616342 (3), Autosomal recessive
chr7	SLC4A2	109280.0 | SLC4A2, AE2, EPB3L1, OPTB9 | Solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1) | 6522.0 | ENSG00000164889 | mutation identified in 1 OPTB9 patient | ?Osteopetrosis, autosomal recessive 9, 620366 (3), Autosomal recessive
chr7	FASTK	606965.0 | FASTK, FAST | Fas-activated serine/threonine kinase | 10922.0 | ENSG00000164896 | nan | nan
chr7	TMUB1	614792.0 | TMUB1, DULP, SB144, C7orf21 | Transmembrane and ubiquitin-like domain-containing protein 1 | 83590.0 | ENSG00000164897 | nan | nan
chr7	AGAP3	616813.0 | AGAP3, CENTG3, CRAG | ARF GTPase-activating protein with GTPase domain, ankyrin repeat, and pleckstrin homology domain 3 | 116988.0 | ENSG00000133612 | nan | nan
chr7	GBX1	603354.0 | GBX1 | Gastrulation brain homeobox 1 | 2636.0 | ENSG00000164900 | nan | nan
chr7	ASB10	615054.0 | ASB10, GLC1F | Ankyrin repeat- and SOCS box-containing protein 10 | 136371.0 | ENSG00000146926 | nan | Glaucoma 1, open angle, F, 603383 (3), Autosomal dominant
chr7	ABCF2	612510.0 | ABCF2, HUSSY18 | ATP-binding cassette, subfamily F, member 2 | 10061.0 | ENSG00000033050 | nan | nan
chr7	CHPF2	608037.0 | CHPF2, KIAA1402, CSGlcAT | Chondroitin polymerizing factor 2 | 54480.0 | ENSG00000033100 | nan | nan
chr7	MIR671	615245.0 | MIR671 | Micro RNA 671 | 768213.0 | ENSG00000284191 | nan | nan
chr7	SMARCD3	601737.0 | SMARCD3, BAF60C | SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily D, member 3 | 6604.0 | ENSG00000082014 | nan | nan
chr7	NUB1	607981.0 | NUB1 | Negative regulator of ubiquitin-like proteins 1 | 51667.0 | ENSG00000013374 | nan | nan
chr7	CRYGN	609603.0 | CRYGN | Crystallin, gamma-N | 155051.0 | ENSG00000127377 | nan | nan
chr7	RHEB	601293.0 | RHEB, RHEB2 | Ras homolog enriched in brain | 6009.0 | ENSG00000106615 | nan | nan
chr7	PRKAG2	602743.0 | PRKAG2, WPWS, CMH6 | Protein kinase, AMP-activated, noncatalytic, gamma-2 | 51422.0 | ENSG00000106617 | nan | Glycogen storage disease of heart, lethal congenital, 261740 (3), Autosomal dominant; Wolff-Parkinson-White syndrome, 194200 (3), Autosomal dominant; Cardiomyopathy, hypertrophic 6, 600858 (3), Autosomal dominant
chr7	GALNTL5	615133.0 | GALNTL5, GALNACT19 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5 | 168391.0 | ENSG00000106648 | nan | nan
chr7	GALNT11	615130.0 | GALNT11, GALNACT11 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 | 63917.0 | ENSG00000178234 | nan | nan
chr7	KMT2C	606833.0 | KMT2C, MLL3, KIAA1506, KLEFS2 | Lysine (K)-specific methyltransferase 2C | 58508.0 | ENSG00000055609 | nan | Kleefstra syndrome 2, 617768 (3), Autosomal dominant
chr7	XRCC2	600375.0 | XRCC2, FANCU, SPGF50, POF17 | X-ray repair cross complementing 2 | 7516.0 | ENSG00000196584 | mutation identified in 1 FANCU patient and 1 POF17 patient | Spermatogenic failure 50, 619145 (3), Autosomal recessive; ?Premature ovarian failure 17, 619146 (3), Autosomal recessive; ?Fanconi anemia, complementation group U, 617247 (3), Autosomal recessive
chr7	DPP6	126141.0 | DPP6, VF2, MRD33 | Dipeptidylpeptidase VI | 1804.0 | ENSG00000130226 | nan | Intellectual developmental disorder, autosomal dominant 33, 616311 (3), Autosomal dominant; {Ventricular fibrillation, paroxysmal familial, 2}, 612956 (3), Autosomal dominant
chr7	PAXIP1	608254.0 | PAXIP1, PAXIP1L, PTIP | PAX transcription activation domain-interacting protein 1 | 22976.0 | ENSG00000157212 | nan | nan
chr7	HTR5A	601305.0 | HTR5A | 5-hydroxytryptamine (serotonin) receptor-5A | 3361.0 | ENSG00000157219 | nan | nan
chr7		613959.0 | SCZD16, C16DUPq36.3, DUP7q36.3 | Chromosome 7q36.3 duplication syndrome, 362kb | nan | nan | 362kb duplication that includes VIPR2 | Schizophrenia 16, 613959 (4)
chr7	INSIG1	602055.0 | INSIG1 | Insulin-induced gene 1 | 3638.0 | ENSG00000186480 | nan | nan
chr7	BLACE	608450.0 | BLACE | B-cell acute lymphoblastic leukemia-expressed gene | 338436.0 | ENSG00000204960 | nan | nan
chr7	EN2	131310.0 | EN2 | Engrailed-2 | 2020.0 | ENSG00000164778 | nan | nan
chr7	CNPY1	612493.0 | CNPY1 | Canopy 1, zebrafish, homolog of | 285888.0 | ENSG00000146910 | nan | nan
chr7	RBM33	620833.0 | RBM33 | RNA-binding motif protein 33 | 155435.0 | ENSG00000184863 | nan | nan
chr7	SHH	600725.0 | SHH, HPE3, HLP3, SMMCI, MCOPCB5 | Sonic hedgehog signaling molecule | 6469.0 | ENSG00000164690 | separate from TPT1 | Single median maxillary central incisor, 147250 (3), Autosomal dominant; Holoprosencephaly 3, 142945 (3), Autosomal dominant; Microphthalmia/coloboma 5, 611638 (3), Autosomal dominant
chr7	RNF32-DT	610242.0 | C7orf13 | Chromosome 7 open reading frame 13 | 100506380.0 | ENSG00000182648 | overlaps RNF32 on the opposite strand | nan
chr7	RNF32	610241.0 | RNF32 | RING finger protein 32 | 140545.0 | ENSG00000105982 | nan | nan
chr7	LMBR1	605522.0 | LMBR1, ACHP, C7orf2, LSS, TPTPS | Limb development membrane protein 1 | 64327.0 | ENSG00000105983 | nan | Syndactyly, type IV, 186200 (3), Autosomal dominant; Laurin-Sandrow syndrome, 135750 (3), Autosomal dominant; Acheiropody, 200500 (3), Autosomal recessive; Triphalangeal thumb-polysyndactyly syndrome, 190605 (3), Autosomal dominant
chr7		620738.0 | ZRS | ZPA regulatory sequence | 105804841.0 | nan | nan | Polydactyly, preaxial II, 174500 (3), Autosomal dominant; Triphalangeal thumb, 174500 (3), Autosomal dominant; Tibia, hypoplasia or aplasia of, with polydactyly, 188740 (3), Autosomal recessive, Autosomal dominant
chr7	NOM1	611269.0 | NOM1, C7orf3 | Nucleolar protein with MIF4G domain 1 | 64434.0 | ENSG00000146909 | nan | nan
chr7	MNX1	142994.0 | MNX1, HLXB9, HOXHB9, SCRA1 | Motor neuron and pancreas homeobox 1 | 3110.0 | ENSG00000130675 | nan | Currarino syndrome, 176450 (3), Autosomal dominant
chr7	UBE3C	614454.0 | UBE3C, HECTH2, KIAA0010, KIAA10, NEDSMBA | Ubiquitin protein ligase E3C | 9690.0 | ENSG00000009335 | mutation identified in 1 NDSMBA | Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities, 620270 (3), Autosomal recessive
chr7	DNAJB6	611332.0 | DNAJB6, MRJ, DJ4, LGMDD1 | DNAJ/HSP40 homolog, subfamily B, member 6 | 10049.0 | ENSG00000105993 | nan | Muscular dystrophy, limb-girdle, autosomal dominant 1, 603511 (3), Autosomal dominant
chr7	PTPRN2	601698.0 | PTPRN2, IAR, ICAAR | Protein-tyrosine phosphatase, receptor-type, N, polypeptide 2 | 5799.0 | ENSG00000155093 | nan | nan
chr7	NCAPG2	608532.0 | NCAPG2, CAPG2, MTB, 3KS | Non-SMC condensin II complex subunit G2 | 54892.0 | ENSG00000146918 | nan | Khan-Khan-Katsanis syndrome, 618460 (3), Autosomal recessive
chr7	ESYT2	616691.0 | ESYT2, FAM62B | Extended synaptotagmin-like protein 2 | 57488.0 | ENSG00000117868 | nan | nan
chr7	DYNC2I1	615462.0 | WDR60, SRTD8, SRPS6 | WD repeat containing protein 60 | 55112.0 | ENSG00000126870 | nan | Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3), Autosomal recessive
chr7	VIPR2	601970.0 | VIPR2 | Vasoactive intestinal peptide receptor 2 | 7434.0 | ENSG00000106018 | nan | nan
chr7	AIS2	608391.0 | AIS2, VAMAS3 | Autoimmune disease, susceptibility to, 2 | 378426.0 | nan | nan | {Autoimmune disease, susceptibility to, 2}, 608391 (2)
chr8	DBA2	606129.0 | DBA2 | Diamond-Blackfan anemia 2 | 114086.0 | nan | nan | Diamond-Blackfan anemia 2, 606129 (2)
chr8	GEFSP6	612279.0 | GEFSP6 | Generalized epilepsy with febrile seizures plus, type 6 | 100190787.0 | nan | between D8S1706 and D8S549 | Generalized epilepsy with febrile seizures plus, type 6, 612279 (2)
chr8	MYP10	609259.0 | MYP10 | Myopia 10 | 553195.0 | nan | nan | Myopia 10, 609259 (2), Multifactorial
chr8	TDH	615174.0 | TDH | L-threonine dehydrogenase, pseudogene | 157739.0 | ENSG00000293451 | nan | nan
chr8	WS2C	606662.0 | WS2C | Waardenburg syndrome, type 2C | 170594.0 | nan | nan | Waardenburg syndrome, type 2C, 606662 (2)
chr8	FBXO25	609098.0 | FBXO25, FBX25 | F-box only protein 25 | 26260.0 | ENSG00000147364 | nan | nan
chr8	TDRP	619049.0 | TDRP | Testis development-related protein | 157695.0 | ENSG00000180190 | nan | nan
chr8	DLGAP2	605438.0 | DLGAP2, DAP2 | Discs large associated protein 2 | 9228.0 | ENSG00000198010 | nan | nan
chr8	CLN8	607837.0 | CLN8, EPMR | CLN8 transmembrane ER and ERGIC protein | 2055.0 | ENSG00000182372 | nan | Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3), Autosomal recessive; Ceroid lipofuscinosis, neuronal, 8, 600143 (3), Autosomal recessive
chr8	ARHGEF10	608136.0 | ARHGEF10, KIAA0294, SNCV | Rho guanine nucleotide exchange factor 10 | 9639.0 | ENSG00000104728 | mutation identified in 1 SNCV family | ?Slowed nerve conduction velocity, AD, 608236 (3), Autosomal dominant
chr8	KBTBD11	618794.0 | KBTBD11, KIAA0711 | Kelch repeat- and BTB/POZ domain-containing protein 11 | 9920.0 | ENSG00000176595 | nan | nan
chr8	MYOM2	603509.0 | MYOM2 | Myomesin 2 | 9172.0 | ENSG00000036448 | nan | nan
chr8	CSMD1	608397.0 | CSMD1, KIAA1890 | Cub and Sushi multiple domains 1 | 64478.0 | ENSG00000183117 | nan | nan
chr8	DIH2	222400.0 | DIH2 | Diaphragmatic hernia 2 | 780899.0 | nan | nan | Diaphragmatic hernia 2, 222400 (2), Autosomal recessive
chr8	SLEB12	612254.0 | SLEB12 | Systemic lupus erythematosus, susceptibility to, 12 | 100190928.0 | nan | associated with rs13277113 | {Systemic lupus erythematosus, susceptibility to, 12}, 612254 (2)
chr8	MCPH1	607117.0 | MCPH1 | Microcephalin | 79648.0 | ENSG00000147316 | genetic heterogeneity | Microcephaly 1, primary, autosomal recessive, 251200 (3), Autosomal recessive
chr8	ANGPT2	601922.0 | ANGPT2, ANG2, LMPHM10 | Angiopoietin 2 | 285.0 | ENSG00000091879 | close to MCPH1 | Lymphatic malformation 10, 619369 (3), Autosomal dominant
chr8	AGPAT5	614796.0 | AGPAT5 | 1-acylglycerol-3-phosphate O-acyltransferase 5 | 55326.0 | ENSG00000155189 | nan | nan
chr8	DEFB1	602056.0 | DEFB1 | Defensin, beta-1 | 1672.0 | ENSG00000164825 | nan | nan
chr8	DEFA6	600471.0 | DEFA6, DEF6 | Defensin, alpha-6, Paneth cell-specific | 1671.0 | ENSG00000164822 | nan | nan
chr8	DEFA4	601157.0 | DEFA4, DEF4, HP4 | Defensin, alpha-4, corticostatin | 1669.0 | ENSG00000164821 | nan | nan
chr8	DEFA1	125220.0 | DEFA1, DEF1, MRS | Defensin, alpha-1, myeloid-related sequence | 1667.0 | ENSG00000206047 | nan | nan
chr8	DEFA3	604522.0 | DEFA3, DEF3, HNP3 | Defensin, alpha, 3 | 1668.0 | ENSG00000239839 | nan | nan
chr8	DEFA5	600472.0 | DEFA5, DEF5 | Defensin, alpha-5, Paneth cell-specific | 1670.0 | ENSG00000164816 | nan | nan
chr8	FAM90A15	613051.0 | FAM90A15P, FAM90A15 | Family with sequence similarity 90, member A15, pseudogene | 389630.0 | ENSG00000230045 | copy 1 | nan
chr8	FAM90A3	613042.0 | FAM90A3P, FAM90A3 | Family with sequence similarity 90, member A3, pseudogene | 389611.0 | ENSG00000233132 | copy 2 | nan
chr8	FAM90A13	613049.0 | FAM90A13P, FAM90A13 | Family with sequence similarity 90, member A13, pseudogene | 441314.0 | ENSG00000223885 | copy 4 | nan
chr8	FAM90A5	613043.0 | FAM90A5P, FAM90A5 | Family with sequence similarity 90, member A5, pseudogene | 441315.0 | ENSG00000215373 | copy 5 | nan
chr8	FAM90A20	613054.0 | FAM90A20P, FAM90A20 | Family with sequence similarity 90, member A20, pseudogene | 728430.0 | ENSG00000233295 | copy 6 | nan
chr8	DEFB103B	606611.0 | DEFB103A, DEFB3, HBD3, HBP3 | Defensin, beta 103A | 55894.0 | ENSG00000177243 | nan | nan
chr8	SPAG11B	606560.0 | SPAG11B, HE2, EP2 | Sperm-associated antigen 11B | 10407.0 | ENSG00000164871 | nan | nan
chr8	FAM90A7	613044.0 | FAM90A7P, FAM90A7 | Family with sequence similarity 90, member A7, pseudogene | 441317.0 | ENSG00000285975 | copy 8 | nan
chr8	FAM90A14	613050.0 | FAM90A14P, FAM90A14 | Family with sequence similarity 90, member A14, pseudogene | 645651.0 | ENSG00000285814 | copy 12 | nan
chr8	FAM90A18	613052.0 | FAM90A18P, FAM90A18 | Family with sequence similarity 90, member A18, pseudogene | 441326.0 | ENSG00000285913 | copy 13 | nan
chr8	FAM90A8	613045.0 | FAM90A8P, FAM90A8 | Family with sequence similarity 90, member A8, pseudogene | 441324.0 | ENSG00000285937 | copy 15 | nan
chr8	FAM90A19	613053.0 | FAM90A19P, FAM90A19 | Family with sequence similarity 90, member A19, pseudogene | 728753.0 | ENSG00000285657 | copy 17 | nan
chr8	FAM90A9	613046.0 | FAM90A9P, FAM90A9 | Family with sequence similarity 90, member A9, pseudogene | 441327.0 | ENSG00000285607 | copy 18 | nan
chr8	FAM90A10	613047.0 | FAM90A10P, FAM90A10 | Family with sequence similarity 90, member A10, pseudogene | 441328.0 | ENSG00000285950 | copy 19 | nan
chr8	DEFB4A	602215.0 | DEFB4A, DEFB4, DEFB2 | Defensin, beta-4a (formerly defensin, beta-2) | 1673.0 | ENSG00000171711 | nan | nan
chr8	FAM90A12	613048.0 | FAM90A12P, FAM90A12 | Family with sequence similarity 90, member A12, pseudogene | 645879.0 | ENSG00000254229 | copy 22 | nan
chr8	PRAG1	617344.0 | PRAG1, PRAGMIN, NACK | PEAK1-related kinase-activating pseudokinase 1 | 157285.0 | ENSG00000275342 | nan | nan
chr8	CLDN23	609203.0 | CLDN23 | Claudin 23 | 137075.0 | ENSG00000253958 | nan | nan
chr8	MFHAS1	605352.0 | MFHAS1, MASL1 | Malignant fibrous histiocytoma-amplified sequences with leucine-rich tandem repeats-1 | 9258.0 | ENSG00000147324 | nan | Malignant fibrous histiocytoma, 605352 (2)
chr8	ERI1	608739.0 | ERI1, HEXO, SEMDGC, HXAL | Exoribonuclease 1 | 90459.0 | ENSG00000104626 | nan | Hoxha-Aliu syndrome, 620662 (3), Autosomal recessive; Spondyloepimetaphyseal dysplasia, Guo-Campeau type, 620663 (3), Autosomal recessive
chr8	PPP1R3B	610541.0 | PPP1R3B, GL | Protein phosphatase 1, regulatory subunit 3B | 79660.0 | ENSG00000173281 | nan | nan
chr8	TNKS	603303.0 | TNKS, TNKS1 | Tankyrase | 8658.0 | ENSG00000173273 | nan | nan
chr8	MIR124-1	609327.0 | MIR124-1, MIR124A | Micro RNA 124-1 | 406907.0 | ENSG00000284321 | nan | nan
chr8	MSRA	601250.0 | MSRA | Peptide methionine sulfoxide reductase | 4482.0 | ENSG00000175806 | nan | nan
chr8	PRSS55	615144.0 | PRSS55, TSP1 | Protease, serine, 55 | 203074.0 | ENSG00000184647 | nan | nan
chr8	RP1L1	608581.0 | RP1L1, OCMD, RP88 | RP1-like protein 1 | 94137.0 | ENSG00000183638 | nan | Occult macular dystrophy, 613587 (3), Autosomal dominant; Retinitis pigmentosa 88, 618826 (3), Autosomal recessive
chr8	SOX7	612202.0 | SOX7 | SRY-box 7 | 83595.0 | ENSG00000171056 | nan | nan
chr8	PINX1	606505.0 | PINX1 | PIN2-interacting protein 1 | 54984.0 | ENSG00000254093 | nan | nan
chr8	MTMR9	606260.0 | MTMR9, MTMR8 | Myotubularin-related protein 9 | 66036.0 | ENSG00000104643 | nan | nan
chr8	SLC35G5	615199.0 | SLC35G5, AMAC, AMAC1L2 | Solute carrier family 35, member G5 | 83650.0 | ENSG00000177710 | nan | nan
chr8	FAM167A	610085.0 | FAM167A, C8orf13 | Family with sequence similarity 167, member A | 83648.0 | ENSG00000154319 | nan | nan
chr8	BLK	191305.0 | BLK, MODY11 | BLK protooncogene, SRC family tyrosinase kinase | 640.0 | ENSG00000136573 | nan | Maturity-onset diabetes of the young, type 11, 613375 (3), Autosomal dominant
chr8	GATA4	600576.0 | GATA4, ASD2, VSD1, TACHD, TOF | GATA-binding protein-4 | 2626.0 | ENSG00000136574 | mutations identified in 1 TACHD family | Tetralogy of Fallot, 187500 (3), Autosomal dominant; Atrial septal defect 2, 607941 (3), Autosomal dominant; Ventricular septal defect 1, 614429 (3), Autosomal dominant; Atrioventricular septal defect 4, 614430 (3), Autosomal dominant; ?Testicular anomalies with or without congenital heart disease, 615542 (3), Autosomal dominant
chr8	NEIL2	608933.0 | NEIL2, NEI2 | Endonuclease VIII-like 2 | 252969.0 | ENSG00000154328 | nan | nan
chr8	FDFT1	184420.0 | FDFT1, DGPT, SQSD | Farnesyl-diphosphate farnesyltransferase 1 (squalene synthase) | 2222.0 | ENSG00000079459 | nan | Squalene synthase deficiency, 618156 (3), Autosomal recessive
chr8	CTSB	116810.0 | CTSB, CPSB, RECEUP | Cathepsin B (regulatory element, cis-acting, enhancer upstream of CTSB, included) | 1508.0 | ENSG00000164733 | KWE due to duplication upstream of CTSB that disrupts a cis-acting regulatory element | Keratolytic winter erythema, 148370 (4), Autosomal dominant
chr8	USP17L2	610186.0 | USP17L2, DUB3 | Ubiquitin specific peptidase 17-like family member 2 | 377630.0 | ENSG00000223443 | nan | nan
chr8	FAM86B1	616122.0 | FAM86B1 | Family with sequence similarity 86, member B1 | 85002.0 | ENSG00000186523 | nan | nan
chr8	FAM86B2	616123.0 | FAM86B2 | Family with sequence similarity 86, member B2 | 653333.0 | ENSG00000145002 | nan | nan
chr8	ANIB11	614252.0 | ANIB11 | Aneurysm, intracranial berry, 11 | 100750328.0 | nan | max lod at D8S552 | Aneurysm, intracranial berry, 11, 614252 (2)
chr8	CHDS9	612030.0 | CHDS9 | Coronary heart disease, susceptibility to, 9 | 100188877.0 | nan | max lod at D8S1106 | {Coronary heart disease, susceptibility to, 9}, 612030 (2)
chr8	DFNB71	612789.0 | DFNB71 | Deafness, autosomal recessive 71 | 100302513.0 | nan | max lod at D8S261 | Deafness, autosomal recessive 71, 612789 (2), Autosomal recessive
chr8	TRMT9B	615666.0 | TRMT9B, TRM9L, KIAA1456 | Putative tRNA methyltransferase 9B | 57604.0 | ENSG00000250305 | nan | nan
chr8	DLC1	604258.0 | DLC1 | DLC1 Rho GTPase activating protein | 10395.0 | ENSG00000164741 | nan | Colorectal cancer, somatic, 114500 (3)
chr8	SGCZ	608113.0 | SGCZ, ZSG1 | Sarcoglycan, zeta | 137868.0 | ENSG00000185053 | nan | nan
chr8	TUSC3	601385.0 | TUSC3, M33, D8S1992, MRT7, MRT22 | Tumor suppressor candidate 3 | 7991.0 | ENSG00000104723 | nan | Intellectual developmental disorder, autosomal recessive 7, 611093 (3), Autosomal recessive
chr8	MSR1	153622.0 | MSR1, SCARA1, SRA | Macrophage scavenger receptor | 4481.0 | ENSG00000038945 | ~11cM distal to LPL | Barrett esophagus/esophageal adenocarcinoma, 614266 (3)
chr8	FGF20	605558.0 | FGF20, RHDA2 | Fibroblast growth factor-20 | 26281.0 | ENSG00000078579 | mutation identified in 1 RHDA2 family | ?Renal hypodysplasia/aplasia 2, 615721 (3), Autosomal recessive
chr8	MICU3	610633.0 | MICU3, EFHA2 | Mitochondrial calcium uptake protein 3 | 286097.0 | ENSG00000155970 | nan | nan
chr8	ZDHHC2	618621.0 | ZDHHC2, DHHC2, ZNF372, REAM | Zinc finger DHHC-type palmitoyltransferase 2 | 51201.0 | ENSG00000104219 | nan | nan
chr8	CNOT7	604913.0 | CNOT7, CAF1 | CCR4-NOT transcription complex, subunit 7 | 29883.0 | ENSG00000198791 | nan | nan
chr8	VPS37A	609927.0 | VPS37A, HCRP1, SPG53 | VPS37A subunit of ESCRIT-I | 137492.0 | ENSG00000155975 | nan | Spastic paraplegia 53, autosomal recessive, 614898 (3), Autosomal recessive
chr8	MTMR7	603562.0 | MTMR7 | Myotubularin-related protein 7 | 9108.0 | ENSG00000003987 | nan | nan
chr8	SLC7A2	601872.0 | SLC7A2, ATRC2, HCAT2 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 | 6542.0 | ENSG00000003989 | nan | nan
chr8	PDGFRL	604584.0 | PDGFRL, PDGRL, PRLTS | Platelet-derived growth factor receptor-like | 5157.0 | ENSG00000104213 | nan | Hepatocellular cancer, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3)
chr8	MTUS1	609589.0 | MTUS1, ATIP, KIAA1288 | Microtubule-associated scaffold protein 1 | 57509.0 | ENSG00000129422 | nan | nan
chr8	FGL1	605776.0 | FGL1, HFREP1 | Fibrinogen-like 1 | 2267.0 | ENSG00000104760 | nan | nan
chr8	PCM1	600299.0 | PCM1, PTC4 | Pericentriolar material 1 | 5108.0 | ENSG00000078674 | fused with RET to form PTC4 | nan
chr8	ASAH1	613468.0 | ASAH1, AC, SMAPME | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | 427.0 | ENSG00000104763 | nan | Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3), Autosomal recessive; Farber lipogranulomatosis, 228000 (3), Autosomal recessive
chr8	NAT1	108345.0 | NAT1, AAC1 | Arylamine N-acetyltransferase-1 | 9.0 | ENSG00000171428 | nan | nan
chr8	NAT2	612182.0 | NAT2, AAC2 | Arylamine N-acetyltransferase-2 | 10.0 | ENSG00000156006 | acetylation polymorphism | [Acetylation, slow], 243400 (3), Autosomal recessive
chr8	PSD3	614440.0 | PSD3, HCA67, EFA6R | Pleckstrin and Sec7 domains-containing protein 3 | 23362.0 | ENSG00000156011 | nan | nan
chr8	SCZD6	603013.0 | SCZD6 | Schizophrenia susceptibility locus, chromosome 8p-related | 8400.0 | nan | ?neuregulin 1 | {Schizophrenia}, 181500 (2), Autosomal dominant
chr8	SH2D4A	614968.0 | SH2D4A, SH2A, PPP1R38 | SH2 domain-containing protein 4A | 63898.0 | ENSG00000104611 | nan | nan
chr8	CSGALNACT1	616615.0 | CSGALNACT1, SDJLABA | Chondroitin sulfate N-acetylgalactosaminyltransferase 1 | 55790.0 | ENSG00000147408 | nan | Skeletal dysplasia, mild, with joint laxity and advanced bone age, 618870 (3), Autosomal recessive
chr8	INTS10	611353.0 | INTS10, INT10 | Integrator complex subunit 10 | 55174.0 | ENSG00000104613 | nan | nan
chr8	LPL	609708.0 | LPL, LIPD, HDLCQ11 | Lipoprotein lipase | 4023.0 | ENSG00000175445 | nan | Lipoprotein lipase deficiency, 238600 (3), Autosomal recessive; [High density lipoprotein cholesterol level QTL 11], 238600 (3), Autosomal recessive; Combined hyperlipidemia, familial, 144250 (3), Autosomal dominant
chr8	SLC18A1	193002.0 | SLC18A1, VMAT1, VAT1, CGAT | Solute carrier family 18 (vesicular monoamine), member 1 | 6570.0 | ENSG00000036565 | nan | nan
chr8	ATP6V1B2	606939.0 | ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2 | ATPase, H+ transporting, V1 subunit B2 | 526.0 | ENSG00000147416 | nan | Zimmermann-Laband syndrome 2, 616455 (3), Autosomal dominant; Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3), Autosomal dominant
chr8	LZTS1	606551.0 | LZTS1, F37, FEZ1 | Leucine zipper, putative tumor suppressor 1 | 11178.0 | ENSG00000061337 | nan | Esophageal squamous cell carcinoma, somatic, 133239 (3)
chr8	GFRA2	601956.0 | GFRA2, GDNFRB | GDNF family receptor alpha-2 | 2675.0 | ENSG00000168546 | nan | nan
chr8	DOK2	604997.0 | DOK2, P56DOK | Docking protein 2 | 9046.0 | ENSG00000147443 | nan | nan
chr8	XPO7	606140.0 | XPO7, RANBP16, KIAA0745 | Exportin 7 | 23039.0 | ENSG00000130227 | nan | nan
chr8	NPM2	608073.0 | NPM2 | Nucleophosmin/nucleoplasmin family, member 2 | 10361.0 | ENSG00000158806 | nan | nan
chr8	FGF17	603725.0 | FGF17, HH20 | Fibroblast growth factor 17 | 8822.0 | ENSG00000158815 | nan | Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3), Autosomal dominant
chr8	DMTN	125305.0 | EPB49, DMT | Erythrocyte membrane protein band 49 (dematin) | 2039.0 | ENSG00000158856 | nan | nan
chr8	FHIP2B	620230.0 | FHIP2B, FAI16, RAM160B2 | FHF complex subunit hook-interacting protein 2B | 64760.0 | ENSG00000158863 | nan | nan
chr8	NUDT18	615791.0 | NUDT18, MTH3 | Nudix hydrolase 18 | 79873.0 | ENSG00000275074 | nan | nan
chr8	HR	602302.0 | HR, AU, MUHH1 | HR lysine demethylase and nuclear receptor corepressor | 55806.0 | ENSG00000168453 | nan | Atrichia with papular lesions, 209500 (3), Autosomal recessive; Alopecia universalis, 203655 (3), Autosomal recessive
chr8	HRURF	619257.0 | HRURF, U2HR | HR upstream open reading frame, U2HR | 120766137.0 | ENSG00000288677 | nan | Hypotrichosis 4, 146550 (3), Autosomal dominant
chr8	REEP4	609349.0 | REEP4, C8orf20 | Receptor expression-enhancing protein 4 | 80346.0 | ENSG00000168476 | nan | nan
chr8	LGI3	608302.0 | LGI3, IDDMDS | Leucine-rich gene, glioma-inactivated, 3 | 203190.0 | ENSG00000168481 | nan | Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects, 620007 (3), Autosomal recessive
chr8	SFTPC	178620.0 | SFTPC, SFTP2, SMDP2 | Surfactant, pulmonary-associated protein C (pulmonary surfactant apoprotein-2, SP-C) | 6440.0 | ENSG00000168484 | nan | Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3), Autosomal dominant
chr8	BMP1	112264.0 | BMP1, OI13 | Bone morphogenetic protein-1 | 649.0 | ENSG00000168487 | 1kb 3' to SFTP2 | Osteogenesis imperfecta, type XIII, 614856 (3), Autosomal recessive
chr8	PHYHIP	608511.0 | PHYHIP, PAHXAP1, KIAA0273 | Phytanoyl-CoA hydroxylase-interacting protein | 9796.0 | ENSG00000168490 | nan | nan
chr8	MIR320A	614112.0 | MIR320A, MIRN320A | Micro RNA 320A | 407037.0 | ENSG00000208037 | nan | nan
chr8	POLR3D	187280.0 | POLR3D, BN51T, TSBN51 | Polymerase III, RNA, subunit D | 661.0 | ENSG00000168495 | nan | nan
chr8	PIWIL2	610312.0 | PIWIL2, MILI | PIWI-like RNA-mediated gene silencing 2 | 55124.0 | ENSG00000197181 | nan | nan
chr8	SLC39A14	608736.0 | SLC39A14, ZIP14, KIAA0062, HMNDYT2, HCIN | Solute carrier family 39 (zinc transporter), member 14 | 23516.0 | ENSG00000104635 | mutation identified in 1 HCTN family | ?Hyperostosis cranalis interna, 144755 (3), Autosomal dominant; Hypermanganesemia with dystonia 2, 617013 (3), Autosomal recessive
chr8	PPP3CC	114107.0 | PPP3CC, CALNA3 | Protein phosphatase-3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) | 5533.0 | ENSG00000120910 | nan | nan
chr8	SORBS3	610795.0 | SORBS3, SCAM1, SH3D4 | Sorbin and SH3 domains-containing 3 | 10174.0 | ENSG00000120896 | nan | nan
chr8	PDLIM2	609722.0 | PDLIM2, MYSTIQUE | PDZ and LIM domain protein 2 | 64236.0 | ENSG00000120913 | nan | nan
chr8	CCAR2	607359.0 | CCAR2, DBC1, KIAA1967 | Cell division cycle and apoptosis regulator 2 | 57805.0 | ENSG00000158941 | nan | nan
chr8	BIN3	606396.0 | BIN3 | Bridging integrator 3 | 55909.0 | ENSG00000147439 | nan | nan
chr8	EGR3	602419.0 | EGR3 | Early growth response 3 | 1960.0 | ENSG00000179388 | nan | nan
chr8	PEBP4	612473.0 | PEPB4, CORK1 | Phosphatidylethanolamine-binding protein 4 | 157310.0 | ENSG00000134020 | nan | nan
chr8	RHOBTB2	607352.0 | RHOBTB2, DBC2, KIAA0717, DEE64 | Rho-related BTB domain-containing protein 2 | 23221.0 | ENSG00000008853 | nan | Developmental and epileptic encephalopathy 64, 618004 (3), Autosomal dominant
chr8	TNFRSF10B	603612.0 | TNFRSF10B, DR5, TRAILR2 | Tumor necrosis factor receptor superfamily, member 10B | 8795.0 | ENSG00000120889 | nan | Squamous cell carcinoma, head and neck, 275355 (3), Autosomal recessive
chr8	TNFRSF10C	603613.0 | TNFRSF10C, DCR1, TRAILR3, TRID | Tumor necrosis factor receptor superfamily, member 10C | 8794.0 | ENSG00000173535 | nan | nan
chr8	TNFRSF10D	603614.0 | TNFRSF10D, DCR2, TRAILR4 | Tumor necrosis factor receptor superfamily, member 10D | 8793.0 | ENSG00000173530 | nan | nan
chr8	TNFRSF10A	603611.0 | TNFRSF10A, DR4, TRAILR1, APO2 | Tumor necrosis factor receptor superfamily, member 10A | 8797.0 | ENSG00000104689 | nan | nan
chr8	CHMP7	611130.0 | CHMP7 | Charged multivesicular body protein 7 | 91782.0 | ENSG00000147457 | nan | nan
chr8	LOXL2	606663.0 | LOXL2 | Lysyl oxidase-like 2 | 4017.0 | ENSG00000134013 | nan | nan
chr8	ENTPD4	607577.0 | ENTPD4, LYSAL1, LAP70, KIAA0392 | Ectonucleoside triphosphate diphosphohydrolase 4 | 9583.0 | ENSG00000197217 | nan | nan
chr8	SLC25A37	610387.0 | SLC25A37, MFRN, MFRN1 | Solute carrier family 25 (mitochondrial iron carrier), member 37 | 51312.0 | ENSG00000147454 | nan | nan
chr8	NKX3-1	602041.0 | NKX3-1, NKX3A, BAPX2 | NK3 homeobox 1 | 4824.0 | ENSG00000167034 | nan | nan
chr8	NKX2-6	611770.0 | NKX2-6, CSX2, CTHM | NK2, Drosophila, homolog of, 6 | 137814.0 | ENSG00000180053 | nan | Persistent truncus arteriosus, 217095 (3); Conotruncal heart malformations, 217095 (3)
chr8	STC1	601185.0 | STC1, STC | Stanniocalcin 1 | 6781.0 | ENSG00000159167 | nan | nan
chr8	ADAM28	606188.0 | ADAM28, MDCL | ADAM metallopeptidase domain 28 | 10863.0 | ENSG00000042980 | nan | nan
chr8	ADAMDEC1	606393.0 | ADAMDEC1, DECYSIN | ADAM-like decysin 1 | 27299.0 | ENSG00000134028 | nan | nan
chr8	ADAM7	607310.0 | ADAM7 | ADAM metallopeptidase domain 7 | 8756.0 | ENSG00000069206 | nan | nan
chr8	NEFM	162250.0 | NEFM, NEF3, NFM | Neurofilament protein, medium polypeptide | 4741.0 | ENSG00000104722 | nan | nan
chr8	NEFL	162280.0 | NEFL, CMT2E, CMT1F, CMTDIG | Neurofilament, light polypeptide | 4747.0 | ENSG00000277586 | nan | Charcot-Marie-Tooth disease, type 1F, 607734 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate G, 617882 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2E, 607684 (3), Autosomal dominant
chr8	DOCK5	616904.0 | DOCK5 | Dedicator of cytokinesis 5 | 80005.0 | ENSG00000147459 | nan | nan
chr8	GNRH1	152760.0 | GNRH1, LNRH, HH12 | Gonadotropin-releasing hormone-1 (luteinizing-releasing hormone) | 2796.0 | ENSG00000147437 | mutation identified in 1 HH12 family | ?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3), Autosomal recessive
chr8	KCTD9	617265.0 | KCTD9, BTBD27 | Potassium channel tetramerization domain-containing protein 9 | 54793.0 | ENSG00000104756 | nan | nan
chr8	CDCA2	618785.0 | CDCA2, PPP1R81 | Cell division cycle-associated protein 2 | 157313.0 | ENSG00000184661 | nan | nan
chr8	EBF2	609934.0 | EBF2 | Early B-cell factor 2 | 64641.0 | ENSG00000221818 | nan | nan
chr8	PPP2R2A	604941.0 | PPP2R2A | Protein phosphatase 2, regulatory subunit B, alpha | 5520.0 | ENSG00000221914 | nan | nan
chr8	BNIP3L	605368.0 | BNIP3L, NIX | BCL2/adenovirus E1B 19-kD protein-interacting protein 3-like | 665.0 | ENSG00000104765 | nan | nan
chr8	PNMA2	603970.0 | PNMA2, MA2, MM2 | Paraneoplastic MA antigen 2 | 10687.0 | ENSG00000240694 | nan | nan
chr8	DPYSL2	602463.0 | DPYSL2, DRP2, CRMP2 | Dihydropyrimidinase-like 2 | 1808.0 | ENSG00000092964 | nan | nan
chr8	ADRA1A	104221.0 | ADRA1C | Adrenergic, alpha-1C-, receptor | 148.0 | ENSG00000120907 | .03cM from NEFL | nan
chr8	STMN4	620740.0 | STMN4, RB3 | Stathmin 4 | 81551.0 | ENSG00000015592 | nan | nan
chr8	TRIM35	617007.0 | TRIM35, MAIR, HLS5, KIAA1098 | Tripartite motif-containing protein 35 | 23087.0 | ENSG00000104228 | nan | nan
chr8	PTK2B	601212.0 | PTK2B, FAK2, PYK2 | Protein tyrosine kinase-2, beta (focal adhesion kinase 2) | 2185.0 | ENSG00000120899 | nan | nan
chr8	CHRNA2	118502.0 | CHRNA2 | Cholinergic receptor, nicotinic, alpha polypeptide-2 | 1135.0 | ENSG00000120903 | nan | Epilepsy, nocturnal frontal lobe, type 4, 610353 (3), Autosomal dominant
chr8	EPHX2	132811.0 | EPHX2 | Epoxide hydrolase 2, cytoplasmic | 2053.0 | ENSG00000120915 | nan | {Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3), Autosomal recessive, Autosomal dominant
chr8	GULOP	240400.0 | GULOP, GULO | Gulonolactone (L-) oxidase pseudogene | 2989.0 | nan | nan | Scurvy (3)
chr8	SPG37	611945.0 | SPG37 | Spastic paraplegia 37 | 100049159.0 | nan | max lod at D8S601 | Spastic paraplegia 37, autosomal dominant, 611945 (2), Autosomal dominant
chr8	CLU	185430.0 | CLU, CLI, SGP2, TRPM2 | Clusterin (complement lysis inhibitor, SP-40,40; sulfated glycoprotein 2; testosterone-repressed prostate message-2; apolipoprotein J) | 1191.0 | ENSG00000120885 | nan | nan
chr8	SCARA3	602728.0 | SCARA3, MSLR1, CSR | Scavenger receptor class A, member 3 | 51435.0 | ENSG00000168077 | nan | nan
chr8	CCDC25	619100.0 | CCDC25 | Coiled-coil domain-containing protein 25 | 55246.0 | ENSG00000147419 | nan | nan
chr8	ESCO2	609353.0 | ESCO2, RBS, JHS | Establishment of sister chromatid cohesion N-acetyltransferase 2 | 157570.0 | ENSG00000171320 | nan | Juberg-Hayward syndrome, 216100 (3), Autosomal recessive; Roberts-SC phocomelia syndrome, 268300 (3), Autosomal recessive
chr8	PBK	611210.0 | PBK, TOPK | PDZ-binding kinase | 55872.0 | ENSG00000168078 | nan | nan
chr8	SCARA5	611306.0 | SCARA5 | Scavenger receptor class A, member 5 | 286133.0 | ENSG00000168079 | nan | nan
chr8	NUGGC	619088.0 | NUGGC, SLIPGC | Nuclear GTPase, germinal center-associated | 389643.0 | ENSG00000189233 | nan | nan
chr8	ELP3	612722.0 | ELP3, KAT9 | Elongator acetytransferase complex, subunit 3 | 55140.0 | ENSG00000134014 | nan | nan
chr8	PNOC	601459.0 | PNOC, PPNOC | Prepronociceptin | 5368.0 | ENSG00000168081 | nan | nan
chr8	ZNF395	609494.0 | ZNF395, PBF, HDBP2 | Zinc finger protein 395 | 55893.0 | ENSG00000186918 | nan | nan
chr8	FBXO16	608519.0 | FBXO16, FBX16 | F-box only protein 16 | 157574.0 | ENSG00000214050 | ?8p12 | nan
chr8	FZD3	606143.0 | FZD3 | Frizzled class receptor 3 | 7976.0 | ENSG00000104290 | nan | nan
chr8	EXTL3	605744.0 | EXTL3, EXTR1, ISDNA | Exostosin-like 3 | 2137.0 | ENSG00000012232 | nan | Immunoskeletal dysplasia with neurodevelopmental abnormalities, 617425 (3), Autosomal recessive
chr8	INTS9	611352.0 | INTS9, INT9, RC74 | Integrator complex subunit 9 | 55756.0 | ENSG00000104299 | nan | nan
chr8	HMBOX1	618610.0 | HMBOX1, TAH1, PBHNF | Homeobox-containing protein 1 | 79618.0 | ENSG00000147421 | nan | nan
chr8	AD12	611073.0 | AD12 | Alzheimer disease 12 | 100188830.0 | nan | max lod at D8S1119 | {Alzheimer disease 12}, 611073 (2)
chr8	THPH9	612348.0 | THPH9 | Thrombophilia due to decreased release of tissue plasminogen activator | 137299211.0 | nan | nan | ?Thrombophilia 9 due to decreased release of tissue plasminogen, 612348 (2)
chr8	KIF13B	607350.0 | KIF13B, GAKIN, KIAA0639 | Kinesin family member 13B | 23303.0 | ENSG00000197892 | nan | nan
chr8	DUSP4	602747.0 | DUSP4, MKP2, HVH2 | Dual-specificity phosphatase-4 (MAP kinase phosphatase-2) | 1846.0 | ENSG00000120875 | nan | nan
chr8	SARAF	614768.0 | TMEM66, SARAF | Transmembrane protein 66 | 51669.0 | ENSG00000133872 | nan | nan
chr8	LEPROTL1	607338.0 | LEPROTL1 | Leptin receptor overlapping transcript-like 1 | 23484.0 | ENSG00000104660 | nan | nan
chr8	MBOAT4	611940.0 | MBOAT4, GOAT | Membrane-bound O-acetyltransferase domain-containing 4 | 619373.0 | ENSG00000177669 | nan | nan
chr8	DCTN6	612963.0 | DCTN6, WS3, P27 | Dynactin 6 | 10671.0 | ENSG00000104671 | nan | nan
chr8	RBPMS	601558.0 | RBPMS | RNA-binding protein, mRNA-processing factor | 11030.0 | ENSG00000157110 | nan | nan
chr8	GTF2E2	189964.0 | GTF2E2, TTD6 | General transcription factor IIE, polypeptide 2, beta subunit, 34kD | 2961.0 | ENSG00000197265 | nan | Trichothiodystrophy 6, nonphotosensitive, 616943 (3), Autosomal recessive
chr8	GSR	138300.0 | GSR, GSRD, CNSHA10 | Glutathione reductase | 2936.0 | ENSG00000104687 | nan | Anemia, congenital, nonspherocytic hemolytic, 10, glutathione reductase deficient, 618660 (3), Autosomal recessive
chr8	UBXN8	602155.0 | UBXN8, D8S2298E, REP8 | UBX domain protein 8 | 7993.0 | ENSG00000104691 | nan | nan
chr8	PPP2CB	176916.0 | PPP2CB | Protein phosphatase-2 (formerly 2A), catalytic subunit, beta isoform | 5516.0 | ENSG00000104695 | pseudogene on 16 | nan
chr8	TEX15	605795.0 | TEX15, SPGF25 | Testis-expressed gene 15 | 56154.0 | ENSG00000133863 | nan | Spermatogenic failure 25, 617960 (3), Autosomal recessive
chr8	PURG	618041.0 | PURG, PURGA, PURGB | Purine-rich element-binding protein G | 29942.0 | ENSG00000172733 | nan | nan
chr8	WRN	604611.0 | RECQL2, RECQ3, WRN | DNA helicase, RecQ-like 2 | 7486.0 | ENSG00000165392 | nan | Werner syndrome, 277700 (3), Autosomal recessive
chr8	NRG1	142445.0 | NRG1, HGL, HRGA, ARIA | Neuregulin 1 (heregulin, alpha, 45kD; ERBB2 p185-activator) | 3084.0 | ENSG00000157168 | nan | {?Schizophrenia, susceptibility to}, 603013 (1)
chr8	FUT10	616931.0 | FUT10, FUCTX | Fucosyltransferase 10 | 84750.0 | ENSG00000172728 | nan | nan
chr8	TTI2	614426.0 | TTI2, C8orf41, MRT39 | TELO2-interacting protein 2 | 80185.0 | ENSG00000129696 | nan | Intellectual developmental disorder, autosomal recessive 39, 615541 (3), Autosomal recessive
chr8	SNORD13	616664.0 | SNORD13 | Small nucleolar RNA, C/D box, 13 | 692084.0 | ENSG00000239039 | nan | nan
chr8	RNF122	620523.0 | RNF122 | RING finger protein 122 | 79845.0 | ENSG00000133874 | nan | nan
chr8	DUSP26	618368.0 | DUSP26, MKP8, LDP4, NEAP | Dual-specificity phosphatase 26 | 78986.0 | ENSG00000133878 | nan | nan
chr8	UNC5D	616466.0 | UNC5D, UNC5H4 | unc-5 netrin receptor D | 137970.0 | ENSG00000156687 | nan | nan
chr8		613523.0 | SCLL | Chromosome 8p11 myeloproliferative syndrome (stem cell leukemia/lymphoma) | nan | nan | translocation of FGFR1 (8p11) and various partners | Chromosome 8p11 myeloproliferative syndrome, 613523 (4)
chr8	KCNU1	615215.0 | KCNU1, SLO3, SPGF79 | Potassium channel, subfamily U, member 1 | 157855.0 | ENSG00000215262 | nan | Spermatogenic failure 79, 620196 (3), Autosomal recessive
chr8	ZNF703	617045.0 | ZNF703, ZEPPO1, NLZ1 | Zinc finger protein 703 | 80139.0 | ENSG00000183779 | nan | nan
chr8	ERLIN2	611605.0 | ERLIN2, SPFH2, C8orf2, SPG18A, SPG18B | Endoplasmic reticulum lipid raft-associated protein 2 | 11160.0 | ENSG00000147475 | nan | Spastic paraplegia 18A, autosomal dominant, 620512 (3), Autosomal dominant; Spastic paraplegia 18B, autosomal recessive, 611225 (3), Autosomal recessive
chr8	PLPBP	604436.0 | PLPBP, PROSC, EPVB6D, EPEO1 | Pyridoxal phosphate-binding protein | 11212.0 | ENSG00000147471 | nan | Epilepsy, early-onset, 1, vitamin B6-dependent, 617290 (3), Autosomal recessive
chr8	ADGRA2	606823.0 | ADGRA2, GPR124, TEM5, KIAA1531 | Adhesion G protein-coupled receptor A2 | 25960.0 | ENSG00000020181 | nan | nan
chr8	BRF2	607013.0 | BRF2, BRFU, TFIIIB50 | BRF2 subunit of RNA polymerase III transcription initiation factor | 55290.0 | ENSG00000104221 | nan | nan
chr8	RAB11FIP1	608737.0 | RAB11FIP1, RCP | RAB11 family-interacting protein 1 | 80223.0 | ENSG00000156675 | nan | nan
chr8	ADRB3	109691.0 | ADRB3 | Adrenergic, beta-3-, receptor | 155.0 | ENSG00000188778 | nan | {Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant
chr8	EIF4EBP1	602223.0 | EIF4EBP1, 4EBP1 | Eukaryotic translation initiation factor-4E binding protein-1 | 1978.0 | ENSG00000187840 | nan | nan
chr8	ASH2L	604782.0 | ASH2L, ASH2L2, ASH2L1 | ASH2, Drosophila, homolog of | 9070.0 | ENSG00000129691 | nan | nan
chr8	STAR	600617.0 | STAR | Steroidogenic acute regulatory protein | 6770.0 | ENSG00000147465 | nan | Lipoid adrenal hyperplasia, 201710 (3), Autosomal recessive
chr8	LSM1	607281.0 | LSM1, CASM | LSM1 homolog, mRNA degradation-associated | 27257.0 | ENSG00000175324 | nan | nan
chr8	BAG4	603884.0 | BAG4, SODD | BAG cochaperone 4 | 9530.0 | ENSG00000156735 | nan | nan
chr8	DDHD2	615003.0 | DDHD2, KIAA0725, SPG54 | DDHD domain-containing protein 2 | 23259.0 | ENSG00000085788 | nan | Spastic paraplegia 54, autosomal recessive, 615033 (3), Autosomal recessive
chr8	PLPP5	610626.0 | PLPP5, PPAPDC1B, HTPAP | Phospholipid phosphatase 5 | 84513.0 | ENSG00000147535 | nan | nan
chr8	NSD3	607083.0 | NSD3, WHSC1L1 | Nuclear receptor-binding SET domain protein 3 | 54904.0 | ENSG00000147548 | pseudogene on 17q21; fusion partner with NUP98 in AML | nan
chr8	LETM2	620380.0 | LETM2 | Leucine zipper/EF-hand-containing transmembrane protein 2 | 137994.0 | ENSG00000165046 | nan | nan
chr8	FGFR1	136350.0 | FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL | Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2) | 2260.0 | ENSG00000077782 | fused with BCR, CEP1, FOP, FIM in hematologic malignancies | Pfeiffer syndrome, 101600 (3), Autosomal dominant; Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3), Autosomal dominant; Jackson-Weiss syndrome, 123150 (3), Autosomal dominant; Hartsfield syndrome, 615465 (3), Autosomal dominant; Trigonocephaly 1, 190440 (3), Autosomal dominant; Osteoglophonic dysplasia, 166250 (3), Autosomal dominant; Encephalocraniocutaneous lipomatosis, somatic mosaic, 613001 (3)
chr8	TACC1	605301.0 | TACC1 | Transforming, acidic, coiled-coil-containing protein-1 | 6867.0 | ENSG00000147526 | nan | nan
chr8	PLEKHA2	607773.0 | PLEKHA2, TAPP2 | Pleckstrin homology domain-containing protein, family A, member 2 | 59339.0 | ENSG00000169499 | nan | nan
chr8	HTRA4	610700.0 | HTRA4 | HTRA serine peptidase 4 | 203100.0 | ENSG00000169495 | nan | nan
chr8	TM2D2	610081.0 | TM2D2, BLP1 | TM2 domain-containing protein 2 | 83877.0 | ENSG00000169490 | nan | nan
chr8	ADAM9	602713.0 | ADAM9, MDC9, MCMP, CORD9 | ADAM metallopeptidase domain 9 | 8754.0 | ENSG00000168615 | nan | Cone-rod dystrophy 9, 612775 (3), Autosomal recessive
chr8	ADAM32	618602.0 | ADAM32 | ADAM metallopeptidase domain 32 | 203102.0 | ENSG00000197140 | nan | nan
chr8	ADAM18	619495.0 | ADAM18, TMDCIII | ADAM metallopeptidase domain-containing protein 18 | 8749.0 | ENSG00000168619 | nan | nan
chr8	ADAM2	601533.0 | ADAM2, FTNB, PH30, CRYN1, CRYN2 | ADAM metallopeptidase domain 2 (fertilin, beta) | 2515.0 | ENSG00000104755 | nan | nan
chr8	IDO1	147435.0 | IDO1, INDO, IDO | Indoleamine 2,3-dioxygenase | 3620.0 | ENSG00000131203 | nan | nan
chr8	IDO2	612129.0 | IDO2, INDOL1 | Indoleamine 2,3-dioxygenase 2 | 169355.0 | ENSG00000188676 | nan | nan
chr8	TCIM	607702.0 | TCIM, C8orf4 | Transcriptional and immune response regulator | 56892.0 | ENSG00000176907 | nan | nan
chr8	SFRP1	604156.0 | SFRP1, FRP, SARP2 | Secreted frizzled-related protein 1 | 6422.0 | ENSG00000104332 | nan | nan
chr8	GOLGA7	609453.0 | GOLGA7, GCP16 | Golgin A7 | 51125.0 | ENSG00000147533 | nan | nan
chr8	GINS4	610611.0 | GINS4, SLD5 | GINS complex subunit 4 | 84296.0 | ENSG00000147536 | nan | nan
chr8	GPAT4	608143.0 | AGPAT6, LPAATZ | 1-acylglycerol-3-phosphate O-acyltransferase 6 | 137964.0 | ENSG00000158669 | nan | nan
chr8	NKX6-3	610772.0 | NKX6-3, NKX6.3 | NK6, Drosophila, homolog of | 157848.0 | ENSG00000165066 | nan | nan
chr8	ANK1	612641.0 | ANK1, SPH1 | Ankyrin-1, erythrocytic | 286.0 | ENSG00000029534 | nan | Spherocytosis, type 1, 182900 (3), Autosomal recessive, Autosomal dominant
chr8	KAT6A	601408.0 | KAT6A, MYST3, MOZ, ZNF220, ARTHS | K(lysine) acetyltransferase 6A | 7994.0 | ENSG00000083168 | nan | Arboleda-Tham syndrome, 616268 (3), Autosomal dominant
chr8	AP3M2	610469.0 | AP3M2, CLA20 | Adaptor-related protein complex 3, mu-2 subunit | 10947.0 | ENSG00000070718 | nan | nan
chr8	PLAT	173370.0 | PLAT, TPA | Plasminogen activator, tissue type | 5327.0 | ENSG00000104368 | nan | nan
chr8	IKBKB	603258.0 | IKBKB, NFKBIKB, IMD15B, IMD15A | Inhibitor of nuclear factor kappa-B kinase, subunit beta | 3551.0 | ENSG00000104365 | nan | Immunodeficiency 15B, 615592 (3), Autosomal recessive; Immunodeficiency 15A, 618204 (3), Autosomal dominant
chr8	POLB	174760.0 | POLB | Polymerase (DNA directed), beta | 5423.0 | ENSG00000070501 | nan | nan
chr8	DKK4	605417.0 | DKK4 | Dickkopf WNT signaling pathway inhibitor 4 | 27121.0 | ENSG00000104371 | nan | nan
chr8	VDAC3	610029.0 | VDAC3 | Voltage-dependent anion channel 3 | 7419.0 | ENSG00000078668 | nan | nan
chr8	SLC20A2	158378.0 | SLC20A2, MLVAR, GLVR2, IBGC1, IBGC2 | Solute carrier family 20, phosphate transporter, member 2 | 6575.0 | ENSG00000168575 | nan | Basal ganglia calcification, idiopathic, 1, 213600 (3), Autosomal dominant
chr8	CHRNB3	118508.0 | CHRNB3 | Cholinergic receptor, nicotinic, beta polypeptide-3 | 1142.0 | ENSG00000147432 | nan | nan
chr8	CHRNA6	606888.0 | CHRNA6 | Cholinergic receptor, neuronal nicotinic, alpha polypeptide 6 | 8973.0 | ENSG00000147434 | nan | nan
chr8	THAP1	609520.0 | THAP1, DYT6 | THAP domain-containing protein 1 | 55145.0 | ENSG00000131931 | nan | Dystonia 6, torsion, 602629 (3), Autosomal dominant
chr8	RNF170	614649.0 | RNF170, SNAX1, SPG85 | RING finger protein 170 | 81790.0 | ENSG00000120925 | nan | Ataxia, sensory, 1, autosomal dominant, 608984 (3), Autosomal dominant; Spastic paraplegia 85, autosomal recessive, 619686 (3), Autosomal recessive
chr8	HOOK3	607825.0 | HOOK3, HK3 | Hook, Drosophila, homolog of, 3 | 84376.0 | ENSG00000168172 | nan | nan
chr8	FNTA	134635.0 | FNTA | Farnesyltransferase, CAAX box, alpha | 2339.0 | ENSG00000168522 | related FNTAL1 on 11, FNTAL2 on 13 | nan
chr8	POMK	615247.0 | POMK, SGK196, MDDGA12, MDDGC12 | Protein-O-mannose kinase | 84197.0 | ENSG00000185900 | mutation in 1 MDDGC12 family has been reported | ?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12, 616094 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3), Autosomal recessive
chr8	HGSNAT	610453.0 | HGSNAT, TMEM76, MPS3C, RP73 | Heparan-alpha-glucosaminide N-acetyltransferase | 138050.0 | ENSG00000165102 | nan | Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3), Autosomal recessive; Retinitis pigmentosa 73, 616544 (3), Autosomal recessive
chr8	POTEA	608915.0 | POTEA, POTE8 | POTE ankyrin domain family, member A | 340441.0 | ENSG00000188877 | nan | nan
chr8	CCAL1	600668.0 | CCAL1 | Chondrocalcinosis 1 | 882.0 | nan | nan | Chondrocalcinosis with early-onset osteoarthritis, 600668 (2), Autosomal dominant
chr8	HBFQTL4	606789.0 | HBFQTL4 | Fetal hemoglobin quantitative trait locus 4 | 171515.0 | nan | nan | Fetal hemoglobin quantitative trait locus 4, 606789 (2)
chr8	PAFC	128700.0 | PAFC | Preauricular fistulae, congenital | 404715.0 | nan | between D8S532 and D8S279 | ?Preauricular fistulae, congenital, 128700 (2), Autosomal dominant
chr8	LINC00293	609543.0 | LINC00293, BEYLA | Long intergenic noncoding RNA 293 | 497634.0 | ENSG00000253314 | nan | nan
chr8	GCCD3	609197.0 | GCCD3, FGD3, GCCD2 | Glucocorticoid deficiency 3 | 619477.0 | nan | between D8S285 and D8S1718 | Glucocorticoid deficiency 3, 609197 (2), Autosomal recessive
chr8	SPIDR	615384.0 | SPIDR, KIAA0146, ODG9 | Scaffolding protein involved in DNA repair | 23514.0 | ENSG00000164808 | nan | Ovarian dysgenesis 9, 619665 (3), Autosomal recessive
chr8	CEBPD	116898.0 | CEBPD | CCAAT/enhancer-binding protein (C/EBP), delta | 1052.0 | ENSG00000221869 | earlier mapped to 8q11 | nan
chr8	PRKDC	600899.0 | PRKDC, HYRC1, DNPK1, IMD26 | Protein kinase, DNA-activated, catalytic polypeptide (hyperradiosensitivity of murine SCID mutation, complementing-1) | 5591.0 | ENSG00000253729 | nan | Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive
chr8	MCM4	602638.0 | MCM4, NKGCD, NKCD, IMD54 | Minichromosome maintenance complex component 4 | 4173.0 | ENSG00000104738 | nan | Immunodeficiency 54, 609981 (3), Autosomal recessive
chr8	UBE2V2	603001.0 | UBE2V2, UEV2, DDVIT1, EDPF1, MMS2 | Ubiquitin-conjugating enzyme E2 V2 | 7336.0 | ENSG00000169139 | nan | nan
chr8	CLXN	619564.0 | CLXN, EFCAB1, CILD53 | Calaxin | 79645.0 | ENSG00000034239 | nan | Ciliary dyskinesia, primary, 53, 620642 (3), Autosomal recessive
chr8	SNAI2	602150.0 | SNAI2, SLUG, WS2D | Snail family transcriptional repressor 2 | 6591.0 | ENSG00000019549 | nan | nan
chr8	SNTG1	608714.0 | SNTG1, SYN4 | Syntrophin, gamma-1 | 54212.0 | ENSG00000147481 | implicated in idiopathic scoliosis | nan
chr8	PXDNL	615904.0 | PXDNL, PMR1, VPO2 | Peroxidasin, Drosophila, homolog-like | 137902.0 | ENSG00000147485 | nan | nan
chr8	PCMTD1	620091.0 | PCMTD1 | Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain-containing protein 1 | 115294.0 | ENSG00000168300 | nan | nan
chr8	ST18	617155.0 | ST18, ZNF387, KIAA0535 | Suppression of tumorigenicity 18 | 9705.0 | ENSG00000147488 | nan | nan
chr8	ALKAL1	619670.0 | ALKAL1, FAM150A, AUGB | ALK and LTK ligand 1 | 389658.0 | ENSG00000196711 | nan | nan
chr8	RB1CC1	606837.0 | RB1CC1, CC1, KIAA0203 | RB1-inducible coiled-coil 1 | 9821.0 | ENSG00000023287 | nan | Breast cancer, somatic, 114480 (3)
chr8	NPBWR1	600730.0 | NPBWR1, GPR7 | Neuropeptides B and W receptor 1 | 2831.0 | ENSG00000288611 | previously assigned to 10q11.2-q21.1 by FISH | nan
chr8	OPRK1	165196.0 | OPRK1 | Opiate receptor, kappa-1 | 4986.0 | ENSG00000082556 | nan | nan
chr8	ATP6V1H	608861.0 | ATP6V1H, NBP1, VMA13 | ATPase, H+ transporting V1, subunit H | 51606.0 | ENSG00000047249 | nan | nan
chr8	RGS20	607193.0 | RGS20 | Regulator of G protein signaling 20 | 8601.0 | ENSG00000147509 | nan | nan
chr8	TCEA1	601425.0 | TCEA1, TF2S, GTF2S | Transcription elongation factor A, SII, 1 | 6917.0 | ENSG00000187735 | previously mapped to 3p22-p21.3 | nan
chr8	LYPLA1	605599.0 | LYPLA1 | Lysophospholipase I | 10434.0 | ENSG00000120992 | nan | nan
chr8	MRPL15	611828.0 | MRPL15 | Mitochondrial ribosomal protein L15 | 29088.0 | ENSG00000137547 | nan | nan
chr8	SOX17	610928.0 | SOX17, VUR3 | SRY-box 17 | 64321.0 | ENSG00000164736 | nan | Vesicoureteral reflux 3, 613674 (3), Autosomal dominant
chr8	RP1	603937.0 | RP1, ORP1 | RP1 axonemal microtubule-associated protein | 6101.0 | ENSG00000104237 | nan | Retinitis pigmentosa 1, 180100 (3), Autosomal recessive, Autosomal dominant
chr8	ANIB10	612587.0 | ANIB10 | Aneurysm, intracranial berry, 10 | 100271689.0 | nan | associated with rs10958409 | {Aneurysm, intracranial berry, 10}, 612587 (2)
chr8		608765.0 | IS3 | Scoliosis, isolated, susceptibility to, 3 | nan | nan | nan | {Scoliosis, isolated, susceptibility to, 3}, 608765 (2)
chr8	MTBS2	611046.0 | MTBS2 | Mycobacterium tuberculosis, susceptibility to, 2 | 100188829.0 | nan | max lod at D8S1723 | {Mycobacterium tuberculosis, susceptibility to, 2}, 611046 (2)
chr8	TGS1	606461.0 | TGS1, NCOA6IP, PIMT | Trimethylguanosine synthase 1 | 96764.0 | ENSG00000137574 | nan | nan
chr8	LYN	165120.0 | LYN, SAIDV | LYN protooncogene, SRC family tyrosine kinase | 4067.0 | ENSG00000254087 | nan | Autoinflammatory disease, systemic, with vasculitis, 620376 (3), Autosomal dominant
chr8	RPS20	603682.0 | RPS20 | Ribosomal protein S20 | 6224.0 | ENSG00000008988 | nan | nan
chr8	MOS	190060.0 | MOS, MSV, OZEMA20 | MOS protooncogene, serine/threonine kinase | 4342.0 | ENSG00000172680 | nan | Oocyte/zygote/embryo maturation arrest 20, 620383 (3), Autosomal recessive
chr8	PLAG1	603026.0 | PLAG1, SGPA, PSA, SRS4 | PLAG1 zinc finger protein | 5324.0 | ENSG00000181690 | fused with CTNNB1 in SGPA | Adenomas, salivary gland pleomorphic, somatic, 181030 (3); Silver-Russell syndrome 4, 618907 (3), Autosomal dominant
chr8	CHCHD7	611238.0 | CHCHD7 | Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 | 79145.0 | ENSG00000170791 | nan | nan
chr8	SDR16C5	608989.0 | RDHE2 | Retinal dehydrogenase, epidermal, 2 | 195814.0 | ENSG00000170786 | nan | nan
chr8	PENK	131330.0 | PENK | Proenkephalin | 5179.0 | ENSG00000181195 | nan | nan
chr8	BPNT2	614010.0 | IMPAD1, GPAPP, IMPA3 | Inositol monophosphatase domain-containing protein 1 | 54928.0 | ENSG00000104331 | nan | Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3), Autosomal recessive
chr8	FAM110B	611394.0 | FAM110B, C8orf72 | Family with sequence similarity 110, member B | 90362.0 | ENSG00000169122 | nan | nan
chr8	UBXN2B	610686.0 | UBXN2B, LOC137886, p37 | UBX domain protein 2B | 137886.0 | ENSG00000215114 | nan | nan
chr8	CYP7A1	118455.0 | CYP7A1, CYP7 | Cytochrome P450, subfamily VII (cholesterol 7-alpha-monooxygenase), polypeptide 1 | 1581.0 | ENSG00000167910 | nan | nan
chr8	SDCBP	602217.0 | SDCBP, TACIP18, MDA9 | Syndecan-binding protein | 6386.0 | ENSG00000137575 | nan | nan
chr8	NSMAF	603043.0 | NSMAF, FAN | Neutral sphingomyelinase activation-associated factor | 8439.0 | ENSG00000035681 | nan | nan
chr8	TOX	606863.0 | TOX, KIAA0808 | Thymus high mobility group box protein, mouse, homolog of | 9760.0 | ENSG00000198846 | nan | nan
chr8	CA8	114815.0 | CA8, CALS, CARP, SCAR34 | Carbonic anhydrase VIII | 767.0 | ENSG00000178538 | nan | Spinocerebellar ataxia, autosomal recessive 34, 613227 (3), Autosomal recessive
chr8	RAB2A	179509.0 | RAB2, RAB2A | Ras-associated protein RAB2 | 5862.0 | ENSG00000104388 | nan | nan
chr8		600257.0 | DEL8q12q21, C8DELq12q21 | Bor-Duane hydrocephalus contiguous gene syndrome (chromosome 8q12.1-q21.2 deletion syndrome) | nan | nan | nan | Bor-Duane hydrocephalus contiguous gene syndrome, 600257 (4), Autosomal dominant
chr8	HDCPH1	123155.0 | HDCPH1 | Hydrocephalus, autosomal dominant | 137299210.0 | nan | nan | ?Hydrocephalus, autosomal dominant, 123155 (2), Autosomal dominant
chr8	CHD7	608892.0 | CHD7, HH5 | Chromodomain helicase DNA binding protein 7 | 55636.0 | ENSG00000171316 | nan | Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3), Autosomal dominant; CHARGE syndrome, 214800 (3), Autosomal dominant
chr8	CLVS1	611292.0 | CLVS1, RLBP1L1, CRALBPL | Clavesin 1 | 157807.0 | ENSG00000177182 | nan | nan
chr8	ASPH	600582.0 | ASPH, HAAH, FDLAB | Aspartate beta-hydroxylase (junctin; junctate) | 444.0 | ENSG00000198363 | nan | Traboulsi syndrome, 601552 (3), Autosomal recessive
chr8	NKAIN3	612872.0 | NKAIN3 | Na+/K+ transporting ATPase-interacting 3 | 286183.0 | ENSG00000185942 | nan | nan
chr8	GGH	601509.0 | GGH | Gamma-glutamyl hydrolase | 8836.0 | ENSG00000137563 | nan | nan
chr8	TTPA	600415.0 | TTPA, TTP1, AVED | Tocopherol, alpha, transfer protein | 7274.0 | ENSG00000137561 | nan | Ataxia with isolated vitamin E deficiency, 277460 (3), Autosomal recessive
chr8	YTHDF3	618669.0 | YTHDF3 | YTH N6-methyladenosine RNA-binding protein 3 | 253943.0 | ENSG00000185728 | nan | nan
chr8	BHLHE22	613483.0 | BHLHE22, BHLHB5, BETA3 | Basic helix-loop-helix family, member E22 | 27319.0 | ENSG00000180828 | nan | nan
chr8	CYP7B1	603711.0 | CYP7B1, CBAS3, SPG5A | Cytochrome P450, subfamily VIIB (oxysterol 7-alpha-hydroxylase), polypeptide 1 | 9420.0 | ENSG00000172817 | nan | Spastic paraplegia 5A, autosomal recessive, 270800 (3), Autosomal recessive; Bile acid synthesis defect, congenital, 3, 613812 (3), Autosomal recessive
chr8	CMT2H	607731.0 | CMT2H | Charcot-Marie-Tooth disease, axonal, type 2H | 619496.0 | nan | between D8S1807 and D8S548 | Charcot-Marie-Tooth disease, axonal, type 2H, 607731 (2), Autosomal recessive
chr8		600383.0 | DEL8q13, C8DELq13 | Mesomelia-synostoses syndrome (Chromosome 8q13 deletion syndrome) | nan | nan | contiguous gene deletion of SULF1 and SLCO5A1 | Mesomelia-synostoses syndrome, 600383 (4), Autosomal dominant
chr8	DURS1	126800.0 | DURS1, DUS | Duane retraction syndrome 1 | 10674.0 | nan | nan | Duane retraction syndrome 1, 126800 (2), Autosomal dominant
chr8	FEB1	121210.0 | FEB1 | Febrile seizures, familial, 1 | 2233.0 | nan | nan | Febrile seizures, familial, 1, 121210 (2), Autosomal dominant
chr8	ARMC1	620385.0 | ARMC1 | Armadillo repeat-containing protein 1 | 55156.0 | ENSG00000104442 | nan | nan
chr8	MTFR1	619414.0 | MTFR1, CHPPR, KIAA0009 | Mitochondrial fission regulator 1 | 9650.0 | ENSG00000066855 | nan | nan
chr8	PDE7A	171885.0 | PDE7A, HCP1 | Phosphodiesterase-7A | 5150.0 | ENSG00000205268 | nan | nan
chr8	DNAJC5B	613945.0 | DNAJC5B | DNAJ/HSP40 homolog, subfamily C, member 5, beta | 85479.0 | ENSG00000147570 | nan | nan
chr8	TRIM55	606469.0 | TRIM55, RNF29, MURF2 | Tripartite motif containing 55 | 84675.0 | ENSG00000147573 | nan | nan
chr8	CRH	122560.0 | CRH | Corticotropin releasing hormone | 1392.0 | ENSG00000147571 | nan | nan
chr8	RRS1	618311.0 | RRS1 | Ribosome biogenesis regulator 1 homolog | 23212.0 | ENSG00000179041 | nan | nan
chr8	ADHFE1	611083.0 | ADHFE1, HOT, ADH8 | Alcohol dehydrogenase, iron-containing, 1 | 137872.0 | ENSG00000147576 | nan | nan
chr8	MYBL1	159405.0 | MYBL1 | Avian myeloblastosis viral (v-myb) oncogene homolog like-1 | 4603.0 | ENSG00000185697 | nan | nan
chr8	VCPIP1	611745.0 | VCPIP1 VCIP135, KIAA1850 | VCP/p47 complex-interacting protein 1 | 80124.0 | ENSG00000175073 | nan | nan
chr8	SGK3	607591.0 | SGK3, SGKL, CISK | Serum/glucocorticoid-regulated kinase 3 | 23678.0 | ENSG00000104205 | nan | nan
chr8	MCMDC2	617545.0 | MCMDC2, C8orf45 | Minichromosome maintenance domain-containing protein 2 | 157777.0 | ENSG00000178460 | nan | nan
chr8	SNHG6	612215.0 | SNHG6, U87HG | Small nucleolar RNA host gene 6 | 641638.0 | nan | nan | nan
chr8	SNORD87	612216.0 | SNORD87, U87 | Small nucleolar RNA, C/D box, 87 | 641648.0 | ENSG00000254341 | within intron 2 of SNHG6 | nan
chr8	PPP1R42	617720.0 | PPP1R42, TLRR, LRRC67 | Protein phosphatase 1, regulatory subunit 42 | 286187.0 | ENSG00000178125 | nan | nan
chr8	COPS5	604850.0 | COPS5, JAB1, SGN5 | COP9, subunit 5 | 10987.0 | ENSG00000121022 | nan | nan
chr8	CSPP1	611654.0 | CSPP1, CSPP, JBTS21 | Centrosome spindle pole-associated protein 1 | 79848.0 | ENSG00000104218 | nan | Joubert syndrome 21, 615636 (3), Autosomal recessive
chr8	ARFGEF1	604141.0 | ARFGEF1, ARFGEP1, BIG1, P200, DEDISB | ADP-ribosylation factor guanine nucleotide exchange factor 1 | 10565.0 | ENSG00000066777 | nan | Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures, 619964 (3), Autosomal dominant
chr8	CPA6	609562.0 | CPA6, CPAH, ETL5, FEB11 | Carboxypeptidase A6 | 57094.0 | ENSG00000165078 | nan | Febrile seizures, familial, 11, 614418 (3), Autosomal recessive; Epilepsy, familial temporal lobe, 5, 614417 (3), Autosomal recessive, Autosomal dominant
chr8	PREX2	612139.0 | PREX2, DEPDC2 | Phosphatidylinositol 3,4,5-trisphosphate-dependent RAC exchanger 2 | 80243.0 | ENSG00000046889 | nan | nan
chr8	SULF1	610012.0 | SULF1, KIAA1077 | Sulfatase 1 | 23213.0 | ENSG00000137573 | nan | nan
chr8	BTF3P12	603738.0 | BTF3P12, BTF3L2 | Basic transcription factor 3 pseudogene 12 | 652963.0 | nan | nan | nan
chr8	SLCO5A1	613543.0 | SLCO5A1, OATPRP4, SLC21A15, OATPJ, OATP5A1 | Solute carrier organic anion transporter family, member 5A1 | 81796.0 | ENSG00000137571 | nan | nan
chr8	PRDM14	611781.0 | PRDM14, PFM11 | PR domain-containing protein 14 | 63978.0 | ENSG00000147596 | nan | nan
chr8	NCOA2	601993.0 | NCOA2, GRIP1, TIF2, SRC2 | Nuclear receptor coactivator 2 | 10499.0 | ENSG00000140396 | nan | nan
chr8	TRAM1	605190.0 | TRAM | Translocating chain-associating membrane protein | 23471.0 | ENSG00000067167 | nan | nan
chr8	LACTB2	618921.0 | LACTB2 | Lactamase, beta-2 | 51110.0 | ENSG00000147592 | nan | nan
chr8	EYA1	601653.0 | EYA1, BOR, BOS1, OTFCS | EYA transcriptional coactivator and phosphatase 1 | 2138.0 | ENSG00000104313 | mutation identified in 1 OTFCS family | Branchiootic syndrome 1, 602588 (3), Autosomal dominant; Branchiootorenal syndrome 1, with or without cataracts, 113650 (3), Autosomal dominant; Anterior segment anomalies with or without cataract, 602588 (3), Autosomal dominant; ?Otofaciocervical syndrome, 166780 (3), Autosomal dominant
chr8	MSC	603628.0 | MSC, ABF1, MYOR | Musculin | 9242.0 | ENSG00000178860 | nan | nan
chr8		614230.0 | DEL8q21.11, C8DELq21.11 | Chromosome 8q21.11 deletion syndrome | nan | nan | contiguous gene deletion; minimal region (GRCh37, 8:77226464-77766239) | Chromosome 8q21.11 deletion syndrome, 614230 (4), Isolated cases, Autosomal dominant
chr8	OPA6	258500.0 | OPA6 | Optic atrophy 6 | 777778.0 | nan | between D8S1702 and D8S1794 | Optic atrophy 6, 258500 (2), Autosomal recessive
chr8	TRPA1	604775.0 | TRPA1, ANKTM1, FEPS1 | Transient receptor potential cation channel, subfamily A, member 1 | 8989.0 | ENSG00000104321 | mutation identified in 1 FEPS1 family | ?Episodic pain syndrome, familial, 1, 615040 (3), Autosomal dominant
chr8	KCNB2	607738.0 | KCNB2, KV2.2 | Potassium channel, voltage-gated, shab-related subfamily, member 2 | 9312.0 | ENSG00000182674 | nan | nan
chr8	TERF1	600951.0 | TERF1, TRF1 | Telomeric repeat binding factor 1 | 7013.0 | ENSG00000147601 | nan | nan
chr8	RPL7	604166.0 | RPL7 | Ribosomal protein L7 | 6129.0 | ENSG00000147604 | pseudogene on chr.5 | nan
chr8	RDH10	607599.0 | RDH10 | Retinol dehydrogenase 10 | 157506.0 | ENSG00000121039 | nan | nan
chr8	STAU2	605920.0 | STAU2 | Staufen, Drosophila, homolog of, 2 | 27067.0 | ENSG00000040341 | nan | nan
chr8	UBE2W	614277.0 | UBE2W, UBC16 | Ubiquitin-conjugating enzyme E2 W | 55284.0 | ENSG00000104343 | nan | nan
chr8	ELOC	600788.0 | TCEB1 | Transcription elongation factor B, polypeptide 1, 15kD (elongin C) | 6921.0 | ENSG00000154582 | nan | nan
chr8	TMEM70	612418.0 | TMEM70, MC5DN2 | Transmembrane protein 70 | 54968.0 | ENSG00000175606 | nan | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3), Autosomal recessive
chr8	LY96	605243.0 | LY96, MD2 | Lymphocyte antigen 96 | 23643.0 | ENSG00000154589 | nan | nan
chr8	JPH1	605266.0 | JPH1, JP1, CMT2K, CMYO25 | Junctophilin 1 | 56704.0 | ENSG00000104369 | mutation identified in 1 CMT2Km family | Congenital myopathy 25, 620964 (3), Autosomal recessive; {?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, modifier of}, 607831 (3), Autosomal recessive, Autosomal dominant
chr8	GDAP1	606598.0 | GDAP1, CMT4A, CMT2K, CMTRIA | Ganglioside-induced differentiation-associated protein 1 | 54332.0 | ENSG00000104381 | nan | Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 4A, 214400 (3), Autosomal recessive
chr8	STQTL15	612578.0 | STQTL15 | Stature quantitative trait locus 15 | 100270801.0 | nan | associated with rs2220456 | {Stature QTL 15}, 612578 (2)
chr8	PI15	607076.0 | PI15, P25TI | Protease inhibitor 15 | 51050.0 | ENSG00000137558 | nan | nan
chr8	HNF4G	605966.0 | HNF4G | Hepatocyte nuclear factor 4-gamma | 3174.0 | ENSG00000164749 | nan | nan
chr8	ZFHX4	606940.0 | ZFHX4, ZFH4 | Zinc finger homeobox 4 | 79776.0 | ENSG00000091656 | nan | ?Ptosis, congenital, 178300 (2), Autosomal dominant
chr8	PEX2	170993.0 | PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3 | Peroxisome biogenesis factor 2 | 5828.0 | ENSG00000164751 | nan | Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3), Autosomal recessive; Peroxisome biogenesis disorder 5B, 614867 (3), Autosomal recessive
chr8	PKIA	606059.0 | PKIA | Protein kinase, cAMP-dependent catalytic, inhibitor alpha | 5569.0 | ENSG00000171033 | nan | nan
chr8	IL7	146660.0 | IL7 | Interleukin-7 | 3574.0 | ENSG00000104432 | mutation identified in 1 EV5 family | {?Epidermodysplasia verruciformis, susceptibility to, 5}, 618309 (3), Autosomal recessive
chr8	STMN2	600621.0 | STMN2, SCGN10, SCG10 | Stathmin-like 2 | 11075.0 | ENSG00000104435 | nan | nan
chr8	HEY1	602953.0 | HEY1, HERP2, HESR1 | HES-related family bHLH transcription factor with YRPW motif 1 | 23462.0 | ENSG00000164683 | nan | nan
chr8	MRPS28	611990.0 | MRPS28, MRPS35, COXPD47 | Mitochondrial ribosomal protein S28 | 28957.0 | ENSG00000147586 | mutation identified in 1 COXPD47 patient | ?Combined oxidative phosphorylation deficiency 47, 618958 (3), Autosomal recessive
chr8	TPD52	604068.0 | TPD52, D52 | Tumor protein D52 | 7163.0 | ENSG00000076554 | nan | nan
chr8	ZBTB10	618576.0 | ZBTB10, RINZF | Zinc finger and BTB domain-containing protein 10 | 65986.0 | ENSG00000205189 | nan | nan
chr8	PAG1	605767.0 | PAG | Phosphoprotein associated with glycosphingolipid-enriched microdomains | 55824.0 | ENSG00000076641 | nan | nan
chr8	FABP5	605168.0 | FABP5, PAFABP, EFABP | Fatty acid-binding protein 5 | 2171.0 | ENSG00000164687 | nan | nan
chr8	PMP2	170715.0 | PMP2, CMT1G | Peripheral myelin protein-2 | 5375.0 | ENSG00000147588 | nan | Charcot-Marie-Tooth disease, demyelinating, type 1G, 618279 (3), Autosomal dominant
chr8	FABP9	620856.0 | FABP9, PERF15 | Fatty acid-binding protein 9 | 646480.0 | ENSG00000205186 | nan | nan
chr8	FABP4	600434.0 | FABP4 | Fatty acid-binding protein-4, adipocyte | 2167.0 | ENSG00000170323 | nan | nan
chr8	FABP12	618923.0 | FABP12 | Fatty acid-binding protein 12 | 646486.0 | ENSG00000197416 | nan | nan
chr8	IMPA1	602064.0 | IMPA1, MRT59 | Inositol(myo)-1(or 4)-monophosphatase-1 | 3612.0 | ENSG00000133731 | nan | Intellectual developmental disorder, autosomal recessive 59, 617323 (3), Autosomal recessive
chr8	SLC10A5	618582.0 | SLC10A5, P5 | Solute carrier family 10 (sodium/bile acid cotransporter family), member A5 | 347051.0 | ENSG00000253598 | nan | nan
chr8	CHMP4C	610899.0 | CHMP4C, SNF7-3 | Charged multivesicular body protein 4C | 92421.0 | ENSG00000164695 | nan | nan
chr8	SNX16	614903.0 | SNX16 | Sorting nexin 16 | 64089.0 | ENSG00000104497 | nan | nan
chr8	RALYL	614648.0 | RALYL | RALY-like protein | 138046.0 | ENSG00000184672 | nan | nan
chr8	LRRCC1	617791.0 | LRRCC1, CLERK, KIAA1764 | Leucine-rich repeat- and coiled-coil domain-containing centrosomal protein 1 | 85444.0 | ENSG00000133739 | nan | nan
chr8	E2F5	600967.0 | E2F5 | E2F transcription factor 5 | 1875.0 | ENSG00000133740 | nan | nan
chr8	CA13	611436.0 | CA13 | Carbonic anhydrase XIII | 377677.0 | ENSG00000185015 | nan | nan
chr8	CA1	114800.0 | CA1 | Carbonic anhydrase I | 759.0 | ENSG00000133742 | nan | nan
chr8	CA3	114750.0 | CA3 | Carbonic anhydrase III | 761.0 | ENSG00000164879 | nan | nan
chr8	CA2	611492.0 | CA2 | Carbonic anhydrase II | 760.0 | ENSG00000104267 | CA1, CA2 linked in monkey and mouse | Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3), Autosomal recessive
chr8	PSKH2	620394.0 | PSKH2 | Protein serine kinase H2 | 85481.0 | ENSG00000147613 | nan | nan
chr8	ATP6V0D2	618072.0 | ATP6V0D2 | ATPase, H+ transporting, V0 subunit D2 | 245972.0 | ENSG00000147614 | nan | nan
chr8	SLC7A13	617256.0 | SLC7A13, AGT1, XAT2 | Solute carrier family 7, member 13 | 157724.0 | ENSG00000164893 | nan | nan
chr8	WWP1	602307.0 | WWP1, TIUL1 | WW domain-containing protein 1 | 11059.0 | ENSG00000123124 | nan | nan
chr8	RMDN1	611871.0 | RMDN1 FAM82B, RMD1 | Regulator of microtubule dynamics 1 | 51115.0 | ENSG00000176623 | nan | nan
chr8	CPNE3	604207.0 | CPNE3, CPN3 | Copine III | 8895.0 | ENSG00000085719 | nan | nan
chr8	CNGB3	605080.0 | CNGB3, ACHM3, ACHM1 | Cyclic nucleotide-gated channel, beta-3 | 54714.0 | ENSG00000170289 | nan | Achromatopsia 3, 262300 (3), Autosomal recessive
chr8	DCAF4L2	620421.0 | DCAF4L2 | DDB1- and CUL4-associated factor 4-like 2 | 138009.0 | ENSG00000176566 | nan | nan
chr8	MMP16	602262.0 | MMP16 | Matrix metalloproteinase 16 (membrane-inserted) | 4325.0 | ENSG00000156103 | nan | nan
chr8	RIPK2	603455.0 | RIPK2, CARDIAK, RIP2, RICK | Receptor-interacting serine/threonine kinase 2 | 8767.0 | ENSG00000104312 | nan | nan
chr8	OSGIN2	604598.0 | OSGIN2, C8orf1 | Oxidative stress-induced growth inhibitor family member 2 | 734.0 | ENSG00000164823 | nan | nan
chr8	NBN	602667.0 | NBN, NBS1 | Nibrin | 4683.0 | ENSG00000104320 | nan | Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive
chr8	DECR1	222745.0 | DECR1 | 2,4-dienoyl CoA reductase | 1666.0 | ENSG00000104325 | nan | nan
chr8	CALB1	114050.0 | CALB1 | Calbindin 1, 28kD | 793.0 | ENSG00000104327 | nan | nan
chr8	TMEM64	620429.0 | TMEM64 | Transmembrane protein 64 | 169200.0 | ENSG00000180694 | nan | nan
chr8	PIP4P2	609864.0 | TMEM55A | Transmembrane protein 55A | 55529.0 | ENSG00000155099 | nan | nan
chr8	OTUD6B	612021.0 | OTUD6B, DUBA5, IDDFSDA | OTU domain-containing protein 6B | 51633.0 | ENSG00000155100 | nan | Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies, 617452 (3), Autosomal recessive
chr8	SLC26A7	608479.0 | SLC26A7 | Solute carrier family 26 (sulfate transporter), member 7 | 115111.0 | ENSG00000147606 | nan | nan
chr8	RUNX1T1	133435.0 | RUNX1T1, CBFA2T1, AML1T1, ETO | unt-related transcription factor 1, translocated to, 1, cyclin D-related | 862.0 | ENSG00000079102 | fused with AML1 in t(8;21) | nan
chr8		619553.0 | DFNB118 | Deafness, autosomal recessive 118, with cochlear aplasia | nan | nan | deletion of 200kb downstream of GDF6 | Deafness, autosomal recessive 118, with cochlear aplasia, 619553 (4), Autosomal recessive
chr8		151200.0 | DUP8q22.1, C8DUPq22.1 | Chromosome 8q22.1 duplication syndrome (Leri pleonosteosis) | nan | nan | duplication of 0.9-1.2 Mb on 8q22.1 | Leri pleonosteosis chromosome duplication syndrome, 151200 (4), Autosomal dominant
chr8	HTC1	145701.0 | HTC1 | Hypertrichosis universalis congenita, Ambras type | 3341.0 | nan | nan | ?Hypertrichosis universalis congenita, Ambras type, 145701 (2), Autosomal dominant
chr8		608156.0 | NMLFS, DEL8q22.1, C8DELq22.1 | Nablus mask-like facial syndrome (chromosome 8q22.1 deletion syndrome) | nan | nan | nan | Nablus mask-like facial syndrome, 608156 (4), Autosomal dominant
chr8	CIBAR1	617273.0 | FAM92A, FAM92A1, PAPA9 | Family with sequence similarity 92, member A | 137392.0 | ENSG00000188343 | mutation identified in 1 PAPA9 family | ?Polydactyly, postaxial, type A9, 618219 (3), Autosomal recessive
chr8	TMEM67	609884.0 | TMEM67, MKS3, JBTS6, NPHP11 | Transmembrane protein 67 (meckelin) | 91147.0 | ENSG00000164953 | mutation identified in 1 RHYNS patient | Nephronophthisis 11, 613550 (3), Autosomal recessive; {Bardet-Biedl syndrome 14, modifier of}, 615991 (3), Autosomal recessive; Joubert syndrome 6, 610688 (3), Autosomal recessive; Meckel syndrome 3, 607361 (3), Autosomal recessive; ?RHYNS syndrome, 602152 (3), Autosomal recessive; COACH syndrome 1, 216360 (3), Autosomal recessive
chr8	PDP1	605993.0 | PDP1, PPM2C, PDPC | Pyruvate dehydrogenase phosphatase catalytic subunit 1 | 54704.0 | ENSG00000164951 | nan | Pyruvate dehydrogenase phosphatase deficiency, 608782 (3), Autosomal recessive
chr8	CDH17	603017.0 | CDH17, CDH16, HPT1 | Cadherin-17, liver-intestine | 1015.0 | ENSG00000079112 | nan | nan
chr8	GEM	600164.0 | GEM | GTP-binding protein overexpressed in skeletal muscle | 2669.0 | ENSG00000164949 | nan | nan
chr8	RAD54B	604289.0 | RAD54B | RAD54 homolog B | 25788.0 | ENSG00000197275 | nan | Colon cancer, somatic, 114500 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3)
chr8	FSBP	616306.0 | FSBP | Fibrinogen silencer-binding protein | 100861412.0 | ENSG00000265817 | nan | nan
chr8	VIRMA	616447.0 | VIRMA, KIAA0922 | VIR-like M6A methyltransferase-associated protein | 25962.0 | ENSG00000164944 | nan | nan
chr8	ESRP1	612959.0 | ESRP1, RMB35A, DFNB109 | Epithelial splicing regulatory protein 1 | 54845.0 | ENSG00000104413 | mutation identified in 1 DFNB109 family | ?Deafness, autosomal recessive 109, 618013 (3), Autosomal recessive
chr8	DPY19L4	613895.0 | DPY19L4 | DPY19-like 4 | 286148.0 | ENSG00000156162 | nan | nan
chr8	INTS8	611351.0 | INTS8, INT8, NEDCHS | Integrator complex subunit 8 | 55656.0 | ENSG00000164941 | mutation identified in 1 NEDCHS family | ?Neurodevelopmental disorder with cerebellar hypoplasia and spasticity, 618572 (3), Autosomal recessive
chr8	CCNE2	603775.0 | CCNE2 | Cyclin E2 | 9134.0 | ENSG00000175305 | nan | nan
chr8	NDUFAF6	612392.0 | NDUFAF6, C8orf38, MC1DN17, FRTS5 | NADH-ubiquinone oxidoreductase complex assembly factor 6 | 137682.0 | ENSG00000156170 | nan | Mitochondrial complex I deficiency, nuclear type 17, 618239 (3), Autosomal recessive; Fanconi renotubular syndrome 5, 618913 (3), Autosomal recessive
chr8	TP53INP1	606185.0 | TP53DINP1, P53DINP1 | Tumor protein p53 inducible nuclear protein 1 | 94241.0 | ENSG00000164938 | nan | nan
chr8	PLEKHF2	615208.0 | PLEKHF2, EAPF, PHAFIN2 | Pleckstrin homology domain-containing protein, family F, member 2 | 79666.0 | ENSG00000175895 | nan | nan
chr8	CFAP418	614477.0 | CFAP418, C8orf37, CORD16, RP64, BBS21 | Cilia- and flagella-associated protein 418 | 157657.0 | ENSG00000156172 | nan | Retinitis pigmentosa 64, 614500 (3), Autosomal recessive; Cone-rod dystrophy 16, 614500 (3), Autosomal recessive; Bardet-Biedl syndrome 21, 617406 (3), Autosomal recessive
chr8	GDF6	601147.0 | GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4 | Growth/differentiation factor 6 | 392255.0 | ENSG00000156466 | nan | Microphthalmia with coloboma 6, digenic, 613703 (3), Autosomal dominant; Microphthalmia, isolated 4, 613094 (3); Leber congenital amaurosis 17, 615360 (3), Autosomal recessive; Multiple synostoses syndrome 4, 617898 (3), Autosomal dominant; Klippel-Feil syndrome 1, autosomal dominant, 118100 (3), Autosomal dominant
chr8	UQCRB	191330.0 | UQCRB, UQBP, QPC, MC3DN3 | Ubiquinol-cytochrome c reductase binding protein | 7381.0 | ENSG00000156467 | nan | Mitochondrial complex III deficiency, nuclear type 3, 615158 (3), Autosomal recessive
chr8	MTERF3	616930.0 | MTERF3, MTERFD1 | Transcription termination factor 3, mitochondrial | 51001.0 | ENSG00000156469 | nan | nan
chr8	PTDSS1	612792.0 | PTDSS1, PSS1, KIAA0024, LMHD | Phosphatidylserine synthase 1 | 9791.0 | ENSG00000156471 | nan | Lenz-Majewski hyperostotic dwarfism, 151050 (3), Autosomal dominant
chr8	SDC2	142460.0 | SDC2, HSPG1 | Syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated; fibroglycan) | 6383.0 | ENSG00000169439 | nan | nan
chr8	CPQ	618754.0 | CPQ, PGCP | Carboxypeptidase Q | 10404.0 | ENSG00000104324 | nan | nan
chr8	TSPYL5	614721.0 | TSPYL5, KIAA1750 | TSPY-like 5 | 85453.0 | ENSG00000180543 | nan | nan
chr8	MTDH	610323.0 | MTDH, AEG1, LYRIC | Metadherin | 92140.0 | ENSG00000147649 | nan | nan
chr8	LAPTM4B	613296.0 | LAPTM4B | Lysosome-associated protein, transmembrane 4, beta | 55353.0 | ENSG00000104341 | pseudogenes on 1q, 3q,3p, 4q, and 7q33-q35 | nan
chr8	MATN2	602108.0 | MATN2 | Matrilin 2 | 4147.0 | ENSG00000132561 | nan | nan
chr8	RPL30	180467.0 | RPL30 | Ribosomal protein L30 | 6156.0 | ENSG00000156482 | nan | nan
chr8	ERICH5	620895.0 | ERICH5 | Glutamate-rich protein 5 | 203111.0 | ENSG00000177459 | nan | nan
chr8	RIDA	602487.0 | HRSP12, PSP, UK114 | Heat-responsive protein 12 | 10247.0 | ENSG00000132541 | nan | nan
chr8	POP1	602486.0 | POP1, ANXD2 | POP1 homolog, ribonuclease P/MRP subunit | 10940.0 | ENSG00000104356 | nan | Anauxetic dysplasia 2, 617396 (3), Autosomal recessive
chr8	STK3	605030.0 | STK3, MST2, KRS1 | Serine/threonine protein kinase 3 | 6788.0 | ENSG00000104375 | nan | nan
chr8	KCNS2	602906.0 | KCNS2 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member-2 | 3788.0 | ENSG00000156486 | nan | nan
chr8	OSR2	611297.0 | OSR2 | Odd-skipped-related 2 | 116039.0 | ENSG00000164920 | nan | nan
chr8	VPS13B	607817.0 | VPS13B, KIAA0532, COH1 | Vacuolar protein sorting 12 homolog B | 157680.0 | ENSG00000132549 | nan | Cohen syndrome, 216550 (3), Autosomal recessive
chr8	COX6C	124090.0 | COX6C | Cytochrome c oxidase, subunit VIc | 1345.0 | ENSG00000164919 | pseudogene on 16p12 | nan
chr8	RGS22	615650.0 | RGS22 | Regulator of G protein signaling 22 | 26166.0 | ENSG00000132554 | nan | nan
chr8	FBXO43	609110.0 | FBXO43, EMI2, ERP1, FBX43, SPGF64, OZEMA12 | F-box only protein 43 | 286151.0 | ENSG00000156509 | nan | Spermatogenic failure 64, 619696 (3), Autosomal recessive; Oocyte/zygote/embryo maturation arrest 12, 619697 (3), Autosomal recessive
chr8	POLR2K	606033.0 | POLR2K, RPB12 | Polymerase II, RNA, subunit K | 5440.0 | ENSG00000147669 | nan | nan
chr8	SPAG1	603395.0 | SPAG1, CILD28 | Sperm-associated antigen-1 | 6674.0 | ENSG00000104450 | nan | Ciliary dyskinesia, primary, 28, 615505 (3), Autosomal recessive
chr8	RNF19A	607119.0 | RNF19A, DORFIN | Ring finger protein 19A, RBR E3 ubiquitin protein ligase | 25897.0 | ENSG00000034677 | nan | nan
chr8	KTWS	149000.0 | KTWS, KTS | Klippel-Trenaunay-Weber syndrome | 791122.0 | nan | translocation with 14q13 | Klippel-Trenaunay-Weber syndrome, 149000 (2), Isolated cases
chr8	MMD2	613318.0 | MMD2 | Miyoshi muscular dystrophy 2 | 100505381.0 | nan | max lod at D10S2325 | Miyoshi muscular dystrophy 2, 613318 (2)
chr8	SNX31	619839.0 | SNX31 | Sorting nexin 31 | 169166.0 | ENSG00000174226 | nan | nan
chr8	PABPC1	604679.0 | PABPC1, PAB1, PABP1, PABP | Polyadenylate-binding protein, cytoplasmic, 1 | 26986.0 | ENSG00000070756 | nan | nan
chr8	YWHAZ	601288.0 | YWHAZ | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 7534.0 | ENSG00000164924 | pseudogene on 2p25 | nan
chr8	ZNF706	619526.0 | ZNF706, HSPC038 | Zinc finger protein 706 | 51123.0 | ENSG00000120963 | nan | nan
chr8	GRHL2	608576.0 | GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4 | Grainyhead-like 2 | 79977.0 | ENSG00000083307 | nan | Deafness, autosomal dominant 28, 608641 (3), Autosomal dominant; Ectodermal dysplasia/short stature syndrome, 616029 (3), Autosomal recessive; Corneal dystrophy, posterior polymorphous, 4, 618031 (3), Autosomal dominant
chr8	NCALD	606722.0 | NCALD | Neurocalcin, delta | 83988.0 | ENSG00000104490 | nan | nan
chr8	RRM2B	604712.0 | RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B, RCDFRD | Ribonucleotide reductase regulatory TP53 inducible subunit M2B | 50484.0 | ENSG00000048392 | nan | Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3), Autosomal recessive; Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3), Autosomal recessive; Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction, 268315 (3), Autosomal recessive; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3), Autosomal dominant
chr8	UBR5	608413.0 | UBR5, EDD1, HYD, KIAA0896 | Ubiquitin protein ligase E3 component n-recognin 5 | 51366.0 | ENSG00000104517 | nan | nan
chr8	ODF1	182878.0 | ODF1 | Outer dense fiber of sperm tails 1 | 4956.0 | ENSG00000155087 | nan | nan
chr8	KLF10	601878.0 | KLF10, TIEG | Kruppel-like factor 10 | 7071.0 | ENSG00000155090 | nan | nan
chr8	AZIN1	607909.0 | AZIN1, OAZIN | Antizyme inhibitor 1 | 51582.0 | ENSG00000155096 | nan | nan
chr8	ATP6V1C1	603097.0 | ATP6V1C1, ATP6C, ATP6D | ATPase, H+ transporting, V1 subunit C1 | 528.0 | ENSG00000155097 | nan | nan
chr8	BAALC	606602.0 | BAALC | Brain and acute leukemia gene, cytoplasmic | 79870.0 | ENSG00000164929 | nan | nan
chr8	FZD6	603409.0 | FZD6, NDNC1 | Frizzled class receptor 6 | 8323.0 | ENSG00000164930 | nan | Nail disorder, nonsyndromic congenital, 1, 161050 (3), Autosomal recessive
chr8	CTHRC1	610635.0 | CTHRC1 | Collagen triple-helix repeat-containing protein 1 | 115908.0 | ENSG00000164932 | nan | Barrett esophagus/esophageal adenocarcinoma, 614266 (3)
chr8	SLC25A32	138480.0 | SLC25A32, MFT, GLYB, RREI | Solute carrier family 25 (mitochondrial carrier, folate), member 32 | 81034.0 | ENSG00000164933 | mutation identified in 1 RREI patient | ?Exercise intolerance, riboflavin-responsive, 616839 (3), Autosomal recessive
chr8	DCAF13	616196.0 | DCAF13, WDSOF1 | DDB1- and CUL4-associated factor 13 | 25879.0 | ENSG00000164934 | nan | nan
chr8	RIMS2	606630.0 | RIMS2, KIAA0751, RIM2, OBOE, CRSDS | Regulating synaptic membrane exocytosis-2 | 9699.0 | ENSG00000176406 | nan | Cone-rod synaptic disorder syndrome, congenital nonprogressive, 618970 (3), Autosomal recessive
chr8	DCSTAMP	605933.0 | DCSTAMP, TM7SF4, FIND | Dendrocyte-expressed 7-transmembrane protein | 81501.0 | ENSG00000164935 | nan | nan
chr8	DPYS	613326.0 | DPYS, DHP | Dihydropyrimidinase | 1807.0 | ENSG00000147647 | nan | Dihydropyrimidinuria, 222748 (3), Autosomal recessive
chr8	LRP12	618299.0 | LRP12, MIG13A, ALS28 | Low density lipoprotein receptor-related protein 12 | 29967.0 | ENSG00000147650 | nan | Oculopharyngodistal myopathy 1, 164310 (3), Autosomal dominant; Amyotrophic lateral sclerosis 28, 620452 (3), Autosomal dominant
chr8	CRCS6	612231.0 | CRCS6 | Colorectal cancer, susceptibility to, 6 | 100187710.0 | nan | associated with rs16892766 | {Colorectal cancer, susceptibility to, 6}, 612231 (2)
chr8	GLC1D	602429.0 | GLC1D | Glaucoma 1, open angle, D | 2724.0 | nan | nan | Glaucoma 1D, primary open angle, 602429 (2)
chr8	HDLCQ2	607053.0 | HDLCQ2 | High density lipoprotein cholesterol level QTL 2 | 353127.0 | nan | nan | [High density lipoprotein cholesterol level QTL 2], 607053 (2)
chr8	HT	140300.0 | HT | Hashimoto thyroiditis | 140805.0 | nan | ?chr.12 | Hashimoto thyroiditis, 140300 (2), Autosomal dominant
chr8	LBMQTL1	612729.0 | LBMQTL1 | Lean body mass quantitative trait locus 1 | 100294719.0 | nan | associated with rs16892496 and rs7832552 | [Lean body mass QTL 1], 612729 (2)
chr8	MYMY3	608796.0 | MYMY3 | Moyamoya disease 3 | 493818.0 | nan | max lod at D8S546 | Moyamoya disease 3, 608796 (2)
chr8	ZFPM2	603693.0 | ZFPM2, FOG2, DIH3, SRXY9 | Zinc finger protein, multitype 2 (friend of GATA2) | 23414.0 | ENSG00000169946 | nan | Diaphragmatic hernia 3, 610187 (3); 46XY sex reversal 9, 616067 (3), Autosomal dominant; Tetralogy of Fallot, 187500 (3), Autosomal dominant
chr8	OXR1	605609.0 | OXR1, CHEGDD | Oxidation resistance 1 | 55074.0 | ENSG00000164830 | nan | Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, 213000 (3), Autosomal recessive
chr8	ABRA	609747.0 | ABRA, STARS | Actin-binding RHO-activating protein | 137735.0 | ENSG00000174429 | nan | nan
chr8	ANGPT1	601667.0 | ANGPT1, ANG1, HAE5 | Angiopoietin-1 | 284.0 | ENSG00000154188 | mutation identified in 1 HAE5 family | ?Angioedema, hereditary, 5, 619361 (3), Autosomal dominant
chr8	RSPO2	610575.0 | RSPO2, CRISTIN2, TETAMS2, HHRRD | R-spondin member 2 | 340419.0 | ENSG00000147655 | mutation identified in 1 HHRRD family | ?Humerofemoral hypoplasia with radiotibial ray deficiency, 618022 (3), Autosomal recessive; Tetraamelia syndrome 2, 618021 (3), Autosomal recessive
chr8	EIF3E	602210.0 | EIF3E, EIF3S6, INT6 | Eukaryotic translation initiation factor 3, subunit E (oncogene INT6) | 3646.0 | ENSG00000104408 | nan | nan
chr8	EMC2	607722.0 | EMC2, KIAA0103 | ER membrane protein complex subunit 2 | 9694.0 | ENSG00000104412 | nan | nan
chr8	TMEM74	613935.0 | TMEM74 | Transmembrane protein 74 | 157753.0 | ENSG00000164841 | nan | nan
chr8	TRHR	188545.0 | TRHR, CHNG7 | Thyrotropin-releasing hormone receptor | 7201.0 | ENSG00000174417 | nan | Hypothyroidism, congenital, nongoitrous, 7, 618573 (3), Autosomal recessive
chr8	NUDCD1	606109.0 | CML66 | Immunogenic tumor antigen CML66 | 84955.0 | ENSG00000120526 | nan | nan
chr8	ENY2	619015.0 | ENY2, SUS1 | ENY2 transcription and export complex 2 subunit | 56943.0 | ENSG00000120533 | nan | nan
chr8	PKHD1L1	607843.0 | PKHD1L1, DFNB124 | PKHD1-like 1 | 93035.0 | ENSG00000205038 | nan | Deafness, autosomal recessive 124, 620794 (3), Autosomal recessive
chr8	EBAG9	605772.0 | EBAG9, RCAS1, EB9 | Estrogen receptor-binding site-associated antigen 9 | 9166.0 | ENSG00000147654 | nan | nan
chr8	SYBU	611568.0 | GOLSYN, SYBU, KIAA1472 | Golgi-localized syntaphilin-related protein | 55638.0 | ENSG00000147642 | nan | nan
chr8	KCNV1	608164.0 | KCNV1, KV8.1 | Potassium channel, voltage-gated, subfamily V, member 1 | 27012.0 | ENSG00000164794 | nan | nan
chr8	CSMD3	608399.0 | CSMD3, KIAA1894 | Cub and Sushi multiple domains 3 | 114788.0 | ENSG00000164796 | nan | nan
chr8	TRPS1	604386.0 | TRPS1 | Zinc finger transcription factor TRPS1 | 7227.0 | ENSG00000104447 | nan | Trichorhinophalangeal syndrome, type III, 190351 (3), Autosomal dominant; Trichorhinophalangeal syndrome, type I, 190350 (3), Autosomal dominant
chr8	EIF3H	603912.0 | EIF3H, EIF3S3 | Eukaryotic translation initiation factor 3, subunit H | 8667.0 | ENSG00000147677 | nan | nan
chr8	BMND10	612113.0 | BMND10 | Bone mineral density quantitative trait locus 10 | 100188883.0 | nan | associated with rs6469804 and rs6993813 | [Bone mineral density QTL 10], 612113 (2)
chr8	BSZQTL3	610649.0 | BSZQTL3 | Bone size quantitative trait locus 3 | 100188815.0 | nan | nan | [Bone size quantitative trait locus 3], 610649 (2)
chr8	CRCS2	611469.0 | CRCS2 | Colorectal cancer, susceptibility to, 2 | 100188841.0 | nan | associated with rs7014346 | {Colorectal cancer, susceptibility to, 2}, 611469 (2)
chr8	ECA1	600131.0 | ECA1 | Epilepsy, childhood absence, 1 | 50966.0 | nan | nan | Epilepsy, childhood absence, 1, 600131 (2), Autosomal dominant
chr8	EGI	600669.0 | EIG1 | Epilepsy, idiopathic generalized, susceptibility to 1 | 1957.0 | nan | ?same as EBN2 | {Epilepsy, idiopathic generalized, susceptibility to, 1}, 600669 (2), Autosomal dominant
chr8	HPC10	611100.0 | HPC10 | Prostate cancer, hereditary, 10 | 100188834.0 | nan | strongest assoc. with rs1447295 | {Prostate cancer, hereditary, 10}, 611100 (2)
chr8	HPV18I1	167959.0 | HPV18I1 | Human papillomavirus type 18 integration site-1 | 3260.0 | nan | nan | nan
chr8	THMA	275220.0 | THM | Tibial hemimelia | 117193.0 | nan | nan | ?Tibial hemimelia, 275220 (2), Autosomal recessive
chr8		150230.0 | TRPS2, LGCR, LGS | Trichorhinophalangeal syndrome, type II (Langer-Giedion syndrome) | nan | nan | contiguous gene syndrome involving TRPS1 and EXT1 | Trichorhinophalangeal syndrome, type II, 150230 (4), Autosomal dominant
chr8	RAD21	606462.0 | RAD21, SCC1, NXP1, KIAA0078, CDLS4, MGS | RAD21 cohesin complex component | 5885.0 | ENSG00000164754 | mutation identified in 1 MGS family | Cornelia de Lange syndrome 4, 614701 (3), Autosomal dominant; ?Mungan syndrome, 611376 (3), Autosomal recessive
chr8	SLC30A8	611145.0 | SLC30A8, ZNT8 | Solute carrier family 30 (zinc transporter), member 8 | 169026.0 | ENSG00000164756 | nan | {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant
chr8	MED30	610237.0 | MED30, TRAP25, THRAP6 | Mediator complex subunit 30 | 90390.0 | ENSG00000164758 | nan | nan
chr8	EXT1	608177.0 | EXT1 | Exostosin 1 | 2131.0 | ENSG00000182197 | distal to TRPS1 | Exostoses, multiple, type 1, 133700 (3), Autosomal dominant; Chondrosarcoma, 215300 (3), Somatic mutation
chr8	SAMD12	618073.0 | SAMD12 | Sterile alpha motif domain containing 12 | 401474.0 | ENSG00000177570 | nan | Epilepsy, familial adult myoclonic, 1, 601068 (3), Autosomal dominant
chr8	TNFRSF11B	602643.0 | TNFRSF11B, OPG, OCIF, PDB5 | Tumor necrosis factor receptor superfamily, member 11B (osteoprotegerin) | 4982.0 | ENSG00000164761 | nan | Paget disease of bone 5, juvenile-onset, 239000 (3), Autosomal recessive
chr8	COLEC10	607620.0 | COLEC10, CLL1, 3MC3 | Collectin 10 | 10584.0 | ENSG00000184374 | nan | 3MC syndrome 3, 248340 (3), Autosomal recessive
chr8	MAL2	609684.0 | MAL2 | MAL proteolipid protein 2 | 114569.0 | ENSG00000147676 | nan | nan
chr8	CCN3	164958.0 | CCN3, NOV | Cellular communication network factor 3 | 4856.0 | ENSG00000136999 | proximal to MYC | nan
chr8	ENPP2	601060.0 | ENPP2, PDNP2 | Ectonucleotide pyrophosphatase/phosphodiesterase 2 | 5168.0 | ENSG00000136960 | nan | nan
chr8	TAF2	604912.0 | TAF2, TAF2B, TAFII150, CIF150, MRT40 | TAF2 RAN polymerase II, TATA box-binding protein-associated factor, 150kD | 6873.0 | ENSG00000064313 | nan | Intellectual developmental disorder, autosomal recessive 40, 615599 (3), Autosomal recessive
chr8	DSCC1	613203.0 | DSCC1, DCC1 | DNA replication and sister chromatid cohesion 1 | 79075.0 | ENSG00000136982 | nan | nan
chr8	DEPTOR	612974.0 | DEPDC6, DEPTOR | DEP domain-containing protein 6 | 64798.0 | ENSG00000155792 | nan | nan
chr8	COL14A1	120324.0 | COL14A1, UND | Collagen, type XIV, alpha-1 (undulin) | 7373.0 | ENSG00000187955 | nan | nan
chr8	MRPL13	610200.0 | MRPL13, RPML13, L13A | Mitochondrial ribosomal protein L13 | 28998.0 | ENSG00000172172 | nan | nan
chr8	MTBP	605927.0 | MDM2BP, MTBP | MDM2-binding protein | 27085.0 | ENSG00000172167 | nan | nan
chr8	SNTB1	600026.0 | SNT2B1, A1B, SNTB1 | Syntrophin, beta 1 (dystrophin-associated protein A1, 59kD, basic basic component 1) | 6641.0 | ENSG00000172164 | nan | nan
chr8	ARHI1	612448.0 | ARHI1 | Age-related hearing impairment 1 | 100233147.0 | nan | between rs3765212 and rs4601326 | {Age-related hearing impairment 1}, 612448 (2)
chr8	PPKP1B	614936.0 | PPKP1B | Keratoderma, palmoplantar, punctate type IB | 101154752.0 | nan | between D8S1804 and D8S1720 | Keratoderma, palmoplantar, punctate type IB, 614936 (2), Autosomal dominant
chr8	HAS2	601636.0 | HAS2 | Hyaluronan synthase-2 | 3037.0 | ENSG00000170961 | nan | nan
chr8	HAS2-AS1	614353.0 | HAS2AS1, HASNT | HAS2 antisense RNA 1 | 594842.0 | ENSG00000248690 | nan | nan
chr8	ZHX2	609185.0 | ZHX2, AFR1, KIAA0854 | Zinc finger and homeodomain protein 2 | 22882.0 | ENSG00000178764 | nan | nan
chr8	DERL1	608813.0 | DERL1, DER1 | DER1-like domain family, member 1 | 79139.0 | ENSG00000136986 | nan | nan
chr8	ZHX1	604764.0 | ZHX1 | Zinc finger and homeodomain protein 1 | 11244.0 | ENSG00000165156 | nan | nan
chr8	ATAD2	611941.0 | ATAD2, ANCCA | ATPase family, AAA domain-containing, member 2 | 29028.0 | ENSG00000156802 | nan | nan
chr8	NTAQ1	620846.0 | NTAQ1, C8orf32, WDYHV1 | N-terminal glutamine amidase 1 | 55093.0 | ENSG00000156795 | nan | nan
chr8	FBXO32	606604.0 | FBXO32, MAFBX, FLJ32424, ATROGIN1 | F-box only protein 32 | 114907.0 | ENSG00000156804 | nan | nan
chr8	ANXA13	602573.0 | ANX13, ISA | Annexin XIII | 312.0 | ENSG00000104537 | nan | nan
chr8	FER1L6	620884.0 | FER1L6 | FER1-like family, member 6 | 654463.0 | ENSG00000214814 | nan | nan
chr8	TMEM65	616609.0 | TMEM65 | Transmembrane protein 65 | 157378.0 | ENSG00000164983 | nan | nan
chr8	TRMT12	611244.0 | TRMT12, TRM12 | tRNA methyltransferase 12 homolog | 55039.0 | ENSG00000183665 | nan | nan
chr8	RNF139	603046.0 | RNF139, TRC8, RCA1 | RING finger protein 139 | 11236.0 | ENSG00000170881 | nan | Renal cell carcinoma, 144700 (3)
chr8	TATDN1	619364.0 | TATDN1 | TatD DNase domain-containing protein 1 | 83940.0 | ENSG00000147687 | nan | nan
chr8	NDUFB9	601445.0 | NDUFB9, UQOR22, MC1DN24 | NADH-ubiquinone oxidoreductase subunit B9 | 4715.0 | ENSG00000147684 | mutation identified in 1 MC1DN24 family | ?Mitochondrial complex I deficiency, nuclear type 24, 618245 (3), Autosomal recessive
chr8	MTSS1	608486.0 | MTSS1, MIM, KIAA0429 | MTSS I-BAR domain containing 1 protein | 9788.0 | ENSG00000170873 | nan | nan
chr8	SQLE	602019.0 | SQLE | Squalene epoxidase | 6713.0 | ENSG00000104549 | nan | nan
chr8	WASHC5	610657.0 | WASHC5, KIAA0196, SPG8, RTSC1 | WASH complex, subunit 5 | 9897.0 | ENSG00000164961 | nan | Ritscher-Schinzel syndrome 1, 220210 (3), Autosomal recessive; Spastic paraplegia 8, autosomal dominant, 603563 (3), Autosomal dominant
chr8	NSMCE2	617246.0 | NSMCE2, NSE2, MMS21 | NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase | 286053.0 | ENSG00000156831 | nan | Seckel syndrome 10, 617253 (3), Autosomal recessive
chr8	TRIB1	609461.0 | TRIB1, TRB1, SKIP1, C8FW | Tribbles pseudokinase 1 | 10221.0 | ENSG00000173334 | nan | nan
chr8	LRATD2	609483.0 | LRATD2, FAM84B, BCMP101 | LRAT domain containing 2 gene | 157638.0 | ENSG00000168672 | nan | nan
chr8	PCAT1	616043.0 | PCAT1 | Prostate cancer-associated transcript 1, noncoding | 100750225.0 | ENSG00000253438 | nan | nan
chr8	PCAT2	617678.0 | PCAT2, PCA2, CARLO4 | Prostate cancer-associated transcript 2, noncoding | 103164619.0 | ENSG00000254166 | nan | nan
chr8	PRNCR1	615452.0 | PRNCR1, PCAT8 | Prostate cancer-associated noncoding RNA 1 | 101867536.0 | ENSG00000282961 | nan | nan
chr8	CASC19	617703.0 | CASC19, LINC01245, CARLO6 | Cancer susceptibility candidate 19, noncoding | 103021165.0 | nan | nan | nan
chr8	CCAT1	617705.0 | CCAT1, CARLO5 | Colon cancer-associated transcript 1, noncoding | 100507056.0 | nan | nan | nan
chr8	CASC21	617702.0 | CASC21, LINC01244, CARLO2 | Cancer susceptibility candidate 21, noncoding | 103021164.0 | nan | nan | nan
chr8	CASC8	617701.0 | CASC8, LINC00860, CARLO1 | Cancer susceptibility candidate 8, noncoding | 727677.0 | ENSG00000246228 | nan | nan
chr8	CCAT2	619403.0 | CCAT2 | Colon cancer-associated transcript 2, noncoding | 101805488.0 | ENSG00000280997 | nan | nan
chr8	POU5F1B	615739.0 | POU5F1B, POU5F1P1, OCT4PG1 | POU domain, class 5, transcription factor 1B | 5462.0 | ENSG00000212993 | nan | nan
chr8	CASC11	617704.0 | CASC11, LINC00990, CARLO7 | Cancer susceptibility candidate 11, noncoding | 100270680.0 | ENSG00000249375 | nan | nan
chr8	MYC	190080.0 | MYC | MYC protooncogene, bHLH transcription factor | 4609.0 | ENSG00000136997 | cen-5'-3'-ter | Burkitt lymphoma, somatic, 113970 (3)
chr8	PVT1	165140.0 | PVT1 | Pvt1 oncogene (MYC activator) | 5820.0 | ENSG00000249859 | nan | nan
chr8	CCDC26	613040.0 | CCDC26, RAM, GLM7 | CCDC26 long non-coding RNA | 137196.0 | ENSG00000229140 | nan | {Glioma susceptibility 7}, 613032 (3)
chr8	GSDMC	608384.0 | GSDMC, MLZE | Gasdermin C | 56169.0 | ENSG00000147697 | nan | nan
chr8	CYRIB	617978.0 | FAM149B | Family with sequence similarity 49, member B | 51571.0 | ENSG00000153310 | nan | nan
chr8	ASAP1	605953.0 | ASAP1, DDEF1 | Arf GTPase-activating protein with SH3 domain, ankyrin repeat, and PH domain 1 | 50807.0 | ENSG00000153317 | nan | nan
chr8	ADCY8	103070.0 | ADCY8, ADCY3 | Adenylyl cyclase-8, brain | 114.0 | ENSG00000155897 | nan | nan
chr8	EFR3A	611798.0 | EFR3A, KIAA0143 | EFR3 homolog A | 23167.0 | ENSG00000132294 | nan | nan
chr8	OC90	601658.0 | OC90, PLA2L | Otoconin 90 (phospholipase A2-like) | 729330.0 | ENSG00000253117 | PLA2L = fusion between HHLA1 and OC90 | nan
chr8	HHLA1	604109.0 | HHLA1 | Human endogenous retrovirus-H long terminal repeat-associating 1 | 10086.0 | ENSG00000132297 | nan | nan
chr8	KCNQ3	602232.0 | KCNQ3, EBN2, BFNC2 | Potassium voltage-gated channel, KQT-like subfamily, member 3 | 3786.0 | ENSG00000184156 | nan | Seizures, benign neonatal, 2, 121201 (3), Autosomal dominant
chr8	DNAAF11	614930.0 | LRRC6, LRTP, CILD19 | Leucine-rich repeat-containing protein 6 | 23639.0 | ENSG00000129295 | nan | Ciliary dyskinesia, primary, 19, 614935 (3), Autosomal recessive
chr8	TMEM71	620287.0 | TMEM71 | Transmembrane protein 71 | 137835.0 | ENSG00000165071 | nan | nan
chr8	PHF20L1	620050.0 | PHF20L1 | PHD finger protein 20-like 1 | 51105.0 | ENSG00000129292 | nan | nan
chr8	TG	188450.0 | TG, AITD3, TDH3 | Thyroglobulin | 7038.0 | ENSG00000042832 | distal to MYC | {Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3); Thyroid dyshormonogenesis 3, 274700 (3), Autosomal recessive
chr8	SLA	601099.0 | SLA | Src-like-adaptor | 6503.0 | ENSG00000155926 | in intron of TG | nan
chr8	PTCSC1	617440.0 | PTCSC1, NCRNA00197 | Papillary thyroid carcinoma susceptibility candidate 1 gene | 100302522.0 | ENSG00000287736 | nan | nan
chr8	CCN4	603398.0 | CCN4, WISP1 | Cellular communication netowrk factor 4 | 8840.0 | ENSG00000104415 | nan | nan
chr8	NDRG1	605262.0 | NDRG1, HMSNL, CMT4D | N-myc downstream-regulated gene 1 | 10397.0 | ENSG00000104419 | nan | Charcot-Marie-Tooth disease, type 4D, 601455 (3), Autosomal recessive
chr8	ST3GAL1	607187.0 | ST3GAL1, SIAT4A, ST3O | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | 6482.0 | ENSG00000008513 | nan | nan
chr8	ZFAT	610931.0 | ZFAT1, ZNF406, AITD3 | Zinc finger gene in autoimmune thyroid disease 1 | 57623.0 | ENSG00000066827 | nan | {Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)
chr8	MIR30B	619018.0 | MIR30B | Micro RNA 30B | 407030.0 | ENSG00000207582 | nan | nan
chr8	MIR30D	619019.0 | MIR30D | Micro RNA 30D | 407033.0 | ENSG00000199153 | nan | nan
chr8	KHDRBS3	610421.0 | KHDRBS3, TSTAR, SALP, SLM2, ETOILE | KH domain-containing, RNA-binding, signal transduction-associated protein 3 | 10656.0 | ENSG00000131773 | nan | nan
chr8	COL22A1	610026.0 | COL22A1 | Collagen, type XXII, alpha-1 polypeptide | 169044.0 | ENSG00000169436 | nan | nan
chr8	OFC12	612858.0 | OFC12 | Orofacial cleft 12 | 100302515.0 | nan | associated with rs987525 | Orofacial cleft 12, 612858 (2)
chr8	KCNK9	605874.0 | KCNK9, TASK32, BIBARS | Potassium channel, subfamily K, member 9 | 51305.0 | ENSG00000169427 | nan | Birk-Barel syndrome, 612292 (3)
chr8	TRAPPC9	611966.0 | TRAPPC9, NIBP, KIAA1882, MRT13 | Trafficking protein particle complex 9 | 83696.0 | ENSG00000167632 | nan | Intellectual developmental disorder, autosomal recessive 13, 613192 (3), Autosomal recessive
chr8	C8orf17	616992.0 | C8orf17, MOST1 | Chromosome 8 open reading frame 17 | 100507249.0 | ENSG00000250733 | nan | nan
chr8	CHRAC1	607268.0 | CHARC1, CHARC15, YCL1 | Chromatin accessibility complex, subunit 1 | 54108.0 | ENSG00000104472 | nan | nan
chr8	AGO2	606229.0 | AGO2, EIF2C2, LESKRES | Argonaute RISC component 2 | 27161.0 | ENSG00000123908 | nan | Lessel-Kreienkamp syndrome, 619149 (3), Autosomal dominant
chr8	PTK2	600758.0 | PTK2, FADK | PTK2 protein tyrosine kinase | 5747.0 | ENSG00000169398 | nan | nan
chr8	MIR151A	620127.0 | MIR151A | Micro RNA 151A | 442893.0 | ENSG00000254324 | nan | nan
chr8	DENND3	617503.0 | DENND3, KIAA0870 | DENN domain-containing protein 3 | 22898.0 | ENSG00000105339 | nan | nan
chr8	SLC45A4	619581.0 | SLC45A4, KIAA1126 | Solute carrier family 45, member 4 | 57210.0 | ENSG00000022567 | nan | nan
chr8	GPR20	601908.0 | GPR20 | G protein-coupled receptor-20 | 2843.0 | ENSG00000204882 | nan | nan
chr8	PTP4A3	606449.0 | PTP4A3, PRL3 | Protein-tyrosine phosphatase, type 4A, 3 | 11156.0 | ENSG00000184489 | nan | nan
chr8	TSNARE1	620986.0 | TSNARE1 | T-snare domain-containing protein 1 | 203062.0 | ENSG00000171045 | nan | nan
chr8	ADGRB1	602682.0 | ADGRB1, BAI1, GDAIF | Adhesion G protein-coupled receptor B1 | 575.0 | ENSG00000181790 | nan | nan
chr8	ARC	612461.0 | ARC, KIAA0278 | Activity-regulated cytoskeleton-associated protein | 23237.0 | ENSG00000198576 | nan | nan
chr8	JRK	603210.0 | JRK, JH8 | JRK helix-turn-helix protein | 8629.0 | ENSG00000234616 | nan | nan
chr8	PSCA	602470.0 | PSCA | Prostate stem cell antigen | 8000.0 | ENSG00000167653 | nan | nan
chr8	LY6K	615093.0 | LY6K | Lymphocyte antigen 6 complex, locus K | 54742.0 | ENSG00000160886 | nan | nan
chr8	SLURP1	606119.0 | SLURP1, MDM | Secreted LY6/uPAR-related protein 1 | 57152.0 | ENSG00000126233 | nan | Meleda disease, 248300 (3), Autosomal recessive
chr8	LYNX1	606110.0 | LYNX1 | Lynx1, mouse, homolog of | 66004.0 | ENSG00000180155 | nan | nan
chr8	LY6D	606204.0 | LY6D, E48 | Lymphocyte antigen 6 complex, locus D | 8581.0 | ENSG00000167656 | ?pseudogene ono 15q22 | nan
chr8	GML	602370.0 | GML | Glycosylphosphatidylinositol-anchored molecule-like protein | 2765.0 | ENSG00000104499 | nan | nan
chr8	CYP11B1	610613.0 | CYP11B1, P450C11, FHI | Cytochrome P450, subfamily XIB, polypeptide 1 (11-beta-hydroxylase; corticosteroid methyl-oxidase II (CMO II)) | 1584.0 | ENSG00000160882 | chimeric CYP11B1/CYP11B2 gene = anti-Lepore-like | Aldosteronism, glucocorticoid-remediable, 103900 (3), Autosomal dominant; Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3), Autosomal recessive
chr8	CYP11B2	124080.0 | CYP11B2 | Cytochrome P450, subfamily XIB, polypeptide 2 | 1585.0 | ENSG00000179142 | nan | Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3), Autosomal recessive; Aldosterone to renin ratio raised (3); {Low renin hypertension, susceptibility to} (3); Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3), Autosomal recessive
chr8	LY6E	601384.0 | LY6E, RIGE, SCA2 | Lymphocyte antigen 6 complex, locus E (retinoic acid induced gene E) | 4061.0 | ENSG00000160932 | nan | nan
chr8	LY6H	603625.0 | LY6H | Lymphocyte antigen 6 complex, locus H | 4062.0 | ENSG00000176956 | nan | nan
chr8	GPIHBP1	612757.0 | GPIHBP1, HYPL1D | Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 | 338328.0 | ENSG00000277494 | nan | Hyperlipoproteinemia, type 1D, 615947 (3), Autosomal recessive
chr8	GLI4	165280.0 | GLI4, HKR4 | GLI-Kruppel family member GLI4 (oncogene HKR4) | 2738.0 | ENSG00000250571 | nan | nan
chr8	TOP1MT	606387.0 | TOP1MT | Topoisomerase I, mitochondrial | 116447.0 | ENSG00000184428 | nan | nan
chr8	RHPN1	601031.0 | RHPN1, ODF5 | Rhophilin 1 | 114822.0 | ENSG00000158106 | nan | nan
chr8	MAFA	610303.0 | MAFA, RIPE3B1, INSDM | MAF bZIP transcription factor A | 389692.0 | ENSG00000182759 | nan | Insulinomatosis and diabetes mellitus, 147630 (3), Autosomal dominant
chr8	ZC3H3	618640.0 | ZC3H3, SMICL | Zinc finger CCCH domain-containing protein 3 | 23144.0 | ENSG00000014164 | nan | nan
chr8	GSDMD	617042.0 | GSDMD, GSDMDC1, DFNA5L | Gasdermin D | 79792.0 | ENSG00000104518 | nan | nan
chr8	NAPRT	611552.0 | NAPRT, NAPRT1 | Nicotinate phosphoribosyltransferase | 93100.0 | ENSG00000147813 | nan | nan
chr8	EEF1D	130592.0 | EEF1D, EF1D | Eukaryotic translation elongation factor 1, delta | 1936.0 | ENSG00000104529 | nan | nan
chr8	PYCR3	616408.0 | PYCRL, PYCR3 | Pyrroline-5-carboxylate reductase-like | 65263.0 | ENSG00000104524 | nan | nan
chr8	GFUS	137020.0 | GFUS, TSTA3, FX | GDP-L-fucose synthase | 7264.0 | ENSG00000104522 | nan | nan
chr8	MAPK15	618616.0 | MAPK15, ERK8 | Mitogen-activated protein kianse 15 | 225689.0 | ENSG00000181085 | nan | nan
chr8	FAM83H	611927.0 | FAM83H, AI3A | Family with sequence similarity 83, member H | 286077.0 | ENSG00000180921 | nan | Amelogenesis imperfecta, type IIIA, 130900 (3), Autosomal dominant
chr8	IQANK1	618942.0 | IQANK1, FAM83HAS1 | IQ motif- and ankyrin repeat-containing protein 1 | 642574.0 | ENSG00000203499 | nan | nan
chr8	SCRIB	607733.0 | SCRIB, SCRB1, KIAA0147 | Scribble planar cell polarity protein | 23513.0 | ENSG00000180900 | nan | nan
chr8	PUF60	604819.0 | PUF60, FIR, SIAHBP1, VRJS | Poly-U-binding splicing factor, 60kD | 22827.0 | ENSG00000179950 | nan | Verheij syndrome, 615583 (3), Autosomal dominant
chr8	NRBP2	615563.0 | NRBP2 | Nuclear receptor-binding protein 2 | 340371.0 | ENSG00000185189 | nan | nan
chr8	EPPK1	607553.0 | EPPK1 | Epiplakin 1 | 83481.0 | ENSG00000261150 | nan | nan
chr8	PLEC	601282.0 | PLEC1, PLEC, PLTN, LGMDR17, EBS5A, EBS5B, EBS5C, EBS5D | Plectin 1 | 5339.0 | ENSG00000178209 | mutation identified in 1 EBS5D family | ?Epidermolysis bullosa simplex 5D, generalized intermediate, autosomal recessive, 616487 (3), Autosomal recessive; Epidermolysis bullosa simplex 5B, with muscular dystrophy, 226670 (3), Autosomal recessive; Epidermolysis bullosa simplex 5C, with pyloric atresia, 612138 (3), Autosomal recessive; Epidermolysis bullosa simplex 5A, Ogna type, 131950 (3), Autosomal dominant; Muscular dystrophy, limb-girdle, autosomal recessive 17, 613723 (3), Autosomal recessive
chr8	MIR661	613716.0 | MIR661, MIRN661 | Micro RNA 661 | 724031.0 | ENSG00000207574 | nan | nan
chr8	PARP10	609564.0 | PARP10 | Poly(ADP-ribose) polymerase 10 | 84875.0 | ENSG00000178685 | nan | nan
chr8	GRINA	138251.0 | GRINA, NMDARA1 | Glutamate receptor, ionotropic, N-methyl | 2907.0 | ENSG00000178719 | nan | nan
chr8	SPATC1	610874.0 | SPATC1 | Spermatogenesis- and centriole-associated 1 (speriolin) | 375686.0 | ENSG00000186583 | nan | nan
chr8	OPLAH	614243.0 | OPLAH, OPLAHD | 5-oxoprolinase (ATP-hydrolyzing) | 26873.0 | ENSG00000178814 | nan | 5-oxoprolinase deficiency, 260005 (3), Autosomal recessive, Autosomal dominant
chr8	EXOSC4	606491.0 | EXOSC4, RRP41 | Exosome component 4 | 54512.0 | ENSG00000178896 | nan | nan
chr8	GPAA1	603048.0 | GPAA1, GAA1, GPIBD15 | Glycophosphatidylinositol anchor attachment protein 1 | 8733.0 | ENSG00000197858 | nan | Glycosylphosphatidylinositol biosynthesis defect 15, 617810 (3), Autosomal recessive
chr8	CYC1	123980.0 | CYC1, MC3DN6 | Cytochrome c1 | 1537.0 | ENSG00000179091 | nan | Mitochondrial complex III deficiency, nuclear type 6, 615453 (3), Autosomal recessive
chr8	SHARPIN	611885.0 | SHARPIN, SIPL1, AIFID | SHANK-associated RH domain interactor | 81858.0 | ENSG00000179526 | nan | Autoinflammation with episodic fever and immune dysregulation, 620795 (3), Autosomal recessive
chr8	MAF1	610210.0 | MAF1 | MAF1 homolog, negative regulator of RNA polymerase III | 84232.0 | ENSG00000179632 | nan | nan
chr8	HGH1	620684.0 | HGH1, FAM203A, FAM203B, C8orf30A, C8orf30B | HGH1 homolog | 51236.0 | ENSG00000235173 | nan | nan
chr8	BOP1	610596.0 | BOP1, KIAA0124 | Block of proliferation 1 | 23246.0 | ENSG00000261236 | nan | nan
chr8	SCX	609067.0 | SCX, SCXA, SCXB | Scleraxis bHLH transcription factor | 642658.0 | ENSG00000260428 | nan | nan
chr8	HSF1	140580.0 | HSF1 | Heat-shock transcription factor 1 | 3297.0 | ENSG00000185122 | nan | nan
chr8	DGAT1	604900.0 | DGAT1, ARGP1, DIAR7 | Diacylglycerol O-acyltransferase 1 | 8694.0 | ENSG00000185000 | nan | Diarrhea 7, protein-losing enteropathy type, 615863 (3), Autosomal recessive
chr8	SCRT1	605858.0 | SCRT1 | Scratch family transcriptional repressor 1 | 83482.0 | ENSG00000261678 | nan | nan
chr8	FBXL6	609076.0 | FBXL6, FBL6, FBL6A | F-box and leucine-rich repeat protein 6 | 26233.0 | ENSG00000182325 | nan | nan
chr8	SLC52A2	607882.0 | SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2 | Solute carrier family 52, riboflavin transporter, member 2 | 79581.0 | ENSG00000185803 | nan | Brown-Vialetto-Van Laere syndrome 2, 614707 (3), Autosomal recessive
chr8	CPSF1	606027.0 | CPSF1, CPSF160, MYP27 | Cleavage and polyadenylation specificity factor 1 | 29894.0 | ENSG00000071894 | nan | Myopia 27, 618827 (3), Autosomal dominant
chr8	SLC39A4	607059.0 | SLC39A4, ZIP4 | Solute carrier family 36 (zinc transporter), member 4 | 55630.0 | ENSG00000147804 | nan | Acrodermatitis enteropathica, 201100 (3), Autosomal recessive
chr8	VPS28	611952.0 | VPS28 | VPS28 subunit of ESCRT-I | 51160.0 | ENSG00000160948 | nan | nan
chr8	TONSL	604546.0 | TONSL, NFKBIL2, IKBR, SEMDSP | Tonsoku-like DNA repair protein | 4796.0 | ENSG00000160949 | nan | Spondyloepimetaphyseal dysplasia, sponastrime type, 271510 (3), Autosomal recessive
chr8	ZFTRAF1	616635.0 | CYHR1, KIAA0496 | Cysteine- and histidine-rich protein 1 | 50626.0 | ENSG00000187954 | nan | nan
chr8	KIFC2	615216.0 | KIFC2 | Kinesin family member C2 | 90990.0 | ENSG00000167702 | nan | nan
chr8	FOXH1	603621.0 | FAST1 | Forkhead activin signal transducer 1, Xenopus, homolog of | 8928.0 | ENSG00000160973 | nan | nan
chr8	PPP1R16A	609172.0 | PPP1R16A, MYPT3 | Protein phosphatase 1, regulatory subunit 16A | 84988.0 | ENSG00000160972 | nan | nan
chr8	GPT	138200.0 | GPT, GPT1, AAT1 | Glutamic-pyruvate transaminase (alanine aminotransferase) | 2875.0 | ENSG00000167701 | nan | nan
chr8	MFSD3	620308.0 | MFSD3 | Major facilitator superfamily domain-containing protein 3 | 113655.0 | ENSG00000167700 | nan | nan
chr8	RECQL4	603780.0 | RECQL4, RTS, RECQ4 | DNA helicase, RecQ-like 4 | 9401.0 | ENSG00000160957 | nan | Baller-Gerold syndrome, 218600 (3), Autosomal recessive; Rothmund-Thomson syndrome, type 2, 268400 (3), Autosomal recessive; RAPADILINO syndrome, 266280 (3), Autosomal recessive
chr8	LRRC14	619368.0 | LRRC14, KIAA0014 | Leucine-rich repeat-containing protein 14 | 9684.0 | ENSG00000160959 | nan | nan
chr8	LRRC24	620672.0 | LRRC24 | Leucine-rich repeat-containing protein 24 | 441381.0 | ENSG00000254402 | nan | nan
chr8	ARHGAP39	615880.0 | ARHGAP39, VILSE, KIAA1688 | RHO GTPase-activating protein 39 | 80728.0 | ENSG00000147799 | nan | nan
chr8	ZNF34	194526.0 | ZNF34, KOX32 | Zinc finger protein-34 (KOX32) | 80778.0 | ENSG00000196378 | nan | nan
chr8	RPL8	604177.0 | RPL8 | Ribosomal protein L8 | 6132.0 | ENSG00000161016 | nan | nan
chr8	ZNF7	194531.0 | ZNF7, KOX4 | Zinc finger protein-7 (KOX4) | 7553.0 | ENSG00000147789 | nan | nan
chr8	COMMD5	608216.0 | COMMD5, HCARG | COMM domain-containing protein 5 | 28991.0 | ENSG00000170619 | nan | nan
chr8	ZNF16	601262.0 | ZNF16, KOX9 | Zinc finger protein-16 (KOX 9) | 7564.0 | ENSG00000170631 | nan | nan
chr8	AIS3	608392.0 | AIS3, VAMAS4 | Autoimmune disease, susceptibility to, 3 | 378427.0 | nan | nan | {Autoimmune disease, susceptibility to, 3}, 608392 (2)
chr8		147860.0 | IFNB3 | Interferon, beta-3, fibroblast | nan | nan | previously assigned to 2p23-qter | nan
chr9		158170.0 | DEL9p, C9DELp | Chromosome 9p deletion syndrome | nan | nan | nan | Chromosome 9p deletion syndrome, 158170 (4), Autosomal dominant
chr9		154230.0 | DEL9p24.3, C9DELp24.3, SRXY4 | Chromosome 9p24.3 deletion syndrome | nan | nan | nan | 46XY sex reversal 4, 154230 (4), Isolated cases
chr9	HDLCQ1	606613.0 | HDLCQ1 | High density lipoprotein cholesterol level QTL 1 | 192144.0 | nan | nan | [High density lipoprotein cholesterol level QTL 1], 606613 (2)
chr9		614113.0 | MRD2 | Intellectual developmental disorder, autosomal dominant 2 | nan | nan | 2 patients reported with genomic deletion or rearrangement including disruption of DOCK8 | Intellectual developmental disorder, autosomal dominant 2, 614113 (4), Autosomal dominant
chr9	RLS3	610438.0 | RLS3 | Restless legs syndrome, susceptibility to, 3 | 100188812.0 | nan | associated with rs4626664 and rs1975197 | {Restless legs syndrome 3}, 610438 (2)
chr9	WASHC1	613632.0 | WASHC1, WASH1 | WASH complex, subunit 1 | 100287171.0 | ENSG00000181404 | pseudogenes on 1p, 15q, 16p, Xq/Yq | nan
chr9	FOXD4	601092.0 | FOXD4, FKHL9 | Forkhead box D4 | 2298.0 | ENSG00000170122 | nan | nan
chr9	ZNG1A	611078.0 | CBWD1 | Cobalamin synthetase W domain-containing protein 1 | 55871.0 | ENSG00000172785 | nan | nan
chr9	DOCK8	611432.0 | DOCK8, HIES2 | Dedicator of cytokinesis 8 | 81704.0 | ENSG00000107099 | nan | Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections, 243700 (3), Autosomal recessive
chr9	KANK1	607704.0 | KANK1, KANK, ANKRD15, KIAA0172, CPSQ2 | KN motif- and ankyrin repeat domain-containing protein 1 | 23189.0 | ENSG00000107104 | nan | Cerebral palsy, spastic quadriplegic, 2, 612900 (3)
chr9	DMRT1	602424.0 | DMRT1, DMT1 | Double sex and mab-3-related transcription factor-1 | 1761.0 | ENSG00000137090 | nan | nan
chr9	DMRT3	614754.0 | DMRT3, DMRTA3 | Doublesex-and mab3-related transcription factor 3 | 58524.0 | ENSG00000064218 | nan | nan
chr9	DMRT2	604935.0 | DMRT2 | Double sex and mab-3-related transcription factor-2 | 10655.0 | ENSG00000173253 | nan | nan
chr9	SMARCA2	600014.0 | SMARCA2, SNF2L2, NCBRS, BIS | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 6595.0 | ENSG00000080503 | nan | Nicolaides-Baraitser syndrome, 601358 (3), Autosomal dominant; Blepharophimosis-impaired intellectual development syndrome, 619293 (3), Autosomal dominant
chr9	VLDLR	192977.0 | VLDLR, CAMRQ1 | Very low density lipoprotein receptor | 7436.0 | ENSG00000147852 | nan | Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1, 224050 (3), Autosomal recessive
chr9	KCNV2	607604.0 | KCNV2, KV11.1, RCD3B | Potassium channel, voltage-gated, subfamily V, member 2 | 169522.0 | ENSG00000168263 | nan | Retinal cone dystrophy 3B, 610356 (3), Autosomal recessive
chr9	PUM3	609960.0 | PUM3, KIAA0020, HLA-HA8 | Pumilio RNA-binding family, member 3 | 9933.0 | ENSG00000080608 | nan | nan
chr9	RFX3	601337.0 | RFX3 | Regulatory factor X, 3 | 5991.0 | ENSG00000080298 | nan | nan
chr9	GLIS3	610192.0 | GLIS3, ZNF515, NDH | GLIS family zinc finger protein 3 | 169792.0 | ENSG00000107249 | nan | Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3), Autosomal recessive
chr9	SLC1A1	133550.0 | SLC1A1, EAAC1, SCZD18, DCBXA | Solute carrier family 1, member 1 (high-affinity glutamate transporter; excitatory amino acid carrier 1) | 6505.0 | ENSG00000106688 | mutation identified in 1 SCZD18 family | Dicarboxylic aminoaciduria, 222730 (3), Autosomal recessive; {?Schizophrenia susceptibility 18}, 615232 (3)
chr9	FECD7	613271.0 | FECD7, FCD4 | Corneal dystrophy, Fuchs endothelial, 7 | 100380875.0 | nan | max lod at D9S256 | Corneal dystrophy, Fuchs endothelial, 7, 613271 (2)
chr9	PLPP6	611666.0 | PLPP6, PPAPDC2 | PPAP2 domain-containing protein 2 | 403313.0 | ENSG00000205808 | nan | nan
chr9	CDC37L1	610346.0 | CDC37L1, HARC, FLJ20639 | CDC37-like 1 | 55664.0 | ENSG00000106993 | nan | nan
chr9	AK3	609290.0 | AK3, AK3L1 | Adenylate kinase 3 | 50808.0 | ENSG00000147853 | nan | nan
chr9	RCL1	611405.0 | RCL1, RPCL1, RNAC | RNA terminal phosphate cyclase-like 1 | 10171.0 | ENSG00000120158 | nan | nan
chr9	MIR101-2	612512.0 | MIR101-2, MIRN101-2 | Micro RNA 101-2 | 406894.0 | ENSG00000199065 | another locus, MIRN101-1, on 1p31 | nan
chr9	JAK2	147796.0 | JAK2, THCYT3 | Janus kinase 2 (a protein-tyrosine kinase) | 3717.0 | ENSG00000096968 | nan | {Budd-Chiari syndrome, somatic}, 600880 (3); Myelofibrosis, somatic, 254450 (3); Erythrocytosis, somatic, 133100 (3); Leukemia, acute myeloid, somatic, 601626 (3); Thrombocythemia 3, 614521 (3), Somatic mutation, Autosomal dominant; Polycythemia vera, somatic, 263300 (3)
chr9	INSL6	606414.0 | INSL6 | Insulin-like 6 | 11172.0 | ENSG00000120210 | nan | nan
chr9	INSL4	600910.0 | INSL4 | Insulin-like 4, placenta | 3641.0 | ENSG00000120211 | nan | nan
chr9	RLN2	179740.0 | RLN2 | Relaxin, H2 | 6019.0 | ENSG00000107014 | nan | nan
chr9	RLN1	179730.0 | RLN1 | Relaxin, H1 | 6013.0 | ENSG00000107018 | nan | nan
chr9	PLGRKT	618444.0 | PLGRKT | Plasminogen receptor with C-terminal lysine | 55848.0 | ENSG00000107020 | nan | nan
chr9	CD274	605402.0 | CD274, PDCD1LG1, B7H1 | CD274 molecule | 29126.0 | ENSG00000120217 | nan | nan
chr9	PDCD1LG2	605723.0 | PDCD1L2, PDL2 | Programmed cell death 1 ligand 2 | 80380.0 | ENSG00000197646 | nan | nan
chr9	RIC1	610354.0 | RIC1, CIP150, KIAA1432, CATIFA | RIC1 homolog, RAB6A GEF complex partner 1 | 57589.0 | ENSG00000107036 | nan | CATIFA syndrome, 618761 (3), Autosomal recessive
chr9	ERMP1	611156.0 | ERMP1, KIAA1815, FXNA | Endoplasmic reticulum metallopeptidase 1 | 79956.0 | ENSG00000099219 | nan | nan
chr9	MLANA	605513.0 | MLANA, MART1 | Melan A | 2315.0 | ENSG00000120215 | nan | nan
chr9	IL33	608678.0 | IL33, C9orf26, NFEHEV | Interleukin 33 | 90865.0 | ENSG00000137033 | nan | nan
chr9	TPD52L3	617567.0 | TPD52L3 | Tumor protein D52-like 3 | 89882.0 | ENSG00000170777 | nan | nan
chr9	UHRF2	615211.0 | UHRF2, NIRF | Ubiquitin-like protein containing PDH and RING finger domains 2, E3 ubiquitin protein ligase | 115426.0 | ENSG00000147854 | nan | nan
chr9	GLDC	238300.0 | GLDC, HYGN1, GCSP, GCE1, NKH | Glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) | 2731.0 | ENSG00000178445 | nan | Glycine encephalopathy1, 605899 (3), Autosomal recessive
chr9	KDM4C	605469.0 | KDM4C, JMJD2C, GASC1, KIAA0780 | Lysine demethylase 4C | 23081.0 | ENSG00000107077 | nan | nan
chr9	DMAC1	617261.0 | TMEM261, DMAC1, C9orf123 | Transmembrane protein 261 | 90871.0 | ENSG00000137038 | nan | nan
chr9	PTPRD	601598.0 | PTPRD, PTPD, HPTP | Protein tyrosine phosphatase, receptor type, delta polypeptide | 5789.0 | ENSG00000153707 | nan | nan
chr9	DFNB83	613685.0 | DFNB83 | Deafness, autosomal recessive 83 | 100359400.0 | nan | between rs4742645 and rs1471364 | Deafness, autosomal recessive 83, 613685 (2), Autosomal recessive
chr9	FRDA2	601992.0 | FRDA2 | Friedreich ataxia 2 | 2420.0 | nan | nan | Friedreich ataxia 2, 601992 (2), Autosomal recessive
chr9	MRT16	614208.0 | MRT16 | Intellectual developmental disorder, autosomal recessive 16 | 100689014.0 | nan | between rs10738277 and rs12376565 | Intellectual developmental disorder, autosomal recessive 16, 614208 (2), Autosomal recessive
chr9	TYRP1	115501.0 | TYRP1, CAS2, GP75, SHEP11 | Tyrosinase-related protein 1 | 7306.0 | ENSG00000107165 | nan | [Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3); Albinism, oculocutaneous, type III, 203290 (3), Autosomal recessive
chr9	LURAP1L	616130.0 | LURAP1L, LRAP35B | Leucine-rich adaptor protein 1-like | 286343.0 | ENSG00000153714 | nan | nan
chr9	MPDZ	603785.0 | MPDZ, MUPP1, HYC2 | Multiple PDZ domain protein | 8777.0 | ENSG00000107186 | nan | Hydrocephalus, congenital, 2, with or without brain or eye anomalies, 615219 (3), Autosomal recessive
chr9	NFIB	600728.0 | NFIB, MACID | Nuclear factor I/B | 4781.0 | ENSG00000147862 | nan | Macrocephaly, acquired, with impaired intellectual development, 618286 (3), Autosomal dominant
chr9	DFNA47	608652.0 | DFNA47, DFNB83 | Deafness, autosomal dominant 47 | 246289.0 | nan | between D9S268 and D9S942; possibly allelic to DFNB83 | Deafness, autosomal dominant 47, 608652 (2), Autosomal dominant
chr9	LALL	247640.0 | LALL | Lymphomatous acute lymphoblastic leukemia | 8009.0 | nan | nan | Leukemia, acute lymphoblastic, 247640 (2), Autosomal recessive
chr9	ZDHHC21	614605.0 | ZDHHC21, DHHC21 | Zinc finger DHHC domain-containing protein 21 | 340481.0 | ENSG00000175893 | nan | nan
chr9	CER1	603777.0 | CER1 | Cerebrus 1, Xenopus, homolog of | 9350.0 | ENSG00000147869 | nan | nan
chr9	FREM1	608944.0 | FREM1, C9orf154, BNAR, MOTA, TRIGNO2 | FRAS1-related extracellular matrix protein 1 | 158326.0 | ENSG00000164946 | nan | Manitoba oculotrichoanal syndrome, 248450 (3), Autosomal recessive; Bifid nose with or without anorectal and renal anomalies, 608980 (3), Autosomal recessive; Trigonocephaly 2, 614485 (3), Autosomal dominant
chr9	TTC39B	613574.0 | TTC39B | Tetratricopeptide repeat domain 39B | 158219.0 | ENSG00000155158 | nan | nan
chr9	SNAPC3	602348.0 | SNAPC3, SNAP50 | Small nuclear RNA-activating protein complex, polypeptide 3 | 6619.0 | ENSG00000164975 | nan | nan
chr9	PSIP1	603620.0 | PSIP1, LEDGF | PC4- and SFRS1-interacting protein 1 | 11168.0 | ENSG00000164985 | nan | nan
chr9	BNC2	608669.0 | BNC2, LUTO | Basonuclin 2 | 54796.0 | ENSG00000173068 | nan | Lower urinary tract obstruction, congenital, 618612 (3), Autosomal dominant
chr9	CNTLN	611870.0 | CNTLN, C9orf101, C9orf39 | Centlein | 54875.0 | ENSG00000044459 | nan | nan
chr9	SH3GL2	604465.0 | SH3GL2, SH3P4 | SH3 domain, GRB2-like, 2 | 6456.0 | ENSG00000107295 | nan | nan
chr9	ADAMTSL1	609198.0 | ADAMTSL1 | ADAMTS-like protein 1 | 92949.0 | ENSG00000178031 | nan | nan
chr9	AD11	609790.0 | AD11 | Alzheimer disease 11 | 100188795.0 | nan | between D9S157 and D9S259 | Alzheimer disease-11, 609790 (2)
chr9	SAXO1	616292.0 | SAXO1, FAM154A | Stabilizer of axonemal microtubules 1 | 158297.0 | ENSG00000155875 | nan | nan
chr9	RRAGA	612194.0 | RRAGA, RAGA, FIP1 | Ras-related GTP-binding protein A | 10670.0 | ENSG00000155876 | nan | nan
chr9	HAUS6	613433.0 | HAUS6, DGT6, FAM29A | HAUS, augmin-like complex, subunit 6 | 54801.0 | ENSG00000147874 | nan | nan
chr9	SCARNA8	615646.0 | SCARNA8 | Small Cajal body-specific RNA 8 | 677776.0 | ENSG00000251733 | nan | nan
chr9	PLIN2	103195.0 | PLIN2 | Perilipin 2 | 123.0 | ENSG00000147872 | nan | nan
chr9	RPS6	180460.0 | RPS6 | Ribosomal protein S6 | 6194.0 | ENSG00000137154 | nan | nan
chr9	ACER2	613492.0 | ACER2 | Alkaline ceramidase 2 | 340485.0 | ENSG00000177076 | nan | nan
chr9	SLC24A2	609838.0 | SLC24A2, NCKX2 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 | 25769.0 | ENSG00000155886 | nan | nan
chr9	AAA3	611891.0 | AAA3 | Aneurysm, familial abdominal 3 | 100188857.0 | nan | associated with rs10757278 | {Aneurysm, familial abdominal 3}, 611891 (2)
chr9	ANIB6	611892.0 | ANIB6 | Aneurysm, intracranial berry, 6 | 100188858.0 | nan | associated with rs10757278 | {Aneurysm, intracranial berry, 6}, 611892 (2)
chr9	BCC5	613062.0 | BCC5 | Basal cell carcinoma, susceptibility to, 5 | 100307122.0 | nan | associated with rs2151280 | {Basal cell carcinoma, susceptibility to, 5}, 613062 (2)
chr9	CHDS8	611139.0 | CHDS8 | Coronary heart disease, susceptibility to, 8 | 100188836.0 | nan | strongest linkage with dbSNP rs1333049 | {Coronary heart disease, susceptibility to, 8}, 611139 (2)
chr9	GLM5	613030.0 | GLM5 | Glioma susceptibility 5 | 100415894.0 | nan | associated with rs4977756 | {Glioma susceptibility 5}, 613030 (2)
chr9	MFT2	612099.0 | MFT2, TEM | Trichoepithelioma, multiple familial, 2 | 100188881.0 | nan | max lod at D9S171 | Trichoepithelioma, multiple familial, 2, 612099 (2)
chr9	MLLT3	159558.0 | MLLT3, AF9 | Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 3 | 4300.0 | ENSG00000171843 | fuses with ALL1 | nan
chr9	FOCAD	614606.0 | FOCAD, KIAA1797, SCOLIV | Focadhesin | 54914.0 | ENSG00000188352 | nan | Liver disease, severe congenital, 619991 (3), Autosomal recessive
chr9	HACD4	615941.0 | PTPLAD2, HACD4 | Protein tyrosine phosphatase-like A domain-containing protein 2 | 401494.0 | ENSG00000188921 | nan | nan
chr9	IFNB1	147640.0 | IFNB1 | Interferon, beta-1, fibroblast | 3456.0 | ENSG00000171855 | distal to IFL; ?9p23-p22; IFF duplicate in some | nan
chr9	IFNW1	147553.0 | IFNW1 | Interferon, omega-1 | 3467.0 | ENSG00000177047 | pseudogene IFNWP2; interspersed with IFNA | nan
chr9	IFNA21	147584.0 | IFNA21 | Interferon, alpha-21 | 3452.0 | ENSG00000137080 | nan | nan
chr9	IFNA4	147564.0 | IFNA4 | Interferon, alpha-4 | 3441.0 | ENSG00000236637 | nan | nan
chr9	IFNA7	147567.0 | IFNA7 | Interferon, alpha-7 | 3444.0 | ENSG00000214042 | nan | nan
chr9	IFNA10	147577.0 | IFNA10 | Interferon, alpha-10 | 3446.0 | ENSG00000186803 | nan | nan
chr9	IFNA16	147580.0 | IFNA16 | Interferon, alpha-16 | 3449.0 | ENSG00000147885 | nan | nan
chr9	IFNA17	147583.0 | IFNA17 | Interferon, alpha-17 | 3451.0 | ENSG00000234829 | nan | nan
chr9	IFNA14	147579.0 | IFNA14 | Interferon, alpha-14 | 3448.0 | ENSG00000228083 | nan | nan
chr9	IFNA5	147565.0 | IFNA5 | Interferon, alpha-5 | 3442.0 | ENSG00000147873 | nan | nan
chr9	KLHL9	611201.0 | KLHL9, KIAA1354 | Kelch-like 9 | 55958.0 | ENSG00000198642 | nan | nan
chr9	IFNA6	147566.0 | IFNA6 | Interferon, alpha-6 | 3443.0 | ENSG00000120235 | nan | nan
chr9	IFNA13	147578.0 | IFNA13 | Interferon, alpha-13 | 3447.0 | ENSG00000233816 | nan | nan
chr9	IFNA2	147562.0 | IFNA2 | Interferon, alpha-2 | 3440.0 | ENSG00000188379 | nan | nan
chr9	IFNA8	147568.0 | IFNA8 | Interferon, alpha-8 | 3445.0 | ENSG00000120242 | nan | nan
chr9	IFNA1	147660.0 | IFNA1, IFNA@ | Interferon, alpha-1 | 3439.0 | ENSG00000197919 | very close to IFF by Fd, LD; 15-30 genes | Interferon, alpha, deficiency (1)
chr9	MIR31HG	616356.0 | MIR31HG, LOC554202 | Micro RNA 31 host gene, noncoding | 554202.0 | ENSG00000171889 | nan | nan
chr9	IFNE	615223.0 | IFNE, INFE1, IFNT1 | Interferon, epsilon | 338376.0 | ENSG00000184995 | nan | nan
chr9	MIR31	612155.0 | MIR31, MIRN31 | Micro RNA 31 | 407035.0 | ENSG00000199177 | nan | nan
chr9	MTAP	156540.0 | MTAP, DMSMFH | Methylthioadenosine phosphorylase | 4507.0 | ENSG00000099810 | nan | Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3), Autosomal dominant
chr9	CDKN2A	600160.0 | CDKN2A, MTS1, P16, MLM, CMM2 | Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4) | 1029.0 | ENSG00000147889 | nan | {Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant
chr9	CDKN2B-AS1	613149.0 | CDKN2BAS, ANRIL | CDKN2B antisense RNA | 100048912.0 | ENSG00000240498 | nan | nan
chr9	CDKN2B	600431.0 | CDKN2B, MTS2, P15, INK4B | Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 1030.0 | ENSG00000147883 | tandem with MTS1 | nan
chr9	DMRTA1	614803.0 | DMRTA1, DMRT4 | Doublesex- and MAB3-related transcription factor A1 | 63951.0 | ENSG00000176399 | nan | nan
chr9	ELAVL2	601673.0 | ELAVL2, HELN1, HUB | ELAV-like RNA binding protein 2 (Hu antigen B) | 1993.0 | ENSG00000107105 | nan | nan
chr9	IZUMO3	618896.0 | IZUMO3 | IZUMO family, member 3 | 100129669.0 | ENSG00000205442 | nan | nan
chr9		617651.0 | EMICER1 | EQTN, MOB3B, IFNK, and C9orf72 enhancer RNA I, noncoding | nan | nan | nan | nan
chr9	TUSC1	610529.0 | TUSC1, TSG9 | Tumor suppressor candidate 1 | 286319.0 | ENSG00000198680 | nan | nan
chr9	PLAA	603873.0 | PLAA, PLAP, NDMSBA | Phospholipase A2-activating protein | 9373.0 | ENSG00000137055 | nan | Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, 617527 (3), Autosomal recessive
chr9	IFT74	608040.0 | IFT74, CCDC2, CMG1, BBS22, JBTS40, SPGF58 | Intraflagellar transport 74 | 80173.0 | ENSG00000096872 | nan | Bardet-Biedl syndrome 22, 617119 (3), Autosomal recessive; Spermatogenic failure 58, 619585 (3), Autosomal recessive; Joubert syndrome 40, 619582 (3), Autosomal recessive
chr9	LRRC19	619068.0 | LRRC19 | Leucine-rich repeat-containing protein 19 | 64922.0 | ENSG00000184434 | nan | nan
chr9	TEK	600221.0 | TEK, TIE2, VMCM, GLC3E | TEK tyrosine kinase, endothelial | 7010.0 | ENSG00000120156 | nan | Venous malformations, multiple cutaneous and mucosal, 600195 (3), Autosomal dominant; Glaucoma 3, primary congenital, E, 617272 (3), Autosomal dominant
chr9	EQTN	617653.0 | EQTN, AFAF, SPACA8, C9orf11 | Equatorin | 54586.0 | ENSG00000120160 | nan | nan
chr9	MOB3B	617652.0 | MOB3B, MOB1D, MOBKL2B, C9orf35 | MOB kinase activator 3B | 79817.0 | ENSG00000120162 | nan | nan
chr9	IFNK	615326.0 | IFNK | Interferon, kappa | 56832.0 | ENSG00000147896 | nan | nan
chr9	C9orf72	614260.0 | C9orf72, FTDALS1, FTDALS, ALSFTD | Chromosome 9 open reading frame 72 | 203228.0 | ENSG00000147894 | nan | Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3), Autosomal dominant
chr9	LINGO2	609793.0 | LRRN6C, LINGO2, LERN3 | Leucine-rich repeat protein, neuronal, 6C | 158038.0 | ENSG00000174482 | nan | nan
chr9	MIR873	616137.0 | MIR873 | Micro RNA 873 | 100126316.0 | ENSG00000215939 | nan | nan
chr9	ACO1	100880.0 | ACO1, IREB1 | Aconitase 1 (iron-responsive element-binding protein-1) | 48.0 | ENSG00000122729 | nan | nan
chr9	RIGI	609631.0 | DDX58, RIGI, SGMRT2 | DExD/H-box helicase 58 | 23586.0 | ENSG00000107201 | nan | Singleton-Merten syndrome 2, 616298 (3), Autosomal dominant
chr9	TOPORS	609507.0 | TOPORS, P53BP3, LUN, RP31 | Topoisomerase I-binding arginine/serine-rich protein | 10210.0 | ENSG00000197579 | nan | Retinitis pigmentosa 31, 609923 (3), Autosomal dominant
chr9	NDUFB6	603322.0 | NDUFB6 | NADH-ubiquinone oxidoreductase subunit B6 | 4712.0 | ENSG00000165264 | nan | nan
chr9	TAF1L	607798.0 | TAF1L | TATA box-binding protein-associated factor 1-like | 138474.0 | ENSG00000122728 | nan | nan
chr9	APTX	606350.0 | APTX, AOA, AOA1 | Aprataxin | 54840.0 | ENSG00000137074 | nan | Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3), Autosomal recessive
chr9	DNAJA1	602837.0 | DNAJA1, HSDJ, HSPF4 | DNAJ/HSP40 homolog, subfamily A, member 1 | 3301.0 | ENSG00000086061 | nan | nan
chr9	SMU1	617811.0 | SMU1 | DNA replication regulator and spliceosomal factor SMU1 | 55234.0 | ENSG00000122692 | nan | nan
chr9	B4GALT1	137060.0 | B4GALT1, GGTB2, GT1, GTB, CDG2D, CLDLFIB | Glycoprotein-4-beta-galactosyltransferase-2 (EC 2.4.1.22) | 2683.0 | ENSG00000086062 | nan | Combined low LDL and fibrinogen, 620364 (3), Autosomal recessive; Congenital disorder of glycosylation, type IId, 607091 (3), Autosomal recessive
chr9	PEE3	609403.0 | PEE3 | Preeclampsia/eclampsia 3 | 780909.0 | nan | nan | Preeclampsia/eclampsia 3, 609403 (2)
chr9	SPINK4	613929.0 | SPINK4, PEC60 | Serine protease inhibitor, Kazal-type, 4 | 27290.0 | ENSG00000122711 | nan | nan
chr9	BAG1	601497.0 | BAG1 | BAG cochaperone 1 | 573.0 | ENSG00000107262 | nan | nan
chr9	CHMP5	610900.0 | CHMP5 | Charged multivesicular body protein 5 | 51510.0 | ENSG00000086065 | nan | nan
chr9	NFX1	603255.0 | NFX1 | Nuclear transcription factor, X box-binding, protein 1 | 4799.0 | ENSG00000086102 | nan | nan
chr9	AQP7	602974.0 | AQP7, GLYCQTL | Aquaporin-7 | 364.0 | ENSG00000165269 | nan | [Glycerol quantitative trait locus], 614411 (3), Autosomal recessive
chr9	AQP3	600170.0 | AQP3 | Aquaporin-3 | 360.0 | ENSG00000165272 | incorrectly mapped to chr.7 | [Blood group GIL], 607457 (3)
chr9	NOL6	611532.0 | NOL6, NRAP | Nucleolar protein 6 | 65083.0 | ENSG00000165271 | nan | nan
chr9	ANKRD18B	618930.0 | ANKRD18B | Ankyrin repeat domain-containing protein 18B | 441459.0 | ENSG00000230453 | nan | nan
chr9	PTENP1	613531.0 | PTENP1 | Phosphatase and tensin homolog pseudogene 1 (functional) | 11191.0 | ENSG00000293199 | nan | nan
chr9	PRSS3	613578.0 | PRSS3, TRY3, T9 | Protease, serine, 3 | 5646.0 | ENSG00000010438 | nan | nan
chr9	UBE2R2	612506.0 | UBE2R2, UBC3B | Ubiquitin-conjugating enzyme E2 R2 | 54926.0 | ENSG00000107341 | nan | nan
chr9	DCAF12	620087.0 | DCAF12, KIAA1892, TCC52 | DDB1- and CUL4-associated factor 12 | 25853.0 | ENSG00000198876 | nan | nan
chr9	UBAP1	609787.0 | UBAP1, UBAP, SPG80 | Ubiquitin-associated protein 1 | 51271.0 | ENSG00000165006 | nan | Spastic paraplegia 80, autosomal dominant, 618418 (3), Autosomal dominant
chr9	KIF24	613747.0 | KIF24 | Kinesin family member 24 | 347240.0 | ENSG00000186638 | nan | nan
chr9	NUDT2	602852.0 | NUDT2, APAH1, IDDPN | Nudix hydrolase 2 | 318.0 | ENSG00000164978 | nan | Intellectual developmental disorder with or without peripheral neuropathy, 619844 (3), Autosomal recessive
chr9	MYORG	618255.0 | MYORG, NET37, KIAA1161, IBGC7 | Myogenesis-regulating glycosidase | 57462.0 | ENSG00000164976 | nan | Basal ganglia calcification, idiopathic, 7, autosomal recessive, 618317 (3), Autosomal recessive
chr9	SPMIP6	619502.0 | C9orf24, CBE1 | Chromosome 9 open reading frame 24 | 84688.0 | ENSG00000164972 | nan | nan
chr9	DNAI1	604366.0 | DNAI1, CILD1, ICS, PCD | Dynein, axonemal, intermediate chain 1 | 27019.0 | ENSG00000122735 | nan | Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3), Autosomal recessive
chr9	ENHO	618556.0 | ENHO | Energy homeostasis-associated protein | 375704.0 | ENSG00000168913 | nan | nan
chr9	CNTFR	118946.0 | CNTFR | Ciliary neurotrophic factor receptor | 1271.0 | ENSG00000122756 | nan | nan
chr9	DCTN3	607387.0 | DCTN3, DCTN22 | Dynactin 3 | 11258.0 | ENSG00000137100 | nan | nan
chr9	ARID3C	620868.0 | ARID3C | AT-rich interaction domain-containing protein 3C | 138715.0 | ENSG00000205143 | nan | nan
chr9	SIGMAR1	601978.0 | SIGMAR1, SRBP, ALS16, HMNR2 | Sigma nonopioid intracellular receptor 1 | 10280.0 | ENSG00000147955 | mutation identified in 1 ALS16 family and 1 HMNR2 family | ?Neuronopathy, distal hereditary motor, autosomal recessive 2, 605726 (3), Autosomal recessive; ?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3), Autosomal recessive
chr9	GALT	606999.0 | GALT | Galactose-1-phosphate uridyltransferase | 2592.0 | ENSG00000213930 | nan | Galactosemia, 230400 (3), Autosomal recessive
chr9	IL11RA	600939.0 | IL11RA, CRSDA | Interleukin-11 receptor, alpha | 3590.0 | ENSG00000137070 | nan | Craniosynostosis and dental anomalies, 614188 (3), Autosomal recessive
chr9	CCL27	604833.0 | CCL27, SCYA27, ILC, CTACK | Chemokine, C-C motif, ligand 27 | 10850.0 | ENSG00000213927 | nan | nan
chr9	PHF24	619928.0 | PHF24, GINIP, KIAA1045 | PHD finger protein 24 | 23349.0 | ENSG00000122733 | nan | nan
chr9	CCL19	602227.0 | CCL19, SCYA19, ELC, MIP3B | Chemokine, C-C motif, ligand 19 | 6363.0 | ENSG00000172724 | nan | nan
chr9	CCL21	602737.0 | CCL21, SCYA21, SLC | Chemokine, C-C motif, ligand 21 | 6366.0 | ENSG00000137077 | nan | nan
chr9	DNAJB5	611328.0 | DNAJB5, KIAA1045, HSC40 | DNAJ/HSP40 homolog, subfamily B, member 5 | 25822.0 | ENSG00000137094 | nan | nan
chr9	VCP	601023.0 | VCP, IBMPFD1, CMT2Y, FTDALS6 | Valosin-containing protein | 7415.0 | ENSG00000165280 | nan | Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant; Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant
chr9	FANCG	602956.0 | XRCC9, FANCG | X-ray repair cross complementing 9 (FA complementation group G) | 2189.0 | ENSG00000221829 | nan | Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive
chr9	PIGO	614730.0 | PIGO, HPMRS2 | Phosphatidylinositol glycan, class O | 84720.0 | ENSG00000165282 | nan | Hyperphosphatasia with impaired intellectual development syndrome 2, 614749 (3), Autosomal recessive
chr9	STOML2	608292.0 | STOML2 | Stomatin-like protein 2 | 30968.0 | ENSG00000165283 | nan | nan
chr9	ATOSB	620169.0 | ATOSB, KIAA1539 | ATOS homolog B | 80256.0 | ENSG00000005238 | nan | nan
chr9	UNC13B	605836.0 | UNC13B, UNC13, MUNC13 | unc-13 homolog B | 10497.0 | ENSG00000198722 | nan | nan
chr9	RUSC2	611053.0 | RUSC2, KIAA0375, IPORIN, MRT61 | RUN and SH3 domain-containing 2 | 9853.0 | ENSG00000198853 | nan | Intellectual developmental disorder, autosomal recessive 61, 617773 (3), Autosomal recessive
chr9	TESK1	601782.0 | TESK1 | Testis-associated actin-modeling kinase 1 | 7016.0 | ENSG00000107140 | nan | nan
chr9	CD72	107272.0 | CD72, LYB2 | CD72 antigen | 971.0 | ENSG00000137101 | nan | nan
chr9	SIT1	604964.0 | SIT | SHP2-interacting transmembrane adaptor protein | 27240.0 | ENSG00000137078 | nan | nan
chr9	RMRP	157660.0 | RMRP, RMRPR, CHH | Mitochondrial RNA-processing endoribonuclease | 6023.0 | ENSG00000277027 | nan | Anauxetic dysplasia 1, 607095 (3), Autosomal recessive; Metaphyseal dysplasia without hypotrichosis, 250460 (3), Autosomal recessive; Cartilage-hair hypoplasia, 250250 (3), Autosomal recessive
chr9	CA9	603179.0 | CA9, MN | Carbonic anhydrase IX | 768.0 | ENSG00000107159 | previously assigned to 17q21.2 | nan
chr9	TPM2	190990.0 | TPM2, TMSB, AMCD1, DA1, DA2B4, CMYO23 | Tropomyosin-2, beta | 7169.0 | ENSG00000198467 | nan | Arthrogryposis, distal, type 2B4, 108120 (3), Autosomal dominant; Arthrogryposis, distal, type 1A, 108120 (3), Autosomal dominant; Congenital myopathy 23, 609285 (3), Autosomal dominant
chr9	TLN1	186745.0 | TLN1 | Talin 1 | 7094.0 | ENSG00000137076 | nan | nan
chr9	CREB3	606443.0 | CREB3, LZIP | cAMP response element-binding protein 3 | 10488.0 | ENSG00000107175 | nan | nan
chr9	GBA2	609471.0 | GBA2, KIAA1605, SPG46 | Glucosidase, beta, acid 2 | 57704.0 | ENSG00000070610 | nan | Spastic paraplegia 46, autosomal recessive, 614409 (3), Autosomal recessive
chr9	RGP1	615742.0 | RGP1, KIAA0258 | RGP1 homolog, RAB6A GEF complex partner 1 | 9827.0 | ENSG00000107185 | nan | nan
chr9	MSMP	612191.0 | MSMP, PSMP | Microseminoprotein, prostate-associated | 692094.0 | ENSG00000215183 | nan | nan
chr9	NPR2	108961.0 | NPR2, ANPRB, AMD1, ECDM, SNSK | Natiuretic peptide receptor 2 | 4882.0 | ENSG00000159899 | nan | Epiphyseal chondrodysplasia, Miura type, 615923 (3), Autosomal dominant; Short stature with nonspecific skeletal abnormalities, 616255 (3), Autosomal dominant; Acromesomelic dysplasia 1, Maroteaux type, 602875 (3), Autosomal recessive
chr9	SPAG8	605731.0 | SPAG8, SMP1 | Sperm-associated antigen 8 | 26206.0 | ENSG00000137098 | nan | nan
chr9	HINT2	609997.0 | HINT2 | Histidine triad nucleotide-binding protein 2 | 84681.0 | ENSG00000137133 | nan | nan
chr9	TMEM8B	616888.0 | TMEM8B, NGX6, NAG5 | Transmembrane protein 8B | 51754.0 | ENSG00000137103 | nan | nan
chr9	SPAAR	617627.0 | SPAAR, LINC00961 | Small regulatory polypeptide of amino acid response | 158376.0 | ENSG00000235387 | nan | nan
chr9	RECK	605227.0 | RECK, ST15 | Reversion-inducing cysteine-rich protein with kazal motifs (suppressor of tumorigenicity 15) | 8434.0 | ENSG00000122707 | nan | nan
chr9	GLIPR2	607141.0 | GLIPR2, GAPR1, C9orf19 | GLI pathogenesis-related 2 | 152007.0 | ENSG00000122694 | nan | nan
chr9	CCIN	603960.0 | CCIN, SPGF91 | Calicin | 881.0 | ENSG00000185972 | nan | Spermatogenic failure 91, 620838 (3), Autosomal recessive
chr9	CLTA	118960.0 | CLTA | Clathrin, light polypeptide (Lca) | 1211.0 | ENSG00000122705 | previously mapped to 12q23-q24 | nan
chr9	GNE	603824.0 | GNE, GLCNE, IBM2, DMRV, NM, THC12 | UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase | 10020.0 | ENSG00000159921 | nan | Sialuria, 269921 (3), Autosomal dominant; Thrombocytopenia 12 with or without myopathy, 620757 (3), Autosomal recessive; Nonaka myopathy, 605820 (3), Autosomal recessive
chr9	RNF38	612488.0 | RNF38 | Ring finger protein 38 | 152006.0 | ENSG00000137075 | nan | nan
chr9	MELK	607025.0 | MELK, KIAA0175 | Maternal embryonic leucine zipper kinase | 9833.0 | ENSG00000165304 | nan | nan
chr9	PAX5	167414.0 | PAX5, BSAP, ALL3 | Paired box homeotic gene-5 (B-cell lineage specific activator protein) | 5079.0 | ENSG00000196092 | nan | {Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3)
chr9	GRHPR	604296.0 | GRHPR, GLXR | Glyoxylate reductase/hydroxypyruvate reductase | 9380.0 | ENSG00000137106 | nan | Hyperoxaluria, primary, type II, 260000 (3), Autosomal recessive
chr9	ZBTB5	616590.0 | ZBTB5, KIAA0354 | Zinc finger- and BTB domain-containing protein 5 | 9925.0 | ENSG00000168795 | nan | nan
chr9	FBXO10	609092.0 | FBXO10, FBX10 | F-box only protein 10 | 26267.0 | ENSG00000147912 | nan | nan
chr9	TOMM5	616169.0 | TOMM5, TOM5 | Translocase of outer mitochondrial membrane 5 | 401505.0 | ENSG00000175768 | nan | nan
chr9	FRMPD1	616919.0 | FRMPD1, FRMD2, KIAA0967 | FERM and PDZ domains-containing protein 1 | 22844.0 | ENSG00000070601 | nan | nan
chr9	TRMT10B	620957.0 | TRMT10B | tRNA methyltransferase 10B | 158234.0 | ENSG00000165275 | nan | nan
chr9	EXOSC3	606489.0 | EXOSC3, RRP40, PCH1B | Exosome component 3 | 51010.0 | ENSG00000107371 | nan | Pontocerebellar hypoplasia, type 1B, 614678 (3), Autosomal recessive
chr9	DCAF10	620295.0 | DCAF10 | DDB1- and CUL4-associated factor 10 | 79269.0 | ENSG00000122741 | nan | nan
chr9	SLC25A51	619153.0 | SLC25A51, MCART1 | Solute carrier family 25 (mitochondrial carrier, NAD+ transporter), member 51 | 92014.0 | ENSG00000122696 | nan | nan
chr9	OTSC8	612096.0 | OTSC8 | Otosclerosis 8 | 100151644.0 | nan | between D9S970 and D9S1799 | Otosclerosis 8, 612096 (2), Autosomal dominant
chr9	SHB	600314.0 | SHB | SHB adaptor protein (a Src homology 2 protein) | 6461.0 | ENSG00000107338 | nan | nan
chr9	ALDH1B1	100670.0 | ALDH1B1, ALDH5 | Aldehyde dehydrogenase 1 family, member B1 | 219.0 | ENSG00000137124 | nan | nan
chr9	IGFBPL1	610413.0 | IGFBPL1, IGFBPRP4 | Insulin-like growth factor binding protein-like 1 | 347252.0 | ENSG00000137142 | nan | nan
chr9	ANKRD18A	620259.0 | ANKRD18A | Ankyrin repeat domain-containing protein 18A | 253650.0 | ENSG00000180071 | nan | nan
chr9	CPAT1	605388.0 | ACP | Cerebral palsy, ataxic, autosomal recessive | 60502.0 | nan | nan | Cerebral palsy, ataxic, autosomal recessive, 605388 (2), Autosomal recessive
chr9	CNTNAP3	610517.0 | CNTNAP3, KIAA1714 | Contactin-associated protein-like 3 | 79937.0 | ENSG00000106714 | nan | nan
chr9	MROS	155900.0 | MROS | Melkersson-Rosenthal syndrome | 8011.0 | nan | nan | ?Melkersson-Rosenthal syndrome, 155900 (2), Autosomal dominant
chr9	HCHGQ2	609320.0 | HCHGQ2 | Hematocrit/hemoglobin quantitative trait locus 2 | 100381205.0 | nan | nan | [Hematocrit/hemoglobin quantitative trait locus 2], 609320 (2)
chr9	SPG19	607152.0 | SPG19 | Spastic paraplegia-19 | 140907.0 | nan | nan | Spastic paraplegia 19, autosomal dominant, 607152 (2), Autosomal dominant
chr9		126330.0 | DNCM | Cytoplasmic membrane DNA | 1784.0 | nan | in 9qh | nan
chr9	SPATA31A7	616584.0 | SPATA31A7, AEP1, FAM75A7, C9orf36 | Spermatogenesis-associated protein 31, subfamily A, member 7 | 26165.0 | ENSG00000276040 | nan | nan
chr9	CMD1B	600884.0 | CMD1B, CMPD1, FDC | Cardiomyopathy, dilated-1B, autosomal dominant | 1218.0 | nan | nan | Cardiomyopathy, dilated 1B, 600884 (2), Autosomal dominant
chr9	CTPL1	605749.0 | CTRCT26, CAAR | Cataract 26, multiple types | 81863.0 | nan | nan | Cataract 26, multiple types, 605749 (2)
chr9	GSM1	190100.0 | GSM1, GSP | Geniospasm 1 | 2933.0 | nan | nan | Geniospasm, 190100 (2), Autosomal dominant
chr9		613558.0 | DFNA51, C9DUPq21.11, DUP9q21.11 | Deafness, autosomal dominant 51 (chromosome 9q21.11 duplication syndrome) | nan | nan | 259kb duplication involving TJP2 and FAM189A2 | Deafness, autosomal dominant 51, 613558 (4), Autosomal dominant
chr9	ETL4	611631.0 | ETL4, ETOLM | Epilepsy, familial temporal lobe, 4 | 100144434.0 | nan | between GATA152H04 and D9S253 | Epilepsy, familial temporal lobe, 4, 611631 (2), Autosomal dominant
chr9	PVOP2	613088.0 | PVOP2 | Pelvic organ prolapse, susceptibility to, 2 | 100312955.0 | nan | between rs4077632 and rs10868525 | {Pelvic organ prolapse, susceptibility to, 2}, 613088 (2)
chr9	FOXD4L4	611085.0 | FOXD4L4, FOXD4L2 | Forkhead box D4-like 4 | 349334.0 | ENSG00000184659 | nan | nan
chr9	ZNF658	616290.0 | ZNF658 | Zinc finger protein 658 | 26149.0 | ENSG00000274349 | nan | nan
chr9	ZNG1C	611080.0 | CBWD3 | Cobalamin synthetase W domain-containing protein 3 | 445571.0 | ENSG00000196873 | nan | nan
chr9	FOXD4L3	611086.0 | FOXD4L3 | Forkhead box D4-like 3 | 286380.0 | ENSG00000187559 | nan | nan
chr9	PGM5	600981.0 | PGM5 | Phosphoglucomutase-5 | 5239.0 | ENSG00000154330 | nan | nan
chr9	PIP5K1B	602745.0 | PIP5K1B, STM7, MSS4 | Phosphatidylinositol-4-phosphate 5-kinase, type I, beta | 8395.0 | ENSG00000107242 | nan | nan
chr9	PABIR1	617249.0 | FAM122A, C9orf42 | Family with sequence similarity 122, member A | 116224.0 | ENSG00000187866 | nan | nan
chr9	PRKACG	176893.0 | PRKACG, BDPLT19 | Protein kinase, cAMP-dependent, catalytic, gamma | 5568.0 | ENSG00000165059 | mutation identified in 1 BDPLT19 family | ?Bleeding disorder, platelet-type, 19, 616176 (3), Autosomal recessive
chr9	FXN	606829.0 | FXN, FRDA, FARR, X25 | Frataxin | 2395.0 | ENSG00000165060 | nan | Friedreich ataxia with retained reflexes, 229300 (3), Autosomal recessive; Friedreich ataxia, 229300 (3), Autosomal recessive
chr9	TJP2	607709.0 | TJP2, ZO2, PFIC4, FHCA1 | Tight junction protein 2 | 9414.0 | ENSG00000119139 | nan | Hypercholanemia, familial 1, 607748 (3), Autosomal recessive; Cholestasis, progressive familial intrahepatic 4, 615878 (3), Autosomal recessive
chr9	BANCR	619589.0 | BANCR | BRAF-activated noncoding RNA | 100885775.0 | ENSG00000278910 | nan | nan
chr9	ENTREP1	607710.0 | ENTREP1, FAM189A2, X123, C9orf61 | Endosomal transmembrane epsin interactor 1 | 9413.0 | ENSG00000135063 | nan | nan
chr9	APBA1	602414.0 | APBA1, X11, D9S411E, MINT1, LIN10 | Amyloid beta A4 precursor protein-binding, family A, member 1 | 320.0 | ENSG00000107282 | nan | nan
chr9	MAMDC2	612879.0 | MAMDC2 | MAM domain-containing 2 | 256691.0 | ENSG00000165072 | nan | nan
chr9	SMC5	609386.0 | SMC5, SMC5L1, KIAA0594, ATELS2 | Structural maintenance of chromosomes 5 | 23137.0 | ENSG00000198887 | nan | Atelis syndrome 2, 620185 (3), Autosomal recessive
chr9	KLF9	602902.0 | BTEB1, BTEB | Basic transcription element-binding protein 1 | 687.0 | ENSG00000119138 | nan | nan
chr9	TRPM3	608961.0 | TRPM3, MLSN2, LTRPC3, KIAA1616, NEDFSS, CTRCT50 | Transient receptor potential cation channel, subfamily M, member 3 | 80036.0 | ENSG00000083067 | mutation identified in 1 CTRCT50 family | ?Cataract 50 with or without glaucoma, 620253 (3), Autosomal dominant; Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures, 620224 (3), Autosomal dominant
chr9	MIR204	610942.0 | MIR204, MIRN204, RDICC | Micro RNA 204 | 406987.0 | ENSG00000207935 | nan | Retinal dystrophy and iris coloboma with or without cataract, 616722 (3), Autosomal dominant
chr9	CEMIP2	605835.0 | CEMIP2, TMEM2 | Cell migration-inducing hyaluronidase 2 | 23670.0 | ENSG00000135048 | nan | nan
chr9	ABHD17B	617943.0 | ABHD17B, FAM108B1 | Abhydrolase domain-containing protein 17B, depalmitoylase | 51104.0 | ENSG00000107362 | nan | nan
chr9	C9orf85	620761.0 | C9orf85 | Chromosome 9 open reading frame 85 | 138241.0 | ENSG00000155621 | nan | nan
chr9	GDA	139260.0 | GDA, CYPIN | Guanine deaminase | 9615.0 | ENSG00000119125 | nan | nan
chr9	ZFAND5	604761.0 | ZFAND5, ZNF216 | Zinc finger AN1 domain-containing protein 5 | 7763.0 | ENSG00000107372 | nan | nan
chr9	TMC1	606706.0 | TMC1, DFNB7, DFNB11, DFNA36 | Transmembrane channel-like protein 1 | 117531.0 | ENSG00000165091 | nan | Deafness, autosomal dominant 36, 606705 (3), Autosomal dominant; Deafness, autosomal recessive 7, 600974 (3), Autosomal recessive
chr9	ALDH1A1	100640.0 | ALDH1A1 | Aldehyde dehydrogenase-1 family, member A1, soluble | 216.0 | ENSG00000165092 | nan | nan
chr9	ANXA1	151690.0 | ANXA1, LPC1 | Annexin A1 (lipocortin I) | 301.0 | ENSG00000135046 | nan | nan
chr9	RORB	601972.0 | RORB, RZRB, EIG15 | RAR-related orphan receptor B | 6096.0 | ENSG00000198963 | nan | {Epilepsy, idiopathic generalized, susceptibility to, 15}, 618357 (3), Autosomal dominant
chr9	TRPM6	607009.0 | TRPM6, CHAK2, HOMG1 | Transient receptor potential cation channel, subfamily M, member 6 | 140803.0 | ENSG00000119121 | nan | Hypomagnesemia 1, intestinal, 602014 (3), Autosomal recessive
chr9	CARNMT1	616552.0 | CARNMT1, C9orf41, UPF0586 | Carnosine N-methyltransferase 1 | 138199.0 | ENSG00000156017 | nan | nan
chr9	NMRK1	608704.0 | NMRK1, C9orf95 | Nicotinamide riboside kinase 1 | 54981.0 | ENSG00000106733 | nan | nan
chr9	OSTF1	610180.0 | OSTF1, OSF, SH3P2 | Osteoclast-stimulating factor 1 | 26578.0 | ENSG00000134996 | nan | nan
chr9	PCSK5	600488.0 | PCSK5 | Proprotein convertase subtilisin/kexin type 5 | 5125.0 | ENSG00000099139 | ?close to LPC1 on 9q | nan
chr9	RFK	613010.0 | RFK | Riboflavin kinase | 55312.0 | ENSG00000135002 | nan | nan
chr9	GCNT1	600391.0 | GCNT1 | Glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase) | 2650.0 | ENSG00000187210 | nan | nan
chr9	PRUNE2	610691.0 | PRUNE2, BMCC1, KIAA0367 | PRUNE homolog 2 with BCH domain | 158471.0 | ENSG00000106772 | nan | nan
chr9	PCA3	604845.0 | PCA3, DD3 | Prostate cancer antigen 3 | 50652.0 | ENSG00000225937 | nan | nan
chr9	FOXB2	619962.0 | FOXB2, FKH4 | Forkhead box B2 | 442425.0 | ENSG00000204612 | nan | nan
chr9	VPS13A	605978.0 | VPS13A, CHAC | Vacuolar protein sorting 13 homolog A (chorein) | 23230.0 | ENSG00000197969 | nan | Choreoacanthocytosis, 200150 (3), Autosomal recessive
chr9	GNA14	604397.0 | GNA14 | Guanine nucleotide-binding protein, alpha-14 | 9630.0 | ENSG00000156049 | nan | nan
chr9	GNAQ	600998.0 | GNAQ, SWS, CMC1 | Guanine nucleotide-binding protein (G protein), q | 2776.0 | ENSG00000156052 | pseudogene on 2q | Capillary malformations, congenital, 1, somatic, mosaic, 163000 (3); Sturge-Weber syndrome, somatic, mosaic, 185300 (3)
chr9	CEP78	617110.0 | CEP78, CRDHL | Centrosomal protein, 78kD | 84131.0 | ENSG00000148019 | nan | Cone-rod dystrophy and hearing loss, 617236 (3), Autosomal recessive
chr9	PSAT1	610936.0 | PSAT1, PSAT, EPIP, PSATD, NLS2 | Phosphoserine aminotransferase 1 | 29968.0 | ENSG00000135069 | nan | Neu-Laxova syndrome 2, 616038 (3), Autosomal recessive; Phosphoserine aminotransferase deficiency, 610992 (3), Autosomal recessive
chr9	HPLH1	267700.0 | FHL1, HPLH1, HLH1 | Hemophagocytic lymphohistiocytosis, familial, 1 | 27259.0 | nan | nan | Hemophagocytic lymphohistiocytosis, familial, 1, 267700 (2), Autosomal recessive
chr9	TLE4	605132.0 | TLE4, ESG4, GRG4 | TLE family member 4, transcriptional corepressor | 7091.0 | ENSG00000106829 | nan | nan
chr9	TLE1	600189.0 | TLE1, ESG1, GRG1 | TLE family member 1, transcriptional corepressor | 7088.0 | ENSG00000196781 | conflicting assignment to chr.19 | nan
chr9	RASEF	611344.0 | RASEF | RAS and EF-hand domains-containing protein | 158158.0 | ENSG00000165105 | nan | nan
chr9	FRMD3	607619.0 | FRMD3, EPB41LO | FERM domain-containing 3 | 257019.0 | ENSG00000172159 | nan | nan
chr9	IDNK	611343.0 | IDNK, C9orf103 | IDNK gluconokinase | 414328.0 | ENSG00000148057 | nan | nan
chr9	UBQLN1	605046.0 | UBQLN1, DA41 | Ubiquilin 1 (Da41, rat, homolog of) | 29979.0 | ENSG00000135018 | nan | nan
chr9	GKAP1	611356.0 | GKAP1, GKAP42 | G kinase-anchoring protein 1 | 80318.0 | ENSG00000165113 | nan | nan
chr9	KIF27	611253.0 | KIF27 | Kinesin family member 27 | 55582.0 | ENSG00000165115 | nan | nan
chr9	QNG1	611342.0 | C9orf64 | Chromosome 9 open reading frame 64 | 84267.0 | ENSG00000165118 | nan | nan
chr9	HNRNPK	600712.0 | HNRNPK, HNRPK, AUKS | Heterogeneous nuclear ribonucleoprotein K | 3190.0 | ENSG00000165119 | nan | Au-Kline syndrome, 616580 (3), Autosomal dominant
chr9	MIR7-1	615239.0 | MIR7-1 | Micro RNA 7-1 | 407043.0 | ENSG00000284179 | nan | nan
chr9	RMI1	610404.0 | RMI1, BLAP75, C9orf76 | RecQ-mediated genome instability 1 protein | 80010.0 | ENSG00000178966 | nan | nan
chr9	SLC28A3	608269.0 | SLC28A3, CNT3 | Solute carrier family (sodium-coupled nucleoside transporter), member 3 | 64078.0 | ENSG00000197506 | nan | nan
chr9	NTRK2	600456.0 | NTRK2, TRKB, OBHD, DEE58 | Neurotrophic tyrosine kinase, receptor, type 2 | 4915.0 | ENSG00000148053 | nan | Developmental and epileptic encephalopathy 58, 617830 (3), Autosomal dominant; Obesity, hyperphagia, and developmental delay, 613886 (3), Autosomal dominant
chr9	AGTPBP1	606830.0 | AGTPBP1, NNA1, KIAA1035, CCP1, CONDCA | ATP/GTP-binding protein 1 | 23287.0 | ENSG00000135049 | nan | Neurodegeneration, childhood-onset, with cerebellar atrophy, 618276 (3), Autosomal recessive
chr9	NAA35	619438.0 | NAA35, MAK10 | N-alpha-acetyltransferase 35, NatC auxiliary subunit | 60560.0 | ENSG00000135040 | nan | nan
chr9	GOLM1	606804.0 | GOLM1, GOLPH2, GP73, C9orf155 | Golgi membrane protein 1 | 51280.0 | ENSG00000135052 | nan | nan
chr9	ISCA1	611006.0 | ISCA1, HBLD2, HISCA, MMDS5 | Iron-sulfur cluster assembly 1 | 81689.0 | ENSG00000135070 | nan | Multiple mitochondrial dysfunctions syndrome 5, 617613 (3), Autosomal recessive
chr9	TUT7	613467.0 | TUT6, ZCCHC6, KIAA1711 | Terminal uridylyl transferase 7 | 79670.0 | ENSG00000083223 | nan | nan
chr9	GAS1	139185.0 | GAS1 | Growth arrest-specific gene-1 | 2619.0 | ENSG00000180447 | nan | nan
chr9	DAPK1	600831.0 | DAPK1 | Death-associated protein kinase-1 | 1612.0 | ENSG00000196730 | nan | nan
chr9	CTSL	116880.0 | CTSL | Cathepsin L | 1514.0 | ENSG00000135047 | \'like\' sequence on 10q23-q24 | nan
chr9	GLC1J	608695.0 | JOAG2 | Glaucoma, primary open angle, juvenile-onset, 2 | 574078.0 | nan | between D9S1803 and D9S196 | Glaucoma, primary open angle, juvenile-onset, 2, 608695 (2)
chr9	STQTL8	610114.0 | STQTL8 | Stature quantitative trait locus 8 | 100037266.0 | nan | between GATA81C04M and ATA18A07M | {Stature QTL 8}, 610114 (2)
chr9	CDK20	610076.0 | CDK20, CCRK, CDCH, P42 | Cyclin-dependent kinase 20 | 23552.0 | ENSG00000156345 | nan | nan
chr9	SPIN1	609936.0 | SPIN, SPIN1 | Spindlin | 10927.0 | ENSG00000106723 | nan | nan
chr9	NXNL2	615299.0 | NXNL2, RDCVF2 | Nucleoredoxin-like protein 2 | 158046.0 | ENSG00000130045 | nan | nan
chr9	S1PR3	601965.0 | S1PR3, EDG3 | Sphingosine-1-phosphate receptor 3 | 1903.0 | ENSG00000213694 | nan | nan
chr9	SHC3	605263.0 | SHC3, NSHC, RAI, SHCC | SHC transforming protein 3 | 53358.0 | ENSG00000148082 | nan | nan
chr9	CKS2	116901.0 | CKS2 | CDC2-associated protein CKS2 | 1164.0 | ENSG00000123975 | nan | nan
chr9	SECISBP2	607693.0 | SECISBP2, SBP2, THMA1 | Selenocysteine insertion sequence-binding protein 2 | 79048.0 | ENSG00000187742 | nan | Thyroid hormone metabolism, abnormal, 1, 609698 (3), Autosomal recessive
chr9	SEMA4D	601866.0 | SEMA4D, SEMAJ, CD100, COLL4 | Semaphorin 4D | 10507.0 | ENSG00000187764 | nan | nan
chr9	GADD45G	604949.0 | GADD45G, GRP17 | Growth arrest- and DNA damage-inducible gene 45, gamma | 10912.0 | ENSG00000130222 | nan | nan
chr9	DIRAS2	607863.0 | DIRAS2 | DIRAS family, GTP-binding Ras-like protein 2 | 54769.0 | ENSG00000165023 | nan | nan
chr9	SYK	600085.0 | SYK, IMD82 | Protein-tyrosine kinase SYK | 6850.0 | ENSG00000165025 | nan | Immunodeficiency 82 with systemic inflammation, 619381 (3), Autosomal dominant
chr9	AUH	600529.0 | AUH | AU-specific RNA-binding protein (3-methylglutaconyl-CoA hydratase) | 549.0 | ENSG00000148090 | nan | 3-methylglutaconic aciduria, type I, 250950 (3), Autosomal recessive
chr9	NFIL3	605327.0 | NFIL3, NFIL3A, E4BP4 | Nuclear factor, interleukin 3-regulated | 4783.0 | ENSG00000165030 | nan | nan
chr9	ROR2	602337.0 | ROR2, BDB1, BDB, NTRKR2 | Receptor tyrosine kinase-like orphan receptor 2 | 4920.0 | ENSG00000169071 | nan | Brachydactyly, type B1, 113000 (3), Autosomal dominant; Robinow syndrome, autosomal recessive, 268310 (3), Autosomal recessive
chr9	SPTLC1	605712.0 | SPTLC1, LBC1, SPT1, HSN1, HSAN, ALS27 | Serine palmitoyltransferase, long-chain base subunit 1 | 10558.0 | ENSG00000090054 | nan | Amyotrophic lateral sclerosis 27, juvenile, 620285 (3), Autosomal dominant; Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3), Autosomal dominant
chr9	IARS1	600709.0 | IARS1, IARS, GRIDHH | Isoleucine-tRNA synthetase 1 | 3376.0 | ENSG00000196305 | nan | Growth retardation, impaired intellectual development, hypotonia, and hepatopathy, 617093 (3), Autosomal recessive
chr9	NOL8	611534.0 | NOL8, NOP132 | Nucleolar protein 8 | 55035.0 | ENSG00000198000 | nan | nan
chr9	CENPP	611505.0 | CENPP | Centromeric protein P | 401541.0 | ENSG00000188312 | nan | nan
chr9	OGN	602383.0 | OGN, OIF | Osteoglycin | 4969.0 | ENSG00000106809 | nan | nan
chr9	OMD	618926.0 | OMD, OSAD | Osteomodulin | 4958.0 | ENSG00000127083 | nan | nan
chr9	ASPN	608135.0 | ASPN, PLAP1, OS3 | Asporin | 54829.0 | ENSG00000106819 | nan | {Lumbar disc degeneration}, 603932 (3); {Osteoarthritis susceptibility 3}, 607850 (3), Autosomal dominant
chr9	ECM2	603479.0 | ECM2 | Extracellular matrix protein-2 | 1842.0 | ENSG00000106823 | nan | nan
chr9	IPPK	619043.0 | IPPK, IP5K | Inositol-pentakisphosphate 2-kinase | 64768.0 | ENSG00000127080 | nan | nan
chr9	BICD2	609797.0 | BICD2, KIAA0699, SMALED2A, SMALED2B | BICD carbo adaptor 2 | 23299.0 | ENSG00000185963 | nan | Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant, 618291 (3), Autosomal dominant; Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant, 615290 (3), Autosomal dominant
chr9	FGD3	617554.0 | FGD3, ZFYVE5 | FYVE, RhoGEF, and Ph domain-containing protein 3 | 89846.0 | ENSG00000127084 | nan | nan
chr9	SUSD3	616429.0 | SUSD3 | SUSHI domain-containing protein 3 | 203328.0 | ENSG00000157303 | nan | nan
chr9	CARD19	617726.0 | CARD19, BINCARD, C9orf89 | Caspase recruitment domain-containing protein 19 | 84270.0 | ENSG00000165233 | nan | nan
chr9	NINJ1	602062.0 | NINJ1 | Ninjurin | 4814.0 | ENSG00000131669 | nan | nan
chr9	WNK2	606249.0 | WNK2, PRKWNK2 | WNK lysine deficient protein kinase 2 | 65268.0 | ENSG00000165238 | nan | nan
chr9	FAM120A	612265.0 | FAM120A, C9orf10, KIAA0183 | Family with sequence similarity 120, member A | 23196.0 | ENSG00000048828 | nan | nan
chr9	PHF2	604351.0 | PHF2 | PHD finger protein-2 | 5253.0 | ENSG00000197724 | nan | nan
chr9	BARX1	603260.0 | BARX1 | BarH-like homeobox gene 1 | 56033.0 | ENSG00000131668 | nan | nan
chr9	MIRLET7A1	605386.0 | MIRLET7A1, LET7A1, MIRNLET7A1 | Micro RNA Let7a1 | 406881.0 | ENSG00000199165 | nan | nan
chr9	MIRLET7F1	612146.0 | MIRLET7F1, LET7F1, MIRNLET7F1 | Micro RNA Let7f1 | 406888.0 | ENSG00000199072 | nan | nan
chr9	MIRLET7D	612145.0 | MIRLET7D, LET7D, MIRNLET7D | Micro RNA Let7d | 406886.0 | ENSG00000199133 | nan | nan
chr9	ZNF169	603404.0 | ZNF169 | Zinc finger protein-169 | 169841.0 | ENSG00000175787 | nan | nan
chr9	MFSD14B	620348.0 | MFSD14B | Major facilitator superfamily domain-containing protein 14B | 84641.0 | ENSG00000148110 | nan | nan
chr9	FBP2	603027.0 | FBP2, CORLK | Fructose-1,6-bisphosphatase 2 | 8789.0 | ENSG00000130957 | mutation identified in 1 CORLK family | ?Leukodystrophy, childhood-onset, remitting, 619864 (3), Autosomal dominant
chr9	FBP1	611570.0 | FBP1 | Fructose-bisphosphatase 1 | 2203.0 | ENSG00000165140 | nan | Fructose-1,6-bisphosphatase deficiency, 229700 (3), Autosomal recessive
chr9	AOPEP	619600.0 | AOPEP, C9orf3, DYT31 | Aminopeptidase O | 84909.0 | ENSG00000148120 | nan | Dystonia 31, 619565 (3), Autosomal recessive
chr9	MIR23B	610723.0 | MIR23B, MIRN23B | Micro RNA 23B | 407011.0 | ENSG00000207563 | nan | nan
chr9	MIR27B	610636.0 | MIR27B, MIRN27B | Micro RNA 27B | 407019.0 | ENSG00000207864 | nan | nan
chr9	MIR24-1	609705.0 | MIR189, MIRN24-1 | Micro RNA 24-1 | 407012.0 | ENSG00000284459 | nan | nan
chr9	FANCC	613899.0 | FANCC, FACC | Fanconi anemia, complementation group C | 2176.0 | ENSG00000158169 | nan | Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive
chr9	PTCH1	601309.0 | PTCH1, NBCCS, BCNS1, HPE7 | Patched 1 | 5727.0 | ENSG00000185920 | nan | Basal cell nevus syndrome 1, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant
chr9	ERCC6L2	615667.0 | ERCC6L2, RAD26L, BMFS2 | ERCC6 excision repair 6-like 2 | 375748.0 | ENSG00000182150 | nan | Bone marrow failure syndrome 2, 615715 (3), Autosomal recessive
chr9	HSD17B3	605573.0 | HSD17B3, EDH17B3 | Hydroxysteroid (17-beta) dehydrogenase 3 | 3293.0 | ENSG00000130948 | nan | Pseudohermaphroditism, male, with gynecomastia, 264300 (3), Autosomal recessive
chr9	SLC35D2	609182.0 | SLC35D2, HFRC1, SQV7L | Solute carrier family 35, member D2 | 11046.0 | ENSG00000130958 | nan | nan
chr9	ZNF367	610160.0 | ZNF367, AFF29 | Zinc finger protein 367 | 195828.0 | ENSG00000165244 | nan | nan
chr9	HABP4	617369.0 | HABP4, IHABP4 | Hyaluronan-binding protein 4 | 22927.0 | ENSG00000130956 | nan | nan
chr9	CDC14B	603505.0 | CDC14B | Cell division cycle 14B | 8555.0 | ENSG00000081377 | nan | nan
chr9	ZNF510	619385.0 | ZNF510, KIAA0972 | Zinc finger protein 510 | 22869.0 | ENSG00000081386 | nan | nan
chr9	CTSV	603308.0 | CTSV, CTSL2 | Cathepsin V | 1515.0 | ENSG00000136943 | nan | nan
chr9	TDRD7	611258.0 | TDRD7, KIAA1529, TRAP, CATC4, CTRCT36 | Tudor domain-containing protein 7 | 23424.0 | ENSG00000196116 | nan | Cataract 36, 613887 (3), Autosomal recessive
chr9	TMOD1	190930.0 | TMOD1, ETMOD | Tropomodulin 1 | 7111.0 | ENSG00000136842 | nan | nan
chr9	NCBP1	600469.0 | NCBP1 | Nuclear cap binding protein 1, 80kD | 4686.0 | ENSG00000136937 | in 500kb of XPA | nan
chr9	XPA	611153.0 | XPA, XPAC | XPA complementing gene | 7507.0 | ENSG00000136936 | nan | Xeroderma pigmentosum, group A, 278700 (3), Autosomal recessive
chr9	FOXE1	602617.0 | FOXE1, FKHL15, TITF2, TTF2, NMTC4, BAMLAZ | Forkhead box E1 (thyroid transcription factor-2) | 2304.0 | ENSG00000178919 | nan | Bamforth-Lazarus syndrome, 241850 (3), Autosomal recessive; {Thyroid cancer, nonmedullary, 4}, 616534 (3), Autosomal dominant
chr9	HEMGN	610715.0 | HEMGN, EDAG | Hemogen | 55363.0 | ENSG00000136929 | nan | nan
chr9	ANP32B	619823.0 | ANP32B, SSP29, APRIL | Acidic nuclear phosphoprotein 32 family, member B | 10541.0 | ENSG00000136938 | nan | nan
chr9	TRIM14	606556.0 | TRIM14, KIAA0129 | Tripartite motif-containing protein 14 | 9830.0 | ENSG00000106785 | nan | nan
chr9	NANS	605202.0 | NANS, SAS, SEMDG | N-acetylneuraminic acid synthase (sialic acid synthase) | 54187.0 | ENSG00000095380 | nan | Spondyloepimetaphyseal dysplasia, Genevieve type, 610442 (3), Autosomal recessive
chr9	CORO2A	602159.0 | CORO2A, WDR2, IR10 | Coronin 2A | 7464.0 | ENSG00000106789 | nan | nan
chr9	TBC1D2	609871.0 | TBC1D2, PARIS1 | TBC1 domain family, member 2 | 55357.0 | ENSG00000095383 | nan | nan
chr9	GABBR2	607340.0 | GABBR2, GPR51, DEE59, NDPLHS | Gamma-aminobutyric acid B receptor 2 | 9568.0 | ENSG00000136928 | nan | {Nicotine dependence, protection against}, 188890 (3); {Nicotine dependence, susceptibility to}, 188890 (3); Developmental and epileptic encephalopathy 59, 617904 (3), Autosomal dominant; Neurodevelopmental disorder with poor language and loss of hand skills, 617903 (3), Autosomal dominant
chr9	ANKS6	615370.0 | ANKS6, PKDR1, NPHP16 | Ankyrin repeat and sterile alpha motif domains-containing protein 6 | 203286.0 | ENSG00000165138 | nan | Nephronophthisis 16, 615382 (3), Autosomal recessive
chr9	GALNT12	610290.0 | GALNT12, CRCS1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 | 79695.0 | ENSG00000119514 | nan | {Colorectal cancer, susceptibility to, 1}, 608812 (3)
chr9	COL15A1	120325.0 | COL15A1 | Collagen XV, alpha-1 polypeptide | 1306.0 | ENSG00000204291 | nan | nan
chr9	TGFBR1	190181.0 | TGFBR1, ALK5, AAT5, LDS1, MSSE | Transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD) | 7046.0 | ENSG00000106799 | nan | {Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3), Autosomal dominant; Loeys-Dietz syndrome 1, 609192 (3), Autosomal dominant
chr9	ALG2	607905.0 | ALG2, CDGII, CMSTA3, CMS14 | ALG2 alpha-1,3/1,6-mannosyltransferase | 85365.0 | ENSG00000119523 | nan | Congenital disorder of glycosylation, type Ii, 607906 (3), Autosomal recessive; Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3), Autosomal recessive
chr9	SEC61B	609214.0 | SEC61B | SEC61 translocon, beta subunit | 10952.0 | ENSG00000106803 | nan | nan
chr9	NAMA	620412.0 | NAMA | Noncoding RNA associated with MAP kinase pathway and growth arrest | 100996569.0 | ENSG00000271086 | nan | nan
chr9	CHDT3	614954.0 | CHDT3 | Congenital heart defects, multiple types, 3 | 101154642.0 | nan | max lod at D9S1690 | Congenital heart defects, multiple types, 3, 614954 (2), Autosomal dominant
chr9	HNP1	608026.0 | HNP1 | Hypertensive nephropathy | 574045.0 | nan | nan | Hypertensive nephropathy, 608026 (2)
chr9	HSCR5	600156.0 | HSCR5 | Hirschsprung disease, susceptibility to, 5 | 404720.0 | nan | nan | {Hirschsprung disease, susceptibility to, 5}, 600156 (2), Autosomal dominant
chr9	PAND2	607853.0 | PAND2 | Panic disorder 2 | 619493.0 | nan | max lod at D9S271 | Panic disorder 2, 607853 (2)
chr9	SPDA2	183840.0 | SPDA2 | Spondyloarthropathy, susceptibility to, 2 | 791255.0 | nan | max lod at D9S1776 | {Spondyloarthropathy, susceptibility to, 2}, 183840 (2), Autosomal dominant
chr9	NR4A3	600542.0 | CSMF | Chondrosarcoma, extraskeletal myxoid, fused to EWS in | 8013.0 | ENSG00000119508 | t(9;17)(q22;q11); t(9;22)(q22;q11-q12) | Chondrosarcoma, extraskeletal myxoid, 612237 (3)
chr9	STX17	604204.0 | STX17 | Syntaxin 17 | 55014.0 | ENSG00000136874 | nan | nan
chr9	ERP44	609170.0 | TXNDC4, KIAA0573 | Thioredoxin domain-containing protein 4 | 23071.0 | ENSG00000023318 | nan | nan
chr9	INVS	243305.0 | INVS, INV, NPHP2, NPH2 | Inversin | 27130.0 | ENSG00000119509 | nan | Nephronophthisis 2, infantile, 602088 (3), Autosomal recessive
chr9	TEX10	616717.0 | TEX10 | Testis-expressed gene 10 | 54881.0 | ENSG00000136891 | nan | nan
chr9	TMEFF1	603421.0 | TMEFF1, C9orf2 | Transmembrane protein with EGF-like and 2 follistatin-like domains 1 | 8577.0 | ENSG00000241697 | nan | nan
chr9	CAVIN4	617714.0 | CAVIN4, MURC | Caveolae-associated protein 4 | 347273.0 | ENSG00000170681 | nan | nan
chr9	PLPPR1	619590.0 | PLPPR1, PRG3 | Phospholipid phosphatase-related protein 1 | 54886.0 | ENSG00000148123 | nan | nan
chr9	BAAT	602938.0 | BAAT, HCHO, BACD1 | Bile acid coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase) | 570.0 | ENSG00000136881 | nan | Bile acid conjugation defect 1, 619232 (3), Autosomal recessive
chr9	MRPL50	611854.0 | MRPL50 | Mitochondrial ribosomal protein L50 | 54534.0 | ENSG00000136897 | pseudogenes on 2, 5, and 10 | nan
chr9	ZNF189	603132.0 | ZNF189 | Zinc finger protein-189 | 7743.0 | ENSG00000136870 | nan | nan
chr9	ALDOB	612724.0 | ALDOB | Aldolase B, fructose-bisphosphatase | 229.0 | ENSG00000136872 | nan | Fructose intolerance, hereditary, 229600 (3), Autosomal recessive
chr9	PGAP4	620264.0 | PGAP4, C9orf125, TMEM246 | Post-GPI attachment to proteins, GalNAc transferase, 4 | 84302.0 | ENSG00000165152 | nan | nan
chr9	RNF20	607699.0 | RNF20, BRE1A | Ring finger protein 20 | 56254.0 | ENSG00000155827 | nan | nan
chr9	GRIN3A	606650.0 | GRIN3A, NR3A | Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A | 116443.0 | ENSG00000198785 | nan | nan
chr9	PPP3R2	613821.0 | PPP3R2, PPP3RL, CBLP | Protein phosphatase 3, regulatory subunit B, beta | 5535.0 | ENSG00000188386 | nan | nan
chr9	CYLC2	604035.0 | CYLC2 | Cylicin 2 | 1539.0 | ENSG00000155833 | nan | nan
chr9	SMC2	605576.0 | CAPE | Chromosome-associated protein E | 10592.0 | ENSG00000136824 | nan | nan
chr9	NIPSNAP3A	608871.0 | NIPSNAP3A, TASSC, NIPSNAP4 | Nipsnap homolog 3A | 25934.0 | ENSG00000136783 | nan | nan
chr9	NIPSNAP3B	608872.0 | NIPSNAP3B | Nipsnap homolog 3B | 55335.0 | ENSG00000165028 | nan | nan
chr9	ABCA1	600046.0 | ABCA1, ABC1, HPALP1, TGD, HDLCQTL13 | ATP-binding cassette 1 | 19.0 | ENSG00000165029 | nan | Tangier disease, 205400 (3), Autosomal recessive; HDL deficiency, familial, 1, 604091 (3), Autosomal dominant
chr9	SLC44A1	606105.0 | SLC44A1, CTL1, CDW92, CONATOC | Solute carrier family 44, member 1 | 23446.0 | ENSG00000070214 | nan | Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline, 618868 (3), Autosomal recessive
chr9	IS4	612238.0 | IS4 | Scoliosis, idiopathic, susceptibility to, 4 | 100190785.0 | nan | max lod at D9S2157 | {Scoliosis, idiopathic, susceptibility to, 4}, 612238 (2)
chr9	MENAQ3	612883.0 | MENAQ3 | Menarche, age at, QTL3 | 100302563.0 | nan | associated with rs2090409 | {Menarche, age at, QTL3}, 612883 (2)
chr9	FSD1L	609829.0 | FSD1NL, FSD1L, MIR1, CCDC10 | FSD1 N-terminus-like protein | 83856.0 | ENSG00000106701 | nan | nan
chr9	FKTN	607440.0 | FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4 | Fukutin | 2218.0 | ENSG00000106692 | nan | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3), Autosomal recessive; Cardiomyopathy, dilated, 1X, 611615 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 4, 613152 (3), Autosomal recessive
chr9	TAL2	186855.0 | TAL2 | T-cell acute lymphocytic leukemia-2 | 6887.0 | ENSG00000186051 | 33kb from breakpoint in t(7;9) | Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)
chr9	TMEM38B	611236.0 | TMEM38B, TRICB, OI14 | Transmembrane protein 38B | 55151.0 | ENSG00000095209 | nan | Osteogenesis imperfecta, type XIV, 615066 (3), Autosomal recessive
chr9	ZNF462	617371.0 | ZNF462, KIAA1803, WSKA | Zinc finger protein 462 | 58499.0 | ENSG00000148143 | nan | Weiss-Kruszka syndrome, 618619 (3), Autosomal dominant
chr9	RAD23B	600062.0 | RAD23B | RAD23 homolog B, nucleotide excision repair protein | 5887.0 | ENSG00000119318 | previously 3p25.1 | nan
chr9	KLF4	602253.0 | KLF4, EZF, GKLF | Kruppel-like factor 4 | 9314.0 | ENSG00000136826 | nan | nan
chr9	ACTL7B	604304.0 | ACTL7B | Actin-like 7B | 10880.0 | ENSG00000148156 | nan | nan
chr9	ACTL7A	604303.0 | ACTL7A, SPGF86 | Actin-like 7A | 10881.0 | ENSG00000187003 | nan | Spermatogenic failure 86, 620499 (3), Autosomal recessive
chr9	ELP1	603722.0 | ELP1, IKBKAP, IKAP | Elongator complex protein 1 | 8518.0 | ENSG00000070061 | nan | {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; Dysautonomia, familial, 223900 (3), Autosomal recessive
chr9	ABITRAM	620392.0 | ABITRAM, C9orf6, FAM206A | Actin-binding transcription modulator | 54942.0 | ENSG00000119328 | nan | nan
chr9	CTNNAL1	604785.0 | CTNNAL1 | Catenin, alpha-like, 1 | 8727.0 | ENSG00000119326 | nan | nan
chr9	TMEM245	620252.0 | TMEM245, CG2 | Transmembrane protein 245 | 23731.0 | ENSG00000106771 | nan | nan
chr9	MIR32	609355.0 | MIR32, MIRN32 | Micro RNA 32 | 407036.0 | ENSG00000207698 | nan | nan
chr9	FRRS1L	604574.0 | FRRS1L, C9orf4, CG6, DEE37 | Ferric-chelate reductase 1-like | 23732.0 | ENSG00000260230 | nan | Developmental and epileptic encephalopathy 37, 616981 (3), Autosomal recessive
chr9	EPB41L4B	610340.0 | EPB41L4B, EHM2 | Erythrocyte membrane protein band 4.1-like 4B | 54566.0 | ENSG00000095203 | nan | nan
chr9	PTPN3	176877.0 | PTPN3, PTPH1 | Protein-tyrosine phosphatase, nonreceptor-type, 3 | 5774.0 | ENSG00000070159 | nan | nan
chr9	PALM2AKAP2	604582.0 | PALM2AKAP2, AKAP2, AKAPKL, KIAA0920, PALM2, MISP2 | PALM2 and AKAP2 fusion | 445815.0 | ENSG00000157654 | multiple splice variants | nan
chr9	TXN	187700.0 | TXN | Thioredoxin | 7295.0 | ENSG00000136810 | incorrectly assigned to 3 | nan
chr9	TXNDC8	617789.0 | TXNDC8, SPTRX3 | Thioredoxin domain-containing protein 8 | 255220.0 | ENSG00000204193 | nan | nan
chr9	SVEP1	611691.0 | SVEP1, POLYDOM, SELOB | Sushi, von willebrand factor type A, EGF, and pentraxin domain-containing 1 | 79987.0 | ENSG00000165124 | nan | nan
chr9	MUSK	601296.0 | MUSK, CMS9, FADS1 | Receptor tyrosine kinase MuSK | 4593.0 | ENSG00000030304 | nan | Fetal akinesia deformation sequence 1, 208150 (3), Autosomal recessive; Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3), Autosomal recessive
chr9	LPAR1	602282.0 | LPAR1, EDG2, LPA1, VZG1 | Lysophosphatidic acid receptor 1 | 1902.0 | ENSG00000198121 | nan | nan
chr9	ECPAS	616694.0 | ECPAS, ECM29, KIAA0368 | ECM29 proteasome adaptor and scaffold protein | 23392.0 | ENSG00000136813 | nan | nan
chr9	PTGR1	601274.0 | PTGR1, LTB4DH | Prostaglandin reductase 1 | 22949.0 | ENSG00000106853 | nan | nan
chr9	GNG10	604389.0 | GNG10 | Guanine nucleotide-binding protein, gamma 10 | 2790.0 | ENSG00000242616 | nan | nan
chr9	SHOC1	618038.0 | SHOC1, C9orf84, ZIP2, SPGF75 | Shortage in chiasmata 1 | 158401.0 | ENSG00000165181 | nan | Spermatogenic failure 75, 619949 (3), Autosomal recessive
chr9	UGCG	602874.0 | UGCG, GCS | UDP-glucose ceramide glucosyltransferase | 7357.0 | ENSG00000148154 | nan | nan
chr9		611488.0 | ARMD10 | Macular degeneration, age-related, 10 | nan | nan | nan | Macular degeneration, age-related, 10, 611488 (2)
chr9	EIG3	608762.0 | EIG3 | Epilepsy, idiopathic generalized, susceptibility to 3 | 432400.0 | nan | nan | {Epilepsy, idiopathic generalized, susceptibility to, 3}, 608762 (2), Autosomal recessive
chr9	IBD16	612259.0 | IBD16 | Inflammatory bowel disease 16, susceptibility to | 100190930.0 | nan | nan | {Inflammatory bowel disease 16}, 612259 (2)
chr9	PTBP3	607527.0 | PTBP3, ROD1 | Polypyrimidine tract binding protein 3 | 9991.0 | ENSG00000119314 | nan | nan
chr9	KIAA1958	617390.0 | KIAA1958 | KIAA1958 gene | 158405.0 | ENSG00000165185 | nan | nan
chr9	INIP	613273.0 | INIP, C9orf80, SOSSC | INST3- and NABP-interacting protein | 58493.0 | ENSG00000148153 | nan | nan
chr9	SNX30	620955.0 | SNX30 | Sorting nexin 30 | 401548.0 | ENSG00000148158 | nan | nan
chr9	SLC46A2	608956.0 | SLC46A2, TSCOT | Solute carrier family 46, member 2 | 57864.0 | ENSG00000119457 | nan | nan
chr9	ZFP37	602951.0 | ZFP37 | Zinc finger protein-37, mouse, homolog of | 7539.0 | ENSG00000136866 | ?candidate for Nager syndrome | nan
chr9	SLC31A2	603088.0 | SLC13A2, COPT2, CTR2 | Solute carrier family 31 (copper transporter), member 2 | 1318.0 | ENSG00000136867 | nan | nan
chr9	FKBP15	617398.0 | FKBP15, FKBP133, KIAA0674, WAFL | FK506-binding protein 15 | 23307.0 | ENSG00000119321 | nan | nan
chr9	SLC31A1	603085.0 | SLC31A1, COPT1, CTR1, NSCT | Solute carrier family 31 (copper transporter), member 1 | 1317.0 | ENSG00000136868 | nan | Neurodegeneration and seizures due to copper transport defect, 620306 (3), Autosomal recessive
chr9	CDC26	614533.0 | CDC26, APC12 | Cell division cycle 26 | 246184.0 | ENSG00000176386 | pseudogene on 7q32.1 | nan
chr9	PRPF4	607795.0 | PRPF4, PRP4, HPRP4, RP70 | Pre-mRNA processing factor 4 | 9128.0 | ENSG00000136875 | nan | Retinitis pigmentosa 70, 615922 (3), Autosomal dominant
chr9	WDR31	620951.0 | WDR31 | WD repeat-containing protein 31 | 114987.0 | ENSG00000148225 | nan | nan
chr9	BSPRY	619683.0 | BSPRY | B-box- and SPRY domain-containing protein | 54836.0 | ENSG00000119411 | nan | nan
chr9	ALAD	125270.0 | ALAD, ALADH, PBGS | Aminolevulinate, delta-, dehydratase | 210.0 | ENSG00000148218 | linked to ABO; ORM-ALAD-AK-ABO | Porphyria, acute hepatic, 612740 (3), Autosomal recessive; {Lead poisoning, susceptibility to}, 612740 (3), Autosomal recessive
chr9	POLE3	607267.0 | POLE3, CHARAC17, YBL1 | Polymerase, DNA, epsilon-3 | 54107.0 | ENSG00000148229 | nan | nan
chr9	RGS3	602189.0 | RGS3 | Regulator of G-protein signaling-3 | 5998.0 | ENSG00000138835 | nan | nan
chr9	ZNF618	617077.0 | ZNF618, NEDD10, KIAA1952 | Zinc finger protein 618 | 114991.0 | ENSG00000157657 | nan | nan
chr9	AMBP	176870.0 | AMBP, ITIL, ITI, HCP | Alpha-1-microglobulin/bikunin precursor (inter-alpha-trypsin inhibitor, light chain; protein HC) | 259.0 | ENSG00000106927 | nan | nan
chr9	KIF12	611278.0 | KIF12, PFIC8 | Kinesin family member 12 | 113220.0 | ENSG00000136883 | nan | Cholestasis, progressive familial intrahepatic, 8, 619662 (3), Autosomal recessive
chr9	COL27A1	608461.0 | COL27A1, KIAA1870, STLS | Collagen, type XXVII, alpha-1 | 85301.0 | ENSG00000196739 | nan | Steel syndrome, 615155 (3), Autosomal recessive
chr9	ORM1	138600.0 | ORM1, AGP1 | Orosomucoid-1 (alpha-1-acid glycoprotein-1) | 5004.0 | ENSG00000229314 | linked to ABO, AK1, ALAD | nan
chr9	ORM2	138610.0 | ORM2 | Orosomucoid-2 | 5005.0 | ENSG00000228278 | nan | nan
chr9	AKNA	605729.0 | AKNA | AT-hook transcription factor | 80709.0 | ENSG00000106948 | nan | nan
chr9	WHRN	607928.0 | WHRN, CIP98, KIAA1526, DFNB31, USH2D | Whirlin | 25861.0 | ENSG00000095397 | nan | Deafness, autosomal recessive 31, 607084 (3), Autosomal recessive; Usher syndrome, type 2D, 611383 (3), Autosomal recessive
chr9	ATP6V1G1	607296.0 | ATP6V1G1, ATP6G1 | ATPase, H+ transporting, V1 subunit G1 | 9550.0 | ENSG00000136888 | nan | nan
chr9	TNFSF15	604052.0 | TNFSF15, TL1, VEGI | Tumor necrosis factor ligand superfamily, member 15 (vascular endothelial growth inhibitor) | 9966.0 | ENSG00000181634 | nan | nan
chr9	TNFSF8	603875.0 | TNFSF8, CD30L, CD30LG | Tumor necrosis factor ligand superfamily, member 8 (CD30 ligand) | 944.0 | ENSG00000106952 | nan | nan
chr9	ASRT8	613207.0 | ASRT8 | Asthma-related traits, susceptibility to, 8 | 100415896.0 | nan | associated with rs3789873 | {Asthma-related traits, susceptibility to, 8}, 613207 (2)
chr9	TNC	187380.0 | TNC, HXB, DFNA56 | Tenascin C (hexabrachion) | 3371.0 | ENSG00000041982 | proximal to ABL | Deafness, autosomal dominant 56, 615629 (3), Autosomal dominant
chr9	DELEC1	604767.0 | DEC1 | Deleted in esophageal cancer 1 | 50514.0 | ENSG00000173077 | nan | nan
chr9	PAPPA	176385.0 | PAPPA, DIPLA1 | Pappalysin 1 | 5069.0 | ENSG00000182752 | nan | nan
chr9	PAPPA-AS1	610689.0 | DIPAS | DIPLA1, antisense | 493913.0 | ENSG00000256040 | nan | nan
chr9	ASTN2	612856.0 | ASTN2, KIAA0634 | Astrotactin 2 | 23245.0 | ENSG00000148219 | nan | nan
chr9	TRIM32	602290.0 | TRIM32, HT2A, LGMDR8, BBS11 | Tripartite-motif-containing protein 32 | 22954.0 | ENSG00000119401 | mutation identified in 1 BBS11 family | ?Bardet-Biedl syndrome 11, 615988 (3), Autosomal recessive; Muscular dystrophy, limb-girdle, autosomal recessive 8, 254110 (3), Autosomal recessive
chr9	TLR4	603030.0 | TLR4 | Toll-like receptor-4 | 7099.0 | ENSG00000136869 | nan | nan
chr9	BRINP1	602865.0 | BRINP1, DBC1, DBCCR1 | Bone morphogenetic protein/retinoic acid-inducible neural-specific protein 1 | 1620.0 | ENSG00000078725 | nan | nan
chr9	CDK5RAP2	608201.0 | CDK5RAP2, KIAA1633, MCPH3 | CDK5 regulatory subunit-associated protein 2 | 55755.0 | ENSG00000136861 | nan | Microcephaly 3, primary, autosomal recessive, 604804 (3), Autosomal recessive
chr9	MEGF9	604268.0 | MEGF9, EGFL5 | Multiple epidermal growth factor-like domains 9 | 1955.0 | ENSG00000106780 | nan | nan
chr9	FBXW2	609071.0 | FBXW2, FBW2, FWD2 | F-box and WD40 domain protein 2 | 26190.0 | ENSG00000119402 | nan | nan
chr9	B3GALT9	620239.0 | B3GALT9, KIAA0072, B3GNT10 | Beta-1,3-galactosyltransferase 9 | 100288842.0 | ENSG00000214654 | nan | nan
chr9	PSMD5	604452.0 | PSMD5, S5B | Proteasome 26S subunit, non-ATPase, 5 | 5711.0 | ENSG00000095261 | nan | nan
chr9	PHF19	609740.0 | PHF19 | PHD finger protein 19 | 26147.0 | ENSG00000119403 | nan | nan
chr9	TRAF1	601711.0 | TRAF1 | TNF receptor-associated factor 2 | 7185.0 | ENSG00000056558 | nan | nan
chr9	C5	120900.0 | C5, C5D, ECLZB | Complement component-5 | 727.0 | ENSG00000106804 | nan | C5 deficiency, 609536 (3), Autosomal recessive; [Eculizumab, poor response to], 615749 (3), Autosomal dominant
chr9	CNTRL	605496.0 | CEP1, CEP110, FAN | Centrosomal protein 1 | 11064.0 | ENSG00000119397 | nan | nan
chr9	RAB14	612673.0 | RAB14 | Ras-associated protein | 51552.0 | ENSG00000119396 | nan | nan
chr9	GSN	137350.0 | GSN, AMYLD4 | Gelsolin | 2934.0 | ENSG00000148180 | 40kb proximal to ABL | Amyloidosis, Finnish type, 105120 (3), Autosomal dominant
chr9	STOM	133090.0 | STOM, EPB72, BND7 | Stomatin (erythrocyte membrane protein band 7.2) | 2040.0 | ENSG00000148175 | proximal to ABL | nan
chr9	GGTA1	104175.0 | GGTA1P, GGTA1 | Glycoprotein, alpha-galactosyltransferase-1 pseudogene | 2681.0 | ENSG00000204136 | processed pseudogene GGTA1P on 12q14-q15 | nan
chr9	DAB2IP	609205.0 | DAB2IP, AIP1, KIAA1743 | DAB2-interacting protein | 153090.0 | ENSG00000136848 | nan | nan
chr9	TTLL11	620694.0 | TTLL11 | Tubulin tyrosine ligase-like 11 | 158135.0 | ENSG00000175764 | nan | nan
chr9	NDUFA8	603359.0 | NDUFA8, MC1DN37 | NADH-ubiquinone oxidoreductase subunit A8 | 4702.0 | ENSG00000119421 | nan | Mitochondrial complex I deficiency, nuclear type 37, 619272 (3), Autosomal recessive
chr9	MORN5	619837.0 | MORN5 | MORN repeat-containing protein 5 | 254956.0 | ENSG00000185681 | nan | nan
chr9	LHX6	608215.0 | LHX6 | LIM homeobox gene 6 | 26468.0 | ENSG00000106852 | nan | nan
chr9	MRRF	604602.0 | MRFF, RRF | Ribosome-recycling factor, mitochondrial | 92399.0 | ENSG00000148187 | nan | nan
chr9	PTGS1	176805.0 | PTGS1, COX1, PGHS1, COX3, PCOX1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 5742.0 | ENSG00000095303 | nan | nan
chr9	PDCL	604421.0 | PDCL | Phosducin-like | 5082.0 | ENSG00000136940 | nan | nan
chr9	RC3H2	615231.0 | RC3H2, MNAB | RING finger and CCCH-type zinc finger domains-containing protein 2 | 54542.0 | ENSG00000056586 | nan | nan
chr9	ZBTB6	605976.0 | ZBTB6, ZID | Zinc finger- and BTB domain-containing protein 6 | 10773.0 | ENSG00000186130 | nan | nan
chr9	ZBTB26	620164.0 | ZBTB26 | Zinc finger- and BTB domain-containing protein 26 | 57684.0 | ENSG00000171448 | nan | nan
chr9	RABGAP1	615882.0 | RABGAP1, GAPCENA, TBC1D11 | RAB GTPase-activating protein 1 | 23637.0 | ENSG00000011454 | nan | nan
chr9	GPR21	601909.0 | GPR21 | G protein-coupled receptor-21 | 2844.0 | ENSG00000188394 | nan | nan
chr9	STRBP	611138.0 | STRBP, SPNR, p74 | Spermatid perinuclear RNA-binding protein | 55342.0 | ENSG00000165209 | nan | nan
chr9	CRB2	609720.0 | CRB2, FSGS9, VMCKD | Crumbs cell polarity complex component 2 | 286204.0 | ENSG00000148204 | nan | Focal segmental glomerulosclerosis 9, 616220 (3), Autosomal recessive; Ventriculomegaly with cystic kidney disease, 219730 (3), Autosomal recessive
chr9	DENND1A	613633.0 | DENND1A, KIAA1608 | DENN/MADD domain-containing protein 1A | 57706.0 | ENSG00000119522 | nan | nan
chr9	LHX2	603759.0 | LHX2, LH2 | LIM/homeodomain protein LHX2 | 9355.0 | ENSG00000106689 | nan | nan
chr9	NEK6	604884.0 | NEK6 | NIMA-related kinase 6 | 10783.0 | ENSG00000119408 | nan | nan
chr9	PSMB7	604030.0 | PSMB7 | Proteasome subunit, beta-type, 7 | 5695.0 | ENSG00000136930 | nan | nan
chr9	ADGRD2	620837.0 | PDGRD2, GPR144, PGR24 | Adhesion G protein-coupled receptor D2 | 347088.0 | ENSG00000180264 | nan | nan
chr9	NR5A1	184757.0 | NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4 | Nuclear receptor subfamily 5, group A, member 1 | 2516.0 | ENSG00000136931 | nan | 46XX sex reversal 4, 617480 (3), Autosomal dominant; Premature ovarian failure 7, 612964 (3), Autosomal dominant; 46XY sex reversal 3, 612965 (3), Autosomal dominant; Adrenocortical insufficiency, 612964 (3), Autosomal dominant; Spermatogenic failure 8, 613957 (3), Autosomal dominant
chr9	NR6A1	602778.0 | GCNF | Germ cell nuclear factor | 2649.0 | ENSG00000148200 | nan | nan
chr9	MIR181A2	612743.0 | MIR181A2, MIRN181A2 | Micro RNA 181A2 | 406954.0 | ENSG00000207595 | nan | nan
chr9	MIR181B2	612745.0 | MIR181B2, MIRN181B2 | Micro RNA 181B2 | 406956.0 | ENSG00000207737 | nan | nan
chr9	OLFML2A	615899.0 | OLFML2A | Olfactomedin-like 2A | 169611.0 | ENSG00000185585 | nan | nan
chr9	RPL35	618315.0 | RPL35, DBA19 | Ribosomal protein L35 | 11224.0 | ENSG00000136942 | mutation identified in 1 DBA19 family | ?Diamond-Blackfan anemia 19, 618312 (3), Autosomal dominant
chr9	GOLGA1	602502.0 | GOLGA1 | Golgin A1 | 2800.0 | ENSG00000136935 | nan | nan
chr9	SCAI	619222.0 | SCAI, C9orf126 | Suppressor of cancer cell invasion | 286205.0 | ENSG00000173611 | nan | nan
chr9	PPP6C	612725.0 | PPP6C | Protein phosphatase 6, catalytic subunit | 5537.0 | ENSG00000119414 | highly related sequence on Xq22.3 | nan
chr9	RABEPK	605962.0 | RABEPK | RAB9 effector protein with kelch motifs | 10244.0 | ENSG00000136933 | nan | nan
chr9	HSPA5	138120.0 | HSPA5, GRP78 | Heat-shock 70kD protein-5 (glucose-regulated protein, 78kD) | 3309.0 | ENSG00000044574 | nan | nan
chr9	GAPVD1	611714.0 | GAPVD1, RAP6, GAPEX5, KIAA1521 | GTPase-activating protein and VPS9 domains 1 | 26130.0 | ENSG00000165219 | nan | nan
chr9	MAPKAP1	610558.0 | MAPKAP1, SIN1, MIP1, JC310 | Mitogen-activated protein kinase-associated protein 1 | 79109.0 | ENSG00000119487 | nan | nan
chr9	PBX3	176312.0 | PBX3 | Pre-B-cell leukemia transcription factor-3 | 5090.0 | ENSG00000167081 | nan | nan
chr9	NRON	609618.0 | NRON | Noncoding repressor of NFAT | 641373.0 | nan | nan | nan
chr9	LMX1B	602575.0 | LMX1B, NPS1, FSGS10 | LIM homeobox transcription factor 1, beta | 4010.0 | ENSG00000136944 | nan | Focal segmental glomerulosclerosis 10, 256020 (3), Autosomal dominant; Nail-patella syndrome, 161200 (3), Autosomal dominant
chr9	ZBTB43	618676.0 | ZBTB43 | Zinc finger- and BTB domain-containing protein 43 | 23099.0 | ENSG00000169155 | nan | nan
chr9	ZBTB34	611692.0 | ZBTB34, KIAA1993 | Zinc finger- and BTB domain-containing protein 34 | 403341.0 | ENSG00000177125 | nan | nan
chr9	RALGPS1	614444.0 | RALGPS1, RALGEF2, KIAA0351 | Ral guanine nucleotide exchange factor with PH domain and SH3 domain-binding motif 1 | 9649.0 | ENSG00000136828 | nan | nan
chr9	ANGPTL2	605001.0 | ANGPTL2, ARP2 | Angiopoietin-like 2 | 23452.0 | ENSG00000136859 | nan | nan
chr9	SLC2A8	605245.0 | SLC2A8, GLUT8 | Solute carrier family 2, (facilitated glucose transporter) member 8 | 29988.0 | ENSG00000136856 | nan | nan
chr9	ZNF79	194552.0 | ZNF79 | Zinc finger protein-79 (pT7) | 7633.0 | ENSG00000196152 | nan | nan
chr9	RPL12	180475.0 | RPL12 | Ribosomal protein L12 | 6136.0 | ENSG00000197958 | nan | nan
chr9	LRSAM1	610933.0 | LRSAM1, TAL, RIFLE, CMT2P | Leucine-rich repeat- and sterile alpha motif-containing 1 | 90678.0 | ENSG00000148356 | nan | Charcot-Marie-Tooth disease, axonal, type 2P, 614436 (3), Autosomal recessive, Autosomal dominant
chr9	CLLS3	612557.0 | CLLS3 | Leukemia, chronic lymphocytic, susceptibility to, 3 | 100270642.0 | nan | associated with SNP -6531 upstream of DAPK1 promoter | {Leukemia, chronic lymphocytic, susceptibility to, 3}, 612557 (2)
chr9	DYT23	614860.0 | DYT23 | Dystonia 23 | 115029024.0 | nan | linkage to D9S159 and D9S1818 | Dystonia 23, 614860 (2), Autosomal dominant
chr9	KTCN6	614623.0 | KTCN6 | Keratoconus 6 | 100885802.0 | nan | max lod at 159cM | Keratoconus 6, 614623 (2), Autosomal dominant
chr9	NIBAN2	614045.0 | FAM129B, MINERVA | Family with sequence similarity 129, member B | 64855.0 | ENSG00000136830 | nan | nan
chr9	STXBP1	602926.0 | STXBP1, UNC18, DEE4 | Syntaxin-binding protein 1 | 6812.0 | ENSG00000136854 | nan | Developmental and epileptic encephalopathy 4, 612164 (3), Autosomal recessive, Autosomal dominant
chr9	TOR2A	608052.0 | TOR2A, TORP1 | Torsin 2A | 27433.0 | ENSG00000160404 | nan | nan
chr9	SH2D3C	604722.0 | SH2D3C, NSP3 | SH2 domain-containing protein 3C | 10044.0 | ENSG00000095370 | nan | nan
chr9	MIR2861	613405.0 | MIR2861, MIRN2861, BMND15 | Micro RNA 2861 | 100422910.0 | ENSG00000284547 | nan | [Bone mineral density QTL 15], 613418 (3), Autosomal recessive, Autosomal dominant
chr9	CDK9	603251.0 | CDK9, CDC2L4 | Cyclin-dependent kinase-9 | 1025.0 | ENSG00000136807 | nan | nan
chr9	FPGS	136510.0 | FPGS | Folylpolyglutamate synthetase | 2356.0 | ENSG00000136877 | nan | nan
chr9	ENG	131195.0 | ENG, END, HHT1, ORW | Endoglin | 2022.0 | ENSG00000106991 | nan | Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3), Autosomal dominant
chr9	AK1	103000.0 | AK1, CNSHA3 | Adenylate kinase-1 | 203.0 | ENSG00000106992 | nan | Anemia, congenital, nonspherocytic hemolytic, 3, adenylate kinase deficient, 612631 (3), Autosomal recessive
chr9	ST6GALNAC6	610135.0 | ST6GALNAC6, SIAT7F | ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 | 30815.0 | ENSG00000160408 | nan | nan
chr9	ST6GALNAC4	606378.0 | SIAT7D, SIAT3C | Sialyltransferase 7D | 27090.0 | ENSG00000136840 | nan | nan
chr9	PIP5KL1	612865.0 | PIP5KL1, PIPKH | Phosphatidylinositol-4-phosphate-5-kinase-like 1 | 138429.0 | ENSG00000167103 | nan | nan
chr9	DPM2	603564.0 | DPM2, CDG1U | Dolichyl-phosphate mannosyltransferase 2, regulatory subunit | 8818.0 | ENSG00000136908 | nan | Congenital disorder of glycosylation, type Iu, 615042 (3), Autosomal recessive
chr9	EEIG1	610891.0 | FAM102A, EEIG1 | Family with sequence similarity 102, member A | 399665.0 | ENSG00000167106 | nan | nan
chr9	NAIF1	610673.0 | C9orf90, NAIF1 | Nuclear apoptosis-inducing factor 1 | 203245.0 | ENSG00000171169 | nan | nan
chr9	SLC25A25	608745.0 | SLC25A25, SCAMC2, MCSC, KIAA1896 | Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 | 114789.0 | ENSG00000148339 | nan | nan
chr9	PTGES2	608152.0 | PTGES2, PGES2, GBF1 | Prostaglandin E synthase 2 | 80142.0 | ENSG00000148334 | nan | nan
chr9	LCN2	600181.0 | LCN2, NGAL | Lipocalin 2 (oncogene 24p3) | 3934.0 | ENSG00000148346 | nan | nan
chr9	CIZ1	611420.0 | CIZ1, ZNF356, LSFR1, NP94 | CDKN1A-interacting zinc finger protein 1 | 25792.0 | ENSG00000148337 | nan | nan
chr9	DNM1	602377.0 | DNM1, DEE31A, DEE31B | Dynamin-1 | 1759.0 | ENSG00000106976 | nan | Developmental and epileptic encephalopathy 31B, autosomal recessive, 620352 (3), Autosomal recessive; Developmental and epileptic encephalopathy 31A, autosomal dominant, 616346 (3), Autosomal dominant
chr9	MIR199B	614791.0 | MIR199B | Micro RNA 199B | 406978.0 | ENSG00000207581 | nan | nan
chr9	GOLGA2	602580.0 | GOLGA2, GM130, DEDHMB | Golgin A2 | 2801.0 | ENSG00000167110 | nan | Developmental delay with hypotonia, myopathy, and brain abnormalities, 620240 (3), Autosomal recessive
chr9	SWI5	616528.0 | SWI5, SAE3, C9orf119 | SWi5 homologous recombination repair protein | 375757.0 | ENSG00000175854 | nan | nan
chr9	TRUB2	610727.0 | TRUB2 | TRUB pseudouridine synthase, E. coli, homolog of, 2 | 26995.0 | ENSG00000167112 | nan | nan
chr9	COQ4	612898.0 | COQ4, COQ10D7, SPAX10 | Coenzyme Q4 | 51117.0 | ENSG00000167113 | nan | Coenzyme Q10 deficiency, primary, 7, 616276 (3), Autosomal recessive; Spastic ataxia 10, autosomal recessive, 620666 (3), Autosomal recessive
chr9	SLC27A4	604194.0 | SLC27A4, FATP4, IPS | Solute carrier family 27 (fatty acid transporter), member 4 | 10999.0 | ENSG00000167114 | nan | Ichthyosis prematurity syndrome, 608649 (3), Autosomal recessive
chr9	URM1	612693.0 | URM1 | Ubiquitin-related modifier 1 | 81605.0 | ENSG00000167118 | nan | nan
chr9	CERCAM	616626.0 | CERCAM | Cerebral endothelial cell adhesion molecule | 51148.0 | ENSG00000167123 | nan | nan
chr9	ODF2	602015.0 | ODF2, ODF84 | Outer dense fiber of sperm tails 2 | 4957.0 | ENSG00000136811 | nan | nan
chr9	GLE1	603371.0 | GLE1, GLE1L, LCCS, LCCS1, CAAHD | GLE1, RNA export mediator | 2733.0 | ENSG00000119392 | nan | Lethal congenital contracture syndrome 1, 253310 (3), Autosomal recessive; Congenital arthrogryposis with anterior horn cell disease, 611890 (3), Autosomal recessive
chr9	SPTAN1	182810.0 | SPTAN1, NEAS, DEE5, HMND11, DEVEP, SPG91 | Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin) | 6709.0 | ENSG00000197694 | nan | Developmental delay with or without epilepsy, 620540 (3), Autosomal dominant; Developmental and epileptic encephalopathy 5, 613477 (3), Autosomal dominant; Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia, 620538 (3), Autosomal dominant; Neuronopathy, distal hereditary motor, autosomal dominant 11, 620528 (3), Autosomal dominant
chr9	DYNC2I2	613363.0 | WDR34, SRTD11 | WD repeat-containing protein 34 | 89891.0 | ENSG00000119333 | nan | Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3), Autosomal recessive
chr9	SET	600960.0 | SET, MRD58 | SET gene | 6418.0 | ENSG00000119335 | fused with CAIN in acute undifferentiated leukemia | Intellectual developmental disorder, autosomal dominant 58, 618106 (3), Autosomal dominant
chr9	PKN3	610714.0 | PKN3 | Protein kinase N3 | 29941.0 | ENSG00000160447 | nan | nan
chr9	ZER1	617764.0 | ZER1, ZYG11BL, C9orf60 | Zyg11-related cell cycle regulator | 10444.0 | ENSG00000160445 | nan | nan
chr9	TBC1D13	616218.0 | TBC1D13 | TBC1 domain family, member 13 | 54662.0 | ENSG00000107021 | nan | nan
chr9	ENDOG	600440.0 | ENDOG | Endonuclease G | 2021.0 | ENSG00000167136 | nan | nan
chr9	SPOUT1	617614.0 | SPOUT1, CENP32, C9orf114 | SPOUT domain-containing methyltransferase 1 | 51490.0 | ENSG00000198917 | nan | nan
chr9	KYAT1	600547.0 | KYAT1, CCBL1, KAT1 | Kynurenine aminotransferase 1 | 883.0 | ENSG00000171097 | nan | nan
chr9	LRRC8A	608360.0 | LRRC8A, KIAA1437, AGM5 | Leucine-rich repeat-containing 8A | 56262.0 | ENSG00000136802 | mutation identified in 1 AGM5 patient | ?Agammaglobulinemia 5, 613506 (3), Autosomal dominant
chr9	PHYHD1	620042.0 | PHYHD1 | Phytanoyl-CoA dioxygenase domain-containing protein 1 | 254295.0 | ENSG00000175287 | nan | nan
chr9	DOLK	610746.0 | DOLK, TMEM15, DK1, SEC59, KIAA1094, CDG1M | Dolichol kinase | 22845.0 | ENSG00000175283 | nan | Congenital disorder of glycosylation, type Im, 610768 (3), Autosomal recessive
chr9	NUP188	615587.0 | NUP188, KIAA1069, SANDSTEF | Nucleoporin, 188kD | 23511.0 | ENSG00000095319 | nan | Sandestig-Stefanova syndrome, 618804 (3), Autosomal recessive
chr9	SH3GLB2	609288.0 | SH3GLB2, KIAA1848 | SH3 domain, GRB2-like, endophilin B2 | 56904.0 | ENSG00000148341 | nan | nan
chr9	MIGA2	616774.0 | MIGA2, FAM73B, C9orf54 | Mitoguardin 2 | 84895.0 | ENSG00000148343 | nan | nan
chr9	DOLPP1	614516.0 | DOLPP1, LSFR2 | Dolichyl pyrophosphate phosphatase 1 | 57171.0 | ENSG00000167130 | nan | nan
chr9	CRAT	600184.0 | CRAT, CAT1, NBIA8 | Carnitine acetyltransferase | 1384.0 | ENSG00000095321 | mutation identified in 1 NBIA8 patient | ?Neurodegeneration with brain iron accumulation 8, 617917 (3), Autosomal recessive
chr9	PTPA	600756.0 | PTPA, PPP2R4, PARK25 | Protein phosphatase 2 phosphatase activator | 5524.0 | ENSG00000119383 | proximal to ABL | Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development, 620482 (3), Autosomal recessive
chr9	NTMT1	613560.0 | NTMT1, METTL11A, NRMT, C9orf32 | N-terminal X-Pro-Lys N-methyltransferase 1 | 28989.0 | ENSG00000148335 | nan | nan
chr9	ASB6	615051.0 | ASB6 | Ankyrin repeat- and SOCS box-containing protein 6 | 140459.0 | ENSG00000148331 | nan | nan
chr9	PRRX2	604675.0 | PRRX2, PRX2 | Paired-related homeobox gene 2 | 51450.0 | ENSG00000167157 | nan | nan
chr9	PTGES	605172.0 | PTGES, PGES, PIG12, MGST1L1 | Prostaglandin E synthase | 9536.0 | ENSG00000148344 | nan | nan
chr9	TOR1B	608050.0 | TOR1B, DQ1 | Torsin 1B | 27348.0 | ENSG00000136816 | centromeric to TOR1A; pseudogene on chr.2 | nan
chr9	TOR1A	605204.0 | TOR1A, DYT1, AMC5 | Torsin 1A | 1861.0 | ENSG00000136827 | nan | {Dystonia-1, modifier of} (3); Arthrogryposis multiplex congenita 5, 618947 (3), Autosomal recessive; Dystonia-1, torsion, 128100 (3), Autosomal dominant
chr9	C9orf78	619569.0 | C9orf78, TLS1 | Chromosome 9 open reading frame 78 | 51759.0 | ENSG00000136819 | nan | nan
chr9	USP20	615143.0 | USP20, VDU2 | Ubiquitin-specific protease 20 | 10868.0 | ENSG00000136878 | nan | nan
chr9	FNBP1	606191.0 | FNBP1, FBP17 | Formin-binding protein 17 | 23048.0 | ENSG00000187239 | fused with MLL in chronic myeloid leukemia | nan
chr9	GPR107	618490.0 | GPR107, LUSTR1 | G protein-coupled receptor 107 | 57720.0 | ENSG00000148358 | nan | nan
chr9	NCS1	603315.0 | NCS1, FREQ | Neuronal calcium sensor 1 | 23413.0 | ENSG00000107130 | nan | nan
chr9	ASS1	603470.0 | ASS1, ASS | Argininosuccinate synthetase 1 | 445.0 | ENSG00000130707 | 14 pseudogenes on 11 chromosomes, including X and Y and ASSP2 on 6p23-q12 | Citrullinemia, 215700 (3), Autosomal recessive
chr9	FUBP3	603536.0 | FUBP3, FBP3 | FAR upstream element-binding protein 3 | 8939.0 | ENSG00000107164 | nan | nan
chr9	PRDM12	616458.0 | PRDM12, HSAN8 | PR domain-containing protein 12 | 59335.0 | ENSG00000130711 | nan | Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3), Autosomal recessive
chr9	EXOSC2	602238.0 | EXOSC2, RRP4, SHRF | Exosome component 2 | 23404.0 | ENSG00000130713 | nan | Short stature, hearing loss, retinitis pigmentosa, and distinctive facies, 617763 (3), Autosomal recessive
chr9	ABL1	189980.0 | ABL1, CHDSKM | ABL protooncogene 1, nonreceptor tyrosine kinase | 25.0 | ENSG00000097007 | fusion hybrid gene with BCR1 in CML | Leukemia, Philadelphia chromosome-positive, resistant to imatinib, 608232 (3), Somatic mutation; Congenital heart defects and skeletal malformations syndrome, 617602 (3), Autosomal dominant
chr9	QRFP	609795.0 | QRFP, P518, 26RFA | Pyroglutamylated FR-amide peptide precursor protein | 347148.0 | ENSG00000188710 | nan | nan
chr9	FIBCD1	613357.0 | FIBCD1 | Fibrinogene C domain-containing protein 1 | 84929.0 | ENSG00000130720 | nan | nan
chr9	LAMC3	604349.0 | LAMC3, OCCM | Laminin, gamma-3 | 10319.0 | ENSG00000050555 | nan | Cortical malformations, occipital, 614115 (3), Autosomal recessive
chr9	ALPQTL1	171720.0 | ALPQTL1 | Alkaline phosphatase, plasma level of, QTL 1 | 100196909.0 | nan | linkage with rs657152 | {Alkaline phosphatase, plasma level of, QTL1}, 171720 (2), ?Autosomal dominant
chr9	NUP214	114350.0 | NUP214, D9S46E, CAN, CAIN, IIAE9 | Nucleoporin, 214kD | 8021.0 | ENSG00000126883 | fused with DEK in AML; fused with ABL1 in T-ALL | Leukemia, T-cell acute lymphoblastic, somatic, 613065 (3); Leukemia, acute myeloid, somatic, 601626 (3); {Encephalopathy, acute, infection-induced, susceptibility to, 9}, 618426 (3), Autosomal recessive
chr9	PLPP7	618743.0 | PLPP7, PPAPDC3, NET39, C9orf67 | Phospholipid phosphatase 7 | 84814.0 | ENSG00000160539 | nan | nan
chr9	PRRC2B	619544.0 | PRRC2B, KIAA0515 | Proline-rich coiled-coil protein 2B | 84726.0 | ENSG00000288701 | nan | nan
chr9	POMT1	607423.0 | POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11 | Protein O-mannosyltransferase 1 | 10585.0 | ENSG00000130714 | nan | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 1, 613155 (3), Autosomal recessive
chr9	UCK1	609328.0 | UCK1 | Uridine/cytidine kinase 1 | 83549.0 | ENSG00000130717 | nan | nan
chr9	RAPGEF1	600303.0 | RAPGEF1, GRF2, C3G | RAP guanine nucleotide exchange factor 1 | 2889.0 | ENSG00000107263 | nan | nan
chr9	MED27	605044.0 | MED27, CRSP8, CRAP34, NEDSCAC | Mediator complex subunit 27 | 9442.0 | ENSG00000160563 | nan | Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia, 619286 (3), Autosomal recessive
chr9	NTNG2	618689.0 | NTNG2, NEDBASH | Netrin G2 | 84628.0 | ENSG00000196358 | nan | Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia, 618718 (3), Autosomal recessive
chr9	SETX	608465.0 | SETX, SCAN2, AOA2, ALS4 | Senataxin | 23064.0 | ENSG00000107290 | nan | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2, 606002 (3), Autosomal recessive; Amyotrophic lateral sclerosis 4, juvenile, 602433 (3), Autosomal dominant
chr9	TTF1	600777.0 | TTF1 | Transcription termination factor, RNA polymerase I | 7270.0 | ENSG00000125482 | nan | nan
chr9	BARHL1	605211.0 | BARHL1 | BARH-like 1 | 56751.0 | ENSG00000125492 | nan | nan
chr9	DDX31	616533.0 | DDX31, PPP1R25 | DEAD-box helicase 31 | 64794.0 | ENSG00000125485 | nan | nan
chr9	GTF3C4	604892.0 | GTF3C4, TFIIIC90 | General transcription factor 3C, polypeptide 4 | 9329.0 | ENSG00000125484 | nan | nan
chr9	AK8	615365.0 | AK8 | Adenylate kinase 8 | 158067.0 | ENSG00000165695 | nan | nan
chr9	SPACA9	618552.0 | SPACA9 | Sperm acrosome associated 9 | 11092.0 | ENSG00000165698 | nan | nan
chr9	TSC1	605284.0 | TSC1, LAM | Hamartin (tuberous sclerosis 1 gene) | 7248.0 | ENSG00000165699 | linked to ABO, ABL | Focal cortical dysplasia, type II, somatic, 607341 (3); Tuberous sclerosis-1, 191100 (3), Autosomal dominant; Lymphangioleiomyomatosis, 606690 (3)
chr9	GFI1B	604383.0 | GFI1B, BDPLT17 | Growth factor-independent 1B | 8328.0 | ENSG00000165702 | nan | Bleeding disorder, platelet-type, 17, 187900 (3), Autosomal recessive, Autosomal dominant
chr9	GTF3C5	604890.0 | GTF3C5, TFIIIC63 | General transcription factor 3C, polypeptide 5 | 9328.0 | ENSG00000148308 | nan | nan
chr9	CEL	114840.0 | CEL, BSSL, CELL, MODY8 | Carboxyl-ester lipase (bile-salt stimulated lipase) | 1056.0 | ENSG00000170835 | nan | Maturity-onset diabetes of the young, type VIII, 609812 (3), Autosomal dominant
chr9	RALGDS	601619.0 | RALGDS | ral guanine nucleotide dissociation stimulator | 5900.0 | ENSG00000160271 | nan | nan
chr9	GBGT1	606074.0 | GBGT1, FS | Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (Forssman synthetase) | 26301.0 | ENSG00000148288 | nan | nan
chr9	OBP2B	604606.0 | OBP2B | Odorant-binding protein 2B | 29989.0 | ENSG00000171102 | nan | nan
chr9	ABO	110300.0 | ABO | ABO glycosyltransferase | 28.0 | ENSG00000175164 | linked to AK1 | [Blood group, ABO system], 616093 (3)
chr9	SURF6	185642.0 | SURF6 | Surfeit-6 | 6838.0 | ENSG00000148296 | nan | nan
chr9	MED22	185641.0 | SURF5 | Surfeit-5 | 6837.0 | ENSG00000148297 | nan | nan
chr9	RPL7A	185640.0 | RPL7A, SURF3 | Ribosomal protein L7a (surfeit-3) | 6130.0 | ENSG00000148303 | in cluster with SURF1 | nan
chr9	SURF1	185620.0 | SURF1, CMT4K, MC4DN1 | Surfeit-1 | 6834.0 | ENSG00000148290 | distal to ABL, CAN | Charcot-Marie-Tooth disease, type 4K, 616684 (3), Autosomal recessive; Mitochondrial complex IV deficiency, nuclear type 1, 220110 (3), Autosomal recessive
chr9	SURF2	185630.0 | SURF2 | Surfeit-2 | 6835.0 | ENSG00000148291 | nan | nan
chr9	SURF4	185660.0 | SURF4 | Surfeit-4 | 6836.0 | ENSG00000148248 | nan | nan
chr9	STKLD1	618530.0 | STKLD1, C9orf96 | Serine/threonine kinase-like domain containing protein 1 | 169436.0 | ENSG00000198870 | nan | nan
chr9	REXO4	602930.0 | REXO4, XPMC2H | REX4 homolog, 3',5'-exonuclease | 57109.0 | ENSG00000148300 | nan | nan
chr9	ADAMTS13	604134.0 | ADAMTS13, VWFCP, TTP | ADAM metallopeptidase domain with thrombospondin type 1 motif, 13 | 11093.0 | ENSG00000160323 | nan | Thrombotic thrombocytopenic purpura, hereditary, 274150 (3), Autosomal recessive
chr9	CACFD1	613104.0 | CACFD1, FLOWER, C9orf7 | Calcium channel FLOWER-domain containing protein 1 | 11094.0 | ENSG00000160325 | nan | nan
chr9	SLC2A6	606813.0 | SLC2A6 | Solute carrier family 2, member 6 | 11182.0 | ENSG00000160326 | nan | nan
chr9	MYMK	615345.0 | MYMK, TMEM8C | Myomaker | 389827.0 | ENSG00000187616 | nan | Carey-Fineman-Ziter syndrome, 254940 (3), Autosomal recessive
chr9	ADAMTSL2	612277.0 | ADAMTSL2, KIAA0605, GPHYSD1 | ADAMTS-like protein 2 | 9719.0 | ENSG00000197859 | nan | Geleophysic dysplasia 1, 231050 (3), Autosomal recessive
chr9	DBH	609312.0 | DBH, ORTHYP1 | Dopamine-beta-hydroxylase | 1621.0 | ENSG00000123454 | tightly linked to ABO | Orthostatic hypotension 1, due to DBH deficiency, 223360 (3), Autosomal recessive
chr9	SARDH	604455.0 | SARDH, SARD, SAR | Sarcosine dehydrogenase | 1757.0 | ENSG00000123453 | nan | [Sarcosinemia], 268900 (3), Autosomal recessive
chr9	VAV2	600428.0 | VAV2 | VAV guanine nucleotide exchange factor 2 | 7410.0 | ENSG00000160293 | nan | nan
chr9	BRD3	601541.0 | RING3L, ORFX | RING3-like gene (open reading frame X) | 8019.0 | ENSG00000169925 | nan | nan
chr9	WDR5	609012.0 | WDR5, BIG3 | WD repeat-containing protein 5 | 11091.0 | ENSG00000196363 | nan | nan
chr9	RNU6ATAC	601429.0 | RNU6ATAC, U6ATAC | RNA, U6ATAC small nuclear | 100151684.0 | ENSG00000221676 | nan | nan
chr9	RXRA	180245.0 | RXRA | Retinoid X receptor, alpha | 6256.0 | ENSG00000186350 | distal to DBH | nan
chr9	COL5A1	120215.0 | COL5A1, EDSCL1, FMDMF | Collagen V, alpha-1 polypeptide | 1289.0 | ENSG00000130635 | nan | Ehlers-Danlos syndrome, classic type, 1, 130000 (3), Autosomal dominant; Fibromuscular dysplasia, multifocal, 619329 (3), Autosomal dominant
chr9	FCN2	601624.0 | FCN2 | Ficolin (collagen/fibrinogen domain-containing lectin) 2 | 2220.0 | ENSG00000160339 | nan | nan
chr9	FCN1	601252.0 | FCN1 | Ficolin (collagen/fibrinogen domain-containing) 1 | 2219.0 | ENSG00000085265 | nan | nan
chr9	OLFM1	605366.0 | OLFM1, AMY | Olfactomedin 1 | 10439.0 | ENSG00000130558 | nan | nan
chr9	PPP1R26	614056.0 | PPP1R26, KIAA0649 | Protein phosphatase 1, regulatory subunit 26 | 9858.0 | ENSG00000196422 | nan | nan
chr9	PIERCE1	614502.0 | PIERCE1, C9orf116 | Piercer of microtubule wall 1 | 138162.0 | ENSG00000160345 | nan | nan
chr9	MRPS2	611971.0 | MRPS2, COXPD36 | Mitochondrial ribosomal protein S2 | 51116.0 | ENSG00000122140 | nan | Combined oxidative phosphorylation deficiency 36, 617950 (3), Autosomal recessive
chr9	LCN1	151675.0 | LCN1 | Lipocalin 1 (protein migrating faster than albumin, tear prealbumin) | 3933.0 | ENSG00000160349 | nan | nan
chr9	OBP2A	164320.0 | OBP2A | Odorant-binding protein 2A | 29991.0 | ENSG00000122136 | nan | nan
chr9	PAEP	173310.0 | PAEP, PP14 | Progestagen-associated endometrial protein (placental protein 14) | 5047.0 | ENSG00000122133 | nan | nan
chr9	GLT6D1	613699.0 | GLT6D1, GT6M7, GLTDC1 | Glycosyltransferase 6 domain-containing 1 | 360203.0 | ENSG00000204007 | nan | nan
chr9	LCN9	612903.0 | LCN9 | Lipocalin 9 | 392399.0 | ENSG00000148386 | nan | nan
chr9	SOHLH1	610224.0 | SOHLH1, NOHLH, TEB2, ODG5, SPGF32 | Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 1 | 402381.0 | ENSG00000165643 | nan | Ovarian dysgenesis 5, 617690 (3), Autosomal recessive; Spermatogenic failure 32, 618115 (3), Autosomal dominant
chr9	KCNT1	608167.0 | KCNT1, KIAA1422, DEE14, ENFL5 | Potassium channel, subfamily T, member 1 | 57582.0 | ENSG00000107147 | nan | Developmental and epileptic encephalopathy 14, 614959 (3), Autosomal dominant; Epilepsy nocturnal frontal lobe, 5, 615005 (3), Autosomal dominant
chr9	CAMSAP1	613774.0 | CAMSAP1, CDCBM12 | Calmodulin-regulated spectrin-associated protein 1 | 157922.0 | ENSG00000130559 | nan | Cortical dysplasia, complex, with other brain malformations 12, 620316 (3), Autosomal recessive
chr9	UBAC1	608129.0 | UBAC1, GBDR1 | Ubiquitin-associated domain-containing protein 1 | 10422.0 | ENSG00000130560 | nan | nan
chr9	NACC2	615786.0 | NACC2, RBB | NACC family, member 2, BEN and BTB/POZ domains-containing | 138151.0 | ENSG00000148411 | nan | nan
chr9	LHX3	600577.0 | LHX3, CPHD3 | LIM/homeodomain protein LHX3 | 8022.0 | ENSG00000107187 | in mouse, close to Notch1; centromeric to ABL | Pituitary hormone deficiency, combined, 3, 221750 (3), Autosomal recessive
chr9	QSOX2	612860.0 | QSOX2, SOXN | Quiescin Q6 sulfhydryl oxidase 2 | 169714.0 | ENSG00000165661 | nan | nan
chr9	GPSM1	609491.0 | GPSM1, AGS3 | G-protein signaling modulator 1 | 26086.0 | ENSG00000160360 | nan | nan
chr9	DNLZ	620797.0 | DNLZ, HEP, HEP1 | DNL-type zinc finger protein | 728489.0 | ENSG00000213221 | nan | nan
chr9	CARD9	607212.0 | CARD9, CANDF2, IMD103 | Caspase recruitment domain-containing protein 9 | 64170.0 | ENSG00000187796 | nan | Immunodeficiency 103, susceptibility to fungal infection, 212050 (3), Autosomal recessive
chr9	SNAPC4	602777.0 | SNAPC4, SNAP190, NEDRSO | Small nuclear RNA-activating protein complex, polypeptide 4 | 6621.0 | ENSG00000165684 | nan | Neurodevelopmental disorder with motor regression, progressive spastic paraplegia, and oromotor dysfunction, 620515 (3), Autosomal recessive
chr9	ENTR1	618289.0 | ENTR1, SDDAG3 | Endosome-associated trafficking regulator 1 | 10807.0 | ENSG00000165689 | nan | nan
chr9	PMPCA	613036.0 | PMPCA, KIAA0123, SCAR2 | Peptidase, mitochondrial processing, alpha | 23203.0 | ENSG00000165688 | nan | Spinocerebellar ataxia, autosomal recessive 2, 213200 (3), Autosomal recessive
chr9	INPP5E	613037.0 | INPP5E, MORMS, JBTS1, CORS1 | Inositol polyphosphate-5-phosphatase, 72kD | 56623.0 | ENSG00000148384 | nan | Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis syndrome, 610156 (3), Autosomal recessive; Joubert syndrome 1, 213300 (3), Autosomal recessive
chr9	SEC16A	612854.0 | SEC16A, SEC16L, KIAA0310, p250 | SEC16 homolog A, endoplasmic reticulum export factor | 9919.0 | ENSG00000148396 | nan | nan
chr9	NOTCH1	190198.0 | NOTCH1, TAN1, AOS5, AOVD1 | Notch receptor 1 | 4851.0 | ENSG00000148400 | nan | Adams-Oliver syndrome 5, 616028 (3), Autosomal dominant; Aortic valve disease 1, 109730 (3), Autosomal dominant
chr9	EGFL7	608582.0 | EGFL7 | Epidermal growth factor-like 7 | 51162.0 | ENSG00000172889 | nan | nan
chr9	MIR126	611767.0 | MIR126, MIRN126 | Micro RNA 126 | 406913.0 | ENSG00000199161 | nan | nan
chr9	AGPAT2	603100.0 | AGPAT2, LPAAB, BSCL, BSCL1 | 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase-beta) | 10555.0 | ENSG00000169692 | nan | Lipodystrophy, congenital generalized, type 1, 608594 (3), Autosomal recessive
chr9	DIPK1B	614543.0 | DIPK1B, FAM69B | Divergent protein kinase domain 1B | 138311.0 | ENSG00000165716 | nan | nan
chr9	LCN10	612904.0 | LCN10 | Lipocalin 10 | 414332.0 | ENSG00000187922 | nan | nan
chr9	LCN6	609379.0 | LCN6 | Lipocalin 6 | 158062.0 | ENSG00000267206 | nan | nan
chr9	LCN8	612902.0 | LCN8 | Lipocalin 8 | 138307.0 | ENSG00000204001 | nan | nan
chr9	CCDC183	615955.0 | CCDC183, KIAA1984 | Coiled-coil domain-containing protein 183 | 84960.0 | ENSG00000213213 | nan | nan
chr9	RABL6	610615.0 | RABL6, PARF, C9orf86 | RAB-like protein 6 | 55684.0 | ENSG00000196642 | nan | nan
chr9	PHPT1	610167.0 | PHPT1 | Phosphohistidine phosphatase 1 | 29085.0 | ENSG00000054148 | nan | nan
chr9	MAMDC4	617208.0 | MAMDC4 | MAM domain-containing protein 4 | 158056.0 | ENSG00000177943 | nan | nan
chr9	EDF1	605107.0 | EDF1 | Endothelial differentiation-related factor 1 | 8721.0 | ENSG00000107223 | nan | nan
chr9	TRAF2	601895.0 | TRAF2, TRAP | TNF receptor-associated factor 2 | 7186.0 | ENSG00000127191 | nan | nan
chr9	FBXW5	609072.0 | FBXW5, FBW5 | F-box and WD40 domain protein 5 | 54461.0 | ENSG00000159069 | nan | nan
chr9	C8G	120930.0 | C8G | Complement component-8, gamma polypeptide | 733.0 | ENSG00000176919 | nan | nan
chr9	LCN12	612905.0 | LCN12 | Lipocalin 12 | 286256.0 | ENSG00000184925 | nan | nan
chr9	PTGDS	176803.0 | PTGDS | Prostaglandin D2 synthase (21kD, brain) | 5730.0 | ENSG00000107317 | distal to ABL | nan
chr9	PAXX	616315.0 | PAXX, C9orf142 | PAXX nonhomologous end joining factor | 286257.0 | ENSG00000148362 | nan | nan
chr9	CLIC3	606533.0 | CLIC3 | Chloride intracellular channel 3 | 9022.0 | ENSG00000169583 | nan | nan
chr9	ABCA2	600047.0 | ABCA2, ABC2, IDPOGSA | ATP-binding cassette 2 | 20.0 | ENSG00000107331 | nan | Intellectual developmental disorder with poor growth and with or without seizures or ataxia, 618808 (3), Autosomal recessive
chr9	FUT7	602030.0 | FUT7 | Fucosyltransferase 7 (alpha (1,3) fucosyltransferase) | 2529.0 | ENSG00000180549 | nan | nan
chr9	NPDC1	605798.0 | NPDC1, CAB1 | Neural proliferation, differentiation, and control protein 1 | 56654.0 | ENSG00000107281 | nan | nan
chr9	ENTPD2	602012.0 | ENTPD2, CD39L1 | Ectonucleoside triphosphate diphosphohydrolase 2 | 954.0 | ENSG00000054179 | same cosmid as ABC2 | nan
chr9	SAPCD2	612057.0 | SAPCD2, C9orf140, P42.3 | Suppressor APC domain-containing protein 2 | 89958.0 | ENSG00000186193 | nan | nan
chr9	MAN1B1	604346.0 | MAN1B1, MRT15 | Mannosidase, alpha, class 1B member 1 | 11253.0 | ENSG00000177239 | nan | Rafiq syndrome, 614202 (3), Autosomal recessive
chr9	DPP7	610537.0 | DPP7, QPP | Dipeptidyl peptidase VII | 29952.0 | ENSG00000176978 | nan | nan
chr9	GRIN1	138249.0 | GRIN1, NMDAR1, NDHMSR, NDHMSD, DEE101 | Glutamate receptor, ionotropic, N-methyl D-aspartate 1 | 2902.0 | ENSG00000176884 | nan | Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive, 617820 (3), Autosomal recessive; Developmental and epileptic encephalopathy 101, 619814 (3), Autosomal recessive; Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant, 614254 (3), Autosomal dominant
chr9	LRRC26	613505.0 | LRRC26, CAPC | Leucine-rich repeat-containing protein 26 | 389816.0 | ENSG00000184709 | nan | nan
chr9	ANAPC2	606946.0 | ANAPC2, APC2, KIAA1406 | Anaphase-promoting complex, subunit 2 | 29882.0 | ENSG00000176248 | nan | nan
chr9	SSNA1	610882.0 | SSNA1, NA14 | Sjogren syndrome nuclear autoantigen 1 | 8636.0 | ENSG00000176101 | nan | nan
chr9	TPRN	613354.0 | TPRN, C9orf75, DFNB79 | Taperin | 286262.0 | ENSG00000176058 | nan | Deafness, autosomal recessive 79, 613307 (3), Autosomal recessive
chr9	TMEM203	616499.0 | TMEM203 | Transmembrane protein 203 | 94107.0 | ENSG00000187713 | nan | nan
chr9	NDOR1	606073.0 | NR1 | NADPH-dependent FMN- and FAD-containing oxidoreductase | 27158.0 | ENSG00000188566 | nan | nan
chr9	RNF208	618993.0 | RNF208 | RING finger protein 208 | 727800.0 | ENSG00000212864 | nan | nan
chr9	SLC34A3	609826.0 | SLC34A3, NPTIIC, HHRH | Solute carrier family 34 (sodium/phosphate cotransporter), member 3 | 142680.0 | ENSG00000198569 | nan | Hypophosphatemic rickets with hypercalciuria, 241530 (3), Autosomal recessive
chr9	TUBB4B	602660.0 | TUBB4B, TUBB2C, LCAEOD | Tubulin, beta-4B | 10383.0 | ENSG00000188229 | nan | Leber congenital amaurosis with early-onset deafness, 617879 (3), Autosomal dominant
chr9	NELFB	611180.0 | NELFB, COBRA1, KIAA1182 | Negative elongation factor complex, member B | 25920.0 | ENSG00000188986 | nan | nan
chr9	NRARP	619987.0 | NRARP | Notch-regulated ankyrin repeat-containing protein | 441478.0 | ENSG00000198435 | nan | nan
chr9	EXD3	620859.0 | EXD3 | Exonuclease 3'-to-5' domain-containing protein 3 | 54932.0 | ENSG00000187609 | nan | nan
chr9	NOXA1	611255.0 | NOXA1 | NADPH oxidase activator 1 | 10811.0 | ENSG00000188747 | nan | nan
chr9	ENTPD8	616748.0 | ENTPD8 | Ectonucleoside triphosphate diphosphohydrolase 8 | 377841.0 | ENSG00000188833 | nan | nan
chr9	NSMF	608137.0 | NSMF, NELF, HH9 | NMDA receptor synaptonuclear signaling and neuronal migration factor | 26012.0 | ENSG00000165802 | nan | Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3), Autosomal dominant
chr9	PNPLA7	612122.0 | PNPLA7 | Patatin-like phospholipase domain containing 7 | 375775.0 | ENSG00000130653 | nan | nan
chr9	MRPL41	611846.0 | MRPL41, MRPL27 | Mitochondrial ribosomal protein L41 | 64975.0 | ENSG00000182154 | nan | nan
chr9	DPH7	613210.0 | DPH7, WDR85 | Diphthamide biosynthesis 7 | 92715.0 | ENSG00000148399 | nan | nan
chr9	ZMYND19	611424.0 | ZMYND19, MIZIP | Zinc finger MYND domain-containing protein 19 | 116225.0 | ENSG00000165724 | nan | nan
chr9	ARRDC1	619768.0 | ARRDC1 | Arrestin domain-containing protein 1 | 92714.0 | ENSG00000197070 | nan | nan
chr9	EHMT1	607001.0 | EHMT1, EUHMTASE1, KMT1D, DEL9q34, KLEFS1 | Euchromatic histone methyltransferase 1 | 79813.0 | ENSG00000181090 | nan | Kleefstra syndrome 1, 610253 (3), Autosomal dominant
chr9	CACNA1B	601012.0 | CACNA1B, CACNL1A5, NEDNEH | Calcium channel, voltage-dependent, L type, alpha 1B subunit | 774.0 | ENSG00000148408 | nan | Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, 618497 (3), Autosomal recessive
chr9	H142T	187290.0 | H142T | Temperature sensitivity complementation, H142 | 8023.0 | nan | nan | nan
chr10	BMIQ8	603188.0 | BMIQ8 | Body mass index quantitative trait locus 8 | 56694.0 | nan | nan | {Obesity, susceptibility to, BMIQ8}, 603188 (2)
chr10	BULN	607499.0 | BULN | Bulimia nervosa, susceptibility to | 337893.0 | nan | between D10S1430 and D10S1423 | {Bulimia nervosa, susceptibility to}, 607499 (2), Multifactorial
chr10	PFFE1	611384.0 | PFFE1 | Plasmodium falciparum fever episodes QTL1 | 101910199.0 | nan | nan | {Plasmodium falciparum fever episodes QTL1}, 611384 (2)
chr10		601188.0 | ST12, PAC1 | Suppression of tumorigenicity 12, prostate | nan | nan | nan | Prostate adenocarcinoma, 601188 (2)
chr10	TUBB8	616768.0 | TUBB8, OZEMA2 | Tubulin, beta 8 | 347688.0 | ENSG00000261456 | nan | Oocyte/zygote/embryo maturation arrest 2, 616780 (3), Autosomal recessive, Autosomal dominant
chr10	ZMYND11	608668.0 | ZMYND11, BS69, BRAM1, MRD30 | Zinc finger MYND domain-containing protein 11 | 10771.0 | ENSG00000015171 | nan | Intellectual developmental disorder, autosomal dominant 30, 616083 (3), Autosomal dominant
chr10	DIP2C	611380.0 | DIP2C, KIAA0934 | Disco-interacting protein 2 homolog C | 22982.0 | ENSG00000151240 | nan | nan
chr10	LARP4B	616513.0 | LARP4B, LARP5, KIAA0217 | La ribonucleoprotein 4B | 23185.0 | ENSG00000107929 | nan | nan
chr10	GTPBP4	619169.0 | GTPBP4, CRFG | CTP-binding protein 4 | 23560.0 | ENSG00000107937 | nan | nan
chr10	IDI2	615389.0 | IDI2, IPPI2 | Isopentenyl-diphosphate delta isomerase 2 | 91734.0 | ENSG00000148377 | nan | nan
chr10	IDI2-AS1	615391.0 | IDI2AS1 | IDI2 antisense RNA 1, noncoding | 55853.0 | ENSG00000232656 | nan | nan
chr10	IDI1	604055.0 | IDI1 | Isopentenyl-diphosphate delta isomerase 1 | 3422.0 | ENSG00000067064 | nan | nan
chr10	WDR37	618586.0 | WDR37, NOCGUS | WD repeat-containing protein 37 | 22884.0 | ENSG00000047056 | nan | Neurooculocardiogenitourinary syndrome, 618652 (3), Autosomal dominant
chr10	ADARB2	602065.0 | ADARB2, RED2 | Adenosine deaminase, RNA-specific, B2 (homolog of rat BLUE) | 105.0 | ENSG00000185736 | nan | nan
chr10	PFKP	171840.0 | PFKP | Phosphofructokinase, platelet type | 5214.0 | ENSG00000067057 | nan | nan
chr10	PITRM1	618211.0 | PITRM1, MP1, PREP, SCAR30 | Pitrilysin metallopeptidase 1 | 10531.0 | ENSG00000107959 | nan | Spinocerebellar ataxia, autosomal recessive 30, 619405 (3), Autosomal recessive
chr10	KLF6	602053.0 | KLF6, COPEB, BCD1, ZF9 | Kruppel-like factor-6 | 1316.0 | ENSG00000067082 | nan | Gastric cancer, somatic, 613659 (3); Prostate cancer, somatic, 176807 (3)
chr10	MS2	612594.0 | MS2 | Multiple sclerosis, susceptibility to, 2 | 100271694.0 | nan | associated with rs12722489 and rs2104286 | {Multiple sclerosis, susceptibility to, 2}, 612594 (2)
chr10	AKR1E2	617451.0 | AKR1E2, HTSP, TAKR | Aldo-keto reductase family 1, member E2 | 83592.0 | ENSG00000165568 | nan | nan
chr10	AKR1C1	600449.0 | AKR1C1, DDH1, DD1, HAKRC | Aldo-keto reductase family 1, member 1 (dihydrodiol dehydrogenase, type 1) | 1645.0 | ENSG00000187134 | nan | nan
chr10	AKR1C2	600450.0 | AKR1C2, DDH2, DD2, HAKRD, SRXY8 | Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase, type II) | 1646.0 | ENSG00000151632 | nan | 46XY sex reversal 8, 614279 (3), Autosomal recessive
chr10	AKR1C3	603966.0 | AKR1C3, HAKRB, DD3 | Aldo-keto reductase family 1, member C3 | 8644.0 | ENSG00000196139 | nan | nan
chr10	AKR1C4	600451.0 | AKR1C4, CHDR, CDR, HAKRA, DD4 | Aldo-keto reductase family 1, member C4 (chlordecone reductase) | 1109.0 | ENSG00000198610 | nan | {46XY sex reversal 8, modifier of}, 614279 (3), Autosomal recessive
chr10	UCN3	605901.0 | UCN3, SCP | Urocortin III | 114131.0 | ENSG00000178473 | nan | nan
chr10	TUBAL3	620835.0 | TUBAL3 | Tubulin, alpha-like 3 | 79861.0 | ENSG00000178462 | nan | nan
chr10	NET1	606450.0 | NET1 | Neuroepithelial cell transforming gene 1 | 10276.0 | ENSG00000173848 | nan | nan
chr10	CALML5	605183.0 | CALML5 | Calmodulin-like 5 | 51806.0 | ENSG00000178372 | nan | nan
chr10	CALML3	114184.0 | CALML3 | Calmodulin-like 3 | 810.0 | ENSG00000178363 | nan | nan
chr10	LASTR	618938.0 | LASTR, LINC02657 | Long noncoding RNA associated with SART3 regulation of splicing | 105376382.0 | ENSG00000242147 | nan | nan
chr10	ASB13	615055.0 | ASB13 | Ankyrin repeat- and SOCS box-containing protein 13 | 79754.0 | ENSG00000196372 | nan | nan
chr10	GDI2	600767.0 | GDI2, RABGDIB | GDP dissociation inhibitor 2 | 2665.0 | ENSG00000057608 | pseudogene on chr.7 | nan
chr10	ANKRD16	618017.0 | ANKRD16 | Ankyrin repeat domain-containing protein 16 | 54522.0 | ENSG00000134461 | nan | nan
chr10	FBH1	607222.0 | FBXO18, FBH1, FBX18 | F-box only protein 18 | 84893.0 | ENSG00000134452 | nan | nan
chr10	IL15RA	601070.0 | IL15RA | Interleukin-15 receptor, alpha | 3601.0 | ENSG00000134470 | nan | nan
chr10	IL2RA	147730.0 | IL2RA, CD25, IL2R, IDDM10, IMD41 | Interleukin-2 receptor, alpha | 3559.0 | ENSG00000134460 | nan | Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3), Autosomal recessive; {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)
chr10	RBM17	606935.0 | RBM17, SPF45 | RNA binding motif protein 17 | 84991.0 | ENSG00000134453 | nan | nan
chr10	PFKFB3	605319.0 | PFKFB3, IPFK2 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 5209.0 | ENSG00000170525 | nan | nan
chr10	PRKCQ	600448.0 | PRKCQ | Protein kinase C, theta | 5588.0 | ENSG00000065675 | nan | nan
chr10	ARVD6	604401.0 | ARVD6 | Arrhythmogenic right ventricular dysplasia 6 | 27038.0 | nan | nan | Arrhythmogenic right ventricular dysplasia 6, 604401 (2)
chr10	CRCS5	612230.0 | CRCS5 | Colorectal cancer, susceptibility to, 5 | 100188887.0 | nan | associated with rs10795668 | {Colorectal cancer, susceptibility to, 5}, 612230 (2)
chr10	DGS2	601362.0 | DGCR2, DGS2 | DiGeorge syndrome chromosome region-2 | 8026.0 | nan | nan | DiGeorge syndrome/velocardiofacial syndrome complex-2, 601362 (2)
chr10	SFMBT2	615392.0 | SFMBT2, KIAA1617 | SCM-like protein with 4 MBT domains 2 | 57713.0 | ENSG00000198879 | nan | nan
chr10	ITIH5	609783.0 | ITIH5 | Inter-alpha-trypsin inhibitor, heavy chain 5 | 80760.0 | ENSG00000123243 | nan | nan
chr10	ITIH2	146640.0 | ITIH2 | Inter-alpha (globulin) inhibitor, H2 polypeptide | 3698.0 | ENSG00000151655 | nan | nan
chr10	KIN	601720.0 | KIN, KIN17, BTCD | Antigenic determinant of recombination protein A, mouse, homolog of | 22944.0 | ENSG00000151657 | nan | nan
chr10	ATP5F1C	108729.0 | ATP5F1C, ATP5C1, ATP5CL1, ATP5C | ATP synthase F1, subunit gamma | 509.0 | ENSG00000165629 | nan | nan
chr10	TAF3	606576.0 | TAF3, TAFII140 | TAF3 RNA polymerase II, TATA box-binding protein-associated factor, 140kD | 83860.0 | ENSG00000165632 | nan | nan
chr10	GATA3	131320.0 | GATA3, HDR, HDRS | GATA-binding protein-3 | 2625.0 | ENSG00000107485 | nan | Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3), Autosomal dominant
chr10	CELF2	602538.0 | CELF2, CUGBP2, ETR3, BRUNOL3, DEE97 | CUGbp- and ELAV-like family, member 2 | 10659.0 | ENSG00000048740 | nan | Developmental and epileptic encephalopathy 97, 619561 (3), Autosomal dominant
chr10	USP6NL	605405.0 | USP6NL, RNTRE | USP6 N-terminal-like | 9712.0 | ENSG00000148429 | nan | nan
chr10	ECHDC3	620756.0 | ECHDC3 | Enoyl coenzyme A hydratase domain-containing protein 3 | 79746.0 | ENSG00000134463 | nan | nan
chr10	UPF2	605529.0 | UPF2, RENT2 | UPF2 regulator of nonsense-mediated mRNA decay | 26019.0 | ENSG00000151461 | nan | nan
chr10	DHTKD1	614984.0 | DHTKD1, KIAA1630, AAKAD, CMT2Q | Dehydrogenase E1 and transketolase domains-containing protein 1 | 55526.0 | ENSG00000181192 | mutation identified in 1 CMT2Q family | ?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3), Autosomal dominant; Alpha-aminoadipic and alpha-ketoadipic aciduria, 204750 (3), Autosomal recessive
chr10	SEC61A2	618271.0 | SEC61A2 | SEC61 translocon, alpha-2 subunit | 55176.0 | ENSG00000065665 | nan | nan
chr10	NUDT5	609230.0 | NUDT5, YSA1H | Nudix hydrolase 5 | 11164.0 | ENSG00000165609 | nan | nan
chr10	CDC123	617708.0 | CDC123 | Cell division cycle 123 | 8872.0 | ENSG00000151465 | nan | nan
chr10	AD7	606187.0 | AD7 | Alzheimer disease 7 | 114475.0 | nan | max LOD at D10S1423 | Alzheimer disease-7, 606187 (2)
chr10	LPRS	609888.0 | LPRS | Leprosy, paucibacillary type, susceptibility to | 81861.0 | nan | nan | {Leprosy, paucibacillary type, susceptibility to}, 609888 (2)
chr10	CAMK1D	607957.0 | CAMK1D, CKLIK | Calcium/calmodulin-dependent protein kinase I-delta | 57118.0 | ENSG00000183049 | nan | nan
chr10	CCDC3	620579.0 | CCDC3, FAVINE | Coiled-coil domain-containing protein 3 | 83643.0 | ENSG00000151468 | nan | nan
chr10	OPTN	602432.0 | OPTN, GLC1E, FIP2, HYPL, NRP, ALS12 | Optineurin | 10133.0 | ENSG00000123240 | nan | Glaucoma 1, open angle, E, 137760 (3), Autosomal dominant; Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia, 613435 (3), Autosomal recessive, Autosomal dominant; {Glaucoma, normal tension, susceptibility to}, 606657 (3)
chr10	MCM10	609357.0 | MCM10, CNA43, IMD80 | Minichromosome maintenance complex component 10 | 55388.0 | ENSG00000065328 | nan | Immunodeficiency 80 with or without cardiomyopathy, 619313 (3), Autosomal recessive
chr10	PHYH	602026.0 | PHYH, PAHX | Phytanoyl-CoA hydroxylase | 5264.0 | ENSG00000107537 | nan | Refsum disease, 266500 (3), Autosomal recessive
chr10	SEPHS1	600902.0 | SEPHS1, SPS1 | Selenophosphate synthetase 1 | 22929.0 | ENSG00000086475 | nan | nan
chr10	PRPF18	604993.0 | PRPF18, PRP18 | Pre-mRNA processing factor 18 | 8559.0 | ENSG00000165630 | nan | nan
chr10	FRMD4A	616305.0 | FRMD4A, KIAA1294, CCAFCA | FERM domain-containing protein 4A | 55691.0 | ENSG00000151474 | mutation identified in 1 CCAFCA family | ?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3), Autosomal recessive
chr10	CDNF	611233.0 | ARMETL1, CDNF | Arginine-rich protein mutated in early stage tumors-like 1 | 441549.0 | ENSG00000185267 | nan | nan
chr10	HSPA14	610369.0 | HSPA14, HSP70L1 | Heat-shock 70kD protein 14 | 51182.0 | ENSG00000187522 | nan | nan
chr10	SUV39H2	606503.0 | SUV39H2, FLJ23414 | Suppressor of variegation 3-9, Drosophila, homolog of, 2 | 79723.0 | ENSG00000152455 | nan | nan
chr10	DCLRE1C	605988.0 | DCLRE1C, ARTEMIS, SCIDA | DNA cross-link repair protein 1C | 64421.0 | ENSG00000152457 | nan | Severe combined immunodeficiency, Athabascan type, 602450 (3), Autosomal recessive; Omenn syndrome, 603554 (3), Autosomal recessive
chr10	MEIG1	614174.0 | MEIG1 | Meiosis-expressed gene 1, mouse, homolog of | 644890.0 | ENSG00000197889 | nan | nan
chr10	RPP38	606116.0 | RPP38 | Ribonuclease P/MRP subunit p38 | 10557.0 | ENSG00000152464 | nan | nan
chr10	NMT2	603801.0 | NMT2 | N-myristoyltransferase 2 | 9397.0 | ENSG00000152465 | nan | nan
chr10	ITGA8	604063.0 | ITGA8, RHDA1 | Integrin, alpha-8 | 8516.0 | ENSG00000077943 | nan | Renal hypodysplasia/aplasia 1, 191830 (3), Autosomal recessive
chr10	MINDY3	611649.0 | MINDY3, C10orf97, CARP | MINDY lysine-48 deubiquitinase 3 | 80013.0 | ENSG00000148481 | nan | nan
chr10	PTER	604446.0 | PTER | Phosphotriesterase-related protein | 9317.0 | ENSG00000165983 | nan | nan
chr10	C1QL3	615227.0 | C1QL3, CTRP13, K100 | Complement component 1, q subcomponent-like 3 | 389941.0 | ENSG00000165985 | nan | nan
chr10	RSU1	179555.0 | RSU1 | Ras suppressor protein 1 | 6251.0 | ENSG00000148484 | nan | nan
chr10	CUBN	602997.0 | CUBN, IFCR, IGS1 | Cubilin (intrinsic factor-cobalamin receptor) | 8029.0 | ENSG00000107611 | nan | [Proteinuria, chronic benign], 618884 (3), Autosomal recessive; Imerslund-Grasbeck syndrome 1, 261100 (3), Autosomal recessive
chr10	TRDMT1	602478.0 | TRDMT1, DMNT2 | tRNA aspartic acid methyltransferase 1 (DNA methyltransferase 2) | 1787.0 | ENSG00000107614 | nan | nan
chr10	VIM-AS1	619982.0 | VIMAS1 | Vimentin antisense RNA 1 | 100507347.0 | ENSG00000229124 | nan | nan
chr10	VIM	193060.0 | VIM, CTRCT30 | Vimentin | 7431.0 | ENSG00000026025 | nan | Cataract 30, pulverulent, 116300 (3), Autosomal dominant
chr10	ST8SIA6	610139.0 | ST8SIA6, SIAT8F | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 | 338596.0 | ENSG00000148488 | nan | nan
chr10	HACD1	610467.0 | HACD1, PTPLA, CMYO11 | 3-hydroxyacyl-CoA dehydratase 1 | 9200.0 | ENSG00000165996 | nan | Congenital myopathy 11, 619967 (3), Autosomal recessive
chr10	STAM	601899.0 | STAM | Signal transducing adaptor molecule | 8027.0 | ENSG00000136738 | nan | nan
chr10	MRC1	153618.0 | MRC1, MMR | Mannose receptor, C type 1 | 4360.0 | ENSG00000260314 | nan | nan
chr10	SLC39A12	608734.0 | SLC39A12, ZIP12 | Solute carrier family 39 (zinc transporter), member 12 | 221074.0 | ENSG00000148482 | nan | nan
chr10	CACNB2	600003.0 | CACNB2 | Calcium channel, voltage-dependent, beta 2 subunit | 783.0 | ENSG00000165995 | nan | Brugada syndrome 4, 611876 (3), Autosomal dominant
chr10	NSUN6	617199.0 | NSUN6, MRT82 | NOP2/SUN RNA methyltransferase family, member 6 | 221078.0 | ENSG00000241058 | nan | Intellectual developmental disorder, autosomal recessive 82, 620779 (3), Autosomal recessive
chr10	ARL5B	608909.0 | ARL5B, ARL8 | ADP ribosylation factor-like GTPase 5B | 221079.0 | ENSG00000165997 | nan | nan
chr10	MALRD1	617715.0 | MALRD1, C10orf112, DIET1 | MAM and LDL receptor class A domain-containing protein 1 | 340895.0 | ENSG00000204740 | nan | nan
chr10	PLXDC2	606827.0 | PLXDC2, TEM7R | Plexin domain containing 2 | 84898.0 | ENSG00000120594 | nan | nan
chr10	NEBL	605491.0 | NEBL | Nebulette | 10529.0 | ENSG00000078114 | nan | nan
chr10	MIR1915	615202.0 | MIR1915 | Micro RNA 1915 | 100302129.0 | ENSG00000222071 | nan | nan
chr10	MLLT10	602409.0 | AF10 | ALL1 fused gene from chromosome 10 | 8028.0 | ENSG00000078403 | fuses with MLL and HEAB | Leukemia, acute myeloid, 601626 (3), Somatic mutation, Autosomal dominant
chr10	DNAJC1	611207.0 | DNAJC1, HTJ1 | DNAJ/HSP40 homolog, subfamily C, member 1 | 64215.0 | ENSG00000136770 | nan | nan
chr10	EBLN1	613249.0 | EBLN1 | Endogenous Borna-like N element-containing protein 1 | 340900.0 | ENSG00000223601 | nan | nan
chr10	COMMD3	616700.0 | COMMD3 | COMM domain-containing protein 3 | 23412.0 | ENSG00000148444 | nan | nan
chr10	BMI1	164831.0 | BMI1 | Oncogene BMI-1 | 648.0 | ENSG00000168283 | nan | nan
chr10	SPAG6	605730.0 | SPAG6 | Sperm-associated antigen 6 | 9576.0 | ENSG00000077327 | nan | nan
chr10	PIP4K2A	603140.0 | PIP4K2A, PI5P4KA, PIP5K2A | Phosphatidylinositol 5-phosphate 4-kinase, type II, alpha | 5305.0 | ENSG00000150867 | nan | nan
chr10	ARMC3	611226.0 | ARMC3 | Armadillo repeat-containing protein 3 | 219681.0 | ENSG00000165309 | nan | nan
chr10	MSRB2	613782.0 | MSRB2, CBS1 | Methionine sulfoxide reductase B2 | 22921.0 | ENSG00000148450 | nan | nan
chr10	PTF1A	607194.0 | PTF1A, PACA, PAGEN2 | Pancreas transcription factor 1, alpha subunit | 256297.0 | ENSG00000168267 | nan | Pancreatic and cerebellar agenesis, 609069 (3), Autosomal recessive; Pancreatic agenesis 2, 615935 (3), Autosomal recessive
chr10	OTUD1	612022.0 | OTUD1, DUBA7 | OTU domain-containing protein 1 | 220213.0 | ENSG00000165312 | nan | nan
chr10	KIAA1217	617367.0 | KIAA1217, SKT | KIAA1217 gene | 56243.0 | ENSG00000120549 | nan | nan
chr10	ARHGAP21	609870.0 | ARHGAP21, KIAA1424 | GTPase-activating protein, Rho, 21 | 57584.0 | ENSG00000107863 | pseudogene on chr.6 | nan
chr10	PRTFDC1	610751.0 | PRTFDC1 | Phosphoribosyl transferase domain-containing protein 1 | 56952.0 | ENSG00000099256 | nan | nan
chr10	THNSL1	611260.0 | THNSL1, TSH1 | Threonine synthase-like 1 | 79896.0 | ENSG00000185875 | nan | nan
chr10	ENKUR	611025.0 | ENKUR, C10orf63 | Enkurin, TRPC channel-interacting protein | 219670.0 | ENSG00000151023 | nan | nan
chr10	GPR158	614573.0 | GPR158, KIAA1136 | G protein-coupled receptor 158 | 57512.0 | ENSG00000151025 | nan | nan
chr10	MYO3A	606808.0 | MYO3A, DFNB30, DFNA90 | Myosin IIIA | 53904.0 | ENSG00000095777 | nan | Deafness, autosomal recessive 30, 607101 (3), Autosomal recessive; Deafness, autosomal dominant 90, 620722 (3), Autosomal dominant
chr10	GAD2	138275.0 | GAD2 | Glutamate decarboxylase-2, pancreas | 2572.0 | ENSG00000136750 | nan | nan
chr10	APBB1IP	609036.0 | APBB1IP, RIAM, RARP1 | APBB1-interacting protein | 54518.0 | ENSG00000077420 | nan | nan
chr10	PDSS1	607429.0 | PDSS1, TPT, COQ1, COQ10D2 | Prenyl diphosphate synthase, subunit 1 | 23590.0 | ENSG00000148459 | nan | Coenzyme Q10 deficiency, primary, 2, 614651 (3), Autosomal recessive
chr10	ABI1	603050.0 | ABI1 | ABL-interactor 1 | 10006.0 | ENSG00000136754 | nan | nan
chr10	ANKRD26	610855.0 | ANKRD26, KIAA1074, THC2 | Ankyrin repeat domain-containing protein 26 | 22852.0 | ENSG00000107890 | nan | Thrombocytopenia 2, 188000 (3), Autosomal dominant
chr10	YME1L1	607472.0 | YME1L1, YME1L, PAMP, OPA11 | Mitochondrial escape 1-like 1 | 10730.0 | ENSG00000136758 | mutation identified in1 OPA11 family | ?Optic atrophy 11, 617302 (3), Autosomal recessive
chr10	MASTL	608221.0 | MASTL, FLJ14813, GWL | Microtubule-associated serine/threonine kinase-like | 84930.0 | ENSG00000120539 | nan | nan
chr10	ACBD5	616618.0 | ACBD5, KIAA1996, RDLKD | Acyl-CoA-binding domain-containing protein 5 | 91452.0 | ENSG00000107897 | nan | Retinal dystrophy with leukodystrophy, 618863 (3), Autosomal recessive
chr10	PTCHD3	611791.0 | PTCHD3 | Patched domain-containing protein 3 | 374308.0 | ENSG00000182077 | nan | nan
chr10	RAB18	602207.0 | RAB18, WARBM3 | Ras-associated protein RAB18 | 22931.0 | ENSG00000099246 | nan | Warburg micro syndrome 3, 614222 (3), Autosomal recessive
chr10	MKX	601332.0 | MKX, IFRX, IRXL1 | Mohawk homeobox | 283078.0 | ENSG00000150051 | nan | nan
chr10	ODAD2	615408.0 | ODAD2, ARMC4, CILD23 | Outer dynein arm docking complex subunit 2 | 55130.0 | ENSG00000169126 | nan | Ciliary dyskinesia, primary, 23, 615451 (3), Autosomal recessive
chr10	MPP7	610973.0 | MPP7 | Membrane protein, palmitoylated 7 | 143098.0 | ENSG00000150054 | nan | nan
chr10	WAC	615049.0 | WAC, KIAA1844, DESSH | WW domain-containing adaptor with coiled-coil region | 51322.0 | ENSG00000095787 | nan | Desanto-Shinawi syndrome, 616708 (3), Autosomal dominant
chr10	BAMBI	604444.0 | BAMBI, NMA | BMP and activin membrane-bound inhibitor, xenopus, homolog of | 25805.0 | ENSG00000095739 | nan | nan
chr10	DFNB33	607239.0 | DFNB33 | Deafness, autosomal recessive 33 | 170508.0 | nan | prev. assignment to chr. 9 an error | Deafness, autosomal recessive 33, 607239 (2), Autosomal recessive
chr10	SVIL	604126.0 | SVIL, MFM10 | Supervillin | 6840.0 | ENSG00000197321 | nan | Myofibrillar myopathy 10, 619040 (3), Autosomal recessive
chr10	JCAD	614398.0 | KIAA1462, JCAD | KIAA1462 gene | 57608.0 | ENSG00000165757 | nan | nan
chr10	MTPAP	613669.0 | MTPAP, PAPD1, SPAX4 | Mitochondrial poly(A) polymerase | 55149.0 | ENSG00000107951 | mutation identified in 1 SPAX4 family | ?Spastic ataxia 4, autosomal recessive, 613672 (3), Autosomal recessive
chr10	MAP3K8	191195.0 | MAP3K8, COT, EST, TPL2 | Mitogen-activated protein kinase kinase kinase 8 (cancer Osaka thyroid oncogene) | 1326.0 | ENSG00000107968 | nan | Lung cancer, somatic, 211980 (3)
chr10	LYZL2	612748.0 | LYZL2 | Lysozyme-like 2 | 119180.0 | ENSG00000151033 | nan | nan
chr10	ZNF438	620749.0 | ZNF438 | Zinc finger protein 438 | 220929.0 | ENSG00000183621 | nan | nan
chr10	EIG5	611934.0 | EIG5 | Epilepsy, idiopathic generalized, susceptibility to, 5 | 100188861.0 | nan | max lod at D10S1426 | {Epilepsy, idiopathic generalized, susceptibility to, 5}, 611934 (2)
chr10	ZEB1	189909.0 | ZEB1, TCF8, NIL2A, PPCD3, FECD6 | Zinc finger E box-binding homeobox 1 | 6935.0 | ENSG00000148516 | nan | Corneal dystrophy, posterior polymorphous, 3, 609141 (3), Autosomal dominant; Corneal dystrophy, Fuchs endothelial, 6, 613270 (3), Autosomal dominant
chr10	ARHGAP12	610577.0 | ARHGAP12 | Rho GTPase-activating protein 12 | 94134.0 | ENSG00000165322 | nan | nan
chr10	KIF5B	602809.0 | KIF5B, KNS1, UKHC | Kinesin 1 | 3799.0 | ENSG00000170759 | nan | nan
chr10	EPC1	610999.0 | EPC1 | Enhancer of polycomb, Drosophila, homolog of, 1 | 80314.0 | ENSG00000120616 | nan | nan
chr10	CCDC7	619444.0 | CCDC7 | Coiled-coil domain-containing protein 7 | 79741.0 | ENSG00000216937 | nan | nan
chr10	ITGB1	135630.0 | ITGB1, FNRB | Integrin, beta-1 (fibronectin receptor, beta polypeptide; antigen CD29 includes MDF2, MSK12) | 3688.0 | ENSG00000150093 | pseudogene FNRBL on 19p | nan
chr10	NRP1	602069.0 | NRP1, NRP, VEGF165R | Neuropilin 1 | 8829.0 | ENSG00000099250 | nan | nan
chr10	PARD3	606745.0 | PARD3, PAR3 | PAR3 family cell polarity regulator | 56288.0 | ENSG00000148498 | nan | nan
chr10	USH1K	614990.0 | USH1K | Usher syndrome, type IK | 101180907.0 | nan | max lod at D10S539 | Usher syndrome, type IK, 614990 (2), Autosomal recessive
chr10	CUL2	603135.0 | CUL2 | Cullin 2 | 8453.0 | ENSG00000108094 | nan | nan
chr10	CREM	123812.0 | CREM | cAMP-responsive element modulator | 1390.0 | ENSG00000095794 | nan | nan
chr10	CCNY	612786.0 | CCNY, CFP1, CCNX, C10orf9 | Cyclin Y | 219771.0 | ENSG00000108100 | nan | nan
chr10	GJD4	611922.0 | GJD4, CX40.1 | Gap junction protein, delta-4 | 219770.0 | ENSG00000177291 | nan | nan
chr10	FZD8	606146.0 | FZD8 | Frizzled class receptor 8 | 8325.0 | ENSG00000177283 | nan | nan
chr10	ANKRD30A	610856.0 | ANKRD30A | Ankyrin repeat domain-containing protein 30A | 91074.0 | ENSG00000148513 | nan | nan
chr10	ZNF25	194528.0 | ZNF25, KOX19 | Zinc finger protein-25 (KOX 19) | 219749.0 | ENSG00000175395 | nan | nan
chr10	ZNF33A	194521.0 | ZNF33A, NF11A, KOX2 | Zinc finger protein-33a | 7581.0 | ENSG00000189180 | nan | nan
chr10	ZNF37A	616085.0 | ZNF37A, KOX21, ZNF37 | Zinc finger protein 37A | 7587.0 | ENSG00000075407 | nan | nan
chr10	AITD4	608176.0 | AITD4 | Autoimmune thyroid disease, susceptibility to, 4 | 387581.0 | nan | nan | {Autoimmune thyroid disease, susceptibility to, 4}, 608176 (2)
chr10	STHAG5	610926.0 | STHAG5 | Tooth agenesis, selective, 5 | 100188748.0 | nan | D10S604 and D10S568 | Tooth agenesis, selective, 5, 610926 (2)
chr10	ZNF33B	194522.0 | ZNF33B, ZNF11B, KOX2 | Zinc finger protein-33b | 7582.0 | ENSG00000196693 | nan | nan
chr10	BMS1	611448.0 | BMS1, BMS1L, KIAA0187, ACC | BMS1 ribosome biogenesis factor | 9790.0 | ENSG00000165733 | mutation identified in one ACC family | ?Aplasia cutis congenita, nonsyndromic, 107600 (3), Autosomal dominant
chr10	RET	164761.0 | RET, MEN2A, HSCR1 | RET transforming sequence; oncogene RET | 5979.0 | ENSG00000165731 | nan | {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant
chr10	CSGALNACT2	616616.0 | CSGALNACT2 | Chondroitin sulfate N-acetylgalactosaminyltransferase 2 | 55454.0 | ENSG00000169826 | nan | nan
chr10	RASGEF1A	614531.0 | RASFEF1A | RASGEF domain family, member 1A | 221002.0 | ENSG00000198915 | nan | nan
chr10	FXYD4	616926.0 | FXYD4, CHIF | FXYD domain-containing ion transport regulator 4 | 53828.0 | ENSG00000150201 | nan | nan
chr10	HNRNPF	601037.0 | HNRPF | Heterogeneous nuclear ribonucleoprotein F | 3185.0 | ENSG00000169813 | nan | nan
chr10	ZNF239	601069.0 | ZNF239, MOK2 | Zinc finger protein-239 | 8187.0 | ENSG00000196793 | previously 19q13.2-q13.3 | nan
chr10	ZNF32	194539.0 | ZNF32, KOX30 | Zinc finger protein-32 (KOX30) | 7580.0 | ENSG00000169740 | nan | nan
chr10	CXCL12	600835.0 | CXCL12, SDF1 | Chemokine, C-X-C motif, ligand 12 (stromal cell-derived factor 1) | 6387.0 | ENSG00000107562 | nan | {AIDS, resistance to}, 609423 (3)
chr10	RASSF4	610559.0 | RASSF4, AD037 | Ras association domain family, member 4 | 83937.0 | ENSG00000107551 | nan | nan
chr10	DEPP1	611309.0 | DEPP1, C10orf10, DEPP, FIG | DEPP1 autophagy regulator | 11067.0 | ENSG00000165507 | nan | nan
chr10	ZNF22	194529.0 | ZNF22, KOX15 | Zinc finger protein-22 (KOX15) | 7570.0 | ENSG00000165512 | nan | nan
chr10	ALOX5	152390.0 | ALOX5 | Arachidonate 5-lipoxygenase | 240.0 | ENSG00000012779 | nan | {Atherosclerosis, susceptibility to} (3); {Asthma, diminished response to antileukotriene treatment in}, 600807 (3), Autosomal dominant
chr10	MARCHF8	613335.0 | MARCH8 | Membrane-associated RING-CH finger protein 8 | 220972.0 | ENSG00000165406 | nan | nan
chr10	WASHC2C	613631.0 | WASHC2C, FAM21C, VPEF, KIAA0592 | WASH complex, subunit 2C | 253725.0 | ENSG00000172661 | nan | nan
chr10	TIMM23	605034.0 | TIMM23 | Translocase of inner mitochondrial membrane 23 | 100287932.0 | ENSG00000265354 | nan | nan
chr10	NCOA4	601984.0 | NCOA4, ELE1, PTC3 | Nuclear receptor coactivator 4 | 8031.0 | ENSG00000266412 | fused with RET to form PTC3 | nan
chr10	MSMB	157145.0 | MSMB, HPC13 | Microseminoprotein, beta | 4477.0 | ENSG00000263639 | nan | {Prostate cancer, hereditary, 13}, 611928 (3)
chr10	NPY4R	601790.0 | PPYR1, NPY4R, PP1 | Pancreatic polypeptide receptor-1 | 5540.0 | ENSG00000204174 | nan | nan
chr10	GPRIN2	611240.0 | GPRIN2, GRIN2 | GPRIN family, member 2 | 9721.0 | ENSG00000204175 | nan | nan
chr10	SYT15	608081.0 | SYT15 | Synaptotagmin 15 | 83849.0 | ENSG00000204176 | nan | nan
chr10	PTPN20	610630.0 | PTPN20 | Protein tyrosine phosphatase, nonreceptor-type, 20 | 26095.0 | ENSG00000204179 | nan | nan
chr10	GDF10	601361.0 | GDF10, BMP3B | Growth/differentiation factor 10 | 2662.0 | ENSG00000266524 | nan | nan
chr10	GDF2	605120.0 | GDF2, BMP9, HHT5 | Growth differentiation factor 2 (bone morphogenetic protein 9) | 2658.0 | ENSG00000263761 | nan | Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3), Autosomal dominant
chr10	RBP3	180290.0 | RBP3, RP66 | Retinol-binding protein-3, interstitial | 5949.0 | ENSG00000265203 | 1 family identified with mutation | ?Retinitis pigmentosa 66, 615233 (3), Autosomal recessive
chr10	ANXA8	602396.0 | ANXA8 | Annexin A8 | 653145.0 | ENSG00000265190 | nan | nan
chr10	FRMPD2	613323.0 | FRMPD2 | FERM and PDZ domains-containing protein 2 | 143162.0 | ENSG00000170324 | nan | nan
chr10	MAPK8	601158.0 | MAPK8, PRKM8, JNK1, SAPK1 | Mitogen-activated protein kinase 8 | 5599.0 | ENSG00000107643 | nan | nan
chr10	ARHGAP22	610585.0 | ARHGAP22 | Rho GTPase-activating protein 22 | 58504.0 | ENSG00000128805 | nan | nan
chr10	HYPT9	614237.0 | HYPT9 | Hypotrichosis 9 | 100736250.0 | nan | between D10S538 and D10S2327 | Hypotrichosis 9, 614237 (2), Autosomal recessive
chr10	WDFY4	613316.0 | WDFY4, KIAA1607 | WD repeat- and FYVE domain-containing protein 4 | 57705.0 | ENSG00000128815 | nan | nan
chr10	LRRC18	619002.0 | LRRC18 | Leucine-rich repeat-containing protein 18 | 474354.0 | ENSG00000165383 | nan | nan
chr10	DRGX	606701.0 | DRGX, DRG11 | Dorsal root ganglia homeobox | 644168.0 | ENSG00000165606 | nan | nan
chr10	ERCC6	609413.0 | ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11 | ERCC excision repair 6, chromatin remodeling factor | 2074.0 | ENSG00000225830 | mutation identified in 1 DSCS family | UV-sensitive syndrome 1, 600630 (3), Autosomal recessive; Cerebrooculofacioskeletal syndrome 1, 214150 (3), Autosomal recessive; ?De Sanctis-Cacchione syndrome, 278800 (3), Autosomal recessive; Cockayne syndrome, type B, 133540 (3), Autosomal recessive; {Macular degeneration, age-related, susceptibility to, 5}, 613761 (3); Premature ovarian failure 11, 616946 (3), Autosomal dominant; {Lung cancer, susceptibility to}, 211980 (3), Somatic mutation, Autosomal dominant
chr10	CHAT	118490.0 | CHAT, CMS6 | Choline acetyltransferase | 1103.0 | ENSG00000070748 | nan | Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3), Autosomal recessive
chr10	SLC18A3	600336.0 | SLC18A3, VACHT, CMS21 | Solute carrier family 18 (vesicular acetylcholine), member 3 | 6572.0 | ENSG00000187714 | nan | Myasthenic syndrome, congenital, 21, presynaptic, 617239 (3), Autosomal recessive
chr10	OGDHL	617513.0 | OGDHL, KIAA1290, YOBELN | Oxoglutarate dehydrogenase-like protein | 55753.0 | ENSG00000197444 | nan | Yoon-Bellen neurodevelopmental syndrome, 619701 (3), Autosomal recessive
chr10	PARG	603501.0 | PARG | Poly(ADP-ribose) glycohydrolase | 8505.0 | ENSG00000227345 | nan | nan
chr10	TIMM23B	620758.0 | TIMM23B | Translocase of inner mitochondrial membrane 23B | 100652748.0 | ENSG00000204152 | nan | nan
chr10	ASAH2	611202.0 | ASAH2 | N-acylsphingosine amidohydrolase 2 | 56624.0 | ENSG00000188611 | nan | nan
chr10	SGMS1	611573.0 | SGMS1, SMS1, TMEM23, MOB | Sphingomyelin synthase 1 | 259230.0 | ENSG00000198964 | nan | nan
chr10	ASAH2B	610987.0 | ASAH2B, ASAH2C, ASAH2L | N-acylsphingosine amidohydrolase 2B | 653308.0 | ENSG00000204147 | nan | nan
chr10	A1CF	618199.0 | A1CF, ASP | APOBEC1 complementation factor | 29974.0 | ENSG00000148584 | nan | nan
chr10	PRKG1	176894.0 | PRKG1, PRKG1B, PRKGR1B, AAT8 | Protein kinase, cGMP-dependent, regulatory, type I | 5592.0 | ENSG00000185532 | nan | Aortic aneurysm, familial thoracic 8, 615436 (3), Autosomal dominant
chr10	ALL1	613065.0 | ALL1 | Leukemia, acute lymphocytic, susceptibility to, 1 | 100310785.0 | nan | associated with rs10821936 | {Leukemia, acute lymphocytic, susceptibility to, 1}, 613065 (2)
chr10	ALPQTL4	612369.0 | ALPQTL4 | Alkaline phosphatase, plasma level of, QTL 4 | 100196916.0 | nan | linkage with rs12355784 | {Alkaline phosphatase, plasma level of, QTL4}, 612369 (2)
chr10	IBD15	612255.0 | IBD15 | Inflammatory bowel disease 15 | 100190929.0 | nan | association with rs10761659 | {Inflammatory bowel disease 15}, 612255 (2)
chr10	MAFD8	612357.0 | MAFD8 | Major affective disorder 8 | 100196912.0 | nan | associated with rs20994336 | {Major affective disorder-8, susceptibility to}, 612357 (2)
chr10	MYP15	612717.0 | MYP15 | Myopia 15 | 100294716.0 | nan | max lod at D10S1643 | Myopia 15, 612717 (2), Autosomal dominant
chr10	CSTF2T	611968.0 | CSTF2T, KIAA0689 | Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD, tau variant | 23283.0 | ENSG00000177613 | nan | nan
chr10	DKK1	605189.0 | DKK1 | Dickkopf WNT signaling pathway inhibitor 1 | 22943.0 | ENSG00000107984 | nan | nan
chr10	MBL2	154545.0 | MBL2, MBL, MBP1, MBL2D, MBPD | Mannose-binding lectin 2, soluble (opsonic defect) | 4153.0 | ENSG00000165471 | near MEN2A | {Chronic infections, due to MBL deficiency}, 614372 (3), Autosomal dominant
chr10	PCDH15	605514.0 | PCDH15, DFNB23, USH1F | Protocadherin 15 | 65217.0 | ENSG00000150275 | nan | Usher syndrome, type 1D/F digenic, 601067 (3), Autosomal recessive, Digenic recessive; Deafness, autosomal recessive 23, 609533 (3), Autosomal recessive; Usher syndrome, type 1F, 602083 (3), Autosomal recessive
chr10	ZWINT	609177.0 | ZWINT, SIP30 | ZW10 interacting kinetochore protein | 11130.0 | ENSG00000122952 | nan | nan
chr10	IPMK	609851.0 | IPMK | Inositol polyphosphate multikinase | 253430.0 | ENSG00000151151 | nan | nan
chr10	CISD1	611932.0 | CISD1, MITONEET | CDGSH iron sulfur domain protein 1 | 55847.0 | ENSG00000122873 | nan | nan
chr10	UBE2D1	602961.0 | UBE2D1, UBCH5A, UBCH5 | Ubiquitin-conjugating enzyme E2 D1 | 7321.0 | ENSG00000072401 | nan | nan
chr10	TFAM	600438.0 | TFAM, TCF6L2, TCF6L1, TCF6L3, MTTF1, TCF6, MTDPS15 | Transcription factor A, mitochondrial | 7019.0 | ENSG00000108064 | mutation identified in 1 MTDPS15 family | ?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type), 617156 (3), Autosomal recessive
chr10	BICC1	614295.0 | BICC1, BICC, CYSRD | Bicaudal C, Drosophila, homolog of, 1 | 80114.0 | ENSG00000122870 | nan | {Renal dysplasia, cystic, susceptibility to}, 601331 (3), Autosomal dominant
chr10	SLC16A9	614242.0 | SLC16A9, MCT9 | Solute carrier family 16 (monocarboxylic acid transporter), member 9 | 220963.0 | ENSG00000165449 | nan | nan
chr10	MRLN	616246.0 | MRLN, LINC00948 | Myoregulin | 100507027.0 | ENSG00000227877 | nan | nan
chr10	CCDC6	601985.0 | CCDC6, D10S170, H4, TST1 | Coiled-coil domain-containing 6 | 8030.0 | ENSG00000108091 | fused with RET to form PTC1 | nan
chr10	ANK3	600465.0 | ANK3, MRT37 | Ankyrin-3, node of Ranvier | 288.0 | ENSG00000151150 | nan | Intellectual developmental disorder, autosomal recessive 37, 615493 (3), Autosomal recessive
chr10	CDK1	116940.0 | CDK1, CDC2 | Cyclin-dependent kinase 1 | 983.0 | ENSG00000170312 | nan | nan
chr10	RHOBTB1	607351.0 | RHOBTB1, KIAA0740 | Rho-related BTB domain-containing protein 1 | 9886.0 | ENSG00000072422 | nan | nan
chr10	TMEM26	617803.0 | TMEM26 | Transmembrane protein 26 | 219623.0 | ENSG00000196932 | nan | nan
chr10	ARID5B	608538.0 | ARID5B, MRF2, DESRT | AT-rich interaction domain-containing protein 5B | 84159.0 | ENSG00000150347 | nan | nan
chr10	RTKN2	618450.0 | RTKN2 | Rhotekin 2 | 219790.0 | ENSG00000182010 | nan | nan
chr10	ZNF365	607818.0 | ZNF365, UAN | Zinc finger protein 365 | 22891.0 | ENSG00000138311 | nan | {Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)
chr10	MBS3	604185.0 | HCFP2 | Facial paresis, hereditary congenital, 2 | 22811.0 | nan | nan | Facial paresis, hereditary congenital, 2, 604185 (2), Autosomal dominant
chr10	HWE1	613339.0 | HWE1 | Epilepsy, hot water, 1 | 100415903.0 | nan | max lod at D10S412 | Epilepsy, hot water, 1, 613339 (2), Autosomal dominant
chr10		614996.0 | MSE | Myelinating Schwann cell element | 101180900.0 | nan | nan | nan
chr10	ADO	611392.0 | ADO, C10orf22 | 2-aminoethanethiol dioxygenase | 84890.0 | ENSG00000181915 | nan | nan
chr10	EGR2	129010.0 | EGR2, KROX20, CHN1 | KROX-20, Drosophila, homolog of (early growth response-2) | 1959.0 | ENSG00000122877 | nan | Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 1D, 607678 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 1, 605253 (3), Autosomal recessive, Autosomal dominant
chr10	NRBF2	616477.0 | NRBF2, COPR | Nuclear receptor-binding factor 2 | 29982.0 | ENSG00000148572 | nan | nan
chr10	JMJD1C	604503.0 | JMJD1C, TRIP8, KIAA1380 | Jumonji domain-containing protein 1C | 221037.0 | ENSG00000171988 | nan | nan
chr10	REEP3	609348.0 | REEP3, C10orf74 | Receptor expression-enhancing protein 3 | 221035.0 | ENSG00000165476 | nan | nan
chr10	CTNNA3	607667.0 | CTNNA3, ARVD13 | Catenin, alpha-3 | 29119.0 | ENSG00000183230 | nan | Arrhythmogenic right ventricular dysplasia 13, 615616 (3), Autosomal dominant
chr10	LRRTM3	610869.0 | LRRTM3 | Leucine-rich repeat transmembrane protein 3 | 347731.0 | ENSG00000198739 | nan | nan
chr10	DNAJC12	606060.0 | DNAJC12, JDP1, HPANBH4 | DNAJ/HSP40 homolog, subfamily C, member 12 | 56521.0 | ENSG00000108176 | nan | Hyperphenylalaninemia, mild, non-BH4-deficient, 617384 (3), Autosomal recessive
chr10	SIRT1	604479.0 | SIRT1, SIR2L1 | Sirtuin 1 | 23411.0 | ENSG00000096717 | nan | nan
chr10	HERC4	609248.0 | HERC4 | HECT domain and RCC1-like domain 4 | 26091.0 | ENSG00000148634 | nan | nan
chr10	MYPN	608517.0 | MYPN, CMD1DD, CMH22, RCM4, CMYO24 | Myopalladin | 84665.0 | ENSG00000138347 | nan | Cardiomyopathy, hypertrophic, 22, 615248 (3), Autosomal dominant; Congenital myopathy 24, 617336 (3), Autosomal recessive; Cardiomyopathy, familial restrictive, 4, 615248 (3), Autosomal dominant; Cardiomyopathy, dilated, 1KK, 615248 (3), Autosomal dominant
chr10	ATOH7	609875.0 | ATOH7, PHPVAR, NCRNA | Atonal, Drosophila, homolog of, 7 | 220202.0 | ENSG00000179774 | nan | Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3), Autosomal recessive
chr10	PBLD	612189.0 | PBLD, MAWBP, MAWDBP | Phenazine biosynthesis-like protein domain-containing protein | 64081.0 | ENSG00000108187 | nan | nan
chr10	HNRNPH3	602324.0 | HNRPH3, 2H9 | Heterogeneous nuclear ribonucleoprotein H3 | 3189.0 | ENSG00000096746 | nan | nan
chr10	RUFY2	610328.0 | RUFY2, KIAA1537 | RUN and FYVE domains-containing protein 2 | 55680.0 | ENSG00000204130 | nan | nan
chr10	DNA2	601810.0 | DNA2, DNA2L, KIAA0083, PEOA6, SCKL8, RTS4 | DNA replication helicase/nuclease 2 | 1763.0 | ENSG00000138346 | nan | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3), Autosomal dominant; Rothmund-Thomson syndrome, type 4, 620819 (3), Autosomal recessive; Seckel syndrome 8, 615807 (3), Autosomal recessive
chr10	SLC25A16	139080.0 | SLC25A16, D10S105E, GDA | Solute carrier family 25 (mitochondrial carrier), member 16 (Graves disease autoantigen) | 8034.0 | ENSG00000122912 | nan | nan
chr10	TET1	607790.0 | TET1, CXXC6, LCX, KIAA1676 | tet methylcytosine dioxygenase 1 | 80312.0 | ENSG00000138336 | nan | nan
chr10	CCAR1	612569.0 | CCAR1, CARP1 | Cell division cycle and apoptosis regulator 1 | 55749.0 | ENSG00000060339 | nan | nan
chr10	ATFB1	608583.0 | ATFB1 | Atrial fibrillation, familial, 1 | 406216.0 | nan | nan | Atrial fibrillation, familial, 1, 608583 (2), Autosomal dominant
chr10	MGR12	611706.0 | MGR12 | Migraine, with or without aura, susceptibility to, 12 | 100188851.0 | nan | max lod at 100cM | {Migraine, with or without aura, susceptibility to, 12}, 611706 (2), Autosomal dominant
chr10	SPG27	609041.0 | SPG27 | Spastic paraplegia-27, autosomal recessive | 414886.0 | nan | between  D10S606 and D10S1758 | Spastic paraplegia 27, autosomal recessive, 609041 (2), Autosomal recessive
chr10	SQTL1	611003.0 | SQTL1 | Smoking as a quantitative trait locus 1 | 100188827.0 | nan | near D10S1432 | {Smoking as a quantitative trait locus 1}, 611003 (2)
chr10	STOX1	609397.0 | STOX1, PEE4 | Storkhead box 1 | 219736.0 | ENSG00000165730 | nan | Preeclampsia/eclampsia 4, 609404 (3), Autosomal dominant
chr10	DDX50	610373.0 | DDX50, GUB | DExD-box helicase 50 | 79009.0 | ENSG00000107625 | nan | nan
chr10	DDX21	606357.0 | DDX21 | DExD-box helicase 21 | 9188.0 | ENSG00000165732 | nan | nan
chr10	KIFBP	609367.0 | KIFBP, KIAA1279 | Kinesin family binding protein | 26128.0 | ENSG00000198954 | nan | Goldberg-Shprintzen megacolon syndrome, 609460 (3), Autosomal recessive
chr10	SRGN	177040.0 | SRGN, PRG1, PRG | Serglycin | 5552.0 | ENSG00000122862 | nan | nan
chr10	VPS26A	605506.0 | VPS26A, VPS26, HB58 | VPS26 retromer complex component A | 9559.0 | ENSG00000122958 | nan | nan
chr10	SUPV3L1	605122.0 | SUPV3L1 | Suv3-like 1 | 6832.0 | ENSG00000156502 | nan | nan
chr10	HKDC1	617221.0 | HKDC1, RP92 | Hexokinase domain-containing protein 1 | 80201.0 | ENSG00000156510 | nan | Retinitis pigmentosa 92, 619614 (3), Autosomal recessive
chr10	HK1	142600.0 | HK1, HKD, HMSNR, RP79, NEDVIBA, CNSHA5 | Hexokinase-1 | 3098.0 | ENSG00000156515 | nan | Anemia, congenital, nonspherocytic hemolytic, 5, hexokinase deficient, 235700 (3), Autosomal recessive; Retinitis pigmentosa 79, 617460 (3), Autosomal dominant; Neuropathy, hereditary motor and sensory, Russe type, 605285 (3), Autosomal recessive; Neurodevelopmental disorder with visual defects and brain anomalies, 618547 (3), Autosomal dominant
chr10	TACR2	162321.0 | TACR2, TAC2R, NKNAR | Tachykinin receptor 2 (substance K receptor; neurokinin 2 receptor) | 6865.0 | ENSG00000075073 | nan | nan
chr10	TSPAN15	613140.0 | TSPAN15, NET7 | Tetraspanin 15 | 23555.0 | ENSG00000099282 | nan | nan
chr10	NEUROG3	604882.0 | NEUROG3, NGN3, ATOH5 | Neurogenin 3 | 50674.0 | ENSG00000122859 | nan | Diarrhea 4, malabsorptive, congenital, 610370 (3), Autosomal recessive
chr10	COL13A1	120350.0 | COL13A1, CMS19 | Collagen XIII, alpha-1 polypeptide | 1305.0 | ENSG00000197467 | ~550kb proximal to P4HA | Myasthenic syndrome, congenital, 19, 616720 (3), Autosomal recessive
chr10	MACROH2A2	616141.0 | MACROH2A2, H2AFY2 | MacroH2A.2 histone | 55506.0 | ENSG00000099284 | nan | nan
chr10	AIFM2	605159.0 | AIFM2, FSP1, PRG3 | Apoptosis-inducing factor, mitochondria-associated, 2 | 84883.0 | ENSG00000042286 | nan | nan
chr10	TYSND1	611017.0 | TYSND1 | Trypsin domain-containing protein 1 | 219743.0 | ENSG00000156521 | nan | nan
chr10	SAR1A	607691.0 | SARA1, SAR1A | Secretion-associated RAS-related GTPase 1A | 56681.0 | ENSG00000079332 | nan | nan
chr10	PPA1	179030.0 | PP | Inorganic pyrophosphatase | 5464.0 | ENSG00000180817 | nan | nan
chr10	NPFFR1	607448.0 | NPFFR1, NPFF1, GPR147 | Neuropeptide FF receptor 1 | 64106.0 | ENSG00000148734 | nan | nan
chr10	EIF4EBP2	602224.0 | EIF4EBP2, 4EBP2 | Eukaryotic translation initiation factor-4E binding protein-1 | 1979.0 | ENSG00000148730 | nan | nan
chr10	NODAL	601265.0 | NODAL, HTX5 | Nodal, mouse, homolog of | 4838.0 | ENSG00000156574 | nan | Heterotaxy, visceral, 5, 270100 (3), Autosomal dominant
chr10	PALD1	614656.0 | KIAA1274, PALD | Paladin, mouse, homolog of | 27143.0 | ENSG00000107719 | nan | nan
chr10	PRF1	170280.0 | PRF1, HPLH2, FLH2 | Perforin | 5551.0 | ENSG00000180644 | mistakenly assigned to chr.17 | Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3), Autosomal recessive; Aplastic anemia, 609135 (3); Lymphoma, non-Hodgkin, 605027 (3)
chr10	ADAMTS14	607506.0 | ADAMTS14 | ADAM metallopeptidase domain with thrombospondin type 1 motif, 14 | 140766.0 | ENSG00000138316 | nan | nan
chr10	TBATA	612640.0 | C10orf27 | chromosome 10 open reading frame 27 | 219793.0 | ENSG00000166220 | nan | nan
chr10	SGPL1	603729.0 | SGPL1, SPL, RENI, NPHS14 | Sphingosine-1-phosphate lyase 1 | 8879.0 | ENSG00000166224 | nan | RENI syndrome, 617575 (3), Autosomal recessive
chr10	PCBD1	126090.0 | PCBD1, DCOH | Pterin-4a-carbinolamine dehydratase 1 | 5092.0 | ENSG00000166228 | nan | Hyperphenylalaninemia, BH4-deficient, D, 264070 (3), Autosomal recessive
chr10	UNC5B	607870.0 | UNC5B, UNC5H2 | unc-5 netrin receptor B | 219699.0 | ENSG00000107731 | nan | nan
chr10	SLC29A3	612373.0 | SLC29A3, ENT3, PHID, HCLAP | Solute carrier family 29 (nucleoside transporter), member 3 | 55315.0 | ENSG00000198246 | nan | Histiocytosis-lymphadenopathy plus syndrome, 602782 (3), Autosomal recessive
chr10	CDH23	605516.0 | CDH23, USH1D, DFNB12, PITA5 | Cadherin-23 (otocadherin) | 64072.0 | ENSG00000107736 | between D10S529 and D10S573 | Usher syndrome, type 1D, 601067 (3), Autosomal recessive, Digenic recessive; {Pituitary adenoma 5, multiple types}, 617540 (3), Autosomal dominant; Usher syndrome, type 1D/F digenic, 601067 (3), Autosomal recessive, Digenic recessive; Deafness, autosomal recessive 12, 601386 (3), Autosomal recessive
chr10	VSIR	615608.0 | VSIR, C10orf54, B7H5 | V-set immunoregulatory receptor | 64115.0 | ENSG00000107738 | nan | nan
chr10	PSAP	176801.0 | PSAP, SAP1, PSAPD, PARK24 | Prosaposin (sphingolipid activator protein-1) | 5660.0 | ENSG00000197746 | nan | Combined SAP deficiency, 611721 (3), Autosomal recessive; Krabbe disease, atypical, 611722 (3), Autosomal recessive; Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3), Autosomal recessive; Gaucher disease, atypical, 610539 (3); {Parkinson disease 24, autosomal dominant, susceptibility to}, 619491 (3), Autosomal dominant
chr10	CHST3	603799.0 | CHST3, C6ST, C6ST1, HSD | Carbohydrate sulfotransferase 3 | 9469.0 | ENSG00000122863 | nan | Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3), Autosomal recessive
chr10	SPOCK2	607988.0 | SPOCK2, KIAA0275 | SPARC/osteonectin, CWCV, and KAZAL-like domains proteoglycan 2 | 9806.0 | ENSG00000107742 | nan | nan
chr10	ASCC1	614215.0 | ASCC1, p50, SMABF2 | Activating signal cointegrator 1 complex, subunit 1 | 51008.0 | ENSG00000138303 | nan | Spinal muscular atrophy with congenital bone fractures 2, 616867 (3), Autosomal recessive; Barrett esophagus/esophageal adenocarcinoma, 614266 (3)
chr10	ANAPC16	613427.0 | ANAPC16, MSAG, C10orf104 | Anaphase-promoting complex, subunit 16 | 119504.0 | ENSG00000166295 | nan | nan
chr10	DDIT4	607729.0 | DDIT4, REDD1, RTP801 | DNA damage-inducible transcript 4 | 54541.0 | ENSG00000168209 | nan | nan
chr10	DNAJB12	608376.0 | DNAJB12, DJ10, FLJ0027 | DNAJ, E. coli, homolog of, subfamily B, member 12 | 54788.0 | ENSG00000148719 | nan | nan
chr10	MICU1	605084.0 | MICU1, CBARA1, MPXPS | Mitochondrial calcium uptake protein 1 | 10367.0 | ENSG00000107745 | nan | Myopathy with extrapyramidal signs, 615673 (3), Autosomal recessive
chr10	MCU	614197.0 | MCU, CCDC109A | Mitochondrial calcium uniporter | 90550.0 | ENSG00000156026 | nan | nan
chr10	OIT3	609330.0 | OIT3, LZP | Oncoprotein-induced transcript 3, mouse, homolog of | 170392.0 | ENSG00000138315 | nan | nan
chr10	PLA2G12B	611653.0 | PLA2G12B, GXIIB | Phospholipase A2, group XIIB | 84647.0 | ENSG00000138308 | nan | nan
chr10	P4HA1	176710.0 | P4HA1, P4HA | Procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide 1 | 5033.0 | ENSG00000122884 | nan | nan
chr10	NUDT13	609233.0 | NUDT13 | Nudix hydrolase 13 | 25961.0 | ENSG00000166321 | nan | nan
chr10	ECD	616464.0 | ECD, SGT1 | Ecdysoneless cell cycle regulator | 11319.0 | ENSG00000122882 | nan | nan
chr10	FAM149B1	618413.0 | FAM149B1, KIAA0974, JBTS36 | Family with sequence similarity 149, member B1 | 317662.0 | ENSG00000138286 | nan | Joubert syndrome 36, 618763 (3), Autosomal recessive
chr10	DNAJC9	611206.0 | DNAJC9, JDD1, KIAA0974 | DNAJ/HSP40 homolog, subfamily C, member 9 | 23234.0 | ENSG00000213551 | nan | nan
chr10	MRPS16	609204.0 | MRPS16, COXPD2 | Mitochondrial ribosomal protein S16 | 51021.0 | ENSG00000182180 | nan | Combined oxidative phosphorylation deficiency 2, 610498 (3), Autosomal recessive
chr10	CFAP70	618661.0 | CFAP70, TTC18, SPGF41 | Cilia- and flagella-associated protein 70 | 118491.0 | ENSG00000156042 | mutation identified in 1 SPGF41 patient | ?Spermatogenic failure 41, 618670 (3), Autosomal recessive
chr10	ANXA7	186360.0 | ANXA7, SNX | Annexin A7 (synexin) | 310.0 | ENSG00000138279 | nan | nan
chr10	MSS51	614773.0 | MSS51, ZMYND17 | MSS51 mitochondrial translational activator | 118490.0 | ENSG00000166343 | nan | nan
chr10	PPP3CB	114106.0 | PPP3CB, CALNB | Protein phosphatase-3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) | 5532.0 | ENSG00000107758 | nan | nan
chr10	MYOZ1	605603.0 | MYOZ1 | Myozenin 1 (calsarcin 2) | 58529.0 | ENSG00000177791 | nan | nan
chr10	SEC24C	607185.0 | SEC24C, KIAA0079 | SEC24-related gene family, member C | 9632.0 | ENSG00000176986 | nan | nan
chr10	FUT11	616932.0 | FUT11, FUCTXI | Fucosyltransferase 11 | 170384.0 | ENSG00000196968 | nan | nan
chr10	CHCHD1	608842.0 | CHCHD1 | Coiled-coil-helix-coiled-coil-helix domain-containing protein 1 | 118487.0 | ENSG00000172586 | nan | nan
chr10	ZSWIM8	619213.0 | ZSWIM8, KIAA0913 | Zinc finger SWIM domain-containing protein 8 | 23053.0 | ENSG00000214655 | nan | nan
chr10	NDST2	603268.0 | NDST2 | N-deacetylase/N-sulfotransferase 2 | 8509.0 | ENSG00000166507 | in intron of PCDH15 | nan
chr10	CAMK2G	602123.0 | CAMK2G, CAMKG, MRD59 | Calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma | 818.0 | ENSG00000148660 | in intron of PCDH15 | Intellectual developmental disorder, autosomal dominant 59, 618522 (3), Autosomal dominant
chr10	PLAU	191840.0 | PLAU, URK, QPD, BDPLT5 | Plasminogen activator, urokinase | 5328.0 | ENSG00000122861 | proximal to HOX11 | Quebec platelet disorder, 601709 (3), Autosomal dominant; {Alzheimer disease, late-onset, susceptibility to}, 104300 (3), Autosomal dominant
chr10	VCL	193065.0 | VCL, CMD1W, CMH15 | Vinculin | 7414.0 | ENSG00000035403 | nan | Cardiomyopathy, dilated, 1W, 611407 (3); Cardiomyopathy, hypertrophic, 15, 613255 (3), Autosomal dominant
chr10	AP3M1	610366.0 | AP3M1 | Adaptor-related protein complex 3, mu-1 subunit | 26985.0 | ENSG00000185009 | nan | nan
chr10	ADK	102750.0 | ADK | Adenosine kinase | 132.0 | ENSG00000156110 | nan | Hypermethioninemia due to adenosine kinase deficiency, 614300 (3), Autosomal recessive
chr10	KAT6B	605880.0 | KAT6B, MYST4, MORF, GTPTS | Lysine acetyltransferase 6B | 23522.0 | ENSG00000156650 | nan | SBBYSS syndrome, 603736 (3), Autosomal dominant; Genitopatellar syndrome, 606170 (3), Autosomal dominant
chr10	DUSP29	618574.0 | DUPD1, DUSP27, FMDSP | Dual-specificity phosphatase domain- and proline isomerase | 338599.0 | ENSG00000188716 | nan | nan
chr10	DUSP13B	613191.0 | DUSP13, TMDP, MDSP | Dual-specificity phosphatase 13 | 51207.0 | ENSG00000079393 | nan | nan
chr10	SAMD8	611575.0 | SAMD8, SMSR | Sterile alpha motif domain-containing 8 | 142891.0 | ENSG00000156671 | nan | nan
chr10	VDAC2	193245.0 | VDAC2 | Voltage-dependent anion channel 2 | 7417.0 | ENSG00000165637 | nan | nan
chr10	ZNF503	613902.0 | ZNF503, NOLZ1 | Zinc finger protein 503 | 84858.0 | ENSG00000165655 | nan | nan
chr10	LRMDA	614537.0 | LRMDA, C10orf11, OCA7 | Leucine-rich melanocyte differentiation-associated protein | 83938.0 | ENSG00000148655 | nan | Albinism, oculocutaneous, type VII, 615179 (3), Autosomal recessive
chr10	SCZD11	608078.0 | SCZD11 | Schizophrenia susceptibility locus, chromosome 10q-related | 404686.0 | nan | between D10S1677 and D10S1753 | {Schizophrenia}, 181500 (2), Autosomal dominant
chr10	SLEN1	607965.0 | SLEN1 | Systemic lupus erythematosus with nephritis, susceptibility to, 1 | 192677.0 | nan | nan | {Systemic lupus erythematosus with nephritis, susceptibility to, 1}, 607965 (2)
chr10	SS3	612388.0 | SS3 | Sarcoidosis, susceptibility to, 3 | 100196919.0 | nan | associated with rs2789679 and rs1049550 | {Sarcoidosis, susceptibility to, 3}, 612388 (2)
chr10	KCNMA1	600150.0 | KCNMA1, SLO, PNKD3, CADEDS, IEG16, LIWAS | Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of) | 3778.0 | ENSG00000156113 | nan | {Epilepsy, idiopathic generalized, susceptibility to, 16}, 618596 (3), Autosomal dominant; Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy, 609446 (3), Autosomal dominant; Cerebellar atrophy, developmental delay, and seizures, 617643 (3), Autosomal recessive; Liang-Wang syndrome, 618729 (3), Autosomal dominant
chr10	DLG5	604090.0 | DLG5, PDLG, KIAA0583, YUVOB | Discs large MAGUK scaffold protein 5 | 9231.0 | ENSG00000151208 | nan | Yuksel-Vogel-Bauser syndrome, 620703 (3), Autosomal recessive
chr10	POLR3A	614258.0 | POLR3A, RPC1, RPC155, ADDH, HLD7, WDRTS | Polymerase III, RNA, subunit A | 11128.0 | ENSG00000148606 | nan | Wiedemann-Rautenstrauch syndrome, 264090 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3), Autosomal recessive
chr10	RPS24	602412.0 | RPS24, DBA3 | Ribosomal protein S24 | 6229.0 | ENSG00000138326 | nan | Diamond-blackfan anemia 3, 610629 (3), Autosomal dominant
chr10	ZMIZ1	607159.0 | ZMIZ1, RAI17, KIAA1224, ZIMP10, NEDDFSA | Zinc finger MIZ-domain containing 1 | 57178.0 | ENSG00000108175 | nan | Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies, 618659 (3), Autosomal dominant
chr10	PPIF	604486.0 | PPIF, CYP3 | Peptidylprolyl-cis-trans-isomerase, mitochondrial | 10105.0 | ENSG00000108179 | nan | nan
chr10	SFTPA2	178642.0 | SFTPA2, SPA2, COLEC5, ILD2 | Surfactant, pulmonary-associated protein A2 | 729238.0 | ENSG00000185303 | contiguous with SFTPA1 | Interstitial lung disease 2, 178500 (3), Autosomal dominant
chr10	SFTPA1	178630.0 | SFTPA1, SFTP1, ILD1 | Surfactant, pulmonary-associated protein A1 | 653509.0 | ENSG00000122852 | contiguous with SFTPA2 | Interstitial lung disease 1, 619611 (3), Autosomal recessive, Autosomal dominant
chr10	NUTM2B-AS1	618639.0 | NUTM2B-AS1, OPML1 | NUTM2B antisense RNA 1 | 101060691.0 | ENSG00000225484 | mutation identified in 1 OPML1 family | ?Oculopharyngeal myopathy with leukoencephalopathy 1, 618637 (3), Autosomal dominant
chr10	SFTPD	178635.0 | SFTPD, SFTP4 | Surfactant, pulmonary-associated protein D | 6441.0 | ENSG00000133661 | nan | nan
chr10	PLAC9	612857.0 | PLAC9 | Placenta-specific gene 9 | 219348.0 | ENSG00000189129 | nan | nan
chr10	ANXA11	602572.0 | ANXA11, ANX11, ALS23, IBMWMA | Annexin A11 (annexin XI) | 311.0 | ENSG00000122359 | nan | Amyotrophic lateral sclerosis 23, 617839 (3), Autosomal dominant; Inclusion body myopathy and brain white matter abnormalities, 619733 (3), Autosomal dominant
chr10	MAT1A	610550.0 | MAT1A, MATA1, SAMS1 | Methionine adenosyltransferase I, alpha | 4143.0 | ENSG00000151224 | nan | Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3), Autosomal recessive, Autosomal dominant; Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3), Autosomal recessive, Autosomal dominant
chr10	CPROTQ	611920.0 | CPROTQ | C-reactive protein QTL | 100188860.0 | nan | max lod at D10S1239 | [C-reactive protein QTL], 611920 (2)
chr10		612242.0 | DEL10q23, C10DELq23 | Chromosome 10q22.3-q23.2 deletion syndrome | nan | nan | nan | Chromosome 10q22.3-q23.2 deletion syndrome, 612242 (4)
chr10	IBD20	612288.0 | IBD20 | Inflammatory bowel disease 20 | 100190788.0 | nan | associated with rs11190140 | {Inflammatory bowel disease 20}, 612288 (2)
chr10	DYDC1	615154.0 | DYDC1 | DPY30 domain-containing protein 1 | 143241.0 | ENSG00000170788 | nan | nan
chr10	PRXL2A	617165.0 | FAM213A, PAMM | Family with sequence similarity 213, member A | 84293.0 | ENSG00000122378 | nan | nan
chr10	NRG3	605533.0 | NRG3 | Neuregulin 3 | 10718.0 | ENSG00000185737 | nan | nan
chr10	GHITM	619205.0 | GHITM, MICS1, TMBIM5 | Growth hormone-inducible transmembrane protein | 27069.0 | ENSG00000165678 | nan | nan
chr10	CERNA2	617434.0 | HOST2 | Long noncoding RNA HOST2 | 642934.0 | ENSG00000285972 | nan | nan
chr10	GPR15LG	617775.0 | C10orf99, CSBF, AP57 | Chromosome 10 open reading frame 99 | 387695.0 | ENSG00000188373 | nan | nan
chr10	CDHR1	609502.0 | CDHR1, PCDH21, PRCAD, CORD15, RP65 | Cadherin-related family, member 1 | 92211.0 | ENSG00000148600 | nan | Macular dystrophy, retinal, 613660 (3), Autosomal recessive; Cone-rod dystrophy 15, 613660 (3), Autosomal recessive; Retinitis pigmentosa 65, 613660 (3), Autosomal recessive
chr10	LRIT1	616103.0 | LRIT1, PAL | Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 1 | 26103.0 | ENSG00000148602 | REc, A | nan
chr10	RGR	600342.0 | RGR, RP44 | Retinal G protein coupled receptor | 5995.0 | ENSG00000148604 | nan | Retinitis pigmentosa 44, 613769 (3)
chr10	CCSER2	619944.0 | CCSER2, FAM190B, KIAA1128 | Coiled-coil serine-rich protein 2 | 54462.0 | ENSG00000107771 | nan | nan
chr10	GRID1	610659.0 | GRID1, KIAA1220 | Glutamate receptor, inotropic, delta 1 | 2894.0 | ENSG00000182771 | nan | nan
chr10	MIR346	611190.0 | MIR346 | Micro RNA 346 | 442911.0 | ENSG00000199104 | nan | nan
chr10	WAPL	610754.0 | WAPAL, KIAA0261, FOE, WAPL | Wings apart-like protein, Drosophila, homolog of | 23063.0 | ENSG00000062650 | nan | nan
chr10	OPN4	606665.0 | OPN4 | Opsin 4 | 94233.0 | ENSG00000122375 | nan | nan
chr10	LDB3	605906.0 | LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3 | LIM domain binding 3 | 11155.0 | ENSG00000122367 | nan | Left ventricular noncompaction 3, 601493 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 24, 601493 (3), Autosomal dominant; Myopathy, myofibrillar, 4, 609452 (3), Autosomal dominant; Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3), Autosomal dominant
chr10	BMPR1A	601299.0 | BMPR1A, ACVRLK3, ALK3 | Bone morphogenetic protein receptor, type IA | 657.0 | ENSG00000107779 | nan | Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant
chr10	MMRN2	608925.0 | MMRN2 | Multimerin 2 | 79812.0 | ENSG00000173269 | nan | nan
chr10	SNCG	602998.0 | SNCG, BCSG1 | Synuclein, gamma (breast cancer-specific gene 1) | 6623.0 | ENSG00000173267 | nan | nan
chr10	GLUD1	138130.0 | GLUD1 | Glutamate dehydrogenase-1 | 2746.0 | ENSG00000148672 | pseudogene on Xq26-q28 | Hyperinsulinism-hyperammonemia syndrome, 606762 (3), Autosomal dominant
chr10	SHLD2	618029.0 | SHLD2, RINN2, FAM35A | Shield complex, subunit 2 | 54537.0 | ENSG00000122376 | nan | nan
chr10	MINPP1	605391.0 | MINPP1, HIPER1, PCH16 | Multiple inositol polyphosphate phosphatase 1 | 9562.0 | ENSG00000107789 | nan | {Thyroid carcinoma, follicular}, 188470 (3), Somatic mutation, Autosomal dominant; Pontocerebellar hypoplasia, type 16, 619527 (3), Autosomal recessive
chr10	PAPSS2	603005.0 | PAPSS2, ATPSK2, BCYM4 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 | 9060.0 | ENSG00000198682 | nan | Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3), Autosomal recessive
chr10	IDDM24	613006.0 | IDDM24 | Diabetes mellitus, insulin-dependent, 24 | 100303715.0 | nan | associated with rs10509540 | {Diabetes mellitus, insulin-dependent, 24}, 613006 (2)
chr10	MLDHR	620760.0 | MLDHR, MP31, PTENURF | Mitochondrial lactate dehydrogenase regulator | 133834869.0 | nan | nan | nan
chr10	RCM2	609578.0 | RCM2 | Cardiomyopathy, familial restrictive, 2 | 619468.0 | nan | max lod at D10S1242 | Cardiomyopathy, familial restrictive, 2, 609578 (2)
chr10	ATAD1	614452.0 | ATAD1, THORASE, HKPX4 | ATPase family, AAA domain-containing, member 1 | 84896.0 | ENSG00000138138 | nan | Hyperekplexia 4, 618011 (3), Autosomal recessive
chr10	KLLN	612105.0 | KLLN, CWS4 | Killin | 100144748.0 | ENSG00000227268 | nan | Cowden syndrome 4, 615107 (3)
chr10	PTEN	601728.0 | PTEN, MMAC1, GLM2, CWS1 | Phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | 5728.0 | ENSG00000171862 | nan | {Glioma susceptibility 2}, 613028 (3), Autosomal dominant; {Meningioma}, 607174 (3), Autosomal dominant; Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos disease, 158350 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3); Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant
chr10	RNLS	609360.0 | RNLS, C10orf59 | Renalase | 55328.0 | ENSG00000184719 | nan | nan
chr10	LIPJ	613921.0 | LIPJ, LIPL1 | Lipase J | 142910.0 | ENSG00000204022 | nan | nan
chr10	LIPF	601980.0 | LIPF | Lipase F, gastric type | 8513.0 | ENSG00000182333 | nan | nan
chr10	LIPK	613922.0 | LIPK, LIPL2 | Lipase family, member K | 643414.0 | ENSG00000204021 | nan | nan
chr10	LIPN	613924.0 | LIPN, LIPL4, ARCI8, LI4 | Lipase family, member N | 643418.0 | ENSG00000204020 | nan | Ichthyosis, congenital, autosomal recessive 8, 613943 (3), Autosomal recessive
chr10	LIPM	613923.0 | LIPM, LIPL3 | Lipase family, member M | 340654.0 | ENSG00000173239 | nan | nan
chr10	STAMBPL1	612352.0 | STAMBPL1, KIAA1373 | STAM-binding protein-like 1 | 57559.0 | ENSG00000138134 | nan | nan
chr10	ACTA2	102620.0 | ACTA2, ACTSA, AAT6, MYMY5, SMDYS | Actin, alpha-2, smooth muscle, aorta | 59.0 | ENSG00000107796 | nan | Smooth muscle dysfunction syndrome, 613834 (3), Autosomal dominant; Aortic aneurysm, familial thoracic 6, 611788 (3), Autosomal dominant; Moyamoya disease 5, 614042 (3)
chr10	FAS	134637.0 | FAS, TNFRSF6, APT1, CD95, ALPS1A | Fas cell surface death receptor | 355.0 | ENSG00000026103 | nan | Squamous cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3), Autosomal dominant; {Autoimmune lymphoproliferative syndrome}, 601859 (3), Autosomal dominant
chr10	CH25H	604551.0 | CH25H | Cholesterol 25-hydroxylase | 9023.0 | ENSG00000138135 | nan | nan
chr10	LIPA	613497.0 | LIPA, CESD | Lipase A, lysosomal acid, cholesterol esterase | 3988.0 | ENSG00000107798 | ?close to GOT | Wolman disease, 620151 (3), Autosomal recessive; Cholesteryl ester storage disease, 278000 (3), Autosomal recessive
chr10	IFIT2	147040.0 | IFIT2, IFI54, G10P2 | Interferon-induced protein with tetratricopeptide repeats 2 | 3433.0 | ENSG00000119922 | nan | nan
chr10	IFIT3	604650.0 | IFIT4 | Interferon-induced protein with tetratricopeptide repeats 4 | 3437.0 | ENSG00000119917 | nan | nan
chr10	IFIT1	147690.0 | IFIT1, IFI56, G10P1, IFNAI1 | Interferon-induced protein with tetratricopeptide repeats 1 | 3434.0 | ENSG00000185745 | 10q25-q26 = conflicting site | nan
chr10	IFIT5	616135.0 | IFIT5, RI58, ISG58 | Interferon-induced protein with tetratricopeptide repeats 5 | 24138.0 | ENSG00000152778 | nan | nan
chr10	SLC16A12	611910.0 | SLC16A12, MCT12, CTRCT47 | Solute carrier family 16 (monocarboxylic acid transporter), member 12 | 387700.0 | ENSG00000152779 | mutation identified in 1 CTRCT47 family | Cataract 47, juvenile, with microcornea, 612018 (3), Autosomal dominant
chr10	PANK1	606160.0 | PANK1 | Pantothenate kinase 1 | 53354.0 | ENSG00000152782 | nan | nan
chr10	MIR107	613189.0 | MIR107, MIRN107 | Micro RNA 107 | 406901.0 | ENSG00000198997 | nan | nan
chr10	KIF20B	605498.0 | MPHOSPH1, MPP1 | M-phase phosphoprotein 1 | 9585.0 | ENSG00000138182 | nan | nan
chr10	HTR7	182137.0 | HTR7 | 5-hydroxytryptamine (serotonin) receptor-7, adenylate cyclase-coupled | 3363.0 | ENSG00000148680 | nan | nan
chr10	RPP30	606115.0 | RPP30 | Ribonuclease P/MRP subunit p30 | 10556.0 | ENSG00000148688 | nan | nan
chr10	ANKRD1	609599.0 | ANKRD1, CARP | Ankyrin repeat domain-containing protein 1 | 27063.0 | ENSG00000148677 | nan | nan
chr10	PCGF5	617407.0 | PCGF5 | Polycomb group ring finger protein 5 | 84333.0 | ENSG00000180628 | nan | nan
chr10	HECTD2	620876.0 | HECTD2 | HECT domain E3 ubiquitin protein ligase 2 | 143279.0 | ENSG00000165338 | nan | nan
chr10	PPP1R3C	602999.0 | PPP1R3C, PPP1R5 | Phosphatase 1, regulatory subunit 3C | 5507.0 | ENSG00000119938 | nan | nan
chr10	TNKS2	607128.0 | TNKS2, TANK2, TNKL | Tankyrase 2 | 80351.0 | ENSG00000107854 | nan | nan
chr10	FGFBP3	620879.0 | FGFBP3 | Fibroblast growth factor-binding protein 3 | 143282.0 | ENSG00000174721 | nan | nan
chr10	BTAF1	605191.0 | BTAF1, TAFII170, TAF172, MOT1 | BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kD (Mot1, S. cerevisiae, homolog of) | 9044.0 | ENSG00000095564 | nan | nan
chr10	CPEB3	610606.0 | CPEB3, KIAA0940 | Cytoplasmic polyadenylation element-binding protein 3 | 22849.0 | ENSG00000107864 | nan | nan
chr10	MARCHF5	610637.0 | MARCH5 | Membrane-associated RING-CH finger protein 5 | 54708.0 | ENSG00000198060 | nan | nan
chr10	IDE	146680.0 | IDE | Insulin-degrading enzyme | 3416.0 | ENSG00000119912 | nan | nan
chr10	KIF11	148760.0 | KIF11, KNSL1, MCLMR | Kinesin family member 11 | 3832.0 | ENSG00000138160 | nan | Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development, 152950 (3), Autosomal dominant
chr10	HHEX	604420.0 | HHEX, PRHX, PRH | Hematopoietically expressed homeobox | 3087.0 | ENSG00000152804 | nan | nan
chr10	EXOC6	609672.0 | EXOC6, SEC15L1, SEC15L, SEC15 | Exocyst complex component 6 | 54536.0 | ENSG00000138190 | nan | nan
chr10	CYP26C1	608428.0 | CYP26C1, FFDD4 | Cytochrome P450, subfamily XXVIC, polypeptide 1 | 340665.0 | ENSG00000187553 | nan | Focal facial dermal dysplasia 4, 614974 (3), Autosomal recessive
chr10	CYP26A1	602239.0 | CYP26A1 | Cytochrome p450, subfamily XXVIA, polypeptide 1 | 1592.0 | ENSG00000095596 | nan | nan
chr10	MYOF	604603.0 | MYOF, FER1L3, HAE7 | Myoferlin | 26509.0 | ENSG00000138119 | mutation identified in 1 HAE7 family | ?Angioedema, hereditary, 7, 619366 (3), Autosomal dominant
chr10	CEP55	610000.0 | CEP55, MARCH | Centrosomal protein, 55kD | 55165.0 | ENSG00000138180 | nan | Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly, 236500 (3), Autosomal recessive
chr10	FFAR4	609044.0 | FFAR4, O3FAR1, GPR120, PGR4, BMIQ10 | Free fatty acid receptor 4 | 338557.0 | ENSG00000186188 | nan | {Obesity, susceptibility to}, 607514 (3)
chr10	RBP4	180250.0 | RBP4, RDCCAS, MCOPCB10 | Retinol-binding protein-4, interstitial | 5950.0 | ENSG00000138207 | just centromeric of CYP2C cluster | Microphthalmia/coloboma 10, 616428 (3), Autosomal dominant; Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3), Autosomal recessive
chr10	PDE6C	600827.0 | PDE6C, PDEA2, COD4 | Phosphodiesterase 6C | 5146.0 | ENSG00000095464 | nan | Cone dystrophy 4, 613093 (3), Autosomal recessive
chr10	FRA10AC1	608866.0 | FRA10AC1, FRA10A, C10orf4, NEDGFC | FRA10A associated CGG repeat 1 | 118924.0 | ENSG00000148690 | nan | Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities, 620113 (3), Autosomal recessive
chr10	LGI1	604619.0 | LGI1, EPT, ETL1, ADLTE, ADPEAF | Leucine-rich gene, glioma-inactivated, 1 | 9211.0 | ENSG00000108231 | nan | Epilepsy, familial temporal lobe, 1, 600512 (3), Autosomal dominant
chr10	SLC35G1	617167.0 | SLC35G1, POST, TMEM20, C10orf60 | Solute carrier family 35, member G1 | 159371.0 | ENSG00000176273 | nan | nan
chr10	PLCE1	608414.0 | PLCE1, KIAA1516, NPHS3 | Phospholipase C, epsilon-1 | 51196.0 | ENSG00000138193 | nan | Nephrotic syndrome, type 3, 610725 (3), Autosomal recessive
chr10	NOC3L	610769.0 | NOC3L, FAD24 | NOC3-like DNA replication regulator | 64318.0 | ENSG00000173145 | nan | nan
chr10	TBC1D12	620003.0 | TBC1D12, KIAA0608 | TBC1 domain family, member 12 | 23232.0 | ENSG00000108239 | nan | nan
chr10	HELLS	603946.0 | HELLS, LSH, ICF4 | Helicase, lymphoid-specific | 3070.0 | ENSG00000119969 | nan | Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3), Autosomal recessive
chr10	CYP2C18	601131.0 | CYP2C18 | Cytochrome P450, subfamily IIC, polypeptide 18 | 1562.0 | ENSG00000108242 | nan | nan
chr10	CYP2C19	124020.0 | CYP2C, CYP2C19 | Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase) | 1557.0 | ENSG00000165841 | 4 genes in order: cen-C18-C19-C9-C8-tel | Proguanil poor metabolizer, 609535 (3), Autosomal recessive; Mephenytoin poor metabolizer, 609535 (3), Autosomal recessive; Clopidogrel, impaired responsiveness to, 609535 (3), Autosomal recessive; Omeprazole poor metabolizer, 609535 (3), Autosomal recessive
chr10	CYP2C9	601130.0 | CYP2C9 | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9 | 1559.0 | ENSG00000138109 | nan | Warfarin sensitivity, 122700 (3), Autosomal dominant; Tolbutamide poor metabolizer (3)
chr10	CYP2C8	601129.0 | CYP2C8, CYP2C8DM | Cytochrome P450, subfamily IIc, polypeptide 8 | 1558.0 | ENSG00000138115 | nan | {Drug metabolism, altered, CYP2C8-related}, 618018 (3)
chr10	PDLIM1	605900.0 | PDLIM1, CLP36, CLIM1 | PDZ and LIM domain protein 1 | 9124.0 | ENSG00000107438 | nan | nan
chr10	AD6	605526.0 | AD6 | Alzheimer disease 6 | 64851.0 | nan | nan | Alzheimer disease 6, 605526 (2)
chr10	CMTD1A	620378.0 | CMTD1A | Charcot-Marie-Tooth disease, dominant intermediate A | 130068899.0 | nan | nan | Charcot-Marie-Tooth disease, dominant intermediate A, 620378 (2), Autosomal dominant
chr10		619545.0 | HYPOFP | Hypoplastic femurs and pelvis | nan | nan | duplication of ~500kb on 10q24 | Hypoplastic femurs and pelvis, 619545 (4), Autosomal dominant
chr10		246560.0 | SHFM3, SHSF3, DUP10q24, C10DUPq24 | Split-hand/foot malformation 3 (Chromosome 10q24 duplication syndrome) | nan | nan | contiguous gene duplication syndrome | Split-hand/foot malformation 3, gene duplication syndrome, 246560 (4), Autosomal dominant
chr10	SORBS1	605264.0 | SORBS1, SH3D5, SH3P12, KIAA1296 | Sorbin and SH3 domain containing 1 | 10580.0 | ENSG00000095637 | nan | nan
chr10	ALDH18A1	138250.0 | ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3 | Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase) | 5832.0 | ENSG00000059573 | GOT1 and GSAS in same pathway | Spastic paraplegia 9A, autosomal dominant, 601162 (3), Autosomal dominant; Cutis laxa, autosomal recessive, type IIIA, 219150 (3), Autosomal recessive; Spastic paraplegia 9B, autosomal recessive, 616586 (3), Autosomal recessive; Cutis laxa, autosomal dominant 3, 616603 (3), Autosomal dominant
chr10	TCTN3	613847.0 | TCTN3, TECT3, C10orf61, OFD4, JBTS18 | Tectonic family, member 3 | 26123.0 | ENSG00000119977 | nan | Joubert syndrome 18, 614815 (3), Autosomal recessive; Orofaciodigital syndrome IV, 258860 (3), Autosomal recessive
chr10	ENTPD1	601752.0 | ENTPD1, CD39, SPG64 | Ectonucleoside triphosphate diphosphohydrolase 1 (CD39 antigen) | 953.0 | ENSG00000138185 | nan | Spastic paraplegia 64, autosomal recessive, 615683 (3), Autosomal recessive
chr10	CCNJ	620395.0 | CCNJ | Cyclin J | 54619.0 | ENSG00000107443 | nan | nan
chr10	ZNF518A	617733.0 | ZNF518A, KIAA0335 | Zinc finger protein 518A | 9849.0 | ENSG00000177853 | nan | nan
chr10	BLNK	604515.0 | BLNK, SLP65, AGM4 | B-cell linker protein (SH2 domain-containing leukocyte protein, 65kD) | 29760.0 | ENSG00000095585 | mutation identified in 1 AGM4 family | ?Agammaglobulinemia 4, 613502 (3), Autosomal recessive
chr10	DNTT	187410.0 | DNTT, TDT | Terminal deoxynucleotidyltransferase | 1791.0 | ENSG00000107447 | nan | nan
chr10	OPALIN	617200.0 | OPALIN, TMEM10, TMP10 | Oligodendrocytic myelin paranodal and inner loop protein | 93377.0 | ENSG00000197430 | nan | nan
chr10	TLL2	606743.0 | TLL2, KIAA0932 | Tolloid-like 2 | 7093.0 | ENSG00000095587 | nan | nan
chr10	TM9SF3	616872.0 | TM9SF3, SMBP | Transmembrane 9 superfamily, member 3 | 56889.0 | ENSG00000077147 | nan | nan
chr10	PIK3AP1	607942.0 | PIK3AP1, BCAP, FLJ35564 | Phosphoinositide 3-kinase adaptor protein 1 | 118788.0 | ENSG00000155629 | nan | nan
chr10	LCOR	607698.0 | LCOR, MLR2, KIAA1795 | Ligand-dependent nuclear receptor corepressor | 84458.0 | ENSG00000196233 | nan | nan
chr10	SLIT1	603742.0 | SLIT1, SLIL1, MEGF4 | SLIT guidance ligand 1 | 6585.0 | ENSG00000187122 | nan | nan
chr10	ARHGAP19	611587.0 | ARHGAP19 | RHO GTPase-activating protein 19 | 84986.0 | ENSG00000213390 | nan | nan
chr10	FRAT1	602503.0 | FRAT1 | Frequently rearranged in advanced T-cell lymphomas 1 | 10023.0 | ENSG00000165879 | nan | nan
chr10	FRAT2	605006.0 | FRAT2 | Frequently rearranged in advanced T-cell lymphomas 2 | 23401.0 | ENSG00000181274 | nan | nan
chr10	RRP12	617723.0 | RRP12, KIAA0690 | Ribosomal RNA-processing protein 12, S. cerevisiae, homolog of | 23223.0 | ENSG00000052749 | nan | nan
chr10	PGAM1	172250.0 | PGAM1 | Phosphoglycerate mutase A, nonmuscle form | 5223.0 | ENSG00000171314 | nan | nan
chr10	EXOSC1	606493.0 | EXOSC1, CSL4, PCH1F | Exosome component 1 | 51013.0 | ENSG00000171311 | mutation identified in 1 PCH1F patient | ?Pontocerebellar hypoplasia, type 1F, 619304 (3), Autosomal recessive
chr10	ZDHHC16	616750.0 | ZDHHC16, APH2 | Zinc finger DHHC domain-containing protein 16 | 84287.0 | ENSG00000171307 | nan | nan
chr10	MMS19	614777.0 | SLCO1B7, MMS19, MMS19L | Solute carrier organic anion transporter family, member 1B7 | 64210.0 | ENSG00000155229 | nan | nan
chr10	UBTD1	616388.0 | UBTD1 | Ubiquitin domain-containing protein 1 | 80019.0 | ENSG00000165886 | nan | nan
chr10	ANKRD2	610734.0 | ANKRD2, ARPP | Ankyrin repeat domain-containing protein 2 | 26287.0 | ENSG00000165887 | nan | nan
chr10	HOGA1	613597.0 | HOGA1, DHDPSL, HP3 | 4-hydroxy-2-oxoglutarate aldolase 1 | 112817.0 | ENSG00000241935 | nan | Hyperoxaluria, primary, type III, 613616 (3), Autosomal recessive
chr10	MORN4	617736.0 | MORN4, RTP, UTA | MORN repeat-containing protein 4 | 118812.0 | ENSG00000171160 | nan | nan
chr10	PI4K2A	609763.0 | PI4K2A, NEDMSB | Phosphatidylinositol 4-kinase type 2 alpha | 55361.0 | ENSG00000155252 | nan | Neurodevelopmental disorder with hyperkinetic movements, seizures and structural brain abnormalities, 620732 (3), Autosomal recessive
chr10	AVPI1	618537.0 | AVPI1, VIT32 | Arginine vasopressin-induced protein 1 | 60370.0 | ENSG00000119986 | nan | nan
chr10	MARVELD1	616970.0 | MARVELD1, MARVD1 | Marvel domain-containing protein 1 | 83742.0 | ENSG00000155254 | nan | nan
chr10	ZFYVE27	610243.0 | ZFYVE27 | Zinc finger FYVE domain-containing protein 27 | 118813.0 | ENSG00000155256 | nan | nan
chr10	SFRP5	604158.0 | SFRP5, SARP3 | Secreted frizzled-related protein 5 | 6425.0 | ENSG00000120057 | nan | nan
chr10	GOLGA7B	614189.0 | GOLGA7B, C10orf132 | Golgin A7 family, member B | 401647.0 | ENSG00000155265 | nan | nan
chr10	CRTAC1	606276.0 | CRTAC1, CEP68, LOTUS | Cartilage acidic protein 1 | 55118.0 | ENSG00000095713 | nan | nan
chr10	LOXL4	607318.0 | LOXL4 | Lysyl oxidate-like 4 | 84171.0 | ENSG00000138131 | nan | nan
chr10	PYROXD2	617889.0 | PYROXD2, C10orf33, YUEF | Pyridine nucleotide-disulphide oxidoreductase domain-containing protein 2 | 84795.0 | ENSG00000119943 | nan | nan
chr10	HPS1	604982.0 | HPS1 | HPS1 biogenesis of lysosomal organelles complex 3 subunit 1 | 3257.0 | ENSG00000107521 | nan | Hermansky-Pudlak syndrome 1, 203300 (3), Autosomal recessive
chr10	HPSE2	613469.0 | HPSE2, HPA2, UFS1 | Heparanase 2 | 60495.0 | ENSG00000172987 | nan | Urofacial syndrome 1, 236730 (3), Autosomal recessive
chr10	CNNM1	607802.0 | CNNM1, ACDP1 | Cyclin M1 (ancient conserved domain protein 1) | 26507.0 | ENSG00000119946 | nan | nan
chr10	GOT1	138180.0 | GOT1, ASTQTL1 | Glutamic-oxaloacetic transaminase 1, soluble | 2805.0 | ENSG00000120053 | 10q26.1 = conflicting localization | Aspartate aminotransferase, serum level of, QTL1, 614419 (3)
chr10	NKX2-3	606727.0 | NKX2C, NK2.3, CSX3 | NK2, Drosophila, homolog of, C | 159296.0 | ENSG00000119919 | nan | nan
chr10	SLC25A28	609767.0 | SLC25A28, MRS4L, NPD016 | Solute carrier family 25 (mitochondrial carrier), member 28 | 81894.0 | ENSG00000155287 | nan | nan
chr10	ENTPD7	616753.0 | ENTPD7, LALP1 | Ectonucleoside triphosphate diphosphohydrolase 7 | 57089.0 | ENSG00000198018 | nan | nan
chr10	COX15	603646.0 | COX15, MC4DN6 | Cytochrome c oxidase, subunit 15 | 1355.0 | ENSG00000014919 | nan | Mitochondrial complex IV deficiency, nuclear type 6, 615119 (3), Autosomal recessive
chr10	CUTC	610101.0 | CUTC | CutC copper transporter | 51076.0 | ENSG00000119929 | nan | nan
chr10	ABCC2	601107.0 | ABCC2, CMOAT | ATP-binding cassette, subfamily C, member 2 (canalicular multispecific organic anion transporter) | 1244.0 | ENSG00000023839 | nan | Dubin-Johnson syndrome, 237500 (3), Autosomal recessive
chr10	DNMBP	611282.0 | DNMBP, TUBA, KIAA1010, CTRCT48 | Dynamin-binding protein | 23268.0 | ENSG00000107554 | nan | Cataract 48, 618415 (3), Autosomal recessive
chr10	CPN1	603103.0 | CPN1, SCPN, CPN | Carboxypeptidase N, polypeptide 1, 50-kD | 1369.0 | ENSG00000120054 | nan | Carboxypeptidase N deficiency, 212070 (3), Autosomal recessive
chr10	ERLIN1	611604.0 | ERLIN1, SPG62 | Endoplasmic reticulum lipid raft-associated protein 1 | 10613.0 | ENSG00000107566 | nan | Spastic paraplegia 62, autosomal recessive, 615681 (3), Autosomal recessive
chr10	CHUK	600664.0 | CHUK, IKBKA, NFKBIKA, IKKA, IKK1, BPS2 | Component of nuclear factor kappa-B kinase complex | 1147.0 | ENSG00000213341 | mutation identified in 1 BPS2 patient and 1 family | ?Popliteal pterygium syndrome, Bartsocas-Papas type 2, 619339 (3), Autosomal recessive; ?Cocoon syndrome, 613630 (3), Autosomal recessive
chr10	CWF19L1	616120.0 | CWF19L1, C19L1, SCAR17 | CWF19-like cell cycle control factor 1 | 55280.0 | ENSG00000095485 | nan | Spinocerebellar ataxia, autosomal recessive 17, 616127 (3), Autosomal recessive
chr10	SNORA12	611330.0 | SNORA12 | Small nucleolar RNA, H/ACA box, 12 | 677800.0 | ENSG00000212464 | in intron 11 of CWF19L1 | nan
chr10	BLOC1S2	609768.0 | BLOC1S2, BLOS2 | Biogenesis of lysosome-related organelles complex 1, subunit 2 | 282991.0 | ENSG00000196072 | nan | nan
chr10	PKD2L1	604532.0 | PKD2L1, PKDL, PKD2L | Polycystin L | 9033.0 | ENSG00000107593 | nan | nan
chr10	SCD	604031.0 | SCD | Stearoyl-CoA desaturase | 6319.0 | ENSG00000099194 | pseudogene on chr.17 | nan
chr10	OLMALINC	616240.0 | OLMALINC, LINC00263, OLMALINCAS | Oligodendrocyte maturation-associated long intergenic noncoding RNA | 90271.0 | ENSG00000235823 | OLMALINCAS is on opposite strand overlapping exon 1 of OLMALINC | nan
chr10	WNT8B	601396.0 | WNT8B | Wingless-type MMTV integration site family, member 8B | 7479.0 | ENSG00000075290 | nan | nan
chr10	SEC31B	610258.0 | SEC31B, SEC31L2 | SEC31 homolog B, COPII coat complex component | 25956.0 | ENSG00000075826 | nan | nan
chr10	NDUFB8	602140.0 | NDUFB8, MC1DN32 | NADH-ubiquinone oxidoreductase subunit B8 | 4714.0 | ENSG00000166136 | previously assigned to 12q21 | Mitochondrial complex I deficiency, nuclear type 32, 618252 (3), Autosomal recessive
chr10	HIF1AN	606615.0 | HIF1AN, FIH1 | Hypoxia-inducible factor 1-alpha inhibitor | 55662.0 | ENSG00000166135 | nan | nan
chr10	PAX2	167409.0 | PAX2, PAPRS, FSGS7 | Paired box homeotic gene-2 | 5076.0 | ENSG00000075891 | nan | Glomerulosclerosis, focal segmental, 7, 616002 (3), Autosomal dominant; Papillorenal syndrome, 120330 (3), Autosomal dominant
chr10	SLF2	610348.0 | SLF2, FAM178A, C10orf6, ATELS1 | SMC5-SMC6 complex localization factor 2 | 55719.0 | ENSG00000119906 | nan | Atelis syndrome 1, 620184 (3), Autosomal recessive
chr10	SEMA4G	618991.0 | SEMA4G | Semaphorin 4G | 57715.0 | ENSG00000095539 | nan | nan
chr10	MRPL43	611848.0 | MRPL43 | Mitochondrial ribosomal protein L43 | 84545.0 | ENSG00000055950 | nan | nan
chr10	TWNK	606075.0 | TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5 | Twinkle mtDNA helicase | 56652.0 | ENSG00000107815 | PEO digenic with POLG | Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3), Autosomal recessive; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3), Autosomal dominant; Perrault syndrome 5, 616138 (3), Autosomal recessive
chr10	LZTS2	610454.0 | LZTS2, KIAA1813, LAPSER1 | Leucine zipper, putative tumor suppressor 2 | 84445.0 | ENSG00000107816 | nan | nan
chr10	PDZD7	612971.0 | PDZD7, DFNB57 | PDZ domain-containing 7 | 79955.0 | ENSG00000186862 | nan | Deafness, autosomal recessive 57, 618003 (3), Autosomal recessive; {Retinal disease in Usher syndrome type IIA, modifier of}, 276901 (3), Autosomal recessive; Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3), Autosomal recessive, Digenic dominant
chr10	SFXN3	615571.0 | SFXN3 | Sideroflexin 3 | 81855.0 | ENSG00000107819 | nan | nan
chr10	KAZALD1	609208.0 | KAZALD1 | Kazal-type serine peptidase inhibitor domain 1 | 81621.0 | ENSG00000107821 | nan | nan
chr10	TLX1NB	612734.0 | TLX1NB, TD1 | TLX1 neighbor | 100038246.0 | ENSG00000236311 | nan | nan
chr10	TLX1	186770.0 | TLX1, HOX11, TCL3 | T-cell leukemia, homeobox 1 | 3195.0 | ENSG00000107807 | t(7;10) or t(10;4) in T-ALL | nan
chr10	ECTD5	614927.0 | ECTD5 | Ectodermal dysplasia 5, hair/nail type | 101101769.0 | nan | between D10S1239 and D10S1264 | Ectodermal dysplasia 5, hair/nail type, 614927 (2), Autosomal recessive
chr10	LBX1	604255.0 | LBX1, LBX1H, CCHS3 | Lady bird late, Drosophila, homolog of, 1 | 10660.0 | ENSG00000138136 | mutation identified in 1 CCHS3 family | ?Central hypoventilation syndrome, congenital, 3, 619483 (3), Autosomal recessive
chr10	BTRC	603482.0 | BTRC, BTRCP | Beta-transducin repeat-containing protein | 8945.0 | ENSG00000166167 | nan | nan
chr10	POLL	606343.0 | POLL | Polymerase, DNA, lambda | 27343.0 | ENSG00000166169 | nan | nan
chr10	DPCD	616467.0 | DPCD | Deleted in primary ciliary dyskinesia, mouse, homolog of | 25911.0 | ENSG00000166171 | nan | nan
chr10	FBXW4	608071.0 | FBXW4, DAC, FBW4, FBWD4 | F-box and WD repeat domain containing 4 | 6468.0 | ENSG00000107829 | nan | nan
chr10	FGF8	600483.0 | FGF8, HH6 | Fibroblast growth factor-8 | 2253.0 | ENSG00000107831 | nan | Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3), Autosomal dominant
chr10	NPM3	606456.0 | NPM3 | Nucleophosmin/nucleoplasmin family, member 3 | 10360.0 | ENSG00000107833 | nan | nan
chr10	OGA	604039.0 | OGA, MGEA5, NCOAT | O-GlcNAcase | 10724.0 | ENSG00000198408 | nan | nan
chr10	KCNIP2	604661.0 | KCNIP2, KCHIP2 | Potassium channel-interacting protein 2 | 30819.0 | ENSG00000120049 | nan | nan
chr10	ARMH3	620867.0 | ARMH3, C10orf76 | Armadillo-like helical domain-containing protein 3 | 79591.0 | ENSG00000120029 | nan | nan
chr10	HPS6	607522.0 | HPS6, RU | HPS6 biogenesis of lysosomal organelles complex 2 subunit 3 | 79803.0 | ENSG00000166189 | nan | Hermansky-Pudlak syndrome 6, 614075 (3), Autosomal recessive
chr10	LDB1	603451.0 | LDB1, CLIM2, NLI | LIM domain-binding factor-1 | 8861.0 | ENSG00000198728 | nan | nan
chr10	PPRC1	617462.0 | PPRC1, PRC, KIAA0595 | Peroxisome proliferator-activated receptor-gamma, coactivator-related protein 1 | 23082.0 | ENSG00000148840 | nan | nan
chr10	NOLC1	602394.0 | NOLC1, p130, NOPP140 | Nucleolar and coiled-body phosphoprotein 1 | 9221.0 | ENSG00000166197 | nan | nan
chr10	ELOVL3	611815.0 | ELOVL3, CIG30 | Elongation of very long chain fatty acids-like 3 | 83401.0 | ENSG00000119915 | nan | nan
chr10	PITX3	602669.0 | PITX3, CTPP4, CTRCT11, ASGD1 | Paired-like homeodomain transcription factor-3 | 5309.0 | ENSG00000107859 | nan | Cataract 11, multiple types, 610623 (3), Autosomal recessive, Autosomal dominant; Anterior segment dysgenesis 1, multiple subtypes, 107250 (3), Autosomal dominant; Cataract 11, syndromic, autosomal recessive, 610623 (3), Autosomal recessive, Autosomal dominant
chr10	GBF1	603698.0 | GBF1, CMT2GG | Golgi-specific brefeldin-A resistance factor 1 | 8729.0 | ENSG00000107862 | nan | Charcot-Marie-Tooth disease, axonal, type 2GG, 606483 (3), Autosomal dominant
chr10	NFKB2	164012.0 | NFKB2, LYT10, CVID10 | Nuclear factor kappa-B, subunit 2 (p49/p100) | 4791.0 | ENSG00000077150 | nan | Immunodeficiency, common variable, 10, 615577 (3), Autosomal dominant
chr10	PSD	602327.0 | PSD | Pleckstrin and Sec7 domain protein | 5662.0 | ENSG00000059915 | nan | nan
chr10	FBXL15	610287.0 | FBXL15, JET | F-box and leucine-rich repeat protein 15 | 79176.0 | ENSG00000107872 | nan | nan
chr10	CUEDC2	614142.0 | CUEDC2 | Cue domain-containing protein 2 | 79004.0 | ENSG00000107874 | nan | nan
chr10	MIR146B	610567.0 | MIR146B | Micro RNA 146B | 574447.0 | ENSG00000202569 | nan | nan
chr10	MFSD13A	620255.0 | MFSD13A, TMEM180 | Major facilitator superfamily domain-containing protein 13A | 79847.0 | ENSG00000138111 | nan | nan
chr10	ACTR1A	605143.0 | ACTR1A, ARP1 | Actin-related protein 1A | 10121.0 | ENSG00000138107 | nan | nan
chr10	SUFU	607035.0 | SUFU, SUFUXL, SUFUH, JBTS32, BCNS2 | Suppressor of fused | 51684.0 | ENSG00000107882 | nan | {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome 2, 620343 (3); {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation
chr10	TRIM8	606125.0 | TRIM8, RNF27, GERP, FSGSNEDS | Tripartite motif-containing 8 | 81603.0 | ENSG00000171206 | nan | Focal segmental glomerulosclerosis and neurodevelopmental syndrome, 619428 (3), Autosomal dominant
chr10	ARL3	604695.0 | ARL3, ARFL3, JBTS35, RP83 | ADP ribosylation factor-like GTPase 3 | 403.0 | ENSG00000138175 | nan | Retinitis pigmentosa 83, 618173 (3), Autosomal dominant; Joubert syndrome 35, 618161 (3), Autosomal recessive
chr10	SFXN2	615570.0 | SFXN2 | Sideroflexin 2 | 118980.0 | ENSG00000156398 | nan | nan
chr10	WBP1L	611129.0 | C10orf26, OPAL1 | Chromosome 10 open reading frame 26 | 54838.0 | ENSG00000166272 | nan | nan
chr10	CYP17A1	609300.0 | CYP17A1, CYP17, P450C17 | Cytochrome P450, family 17, subfamily A, polypeptide 1 (steroid 17-alpha-hydroxylase) | 1586.0 | ENSG00000148795 | at least 2 genes; distal to GOT1 | 17,20-lyase deficiency, isolated, 202110 (3), Autosomal recessive; 17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3), Autosomal recessive
chr10	BORCS7	616600.0 | BORCS7, C10orf32 | BLOC1-related complex, subunit 7 | 119032.0 | ENSG00000166275 | nan | nan
chr10	AS3MT	611806.0 | AS3MT, CYT19 | Arsenic (+3 oxidation state) methyltransferase | 57412.0 | ENSG00000214435 | nan | nan
chr10	CNNM2	607803.0 | CNNM2, ACDP2, HOMG6, HOMGSMR | Cyclin M2 | 54805.0 | ENSG00000148842 | nan | Hypomagnesemia 6, renal, 613882 (3), Autosomal dominant; Hypomagnesemia, seizures, and impaired intellectual development 1, 616418 (3), Autosomal recessive, Autosomal dominant
chr10	NT5C2	600417.0 | NT5C2, NT5B, PNT5, SPG45 | 5' nucleotidase, cytosolic II | 22978.0 | ENSG00000076685 | nan | Spastic paraplegia 45, autosomal recessive, 613162 (3), Autosomal recessive
chr10	INA	605338.0 | INA, NF66, NEF5 | Internexin, alpha | 9118.0 | ENSG00000148798 | nan | nan
chr10	PCGF6	607816.0 | PCGF6, RNF134, MBLR | Polycomb group ring finger 6 | 84108.0 | ENSG00000156374 | nan | nan
chr10	TAF5	601787.0 | TAF5, TAF2D, TAFII100 | TAF5 RNA polymerase II, TATA box binding protein-associated factor, 100kD | 6877.0 | ENSG00000148835 | nan | nan
chr10	ATP5MK	615204.0 | ATP5MD, USMG5, DAPIT, MC5DN6 | ATP synthase membrane subunit DAPIT | 84833.0 | ENSG00000173915 | nan | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 6, 618683 (3), Autosomal recessive
chr10	PDCD11	612333.0 | PDCD11, ALG4, NFBP, KIAA0185 | Programmed cell death 11 | 22984.0 | ENSG00000148843 | nan | nan
chr10	CALHM2	612235.0 | CALHM2, FAM26B | Calcium homeostasis modulator 2 | 51063.0 | ENSG00000138172 | nan | nan
chr10	CALHM1	612234.0 | CALHM1, FAM26C | Calcium homeostasis modulator 1 | 255022.0 | ENSG00000185933 | ?Alzheimer disease, 605526 | nan
chr10	CALHM3	618263.0 | CALHM3 | Calcium homeostasis modulator 3 | 119395.0 | ENSG00000183128 | nan | nan
chr10	NEURL1	603804.0 | NEURL1, NEURL, NEUR1 | Neuralized E3 ubiquitin protein ligase 1 | 9148.0 | ENSG00000107954 | nan | nan
chr10	SH3PXD2A	619455.0 | SH3PXD2A, FISH, TKS5 | SH3 and PX domains-containing protein 2A | 9644.0 | ENSG00000107957 | nan | nan
chr10	STN1	613128.0 | STN1, OBFC1, AAF44 | STN1, CST complex subunit | 79991.0 | ENSG00000107960 | nan | Cerebroretinal microangiopathy with calcifications and cysts 2, 617341 (3), Autosomal recessive
chr10	SLK	616563.0 | SLK, LOSK, KIAA0204 | STE20-like protein kinase | 9748.0 | ENSG00000065613 | nan | nan
chr10	EIG4	609750.0 | EIG4 | Epilepsy, idiopathic generalized, susceptibility to 4 | 780913.0 | nan | between D16S397 and D16S3095 | {Epilepsy, idiopathic generalized, susceptibility to 4}, 609750 (2)
chr10	IDDM17	603266.0 | IDDM17 | Insulin-dependent diabetes mellitus-17 | 8691.0 | nan | nan | {Diabetes mellitus, insulin-dependent, 17}, 603266 (2)
chr10	COL17A1	113811.0 | COL17A1, BPAG2, ERED, JEB4 | Collagen XVII, alpha-1 polypeptide | 1308.0 | ENSG00000065618 | nan | Epithelial recurrent erosion dystrophy, 122400 (3), Autosomal dominant; Epidermolysis bullosa, junctional 4, intermediate, 619787 (3), Autosomal recessive
chr10	SFR1	616527.0 | SFR1, MEI5, C10orf78 | SWI5-dependent homologous recombination repair protein 1 | 119392.0 | ENSG00000156384 | nan | nan
chr10	CFAP43	617558.0 | CFAP43, WDR96, C10orf79, SPGF19, HYDNP1 | Cilia- and flagella-associated protein 43 | 80217.0 | ENSG00000197748 | mutation identified in 1 HYDNP1 family | Hydrocephalus, normal pressure, 1, 236690 (3), Autosomal dominant; Spermatogenic failure 19, 617592 (3), Autosomal recessive
chr10	GSTO1	605482.0 | GSTO1 | Glutathione S-transferase, omega-1 | 9446.0 | ENSG00000148834 | nan | nan
chr10	GSTO2	612314.0 | GSTO2 | Glutathione S-transferase, omega-2 | 119391.0 | ENSG00000065621 | nan | nan
chr10	ITPRIP	620205.0 | ITPRIP, DANGER, KIAA1754 | Inositol 1,4,5-trisphosphate receptor-interacting protein | 85450.0 | ENSG00000148841 | nan | nan
chr10	CFAP58	619129.0 | CFAP58, SPGF49 | Cilia- and flagella-associated protein 58 | 159686.0 | ENSG00000120051 | nan | Spermatogenic failure 49, 619144 (3), Autosomal recessive
chr10	SORCS3	606285.0 | SORCS3, KIAA1059 | SORCS receptor 3 | 22986.0 | ENSG00000156395 | nan | nan
chr10	SORCS1	606283.0 | SORCS1 | Sortilin-related VPS10 domain-containing receptor 1 | 114815.0 | ENSG00000108018 | nan | nan
chr10	XPNPEP1	602443.0 | XPNPEP1, SAMP, XPNPEPL | X-prolyl aminopeptidase P1 | 7511.0 | ENSG00000108039 | nan | nan
chr10	ADD3	601568.0 | ADD3, ADDL, CPSQ3 | Adducin-3, gamma | 120.0 | ENSG00000148700 | fusion with NUP98 in T-ALL | Cerebral palsy, spastic quadriplegic, 3, 617008 (3), Autosomal recessive
chr10	MXI1	600020.0 | MXI1 | MAX-interacting protein 1 | 4601.0 | ENSG00000119950 | nan | Prostate cancer, somatic, 176807 (3); Neurofibrosarcoma, somatic (3)
chr10	SMNDC1	603519.0 | SMNR, SPF30 | Survival motor neuron-related protein | 10285.0 | ENSG00000119953 | nan | nan
chr10	DUSP5	603069.0 | DUSP5, HVH3 | Dual-specificity phosphatase-5 | 1847.0 | ENSG00000138166 | nan | nan
chr10	SMC3	606062.0 | SMC3, CSPG6, HCAP, BAM, CDLS3 | Structural maintenance of chromosomes 3 | 9126.0 | ENSG00000108055 | nan | Cornelia de Lange syndrome 3, 610759 (3), Autosomal dominant
chr10	RBM20	613171.0 | RBM20 | RNA-binding motif protein 20 | 282996.0 | ENSG00000203867 | nan | Cardiomyopathy, dilated, 1DD, 613172 (3), Autosomal dominant
chr10	PDCD4	608610.0 | PDCD4 | Programmed cell death 4 | 27250.0 | ENSG00000150593 | nan | nan
chr10	BBIP1	613605.0 | BBIP1, NCRNA00081, BBIP10, BBS18 | BBSome interacting protein 1 | 92482.0 | ENSG00000214413 | nan | Bardet-Biedl syndrome 18, 615995 (3), Autosomal recessive
chr10	SHOC2	602775.0 | SHOC2, SIAA0862, SOC2, SUR8, NSLH1 | SHOC2 leucine-rich repeat scaffold protein | 8036.0 | ENSG00000108061 | nan | Noonan syndrome-like with loose anagen hair 1, 607721 (3), Autosomal dominant
chr10	ADRA2A	104210.0 | ADRA2A, ADRA2R, FPLD8 | Adrenergic, alpha-2A-, receptor | 150.0 | ENSG00000150594 | mutation identified in 1 FPLD8 family | ?Lipodystrophy, familial partial, type 8, 620679 (3), Autosomal dominant
chr10	GPAM	602395.0 | GPAM | Glycerol-3-phosphate acyltransferase | 57678.0 | ENSG00000119927 | nan | nan
chr10	TECTB	602653.0 | TECTB | Tectorin, beta | 6975.0 | ENSG00000119913 | nan | nan
chr10	ACSL5	605677.0 | ACSL5, FACL5, ACS5, DIAR13 | Acyl-CoA synthetase long-chain family member 5 | 51703.0 | ENSG00000197142 | mutation identified in 1 DIAR13 family | ?Diarrhea 13, 620357 (3), Autosomal recessive
chr10	ZDHHC6	618715.0 | ZDHHC6, DHHC6 | Zinc finger DHHC-type palmitoyltransferase 6 | 64429.0 | ENSG00000023041 | nan | nan
chr10	VTI1A	614316.0 | VTI1A, VTI1RP2, MMDS3 | Vesicle transport through interaction with T-snares 1A | 143187.0 | ENSG00000151532 | nan | nan
chr10	TCF7L2	602228.0 | TCF7L2, TCF4 | Transcription factor 7-like 2 | 6934.0 | ENSG00000148737 | nan | {Diabetes mellitus, type 2, susceptibility to}, 125853 (3), Autosomal dominant
chr10	HABP2	603924.0 | HABP2, PHBP, HGFAL, FSAP, NMTC5 | Hyaluronan-binding protein 2 | 3026.0 | ENSG00000148702 | mutation identified in 1 NMTC5 family | {?Thyroid cancer, nonmedullary, 5}, 616535 (3), Autosomal dominant; {Venous thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant
chr10	NRAP	602873.0 | NRAP | Nebulin-related anchoring protein | 4892.0 | ENSG00000197893 | nan | nan
chr10	CASP7	601761.0 | CASP7, MCH3 | Caspase 7, apoptosis-related cysteine protease | 840.0 | ENSG00000165806 | nan | nan
chr10	DCLRE1A	609682.0 | DCLRE1A, SNM1, SNM1A, KIAA0086 | DNA cross-link repair protein 1A | 9937.0 | ENSG00000198924 | nan | nan
chr10	NHLRC2	618277.0 | NHLRC2, FINCA | NHL repeat-containing protein 2 | 374354.0 | ENSG00000196865 | nan | FINCA syndrome, 618278 (3), Autosomal recessive
chr10	ADRB1	109630.0 | ADRB1, ADRB1R, FNSS2 | Adrenergic, beta-1-, receptor | 153.0 | ENSG00000043591 | mutation identified in 1 FNSS2 family | ?[Short sleep, familial natural, 2], 618591 (3), Autosomal dominant; [Resting heart rate], 607276 (3)
chr10	CCDC186	619249.0 | CCDC186, CCCP1, C10orf118 | Coiled-coil domain-containing protein 186 | 55088.0 | ENSG00000165813 | nan | nan
chr10	TDRD1	605796.0 | TDRD1 | Tudor domain protein 1 | 56165.0 | ENSG00000095627 | nan | nan
chr10	VWA2	618281.0 | VWA2, CCSP2, AMACO | von Willebrand factor A domain-containing protein 2 | 340706.0 | ENSG00000165816 | nan | nan
chr10	AFAP1L2	612420.0 | AFAP1L2, XB130, KIAA1914 | Actin filament-associated protein 1-like protein 2 | 84632.0 | ENSG00000169129 | nan | nan
chr10	ABLIM1	602330.0 | LIMAB1 | LIM actin-binding protein-1 | 3983.0 | ENSG00000099204 | nan | nan
chr10	FHIP2A	617312.0 | FHIP2A, FAM160B1, KIAA1600 | FHF complex subunit hook-interacting protein 2A | 57700.0 | ENSG00000151553 | nan | nan
chr10	TRUB1	610726.0 | TRUB1, PUS4 | TRUB pseudouridine synthase, E. coli, homolog of, 1 | 142940.0 | ENSG00000165832 | nan | nan
chr10	ATRNL1	612869.0 | ATRNL1, KIAA0534, ALP | Attractin-like 1 | 26033.0 | ENSG00000107518 | nan | nan
chr10	GFRA1	601496.0 | GFRA1, GDNFRA, GDNFR, RHDA4 | GDNF family receptor, alpha-1 | 2674.0 | ENSG00000151892 | nan | Renal hypodysplasia/aplasia 4, 619887 (3), Autosomal recessive
chr10	PNLIP	246600.0 | PNLIP, PNLIPD | Pancreatic lipase | 5406.0 | ENSG00000175535 | mutation identified in 1 family | ?Pancreatic lipase deficiency, 614338 (3), Autosomal recessive
chr10	PNLIPRP1	604422.0 | PNLIPRP1, PLRP1 | Pancreatic lipase-related protein 1 | 5407.0 | ENSG00000187021 | nan | nan
chr10	PNLIPRP2	604423.0 | PNLIPRP2, PLRP2 | Pancreatic lipase-related protein 2 | 5408.0 | ENSG00000266200 | nan | nan
chr10	HSPA12A	610701.0 | HSPA12A, KIAA0417 | Heat-shock 70kD protein 12A | 259217.0 | ENSG00000165868 | nan | nan
chr10	ENO4	131375.0 | ENO4, ENOS | Enolase 4 | 387712.0 | ENSG00000188316 | nan | nan
chr10	SHTN1	611171.0 | SHTN1, KIAA1598, SHOOTIN1 | Shootin1 | 57698.0 | ENSG00000187164 | nan | nan
chr10	VAX1	604294.0 | VAX1, MCOPS11 | Ventral anterior homeobox 1 | 11023.0 | ENSG00000148704 | mutation identified in one MCOPS11 family | ?Microphthalmia, syndromic 11, 614402 (3), Autosomal recessive
chr10	KCNK18	613655.0 | KCNK18, TRESK, TRIK, MGR13 | Potassium channel, subfamily K, member 18 | 338567.0 | ENSG00000186795 | nan | {Migraine, with or without aura, susceptibility to, 13}, 613656 (3), Autosomal dominant
chr10	SLC18A2	193001.0 | SLC18A2, VAT2, SVMT, PKDYS2 | Solute carrier family 18 (vesicular monoamine), member 2 | 6571.0 | ENSG00000165646 | nan | Parkinsonism-dystonia, infantile, 2, 618049 (3), Autosomal recessive
chr10	PDZD8	614235.0 | PDZD8, IDDADF | PDZ domain-containing protein 8 | 118987.0 | ENSG00000165650 | nan | Intellectual developmental disorder with autism and dysmorphic facies, 620021 (3), Autosomal recessive
chr10	CORD17	615163.0 | CORD17 | Cone-rod dystrophy 17 | 101409267.0 | nan | between D10S1757 and D10S1782 | Cone-rod dystrophy 17, 615163 (2), Autosomal dominant
chr10		609625.0 | DEL10q26, C10q26DEL | Chromosome 10q26 deletion syndrome | nan | nan | nan | Chromosome 10q26 deletion syndrome, 609625 (4), Autosomal dominant
chr10	ENDO1	131200.0 | ENDO1 | Endometriosis, susceptibility to, 1 | 100188863.0 | nan | max lod at D10S587 | {Endometriosis, susceptibility to, 1}, 131200 (2), Autosomal recessive, Multifactorial
chr10	RRIS	609116.0 | RRIS | Respiratory rhythmicity in sleep | 497662.0 | nan | nan | [Respiratory rhythmicity in sleep], 609116 (2)
chr10	EMX2OS	607637.0 | EMX2OS | EMX2 opposite strand/ antisense RNA | 196047.0 | ENSG00000229847 | non-coding RNA | nan
chr10	EMX2	600035.0 | EMX2 | Empty spiracles homeobox 2 | 2018.0 | ENSG00000170370 | close to VAX1 | Schizencephaly, 269160 (3)
chr10	RAB11FIP2	608599.0 | RAB11FIP2, KIAA0941 | RAB11 family-interacting protein 2 | 22841.0 | ENSG00000107560 | nan | nan
chr10	CASC2	608598.0 | CASC2 | Cancer susceptibility candidate 2 | 255082.0 | ENSG00000177640 | head-to-head orientation with RAB11FIP2 | nan
chr10	PRLHR	600895.0 | GPR10 | G protein-coupled receptor-10 | 2834.0 | ENSG00000119973 | nan | nan
chr10	CACUL1	618764.0 | CACUL1, CAC1, C10orf46 | CDK2-associated cullin domain-containing protein 1 | 143384.0 | ENSG00000151893 | nan | nan
chr10	NANOS1	608226.0 | NANOS1, NOS1, SPGF12 | NANOS C2HC-type zinc finger 1 | 340719.0 | ENSG00000188613 | nan | Spermatogenic failure 12, 615413 (3), Autosomal dominant
chr10	EIF3A	602039.0 | EIF3A, EIF3S10, P167 | Eukaryotic translation initiation factor 3, subunit A | 8661.0 | ENSG00000107581 | nan | nan
chr10	SFXN4	615564.0 | SFXN4, COXPD18 | Sideroflexin 4 | 119559.0 | ENSG00000183605 | nan | Combined oxidative phosphorylation deficiency 18, 615578 (3), Autosomal recessive
chr10	PRDX3	604769.0 | PRDX3, AOP1, SCAR32, PPPCD | Peroxiredoxin 3 (antioxidant protein 1) | 10935.0 | ENSG00000165672 | nan | Spinocerebellar ataxia, autosomal recessive 32, 619862 (3), Autosomal recessive; Corneal dystrophy, punctiform and polychromatic pre-Descemet, 619871 (3), Autosomal dominant
chr10	GRK5	600870.0 | GRK5, GPRK5 | G protein-coupled receptor kinase 5 | 2869.0 | ENSG00000198873 | nan | nan
chr10	RGS10	602856.0 | RGS10 | Regulator of G protein signaling 10 | 6001.0 | ENSG00000148908 | nan | nan
chr10	TIAL1	603413.0 | TIAL1, TIAR, TCBP | Tia1 cytotoxic granule-associated RNA-binding protein-like 1 | 7073.0 | ENSG00000151923 | nan | nan
chr10	BAG3	603883.0 | BAG3, MFM6 | BCL2-associated athanogene 3 | 9531.0 | ENSG00000151929 | nan | Cardiomyopathy, dilated, 1HH, 613881 (3), Autosomal dominant; Myopathy, myofibrillar, 6, 612954 (3), Autosomal dominant
chr10	INPP5F	609389.0 | INPP5F, SAC2, KIAA0966 | Inositol polyphosphate 5-phosphatase F | 22876.0 | ENSG00000198825 | nan | nan
chr10	MCMBP	610909.0 | MCMBP, C10orf119 | Minichromosome maintenance complex-binding protein | 79892.0 | ENSG00000197771 | nan | nan
chr10	SEC23IP	617852.0 | SEC23IP | SEC23-interacting protein | 11196.0 | ENSG00000107651 | nan | nan
chr10	WDR11	606417.0 | WDR11, DR11, KIAA1351, BRWD2, HH14 | WD repeat-containing protein 11 | 55717.0 | ENSG00000120008 | nan | Intellectual developmental disorder, autosomal recessive 78, 620237 (3), Autosomal recessive; Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3), Autosomal dominant
chr10	FGFR2	176943.0 | FGFR2, BEK, CFD1, JWS, TK14, BBDS | Fibroblast growth factor receptor-2 (bacteria-expressed kinase) | 2263.0 | ENSG00000066468 | nan | Bent bone dysplasia syndrome, 614592 (3), Autosomal dominant; LADD syndrome 1, 149730 (3), Autosomal dominant; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3), Autosomal dominant; Scaphocephaly and Axenfeld-Rieger anomaly (3); Jackson-Weiss syndrome, 123150 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3); Craniofacial-skeletal-dermatologic dysplasia, 101600 (3), Autosomal dominant; Apert syndrome, 101200 (3), Autosomal dominant; Pfeiffer syndrome, 101600 (3), Autosomal dominant; Craniosynostosis, nonspecific (3); ?Scaphocephaly, maxillary retrusion, and impaired intellectual development, 609579 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3), Autosomal dominant; Crouzon syndrome, 123500 (3), Autosomal dominant; Saethre-Chotzen syndrome, 101400 (3), Autosomal dominant
chr10	ATE1	607103.0 | ATE1 | Arginyltransferase 1 | 11101.0 | ENSG00000107669 | nan | nan
chr10	NSMCE4A	612987.0 | NSMCE4A, NSE4A | NSE4 homolog A, SMC5-SMC6 complex component | 54780.0 | ENSG00000107672 | nan | nan
chr10	TACC2	605302.0 | TACC2 | Transforming, acidic, coiled-coil-containing protein 2 | 10579.0 | ENSG00000138162 | nan | nan
chr10	PLEKHA1	607772.0 | PLEKHA1, TAPP1 | Pleckstrin homology domain-containing protein, family A, member 1 | 59338.0 | ENSG00000107679 | nan | nan
chr10	ARMS2	611313.0 | LOC387715, ARMD8 | LOC387715 gene | 387715.0 | ENSG00000254636 | nan | {Macular degeneration, age-related, 8}, 613778 (3)
chr10	HTRA1	602194.0 | HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2 | HTRA serine peptidase 1 | 5654.0 | ENSG00000166033 | nan | {Macular degeneration, age-related, neovascular type}, 610149 (3); {Macular degeneration, age-related, 7}, 610149 (3); CARASIL syndrome, 600142 (3), Autosomal recessive; Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3), Autosomal dominant
chr10	DMBT1	601969.0 | DMBT1 | Deleted in malignant brain tumors 1 | 1755.0 | ENSG00000187908 | nan | nan
chr10	CUZD1	616644.0 | CUZD1, ERG1, ITMAP1 | Cub and zona pellucida-like domains 1 | 50624.0 | ENSG00000138161 | nan | nan
chr10	C10orf88	620661.0 | C10orf88, PAAT | Chromosome 10 open reading frame 88 | 80007.0 | ENSG00000119965 | nan | nan
chr10	PSTK	611310.0 | PSTK, C10orf89 | Phosphoseryl-tRNA kinase | 118672.0 | ENSG00000179988 | nan | nan
chr10	IKZF5	606238.0 | IKZF5, ZNFN1A5, PEGASUS, THC7 | Ikaros family zinc finger 5 | 64376.0 | ENSG00000095574 | nan | Thrombocytopenia, autosomal dominant, 7, 619130 (3), Autosomal dominant
chr10	ACADSB	600301.0 | ACADSB, SBCAD | Acyl-Coenzyme A dehydrogenase, short/branched chain | 36.0 | ENSG00000196177 | nan | 2-methylbutyrylglycinuria, 610006 (3), Autosomal recessive
chr10	HMX3	613380.0 | HMX3, NKX5.1 | H6 family homeobox 3 | 340784.0 | ENSG00000188620 | nan | nan
chr10	HMX2	600647.0 | HMX2 | Homeobox (H6 family) 2 | 3167.0 | ENSG00000188816 | nan | nan
chr10	BUB3	603719.0 | BUB3 | BUB3 mitotic checkpoint protein | 9184.0 | ENSG00000154473 | nan | nan
chr10	GPR26	604847.0 | GPR26 | G protein-coupled receptor 26 | 2849.0 | ENSG00000154478 | nan | nan
chr10	CPXM2	617348.0 | CPXM2, CPX2 | Carboxypeptidase X, M14 family, member 2 | 119587.0 | ENSG00000121898 | nan | nan
chr10	CHST15	608277.0 | CHST15, BRAG, KIAA0598 | Carbohydrate sulfotransferase 15 | 51363.0 | ENSG00000182022 | nan | nan
chr10	OAT	613349.0 | OAT, GACR | Ornithine aminotransferase | 4942.0 | ENSG00000065154 | pseudogene at Xp11.2 | Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3), Autosomal recessive
chr10	LHPP	617231.0 | LHPP | Phospholysine phosphohistidine inorganic pyrophosphate phosphatase | 64077.0 | ENSG00000107902 | nan | nan
chr10	FAM53B	617289.0 | FAM53B, KIAA0140 | Family with sequence similarity 53, member B | 9679.0 | ENSG00000189319 | nan | nan
chr10	EEF1AKMT2	617794.0 | EEF1AKMT2, METTL10 | EEF1A lysine methyltransferase 2 | 399818.0 | ENSG00000203791 | nan | nan
chr10	ABRAXAS2	611144.0 | ABRAXAS2, FAM175B, ABRO1, KIAA0157 | Abraxas 2, BRISC complex subunit | 23172.0 | ENSG00000165660 | nan | nan
chr10	ZRANB1	611749.0 | ZRANB1, TRABID | Zinc finger- and RAN-binding domain-containing protein 1 | 54764.0 | ENSG00000019995 | nan | nan
chr10	CTBP2	602619.0 | CTBP2 | C-terminal-binding protein 2 | 1488.0 | ENSG00000175029 | nan | nan
chr10	EDRF1	620463.0 | EDRF1, C10orf137 | Erythroid differentiation regulatory factor 1 | 26098.0 | ENSG00000107938 | nan | nan
chr10	MMP21	608416.0 | MMP21, HTX7 | Matrix metalloproteinase 21 | 118856.0 | ENSG00000154485 | nan | Heterotaxy, visceral, 7, autosomal, 616749 (3), Autosomal recessive
chr10	UROS	606938.0 | UROS | Uroporphyrinogen III synthase | 7390.0 | ENSG00000188690 | nan | Porphyria, congenital erythropoietic, 263700 (3), Autosomal recessive
chr10	BCCIP	611883.0 | BCCIP, TOK1 | BRCA2- and CDKN1A-interacting protein | 56647.0 | ENSG00000107949 | nan | nan
chr10	DHX32	607960.0 | DHX32, DDX32 | DEAH-box helicase 32 (putative) | 55760.0 | ENSG00000089876 | nan | nan
chr10	FANK1	611640.0 | FANK1 | Fibronectin type III and ankyrin repeat domains 1 | 92565.0 | ENSG00000203780 | nan | nan
chr10	ADAM12	602714.0 | ADAM12, MLTN | ADAM metallopeptidase domain 12 | 8038.0 | ENSG00000148848 | nan | nan
chr10	C10orf90	617735.0 | C10orf90, FATS | Chromosome 10 open reading frame 90 | 118611.0 | ENSG00000154493 | nan | nan
chr10	DOCK1	601403.0 | DOCK1, DOCK180 | Dedicator of cytokinesis-1 | 1793.0 | ENSG00000150760 | nan | nan
chr10	INSYN2A	617129.0 | FAM196A, C10orf141, INSYN2 | Family with sequence similarity 196, member A | 642938.0 | ENSG00000188916 | nan | nan
chr10	NPS	609513.0 | NPS | Neuropeptide S | 594857.0 | ENSG00000214285 | nan | nan
chr10	FOXI2	617202.0 | FOXI2 | Forkhead box I2 | 399823.0 | ENSG00000186766 | nan | nan
chr10	CLRN3	620256.0 | CLRN3, TMEM12 | Clarin 3 | 119467.0 | ENSG00000180745 | nan | nan
chr10	PTPRE	600926.0 | PTPRE | Protein tyrosine phosphatase, receptor type, epsilon | 5791.0 | ENSG00000132334 | nan | nan
chr10	MKI67	176741.0 | MKI67 | Proliferation-related Ki-67 antigen | 4288.0 | ENSG00000148773 | nan | nan
chr10	MGMT	156569.0 | MGMT | Methylguanine-DNA methyltransferase | 4255.0 | ENSG00000170430 | nan | nan
chr10	EBF3	607407.0 | EBF3, COE3, HADDS | Early B-cell factor 3 | 253738.0 | ENSG00000108001 | nan | Hypotonia, ataxia, and delayed development syndrome, 617330 (3), Autosomal dominant
chr10	GLRX3	612754.0 | GLRX3, PICOT | Glutaredoxin 3 | 10539.0 | ENSG00000108010 | nan | nan
chr10	TCERG1L	620498.0 | TCERG1L | Transcription elongation regulator 1-like | 256536.0 | ENSG00000176769 | nan | nan
chr10	PPP2R2D	613992.0 | PPP2R2D | Protein phosphatase 2, regulatory subunit B, delta | 55844.0 | ENSG00000175470 | nan | nan
chr10	BNIP3	603293.0 | BNIP3, NIP3 | BCL2/adenovirus E1B 19-kD protein-interacting protein 3 | 664.0 | ENSG00000176171 | nan | nan
chr10	JAKMIP3	611198.0 | JAKMIP3, C10orf39, NECC2, JAMIP3 | Janus kinase and microtubule interacting protein 3 | 282973.0 | ENSG00000188385 | nan | nan
chr10	DPYSL4	608407.0 | DPYSL4, CRMP3, ULIP4 | Dihydropyrimidinase-like 4 | 10570.0 | ENSG00000151640 | nan | nan
chr10	INPP5A	600106.0 | INPP5A | Inositol polyphosphate-5-phosphatase, 40kD | 3632.0 | ENSG00000068383 | nan | nan
chr10	NKX6-2	605955.0 | NKX6-2, NKX6B, NKX6.2, SPAX8 | NK6 transcription factor related, locus 2 (Drosophila) | 84504.0 | ENSG00000148826 | nan | Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy, 617560 (3), Autosomal recessive
chr10	CFAP46	618543.0 | CFAP46, TTC40 | Cilia- and flagella-associated protein 46 | 54777.0 | ENSG00000171811 | nan | nan
chr10	ADGRA1	612302.0 | ADGRA1, GPR123, KIAA1828 | Adhesion G protein-coupled receptor A1 | 84435.0 | ENSG00000197177 | nan | nan
chr10	KNDC1	616237.0 | KNDC1, RASGEF2, KIAA1768 | Kinase noncatalytic C-lobe domain-containing protein 1 | 85442.0 | ENSG00000171798 | nan | nan
chr10	UTF1	604130.0 | UTF1 | Undifferentiated embryonic cell transcription factor 1 | 8433.0 | ENSG00000171794 | nan | nan
chr10	VENTX	607158.0 | VENTX, VENTX2, HPX42B | VENT homeobox | 27287.0 | ENSG00000151650 | nan | nan
chr10	ADAM8	602267.0 | ADAM8, CD156 | ADAM metallopeptidase domain 8 | 101.0 | ENSG00000151651 | nan | nan
chr10	TUBGCP2	617817.0 | TUBGCP2, GCP2, GRIP103, SPC97, ALP4, PAMDDFS | Tubulin-gamma complex-associated protein 2 | 10844.0 | ENSG00000130640 | nan | Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures, 618737 (3), Autosomal recessive
chr10	CALY	604647.0 | CALY, DRD1IP | Calcyon neuron-specific vesicular protein | 50632.0 | ENSG00000130643 | nan | nan
chr10	PRAP1	609776.0 | PRAP1 | Proline-rich acidic protein 1 | 118471.0 | ENSG00000165828 | nan | nan
chr10	FUOM	617725.0 | FUOM, FUCU | Fucose mutarotase | 282969.0 | ENSG00000148803 | nan | nan
chr10	ECHS1	602292.0 | ECHS1, SCEH, ECHS1D | Enoyl-CoA hydratase, short-chain, 1, mitochondrial | 1892.0 | ENSG00000127884 | nan | Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3), Autosomal recessive
chr10	PAOX	615853.0 | PAOX, PAO | Polyamine oxidase | 196743.0 | ENSG00000148832 | nan | nan
chr10	SPRN	610447.0 | SPRN, SHADOO, SHO | Shadow of prion protein | 503542.0 | ENSG00000203772 | nan | nan
chr10	CYP2E1	124040.0 | CYP2E, CYP2E1, P450C2E | Cytochrome P450, subfamily IIE, ethanol-inducible | 1571.0 | ENSG00000130649 | nan | nan
chr10	SYCE1	611486.0 | SYCE1, POF12, SPGF15 | Synaptonemal complex central element protein 1 | 93426.0 | ENSG00000171772 | mutation identified in 1 POF12 and 1 SPGF15 family | ?Spermatogenic failure 15, 616950 (3), Autosomal recessive; ?Premature ovarian failure 12, 616947 (3), Autosomal recessive
chr11		606528.0 | DEL11p15p14, C11DELp15p14 | Chromosome 11p15-p14 deletion syndrome (homozygous) | nan | nan | contiguous gene deletion syndrome | Chromosome 11p15-p14 deletion syndrome, 606528 (4), Autosomal recessive
chr11	GINGF4	611010.0 | GINGF4, HGF4, GGF4 | Fibromatosis, gingival, 4 | 100124414.0 | nan | between D11S1984 and D11S1338 | Fibromatosis, gingival, 4, 611010 (2)
chr11	HYPLIP2	604499.0 | HYPLIP2 | Hyperlipidemia, combined, 2 | 28515.0 | nan | nan | Hyperlipidemia, combined, 2, 604499 (2)
chr11	IH	235000.0 | IH, HHP | Hemihyperplasia, isolated | 100188864.0 | nan | epigenetic or uniparental disomy | Hemihypertrophy, 235000 (2), Autosomal dominant
chr11		147510.0 | IRDN, ILPR | Insulin-related DNA polymorphism (insulin-related VNTR) | nan | nan | nan | nan
chr11	LVNC2	609470.0 | LVNC2 | Left ventricular noncompaction 2 | 619411.0 | nan | max lod at D11S902 | Left ventricular noncompaction 2, 609470 (2)
chr11	NBLST7	616792.0 | NBLST7 | Neuroblastoma, susceptibility to, 7 | 107181289.0 | nan | associated with rs2168101 | {Neuroblastoma, susceptibility to, 7}, 616792 (2)
chr11	NNO1	600165.0 | NNO1 | Nanophthalmos 1 | 23691.0 | nan | nan | Nanophthalmos-1, 600165 (2), Autosomal dominant
chr11	SLEN3	607967.0 | SLEN3 | Systemic lupus erythematosus with nephritis, susceptibility to, 3 | 282849.0 | nan | nan | {Systemic lupus erythematosus with nephritis, susceptibility to, 3}, 607967 (2)
chr11	SCGB1C1	610176.0 | SCGB1C1, RYD5 | Secretoglobin, family 1C, member 1 | 147199.0 | ENSG00000188076 | nan | nan
chr11	CIMAP1A	608356.0 | ODF3, SHIPPO1 | Outer dense fiber of sperm tails 3 | 113746.0 | ENSG00000177947 | nan | nan
chr11	BET1L	615417.0 | BET1L, GS15 | BET1-like protein | 51272.0 | ENSG00000177951 | nan | nan
chr11	RIC8A	609146.0 | RIC8A | RIC8 guanine nucleotide exchange factor A | 60626.0 | ENSG00000177963 | nan | nan
chr11	SIRT3	604481.0 | SIRT3, SIR2L3 | Sirtuin 3 | 23410.0 | ENSG00000142082 | nan | nan
chr11	PSMD13	603481.0 | PSMD13, S11 | Proteasome 26S subunit, non-ATPase, 13 | 5719.0 | ENSG00000185627 | nan | nan
chr11	NLRP6	609650.0 | NLRP6, NALP6, PYPAF5 | NLR family pyrin-domain containing 6 | 171389.0 | ENSG00000174885 | nan | nan
chr11	PGGHG	617032.0 | PGGHG, ATHL1 | Protein-glucosylgalactosylhydroxylysine glucosidase | 80162.0 | ENSG00000142102 | nan | nan
chr11	IFITM5	614757.0 | IFITM5, OI5 | Interferon-induced transmembrane protein 5 | 387733.0 | ENSG00000206013 | nan | Osteogenesis imperfecta, type V, 610967 (3), Autosomal dominant
chr11	IFITM2	605578.0 | IFITM2 | Interferon-induced transmembrane protein 1 | 10581.0 | ENSG00000185201 | nan | nan
chr11	IFITM1	604456.0 | IFITM1, IFI17, LEU13 | Interferon-induced transmembrane protein 1 | 8519.0 | ENSG00000185885 | nan | nan
chr11	IFITM3	605579.0 | IFITM3 | Interferon-induced transmembrane protein 3 | 10410.0 | ENSG00000142089 | nan | {Influenza, severe, susceptibility to}, 614680 (3)
chr11	B4GALNT4	618560.0 | B4GALNT4 | Beta-1,4-N-acetyl-galactosaminyltransferase 4 | 338707.0 | ENSG00000182272 | nan | nan
chr11	PKP3	605561.0 | PKP3 | Plakophilin-3 | 11187.0 | ENSG00000184363 | nan | nan
chr11	SIGIRR	605478.0 | SIGIRR | Single immunoglobulin domain-containing IL1R-related protein | 59307.0 | ENSG00000185187 | nan | nan
chr11	ANO9	619963.0 | ANO9, TMEM16J, TP53I5 | Anoctamin 9 | 338440.0 | ENSG00000185101 | nan | nan
chr11	PTDSS2	612793.0 | PTDSS2, PSS2 | Phosphatidylserine synthase 2 | 81490.0 | ENSG00000174915 | nan | nan
chr11	RNH1	173320.0 | RNH1, RNH, IIAE12 | Ribonuclease/angiogenin inhibitor 1 | 6050.0 | ENSG00000023191 | nan | {Encephalopathy, acute, infection-induced, susceptibility to, 12}, 620461 (3), Autosomal recessive
chr11	LRRC56	618227.0 | LRRC56, CILD39 | Leucine-rich repeat-containing protein 56 | 115399.0 | ENSG00000161328 | nan | Ciliary dyskinesia, primary, 39, 618254 (3), Autosomal recessive
chr11	HRAS	190020.0 | HRAS | Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog | 3265.0 | ENSG00000174775 | pseudogene HRASP on X | Bladder cancer, somatic, 109800 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Congenital myopathy with excess of muscle spindles, 218040 (3), Autosomal dominant; Nevus sebaceous or woolly hair nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Spitz nevus or nevus spilus, somatic, 137550 (3); Costello syndrome, 218040 (3), Autosomal dominant
chr11	RASSF7	143023.0 | RASSF7, C11orf13, HRC1 | Ras association domain family, member 7 | 8045.0 | ENSG00000099849 | 29kb 5' to HRAS1; divergently transcribed | nan
chr11	MIR210	612982.0 | MIR210, MIRN210 | Micro RNA 210 | 406992.0 | ENSG00000199038 | nan | nan
chr11	PHRF1	611780.0 | PHRF1, KIAA1542 | PHD and RING finger domain-containing protein 1 | 57661.0 | ENSG00000070047 | nan | nan
chr11	IRF7	605047.0 | IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39 | Interferon regulatory factor 7 | 3665.0 | ENSG00000185507 | mutation identified in 1 family | ?Immunodeficiency 39, 616345 (3), Autosomal recessive
chr11	CDHR5	606839.0 | CDHR5, MUCDHL | Cadherin-related family, member 5 | 53841.0 | ENSG00000099834 | nan | nan
chr11	SCT	182099.0 | SCT | Secretin | 6343.0 | ENSG00000070031 | nan | nan
chr11	DRD4	126452.0 | DRD4 | Dopamine receptor D4 | 1815.0 | ENSG00000069696 | proximal to HRAS | {Attention deficit-hyperactivity disorder}, 143465 (3), Autosomal dominant; Autonomic nervous system dysfunction (3)
chr11	DEAF1	602635.0 | DEAF1, SPN, ZMYND5, VSVS, NEDHELS | DEAF1 transcription factor | 10522.0 | ENSG00000177030 | nan | Vulto-van Silfout-de Vries syndrome, 615828 (3), Autosomal dominant; Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures, 617171 (3), Autosomal recessive
chr11	TMEM80	620248.0 | TMEM80 | Transmembrane protein 80 | 283232.0 | ENSG00000177042 | nan | nan
chr11	EPS8L2	614988.0 | EPS8L2, EPS8R2, DFNB106 | EPS8-like protein 2 | 64787.0 | ENSG00000177106 | nan | Deafness autosomal recessive 106, 617637 (3), Autosomal recessive
chr11	TALDO1	602063.0 | TALDO1 | Transaldolase-1 | 6888.0 | ENSG00000177156 | pseudogene on chr.1 | Transaldolase deficiency, 606003 (3), Autosomal recessive
chr11	CEND1	608213.0 | CEND1, BM88 | Cell cycle exit and neuronal differentiation 1 | 51286.0 | ENSG00000184524 | nan | nan
chr11	SLC25A22	609302.0 | SLC25A22, GC1, DEE3 | Solute carrier family 25 (mitochondrial carrier, glutamate), member 22 | 79751.0 | ENSG00000177542 | nan | Developmental and epileptic encephalopathy 3, 609304 (3), Autosomal recessive
chr11	PANO1	620541.0 | PANO1 | Proapoptotic nucleolar protein 1 | 101927423.0 | ENSG00000288675 | nan | nan
chr11	PIDD1	605247.0 | PIDD1, LRDD, MRT75 | p53-induced death domain protein 1 | 55367.0 | ENSG00000177595 | nan | Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly, 619827 (3), Autosomal recessive
chr11	RPLP2	180530.0 | RPLP2 | Ribosomal protein lateral stalk subunit P2 | 6181.0 | ENSG00000177600 | nan | nan
chr11	PNPLA2	609059.0 | PNPLA2, TTS2, ATGL | Patatin-like phospholipase domain-containing protein 2 | 57104.0 | ENSG00000177666 | nan | Neutral lipid storage disease with myopathy, 610717 (3), Autosomal recessive
chr11	CRACR2B	614177.0 | EFCAB4A, CRACR2B | EF-hand calcium-binding domain-containing protein 4A | 283229.0 | ENSG00000177685 | nan | nan
chr11	CD151	602243.0 | CD151, PETA3, SFA1, MER2, EBS7 | CD151 antigen | 977.0 | ENSG00000177697 | nan | [Blood group, Raph], 179620 (3); Epidermolysis bullosa simplex 7, with nephropathy and deafness, 609057 (3), Autosomal recessive
chr11	POLR2L	601189.0 | POLR2L, RPB10 | Polymerase II, RNA, subunit L | 5441.0 | ENSG00000177700 | nan | nan
chr11	TSPAN4	602644.0 | TSPAN4, TM4SF7, NAG2 | Tetraspanin 4 | 7106.0 | ENSG00000214063 | nan | nan
chr11	CHID1	615692.0 | CHID1, SICLP | Chitinase domain-containing protein 1 | 66005.0 | ENSG00000177830 | nan | nan
chr11	AP2A2	607242.0 | AP2A2, KIAA0899 | Adaptor-related protein complex 2, alpha-2 subunit | 161.0 | ENSG00000183020 | nan | nan
chr11	MUC6	158374.0 | MUC6 | Mucin 6, gastric | 4588.0 | ENSG00000184956 | order: tel-HRAS-MUC6-MUC2-MUC5AC-MUC5B-IGF2-cen | nan
chr11	MUC2	158370.0 | MUC2 | Mucin 2, intestinal/tracheal | 4583.0 | ENSG00000198788 | nan | nan
chr11	MUC5AC	158373.0 | MUC5AC, MUC5 | Mucin 5, subtypes A and C, tracheobronchial/gastric | 4586.0 | ENSG00000215182 | nan | nan
chr11	MUC5B	600770.0 | MUC5B | Mucin 5, subtype B, tracheobronchial | 727897.0 | ENSG00000117983 | nan | {Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant
chr11	TOLLIP	606277.0 | TOLLIP | Toll-interacting protein | 54472.0 | ENSG00000078902 | nan | nan
chr11	BRSK2	609236.0 | BRSK2, SAD1, PEN11B | BR serine/threonine kinase 2 | 9024.0 | ENSG00000174672 | nan | nan
chr11	MOB2	611969.0 | MOB2, HCCA2 | MOB kinase activator 2 | 81532.0 | ENSG00000182208 | nan | nan
chr11	DUSP8	602038.0 | DUSP8, HVH8 | Dual specificity phosphatase-8 | 1850.0 | ENSG00000184545 | pseudogene on 10q11.2 | nan
chr11	KRTAP5-1	148022.0 | KRTAP5-1, KRN1L | Keratin associated protein 5-1 | 387264.0 | ENSG00000205869 | nan | nan
chr11	IFITM10	618293.0 | IFITM10, DSPA3 | Interferon-induced transmembrane protein 10 | 402778.0 | ENSG00000244242 | nan | nan
chr11	CTSD	116840.0 | CTSD, CPSD, CLN10 | Cathepsin D (lysosomal aspartyl protease) | 1509.0 | ENSG00000117984 | nan | Ceroid lipofuscinosis, neuronal, 10, 610127 (3), Autosomal recessive
chr11	SYT8	607719.0 | SYT8 | Synaptotagmin 8 | 90019.0 | ENSG00000149043 | nan | nan
chr11	TNNI2	191043.0 | TNNI2, AMCD2B, DA2B1, FSSV | Troponin I, fast-twitch skeletal muscle isoform | 7136.0 | ENSG00000130598 | nan | Arthrogryposis, distal, type 2B1, 601680 (3), Autosomal dominant
chr11	LSP1	153432.0 | LSP1 | Lymphocyte-specific protein pp52 | 4046.0 | ENSG00000130592 | nan | nan
chr11	TNNT3	600692.0 | TNNT3, AMCD2B, DA2B2, FSSV | Troponin-T3, skeletal, fast | 7140.0 | ENSG00000130595 | nan | Arthrogryposis, distal, type 2B2, 618435 (3), Autosomal dominant
chr11	MRPL23	600789.0 | RPL23L, L23MRP, MRPL23 | Ribosomal protein L23-like (L23 mitochondrial-related protein) | 6150.0 | ENSG00000214026 | nan | nan
chr11	H19	103280.0 | H19, D11S813E, ASM1 | H19 gene | 283120.0 | ENSG00000130600 | same 200kb fragment as IGF2 | nan
chr11	MIR675	615509.0 | MIR675 | Micro RNA 675 | 100033819.0 | ENSG00000284010 | nan | nan
chr11		616186.0 | ICR1, BWS, WT2, SRS1 | H19-IGF2-imprinting control region | 105259599.0 | nan | nan | Wilms tumor 2, 194071 (3), Somatic mutation, Autosomal dominant; Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominant; Silver-Russell syndrome 1, 180860 (3), Autosomal dominant
chr11	IGF2	147470.0 | IGF2, GRDF, SRS3 | Insulin-like growth factor-2, or somatomedin A | 3481.0 | ENSG00000167244 | mutation identified in 1 GRDF family | Silver-Russell syndrome 3, 616489 (3), Autosomal dominant
chr11	IGF2-AS	610146.0 | IGF2AS, PEG8 | Insulin-like growth factor II, antisense | 51214.0 | ENSG00000099869 | nan | nan
chr11	INS	176730.0 | INS, MODY10, IDDM2, PNDM4 | Insulin | 3630.0 | ENSG00000254647 | 5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH | Diabetes mellitus, insulin-dependent, 2, 125852 (3), Autosomal dominant; Maturity-onset diabetes of the young, type 10, 613370 (3), Autosomal dominant; Hyperproinsulinemia, 616214 (3), Autosomal dominant; Diabetes mellitus, permanent neonatal 4, 618858 (3), Autosomal recessive, Autosomal dominant
chr11	TH	191290.0 | TH, TYH | Tyrosine hydroxylase | 7054.0 | ENSG00000180176 | distal to HRAS1 | Segawa syndrome, recessive, 605407 (3), Autosomal recessive
chr11	ASCL2	601886.0 | ASCL2 | Achaete-scute complex, Drosophila, homolog-like 2 | 430.0 | ENSG00000183734 | nan | nan
chr11	C11orf21	611033.0 | C11orf21 | Chromosome 11 open reading frame 21 | 29125.0 | ENSG00000110665 | nan | nan
chr11	TSPAN32	603853.0 | TSPAN32, PHEMX, TSSC6 | Tetraspanin 32 | 10077.0 | ENSG00000064201 | not imprinted | nan
chr11	CD81	186845.0 | CD81, TAPA1, CVID6 | CD81 antigen (target of antiproliferative antibody-1) | 975.0 | ENSG00000110651 | nan | Immunodeficiency, common variable, 6, 613496 (3), Autosomal recessive
chr11	TSSC4	603852.0 | TSSC4 | Tumor-suppressing subchromosomal transferable fragment cDNA 4 | 10078.0 | ENSG00000184281 | not imprinted | nan
chr11	TRPM5	604600.0 | TRPM5, MTR1 | Transient receptor potential cation channel, subfamily M, member 5 (MLSN1- and TRP-related gene 1) | 29850.0 | ENSG00000070985 | maternal allele imprinted | nan
chr11	KCNQ1	607542.0 | KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | 3784.0 | ENSG00000053918 | nan | Short QT syndrome 2, 609621 (3), Autosomal dominant; Atrial fibrillation, familial, 3, 607554 (3), Autosomal dominant; Long QT syndrome 1, 192500 (3), Autosomal dominant; {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3), Autosomal dominant; Jervell and Lange-Nielsen syndrome, 220400 (3), Autosomal recessive
chr11	KCNQ1OT1	604115.0 | KCNQ1OT1, LIT1 | KCNQ1-opposite strand/antisense transcript 1 | 10984.0 | ENSG00000269821 | nan | Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominant
chr11	GVINP1	616121.0 | GVINP1, VLIG1 | GTPase, very large interferon-inducible, pseudogene 1 | 387751.0 | ENSG00000254838 | nan | nan
chr11	KCNQ1DN	610980.0 | KCNQ1DN | KCNQ1 downstream neighbor | 55539.0 | ENSG00000237941 | nan | nan
chr11	CDKN1C	600856.0 | CDKN1C, KIP2, BWS, IMAGE | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | 1028.0 | ENSG00000129757 | rare cause of BWS | IMAGE syndrome, 614732 (3), Autosomal dominant; Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominant
chr11	SLC22A18AS	603240.0 | SLC22A1LS, ORCTL2S, BWSCR1B | Solute carrier family 22, member 1-like-antisense | 5003.0 | ENSG00000254827 | nan | nan
chr11	SLC22A18	602631.0 | SLC22A1L, BWSCR1A, IMPT1 | Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2) | 5002.0 | ENSG00000110628 | nan | Breast cancer, somatic, 114480 (3); Lung cancer, somatic, 211980 (3); Rhabdomyosarcoma, somatic, 268210 (3)
chr11	PHLDA2	602131.0 | PHLDA2, TSSC3, IPL, BRW1C | Pleckstrin homology-like domain, family A, member 2 | 7262.0 | ENSG00000181649 | nan | nan
chr11	NAP1L4	601651.0 | NAP1L4, NAP2L, NAP2 | Nucleosome assembly protein 1-like 4 | 4676.0 | ENSG00000205531 | nan | nan
chr11	CARS1	123859.0 | CARS1, CARS, MDBH | Cysteinyl-tRNA synthetase 1 | 833.0 | ENSG00000110619 | nan | Microcephaly, developmental delay, and brittle hair syndrome, 618891 (3), Autosomal recessive
chr11	OSBPL5	606733.0 | OSBPL5, ORP5, KIAA1534 | Oxysterol-binding protein-like protein 5 | 114879.0 | ENSG00000021762 | nan | nan
chr11	MRGPRG	607234.0 | MRGPRG, MRGG | MAS-related G protein-coupled receptor family, member G | 386746.0 | ENSG00000182170 | nan | nan
chr11	MRGPRE	607232.0 | MRGPRE, MRGE | Mas-related G protein-coupled receptor family, member E | 116534.0 | ENSG00000184350 | nan | nan
chr11	ZNF195	602187.0 | ZNF195 | Zinc finger protein-195 | 7748.0 | ENSG00000005801 | nan | nan
chr11	TSSC2	608999.0 | TSSC2 | Tumor-suppressing subtransferable fragment candidate gene 2 | 650368.0 | ENSG00000290960 | nan | nan
chr11	ART5	610625.0 | ART5 | ADP-ribosyltransferase 5 | 116969.0 | ENSG00000167311 | nan | nan
chr11	ART1	601625.0 | ART1 | ADP-ribosyltransferase 1 | 417.0 | ENSG00000129744 | nan | nan
chr11	CHRNA10	606372.0 | CHRNA10 | Cholinergic receptor, neuronal nicotinic, alpha polypeptide 10 | 57053.0 | ENSG00000129749 | nan | nan
chr11	NUP98	601021.0 | NUP98 | Nucleoporin, 98kD | 4928.0 | ENSG00000110713 | fused with HOXA9, NSD1, NSD3, PMX1, HOXC13, DDX10, TOP1, HOXD11 in myeloid leukemia | nan
chr11	PGAP2	615187.0 | PGAP2, FRAG1, HPMRS3, MRT17, MRT21 | Post-GPI attachment to proteins 2 | 27315.0 | ENSG00000148985 | nan | Hyperphosphatasia with impaired intellectual development syndrome 3, 614207 (3), Autosomal recessive
chr11	RHOG	179505.0 | ARHG | ras homolog gene family, member G (rho G) | 391.0 | ENSG00000177105 | nan | nan
chr11	STIM1	605921.0 | STIM1, TAM1, IMD10, STRMK | Stromal interaction molecule 1 | 6786.0 | ENSG00000167323 | nan | Myopathy, tubular aggregate, 1, 160565 (3), Autosomal dominant; Stormorken syndrome, 185070 (3), Autosomal dominant; Immunodeficiency 10, 612783 (3), Autosomal recessive
chr11	RRM1	180410.0 | RRM1, PEOB6 | Ribonucleotide reductase, M1 polypeptide | 6240.0 | ENSG00000167325 | nan | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 6, 620647 (3), Autosomal recessive, Autosomal dominant
chr11	TRIM21	109092.0 | TRIM21, SSA1, RO52 | Tripartite motif-containing protein 21 | 6737.0 | ENSG00000132109 | nan | nan
chr11	TRIM68	613184.0 | TRIM68, SS56, GC109 | Tripartite motif-containing protein 68 | 55128.0 | ENSG00000167333 | incorrectly assigned to 2p24 by FISH | nan
chr11	OR51E1	611267.0 | OR51E1, DGPCR, PSGR2 | Olfactory receptor, family 51, subfamily E, member 1 | 143503.0 | ENSG00000180785 | nan | nan
chr11	OR51E2	611268.0 | OR51E2, PSGR | Olfactory receptor, family 51, subfamily E, member 2 | 81285.0 | ENSG00000167332 | nan | nan
chr11	MMP26	605470.0 | MMP26 | Matrix metalloproteinase 26 (matrilysin 2) | 56547.0 | ENSG00000167346 | nan | nan
chr11	HBB	141900.0 | HBB, ECYT6 | Hemoglobin beta | 3043.0 | ENSG00000244734 | pseudogene HBBP1 between HBG and HBD loci | Methemoglobinemia, beta type, 617971 (3), Autosomal dominant; Thalassemia-beta, dominant inclusion-body, 603902 (3), Autosomal dominant; Sickle cell disease, 603903 (3), Autosomal recessive; Thalassemia, beta, 613985 (3); Delta-beta thalassemia, 141749 (3), Autosomal dominant; {Malaria, resistance to}, 611162 (3); Hereditary persistence of fetal hemoglobin, 141749 (3), Autosomal dominant; Erythrocytosis, familial, 6, 617980 (3), Autosomal dominant; Heinz body anemia, 140700 (3), Autosomal dominant
chr11	HBD	142000.0 | HBD | Hemoglobin delta | 3045.0 | ENSG00000223609 | nan | Thalassemia due to Hb Lepore (3); Thalassemia, delta- (3)
chr11	BGLT3	616308.0 | BGLT3, LINC01083 | Beta-globin locus transcript 3, noncoding | 103344929.0 | ENSG00000260629 | nan | nan
chr11	HBG1	142200.0 | HBG1 | Hemoglobin, gamma A | 3047.0 | ENSG00000213934 | nan | Fetal hemoglobin quantitative trait locus 1, 141749 (3), Autosomal dominant
chr11	HBG2	142250.0 | HBG2, TNCY | Hemoglobin, gamma G | 3048.0 | ENSG00000196565 | nan | Fetal hemoglobin quantitative trait locus 1, 141749 (3), Autosomal dominant; Cyanosis, transient neonatal, 613977 (3), Autosomal dominant
chr11	HBE1	142100.0 | HBE1 | Hemoglobin epsilon | 3046.0 | ENSG00000213931 | nan | nan
chr11		152424.0 | LCRB | Locus control region beta | 109580095.0 | nan | nan | Thalassemia, Hispanic gamma-delta-beta, 613985 (3)
chr11	UBQLN3	605473.0 | UBQLN3 | Ubiquilin 3 | 50613.0 | ENSG00000175520 | nan | nan
chr11	TRIM5	608487.0 | TRIM5, RNF88 | Tripartite motif-containing protein 5 | 85363.0 | ENSG00000132256 | nan | nan
chr11	TRIM6	607564.0 | TRIM6 | Tripartite motif-containing protein 6 | 117854.0 | ENSG00000121236 | nan | nan
chr11	TRIM34	605684.0 | TRIM34, RNF21, IFP1 | Tripartite motif-containing 34 (RING finger protein-21) | 53840.0 | ENSG00000258659 | nan | nan
chr11	TRIM22	606559.0 | TRIM22, STAF50 | Tripartite motif-containing protein 22 | 10346.0 | ENSG00000132274 | nan | nan
chr11	FHIP1B	620229.0 | FHIP1B, FAM160A2, C11orf56 | FHF complex subunit hook-interacting protein 1B | 84067.0 | ENSG00000051009 | nan | nan
chr11	CNGA4	609472.0 | CNGA4 | Cyclic nucleotide-gated channel, alpha-4 | 1262.0 | ENSG00000132259 | nan | nan
chr11	CCKBR	118445.0 | CCKBR, GASR | Cholecystokinin B receptor | 887.0 | ENSG00000110148 | nan | nan
chr11	CAVIN3	618303.0 | CAVIN3, SRBC | Caveolae-associated protein 3 | 112464.0 | ENSG00000170955 | nan | nan
chr11	SMPD1	607608.0 | SMPD1, NPD | Sphingomyelin phosphodiesterase-1, acid lysosomal | 6609.0 | ENSG00000166311 | nan | Niemann-Pick disease, type B, 607616 (3), Autosomal recessive; Niemann-Pick disease, type A, 257200 (3), Autosomal recessive
chr11	APBB1	602709.0 | APBB1, FE65 | Amyloid beta A4 precursor protein-binding, family B, member-1 | 322.0 | ENSG00000166313 | nan | nan
chr11	HPX	142290.0 | HPX | Hemopexin | 3263.0 | ENSG00000110169 | nan | nan
chr11	TRIM3	605493.0 | TRIM3, RNF22, BERP | Tripartite motif-containing 3 | 10612.0 | ENSG00000110171 | nan | nan
chr11	ARFIP2	601638.0 | ARFIP2, POR1 | ADP-ribosylation factor-interacting protein 2 | 23647.0 | ENSG00000132254 | nan | nan
chr11	TIMM10B	607388.0 | FXC1, TIMM10B | Fracture callus 1, rat, homolog of | 26515.0 | ENSG00000132286 | nan | nan
chr11	DNHD1	617277.0 | DNHD1, FLJ00251, SPGF65 | Dynein heavy chain domain 1 | 144132.0 | ENSG00000179532 | nan | Spermatogenic failure 65, 619712 (3), Autosomal recessive
chr11	RRP8	615818.0 | RRP8, NML, KIAA0409 | Ribosomal RNA processing protein 8, homolog of | 23378.0 | ENSG00000132275 | nan | nan
chr11	ILK	602366.0 | ILK, P59 | Integrin-linked kinase | 3611.0 | ENSG00000166333 | nan | nan
chr11	TAF10	600475.0 | TAF10, TAF2H, TAF2A | TAF10 RNA polymerase II, TATA box-binding protein-associated factor, 30kD | 6881.0 | ENSG00000166337 | nan | nan
chr11	TPP1	607998.0 | TPP1, CLN2, SCAR7 | Tripeptidyl peptidase 1 | 1200.0 | ENSG00000166340 | nan | Ceroid lipofuscinosis, neuronal, 2, 204500 (3), Autosomal recessive; Spinocerebellar ataxia, autosomal recessive 7, 609270 (3), Autosomal recessive
chr11	DCHS1	603057.0 | DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2 | Dachsous, Drosophila, homolog of, 1 | 8642.0 | ENSG00000166341 | nan | Mitral valve prolapse 2, 607829 (3), Autosomal dominant; Van Maldergem syndrome 1, 601390 (3), Autosomal recessive
chr11	MRPL17	611830.0 | MRPL17 | Mitochondrial ribosomal protein L17 | 63875.0 | ENSG00000158042 | nan | nan
chr11	OR6A2	608495.0 | OR6A2, OR6A1 | Olfactory receptor, family 6, subfamily A, member 2 | 8590.0 | ENSG00000184933 | nan | nan
chr11	OR10A5	608493.0 | OR10A1 | Olfactory receptor, family 10, subfamily A, member 1 | 144124.0 | ENSG00000166363 | nan | nan
chr11	OR2D2	608494.0 | OR2D2 | Olfactory receptor, family 2, subfamily D, member 2 | 120776.0 | ENSG00000166368 | nan | nan
chr11	ZNF215	605016.0 | ZNF215 | Zinc finger protein-215 | 7762.0 | ENSG00000149054 | nan | nan
chr11	ZNF214	605015.0 | ZNF214 | Zinc finger protein-214 | 7761.0 | ENSG00000149050 | nan | nan
chr11	NLRP14	609665.0 | NLRP1, NALP14, NOD5 | NLR family, pyrin domain containing 1 | 338323.0 | ENSG00000158077 | nan | nan
chr11	RBMXL2	605444.0 | RBMXL2, HNRNPGT, HNRPGT | RNA-binding motif protein, X chromosome, like 2 | 27288.0 | ENSG00000170748 | nan | nan
chr11	SYT9	613528.0 | SYT9 | Synaptotagmin 9 | 143425.0 | ENSG00000170743 | nan | nan
chr11	PPFIBP2	603142.0 | PPFIB2 | PPFIA-binding protein 2 | 8495.0 | ENSG00000166387 | nan | nan
chr11	CYB5R2	608342.0 | CYB5R2 | Cytochrome b5 reductase 2 | 51700.0 | ENSG00000166394 | nan | nan
chr11	OVCH2	618962.0 | OVCH2 | Ovochymase 2 | 341277.0 | ENSG00000183378 | nan | nan
chr11	NLRP10	609662.0 | NLRP10, NALP10, PYNOD, NOD8 | NLR family, pyrin domain containing 10 | 338322.0 | ENSG00000182261 | nan | nan
chr11	EIF3F	603914.0 | EIF3F, EIF3S5, MRT67 | Eukaryotic translation initiation factor 3, subunit F | 8665.0 | ENSG00000175390 | nan | Intellectual developmental disorder, autosomal recessive 67, 618295 (3), Autosomal recessive
chr11	TUB	601197.0 | TUB, RDOB | Tubby, mouse, homolog of | 7275.0 | ENSG00000166402 | mutation identified in 1 RDOB family | ?Retinal dystrophy and obesity, 616188 (3), Autosomal recessive
chr11	RIC3	610509.0 | RIC3 | RIC3 acetylcholine receptor chaperone | 79608.0 | ENSG00000166405 | nan | nan
chr11	LMO1	186921.0 | LMO1, RBTN1, RHOM1 | LIM domain only 1 (rhombotin 1) | 4004.0 | ENSG00000166407 | nan | Leukemia, T-cell acute lymphoblastic, 186921 (2)
chr11	STK33	607670.0 | STK33, SPGF93 | Serine/threonine protein kinase 33 | 65975.0 | ENSG00000130413 | mutation identified in 1 SPGF93 family | ?Spermatogenic failure 93, 620849 (3)
chr11	TRIM66	612000.0 | TRIM66, TIF1D, KIAA0298 | Tripartite motif-containing protein 66 | 9866.0 | ENSG00000166436 | nan | nan
chr11	RPL27A	603637.0 | RPL27A | Ribosomal protein L27a | 6157.0 | ENSG00000166441 | nan | nan
chr11	SNORA3B	611333.0 | SNORA3B, SNORA45 | Small nucleolar RNA, H/ACA box 3B | 677826.0 | ENSG00000212607 | nan | nan
chr11	DENND2B	140750.0 | ST5, HTS1 | Suppression of tumorigenicity-5 | 6764.0 | ENSG00000166444 | nan | nan
chr11	AKIP1	609191.0 | AKIP1, BCA3, C11orf17 | Protein kinase A-interacting protein 1 | 56672.0 | ENSG00000166452 | nan | nan
chr11	ASCL3	609154.0 | ASCL3, SGN1 | Achaete-scute family bHLH transcription factor 3 | 56676.0 | ENSG00000176009 | nan | nan
chr11	TMEM9B	620293.0 | TMEM9B | TMEM9 domain family, member B | 56674.0 | ENSG00000175348 | nan | nan
chr11	NRIP3	613125.0 | NRIP3 | Nuclear receptor-interacting protein 3 | 56675.0 | ENSG00000175352 | nan | nan
chr11	SCUBE2	611747.0 | SCUBE2 | Signal peptide-, CUB domain-, and EGF-like domains-containing protein 2 | 57758.0 | ENSG00000175356 | nan | nan
chr11	DENND5A	617278.0 | DENND5A, RAB6IP1, KIAA1091, DEE49 | DENN domain-containing protein 5A | 23258.0 | ENSG00000184014 | nan | Developmental and epileptic encephalopathy 49, 617281 (3), Autosomal recessive
chr11	TMEM41B	620271.0 | TMEM41B, STASIMON | Transmembrane protein 41B | 440026.0 | ENSG00000166471 | nan | nan
chr11	IPO7	605586.0 | IPO7, RANBP7 | Importin 7 | 10527.0 | ENSG00000205339 | nan | nan
chr11	ZNF143	603433.0 | ZNF143, SBF | Zinc finger protein-143 | 7702.0 | ENSG00000166478 | nan | nan
chr11	WEE1	193525.0 | WEE1 | WEE1 G2 checkpoint kinase | 7465.0 | ENSG00000166483 | nan | nan
chr11	SWAP70	604762.0 | SWAP70 | Switch-associated protein 70 | 23075.0 | ENSG00000133789 | nan | nan
chr11	SBF2	607697.0 | SBF2, MTMR13, CMT4B2 | SET binding factor 2 (myotubularin-related 13) | 81846.0 | ENSG00000133812 | nan | Charcot-Marie-Tooth disease, type 4B2, 604563 (3), Autosomal recessive
chr11	ADM	103275.0 | ADM | Adrenomedullin | 133.0 | ENSG00000148926 | nan | nan
chr11	AMPD3	102772.0 | AMPD3 | Adenosine monophosphate deaminase-3, isoform E | 272.0 | ENSG00000133805 | nan | [AMP deaminase deficiency, erythrocytic], 612874 (3), Autosomal recessive
chr11	RNF141	616641.0 | RNF141, ZNF230 | RING finger protein 141 | 50862.0 | ENSG00000110315 | nan | nan
chr11	LYVE1	605702.0 | LYVE1 | Lymphatic vessel endothelial hyaluronan receptor 1 | 10894.0 | ENSG00000133800 | nan | nan
chr11	IRAG1	604673.0 | IRAG1, MRVI1 | Inositol 1,4,5-triphosphate receptor associated 1 | 10335.0 | ENSG00000072952 | nan | nan
chr11	CTR9	609366.0 | SH2BP1, KIAA0155, p150 | SH2 domain-binding protein 1 | 9646.0 | ENSG00000198730 | nan | nan
chr11	EIF4G2	602325.0 | EIF4G2, DAP5 | Eukaryotic translation initiation factor 4G-like 1 | 1982.0 | ENSG00000110321 | nan | nan
chr11	ZBED5	615251.0 | ZBED5, BUSTER1 | Zinc finger BED domain-containing protein 5 | 58486.0 | ENSG00000236287 | nan | nan
chr11	GALNT18	615136.0 | GALNT18, GALNACT18, GALNTL4 | UPD-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 18 | 374378.0 | ENSG00000110328 | nan | nan
chr11	USP47	614460.0 | USP47 | Ubiquitin-specific protease 47 | 55031.0 | ENSG00000170242 | nan | nan
chr11	DKK3	605416.0 | DKK3, RIG | Dickkopf WNT signaling pathway inhibitor 3 | 27122.0 | ENSG00000050165 | nan | nan
chr11	MICAL2	608881.0 | MICAL2, KIAA0750, EBITEIN1 | Microtubule-associated monooxygenase, calponin and LIM domains-containing 2 | 9645.0 | ENSG00000133816 | nan | nan
chr11	PARVA	608120.0 | PARVA | Parvin, alpha | 55742.0 | ENSG00000197702 | nan | nan
chr11	TEAD1	189967.0 | TEAD1, TCF13, REF1 | TEA domain family member 1 | 7003.0 | ENSG00000187079 | nan | Sveinsson chorioretinal atrophy, 108985 (3), Autosomal dominant
chr11	LINC00958	618335.0 | LINC00958, BLACAT2 | Long intergenic noncoding RNA 958 | 100506305.0 | ENSG00000251381 | nan | nan
chr11	RASSF10	614713.0 | RASSF10 | Ras association domain family, member 10 | 644943.0 | ENSG00000189431 | nan | nan
chr11	BMAL1	602550.0 | ARNTL, BMAL1, TIC | Aryl hydrocarbon receptor nuclear translocator-like | 406.0 | ENSG00000133794 | nan | nan
chr11	BTBD10	615933.0 | BTBD10 | BTB/POZ domain-containing protein 10 | 84280.0 | ENSG00000148925 | nan | nan
chr11	PTH	168450.0 | PTH, FIH1 | Parathyroid hormone | 5741.0 | ENSG00000152266 | ~9cM distal to CALC1; distal to MYOD | Hypoparathyroidism, familial isolated 1, 146200 (3), Autosomal recessive, Autosomal dominant
chr11	FAR1	616107.0 | FAR1, MLSTD2, PFCRD, CSPSD | Fatty acyl CoA reductase 1 | 84188.0 | ENSG00000197601 | nan | Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3), Autosomal recessive; Cataracts, spastic paraparesis, and speech delay, 619338 (3), Autosomal dominant
chr11	SPON1	604989.0 | SPON1 | F-spondin, Rat, homolog of | 10418.0 | ENSG00000262655 | nan | nan
chr11	RRAS2	600098.0 | RRAS2, TC21, NS12 | Related Ras viral oncogene homolog 2 | 22800.0 | ENSG00000133818 | nan | Ovarian carcinoma (3); Noonan syndrome 12, 618624 (3), Autosomal dominant
chr11	COPB1	600959.0 | COPB1, COPB, BARMACS | Coatomer protein complex, subunit beta 1 | 1315.0 | ENSG00000129083 | nan | Baralle-Macken syndrome, 619255 (3), Autosomal recessive
chr11	PSMA1	602854.0 | PSMA1, PROS30 | Proteasome subunit, alpha-type, 1 | 5682.0 | ENSG00000129084 | nan | nan
chr11	PDE3B	602047.0 | PDE3B | Phosphodiesterase-3B, cGMP-inhibited | 5140.0 | ENSG00000152270 | nan | nan
chr11	CYP2R1	608713.0 | CYP2R1 | Cytochrome P450, subfamily IIR, polypeptide 1 (vitamin D 25-hydroxylase) | 120227.0 | ENSG00000186104 | nan | Rickets due to defect in vitamin D 25-hydroxylation deficiency, 600081 (3), Autosomal recessive
chr11	CALCA	114130.0 | CALCA, CALC1 | Calcitonin/calcitonin-related polypeptide, alpha | 796.0 | ENSG00000110680 | same 220kb fragment as CALCB | nan
chr11	CALCB	114160.0 | CALCB, CALC2 | Calcitonin-related polypeptide, beta | 797.0 | ENSG00000175868 | nan | nan
chr11	INSC	610668.0 | INSC | INSC spindle orientation adaptor protein | 387755.0 | ENSG00000188487 | nan | nan
chr11	SOX6	607257.0 | SOX6, TOLCAS | SRY-box 6 | 55553.0 | ENSG00000110693 | nan | Tolchin-Le Caignec syndrome, 618971 (3), Autosomal dominant
chr11	C11orf58	619625.0 | C11orf58 | Chromosome 11 open reading frame 58 | 10944.0 | ENSG00000110696 | nan | nan
chr11	PLEKHA7	612686.0 | PLEKHA7 | Pleckstrin homology domain-containing protein, family A, member 7 | 144100.0 | ENSG00000166689 | nan | nan
chr11	RPS13	180476.0 | RPS13 | Ribosomal protein S13 | 6207.0 | ENSG00000110700 | nan | nan
chr11	PIK3C2A	603601.0 | PIK3C2A, CPK, OCSKD | Phosphatidylinositol 3-kinase, class 2, alpha | 5286.0 | ENSG00000011405 | nan | Oculoskeletodental syndrome, 618440 (3), Autosomal recessive
chr11	NUCB2	608020.0 | NUCB2, NEFA | Nucleobindin 2 | 4925.0 | ENSG00000070081 | nan | nan
chr11	NCR3LG1	613714.0 | NCR3LG1, B7H6 | Natural killer cell cytotoxicity receptor 3 ligand 1 | 374383.0 | ENSG00000188211 | nan | nan
chr11	KCNJ11	600937.0 | KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2 | Potassium inwardly-rectifying channel, subfamily J, member 11 | 3767.0 | ENSG00000187486 | 4.5kb 3' of SUR | Diabetes, permanent neonatal 2, with or without neurologic features, 618856 (3), Autosomal dominant; {Diabetes mellitus, type 2, susceptibility to}, 125853 (3), Autosomal dominant; Maturity-onset diabetes of the young, type 13, 616329 (3), Autosomal dominant; Diabetes mellitus, transient neonatal 3, 610582 (3), Autosomal dominant; Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3), Autosomal recessive, Autosomal dominant
chr11	ABCC8	600509.0 | ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3 | ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor) | 6833.0 | ENSG00000006071 | nan | Diabetes mellitus, permanent neonatal 3, with or without neurologic features, 618857 (3), Autosomal recessive, Autosomal dominant; Diabetes mellitus, transient neonatal 2, 610374 (3); Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominant; Hypoglycemia of infancy, leucine-sensitive, 240800 (3), Autosomal dominant; Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3), Autosomal recessive, Autosomal dominant
chr11	USH1C	605242.0 | USH1C, DFNB18A | USH1 protein network component harmonin | 10083.0 | ENSG00000006611 | Acadian and Samaritan variety | Usher syndrome, type 1C, 276904 (3), Autosomal recessive; Deafness, autosomal recessive 18A, 602092 (3), Autosomal recessive
chr11	OTOG	604487.0 | OTOG, OTGN, DFNB18B | Otogelin | 340990.0 | ENSG00000188162 | nan | Deafness, autosomal recessive 18B, 614945 (3), Autosomal recessive
chr11	MYOD1	159970.0 | MYOD1, MYF3, CMYO17 | Myogenic differentiation 1 | 4654.0 | ENSG00000129152 | nan | Congenital myopathy 17, 618975 (3), Autosomal recessive
chr11	KCNC1	176258.0 | KCNC1, EPM7 | Potassium voltage-gated channel, Shaw-related subfamily, member 1 | 3746.0 | ENSG00000129159 | nan | Epilepsy, progressive myoclonic 7, 616187 (3), Autosomal dominant
chr11	SERGEF	606051.0 | SERGEF, DELGEF | Secretion-regulating guanine nucleotide exchange factor | 26297.0 | ENSG00000129158 | nan | nan
chr11	TPH1	191060.0 | TPH1, TPH | Tryptophan hydroxylase 1 (tryptophan-5-monooxygenase) | 7166.0 | ENSG00000129167 | nan | nan
chr11	MRGPRX3	607229.0 | MRGPRX3, MRGX3 | Mas-related G protein-coupled receptor family, member X3 | 117195.0 | ENSG00000179826 | nan | nan
chr11	MRGPRX4	607230.0 | MRGPRX4, MRGX4 | Mas-related G protein-coupled receptor family, member X4 | 117196.0 | ENSG00000179817 | nan | nan
chr11	SAA4	104752.0 | SAA4 | Serum amyloid A4, constitutive | 6291.0 | ENSG00000148965 | nan | nan
chr11	SAA2	104751.0 | SAA2 | Serum amyloid A2 | 6289.0 | ENSG00000134339 | pseudogene = SAA3 | nan
chr11	SAA1	104750.0 | SAA1 | Serum amyloid A1 | 6288.0 | ENSG00000173432 | nan | nan
chr11	HPS5	607521.0 | HPS5, RU2, KIAA1017 | HPS5 biogenesis of lysosomal organelles complex 2 subunit 2 | 11234.0 | ENSG00000110756 | nan | Hermansky-Pudlak syndrome 5, 614074 (3), Autosomal recessive
chr11	GTF2H1	189972.0 | GTF2H1 | General transcription factor IIH, polypeptide 1 (62kD subunit) | 2965.0 | ENSG00000110768 | within 50kb of LDHA | nan
chr11	LDHA	150000.0 | LDHA, LDH1, GSD11 | Lactate dehydrogenase A | 3939.0 | ENSG00000134333 | nan | Glycogen storage disease XI, 612933 (3), Autosomal recessive
chr11	LDHC	150150.0 | LDHC, LDH3 | Lactate dehydrogenase C | 3948.0 | ENSG00000166796 | closely linked to LDHB in other species; in man syntenic with LDHA; ?close to LDHA | nan
chr11	LDHAL6A	618928.0 | LDHAL6A | Lactate dehydrogenase A-like protein 6A | 160287.0 | ENSG00000166800 | nan | nan
chr11	TSG101	601387.0 | TSG101 | Tumor susceptibility gene 101 | 7251.0 | ENSG00000074319 | nan | nan
chr11	UEVLD	610985.0 | UEVLD, UEV3, ATTP | Ubiquitin E2 variant and lactate/malate dehydrogenase domains-containing protein | 55293.0 | ENSG00000151116 | nan | nan
chr11	MISFA	620764.0 | MISFA, KASTOR, POLLUKS | Mitochondrial sheath formation-associated gene | 100506540.0 | ENSG00000247595 | nan | nan
chr11	PTPN5	176879.0 | PTPN5, STEP, STEP61 | Protein tyrosine phosphatase, nonreceptor-type, 5 (striatum-enriched) | 84867.0 | ENSG00000110786 | nan | nan
chr11	MRGPRX1	607227.0 | MRGPRX1, MRGX1 | Mas-related G protein-coupled receptor family, member X1 | 259249.0 | ENSG00000170255 | nan | nan
chr11	MRGPRX2	607228.0 | MRGPRX2, MRGX2 | Mas-related G protein-coupled receptor family, member X2 | 117194.0 | ENSG00000183695 | nan | nan
chr11	ZDHHC13	612815.0 | ZDHHC13, HIP14L | Zinc finger DHHC domain-containing protein 13 | 54503.0 | ENSG00000177054 | nan | nan
chr11	CSRP3	600824.0 | CSRP3, CRP3, CLP, CMD1M, CMH12 | Cysteine- and glycine-rich protein 3 | 8048.0 | ENSG00000129170 | mutation identified in 1 CMD1M family | ?Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy, hypertrophic, 12, 612124 (3), Autosomal dominant
chr11	E2F8	612047.0 | E2F8 | E2F transcription factor 8 | 79733.0 | ENSG00000129173 | nan | nan
chr11	NAV2	607026.0 | NAV2, RAINB1, KIAA1419 | Neuron navigator 2 | 89797.0 | ENSG00000166833 | nan | nan
chr11	DBX1	619830.0 | DBX1, HLX1 | Developing brain homeobox 1 | 120237.0 | ENSG00000109851 | nan | nan
chr11	HTATIP2	605628.0 | HTATIP2, TIP30, CC3 | HIV-1 TAT-interacting protein 2, 30kD | 10553.0 | ENSG00000109854 | nan | nan
chr11	PRMT3	603190.0 | PRMT3, HRMT1L3 | Protein arginine methyltransferase 3 | 10196.0 | ENSG00000185238 | nan | nan
chr11	SLC6A5	604159.0 | SLC6A5, GLYT2, HKPX3 | Solute carrier family 6 (neurotransmitter transporter, glycine), member 5 | 9152.0 | ENSG00000165970 | nan | Hyperekplexia 3, 614618 (3), Autosomal recessive, Autosomal dominant
chr11	NELL1	602319.0 | NELL1 | Neural epidermal growth factor-like protein 1 | 4745.0 | ENSG00000165973 | nan | nan
chr11	ST2	185440.0 | ST2 | Suppression of tumorigenicity-2 | 6761.0 | nan | nan | nan
chr11	TST1	613636.0 | TST1 | Tuberculin skin test reactivity, absence of | 100526790.0 | nan | at chr11:26.37M | [Tuberculin skin test reactivity, absence of], 613636 (2)
chr11	ANO5	608662.0 | ANO5, TMEM16E, GDD1, LGMDR12 | Anoctamin 5 | 203859.0 | ENSG00000171714 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 12, 611307 (3), Autosomal recessive; Miyoshi muscular dystrophy 3, 613319 (3), Autosomal recessive; Gnathodiaphyseal dysplasia, 166260 (3), Autosomal dominant
chr11	SLC17A6	607563.0 | SLC17A6, VGLUT2, DNPI | Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 | 57084.0 | ENSG00000091664 | nan | nan
chr11	FANCF	613897.0 | FANCF | Fanconi anemia, complementation group F | 2188.0 | ENSG00000183161 | nan | Fanconi anemia, complementation group F, 603467 (3), Autosomal recessive
chr11	GAS2	602835.0 | GAS2, DFNB125 | Growth arrest-specific 2 | 2620.0 | ENSG00000148935 | mutation identified in 1 GAS2 family | ?Deafness, autosomal recessive 125, 620877 (3), Autosomal recessive
chr11	SVIP	620965.0 | SVIP | Small VCP-interacting protein | 258010.0 | ENSG00000198168 | nan | nan
chr11	LUZP2	608178.0 | LUZP2 | Leucine zipper protein 2 | 338645.0 | ENSG00000187398 | nan | nan
chr11	ANO3	610110.0 | ANO3, TMEM16C, C11orf25, DYT24 | Anoctamin 3 | 63982.0 | ENSG00000134343 | nan | Dystonia 24, 615034 (3), Autosomal dominant
chr11	DFNA59	612642.0 | DFNA59 | Deafness, autosomal dominant 59 | 100271924.0 | nan | between D22S929 and D11S480 | Deafness, autosomal dominant 59, 612642 (2), Autosomal dominant
chr11	MUC15	608566.0 | MUC15, PAS3 | Mucin 15, transmembrane | 143662.0 | ENSG00000169550 | nan | nan
chr11	SLC5A12	612455.0 | SLC5A12, SMCT2 | Solute carrier family 5 (sodium/glucose cotransporter), member 12 | 159963.0 | ENSG00000148942 | nan | nan
chr11	FIBIN	617085.0 | FIBIN | Fin bud initiation factor, zebrafish, homolog of | 387758.0 | ENSG00000176971 | nan | nan
chr11	BBOX1	603312.0 | BBOX1, BBOX | Butyrobetaine-gamma, 2-oxoglutarate dioxygenase 1 | 8424.0 | ENSG00000129151 | nan | nan
chr11	SPG41	613364.0 | SPG41 | Spastic paraplegia 41 | 100359402.0 | nan | max lod 2.36; between D11S1324 and D11S1993 | ?Spastic paraplegia 41, autosomal dominant, 613364 (2), Autosomal dominant
chr11	CCDC34	612324.0 | CCDC34, SPGF76 | Coiled-coil domain-containing protein 34 | 91057.0 | ENSG00000109881 | nan | Spermatogenic failure 76, 620084 (3), Autosomal recessive
chr11	LGR4	606666.0 | LGR4, GPR48, BNMD17, DPSL | Leucine-rich repeat-containing G protein-coupled receptor 4 | 55366.0 | ENSG00000205213 | previously mapped to 5q34-q35.1 | Delayed puberty, self-limited, 619613 (3), Autosomal dominant; {Bone mineral density, low, susceptibility to}, 615311 (3), Autosomal dominant
chr11	LIN7C	612332.0 | LIN7C, VELI3, MALS3 | Lin7 homolog C, crumbs cell polarity complex component | 55327.0 | ENSG00000148943 | nan | nan
chr11	BDNF-AS	611468.0 | BDNFAS, BDNFOS | BDNF antisense RNA | 497258.0 | ENSG00000245573 | nan | nan
chr11	BDNF	113505.0 | BDNF | Brain-derived neurotrophic factor | 627.0 | ENSG00000176697 | homeology with NRF3 on 12p; at p14 boundary | nan
chr11	HSP90AA2P	140575.0 | HSP90AA2P, HSP90AA2, HSPCAL3 | Heat-shock protein, 90kD, alpha, class A, member 2, pseudogene | 3324.0 | nan | nan | nan
chr11	KIF18A	611271.0 | KIF18A | Kinesin family member 18A | 81930.0 | ENSG00000121621 | nan | nan
chr11	MIR610	612330.0 | MIR610, MIRN610 | Micro RNA 610 | 693195.0 | ENSG00000207874 | nan | nan
chr11	METTL15	618711.0 | METTL15 | Methyltransferase-like 15 | 196074.0 | ENSG00000169519 | nan | nan
chr11	KCNA4	176266.0 | KCNA4, KCNA8, MCIDDS | Potassium voltage-gated channel, shaker-related subfamily, member 4 | 3739.0 | ENSG00000182255 | other map to 11p | Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum, 618284 (3), Autosomal recessive
chr11	FSHB	136530.0 | FSHB, HH24 | Follicle-stimulating hormone, beta polypeptide | 2488.0 | ENSG00000131808 | distal to AN2 | Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3), Autosomal recessive
chr11	ARL14EP	612295.0 | C11orf46 | Chromosome 11 open reading frame 46 | 120534.0 | ENSG00000152219 | nan | nan
chr11	MPPED2	600911.0 | MPPED2, C11orf8, D11S302E, 239FB | Metallophosphoesterase domain-containing protein 2 | 744.0 | ENSG00000066382 | nan | nan
chr11	DCDC1	608062.0 | DCDC1, DCDC5 | Doublecortin domain-containing protein 1 | 341019.0 | ENSG00000170959 | nan | nan
chr11	CANDN1	607644.0 | CANDF3, CANDN1, FCNC | Candidiasis, familial, 3 | 338434.0 | nan | between D11S1312 and D11S4191 | Candidiasis, familial, 3, 607644 (2), Autosomal dominant
chr11		616902.0 | DEL11p13, C11DELp13 | Chromosome 11p13 deletion syndrome, distal | nan | nan | nan | Chromosome 11p13 deletion syndrome, distal, 616902 (4), Autosomal dominant
chr11		194072.0 | DEL11p13, C11DELp13, WAGR | Wilms tumor, aniridia, genitourinary anomalies and impaired intellectual development syndrome (chromosome 11p13 deletion syndrome) | nan | nan | deletion of WT1 and PAX6 genes | Wilms tumor, aniridia, genitourinary anomalies and impaired intellectual development syndrome, 194072 (4), Somatic mutation, Autosomal dominant
chr11	DFNB51	609941.0 | DFNB51 | Deafness, autosomal recessive 51 | 448963.0 | nan | max lod at D11S4102 | Deafness, autosomal recessive 51, 609941 (2), Autosomal recessive
chr11	ECT	117100.0 | ECT, BECTS | Centrotemporal epilepsy | 100379198.0 | nan | previously assigned to 15q14 | Centrotemporal epilepsy, 117100 (2), Isolated cases
chr11	EVR3	605750.0 | EVR3 | Exudative vitreoretinopathy 3 | 81864.0 | nan | nan | Exudative vitreoretinopathy 3, 605750 (2), Autosomal dominant
chr11	MRT23	614344.0 | MRT23 | Intellectual developmental disorder, autosomal recessive 23 | 100852398.0 | nan | between rs604518 and rs10899421 | Intellectual developmental disorder, autosomal recessive 23, 614344 (2), Autosomal recessive
chr11	MYP7	609256.0 | MYP7 | Myopia 7 | 553190.0 | nan | nan | Myopia 7, 609256 (2), Multifactorial
chr11		612469.0 | WAGRO, DEL11p14p12 | Wilms tumor, aniridia, genitourinary anomalies, impaired intellectual development and obesity syndrome | nan | nan | contiguous gene deletion syndrome | WAGRO syndrome, 612469 (4), Autosomal dominant
chr11	DNAJC24	611072.0 | DNAJC24, DPH4 | DNAJ/HSP40 homolog, subfamily C, member 24 | 120526.0 | ENSG00000170946 | nan | nan
chr11	IMMP1L	612323.0 | IMMP1L, IMP1 | Inner mitochondrial membrane peptidase, subunit 1 | 196294.0 | ENSG00000148950 | nan | nan
chr11	ELP4	606985.0 | ELP4, PAX6NEB, AN2 | Elongation protein 4, S. cerevisiae, homolog of | 26610.0 | ENSG00000109911 | mutation identified in 1 AN2 patient | ?Aniridia 2, 617141 (3), Autosomal dominant
chr11	PAX6	607108.0 | PAX6, AN2, MGDA, FVH1, ASGD5 | Paired box homeotic gene-6 | 5080.0 | ENSG00000007372 | mutation identified in 1 patient each with MDGA, COLBN, or COLB | Optic nerve hypoplasia, 165550 (3), Autosomal dominant; Cataract with late-onset corneal dystrophy, 106210 (3), Autosomal dominant; Microphthalmia/coloboma 12, 120200 (3), Autosomal dominant; ?Coloboma of optic nerve, 120430 (3), Autosomal dominant; Aniridia, 106210 (3), Autosomal dominant; Anterior segment dysgenesis 5, multiple subtypes, 604229 (3), Autosomal dominant; ?Morning glory disc anomaly, 120430 (3), Autosomal dominant; Foveal hypoplasia 1, 136520 (3), Autosomal dominant; Keratitis, 148190 (3), Autosomal dominant
chr11	RCN1	602735.0 | RCN1 | Reticulocalbin 1 | 5954.0 | ENSG00000049449 | nan | nan
chr11	WT1	607102.0 | WT1, NPHS4 | WT1 transcription factor | 7490.0 | ENSG00000184937 | clumped: pter-FSHB-AN2-WT1-CAT | Mesothelioma, somatic, 156240 (3); Meacham syndrome, 608978 (3), Autosomal dominant; Frasier syndrome, 136680 (3), Somatic mutation, Autosomal dominant; Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant; Denys-Drash syndrome, 194080 (3), Somatic mutation, Autosomal dominant; Wilms tumor, type 1, 194070 (3), Somatic mutation, Autosomal dominant
chr11	WT1-AS	607899.0 | WT1AS, WIT1 | WT1 antisense RNA | 51352.0 | ENSG00000183242 | nan | nan
chr11	EIF3M	609641.0 | EIF3M, PCID1, B5, GA17 | Eukaryotic translation initiation factor 3, subunit M | 10480.0 | ENSG00000149100 | nan | nan
chr11	CCDC73	612328.0 | CCDC73 | Coiled-coil domain-containing protein 73 | 493860.0 | ENSG00000186714 | nan | nan
chr11	PRRG4	611690.0 | PRRG4, PRGP4, TMG4 | Proline-rich gamma-carboxyglutamic acid protein 4 | 79056.0 | ENSG00000135378 | nan | nan
chr11	QSER1	619440.0 | QSER1 | Glutamine- and serine-rich protein 1 | 79832.0 | ENSG00000060749 | nan | nan
chr11	DEPDC7	612294.0 | DEPDC7, TR2 | DEP domain-containing protein 7 | 91614.0 | ENSG00000121690 | nan | nan
chr11	LINC00294	612296.0 | LOC283267 | Long intergenic noncoding RNA 294 | 283267.0 | ENSG00000280798 | nan | nan
chr11	CSTF3	600367.0 | CSTF3 | Cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kD | 1479.0 | ENSG00000176102 | nan | nan
chr11	HIPK3	604424.0 | HIPK3, PKY, DYRK6 | Homeodomain-interacting protein kinase-3 | 10114.0 | ENSG00000110422 | nan | nan
chr11	KIAA1549L	612297.0 | C11orf41, G2 | Chromosome 11 open reading frame 41 | 25758.0 | ENSG00000110427 | nan | nan
chr11	CD59	107271.0 | CD59, MIC11 | CD59 antigen (p18-20) | 966.0 | ENSG00000085063 | in mouse Ly-6 = multigene complex | Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3), Autosomal recessive
chr11	FBXO3	609089.0 | FBXO3, FBX3, FBA | F-box only protein 3 | 26273.0 | ENSG00000110429 | nan | nan
chr11	LMO2	180385.0 | LMO2, RBTNL1, RHOM2, TTG2 | LIM domain only 2 (rhombotin-like 1) | 4005.0 | ENSG00000135363 | 3rd rhombotin gene not on 11 | Leukemia, acute T-cell, 180385 (2)
chr11	CAPRIN1	601178.0 | CAPRIN1, M11S1, GPIAP1, GRIP137, CONDCAC, NEDLAAD | Cell cycle associated protein 1 | 4076.0 | ENSG00000135387 | nan | Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder, 620782 (3), Autosomal dominant; Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline, 620636 (3), Autosomal dominant
chr11	NAT10	609221.0 | NAT10, ALP, KIAA1709 | N-acetyltransferase 10 | 55226.0 | ENSG00000135372 | nan | nan
chr11	CAT	115500.0 | CAT | Catalase | 847.0 | ENSG00000121691 | cen-CAT-WT1-AN2-pter | Acatalasemia, 614097 (3)
chr11	ELF5	605169.0 | ELF5, ESE2 | E74-like factor 5 (epithelium-specific ETS factor 2) | 2001.0 | ENSG00000135374 | nan | nan
chr11	EHF	605439.0 | EHF, ESE3 | ETS homologous factor | 26298.0 | ENSG00000135373 | nan | nan
chr11	APIP	612491.0 | APIP, CGI29, MMRP19 | APAF1-interacting protein | 51074.0 | ENSG00000149089 | nan | nan
chr11	PDHX	608769.0 | PDHX, PDX1, E3BP, PDHXD | Pyruvate dehydrogenase complex, lipoyl-containing component X | 8050.0 | ENSG00000110435 | nan | Lacticacidemia due to PDX1 deficiency, 245349 (3), Autosomal recessive
chr11	CD44	107269.0 | CD44, MDU2, MDU3, MIC4, IN | CD44 antigen (homing function) | 960.0 | ENSG00000026508 | nan | [Blood group, Indian system], 609027 (3)
chr11	SLC1A2	600300.0 | SLC1A2, EAAT2, DEE41 | Solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 6506.0 | ENSG00000110436 | nan | Developmental and epileptic encephalopathy 41, 617105 (3), Autosomal dominant
chr11	FJX1	612206.0 | FJX1 | Four-jointed box kinase 1 | 24147.0 | ENSG00000179431 | nan | nan
chr11	TRIM44	612298.0 | TRIM44, AN3 | Tripartite motif-containing protein 44 | 54765.0 | ENSG00000166326 | mutation identified in 1 AN3 family | ?Aniridia 3, 617142 (3), Autosomal dominant
chr11	LDLRAD3	617986.0 | LDLRAD3, LRAD3 | Low density lipoprotein receptor class A domain-containing protein 3 | 143458.0 | ENSG00000179241 | nan | nan
chr11	COMMD9	612299.0 | COMM9 | COMM domain-containing protein 9 | 29099.0 | ENSG00000110442 | nan | nan
chr11	PRR5L	611728.0 | PRR5L, PROTOR2, FLJ14213 | Proline-rich protein 5-like | 79899.0 | ENSG00000135362 | nan | nan
chr11	BMND8	611739.0 | BMND8 | Bone mineral density QTL 8 | 100188854.0 | nan | between D11S1392 and D11S4102 | {Osteoporosis}, 166710 (2), Autosomal dominant
chr11	PSNP3	610898.0 | PSNP3 | Supranuclear palsy, progressive, 3 | 100038248.0 | nan | nan | Supranuclear palsy, progressive, 3, 610898 (2)
chr11	TRAF6	602355.0 | TRAF6 | TNF receptor-associated factor 6 | 7189.0 | ENSG00000175104 | nan | nan
chr11	RAG1	179615.0 | RAG1 | Recombination activating gene-1 | 5896.0 | ENSG00000166349 | assignment to 14 in error | Omenn syndrome, 603554 (3), Autosomal recessive; Severe combined immunodeficiency, B cell-negative, 601457 (3), Autosomal recessive; Combined cellular and humoral immune defects with granulomas, 233650 (3), Autosomal recessive; Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3)
chr11	RAG2	179616.0 | RAG2 | Recombination activating gene-2 | 5897.0 | ENSG00000175097 | assignment to 14 in error | Severe combined immunodeficiency, B cell-negative, 601457 (3), Autosomal recessive; Combined cellular and humoral immune defects with granulomas, 233650 (3), Autosomal recessive; Omenn syndrome, 603554 (3), Autosomal recessive
chr11	IFTAP	619270.0 | IFTAP, HEPIS, NWC, C11orf74 | Intraflagellar transport-associated protein | 119710.0 | ENSG00000166352 | nan | nan
chr11	LRRC4C	608817.0 | LRRC4C, NGL1, KIAA1580 | Leucine rich repeat containing 4C (netrin-G1 ligand) | 57689.0 | ENSG00000148948 | nan | nan
chr11	API5	609774.0 | API5, AAC11 | Apoptosis inhibitor 5 | 8539.0 | ENSG00000166181 | nan | nan
chr11	TTC17	619388.0 | TTC17 | Tetratricopeptide repeat domain-containing protein 17 | 55761.0 | ENSG00000052841 | nan | nan
chr11	CLLS1	609630.0 | CLLS1 | Leukemia, chronic lymphocytic, susceptibility to, 1 | 100188791.0 | nan | nan | {Leukemia, chronic lymphocytic, susceptibility to, 1}, 609630 (2)
chr11		601224.0 | PSS | Potocki-Shaffer syndrome | nan | nan | contiguous gene syndrome caused by deletion of 11p11.2 | Potocki-Shaffer syndrome, 601224 (4), Autosomal dominant
chr11	TYRL	191270.0 | TYRL | Tyrosinase-like | 7300.0 | nan | nan | nan
chr11	HSD17B12	609574.0 | HSD17B12, KAR | 17-beta-hydroxysteroid dehydrogenase XII | 51144.0 | ENSG00000149084 | nan | nan
chr11	ALKBH3	610603.0 | ALKBH3, PCA1, DEPC1, ABH3 | AlkB homolog 3, alpha-ketoglutarate-dependent dioxygenase | 221120.0 | ENSG00000166199 | nan | nan
chr11	ACCS	608405.0 | ACCS, ACS, PHACS | 1-aminocyclopropane-1-carboxylate synthase | 84680.0 | ENSG00000110455 | nan | nan
chr11	EXT2	608210.0 | EXT2, SSMS | Exostosin glycosyltransferase 2 | 2132.0 | ENSG00000151348 | nan | Seizures, scoliosis, and macrocephaly syndrome, 616682 (3), Autosomal recessive; Exostoses, multiple, type 2, 133701 (3), Autosomal dominant
chr11	ALX4	605420.0 | ALX4, PFM2, FPP, FND2, CRS5 | Aristaless-like 4, mouse, homolog of | 60529.0 | ENSG00000052850 | nan | Parietal foramina 2, 609597 (3), Autosomal dominant; {Craniosynostosis 5, susceptibility to}, 615529 (3), Autosomal dominant; Frontonasal dysplasia 2, 613451 (3), Autosomal recessive
chr11	CD82	600623.0 | CD82, SAR2, KAI1, ST6 | CD82 antigen | 3732.0 | ENSG00000085117 | nan | nan
chr11	TSPAN18	619399.0 | TSPAN18 | Tetraspanin 18 | 90139.0 | ENSG00000157570 | nan | nan
chr11	TP53I11	617867.0 | TP53I11, PIG11 | Tumor protein p53-inducible protein 11 | 9537.0 | ENSG00000175274 | nan | nan
chr11	PRDM11	616347.0 | PRDM11, PFM8 | PR domain-containing protein 11 | 56981.0 | ENSG00000019485 | nan | nan
chr11	SYT13	607716.0 | SYT13, KIAA1427 | Synaptotagmin 13 | 57586.0 | ENSG00000019505 | nan | nan
chr11	CHST1	603797.0 | CHST1, KSGAL6ST | Carbohydrate sulfotransferase-1 | 8534.0 | ENSG00000175264 | nan | nan
chr11	SLC35C1	605881.0 | SLC35C1, FUCT1, CDG2C | Solute carrier family 35, member C1 (GDP-Fucose transporter 1) | 55343.0 | ENSG00000181830 | nan | Congenital disorder of glycosylation, type IIc, 266265 (3), Autosomal recessive
chr11	CRY2	603732.0 | CRY2 | Cryptochrome 2 | 1408.0 | ENSG00000121671 | nan | nan
chr11	MAPK8IP1	604641.0 | MAPK8IP1, IB1 | Mitogen-activated protein kinase 8-interacting protein 1 | 9479.0 | ENSG00000121653 | nan | {Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant
chr11	PEX16	603360.0 | PEX16, PBD8A, PBD8B | Peroxisome biogenesis factor 16 | 9409.0 | ENSG00000121680 | nan | Peroxisome biogenesis disorder 8B, 614877 (3), Autosomal recessive; Peroxisome biogenesis disorder 8A (Zellweger), 614876 (3), Autosomal recessive
chr11	LARGE2	609709.0 | GYLTL1B, LARGE2 | Glycosyltransferase-like 1B | 120071.0 | ENSG00000165905 | nan | nan
chr11	PHF21A	608325.0 | PHF21A, BHC80, KIAA1696, IDDBCS | PHD finger protein 21A | 51317.0 | ENSG00000135365 | nan | Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures, 618725 (3), Autosomal dominant
chr11	CREB3L1	616215.0 | CREB3L1, OASIS, OI16 | cAMP response element-binding protein 3-like 1 | 90993.0 | ENSG00000157613 | nan | Osteogenesis imperfecta, type XVI, 616229 (3), Autosomal recessive
chr11	DGKZ	601441.0 | DGKZ | Diacylglycerol kinase, zeta, 104kD | 8525.0 | ENSG00000149091 | nan | nan
chr11	MDK	162096.0 | MDK, NEGF2 | Midkine (neurite growth-promoting factor 2) | 4192.0 | ENSG00000110492 | nan | nan
chr11	CHRM4	118495.0 | CHRM4 | Cholinergic receptor, muscarinic, 4 | 1132.0 | ENSG00000180720 | nan | nan
chr11	AMBRA1	611359.0 | AMBRA1, KIAA1736 | Activating molecule in beclin 1-regulated autophagy | 55626.0 | ENSG00000110497 | nan | nan
chr11	HARBI1	615086.0 | HARBI1 | Harbinger transposase-derived gene 1 | 283254.0 | ENSG00000180423 | nan | nan
chr11	ATG13	615088.0 | ATG13, KIAA0652, PARATARG8 | Autophagy related 13 | 9776.0 | ENSG00000175224 | nan | nan
chr11	ARHGAP1	602732.0 | ARHGAP1, RHOGAP1, CDC42GAP | RHO GTPase-activating protein 1 | 392.0 | ENSG00000175220 | nan | nan
chr11	ZNF408	616454.0 | ZNF408, EVR6, RP72 | Zinc finger protein 408 | 79797.0 | ENSG00000175213 | mutation identified in 1 EVR6 family | Retinitis pigmentosa 72, 616469 (3), Autosomal recessive; ?Exudative vitreoretinopathy 6, 616468 (3), Autosomal dominant
chr11	F2	176930.0 | F2, THPH1, RPRGL2 | Coagulation factor II (thrombin) | 2147.0 | ENSG00000180210 | nan | Hypoprothrombinemia, 613679 (3), Autosomal recessive; {Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3), Autosomal dominant; Dysprothrombinemia, 613679 (3), Autosomal recessive; Thrombophilia 1 due to thrombin defect, 188050 (3), Autosomal dominant; {Stroke, ischemic, susceptibility to}, 601367 (3), Multifactorial
chr11	CKAP5	611142.0 | CKAP5, CHTOG, MSPS, KIAA0097 | Cytoskeleton-associated protein 5 | 9793.0 | ENSG00000175216 | nan | nan
chr11	LRP4	604270.0 | LRP4, MEGF7, CLSS, SOST2, CMS17 | Low density lipoprotein receptor-related protein 4 | 4038.0 | ENSG00000134569 | mutation identified in 1 CMS17 family | ?Myasthenic syndrome, congenital, 17, 616304 (3), Autosomal recessive; Sclerosteosis 2, 614305 (3), Autosomal recessive, Autosomal dominant; Cenani-Lenz syndactyly syndrome, 212780 (3), Autosomal recessive
chr11	CSTPP1	620479.0 | CSTPP1, C11orf49 | Centriolar satellite-associated tubulin polyglutamylase complex regulator 1 | 79096.0 | ENSG00000149179 | nan | nan
chr11	ARFGAP2	606908.0 | ARFGAP2, ZNF289 | ADP-ribosylation factor GTPase-activating protein 2 | 84364.0 | ENSG00000149182 | nan | nan
chr11	PACSIN3	606513.0 | PACSIN3 | Protein kinase C and casein kinase substrate in neurons 3 | 29763.0 | ENSG00000165912 | nan | nan
chr11	DDB2	600811.0 | DDB2 | Damage-specific DNA binding protein 2, 48kD | 1643.0 | ENSG00000134574 | nan | Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3), Autosomal recessive
chr11	ACP2	171650.0 | ACP2 | Acid phosphatase 2, lysosomal | 53.0 | ENSG00000134575 | nan | ?Lysosomal acid phosphatase deficiency, 200950 (1), Autosomal recessive
chr11	NR1H3	602423.0 | NR1H3, LXRA | Nuclear receptor subfamily 1, group H, member 3 | 10062.0 | ENSG00000025434 | nan | nan
chr11	MADD	603584.0 | MADD, DENN, NEDDISH, DEEAH | MAP kinase-activating death domain (differentially expressed in normal and neoplastic cells) | 8567.0 | ENSG00000110514 | nan | Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia, 619005 (3), Autosomal recessive; DEEAH syndrome, 619004 (3), Autosomal recessive
chr11	MYBPC3	600958.0 | MYBPC3, CMH4, CMD1MM, LVNC10 | Myosin-binding protein C, cardiac | 4607.0 | ENSG00000134571 | nan | Cardiomyopathy, hypertrophic, 4, 115197 (3), Autosomal recessive, Autosomal dominant; Cardiomyopathy, dilated, 1MM, 615396 (3), Autosomal dominant; Left ventricular noncompaction 10, 615396 (3), Autosomal dominant
chr11	SPI1	165170.0 | SPI1, SFPI1, AGM10 | SPI1 protooncogene | 6688.0 | ENSG00000066336 | nan | Agammaglobulinemia 10, autosomal dominant, 619707 (3), Autosomal dominant
chr11	SLC39A13	608735.0 | SLC39A13, ZIP13, EDSSPD3 | Solute carrier family 39 (zinc transporter), member 13 | 91252.0 | ENSG00000165915 | nan | Ehlers-Danlos syndrome, spondylodysplastic type, 3, 612350 (3), Autosomal recessive
chr11	PSMC3	186852.0 | PSMC3, TBP1, DCIDP | Proteasome (prosome, macropain) 26S subunit, ATPase, 3 | 5702.0 | ENSG00000165916 | mutation identified in 1 DCIDP family | ?Deafness, cataract, impaired intellectual development, and polyneuropathy, 619354 (3), Autosomal recessive
chr11	RAPSN	601592.0 | RAPSN, CMS1D, CMS11, FADS2 | Receptor-associated protein of the synapse, 43kD | 5913.0 | ENSG00000165917 | nan | Fetal akinesia deformation sequence 2, 618388 (3), Autosomal recessive; Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3), Autosomal recessive
chr11	CELF1	601074.0 | CELF1, CUGBP1, NAB50, BRUNOL2, CUGBP | CUGbp and ELAV-like family, member 1 | 10658.0 | ENSG00000149187 | nan | nan
chr11	PTPMT1	609538.0 | PTPMT1, PLIP | Protein-tyrosine phosphatase, mitochondrial, 1 | 114971.0 | ENSG00000110536 | nan | nan
chr11	KBTBD4	617645.0 | KBTBD4, HSPC252, BKLHD4 | Kelch repeat- and BTB/POZ domain-containing protein 4 | 55709.0 | ENSG00000123444 | nan | nan
chr11	NDUFS3	603846.0 | NDUFS3, MC1DN8 | NADH-ubiquinone oxidoreductase core subunit S3 | 4722.0 | ENSG00000213619 | nan | Mitochondrial complex I deficiency, nuclear type 8, 618230 (3), Autosomal recessive
chr11	C1QTNF4	614911.0 | C1QTNF4, CTRP4 | C1q- and tumor necrosis factor-related protein 4 | 114900.0 | ENSG00000172247 | nan | nan
chr11	MTCH2	613221.0 | MTCH2 | Mitochondrial carrier homolog 2 | 23788.0 | ENSG00000109919 | nan | nan
chr11	AGBL2	617345.0 | AGBL2, CCP2 | ATP/GTP-binding protein-like 2 | 79841.0 | ENSG00000165923 | nan | nan
chr11	FNBP4	615265.0 | FNBP4, FBP30, KIAA1014 | Formin-binding protein 4 | 23360.0 | ENSG00000109920 | nan | nan
chr11	NUP160	607614.0 | NUP160, KIAA0197, NPHS19 | Nucleoporin, 160kD | 23279.0 | ENSG00000030066 | mutation identified in 1 NPHS19 family | ?Nephrotic syndrome, type 19, 618178 (3), Autosomal recessive
chr11	PTPRJ	600925.0 | PTPRJ, DEP1, THC10 | Protein tyrosine phosphatase, receptor type, J polypeptide | 5795.0 | ENSG00000149177 | nan | Colon cancer, somatic, 114500 (3); Thrombocytopenia 10, 620484 (3), Autosomal recessive
chr11	FOLH1	600934.0 | FOLH1, FOLH, PSM, PSMA | Folate hydrolase 1 (prostate-specific membrane antigen) | 2346.0 | ENSG00000086205 | ?pseudogene on 11q14 | nan
chr11	OR4C46	614273.0 | OR4C46 | Olfactory receptor, family 4, subfamily C, member 46 | 119749.0 | ENSG00000185926 | nan | nan
chr11		135610.0 | FNL2 | Fibronectin-like-2 | nan | nan | nan | nan
chr11	PURAQTL1	612795.0 | PURAQTL1 | Polyunsaturated fatty acids plasma level QTL1 | 100302559.0 | nan | associated with rs174537 | [Polyunsaturated fatty acids plasma level QTL1], 612795 (2)
chr11		608687.0 | SCA20, DUP11q12, C11DUPq12 | Spinocerebellar ataxia 20 (chromosome 11q12 duplication syndrome, 260kb) | nan | nan | contiguous gene duplication syndrome | Spinocerebellar ataxia 20, 608687 (4), Autosomal dominant
chr11	OR5I1	608496.0 | OR5I1, OLF1 | Olfactory receptor, family 5, subfamily I, member 1 | 10798.0 | ENSG00000167825 | nan | nan
chr11	OR5F1	608492.0 | OR5F1 | Olfactory receptor, family 5, subfamily F, member 1 | 338674.0 | ENSG00000149133 | nan | nan
chr11	LRRC55	615213.0 | LRRC55 | Leucine-rich repeat-containing protein 55 | 219527.0 | ENSG00000183908 | nan | nan
chr11	APLNR	600052.0 | APLNR, AGTRL1, APJ | Apelin receptor | 187.0 | ENSG00000134817 | nan | nan
chr11	TNKS1BP1	607104.0 | TNKS1BP1, TAB182, KIAA1741 | Tankyrase 1-binding protein 1, 182kD | 85456.0 | ENSG00000149115 | nan | nan
chr11	SSRP1	604328.0 | SSRP1, FACT | Structure-specific recognition protein 1 | 6749.0 | ENSG00000149136 | nan | nan
chr11	P2RX3	600843.0 | P2RX3, P2X3 | Purinergic receptor P2X, ligand-gated ion channel, 3 | 5024.0 | ENSG00000109991 | nan | nan
chr11	PRG3	606814.0 | PRG3, MBPH | Proteoglycan 3 | 10394.0 | ENSG00000156575 | nan | nan
chr11	PRG2	605601.0 | PRG2, MBP | Proteoglycan 2 | 5553.0 | ENSG00000186652 | nan | nan
chr11	SLC43A3	618034.0 | SLC43A3, EEG1, ENBT1 | Solute carrier family 43, member 3 | 29015.0 | ENSG00000134802 | nan | nan
chr11	RTN4RL2	610462.0 | RTN4RL2, NGRH1, NGR2 | Reticulon 4 receptor-like 2 | 349667.0 | ENSG00000186907 | nan | nan
chr11	SLC43A1	603733.0 | SLC43A1, LAT3, POV1 | Solute carrier family 43 (L-type amino acid transporter), member 1 | 8501.0 | ENSG00000149150 | nan | nan
chr11	TIMM10	602251.0 | TIMM10, TIM10A, TIM10 | Translocase of inner mitochondrial membrane 10 | 26519.0 | ENSG00000134809 | nan | nan
chr11	SMTNL1	613664.0 | SMTNL1, CHASM | Smoothelin-like 1 | 219537.0 | ENSG00000214872 | nan | nan
chr11	UBE2L6	603890.0 | UBE2L6, UBCH8 | Ubiquitin-conjugating enzyme E2 L6 | 9246.0 | ENSG00000156587 | nan | nan
chr11	SERPING1	606860.0 | SERPING1, C1NH, HAE1, HAE2 | Serpin family G member 1 (complement component-1 inhibitor) | 710.0 | ENSG00000149131 | nan | Angioedema, hereditary, 1 and 2, 106100 (3), Autosomal recessive, Autosomal dominant; Complement component 4, partial deficiency of, 120790 (3), Autosomal dominant
chr11	MIR130A	610175.0 | MIR130A, MIRN130A | Micro RNA 130A | 406919.0 | ENSG00000208009 | nan | nan
chr11	YPEL4	609725.0 | YPEL4 | Yippee-like 4 | 219539.0 | ENSG00000166793 | nan | nan
chr11	CLP1	608757.0 | CLP1, HEAB, PCH10 | Cleavage and polyadenylation factor I subunit 1, yeast, homolog of | 10978.0 | ENSG00000172409 | nan | Pontocerebellar hypoplasia, type 10, 615803 (3), Autosomal recessive
chr11	ZDHHC5	614586.0 | ZDHHC5, DHHC5, ZNF375, KIAA1748 | Zinc finger DHHC domain-containing protein 5 | 25921.0 | ENSG00000156599 | nan | nan
chr11	MED19	612385.0 | MED19 | Mediator complex subunit 19 | 219541.0 | ENSG00000156603 | nan | nan
chr11	TMX2	616715.0 | TMX2, NEDMCMS | Thioredoxin-related transmembrane protein 2 | 51075.0 | ENSG00000213593 | nan | Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity, 618730 (3), Autosomal recessive
chr11	SELENOH	607914.0 | SELENOH, SELH | Selenoprotein H | 280636.0 | ENSG00000211450 | nan | nan
chr11	CTNND1	601045.0 | CTNND1, CTNND, BCDS2 | Catenin (cadherin-associated protein), delta 1 | 1500.0 | ENSG00000198561 | nan | Blepharocheilodontic syndrome 2, 617681 (3), Autosomal dominant
chr11	OR9I1	620828.0 | OR9I1 | Olfactory receptor, family 9, subfamily I, member 1 | 219954.0 | ENSG00000172377 | nan | nan
chr11	LPXN	605390.0 | LPXN | Leupaxin | 9404.0 | ENSG00000110031 | nan | nan
chr11	ZFP91	619289.0 | ZFP91, DSM8 | Zinc finger protein 91, atypical E3 ubiquitin ligase | 80829.0 | ENSG00000186660 | nan | nan
chr11	CNTF	118945.0 | CNTF | Ciliary neurotrophic factor | 1270.0 | ENSG00000242689 | nan | nan
chr11	GLYAT	607424.0 | GLYAT, ACGNAT, CAT | Glycine-N-acyltransferase | 10249.0 | ENSG00000149124 | nan | nan
chr11	GLYATL2	614762.0 | GLYATL2 | Glycine N-acyltransferase-like 2 | 219970.0 | ENSG00000156689 | nan | nan
chr11	GLYATL1	614761.0 | GLYATL1 | Glycine-N-acyltransferase-like 1 | 92292.0 | ENSG00000166840 | nan | nan
chr11	FAM111B	615584.0 | FAM111B, POIKTMP | Family with sequence similarity 111, member B | 374393.0 | ENSG00000189057 | nan | Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3), Autosomal dominant
chr11	FAM111A	615292.0 | FAM111A, KIAA1895, KCS2, GCLEB | Family with sequence similarity 111, member A | 63901.0 | ENSG00000166801 | nan | Kenny-Caffey syndrome, type 2, 127000 (3), Autosomal dominant; Gracile bone dysplasia, 602361 (3), Autosomal dominant
chr11	DTX4	616110.0 | DTX4, RNF155, KIAA0937 | Deltex E3 ubiquitin ligase 4 | 23220.0 | ENSG00000110042 | nan | nan
chr11	MPEG1	610390.0 | MPEG1, MPG1, IMD77 | Macrophage expressed gene 1 | 219972.0 | ENSG00000197629 | nan | Immunodeficiency 77, 619223 (3), Autosomal dominant
chr11	OR5AN1	615702.0 | OR5AN1 | Olfactory receptor, family 5, subfamily AN, member 1 | 390195.0 | ENSG00000176495 | nan | nan
chr11	OSBP	167040.0 | OSBP | Oxysterol-binding protein | 5007.0 | ENSG00000110048 | nan | nan
chr11	PATL1	614660.0 | PATL1, PAT1B | PAT1 homolog 1, processing body mRNA decay factor | 219988.0 | ENSG00000166889 | nan | nan
chr11	STX3	600876.0 | STX3, STX3A, DIAR12, MVID2, RDMVID | Syntaxin 3 | 6809.0 | ENSG00000166900 | nan | Retinal dystrophy and microvillus inclusion disease, 619446 (3), Autosomal recessive; Diarrhea 12, with microvillus atrophy, 619445 (3), Autosomal recessive
chr11	MRPL16	611829.0 | MRPL16 | Mitochondrial ribosomal protein L16 | 54948.0 | ENSG00000166902 | nan | nan
chr11	CBLIF	609342.0 | CBLIF, GIF, IF | Cobalamin-binding intrinsic factor (gastric intrinsic factor) | 2694.0 | ENSG00000134812 | nan | Intrinsic factor deficiency, 261000 (3), Autosomal recessive
chr11	TCN1	189905.0 | TCN1, TC1 | Transcobalamin I | 6947.0 | ENSG00000134827 | nan | nan
chr11	OOSP2	620263.0 | OOSP2 | Oocyte-secreted protein 2 | 219990.0 | ENSG00000149507 | nan | nan
chr11	MS4A3	606498.0 | MS4A3, HTM4, CD20L | Membrane-spanning 4-domains, subfamily A, member 3 | 932.0 | ENSG00000149516 | nan | nan
chr11	MS4A2	147138.0 | MS4A2, FCER1B | Membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for, beta polypeptide) | 2206.0 | ENSG00000149534 | nan | nan
chr11	MS4A6A	606548.0 | MS4A6A, MS4A6 | Membrane-spanning 4-domains, subfamily A, member 6A | 64231.0 | ENSG00000110077 | nan | nan
chr11	MS4A4E	608401.0 | MS4A4E | Membrane-spanning 4-domains, subfamily A, member 4E | 643680.0 | ENSG00000214787 | nan | nan
chr11	MS4A4A	606547.0 | MS4A4A, MS4A4 | Membrane-spanning 4-domains, subfamily A, member 4A | 51338.0 | ENSG00000110079 | nan | nan
chr11	MS4A6E	608402.0 | MS4A6E | Membrane-spanning 4-domains, subfamily A, member 6E | 245802.0 | ENSG00000166926 | nan | nan
chr11	MS4A7	606502.0 | MS4A7, CFFM4 | Membrane-spanning 4-domains, subfamily A, member 7 | 58475.0 | ENSG00000166927 | nan | nan
chr11	MS4A5	606499.0 | MS4A5, TETM4, CD20L2 | Membrane-spanning 4-domains, subfamily A, member 5 | 64232.0 | ENSG00000166930 | nan | nan
chr11	MS4A1	112210.0 | MS4A1, CD20, CVID5 | Membrane-spanning 4-domains, subfamily A, member 1 | 931.0 | ENSG00000156738 | mutation identified in 1 CVID5 patient | ?Immunodeficiency, common variable, 5, 613495 (3), Autosomal recessive
chr11	MS4A12	606550.0 | MS4A12 | Membrane-spanning 4-domains, subfamily A, member 12 | 54860.0 | ENSG00000071203 | nan | nan
chr11	MS4A8	606549.0 | MS4A8B | Membrane-spanning 4-domains, subfamily A, member 8B | 83661.0 | ENSG00000166959 | nan | nan
chr11	MS4A10	608403.0 | MS4A10 | Membrane-spanning 4-domains, subfamily A, member 10 | 341116.0 | ENSG00000172689 | nan | nan
chr11	CCDC86	611293.0 | CCDC86, CYCLON | Coiled-coil domain-containing protein 86 | 79080.0 | ENSG00000110104 | nan | nan
chr11	PTGDR2	604837.0 | PTGDR2, GPR44 | Prostaglandin D2 receptor 2 | 11251.0 | ENSG00000183134 | nan | nan
chr11	ZP1	195000.0 | ZP1, OZEMA1 | Zona pellucida glycoprotein 1 | 22917.0 | ENSG00000149506 | nan | Oocyte/zygote/embryo maturation arrest 1, 615774 (3), Autosomal recessive
chr11	PRPF19	608330.0 | PRPF19, PRP19, PSO4, NMP200 | Pre-mRNA processing factor 19 | 27339.0 | ENSG00000110107 | nan | nan
chr11	TMEM109	619168.0 | TMEM109, MG23 | Transmembrane protein 109 | 79073.0 | ENSG00000110108 | nan | nan
chr11	TMEM132A	617363.0 | TMEM132A, KIAA1583 | Transmembrane protein 132A | 54972.0 | ENSG00000006118 | nan | nan
chr11	SLC15A3	610408.0 | SLC15A3, PHT2 | Solute carrier family 15 (oligopeptide transporter), member 3 | 51296.0 | ENSG00000110446 | nan | nan
chr11	CD6	186720.0 | CD6, TP120 | CD6 antigen | 923.0 | ENSG00000013725 | nan | nan
chr11	CD5	153340.0 | CD5, LEU1 | CD5 antigen (p56-62) | 921.0 | ENSG00000110448 | nan | nan
chr11	VPS37C	610038.0 | VPS37C | VPS37C subunit of ESCRT-I | 55048.0 | ENSG00000167987 | nan | nan
chr11	PGA4	169720.0 | PGA4 | Pepsinogen A4 | 643847.0 | ENSG00000229183 | nan | nan
chr11	PGA5	169730.0 | PGA5 | Pepsinogen A5 | 5222.0 | ENSG00000256713 | pter-5'HRAS--5'INS--cen | nan
chr11	VWCE	611115.0 | VWC1, URG11 | von Willebrand factor C and EGF domain-containing protein | 220001.0 | ENSG00000167992 | nan | nan
chr11	DDB1	600045.0 | DDB1, WHIKERS | Damage-specific DNA binding protein 1, 127kD | 1642.0 | ENSG00000167986 | nan | White-Kernohan syndrome, 619426 (3), Autosomal dominant
chr11	TKFC	615844.0 | TKFC, DAK, TKFCD | Triokinase and FMN cyclase | 26007.0 | ENSG00000149476 | nan | Triokinase and FMN cyclase deficiency syndrome, 618805 (3), Autosomal recessive
chr11	CYB561A3	618757.0 | CYB561A3, LCYTB, CYBASC3 | Cytochrome b561 family, member A3 | 220002.0 | ENSG00000162144 | nan | nan
chr11	TMEM138	614459.0 | TMEM138, JBTS16 | Transmembrane protein 138 | 51524.0 | ENSG00000149483 | nan | Joubert syndrome 16, 614465 (3), Autosomal recessive
chr11	TMEM216	613277.0 | TMEM216, JBTS2, CORS2, MKS2, RP98 | Transmembrane protein 216 | 51259.0 | ENSG00000187049 | nan | Joubert syndrome 2, 608091 (3), Autosomal recessive; Retinitis pigmentosa 98, 620996 (3); Meckel syndrome 2, 603194 (3), Autosomal recessive
chr11	SDHAF2	613019.0 | SDHAF2, SDH5, PPGL2 | Succinate dehydrogenase complex assembly factor 2 | 54949.0 | ENSG00000167985 | nan | Pheochromocytoma/paraganglioma syndrome 2, 601650 (3), Autosomal dominant
chr11	SAXO4	619047.0 | PPP1R32, IIIG9, C11orf66 | Protein phosphatase 1, regulatory subunit 32 | 220004.0 | ENSG00000162148 | nan | nan
chr11	SYT7	604146.0 | SYT7 | Synaptotagmin 7 | 9066.0 | ENSG00000011347 | nan | nan
chr11	DAGLA	614015.0 | DAGLA, KIAA0659, NOC2 | Diacylglycerol lipase, alpha | 747.0 | ENSG00000134780 | nan | Neuroocular syndrome 2, paroxysmal type, 168885 (3), Autosomal dominant
chr11	MYRF	608329.0 | MYRF, C11orf9, KIAA0954, MMERV, CUGS | Myelin regulatory factor | 745.0 | ENSG00000124920 | nan | Encephalitis/encephalopathy, mild, with reversible myelin vacuolization, 618113 (3), Autosomal dominant; Cardiac-urogenital syndrome, 618280 (3), Autosomal dominant
chr11	TMEM258	617615.0 | TMEM258, C11orf10 | Transmembrane protein 258 | 746.0 | ENSG00000134825 | nan | nan
chr11	FEN1	600393.0 | FEN1 | Flap structure-specific endonuclease 1 | 2237.0 | ENSG00000168496 | nan | nan
chr11	FADS1	606148.0 | FADS1 | Fatty acid desaturase 1 | 3992.0 | ENSG00000149485 | nan | nan
chr11	FADS2	606149.0 | FADS2 | Fatty acid desaturase 2 | 9415.0 | ENSG00000134824 | nan | nan
chr11	FADS3	606150.0 | FADS3 | Fatty acid desaturase 3 | 3995.0 | ENSG00000221968 | nan | nan
chr11	BEST1	607854.0 | BEST1, VMD2, ARB, RP50 | Bestrophin 1 | 7439.0 | ENSG00000167995 | mutation identified in 1 MRCS family | Macular dystrophy, vitelliform, 2, 153700 (3), Autosomal dominant; ?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2, 193220 (3), Autosomal dominant; Retinitis pigmentosa-50, 613194 (3); Retinitis pigmentosa, concentric, 613194 (3); Vitreoretinochoroidopathy, 193220 (3), Autosomal dominant; Bestrophinopathy, autosomal recessive, 611809 (3)
chr11	FTH1	134770.0 | FTH1, FTHL6, HFE5, NBIA9 | Ferritin, heavy polypeptide 1 | 2495.0 | ENSG00000167996 | mutation identified in 1 HFE5 family | Neurodegeneration with brain iron accumulation 9, 620669 (3), Autosomal dominant; ?Hemochromatosis, type 5, 615517 (3), Autosomal dominant
chr11	INCENP	604411.0 | INCENP | Inner centromere protein | 3619.0 | ENSG00000149503 | nan | nan
chr11	SCGB1D1	615060.0 | SCGB1D1, LPNA | Secretoglobin, family 1D, member 1 | 10648.0 | ENSG00000168515 | previously mapped to 15q12-q13 | nan
chr11	SCGB2A1	604398.0 | SCGB2A1, MGB2, LPNC | Secretoglobin, family 2A, member 1 (mammaglobin 2) | 4246.0 | ENSG00000124939 | nan | nan
chr11	SCGB1D2	615061.0 | SCGB1D2, LPNB | Secretoglobin, family 1D, member 2 | 10647.0 | ENSG00000124935 | previously mapped to 10q23 | nan
chr11	SCGB2A2	605562.0 | MGB1, SCGB2A2 | Mammaglobin 1 (secretoglobin, family 2A, member 2) | 4250.0 | ENSG00000110484 | nan | nan
chr11	SCGB1D4	615062.0 | SCGB1D4, IIS | Secretoglobin, family 1D, member 4 | 404552.0 | ENSG00000197745 | nan | nan
chr11	ASRGL1	609212.0 | ASRGL1, ALP | Asparaginase-like protein 1 | 80150.0 | ENSG00000162174 | nan | nan
chr11	SCGB1A1	192020.0 | SCGB1A1, UGB, CC10, CCSP | Secretoglobin, family 1A, member 1 (uteroglobin) | 7356.0 | ENSG00000149021 | nan | nan
chr11	AHNAK	103390.0 | AHNAK | AHNAK nucleoprotein (desmoyokin) | 79026.0 | ENSG00000124942 | nan | nan
chr11	EEF1G	130593.0 | EEF1G, EF1G | Eukaryotic translation elongation factor 1, gamma | 1937.0 | ENSG00000254772 | nan | nan
chr11	TUT1	610641.0 | TUT1, PAPD2 | Terminal uridylyl transferase 1, U6 snRNA-specific | 64852.0 | ENSG00000149016 | nan | nan
chr11	MTA2	603947.0 | MTA2, MTA1L1 | Metastasis-associated protein 2 | 9219.0 | ENSG00000149480 | nan | nan
chr11	EML3	618118.0 | EML3, EMAP3, EMAP95 | Echinoderm microtubule-associated protein-like 3 | 256364.0 | ENSG00000149499 | nan | nan
chr11	ROM1	180721.0 | ROM1, ROSP1, RP7 | Rod outer segment membrane protein-1 | 6094.0 | ENSG00000149489 | digenic RP with RDS | Retinitis pigmentosa 7, digenic form, 608133 (3), Autosomal recessive, Autosomal dominant, Digenic dominant
chr11	B3GAT3	606374.0 | B3GAT3, GLCATI, JDSCD | Beta-1,3-glucuronyltransferase 3 | 26229.0 | ENSG00000149541 | pseudogene on chr.3 | Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3), Autosomal recessive
chr11	GANAB	104160.0 | GANAB, PKD3 | Neutral alpha-glucosidase AB | 23193.0 | ENSG00000089597 | nan | Polycystic kidney disease 3, 600666 (3), Autosomal dominant
chr11	INTS5	611349.0 | INTS5, INT5, KIAA1698 | Integrator complex subunit 5 | 80789.0 | ENSG00000185085 | nan | nan
chr11	CSKMT	617897.0 | CSKMT, METTL12 | Citrate synthase lysine methyltransferase | 751071.0 | ENSG00000214756 | nan | nan
chr11	UQCC3	616097.0 | UQCC3, C11orf83, MC3DN9 | Ubiquinol-cytochrome c reductase complex assembly factor 3 | 790955.0 | ENSG00000204922 | mutation identified in 1 MC3DN9 patient | ?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3), Autosomal recessive
chr11	UBXN1	616378.0 | UBXN1, SAKS1 | UBX domain protein 1 | 51035.0 | ENSG00000162191 | nan | nan
chr11	BSCL2	606158.0 | BSCL2, SPG17, PELD, HMND13 | Seipin | 26580.0 | ENSG00000168000 | nan | Lipodystrophy, congenital generalized, type 2, 269700 (3), Autosomal recessive; Neuronopathy, distal hereditary motor, autosomal dominant 13, 619112 (3), Autosomal dominant; Silver spastic paraplegia syndrome, 270685 (3), Autosomal dominant; Encephalopathy, progressive, with or without lipodystrophy, 615924 (3), Autosomal recessive
chr11	GNG3	608941.0 | GNG3 | Guanine nucleotide-binding protein, gamma-3 | 2785.0 | ENSG00000162188 | nan | nan
chr11	POLR2G	602013.0 | POLR2G | Polymerase (RNA) II (DNA directed) polypeptide G | 5436.0 | ENSG00000168002 | nan | nan
chr11	TMEM223	620434.0 | TMEM223 | Transmembrane protein 223 | 79064.0 | ENSG00000168569 | nan | nan
chr11	TAF6L	602946.0 | TAF6L, PAF65A | TAF6-like RNA polymerase II | 10629.0 | ENSG00000162227 | nan | nan
chr11	NXF1	602647.0 | NXF1, TAP, MEX67 | Nuclear RNA export factor 1 | 10482.0 | ENSG00000162231 | nan | nan
chr11	STX5	603189.0 | STX5, STX5A, CDG2AA | Syntaxin 5 | 6811.0 | ENSG00000162236 | mutation identified in 1 CDG2AA family | ?Congenital disorder of glycosylation, type IIaa, 620454 (3), Autosomal recessive
chr11	WDR74	617947.0 | WDR74 | WD repeat-containing protein 74 | 54663.0 | ENSG00000133316 | nan | nan
chr11	SNHG1	603222.0 | UHG, U22HG | U22 host gene | 23642.0 | ENSG00000255717 | nan | nan
chr11	SNORD22	603223.0 | RNU22 | RNA, U22 small nucleolar | 9304.0 | ENSG00000277194 | nan | nan
chr11	SNORD31	603230.0 | SNORD31, RNU31 | Small nucleolar RNA, C/D box 31 | 9298.0 | nan | nan | nan
chr11	SNORD30	603229.0 | RNU30 | RNA, U30 small nucleolar | 9299.0 | ENSG00000277846 | nan | nan
chr11	SNORD29	603228.0 | RNU29 | RNA, U29 small nucleolar | 9297.0 | nan | nan | nan
chr11	SNORD28	603227.0 | RNU28 | RNA, U28 small nucleolar | 9300.0 | ENSG00000274544 | nan | nan
chr11	SNORD27	603226.0 | RNU27 | RNA, U27 small nucleolar | 9301.0 | ENSG00000275996 | nan | nan
chr11	SNORD26	603225.0 | RNU26 | RNA, U26 small nucleolar | 9302.0 | ENSG00000276788 | nan | nan
chr11	SNORD25	603224.0 | RNU25 | RNA, U25 small nucleolar | 9303.0 | ENSG00000275043 | nan | nan
chr11	SLC3A2	158070.0 | SLC3A2, MDU1, NACAE | Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | 6520.0 | ENSG00000168003 | prob. 11q13 | nan
chr11	CHRM1	118510.0 | CHRM1 | Cholinergic receptor, muscarinic, 1 | 1128.0 | ENSG00000168539 | nan | nan
chr11	SLC22A6	607582.0 | SLC22A6, OAT1, PAHT | Solute carrier family 22 (organic anion transporter), member 6 | 9356.0 | ENSG00000197901 | nan | nan
chr11	SLC22A8	607581.0 | SLC22A8, OAT3 | Solute carrier family 22 (organic anion transporter), member 8 | 9376.0 | ENSG00000149452 | nan | nan
chr11	SLC22A24	611698.0 | SLC22A24 | Solute carrier family 22, member 24 | 283238.0 | ENSG00000197658 | nan | nan
chr11	SLC22A25	610792.0 | UST6 | Organic anion transporter UST6 | 387601.0 | ENSG00000196600 | nan | nan
chr11	SLC22A10	607580.0 | SLC22A10, OAT5 | Solute carrier family 22 (organic anion/cation transporter), member 10 | 387775.0 | ENSG00000184999 | nan | nan
chr11	SLC22A9	607579.0 | SLC22A9, OAT4, UST3 | Solute carrier family 22 (organic anion/cation transporter), member 9 | 114571.0 | ENSG00000149742 | nan | nan
chr11	PLAAT5	611474.0 | PLAAT5, HRASLS5, RLP1, HRLP5 | Phospholipase A and acyltransferase 5 | 117245.0 | ENSG00000168004 | nan | nan
chr11	LGALS12	606096.0 | LGALS12 | Lectin, galactoside-binding, soluble, 12 | 85329.0 | ENSG00000133317 | nan | nan
chr11	PLAAT4	605092.0 | PLAAT4, RARRES3, TIG3 | Phospholipase A and acyltransferase 4 | 5920.0 | ENSG00000133321 | nan | nan
chr11	PLAAT2	613866.0 | PLAAT2, HRASLS2 | Phospholipase A and acyltransferase 2 | 54979.0 | ENSG00000133328 | nan | nan
chr11	PLAAT3	613867.0 | PLAAT3, PLA2G16, HRASLS3, HRSL3, HREV107, FPLD9 | Phospholipase A and acyltransferase 3 | 11145.0 | ENSG00000176485 | nan | Lipodystrophy, familial partial, type 9, 620683 (3), Autosomal recessive
chr11	ESA4	133220.0 | ESA4 | Esterase-A4 | 2090.0 | nan | nan | nan
chr11	SMAR	607088.0 | HMNR3 | Neuronopathy, distal hereditary motor, autosomal recessive 3 | 246751.0 | nan | no mutations found in IGHMBP2 | Neuronopathy, distal hereditary motor, autosomal recessive 3, 607088 (2), Autosomal recessive
chr11	HPC14	611958.0 | HPC14 | Prostate cancer, hereditary, 14 | 100188867.0 | nan | associated with rs7931342 | {Prostate cancer, hereditary, 14}, 611958 (2)
chr11	IDDM4	600319.0 | IDDM4 | Insulin-dependent diabetes mellitus-4 | 3403.0 | nan | nan | {Diabetes mellitus, insulin-dependent, 4}, 600319 (2)
chr11		166750.0 | OTDD, DEL11q13, C11DELq13 | Otodental dysplasia (chromosome 11q13 deletion syndrome) | nan | nan | between rs9666584 and rs41408348 | Otodental dysplasia chromosome deletion syndrome, 166750 (4), Autosomal dominant
chr11	PGA3	169710.0 | PGA3 | Pepsinogen A3 | 643834.0 | ENSG00000229859 | nan | nan
chr11	SEA	165110.0 | SEA | Oncogene SEA (S13 avian erythroblastosis) | 6395.0 | nan | nan | nan
chr11	ST3	191181.0 | ST3 | Suppression of tumorigenicity-3 (tumor-suppressor gene, HELA cell type) | 6762.0 | nan | nan | Cervical carcinoma, 191181 (2)
chr11	ATL3	609369.0 | ATL3, HSN1F | Atlastin GTPase 3 | 25923.0 | ENSG00000184743 | nan | Neuropathy, hereditary sensory, type IF, 615632 (3), Autosomal dominant
chr11	RTN3	604249.0 | RTN3, NSPL2 | Reticulon 3 | 10313.0 | ENSG00000133318 | pseudogene on chr.4 | nan
chr11	ZFTA	615699.0 | ZFTA, C11orf95 | Zinc finger translocation-associated protein | 65998.0 | ENSG00000188070 | nan | nan
chr11	MARK2	600526.0 | MARK2, EMK1 | MAP/microtubule affinity-regulating kinase 2 | 2011.0 | ENSG00000072518 | nan | nan
chr11	RCOR2	616019.0 | RCOR2 | Rest corepressor 2 | 283248.0 | ENSG00000167771 | nan | nan
chr11	NAA40	619999.0 | NAA40, PATT1 | N-alpha-acetyltransferase 40, NatD catalytic subunit | 79829.0 | ENSG00000110583 | nan | nan
chr11	COX8A	123870.0 | COX8A, MC4DN15 | Cytochrome c oxidase, subunit VIIIA | 1351.0 | ENSG00000176340 | mutation identified in 1 MC4DN15 patient | ?Mitochondrial complex IV deficiency, nuclear type 15, 619059 (3), Autosomal recessive
chr11	OTUB1	608337.0 | OTUB1, OTU1, OTB1 | OTU domain-containing ubiquitin aldehyde-binding protein 1 | 55611.0 | ENSG00000167770 | nan | nan
chr11	MACROD1	610400.0 | MACROD1, LRP16 | Macro domain-containing 1 | 28992.0 | ENSG00000133315 | nan | nan
chr11	FLRT1	604806.0 | FLRT1 | Fibronectin-like domain-containing leucine-rich transmembrane protein-1 | 23769.0 | ENSG00000126500 | nan | nan
chr11	STIP1	605063.0 | STIP1, HOP | Stress-induced phosphoprotein 1 | 10963.0 | ENSG00000168439 | nan | nan
chr11	FERMT3	607901.0 | FERMT3, KIND3, URP2, MIG2B | FERM domain-containing kindlin 3 | 83706.0 | ENSG00000149781 | nan | Leukocyte adhesion deficiency, type III, 612840 (3), Autosomal recessive
chr11	TRPT1	610470.0 | TRPT1 | Transfer RNA phosphotransferase 1 | 83707.0 | ENSG00000149743 | nan | nan
chr11	DNAJC4	604189.0 | DANJC4, HSPF2 | DnaJ, E. coli, homolog of, subfamily C, member 4 (heat-shock 40kD protein 2) | 3338.0 | ENSG00000110011 | nan | nan
chr11	VEGFB	601398.0 | VEGFB, VRF | Vascular endothelial growth factor B | 7423.0 | ENSG00000173511 | nan | nan
chr11	FKBP2	186946.0 | FKBP2 | FK506-binding protein-2, 13kD | 2286.0 | ENSG00000173486 | nan | nan
chr11	PPP1R14B	601140.0 | PPP1R14B, PLCB3N, PNG | Protein phosphatase 1, regulatory subunit 14B | 26472.0 | ENSG00000173457 | nan | nan
chr11	PLCB3	600230.0 | PLCB3, SMDCD | Phospholipase C, beta 3 (phosphatidylinositol-specific) | 5331.0 | ENSG00000149782 | within 900kb of MEN1 | Spondylometaphyseal dysplasia with corneal dystrophy, 618961 (3), Autosomal recessive
chr11	BAD	603167.0 | BAD, BCL2L8 | BCL1 antagonist of cell death | 572.0 | ENSG00000002330 | nan | nan
chr11	KCNK4	605720.0 | KCNK4, TRAAK, FHEIG | Potassium channel, subfamily K, member 4 | 50801.0 | ENSG00000182450 | nan | Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome, 618381 (3), Autosomal dominant
chr11	CATSPERZ	617511.0 | CATSPERZ, TEX40 | Cation channel, sperm-associated, auxiliary subunit zeta | 25858.0 | ENSG00000219435 | nan | nan
chr11	ESRRA	601998.0 | ESRRA, ESRL1 | Estrogen-related receptor, alpha | 2101.0 | ENSG00000173153 | nan | nan
chr11	TRMT112	618630.0 | TRMT112 | tRNA methyltransferase subunit 11-2 | 51504.0 | ENSG00000173113 | nan | nan
chr11	PRDX5	606583.0 | PRDX5, AOEB166 | Peroxiredoxin 5 | 25824.0 | ENSG00000126432 | nan | nan
chr11	CCDC88B	611205.0 | CCDC88B, GIPIE | Coiled-coil domain-containing protein 88B | 283234.0 | ENSG00000168071 | nan | nan
chr11	RPS6KA4	603606.0 | RPS6KA4, RSKB, MSK2 | Ribosomal protein S6 kinase A4 | 8986.0 | ENSG00000162302 | nan | nan
chr11	SLC22A11	607097.0 | SLC22A11, OAT4 | Solute carrier family 22 (organic anion/cation transporter), member 11 | 55867.0 | ENSG00000168065 | nan | nan
chr11	SLC22A12	607096.0 | SLC22A12, OAT4L, URAT1 | Solute carrier family 22 (urate transporter), member 12 | 116085.0 | ENSG00000197891 | nan | Hypouricemia, renal, 220150 (3), Autosomal recessive
chr11	NRXN2	600566.0 | NRXN2 | Neurexin 2 | 9379.0 | ENSG00000110076 | nan | nan
chr11	RASGRP2	605577.0 | RASGRP2, CDC25L | Ras guanyl nucleotide-releasing protein 2 | 10235.0 | ENSG00000068831 | mutation identified in 1 BDPLT18 family | ?Bleeding disorder, platelet-type, 18, 615888 (3), Autosomal recessive
chr11	PYGM	608455.0 | PYGM | Phosphorylase, glycogen, muscle | 5837.0 | ENSG00000068976 | nan | McArdle disease, 232600 (3), Autosomal recessive
chr11	SF1	601516.0 | SF1, ZNF162, D11S636, ZFM1 | Splicing factor 1 (zinc finger protein-162) | 7536.0 | ENSG00000168066 | nan | nan
chr11	MAP4K2	603166.0 | MAP4K2, RAB8IP, GCK | Mitogen-activating protein kinase kinase kinase kinase 2 (RAB8-interacting protein; germinal center kinase) | 5871.0 | ENSG00000168067 | nan | nan
chr11	MEN1	613733.0 | MEN1 | Menin | 4221.0 | ENSG00000133895 | linked distal to PYGM | Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)
chr11	CDC42BPG	613991.0 | CDC42BPG, MRCKG | CDC42-binding protein kinase, gamma | 55561.0 | ENSG00000171219 | nan | nan
chr11	EHD1	605888.0 | EHD1 | EH domain-containing 1 protein | 10938.0 | ENSG00000110047 | nan | nan
chr11	MIR192	610939.0 | MIR192, MIRN192 | Micro RNA 192 | 406967.0 | ENSG00000283926 | nan | nan
chr11	MIR194-2	610941.0 | MIR194-2, MIRN194-2 | Micro RNA 194-2 | 406970.0 | ENSG00000284155 | nan | nan
chr11	ATG2A	616225.0 | ATG2A, KIAA0404 | Autophagy related 2A | 23130.0 | ENSG00000110046 | nan | nan
chr11	PPP2R5B	601644.0 | PPP2R5B | Protein phosphatase-2, regulatory subunit B (B56), beta isoform | 5526.0 | ENSG00000068971 | nan | nan
chr11	GPHA2	609651.0 | GPHA2, GPA2 | Glycoprotein hormone, alpha-2 | 170589.0 | ENSG00000149735 | nan | nan
chr11	MAJIN	617130.0 | MAJIN, C11orf85 | Membrane-anchored junction protein | 283129.0 | ENSG00000168070 | nan | nan
chr11	BATF2	614983.0 | BATF2, SARI | Basic leucine zipper transcription factor, ATF-like 2 | 116071.0 | ENSG00000168062 | nan | nan
chr11	ARL2	601175.0 | ARL2, MRCS1 | ADP ribosylation factor-like GTPase 2 | 402.0 | ENSG00000213465 | mutation identified in 1 MRCS1 family | ?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1, 619082 (3), Autosomal dominant
chr11	SNX15	605964.0 | SNX15 | Sorting nexin 15 | 29907.0 | ENSG00000110025 | nan | nan
chr11	SAC3D1	618796.0 | SAC3D1, SHD1 | SAC3 domain-containing protein 1 | 29901.0 | ENSG00000168061 | nan | nan
chr11	NAALADL1	602640.0 | NAALADL1, I100 | N-acetylated alpha-linked acidic dipeptidase-like 1 | 10004.0 | ENSG00000168060 | nan | nan
chr11	CDCA5	609374.0 | CDCA5, SORORIN | Cell division cycle-associated protein 5 (sororin) | 113130.0 | ENSG00000146670 | nan | nan
chr11	ZFPL1	619397.0 | ZFPL1 | Zinc finger protein-like 1 | 7542.0 | ENSG00000162300 | nan | nan
chr11	VPS51	615738.0 | VPS51, ANG2, PCH13 | VPS51 subunit of GARP complex | 738.0 | ENSG00000149823 | nan | Pontocerebellar hypoplasia, type 13, 618606 (3), Autosomal recessive
chr11	TM7SF2	603414.0 | TM7SF2, ANG1 | Transmembrane 7 superfamily, member 2 | 7108.0 | ENSG00000149809 | nan | nan
chr11	ZNHIT2	604575.0 | ZNHIT2, C11orf5, FON | Zinc finger HIT domain containing protein 2 | 741.0 | ENSG00000174276 | nan | nan
chr11	FAU	134690.0 | FAU | FAU ubiquitin like and ribosomal protein S30 fusion | 2197.0 | ENSG00000149806 | nan | nan
chr11	MRPL49	606866.0 | MRPL49, NOF1 | Mitochondrial ribosomal protein L49 | 740.0 | ENSG00000149792 | nan | nan
chr11	SYVN1	608046.0 | SYVN1, HRD1, KIAA1810 | Synovial apoptosis inhibitor 1 | 84447.0 | ENSG00000162298 | nan | nan
chr11	SPDYC	614030.0 | SPDYC, SPDYE4, RINGOC | Speedy/RINGO cell cycle regulator family, member C | 387778.0 | ENSG00000204710 | nan | nan
chr11	CAPN1	114220.0 | CAPN1, SPG76 | Calpain, large polypeptide L1 | 823.0 | ENSG00000014216 | nan | Spastic paraplegia 76, autosomal recessive, 616907 (3), Autosomal recessive
chr11	SLC22A20P	611696.0 | SLC22A20, OAT6 | Solute carrier family 22, member 20 | 440044.0 | ENSG00000293475 | nan | nan
chr11	POLA2	620063.0 | POLA2 | DNA polymerase alpha-2, accessory subunit | 23649.0 | ENSG00000014138 | nan | nan
chr11	CDC42EP2	606132.0 | CDC42EP2, CEP2, BORG1 | CDC42 effector protein 2 | 10435.0 | ENSG00000149798 | nan | nan
chr11	DPF2	601671.0 | DPF2, REQ, UBID4, CSS7 | D4, zinc, and double PHD fingers family, member 2 | 5977.0 | ENSG00000133884 | nan | Coffin-Siris syndrome 7, 618027 (3), Autosomal dominant
chr11	TIGD3	619084.0 | TIGD3 | Tigger transposable element-derived gene 3 | 220359.0 | ENSG00000173825 | nan | nan
chr11	FRMD8	618337.0 | FRMD8, ITAP | FERM domain-containing protein 8 | 83786.0 | ENSG00000126391 | nan | nan
chr11	SLC25A45	610825.0 | SLC25A45 | Solute carrier family 25, member 45 | 283130.0 | ENSG00000162241 | nan | nan
chr11	NEAT1	612769.0 | NEAT1, TNCRNA | Noncoding nuclear-enriched abundant transcript 1 | 283131.0 | ENSG00000245532 | nan | nan
chr11	MALAT1	607924.0 | MALAT1, PRO1073 | Metastasis-associated lung adenocarcinoma transcript 1 | 378938.0 | nan | fused with TFEB in renal tumors | nan
chr11	SCYL1	607982.0 | SCYL1, NTKL, SCAR21 | SCY1-like 1 | 57410.0 | ENSG00000142186 | nan | Spinocerebellar ataxia, autosomal recessive 21, 616719 (3), Autosomal recessive
chr11	LTBP3	602090.0 | LTBP3, LTBP2, DASS, GPHYSD3 | Latent transforming growth factor beta binding protein-3 | 4054.0 | ENSG00000168056 | nan | Dental anomalies and short stature, 601216 (3), Autosomal recessive; Geleophysic dysplasia 3, 617809 (3), Autosomal dominant
chr11	ZNRD2	606044.0 | ZNRD2, SSSCA1 | Zinc ribbon domain containing 2 | 10534.0 | ENSG00000173465 | nan | nan
chr11	FAM89B	616128.0 | FAM89B, MTVR, LRAP25 | Family with sequence similarity 89, member B | 23625.0 | ENSG00000176973 | nan | nan
chr11	EHBP1L1	619583.0 | EHBP1L1 | EH domain-binding protein 1-like 1 | 254102.0 | ENSG00000173442 | nan | nan
chr11	KCNK7	603940.0 | KCNK7 | Potassium channel, subfamily K, member 7 | 10089.0 | ENSG00000173338 | nan | nan
chr11	MAP3K11	600050.0 | MAP3K11, MLK3, PTK1, SPRK | Mitogen-activated protein kinase kinase kinase 11 | 4296.0 | ENSG00000173327 | nan | nan
chr11	PCNX3	617657.0 | PCNX3 | Pecanex 3 | 399909.0 | ENSG00000197136 | nan | nan
chr11	SIPA1	602180.0 | SIPA1, SPA1 | Signal-induced proliferation-associated gene-1 | 6494.0 | ENSG00000213445 | nan | nan
chr11	RELA	164014.0 | RELA, NFKB3, CMCU, AIF3BL3 | RELA protooncogene, NF-kB subunit | 5970.0 | ENSG00000173039 | nan | Autoinflammatory disease, familial, Behcet-like-3, 618287 (3), Autosomal dominant
chr11	KAT5	601409.0 | KAT5, HTATIP, TIP60, ESA1, PLIP, NEDFASB | Lysine acetyltransferase 5 | 10524.0 | ENSG00000172977 | nan | Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities, 619103 (3), Autosomal dominant
chr11	RNASEH2C	610330.0 | RNASEH2C, AYP1, FLJ20974, AGS3 | Ribonuclease H2, subunit C | 84153.0 | ENSG00000172922 | nan | Aicardi-Goutieres syndrome 3, 610329 (3), Autosomal recessive
chr11	AP5B1	614367.0 | AP5B1, DKFZp761E198 | Adaptor-related protein complex 5, beta-1 subunit | 91056.0 | ENSG00000254470 | nan | nan
chr11	OVOL1	602313.0 | OVOL1 | Ovo, Drosophila, homolog-like, 1 | 5017.0 | ENSG00000172818 | nan | nan
chr11	CFL1	601442.0 | CFL1 | Cofilin 1 (non-muscle) | 1072.0 | ENSG00000172757 | nan | nan
chr11	MUS81	606591.0 | MUS81 | MUS81 structure-specific endonuclease subunit | 80198.0 | ENSG00000172732 | nan | nan
chr11	EFEMP2	604633.0 | EFEMP2, FBLN4, UPH1, ARCL1B | EGF-containing fibulin-like extracellular matrix protein 2 (fibulin 4) | 30008.0 | ENSG00000172638 | nan | Cutis laxa, autosomal recessive, type IB, 614437 (3), Autosomal recessive
chr11	CTSW	602364.0 | CTSW | Cathepsin W | 1521.0 | ENSG00000172543 | nan | nan
chr11	FIBP	608296.0 | FIBP, TROFAS | Fibroblast growth factor, acidic, intracellular binding protein | 9158.0 | ENSG00000172500 | nan | Thauvin-Robinet-Faivre syndrome, 617107 (3), Autosomal recessive
chr11	CCDC85B	605360.0 | DIPA | Delta antigen-interacting protein A | 11007.0 | ENSG00000175602 | nan | nan
chr11	FOSL1	136515.0 | FOSL1, FRA1 | FOS-like 1, AP-1 transcription factor subunit | 8061.0 | ENSG00000175592 | nan | nan
chr11	DRAP1	602289.0 | DRAP1 | DR1-associated protein 1 | 10589.0 | ENSG00000175550 | nan | nan
chr11	SART1	605941.0 | SART1, HOMS1 | Spliceosome-associated factor 1, recruiter of U4/U6.U5 tri-snRNP | 9092.0 | ENSG00000175467 | nan | nan
chr11	EIF1AD	618473.0 | EIF1AD, OBELIX | Eukaryotic translation initiation factor 1A domain-containing protein | 84285.0 | ENSG00000175376 | nan | nan
chr11	BANF1	603811.0 | BANF1, BAF, NGPS | Barrier to autointegration factor 1 | 8815.0 | ENSG00000175334 | nan | Nestor-Guillermo progeria syndrome, 614008 (3), Autosomal recessive
chr11	CST6	601891.0 | CST6, ECTD15 | Cystatin-M | 1474.0 | ENSG00000175315 | mutation identified in 1 ECTD15 family | ?Ectodermal dysplasia 15, hypohidrotic/hair type, 618535 (3), Autosomal recessive
chr11	CATSPER1	606389.0 | CATSPER1, CATSPER, SPGF7 | Cation channel, sperm-associated, 1 | 117144.0 | ENSG00000175294 | nan | Spermatogenic failure 7, 612997 (3), Autosomal recessive
chr11	GAL3ST3	608234.0 | GAL3ST3, GAL3ST2 | Galactose-3-O-sulfotransferase 3 | 89792.0 | ENSG00000175229 | nan | nan
chr11	SF3B2	605591.0 | SF3B2, SF3B145, SAP145, CFM | Splicing factor 3B, subunit 2 | 10992.0 | ENSG00000087365 | nan | Craniofacial microsomia, 164210 (3), Autosomal dominant
chr11	PACS1	607492.0 | PACS1, SHMS, MRD17 | Phosphofurin acidic cluster sorting protein 1 | 55690.0 | ENSG00000175115 | nan | Schuurs-Hoeijmakers syndrome, 615009 (3), Autosomal dominant
chr11	KLC2	611729.0 | KLC2, SPOAN | Kinesin, light chain 2 | 64837.0 | ENSG00000174996 | nan | Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3), Autosomal recessive
chr11	RAB1B	612565.0 | RAB1B | Ras-associated protein RAB1B | 81876.0 | ENSG00000174903 | nan | nan
chr11	CNIH2	611288.0 | CNIH2, CNIL | Cornichon, Drosophila, homolog of, 2 | 254263.0 | ENSG00000174871 | nan | nan
chr11	YIF1A	611484.0 | YIF1A, YIF1 | YIP1-interacting factor homolog A, membrane-trafficking protein | 10897.0 | ENSG00000174851 | nan | nan
chr11	TMEM151A	620108.0 | TMEM151A, EKD3, DYT36 | Transmembrane protein 151A | 256472.0 | ENSG00000179292 | nan | Episodic kinesigenic dyskinesia 3, 620245 (3), Autosomal dominant
chr11	CD248	606064.0 | CD248, TEM1 | CD248 antigen | 57124.0 | ENSG00000174807 | nan | nan
chr11	RIN1	605965.0 | RIN1 | Ras and Rab interactor 1 | 9610.0 | ENSG00000174791 | nan | nan
chr11	BRMS1	606259.0 | BRMS1 | BRMS1 transcriptional repressor and anoikis regulator | 25855.0 | ENSG00000174744 | nan | nan
chr11	B4GAT1	605517.0 | B4GAT1, B3GNT1, IGNT, IGAT, MDDGA13 | Beta-1,4glucuronyltransferase 1 | 11041.0 | ENSG00000174684 | nan | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3), Autosomal recessive
chr11	SLC29A2	602110.0 | SLC29A2, HNP36, DER12 | Solute carrier family 29 (nucleoside transporters), member 2 (hydrophobic nucleolar protein, 36kD) | 3177.0 | ENSG00000174669 | nan | nan
chr11	NPAS4	608554.0 | NPAS4, NXF | Neuronal PAS domain protein 4 | 266743.0 | ENSG00000174576 | nan | nan
chr11	MRPL11	611826.0 | MRPL11 | Mitochondrial ribosomal protein L11 | 65003.0 | ENSG00000174547 | nan | nan
chr11	PELI3	609827.0 | PELI3 | Pellino E3 ubiquitin protein ligase 3 | 246330.0 | ENSG00000174516 | nan | nan
chr11	DPP3	606818.0 | DPP3 | Dipeptidyl peptidase III | 10072.0 | ENSG00000254986 | nan | nan
chr11	BBS1	209901.0 | BBS1 | BBS1 gene | 582.0 | ENSG00000174483 | nan | Bardet-Biedl syndrome 1, 209900 (3), Autosomal recessive, Digenic recessive
chr11	ACTN3	102574.0 | ACTN3, ACTN3D | Actinin, alpha-3 | 89.0 | ENSG00000248746 | nan | [Sprinting performance], 617749 (3), Autosomal recessive; [Alpha-actinin-3 deficiency], 617749 (3), Autosomal recessive
chr11	CTSF	603539.0 | CTSF, CLN13 | Cathepsin F | 8722.0 | ENSG00000174080 | nan | Ceroid lipofuscinosis, neuronal, 13 (Kufs type), 615362 (3), Autosomal recessive
chr11	CCS	603864.0 | CCS | Copper chaperone for superoxide dismutase | 9973.0 | ENSG00000173992 | nan | nan
chr11	RBM14	612409.0 | RBM14, PSP2, COAA, SIP | RNA-binding motif protein 14 | 10432.0 | ENSG00000239306 | nan | nan
chr11	RBM4	602571.0 | RBM4. LARK | RNA-binding motif protein-4 (lark, Drosophila, homolog of) | 5936.0 | ENSG00000173933 | nan | nan
chr11	SPTBN2	604985.0 | SPTBN2, SCA5, SCAR14 | Spectrin, beta, nonerythrocytic, 2 | 6712.0 | ENSG00000173898 | nan | Spinocerebellar ataxia 5, 600224 (3), Autosomal dominant; Spinocerebellar ataxia, autosomal recessive 14, 615386 (3), Autosomal recessive
chr11	TOP6BL	616109.0 | C11orf80, HYDM4 | Chromosome 11 open reading frame 80 | 79703.0 | ENSG00000173715 | nan | Hydatidiform mole, recurrent, 4, 618432 (3), Autosomal recessive
chr11	RCE1	605385.0 | RCE1 | Ras converting CAAX endopeptidase 1 | 9986.0 | ENSG00000173653 | nan | nan
chr11	PC	608786.0 | PC | Pyruvate carboxylase | 5091.0 | ENSG00000173599 | nan | Pyruvate carboxylase deficiency, 266150 (3), Autosomal recessive
chr11	LRFN4	612810.0 | LRFN4, SALM3 | Leucine-rich repeat and fibronectin type III domain-containing protein 4 | 78999.0 | ENSG00000173621 | nan | nan
chr11	SYT12	606436.0 | SYT12, SRG1 | Synaptotagmin 12 | 91683.0 | ENSG00000173227 | nan | nan
chr11	RHOD	605781.0 | RHOD, ARHD, RHOHP1 | Ras homolog gene family, member D | 29984.0 | ENSG00000173156 | nan | nan
chr11	KDM2A	605657.0 | KDM2A, FBXL11, FBL11 | Lysine demethylase 2A | 22992.0 | ENSG00000173120 | nan | nan
chr11	GRK2	109635.0 | GRK2, ADRBK1 | G protein-coupled receptor kinase 2 | 156.0 | ENSG00000173020 | nan | nan
chr11	ANKRD13D	615126.0 | ANKRD13D | Ankyrin repeat domain-containing protein 13D | 338692.0 | ENSG00000172932 | nan | nan
chr11	SSH3	606780.0 | SSH3 | Slingshot, Drosophila, homolog of, 3 | 54961.0 | ENSG00000172830 | nan | nan
chr11	POLD4	611525.0 | POLD4, POLDS, P12 | Polymerase, DNA-directed, delta 4 | 57804.0 | ENSG00000175482 | nan | nan
chr11	CLCF1	607672.0 | CLCF1, BSF3, CLC, CISS2 | Cardiotrophin-like cytokine | 23529.0 | ENSG00000175505 | nan | Cold-induced sweating syndrome 2, 610313 (3), Autosomal recessive
chr11	RAD9A	603761.0 | RAD9A, RAD9 | RAD9 checkpoint clamp component A | 5883.0 | ENSG00000172613 | nan | nan
chr11	PPP1CA	176875.0 | PPP1CA, PPP1A | Protein phosphatase-1, catalytic subunit, alpha isoform | 5499.0 | ENSG00000172531 | nan | nan
chr11	TBC1D10C	610831.0 | TBC1D10C, CARABIN | TBC1 domain family, member 10C | 374403.0 | ENSG00000175463 | nan | nan
chr11	CARNS1	613368.0 | CARNS1, ATPGD1, KIAA1394 | Carnosine synthase 1 | 57571.0 | ENSG00000172508 | nan | nan
chr11	RPS6KB2	608939.0 | RPS6KB2, S6K2 | Ribosomal protein S6 kinase B2 | 6199.0 | ENSG00000175634 | nan | nan
chr11	CORO1B	609849.0 | CORO1B | Coronin 1B | 57175.0 | ENSG00000172725 | nan | nan
chr11	PTPRCAP	601577.0 | PTPRCAP, LPAP | Protein tyrosine phosphatase, receptor type, c polypeptide-associated protein | 5790.0 | ENSG00000213402 | nan | nan
chr11	CABP4	608965.0 | CABP4, CRSD, CSNB2B | Calcium-binding protein 4 | 57010.0 | ENSG00000175544 | nan | Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3), Autosomal recessive
chr11	AIP	605555.0 | AIP, XAP2, ARA9, PITA1 | Aryl hydrocarbon receptor-interacting protein | 9049.0 | ENSG00000110711 | nan | Pituitary adenoma 1, multiple types, 102200 (3), Somatic mutation, Autosomal dominant; Pituitary adenoma predisposition, 102200 (3), Somatic mutation, Autosomal dominant
chr11	PITPNM1	608794.0 | PITPNM1, NIR2, RDGBA | Phosphatidylinositol transfer protein, membrane-associated, 1 | 9600.0 | ENSG00000110697 | nan | nan
chr11	CDK2AP2	620061.0 | CDK2AP2, DOC1R | CDK2-associated protein 2 | 10263.0 | ENSG00000167797 | nan | nan
chr11	CABP2	607314.0 | CABP2, DFNB93 | Calcium-binding protein 2 | 51475.0 | ENSG00000167791 | nan | Deafness, autosomal recessive 93, 614899 (3), Autosomal recessive
chr11	GSTP1	134660.0 | GSTP1, GST3 | Glutathione S-transferase pi | 2950.0 | ENSG00000084207 | formerly called GST1 | nan
chr11	NDUFV1	161015.0 | NDUFV1, UQOR1, MC1DN4 | NADH-ubiquinone oxidoreductase core subunit V1 | 4723.0 | ENSG00000167792 | nan | Mitochondrial complex I deficiency, nuclear type 4, 618225 (3), Autosomal recessive
chr11	TBX10	604648.0 | TBX10 | T-box 10 | 347853.0 | ENSG00000167800 | nan | nan
chr11	ACY3	614413.0 | ACY3, HCBP1 | Aminoacylase 3 | 91703.0 | ENSG00000132744 | nan | nan
chr11	ALDH3B2	601917.0 | ALDH3B2, ALDH8 | Aldehyde dehydrogenase 3 family, member B2 | 222.0 | ENSG00000132746 | nan | nan
chr11	UNC93B1	608204.0 | UNC93B1, IIAE1 | unc-93 homolog B1, TLR signaling regulator | 81622.0 | ENSG00000110057 | nan | {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}, 610551 (3), Autosomal recessive
chr11	ALDH3B1	600466.0 | ALDH3B1, ALDH7 | Aldehyde dehydrogenase 3 family, member B1 | 221.0 | ENSG00000006534 | nan | nan
chr11	NDUFS8	602141.0 | NDUFS8, MC1DN2 | NADH-ubiquinone oxidoreductase core subunit S8 | 4728.0 | ENSG00000110717 | previously assigned to 3q28 | Mitochondrial complex I deficiency, nuclear type 2, 618222 (3), Autosomal recessive
chr11	TCIRG1	604592.0 | TCIRG1, TIRC7, OC116, OPTB1 | T-cell immune regulator 1 | 10312.0 | ENSG00000110719 | nan | Osteopetrosis, autosomal recessive 1, 259700 (3), Autosomal recessive
chr11	CHKA	118491.0 | CHKA, CHK, NEDMIMS | Choline kinase, alpha | 1119.0 | ENSG00000110721 | nan | Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures, 620023 (3), Autosomal recessive
chr11	KMT5B	610881.0 | KMT5B, SUV420H1, CGI85, MRD51 | Lysine methyltransferase 5B | 51111.0 | ENSG00000110066 | nan | Intellectual developmental disorder, autosomal dominant 51, 617788 (3), Autosomal dominant
chr11	C11orf24	610880.0 | C11orf24 | Chromosome 11 open reading frame 24 | 53838.0 | ENSG00000171067 | nan | nan
chr11	LRP5	603506.0 | LRP5, BMND1, LRP7, LR3, OPPG, OPTA1, EVR4, PCLD4 | Low density lipoprotein receptor-related protein-5 | 4041.0 | ENSG00000162337 | nan | Osteopetrosis, autosomal dominant 1, 607634 (3), Autosomal dominant; [Bone mineral density variability 1], 601884 (3), Autosomal dominant; Polycystic liver disease 4 with or without kidney cysts, 617875 (3), Autosomal dominant; Endosteal hyperostosis, 144750 (3), Autosomal dominant; Osteoporosis-pseudoglioma syndrome, 259770 (3), Autosomal recessive; Exudative vitreoretinopathy 4, 601813 (3), Autosomal recessive, Autosomal dominant
chr11	PPP6R3	610879.0 | PPP6R3, SAPS3, PP6R3, C11orf23, KIAA1558 | Protein phosphatase 6, regulatory subunit 3 | 55291.0 | ENSG00000110075 | nan | nan
chr11	GAL	137035.0 | GAL, GALN, GLNN, ETL8 | Galanin | 51083.0 | ENSG00000069482 | mutation identified in 1 ETL8 family | ?Epilepsy, familial temporal lobe, 8, 616461 (3), Autosomal dominant
chr11		194633.0 | ZNF126 | Zinc finger protein-126 (HZF-2) | nan | nan | nan | nan
chr11	TESMIN	604374.0 | MTL5, TESMIN | Metallothionein-like 5, testis-specific | 9633.0 | ENSG00000132749 | nan | nan
chr11	CPT1A	600528.0 | CPT1A | Carnitine palmitoyltransferase I, liver | 1374.0 | ENSG00000110090 | nan | CPT deficiency, hepatic, type IA, 255120 (3), Autosomal recessive
chr11	MRPL21	611834.0 | MRPL21 | Mitochondrial ribosomal protein L21 | 219927.0 | ENSG00000197345 | nan | nan
chr11	IGHMBP2	600502.0 | IGHMBP2, SMUBP2, CATF1, SMARD1, HMNR1, CMT2S | Immunoglobulin mu binding protein 2 | 3508.0 | ENSG00000132740 | nan | Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3), Autosomal recessive; Neuronopathy, distal hereditary motor, autosomal recessive 1, 604320 (3), Autosomal recessive
chr11	MRGPRD	607231.0 | MRGPRD, MRGD | Mas-related G protein-coupled receptor family, member D | 116512.0 | ENSG00000172938 | nan | nan
chr11	MRGPRF	607233.0 | MRGPRF, MRGF, RTA | Mas-related G protein-coupled receptor family, member F | 116535.0 | ENSG00000172935 | nan | nan
chr11	TPCN2	612163.0 | TPCN2, TPC2, SHEP10 | Two-pore segment channel 2 | 219931.0 | ENSG00000162341 | nan | [Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)
chr11	MYEOV	605625.0 | MYEOV | Myeloma overexpressed gene | 26579.0 | ENSG00000172927 | nan | nan
chr11	LINC02747	617697.0 | LINC02747, CUPID2 | Long intergenic noncoding RNA 2747 | 105379407.0 | ENSG00000255774 | nan | nan
chr11	LINC01488	617696.0 | CUPID1, LINC01488, BRCAT8 | CCND1 upstream intergenic DNA repair 1, noncoding | 101928292.0 | ENSG00000285094 | nan | nan
chr11	CCND1	168461.0 | CCND1, PRAD1, BCL1 | Cyclin D1 | 595.0 | ENSG00000110092 | pseudogene on 11q13 | {von Hippel-Lindau syndrome, modifier of}, 193300 (3), Autosomal dominant; {Colorectal cancer, susceptibility to}, 114500 (3), Somatic mutation, Autosomal dominant; {Multiple myeloma, susceptibility to}, 254500 (3), Somatic mutation
chr11	LTO1	607224.0 | ORAOV1, TAOS1 | Oral cancer overexpressed gene 1 | 220064.0 | ENSG00000149716 | nan | nan
chr11	FGF19	603891.0 | FGF19 | Fibroblast growth factor 19 | 9965.0 | ENSG00000162344 | nan | nan
chr11	FGF4	164980.0 | FGF4, HSTF1 | Fibroblast growth factor-4 (heparin secretory transforming protein-1; Kaposi sarcoma oncogene) | 2249.0 | ENSG00000075388 | coamplified with FGF3 in melanoma | nan
chr11	FGF3	164950.0 | FGF3, INT2 | Fibroblast growth factor-3 (oncogene INT2) | 2248.0 | ENSG00000186895 | 35kb 5' to HST1 | Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3), Autosomal recessive
chr11	ANO1	610108.0 | ANO1, TMEM16A, FLJ10261, INDMS, MYMY7 | Anoctamin 1, calcium activated chloride channel | 55107.0 | ENSG00000131620 | mutation identified in 1 INDMS family and 1 MYMY7 AR patient | Moyamoya disease 7, 620687 (3), Autosomal recessive, Autosomal dominant; ?Intestinal dysmotility syndrome, 620045 (3), Autosomal recessive
chr11	FADD	602457.0 | FADD, IMD90 | FAS-associating protein with death domain | 8772.0 | ENSG00000168040 | nan | Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction, 613759 (3), Autosomal recessive
chr11	PPFIA1	611054.0 | PPFIA1, LIP1 | PTPRF-interacting protein alpha-1 | 8500.0 | ENSG00000131626 | nan | nan
chr11	CTTN	164765.0 | CTTN, EMS1 | Cortactin | 2017.0 | ENSG00000085733 | amplified in breast cancer and squamous cell cancer | nan
chr11	SHANK2	603290.0 | SHANK2, CORTBP1, AUTS17 | SH3 and multiple ankyrin repeat domains 2 | 22941.0 | ENSG00000162105 | nan | {Autism susceptibility 17}, 613436 (3)
chr11	DHCR7	602858.0 | DHCR7, SLOS | Delta-7-dehydrocholesterol reductase | 1717.0 | ENSG00000172893 | nan | Smith-Lemli-Opitz syndrome, 270400 (3), Autosomal recessive
chr11	NADSYN1	608285.0 | NADSYN1, VCRL3 | NAD synthetase 1 | 55191.0 | ENSG00000172890 | nan | Vertebral, cardiac, renal, and limb defects syndrome 3, 618845 (3), Autosomal recessive
chr11	KRTAP5-9	148021.0 | KRTAP5-9, KRN1 | Keratin associated protein 5-9 | 3846.0 | ENSG00000254997 | nan | nan
chr11	FAM86C1P	616124.0 | FAM86C1P, FAM86C1 | Family with sequence similarity 86, member C1, pseudogene | 55199.0 | ENSG00000158483 | nan | nan
chr11	RNF121	620529.0 | RNF121 | RING finger protein 121 | 55298.0 | ENSG00000137522 | nan | nan
chr11	IL18BP	604113.0 | IL18BP, FVH | Interleukin 18-binding protein | 10068.0 | ENSG00000137496 | mutation identified in 1 FVH patient | {?Hepatitis, fulminant viral, susceptibility to}, 618549 (3), Autosomal recessive
chr11	NUMA1	164009.0 | NUMA1 | Nuclear mitotic apparatus protein-1 | 4926.0 | ENSG00000137497 | fused with RARA in acute promyelocytic leukemia (APL) | nan
chr11	LRTOMT	612414.0 | LRTOMT, LRTOMT1, LRTOMT2, DFNB63 | Leucine-rich transmembrane O-methyltransferase | 220074.0 | ENSG00000284922 | nan | Deafness, autosomal recessive 63, 611451 (3), Autosomal recessive
chr11	LAMTOR1	613510.0 | LAMTOR1, C11orf59, PDRO | Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 1 | 55004.0 | ENSG00000149357 | nan | nan
chr11	ANAPC15	614717.0 | ANAPC15, APC15 | Anaphase-promoting complex, subunit 15 | 25906.0 | ENSG00000110200 | nan | nan
chr11	FOLR3	602469.0 | FOLR3 | Folate receptor 3 | 2352.0 | ENSG00000110203 | nan | nan
chr11	FOLR1	136430.0 | FOLR1, NCFTD | Folate receptor, alpha | 2348.0 | ENSG00000110195 | telomeric of FGF3 | Neurodegeneration due to cerebral folate transport deficiency, 613068 (3), Autosomal recessive
chr11	FOLR2	136425.0 | FOLR2 | Folate receptor, beta | 2350.0 | ENSG00000165457 | 23kb from FOLR1 | nan
chr11	INPPL1	600829.0 | INPPL1, OPSMD | Inositol polyphosphate phosphatase-like 1 | 3636.0 | ENSG00000165458 | nan | Opsismodysplasia, 258480 (3), Autosomal recessive
chr11	PHOX2A	602753.0 | PHOX2A, ARIX, CFEOM2 | Paired-like homeobox 2a | 401.0 | ENSG00000165462 | nan | Fibrosis of extraocular muscles, congenital, 2, 602078 (3), Autosomal recessive
chr11	CLPB	616254.0 | CLPB, SKD3, MGCA7, MEGCANN, SCN9, MGCA7A | Caseinolytic peptidase B | 81570.0 | ENSG00000162129 | nan | Neutropenia, severe congenital, 9, autosomal dominant, 619813 (3), Autosomal dominant; 3-methylglutaconic aciduria, type VIIB, autosomal recessive, 616271 (3), Autosomal recessive; 3-methylglutaconic aciduria, type VIIA, autosomal dominant, 619835 (3), Autosomal dominant
chr11	PDE2A	602658.0 | PDE2A, IDDPADS | Phosphodiesterase 2A | 5138.0 | ENSG00000186642 | nan | Intellectual developmental disorder with paroxysmal dyskinesia or seizures, 619150 (3), Autosomal recessive
chr11	MIR139	615017.0 | MIR139, MIR139-3p | Micro RNA 139 | 406931.0 | ENSG00000272036 | nan | nan
chr11	ARAP1	606646.0 | ARAP1, CENTD2, KIAA0782 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 116985.0 | ENSG00000186635 | nan | nan
chr11	STARD10	617382.0 | STARD10 | START domain-containing protein 10 | 10809.0 | ENSG00000214530 | nan | nan
chr11	ATG16L2	618716.0 | ATG16L2 | Autophagy 16-like 2 | 89849.0 | ENSG00000168010 | nan | nan
chr11	FCHSD2	617556.0 | FCHSD2, KIAA0769, NWK | FCH and double SH3 domains protein 2 | 9873.0 | ENSG00000137478 | nan | nan
chr11	P2RY2	600041.0 | P2RY2, P2Y2, P2U | Purinergic receptor P2Y, G-protein coupled, 2 | 5029.0 | ENSG00000175591 | nan | nan
chr11	P2RY6	602451.0 | P2RY6, P2Y6 | Pyrimidinergic receptor P2Y, G protein-coupled, 6 | 5031.0 | ENSG00000171631 | nan | nan
chr11	ARHGEF17	617043.0 | ARHGEF17, RHOGEF17, TEM4, KIAA0337 | Rho guanine nucleotide exchange factor 17 | 9828.0 | ENSG00000110237 | nan | nan
chr11	RELT	611211.0 | RELT, TNFRSF19L, AI3C | Receptor expressed in lymphoid tissues | 84957.0 | ENSG00000054967 | nan | Amelogenesis imperfecta, type IIIC, 618386 (3), Autosomal recessive
chr11	FAM168A	616316.0 | RAM168A, TCRP1, KIAA0280 | Family with sequence similarity 168, member A | 23201.0 | ENSG00000054965 | nan | nan
chr11	PLEKHB1	607651.0 | PLEKHB1, PHR1, KPL1 | Pleckstrin homology domain-containing protein, family B, member 1 | 58473.0 | ENSG00000021300 | nan | nan
chr11	RAB6A	179513.0 | RAB6A, RAB6 | Oncogene RAB6 | 5870.0 | ENSG00000175582 | previously assigned to 2q14-q21 | nan
chr11	MRPL48	611853.0 | MRPL48 | Mitochondrial ribosomal protein L48 | 51642.0 | ENSG00000175581 | pseudogene on 6 | nan
chr11	COA4	608016.0 | COA4, CHCHD8, E2IG2 | Cytochrome c oxidase assembly factor 4 homolog | 51287.0 | ENSG00000181924 | nan | nan
chr11	PAAF1	619772.0 | PAAF1 | Proteasomal ATPase-associated factor 1 | 80227.0 | ENSG00000175575 | nan | nan
chr11	DNAJB13	610263.0 | DNAJB13, TSARG6, CILD34 | DNAJ/HSP40 homolog, subfamily B, member 13 | 374407.0 | ENSG00000187726 | nan | Ciliary dyskinesia, primary, 34, 617091 (3), Autosomal recessive
chr11	UCP2	601693.0 | UCP2, BMIQ4 | Uncoupling protein-2 | 7351.0 | ENSG00000175567 | nan | {Obesity, susceptibility to, BMIQ4}, 607447 (3)
chr11	UCP3	602044.0 | UCP3 | Uncoupling protein-3 | 7352.0 | ENSG00000175564 | nan | {Obesity, severe, and type II diabetes}, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant
chr11	C2CD3	615944.0 | C2CD3, OFD14 | C2 calcium-dependent domain-containing protein 3 | 26005.0 | ENSG00000168014 | nan | Orofaciodigital syndrome XIV, 615948 (3), Autosomal recessive
chr11	PPME1	611117.0 | PPME1 | Protein phosphatase methylesterase 1 | 51400.0 | ENSG00000214517 | nan | nan
chr11	P4HA3	608987.0 | P4HA3 | Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 3 | 283208.0 | ENSG00000149380 | nan | nan
chr11	PGM2L1	611610.0 | PGM2L1, NEDHFS | Phosphoglucomutase 2-like 1 | 283209.0 | ENSG00000165434 | nan | Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities, 620191 (3), Autosomal recessive
chr11	KCNE3	604433.0 | KCNE3, HOKPP, HYPP | Potassium voltage-gated channel, ISK-related subfamily, member 3 | 10008.0 | ENSG00000175538 | mutation identified in 1 BRGDA6 family | ?Brugada syndrome 6, 613119 (3)
chr11	LIPT2	617659.0 | LIPT2 | Lipoyl(octanoyl) transferase 2 | 387787.0 | ENSG00000175536 | nan | Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities, 617668 (3), Autosomal recessive
chr11	POLD3	611415.0 | POLD3, KIAA0039, IMD122 | Polymerase (DNA-directed), delta 3, accessory subunit | 10714.0 | ENSG00000077514 | nan | Immunodeficiency 122, 620869 (3), Autosomal recessive
chr11	CHRDL2	613127.0 | CHRDL2, CHL2, BNF1 | Chordin-like 2 | 25884.0 | ENSG00000054938 | nan | nan
chr11	RNF169	618650.0 | RNF169, KIAA1991 | RING finger protein 169 | 254225.0 | ENSG00000166439 | nan | nan
chr11	XRRA1	609788.0 | XRRA1 | X-ray radiation resistance-associated 1 | 143570.0 | ENSG00000166435 | nan | nan
chr11	SPCS2	619411.0 | SPCS2, KIAA0102 | Signal peptidase complex, subunit 2 | 9789.0 | ENSG00000118363 | nan | nan
chr11	NEU3	604617.0 | NEU3, SIAL3 | Neuraminidase 3 (membrane sialidase; sialidase 3) | 10825.0 | ENSG00000162139 | nan | nan
chr11	SLCO2B1	604988.0 | SLC21A9, OATPB | Solute carrier family 21 (organic anion transporter), member 9 | 11309.0 | ENSG00000137491 | nan | nan
chr11	ARRB1	107940.0 | ARRB1 | Arrestin, beta 1 | 408.0 | ENSG00000137486 | nan | nan
chr11	MIR326	613755.0 | MIR326, MIRN326 | Micro RNA 326 | 442900.0 | ENSG00000199090 | nan | nan
chr11	RPS3	600454.0 | RPS3 | Ribosomal protein S3 | 6188.0 | ENSG00000149273 | nan | nan
chr11	SNORD15A	600455.0 | RNU15A | RNA, U15a small nucleolar | 6079.0 | ENSG00000206941 | processed from intron of RPS3 | nan
chr11	GDPD5	609632.0 | GDPD5, GDE2, PP1665 | Glycerophosphodiester phosphodiesterase domain-containing protein 3 | 81544.0 | ENSG00000158555 | nan | nan
chr11	ATOD7	613064.0 | ATOD7 | Dermatitis, atopic, 7 | 100310755.0 | nan | associated with rs7927894 | {Dermatitis, atopic, susceptibility to, 7}, 613064 (2)
chr11	SERPINH1	600943.0 | SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10 | Serpin peptidase inhibitor, clade H, member 1 | 871.0 | ENSG00000149257 | nan | {Preterm premature rupture of the membranes, susceptibility to}, 610504 (3), Multifactorial; Osteogenesis imperfecta, type X, 613848 (3), Autosomal recessive
chr11	MAP6	601783.0 | MAP6, MTAP6, STOP, KIAA1878 | Microtubule-associated protein 6 | 4135.0 | ENSG00000171533 | nan | nan
chr11	MOGAT2	610270.0 | MOGAT2, MGAT2 | Monoacylglycerol O-acyltransferase 2 | 80168.0 | ENSG00000166391 | nan | nan
chr11	DGAT2	606983.0 | DGAT2 | Diacylglycerol O-acyltransferase 2 | 84649.0 | ENSG00000062282 | nan | nan
chr11	UVRAG	602493.0 | UVRAG | UV radiation resistance-associated gene | 7405.0 | ENSG00000198382 | nan | nan
chr11	WNT11	603699.0 | WNT11 | Wingless-type MMTV integration site family, member 11 | 7481.0 | ENSG00000085741 | nan | nan
chr11	THAP12	607374.0 | PRKRIR | PRKR inhibitor, repressor of | 5612.0 | ENSG00000137492 | nan | nan
chr11	EMSY	608574.0 | EMSY, C11orf30 | EMSY transcriptional repressor, BRCA2 interacting | 56946.0 | ENSG00000158636 | 100kb from GARP | nan
chr11	LRRC32	137207.0 | LRRC32, GARP, D11S833E, CPPRDD | Leucine rich repeat containing 32 | 2615.0 | ENSG00000137507 | nan | Cleft palate, proliferative retinopathy, and developmental delay, 619074 (3), Autosomal recessive
chr11	TSKU	608015.0 | TSKU, E2IG4, TSK | Tsukushin | 25987.0 | ENSG00000182704 | nan | nan
chr11	ACER3	617036.0 | ACER3, APHC, PHCA, PLDECO | Alkaline ceramidase 3 | 55331.0 | ENSG00000078124 | mutation identified in 1 PLDECO family | ?Leukodystrophy, progressive, early childhood-onset, 617762 (3), Autosomal recessive
chr11	B3GNT6	615315.0 | B3GNT6 | Beta-1,3-N-acetylglucosaminyltransferase 6 | 192134.0 | ENSG00000198488 | nan | nan
chr11	CAPN5	602537.0 | CAPN5, HTRA3, VRNI | Calpain 5 | 726.0 | ENSG00000149260 | nan | Vitreoretinopathy, neovascular inflammatory, 193235 (3), Autosomal dominant
chr11	OMP	164340.0 | OMP | Olfactory marker protein | 4975.0 | ENSG00000254550 | nan | nan
chr11	MYO7A	276903.0 | MYO7A, USH1B, DFNB2, DFNA11 | Myosin VIIA | 4647.0 | ENSG00000137474 | nan | Deafness, autosomal recessive 2, 600060 (3), Autosomal recessive; Usher syndrome, type 1B, 276900 (3), Autosomal recessive; Deafness, autosomal dominant 11, 601317 (3), Autosomal dominant
chr11	PAK1	602590.0 | PAK1, IDDMSSD | p21/CDC42/RAC1-activated kinase 1 | 5058.0 | ENSG00000149269 | nan | Intellectual developmental disorder with macrocephaly, seizures, and speech delay, 618158 (3), Autosomal dominant
chr11		610888.0 | GCRG224 | Gastric cancer-related gene 224 | 360219.0 | nan | nan | nan
chr11	IHPS3	612017.0 | IHPS3 | Pyloric stenosis, infantile hypertrophic, 3 | 100188876.0 | nan | max lod at rs541821 | Pyloric stenosis, infantile hypertrophic, 3, 612017 (2)
chr11	SCZD2	603342.0 | SCZD2 | Schizophrenia susceptibility locus, chromosome 11-related | 6378.0 | nan | nan | {?Schizophrenia}, 181500 (2), Autosomal dominant
chr11	SLEH1	607279.0 | SLEH1 | Systemic lupus erythematosus with hemolytic anemia, susceptibility to, 1 | 170682.0 | nan | nan | {Systemic lupus erythematosus with hemolytic anemia}, 607279 (2)
chr11	AQP11	609914.0 | AQP11, AQPX1 | Aquaporin 11 | 282679.0 | ENSG00000178301 | nan | nan
chr11	CLNS1A	602158.0 | CLNS1A, CLNS1B | Chloride channel, nucleotide-sensitive, 1A | 1207.0 | ENSG00000074201 | CLNS1B on 6p12.1-q13 = pseudogene? | nan
chr11	RSF1	608522.0 | HBXAP, RSF1 | Hepatitis B virus X-associated protein | 51773.0 | ENSG00000048649 | nan | nan
chr11	AAMDC	620474.0 | AAMDC | Adipogenesis-associated MTH938 domain-containing protein | 28971.0 | ENSG00000087884 | nan | nan
chr11	INTS4	611348.0 | INTS4, INT4 | Integrator complex subunit 4 | 92105.0 | ENSG00000149262 | nan | nan
chr11	THRSP	601926.0 | THRSP | Thyroid hormone-responsive protein | 7069.0 | ENSG00000151365 | nan | nan
chr11	NDUFC2	603845.0 | NDUFC2, MC1DN36 | NADH-ubiquinone oxidoreductase subunit C2 | 4718.0 | ENSG00000151366 | nan | Mitochondrial complex I deficiency, nuclear type 36, 619170 (3), Autosomal recessive
chr11	ALG8	608103.0 | ALG8, CDG1H, PCLD3 | ALG8 alpha-1,3-glucosyltransferase | 79053.0 | ENSG00000159063 | nan | Congenital disorder of glycosylation, type Ih, 608104 (3), Autosomal recessive; Polycystic liver disease 3 with or without kidney cysts, 617874 (3), Autosomal dominant
chr11	KCTD21	618790.0 | KCTD21, KCASH2 | Potassium channel tetramerization domain-containing protein 21 | 283219.0 | ENSG00000188997 | nan | nan
chr11	USP35	620959.0 | USP35 | Ubiquitin-specific peptidase 35 | 57558.0 | ENSG00000118369 | nan | nan
chr11	GAB2	606203.0 | GAB2 | GRB2-associated binding protein 2 | 9846.0 | ENSG00000033327 | nan | nan
chr11	NARS2	612803.0 | NARS2, COXPD24, DFNB94 | Asparaginyl-tRNA synthetase 2 | 79731.0 | ENSG00000137513 | mutation identified in 1 DFNB94 family | Combined oxidative phosphorylation deficiency 24, 616239 (3), Autosomal recessive; ?Deafness, autosomal recessive 94, 618434 (3), Autosomal recessive
chr11	TENM4	610084.0 | TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5 | Teneurin transmembrane protein 4 | 26011.0 | ENSG00000149256 | nan | Essential tremor, hereditary, 5, 616736 (3), Autosomal dominant
chr11	MIR708	620733.0 | MIR708 | Micro RNA 708 | 100126333.0 | ENSG00000211997 | nan | nan
chr11	PRCP	176785.0 | PRCP, PCP | Prolylcarboxypeptidase (angiotensinase C) | 5547.0 | ENSG00000137509 | nan | nan
chr11	DDIAS	618045.0 | DDIAS, NOXIN, C11orf82 | DNA damage-induced apoptosis suppressor | 220042.0 | ENSG00000165490 | nan | nan
chr11	RAB30	605693.0 | RAB30 | Ras-associated protein RAB30 | 27314.0 | ENSG00000137502 | nan | nan
chr11	PCF11	608876.0 | PCF11, KIAA0824 | PCF11, yeast, homolog of | 51585.0 | ENSG00000165494 | nan | nan
chr11	ANKRD42	619778.0 | ANKRD42, SARP | Ankyrin repeat domain-containing protein 42 | 338699.0 | ENSG00000137494 | nan | nan
chr11	CCDC90B	620753.0 | CCDC90B | Coiled-coil domain-containing protein 90B | 60492.0 | ENSG00000137500 | nan | nan
chr11	DLG2	603583.0 | DLG2 | Discs large MAGUK scaffold protein 2 | 1740.0 | ENSG00000150672 | nan | nan
chr11	TMEM126B	615533.0 | TMEM126B, MC1DN29 | Transmembrane protein 126B | 55863.0 | ENSG00000171204 | nan | Mitochondrial complex I deficiency, nuclear type 29, 618250 (3), Autosomal recessive
chr11	TMEM126A	612988.0 | TMEM126A, OPA7 | Transmembrane protein 126A | 84233.0 | ENSG00000171202 | nan | Optic atrophy 7, 612989 (3), Autosomal recessive
chr11	CREBZF	606444.0 | CREBZF, ZF | CREB/ATF bZIP transcription factor | 58487.0 | ENSG00000137504 | nan | nan
chr11	SYTL2	612880.0 | SYTL2, SLP2, SLP2A, EXO4, KIAA1597 | Synaptotagmin-like 2 | 54843.0 | ENSG00000137501 | nan | nan
chr11	PICALM	603025.0 | PICALM, CALM, CLTH, LAP | Phosphatidylinositol-binding clathrin assembly protein | 8301.0 | ENSG00000073921 | fuses with AF10 in t(10;11) | Leukemia, acute myeloid, somatic, 601626 (3)
chr11	EED	605984.0 | EED, WAIT1, COGIS | Embryonic ectoderm development protein | 8726.0 | ENSG00000074266 | nan | Cohen-Gibson syndrome, 617561 (3), Autosomal dominant
chr11	HIKESHI	614908.0 | HIKESHI, C11orf73, HLD13 | Hikeshi | 51501.0 | ENSG00000149196 | nan | Leukodystrophy, hypomyelinating, 13, 616881 (3), Autosomal recessive
chr11	ME3	604626.0 | ME3 | Malic enzyme 3 | 10873.0 | ENSG00000151376 | nan | nan
chr11	PRSS23	618376.0 | PRSS23 | Protease, serine, 23 | 11098.0 | ENSG00000150687 | nan | nan
chr11	FZD4	604579.0 | FZD4, EVR1 | Frizzled, Drosophila, homolog of, 4 | 8322.0 | ENSG00000174804 | nan | Retinopathy of prematurity, 133780 (3), Autosomal dominant; Exudative vitreoretinopathy 1, 133780 (3), Autosomal dominant
chr11	TMEM135	616360.0 | TMEM135, PMP52 | Transmembrane protein 135 | 65084.0 | ENSG00000166575 | nan | nan
chr11	RAB38	606281.0 | RAB38 | Ras-family, member RAB38 | 23682.0 | ENSG00000123892 | nan | nan
chr11	CTSC	602365.0 | CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD | Cathepsin C | 1075.0 | ENSG00000109861 | nan | Periodontitis 1, juvenile, 170650 (3), Autosomal recessive; Haim-Munk syndrome, 245010 (3), Autosomal recessive; Papillon-Lefevre syndrome, 245000 (3), Autosomal recessive
chr11	GRM5	604102.0 | GRM5, MGLUR5 | Glutamate receptor, metabotropic, 5 | 2915.0 | ENSG00000168959 | nan | nan
chr11	TYR	606933.0 | TYR, SHEP3, CMM8, OCA1A, ATN | Tyrosinase | 7299.0 | ENSG00000077498 | nan | [Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3), Autosomal dominant; [Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3), Autosomal dominant; {Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3), Autosomal dominant; Albinism, oculocutaneous, type IB, 606952 (3), Autosomal recessive; Albinism, oculocutaneous, type IA, 203100 (3), Autosomal recessive
chr11	NOX4	605261.0 | NOX4, RENOX | NADPH oxidase 4 | 50507.0 | ENSG00000086991 | nan | nan
chr11	FOLH1B	609020.0 | FOLH1B, PSMAL, GCP3 | Folate hydrolase 1B | 219595.0 | nan | nan | nan
chr11	TRIM49	606124.0 | RNF18 | RING finger protein-18 | 57093.0 | ENSG00000168930 | nan | nan
chr11	UBTFL1	613696.0 | UBTFL1, HMGPI | Upstream binding transcription factor (RNA polymerase I)-like 1 | 642623.0 | ENSG00000255009 | nan | nan
chr11	NAALAD2	611636.0 | NAALAD2 | N-acetylated alpha-linked acidic dipeptidase 2 | 10003.0 | ENSG00000077616 | nan | nan
chr11	CHORDC1	604353.0 | CHRODC1, CHP1 | Cysteine- and histidine-rich domain-containing protein 1 | 26973.0 | ENSG00000110172 | nan | nan
chr11	FAT3	612483.0 | FAT3 | FAT atypical cadherin 3 | 120114.0 | ENSG00000165323 | nan | nan
chr11	MTNR1B	600804.0 | MTNR1B | Melatonin receptor 1B | 4544.0 | ENSG00000134640 | nan | {Diabetes mellitus, type 2, susceptibility to}, 125853 (3), Autosomal dominant
chr11	FGQTL3	613233.0 | FGQTL3 | Fasting plasma glucose level QTL 3 | 100379217.0 | nan | associated with rs10830963 | [Fasting plasma glucose level QTL 3], 613233 (2)
chr11	SLC36A4	613760.0 | SLC36A4, PAT4 | Solute carrier family 36, member 4 | 120103.0 | ENSG00000180773 | nan | nan
chr11	DEUP1	617148.0 | DEUP1, CCDC67 | Deuterosome assembly protein 1 | 159989.0 | ENSG00000165325 | nan | nan
chr11	SMCO4	609477.0 | C11orf75, FN5 | FN5, pufferfish, homolog of | 56935.0 | ENSG00000166002 | nan | nan
chr11	CEP295	617728.0 | CEP295, KIAA1731, SCKL11 | Centrosomal protein, 295kD | 85459.0 | ENSG00000166004 | nan | Seckel syndrome 11, 620767 (3), Autosomal recessive
chr11	TAF1D	612823.0 | TAF1D, RAFI41, JOSD3 | TATA box-binding protein-associated factor 1D | 79101.0 | ENSG00000166012 | nan | nan
chr11	C11orf54	615810.0 | C11orf54, PTOD012 | Chromosome 11 open reading frame 54 | 28970.0 | ENSG00000182919 | nan | nan
chr11	MED17	603810.0 | MED17, CRSP6, CRSP77, TRAP80, DRIP80 | Mediator complex subunit 17 | 9440.0 | ENSG00000042429 | nan | Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3), Autosomal recessive
chr11	HEPHL1	618455.0 | HEPHL1, ZP, HJDD | Hephaestin-like protein 1 | 341208.0 | ENSG00000181333 | mutation identified in 1 HJDD patient | ?Abnormal hair, joint laxity, and developmental delay, 261990 (3), Autosomal recessive
chr11	PANX1	608420.0 | PANX1, PX1, OZEMA7 | Pannexin 1 | 24145.0 | ENSG00000110218 | nan | Oocyte/zygote/embryo maturation arrest 7, 618550 (3), Autosomal dominant
chr11	IZUMO1R	615737.0 | IZUMO1R, FOLR4 | Izumo1 receptor, Juno | 390243.0 | ENSG00000183560 | nan | nan
chr11	GPR83	605569.0 | GPR83, GIR, GPR72 | G protein-coupled receptor 83 | 10888.0 | ENSG00000123901 | nan | nan
chr11	MRE11	600814.0 | MRE11A, MRE11, ATLD | MRE11 homolog, double-strand break repair nuclease | 4361.0 | ENSG00000020922 | nan | Ataxia-telangiectasia-like disorder 1, 604391 (3), Autosomal recessive
chr11	ANKRD49	619571.0 | ANKRD49, FGIF | Ankyrin repeat domain-containing protein 49 | 54851.0 | ENSG00000168876 | nan | nan
chr11	FUT4	104230.0 | FUT4, FCT3A, CD15 | Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | 2526.0 | ENSG00000196371 | nan | nan
chr11	PIWIL4	610315.0 | PIWI-like RNA-mediated gene silencing 4 | PIWI-like 4 | 143689.0 | ENSG00000134627 | nan | nan
chr11	AMOTL1	614657.0 | AMOTL1, JEAP | Angiomotin-like 1 | 154810.0 | ENSG00000166025 | nan | nan
chr11	KDM4D	609766.0 | KDM4D, JMJD2D | Lysine demethylase 4D | 55693.0 | ENSG00000186280 | nan | nan
chr11	KDM4E	616581.0 | KDM4E, JMJD2E | Lysine demethylase 4E | 390245.0 | ENSG00000235268 | nan | nan
chr11	SRSF8	603269.0 | SRSF8, SFRS2B, SRp46 | Splicing factor, arginine/serine-rich, 8 | 10929.0 | ENSG00000263465 | nan | nan
chr11	ENDOD1	619568.0 | ENDOD1, KIAA0830 | Endonuclease domain-containing protein 1 | 23052.0 | ENSG00000149218 | nan | nan
chr11	SESN3	607768.0 | SEST3 | Sestrin 3 | 143686.0 | ENSG00000149212 | nan | nan
chr11	CEP57	607951.0 | CEP57, PIG8, TSP57, KIAA0092, MVA2 | Centrosomal protein 57kD | 9702.0 | ENSG00000166037 | nan | Mosaic variegated aneuploidy syndrome 2, 614114 (3), Autosomal recessive
chr11	MTMR2	603557.0 | MTMR2, CMT4B1 | Myotubularin-related protein 2 | 8898.0 | ENSG00000087053 | nan | Charcot-Marie-Tooth disease, type 4B1, 601382 (3), Autosomal recessive
chr11	MAML2	607537.0 | MAML2, MAM3 | Mastermind-like 2 | 84441.0 | ENSG00000184384 | t(11;19) | Mucoepidermoid salivary gland carcinoma (3)
chr11	MIR1260B	615372.0 | MIR1260B | Micro RNA 1260B | 100422991.0 | ENSG00000266192 | nan | nan
chr11	CCDC82	619870.0 | CCDC82, HSPC048 | Coiled-coil domain-containing protein 82 | 79780.0 | ENSG00000149231 | nan | nan
chr11	JRKL	603211.0 | JRKL, HHMJG | JRK-like protein | 8690.0 | ENSG00000183340 | nan | nan
chr11	ANC	105580.0 | ANC | Anal canal carcinoma | 8066.0 | nan | 3p22 also deleted | ?Anal canal carcinoma, 105580 (2), Autosomal dominant
chr11	CNTN5	607219.0 | CNTN5, NB2 | Contactin 5 | 53942.0 | ENSG00000149972 | nan | nan
chr11	ARHGAP42	615936.0 | ARHGAP42, GRAF3 | Rho GTPase-activating protein 42 | 143872.0 | ENSG00000165895 | nan | nan
chr11	PGR	607311.0 | PGR | Progesterone receptor | 5241.0 | ENSG00000082175 | 11q13 = earlier regionalization | ?Progesterone resistance, 264080 (2), Autosomal recessive
chr11	TRPC6	603652.0 | TRPC6, TRP6, FSGS2 | Transient receptor potential channel-6 | 7225.0 | ENSG00000137672 | nan | Glomerulosclerosis, focal segmental, 2, 603965 (3), Autosomal dominant
chr11	ANGPTL5	607666.0 | ANGPTL5 | Angiopoietin-like 5 | 253935.0 | ENSG00000187151 | nan | nan
chr11	CEP126	614634.0 | KIAA1377 | KIAA1377 gene | 57562.0 | ENSG00000110318 | nan | nan
chr11	CFAP300	618058.0 | CFAP300, C11orf70, CILD38 | Cilia- and flagella-associated protein 300 | 85016.0 | ENSG00000137691 | nan | Ciliary dyskinesia, primary, 38, 618063 (3), Autosomal recessive
chr11	YAP1	606608.0 | YAP1, COB1 | YES1-associated transcriptional regulator | 10413.0 | ENSG00000137693 | nan | Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development, 120433 (3), Autosomal dominant
chr11	BIRC3	601721.0 | API2, HAIP1 | Apoptosis inhibitor-2 | 330.0 | ENSG00000023445 | fused with MALT1 in MALT lymphoma | nan
chr11	BIRC2	601712.0 | API1, HIAP2 | Apoptosis inhibitor-1 | 329.0 | ENSG00000110330 | nan | nan
chr11	TMEM123	606356.0 | TMEM123, PORIMIN | Transmembrane protein 123 | 114908.0 | ENSG00000152558 | nan | nan
chr11	MMP7	178990.0 | MMP7 | Matrix metalloproteinase 7 (matrilysin, uterine) | 4316.0 | ENSG00000137673 | nan | nan
chr11	MMP20	604629.0 | MMP20, AI2A2 | Matrix metalloproteinase-20 (enamelysin) | 9313.0 | ENSG00000137674 | nan | Amelogenesis imperfecta, type IIA2, 612529 (3), Autosomal recessive
chr11	MMP27	618101.0 | MMP27 | Matrix metalloproteinase 27 | 64066.0 | ENSG00000137675 | nan | nan
chr11	MMP8	120355.0 | MMP8, CLG1 | Matrix metalloproteinase 8 (neutrophil collagenase) | 4317.0 | ENSG00000118113 | nan | nan
chr11	MMP10	185260.0 | MMP10, STMY2 | Matrix metalloproteinase 10 (stromelysin 2) | 4319.0 | ENSG00000166670 | nan | nan
chr11	MMP1	120353.0 | MMP1, CLG | Matrix metalloproteinase 1 (interstitial collagenase) | 4312.0 | ENSG00000196611 | nan | nan
chr11	MMP3	185250.0 | MMP3, STMY1, CHDS6 | Matrix metalloproteinase 3 (stromelysin 1, progelatinase) | 4314.0 | ENSG00000149968 | nan | {Coronary heart disease, susceptibility to, 6}, 614466 (3)
chr11	MMP12	601046.0 | MMP12 | Matrix metalloproteinase 12 (macrophage elastase) | 4321.0 | ENSG00000262406 | nan | nan
chr11	MMP13	600108.0 | MMP13, CLG3, MANDP1, MDST | Matrix metalloproteinase 13 (collagenase 3) | 4322.0 | ENSG00000137745 | mutation identified in 1 SEMDM family | ?Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3), Autosomal dominant; Metaphyseal anadysplasia 1, 602111 (3), Autosomal dominant; Metaphyseal dysplasia, Spahr type, 250400 (3), Autosomal recessive
chr11	DCUN1D5	616522.0 | DCUN1D5, SCCRO5 | DCN1 domain-containing protein 5 | 84259.0 | ENSG00000137692 | nan | nan
chr11	DYNC2H1	603297.0 | DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3 | Dynein, cytoplasmic-2, heavy chain-1 | 79659.0 | ENSG00000187240 | 1 patient showed heterozygous NEK2 and DYNC2H1 mutations | Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3), Autosomal recessive, Digenic recessive
chr11	PDGFD	609673.0 | PDGFD, SCDGFB, IEGF | Platelet-derived growth factor D | 80310.0 | ENSG00000170962 | nan | nan
chr11	DDI1	620870.0 | DDI1 | DNA damage-inducible 1 homolog 1 | 414301.0 | ENSG00000170967 | nan | nan
chr11	CASP12	608633.0 | CASP12, CASP12P1 | Caspase 12, apoptosis-related cysteine protease | 100506742.0 | nan | nan | {Sepsis, susceptibility to} (3)
chr11	CASP4	602664.0 | CASP4 | Caspase 4, apoptosis-related cysteine protease | 837.0 | ENSG00000196954 | nan | nan
chr11	CASP5	602665.0 | CASP5 | Caspase 5, apoptosis-related cysteine protease | 838.0 | ENSG00000137757 | nan | nan
chr11	CASP1	147678.0 | CASP1, IL1BC | Caspase 1, apoptosis-related cysteine protease (interleukin-1, beta convertase) | 834.0 | ENSG00000137752 | nan | nan
chr11	CARD16	615680.0 | CARD16, COP1 | Caspase recruitment domain-containing protein 16 | 114769.0 | ENSG00000204397 | nan | nan
chr11	CARD17P	609490.0 | INCA | Inhibitory caspase recruitment domain protein | 440068.0 | nan | nan | nan
chr11	CARD18	605354.0 | CARD18, ICEBERG | Caspase recruitment domain-containing protein 18 | 59082.0 | ENSG00000255501 | nan | nan
chr11	GRIA4	138246.0 | GRIA4, GLUR4, NEDSGA | Glutamate receptor, ionotropic, AMPA 4 | 2893.0 | ENSG00000152578 | nan | Neurodevelopmental disorder with or without seizures and gait abnormalities, 617864 (3), Autosomal dominant
chr11	AASDHPPT	607756.0 | AASDHPPT | Alpha-aminoadipate semialdehyde dehydrogenase-phosphopantetheinyl transferase | 60496.0 | ENSG00000149313 | nan | nan
chr11	GUCY1A2	601244.0 | GUCY1A2, GUC1A2 | Guanylate cyclase 1, soluble, alpha 2 | 2977.0 | ENSG00000152402 | nan | nan
chr11	ALKBH8	613306.0 | ALKBH8, ABH8, MRT71 | AlkB homolog 8, tRNA methyltransferase | 91801.0 | ENSG00000137760 | nan | Intellectual developmental disorder, autosomal recessive 71, 618504 (3), Autosomal recessive
chr11	ELMOD1	615456.0 | ELMOD1 | ELMO/CED12 domain-containing protein 1 | 55531.0 | ENSG00000110675 | nan | nan
chr11	SLN	602203.0 | SLN | Sarcolipin | 6588.0 | ENSG00000170290 | nan | nan
chr11	SLC35F2	620350.0 | SLC35F2 | Solute carrier family 35, member F2 | 54733.0 | ENSG00000110660 | nan | nan
chr11	RAB39A	619558.0 | RAB39A, K28 | RAB39A, member Ras oncogene family | 54734.0 | ENSG00000179331 | nan | nan
chr11	CUL5	601741.0 | CUL5, VACM1 | Cullin-5 (vasopressin-activated calcium-mobilizing receptor-1) | 8065.0 | ENSG00000166266 | nan | nan
chr11	ACAT1	607809.0 | ACAT1 | Acetyl-Coenzyme A acetyltransferase-1 (acetoacetyl Coenzyme A thiolase) | 38.0 | ENSG00000075239 | cluster: cen-STMY2-CLG-STMY1-ter | Alpha-methylacetoacetic aciduria, 203750 (3), Autosomal recessive
chr11	NPAT	601448.0 | NPAT, E14 | Nuclear protein, ataxia-telangiectasia locus | 4863.0 | ENSG00000149308 | nan | nan
chr11	ATM	607585.0 | ATM, ATA, AT1 | ATM serine/threonine kinase | 472.0 | ENSG00000149311 | nan | Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)
chr11	POGLUT3	618503.0 | POGLUT3, KDELC2 | Protein O-glucosyltransferase 3 | 143888.0 | ENSG00000178202 | nan | nan
chr11	EXPH5	612878.0 | EXPH5, SLAC2B, KIAA0624, EBS4 | Exophilin 5 | 23086.0 | ENSG00000110723 | nan | Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive, 615028 (3), Autosomal recessive
chr11	DDX10	601235.0 | DDX10 | DEAD-box helicase 10 | 1662.0 | ENSG00000178105 | 400kb telomeric to ATM; pseudogene on 9q21-q22; fused with NUP98 in AML | nan
chr11	ZC3H12C	615001.0 | ZC3H12C, MCPIP3 | Zinc finger CCCH domain-containing protein 12C | 85463.0 | ENSG00000149289 | nan | nan
chr11	RDX	179410.0 | RDX, DFNB24 | Radixin | 5962.0 | ENSG00000137710 | nan | Deafness, autosomal recessive 24, 611022 (3), Autosomal recessive
chr11	FDX1	103260.0 | FDX1, ADX | Ferredoxin-1 (adrenodoxin) | 2230.0 | ENSG00000137714 | pseudogene on 20q11-q12 | nan
chr11	ARHGAP20	609568.0 | ARHGAP20, KIAA1391 | Rho GTPase-activating protein 20 | 57569.0 | ENSG00000137727 | nan | nan
chr11	ADIPQTL4	612629.0 | ADIPQTL4 | Adiponectin, serum level of, quantitative trait locus locus 4 | 100271698.0 | nan | between D11S925 and D11S968 | {Adiponectin, serum level of, QTL4}, 612629 (2)
chr11		620058.0 | APOGCDS | Familial apolipoprotein gene cluster deletion syndrome | nan | nan | nan | Familial apolipoprotein gene cluster deletion syndrome, 620058 (4), Autosomal dominant
chr11	BMND5	609354.0 | BMND5 | Bone mineral density QTL 5 | 554315.0 | nan | between D11S901 and D11S925 | [Bone mineral density QTL 5], 609354 (2)
chr11	CRCS7	612232.0 | CRCS7 | Colorectal cancer, susceptibility to, 7 | 100187711.0 | nan | associated with rs3802842 | {Colorectal cancer, susceptibility to, 7}, 612232 (2)
chr11	NAFLD2	613387.0 | FLD1, NAFLD2 | Fatty liver disease, susceptibility to, 2 | 100462725.0 | nan | associated with rs2854116, rs2854117 | {Fatty liver disease, susceptibility to, 2}, 613387 (2), Multifactorial
chr11		137580.0 | GTS | Gilles de la Tourette syndrome | nan | nan | several loci suspected (e.g., 17q25) | Tourette syndrome, 137580 (2), Autosomal dominant
chr11		188025.0 | TCPT | Thrombocytopenia, Paris-Trousseau type (deletion 11q23 syndrome) | nan | nan | contiguous gene deletion of 11q23 | ?Thrombocytopenia, Paris-Trousseau type, 188025 (4), Isolated cases
chr11	TSG11	603040.0 | TSG11 | Tumor suppressor gene on chromosome 11 | 50970.0 | nan | nan | {Nonsmall cell lung cancer}, 603040 (2)
chr11	ZNF123P	194630.0 | ZNF123P, ZNF123 | Zinc finger protein 123, pseudogene | 100188891.0 | ENSG00000255259 | nan | nan
chr11		194632.0 | ZNF125 | Zinc finger protein-125 (HZF-3) | nan | nan | nan | nan
chr11	POU2AF2	620671.0 | POU2AF2, C11orf53, OCAT1 | POU class 2 homeobox-associating factor 2 | 341032.0 | ENSG00000150750 | nan | nan
chr11	COLCA1	615693.0 | COLCA1 | Colorectal cancer-associated gene 1 | 399948.0 | ENSG00000196167 | nan | nan
chr11	POU2AF3	615694.0 | POU2AF3, COLCA2, C11orf93 | POU class 2 homeobox-associating factor 3 | 120376.0 | ENSG00000214290 | opposite strand from COLCA1 | nan
chr11	POU2AF1	601206.0 | POU2AF1, OBF1 | POU class 2 homeobox-associating factor 1 | 5450.0 | ENSG00000110777 | nan | nan
chr11	BTG4	605673.0 | BTG4, PC3B, OZEMA8 | BTG antiproliferation factor 4 | 54766.0 | ENSG00000137707 | nan | Oocyte/zygote/embryo maturation arrest 8, 619009 (3), Autosomal recessive
chr11	MIR34B	611374.0 | MIR34B | Micro RNA 34B | 407041.0 | ENSG00000207811 | nan | nan
chr11	MIR34C	611375.0 | MIR34C | Micro RNA 34C | 407042.0 | ENSG00000207562 | nan | nan
chr11	LAYN	618843.0 | LAYN | Layilin | 143903.0 | ENSG00000204381 | nan | nan
chr11	SIK2	608973.0 | SIK2, KIAA0781 | Salt-inducible kinase 2 | 23235.0 | ENSG00000170145 | nan | nan
chr11	PPP2R1B	603113.0 | PPP2R1B | Protein phosphatase 2, structural/regulatory subunit A, beta | 5519.0 | ENSG00000137713 | nan | Lung cancer, somatic, 211980 (3)
chr11	ALG9	606941.0 | ALG9, DIBD1, CDG1L, GIKANIS | ALG9 alpha-1,2-mannosyltransferase | 79796.0 | ENSG00000086848 | nan | Gillessen-Kaesbach-Nishimura syndrome, 263210 (3), Autosomal recessive; Congenital disorder of glycosylation, type Il, 608776 (3), Autosomal recessive
chr11	CRYAB	123590.0 | CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2 | Crystallin, alpha B | 1410.0 | ENSG00000109846 | nan | Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related, 613869 (3), Autosomal recessive; Myopathy, myofibrillar, 2, 608810 (3), Autosomal dominant; Cataract 16, multiple types, 613763 (3), Autosomal recessive, Autosomal dominant; Cardiomyopathy, dilated, 1II, 615184 (3), Autosomal dominant
chr11	HSPB2	602179.0 | HSPB2 | Heat-shock 27kD protein-2 | 3316.0 | ENSG00000170276 | nan | nan
chr11	DIXDC1	610493.0 | DIXDC1, CCD1, KIAA1735 | DIX domain-containing protein 1 | 85458.0 | ENSG00000150764 | nan | nan
chr11	DLAT	608770.0 | DLAT, PDCE2 | Dihydrolipoamide S-acetyltransferase | 1737.0 | ENSG00000150768 | nan | Pyruvate dehydrogenase E2 deficiency, 245348 (3), Autosomal recessive
chr11	TIMM8B	606659.0 | TIMM8B, DDP2 | Translocase of inner mitochondrial membrane 8B | 26521.0 | ENSG00000150779 | nan | nan
chr11	SDHD	602690.0 | SDHD, PPGL1, MC2DN3 | Succinate dehydrogenase complex, subunit D | 6392.0 | ENSG00000204370 | nan | Pheochromocytoma/paraganglioma syndrome 1, 168000 (3), Autosomal dominant; Paraganglioma and gastric stromal sarcoma, 606864 (3); Mitochondrial complex II deficiency, nuclear type 3, 619167 (3), Autosomal recessive
chr11	IL18	600953.0 | IL18, IGIF | Interleukin-18 | 3606.0 | ENSG00000150782 | nan | nan
chr11	TEX12	605791.0 | TEX12 | Testis-expressed gene 12 | 56158.0 | ENSG00000150783 | nan | nan
chr11	BCO2	611740.0 | BCO2, BCDO2 | Beta-carotene oxygenase 2 | 83875.0 | ENSG00000197580 | nan | nan
chr11	PTS	612719.0 | PTS | 6-pyruvoyltetrahydropterin synthase | 5805.0 | ENSG00000150787 | nan | Hyperphenylalaninemia, BH4-deficient, A, 261640 (3), Autosomal recessive
chr11	PLET1	611904.0 | C11orf34, PLET1 | Chromosome 11 open reading frame 34 | 349633.0 | ENSG00000188771 | nan | nan
chr11	NCAM1	"116930.0 | NCAM1, MSK39 | Neural cell adhesion molecule 1 | 4684.0 | ENSG00000149294 | defective in ""staggerer"" in mice | nan"
chr11	TTC12	610732.0 | TTC12, TPARM, CILD45 | Tetratricopeptide repeat domain 12 | 54970.0 | ENSG00000149292 | nan | Ciliary dyskinesia, primary, 45, 618801 (3), Autosomal recessive
chr11	ANKK1	608774.0 | ANKK1 | Ankyrin repeat and kinase domain containing 1 | 255239.0 | ENSG00000170209 | nan | nan
chr11	DRD2	126450.0 | DRD2 | Dopamine receptor D2 | 1813.0 | ENSG00000149295 | 11q22-q23 junction; 150kb 5' to NCAM; centromeric to APOA1; telomeric to STMY1 | nan
chr11	TMPRSS5	606751.0 | TMPRSS5 | Transmembrane protease, serine 5 | 80975.0 | ENSG00000166682 | nan | nan
chr11	ZW10	603954.0 | ZW10 | ZW10 kinetochore protein | 9183.0 | ENSG00000086827 | nan | nan
chr11	CLDN25	620812.0 | CLDN25 | Claudin 25 | 644672.0 | ENSG00000228607 | nan | nan
chr11	USP28	610748.0 | USP28, KIAA1515 | Ubiquitin-specific protease 28 | 57646.0 | ENSG00000048028 | nan | nan
chr11	HTR3B	604654.0 | HTR3B | 5-hydroxytryptamine receptor 3B | 9177.0 | ENSG00000149305 | nan | nan
chr11	HTR3A	182139.0 | HTR3 | 5-hydroxytryptamine (serotonin) receptor-3 | 3359.0 | ENSG00000166736 | nan | nan
chr11	ZBTB16	176797.0 | ZBTB16, ZNF145, PLZF | Zinc finger- and BTB domain-containing protein 16 (promyelocytic leukemia zinc finger) | 7704.0 | ENSG00000109906 | fused with RARA in APL of t(11;17) type | Leukemia, acute promyelocytic, PL2F/RARA type (3)
chr11	NNMT	600008.0 | NNMT | Nicotinamide N-methyltransferase | 4837.0 | ENSG00000166741 | nan | Homocysteine plasma level, 600008 (2)
chr11	RBM7	612413.0 | RBM7 | RNA-binding motif protein 7 | 10179.0 | ENSG00000076053 | nan | nan
chr11	REXO2	607149.0 | REXO2, RFN | RNA exonuclease 2, S. cerevisiae, homolog of | 25996.0 | ENSG00000076043 | nan | nan
chr11	NXPE4	618133.0 | NXPE4, C11orf33 | Neurexophilin and PC-esterase domain family, member 4 | 54827.0 | ENSG00000137634 | nan | nan
chr11	AAT1	607086.0 | AAT1, FAA1 | Aortic aneurysm, familial thoracic 1 | 252842.0 | nan | nan | Aortic aneurysm, familial thoracic 1, 607086 (2)
chr11	HDLCQ14	605201.0 | HDLCQ14, HYLAP | High density lipoprotein cholesterol level quantitative trait locus 14 | 56801.0 | nan | nan | High density lipoprotein cholesterol level QTL14, 605201 (2)
chr11		147791.0 | JBS | Jacobsen syndrome | nan | nan | contiguous gene deletion syndrome | Jacobsen syndrome, 147791 (4), Isolated cases
chr11	CADM1	605686.0 | CADM1, IGSF4, TSLC1 | Cell adhesion molecule 1 | 23705.0 | ENSG00000182985 | nan | nan
chr11	BUD13	620691.0 | BUD13 | BUD13 homolog | 84811.0 | ENSG00000137656 | nan | nan
chr11	ZPR1	603901.0 | ZPR1, ZNF259, GKAF | ZPR1 zinc finger protein | 8882.0 | ENSG00000109917 | mutation identified in 1 GKAF patient | ?Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies, 619321 (3), Autosomal recessive
chr11	APOA5	606368.0 | APOA5 | Apolipoprotein A-V | 116519.0 | ENSG00000110243 | proximal to APOA1, APOC3, APOA4 | Hyperchylomicronemia, late-onset, 144650 (3), Autosomal dominant; {Hypertriglyceridemia, susceptibility to}, 145750 (3), Autosomal dominant
chr11	APOA4	107690.0 | APOA4 | Apolipoprotein A-IV | 337.0 | ENSG00000110244 | 12 kb 3' to APOA1 | nan
chr11	APOC3	107720.0 | APOC3, HALP2 | Apolipoprotein C-III | 345.0 | ENSG00000110245 | 2.6kb 3' to APOA1 | Apolipoprotein C-III deficiency, 614028 (3)
chr11	APOA1	107680.0 | APOA1, HPALP2, AMYLD3 | Apolipoprotein A-I | 335.0 | ENSG00000118137 | nan | Hypoalphalipoproteinemia, primary, 2, 618463 (3), Autosomal recessive; Amyloidosis, hereditary systemic 3, 620657 (3); Hypoalphalipoproteinemia, primary, 2, intermediate, 619836 (3), Autosomal dominant
chr11	APOA1-AS	620112.0 | APOA1AS | APOA1 antisense RNA, noncoding | 104326055.0 | nan | nan | nan
chr11	SIK3	614776.0 | SIK3, KIAA0999, SEMDK | Salt-inducible kinase 3 | 23387.0 | ENSG00000160584 | mutation identified in 1 SEMDK family | ?Spondyloepimetaphyseal dysplasia, Krakow type, 618162 (3), Autosomal recessive
chr11	PAFAH1B2	602508.0 | PAFAH1B2 | Platelet-activating factor acetylhydrolase, isoform Ib, beta subunit | 5049.0 | ENSG00000168092 | nan | nan
chr11	SIDT2	617551.0 | SIDT2 | SID1 transmembrane family, member 2 | 51092.0 | ENSG00000149577 | nan | nan
chr11	TAGLN	600818.0 | TAGLN, SMCC, SM22 | Transgelin | 6876.0 | ENSG00000149591 | nan | nan
chr11	PCSK7	604872.0 | PCSK7, PC8, PC7, LPC | Proprotein convertase, subtilisin/kexin-type, 7 | 9159.0 | ENSG00000160613 | nan | nan
chr11	BACE1	604252.0 | BACE1, BACE | Beta-site amyloid beta A4 precursor protein-cleaving enzyme (secretase, beta; memapsin 2) | 23621.0 | ENSG00000186318 | nan | nan
chr11	BACE1-AS	614263.0 | BACE1AS | BACE1 antisense RNA | 100379571.0 | ENSG00000278768 | nan | nan
chr11	CEP164	614848.0 | CEP164, KIAA1052 | Centrosomal protein, 164kD | 22897.0 | ENSG00000110274 | nan | Nephronophthisis 15, 614845 (3), Autosomal recessive
chr11	DSCAML1	611782.0 | DSCAML1, KIAA1132, DSCAM2 | DS cell adhesion molecule-like 1 | 57453.0 | ENSG00000177103 | nan | nan
chr11	FXYD2	601814.0 | FXYD2, ATP1G1, HOMG2 | FXYD domain-containing ion transport regulator 2 (sodium-potassium-ATPase, gamma polypeptide) | 486.0 | ENSG00000137731 | nan | Hypomagnesemia 2, renal, 154020 (3), Autosomal dominant
chr11	FXYD6	606683.0 | FXYD6 | FXYD domain-containing ion transport regulator 6 | 53826.0 | ENSG00000137726 | nan | nan
chr11	TMPRSS13	610050.0 | TMPRSS13, MSPL, MSPS | Transmembrane protease, serine 13 | 84000.0 | ENSG00000137747 | nan | nan
chr11	IL10RA	146933.0 | IL10RA, IL10R, IBD28 | Interleukin-10 receptor, alpha | 3587.0 | ENSG00000110324 | nan | Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3), Autosomal recessive
chr11	TMPRSS4	606565.0 | TMPRSS4 | Transmembrane protease, serine 4 | 56649.0 | ENSG00000137648 | nan | nan
chr11	SCN4B	608256.0 | SCN4B, LQT10, ATFB17 | Sodium voltage-gated channel, beta subunit 4 | 6330.0 | ENSG00000177098 | nan | Atrial fibrillation, familial, 17, 611819 (3), Autosomal dominant; Long QT syndrome 10, 611819 (3), Autosomal dominant
chr11	SCN2B	601327.0 | SCN2B, ATFB14 | Sodium voltage-gated channel, beta subunit 1 | 6327.0 | ENSG00000149575 | nan | Atrial fibrillation, familial, 14, 615378 (3), Autosomal dominant
chr11	JAML	609770.0 | JAML, AMICA1 | Junctional adhesion molecule-like | 120425.0 | ENSG00000160593 | nan | nan
chr11	MPZL3	611707.0 | MPZL3 | Myelin protein zero-like 3 | 196264.0 | ENSG00000160588 | nan | nan
chr11	MPZL2	604873.0 | MPZL2, EVA1, EVA, DFNB111 | Myelin protein zero-like 2 | 10205.0 | ENSG00000149573 | nan | Deafness, autosomal recessive 111, 618145 (3), Autosomal recessive
chr11	CD3E	186830.0 | CD3E, IMD18 | CD3E antigen, epsilon polypeptide (TiT3 complex) | 916.0 | ENSG00000198851 | nan | Immunodeficiency 18, 615615 (3), Autosomal recessive; Immunodeficiency 18, SCID variant, 615615 (3), Autosomal recessive
chr11	CD3D	186790.0 | CD3D, T3D, IMD19 | CD3D antigen, delta polypeptide (TiT3 complex) | 915.0 | ENSG00000167286 | 3 CD3 genes in 50kb | Immunodeficiency 19, severe combined, 615617 (3), Autosomal recessive
chr11	CD3G	186740.0 | CD3G, IMD17 | CD3G antigen, gamma polypeptide (TiT3 complex) | 917.0 | ENSG00000160654 | nan | Immunodeficiency 17, CD3 gamma deficient, 615607 (3), Autosomal recessive
chr11	UBE4A	603753.0 | UBE4A, UFD2, E4, NEDHMS | Ubiquitination factor E4A | 9354.0 | ENSG00000110344 | nan | Neurodevelopmental disorder with hypotonia and gross motor and speech delay, 619639 (3), Autosomal recessive
chr11	ATP5MG	617473.0 | ATP5JG | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G | 10632.0 | ENSG00000167283 | nan | nan
chr11	KMT2A	159555.0 | KMT2A, MLL, HRX, WDSTS | Lysine-specific methyltransferase 2E | 4297.0 | ENSG00000118058 | fuses with ENL, AF4, AF9, GMPS | Wiedemann-Steiner syndrome, 605130 (3), Autosomal dominant
chr11	TTC36	620701.0 | TTC36, HBP21 | Tetratricopeptide repeat domain 36 | 143941.0 | ENSG00000172425 | nan | nan
chr11	TMEM25	613934.0 | TMEM25 | Transmembrane protein 25 | 84866.0 | ENSG00000149582 | nan | nan
chr11	IFT46	620506.0 | IFT46, C11orf60 | Intraflagellar transport 46 | 56912.0 | ENSG00000118096 | nan | nan
chr11	ARCN1	600820.0 | ARCN1, SSMG | Archain 1 | 372.0 | ENSG00000095139 | 60kb telomeric to MLL | Short stature-micrognathia syndrome, 617164 (3), Autosomal dominant
chr11	PHLDB1	612834.0 | PHLDB1, LL5A, KIAA0638, OI23 | Pleckstrin homology-like domain, family B, member 1 | 23187.0 | ENSG00000019144 | nan | Osteogenesis imperfecta, type XXIII, 620639 (3), Autosomal recessive
chr11	TREH	275360.0 | TREH, TREHD | Trehalase | 11181.0 | ENSG00000118094 | nan | Trehalase deficiency, 612119 (3), Autosomal recessive
chr11	DDX6	600326.0 | DDX6, HLR2, IDDILF | DEAD-box helicase 6 | 1656.0 | ENSG00000110367 | nan | Intellectual developmental disorder with impaired language and dysmorphic facies, 618653 (3), Autosomal dominant
chr11	CXCR5	601613.0 | CXCR5, BLR1 | Chemokine, CXC motif, receptor 5 | 643.0 | ENSG00000160683 | nan | nan
chr11	BCL9L	609004.0 | BCL9L | B-cell CLL/lymphoma 9-like | 283149.0 | ENSG00000186174 | nan | nan
chr11	UPK2	611558.0 | UPK2, UP2, UPII | Uroplakin 2 | 7379.0 | ENSG00000110375 | nan | nan
chr11	FOXR1	615755.0 | FOXR1, FOXN5 | Forkhead box R1 | 283150.0 | ENSG00000176302 | nan | nan
chr11	CENATAC	620142.0 | CENATAC, CCDC84, MVA4 | Centrosomal AT-AC splicing factor | 338657.0 | ENSG00000186166 | mutation identified in 1 MVA4 family | ?Mosaic variegated aneuploidy syndrome 4, 620153 (3), Autosomal recessive
chr11	RPS25	180465.0 | RPS25 | Ribosomal protein S25 | 6230.0 | ENSG00000118181 | nan | nan
chr11	TRAPPC4	610971.0 | TRAPPC4, NEDESBA | Trafficking protein particle complex, subunit 4 (synbindin) | 51399.0 | ENSG00000196655 | nan | Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy, 618741 (3), Autosomal recessive
chr11	SLC37A4	602671.0 | SLC37A4, G6PT1, CDG2W | Solute carrier family 37 (glucose-6-phosphate transporter), member 4 | 2542.0 | ENSG00000137700 | nan | Glycogen storage disease Ib, 232220 (3), Autosomal recessive; Congenital disorder of glycosylation, type IIw, 619525 (3), Autosomal dominant; Glycogen storage disease Ic, 232240 (3), Autosomal recessive
chr11	HYOU1	601746.0 | HYOU1, IMD59 | Hypoxia-upregulated 1 | 10525.0 | ENSG00000149428 | mutation identified in 1 IMD59 patient | ?Immunodeficiency 59 and hypoglycemia, 233600 (3), Autosomal recessive
chr11	VPS11	608549.0 | VPS11, HLD12; DYT32 | VPS11 core subunit of CORVET and HOPS complexes | 55823.0 | ENSG00000160695 | mutation identified in 1 DYT32 patient | ?Dystonia 32, 619637 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 12, 616683 (3), Autosomal recessive
chr11	HMBS	609806.0 | HMBS, PBGD, UPS, ENCEP, LENCEP | Hydroxymethylbilane synthase | 3145.0 | ENSG00000256269 | nan | Leukoencephalopathy, porphyria-related, 620711 (3), Autosomal recessive; Encephalopathy, porphyria-related, 620704 (3), Autosomal recessive; Porphyria, acute intermittent, nonerythroid variant, 176000 (3), Autosomal dominant; Porphyria, acute intermittent, 176000 (3), Autosomal dominant
chr11	DPAGT1	191350.0 | DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13 | Dolichyl-phosphate N-acetylglucosamine phosphotransferase | 1798.0 | ENSG00000172269 | nan | Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3), Autosomal recessive; Congenital disorder of glycosylation, type Ij, 608093 (3), Autosomal recessive
chr11	H2AX	601772.0 | H2AX | H2AX histone | 3014.0 | ENSG00000188486 | nan | nan
chr11	C2CD2L	617582.0 | C2CD2L, TMEM24 | C2 calcium-dependent domain-containing protein 2-like | 9854.0 | ENSG00000172375 | nan | nan
chr11	HINFP	607099.0 | HINFP, MIZF | Histone H4 transcription factor | 25988.0 | ENSG00000172273 | nan | nan
chr11	ABCG4	607784.0 | ABCG4, WHITE2 | ATP-binding cassette, subfamily G, member 4 | 64137.0 | ENSG00000172350 | nan | nan
chr11	NLRX1	611947.0 | NLRX1, NOD9, CLR11.3 | NLR family member X1 | 79671.0 | ENSG00000160703 | nan | nan
chr11	NHERF4	607146.0 | PDZD3, IKEPP | PDZ domain-containing 3 | 79849.0 | ENSG00000172367 | nan | nan
chr11	CBL	165360.0 | CBL, CBL2, NSLL | CBL protooncogene | 867.0 | ENSG00000110395 | mutation identified in 1 JMML family | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3), Autosomal dominant; ?Juvenile myelomonocytic leukemia, 607785 (3), Somatic mutation, Autosomal dominant
chr11	MCAM	155735.0 | MCAM, MUC18, CD146 | Melanoma adhesion molecule | 4162.0 | ENSG00000076706 | nan | nan
chr11	RNF26	606130.0 | RNF26 | RING finger protein-26 | 79102.0 | ENSG00000173456 | nan | nan
chr11	C1QTNF5	608752.0 | C1QTNF5, CTRP5, LORD | C1q- and tumor necrosis factor-related protein 5 | 114902.0 | ENSG00000223953 | nan | Retinal degeneration, late-onset, autosomal dominant, 605670 (3), Autosomal dominant
chr11	MFRP	606227.0 | MFRP, MCOP5, NNO2 | Membrane-type frizzled-related protein | 83552.0 | ENSG00000235718 | nan | Microphthalmia, isolated 5, 611040 (3), Autosomal recessive; Nanophthalmos 2, 609549 (3)
chr11	USP2	604725.0 | USP2, UBP41 | Ubiquitin-specific protease 2 | 9099.0 | ENSG00000036672 | nan | nan
chr11	THY1	188230.0 | THY1 | Thy-1 T-cell antigen | 7070.0 | ENSG00000154096 | nan | nan
chr11	NECTIN1	600644.0 | NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1 | Nectin 1 | 5818.0 | ENSG00000110400 | nan | Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3), Autosomal recessive; Orofacial cleft 7, 225060 (3), Autosomal recessive
chr11	TRIM29	610658.0 | TRIM29, ATDC | Tripartite motif-containing protein 29 | 23650.0 | ENSG00000137699 | nan | nan
chr11	POU2F3	607394.0 | POU2F3, OCT11 | POU domain, class 2, transcription factor 3 | 25833.0 | ENSG00000137709 | nan | nan
chr11	ARHGEF12	604763.0 | ARHGEF12, LARG, KIAA0382 | Rho guanine nucleotide exchange factor 12, leukemia-associated | 23365.0 | ENSG00000196914 | fused with MLL in AML | nan
chr11	GRIK4	600282.0 | GRIK4 | Glutamate receptor, ionotropic, kainate 4 | 2900.0 | ENSG00000149403 | nan | nan
chr11	TBCEL	610451.0 | LRRC35, EL | Leucine-rich repeat-containing protein 35 | 219899.0 | ENSG00000154114 | nan | nan
chr11	TECTA	602574.0 | TECTA, DFNA8, DFNA12, DFNB21 | Tectorin, alpha | 7007.0 | ENSG00000109927 | nan | Deafness, autosomal dominant 8/12, 601543 (3), Autosomal dominant; Deafness, autosomal recessive 21, 603629 (3), Autosomal recessive
chr11	SC5D	602286.0 | SC5D, ERG3 | Sterol C5-desaturase | 6309.0 | ENSG00000109929 | nan | Lathosterolosis, 607330 (3), Autosomal recessive
chr11	ANIB7	612161.0 | ANIB7 | Aneurysm, intracranial berry, 7 | 100188885.0 | nan | between rs618176 and rs1940033 | Aneurysm, intracranial berry, 7, 612161 (2)
chr11	CLLS5	612559.0 | CLLS5 | Leukemia, chronic lymphocytic susceptibility to, 5 | 100270644.0 | nan | associated with rs735665 | {Leukemia, chronic lymphocytic susceptibility to, 5}, 612559 (2)
chr11	MGR9	609670.0 | MGR9 | Migraine with aura, susceptibility to, 9 | 100415943.0 | nan | max lod at GATA64D03 | {Migraine with aura, susceptibility to, 9}, 609670 (2)
chr11	NEDE	609469.0 | NEDE | Nephropathy, progressive, with deafness | 619410.0 | nan | max lod at D11S4464 | Nephropathy, progressive, with deafness, 609469 (2)
chr11	SORL1	602005.0 | SORL1, LR11, SORLA | Sortilin-related receptor, L(DLR class) A repeats-containing | 6653.0 | ENSG00000137642 | nan | nan
chr11	MIR100HG	615965.0 | MIR100HG, AGD1 | MIR100-LET7A2 cluster host gene, noncoding | 399959.0 | ENSG00000255248 | nan | nan
chr11	MIR125B1	610104.0 | MIR125B1, MIRN125B1 | Micro RNA 125B-1 | 406911.0 | ENSG00000207971 | nan | nan
chr11	BLID	608853.0 | BLID, BRCC@ | BH3-like motif-containing cell death inducer | 414899.0 | ENSG00000259571 | distal to SORL1 | nan
chr11	MIRLET7A2	612142.0 | MIRLET7A2, LET7A2, MIRNLET7A2 | Micro RNA let7a2 | 406882.0 | ENSG00000198975 | nan | nan
chr11	MIR100	613186.0 | MIR100, MIRN100 | Micro RNA 100 | 406892.0 | ENSG00000207994 | nan | nan
chr11	UBASH3B	609201.0 | UBASH3B, STS1, KIAA1959, P70 | Ubiquitin-associated and SH3 domain-containing protein B | 84959.0 | ENSG00000154127 | nan | nan
chr11	CRTAM	612597.0 | CRTAM | Cytotoxic and regulatory T-cell molecule | 56253.0 | ENSG00000109943 | nan | nan
chr11	JHY	617594.0 | JHY, C11orf63 | Jhy, mouse, homology of | 79864.0 | ENSG00000109944 | nan | nan
chr11	BSX	611074.0 | BSX1 | Brain-specific homeobox, mouse, homolog of | 390259.0 | ENSG00000188909 | nan | nan
chr11	HSPA8	600816.0 | HSPA8, HSP73 | Heat-shock 70kD protein-8 (HSP73) | 3312.0 | ENSG00000109971 | nan | nan
chr11	CLMP	611693.0 | CLMP, ASAM, ACAM, CSBS | Coxsackievirus- and adenovirus receptor-like membrane protein | 79827.0 | ENSG00000166250 | nan | Congenital short bowel syndrome, 615237 (3), Autosomal recessive
chr11	GRAMD1B	620179.0 | GRAMD1B | GRAM domain-containing protein 1B | 57476.0 | ENSG00000023171 | nan | nan
chr11	SCN3B	608214.0 | SCN3B, SCNB3, BRGDA7, ATFB16 | Sodium voltage-gated channel, beta subunit 3 | 55800.0 | ENSG00000166257 | nan | Atrial fibrillation, familial, 16, 613120 (3), Autosomal dominant; Brugada syndrome 7, 613120 (3), Autosomal dominant
chr11	ZNF202	603430.0 | ZNF202 | Zinc finger protein-202 | 7753.0 | ENSG00000166261 | nan | nan
chr11	MRD4	612581.0 | MRD4 | Intellectual developmental disorder, autosomal dominant 4 | 112441440.0 | nan | translocation t(11;16)(q24.2;q24) | Intellectual developmental disorder, autosomal dominant 4, 612581 (2), Autosomal dominant
chr11	VWA5A	602929.0 | VWA5A, LOH11CR2A, BCSC1 | von Willebrand factor A domain-containing protein 5A | 4013.0 | ENSG00000110002 | nan | nan
chr11	PANX3	608422.0 | PANX3, PX3 | Pannexin 3 | 116337.0 | ENSG00000154143 | nan | nan
chr11	TBRG1	610614.0 | TBRG1, NIAM | Transforming growth factor-beta regulator 1 | 84897.0 | ENSG00000154144 | nan | nan
chr11	SIAE	610079.0 | SIAE, AIS6 | Sialic acid acetylesterase | 54414.0 | ENSG00000110013 | nan | {Autoimmune disease, susceptibility to, 6}, 613551 (3)
chr11	SPA17	608621.0 | SPA17, SP17 | Sperm autoantigenic protein 17 | 53340.0 | ENSG00000064199 | nan | nan
chr11	NRGN	602350.0 | NRGN | Neurogranin | 4900.0 | ENSG00000154146 | nan | nan
chr11	VSIG2	606011.0 | VSIG2, CTXL | V-set and immunoglobulin domains-containing protein 2 | 23584.0 | ENSG00000019102 | nan | nan
chr11	ESAM	614281.0 | ESAM, NEDIHSS | Endothelial cell adhesion molecule | 90952.0 | ENSG00000149564 | nan | Neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity, 620371 (3), Autosomal recessive
chr11	ROBO3	608630.0 | ROBO3, RBIG1, RIG1, HGPPS1 | Roundabout guidance receptor 3 | 64221.0 | ENSG00000154134 | nan | Gaze palsy, familial horizontal, with progressive scoliosis, 1, 607313 (3), Autosomal recessive
chr11	ROBO4	607528.0 | ROBO4, AOVD3 | Roundabout guidance receptor 4 | 54538.0 | ENSG00000154133 | nan | Aortic valve disease 3, 618496 (3), Autosomal dominant
chr11	HEPACAM	611642.0 | HEPACAM, MLC2A, MLC2B | Hepatocyte cell adhesion molecule | 220296.0 | ENSG00000165478 | nan | Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3), Autosomal recessive; Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development, 613926 (3), Autosomal dominant
chr11	HEPN1	611641.0 | HEPN1 | Cancer susceptibility gene HEPN1 | 641654.0 | ENSG00000221932 | nan | nan
chr11	SLC37A2	619136.0 | SLC37A2, SPX2 | Solute carrier family 37 (glucose-6-phosphate transporter), member A2 | 219855.0 | ENSG00000134955 | nan | nan
chr11	TMEM218	619285.0 | TMEM218, JBTS39 | Transmembrane protein 218 | 219854.0 | ENSG00000150433 | nan | Joubert syndrome 39, 619562 (3), Autosomal recessive
chr11	PKNOX2	613066.0 | PKNOX2, PREP2 | PBX/Knotted 1 homeobox 2 | 63876.0 | ENSG00000165495 | nan | nan
chr11	FEZ1	604825.0 | FEZ1 | Fasciculation and elongation protein zeta 1 | 9638.0 | ENSG00000149557 | nan | nan
chr11	EI24	605170.0 | EI24, PIG8, EPG4 | Etoposide-induced 1.4 mRNA | 9538.0 | ENSG00000149547 | nan | nan
chr11	STT3A	601134.0 | STT3A, ITM1, TMC, CDG1WAR, CDG1WAD | STT3A, subunit of the oligosaccharyltransferase complex (catalytic) | 3703.0 | ENSG00000134910 | nan | Congenital disorder of glycosylation, type Iw, autosomal dominant, 619714 (3), Autosomal dominant; Congenital disorder of glycosylation, type Iw, autosomal recessive, 615596 (3), Autosomal recessive
chr11	CHEK1	603078.0 | CHEK1, CHK1, OZEMA21 | Checkpoint kinase 1 | 1111.0 | ENSG00000149554 | nan | Oocyte/zygote/embryo maturation arrest 21, 620610 (3), Autosomal dominant
chr11	ACRV1	102525.0 | ACRV1 | Acrosomal vesicle protein-1 | 56.0 | ENSG00000134940 | nan | nan
chr11	PATE1	606861.0 | PATE | Prostate- and testis-expressed gene | 160065.0 | ENSG00000171053 | nan | nan
chr11	HYLS1	610693.0 | HYLS1, FLJ32915 | HYLS1 centriolar and ciliogenesis-associated protein | 219844.0 | ENSG00000198331 | nan | Hydrolethalus syndrome, 236680 (3), Autosomal recessive
chr11	PUS3	616283.0 | PUS3, MRT55, NEDMIGS | Pseudouridylate synthase 3 | 83480.0 | ENSG00000110060 | nan | Neurodevelopmental disorder with microcephaly and gray sclerae, 617051 (3), Autosomal recessive
chr11	DDX25	607663.0 | GRTH | Gonadotropin-regulated testicular RNA helicase | 29118.0 | ENSG00000109832 | nan | nan
chr11	CDON	608707.0 | CDON, CDO, HPE11 | Cell adhesion molecule-related/downregulated by oncogenes | 50937.0 | ENSG00000064309 | nan | Holoprosencephaly 11, 614226 (3), Autosomal dominant
chr11	RPUSD4	617488.0 | RPUSD4 | RNA pseudouridylate synthase domain-containing protein 4 | 84881.0 | ENSG00000165526 | nan | nan
chr11	FAM118B	616587.0 | FAM118B | Family with sequence similarity 118, member B | 79607.0 | ENSG00000197798 | nan | nan
chr11	SRPRA	182180.0 | SRPRA, SRPR, DP | SRP receptor subunit, alpha | 6734.0 | ENSG00000182934 | nan | nan
chr11	FOXRED1	613622.0 | FOXRED1, MC1DN19 | FAD-dependent oxidoreductase domain-containing protein 1 | 55572.0 | ENSG00000110074 | nan | Mitochondrial complex I deficiency, nuclear type 19, 618241 (3), Autosomal recessive
chr11	TIRAP	606252.0 | TIRAP, BACTS1 | TIR domain-containing adaptor protein | 114609.0 | ENSG00000150455 | nan | {Malaria, protection against}, 611162 (3); {Tuberculosis, protection against}, 607948 (3); {Bacteremia, protection against}, 614382 (3)
chr11	DCPS	610534.0 | DCPS, HINT5, DCS1, ARS | Decapping enzyme, scavenger | 28960.0 | ENSG00000110063 | nan | Al-Raqad syndrome, 616459 (3), Autosomal recessive
chr11	ST3GAL4	104240.0 | ST3GAL4, SIAT4C, SIAT4, CGS23, NANTA3 | ST3 beta-galactoside alpha-2,3-sialyltransferase 4 | 6484.0 | ENSG00000110080 | nan | nan
chr11	KIRREL3	607761.0 | KIRREL3, NEPH2, KIAA1867, KIRRE | Kirre-like nephrin family adhesion molecule 3 | 84623.0 | ENSG00000149571 | nan | nan
chr11	ETS1	164720.0 | ETS1 | ETS protooncogene 1, transcription factor | 2113.0 | ENSG00000134954 | shown by HSR; 19cM distal to THY1; Ewing sarcoma breakpoint region-2 splices to EWSR1 | nan
chr11	FLI1	193067.0 | FLI1, BDPLT21 | FLI1 protooncogene, ETS transcription factor | 2313.0 | ENSG00000151702 | fused with EWS in Ewing sarcoma | Bleeding disorder, platelet-type, 21, 617443 (3), Autosomal recessive, Autosomal dominant
chr11	SENCR	615815.0 | SENCR, lncRNA9 | Smooth muscle- and endothelial cell-enriched migration/differentiation-associated long noncoding RNA | 100507392.0 | ENSG00000254703 | nan | nan
chr11	KCNJ1	600359.0 | KCNJ1, ROMK1 | Potassium inwardly-rectifying channel, subfamily J, member 1 | 3758.0 | ENSG00000151704 | nan | Bartter syndrome, type 2, 241200 (3), Autosomal recessive
chr11	KCNJ5	600734.0 | KCNJ5, GIRK4, KATP1, LQT13 | Potassium inwardly-rectifying channel, subfamily J, member 5 | 3762.0 | ENSG00000120457 | nan | Long QT syndrome 13, 613485 (3), Autosomal dominant; Hyperaldosteronism, familial, type III, 613677 (3), Autosomal dominant
chr11	TP53AIP1	605426.0 | TP53AIP1, P53AIP1 | Tumor protein p53-regulated apoptosis-inducing protein 1 | 63970.0 | ENSG00000120471 | nan | nan
chr11	ARHGAP32	608541.0 | ARHGAP32, RICS, GRIT, p200RHOGAP, p250GAP | Rho GTPase activating protein 32 | 9743.0 | ENSG00000134909 | nan | nan
chr11	BARX2	604823.0 | BARX2 | BARX homeobox 2 | 8538.0 | ENSG00000043039 | nan | nan
chr11	NFRKB	164013.0 | NFRKB | Nuclear factor related to kappa B-binding protein | 4798.0 | ENSG00000170322 | most telomeric 11q marker | nan
chr11	PRDM10	618319.0 | PRDM10, TRIS, KIAA1231, BHD2 | PR domain-containing protein 10 | 56980.0 | ENSG00000170325 | mutation identified in 1 BHD2 family | ?Birt-Hogg-Dube syndrome 2, 620459 (3), Autosomal dominant
chr11	APLP2	104776.0 | APLP2 | Amyloid beta (A4) precursor-like protein-2 | 334.0 | ENSG00000084234 | nan | nan
chr11	ST14	606797.0 | ST14, MTSP1, ARCI11 | ST14 transmembrane serine protease matriptase | 6768.0 | ENSG00000149418 | nan | Ichthyosis, congenital, autosomal recessive 11, 602400 (3), Autosomal recessive
chr11	ADAMTS8	605175.0 | ADAMTS8, METH2 | ADAM metallopeptidase domain with thrombospondin type 1 motif, 8 | 11095.0 | ENSG00000134917 | nan | nan
chr11	ADAMTS15	607509.0 | ADAMTS15, DA12 | ADAM metallopeptidase domain with thrombospondin type 1 motif, 15 | 170689.0 | ENSG00000166106 | nan | Arthrogryposis, distal, type 12, 620545 (3), Autosomal recessive
chr11	DFNB20	604060.0 | DFNB20 | Deafness, autosomal recessive 20 | 1713.0 | nan | nan | Deafness, autosomal recessive 20, 604060 (2), Autosomal recessive
chr11	NTM	607938.0 | NTM, HNT | Neurotrimin | 50863.0 | ENSG00000182667 | nan | nan
chr11	OPCML	600632.0 | OPCML | Opioid-binding protein/cell adhesion molecule-like | 4978.0 | ENSG00000183715 | nan | Ovarian cancer, somatic, 167000 (3)
chr11	SPATA19	609805.0 | SPATA19 | Spermatogenesis-associated protein 19 | 219938.0 | ENSG00000166118 | nan | nan
chr11	IGSF9B	613773.0 | IGSF9B, KIAA1030 | Immunoglobulin superfamily, member 9B | 22997.0 | ENSG00000080854 | nan | nan
chr11	JAM3	606871.0 | JAM3 | Junctional adhesion molecule 3 | 83700.0 | ENSG00000166086 | nan | Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3), Autosomal recessive
chr11	NCAPD3	609276.0 | NCAPD3, CAPD3, KIAA0056, MCPH22 | Non-SMC condensin II complex subunit D3 | 23310.0 | ENSG00000151503 | nan | Microcephaly 22, primary, autosomal recessive, 617984 (3), Autosomal recessive
chr11	VPS26B	610027.0 | VPS26B | VPS26 retromer complex component B | 112936.0 | ENSG00000151502 | nan | nan
chr11	THYN1	613739.0 | THYN1, HSPC144, THY28 | Thymocyte nuclear protein 1 | 29087.0 | ENSG00000151500 | nan | nan
chr11	ACAD8	604773.0 | ACAD8 | Acyl-CoA dehydrogenase family, member 8 | 27034.0 | ENSG00000151498 | nan | Isobutyryl-CoA dehydrogenase deficiency, 611283 (3), Autosomal recessive
chr11	B3GAT1	151290.0 | B3GAT1, GLCATP, CD57, HNK1 | Beta-1,3-glucuronyltransferase 1 | 27087.0 | ENSG00000109956 | nan | nan
chr11	AOCH	606049.0 | AOCH | Acromegaloid features, overgrowth, cleft palate, and hernia | 93956.0 | nan | pericentric inversion (46,XY,inv(11)(p15.3;q23.3)) | Acromegaloid features, overgrowth, cleft palate, and hernia, 606049 (2)
chr12	DDX12P	601151.0 | DDX12P, CHLR2 | DEAD/H-box helicase 12, pseudogene | 440081.0 | nan | nan | nan
chr12	MAFD9	612372.0 | MAFD9 | Major affective disorder 9 | 100196917.0 | nan | associated with rs1006737 | {Major affective disorder-9, susceptibility to}, 612372 (2)
chr12		601803.0 | PKS | Pallister-Killian syndrome | nan | nan | nan | Pallister-Killian syndrome, 601803 (4), Somatic mosaicism
chr12	IQSEC3	612118.0 | IQSEC3, KIAA1110 | IQ motif- and SEC7 domain-containing protein 3 | 440073.0 | ENSG00000120645 | nan | nan
chr12	SLC6A12	603080.0 | SLC6A12 | Solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 6539.0 | ENSG00000111181 | nan | nan
chr12	SLC6A13	615097.0 | SLC6A13, GAT2, GAT3 | Solute carrier family 6 (neurotransmitter transporter, GABA), member 13 | 6540.0 | ENSG00000010379 | nan | nan
chr12	KDM5A	180202.0 | KDM5A, JARID1A, RBP2, RBBP2, NEDEHC | Lysine demethylase 5A | 5927.0 | ENSG00000073614 | nan | El Hayek-Chahrour neurodevelopmental syndrome, 620820 (3), Autosomal recessive
chr12	B4GALNT3	612220.0 | B4GALNT3 | Beta-1,4-N-acetylgalactosaminyltransferase 3 | 283358.0 | ENSG00000139044 | nan | nan
chr12	NINJ2	607297.0 | NINJ2 | Nerve injury-induced protein 2 | 4815.0 | ENSG00000171840 | nan | nan
chr12	WNK1	605232.0 | WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2 | WNK lysine deficient protein kinase 1 | 65125.0 | ENSG00000060237 | nan | Neuropathy, hereditary sensory and autonomic, type II, 201300 (3), Autosomal recessive; Pseudohypoaldosteronism, type IIC, 614492 (3), Autosomal dominant
chr12	RAD52	600392.0 | RAD52 | RAD52 homolog, DNA repair protein | 5893.0 | ENSG00000002016 | nan | nan
chr12	ERC1	607127.0 | ERC1, RAB6IP2, KIAA1081 | ELKS/RAB6-interacting/CAST family, member 1 | 23085.0 | ENSG00000082805 | nan | nan
chr12	FBXL14	609081.0 | FBXL14, FBL14 | F-box and leucine-rich repeat protein 14 | 144699.0 | ENSG00000171823 | nan | nan
chr12	WNT5B	606361.0 | WNT5B | Wingless-type MMTV integration site family, member 5B | 81029.0 | ENSG00000111186 | nan | nan
chr12	ADIPOR2	607946.0 | ADIPOR2, FLJ21432 | Adiponectin receptor 2 | 79602.0 | ENSG00000006831 | nan | nan
chr12	CACNA2D4	608171.0 | CACNA2D4, RCD4 | Calcium channel, voltage-dependent, alpha-2/delta subunit 4 | 93589.0 | ENSG00000151062 | nan | Retinal cone dystrophy 4, 610478 (3), Autosomal recessive
chr12	DCP1B	609843.0 | DCP1B, DCP1 | Decapping enzyme 1, S. cerevisiae, homolog of | 196513.0 | ENSG00000151065 | nan | nan
chr12	CACNA1C	114205.0 | CACNA1C, CACNL1A1, CCHL1A1, TS, LQT8, NEDHLSS | Calcium channel, voltage-dependent, L type, alpha 1C subunit | 775.0 | ENSG00000151067 | nan | Timothy syndrome, 601005 (3), Autosomal dominant; Long QT syndrome 8, 618447 (3), Autosomal dominant; Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, 620029 (3), Autosomal dominant; Brugada syndrome 3, 611875 (3), Autosomal dominant
chr12	FKBP4	600611.0 | FKBP4, FKBP52 | FK506-binding protein 4 | 2288.0 | ENSG00000004478 | nan | nan
chr12	ITFG2	617421.0 | ITFG2, FGGAP1 | Integrin-alpha FG-GAP repeat-containing protein 2 | 55846.0 | ENSG00000111203 | nan | nan
chr12	FOXM1	602341.0 | FOXM1, FKHL16, HFH11 | Forkhead box M1 | 2305.0 | ENSG00000111206 | nan | nan
chr12	RHNO1	614085.0 | RHNO1, RHINO, C12orf32 | Rad9-, Rad1-, and Hus1-interacting nuclear orphan 1 | 83695.0 | ENSG00000171792 | nan | nan
chr12	TULP3	604730.0 | TULP3, HRCDF | TUB-like protein 3 | 7289.0 | ENSG00000078246 | nan | Hepatorenocardiac degenerative fibrosis, 619902 (3), Autosomal recessive
chr12	TEAD4	601714.0 | TEAD4, TCF13L1, RTEF1 | TEA domain family, member 4 | 7004.0 | ENSG00000197905 | nan | nan
chr12	TSPAN9	613137.0 | TSPAN9, NET5 | Tetraspanin 9 | 10867.0 | ENSG00000011105 | nan | nan
chr12	PRMT8	610086.0 | PRMT8, HRMT1L3, HRMT1L4 | Protein arginine methyltransferase 8 | 56341.0 | ENSG00000111218 | nan | nan
chr12	CRACR2A	614178.0 | EFCAB4B, CRACR2A | EF-hand calcium-binding domain-containing protein 4B | 84766.0 | ENSG00000130038 | nan | nan
chr12	PARP11	616706.0 | PARP11, ARTD11 | Poly(ADP-ribose) polymerase family, member 11 | 57097.0 | ENSG00000111224 | nan | nan
chr12	CCND2	123833.0 | CCND2, MPPH3 | Cyclin D2 | 894.0 | ENSG00000118971 | nan | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3), Autosomal dominant
chr12	TIGAR	610775.0 | TIGAR, C12orf5 | TP53-induced glycolysis and apoptosis regulator | 57103.0 | ENSG00000078237 | nan | nan
chr12	FGF23	605380.0 | FGF23, ADHR, HPDR2, PHPTC, HFTC2 | Fibroblast growth factor 23 | 8074.0 | ENSG00000118972 | nan | Tumoral calcinosis, hyperphosphatemic, familial, 2, 617993 (3), Autosomal recessive; Hypophosphatemic rickets, autosomal dominant, 193100 (3), Autosomal dominant
chr12	FGF6	134921.0 | FGF6 | Fibroblast growth factor-6 | 2251.0 | ENSG00000111241 | nan | nan
chr12	FERRY3	616082.0 | C12orf4, MRT66 | Chromosome 12 open reading frame 4 | 57102.0 | ENSG00000047621 | nan | Intellectual developmental disorder, autosomal recessive 66, 618221 (3), Autosomal recessive
chr12	RAD51AP1	603070.0 | RAD51AP1, PIR51 | Rad51-associated protein 1 | 10635.0 | ENSG00000111247 | nan | nan
chr12	DYRK4	609181.0 | DYRK4 | Dual-specificity tyrosine phosphorylation-regulated kinase 4 | 8798.0 | ENSG00000010219 | nan | nan
chr12	AKAP3	604689.0 | AKAP3, AKAP110, FSP95, SOB1, SPGF82 | A-kinase anchor protein 3 | 10566.0 | ENSG00000111254 | nan | Spermatogenic failure 82, 620353 (3), Autosomal recessive
chr12	NDUFA9	603834.0 | NDUFA9, MC1DN26 | NADH-ubiquinone oxidoreductase subunit A9 | 4704.0 | ENSG00000139180 | nan | Mitochondrial complex I deficiency, nuclear type 26, 618247 (3), Autosomal recessive
chr12	GALNT8	606250.0 | GALNT8 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 | 26290.0 | ENSG00000130035 | nan | nan
chr12	KCNA6	176257.0 | KCNA6 | Potassium voltage-gated channel, shaker-related subfamily, member 6 | 3742.0 | ENSG00000151079 | nan | nan
chr12	KCNA1	176260.0 | KCNA1, AEMK, EA1 | Potassium voltage-gated channel, shaker-related subfamily, member 1 | 3736.0 | ENSG00000111262 | close to VWF | Episodic ataxia/myokymia syndrome, 160120 (3), Autosomal dominant
chr12	KCNA5	176267.0 | KCNA5, ATFB7 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | 3741.0 | ENSG00000130037 | nan | Atrial fibrillation, familial, 7, 612240 (3), Autosomal dominant
chr12	NTF3	162660.0 | NTF3 | Neurotrophin-3 | 4908.0 | ENSG00000185652 | nan | nan
chr12	ANO2	610109.0 | ANO2, TMEM16B, C12orf3 | Anoctamin 2 | 57101.0 | ENSG00000047617 | nan | nan
chr12	VWF	613160.0 | VWF, F8VWF | Coagulation factor VIII VWF (von Willebrand factor) | 7450.0 | ENSG00000110799 | pseudogene on chr. 22 | von Willebrand disease, type 1, 193400 (3), Autosomal dominant; von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3), Autosomal recessive, Autosomal dominant; von Willebrand disease, type 3, 277480 (3), Autosomal recessive
chr12	CD9	143030.0 | CD9, MIC3 | CD9 antigen (p24) | 928.0 | ENSG00000010278 | nan | nan
chr12	PLEKHG6	611743.0 | PLEKHG6, MYOGEF | Pleckstrin homology domain- and RhoGEF domain-containing protein G6 | 55200.0 | ENSG00000008323 | nan | nan
chr12	TNFRSF1A	191190.0 | TNFRSF1A, TNFR1, TNFAR, FPF, MS5 | Tumor necrosis factor receptor superfamily, member 1A | 7132.0 | ENSG00000067182 | nan | {Multiple sclerosis, susceptibility to, 5}, 614810 (3); Periodic fever, familial, 142680 (3), Autosomal dominant
chr12	SCNN1A	600228.0 | SCNN1A, BESC2, LIDLS3, PHA1B1 | Sodium channel, epithelial 1, subunit alpha | 6337.0 | ENSG00000111319 | mutation identified in 1 LIDLS3 patient | Pseudohypoaldosteronism, type IB1, autosomal recessive, 264350 (3), Autosomal recessive; ?Liddle syndrome 3, 618126 (3), Autosomal dominant; Bronchiectasis with or without elevated sweat chloride 2, 613021 (3), Autosomal dominant
chr12	LTBR	600979.0 | LTBR, TNFCR | Lymphotoxin-beta receptor (tumor necrosis factor C receptor) | 4055.0 | ENSG00000111321 | tightly linked to TNFR1 in mouse | nan
chr12	CD27	186711.0 | CD27, TNFRSF7, S152. LPFS2 | CD27 antigen | 939.0 | ENSG00000139193 | nan | Lymphoproliferative syndrome 2, 615122 (3), Autosomal recessive
chr12	TAPBPL	607081.0 | TAPBPR | TAP-binding protein-related protein | 55080.0 | ENSG00000139192 | nan | nan
chr12	VAMP1	185880.0 | VAMP1, SYB1, SPAX1, CMS25 | Vesicle-associated membrane protein-1 (synaptobrevin-1) | 6843.0 | ENSG00000139190 | nan | Myasthenic syndrome, congenital, 25, 618323 (3), Autosomal recessive; Spastic ataxia 1, autosomal dominant, 108600 (3), Autosomal dominant
chr12	MRPL51	611855.0 | MRPL51, MRP64 | Mitochondrial ribosomal protein L51 | 51258.0 | ENSG00000111639 | nan | nan
chr12	NCAPD2	615638.0 | NCAPD2, CNAP1, KIAA0159, MCPH21 | Non-SMC condensin I complex subunit D2 | 9918.0 | ENSG00000010292 | nan | Microcephaly 21, primary, autosomal recessive, 617983 (3), Autosomal recessive
chr12	SCARNA10	615639.0 | SCARNA10 | Small cajal body-specific RNA 10 | 692148.0 | ENSG00000239002 | in intron 4 of NCAPD2 | nan
chr12	GAPDH	138400.0 | GAPDH, GAPD | Glyceraldehyde-3-phosphate dehydrogenase | 2597.0 | ENSG00000111640 | pseudogene on Xp21-q11 | nan
chr12	IFFO1	610495.0 | IFFO1 | Intermediate filament family orphan 1 | 25900.0 | ENSG00000010295 | nan | nan
chr12	NOP2	164031.0 | NOP2, NOL1 | Nucleolar protein NOP2 | 4839.0 | ENSG00000111641 | nan | nan
chr12	CHD4	603277.0 | CHD4, SIHIWES | Chromodomain helicase DNA-binding protein-4 | 1108.0 | ENSG00000111642 | nan | Sifrim-Hitz-Weiss syndrome, 617159 (3), Autosomal dominant
chr12	LPAR5	606926.0 | LPAR5, GPR92, GPR93, LPA5 | Lysophosphatidic acid receptor 5 | 57121.0 | ENSG00000184574 | nan | nan
chr12	ACRBP	608352.0 | ACRBP, SP32 | Acrosin-binding protein | 84519.0 | ENSG00000111644 | nan | nan
chr12	ING4	608524.0 | ING4 | Inhibitor of growth-4 | 51147.0 | ENSG00000111653 | nan | nan
chr12	ZNF384	609951.0 | ZNF384, CIZ, CAGH1, NMP4 | Zinc finger protein 384 | 171017.0 | ENSG00000126746 | nan | nan
chr12	PIANP	616065.0 | PIANP, PANP, LEDA1 | PILR-alpha-associated neural protein | 196500.0 | ENSG00000139200 | nan | nan
chr12	COPS7A	616009.0 | COPS7A, CSN7 | COP9 signalosome, subunit 7A | 50813.0 | ENSG00000111652 | nan | nan
chr12	MLF2	601401.0 | MLF2 | Myeloid leukemia factor-2 | 8079.0 | ENSG00000089693 | nan | nan
chr12	PTMS	168440.0 | PTMS | Parathymosin | 5763.0 | ENSG00000159335 | previously assigned to 17q12-q22 | nan
chr12	LAG3	153337.0 | LAG3 | Lymphocyte activation gene-3 | 3902.0 | ENSG00000089692 | nan | nan
chr12	CD4	186940.0 | CD4, OKT4D, IMD79 | CD4 antigen (p55) | 920.0 | ENSG00000010610 | CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens | Immunodeficiency 79, 619238 (3), Autosomal recessive; OKT4 epitope deficiency, 613949 (3)
chr12	P3H3	610342.0 | P3H3, LEPREL2 | Prolyl 3-hydroxylase 3 | 10536.0 | ENSG00000110811 | nan | nan
chr12	GNB3	139130.0 | GNB3, CSNB1H | Guanine nucleotide-binding protein, beta polypeptide-3 | 2784.0 | ENSG00000111664 | nan | Night blindness, congenital stationary, type 1H, 617024 (3), Autosomal recessive; {Hypertension, essential, susceptibility to}, 145500 (3), Multifactorial
chr12	CDCA3	607749.0 | CDCA3, TOME1 | Cell division cycle-associated protein 3 | 83461.0 | ENSG00000111665 | nan | nan
chr12	USP5	601447.0 | USP5, ISOT | Ubiquitin-specific protease-5 (ubiquitin isopeptidase T) | 8078.0 | ENSG00000111667 | nan | nan
chr12	TPI1	190450.0 | TPI1, TPID | Triosephosphate isomerase-1 | 7167.0 | ENSG00000111669 | nan | Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3), Autosomal recessive
chr12	SPSB2	611658.0 | SPSB2, SSB2 | SPRY domain- and SOCS box-containing 2 | 84727.0 | ENSG00000111671 | nan | nan
chr12	LRRC23	620708.0 | LRRC23, SPGF92 | Leucine-rich repeat-containing protein 23 | 10233.0 | ENSG00000010626 | nan | Spermatogenic failure 92, 620848 (3), Autosomal recessive
chr12	ENO2	131360.0 | ENO2 | Enolase-2, gamma, neuronal | 2026.0 | ENSG00000111674 | nan | nan
chr12	ATN1	607462.0 | ATN1, DRPLA, HRS, NOD, CHEDDA | Atrophin 1 | 1822.0 | ENSG00000111676 | nan | Dentatorubral-pallidoluysian atrophy, 125370 (3), Autosomal dominant; Congenital hypotonia, epilepsy, developmental delay, and digital anomalies, 618494 (3), Autosomal dominant
chr12	C12orf57	615140.0 | C12orf57, C10, TEMTYS | Chromosome 12 open reading frame 57 | 113246.0 | ENSG00000111678 | nan | Temtamy syndrome, 218340 (3), Autosomal recessive
chr12	RNU7-1	617876.0 | RNU7-1, RNU7, AGS9 | RNA, U7 small nuclear, 1 | 100147744.0 | ENSG00000238923 | nan | Aicardi-Goutieres syndrome 9, 619487 (3), Autosomal recessive
chr12	PTPN6	176883.0 | PTPN6 | Protein tyrosine phosphatase, nonreceptor-type, 6 | 5777.0 | ENSG00000111679 | nan | nan
chr12	MIR200C	612092.0 | MIR200C, MIRN200C | Micro RNA 200C | 406985.0 | ENSG00000207713 | nan | nan
chr12	MIR141	612093.0 | MIR141, MIRN141 | Micro RNA 141 | 406933.0 | ENSG00000207708 | nan | nan
chr12	PHB2	610704.0 | PHB2, REA | Prohibitin 2 | 11331.0 | ENSG00000215021 | nan | nan
chr12	SCARNA12	615642.0 | SCARNA12 | Small Cajal body-specific RNA 12 | 677777.0 | ENSG00000238795 | nan | nan
chr12	EMG1	611531.0 | EMG1, NEP1, C2F, BWCNS | EMG1 N1-specific pseudouridine methyltransferase | 10436.0 | ENSG00000126749 | nan | Bowen-Conradi syndrome, 211180 (3), Autosomal recessive
chr12	LPCAT3	611950.0 | LPCAT3, MBOAT5, NESSY | Lysophosphatidylcholine acyltransferase 3 | 10162.0 | ENSG00000111684 | nan | nan
chr12	C1S	120580.0 | C1S, EDSPD2 | Complement component-1, s subcomponent | 716.0 | ENSG00000182326 | nan | C1s deficiency, 613783 (3); Ehlers-Danlos syndrome, periodontal type, 2, 617174 (3), Autosomal dominant
chr12	C1R	613785.0 | C1R, EDSPD1 | Complement component-1, r subcomponent | 715.0 | ENSG00000159403 | nan | Ehlers-Danlos syndrome, periodontal type, 1, 130080 (3), Autosomal dominant
chr12	C1RL	608974.0 | C1RL, CLSPA, C1RLP | Complement component C1r-like protein | 51279.0 | ENSG00000139178 | nan | nan
chr12	RBP5	611866.0 | RBP5, CRBP3 | Retinol-binding protein 5 | 83758.0 | ENSG00000139194 | nan | nan
chr12	CLSTN3	611324.0 | CLSTN3, KIAA0726 | Calsyntenin 3 | 9746.0 | ENSG00000139182 | nan | nan
chr12	PEX5	600414.0 | PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5 | Peroxisome biogenesis factor 5 | 5830.0 | ENSG00000139197 | nan | Peroxisome biogenesis disorder 2B, 202370 (3), Autosomal recessive; Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3), Autosomal recessive; Rhizomelic chondrodysplasia punctata, type 5, 616716 (3), Autosomal recessive
chr12	ACSM4	614360.0 | ACSM4 | Acyl-CoA synthetase medium-chain family, member 4 | 341392.0 | ENSG00000215009 | nan | nan
chr12	CD163L1	606079.0 | CD164L1, CD163B, M160 | CD164 antigen-like 1 | 283316.0 | ENSG00000177675 | nan | nan
chr12	CD163	605545.0 | CD163 | CD163 antigen (hemoglobin scavenger receptor) | 9332.0 | ENSG00000177575 | nan | nan
chr12	APOBEC1	600130.0 | APOBEC1, BEDP | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | 339.0 | ENSG00000111701 | nan | nan
chr12	GDF3	606522.0 | GDF3, KFS3, MCOPCB6, MCOP7 | Growth differentiation factor 3 | 9573.0 | ENSG00000184344 | nan | Klippel-Feil syndrome 3, autosomal dominant, 613702 (3); Microphthalmia, isolated, with coloboma 6, 613703 (3), Autosomal dominant; Microphthalmia, isolated 7, 613704 (3), Autosomal dominant
chr12	DPPA3	608408.0 | DPPA3 | Developmental pluripotency-associated gene 3 | 359787.0 | ENSG00000187569 | nan | nan
chr12	CLEC4C	606677.0 | CLEC4C, CLECSF11, DLEC, BDCA2 | C-type lectin domain family 4, member C | 170482.0 | ENSG00000198178 | nan | nan
chr12	NANOGNB	620692.0 | NANOGNB | NANOG enighbor homeobox | 360030.0 | ENSG00000205857 | nan | nan
chr12	NANOG	607937.0 | NANOG | NANOG homeobox | 79923.0 | ENSG00000111704 | nan | nan
chr12	SLC2A14	611039.0 | SLC2A14, GLUT14 | Solute carrier family 2 (facilitated glucose transporter), member 14 | 144195.0 | ENSG00000173262 | nan | nan
chr12	SLC2A3	138170.0 | SLC2A3, GLUT3 | Solute carrier family 2 (facilitated glucose transporter), member 3 | 6515.0 | ENSG00000059804 | pseudogene SLC2A3P on 5q34 | nan
chr12	FOXJ2	619162.0 | FOXJ2, FHX | Forkhead box J2 | 55810.0 | ENSG00000065970 | nan | nan
chr12	C3AR1	605246.0 | C3AR1, C3AR | Complement component 3a receptor 1 | 719.0 | ENSG00000171860 | nan | nan
chr12	NECAP1	611623.0 | NECAP1, DEE21 | NECAP endocytosis-associated protein 1 | 25977.0 | ENSG00000089818 | nan | Developmental and epileptic encephalopathy 21, 615833 (3), Autosomal recessive
chr12	CLEC4A	605306.0 | CLEC4A, CLECSF6, DCIR, DDB27 | C-type lectin domain family 4, member A | 50856.0 | ENSG00000111729 | nan | nan
chr12	FAM90A1	613041.0 | FAM90A1 | Family with sequence similarity 90, member A1 | 55138.0 | ENSG00000171847 | other family members on chr. 8 | nan
chr12	CLEC6A	613579.0 | CLEC6A, CLEC4N | C-type lectin domain family 6, member A | 93978.0 | ENSG00000205846 | nan | nan
chr12	CLEC4D	609964.0 | CLEC4D, CLECSF8, CLEC6 | C-type lectin domain family 4, member D | 338339.0 | ENSG00000166527 | nan | nan
chr12	CLEC4E	609962.0 | CLEC4E, MINCLE | C-type lectin domain family 4, member E | 26253.0 | ENSG00000166523 | nan | nan
chr12	AICDA	605257.0 | AICDA, AID, HIGM2 | Activation-induced cytidine deaminase | 57379.0 | ENSG00000111732 | nan | Immunodeficiency with hyper-IgM, type 2, 605258 (3), Autosomal recessive
chr12	MFAP5	601103.0 | MFAP5, MAGP2, AAT9 | Microfibril-associated protein 5 | 8076.0 | ENSG00000197614 | nan | Aortic aneurysm, familial thoracic 9, 616166 (3), Autosomal dominant
chr12	RIMKLB	614054.0 | RIMKLB, NAAGS | Ribosomal modification protein RimK-like family, member B | 57494.0 | ENSG00000166532 | nan | nan
chr12	A2ML1	610627.0 | A2ML1, OMS | Alpha-2-macroglobulin-like 1 | 144568.0 | ENSG00000166535 | nan | {Otitis media, susceptibility to}, 166760 (3), Autosomal dominant
chr12	PHC1	602978.0 | PHC1, EDR1, HPH1, RAE28, MCPH11 | Polyhomeotic-like 1 | 1911.0 | ENSG00000111752 | mutations identified in 1 family | ?Microcephaly 11, primary, autosomal recessive, 615414 (3), Autosomal recessive
chr12	M6PR	154540.0 | M6PR | Mannose-6-phosphate receptor, cation-dependent | 4074.0 | ENSG00000003056 | nan | nan
chr12	KLRG1	604874.0 | KLRG1, MAFA, MAFAL | Killer cell lectin-like receptor, subfamily G, member 1 | 10219.0 | ENSG00000139187 | nan | nan
chr12	A2M	103950.0 | A2M | Alpha-2-macroglobulin | 2.0 | ENSG00000175899 | cluster of genes | nan
chr12	PZP	176420.0 | PZP | Pregnancy zone protein | 5858.0 | ENSG00000126838 | nan | nan
chr12	KLRB1	602890.0 | KLRB1, NKRP1A | Killer cell lectin-like receptor, subfamily B, member 1 | 3820.0 | ENSG00000111796 | nan | nan
chr12	CLEC2D	605659.0 | CLEC2D, LLT1 | C-type lectin domain family 2, member D | 29121.0 | ENSG00000069493 | nan | nan
chr12	CLECL1P	607467.0 | CLECL1, DCAL1 | C-type lectin-like 1 | 160365.0 | nan | nan | nan
chr12	CD69	107273.0 | CD69 | CD69 antigen (p60, early T-cell activation antigen) | 969.0 | ENSG00000110848 | nan | nan
chr12	KLRF1	605029.0 | KLRF1 | Killer cell lectin-like receptor, subfamily F, member 1 | 51348.0 | ENSG00000150045 | nan | nan
chr12	CLEC2B	603242.0 | CLEC2B, CLECSF2, AICL | C-type lectin domain family 2, member B | 9976.0 | ENSG00000110852 | nan | nan
chr12	CLEC2A	612087.0 | CLEC2A | C-type lectin domain family 2, member A | 387836.0 | ENSG00000188393 | nan | nan
chr12	KLRF2	618814.0 | KLRF2 | Killer cell lectin-like receptor F2 | 100431172.0 | ENSG00000256797 | nan | nan
chr12	CLEC12A	612088.0 | CLEC12A, MICL | C-type lectin domain family 12, member A | 160364.0 | ENSG00000172322 | nan | nan
chr12	CLEC1B	606783.0 | CLEC2B, CLEC2 | C-type lectin domain family 1, member B | 51266.0 | ENSG00000165682 | nan | nan
chr12	DFNB62	610143.0 | DFNB62 | Deafness, autosomal recessive 62 | 692220.0 | nan | between D12S358 and D12S1042 | Deafness, autosomal recessive 62, 610143 (2), Autosomal recessive
chr12	IBD2	601458.0 | IBD2 | Inflammatory bowel disease 2 | 3378.0 | nan | mainly ulcerative colitis | {Inflammatory bowel disease 2}, 601458 (2)
chr12		168710.0 | PCS | Parotid proline-rich salivary protein Pc | nan | nan | linked to PRB2 | nan
chr12	TAS2R45	613967.0 | TAS2R45, T2R45 | Taste receptor, type 2, member 45 | 259291.0 | nan | nan | nan
chr12	CLEC12B	617573.0 | CLEC12B | C-type lectin domain family 12, member B | 387837.0 | ENSG00000256660 | nan | nan
chr12	CLEC9A	612252.0 | CLEC9A, DNGR1 | C-type lectin domain family 9, member A | 283420.0 | ENSG00000197992 | nan | nan
chr12	CLEC1A	606782.0 | CLEC1A, CLEC1 | C-type lectin domain family 1, member A | 51267.0 | ENSG00000150048 | nan | {Aspergillosis, susceptibility to}, 614079 (3)
chr12	CLEC7A	606264.0 | CLEC7A, CLECSF12, DECTIN1, CANDF4 | C-type lectin domain family 7, member A | 64581.0 | ENSG00000172243 | in natural killer gene complex | Candidiasis, familial, 4, autosomal recessive, 613108 (3), Autosomal recessive; {Aspergillosis, susceptibility to}, 614079 (3)
chr12	OLR1	602601.0 | OLR1, LOX1 | Low density lipoprotein, oxidized, receptor 1 | 4973.0 | ENSG00000173391 | nan | {Myocardial infarction, susceptibility to}, 608446 (3)
chr12	GABARAPL1	607420.0 | GABARAPL1, GEC1 | GABA-A receptor-associated protein-like protein 1 | 23710.0 | ENSG00000139112 | nan | nan
chr12	KLRD1	602894.0 | KLRD1, CD94 | Killer cell lectin-like receptor, subfamily D, member 1 | 3824.0 | ENSG00000134539 | nan | nan
chr12	KLRK1	611817.0 | KLRK1, NKG2D | Kill cell lectin-like receptor, subfamily K, member 1 | 22914.0 | ENSG00000213809 | nan | nan
chr12	KLRC4	602893.0 | KLRC4, NKG2F, D12S2489E | Killer cell lectin-like receptor, subfamily C, member 4 | 8302.0 | ENSG00000183542 | nan | nan
chr12	KLRC3	602892.0 | KLRC3, NKG2E | Killer cell lectin-like receptor, subfamily C, member 3 | 3823.0 | ENSG00000205810 | nan | nan
chr12	KLRC2	602891.0 | KLRC2, NKG2C | Killer cell lectin-like receptor, subfamily C, member 2 | 3822.0 | ENSG00000205809 | nan | nan
chr12	KLRC1	161555.0 | KLRC1, NKG2, NKG2A | Killer cell lectin-like receptor, subfamily C, member 1 | 3821.0 | ENSG00000134545 | family of at least 3 genes on 12 | nan
chr12	KLRA1P	604274.0 | KLRA1P, KLRA1, LY49L | Killer cell lectin like receptor A1, pseudogene | 10748.0 | nan | ?functional | nan
chr12	MAGOHB	619552.0 | MAGOHB | MAGO homolog B, exon junction complex subunit | 55110.0 | ENSG00000111196 | nan | nan
chr12	STYK1	611433.0 | STYK1, NOK | Serine/threonine/tyrosine kinase 1 | 55359.0 | ENSG00000060140 | nan | nan
chr12	YBX3	603437.0 | YBX3, CSDA, DBPA | Y-box binding protein 3 | 8531.0 | ENSG00000060138 | nan | nan
chr12	TAS2R7	604793.0 | TRB4, T2R7 | Taste receptor, family B, member 4 | 50837.0 | ENSG00000121377 | nan | nan
chr12	TAS2R8	604794.0 | TRB5, T2R8 | Taste receptor, family B, member 5 | 50836.0 | ENSG00000121314 | nan | nan
chr12	TAS2R9	604795.0 | TRB6, T2R9 | Taste receptor, family B, member 6 | 50835.0 | ENSG00000121381 | nan | nan
chr12	TAS2R10	604791.0 | TRB2, T2R10 | Taste receptor, family B, member 2 | 50839.0 | ENSG00000121318 | nan | nan
chr12	PRR4	605359.0 | PROL4, LPRP | Proline rich 4, lacrimal | 11272.0 | ENSG00000111215 | nan | nan
chr12	PRH1	168730.0 | PRH1 | Proline-rich protein HaeIII, subfamily-1 | 5554.0 | ENSG00000231887 | Pa, Db, PIF alleles | nan
chr12	TAS2R13	604792.0 | TRB3, T2R13 | Taste receptor, family B, member 3 | 50838.0 | ENSG00000212128 | nan | nan
chr12	PRH2	168790.0 | PRH2 | Proline-rich protein HaeIII, subfamily-2 | 5555.0 | ENSG00000134551 | Pr allele | nan
chr12	TAS2R14	604790.0 | TRB1, T2R14 | Taste receptor, family B, member 1 | 50840.0 | ENSG00000212127 | nan | nan
chr12	TAS2R50	609627.0 | TAS2R50, T2R50, TAS2R51, T2R51 | Taste receptor, type 2, member 50 | 259296.0 | ENSG00000212126 | nan | nan
chr12	TAS2R20	613962.0 | TAS2R20, T2R56 | Taste receptor, type 2, member 20 | 259295.0 | ENSG00000255837 | nan | nan
chr12	TAS2R19	613961.0 | TAS2R19, T2R19, T2R48 | Taste receptor, type 2, member 19 | 259294.0 | ENSG00000212124 | nan | nan
chr12	TAS2R31	612669.0 | TAS2R31, TAS2R44, T2R53 | Taste receptor, type 2, member 31 | 259290.0 | ENSG00000256436 | nan | nan
chr12	TAS2R46	612774.0 | TAS2R46, T2R46, T2R54 | Taste receptor, type 2, member 46 | 259292.0 | ENSG00000226761 | nan | nan
chr12	TAS2R43	612668.0 | TAS2R43, T2R52 | Taste receptor, type 2, member 43 | 259289.0 | ENSG00000255374 | nan | nan
chr12	TAS2R30	613963.0 | TAS2R30, T2R30, T2R47 | Taste receptor, type 2, member 30 | 259293.0 | ENSG00000256188 | previously assigned to chr.1 | nan
chr12	TAS2R42	613966.0 | TAS2R42, T2R42, T2R55 | Taste receptor, type 2, member 42 | 353164.0 | ENSG00000186136 | nan | nan
chr12	PRB3	168840.0 | PRB3 | Proline-rich protein BstNI, subfamily-3 (parotid salivary glycoprotein) | 5544.0 | ENSG00000197870 | G1 allele | nan
chr12	PRB4	180990.0 | PRB4 | Proline-rich protein BstNI, subfamily-4 | 5545.0 | ENSG00000230657 | Po, CON1, CON2 alleles | nan
chr12	PRB1	180989.0 | PRB1 | Proline-rich protein BstNI, subfamily-1 | 5542.0 | ENSG00000251655 | nan | nan
chr12	PRB2	168810.0 | PRB2 | Proline-rich protein BstNI, subfamily-2 (parotid size variant) | 653247.0 | ENSG00000121335 | Ps allele | nan
chr12	ETV6	600618.0 | ETV6, TEL, THC5 | ETS variant transcription factor 6 | 2120.0 | ENSG00000139083 | fused to PDGFRB or AML1 in leukemia | Thrombocytopenia 5, 616216 (3), Autosomal dominant; Leukemia, acute myeloid, somatic, 601626 (3)
chr12	BCL2L14	606126.0 | BCL2L14, BCLG | BCL2-like 14 | 79370.0 | ENSG00000121380 | nan | nan
chr12	LRP6	603507.0 | LRP6, ADCAD2, STHAG7 | Low density lipoprotein receptor-related protein 6 | 4040.0 | ENSG00000070018 | nan | {Coronary artery disease, autosomal dominant, 2}, 610947 (3), Autosomal dominant; Tooth agenesis, selective, 7, 616724 (3), Autosomal dominant
chr12	BORCS5	616598.0 | BORCS5, LOH12CR1, MYRLYSIN | BLOC1-related complex, subunit 5 | 118426.0 | ENSG00000165714 | nan | nan
chr12	DUSP16	607175.0 | DUSP16, MKP7, KIAA1700 | Dual-specificity phosphatase 16 | 80824.0 | ENSG00000111266 | nan | nan
chr12	CREBL2	603476.0 | CREBL2 | Cyclic AMP response element-binding protein-like 2 | 1389.0 | ENSG00000111269 | nan | nan
chr12	GPR19	602927.0 | GPR19 | G protein-coupled receptor-19 | 2842.0 | ENSG00000183150 | nan | nan
chr12	CDKN1B	600778.0 | CDKN1B, KIP1, CDKN4, MEN4 | Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 1027.0 | ENSG00000111276 | nan | Multiple endocrine neoplasia, type IV, 610755 (3), Autosomal dominant
chr12	APOLD1	612456.0 | APOLD1, VERGE, BDVAS | Apolipoprotein L domain-containing 1 | 81575.0 | ENSG00000178878 | mutation identified in 1 BDVAS family | ?Bleeding disorder, vascular-type, 620715 (3), Autosomal dominant
chr12	DDX47	615428.0 | DDX47 | DEAD-box helicase 47 | 51202.0 | ENSG00000213782 | nan | nan
chr12	GPRC5A	604138.0 | GPRC5A, RAI3, RAIG1 | G protein-coupled receptor, family C, group 5, member A | 9052.0 | ENSG00000013588 | nan | nan
chr12	GPRC5D	607437.0 | GPRC5D | G protein-coupled receptor, family C, group 5, member D | 55507.0 | ENSG00000111291 | nan | nan
chr12	HEBP1	605826.0 | HEBP1, HBP | Heme-binding protein 1 | 50865.0 | ENSG00000013583 | nan | nan
chr12	FAM234B	617838.0 | FAM234B, KIAA1467 | Family with sequence similarity 234, member B | 57613.0 | ENSG00000084444 | nan | nan
chr12	EMP1	602333.0 | EMP1, TMP | Epithelial membrane protein-1 | 2012.0 | ENSG00000134531 | nan | nan
chr12	GRIN2B	138252.0 | GRIN2B, NMDAR2B, MRD6, DEE27 | Glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 2904.0 | ENSG00000273079 | nan | Developmental and epileptic encephalopathy 27, 616139 (3), Autosomal dominant; Intellectual developmental disorder, autosomal dominant 6, with or without seizures, 613970 (3), Autosomal dominant
chr12	GNAI2P1	139180.0 | GNAI2P1, GNAI2L, GNAI2A | Guanine nucleotide-binding protein (G protein), alpha-inhibiting, polypeptide 2 pseudogene 1 | 2772.0 | nan | nan | nan
chr12	ATF7IP	613644.0 | ATF7IP, AM, MCAF, MCAF1 | Activating transcription factor 7-interacting protein | 55729.0 | ENSG00000171681 | nan | nan
chr12	PLBD1	618486.0 | PLBD1 | Phospholipase B domain-containing protein 1 | 79887.0 | ENSG00000121316 | nan | nan
chr12	GUCY2C	601330.0 | GUCY2C, GUC2C, DIAR6, MECIL | Guanylate cyclase 2C (heat stable enterotoxin receptor) | 2984.0 | ENSG00000070019 | nan | Diarrhea 6, 614616 (3), Autosomal dominant; Meconium ileus, 614665 (3), Autosomal recessive
chr12	H4C16	615069.0 | H4-16, HIST4H4 | H4 histone 16 | 121504.0 | ENSG00000197837 | nan | nan
chr12	WBP11	618083.0 | WBP11, NPWBP, SIPP1, VCTERL | WW-binding protein 11 | 51729.0 | ENSG00000084463 | nan | Vertebral, cardiac, tracheoesophageal, renal, and limb defects, 619227 (3), Autosomal dominant
chr12	ART4	110600.0 | ART4, DO, DOK1 | ADP-ribosyltransferase-4 (Dombrock blood group) | 420.0 | ENSG00000111339 | nan | [Blood group, Dombrock], 616060 (3)
chr12	MGP	154870.0 | MGP | Matrix Gla protein | 4256.0 | ENSG00000111341 | nan | Keutel syndrome, 245150 (3), Autosomal recessive
chr12	ERP27	610642.0 | ERP27, C12orf46 | Endoplasmic reticulum protein, 27kD | 121506.0 | ENSG00000139055 | nan | nan
chr12	ARHGDIB	602843.0 | ARHGDIB, GDID4, D4 | Rho GDP dissociation inhibitor (GDI) beta | 397.0 | ENSG00000111348 | nan | nan
chr12	PDE6H	601190.0 | PDE6H, RCD3, ACHM6 | Phosphodiesterase 6H | 5149.0 | ENSG00000139053 | nan | Retinal cone dystrophy 3, 610024 (3), Autosomal recessive, Autosomal dominant; Achromatopsia 6, 610024 (3), Autosomal recessive, Autosomal dominant
chr12	RERG	612664.0 | RERG | Ras-like and estrogen-regulated growth inhibitor | 85004.0 | ENSG00000134533 | nan | nan
chr12	PTPRO	600579.0 | PTPRO, GLEPP1, NPHS6 | Protein tyrosine phosphatase, receptor type, O | 5800.0 | ENSG00000151490 | nan | Nephrotic syndrome, type 6, 614196 (3), Autosomal recessive
chr12	EPS8	600206.0 | EPS8, DFNB102 | Epidermal growth factor receptor pathway substrate-8 | 2059.0 | ENSG00000151491 | mutation identified in 1 DFNB102 family | ?Deafness, autosomal recessive 102, 615974 (3), Autosomal recessive
chr12	STRAP	605986.0 | STRAP, UNRIP, MAWD | Serine/threonine kinase receptor-associated protein | 11171.0 | ENSG00000023734 | previously assigned to 12q | nan
chr12	DERA	619668.0 | DERA, DEOC | Deoxyribose-phosphate aldolase | 51071.0 | ENSG00000023697 | nan | nan
chr12	SLC15A5	620324.0 | SLC15A5 | Solute carrier family 15, member 5 | 729025.0 | ENSG00000188991 | nan | nan
chr12	LMO3	180386.0 | LMO3, RBTNL2, RHOM3 | LIM domain only 3 (rhombotin-like 2) | 55885.0 | ENSG00000048540 | expressed mainly in brain | nan
chr12	MGST1	138330.0 | MGST1, GST12 | Microsomal glutathione S-transferase 1 | 4257.0 | ENSG00000008394 | pseudogene at 12q13-q14 | nan
chr12	SKP1P2	601435.0 | SKP1P2, SKP1B | S-phase kinase-associated protein 1 pseudogene 2 (p19B) | 728622.0 | nan | nan | nan
chr12	PIK3C2G	609001.0 | PIK3C2G | Phosphatidylinositol 3-kinase, class 2, gamma | 5288.0 | ENSG00000139144 | nan | nan
chr12	PLCZ1	608075.0 | PLCZ1, SPGF17 | Phospholipase C, zeta-1 | 89869.0 | ENSG00000139151 | nan | Spermatogenic failure 17, 617214 (3), Autosomal recessive
chr12	CAPZA3	608722.0 | CAPZA3, CAPPA3 | Capping protein, actin, alpha-3 | 93661.0 | ENSG00000177938 | nan | nan
chr12	PLEKHA5	607770.0 | PEPP2, KIAA1686 | Phosphatidylinositol 3-phosphate-binding PH domain protein 2 | 54477.0 | ENSG00000052126 | nan | nan
chr12	AEBP2	617934.0 | AEBP2 | AE-binding protein 2 | 121536.0 | ENSG00000139154 | nan | nan
chr12	HYT4	608742.0 | HYT4 | Hypertension, essential, susceptibility to, 4 | 444980.0 | nan | nan | {Hypertension, essential, susceptibility to, 4}, 145500 (2), Multifactorial
chr12	SLCO1B7	619875.0 | SLC01B7, SLC21A21, OATP1B7 | Solute carrier organic anion transporter family, member 1B7 | 338821.0 | nan | nan | nan
chr12	PDE3A	123805.0 | PDE3A, HTNB | Phosphodiesterase 3A, cGMP-inhibited | 5139.0 | ENSG00000172572 | nan | Hypertension and brachydactyly syndrome, 112410 (3), Autosomal dominant
chr12	SLCO1C1	613389.0 | SLCO1C1, OATPF, OATP14, SLC21A14 | Solute carrier organic anion transporter family, member 1C1 | 53919.0 | ENSG00000139155 | nan | nan
chr12	SLCO1B3	605495.0 | SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR | Solute carrier organic anion transporter family, member 1B3 | 28234.0 | ENSG00000111700 | HBLRR digenic with SLCO1B1 | Hyperbilirubinemia, Rotor type, digenic, 237450 (3), Digenic recessive
chr12	SLCO1B1	604843.0 | SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR | Solute carrier organic anion transporter family, member 1B1 | 10599.0 | ENSG00000134538 | HBLRR digenic with SLCO1B3 | Hyperbilirubinemia, Rotor type, digenic, 237450 (3), Digenic recessive
chr12	SLCO1A2	602883.0 | SLC21A3, OATP | Solute carrier family 21 (organic anion transporter), member 3 | 6579.0 | ENSG00000084453 | nan | nan
chr12	IAPP	147940.0 | IAPP | Islet amyloid polypeptide (diabetes-associated peptide; amylin) | 3375.0 | ENSG00000121351 | nan | nan
chr12	PYROXD1	617220.0 | PYROXD1, MFM8 | Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 | 79912.0 | ENSG00000121350 | nan | Myopathy, myofibrillar, 8, 617258 (3), Autosomal recessive
chr12	RECQL	600537.0 | RECQL, RECQL1, RECON | RecQ helicase-like (DNA helicase, RecQ-like 1) | 5965.0 | ENSG00000004700 | nan | RECON progeroid syndrome, 620370 (3), Autosomal recessive
chr12	GOLT1B	615078.0 | GOLT1B, GOT1B, GCT2 | Golgi transport 1B | 51026.0 | ENSG00000111711 | nan | nan
chr12	SPX	619246.0 | SPX, C12orf39 | Spexin hormone | 80763.0 | ENSG00000134548 | nan | nan
chr12	GYS2	138571.0 | GYS2 | Glycogen synthase-2, liver | 2998.0 | ENSG00000111713 | nan | Glycogen storage disease 0, liver, 240600 (3), Autosomal recessive
chr12	LDHB	150100.0 | LDHB, LDHBD | Lactate dehydrogenase B | 3945.0 | ENSG00000111716 | nan | [Lactate dehydrogenase-B deficiency], 614128 (3)
chr12	KCNJ8	600935.0 | KCNJ8 | Potassium inwardly-rectifying channel, subfamily J, member 8 | 3764.0 | ENSG00000121361 | nan | nan
chr12	ABCC9	601439.0 | ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS | ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2) | 10060.0 | ENSG00000069431 | mutation identified in 1 ATFB12 patient | Cardiomyopathy, dilated, 1O, 608569 (3), Autosomal dominant; Hypertrichotic osteochondrodysplasia (Cantu syndrome), 239850 (3), Autosomal dominant; ?Atrial fibrillation, familial, 12, 614050 (3), Autosomal dominant; Intellectual disability and myopathy syndrome, 619719 (3), Autosomal recessive
chr12	CMAS	603316.0 | CMAS | Cytidine monophosphate N-acetylneuraminic acid synthetase | 55907.0 | ENSG00000111726 | nan | nan
chr12	ST8SIA1	601123.0 | SIAT8 | Sialyltransferase-8 (alpha-N-acetylneuraminate: alpha-2,8-sialyltransferase, GD3 synthase) | 6489.0 | ENSG00000111728 | nan | nan
chr12	C2CD5	618044.0 | C2CD5, CDP138, KIAA0528 | C2 calcium-dependent domain-containing protein 5 | 9847.0 | ENSG00000111731 | nan | nan
chr12	ETNK1	609858.0 | ETNK1, EKI1 | Ethanolamine kinase 1 | 55500.0 | ENSG00000139163 | nan | nan
chr12	SOX5	604975.0 | SOX5, LAMSHF | SRY-box 5 | 6660.0 | ENSG00000134532 | some LAMSHF patients have 12p12 deletions | Lamb-Shaffer syndrome, 616803 (3), Autosomal dominant
chr12	BCAT1	113520.0 | BCAT1, BCT1 | Branched chain aminotransferase-1, cytosolic | 586.0 | ENSG00000060982 | nan | nan
chr12	DAD1P1	609860.0 | DADR | DAD1-related gene | 56286.0 | nan | nan | nan
chr12	IRAG2	602003.0 | LRMP, JAW1 | Lymphoid-restricted membrane protein | 4033.0 | ENSG00000118308 | nan | nan
chr12	DNAI7	616906.0 | CASC1, LAS1, PPP1R54 | Cancer susceptibility candidate 1 | 55259.0 | ENSG00000118307 | nan | nan
chr12	KRAS	190070.0 | KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES | KRAS protooncogene, GTPase | 3845.0 | ENSG00000133703 | pseudogene KRAS1P on 6p12-p11 | Gastric cancer, somatic, 613659 (3); Oculoectodermal syndrome, somatic, 600268 (3); Breast cancer, somatic, 114480 (3); Noonan syndrome 3, 609942 (3), Autosomal dominant; RAS-associated autoimmune leukoproliferative disorder, 614470 (3), Autosomal dominant; Arteriovenous malformation of the brain, somatic, 108010 (3); Lung cancer, somatic, 211980 (3); Pancreatic carcinoma, somatic, 260350 (3); Leukemia, acute myeloid, somatic, 601626 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Cardiofaciocutaneous syndrome 2, 615278 (3), Autosomal dominant; Bladder cancer, somatic, 109800 (3)
chr12	LMNTD1	617254.0 | LMNTD1, IFLTD1, LMNARS1, PAS1C1 | Lamin tail domain-containing protein 1 | 160492.0 | ENSG00000152936 | nan | nan
chr12	RASSF8	608231.0 | RASSF8, C12orf2 | Ras association domain family, member 8 | 11228.0 | ENSG00000123094 | nan | nan
chr12	BHLHE41	606200.0 | BHLHE41, BHLHB3, DEC2, SHARP1, FNSS1 | Basic helix-loop-helix domain-containing protein, member E41 | 79365.0 | ENSG00000123095 | nan | [Short sleep, familial natural, 1], 612975 (3), Autosomal dominant
chr12	SSPN	601599.0 | SSPN, KRAG | Sarcospan (Kirsten-ras associated gene) | 8082.0 | ENSG00000123096 | nan | nan
chr12	AD5	602096.0 | AD5 | Alzheimer disease, familial, type 5 | 8081.0 | nan | nan | Alzheimer disease-5, 602096 (2), Autosomal dominant
chr12	ARCI7	615022.0 | ARCI7 | Ichthyosis, congenital, autosomal recessive 7 | 101202686.0 | nan | between D12S345 and D12S390 | Ichthyosis, congenital, autosomal recessive 7, 615022 (2), Autosomal recessive
chr12	STQTL3	606257.0 | STQTL3 | Stature quantitative trait locus 3 | 282549.0 | nan | max lod at D12S398 and D12S10990 | {Stature QTL 3}, 606257 (2)
chr12	VUR7	615390.0 | VUR7 | Vesicoureteral reflux 7 | 102095631.0 | nan | max lod at D12S1048 | Vesicoureteral reflux 7, 615390 (2)
chr12	ITPR2	600144.0 | ITPR2, ANHD | Inositol 1,4,5-triphosphate receptor, type 2 | 3709.0 | ENSG00000123104 | mutation has been identified in 1 ANHD family | ?Anhidrosis, isolated, with normal sweat glands, 106190 (3), Autosomal recessive
chr12	INTS13	615079.0 | INTS13, ASUN, MAT89BB, GCT1 | Integrator complex subunit 13 | 55726.0 | ENSG00000064102 | nan | nan
chr12	FGFR1OP2	608858.0 | FGFR1OP2 | Fibroblase growth factor receptor 1 oncogene partner 2 | 26127.0 | ENSG00000111790 | nan | nan
chr12	TM7SF3	605181.0 | TM7SF3 | Transmembrane 7 superfamily, member 3 | 51768.0 | ENSG00000064115 | nan | nan
chr12	MED21	603800.0 | MED21, SURB7, SRB7 | Mediator complex subunit 21 | 9412.0 | ENSG00000152944 | nan | nan
chr12	STK38L	615836.0 | STK38L, NDR2, KIAA0965 | Serine/threonine protein kinase 38-like protein | 23012.0 | ENSG00000211455 | nan | nan
chr12	BMAL2	614517.0 | ARNTL2, BMAL2, CLIF | Aryl hydrocarbon receptor nuclear translocator-like protein 2 | 56938.0 | ENSG00000029153 | nan | nan
chr12	PPFIBP1	603141.0 | PPFIBP1, NEDSMBA | PPFIA-binding protein 1 | 8496.0 | ENSG00000110841 | nan | Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities, 620024 (3), Autosomal recessive
chr12	REP15	610848.0 | REP15 | Rab15 effector protein | 387849.0 | ENSG00000174236 | nan | nan
chr12	MRPS35	611995.0 | MRPS35, MRPS28 | Mitochondrial ribosomal protein S35 | 60488.0 | ENSG00000061794 | 3 pseudogenes | nan
chr12	KLHL42	618919.0 | KLHL42, KLHDC5, CTB9 | Kelch-like family, member 42 | 57542.0 | ENSG00000087448 | nan | nan
chr12	PTHLH	168470.0 | PTHLH, BDE2 | Parathyroid hormone-like hormone | 5744.0 | ENSG00000087494 | nan | Brachydactyly, type E2, 613382 (3), Autosomal dominant
chr12	CCDC91	617366.0 | CCDC91 | Coiled-coil domain-containing protein 91 | 55297.0 | ENSG00000123106 | nan | nan
chr12	FAR2	616156.0 | FAR2, MLSTD1 | Fatty acyl CoA reductase 2 | 55711.0 | ENSG00000064763 | nan | nan
chr12	ERGIC2	612236.0 | ERGIC2, CDA14, PTX1 | Endoplasmic reticulum-golgi intermediate compartment protein 2 | 51290.0 | ENSG00000087502 | nan | nan
chr12	TMTC1	615855.0 | TMTC1 | Transmembrane and tetratricopeptide repeat domains-containing protein 1 | 83857.0 | ENSG00000133687 | nan | nan
chr12	IPO8	605600.0 | IPO8, RANBP8, VISS | Importin 8 | 10526.0 | ENSG00000133704 | nan | VISS syndrome, 619472 (3), Autosomal recessive
chr12	CAPRIN2	610375.0 | CAPRIN2, C1QDC1, EEG1, KIAA1873 | Caprin family, member 2 | 65981.0 | ENSG00000110888 | nan | nan
chr12	LINC00941	620799.0 | LINC00941 | Long intergenic noncoding RNA 941 | 100287314.0 | ENSG00000285517 | nan | nan
chr12	DDX11	601150.0 | DDX11, CHLR1, KRG2 | DEAD/H-box helicase 11 | 1663.0 | ENSG00000013573 | nan | Warsaw breakage syndrome, 613398 (3), Autosomal recessive
chr12	SINHCAF	615027.0 | SINHCAF, FAM60A | SIN3-HDAC complex associated factor | 58516.0 | ENSG00000139146 | nan | nan
chr12	DENND5B	617279.0 | DENND5B | DENN domain-containing protein 5B | 160518.0 | ENSG00000170456 | nan | nan
chr12	ETFBKMT	615256.0 | ETFBKMT, METTL20, C12orf72 | Electron transfer flavoprotein beta-subunit lysine methyltransferase | 254013.0 | ENSG00000139160 | nan | nan
chr12	AMN1	620564.0 | AMN1 | Antongonist of mitotic exit network 1 | 196394.0 | ENSG00000151743 | nan | nan
chr12	H3-5	616134.0 | H3-5, H3F3C | H3.5 histone | 440093.0 | ENSG00000188375 | nan | nan
chr12	RESF1	615621.0 | RESF1, GET, KIAA1551, C12orf35 | Retroelement silencing factor 1 | 55196.0 | ENSG00000174718 | nan | nan
chr12	BICD1	602204.0 | BICD1 | BICD cargo adaptor 1 | 636.0 | ENSG00000151746 | nan | nan
chr12	FGD4	611104.0 | FGD4, FRABIN, CMT4H | FYVE, RhoGEF, and PH domain-containing protein 4 | 121512.0 | ENSG00000139132 | nan | Charcot-Marie-Tooth disease, type 4H, 609311 (3), Autosomal recessive
chr12	DNM1L	603850.0 | DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5 | Dynamin 1-like | 10059.0 | ENSG00000087470 | nan | Optic atrophy 5, 610708 (3), Autosomal dominant; Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1, 614388 (3), Autosomal recessive, Autosomal dominant
chr12	YARS2	610957.0 | YARS2, TYRRS, MLASA2 | Tyrosyl-tRNA synthetase 2 | 51067.0 | ENSG00000139131 | nan | Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3), Autosomal recessive
chr12	PKP2	602861.0 | PKP2, ARVD9 | Plakophilin-2 | 5318.0 | ENSG00000057294 | pseudogene on 12p13 | Arrhythmogenic right ventricular dysplasia 9, 609040 (3), Autosomal dominant
chr12	ALG10	618355.0 | ALG10, ALG10A | ALG10 alpha-1,2-glucosyltransferase | 84920.0 | ENSG00000139133 | nan | nan
chr12		179010.0 | IHPS1, IHPS | Pyloric stenosis, infantile hypertrophic 1 | nan | nan | nan | Pyloric stenosis, infantile hypertrophic 1, 179010 (2), Multifactorial, Autosomal dominant
chr12	RLS1	102300.0 | RLS1 | Restless legs syndrome, susceptibility to, 1 | 192142.0 | nan | between D12S1044 and D12S78 | {Restless legs syndrome 1}, 102300 (2), Autosomal dominant
chr12	ALG10B	603313.0 | ALG10B, KCR1, ALG10 | ALG10 alpha-1,2-glucosyltransferase B | 144245.0 | ENSG00000175548 | nan | {Long QT syndrome, acquired, reduced susceptibility to}, 613688 (3), Autosomal dominant
chr12	KIF21A	608283.0 | KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B | Kinesin family member 21A | 55605.0 | ENSG00000139116 | nan | Fibrosis of extraocular muscles, congenital, 3B, 135700 (3), Autosomal dominant; Fibrosis of extraocular muscles, congenital, 1, 135700 (3), Autosomal dominant
chr12	ABCD2	601081.0 | ABCD2, ALDR, ALDL1 | ATP-binding cassette, subfamily D, member 2 | 225.0 | ENSG00000173208 | nan | nan
chr12	REDIC1	620495.0 | C12orf40, HEIP1 | Chromosome 12 open reading frame 40 | 283461.0 | ENSG00000180116 | nan | nan
chr12	SLC2A13	611036.0 | SLC2A13, HMIT | Solute carrier family 2 (facilitated glucose transporter), member 13 | 114134.0 | ENSG00000151229 | nan | nan
chr12	LRRK2	609007.0 | LRRK2, PARK8 | Leucine-rich repeat kinase 2 (dardarin) | 120892.0 | ENSG00000188906 | nan | {Parkinson disease 8}, 607060 (3), Autosomal dominant
chr12	MUC19	612170.0 | MUC19 | Mucin 19, oligomeric | 283463.0 | ENSG00000205592 | nan | nan
chr12	CNTN1	600016.0 | CNTN1, CMYO12 | Contactin 1 | 1272.0 | ENSG00000018236 | nan | Congenital myopathy 12, 612540 (3), Autosomal recessive
chr12	PDZRN4	609730.0 | PDZRN4 | PDZ domain-containing ring finger protein 4 | 29951.0 | ENSG00000165966 | nan | nan
chr12	GXYLT1	613321.0 | GXYLT1, GLT8D3 | Glucoside xylosyltransferase 1 | 283464.0 | ENSG00000151233 | nan | nan
chr12	YAF2	607534.0 | YAF2 | YY1-associated factor 2 | 10138.0 | ENSG00000015153 | nan | nan
chr12	ZCRB1	610750.0 | ZCRB1, MADP1 | Zinc finger CCHC domain- and RNA-binding motif-containing protein 1 | 85437.0 | ENSG00000139168 | possible pseudogenes on chr16, X, and 6 | nan
chr12	PPHLN1	608150.0 | PPHLN1 | Periphilin 1 | 51535.0 | ENSG00000134283 | nan | nan
chr12	PRICKLE1	608500.0 | PRICKLE1, RILP, EPM1B | Prickle-like 1 | 144165.0 | ENSG00000139174 | nan | Epilepsy, progressive myoclonic 1B, 612437 (3), Autosomal recessive
chr12	ADAMTS20	611681.0 | ADAMTS20 | ADAM metallopeptidase domain with thrombospondin type 1 motif, 20 | 80070.0 | ENSG00000173157 | nan | nan
chr12	IRAK4	606883.0 | IRAK4, REN64, IPD1, IMD67 | Interleukin 1 receptor-associated kinase 4 | 51135.0 | ENSG00000198001 | nan | Immunodeficiency 67, 607676 (3), Autosomal recessive
chr12	TWF1	610932.0 | TWF1, PTK9 | Twinfilin actin-binding protein 1 | 5756.0 | ENSG00000151239 | nan | nan
chr12	NELL2	602320.0 | NELL2 | Nel-like 2 | 4753.0 | ENSG00000184613 | nan | nan
chr12	DBX2	620706.0 | DBX2 | Developing brain homeobox 2 | 440097.0 | ENSG00000185610 | nan | nan
chr12	ANO6	608663.0 | ANO6, TMEM16F, SCTS, BDPLT7 | Anoctamin 6 | 196527.0 | ENSG00000177119 | nan | Scott syndrome, 262890 (3), Autosomal recessive
chr12	ARID2	609539.0 | ARID2, BAF200, KIAA1557, CSS6 | AT-rich interaction domain-containing protein 2 | 196528.0 | ENSG00000189079 | nan | Coffin-Siris syndrome 6, 617808 (3), Autosomal dominant
chr12	SCAF11	603668.0 | SCAF11, SFRS2IP, SIP1, CASP11, SRRP129 | SR-related C-terminal domain-associated factor 11 | 9169.0 | ENSG00000139218 | previously assigned to 21q22.3 | nan
chr12	BCC4	613061.0 | BCC4 | Basal cell carcinoma, susceptibility to, 4 | 100307121.0 | nan | associated with rs11170164 | {Basal cell carcinoma, susceptibility to, 4}, 613061 (2)
chr12	CMTS	616182.0 | CMTS | Chronic mountain sickness, susceptibility to | 105180377.0 | nan | nan | {Chronic mountain sickness, susceptibility to}, 616182 (2)
chr12		607841.0 | DFNA48 | Deafness, autosomal dominant 48 | nan | nan | nan | Deafness, autosomal dominant 48, 607841 (2), Autosomal dominant
chr12	ENUR2	600808.0 | ENUR2 | Enuresis, nocturnal, 2 | 2032.0 | nan | nan | Enuresis, nocturnal, 2, 600808 (2), Autosomal dominant
chr12	HPV18I2	167960.0 | HPV18I2 | Human papillomavirus type 18 integration site-2 | 3261.0 | nan | on 8 near MYC in HeLa | nan
chr12	MRT25	614346.0 | MRT25 | Intellectual developmental disorder, autosomal recessive 25 | 100852403.0 | nan | between rs4760658 and rs1882033 | Intellectual developmental disorder, autosomal recessive 25, 614346 (2), Autosomal recessive
chr12		613488.0 | MXLPO | Myxoid liposarcoma | nan | nan | fusion of DDIT3 and FUS | Myxoid liposarcoma, 613488 (4)
chr12	SPDT	184100.0 | SPDT | Spondyloepiphyseal dysplasia tarda, autosomal dominant | 103875461.0 | nan | nan | Spondyloepiphyseal dysplasia tarda, autosomal dominant, 184100 (2), Autosomal dominant
chr12	SLC38A1	608490.0 | SLC38A1 | Solute carrier family 38 (amino acid transporter), member 1 | 81539.0 | ENSG00000111371 | nan | nan
chr12	SLC38A2	605180.0 | SLC38A2, ATA2, KIAA1382 | Solute carrier family 38, member 2 | 54407.0 | ENSG00000134294 | nan | nan
chr12	SLC38A4	608065.0 | SLC38A4, NAT3, ATA3 | Solute carrier family 38 (amino acid transporter), member 4 | 55089.0 | ENSG00000139209 | nan | nan
chr12	AMIGO2	615690.0 | AMIGO2, ALI1 | Adhesion molecule with Ig-like domain 2 | 347902.0 | ENSG00000139211 | nan | nan
chr12	RPAP3	611477.0 | RPAP3 | RNA polymerase II-associated protein 3 | 79657.0 | ENSG00000005175 | nan | nan
chr12	ENDOU	606720.0 | ENDOU, PP11 | Endonuclease polyU-specific | 8909.0 | ENSG00000111405 | nan | nan
chr12	SLC48A1	612187.0 | SLC48A1, HRG | Solute carrier family 48, member 1 | 55652.0 | ENSG00000211584 | nan | nan
chr12	RAPGEF3	606057.0 | EPAC | cAMP-regulated guanine nucleotide exchange factor I | 10411.0 | ENSG00000079337 | nan | nan
chr12	HDAC7	606542.0 | HDAC7A, HDAC7 | Histone deacetylase 7A | 51564.0 | ENSG00000061273 | nan | nan
chr12	VDR	601769.0 | VDR | Vitamin D (1,25-dihydroxyvitamin D3) receptor | 7421.0 | ENSG00000111424 | nan | Rickets, vitamin D-resistant, type IIA, 277440 (3), Autosomal recessive
chr12	COL2A1	120140.0 | COL2A1 | Collagen II, alpha-1 polypeptide | 1280.0 | ENSG00000139219 | mutation identified in 1 VPED family | ?Vitreoretinopathy with phalangeal epiphyseal dysplasia, 619248 (3), Autosomal dominant; Czech dysplasia, 609162 (3), Autosomal dominant; Achondrogenesis, type II or hypochondrogenesis, 200610 (3), Autosomal dominant; Spondyloperipheral dysplasia, 271700 (3), Autosomal dominant; SMED Strudwick type, 184250 (3), Autosomal dominant; ?Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3), Autosomal dominant; SED congenita, 183900 (3), Autosomal dominant; Kniest dysplasia, 156550 (3), Autosomal dominant; Stickler syndrome, type I, nonsyndromic ocular, 609508 (3), Autosomal dominant; Osteoarthritis with mild chondrodysplasia, 604864 (3), Autosomal dominant; Stickler syndrome, type I, 108300 (3), Autosomal dominant; Platyspondylic skeletal dysplasia, Torrance type, 151210 (3), Autosomal dominant; Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3), Autosomal dominant; Avascular necrosis of the femoral head, 608805 (3), Autosomal dominant; Legg-Calve-Perthes disease, 150600 (3), Autosomal dominant
chr12	SENP1	612157.0 | SENP1 | Sentrin-specific protease family, member 1 | 29843.0 | ENSG00000079387 | nan | nan
chr12	PFKM	610681.0 | PFKM, GSD7 | Phosphofructokinase, muscle type | 5213.0 | ENSG00000152556 | incorrectly assigned to chr.1 | Glycogen storage disease VII, 232800 (3), Autosomal recessive
chr12	ASB8	615053.0 | ASB8 | Ankyrin repeat- and SOCS box-containing protein 8 | 140461.0 | ENSG00000177981 | nan | nan
chr12	H1-7	618565.0 | H1-7, H1FNT, HANP1, H1T2 | H1.7 linker histone | 341567.0 | ENSG00000187166 | nan | nan
chr12	ZNF641	613906.0 | ZNF641 | Zinc finger protein 641 | 121274.0 | ENSG00000167528 | nan | nan
chr12	ANP32D	606878.0 | ANP32D, PP32R2 | Acidic leucine-rich nuclear phosphoprotein 32 family, member D | 23519.0 | ENSG00000139223 | nan | nan
chr12	LALBA	149750.0 | LALBA | Lactalbumin, alpha | 3906.0 | ENSG00000167531 | nan | nan
chr12	KANSL2	615488.0 | KANSL2, NSL2, C12orf41 | KAT8 regulatory NSL complex, subunit 2 | 54934.0 | ENSG00000139620 | nan | nan
chr12	SNORA2C	615487.0 | SNORA2C, SNORA34, ACA34, MIR1291 | Small nucleolar RNA, H/ACA box, 34 | 677815.0 | ENSG00000221491 | MIR1291 in intron of SNORA34 | nan
chr12	CCNT1	143055.0 | CCNT1, CCNT | Cyclin T1 | 904.0 | ENSG00000129315 | nan | nan
chr12	ADCY6	600294.0 | ADCY6, LCCS8 | Adenylate cyclase-6 | 112.0 | ENSG00000174233 | nan | Lethal congenital contracture syndrome 8, 616287 (3), Autosomal recessive
chr12	CACNB3	601958.0 | CACNB3 | Calcium channel, voltage-dependent, beta 3 subunit | 784.0 | ENSG00000167535 | nan | nan
chr12	DDX23	612172.0 | DDX23, PRP28 | DEAD-box helicase 23 | 9416.0 | ENSG00000174243 | nan | nan
chr12	RND1	609038.0 | RND1, RHO6 | Rho family GTPase 1 | 27289.0 | ENSG00000172602 | nan | nan
chr12	CCDC65	611088.0 | CCDC65, CILD27 | Coiled-coil domain-containing protein 65 | 85478.0 | ENSG00000139537 | nan | Ciliary dyskinesia, primary, 27, 615504 (3), Autosomal recessive
chr12	FKBP11	610571.0 | FKBP11, FKBP19 | FK506-binding protein 11 | 51303.0 | ENSG00000134285 | nan | nan
chr12	ARF3	103190.0 | ARF3 | ADP-ribosylation factor-3 | 377.0 | ENSG00000134287 | nan | nan
chr12	WNT10B	601906.0 | WNT10B, SHFM6, STHAG8 | Wingless-type MMTV integration site family, member 10B | 7480.0 | ENSG00000169884 | nan | Tooth agenesis, selective, 8, 617073 (3), Autosomal dominant; Split-hand/foot malformation 6, 225300 (3), Autosomal recessive
chr12	WNT1	164820.0 | WNT1, INT1, OI15, BMND16 | Wingless-type MMTV integration site family, member 1 (oncogene INT1) | 7471.0 | ENSG00000125084 | nan | {Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3), Autosomal dominant; Osteogenesis imperfecta, type XV, 615220 (3), Autosomal recessive
chr12	DDN	610588.0 | DDN, KIAA0749 | Dendrin | 23109.0 | ENSG00000181418 | nan | nan
chr12	PRKAG1	602742.0 | PRKAG1 | Protein kinase, AMP-activated, noncatalytic, gamma-1 | 5571.0 | ENSG00000181929 | nan | nan
chr12	KMT2D	602113.0 | KMT2D, MLL2, ALR, KABUK1, BCAHH | Lysine methyltransferase 2D | 8085.0 | ENSG00000167548 | nan | Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome, 620186 (3), Autosomal dominant; Kabuki syndrome 1, 147920 (3), Autosomal dominant
chr12	RHEBL1	618956.0 | RHEBL1, RHEB2 | RHEB-like protein 1 | 121268.0 | ENSG00000167550 | nan | nan
chr12	DHH	605423.0 | DHH, SRXY7, GDMN | Desert hedgehog signaling molecule | 50846.0 | ENSG00000139549 | nan | 46XY gonadal dysgenesis with minifascicular neuropathy, 607080 (3), Autosomal recessive; 46XY sex reversal 7, 233420 (3), Autosomal recessive
chr12	LMBR1L	610007.0 | LMBR1L, LIMR, KIAA1174 | Limb region 1 homolog-like | 55716.0 | ENSG00000139636 | nan | nan
chr12	TUBA1B	602530.0 | TUBA1B | Tubulin, alpha-1B | 10376.0 | ENSG00000123416 | nan | nan
chr12	TUBA1A	602529.0 | TUBA1A, TUBA3, LIS3 | Tubulin, alpha-1A | 7846.0 | ENSG00000167552 | nan | Lissencephaly 3, 611603 (3), Autosomal dominant
chr12	PRPH	170710.0 | PRPH | Peripherin | 5630.0 | ENSG00000135406 | nan | {Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3), Autosomal recessive, Autosomal dominant
chr12	TROAP	603872.0 | TROAP, TASTIN | Trophinin-associated protein | 10024.0 | ENSG00000135451 | nan | nan
chr12	C1QL4	615229.0 | C1QL4, CTRP11 | Complement component 1, q subcomponent-like 4 | 338761.0 | ENSG00000186897 | nan | nan
chr12	SPATS2	611667.0 | SPATS2, SPATA10, P59SCR, SCR59 | Spermatogenesis-associated serine-rich protein 2 | 65244.0 | ENSG00000123352 | nan | nan
chr12	KCNH3	604527.0 | KCNH3, BEC1 | Potassium voltage-gated channel, subfamily H (eag-related), member 3 | 23416.0 | ENSG00000135519 | nan | nan
chr12	MCRS1	609504.0 | MCRS1, MSP58, MCRS2 | Microspherule protein 1 (microspherule protein 2, included) | 10445.0 | ENSG00000187778 | nan | nan
chr12	FMNL3	616288.0 | FMNL3, FRL2 | Formin-like 3 | 91010.0 | ENSG00000161791 | nan | nan
chr12	TMBIM6	600748.0 | TMBIM6, TEGT | Transmembrane BAX inhibitor motif-containing protein 6 | 7009.0 | ENSG00000139644 | nan | nan
chr12	NCKAP5L	615104.0 | NCKAP5L, KIAA1602 | NCK-associated protein 5-like | 57701.0 | ENSG00000167566 | nan | nan
chr12	BCDIN3D	619601.0 | BCDIN3D | BCDIN3 domain-containing RNA methyltransferase | 144233.0 | ENSG00000186666 | nan | nan
chr12	FAIM2	604306.0 | FAIM2, LFG, NMP35 | FAS apoptotic inhibitory molecule 2 | 23017.0 | ENSG00000135472 | nan | nan
chr12	AQP2	107777.0 | AQP2, NDI2 | Aquaporin-2 (collecting duct) | 359.0 | ENSG00000167580 | nan | Diabetes insipidus, nephrogenic, 2, 125800 (3), Autosomal recessive, Autosomal dominant
chr12	AQP5	600442.0 | AQP5, PPKB | Aquaporin-5 | 362.0 | ENSG00000161798 | nan | Palmoplantar keratoderma, Bothnian type, 600231 (3), Autosomal dominant
chr12	AQP6	601383.0 | AQP6, AQP2L | Aquaporin-6, kidney specific | 363.0 | ENSG00000086159 | nan | nan
chr12	RACGAP1	604980.0 | RCGAP1, MGCRACGAP, CYK4, CDAN3B | GTPase-activating protein, Rac, 1 | 29127.0 | ENSG00000161800 | nan | Anemia, congenital dyserythropoietic, type IIIb, autosomal recessive, 619789 (3), Autosomal recessive
chr12	ASIC1	602866.0 | ACCN2 | Cation channel, amiloride-sensitive, neuronal, 2 | 41.0 | ENSG00000110881 | nan | nan
chr12	SMARCD1	601735.0 | SMARCD1, BAF60A, CSS11 | SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 6602.0 | ENSG00000066117 | nan | Coffin-Siris syndrome 11, 618779 (3), Autosomal dominant
chr12	GPD1	138420.0 | GPD1, HTGTI | Glycerol-3-phosphate dehydrogenase, soluble | 2819.0 | ENSG00000167588 | nan | Hypertriglyceridemia, transient infantile, 614480 (3), Autosomal recessive
chr12	COX14	614478.0 | COX14, C12orf62, MC4DN10 | Cytochrome c oxidase assembly protein COX14 | 84987.0 | ENSG00000178449 | mutation identified in 1 MC4DN10 family | ?Mitochondrial complex IV deficiency, nuclear type 10, 619053 (3), Autosomal recessive
chr12	CERS5	615335.0 | CERS5, LASS5, TRH4 | Ceramide synthase 5 | 91012.0 | ENSG00000139624 | nan | nan
chr12	LIMA1	608364.0 | LIMA1, EPLIN, SREBP3, LDLCQ8 | LIM domain and actin-binding protein 1 | 51474.0 | ENSG00000050405 | nan | [Low density lipoprotein cholesterol level QTL 8], 618079 (3)
chr12	LARP4	618657.0 | LARP4 | La ribonucleoprotein 4 | 113251.0 | ENSG00000161813 | nan | nan
chr12	DIP2B	611379.0 | DIP2B, KIAA1463 | Disco-interacting protein 2 homolog B | 57609.0 | ENSG00000066084 | nan | Intellectual developmental disorder, autosomal dominant, FRA12A type, 136630 (3), Autosomal dominant
chr12	ATF1	123803.0 | ATF1, TREB36 | Activating transcription factor 1 | 466.0 | ENSG00000123268 | fused with EWS in soft tissue clear cell sarcoma, with FUS in angiomatoid fibrous histiocytoma | nan
chr12	TMT1A	618338.0 | TMT1A, METTL7A, AAMB | Thiol methyltransferase 1A | 25840.0 | ENSG00000185432 | nan | nan
chr12	HIGD1C	620803.0 | HIGD1C | HIG1 hypoxia-inducible domain family, member 1C | 613227.0 | ENSG00000214511 | nan | nan
chr12	SLC11A2	600523.0 | SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1 | Solute carrier family 11 (proton-coupled divalent metal ion transporter) member 2 | 4891.0 | ENSG00000110911 | nan | Anemia, hypochromic microcytic, with iron overload 1, 206100 (3), Autosomal recessive
chr12	LETMD1	619070.0 | LETMD1, HCCR | LETM1 domain-containing protein 1 | 25875.0 | ENSG00000050426 | nan | nan
chr12	CSRNP2	620404.0 | CSRNP2 | Cysteine- and serine-rich nuclear protein 2 | 81566.0 | ENSG00000110925 | nan | nan
chr12	TFCP2	189889.0 | TFCP2 | Transcription factor CP2, alpha globin | 7024.0 | ENSG00000135457 | nan | nan
chr12	POU6F1	618043.0 | POU6F1, BRN5, MPOU | POU domain, class 6, transcription factor 1 | 5463.0 | ENSG00000184271 | nan | nan
chr12	DAZAP2	607431.0 | DAZAP2, KIAA0058 | DAZ-associated protein 2 | 9802.0 | ENSG00000183283 | nan | nan
chr12	BIN2	605936.0 | BIN2 | Bridging integrator 2 | 51411.0 | ENSG00000110934 | previously mapped to 4q22.1 | nan
chr12	CELA1	130120.0 | CELA1, ELA1 | Chymotrypsin-like elastase family, member 1 | 1990.0 | ENSG00000139610 | on proximal 12p | nan
chr12	GALNT6	605148.0 | GALNT6, GalNAcT6 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 | 11226.0 | ENSG00000139629 | nan | nan
chr12	SLC4A8	605024.0 | SLC4A8, NBC3 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 8 | 9498.0 | ENSG00000050438 | nan | nan
chr12	SCN8A	600702.0 | SCN8A, CIAT, DEE13, BFIS5, MYOCL2 | Sodium voltage-gated channel, alpha subunit 8 | 6334.0 | ENSG00000196876 | mutation identified in 1 MYOCL2 family | ?Myoclonus, familial, 2, 618364 (3), Autosomal dominant; Seizures, benign familial infantile, 5, 617080 (3), Autosomal dominant; Cognitive impairment with or without cerebellar ataxia, 614306 (3), Autosomal dominant; Developmental and epileptic encephalopathy 13, 614558 (3), Autosomal dominant
chr12	FIGNL2	620503.0 | FIGNL2 | Fidgetin-like protein 2 | 401720.0 | ENSG00000261308 | nan | nan
chr12	ANKRD33	620857.0 | ANKRD33, PANKY | Ankyrin repeat domain-containing protein 33 | 341405.0 | ENSG00000167612 | nan | nan
chr12	ACVRL1	601284.0 | ACVRL1, ACVRLK1, ALK1, HHT2 | Activin A receptor, type II-like kinase 1 | 94.0 | ENSG00000139567 | nan | Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3), Autosomal dominant
chr12	ACVR1B	601300.0 | ACVR1B, ACVRLK4, ALK4 | Activin A receptor, type IB | 91.0 | ENSG00000135503 | nan | Pancreatic cancer, somatic, 260350 (3)
chr12	TAMALIN	612027.0 | TAMALIN, GRASP | Trafficking regulator and scaffold protein tamalin | 160622.0 | ENSG00000161835 | nan | nan
chr12	NR4A1	139139.0 | NR4A1, HMR, NP10, GFRP1 | Nuclear receptor subfamily 4, group A, member 1 | 3164.0 | ENSG00000123358 | nan | nan
chr12	ATG101	615089.0 | ATG101, C12orf44 | Autophagy related 101 | 60673.0 | ENSG00000123395 | nan | nan
chr12	KRT80	611161.0 | KRT80, KB20 | Keratin 80 | 144501.0 | ENSG00000167767 | nan | nan
chr12	KRT7	148059.0 | KRT7 | Keratin 7 | 3855.0 | ENSG00000135480 | nan | nan
chr12	KRT86	601928.0 | KRT86, KRTHB6, HB6 | Keratin 86 | 3892.0 | ENSG00000170442 | nan | Monilethrix, 158000 (3), Autosomal dominant
chr12	KRT81	602153.0 | KRT81, KRTHB1, HB1 | Keratin 81 | 3887.0 | ENSG00000205426 | nan | Monilethrix, 158000 (3), Autosomal dominant
chr12	KRT83	602765.0 | KRT83, KRTHB3, HB3, MNLIX, EKVP5 | Keratin 83 | 3889.0 | ENSG00000170523 | nan | Monilethrix, 158000 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 5, 617756 (3), Autosomal recessive
chr12	KRT85	602767.0 | KRT85, KRTHB5, HB5, ECTD4 | Keratin 85 | 3891.0 | ENSG00000135443 | nan | Ectodermal dysplasia 4, hair/nail type, 602032 (3), Autosomal recessive
chr12	KRT84	602766.0 | KRT84, KRTHB4, HB4 | Keratin 84 | 3890.0 | ENSG00000161849 | nan | nan
chr12	KRT82	601078.0 | KRT82, KRTHB2, HB2 | Keratin 82 | 3888.0 | ENSG00000161850 | nan | nan
chr12	KRT75	609025.0 | KRT75, K6HF, PFB | Keratin 75 | 9119.0 | ENSG00000170454 | nan | {Pseudofolliculitis barbae, susceptibility to}, 612318 (3)
chr12	KRT6B	148042.0 | KRT6B, PC4 | Keratin 6B | 3854.0 | ENSG00000185479 | nan | Pachyonychia congenita 4, 615728 (3), Autosomal dominant
chr12	KRT6C	612315.0 | KRT6C, PPKNEFD | Keratin 6C | 286887.0 | ENSG00000170465 | nan | Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3), Autosomal dominant
chr12	KRT6A	148041.0 | KRT6A, PC3 | Keratin 6A | 3853.0 | ENSG00000205420 | nan | Pachyonychia congenita 3, 615726 (3), Autosomal dominant
chr12	KRT5	148040.0 | KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F | Keratin 5 | 3852.0 | ENSG00000186081 | nan | Epidermolysis bullosa simplex 2A, generalized severe, 619555 (3), Autosomal dominant; Dowling-Degos disease 1, 179850 (3), Autosomal dominant; Epidermolysis bullosa simplex 2F, with mottled pigmentation, 131960 (3), Autosomal dominant; Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive, 619599 (3), Autosomal recessive; Epidermolysis bullosa simplex 2B, generalized intermediate, 619588 (3), Autosomal dominant; Epidermolysis bullosa simplex 2C, localized, 619594 (3), Autosomal dominant; Epidermolysis bullosa simplex 2E, with migratory circinate erythema, 609352 (3), Autosomal dominant
chr12	KRT71	608245.0 | KRT71, K6IRS1, KRT6IRS1, HYPT13 | Keratin 71 | 112802.0 | ENSG00000139648 | mutation identified in 1 HYPT13 family | ?Hypotrichosis 13, 615896 (3), Autosomal dominant
chr12	KRT74	608248.0 | KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH | Keratin 74 | 121391.0 | ENSG00000170484 | mutation identified in 1 HYPT3 family and ECTD7 family | Woolly hair, autosomal dominant, 194300 (3), Autosomal dominant; ?Hypotrichosis 3, 613981 (3), Autosomal dominant; ?Ectodermal dysplasia 7, hair/nail type, 614929 (3), Autosomal recessive
chr12	KRT72	608246.0 | KRT72, K6IRS2, KRT6IRS2 | Keratin 72 | 140807.0 | ENSG00000170486 | nan | nan
chr12	KRT73	608247.0 | KRT73, K6IRS3, KRT6IRS3 | Keratin 73 | 319101.0 | ENSG00000186049 | nan | nan
chr12	KRT2	600194.0 | KRT2, KRT2A, KRT2E | Keratin 2 | 3849.0 | ENSG00000172867 | nan | Ichthyosis bullosa of Siemens, 146800 (3), Autosomal dominant
chr12	KRT1	139350.0 | KRT1, EPPK, NEPPK, EHK1, AEI2 | Keratin 1 | 3848.0 | ENSG00000167768 | close to Hox-3 in mouse; class II keratin | Ichthyosis, annular epidermolytic 2, 620148 (3), Autosomal dominant; Palmoplantar keratoderma, nonepidermolytic, 600962 (3), Autosomal dominant; Epidermolytic hyperkeratosis 1, 113800 (3), Autosomal dominant; Palmoplantar keratoderma, epidermolytic, 2, 620411 (3), Autosomal dominant; Keratosis palmoplantaris striata III, 607654 (3); Ichthyosis histrix, Curth-Macklin type, 146590 (3), Autosomal dominant
chr12	KRT77	611158.0 | KRT77, K1B | Keratin 77 | 374454.0 | ENSG00000189182 | nan | nan
chr12	KRT76	616671.0 | KRT76, K76, KRT2P | Keratin 76, type II | 51350.0 | ENSG00000185069 | nan | nan
chr12	KRT3	148043.0 | KRT3, MECD2 | Keratin 3 | 3850.0 | ENSG00000186442 | nan | Meesmann corneal dystrophy 2, 618767 (3), Autosomal dominant
chr12	KRT4	123940.0 | KRT4, CYK4, WSN1 | Keratin 4 | 3851.0 | ENSG00000170477 | class II keratin | White sponge nevus 1, 193900 (3), Autosomal dominant
chr12	KRT79	611160.0 | KRT79,  KRT6L, K6L | Keratin 79 | 338785.0 | ENSG00000185640 | nan | nan
chr12	KRT78	611159.0 | KRT78, K5B | Keratin 78 | 196374.0 | ENSG00000170423 | nan | nan
chr12	KRT8	148060.0 | KRT8 | Keratin 8 | 3856.0 | ENSG00000170421 | nan | nan
chr12	KRT18	148070.0 | KRT18 | Keratin 18 | 3875.0 | ENSG00000111057 | contiguous to KRT8, type II heteromer partner | Cirrhosis, cryptogenic, 215600 (3), Autosomal recessive; {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3), Autosomal recessive
chr12	EIF4B	603928.0 | EIF4B | Eukaryotic translation initiation factor 4B | 1975.0 | ENSG00000063046 | nan | nan
chr12	TNS2	607717.0 | TNS2, TENC1, C1TEN, KIAA1075 | Tensin 2 | 23371.0 | ENSG00000111077 | nan | nan
chr12	IGFBP6	146735.0 | IGFBP6 | Insulin-like growth factor-binding protein-6 | 3489.0 | ENSG00000167779 | nan | nan
chr12	SOAT2	601311.0 | SOAT2, ACACT2 | Sterol O-acyltransferase 2 | 8435.0 | ENSG00000167780 | nan | nan
chr12	CSAD	616569.0 | CSAD, CSD, PCAP | Cysteine sulfinic acid decarboxylase | 51380.0 | ENSG00000139631 | nan | nan
chr12	ZNF740	620976.0 | ZNF740 | Zinc finger protein 740 | 283337.0 | ENSG00000139651 | nan | nan
chr12	ITGB7	147559.0 | ITGB7 | Integrin, beta-7 | 3695.0 | ENSG00000139626 | nan | nan
chr12	RARG	180190.0 | RARG | Retinoic acid receptor, gamma polypeptide | 5916.0 | ENSG00000172819 | nan | nan
chr12	MFSD5	620345.0 | MFSD5 | Major facilitator superfamily domain-containing protein 5 | 84975.0 | ENSG00000182544 | nan | nan
chr12	ESPL1	604143.0 | ESPL1, ESP1 | Extra spindle poles-like 1 | 9700.0 | ENSG00000135476 | prev. mapping to chr.8 | nan
chr12	PFDN5	604899.0 | PFDN5, MM1 | Prefoldin 5 | 5204.0 | ENSG00000123349 | nan | nan
chr12	MYG1	611366.0 | MYG1, C12orf10 | MYG1 exonuclease | 60314.0 | ENSG00000139637 | nan | nan
chr12	AAAS	605378.0 | AAAS, AAA | Aladin WD repeat nucleoporin | 8086.0 | ENSG00000094914 | nan | Achalasia-addisonianism-alacrimia syndrome, 231550 (3), Autosomal recessive
chr12	SP7	606633.0 | SP7, OSX, OI12 | Transcription factor Sp7 | 121340.0 | ENSG00000170374 | nan | Osteogenesis imperfecta, type XII, 613849 (3), Autosomal recessive
chr12	SP1	189906.0 | SP1 | Sp1 transcription factor | 6667.0 | ENSG00000185591 | nan | nan
chr12	AMHR2	600956.0 | AMHR2, AMHR | Anti-Mullerian hormone receptor, type II | 269.0 | ENSG00000135409 | nan | Persistent Mullerian duct syndrome, type II, 261550 (3), Autosomal recessive
chr12	PRR13	610459.0 | PRR13, TXR1 | Proline-rich protein 13 | 54458.0 | ENSG00000205352 | nan | nan
chr12	PCBP2	601210.0 | PCBP2 | Poly(rC)-binding protein-2 | 5094.0 | ENSG00000197111 | nan | nan
chr12	MAP3K12	600447.0 | MAP3K12, ZPK | Mitogen-activated protein kinase kinase kinase 12 | 7786.0 | ENSG00000139625 | nan | nan
chr12	TARBP2	605053.0 | TARBP2 | TAR RNA-binding protein 2 | 6895.0 | ENSG00000139546 | pseudogene on 8q22-qter | nan
chr12	NPFF	604643.0 | NPFF | Neuropeptide FF-amide peptide | 8620.0 | ENSG00000139574 | nan | nan
chr12	ATF7	606371.0 | ATF7 | Activating transcription factor 7 | 11016.0 | ENSG00000170653 | nan | nan
chr12	ATP5MC2	603193.0 | ATP5G2 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C, isoform 2 | 517.0 | ENSG00000135390 | nan | nan
chr12	HOXC13	142976.0 | HOXC13, HOX3G, ECTD9 | Homeobox C13 | 3229.0 | ENSG00000123364 | fused with NUP98 in AML | Ectodermal dysplasia 9, hair/nail type, 614931 (3), Autosomal recessive
chr12	HOXC12	142975.0 | HOXC12, HOX3F | Homeobox C12 | 3228.0 | ENSG00000123407 | nan | nan
chr12	HOTAIR	611400.0 | HOTAIR | Hox transcript antisense RNA | 100124700.0 | ENSG00000228630 | nan | nan
chr12	HOXC11	605559.0 | HOXC11 | Homeobox-C11 | 3227.0 | ENSG00000123388 | nan | nan
chr12	HOXC10	605560.0 | HOXC10 | Homeobox C10 | 3226.0 | ENSG00000180818 | nan | nan
chr12	MIR196A2	609687.0 | MIR196A2, MIRN196A2 | Micro RNA 196A2 | 406973.0 | ENSG00000207924 | nan | nan
chr12	HOXC9	142971.0 | HOXC9, HOX3B | Homeobox C9 | 3225.0 | ENSG00000180806 | nan | nan
chr12	HOXC8	142970.0 | HOXC8, HOX3A | Homeobox C8 | 3224.0 | ENSG00000037965 | nan | nan
chr12	HOXC4	142974.0 | HOXC4, HOX3E | Homeobox C4 | 3221.0 | ENSG00000198353 | nan | nan
chr12	HOXC5	142973.0 | HOXC5, HOX3D | Homeobox C5 | 3222.0 | ENSG00000172789 | nan | nan
chr12	HOXC6	142972.0 | HOXC6, HOX3C | Homeobox C6 | 3223.0 | ENSG00000197757 | nan | nan
chr12	LINC02381	620723.0 | LINC02381, HMS | Long intergenic noncoding RNA 2381 | 400043.0 | ENSG00000250742 | nan | nan
chr12	SMUG1	607753.0 | SMUG1 | Single-strand-selective monofunctional uracil-DNA glycosylase 1 | 23583.0 | ENSG00000123415 | nan | nan
chr12	CBX5	604478.0 | CBX5, HP1 | Chromobox 5 | 23468.0 | ENSG00000094916 | nan | nan
chr12	HNRNPA1	164017.0 | HNRNPA1, IBMPFD3, ALS20, MPD3 | Heterogeneous nuclear ribonucleoprotein A1 | 3178.0 | ENSG00000135486 | mutation identified in 1 IBMPFD3 family and 1 MPD3 family | ?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3, 615424 (3), Autosomal dominant; ?Myopathy, distal, 3, 610099 (3), Autosomal dominant; Amyotrophic lateral sclerosis 20, 615426 (3), Autosomal dominant
chr12	NFE2	601490.0 | NFE2 | Nuclear factor, erythroid-derived 2, 45kD | 4778.0 | ENSG00000123405 | nan | nan
chr12	COPZ1	615472.0 | COPZ1, COPZ | Coatomer protein complex, subunit zeta-1 | 22818.0 | ENSG00000111481 | nan | nan
chr12	MIR148B	613787.0 | MIR148B, MIRN148B | Micro RNA 148B | 442892.0 | ENSG00000199122 | nan | nan
chr12	GPR84	606383.0 | GPR84 | G protein-coupled receptor 84 | 53831.0 | ENSG00000139572 | nan | nan
chr12	ZNF385A	609124.0 | ZNF385A, ZNF385, RZF, HZF | Zinc finger protein 385A | 25946.0 | ENSG00000161642 | nan | nan
chr12	ITGA5	135620.0 | ITGA5, FNRA, VLA5A | Integrin, alpha-5 (fibronectin receptor, alpha subunit; very late activation protein-5, alpha subunit) | 3678.0 | ENSG00000161638 | nan | nan
chr12	GTSF1	617484.0 | GTSF1, FAM112B | Gametocyte-specific factor 1 | 121355.0 | ENSG00000170627 | nan | nan
chr12	NCKAP1L	141180.0 | NCKAP1L, HEM1, IMD72 | NCK associated protein 1-like | 3071.0 | ENSG00000123338 | nan | Immunodeficiency 72 with autoinflammation, 618982 (3), Autosomal recessive
chr12	PDE1B	171891.0 | PDE1B1, PDES1B, PDE1B | Phosphodiesterase-1B | 5153.0 | ENSG00000123360 | nan | nan
chr12	PPP1R1A	613246.0 | PPP1R1A, IPP1, I1 | Protein phosphatase 1, regulatory subunit 1A | 5502.0 | ENSG00000135447 | nan | nan
chr12	LACRT	607360.0 | LACRT | Lacritin | 90070.0 | ENSG00000135413 | nan | nan
chr12	DCD	606634.0 | DCD | Dermcidin | 117159.0 | ENSG00000161634 | nan | nan
chr12	MUCL1	610857.0 | MUCL1, SBEM | Mucin-like 1 | 118430.0 | ENSG00000172551 | nan | nan
chr12	TESPA1	615664.0 | TESPA1, KIAA0748 | Thymocyte-expressed positive selection-associated protein 1 | 9840.0 | ENSG00000135426 | nan | nan
chr12	NEUROD4	611635.0 | NEUROD4, MATH3 | Neurogenic differentiation 4 | 58158.0 | ENSG00000123307 | nan | nan
chr12	ITGA7	600536.0 | ITGA7 | Integrin, alpha-7 | 3679.0 | ENSG00000135424 | nan | Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3), Autosomal recessive
chr12	BLOC1S1	601444.0 | GCN5L1 | GCN5 (general control of amino-acid synthesis, yeast, homolog)-like 1 | 2647.0 | ENSG00000135441 | nan | nan
chr12	RDH5	601617.0 | RDH5 | Retinol dehydrogenase-5 | 5959.0 | ENSG00000135437 | nan | Fundus albipunctatus, 136880 (3), Autosomal recessive, Autosomal dominant
chr12	CD63	155740.0 | CD63, MLA1 | CD63 antigen (melanoma 1 antigen) | 967.0 | ENSG00000135404 | nan | nan
chr12	GDF11	603936.0 | GDF11, BMP11, VHO | Growth/differentiation factor 11 | 10220.0 | ENSG00000135414 | mutation identified in 1 VHO family | ?Vertebral hypersegmentation and orofacial anomalies, 619122 (3), Autosomal dominant
chr12	SARNP	610049.0 | SARNP, CIP29, HCC1, HSPC316 | SAP domain-containing ribonucleoprotein | 84324.0 | ENSG00000205323 | fused with MLL in AML | nan
chr12	ORMDL2	610074.0 | ORMDL2 | ORM1-like protein 2 | 29095.0 | ENSG00000123353 | pseudogene on 8q22.1 | nan
chr12	DNAJC14	606092.0 | DRIP78, HDJ3 | Dopamine receptor-interacting protein, 78kD | 85406.0 | ENSG00000135392 | nan | nan
chr12	MMP19	601807.0 | MMP19, MMP18, CODA | Matrix metalloproteinase-19 | 4327.0 | ENSG00000123342 | triplication in upstream regulatory region | Cavitary optic disc anomalies, 611543 (3), Autosomal dominant
chr12	PYM1	619753.0 | PYM1 | PYM homolog 1, exon junction complex-associated factor | 84305.0 | ENSG00000170473 | nan | nan
chr12	DGKA	125855.0 | DGKA, DAGK1 | Diacylglycerol kinase, alpha, 80kD | 1606.0 | ENSG00000065357 | nan | nan
chr12	PMEL	155550.0 | SILV, D12S53E, PMEL17 | Silver, mouse, homolog of | 6490.0 | ENSG00000185664 | nan | nan
chr12	CDK2	116953.0 | CDK2 | Cyclin-dependent kinase 2 | 1017.0 | ENSG00000123374 | nan | nan
chr12	RAB5B	179514.0 | RAB5B | Ras-associated protein RAB5B | 5869.0 | ENSG00000111540 | nan | nan
chr12	SUOX	606887.0 | SUOX | Sulfite oxidase | 6821.0 | ENSG00000139531 | nan | Sulfite oxidase deficiency, 272300 (3), Autosomal recessive
chr12	IKZF4	606239.0 | IKZF4, ZNFN1A4, EOS, KIAA1782 | Ikaros family zinc finger 4 | 64375.0 | ENSG00000123411 | nan | nan
chr12	RPS26	603701.0 | RPS26, DBA10 | Ribosomal protein S26 | 6231.0 | ENSG00000197728 | nan | Diamond-Blackfan anemia 10, 613309 (3), Autosomal dominant
chr12	ERBB3	190151.0 | ERBB3, LCCS2, FERLK, VSCN1 | Transformation gene ERBB-3 | 2065.0 | ENSG00000065361 | mutations identified in 1 LCCS2 family and 1 FERLK family | ?Lethal congenital contractural syndrome 2, 607598 (3), Autosomal recessive; {?Erythroleukemia, familial, susceptibility to}, 133180 (3), Autosomal dominant; Visceral neuropathy, familial, 1, autosomal recessive, 243180 (3), Autosomal recessive
chr12	PA2G4	602145.0 | PA2G4 | Proliferation-associated 2G4, 38kD | 5036.0 | ENSG00000170515 | family of genes on 7 chromosomes | nan
chr12	RPL41	613315.0 | RPL41, HG12 | Ribosomal protein L41 | 6171.0 | ENSG00000229117 | nan | nan
chr12	ESYT1	616670.0 | ESYT1, MBC2, FAM62A | Extended synaptotagmin-like protein 1 | 23344.0 | ENSG00000139641 | nan | nan
chr12	MYL6B	609930.0 | MYL6B, MLC1SA | Myosin, light chain 6B, alkali, smooth muscle and nonmuscle, slow | 140465.0 | ENSG00000196465 | nan | nan
chr12	MYL6	609931.0 | MYL6 | Myosin light chain 6, alkali, smooth muscle and nonmuscle | 4637.0 | ENSG00000092841 | nan | nan
chr12	SMARCC2	601734.0 | SMARCC2, BAF170, CSS8 | SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | 6601.0 | ENSG00000139613 | nan | Coffin-Siris syndrome 8, 618362 (3), Autosomal dominant
chr12	AAA4	614375.0 | AAA4 | Aortic aneurysm, familial abdominal 4 | 100859927.0 | nan | associated with rs1466535 | Aortic aneurysm, familial abdominal 4, 614375 (2)
chr12	RNF41	620051.0 | RNF41, FLRF, NRDP1 | RING finger protein 41, E3 ubiquitin protein ligase | 10193.0 | ENSG00000181852 | nan | nan
chr12	NABP2	612104.0 | NAPB2, OBFC2B, SSB1 | Nucleic acid-binding protein 2 | 79035.0 | ENSG00000139579 | nan | nan
chr12	SLC39A5	608730.0 | SLC39A5, MYP24 | Solute carrier family 39 (zinc transporter), member 5 | 283375.0 | ENSG00000139540 | nan | Myopia 24, autosomal dominant, 615946 (3), Autosomal dominant
chr12	ANKRD52	620862.0 | ANKRD52, ARSC | Ankyrin repeat domain-containing protein 52 | 283373.0 | ENSG00000139645 | nan | nan
chr12	COQ10A	620736.0 | COQ10A | Coenzyme Q10A | 93058.0 | ENSG00000135469 | nan | nan
chr12	CS	118950.0 | CS | Citrate synthase | 1431.0 | ENSG00000062485 | nan | nan
chr12	CNPY2	605861.0 | CNPY4, TMEM4, MSAP | Canopy 2, zebrafish, homolog of | 10330.0 | ENSG00000257727 | nan | nan
chr12	PAN2	617447.0 | PAN2, USP52, KIAA0710 | PABP-dependent poly(A) nuclease 2 | 9924.0 | ENSG00000135473 | nan | nan
chr12	IL23A	605580.0 | IL23A, SGRF, P19, IL23P19 | Interleukin 23, p19 subunit | 51561.0 | ENSG00000110944 | nan | nan
chr12	STAT2	600556.0 | STAT2, IMD44, PTORCH3 | Signal transducer and activator of transcription 2 | 6773.0 | ENSG00000170581 | nan | Pseudo-TORCH syndrome 3, 618886 (3), Autosomal recessive; Immunodeficiency 44, 616636 (3), Autosomal recessive
chr12	APOF	107760.0 | APOF, LTIP | Apolipoprotein F | 319.0 | ENSG00000175336 | nan | nan
chr12	TIMELESS	603887.0 | TIMELESS, TIM, TIM1, FASPS4 | Timeless circadian regulator | 8914.0 | ENSG00000111602 | mutation identified in 1 FASPS4 family | ?Advance sleep phase syndrome, familial, 4, 620015 (3), Autosomal dominant
chr12	MIP	154050.0 | MIP, AQP0, CTRCT15 | Major intrinsic protein of lens fiber | 4284.0 | ENSG00000135517 | slightly distal to AQP2 | Cataract 15, multiple types, 615274 (3), Autosomal dominant
chr12	GLS2	606365.0 | GLS2, GA | Glutaminase, liver | 27165.0 | ENSG00000135423 | nan | nan
chr12	RBMS2	602387.0 | RBMS2, SCR3 | RNA-binding motif protein, single strand interacting, 2 | 5939.0 | ENSG00000076067 | nan | nan
chr12	BAZ2A	605682.0 | BAZ2A | Bromodomain adjacent to zinc finger domain, 2A | 11176.0 | ENSG00000076108 | nan | nan
chr12	ATP5F1B	102910.0 | ATP5B, ATPSB, HUMOP2 | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | 506.0 | ENSG00000110955 | mutation identified in 1 HUMOP2 family | ?Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2, 620085 (3), Autosomal dominant
chr12	PTGES3	607061.0 | PTGES3, P23, CPGES | Prostaglandin E synthase 3 | 10728.0 | ENSG00000110958 | nan | nan
chr12	NACA	601234.0 | NACA | Nascent-polypeptide-associated complex alpha polypeptide | 4666.0 | ENSG00000196531 | nan | nan
chr12	PRIM1	176635.0 | PRIM1, PDIL | Primase, polypeptide-1, 49kD | 5557.0 | ENSG00000198056 | nan | Primordial dwarfism-immunodeficiency-lipodystrophy syndrome, 620005 (3), Autosomal recessive
chr12	HSD17B6	606623.0 | HSE | 3-alpha-hydroxysteroid epimerase | 8630.0 | ENSG00000025423 | nan | nan
chr12	SDR9C7	609769.0 | SDR9C7, SDRO, ARCI13 | Short chain dehydrogenase/reductase family 9C member 7 | 121214.0 | ENSG00000170426 | nan | Ichthyosis, congenital, autosomal recessive 13, 617574 (3), Autosomal recessive
chr12	RDH16	620043.0 | RDH16, RODH4 | Retinol dehydrogenase 16 | 8608.0 | ENSG00000139547 | nan | nan
chr12	GPR182	605307.0 | ADMR, AMR | Adrenomedullin receptor | 11318.0 | ENSG00000166856 | nan | nan
chr12	ZBTB39	619384.0 | ZBTB39, ZNF922, KIAA0352 | Zinc finger- and BTB domain-containing protein 39 | 9880.0 | ENSG00000166860 | nan | nan
chr12	TAC3	162330.0 | TAC3, NKNB, HH10 | Tachykinin 3 (neuromedin K, neurokinin B) | 6866.0 | ENSG00000166863 | nan | Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3), Autosomal recessive
chr12	MYO1A	601478.0 | MYO1A | Myosin IA | 4640.0 | ENSG00000166866 | nan | nan
chr12	NEMP1	616496.0 | NEMP1, TMEM194A | Nuclear envelope integral membrane protein 1 | 23306.0 | ENSG00000166881 | nan | nan
chr12	NAB2	602381.0 | NAB2 | NGFIA-binding protein-2 | 4665.0 | ENSG00000166886 | nan | nan
chr12	STAT6	601512.0 | STAT6, HIES6 | Signal transducer and activator of transcription-6, interleukin-4 induced | 6778.0 | ENSG00000166888 | nan | Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections, 620532 (3), Autosomal dominant
chr12	LRP1	107770.0 | LRP1, A2MR, KPA, DDH3 | Low density lipoprotein-related protein-1 (alpha-2-macroglobulin receptor) | 4035.0 | ENSG00000123384 | mutation identified in 1 KPA family | ?Keratosis pilaris atrophicans, 604093 (3), Autosomal recessive; Developmental dysplasia of the hip 3, 620690 (3), Autosomal dominant
chr12	NXPH4	604637.0 | NXPH4, NPH4 | Neuroexophilin 4 | 11247.0 | ENSG00000182379 | nan | nan
chr12	SHMT2	138450.0 | SHMT2, GLYA, NEDCASB | Serine hydroxymethyltransferase | 6472.0 | ENSG00000182199 | glycine A auxotroph | Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities, 619121 (3), Autosomal recessive
chr12	STAC3	615521.0 | STAC3, NAM, CMYO13 | SH3 and cystein-rich domains 3 | 246329.0 | ENSG00000185482 | nan | Congenital myopathy 13, 255995 (3), Autosomal recessive
chr12	R3HDM2	619886.0 | R3HDM2, KIAA1002 | R3H domain-containing protein 2 | 22864.0 | ENSG00000179912 | nan | nan
chr12	INHBC	601233.0 | INHBC | Inhibin, beta C | 3626.0 | ENSG00000175189 | nan | nan
chr12	INHBE	612031.0 | INHBE | Inhibin, beta E | 83729.0 | ENSG00000139269 | nan | nan
chr12	GLI1	165220.0 | GLI1, PAPA8, PPD1 | GLI family zinc finger 1 | 2735.0 | ENSG00000111087 | mutation identified in 1 PPD1 family | Polydactyly, preaxial I, 174400 (3), Autosomal recessive; Polydactyly, postaxial, type A8, 618123 (3), Autosomal recessive
chr12	ARHGAP9	610576.0 | ARHGAP9 | Rho GTPase-activating protein 9 | 64333.0 | ENSG00000123329 | nan | nan
chr12	MARS1	156560.0 | MARS1, MARS, MTRNS, METRS, ILLD, CMT2U, TTD9, SPG70 | Methioninyl-tRNA synthetase 1 | 4141.0 | ENSG00000166986 | mutation identified in 1 TTD9 patient | Spastic paraplegia 70, autosomal recessive, 620323 (3), Autosomal recessive; Interstitial lung and liver disease, 615486 (3), Autosomal recessive; ?Trichothiodystrophy 9, nonphotosensitive, 619692 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3), Autosomal dominant
chr12	DDIT3	126337.0 | DDIT3, GADD153, CHOP10 | DNA-damage-inducible transcript-3 | 1649.0 | ENSG00000175197 | fused with FUS in myxoid liposarcoma | nan
chr12	MIR616	614489.0 | MIR616 | Micro RNA 616 | 693201.0 | ENSG00000208028 | nan | nan
chr12	MBD6	619458.0 | MBD6, KIAA1887 | Methyl-CpG-binding domain protein 6 | 114785.0 | ENSG00000166987 | nan | nan
chr12	DCTN2	607376.0 | DCTN2, DCTN50 | Dynactin 2 | 10540.0 | ENSG00000175203 | nan | nan
chr12	KIF5A	602821.0 | KIF5A, NKHC, SPG10, NEIMY, ALS25 | Kinesin family member 5A | 3798.0 | ENSG00000155980 | nan | Myoclonus, intractable, neonatal, 617235 (3), Autosomal dominant; {Amyotrophic lateral sclerosis, susceptibility to, 25}, 617921 (3), Autosomal dominant; Spastic paraplegia 10, autosomal dominant, 604187 (3), Autosomal dominant
chr12	PIP4K2C	617104.0 | PIP4K2C, PIP5K2C | Phosphatidylinositol 5-phosphate 4-kinase, type II, gamma | 79837.0 | ENSG00000166908 | nan | nan
chr12	DTX3	613142.0 | DTX3 | Deltex E3 ubiquitin ligase 3 | 196403.0 | ENSG00000178498 | nan | nan
chr12	ARHGEF25	610215.0 | ARHGEF25, GEFT | Rho guanine nucleotide exchange factor 25 | 115557.0 | ENSG00000240771 | nan | nan
chr12	B4GALNT1	601873.0 | B4GALNT1, GALGT, GALNACT, SPG26 | Beta-1,4-N-acetylgalactosaminyltransferase 1 | 2583.0 | ENSG00000135454 | nan | Spastic paraplegia 26, autosomal recessive, 609195 (3), Autosomal recessive
chr12	OS9	609677.0 | OS9 | OS9 endoplasmic reticulum lectin | 10956.0 | ENSG00000135506 | nan | nan
chr12		177700.0 | GLC1P | Glaucoma 1, open angle, P | nan | nan | caused by 300kb duplication | Glaucoma 1, open angle, P, 177700 (4), Autosomal dominant
chr12		614354.0 | PRO2268 | PRO2268 gene | 55390.0 | nan | nan | nan
chr12	AGAP2	605476.0 | AGAP2, CENTG1, PIKE | ARF-GAP with GTP-binding protein-like, ankyrin repeat, and pleckstrin homology domains 2 | 116986.0 | ENSG00000135439 | nan | nan
chr12	TSPAN31	181035.0 | TSPAN31, SAS | Tetraspanin 31 | 6302.0 | ENSG00000135452 | nan | nan
chr12	CDK4	123829.0 | CDK4, CMM3 | Cyclin-dependent kinase 4 | 1019.0 | ENSG00000135446 | nan | {Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant
chr12	MARCHF9	613336.0 | MARCH9 | Membrane-associated RING-CH finger protein 9 | 92979.0 | ENSG00000139266 | nan | nan
chr12	CYP27B1	609506.0 | CYP27B1, VDD1, PDDR | Cytochrome P450, subfamily XXVIIB, polypeptide 1 | 1594.0 | ENSG00000111012 | nan | Vitamin D-dependent rickets, type I, 264700 (3), Autosomal recessive
chr12	METTL1	604466.0 | METTL1 | Methyltransferase 1, tRNA methylguanosine | 4234.0 | ENSG00000037897 | nan | nan
chr12	EEF1AKMT3	615258.0 | EEF1AKMT3, METTL21B, FAM119B | EEF1A lysine methyltransferase 3 | 25895.0 | ENSG00000123427 | nan | nan
chr12	TSFM	604723.0 | TSFM, COXPD3 | Ts translation elongation factor, mitochondrial | 10102.0 | ENSG00000123297 | nan | Combined oxidative phosphorylation deficiency 3, 610505 (3), Autosomal recessive
chr12	AVIL	613397.0 | AVIL, NPHS21 | Advillin | 10677.0 | ENSG00000135407 | nan | Nephrotic syndrome, type 21, 618594 (3), Autosomal recessive
chr12	CTDSP2	608711.0 | CTDSP2, SCP2, OS4 | CTD small phosphatase 2 | 10106.0 | ENSG00000175215 | nan | nan
chr12	MIR26A2	613057.0 | MIR26A2, MIRN26A2 | Micro RNA 26A2 | 407016.0 | ENSG00000207789 | nan | nan
chr12	ATP23	619760.0 | ATP23, KUB3, XRCC6BP1 | ATP23 metallopeptidase and ATP synthase assembly factor homolog | 91419.0 | ENSG00000166896 | nan | nan
chr12	LRIG3	608870.0 | LIRG3, LIG3 | Leucine-rich repeats- and immunoglobulin-like domains-containing protein 3 | 121227.0 | ENSG00000139263 | nan | nan
chr12	SLC16A7	603654.0 | SLC16A7, MCT2 | Solute carrier family 16 (monocarboxylic acid transporters), member 7 | 9194.0 | ENSG00000118596 | nan | nan
chr12	TAFA2	617496.0 | FAM19A2, TAFA2 | Family with sequence similarity 19, member A2, CC motif chemokine-like | 338811.0 | ENSG00000198673 | nan | nan
chr12	USP15	604731.0 | USP15 | Ubiquitin-specific protease 15 | 9958.0 | ENSG00000135655 | nan | nan
chr12	MON2	616822.0 | MON2, KIAA1040 | Mon2, S. cerevisiae, homolog of | 23041.0 | ENSG00000061987 | nan | nan
chr12	MIRLET7I	612148.0 | MIRLET7I, LET7I, MIRNLET7I | Micro RNA Let7i | 406891.0 | ENSG00000199179 | nan | nan
chr12	PPM1H	616016.0 | PPM1H, KIAA1157 | Protein phosphatase, magnesium/manganese-dependent, 1H | 57460.0 | ENSG00000111110 | nan | nan
chr12	AUTS13	610908.0 | AUTS13 | Autism, susceptibility to, 13 | 100188317.0 | nan | linkage with rs1445442 | {Autism susceptibility 13}, 610908 (2)
chr12	AVPR1A	600821.0 | AVPR1A | Arginine vasopressin receptor-1A | 552.0 | ENSG00000166148 | nan | nan
chr12	DPY19L2	613893.0 | DPY19L2, SPGF9 | DPY19-like 2 | 283417.0 | ENSG00000177990 | pseudogene on 7p14.3 | Spermatogenic failure 9, 613958 (3), Autosomal recessive
chr12	RXYLT1	605862.0 | RXYLT1, TMEM5, MDDGA10 | Ribitol xylosyltransferase 1 | 10329.0 | ENSG00000118600 | nan | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3), Autosomal recessive
chr12	SRGAP1	606523.0 | SRGAP1, KIAA1304, NMTC2 | Slit-robo GTPase-activating protein, rho, 1 | 57522.0 | ENSG00000196935 | nan | {Thyroid cancer, nonmedullary, 2}, 188470 (3), Somatic mutation, Autosomal dominant
chr12	KICS2	617420.0 | KICS2, C12orf66 | KICSTOR subunit 2 | 144577.0 | ENSG00000174206 | nan | nan
chr12	XPOT	603180.0 | XPOT | Exportin, tRNA | 11260.0 | ENSG00000184575 | nan | nan
chr12	TBK1	604834.0 | TBK1, NAK, FTDALS4, IIAE8, AIARV | TANK-binding kinase 1 | 29110.0 | ENSG00000183735 | nan | {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}, 617900 (3), Autosomal dominant; Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3), Autosomal dominant; Autoinflammation with arthritis and vasculitis, 620880 (3), Autosomal recessive
chr12	RASSF3	607019.0 | RASSF3 | Ras association domain family protein 3 | 283349.0 | ENSG00000153179 | nan | nan
chr12		611547.0 | STQTL9 | Stature quantitative trait locus 9 | nan | nan | associated with rs1042725 | {Stature QTL 9}, 611547 (2)
chr12	GNS	607664.0 | GNS, G6S | N-acetylglucosamine-6-sulfatase | 2799.0 | ENSG00000135677 | nan | Mucopolysaccharidosis type IIID, 252940 (3), Autosomal recessive
chr12	TBC1D30	615077.0 | TBC1D30, KIAA0984 | TBC1 domain family, member 30 | 23329.0 | ENSG00000111490 | nan | nan
chr12	WIF1	605186.0 | WIF1 | WNT inhibitory factor 1 | 11197.0 | ENSG00000156076 | nan | nan
chr12	LEMD3	607844.0 | LEMD3, MAN1 | LEM domain-containing 3 | 23592.0 | ENSG00000174106 | nan | Buschke-Ollendorff syndrome, 166700 (3), Autosomal dominant; Osteopoikilosis with or without melorheostosis, 166700 (3), Autosomal dominant
chr12	MSRB3	613719.0 | MSRB3, DFNB74 | Methionine sulfoxide reductase B3 | 253827.0 | ENSG00000174099 | nan | Deafness, autosomal recessive 74, 613718 (3), Autosomal recessive
chr12	HMGA2	600698.0 | HMGA2, HMGIC, BABL, SRS5 | High-mobility group AT-hook 2 | 8091.0 | ENSG00000149948 | fusion partners with RAD51B, ALDH2, COX6C, HEI10 in uterine leiomyomas | Silver-Russell syndrome 5, 618908 (3), Autosomal dominant
chr12	LLPH	616998.0 | LLPH | LLP, Aplysia, homolog of | 84298.0 | ENSG00000139233 | nan | nan
chr12	TMBIM4	616874.0 | TMBIM4, GAAP, S1R | Transmembrane BAX inhibitor motif-containing protein 4 | 51643.0 | ENSG00000155957 | nan | nan
chr12	IRAK3	604459.0 | IRAK3, IRAKM, ASRT5 | Interleukin 1 receptor-associated kinase 3 | 11213.0 | ENSG00000090376 | nan | {Asthma susceptibility 5}, 611064 (3)
chr12	HELB	614539.0 | HELB, HDHB | Helicase, DNA, B | 92797.0 | ENSG00000127311 | nan | nan
chr12	GRIP1	604597.0 | GRIP1, FRASRS3 | Glutamate receptor-interacting protein 1 | 23426.0 | ENSG00000155974 | nan | Fraser syndrome 3, 617667 (3), Autosomal recessive
chr12	CAND1	607727.0 | CAND1, TIP120A, TIP120, KIAA0829 | Cullin-associated neddylation-dissociated protein 1 | 55832.0 | ENSG00000111530 | nan | nan
chr12	IBD26	612639.0 | IBD26 | Inflammatory bowel disease 26 | 100271838.0 | nan | associated with rs1558744 | {Inflammatory bowel disease 26}, 612639 (2)
chr12	DYRK2	603496.0 | DYRK2 | Dual-specificity tyrosine phosphorylation-regulated kinase 2 | 8445.0 | ENSG00000127334 | nan | nan
chr12	IFNG	147570.0 | IFNG, IFG, IFI, IMD69 | Interferon, gamma | 3458.0 | ENSG00000111537 | mutation identified in 1 IMD69 family | {Hepatitis C virus, response to therapy of}, 609532 (3); {TSC2 angiomyolipomas, renal, modifier of}, 613254 (3), Autosomal dominant; {Aplastic anemia}, 609135 (3); ?Immunodeficiency 69, mycobacteriosis, 618963 (3), Autosomal recessive; {Tuberculosis, protection against}, 607948 (3); {AIDS, rapid progression to}, 609423 (3)
chr12	IL26	605679.0 | IL26, AK155 | Interleukin 26 | 55801.0 | ENSG00000111536 | nan | nan
chr12	IL22	605330.0 | IL22, IL21, ILTIF | Interleukin 22 | 50616.0 | ENSG00000127318 | nan | nan
chr12	MDM1	613813.0 | MDM1 | MDM1 nuclear protein | 56890.0 | ENSG00000111554 | nan | nan
chr12	RAP1B	179530.0 | RAP1B, THC11 | RAS-related protein RAP1B | 5908.0 | ENSG00000127314 | nan | Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies, 620654 (3), Autosomal dominant
chr12	NUP107	607617.0 | NUP107, NUP84, NPHS11, ODG6; GAMOS7 | Nucleoporin, 107kD | 57122.0 | ENSG00000111581 | mutation identified in 1 ODG6 family | ?Ovarian dysgenesis 6, 618078 (3), Autosomal recessive; Galloway-Mowat syndrome 7, 618348 (3), Autosomal recessive; Nephrotic syndrome, type 11, 616730 (3), Autosomal recessive
chr12	SLC35E3	620355.0 | SLC35E3, BLOV1 | Solute carrier family 35, member E3 | 55508.0 | ENSG00000175782 | nan | nan
chr12	MDM2	164785.0 | MDM2, ACTFS, LSKB | MDM2 protooncogene | 4193.0 | ENSG00000135679 | mutation identified in 1 LSKB patient | {Accelerated tumor formation, susceptibility to}, 614401 (3), Autosomal dominant; ?Lessel-Kubisch syndrome, 618681 (3), Autosomal recessive
chr12	CPM	114860.0 | CPM | Carboxypeptidase M | 1368.0 | ENSG00000135678 | nan | nan
chr12	CPSF6	604979.0 | CPSF6, CFIM | Cleavage and polyadenylation specific factor 6, 68kD subunit | 11052.0 | ENSG00000111605 | nan | nan
chr12	LYZ	153450.0 | LYZ, AMYLD5 | Lysozyme | 4069.0 | ENSG00000090382 | nan | Amyloidosis, hereditary systemic 5, 620658 (3)
chr12	YEATS4	602116.0 | YEATS4, GAS41 | YEATS domain-containing protein 4 | 8089.0 | ENSG00000127337 | nan | nan
chr12	FRS2	607743.0 | FRS2, FRS1A, SNT1 | Fibroblast growth factor receptor substrate 2 | 10818.0 | ENSG00000166225 | nan | nan
chr12	CCT2	605139.0 | CCT2, CCTB | Chaperonin containing T-complex polypeptide 1, subunit 2 | 10576.0 | ENSG00000166226 | nan | nan
chr12	LRRC10	610846.0 | LRRC10, HRLRRP | Leucine-rich repeat-containing protein 10 | 376132.0 | ENSG00000198812 | nan | nan
chr12	BEST3	607337.0 | BEST3, VMD2L3 | Bestrophin 3 | 144453.0 | ENSG00000127325 | nan | nan
chr12	RAB3IP	608686.0 | RAB3IP, RABIN8, RABIN3 | RAB3A-interacting protein | 117177.0 | ENSG00000127328 | nan | nan
chr12	PRANCR	619085.0 | PRANCR, LINC01481 | Progenitor renewal-associated noncoding RNA | 101928062.0 | ENSG00000257815 | nan | nan
chr12	CNOT2	604909.0 | CNOT2, NOT2, IDNADFS | CCR4-NOT transcription complex, subunit 2 | 4848.0 | ENSG00000111596 | nan | Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies, 618608 (3), Autosomal dominant
chr12	KCNMB4	605223.0 | KCNMB4 | Potassium large conductance calcium-activated channel, subfamily M, beta member 4 | 27345.0 | ENSG00000135643 | nan | nan
chr12	PTPRB	176882.0 | PTPRB | Protein tyrosine phosphatase, receptor type, beta polypeptide | 5787.0 | ENSG00000127329 | nan | nan
chr12	PTPRR	602853.0 | PTPRR, PCPTP1 | Protein-tyrosine phosphatase, receptor type, R | 5801.0 | ENSG00000153233 | nan | nan
chr12	DUH2	612715.0 | DUH2 | Dyschromatosis universalis hereditaria 2 | 100301525.0 | nan | between rs1921045 and rs2373584 | Dyschromatosis universalis hereditaria 2, 612715 (2)
chr12	MYP3	603221.0 | MYP3 | Myopia, high grade, 3, autosomal dominant | 8782.0 | nan | nan | Myopia-3, 603221 (2), Autosomal dominant
chr12	PEPB	169900.0 | PEPB | Peptidase B | 5182.0 | nan | nan | nan
chr12	TSPAN8	600769.0 | TSPAN8, TM4SF3 | Tetraspanin 8 | 7103.0 | ENSG00000127324 | nan | nan
chr12	LGR5	606667.0 | LGR5, GPR49 | Leucine-rich repeat-containing G protein-coupled receptor 5 | 8549.0 | ENSG00000139292 | nan | nan
chr12	ZFC3H1	620956.0 | ZFC3H1, PSRC2, CCDC131, CSRC2 | Zinc finger C3H1 domain-containing protein | 196441.0 | ENSG00000133858 | nan | nan
chr12	THAP2	612531.0 | THAP2 | THAP domain-containing protein 2 | 83591.0 | ENSG00000173451 | nan | nan
chr12	RAB21	612398.0 | RAB21, KIAA0118 | RAB-associated protein RAB21 | 23011.0 | ENSG00000080371 | nan | nan
chr12	TBC1D15	612662.0 | TBC1D15 | TBC1 domain family, member 15 | 64786.0 | ENSG00000121749 | nan | nan
chr12	TPH2	607478.0 | TPH2, NTPH, ADHD7 | Tryptophan hydroxylase 2 | 121278.0 | ENSG00000139287 | mutation identified in 1 ADHD7 family | {?Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3); {Unipolar depression, susceptibility to}, 608516 (3)
chr12	TRHDE	606950.0 | TRHDE | Thyrotropin-releasing hormone-degrading ectoenzyme | 29953.0 | ENSG00000072657 | nan | nan
chr12	ATXN7L3B	615579.0 | ATXN7L3B | Ataxin 7-like 3B | 552889.0 | ENSG00000253719 | nan | nan
chr12	KCNC2	176256.0 | KCNC2, DEE103 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | 3747.0 | ENSG00000166006 | previously on 19q13.3-q13.4 | Developmental and epileptic encephalopathy 103, 619913 (3), Autosomal dominant
chr12	CAPS2	607724.0 | CAPS2 | Calcyphosine 2 | 84698.0 | ENSG00000180881 | nan | nan
chr12	GLIPR1L1	610395.0 | GLIPR1L1 | GLIPR1-like protein 1 | 256710.0 | ENSG00000173401 | nan | nan
chr12	GLIPR1L2	610394.0 | GLIPR1L2 | GLIPR1-like protein 2 | 144321.0 | ENSG00000180481 | nan | nan
chr12	GLIPR1	602692.0 | GLIPR1, GLIPR, RTVP1 | Glioma pathogenesis-related protein 1 | 11010.0 | ENSG00000139278 | nan | nan
chr12	KRR1	612817.0 | KRR1 | KRR1 small subunitprocessome component homolog | 11103.0 | ENSG00000111615 | nan | nan
chr12	PHLDA1	605335.0 | PHLDA1, TDAG51 | Pleckstrin homology-like domain, family A, member 1 | 22822.0 | ENSG00000139289 | nan | nan
chr12	NAP1L1	164060.0 | NAP1L1, NAP1L | Nucleosome assembly protein 1-like 1 | 4673.0 | ENSG00000187109 | nan | nan
chr12	BBS10	610148.0 | BBS10, C12orf58, FLJ23560 | BBS10 gene | 79738.0 | ENSG00000179941 | nan | Bardet-Biedl syndrome 10, 615987 (3), Autosomal recessive
chr12	OSBPL8	606736.0 | OSBPL8, ORP8, KIAA1451 | Oxysterol-binding protein-like protein 8 | 114882.0 | ENSG00000091039 | nan | nan
chr12	ZDHHC17	607799.0 | ZDHHC17, HIP14 | Zinc finger DHHC domain-containing protein 17 | 23390.0 | ENSG00000186908 | nan | nan
chr12	CSRP2	601871.0 | CSRP2, LMO5 | Cysteine and glycine-rich protein-2 (LIM domain only 5, smooth muscle) | 1466.0 | ENSG00000175183 | pseudogene on 3q21.1 | nan
chr12	E2F7	612046.0 | E2F7 | E2F transcription factor 7 | 144455.0 | ENSG00000165891 | nan | nan
chr12	NAV3	611629.0 | NAV3, POMFIl1, KIAA0938 | Neuron navigator 3 | 89795.0 | ENSG00000067798 | nan | nan
chr12	SYT1	185605.0 | SYT1, BAGOS | Synaptotagmin-1 | 6857.0 | ENSG00000067715 | nan | Baker-Gordon syndrome, 618218 (3), Autosomal dominant
chr12	PAWR	601936.0 | PAWR, PAR4 | PRKC, apoptosis, WT1, regulator | 5074.0 | ENSG00000177425 | nan | nan
chr12	PPP1R12A	602021.0 | PPP1R12A, MYPT1, GUBS | Protein phosphatase 1, regulatory subunit 12A (myosin phosphatase target subunit 1) | 4659.0 | ENSG00000058272 | nan | Genitourinary and/or/brain malformation syndrome, 618820 (3), Autosomal dominant
chr12	OTOGL	614925.0 | OTOGL, C12orf64, DFNB84B | Otogelin-like protein | 283310.0 | ENSG00000165899 | nan | Deafness, autosomal recessive 84B, 614944 (3), Autosomal recessive
chr12	PTPRQ	603317.0 | PTPRQ, PTPGMC1, DFNB84A, DFNA73 | Protein-tyrosine phosphatase, receptor-type, Q | 374462.0 | ENSG00000139304 | mutation identified in 1 DFNA73 family | Deafness, autosomal dominant 73, 617663 (3), Autosomal dominant; Deafness, autosomal recessive 84A, 613391 (3), Autosomal recessive
chr12	MYF6	159991.0 | MYF6, CNM3 | Myogenic factor-6 | 4618.0 | ENSG00000111046 | nan | nan
chr12	MYF5	159990.0 | MYF5, EORVA | Myogenic factor-5 | 4617.0 | ENSG00000111049 | nan | Ophthalmoplegia, external, with rib and vertebral anomalies, 618155 (3), Autosomal recessive
chr12	LIN7A	603380.0 | LIN7A, VELI1, MALS1 | Lin7 homolog A, crumbs cell polarity complex component | 8825.0 | ENSG00000111052 | nan | nan
chr12	ACSS3	614356.0 | ACSS3 | Acyl-CoA synthetase short-chain family, member 3 | 79611.0 | ENSG00000111058 | nan | nan
chr12	PPFIA2	603143.0 | PPFIA2 | PTPRF-interacting protein alpha-2 | 8499.0 | ENSG00000139220 | nan | nan
chr12	CCDC59	619280.0 | CCDC59, BR22, TAP26 | Coiled-coil domain-containing protein 59 | 29080.0 | ENSG00000133773 | nan | nan
chr12	TMTC2	615856.0 | TMTC2 | Transmembrane and tetratricopeptide repeat domains-containing protein 2 | 160335.0 | ENSG00000179104 | nan | nan
chr12	SLC6A15	607971.0 | SLC6A15, SBAT1 | Solute carrier family 6 (neurotransmitter transporter), member 15 | 55117.0 | ENSG00000072041 | nan | nan
chr12	LRRIQ1	620922.0 | LRRIQ1 | Leucine-rich repeats- and IQ motif-containing protein 1 | 84125.0 | ENSG00000133640 | nan | nan
chr12	ALX1	601527.0 | ALX1, CART1, FND3 | Aristaless-like homeobox 1 (cartilage homeoprotein 1) | 8092.0 | ENSG00000180318 | nan | Frontonasal dysplasia 3, 613456 (3), Autosomal recessive
chr12	RASSF9	610383.0 | RASSF9, PAMCI, PCIP1 | Ras association domain family, member 9 | 9182.0 | ENSG00000198774 | nan | nan
chr12	NTS	162650.0 | NTS | Neurotensin | 4922.0 | ENSG00000133636 | nan | nan
chr12	MGAT4C	607385.0 | GNTIVH | UDP-N-acetylglucosamine:alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV | 25834.0 | ENSG00000182050 | nan | nan
chr12	CEP290	610142.0 | CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14 | Centrosomal protein, 290kD | 80184.0 | ENSG00000198707 | mutation identified in 1 BBS14 family | Leber congenital amaurosis 10, 611755 (3); Joubert syndrome 5, 610188 (3), Autosomal recessive; Senior-Loken syndrome 6, 610189 (3), Autosomal recessive; ?Bardet-Biedl syndrome 14, 615991 (3), Autosomal recessive; Meckel syndrome 4, 611134 (3), Autosomal recessive
chr12	TMTC3	617218.0 | TMTC3, SMILE, LIS8 | Transmembrane and tetratricopeptide repeat domains-containing protein 3 | 160418.0 | ENSG00000139324 | nan | Lissencephaly 8, 617255 (3), Autosomal recessive
chr12	KITLG	184745.0 | KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69, WS2F | KIT ligand (mast cell growth factor; steel, mouse, homolog of) | 4254.0 | ENSG00000049130 | associated with dbSNP rs12821256 | Hyperpigmentation with or without hypopigmentation, 145250 (3), Autosomal dominant; Waardenburg syndrome, type 2F, 619947 (3), Autosomal recessive; Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3), Autosomal dominant; [Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)
chr12	CNA1	121400.0 | CNA1 | Cornea plana 1, autosomal dominant | 1255.0 | nan | between D12S82 and D12S351 | Cornea plana 1, autosomal dominant, 121400 (2), Autosomal dominant
chr12		612868.0 | PACD | Corneal dystrophy, posterior amorphous | nan | nan | contiguous gene deletion syndrome | Corneal dystrophy, posterior amorphous, 612868 (4), Autosomal dominant
chr12	DUSP6	602748.0 | DUSP6, MKP3, PYST1, HH19 | Dual-specificity phosphatase-6 | 1848.0 | ENSG00000139318 | nan | Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3), Autosomal dominant
chr12	POC1B	614784.0 | POC1B, PIX1, CORD20 | POC1B antisense RNA 1 | 282809.0 | ENSG00000139323 | nan | Cone-rod dystrophy 20, 615973 (3), Autosomal recessive
chr12	GALNT4	603565.0 | GALNT4, GalNAcT4 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 | 8693.0 | ENSG00000257594 | nan | nan
chr12	ATP2B1	108731.0 | ATP2B1, PMCA1, MRD66 | ATPase, Ca++ transporting, plasma membrane, 1 | 490.0 | ENSG00000070961 | nan | Intellectual developmental disorder, autosomal dominant 66, 619910 (3), Autosomal dominant
chr12	CCER1	620881.0 | CCER1 | Coiled-coil glutamate-rich protein 1 | 196477.0 | ENSG00000197651 | nan | nan
chr12	EPYC	601657.0 | EPYC, DSPG3 | Epiphycan | 1833.0 | ENSG00000083782 | nan | nan
chr12	KERA	603288.0 | KERA, CNA2 | Keratocan | 11081.0 | ENSG00000139330 | nan | Cornea plana 2, autosomal recessive, 217300 (3), Autosomal recessive
chr12	LUM	600616.0 | LUM, LDC | Lumican | 4060.0 | ENSG00000139329 | nan | nan
chr12	DCN	125255.0 | DCN, CSCD | Decorin | 1634.0 | ENSG00000011465 | conflicting assignments to 12q23 and 12q13.2 | Corneal dystrophy, congenital stromal, 610048 (3), Autosomal dominant
chr12	BTG1	109580.0 | BTG1 | BTG antiproliferation factor 1 | 694.0 | ENSG00000133639 | nan | nan
chr12	ETL2	608096.0 | ETL2, FTLE | Epilepsy, familial temporal lobe | 619399.0 | nan | max lod at D12S1706 | Epilepsy, familial temporal lobe, 2, 608096 (2), Autosomal dominant
chr12	MDD1	608520.0 | MDD1 | Major depressive disorder | 431708.0 | nan | max lod with D12S1706 | Major depressive disorder 1, 608516 (2)
chr12	CLLU1-AS1	616989.0 | CLLU1OS | Chronic lymphocytic leukemia upregulated 1, opposite strand | 574016.0 | ENSG00000205057 | nan | nan
chr12	CLLU1	616988.0 | CLLU1 | Chronic lymphocytic leukemia upregulated gene 1 | 574028.0 | ENSG00000257127 | nan | nan
chr12	EEA1	605070.0 | EEA1 | Early endosome antigen 1 | 8411.0 | ENSG00000102189 | nan | nan
chr12	NUDT4	609229.0 | NUDT4, DIPP2, KIAA0487 | Nudix hydrolase 4 | 11163.0 | ENSG00000173598 | nan | nan
chr12	UBE2N	603679.0 | UBE2N, UBCHBEN, UBC13 | Ubiquitin-conjugating enzyme E2 N | 7334.0 | ENSG00000177889 | nan | nan
chr12	MRPL42	611847.0 | MRPL42, MRPL31, MRPS32 | Mitochondrial ribosomal protein L42 | 28977.0 | ENSG00000198015 | nan | nan
chr12	SOCS2-AS1	617269.0 | SOCS2AS1 | SOCS2 antisense RNA 1 | 144481.0 | ENSG00000246985 | nan | nan
chr12	SOCS2	605117.0 | SOCS2, STATI2, CIS2 | Suppressor of cytokine signaling 2 | 8835.0 | ENSG00000120833 | nan | nan
chr12	CRADD	603454.0 | CRADD, RAIDD, MRT34 | Caspase and RIP adaptor with death domain | 8738.0 | ENSG00000169372 | nan | Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly, 614499 (3), Autosomal recessive
chr12	CEP83	615847.0 | CEP83, CCDC41, NPHP18 | Centrosomal protein, 83kD | 51134.0 | ENSG00000173588 | nan | Nephronophthisis 18, 615862 (3), Autosomal recessive
chr12	PLXNC1	604259.0 | VESPR | Virus-encoded semaphorin protein receptor | 10154.0 | ENSG00000136040 | nan | nan
chr12	TMCC3	617459.0 | TMCC3 | Transmembrane and coiled-coil domain family, member 3 | 57458.0 | ENSG00000057704 | nan | nan
chr12	MIR492	614384.0 | MIR492 | Micro RNA 492 | 574449.0 | ENSG00000283998 | within KRT19 | nan
chr12	NDUFA12	614530.0 | NDUFA12, MC1DN23 | NADH-ubiquinone oxidoreductase subunit A12 | 55967.0 | ENSG00000184752 | nan | Mitochondrial complex I deficiency, nuclear type 23, 618244 (3), Autosomal recessive
chr12	NR2C1	601529.0 | NR2C1, TR2 | Nuclear receptor subfamily 2, group C, member 1 | 7181.0 | ENSG00000120798 | nan | nan
chr12	FGD6	613520.0 | FGD6, ZFYVE24 | FYVE, RhoGEF, and ph domain-containing protein 6 | 55785.0 | ENSG00000180263 | nan | nan
chr12	VEZT	619749.0 | VEZT | Vezatin, adherens junctions transmembrane protein | 55591.0 | ENSG00000028203 | nan | nan
chr12	METAP2	601870.0 | METAP2, p67 | Methionine aminopeptidase 2 | 10988.0 | ENSG00000111142 | nan | nan
chr12	USP44	610993.0 | USP44 | Ubiquitin-specific protease 44 | 84101.0 | ENSG00000136014 | nan | nan
chr12	NTN4	610401.0 | NTN4 | Netrin 4 | 59277.0 | ENSG00000074527 | nan | nan
chr12	SPG36	613096.0 | SPG36 | Spastic paraplegia-36 | 791228.0 | nan | between D12S360 and D12S354 | Spastic paraplegia 36, autosomal dominant, 613096 (2), Autosomal dominant
chr12	SNRPF	603541.0 | SNRPF | Small nuclear ribonucleoprotein polypeptide F | 6636.0 | ENSG00000139343 | nan | nan
chr12	AMDHD1	620863.0 | AMDHD1 | Amidohydrolase domain-containing protein 1 | 144193.0 | ENSG00000139344 | nan | nan
chr12	HAL	609457.0 | HAL, HSTD | Histidine ammonia-lyase (histidase) | 3034.0 | ENSG00000084110 | nan | [Histidinemia], 235800 (3), Autosomal recessive, Autosomal dominant
chr12	LTA4H	151570.0 | LTA4H | Leukotriene A4 hydrolase | 4048.0 | ENSG00000111144 | nan | nan
chr12	ELK3	600247.0 | ELK3, SAP2, ERP | ELK3, ETS-domain protein (SRF accessory protein 2) | 2004.0 | ENSG00000111145 | nan | nan
chr12	CDK17	603440.0 | CDK17, PCTK2, PCTAIRE2 | Cyclin-dependent kinase 17 | 5128.0 | ENSG00000059758 | nan | nan
chr12	NEDD1	600372.0 | NEDD1 | Neural precursor cell expressed, developmentally down-regulated 1 | 121441.0 | ENSG00000139350 | nan | nan
chr12	RMST	607045.0 | RMST, NCRMS, NCRNA00054 | Rhabdomyosarcoma 2-associated transcript | 196475.0 | ENSG00000255794 | nan | nan
chr12	TMPO	188380.0 | TMPO, LAP2 | Thymopoietin | 7112.0 | ENSG00000120802 | nan | nan
chr12	SLC25A3	600370.0 | SLC25A3, PHC | Solute carrier family 25 (mitochondrial carrier), member 3 | 5250.0 | ENSG00000075415 | nan | Mitochondrial phosphate carrier deficiency, 610773 (3), Autosomal recessive
chr12	IKBIP	609861.0 | IKIP | I-kappa-B kinase-interacting protein | 121457.0 | ENSG00000166130 | nan | nan
chr12	APAF1	602233.0 | APAF1 | Apoptotic protease activating factor 1 | 317.0 | ENSG00000120868 | nan | nan
chr12	ANKS1B	607815.0 | ANKS1B, EB1 | Ankyrin repeat and sterile alpha motif domain-containing protein 1B | 56899.0 | ENSG00000185046 | nan | nan
chr12	BLTP3B	619811.0 | UHRF1BP1L, SHIP164, KIAA0701 | UHRF1-binding protein 1-like | 23074.0 | ENSG00000111647 | nan | nan
chr12	ACTR6	619729.0 | ACTR6, ARP6 | Actin-related protein 6 | 64431.0 | ENSG00000075089 | nan | nan
chr12	SCYL2	616365.0 | SCYL2, CVAK104, KIAA1360, AMC4 | SCY1-like protein 2 | 55681.0 | ENSG00000136021 | nan | Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum, 618766 (3), Autosomal recessive
chr12	SLC17A8	607557.0 | SLC17A8, VGLUT3, DFNA25 | Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 (vesicular glutamate transporter 3) | 246213.0 | ENSG00000179520 | nan | Deafness, autosomal dominant 25, 605583 (3), Autosomal dominant
chr12	NR1H4	603826.0 | NR1H4, FXR, RIP14, PFIC5 | Nuclear receptor subfamily 1 group H member 4 | 9971.0 | ENSG00000012504 | nan | Cholestasis, progressive familial intrahepatic, 5, 617049 (3), Autosomal recessive
chr12	GAS2L3	617224.0 | GAS2L3, G2L3 | Growth arrest-specific 2-like 3 | 283431.0 | ENSG00000139354 | nan | nan
chr12	ANO4	610111.0 | TMEM16D, FLJ34272 | Transmembrane protein 16D | 121601.0 | ENSG00000151572 | nan | nan
chr12	SLC5A8	608044.0 | SLC5A8, AIT, SMCT | Solute carrier family (iodide transporter), member 8 | 160728.0 | ENSG00000256870 | nan | nan
chr12	HELLPAR	614985.0 | HELLPAR, lncHELLP | HELLP syndrome-associated long noncoding RNA | 101101692.0 | nan | nan | nan
chr12	UTP20	612822.0 | UTP20, DRIM | UTP20 small subunit processome component | 27340.0 | ENSG00000120800 | nan | nan
chr12	ARL1	603425.0 | ARL1 | ADP ribosylation factor-like GTPase 1 | 400.0 | ENSG00000120805 | nan | nan
chr12	SPIC	612568.0 | SPIC | SPIC transcription factor | 121599.0 | ENSG00000166211 | nan | nan
chr12	MYBPC1	160794.0 | MYBPC1, LCCS4, CMYO16 | Myosin-binding protein C, slow type | 4604.0 | ENSG00000196091 | nan | Congenital myopathy 16, 618524 (3), Autosomal dominant; Lethal congenital contracture syndrome 4, 614915 (3), Autosomal recessive; Arthrogryposis, distal, type 1B, 614335 (3), Autosomal dominant
chr12	CHPT1	616747.0 | CHPT1, CPT, CPT1 | Choline phosphotransferase 1 | 56994.0 | ENSG00000111666 | nan | nan
chr12	SYCP3	604759.0 | SYCP3, SCP3, COR1, SPGF4, RPRGL4 | Synaptonemal complex protein 3 | 50511.0 | ENSG00000139351 | nan | Pregnancy loss, recurrent, 4, 270960 (3), Autosomal dominant; Spermatogenic failure 4, 270960 (3), Autosomal dominant
chr12	GNPTAB	607840.0 | GNPTAB, GNPTA | N-acetylglucosamine-1-phosphate transferase, alpha/beta subunits | 79158.0 | ENSG00000111670 | conflicting assignment to 4q | Mucolipidosis III alpha/beta, 252600 (3), Autosomal recessive; Mucolipidosis II alpha/beta, 252500 (3), Autosomal recessive
chr12	DRAM1	610776.0 | DRAM1 | Damage-regulated autophagy modulator 1 | 55332.0 | ENSG00000136048 | nan | nan
chr12	WASHC3	619925.0 | WASHC3, CCDC53 | WASH complex, subunit 3 | 51019.0 | ENSG00000120860 | nan | nan
chr12	NUP37	609264.0 | NUP37, p37, MCPH24 | Nucleoporin, 37kD | 79023.0 | ENSG00000075188 | mutation identified in 1 MCPH24 family | ?Microcephaly 24, primary, autosomal recessive, 618179 (3), Autosomal recessive
chr12	PARPBP	613687.0 | C12orf48, AROM, PARPBP | Chromosome 12 open reading frame 48 | 55010.0 | ENSG00000185480 | nan | nan
chr12	PMCH	176795.0 | PMCH | Pro-melanin-concentrating hormone | 5367.0 | ENSG00000183395 | nan | nan
chr12	IGF1	147440.0 | IGF1 | Insulin-like growth factor-1, or somatomedin C | 3479.0 | ENSG00000017427 | nan | Insulin-like growth factor I deficiency, 608747 (3), Autosomal recessive
chr12	PAH	612349.0 | PAH, PKU1 | Phenylalanine hydroxylase | 5053.0 | ENSG00000171759 | close to IGF1 | [Hyperphenylalaninemia, non-PKU mild], 261600 (3), Autosomal recessive; Phenylketonuria, 261600 (3), Autosomal recessive
chr12	ASCL1	100790.0 | ASCL1, ASH1 | Achaete-scute family bHLH transcription factor 1 | 429.0 | ENSG00000139352 | distal to PAH and proximal to TRA1 | nan
chr12	STAB2	608561.0 | STAB2, FEEL2 | Stabilin 2 | 55576.0 | ENSG00000136011 | nan | nan
chr12	NT5DC3	611076.0 | NT5DC3, TU12B1TY, GNN | 5' nucleotidase domain-containing protein 3 | 51559.0 | ENSG00000111696 | nan | nan
chr12	HSP90B1	191175.0 | HSP90B1, TRA1, GRP94, GP96 | Heat-shock protein, 90kD, beta, 1 | 7184.0 | ENSG00000166598 | nan | nan
chr12	UQCC6	618812.0 | C12orf73, BR | Chromosome 12 open reading frame 73 (brawnin) | 728568.0 | ENSG00000204954 | nan | nan
chr12	TDG	601423.0 | TDG | Thymine-DNA glycosylase | 6996.0 | ENSG00000139372 | nan | nan
chr12	HCFC2	607926.0 | HCFC2, HCF2 | Host cell factor C2 | 29915.0 | ENSG00000111727 | nan | nan
chr12	NFYB	189904.0 | NFYB | Transcription factor NF-Y, B subunit | 4801.0 | ENSG00000120837 | nan | nan
chr12	TXNRD1	601112.0 | TXNRD1, TXNR | Thioredoxin reductase-1 | 7296.0 | ENSG00000198431 | nan | nan
chr12	EID3	612986.0 | EID3, NSMCE4B, NSE4B | E1A-like inhibitor of differentiation 3 | 493861.0 | ENSG00000255150 | nan | nan
chr12	CHST11	610128.0 | CHST11, C4ST1, OCBMD | Carbohydrate sulfotransferase 11 | 50515.0 | ENSG00000171310 | mutation identified in 1 OCBMD family | ?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits, 618167 (3), Autosomal recessive
chr12	SLC41A2	610802.0 | SLC41A2 | Solute carrier family 41, member 2 | 84102.0 | ENSG00000136052 | nan | nan
chr12	ALDH1L2	613584.0 | ALDH1L2 | Aldehyde dehydrogenase 1 family, member L2 | 160428.0 | ENSG00000136010 | nan | nan
chr12	WASHC4	615748.0 | WASHC4, KIAA1033, SWIP, MRT43 | WASH complex, subunit 4 | 23325.0 | ENSG00000136051 | nan | Intellectual developmental disorder, autosomal recessive 43, 615817 (3), Autosomal recessive
chr12	APPL2	606231.0 | APPL2, FLJ10659 | Adaptor protein, phosphotyrosine interaction, PH domain, and leucine zipper-containing protein 2 | 55198.0 | ENSG00000136044 | nan | nan
chr12	NUAK1	608130.0 | NUAK1, ARK5,  KIAA0537 | NUAK family, SNF1-like kinase, 1 | 9891.0 | ENSG00000074590 | nan | nan
chr12	CKAP4	618595.0 | CKAP4, CLIMP63 | Cytoskeleton-associated protein 4 | 10970.0 | ENSG00000136026 | nan | nan
chr12	TCP11L2	619889.0 | TCP11L2 | T-complex protein 11-like 2 | 255394.0 | ENSG00000166046 | nan | nan
chr12	POLR3B	614366.0 | POLR3B, RPC2, C128, HLD8, CMT1I | Polymerase III, RNA, subunit B | 55703.0 | ENSG00000013503 | nan | Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3), Autosomal recessive; Charcot-Marie-Tooth disease, demyelinating, type 1I, 619742 (3), Autosomal dominant
chr12	RFX4	603958.0 | RFX4 | Regulatory factor X, 4 | 5992.0 | ENSG00000111783 | nan | nan
chr12	RIC8B	609147.0 | RIC8B | RIC8 guanine nucleotide exchange factor B | 55188.0 | ENSG00000111785 | nan | nan
chr12	MTERF2	616929.0 | MTERF2, MTERFD3 | Transcription termination factor 2, mitochondrial | 80298.0 | ENSG00000120832 | nan | nan
chr12	CRY1	601933.0 | CRY1, PHLL1, DSPD | Cryptochrome 1 (photolyase-like) | 1407.0 | ENSG00000008405 | nan | {Delayed sleep phase disorder, susceptibility to}, 614163 (3), Autosomal dominant
chr12	PWP1	620055.0 | PWP1, NCLB | PWP1 homolog, endonuclein | 11137.0 | ENSG00000136045 | nan | nan
chr12	PRDM4	605780.0 | PRDM4, PFM1 | PR domain-containing protein 4 | 11108.0 | ENSG00000110851 | nan | nan
chr12	ASCL4	609155.0 | ASCL4, HASH4 | Achaete-scute family bHLH transcription factor 4 | 121549.0 | ENSG00000187855 | nan | nan
chr12	WSCD2	619253.0 | WSCD2, KIAA0789 | WSC domain-containing protein 2 | 9671.0 | ENSG00000075035 | nan | nan
chr12	CMKLR1	602351.0 | CMKLR1 | Chemokine-like receptor 1 | 1240.0 | ENSG00000174600 | nan | nan
chr12	FICD	620875.0 | FICD, HYPE, SPG92 | FIC domain-containing protein adenylyltransferase | 11153.0 | ENSG00000198855 | nan | Spastic paraplegia 92, autosomal recessive, 620911 (3), Autosomal recessive
chr12	SART3	611684.0 | SART3, P100, KIAA0156, TIP110 | Spliceosome-associated factor 3, U4/U6 recycling protein | 9733.0 | ENSG00000075856 | nan | nan
chr12	ISCU	611911.0 | ISCU, HML | Iron-sulfur cluster assembly enzyme | 23479.0 | ENSG00000136003 | nan | Myopathy with lactic acidosis, hereditary, 255125 (3), Autosomal recessive
chr12	TMEM119	618989.0 | TMEM119, OBIF | Transmembrane protein 119 | 338773.0 | ENSG00000183160 | nan | nan
chr12	CELIAC13	612011.0 | CELIAC13 | Celiac disease, susceptibility to, 13 | 100188875.0 | nan | associated with rs3184504 | {Celiac disease, susceptibility to, 13}, 612011 (2)
chr12	CIMT	608447.0 | CIMT | Carotid intimal medial thickness | 404677.0 | nan | 161cM from pter; near SCARB1 | Carotid intimal medial thickness, 608447 (2)
chr12	PDA1	607411.0 | PDA1 | Patent ductus arteriosus | 100996949.0 | nan | nan | {Patent ductus arteriosus, susceptibility to}, 607411 (2), Autosomal recessive
chr12	POROK2	175850.0 | POROK2, PPPD1 | Porokeratosis 2, palmar, plantar, and disseminated | 100196910.0 | nan | between D12S1613 and D12S1341 | Porokeratosis 2, palmar, plantar, and disseminated, 175850 (2), Autosomal dominant
chr12	SLEB4	608437.0 | SLEB4 | Systemic lupus erythematosus, susceptibility to, 4 | 404714.0 | nan | nan | {Systemic lupus erythematosus, susceptibility to, 4}, 608437 (2)
chr12	STUT2	609261.0 | STUT2 | Stuttering, familial persistent, 2 | 100049543.0 | nan | max lod with PAH | Stuttering, familial persistent, 2, 609261 (2)
chr12	SELPLG	600738.0 | SELPLG, PSGL1 | Selectin P ligand | 6404.0 | ENSG00000110876 | nan | nan
chr12	CORO1C	605269.0 | CORO1C | Coronin 1C | 23603.0 | ENSG00000110880 | nan | nan
chr12	SSH1	606778.0 | SSH1, KIAA1298 | Slingshot protein phosphatase 1 | 54434.0 | ENSG00000084112 | nan | nan
chr12	DAO	124050.0 | DAO, DAMOX | D-amino-acid oxidase | 1610.0 | ENSG00000110887 | nan | nan
chr12	SVOP	611699.0 | SVOP | SV2-related protein | 55530.0 | ENSG00000166111 | nan | nan
chr12	USP30	612492.0 | USP30 | Ubiquitin-specific protease 30 | 84749.0 | ENSG00000135093 | nan | nan
chr12	ALKBH2	610602.0 | ALKBH2, ABH2 | AlkB homolog 2, alpha-ketoglutarate-dependent dioxygenase | 121642.0 | ENSG00000189046 | nan | nan
chr12	UNG	191525.0 | UNG, DGU, HIGM5 | Uracil-DNA glycosylase | 7374.0 | ENSG00000076248 | nan | Immunodeficiency with hyper IgM, type 5, 608106 (3), Autosomal recessive
chr12	ACACB	601557.0 | ACACB, ACCB, ACC2 | Acetyl-Coenzyme A carboxylase, beta | 32.0 | ENSG00000076555 | nan | nan
chr12	FOXN4	609429.0 | FOXN4 | Forkhead box N4 | 121643.0 | ENSG00000139445 | nan | nan
chr12	MYO1H	614636.0 | MYO1H, CCHS2 | Myosin IH | 283446.0 | ENSG00000174527 | mutation identified in 1 CCHS2 family | ?Central hypoventilation syndrome, congenital, 2, and autonomic dysfunction, 619482 (3), Autosomal recessive
chr12	KCTD10	613421.0 | KCTD10 | Potassium channel tetramerization domain-containing 10 | 83892.0 | ENSG00000110906 | nan | nan
chr12	UBE3B	608047.0 | UBE3B, BPIDS, KOS | Ubiquitin-protein ligase E3B | 89910.0 | ENSG00000151148 | nan | Kaufman oculocerebrofacial syndrome, 244450 (3), Autosomal recessive
chr12	MMAB	607568.0 | MMAB | Metabolism of cobalamin associated B | 326625.0 | ENSG00000139428 | nan | Methylmalonic aciduria, vitamin B12-responsive, cblB type, 251110 (3), Autosomal recessive
chr12	MVK	251170.0 | MVK, MVLK, POROK3 | Mevalonate kinase | 4598.0 | ENSG00000110921 | nan | Hyper-IgD syndrome, 260920 (3), Autosomal recessive; Porokeratosis 3, multiple types, 175900 (3), Autosomal dominant; Mevalonic aciduria, 610377 (3), Autosomal recessive
chr12	TRPV4	605427.0 | TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3 | Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel) | 59341.0 | ENSG00000111199 | mutation identified in 1 ANFH2 family | Neuronopathy, distal hereditary motor, autosomal dominant 8, 600175 (3), Autosomal dominant; Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3), Autosomal dominant; Digital arthropathy-brachydactyly, familial, 606835 (3), Autosomal dominant; [Sodium serum level QTL 1], 613508 (3); SED, Maroteaux type, 184095 (3), Autosomal dominant; Metatropic dysplasia, 156530 (3), Autosomal dominant; Scapuloperoneal spinal muscular atrophy, 181405 (3), Autosomal dominant; Hereditary motor and sensory neuropathy, type IIc, 606071 (3), Autosomal dominant; ?Avascular necrosis of femoral head, primary, 2, 617383 (3), Autosomal dominant; Parastremmatic dwarfism, 168400 (3), Autosomal dominant; Brachyolmia type 3, 113500 (3), Autosomal dominant
chr12	GLTP	608949.0 | GLTP | Glycolipid transfer protein | 51228.0 | ENSG00000139433 | nan | nan
chr12	TCHP	612654.0 | TCHP | Trichoplein | 84260.0 | ENSG00000139437 | nan | nan
chr12	GIT2	608564.0 | GIT2, CAT2 | GIT ArfGAP 2 | 9815.0 | ENSG00000139436 | nan | nan
chr12	ANKRD13A	615123.0 | ANKRD13A | Ankyrin repeat domain-containing protein 13A | 88455.0 | ENSG00000076513 | nan | nan
chr12	IFT81	605489.0 | IFT81, DV1, CDV1R, SRTD19 | Intraflagellar transport 81 | 28981.0 | ENSG00000122970 | nan | Short-rib thoracic dysplasia 19 with or without polydactyly, 617895 (3), Autosomal recessive
chr12	ATP2A2	108740.0 | ATP2A2, ATP2B, DAR | ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2 | 488.0 | ENSG00000174437 | nan | Acrokeratosis verruciformis, 101900 (3), Autosomal dominant; Darier disease, 124200 (3), Autosomal dominant
chr12	ANAPC7	606949.0 | ANAPC7, APC7, FERBON | Anaphase-promoting complex, subunit 7 | 51434.0 | ENSG00000196510 | nan | Ferguson-Bonni neurodevelopmental syndrome, 619699 (3), Autosomal recessive
chr12	ARPC3	604225.0 | ARPC3, ARC21 | Actin-related protein 2/3 complex, subunit 3 | 10094.0 | ENSG00000111229 | nan | nan
chr12	VPS29	606932.0 | VPS29, PEP11 | VPS29 retromer complex component | 51699.0 | ENSG00000111237 | nan | nan
chr12	RAD9B	608368.0 | RAD9B | RAD9 checkpoint clamp component B | 144715.0 | ENSG00000151164 | nan | nan
chr12	PPTC7	609668.0 | PPTC7, TAPP2C | Protein phosphatase targeting CoQ7 | 160760.0 | ENSG00000196850 | nan | nan
chr12	TCTN1	609863.0 | TECT1, JBTS13 | Tectonic family, member 1 | 79600.0 | ENSG00000204852 | nan | Joubert syndrome 13, 614173 (3), Autosomal recessive
chr12	HVCN1	611227.0 | HVCN1, HV1, VSOP | Hydrogen voltage-gated channel 1 | 84329.0 | ENSG00000122986 | nan | nan
chr12	PPP1CC	176914.0 | PPP1CC | Protein phosphatase-1, catalytic subunit, gamma isoform | 5501.0 | ENSG00000186298 | nan | nan
chr12	CCDC63	617969.0 | CCDC63, ODA5 | Coiled-coil domain-containing protein 63 | 160762.0 | ENSG00000173093 | nan | nan
chr12	MYL2	160781.0 | MYL2, CMH10, MFM12 | Myosin, light polypeptide-2, regulatory, cardiac, slow | 4633.0 | ENSG00000111245 | nan | Cardiomyopathy, hypertrophic, 10, 608758 (3), Autosomal dominant; Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy, 619424 (3), Autosomal recessive
chr12	CUX2	610648.0 | CUX2, CDP2, CUTL2, DEE67 | Cut-like homeobox 2 | 23316.0 | ENSG00000111249 | nan | Developmental and epileptic encephalopathy 67, 618141 (3), Autosomal dominant
chr12	PHETA1	614239.0 | PHETA1, FAM109A, SES1, IPIP27A | PH domain-containing endocytic trafficking adaptor 1 | 144717.0 | ENSG00000198324 | nan | nan
chr12	SH2B3	605093.0 | SH2B3, LNK | SH2B adaptor protein 3 | 10019.0 | ENSG00000111252 | nan | Thrombocythemia, somatic, 187950 (3); Myelofibrosis, somatic, 254450 (3); Erythrocytosis, somatic, 133100 (3)
chr12	ATXN2	601517.0 | ATXN2, ATX2, SCA2, ASL13 | Ataxin-2 | 6311.0 | ENSG00000204842 | nan | {Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3), Autosomal dominant; Spinocerebellar ataxia 2, 183090 (3), Autosomal dominant; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant
chr12	BRAP	604986.0 | BRAP, BRAP2, IMP | BRCA1-associated protein | 8315.0 | ENSG00000089234 | nan | nan
chr12	ACAD10	611181.0 | ACAD10 | Acyl-CoA dehydrogenase family, member 10 | 80724.0 | ENSG00000111271 | nan | nan
chr12	ALDH2	100650.0 | ALDH2 | Aldehyde dehydrogenase 2 family, mitochondrial | 217.0 | ENSG00000111275 | nan | {Esophageal cancer, alcohol-related, susceptibility to} (3); {Sublingual nitroglycerin, susceptibility to poor response to} (3); Alcohol sensitivity, acute, 610251 (3), Autosomal dominant; {Hangover, susceptibility to}, 610251 (3), Autosomal dominant
chr12	MAPKAPK5	606723.0 | MAPKAPK5, PRAK, NCFD | Mitogen-activated protein kinase-activated protein kinase 5 | 8550.0 | ENSG00000089022 | nan | Neurocardiofaciodigital syndrome, 619869 (3), Autosomal recessive
chr12	ERP29	602287.0 | C12orf8, ERP28, ERP29 | Endoplasmic reticulum lumenal protein 28 | 10961.0 | ENSG00000089248 | nan | nan
chr12	NAA25	612755.0 | NAA25, MDM20, C12orf30 | N-alpha-acetyltransferase 25, NatB auxiliary subunit | 80018.0 | ENSG00000111300 | nan | nan
chr12	TRAFD1	613197.0 | TRAFD1, FLN29 | TRAF-type zinc finger domain-containing 1 | 10906.0 | ENSG00000135148 | nan | nan
chr12	HECTD4	620209.0 | HECTD4, C12orf51, NEDSSCC | HECT domain E3 ubiquitin protein ligase 4 | 283450.0 | ENSG00000173064 | nan | Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum, 620250 (3), Autosomal recessive
chr12	RPL6	603703.0 | RPL6 | Ribosomal protein L6 | 6128.0 | ENSG00000089009 | nan | nan
chr12	PTPN11	176876.0 | PTPN11, PTP2C, SHP2, NS1, JMML, METCDS | Protein tyrosine phosphatase, nonreceptor-type, 11 | 5781.0 | ENSG00000179295 | nan | Noonan syndrome 1, 163950 (3), Autosomal dominant; LEOPARD syndrome 1, 151100 (3), Autosomal dominant; Metachondromatosis, 156250 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, somatic, 607785 (3)
chr12	RPH3A	612159.0 | RPH3A, KIAA0985 | Rabphilin 3A | 22895.0 | ENSG00000089169 | nan | nan
chr12	OAS1	164350.0 | OAS1, OIAS, IMD100 | 2',5'-oligoadenylate synthetase-1 | 4938.0 | ENSG00000089127 | nan | Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia, 618042 (3), Autosomal dominant
chr12	OAS3	603351.0 | OAS3 | 2',5'-oligoadenylate synthetase-3 | 4940.0 | ENSG00000111331 | nan | nan
chr12	OAS2	603350.0 | OAS2 | 2',5'-oligoadenylate synthetase-2 | 4939.0 | ENSG00000111335 | nan | nan
chr12	DTX1	602582.0 | DTX1 | Deltex E3 ubiquitin ligase 1 | 1840.0 | ENSG00000135144 | nan | nan
chr12	RASAL1	604118.0 | RASAL1, RASAL | Ras protein activator-like 1 | 8437.0 | ENSG00000111344 | nan | nan
chr12	DDX54	611665.0 | DDX54, DP97 | DEAD-box helicase 54 | 79039.0 | ENSG00000123064 | nan | nan
chr12	RITA1	620696.0 | RITA1 | RBPJ-interacting and tubulin-associated protein 1 | 84934.0 | ENSG00000139405 | nan | nan
chr12	TPCN1	609666.0 | TPCN1, TPC1, KIAA1169 | Two-pore segment channel 1 | 53373.0 | ENSG00000186815 | nan | nan
chr12	SLC8B1	609841.0 | SLC8B1, SLC24A6, NCKX6 | Solute carrier family 8 member B1 | 80024.0 | ENSG00000089060 | nan | nan
chr12	PLBD2	620097.0 | PLBD2, p76 | Phospholipase B domain containing 2 | 196463.0 | ENSG00000151176 | nan | nan
chr12	SDS	182128.0 | SDS, SDH | Serine dehydratase | 10993.0 | ENSG00000135094 | nan | nan
chr12	SDSL	620735.0 | SDSL, SDHL, CSDH | Serine dehydratase-like protein | 113675.0 | ENSG00000139410 | nan | nan
chr12	LHX5	605992.0 | LHX5 | LIM homeobox protein 5 | 64211.0 | ENSG00000089116 | nan | nan
chr12	RBM19	616444.0 | RBM19, KIAA0682 | RNA-binding motif protein 19 | 9904.0 | ENSG00000122965 | nan | nan
chr12	CTRCT37	614422.0 | CTRCT37, CCA5 | Cataract 37 | 100861439.0 | nan | between D12S1718 and D12S1723 | Cataract 37, autosomal dominant, 614422 (2), Autosomal dominant
chr12	NIDDM2	601407.0 | NIDDM2 | Diabetes mellitus, noninsulin-dependent, 2 | 4813.0 | nan | no mutations found in HNF1A | Diabetes mellitus, noninsulin-dependent, 2, 601407 (2)
chr12	RPL21P1	603416.0 | RPL21P1, ALFN1, HALF1 | Ribosomal protein L21 pseudogene 1 | 6145.0 | ENSG00000214760 | nan | nan
chr12	TBX5	601620.0 | TBX5 | T-box 5 | 6910.0 | ENSG00000089225 | nan | Holt-Oram syndrome, 142900 (3), Autosomal dominant
chr12	TBX3	601621.0 | TBX3 | T-box 3 | 6926.0 | ENSG00000135111 | nan | Ulnar-mammary syndrome, 181450 (3), Autosomal dominant
chr12	MED13L	608771.0 | MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD | Mediator complex subunit 13-like | 23389.0 | ENSG00000123066 | nan | Impaired intellectual development and distinctive facial features with or without cardiac defects, 616789 (3), Autosomal dominant
chr12	MAP1LC3B2	620673.0 | MAP1LC3B2 | Microtubule-associated protein 1, light chain 3, beta-2 | 643246.0 | ENSG00000258102 | nan | nan
chr12	RNFT2	620254.0 | RNFT2 | RING finger protein, transmembrane 2 | 84900.0 | ENSG00000135119 | nan | nan
chr12	HRK	603447.0 | HRK, DP5 | Harakiri | 8739.0 | ENSG00000135116 | nan | nan
chr12	FBXW8	609073.0 | FBXW8, FBW8, FBXW6, FBW6, FBXO29, FBX29 | F-box and WD40 domain protein 8 | 26259.0 | ENSG00000174989 | nan | nan
chr12	TESC	611585.0 | TESC, TSC | Tescalcin, mouse, homolog of | 54997.0 | ENSG00000088992 | nan | nan
chr12	FBXO21	609095.0 | FBXO21, FBX21, KIAA0875 | F-box only protein 21 | 23014.0 | ENSG00000135108 | nan | nan
chr12	NOS1	163731.0 | NOS1 | Nitric oxide synthase 1, neuronal | 4842.0 | ENSG00000089250 | nan | nan
chr12	KSR2	610737.0 | KSR2 | Kinase suppressor of RAS 2 | 283455.0 | ENSG00000171435 | nan | nan
chr12	RFC5	600407.0 | RFC5 | Replication factor C5, 36.5kD (activator 1, 36.5kD) | 5985.0 | ENSG00000111445 | nan | nan
chr12	PEBP1	604591.0 | PEBP1, PBP, RKIP | Phosphatidylethanolamine-binding protein 1 | 5037.0 | ENSG00000089220 | nan | nan
chr12	TAOK3	616711.0 | TAOK3, JIK, DPK | TAO kinase 3 | 51347.0 | ENSG00000135090 | nan | nan
chr12	SUDS3	608250.0 | SUDS3, SDS3, SAP45 | SDS3 homolog, SIN3A corepressor complex component | 64426.0 | ENSG00000111707 | nan | nan
chr12	SRRM4	613103.0 | SRRM4, KIAA1853, NSR100 | Serine/arginine repetitive matrix protein 4 | 84530.0 | ENSG00000139767 | nan | nan
chr12	HSPB8	608014.0 | HSPB8, H11, E2IG1, CMT2L, HMND2 | Heat-shock 22-kD protein 8 | 26353.0 | ENSG00000152137 | nan | Neuronopathy, distal hereditary motor, autosomal dominant 2, 158590 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3), Autosomal dominant
chr12	TMEM233	618296.0 | TMEM233, DSPB2 | Transmembrane protein 233 | 387890.0 | ENSG00000224982 | nan | nan
chr12	PRKAB1	602740.0 | PRKAB1 | Protein kinase, AMP-activated, noncatalytic, beta-1 | 5564.0 | ENSG00000111725 | nan | nan
chr12	CIT	605629.0 | CIT, STK21, CRIK, MCPH17 | Citron rho-interacting serine/threonine kinase | 11113.0 | ENSG00000122966 | nan | Microcephaly 17, primary, autosomal recessive, 617090 (3), Autosomal recessive
chr12	BICDL1	617002.0 | BICDL1, BICDR1, CCDC64 | BICD family-like cargo adaptor 1 | 92558.0 | ENSG00000135127 | nan | nan
chr12	RAB35	604199.0 | RAB35 | Ras-associated protein Rab35 | 11021.0 | ENSG00000111737 | nan | nan
chr12	GCN1	605614.0 | GCN1, GCN1L1 | GCN1 activator of EIF2AK4 | 10985.0 | ENSG00000089154 | nan | nan
chr12	RPLP0	180510.0 | RPLP0 | Ribosomal protein lateral stalk subunit P0 | 6175.0 | ENSG00000089157 | nan | nan
chr12	PXN	602505.0 | PXN | Paxillin | 5829.0 | ENSG00000089159 | nan | nan
chr12	RNU4-2	620823.0 | RNU4-2, NEDHAFA, RENU | RNA, U4 small nuclear 2 | 26834.0 | ENSG00000202538 | nan | ReNU syndrome, 620851 (3), Autosomal dominant
chr12	SIRT4	604482.0 | SIRT4, SIR2L4 | Sirtuin 4 | 23409.0 | ENSG00000089163 | nan | nan
chr12	RNU4-1	620822.0 | RNU4-1 | RNA, U4 small nuclear 1 | 26835.0 | ENSG00000200795 | nan | nan
chr12	MPVQTL1	612573.0 | MPVQTL1 | Mean platelet volume quantitative trait locus 1 | 100271867.0 | nan | associated with rs7961894 | [Mean platelet volume QTL1], 612573 (2)
chr12	PLA2G1B	172410.0 | PLA2G1B, PLA2A, PLA2, PPLA2 | Phospholipase A2, group IB, pancreas | 5319.0 | ENSG00000170890 | nan | nan
chr12	MSI1	603328.0 | MSI1 | Musashi RNA binding protein 1 | 4440.0 | ENSG00000135097 | nan | nan
chr12	COX6A1	602072.0 | COX6A1, CMTRID | Cytochrome c oxidase, subunit VIa, polypeptide-1 | 1337.0 | ENSG00000111775 | pseudogenes on chr.7 and chr.6 | Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3), Autosomal recessive
chr12	TRIAP1	614943.0 | TRIAP1, HSPC132 | TP53-regulated inhibitor of apoptosis 1 | 51499.0 | ENSG00000170855 | nan | nan
chr12	GATC	617210.0 | GATC, COXPD42 | Glutamyl-tRNA amidotransferase, subunit C | 283459.0 | ENSG00000257218 | nan | Combined oxidative phosphorylation deficiency 42, 618839 (3), Autosomal recessive
chr12	SRSF9	601943.0 | SRSF9, SFRS9, SRp30c | Splicing factor, serine/arginine-rich, 9 | 8683.0 | ENSG00000111786 | nan | nan
chr12	DYNLL1	601562.0 | DYNLL1, DNCL1, DLC1, PIN | Dynein, light chain, LC8-type 1 | 8655.0 | ENSG00000088986 | possible pseudogene on 14q24 | nan
chr12	NRAV	616207.0 | NRAV, DYNLL1AS1 | Negative regulator of antiviral response, noncoding | 100506668.0 | ENSG00000248008 | overlaps intron 1 of DYNLL1 in antisense orientation | nan
chr12	COQ5	616359.0 | COQ5, COQ10D9 | Coenzyme Q5, methyltransferasef | 84274.0 | ENSG00000110871 | mutation identified in 1 COQ10D9 family | ?Coenzyme Q10 deficiency, primary, 9, 619028 (3), Autosomal recessive
chr12	RNF10	615998.0 | RNF10, KIAA0262 | RING finger protein 10 | 9921.0 | ENSG00000022840 | nan | nan
chr12	POP5	609992.0 | POP5, HSPC004 | Processing of precursor 5, S. cerevisiae, homolog of | 51367.0 | ENSG00000167272 | nan | nan
chr12	CABP1	605563.0 | CABP1, CALBRAIN | Calcium-binding protein 1 | 9478.0 | ENSG00000157782 | nan | nan
chr12	MLEC	613802.0 | MLEC, KIAA0152 | Malectin | 9761.0 | ENSG00000110917 | nan | nan
chr12	UNC119B	620513.0 | UNC119B | UNC119 lipid-binding chaperone B | 84747.0 | ENSG00000175970 | nan | nan
chr12	ACADS	606885.0 | ACADS, SCAD | Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain | 35.0 | ENSG00000122971 | nan | Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3), Autosomal recessive
chr12	SPPL3	608240.0 | SPPL3, IMP2 | Signal peptide peptidase-like 3 | 121665.0 | ENSG00000157837 | nan | nan
chr12	HNF1A	142410.0 | HNF1A, TCF1, MODY3, IDDM20 | HNF1 homeobox B | 6927.0 | ENSG00000135100 | nan | Hepatic adenoma, somatic, 142330 (3); Diabetes mellitus, insulin-dependent, 20, 612520 (3); {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant; MODY, type III, 600496 (3), Autosomal dominant; {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive; Renal cell carcinoma, 144700 (3)
chr12	OASL	603281.0 | OASL, TRIP14 | 2',5'-oligoadenylate synthetase-like | 8638.0 | ENSG00000135114 | nan | nan
chr12	P2RX7	602566.0 | P2RX7, P2X7 | Purinergic receptor P2X, ligand-gated ion channel, 7 | 5027.0 | ENSG00000089041 | nan | nan
chr12	P2RX4	600846.0 | P2RX4, P2X4 | Purinergic receptor P2X, ligand-gated ion channel, 4 | 5025.0 | ENSG00000135124 | nan | nan
chr12	CAMKK2	615002.0 | CAMKK2, KIAA0787, CAMKKB | Calcium/calmodulin-dependent protein kinase kinase 2, beta | 10645.0 | ENSG00000110931 | nan | nan
chr12	ANAPC5	606948.0 | ANAPC5, APC5 | Anaphase-promoting complex, subunit 5 | 51433.0 | ENSG00000089053 | nan | nan
chr12	RNF34	608299.0 | RNF34, RFI | Ring finger protein 34 | 80196.0 | ENSG00000170633 | nan | nan
chr12	KDM2B	609078.0 | KDM2B, FBXL10, FBL10, CXXC2, JHDM1B | Lysine demethylase 2B | 84678.0 | ENSG00000089094 | nan | nan
chr12	ORAI1	610277.0 | ORAI1, TMEM142A, CRACM1, IMD9, TAM2 | ORAI calcium release-activated calcium modulator 1 | 84876.0 | ENSG00000276045 | nan | Immunodeficiency 9, 612782 (3), Autosomal recessive; Myopathy, tubular aggregate, 2, 615883 (3), Autosomal dominant
chr12	TMEM120B	616551.0 | TMEM120B | Transmembrane protein 120B | 144404.0 | ENSG00000188735 | nan | nan
chr12	RHOF	618867.0 | RHOF, RIF | RAS homolog gene family, member F, filopodia-associated | 54509.0 | ENSG00000139725 | nan | nan
chr12	SETD1B	611055.0 | SETD1B, SET1B, KIAA1076, IDDSELD | SET domain-containing protein 1B | 23067.0 | ENSG00000139718 | nan | Intellectual developmental disorder with seizures and language delay, 619000 (3), Autosomal dominant
chr12	HPD	609695.0 | HPD | 4-hydroxyphenylpyruvate dioxygenase | 3242.0 | ENSG00000158104 | nan | Hawkinsinuria, 140350 (3), Autosomal dominant; Tyrosinemia, type III, 276710 (3), Autosomal recessive
chr12	PSMD9	603146.0 | PSMD9 | Proteasome 26S subunit, non-ATPase, 9 | 5715.0 | ENSG00000110801 | nan | nan
chr12	CFAP251	618146.0 | WDR66, CFAP251, SPGF33 | WD repeat-containing protein 66 | 144406.0 | ENSG00000158023 | nan | Spermatogenic failure 33, 618152 (3), Autosomal recessive
chr12	BCL7A	601406.0 | BCL7A, BCL7 | BAF chromatin remodeling complex subunit BCL7A | 605.0 | ENSG00000110987 | nan | nan
chr12	MLXIP	608090.0 | MLXIP, MONDOA, KIAA0867 | MLX-interacting protein | 22877.0 | ENSG00000175727 | nan | nan
chr12	IL31	609509.0 | IL31 | Interleukin 31 | 386653.0 | ENSG00000204671 | nan | nan
chr12	B3GNT4	605864.0 | B3GNT4 | Beta-1,3-N-acetylglucosaminyltransferase 4 | 79369.0 | ENSG00000176383 | nan | nan
chr12	DIABLO	605219.0 | DIABLO, SMAC, DFNA64 | Diablo IAP-binding mitochondrial protein | 56616.0 | ENSG00000184047 | nan | Deafness, autosomal dominant 64, 614152 (3), Autosomal dominant
chr12	VPS33A	610034.0 | VPS33A, MPSPS | VPS33A core subunit of CORVET and HOPS complexes | 65082.0 | ENSG00000139719 | nan | Mucopolysaccharidosis-plus syndrome, 617303 (3), Autosomal recessive
chr12	CLIP1	179838.0 | CLIP1, RSN, CYLN1, CLIP170 | CAP-GLY domain containing linker protein 1 | 6249.0 | ENSG00000130779 | nan | nan
chr12	ZCCHC8	616381.0 | ZCCHC8, PFBMFT5 | Zinc finger CCHC domain-containing protein 8 | 55596.0 | ENSG00000033030 | mutation identified in 1 PFBMFT5 family | ?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 5, 618674 (3), Autosomal dominant
chr12	RSRC2	619996.0 | RSRC2 | Arginine- and serine-rich coiled-coil protein 2 | 65117.0 | ENSG00000111011 | nan | nan
chr12	KNTC1	607363.0 | KNTC1, ROD, KIAA0166 | Kinetochore-associated protein 1 | 9735.0 | ENSG00000184445 | previously assigned to chr.17 | nan
chr12	HCAR2	609163.0 | HCAR2, GPR109A, HM74A | Hydroxycarboxylic acid receptor 2 | 338442.0 | ENSG00000182782 | nan | nan
chr12	HCAR3	606039.0 | HCAR3, GPR109B, HM74, PUMAG | Hydroxycarboxylic acid receptor 3 | 8843.0 | ENSG00000255398 | nan | nan
chr12	HCAR1	606923.0 | HCAR1, GPR81, TAGPCR | Hydroxycarboxylic acid receptor 1 | 27198.0 | ENSG00000196917 | nan | nan
chr12	DENR	604550.0 | DENR, DRP | Density-regulated protein | 8562.0 | ENSG00000139726 | nan | nan
chr12	CCDC62	613481.0 | CCDC62, ERAP75, SPGF67 | Coiled-coil domain-containing protein 62 | 84660.0 | ENSG00000130783 | mutation identified in 1 SPGF67 patient | ?Spermatogenic failure 67, 619803 (3), Autosomal recessive
chr12	HIP1R	605613.0 | HIP1R, HIP12 | Huntingtin-interacting protein 1-related protein | 9026.0 | ENSG00000130787 | nan | nan
chr12	VPS37B	610037.0 | VPS37B | VPS37B subunit of ESCRT-I | 79720.0 | ENSG00000139722 | nan | nan
chr12	ABCB9	605453.0 | ABCB9 | ATP-binding cassette, subfamily B, member 9 | 23457.0 | ENSG00000150967 | nan | nan
chr12	ARL6IP4	607668.0 | ARL6IP4 | ADP ribosylation factor-like GTPase 6 interacting protein 4 | 51329.0 | ENSG00000182196 | nan | nan
chr12	PITPNM2	608920.0 | PITPNM2, NIR3, KIAA1457 | Phosphatidylinositol transfer protein, membrane-associated, 2 | 57605.0 | ENSG00000090975 | nan | nan
chr12	MTRFR	613541.0 | MTRFR, C12orf65, COXPD7, SPG55 | Mitochondrial translation release factor in rescue | 91574.0 | ENSG00000130921 | nan | Spastic paraplegia 55, autosomal recessive, 615035 (3), Autosomal recessive; Combined oxidative phosphorylation deficiency 7, 613559 (3), Autosomal recessive
chr12	MPHOSPH9	605501.0 | MPHOSPH9, MPP9 | M-phase phosphoprotein 9 | 10198.0 | ENSG00000051825 | nan | nan
chr12	CDK2AP1	602198.0 | CDK2AP1, DOC1 | CDK-associated protein 1 (deleted in oral cancer-1) | 8099.0 | ENSG00000111328 | nan | nan
chr12	SBNO1	614274.0 | SBNO1 | Strawberry notch, Drosophila, homolog of, 1 | 55206.0 | ENSG00000139697 | nan | nan
chr12	KMT5A	607240.0 | KMT5A, SET8 | Lysine methyltransferase 5A | 387893.0 | ENSG00000183955 | nan | nan
chr12	RILPL2	614093.0 | RILPL2, RLP2 | RAB-interacting lysosomal protein-like 2 | 196383.0 | ENSG00000150977 | nan | nan
chr12	SNRNP35	619631.0 | SNRNP35, HM1 | Small nuclear ribonucleoprotein U11/U12, subunit 35 | 11066.0 | ENSG00000184209 | nan | nan
chr12	RILPL1	614092.0 | RILPL1, RLP1, GOSPEL, OPDM4 | RAB-interacting lysosomal protein-like 1 | 353116.0 | ENSG00000188026 | nan | Oculopharyngodistal myopathy 4, 619790 (3), Autosomal dominant
chr12	TMED2	619642.0 | TMED2 | Transmembrane p24 trafficking protein 2 | 10959.0 | ENSG00000086598 | nan | nan
chr12	DDX55	620176.0 | DDX55, KIAA1695 | DEAD-box helicase 55 | 57696.0 | ENSG00000111364 | nan | nan
chr12	EIF2B1	606686.0 | EIF2B1, EIF2BA, VWM1 | Eukaryotic translation initiation factor 2B, subunit 1 | 1967.0 | ENSG00000111361 | nan | Leukoencephalopathy with vanishing white matter 1, with or without ovarian failure, 603896 (3), Autosomal recessive
chr12	GTF2H3	601750.0 | GTF2H3, TFB4 | General transcription factor IIH, polypeptide 3 | 2967.0 | ENSG00000111358 | nan | nan
chr12	TCTN2	613846.0 | TCTN2, TECT2, MKS8, JBTS24 | Tectonic family, member 2 | 79867.0 | ENSG00000168778 | mutation identified in 1 MKS8 family | Joubert syndrome 24, 616654 (3), Autosomal recessive; ?Meckel syndrome 8, 613885 (3), Autosomal recessive
chr12	ATP6V0A2	611716.0 | ATP6V0A2, WSS, ARCL2A | ATPase, H+ transporting, V0 subunit A2 | 23545.0 | ENSG00000185344 | nan | Wrinkly skin syndrome, 278250 (3), Autosomal recessive; Cutis laxa, autosomal recessive, type IIA, 219200 (3), Autosomal recessive
chr12	DNAH10	605884.0 | DNAH10, SPGF56 | Dynein, axonemal, heavy chain 10 | 196385.0 | ENSG00000197653 | nan | Spermatogenic failure 56, 619515 (3), Autosomal recessive
chr12	ZNF664	617890.0 | ZNF664, ZFOC1 | Zinc finger protein 664 | 144348.0 | ENSG00000179195 | nan | nan
chr12	RFLNA	615927.0 | RFLNA, FAM101A, CFM2 | Refilin A | 144347.0 | ENSG00000178882 | nan | nan
chr12	NCOR2	600848.0 | NCOR2, SMRT | Nuclear receptor corepressor 2 | 9612.0 | ENSG00000196498 | nan | nan
chr12	SCARB1	601040.0 | SCARB1, CD36L1, CLA1, HDLQTL6 | Scavenger receptor class B, member 1 (CD36 antigen-like 1) | 949.0 | ENSG00000073060 | nan | [High density lipoprotein cholesterol level QTL6], 610762 (3)
chr12	UBC	191340.0 | UBC | Ubiquitin C | 7316.0 | ENSG00000150991 | nan | nan
chr12	DHX37	617362.0 | DHX37, KIAA1517, NEDBAVC, SRXY11 | DEAH-box helicase 37 | 57647.0 | ENSG00000150990 | nan | Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies, 618731 (3), Autosomal recessive; 46XY sex reversal 11, 273250 (3), Autosomal dominant
chr12	BRI3BP	615627.0 | BRI3BP | BRI3-binding protein | 140707.0 | ENSG00000184992 | nan | nan
chr12	THRIL	615622.0 | THRIL, LINC1992, BRI3BPAS1 | TNF- and HNRNPL-related immunoregulatory long noncoding RNA | 102659353.0 | ENSG00000280634 | nan | nan
chr12	AACS	614364.0 | AACS, ACSF1 | Acetoacetyl-CoA synthetase | 65985.0 | ENSG00000081760 | nan | nan
chr12	TMEM132B	620260.0 | TMEM132B | Transmembrane protein 132B | 114795.0 | ENSG00000139364 | nan | nan
chr12	SLC15A4	615806.0 | SLC15A4, PHT1, PTR4 | Solute carrier family 15 (oligopeptide transporter), member 4 | 121260.0 | ENSG00000139370 | nan | nan
chr12	TMEM132D	611257.0 | TMEM132D, KIAA1944, MOLT | Transmembrane protein 132D | 121256.0 | ENSG00000151952 | nan | nan
chr12	FZD10	606147.0 | FZD10 | Frizzled class receptor 10 | 11211.0 | ENSG00000111432 | nan | nan
chr12	PIWIL1	605571.0 | PIWIL1 | PIWI-like RNA-mediated gene silencing 1 | 9271.0 | ENSG00000125207 | nan | nan
chr12	RIMBP2	611602.0 | RIMBP2, KIAA0318 | RIMS-binding protein 2 | 23504.0 | ENSG00000060709 | nan | nan
chr12	STX2	132350.0 | STX2, EPIM, STX2C, STX2B, STX2A | Epimorphin (syntaxin 2) | 2054.0 | ENSG00000111450 | nan | nan
chr12	RAN	601179.0 | RAN, ARA24 | Ras-related nuclear protein | 5901.0 | ENSG00000132341 | nan | nan
chr12	ADGRD1	613639.0 | ADGRD1, GPR133, PGR25 | Adhesion G protein-coupled receptor D1 | 283383.0 | ENSG00000111452 | nan | nan
chr12	SFSWAP	601945.0 | SFSWAP, SFRS8, SWAP | Splicing factor, suppressor-of-white-apricot family | 6433.0 | ENSG00000061936 | nan | nan
chr12	MMP17	602285.0 | MMP17 | Matrix metalloproteinase 17 | 4326.0 | ENSG00000198598 | nan | nan
chr12	ULK1	603168.0 | ULK1, UNC51 | UNC51-like kinase 1 | 8408.0 | ENSG00000177169 | nan | nan
chr12	PUS1	608109.0 | PUS1, MLASA1 | Pseudourine synthase 1 | 80324.0 | ENSG00000177192 | nan | Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3), Autosomal recessive
chr12	EP400	606265.0 | EP400, TNRC12, KIAA1498 | p400 SWI2/SNF2-related protein | 57634.0 | ENSG00000183495 | nan | nan
chr12	NOC4L	612819.0 | NOC4L, NOC4 | Nucleolar complex-associated protein 4 homolog | 79050.0 | ENSG00000184967 | nan | nan
chr12	GALNT9	606251.0 | GALNT9, GALNACT9 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 | 50614.0 | ENSG00000182870 | REc | nan
chr12	MUC8	601932.0 | MUC8 | Mucin 8, tracheobronchial | 100129528.0 | nan | nan | nan
chr12	FBRSL1	620123.0 | FBRSL1, KIAA1545 | Fibrosin-like 1 | 57666.0 | ENSG00000112787 | nan | nan
chr12	P2RX2	600844.0 | P2RX2, P2X2, DFNA41 | Purinergic receptor P2X, ligand-gated ion channel, 2 | 22953.0 | ENSG00000187848 | nan | Deafness, autosomal dominant 41, 608224 (3), Autosomal dominant
chr12	POLE	174762.0 | POLE, CRCS12, FILS, IMAGEI | Polymerase, DNA, epsilon | 5426.0 | ENSG00000177084 | nan | {Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant; FILS syndrome, 615139 (3), Autosomal recessive; IMAGE-I syndrome, 618336 (3), Autosomal recessive
chr12	PXMP2	617399.0 | PXMP2 | Peroxisomal membrane protein 2 | 5827.0 | ENSG00000176894 | nan | nan
chr12	PGAM5	614939.0 | PGAM5 | Phosphogycerate mutase family, member 5 | 192111.0 | ENSG00000247077 | nan | nan
chr12	ANKLE2	616062.0 | ANKLE2, LEM4, KIAA0692, MCPH16 | Ankyrin repeat- and LEM domain-containing protein 2 | 23141.0 | ENSG00000176915 | nan | Microcephaly 16, primary, autosomal recessive, 616681 (3), Autosomal recessive
chr12	GOLGA3	602581.0 | GOLGA3 | Golgin A3 | 2802.0 | ENSG00000090615 | nan | nan
chr12	CHFR	605209.0 | CHFR | Checkpoint protein with FHA and ring-finger domains | 55743.0 | ENSG00000072609 | nan | nan
chr12	ZNF26	194537.0 | ZNF26 | Zinc finger protein-26 (KOX20) | 7574.0 | ENSG00000198393 | nan | nan
chr12	ZNF84	618554.0 | ZNF84, HPF2 | Zinc finger protein 84 | 7637.0 | ENSG00000198040 | nan | nan
chr12	ZNF140	604082.0 | ZNF140 | Zinc finger protein-140 | 7699.0 | ENSG00000196387 | nan | nan
chr12	ZNF10	194538.0 | ZNF10, KOX1 | Zinc finger protein-10 (KOX 1) | 7556.0 | ENSG00000256223 | same 300kb fragment as ZNF26 | nan
chr12	ZNF268	604753.0 | ZNF268 | Zinc finger protein 268 | 10795.0 | ENSG00000090612 | nan | nan
chr12		191120.0 | TUBAL1 | Tubulin, alpha-like-1 | nan | nan | nan | nan
chr13	FECD2	610158.0 | FECD2, FCD1 | Corneal dystrophy, Fuchs endothelial, 2 | 100188278.0 | nan | max lod at D13S1304 | Corneal dystrophy, Fuchs endothelial, 2, 610158 (2), Autosomal dominant
chr13	RNR1	180450.0 | RNR1 | Ribosomal RNA-1 | 6052.0 | nan | nan | nan
chr13	CLQTL1	604595.0 | CLQTL1, CLF | Cholesterol level quantitative trait locus 1 | 54501.0 | nan | nan | [Cholesterol level QTL 1], 604595 (2)
chr13	ADHD6	612312.0 | ADHD6 | Attention deficit-hyperactivity disorder, susceptibility to, 6 | 100190791.0 | nan | max lod at rs1974047 | {Attention deficit-hyperactivity disorder, susceptibility to, 6}, 612312 (2)
chr13	ATOD5	605844.0 | ATOD5 | Dermatitis, atopic, 5 | 117188.0 | nan | max lod at D13S218 | {Dermatitis, atopic, susceptibility to, 5}, 605844 (2)
chr13		609384.0 | CFEOM3C, FEOM4 | Fibrosis of extraocular muscles, congenital, 3C | nan | nan | nan | Fibrosis of extraocular muscles, congenital, 3C, 609384 (2), Autosomal dominant
chr13	MCI2	608557.0 | MCI2 | Myocardial infarction, susceptibility to, 2 | 100233226.0 | nan | defined by 4-SNP haplotype HapA | {Myocardial infarction, susceptibility to, 2}, 608557 (2)
chr13	TUBA3C	602528.0 | TUBA2 | Tubulin, alpha 2 | 7278.0 | ENSG00000198033 | nan | nan
chr13	TPTE2	606791.0 | TPTE2, TPIP | Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 | 93492.0 | ENSG00000132958 | nan | nan
chr13	MPHOSPH8	611626.0 | MPHOSPH8, TWA3 | M-phase phosphoprotein 8 | 54737.0 | ENSG00000196199 | nan | nan
chr13	PSPC1	612408.0 | PSPC1, PSP1 | Paraspeckle component 1 | 55269.0 | ENSG00000121390 | nan | nan
chr13	ZMYM5	616443.0 | ZMYM5, ZNF237, ZNF198L1 | Zinc finger, MYM-type 5 | 9205.0 | ENSG00000132950 | nan | nan
chr13	ZMYM2	602221.0 | ZMYM2, ZNF198, RAMP, FIM, NECRC | Zinc finger, MYM-type 2 | 7750.0 | ENSG00000121741 | nan | Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, 619522 (3), Autosomal dominant
chr13	GJA3	121015.0 | GJA3, CX46, CZP3, CAE3, CTRCT14 | Gap junction protein, alpha-3, 46kD (connexin 46) | 2700.0 | ENSG00000121743 | nan | Cataract 14, multiple types, 601885 (3), Autosomal dominant
chr13	GJB2	121011.0 | GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS | Gap junction protein, beta-2, 26kD (connexin 26) | 2706.0 | ENSG00000165474 | nan | Keratoderma, palmoplantar, with deafness, 148350 (3), Autosomal dominant; Deafness, autosomal recessive 1A, 220290 (3), Autosomal recessive, Digenic dominant; Deafness, autosomal dominant 3A, 601544 (3), Autosomal dominant; Hystrix-like ichthyosis with deafness, 602540 (3), Autosomal dominant; Bart-Pumphrey syndrome, 149200 (3), Autosomal dominant; Keratitis-ichthyosis-deafness syndrome, 148210 (3), Autosomal dominant; Vohwinkel syndrome, 124500 (3), Autosomal dominant
chr13	GJB6	604418.0 | GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2 | Gap junction protein, beta-6 (connexin-30) | 10804.0 | ENSG00000121742 | nan | Ectodermal dysplasia 2, Clouston type, 129500 (3), Autosomal dominant; Deafness, autosomal dominant 3B, 612643 (3), Autosomal dominant; Deafness, autosomal recessive 1B, 612645 (3), Autosomal recessive; Deafness, digenic GJB2/GJB6, 220290 (3), Autosomal recessive, Digenic dominant
chr13	CRYL1	609877.0 | CRYL1 | Crystallin, lambda-1 | 51084.0 | ENSG00000165475 | nan | nan
chr13	IFT88	600595.0 | IFT88, D13S1056E, TG737 | Intraflagellar transport 88 | 8100.0 | ENSG00000032742 | nan | nan
chr13	IL17D	607587.0 | IL17D | Interleukin 17D | 53342.0 | ENSG00000172458 | ?associated with Hodgkin lymphoma | nan
chr13	EEF1AKMT1	617793.0 | EEF1AKMT1, N6AMT2 | EEF1A lysine methyltransferase 1 | 221143.0 | ENSG00000150456 | nan | nan
chr13	XPO4	611449.0 | XPO4, KIAA1721 | Exportin 4 | 64328.0 | ENSG00000132953 | nan | nan
chr13	LATS2	604861.0 | LATS2 | Large tumor suppressor kinase 2 | 26524.0 | ENSG00000150457 | nan | nan
chr13	SAP18	602949.0 | SAP18 | Sin3-associated polypeptide, 18kD | 10284.0 | ENSG00000150459 | nan | nan
chr13	SKA3	619247.0 | SKA3, C13orf3 | Spindle- and kinetochore-associated complex, subunit 3 | 221150.0 | ENSG00000165480 | nan | nan
chr13	MRPL57	611997.0 | MRP63 | Mitochondrial ribosomal protein 63 | 78988.0 | ENSG00000173141 | 10 pseudogenes | nan
chr13	ZDHHC20	617972.0 | ZDHHC20, DHHC20 | Zinc finger DHHC domain-containing protein 20 | 253832.0 | ENSG00000180776 | nan | nan
chr13	MICU2	610632.0 | MICU2, EFHA1 | Mitochondrial calcium uptake protein 2 | 221154.0 | ENSG00000165487 | nan | nan
chr13	FGF9	600921.0 | FGF9, SYNS3 | Fibroblast growth factor-9 (glia-activating factor) | 2254.0 | ENSG00000102678 | nan | Multiple synostoses syndrome 3, 612961 (3), Autosomal dominant
chr13	MYP20	614166.0 | MYP20 | Myopia 20, autosomal dominant | 100682326.0 | nan | associated with rs9318086 | Myopia 20, autosomal dominant, 614166 (2)
chr13	SGCG	608896.0 | SGCG, LGMDR5, DMDA1, SCG3 | Sarcoglycan, gamma (35kD dystrophin-associated glycoprotein) | 6445.0 | ENSG00000102683 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 5, 253700 (3), Autosomal recessive
chr13	SACS	604490.0 | SACS, ARSACS | Sacsin | 26278.0 | ENSG00000151835 | nan | Spastic ataxia, Charlevoix-Saguenay type, 270550 (3), Autosomal recessive
chr13	TNFRSF19	606122.0 | TAJ, TROY | Toxicity and JNK inducer | 55504.0 | ENSG00000127863 | nan | nan
chr13	MIPEP	602241.0 | MIPEP, COXPD31 | Mitochondrial intermediate peptidase | 4285.0 | ENSG00000027001 | nan | Combined oxidative phosphorylation deficiency 31, 617228 (3), Autosomal recessive
chr13	PCOTH	617122.0 | C1QTNF9BAS1, PCOTH | C1QTNF9B antisense RNA 1 | 542767.0 | ENSG00000205861 | nan | nan
chr13	C1QTNF9B	614148.0 | C1QTNF9B, CTRP9B | C1q- and tumor necrosis factor-related protein 9B | 387911.0 | ENSG00000205863 | nan | nan
chr13	SPATA13	613324.0 | SPATA13, ASEF2 | Spermatogenesis-associated protein 13 | 221178.0 | ENSG00000182957 | nan | nan
chr13	C1QTNF9	614285.0 | C1QTNF9A, CTRP9, C1QTNF9 | C1q- and tumor necrosis factor-related protein 9A | 338872.0 | ENSG00000240654 | nan | nan
chr13	PARP4	607519.0 | PARP4, ADPRTL1, VPARP, KIAA0177 | Poly(ADP-ribose) polymerase 4 | 143.0 | ENSG00000102699 | nan | nan
chr13	ATP12A	182360.0 | ATP12A, ATP1AL1 | ATPase, H+/K+ transporting, nongastric, alpha polypeptide | 479.0 | ENSG00000075673 | nan | nan
chr13	RNF17	605793.0 | RNF17 | RING finger protein-17 | 56163.0 | ENSG00000132972 | nan | nan
chr13	CPAP	609279.0 | CENPJ, CPAP, MCPH6, SCKL4 | Centromeric protein J | 55835.0 | ENSG00000151849 | mutation identified in 1 SCKL4 family | Microcephaly 6, primary, autosomal recessive, 608393 (3), Autosomal recessive; ?Seckel syndrome 4, 613676 (3), Autosomal recessive
chr13	PABPC3	604680.0 | PABPC3, PABP3, PABPL3 | Polyadenylate-binding protein, cytoplasmic, 3 | 5042.0 | ENSG00000151846 | nan | nan
chr13	AMER2	614659.0 | FAM123A, AMER2 | Family with sequence similarity 123, member A (APC membrane recruitment protein 2) | 219287.0 | ENSG00000165566 | nan | nan
chr13	MTMR6	603561.0 | MTMR6 | Myotubularin-related protein 6 | 9107.0 | ENSG00000139505 | nan | nan
chr13	NUP58	607615.0 | NUP58, NUPL1, KIAA0410 | Nucleoporin 58kDa | 9818.0 | ENSG00000139496 | nan | nan
chr13	ATP8A2	605870.0 | ATP8A2, ATPIB, CAMRQ4 | ATPase, class I, type 8A, member 2 | 51761.0 | ENSG00000132932 | nan | Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4, 615268 (3), Autosomal recessive
chr13	SHISA2	617324.0 | SHISA2, C13orf13, TMEM46 | Shisa family, member 2 | 387914.0 | ENSG00000180730 | nan | nan
chr13	RNF6	604242.0 | RNF6 | RING finger protein-6 | 6049.0 | ENSG00000127870 | nan | Esophageal carcinoma, somatic, 133239 (3)
chr13	CDK8	603184.0 | CDK8, IDDHBA | Cyclin-dependent kinase 8 | 1024.0 | ENSG00000132964 | nan | Intellectual developmental disorder with hypotonia and behavioral abnormalities, 618748 (3), Autosomal dominant
chr13	WASF3	605068.0 | WASF3, WAVE3, SCAR3 | WAS protein family member 3 | 10810.0 | ENSG00000132970 | nan | nan
chr13	GPR12	600752.0 | GPR12 | G protein-coupled receptor-12 | 2835.0 | ENSG00000132975 | nan | nan
chr13	USP12	603091.0 | USP12, UBH1 | Ubiquitin-specific protease 12 | 219333.0 | ENSG00000152484 | nan | nan
chr13	MBS1	157900.0 | MBS, MBS1 | Moebius syndrome | 4156.0 | nan | nan | ?Moebius syndrome, 157900 (2), Isolated cases, Autosomal dominant
chr13	RPL21	603636.0 | RPL21, HYPT12 | Ribosomal protein L21 | 6144.0 | ENSG00000122026 | nan | Hypotrichosis 12, 615885 (3), Autosomal dominant
chr13	RASL11A	612403.0 | RASL11A | RAS-like, family 11, member A | 387496.0 | ENSG00000122035 | nan | nan
chr13	GTF3A	600860.0 | GTF3A, TFIIIA | General transcription factor IIIA | 2971.0 | ENSG00000122034 | nan | nan
chr13	MTIF3	619554.0 | MTIF3, IF3MT | Mitochondrial translational initiation factor 3 | 219402.0 | ENSG00000122033 | nan | nan
chr13	LNX2	609733.0 | LNX2, PDZRN1 | Ligand of numb protein X2 | 222484.0 | ENSG00000139517 | nan | nan
chr13	POLR1D	613715.0 | POLR1D, RPA16, RPAC2, TCS2 | Polymerase I, RNA, subunit D | 51082.0 | ENSG00000186184 | nan | Treacher Collins syndrome 2, 613717 (3), Autosomal recessive, Autosomal dominant
chr13	GSX1	616542.0 | GSX1, GSH1 | GS homeobox 1 | 219409.0 | ENSG00000169840 | nan | nan
chr13	PDX1	600733.0 | PDX1, IPF1, MODY4, PAGEN1 | Pancreas/duodenum homeobox protein 1 | 3651.0 | ENSG00000139515 | nan | {Diabetes mellitus, type II, susceptibility to}, 125853 (3), Autosomal dominant; Pancreatic agenesis 1, 260370 (3), Autosomal recessive; MODY, type IV, 606392 (3)
chr13	CDX2	600297.0 | CDX2, CDX3 | Caudal type homeobox transcription factor 2 | 1045.0 | ENSG00000165556 | nan | nan
chr13	URAD	615804.0 | URAD | Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase | 646625.0 | ENSG00000183463 | nan | nan
chr13	FLT3	136351.0 | FLT3 | fms-related tyrosine kinase-3 | 2322.0 | ENSG00000122025 | nan | Leukemia, acute lymphoblastic, somatic, 613065 (3); Leukemia, acute myeloid, reduced survival in, somatic, 601626 (3); Leukemia, acute myeloid, somatic, 601626 (3)
chr13	PAN3	617448.0 | PAN3 | PABP-dependent poly(A) nuclease 3 | 255967.0 | ENSG00000152520 | nan | nan
chr13	FLT1	165070.0 | FLT1 | fms-related tyrosine kinase-1 (vascular endothelial growth factor/vascular permeability factor receptor) | 2321.0 | ENSG00000102755 | 150kb from FLT3 | nan
chr13	POMP	613386.0 | POMP, UMP1, PRAAS2 | Proteasome maturation protein | 51371.0 | ENSG00000132963 | nan | Proteasome-associated autoinflammatory syndrome 2, 618048 (3), Autosomal dominant; Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3), Autosomal recessive
chr13	SLC46A3	616764.0 | SLC46A3 | Solute carrier family 46, member 3 | 283537.0 | ENSG00000139508 | nan | nan
chr13	MTUS2	619358.0 | MTUS2, TIP150, CAZIP, KIAA0774 | Micortubule-associated scaffold protein 2 | 23281.0 | ENSG00000132938 | nan | nan
chr13	SLC7A1	104615.0 | SLC7A1, ATRC1 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | 6541.0 | ENSG00000139514 | distal to ATP1AL1 | nan
chr13	UBL3	604711.0 | UBL3 | Ubiquitin-like 3 | 5412.0 | ENSG00000122042 | nan | nan
chr13	KATNAL1	614764.0 | KATNAL1 | Katanin p60 subunit A-like 1 | 84056.0 | ENSG00000102781 | nan | nan
chr13	HMGB1	163905.0 | HMGB1, HMG1 | High-mobility group box 1 (high-mobility group (nonhistone chromosomal) protein 1) | 3146.0 | ENSG00000189403 | nan | nan
chr13	USPL1	617470.0 | USPL1 | Ubiquitin-specific peptidase-like 1 | 10208.0 | ENSG00000132952 | nan | nan
chr13	ALOX5AP	603700.0 | ALOX5AP, FLAP | Arachidonate 5-lipoxygenase-activating protein | 241.0 | ENSG00000132965 | nan | {Stroke, susceptibility to}, 601367 (3), Multifactorial
chr13	HSPH1	610703.0 | HSPH1, HSP105, KIAA0201 | Heat-shock 105/110kD protein 1 | 10808.0 | ENSG00000120694 | nan | nan
chr13	B3GLCT	610308.0 | B3GLCT, B3GALTL, B3GTL | Beta 3-glucosyltransferase | 145173.0 | ENSG00000187676 | nan | Peters-plus syndrome, 261540 (3), Autosomal recessive
chr13	ENUR1	600631.0 | ENUR1 | Enuresis, nocturnal, 1 | 2031.0 | nan | nan | Enuresis, nocturnal, 1, 600631 (2), Autosomal dominant
chr13	HPRHP	612089.0 | HPRHP | Hypophosphatemic rickets and hyperparathyroidism | 100188880.0 | nan | ?due to altered KLOTHO expression | Hypophosphatemic rickets and hyperparathyroidism, 612089 (2), Autosomal dominant
chr13	RXFP2	606655.0 | LGR8, GREAT | Leucine-rich repeat-containing G protein-coupled receptor 8 | 122042.0 | ENSG00000133105 | nan | nan
chr13	FRY	614818.0 | FRY, C13orf14 | FRY microtubule-binding protein | 10129.0 | ENSG00000073910 | nan | nan
chr13	ZAR1L	620424.0 | ZAR1L, ZAR2 | Zygote arrest 1-like | 646799.0 | ENSG00000189167 | nan | nan
chr13	BRCA2	600185.0 | BRCA2, FANCD1, BROVCA2, GLM3, PNCA2 | BRCA2 DNA repair-associated protein | 675.0 | ENSG00000139618 | nan | Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant
chr13	N4BP2L2	615788.0 | N4BP2L2, PFAAP5 | NEDD4-binding protein 2-like 2 | 10443.0 | ENSG00000244754 | nan | nan
chr13	PDS5B	605333.0 | PDS5B, AS3, APRIN | PDS5 cohesin-associated factor B | 23047.0 | ENSG00000083642 | nan | nan
chr13	KL	604824.0 | KL, KLOTHO, HFTC3 | Klotho | 9365.0 | ENSG00000133116 | mutation identified in 1 HFTC3 patient | ?Tumoral calcinosis, hyperphosphatemic, familial, 3, 617994 (3), Autosomal recessive
chr13	STARD13	609866.0 | STARD13, DLC2 | Start domain-containing protein 13 | 90627.0 | ENSG00000133121 | nan | nan
chr13	AUTS3	608049.0 | AUTS3 | Autism, susceptibility to, 3 | 387577.0 | nan | nan | {Autism susceptibility 3}, 608049 (2), Isolated cases, Multifactorial
chr13	RFC3	600405.0 | RFC3 | Replication factor C3, 38kD (activator 1, 38kD) | 5983.0 | ENSG00000133119 | nan | nan
chr13	IBD27	612796.0 | IBD27 | Inflammatory bowel disease 27 | 100302059.0 | nan | nan | {Inflammatory bowel disease 27}, 612796 (2)
chr13	PAPA5	263450.0 | PAPA5 | Polydactyly, postaxial, type A5 | 101241897.0 | nan | between D13S1288 and D13S632 | Polydactyly, postaxial, type A5, 263450 (2), Autosomal recessive
chr13	NBEA	604889.0 | NBEA, NEDEGE | Neurobeachin | 26960.0 | ENSG00000172915 | site of FRA13A | Neurodevelopmental disorder with or without early-onset generalized epilepsy, 619157 (3), Autosomal dominant
chr13	MAB21L1	601280.0 | MAB21L1, COFG | mab-21 like 1 | 4081.0 | ENSG00000180660 | nan | Cerebellar, ocular, craniofacial, and genital syndrome, 618479 (3), Autosomal recessive
chr13	DCLK1	604742.0 | DCLK1, DCAMKL1, CLICK1, CL1, KIAA0369 | Doublecortin-like kinase 1 | 9201.0 | ENSG00000133083 | nan | nan
chr13	SOHLH2	616066.0 | SOHLH2 | Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 2 | 54937.0 | ENSG00000120669 | nan | nan
chr13	SPART	607111.0 | SPART, KIAA0610, SPG20 | Spartin | 23111.0 | ENSG00000133104 | nan | Troyer syndrome, 275900 (3), Autosomal recessive
chr13	CCNA1	604036.0 | CCNA1 | Cyclin A1 | 8900.0 | ENSG00000133101 | nan | nan
chr13	RFXAP	601861.0 | RFXAP, MHC2D4 | Regulatory factor X-associated protein | 5994.0 | ENSG00000133111 | nan | MHC class II deficiency 4, 620817 (3), Autosomal recessive
chr13	SMAD9	603295.0 | MADH9, SMAD9, MADH6, PPH2 | Mothers against decapentaplegic, Drosophila, homolog of, 9 | 4093.0 | ENSG00000120693 | nan | Pulmonary hypertension, primary, 2, 615342 (3), Autosomal dominant
chr13	ALG5	604565.0 | ALG5, PKD7 | ALG5 dolichyl-phosphate beta-glucosyltransferase | 29880.0 | ENSG00000120697 | nan | Polycystic kidney disease 7, 620056 (3), Autosomal dominant
chr13	EXOSC8	606019.0 | EXOSC8, OIP2, RRP43, PCH1C | Exosome component 8 | 11340.0 | ENSG00000120699 | nan | Pontocerebellar hypoplasia, type 1C, 616081 (3), Autosomal recessive
chr13	SUPT20H	613417.0 | FAM48A, P38IP, C13orf19 | Family with sequence similarity 48, member A | 55578.0 | ENSG00000102710 | nan | nan
chr13	POSTN	608777.0 | POSTN, OSF2, PN | Periostin | 10631.0 | ENSG00000133110 | nan | nan
chr13	TRPC4	603651.0 | TRPC4, TRP4 | Transient receptor potential cation channel, subfamily C, member 4 | 7223.0 | ENSG00000133107 | nan | nan
chr13	UFM1	610553.0 | UFM1, HLD14 | Ubiquitin-fold modifier 1 | 51569.0 | ENSG00000120686 | nan | Leukodystrophy, hypomyelinating, 14, 617899 (3), Autosomal recessive
chr13	FREM2	608945.0 | FREM2, FRASRS2, CRYPTOP | FRAS1-related extracellular matrix protein 2 | 341640.0 | ENSG00000150893 | nan | Fraser syndrome 2, 617666 (3), Autosomal recessive; Cryptophthalmos, unilateral or bilateral, isolated, 123570 (3), Autosomal recessive
chr13	STOML3	608327.0 | STOML3, SRO | Stomatin-like protein 3 | 161003.0 | ENSG00000133115 | nan | nan
chr13	PROSER1	620773.0 | PROSER1 | Proline- adn serine-rich protein 1 | 80209.0 | ENSG00000120685 | nan | nan
chr13	LHFPL6	606710.0 | LHFPL6 | LHFPL tetraspan subfamily, member 6 | 10186.0 | ENSG00000183722 | nan | nan
chr13	BMIQ2	606643.0 | BMIQ2 | Body mass index quantitative trait locus 2 | 192149.0 | nan | max lod at D13S257 | [Body mass index QTL2], 606643 (2)
chr13	BMND9	612110.0 | BMND9 | Bone mineral density quantitative trait locus 9 | 100188882.0 | nan | associated with rs9594759 | [Bone mineral density QTL 9], 612110 (2)
chr13	CLLS2	109543.0 | CLLS2, D13S25, DBM | Leukemia, chronic lymphocytic, susceptibility to, 2 | 8101.0 | nan | >530kb telomeric to RB1 | {Leukemia, chronic lymphocytic, susceptibility to, 2}, 109543 (2), Autosomal dominant
chr13		613884.0 | DEL13q14, C13DELq14 | Chromosome 13q14 deletion syndrome | nan | nan | nan | Chromosome 13q14 deletion syndrome, 613884 (4), Isolated cases, Autosomal dominant
chr13	GER	109350.0 | GER | Gastroesophageal reflux | 59330.0 | nan | nan | Gastroesophageal reflux, 109350 (2), Autosomal dominant
chr13	LPRS6	613407.0 | LPRS6 | Leprosy, susceptibility to, 6 | 100499166.0 | nan | associated with rs9533634 and rs3764147 | {Leprosy, susceptibility to, 6}, 613407 (2)
chr13	RIEG2	601499.0 | RIEG2, RGS2 | Rieger syndrome, type 2 | 6012.0 | nan | nan | Rieger syndrome, type 2, 601499 (2), Autosomal dominant
chr13	SPG24	607584.0 | SPG24 | Spastic paraplegia 24, autosomal recessive | 338090.0 | nan | nan | Spastic paraplegia 24, autosomal recessive, 607584 (2), Autosomal recessive
chr13	XRS	194370.0 | XRS | X-ray sensitivity | 8102.0 | nan | nan | nan
chr13	COG6	606977.0 | COG6, COD2, KIAA1134, CDG2L, SHNS | Component of oligomeric golgi complex 6 | 57511.0 | ENSG00000133103 | nan | Shaheen syndrome, 615328 (3), Autosomal recessive; Congenital disorder of glycosylation, type IIl, 614576 (3), Autosomal recessive
chr13	LINC00598	619008.0 | LINC00598, TTL | Long intergenic noncoding RNA 598 | 646982.0 | ENSG00000215483 | nan | nan
chr13	FOXO1	136533.0 | FOXO1A, FKHR | Forkhead box O1A (forkhead in rhabdomyosarcoma) | 2308.0 | ENSG00000150907 | chimeric with PAX3 in t(2;13); fuses with PAX3 | Rhabdomyosarcoma, alveolar, 268220 (3), Somatic mutation
chr13	MRPS31	611992.0 | MRPS31 | Mitochondrial ribosomal protein S31 | 10240.0 | ENSG00000102738 | 4 pseudogenes | nan
chr13	SLC25A15	603861.0 | SLC25A15, ORNT1, HHH | Solute carrier family 25 (mitochondrial carrier), member 15 (ornithine transporter 1) | 10166.0 | ENSG00000102743 | with deficiency of factors VII and X in 3 unrelated cases | Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3), Autosomal recessive
chr13	ELF1	189973.0 | ELF1, RIA1, EFTUD1 | E74-like ETS transcription factor 1 | 1997.0 | ENSG00000120690 | nan | nan
chr13	WBP4	604981.0 | WBP4, FBP21, NEDHFDB | WW domain-containing binding protein 4 | 11193.0 | ENSG00000120688 | nan | Neurodevelopemental disorder with hypotonia, feeding difficulties, facial dysmorphism, and brain abnormalities, 620852 (3), Autosomal recessive
chr13	KBTBD6	617738.0 | KBTBD6 | Kelch repeat- and BTB domain-containing protein 6 | 89890.0 | ENSG00000165572 | nan | nan
chr13	KBTBD7	617739.0 | KBTBD7 | Kelch repeat- and BTB domain-containing protein 7 | 84078.0 | ENSG00000120696 | nan | nan
chr13	MTRF1	604601.0 | MTRF1 | Translational release factor, mitochondrial, 1 | 9617.0 | ENSG00000120662 | nan | nan
chr13	NAA16	619497.0 | NAA16, NARG1L | N-alpha-acetyltransferase 16, NatA auxiliary subunit | 79612.0 | ENSG00000172766 | nan | nan
chr13	RGCC	610077.0 | RGC32 | Response gene to complement 32 | 28984.0 | ENSG00000102760 | nan | nan
chr13	VWA8	617509.0 | VWA8, KIAA0564, RP97 | von Willebrand factor A domain-containing protein 8 | 23078.0 | ENSG00000102763 | mutation identified in 1 RP97 family | ?Retinitis pigmentosa 97, 620422 (3), Autosomal dominant
chr13	DGKH	604071.0 | DGKH | Diacylglycerol kinase, eta, 130kD | 160851.0 | ENSG00000102780 | nan | nan
chr13	AKAP11	604696.0 | AKAP11, AKAP220 | A-kinase anchor protein 11 | 11215.0 | ENSG00000023516 | nan | nan
chr13	TNFSF11	602642.0 | TNFSF11, OPGL, TRANCE, OPTB2 | Tumor necrosis factor ligand superfamily, member 11 (osteoprotegerin ligand) | 8600.0 | ENSG00000120659 | nan | Osteopetrosis, autosomal recessive 2, 259710 (3), Autosomal recessive
chr13	EPSTI1	607441.0 | EPSTI1 | Epithelial stromal interaction 1 | 94240.0 | ENSG00000133106 | nan | nan
chr13	DNAJC15	615339.0 | DNAJC15, MCJ | DNAJ/HSP40 homolog, subfamily C, member 15 | 29103.0 | ENSG00000120675 | nan | nan
chr13	ENOX1	610914.0 | ENOX1, CNOX | ECTO-NOX disulfide-thiol exchanger 1 | 55068.0 | ENSG00000120658 | nan | nan
chr13	CCDC122	613408.0 | CCDC122 | Coiled-coil domain-containing protein 122 | 160857.0 | ENSG00000151773 | nan | nan
chr13	LACC1	613409.0 | LACC1, C13orf31, JUVAR | Laccase (multicopper reductase) domain-containing protein 1 | 144811.0 | ENSG00000179630 | nan | Juvenile arthritis, 618795 (3), Autosomal recessive
chr13	TSC22D1	607715.0 | TSC22D1, TSC22 | TSC22 domain family, member 1 | 8848.0 | ENSG00000102804 | nan | nan
chr13	NUFIP1	604354.0 | NUFIP1, NUFIP | Nuclear FMR1 interacting protein 1 | 26747.0 | ENSG00000083635 | pseudogene on 6q12 | nan
chr13	GTF2F2	189969.0 | GTF2F2, TF2F2, RAP30 | General transcription factor IIF, polypeptide 2, 30kD | 2963.0 | ENSG00000188342 | nan | nan
chr13	KCTD4	620638.0 | KCTD4 | Potassium channel tetramerization domain-containing protein 4 | 386618.0 | ENSG00000180332 | nan | nan
chr13	TPT1	600763.0 | TPT1, HRF | Tumor protein, translationally-controlled 1 | 7178.0 | ENSG00000133112 | nan | nan
chr13	SNORA31	619378.0 | SNORA31, IIAE10 | Small nucleolar RNA, H/ACA box, 31 | 677814.0 | ENSG00000199477 | nan | {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 10}, 619396 (3), Autosomal dominant
chr13	SLC25A30	610793.0 | SLC25A30, KMCP1 | Solute carrier family 25 (mitochondrial carrier, kidney), member 30 | 253512.0 | ENSG00000174032 | nan | nan
chr13	COG3	606975.0 | COG3, SEC34, CDG2BB | Component of oligomeric golgi complex 3 | 83548.0 | ENSG00000136152 | nan | Congenital disorder of glycosylation, type IIbb, 620546 (3), Autosomal recessive
chr13	CBY2	618614.0 | CBY2, NURIT, SPERT | Chibby family, member 2 | 220082.0 | ENSG00000174015 | nan | nan
chr13	SIAH3	615609.0 | SIAH3 | SIAH E3 ubiquitin protein ligase family, member 3 | 283514.0 | ENSG00000215475 | nan | nan
chr13	ZC3H13	616453.0 | ZC3H13, KIAA0853 | Zinc finger CCCH domain-containing protein 13 | 23091.0 | ENSG00000123200 | nan | nan
chr13	CPB2	603101.0 | CPB2, CPU, TAFI | Carboxypeptidase B2, plasma (carboxypeptidase U) | 1361.0 | ENSG00000080618 | nan | nan
chr13	LCP1	153430.0 | LCP1 | Lymphocyte cytosolic protein-1 (plasmin) | 3936.0 | ENSG00000136167 | nan | nan
chr13	RUBCNL	620175.0 | RUBCNL, PACER | Rubicon-like autophagy enhancer | 80183.0 | ENSG00000102445 | nan | nan
chr13	LRCH1	610368.0 | LRCH1, KIAA1016 | Leucine-rich repeats and calponin homology domain-containing 1 | 23143.0 | ENSG00000136141 | nan | nan
chr13	ESD	133280.0 | ESD | Esterase D; S-formylglutathione hydrolase | 2098.0 | ENSG00000139684 | proximal to RB1, WND | nan
chr13	HTR2A	182135.0 | HTR2A | 5-hydroxytryptamine (serotonin) receptor-2A | 3356.0 | ENSG00000102468 | nan | {Major depressive disorder, response to citalopram therapy in}, 608516 (3); {Obsessive-compulsive disorder, susceptibility to}, 164230 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant
chr13	SUCLA2	603921.0 | SUCLA2, MTDPS5 | Succinate-CoA ligase, ADP-forming, beta subunit | 8803.0 | ENSG00000136143 | nan | Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3), Autosomal recessive
chr13	NUDT15	615792.0 | NUDT15, MTH2, NUDT15D | Nudix hydrolase 15 | 55270.0 | ENSG00000136159 | nan | {Thiopurines, poor metabolism of, 2}, 616903 (3), Autosomal dominant
chr13	MED4	605718.0 | MED4, DRIP36, HSPC126 | Mediator of RNA polymerase II transcription, subunit 4, S. cerevisiae, homolog of | 29079.0 | ENSG00000136146 | nan | nan
chr13	ITM2B	603904.0 | ITM2B, BRI, ABRI, FBD, RDGCA | Integral membrane protein 2B (BRI gene) | 9445.0 | ENSG00000136156 | mutation identified in 1 RDGCA family | ?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3), Autosomal dominant; Dementia, familial British, 176500 (3), Autosomal dominant; Dementia, familial Danish, 117300 (3), Autosomal dominant
chr13	RB1	614041.0 | RB1 | Retinoblastoma-1 | 5925.0 | ENSG00000139687 | nan | Small cell cancer of the lung, somatic, 182280 (3); Bladder cancer, somatic, 109800 (3); Retinoblastoma, trilateral, 180200 (3), Somatic mutation, Autosomal dominant; Osteosarcoma, somatic, 259500 (3); Retinoblastoma, 180200 (3), Somatic mutation, Autosomal dominant
chr13	LPAR6	609239.0 | LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8 | Lysophosphatidic acid receptor 6 | 10161.0 | ENSG00000139679 | in intron 17 of RB gene | Hypotrichosis 8, 278150 (3), Autosomal recessive; Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3), Autosomal recessive
chr13	RCBTB2	603524.0 | RCBTB2, CHC1L | RCC1 domain- and BTB domain-containing protein 2 | 1102.0 | ENSG00000136161 | nan | nan
chr13	CYSLTR2	605666.0 | CYSLTR2, CYSLT2 | Cysteinyl leukotriene receptor 2 | 57105.0 | ENSG00000152207 | nan | nan
chr13	FNDC3A	615794.0 | FNDC3A, KIAA0970, HUGO | Fibronectin type III domain-containing protein 3A | 22862.0 | ENSG00000102531 | nan | nan
chr13	MLNR	602885.0 | MLNR, GPR38 | Motilin receptor | 2862.0 | ENSG00000102539 | nan | nan
chr13	CDADC1	618997.0 | CDADC1 | Cytidine and deoxycytidylate deaminase domain-containing protein 1 | 81602.0 | ENSG00000102543 | nan | nan
chr13	CAB39L	612175.0 | CAB39L | Calcium-binding protein 39-like protein | 81617.0 | ENSG00000102547 | nan | nan
chr13	SETDB2	607865.0 | SETDB2, CLLD8 | SET domain protein, bifurcated, 2 | 83852.0 | ENSG00000136169 | nan | nan
chr13	PHF11	607796.0 | PHF11, NYREN34 | PHD finger protein 11 | 51131.0 | ENSG00000136147 | nan | nan
chr13	RCBTB1	607867.0 | RCBTB1, CLLD7, GLP, RDEOA | RCC1 domain- and BTB domain-containing protein 1 | 55213.0 | ENSG00000136144 | nan | Retinal dystrophy with or without extraocular anomalies, 617175 (3), Autosomal recessive
chr13	ARL11	609351.0 | ARL11, ARLTS1 | ADP ribosylation factor-like GTPase 11 | 115761.0 | ENSG00000152213 | nan | nan
chr13	EBPL	617335.0 | EBPL | Emopamil-binding protein-like | 84650.0 | ENSG00000123179 | nan | nan
chr13	KPNA3	601892.0 | KPNA3, SPG88 | Karyopherin (importin) alpha-3 | 3839.0 | ENSG00000102753 | nan | Spastic paraplegia 88, autosomal dominant, 620106 (3), Autosomal dominant
chr13	SPRYD7	607866.0 | CLLD6, C13orf1 | Chronic lymphocytic leukemia deletion region gene 6 | 57213.0 | ENSG00000123178 | nan | nan
chr13	DLEU2	605766.0 | DLEU2, LEU2, BCMSUN | Deleted in lymphocytic leukemia 2 | 8847.0 | ENSG00000231607 | nan | nan
chr13	TRIM13	605661.0 | TRIM13, RFP2, LEU5 | Tripartite motif-containing protein 13 | 10206.0 | ENSG00000204977 | nan | nan
chr13	KCNRG	607947.0 | KCNRG, DLTET | Potassium channel regulator | 283518.0 | ENSG00000198553 | nan | nan
chr13	MIR16-1	609704.0 | MIR16-1, MIRN16-1 | Micro RNA 16-1 | 406950.0 | ENSG00000208006 | nan | nan
chr13	MIR15A	609703.0 | MIR15A, MIRN15A | Micro RNA 15A | 406948.0 | ENSG00000283785 | nan | nan
chr13	DLEU1	605765.0 | DLEU1, LEU1 | Deleted in lymphocytic leukemia 1 | 10301.0 | ENSG00000176124 | nan | nan
chr13	STQTL20	612894.0 | STQTL20 | Stature quantitative trait locus 20 | 100302685.0 | nan | associated with rs3118914 | {Stature QTL 20}, 612894 (2)
chr13	DLEU7	618634.0 | DLEU7 | Deleted in lymphocytic leukemia 7 | 220107.0 | ENSG00000186047 | nan | nan
chr13	RNASEH2B	610326.0 | RNASEH2B, DLEU8, FLJ11712, AGS2 | Ribonuclease H2, subunit B | 79621.0 | ENSG00000136104 | nan | Aicardi-Goutieres syndrome 2, 610181 (3), Autosomal recessive
chr13	GUCY1B2	603695.0 | GUCY1B2 | Guanylate cyclase 1, soluble, beta-2 | 2974.0 | ENSG00000293412 | nan | nan
chr13	INTS6	604331.0 | INTS6, DDX26, DICE1 | Integrator complex subunit 6 | 26512.0 | ENSG00000102786 | nan | nan
chr13	SERPINE3	620989.0 | SERPINE3 | Serpin family E, member 3 | 647174.0 | ENSG00000253309 | nan | nan
chr13	WDFY2	610418.0 | WDFY2 | WD repeat- and FYVE domain-containing protein 2 | 115825.0 | ENSG00000139668 | nan | nan
chr13	DHRS12	616163.0 | DHRS12, SDR40C1 | Short-chain dehydrogenase reductase family, member 12 | 79758.0 | ENSG00000102796 | nan | nan
chr13	CTAGE3P	608857.0 | CTAGE3 | Cutaneous T-cell lymphoma-associated antigen 3 | 220112.0 | ENSG00000232872 | nan | nan
chr13	ATP7B	606882.0 | ATP7B, WND | ATPase, Cu++ transporting, beta polypeptide | 540.0 | ENSG00000123191 | nan | Wilson disease, 277900 (3), Autosomal recessive
chr13	ALG11	613666.0 | ALG11, KIAA1266, CDG1P | ALG11 alpha-1,2-mannosyltransferase | 440138.0 | ENSG00000253710 | nan | Congenital disorder of glycosylation, type Ip, 613661 (3), Autosomal recessive
chr13	UTP14C	608969.0 | UTP14C, UTP14B, KIAA0266 | UTP14C small subunit processome component | 9724.0 | ENSG00000253797 | pseudogene on chr.2 | nan
chr13	NEK5	616731.0 | NEK5 | NIMA-related kinase 5 | 341676.0 | ENSG00000197168 | nan | nan
chr13	NEK3	604044.0 | NEK3 | Never in mitosis gene A-related kinase 3 | 4752.0 | ENSG00000136098 | nan | nan
chr13	THSD1	616821.0 | THSD1, TMTSP, ANIB12, LMPHM13 | Thrombospondin type 1 domain-containing protein 1 | 55901.0 | ENSG00000136114 | mutation identified in 1 ANIB12 family | ?Aneurysm, intracranial berry, 12, 618734 (3), Autosomal dominant; Lymphatic malformation 13, 620244 (3), Autosomal recessive
chr13	VPS36	610903.0 | VPS36, EAP45 | Vacuolar protein sorting 36 homolog | 51028.0 | ENSG00000136100 | nan | nan
chr13	CKAP2	611569.0 | CKAP2, TMAP, LB1 | Cytoskeleton-associated protein 2 | 26586.0 | ENSG00000136108 | nan | nan
chr13	SUGT1	604098.0 | SUGT1, SGT1 | SGT1 homolog, MIS12 kinetochore complex assembly cochaperone | 10910.0 | ENSG00000165416 | nan | nan
chr13	CNMD	605147.0 | LECT1, CHM1 | Leukocyte cell derived chemotaxin 1 (chondromodulin) | 11061.0 | ENSG00000136110 | nan | nan
chr13	PCDH8	603580.0 | PCDH8 | Protocadherin 8 | 5100.0 | ENSG00000136099 | nan | nan
chr13	OLFM4	614061.0 | OLFM4, GC1, GW112 | Olfactomedin 4 | 10562.0 | ENSG00000102837 | nan | nan
chr13	ATXN8	613289.0 | ATXN8 | Ataxin 8 | 724066.0 | nan | CAG repeat results in polyglutamine expansion protein | Spinocerebellar ataxia 8, 608768 (3), Autosomal dominant
chr13	PAPA2	602085.0 | PAPA2 | Postaxial polydactyly, type A2 | 8103.0 | nan | nan | Postaxial polydactyly, type A2, 602085 (2), Autosomal dominant
chr13	SLI3	607134.0 | SLI3 | Specific language impairment QTL, 3 | 780906.0 | nan | max with D13S1317 | Specific language impairment QTL, 3, 607134 (2)
chr13	PCDH17	611760.0 | PCDH17, PCDH68 | Protocadherin 17 | 27253.0 | ENSG00000118946 | nan | nan
chr13	DIAPH3	614567.0 | DIAPH3, DIA2, DRF3, AUNA1, NSDAN | Diaphanous-related formin 3 | 81624.0 | ENSG00000139734 | nan | Auditory neuropathy, autosomal dominant 1, 609129 (3), Autosomal dominant
chr13	TDRD3	614392.0 | TDRD3 | Tudor domain-containing protein 3 | 81550.0 | ENSG00000083544 | nan | nan
chr13	PCDH20	614449.0 | PCDH20, PCDH13 | Protocadherin 20 | 64881.0 | ENSG00000280165 | nan | nan
chr13	PCDH9	603581.0 | PCDH9 | Protocadherin 9 | 5101.0 | ENSG00000184226 | nan | nan
chr13	KLHL1	605332.0 | KLHL1 | Kelch-like 1 | 57626.0 | ENSG00000150361 | nan | nan
chr13	ATXN8OS	603680.0 | ATXN8OS, SCA8, KLHL1AS | Ataxin 8 opposite strand | 6315.0 | ENSG00000230223 | due to CTG repeat in untranslated DNA | {Parkinson disease, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant; Spinocerebellar ataxia 8, 608768 (3), Autosomal dominant
chr13	DACH1	603803.0 | DACH1 | Dachshund family transcription factor 1 | 1602.0 | ENSG00000276644 | nan | nan
chr13	MZT1	613448.0 | C13orf37, MOZART1 | Mitotic spindle-organizing protein associated with a ring of gamma-tubulin | 440145.0 | ENSG00000204899 | nan | nan
chr13	BORA	610510.0 | BORA, C13orf34 | Aurora borealis | 79866.0 | ENSG00000136122 | nan | nan
chr13	DIS3	607533.0 | DIS3, KIAA1008 | DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease | 22894.0 | ENSG00000083520 | nan | nan
chr13	PIBF1	607532.0 | PIBF1, JBTS33 | Progesterone-induced blocking factor 1 | 10464.0 | ENSG00000083535 | nan | Joubert syndrome 33, 617767 (3), Autosomal recessive
chr13	ACTD	142700.0 | DDH1 | Developmental dysplasia of the hip 1 | 780896.0 | nan | nan | Developmental dysplasia of the hip 1, 142700 (2), Multifactorial
chr13	PAND1	167870.0 | PAND1 | Panic disorder syndrome 1 | 387572.0 | nan | nan | Panic disorder syndrome 1, 167870 (2), ?Autosomal dominant
chr13	KLF5	602903.0 | KLF5, BTEB2 | Krupple-like factor 5 | 688.0 | ENSG00000102554 | nan | nan
chr13	KLF12	607531.0 | KLF12, AP2REP | Kruppel-like factor 12 | 11278.0 | ENSG00000118922 | nan | nan
chr13	TBC1D4	612465.0 | TBC1D4, AS160, KIAA0603, NIDDM5 | TPC1 domain family, member 4 | 9882.0 | ENSG00000136111 | nan | {Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3)
chr13	COMMD6	612377.0 | COMMD6 | COMM domain-containing protein 6 | 170622.0 | ENSG00000188243 | nan | nan
chr13	UCHL3	603090.0 | UCHL3 | Ubiquitin carboxyl-terminal esterase L3 | 7347.0 | ENSG00000118939 | nan | nan
chr13	LMO7	604362.0 | LMO7, FBXO20, FBX20, KIAA0858 | LIM domain only 7 | 4008.0 | ENSG00000136153 | nan | nan
chr13		617979.0 | lncRNA-ACOD1, LOC105370268 | Long noncoding RNA near ACOD1 | 105370268.0 | nan | nan | nan
chr13	KCTD12	610521.0 | KCTD12, PFET1, KIAA1778, C13orf2 | Potassium channel tetramerization domain-containing protein 12 | 115207.0 | ENSG00000178695 | nan | nan
chr13	BTF3P11	602543.0 | BTF3P11, BRF3L1 | Basic transcription factor 3 pseudogene 11 | 690.0 | nan | nan | nan
chr13	ACOD1	615275.0 | ACOD1, IRG1 | Aconitate decarboxylase 1 | 730249.0 | ENSG00000102794 | nan | nan
chr13	CLN5	608102.0 | CLN5 | CLN5 intracellular trafficking protein | 1203.0 | ENSG00000102805 | nan | Ceroid lipofuscinosis, neuronal, 5, 256731 (3), Autosomal recessive
chr13	FBXL3	605653.0 | FBXL3, FBXL3A, FBL3, IDDSFAS | F-box and leucine-rich repeat protein 3 | 26224.0 | ENSG00000005812 | nan | Intellectual developmental disorder with short stature, facial anomalies, and speech defects, 606220 (3), Autosomal recessive
chr13	MYCBP2	610392.0 | MYCBP2, PAM, KIAA0916 | Myc-binding protein 2 | 23077.0 | ENSG00000005810 | nan | nan
chr13	SCEL	604112.0 | SCEL | Sciellin | 8796.0 | ENSG00000136155 | nan | nan
chr13	SLAIN1	610491.0 | SLAIN1 | SLAIN motif family, member 1 | 122060.0 | ENSG00000139737 | nan | nan
chr13	EDNRB	131244.0 | EDNRB, HSCR2, ABCDS, WS4A | Endothelin receptor type B | 1910.0 | ENSG00000136160 | mutation identified in 1 ABCD family | {Hirschsprung disease, susceptibility to, 2}, 600155 (3), Autosomal dominant; ?ABCD syndrome, 600501 (3), Autosomal recessive; Waardenburg syndrome, type 4A, 277580 (3), Autosomal recessive, Autosomal dominant
chr13	POU4F1	601632.0 | POU4F1, BRN3A, ATITHS | POU domain, class 4, transcription factor 1 | 5457.0 | ENSG00000152192 | nan | Ataxia, intention tremor, and hypotonia syndrome, childhood-onset, 619352 (3), Autosomal dominant
chr13	OBI1	615906.0 | OBI1, RNF219, C13orf7 | ORC ubiquitin ligase 1 | 79596.0 | ENSG00000152193 | nan | nan
chr13	RBM26	620081.0 | RBM26 | RNA-binding motif protein 26 | 64062.0 | ENSG00000139746 | nan | nan
chr13	NDFIP2	610041.0 | NDFIP2, N4WBP5A, KIAA1165 | NEDD4 family-interacting protein 2 | 54602.0 | ENSG00000102471 | nan | nan
chr13	LINC01080	615230.0 | LNCR13Q1 | Long noncoding RNA on 13q (TCONS_00021856) | 101515984.0 | nan | nan | nan
chr13	SPRY2	602466.0 | SPRY2, IGAN3 | Sprouty RTK signaling antagonist 2 | 10253.0 | ENSG00000136158 | mutation identified in 1 IGAN3 family | {?IgA nephropathy, susceptibility to, 3}, 616818 (3), Autosomal dominant
chr13	SLITRK1	609678.0 | SLITRK1, KIAA1910, TTM | SLIT- and NTRK-like family, member 1 | 114798.0 | ENSG00000178235 | mutation identified in 1 TTM patient | Tourette syndrome, 137580 (3), Autosomal dominant; ?Trichotillomania, 613229 (3), Multifactorial, Autosomal dominant
chr13	SLITRK6	609681.0 | SLITRK6, DFNMYP | SLIT- and NTRK-like family, member 6 | 84189.0 | ENSG00000184564 | nan | Deafness and myopia, 221200 (3), Autosomal recessive
chr13	SLITRK5	609680.0 | SLITRK5, KIAA0918 | SLIT- and NTRK-like family, member 5 | 26050.0 | ENSG00000165300 | nan | nan
chr13		614326.0 | FGLDS2 | Feingold syndrome 2 | nan | nan | contiguous gene deletion syndrome | Feingold syndrome 2, 614326 (4), Autosomal dominant
chr13	PPR2	609572.0 | PPR2 | Photoparoxysmal response 2 | 780910.0 | nan | max lod at D13S1230 | Photoparoxysmal response 2, 609572 (2)
chr13	MIR17HG	609415.0 | MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25 | Micro RNA 17 host gene | 407975.0 | ENSG00000215417 | nan | nan
chr13	MIR17	609416.0 | MIR17, MIR91, MIRN17 | Micro RNA 17 | 406952.0 | ENSG00000284536 | within C13orf25; sequence encodes 2 micro RNAs | nan
chr13	MIR18A	609417.0 | MIR18A, MIRN18A | Micro RNA 18A | 406953.0 | ENSG00000283815 | within C13orf25 | nan
chr13	MIR19A	609418.0 | MIR19A, MIRN19A | Micro RNA 19A | 406979.0 | ENSG00000284204 | within C13orf25 | nan
chr13	MIR20A	609420.0 | MIR20A, MIRN20A | Micro RNA 20A | 406982.0 | ENSG00000283762 | within C13orf25 | nan
chr13	MIR19B1	609419.0 | MIR19B1, MIRN19B1 | Micro RNA 19B1 | 406980.0 | ENSG00000284375 | within C13orf25 | nan
chr13	MIR92A1	609422.0 | MIR92A1, MIR92-1, MIRN92-1 | Micro RNA 92A1 | 407048.0 | ENSG00000283705 | within C13orf25 | nan
chr13	GPC5	602446.0 | GPC5 | Glypican 5 | 2262.0 | ENSG00000179399 | nan | nan
chr13	GPC6	604404.0 | GPC6, OMIMD1 | Glypican 6 | 10082.0 | ENSG00000183098 | nan | Omodysplasia 1, 258315 (3), Autosomal recessive
chr13	KTCN7	614629.0 | KTCN7 | Keratoconus 7 | 100887822.0 | nan | max lod at D13S159 | Keratoconus 7, 614629 (2), Autosomal dominant
chr13		156600.0 | MCOR, C13DELq32, DEL13q32 | Microcoria, congenital (chromosome 13q32 deletion syndrome) | nan | nan | 35-80kb deletion encompassing TGDS and GPR180 | Microcoria, congenital, 156600 (4), Autosomal dominant
chr13	SCZD7	603176.0 | SCZD7 | Schizophrenia susceptibility locus, chromosome 13q-related | 8401.0 | nan | nan | {Schizophrenia}, 181500 (2), Autosomal dominant
chr13	SLEB5	609903.0 | SLEB5 | Systemic lupus erythematosus, susceptibility to, 5 | 100188798.0 | nan | max lod at D13S892 | {Systemic lupus erythematosus, susceptibility to, 5}, 609903 (2)
chr13	STQTL4	606258.0 | STQTL4 | Stature quantitative trait locus 4 | 282550.0 | nan | max lod at D13S779 and D13S797 | {Stature QTL 4}, 606258 (2)
chr13	DCT	191275.0 | DCT, TYRP2, OCA8 | Dopachrome tautomerase (dopachrome delta-isomerase; tyrosinase-related protein 2) | 1638.0 | ENSG00000080166 | nan | Oculocutaneous albinism, type VIII, 619165 (3), Autosomal recessive
chr13	TGDS	616146.0 | TGDS, SDR2E1, CATMANS | TDP-glucose 4,6-dehydratase | 23483.0 | ENSG00000088451 | nan | Catel-Manzke syndrome, 616145 (3), Autosomal recessive
chr13	GPR180	607787.0 | GPR180, ITR | G protein-coupled receptor 180 | 160897.0 | ENSG00000152749 | nan | nan
chr13	SOX21	604974.0 | SOX21 | SRY-box 21 | 11166.0 | ENSG00000125285 | nan | nan
chr13	ABCC4	605250.0 | ABCC4, MRP4, MOATB | ATP-binding cassette, subfamily C, member 4 | 10257.0 | ENSG00000125257 | nan | nan
chr13	CLDN10	617579.0 | CLDN10, OSPL, CPETRL3, HELIX | Claudin 10 | 9071.0 | ENSG00000134873 | nan | HELIX syndrome, 617671 (3), Autosomal recessive
chr13	DZIP1	608671.0 | DZIP1, KIAA0996, SPGF47, MVP3 | DAZ-interacting zinc finger protein 1 | 22873.0 | ENSG00000134874 | mutation identified in 1 MVP3 family | Spermatogenic failure 47, 619102 (3), Autosomal recessive; ?Mitral valve prolapse 3, 610840 (3), Autosomal dominant
chr13	DNAJC3	601184.0 | DNAJC3, PRKRI, P58, ACPHD | DnaJ, E. coli, homolog of, subfamily C, member 3 (protein kinase inhibitor p58) | 5611.0 | ENSG00000102580 | mutation identified in 1 ACPHD family | Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3), Autosomal recessive
chr13	UGGT2	605898.0 | UGGT2, HUGT2 | UDP-glucose glycoprotein glucosyltransferase 2 | 55757.0 | ENSG00000102595 | nan | nan
chr13	HS6ST3	609401.0 | HS6ST3 | Heparan sulfate 6-O-sulfotransferase 3 | 266722.0 | ENSG00000185352 | nan | nan
chr13	OXGR1	606922.0 | OXGR1, GPR80, CAON2 | Oxoglutarate receptor 1 | 27199.0 | ENSG00000165621 | nan | Nephrolithiasis, calcium oxalate, 2, with nephrocalcinosis, 620374 (3), Autosomal dominant
chr13	MBNL2	607327.0 | MBNL2, MBLL | Muscleblind-like splicing regulator 2 | 10150.0 | ENSG00000139793 | nan | nan
chr13	RAP2A	179540.0 | RAP2A | RAP2, member of RAS oncogene family (K-rev) | 5911.0 | ENSG00000125249 | nan | nan
chr13	IPO5	602008.0 | IPO5, RANBP5, KPNB3 | Importin 5 | 3843.0 | ENSG00000065150 | nan | nan
chr13	FARP1	602654.0 | FARP1, CDEP | FERM, ARHGEF, and pleckstrin domain-containing protein 1 | 10160.0 | ENSG00000152767 | nan | nan
chr13	STK24	604984.0 | STK24, MST3, MST3B | Serine/threonine protein kinase 24 | 8428.0 | ENSG00000102572 | nan | nan
chr13	SLC15A1	600544.0 | SLC15A1, HPECT1 | Solute carrier family 15 (oligopeptide transporter), member 1 | 6564.0 | ENSG00000088386 | nan | nan
chr13	DOCK9	607325.0 | ZIZ1, KIAA1058 | Zizimin 1 | 23348.0 | ENSG00000088387 | nan | nan
chr13	GPR18	602042.0 | GPR18 | G protein-coupled receptor-18 | 2841.0 | ENSG00000125245 | nan | nan
chr13	GPR183	605741.0 | GPR183, EBI2 | G protein-coupled receptor 183 | 1880.0 | ENSG00000169508 | nan | nan
chr13	TM9SF2	604678.0 | TM9SF2 | Transmembrane 9 superfamily, member 2 | 9375.0 | ENSG00000125304 | nan | nan
chr13	CLYBL	609686.0 | CLYBL, CLB | Citrate lyase beta-like | 171425.0 | ENSG00000125246 | nan | nan
chr13	ZIC5	617896.0 | ZIC5, OPR | Zic family, member 5 | 85416.0 | ENSG00000139800 | nan | nan
chr13	ZIC2	603073.0 | ZIC2, HPE5 | ZIC family, member 2 | 7546.0 | ENSG00000043355 | nan | Holoprosencephaly 5, 609637 (3), Autosomal dominant
chr13	PCCA	232000.0 | PCCA | Propionyl Coenzyme A carboxylase, alpha polypeptide | 5095.0 | ENSG00000175198 | nan | Propionicacidemia, 606054 (3), Autosomal recessive
chr13	GGACT	613378.0 | A2LD1, GGACT | AIG1-like domain-containing protein 1 | 87769.0 | ENSG00000134864 | nan | nan
chr13	TMTC4	618203.0 | TMTC4, DFNB122 | Transmembrane and tetratricopeptide repeat domains-containing protein 4 | 84899.0 | ENSG00000125247 | mutation identified in 1 DFNB122 family | ?Deafness, autosomal recessive 122, 620714 (3), Autosomal recessive
chr13	NALCN	611549.0 | NALCN, IHPRF1, CLIFAHDD | Sodium leak channel, nonselective | 259232.0 | ENSG00000102452 | nan | Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3), Autosomal dominant; Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3), Autosomal recessive
chr13		619148.0 | DEL13q33q34, C13DELq33q34 | Chromosome 13q33-q34 deletion syndrome | nan | nan | nan | Chromosome 13q33-q34 deletion syndrome, 619148 (4), Autosomal dominant
chr13	OFC9	610361.0 | OFC9 | Orofacial cleft 9 | 100462724.0 | nan | associated with rs1830756 | Orofacial cleft 9, 610361 (2)
chr13	ITGBL1	604234.0 | ITGBL1, TIED | Integrin, beta-like 1 | 9358.0 | ENSG00000198542 | nan | nan
chr13	FGF14	601515.0 | FGF14, FHF4, SCA27A, SCA27B | Fibroblast growth factor-14 | 2259.0 | ENSG00000102466 | nan | Spinocerebellar ataxia 27A, 193003 (3), Autosomal dominant; Spinocerebellar ataxia 27B, late-onset, 620174 (3), Autosomal dominant
chr13	TPP2	190470.0 | TPP2, IMD78 | Tripeptidyl peptidase II | 7174.0 | ENSG00000134900 | nan | Immunodeficiency 78 with autoimmunity and developmental delay, 619220 (3), Autosomal recessive
chr13	METTL21C	615259.0 | METTL21C, C13orf39 | Methyltransferase 21C, AARS1 lysine | 196541.0 | ENSG00000139780 | nan | nan
chr13	POGLUT2	611613.0 | POGLUT2, KDELC1, EP58 | Protein O-glucosyltransferase 2 | 79070.0 | ENSG00000134901 | nan | nan
chr13	BIVM	619006.0 | BIVM | Basic immunoglobulin-like variable motif-containing protein | 54841.0 | ENSG00000134897 | nan | nan
chr13	ERCC5	133530.0 | ERCC5, XPG, COFS3 | ERCC excision repair 5, endonuclease | 2073.0 | ENSG00000134899 | nan | Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive; Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive; Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive
chr13	SLC10A2	601295.0 | SLC10A2, NTCP2, PBAM1 | Solute carrier family 10 (sodium/bile acid cotransporter family), member 2 | 6555.0 | ENSG00000125255 | mutation identified in 1 PBAM1 patient | ?Bile acid malabsorption, primary, 1, 613291 (3), Autosomal recessive
chr13	VUR5	614318.0 | VUR5 | Vesicoureteral reflux 5 | 100820760.0 | nan | nearest marker rs4476030 | Vesicoureteral reflux 5, 614318 (2)
chr13	DAOA-AS1	607415.0 | DAOAAS, G30 | DAOA antisense RAN | 282706.0 | ENSG00000232307 | nan | nan
chr13	DAOA	607408.0 | DAOA, G72 | D-amino acid oxidase activator | 267012.0 | ENSG00000182346 | nan | {Schizophrenia}, 181500 (2), Autosomal dominant
chr13	EFNB2	600527.0 | EFNB2, EPLG5, LERK5, HTKL | eph-related receptor tyrosine kinase ligand 5 (ephrin-B2) | 1948.0 | ENSG00000125266 | nan | nan
chr13	ARGLU1	614046.0 | ARGLU1 | Arginine- and glutamate-rich protein 1 | 55082.0 | ENSG00000134884 | nan | nan
chr13	NALF1	619899.0 | NALF1, NLF1 | NALCN channel auxiliary factor 1 | 728215.0 | ENSG00000204442 | nan | nan
chr13	LIG4	601837.0 | LIG4, LIG4S | Ligase IV, DNA, ATP-dependent | 3981.0 | ENSG00000174405 | nan | LIG4 syndrome, 606593 (3), Autosomal recessive; {Multiple myeloma, resistance to}, 254500 (3), Somatic mutation
chr13	TNFSF13B	603969.0 | TNFSF13B, BLYS, BAFF | Tumor necrosis factor ligand superfamily, member 13B | 10673.0 | ENSG00000102524 | nan | nan
chr13	MYO16	615479.0 | MYO16, MYAP3, KIAA0865 | Myosin XVI | 23026.0 | ENSG00000041515 | nan | nan
chr13	IRS2	600797.0 | IRS2 | Insulin receptor substrate 2 | 8660.0 | ENSG00000185950 | nan | {Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant
chr13	COL4A1	120130.0 | COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL | Collagen IV, alpha-1 polypeptide | 1282.0 | ENSG00000187498 | mutation identified in 1 RATOR family | ?Retinal arteries, tortuosity of, 180000 (3), Autosomal dominant; {Hemorrhage, intracerebral, susceptibility to}, 614519 (3); Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3), Autosomal dominant; Microangiopathy and leukoencephalopathy, pontine, autosomal dominant, 618564 (3), Autosomal dominant; Brain small vessel disease with or without ocular anomalies, 175780 (3), Autosomal dominant
chr13	COL4A2	120090.0 | COL4A2, BSVD2, ICH | Collagen IV, alpha-2 polypeptide | 1284.0 | ENSG00000134871 | nan | Brain small vessel disease 2, 614483 (3), Autosomal dominant; {Hemorrhage, intracerebral, susceptibility to}, 614519 (3)
chr13	NAXD	615910.0 | NAXD, CARKD, PEBEL2 | NAD(P)HX dehydratase | 55739.0 | ENSG00000213995 | nan | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2, 618321 (3), Autosomal recessive
chr13	CARS2	612800.0 | CARS2, COXPD27 | Cysteinyl-tRNA synthetase 2 | 79587.0 | ENSG00000134905 | nan | Combined oxidative phosphorylation deficiency 27, 616672 (3), Autosomal recessive
chr13	ING1	601566.0 | ING1 | Inhibitor of growth 1 | 3621.0 | ENSG00000153487 | nan | Squamous cell carcinoma, head and neck, somatic, 275355 (3)
chr13	ARHGEF7	605477.0 | ARHGEF7, PIXB, COOL1 | Rho guanine nucleotide exchange factor 7 (PAK-interacting exchange factor, beta) | 8874.0 | ENSG00000102606 | nan | nan
chr13	SOX1	602148.0 | SOX1 | SRY (sex determining region Y)-box 1 | 6656.0 | ENSG00000182968 | nan | nan
chr13	TUBGCP3	617818.0 | TUBGCP3, GCP3, GRIP104, SPC98, ALP6 | Tubulin-gamma complex-associated protein 3 | 10426.0 | ENSG00000126216 | nan | nan
chr13	ATP11A	605868.0 | ATP11A, ATPIS, ATPIH, DFNA84, HLD24, AUNA2 | ATPase, class VI, type 11A | 23250.0 | ENSG00000068650 | mutation identified in 1 HLD24 patient and 1 AUNA2 family | ?Auditory neuropathy, autosomal dominant 2, 620384 (3), Autosomal dominant; ?Leukodystrophy, hypomyelinating, 24, 619851 (3), Autosomal dominant; Deafness, autosomal dominant 84, 619810 (3), Autosomal dominant
chr13	MCF2L	609499.0 | MCF2L, OST, KIAA0362 | MCF.2 cell line-derived transforming sequence-like | 23263.0 | ENSG00000126217 | nan | nan
chr13	F7	613878.0 | F7 | Coagulation factor VII | 2155.0 | ENSG00000057593 | nan | {Myocardial infarction, decreased susceptibility to}, 608446 (3); Factor VII deficiency, 227500 (3), Autosomal recessive
chr13	F10	613872.0 | F10 | Coagulation factor X | 2159.0 | ENSG00000126218 | nan | Factor X deficiency, 227600 (3), Autosomal recessive
chr13	PROZ	176895.0 | PROZ, PZ | Protein Z | 8858.0 | ENSG00000126231 | nan | [Protein Z deficiency], 614024 (3)
chr13	PCID2	613713.0 | PCID2 | PCI domain-containing protein 2 | 55795.0 | ENSG00000126226 | nan | nan
chr13	CUL4A	603137.0 | CUL4A | Cullin 4A | 8451.0 | ENSG00000139842 | nan | nan
chr13	LAMP1	153330.0 | LAMP1 | Lysosome-associated membrane protein-1 | 3916.0 | ENSG00000185896 | nan | nan
chr13	GRTP1	620890.0 | GRTP1, TBC1D6 | Growth hormone-regulated TBC protein 1 | 79774.0 | ENSG00000139835 | nan | nan
chr13	ADPRHL1	610620.0 | ADPRHL1, ARH2 | ADP-ribosylhydrolase-like 1 | 113622.0 | ENSG00000153531 | nan | nan
chr13	TMCO3	617134.0 | TMCO3, C13orf11 | Transmembrane and coiled-coil domains protein 3 | 55002.0 | ENSG00000150403 | nan | nan
chr13	TFDP1	189902.0 | TFDP1, DP1, DRTF1 | Transcription factor Dp-1 | 7027.0 | ENSG00000198176 | pseudogene on 1q32.3 | nan
chr13	GRK1	180381.0 | GRK1, RHOK, RK | G protein-dependent receptor kinase 1 (rhodopsin kinase) | 6011.0 | ENSG00000185974 | nan | Oguchi disease-2, 613411 (3)
chr13	ATP4B	137217.0 | ATP4B | ATPase, H+, K+ transporting, beta | 496.0 | ENSG00000186009 | nan | nan
chr13	GAS6	600441.0 | GAS6, AXLLG, AXSF | Growth arrest-specific 6 | 2621.0 | ENSG00000183087 | nan | nan
chr13	RASA3	605182.0 | RASA3 | Ras p21 protein activator 3 | 22821.0 | ENSG00000185989 | nan | nan
chr13	CDC16	603461.0 | CDC16, APC6 | Cell division cycle 16 | 8881.0 | ENSG00000130177 | nan | nan
chr13	UPF3A	605530.0 | UPF3A, RENT3A | UPF3A regulator of nonsense-mediated mRNA decay | 65110.0 | ENSG00000169062 | nan | nan
chr13	CHAMP1	616327.0 | CHAMP1, ZNF828, C13orf8, KIAA1802, NEDHILD | Chromosome alignment-maintaining phosphoprotein 1 | 283489.0 | ENSG00000198824 | nan | Neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features, 616579 (3), Autosomal dominant
chr14	RNR2	180451.0 | RNR2 | Ribosomal RNA-2 | 6053.0 | nan | nan | nan
chr14	ADIPQTL3	606771.0 | ADIPQTL3, CAQ14 | Adiponectin, serum level of, quantitative trait locus 3 | 171512.0 | nan | between D14S608 and D14S599 | {Adiponectin, serum level of, QTL3}, 606771 (2)
chr14		613457.0 | DEL14q11q22, C14DELq11q22 | Chromosome 14q11-q22 deletion syndrome | nan | nan | contiguous gene syndrome | Chromosome 14q11-q22 deletion syndrome, 613457 (4), Isolated cases
chr14	IBD4	606675.0 | IBD4 | Inflammatory bowel disease 4 | 50608.0 | nan | nan | {Inflammatory bowel disease 4}, 606675 (2)
chr14	ZFHX2-AS1	617833.0 | ZFHX2AS1 | ZFHX2 antisense RNA 1 | 109729160.0 | nan | nan | nan
chr14	DFNA53	609965.0 | DFNA53 | Deafness, autosomal dominant 53 | 353347.0 | nan | max lod at D14S1280 | Deafness, autosomal dominant 53, 609965 (2), Autosomal dominant
chr14	HHPP	144110.0 | HHPP | Hyperhidrosis palmaris et plantaris | 100861529.0 | nan | between D14S283 and D14S264 | Hyperhidrosis palmaris et plantaris, 144110 (2), Autosomal dominant
chr14	MRT9	611095.0 | MRT9, MRT26 | Intellectual developmental disorder, autosomal recessive 9/26 | 100101424.0 | nan | between rs1998463 and rs243286 | Intellectual developmental disorder, autosomal recessive 9/26, 611095 (2), Autosomal recessive
chr14	NRCLP5	612851.0 | NRCLP5 | Narcolepsy 5 | 100302514.0 | nan | associated with rs1154155, rs12587781, rs1263646 | {Narcolepsy 5}, 612851 (2)
chr14	PAURT1	610420.0 | PAURT1 | Preauricular tag, isolated, autosomal dominant, 1 | 101669760.0 | nan | between D14S990 and D14S264 | Preauricular tag, isolated, autosomal dominant, 1, 610420 (2), Autosomal dominant
chr14	RSCIS	605463.0 | RSCIS | Radiation sensitivity/chromosome instability syndrome, autosomal dominant | 64239.0 | nan | nan | Radiation sensitivity/chromosome instability syndrome, autosomal dominant (1)
chr14	SPD3	610234.0 | SPD3 | Synpolydactyly 3 | 780922.0 | nan | max lod at D14S264 | Synpolydactyly 3, 610234 (2)
chr14		615443.0 | TRAJ@ | T-cell receptor alpha chain joining gene cluster | nan | nan | nan | nan
chr14		615442.0 | TRAV@ | T-cell receptor alpha chain variable gene cluster | nan | nan | nan | nan
chr14		615460.0 | TRDD@ | T-cell receptor delta chain diversity gene cluster | nan | nan | nan | nan
chr14		615461.0 | TRDJ@ | T-cell receptor delta chain joining gene cluster | nan | nan | nan | nan
chr14		615459.0 | TRDV@ | T-cell receptor delta chain variable gene cluster | nan | nan | nan | nan
chr14	POTEG	608916.0 | POTEG, POTE14 | POTE ankyrin domain family, member G | 404785.0 | ENSG00000187537 | nan | nan
chr14	OR4M1	619939.0 | OR4M1, OLFR734 | Olfactory receptor, family 4, subfamily M, member 1 | 441670.0 | ENSG00000176299 | nan | nan
chr14	TTC5	619014.0 | TTC5, NEDCAFD | Tetratricopeptide repeat domain-containing protein 5 | 91875.0 | ENSG00000136319 | nan | Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism, 619244 (3), Autosomal recessive
chr14	CCNB1IP1	608249.0 | C14orf18, HEI10 | Human enhancer of invasion 10 | 57820.0 | ENSG00000100814 | nan | nan
chr14	RPPH1	608513.0 | RPPH1, H1RNA | Ribonuclease P, RNA component H1 | 85495.0 | ENSG00000277209 | nan | nan
chr14	PARP2	607725.0 | PARP2, ADPRTL2, ADPRT2 | Poly(ADP-ribose) polymerase 2 | 10038.0 | ENSG00000129484 | nan | nan
chr14	TEP1	601686.0 | TEP1, TP1 | Telomerase-associated protein-1 | 7011.0 | ENSG00000129566 | nan | nan
chr14	OSGEP	610107.0 | OSGEP, FLJ20411, GAMOS3 | O-sialoglycoprotein endopeptidase | 55644.0 | ENSG00000092094 | nan | Galloway-Mowat syndrome 3, 617729 (3), Autosomal recessive
chr14	APEX1	107748.0 | APEX, APE | APEX nuclease (multifunctional DNA repair enzyme) | 328.0 | ENSG00000100823 | nan | nan
chr14	PIP4P1	609865.0 | PIP4P1, TMEM55B, C14orf9 | Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1 | 90809.0 | ENSG00000165782 | nan | nan
chr14	PNP	164050.0 | PNP, NP | Purine nucleoside phosphorylase | 4860.0 | ENSG00000198805 | centromeric to TCRA | Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3), Autosomal recessive
chr14	RNASE9	614014.0 | RNAE9 | Ribonuclease A family, 9 | 390443.0 | ENSG00000188655 | nan | nan
chr14	TRP-AGG2-5	189930.0 | TRNAP1, TRP1 | tRNA proline-1 | 7217.0 | nan | nan | nan
chr14	TRL-AAG2-3	189932.0 | TRL-AAG2-1, TRNAL1, TRL1 | tRNA leucine (AAG) 2-1 | 7207.0 | nan | nan | nan
chr14	TRP-AGG2-6	189931.0 | TRNAP2, TRP2 | tRNA proline-2 | 7218.0 | nan | nan | nan
chr14	TRT-TGT3-1	189933.0 | TRT-TGT3-1, TRNAT2, TRT2 | tRNA threonine (anticodon TGT) 3-1 | 7237.0 | nan | nan | nan
chr14	ANG	105850.0 | ANG, RNASE5, ALS9 | Angiogenin | 283.0 | ENSG00000214274 | proximal to TCRA/TCRD | Amyotrophic lateral sclerosis 9, 611895 (3)
chr14	RNASE4	601030.0 | RNASE4, RNS4 | Ribonuclease, RNase A family, 4 | 6038.0 | ENSG00000258818 | nan | nan
chr14	EDDM3A	611580.0 | EDDM3A, FAM12A, HE3A | Epididymal protein 3A | 10876.0 | ENSG00000181562 | nan | nan
chr14	EDDM3B	611582.0 | FAM12B, HE3B | Family with sequence similarity 12, member B | 64184.0 | ENSG00000181552 | nan | nan
chr14	RNASE6	601981.0 | RNASE6 | Ribonuclease, RNase A family, k6 | 6039.0 | ENSG00000169413 | nan | nan
chr14	RNASE1	180440.0 | RNASE1, RNS1 | Ribonuclease, RNase A family, 1 (pancreatic) | 6035.0 | ENSG00000129538 | nan | nan
chr14	RNASE3	131398.0 | RNASE3, RNS3, ECP | Ribonuclease, RNase A family, 3 (eosinophil cationic protein) | 6037.0 | ENSG00000169397 | nan | nan
chr14	RNASE2	131410.0 | RNASE2, RNS2, EDN | Ribonuclease, RNase A family, 2, liver (eosinophil-derived neurotoxin) | 6036.0 | ENSG00000169385 | nan | nan
chr14	METTL17	616091.0 | METTL17, METT11D1 | Methyltransferase-like 17 | 64745.0 | ENSG00000165792 | nan | nan
chr14	SLC39A2	612166.0 | SLC39A2, ZIP2 | Solute carrier family 39 (zinc transporter), member 2 | 29986.0 | ENSG00000165794 | nan | nan
chr14	NDRG2	605272.0 | NDRG2 | N-myc downstream-regulated gene 2 | 57447.0 | ENSG00000165795 | nan | nan
chr14	TPPP2	616956.0 | TPPP2, p18 | Tubulin polymerization-promoting protein family, member 2 | 122664.0 | ENSG00000179636 | nan | nan
chr14	RNASE7	612484.0 | RNASE7 | Ribonuclease A family 7 | 84659.0 | ENSG00000165799 | nan | nan
chr14	RNASE8	612485.0 | RNASE8 | Ribonuclease A family, 8 | 122665.0 | ENSG00000173431 | nan | nan
chr14	ARHGEF40	610018.0 | ARHGEF40, SOLO, FLJ10357 | RHO guanine nucleotide exchange factor 40 | 55701.0 | ENSG00000165801 | nan | nan
chr14	ZNF219	605036.0 | ZNF219 | Zinc finger protein-219 | 51222.0 | ENSG00000165804 | nan | nan
chr14	HNRNPC	164020.0 | HNRNPC, HNRPC, MRD74 | Heterogeneous nuclear ribonucleoprotein C | 3183.0 | ENSG00000092199 | nan | Intellectual developmental disorder, autosomal dominant 74, 620688 (3), Autosomal dominant
chr14	RPGRIP1	605446.0 | RPGRIP1, LCA6, CORD13 | RPGR interacting protein 1 | 57096.0 | ENSG00000092200 | nan | Cone-rod dystrophy 13, 608194 (3), Autosomal recessive; Leber congenital amaurosis 6, 613826 (3), Autosomal recessive
chr14	SUPT16H	605012.0 | SUPT16H, SPT16, NEDDFAC | SPT16 homolog, facilitates chromatin remodeling subunit | 11198.0 | ENSG00000092201 | nan | Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum, 619480 (3), Autosomal dominant
chr14	CHD8	610528.0 | CHD8, DUPLIN, KIAA1564, IDDAM | Chromodomain helicase DNA-binding protein 8 | 57680.0 | ENSG00000100888 | nan | Intellectual developmental disorder with autism and macrocephaly, 615032 (3), Autosomal dominant
chr14	SNORD8	618943.0 | SNORD8, RNU6C | Small nucleolar RNA, C/D box, 8 | 319103.0 | ENSG00000200785 | nan | nan
chr14	RAB2B	607466.0 | RAB2B | Ras-associated protein RAB2B | 84932.0 | ENSG00000129472 | nan | nan
chr14	TOX4	614032.0 | TOX4, LCP1, KIAA0737 | TOX high mobility group box family member 4 | 9878.0 | ENSG00000092203 | nan | nan
chr14	METTL3	612472.0 | METTL3, IME4 | Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit | 56339.0 | ENSG00000165819 | nan | nan
chr14	SALL2	602219.0 | SALL2, HSAL2, COLB | Sal-like 2 | 6297.0 | ENSG00000165821 | mutation identified in 1 COLB family | ?Coloboma, ocular, autosomal recessive, 216820 (3), Autosomal recessive
chr14	TRDC	186810.0 | TRDC | T-cell receptor delta chain constant region | 28526.0 | nan | in midst of TCRA | nan
chr14	TRAC	186880.0 | TRAC, TRCA, TRA, IMD7 | T-cell receptor alpha | 28755.0 | ENSG00000277734 | cen--V-C--ter | Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3), Autosomal recessive
chr14	DAD1	600243.0 | DAD1 | Defender against cell death 1 | 1603.0 | ENSG00000129562 | nan | nan
chr14	ABHD4	619728.0 | ABHD4, ABH4 | Abhydrolase domain-containing protein 4, N-acyl phospholipase B | 63874.0 | ENSG00000100439 | nan | nan
chr14	OXA1L	601066.0 | OXA1L | Oxidase (cytochrome c) assembly 1-like | 5018.0 | ENSG00000155463 | nan | nan
chr14	SLC7A7	603593.0 | SLC7A7, LPI | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 | 9056.0 | ENSG00000155465 | nan | Lysinuric protein intolerance, 222700 (3), Autosomal recessive
chr14	MRPL52	611856.0 | MRPL52 | Mitochondrial ribosomal protein L52 | 122704.0 | ENSG00000172590 | nan | nan
chr14	MMP14	600754.0 | MMP14, WNCHRS | Matrix metalloproteinase 14 (membrane-inserted) | 4323.0 | ENSG00000157227 | nan | Winchester syndrome, 277950 (3), Autosomal recessive
chr14	LRP10	609921.0 | LRP10, LRP9 | Low density lipoprotein receptor-related protein 10 | 26020.0 | ENSG00000197324 | nan | nan
chr14	REM2	616955.0 | REM2 | RRAD- and GEM-like GTPase 2 | 161253.0 | ENSG00000139890 | nan | nan
chr14	PRMT5	604045.0 | PRMT5, SKB1, IBP72, JBP1, HSL7 | Protein arginine methyltransferase 5 | 10419.0 | ENSG00000100462 | nan | nan
chr14	HAUS4	613431.0 | HAUS4, C14orf94 | HAUS augmin-like complex, subunit 4 | 54930.0 | ENSG00000092036 | nan | nan
chr14	AJUBA	609066.0 | AJUBA, JUB | AJUBA LIM protein | 84962.0 | ENSG00000129474 | nan | nan
chr14	PSMB5	600306.0 | PSMB5, LMPX | Proteasome subunit, beta type, 5 | 5693.0 | ENSG00000100804 | nan | nan
chr14	PSMB11	611137.0 | PSMB11 | Proteasome subunit, beta-type, 11 | 122706.0 | ENSG00000222028 | nan | nan
chr14	CDH24	618599.0 | CDH24 | Cadherin 24 | 64403.0 | ENSG00000139880 | nan | nan
chr14	ACIN1	604562.0 | ACIN1, KIAA0670 | Acinus | 22985.0 | ENSG00000100813 | nan | nan
chr14	CIROP	619703.0 | CIROP, LMLN2, HTX12 | Ciliated left-right organizer metallopeptidase | 100128908.0 | ENSG00000283654 | nan | Heterotaxy, visceral, 12, autosomal, 619702 (3), Autosomal recessive
chr14	CEBPE	600749.0 | CEBPE, CRP1, SGD1, IMD108 | CCAAT/enhancer-binding protein (C/EBP), epsilon | 1053.0 | ENSG00000092067 | mutation identified in 1 IMD108 family | ?Immunodeficiency 108 with autoinflammation, 260570 (3), Autosomal recessive; Specific granule deficiency, 245480 (3), Autosomal recessive, Autosomal dominant
chr14	SLC7A8	604235.0 | SLC7A8, LAT2 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 | 23428.0 | ENSG00000092068 | nan | nan
chr14	HOMEZ	608119.0 | HOMEZ, KIAA1443 | Homeodomain leucine zipper-containing factor | 57594.0 | ENSG00000290292 | nan | nan
chr14	PPP1R3E	619540.0 | PPP1R3E | Protein phosphatase 1, regulatory subunit 3E | 90673.0 | ENSG00000235194 | nan | nan
chr14	BCL2L2	601931.0 | BCL2L2, BCLW | BCL2-like 2 | 599.0 | ENSG00000129473 | nan | nan
chr14	PABPN1	602279.0 | PABPN1, PABP2, PAB2 | Poly(A)-binding protein, nuclear 1 | 8106.0 | ENSG00000100836 | nan | Oculopharyngeal muscular dystrophy, 164300 (3), Autosomal dominant
chr14	SLC22A17	611461.0 | SLC22A17, NGALR, BOIT, BOCT, NGALR2, NGALR3 | Solute carrier family 22, organic cation transporter, member 17 | 51310.0 | ENSG00000092096 | nan | nan
chr14	EFS	609906.0 | EFS | Embryonal FYN-associated substrate | 10278.0 | ENSG00000100842 | nan | nan
chr14	IL25	605658.0 | IL25, IL17E | Interleukin 25 | 64806.0 | ENSG00000166090 | nan | nan
chr14	CMTM5	607888.0 | CMTM5, CKLFSF5 | CKLF-like marvel transmembrane domain-containing 5 | 116173.0 | ENSG00000166091 | nan | nan
chr14	MYH6	160710.0 | MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3 | Myosin, heavy polypeptide-6, cardiac muscle, alpha | 4624.0 | ENSG00000197616 | nan | {Sick sinus syndrome 3}, 614090 (3); Atrial septal defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 14, 613251 (3), Autosomal dominant
chr14	MIR208A	611116.0 | MIR208A, MIRN208A, MIR208, MIRN208 | Micro RNA 208A | 406990.0 | ENSG00000199157 | nan | nan
chr14	MYH7	160760.0 | MYH7, CMH1, MPD1, CMD1S, CMYO7A, CMYO7B | Myosin, heavy polypeptide-7, cardiac muscle, beta | 4625.0 | ENSG00000092054 | nan | Laing distal myopathy, 160500 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 1, 192600 (3), Digenic dominant, Autosomal dominant; Left ventricular noncompaction 5, 613426 (3), Autosomal dominant; Cardiomyopathy, dilated, 1S, 613426 (3), Autosomal dominant; Congenital myopathy 7B, myosin storage, autosomal recessive, 255160 (3), Autosomal recessive; Congenital myopathy 7A, myosin storage, autosomal dominant, 608358 (3), Autosomal dominant
chr14	MHRT	616096.0 | MHRT | Myosin heavy chain-associated RNA transcript, noncoding | 104564225.0 | nan | nan | nan
chr14	MIR208B	613613.0 | MIR208B, MIRN208B | Micro RNA 208B | 100126336.0 | ENSG00000215991 | nan | nan
chr14	NGDN	610777.0 | NGDN, NGD | Neuroguidin | 25983.0 | ENSG00000129460 | nan | nan
chr14	THTPA	611612.0 | THTPA | Thiamine triphosphatase | 79178.0 | ENSG00000259431 | nan | nan
chr14	ZFHX2	617828.0 | ZFHX2, ZFH5, ZNF409, KIAA1056, KIAA1762, MARSIS | Zinc finger homeobox 2 | 85446.0 | ENSG00000136367 | mutation identified in 1 MARSIS family | ?Marsili syndrome, 147430 (3), Autosomal dominant
chr14	AP1G2	603534.0 | AP1G2 | Adaptor-related protein complex 1, gamma-2 subunit | 8906.0 | ENSG00000213983 | nan | nan
chr14	JPH4	619863.0 | JPH4, JP4 | Junctophilin 4 | 84502.0 | ENSG00000092051 | nan | nan
chr14	DHRS2	615194.0 | DHRS2, HEP27 | Short-chain dehydrogenase/reductase family, member 2 | 10202.0 | ENSG00000100867 | nan | nan
chr14	DHRS4-AS1	616925.0 | DHRS4AS1, AS1DHRS4, C14orf67 | DDHRS4 antisense RNA 1, noncoding | 55449.0 | ENSG00000215256 | nan | nan
chr14	DHRS4	611596.0 | DHRS4, NRDR | Short-chain dehydrogenase/reductase family, member 4 | 10901.0 | ENSG00000157326 | nan | nan
chr14	DHRS4L2	615196.0 | DHRS4L2 | Short-chain dehydrogenase/reductase family, member 4-like 2 | 317749.0 | ENSG00000187630 | nan | nan
chr14	DHRS4L1	615195.0 | DHRS4L1 | Short-chain dehydrogenase/reductase family, member 4-like 1 | 728635.0 | ENSG00000291039 | nan | nan
chr14	CARMIL3	614716.0 | LRRC16B | Leucine-rich repeat-containing protein 16B | 90668.0 | ENSG00000186648 | nan | nan
chr14	CPNE6	605688.0 | CPNE6 | Copine VI | 9362.0 | ENSG00000100884 | nan | nan
chr14	NRL	162080.0 | NRL, D14S46E, RP27 | Neural retina leucine zipper | 4901.0 | ENSG00000129535 | nan | Retinitis pigmentosa 27, 613750 (3), Autosomal dominant; Retinal degeneration, autosomal recessive, clumped pigment type (3)
chr14	PCK2	614095.0 | PCK2, PEPCK2 | Phosphoenolpyruvate carboxykinase 2, mitochondrial | 5106.0 | ENSG00000100889 | nan | PEPCK deficiency, mitochondrial, 261650 (1), Autosomal recessive
chr14	ARVD3	602086.0 | ARVD3 | Arrhythmogenic right ventricular dysplasia 3 | 424.0 | nan | ?distinct from ARVD1 | Arrhythmogenic right ventricular dysplasia 3, 602086 (2), Autosomal dominant
chr14	DFNB5	600792.0 | DFNB5 | Deafness, autosomal recessive 5 | 1697.0 | nan | nan | Deafness, autosomal recessive 5, 600792 (2), Autosomal recessive
chr14	SPG32	611252.0 | SPG32 | Spastic paraplegia-32 | 724107.0 | nan | between D14S264 and D14S978 | Spastic paraplegia 32, autosomal recessive, 611252 (2), Autosomal recessive
chr14	DCAF11	613317.0 | DCAF11, WDR23 | DDB1- and CUL4-associated factor 11 | 80344.0 | ENSG00000100897 | nan | nan
chr14	FITM1	612028.0 | FITM1, FIT1 | Fat storage-inducing transmembrane protein 1 | 161247.0 | ENSG00000139914 | nan | nan
chr14	PSME1	600654.0 | PSME1, IFI5111 | Proteasome activator subunit-1 | 5720.0 | ENSG00000092010 | nan | nan
chr14	PSME2	602161.0 | PSME2 | Proteasome activator subunit-2 | 5721.0 | ENSG00000100911 | nan | nan
chr14	RNF31	612487.0 | RNF31, ZIBRA, IMD115 | Ring finger protein 31 | 55072.0 | ENSG00000092098 | nan | Immunodeficiency 115 with autoinflammation, 620632 (3), Autosomal recessive
chr14	IRF9	147574.0 | IRF9, ISGF3, ISGF3G | Interferon regulatory factor 9 | 10379.0 | ENSG00000213928 | nan | Immunodeficiency 65, susceptibility to viral infections, 618648 (3), Autosomal recessive
chr14	REC8	608193.0 | REC8L1, REC8 | Rec8, S. pombe, homolog of | 9985.0 | ENSG00000100918 | nan | nan
chr14	TM9SF1	618965.0 | TM9SF1, HMP70 | Transmembrane protein 9 superfamily, member 1 | 10548.0 | ENSG00000100926 | nan | nan
chr14	TSSK4	610711.0 | TSSK4, TSSK5 | Testis-specific serine/threonine kinase 4 | 283629.0 | ENSG00000139908 | nan | nan
chr14	CHMP4A	610051.0 | CHMP4A, SNF7 | Charged multivesicular body protein 4A | 29082.0 | ENSG00000254505 | nan | nan
chr14	NEDD8	603171.0 | NEDD8 | Neural precursor cel expressed, developmentally downregulated 8 | 4738.0 | ENSG00000129559 | nan | nan
chr14	GMPR2	610781.0 | GMPR2 | Guanosine monophosphate reductase 2 | 51292.0 | ENSG00000100938 | nan | nan
chr14	TINF2	604319.0 | TINF2, TIN2, DKCA3 | TERF1-interacting nuclear factor 2 | 26277.0 | ENSG00000092330 | nan | Dyskeratosis congenita, autosomal dominant 3, 613990 (3), Autosomal dominant; Revesz syndrome, 268130 (3), Autosomal dominant
chr14	TGM1	190195.0 | TGM1, ICR2, ARCI1 | Transglutaminase-1 (K polypeptide epidermal type I, protein-glutamine gamma-glutamyltransferase) | 7051.0 | ENSG00000092295 | nan | Ichthyosis, congenital, autosomal recessive 1, 242300 (3), Autosomal recessive
chr14	RABGGTA	601905.0 | RABGGTA | Rab geranylgeranyltransferase, alpha subunit | 5875.0 | ENSG00000100949 | nan | nan
chr14	NOP9	618308.0 | NOP9 | NOP9, S. cerevisiae, homolog of | 161424.0 | ENSG00000196943 | nan | nan
chr14	DHRS1	610410.0 | DHRS1 | Short-chain dehydrogenase/reductase family, member 1 | 115817.0 | ENSG00000157379 | nan | nan
chr14	CIDEB	604441.0 | CIDEB | Cell death-inducing DFFA-like effector B | 27141.0 | ENSG00000136305 | nan | nan
chr14	LTB4R2	605773.0 | LTB4R2, BLTR2, BLT2 | Leukotriene B4 receptor 2 | 56413.0 | ENSG00000213906 | nan | nan
chr14	LTB4R	601531.0 | LTB4R, CMKRL1, P2RY7, BLTR | Leukotriene b4 receptor (purinergic receptor P2Y, G protein-coupled, 7; chemokine receptor-like 1) | 1241.0 | ENSG00000213903 | nan | nan
chr14	ADCY4	600292.0 | ADCY4 | Adenylate cyclase-4 | 196883.0 | ENSG00000129467 | nan | nan
chr14	RIPK3	605817.0 | RIPK3, RIP3 | Receptor-interacting serine/threonine kinase 3 | 11035.0 | ENSG00000129465 | nan | nan
chr14	NFATC4	602699.0 | NFATC4 | Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 4 | 4776.0 | ENSG00000100968 | nan | nan
chr14	NYNRIN	620129.0 | NYNRIN, KIAA1305 | NYN domain- and retroviral integrase-containing protein | 57523.0 | ENSG00000205978 | nan | nan
chr14	KHNYN	619579.0 | KHNYN | KH domain- and NYN domain-containing protein | 23351.0 | ENSG00000100441 | nan | nan
chr14	CBLN3	612978.0 | CBLN3 | Precerebellin 3 | 643866.0 | ENSG00000139899 | nan | nan
chr14	SDR39U1	616162.0 | SDR39U1 | Short-chain dehydrogenase/reductase family 39U, member 1 | 56948.0 | ENSG00000100445 | nan | nan
chr14	CMA1	118938.0 | CMA1 | Chymase-1, mast cell | 1215.0 | ENSG00000092009 | nan | nan
chr14	CTSG	116830.0 | CTSG | Cathepsin G | 1511.0 | ENSG00000100448 | nan | nan
chr14	GZMH	116831.0 | GZMH, CTSGL2 | Granzyme H (cathepsin G-like 2) | 2999.0 | ENSG00000100450 | nan | nan
chr14	GZMB	123910.0 | GZMB, CTLA1, CSPB | Granzyme B (cytotoxic T-lymphocyte-associated serine esterase-1; cathepsin G-like 1) | 3002.0 | ENSG00000100453 | nan | nan
chr14	STXBP6	607958.0 | STXBP6, AMISYN, HSPC156 | Syntaxin-binding protein 6 | 29091.0 | ENSG00000168952 | nan | nan
chr14	NOVA1	602157.0 | NOVA1 | NOVA alternative splicing regulator 1 | 4857.0 | ENSG00000139910 | nan | nan
chr14	FOXG1	164874.0 | FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1 | Forkhead box G1B | 2290.0 | ENSG00000176165 | nan | Rett syndrome, congenital variant, 613454 (3), Autosomal dominant
chr14	PRKD1	605435.0 | PRKD1, PRKCM, PKD, CHDED | Protein kinase D1 | 5587.0 | ENSG00000184304 | nan | Congenital heart defects and ectodermal dysplasia, 617364 (3), Autosomal dominant
chr14	G2E3	611299.0 | G2E3, KIAA1333 | G2/M phase-specific E3 ubiquitin ligase | 55632.0 | ENSG00000092140 | nan | nan
chr14	SCFD1	618207.0 | SCFD1, SLY1, RA410 | Sec1 family domain-containing protein 1 | 23256.0 | ENSG00000092108 | nan | nan
chr14	COCH	603196.0 | COCH, DFNA9, DFNB110 | Cochlin | 1690.0 | ENSG00000100473 | mutation identified in 1 DFNB110 family | Deafness, autosomal dominant 9, 601369 (3), Autosomal dominant; ?Deafness, autosomal recessive 110, 618094 (3), Autosomal recessive
chr14	STRN3	614766.0 | STRN3, SG2NA | Striatin, calmodulin-binding protein 3 | 29966.0 | ENSG00000196792 | nan | nan
chr14	AP4S1	607243.0 | AP4S1, CPSQ6, SPG52 | Adaptor-related protein complex 4, sigma-1 subunit | 11154.0 | ENSG00000100478 | nan | Spastic paraplegia 52, autosomal recessive, 614067 (3), Autosomal recessive
chr14	HECTD1	618649.0 | HECTD1 | HECT domain-containing E3 ubiquitin protein ligase 1 | 25831.0 | ENSG00000092148 | nan | nan
chr14	GPR33	610118.0 | GPR33 | G protein-coupled receptor 33 | 2856.0 | ENSG00000214943 | nan | nan
chr14	NUBPL	613621.0 | NUBPL, IND1, MC1DN21 | Nucleotide-binding protein-like protein | 80224.0 | ENSG00000151413 | nan | Mitochondrial complex I deficiency, nuclear type 21, 618242 (3), Autosomal recessive
chr14	ARHGAP5	602680.0 | ARHGAP5, RHOGAP5 | RHO GTPase-activating protein 5 | 394.0 | ENSG00000100852 | nan | nan
chr14	AKAP6	604691.0 | ADAP6, ADAP100 | A-kinase anchor protein 6 | 9472.0 | ENSG00000151320 | nan | nan
chr14	HPE8	609408.0 | HPE8 | Holoprosencephaly 8 | 619406.0 | nan | between D14S49 and D14S1014 | Holoprosencephaly 8, 609408 (2)
chr14	RLS2	608831.0 | RLS2 | Restless legs syndrome, susceptibility to, 2 | 450097.0 | nan | max lod at D14S288 | {Restless legs syndrome 2}, 608831 (2)
chr14	NPAS3	609430.0 | NPAS3, MOP6 | Neuronal PAS domain protein 3 | 64067.0 | ENSG00000151322 | nan | nan
chr14	EGLN3	606426.0 | EGLN3, PHD3, HIFP4H3 | egl-9 family hypoxia inducible factor 3 | 112399.0 | ENSG00000129521 | nan | nan
chr14	SPTSSA	613540.0 | SPTSSA, C14orf147, SSSPTA, SPG90A, SPG90B | Serine palmitoyltransferase, small subunit, A | 171546.0 | ENSG00000165389 | mutation identified in 1 SPG90B patient | Spastic paraplegia 90A, autosomal dominant, 620416 (3), Autosomal dominant; ?Spastic paraplegia 90B, autosomal recessive, 620417 (3), Autosomal dominant
chr14	EAPP	609486.0 | EAPP, C14orf11 | E2F-associated phosphoprotein | 55837.0 | ENSG00000129518 | nan | nan
chr14	SNX6	606098.0 | SNX6 | Sorting nexin 6 | 58533.0 | ENSG00000129515 | nan | nan
chr14	CFL2	601443.0 | CFL2, NEM7 | Cofilin 2, muscle | 1073.0 | ENSG00000165410 | nan | Nemaline myopathy 7, autosomal recessive, 610687 (3), Autosomal recessive
chr14	BAZ1A	605680.0 | BAZ1A | Bromodomain adjacent to zinc finger domain, 1A | 11177.0 | ENSG00000198604 | nan | nan
chr14	SRP54	604857.0 | SRP54, SCN8 | Signal recognition particle, 54kD | 6729.0 | ENSG00000100883 | nan | Neutropenia, severe congenital, 8, autosomal dominant, 618752 (3), Autosomal dominant
chr14	FAM177A1	619181.0 | FAM177A1, C14orf24 | Family with sequence similarity 177, member A1 | 283635.0 | ENSG00000151327 | nan | nan
chr14	PPP2R3C	615902.0 | PPP2R3C, G5PR, MEGD, SPGF36 | Protein phosphatase 2, regulatory subunit B-double prime, gamma | 55012.0 | ENSG00000092020 | nan | Spermatogenic failure 36, 618420 (3), Autosomal dominant; Myoectodermal gonadal dysgenesis syndrome, 618419 (3), Autosomal recessive
chr14	PRORP	609947.0 | PRORP, KIAA0391, COXPD54 | Protein only RNase P catalytic subunit | 9692.0 | ENSG00000100890 | nan | Combined oxidative phosphorylation deficiency 54, 619737 (3), Autosomal recessive
chr14	PSMA6	602855.0 | PSMA6, PROS27, P27K | Proteasome subunit, alpha-type, 6 | 5687.0 | ENSG00000100902 | nan | {Myocardial infarction, susceptibility to}, 608446 (3)
chr14	NFKBIA	164008.0 | NFKBIA, IKBA, EDAID2 | Nuclear factor kappa-B inhibitor, alpha | 4792.0 | ENSG00000100906 | nan | Ectodermal dysplasia and immunodeficiency 2, 612132 (3), Autosomal dominant
chr14	INSM2	614027.0 | INSM2, IA6 | Insulinoma-associated 2 | 84684.0 | ENSG00000168348 | nan | nan
chr14	RALGAPA1	608884.0 | RALGAPA1, GARNL1, TULIP1, GRIPE, KIAA0884, NEDHRIT | Ral GTPase activating protein, alpha subunit 1 (catalytic) | 253959.0 | ENSG00000174373 | pseudogene on 9q31.1 | Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation, 618797 (3), Autosomal recessive
chr14	BRMS1L	618514.0 | BRMS1L | BRMS1-like transcriptional repressor | 84312.0 | ENSG00000100916 | nan | nan
chr14	HPV6AI1	604461.0 | HPV6AI1 | Human papillomavirus type 6A integration site 1 | 3259.0 | nan | previously assigned to 10q24 | nan
chr14	PTCSC3	614821.0 | PTCSC3 | PTCSC3 gene | 100886964.0 | ENSG00000259104 | nan | nan
chr14	MBIP	609431.0 | MBIP | MAP3K12-binding inhibitory protein | 51562.0 | ENSG00000151332 | nan | nan
chr14	SFTA3	617860.0 | SFTA3, SPH | Surfactant-associated protein 3 | 253970.0 | ENSG00000257520 | nan | nan
chr14	NKX2-1	600635.0 | NKX2-1, TITF1, NKX2A, TTF1, NMTC1 | NK2 homeobox 1 | 7080.0 | ENSG00000136352 | nan | Chorea, hereditary benign, 118700 (3), Autosomal dominant; {Thyroid cancer, nonmedullary, 1}, 188550 (3), Autosomal dominant; Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3), Autosomal dominant
chr14	NKX2-8	603245.0 | NKX2-8, NKX2H, NKX2.8 | NK2 homeobox 8 | 26257.0 | ENSG00000136327 | nan | nan
chr14	PAX9	167416.0 | PAX9, STHAG3 | Paired box gene 9 | 5083.0 | ENSG00000198807 | nan | Tooth agenesis, selective, 3, 604625 (3), Autosomal dominant
chr14	SLC25A21	607571.0 | SLC25A21, ODC, MTDPS18 | Solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 | 89874.0 | ENSG00000183032 | mutation identified in 1 MTDPS18 patient | ?Mitochondrial DNA depletion syndrome 18, 618811 (3), Autosomal recessive
chr14	MIPOL1	606850.0 | MIPOL1 | MIPOL1 gene | 145282.0 | ENSG00000151338 | nan | nan
chr14	FOXA1	602294.0 | FOXA1, HNF3A | Forkhead box A1 (hepatocyte nuclear factor-3, alpha) | 3169.0 | ENSG00000129514 | nan | nan
chr14	TTC6	620954.0 | TTC6 | Tetratricopeptide repeat domain-containing protein 6 | 319089.0 | ENSG00000139865 | nan | nan
chr14	SSTR1	182451.0 | SSTR1 | Somatostatin receptor-1 | 6751.0 | ENSG00000139874 | nan | nan
chr14	CLEC14A	616845.0 | CLEC14A | C-type lectin domain family 14, member A | 161198.0 | ENSG00000176435 | nan | nan
chr14	SEC23A	610511.0 | SEC23A, CLSD | SEC23 homolog A, coat complex II component | 10484.0 | ENSG00000100934 | nan | Craniolenticulosutural dysplasia, 607812 (3), Autosomal recessive, Autosomal dominant
chr14	GEMIN2	602595.0 | GEMIN2, SIP1 | GEM-associated protein 2 | 8487.0 | ENSG00000092208 | nan | nan
chr14	TRAPPC6B	610397.0 | TRAPPC6B, TPC6, NEDMEBA | Trafficking protein particle complex, subunit 6B | 122553.0 | ENSG00000182400 | nan | Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy, 617862 (3), Autosomal recessive
chr14	PNN	603154.0 | PNN, DRS | Pinin | 5411.0 | ENSG00000100941 | nan | nan
chr14	MIA2	602132.0 | MGEA, MEA6 | Meningioma-expressed antigen 6 | 4253.0 | ENSG00000150527 | ?pseudogenes on other chromosomes | nan
chr14	FBXO33	609103.0 | FBXO33, FBX33, BMND12 | F-box only protein 33 | 254170.0 | ENSG00000165355 | nan | nan
chr14	LRFN5	612811.0 | LRFN5, SALM5 | Leucine-rich repeat and fibronectin type III domain-containing protein 5 | 145581.0 | ENSG00000165379 | nan | nan
chr14	MGR4	607501.0 | MGR4, MGOA | Migraine without aura, susceptibility to, 4 | 338342.0 | nan | between D14S976 and D14S978 | {Migraine without aura, susceptibility to, 4}, 607501 (2), Autosomal dominant
chr14	FSCB	611779.0 | FSCB, C14orf155 | Fibrous sheath cabyr-binding protein | 84075.0 | ENSG00000189139 | nan | nan
chr14	TOGARAM1	617618.0 | TOGARAM1, FAM179B, KIAA0423, JBTS37 | TOG array regulator of axonemal microtubules 1 | 23116.0 | ENSG00000198718 | nan | Joubert syndrome 37, 619185 (3), Autosomal recessive
chr14	PRPF39	614907.0 | PRPF39 | Pre-mRNA processing factor 39 | 55015.0 | ENSG00000185246 | nan | nan
chr14	FKBP3	186947.0 | FKBP3, FKBP25 | FK506-binding protein 3 | 2287.0 | ENSG00000100442 | nan | nan
chr14	FANCM	609644.0 | FANCM, KIAA1596, SPGF28, POF15 | FANCM gene | 57697.0 | ENSG00000187790 | nan | Premature ovarian failure 15, 618096 (3), Autosomal recessive; Spermatogenic failure 28, 618086 (3), Autosomal recessive
chr14	MIS18BP1	618139.0 | MIS18BP, C14orf106 | Mis18-binding protein 1 | 55320.0 | ENSG00000129534 | nan | nan
chr14	RPL10L	619655.0 | RPL10L, SPGF63 | Ribosomal protein L10-like | 140801.0 | ENSG00000165496 | mutation identified in 1 SPGF63 family | ?Spermatogenic failure 63, 619689 (3), Autosomal recessive
chr14	MDGA2	611128.0 | MDGA2 | MAM domain-containing glycosylphosphatidylinositol anchor 2 | 161357.0 | ENSG00000139915 | nan | nan
chr14	RPS29	603633.0 | RPS29, DBA13 | Ribosomal protein S29 | 6235.0 | ENSG00000213741 | nan | Diamond-Blackfan anemia 13, 615909 (3), Autosomal dominant
chr14	RN7SL1	612177.0 | RN7SL1, 7SL, 7L1A | RNA, 7SL, cytoplasmic 1 | 6029.0 | ENSG00000276168 | nan | nan
chr14	LRR1	609193.0 | LRR1, PPIL5 | Leucine rich repeat protein 1 | 122769.0 | ENSG00000165501 | nan | nan
chr14	RPL36AL	180469.0 | RPL36AL, RPL36A | Ribosomal protein L36a-like | 6166.0 | ENSG00000165502 | nan | nan
chr14	MGAT2	602616.0 | MGAT2, CDGS2, CDG2A | Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyl- transferase | 4247.0 | ENSG00000168282 | nan | Congenital disorder of glycosylation, type IIa, 212066 (3), Autosomal recessive
chr14	DNAAF2	612517.0 | DNAAF2, KTU, C14orf104, CILD10 | Dynein, axonemal, assembly factor 2 | 55172.0 | ENSG00000165506 | nan | Ciliary dyskinesia, primary, 10, 612518 (3), Autosomal recessive
chr14	POLE2	602670.0 | POLE2, DPE2 | Polymerase, DNA, epsilon-2 | 5427.0 | ENSG00000100479 | nan | nan
chr14	KLHDC1	611281.0 | KLHDC1 | Kelch domain-containing protein 1 | 122773.0 | ENSG00000197776 | nan | nan
chr14	KLHDC2	611280.0 | KLHDC2, HCLP1 | Kelch domain-containing protein 2 | 23588.0 | ENSG00000165516 | nan | nan
chr14	NEMF	608378.0 | NEMF, SDCCAG1, IDDSAPN | Nuclear export mediator factor | 9147.0 | ENSG00000165525 | nan | Intellectual developmental disorder with speech delay and axonal peripheral neuropathy, 619099 (3), Autosomal recessive
chr14	RN7SL3	612180.0 | RN7SL3 | RNA, 7SL, cytoplasmic 3 | 378707.0 | ENSG00000278771 | nan | nan
chr14	RN7SL2	612179.0 | RN7SL2, 7L1C | RNA, 7SL, cytoplasmic 2 | 378706.0 | ENSG00000274012 | nan | nan
chr14	ARF6	600464.0 | ARF6 | ADP-ribosylation factor 6 | 382.0 | ENSG00000165527 | nan | nan
chr14	VCPKMT	615260.0 | VCPKMT, METTL21D, C14orf138 | Valosin-containing protein lysine methyltransferase | 79609.0 | ENSG00000100483 | nan | nan
chr14	SOS2	601247.0 | SOS2, NS9 | SOS Ras/Rac guanine nucleotide exchange factor 2 | 6655.0 | ENSG00000100485 | nan | Noonan syndrome 9, 616559 (3), Autosomal dominant
chr14	L2HGDH	609584.0 | L2HGDH, C14orf160, L2HGA | L-2-hydroxyglutarate dehydrogenase | 79944.0 | ENSG00000087299 | nan | L-2-hydroxyglutaric aciduria, 236792 (3), Autosomal recessive
chr14	DMAC2L	618579.0 | DMAC2L, ATP5S, FB | Distal membrane arm assembly complex 2-like protein | 27109.0 | ENSG00000125375 | nan | nan
chr14	CDKL1	603441.0 | CDKL1, KKIALRE, p42 | Cyclin-dependent kinase-like 1 | 8814.0 | ENSG00000100490 | nan | nan
chr14	CTAA1	115650.0 | CTRCT32, CTAA1, CAP, CTPP5 | Cataract 32, multiple types | 1483.0 | nan | between D14S980 and D14S1069 | Cataract 32, multiple types, 115650 (2), Autosomal dominant
chr14		609640.0 | FRIASS, DEL14q22, C14DELq22 | Frias syndrome | nan | nan | deletion spans 4.1 Mb on 14q22.1-q22.3 | Frias syndrome, 609640 (4), Autosomal dominant
chr14	MYP18	255500.0 | MYP18 | Myopia 18 | 100359406.0 | nan | between D14S984 and D14S999 | Myopia 18, 255500 (2), Autosomal recessive
chr14	ATL1	606439.0 | ATL1, SPG3A, HSN1D | Atlastin GTPase 1 | 51062.0 | ENSG00000198513 | nan | Spastic paraplegia 3A, autosomal dominant, 182600 (3), Autosomal dominant; Neuropathy, hereditary sensory, type ID, 613708 (3), Autosomal dominant
chr14	MAP4K5	604923.0 | MAP4K5, MAPKKKK5 | Mitogen-activated protein kinase kinase kinase kinase-5 | 11183.0 | ENSG00000012983 | nan | nan
chr14	SAV1	607203.0 | SAV1, WW45, SAV | Salvador family WW domain containing protein 1 | 60485.0 | ENSG00000151748 | nan | nan
chr14	NIN	608684.0 | NIN, KIAA1565, SCKL7 | Ninein | 51199.0 | ENSG00000100503 | mutation identified in 1 SCKL7 family | ?Seckel syndrome 7, 614851 (3), Autosomal recessive
chr14	PYGL	613741.0 | PYGL | Phosphorylase, glycogen, liver | 5836.0 | ENSG00000100504 | nan | Glycogen storage disease VI, 232700 (3), Autosomal recessive
chr14	TRIM9	606555.0 | TRIM9, SPRING, KIAA0282 | Tripartite motif-containing protein 9 | 114088.0 | ENSG00000100505 | nan | nan
chr14	TMX1	610527.0 | TXNDC1, TMX | Thioredoxin domain-containing 1 | 81542.0 | ENSG00000139921 | nan | nan
chr14	FRMD6	614555.0 | FRMD6, WILLIN, C14orf31 | FERM domain-containing protein 6 | 122786.0 | ENSG00000139926 | nan | nan
chr14	GNG2	606981.0 | GNG2 | Guanine nucleotide-binding protein, gamma-2 | 54331.0 | ENSG00000186469 | nan | nan
chr14	RTRAF	610858.0 | C14orf166, CGI99 | Chromosome 14 open reading frame 166 | 51637.0 | ENSG00000087302 | nan | nan
chr14	NID2	605399.0 | NID2 | Nidogen 2 | 22795.0 | ENSG00000087303 | nan | nan
chr14	PTGDR	604687.0 | PTGDR, AS1, ASRT1 | Prostaglandin D2 receptor | 5729.0 | ENSG00000168229 | nan | {Asthma, susceptibility to, 1}, 607277 (3)
chr14	PTGER2	176804.0 | PTGER2 | Prostaglandin E receptor 2, EP2 subtype, 53kD | 5732.0 | ENSG00000125384 | nan | {Asthma, aspirin-induced, susceptibility to}, 208550 (3), Autosomal recessive
chr14	TXNDC16	616179.0 | TXNDC16, KIAA1344 | Thioredoxin domain-containing protein 16 | 57544.0 | ENSG00000087301 | nan | nan
chr14	ERO1A	615435.0 | ERO1L, ERO1LA | Endoplasmic reticulum oxidoreduction 1-like | 30001.0 | ENSG00000197930 | nan | nan
chr14	PSMC6	602708.0 | PSMC6 | Proteasome 26S subunit, ATPase, 6 | 5706.0 | ENSG00000100519 | previously assigned to 12q15 by FISH | nan
chr14	STYX	615814.0 | STYX | Serine/threonine/tyrosine-interacting protein | 6815.0 | ENSG00000198252 | nan | nan
chr14	GNPNAT1	616510.0 | GNPNAT1, GNA1, RHZDAN | Glucosamine-phosphate N-acetyltransferase 1 | 64841.0 | ENSG00000100522 | mutation identified 1 RHZDAN family | ?Rhizomelic dysplasia, Ain-Naz type, 616510 (3)
chr14	FERMT2	607746.0 | FERMT2, PLEKHC1, MIG2, UNC112, KIND2 | FERM domain-containing kindlin 2 | 10979.0 | ENSG00000073712 | nan | nan
chr14	DDHD1	614603.0 | DDHD1, PAPLA1, KIAA1705, SPG28 | DDHD domain-containing protein 1 | 80821.0 | ENSG00000100523 | nan | Spastic paraplegia 28, autosomal recessive, 609340 (3), Autosomal recessive
chr14	CRCS8	612589.0 | CRCS8 | Colorectal cancer, susceptibility to, 8 | 100271690.0 | nan | associated with rs4444235 | {Colorectal cancer, susceptibility to, 8}, 612589 (2)
chr14	BMP4	112262.0 | BMP4, BMP2B1, BMP2B, MCOPS6, OFC11 | Bone morphogenetic protein-4 | 652.0 | ENSG00000125378 | nan | Orofacial cleft 11, 600625 (3); Microphthalmia, syndromic 6, 607932 (3), Autosomal dominant
chr14	CDKN3	123832.0 | CDKN3 | Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) | 1033.0 | ENSG00000100526 | nan | nan
chr14	CNIH1	611287.0 | CNIH, TGAM77 | Cornichon, Drosophila, homolog of | 10175.0 | ENSG00000100528 | nan | nan
chr14	GMFB	601713.0 | GMFB, GMF | Glia maturation factor, beta | 2764.0 | ENSG00000197045 | nan | nan
chr14	CGRRF1	606138.0 | GCRRF1, CGR19 | Cell growth regulator with ring finger domain 1 | 10668.0 | ENSG00000100532 | nan | nan
chr14	SAMD4A	610747.0 | SAMD4A, SMAUG1, KIAA1053 | Sterile alpha motif domain-containing 4A | 23034.0 | ENSG00000020577 | nan | nan
chr14	GCH1	600225.0 | GCH1, DYT5, HPABH4B | GTP cyclohydrolase 1 | 2643.0 | ENSG00000131979 | nan | Dystonia, DOPA-responsive, 128230 (3), Autosomal recessive, Autosomal dominant; Hyperphenylalaninemia, BH4-deficient, B, 233910 (3), Autosomal recessive
chr14	WDHD1	608126.0 | WDHD1, AND1 | WD repeat and HMG-box DNA binding protein 1 | 11169.0 | ENSG00000198554 | nan | nan
chr14	SOCS4	616337.0 | SOCS4, SOCS7 | Suppressor of cytokine signaling 4 | 122809.0 | ENSG00000180008 | nan | nan
chr14	MAPK1IP1L	617226.0 | MAP1IP1L, MISS | Mitogen-activated protein kinase 1-interacting protein 1-like protein | 93487.0 | ENSG00000168175 | nan | nan
chr14	LGALS3	153619.0 | LGALS3, MAC2, GALBP | Lectin, galactose-binding, soluble, 3 | 3958.0 | ENSG00000131981 | assigned earlier to 1p13 | nan
chr14	DLGAP5	617859.0 | DLGAP5, DLG7, HURP, KIAA0008 | Discs large-associated protein 5 | 9787.0 | ENSG00000126787 | nan | nan
chr14	UBE2L1	600012.0 | UBE2L1, UBCL, UBC4 | Ubiquitin-conjugating enzyme E2 L1 (pseudogene) | 283556.0 | nan | nan | nan
chr14	FBXO34	609104.0 | FBXO34, FBX34 | F-box only protein 34 | 55030.0 | ENSG00000178974 | nan | nan
chr14	ATG14	613515.0 | ATG14, ATG14L, KIAA0831, BARKOR | Autophagy related 14 | 22863.0 | ENSG00000126775 | nan | nan
chr14	TBPL2	608964.0 | TBPL2, TRF3 | TATA box-binding protein-like protein 2 | 387332.0 | ENSG00000182521 | nan | nan
chr14	KTN1	600381.0 | KTN1, CG1 | Kinectin | 3895.0 | ENSG00000126777 | nan | nan
chr14	LINC00520	620533.0 | LINC00520, LEENE, LASSIE | Long intergenic noncoding RNA 520 | 645687.0 | ENSG00000258791 | nan | nan
chr14	PELI2	614798.0 | PELI2 | Pellino, Drosophila, homolog of, 2 | 57161.0 | ENSG00000139946 | nan | nan
chr14	TMEM260	617449.0 | TMEM260, C14orf101, SHDRA | Transmembrane protein 260 | 54916.0 | ENSG00000070269 | nan | Structural heart defects and renal anomalies syndrome, 617478 (3), Autosomal recessive
chr14	OTX2	600037.0 | OTX2, MCOPS5, CPHD6 | Orthodenticle homeobox 2 | 5015.0 | ENSG00000165588 | nan | Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3), Autosomal dominant; Pituitary hormone deficiency, combined, 6, 613986 (3), Autosomal dominant; Microphthalmia, syndromic 5, 610125 (3), Autosomal dominant
chr14	EXOC5	604469.0 | EXOC5, SEC10L1 | Exocyst complex component 5 | 10640.0 | ENSG00000070367 | nan | nan
chr14	AP5M1	614368.0 | AP5M1, MUDENG, MUD, C14orf108 | Adaptor-related protein complex 5, mu-1 subunit | 55745.0 | ENSG00000053770 | nan | nan
chr14	NAA30	617989.0 | NAA30, NAT12, MAK3, C14orf35 | N-alpha-acetyltransferase 30, NatC catalytic subunit | 122830.0 | ENSG00000139977 | nan | nan
chr14	ANIB8	612162.0 | ANIB8 | Aneurysm, intracranial berry, 8 | 100188886.0 | nan | associated with rs767603 | Aneurysm, intracranial berry, 8, 612162 (2)
chr14	EIG2	606972.0 | EIG2 | Epilepsy, idiopathic generalized, susceptibility to, 2 | 353124.0 | nan | nan | {Epilepsy, idiopathic generalized, susceptibility to, 2}, 606972 (2)
chr14	ACTR10	619731.0 | ACTR10, ARP11 | Actin-related protein 10 | 55860.0 | ENSG00000131966 | nan | nan
chr14	PSMA3	176843.0 | PSMA3 | Proteasome (prosome, macropain) subunit, alpha type, 3 | 5684.0 | ENSG00000100567 | nan | nan
chr14	ARID4A	180201.0 | ARID4A, RBP1, RBBP1 | AT-rich interactive domain-containing protein 4A | 5926.0 | ENSG00000032219 | nan | nan
chr14	TIMM9	607384.0 | TIMM9, TIM9 | Translocase of inner mitochondrial membrane 9 | 26520.0 | ENSG00000100575 | nan | nan
chr14	KIAA0586	610178.0 | KIAA0586, TALPID3, JBTS23, SRTD14 | KIAA0586 gene | 9786.0 | ENSG00000100578 | nan | Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3), Autosomal recessive; Joubert syndrome 23, 616490 (3), Autosomal recessive
chr14	DACT1	607861.0 | DACT1, DPR1, DAPPER1, FRODO, TBS2 | Dapper, antagonist of beta-catenin, 1 | 51339.0 | ENSG00000165617 | nan | Townes-Brocks syndrome 2, 617466 (3), Autosomal dominant
chr14	DAAM1	606626.0 | DAAM1, KIAA0666 | Dishevelled-associated activator of morphogenesis 1 | 23002.0 | ENSG00000100592 | nan | nan
chr14	GPR135	607970.0 | GPR135 | G protein-coupled receptor 135 | 64582.0 | ENSG00000181619 | nan | nan
chr14	L3HYPDH	614811.0 | L3HYPDH, C14orf149 | L-3-hydroxyproline dehydratase, trans | 112849.0 | ENSG00000126790 | nan | nan
chr14	JKAMP	611176.0 | JKAMP, C24orf100, JAMP | JNK1/MAPK8-associated membrane protein | 51528.0 | ENSG00000050130 | nan | nan
chr14	RTN1	600865.0 | RTN1, NSP | Reticulon 1 (neuroendocrine-specific protein) | 6252.0 | ENSG00000139970 | nan | nan
chr14	DHRS7	612833.0 | DHRS7, RETSDR4 | Short-chain dehydrogenase/reductase family, member 7 | 51635.0 | ENSG00000100612 | nan | nan
chr14	PPM1A	606108.0 | PPM1A, PP2CA | Protein phosphatase, magnesium/manganese-dependent, 1A | 5494.0 | ENSG00000100614 | nan | nan
chr14	C14orf39	617307.0 | C14orf39, SIX6OS1, SPGF52, POF18 | Chromosome 14 open reading frame 39 | 317761.0 | ENSG00000179008 | mutation identified in 1 POF18 patient | Spermatogenic failure 52, 619202 (3), Autosomal recessive; ?Premature ovarian failure 18, 619203 (3), Autosomal recessive
chr14	SIX6	606326.0 | SIX6, ODRMD | SIX homeobox 6 | 4990.0 | ENSG00000184302 | nan | Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3), Autosomal recessive
chr14	SIX1	601205.0 | SIX1, BOS3, DFNA23 | SIX homeobox 1 | 6495.0 | ENSG00000126778 | nan | Deafness, autosomal dominant 23, 605192 (3), Autosomal dominant; Branchiootic syndrome 3, 608389 (3), Autosomal dominant
chr14	SIX4	606342.0 | SIX4 | SIX homeobox 4 | 51804.0 | ENSG00000100625 | nan | nan
chr14	MNAT1	602659.0 | MNAT1, MAT1 | Menage a trois 1 | 4331.0 | ENSG00000020426 | nan | nan
chr14	TRMT5	611023.0 | TRMT5, TRM5, KIAA1393, PNSED | tRNA methyltransferase 5 | 57570.0 | ENSG00000126814 | nan | Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay, 616539 (3), Autosomal recessive
chr14	SLC38A6	616518.0 | SLC38A6, SNAT6 | Solute carrier family 38 (amino acid transporter), member 6 | 145389.0 | ENSG00000139974 | nan | nan
chr14	PRKCH	605437.0 | PRKCH, PKCL, PRKCL | Protein kinase C, eta | 5583.0 | ENSG00000027075 | nan | {Cerebral infarction, susceptibility to}, 601367 (3), Multifactorial
chr14	TMEM30B	611029.0 | TMEM30B, CDC50B | Transmembrane protein 30B | 161291.0 | ENSG00000182107 | nan | nan
chr14	TELM	609113.0 | TELM | Telomere length, mean leukocyte | 550641.0 | nan | suggestive QTL on 12, 10q, 3p | [Telomere length, mean leukocyte], 609113 (2)
chr14	HIF1A-AS1	614528.0 | HIF1AAS1 | HIF1A antisense RNA 1 | 100750246.0 | nan | nan | nan
chr14	HIF1A	603348.0 | HIF1A, MOP1 | Hypoxia-inducible factor 1, alpha subunit | 3091.0 | ENSG00000100644 | nan | nan
chr14	HIF1A-AS2	614529.0 | HIF1AAS2 | HIF1A antisense RNA 2 | 100750247.0 | nan | nan | nan
chr14	SNAPC1	600591.0 | SNAPC1, SNAP43 | Small nuclear RNA-activating protein complex, polypeptide 1 | 6617.0 | ENSG00000023608 | nan | nan
chr14	SYT16	610950.0 | SYT16, STREP14 | Synaptotagmin 16 | 83851.0 | ENSG00000139973 | nan | nan
chr14	KCNH5	605716.0 | KCNH5, DEE112 | Potassium voltage-gated channel, subfamily H, member 5 | 27133.0 | ENSG00000140015 | nan | Developmental and epileptic encephalopathy 112, 620537 (3), Autosomal dominant
chr14	RHOJ	607653.0 | RHOJ, ARHJ, TCL | Ras homolog gene family, member J | 57381.0 | ENSG00000126785 | nan | nan
chr14	GPHB5	609652.0 | GPHB5, GPB5 | Glycoprotein hormone, beta-5 | 122876.0 | ENSG00000179600 | nan | nan
chr14	PPP2R5E	601647.0 | PPP2R5E | Protein phosphatase-2, regulatory subunit B (B56), epsilon isoform | 5529.0 | ENSG00000154001 | incorrectly assigned to 7p12-p11.2 by FISH | nan
chr14	SGPP1	612826.0 | SGPP1, SPPASE1 | Sphingosine-1-phosphate phosphatase 1 | 81537.0 | ENSG00000126821 | nan | nan
chr14	SYNE2	608442.0 | SYNE2, NUANCE, KIAA1011, EDMD5 | Spectrin repeat-containing nuclear envelope protein 2 (nesprin 2) | 23224.0 | ENSG00000054654 | nan | Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3), Autosomal dominant
chr14	ESR2	601663.0 | ESR2, ODG8 | Estrogen receptor-2 (ER beta) | 2100.0 | ENSG00000140009 | mutation identified in 1 ODG8 patient | ?Ovarian dysgenesis 8, 618187 (3), Autosomal dominant
chr14	MTHFD1	172460.0 | MTHFD1, MTHFC, CIMAH | Methylenetetrahydrofolate dehydrogenase 1 | 4522.0 | ENSG00000100714 | trifunctional protein | {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, 617780 (3), Autosomal recessive
chr14	ZBTB25	194541.0 | ZBTB25, ZNF46, KUP | Zinc finger and BTB domain containing 25 | 7597.0 | ENSG00000089775 | nan | nan
chr14	AKAP5	604688.0 | AKAP5, AKAP79 | A-kinase anchor protein 5 | 9495.0 | ENSG00000179841 | nan | nan
chr14	ZBTB1	616578.0 | ZBTB1 | Zinc finger- and BTB domain-containing protein 1 | 22890.0 | ENSG00000126804 | nan | nan
chr14	HSPA2	140560.0 | HSPA2 | Heat-shock 70kD protein-2 | 3306.0 | ENSG00000126803 | nan | nan
chr14	PPP1R36	619923.0 | PPP1R36 | Protein phosphatase 1, regulatory subunit 36 | 145376.0 | ENSG00000165807 | nan | nan
chr14	PLEKHG3	617940.0 | PLEKHG2, ARHGEF43, KIAA0599 | Pleckstrin homology domain- and RhoGEF domain-containing protein G3 | 26030.0 | ENSG00000126822 | nan | nan
chr14	SPTB	182870.0 | SPTB, SPH2, EL3, HS2 | Spectrin, beta, erythrocytic | 6710.0 | ENSG00000070182 | nan | Anemia, neonatal hemolytic, fatal or near-fatal, 617948 (3), Autosomal recessive, Autosomal dominant; Elliptocytosis-3, 617948 (3), Autosomal recessive, Autosomal dominant; Spherocytosis, type 2, 616649 (3), Autosomal dominant
chr14	CHURC1	608577.0 | CHURC1, CHCH, C14orf52 | Churchill domain-containing 1 | 91612.0 | ENSG00000258289 | nan | nan
chr14	GPX2	138319.0 | GPX2 | Glutathione peroxidase-2, gastrointestinal | 2877.0 | ENSG00000176153 | nan | nan
chr14	RAB15	619547.0 | RAB15 | RAB15, member Ras oncogene family | 376267.0 | ENSG00000139998 | nan | nan
chr14	FNTB	134636.0 | FNTB | Farnesyltransferase, CAAX box, beta | 2342.0 | ENSG00000257365 | related FNTBL1 on 9 | nan
chr14	MAX	154950.0 | MAX, PDMCS | MYC associated factor X | 4149.0 | ENSG00000125952 | interacts with MYC | Polydactyly-macrocephaly syndrome, 620712 (3), Autosomal dominant; {Pheochromocytoma, susceptibility to}, 171300 (3), Autosomal dominant
chr14	FUT8	602589.0 | FUT8, CDGF1 | Fucosyltransferase 8 | 2530.0 | ENSG00000033170 | nan | Congenital disorder of glycosylation with defective fucosylation 1, 618005 (3), Autosomal recessive
chr14	GPHN	603930.0 | GPHN, GPH, KIAA1385, GEPH, MOCODC | Gephyrin | 10243.0 | ENSG00000171723 | nan | Molybdenum cofactor deficiency C, 615501 (3), Autosomal recessive
chr14	GARIN2	619898.0 | GARIN2, FAM71D, C14orf54 | Golgi-associated Rab2 interactor family, member 2 | 161142.0 | ENSG00000172717 | nan | nan
chr14	PALS1	606958.0 | MPP5, PALS1 | Membrane protein, palmitoylated 5 | 64398.0 | ENSG00000072415 | nan | nan
chr14	ATP6V1D	609398.0 | ATP6V1D, ATP6M | ATPase, H+ transporting, V1 subunit D | 51382.0 | ENSG00000100554 | nan | nan
chr14	EIF2S1	603907.0 | EIF2S1 | Eukaryotic translation initiation factor 2, subunit 1 | 1965.0 | ENSG00000134001 | nan | nan
chr14	PLEK2	608007.0 | PLEK2 | Pleckstrin 2 | 26499.0 | ENSG00000100558 | nan | nan
chr14	TMEM229B	619022.0 | TMEM229B | Transmembrane protein 229B | 161145.0 | ENSG00000198133 | nan | nan
chr14	PIGH	600154.0 | PIGH | Phosphatidylinositol glycan, class H | 5283.0 | ENSG00000100564 | nan | Glycosylphosphatidylinositol biosynthesis defect 17, 618010 (3), Autosomal recessive
chr14	ARG2	107830.0 | ARG2 | Arginase II | 384.0 | ENSG00000081181 | nan | nan
chr14	VTI1B	603207.0 | VTI1B, VTI1, VTI1L | Vesicle transport through interaction with T-snares 1B | 10490.0 | ENSG00000100568 | nan | nan
chr14	RDH11	607849.0 | RDH11, PSDR1, RALR1, RDJCSS | Retinol dehydrogenase 11 | 51109.0 | ENSG00000072042 | mutation identified in 1 RDJCSS family | ?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3), Autosomal recessive
chr14	RDH12	608830.0 | RDH12, LCA13 | Retinol dehydrogenase 12 | 145226.0 | ENSG00000139988 | near RDH11 | Leber congenital amaurosis 13, 612712 (3), Autosomal recessive, Autosomal dominant
chr14	ZFYVE26	612012.0 | ZFYVE26, KIAA0321, SPG15 | Zinc finger FYVE domain-containing protein 26 | 23503.0 | ENSG00000072121 | nan | Spastic paraplegia 15, autosomal recessive, 270700 (3), Autosomal recessive
chr14	RAD51B	602948.0 | RAD51B, RAD51L1 | RAD51 paralog B | 5890.0 | ENSG00000182185 | fused with HMGA2 in uterine leiomyoma | nan
chr14	ZFP36L1	601064.0 | ZFP36L1, BRF1, ERF1 | Zinc finger protein 36, C3H type-like 1 (butyrate response factor 1; EGF-response factor 1) | 677.0 | ENSG00000185650 | nan | nan
chr14	ACTN1	102575.0 | ACTN1, BDPLT15 | Actinin, alpha-1 | 87.0 | ENSG00000072110 | nan | Bleeding disorder, platelet-type, 15, 615193 (3), Autosomal dominant
chr14	DCAF5	603812.0 | DCAF5, WDR22, BCRP2, D14S1461E | DDB1- and CUL4-associated factor 5 | 8816.0 | ENSG00000139990 | nan | nan
chr14	EXD2	616940.0 | EXD2, EXDL2 | Exonuclease 3'-to-5' domain-containing protein 2 | 55218.0 | ENSG00000081177 | nan | nan
chr14	GALNT16	615132.0 | GALNT16, GALNACT16, GALNTL1, KIAA1130 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 | 57452.0 | ENSG00000100626 | nan | nan
chr14	ERH	601191.0 | ERH | ERH mRNA splicing and mitosis factor | 2079.0 | ENSG00000100632 | possible pseudogene on 7q34 | nan
chr14	SLC39A9	619116.0 | SLC39A9, ZIP9 | Solute carrier family 39 (zinc transporter), member 9 | 55334.0 | ENSG00000029364 | nan | nan
chr14	SUSD6	616761.0 | SUSD6, DRAGO, KIAA0247 | SUSHI domain-containing protein 6 | 9766.0 | ENSG00000100647 | nan | nan
chr14	SRSF5	600914.0 | SRSF5, SFRS5, SRp40 | Splicing factor, serine/arginine-rich, 5 | 6430.0 | ENSG00000100650 | nan | nan
chr14	SLC10A1	182396.0 | SLC10A1, NTCP1, FHCA2 | Solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 6554.0 | ENSG00000100652 | nan | Hypercholanemia, familial 2, 619256 (3), Autosomal recessive
chr14	SMOC1	608488.0 | SMOC1, OAS | SPARC-related modular calcium-binding 1 | 64093.0 | ENSG00000198732 | nan | Microphthalmia with limb anomalies, 206920 (3), Autosomal recessive
chr14	SLC8A3	607991.0 | SLC8A3, NCX3 | Solute carrier family 8 (sodium-calcium exchanger), member A3 | 6547.0 | ENSG00000100678 | nan | nan
chr14	COX16	618064.0 | COX16, MC4DN22 | Cytochrome c oxidase assembly factor 16 | 51241.0 | ENSG00000133983 | nan | Mitochondrial complex IV deficiency, nuclear type 22, 619355 (3), Autosomal recessive
chr14	SYNJ2BP	609411.0 | SYNJ2BP, OMP25, ARIP2 | Synaptojanin 2-binding protein | 55333.0 | ENSG00000213463 | nan | nan
chr14	ADAM21	603713.0 | ADAM21 | ADAM metallopeptidase domain 21 | 8747.0 | ENSG00000139985 | nan | nan
chr14	ADAM20	603712.0 | ADAM20 | ADAM metallopeptidase domain 20 | 8748.0 | ENSG00000134007 | nan | nan
chr14	MED6	602984.0 | MED6 | Mediator complex subunit 6 | 10001.0 | ENSG00000133997 | nan | nan
chr14	TTC9	610488.0 | TTC9, KIAA0227 | Tetratricopeptide repeat domain-containing protein 9 | 23508.0 | ENSG00000133985 | nan | nan
chr14	MAP3K9	600136.0 | MAP3K9, MLK1 | Mitogen-activated protein kinase kinase kinase 9 | 4293.0 | ENSG00000006432 | nan | nan
chr14	PCNX1	617655.0 | PCNX1, KIAA0995 | Pecanex 1 | 22990.0 | ENSG00000100731 | nan | nan
chr14	SIPA1L1	617504.0 | SIPA1L1, E6TP1, KIAA0440 | SIPA1-like protein 1 | 26037.0 | ENSG00000197555 | nan | nan
chr14	RGS6	603894.0 | RGS6 | Regulator of G protein signaling 6 | 9628.0 | ENSG00000182732 | nan | nan
chr14	DPF3	601672.0 | DPF3, CERD4 | D4, zinc and double PHD fingers, family 3 | 8110.0 | ENSG00000205683 | nan | nan
chr14	DCAF4	616372.0 | DCAF4, WDR21, WDR21A | DDB1- and CUL4-associated factor 4 | 26094.0 | ENSG00000119599 | nan | nan
chr14	ZFYVE1	605471.0 | ZFYVE1, ZNFN2A1, DFCP1, TAFF1 | Zinc finger FYVE type-containing protein 1 | 53349.0 | ENSG00000165861 | nan | nan
chr14	RBM25	612427.0 | RBM25, RED120 | RNA-binding motif protein 25 | 58517.0 | ENSG00000119707 | nan | nan
chr14	PSEN1	104311.0 | PSEN1, AD3, ACNINV3, CMD1U | Presenilin 1 | 5663.0 | ENSG00000080815 | mutation identified in 1 ACNINV3 family and 1 CMD1U family | Pick disease, 172700 (3), Autosomal dominant; Dementia, frontotemporal, 600274 (3), Autosomal dominant; ?Acne inversa, familial, 3, 613737 (3), Autosomal dominant; ?Cardiomyopathy, dilated, 1U, 613694 (3), Autosomal dominant; Alzheimer disease, type 3, with or without spastic paraparesis, 607822 (3), Autosomal dominant
chr14	PAPLN	617785.0 | PAPLN, PPN | Papilin, proteoglycan-like sulfated glycoprotein | 89932.0 | ENSG00000100767 | nan | nan
chr14	NUMB	603728.0 | NUMB, S171 | Numb, Drosophila, homolog of | 8650.0 | ENSG00000133961 | nan | nan
chr14	GLC3C	613085.0 | GLC3C | Glaucoma 3, primary congenital, C | 399565.0 | nan | between D14S61 and D14S1000 | Glaucoma 3, primary congenital, C, 613085 (2)
chr14	IDDM11	601208.0 | IDDM11 | Insulin-dependent diabetes mellitus-11 | 3410.0 | nan | nan | {Diabetes mellitus, insulin-dependent, 11}, 601208 (2)
chr14	KTCN8	614628.0 | KTCN8 | Keratoconus 8 | 100885803.0 | nan | between rs1074501 and rs755212 | Keratoconus 8, 614628 (2), Autosomal dominant
chr14	MUSTQTL1	612083.0 | MUSTQTL1 | Muscle strength quantitative trait locus 1 | 100192311.0 | nan | nan | Muscle strength quantitative trait locus 1, 612083 (2)
chr14	ACOT1	614313.0 | ACOT1 | Acyl-CoA thioesterase 1 | 641371.0 | ENSG00000184227 | nan | nan
chr14	RIOX1	611919.0 | RIOX1, C14orf169, NO66, MAPJD | Ribosomal oxygenase 1 | 79697.0 | ENSG00000170468 | nan | nan
chr14	ACOT2	609972.0 | ACOT2, PTE2, MTE1 | Acyl-CoA thioesterase 2 | 10965.0 | ENSG00000119673 | nan | nan
chr14	ACOT4	614314.0 | ACOT4 | Acyl-CoA thioesterase 4 | 122970.0 | ENSG00000177465 | ?pseudogene on 19q13.12 | nan
chr14	ACOT6	614267.0 | ACOT6 | Acyl-CoA thioesterase 6 | 641372.0 | ENSG00000205669 | nan | nan
chr14	DNAL1	610062.0 | DNAL1, C14orf168, CILD16 | Dynein, axonemal, light chain 1 | 83544.0 | ENSG00000119661 | nan | Ciliary dyskinesia, primary, 16, 614017 (3), Autosomal recessive
chr14	PNMA1	604010.0 | PNMA1, MA1 | Paraneoplastic MA antigen 1 | 9240.0 | ENSG00000176903 | nan | nan
chr14	PTGR2	608642.0 | ZADH1 | Zinc-binding alcohol dehydrogenase domain-containing protein 1 | 145482.0 | ENSG00000140043 | nan | nan
chr14	ZNF410	619427.0 | ZNF410, APA1 | Zinc finger protein 410 | 57862.0 | ENSG00000119725 | nan | nan
chr14	COQ6	614647.0 | COQ6, CGI10, COQ10D6 | Coq6, S. cerevisiae, homolog of | 51004.0 | ENSG00000119723 | nan | Coenzyme Q10 deficiency, primary, 6, 614650 (3), Autosomal recessive
chr14	ENTPD5	603162.0 | ENTPD5, CD39L4 | Ectonucleoside triphosphate diphosphohydrolase 5 | 957.0 | ENSG00000187097 | nan | nan
chr14	BBOF1	620496.0 | BBOF1 | Basal body orientation factor 1 | 80127.0 | ENSG00000119636 | nan | nan
chr14	ALDH6A1	603178.0 | ALDH6A1, MMSDH | Aldehyde dehydrogenase 6 family, member A1 (methylmalonate semialdehyde dehydrogenase) | 4329.0 | ENSG00000119711 | nan | Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3), Autosomal recessive
chr14	VSX2	142993.0 | VSX2, CHX10, HOX10, MCOP2, MCOPCB3 | Visual system homeobox 2 | 338917.0 | ENSG00000119614 | nan | Microphthalmia, isolated 2, 610093 (3), Autosomal recessive; Microphthalmia/coloboma 3, 610092 (3), Autosomal recessive
chr14	ABCD4	603214.0 | ABCD4, PXMP1L, P79R, PMP69, MAHCJ | ATP-binding cassette, subfamily D, member 4 (peroxisomal membrane protein 1-like) | 5826.0 | ENSG00000119688 | nan | Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3), Autosomal recessive
chr14	VRTN	620468.0 | VRTN | Vertebrae development-associated gene (vertnin) | 55237.0 | ENSG00000133980 | nan | nan
chr14	SYNDIG1L	609999.0 | SYNDIG1L, TMEM90A, CAPUCIN | Synapse differentiation-induced gene 1-like | 646658.0 | ENSG00000183379 | nan | nan
chr14	NPC2	601015.0 | NPC2, HE1 | NPC intracellular cholesterol tranporter 2 | 10577.0 | ENSG00000119655 | nan | Niemann-pick disease, type C2, 607625 (3), Autosomal recessive
chr14	ISCA2	615317.0 | ISCA2, MMDS4 | Iron-sulfur cluster assembly 2 | 122961.0 | ENSG00000165898 | nan | Multiple mitochondrial dysfunctions syndrome 4, 616370 (3), Autosomal recessive
chr14	LTBP2	602091.0 | LTBP2, LTBP3, GLC3D, MSPKA, WMS3 | Latent transforming growth factor beta binding protein-2 | 4053.0 | ENSG00000119681 | mutation identified in 1 WMS3 family | Glaucoma 3, primary congenital, D, 613086 (3); Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3), Autosomal recessive; ?Weill-Marchesani syndrome 3, recessive, 614819 (3), Autosomal recessive
chr14	AREL1	615380.0 | AREL1, KIAA0317 | Apoptosis-resistant E3 ubiquitin protein ligase 1 | 9870.0 | ENSG00000119682 | nan | nan
chr14	YLPM1	619766.0 | YLPM1, ZAP3 | YLP motif-containing protein 1 | 56252.0 | ENSG00000119596 | nan | nan
chr14	PROX2	615094.0 | PROX2 | Prospero-related homeobox 2 | 283571.0 | ENSG00000119608 | nan | nan
chr14	DLST	126063.0 | DLST, PPGL7 | Dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) | 1743.0 | ENSG00000119689 | nan | Pheochromocytoma/paraganglioma syndrome 7, 618475 (3), Autosomal dominant
chr14	PGF	601121.0 | PGF, PLGF | Placental growth factor, vascular endothelial growth factor-related protein | 5228.0 | ENSG00000119630 | nan | nan
chr14	EIF2B2	606454.0 | EIF2B2, VWM2 | Eukaryotic translation initiation factor 2B, subunit 2 | 8892.0 | ENSG00000119718 | nan | Leukoencephalopathy with vanishing white matter 2, with or without ovarian failure, 620312 (3), Autosomal recessive
chr14	MLH3	604395.0 | MLH3, HNPCC7 | DNA mismatch repair gene MLH3 | 27030.0 | ENSG00000119684 | nan | {Endometrial cancer, susceptibility to}, 608089 (3), Somatic mutation, Autosomal dominant; Colorectal cancer, somatic, 114500 (3); Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3)
chr14	ACYP1	600875.0 | ACYP1, ACYPE | Acylphosphatase, erythrocyte | 97.0 | ENSG00000119640 | nan | nan
chr14	NEK9	609798.0 | NEK9, NERCC1, LCCS10, APUG, NC | NIMA-related kinase 9 | 91754.0 | ENSG00000119638 | mutation identified in 1 APUG family | ?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3), Autosomal recessive; Nevus comedonicus, somatic, 617025 (3); Lethal congenital contracture syndrome 10, 617022 (3), Autosomal recessive
chr14	TMED10	605406.0 | TMED10, TMP21 | Transmembrane p24 trafficking protein 10 | 10972.0 | ENSG00000170348 | nan | nan
chr14	FOS	164810.0 | FOS | FOS protooncogene, AP1 transcription factor subunit | 2353.0 | ENSG00000170345 | nan | nan
chr14	JDP2	608657.0 | JDP2 | JUN dimerization protein 2 | 122953.0 | ENSG00000140044 | nan | nan
chr14	BATF	612476.0 | BATF, BATF1, SFA2 | Basic leucine zipper transcription factor, ATF-like | 10538.0 | ENSG00000156127 | nan | nan
chr14	FLVCR2	610865.0 | FLVCR2, C14orf58, CCT, PVHH, EPV | FLVCR heme transporter 2 | 55640.0 | ENSG00000119686 | nan | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, 225790 (3), Autosomal recessive
chr14	ERG28	604576.0 | ERG28, C14orf1 | Ergosterol biosynthesis 28 homolog | 11161.0 | ENSG00000133935 | nan | nan
chr14	TTLL5	612268.0 | TTLL5, STAMP, KIAA0998, CORD19 | Tubulin tyrosine ligase-like 5 | 23093.0 | ENSG00000119685 | nan | Cone-rod dystrophy 19, 615860 (3), Autosomal recessive
chr14	TGFB3	190230.0 | TGFB3, ARVD1, RNHF, LDS5 | Transforming growth factor, beta-3 | 7043.0 | ENSG00000119699 | nan | Arrhythmogenic right ventricular dysplasia 1, 107970 (3), Autosomal dominant; Loeys-Dietz syndrome 5, 615582 (3), Autosomal dominant
chr14	IFT43	614068.0 | IFT43, C14orf179, CED3, SRTD18, RP81 | Intraflagellar transport 43 | 112752.0 | ENSG00000119650 | mutation identified in 1 CED3 family and 1 RP81 family | ?Cranioectodermal dysplasia 3, 614099 (3), Autosomal recessive; ?Retinitis pigmentosa 81, 617871 (3), Autosomal recessive; Short-rib thoracic dysplasia 18 with polydactyly, 617866 (3), Autosomal recessive
chr14	ESRRB	602167.0 | ESRRB, ESRL2, DFNB35 | Estrogen-related receptor beta | 2103.0 | ENSG00000119715 | nan | Deafness, autosomal recessive 35, 608565 (3), Autosomal recessive
chr14	VASH1	609011.0 | VASH1, KIAA1036 | Vasohibin 1 | 22846.0 | ENSG00000071246 | nan | nan
chr14	ANGEL1	619537.0 | ANGEL1 | Angel homolog 1 | 23357.0 | ENSG00000013523 | nan | nan
chr14	IRF2BPL	611720.0 | IRF2BPL, C14orf4, EAP1, NEDAMSS | Interferon regulatory factor 2-binding protein like | 64207.0 | ENSG00000119669 | nan | Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures, 618088 (3), Autosomal dominant
chr14	CIPC	616995.0 | CIPC, KIAA1737 | Clock-interacting pacemaker | 85457.0 | ENSG00000198894 | nan | nan
chr14	TMEM63C	619953.0 | TMEM63C, SPG87 | Transmembrane protein 63C | 57156.0 | ENSG00000165548 | nan | Spastic paraplegia 87, autosomal recessive, 619966 (3), Autosomal recessive
chr14	NGB	605304.0 | NGB | Neuroglobin | 58157.0 | ENSG00000165553 | nan | nan
chr14	POMT2	607439.0 | POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14 | Putative protein O-mannosyltransferase 2 | 29954.0 | ENSG00000009830 | nan | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2, 613156 (3), Autosomal recessive
chr14	GSTZ1	603758.0 | GSTZ1, MAAI, MAAID | Glutathione S-transferase, zeta-1 (maleylacetoacetate isomerase) | 2954.0 | ENSG00000100577 | nan | [Maleylacetoacetate isomerase deficiency], 617596 (3), Autosomal recessive
chr14	VIPAS39	613401.0 | VIPAS39, VIPAR, SPE39, C14orf133 | VPS33B-interacting protein, apical-basolateral polarity regulator, spe-39 homolog | 63894.0 | ENSG00000151445 | nan | Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3), Autosomal recessive
chr14	AHSA1	608466.0 | AHSA1, AHA1 | Activator of heat-shock 90kD protein ATPase 1 | 10598.0 | ENSG00000100591 | nan | nan
chr14	ISM2	612684.0 | ISM2, THSD3, TAIL1 | Isthmin 2 | 145501.0 | ENSG00000100593 | nan | nan
chr14	SPTLC2	605713.0 | SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C | Serine palmitoyltransferase, long-chain base subunit 2 | 9517.0 | ENSG00000100596 | nan | Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3), Autosomal dominant
chr14	ALKBH1	605345.0 | ALKBH1, ALKB | AlkB homolog 1, histone H2A dioxygenase | 8846.0 | ENSG00000100601 | nan | nan
chr14	SLIRP	610211.0 | SLIRP, C14orf156 | SRA stem loop-interacting RNA-binding protein | 81892.0 | ENSG00000119705 | nan | nan
chr14	SNW1	603055.0 | SKIIP, SKIP, SNW1, BX42 | SKI-interacting protein | 22938.0 | ENSG00000100603 | nan | nan
chr14	ADCK1	620399.0 | ADCK1, MCP2 | AARF domain-containing kinase 1 | 57143.0 | ENSG00000063761 | nan | nan
chr14	NRXN3	600567.0 | NRXN3 | Neurexin 3 | 9369.0 | ENSG00000021645 | nan | nan
chr14	GRD1	275000.0 | GRD1 | Graves disease, susceptibility to, 1 | 100312954.0 | nan | associated with rs2268458 | {Graves disease, susceptibility to, 1}, 275000 (2), Autosomal recessive
chr14	HPPD	614187.0 | HPPD | Hypertelorism, preauricular sinus, punctal pits, and deafness | 100682260.0 | nan | nan | Hypertelorism, preauricular sinus, punctal pits, and deafness, 614187 (2), Autosomal dominant
chr14	DIO2	601413.0 | DIO2, TXDI2, D2 | Deiodinase, iodothyronine, type II | 1734.0 | ENSG00000211448 | nan | nan
chr14	CEP128	620667.0 | CEP128 | Centrosomal protein, 128kD | 145508.0 | ENSG00000100629 | nan | nan
chr14	TSHR	603372.0 | TSHR, CHNG1 | Thyroid-stimulating hormone receptor | 7253.0 | ENSG00000165409 | nan | Hyperthyroidism, familial gestational, 603373 (3), Autosomal dominant; Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant; Thyroid adenoma, hyperfunctioning, somatic, 609152 (3); Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive; Thyroid carcinoma with thyrotoxicosis, somatic, 609152 (3)
chr14	GTF2A1	600520.0 | GTF2A1, TF2A1 | General transcription factor IIA, alpha/beta subunits | 2957.0 | ENSG00000165417 | nan | nan
chr14	STON2	608467.0 | STON2, STN2, STNB | Stonin 2 | 85439.0 | ENSG00000140022 | nan | nan
chr14	SEL1L	602329.0 | SEL1L | SEL1L adaptor subunit ERAD E3 ubiquitin ligase | 6400.0 | ENSG00000071537 | nan | nan
chr14	FLRT2	604807.0 | FLRT2 | Fibronectin-like domain-containing leucine-rich transmembrane protein-2 | 23768.0 | ENSG00000185070 | nan | nan
chr14	GALC	606890.0 | GALC | Galactosylceramidase | 2581.0 | ENSG00000054983 | nan | Krabbe disease, 245200 (3), Autosomal recessive
chr14	GPR65	604620.0 | GPR65, TDAG8 | G protein-coupled receptor 65 | 8477.0 | ENSG00000140030 | nan | nan
chr14	KCNK10	605873.0 | KCNK10, TREK2 | Potassium channel, subfamily K, member 10 | 54207.0 | ENSG00000100433 | nan | nan
chr14	SPATA7	609868.0 | SPATA7, HSD3, LCA3, RP94 | Spermatogenesis-associated protein 7 | 55812.0 | ENSG00000042317 | nan | Leber congenital amaurosis 3, 604232 (3), Autosomal recessive; Retinitis pigmentosa 94, variable age at onset, autosomal recessive, 604232 (3), Autosomal recessive
chr14	PTPN21	603271.0 | PTPN21, PTPD1 | Protein-tyrosine phosphatase, nonreceptor-type, 21 | 11099.0 | ENSG00000070778 | nan | nan
chr14	ZC3H14	613279.0 | ZC3H14, SUT2, MRT56 | Zinc finger CCCH domain-containing protein 14 | 79882.0 | ENSG00000100722 | nan | Intellectual developmental disorder, autosomal recessive 56, 617125 (3), Autosomal recessive
chr14	EML5	618119.0 | EML5 | Echinoderm microtubule-associated protein-like 5 | 161436.0 | ENSG00000165521 | nan | nan
chr14	TTC8	608132.0 | TTC8, BBS8, RP51 | Tetratricopeptide repeat domain 8 | 123016.0 | ENSG00000165533 | mutation identified in 1 RP51 family | Bardet-Biedl syndrome 8, 615985 (3), Autosomal recessive; ?Retinitis pigmentosa 51, 613464 (3), Autosomal recessive
chr14	FOXN3	602628.0 | FOXN3, CHES1 | Forkhead box N3 | 1112.0 | ENSG00000053254 | nan | nan
chr14	CHDS4	608318.0 | CHDS4 | Coronary heart disease, susceptibility to, 4 | 387585.0 | nan | highest LOD with D14S1426 | {Coronary heart disease, susceptibility to, 4}, 608318 (2)
chr14	CKBE	123270.0 | CKBE | Creatine kinase, ectopic expression | 1156.0 | nan | linked to IGH, PI; ?same locus as CKBB | [Creatine kinase, brain type, ectopic expression of], 123270 (2)
chr14		616604.0 | DUP14q32, C14DUPq32 | Chromosome 14q32 duplication syndrome, 700kB | nan | nan | heterozygous germline duplication of 700kb | {Myeloproliferative neoplasms, familial, susceptibility to}, 616604 (4), Autosomal dominant
chr14	GEVQ1	608875.0 | GEVQ1 | Gene expression, variation in, quantitative trait locus on chromosome 14 | 474334.0 | nan | nan | {Gene expression, variation in, QTL}, 608875 (2)
chr14		608149.0 | KAOGS | Kagami-Ogata syndrome | nan | nan | uniparental isodisomy of imprinted region of chromosome 14 | Kagami-Ogata syndrome, 608149 (4), Autosomal dominant
chr14	MCOP1	251600.0 | MCOP1 | Microphthalmia, isolated 1 | 8113.0 | nan | nan | Microphthalmia, isolated 1, 251600 (2), Autosomal recessive
chr14	SERPINA2	107410.0 | SERPINA2P, PIL, ATR, ARGS | Serpin peptidase inhibitor, clade A, member 2, pseudogene | 390502.0 | ENSG00000258597 | ?pseudogene | nan
chr14		616222.0 | TEMPS | Temple syndrome (maternal uniparental disomy chromosome 14) | nan | nan | nan | Temple syndrome, 616222 (4), Autosomal dominant
chr14	TDP1	607198.0 | TDP1, SCAN1 | Tyrosyl-DNA phosphodiesterase 1 | 55775.0 | ENSG00000042088 | mutation identified in 1 SCAN1 family | ?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1, 607250 (3), Autosomal recessive
chr14	KCNK13	607367.0 | KCNK13, THIK1 | Potassium channel, subfamily K, member 13 | 56659.0 | ENSG00000152315 | nan | nan
chr14	PSMC1	602706.0 | PSMC1, S4, NEDGTH | Proteasome 26S subunit, ATPase, 1 | 5700.0 | ENSG00000100764 | mutation identified in 1 NEDGTH family | ?Birk-Aharoni syndrome, 620071 (3), Autosomal recessive
chr14	NRDE2	618631.0 | NRDE2, C14orf102 | NRDE2, necessary for RNA interference, domain containing | 55051.0 | ENSG00000119720 | nan | nan
chr14	CALM1	114180.0 | CALM1, PHKD, CPVT4, LQT14 | Calmodulin-1 (phosphorylase kinase, delta) | 801.0 | ENSG00000198668 | nan | Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3), Autosomal dominant; Long QT syndrome 14, 616247 (3), Autosomal dominant
chr14	TTC7B	620060.0 | TTC7B | Tetratricopeptide repeat domain-containing protein 7B | 145567.0 | ENSG00000165914 | nan | nan
chr14	RPS6KA5	603607.0 | RPS6KA5, MSK1 | Ribosomal protein S6 kinase A5 | 9252.0 | ENSG00000100784 | nan | nan
chr14	DGLUCY	620716.0 | DGLUCY | D-glutamate cyclase | 80017.0 | ENSG00000133943 | nan | nan
chr14	GPR68	601404.0 | GPR68, OGR1, AI2A6 | G protein-coupled receptor 68 | 8111.0 | ENSG00000119714 | nan | Amelogenesis imperfecta, hypomaturation type, IIA6, 617217 (3), Autosomal recessive
chr14	CCDC88C	611204.0 | CCDC88C, HKRP2, DAPLE, KIAA1509, HYC1, SCA40 | Coiled-coil domain-containing protein 88C | 440193.0 | ENSG00000015133 | mutation identified in 1 SCA40 family | ?Spinocerebellar ataxia 40, 616053 (3), Autosomal dominant; Hydrocephalus, congenital, 1, 236600 (3), Autosomal recessive
chr14	PPP4R3A	610351.0 | PPP4R3A, SMEK1, PP4R3A, KIAA2010 | Protein phosphatase 4, regulatory subunit 3, alpha | 55671.0 | ENSG00000100796 | nan | nan
chr14	CATSPERB	611169.0 | CATSPERB, C14orf161 | Cation channel, sperm-associated, beta | 79820.0 | ENSG00000133962 | nan | nan
chr14	TC2N	619305.0 | TC2N, TAC2N | Tandem C2 domains protein, nuclear | 123036.0 | ENSG00000165929 | nan | nan
chr14	FBLN5	604580.0 | FBLN5, ARMD3, ADCL2, ARCL1A, CMT1H | Fibulin 5 | 10516.0 | ENSG00000140092 | mutation identified in 1 ADCL2 patient | Cutis laxa, autosomal recessive, type IA, 219100 (3), Autosomal recessive; Charcot-Marie-Tooth disease, demyelinating, type 1H, 619764 (3), Autosomal dominant; Macular degeneration, age-related, 3, 608895 (3), Autosomal dominant; ?Cutis laxa, autosomal dominant 2, 614434 (3), Autosomal dominant
chr14	TRIP11	604505.0 | TRIP11, TRIP230, CEV14, ACG1A, ODCD1 | Thyroid hormone receptor interactor 11 | 9321.0 | ENSG00000100815 | nan | Odontochondrodysplasia 1, 184260 (3), Autosomal recessive; Achondrogenesis, type IA, 200600 (3), Autosomal recessive
chr14	ATXN3	607047.0 | ATXN3, MJD, SCA3 | Ataxin-3 (josephin) | 4287.0 | ENSG00000066427 | nan | {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant; Machado-Joseph disease, 109150 (3), Autosomal dominant
chr14	NDUFB1	603837.0 | NDUFB1 | NADH-ubiquinone oxidoreductase subunit B1 | 4707.0 | ENSG00000183648 | nan | nan
chr14	CPSF2	606028.0 | CPSF2, CPSF100 | Cleavage and polyadenylation specificity factor 2 | 53981.0 | ENSG00000165934 | nan | nan
chr14	SLC24A4	609840.0 | SLC24A4, NCKX4, SHEP6, AI2A5 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 | 123041.0 | ENSG00000140090 | nan | [Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3), Autosomal recessive; Amelogenesis imperfecta, type IIA5, 615887 (3), Autosomal recessive; [Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3), Autosomal recessive
chr14	RIN3	610223.0 | RIN3, FLJ22349 | Ras and Rab interactor 3 | 79890.0 | ENSG00000100599 | nan | nan
chr14	LGMN	602620.0 | LGMN, PRSC1 | Legumain (protease, cysteine, 1) | 5641.0 | ENSG00000100600 | nan | nan
chr14	GOLGA5	606918.0 | GOLGA5, RFG5 | Golgin A5 | 9950.0 | ENSG00000066455 | fused with RET to form PTC5 | nan
chr14	CHGA	118910.0 | CHGA | Chromogranin A, parathyroid secretory protein-1 | 1113.0 | ENSG00000100604 | nan | nan
chr14	ITPK1	601838.0 | ITPK1, ITRPK1 | Inositol 1,3,4-trisphosphate 5/6-kinase | 3705.0 | ENSG00000100605 | nan | nan
chr14	MOAP1	609485.0 | MOAP1, MAP1, PNMA4 | Modulator of apoptosis 1 | 64112.0 | ENSG00000165943 | nan | nan
chr14	LYSET	619332.0 | LYSET, TMEM251, C14orf109, DMAN | Lysosomal enzyme trafficking factor | 26175.0 | ENSG00000153485 | nan | Dysostosis multiplex, Ain-Naz type, 619345 (3), Autosomal recessive
chr14	GON7	617436.0 | GON7, C14orf142 | GON7 subunit of KEOPS complex | 84520.0 | ENSG00000170270 | nan | Galloway-Mowat syndrome 9, 619603 (3), Autosomal recessive
chr14	UBR7	613816.0 | UBR7, LICAS | Ubiquitin protein ligase E3 component N-recognin 7 | 55148.0 | ENSG00000012963 | nan | Li-Campeau syndrome, 619189 (3), Autosomal recessive
chr14	BTBD7	610386.0 | BTBD7, FUP1 | BTB/POX domain-containing protein 7 | 55727.0 | ENSG00000011114 | nan | nan
chr14	UNC79	616884.0 | UNC79 | unc-79 homolog, NALCN channel complex subunit | 57578.0 | ENSG00000133958 | nan | nan
chr14	COX8C	616855.0 | COX8C | Cytochrome c oxidase, subunit 8c | 341947.0 | ENSG00000187581 | nan | nan
chr14	PRIMA1	613851.0 | PRIMA1, PRIMA | Proline-rich membrane anchor 1 | 145270.0 | ENSG00000175785 | nan | nan
chr14	ASB2	605759.0 | ASB2 | Ankyrin repeat-containing SOCS box protein 2 | 51676.0 | ENSG00000100628 | nan | nan
chr14	OTUB2	608338.0 | OTUB2, OTU2, OTB2, C14orf137 | OTU domain-containing ubiquitin aldehyde-binding protein 2 | 78990.0 | ENSG00000089723 | nan | nan
chr14	DDX24	606181.0 | DDX24 | DEAD-box helicase 24 | 57062.0 | ENSG00000089737 | nan | nan
chr14	IFI27L1	611320.0 | IFI27L1, ISG12C, FAM14B | Interferon-alpha-inducible protein 27-like 1 | 122509.0 | ENSG00000165948 | nan | nan
chr14	IFI27	600009.0 | IFI27 | Interferon, alpha-inducible protein-27 | 3429.0 | ENSG00000165949 | nan | nan
chr14	IFI27L2	611319.0 | IFI27L2, FAM14A, ISG12B | Interferon alpha inducible protein 27 like 2 | 83982.0 | ENSG00000119632 | nan | nan
chr14	PPP4R4	616790.0 | PPP4R4, PP4R4, KIAA1622 | Protein phosphatase 4, regulatory subunit 4 | 57718.0 | ENSG00000119698 | nan | nan
chr14	SERPINA10	605271.0 | SERPINA10, ZPI | Serine (or cysteine) proteinase inhibitor, clade A, member 10 (protein Z-dependent protease inhibitor precursor) | 51156.0 | ENSG00000140093 | nan | nan
chr14	SERPINA6	122500.0 | CBG, SERPINA6 | Corticosteroid-binding globulin | 866.0 | ENSG00000170099 | nan | Corticosteroid-binding globulin deficiency, 611489 (3), Autosomal recessive, Autosomal dominant
chr14	SERPINA1	107400.0 | SERPINA1, PI, AAT | Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1) | 5265.0 | ENSG00000197249 | nan | Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3), Autosomal recessive; Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive; Emphysema-cirrhosis, due to AAT deficiency, 613490 (3), Autosomal recessive
chr14	SERPINA11	619619.0 | SERPINA11 | Serpin family A, member 11 | 256394.0 | ENSG00000186910 | nan | nan
chr14	SERPINA9	615677.0 | SERPINA9, GCET1, CENTERIN | Serpin peptidase inhibitor, clade A, member 9 | 327657.0 | ENSG00000170054 | nan | nan
chr14	SERPINA12	617471.0 | SERPINA12, VASPIN | Serpin peptidase inhibitor, clade A, member 12 (vaspin) | 145264.0 | ENSG00000165953 | nan | nan
chr14	SERPINA4	147935.0 | SERPINA4, KST, PI4 | Serpin peptidase inhibitor, clade A, member 4 | 5267.0 | ENSG00000100665 | in cluster with related AAT, AACT, CBG, PCI | nan
chr14	SERPINA5	601841.0 | SERPNA5, PCI | Serpin peptidase inhibitor, clade A, member 5 (protein C inhibitor) | 5104.0 | ENSG00000188488 | nan | nan
chr14	SERPINA3	107280.0 | SERPINA3, AACT, ACT | Alpha-1-antichymotrypsin | 12.0 | ENSG00000196136 | 220kb from PI | Alpha-1-antichymotrypsin deficiency (3); Cerebrovascular disease, occlusive (3)
chr14	GSC	138890.0 | GSC, SAMS | Goosecoid | 145258.0 | ENSG00000133937 | nan | Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3), Autosomal recessive
chr14	DICER1	606241.0 | DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW | dicer 1, ribonuclease III | 23405.0 | ENSG00000100697 | nan | Pleuropulmonary blastoma, 601200 (3), Autosomal dominant; Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant; GLOW syndrome, somatic mosaic, 618272 (3); Rhabdomyosarcoma, embryonal, 2, 180295 (3)
chr14	CLMN	611121.0 | CLMN, KIAA1188 | Calmin | 79789.0 | ENSG00000165959 | nan | nan
chr14	SYNE3	610861.0 | SYNE3, C14orf49 | Spectrin repeat-containing nuclear envelope protein 3 (nesprin 3) | 161176.0 | ENSG00000176438 | nan | nan
chr14	GLRX5	609588.0 | GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC | Glutaredoxin 5 | 51218.0 | ENSG00000182512 | nan | Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3), Autosomal recessive; Spasticity, childhood-onset, with hyperglycinemia, 616859 (3), Autosomal recessive
chr14	TCL6	604412.0 | TCL6, TNG1, TNG2 | T-cell leukemia/lymphoma 6 | 27004.0 | nan | nan | nan
chr14	TCL1B	603769.0 | TCL1B, TML1 | T-cell lymphoma/leukemia 1B | 9623.0 | ENSG00000213231 | nan | Leukemia/lymphoma, T-cell, 603769 (2)
chr14	TCL1A	186960.0 | TCL1A, TCL1 | T-cell lymphoma/leukemia 1A | 8115.0 | ENSG00000100721 | nan | Leukemia/lymphoma, T-cell, 186960 (2)
chr14	TUNAR	615719.0 | TUNAR, TUNA, LINC00617 | TCL1 upstream neural differentiation-associated RNA | 100507043.0 | ENSG00000250366 | nan | nan
chr14	BDKRB2	113503.0 | BDKRB2 | Bradykinin receptor B2 | 624.0 | ENSG00000168398 | nan | nan
chr14	BDKRB1	600337.0 | BDKRB1 | Bradykinin receptor B1 | 623.0 | ENSG00000100739 | nan | nan
chr14	ATG2B	616226.0 | ATG2B | Autophagy related 2B | 55102.0 | ENSG00000066739 | nan | nan
chr14	GSKIP	616605.0 | GSKIP, C14orf129 | GSK3B-interacting protein | 51527.0 | ENSG00000100744 | nan | nan
chr14	AK7	615364.0 | AK7, SPGF27 | Adenylate kinase 7 | 122481.0 | ENSG00000140057 | mutation identified in 1 SPGF27 family | ?Spermatogenic failure 27, 617965 (3), Autosomal recessive
chr14	PAPOLA	605553.0 | PAPOLA, PAP | Poly(A) polymerase | 10914.0 | ENSG00000090060 | nan | nan
chr14	VRK1	602168.0 | VRK1, PCH1A, HMNR10 | VRK serine/threonine kinase 1 | 7443.0 | ENSG00000100749 | nan | Pontocerebellar hypoplasia type 1A, 607596 (3), Autosomal recessive; Neuronopathy, distal hereditary motor, autosomal recessive 10, 620542 (3), Autosomal recessive
chr14	BCL11B	606558.0 | BCL11B, CTIP2, IMD49, IDDFSTA | BAF chromatin remodeling complex subunit BCL11B | 64919.0 | ENSG00000127152 | nan | Immunodeficiency 49, severe combined, 617237 (3), Autosomal dominant; Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities, 618092 (3), Autosomal dominant
chr14	SETD3	615671.0 | SETD3 | SET domain-containing protein 3 | 84193.0 | ENSG00000183576 | nan | nan
chr14	CCNK	603544.0 | CCNK, IDDHDF | Cyclin K | 8812.0 | ENSG00000090061 | mutation identified in 1 IDDHDF patient | ?Intellectual developmental disorder with hypertelorism and distinctive facies, 618147 (3), Autosomal dominant
chr14	CYP46A1	604087.0 | CYP46A1, CYP46 | Cytochrome P450, family 46, subfamily A, polypeptide 1 (cholesterol 24-hydroxylase) | 10858.0 | ENSG00000036530 | nan | nan
chr14	EML1	602033.0 | EML1, EMAPL, EMAP, BH | Echinoderm microtubule associated protein like 1 | 2009.0 | ENSG00000066629 | nan | Band heterotopia, 600348 (3), Autosomal recessive
chr14	EVL	616912.0 | EVL | ENAH/VASP-like protein | 51466.0 | ENSG00000196405 | nan | nan
chr14	DEGS2	610862.0 | DEGS2, DES2 | Delta(4)-desaturase, sphingolipid, 2 | 123099.0 | ENSG00000168350 | nan | nan
chr14	YY1	600013.0 | YY1, GADEVS | YY1 transcription factor | 7528.0 | ENSG00000100811 | nan | Gabriele-de Vries syndrome, 617557 (3), Autosomal dominant
chr14	SLC25A29	615064.0 | SLC25A29, CACL, ORNT3 | Solute carrier family 25 (carnitine/acylcarnitine translocase), member 29 | 123096.0 | ENSG00000197119 | nan | nan
chr14	SLC25A47	609911.0 | HDMCP, C14orf68 | Hepatocellular carcinoma-downregulated mitochondrial carrier protein | 283600.0 | ENSG00000140107 | nan | nan
chr14	WARS1	191050.0 | WARS1, WARS, HMND9, NEDMSBA | Tryptophanyl-tRNA synthetase 1 | 7453.0 | ENSG00000140105 | nan | Neuronopathy, distal hereditary motor, autosomal dominant 9, 617721 (3), Autosomal dominant; Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities, 620317 (3), Autosomal recessive
chr14	WDR25	618059.0 | WDR25 | WD repeat-containing protein 25 | 79446.0 | ENSG00000176473 | nan | nan
chr14	BEGAIN	618597.0 | BEGAIN | Brain-enriched guanylate kinase-associated protein | 57596.0 | ENSG00000183092 | nan | nan
chr14	DLK1	176290.0 | DLK1, PREF1, FA1 | Delta-like noncanonical NOTCH ligand 1 | 8788.0 | ENSG00000185559 | nan | nan
chr14	MEG3	605636.0 | MEG3, GTL2 | Maternally expressed gene 3 | 55384.0 | ENSG00000214548 | 100kb from DLK1 | nan
chr14	MIR337	620408.0 | MIR337 | Micro RNA 337 | 442905.0 | ENSG00000199151 | nan | nan
chr14	RTL1	611896.0 | RTL1, PEG11 | Retrotransposon-like gene 1 | 388015.0 | ENSG00000254656 | nan | nan
chr14	MIR431	611708.0 | MIR431, MIRN431 | Micro RNA 431 | 574038.0 | ENSG00000208001 | nan | nan
chr14	MIR433	611711.0 | MIR433, MIRN433 | Micro RNA 433 | 574034.0 | ENSG00000207569 | nan | nan
chr14	MIR127	611709.0 | MIR127, MIRN127 | Micro RNA 127 | 406914.0 | ENSG00000207608 | nan | nan
chr14	MIR136	611710.0 | MIR136, MIRN136 | Micro RNA 136 | 406927.0 | ENSG00000207942 | nan | nan
chr14	MEG8	613648.0 | MEG8 | Maternally expressed gene 8 | 79104.0 | nan | nan | nan
chr14	SNORD112	613649.0 | SNORD112 | Small nucleolar, C/D box, 112 | 692215.0 | ENSG00000275662 | located in an intron of MEG8 | nan
chr14	MIR370	612553.0 | MIR370, MIRN370 | Micro RNA 370 | 442915.0 | ENSG00000199005 | nan | nan
chr14	SNORD113-1	613650.0 | SNORD113-1 | Small nucleolar RNA, C/D box, 113-1 | 767561.0 | ENSG00000202191 | nan | nan
chr14	SNORD114-1	613651.0 | SNORD114-1 | Small nucleolar RNA, C/D box, 114-1 | 767577.0 | ENSG00000199575 | nan | nan
chr14	MIR379	616358.0 | MIR379 | Micro RNA 379 | 494328.0 | ENSG00000199088 | nan | nan
chr14	MIR380	613654.0 | MIR380, MIRN380 | Micro RNA 380 | 494329.0 | ENSG00000198982 | nan | nan
chr14	MIR494	616036.0 | MIR494 | Micro RNA 494 | 574452.0 | ENSG00000194717 | nan | nan
chr14	MIR495	615149.0 | MIR495 | Micro RNA 495 | 574453.0 | ENSG00000207743 | nan | nan
chr14	MIR376C	610983.0 | MIR376C, MIR368 | Micro RNA 368C | 442913.0 | ENSG00000283279 | nan | nan
chr14	MIR376A2	610960.0 | MIR376A-2, MIRN376A-2 | Micro RNA 376A-2 | 664615.0 | ENSG00000283561 | nan | nan
chr14	MIR376B	610961.0 | MIR376B, MIRN376B | Micro RNA 376b | 574435.0 | ENSG00000283556 | nan | nan
chr14	MIR376A1	610959.0 | MIR376A-1, MIRN376A-1 | Micro RNA 376A-1 | 494325.0 | ENSG00000283588 | nan | nan
chr14	MIR487B	615037.0 | MIR487B | Micro RNA 487B | 664616.0 | ENSG00000207754 | nan | nan
chr14	MIR134	610164.0 | MIR134 | Micro RNA 134 | 406924.0 | ENSG00000207993 | nan | nan
chr14	MIR485	615385.0 | MIR485 | Micro RNA 485 | 574436.0 | ENSG00000208027 | nan | nan
chr14	MIR409	614057.0 | MIR409, MIRN409 | Micro RNA 409 | 574413.0 | ENSG00000199107 | nan | nan
chr14	MIR369	611794.0 | MIR369, MIR369-3, MIRN369-3 | Micro RNA 369 | 442914.0 | ENSG00000199025 | nan | nan
chr14	MIR410	615036.0 | MIR410 | Micro RNA 410 | 574434.0 | ENSG00000199092 | nan | nan
chr14	MIR656	616376.0 | MIR656 | Micro RNA 656 | 724026.0 | ENSG00000207959 | nan | nan
chr14	DIO3OS	608523.0 | DIO3OS | Deiodinase, iodothyronine, type 3, opposite strand | 64150.0 | ENSG00000258498 | nan | nan
chr14	DIO3	601038.0 | DIO3, TXDI3 | Deiodinase, iodothyronine, type 3 | 1735.0 | ENSG00000197406 | nan | nan
chr14	PPP2R5C	601645.0 | PPP2R5C | Protein phosphatase-2, regulatory subunit B (B56), gamma isoform | 5527.0 | ENSG00000078304 | pseudogene on 3p21 | nan
chr14	DYNC1H1	600112.0 | DYNC1H1, DNCL, DNECL, CMT2O, SMALED1, CDCBM13 | Dynein, cytoplasmic-1, heavy chain-1 | 1778.0 | ENSG00000197102 | nan | Charcot-Marie-Tooth disease, axonal, type 2O, 614228 (3), Autosomal dominant; Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3), Autosomal dominant; Cortical dysplasia, complex, with other brain malformations 13, 614563 (3), Autosomal dominant
chr14	HSP90AA1	140571.0 | HSP90AA1, HSPCA, HSPC1, HSP90A, HSP89A, HSPCAL4, LAP2 | Heat-shock protein, 90kD, alpha, class A, member 1 | 3320.0 | ENSG00000080824 | nan | nan
chr14	WDR20	617741.0 | WDR20 | WD repeat-containing protein 20 | 91833.0 | ENSG00000140153 | nan | nan
chr14	MOK	605762.0 | MOK, RAGE | MOK protein kinase | 5891.0 | ENSG00000080823 | nan | nan
chr14	CINP	613362.0 | CINP | CDK2-interacting protein | 51550.0 | ENSG00000100865 | nan | nan
chr14	TECPR2	615000.0 | TECPR2, KIAA0329, HSAN9 | Tectonin beta-propeller repeat-containing protein 2 | 9895.0 | ENSG00000196663 | nan | Neuropathy, hereditary sensory and autonomic, type IX, with developmental delay, 615031 (3), Autosomal recessive
chr14	ANKRD9	618605.0 | ANKRD9 | Ankyrin repeat domain-containing protein 9 | 122416.0 | ENSG00000156381 | nan | nan
chr14	RCOR1	607675.0 | RCOR, COREST, KIAA0071 | REST corepressor | 23186.0 | ENSG00000089902 | nan | nan
chr14	TRAF3	601896.0 | TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5 | TNF receptor-associated factor 3 | 7187.0 | ENSG00000131323 | mutation identified in 1 IIAE5 patient | {?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}, 614849 (3), Autosomal dominant
chr14	AMN	605799.0 | AMN, IGS2 | Amnion associated transmembrane protein | 81693.0 | ENSG00000166126 | nan | Imerslund-Grasbeck syndrome 2, 618882 (3), Autosomal recessive
chr14	CDC42BPB	614062.0 | CDC42BPB, MRCKB, CHOCNS | CDC42-binding protein kinase, beta | 9578.0 | ENSG00000198752 | nan | Chilton-Okur-Chung neurodevelopmental syndrome, 619841 (3), Autosomal dominant
chr14	TNFAIP2	603300.0 | TNFAIP2 | Tumor necrosis factor, alpha-induced protein-2 | 7127.0 | ENSG00000185215 | nan | nan
chr14	EIF5	601710.0 | EIF5 | Eukaryotic translation initiation factor 5 | 1983.0 | ENSG00000100664 | nan | nan
chr14	MARK3	602678.0 | MARK3, VIPB | MAP/microtubule affinity-regulating kinase-3 | 4140.0 | ENSG00000075413 | mutation identified in 1 VIPB family | ?Visual impairment and progressive phthisis bulbi, 618283 (3), Autosomal recessive
chr14		144120.0 | IGHR | Immunoglobulin heavy chain regulator | nan | nan | nan | ?Hyperimmunoglobulin G1 syndrome, 144120 (2), Autosomal dominant
chr14	CKB	123280.0 | CKB, CKBB, BCK | Creatine kinase, brain type | 1152.0 | ENSG00000166165 | distal to PI and AACT; closely linked to AKT1 and IGH; proximal to IGH | nan
chr14	TRMT61A	620885.0 | TRMT61A | tRNA methyltransferase 61A | 115708.0 | ENSG00000166166 | nan | nan
chr14	BAG5	603885.0 | BAG5, CMD2F | BAG cochaperone 5 | 9529.0 | ENSG00000166170 | nan | Cardiomyopathy, dilated, 2F, 619747 (3), Autosomal recessive
chr14	COA8	616003.0 | APOPT1, APOP, MC4DN17 | Apoptogenic protein 1, mitochondrial | 84334.0 | ENSG00000256053 | nan | Mitochondrial complex IV deficiency, nuclear type 17, 619061 (3), Autosomal recessive
chr14	KLC1	600025.0 | KLC1, KNS2, KNS2A | Kinesin, light chain 1 | 3831.0 | ENSG00000126214 | nan | nan
chr14	XRCC3	600675.0 | XRCC3, CMM6 | X-ray repair corss complementing 3 | 7517.0 | ENSG00000126215 | nan | {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Melanoma, cutaneous malignant, 6}, 613972 (3)
chr14	ZFYVE21	613504.0 | ZFYVE21, ZF21 | Zinc finger FYVE domain-containing protein 21 | 79038.0 | ENSG00000100711 | nan | nan
chr14	PPP1R13B	606455.0 | PPP1R13B, ASPP1, KIAA0771 | Protein phosphatase 1, regulatory subunit 13B | 23368.0 | ENSG00000088808 | nan | nan
chr14	PPP1R13B-DT	620544.0 | PPP1R13BDT, HITT, LINC00637 | PPP1R13B divergent transcript, noncoding | 145216.0 | ENSG00000258735 | nan | nan
chr14	ATP5MJ	604573.0 | ATP5MPL, C14orf2, MP68 | ATP synthase membrane subunit 6.8PL | 9556.0 | ENSG00000156411 | nan | nan
chr14	TDRD9	617963.0 | TDRD9, C14orf75, HLS, SPNE, SPGF30 | TUDOR domain-containing protein 9 | 122402.0 | ENSG00000156414 | mutation identified in one SPGF30 family | ?Spermatogenic failure 30, 618110 (3), Autosomal recessive
chr14	ASPG	618472.0 | ASPG, LYSOLP | Asparaginase | 374569.0 | ENSG00000166183 | nan | nan
chr14	MIR203A	611899.0 | MIR203A, MIRN203 | Micro RNA 203A | 406986.0 | ENSG00000207568 | nan | nan
chr14	KIF26A	613231.0 | KIF26A, KIAA1236, CDCBM11 | Kinesin family member 26A | 26153.0 | ENSG00000066735 | nan | Cortical dysplasia, complex, with other brain malformations 11, 620156 (3), Autosomal recessive
chr14	C14orf180	619392.0 | C14orf180, NRAC | Chromosome 14 open reading frame 180 | 400258.0 | ENSG00000184601 | nan | nan
chr14	INF2	610982.0 | INF2, FSGS5, C14orf173, CMTDIE | Inverted formin 2 | 64423.0 | ENSG00000203485 | nan | Glomerulosclerosis, focal segmental, 5, 613237 (3); Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3), Autosomal dominant
chr14	ADSS1	612498.0 | ADSS1, ADSSL1, MPD5 | Adenylosuccinate synthase 1 | 122622.0 | ENSG00000185100 | nan | Myopathy, distal, 5, 617030 (3), Autosomal recessive
chr14	SIVA1	605567.0 | SIVA1, CD27BP | SIVA apoptosis-inducing factor 1 | 10572.0 | ENSG00000184990 | nan | nan
chr14	AKT1	164730.0 | AKT1, CWS6 | AKT serine/threonine kinase 1 | 207.0 | ENSG00000142208 | proximal to IGH | Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)
chr14	ZBTB42	613915.0 | ZBTB42, ZNF925, LCCS6 | Zinc finger- and BTB domain-containing protein 42 | 100128927.0 | ENSG00000179627 | mutation identified in 1 LCCS6 family | ?Lethal congenital contracture syndrome 6, 616248 (3), Autosomal recessive
chr14	CEP170B	620251.0 | CEP170B, KIAA0284 | Centrosomal protein 170B | 283638.0 | ENSG00000099814 | nan | nan
chr14	PLD4	618488.0 | PLD4 | Phospholipase D family, member 4 | 122618.0 | ENSG00000166428 | nan | nan
chr14	AHNAK2	608570.0 | AHNAK2, C14orf78, KIAA2019 | AHNAK nucleoprotein 2 | 113146.0 | ENSG00000185567 | nan | nan
chr14	CDCA4	612270.0 | CDCA4, HEPP | Cell division cycle-associated protein 4 | 55038.0 | ENSG00000170779 | nan | nan
chr14	GPR132	606167.0 | GPR132, G2A | G protein-coupled receptor-132 | 29933.0 | ENSG00000183484 | nan | nan
chr14	JAG2	602570.0 | JAG2, LGMDR27 | Jagged 2 | 3714.0 | ENSG00000184916 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 27, 619566 (3), Autosomal recessive
chr14	NUDT14	609219.0 | NUDT14, UGPP | Nudix hydrolase 14 | 256281.0 | ENSG00000183828 | nan | nan
chr14	BRF1	604902.0 | BRF1, TAF3C, GTF3B, TF3B90, CFDS | BRF1, S. cerevisiae, homolog of (TATA box-binding protein-associated factor 3C) | 2972.0 | ENSG00000185024 | nan | Cerebellofaciodental syndrome, 616202 (3), Autosomal recessive
chr14	PACS2	610423.0 | PACS2, KIAA0602, DEE66 | Phosphofurin acidic cluster sorting protein 2 | 23241.0 | ENSG00000179364 | nan | Developmental and epileptic encephalopathy 66, 618067 (3), Autosomal dominant
chr14	MTA1	603526.0 | MTA1 | Metastasis-associated gene 1 | 9112.0 | ENSG00000182979 | nan | nan
chr14	CRIP2	601183.0 | CRIP2, CRP2 | Cysteine-rich intestinal protein 2 | 1397.0 | ENSG00000182809 | nan | nan
chr14	CRIP1	123875.0 | CRIP1, CRIP | Cysteine-rich intestinal protein 1 | 1396.0 | ENSG00000213145 | previously assigned to 7q11.23 | nan
chr14	IGH	146910.0 | IGHD@ | Immunoglobulin heavy chain diversity gene cluster | 3492.0 | nan | many genes | nan
chr14	IGH	147010.0 | IGHJ@ | Immunoglobulin heavy chain joining gene cluster | 3492.0 | nan | more than 4 genes | nan
chr14	IGH	147070.0 | IGHV@ | Immunoglobin heavy polypeptide, variable gene cluster | 3492.0 | nan | ~250 genes; orientation: cen-PI-D14S1-IGH-IGHV--qter; 3' centromeric, 5' telomeric; IgM telomeric to IgG | nan
chr14	IGHA2	147000.0 | IGHA2, A2M | Constant region of heavy chain of IgA2 | 3494.0 | ENSG00000211890 | nan | nan
chr14	IGHE	147180.0 | IGHE | Constant region of heavy chain of IgE | 3497.0 | ENSG00000211891 | pseudogene IGHEP1 nearby; IGHEP2 on chr.9 | nan
chr14	IGHG4	147130.0 | IGHG4 | Constant region of heavy chain of IgG4 | 3503.0 | ENSG00000211892 | nan | nan
chr14	IGHG2	147110.0 | IGHG2 | Constant region of heavy chain of IgG2 | 3501.0 | ENSG00000211893 | 5'-G2-17kb-G4-3'; closeness of IGG3 and IGG1 known from Lepore-like myeloma protein | IgG2 deficiency, selective (3)
chr14	IGHA1	146900.0 | IGHA1 | Constant region of heavy chain of IgA1 | 3493.0 | ENSG00000211895 | Fused with IRTA1 in multiple myeloma | nan
chr14	IGHG1	147100.0 | IGHG1 | Constant region of heavy chain of IgG1 | 3500.0 | ENSG00000211896 | nan | nan
chr14	IGHG3	147120.0 | IGHG3 | Constant region of heavy chain of IgG3 | 3502.0 | ENSG00000211897 | nan | nan
chr14	IGHD	147170.0 | IGHD | Constant region of heavy chain of IgD | 3495.0 | ENSG00000211898 | nan | nan
chr14	IGHM	147020.0 | IGHM, MU, AGM1 | Constant region of heavy chain of IgM | 3507.0 | ENSG00000211899 | nan | Agammaglobulinemia 1, 601495 (3), Autosomal recessive
chr14	IGHD3-3	611937.0 | IGHD3-3, DXP4 | Immunoglobulin heavy chain diversity gene 3-3 | 28501.0 | ENSG00000211930 | nan | nan
chr14	FAM30A	616623.0 | KIAA0125, FAM30A, C14orf110 | KIAA0125 gene, noncoding | 9834.0 | ENSG00000226777 | nan | nan
chr14	IGHV3-23	611939.0 | IGHV3-23, IGHV323, DP47, VH26 | Immunoglobulin heavy chain variable gene 3-23 | 28442.0 | ENSG00000211949 | nan | nan
chr14		151020.0 | LCH | Lentil agglutinin-binding | nan | nan | nan | nan
chr14	PHOBS	608251.0 | PHOBS | Phobia, specific | 404684.0 | nan | nan | Phobia, specific, 608251 (2)
chr14		616606.0 | RC14S | Ring chromosome 14 syndrome | nan | nan | nan | Ring chromosome 14 syndrome, 616606 (4), Isolated cases
chr15	RNR3	180452.0 | RNR3 | Ribosomal RNA-3 | 6054.0 | nan | nan | nan
chr15		608636.0 | AUTS4 | Autism, susceptibility to, 4 | nan | nan | nan | {Autism susceptibility 4}, 608636 (2), Autosomal dominant
chr15	CELIAC5	607202.0 | CELIAC5, GSES | Celiac disease, susceptibility to, 5 | 338332.0 | nan | in homogeneous Finnish population | {Celiac disease, susceptibility to, 5}, 607202 (2)
chr15	GLC1I	609745.0 | GLC1I | Glaucoma 1, open angle, I | 497188.0 | nan | max lod at GABRB3 | Glaucoma 1, open angle, I, 609745 (2)
chr15	HCVS	122460.0 | HCVS | Human coronavirus sensitivity | 3063.0 | nan | nan | {Human coronavirus sensitivity}, 122460 (2), Autosomal dominant
chr15	HYT2	604329.0 | HYT2 | Hypertension, essential, susceptibility to, 2 | 50986.0 | nan | nan | {Hypertension, essential, susceptibility to, 2}, 145500 (2), Multifactorial
chr15		146990.0 | IGHDY2 | Immunoglobulin heavy chain diversity region-2 | 3496.0 | nan | ?functional | nan
chr15	LCS1	214900.0 | LCS1, CHLS | Cholestasis-lymphedema syndrome | 84565.0 | nan | nan | Cholestasis-lymphedema syndrome, 214900 (2), Autosomal recessive
chr15		603857.0 | MRKN3-AS1, ZNF127AS | MKRN3 antisense RNA 1 | 10108.0 | nan | nan | nan
chr15		176270.0 | PWS | Prader-Willi syndrome | nan | nan | loss of paternal allele | Prader-Willi syndrome, 176270 (4), Autosomal dominant
chr15		615656.0 | DEL15q11.2, C15DELq11.2 | Chromosome 15q11.2 deletion syndrome | nan | nan | deleted region spans 300-500kb between BP1 and BP2 | Chromosome 15q11.2 deletion syndrome, 615656 (4), Autosomal dominant
chr15	MGR7	609179.0 | MGR7 | Migraine with aura, susceptibility to, 7 | 553992.0 | nan | between D15S113 and D15S1019 | {Migraine with aura, susceptibility to, 7}, 609179 (2)
chr15	NBEAP1	601889.0 | NBEAP1, BCL8 | Neurobeachin pseudogene 1 | 606.0 | nan | nan | nan
chr15	POTEB	608912.0 | POTEB, POTE15 | POTE ankyrin domain family, member B | 100996331.0 | ENSG00000233917 | nan | nan
chr15	NIPA1	608145.0 | NIPA1, SPG6 | NIPA magnesium transporter 1 | 123606.0 | ENSG00000170113 | nan | Spastic paraplegia 6, autosomal dominant, 600363 (3), Autosomal dominant
chr15	NIPA2	608146.0 | NIPA2 | NIPA magnesium transporter 2 | 81614.0 | ENSG00000140157 | nan | nan
chr15	CYFIP1	606322.0 | CYFIP1, KIAA0068 | Cytoplasmic FMRP interacting protein 1 | 23191.0 | ENSG00000273749 | nan | nan
chr15	TUBGCP5	608147.0 | TUBGCP5, GCP5, KIAA1899 | Tubulin-gamma complex-associated protein 5 | 114791.0 | ENSG00000275835 | nan | nan
chr15	MKRN3	603856.0 | MKRN3, ZFP127, ZNF127, CPPB2 | Makorin 3 | 7681.0 | ENSG00000179455 | expressed only from paternal allele | Precocious puberty, central, 2, 615346 (3), Autosomal dominant
chr15	MAGEL2	605283.0 | MAGEL2, NDNL1, SHFYNG | MAGE-like 2 | 54551.0 | ENSG00000254585 | nan | Schaaf-Yang syndrome, 615547 (3), Autosomal dominant
chr15	NDN	602117.0 | NDN | Necdin | 4692.0 | ENSG00000182636 | involved in Prader-Willi syndrome | nan
chr15	PWRN2	611217.0 | PWRN2 | Prader-Willi region noncoding RNA 2 | 791115.0 | ENSG00000260551 | nan | nan
chr15	PWRN1	611215.0 | PWRN1 | Prader-Willi region noncoding RNA 1 | 791114.0 | ENSG00000259905 | nan | nan
chr15	NPAP1	610922.0 | NPAP1, C15orf2 | Nuclear pore associated protein 1 | 23742.0 | ENSG00000185823 | nan | nan
chr15	SNHG14	616259.0 | SNHG14, LNCAT, UBE3AATS | Small nucleolar RNA host gene 14 | 104472715.0 | nan | nan | nan
chr15	SNRPN	182279.0 | SNRPN | Small nuclear ribonucleoprotein polypeptide N | 6638.0 | ENSG00000128739 | involved in Prader-Willi syndrome | nan
chr15	PWAR5	600162.0 | D15S226E, PAR5 | Prader-Willi/Angelman syndrome-5 | 8123.0 | ENSG00000279192 | paternally imprinted | nan
chr15	SNORD116-1	605436.0 | SNORD116-1, PWCR1 | Small nucleolar RNA, C/D box, 116-1 | 100033413.0 | ENSG00000207063 | nan | nan
chr15	IPW	601491.0 | IPW | Imprinted in Prader-Willi syndrome | 3653.0 | nan | nan | nan
chr15	PWAR1	600161.0 | D15S227E, PAR1 | Prader-Willi/Angelman region-1 | 145624.0 | ENSG00000279050 | paternally imprinted | nan
chr15	SNORD115-1	609837.0 | SNORD115-1, RNHBII52 | Small nucleolar RNA, C/D box, 115-1 | 338433.0 | ENSG00000201831 | nan | nan
chr15	UBE3A	601623.0 | UBE3A, ANCR | Ubiquitin protein ligase E3A | 7337.0 | ENSG00000114062 | same location as PWS | Angelman syndrome, 105830 (3), Autosomal dominant
chr15	HPC7	610321.0 | HPC7 | Prostate cancer, hereditary, 7 | 100188809.0 | nan | nan | {Prostate cancer, hereditary, 7}, 610321 (2)
chr15	MCOPCB2	605738.0 | MCOPCB2 | Microphthalmia/coloboma 2 | 80771.0 | nan | nan | Microphthalmia/coloboma 2, 605738 (2), Autosomal dominant
chr15	ATP10A	605855.0 | ATP10A, ATP10C, ATPVC | ATPase, phospholipid-transporting, 10A | 57194.0 | ENSG00000206190 | nan | nan
chr15	GABRB3	137192.0 | GABRB3, ECA5, DEE43 | Gamma-aminobutyric acid (GABA) A receptor, beta-3 | 2562.0 | ENSG00000166206 | nan | {Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3); Developmental and epileptic encephalopathy 43, 617113 (3), Autosomal dominant
chr15	GABRA5	137142.0 | GABRA5, DEE79 | Gamma-aminobutyric acid (GABA) A receptor, alpha-5 | 2558.0 | ENSG00000186297 | 100kb from GABRB3 | Developmental and epileptic encephalopathy 79, 618559 (3), Autosomal dominant
chr15	GABRG3	600233.0 | GABRG3 | Gamma-aminobutyric acid (GABA) A receptor, gamma-3 | 2567.0 | ENSG00000182256 | cen--G3--A5--B3 | nan
chr15	OCA2	611409.0 | OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1 | Pink-eye dilution, murine, homolog of (oculocutaneous albinism II) | 4948.0 | ENSG00000104044 | ?hypopigmentation in PWS and AS | [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; Albinism, brown oculocutaneous, 203200 (3), Autosomal recessive; Albinism, oculocutaneous, type II, 203200 (3), Autosomal recessive
chr15	B2MR	109710.0 | B2MR | Beta-2-microglobulin regulator | 568.0 | nan | nan | nan
chr15	CILD4	608646.0 | CILD4 | Ciliary dyskinesia, primary, 4 | 408257.0 | nan | between D15S1012 and D15S1048 | Ciliary dyskinesia, primary, 4, 608646 (2), Autosomal recessive
chr15		601228.0 | HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq | Polyposis syndrome, hereditary mixed 1 | nan | nan | duplication of 40kb of 15q resulting in overexpression of GREM1 | Polyposis syndrome, hereditary mixed 1, 601228 (4), Autosomal dominant; {Colorectal cancer, susceptibility to, 4}, 601228 (4), Autosomal dominant
chr15	SCZD13	613025.0 | SCZD13 | Schizophrenia 13 | 100329170.0 | nan | associated with deletion at 15q13.3 | {Schizophrenia, susceptibility to, 13}, 613025 (2)
chr15	ATD	208500.0 | SRTD1, ATD1 | Short-rib thoracic dysplasia 1 with or without polydactyly | 465.0 | nan | nan | Short-rib thoracic dysplasia 1 with or without polydactyly, 208500 (2), Autosomal recessive
chr15	HERC2	605837.0 | HERC2, SHEP1, MRT38 | HECT domain and RCC1-like domain 2 | 8924.0 | ENSG00000128731 | mutations in intron 4 | Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive
chr15	APBA2	602712.0 | APBA2 | Amyloid beta A4 precursor protein-binding, family A, member 2 | 321.0 | ENSG00000034053 | nan | nan
chr15	ENTREP2	620052.0 | ENTREP2, TMEM228, FAM189A1, KIAA0574 | Endosomal transmembrane epsin interactor 2 | 23359.0 | ENSG00000104059 | nan | nan
chr15	NSMCE3	608243.0 | NSMCE3, NDNL2, MAGEG1, LICS | NSE3 homolog, SMC5-SMC6 complex component | 56160.0 | ENSG00000185115 | nan | Lung disease, immunodeficiency, and chromosome breakage syndrome, 617241 (3), Autosomal recessive
chr15	TJP1	601009.0 | TJP1 | Tight junction protein 1 (zona occludens 1) | 7082.0 | ENSG00000104067 | nan | nan
chr15	CHRFAM7A	609756.0 | CHRFAM7A | CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion | 89832.0 | ENSG00000166664 | nan | nan
chr15	ARHGAP11B	616310.0 | ARHGAP11B, FAM7B1 | RHO GTPase-activating protein 11B | 89839.0 | ENSG00000285077 | nan | nan
chr15		612001.0 | DEL15q13.3, MICRODEL15q13.3 | Chromosome 15q13.3 microdeletion syndrome | nan | nan | nan | Chromosome 15q13.3 microdeletion syndrome, 612001 (4)
chr15	FAN1	613534.0 | FAN1, MTMR15, KIAA1018, KMIN | FANCD2/FANCI-associated nuclease 1 | 22909.0 | ENSG00000198690 | nan | Interstitial nephritis, karyomegalic, 614817 (3), Autosomal recessive
chr15	TRPM1	603576.0 | TRPM1, MLSN1, CSNB1C | Transient receptor potential cation channel, subfamily M, member 1 (melastatin) | 4308.0 | ENSG00000134160 | nan | Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3), Autosomal recessive
chr15	MIR211	613753.0 | MIR211, MIRN211 | Micro RNA 211 | 406993.0 | ENSG00000207702 | nan | nan
chr15	KLF13	605328.0 | KLF13, RFLAT1, FKLF2 | Kruppel-like factor 13 | 51621.0 | ENSG00000169926 | nan | nan
chr15	OTUD7A	612024.0 | OTUD7A, OTUD7, C16orf15, CEZANNE2, NEDHS | OTU domain-containing protein 7A | 161725.0 | ENSG00000169918 | nan | Neurodevelopmental disorder with hypotonia and seizures, 620790 (3), Autosomal recessive
chr15	CHRNA7	118511.0 | CHRNA7 | Cholinergic receptor, nicotinic, alpha polypeptide-7 | 1139.0 | ENSG00000175344 | nan | nan
chr15	ARHGAP11A	610589.0 | ARHGAP11A, KIAA0013 | RHO GTPase-activating protein 11A | 9824.0 | ENSG00000198826 | nan | nan
chr15	SCG5	173120.0 | SCG5, SGNE1 | Secretogranin V (7B2 protein ) | 6447.0 | ENSG00000166922 | nan | nan
chr15	GREM1	603054.0 | GREM1, CKTSF1B1 | Gremlin 1, DAN family BMP antagonist | 26585.0 | ENSG00000166923 | nan | nan
chr15	FMN1	136535.0 | FMN, LD | Formin (limb deformity) | 342184.0 | ENSG00000248905 | nan | nan
chr15	RYR3	180903.0 | RYR3, CMYO20 | Ryanodine receptor-3 | 6263.0 | ENSG00000198838 | nan | Congenital myopathy 20, 620310 (3), Autosomal recessive
chr15		616898.0 | DEL15q14, C15DELq14 | Chromosome 15q14 deletion syndrome | nan | nan | nan | Chromosome 15q14 deletion syndrome, 616898 (4), Autosomal dominant
chr15	EJM2	604827.0 | EIG7, EJM2 | Epilepsy, idiopathic generalized, susceptibility to, 7 | 50715.0 | nan | ?role of CHRNA7 | {Epilepsy, idiopathic generalized, susceptibility to, 7}, 604827 (2), Isolated cases; Epilepsy, juvenile myoclonic, 604827 (2), Isolated cases
chr15	CHRM5	118496.0 | CHRM5 | Cholinergic receptor, muscarinic, 5 | 1133.0 | ENSG00000184984 | nan | nan
chr15	AVEN	605265.0 | AVEN | Cell death regulator AVEN | 57099.0 | ENSG00000169857 | nan | nan
chr15	EMC7	620631.0 | EMC7 | Endoplasmic reticulum membrane protein complex, subunit 7 | 56851.0 | ENSG00000134153 | nan | nan
chr15	KATNBL1	616235.0 | KATNBL1, C15orf29 | Katanin, p80 subunit, B-like 1 | 79768.0 | ENSG00000134152 | nan | nan
chr15	EMC4	616245.0 | EMC4, TMEM85, PIG17 | ER membrane protein complex subunit 4 | 51234.0 | ENSG00000128463 | nan | nan
chr15	SLC12A6	604878.0 | SLC12A6, KCC3A, KCC3B, KCC3, ACCPN, CMT2II | Solute carrier family 12 (potassium/chloride transporters), member 6 | 9990.0 | ENSG00000140199 | nan | Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2II, 620068 (3), Autosomal dominant
chr15	NOP10	606471.0 | NOP10, NOLA3, DKCB1, PFBMFT9, CHINE2 | NOP10 ribonucleoprotein | 55505.0 | ENSG00000182117 | mutation identified in 1 PFBMFT9 family and 1 DKCB1 family and 1 CHINE2 family | ?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 9, 620400 (3), Autosomal dominant; ?Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 2, 620425 (3), Autosomal recessive; ?Dyskeratosis congenita, autosomal recessive 1, 224230 (3), Autosomal recessive
chr15	NUTM1	608963.0 | NUTM1 | NUT midline carcinoma family member 1 | 256646.0 | ENSG00000184507 | nan | nan
chr15	LPCAT4	612039.0 | AGPAT7, AYTL3 | 1-acylglycerol-3-phosphate O-acyltransferase 7 | 254531.0 | ENSG00000176454 | nan | nan
chr15	GOLGA8A	616180.0 | GOLGA8A, KIAA0855 | Golgin A8 family, member A | 23015.0 | ENSG00000175265 | nan | nan
chr15	GOLGA8B	609619.0 | GOLGA8B, KIAA0855 | Golgin A8 family, member B | 440270.0 | ENSG00000215252 | nan | nan
chr15	GJD2	607058.0 | GJD2, GJA9, CX36 | Gap junction protein, delta-2 (connexin 36) | 57369.0 | ENSG00000159248 | nan | nan
chr15	ACTC1	102540.0 | ACTC1, CMD1R, CMH11, ASD5, LVNC4 | Actin, alpha, cardiac muscle | 70.0 | ENSG00000159251 | nan | Left ventricular noncompaction 4, 613424 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 11, 612098 (3), Autosomal dominant; Atrial septal defect 5, 612794 (3), Autosomal dominant; Cardiomyopathy, dilated, 1R, 613424 (3), Autosomal dominant
chr15	AQR	610548.0 | AQR, IBP160, KIAA0560 | Aquarius, mouse, homolog of | 9716.0 | ENSG00000021776 | nan | nan
chr15	DPH6	618391.0 | DPH6 | Diphthamide biosynthesis protein 6 | 89978.0 | ENSG00000134146 | nan | nan
chr15	CDIN1	615626.0 | CDIN1, C15orf41 | CDAN1-interacting nuclease 1 | 84529.0 | ENSG00000186073 | nan | Dyserythropoietic anemia, congenital, type Ib, 615631 (3), Autosomal recessive
chr15	MEIS2	601740.0 | MEIS2, MRG1, CPCMR | Meis homeobox 2 | 4212.0 | ENSG00000134138 | nan | Cleft palate, cardiac defects, and impaired intellectual development, 600987 (3), Autosomal dominant
chr15	SPRED1	609291.0 | SPRED1, NFLS, LGSS | Sprouty-related EVH1 domain-containing protein 1 | 161742.0 | ENSG00000166068 | nan | Legius syndrome, 611431 (3), Autosomal dominant
chr15	FAM98B	616142.0 | FAM98B | Family with sequence similarity 98, member B | 283742.0 | ENSG00000171262 | nan | nan
chr15	RASGRP1	603962.0 | RASGRP1, IMD64 | Ras guanyl nucleotide releasing protein-1 | 10125.0 | ENSG00000172575 | nan | Immunodeficiency 64, 618534 (3), Autosomal recessive
chr15	THBS1	188060.0 | THBS1 | Thrombospondin 1 | 7057.0 | ENSG00000137801 | nan | nan
chr15	FSIP1	615795.0 | FSIP1, HSD10 | Fibrous sheath-interacting protein 1 | 161835.0 | ENSG00000150667 | nan | nan
chr15	GPR176	612183.0 | GPR176 | G protein-coupled receptor 176 | 11245.0 | ENSG00000166073 | nan | nan
chr15	SCZD10	605419.0 | SCZD10 | Schizophrenia 10 | 63944.0 | nan | between D15S1042 and D15S659 | {Schizophrenia 10}, 605419 (2), Autosomal dominant
chr15	EIF2AK4	609280.0 | EIF2AK4, GCN2, KIAA1338, PVOD2 | Eukaryotic translation initiation factor 2-alpha kinase 4 | 440275.0 | ENSG00000128829 | nan | Pulmonary venoocclusive disease 2, 234810 (3), Autosomal recessive
chr15	SRP14	600708.0 | SRP14, ALURBP | Signal recognition particle, 14kD | 6727.0 | ENSG00000140319 | nan | nan
chr15	BMF	606266.0 | BMF | BCL2-modifying factor | 90427.0 | ENSG00000104081 | nan | nan
chr15	BUB1B	602860.0 | BUB1B, BUBR1, MVA1 | BUB1 mitotic checkpoint serine/threonine kinase B | 701.0 | ENSG00000156970 | nan | Colorectal cancer, somatic, 114500 (3); [Premature chromatid separation trait], 176430 (3), Autosomal dominant; Mosaic variegated aneuploidy syndrome 1, 257300 (3), Autosomal recessive
chr15	PAK6	608110.0 | PAK6 | p21-activated kinase 6 | 56924.0 | ENSG00000137843 | nan | nan
chr15	PLCB2	604114.0 | PLCB2 | Phospholipase C, beta-2 | 5330.0 | ENSG00000137841 | nan | Platelet PLC beta-2 deficiency (1)
chr15	DISP2	607503.0 | DISP2, DISPB, KIAA1742 | Dispatched RND transporter family, member 2 | 85455.0 | ENSG00000140323 | nan | nan
chr15	KNSTRN	614718.0 | KNSTRN, C15orf23, SKAP, ROCHIS | Kinetochore-localized astrin/SPAG5 binding protein | 90417.0 | ENSG00000128944 | mutation identified in 1 ROCHIS family | ?Roifman-Chitayat syndrome, digenic, 613328 (3), Digenic recessive
chr15	IVD	607036.0 | IVD | Isovaleryl Coenzyme A dehydrogenase | 3712.0 | ENSG00000128928 | nan | Isovaleric acidemia, 243500 (3), Autosomal recessive
chr15	BAHD1	613880.0 | BAHD1, KIAA0945 | BROMO-adjacent homology domain-containing protein 1 | 22893.0 | ENSG00000140320 | nan | nan
chr15	CHST14	608429.0 | CHST14, D4ST1, ATCS, EDSMC1 | Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14 | 113189.0 | ENSG00000169105 | nan | Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3), Autosomal recessive
chr15	CCDC32	618941.0 | CCDC32, CFNDS, C15orf57 | Coiled-coil domain-containing protein 32 | 90416.0 | ENSG00000128891 | nan | Cardiofacioneurodevelopmental syndrome, 619123 (3), Autosomal recessive
chr15	KNL1	609173.0 | KNL1, CASC5, AF15Q14, KIAA1570, D40, MCPH4 | Kinetochore scaffold 1 | 57082.0 | ENSG00000137812 | nan | Microcephaly 4, primary, autosomal recessive, 604321 (3), Autosomal recessive
chr15	RAD51	179617.0 | RAD51, RECA, MRMV2, FANCR | RAD51 recombinase | 5888.0 | ENSG00000051180 | nan | Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant
chr15	RMDN3	611873.0 | RMDN3, FAM82A2, FAM82C, RMD3, PTPIP51 | Regulator of microtubule dynamics 3 | 55177.0 | ENSG00000137824 | nan | nan
chr15	GCHFR	602437.0 | GCHFR, GFRP | GTP cyclohydrolase I feedback regulatory protein | 2644.0 | ENSG00000137880 | nan | nan
chr15	DNAJC17	616844.0 | DNAJC17 | DNAJ/HSP40 homolog, subfamily C, member 17 | 55192.0 | ENSG00000104129 | nan | nan
chr15	ZFYVE19	619635.0 | ZFYVE19, ANCHR, PFIC9 | Zinc finger FYVE domain-containing protein 19 | 84936.0 | ENSG00000166140 | nan | Cholestasis, progressive familial intrahepatic, 9, 619849 (3), Autosomal recessive
chr15	PPP1R14D	613256.0 | PPP1R14D, GBPI1 | Protein phosphatase 1, regulatory subunit 14D | 54866.0 | ENSG00000166143 | nan | nan
chr15	SPINT1	605123.0 | SPINT1, HAI | Serine peptidase inhibitor, Kunitz-type, 1 | 6692.0 | ENSG00000166145 | nan | nan
chr15	RHOV	620101.0 | RHOV, CHP | Ras homolog family, member V | 171177.0 | ENSG00000104140 | nan | nan
chr15	VPS18	608551.0 | VPS18 | VPS18 core subunit of CORVET and HOPS complexes | 57617.0 | ENSG00000104142 | nan | nan
chr15	DLL4	605185.0 | DLL4, AOS6 | Delta-like canonical Notch ligand 4 | 54567.0 | ENSG00000128917 | nan | Adams-Oliver syndrome 6, 616589 (3), Autosomal dominant
chr15	CHAC1	614587.0 | CHAC1 | ChaC, E. coli, homolog of, 1 | 79094.0 | ENSG00000128965 | nan | nan
chr15	INO80	610169.0 | INO80, INOC1 | INO80 complex, ATPase subunit | 54617.0 | ENSG00000128908 | nan | nan
chr15	CHP1	606988.0 | CHP1, SPAX9 | Calcineurin like EF-hand protein 1 | 11261.0 | ENSG00000187446 | mutation identified in 1 SPAX9 family | ?Spastic ataxia 9, autosomal recessive, 618438 (3), Autosomal recessive
chr15	OIP5	606020.0 | OIP5, MIS18B | OPA-interacting protein 5 | 11339.0 | ENSG00000104147 | nan | nan
chr15	NUSAP1	612818.0 | NUSAP1, ANKT, NUSAP | Nucleolar and spindle-associated protein 1 | 51203.0 | ENSG00000137804 | nan | nan
chr15	NDUFAF1	606934.0 | NDUFAF1, CIA30, CGI65, MC1DN11 | NADH-ubiquinone oxidoreductase complex assembly factor 1 | 51103.0 | ENSG00000137806 | nan | Mitochondrial complex I deficiency, nuclear type 11, 618234 (3), Autosomal recessive
chr15	RTF1	611633.0 | RTF1, KIAA0252 | RTF1, S. cerevisiae, homolog of | 23168.0 | ENSG00000137815 | nan | nan
chr15	ITPKA	147521.0 | ITPKA | Inositol 1,4,5-trisphosphate 3-kinase A | 3706.0 | ENSG00000137825 | nan | nan
chr15	LTK	151520.0 | LTK, TYK1 | Leukocyte tyrosine kinase | 4058.0 | ENSG00000062524 | nan | nan
chr15	RPAP1	611475.0 | RPAP1, KIAA1403 | RNA polymerase II-associated protein 1 | 26015.0 | ENSG00000103932 | nan | nan
chr15	TYRO3	600341.0 | TYRO3 | TYRO3 protein tyrosine kinase | 7301.0 | ENSG00000092445 | nan | nan
chr15	MGA	616061.0 | MGA, KIAA0518 | MAX dimerization protein MGA | 23269.0 | ENSG00000174197 | nan | nan
chr15	MAPKBP1	616786.0 | MAPKBP1, JNKBP1, NPHP20 | Mitogen-activated protein kinase-binding protein 1 | 23005.0 | ENSG00000137802 | nan | Nephronophthisis 20, 617271 (3), Autosomal recessive
chr15	PLA2G4B	606088.0 | PLA2G4B | Phospholipase A2, group IVB | 100137049.0 | ENSG00000243708 | nan | nan
chr15	SPTBN5	605916.0 | SPTBN5, BSPECV | Spectrin, beta, non-erythrocytic 5 | 51332.0 | ENSG00000137877 | nan | nan
chr15	EHD4	605892.0 | EHD4 | EH domain-containing 4 | 30844.0 | ENSG00000103966 | nan | nan
chr15	PLA2G4E	620649.0 | PLA2G4E | Phospholipase A2, group IVe | 123745.0 | ENSG00000188089 | nan | nan
chr15	PLA2G4D	612864.0 | PLA2G4D | Phospholipase A2, Group IVD | 283748.0 | ENSG00000159337 | nan | nan
chr15	VPS39	612188.0 | VPS39, VAM6, TLP, KIAA0770 | VPS39 subunit of HOPS complex | 23339.0 | ENSG00000166887 | nan | nan
chr15	GANC	104180.0 | GANC | Neutral alpha-glucosidase C | 2595.0 | ENSG00000214013 | nan | nan
chr15	CAPN3	114240.0 | CAPN3, CANP3, LGMDR1, LGMDD4 | Calpain, large polypeptide L3 | 825.0 | ENSG00000092529 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 1, 253600 (3), Autosomal recessive; Muscular dystrophy, limb-girdle, autosomal dominant 4, 618129 (3), Autosomal dominant
chr15	ZNF106	603988.0 | ZNF106, SH3BP3, ZNF474 | Zinc finger protein 106 | 64397.0 | ENSG00000103994 | nan | nan
chr15	SNAP23	602534.0 | SNAP23 | Synaptosomal-associated protein, 23kD | 8773.0 | ENSG00000092531 | nan | nan
chr15	HAUS2	613429.0 | HAUS2, CEP27 | HAUS augmin-like complex, subunit 2 | 55142.0 | ENSG00000137814 | nan | nan
chr15	STARD9	614642.0 | STARD9, KIAA1300 | START domain-containing protein 9 | 57519.0 | ENSG00000159433 | nan | nan
chr15	CDAN1	607465.0 | CDAN1, CDA1, CDAN1A | Codanin 1 | 146059.0 | ENSG00000140326 | nan | Dyserythropoietic anemia, congenital, type Ia, 224120 (3), Autosomal recessive
chr15	TTBK2	611695.0 | TTBK2, SCA11 | Tau tubulin kinase 2 | 146057.0 | ENSG00000128881 | nan | Spinocerebellar ataxia 11, 604432 (3), Autosomal dominant
chr15	UBR1	605981.0 | UBR1, JBS | Ubiquitin-protein ligase E3-alpha | 197131.0 | ENSG00000159459 | nan | Johanson-Blizzard syndrome, 243800 (3), Autosomal recessive
chr15	CCNDBP1	607089.0 | CCNDBP1, GCIP | Cyclin D-type-binding protein 1 | 23582.0 | ENSG00000166946 | nan | nan
chr15	EPB42	177070.0 | EPB42, SPH5 | Erythrocyte surface protein band 4.2 | 2038.0 | ENSG00000166947 | nan | Spherocytosis, type 5, 612690 (3)
chr15	TGM5	603805.0 | TGM5, TGX, PSS2 | Transglutaminase 5 | 9333.0 | ENSG00000104055 | nan | Peeling skin syndrome 2, 609796 (3), Autosomal recessive
chr15	TGM7	606776.0 | TGM7, TGMZ | Transglutaminase 7 | 116179.0 | ENSG00000159495 | nan | nan
chr15		611102.0 | DEL15q15.3, C15DELq15.3 | Chromosome 15q15.3 deletion syndrome | nan | nan | nan | Deafness and male infertility, 611102 (4), Autosomal recessive
chr15	LCMT2	611246.0 | LCMT2, TYW4, KIAA0547 | Leucine carboxyl methyltransferase 2 | 9836.0 | ENSG00000168806 | nan | nan
chr15	MAPDA	619346.0 | ADAL | Adenosine deaminase-like protein | 161823.0 | ENSG00000168803 | nan | nan
chr15	ZSCAN29	620932.0 | ZSCAN29, ZFP690 | Zinc finger- and SCAN domain-containing protein 29 | 146050.0 | ENSG00000140265 | nan | nan
chr15	TUBGCP4	609610.0 | TUBGCP4, GCP4, MCCRP3 | Tubulin-gamma complex-associated protein 4 | 27229.0 | ENSG00000137822 | nan | Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive
chr15	TP53BP1	605230.0 | TP53BP1, 53BP1 | Tumor protein p53-binding protein-1 | 7158.0 | ENSG00000067369 | nan | nan
chr15	MAP1A	600178.0 | MAP1A, MAP1L | Microtubule-associated protein 1A | 4130.0 | ENSG00000166963 | nan | nan
chr15	PPIP5K1	610979.0 | PPIP5K1, HISPPD2A, IPS1, KIAA0377 | Diphosphoinositol pentakisphosphate kinase 1 | 9677.0 | ENSG00000168781 | nan | nan
chr15	CKMT1B	123290.0 | CKMT1B, CKMT1 | Creatine kinase, mitochondrial 1B | 1159.0 | ENSG00000237289 | centromeric to CKMT1A | nan
chr15	STRC	606440.0 | STRC, DFNB16 | Stereocilin | 161497.0 | ENSG00000242866 | nan | Deafness, autosomal recessive 16, 603720 (3), Autosomal recessive
chr15	CATSPER2	607249.0 | CATSPER2 | Cation channel, sperm-associated, 2 | 117155.0 | ENSG00000166762 | in region with tandem duplication containing a CATSPER2 pseudogene | nan
chr15	CKMT1A	613415.0 | CKMT1A | Creatine kinase, mitochondrial 1A | 548596.0 | ENSG00000223572 | telomeric to CKMT1B | nan
chr15	PDIA3	602046.0 | GRP58 | Glucose regulated protein, 58kD | 2923.0 | ENSG00000167004 | nan | nan
chr15	ELL3	609885.0 | ELL3 | Elongation factor, RNA polymerase II, 3 | 80237.0 | ENSG00000128886 | nan | nan
chr15	SERF2	605054.0 | SERF2, H4F5REL | Small EDRK-rich factor 2 | 10169.0 | ENSG00000140264 | nan | nan
chr15	SERINC4	614550.0 | SERINC4 | Serine incorporator 4 | 619189.0 | ENSG00000184716 | nan | nan
chr15	HYPK	612784.0 | HYPK | Huntingtin-interacting protein K | 25764.0 | ENSG00000242028 | nan | nan
chr15	MFAP1	600215.0 | MFAP1 | Microfibrillar-associated protein-1 | 4236.0 | ENSG00000140259 | nan | nan
chr15	WDR76	620302.0 | WDR76, CMR1 | WD repeat-containing protein 76 | 79968.0 | ENSG00000092470 | nan | nan
chr15	FRMD5	616309.0 | FRMD5, NEDEMA | FERM domain-containing protein 5 | 84978.0 | ENSG00000171877 | nan | Neurodevelopmental disorder with eye movement abnormalities and ataxia, 620094 (3), Autosomal dominant
chr15	CTDSPL2	618739.0 | CTDSPL2, SCP4 | CTD small phosphatase-like protein 2 | 51496.0 | ENSG00000137770 | nan | nan
chr15	CTRCT25	605728.0 | CTRCT25, CCSSO | Cataract 25 | 80770.0 | nan | nan | Cataract 25, 605728 (2)
chr15	EIF3J	603910.0 | EIF3J, EIF3S1 | Eukaryotic translation initiation factor 3, subunit J | 8669.0 | ENSG00000104131 | nan | nan
chr15	SPG11	610844.0 | SPG11, KIAA1840, FLJ21439, ALS5, CMT2X | SPG11 vesicle trafficking associated, spatacsin | 80208.0 | ENSG00000104133 | nan | Amyotrophic lateral sclerosis 5, juvenile, 602099 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3), Autosomal recessive; Spastic paraplegia 11, autosomal recessive, 604360 (3), Autosomal recessive
chr15	PATL2	614661.0 | PATL2, PAT1A, OZEMA4 | PAT1 homolog 2 | 197135.0 | ENSG00000229474 | nan | Oocyte/zygote/embryo maturation arrest 4, 617743 (3), Autosomal recessive
chr15	B2M	109700.0 | B2M, IMD43, AMYLD6, MHC1D4 | Beta-2-microglobulin | 567.0 | ENSG00000166710 | nan | Amyloidosis, hereditary systemic 6, 620659 (3); Immunodeficiency 43, 241600 (3), Autosomal recessive
chr15	TRIM69	616017.0 | TRIM69, TRIF, RNF36 | Tripartite motif-containing protein 69 | 140691.0 | ENSG00000185880 | nan | nan
chr15	TERB2	617131.0 | TERB2, C15orf43, SPGF59 | Telomere repeat-binding bouquet formation protein 2 | 145645.0 | ENSG00000167014 | mutation identified in 1 SPGF59 family | ?Spermatogenic failure 59, 619645 (3), Autosomal recessive
chr15	SORD	182500.0 | SORD, SORD1, HMNR8 | Sorbitol dehydrogenase | 6652.0 | ENSG00000140263 | nan | Neuronopathy, distal hereditary motor, autosomal recessive 8, 618912 (3), Autosomal recessive
chr15	DUOX2	606759.0 | DUOX2, THOX2, TDH6 | Dual oxidase 2 (thyroid oxidase 2) | 50506.0 | ENSG00000140279 | nan | Thyroid dyshormonogenesis 6, 607200 (3), Autosomal recessive
chr15	DUOXA2	612772.0 | DUOXA2, TDH5 | Dual oxidase maturation factor 2 | 405753.0 | ENSG00000140274 | head-to-head with DUOX2 | Thyroid dyshormonogenesis 5, 274900 (3), Autosomal recessive
chr15	DUOXA1	612771.0 | DUOXA1 | Dual oxidase maturation factor 1 | 90527.0 | ENSG00000140254 | tail-to-tail with DUOXA2 | nan
chr15	DUOX1	606758.0 | DUOX1, THOX1 | Dual oxidase 1 (thyroid oxidase 1) | 53905.0 | ENSG00000137857 | nan | nan
chr15	SHF	617313.0 | SHF | SH2 domain-containing adaptor protein F | 90525.0 | ENSG00000138606 | nan | nan
chr15	SLC28A2	606208.0 | SLC28A2, CNT2, SPNT1 | Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 | 9153.0 | ENSG00000137860 | nan | nan
chr15	GATM	602360.0 | GATM, AGAT, CCDS3, FRTS1 | L-arginine:glycine amidinotransferase | 2628.0 | ENSG00000171766 | nan | Cerebral creatine deficiency syndrome 3, 612718 (3), Autosomal recessive; Fanconi renotubular syndrome 1, 134600 (3), Autosomal dominant
chr15	AFG2B	619578.0 | AFG2B, SPATA5L1, DFNB119, NEDHLS | AFG2 AAA ATPase homolog B | 79029.0 | ENSG00000171763 | nan | Deafness, autosomal recessive 119, 619615 (3), Autosomal recessive; Neurodevelopmental disorder with hearing loss and spasticity, 619616 (3), Autosomal recessive
chr15	C15orf48	608409.0 | C15orf48, NMES1 | Chromosome 15 open reading frame 48 | 84419.0 | ENSG00000166920 | nan | nan
chr15	SLC30A4	602095.0 | SLC30A4, ZNT4 | Solute carrier family 30 (zinc transporter), member 4 | 7782.0 | ENSG00000104154 | nan | nan
chr15	HMGN2P46	611314.0 | HMGN2P46, C15orf21 | High mobility group nucleosomal binding domain 2 pseudogene 46 | 283651.0 | nan | nan | nan
chr15	BLOC1S6	604310.0 | BLOC1S6, BLOS6, PLDN, PA, HPS9 | Biogenesis of lysosome-related organelles complex 1, subunit 6 | 26258.0 | ENSG00000104164 | nan | Hermansky-Pudlak syndrome 9, 614171 (3), Autosomal recessive
chr15	SQOR	617658.0 | SQOR, SQRDL | Sulfide quinone oxidoreductase | 58472.0 | ENSG00000137767 | nan | Sulfide:quinone oxidoreductase deficiency, 619221 (3), Autosomal recessive
chr15	SEMA6D	609295.0 | SEMA6D, KIAA1479 | Semaphorin 6D | 80031.0 | ENSG00000137872 | nan | nan
chr15	SLC24A5	609802.0 | SLC24A5, NCKX5, SHEP4, OCA6 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5 | 283652.0 | ENSG00000188467 | nan | [Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3), Autosomal recessive; Albinism, oculocutaneous, type VI, 113750 (3), Autosomal recessive
chr15	MYEF2	619395.0 | MYEF2, KIAA1341 | Myelin expression factor 2 | 50804.0 | ENSG00000104177 | nan | nan
chr15	SLC12A1	600839.0 | SLC12A1, NKCC2 | Solute carrier family 12 (sodium/potassium/chloride transporters), member 1 | 6557.0 | ENSG00000074803 | nan | Bartter syndrome, type 1, 601678 (3), Autosomal recessive
chr15	DUT	601266.0 | DUT, BMFDMS | dUTP pyrophosphatase | 1854.0 | ENSG00000128951 | nan | Bone marrow failure and diabetes mellitus syndrome, 620044 (3), Autosomal recessive
chr15	FBN1	134797.0 | FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS | Fibrillin-1 | 2200.0 | ENSG00000166147 | nan | Geleophysic dysplasia 2, 614185 (3), Autosomal dominant; Weill-Marchesani syndrome 2, dominant, 608328 (3), Autosomal dominant; Ectopia lentis, familial, 129600 (3), Autosomal dominant; MASS syndrome, 604308 (3), Autosomal dominant; Marfan lipodystrophy syndrome, 616914 (3), Autosomal dominant; Acromicric dysplasia, 102370 (3), Autosomal dominant; Marfan syndrome, 154700 (3), Autosomal dominant; Stiff skin syndrome, 184900 (3), Autosomal dominant
chr15	CEP152	613529.0 | CEP152, KIAA0912, MCPH9, SCKL5 | Centrosomal protein, 152kD | 22995.0 | ENSG00000103995 | nan | Microcephaly 9, primary, autosomal recessive, 614852 (3), Autosomal recessive; Seckel syndrome 5, 613823 (3), Autosomal recessive
chr15	SHC4	617372.0 | SHC4, RALP, SHCD | SHC transforming protein 4 | 399694.0 | ENSG00000185634 | nan | nan
chr15	EID1	605894.0 | EID1, CRI1, C15orf3 | EP300-interacting inhibitor of differentiation 1 | 23741.0 | ENSG00000255302 | nan | nan
chr15	SECISBP2L	615756.0 | SECISBP2L, SBP2L, KIAA0256 | Selenocysteine insertion sequence-binding protein 2-like | 9728.0 | ENSG00000138593 | nan | nan
chr15	COPS2	604508.0 | TRIP15, SGN2, COPS2 | Thyroid hormone receptor interactor-15 | 9318.0 | ENSG00000166200 | nan | nan
chr15	GALK2	137028.0 | GALK2, GK2 | Galactokinase-2 | 2585.0 | ENSG00000156958 | nan | nan
chr15	FGF7	148180.0 | FGF7 | Fibroblast growth factor-7 (keratinocyte growth factor) | 2252.0 | ENSG00000140285 | nan | nan
chr15	ATP8B4	609123.0 | ATP8B4, KIAA1939 | ATPase, class I, type 8B, member 4 | 79895.0 | ENSG00000104043 | nan | nan
chr15	SLC27A2	603247.0 | SLC27A2, FACVL1, VLACS | Solute carrier family 27 (fatty acid transporter), member 2 (fatty acid CoA ligase, very long-chain 1) | 11001.0 | ENSG00000140284 | nan | nan
chr15	HDC	142704.0 | HDC | Histidine decarboxylase | 3067.0 | ENSG00000140287 | nan | {Gilles de la Tourette syndrome, susceptibility to}, 137580 (3), Autosomal dominant
chr15	GABPB1	600610.0 | GABPB, BABPB2, GABPB1, E4TF1B, NRF2B1 | GA-binding protein transcription factor, beta subunit | 2553.0 | ENSG00000104064 | nan | nan
chr15	USP8	603158.0 | USP8, HUMORF8, PITA4 | Ubiquitin-specific protease 8 | 9101.0 | ENSG00000138592 | nan | Pituitary adenoma 4, ACTH-secreting, somatic, 219090 (3)
chr15	USP50	620563.0 | USP50 | Ubiquitin-specific peptidase 50 | 373509.0 | ENSG00000170236 | nan | nan
chr15	TRPM7	605692.0 | TRPM7, LTRPC7, CHAK, ALSPDC | Transient receptor potential cation channel, subfamily M, member 7 | 54822.0 | ENSG00000092439 | nan | {Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3), Autosomal dominant
chr15	SPPL2A	608238.0 | SPPL2A, IMP3, IMD86 | Signal peptide peptidase-like 2A | 84888.0 | ENSG00000138600 | nan | Immunodeficiency 86, mycobacteriosis, 619549 (3), Autosomal recessive
chr15	AP4E1	607244.0 | AP4E1, SPG51, CPSQ4, STUT1 | Adaptor-related protein complex 4, epsilon-1 subunit | 23431.0 | ENSG00000081014 | nan | Stuttering, familial persistent, 1, 184450 (3), Autosomal dominant; Spastic paraplegia 51, autosomal recessive, 613744 (3), Autosomal recessive
chr15	TNFAIP8L3	616438.0 | TNFAIP8L3, TIPE3 | Tumor necrosis factor-alpha-induced protein 8-like 3 | 388121.0 | ENSG00000183578 | nan | nan
chr15	CYP19A1	107910.0 | CYP19A1, CYP19, ARO | Cytochrome P450, family 19, subfamily A, polypeptide 1 (aromatization of androgens) | 1588.0 | ENSG00000137869 | close to CYP11 in mouse | Aromatase deficiency, 613546 (3); Aromatase excess syndrome, 139300 (3), Autosomal dominant
chr15	GLDN	608603.0 | GLDN, CRGL2, LCCS11 | Gliomedin | 342035.0 | ENSG00000186417 | nan | Lethal congenital contracture syndrome 11, 617194 (3), Autosomal recessive
chr15	DMXL2	612186.0 | DMXL2, RC3, KIAA0856, PEPNS, DFNA71, DEE81 | DMX-like 2 | 23312.0 | ENSG00000104093 | mutation identified in 1 PEPNS family and 1 DFNA71 family | Developmental and epileptic encephalopathy 81, 618663 (3), Autosomal recessive; ?Deafness, autosomal dominant 71, 617605 (3), Autosomal dominant; ?Polyendocrine-polyneuropathy syndrome, 616113 (3), Autosomal recessive
chr15	SCG3	611796.0 | SCG3 | Secretogranin III | 29106.0 | ENSG00000104112 | nan | nan
chr15	TMOD2	602928.0 | TMOD2 | Tropomodulin 2, neuronal | 29767.0 | ENSG00000128872 | nan | nan
chr15	TMOD3	605112.0 | TMOD3 | Tropomodulin 3 | 29766.0 | ENSG00000138594 | nan | nan
chr15	LEO1	610507.0 | LEO1, RDL | LEO1 RNA polymerase II associated factor, S. cerevisiae, homolog of | 123169.0 | ENSG00000166477 | nan | nan
chr15	MAPK6	602904.0 | MAPK6, PRKM6, ERK3 | Mitogen-activated protein kinase 6 | 5597.0 | ENSG00000069956 | nan | nan
chr15	BCL2L10	606910.0 | BCL2L10 | BCL2-like 10 | 10017.0 | ENSG00000137875 | nan | nan
chr15	GNB5	604447.0 | GNB5, GB5, LDMLS1, LDMLS2 | Guanine nucleotide-binding protein, beta-5 | 10681.0 | ENSG00000069966 | nan | Lodder-Merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia, 617182 (3), Autosomal recessive; Lodder-Merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia, 617173 (3), Autosomal recessive
chr15	MYO5C	610022.0 | MYO5C | Myosin Vc | 55930.0 | ENSG00000128833 | nan | nan
chr15	MYO5A	160777.0 | MYO5A, MYH12, GS1 | Myosin Va | 4644.0 | ENSG00000197535 | nan | Griscelli syndrome, type 1, 214450 (3), Autosomal recessive
chr15	ARPP19	605487.0 | ARPP19, ARPP16 | cAMP-regulated phosphoprotein 19 | 10776.0 | ENSG00000128989 | nan | nan
chr15	ATOSA	620168.0 | ATOSA, KIAA1370 | ATOS homolog A | 56204.0 | ENSG00000047346 | nan | nan
chr15	ONECUT1	604164.0 | ONECUT1, HNF6A, HNF6 | One cut domain, family member 1 (hepatocyte nuclear factor 6-alpha) | 3175.0 | ENSG00000169856 | nan | nan
chr15	WDR72	613214.0 | WDR72, AI2A3 | WD repeat-containing protein 72 | 256764.0 | ENSG00000166415 | nan | Amelogenesis imperfecta, type IIA3, 613211 (3), Autosomal recessive
chr15	UNC13C	614568.0 | UNC13C | unc-13 homolog C | 440279.0 | ENSG00000137766 | nan | nan
chr15	RSL24D1	613262.0 | RSL24D1, RLP24 | Ribosomal protein L24 domain-containing protein 1 | 51187.0 | ENSG00000137876 | nan | nan
chr15	RAB27A	603868.0 | RAB27A, RAM, GS2 | Ras-associated protein RAB27A | 5873.0 | ENSG00000069974 | nan | Griscelli syndrome, type 2, 607624 (3), Autosomal recessive
chr15	PIGBOS1	618809.0 | PIGBOS1 | PIGB opposite strand 1 | 101928527.0 | ENSG00000225973 | nan | nan
chr15	PIGB	604122.0 | PIGB, DEE80 | Phosphatidylinositol glycan, class B | 9488.0 | ENSG00000069943 | nan | Developmental and epileptic encephalopathy 80, 618580 (3), Autosomal recessive
chr15	CCPG1	611326.0 | CCPG1, KIAA1254, CPR8 | Cell cycle progression 1 | 9236.0 | ENSG00000260916 | nan | nan
chr15	PIERCE2	619669.0 | PIERCE2, C14orf65 | Piercer of microtubule wall 2 | 145788.0 | ENSG00000261652 | nan | nan
chr15	DNAAF4	608706.0 | DNAAF4, DYX1C1, DYXC1, DYX1, CILD25 | Dynein, axonemal, assembly factor 4 | 161582.0 | ENSG00000256061 | not confirmed by some studies | {Dyslexia, susceptibility to, 1}, 127700 (3), Autosomal dominant; Ciliary dyskinesia, primary, 25, 615482 (3), Autosomal recessive
chr15	PYGO1	606902.0 | PYGO1 | Pygopus, Drosophila, homolog of, 1 | 26108.0 | ENSG00000171016 | nan | nan
chr15	PRTG	613261.0 | PRTG | Protogenin | 283659.0 | ENSG00000166450 | nan | nan
chr15	NEDD4	602278.0 | NEDD4 | Neural precursor cell expressed, developmentally downregulated-4 | 4734.0 | ENSG00000069869 | nan | nan
chr15	RFX7	612660.0 | RFX7, RFXDC2, MRD71 | Regulatory factor X, 7 | 64864.0 | ENSG00000181827 | nan | Intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities, 620330 (3), Autosomal dominant
chr15	TEX9	620935.0 | TEX9 | Testis-expressed gene 9 | 374618.0 | ENSG00000151575 | nan | nan
chr15	MNS1	610766.0 | MNS1, FLJ11222, HTX9 | Meiosis-specific nuclear structural protein 1 | 55329.0 | ENSG00000138587 | nan | Heterotaxy, visceral, 9, autosomal, with male infertility, 618948 (3), Autosomal recessive
chr15	TCF12	600480.0 | TCF12, HTF4, CRS3, HH26 | Transcription factor-12 (HTF4, helix-loop-helix transcription factors-4) | 6938.0 | ENSG00000140262 | nan | Craniosynostosis 3, 615314 (3), Autosomal dominant; Hypogonadotropic hypogonadism 26 with or without anosmia, 619718 (3), Autosomal recessive, Autosomal dominant
chr15	CGNL1	607856.0 | CGNL1, FLJ14957, KIAA1749 | Cingulin-like 1 | 84952.0 | ENSG00000128849 | nan | nan
chr15	MYZAP	614071.0 | MYZAP, GCOM1, GUP, CMD2K | Myocardial zonula adherens protein | 100820829.0 | ENSG00000263155 | nan | Cardiomyopathy, dilated, 2K, 620894 (3), Autosomal recessive
chr15	POLR2M	606485.0 | POLR2M, GDOWN, GRINL1A | Polymerase II, RNA, subunit M | 81488.0 | ENSG00000255529 | nan | nan
chr15	ALDH1A2	603687.0 | ALDH1A2, RALDH2, DIH4 | Aldehyde dehydrogenase 1 family, member A2 (retinaldehyde dehydrogenase 2) | 8854.0 | ENSG00000128918 | nan | Diaphragmatic hernia 4, with cardiovascular defects, 620025 (3), Autosomal recessive
chr15	AQP9	602914.0 | AQP9 | Aquaporin 9 | 366.0 | ENSG00000103569 | nan | nan
chr15	LIPC	151670.0 | LIPC, HL, LIPH, HDLCQ12 | Lipase C, hepatic | 3990.0 | ENSG00000166035 | nan | {Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant; Hepatic lipase deficiency, 614025 (3), Autosomal recessive; [High density lipoprotein cholesterol level QTL 12], 612797 (3)
chr15	ADAM10	602192.0 | ADAM10, MADM, RAK, AD18 | ADAM metallopeptidase domain 10 | 102.0 | ENSG00000137845 | nan | {Alzheimer disease 18, susceptibility to}, 615590 (3); Reticulate acropigmentation of Kitamura, 615537 (3), Autosomal dominant
chr15	MINDY2	618408.0 | MINDY2, FAM63B | MINDY lysine-48 deubiquitinase 2 | 54629.0 | ENSG00000128923 | nan | nan
chr15	GLC1N	611274.0 | GLC1N | Glaucoma 1, open angle, N | 777645.0 | nan | max lod at D15S125 | Glaucoma 1, open angle, N, 611274 (2)
chr15	USH1H	612632.0 | USH1H | Usher syndrome, type 1H | 100271837.0 | nan | max lod at D15S980 | Usher syndrome, type 1H, 612632 (2)
chr15	SLTM	620992.0 | SLTM, MET | SAFB-like transcription modulator | 79811.0 | ENSG00000137776 | nan | nan
chr15	RNF111	605840.0 | RNF111 | Ring finger protein 111 | 54778.0 | ENSG00000157450 | nan | nan
chr15	CCNB2	602755.0 | CCNB2 | Cyclin B2 | 9133.0 | ENSG00000157456 | nan | nan
chr15	MYO1E	601479.0 | MYO1E, MYO1C, FSGS6 | Myosin IE | 4643.0 | ENSG00000157483 | nan | Glomerulosclerosis, focal segmental, 6, 614131 (3), Autosomal recessive
chr15	GCNT3	606836.0 | GCNT3 | Glucosaminyl (N-acetyl) transferase 3, mucin-type | 9245.0 | ENSG00000140297 | nan | nan
chr15	GTF2A2	600519.0 | GTF2A2, TF2A2 | General transcription factor IIA, gamma subunit | 2958.0 | ENSG00000140307 | pseudogenes on chr. 1, 8, 9 | nan
chr15	BNIP2	603292.0 | BNIP2, NIP2 | BCL2/adenovirus E1B 19kD protein-interacting protein 2 | 663.0 | ENSG00000140299 | nan | nan
chr15	FOXB1	619961.0 | FOXB1, FKH5 | Forkhead box B1 | 27023.0 | ENSG00000171956 | nan | nan
chr15	ANXA2	151740.0 | ANXA2, ANX2L4, LPC2D, LIP2 | Annexin A2 (lipocortin I) | 302.0 | ENSG00000182718 | pseudogenes ANX2P1 on 4q21-q31; ANX2P2 on 9p13; ANX2P3 on 10q24-q22 | nan
chr15	ICE2	610835.0 | NARG2 | NMDA receptor-regulated 2 | 79664.0 | ENSG00000128915 | pseudogenes on chr.4 and chr.3 | nan
chr15	RORA	600825.0 | RORA, IDDECA | RAR-related orphan receptor A | 6095.0 | ENSG00000069667 | nan | Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, 618060 (3), Autosomal dominant
chr15	VPS13C	608879.0 | VPS13C, KIAA1421, PARK23 | Vacuolar protein sorting 13 homolog C | 54832.0 | ENSG00000129003 | nan | Parkinson disease 23, autosomal recessive, early onset, 616840 (3), Autosomal recessive
chr15	C2CD4A	610343.0 | C2CD4A, NLF1 | C2 calcium-dependent domain containing 4A | 145741.0 | ENSG00000198535 | nan | nan
chr15	C2CD4B	610344.0 | C2CD4B, NLF2 | C2 calcium-dependent domain containing 4B | 388125.0 | ENSG00000205502 | nan | nan
chr15	TLN2	607349.0 | TLN2, KIAA0320 | Talin 2 | 83660.0 | ENSG00000171914 | nan | nan
chr15	MIR190A	615845.0 | MIR190A | Micro RNA 190A | 406965.0 | ENSG00000211137 | nan | nan
chr15	TPM1	191010.0 | TPM1, CMH3, CMD1Y , LVNC9 | Tropomyosin 1, alpha | 7168.0 | ENSG00000140416 | nan | Left ventricular noncompaction 9, 611878 (3), Autosomal dominant; Cardiomyopathy, hypertrophic, 3, 115196 (3), Autosomal dominant; Cardiomyopathy, dilated, 1Y, 611878 (3), Autosomal dominant
chr15	LACTB	608440.0 | LACTB | Lactamase, beta | 114294.0 | ENSG00000103642 | nan | nan
chr15	RPS27L	612055.0 | RPS27L | Ribosomal protein S27-like | 51065.0 | ENSG00000185088 | nan | nan
chr15	RAB8B	613532.0 | RAB8B | Ras-associated protein RAB8B | 51762.0 | ENSG00000166128 | nan | nan
chr15	APH1B	607630.0 | APH1B | Aph-1 homolog B, gamma-secretase subunit | 83464.0 | ENSG00000138613 | nan | nan
chr15	CA12	603263.0 | CA12 | Carbonic anhydrase XII | 771.0 | ENSG00000074410 | nan | Hyperchlorhidrosis, isolated, 143860 (3), Autosomal recessive
chr15	USP3	604728.0 | USP3 | Ubiquitin-specific protease 3 | 9960.0 | ENSG00000140455 | nan | nan
chr15	FBXL22	609088.0 | FBXL22, FBL22 | F-box and leucine-rich repeat protein 22 | 283807.0 | ENSG00000197361 | nan | nan
chr15	HERC1	605109.0 | HERC1, MDFPMR | HECT domain and RCC1-like domain 1 | 8925.0 | ENSG00000103657 | nan | Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3), Autosomal recessive
chr15	DAPK2	616567.0 | DAPK2, DRP1 | Death-associated protein kinase 2 | 23604.0 | ENSG00000035664 | nan | nan
chr15	CIAO2A	618382.0 | CIAO2A, CIA2A, FAM96A | Cytosolic iron-sulfur assembly component 2A | 84191.0 | ENSG00000166797 | nan | nan
chr15	SNX1	601272.0 | SNX1, SNX1A | Sorting nexin 1 | 6642.0 | ENSG00000028528 | nan | nan
chr15	PPIB	123841.0 | PPIB, CYPB, OI9 | Peptidyl-prolyl isomerase B | 5479.0 | ENSG00000166794 | nan | Osteogenesis imperfecta, type IX, 259440 (3), Autosomal recessive
chr15	CSNK1G1	606274.0 | CSNK1G1 | Casein kinase I, gamma-1 | 53944.0 | ENSG00000169118 | nan | nan
chr15	PCLAF	610696.0 | PAF, OEATC1, KIAA0101 | PCNA-associated factor, 15kD | 9768.0 | ENSG00000166803 | nan | nan
chr15	TRIP4	604501.0 | TRIP4, ASC1, SMABF1, MDCDC | Thyroid hormone receptor interactor 4 | 9325.0 | ENSG00000103671 | mutation identified in 1 MDCDC family | ?Muscular dystrophy, congenital, Davignon-Chauveau type, 617066 (3), Autosomal recessive; Spinal muscular atrophy with congenital bone fractures 1, 616866 (3), Autosomal recessive
chr15	ZNF609	617474.0 | ZNF609, KIAA0295 | Zinc finger ptoein 609 | 23060.0 | ENSG00000180357 | nan | nan
chr15	OAZ2	604152.0 | OAZ2 | Ornithine decarboxylase antizyme 2 | 4947.0 | ENSG00000180304 | nan | nan
chr15	RBPMS2	619034.0 | RBPMS2 | RNA-binding protein, mRNA-processing factor, 2 | 348093.0 | ENSG00000166831 | nan | nan
chr15	PIF1	610953.0 | PIF1, PIF | Pif1, S. cerevisiae, homolog of | 80119.0 | ENSG00000140451 | nan | nan
chr15	SPG21	608181.0 | ACP33, MAST, SPG21 | Acidic cluster protein, 33kD, (maspardin) | 51324.0 | ENSG00000090487 | nan | Mast syndrome, 248900 (3), Autosomal recessive
chr15	MTFMT	611766.0 | MTFMT, COXPD15, MC1DN27 | Mitochondrial methionyl-tRNA formyltransferase | 123263.0 | ENSG00000103707 | nan | Combined oxidative phosphorylation deficiency 15, 614947 (3), Autosomal recessive; Mitochondrial complex I deficiency, nuclear type 27, 618248 (3), Autosomal recessive
chr15	SLC51B	612085.0 | SLC51B, OSTB, PBAM2 | Solute carrier family 51, beta subunit (organic solute transporter, beta) | 123264.0 | ENSG00000186198 | mutation identified in 1 PBAM2 family | ?Bile acid malabsorption, primary, 2, 619481 (3), Autosomal recessive
chr15	KBTBD13	613727.0 | KBTBD13, NEM6 | Kelch repeat and BTB/POZ domains-containing protein 13 | 390594.0 | ENSG00000234438 | nan | Nemaline myopathy 6, autosomal dominant, 609273 (3), Autosomal dominant
chr15	PDCD7	608138.0 | PDCD7 | Programmed cell death 7 | 10081.0 | ENSG00000090470 | nan | nan
chr15	CLPX	615611.0 | CLPX, EPP2 | Caseinolytic mitochondrial matrix peptidase chaperone subunit | 10845.0 | ENSG00000166855 | mutation identified in 1 EPP2 family | ?Protoporphyria, erythropoietic, 2, 618015 (3), Autosomal dominant
chr15	CILP	603489.0 | CILP | Cartilage intermediate layer protein | 8483.0 | ENSG00000138615 | nan | {Lumbar disc disease, susceptibility to}, 603932 (3)
chr15	PARP16	620391.0 | PARP16, ARTD15 | Poly(ADP-ribose) polymerase family, member 16 | 54956.0 | ENSG00000138617 | nan | nan
chr15	RNU5A-1	180691.0 | RNU5A-1, RNU5 | RNA, U5A small nuclear 1 | 26831.0 | ENSG00000199568 | nan | nan
chr15	IGDCC3	604184.0 | PUNC | Putative neuronal cell adhesion molecule | 9543.0 | ENSG00000174498 | nan | nan
chr15	IGDCC4	616810.0 | IGDCC4, NOPE, KIAA1628 | Immunoglobulin superfamily, DCC subclass, member 4 | 57722.0 | ENSG00000103742 | nan | nan
chr15	DPP8	606819.0 | DPP8 | Dipeptidyl peptidase 8 | 54878.0 | ENSG00000074603 | nan | nan
chr15	HACD3	615940.0 | PTPLAD1, BIND1, HACD3 | Protein tyrosine phosphatase-like A domain-containing protein 1 | 51495.0 | ENSG00000074696 | nan | nan
chr15	INTS14	620878.0 | INTS14, VWA9 | Integrator complex subunit 14 | 81556.0 | ENSG00000138614 | nan | nan
chr15	SLC24A1	603617.0 | SLC24A1, NCKX1, CSNB1D | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 | 9187.0 | ENSG00000074621 | nan | Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3), Autosomal recessive
chr15	DENND4A	600382.0 | DENND4A | DENN/MADD domain containing 4A | 10260.0 | ENSG00000174485 | nan | nan
chr15	RAB11A	605570.0 | RAB11A | Ras family, member RAB11A | 8766.0 | ENSG00000103769 | nan | nan
chr15	MEGF11	612454.0 | MEGF11, KIAA1781 | Multiple epidermal growth factor-like domains 11 | 84465.0 | ENSG00000157890 | nan | nan
chr15	DIS3L	614183.0 | DIS3L, DIS3L1, KIAA1955 | DIS3 like exosome 3'-5' exoribonuclease | 115752.0 | ENSG00000166938 | nan | nan
chr15	TIPIN	610716.0 | TIPIN | Timeless-interacting protein | 54962.0 | ENSG00000075131 | nan | nan
chr15	MAP2K1	176872.0 | MAP2K1, PRKMK1, MKK1, MEK1, CFC3, MEL | Mitogen-activated protein kinase kinase 1 | 5604.0 | ENSG00000169032 | pseudogene on 8p21 | Cardiofaciocutaneous syndrome 3, 615279 (3), Autosomal dominant; Melorheostosis, isolated, somatic mosaic, 155950 (3)
chr15	SNAPC5	605979.0 | SNAPC5, SNAP19 | Small nuclear RNA-activating protein complex, polypeptide 5 | 10302.0 | ENSG00000174446 | nan | nan
chr15	RPL4	180479.0 | RPL4 | Ribosomal protein L4 | 6124.0 | ENSG00000174444 | nan | nan
chr15	ZWILCH	609984.0 | ZWILCH | ZWILCH kinetochore protein | 55055.0 | ENSG00000174442 | nan | nan
chr15	LCTL	617060.0 | LCTL, KLG, KLPH | Lactase-like protein | 197021.0 | ENSG00000188501 | nan | nan
chr15	SMAD6	602931.0 | SMAD6, MADH6, AOVD2 | SMAD family member 6 | 4091.0 | ENSG00000137834 | nan | Aortic valve disease 2, 614823 (3), Autosomal dominant; {Radioulnar synostosis, nonsyndromic}, 179300 (3), Autosomal dominant; {Craniosynostosis 7, susceptibility to}, 617439 (3), Autosomal dominant
chr15	STQTL16	612579.0 | STQTL16 | Stature quantitative trait locus 16 | 100270802.0 | nan | associated with rs8038652 | {Stature QTL 16}, 612579 (2)
chr15	SMAD3	603109.0 | SMAD3, MADH3, LDS3 | SMAD family member 3 | 4088.0 | ENSG00000166949 | nan | Loeys-Dietz syndrome 3, 613795 (3), Autosomal dominant
chr15	GLM4	607248.0 | GLM4 | Glioma susceptibility 4 | 338030.0 | nan | max lod at D15S130 | {Glioma susceptibility 4}, 607248 (2)
chr15	AAGAB	614888.0 | AAGAB, p34, PPKP1A, PPKP1, KPPP1 | Alpha- and gamma-adaptin-binding protein | 79719.0 | ENSG00000103591 | nan | Keratoderma, palmoplantar, punctate type IA, 148600 (3), Autosomal dominant
chr15	IQCH	612523.0 | IQCH, NYDSP5 | IQ motif-containing protein H | 64799.0 | ENSG00000103599 | nan | nan
chr15	MAP2K5	602520.0 | MAP2K5, PRKMK5, MEK5, MAPKK5 | Mitogen-activated protein kinase kinase 5 | 5607.0 | ENSG00000137764 | nan | nan
chr15	SKOR1	611273.0 | SKOR1, LBXCOR1, CORL1 | SKI family transcriptional corepressor 1 | 390598.0 | ENSG00000188779 | nan | nan
chr15	RNU6-1	180692.0 | RNU6-1, RNU6A, RNU6 | RNA, U6 small nuclear 1 | 26827.0 | ENSG00000206625 | nan | nan
chr15	PIAS1	603566.0 | PIAS1, DDXBP1, GBP | protein inhibitor of activated STAT, 1 | 8554.0 | ENSG00000033800 | nan | nan
chr15	CALML4	620520.0 | CALML4 | Calmodulin-like 4 | 91860.0 | ENSG00000129007 | nan | nan
chr15	CLN6	606725.0 | CLN6, CLN6A | CLN6 transmembrane ER protein | 54982.0 | ENSG00000128973 | nan | Ceroid lipofuscinosis, neuronal, 6B (Kufs type), 204300 (3), Autosomal recessive; Ceroid lipofuscinosis, neuronal, 6A, 601780 (3), Autosomal recessive
chr15	FEM1B	613539.0 | FEM1B, KIAA0396 | Fem-1 homolog B | 10116.0 | ENSG00000169018 | nan | nan
chr15	ITGA11	604789.0 | ITGA11 | Integrin, alpha-11 | 22801.0 | ENSG00000137809 | nan | nan
chr15	CORO2B	605002.0 | CORO2B, CLIPINC | Coronin 2B | 10391.0 | ENSG00000103647 | nan | nan
chr15	ANP32A	600832.0 | ANP32A, PHAP1 | Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A | 8125.0 | ENSG00000140350 | nan | nan
chr15	SPESP1	609399.0 | SPESP1 | Sperm equatorial segment protein 1 | 246777.0 | ENSG00000258484 | nan | nan
chr15	NOX5	606572.0 | NOX5 | NADPH oxidase 5 | 79400.0 | nan | nan | nan
chr15	EWSAT1	616492.0 | EWSAT1, LINC00277 | Ewing sarcoma-associated transcript 1, noncoding | 283673.0 | ENSG00000212766 | nan | nan
chr15	GLCE	612134.0 | GLCE, HSEPI, KIAA0836 | Glucuronic acid epimerase | 26035.0 | ENSG00000138604 | nan | nan
chr15	PAQR5	607781.0 | PAQR5, MPRG | Progestin and ADIPOQ receptor family, member 5 | 54852.0 | ENSG00000137819 | nan | nan
chr15	KIF23	605064.0 | KIF23, KNSL5, MKLP1, CDAN3A | Kinesin family member 23 | 9493.0 | ENSG00000137807 | nan | Anemia, congenital dyserythropoietic, type IIIA, 105600 (3), Autosomal dominant
chr15	RPLP1	180520.0 | RPLP1 | Ribosomal protein lateral stalk subunit P1 | 6176.0 | ENSG00000137818 | nan | nan
chr15	DRAIC	616387.0 | DRAIC | Downregulated RNA in androgen-independent cells, noncoding | 145837.0 | ENSG00000245750 | nan | nan
chr15	PCAT29	616273.0 | PCAT29 | Prostate cancer-associated transcript 29, noncoding | 104472713.0 | ENSG00000245750 | nan | nan
chr15	TLE3	600190.0 | TLE3, ESG | TLE family member 3, transcriptional corepressor | 7090.0 | ENSG00000140332 | nan | nan
chr15	UACA	612516.0 | UACA, NUCLING | Uveal autoantigen with coiled-coil domains and ankyrin repeats | 55075.0 | ENSG00000137831 | nan | nan
chr15	LARP6	611300.0 | LARP6, ACHN | La ribonucleoprotein 6, translational regulator | 55323.0 | ENSG00000166173 | nan | nan
chr15	LRRC49	620497.0 | LRRC49 | Leucine-rich repeat-containing protein 49 | 54839.0 | ENSG00000137821 | nan | nan
chr15	THAP10	612538.0 | THAP10 | THAP domain-containing protein 10 | 56906.0 | ENSG00000129028 | nan | nan
chr15	THSD4	614476.0 | THSD4, ADAMTSL6, AAT12 | Thrombospondin type-1 domain-containing 4 | 79875.0 | ENSG00000187720 | nan | Aortic aneurysm, familial thoracic 12, 619825 (3), Autosomal dominant
chr15	NR2E3	604485.0 | NR2E3, PNR, ESCS, RP37 | Nuclear receptor subfamily 2, group E, member 3 | 10002.0 | ENSG00000278570 | near BBS4 | Retinitis pigmentosa 37, 611131 (3), Autosomal recessive, Autosomal dominant; Enhanced S-cone syndrome, 268100 (3), Autosomal recessive
chr15	MYO9A	604875.0 | MYO9A, CMS24 | Myosin IXa | 4649.0 | ENSG00000066933 | nan | Myasthenic syndrome, congenital, 24, presynaptic, 618198 (3), Autosomal recessive
chr15	SENP8	608659.0 | SENP8, NEDP1, DEN1 | Sentrin-specific protease family, member 8 | 123228.0 | ENSG00000166192 | nan | nan
chr15	GRAMD2A	620181.0 | GRAMD2A | GRAM domain-containing protein 2A | 196996.0 | ENSG00000175318 | nan | nan
chr15	PKM	179050.0 | PKM, PKM2, PK3, THBP1 | Pyruvate kinase, muscle | 5315.0 | ENSG00000067225 | nan | nan
chr15	PARP6	619439.0 | PARP6 | Poly(ADP-ribose) polymerase family, member 6 | 56965.0 | ENSG00000137817 | nan | nan
chr15	CELF6	612681.0 | CELF6, BRUNOL6 | CUGbp- and ELAV-like family, member 6 | 60677.0 | ENSG00000140488 | nan | nan
chr15	HEXA	606869.0 | HEXA, TSD | Hexosaminidase A, alpha polypeptide | 3073.0 | ENSG00000213614 | on 15q+ in APL | [Hex A pseudodeficiency], 272800 (3), Autosomal recessive; GM2-gangliosidosis, several forms, 272800 (3), Autosomal recessive; Tay-Sachs disease, 272800 (3), Autosomal recessive
chr15	CILD8	612274.0 | CILD8 | Ciliary dyskinesia, primary, 8 | 100190786.0 | nan | max lod at D15S154 | Ciliary dyskinesia, primary, 8, 612274 (2), Autosomal recessive
chr15	ENFL2	603204.0 | ENFL2 | Epilepsy, nocturnal frontal lobe, type 2 | 50971.0 | nan | some ENFL not on 20q or 15q | Epilepsy, nocturnal frontal lobe, type 2, 603204 (2), Autosomal dominant
chr15	MRST	602685.0 | MRST | Impaired intellectual development with spasticity and tapetoretinal degeneration | 8126.0 | nan | nan | Impaired intellectual development with spasticity and tapetoretinal degeneration, 602685 (2)
chr15	ARIH1	605624.0 | ARIH1, ARI, UBCH7BP | Ariadne, Drosophila, homolog of, 1 | 25820.0 | ENSG00000166233 | nan | nan
chr15	BBS4	600374.0 | BBS4 | BBS4 gene | 585.0 | ENSG00000140463 | nan | Bardet-Biedl syndrome 4, 615982 (3), Autosomal recessive
chr15	ADPGK	611861.0 | ADPGK | ADP-dependent glucokinase | 83440.0 | ENSG00000159322 | nan | nan
chr15	NEO1	601907.0 | NEO1, NGN | Neogenin, chicken, homolog of, 1 | 4756.0 | ENSG00000067141 | nan | nan
chr15	HCN4	605206.0 | HCN4, SSS2, BRGDA8, EIG18 | Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4 | 10021.0 | ENSG00000138622 | mutation identified in 1 EIG18 family | Sick sinus syndrome 2, 163800 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 18}, 619521 (3), Autosomal dominant; Brugada syndrome 8, 613123 (3)
chr15	REC114	618421.0 | REC114, OZEMA10 | Rec114 meiotic recombination protein | 283677.0 | ENSG00000183324 | nan | Oocyte/zygote/embryo maturation arrest 10, 619176 (3), Autosomal recessive
chr15	NPTN	612820.0 | NPTN, SDFR1, GP55, NP55, GP65, NP65 | Neuroplastin | 27020.0 | ENSG00000156642 | nan | nan
chr15	NPTN-IT1	615176.0 | NPTNIT1 | NPTN intronic transcript 1, noncoding | 101241892.0 | ENSG00000281183 | nan | nan
chr15	CD276	605715.0 | CD276, B7H3 | CD276 molecule | 80381.0 | ENSG00000103855 | nan | nan
chr15	INSYN1	617128.0 | C15orf59, INSYN1 | Chromosome 15 open reading frame 59 | 388135.0 | ENSG00000205363 | nan | nan
chr15	TBC1D21	620387.0 | TBC1D21, MGCRABGAP | TBC1 domain family, member 21 | 161514.0 | ENSG00000167139 | nan | nan
chr15	LOXL1-AS1	616800.0 | LOXL1AS1 | LOXL1 antisense RNA 1 | 100287616.0 | ENSG00000261801 | nan | nan
chr15	LOXL1	153456.0 | LOXL1, LOXL | Lysyl oxidase-like 1 | 4016.0 | ENSG00000129038 | nan | {Exfoliation syndrome, susceptibility to}, 177650 (3), Autosomal dominant
chr15	STOML1	608326.0 | STOML1, STORP | Stomatin-like protein 1 | 9399.0 | ENSG00000067221 | nan | nan
chr15	PML	102578.0 | PML, MYL | Promyelocytic leukemia, inducer of | 5371.0 | ENSG00000140464 | fused with RARA in APL | nan
chr15	GOLGA6A	610288.0 | GOLGA6, GLP | Golgin A6 | 342096.0 | ENSG00000159289 | nan | nan
chr15	ISLR2	614179.0 | ISLR2, LINX, KIAA1464 | Immunoglobulin superfamily containing leucine-rich repeat 2 | 57611.0 | ENSG00000167178 | nan | nan
chr15	ISLR	602059.0 | ISLR | Immunoglobulin superfamily containing leucine-rich repeat | 3671.0 | ENSG00000129009 | nan | nan
chr15	STRA6	610745.0 | STRA6, MCOPS9, MCOPCB8 | Stimulated by retinoic acid 6, mouse, homolog of | 64220.0 | ENSG00000137868 | nan | Microphthalmia, syndromic 9, 601186 (3), Autosomal recessive; Microphthalmia, isolated, with coloboma 8, 601186 (3), Autosomal recessive
chr15	CCDC33	618525.0 | CCDC33, CT61 | Coiled-coil domain containing protein 33 | 80125.0 | ENSG00000140481 | nan | nan
chr15	CYP11A1	118485.0 | CYP11A1, P450SCC | Cytochrome P450, subfamily XIA, polypeptide 1 (cholesterol side chain cleavage enzyme) | 1583.0 | ENSG00000140459 | nan | Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)
chr15	SEMA7A	607961.0 | SEMA7A, SEMAL, SEMAK1, CDW108, JMH, PFIC11 | Semaphorin 7A | 8482.0 | ENSG00000138623 | mutation identified in 1 PFIC11 patient | ?Cholestasis, progressive familial intrahepatic, 11, 619874 (3), Autosomal recessive; [Blood group, John-Milton-Hagen system], 614745 (3)
chr15	UBL7	609748.0 | UBL7 | Ubiquitin-like 7 | 84993.0 | ENSG00000138629 | nan | nan
chr15	ARID3B	612457.0 | ARID3B, DRIL2, BDP | AT-rich interactive domain-containing protein 3B | 10620.0 | ENSG00000179361 | nan | nan
chr15	CLK3	602990.0 | CLK3 | CDC-like kinase 3 | 1198.0 | ENSG00000179335 | nan | nan
chr15	EDC3	609842.0 | EDC3, YJDC, MRT50 | Enhancer of mRNA decapping 3 | 80153.0 | ENSG00000179151 | mutation identified in 1 MRT50 family | ?Intellectual developmental disorder, autosomal recessive 50, 616460 (3), Autosomal recessive
chr15	CYP1A1	108330.0 | CYP1A1, CYP1 | Cytochrome P450, subfamily I, aromatic compound-inducible, polypeptide 1 | 1543.0 | ENSG00000140465 | head-to-head with CYP1A2 | nan
chr15	CYP1A2	124060.0 | CYP1A2 | Cytochrome P450, subfamily I, aromatic compound-inducible, polypeptide 2 | 1544.0 | ENSG00000140505 | 23.3kb from CYP1A1 | nan
chr15	CSK	124095.0 | CSK | c-src tyrosine kinase | 1445.0 | ENSG00000103653 | nan | nan
chr15	LMAN1L	609548.0 | LMAN1L, ERGL | Lectin, mannose binding 1-like | 79748.0 | ENSG00000140506 | nan | nan
chr15	CPLX3	609585.0 | CPLX3 | Complexin 3 | 594855.0 | ENSG00000213578 | nan | nan
chr15	ULK3	613472.0 | ULK3 | UNC51-like kinase 3 | 25989.0 | ENSG00000140474 | nan | nan
chr15	SCAMP2	606912.0 | SCAMP2 | Secretory carrier membrane protein 2 | 10066.0 | ENSG00000140497 | nan | nan
chr15	MPI	154550.0 | MPI, PMI1, CDG1B | Mannosephosphate isomerase (phosphomannose isomerase 1) | 4351.0 | ENSG00000178802 | nan | Congenital disorder of glycosylation, type Ib, 602579 (3), Autosomal recessive
chr15	COX5A	603773.0 | COX5A, MC4DN20 | Cytochrome C oxidase, subunit Va | 9377.0 | ENSG00000178741 | pseudogene on 14q22 | Mitochondrial complex IV deficiency, nuclear type 20, 619064 (3), Autosomal recessive
chr15	RPP25	619235.0 | RPP25 | Ribonuclease P/MRP, 25kD subunit | 54913.0 | ENSG00000178718 | nan | nan
chr15	SCAMP5	613766.0 | SCAMP5 | Secretory carrier membrane protein 5 | 192683.0 | ENSG00000198794 | nan | nan
chr15	PPCDC	609854.0 | PPCDC | Phosphopantothenoylcysteine decarboxylase | 60490.0 | ENSG00000138621 | nan | nan
chr15	COMMD4	616701.0 | COMMD4 | COMM domain-containing protein 4 | 54939.0 | ENSG00000140365 | nan | nan
chr15	NEIL1	608844.0 | NEIL1, NEI1, FPG1 | Endonuclease VIII-like 1 | 79661.0 | ENSG00000140398 | nan | nan
chr15	MAN2C1	154580.0 | MAN2C1, MANA, CDDG2 | Mannosidase, alpha, class 2C, member 1 | 4123.0 | ENSG00000140400 | nan | Congenital disorder of deglycosylation 2, 619775 (3), Autosomal recessive
chr15	SIN3A	607776.0 | SIN3A, WITKOS | Sin3, yeast, homolog of, A | 25942.0 | ENSG00000169375 | nan | Witteveen-Kolk syndrome, 613406 (3), Autosomal dominant
chr15	PTPN9	600768.0 | PTPN9 | Protein-tyrosine phosphatase, nonreceptor-type, 9 | 5780.0 | ENSG00000169410 | nan | nan
chr15	SNUPN	607902.0 | SNUPN, RNUT1, LGMDR29 | Snurportin 1 | 10073.0 | ENSG00000169371 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 29, 620793 (3), Autosomal recessive
chr15	IMP3	612980.0 | IMP3, MRPS4, BRMS2 | Imp3, S. cerevisiae, homolog of | 55272.0 | ENSG00000177971 | nan | nan
chr15	SNX33	619107.0 | SNX33 | Sorting nexin 33 | 257364.0 | ENSG00000173548 | nan | nan
chr15	CSPG4	601172.0 | CSPG4, MCSPG, MSK16, NG2 | Chondroitin sulfate proteoglycan | 1464.0 | ENSG00000173546 | nan | nan
chr15	UBE2Q2	612501.0 | UBE2Q2, LOC92912 | Ubiquitin-conjugating enzyme E2 Q2 | 92912.0 | ENSG00000140367 | nan | nan
chr15	FBXO22	609096.0 | FBXO22, FBX22 | F-box only protein 22 | 26263.0 | ENSG00000167196 | nan | nan
chr15	NRG4	610894.0 | NRG4, HRG4 | Neuregulin 4 | 145957.0 | ENSG00000169752 | nan | nan
chr15	TMEM266	618691.0 | TMEM266, HVRP1, C15orf27 | Transmembrane protein 266 | 123591.0 | ENSG00000169758 | nan | nan
chr15	ETFA	608053.0 | ETFA, GA2, MADD | Electron transfer flavoprotein, alpha polypeptide | 2108.0 | ENSG00000140374 | nan | Glutaric acidemia IIA, 231680 (3), Autosomal recessive
chr15	ISL2	609481.0 | ISL2 | ISL2 transcription factor, LIM/homeodomain | 64843.0 | ENSG00000159556 | nan | nan
chr15	SCAPER	611611.0 | SCAPER, KIAA1454, IDDRP | S-phase cyclin A-associated protein in the endoplasmic reticulum | 49855.0 | ENSG00000140386 | nan | Intellectual developmental disorder and retinitis pigmentosa, 618195 (3), Autosomal recessive
chr15	RCN2	602584.0 | RCN2, ERC55 | Reticulocalbin 2, EF-hand calcium binding domain (endoplasmic reticulum calcium-binding protein, 55kD) | 5955.0 | ENSG00000117906 | nan | nan
chr15	PSTPIP1	606347.0 | PSTPIP1, PSTPIP, CD2BP1, AICZC, PAPA | Proline-serine-threonine phosphatase-interacting protein 1 | 9051.0 | ENSG00000140368 | nan | Autoinflammatory syndrome with cytopenia, hyperzincemia, and hypercalprotectinemia, 601979 (3), Autosomal dominant; Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3), Autosomal dominant
chr15	TSPAN3	613134.0 | TSPAN3 | Tetraspanin 3 | 10099.0 | ENSG00000140391 | nan | nan
chr15	PEAK1	614248.0 | PEAK1, KIAA2002 | Pseudopodium-enriched atypical kinase 1 | 79834.0 | ENSG00000173517 | nan | nan
chr15	HMG20A	605534.0 | HMG20A | High mobility group protein 20A | 10363.0 | ENSG00000140382 | nan | nan
chr15	LINGO1	609791.0 | LINGO1, LRRN6A, LERN1, MRT64 | Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 1 | 84894.0 | ENSG00000169783 | nan | Intellectual developmental disorder, autosomal recessive 64, 618103 (3), Autosomal recessive
chr15	TBC1D2B	619152.0 | TBC1D2B, KIAA1055, NEDSGO | TBC1 domain family, member 2B | 23102.0 | ENSG00000167202 | nan | Neurodevelopmental disorder with seizures and gingival overgrowth, 619323 (3), Autosomal recessive
chr15		614294.0 | DEL15q25, C15DELq25 | Chromosome 15q25 deletion syndrome | nan | nan | chr15:82,889,423-83,552,890, NCBI36 | Chromosome 15q25 deletion syndrome, 614294 (4), Autosomal dominant
chr15	DFNA30	606451.0 | DFNA30 | Deafness, autosomal dominant 30 | 23719.0 | nan | nan | Deafness, autosomal dominant 30, 606451 (2), Autosomal dominant
chr15	POROK4	607728.0 | POROK4, DSAP2 | Porokeratosis 4, disseminated superficial actinic | 353147.0 | nan | between D15S1023 and D15S1030 | Porokeratosis 4, disseminated superficial actinic, 607728 (2)
chr15	CIB2	605564.0 | CIB2, KIP2 | Calcium- and integrin-binding protein 2 | 10518.0 | ENSG00000136425 | nan | Deafness, autosomal recessive 48, 609439 (3), Autosomal recessive; Usher syndrome, type IJ, 614869 (3), Autosomal recessive
chr15	IDH3A	601149.0 | IDH3A, RP90 | Isocitrate dehydrogenase (NAD+) 3, catalytic, alpha subunit | 3419.0 | ENSG00000166411 | nan | Retinitis pigmentosa 90, 619007 (3), Autosomal recessive
chr15	ACSBG1	614362.0 | ACSBG1, BG, BG1, KIAA0631 | Acyl-CoA synthetase, bubble gum family, member 1 | 23205.0 | ENSG00000103740 | nan | nan
chr15	SKIC8	609540.0 | SKIC8, WDR61, SKI8 | SKI8 subunit of superkiller complex | 80349.0 | ENSG00000140395 | nan | nan
chr15	CRABP1	180230.0 | CRABP1, RBP5 | Cellular retinoic acid-binding protein-1 | 1381.0 | ENSG00000166426 | distal to APL breakpoint | nan
chr15	IREB2	147582.0 | IREB2, NDCAMA | Iron-responsive element-binding protein-2 | 3658.0 | ENSG00000136381 | nan | Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia, 618451 (3), Autosomal recessive
chr15	HYKK	614681.0 | AGPHD1 | Aminoglycoside phosphotransferase domain-containing protein 1 | 123688.0 | ENSG00000188266 | nan | nan
chr15	PSMA4	176846.0 | PSMA4, PSC9, HC9 | Proteasome subunit, alpha-type, 4 | 5685.0 | ENSG00000041357 | nan | nan
chr15	CHRNA5	118505.0 | CHRNA5, LNCR2 | Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5 | 1138.0 | ENSG00000169684 | nan | {Nicotine dependence, susceptibility to}, 612052 (3); {Lung cancer susceptibility 2}, 612052 (3)
chr15	CHRNA3	118503.0 | CHRNA3, LNCR2, PAOD2, BAIPRCK | Cholinergic receptor, neuronal nicotinic, alpha polypeptide-3 | 1136.0 | ENSG00000080644 | nan | {Lung cancer susceptibility 2}, 612052 (3); Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT, 191800 (3), Autosomal recessive
chr15	CHRNB4	118509.0 | CHRNB4 | Cholinergic receptor, neuronal nicotinic, beta polypeptide-4 | 1143.0 | ENSG00000117971 | nan | nan
chr15	ADAMTS7	605009.0 | ADAMTS7 | ADAM metallopeptidase domain with thrombospondin type 1 motif, 7 | 11173.0 | ENSG00000136378 | nan | nan
chr15	MORF4L1	607303.0 | MORF4L1, MRG15 | Mortality factor 4-like 1 | 10933.0 | ENSG00000185787 | nan | nan
chr15	CTSH	116820.0 | CTSH | Cathepsin H | 1512.0 | ENSG00000103811 | nan | nan
chr15	RASGRF1	606600.0 | RASGRF1, GRF55 | Ras protein-specific guanine nucleotide-releasing factor 1 | 5923.0 | ENSG00000058335 | nan | nan
chr15	MIR184	613146.0 | MIR184, MIRN184, KTCNCT, EDICT | Micro RNA 184 | 406960.0 | ENSG00000207695 | nan | EDICT syndrome, 614303 (3), Autosomal dominant
chr15	TMED3	620437.0 | TMED3 | Transmembrane p24 trafficking protein 3 | 23423.0 | ENSG00000166557 | nan | nan
chr15	MINAR1	618054.0 | KIAA1024, MINAR1 | Major intrinsically disordered NOTCH2-binding receptor 1 | 23251.0 | ENSG00000169330 | nan | nan
chr15	MTHFS	604197.0 | MTHFS, NEDMEHM | 5,10-methenyltetrahydrofolate synthetase | 10588.0 | ENSG00000136371 | nan | Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination, 618367 (3), Autosomal recessive
chr15	BCL2A1	601056.0 | BCL2A1 | BCL2-related protein A1 | 597.0 | ENSG00000140379 | nan | nan
chr15	ZFAND6	610183.0 | ZFAND6, ZA20D3, AWP1 | Zinc finger AN1 domain-containing protein 6 | 54469.0 | ENSG00000086666 | nan | nan
chr15	FAH	613871.0 | FAH | Fumarylacetoacetase | 2184.0 | ENSG00000103876 | nan | Tyrosinemia, type I, 276700 (3), Autosomal recessive
chr15	ARNT2	606036.0 | ARNT2, WEDAS | Aryl hydrocarbon receptor nuclear translocator 2 | 9915.0 | ENSG00000172379 | mutation identified in 1 WEDAS family | ?Webb-Dattani syndrome, 615926 (3), Autosomal recessive
chr15	ABHD17C	617944.0 | ABHD17C, FAM108C1 | Abhydrolase domain-containing protein 17C, depalmitoylase | 58489.0 | ENSG00000136379 | nan | nan
chr15	CEMIP	608366.0 | CEMIP, KIAA1199 | Cell migration-inducing hyaluronidase 1 | 57214.0 | ENSG00000103888 | nan | nan
chr15	MESD	607783.0 | MESD, MESDC2, BOCA, KIAA0081, OI20 | Mesoderm development LRP chaperone | 23184.0 | ENSG00000117899 | nan | Osteogenesis imperfecta, type XX, 618644 (3), Autosomal recessive
chr15	TLNRD1	615466.0 | TLNRD1, MESDC1 | Talin rod domain containing 1 | 59274.0 | ENSG00000140406 | nan | nan
chr15	IL16	603035.0 | IL16, LCF | Interleukin 16 | 3603.0 | ENSG00000172349 | nan | nan
chr15	STARD5	607050.0 | STARD5 | Start domain-containing protein 5 | 80765.0 | ENSG00000172345 | nan | nan
chr15	TMC3	617196.0 | TMC3 | Transmembrane channel-like protein 3 | 342125.0 | ENSG00000188869 | nan | nan
chr15	MEX3B	611008.0 | MEX3B, RKHD3 | Mex-3, C. elegans, homolog of, B | 84206.0 | ENSG00000183496 | nan | nan
chr15	EFL1	617538.0 | EFL1, RIA1, EFTUD1, FAM42A, SDS2 | Elongation factor-like GTPase 1 | 79631.0 | ENSG00000140598 | nan | Shwachman-Diamond syndrome 2, 617941 (3), Autosomal recessive
chr15	RPS17	180472.0 | RPS17, RPS17L1, RPS17L2, DBA4 | Ribosomal protein S17 | 6218.0 | ENSG00000182774 | previously on chr.11; pseudogenes on 5q33-qter and 17q | Diamond-Blackfan anemia 4, 612527 (3), Autosomal dominant
chr15	CPEB1	607342.0 | CPEB1 | Cytoplasmic polyadenylation element-binding protein 1 | 64506.0 | ENSG00000214575 | nan | nan
chr15	AP3B2	602166.0 | AP3B2, NAPTB, DEE48 | Adaptor-related protein complex 3, beta 2 subunit | 8120.0 | ENSG00000103723 | nan | Developmental and epileptic encephalopathy 48, 617276 (3), Autosomal recessive
chr15	SCARNA15	612675.0 | SCARNA15, ACA45 | Small cajal body-specific RNA 15 | 677778.0 | ENSG00000277864 | nan | nan
chr15	WHAMM	612393.0 | WHAMM, KIAA1971 | Was protein homolog associated with actin, golgi membranes, and microtubules | 123720.0 | ENSG00000156232 | nan | nan
chr15	HOMER2	604799.0 | HOMER2, HOMER2B, HOMER2A, DFNA68 | Homer scaffold protein 2 | 9455.0 | ENSG00000103942 | mutation identified in 1 DFNA68 family | ?Deafness, autosomal dominant 68, 616707 (3), Autosomal dominant
chr15	RAMAC	614547.0 | FAM103A1, RAM | Family with sequence similarity 103, member A1 | 83640.0 | ENSG00000169612 | nan | nan
chr15	BTBD1	608530.0 | BTBD1 | BTB/POZ domain-containing protein 1 | 53339.0 | ENSG00000064726 | nan | nan
chr15	TM6SF1	606562.0 | TM6SF1 | Transmembrane 6 superfamily, member 1 | 53346.0 | ENSG00000136404 | nan | nan
chr15	HDGFL3	616643.0 | HRP3, HDGFRP3 | Hepatoma-derived growth factor-related protein 3 | 50810.0 | ENSG00000166503 | nan | nan
chr15	BNC1	601930.0 | BNC1, POF16 | Basonuclin | 646.0 | ENSG00000169594 | mutation identified in 1 POF16 family | ?Premature ovarian failure 16, 618723 (3), Autosomal dominant
chr15	SH3GL3	603362.0 | SH3GL3 | SH3-domain GRB2-like 3 | 6457.0 | ENSG00000140600 | nan | nan
chr15	ADAMTSL3	609199.0 | ADAMTSL3, KIAA1233 | ADAMTS-like protein 3 | 57188.0 | ENSG00000156218 | nan | nan
chr15	SCAND2P	610417.0 | SCAND2 | SCAN domain-containing 2 | 54581.0 | nan | nan | nan
chr15	WDR73	616144.0 | WDR73, HSPC264, GAMOS1 | WD repeat-containing protein 73 | 84942.0 | ENSG00000177082 | nan | Galloway-Mowat syndrome 1, 251300 (3), Autosomal recessive
chr15	NMB	162340.0 | NMB | Neuromedin B | 4828.0 | ENSG00000197696 | nan | nan
chr15	SEC11A	618258.0 | SEC11A, SPC18 | SEC11 homolog A, signal peptidase complex subunit | 23478.0 | ENSG00000140612 | nan | nan
chr15		609893.0 | CHNG3, RTSH | Hypothyroidism, congenital, nongoitrous, 3 | nan | nan | max lod at D15S655 | Hypothyroidism, congenital, nongoitrous, 3, 609893 (2), Autosomal dominant
chr15	MDD2	608691.0 | MDD2 | Major depressive disorder 2 | 431709.0 | nan | nan | Major depressive disorder 2, 608516 (2)
chr15	ZNF592	613624.0 | ZNF592, KIAA0211 | Zinc finger protein 592 | 9640.0 | ENSG00000166716 | nan | nan
chr15	ALPK3	617608.0 | ALPK3, MIDORI, KIAA1330, CMH27 | Alpha kinase 3 | 57538.0 | ENSG00000136383 | nan | Cardiomyopathy, familial hypertrophic 27, 618052 (3), Autosomal recessive
chr15	SLC28A1	606207.0 | SLC28A1, CNT1, URCTU | Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 | 9154.0 | ENSG00000156222 | nan | [Uridine-cytidineuria], 618477 (3), Autosomal recessive
chr15	PDE8A	602972.0 | PDE8A | Phosphodiesterase 8A | 5151.0 | ENSG00000073417 | nan | nan
chr15	AKAP13	604686.0 | AKAP13, HT31, LBC, BRX | A-kinase anchor protein 13 | 11214.0 | ENSG00000170776 | nan | nan
chr15	KLHL25	619893.0 | KLHL25 | Kelch-like family, member 25 | 64410.0 | ENSG00000183655 | nan | nan
chr15	AGBL1	615496.0 | AGBL1, CCP4, FECD8 | ATP/GTP-binding protein-like 1 | 123624.0 | ENSG00000273540 | nan | Corneal dystrophy, Fuchs endothelial, 8, 615523 (3), Autosomal dominant
chr15	NTRK3	191316.0 | NTRK3, TRKC | Neurotrophic tyrosine kinase, receptor, type 3 | 4916.0 | ENSG00000140538 | nan | nan
chr15	MRPL46	611851.0 | MRPL46 | Mitochondrial ribosomal protein L46 | 26589.0 | ENSG00000259494 | nan | nan
chr15	MRPS11	611977.0 | MRPS11 | Mitochondrial ribosomal protein S11 | 64963.0 | ENSG00000181991 | nan | nan
chr15		612626.0 | DEL15q26qter, C15DELq26qter | Chromosome 15q26-qter deletion syndrome | nan | nan | contiguous gene deletion syndrome | Chromosome 15q26-qter deletion syndrome, 612626 (4), Isolated cases
chr15	DIH1	142340.0 | DIH1, HCD | Diaphragmatic hernia 1 | 1732.0 | nan | nan | Diaphragmatic hernia 1, 142340 (2), Multifactorial
chr15	IDDM3	600318.0 | IDDM3 | Insulin-dependent diabetes mellitus-3 | 3402.0 | nan | nan | {Diabetes mellitus, insulin-dependent, 3}, 600318 (2)
chr15		614846.0 | LVSKS | Levy-Shanske syndrome (tetrasomy 15q26) | nan | nan | nan | Levy-Shanske syndrome, 614846 (4), Isolated cases
chr15	OTSC1	166800.0 | OTSC1, OTS | Otosclerosis 1 | 5012.0 | nan | nan | Otosclerosis 1, 166800 (2), Autosomal dominant
chr15		620900.0 | STRTS | Short tandem repeat, TTTG(4), thyroid-specific | 136932118.0 | nan | nan | Hypothyroidism, congenital, nongoitrous, 3, 609893 (3), Autosomal dominant
chr15	VVS	609289.0 | VVS | Syncope, familial vasovagal | 105031671.0 | nan | nan | Syncope, familial vasovagal, 609289 (2), Autosomal dominant
chr15	DET1	608727.0 | DET1 | DET1 partner of COP1 E2 ubiquitin ligase | 55070.0 | ENSG00000140543 | nan | nan
chr15	AEN	610177.0 | ISG20L1, AEN | Interferon-stimulated exonuclease gene 20kD-like 1 | 64782.0 | ENSG00000181026 | nan | nan
chr15	MIR1179	620899.0 | MIR1179 | Micro RNA 1179 | 100302235.0 | ENSG00000221630 | nan | nan
chr15	MIR7-2	620898.0 | MIR7-2 | Micro RNA 7-2 | 407044.0 | ENSG00000207703 | nan | nan
chr15	ISG20	604533.0 | ISG20, HEM45 | Interferon-stimulated exonuclease gene 20 | 3669.0 | ENSG00000172183 | nan | nan
chr15	ACAN	155760.0 | ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD | Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122) | 176.0 | ENSG00000157766 | mutation identified in 1 SEDK family | ?Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3), Autosomal dominant; Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3), Autosomal dominant; Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3), Autosomal recessive
chr15	MFGE8	602281.0 | MFGE8 | Milk fat globule-EGF factor 8 | 4240.0 | ENSG00000140545 | nan | nan
chr15	ABHD2	612196.0 | ABHD2, LABH2 | Abhydrolase domain-containing 2, acylglycerol lipase | 11057.0 | ENSG00000140526 | nan | nan
chr15	RLBP1	180090.0 | RLBP1 | Retinaldehyde-binding protein-1, cellular | 6017.0 | ENSG00000140522 | nan | Bothnia retinal dystrophy, 607475 (3), Autosomal recessive; Newfoundland rod-cone dystrophy, 607476 (3); Retinitis punctata albescens, 136880 (3), Autosomal recessive, Autosomal dominant; Fundus albipunctatus, 136880 (3), Autosomal recessive, Autosomal dominant
chr15	FANCI	611360.0 | FANCI, KIAA1794 | FANCI gene | 55215.0 | ENSG00000140525 | nan | Fanconi anemia, complementation group I, 609053 (3), Autosomal recessive
chr15	POLG	174763.0 | POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS | Polymerase (DNA directed), gamma | 5428.0 | ENSG00000140521 | PEO also digenic with C10orf2 | Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive; Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive; Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive; Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant; Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive
chr15	POLGARF	620759.0 | POLGARF | POLG alternative reading frame | 125316803.0 | ENSG00000291307 | nan | nan
chr15	MIR9-3	611188.0 | MIR9-3, MIRN9-3 | Micro RNA 9-3 | 407051.0 | ENSG00000284329 | nan | nan
chr15	RHCG	605381.0 | RHCG, RHGK | Rhesus blood group-associated kidney homolog | 51458.0 | ENSG00000140519 | nan | nan
chr15	TICRR	613298.0 | C15orf42, TRESLIN | Treslin | 90381.0 | ENSG00000140534 | nan | nan
chr15	KIF7	611254.0 | KIF7, HLS2, ACLS, JBTS12, AGBK | Kinesin family member 7 | 374654.0 | ENSG00000166813 | mutation identified in 1 HLS2 family and 1 AGBK family | Joubert syndrome 12, 200990 (3), Autosomal recessive; Acrocallosal syndrome, 200990 (3), Autosomal recessive; ?Hydrolethalus syndrome 2, 614120 (3), Autosomal recessive; ?Al-Gazali-Bakalinova syndrome, 607131 (3), Autosomal recessive
chr15	PLIN1	170290.0 | PLIN1, PLIN, FPLD4 | Perilipin 1 | 5346.0 | ENSG00000166819 | nan | Lipodystrophy, familial partial, type 4, 613877 (3), Autosomal dominant
chr15	PEX11A	603866.0 | PEX11A | Peroxisome biogenesis factor 11A | 8800.0 | ENSG00000166821 | nan | nan
chr15	WDR93	619891.0 | WDR93 | WD repeat-containing protein 93 | 56964.0 | ENSG00000140527 | nan | nan
chr15	MESP1	608689.0 | MESP1 | Mesoderm posterior bHLH transcription factor 1 | 55897.0 | ENSG00000166823 | nan | nan
chr15	MESP2	605195.0 | MESP2, SCDO2 | Mesoderm posterior bHLH transcription factor 2 | 145873.0 | ENSG00000188095 | nan | Spondylocostal dysostosis 2, autosomal recessive, 608681 (3), Autosomal recessive
chr15	ANPEP	151530.0 | ANPEP, PEPN, CD13 | Alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150) | 290.0 | ENSG00000166825 | nan | nan
chr15	AP3S2	602416.0 | AP3S2 | Adaptor-related protein complex 3, sigma-2 subunit | 10239.0 | ENSG00000157823 | nan | nan
chr15	ARPIN	615543.0 | C15orf38, ARPIN | Chromosome 15 open reading frame 38 | 348110.0 | ENSG00000242498 | nan | nan
chr15	IDH2	147650.0 | IDH2, IDPM, D2HGA2 | Isocitrate dehydrogenase (NADP+) 2 | 3418.0 | ENSG00000182054 | nan | D-2-hydroxyglutaric aciduria 2, 613657 (3)
chr15	SEMA4B	617029.0 | SEMA4B | Semaphorin 4B | 10509.0 | ENSG00000185033 | nan | nan
chr15	CIB1	602293.0 | CIB1, KIP, EV3 | Calcium- and integrin-binding protein 1 | 10519.0 | ENSG00000185043 | nan | {Epidermodysplasia verruciformis, susceptibility to, 3}, 618267 (3), Autosomal recessive
chr15	GDPGP1	619240.0 | GDPGP1 | GDP-D-glucose phosphorylase 1 | 390637.0 | ENSG00000183208 | nan | nan
chr15	TTLL13	620485.0 | TTLL13 | Tubulin tyrosine ligase-like 13 | 440307.0 | ENSG00000213471 | nan | nan
chr15	NGRN	616718.0 | NGRN | Neurite outgrowth-associated protein | 51335.0 | ENSG00000182768 | nan | nan
chr15	IQGAP1	603379.0 | IQGAP1, SAR1 | RASGAP-like with IQ motifs (sar1, S. pombe, homolog of) | 8826.0 | ENSG00000140575 | amplified in gastric cancer | nan
chr15	CRTC3	608986.0 | CRTC3, TORC3 | CREB-regulated transcription coactivator 3 | 64784.0 | ENSG00000140577 | nan | nan
chr15	BLM	604610.0 | RECQL3, RECQ2, BLM, BS, MGRISCE1 | DNA helicase, RecQ-like 3 | 641.0 | ENSG00000197299 | nan | Bloom syndrome, 210900 (3), Autosomal recessive
chr15	FURIN	136950.0 | FURIN, PACE, FUR, PCSK3 | Furin (paired basic amino acid cleaving enzyme) | 5045.0 | ENSG00000140564 | less than 1.1kb 5' to FES | nan
chr15	FES	190030.0 | FES | Oncogene FES, feline sarcoma virus | 2242.0 | ENSG00000182511 | nan | nan
chr15	MAN2A2	600988.0 | MAN2A2, MANA2X | Mannosidase, alpha-, type II, isozyme X | 4122.0 | ENSG00000196547 | nan | nan
chr15	UNC45A	611219.0 | UNC45A, SMAP1, GCUNC45, OOHE | unc-45 myosin chaperone A | 55898.0 | ENSG00000140553 | nan | Osteootohepatoenteric syndrome, 619377 (3), Autosomal recessive
chr15	RCCD1	617997.0 | RCCD1 | RCC1 domain-containing protein 1 | 91433.0 | ENSG00000166965 | nan | nan
chr15	PRC1	603484.0 | PRC1 | Protein regulating cytokinesis 1 | 9055.0 | ENSG00000198901 | nan | nan
chr15	VPS33B	608552.0 | VPS33B, KDIDAR, PFIC12 | VPS33B late endosome and lysosome associated | 26276.0 | ENSG00000184056 | nan | Keratoderma-ichthyosis-deafness syndrome, autosomal recessive, 620009 (3), Autosomal recessive; Cholestasis, progressive familial intrahepatic, 12, 620010 (3), Autosomal recessive; Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3), Autosomal recessive
chr15	SV2B	185861.0 | SV2B, KIAA0735 | Synaptic vesicle glycoprotein 2B | 9899.0 | ENSG00000185518 | nan | nan
chr15	SLCO3A1	612435.0 | SLCO3A1, OATPD, OATP3A1 | Solute carrier organic anion transporter family, member 3A1 | 28232.0 | ENSG00000176463 | nan | nan
chr15	ST8SIA2	602546.0 | STX | Sialyltransferase X | 8128.0 | ENSG00000140557 | nan | nan
chr15	CHASERR	620993.0 | CHASERR, LINC01578 | CHD2-adjacent suppressive regulatory RNA | 100507217.0 | nan | nan | nan
chr15	CHD2	602119.0 | CHD2, DEE94 | Chromodomain helicase DNA binding protein-2 | 1106.0 | ENSG00000173575 | nan | Developmental and epileptic encephalopathy 94, 615369 (3), Autosomal dominant
chr15	RGMA	607362.0 | RGMA | RGM domain family, member A (repulsive guidance molecule) | 56963.0 | ENSG00000182175 | nan | nan
chr15	MCTP2	616297.0 | MCTP2 | Multiple C2 domains-containing transmembrane protein 2 | 55784.0 | ENSG00000140563 | nan | nan
chr15	NR2F2	107773.0 | NR2F2, TFCOUP2, ARP1, CHTD4, SRXX5 | Nuclear receptor subfamily 2, group F, member 2 (transcription factor COUP 2) | 7026.0 | ENSG00000185551 | nan | 46XX sex reversal 5, 618901 (3), Autosomal dominant; Congenital heart defects, multiple types, 4, 615779 (3), Autosomal dominant
chr15	SPATA8	613948.0 | SPATA8, SRG8 | Spermatogenesis-associated protein 8 | 145946.0 | ENSG00000185594 | nan | nan
chr15	ARRDC4	619788.0 | ARRDC4 | Arrestin domain-containing protein 4 | 91947.0 | ENSG00000140450 | nan | nan
chr15	IRAIN	619212.0 | IRAIN, IGF1RAS | IGF1R antisense imprinted noncoding RNA | 104472848.0 | nan | nan | nan
chr15	IGF1R	147370.0 | IGF1R | Insulin-like growth factor-1 receptor | 3480.0 | ENSG00000140443 | nan | Insulin-like growth factor I, resistance to, 270450 (3), Autosomal recessive, Autosomal dominant
chr15	SYNM	606087.0 | SYNM, DMN | Synemin | 23336.0 | ENSG00000182253 | nan | nan
chr15	MEF2A	600660.0 | MEF2A, ADCAD1 | MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A) | 4205.0 | ENSG00000068305 | nan | {Coronary artery disease, autosomal dominant, 1}, 608320 (3), Autosomal dominant
chr15	ADAMTS17	607511.0 | ADAMTS17, WMS4 | ADAM metallopeptidase domain with thrombospondin type 1 motif, 17 | 170691.0 | ENSG00000140470 | nan | Weill-Marchesani 4 syndrome, recessive, 613195 (3), Autosomal recessive
chr15	CERS3	615276.0 | CERS3, LASS3, ARCI9 | Ceramide synthase 3 | 204219.0 | ENSG00000154227 | nan | Ichthyosis, congenital, autosomal recessive 9, 615023 (3), Autosomal recessive
chr15	LINS1	610350.0 | LINS1, WINS1, FLJ10583, MRT27 | Lines homolog 1 | 55180.0 | ENSG00000140471 | nan | Intellectual developmental disorder, autosomal recessive 27, 614340 (3), Autosomal recessive
chr15	ASB7	615052.0 | ASB7 | Ankyrin repeat- and SOCS box-containing protein 7 | 140460.0 | ENSG00000183475 | nan | nan
chr15	ALDH1A3	600463.0 | ALDH1A3, ALDH6, MCOP8 | Aldehyde dehydrogenase 1 family, member A3 | 220.0 | ENSG00000184254 | nan | Microphthalmia, isolated 8, 615113 (3), Autosomal recessive
chr15	LRRK1	610986.0 | LRRK1, OSMD | Leucine-rich repeat kinase 1 | 79705.0 | ENSG00000154237 | nan | Osteosclerotic metaphyseal dysplasia, 615198 (3), Autosomal recessive
chr15	CHSY1	608183.0 | CHSY1, KIAA0990, TPBS | Carbohydrate synthase 1 | 22856.0 | ENSG00000131873 | nan | Temtamy preaxial brachydactyly syndrome, 605282 (3), Autosomal recessive
chr15	SELENOS	607918.0 | SELENOS, SEPS1, SELS, VIMP, ADO15 | Selenoprotein S | 55829.0 | ENSG00000131871 | nan | nan
chr15	SNRPA1	603521.0 | SNRPA1 | Small nuclear ribonucleoprotein polypeptide A' | 6627.0 | ENSG00000131876 | nan | nan
chr15	PCSK6	167405.0 | PCSK6, PACE4, SPC4 | Proprotein convertase subtilisin/kexin type 6 | 5046.0 | ENSG00000140479 | nan | nan
chr15	TM2D3	610014.0 | TM2D3, BLP2 | TM2 domain-containing protein 3 | 80213.0 | ENSG00000184277 | nan | nan
chr15	COL1AR	120340.0 | COL1AR | Collagen I, alpha, receptor | 1279.0 | nan | nan | nan
chr16	ADHD1	608903.0 | ADHD1 | Attention deficit-hyperactivity disorder, susceptibility to, 1 | 450087.0 | nan | max lod at D16S3114 | {Attention deficit-hyperactivity disorder, susceptibility to, 1}, 608903 (2)
chr16	BMIQ5	608558.0 | BMIQ5 | Body mass index quantitative trait locus 5 | 449016.0 | nan | near D16S404 and D16S764 | [Body mass index QTL5], 608558 (2)
chr16	CHDS1	607339.0 | CHDS1 | Coronary heart disease, susceptibility to, 1 | 338334.0 | nan | nan | {Coronary heart disease, susceptibility to}, 607339 (2)
chr16		610543.0 | DEL16p13.3, RSTSS | Chromosome 16p13.3 deletion syndrome (Rubinstein-Taybi deletion syndrome) | nan | nan | contiguous gene deletion syndrome | Chromosome 16p13.3 deletion syndrome, 610543 (4)
chr16		613458.0 | DUP16p13.3, C16DUPq13.3 | Chromosome 16p13.3 duplication syndrome | nan | nan | contiguous gene duplication syndrome | Chromosome 16p13.3 duplication syndrome, 613458 (4), Isolated cases, Autosomal dominant
chr16		141750.0 | HBHR, ATR1 | Alpha-thalassemia/impaired intellectual development syndrome, deletion type | nan | nan | contiguous gene syndrome involving deletion of HBA1 and HBA2 | Alpha-thalassemia/impaired intellectual development syndrome, deletion type, 141750 (4), Autosomal dominant
chr16	IBD8	606668.0 | IBD8 | Inflammatory bowel disease 8 | 170595.0 | nan | nan | {Inflammatory bowel disease 8}, 606668 (2)
chr16	IHPS2	610260.0 | IHPS2 | Pyloric stenosis, infantile hypertrophic, 2 | 780923.0 | nan | nan | Pyloric stenosis, infantile hypertrophic, 2, 610260 (2)
chr16	MCOPCT1	156850.0 | MCOPCT1 | Microphthalmia with cataract 1 | 8130.0 | nan | proximal to HBA1 | Microphthalmia with cataract 1, 156850 (2), Autosomal dominant
chr16		600273.0 | PKDTS | Polycystic kidney disease, infantile severe, with tuberous sclerosis | nan | nan | contiguous gene syndrome caused by deletion of TSC2 and PKD1 | Polycystic kidney disease, infantile severe, with tuberous sclerosis, 600273 (4), Autosomal dominant
chr16	POLR3K	606007.0 | POLR3K, RPC11, HLD21 | Polymerase III, RNA, subunit K | 51728.0 | ENSG00000161980 | nan | Leukodystrophy, hypomyelinating, 21, 619310 (3), Autosomal recessive
chr16	RHBDF1	614403.0 | RHBDF1, IRHOM1, DIST1 | Rhomboid 5, Drosophila, homolog of, 1 | 64285.0 | ENSG00000007384 | nan | nan
chr16	MPG	156565.0 | MPG, MDG | N-methylpurine DNA glycosylase | 4350.0 | ENSG00000103152 | 75kb upstream of HBZ | nan
chr16	NPRL3	600928.0 | NPRL3, CGTHBA, FFEVF3 | Nitrogen permease regulator-like 3 | 8131.0 | ENSG00000103148 | nan | Epilepsy, familial focal, with variable foci 3, 617118 (3), Autosomal dominant
chr16	HBZ	142310.0 | HBZ | Hemoglobin, zeta | 3050.0 | ENSG00000130656 | nan | nan
chr16	HBM	609639.0 | HBM | Hemoglobin mu | 3042.0 | ENSG00000206177 | ?functional | nan
chr16	HBA2	141850.0 | HBA2, HBH, ECYT7 | Hemoglobin alpha-2 | 3040.0 | ENSG00000188536 | nan | Heinz body anemia, 140700 (3), Autosomal dominant; Thalassemia, alpha-, 604131 (3); Erythrocytosis, familial, 7, 617981 (3), Autosomal dominant; Hemoglobin H disease, deletional and nondeletional, 613978 (3)
chr16	HBA1	141800.0 | HBA1, HBH, METHBA, ECYT7 | Hemoglobin alpha-1 | 3039.0 | ENSG00000206172 | 1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3' | Hemoglobin H disease, nondeletional, 613978 (3); Thalassemias, alpha-, 604131 (3); Heinz body anemias, alpha-, 140700 (3), Autosomal dominant; Methemoglobinemia, alpha type, 617973 (3), Autosomal dominant; Erythrocytosis, familial, 7, 617981 (3), Autosomal dominant
chr16	HBQ1	142240.0 | HBQ1 | Hemoglobin theta-1 | 3049.0 | ENSG00000086506 | nan | nan
chr16	LUC7L	607782.0 | LUC7L | LUC7-like | 55692.0 | ENSG00000007392 | nan | nan
chr16	RGS11	603895.0 | RS11 | Regulator of G protein signaling 11 | 8786.0 | ENSG00000076344 | nan | nan
chr16	ARHGDIG	602844.0 | ARHGDIG | Rho GDP-dissociation inhibitor gamma | 398.0 | ENSG00000242173 | nan | nan
chr16	PDIA2	608012.0 | PDIA2, PDIP | Protein disulfide isomerase, family A, member 2 | 64714.0 | ENSG00000185615 | nan | nan
chr16	AXIN1	603816.0 | AXIN1, AXIN, CMDOH | Axis inhibitor 1 | 8312.0 | ENSG00000103126 | hypermethylation of AXIN1 promoter seen in 1 CDUP patient | Hepatocellular carcinoma, somatic, 114550 (3); Craniometadiaphyseal osteosclerosis with hip dysplasia, 620558 (3), Autosomal recessive; ?Caudal duplication anomaly, 607864 (3)
chr16	MRPL28	604853.0 | MRPL28, MAAT1 | Mitochondrial ribosomal protein L28 | 10573.0 | ENSG00000086504 | nan | nan
chr16	PGAP6	619342.0 | PGAP6, TMEM8A | Post-GPI attachment to proteins 6 | 58986.0 | ENSG00000129925 | nan | nan
chr16	NME4	601818.0 | NME4 | NME/NM23 nucleoside diphosphate kinase 4 | 4833.0 | ENSG00000103202 | nan | nan
chr16	DECR2	615839.0 | DECR2, PDCR | 2,4-dienoyl-CoA reductase 2, peroxisomal | 26063.0 | ENSG00000242612 | nan | nan
chr16	RAB11FIP3	608738.0 | RAB11FIP3, EFERIN, KIAA0665 | RAB11 family-interacting protein 3 | 9727.0 | ENSG00000090565 | nan | nan
chr16	CAPN15	603267.0 | CAPN15, SOLH, OGIN | Calpain 15 | 6650.0 | ENSG00000103326 | nan | Oculogastrointestinal neurodevelopmental syndrome, 619318 (3), Autosomal recessive
chr16	PIGQ	605754.0 | PIGQ, MCAHS4, DEE77, GPIBD19 | Phosphatidylinositol glycan anchor biosynthesis class Q protein | 9091.0 | ENSG00000007541 | nan | Multiple congenital anomalies-hypotonia-seizures syndrome 4, 618548 (3), Autosomal recessive
chr16	RAB40C	619551.0 | RAB40C | RAB40C, member Ras oncogene family | 57799.0 | ENSG00000197562 | nan | nan
chr16	WFIKKN1	608021.0 | WFIKKN1, WFIKKN | WAP, follistatin, immunoglobulin, Kunitz, and NTR domains-containing protein 1 | 117166.0 | ENSG00000127578 | nan | nan
chr16	WDR90	618290.0 | WDR90, KIAA1924 | WD repeat-containing protein 90 | 197335.0 | ENSG00000161996 | nan | nan
chr16	RHOT2	613889.0 | RHOT2, MIRO2, ARHT2 | Ras homolog gene family, member T2 | 89941.0 | ENSG00000140983 | nan | nan
chr16	RHBDL1	603264.0 | RHBDL, RRP | Rhomboid, Drosophila, homolog of | 9028.0 | ENSG00000103269 | nan | nan
chr16	STUB1	607207.0 | STUB1, CHIP, SCAR16, SCA48 | STIP1 homologous and U box-containing protein 1 | 10273.0 | ENSG00000103266 | nan | Spinocerebellar ataxia 48, 618093 (3), Autosomal dominant; Spinocerebellar ataxia, autosomal recessive 16, 615768 (3), Autosomal recessive
chr16	WDR24	620307.0 | WDR24 | WD repeat-containing protein 24 | 84219.0 | ENSG00000127580 | nan | nan
chr16	FBXL16	609082.0 | FBXL16, FBL16, C16orf22 | F-box and leucine-rich repeat protein 16 | 146330.0 | ENSG00000127585 | nan | nan
chr16	METRN	610998.0 | METRN | Meteorin | 79006.0 | ENSG00000103260 | nan | nan
chr16	ANTKMT	618566.0 | ANTKMT | Adenine nucleotide translocase lysine methyltransferase | 65990.0 | ENSG00000103254 | nan | nan
chr16	CCDC78	614666.0 | CCDC78, C16orf25, CNM4 | Coiled-coil domain-containing protein 78 | 124093.0 | ENSG00000162004 | mutation identified in 1 CNM4 family | ?Centronuclear myopathy 4, 614807 (3), Autosomal dominant
chr16	CIAO3	611118.0 | NARFL, IOP1 | Nuclear prelamin A recognition factor-like | 64428.0 | ENSG00000103245 | nan | nan
chr16	MSLN	601051.0 | MSLN | Mesothelin | 10232.0 | ENSG00000102854 | nan | nan
chr16	CHTF18	613201.0 | CHTF18, CHL12, CTF18 | Chromosome transmission fidelity factor 18 | 63922.0 | ENSG00000127586 | nan | nan
chr16	GNG13	607298.0 | GNG13 | Guanine nucleotide-binding protein, gamma-13 | 51764.0 | ENSG00000127588 | nan | nan
chr16	LMF1	611761.0 | LMF1, TMEM112 | Lipase maturation factor 1 | 64788.0 | ENSG00000103227 | nan | Lipase deficiency, combined, 246650 (3), Autosomal recessive
chr16	SOX8	605923.0 | SOX8 | SRY-box 8 | 30812.0 | ENSG00000005513 | nan | nan
chr16	SSTR5	182455.0 | SSTR5 | Somatostatin receptor-5 | 6755.0 | ENSG00000162009 | nan | nan
chr16	C1QTNF8	614147.0 | C1QTNF8, CTRP8 | C1q- and tumor necrosis factor-related protein 8 | 390664.0 | ENSG00000184471 | nan | nan
chr16	CACNA1H	607904.0 | CACNA1H, EIG6, ECA6, HALD4 | Calcium channel, voltage-dependent, T type, alpha-1H subunit | 8912.0 | ENSG00000196557 | nan | {Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3); Hyperaldosteronism, familial, type IV, 617027 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3)
chr16	TPSG1	609341.0 | TPSG1, TMT | Tryptase, gamma-1 | 25823.0 | ENSG00000116176 | nan | nan
chr16	TPSB2	191081.0 | TPSB2, TPS2 | Tryptase, beta 2 | 64499.0 | ENSG00000197253 | nan | nan
chr16	TPSAB1	191080.0 | TPSAB1, TPS1 | Tryptase, alpha/beta-1 | 7177.0 | ENSG00000172236 | nan | nan
chr16	TPSD1	609272.0 | TPSD1, MCP7L1 | Tryptase, delta-1 | 23430.0 | ENSG00000095917 | nan | nan
chr16	UBE2I	601661.0 | UBE2I | Ubiquitin-conjugating enzyme E2 I | 7329.0 | ENSG00000103275 | nan | nan
chr16	BAIAP3	604009.0 | BAIAP3, BAP3 | BAI1-associated protein 3 | 8938.0 | ENSG00000007516 | nan | nan
chr16	TSR3	617058.0 | TSR3 | TSR3, aminocarboxypropyl transferase ribosome maturation factor | 115939.0 | ENSG00000007520 | nan | nan
chr16	GNPTG	607838.0 | GNPTG, GNPTAG | N-acetylglucosamine-1-phosphotransferase, gamma subunit | 84572.0 | ENSG00000090581 | nan | Mucolipidosis III gamma, 252605 (3), Autosomal recessive
chr16	UNKL	617463.0 | UNKL, ZC3H5L, C16orf28 | Unkempt family-like zinc finger | 64718.0 | ENSG00000059145 | nan | nan
chr16	UQCC4	620578.0 | UQCC4, C16orf91 | Ubiquinol-cytochrome c reductase complex assembly factor 4 | 283951.0 | ENSG00000174109 | nan | nan
chr16	PERCC1	618656.0 | PERCC1, ICR, DIAR11 | Proline- and glutamate-rich protein with coiled-coil domain 1 | 105371045.0 | ENSG00000284395 | Intestine Critical Region (ICR) upstream of PERCC1 deleted in DIAR11 | Diarrhea 11, malabsorptive, congenital, 618662 (3), Autosomal recessive
chr16	CCDC154	618740.0 | CCDC154, C16orf29 | Coiled-coil domain-containing protein 154 | 645811.0 | ENSG00000197599 | nan | nan
chr16	CLCN7	602727.0 | CLCN7, CLC7, OPTA2, OPTB4, HOD | Chloride channel-7 | 1186.0 | ENSG00000103249 | nan | Hypopigmentation, organomegaly, and delayed myelination and development, 618541 (3), Autosomal dominant; Osteopetrosis, autosomal recessive 4, 611490 (3), Autosomal recessive; Osteopetrosis, autosomal dominant 2, 166600 (3), Autosomal dominant
chr16	PTX4	613442.0 | PTX4 | Pentraxin 4, long | 390667.0 | ENSG00000251692 | nan | nan
chr16	TELO2	611140.0 | TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS | Telomere maintenance 2 | 9894.0 | ENSG00000100726 | nan | You-Hoover-Fong syndrome, 616954 (3), Autosomal recessive
chr16	IFT140	614620.0 | IFT140, KIAA0590, SRTD9, MZSDS, RP80 | Intraflagellar transport 140 | 9742.0 | ENSG00000187535 | nan | Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3), Autosomal recessive; Retinitis pigmentosa 80, 617781 (3), Autosomal recessive
chr16	TMEM204	611002.0 | TMEM204, C16orf30, CLP24 | Transmembrane protein 204 | 79652.0 | ENSG00000131634 | nan | nan
chr16	JPT2	619241.0 | JPT2, C16orf34, HN1L | Jupiter microtubule-associated homolog 2 | 90861.0 | ENSG00000206053 | nan | nan
chr16	MAPK8IP3	605431.0 | MAPK8IP3, SYD2, JSAP1, JIP3, NEDBA | Mitogen-activated protein kinase 8-interacting protein 3 | 23162.0 | ENSG00000138834 | nan | Neurodevelopmental disorder with or without variable brain abnormalities, 618443 (3), Autosomal dominant
chr16	NME3	601817.0 | NME3, NM23H3 | NME/NM23 nucleoside diphosphate kinase 3 | 4832.0 | ENSG00000103024 | nan | nan
chr16	MRPS34	611994.0 | MRPS34, MRPS12, COXPD32 | Mitochondrial ribosomal protein S34 | 65993.0 | ENSG00000074071 | nan | Combined oxidative phosphorylation deficiency 32, 617664 (3), Autosomal recessive
chr16	EME2	610886.0 | EME2 | Essential meiotic structure-specific endonuclease 2 | 197342.0 | ENSG00000197774 | nan | nan
chr16	SPSB3	611659.0 | SPSB3, SSB3 | SPRY domain- and SOCS box-containing 3 | 90864.0 | ENSG00000162032 | nan | nan
chr16	NUBP2	610779.0 | NUBP2, CFD1 | Nucleotide-binding protein 2 | 10101.0 | ENSG00000095906 | nan | nan
chr16	IGFALS	601489.0 | IGFALS, ALS, ACLSD | Insulin-like growth factor-binding protein, acid-labile subunit | 3483.0 | ENSG00000099769 | nan | Acid-labile subunit, deficiency of, 615961 (3), Autosomal recessive
chr16	HAGH	138760.0 | HAGH, GLO2, GLO2D | Hydroxyacyl glutathione hydrolase; glyoxalase II | 3029.0 | ENSG00000063854 | nan | [Glyoxalase II deficiency], 614033 (1), Autosomal dominant
chr16	FAHD1	616320.0 | FAHD1, FLJ36880 | Fumarylacetoacetate hydrolase domain-containing protein 1 | 81889.0 | ENSG00000180185 | nan | nan
chr16	MEIOB	617670.0 | MEIOB, SPGF22, POF23 | Meiosis-specific protein with OB domains | 254528.0 | ENSG00000162039 | nan | Premature ovarian failure 23, 620686 (3), Autosomal recessive; Spermatogenic failure 22, 617706 (3), Autosomal recessive
chr16	HS3ST6	619210.0 | HS3ST6, 3OST6, HAE8 | Heparan sulfate-glucosamine 3-sulfotransferase 6 | 64711.0 | ENSG00000162040 | mutation identified in 1 HAE8 family | ?Angioedema, hereditary, 8, 619367 (3), Autosomal dominant
chr16	MSRB1	606216.0 | MSRB1, SEPX1, SELX | Methionine sulfoxide reductase B1 | 51734.0 | ENSG00000198736 | nan | nan
chr16	RPL3L	617416.0 | RPL3L, CMD2D | Ribosomal protein L3-like | 6123.0 | ENSG00000140986 | nan | Cardiomyopathy, dilated, 2D, 619371 (3), Autosomal recessive
chr16	NDUFB10	603843.0 | NDUFB10, MC1DN35 | NADH-ubiquinone oxidoreductase subunit B10 | 4716.0 | ENSG00000140990 | mutation identified in 1 MC1DN35 patient | ?Mitochondrial complex I deficiency, nuclear type 35, 619003 (3), Autosomal recessive
chr16	RPS2	603624.0 | RPS2 | Ribosomal protein S2 | 6187.0 | ENSG00000140988 | nan | nan
chr16	TBL3	605915.0 | TBL3 | Transducin-beta-like 3 | 10607.0 | ENSG00000183751 | nan | nan
chr16	NOXO1	611256.0 | NOXO1 | NADPH oxidase organizer 1 | 124056.0 | ENSG00000196408 | nan | nan
chr16	GFER	600924.0 | GFER, ERV1, ALR, MPMCD | Growth factor, ERV1-like | 2671.0 | ENSG00000127554 | nan | Myopathy, mitochondrial progressive, with congenital cataract and developmental delay, 613076 (3), Autosomal recessive
chr16	SYNGR3	603927.0 | SYNGR3 | Synaptogyrin 3 | 9143.0 | ENSG00000127561 | nan | nan
chr16	ZNF598	617508.0 | ZNF598 | Zinc finger protein 598 | 90850.0 | ENSG00000167962 | nan | nan
chr16	NPW	607997.0 | NPW, PPNPW, PPL8 | Neuropeptide W | 283869.0 | ENSG00000183971 | nan | nan
chr16	NHERF2	606553.0 | SLC9A3R2, SIP1, NHERF2 | Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 2 | 9351.0 | ENSG00000065054 | nan | nan
chr16	NTHL1	602656.0 | NTHL1, OCTS3, FAP3 | Endonuclease III, E. coli, homolog of | 4913.0 | ENSG00000065057 | nan | Familial adenomatous polyposis 3, 616415 (3), Autosomal recessive
chr16	TSC2	191092.0 | TSC2, LAM | Tuberin (tuberous sclerosis 2 gene) | 7249.0 | ENSG00000103197 | somatic mutation identified in 1 FCORD2 patient | Lymphangioleiomyomatosis, somatic, 606690 (3); ?Focal cortical dysplasia, type II, somatic, 607341 (3); Tuberous sclerosis-2, 613254 (3), Autosomal dominant
chr16	PKD1	601313.0 | PKD1 | Polycystin-1 | 5310.0 | ENSG00000008710 | nan | Polycystic kidney disease 1, 173900 (3), Autosomal dominant
chr16	MIR1225	611621.0 | MIR1225, MIRN1225 | Micro RNA 1225 | 100188847.0 | ENSG00000221656 | nan | nan
chr16	RAB26	605455.0 | RAB26 | RAS-associated protein RAB26 | 25837.0 | ENSG00000167964 | nan | nan
chr16	TRAF7	606692.0 | TRAF7, RFWD1, CAFDADD | TNF receptor-associated factor 7 | 84231.0 | ENSG00000131653 | nan | Cardiac, facial, and digital anomalies with developmental delay, 618164 (3), Autosomal dominant
chr16	CASKIN1	612184.0 | CASKIN1, KIAA1306 | CASK-interacting protein 1 | 57524.0 | ENSG00000167971 | nan | nan
chr16	MLST8	612190.0 | MLST8, GBL, LST8, WAT1, POP3 | MTOR-associated protein LST8 | 64223.0 | ENSG00000167965 | nan | nan
chr16	PGP	172280.0 | PGP | Phosphoglycolate phosphatase | 283871.0 | ENSG00000184207 | no recombination with PKD1 | nan
chr16	E4F1	603022.0 | E4F1, E4F | E4F transcription factor 1 | 1877.0 | ENSG00000167967 | nan | nan
chr16	DNASE1L2	602622.0 | DNASE1L2 | Deoxyribonuclease I-like 2 | 1775.0 | ENSG00000167968 | nan | nan
chr16	ECI1	600305.0 | ECI1, DCI | Enoyl-CoA delta isomerase 1 | 1632.0 | ENSG00000167969 | nan | nan
chr16	RNPS1	606447.0 | RNPS1 | RNA-binding protein S1 | 10921.0 | ENSG00000205937 | nan | nan
chr16	ABCA3	601615.0 | ABCA3, ABC3, SMDP3 | ATP-binding cassette-3 | 21.0 | ENSG00000167972 | nan | Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3), Autosomal recessive
chr16	CCNF	600227.0 | CCNF, FBX1, FTDALS5 | Cyclin F | 899.0 | ENSG00000162063 | nan | Frontotemporal dementia and/or amyotrophic lateral sclerosis 5, 619141 (3), Autosomal dominant
chr16	NTN3	602349.0 | NTN3, NTN2L | Netrin 3 | 4917.0 | ENSG00000162068 | nan | nan
chr16	TBC1D24	613577.0 | TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC | TBC1 domain family, member 24 | 57465.0 | ENSG00000162065 | nan | Deafness, autosomal recessive 86, 614617 (3), Autosomal recessive; Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp, 608105 (3), Autosomal recessive; Myoclonic epilepsy, infantile, familial, 605021 (3), Autosomal recessive; Deafness, autosomal dominant 65, 616044 (3), Autosomal dominant; Developmental and epileptic encephalopathy 16, 615338 (3), Autosomal recessive; DOORS syndrome, 220500 (3), Autosomal recessive
chr16	ATP6V0C	108745.0 | ATP6V0C, ATP6L, ATP6C, EPEO3 | ATPase, H+ transporting, V0 subunit C | 527.0 | ENSG00000185883 | nan | Epilepsy, early-onset, 3, with or without developmental delay, 620465 (3), Autosomal dominant
chr16	AMDHD2	620864.0 | AMDHD2 | Amindohydrolase domain-containing protein 2 | 51005.0 | ENSG00000162066 | nan | nan
chr16	CEMP1	611113.0 | CEMP1, CP23 | Cementum protein 1 | 752014.0 | ENSG00000205923 | nan | nan
chr16	PDPK1	605213.0 | PDPK1, PDK1 | 3-phosphoinositide-dependent protein kinase 1 | 5170.0 | ENSG00000140992 | nan | nan
chr16	KCTD5	611285.0 | KCTD5 | Potassium channel tetramerization domain-containing protein 5 | 54442.0 | ENSG00000167977 | nan | nan
chr16	PRSS27	608018.0 | PRSS27 | Serine protease 27 | 83886.0 | ENSG00000172382 | nan | nan
chr16	SRRM2	606032.0 | SRRM2, SRM300, KIAA0324, MRD72 | Serine/arginine repetitive matrix 2 (ser/arg-rich splicing factor-related nuclear matrix protein, 300kD) | 23524.0 | ENSG00000167978 | nan | Intellectual developmental disorder, autosomal dominant 72, 620439 (3), Autosomal dominant
chr16	ELOB	600787.0 | TCEB2, ELOB | Transcription elongation factor B, polypeptide 2 | 6923.0 | ENSG00000103363 | nan | nan
chr16	PRSS33	613797.0 | PRSS33, EOS | Protease, serine, 33 | 260429.0 | ENSG00000103355 | nan | nan
chr16	PRSS21	608159.0 | PRSS21, ESP1 | Protease, serine, 21 (testisin) | 10942.0 | ENSG00000007038 | nan | nan
chr16	ZG16B	620477.0 | ZG16B, PAUF | Zymogen granule protein 16B | 124220.0 | ENSG00000162078 | nan | nan
chr16	PRSS22	609343.0 | PRSS22 | Protease, serine, 22 | 64063.0 | ENSG00000005001 | nan | nan
chr16	FLYWCH1	620431.0 | FLYWCH1 | FLYWCH-type zinc finger protein 1 | 84256.0 | ENSG00000059122 | nan | nan
chr16	KREMEN2	609899.0 | KREMEN2, KRM2 | Kringle domain-containing transmembrane protein 2 | 79412.0 | ENSG00000131650 | nan | nan
chr16	PAQR4	614578.0 | PAQR4 | Progestin and ADIPOQ receptor family, member 4 | 124222.0 | ENSG00000162073 | nan | nan
chr16	PKMYT1	602474.0 | PKMYT1, MYT1 | Protein kinase, membrane-associated tyrosine/threonine, 1 | 9088.0 | ENSG00000127564 | nan | nan
chr16	CLDN9	615799.0 | CLDN9, DFNB116 | Claudin 9 | 9080.0 | ENSG00000213937 | nan | Deafness, autosomal recessive 116, 619093 (3), Autosomal recessive
chr16	CLDN6	615798.0 | CLDN6 | Claudin 6 | 9074.0 | ENSG00000184697 | nan | nan
chr16	TNFRSF12A	605914.0 | TNFRSF12A, FN14, TWEAKR | Tumor necrosis factor receptor superfamily, member 12A | 51330.0 | ENSG00000006327 | nan | nan
chr16	HCFC1R1	618818.0 | HCFC1R1, HPIP | Host cell factor C1 regulator 1 | 54985.0 | ENSG00000103145 | nan | nan
chr16	THOC6	615403.0 | THOC6, FSAP35, BBIS | THO complex subunit 6 | 79228.0 | ENSG00000131652 | nan | Beaulieu-Boycott-Innes syndrome, 613680 (3), Autosomal recessive
chr16	BICDL2	617003.0 | BICDL2, BICDR2, CCDC64B | BICD family-like cargo adaptor 2 | 146439.0 | ENSG00000162069 | nan | nan
chr16	MMP25	608482.0 | MMP25, MMP20A | Matrix metalloproteinase 25 | 64386.0 | ENSG00000008516 | nan | nan
chr16	IL32	606001.0 | IL32, NK4 | Interleukin 32 | 9235.0 | ENSG00000008517 | nan | nan
chr16	ZSCAN10	618365.0 | ZSCAN10, ZFP206, OFNS | Zinc finger- and SCAN domain-containing protein 10 | 84891.0 | ENSG00000130182 | nan | Otofacial neurodevelopmental syndrome, 620910 (3), Autosomal recessive
chr16	ZNF205	603436.0 | ZNF205, ZNF210 | Zinc finger protein-205 | 7755.0 | ENSG00000122386 | nan | nan
chr16	ZNF213	608387.0 | ZNF213, CR53 | Zinc finger protein 213 | 7760.0 | ENSG00000085644 | nan | nan
chr16	OR1F1	603232.0 | OR1F1, OLFMF | Olfactory receptor, family 1, subfamily F, member 1 | 4992.0 | ENSG00000168124 | nan | nan
chr16	ZNF200	603231.0 | ZNF200 | Zinc finger protein-200 | 7752.0 | ENSG00000010539 | nan | nan
chr16	MEFV	608107.0 | MEFV, MEF, FMF, PAAND | MEFV innate immunity regulator, pyrin | 4210.0 | ENSG00000103313 | between D16S80 and D16S283 | Neutrophilic dermatosis, acute febrile, 608068 (3), Autosomal dominant; Familial Mediterranean fever, AR, 249100 (3), Autosomal recessive; Familial Mediterranean fever, AD, 134610 (3), Autosomal dominant
chr16	ZNF263	604191.0 | ZNF263 | Zinc finger protein 263 | 10127.0 | ENSG00000006194 | nan | nan
chr16	TIGD7	612969.0 | TIGD7, SANCHO | Tigger transposable element-derived gene 7 | 91151.0 | ENSG00000140993 | nan | nan
chr16	ZNF75A	601473.0 | ZNF75A | Zinc finger protein-75A | 7627.0 | ENSG00000162086 | nan | nan
chr16	ZNF174	603900.0 | ZNF174 | Zinc finger protein-174 | 7727.0 | ENSG00000103343 | nan | nan
chr16	ZNF597	614685.0 | ZNF597 | Zinc finger protein 597 | 146434.0 | ENSG00000167981 | nan | nan
chr16	NAA60	614246.0 | NAA60, NAT15, IBGC9 | N-alpha-acetyltransferase 60, NatF catalytic subunit | 79903.0 | ENSG00000122390 | nan | Basal ganglia calcification, idiopathic, 9, autosomal recessive, 620786 (3), Autosomal recessive
chr16	CLUAP1	616787.0 | CLUAP1, QILIN, FAP22, KIAA0643 | Clusterin-associated protein 1 | 23059.0 | ENSG00000103351 | nan | nan
chr16	NLRC3	615648.0 | NLRC3 | NLR family, caspase recruitment domain-containing 3 | 197358.0 | ENSG00000167984 | nan | nan
chr16	SLX4	613278.0 | SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP | SLX4 structure-specific endonuclease subunit | 84464.0 | ENSG00000188827 | nan | Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive
chr16	DNASE1	125505.0 | DNASE1, DNL1 | Deoxyribonuclease I | 1773.0 | ENSG00000213918 | nan | {Systemic lupus erythematosus, susceptibility to}, 152700 (3), Autosomal dominant
chr16	TRAP1	606219.0 | TRAP1, HSP75, HSP90L | Tumor necrosis factor receptor-associated protein 1 | 10131.0 | ENSG00000126602 | nan | nan
chr16	CREBBP	600140.0 | CREBBP, CBP, RSTS1, MKHK1 | CREB binding protein | 1387.0 | ENSG00000005339 | fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemia; fusion partner with MOZ in AML | Menke-Hennekam syndrome 1, 618332 (3), Autosomal dominant; Rubinstein-Taybi syndrome 1, 180849 (3), Autosomal dominant
chr16	ADCY9	603302.0 | ADCY9 | Adenylate cyclase-9 | 115.0 | ENSG00000162104 | nan | nan
chr16	SRL	604992.0 | SRL | Sarcalumenin | 6345.0 | ENSG00000185739 | nan | nan
chr16	TFAP4	600743.0 | TFAP4 | Transcription factor AP-4 (activating enhancer-binding protein 4) | 7023.0 | ENSG00000090447 | nan | nan
chr16	GLIS2	608539.0 | GLIS2, NPHP7 | GLIS family zinc finger protein 2 | 84662.0 | ENSG00000126603 | nan | Nephronophthisis 7, 611498 (3), Autosomal recessive
chr16	PAM16	614336.0 | PAM16, MAGMAS, SMDMDM | Presequence translocase-associated motor 16 | 51025.0 | ENSG00000217930 | nan | Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3), Autosomal recessive
chr16	CORO7	611668.0 | CORO7, POD1, CRN7 | Coronin 7 | 79585.0 | ENSG00000262246 | nan | nan
chr16	VASN	608843.0 | VASN | Vasorin | 114990.0 | ENSG00000168140 | nan | nan
chr16	DNAJA3	608382.0 | DNAJA3, TID1 | DNAJ, E. coli, homolog of, subfamily A, member 3 | 9093.0 | ENSG00000103423 | nan | nan
chr16	NMRAL1	620004.0 | NMRAL1, HSCARG | NMRA-like redox sensor 1 | 57407.0 | ENSG00000153406 | nan | nan
chr16	HMOX2	141251.0 | HMOX2 | Heme oxygenase 2 | 3163.0 | ENSG00000103415 | nan | nan
chr16	CDIP1	610503.0 | CDIP1, C16orf5 | Cell death-inducing p53 target 1 | 29965.0 | ENSG00000089486 | nan | nan
chr16	MGRN1	607559.0 | MGRN1, KIAA0544 | Mahogunin, ring finger 1 | 23295.0 | ENSG00000102858 | nan | nan
chr16	NUDT16L1	617338.0 | NUDT16L1, SDOS | Nudix hydrolase 16-like 1 | 84309.0 | ENSG00000168101 | nan | nan
chr16	ANKS3	617310.0 | ANKS3 | Ankyrin repeat and sterile alpha motif domains-containing protein 3 | 124401.0 | ENSG00000168096 | nan | nan
chr16	SEPTIN12	611562.0 | SEPT12, SPGF10 | Septin 12 | 124404.0 | ENSG00000140623 | nan | Spermatogenic failure 10, 614822 (3), Autosomal dominant
chr16	ROGDI	614574.0 | ROGDI, KTZS | Rogdi atypical leucine zipper | 79641.0 | ENSG00000067836 | nan | Kohlschutter-Tonz syndrome, 226750 (3), Autosomal recessive
chr16	GLYR1	610660.0 | GLYR1, NP60 | Glyoxylate reductase 1 homolog | 84656.0 | ENSG00000140632 | nan | nan
chr16	UBN1	609771.0 | UBN1 | Ubinuclein 1 | 29855.0 | ENSG00000118900 | nan | nan
chr16	PPL	602871.0 | PPL | Periplakin | 5493.0 | ENSG00000118898 | nan | nan
chr16	SEC14L5	619412.0 | SEC14L5, KIAA0420 | Sec14-like lipid-binding protein 5 | 9717.0 | ENSG00000103184 | nan | nan
chr16	NAGPA	607985.0 | NAGPA, UCE | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | 51172.0 | ENSG00000103174 | nan | nan
chr16	ALG1	605907.0 | ALG1, HMAT1, HMT1, CDG1K | ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase | 56052.0 | ENSG00000033011 | nan | Congenital disorder of glycosylation, type Ik, 608540 (3), Autosomal recessive
chr16	EEF2KMT	615263.0 | EEF2KMT, FAM86A | Eukaryotic elongation factor 2 lysine methyltransferase | 196483.0 | ENSG00000118894 | nan | nan
chr16	RBFOX1	605104.0 | RBFOX1, 2BP1, FOX1, HRNBP1 | RNA-binding protein FOX1, C. elegans, homolog of, 1 | 54715.0 | ENSG00000078328 | nan | nan
chr16	TMEM114	611579.0 | TMEM114 | Transmembrane protein 114 | 283953.0 | ENSG00000232258 | nan | nan
chr16	METTL22	615261.0 | METTL22, C16orf68 | Methyltransferase 22, Kin17 lysine | 79091.0 | ENSG00000067365 | nan | nan
chr16	ABAT	137150.0 | ABAT, GABAT | 4-aminobutyrate aminotransferase | 18.0 | ENSG00000183044 | nan | GABA-transaminase deficiency, 613163 (3), Autosomal recessive
chr16	TMEM186	620433.0 | TMEM186 | Transmembrane protein 186 | 25880.0 | ENSG00000184857 | nan | nan
chr16	PMM2	601785.0 | PMM2, CDG1A | Phosphomannomutase 2 | 5373.0 | ENSG00000140650 | nan | Congenital disorder of glycosylation, type Ia, 212065 (3), Autosomal recessive
chr16	CARHSP1	616885.0 | CARHSP1, CRHSP24 | Calcium-regulated heat-stable protein 1 | 23589.0 | ENSG00000153048 | nan | nan
chr16	USP7	602519.0 | USP7, HAUSP, HAFOUS | Ubiquitin-specific protease-7, herpes virus-associated | 7874.0 | ENSG00000187555 | nan | Hao-Fountain syndrome, 616863 (3), Autosomal dominant
chr16	GRIN2A	138253.0 | GRIN2A, NMDAR2A, FESD, LKS | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 2903.0 | ENSG00000183454 | nan | Epilepsy, focal, with speech disorder and with or without impaired intellectual development, 245570 (3), Autosomal dominant
chr16	ATF7IP2	613645.0 | ATF7IP2, MCAF2 | Activating transcription factor 7-interacting protein 2 | 80063.0 | ENSG00000166669 | nan | nan
chr16	EMP2	602334.0 | EMP2, NPHS10 | Epithelial membrane protein 2 | 2013.0 | ENSG00000213853 | nan | Nephrotic syndrome, type 10, 615861 (3), Autosomal recessive
chr16	TEKT5	618686.0 | TEKT5 | Tektin 5 | 146279.0 | ENSG00000153060 | nan | nan
chr16	NUBP1	600280.0 | NUBP1, NBP | Nucleotide-binding protein 1 | 4682.0 | ENSG00000103274 | nan | nan
chr16	CIITA	600005.0 | CIITA, MHC2TA, C2TA, MHC2D1 | Class II major histocompatibility complex transactivator | 4261.0 | ENSG00000179583 | nan | {Rheumatoid arthritis, susceptibility to}, 180300 (3); MHC class II deficiency 1, 209920 (3), Autosomal recessive
chr16	DEXI	617901.0 | DEXI, MYLE | Dexamethasone-induced gene | 28955.0 | ENSG00000182108 | nan | nan
chr16	CLEC16A	611303.0 | CLEC16A, KIAA0350 | C-type lectin domain family 16, member A | 23274.0 | ENSG00000038532 | nan | nan
chr16	SOCS1	603597.0 | SOCS1, SSI1, CIS1, CISH1, AISIMD | Suppressor of cytokine signaling 1 | 8651.0 | ENSG00000185338 | nan | Autoinflammatory syndrome, familial, with or without immunodeficiency, 619375 (3), Autosomal dominant
chr16	TNP2	190232.0 | TNP2 | Transition protein-2 (during histone to protamine replacement) | 7142.0 | ENSG00000178279 | in 13kb segment with PRM1 and PRM2 | nan
chr16	PRM2	182890.0 | PRM2 | Sperm protamine P2 | 5620.0 | ENSG00000122304 | in same 4.8kb fragment as PRM2 | nan
chr16	PRM1	182880.0 | PRM1 | Sperm protamine P1 | 5619.0 | ENSG00000175646 | 16q21 = conflicting localization | nan
chr16	RMI2	612426.0 | RMI2, C16orf75, BLAP18 | RecQ-mediated genome instability 2 | 116028.0 | ENSG00000175643 | nan | nan
chr16	LITAF	603795.0 | LITAF, CMT1C | LPS-induced TNFA factor | 9516.0 | ENSG00000189067 | nan | Charcot-Marie-Tooth disease, type 1C, 601098 (3), Autosomal dominant
chr16	SNN	603032.0 | SNN | Stannin | 8303.0 | ENSG00000184602 | nan | nan
chr16	TXNDC11	617792.0 | TXNDC11, EFP1 | Thioredoxin domain-containing protein 11 | 51061.0 | ENSG00000153066 | nan | nan
chr16	ZC3H7A	619819.0 | ZC3H7A | Zinc finger CCCH domain-containing protein 7A | 29066.0 | ENSG00000122299 | nan | nan
chr16	BCAR4	613746.0 | BCAR4 | Breast cancer antiestrogen resistance 4 | 400500.0 | ENSG00000262117 | nan | nan
chr16	RSL1D1	615874.0 | RSL1D1, CSIG, PBK1 | Ribosomal L1 domain-containing protein 1 | 26156.0 | ENSG00000171490 | nan | nan
chr16	GSPT1	139259.0 | GSPT1 | G1 to S phase transition-1 | 2935.0 | ENSG00000103342 | nan | nan
chr16	TNFRSF17	109545.0 | TNFRSF17, BCMA | Tumor necrosis factor receptor superfamily, member 17 (B-cell maturation factor) | 608.0 | ENSG00000048462 | nan | nan
chr16	CPPED1	615603.0 | CPPED1 | Calcineurin-like phosphoesterase domain-containing protein 1 | 55313.0 | ENSG00000103381 | nan | nan
chr16	SHISA9	613346.0 | SHISA9, CKAMP44 | Shisa family, member 9 | 729993.0 | ENSG00000237515 | nan | nan
chr16	ERCC4	133520.0 | ERCC4, XPF, FANCQ, XFEPS | ERCC excision repair 4, endonuclease catalytic subunit | 2072.0 | ENSG00000175595 | nan | Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive; XFE progeroid syndrome, 610965 (3), Autosomal recessive; Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive; Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive
chr16	MRTFB	609463.0 | MRTFB, MKL2 | Myocardin-related transcription factor B | 57496.0 | ENSG00000186260 | nan | nan
chr16	MIR193B	614734.0 | MIR193B | Micro RNA 193B | 574455.0 | ENSG00000207639 | nan | nan
chr16	MIR365A	614735.0 | MIR365A | Micro RNA 365A | 100126355.0 | ENSG00000199130 | nan | nan
chr16	PARN	604212.0 | PARN, DAN, DKCB6, PFBMFT4 | Polyadenylate-specific ribonuclease | 5073.0 | ENSG00000140694 | nan | Dyskeratosis congenita, autosomal recessive 6, 616353 (3), Autosomal recessive; Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 4, 616371 (3), Autosomal dominant
chr16	BFAR	619516.0 | BFAR, BAR | Bifunctional apoptosis regulator | 51283.0 | ENSG00000103429 | nan | nan
chr16	PLA2G10	603603.0 | PLA2G10, SPLA2, GXSPLA2 | Phospholipase A2, group X | 8399.0 | ENSG00000069764 | nan | nan
chr16	NOMO1	609157.0 | NOMO1 | Nodal modulator 1 | 23420.0 | ENSG00000103512 | nan | nan
chr16	NPIPA1	606406.0 | NPIP | Nuclear pore complex-interacting protein | 9284.0 | ENSG00000183426 | nan | nan
chr16	PDXDC1	614244.0 | PDXDC1, KIAA0251 | Pyridoxal-dependent decarboxylase domain-containing protein 1 | 23042.0 | ENSG00000179889 | nan | nan
chr16	NTAN1	615367.0 | NTAN1 | N-terminal asparagine amidase | 123803.0 | ENSG00000157045 | nan | nan
chr16	RRN3	605121.0 | RRN3, TIFIA | RRN3, S. cerevisiae, homolog of | 54700.0 | ENSG00000085721 | nan | nan
chr16	MPV17L	618100.0 | MPV17L | MPV17 mitochondrial inner membrane protein-like | 255027.0 | ENSG00000156968 | nan | nan
chr16	MARF1	614593.0 | MARF1, KIAA0430, LKAP | Meiosis regulator and mRNA stability factor 1 | 9665.0 | ENSG00000166783 | nan | nan
chr16	NDE1	609449.0 | NDE1, NUDE, LIS4, MHAC | nudE neurodevelopment protein 1 | 54820.0 | ENSG00000072864 | nan | Microhydranencephaly, 605013 (3), Autosomal recessive; Lissencephaly 4 (with microcephaly), 614019 (3), Autosomal recessive
chr16	MYH11	160745.0 | MYH11, AAT4, FAA4, VSCM2 | Myosin, heavy polypeptide-11, smooth muscle | 4629.0 | ENSG00000133392 | fused with CBFB by inversion in acute myelomonocytic leukemia | Megacystis-microcolon-intestinal hypoperistalsis syndrome 2, 619351 (3), Autosomal recessive; Aortic aneurysm, familial thoracic 4, 132900 (3), Autosomal dominant; Visceral myopathy 2, 619350 (3), Autosomal dominant
chr16	CEP20	617149.0 | CEP20, FOPNL, FOR20, C16orf63 | Centrosomal protein 20 | 123811.0 | ENSG00000133393 | nan | nan
chr16	ABCC1	158343.0 | ABCC1, MRP1, MRP, DFNA77 | ATP-binding cassette, subfamily C, member 1 (multidrug resistance-associated protein 1) | 4363.0 | ENSG00000103222 | mutation identified in 1 DFNA77 family | ?Deafness, autosomal dominant 77, 618915 (3), Autosomal dominant
chr16	ABCC6	603234.0 | ABCC6, ARA, ABC34, MLP1, PXE, GACI2 | ATP-binding cassette, subfamily C, member 6 | 368.0 | ENSG00000091262 | nan | Pseudoxanthoma elasticum, 264800 (3), Autosomal recessive; Arterial calcification, generalized, of infancy, 2, 614473 (3), Autosomal recessive; Pseudoxanthoma elasticum, forme fruste, 177850 (3), Autosomal dominant
chr16	NOMO3	609159.0 | NOMO3 | Nodal modulator 3 | 408050.0 | ENSG00000103226 | nan | nan
chr16		136570.0 | DEL16p12.1, C16DELp12.1 | Chromosome 16p12.1 deletion syndrome, 520kb | nan | nan | between 21.85-22.37 Mb | Chromosome 16p12.1 deletion syndrome, 520kb, 136570 (4)
chr16	MAFD4	611247.0 | MAFD4, BPAD | Major affective disorder 4 | 100126593.0 | nan | max lod at D16S769 | Major affective disorder 4, 611247 (2)
chr16	RP22	602594.0 | RP22 | Retinitis pigmentosa-22 | 6114.0 | nan | nan | Retinitis pigmentosa 22, 602594 (2)
chr16		609939.0 | SLEB6 | Systemic lupus erythematosus, susceptibility to, 6 | nan | nan | nan | {Systemic lupus erythematosus, susceptibility to, 6}, 609939 (2)
chr16	XYLT1	608124.0 | XYLT1, XT1, DBQD2 | Xylosyltransferase 1 | 64131.0 | ENSG00000103489 | nan | Desbuquois dysplasia 2, 615777 (3), Autosomal recessive; {Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3), Autosomal recessive
chr16	NOMO2	609158.0 | NOMO2 | Nodal modulator 2 | 283820.0 | ENSG00000185164 | nan | nan
chr16	RPS15A	603674.0 | RPS15A, DBA20 | Ribosomal protein S15a | 6210.0 | ENSG00000134419 | mutation identified in 1 DBA20 family | ?Diamond-Blackfan anemia 20, 618313 (3), Autosomal dominant
chr16	ARL6IP1	607669.0 | ARL6IP1, KIAA0069, SPG61 | ADP ribosylation factor-like GTPase 6 interacting protein 1 | 23204.0 | ENSG00000170540 | nan | Spastic paraplegia 61, autosomal recessive, 615685 (3), Autosomal recessive
chr16	SMG1	607032.0 | SMG1, LIP, KIAA0421 | SMG1 nonsense-mediated mRNA decay-associated PI3K-related kinase | 23049.0 | ENSG00000157106 | nan | nan
chr16	TMC7	617198.0 | TMC7 | Transmembrane channel-like protein 7 | 79905.0 | ENSG00000170537 | nan | nan
chr16	COQ7	601683.0 | COQ7, CLK1, COQ10D8, HMNR9 | COQ7, S. cerevisiae, homolog of | 10229.0 | ENSG00000167186 | nan | Coenzyme Q10 deficiency, primary, 8, 616733 (3), Autosomal recessive; Neuronopathy, distal hereditary motor, autosomal recessive 9, 620402 (3), Autosomal recessive
chr16	TMC5	617197.0 | TMC5 | Transmembrane channel-like protein 5 | 79838.0 | ENSG00000103534 | nan | nan
chr16	GDE1	605943.0 | GDE1, MIR16 | Glycerophosphodiester phosphodiesterase 1 | 51573.0 | ENSG00000006007 | nan | nan
chr16	CCP110	609544.0 | CCP110, CP110, KIAA0419 | Centrosomal coiled-coil protein, 110kD | 9738.0 | ENSG00000103540 | nan | nan
chr16	VPS35L	618981.0 | VPS35L, C16orf62, EC97, RTSC3 | VPS35 endosomal protein-sorting factor-like | 57020.0 | ENSG00000103544 | nan | Ritscher-Schinzel syndrome 3, 619135 (3), Autosomal recessive
chr16	GPRC5B	605948.0 | GPRC5B, RAIG2, MLC3 | G protein-coupled receptor, family C, group 5, member B | 51704.0 | ENSG00000167191 | nan | Megalencephalic leukoencephalopathy with subcortical cysts 3, 620447 (3), Autosomal dominant
chr16	GPR139	618448.0 | GPR139, GPRG1 | G protein-coupled receptor 139 | 124274.0 | ENSG00000180269 | nan | nan
chr16	GP2	602977.0 | GP2 | Glycoprotein 2, zymogen granule membrane | 2813.0 | ENSG00000169347 | previously assigned to chr.9 | nan
chr16	UMOD	191845.0 | UMOD, ADTKD1 | Uromodulin (uromucoid, Tamm-Horsfall glycoprotein) | 7369.0 | ENSG00000169344 | nan | Tubulointerstitial kidney disease, autosomal dominant, 1, 162000 (3), Autosomal dominant
chr16	PDILT	618588.0 | PDILT, PDIA7 | Protein disulfide isomerase-like protein, testis-expressed | 204474.0 | ENSG00000169340 | nan | nan
chr16	ACSM5	614361.0 | ACSM5 | Acyl-CoA synthetase medium-chain family, member 5 | 54988.0 | ENSG00000183549 | nan | nan
chr16	ACSM2A	614358.0 | ACSM2A | Acyl-CoA synthetase medium-chain family, member 2A | 123876.0 | ENSG00000183747 | nan | nan
chr16	ACSM2B	614359.0 | ACSM2B, HXMA | Acyl-CoA synthetase medium-chain family, member 2B | 348158.0 | ENSG00000066813 | nan | nan
chr16	ACSM1	614357.0 | ACSM1, MACS1 | Acyl-CoA synthetase medium-chain family, member 1 | 116285.0 | ENSG00000166743 | nan | nan
chr16	ACSM3	145505.0 | ACSM3, SAH | Acyl-CoA synthetase medium-chain family member 3 | 6296.0 | ENSG00000005187 | nan | {?Hypertension, essential} (1)
chr16	THUMPD1	616662.0 | THUMPD1, NEDSOA | THUMP domain-containing protein 1 | 55623.0 | ENSG00000066654 | nan | Neurodevelopmental disorder with speech delay and variable ocular anomalies, 619989 (3), Autosomal recessive
chr16	DCUN1D3	616167.0 | DCUN1D3, SCCRO3 | DCN1 domain-containing protein 3 | 123879.0 | ENSG00000188215 | nan | nan
chr16	LYRM1	614709.0 | LYRM1 | LYR motif-containing protein 1 | 57149.0 | ENSG00000102897 | nan | nan
chr16	DNAH3	603334.0 | DNAH3, DNAHC3B | Dynein, axonemal, heavy chain 3 | 55567.0 | ENSG00000158486 | nan | nan
chr16	LDAF1	611304.0 | TMEM159 | Transmembrane protein 159 | 57146.0 | ENSG00000011638 | nan | nan
chr16	ZP2	182888.0 | ZP2, OZEMA6 | Zona pellucida glycoprotein 2 | 7783.0 | ENSG00000103310 | nan | Oocyte/zygote/embryo maturation arrest 6, 618353 (3), Autosomal recessive
chr16		613604.0 | DEL16p12.1p11.2, C16DELp12.1p11.2 | Chromosome 16p12.2-p11.2 deletion syndrome | nan | nan | 17.1-8.7 Mb contiguous gene deletion syndrome | Chromosome 16p12.2-p11.2 deletion syndrome, 613604 (4), Isolated cases
chr16	MRT10	611096.0 | MRT10, MRT20 | Intellectual developmental disorder, autosomal recessive 10/20 | 100101425.0 | nan | between rs724466 and rs3901517, rs7197568 and rs71972227 | Intellectual developmental disorder, autosomal recessive 10/20, 611096 (2), Autosomal recessive
chr16	ANKS4B	609901.0 | ANKS4B, HARP, FLJ38819 | Ankyrin repeat and sterile alpha motif domain-containing protein 4B | 257629.0 | ENSG00000175311 | nan | nan
chr16	CRYM	123740.0 | CRYM, DFNA40 | Crystallin, mu | 1428.0 | ENSG00000103316 | nan | Deafness, autosomal dominant 40, 616357 (3), Autosomal dominant
chr16	NPIPB3	619984.0 | NPIPB3, KIAA0220L | Nuclear pore complex-interacting protein family, member B3 | 23117.0 | nan | nan | nan
chr16	METTL9	609388.0 | METTL9, DREV | Methyltransferase-like 9 | 51108.0 | ENSG00000197006 | nan | nan
chr16	IGSF6	606222.0 | IGSF6, DORA | Immunoglobulin superfamily, member 6 | 10261.0 | ENSG00000140749 | nan | nan
chr16	OTOA	607038.0 | OTOA, DFNB22 | Otoancorin | 146183.0 | ENSG00000155719 | nan | Deafness, autosomal recessive 22, 607039 (3), Autosomal recessive
chr16	UQCRC2	191329.0 | UQCRC2, MC3DN5 | Ubiquinol-cytochrome c reductase core protein II | 7385.0 | ENSG00000140740 | nan | Mitochondrial complex III deficiency, nuclear type 5, 615160 (3), Autosomal recessive
chr16	EEF2K	606968.0 | EEF2K | Elongation factor 2 kinase | 29904.0 | ENSG00000103319 | nan | nan
chr16	POLR3E	617815.0 | POLR3E, SIN, KIAA1452 | Polymerase III, RNA, subunit E | 55718.0 | ENSG00000058600 | nan | nan
chr16	CDR2	117340.0 | CDR2 | Cerebellar degeneration-related antigen-2, 62kD | 1039.0 | ENSG00000140743 | nan | nan
chr16	HS3ST2	604056.0 | HS3ST2, 30ST2 | Heparan sulfate-glucosamine 3-sulfotransferase 2 | 9956.0 | ENSG00000122254 | nan | nan
chr16	USP31	619536.0 | USP31, KIAA1203 | Ubiquitin-specific peptidase 31 | 57478.0 | ENSG00000103404 | nan | nan
chr16	SCNN1G	600761.0 | SCNN1G, PHA1B3, BESC3, LDLS2 | Sodium channel, epithelial 1, subunit gamma | 6340.0 | ENSG00000166828 | same 400kb fragment as SCNN1B | Bronchiectasis with or without elevated sweat chloride 3, 613071 (3), Autosomal dominant; Pseudohypoaldosteronism, type IB3, autosomal recessive, 620126 (3), Autosomal recessive; Liddle syndrome 2, 618114 (3), Autosomal dominant
chr16	SCNN1B	600760.0 | SCNN1B, BESC1, LIDLS1, PHA1B2 | Sodium channel, epithelial 1, subunit beta | 6338.0 | ENSG00000168447 | nan | Bronchiectasis with or without elevated sweat chloride 1, 211400 (3), Autosomal dominant; Pseudohypoaldosteronism, type IB2, autosomal recessive, 620125 (3), Autosomal recessive; Liddle syndrome 1, 177200 (3), Autosomal dominant
chr16	COG7	606978.0 | COG7, CDG2E | Component of oligomeric golgi complex 7 | 91949.0 | ENSG00000168434 | nan | Congenital disorder of glycosylation, type IIe, 608779 (3), Autosomal recessive
chr16	GGA2	606005.0 | GGA2, VEAR | Golgi-associated, gamma-adaptin ear-containing, ARF-binding protein 2 | 23062.0 | ENSG00000103365 | nan | nan
chr16	EARS2	612799.0 | EARS2, KIAA1970, COXPD12 | Glutamyl-tRNA synthetase 2 | 124454.0 | ENSG00000103356 | nan | Combined oxidative phosphorylation deficiency 12, 614924 (3), Autosomal recessive
chr16	NDUFAB1	603836.0 | NDUFAB1 | NADH-ubiquinone oxidoreductase subunit AB1 | 4706.0 | ENSG00000004779 | nan | nan
chr16	PALB2	610355.0 | PALB2, FANCN, PNCA3, BROVCA5 | Partner and localizer of BRCA2 | 79728.0 | ENSG00000083093 | nan | {Breast-ovarian cancer, familial, susceptibility to, 5}, 620442 (3), Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3), Autosomal dominant; Fanconi anemia, complementation group N, 610832 (3)
chr16	DCTN5	612962.0 | DCTN5, p25 | Dynactin 5 | 84516.0 | ENSG00000166847 | nan | nan
chr16	PLK1	602098.0 | PLK1, STPK13 | Polo-like kinase 1 | 5347.0 | ENSG00000166851 | nan | nan
chr16	ERN2	604034.0 | ERN2 | Endoplasmic reticulum-to-nucleus signaling 2 | 10595.0 | ENSG00000134398 | nan | nan
chr16	PRKCB	176970.0 | PRKCB1, PKCB | Protein kinase C, beta 1 polypeptide | 5579.0 | ENSG00000166501 | nan | nan
chr16	MMVP1	157700.0 | MMVP1, MVP, PMV | Mitral valve prolapse, myxomatous 1 | 50951.0 | nan | nan | Mitral valve prolapse, myxomatous 1, 157700 (2), Autosomal dominant
chr16	CACNG3	606403.0 | CACNG3 | Calcium channel, voltage-dependent, gamma-3 subunit | 10368.0 | ENSG00000006116 | nan | nan
chr16	RBBP6	600938.0 | RBBP6 | Retinoblastoma-binding protein-6 | 5930.0 | ENSG00000122257 | nan | nan
chr16	TNRC6A	610739.0 | TNRC6A, GW182, KIAA1460, FAME6 | Trinucleotide repeat-containing gene 6A | 27327.0 | ENSG00000090905 | mutation identified in 1 FAME6 family | ?Epilepsy, familial adult myoclonic, 6, 618074 (3), Autosomal dominant
chr16	SLC5A11	610238.0 | SLC5A11, KST1, SGLT6, SMIT2 | Solute carrier family 5 (sodium/glucose cotransporter), member 11 | 115584.0 | ENSG00000158865 | nan | nan
chr16	ARHGAP17	608293.0 | ARHGAP17, RICH1 | RHO GTPase-activating protein 17 | 55114.0 | ENSG00000140750 | nan | nan
chr16	LCMT1	610286.0 | LCMT1 | Leucine carboxyl methyltransferase 1 | 51451.0 | ENSG00000205629 | nan | nan
chr16	AQP8	603750.0 | AQP8 | Aquaporin 8 | 343.0 | ENSG00000103375 | nan | nan
chr16	HS3ST4	604059.0 | HS3ST4, 30ST4 | Heparan sulfate-glucosamine 3-sulfotransferase 4 | 9951.0 | ENSG00000182601 | nan | nan
chr16	KDM8	611917.0 | KDM8, JMJD5 | Lysine demethylase 8 | 79831.0 | ENSG00000155666 | nan | nan
chr16	NSMCE1	617263.0 | NSMCE1, NSE1 | NSE1 homolog, SMC5-SMC6 complex component | 197370.0 | ENSG00000169189 | nan | nan
chr16	IL4R	147781.0 | IL4R, IL4RA | Interleukin-4 receptor | 3566.0 | ENSG00000077238 | nan | nan
chr16	IL21R	605383.0 | IL21R, IMD56 | Interleukin 21 receptor | 50615.0 | ENSG00000103522 | fusion partner with BCL6 | Immunodeficiency 56, 615207 (3), Autosomal recessive
chr16	GTF3C1	603246.0 | GTF3C1 | General transcription factor 3C, polypeptide 1 | 2975.0 | ENSG00000077235 | nan | nan
chr16	KATNIP	616650.0 | KATNIP, KIAA0556 | Katanin-interacting protein | 23247.0 | ENSG00000047578 | nan | Joubert syndrome 26, 616784 (3), Autosomal recessive
chr16	GSG1L	617161.0 | GSG1L | GSG1-like protein | 146395.0 | ENSG00000169181 | nan | nan
chr16	XPO6	608411.0 | XPO6, EXP6, KIAA0370 | Exportin 6 | 23214.0 | ENSG00000169180 | nan | nan
chr16	SBK1	620212.0 | SBK1 | SH3 domain-binding kinase 1 | 388228.0 | ENSG00000188322 | nan | nan
chr16	CLN3	607042.0 | CLN3, BTS | CLN3 lysosomal/endosomal transmembrane protein, Battenin | 1201.0 | ENSG00000188603 | nan | Ceroid lipofuscinosis, neuronal, 3, 204200 (3), Autosomal recessive
chr16	APOBR	605220.0 | APOBR, APOB48R | Apolipoprotein B receptor | 55911.0 | ENSG00000184730 | nan | nan
chr16	IL27	608273.0 | IL27, IL30 | Interleukin 27 | 246778.0 | ENSG00000197272 | nan | nan
chr16		613444.0 | BMIQ16, DEL16p.11.2, C16DELp11.2 | Chromosome 16p11.2 deletion syndrome, 220kb | nan | nan | nan | Chromosome 16p11.2 deletion syndrome, 220kb, 613444 (4), Isolated cases, Autosomal dominant; [Body mass index QTL16], 613444 (4), Isolated cases, Autosomal dominant
chr16		611913.0 | DEL16p11.2, C16DELp11.2, AUTS14A | Chromosome 16p11.2 deletion syndrome, 593kb | nan | nan | nan | {Autism susceptibility 14A}, 611913 (2), Autosomal dominant; Chromosome 16p11.2 deletion syndrome, 593kb, 611913 (4), Autosomal dominant
chr16		614671.0 | DUP16p11.2, C16DUPp11.2, AUTS14B | Chromosome 16p11.2 duplication syndrome | nan | nan | nan | Chromosome 16p11.2 duplication syndrome, 614671 (4), Isolated cases, Autosomal dominant; {Autism, susceptibility to, 14B}, 614671 (2), Isolated cases, Autosomal dominant
chr16		615835.0 | INV16p11 | Chromosome 16p11 inversion (0.45Mb) | nan | nan | nan | nan
chr16	NUPR1	614812.0 | NUPR1, COM1, p8 | Nuclear protein, transcriptional regulator, 1 | 26471.0 | ENSG00000176046 | nan | nan
chr16	SGF29	613374.0 | CCDC101, STAF36 | Coiled-coil domain-containing protein 101 | 112869.0 | ENSG00000176476 | nan | nan
chr16	SULT1A2	601292.0 | SULT1A2, STP2 | Sulfotransferase family 1A, phenol-preferring, member 2 | 6799.0 | ENSG00000197165 | 45kb from STP1 | nan
chr16	SULT1A1	171150.0 | SULT1A1, STP1, STP, PST | Sulfotransferase family 1A, phenol-preferring, member 1 | 6817.0 | ENSG00000196502 | nan | nan
chr16	EIF3C	603916.0 | EIF3C, EIF3S8 | Eukaryotic translation initiation factor 3, subunit C | 8663.0 | ENSG00000184110 | nan | nan
chr16	ATXN2L	607931.0 | ATXN2L, A2D | Ataxin 2-like | 11273.0 | ENSG00000168488 | pseudogene at 7p21 | nan
chr16	TUFM	602389.0 | TUFM, EFTU, COXPD4 | Tu translation elongation factor, mitochondrial | 7284.0 | ENSG00000178952 | pseudogene on chr.17 | Combined oxidative phosphorylation deficiency 4, 610678 (3), Autosomal recessive
chr16	SH2B1	608937.0 | SH2B1, SH2B, KIAA1299 | SH2B adaptor protein 1 | 25970.0 | ENSG00000178188 | nan | nan
chr16	ATP2A1	108730.0 | ATP2A1, SERCA1 | ATPase, Ca++ transporting, fast-twitch, 1 | 487.0 | ENSG00000196296 | nan | Brody myopathy, 601003 (3), Autosomal recessive
chr16	RABEP2	611869.0 | RABEP2 | RAB GTPase-binding effector protein 2 | 79874.0 | ENSG00000177548 | nan | nan
chr16	CD19	107265.0 | CD19, CVID3 | CD19 antigen | 930.0 | ENSG00000177455 | nan | Immunodeficiency, common variable, 3, 613493 (3), Autosomal recessive
chr16	NFATC2IP	614525.0 | NFATC2IP, NIP45 | NFATC2-interacting protein | 84901.0 | ENSG00000176953 | nan | nan
chr16	SPNS1	612583.0 | SPNS1, SPIN1 | Spinster, Drosophila, homolog of, 1 | 83985.0 | ENSG00000169682 | nan | nan
chr16	LAT	602354.0 | LAT, IMD52 | Linker for activation of T cells | 27040.0 | ENSG00000213658 | nan | Immunodeficiency 52, 617514 (3), Autosomal recessive
chr16	BOLA2	613182.0 | BOLA2 | bolA family member 2 | 552900.0 | ENSG00000183336 | nan | nan
chr16	SLX1B	615823.0 | SLX1B, GIYD2 | SLX1 homolog B, structure-specific endonuclease subunit | 79008.0 | ENSG00000181625 | nan | nan
chr16	SULT1A4	615819.0 | SULT1A4 | Sulfotransferase family 1A, cytosolic, phenol-preferring, member 4 | 445329.0 | ENSG00000213648 | nan | nan
chr16	SPN	182160.0 | SPN, LSN, CD43 | Sialophorin (leukosialin) | 6693.0 | ENSG00000197471 | nan | nan
chr16	QPRT	606248.0 | QPRT | Quinolinate phosphoribosyltransferase | 23475.0 | ENSG00000103485 | nan | nan
chr16	ZG16	617311.0 | ZG16, ZG16A, JCLN1 | Zymogen granule protein, 16-kD | 653808.0 | ENSG00000174992 | nan | nan
chr16	KIF22	603213.0 | KIF22, KNSL4, KID, OBP, SEMDJL2 | Kinesin family member 22 | 3835.0 | ENSG00000079616 | nan | Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3), Autosomal dominant
chr16	MAZ	600999.0 | MAZ, ZF87, PUR1 | MYC-associated zinc finger protein | 4150.0 | ENSG00000103495 | nan | nan
chr16	PRRT2	614386.0 | PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA | Proline-rich transmembrane protein 2 | 112476.0 | ENSG00000167371 | nan | Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3), Autosomal dominant; Seizures, benign familial infantile, 2, 605751 (3), Autosomal dominant; Episodic kinesigenic dyskinesia 1, 128200 (3), Autosomal dominant
chr16	PAGR1	612033.0 | PAGR1, C16orf53, PA1 | PAXIP1-associated glutamate-rich protein 1 | 79447.0 | ENSG00000280789 | nan | nan
chr16	MVP	605088.0 | MVP, LRP | Major vault protein | 9961.0 | ENSG00000013364 | nan | nan
chr16	CDIPT	605893.0 | CDIPT, PIS1 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase | 10423.0 | ENSG00000103502 | nan | nan
chr16	SEZ6L2	616667.0 | SEZ6L2, BSRPA | SEZ6-like protein 2 | 26470.0 | ENSG00000174938 | nan | nan
chr16	KCTD13	608947.0 | KCTD13, POLDIP1, FKSG86 | Potassium channel tetramerization domain-containing 13 | 253980.0 | ENSG00000174943 | nan | nan
chr16	TMEM219	620290.0 | TMEM219, IGFBP3R | Transmembrane protein 219 | 124446.0 | ENSG00000149932 | nan | nan
chr16	TAOK2	613199.0 | TAOK2, TAO2, KIAA0881, PSK, PSK1 | Tao kinase 2 | 9344.0 | ENSG00000149930 | nan | nan
chr16	HIRIP3	603365.0 | HIRIP3 | HIRA-interacting protein 3 | 8479.0 | ENSG00000149929 | nan | nan
chr16	DOC2A	604567.0 | DOC2A | Double C2-like domain-containing protein, alpha | 8448.0 | ENSG00000149927 | nan | nan
chr16	C16orf92	618911.0 | C16orf92, FIMP | Chromosome 16 open reading frame 92 | 146378.0 | ENSG00000167194 | nan | nan
chr16	TLCD3B	615175.0 | TLCD3B, FAM57B, CORD22 | TLC domain-containing protein 3B | 83723.0 | ENSG00000149926 | nan | Cone-rod dystrophy 22, 619531 (3), Autosomal recessive
chr16	ALDOA	103850.0 | ALDOA, GSD12 | Aldolase A, fructose-bisphosphatase | 226.0 | ENSG00000149925 | pseudogenes on 3 and 10 | Glycogen storage disease XII, 611881 (3), Autosomal recessive
chr16	PPP4C	602035.0 | PPP4C, PP4, PPX | Protein phosphatase 4, catalytic subunit | 5531.0 | ENSG00000149923 | nan | nan
chr16	TBX6	602427.0 | TBX6, SCDO5 | T-box 6 | 6911.0 | ENSG00000149922 | nan | Spondylocostal dysostosis 5, 122600 (3), Autosomal recessive, Autosomal dominant
chr16	YPEL3	609724.0 | YPEL3 | Yippee-like 3 | 83719.0 | ENSG00000090238 | nan | nan
chr16	GDPD3	616318.0 | GDPD3, GDE7 | Glycerophosphodiester phosphodiesterase domain-containing protein 3 | 79153.0 | ENSG00000102886 | nan | nan
chr16	MAPK3	601795.0 | MAPK3, PRKM3, ERK1 | Mitogen-activated protein kinase 3 | 5595.0 | ENSG00000102882 | nan | nan
chr16	CORO1A	605000.0 | CORO1A, TACO, CLIPINA, IMD8 | Coronin 1A | 11151.0 | ENSG00000102879 | nan | Immunodeficiency 8, 615401 (3), Autosomal recessive
chr16	SLX1A	615822.0 | SLX1A, GIYD1 | SLX1 homolog A, structure-specific endonuclease subunit | 548593.0 | ENSG00000132207 | nan | nan
chr16	SULT1A3	600641.0 | SULT1A3, STM | Sulfotransferase family 1A, phenol-preferring, member 3 | 6818.0 | ENSG00000261052 | nan | nan
chr16	CD2BP2	604470.0 | CD2BP2 | CD2 antigen-binding protein 2 | 10421.0 | ENSG00000169217 | nan | nan
chr16	TBC1D10B	613620.0 | TBC1D10B | TBC1 domain family, member 10B | 26000.0 | ENSG00000169221 | nan | nan
chr16	MYL11	617378.0 | MYL11, MLC2B, MRLC2, MYLPF, DA1C | Myosin light chain 11 | 29895.0 | ENSG00000180209 | nan | Arthrogryposis, distal, type 1C, 619110 (3), Autosomal recessive, Autosomal dominant
chr16	SEPTIN1	612897.0 | SEPT1, DIFF6 | Septin 1 | 1731.0 | ENSG00000180096 | nan | nan
chr16	DCTPP1	615840.0 | DCTPP1 | dCTP pyrophosphatase 1 | 79077.0 | ENSG00000179958 | nan | nan
chr16	SEPHS2	606218.0 | SEPHS2, SPS2 | Selenophosphate synthetase 2 | 22928.0 | ENSG00000179918 | nan | nan
chr16	ITGAL	153370.0 | ITGAL, CD11A, LFA1A | Integrin, alpha-L (antigen CD11A (p180), lymphocyte function-associated antigen-1, alpha polypeptide) | 3683.0 | ENSG00000005844 | nan | nan
chr16	ZNF768	618032.0 | ZNF768 | Zinc finger protein 768 | 79724.0 | ENSG00000169957 | nan | nan
chr16	ZNF764	619524.0 | ZNF764 | Zinc finger protein 764 | 92595.0 | ENSG00000169951 | nan | nan
chr16	ZNF689	618033.0 | ZNF689, TIPUH1 | Zinc finger protein 689 | 115509.0 | ENSG00000156853 | nan | nan
chr16	PRR14	617423.0 | PRR14 | Proline-rich protein 14 | 78994.0 | ENSG00000156858 | nan | nan
chr16	FBRS	608601.0 | FBRS, FBS1 | Fibrosin | 64319.0 | ENSG00000156860 | nan | nan
chr16	SRCAP	611421.0 | SRCAP, SWR1, KIAA0309, FLHS, DEHMBA | SNF2-related CBP activator protein | 10847.0 | ENSG00000080603 | nan | Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities, 619595 (3), Autosomal dominant; Floating-Harbor syndrome, 136140 (3), Autosomal dominant
chr16	PHKG2	172471.0 | PHKG2, GSD9C | Phosphorylase kinase, gamma 2 (testis/liver) | 5261.0 | ENSG00000156873 | nan | Glycogen storage disease IXc, 613027 (3), Autosomal recessive
chr16	CFAP119	618318.0 | CFAP119, CCDC189, C16orf93 | Cilia- and flagella-associated protein 119 | 90835.0 | ENSG00000196118 | nan | nan
chr16	RNF40	607700.0 | RNF40, BRE1B, RBP95, KIAA0661 | Ring finger protein 40 | 9810.0 | ENSG00000103549 | nan | nan
chr16	ZNF629	619587.0 | ZNF629, KIAA0326 | Zinc finger protein 629 | 23361.0 | ENSG00000102870 | nan | nan
chr16	BCL7C	605847.0 | BCL7C | BAF chromatin remodeling complex subunit BCL7C | 9274.0 | ENSG00000099385 | nan | nan
chr16	CTF1	600435.0 | CTF1, CT1 | Cardiotrophin 1 | 1489.0 | ENSG00000150281 | nan | nan
chr16	FBXL19	609085.0 | FBXL19, FBL19 | F-box and leucine-rich repeat protein 19 | 54620.0 | ENSG00000099364 | nan | nan
chr16	ORAI3	610930.0 | ORAI3, TMEM142C | ORAI calcium release-activated calcium modulator 3 | 93129.0 | ENSG00000175938 | nan | nan
chr16	SETD1A	611052.0 | SETD1A, SET1A, SET1, KIAA0339, EPEO2, NEDSID | SET domain-containing protein 1A | 9739.0 | ENSG00000099381 | nan | Epilepsy, early-onset, 2, with or without developmental delay, 618832 (3), Autosomal dominant; Neurodevelopmental disorder with speech impairment and dysmorphic facies, 619056 (3), Autosomal dominant
chr16	HSD3B7	607764.0 | HSD3B7, CBAS1 | 3-beta-hydroxy-delta-5-C27-steroid oxidoreductase | 80270.0 | ENSG00000099377 | nan | Bile acid synthesis defect, congenital, 1, 607765 (3), Autosomal recessive
chr16	STX1B	601485.0 | STX1B, GEFSP9 | Syntaxin 1B | 112755.0 | ENSG00000099365 | nan | Generalized epilepsy with febrile seizures plus, type 9, 616172 (3), Autosomal dominant
chr16	STX4	186591.0 | STX4, STX4A, DFNB123 | Syntaxin 4 | 6810.0 | ENSG00000103496 | mutation identified in 1 DFNB123 family | ?Deafness, autosomal recessive 123, 620745 (3), Autosomal recessive
chr16	ZNF668	617103.0 | ZNF668, NEDGEF | Zinc finger protein 668 | 79759.0 | ENSG00000167394 | nan | Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies, 620194 (3), Autosomal recessive
chr16	ZNF646	619299.0 | ZNF646 | Zinc finger protein | 9726.0 | ENSG00000167395 | nan | nan
chr16	PRSS53	610561.0 | PRSS53, POL3S | Protease, serine, 53 | 339105.0 | ENSG00000151006 | nan | nan
chr16	VKORC1	608547.0 | VKORC1, VKOR, VKCFD2, FLJ00289 | Vitamin K epoxide reductase complex, subunit 1 | 79001.0 | ENSG00000167397 | nan | Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3), Autosomal recessive; Warfarin resistance, 122700 (3), Autosomal dominant
chr16	BCKDK	614901.0 | BCKDK, BDK, BCKDKD | Branched-chain alpha-keto acid dehydrogenase kinase | 10295.0 | ENSG00000103507 | nan | Branched-chain keto acid dehydrogenase kinase deficiency, 614923 (3), Autosomal recessive
chr16	KAT8	609912.0 | KAT8, MYST1, MOF, LIGOWS | K(lysine) acetyltransferase 8 | 84148.0 | ENSG00000103510 | nan | Li-Ghorgani-Weisz-Hubshman syndrome, 618974 (3), Autosomal dominant
chr16	PRSS8	600823.0 | PRSS8 | Protease, serine, 8 (prostasin) | 5652.0 | ENSG00000052344 | nan | nan
chr16	PRSS36	610560.0 | PRSS36 | Protease, serine, 36 | 146547.0 | ENSG00000178226 | nan | nan
chr16	FUS	137070.0 | FUS, TLS, ALS6, ETM4 | FUS RNA-binding protein | 2521.0 | ENSG00000089280 | fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma | Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3); Essential tremor, hereditary, 4, 614782 (3), Autosomal dominant
chr16	PYCARD	606838.0 | PYCARD, TMS1, ASC | PYD and CARD domain-containing protein (target of methylation-induced silencing 1) | 29108.0 | ENSG00000103490 | nan | nan
chr16	TRIM72	613288.0 | TRIM72, MG53 | Tripartite motif-containing protein 72 | 493829.0 | ENSG00000177238 | nan | nan
chr16	PYDC1	615700.0 | PYDC1, POP1, PYC1, ASC2 | Pyrin domain-containing protein 1 | 260434.0 | ENSG00000169900 | nan | nan
chr16	ITGAM	120980.0 | ITGAM, CR3A, CD11B, MAC1A, SLEB6 | Integrin, alpha-M (complement component receptor-3, alpha; antigen CD11B (p170); macrophage antigen, alpha polypeptide) | 3684.0 | ENSG00000169896 | ?in same restriction fragment as LFA1A | nan
chr16	ITGAX	151510.0 | ITGAX, CD11C | Integrin, alpha-X (antigen CD11C (p150), alpha polypeptide) | 3687.0 | ENSG00000140678 | nan | nan
chr16	ITGAD	602453.0 | ITGAD, CD11D | Integrin, alpha D | 3681.0 | ENSG00000156886 | nan | nan
chr16	COX6A2	602009.0 | COX6A2, MC4DN18 | Cytochrome c oxidase, subunit 6A2 | 1339.0 | ENSG00000156885 | nan | Mitochondrial complex IV deficiency, nuclear type 18, 619062 (3), Autosomal recessive
chr16	ARMC5	615549.0 | ARMC5, AIMAH2 | Armadillo repeat-containing protein 5 | 79798.0 | ENSG00000140691 | nan | {ACTH-independent macronodular adrenal hyperplasia 2}, 615954 (3), Autosomal dominant
chr16	TGFB1I1	602353.0 | TGFB1I1, ARA55, HIC5 | Transforming growth factor, beta-1-induced 1 | 7041.0 | ENSG00000140682 | nan | nan
chr16	SLC5A2	182381.0 | SLC5A2, SGLT2 | Solute carrier family 5 (sodium/glucose cotransporter), member 2 | 6524.0 | ENSG00000140675 | nan | Renal glucosuria, 233100 (3), Autosomal recessive, Autosomal dominant
chr16	AHSP	605821.0 | AHSP, ERAF, EDRF | Alpha-hemoglobin stabilizing protein | 51327.0 | ENSG00000169877 | nan | nan
chr16	ZNF267	604752.0 | ZNF267, HZF2 | Zinc finger protein-167 | 10308.0 | ENSG00000185947 | nan | nan
chr16	TP53TG3	617482.0 | TP53TG3 | TP53 target gene 3 | 24150.0 | ENSG00000183632 | nan | nan
chr16	AA2	610753.0 | AA2 | Alopecia areata 2 | 100034703.0 | nan | max lod at D16S415 | Alopecia areata 2, 610753 (2), Autosomal recessive, Autosomal dominant
chr16	DUPC1	126900.0 | DUPC1 | Dupuytren contracture 1 | 780895.0 | nan | max lod at D16S415 | Dupuytren contracture 1, 126900 (2), Autosomal dominant
chr16	PSORS8	610707.0 | PSORS8 | Psoriasis susceptibility 8 | 140454.0 | nan | proximal to D16S3034 | {Psoriasis susceptibility 8}, 610707 (2)
chr16	SLI1	606711.0 | SLI1 | Specific language impairment QTL, 1 | 171013.0 | nan | nan | Specific language impairment QTL, 1, 606711 (2), Multifactorial
chr16	WT3	194090.0 | WT3 | Wilms tumor-3 | 8136.0 | nan | loss of heterozygosity | Wilms tumor, type 3, 194090 (2), Autosomal dominant
chr16	SHCBP1	611027.0 | SHCBP1, PAL | SHC-binding and spindle-associated protein 1 | 79801.0 | ENSG00000171241 | nan | nan
chr16	VPS35	601501.0 | VPS35, MEM3, PARK17 | VPS35 retromer complex component | 55737.0 | ENSG00000069329 | nan | {Parkinson disease 17}, 614203 (3), Autosomal dominant
chr16	ORC6	607213.0 | ORC6, ORC6L | Origin recognition complex, subunit 6 | 23594.0 | ENSG00000091651 | nan | Meier-Gorlin syndrome 3, 613803 (3), Autosomal recessive
chr16	MYLK3	612147.0 | MYLK3, MLCK | Myosin light chain kinase 3 | 91807.0 | ENSG00000140795 | nan | nan
chr16	GPT2	138210.0 | GPT2, ALT2, NEDSPM | Glutamate pyruvate transaminase 2 | 84706.0 | ENSG00000166123 | nan | Neurodevelopmental disorder with microcephaly and spastic paraplegia, 616281 (3), Autosomal recessive
chr16	DNAJA2	611322.0 | DNAJA2, DJ3, CPR3 | DNAJ/HSP40 homolog, subfamily A, member 2 | 10294.0 | ENSG00000069345 | nan | nan
chr16		619649.0 | C16DUPq12, DUP16q12 | Chromosome 16q12 duplication syndrome | nan | nan | nan | Chromosome 16q12 duplication syndrome, 619649 (4), Autosomal dominant
chr16	HYD2	602639.0 | STHAG2, HYD2 | Tooth agenesis, selective, 2 | 8137.0 | nan | nan | Tooth agenesis, selective, 2, 602639 (2)
chr16	STUT4	614668.0 | STUT4 | Stuttering, familial persistent, 4 | 100909385.0 | nan | max lod at D16S3043 | Stuttering, familial persistent, 4, 614668 (2)
chr16	NETO2	607974.0 | NEOT2 | Neuropilin and tolloid like 2 | 81831.0 | ENSG00000171208 | nan | nan
chr16	ITFG1	611803.0 | ITFG1, TIP | Integrin-alpha FG-gap repeat-containing protein 1 | 81533.0 | ENSG00000129636 | nan | nan
chr16	PHKB	172490.0 | PHKB | Phosphorylase kinase, beta polypeptide | 5257.0 | ENSG00000102893 | nan | Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3), Autosomal recessive
chr16	ABCC12	607041.0 | ABCC12, MRP9 | ATP-binding cassette, subfamily C, member 12 | 94160.0 | ENSG00000140798 | nan | nan
chr16	ABCC11	607040.0 | ABCC11, MRP8, EWWD, WW | ATP-binding cassette, subfamily C, member 11 | 85320.0 | ENSG00000121270 | nan | [Axillary odor, variation in], 117800 (3), Autosomal dominant; [Earwax, wet/dry], 117800 (3), Autosomal dominant; [Colostrum secretion, variation in], 117800 (3), Autosomal dominant
chr16	LONP2	617774.0 | LONP2, PLON, PSLON | LON peptidase 2, peroxisomal | 83752.0 | ENSG00000102910 | nan | nan
chr16	SIAH1	602212.0 | SIAH1, BURHAS | Seven in absentia, Drosophila, homolog of, 1 | 6477.0 | ENSG00000196470 | nan | Buratti-Harel syndrome, 619314 (3), Autosomal dominant
chr16	N4BP1	619138.0 | N4BP1, KIAA0615 | NEDD4-binding protein 1 | 9683.0 | ENSG00000102921 | nan | nan
chr16	CBLN1	600432.0 | CBLN1 | Precerebellin 1 | 869.0 | ENSG00000102924 | nan | nan
chr16	ZNF423	604557.0 | ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19 | Zinc finger protein 423 | 23090.0 | ENSG00000102935 | nan | Nephronophthisis 14, 614844 (3), Autosomal recessive, Autosomal dominant; Joubert syndrome 19, 614844 (3), Autosomal recessive, Autosomal dominant
chr16	CNEP1R1	616869.0 | CNEP1R1, NEP1R1, TMEM188 | C-terminal domain nuclear envelope phosphatase 1 regulatory subunit 1 | 255919.0 | ENSG00000205423 | nan | nan
chr16	HEATR3	614951.0 | HEATR3, SYO1, DBA21 | HEAT repeat-containing protein 3 | 55027.0 | ENSG00000155393 | nan | Diamond-Blackfan anemia 21, 620072 (3), Autosomal recessive
chr16	TENT4B	605540.0 | TENT4B, PAPD5, TUT3 | Terminal nucleotidyltransferase 4B | 64282.0 | ENSG00000121274 | nan | nan
chr16	ADCY7	600385.0 | ADCY7 | Adenylate cyclase-7 | 113.0 | ENSG00000121281 | nan | nan
chr16	BRD7	618489.0 | BRD7, BP75 | Bromodomain-containing protein 7 | 29117.0 | ENSG00000166164 | nan | nan
chr16	NKD1	607851.0 | NKD1 | NKD inhibitor of WNT signaling pathway 1 | 85407.0 | ENSG00000140807 | nan | nan
chr16	SNX20	613281.0 | SNX20, SLIC1 | Sorting nexin 20 | 124460.0 | ENSG00000167208 | nan | nan
chr16	NOD2	605956.0 | NOD2, CARD15, IBD1, CD, YAOS, BLAUS | Nucleotide-binding oligomerization domain protein 2 | 64127.0 | ENSG00000167207 | nan | Blau syndrome, 186580 (3), Autosomal dominant; {Yao syndrome}, 617321 (3), Multifactorial; {Inflammatory bowel disease 1, Crohn disease}, 266600 (3), Multifactorial
chr16	CYLD	605018.0 | CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8 | CYLD lysine-63 deubiquitinase | 1540.0 | ENSG00000083799 | mutation identified in 1 FTDALS8 family | Brooke-Spiegler syndrome, 605041 (3), Autosomal dominant; Cylindromatosis, familial, 132700 (3), Autosomal dominant; Trichoepithelioma, multiple familial, 1, 601606 (3), Autosomal dominant; ?Frontotemporal dementia and/or amyotrophic lateral sclerosis 8, 619132 (3), Autosomal dominant
chr16	SALL1	602218.0 | SALL1, HSAL1, TBS | Sal-like 1 | 6299.0 | ENSG00000103449 | nan | Townes-Brocks syndrome 1, 107480 (3), Autosomal dominant; Townes-Brocks branchiootorenal-like syndrome, 107480 (3), Autosomal dominant
chr16	TOX3	611416.0 | TOX3, TNRC9, CAGF9 | TOX high mobility group box family member 3 | 27324.0 | ENSG00000103460 | nan | nan
chr16	CHD9	616936.0 | CHD9, CREMM, PRIC320, KIAA0308 | Chromodomain helicase DNA-binding protein 9 | 80205.0 | ENSG00000177200 | nan | nan
chr16	RBL2	180203.0 | RBL2, BRUWAG | RB transcriptional corepressor-like 2 | 5934.0 | ENSG00000103479 | nan | Brunet-Wagner neurodevelopmental syndrome, 619690 (3), Autosomal recessive
chr16	AKTIP	608483.0 | AKTIP, FTS, FT1 | AKT-interacting protein | 64400.0 | ENSG00000166971 | nan | nan
chr16	RPGRIP1L	610937.0 | RPGRIP1L, KIAA1005, JBTS7, MKS5, COACH3 | RPGRIP1-like | 23322.0 | ENSG00000103494 | mutation identified in 1 COACH patient | Joubert syndrome 7, 611560 (3), Autosomal recessive; Meckel syndrome 5, 611561 (3), Autosomal recessive; ?COACH syndrome 3, 619113 (3), Autosomal recessive
chr16	FTO	610966.0 | FTO, GDFD, BMIQ14 | FTO alpha-ketoglutarate dependent dioxygenase | 79068.0 | ENSG00000140718 | nan | Growth retardation, developmental delay, facial dysmorphism, 612938 (3), Autosomal recessive; {Obesity, susceptibility to, BMIQ14}, 612460 (3), Autosomal recessive
chr16	IRX3	612985.0 | IRX3, IRXB1 | Iroquois homeobox protein 3 | 79191.0 | ENSG00000177508 | nan | nan
chr16	CRNDE	615624.0 | CRNDE | Colorectal neoplasia differentially expressed gene, noncoding | 643911.0 | ENSG00000245694 | nan | nan
chr16	IRX5	606195.0 | IRX5, HMMS | Iroquois homeobox protein 5 | 10265.0 | ENSG00000176842 | nan | Hamamy syndrome, 611174 (3), Autosomal recessive
chr16	IRX6	606196.0 | IRX6, IRX7 | Iroquois homeobox protein 6 | 79190.0 | ENSG00000159387 | nan | nan
chr16	MMP2	120360.0 | MMP2, CLG4A, MONA | Matrix metalloproteinase 2 (gelatinase A, 72kD type IV collagenase) | 4313.0 | ENSG00000087245 | near MT1,2 | Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3), Autosomal recessive
chr16	LPCAT2	612040.0 | LPCAT1, AYTL1 | Lysophosphatidylcholine acyltransferase 2 | 54947.0 | ENSG00000087253 | nan | nan
chr16	CAPNS2	616767.0 | CAPNS2, CSS2 | Calpain, small subunit 2 | 84290.0 | ENSG00000256812 | nan | nan
chr16	SLC6A2	163970.0 | SLC6A2, NAT1, NET1 | Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, cocaine- and antidepressant-sensitive | 6530.0 | ENSG00000103546 | mutation identified in 1 ORSTI family | ?Orthostatic intolerance, 604715 (3), Autosomal dominant
chr16	CES1	114835.0 | CES1, SES1 | Carboxylesterase 1 (monocyte/macrophage serine esterase 1) | 1066.0 | ENSG00000198848 | nan | Drug metabolism, altered, CES1-related, 618057 (3), Autosomal dominant
chr16	CES5A	618678.0 | CES5A, CAUXIN | Carboxylesterase 5A | 221223.0 | ENSG00000159398 | nan | nan
chr16	ANMA	605746.0 | ANMA | Anisomastia | 80871.0 | nan | nan | Anisomastia, 605746 (2)
chr16	EKD2	611031.0 | EKD2 | Episodic kinesigenic dyskinesia 2 | 100124415.0 | nan | max lod at D16S503 | Episodic kinesigenic dyskinesia 2, 611031 (2), Autosomal dominant
chr16	GNAO1	139311.0 | GNAO1, DEE17, NEDIM | Guanine nucleotide-binding protein (G protein), alpha-activating activity | 2775.0 | ENSG00000087258 | close to MT1 in mouse | Developmental and epileptic encephalopathy 17, 615473 (3), Autosomal dominant; Neurodevelopmental disorder with involuntary movements, 617493 (3), Autosomal dominant
chr16	AMFR	603243.0 | AMFR, GP78, SPG89 | Autocrine motility factor receptor | 267.0 | ENSG00000159461 | nan | Spastic paraplegia 89, autosomal recessive, 620379 (3), Autosomal recessive
chr16	NUDT21	604978.0 | NUDT21, CPSF5, CFIM25 | Nudix hydrolase 21 | 11051.0 | ENSG00000167005 | nan | nan
chr16	OGFOD1	615857.0 | OGFOD1 | 2-oxoglutarate- and iron-dependent oxygenase domain-containing protein 1 | 55239.0 | ENSG00000087263 | nan | nan
chr16	BBS2	606151.0 | BBS2, RP74 | Bardet-Biedl syndrome 2 | 583.0 | ENSG00000125124 | nan | Retinitis pigmentosa 74, 616562 (3), Autosomal recessive; Bardet-Biedl syndrome 2, 615981 (3), Autosomal recessive
chr16	MT4	606206.0 | MT4, MTIV | Metallothionein 4 | 84560.0 | ENSG00000102891 | nan | nan
chr16	MT3	139255.0 | MT3, GIFB | Metallothionein 3 (growth inhibitory factor (neurotrophic)) | 4504.0 | ENSG00000087250 | nan | nan
chr16	MT2A	156360.0 | MT2A, MT2 | Metallothionein 2A | 4502.0 | ENSG00000125148 | pseudogene MT2P1 on 4cen-q21 | nan
chr16	MT1L	156358.0 | MT1L | Metallothionein 1L, pseudogene | 4500.0 | nan | nan | nan
chr16	MT1E	156351.0 | MT1E | Metallothionein 1E (functional) | 4493.0 | ENSG00000169715 | nan | nan
chr16	MT1M	156357.0 | MT1K | Metallothionein 1K | 4499.0 | ENSG00000205364 | nan | nan
chr16	MT1JP	156356.0 | MT1JP | Metallothionein 1J, pseudogene | 4498.0 | ENSG00000290662 | nan | nan
chr16	MT1A	156350.0 | MT1A | Metallothionein 1A (functional) | 4489.0 | ENSG00000205362 | proximal to FRA16B | nan
chr16	MT1B	156349.0 | MT1B | Metallothionein 1B (functional) | 4490.0 | ENSG00000169688 | nan | nan
chr16	MT1F	156352.0 | MT1F | Metallothionein 1F (functional) | 4494.0 | ENSG00000198417 | nan | nan
chr16	MT1G	156353.0 | MT1G | Metallothionein 1G | 4495.0 | ENSG00000125144 | nan | nan
chr16	MT1H	156354.0 | MT1H | Metallothionein 1H | 4496.0 | ENSG00000205358 | nan | nan
chr16	MT1IP	156355.0 | MT1IP | Metallothionein 1I, pseudogene | 644314.0 | ENSG00000290663 | nan | nan
chr16	MT1X	156359.0 | MT1X | Metallothionein 1X | 4501.0 | ENSG00000187193 | nan | nan
chr16	NUP93	614351.0 | NUP93, NIC96, KIAA0095, NPHS12 | Nucleoporin, 93kD | 9688.0 | ENSG00000102900 | nan | Nephrotic syndrome, type 12, 616892 (3), Autosomal recessive
chr16	MIR138-2	613395.0 | MIR138-2, MIRN138-2 | Micro RNA 138-2 | 406930.0 | ENSG00000207649 | nan | nan
chr16	SLC12A3	600968.0 | SLC12A3, NCCT, TSC | Solute carrier family 12 (sodium/potassium/chloride transporters), member 3 | 6559.0 | ENSG00000070915 | nan | Gitelman syndrome, 263800 (3), Autosomal recessive
chr16	HERPUD1	608070.0 | HERPUD1, MIF1, HERP, KIAA0025 | Homocysteine- and endoplasmic reticulum stress-inducible protein, ubiquitin-like domain-containing, 1 | 9709.0 | ENSG00000051108 | nan | nan
chr16	CETP	118470.0 | CETP, HDLCQ10 | Cholesteryl ester transfer protein, plasma | 1071.0 | ENSG00000087237 | nan | [High density lipoprotein cholesterol level QTL 10], 143470 (3), Autosomal dominant; Hyperalphalipoproteinemia, 143470 (3), Autosomal dominant
chr16	NLRC5	613537.0 | NLRC5 | NLR family, caspase recruitment domain-containing 5 | 84166.0 | ENSG00000140853 | nan | nan
chr16	CPNE2	604206.0 | CPNE2, CPN2 | Copine II | 221184.0 | ENSG00000140848 | nan | nan
chr16	PSME3IP1	617766.0 | FAM192A, NIP30, C16orf94 | Family with sequence similarity 192, member A | 80011.0 | ENSG00000172775 | nan | nan
chr16	RSPRY1	616585.0 | RSPRY1, KIAA1972, SEMDFA | RING finger- and SPRY domain-containing protein 11 | 89970.0 | ENSG00000159579 | nan | Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type, 616723 (3), Autosomal recessive
chr16	ARL2BP	615407.0 | ARL2BP, BART, RP82 | ADP ribosylation factor-like GTPase 2 binding protein | 23568.0 | ENSG00000102931 | nan | Retinitis pigmentosa 82 with or without situs inversus, 615434 (3), Autosomal recessive
chr16	PLLP	600340.0 | PLLP, PMLP, TM4SF11 | Plasmolipin | 51090.0 | ENSG00000102934 | nan | nan
chr16	OPA8	616648.0 | OPA8 | Optic atrophy 8 | 106783499.0 | nan | max lod at D16S752 | Optic atrophy 8, 616648 (2), Autosomal dominant
chr16	CCL22	602957.0 | CCL22, SCYA22 | Chemokine, C-C motif, ligand 22 | 6367.0 | ENSG00000102962 | nan | nan
chr16	CX3CL1	601880.0 | CX3CL1, SCYD1, NTT, NTN | Chemokine, C-X3-C motif, ligand 1 (fractalkine; neurotactin) | 6376.0 | ENSG00000006210 | nan | nan
chr16	CCL17	601520.0 | CCL17, SCYA17, TARC | Chemokine, C-C motif, ligand 17 | 6361.0 | ENSG00000102970 | nan | nan
chr16	CIAPIN1	608943.0 | CIAPIN1 | Cytokine-induced apoptosis inhibitor 1 (anamorsin) | 57019.0 | ENSG00000005194 | nan | nan
chr16	COQ9	612837.0 | COQ9, C16orf49, COQ10D5 | Coq9, S. cerevisiae, homolog of | 57017.0 | ENSG00000088682 | nan | Coenzyme Q10 deficiency, primary, 5, 614654 (3), Autosomal recessive
chr16	POLR2C	180663.0 | POLR2C | Polymerase (RNA) II (DNA directed) polypeptide C, 33kD | 5432.0 | ENSG00000102978 | nan | nan
chr16	DOK4	608333.0 | DOK4 | Docking protein 4 | 55715.0 | ENSG00000125170 | nan | nan
chr16	ADGRG5	616965.0 | ADGRG5, GPR114 | Adhesion G protein-coupled receptor G5 | 221188.0 | ENSG00000159618 | nan | nan
chr16	ADGRG1	604110.0 | ADGRG1, GPR56, TM7XN1, CDCBM15A, CDCBM14B | Adhesion G protein-coupled receptor G1 | 9289.0 | ENSG00000205336 | nan | Cortical dysplasia, complex, with other brain malformations 14B, (bilateral perisylvian), 615752 (3); Cortical dysplasia, complex, with other brain malformations 14A, (bilateral frontoparietal), 606854 (3), Autosomal recessive
chr16	ADGRG3	618441.0 | ADGRG3, GPR97 | Adhesion G protein-coupled receptor G3 | 222487.0 | ENSG00000182885 | nan | nan
chr16	DRC7	618769.0 | DRC7, CCDC135, CFAP50, C16orf50 | Dynein regulatory complex subunit 7 | 84229.0 | ENSG00000159625 | nan | nan
chr16	KATNB1	602703.0 | KATNB1, LIS6 | Katanin, p80 subunit, B1 | 10300.0 | ENSG00000140854 | nan | Lissencephaly 6, with microcephaly, 616212 (3), Autosomal recessive
chr16	KIFC3	604535.0 | KIFC3 | Kinesin family member C3 | 3801.0 | ENSG00000140859 | nan | nan
chr16	CNGB1	600724.0 | CNGB1, CNCG3L, CNCG2, RP45 | Cyclic nucleotide gated channel, beta 1 | 1258.0 | ENSG00000070729 | nan | Retinitis pigmentosa 45, 613767 (3), Autosomal recessive
chr16	SPMIP8	610264.0 | TEPP | Testis-prostate-placenta-expressed protein | 374739.0 | ENSG00000159648 | nan | nan
chr16	USB1	613276.0 | USB1, C16orf57, PN | U6 small nuclear RNA biogenesis phosphodiesterase 1 | 79650.0 | ENSG00000103005 | nan | Poikiloderma with neutropenia, 604173 (3), Autosomal recessive
chr16	MMP15	602261.0 | MMP15 | Matrix metalloproteinase 15 | 4324.0 | ENSG00000102996 | nan | nan
chr16	CFAP20	617906.0 | CFAP20, BUG22, C16orf80, FSAP23 | Cilia- and flagella-associated protein 20 | 29105.0 | ENSG00000070761 | nan | nan
chr16	CSNK2A2	115442.0 | CSNK2A2 | Casein kinase-2, alpha-prime polypeptide | 1459.0 | ENSG00000070770 | nan | nan
chr16	CFAP263	616070.0 | CCDC113 | Coiled-coil domain-containing protein 113 | 29070.0 | ENSG00000103021 | nan | nan
chr16	GINS3	610610.0 | GINS3, PSF3 | GINS complex subunit 3 | 64785.0 | ENSG00000181938 | nan | nan
chr16	NDRG4	614463.0 | NDRG4, SMAP8, KIAA1180 | NMYC downstream-regulated gene 4 | 65009.0 | ENSG00000103034 | nan | nan
chr16	SETD6	616424.0 | SETD6 | SET domain-containing protein 6 | 79918.0 | ENSG00000103037 | nan | nan
chr16	CNOT1	604917.0 | CNOT1, NOT1, HPE12, VIBOS | CCR4-NOT transcription complex, subunit 1 | 23019.0 | ENSG00000125107 | nan | Vissers-Bodmer syndrome, 619033 (3), Autosomal dominant; Holoprosencephaly 12, with or without pancreatic agenesis, 618500 (3), Autosomal dominant
chr16	SLC38A7	614236.0 | SLC38A7, SNAT7 | Solute carrier family 38 (amino acid transporter), member 7 | 55238.0 | ENSG00000103042 | nan | nan
chr16	GOT2	138150.0 | GOT2, DEE82 | Glutamic-oxaloacetic transaminase 2, mitochondrial | 2806.0 | ENSG00000125166 | ?pseudogenes on 12 and 1 | Developmental and epileptic encephalopathy 82, 618721 (3), Autosomal recessive
chr16	CDH8	603008.0 | CDH8 | Cadherin-8 | 1006.0 | ENSG00000150394 | nan | nan
chr16	CDH11	600023.0 | CDH11, CAD11, ESWS, TBHS2 | Cadherin-11 (OB-cadherin, osteoblast) | 1009.0 | ENSG00000140937 | nan | Teebi hypertelorism syndrome 2, 619736 (3), Autosomal dominant; Elsahy-Waters syndrome, 211380 (3), Autosomal recessive
chr16	CDH5	601120.0 | CDH5 | Cadherin-5 | 1003.0 | ENSG00000179776 | nan | nan
chr16	BEAN1	612051.0 | BEAN1, BEAN, SCA31 | Brain-expressed, associated with NEDD4 | 146227.0 | ENSG00000166546 | nan | Spinocerebellar ataxia 31, 117210 (3), Autosomal dominant
chr16	TK2	188250.0 | TK2, MTDPS2, PEOB3 | Thymidine kinase, mitochondrial | 7084.0 | ENSG00000166548 | mutation identified in 1 PEOB3 family | Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3), Autosomal recessive; ?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3, 617069 (3), Autosomal recessive
chr16	CKLF	616074.0 | CKLF, HSPC224 | Chemokine-like factor | 51192.0 | ENSG00000217555 | nan | nan
chr16	CMTM1	607884.0 | CMTM1, CKLFSF1 | CKLF-like marvel transmembrane domain-containing 1 | 113540.0 | ENSG00000089505 | nan | nan
chr16	CMTM2	607885.0 | CMTM2, CKLFSF2 | CKLF-like marvel transmembrane domain-containing 2 | 146225.0 | ENSG00000140932 | nan | nan
chr16	CMTM4	607887.0 | CMTM4, CKLFSF4 | CKLF-like marvel transmembrane domain-containing 4 | 146223.0 | ENSG00000183723 | nan | nan
chr16	ANBC	606179.0 | ANBC | Aneurysmal bone cysts | 114293.0 | nan | t(16:17); ?defect at 17p13 | Aneurysmal bone cysts, 606179 (2)
chr16		614541.0 | C16DELq22, DEL16q22 | Chromosome 16q22 deletion syndrome | nan | nan | nan | Chromosome 16q22 deletion syndrome, 614541 (4), Isolated cases
chr16	CRCS9	612590.0 | CRCS9 | Colorectal cancer, susceptibility to, 9 | 100329169.0 | nan | associated with rs9929218 | {Colorectal cancer, susceptibility to, 9}, 612590 (2)
chr16		604901.0 | NAIC | North American Indian childhood cirrhosis | nan | nan | nan | North American Indian childhood cirrhosis, 604901 (2)
chr16	OTSC4	611571.0 | OTSC4 | Otosclerosis 4 | 286751.0 | nan | between D16S3107 and D16S3097 | {Otosclerosis 4}, 611571 (2), Autosomal dominant
chr16	CMTM3	607886.0 | CMTM3, CKLFSF3 | CKLF-like marvel transmembrane domain-containing 3 | 123920.0 | ENSG00000140931 | nan | nan
chr16	DYNC1LI2	611406.0 | DYNC1LI2, LIC2 | Dynein, cytoplasmic 1, light intermediate chain 2 | 1783.0 | ENSG00000135720 | nan | nan
chr16	TERB1	617332.0 | TERB1, CCDC79, SPGF60 | Telomere repeat-binding bouquet formation protein 1 | 283847.0 | ENSG00000249961 | nan | Spermatogenic failure 60, 619646 (3), Autosomal recessive
chr16	NAE1	603385.0 | NAE1, APPBP1, NEDFIH | NEDD8 activating enzyme E1 subunit 1 | 8883.0 | ENSG00000159593 | nan | Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia, 620210 (3), Autosomal recessive
chr16	CA7	114770.0 | CA7 | Carbonic anhydrase VII | 766.0 | ENSG00000168748 | nan | nan
chr16	PDP2	615499.0 | PDP2, KIAA1348 | Pyruvate dehydrogenase phosphatase catalytic subunit 2 | 57546.0 | ENSG00000172840 | nan | nan
chr16	CDH16	603118.0 | CDH16 | Cadherin-16 | 1014.0 | ENSG00000166589 | nan | nan
chr16	RRAD	179503.0 | RRAD | RRAD, Ras-related blycolysis inhibitor and calcium channel regulator | 6236.0 | ENSG00000166592 | nan | nan
chr16	CIAO2B	614778.0 | FAM96B, MIP18 | Family with sequence similarity 96, member B | 51647.0 | ENSG00000166595 | nan | nan
chr16	CES2	605278.0 | CES2 | Carboxylesterase 2 | 8824.0 | ENSG00000172831 | nan | nan
chr16	CES3	605279.0 | CES3, ES31 | Carboxylesterase 3 | 23491.0 | ENSG00000172828 | nan | nan
chr16	CBFB	121360.0 | CBFB, PEBP2B, CLCD2 | Core-binding factor, beta subunit | 865.0 | ENSG00000067955 | inv(16)(p13;q22); fuses to MYH11 | Cleidocranial dysplasia 2, 620099 (3), Autosomal dominant
chr16	TRADD	603500.0 | TRADD | TNRF1-associated death domain protein | 8717.0 | ENSG00000102871 | nan | nan
chr16	FBXL8	609077.0 | FBXL8, FBL8 | F-box and leucine-rich repeat protein 8 | 55336.0 | ENSG00000135722 | nan | nan
chr16	HSF4	602438.0 | HSF4, CTM, CTRCT5 | Heat-shock transcription factor 4 | 3299.0 | ENSG00000102878 | nan | Cataract 5, multiple types, 116800 (3), Autosomal dominant
chr16	NOL3	605235.0 | NOL3, NOP, MYC, ARC, FCM, MYOCL1 | Nucleolar protein 3 | 8996.0 | ENSG00000140939 | mutation identified in 1 MYOCL1 family | ?Myoclonus, familial, 1, 614937 (3), Autosomal dominant
chr16	MATCAP1	619978.0 | MATCAP1, KIAA0895L | Microtubule-associated tyrosine carboxypeptidase 1 | 653319.0 | ENSG00000196123 | nan | nan
chr16	EXOC3L1	614117.0 | EXOC3L1, EXOC3L | Exocyst complex component 3-like 1 | 283849.0 | ENSG00000179044 | nan | nan
chr16	E2F4	600659.0 | E2F4 | E2F transcription factor 4, p107/p130-binding | 1874.0 | ENSG00000205250 | nan | nan
chr16	MIR328	613701.0 | MIR328, MIRN328 | Micro RNA 328 | 442901.0 | ENSG00000207948 | nan | nan
chr16	ELMO3	606422.0 | ELMO3 | Engulfment and cell motility gene 3 | 79767.0 | ENSG00000102890 | nan | nan
chr16	TMEM208	620781.0 | TMEM208, HSPC171 | Transmembrane protein 208 | 29100.0 | ENSG00000168701 | nan | nan
chr16	FHOD1	606881.0 | FHOD1, FHOS | Formin homology 2 domain-containing 1 | 29109.0 | ENSG00000135723 | nan | nan
chr16	SLC9A5	600477.0 | SLC9A5, NHE5 | Solute carrier family 9 (sodium/hydrogen exchanger), member 5 | 6553.0 | ENSG00000135740 | nan | nan
chr16	PLEKHG4	609526.0 | PLEKHG4 | Pleckstrin homology domain- and RhoGEF domain-containing protein G4 | 25894.0 | ENSG00000196155 | nan | nan
chr16	KCTD19	619943.0 | KCTD19 | Potassium channel tetramerization domain-containing protein 19 | 146212.0 | ENSG00000168676 | nan | nan
chr16	TPPP3	616957.0 | TPPP3, p20 | Tubulin polymerization-promoting protein family, member 3 | 51673.0 | ENSG00000159713 | nan | nan
chr16	HSD11B2	614232.0 | HSD11B2, HSD11K, AME | Hydroxysteroid (11-beta) dehydrogenase 2 | 3291.0 | ENSG00000176387 | nan | Apparent mineralocorticoid excess, 218030 (3), Autosomal recessive
chr16	ATP6V0D1	607028.0 | ATP6V0D1 | ATPase, H+ transporting, V0 subunit D1 | 9114.0 | ENSG00000159720 | nan | nan
chr16	AGRP	602311.0 | AGRP, ART, AGRT | Agouti-related neuropeptide | 181.0 | ENSG00000159723 | nan | {Leanness, inherited}, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant; {Obesity, late-onset}, 601665 (3), Autosomal recessive, Multifactorial, Autosomal dominant
chr16	RIPOR1	619842.0 | RIPOR1, FAM65A | RHO family-interacting cell polarization regulator 1 | 79567.0 | ENSG00000039523 | nan | nan
chr16	CTCF	604167.0 | CTCF, MRD21 | CCCTC-binding factor | 10664.0 | ENSG00000102974 | nan | Intellectual developmental disorder, autosomal dominant 21, 615502 (3), Autosomal dominant
chr16	CARMIL2	610859.0 | CARMIL2, RLTPR, IMD58 | Capping protein regulator and myosin 1 linker 2 | 146206.0 | ENSG00000159753 | nan | Immunodeficiency 58, 618131 (3), Autosomal recessive
chr16	ACD	609377.0 | ACD, PTOP, PIP1, TINT1 | ACD shelterin complex subunit and telomerase recruitment factor | 65057.0 | ENSG00000102977 | mutation has been identified in 1 DKCA7 and 1 DKCB7 family | ?Dyskeratosis congenita, autosomal recessive 7, 616553 (3), Autosomal recessive, Autosomal dominant; ?Dyskeratosis congenita, autosomal dominant 6, 616553 (3), Autosomal recessive, Autosomal dominant
chr16	PARD6A	607484.0 | PARD6A, TAX40 | PAR6 family cell polarity regulator alpha | 50855.0 | ENSG00000102981 | nan | nan
chr16	GFOD2	619933.0 | GFOD2 | Glucose-fructose oxidoreductase domain-containing protein 2 | 81577.0 | ENSG00000141098 | nan | nan
chr16	RANBP10	614031.0 | RANBP10, KIAA1464 | Ran-binding protein 10 | 57610.0 | ENSG00000141084 | nan | nan
chr16	TSNAXIP1	607720.0 | TSNAXIP1, TXI1 | Translin-associated factor X-interacting protein 1 | 55815.0 | ENSG00000102904 | nan | nan
chr16	CENPT	611510.0 | CENPT, SSMGA | Centromere protein T | 80152.0 | ENSG00000102901 | mutation identified in 1 SSMGA family | ?Short stature and microcephaly with genital anomalies, 618702 (3), Autosomal recessive
chr16	THAP11	609119.0 | THAP11, RONIN, MAHCL, SCA51 | THAP domain-containing protein 11 | 57215.0 | ENSG00000168286 | mutation identified in 1 MAHCL patient | ?Methylmalonic aciduria and homocystinuria, cblL type, 620940 (3), Autosomal recessive; Spinocerebellar ataxia 51, 620947 (3), Autosomal dominant
chr16	NUTF2	605813.0 | NUTF2, NTF2, PP15 | Nuclear transport factor 2 | 10204.0 | ENSG00000102898 | nan | nan
chr16	EDC4	606030.0 | EDC4, RCD8, GE1, HEDL5 | Enhancer of mRNA decapping 4 | 23644.0 | ENSG00000038358 | nan | nan
chr16	PSKH1	177015.0 | PSKH1, PFIC13 | Putative serine kinase H1 | 5681.0 | ENSG00000159792 | nan | Cholestasis, progressive familial intrahepatic, 13, 620962 (3), Autosomal recessive
chr16	CTRL	118888.0 | CTRL | Chymotrypsin-like protease | 1506.0 | ENSG00000141086 | nan | nan
chr16	PSMB10	176847.0 | PSMB10, MECL1, LMP10, PRAAS5, IMD121 | Proteosome subunit, beta-type, 10 | 5699.0 | ENSG00000205220 | 3.1kb from LCAT | Immunodeficiency 121 with autoinflammation, 620807 (3), Autosomal dominant; Proteasome-associated autoinflammatory syndrome 5, 619175 (3), Autosomal recessive
chr16	LCAT	606967.0 | LCAT | Lecithin-cholesterol acyltransferase | 3931.0 | ENSG00000213398 | very close to HP | Fish-eye disease, 136120 (3), Autosomal recessive; Norum disease, 245900 (3), Autosomal recessive
chr16	SLC12A4	604119.0 | SLC12A4, KCC1 | Solute carrier family 12 (potassium/chloride transporters), member 4 | 6560.0 | ENSG00000124067 | nan | nan
chr16	DPEP3	609926.0 | DPEP3, MBD3 | Dipeptidase 3 | 64180.0 | ENSG00000141096 | nan | nan
chr16	DPEP2	609925.0 | DPEP2, MBD2 | Dipeptidase 2 | 64174.0 | ENSG00000167261 | nan | nan
chr16	DDX28	607618.0 | DDX28, MDDX28 | DEAD-box helicase 28 | 55794.0 | ENSG00000182810 | nan | nan
chr16	DUS2	609707.0 | DUS2L, DUS2 | Dihydrouridine synthase 2-like | 54920.0 | ENSG00000167264 | nan | nan
chr16	ESRP2	612960.0 | ESRP2, RBM35B | Epithelial splicing regulatory protein 2 | 80004.0 | ENSG00000103067 | nan | nan
chr16	NFATC3	602698.0 | NFATC3 | Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 3 | 4775.0 | ENSG00000072736 | nan | nan
chr16	PLA2G15	609362.0 | LYPLA3, LLPL, ACS, LPLA2 | Lysophospholipase 3 | 23659.0 | ENSG00000103066 | nan | nan
chr16	SLC7A6OS	619192.0 | SLC7A6OS, EPM12 | Solute carrier family 7, member 6, opposite strand | 84138.0 | ENSG00000103061 | nan | Epilepsy, progressive myoclonic, 12, 619191 (3), Autosomal recessive
chr16	SLC7A6	605641.0 | SLC7A6 | Solute carrier family 7 (y+L-type amino acid transporter), member 6 | 9057.0 | ENSG00000103064 | nan | nan
chr16	PRMT7	610087.0 | PRMT7, KIAA1933, SBIDDS | Protein arginine N-methyltransferase 7 | 54496.0 | ENSG00000132600 | nan | Short stature, brachydactyly, intellectual developmental disability, and seizures, 617157 (3), Autosomal recessive
chr16	SMPD3	605777.0 | SMPD3, NSMASE2 | Sphingomyelin phosphodiesterase 3, neutral membrane | 55512.0 | ENSG00000103056 | nan | nan
chr16	ZFP90	609451.0 | ZFP90, NK10, KIAA1954 | Zinc finger protein 90, mouse, homolog of | 146198.0 | ENSG00000184939 | nan | nan
chr16	CDH3	114021.0 | CDH3, CDHP, PCAD, HJMD | Cadherin-3 (P-cadherin) | 1001.0 | ENSG00000062038 | in mouse tightly linked to ECAD | Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3), Autosomal recessive; Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3), Autosomal recessive
chr16	CDH1	192090.0 | CDH1, UVO, LCAM, ECAD, BCDS1 | Cadherin-1 (E-cadherin; uvomorulin) | 999.0 | ENSG00000039068 | near LCAT | Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3)
chr16	TANGO6	620188.0 | TANGO6, TMCO7, KIAA1746 | Transport and golgi organization 6 homolog | 79613.0 | ENSG00000103047 | nan | nan
chr16	HAS3	602428.0 | HAS3 | Hyaluronan synthase 3 | 3038.0 | ENSG00000103044 | nan | nan
chr16	CHTF8	613202.0 | CHTF8, CTF8 | Chromosome transmission fidelity factor 8 | 54921.0 | ENSG00000168802 | nan | nan
chr16	UTP4	607456.0 | UTP4, CIRH1A, TEX292, KIAA1988 | UTP4 small subunit processome component | 84916.0 | ENSG00000141076 | nan | nan
chr16	SNTB2	600027.0 | SNTB2, SNT2B2, SNTL | Syntrophin, beta-2 | 6645.0 | ENSG00000168807 | nan | nan
chr16	VPS4A	609982.0 | VPS4A, VPS4, CIMDAG | Vacuolar protein sorting 4 homolog A | 27183.0 | ENSG00000132612 | nan | CIMDAG syndrome, 619273 (3), Autosomal dominant
chr16	COG8	606979.0 | COG8, DOR1, CDG2H | Component of oligomeric golgi complex 8 | 84342.0 | ENSG00000213380 | nan | Congenital disorder of glycosylation, type IIh, 611182 (3)
chr16	PDF	618720.0 | PDF | Peptide deformylase, mitochondrial | 64146.0 | ENSG00000258429 | nan | nan
chr16	NIP7	619204.0 | NIP7, KD93 | Nucleolar pre-rRNA-processing protein NIP7 | 51388.0 | ENSG00000132603 | nan | nan
chr16	TERF2	602027.0 | TERF2, TRF2 | Telomeric repeat-binding factor-2 | 7014.0 | ENSG00000132604 | nan | nan
chr16	CYB5B	611964.0 | CYB5B, CYPB5M | Cytochrome b5, type B (outer mitochondrial membrane) | 80777.0 | ENSG00000103018 | nan | nan
chr16	NFAT5	604708.0 | NFAT5, KIAA0827, NFATL1, TONEBP | Nuclear factor of activated T cells 5 | 10725.0 | ENSG00000102908 | nan | nan
chr16	NQO1	125860.0 | NQO1, DIA4, NMOR1 | NAD(P)H dehydrogenase, quinone 1 (diaphorase-4) | 1728.0 | ENSG00000181019 | nan | {Breast cancer, poor survival after chemotherapy for} (3); {Leukemia, post-chemotherapy, susceptibility to} (3); {Benzene toxicity, susceptibility to} (3)
chr16	NOB1	613586.0 | NOB1 | NIN1 (RPN12)-binding protein 1 homolog | 28987.0 | ENSG00000141101 | nan | nan
chr16	WWP2	602308.0 | WWP2 | WW domain-containing protein 2 | 11060.0 | ENSG00000198373 | nan | nan
chr16	MIR140	611894.0 | MIR140, MIRN140, SEDN | Micro RNA 140 | 406932.0 | ENSG00000208017 | nan | Spondyloepiphyseal dysplasia, Nishimura type, 618618 (3), Autosomal dominant
chr16	CLEC18A	616571.0 | CLEC18A | C-type lecting domain family 18, member A | 348174.0 | ENSG00000157322 | nan | nan
chr16	PDPR	617835.0 | PDPR, KIAA1990 | Pyruvate dehydrogenase phosphatase regulatory subunit | 55066.0 | ENSG00000090857 | nan | nan
chr16	CLEC18C	616573.0 | CLEC18C | C-type lectin domain family 18, member C | 283971.0 | ENSG00000157335 | nan | nan
chr16	EXOSC6	606490.0 | EXOSC6, MTR3 | Exosome component 6 | 118460.0 | ENSG00000223496 | nan | nan
chr16	AARS1	601065.0 | AARS1, AARS, CMT2N, DEE29, HDLS2, TTD8 | Alanyl-tRNA synthetase 1 | 16.0 | ENSG00000090861 | mutation identified in 1 HDLS2 family | Developmental and epileptic encephalopathy 29, 616339 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3), Autosomal dominant; ?Leukoencephalopathy, hereditary diffuse, with spheroids 2, 619661 (3), Autosomal dominant; Trichothiodystrophy 8, nonphotosensitive, 619691 (3), Autosomal recessive
chr16	DDX19B	605812.0 | DDX19B, DBP5 | DEAD/H-box helicase 19B | 11269.0 | ENSG00000157349 | nan | nan
chr16	ST3GAL2	607188.0 | ST3GAL2, SIAT4B | ST3 beta-galactoside alpha-2,3-sialyltransferase 2 | 6483.0 | ENSG00000157350 | nan | nan
chr16	FCSK	608675.0 | FCSK, FUK, CDGF2 | Fucose kinase | 197258.0 | ENSG00000157353 | nan | Congenital disorder of glycosylation with defective fucosylation 2, 618324 (3), Autosomal recessive
chr16	COG4	606976.0 | COG4, COD1, CDG2J, SWILS | Component of oligomeric golgi complex 4 | 25839.0 | ENSG00000103051 | nan | Congenital disorder of glycosylation, type IIj, 613489 (3), Autosomal recessive; Saul-Wilson syndrome, 618150 (3), Autosomal dominant
chr16	SF3B3	605592.0 | SF3B3, SF3B130, SAP130 | Splicing factor 3B, subunit 3 | 23450.0 | ENSG00000189091 | nan | nan
chr16	IL34	612081.0 | IL34, C16orf77 | Interleukin 34 | 146433.0 | ENSG00000157368 | nan | nan
chr16	MTSS2	616951.0 | MTSS2, MTSS1L, ABBA1, IDDOF | MTSS I-BAR domain containing 2 protein | 92154.0 | ENSG00000132613 | nan | Intellectual developmental disorder with ocular anomalies and distinctive facial features, 620086 (3), Autosomal dominant
chr16	VAC14	604632.0 | VAC14, TAX1BP2, TRX, SNDC | VAC14 component of PIKFYVE complex | 55697.0 | ENSG00000103043 | nan | Striatonigral degeneration, childhood-onset, 617054 (3), Autosomal recessive
chr16	HYDIN	610812.0 | HYDIN, HYDIN1, CILD5 | HYDIN axonemal central pair apparatus protein | 54768.0 | ENSG00000157423 | duplicated copy on 1q21.1 | Ciliary dyskinesia, primary, 5, 608647 (3), Autosomal recessive
chr16	CMTR2	616190.0 | CMTR2, MTR2, FTSJD1 | CAP methyltransferase 2 | 55783.0 | ENSG00000180917 | nan | nan
chr16	CALB2	114051.0 | CALB2 | Calbindin 2, 29kD (calretinin) | 794.0 | ENSG00000172137 | nan | nan
chr16	ZNF23	194527.0 | ZNF23, KOX16 | Zinc finger protein-32 (KOX16) | 7571.0 | ENSG00000167377 | nan | nan
chr16	ZNF19	194525.0 | ZNF19, KOX12 | Zinc finger protein-19 (KOX12) | 7567.0 | ENSG00000157429 | ?16q23, 19q13 | nan
chr16	TAT	613018.0 | TAT | Tyrosine aminotransferase, soluble | 6898.0 | ENSG00000198650 | nan | Tyrosinemia, type II, 276600 (3), Autosomal recessive
chr16	MARVELD3	614094.0 | MARVELD3 | Marvel domain-containing protein 3 | 91862.0 | ENSG00000140832 | nan | nan
chr16	PHLPP2	611066.0 | PHLPPL, PHLPP2 | PH domain and leucine-rich repeat protein phosphatase-like | 23035.0 | ENSG00000040199 | nan | nan
chr16	AP1G1	603533.0 | AP1G1, ADTG, CLAPG1, USRISD | Adaptor-related protein complex 1, gamma 1 subunit (adaptin, gamma) | 164.0 | ENSG00000166747 | nan | Usmani-Riazuddin syndrome, autosomal recessive, 619548 (3), Autosomal recessive; Usmani-Riazuddin syndrome, autosomal dominant, 619467 (3), Autosomal dominant
chr16	ATXN1L	614301.0 | ATXN1L, BOAT1 | Ataxin 1-like (brother of ataxin 1) | 342371.0 | ENSG00000224470 | nan | nan
chr16	IST1	616434.0 | IST1, KIAA0174 | IST1 factor associated with ESCRT-III | 9798.0 | ENSG00000182149 | nan | nan
chr16	PKD1L3	607895.0 | PKD1L3 | Polycystin 1-like 3 | 342372.0 | ENSG00000277481 | nan | nan
chr16	DHODH	126064.0 | DHODH, URA1, POADS | Dihydroorotate dehydrogenase | 1723.0 | ENSG00000102967 | nan | Miller syndrome, 263750 (3), Autosomal recessive
chr16	HP	140100.0 | HP | Haptoglobin | 3240.0 | ENSG00000257017 | just distal to fra16q22.1 | [Anhaptoglobinemia], 614081 (3); [Hypohaptoglobinemia], 614081 (3)
chr16	HPR	140210.0 | HPR | Haptoglobin-related locus | 3250.0 | ENSG00000261701 | 2.2kb 3' to HP; multiple tandem genes in blacks | nan
chr16	TXNL4B	617722.0 | TXNL4B, DLP, DIM2 | Thioredoxin-like 4B | 54957.0 | ENSG00000140830 | nan | nan
chr16	DHX38	605584.0 | DHX38, DDX38, PRP16, RP84 | DEAH-box helicase 38 | 9785.0 | ENSG00000140829 | nan | Retinitis pigmentosa 84, 618220 (3), Autosomal recessive
chr16	PMFBP1	618085.0 | PMFBP1, STAP, SPGF31 | Polyamine-modulated factor 1-binding protein 1 | 83449.0 | ENSG00000118557 | nan | Spermatogenic failure 31, 618112 (3), Autosomal recessive
chr16	ZFHX3	104155.0 | ZFHX3, ATBF1, ATFB8, SCA4 | Zinc finger homeobox 3 | 463.0 | ENSG00000140836 | nan | Prostate cancer, somatic, 176807 (3); {Atrial fibrillation 8, susceptibility to}, 613055 (3), Autosomal dominant; Spinocerebellar ataxia 4, 600223 (3), Autosomal dominant
chr16	KTCN2	608932.0 | KTCN2 | Keratoconus 2 | 450092.0 | nan | nan | Keratoconus 2, 608932 (2)
chr16	HCCAT5	615613.0 | HCCAT5, HTA | Hepatocellular carcinoma-associated transcript 5 | 283902.0 | ENSG00000260880 | nan | nan
chr16	BMND13	612727.0 | BMND13 | Bone mineral density quantitative trait locus 13 | 100294717.0 | nan | associated with rs16945612 | [Bone mineral density QTL 13], 612727 (2)
chr16	HSCR8	608462.0 | HSCR8 | Hirschsprung disease, susceptibility to, 8 | 404719.0 | nan | nan | {Hirschsprung disease, susceptibility to, 8}, 608462 (2)
chr16	PSMD7	157970.0 | PSMD7, MOV34 | Proteasome 25S subunit, non-ATPase, 7 (Moloney leukemia virus-34 proviral integration homolog) | 5713.0 | ENSG00000103035 | nan | nan
chr16	CLEC18B	616572.0 | CLEC18B | C-type lectin domain family 18, member B | 497190.0 | ENSG00000140839 | nan | nan
chr16	GLG1	600753.0 | GLG1 | Golgi apparatus protein 1 | 2734.0 | ENSG00000090863 | nan | nan
chr16	RFWD3	614151.0 | RFWD3, FANCW | RING finger and WD repeat domains-containing protein 3 | 55159.0 | ENSG00000168411 | mutation identified in 1 FANCW patient | ?Fanconi anemia, complementation group W, 617784 (3), Autosomal recessive
chr16	MLKL	615153.0 | MLKL | Mixed lineage kinase domain-like protein | 197259.0 | ENSG00000168404 | nan | nan
chr16	FA2H	611026.0 | FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35 | Fatty acid 2-hydroxylase | 79152.0 | ENSG00000103089 | nan | Spastic paraplegia 35, autosomal recessive, 612319 (3), Autosomal recessive
chr16	WDR59	617418.0 | WDR59, KIAA1923 | WD repeat-containing protein 59 | 79726.0 | ENSG00000103091 | nan | nan
chr16	ZNRF1	612060.0 | ZNRF1, NIN283 | Zinc finger and ring finger protein 1 | 84937.0 | ENSG00000186187 | nan | nan
chr16	LDHD	607490.0 | LDHD, DLACD | D-lactate dehydrogenase | 197257.0 | ENSG00000166816 | nan | D-lactic aciduria with susceptibility to gout, 245450 (3), Autosomal recessive
chr16	ZFP1	617230.0 | ZFP1, ZNF475 | Zinc finger protein 1, mouse, homolog of | 162239.0 | ENSG00000184517 | nan | nan
chr16	CTRB2	619620.0 | CTRB2 | Chymotrypsinogen B2 | 440387.0 | ENSG00000168928 | nan | nan
chr16	CTRB1	118890.0 | CTRB1 | Chymotrypsinogen B1 | 1504.0 | ENSG00000168925 | HP-7cM-TAT-9cM-CTRB | nan
chr16	BCAR1	602941.0 | BCAR1, CRKAS, CAS | BCAR1 scaffold protein, CAS family member | 9564.0 | ENSG00000050820 | nan | nan
chr16	CFDP1	608108.0 | CFDP1, CP27, BCNT | Craniofacial development protein 1 | 10428.0 | ENSG00000153774 | nan | nan
chr16	TMEM170A	620630.0 | TMEM170A | Transmembrane protein 170A | 124491.0 | ENSG00000166822 | nan | nan
chr16	CHST6	605294.0 | CHST6, MCDC1 | Carbohydrate sulfotransferase-6 (GlcNAc-6-sulfotransferase, corneal) | 4166.0 | ENSG00000183196 | nan | Macular corneal dystrophy, 217800 (3), Autosomal recessive
chr16	CHST5	604817.0 | CHST5 | Carbohydrate sulfotransferase-5 (GlcNAc-6-O-sulfotransferase, intestinal) | 23563.0 | ENSG00000135702 | nan | nan
chr16	TMEM231	614949.0 | TMEM231, JBTS20, MKS11 | Transmembrane protein 231 | 79583.0 | ENSG00000205084 | nan | Joubert syndrome 20, 614970 (3), Autosomal recessive; Meckel syndrome 11, 615397 (3), Autosomal recessive
chr16	GABARAPL2	607452.0 | GABARAPL2 | GABA-A receptor-associated protein-like protein 2 | 11345.0 | ENSG00000034713 | nan | nan
chr16	ADAT1	604230.0 | ADAT1 | Adenosine deaminase, tRNA-specific, 1 | 23536.0 | ENSG00000065457 | nan | nan
chr16	KARS1	601421.0 | KARS1, KARS, CMTRIB, DFNB89, LEPID, DEAPLE | Lysyl-tRNA synthetase 1 | 3735.0 | ENSG00000065427 | mutation identified in 1 CMTRIB patient | Deafness, autosomal recessive 89, 613916 (3), Autosomal recessive; Leukoencephalopathy, progressive, infantile-onset, with or without deafness, 619147 (3), Autosomal recessive; ?Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3), Autosomal recessive; Deafness, congenital, and adult-onset progressive leukoencephalopathy, 619196 (3), Autosomal recessive
chr16	TERF2IP	605061.0 | TERF2IP, RAP1 | Telomeric repeat binding factor 2, interacting protein | 54386.0 | ENSG00000166848 | nan | nan
chr16	DUXB	618698.0 | DUXB | Double homeobox B | 100033411.0 | ENSG00000282757 | nan | nan
chr16	CPHXL	618700.0 | CPHXL, CPHXL1 | Cytoplasmic polyadenylated homeobox-like | 105371346.0 | ENSG00000283755 | nan | nan
chr16	CNTNAP4	610518.0 | CNTNAP4, CASPR4, KIAA1763 | Contactin-associated protein-like 4 | 85445.0 | ENSG00000152910 | nan | nan
chr16	MON1B	608954.0 | MON1B, SRG1, KIAA0872 | MON1 homolog B, secretory trafficking-associated | 22879.0 | ENSG00000103111 | nan | nan
chr16	SYCE1L	619954.0 | SYCE1L | Synaptonemal complex central element protein 1-like | 100130958.0 | ENSG00000205078 | nan | nan
chr16	ADAMTS18	607512.0 | ADAMTS18, MMCAT | ADAM metallopeptidase domain with thrombospondin type 1 motif, 18 | 170692.0 | ENSG00000140873 | nan | Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3), Autosomal recessive
chr16	NUDT7	609231.0 | NUDT7 | Nudix hydrolase 7 | 283927.0 | ENSG00000140876 | nan | nan
chr16	VAT1L	620202.0 | VAT1L, KIAA1576 | Vesicle amine transport protein 1-like | 57687.0 | ENSG00000171724 | nan | nan
chr16	CLEC3A	613588.0 | CLEC3A, CLECSF1 | C-type lectin domain family 3, member A | 10143.0 | ENSG00000166509 | nan | nan
chr16	WWOX	605131.0 | WWOX, FOR, SCAR12, DEE28 | WW domain-containing oxidoreductase | 51741.0 | ENSG00000186153 | nan | Esophageal squamous cell carcinoma, somatic, 133239 (3); Developmental and epileptic encephalopathy 28, 616211 (3), Autosomal recessive; Spinocerebellar ataxia, autosomal recessive 12, 614322 (3), Autosomal recessive
chr16	MAF	177075.0 | MAF, CCA4, CTRCT21, AYGRP | MAF bZIP transcription factor | 4094.0 | ENSG00000178573 | nan | Cataract 21, multiple types, 610202 (3), Autosomal dominant; Ayme-Gripp syndrome, 601088 (3), Autosomal dominant
chr16	MAFTRR	616264.0 | MAFTRR, lincMAF4 | MAF transcriptional regulator FNA, noncoding | 102467146.0 | ENSG00000261390 | nan | nan
chr16	DYNLRB2	607168.0 | DYNLRB2, DNCL2B | Dynein, light chain, roadblock-type 2 | 83657.0 | ENSG00000168589 | nan | nan
chr16	CDYL2	618816.0 | CDYL2 | CDY-like protein 2 | 124359.0 | ENSG00000166446 | nan | nan
chr16	ARLNC1	618053.0 | ARLNC1, LINC02170 | Androgen receptor-regulated long noncoding RNA 1 | 100996425.0 | ENSG00000260896 | nan | nan
chr16	CENPN	611509.0 | CENPN | Centromere protein N | 55839.0 | ENSG00000166451 | nan | nan
chr16	ATMIN	614693.0 | ATMIN, ASCIZ, KIAA0431 | ATM interactor | 23300.0 | ENSG00000166454 | nan | nan
chr16	GCSH	238330.0 | GCSH, MMDS7 | Glycine cleavage system H protein | 2653.0 | ENSG00000140905 | nan | Multiple mitochondrial dysfunctions syndrome 7, 620423 (3), Autosomal recessive
chr16	PKD1L2	607894.0 | PKD1L2, PC1L2, KIAA1879 | Polycystin 1-like 2 | 114780.0 | ENSG00000166473 | nan | nan
chr16	BCO1	605748.0 | BCO1, BCMO1, BCDO | Beta-carotene oxygenase 1 | 53630.0 | ENSG00000135697 | mutation identified in 1 HCVAD patient | ?Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3), Autosomal dominant
chr16	GAN	605379.0 | GAN, GAN1 | Gigaxonin | 8139.0 | ENSG00000261609 | nan | Giant axonal neuropathy-1, 256850 (3), Autosomal recessive
chr16	CMIP	610112.0 | CMIP, KIAA1694, TCMIP | C-MAF-inducing protein | 80790.0 | ENSG00000153815 | nan | nan
chr16	ADIPQTL5	613836.0 | ADIPQTL5 | Adiponectin, serum level of, quantitative trait locus 5 | 100653375.0 | nan | associated with rs3865188 | [Adiponectin, serum level of, QTL5], 613836 (2)
chr16	PLCG2	600220.0 | PLCG2, FCAS3, APLAID | Phospholipase C, gamma 2 | 5336.0 | ENSG00000197943 | nan | Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant
chr16	SDR42E1	616164.0 | SDR42E1 | Short-chain dehydrogenase/reductase family 42E, member 1 | 93517.0 | ENSG00000184860 | nan | nan
chr16	HSD17B2	109685.0 | HSD17B2, EDH17B2 | Hydroxysteroid (17-beta) dehydrogenase 2 | 3294.0 | ENSG00000086696 | nan | nan
chr16	MPHOSPH6	605500.0 | MPHOSPH6, MPP | M-phase phosphoprotein 6 | 10200.0 | ENSG00000135698 | nan | nan
chr16	CDH13	601364.0 | CDH13, CDHH | Cadherin-13 (H-cadherin, heart) | 1012.0 | ENSG00000140945 | nan | nan
chr16	HSBP1	604553.0 | HSBP1 | Heat-shock factor-binding protein 1 | 3281.0 | ENSG00000230989 | nan | nan
chr16	MLYCD	606761.0 | MLYCD, MCD | Malonyl-CoA decarboxylase | 23417.0 | ENSG00000103150 | nan | Malonyl-CoA decarboxylase deficiency, 248360 (3), Autosomal recessive
chr16	OSGIN1	607975.0 | OSGIN1, OKL38 | Oxidative stress-induced growth inhibitor 1 | 29948.0 | ENSG00000140961 | nan | nan
chr16	NECAB2	618130.0 | NECAB2 | N-terminal EF-hand calcium-binding protein 2 | 54550.0 | ENSG00000103154 | nan | nan
chr16	SLC38A8	615585.0 | SLC38A8, FVH2 | Solute carrier family 38 (amino acid transporter), member 8 | 146167.0 | ENSG00000166558 | nan | Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3), Autosomal recessive
chr16	MBTPS1	603355.0 | MBTPS1, S1P, SEDKF | Membrane-bound transcription factor protease, site 1 | 8720.0 | ENSG00000140943 | mutation identified in 1 SEDKF patient | ?Spondyloepiphyseal dysplasia, Kondo-Fu type, 618392 (3), Autosomal recessive
chr16	HDLC3	607687.0 | HDLC3 | High density lipoprotein cholesterol, low serum, 3 | 353125.0 | nan | nan | {High density lipoprotein cholesterol, low serum, 3}, 607687 (2)
chr16	STQTL22	613547.0 | STQTL22 | Stature quantitative trait locus 22 | 100529227.0 | nan | linked to rs299956 and rs2076962 | {Stature QTL 22}, 613547 (2)
chr16	HSDL1	619067.0 | HSDL1 | Hydroxysteroid dehydrogenase-like protein 1 | 83693.0 | ENSG00000103160 | nan | nan
chr16	DNAAF1	613190.0 | DNAAF1, LRRC50, ODA7, CILD13 | Dynein, axonemal, assembly factor 1 | 123872.0 | ENSG00000154099 | nan | Ciliary dyskinesia, primary, 13, 613193 (3), Autosomal recessive
chr16	TAF1C	604905.0 | TAF1C, TAFI110, SL1 | TATA box-binding protein-associated factor 1C | 9013.0 | ENSG00000103168 | nan | nan
chr16	ADAD2	619532.0 | ADAD2, TENRL | Adenosine deaminase domain-containing protein 2 | 161931.0 | ENSG00000140955 | nan | nan
chr16	KCNG4	607603.0 | KCNG4, KV6.3, KV6.4 | Potassium channel, voltage-gated, subfamily G, member 4 | 93107.0 | ENSG00000168418 | nan | nan
chr16	WFDC1	605322.0 | WFDC1, PS20 | WAP four-disulfide core domain-1, mouse, homolog of | 58189.0 | ENSG00000103175 | nan | nan
chr16	ATP2C2	613082.0 | ATP2C2, SPCA2, KIAA0703 | ATPase, Ca(2+)-transporting, type 2C, member 2 | 9914.0 | ENSG00000064270 | nan | nan
chr16	MEAK7	619331.0 | MEAK7, EAK7, TLDC1, KIAA1609 | MTOR-associated protein, eak7 homolog | 57707.0 | ENSG00000140950 | nan | nan
chr16	COTL1	606748.0 | COTL1, CLP | Coactosin-like protein 1 | 23406.0 | ENSG00000103187 | pseudogenes on 15, 17, and Y | nan
chr16	USP10	609818.0 | USP10, KIAA0190 | Ubiquitin-specific protein 10 | 9100.0 | ENSG00000103194 | nan | nan
chr16	CRISPLD2	612434.0 | CRISPLD2 | Cysteine-rich secretory protein, LCCL domain-containing, 2 | 83716.0 | ENSG00000103196 | nan | nan
chr16	ZDHHC7	614604.0 | ZDHHC7, DHHC7 | Zinc finger DHHC domain-containing protein 7 | 55625.0 | ENSG00000153786 | nan | nan
chr16	KIAA0513	611675.0 | KIAA0513 | KIAA0513 gene | 9764.0 | ENSG00000135709 | nan | nan
chr16	CIBAR2	617274.0 | FAM92B | Family with sequence similarity 92, member B | 339145.0 | ENSG00000153789 | nan | nan
chr16	GSE1	616886.0 | GSE1, KIAA0182 | GSE1 coiled-coil protein | 23199.0 | ENSG00000131149 | nan | nan
chr16	GINS2	610609.0 | GINS2, PSF2 | GINS complex subunit 2 | 51659.0 | ENSG00000131153 | nan | nan
chr16	EMC8	604886.0 | EMC8, NOC4 | ER membrane protein complex subunit 8 | 10328.0 | ENSG00000131148 | nan | nan
chr16	COX4I1	123864.0 | COX4I1, COX4, MC4DN16 | Cytochrome c oxidase, subunit IV, isoform 1 | 1327.0 | ENSG00000131143 | nan | Mitochondrial complex IV deficiency, nuclear type 16, 619060 (3), Autosomal recessive
chr16	IRF8	601565.0 | IRF8, ICSBP1, IMD32A, IMD32B | Interferon regulatory factor 8 | 3394.0 | ENSG00000140968 | nan | Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3), Autosomal dominant; Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 226990 (3), Autosomal recessive
chr16	LINC01082	614978.0 | TCONS00024492 | Long noncoding RNA TCONS_00024492 | 100506542.0 | ENSG00000269186 | nan | nan
chr16	LINC01081	614977.0 | LINC01081, TCONS00024764 | Long intergenic non-protein coding RNA 1081 | 101154687.0 | nan | nan | nan
chr16	FENDRR	614975.0 | FENDRR, FOXF1AS1, TCONS_00024240 | FOXF1 adjacent noncoding developmental regulatory RNA | 400550.0 | ENSG00000268388 | partial overlap with FOXF1 promoter | nan
chr16	FOXF1	601089.0 | FOXF1, FKHL5, ACDMPV | Forkhead box F1 | 2294.0 | ENSG00000103241 | nan | Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3), Autosomal dominant
chr16	MTHFSD	616820.0 | MTHFSD | Methenyltetrahydrofolate synthetase domain-containing protein | 64779.0 | ENSG00000103248 | nan | nan
chr16	FOXC2	602402.0 | FOXC2, FKHL14, MFH1 | Forkhead box C2 | 2303.0 | ENSG00000176692 | nan | Lymphedema-distichiasis syndrome, 153400 (3), Autosomal dominant; Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3), Autosomal dominant
chr16	FOXL1	603252.0 | FOXL1, FKHL11, FREAC7, FKH6, OTSC11 | Forkhead box L1 | 2300.0 | ENSG00000176678 | nan | Otosclerosis 11, 620576 (3), Autosomal dominant
chr16	FBXO31	609102.0 | FBXO31, FBX31, FBXO14, FBX14, MRT45 | F-box only protein 31 | 79791.0 | ENSG00000103264 | mutation identified in 1 MRT45 family | ?Intellectual developmental disorder, autosomal recessive 45, 615979 (3), Autosomal recessive
chr16	MAP1LC3B	609604.0 | MAP1LC3B, LC3B | Microtubule-associated protein 1, light chain 3, beta | 81631.0 | ENSG00000140941 | nan | nan
chr16	ZCCHC14	620697.0 | ZCCHC14 | Zinc finger CCHC domain-containing protein 14 | 23174.0 | ENSG00000140948 | nan | nan
chr16	JPH3	605268.0 | JPH3, JP3, HDL2 | Junctophilin 3 | 57338.0 | ENSG00000154118 | mutation identified in 1 HDL2 family | Huntington disease-like 2, 606438 (3), Autosomal dominant
chr16	KLHDC4	620518.0 | KLHDC4 | Kelch domain-containing protein 4 | 54758.0 | ENSG00000104731 | nan | nan
chr16	SLC7A5	600182.0 | SLC7A5, D16S469E, MPE16 | Solute carrier family 7, member 5 | 8140.0 | ENSG00000103257 | nan | nan
chr16	CA5A	114761.0 | CA5A, CA5AD | Carbonic anhydrase VA (mitochondrial) | 763.0 | ENSG00000174990 | pseudogene on 16p | Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3), Autosomal recessive
chr16	BANP	611564.0 | BANP, SMAR1 | BTG3-associated nuclear protein | 54971.0 | ENSG00000172530 | nan | nan
chr16	ZNF469	612078.0 | ZNF469, KIAA1858, BCS1 | Zinc finger protein 469 | 84627.0 | ENSG00000225614 | nan | Brittle cornea syndrome 1, 229200 (3), Autosomal recessive
chr16	ZFPM1	601950.0 | ZFPM1, FOG, FOG1 | Zinc finger protein, multitype 1 (friend of GATA1) | 161882.0 | ENSG00000179588 | nan | nan
chr16	IL17C	604628.0 | IL17C | Interleukin 17C | 27189.0 | ENSG00000124391 | nan | nan
chr16	CYBA	608508.0 | CYBA, CGD4 | Cytochrome b-245, alpha polypeptide | 1535.0 | ENSG00000051523 | nan | Chronic granulomatous disease 4, autosomal recessive, 233690 (3), Autosomal recessive
chr16	MVD	603236.0 | MVD, MPD, POROK7 | Mevalonate pyrophosphate decarboxylase | 4597.0 | ENSG00000167508 | nan | Porokeratosis 7, multiple types, 614714 (3), Autosomal dominant
chr16	SNAI3	612741.0 | SNAI3, SNAIL3, SMUC, ZFP293 | SNAIL, Drosophila, homolog of, 3 | 333929.0 | ENSG00000185669 | nan | nan
chr16	RNF166	617178.0 | RNF166 | RING finger protein 166 | 115992.0 | ENSG00000158717 | nan | nan
chr16	IHPS5	612525.0 | IHPS5 | Pyloric stenosis, infantile hypertrophic, 5 | 100270639.0 | nan | between rs7197068 and rs750740 | Pyloric stenosis, infantile hypertrophic, 5, 612525 (2)
chr16	CTU2	617057.0 | CTU2, C16orf84, NCS2, MFRG | Cytosolic thiouridylase, subunit 2 | 348180.0 | ENSG00000174177 | nan | Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome, 618142 (3), Autosomal recessive
chr16	PIEZO1	611184.0 | PIEZO1, FAM38A, MIB, DHS, LMPHM6, ER | PIEZO1 ion channel | 9780.0 | ENSG00000103335 | nan | [ER blood group system], 620207 (3), Autosomal recessive; Lymphatic malformation 6, 616843 (3), Autosomal recessive; Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3), Autosomal dominant
chr16	CDT1	605525.0 | CDT1 | Chromatin licensing and DNA replication factor 1 | 81620.0 | ENSG00000167513 | nan | Meier-Gorlin syndrome 4, 613804 (3), Autosomal recessive
chr16	APRT	102600.0 | APRT, APRTD | Adenine phosphoribosyltransferase | 353.0 | ENSG00000198931 | telomeric to GALNS, transcribed in same cen-tel direction | Adenine phosphoribosyltransferase deficiency, 614723 (3), Autosomal recessive
chr16	GALNS	612222.0 | GALNS, MPS4A | Galactosamine (N-acetyl)-6-sulfate sulfatase | 2588.0 | ENSG00000141012 | centromeric to APRT | Mucopolysaccharidosis IVA, 253000 (3), Autosomal recessive
chr16	TRAPPC2L	610970.0 | TRAPPC2L, PERRB | Trafficking protein particle complex 2-like | 51693.0 | ENSG00000167515 | nan | Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis, 618331 (3), Autosomal recessive
chr16	CBFA2T3	603870.0 | CBFA2T3, MTGR2, MTG16 | Core-binding factor, alpha subunit 2, translocated to, 3 | 863.0 | ENSG00000129993 | nan | nan
chr16	ACSF3	614245.0 | ACSF3 | Acyl-CoA synthetase family member 3 | 197322.0 | ENSG00000176715 | nan | Combined malonic and methylmalonic aciduria, 614265 (3), Autosomal recessive
chr16	CDH15	114019.0 | CDH15, CDH14, CDH3, MRD3 | Cadherin-15, M-cadherin (myotubule) | 1013.0 | ENSG00000129910 | tightly linked to Aprt in mouse | Intellectual developmental disorder, autosomal dominant 3, 612580 (3), Autosomal dominant
chr16	ANKRD11	611192.0 | ANKRD11, ANCO1, KBGS | Ankyrin repeat domain-containing protein 11 | 29123.0 | ENSG00000167522 | nan | KBG syndrome, 148050 (3), Autosomal dominant
chr16	SPG7	602783.0 | PGN, SPG7, CMAR, CAR | SPG7 matrix AAA peptidase subunit, paraplegin | 6687.0 | ENSG00000197912 | nan | Spastic paraplegia 7, autosomal recessive, 607259 (3), Autosomal recessive, Autosomal dominant
chr16	RPL13	113703.0 | RPL13, BBC1, D16S44E, SEMDIST | Ribosomal protein L13 | 6137.0 | ENSG00000167526 | nan | Spondyloepimetaphyseal dysplasia, Isidor-Toutain type, 618728 (3), Autosomal dominant
chr16	CPNE7	605689.0 | CPNE7 | Copine VII | 27132.0 | ENSG00000178773 | nan | nan
chr16	DPEP1	179780.0 | DPEP1, RDP, MDP, MBD1 | Dipeptidase 1 | 1800.0 | ENSG00000015413 | nan | nan
chr16	CHMP1A	164010.0 | CHMP1A, PCOLN3, PRSM1, PCH8 | Charged multivesicular body protein 1A | 5119.0 | ENSG00000131165 | nan | Pontocerebellar hypoplasia, type 8, 614961 (3), Autosomal recessive
chr16	SPATA33	615409.0 | SPATA33, C16orf55 | Spermatogenesis-associated protein 33 | 124045.0 | ENSG00000167523 | nan | nan
chr16	CDK10	603464.0 | CDK10, PISSLRE, ALSAS | Cyclin-dependent kinase 10 | 8558.0 | ENSG00000185324 | nan | Al Kaissi syndrome, 617694 (3), Autosomal recessive
chr16	VPS9D1	619292.0 | VPS9D1, ATPBL | VPS9 domain-containing protein 1 | 9605.0 | ENSG00000075399 | nan | nan
chr16	ZNF276	608460.0 | ZFP276 | Zinc finger protein 276 | 92822.0 | ENSG00000158805 | nan | nan
chr16	FANCA	607139.0 | FANCA, FACA, FA1, FA, FAA | Fanconi anemia, complementation group A | 2175.0 | ENSG00000187741 | linkage heterogeneity | Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive
chr16	SPIRE2	609217.0 | SPIRE2, KIAA1832 | Spire-type actin nucleation factor 2 | 84501.0 | ENSG00000204991 | nan | nan
chr16	TCF25	612326.0 | TCF25, NULP1, KIAA1049 | Transcription factor 25 | 22980.0 | ENSG00000141002 | nan | nan
chr16	MC1R	155555.0 | MC1R, SHEP2, CMM5 | Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor) | 4157.0 | ENSG00000258839 | nan | [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3); [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive; [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive; {Melanoma, cutaneous malignant, 5}, 613099 (3); {Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive; {UV-induced skin damage}, 266300 (3), Autosomal recessive
chr16	TUBB3	602661.0 | TUBB3, TUBB4, CFEOM3A, CDCBM1 | Tubulin, beta-3 | 10381.0 | ENSG00000258947 | nan | Fibrosis of extraocular muscles, congenital, 3A, 600638 (3), Autosomal dominant; Cortical dysplasia, complex, with other brain malformations 1, 614039 (3), Autosomal dominant
chr16	AFG3L1P	603020.0 | AFG3L1, AFG3 | AFG3-like matrix AAA peptidase, subunit 1, pseudogene | 172.0 | ENSG00000293510 | nan | nan
chr16	DBNDD1	620388.0 | DBNDD1 | Dysbindin domain-containing protein 1 | 79007.0 | ENSG00000003249 | nan | nan
chr16	GAS8	605178.0 | GAS8, GAS11, CILD33 | Growth arrest-specific 8 | 2622.0 | ENSG00000141013 | nan | Ciliary dyskinesia, primary, 33, 616726 (3), Autosomal recessive
chr16	GAS8-AS1	605179.0 | GAS8-AS1, C16orf3, EID1 | GAS8 antisense RNA 1 | 750.0 | ENSG00000221819 | nan | nan
chr16	URAHP	615805.0 | URAHP, URAH | Urate (hydroxyiso-) hydrolase, pseudogene | 100130015.0 | ENSG00000290738 | nan | nan
chr16	PRDM7	609759.0 | PRDM7 | PR domain-containing protein 7 | 11105.0 | ENSG00000126856 | nan | nan
chr16	ESB3	133290.0 | ESB3 | Esterase-B3 | 2097.0 | nan | nan | nan
chr16	NR3C1P1	138060.0 | GRLL1 | Glucocorticoid receptor-like 1 | 2910.0 | ENSG00000276393 | nan | nan
chr16	IFNR	147573.0 | IFNR | Interferon production regulator | 3466.0 | nan | nan | nan
chr16	LIPB	247980.0 | LIPB | Lipase B, lysosomal acid | 3989.0 | nan | nan | nan
chr17	ASPG2	608631.0 | ASPG2 | Asperger syndrome, susceptibility to, 2 | 431711.0 | nan | breakpoints between CHRNE and GP1BA | {Asperger syndrome susceptibility 2}, 608631 (2), Isolated cases, Multifactorial
chr17		113721.0 | BCPR | Breast cancer-related regulator of TP53 | nan | nan | nan | Breast cancer (1)
chr17	CTAA2	601202.0 | CTRCT24, CTAA2 | Cataract 24, anterior polar | 1484.0 | nan | nan | Cataract 24, anterior polar, 601202 (2), Autosomal dominant
chr17	DDD3	615674.0 | DDD3 | Dowling-Degos disease 3 | 102997065.0 | nan | max lod at D17S1529 | Dowling-Degos disease 3, 615674 (2), Autosomal dominant
chr17		613215.0 | DUP17p13.3, C17DUPp13.3 | Chromosome 17p13.3 duplication syndrome | nan | nan | includes LIS1 and/or YWHAE | Chromosome 17p13.3 duplication syndrome, 613215 (4), Isolated cases, Autosomal dominant
chr17		247200.0 | MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3 | Miller-Dieker lissencephaly syndrome (chromosome 17p13.3 deletion syndrome) | nan | nan | nan | Miller-Dieker lissencephaly syndrome, 247200 (4), Autosomal dominant
chr17	NDIC	605779.0 | NDNC7 | Nail disorder, nonsyndromic congenital, 7 (onychodysplasia, isolated congenital) | 81866.0 | nan | nan | Nail disorder, nonsyndromic congenital, 7, 605779 (2), Autosomal dominant
chr17		612576.0 | SHFLD3, DUP17p13.3, C17DUPp13.3 | Split-hand/foot malformation with long bone deficiency 3 | nan | nan | max lod at or near D17S1533; contiguous gene duplication syndrome | Split-hand/foot malformation with long bone deficiency 3, 612576 (4), Autosomal dominant
chr17	SXGQTL1	613498.0 | SXGQTL1 | Sex hormone-binding globulin circulating level quantitative trait locus 1 | 100528025.0 | nan | associated with rs1799941 | [Sex hormone-binding globulin circulating level QTL 1], 613498 (2)
chr17	DOC2B	604568.0 | DOC2B | Double C2-like domain-containing protein, beta | 8447.0 | ENSG00000272636 | nan | nan
chr17	RPH3AL	604881.0 | RPH3AL, NOC2 | Rabphilin 3A-like | 9501.0 | ENSG00000181031 | nan | nan
chr17	RFLNB	615928.0 | RFLNB, FAM101B, CFM1 | Refilin B | 359845.0 | ENSG00000183688 | nan | nan
chr17	VPS53	615850.0 | VPS53, HCCS1, PCH2E | VPS53 subunit of GARP complex | 55275.0 | ENSG00000141252 | nan | Pontocerebellar hypoplasia, type 2E, 615851 (3), Autosomal recessive
chr17	TLCD3A	611627.0 | TLCD3A, FAM57A, CT120 | TLC domain-containing protein 3A | 79850.0 | ENSG00000167695 | nan | nan
chr17	GEMIN4	606969.0 | GEMIN4, NEDMCR | Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities | 50628.0 | ENSG00000179409 | nan | Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities, 617913 (3), Autosomal recessive
chr17	GLOD4	620650.0 | GLOD4, C17orf25 | Glyoxalase domain-containing protein 4 | 51031.0 | ENSG00000167699 | nan | nan
chr17	MRM3	612600.0 | RNMTL1, HC90 | RNA methyltransferase-like 1 | 55178.0 | ENSG00000171861 | nan | nan
chr17	NXN	612895.0 | NXN, RRS2 | Nucleoredoxin | 64359.0 | ENSG00000167693 | nan | Robinow syndrome, autosomal recessive 2, 618529 (3), Autosomal recessive
chr17	TIMM22	607251.0 | TIMM22, TIM22, COXPD43 | Translocase of inner mitochondrial membrane 22 | 29928.0 | ENSG00000177370 | mutation identified in 1 COXPD43 patient | ?Combined oxidative phosphorylation deficiency 43, 618851 (3), Autosomal recessive
chr17	ABR	600365.0 | ABR | ABR activator of RhoGEF and GTPase | 29.0 | ENSG00000159842 | nan | nan
chr17	BHLHA9	615416.0 | BHLHA9, BHLHF42, MSSD, CCSPD | Basic helix-loop-helix family, member A9 | 727857.0 | ENSG00000205899 | mutation identified in 1 CCSPD family | ?Camptosynpolydactyly, complex, 607539 (3), Autosomal recessive; Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3), Autosomal recessive
chr17	TRARG1	612211.0 | TUSC5, LOST1 | Tumor suppressor candidate 5 | 286753.0 | ENSG00000184811 | nan | nan
chr17	YWHAE	605066.0 | YWHAE, MDCR, MDS | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon isoform | 7531.0 | ENSG00000108953 | nan | nan
chr17	CRK	164762.0 | CRK | Avian sarcoma virus CT10 (v-crk) oncogene homolog | 1398.0 | ENSG00000167193 | nan | nan
chr17	MYO1C	606538.0 | MYO1C | Myosin IC | 4641.0 | ENSG00000197879 | nan | nan
chr17	INPP5K	607875.0 | INPP5K, SKIP, MDCCAID | Inositol polyphosphate-5-phosphatase K | 51763.0 | ENSG00000132376 | nan | Muscular dystrophy, congenital, with cataracts and intellectual disability, 617404 (3), Autosomal recessive
chr17	PITPNA	600174.0 | PITPNA, PITPN | Phosphotidylinositol transfer protein, alpha | 5306.0 | ENSG00000174238 | nan | nan
chr17	SLC43A2	610791.0 | SLC43A2, LAT4 | Solute carrier family 43 (L-type amino acid transporter, member 2) | 124935.0 | ENSG00000167703 | nan | nan
chr17	SCARF1	607873.0 | SCARF1, SREC, KIAA0149 | Scavenger receptor class F, member 1 | 8578.0 | ENSG00000074660 | nan | nan
chr17	RILP	607848.0 | RILP | RAB-interacting lysosomal protein | 83547.0 | ENSG00000167705 | nan | nan
chr17	PRPF8	607300.0 | PRPF8, PRPC8, RP13 | Pre-mRNA processing factor 8 | 10594.0 | ENSG00000174231 | nan | Retinitis pigmentosa 13, 600059 (3), Autosomal dominant
chr17	TLCD2	620967.0 | TLCD2 | TLC domain-containing protein 2 | 727910.0 | ENSG00000185561 | nan | nan
chr17	MIR22	612077.0 | MIR22, MIRN22 | Micro RNA 22 | 407004.0 | ENSG00000283824 | nan | nan
chr17	WDR81	614218.0 | WDR81, CAMRQ2, HYC3 | WD repeat-containing protein 81 | 124997.0 | ENSG00000167716 | nan | Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2, 610185 (3), Autosomal recessive; Hydrocephalus, congenital, 3, with brain anomalies, 617967 (3), Autosomal recessive
chr17	SERPINF2	613168.0 | PLI, SERPINF2 | Alpha-2-plasmin inhibitor | 5345.0 | ENSG00000167711 | nan | Alpha-2-plasmin inhibitor deficiency, 262850 (3), Autosomal recessive
chr17	SERPINF1	172860.0 | SERPINF1, PEDF, OI6 | Serpin peptidase inhibitor, clade F, member 1 | 5176.0 | ENSG00000132386 | same region as RP13 | Osteogenesis imperfecta, type VI, 613982 (3), Autosomal recessive
chr17	SMYD4	619134.0 | SMYD4 | SET and MYND domain-containing protein 4 | 114826.0 | ENSG00000186532 | nan | nan
chr17	RPA1	179835.0 | RPA1, PFBMFT6 | Replication protein A1, 70kD | 6117.0 | ENSG00000132383 | nan | Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6, 619767 (3), Autosomal dominant
chr17	RTN4RL1	610461.0 | RTN4RL1, NGRH2, NGR3 | Reticulon 4 receptor-like 1 | 146760.0 | ENSG00000185924 | nan | nan
chr17	DPH1	603527.0 | DPH1, DPH2L1, OVCA1, DEDSSH | Diphthamide biosynthesis protein 1 | 1801.0 | ENSG00000108963 | nan | Developmental delay with short stature, dysmorphic facial features, and sparse hair, 616901 (3), Autosomal recessive
chr17	OVCA2	607896.0 | OVCA2 | OVCA2 serine hydrolase domain-containing protein | 124641.0 | ENSG00000262664 | nan | nan
chr17	MIR132	610016.0 | MIR132, MIRN132 | Micro RNA 132 | 406921.0 | ENSG00000267200 | nan | nan
chr17	MIR212	613487.0 | MIR212, MIRN212 | Micro RNA 212 | 406994.0 | ENSG00000267195 | nan | nan
chr17	HIC1	603825.0 | HIC1 | Hypermethylated in cancer | 3090.0 | ENSG00000177374 | nan | nan
chr17	SMG6	610963.0 | SMG6, EST1A, KIAA0732 | SMG6 nonsense-mediated mRNA decay factor | 23293.0 | ENSG00000070366 | nan | nan
chr17	SRR	606477.0 | SRR | Serine racemase | 63826.0 | ENSG00000167720 | nan | nan
chr17	TSR1	611214.0 | TSR1, KIAA1401 | TSR1, 20S r RNA accumulation, S. cerevisiae, homolog of | 55720.0 | ENSG00000167721 | nan | nan
chr17	SGSM2	611418.0 | SGSM2, KIAA0397 | Small G protein signaling modulator 2 | 9905.0 | ENSG00000141258 | nan | nan
chr17	MNT	603039.0 | MNT, ROX | MAX network transcriptional repressor | 4335.0 | ENSG00000070444 | nan | nan
chr17	PAFAH1B1	601545.0 | PAFAH1B1, LIS1 | Platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit | 5048.0 | ENSG00000007168 | nan | Subcortical laminar heterotopia, 607432 (3), Autosomal dominant; Lissencephaly 1, 607432 (3), Autosomal dominant
chr17	CLUH	616184.0 | CLUH, CLU1, KIAA0664 | Clustered mitochondria, D. discoideum, homolog of | 23277.0 | ENSG00000132361 | nan | nan
chr17	RAP1GAP2	618714.0 | RAP1GAP2, GARNL4, KIAA1039 | RAP1 GTPase-activating protein 2 | 23108.0 | ENSG00000132359 | nan | nan
chr17	OR1D2	164342.0 | OR1D2, OLFR1 | Olfactory receptor, family 1, subfamily D, member 2 | 4991.0 | ENSG00000184166 | cluster of 16 genes in 350kb | nan
chr17	OR1A2	618047.0 | OR1A2 | Olfactory receptor, family 1, subfamily A, member 2 | 26189.0 | ENSG00000172150 | nan | nan
chr17	OR1A1	618046.0 | OR1A1 | Olfactory receptor, family 1, subfamily A, member 1 | 8383.0 | ENSG00000172146 | nan | nan
chr17	MRT33	614341.0 | MRT33 | Intellectual developmental disorder, autosomal recessive 33 | 100852394.0 | nan | between rs1367950 and rs1826925 | Intellectual developmental disorder, autosomal recessive 33, 614341 (2), Autosomal recessive
chr17	SPATA22	617673.0 | SPATA22 | Spermatogenesis-associated protein 22 | 84690.0 | ENSG00000141255 | nan | nan
chr17	ASPA	608034.0 | ASPA | Aspartoacylase (aminoacylase-2) | 443.0 | ENSG00000108381 | nan | Canavan disease, 271900 (3), Autosomal recessive
chr17	TRPV3	607066.0 | TRPV3, OLMS1, FNEPPK2 | Transient receptor potential cation channel, subfamily V, member 3 | 162514.0 | ENSG00000167723 | mutation identified in 1 FNEPPK2 family | ?Palmoplantar keratoderma, nonepidermolytic, focal 2, 616400 (3), Autosomal dominant; Olmsted syndrome 1, 614594 (3), Autosomal dominant
chr17	TRPV1	602076.0 | TRPV1, VR1 | Transient receptor potential cation channel, subfamily V, member 1 (vanilloid receptor 1; capsaicin receptor) | 7442.0 | ENSG00000196689 | nan | nan
chr17	SHPK	605060.0 | SHPK, CARKL | Sedoheptulokinase | 23729.0 | ENSG00000197417 | nan | [Sedoheptulokinase deficiency], 617213 (3), Autosomal recessive
chr17	CTNS	606272.0 | CTNS | Cystinosin | 1497.0 | ENSG00000040531 | ?3 allelic forms | Cystinosis, nephropathic, 219800 (3), Autosomal recessive; Cystinosis, ocular nonnephropathic, 219750 (3), Autosomal recessive; Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3), Autosomal recessive; Cystinosis, atypical nephropathic, 219800 (3), Autosomal recessive
chr17	TAX1BP3	616484.0 | TAX1BP3, TIP1 | TAX1-binding protein 3 | 30851.0 | ENSG00000213977 | nan | nan
chr17	EMC6	620261.0 | EMC6 | Endoplasmic reticulum membrane protein complex, subunit 6 | 83460.0 | ENSG00000127774 | nan | nan
chr17	P2RX5	602836.0 | P2RX5 | Purinergic receptor P2X, ligand-gated ion channel, 5 | 5026.0 | ENSG00000083454 | nan | nan
chr17	ITGAE	604682.0 | ITGAE, CD103 | Integrin, alpha-E | 3682.0 | ENSG00000083457 | nan | nan
chr17	HASPIN	609240.0 | HASPIN, GSG2 | Histone H3-associated protein kinase | 83903.0 | ENSG00000177602 | nan | nan
chr17	NCBP3	616624.0 | NCBP3, C17orf85 | Nuclear cap-binding protein 3 | 55421.0 | ENSG00000074356 | nan | nan
chr17	CAMKK1	611411.0 | CAMKK1, CAMKKA | Calcium/calmodulin-dependent protein kinase kinase 1, alpha | 84254.0 | ENSG00000004660 | nan | nan
chr17	P2RX1	600845.0 | P2RX1, P2X1 | Purinergic receptor P2X, ligand-gated ion channel, 1 | 5023.0 | ENSG00000108405 | nan | nan
chr17	ATP2A3	601929.0 | ATP2A3, SERCA3 | ATPase, Ca(2+)-transporting, ubiquitous | 489.0 | ENSG00000074370 | nan | nan
chr17	ZZEF1	619459.0 | ZZEF1, KIAA0399 | Zinc finger ZZ-type domain- and EF-hand domain-containing protein 1 | 23140.0 | ENSG00000074755 | nan | nan
chr17	ANKFY1	607927.0 | ANKFY1, ANKHZN, KIAA1255 | Ankyrin repeats- and FYVE domain-containing protein 1 | 51479.0 | ENSG00000185722 | nan | nan
chr17	UBE2G1	601569.0 | UBE2G | Ubiquitin-conjugating enzyme E2 G1 | 7326.0 | ENSG00000132388 | possible pseudogene on 1q42 | nan
chr17	SPNS3	611701.0 | SPNS3 | Spinster, Drosophila, homolog of, 3 | 201305.0 | ENSG00000182557 | nan | nan
chr17	SPNS2	612584.0 | SPNS2, DFNB115 | Sphingolipid transporter 2 | 124976.0 | ENSG00000183018 | mutation identified in 1 DFNB115 patient | ?Deafness, autosomal recessive 115, 618457 (3), Autosomal recessive
chr17	MYBBP1A	604885.0 | MYBBP1A, P160 | MYB-binding protein 1A | 10514.0 | ENSG00000132382 | nan | nan
chr17	GGT6	612341.0 | GGT6 | Gamma-glutamyltransferase 6 | 124975.0 | ENSG00000167741 | nan | nan
chr17	ALOX15	152392.0 | ALOX15 | Arachidonate 15-lipoxygenase | 246.0 | ENSG00000161905 | nan | nan
chr17	PELP1	609455.0 | PELP1, MNAR | Proline-, glutamic acid-, and leucine-rich protein 1 | 27043.0 | ENSG00000141456 | nan | nan
chr17	ARRB2	107941.0 | ARRB2 | Arrestin, beta 2 | 409.0 | ENSG00000141480 | nan | nan
chr17	MED11	612383.0 | MED11, NDDRSB | Mediator complex subunit 11 | 400569.0 | ENSG00000161920 | nan | Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities, 620327 (3), Autosomal recessive
chr17	CXCL16	605398.0 | CXCL16 | CXC chemokine ligand-16 | 58191.0 | ENSG00000161921 | nan | nan
chr17	ZMYND15	614312.0 | ZMYND15, SPGF14 | Zinc finger MYND-containing protein 15 | 84225.0 | ENSG00000141497 | mutation identified in 1 SPGF14 family | ?Spermatogenic failure 14, 615842 (3), Autosomal recessive
chr17	TM4SF5	604657.0 | TM4SF5 | Transmembrane 4 superfamily, member 5 | 9032.0 | ENSG00000142484 | nan | nan
chr17	GLTPD2	620824.0 | GLTPD2 | Glycolipid transfer protein domain-containing protein 2 | 388323.0 | ENSG00000182327 | nan | nan
chr17	PSMB6	600307.0 | PSMB6, LMPY | Proteasome subunit, beta-type, 6 | 5694.0 | ENSG00000142507 | nan | nan
chr17	PLD2	602384.0 | PLD2 | Phospholipase D2 | 5338.0 | ENSG00000129219 | nan | nan
chr17	MINK1	609426.0 | MINK1, MINK | Misshapen/nik-related kinase 1 | 50488.0 | ENSG00000141503 | nan | nan
chr17	CHRNE	100725.0 | CHRNE, SCCMS, CMS4A, CMS4B, CMS4C | Cholinergic receptor, nicotinic, epsilon polypeptide | 1145.0 | ENSG00000108556 | nan | Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3), Autosomal recessive, Autosomal dominant; Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3), Autosomal recessive; Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3), Autosomal recessive
chr17	GP1BA	606672.0 | GP1BA, BSS, BDPLT1, VWDP, BDPLT3 | Glycoprotein Ib, platelet, alpha polypeptide | 2811.0 | ENSG00000185245 | nan | Bernard-Soulier syndrome, type A1 (recessive), 231200 (3), Autosomal recessive; Bernard-Soulier syndrome, type A2 (dominant), 153670 (3), Autosomal dominant; von Willebrand disease, platelet-type, 177820 (3), Autosomal dominant; {Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3), Autosomal recessive
chr17	SLC25A11	604165.0 | SLC25A11, SLC20A4, OGC, PPGL6 | Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 | 8402.0 | ENSG00000108528 | nan | Pheochromocytoma/paraganglioma syndrome 6, 618464 (3), Autosomal dominant
chr17	RNF167	610431.0 | RNF167, RING105 | RING finger protein 167 | 26001.0 | ENSG00000108523 | nan | nan
chr17	PFN1	176610.0 | PFN1, ALS18 | Profilin-1 | 5216.0 | ENSG00000108518 | nan | Amyotrophic lateral sclerosis 18, 614808 (3)
chr17	ENO3	131370.0 | ENO3, GSD13 | Enolase-3, beta, muscle | 2027.0 | ENSG00000108515 | nan | Glycogen storage disease XIII, 612932 (3), Autosomal recessive
chr17	SPAG7	610056.0 | SPAG7 | Sperm-associated antigen 7 | 9552.0 | ENSG00000091640 | nan | nan
chr17	CAMTA2	611508.0 | CAMTA2, KIAA0909 | Calmodulin-binding transcription activator 2 | 23125.0 | ENSG00000108509 | nan | nan
chr17	INCA1	617374.0 | INCA1, HSD45 | Inhibitor of CDK, cyclin A1-interacting protein 1 | 388324.0 | ENSG00000196388 | nan | nan
chr17	KIF1C	603060.0 | KIF1C, LTXS1, KIAA0706, SPAX2 | Kinesin family member 1C | 10749.0 | ENSG00000129250 | nan | Spastic ataxia 2, autosomal recessive, 611302 (3), Autosomal recessive
chr17	SLC52A1	607883.0 | SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD | Solute carrier family 52, riboflavin transporter, member 1 | 55065.0 | ENSG00000132517 | nan | Riboflavin deficiency, 615026 (3), Autosomal dominant
chr17	ZFP3	194480.0 | ZFP3 | Zinc finger protein-3 | 124961.0 | ENSG00000180787 | probably in cluster with ZNF29 proximal to TP53 | nan
chr17	ZNF232	616463.0 | ZNF232, ZSCAN11 | Zinc finger protein 232 | 7775.0 | ENSG00000167840 | nan | nan
chr17	USP6	604334.0 | USP6, TRE2 | Ubiquitin-specific protease 6 | 9098.0 | ENSG00000129204 | nan | nan
chr17	SCIMP	614406.0 | SCIMP, C17orf87 | SLP adaptor- and CSK-interacting membrane protein | 388325.0 | ENSG00000161929 | nan | nan
chr17	RABEP1	603616.0 | RABEP1, RABPT5 | RAB GTPase-binding effector protein 1 | 9135.0 | ENSG00000029725 | fused to PDGFRB in CMML | nan
chr17	NUP88	602552.0 | NUP88, FADS4 | Nucleoporin, 88-kD | 4927.0 | ENSG00000108559 | nan | Fetal akinesia deformation sequence 4, 618393 (3), Autosomal recessive
chr17	RPAIN	617299.0 | RPAIN, RIP | RPA-interacting protein | 84268.0 | ENSG00000129197 | nan | nan
chr17	C1QBP	601269.0 | C1QBP, HABP1, COXPD33 | Complement component C1q binding protein (hyaluronic acid-binding protein 1) | 708.0 | ENSG00000108561 | nan | Combined oxidative phosphorylation deficiency 33, 617713 (3), Autosomal recessive
chr17	DHX33	614405.0 | DHX33 | DEAH-box helicase 33 | 56919.0 | ENSG00000005100 | nan | nan
chr17	DERL2	610304.0 | DERL2 | DER1-like domain family, member 2 | 51009.0 | ENSG00000072849 | nan | nan
chr17	MIS12	609178.0 | MIS12 | MIS12 kinetochore complex component | 79003.0 | ENSG00000167842 | nan | nan
chr17	NLRP1	606636.0 | NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, VAMAS1, MSPC, AIADK, JRRP | NLR family, pyrin domain containing 1 | 22861.0 | ENSG00000091592 | mutation identified in 1 JRRP family | {Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3); ?Respiratory papillomatosis, juvenile recurrent, congenital, 618803 (3), Autosomal recessive; Autoinflammation with arthritis and dyskeratosis, 617388 (3), Autosomal recessive, Autosomal dominant; Palmoplantar carcinoma, multiple self-healing, 615225 (3), Autosomal dominant
chr17	WSCD1	619584.0 | WSCD1, KIAA0523 | WSC domain-containing protein 1 | 23302.0 | ENSG00000179314 | nan | nan
chr17	AIPL1	604392.0 | AIPL1, LCA4 | Arylhydrocarbon-interacting receptor protein-like 1 | 23746.0 | ENSG00000129221 | LCA1 due to GUCY2D mutation also on 17p13.1 | Leber congenital amaurosis 4, 604393 (3), Autosomal recessive, Autosomal dominant; Retinitis pigmentosa, juvenile, 604393 (3), Autosomal recessive, Autosomal dominant; Cone-rod dystrophy, 604393 (3), Autosomal recessive, Autosomal dominant
chr17	PIMREG	617611.0 | PIMREG, RCS1, FAM64A | PICALM-interacting mitotic regulator | 54478.0 | ENSG00000129195 | nan | nan
chr17	PITPNM3	608921.0 | PITPNM3, NIR1, CORD5 | Phosphatidylinositol transfer protein, membrane-associated, 3 | 83394.0 | ENSG00000091622 | nan | Cone-rod dystrophy 5, 600977 (3), Autosomal dominant
chr17		613776.0 | DEL17p13.1, C17DELp13.1 | Chromosome 17p13.1 deletion syndrome | nan | nan | contiguous gene deletion syndrome | Chromosome 17p13.1 deletion syndrome, 613776 (4), Autosomal dominant
chr17	MGR10	610208.0 | MGR10 | Migraine with or without aura, susceptibility to, 10 | 117204002.0 | nan | nan | {Migraine with or without aura, susceptibility to, 10}, 610208 (2), Autosomal dominant
chr17	NOS2P1	600720.0 | NOS2P1, NOS2C | Nitric oxide synthase 2 pseudogene 1 | 645740.0 | ENSG00000297633 | nan | nan
chr17	KIAA0753	617112.0 | KIAA0753, OFIP, OFD15, JBTS38, SRTD21 | KIAA0753 gene | 9851.0 | ENSG00000198920 | mutation identified in 1 OFD15 patient and 1 JBTS38 family | ?Orofaciodigital syndrome XV, 617127 (3), Autosomal recessive; ?Joubert syndrome 38, 619476 (3), Autosomal recessive; Short-rib thoracic dysplasia 21 without polydactyly, 619479 (3), Autosomal recessive
chr17	TXNDC17	616967.0 | TXNDC17, TRP14, TXNL5 | Thioredoxin domain-containing protein 17 | 84817.0 | ENSG00000129235 | nan | nan
chr17	MED31	620492.0 | MED31, SOH1, SEP10 | Mediator complex subunit 31 | 51003.0 | ENSG00000108590 | nan | nan
chr17	SLC13A5	608305.0 | SLC13A5, NACT, DEE25 | Solute carrier family 13 (sodium-dependent citrate transporter), member 5 | 284111.0 | ENSG00000141485 | nan | Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta, 615905 (3), Autosomal recessive
chr17	XAF1	606717.0 | XAF1 | XIAP-associated factor 1 | 54739.0 | ENSG00000132530 | nan | nan
chr17	FBXO39	609106.0 | FBXO39, FBX39 | F-box protein 39 | 162517.0 | ENSG00000177294 | nan | nan
chr17	TEKT1	609002.0 | TEKT1 | Tektin 1 | 83659.0 | ENSG00000167858 | nan | nan
chr17	ALOX12	152391.0 | ALOX12 | Arachidonate 12-lipoxygenase | 239.0 | ENSG00000108839 | pseudogene also on chr.17 | nan
chr17	RNASEK	617098.0 | RNASEK | Ribonuclease K | 440400.0 | ENSG00000219200 | nan | nan
chr17	BACC1	617215.0 | C17orf49, BAP18 | Chromosome 17 open reading frame 49 | 124944.0 | ENSG00000258315 | nan | nan
chr17	MIR195	610718.0 | MIR195, MIRN195 | Micro RNA 195 | 406971.0 | ENSG00000284112 | nan | nan
chr17	MIR497	615672.0 | MIR497 | Micro RNA 497 | 574456.0 | ENSG00000284027 | nan | nan
chr17	BCL6B	608992.0 | BCL6B, BAZF | BCL6B transcription repressor | 255877.0 | ENSG00000161940 | nan | nan
chr17	SLC16A11	615765.0 | SLC16A11, MCT11 | Solute carrier family 16, member 11 | 162515.0 | ENSG00000174326 | nan | nan
chr17	CLEC10A	605999.0 | CLEC10A, CLECSF14, MGL, HML, CD301 | C-type lectin domain family 10, member A | 10462.0 | ENSG00000132514 | nan | nan
chr17	ASGR2	108361.0 | ASGR2 | Asialoglycoprotein receptor-2 | 433.0 | ENSG00000161944 | nan | nan
chr17	ASGR1	108360.0 | ASGR1 | Asialoglycoprotein receptor-1 | 432.0 | ENSG00000141505 | nan | nan
chr17	DLG4	602887.0 | DLG4, PSD95, SAP90, MRD62 | Discs large MAGUK scaffold protein 4 | 1742.0 | ENSG00000132535 | nan | Intellectual developmental disorder, autosomal dominant 62, 618793 (3), Autosomal dominant
chr17	ACADVL	609575.0 | ACADVL, VLCAD | Acyl-Coenzyme A dehydrogenase, very long chain | 37.0 | ENSG00000072778 | nan | VLCAD deficiency, 201475 (3), Autosomal recessive
chr17	DVL2	602151.0 | DVL2 | Dishevelled 2 | 1856.0 | ENSG00000004975 | nan | nan
chr17	PHF23	612910.0 | PHF23 | PHD finger protein 23 | 79142.0 | ENSG00000040633 | nan | nan
chr17	GABARAP	605125.0 | GABARAP | GABA-A receptor-associated protein | 11337.0 | ENSG00000170296 | nan | nan
chr17	CTDNEP1	610684.0 | CTDNEP1, DULLARD | C-terminal domain nuclear envelope phosphatase 1 | 23399.0 | ENSG00000175826 | nan | nan
chr17	ELP5	615019.0 | ELP5, DERP6, C17orf81 | Elongator acetyltransferase complex, subunit 5 | 23587.0 | ENSG00000170291 | nan | nan
chr17	CLDN7	609131.0 | CLDN7 | Claudin 7 | 1366.0 | ENSG00000181885 | nan | nan
chr17	SLC2A4	138190.0 | SLC2A4, GLUT4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | 6517.0 | ENSG00000181856 | nan | nan
chr17	YBX2	611447.0 | YBX2, MSY2, CSDA3, DBPC | Y box-binding protein 2 | 51087.0 | ENSG00000006047 | nan | nan
chr17	EIF5A	600187.0 | EIF5A, FABAS | Eukaryotic translation initiation factor-5A | 1984.0 | ENSG00000132507 | nan | Faundes-Banka syndrome, 619376 (3), Autosomal dominant
chr17	GPS2	601935.0 | GPS2 | G protein pathway suppressor 2 | 2874.0 | ENSG00000132522 | nan | nan
chr17	NEURL4	615865.0 | NEURL4, KIAA1787 | Neuralized E3 ubiquitin protein ligase 4 | 84461.0 | ENSG00000215041 | nan | nan
chr17	ACAP1	607763.0 | CENTB1, KIAA0050, ACAP1 | Centaurin, beta-1 | 9744.0 | ENSG00000072818 | nan | nan
chr17	KCTD11	609848.0 | KCTD11, REn | Potassium channel tetramerization domain-containing protein 11 | 147040.0 | ENSG00000213859 | nan | nan
chr17	TMEM95	617814.0 | TMEM95 | Transmembrane protein 95 | 339168.0 | ENSG00000182896 | nan | nan
chr17	TNK1	608076.0 | TNK1 | Tyrosine kinase, nonreceptor, 1 | 8711.0 | ENSG00000174292 | nan | nan
chr17	PLSCR3	607611.0 | PLSCR3 | Phospholipid scramblase 3 | 57048.0 | ENSG00000187838 | nan | nan
chr17	TMEM256	617779.0 | TMEM256, C17orf61 | Transmembrane protein 256 | 254863.0 | ENSG00000205544 | nan | nan
chr17	NLGN2	606479.0 | NLGN2, KIAA1366 | Neuroligin 2 | 57555.0 | ENSG00000169992 | nan | nan
chr17	SPEM1	615116.0 | SPEM1, C17orf83 | Spermatid maturation protein 1 | 374768.0 | ENSG00000181323 | nan | nan
chr17	TMEM102	613936.0 | TMEM102, CBAP | Transmembrane protein 102 | 284114.0 | ENSG00000181284 | nan | nan
chr17	FGF11	601514.0 | FGF11, FHF3 | Fibroblast growth factor-11 | 2256.0 | ENSG00000161958 | nan | nan
chr17	CHRNB1	100710.0 | CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C | Cholinergic receptor, nicotinic, beta polypeptide-1, muscle | 1140.0 | ENSG00000170175 | mutation identified in 1 CMS2C family | ?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3), Autosomal recessive; Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3), Autosomal dominant
chr17	ZBTB4	612308.0 | ZBTB4, KIAA1538 | Zinc finger and BTB domain-containing 4 | 57659.0 | ENSG00000174282 | nan | nan
chr17	POLR2A	180660.0 | POLR2A, RPOL2, NEDHIB | Polymerase (RNA) II (DNA directed) polypeptide A, 220kD | 5430.0 | ENSG00000181222 | nan | Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, 618603 (3), Autosomal dominant
chr17	TNFSF12	602695.0 | TNFSF12, TWEAK, APO3L, DR3LG | Tumor necrosis factor ligand superfamily, member 12 | 8742.0 | ENSG00000239697 | nan | nan
chr17	TNFSF13	604472.0 | TNFSF13, APRIL, TALL2 | Tumor necrosis factor ligand superfamily, member 13 | 8741.0 | ENSG00000161955 | nan | nan
chr17	SENP3	612844.0 | SENP3 | Sentrin-specific protease family, member 3 | 26168.0 | ENSG00000161956 | nan | nan
chr17	EIF4A1	602641.0 | EIF4A1, DDX2A | Eukaryotic translation initiation factor 4A, isoform 1 | 1973.0 | ENSG00000161960 | nan | nan
chr17	CD68	153634.0 | CD68 | Macrophage antigen CD68 (macrosialin) | 968.0 | ENSG00000129226 | nan | nan
chr17	MPDU1	604041.0 | MPDU1, SL15, CDGIF | Mannose-P-dolichol utilization defect 1 | 9526.0 | ENSG00000129255 | nan | Congenital disorder of glycosylation, type If, 609180 (3), Autosomal recessive
chr17	SOX15	601297.0 | SOX15, SOX20 | SRY (sex-determining region Y)-box 15 | 6665.0 | ENSG00000129194 | nan | nan
chr17	FXR2	605339.0 | FXR2 | FMR1 autosomal homolog 2 | 9513.0 | ENSG00000129245 | nan | nan
chr17	SHBG	182205.0 | SHBG, ABP | Sex hormone-binding globulin (androgen binding protein) | 6462.0 | ENSG00000129214 | nan | nan
chr17	SAT2	611463.0 | SAT2, SSAT2 | Spermidine/spermine N(1)-acetyltransferase 2 | 112483.0 | ENSG00000141504 | nan | nan
chr17	ATP1B2	182331.0 | ATP1B2, AMOG | ATPase, Na+K+ transporting, beta-2 polypeptide | 482.0 | ENSG00000129244 | nan | nan
chr17	TP53	191170.0 | TP53, P53, LFS1 , BCC7, BMFS5 | Tumor protein p53 | 7157.0 | ENSG00000141510 | nan | {Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant
chr17	WRAP53	612661.0 | WRAP53, TCAB1, WDR79, DKCB3 | WD repeat-containing protein antisense to TP53 | 55135.0 | ENSG00000141499 | nan | Dyskeratosis congenita, autosomal recessive 3, 613988 (3), Autosomal recessive
chr17	EFNB3	602297.0 | EFNB3, EPLG8, LERK8, EFL6 | Ephrin B3 | 1949.0 | ENSG00000108947 | nan | nan
chr17	DNAH2	603333.0 | DNAH2, DNAHC2, SPGF45 | Dynein, axonemal, heavy chain-2 | 146754.0 | ENSG00000183914 | nan | Spermatogenic failure 45, 619094 (3), Autosomal recessive
chr17	KDM6B	611577.0 | KDM6B, JMJD3, KIAA0346, NEDSST | Lysine demethylase 6B | 23135.0 | ENSG00000132510 | nan | Stolerman neurodevelopmental syndrome, 618505 (3), Autosomal dominant
chr17	TMEM88	617813.0 | TMEM88 | Transmembrane protein 88 | 92162.0 | ENSG00000167874 | nan | nan
chr17	NAA38	617990.0 | NAA38, LSMD1, MAK31 | N-alpha-acetyltransferase 38, NatC auxiliary subunit | 84316.0 | ENSG00000183011 | nan | nan
chr17	CHD3	602120.0 | CHD3, SNIBCPS | Chromodomain helicase DNA binding protein-3 | 1107.0 | ENSG00000170004 | nan | Snijders Blok-Campeau syndrome, 618205 (3), Autosomal dominant
chr17	KCNAB3	604111.0 | KCNAB3, KCNA3B | Potassium voltage-gated channel, shaker-related subfamily, beta member 3 | 9196.0 | ENSG00000170049 | nan | nan
chr17	TRAPPC1	610969.0 | TRAPPC1, MUM2, BET5 | Trafficking protein particle complex, subunit 1 | 58485.0 | ENSG00000170043 | nan | nan
chr17	CNTROB	611425.0 | CNTROB, LIP8 | Centrobin, centriole duplication and spindle assembly protein | 116840.0 | ENSG00000170037 | nan | nan
chr17	GUCY2D	600179.0 | GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1, CSNB1I | Guanylate cyclase 2D, retinal | 3000.0 | ENSG00000132518 | mutation identified in 1 CACD1 family | Cone-rod dystrophy 6, 601777 (3), Autosomal recessive, Autosomal dominant; ?Choroidal dystrophy, central areolar 1, 215500 (3), Autosomal dominant; Leber congenital amaurosis 1, 204000 (3), Autosomal recessive; Night blindness, congenital stationary, type 1I, 618555 (3), Autosomal recessive
chr17	ALOX15B	603697.0 | ALOX15B | Arachidonate 15-lipoxygenase, second type | 247.0 | ENSG00000179593 | nan | nan
chr17	ALOX12B	603741.0 | ALOX12B, ARCI2 | Archidonate 12-lipoxygenase, R type | 242.0 | ENSG00000179477 | nan | Ichthyosis, congenital, autosomal recessive 2, 242100 (3), Autosomal recessive
chr17	ALOXE3	607206.0 | ALOXE3, ARCI3 | Arachidonate lipoxygenase 3 | 59344.0 | ENSG00000179148 | nan | Ichthyosis, congenital, autosomal recessive 3, 606545 (3), Autosomal recessive
chr17	TRK-TTT3-5	189918.0 | TRNAK1, TRK1, TRK-TTT3-5 | Transfer RNA lysine (TTT) 3-5 | 7206.0 | nan | nan | nan
chr17	TRQ-CTG1-5	189919.0 | TRQ-CTG1-5, TRNAQ1, TRQ1 | tRNA glutamine (anticodon CTG) 1-5 | 7228.0 | nan | nan | nan
chr17	TRL-TAG1-1	189920.0 | TRNAL2, TRL2 | tRNA leucine-2 | 7208.0 | nan | nan | nan
chr17	HES7	608059.0 | HES7, SCDO4 | Hes family bHLH transcription factor 7 | 84667.0 | ENSG00000179111 | nan | Spondylocostal dysostosis 4, autosomal recessive, 613686 (3), Autosomal recessive
chr17	TRR-TCT2-1	610406.0 | TRR-TCT2-1, TRNAR1, TRR1 | tRNA arginine (anticodon TCT) 2-1 | 7230.0 | nan | nan | nan
chr17	TRG-GCC2-6	610407.0 | TRG-GCC2-6, TRNAG2, TRG2 | tRNA glycine (anticodon GCC) 2-6 | 7196.0 | nan | at least 8 copies in this region | nan
chr17	PER1	602260.0 | PER1, PER, RIGUI | Period circadian regulator 1 | 5187.0 | ENSG00000179094 | nan | nan
chr17	VAMP2	185881.0 | VAMP2, SYB2, NEDHAHM | Vesicle-associated membrane protein-2 (synaptobrevin-2) | 6844.0 | ENSG00000220205 | nan | Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements, 618760 (3), Autosomal dominant
chr17	TMEM107	616183.0 | TMEM107, MKS13, JBTS29 | Transmembrane protein 107 | 84314.0 | ENSG00000179029 | mutation identified in 1 JBTS29 | Orofaciodigital syndrome XVI, 617563 (3), Autosomal recessive; Meckel syndrome 13, 617562 (3), Autosomal recessive; ?Joubert syndrome 29, 617562 (3), Autosomal recessive
chr17	SNORD118	616663.0 | SNORD118, LCC | Small nucleolar RNA,  C/D box, 118 | 727676.0 | ENSG00000200463 | nan | Leukoencephalopathy, brain calcifications, and cysts, 614561 (3), Autosomal recessive
chr17	BORCS6	616599.0 | BORCS6, C17orf59, LYSPERSIN | BLOC1-related complex, subunit 6 | 54785.0 | ENSG00000196544 | nan | nan
chr17	AURKB	604970.0 | STK12, ARK2, AIK2, AIM1 | Serine/threonine protein kinase 12 | 9212.0 | ENSG00000178999 | nan | nan
chr17	CTC1	613129.0 | CTC1, CRMCC, C17orf68, AAF132 | Conserved telomere maintenance component 1 | 80169.0 | ENSG00000178971 | nan | Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3), Autosomal recessive
chr17	PFAS	602133.0 | PFAS, FGARAT | phosphoribosylformylglycinamidine synthase (FGAR amidotransferase) | 5198.0 | ENSG00000178921 | nan | nan
chr17	SLC25A35	610818.0 | SLC25A35 | Solute carrier family 25, member 35 | 399512.0 | ENSG00000125434 | nan | nan
chr17	RANGRF	607954.0 | RANGRF, MOG1 | RAN guanine nucleotide release factor | 29098.0 | ENSG00000108961 | nan | nan
chr17	ARHGEF15	608504.0 | ARGEF15, KIAA0915 | Rho guanine nucleotide exchange factor 15 | 22899.0 | ENSG00000198844 | nan | nan
chr17	ODF4	610097.0 | ODF4, OPPO1 | Outer dense fiber of sperm tails 4 | 146852.0 | ENSG00000184650 | nan | nan
chr17	KRBA2	620920.0 | KRBA2 | KRAB-A domain-containing protein 2 | 124751.0 | ENSG00000184619 | nan | nan
chr17	RPL26	603704.0 | RPL26, DBA11 | Ribosomal protein L26 | 6154.0 | ENSG00000161970 | mutation identified in 1 family | ?Diamond-Blackfan anemia 11, 614900 (3), Autosomal dominant
chr17	MYH10	160776.0 | MYH10 | Myosin, heavy polypeptide-10, non-muscle | 4628.0 | ENSG00000133026 | nan | nan
chr17	NDEL1	607538.0 | NUDEL | Nude-like protein (endooligopeptidase A) | 81565.0 | ENSG00000166579 | nan | nan
chr17	SPDYE4	617628.0 | SPDYE4 | Speedy/RINGO cell cycle regulator family, member E4 | 388333.0 | ENSG00000183318 | nan | nan
chr17	PIK3R6	611462.0 | PIK3R6, C17orf38 | Phosphatidylinositol 3-kinase, regulatory subunit 6 | 146850.0 | ENSG00000276231 | nan | nan
chr17	PIK3R5	611317.0 | PIK3R5, p101 | Phosphatidylinositol 3-kinase, regulatory subunit 5 | 23533.0 | ENSG00000141506 | nan | Ataxia-oculomotor apraxia 3, 615217 (3), Autosomal recessive
chr17	NTN1	601614.0 | NTN1, NTN1L, MRMV4 | Netrin 1, mouse, homolog of | 9423.0 | ENSG00000065320 | nan | Mirror movements 4, 618264 (3), Autosomal dominant
chr17	STX8	604203.0 | STX8 | Syntaxin 8 | 9482.0 | ENSG00000170310 | nan | nan
chr17	CFAP52	609804.0 | CFAP52, WDR16, WDRPUH, HTX10 | Cilia- and flagella-associated protein 52 | 146845.0 | ENSG00000166596 | nan | Heterotaxy, visceral, 10, autosomal, with male infertility, 619607 (3), Autosomal recessive
chr17	DHRS7C	616161.0 | DHRS7C, SDR32C2 | Short-chain dehydrogenase reductase family, member 7C | 201140.0 | ENSG00000184544 | nan | nan
chr17	GLP2R	603659.0 | GLP2R | Glucagon-like peptide 2 receptor | 9340.0 | ENSG00000065325 | nan | nan
chr17	RCVRN	179618.0 | RCVRN, RCV1 | Recoverin | 5957.0 | ENSG00000109047 | nan | nan
chr17	GAS7	603127.0 | GAS7 | Growth arrest-specific 7 | 8522.0 | ENSG00000007237 | nan | nan
chr17	MYH13	603487.0 | MYH13 | Myosin, heavy polypeptide 13, skeletal muscle | 8735.0 | ENSG00000006788 | nan | nan
chr17	MYH8	160741.0 | MYH8, DA7 | Myosin, heavy polypeptide-8, skeletal muscle, perinatal | 4626.0 | ENSG00000133020 | nan | Carney complex variant, 608837 (3); Trismus-pseudocamptodactyly syndrome, 158300 (3), Autosomal dominant
chr17	MYH4	160742.0 | MYH4 | Myosin, heavy polypeptide-4, skeletal muscle | 4622.0 | ENSG00000264424 | nan | nan
chr17	MYH1	160730.0 | MYH1 | Myosin, heavy polypeptide-1, skeletal muscle, adult | 4619.0 | ENSG00000109061 | cluster = 6 genes in 500kb | nan
chr17	MYH2	160740.0 | MYH2, CMYO6 | Myosin, heavy polypeptide-2, skeletal muscle, adult | 4620.0 | ENSG00000125414 | nan | Congenital myopathy 6 with ophthalmoplegia, 605637 (3), Autosomal recessive, Autosomal dominant
chr17	MYH3	160720.0 | MYH3, DA2A, DA2B3, DA8, CPSFS1A, CPSFS1B | Myosin, heavy polypeptide-3, skeletal muscle, embryonic | 4621.0 | ENSG00000109063 | nan | Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A, 178110 (3), Autosomal dominant; Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B, 618469 (3), Autosomal recessive; Arthrogryposis, distal, type 2B3 (Sheldon-Hall), 618436 (3), Autosomal dominant; Arthrogryposis, distal, type 2A (Freeman-Sheldon), 193700 (3), Autosomal dominant
chr17	SCO1	603644.0 | SCO1, SCOD1, MC4DN4 | SCO cytochrome c oxidase assembly protein 1 | 6341.0 | ENSG00000133028 | nan | Mitochondrial complex IV deficiency, nuclear type 4, 619048 (3), Autosomal recessive
chr17	AOMS2	605572.0 | AOMS2 | Abdominal obesity-metabolic syndrome QTL2 | 65077.0 | nan | second QTL on 3q27 | Abdominal obesity-metabolic syndrome, 605572 (2), Autosomal dominant
chr17	DFNB85	613392.0 | DFNB85 | Deafness, autosomal recessive 85 | 100359399.0 | nan | between rs230884 and rs12603885 | Deafness, autosomal recessive 85, 613392 (2), Autosomal recessive
chr17	ECTD6	614928.0 | ECTD6 | Ectodermal dysplasia 6, hair/nail type | 101101770.0 | nan | between D17S839 and D17S1299 | Ectodermal dysplasia 6, hair/nail type, 614928 (2), Autosomal recessive
chr17		616652.0 | YUHAL | Yuan-Harel-Lupski syndrome | nan | nan | contiguous gene duplication syndrome | Yuan-Harel-Lupski syndrome, 616652 (4), Autosomal dominant
chr17	PIRT	612068.0 | PIRT | Phosphoinositide-interacting regulator of transient receptor potential channels | 644139.0 | ENSG00000233670 | nan | nan
chr17	SHISA6	617327.0 | SHISA6 | Shisa family, member 6 | 388336.0 | ENSG00000188803 | nan | nan
chr17	DNAH9	603330.0 | DNAH9, DNAH17L, DNEL1, CILD40 | Dynein, axonemal, heavy chain 9 | 1770.0 | ENSG00000007174 | nan | Ciliary dyskinesia, primary, 40, 618300 (3), Autosomal recessive
chr17	ZNF18	194524.0 | ZNF18, KOX11 | Zinc finger protein-18 (KOX11) | 7566.0 | ENSG00000154957 | nan | nan
chr17	MAP2K4	601335.0 | SERK1, PRKMK4, MAPKK4, JNKK1 | SAPK/ERK kinase-1 | 6416.0 | ENSG00000065559 | nan | nan
chr17	MYOCD	606127.0 | MYOCD, MGBL | Myocardin | 93649.0 | ENSG00000141052 | nan | Megabladder, congenital, 618719 (3), Autosomal dominant
chr17	ARHGAP44	617716.0 | ARHGAP44, RICH2, KIAA0672 | RHO GTPase-activating protein 44 | 9912.0 | ENSG00000006740 | nan | nan
chr17	ELAC2	605367.0 | ELAC2, HPC2, COXPD17 | elaC ribonuclease Z 2 | 60528.0 | ENSG00000006744 | at ~365cR | {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3); Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive
chr17	HS3ST3A1	604057.0 | HS3ST3A1, 30ST3A1 | Heparan sulfate-glucosamine 3-sulfotransferase 3A1 | 9955.0 | ENSG00000153976 | nan | nan
chr17	COX10	602125.0 | COX10, MC4DN3 | Cytochrome c oxidase, subunit X | 1352.0 | ENSG00000006695 | nan | Mitochondrial complex IV deficiency, nuclear type 3, 619046 (3), Autosomal recessive
chr17	HS3ST3B1	604058.0 | HS3ST3B1, 30ST3B1 | Heparan sulfate-glucosamine 3-sulfotransferase 3B1 | 9953.0 | ENSG00000125430 | nan | nan
chr17	PMP22	601097.0 | PMP22, CMT1A, CMT1E, DSS, CIDP | Peripheral myelin protein-22 | 5376.0 | ENSG00000109099 | mutation identified in 1 CIDP family | Charcot-Marie-Tooth disease, type 1A, 118220 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 1E, 118300 (3), Autosomal dominant; ?Neuropathy, inflammatory demyelinating, 139393 (3), ?Autosomal dominant; Neuropathy, recurrent, with pressure palsies, 162500 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant
chr17	TEKT3	612683.0 | TEKT3, SPGF81 | Tektin 3 | 64518.0 | ENSG00000125409 | nan | Spermatogenic failure 81, 620277 (3), Autosomal recessive
chr17	FBXW10B	604596.0 | CDRT1, C17orf1A | CMT1A duplicated region transcript 1 | 374286.0 | ENSG00000241322 | nan | nan
chr17	TRIM16	609505.0 | TRIM16, EBBP | Tripartite motif-containing protein 16 | 10626.0 | ENSG00000221926 | nan | nan
chr17	ZNF29P	194535.0 | ZNF29P | Zinc finger protein 29, pseudogene | 7577.0 | ENSG00000108452 | proximal to TP53 | nan
chr17	ADORA2B	600446.0 | ADORA2B | Adenosine A2b receptor | 136.0 | ENSG00000170425 | incorrectly put on 10 | nan
chr17	ZSWIM7	614535.0 | ZSWIM7, SWS1, SPGF71, ODG10 | Zinc finger SWIM domain-containing protein 7 | 125150.0 | ENSG00000214941 | mutation identified in 1 ODG10 family | Spermatogenic failure 71, 619831 (3), Autosomal recessive; ?Ovarian dysgenesis 10, 619834 (3), Autosomal recessive
chr17	TTC19	613814.0 | TTC19, MC3DN2 | Tetratricopeptide repeat domain 19 | 54902.0 | ENSG00000011295 | nan | Mitochondrial complex III deficiency, nuclear type 2, 615157 (3), Autosomal recessive
chr17	NCOR1	600849.0 | NCOR1 | Nuclear receptor corepressor 1 | 9611.0 | ENSG00000141027 | nan | nan
chr17	ADHD2	608904.0 | ADHD2 | Attention deficit-hyperactivity disorder, susceptibility to, 2 | 450088.0 | nan | nan | {Attention deficit-hyperactivity disorder, susceptibility to, 2}, 608904 (2)
chr17	IS2	607354.0 | IS2, AIS2 | Scoliosis, idiopathic 2 | 282552.0 | nan | between D17S947 and D17S798 | Scoliosis, idiopathic 2, 607354 (2)
chr17		610883.0 | PTLS | Potocki-Lupski syndrome | nan | nan | contiguous gene syndrome | Potocki-Lupski syndrome, 610883 (4), Isolated cases
chr17	PIGL	605947.0 | PIGL, CHIME | Phosphatidylinositol glycan, class L | 9487.0 | ENSG00000108474 | nan | CHIME syndrome, 280000 (3), Autosomal recessive
chr17	CENPV	608139.0 | CENPV, P30 | Centromere protein V | 201161.0 | ENSG00000166582 | nan | nan
chr17	UBB	191339.0 | UBB | Ubiquitin B | 7314.0 | ENSG00000170315 | nan | nan
chr17	TRPV2	606676.0 | TRPV2, VRL1 | Transient receptor potential cation channel, subfamily V, member 2 | 51393.0 | ENSG00000187688 | nan | nan
chr17	CCDC144A	619413.0 | CCDC144A, KIAA0565 | Coiled-coil domain-containing protein 144A | 9720.0 | ENSG00000170160 | nan | nan
chr17	TNFRSF13B	604907.0 | TNFRSF13B, TACI, CVID2 | Tumor necrosis factor receptor superfamily, member 13B | 23495.0 | ENSG00000240505 | nan | Immunodeficiency, common variable, 2, 240500 (3), Autosomal recessive, Autosomal dominant; Immunoglobulin A deficiency 2, 609529 (3)
chr17	MPRIP	612935.0 | MPRIP, MRIP, KIAA0864, RIP3, P116RIP | Myosin phosphatase Rho-interacting protein | 23164.0 | ENSG00000133030 | nan | nan
chr17	PLD6	614960.0 | PLD6, ZUC | Phospholipase D family, member 6 | 201164.0 | ENSG00000179598 | nan | nan
chr17	FLCN	607273.0 | FLCN, BHD | Folliculin | 201163.0 | ENSG00000154803 | nan | Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant; Colorectal cancer, somatic, 114500 (3); Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant; Renal carcinoma, chromophobe, somatic, 144700 (3)
chr17	COPS3	604665.0 | COPS3, SGN3 | COP9 signalosome, subunit 3 | 8533.0 | ENSG00000141030 | nan | nan
chr17	NT5M	605292.0 | NT5M, DNT2 | Deoxyribonucleotidase, mitochondrial (5' nucleotidase, mitochondrial) | 56953.0 | ENSG00000205309 | nan | nan
chr17	MED9	609878.0 | MED9, MED25, FLJ10193 | Mediator of RNA polymerase II transcription, subunit 9, S. cerevisiae, homolog of | 55090.0 | ENSG00000141026 | nan | nan
chr17	RASD1	605550.0 | RASD1, DEXRAS1 | Ras protein, dexamethasone-induced, 1 | 51655.0 | ENSG00000108551 | nan | nan
chr17	PEMT	602391.0 | PEMT, PEMPT | Phosphatidylethanolamine N-methyltransferase | 10400.0 | ENSG00000133027 | nan | nan
chr17	RAI1	607642.0 | RAI1, SMCR, SMS | Retinoic acid-induced gene 1 | 10743.0 | ENSG00000108557 | nan | Smith-Magenis syndrome, 182290 (3), Isolated cases, Autosomal dominant
chr17	SREBF1	184756.0 | SREBF1, IFAP2, HMD | Sterol regulatory element binding transcription factor 1 | 6720.0 | ENSG00000072310 | nan | Ichthyosis, follicular, with atrichia and photophobia syndrome 2, 619016 (3), Autosomal dominant; Mucoepithelial dysplasia, hereditary, 158310 (3), Autosomal dominant
chr17	MIR33B	613486.0 | MIR33B, MIRN33B | Micro RNA 33B | 693120.0 | ENSG00000207839 | nan | nan
chr17	TOM1L2	615519.0 | TOM1L2 | Target of MYB1-like 2 membrane trafficking protein | 146691.0 | ENSG00000175662 | nan | nan
chr17	DRC3	618758.0 | DRC3, LRRC48, CFAP134 | Dynein regulatory complex subunit 3 | 83450.0 | ENSG00000171962 | nan | nan
chr17	ATPAF2	608918.0 | ATPAF2, ATP12, MC5DN1 | ATP synthase, mitochondrial F1 complex, assembly factor 2 | 91647.0 | ENSG00000171953 | mutation identified in 1 MC5DN1 patient | ?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3), Autosomal recessive
chr17	GID4	617699.0 | GID4, VID2, C17orf39 | GID complex, subunit 4 | 79018.0 | ENSG00000141034 | nan | nan
chr17	DRG2	602986.0 | DRG2 | Developmentally regulated GTP-binding protein 2 | 1819.0 | ENSG00000108591 | nan | nan
chr17	MYO15A	602666.0 | MYO15A, DFNB3 | Myosin XVA | 51168.0 | ENSG00000091536 | nan | Deafness, autosomal recessive 3, 600316 (3), Autosomal recessive
chr17	ALKBH5	613303.0 | ALKBH5, ABH5 | AlkB homolog 5, RNA demethylase | 54890.0 | ENSG00000091542 | nan | nan
chr17	LLGL1	600966.0 | LLGL1, DLG4 | LLGL scribble cell polarity complex component 1 | 3996.0 | ENSG00000131899 | nan | nan
chr17	FLII	600362.0 | FLII, CMD2J | FLII actin remodeling protein | 2314.0 | ENSG00000177731 | nan | Cardiomyopathy, dilated, 2J, 620635 (3), Autosomal recessive
chr17	MIEF2	615498.0 | MIEF2, SMCR7, MID49, COXPD49 | Mitochondrial elongation factor 2 | 125170.0 | ENSG00000177427 | mutation identified in 1 COXPD49 patient | ?Combined oxidative phosphorylation deficiency 49, 619024 (3), Autosomal recessive
chr17	TOP3A	601243.0 | TOP3A, MGRISCE2, PEOB5 | Topoisomerase (DNA) III, alpha | 7156.0 | ENSG00000177302 | nan | Microcephaly, growth restriction, and increased sister chromatid exchange 2, 618097 (3), Autosomal recessive; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5, 618098 (3), Autosomal recessive
chr17	SMCR8	617074.0 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate gene 8 | 140775.0 | ENSG00000176994 | nan | nan
chr17	SHMT1	182144.0 | SHMT1 | Serine hydroxymethyltransferase (soluble) | 6470.0 | ENSG00000176974 | ?role in Smith-Magenis syndrome | nan
chr17	NOS2P2	600719.0 | NOS2P2, NOS2B | Nitric oxide synthase 2 pseudogene 2 | 201288.0 | nan | nan | nan
chr17	FOXO3B	620471.0 | FOXO3B | Forkhead box O3B | 2310.0 | ENSG00000240445 | nan | nan
chr17	FBXW10	611679.0 | FBXW10 | F-box and WD40 domain protein 10 | 10517.0 | ENSG00000171931 | nan | nan
chr17	PRPSAP2	603762.0 | PRPSAP2, PAP41 | Phosphoribosylpyrophosphate synthetase-associated protein 2 | 5636.0 | ENSG00000141127 | nan | nan
chr17	SLC5A10	618636.0 | SLC5A10, SGLT5 | Solute carrier family 5 (sodium/glucose cotransporter), member 10 | 125206.0 | ENSG00000154025 | nan | nan
chr17	FAM83G	615886.0 | FAM83G, PAWS1 | Family with sequence similarity 83, member G | 644815.0 | ENSG00000188522 | nan | nan
chr17	GRAP	604330.0 | GRAP, DFNB114 | GRB2-related adaptor protein | 10750.0 | ENSG00000154016 | nan | Deafness, autosomal recessive 114, 618456 (3), Autosomal recessive
chr17	SNORD3A	180710.0 | RNU3 | RNA, U3 small nuclear | 780851.0 | nan | deleted in Smith-Magenis syndrome | nan
chr17	B9D1	614144.0 | B9D1, MKSR1, MKS9, JBTS27 | B9 domain-containing protein 1 | 27077.0 | ENSG00000108641 | mutation identified in 1 MKS9 patient | ?Meckel syndrome 9, 614209 (3), Autosomal recessive; Joubert syndrome 27, 617120 (3), Autosomal recessive
chr17	EPN2	607263.0 | EPN2, KIAA1065 | Epsin 2 | 22905.0 | ENSG00000072134 | nan | nan
chr17	MAPK7	602521.0 | MAPK7, PRKM7, ERK5 | Mitogen-activated protein kinase 7 (extracellular signal-regulated kinase 5) | 5598.0 | ENSG00000166484 | nan | nan
chr17	MFAP4	600596.0 | MFAP4 | Microfibrillar-associated protein-4 | 4239.0 | ENSG00000166482 | nan | nan
chr17	RNF112	601237.0 | RNF112, ZNF179, BFP | RING finger protein 112 | 7732.0 | ENSG00000128482 | nan | nan
chr17	SLC47A1	609832.0 | SLC47A1, MATE1, FLJ10847 | Solute carrier family 47, member 1 | 55244.0 | ENSG00000142494 | nan | nan
chr17	ALDH3A2	609523.0 | ALDH3A2, ALDH10, SLS, FALDH | Aldehyde dehydrogenase 3 family, member A2 (fatty aldehyde dehydrogenase) | 224.0 | ENSG00000072210 | nan | Sjogren-Larsson syndrome, 270200 (3), Autosomal recessive
chr17	SLC47A2	609833.0 | SLC47A2, MATE2, FLJ31196, MATE2K | Solute carrier family 47, member 2 | 146802.0 | ENSG00000180638 | nan | nan
chr17	ALDH3A1	100660.0 | ALDH3A1, ALDH3 | Aldehyde dehydrogenase 3 family, member A1 | 218.0 | ENSG00000108602 | nan | nan
chr17	ULK2	608650.0 | ULK2, KIAA0623, UNC51.2 | UNC51-like kinase 2 | 9706.0 | ENSG00000083290 | nan | nan
chr17	AKAP10	604694.0 | AKAP10 | A-kinase anchor protein 10 | 11216.0 | ENSG00000108599 | nan | nan
chr17	SPECC1	608793.0 | SPECC1, HCMOGT1, NSP | Sperm antigen with calponin homology and coiled-coil domains 1 | 92521.0 | ENSG00000128487 | nan | nan
chr17	USP22	612116.0 | USP22, KIAA1064 | Ubiquitin-specific protease 22 | 23326.0 | ENSG00000124422 | nan | nan
chr17	DHRS7B	616160.0 | DHRS7B, SDR32C1 | Short-chain dehydrogenase reductase family, member 7B | 25979.0 | ENSG00000109016 | nan | nan
chr17	TMEM11	618817.0 | TMEM11 | Transmembrane protein 11 | 8834.0 | ENSG00000178307 | nan | nan
chr17	MAP2K3	602315.0 | PRKMK3, MAPKK3, MEK3 | Protein kinase, mitogen-activated, kinase-3 | 5606.0 | ENSG00000034152 | nan | nan
chr17	KCNJ12	602323.0 | KCNJ12, KCNJN1 | Potassium inwardly-rectifying channel, subfamily J, member 12 | 3768.0 | ENSG00000184185 | nan | nan
chr17	KCNJ18	613236.0 | KCNJ18, KIR2.6, TTPP2 | Potassium channel, inwardly rectifying, subfamily J, member 18 | 100134444.0 | ENSG00000260458 | nan | {Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3), Autosomal dominant
chr17		605160.0 | PRG4, FLJ36000 | p53-responsive gene 4 | 284124.0 | ENSG00000276399 | nan | nan
chr17	MTRNR2L1	616985.0 | MTRNR2L1, HN1 | MTRNR2-like 1 | 100462977.0 | nan | nan | nan
chr17	AUTS6	609378.0 | AUTS6 | Autism, susceptibility to, 6 | 554314.0 | nan | max lod at D17S1800 | {Autism susceptibility 6}, 609378 (2)
chr17	ERVE-1	606601.0 | ERVE1, HERVE1 | Endogenous retroviral sequence E, 1 | 85314.0 | nan | nan | nan
chr17	HYT1	603918.0 | HYT1 | Hypertension, essential, susceptibility to, 1 | 117191.0 | nan | ~18cM distal to ACE | {Hypertension, essential, susceptibility to, 1}, 145500 (2), Multifactorial
chr17	WSB1	610091.0 | WSB1, SWIP1 | WD repeat- and SOCS box-containing protein 1 | 26118.0 | ENSG00000109046 | nan | nan
chr17	CCL3L1	601395.0 | CCL3L1, SCYA3L1, LD78 | Chemokine, C-C motif, ligand 3-like 1 | 6349.0 | nan | varies in copy number 1-10 | {HIV/AIDS, susceptibility to}, 609423 (3)
chr17		613675.0 | DEL17q11.2, C17DELq11.2 | Chromosome 17q11.2 deletion syndrome, 1.4Mb (NF1 microdeletion syndrome) | nan | nan | nan | Chromosome 17q11.2 deletion syndrome, 1.4Mb, 613675 (4), Autosomal dominant
chr17		618874.0 | DUP17q11.2, C17DUPq11.2 | Chromosome 17q11.2 duplication syndrome, 1.4-Mb | nan | nan | nan | Chromosome 17q11.2 duplication syndrome, 1.4-Mb, 618874 (4), Isolated cases, Autosomal dominant
chr17	MHS2	154275.0 | MHS2 | Malignant hyperthermia susceptibility 2 | 4264.0 | nan | ?due to mutation in SCN4A | {Malignant hyperthermia susceptibility 2}, 154275 (2), Autosomal dominant
chr17	MPVQTL3	612575.0 | MPVQTL3 | Mean platelet volume quantitative trait locus 3 | 100271869.0 | nan | associated with rs2138852 | [Mean platelet volume QTL3], 612575 (2)
chr17	KSR1	601132.0 | KSR, KSR1 | Kinase suppressor of RAS | 8844.0 | ENSG00000141068 | nan | nan
chr17	LGALS9	601879.0 | LGALS9 | Lectin, galactoside-binding, soluble, 9 | 3965.0 | ENSG00000168961 | nan | nan
chr17	NOS2	163730.0 | NOS2A, NOS2 | Nitric oxide synthase 2A | 4843.0 | ENSG00000007171 | ?cluster of 3 NOS2 genes | {Malaria, resistance to}, 611162 (3)
chr17	NLK	609476.0 | NLK | NEMO-like kinase | 51701.0 | ENSG00000087095 | nan | nan
chr17	PYY2	606637.0 | PYY2 | Peptide YY, 2 | 23615.0 | ENSG00000290671 | nan | nan
chr17	PPY2P	606638.0 | PPY2 | Pancreatic polypeptide 2 | 23614.0 | nan | nan | nan
chr17	TMEM97	612912.0 | TMEM97, MAC30 | Transmembrane protein 97 | 27346.0 | ENSG00000109084 | nan | nan
chr17	IFT20	614394.0 | IFT20 | Intraflagellar transport 20 | 90410.0 | ENSG00000109083 | nan | nan
chr17	TNFAIP1	191161.0 | TNFAIP1 | Tumor necrosis factor, alpha-induced protein-1 (endothelial) | 7126.0 | ENSG00000109079 | nan | nan
chr17	POLDIP2	611519.0 | POLDIP2, PDIP38 | Polymerase delta-interacting protein 2 | 26073.0 | ENSG00000004142 | nan | nan
chr17	TMEM199	616815.0 | TMEM199, VMA12, VPH2, C17orf32, CDG2P | Transmembrane protein 199 | 147007.0 | ENSG00000244045 | nan | Congenital disorder of glycosylation, type IIp, 616829 (3), Autosomal recessive
chr17	SEBOX	610975.0 | SEBOX, OG9 | Skin-, embryo-, brain-, and oocyte-specific homeobox | 645832.0 | ENSG00000274529 | nan | nan
chr17	VTN	193190.0 | VTN, VNT | Vitronectin (serum spreading factor, somatomedin B, complement S-protein) | 7448.0 | ENSG00000109072 | nan | nan
chr17	SARM1	607732.0 | SARM, KIAA0524 | Sterile alpha and heat/armadillo motifs-containing protein | 23098.0 | ENSG00000004139 | nan | nan
chr17	SLC46A1	611672.0 | SLC46A1, HCP1, PCFT | Solute carrier family 46 (folate transporter), member 1 | 113235.0 | ENSG00000076351 | nan | Folate malabsorption, hereditary, 229050 (3), Autosomal recessive
chr17	SLC13A2	604148.0 | SLC13A2, NADC1 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | 9058.0 | ENSG00000007216 | nan | nan
chr17	FOXN1	600838.0 | FOXN1, WHN, TIDAND, TLIND | Forkhead box N1 (winged helix nude) | 8456.0 | ENSG00000109101 | nan | T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant, 618806 (3), Autosomal dominant; T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3), Autosomal recessive
chr17	UNC119	604011.0 | UNC119, HRG4, IMD13, CORD24 | unc-119 lipid binding chaperone | 9094.0 | ENSG00000109103 | mutation identified in 1 IMD13 family | Cone-rod dystrophy 24, 620342 (3), Autosomal dominant; ?Immunodeficiency 13, 615518 (3), Autosomal dominant
chr17	PIGS	610271.0 | PIGS, GPIBD18, DEE95 | Phosphatidylinositol glycan, class S | 94005.0 | ENSG00000087111 | nan | Developmental and epileptic encephalopathy 95, 618143 (3), Autosomal recessive
chr17	ALDOC	103870.0 | ALDOC | Aldolase C, fructose-bisphosphatase | 230.0 | ENSG00000109107 | nan | nan
chr17	SPAG5	615562.0 | SPAG5, MAP126, ASTRIN | Sperm-associated antigen 5 | 10615.0 | ENSG00000076382 | nan | nan
chr17	BLTP2	610664.0 | KIAA0100, BCOX1 | KIAA0100 gene | 9703.0 | ENSG00000007202 | nan | nan
chr17	SDF2	602934.0 | SDF2 | Stromal cell-derived factor-2 | 6388.0 | ENSG00000132581 | nan | nan
chr17	SUPT6H	601333.0 | SUPT6H | SPT6 homolog, histone chaperone and transcription elongation factor | 6830.0 | ENSG00000109111 | nan | nan
chr17	PROCA1	617376.0 | PROCA1 | Proline-rich cyclin A1-interacting protein | 147011.0 | ENSG00000167525 | nan | nan
chr17	RAB34	610917.0 | RAB34, RAH, OFD20 | Ras-associated protein 34 | 83871.0 | ENSG00000109113 | nan | Orofaciodigital syndrome XX, 620718 (3), Autosomal recessive
chr17	RPL23A	602326.0 | RPL23A | Ribosomal protein L23a | 6147.0 | ENSG00000198242 | nan | nan
chr17	TLCD1	620966.0 | TLCD1 | TLC domain-containing protein 1 (calfacilitin) | 116238.0 | ENSG00000160606 | nan | nan
chr17	NEK8	609799.0 | NEK8, JCK, NPHP9, RHPD2, PKD8 | NIMA-related kinase 8 | 284086.0 | ENSG00000160602 | mutations identified in 1 family with NPHP9 | Renal-hepatic-pancreatic dysplasia 2, 615415 (3), Autosomal recessive; Polycystic kidney disease 8, 620903 (3); ?Nephronophthisis 9, 613824 (3)
chr17	TRAF4	602464.0 | TRAF4, MLN62, CART1 | TNF receptor-associated factor 4 | 9618.0 | ENSG00000076604 | nan | nan
chr17	ERAL1	607435.0 | ERAL1, ERAL1A, ERAL1B, PRLTS6 | ERA G-protein-like 1 | 26284.0 | ENSG00000132591 | nan | Perrault syndrome 6, 617565 (3), Autosomal recessive
chr17	MIR451A	612071.0 | MIR451, MIRN451 | Micro RNA 451 | 574411.0 | ENSG00000284565 | nan | nan
chr17	MIR144	612070.0 | MIR144, MIRN144 | Micro RNA 144 | 406936.0 | ENSG00000283819 | nan | nan
chr17	FLOT2	131560.0 | FLOT2, M17S1, ECS1, ESA1 | Flotillin 2 (epidermal surface antigen 1) | 2319.0 | ENSG00000132589 | ~180kb centromeric to NF1 | nan
chr17	DHRS13	616157.0 | DHRS13, SDR7C5 | Short-chain dehydrogenase reductase family, member 13 | 147015.0 | ENSG00000167536 | nan | nan
chr17	PHF12	618645.0 | PHF12, PF1 | PHD finger protein 12 | 57649.0 | ENSG00000109118 | nan | nan
chr17	SEZ6	616666.0 | SEZ6, BSRPC | Seizure-related 6, mouse, homolog of | 124925.0 | ENSG00000063015 | nan | nan
chr17	PIPOX	616713.0 | PIPOX | Pipecolic acid oxidase | 51268.0 | ENSG00000179761 | nan | nan
chr17	MYO18A	610067.0 | MYO18A, SPR210 | Myosin XVIIIA | 399687.0 | ENSG00000196535 | nan | nan
chr17	MYO18A	609517.0 | TIAF1, MYO18A, MYSPDZ, MAJN, SPR210, KIAA0216 | TGFB1-induced antiapoptotic factor 1 | 399687.0 | ENSG00000196535 | nan | nan
chr17	CRYBA1	123610.0 | CRYBA1, CRYB1, CTRCT10 | Crystallin, beta A1 | 1411.0 | ENSG00000108255 | centromeric to NF1 | Cataract 10, multiple types, 600881 (3), Autosomal dominant
chr17	NUFIP2	609356.0 | NUFIP2, KIAA1321, PIG1 | Nuclear FMR1 interacting protein 2 | 57532.0 | ENSG00000108256 | nan | nan
chr17	TAOK1	610266.0 | TAOK1, PSK2, TAO1, MARKK, DDIB | TAO kinase 1 | 57551.0 | ENSG00000160551 | nan | Developmental delay with or without intellectual impairment or behavioral abnormalities, 619575 (3), Autosomal dominant
chr17	ABHD15	619894.0 | ABHD15 | Abhydrolase domain-containing protein 15 | 116236.0 | ENSG00000168792 | nan | nan
chr17	GIT1	608434.0 | GIT1 | GIT ArfGap 1 | 28964.0 | ENSG00000108262 | nan | nan
chr17	ANKRD13B	615124.0 | ANKRD13B | Ankyrin repeat domain-containing protein 13B | 124930.0 | ENSG00000198720 | nan | nan
chr17	SSH2	606779.0 | SSH2, KIAA1725 | Slingshot, Drosophila, homolog of, 2 | 85464.0 | ENSG00000141298 | nan | nan
chr17	NSRP1	616173.0 | NSRP1, NSRP70, CCDC55, NEDSSBA | Nuclear speckle splicing regulatory protein 1 | 84081.0 | ENSG00000126653 | nan | Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities, 620001 (3), Autosomal recessive
chr17	SLC6A4	182138.0 | SLC6A4, HTT, OCD1 | Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | 6532.0 | ENSG00000108576 | nan | {Obsessive-compulsive disorder}, 164230 (3), Autosomal dominant; {Anxiety-related personality traits}, 607834 (3)
chr17	BLMH	602403.0 | BLMH, BMH | Bleomycin hydrolase | 642.0 | ENSG00000108578 | nan | nan
chr17	CPD	603102.0 | CPD | Carboxypeptidase D | 1362.0 | ENSG00000108582 | nan | nan
chr17	GOSR1	604026.0 | GOSR1, GOS28, GS28 | Golgi snap receptor complex member 1 | 9527.0 | ENSG00000108587 | nan | nan
chr17	CRLF3	614853.0 | CRLF3, CYTOR4, CRLM9, CREME9 | Cytokine receptor-like factor 3 | 51379.0 | ENSG00000176390 | nan | nan
chr17	ATAD5	609534.0 | ATAD5, C17orf41, FRAG1, FLJ12735 | ATPase family, AAA domain containing 5 | 79915.0 | ENSG00000176208 | nan | nan
chr17	TEFM	616422.0 | TEFM, C17orf42, COXPD58 | Transcription elongation factor, mitochondrial | 79736.0 | ENSG00000172171 | nan | Combined oxidative phosphorylation deficiency 58, 620451 (3), Autosomal recessive
chr17	ADAP2	608635.0 | ADAP2, CENTA2 | ArfGAP with dual PH domains 2 | 55803.0 | ENSG00000184060 | nan | nan
chr17	RNF135	611358.0 | RNF135 | Ring finger protein 135 | 84282.0 | ENSG00000181481 | nan | nan
chr17	NF1	613113.0 | NF1, VRNF, WSS, NFNS | Neurofibromin (neurofibromatosis, type I) | 4763.0 | ENSG00000196712 | nan | Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant
chr17	OMG	164345.0 | OMG, OMGP | Oligodendrocyte-myelin glycoprotein | 4974.0 | ENSG00000126861 | within the NF1 gene | nan
chr17	EVI2B	158381.0 | EVI2B, EVDB | Ecotropic viral integration site 2B | 2124.0 | ENSG00000185862 | within the NF1 gene | nan
chr17	EVI2A	158380.0 | EVI2A, EVI2, EVDA | Ecotropic viral integration site 2A | 2123.0 | ENSG00000126860 | within the NF1 gene | nan
chr17	RAB11FIP4	611999.0 | RAB11FIP4, KIAA1821 | RAB11 family-interacting protein 4 | 84440.0 | ENSG00000131242 | nan | nan
chr17	MIR193A	614733.0 | MIR193A | Micro RNA 193A | 406968.0 | ENSG00000207614 | nan | nan
chr17	UTP6	620948.0 | UTP6, HCA66 | UTP6 small subunit processome component | 55813.0 | ENSG00000108651 | nan | nan
chr17	SUZ12	606245.0 | SUZ12, JJAZ1, KIAA0160, IMMAS | SUZ12 polycomb repressive complex 2 subunit | 23512.0 | ENSG00000178691 | nan | Imagawa-Matsumoto syndrome, 618786 (3), Autosomal dominant
chr17	LRRC37B	616558.0 | LRRC37B | Leucine-rich repeat-containing protein 37B | 114659.0 | ENSG00000185158 | nan | nan
chr17	RHOT1	613888.0 | RHOT1, MIRO1, ARHT1 | Ras homolog gene family, member T1 | 55288.0 | ENSG00000126858 | nan | nan
chr17	RHBDL3	619017.0 | RHBDL3, VRHO | Rhomboid-like 3 | 162494.0 | ENSG00000141314 | nan | nan
chr17	ZNF207	603428.0 | ZNF207 | Zinc finger protein-207 | 7756.0 | ENSG00000010244 | mapped by FISH to 6p21.3 | nan
chr17	PSMD11	604449.0 | PSMD11, S9 | Proteasome 26S subunit, non-ATPase, 11 | 5717.0 | ENSG00000108671 | nan | nan
chr17	CDK5R1	603460.0 | CDK5R1, p35 | Cyclin-dependent kinase 5, regulatory subunit 1 | 8851.0 | ENSG00000176749 | nan | nan
chr17	MYO1D	606539.0 | MYO1D, KIAA0727 | Myosin ID | 4642.0 | ENSG00000176658 | nan | nan
chr17	TMEM98	615949.0 | TMEM98, NNO4 | Transmembrane protein 98 | 26022.0 | ENSG00000006042 | nan | Nanophthalmos 4, 615972 (3), Autosomal dominant
chr17	SPACA3	612749.0 | SPACA3, LYZL3, SLLP1, LYC3, ALLP17 | Sperm acrosome-associated 3 | 124912.0 | ENSG00000141316 | nan | nan
chr17	ASIC2	601784.0 | ACCN1, BNC1, MDEG | Amiloride-sensitive cation channel 1, neuronal (degenerin) | 40.0 | ENSG00000108684 | nan | nan
chr17	CCL3P1	609467.0 | CCL3P1, CCL3L2 | Chemokine, CC motif, ligane 3, pseudogene 1 | 390788.0 | nan | nan | nan
chr17	CCL4L1	603782.0 | CCL4L, SCYA4L, LAG1 | Chemokine, C-C motif, ligand 4-like | 388372.0 | nan | nan | nan
chr17		614527.0 | DEL17q12, C17DELq12 | Chromosome 17q12 deletion syndrome | nan | nan | nan | Chromosome 17q12 deletion syndrome, 614527 (4), Autosomal dominant
chr17		614526.0 | DUP17q12, C17DUPq12 | Chromosome 17q12 duplication syndrome | nan | nan | nan | Chromosome 17q12 duplication syndrome, 614526 (4), Autosomal dominant
chr17		611955.0 | HPC11 | Prostate cancer, hereditary, 11 | nan | nan | associated with rs4430796 and rs7501939 | {Prostate cancer, hereditary, 11}, 611955 (2)
chr17	PBC5	614221.0 | PBC5 | Biliary cirrhosis, primary, 5 | 100689212.0 | nan | associated with rs9303277 | Biliary cirrhosis, primary, 5, 614221 (2)
chr17	WT4	601363.0 | WT4 | Wilms tumor-4 | 8151.0 | nan | nan | Wilms tumor, type 4, 601363 (2), Autosomal dominant
chr17	CCL2	158105.0 | CCL2, SCYA2, MCP1, MCAF | Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je) | 6347.0 | ENSG00000108691 | nan | {Mycobacterium tuberculosis, susceptibility to}, 607948 (3); {HIV-1, resistance to}, 609423 (3); {Coronary artery disease, modifier of} (3); {Spina bifida, susceptibility to}, 182940 (3), Autosomal dominant
chr17	CCL7	158106.0 | CCL7, SCYA7, MCP3 | Chemokine, C-C motif, ligand 5 | 6354.0 | ENSG00000108688 | close to ERBB2 | nan
chr17	CCL11	601156.0 | CCL11, SCYA11 | Chemokine, C-C motif, ligand 11 | 6356.0 | ENSG00000172156 | nan | {Asthma, susceptibility to}, 600807 (3), Autosomal dominant; {HIV1, resistance to}, 609423 (3)
chr17	CCL8	602283.0 | CCL8, SCYA8 | Chemokine, C-C motif, ligand 8 | 6355.0 | ENSG00000108700 | nan | nan
chr17	CCL13	601391.0 | CCL13, SCYA13, NCC1 | Chemokine, C-C motif, ligand 13 | 6357.0 | ENSG00000181374 | nan | nan
chr17	CCL1	182281.0 | CCL1, SCYA1 | Chemokine, C-C motif, ligand 1 | 6346.0 | ENSG00000108702 | nan | nan
chr17	TMEM132E	616178.0 | TMEM132E, DFNB99 | Transmembrane protein 132E | 124842.0 | ENSG00000181291 | nan | Deafness, autosomal recessive 99, 618481 (3), Autosomal recessive
chr17	CCT6B	610730.0 | CCT6B, CCTZ2 | Chaperonin containing T-complex polypeptide 1, subunit 6B | 10693.0 | ENSG00000132141 | nan | nan
chr17	LIG3	600940.0 | LIG3, MTDPS20 | Ligase III, DNA, ATP-dependent | 3980.0 | ENSG00000005156 | nan | Mitochondrial DNA depletion syndrome 20 (MNGIE type), 619780 (3), Autosomal recessive
chr17	RFFL	609735.0 | RFFL | Ring finger and FYVE-like domain containing 1 (rififylin) | 117584.0 | ENSG00000092871 | nan | nan
chr17	RAD51D	602954.0 | RAD51D, RAD51L3, BROVCA4 | RAD51 paralog D | 5892.0 | ENSG00000185379 | nan | {Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)
chr17	NLE1	620924.0 | NLE1, HUSSY7 | Notchless homolog 1 | 54475.0 | ENSG00000073536 | nan | nan
chr17	UNC45B	611220.0 | UNC45B, SMUNC45, CTRCT43, MFM11 | unc-45 myosin chaperone B | 146862.0 | ENSG00000141161 | mutation identified in 1 CTRCT43 family | ?Cataract 43, 616279 (3), Autosomal dominant; Myofibrillar myopathy 11, 619178 (3), Autosomal recessive
chr17	SLFN5	614952.0 | SLFN5 | Schlafen family, member 5 | 162394.0 | ENSG00000166750 | nan | nan
chr17	SLFN11	614953.0 | SLFN11 | Schlafen family, member 11 | 91607.0 | ENSG00000172716 | nan | nan
chr17	SLFN12	614955.0 | SLFN12 | Schlafen family, member 12 | 55106.0 | ENSG00000172123 | nan | nan
chr17	SLFN13	614957.0 | SLFN13 | Schlafen family, member 13 | 146857.0 | ENSG00000154760 | nan | nan
chr17	SLFN12L	614956.0 | SLFN12L | Schlafen family, member 12-like | 100506736.0 | ENSG00000205045 | nan | nan
chr17	SLFN14	614958.0 | SLFN14, BDPLT20 | Schlafen family, member 14 | 342618.0 | ENSG00000236320 | nan | Bleeding disorder, platelet-type, 20, 616913 (3), Autosomal dominant
chr17	PEX12	601758.0 | PEX12, PBD3A | Peroxisome biogenesis factor 12 | 5193.0 | ENSG00000108733 | nan | Peroxisome biogenesis disorder 3B, 266510 (3), Autosomal recessive; Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3), Autosomal recessive
chr17	AP2B1	601025.0 | AP2B1, CLAPB1, ADTB2 | Adaptor-related protein complex 2, beta 1 subunit | 163.0 | ENSG00000006125 | nan | nan
chr17	RASL10B	612128.0 | RASL10B, RRP17 | Ras-like, family 10, member B | 91608.0 | ENSG00000270885 | nan | nan
chr17	GAS2L2	611398.0 | GAS2L2, GAR17, CILD41 | Growth arrest-specific 2-like 2 | 246176.0 | ENSG00000270765 | mutation identified in 1 CILD41 patient | ?Ciliary dyskinesia, primary, 41, 618449 (3), Autosomal recessive
chr17	MMP28	608417.0 | MMP28 | Matrix metalloproteinase 28 | 79148.0 | ENSG00000271447 | nan | nan
chr17	TAF15	601574.0 | TAF15, TAF2N, RBP56 | TAF15 RNA polymerase II, TATA box-binding protein-associated factor, 68kD | 8148.0 | ENSG00000270647 | fusion gene with CSMF | Chondrosarcoma, extraskeletal myxoid, 612237 (1)
chr17	CCL5	187011.0 | CCL5, SCYA5, D17S136E, TCP228 | Chemokine, C-C motif, ligand 5 | 6352.0 | ENSG00000271503 | nan | {HIV-1 disease, rapid progression of}, 609423 (3); {HIV-1 disease, delayed progression of}, 609423 (3)
chr17	RDM1	612896.0 | RDM1 | RAD52 motif-containing protein 1 | 201299.0 | ENSG00000278023 | nan | nan
chr17	LYZL6	612751.0 | LYZL6 | Lysozyme-like 6 | 57151.0 | ENSG00000275722 | nan | nan
chr17	CCL16	601394.0 | CCL16, SCYA16, NCC4 | Chemokine, C-C motif, ligand 16 | 6360.0 | ENSG00000275152 | nan | nan
chr17	CCL14	601392.0 | CCL14, SCYA14, NCC2 | Chemokine, C-C motif, ligand 14 | 6358.0 | ENSG00000276409 | nan | nan
chr17	CCL15	601393.0 | CCL15, SCYA15, NCC3, LKN1 | Chemokine, C-C motif, ligand 15 | 6359.0 | ENSG00000275718 | nan | nan
chr17	CCL23	602494.0 | CCL23, SCYA23 | Chemokine, C-C motif, ligand 23 | 6368.0 | ENSG00000274736 | nan | nan
chr17	CCL18	603757.0 | CCL18, SCYA18, PARC, AMAC1, DCCK1 | Chemokine, C-C motif, ligand 18 | 6362.0 | ENSG00000275385 | in 47kb, CCL18-CCL3-CCL4 | nan
chr17	CCL3	182283.0 | CCL3, SCYA3, MIP1A | Chemokine, C-C motif, ligand 3 | 6348.0 | ENSG00000277632 | in 47kb, CCL18-CCL3-CCL4 | {HIV infection, resistance to}, 609423 (2)
chr17	CCL4	182284.0 | CCL4, SCYA4, ACT2, MIP1B, AT744.1 | Chemokine, C-C motif, ligand 4 | 6351.0 | ENSG00000275302 | nan | nan
chr17	TBC1D3B	610144.0 | TBC1D3B, PRC17 | TBC1 domain family, member 3B | 414059.0 | ENSG00000274808 | nan | nan
chr17	CCL3L3	609468.0 | CCL3L3 | Chemokine, CC motif, ligand 3-like 3 | 414062.0 | ENSG00000276085 | nan | nan
chr17	CCL4L2	610757.0 | CCL4L2 | Chemokine, CC motif, ligand 4-like 2 | 9560.0 | ENSG00000276070 | nan | nan
chr17	TBC1D3G	610810.0 | TBC1D3G | TBC1 domain family, member 3G | 101060321.0 | ENSG00000260287 | nan | nan
chr17	TBC1D3H	610811.0 | TBC1D3H | TBC1 domain family, member 3H | 729877.0 | ENSG00000274226 | nan | nan
chr17	TBC1D3F	610809.0 | TBC1D3F | TBC1 domain family, member 3F | 84218.0 | ENSG00000275954 | nan | nan
chr17	ZNHIT3	604500.0 | ZNHIT3, TRIP3, PEHO | Zinc finger HIT domain-containing protein 3 | 9326.0 | ENSG00000273611 | nan | PEHO syndrome, 260565 (3), Autosomal recessive
chr17	MYO19	617379.0 | MYO19, MYOHD1 | Myosin XIX | 80179.0 | ENSG00000278259 | nan | nan
chr17	PIGW	610275.0 | PIGW, HPMRS5 | Phosphatidylinositol glycan, class W | 284098.0 | ENSG00000277161 | nan | Glycosylphosphatidylinositol biosynthesis defect 11, 616025 (3), Autosomal recessive
chr17	GGNBP2	612275.0 | GGNBP2, DIF3, LCRG1, LZK1 | Gametogenetin-binding protein 2 | 79893.0 | ENSG00000278311 | nan | nan
chr17	DHRS11	616159.0 | DHRS11, SDR24C1 | Short-chain dehydrogenase reductase family, member 11 | 79154.0 | ENSG00000278535 | nan | nan
chr17	MRM1	618099.0 | MRM1 | Mitochondrial ribosomal RNA methyltransferase 1 | 79922.0 | ENSG00000278619 | nan | nan
chr17	LHX1	601999.0 | LHX1, LIM1 | LIM/homeodomain protein LHX1 | 3975.0 | ENSG00000273706 | previously mapped to 11p13-p12 by FISH | nan
chr17	AATF	608463.0 | AATF, CHE1 | Apoptosis-antagonizing transcription factor | 26574.0 | ENSG00000275700 | nan | nan
chr17	ACACA	200350.0 | ACACA, ACAC, ACC1, ACACAD | Acetyl-Coenzyme A carboxylase, alpha | 31.0 | ENSG00000278540 | nan | Acetyl-CoA carboxylase deficiency, 613933 (3), Autosomal recessive
chr17	TADA2A	602276.0 | TADA2A, TADA2L, ADA2A | Transcriptional adaptor 2A | 6871.0 | ENSG00000276234 | nan | nan
chr17	DUSP14	606618.0 | DUSP14, MKP6 | Dual-specificity phosphatase 14 | 11072.0 | ENSG00000276023 | nan | nan
chr17	SYNRG	607291.0 | SYNRG, AP1GBP1, SYNG | Synergin, gamma | 11276.0 | ENSG00000275066 | nan | nan
chr17	DDX52	612500.0 | DDX52, ROK1, HUSSY19 | DExD-box helicase 52 | 11056.0 | ENSG00000278053 | nan | nan
chr17	HNF1B	189907.0 | HNF1B, TCF2, HNF2, RCAD, T2D, ADTKD3 | HNF1 homeobox B (transcription factor 2) | 6928.0 | ENSG00000275410 | nan | Type 2 diabetes mellitus, 125853 (3), Autosomal dominant; Renal cysts and diabetes syndrome, 137920 (3), Autosomal dominant; {Renal cell carcinoma}, 144700 (3)
chr17	TBC1D3D	610807.0 | TBC1D3D | TBC1 domain family, member 3D | 101060389.0 | ENSG00000274419 | nan | nan
chr17	TBC1D3C	610806.0 | TBC1D3C | TBC1 domain family, member 3C | 414060.0 | ENSG00000278299 | nan | nan
chr17	TBC1D3E	610808.0 | TBC1D3E | TBC1 domain family, member 3E | 102723859.0 | ENSG00000278599 | nan | nan
chr17	TBC1D3	607741.0 | TBC1D3, PRC17, TBC1D3A | TBC1D3 gene | 729873.0 | ENSG00000274611 | nan | nan
chr17	MRPL45	611850.0 | MRPL45 | Mitochondrial ribosomal protein L45 | 84311.0 | ENSG00000278845 | pseudogenes on 2 and 17 | nan
chr17	GPR179	614515.0 | GPR179, GPR158L, GPR158L1, CSNB1E | G protein-coupled receptor 179 | 440435.0 | ENSG00000277399 | nan | Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3), Autosomal recessive
chr17	SOCS7	608788.0 | SOCS7, NAP4 | Suppressor of cytokine signaling 7 | 30837.0 | ENSG00000274211 | nan | nan
chr17	ARHGAP23	610590.0 | ARHGAP23, KIAA1501 | RHO GTPase-activating protein 23 | 57636.0 | ENSG00000275832 | nan | nan
chr17	SRCIN1	610786.0 | SRCIN1, SNIP, KIAA1684 | Src kinase signaling inhibitor 1 | 80725.0 | ENSG00000277363 | nan | nan
chr17	EPOP	617795.0 | EPOP, C17orf96 | Elongin BC- and polycomb repressive complex 2-associated protein | 100170841.0 | ENSG00000273604 | nan | nan
chr17	MLLT6	600328.0 | MLLT6, AF17 | Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 6 | 4302.0 | ENSG00000275023 | nan | nan
chr17	CISD3	611933.0 | CISD3, MINER2 | CDGSH iron sulfur domain protein 3 | 284106.0 | ENSG00000277972 | nan | nan
chr17	PCGF2	600346.0 | PCGF2, RNF110, ZNF144, MEL18, TPFS | Polycomb group ring finger 2 | 7703.0 | ENSG00000277258 | nan | Turnpenny-Fry syndrome, 618371 (3), Autosomal dominant
chr17	PSMB3	602176.0 | PSMB3 | Proteasome subunit, beta type, 3 | 5691.0 | ENSG00000277791 | previously assigned to 2q35 | nan
chr17	PIP4K2B	603261.0 | PIP4K2B, PIP5P4KB, PIP5K2B | Phosphatidylinositol 5-phosphate 4-kinase, type II, beta | 8396.0 | ENSG00000276293 | nan | nan
chr17	RPL23	603662.0 | RPL23 | Ribosomal protein L23 | 9349.0 | ENSG00000125691 | nan | nan
chr17	LASP1	602920.0 | LASP1, MLN50 | LIM and SH3 protein 1 | 3927.0 | ENSG00000002834 | fused to MLL in AML | nan
chr17	LASP1NB	617544.0 | LINC00672 | Long intergenic noncoding RNA 672 | 100505576.0 | ENSG00000263874 | nan | nan
chr17	FBXO47	609498.0 | FBXO47 | F-box only protein 47 | 494188.0 | ENSG00000204952 | nan | nan
chr17	PLXDC1	606826.0 | PLXDC1, TEM7 | Plexin domain containing 1 | 57125.0 | ENSG00000161381 | nan | nan
chr17	CACNB1	114207.0 | CACNB1, CACNLB1, CCHLB1 | Calcium channel, voltage-dependent, beta 1 subunit | 782.0 | ENSG00000067191 | nan | nan
chr17	RPL19	180466.0 | RPL19 | Ribosomal protein L19 | 6143.0 | ENSG00000108298 | nan | nan
chr17	FBXL20	609086.0 | FBXL20, FBL20, FBL2, SCR | F-box and leucine-rich repeat protein 20 | 84961.0 | ENSG00000108306 | nan | nan
chr17	MED1	604311.0 | MED1, PPARBP, PBP, TRAP220 | Mediator complex subunit 1 (peroxisome proliferator-activated receptor-binding protein) | 5469.0 | ENSG00000125686 | nan | nan
chr17	CDK12	615514.0 | CDK12, CRKRS, CRK7, KIAA0904 | Cyclin-dependent kinase 12 | 51755.0 | ENSG00000167258 | nan | nan
chr17	NEUROD2	601725.0 | NEUROD2, DEE72 | Neurogenic differentiation 2 | 4761.0 | ENSG00000171532 | nan | Developmental and epileptic encephalopathy 72, 618374 (3), Autosomal dominant
chr17	PPP1R1B	604399.0 | PPP1R1B, DARPP32 | Protein phosphatase 1, regulatory subunit 1B | 84152.0 | ENSG00000131771 | nan | nan
chr17	STARD3	607048.0 | STARD3, MLN64 | Start domain-containing protein 3 | 10948.0 | ENSG00000131748 | nan | nan
chr17	TCAP	604488.0 | TCAP, LGMDR7, CMH25 | Telethonin | 8557.0 | ENSG00000173991 | nan | Cardiomyopathy, hypertrophic, 25, 607487 (3), Autosomal dominant; Muscular dystrophy, limb-girdle, autosomal recessive 7, 601954 (3), Autosomal recessive
chr17	PNMT	171190.0 | PNMT, PENT | Phenylethanolamine N-methyltransferase | 5409.0 | ENSG00000141744 | nan | nan
chr17	PGAP3	611801.0 | PGAP3, PERLD1, CAB2, MGC9753, HPMRS4 | Post-GPI attachment to proteins 3 | 93210.0 | ENSG00000161395 | nan | Hyperphosphatasia with impaired intellectual development syndrome 4, 615716 (3), Autosomal recessive
chr17	ERBB2	164870.0 | ERBB2, NGL, NEU, HER2, VSCN2 | Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) | 2064.0 | ENSG00000141736 | mutation identified in 1 VSCN2 family | Gastric cancer, somatic, 613659 (3); Adenocarcinoma of lung, somatic, 211980 (3); Ovarian cancer, somatic, 167000 (3); ?Visceral neuropathy, familial, 2, autosomal recessive, 619465 (3), Autosomal recessive; Glioblastoma, somatic, 137800 (3)
chr17	MIEN1	611802.0 | MIEN1, C17orf37, RDX12 | Migration and invasion enhancer 1 | 84299.0 | ENSG00000141741 | nan | nan
chr17	GRB7	601522.0 | GRB7 | Growth factor receptor-bound protein 7 | 2886.0 | ENSG00000141738 | nan | nan
chr17	IKZF3	606221.0 | IKZF3, ZNFN1A3, AIOLOS, IMD84 | Ikaros family zinc finger 3 | 22806.0 | ENSG00000161405 | mutation identified in 1 IMD84 family | ?Immunodeficiency 84, 619437 (3), Autosomal dominant
chr17	ASRT6	611403.0 | ASRT6 | Asthma-related traits, susceptibility to, 6 | 100188840.0 | nan | strongly associated with rs7216389 | {Asthma-related traits, susceptibility to, 6}, 611403 (2)
chr17	AUTS7	610676.0 | AUTS7 | Autism, susceptibility to, 7 | 100188816.0 | nan | max lod at D17S2180 | {Autism susceptibility 7}, 610676 (2)
chr17	MYP5	608474.0 | MYP5 | Myopia 5 | 404682.0 | nan | between D17S787 and D17S1811 | Myopia 5, 608474 (2), Autosomal dominant
chr17	PTLAH	168860.0 | PTLAH, FPAH | Patella aplasia or hypoplasia | 8830.0 | nan | nan | Patella aplasia or hypoplasia, 168860 (2), Autosomal dominant
chr17	ZPBP2	608499.0 | ZPBP2, ZPBPL | Zona pellucida-binding protein 2 | 124626.0 | ENSG00000186075 | nan | nan
chr17	GSDMB	611221.0 | GSDMB, GSDML | Gasdermin B | 55876.0 | ENSG00000073605 | nan | nan
chr17	ORMDL3	610075.0 | ORMDL3 | ORM1-like protein 3 | 94103.0 | ENSG00000172057 | nan | nan
chr17	GSDMA	611218.0 | GSDMA, GSDM1, GSDM | Gasdermin A | 284110.0 | ENSG00000167914 | nan | nan
chr17	PSMD3	617676.0 | PSMD3, RPN3 | Proteasome 26S subunit, non-ATPase, 3 | 5709.0 | ENSG00000108344 | nan | nan
chr17	CSF3	138970.0 | CSF3, GCSF | Colony-stimulating factor-3 (granulocyte) | 1440.0 | ENSG00000108342 | nan | nan
chr17	MED24	607000.0 | MED24, TRAP100, KIAA0130 | Mediator complex subunit 24 | 9862.0 | ENSG00000008838 | nan | nan
chr17	THRA	190120.0 | THRA, ERBA1, THRA1, CHNG6 | Thyroid hormone receptor, alpha (oncogene ERBA1) | 7067.0 | ENSG00000126351 | nan | Hypothyroidism, congenital, nongoitrous, 6, 614450 (3), Autosomal dominant
chr17	NR1D1	602408.0 | NR1D1, THRAL, EAR1 | Nuclear receptor 1, subfamily D, member 1 (thyroid hormone receptor, alpha-1-like) | 9572.0 | ENSG00000126368 | nan | nan
chr17	MSL1	614801.0 | MSL1 | MSL complex subunit 1 | 339287.0 | ENSG00000188895 | nan | nan
chr17	CASC3	606504.0 | MLN51, CASC3 | MLN51 gene | 22794.0 | ENSG00000108349 | nan | nan
chr17	IBD22	612380.0 | IBD22 | Inflammatory bowel disease 22 | 100240732.0 | nan | associated with rs744166 | {Inflammatory bowel disease 22}, 612380 (2)
chr17	WIPF2	609692.0 | WIRE, WICH | WASP-interacting protein-related protein | 147179.0 | ENSG00000171475 | nan | nan
chr17	CDC6	602627.0 | CDC6, CDC18L, MGORS5 | Cell division cycle 6 | 990.0 | ENSG00000094804 | mutation identified in 1 MGORS5 patient | ?Meier-Gorlin syndrome 5, 613805 (3), Autosomal recessive
chr17	RARA	180240.0 | RARA | Retinoic acid receptor, alpha polypeptide | 5914.0 | ENSG00000131759 | fused with MYL in APL | Leukemia, acute promyelocytic, 612376 (1)
chr17	GJD3	607425.0 | GJD3, GJC1, CX31.9 | Gap junction protein, delta-3 (31.9kD) | 125111.0 | ENSG00000183153 | nan | nan
chr17	TOP2A	126430.0 | TOP2A, TOP2 | Topoisomerase (DNA) II, alpha, 170kD | 7153.0 | ENSG00000131747 | nan | DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)
chr17	IGFBP4	146733.0 | IGFBP4 | Insulin-like growth factor-binding protein-4 | 3487.0 | ENSG00000141753 | nan | nan
chr17	TNS4	608385.0 | TNS4, CTEN | Tensin 4 | 84951.0 | ENSG00000131746 | nan | nan
chr17	CCR7	600242.0 | CCR7, CMKBR7, EBI1 | Chemokine (C-C) receptor 7 (Epstein-Barr virus induced gene 1) | 1236.0 | ENSG00000126353 | nan | nan
chr17	SMARCE1	603111.0 | SMARCE1, BAF57, CSS5 | SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1 | 6605.0 | ENSG00000073584 | nan | {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Coffin-Siris syndrome 5, 616938 (3), Autosomal dominant
chr17	KRT24	607742.0 | KRT24, FLJ20261 | Keratin 24 | 192666.0 | ENSG00000167916 | nan | nan
chr17	KRT25	616646.0 | KRT25, K25, KRT24IRS1, ARWH3 | Keratin 25, type I | 147183.0 | ENSG00000204897 | nan | Woolly hair, autosomal recessive 3, 616760 (3), Autosomal recessive
chr17	KRT26	616675.0 | KRT26, K25, K25B, K25IRS2 | Keratin 26, type I | 353288.0 | ENSG00000186393 | nan | nan
chr17	KRT27	616676.0 | KRT27, KRT25C, K25IRS3 | Keratin 27, type I | 342574.0 | ENSG00000171446 | nan | nan
chr17	KRT28	616677.0 | KRT28, K25D, K25IRS4 | Keratin 28, type I | 162605.0 | ENSG00000173908 | nan | nan
chr17	KRT10	148080.0 | KRT10, EHK2A, EHK2B, BCIE, BIE, IHL | Keratin 10 | 3858.0 | ENSG00000186395 | mutation identified in 1 IHL family | Ichthyosis, annular epidermolytic 1, 607602 (3), Autosomal dominant; Epidermolytic hyperkeratosis 2B, autosomal recessive, 620707 (3), Autosomal recessive; Epidermolytic hyperkeratosis 2A, autosomal dominant, 620150 (3), Autosomal dominant; ?Ichthyosis histrix, Lambert type, 146600 (3), Autosomal dominant; Ichthyosis with confetti, 609165 (3), Autosomal dominant
chr17	KRT12	601687.0 | KRT12, MECD1 | Keratin 12 | 3859.0 | ENSG00000187242 | nan | Meesmann corneal dystrophy 1, 122100 (3), Autosomal dominant
chr17	KRT20	608218.0 | KRT20, CD20, KRT21 | Keratin 20 | 54474.0 | ENSG00000171431 | nan | nan
chr17	KRT23	606194.0 | KRT23 | Keratin 23 | 25984.0 | ENSG00000108244 | nan | nan
chr17	KRT39	616678.0 | KRT39 | Keratin 38, type I | 390792.0 | ENSG00000196859 | nan | nan
chr17	KRT40	616679.0 | KRT40, KA36 | Keratin 40, type I | 125115.0 | ENSG00000204889 | nan | nan
chr17	KRTAP1-5	608822.0 | KRTAP-15, KAP1.5 | Keratin-associated protein 1-5 | 83895.0 | ENSG00000221852 | nan | nan
chr17	KRTAP1-4	608821.0 | KRTAP1-4, KAP1.4 | Keratin-associated protein 1-4 | 728255.0 | ENSG00000204887 | nan | nan
chr17	KRTAP1-3	608820.0 | KRTAP1-3, KAP1.3, KAP1.2, KAP1.9 | Keratin-associated protein 1-3 | 81850.0 | ENSG00000221880 | nan | nan
chr17	KRTAP1-1	608819.0 | KRTAP1-1, KAP1.1, KAP1.7, KAP1.6 | Keratin-associated protein 1-1 | 81851.0 | ENSG00000188581 | nan | nan
chr17	KRT33A	602761.0 | KRT33A, KRTHA3A, HA3I | Keratin 33A | 3883.0 | ENSG00000006059 | nan | nan
chr17	KRT33B	602762.0 | KRT33B, KRTHA3A, HA3II | Keratin 33B | 3884.0 | ENSG00000131738 | nan | nan
chr17	KRT34	602763.0 | KRT34, KRTHA4, HA4 | Keratin 34 | 3885.0 | ENSG00000131737 | nan | nan
chr17	KRT31	601077.0 | KRT31, KRTHA1, HA1 | Keratin 31 | 3881.0 | ENSG00000094796 | nan | nan
chr17	KRT37	604541.0 | KRT37, KRTHA7, HA7 | Keratin 37 | 8688.0 | ENSG00000108417 | nan | nan
chr17	KRT38	604542.0 | KRT38,  KRTHA8, HA8 | Keratin 38 | 8687.0 | ENSG00000171360 | nan | nan
chr17	KRT32	602760.0 | KRT32, KRTHA2, HA2 | Keratin 32 | 3882.0 | ENSG00000108759 | nan | nan
chr17	KRT35	602764.0 | KRT35, KRTHA5 | Keratin 35 | 3886.0 | ENSG00000197079 | nan | nan
chr17	KRT36	604540.0 | KRT36, KRTHA6, HA6 | Keratin 36 | 8689.0 | ENSG00000126337 | nan | nan
chr17	KRT13	148065.0 | KRT13, WSN2 | Keratin 13 | 3860.0 | ENSG00000171401 | in same PFGE fragment as KRT10, KRT15 | White sponge nevus 2, 615785 (3), Autosomal dominant
chr17	KRT15	148030.0 | KRT15 | Keratin 15 | 3866.0 | ENSG00000171346 | tightly linked to Hox-2 in mouse | nan
chr17	KRT19	148020.0 | KRT19 | Keratin 19 | 3880.0 | ENSG00000171345 | nan | nan
chr17	LINC00974	620053.0 | LINC00974 | Long intergenic noncoding RNA 974 | 147093.0 | ENSG00000226629 | nan | nan
chr17	KRT9	607606.0 | KRT9, EPPK1 | Keratin 9 | 3857.0 | ENSG00000171403 | nan | Palmoplantar keratoderma, epidermolytic, 1, 144200 (3), Autosomal dominant
chr17	KRT14	148066.0 | KRT14, EBS1A, EBS1B, EBS1C, EBS1D | Keratin 14 | 3861.0 | ENSG00000186847 | nan | Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive, 601001 (3), Autosomal recessive; Epidermolysis bullosa simplex 1C, localized, 131800 (3), Autosomal dominant; Dermatopathia pigmentosa reticularis, 125595 (3), Autosomal dominant; Epidermolysis bullosa simplex 1A, generalized severe, 131760 (3), Autosomal dominant; Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3), Autosomal dominant; Epidermolysis bullosa simplex 1B, generalized intermediate, 131900 (3), Autosomal dominant
chr17	KRT16	148067.0 | KRT16, FNEPPK, PC1 | Keratin 16 | 3868.0 | ENSG00000186832 | probably 17q21-q22 | Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3), Autosomal dominant; Pachyonychia congenita 1, 167200 (3), Autosomal dominant
chr17	KRT17	148069.0 | KRT17, PC2, PCHC1 | Keratin 17 | 3872.0 | ENSG00000128422 | ~5' to KRT16; probably 17q21-q22 | Steatocystoma multiplex, 184500 (3), Autosomal dominant; Pachyonychia congenita 2, 167210 (3), Autosomal dominant
chr17	EIF1	619901.0 | EIF1, SUI1, A121 | Eukaryotic translation initiation factor 1 | 10209.0 | ENSG00000173812 | nan | nan
chr17	GAST	137250.0 | GAST, GAS | Gastrin | 2520.0 | ENSG00000184502 | nan | nan
chr17	HAP1	600947.0 | HAP1, HLP, HAP2 | Huntingtin-associated protein 1 (neuroan 1) | 9001.0 | ENSG00000173805 | nan | nan
chr17	JUP	173325.0 | JUP, DP3, PDGB, ARVD12 | Junction plakoglobin | 3728.0 | ENSG00000173801 | mutation identified in 1 ARVD12 family | Naxos disease, 601214 (3), Autosomal recessive; ?Arrhythmogenic right ventricular dysplasia 12, 611528 (3), Autosomal dominant
chr17	P3H4	617419.0 | P3H4, SC65, LEPREL4 | Proyly 3-hydroxylase 4 | 10609.0 | ENSG00000141696 | nan | nan
chr17	FKBP10	607063.0 | FKBP10, FKBP65, OI11, BRKS1 | FK506-binding protein 10 | 60681.0 | ENSG00000141756 | nan | Osteogenesis imperfecta, type XI, 610968 (3), Autosomal recessive; Bruck syndrome 1, 259450 (3), Autosomal recessive
chr17	NT5C3B	620041.0 | NT5C3B, NT5C3L, CNIIIL | 5'-nucleotidase, cytosolic IIIb | 115024.0 | ENSG00000141698 | nan | nan
chr17	KLHL10	608778.0 | KLHL10, SPGF11 | Kelch-like 10 | 317719.0 | ENSG00000161594 | nan | Spermatogenic failure 11, 615081 (3), Autosomal dominant
chr17	KLHL11	619078.0 | KLHL11 | Kelch-like family, member 11 | 55175.0 | ENSG00000178502 | nan | nan
chr17	ACLY	108728.0 | ACLY | ATP citrate lyase | 47.0 | ENSG00000131473 | nan | nan
chr17	ODAD4	617095.0 | ODAD4, TTC25, CILD35 | Outer dynein arm docking complex subunit 4 | 83538.0 | ENSG00000204815 | nan | Ciliary dyskinesia, primary, 35, 617092 (3), Autosomal recessive
chr17	CNP	123830.0 | CNP, CNP1, HLD20 | 2', 3' cyclic nucleotide 3' phosphohydrolase | 1267.0 | ENSG00000173786 | mutation identified in 1 HLD20 family | ?Leukodystrophy, hypomyelinating, 20, 619071 (3), Autosomal recessive
chr17	DNAJC7	601964.0 | DANJC7, TTC2, TPR2 | DnaJ, E. coli, homolog of, subfamily C, member 7 (tetratricopeptide repeat domain 2) | 7266.0 | ENSG00000168259 | nan | nan
chr17	NKIRAS2	604497.0 | NKIRAS2, KBRAS2 | NFKB inhibitor-interacting Ras-like protein 2 | 28511.0 | ENSG00000168256 | nan | nan
chr17	ZNF385C	620982.0 | ZNF385C | Zinc finger protein 385C | 201181.0 | ENSG00000187595 | nan | nan
chr17	DHX58	608588.0 | DHX58, LGP2, D11LGP2 | DExH-box helicase 58 | 79132.0 | ENSG00000108771 | nan | nan
chr17	KAT2A	602301.0 | KAT2A, GCN5L2, GCN5 | K(lysine) acetyltransferase 2A | 2648.0 | ENSG00000108773 | nan | nan
chr17	HSPB9	608344.0 | HSPB9 | Heat-shock 27kD protein 9 | 94086.0 | ENSG00000260325 | nan | nan
chr17	RAB5C	604037.0 | RAB5C, RABL | Ras-associated protein RAB5c | 5878.0 | ENSG00000108774 | nan | nan
chr17	KCNH4	604528.0 | KCNH4, BEC2 | Potassium channel, voltage-gated, subfamily H, member 4 | 23415.0 | ENSG00000089558 | nan | nan
chr17	HCRT	602358.0 | HCRT, OX, NRCLP1 | Hypocretin | 3060.0 | ENSG00000161610 | mutation identified in 1 NRCLP1 patient | ?Narcolepsy 1, 161400 (3), Autosomal dominant
chr17	GHDC	608587.0 | GHDC, LGP1 | GH3 domain-containing protein | 84514.0 | ENSG00000167925 | nan | nan
chr17	STAT5B	604260.0 | STAT5B, GHISID2 | Signal transducer and activator of transcription 5B | 6777.0 | ENSG00000173757 | fused with RARA in PML | Growth hormone insensitivity with immune dysregulation 1, autosomal recessive, 245590 (3), Autosomal recessive; Growth hormone insensitivity with immune dysregulation 2, autosomal dominant, 618985 (3), Autosomal dominant; Leukemia, acute promyelocytic, somatic, 102578 (3)
chr17	STAT5A	601511.0 | STAT5A, STAT5, MGF | Signal transducer and activator of transcription 5a | 6776.0 | ENSG00000126561 | nan | nan
chr17	STAT3	102582.0 | STAT3, APRF, HIES, ADMIO1 | Signal transducer and activator of transcription-3 (acute-phase response factor) | 6774.0 | ENSG00000168610 | nan | Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections, 147060 (3), Autosomal dominant; Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3), Autosomal dominant
chr17	CAVIN1	603198.0 | CAVIN1, PTRF | Caveolae-associated protein 1 | 284119.0 | ENSG00000177469 | nan | Lipodystrophy, congenital generalized, type 4, 613327 (3), Autosomal recessive
chr17	ATP6V0A1	192130.0 | ATP6V0A1, ATP6N1A, VPP1, DEE104, NEDEBA | ATPase, H+ transporting, V0 subunit A1 | 535.0 | ENSG00000033627 | nan | Neurodevelopmental disorder with epilepsy and brain atrophy, 619971 (3), Autosomal recessive; Developmental and epileptic encephalopathy 104, 619970 (3), Autosomal dominant
chr17	NAGLU	609701.0 | NAGLU, MPS3B, CMT2V | N-acetylglucosaminidase, alpha- | 4669.0 | ENSG00000108784 | mutation identified in 1 CMT2V family | ?Charcot-Marie-Tooth disease, axonal, type 2V, 616491 (3), Autosomal dominant; Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3), Autosomal recessive
chr17	HSD17B1	109684.0 | HSD17B1, EDH17B2 | Estradiol 17-beta-dehydrogenase-1 | 3292.0 | ENSG00000108786 | nan | nan
chr17	COASY	609855.0 | COASY, NBIA6, PCH12 | Coenzyme A synthase | 80347.0 | ENSG00000068120 | nan | Pontocerebellar hypoplasia, type 12, 618266 (3), Autosomal recessive; Neurodegeneration with brain iron accumulation 6, 615643 (3), Autosomal recessive
chr17	MLX	602976.0 | MLX, TCFL4 | MAX-like protein X | 6945.0 | ENSG00000108788 | nan | nan
chr17	PSMC3IP	608665.0 | PSMC3IP, TBPIP, GT198, HOP2, ODG3 | PSMC3-interacting protein | 29893.0 | ENSG00000131470 | nan | Ovarian dysgenesis 3, 614324 (3), Autosomal recessive
chr17	RETREG3	616498.0 | FAM134C | Family with sequence similarity 134, member C | 162427.0 | ENSG00000141699 | nan | nan
chr17	TUBG1	191135.0 | TUBG1, CDCBM4 | Tubulin, gamma 1 | 7283.0 | ENSG00000131462 | nan | Cortical dysplasia, complex, with other brain malformations 4, 615412 (3), Autosomal dominant
chr17	TUBG2	605785.0 | TUBG2 | Tubulin, gamma 2 | 27175.0 | ENSG00000037042 | pseudogene on chr. 7 | nan
chr17	CCR10	600240.0 | CCR10, GPR2 | Chemokine (C-C) receptor 10 | 2826.0 | ENSG00000184451 | nan | nan
chr17	CNTNAP1	602346.0 | CNTNAP1, CASPR, P190, CHN3 | Contactin-associated protein 1 | 8506.0 | ENSG00000108797 | nan | Lethal congenital contracture syndrome 7, 616286 (3), Autosomal recessive; Hypomyelinating neuropathy, congenital, 3, 618186 (3), Autosomal recessive
chr17	EZH1	601674.0 | EZH1 | Enhancer of zeste, Drosophila, homolog of, 1 | 2145.0 | ENSG00000108799 | nan | nan
chr17	RAMP2	605154.0 | RAMP2 | Receptor activity-modifying protein 2 | 10266.0 | ENSG00000131477 | nan | nan
chr17	VPS25	610907.0 | VPS25, FAP20 | Vacuolar protein sorting 25 homolog | 84313.0 | ENSG00000131475 | nan | nan
chr17	WNK4	601844.0 | WNK4, PRKWNK4, PHA2B | WNK lysine deficient protein kinase 4 | 65266.0 | ENSG00000126562 | nan | Pseudohypoaldosteronism, type IIB, 614491 (3), Autosomal dominant
chr17	COA3	614775.0 | COA3, CCDC56, MC4DN14 | Cytochrome c oxidase assembly factor 3 | 28958.0 | ENSG00000183978 | mutation identified in 1 MC4DN14 patient | ?Mitochondrial complex IV deficiency, nuclear type 14, 619058 (3), Autosomal recessive
chr17	CNTD1	618166.0 | CNTD1, COSA1 | Cyclin N-terminal domain-containing protein 1 | 124817.0 | ENSG00000176563 | nan | nan
chr17		613533.0 | DUP17q21.31, C17DUPq21.31 | Chromosome 17q21.31 duplication syndrome | nan | nan | contiguous gene duplication syndrome | Chromosome 17q21.31 duplication syndrome, 613533 (4)
chr17	ERDA1	603279.0 | ERDA1 | Expanded repeat domain, CAG/CTG, 1 | 9030.0 | nan | no apparent pathology | nan
chr17	MRT35	615162.0 | MRT35 | Intellectual developmental disorder, autosomal recessive 35 | 101409266.0 | nan | between rs4792947 and rs11079258 | Intellectual developmental disorder, autosomal recessive 35, 615162 (2), Autosomal recessive
chr17		239100.0 | VBCH | Van Buchem disease | nan | nan | 52-kb deletion 35 kb downlstream of SOST | van Buchem disease, 239100 (4), Autosomal recessive
chr17	BECN1	604378.0 | BECN1 | Beclin 1 | 8678.0 | ENSG00000126581 | nan | nan
chr17	PSME3	605129.0 | PSME3, PA28G | Proteasome activator subunit 3 | 10197.0 | ENSG00000131467 | nan | nan
chr17	AOC2	602268.0 | AOC2, RAO | Amine oxidase, copper-containing, 2 | 314.0 | ENSG00000131480 | nan | nan
chr17	AOC3	603735.0 | AOC3, HPAO, VAP1 | Amine oxidase, copper-containing 3 | 8639.0 | ENSG00000131471 | nan | nan
chr17	G6PC1	613742.0 | G6PC, G6PT | Glucose-6-phosphatase, catalytic | 2538.0 | ENSG00000131482 | nan | Glycogen storage disease Ia, 232200 (3), Autosomal recessive
chr17	AARSD1	613212.0 | AARSD1 | Alanyl-tRNA synthetase domain-containing 1 | 80755.0 | ENSG00000266967 | nan | nan
chr17	RUNDC1	619250.0 | RUNDC1, RUND1 | RUN domain-containing protein 1 | 146923.0 | ENSG00000198863 | nan | nan
chr17	RPL27	607526.0 | RPL27, DBA16 | Ribosomal protein L27 | 6155.0 | ENSG00000131469 | mutation identified in 1 DBA16 patient | ?Diamond-Blackfan anemia 16, 617408 (3), Autosomal dominant
chr17	IFI35	600735.0 | IFI35 | Interferon-induced protein-35 | 3430.0 | ENSG00000068079 | nan | nan
chr17	VAT1	604631.0 | VAT1 | Vesicle amine transport protein 1 | 10493.0 | ENSG00000108828 | nan | nan
chr17	RND2	601555.0 | RND2, ARHN, RHO7 | Ras homolog gene family, member N (GTP-binding protein Rho7) | 8153.0 | ENSG00000108830 | nan | nan
chr17	BRCA1	113705.0 | BRCA1, PSCP, BROVCA1, PNCA4, FANCS | BRCA1 DNA repair-associated protein | 672.0 | ENSG00000012048 | nan | Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)
chr17	NBR2	618708.0 | NBR2 | Neighbor of BRCA1 gene 2, noncoding | 10230.0 | ENSG00000198496 | Head-to-head orientation with BRCA1 | nan
chr17	NBR1	166945.0 | NBR1, M17S2 | NBR1 autophagy cargo receptor | 4077.0 | ENSG00000188554 | nan | nan
chr17	RNU2-1	180690.0 | RNU2-1, RNU2 | RNA, U2 small nuclear, 1 | 6066.0 | ENSG00000274585 | nan | nan
chr17	ARL4D	600732.0 | ARL4D, ARF4L | ADP ribosylation factor-like GTPase 4D | 379.0 | ENSG00000175906 | nan | nan
chr17	DHX8	600396.0 | DHX8, DDX8, HRH1 | DEAH-box helicase 8 | 1659.0 | ENSG00000067596 | nan | nan
chr17	ETV4	600711.0 | ETV4 | ETS variant transcription factor 4 | 2118.0 | ENSG00000175832 | nan | nan
chr17	MEOX1	600147.0 | MEOX1, MOX1, KFS2 | Mesenchyme homeobox 1 | 4222.0 | ENSG00000005102 | nan | Klippel-Feil syndrome 2, 214300 (3), Autosomal recessive
chr17	SOST	605740.0 | SOST, VBCH, CDD, SOST1 | Sclerostin | 50964.0 | ENSG00000167941 | nan | Sclerosteosis 1, 269500 (3), Autosomal recessive; Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3), Autosomal dominant
chr17	DUSP3	600183.0 | DUSP3, VHR | Dual specificity phosphatase-3 (vaccinia virus phosphatase VH1-related) | 1845.0 | ENSG00000108861 | nan | nan
chr17	CFAP97D1	619866.0 | CFAP97D1 | CFAP97 domain-containing protein 1 | 284067.0 | ENSG00000231256 | nan | nan
chr17	MPP3	601114.0 | MPP3, DLG3 | Membrane protein, palmitoylated-3 (MAGUK p55 subfamily member 3) | 4356.0 | ENSG00000161647 | nan | nan
chr17	CD300LG	610520.0 | CD300LG, TREM4, CLM9 | CD300 antigen-like family, member G | 146894.0 | ENSG00000161649 | nan | nan
chr17	MPP2	600723.0 | MPP2, DLG2 | Membrane protein, palmitoylated-2 (MAGUK p55 subfamily member 2) | 4355.0 | ENSG00000108852 | nan | nan
chr17	PPY	167780.0 | PPY | Pancreatic polypeptide | 5539.0 | ENSG00000108849 | in rat, close to GH | nan
chr17	PYY	600781.0 | PYY | Peptide YY | 5697.0 | ENSG00000131096 | 10kb from PPY | nan
chr17	NAGS	608300.0 | NAGS | N-acetylglutamate synthase | 162417.0 | ENSG00000161653 | nan | N-acetylglutamate synthase deficiency, 237310 (3), Autosomal recessive
chr17	LSM12	611793.0 | LSM12 | LSM12 homolog | 124801.0 | ENSG00000161654 | nan | nan
chr17	G6PC3	611045.0 | G6PC3, UGRP, SCN4 | Glucose-6-phosphatase, catalytic, 3 | 92579.0 | ENSG00000141349 | nan | Dursun syndrome, 612541 (3), Autosomal recessive; Neutropenia, severe congenital 4, autosomal recessive, 612541 (3), Autosomal recessive
chr17	HDAC5	605315.0 | HDAC5 | Histone deacetylase 5 | 10014.0 | ENSG00000108840 | nan | nan
chr17	HROB	618611.0 | HROB, MCM8IP, C17orf53, ODG11 | Homologous recombination factor with OB-fold | 78995.0 | ENSG00000125319 | nan | Ovarian dysgenesis 11, 620897 (3), Autosomal recessive
chr17	ASB16	615056.0 | ASB16 | Ankyrin repeat- and SOCS box-containing protein 16 | 92591.0 | ENSG00000161664 | nan | nan
chr17	ATXN7L3	619010.0 | ATXN7L3, SGF11 | ATNX7-like 3 | 56970.0 | ENSG00000087152 | nan | nan
chr17	UBTF	600673.0 | UBTF, UBF, CONDBA | Upstream binding transcription factor, RNA polymerase I | 7343.0 | ENSG00000108312 | nan | Neurodegeneration, childhood-onset, with brain atrophy, 617672 (3), Autosomal dominant
chr17	SHC1P2	600739.0 | SHC1P2, SHCL1 | SHC adaptor protein 1 pseudogene 2 | 6466.0 | nan | nan | nan
chr17	SLC4A1	109270.0 | SLC4A1, AE1, EPB3, SPH4, SAO, CHC | Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 6521.0 | ENSG00000004939 | nan | [Blood group, Swann], 601550 (3); [Blood group, Wright], 112050 (3); Distal renal tubular acidosis 1, 179800 (3), Autosomal dominant; [Blood group, Waldner], 112010 (3); Spherocytosis, type 4, 612653 (3), Autosomal dominant; [Blood group, Froese], 601551 (3); Distal renal tubular acidosis 4 with hemolytic anemia, 611590 (3), Autosomal recessive; {Malaria, resistance to}, 611162 (3); Cryohydrocytosis, 185020 (3), Autosomal dominant; Ovalocytosis, SA type, 166900 (3), Autosomal dominant; [Blood group, Diego], 110500 (3)
chr17	RUNDC3A	605448.0 | RUNDC3A, RPIP8 | RUN domain contain 3A | 10900.0 | ENSG00000108309 | nan | nan
chr17	SLC25A39	610820.0 | SLC25A39, CGI69 | Solute carrier family 25, member 39 | 51629.0 | ENSG00000013306 | nan | nan
chr17	GRN	138945.0 | GRN, CLN11, FTD2 | Granulin | 2896.0 | ENSG00000030582 | nan | Frontotemporal dementia 2, 607485 (3), Autosomal recessive, Autosomal dominant; Aphasia, primary progressive, 607485 (3), Autosomal recessive, Autosomal dominant; Ceroid lipofuscinosis, neuronal, 11, 614706 (3), Autosomal recessive
chr17	ITGA2B	607759.0 | ITGA2B, GP2B, CD41B, GT1, BDPLT2, BDPLT16 | Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B) | 3674.0 | ENSG00000005961 | 3' to GP3A; BAK platelet antigen | Thrombocytopenia, neonatal alloimmune, BAK antigen related (3); Glanzmann thrombasthenia 1, 273800 (3), Autosomal recessive; Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3), Autosomal dominant
chr17	GPATCH8	614396.0 | GPATCH8, KIAA0553 | G-patch domain-containing protein 8 | 23131.0 | ENSG00000186566 | nan | nan
chr17	FZD2	600667.0 | FZD2, OMOD2 | Frizzled class receptor 2 | 2535.0 | ENSG00000180340 | nan | Omodysplasia 2, 164745 (3), Autosomal dominant
chr17	MEIOC	616934.0 | MEIOC, C17orf104 | Meiosis-specific protein with coiled-coil domain | 284071.0 | ENSG00000180336 | nan | nan
chr17	DBF4B	611661.0 | DBF4B, DRF1, ASKL1 | DBF4, S. cerevisiae, homolog of, B | 80174.0 | ENSG00000161692 | nan | nan
chr17	ADAM11	155120.0 | ADAM11, MDC | ADAM metallopeptidase domain 11 | 4185.0 | ENSG00000073670 | nan | nan
chr17	GJC1	608655.0 | GJC1, GJA7, CX45 | Gap junction protein, gamma-1 | 10052.0 | ENSG00000182963 | nan | nan
chr17	HIGD1B	620420.0 | HIGD1B | HIG1 hypoxia-inducible domain family, member 1B | 51751.0 | ENSG00000131097 | nan | nan
chr17	EFTUD2	603892.0 | EFTUD2, KIAA0031, MFDGA | Elongation factor Tu GTP-binding domain-containing 2 | 9343.0 | ENSG00000108883 | nan | Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3), Autosomal dominant
chr17	DNAAF19	614677.0 | CCDC103, SMH, PR46B, CILD17 | Coiled-coil domain-containing protein 103 | 388389.0 | ENSG00000167131 | nan | Ciliary dyskinesia, primary, 17, 614679 (3), Autosomal recessive
chr17	GFAP	137780.0 | GFAP, ALXDRD | Glial fibrillary acidic protein | 2670.0 | ENSG00000131095 | nan | Alexander disease, 203450 (3), Autosomal dominant
chr17	KIF18B	614570.0 | KIF18B | Kinesin family member 18B | 146909.0 | ENSG00000186185 | nan | nan
chr17	C1QL1	611586.0 | C1QL1, CRF, C1QRF | Complement component 1, q subcomponent-like 1 | 10882.0 | ENSG00000131094 | nan | nan
chr17	NMT1	160993.0 | NMT1, NMT | N-myristoyltransferase 1 | 4836.0 | ENSG00000136448 | nan | nan
chr17	PLCD3	608795.0 | PLCD3 | Phospholipase C, delta-3 | 113026.0 | ENSG00000161714 | nan | nan
chr17	ACBD4	619968.0 | ACBD4 | Acyl-CoA-binding domain-containing protein 4 | 79777.0 | ENSG00000181513 | nan | nan
chr17	HEXIM1	607328.0 | CLP1, HIS1 | Cardiac lineage protein 1 | 10614.0 | ENSG00000186834 | nan | nan
chr17	HEXIM2	615695.0 | HEXIM2 | Hexamethylene bis acetamide-inducible protein 2 | 124790.0 | ENSG00000168517 | nan | nan
chr17	FMNL1	604656.0 | FMNL, C17orf1B | Formin-like | 752.0 | ENSG00000184922 | nan | nan
chr17	MAP3K14	604655.0 | MAP3K14, NIK, HSNIK, IMD112 | Mitogen-activated protein kinase kinase kinase-14 | 9020.0 | ENSG00000006062 | nan | Immunodeficiency 112, 620449 (3), Autosomal recessive
chr17	ARHGAP27	610591.0 | ARHGAP27, CAMGAP1 | RHO GTPase-activating protein 27 | 201176.0 | ENSG00000159314 | nan | nan
chr17	PLEKHM1	611466.0 | PLEKHM1, AP162, KIAA0356, OPTB6, OPTA3 | Pleckstrin homology domain-containing protein, family M, member 1 | 9842.0 | ENSG00000225190 | mutation identified in 1 OPTB6 family | ?Osteopetrosis, autosomal recessive 6, 611497 (3), Autosomal recessive; Osteopetrosis, autosomal dominant 3, 618107 (3), Autosomal dominant
chr17	CRHR1	122561.0 | CRHR1, CRHR | Corticotropin releasing hormone receptor 1 | 1394.0 | ENSG00000120088 | nan | nan
chr17	SPPL2C	608284.0 | IMP5 | Intramembrane protease 5 | 162540.0 | ENSG00000185294 | nan | nan
chr17	MAPT	157140.0 | MAPT, MTBT1, DDPAC, MSTD, FTD1 | Microtubule-associated protein tau | 4137.0 | ENSG00000186868 | see 6p21 | Supranuclear palsy, progressive, 601104 (3), Autosomal dominant; Frontotemporal dementia 1, with or without parkinsonism, 600274 (3), Autosomal dominant; Supranuclear palsy, progressive atypical, 260540 (3), Autosomal recessive; {Parkinson disease, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant; Pick disease, 172700 (3), Autosomal dominant
chr17	STH	607067.0 | STH | Saitohin | 246744.0 | ENSG00000256762 | in intron 9 of TAU | nan
chr17	KANSL1	612452.0 | KANSL1, KIAA1267, MSL1V1, KDVS | KAT8 regulatory NSL complex subunit 1 | 284058.0 | ENSG00000120071 | nan | Koolen-De Vries syndrome, 610443 (3), Autosomal dominant
chr17	LRRC37A	616555.0 | LRRC37A | Leucine-rich repeat-containing protein 37A | 9884.0 | ENSG00000176681 | nan | nan
chr17	LRRC37A2	616556.0 | LRRC37A2 | Leucine-rich repeat-containing protein 37A2 | 474170.0 | ENSG00000238083 | nan | nan
chr17	NSF	601633.0 | NSF, DEE96 | N-ethylmaleimide-sensitive factor | 4905.0 | ENSG00000073969 | nan | Developmental and epileptic encephalopathy 96, 619340 (3), Autosomal dominant
chr17	WNT3	165330.0 | WNT3, INT4, TETAMS | Wingless-type MMTV integration site family, member 3 | 7473.0 | ENSG00000108379 | mutation identified in 1 TETAMS1 family | ?Tetra-amelia syndrome 1, 273395 (3), Autosomal recessive
chr17	WNT9B	602864.0 | WNT15 | Wingless-type MMTV integration site family, member 15 | 7484.0 | ENSG00000158955 | nan | nan
chr17	GOSR2	604027.0 | GOSR2, GS27, EPM6, MYOS | Golgi snap receptor complex member 2 | 9570.0 | ENSG00000108433 | nan | Epilepsy, progressive myoclonic 6, 614018 (3), Autosomal recessive; Muscular dystrophy, congenital, with or without seizures, 620166 (3), Autosomal recessive
chr17	CDC27	116946.0 | CDC27 | Cell division cycle 27 | 996.0 | ENSG00000004897 | between ERBB2 and PRKCA | nan
chr17	MYL4	160770.0 | MYL4 | Myosin, light polypeptide-4, alkali, atrial, embryonic | 4635.0 | ENSG00000198336 | mutation identified in 1 ATFB18 family | ?Atrial fibrillation, familial, 18, 617280 (3), Autosomal dominant
chr17	ITGB3	173470.0 | ITGB3, GP3A, GT2, BDPLT24 | Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61) | 3690.0 | ENSG00000259207 | in same 260kb fragment as GP2B; PL(A) platelet antigen | Bleeding disorder, platelet-type, 24, autosomal dominant, 619271 (3), Autosomal dominant; Thrombocytopenia, neonatal alloimmune (3); Purpura, posttransfusion (3); {Myocardial infarction, susceptibility to}, 608446 (3); Glanzmann thrombasthenia 2, 619267 (3), Autosomal recessive
chr17	NPEPPS	606793.0 | NPEPPS, PSA, MP100 | Aminopeptidase, puromycin-sensitive | 9520.0 | ENSG00000141279 | nan | nan
chr17	KPNB1	602738.0 | KPNB1 | Karyopherin beta-1 | 3837.0 | ENSG00000108424 | nan | nan
chr17	TBKBP1	608476.0 | TBKBP1, PROSAPIP2, KIAA0775 | TBK1-binding protein 1 | 9755.0 | ENSG00000198933 | nan | nan
chr17	TBX21	604895.0 | TBX21, TBET, IMD88 | T-box 21 | 30009.0 | ENSG00000073861 | mutation identified in 1 IMD88 patient | Asthma and nasal polyps, 208550 (3), Autosomal recessive; ?Immunodeficiency 88, 619630 (3), Autosomal recessive; {Asthma, aspirin-induced, susceptibility to}, 208550 (3), Autosomal recessive
chr17	OSBPL7	606735.0 | OSBPL7, ORP7 | Oxysterol-binding protein-like protein 7 | 114881.0 | ENSG00000006025 | nan | nan
chr17	MRPL10	611825.0 | MRPL10, MRPL8 | Mitochondrial ribosomal protein L10 | 124995.0 | ENSG00000159111 | nan | nan
chr17	LRRC46	620927.0 | LRRC46 | Leucine-rich repeat-containing protein 46 | 90506.0 | ENSG00000141294 | nan | nan
chr17	SCRN2	614966.0 | SCRN2, SES2 | Secernin 2 | 90507.0 | ENSG00000141295 | nan | nan
chr17	SP6	608613.0 | SP6, KLF14, EPFN, AI1K | Transcription factor Sp6 | 80320.0 | ENSG00000189120 | nan | Amelogenesis imperfecta, type IK, 620104 (3), Autosomal dominant
chr17	SP2	601801.0 | SP2 | Transcription factor Sp2 | 6668.0 | ENSG00000167182 | nan | nan
chr17	PNPO	603287.0 | PNPO | Pyridoxamine 5'-phosphate oxidase | 55163.0 | ENSG00000108439 | nan | Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3), Autosomal recessive
chr17	CDK5RAP3	608202.0 | CDK5RAP3 | CDK5 regulatory subunit-associated protein 3 | 80279.0 | ENSG00000108465 | nan | nan
chr17	COPZ2	615526.0 | COPZ2 | Coatomer protein complex, subunit zeta-2 | 51226.0 | ENSG00000005243 | nan | nan
chr17	MIR152	613788.0 | MIR152, MIRN152 | Micro RNA 152 | 406943.0 | ENSG00000207947 | nan | nan
chr17	NFE2L1	163260.0 | NFE2L1, NRF1 | Nuclear factor, erythroid-derived 2-like 1 | 4779.0 | ENSG00000082641 | nan | nan
chr17	CBX1	604511.0 | CBX1 | Chromobox 1 | 10951.0 | ENSG00000108468 | nan | nan
chr17	SNX11	614906.0 | SNX11 | Sorting nexin 11 | 29916.0 | ENSG00000002919 | nan | nan
chr17	SKAP1	604969.0 | SKAP1, SCAP1, SKAP55 | SRC kinase-associated phosphoprotein 1, 55kD | 8631.0 | ENSG00000141293 | nan | nan
chr17	HOXB1	142968.0 | HOXB1, HOX2I, HCFP3 | Homeobox-B1 | 3211.0 | ENSG00000120094 | nan | Facial paresis, hereditary congenital, 3, 614744 (3), Autosomal recessive
chr17	HOXB2	142967.0 | HOXB2, HOX2H | Homeobox B2 | 3212.0 | ENSG00000173917 | nan | nan
chr17	HOXB-AS1	618066.0 | HOXBAS1, HOXB3OS | Homeobox B cluster antisense RNA 1, noncoding | 100874362.0 | ENSG00000230148 | nan | nan
chr17	HOXB3	142966.0 | HOXB3, HOX2G | Homeobox B3 | 3213.0 | ENSG00000120093 | nan | nan
chr17	HOXB4	142965.0 | HOXB4, HOX2F | Homeobox B4 | 3214.0 | ENSG00000182742 | nan | nan
chr17	MIR10A	610173.0 | MIR10A | Micro RNA 10A | 406902.0 | ENSG00000284038 | nan | nan
chr17	HOXB5	142960.0 | HOXB5, HOX2A | Homeobox B5 | 3215.0 | ENSG00000120075 | nan | nan
chr17	HOXB6	142961.0 | HOXB6, HOX2B | Homeobox B6 | 3216.0 | ENSG00000108511 | nan | nan
chr17	HOXB7	142962.0 | HOXB7, HOX2C | Homeobox B7 | 3217.0 | ENSG00000260027 | nan | nan
chr17	HOXB8	142963.0 | HOXB8, HOX2D | Homeobox B8 | 3218.0 | ENSG00000120068 | nan | nan
chr17	HOXB9	142964.0 | HOXB9, HOX2E | Homeobox B9 | 3219.0 | ENSG00000170689 | nan | nan
chr17	MIR196A1	608632.0 | MIR196A1, MIRN196A1 | Micro RNA 196A1 | 406972.0 | ENSG00000210741 | nan | nan
chr17	PRAC2	610787.0 | PRAC2, HOXBAS5 | PRAC2 small nuclear protein | 360205.0 | ENSG00000229637 | nan | nan
chr17	PRAC1	609819.0 | PRAC1 | PRAC1 small nuclear protein | 84366.0 | ENSG00000159182 | nan | nan
chr17	HOXB13	604607.0 | HOXB13, HPC9 | Homeobox B13 | 10481.0 | ENSG00000159184 | nan | {Prostate cancer, hereditary, 9}, 610997 (3)
chr17	TTLL6	610849.0 | TTLL6 | Tubulin tyrosine ligase-like 6 | 284076.0 | ENSG00000170703 | nan | nan
chr17	CALCOCO2	604587.0 | CALCOCO2, NDP52 | Calcium binding and coiled-coil domain protein 2 | 10241.0 | ENSG00000136436 | nan | nan
chr17	ATP5MC1	603192.0 | ATP5G1 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C, isoform 1 | 516.0 | ENSG00000159199 | nan | nan
chr17	UBE2Z	611362.0 | UBE2Z, USE1 | Ubiquitin-conjugating enzyme E2 Z | 65264.0 | ENSG00000159202 | nan | nan
chr17	SNF8	610904.0 | SNF8, VPS22, EAP30, DEE115, NEDOA | SNF8 subunit of ESCRIT-II | 11267.0 | ENSG00000159210 | nan | Developmental and epileptic encephalopathy 115, 620783 (3), Autosomal recessive; Neurodevelopmental disorder plus optic atrophy, 620784 (3), Autosomal recessive
chr17	GIP	137240.0 | GIP | Gastric inhibitory polypeptide | 2695.0 | ENSG00000159224 | nan | nan
chr17	IGF2BP1	608288.0 | IGF2BP1, IMP1, CRDBP, ZBP1 | Insulin-like growth factor 2 mRNA-binding protein 1 | 10642.0 | ENSG00000159217 | nan | nan
chr17	B4GALNT2	111730.0 | B4GALNT2, GALGT2, SD, SDA | Beta-1,4-N-acetyl-galactosaminyl transferase 2 | 124872.0 | ENSG00000167080 | nan | [Blood group, Sid system], 615018 (3); Sd(a) polyagglutination syndrome, 615018 (3)
chr17	TRQ-TTG1-1	189923.0 | TRQ-TTG1-1, TRNAQ2, TRQ2 | tRNA glutamine (anticodon TTG) 1-1 | 7229.0 | nan | nan | nan
chr17	GNGT2	139391.0 | GNGT2 | Guanine nucleotide-binding protein, gamma-transducing activity polypeptide 2 | 2793.0 | ENSG00000167083 | nan | nan
chr17	ABI3	606363.0 | NESH | NESH protein | 51225.0 | ENSG00000108798 | nan | nan
chr17	ZNF652	613907.0 | ZNF652, KIAA0924 | Zinc finger protein 652 | 22834.0 | ENSG00000198740 | nan | nan
chr17	PHB1	176705.0 | PHB1 | Prohibitin 1 | 5245.0 | ENSG00000167085 | nan | {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant
chr17	NGFR	162010.0 | NGFR, TNFRSF16 | Nerve growth factor receptor | 4804.0 | ENSG00000064300 | distal to APL breakpoint, q21; < 0.5mb from HOX2 | nan
chr17	NXPH3	604636.0 | NXPH3, NPH3 | Neuroexophilin 3 | 11248.0 | ENSG00000182575 | nan | nan
chr17	SPOP	602650.0 | SPOP, NSDVS1, NSDVS2 | Speckle-type POZ protein | 8405.0 | ENSG00000121067 | nan | Nabais Sa-de Vries syndrome, type 1, 618828 (3), Autosomal dominant; Nabais Sa-de Vries syndrome, type 2, 618829 (3), Autosomal dominant
chr17	SLC35B1	610790.0 | SLC35B1, UGTREL1 | Solute carrier family 35, member B1 | 10237.0 | ENSG00000121073 | nan | nan
chr17	KAT7	609880.0 | KAT7, MYST2, HBO1 | K(lysine) acetyltransferase 7 | 11143.0 | ENSG00000136504 | nan | nan
chr17	TAC4	607833.0 | RAC4, PPTC, HK1 | Tachykinin 4 | 255061.0 | ENSG00000176358 | nan | nan
chr17	DLX4	601911.0 | DLX4, DLX7, DLX8, OFC15 | Distal-less homeobox 4 | 1748.0 | ENSG00000108813 | mutation identified in 1 OFC15 family | ?Orofacial cleft 15, 616788 (3), Autosomal dominant
chr17	DLX3	600525.0 | DLX3, TDO, AI4 | Distal-less homeobox 3 | 1747.0 | ENSG00000064195 | nan | Trichodontoosseous syndrome, 190320 (3), Autosomal dominant; Amelogenesis imperfecta, type IV, 104510 (3), Autosomal dominant
chr17	ITGA3	605025.0 | ITGA3, CD49C, GAPB3, JEB7 | Integrin, alpha-3 | 3675.0 | ENSG00000005884 | nan | Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome, 614748 (3), Autosomal recessive
chr17	PDK2	602525.0 | PDK2 | Pyruvate dehydrogenase kinase, isoenzyme 2 | 5164.0 | ENSG00000005882 | nan | nan
chr17	SAMD14	619233.0 | SAMD14 | Sterile alpha motif domain-containing protein 14 | 201191.0 | ENSG00000167100 | nan | nan
chr17	PPP1R9B	603325.0 | PPP1R9B, SPINO | Protein phosphatase 1, regulatory subunit 9B | 84687.0 | ENSG00000108819 | nan | nan
chr17	SGCA	600119.0 | SGCA, ADL, DAG2, LGMDR3 | Sarcoglycan, alpha (50kD dystrophin-associated glycoprotein; adhalin) | 6442.0 | ENSG00000108823 | nan | Muscular dystrophy, limb-girdle, autosomal recessive 3, 608099 (3), Autosomal recessive
chr17	H1-9P	608101.0 | HILS1 | Spermatid-specific linker histone H1-like protein | 373861.0 | ENSG00000253730 | nan | nan
chr17	COL1A1	120150.0 | COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD | Collagen I, alpha-1 polypeptide | 1277.0 | ENSG00000108821 | fused with PDGFB in DFPB | Osteogenesis imperfecta, type II, 166210 (3), Autosomal dominant; Caffey disease, 114000 (3), Autosomal dominant; Ehlers-Danlos syndrome, arthrochalasia type, 1, 130060 (3), Autosomal dominant; Osteogenesis imperfecta, type I, 166200 (3), Autosomal dominant; {Bone mineral density variation QTL, osteoporosis}, 166710 (3), Autosomal dominant; Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1, 619115 (3), Autosomal dominant; Osteogenesis imperfecta, type IV, 166220 (3), Autosomal dominant; Osteogenesis imperfecta, type III, 259420 (3), Autosomal dominant
chr17	TMEM92	619604.0 | TMEM92 | Transmembrane protein 92 | 162461.0 | ENSG00000167105 | nan | nan
chr17	XYLT2	608125.0 | XYLT2, XT2, SOS | Xylosyltransferase 2 | 64132.0 | ENSG00000015532 | nan | {Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3), Autosomal recessive; Spondyloocular syndrome, 605822 (3), Autosomal recessive
chr17	MRPL27	611837.0 | MRPL27 | Mitochondrial ribosomal protein L27 | 51264.0 | ENSG00000108826 | nan | nan
chr17	EME1	610885.0 | EME1 | Essential meiotic structure-specific endonuclease 1 | 146956.0 | ENSG00000154920 | nan | nan
chr17	LRRC59	614854.0 | LRRC59, p34 | Leucine-rich repeat-containing protein 59 | 55379.0 | ENSG00000108829 | nan | nan
chr17	ACSF2	610465.0 | ACSF2, FLJ20920 | Acyl-CoA synthetase family member 2 | 80221.0 | ENSG00000167107 | nan | nan
chr17	CHAD	602178.0 | CHAD | Chondroadherin | 1101.0 | ENSG00000136457 | nan | nan
chr17	RSAD1	620590.0 | RSAD1 | Radical S-adenosyl methionine domain-containing protein 1 | 55316.0 | ENSG00000136444 | nan | nan
chr17	MYCBPAP	609835.0 | MYCBPAP, AMAP1 | MYCBP-associated protein | 84073.0 | ENSG00000136449 | nan | nan
chr17	EPN3	607264.0 | EPN3 | Epsin 3 | 55040.0 | ENSG00000049283 | nan | nan
chr17	SPATA20	613939.0 | SPATA20, SSP411 | Spermatogenesis-associated protein 20 | 64847.0 | ENSG00000006282 | nan | nan
chr17	CACNA1G	604065.0 | CACNA1G, SCA42, SCA42ND | Calcium channel, voltage-dependent, T type, alpha-1G subunit | 8913.0 | ENSG00000006283 | nan | Spinocerebellar ataxia 42, 616795 (3), Autosomal dominant; Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits, 618087 (3), Autosomal dominant
chr17	ABCC3	604323.0 | ABCC3, CMOAT2, MRP3, MLP2 | ATP-binding cassette, sub-family C, member 3 | 8714.0 | ENSG00000108846 | nan | nan
chr17	LUC7L3	609434.0 | LUC7L3, CROP, LUC7A | LUC7-like 3 pre-mRNA splicing factor | 51747.0 | ENSG00000108848 | nan | nan
chr17	WFIKKN2	610895.0 | WFIKKN2, WFIKKNRP | WAP, fillistatin, immunoglobulin, Kunitz, and NTR domains-containing protein 2 | 124857.0 | ENSG00000173714 | nan | nan
chr17	TOB1	605523.0 | TOB1, TOB | Transducer of ERBB2, 1 | 10140.0 | ENSG00000141232 | nan | nan
chr17	SPAG9	605430.0 | SPAG9, SYD1, KIAA0516 | Sperm-associated antigen 9 | 9043.0 | ENSG00000008294 | nan | nan
chr17	NME1	156490.0 | NME1, NM23 | NME/NM23 nucleoside diphosphate kinase 1 | 4830.0 | ENSG00000239672 | nan | nan
chr17	NME2	156491.0 | NME2 | NME/NM23 nucleoside diphosphate kinase 2 | 4831.0 | ENSG00000243678 | nan | nan
chr17	MBTD1	618705.0 | MBTD1 | MBT domain-containing protein 1 | 54799.0 | ENSG00000011258 | nan | nan
chr17	UTP18	612816.0 | UTP18 | UTP18 small subunit processome component | 51096.0 | ENSG00000011260 | nan | nan
chr17	CA10	604642.0 | CA10, CARPX | Carbonic anhydrase X | 56934.0 | ENSG00000154975 | nan | nan
chr17	BCL5	151441.0 | BCL5 | B-cell CLL/lymphoma-5 | 603.0 | nan | nan | nan
chr17	KIF2B	615142.0 | KIF2B | Kinesin family member 2B | 84643.0 | ENSG00000141200 | nan | nan
chr17	TOM1L1	604701.0 | TOM1L1 | Target of MYB1-like 1 membrane trafficking protein | 10040.0 | ENSG00000141198 | nan | nan
chr17	COX11	603648.0 | COX11, MC4DN23 | Cytochrome c oxidase, subunit 11 | 1353.0 | ENSG00000166260 | pseudogene on 6p23-p22 | Mitochondrial complex IV deficiency, nuclear type 23, 620275 (3), Autosomal recessive
chr17	STXBP4	610415.0 | STXBP4, SYNIP | Syntaxin-binding protein 4 | 252983.0 | ENSG00000166263 | nan | nan
chr17	HLF	142385.0 | HLF | Hepatic leukemia factor | 3131.0 | ENSG00000108924 | nan | nan
chr17	MMD	604467.0 | MMD, MMD1, PAQR11 | Monocyte-to-macrophage differentiation-associated protein | 23531.0 | ENSG00000108960 | nan | nan
chr17	TMEM100	616334.0 | TMEM100 | Transmembrane protein 100 | 55273.0 | ENSG00000166292 | nan | nan
chr17	PCTP	606055.0 | PCTP | Phosphatidylcholine transfer protein | 58488.0 | ENSG00000141179 | nan | nan
chr17	ANKFN1	620853.0 | ANKFN1, WAKE | Ankyrin repeat- and fibronectin type III domain-containing protein 1 | 162282.0 | ENSG00000153930 | nan | nan
chr17	NOG	602991.0 | NOG, SYM1, SYNS1A | Noggin | 9241.0 | ENSG00000183691 | nan | Symphalangism, proximal, 1A, 185800 (3), Autosomal dominant; Brachydactyly, type B2, 611377 (3), Autosomal dominant; Stapes ankylosis with broad thumbs and toes, 184460 (3), Autosomal dominant; Tarsal-carpal coalition syndrome, 186570 (3), Autosomal dominant; Multiple synostoses syndrome 1, 186500 (3), Autosomal dominant
chr17	DGKE	601440.0 | DGKE, NPHS7, AHUS7 | Diacylglycerol kinase, epsilon, 64-kD | 8526.0 | ENSG00000153933 | nan | {Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3), Autosomal recessive; Nephrotic syndrome, type 7, 615008 (3), Autosomal recessive
chr17	TRIM25	600453.0 | TRIM25, ZNF147, EFP | Tripartite motif-containing 25 | 7706.0 | ENSG00000121060 | 300kb from MPO | nan
chr17	COIL	600272.0 | COIL, CLN80 | Coilin p80 | 8161.0 | ENSG00000121058 | nan | nan
chr17	SCPEP1	619723.0 | SCPEP1, RISC | Serine carboxypeptidase 1 | 59342.0 | ENSG00000121064 | nan | nan
chr17	AKAP1	602449.0 | AKAP1, AKAP149, SAKAP84 | A-kinase anchor protein 1, 149kD | 8165.0 | ENSG00000121057 | nan | nan
chr17	MSI2	607897.0 | MSI2 | Musashi RNA binding protein 2 | 124540.0 | ENSG00000153944 | nan | nan
chr17	MRPS23	611985.0 | MRPS23, COXPD46 | Mitochondrial ribosomal protein S23 | 51649.0 | ENSG00000181610 | mutation identified in 1 COXPD46 patient | ?Combined oxidative phosphorylation deficiency 46, 618952 (3), Autosomal recessive
chr17	CUEDC1	620552.0 | CUEDC1 | CUE domain-containing protein 1 | 404093.0 | ENSG00000180891 | nan | nan
chr17	VEZF1	606747.0 | VEZF1, ZNF161, CMD1OO | Vascular endothelial zinc finger 1 | 7716.0 | ENSG00000136451 | mutation identified in 1 CMD1OO family | ?Cardiomyopathy, dilated, 1OO, 620247 (3), Autosomal dominant
chr17	SRSF1	600812.0 | SRSF1, SFRS1, ASF, SF2, SRp30a, NEDFBA | Splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor) | 6426.0 | ENSG00000136450 | nan | Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities, 620489 (3), Autosomal dominant
chr17	DYNLL2	608942.0 | DYNLL2, DLC2 | Dynein, light chain, LC8-type 2 | 140735.0 | ENSG00000264364 | nan | nan
chr17	EPX	131399.0 | EPX, EPXD | Eosinophil peroxidase | 8288.0 | ENSG00000121053 | nan | [Eosinophil peroxidase deficiency], 261500 (3), Autosomal recessive
chr17	MKS1	609883.0 | MKS1, MKS, BBS13, JBTS28 | MKS1 transition zone complex subunit 1 | 54903.0 | ENSG00000011143 | frequent in Finland | Bardet-Biedl syndrome 13, 615990 (3), Autosomal recessive; Meckel syndrome 1, 249000 (3), Autosomal recessive; Joubert syndrome 28, 617121 (3), Autosomal recessive
chr17	LPO	150205.0 | LPO | Lactoperoxidase | 4025.0 | ENSG00000167419 | nan | nan
chr17	MPO	606989.0 | MPO | Myeloperoxidase | 4353.0 | ENSG00000005381 | translocated in t(15;17)(q22;q11.2) | {Alzheimer disease, susceptibility to}, 104300 (3), Autosomal dominant; Myeloperoxidase deficiency, 254600 (3), Autosomal recessive; {Lung cancer, protection against, in smokers} (3)
chr17	TSPOAP1	610764.0 | TSPOAP1, RIMBP1, KIAA0612, BZRAP1, PRAX1, DYT22 | TSPO associated protein 1 | 9256.0 | ENSG00000005379 | mutation identified in 1 DYT22AO | Dystonia 22, juvenile-onset, 620453 (3), Autosomal recessive; ?Dystonia 22, adult-onset, 620456 (3), Autosomal recessive
chr17	MIR142	615657.0 | MIR142 | Micro RNA 142 | 406934.0 | ENSG00000284353 | nan | nan
chr17	SUPT4H1	603555.0 | SUPT4H1 | SPT4 homolog, DSIF elongation factor subunit | 6827.0 | ENSG00000213246 | nan | nan
chr17	RNF43	612482.0 | RNF43, RNF124, SSPCS | Ring finger protein 43 | 54894.0 | ENSG00000108375 | nan | Sessile serrated polyposis cancer syndrome, 617108 (3), Autosomal dominant
chr17	HSF5	620843.0 | HSF5 | Heat-shock transcription factor 5 | 124535.0 | ENSG00000176160 | nan | nan
chr17	MTMR4	603559.0 | MTMR4 | Myotubularin-related protein 4 | 9110.0 | ENSG00000108389 | nan | nan
chr17	SEPTIN4	603696.0 | SEPT4, PNUTL2 | Septin 4 | 5414.0 | ENSG00000108387 | nan | nan
chr17	TEX14	605792.0 | TEX14, SPGF23 | Testis-expressed gene 14 | 56155.0 | ENSG00000121101 | nan | Spermatogenic failure 23, 617707 (3), Autosomal recessive
chr17	RAD51C	602774.0 | RAD51C, FANCO, BROVCA3 | RAD52 paralog C | 5889.0 | ENSG00000108384 | nan | {Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive
chr17	PPM1E	619308.0 | PPM1E, CAMKPN | Protein phosphatase, magnesium/manganese-dependent, 1E | 22843.0 | ENSG00000175175 | nan | nan
chr17	TRIM37	605073.0 | TRIM37, MUL, KIAA0898 | Tripartite motif-containing 37 | 4591.0 | ENSG00000108395 | nan | Mulibrey nanism, 253250 (3), Autosomal recessive
chr17	SKA2	616674.0 | SKA2, FAM33A | Spindle- and kinetochore-associated complex, subunit 2 | 348235.0 | ENSG00000182628 | nan | nan
chr17	MIR301A	615675.0 | MIR301A, MIR301 | Micro RNA 301A | 407027.0 | ENSG00000207996 | nan | nan
chr17	PRR11	615920.0 | PRR11 | Proline-rich protein 11 | 55771.0 | ENSG00000068489 | nan | nan
chr17	SMG8	613175.0 | SMG8, C17orf71, ALKUS | SMG8 nonsense-mediated mRNA decay factor | 55181.0 | ENSG00000167447 | nan | Alzahrani-Kuwahara syndrome, 619268 (3), Autosomal recessive
chr17	GDPD1	616317.0 | GDPD1, GDE4 | Glycerophosphodiester phosphodiesterase domain-containing protein 1 | 284161.0 | ENSG00000153982 | nan | nan
chr17	YPEL2	609723.0 | YPEL2 | Yippee-like 2 | 388403.0 | ENSG00000175155 | nan | nan
chr17	BSZQTL	609656.0 | BSZQTL | Bone size quantitative trait locus 1 | 100188793.0 | nan | nan | {Bone size QTL}, 609656 (2)
chr17		613355.0 | DEL17q23.1q23.2, C17DELq23.1q23.2 | Chromosome 17q23.1-q23.2 deletion syndrome | nan | nan | nan | Chromosome 17q23.1-q23.2 deletion syndrome, 613355 (4), Isolated cases
chr17		613618.0 | DUP17q23.1q23.2, C17DUPq23.1q23.2 | Chromosome 17q23.1-q23.2 duplication syndrome | nan | nan | 2.2 Mb contiguous gene duplication syndrome | Chromosome 17q23.1-q23.2 duplication syndrome, 613618 (4), Autosomal dominant
chr17	PEPE	170200.0 | PEPE | Peptidase E | 5185.0 | nan | nan | nan
chr17	DHX40	607570.0 | DHX40, DDX40 | DEAH-box helicase 40 | 79665.0 | ENSG00000108406 | nan | nan
chr17	CLTC	118955.0 | CLTC, MRD56 | Clathrin, heavy polypeptide (Hc) | 1213.0 | ENSG00000141367 | fusion gene with TFE3 in renal adenocarcinoma | Intellectual developmental disorder, autosomal dominant 56, 617854 (3), Autosomal dominant
chr17	PTRH2	608625.0 | PTRH2, BIT1, IMNEPD | Peptidyl-tRNA hydrolase 2 | 51651.0 | ENSG00000141378 | nan | Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3), Autosomal recessive
chr17	VMP1	611753.0 | VMP1, TMEM49, EPG3 | Vacuole membrane protein 1 | 81671.0 | ENSG00000062716 | nan | nan
chr17	MIR21	611020.0 | MIR21, MIRN21 | Micro RNA 21 | 406991.0 | ENSG00000284190 | nan | nan
chr17	TUBD1	607344.0 | TUBD1, TUBD | Tubulin, delta-1 | 51174.0 | ENSG00000108423 | nan | nan
chr17	RPS6KB1	608938.0 | RPS6KB1, S6K1 | Ribosomal protein S6 kinase B1 | 6198.0 | ENSG00000108443 | nan | nan
chr17	RNFT1	615172.0 | RNFT1 | RING finger protein, transmembrane 1 | 51136.0 | ENSG00000189050 | nan | nan
chr17	WFDC21P	615772.0 | WFDC21P, LNCDC, LOC615638 | WAP four-disulfide core domain 21, pseudogene | 645638.0 | ENSG00000293515 | nan | nan
chr17	CA4	114760.0 | CA4 | Carbonic anhydrase IV | 762.0 | ENSG00000167434 | nan | nan
chr17	USP32	607740.0 | USP32, USP10 | Ubiquitin-specific protease 32 | 84669.0 | ENSG00000170832 | nan | nan
chr17	BMIQ15	612967.0 | BMIQ15 | Body mass index quantitative trait locus 15 | 100302719.0 | nan | associated with rs228883 and rs1005651 | [Body mass index QTL 15], 612967 (2)
chr17		600852.0 | RP17 | Retinitis pigmentosa 17 | nan | nan | nan | Retinitis pigmentosa 17, 600852 (4), Autosomal dominant
chr17	APPBP2	605324.0 | APPBP2, PAT1 | Amyloid beta precursor protein-binding protein 2 | 10513.0 | ENSG00000062725 | nan | nan
chr17	PPM1D	605100.0 | PPM1D, WIP1, JDVS | Protein phosphatase, magnesium-dependent, 1, delta isoform | 8493.0 | ENSG00000170836 | amplified in breast cancer | Breast cancer, somatic, 114480 (3); Jansen-de Vries syndrome, 617450 (3), Autosomal dominant
chr17	BCAS3	607470.0 | BCAS3, HEMARS | BCAS3 microtubule associated cell migration factor | 54828.0 | ENSG00000141376 | nan | Hengel-Maroofian-Schols syndrome, 619641 (3), Autosomal recessive
chr17	TBX2	600747.0 | TBX2, VETD | T-box 2 | 6909.0 | ENSG00000121068 | nan | Vertebral anomalies and variable endocrine and T-cell dysfunction, 618223 (3), Autosomal dominant
chr17	TBX4	601719.0 | TBX4, ICPPS, PAPPAS | T-box 4 | 9496.0 | ENSG00000121075 | nan | Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension, 147891 (3), Autosomal dominant; Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome, 601360 (3), Autosomal recessive
chr17	NACA2	609274.0 | NACA2 | Nascent polypeptide-associated complex, alpha polypeptide, 2 | 342538.0 | ENSG00000253506 | nan | nan
chr17	BRIP1	605882.0 | BRIP1, BACH1, FANCJ | BRCA1-associated C-terminal helicase 1 | 83990.0 | ENSG00000136492 | ?or 17q23 | Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant
chr17	INTS2	611346.0 | INTS2, INT2, KIAA1287 | Integrator complex subunit 2 | 57508.0 | ENSG00000108506 | nan | nan
chr17	MED13	603808.0 | MED13, THRAP1, TRAP240, MRD61 | Mediator complex subunit 13 | 9969.0 | ENSG00000108510 | nan | Intellectual developmental disorder, autosomal dominant 61, 618009 (3), Autosomal dominant
chr17	EFCAB3	619567.0 | EFCAB3 | EF-hand calcium-binding domain-containing protein 3 | 146779.0 | ENSG00000172421 | nan | nan
chr17	METTL2A	618902.0 | METTL2A, METTL2 | Methyltransferase 2A, methylcytidine | 339175.0 | ENSG00000087995 | nan | nan
chr17	TLK2	608439.0 | TLK2, MRD57 | Tousled-like kinase 2 | 11011.0 | ENSG00000146872 | nan | Intellectual developmental disorder, autosomal dominant 57, 618050 (3), Autosomal dominant
chr17	MRC2	612264.0 | MRC2, ENDO180, UPARAP, CD280 | Mannose receptor, C-type, 2 | 9902.0 | ENSG00000011028 | nan | nan
chr17	MARCHF10	613337.0 | MARCH10 | Membrane-associated RING-CH finger protein 10 | 162333.0 | ENSG00000173838 | nan | nan
chr17	TANC2	615047.0 | TANC2, KIAA1636, IDDALDS | Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 2 | 26115.0 | ENSG00000170921 | nan | Intellectual developmental disorder with autistic features and language delay, with or without seizures, 618906 (3), Autosomal dominant
chr17	CYB561	600019.0 | CYB561, ORTHYP2 | Cytochrome b-561 | 1534.0 | ENSG00000008283 | nan | Orthostatic hypotension 2, 618182 (3), Autosomal recessive
chr17	ACE	106180.0 | ACE, DCP1, ACE1, MVCD3, ICH | Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1) | 1636.0 | ENSG00000159640 | nan | {Stroke, hemorrhagic}, 614519 (3); Renal tubular dysgenesis, 267430 (3), Autosomal recessive; {Myocardial infarction, susceptibility to} (3); {Microvascular complications of diabetes 3}, 612624 (3); [Angiotensin I-converting enzyme, benign serum increase] (3); {SARS, progression of} (3)
chr17	KCNH6	608168.0 | KCNH6, HERG2 | Potassium channel, voltage-gated, subfamily H, member 6 | 81033.0 | ENSG00000173826 | nan | nan
chr17	DCAF7	605973.0 | DCAF7, AN11 | DDB1- and CUL4-associated factor 7 | 10238.0 | ENSG00000136485 | nan | nan
chr17	TACO1	612958.0 | TACO1, CCDC44, MC4DN8 | Translational activator of mitochondrially encoded cytochrome c oxidase subunit I | 51204.0 | ENSG00000136463 | nan | Mitochondrial complex IV deficiency, nuclear type 8, 619052 (3), Autosomal recessive
chr17	MAP3K3	602539.0 | MAP3K3, MEKK3, MAPKKK3 | Mitogen-activated kinase kinase kinase 3 | 4215.0 | ENSG00000198909 | nan | nan
chr17	STRADA	608626.0 | STRADA, STRAD, LYK5 | STE20-related kinase adaptor alpha | 92335.0 | ENSG00000266173 | nan | Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3), Autosomal recessive
chr17	CCDC47	618260.0 | CCDC47, THNS | Coiled-coil domain-containing protein 47 | 57003.0 | ENSG00000108588 | nan | Trichohepatoneurodevelopmental syndrome, 618268 (3), Autosomal recessive
chr17	DDX42	613369.0 | DDX42, RHELP | DEAD-box helicase 42 | 11325.0 | ENSG00000198231 | nan | nan
chr17	FTSJ3	618411.0 | FTSJ3 | FTSJ RNA 2-prime-O-methyltransferase 3 | 117246.0 | ENSG00000108592 | nan | nan
chr17	PSMC5	601681.0 | PSMC5, TRIP1 | Proteasome (prosome, macropain) 26S subunit, ATPase, 5 | 5705.0 | ENSG00000087191 | nan | nan
chr17	SMARCD2	601736.0 | SMARCD2, BAF60B, SGD2 | SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2 | 6603.0 | ENSG00000108604 | nan | Specific granule deficiency 2, 617475 (3), Autosomal recessive
chr17	TCAM1P	612756.0 | TCAM1P, TCAM1 | Testicular cell adhesion molecule 1, pseudogene | 146771.0 | ENSG00000293480 | nan | nan
chr17	CSH2	118820.0 | CSH2, CSB | Chorionic somatomammotropin B | 1443.0 | ENSG00000213218 | nan | nan
chr17	GH2	139240.0 | GH2, GHV | Growth hormone-2 | 2689.0 | ENSG00000136487 | nan | nan
chr17	CSH1	150200.0 | CSH1, CSA, PL | Chorionic somatomammotropin hormone-1 | 1442.0 | ENSG00000136488 | nan | [Placental lactogen deficiency] (1)
chr17	CSHL1	603515.0 | CSHL1, CSL | Chorionic somatomammotropin hormone-like 1 | 1444.0 | ENSG00000204414 | nan | nan
chr17	GH1	139250.0 | GH1, GHN, IGHD1A, IGHD1B, IGHD2 | Growth hormone-1 | 2688.0 | ENSG00000259384 | 5'-GH1-CSHP1-CSH1-GH2-CSH2-3' | Kowarski syndrome, 262650 (3), Autosomal recessive; Growth hormone deficiency, isolated, type II, 173100 (3), Autosomal dominant; Growth hormone deficiency, isolated, type IB, 612781 (3); Growth hormone deficiency, isolated, type IA, 262400 (3), Autosomal recessive
chr17	CD79B	147245.0 | CD79B, IGB, B29, AGM6 | CD79B antigen | 974.0 | ENSG00000007312 | nan | Agammaglobulinemia 6, 612692 (3), Autosomal recessive
chr17	SCN4A	603967.0 | SCN4A, HYPP, NAC1A, HOKPP2, CMS16, CMYO22A | Sodium voltage-gated channel, alpha subunit 4 | 6329.0 | ENSG00000007314 | 21.5kb from GH1 | Paramyotonia congenita, 168300 (3), Autosomal dominant; Hyperkalemic periodic paralysis, 170500 (3), Autosomal dominant; Congenital myopathy 22B, severe fetal, 620369 (3), Autosomal recessive; Hypokalemic periodic paralysis, type 2, 613345 (3), Autosomal dominant; Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3), Autosomal dominant; Myasthenic syndrome, congenital, 16, 614198 (3), Autosomal recessive; Congenital myopathy 22A, classic, 620351 (3), Autosomal recessive
chr17	ICAM2	146630.0 | ICAM2 | Intercellular adhesion molecule-2 | 3384.0 | ENSG00000108622 | nan | nan
chr17	ERN1	604033.0 | ERN1, IRE1, IRE1A | Endoplasmic reticulum-to-nucleus signaling 1 | 2081.0 | ENSG00000178607 | nan | nan
chr17	TEX2	619929.0 | TEX2, KIAA1738 | Testis-expressed gene 2 | 55852.0 | ENSG00000136478 | nan | nan
chr17	PECAM1	173445.0 | PECAM1 | Platelet/endothelial cell adhesion molecule (CD31 antigen) | 5175.0 | ENSG00000261371 | nan | nan
chr17	POLG2	604983.0 | POLG2, POLGB, PEOA4, MTDPS16A, MTDPS16B | Polymerase, DNA, gamma-2 | 11232.0 | ENSG00000256525 | mutation identified in 1 MTDPS16A patient and 1 MTDPS16B patient | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3), Autosomal dominant; ?Mitochondrial DNA depletion syndrome 16 (hepatic type), 618528 (3), Autosomal recessive; ?Mitochondrial DNA depletion syndrome 16B (neuroophthalmic type), 619425 (3), Autosomal recessive
chr17	DDX5	180630.0 | DDX5, HLR1, G17P1 | DEAD-box helicase 5 | 1655.0 | ENSG00000108654 | near BRCA1 | nan
chr17	SMURF2	605532.0 | SMURF2 | SMAD-specific E3 ubiquitin protein ligase 2 | 64750.0 | ENSG00000108854 | nan | nan
chr17	CCA1	115660.0 | CTRCT7, CCA1 | Cataract 7 | 878.0 | nan | nan | Cataract 7, 115660 (2), Autosomal dominant
chr17		616425.0 | SRXY10 | 46,XY sex reversal 10 | nan | nan | deletion of 32.5kb XYSR regulatory region upstream of SOX9 | 46XY sex reversal 10, 616425 (4), Autosomal dominant
chr17	LRRC37A3	616557.0 | LRRC37A3 | Leucine-rich repeat-containing protein 37A3 | 374819.0 | ENSG00000176809 | nan | nan
chr17	GNA13	604406.0 | GNA13 | Guanine nucleotide-binding protein, alpha-13 | 10672.0 | ENSG00000120063 | nan | nan
chr17	RGS9	604067.0 | RGS9, PERRS1 | Regulator of G protein signaling 9 | 8787.0 | ENSG00000108370 | nan | Prolonged electroretinal response suppression 1, 608415 (3), Autosomal recessive
chr17	AXIN2	604025.0 | AXIN2, ODCRCS | Axis inhibitor 2 (conductin, mouse, homolog of) | 8313.0 | ENSG00000168646 | nan | Colorectal cancer, somatic, 114500 (3); Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant
chr17	CEP112	618980.0 | CEP112, CCDC46, MACOCO, SPGF44 | Centrosomal protein, 112kD | 201134.0 | ENSG00000154240 | nan | Spermatogenic failure 44, 619044 (3), Autosomal recessive
chr17		135400.0 | HTGH, DEL17q24 | Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (chromosome 17q24 microdeletion syndrome) | nan | nan | nan | Hypertrichosis terminalis, generalized, with or without gingival hyperplasia, 135400 (4), Autosomal recessive
chr17	APOH	138700.0 | APOH | Apolipoprotein H (beta-2-glycoprotein I) | 350.0 | ENSG00000091583 | nan | nan
chr17	PRKCA	176960.0 | PRKCA, PKCA | Protein kinase C, alpha polypeptide | 5578.0 | ENSG00000154229 | cen-COL1A1-PKCA-GH1 | Pituitary tumor, invasive (3)
chr17	CACNG5	606405.0 | CACNG5 | Calcium channel, voltage-dependent, gamma-5 subunit | 27091.0 | ENSG00000075429 | nan | nan
chr17	CACNG4	606404.0 | CACNG4 | Calcium channel, voltage-dependent, gamma-4 subunit | 27092.0 | ENSG00000075461 | nan | nan
chr17	CACNG1	114209.0 | CACNG1, CACNLG | Calcium channel, voltage-dependent, gamma-1 subunit | 786.0 | ENSG00000108878 | nan | nan
chr17	HELZ	606699.0 | HELZ, KIAA0054, HUMORF5 | Helicase with zinc finger domain | 9931.0 | ENSG00000198265 | nan | nan
chr17	PSMD12	604450.0 | PSMD12, P55, STISS | Proteasome 26S subunit, non-ATPase, 12 | 5718.0 | ENSG00000197170 | nan | Stankiewicz-Isidor syndrome, 617516 (3), Autosomal dominant
chr17	PITPNC1	605134.0 | PITPNC1, RDGBB | Phosphatidylinositol transfer protein, cytoplasmic, 1 | 26207.0 | ENSG00000154217 | nan | nan
chr17	NOL11	615366.0 | NOL11 | Nucleolar protein 11 | 25926.0 | ENSG00000130935 | nan | nan
chr17	BPTF	601819.0 | BPTF, FALZ, FAC1, NURF301, NEDDFL | Bromodomain PHD finger transcription factor | 2186.0 | ENSG00000171634 | nan | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3), Autosomal dominant; {Kaposi sarcoma, susceptibility to}, 148000 (3), Autosomal dominant
chr17	KPNA2	600685.0 | KPNA2, RCH1, QIP2 | Karyopherin alpha-2 | 3838.0 | ENSG00000182481 | nan | nan
chr17	AMZ2	615169.0 | AMZ2 | Archaelysin family metallopeptidase 2 | 51321.0 | ENSG00000196704 | nan | nan
chr17	ARSG	610008.0 | ARSG, KIAA1001, USH4 | Arylsulfatase G | 22901.0 | ENSG00000141337 | nan | Usher syndrome, type IV, 618144 (3), Autosomal recessive
chr17	SLC16A6	603880.0 | SLC16A6, MCT7 | Solute carrier family 16 (monocarboxylic acid transporter) member 6 | 9120.0 | ENSG00000108932 | nan | nan
chr17	PRKAR1A	188830.0 | PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1 | Protein kinase, cAMP-dependent, regulatory, type I, alpha | 5573.0 | ENSG00000108946 | fused with RET to form PTC2 | Pigmented nodular adrenocortical disease, primary, 1, 610489 (3), Autosomal dominant; Acrodysostosis 1, with or without hormone resistance, 101800 (3), Autosomal dominant; Adrenocortical tumor, somatic (3); Carney complex, type 1, 160980 (3), Autosomal dominant; Myxoma, intracardiac, 255960 (3), Autosomal dominant
chr17	WIPI1	609224.0 | WIPI1, WIPI49 | WD40 repeat protein interacting with phosphoinositides 1 | 55062.0 | ENSG00000070540 | nan | nan
chr17	FAM20A	611062.0 | FAM20A, AIGFS, AI1G | Family with sequence similarity 20, member A | 54757.0 | ENSG00000108950 | nan | Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3), Autosomal recessive
chr17	ABCA8	612505.0 | ABCA8, KIAA0822 | ATP-binding cassette, subfamily A, member 8 | 10351.0 | ENSG00000141338 | nan | nan
chr17	ABCA9	612507.0 | ABCA9 | ATP-binding cassette, subfamily A, member 9 | 10350.0 | ENSG00000154258 | nan | nan
chr17	ABCA6	612504.0 | ABCA6 | ATP-binding cassette, subfamily A, member 6 | 23460.0 | ENSG00000154262 | nan | nan
chr17	PRBNS	261800.0 | PRBNS | Pierre Robin syndrome | 100301572.0 | nan | between D17S795 and D17S929 | Pierre Robin syndrome, 261800 (2), Autosomal recessive
chr17		278850.0 | SRXX2, DUP17q24.3 | 46XX sex reversal 2 | nan | nan | duplication or triplication of 68kb XXSR regulatory region upstream of SOX9 | 46XX sex reversal 2, 278850 (4), Autosomal dominant
chr17	TTPP3	614834.0 | TTPP3 | Thyrotoxic periodic paralysis, susceptibility to, 3 | 112272595.0 | nan | associated with rs312691 | {Thyrotoxic periodic paralysis, susceptibility to, 3}, 614834 (2)
chr17	ABCA10	612508.0 | ABCA10 | ATP-binding cassette, subfamily A, member 10 | 10349.0 | ENSG00000154263 | nan | nan
chr17	ABCA5	612503.0 | ABCA5, KIAA1888, HTC3 | ATP-binding cassette, subfamily A, member 5 | 23461.0 | ENSG00000154265 | mutation identified in 1 HTC3 patient | ?Hypertrichosis, congenital generalized, with gingival hyperplasia, 135400 (3), Autosomal recessive
chr17	MAP2K6	601254.0 | MAP2K6, PRKMK6, MKK6, MEK6, MAPKK6 | Mitogen-activated protein kinase kinase 6 | 5608.0 | ENSG00000108984 | nan | nan
chr17	KCNJ16	605722.0 | KCNJ16, KIR5.1, HKTD | Potassium channel, inwardly rectifying, subfamily J, member 16 | 3773.0 | ENSG00000153822 | nan | Hypokalemic tubulopathy and deafness, 619406 (3), Autosomal recessive
chr17	KCNJ2	600681.0 | KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9 | Potassium channel, inwardly rectifying, subfamily J, member 2 | 3759.0 | ENSG00000123700 | nan | Atrial fibrillation, familial, 9, 613980 (3), Autosomal dominant; Andersen syndrome, 170390 (3), Autosomal dominant; Short QT syndrome 3, 609622 (3), Autosomal dominant
chr17	SOX9	608160.0 | SOX9, CMD1, SRA1 | SRY (sex-determining region Y)-box 9 | 6662.0 | ENSG00000125398 | nan | Campomelic dysplasia with autosomal sex reversal, 114290 (3), Autosomal dominant; Acampomelic campomelic dysplasia, 114290 (3), Autosomal dominant; Campomelic dysplasia, 114290 (3), Autosomal dominant
chr17	LINC00673	617079.0 | LINC00673, HILNC75, SLNCR, LUCAIR1 | Long intergenic noncoding RNA 673 | 100499467.0 | ENSG00000227036 | nan | nan
chr17	SLC39A11	616508.0 | SLC39A11, ZIP11, C17orf26 | Solute carrier family 39 (zinc transporter), member 11 | 201266.0 | ENSG00000133195 | nan | nan
chr17		602197.0 | CDR3 | Cerebellar degeneration-related autoantigen-3 | 8163.0 | nan | nan | nan
chr17		603411.0 | EPR1 | Effector cell protease receptor 1 | nan | nan | nan | nan
chr17	NDNC9	614149.0 | NDNC9 | Nail disorder, nonsyndromic congenital, 9 (anonychia-onycholysis) | 100682325.0 | nan | max lod at D17S1301 | Nail disorder, nonsyndromic congenital, 9, 614149 (2), Autosomal recessive
chr17	SSTR2	182452.0 | SSTR2 | Somatostatin receptor-2 | 6752.0 | ENSG00000180616 | nan | nan
chr17	COG1	606973.0 | COG1, LDLB, KIAA1381, CDG2G | Component of oligomeric golgi complex 1 | 9382.0 | ENSG00000166685 | nan | Congenital disorder of glycosylation, type IIg, 611209 (3), Autosomal recessive
chr17	MTNAP1	620717.0 | MTNAP1, C17orf80 | Mitochondrial nucleoid-associated protein 1 | 55028.0 | ENSG00000141219 | nan | nan
chr17	CDC42EP4	605468.0 | CDC42EP4, BORG4 | CDC42 effector protein 4 (binder of Rho GTPases 4) | 23580.0 | ENSG00000179604 | nan | nan
chr17	SDK2	607217.0 | SDK2, KIAA1514 | Sidekick cell adhesion molecule 2 | 54549.0 | ENSG00000069188 | nan | nan
chr17	RPL38	604182.0 | RPL38 | Ribosomal protein L38 | 6169.0 | ENSG00000172809 | nan | nan
chr17	TTYH2	608855.0 | TTYH2 | Tweety family member 2 | 94015.0 | ENSG00000141540 | nan | nan
chr17	DNAI2	605483.0 | DNAI2, CILD9 | Dynein, axonemal, intermediate chain 2 | 64446.0 | ENSG00000171595 | nan | Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3), Autosomal recessive
chr17	KIF19	619610.0 | KIF19 | Kinesin family member 19 | 124602.0 | ENSG00000196169 | nan | nan
chr17	GPR142	609046.0 | GPR142, PGR2 | G protein-coupled receptor 142 | 350383.0 | ENSG00000257008 | nan | nan
chr17	GPRC5C	605949.0 | GPRC5C, RAIG3 | G protein-coupled receptor, family C, group 5, member C | 55890.0 | ENSG00000170412 | nan | nan
chr17	CD300A	606790.0 | CMRF35H, CMRF35H9 | CMRF35H antigen | 11314.0 | ENSG00000167851 | nan | nan
chr17	CD300LB	610705.0 | CD300LB, TREM5, IREM3 | CD300 antigen-like family, member B | 124599.0 | ENSG00000178789 | nan | nan
chr17	CD300C	606786.0 | CMRF35, CMRF35A | CMRF35 antigen | 10871.0 | ENSG00000167850 | nan | nan
chr17	CD300H	616560.0 | CD300H | CD300H antigen | 100130520.0 | ENSG00000284690 | nan | nan
chr17	CD300LD	616301.0 | CD300LD, CD300D | CD300 antigen-like family, member D | 100131439.0 | ENSG00000204345 | nan | nan
chr17	CD300E	609801.0 | CD300E, CD300LE, IREM2, CLM2 | CD300E antigen | 342510.0 | ENSG00000186407 | nan | nan
chr17	RAB37	609956.0 | RAB37 | Pas-associated protein RAB37 | 326624.0 | ENSG00000172794 | nan | nan
chr17	CD300LF	609807.0 | CD300LF, IGSF13, IREM1, CLM1 | CD300 antigen-like family, member F | 146722.0 | ENSG00000186074 | nan | nan
chr17	NHERF1	604990.0 | SLC9A3R1, EBP50, NHERF1, NPHLOP2 | Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 1 | 9368.0 | ENSG00000109062 | nan | Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3), Autosomal dominant
chr17	NAT9	620913.0 | NAT9 | N-acetyltransferase 9 | 26151.0 | ENSG00000109065 | nan | nan
chr17	GRIN2C	138254.0 | GRIN2C, NMDAR2C | Glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 2905.0 | ENSG00000161509 | nan | nan
chr17	FDXR	103270.0 | FDXR, ADXR, ANOA, MMDS9B | Ferredoxin reductase (adrenodoxin reductase) | 2232.0 | ENSG00000161513 | nan | Multiple mitochondrial dysfunctions syndrome 9B, 620887 (3); Auditory neuropathy and optic atrophy, 617717 (3), Autosomal recessive
chr17	FADS6	620577.0 | FADS6 | Fatty acid desaturase 6 | 283985.0 | ENSG00000172782 | nan | nan
chr17	USH1G	607696.0 | USH1G, SANS | USH1 protein network component SANS | 124590.0 | ENSG00000182040 | ?allelic to DFNA20 | Usher syndrome, type 1G, 606943 (3), Autosomal recessive
chr17	OTOP2	607827.0 | OTOP2 | Otopetrin 2 | 92736.0 | ENSG00000183034 | nan | nan
chr17	OTOP3	607828.0 | OTOP3 | Otopetrin 3 | 347741.0 | ENSG00000182938 | nan | nan
chr17	HID1	605752.0 | HID1, 17orf28, DMC1, DEE105 | HID1 domain-containing protein 1 | 283987.0 | ENSG00000167861 | nan | Developmental and epileptic encephalopathy 105 with hypopituitarism, 619983 (3), Autosomal recessive
chr17	MRPL58	603000.0 | MRPL58, ICT1, DS1 | Mitochondrial ribosomal protein L58 | 3396.0 | ENSG00000167862 | nan | nan
chr17	KCTD2	613422.0 | KCTD2, KIAA0176 | Potassium channel tetramerization domain-containing 2 | 23510.0 | ENSG00000180901 | nan | nan
chr17	ATP5PD	618121.0 | ATP5PD, APT5H | ATP synthase, peripheral stalk, subunit D | 10476.0 | ENSG00000167863 | nan | nan
chr17	SLC16A5	603879.0 | SLC16A5, MCT6 | Solute carrier family 16 (monocarboxylic acid transporter) member 5 | 9121.0 | ENSG00000170190 | nan | nan
chr17	NT5C	191720.0 | NT5C, UMPH2, DNT1 | 5', 3' nucleotidase, cytosolic | 30833.0 | ENSG00000125458 | nan | nan
chr17	JPT1	619242.0 | JPT1, HN1 | Jupiter microtubule-associated homolog 1 | 51155.0 | ENSG00000189159 | pseudogene on chr.2 | nan
chr17	SUMO2	603042.0 | SUMO2, SMT3B | Small ubiquitin-like modifier 2 | 6613.0 | ENSG00000188612 | nan | nan
chr17	NUP85	170285.0 | NUP85, PCNT1, PCNT, NPHS17 | Nucleoporin 85kD | 79902.0 | ENSG00000125450 | nan | Nephrotic syndrome, type 17, 618176 (3), Autosomal recessive
chr17	MRPS7	611974.0 | MRPS7, COXPD34 | Mitochondrial ribosomal protein S7 | 51081.0 | ENSG00000125445 | mutation identified in 1 COXPD34 family | ?Combined oxidative phosphorylation deficiency 34, 617872 (3), Autosomal recessive
chr17	GGA3	606006.0 | GGA3, KIAA0154 | Golgi associated, gamma adaptin ear containing, ARF binding protein 3 | 23163.0 | ENSG00000125447 | nan | nan
chr17	MIF4GD	612072.0 | MIF4GD, SLIP1 | MIF4G domain-containing protein | 57409.0 | ENSG00000125457 | nan | nan
chr17	SLC25A19	606521.0 | SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4 | Solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19 | 60386.0 | ENSG00000125454 | nan | Microcephaly, Amish type, 607196 (3), Autosomal recessive; Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3), Autosomal recessive
chr17	GRB2	108355.0 | GRB2 | Growth factor receptor-bound protein 2 | 2885.0 | ENSG00000177885 | nan | nan
chr17	TMEM94	618163.0 | TMEM94, KIAA0195, IDDCDF | Transmembrane protein 94 | 9772.0 | ENSG00000177728 | nan | Intellectual developmental disorder with cardiac defects and dysmorphic facies, 618316 (3), Autosomal recessive
chr17	CASKIN2	612185.0 | CASKIN2, KIAA1139 | CASK-interacting protein 2 | 57513.0 | ENSG00000177303 | nan | nan
chr17	TSEN54	608755.0 | TSEN54, SEN54, PCH2A, PCH4, PCH5 | tRNA splicing endonuclease, subunit 54 | 283989.0 | ENSG00000182173 | mutation identified in 1 PCH5 patient | Pontocerebellar hypoplasia type 2A, 277470 (3), Autosomal recessive; Pontocerebellar hypoplasia type 4, 225753 (3), Autosomal recessive; ?Pontocerebellar hypoplasia type 5, 610204 (3), Autosomal recessive
chr17	LLGL2	618483.0 | LLGL2 | LLGL scribble cell polarity complex component 2 | 3993.0 | ENSG00000073350 | nan | nan
chr17	MYO15B	620915.0 | MYO15B | Myosin XVB | 80022.0 | ENSG00000266714 | nan | nan
chr17	RECQL5	603781.0 | RECQL5, RECQ5 | DNA helicase, RecQ-like 5 | 9400.0 | ENSG00000108469 | nan | nan
chr17	ERLN	620531.0 | SMIM6, ELN | Small integral membrane protein 6 | 100130933.0 | ENSG00000259120 | nan | nan
chr17	SAP30BP	610218.0 | SAP30BP, HTRP, HCNGP, HTRG | SAP30-binding protein | 29115.0 | ENSG00000161526 | nan | nan
chr17	ITGB4	147557.0 | ITGB4, JEB5B, JEB5A | Integrin, beta-4 | 3691.0 | ENSG00000132470 | nan | Epidermolysis bullosa, junctional 5B, with pyloric atresia, 226730 (3), Autosomal recessive; Epidermolysis bullosa, junctional 5A, intermediate, 619816 (3), Autosomal recessive
chr17	GALK1	604313.0 | GALK1 | Galactokinase-1 | 2584.0 | ENSG00000108479 | nan | Galactokinase deficiency with cataracts, 230200 (3), Autosomal recessive
chr17	H3-3B	601058.0 | H3-3B, H3F3B, BRYLIB2 | H3.3 histone B | 3021.0 | ENSG00000132475 | nan | Bryant-Li-Bhoj neurodevelopmental syndrome 2, 619721 (3), Autosomal dominant
chr17	UNK	616375.0 | UNK, UNKEMPT, ZC3H5, KIAA1753 | Unkempt family zinc finger protein | 85451.0 | ENSG00000132478 | nan | nan
chr17	UNC13D	608897.0 | UNC13D, MUNC13-4, HPLH3, HLH3, FHL3 | unc-13 homolog D | 201294.0 | ENSG00000092929 | nan | Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3), Autosomal recessive
chr17	WBP2	606962.0 | WBP2, DFNB107 | WW domain-binding protein 2 | 23558.0 | ENSG00000132471 | nan | Deafness, autosomal recessive 107, 617639 (3), Autosomal recessive
chr17	TRIM47	611041.0 | TRIM47, GOA | Tripartite motif-containing protein 47 | 91107.0 | ENSG00000132481 | nan | nan
chr17	TRIM65	619408.0 | TRIM65 | Tripartite motif-containing protein 65 | 201292.0 | ENSG00000141569 | nan | nan
chr17	MRPL38	611844.0 | MRPL38 | Mitochondrial ribosomal protein L38 | 64978.0 | ENSG00000204316 | nan | nan
chr17	FBF1	616807.0 | FGF1, ALB | FAS-binding factor 1 | 85302.0 | ENSG00000188878 | nan | nan
chr17	ACOX1	609751.0 | ACOX1, ACOX, SCOX, MITCH | Acyl-Coenzyme A oxidase 1, palmitoyl | 51.0 | ENSG00000161533 | nan | Mitchell syndrome, 618960 (3), Autosomal dominant; Peroxisomal acyl-CoA oxidase deficiency, 264470 (3), Autosomal recessive
chr17	TEN1	613130.0 | TEN1, C17orf106 | TEN1, CST complex subunit | 100134934.0 | ENSG00000257949 | nan | nan
chr17	CDK3	123828.0 | CDK3 | Cyclin-dependent kinase 3 | 1018.0 | ENSG00000250506 | distal to BRCA1 | nan
chr17	EVPL	601590.0 | EVPL | Envoplakin | 2125.0 | ENSG00000167880 | nan | nan
chr17	SRP68	604858.0 | SRP68, SCN10 | Signal recognition particle, 68kD | 6730.0 | ENSG00000167881 | mutation identified in 1 SCN10 patient | ?Neutropenia, severe congenital, 10, autosomal recessive, 620534 (3), Autosomal recessive
chr17	GALR2	603691.0 | GALR2, GALNR2 | Galanin receptor 2 | 8811.0 | ENSG00000182687 | nan | nan
chr17	ZACN	610935.0 | ZACN, LGICZ1, ZAC, L2 | Zinc activated ion channel | 353174.0 | ENSG00000186919 | nan | nan
chr17	EXOC7	608163.0 | EXOC7, EX070, KIAA1067, NEDSEBA | Exocyst complex component 7 | 23265.0 | ENSG00000182473 | nan | Neurodevelopmental disorder with seizures and brain atrophy, 619072 (3), Autosomal recessive
chr17	FOXJ1	602291.0 | FOXJ1, FKHL13, HFH4, CILD43 | Forkhead box J1 | 2302.0 | ENSG00000129654 | nan | Ciliary dyskinesia, primary, 43, 618699 (3), Autosomal dominant
chr17	QRICH2	618304.0 | QRICH2, SPGF35 | Glutamine-rich protein 2 | 84074.0 | ENSG00000129646 | nan | Spermatogenic failure 35, 618341 (3), Autosomal recessive
chr17	PRPSAP1	601249.0 | PRPSAP1 | Phosphoribosyl pyrophosphate synthetase-associated protein-1 | 5635.0 | ENSG00000161542 | nan | nan
chr17	SPHK1	603730.0 | SPHK1 | Sphingosine kinase | 8877.0 | ENSG00000176170 | nan | nan
chr17	UBE2O	617649.0 | UBE2O, KIAA1734 | Ubiquitin-conjugating enzyme E2 O | 63893.0 | ENSG00000175931 | nan | nan
chr17	AANAT	600950.0 | AANAT, SNAT | Arylalkylamine N-acetyltransferase | 15.0 | ENSG00000129673 | nan | nan
chr17	RHBDF2	614404.0 | RHBDF2, IRHOM2, TOC | Rhomboid 5, Drosophila, homolog of, 2 | 79651.0 | ENSG00000129667 | nan | Tylosis with esophageal cancer, 148500 (3), Autosomal dominant
chr17	CYGB	608759.0 | CYGB, HGB, STAP | Cytoglobin | 114757.0 | ENSG00000161544 | nan | nan
chr17	PRCD	610598.0 | PRCD, RP36 | Photoreceptor disc component | 768206.0 | ENSG00000214140 | nan | Retinitis pigmentosa 36, 610599 (3)
chr17	ST6GALNAC2	610137.0 | ST6GALNAC2, SIAT7B, SAITL1 | ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 | 10610.0 | ENSG00000070731 | nan | nan
chr17	ST6GALNAC1	610138.0 | ST6GALNAC1, SIAT7A, STYI | ST6 alpha-N-aetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | 55808.0 | ENSG00000070526 | nan | nan
chr17	JMJD6	604914.0 | JMJD6, PSR | Jumonji domain containing 6 (phosphatidylserine receptor) | 23210.0 | ENSG00000070495 | nan | nan
chr17	METTL23	615262.0 | METTL23, C17orf95, MRT44 | Methyltransferase-like 23 | 124512.0 | ENSG00000181038 | nan | Intellectual developmental disorder, autosomal recessive 44, 615942 (3), Autosomal recessive
chr17	SRSF2	600813.0 | SRSF2, SFRS2, SC35 | Serine/arginine-rich splicing factor 2 | 6427.0 | ENSG00000161547 | nan | nan
chr17	MFSD11	620346.0 | MFSD11 | Major facilitator superfamily domain-containing protein 11 | 79157.0 | ENSG00000092931 | nan | nan
chr17	MGAT5B	612441.0 | MGAT5B | Alpha-1,6-mannosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase isozyme B | 146664.0 | ENSG00000167889 | nan | nan
chr17	SNHG20	620555.0 | SNHG20, LINC00338 | Small nucleolar RNA host gene 20 | 654434.0 | ENSG00000234912 | nan | nan
chr17	SEC14L1	601504.0 | SEC14L | SEC14-like lipid-binding protein 1 | 6397.0 | ENSG00000129657 | nan | nan
chr17		605805.0 | ATOD4 | Dermatitis, atopic, 4 | nan | nan | maximum lod at D17S1290 | {Dermatitis, atopic, susceptibility to, 4}, 605805 (2)
chr17	IS5	612239.0 | IS5 | Scoliosis, idiopathic, susceptibility to, 5 | 100190985.0 | nan | between D17S1806 and 17qter | {Scoliosis, idiopathic, susceptibility to, 5}, 612239 (2)
chr17	SEPTIN9	604061.0 | SEPT9, MSF, MSF1, NAPB | Septin 9 | 10801.0 | ENSG00000184640 | nan | Amyotrophy, hereditary neuralgic, 162100 (3), Autosomal dominant
chr17	TNRC6C	610741.0 | TNRC6C, KIAA1582 | Trinucleotide repeat-containing gene 6C | 57690.0 | ENSG00000078687 | nan | nan
chr17	TMC6	605828.0 | TMC6, EVER1, EV1 | Transmembrane channel-like 6 | 11322.0 | ENSG00000141524 | nan | {Epidermodysplasia verruciformis, susceptibility to, 1}, 226400 (3), Autosomal recessive
chr17	TMC8	605829.0 | TMC8, EVER2, EV2 | Transmembrane channel-like 8 | 147138.0 | ENSG00000167895 | nan | {Epidermodysplasia verruciformis, susceptibility to, 2}, 618231 (3), Autosomal recessive
chr17	SYNGR2	603926.0 | SYNGR2 | Synaptogyrin 2 | 9144.0 | ENSG00000108639 | pseudogene on 15q11; near EV1, EV2, TK1 | nan
chr17	TK1	188300.0 | TK1 | Thymidine kinase-1 | 7083.0 | ENSG00000167900 | nan | nan
chr17	BIRC5	603352.0 | BIRC5, API4 | Baculoviral IAP repeat-containing protein 5 | 332.0 | ENSG00000089685 | nan | nan
chr17	TMEM235	620272.0 | TMEM235 | Transmembrane protein 235 | 283999.0 | ENSG00000204278 | nan | nan
chr17	SOCS3	604176.0 | SOCS3, SSI3, CIS3 | Suppressor of cytokine signaling 3 | 9021.0 | ENSG00000184557 | nan | nan
chr17	PGS1	614942.0 | PGS1 | Phosphatidylglycerophosphate synthase 1 | 9489.0 | ENSG00000087157 | nan | nan
chr17	DNAH17	610063.0 | DNAH17, DNEL2, SPGF39 | Dynein, axonemal, heavy chain 17 | 8632.0 | ENSG00000187775 | nan | Spermatogenic failure 39, 618643 (3), Autosomal recessive
chr17	CYTH1	182115.0 | CYTH1, D17S811E, SEC7 | Cytohesin 1 | 9267.0 | ENSG00000108669 | nan | nan
chr17	USP36	612543.0 | USP36, KIAA1453 | Ubiquitin-specific protease 36 | 57602.0 | ENSG00000055483 | nan | nan
chr17	TIMP2	188825.0 | TIMP2 | Tissue inhibitor of metalloproteinase-2 | 7077.0 | ENSG00000035862 | nan | nan
chr17	LGALS3BP	600626.0 | LGALS3BP | Lectin, galactoside-binding, soluble, 3 binding protein (galectin 6 binding protein) | 3959.0 | ENSG00000108679 | nan | nan
chr17	CANT1	613165.0 | CANT1, SCAN1, DBQD1, EDM7 | Calcium-activated nucleotidase 1 | 124583.0 | ENSG00000171302 | nan | Desbuquois dysplasia 1, 251450 (3), Autosomal recessive; Epiphyseal dysplasia, multiple, 7, 617719 (3), Autosomal recessive
chr17	C1QTNF1	610365.0 | C1QTNF1, GIP | C1q- and tumor necrosis factor-related protein 1 | 114897.0 | ENSG00000173918 | nan | nan
chr17	ENGASE	611898.0 | NAGLUEB, FLJ21865 | N-acetylglucosaminidase, endo-beta | 64772.0 | ENSG00000167280 | nan | nan
chr17	RBFOX3	616999.0 | RBFOX3, FOX3, NEUN, HRNBP3 | RNA-binding protein FOX1, C. Elegans, homolog of, 3 | 146713.0 | ENSG00000167281 | nan | nan
chr17	ENPP7	616997.0 | ENPP7 | Ectonucleotide pyrophosphatase/phosphodiesterase 7 | 339221.0 | ENSG00000182156 | nan | nan
chr17	CBX2	602770.0 | CBX2, M33, SRXY5 | Chromobox 2 | 84733.0 | ENSG00000173894 | mutation identified in 1 SRXY5 patient | ?46XY sex reversal 5, 613080 (3), Autosomal recessive
chr17	CBX8	617354.0 | CBX8, PC3 | Chromobox 8 | 57332.0 | ENSG00000141570 | nan | nan
chr17	CBX4	603079.0 | CBX4, PC2 | Chromobox 4 | 8535.0 | ENSG00000141582 | nan | nan
chr17	TBC1D16	616637.0 | TBC1D16 | TBC1 domain family, member 16 | 125058.0 | ENSG00000167291 | nan | nan
chr17	CCDC40	613799.0 | CCDC40, KIAA1640 | Coiled-coil domain-containing protein 40 | 55036.0 | ENSG00000141519 | nan | Ciliary dyskinesia, primary, 15, 613808 (3), Autosomal recessive
chr17	GAA	606800.0 | GAA | Glucosidase, acid alpha- | 2548.0 | ENSG00000171298 | distal to TK1 | Glycogen storage disease II, 232300 (3), Autosomal recessive
chr17	EIF4A3	608546.0 | EIF4A3, DDX48, MUK34, NMP265, KIAA0111, RCPS | Eukaryotic translation initiation factor 4A3 | 9775.0 | ENSG00000141543 | nan | Robin sequence with cleft mandible and limb anomalies, 268305 (3), Autosomal recessive
chr17	CARD14	607211.0 | CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP | Caspase recruitment domain-containing protein 14 | 79092.0 | ENSG00000141527 | nan | Psoriasis 2, 602723 (3), Autosomal dominant; Pityriasis rubra pilaris, 173200 (3), Autosomal dominant
chr17	SGSH	605270.0 | SGSH, MPS3A, SFMD | N-sulfoglucosamine sulfohydrolase (sulfamidase) | 6448.0 | ENSG00000181523 | nan | Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3), Autosomal recessive
chr17	SLC26A11	610117.0 | SLC26A11 | Solute carrier family 26 (sulfate transporter), member 11 | 284129.0 | ENSG00000181045 | nan | nan
chr17	RNF213	613768.0 | RNF213, ALO17, KIAA1618, MYMY2 | Ring finger protein 213 | 57674.0 | ENSG00000173821 | nan | {Moyamoya disease 2, susceptibility to}, 607151 (3), Autosomal recessive, Autosomal dominant
chr17	ENDOV	619821.0 | ENDOV | Endonuclease V | 284131.0 | ENSG00000173818 | nan | nan
chr17	NPTX1	602367.0 | NPTX1, NP1, SCA50 | Neuronal pentraxin 1 | 4884.0 | ENSG00000171246 | nan | Spinocerebellar ataxia 50, 620158 (3), Autosomal dominant
chr17	RPTOR	607130.0 | RPTOR, RAPTOR, KIAA1303 | Regulatory-associated protein of MTOR | 57521.0 | ENSG00000141564 | nan | nan
chr17	CHMP6	610901.0 | CHMP6 | Charged multivesicular body protein 6 | 79643.0 | ENSG00000176108 | nan | nan
chr17	BAIAP2	605475.0 | BAIAP2, IRSP53 | BAI1-associated protein 2 | 10458.0 | ENSG00000175866 | nan | nan
chr17	AATK	605276.0 | AATK, AATYK | Apoptosis-associated tyrosine kinase | 9625.0 | ENSG00000181409 | nan | nan
chr17	MIR338	614059.0 | MIR338, MIRN338 | Micro RNA 338 | 442906.0 | ENSG00000283604 | nan | nan
chr17	CEP131	613479.0 | AZI1, ZA1, KIAA1118 | 5-azacytidine-induced gene 1, mouse, homolog of | 22994.0 | ENSG00000141577 | nan | nan
chr17	NDUFAF8	618461.0 | NDUFAF8, C17orf89, MC1DN34 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 8 | 284184.0 | ENSG00000224877 | nan | Mitochondrial complex I deficiency, nuclear type 34, 618776 (3), Autosomal recessive
chr17	SLC38A10	616525.0 | SLC38A10 | Solute carrier family 38 (amino acid transporter), member 10 | 124565.0 | ENSG00000157637 | nan | nan
chr17	BAHCC1	617646.0 | BAHCC1, BAHD2, KIAA1447 | BAH domain- and coiled-coil domain-containing protein 1 | 57597.0 | ENSG00000266074 | nan | nan
chr17	ACTG1	102560.0 | ACTG1, DFNA20, DFNA26, BRWS2 | Actin, gamma-1 | 71.0 | ENSG00000184009 | nan | Deafness, autosomal dominant 20/26, 604717 (3), Autosomal dominant; Baraitser-Winter syndrome 2, 614583 (3), Autosomal dominant
chr17	FSCN2	607643.0 | FSCN2, RFSN, RP30 | Fascin, sea urchin, homolog of, 2 | 25794.0 | ENSG00000186765 | within 200kb of ACTG1 | Retinitis pigmentosa 30, 607921 (3)
chr17	FAAP100	611301.0 | C17orf70, FAAP100 | Chromosome 17 open reading frame 70 | 80233.0 | ENSG00000185504 | nan | nan
chr17	NPLOC4	606590.0 | NPL4, KIAA1499 | NPL4 homolog, ubiquitin recognition factor | 55666.0 | ENSG00000182446 | nan | nan
chr17	PDE6G	180073.0 | PDE6G, PDEG, RP57 | Phosphodiesterase 6G | 5148.0 | ENSG00000185527 | nan | Retinitis pigmentosa 57, 613582 (3), Autosomal recessive
chr17	CCDC137	614271.0 | CCDC137 | Coiled-coil domain-containing protein 137 | 339230.0 | ENSG00000185298 | nan | nan
chr17	ARL16	619117.0 | ARL16 | ADP ribosylation factor-like GTPase 16 | 339231.0 | ENSG00000214087 | nan | nan
chr17	HGS	604375.0 | HGS, HRS | Human growth factor-regulated tyrosine kinase substrate | 9146.0 | ENSG00000185359 | nan | nan
chr17	MRPL12	602375.0 | MRPL12, RPML12 | Ribosomal protein, mitochondrial, L12 | 6182.0 | ENSG00000262814 | mutation identified in 1 COXPD45 family | ?Combined oxidative phosphorylation deficiency 45, 618951 (3), Autosomal recessive
chr17	SLC25A10	606794.0 | SLC25A10, DIC, MTDPS19 | Solute carrier family 25 (mitochondrial carrier), member 10 (dicarboxylate ion carrier) | 1468.0 | ENSG00000183048 | mutation identified in 1 MTDPS19 patient | ?Mitochondrial DNA depletion syndrome 19, 618972 (3), Autosomal recessive
chr17	GCGR	138033.0 | GCGR, MVAH | Glucagon receptor | 2642.0 | ENSG00000215644 | nan | Mahvash disease, 619290 (3), Autosomal recessive
chr17	MCRIP1	616514.0 | FAM195B, MCRIP1 | Family with sequence similarity 194, member B | 348262.0 | ENSG00000225663 | nan | nan
chr17	P4HB	176790.0 | P4HB, PROHB, CLCRP1 | Procollagen-proline, 2-oxoglutarate-4-dioxygenase, beta polypeptide | 5034.0 | ENSG00000185624 | nan | Cole-Carpenter syndrome 1, 112240 (3), Autosomal dominant
chr17	ARHGDIA	601925.0 | ARHGDIA, GDIA1, NPHS8 | Rho GDP dissociation inhibitor (GDI) alpha | 396.0 | ENSG00000141522 | nan | Nephrotic syndrome, type 8, 615244 (3), Autosomal recessive
chr17	ALYREF	604171.0 | ALYREF, THOC4, ALY, BEF | ALY/REF export factor | 10189.0 | ENSG00000183684 | nan | nan
chr17	ANAPC11	614534.0 | ANAPC11, APC11 | Anaphase-promoting complex subunit 11 | 51529.0 | ENSG00000141552 | nan | nan
chr17	PCYT2	602679.0 | PCYT2, ET, SPG82 | Phosphate cytidylyltransferase 2, ethanolamine | 5833.0 | ENSG00000185813 | nan | Spastic paraplegia 82, autosomal recessive, 618770 (3), Autosomal recessive
chr17	NPB	607996.0 | NPB, PPL7 | Neuropeptide B | 256933.0 | ENSG00000183979 | nan | nan
chr17	SIRT7	606212.0 | SIRT7, SIR2L7 | Sirtuin 7 | 51547.0 | ENSG00000187531 | nan | nan
chr17	MAFG	602020.0 | MAFG | MAF bZIP transcription factor G | 4097.0 | ENSG00000197063 | nan | nan
chr17	PYCR1	179035.0 | PYCR1, PRO3, ARCL2B, ARCL3B | Pyrroline-5-carboxylate reductase-1 | 5831.0 | ENSG00000183010 | nan | Cutis laxa, autosomal recessive, type IIIB, 614438 (3), Autosomal recessive; Cutis laxa, autosomal recessive, type IIB, 612940 (3), Autosomal recessive
chr17	NOTUM	609847.0 | NOTUM | Notum, palmitoleoyl-protein carboxylesterase | 147111.0 | ENSG00000185269 | nan | nan
chr17	ASPSCR1	606236.0 | ASPSCR1, RCC17, ASPL, ASPS | Alveolar soft-part sarcoma chromosome region, candidate 1 | 79058.0 | ENSG00000169696 | t(X;17)(p11.2;q25) | Alveolar soft-part sarcoma, 606243 (3)
chr17	CENPX	615128.0 | CENPX, STRA13, CENPX, FAAP10, MHF2, D9 | Centromeric protein X | 201254.0 | ENSG00000169689 | nan | nan
chr17	RAC3	602050.0 | RAC3 | Rac family small GTPase 3 | 5881.0 | ENSG00000169750 | nan | Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies, 618577 (3), Autosomal dominant
chr17	DCXR	608347.0 | DCXR, P34H, PNTSU | Dicarbonyl/L-xylulose reductase | 51181.0 | ENSG00000169738 | nan | [Pentosuria], 260800 (3), Autosomal recessive
chr17	RFNG	602578.0 | RFNG | Radical fringe | 5986.0 | ENSG00000169733 | nan | nan
chr17	GPS1	601934.0 | GPS1 | G protein pathway suppressor 1 | 2873.0 | ENSG00000169727 | nan | nan
chr17	FASN	600212.0 | FASN | Fatty acid synthase | 2194.0 | ENSG00000169710 | nan | nan
chr17	SLC16A3	603877.0 | SLC16A3, MCT4 | Solute carrier family 16 (monocarboxylic acid transporter) member 3 | 9123.0 | ENSG00000141526 | nan | nan
chr17	CSNK1D	600864.0 | CSNK1D, ASPS, FASPS2 | Casein kinase-1, delta | 1453.0 | ENSG00000141551 | nan | Advanced sleep-phase syndrome, familial, 2, 615224 (3), Autosomal dominant
chr17	CD7	186820.0 | CD7 | CD7 antigen (p41) | 924.0 | ENSG00000173762 | nan | nan
chr17	SECTM1	602602.0 | SECTM1, K12 | Secreted and transmembrane 1 | 6398.0 | ENSG00000141574 | nan | nan
chr17	TEX19	615647.0 | TEX19 | Testis-expressed gene 19 | 400629.0 | ENSG00000182459 | nan | nan
chr17	UTS2R	600896.0 | GPR14, UTR2, UTR | G protein-coupled receptor-14 (urotensin II receptor) | 2837.0 | ENSG00000181408 | nan | nan
chr17	HEXD	616864.0 | HEXD | Hexosaminidase D | 284004.0 | ENSG00000169660 | nan | nan
chr17	CYBC1	618334.0 | CYBC1, EROS, C17orf62, CGD5 | Cytochrome b(-254) chaperone 1 | 79415.0 | ENSG00000178927 | nan | Chronic granulomatous disease 5, autosomal recessive, 618935 (3), Autosomal recessive
chr17	NARF	605349.0 | NARF, IOP2 | Nuclear prelamin A recognition factor | 26502.0 | ENSG00000141562 | nan | nan
chr17	FOXK2	147685.0 | FOXK2, ILF1 | Forkhead box K2 (interleukin enhancer-binding factor 1) | 3607.0 | ENSG00000141568 | nan | nan
chr17	WDR45B	609226.0 | WDR45B, WIPI3, WDR45L, NEDSBAS | WD repeat domain 45B | 56270.0 | ENSG00000141580 | nan | Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures, 617977 (3), Autosomal recessive
chr17	RAB40B	619550.0 | RAB40B | RAB40B, member Ras oncogene family | 10966.0 | ENSG00000141542 | nan | nan
chr17	FN3KRP	611683.0 | FN3KRP | Fructosamine 3-kinase-related protein | 79672.0 | ENSG00000141560 | nan | nan
chr17	FN3K	608425.0 | FN3K | Fructosamine 3-kinase | 64122.0 | ENSG00000167363 | nan | nan
chr17	TBCD	604649.0 | TBCD, PEBAT | Tubulin-specific chaperone D | 6904.0 | ENSG00000141556 | nan | Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3), Autosomal recessive
chr17	ZNF750	610226.0 | ZNF750, FLJ13841, SLDPE | Zinc finger protein 750 | 79755.0 | ENSG00000141579 | mutation identified in 1 SLDPE family | ?Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)
chr17	B3GNTL1	615337.0 | B3GNTL1 | Beat-1,3-N-acetylglucosaminyltransferase-like 1 | 146712.0 | ENSG00000175711 | nan | nan
chr17	METRNL	616241.0 | METRNL | Meteorin-like protein | 284207.0 | ENSG00000176845 | nan | nan
chr17		138110.0 | G6PDL | Glucose-6-phosphate dehydrogenase-like | nan | nan | nan | nan
chr17	ODS1	610064.0 | ODS1 | Opioid dependence, susceptibility to, 1 | 100188802.0 | nan | nan | {Opioid dependence, susceptibility to, 1}, 610064 (2)
chr18	AA1	104000.0 | AA1 | Alopecia areata 1 | 100034700.0 | nan | max lod at D18S967 | Alopecia areata 1, 104000 (2), Multifactorial
chr18		146390.0 | DEL18p, C18DELp | Chromosome 18p deletion syndrome | nan | nan | nan | Chromosome 18p deletion syndrome, 146390 (4), Autosomal dominant
chr18	DFNB46	609647.0 | DFNB46 | Deafness, neurosensory, autosomal recessive 46 | 449488.0 | nan | between D18S59 and D18S391 | Deafness, autosomal recessive 46, 609647 (2), Autosomal recessive
chr18	DYT15	607488.0 | DYT15 | Dystonia-15, myoclonic | 317714.0 | nan | nan | Dystonia-15, myoclonic, 607488 (2), Autosomal dominant
chr18	DYT7	602124.0 | DYT7 | Dystonia-7 (torsion dystonia, adult-onset, focal) | 1866.0 | nan | nan | Dystonia-7, torsion, 602124 (2), Autosomal dominant
chr18		131150.0 | ERV1 | Oncogene ERV1; endogenous retrovirus-1 | nan | nan | nan | nan
chr18	IBD21	612354.0 | IBD21 | Inflammatory bowel disease 21 | 100192312.0 | nan | associated with rs2542151 | {Inflammatory bowel disease 21}, 612354 (2), Autosomal dominant
chr18	MAFD1	125480.0 | MAFD1, BPAD, MD1 | Major affective disorder 1 | 4095.0 | nan | ?also 18q | {Major affective disorder 1}, 125480 (2), Autosomal dominant
chr18	MRT19	614343.0 | MRT19 | Intellectual developmental disorder, autosomal recessive 19 | 100852395.0 | nan | between rs4606805 and rs1787846 | Intellectual developmental disorder, autosomal recessive 19, 614343 (2), Autosomal recessive
chr18	POROK6	612353.0 | POROK6, DSAP4 | Porokeratosis 6 | 100196911.0 | nan | between telomere and D18S391 | Porokeratosis 6, multiple types, 612353 (2), Autosomal dominant
chr18	SCZD8	603206.0 | SCZD8 | Schizophrenia susceptibility locus, chromosome 18-related | 8806.0 | nan | nan | {Schizophrenia}, 181500 (2), Autosomal dominant
chr18		614290.0 | TET18P | Tetrasomy 18p | nan | nan | nan | Tetrasomy 18p, 614290 (4)
chr18	USP14	607274.0 | USP14, TGT | Ubiquitin-specific protease 14 | 9097.0 | ENSG00000101557 | nan | nan
chr18	THOC1	606930.0 | THOC1, HPR1, DFNA86 | THO complex 1 (nuclear matrix protein p84) | 9984.0 | ENSG00000079134 | mutation identified in 1 DFNA86 family | ?Deafness, autosomal dominant 86, 620280 (3), Autosomal dominant
chr18	COLEC12	607621.0 | COLEC12, SRCL, CLP1 | Collectin 12 | 81035.0 | ENSG00000158270 | nan | nan
chr18	CETN1	603187.0 | CETN1, CEN1 | Centrin-1 | 1068.0 | ENSG00000177143 | nan | nan
chr18	CLUL1	616990.0 | CLUL1 | Clusterin-like protein 1 | 27098.0 | ENSG00000079101 | nan | nan
chr18	TYMS	188350.0 | TYMS, TS, TMS, DKCD | Thymidylate synthase | 7298.0 | ENSG00000176890 | DKCD is digenic with C-A-ins haplotype | Dyskeratosis congenita, digenic, 620040 (3), Digenic dominant
chr18	ENOSF1	607427.0 | ENOSF1, RTS | Enolase superfamily member 1 | 55556.0 | ENSG00000132199 | nan | nan
chr18	YES1	164880.0 | YES1 | Oncogene YES-1 | 7525.0 | ENSG00000176105 | <50 kb from TYMS | nan
chr18	ADCYAP1	102980.0 | ADCYAP1 | Adenylate cyclase activating polypeptide-1 (pituitary) | 116.0 | ENSG00000141433 | nan | nan
chr18	METTL4	619626.0 | METTL4 | Methyltransferase 4, N6-adenosine | 64863.0 | ENSG00000101574 | nan | nan
chr18	NDC80	607272.0 | NDC80, KNTC2, HEC | NDC80 kinetochore complex component | 10403.0 | ENSG00000080986 | nan | nan
chr18	SMCHD1	614982.0 | SMCHD1, KIAA0650, BAMS | Structural maintenance of chromosomes flexible hinge domain-containing protein 1 | 23347.0 | ENSG00000101596 | nan | Facioscapulohumeral muscular dystrophy 2, digenic, 158901 (3), Digenic dominant; Bosma arhinia microphthalmia syndrome, 603457 (3), Autosomal dominant
chr18	EMILIN2	608928.0 | EMILIN2 | Elastin macrofibril interfacer 2 | 84034.0 | ENSG00000132205 | nan | nan
chr18	MYP2	160700.0 | MYP2 | Myopia, high grade, autosomal dominant 1 | 4658.0 | nan | nan | Myopia 2, 160700 (2), Autosomal dominant
chr18	LPIN2	605519.0 | LPIN2, MJDS, CRMO1 | Lipin 2 | 9663.0 | ENSG00000101577 | nan | Majeed syndrome, 609628 (3)
chr18	MYOM1	603508.0 | MYOM1, SKELEMIN | Myomesin 1 | 8736.0 | ENSG00000101605 | nan | nan
chr18	MYL12B	609211.0 | MYL12B, MRLC2 | Myosin, light chain 12B, regulatory | 103910.0 | ENSG00000118680 | nan | nan
chr18	TGIF1	602630.0 | TGIF1, HPE4 | TG-interacting factor 1 | 7050.0 | ENSG00000177426 | nan | Holoprosencephaly 4, 142946 (3), Autosomal dominant
chr18	DLGAP1	605445.0 | DLGAP1, DAP1, DLGAP1A, DLGAP1B | Discs large-associated protein 1 | 9229.0 | ENSG00000170579 | nan | nan
chr18	AKAIN1	616427.0 | C18orf42 | Chromosome 18 open reading frame 42 | 642597.0 | ENSG00000231824 | nan | nan
chr18	ZBTB14	602126.0 | ZFP161, ZF5 | Zinc finger protein-161 | 7541.0 | ENSG00000198081 | nan | nan
chr18	EPB41L3	605331.0 | EPB41L3, DAL1 | Erythrocyte membrane protein band 4.1-like 3 | 23136.0 | ENSG00000082397 | nan | nan
chr18	L3MBTL4	617135.0 | L3MBTL4 | L3MBTL histone methyl-lysine-binding protein 4 | 91133.0 | ENSG00000154655 | nan | nan
chr18	ARHGAP28	610592.0 | ARHGAP28, KIAA1314 | RHO GTPase-activating protein 28 | 79822.0 | ENSG00000088756 | nan | nan
chr18	LAMA1	150320.0 | LAMA1, PTBHS | Laminin, alpha-1 | 284217.0 | ENSG00000101680 | nan | Poretti-Boltshauser syndrome, 615960 (3), Autosomal recessive
chr18	ANIC	107200.0 | ANIC | Anosmia, isolated congenital | 550625.0 | nan | max lod at D18S1108 | Anosmia, isolated congenital, 107200 (2), Autosomal dominant
chr18	DYX6	606616.0 | DYX6, DYXQTL18 | Dyslexia, susceptibility to, 6 | 266691.0 | nan | nan | {Dyslexia, susceptibility to, 6}, 606616 (2)
chr18	FEB6	609253.0 | FEB6 | Febrile seizures, familial, 6 | 619397.0 | nan | max lod at D18S1158 | Febrile seizures, familial, 6, 609253 (2), Autosomal dominant
chr18	PSORS10	612410.0 | PSORS10 | Psoriasis susceptibility 10 | 503613.0 | nan | between D18S63 and D18S967 | {Psoriasis susceptibility 10}, 612410 (2)
chr18	PTPRM	176888.0 | PTPRM, PTPRL1, RPTPM | Protein tyrosine phosphatase, receptor type, mu polypeptide | 5797.0 | ENSG00000173482 | nan | nan
chr18	RAB12	616448.0 | RAB12 | Ras-associated protein RAB12 | 201475.0 | ENSG00000206418 | nan | nan
chr18	GACAT2	616131.0 | GACAT2, MTCL1AS1 | Gastric cancer-associated transcript 2, noncoding | 100287082.0 | ENSG00000265962 | nan | nan
chr18	MTCL1	615766.0 | MTCL1, KIAA0802 | Microtubule crosslinking factor 1 | 23255.0 | ENSG00000168502 | nan | nan
chr18	NDUFV2	600532.0 | NDUFV2, MC1DN7 | NADH-ubiquinone oxidoreductase core subunit V2 | 4729.0 | ENSG00000178127 | pseudogene on 19q13.3-qter | Mitochondrial complex I deficiency, nuclear type 7, 618229 (3), Autosomal recessive
chr18	ANKRD12	610616.0 | ANKRD12, ANCO1, KIAA0874 | Ankyrin repeat domain-containing protein 12 | 23253.0 | ENSG00000101745 | nan | nan
chr18	TWSG1	605049.0 | TWSG1, TSG | Twisted gastrulation BMP modulator 1 | 57045.0 | ENSG00000128791 | nan | nan
chr18	RALBP1	605801.0 | RALBP1, RLIP76 | RALA-binding protein 1 | 10928.0 | ENSG00000017797 | nan | nan
chr18	PPP4R1	604908.0 | PPP4R1, PP4R1 | Protein phosphatase 4, regulatory subunit 1 | 9989.0 | ENSG00000154845 | nan | nan
chr18	RAB31	605694.0 | RAB31 | Ras-associated protein RAB31 | 11031.0 | ENSG00000168461 | nan | nan
chr18	TXNDC2	617790.0 | TXNDC2, SPTRX1 | Thioredoxin domain-containing protein 2 | 84203.0 | ENSG00000168454 | nan | nan
chr18	VAPA	605703.0 | VAPA, VAP33 | VAMP-associated protein A | 9218.0 | ENSG00000101558 | nan | nan
chr18	APCDD1	607479.0 | APCDD1, HHS, HYPT1, HTS | Adenomatosis polyposis coli down-regulated 1 | 147495.0 | ENSG00000154856 | nan | Hypotrichosis 1, 605389 (3), Autosomal dominant
chr18	NAPG	603216.0 | NAPG | NSF attachment protein, gamma | 8774.0 | ENSG00000134265 | nan | nan
chr18	PIEZO2	613629.0 | PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT | PIEZO-type mechanosensitive ion channel component 2 | 63895.0 | ENSG00000154864 | mutation identified in 1 MWKS patient | Arthrogryposis, distal, type 5, 108145 (3), Autosomal dominant; Arthrogryposis, distal, with impaired proprioception and touch, 617146 (3), Autosomal recessive; Arthrogryposis, distal, type 3, 114300 (3), Autosomal dominant; ?Marden-Walker syndrome, 248700 (3), Autosomal dominant
chr18	GNAL	139312.0 | GNAL, DYT25 | Guanine nucleotide-binding protein, alpha-subunit, olfactory type | 2774.0 | ENSG00000141404 | nan | Dystonia 25, 615073 (3), Autosomal dominant
chr18	CHMP1B	606486.0 | CHMP1B, C10orf2 | Charged multivesicular body protein 1B | 57132.0 | ENSG00000255112 | nan | nan
chr18	MPPE1	611900.0 | MPPE1 | Metallophosphoesterase 1 | 65258.0 | ENSG00000154889 | nan | nan
chr18	IMPA2	605922.0 | IMPA2 | Myo-inositol monophosphatase 2 | 3613.0 | ENSG00000141401 | nan | nan
chr18	CIDEA	604440.0 | CIDEA | Cell death-inducing DFFA-like effector A | 1149.0 | ENSG00000176194 | nan | nan
chr18	TUBB6	615103.0 | TUBB6, FPVEPD | Tubulin, beta-6 | 84617.0 | ENSG00000176014 | mutation identified in 1 FPVEPD family | ?Facial palsy, congenital, with ptosis and velopharyngeal dysfunction, 617732 (3), Autosomal dominant
chr18	AFG3L2	604581.0 | AFG3L2, SCA28, SPAX5, OPA12 | AFG3-like matrix AAA peptidase, subunit 2 | 10939.0 | ENSG00000141385 | nan | Spastic ataxia 5, autosomal recessive, 614487 (3), Autosomal recessive; Optic atrophy 12, 618977 (3), Autosomal dominant; Spinocerebellar ataxia 28, 610246 (3), Autosomal dominant
chr18	PRELID3A	616545.0 | PRELID3A, SLMO1, C18orf43 | PRELI domain-containing protein 3A | 10650.0 | ENSG00000141391 | nan | nan
chr18	SPIRE1	609216.0 | SPIRE1, KIAA1135 | Spire-type actin nucleation factor 1 | 56907.0 | ENSG00000134278 | nan | nan
chr18	PSMG2	609702.0 | PSMG2, TNFSF5IP1, HCCA3, CLAST3, PAC2, PRAAS4 | Proteasome (prosome, macropain) assembly chaperone 1 | 56984.0 | ENSG00000128789 | mutation identified in 1 PRAAS4 patient | ?Proteasome-associated autoinflammatory syndrome 4, 619183 (3), Autosomal recessive
chr18	CEP76	620791.0 | CEP76 | Centrosomal protein, 76kD | 79959.0 | ENSG00000101624 | nan | nan
chr18	PTPN2	176887.0 | PTPN2, PTPT | Protein tyrosine phosphatase, nonreceptor-type, 2 | 5771.0 | ENSG00000175354 | nan | nan
chr18	SEH1L	609263.0 | SEH1L, SEH1, SEC13L | Seh1-like protein | 81929.0 | ENSG00000085415 | nan | nan
chr18	CEP192	616426.0 | CEP192, PPP1R62, KIAA1569 | Centrosomal protein, 192kD | 55125.0 | ENSG00000101639 | nan | nan
chr18	LDLRAD4	606571.0 | C18orf1 | Chromosome 18 open reading frame 1 | 753.0 | ENSG00000168675 | nan | nan
chr18	FAM210A	617975.0 | FAM210A, C18orf19 | Family with sequence similarity 210, member A | 125228.0 | ENSG00000177150 | nan | nan
chr18	RNMT	603514.0 | RNMT, MET | RNA guanine-7-methyltransferase | 8731.0 | ENSG00000101654 | nan | nan
chr18	MC5R	600042.0 | MC5R | Melanocortin-5 receptor | 4161.0 | ENSG00000176136 | nan | nan
chr18	MC2R	607397.0 | MC2R | Melanocortin-2 receptor (ACTH receptor) | 4158.0 | ENSG00000185231 | nan | Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3), Autosomal recessive
chr18	ANKRD30B	616565.0 | ANKRD30B | Ankyrin repeat domain-containing protein 30B | 374860.0 | ENSG00000180777 | nan | nan
chr18		601808.0 | DEL18q | Chromosome 18q deletion syndrome | nan | nan | nan | Chromosome 18q deletion syndrome, 601808 (4), Autosomal dominant
chr18	OHDS	143850.0 | OHDS | Orthostatic hypotensive disorder of Streeten | 50948.0 | nan | nan | Orthostatic hypotensive disorder of Streeten, 143850 (2), Autosomal dominant
chr18	ROCK1	601702.0 | ROCK1 | RHO-associated coiled-coil-containing protein kinase 1 | 6093.0 | ENSG00000067900 | nan | nan
chr18	GREB1L	617782.0 | GREB1L, C18orf6, KIAA1772, RHDA3, DFNA80 | GREB1-like retinoic acid receptor coactivator | 80000.0 | ENSG00000141449 | nan | Deafness, autosomal dominant 80, 619274 (3), Autosomal dominant; Renal hypodysplasia/aplasia 3, 617805 (3), Autosomal dominant
chr18	APMR3	613930.0 | APMR3 | Alopecia-intellectual disability syndrome 3 | 100653369.0 | nan | between D18S866 and D18S811 | Alopecia-intellectual disability syndrome 3, 613930 (2), Autosomal recessive
chr18	ESCO1	609674.0 | ESCO1, ECO1, CTF, ESO1, EFO1, KIAA1911 | Establishment of sister chromatid cohesion N-acetyltransferase 1 | 114799.0 | ENSG00000141446 | nan | nan
chr18	SNRPD1	601063.0 | SNRPD1 | Small nuclear ribonucleoprotein polypeptide D1 | 6632.0 | ENSG00000167088 | nan | nan
chr18	ABHD3	612197.0 | ABHD3, LABH3 | Abhydrolase domain-containing 3, phospholipase | 171586.0 | ENSG00000158201 | nan | nan
chr18	MIB1	608677.0 | MIB1, MIB, DIP1, KIAA1323, LVNC7 | Mindbomb E3 ubiquitin protein ligase 1 | 57534.0 | ENSG00000101752 | nan | Left ventricular noncompaction 7, 615092 (3), Autosomal dominant
chr18	MIR133A1	610254.0 | MIR133A1 | Micro RNA 133A1 | 406922.0 | ENSG00000283927 | nan | nan
chr18	MIR1-2	610252.0 | MIR1-2 | Micro RNA 1-2 | 406905.0 | ENSG00000284453 | nan | nan
chr18	GATA6	601656.0 | GATA6, AVSD5, ASD9, PACHD | GATA-binding protein-6 | 2627.0 | ENSG00000141448 | nan | Atrial septal defect 9, 614475 (3), Autosomal dominant; Persistent truncus arteriosus, 217095 (3); Pancreatic agenesis and congenital heart defects, 600001 (3), Autosomal dominant; Atrioventricular septal defect 5, 614474 (3), Autosomal dominant; Tetralogy of Fallot, 187500 (3), Autosomal dominant
chr18	CTAGE1	608856.0 | CTAGE1 | Cutaneous T-cell lymphoma-associated antigen 1 | 64693.0 | ENSG00000212710 | nan | nan
chr18	RBBP8	604124.0 | RBBP8, RIM, SCKL2, JWDS | Retinoblastoma-binding protein 8 | 5932.0 | ENSG00000101773 | nan | Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)
chr18	CABLES1	609194.0 | CABLES1 | CDK5 and ABL enzyme substrate 1 | 91768.0 | ENSG00000134508 | nan | nan
chr18	TMEM241	615430.0 | TMEM241, C18orf45 | Transmembrane protein 241 | 85019.0 | ENSG00000134490 | nan | nan
chr18	RIOK3	603579.0 | RIOK3, SUDD | RIO kinase 3 | 8780.0 | ENSG00000101782 | nan | nan
chr18	RMC1	620267.0 | RMC1, C18orf8 | Regulator of MON1-CCZ1 | 29919.0 | ENSG00000141452 | nan | nan
chr18	NPC1	607623.0 | NPC1, NPC | NPC intracellular cholesterol transporter 1 | 4864.0 | ENSG00000141458 | some families not linked to 18; type D prob. allelic | Niemann-Pick disease, type C1, 257220 (3), Autosomal recessive; Niemann-Pick disease, type D, 257220 (3), Autosomal recessive
chr18	LAMA3	600805.0 | LAMA3, LOCS, JEB2A, JEB2B, JEB2C | Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epiligrin) | 3909.0 | ENSG00000053747 | nan | Epidermolysis bullosa, junctional 2A, intermediate, 619783 (3), Autosomal recessive; Epidermolysis bullosa, junctional 2C, laryngoonychocutaneous, 245660 (3), Autosomal recessive; Epidermolysis bullosa, junctional 2B, severe, 619784 (3), Autosomal recessive
chr18	CABYR	612135.0 | CABYR, FSP2 | Calcium-binding tyrosine phosphorylation-regulated protein | 26256.0 | ENSG00000154040 | nan | nan
chr18	OSBPL1A	606730.0 | OSBPL1A, ORP1 | Oxysterol-binding protein-like protein 1A | 114876.0 | ENSG00000141447 | nan | nan
chr18	IMPACT	615319.0 | IMPACT | Impact RWD domain protein | 55364.0 | ENSG00000154059 | nan | nan
chr18	HRH4	606792.0 | HRH4, HH4R | Histamine receptor H4 | 59340.0 | ENSG00000134489 | nan | nan
chr18	ZNF521	610974.0 | ZNF521, EHZF, EVI3 | Zinc finger protein 521 | 25925.0 | ENSG00000198795 | nan | nan
chr18	SS18	600192.0 | SS18, SSXT, SYT | Synovial sarcoma translocation, chromosome 18 | 6760.0 | ENSG00000141380 | 5' SYST/3' SSRC in t(X;18) | Sarcoma, synovial (1)
chr18	PSMA8	617841.0 | PSMA8, PSMA7L | Proteasome subunit, alpha-type, 8 | 143471.0 | ENSG00000154611 | nan | nan
chr18	TAF4B	601689.0 | TAF4B, TAF2C2, TAFII105, SPGF13 | TAF4b RNA polymerase II, TATA box-binding protein-associated factor, 105kD | 6875.0 | ENSG00000141384 | mutation identified in 1 SPGF13 family | ?Spermatogenic failure 13, 615841 (3), Autosomal recessive
chr18	KCTD1	613420.0 | KCTD1, SENS | Potassium channel tetramerization domain-containing 1 | 284252.0 | ENSG00000134504 | nan | Scalp-ear-nipple syndrome, 181270 (3), Autosomal dominant
chr18	PCAT18	617647.0 | PCAT18, LINC01092 | Prostate cancer-associated transcript 18, noncoding | 728606.0 | ENSG00000265369 | nan | nan
chr18	AQP4	600308.0 | AQP4, MIWC, MLC4 | Aquaporin-4 | 361.0 | ENSG00000171885 | mutation identified in 1 MLC4 family | ?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting, 620448 (3), Autosomal recessive
chr18	CHST9	610191.0 | CHST9, GalNAc4ST2 | Carbohydrate sulfotransferase 9 | 83539.0 | ENSG00000154080 | nan | nan
chr18	MGR11	610209.0 | MGR11 | Migraine with or without aura, susceptibility to, 11 | 117204003.0 | nan | nan | {Migraine with or without aura, susceptibility to, 11}, 610209 (2), Autosomal dominant
chr18	ZNF271P	604754.0 | ZNF271P, ZNFEB, ZNF271 | Zinc finger protein 271, pseudogene | 10778.0 | ENSG00000293516 | nan | nan
chr18	CDH2	114020.0 | CDH2, NCAD, ARVD14, ACOGS, ADHD8 | Cadherin 2 (cadherin, neuronal type; N-cadherin) | 1000.0 | ENSG00000170558 | mutation identified in 1 ADHD8 family | Arrhythmogenic right ventricular dysplasia 14, 618920 (3), Autosomal dominant; ?Attention deficit-hyperactivity disorder 8, 619957 (3), Autosomal recessive; Agenesis of corpus callosum, cardiac, ocular, and genital syndrome, 618929 (3), Autosomal dominant
chr18	DSC3	600271.0 | DSC3, DSC4 | Desmocollin-3 | 1825.0 | ENSG00000134762 | nan | Hypotrichosis and recurrent skin vesicles, 613102 (3), Autosomal recessive
chr18	DSC2	125645.0 | DSC2, DSC3, ARVD11 | Desmocollin-2 | 1824.0 | ENSG00000134755 | nan | Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3), Autosomal recessive, Autosomal dominant; Arrhythmogenic right ventricular dysplasia 11, 610476 (3), Autosomal recessive, Autosomal dominant
chr18	DSC1	125643.0 | DSC1 | Desmocollin-1 | 1823.0 | ENSG00000134765 | nan | nan
chr18	DSG1	125670.0 | DSG1, PPKS1, SPPK1, EPKHE | Desmoglein-1 | 1828.0 | ENSG00000134760 | pemphigus foliaceous antigen | Keratosis palmoplantaris striata I, AD, 148700 (3), Autosomal dominant; Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3), Autosomal recessive
chr18	DSG4	607892.0 | DSG4, LAH, HYPT6 | Desmoglein 4 | 147409.0 | ENSG00000175065 | nan | Hypotrichosis 6, 607903 (3), Autosomal recessive
chr18	DSG3	169615.0 | DSG3, ABOLM | Desmoglein-3 (pemphigus vulgaris antigen) | 1830.0 | ENSG00000134757 | nan | Blistering, acantholytic, of oral and laryngeal mucosa, 619226 (3), Autosomal recessive
chr18	DSG2	125671.0 | DSG2, ARVD10, ARVC10, CMD1BB | Desmoglein-2 | 1829.0 | ENSG00000046604 | nan | Cardiomyopathy, dilated, 1BB, 612877 (3), Autosomal recessive; Arrhythmogenic right ventricular dysplasia 10, 610193 (3), Autosomal dominant
chr18	TTR	176300.0 | TTR, PALB | Transthyretin (prealbumin) | 7276.0 | ENSG00000118271 | nan | Amyloidosis, hereditary, transthyretin-related, 105210 (3), Autosomal dominant; Carpal tunnel syndrome, familial, 115430 (3), Autosomal dominant; [Dystransthyretinemic hyperthyroxinemia], 145680 (3), Autosomal dominant
chr18	B4GALT6	604017.0 | B4GALT6 | Beta-1,4-galactosyltransferase 6 | 9331.0 | ENSG00000118276 | nan | nan
chr18	SLC25A52	616153.0 | SLC25A52, MCART2 | Solute carrier family 25, member 52 | 147407.0 | ENSG00000141437 | nan | nan
chr18	TRAPPC8	614136.0 | TRAPPC8, KIAA1012 | Trafficking protein particle complex, subunit 8 | 22878.0 | ENSG00000153339 | nan | nan
chr18	RNF125	610432.0 | RNF125, TRAC1, TNORS | RING finger protein 125 | 54941.0 | ENSG00000101695 | nan | Tenorio syndrome, 616260 (3), Autosomal dominant
chr18	RNF138	616319.0 | RNF138, NARF | RING finger protein 138 | 51444.0 | ENSG00000134758 | nan | nan
chr18	MEP1B	600389.0 | MEP1B | Meprin A, beta | 4225.0 | ENSG00000141434 | nan | nan
chr18	GAREM1	617998.0 | GAREM1 | GRB2-associated regulator of MAPK1, subtype 1 | 64762.0 | ENSG00000141441 | nan | nan
chr18	KLHL14	613772.0 | KLHL14, PRINTOR, KIAA1384 | Kelch-like 14 | 57565.0 | ENSG00000197705 | nan | nan
chr18	ASXL3	615115.0 | ASXL3, KIAA1713, BRPS | ASXL transcriptional regulator 3 | 80816.0 | ENSG00000141431 | nan | Bainbridge-Ropers syndrome, 615485 (3), Autosomal dominant
chr18	NOL4	603577.0 | NOL4, NOLP | Nucleolar protein 4 | 8715.0 | ENSG00000101746 | nan | nan
chr18	DTNA	601239.0 | DTNA, D18S892E, DRP3, LVNC1, MMCKR2 | Dystobrevin, alpha (dystrophin-related protein 3) | 1837.0 | ENSG00000134769 | nan | Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3), Autosomal dominant; Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 2, 620971 (3), Autosomal dominant
chr18	MAPRE2	605789.0 | MAPRE2, EB2, RP1, CSCSC2 | Microtubule-associated protein, RP/EB family, member 2 | 10982.0 | ENSG00000166974 | nan | Symmetric circumferential skin creases, congenital, 2, 616734 (3), Autosomal dominant
chr18	OPA4	605293.0 | OPA4 | Optic atrophy 4 | 58156.0 | nan | nan | Optic atrophy 4, 605293 (2)
chr18	ZNF397	609601.0 | ZNF397 | Zinc finger protein-397 | 84307.0 | ENSG00000186812 | nan | nan
chr18	ZNF24	194534.0 | ZNF24 | Zinc finger protein-24 (KOX17) | 7572.0 | ENSG00000172466 | nan | nan
chr18	ZNF396	609600.0 | ZNF396 | Zinc finger protein-396 | 252884.0 | ENSG00000186496 | nan | nan
chr18	GALNT1	602273.0 | GALNT1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 | 2589.0 | ENSG00000141429 | nan | nan
chr18	MIR187	612698.0 | MIR187, MIRN187 | Micro RNA 187 | 406963.0 | ENSG00000207797 | nan | nan
chr18	RPRD1A	610347.0 | RPRD1A, P15RS, FLJ10656 | Regulation of nuclear pre-mRNA domain-containing protein 1A | 55197.0 | ENSG00000141425 | nan | nan
chr18	SLC39A6	608731.0 | SLC39A6, LIV1, ZIP6 | Solute carrier family 39 (zinc transporter), member 6 | 25800.0 | ENSG00000141424 | nan | nan
chr18	ELP2	616054.0 | ELP2, STATIP1, MRT58 | Elongator acetyltransferase complex, subunit 2 | 55250.0 | ENSG00000134759 | nan | Intellectual developmental disorder, autosomal recessive 58, 617270 (3), Autosomal recessive
chr18	MOCOS	613274.0 | MOCOS, MCS, XAN2 | Molybdenum cofactor sulfurase | 55034.0 | ENSG00000075643 | nan | Xanthinuria, type II, 603592 (3), Autosomal recessive
chr18	FHOD3	609691.0 | FHOD3, FHOS2, KIAA1695, CMH28 | Formin homology-2 domain-containing protein 3 | 80206.0 | ENSG00000134775 | nan | Cardiomyopathy, familial hypertrophic, 28, 619402 (3), Autosomal dominant
chr18	TPGS2	620710.0 | TPGS2, PGS2 | Tubulin polyglutamylase complex, subunit 2 | 25941.0 | ENSG00000134779 | nan | nan
chr18	KIAA1328	616480.0 | KIAA1328, HINDERIN | Hinderin | 57536.0 | ENSG00000150477 | nan | nan
chr18	CELF4	612679.0 | CELF4, BRUNOL4 | CUGbp- and ELAV-like family, member 4 | 56853.0 | ENSG00000101489 | nan | nan
chr18	VUR6	614319.0 | VUR6 | Vesicoureteral reflux 6 | 100820763.0 | nan | closest marker rs1054986 | Vesicoureteral reflux 6, 614319 (2)
chr18	PIK3C3	602609.0 | PIK3C3 | Phosphatidylinositol 3-kinase, class 3 | 5289.0 | ENSG00000078142 | nan | nan
chr18	RIT2	609592.0 | RIT2, RIN, ROC2 | Ric-like protein without CAAX motif 2 | 6014.0 | ENSG00000152214 | nan | nan
chr18	SYT4	600103.0 | SYT4 | Synaptotagmin-4 | 6860.0 | ENSG00000132872 | nan | nan
chr18	SETBP1	611060.0 | SETBP1, KIAA0437, SEB, MRD29 | SET-binding protein 1 | 26040.0 | ENSG00000152217 | fused with NUP98 in ALL | Schinzel-Giedion midface retraction syndrome, 269150 (3), Autosomal dominant; Intellectual developmental disorder, autosomal dominant 29, 616078 (3), Autosomal dominant
chr18	SLC14A2	601611.0 | SLC14A2, UT2, UTR | Solute carrier family 14 (urea transporter), member 2 | 8170.0 | ENSG00000132874 | nan | nan
chr18	SLC14A1	613868.0 | SLC14A1, JK, UTE, UT1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | 6563.0 | ENSG00000141469 | previous suggestion of chr.7 or chr.2 | [Blood group, Kidd], 111000 (3)
chr18	EPG5	615068.0 | EPG5, KIAA1632, HEEW1, VICIS | Ectopic P-granules autophagy protein 5 homolog | 57724.0 | ENSG00000152223 | nan | Vici syndrome, 242840 (3), Autosomal recessive
chr18	SIGLEC15	618105.0 | SIGLEC15 | Sialic acid-binding immunoglobulin-like lectin 15 | 284266.0 | ENSG00000197046 | nan | nan
chr18	ALS3	606640.0 | ALS3 | Amyotrophic lateral sclerosis 3 | 253.0 | nan | nan | Amyotrophic lateral sclerosis 3, 606640 (2), Autosomal dominant
chr18	CORD1	600624.0 | CORD1, CRD1 | Cone rod dystrophy 1, autosomal dominant | 1319.0 | nan | nan | Cone-rod retinal dystrophy-1, 600624 (2), Autosomal dominant
chr18	IDDM6	601941.0 | IDDM6 | Insulin-dependent diabetes mellitus-6 | 3405.0 | nan | nan | {Diabetes mellitus, insulin-dependent, 6}, 601941 (2)
chr18		182090.0 | SSAV1 | Simian sarcoma-associated virus-1/Gibbon ape leukemia virus | 6739.0 | nan | nan | nan
chr18	PSTPIP2	616046.0 | PSTPIP2, MAYP | Proline/serine/threonine phosphatase-interacting protein 2 | 9050.0 | ENSG00000152229 | nan | nan
chr18	ATP5F1A	164360.0 | ATP5F1A, ATP5A1, ATPM, ATP5A, ORM, MC5DN4B, COXPD22, MC5DN4A | ATP synthase F1, alpha subunit | 498.0 | ENSG00000152234 | pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A, 620358 (3), Autosomal dominant; ?Combined oxidative phosphorylation deficiency 22, 616045 (3), Autosomal recessive; ?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4B, encephalopathic type, 615228 (3), Autosomal recessive
chr18	HAUS1	608775.0 | HAUS1, CCDC5, HEIC | HAUS augmin-like complex, subunit 1 | 115106.0 | ENSG00000152240 | pseudogenes on 5, 8, and X | nan
chr18	LOXHD1	613072.0 | LOXHD1, DFNB77 | Lipoxygenase homology domains-containing 1 | 125336.0 | ENSG00000167210 | nan | Deafness, autosomal recessive 77, 613079 (3), Autosomal recessive
chr18	ST8SIA5	607162.0 | SIAT8E | Sialyltransferase 8E | 29906.0 | ENSG00000101638 | nan | nan
chr18	PIAS2	603567.0 | PIAS2, PIASX | Protein inhibitor of activated STAT2 | 9063.0 | ENSG00000078043 | nan | nan
chr18	KATNAL2	614697.0 | KATNAL2 | Katanin, p60 subunit, A-like protein 2 | 83473.0 | ENSG00000167216 | nan | nan
chr18	ELOA2	609522.0 | ELOA2, TCEB3B | Elongin A2 | 51224.0 | ENSG00000206181 | nan | nan
chr18	IER3IP1	609382.0 | IER3IP1, MEDS | Immediate-early response 3-interacting protein 1 | 51124.0 | ENSG00000134049 | nan | Microcephaly, epilepsy, and diabetes syndrome, 614231 (3), Autosomal recessive
chr18	SKOR2	617138.0 | SKOR2, FUSSEL18, CORL2 | SKI family transcriptional corepressor 2 | 652991.0 | ENSG00000215474 | nan | nan
chr18	SMAD2	601366.0 | SMAD2, MADH2, JV18, LDS6, CHTD8 | SMAD family member 2 | 4087.0 | ENSG00000175387 | nan | Loeys-Dietz syndrome 6, 619656 (3), Autosomal dominant; Congenital heart defects, multiple types, 8, with or without heterotaxy, 619657 (3), Autosomal dominant
chr18	ZBTB7C	616591.0 | ZBTB7C, APM1 | Zinc finger- and BTB domain-containing protein 7C | 201501.0 | ENSG00000184828 | nan | nan
chr18	CTIF	613178.0 | CTIF, KIAA0427 | CAP-binding complex-dependent translation initiation factor | 9811.0 | ENSG00000134030 | nan | nan
chr18	SMAD7	602932.0 | SMAD7, MADH7, CRCS3 | SMAD family member 7 | 4092.0 | ENSG00000101665 | nan | {Colorectal cancer, susceptibility to, 3}, 612229 (3)
chr18	DYM	607461.0 | DYM, FLJ90130, DMC, SMC | Dymeclin | 54808.0 | ENSG00000141627 | nan | Smith-McCort dysplasia, 607326 (3), Autosomal recessive; Dyggve-Melchior-Clausen disease, 223800 (3), Autosomal recessive
chr18	C18orf32	619979.0 | C18orf32, GPIBD25 | Chromosome 18 open reading frame 32 | 497661.0 | ENSG00000177576 | mutation identified in 1 GPIBD25 patient | ?Glycosylphosphatidylinositol biosynthesis defect 25, 619985 (3), Autosomal recessive
chr18	RPL17	603661.0 | RPL17 | Ribosomal protein L17 | 6139.0 | ENSG00000265681 | nan | nan
chr18	LIPG	603684.0 | LIPG, EL, EDL | Lipase G, endothelial | 9388.0 | ENSG00000101670 | nan | nan
chr18	ACAA2	604770.0 | ACAA2 | Acetyl-CoA acyltransferase 2 | 10449.0 | ENSG00000167315 | nan | nan
chr18	SCARNA17	615645.0 | SCARNA17 | Small Cajal body-specific RNA 17 | 677769.0 | ENSG00000267322 | nan | nan
chr18	MYO5B	606540.0 | MYO5B, KIAA1119, DIAR2, MVID1, PFIC10 | Myosin VB | 4645.0 | ENSG00000167306 | nan | Diarrhea 2, with microvillus atrophy, with or without cholestasis, 251850 (3), Autosomal recessive; Cholestasis, progressive familial intrahepatic, 10, 619868 (3), Autosomal recessive
chr18	CFAP53	614759.0 | CFAP53, CCDC11, HTX6 | Cilia- and flagella-associated protein 53 | 220136.0 | ENSG00000172361 | nan | Heterotaxy, visceral, 6, autosomal recessive, 614779 (3), Autosomal recessive
chr18	MBD1	156535.0 | MBD1, PCM1 | Methyl=CpG binding domain protein 1 (protein containing methyl-CpG binding domain 1) | 4152.0 | ENSG00000141644 | nan | nan
chr18	CXXC1	609150.0 | CXXC1, CGBP, PCCX1 | CXXC finger protein 1 | 30827.0 | ENSG00000154832 | nan | nan
chr18	SKA1	616673.0 | SKA1, C18orf24 | Spindle- and kinetochore-associated complex, subunit 1 | 220134.0 | ENSG00000154839 | nan | nan
chr18	MAPK4	176949.0 | MAPK4, PRKM4, ERK3 | Mitogen-activated protein kinase 4 | 5596.0 | ENSG00000141639 | nan | nan
chr18	HYT8	611014.0 | HYT8 | Hypertension, essential, susceptibility to, 8 | 100188321.0 | nan | associated with rs1941958 and rs1893379 | {Hypertension, essential, susceptibility to, 8}, 611014 (2)
chr18	MRO	608080.0 | MRO, B29 | Maestro | 83876.0 | ENSG00000134042 | nan | nan
chr18	ME2	154270.0 | ME2 | Malic enzyme, mitochondrial | 4200.0 | ENSG00000082212 | 10cM distal to F13A; previously mapped to chr.6 | nan
chr18	ELAC1	608079.0 | ELAC1, D29 | elaC ribonuclease Z 1 | 55520.0 | ENSG00000141642 | nan | nan
chr18	SMAD4	600993.0 | SMAD4, MADH4, DPC4, JIP, MYHRS | SMAD family member 4 | 4089.0 | ENSG00000141646 | nan | Pancreatic cancer, somatic, 260350 (3); Myhre syndrome, 139210 (3), Autosomal dominant; Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant
chr18	MEX3C	611005.0 | MEX3C, RKHD2 | Mex-3, C. elegans, homolog of, C | 51320.0 | ENSG00000176624 | nan | nan
chr18	DCC	120470.0 | DCC, MRMV1, HGPPS2 | Deleted in colorectal carcinoma | 1630.0 | ENSG00000187323 | nan | Mirror movements 1 and/or agenesis of the corpus callosum, 157600 (3), Autosomal dominant; Esophageal carcinoma, somatic, 133239 (3); Colorectal cancer, somatic, 114500 (3); Gaze palsy, familial horizontal, with progressive scoliosis, 2, 617542 (3), Autosomal recessive
chr18	MBD2	603547.0 | MBD2 | Methyl-CpG-binding domain protein 2 | 8932.0 | ENSG00000134046 | nan | nan
chr18	POLI	605252.0 | POLI, RAD30B | Polymerase, DNA, iota | 11201.0 | ENSG00000101751 | nan | nan
chr18	STARD6	607051.0 | STARD6 | Start domain-containing protein 6 | 147323.0 | ENSG00000174448 | nan | nan
chr18	C18orf54	613258.0 | C18orf54, LAS2 | Chromosome 18 open reading frame 54 | 162681.0 | ENSG00000166845 | nan | nan
chr18	DYNAP	619421.0 | DYNAP, C18orf26 | Dynactin-associated protein | 284254.0 | ENSG00000178690 | nan | nan
chr18	RAB27B	603869.0 | RAB27B | RAS-associated protein RAB27B | 5874.0 | ENSG00000041353 | nan | nan
chr18	CCDC68	616909.0 | CCDC68 | Coiled-coil domain-containing protein 68 | 80323.0 | ENSG00000166510 | nan | nan
chr18	TCF4	602272.0 | TCF4, SEF2, ITF2, PTHS, FECD3 | Transcription factor-4 (immunoglobulin transcription factor-2) | 6925.0 | ENSG00000196628 | nan | Pitt-Hopkins syndrome, 610954 (3), Autosomal dominant; Corneal dystrophy, Fuchs endothelial, 3, 613267 (3), Autosomal dominant
chr18	CNSN	212200.0 | CNSN | Carnosinemia (carnosinase) | 8173.0 | nan | nan | Carnosinemia, 212200 (2), Autosomal recessive
chr18	TXNL1	603049.0 | TXNL1, TXNL | Thioredoxin-like 1 | 9352.0 | ENSG00000091164 | nan | nan
chr18	WDR7	613473.0 | WDR7, TRAG, KIAA0541 | WD repeat-containing protein 7 | 23335.0 | ENSG00000091157 | nan | nan
chr18	LINC-ROR	615173.0 | LINC-ROR | Long intergenic noncoding RNA, regulator of reprogramming | 100885779.0 | ENSG00000258609 | nan | nan
chr18	ST8SIA3	609478.0 | ST8SIA3 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | 51046.0 | ENSG00000177511 | nan | nan
chr18	ONECUT2	604894.0 | ONECUT2, OC2 | One cut domain, family member 2 | 9480.0 | ENSG00000119547 | nan | nan
chr18	FECH	612386.0 | FECH, FCE, EPP1 | Ferrochelatase | 2235.0 | ENSG00000066926 | nan | Protoporphyria, erythropoietic, 1, 177000 (3), Autosomal recessive
chr18	NARS1	108410.0 | NARS1, NARS, ASNRS, NEDMILG, NEDMILEG | Asparaginyl-tRNA synthetase 1 | 4677.0 | ENSG00000134440 | nan | Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant, 619092 (3), Autosomal dominant; Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, autosomal recessive, 619091 (3), Autosomal recessive
chr18	ATP8B1	602397.0 | ATP8B1, FIC1, BRIC, PFIC1, ICP1 | ATPase, class I, type 8B, member 1 | 5205.0 | ENSG00000081923 | nan | Cholestasis, progressive familial intrahepatic 1, 211600 (3), Autosomal recessive; Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3), Autosomal dominant; Cholestasis, benign recurrent intrahepatic, 243300 (3), Autosomal recessive
chr18	NEDD4L	606384.0 | NEDD4L, KIAA0439, RSP5, PVNH7 | Ubiquitin protein ligase NEDD4-like | 23327.0 | ENSG00000049759 | nan | Periventricular nodular heterotopia 7, 617201 (3), Autosomal dominant
chr18	MIR122	609582.0 | MIR122A, MIRN122A | Micro RNA 122A | 406906.0 | ENSG00000284440 | nan | nan
chr18	ALPK2	619965.0 | ALPK2, HAK | Alpha kinase 2 | 115701.0 | ENSG00000198796 | nan | nan
chr18	MALT1	604860.0 | MALT1, MLT, IMD12 | MALT1 paracaspase | 10892.0 | ENSG00000172175 | fused with API2 in MALT lymphoma | Immunodeficiency 12, 615468 (3), Autosomal recessive
chr18	ZNF532	619066.0 | ZNF532 | Zinc finger protein 532 | 55205.0 | ENSG00000074657 | nan | nan
chr18	GRP	137260.0 | GRP | Gastrin-releasing peptide | 2922.0 | ENSG00000134443 | mammalian equivalent of bombesin | nan
chr18	RAX	601881.0 | RAX, RX, MCOPS16 | Retina and anterior neural fold homeobox gene | 30062.0 | ENSG00000134438 | nan | Microphthalmia, syndromic 16, 611038 (3), Autosomal recessive
chr18	CPLX4	609586.0 | CPLX4 | Complexin 4 | 339302.0 | ENSG00000166569 | nan | nan
chr18	LMAN1	601567.0 | LMAN1, ERGIC53, F5F8D, MCFD1 | Lectin, mannose-binding 1 | 3998.0 | ENSG00000074695 | nan | Combined factor V and VIII deficiency, 227300 (3), Autosomal recessive
chr18	CCBE1	612753.0 | CCBE1, KIAA1983, HKLLS1 | Collagen and calcium-binding EGF domain-containing protein 1 | 147372.0 | ENSG00000183287 | nan | Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3), Autosomal recessive
chr18	PMAIP1	604959.0 | PMAIP1, APR, NOXA | Phorbol-12-myristate-13-acetate-induced protein 1 | 5366.0 | ENSG00000141682 | nan | nan
chr18	MC4R	155541.0 | MC4R, BMIQ20 | Melanocortin-4 receptor | 4160.0 | ENSG00000166603 | nan | Obesity (BMIQ20), 618406 (3), Autosomal recessive, Autosomal dominant; {Obesity, resistance to (BMIQ20)}, 618406 (3), Autosomal recessive, Autosomal dominant
chr18	CDH20	605807.0 | CDH20 | Cadherin 20 | 28316.0 | ENSG00000101542 | nan | nan
chr18	RNF152	616512.0 | RNF152 | Ring finger protein 152 | 220441.0 | ENSG00000176641 | nan | nan
chr18	PIGN	606097.0 | PIGN, MCAHS1 | Phosphatidylinositol glycan, class N | 23556.0 | ENSG00000197563 | nan | Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3), Autosomal recessive
chr18	RELCH	618001.0 | RELCH, KIAA1468 | RAB11 effector containing LIS1 homology domain, coiled-coil domains, and HEAT repeats | 57614.0 | ENSG00000134444 | nan | nan
chr18	TNFRSF11A	603499.0 | TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2 | Tumor necrosis factor receptor superfamily, member 11A | 8792.0 | ENSG00000141655 | nan | Osteopetrosis, autosomal recessive 7, 612301 (3), Autosomal recessive; {Paget disease of bone 2, early-onset}, 602080 (3), Autosomal dominant; Osteolysis, familial expansile, 174810 (3), Autosomal dominant
chr18	ZCCHC2	620095.0 | ZCCHC2, KIAA1744 | Zinc finger CCHC domain-containing protein 2 | 54877.0 | ENSG00000141664 | nan | nan
chr18	PHLPP1	609396.0 | PHLPP1, SCOP, KIAA0606 | PH domain and leucine-rich repeat protein phosphatase | 23239.0 | ENSG00000081913 | nan | nan
chr18	BCL2	151430.0 | BCL2 | B-cell CLL/lymphoma-2 | 596.0 | ENSG00000171791 | most frequent hematologic malignancy t(14;18)(q32;q21) | Leukemia/lymphoma, B-cell, 2 (3)
chr18	KDSR	136440.0 | KDSR, FVT1, EKVP4 | 3-ketodihydrosphingosine reductase | 2531.0 | ENSG00000119537 | ~10kb 5' to BCL2 | Erythrokeratodermia variabilis et progressiva 4, 617526 (3), Autosomal recessive
chr18	VPS4B	609983.0 | VPS4B, SKD1 | Vacuolar protein sorting 4 homolog B | 9525.0 | ENSG00000119541 | nan | nan
chr18	SERPINB5	154790.0 | PI5, SERPINB5 | Protease inhibitor 5 (maspin) | 5268.0 | ENSG00000206075 | in cluster of serpins | nan
chr18	SERPINB12	615662.0 | SERPINB12 | Serpin peptidase inhibitor, clade (ovalbumin), member 12 | 89777.0 | ENSG00000166634 | nan | nan
chr18	SERPINB13	604445.0 | SERPINB13, PI13, HURPIN | Protease inhibitor 13 | 5275.0 | ENSG00000197641 | nan | nan
chr18	SERPINB4	600518.0 | SERPINB4, SCCA2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 4 (squamous cell carcinoma antigen 2) | 6318.0 | ENSG00000206073 | nan | nan
chr18	SERPINB3	600517.0 | SERPINB3, SCCA1 | Serpin peptidase inhibitor, clade B (ovalbumin), member 3 (squamous cell carcinoma antigen 1) | 6317.0 | ENSG00000057149 | nan | nan
chr18	SERPINB11	615682.0 | SERPINB11 | Serpin peptidase inhibitor, clade B (ovalbumin), member 11 | 89778.0 | ENSG00000206072 | nan | nan
chr18	SERPINB7	603357.0 | SERPINB7, MEGSIN, PPKN | Serpin peptidase inhibitor, clade B (ovalbumin), member 7 | 8710.0 | ENSG00000166396 | nan | Palmoplantar keratoderma, Nagashima type, 615598 (3), Autosomal recessive
chr18	SERPINB2	173390.0 | SERPINB2, PAI2, PLANH2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 (Plasminogen activator inhibitor, type II (arginine-serpin)) | 5055.0 | ENSG00000197632 | 600kb telomeric to BCL2 | nan
chr18		609334.0 | DUP18pDEL18q, DUP18qDEL18p | Chromosome 18 pericentric inversion | nan | nan | nan | Chromosome 18 pericentric inversion, 609334 (4)
chr18	ECTD8	602401.0 | ECTD8 | Ectodermal dysplasia 8, hair/tooth/nail type | 101101768.0 | nan | between D18S857 and D18S815 | Ectodermal dysplasia 8, hair/tooth/nail type, 602401 (2), Autosomal recessive
chr18	SERPINB10	602058.0 | SERPINB10, PI10 | Protease inhibitor 10, ovalbumin type (bomapin) | 5273.0 | ENSG00000242550 | nan | nan
chr18	HMSD	612086.0 | HMSD | Minor histocompatibility antigen, serpin domain-containing | 284293.0 | ENSG00000221887 | nan | nan
chr18	SERPINB8	601697.0 | SERPINB8, PI8, CAP2, PSS5 | Serpin family B, member 8 | 5271.0 | ENSG00000166401 | nan | Peeling skin syndrome 5, 617115 (3), Autosomal recessive
chr18	LINC00305	617489.0 | LINC00305 | Long intergenic noncoding RNA 305 | 221241.0 | ENSG00000179676 | nan | nan
chr18	CDH7	605806.0 | CDH7 | Cadherin-7 | 1005.0 | ENSG00000081138 | nan | nan
chr18	CDH19	603016.0 | CDH19, CDH7 | Cadherin 19 | 28513.0 | ENSG00000071991 | nan | nan
chr18	DSEL	611125.0 | DSEL, C18orf4, NCAG1 | Dermatan sulfate epimerase-like | 92126.0 | ENSG00000171451 | nan | nan
chr18	TMX3	616102.0 | TMX3, TXNDC10, KIAA1830 | Thioredoxin-related transmembrane protein 3 | 54495.0 | ENSG00000166479 | nan | nan
chr18	DOK6	611402.0 | DOK6 | Docking protein 6 | 220164.0 | ENSG00000206052 | nan | nan
chr18	CD226	605397.0 | DNAM1, CD226 | DNAX accessory molecule 1 | 10666.0 | ENSG00000150637 | nan | nan
chr18	RTTN	610436.0 | RTTN, MSSP | Rotatin | 25914.0 | ENSG00000176225 | nan | Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3), Autosomal recessive
chr18	SOCS6	605118.0 | SOCS6, SSI4, STAT4, CIS4 | Suppressor of cytokine signaling 6 | 9306.0 | ENSG00000170677 | nan | nan
chr18	CBLN2	600433.0 | CBLN2 | Cerebellin 2 precursor | 147381.0 | ENSG00000141668 | nan | nan
chr18	NETO1	607973.0 | NETO1, BCTL1 | Neuropilin and tolloid like 1 | 81832.0 | ENSG00000166342 | nan | nan
chr18	FBXO15	609093.0 | FBXO15, FBX15 | F-box only protein 15 | 201456.0 | ENSG00000141665 | nan | nan
chr18	TIMM21	615180.0 | TIMM21, TIM21 | Translocase of inner mitochondrial membrane 21 | 29090.0 | ENSG00000075336 | nan | nan
chr18	CYB5A	613218.0 | CYB5A, MCB5, METAG | Cytochrome b5 | 1528.0 | ENSG00000166347 | pseudogenes on X, 14q, 20p; mutation identified in 1 MET5 patient | Methemoglobinemia and ambiguous genitalia, 250790 (3), Autosomal recessive
chr18	DIPK1C	614544.0 | DIPK1C, FAM69C | Divergent protein kinase domain 1C | 125704.0 | ENSG00000187773 | nan | nan
chr18	CNDP2	169800.0 | CNDP2, PEPA, CN2 | Carnosine dipeptidase 2 | 55748.0 | ENSG00000133313 | nan | nan
chr18	CNDP1	609064.0 | CNDP1, CN1 | Carnosine dipeptidase 1 | 84735.0 | ENSG00000150656 | nan | nan
chr18	ZNF407	615894.0 | ZNF407, SIMHA | Zinc finger protein 407 | 55628.0 | ENSG00000215421 | nan | SIMHA syndrome, 619557 (3), Autosomal recessive
chr18	PTGR3	620604.0 | PTGR3, ZADH2 | Prostaglandin reductase 3 | 284273.0 | ENSG00000180011 | nan | nan
chr18	TSHZ1	614427.0 | TSHZ1, TSH1, CAA | Teashirt zinc finger homeobox 1 | 10194.0 | ENSG00000179981 | nan | Aural atresia, congenital, 607842 (3), Autosomal dominant
chr18	ZNF516	615114.0 | ZNF516, KIAA0222 | Zinc finger protein 516 | 9658.0 | ENSG00000101493 | nan | nan
chr18	ZNF236	604760.0 | ZNF236 | Zinc finger protein-236 | 7776.0 | ENSG00000130856 | nan | nan
chr18	MBP	"159430.0 | MBP | Myelin basic protein | 4155.0 | ENSG00000197971 | defective in ""shiverer,"" neurologic mutant in mouse | nan"
chr18	GALR1	600377.0 | GALR1, GALNR1, GALNR | Galanin receptor 1 | 2587.0 | ENSG00000166573 | nan | nan
chr18	SALL3	605079.0 | SALL3 | Sal-like 3 | 27164.0 | ENSG00000256463 | nan | nan
chr18	ATP9B	614446.0 | ATP9B | ATPase, class II, type 9B | 374868.0 | ENSG00000166377 | nan | nan
chr18	NFATC1	600489.0 | NFATC1 | Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1 | 4772.0 | ENSG00000131196 | nan | nan
chr18	CTDP1	604927.0 | CTDP1, FCP1, CCFDN | C-terminal domain of RNA polymerase II subunit A, phosphatase of, subunit 1 | 9150.0 | ENSG00000060069 | nan | Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3), Autosomal recessive
chr18	KCNG2	605696.0 | KCNG2 | Potassium channel, voltage-gated, subfamily G, member 2 | 26251.0 | ENSG00000178342 | nan | nan
chr18	TXNL4A	611595.0 | TXNL4A, DIM1, BMKS | Thioredoxin-like 4A | 10907.0 | ENSG00000141759 | nan | Burn-McKeown syndrome, 608572 (3), Autosomal recessive
chr18	RBFA	620768.0 | RBFA | Ribosome-binding factor A | 79863.0 | ENSG00000101546 | nan | nan
chr18	ADNP2	617422.0 | ADNP2, KIAA0863 | Activity-dependent neuroprotector homeobox 2 | 22850.0 | ENSG00000101544 | nan | nan
chr18	PARD6G	608976.0 | PARD6G | partitioning-defective protein 6, C. elegans, homolog of | 84552.0 | ENSG00000178184 | nan | nan
chr19	ATHS	108725.0 | ATHS, ALP | Atherosclerosis susceptibility (lipoprotein associated) | 470.0 | nan | closely linked to LDLR; may be LDLR | {Atherosclerosis, susceptibility to}, 108725 (2), Autosomal dominant
chr19	CXB3S	120050.0 | CXB3S | Coxsackie virus B3 sensitivity | 1526.0 | nan | nan | nan
chr19	EXT3	600209.0 | EXT3 | Exostoses, multiple, 3 | 2133.0 | nan | nan | Exostoses, multiple, type 3, 600209 (2), Autosomal dominant
chr19		602477.0 | FEB2 | Febrile seizures, familial, 2 | nan | nan | nan | Febrile seizures, familial, 2, 602477 (2), Autosomal dominant
chr19		614233.0 | FPH1, MUH, HPP | Hyperpigmentation, familial progressive, 1 | nan | nan | nan | Hyperpigmentation, familial progressive, 1, 614233 (2)
chr19	IBD6	606674.0 | IBD6 | Inflammatory bowel disease 6 | 50942.0 | nan | nan | {Inflammatory bowel disease 6}, 606674 (2)
chr19	IS1	181800.0 | IS1, AIS | Adolescent idiopathic scoliosis | 260402.0 | nan | nan | Scoliosis, idiopathic 1, 181800 (2), Autosomal dominant
chr19	KIR2DL5A	605305.0 | KIR2DL5A, KIR2DL5 | Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A | 57292.0 | nan | nan | nan
chr19	MGR5	607508.0 | MGR5 | Migraine with or without aura, susceptibility to, 5 | 387576.0 | nan | nan | {Migraine with or without aura, susceptibility to, 5}, 607508 (2), Autosomal dominant
chr19		615830.0 | PPNAD4 | Pigmented nodular adrenocortical disease, primary, 4 | nan | nan | duplication of 294kb to 2.7Mb on 19p13 | Pigmented nodular adrenocortical disease, primary, 4, 615830 (4), Autosomal dominant
chr19	PSORS6	605364.0 | PSORS6 | Psoriasis susceptibility 6 | 63869.0 | nan | nan | {Psoriasis susceptibility 6}, 605364 (2)
chr19	PLPP2	607126.0 | PLPP2, PPAP2C | Phospholipid phosphatase 2 | 8612.0 | ENSG00000141934 | nan | nan
chr19	MIER2	620092.0 | MIER2 | MIER family, member 2 | 54531.0 | ENSG00000105556 | nan | nan
chr19	SPMAP2	609503.0 | SPMAP2, THEG | Sperm microtubule-associated protein 2 | 51298.0 | ENSG00000105549 | nan | nan
chr19	C2CD4C	610336.0 | C2CD4C, NLF3, KIAA1957 | C2 calcium-dependent domain containing 4C | 126567.0 | ENSG00000183186 | nan | nan
chr19	SHC2	605217.0 | SHC2, SHCB, SCK | SHC transforming protein 2 | 25759.0 | ENSG00000129946 | nan | nan
chr19	MADCAM1	102670.0 | MACAM1 | Mucosal addressin cell adhesion molecule-1 | 8174.0 | ENSG00000099866 | nan | nan
chr19	TPGS1	620709.0 | TPGS1, PGS1, GTRGEO22 | Tubulin polyclutamylase complex, subunit 1 | 91978.0 | ENSG00000141933 | nan | nan
chr19	CDC34	116948.0 | CDC34, UBCH3, UBE2R1 | Cell division cycle 34, ubiquitin-conjugating enzyme | 997.0 | ENSG00000099804 | nan | nan
chr19	GZMM	600311.0 | GZMM | Granzyme M (lymphocyte met-ase 1) | 3004.0 | ENSG00000197540 | nan | nan
chr19	BSG	109480.0 | BSG | Basigin (blood group OK) | 682.0 | ENSG00000172270 | nan | [Blood group, OK], 111380 (3)
chr19	HCN2	602781.0 | HCN2, BCNG2, GEFSP11, FEB2, EIG17 | Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2 | 610.0 | ENSG00000099822 | nan | Febrile seizures, familial, 2, 602477 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 17}, 602477 (3), Autosomal dominant; Generalized epilepsy with febrile seizures plus, type 11, 602477 (3), Autosomal dominant
chr19	POLRMT	601778.0 | POLRMT, APOLMT, COXPD55 | Polymerase (RNA) mitochondrial (DNA directed) | 5442.0 | ENSG00000099821 | nan | Combined oxidative phosphorylation deficiency 55, 619743 (3), Autosomal recessive, Autosomal dominant
chr19	FGF22	605831.0 | FGF22 | Fibroblast growth factor 22 | 27006.0 | ENSG00000070388 | nan | nan
chr19	RNF126	615177.0 | RNF126 | RING finger protein 126 | 55658.0 | ENSG00000070423 | nan | nan
chr19	FSTL3	605343.0 | FSTL3, FLRG | Follistatin-like 3 | 10272.0 | ENSG00000070404 | nan | nan
chr19	PALM	608134.0 | PALM, KIAA0270 | Paralemmin | 5064.0 | ENSG00000099864 | nan | nan
chr19	MISP	615289.0 | MISP, C19orf21 | Mitotic spindle-positioning protein | 126353.0 | ENSG00000099812 | nan | nan
chr19	PTBP1	600693.0 | PTBP1, PTB, HNRNPI | Polypyrimidine tract-binding protein 1 | 5725.0 | ENSG00000011304 | pseudogene on chr. 14 | nan
chr19	PLPPR3	610391.0 | PLPPR3, LPPR3, LPR3, PRG2 | Phospholipid phosphatase-related protein 3 | 79948.0 | ENSG00000129951 | nan | nan
chr19	AZU1	162815.0 | AZU1, CAP37 | Azurocidin-1 (cationic antimicrobial protein-37) | 566.0 | ENSG00000172232 | 5\(rm-AZU1-8kb-PR3-3kb-ELAN-3' | nan
chr19	PRTN3	177020.0 | PRTN3, AGP7 | Proteinase 3 | 5657.0 | ENSG00000196415 | nan | nan
chr19	ELANE	130130.0 | ELANE, ELA2, SCN1 | Elastase, neutrophil-expressed | 1991.0 | ENSG00000197561 | nan | Neutropenia, cyclic, 162800 (3), Autosomal dominant; Neutropenia, severe congenital 1, autosomal dominant, 202700 (3), Autosomal dominant
chr19	CFD	134350.0 | CFD, ADN | Complement factor D | 1675.0 | ENSG00000197766 | nan | Complement factor D deficiency, 613912 (3), Autosomal recessive
chr19	MED16	604062.0 | MED16, THRAP5, DRIP92, TRAP95 | Mediator complex subunit 16 | 10025.0 | ENSG00000175221 | nan | nan
chr19	KISS1R	604161.0 | KISS1R, GPR54, HH8, CPPB1 | KISS1 receptor | 84634.0 | ENSG00000116014 | mutation identified in 1 CPPB1 patient | Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3), Autosomal recessive; ?Precocious puberty, central, 1, 176400 (3), Autosomal dominant
chr19	ARID3A	603265.0 | DRIL1 | Dead ringer, Drosophila, homolog-like 1 | 1820.0 | ENSG00000116017 | nan | nan
chr19	WDR18	620291.0 | WDR18 | WD repeat-containing protein 18 | 57418.0 | ENSG00000065268 | nan | nan
chr19	GRIN3B	606651.0 | GRIN3B | Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B | 116444.0 | ENSG00000116032 | nan | nan
chr19	TMEM259	611011.0 | TMEM259, C19orf6 | Transmembrane protein 259 (membralin) | 91304.0 | ENSG00000182087 | nan | nan
chr19	CNN2	602373.0 | CNN2 | Calonin 2 | 1265.0 | ENSG00000064666 | previously assigned to 21q11.1 | nan
chr19	ABCA7	605414.0 | ABCA7, ABCX, AD9 | ATP-binding cassette, subfamily A, member 7 | 10347.0 | ENSG00000064687 | nan | {Alzheimer disease 9, susceptibility to}, 608907 (3), Autosomal dominant
chr19	ARHGAP45	601155.0 | HMHA1, HLA-HA1, KIAA0223 | Minor histocompatibility antigen HA-1 | 23526.0 | ENSG00000180448 | nan | nan
chr19	POLR2E	180664.0 | POLR2E | Polymerase (RNA) II (DNA directed) polypeptide E, 25kD | 5434.0 | ENSG00000099817 | nan | nan
chr19	GPX4	138322.0 | GPX4, SMDS | Glutathione peroxidase-4 (phospholipid hydroperoxidase) | 2879.0 | ENSG00000167468 | nan | Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3), Autosomal recessive
chr19	SBNO2	615729.0 | SBNO2, KIAA0963 | Strawberry notch, Drosophila, homolog of, 2 | 22904.0 | ENSG00000064932 | nan | nan
chr19	STK11	602216.0 | STK11, PJS, LKB1 | Serine/threonine protein kinase-11 | 6794.0 | ENSG00000118046 | nan | Melanoma, malignant, somatic, 155600 (3); Pancreatic cancer, somatic, 260350 (3); Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant; Testicular tumor, somatic, 273300 (3)
chr19	ATP5F1D	603150.0 | ATP5F1D, ATP5D, MC5DN5 | ATP synthase F1 subunit delta | 513.0 | ENSG00000099624 | nan | Mitochondrial complex V (ATP synthase) deficiency, 618120 (3), Autosomal recessive
chr19	MIDN	606700.0 | MIDN | Midnolin, mouse, homolog of | 90007.0 | ENSG00000167470 | nan | nan
chr19	CIRBP	602649.0 | CIRBP | Cold-inducible RNA-binding protein | 1153.0 | ENSG00000099622 | nan | nan
chr19	EFNA2	602756.0 | EFNA2, EPLG6, LERK6 | Ephrin A2 | 1943.0 | ENSG00000099617 | nan | nan
chr19	NDUFS7	601825.0 | NDUFS7, PSST, MC1DN3 | NADH-ubiquinone oxidoreductase core subunit S7 | 374291.0 | ENSG00000115286 | nan | Mitochondrial complex I deficiency, nuclear type 3, 618224 (3), Autosomal recessive
chr19	GAMT	601240.0 | GAMT, CCDS2 | Guanidinoacetate methyltransferase | 2593.0 | ENSG00000130005 | nan | Cerebral creatine deficiency syndrome 2, 612736 (3), Autosomal recessive
chr19	DAZAP1	607430.0 | DAZAP1 | DAZ-associated protein 1 | 26528.0 | ENSG00000071626 | nan | nan
chr19	RPS15	180535.0 | RPS15, RIG | Ribosomal protein S15 | 6209.0 | ENSG00000115268 | nan | nan
chr19	APC2	612034.0 | APC2, APCL, MRT74 | APC regulator of WNT signaling pathway 2 | 10297.0 | ENSG00000115266 | mutation identified in 1 MRT74 family | Cortical dysplasia, complex, with other brain malformations 10, 618677 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 74, 617169 (3), Autosomal recessive
chr19	PCSK4	600487.0 | PCSK4 | Proprotein convertase subtilisin/kexin type 4 | 54760.0 | ENSG00000115257 | nan | nan
chr19	REEP6	609346.0 | REEP6, DP1L1, TB2L1, C19orf32, RP77 | Receptor expression-enhancing protein 6 | 92840.0 | ENSG00000115255 | nan | Retinitis pigmentosa 77, 617304 (3), Autosomal recessive
chr19	MEX3D	611009.0 | MEX3D, RKHD1, TINO, KIAA2031 | Mex-3, C. elegans, homolog of, D | 399664.0 | ENSG00000181588 | nan | nan
chr19	MBD3	603573.0 | MBD3 | Methyl-CpG-binding domain protein 3 | 53615.0 | ENSG00000071655 | nan | nan
chr19	UQCR11	609711.0 | UQCR11, UQCR | Ubiquinol-cytochrome c reductase, complex III subunit XI | 10975.0 | ENSG00000127540 | nan | nan
chr19	TCF3	147141.0 | TCF3, E2A, AGM8A, AGM8B | Transcription factor-3 (E2A immunoglobulin enhancer-binding factors E12/E47) | 6929.0 | ENSG00000071564 | nan | Agammaglobulinemia 8B, autosomal recessive, 619824 (3), Autosomal recessive; Agammaglobulinemia 8A, autosomal dominant, 616941 (3), Autosomal dominant
chr19	ONECUT3	611294.0 | ONECUT3, OC3 | One cut homeobox 3 | 390874.0 | ENSG00000205922 | nan | nan
chr19	ATP8B3	605866.0 | ATP8B3, ATPIK | ATPase, class I, type 8B, member 3 | 148229.0 | ENSG00000130270 | nan | nan
chr19	REXO1	609614.0 | REXO1, REX1, ELOABP1, TCEB3BP1 | RNA exonuclease 1, S. cerevisiae, homolog of | 57455.0 | ENSG00000079313 | nan | nan
chr19	MIR1909	615201.0 | MIR1909 | Micro RNA 1909 | 100302210.0 | ENSG00000284216 | nan | nan
chr19	KLF16	606139.0 | KLF16, BTEB4, DRRF | Kruppel-like factor 16 | 83855.0 | ENSG00000129911 | nan | nan
chr19	ABHD17A	617942.0 | ABHD17A, FAM108A1 | Abhydrolase domain-containing protein 17A, depalmitoylase | 81926.0 | ENSG00000129968 | nan | nan
chr19	ADAT3	615302.0 | ADAT3, TAD3, NEDBGF | Adenosine deaminase, tRNA-specific, 3 | 113179.0 | ENSG00000213638 | nan | Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies, 615286 (3), Autosomal recessive
chr19	SCAMP4	613764.0 | SCAMP4 | Secretory carrier membrane protein 4 | 113178.0 | ENSG00000227500 | nan | nan
chr19	CSNK1G2	602214.0 | CSNK1G2 | Casein kinase 1, gamma-2 | 1455.0 | ENSG00000133275 | nan | nan
chr19	BTBD2	608531.0 | BTBD2 | BTB/POZ domain-containing protein 2 | 55643.0 | ENSG00000133243 | nan | nan
chr19	MKNK2	605069.0 | MKNK2, MNK2, GPRK7 | Mitogen-activated protein kinase-interacting serine/threonine kinase-2 | 2872.0 | ENSG00000099875 | nan | nan
chr19	MOB3A	620929.0 | MOB3A | MOB kinase activator 3A | 126308.0 | ENSG00000172081 | nan | nan
chr19	IZUMO4	618897.0 | IZUMO4 | IZUMO family, member 4 | 113177.0 | ENSG00000099840 | nan | nan
chr19	AP3D1	607246.0 | AP3D1, HPS10 | Adaptor-related protein complex 3, delta-1 subunit | 8943.0 | ENSG00000065000 | mutation identified in 1 HPS10 patient | ?Hermansky-Pudlak syndrome 10, 617050 (3), Autosomal recessive
chr19	DOT1L	607375.0 | DOT1L, DOT1, KIAA1814 | Dot1, yeast, homolog of | 84444.0 | ENSG00000104885 | nan | nan
chr19	PLEKHJ1	617834.0 | PLEKHJ1, GNRPX | Pleckstrin homology domain-containing protein, family J, member 1 | 55111.0 | ENSG00000104886 | nan | nan
chr19	SF3A2	600796.0 | SF3A2, SAP62, PRP11 | Splicing factor 3a, subunit 2, 66kD | 8175.0 | ENSG00000104897 | nan | nan
chr19	AMH	600957.0 | AMH, MIF | Anti-Mullerian hormone | 268.0 | ENSG00000104899 | nan | Persistent Mullerian duct syndrome, type I, 261550 (3), Autosomal recessive
chr19	JSRP1	608743.0 | JSRP1, JP45 | Junctional sarcoplasmic reticulum protein 1 | 126306.0 | ENSG00000167476 | nan | nan
chr19	OAZ1	601579.0 | OAZ1 | Ornithine decarboxylase antizyme 1 | 4946.0 | ENSG00000104904 | nan | nan
chr19	PEAK3	618526.0 | PEAK3, C19orf35 | PEAK family member 3 | 374872.0 | ENSG00000188305 | nan | nan
chr19	LINGO3	609792.0 | LRRN6B, LINGO3, LERN2 | Leucine-rich repeat protein, neuronal, 6B | 645191.0 | ENSG00000220008 | nan | nan
chr19	LSM7	607287.0 | LSM7 | LSM7 protein | 51690.0 | ENSG00000130332 | nan | nan
chr19	SPPL2B	608239.0 | SNPPL2B, IMP4, KIAA1532 | Signal peptide peptidase-like 2B | 56928.0 | ENSG00000005206 | nan | nan
chr19	TMPRSS9	610477.0 | TMPRSS9 | Transmembrane protease, serine 9 | 360200.0 | ENSG00000178297 | nan | nan
chr19	TIMM13	607383.0 | TIMM13 | Translocase of inner mitochondrial membrane 13 | 26517.0 | ENSG00000099800 | nan | nan
chr19	LMNB2	150341.0 | LMNB2, LMN2, EPM9, MCPH27 | Lamin B2 | 84823.0 | ENSG00000176619 | mutation identified in 1 EPM9 family | Microcephaly 27, primary, autosomal dominant, 619180 (3), Autosomal dominant; ?Epilepsy, progressive myoclonic, 9, 616540 (3), Autosomal recessive; {Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3), Autosomal dominant
chr19	GADD45B	604948.0 | GADD45B, MYD118 | Growth arrest- and DNA damage-inducible gene 45, beta | 4616.0 | ENSG00000099860 | nan | nan
chr19	GNG7	604430.0 | GNG7 | Guanine nucleotide-binding protein, gamma-7 | 2788.0 | ENSG00000176533 | nan | nan
chr19	DIRAS1	607862.0 | DIRAS1, RIG | DIRAS family, GTP-binding Ras-like protein 1 | 148252.0 | ENSG00000176490 | nan | nan
chr19	SLC39A3	612168.0 | SLC39A3, ZIP3 | Solute carrier family 39, zinc transporter, member 3 | 29985.0 | ENSG00000141873 | nan | nan
chr19	SGTA	603419.0 | SGTA, SGT | Small glutamine-rich tetratricopeptide repeat-containing cochaperone, alpha | 6449.0 | ENSG00000104969 | nan | nan
chr19	THOP1	601117.0 | THOP1 | Thimet oligopeptidase-1 | 7064.0 | ENSG00000172009 | nan | nan
chr19	ZNF77	194551.0 | ZNF77 | Zinc finger protein-77 (pT1) | 58492.0 | ENSG00000175691 | nan | nan
chr19	TLE6	612399.0 | TLE6, GRG6, OZEMA15 | TLE family member 6, subcortical maternal complex member | 79816.0 | ENSG00000104953 | nan | Oocyte/zygote/embryo maturation arrest 15, 616814 (3), Autosomal recessive
chr19	TLE2	601041.0 | TLE2, ESG2 | TLE family member 2, transcriptional corepressor | 7089.0 | ENSG00000065717 | nan | nan
chr19	TLE5	600188.0 | TLE5, AES, GRG5 | TLE family member 5, transcriptional modulator | 166.0 | ENSG00000104964 | nan | nan
chr19	GNA11	139313.0 | GNA11, HHC2, HYPOC2 | Guanine nucleotide-binding protein (G protein), alpha-11 | 2767.0 | ENSG00000088256 | nan | Hypocalciuric hypercalcemia, type II, 145981 (3), Autosomal dominant; Hypocalcemia, autosomal dominant 2, 615361 (3), Autosomal dominant
chr19	GNA15	139314.0 | GNA15, GNA16 | Guanine nucleotide-binding protein (G protein) alpha 15 (Gq class) | 2769.0 | ENSG00000060558 | nan | nan
chr19	S1PR4	603751.0 | S1PR4, EDG6, S1P4 | Sphingosine-1-phosphate receptor 4 | 8698.0 | ENSG00000125910 | nan | nan
chr19	NCLN	609156.0 | NCLN | Nicalin | 56926.0 | ENSG00000125912 | nan | nan
chr19	CELF5	612680.0 | CELF5, BRUNOL5 | CUGbp- and ELAV-like family, member 5 | 60680.0 | ENSG00000161082 | nan | nan
chr19	NFIC	600729.0 | NFIC | Nuclear factor I/C (CCAAT-binding transcription factor) | 4782.0 | ENSG00000141905 | order: cen-NFIX-NFIC-tel | nan
chr19	DOHH	611262.0 | DOHH, HLRC1, NEDMVIC | Deoxyhypusine hydroxylase | 83475.0 | ENSG00000129932 | nan | Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment, 620066 (3), Autosomal recessive
chr19	FZR1	603619.0 | FZR1, HCDH1, KIAA1242, DEE109 | Fizzy and cell division cycle 20-related protein 1 | 51343.0 | ENSG00000105325 | nan | Developmental and epileptic encephalopathy 109, 620145 (3), Autosomal dominant
chr19	MFSD12	617745.0 | MFSD12, PP3501 | Major facilitator superfamily domain-containing protein 12 | 126321.0 | ENSG00000161091 | nan | nan
chr19	HMG20B	605535.0 | HMG20B, BRAF35 | High mobility group protein 20B | 10362.0 | ENSG00000064961 | nan | nan
chr19	GIPC3	608792.0 | GIPC3, DFNB15, DFNB72, DFNB95 | GAIP C-terminus-interacting protein 3 | 126326.0 | ENSG00000179855 | nan | Deafness, autosomal recessive 15, 601869 (3), Autosomal recessive
chr19	TBXA2R	188070.0 | TBXA2R, BDPLT13 | Thromboxane A2 receptor | 6915.0 | ENSG00000006638 | nan | {Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3), Autosomal dominant
chr19	CACTIN	618536.0 | CACTIN, C19orf29 | Cactin, splicesome C complex subunit | 58509.0 | ENSG00000105298 | nan | nan
chr19	PIP5K1C	606102.0 | PIP5K1C, LCCS3 | Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma | 23396.0 | ENSG00000186111 | nan | Lethal congenital contractural syndrome 3, 611369 (3), Autosomal recessive
chr19	TJP3	612689.0 | TJP3, ZO3 | Tight junction protein 3 | 27134.0 | ENSG00000105289 | nan | nan
chr19	APBA3	604262.0 | APBA3, X11L2, MINT3 | Amyloid beta A4 precursor protein-binding, family A, member 3 | 9546.0 | ENSG00000011132 | nan | nan
chr19	MRPL54	611858.0 | MRPL54 | Mitochondrial ribosomal protein L54 | 116541.0 | ENSG00000183617 | nan | nan
chr19	RAX2	610362.0 | RAX2, RAXL1, QRX, CORD11, ARMD6, RP95 | Retina and anterior neural fold homeobox 2 | 84839.0 | ENSG00000173976 | mutation identified in 1 ARMD6 patient | Retinitis pigmentosa 95, 620102 (3), Autosomal recessive; Cone-rod dystrophy 11, 610381 (3), Autosomal dominant; ?Macular degeneration, age-related, 6, 613757 (3)
chr19	MATK	600038.0 | MATK, HYL, CTK | Megakaryocyte-associated tyrosine kinase | 4145.0 | ENSG00000007264 | nan | nan
chr19	ZFR2	619284.0 | ZFR2, KIAA1086 | Zinc finger RNA-binding protein 2 | 23217.0 | ENSG00000105278 | nan | nan
chr19	ATCAY	608179.0 | ATCAY, CLAC, KIAA1872 | Caytaxin | 85300.0 | ENSG00000167654 | nan | Ataxia, cerebellar, Cayman type, 601238 (3), Autosomal recessive
chr19	NMRK2	608705.0 | ITGB1BP3, MIBP | Integrin, beta-1, binding protein of, 3 | 27231.0 | ENSG00000077009 | nan | nan
chr19	DAPK3	603289.0 | ZIPK | ZIP kinase | 1613.0 | ENSG00000167657 | nan | nan
chr19	EEF2	130610.0 | EEF2, EF2, SCA26 | Eukaryotic translation elongation factor-2 | 1938.0 | ENSG00000167658 | mutation identified in 1 family | ?Spinocerebellar ataxia 26, 609306 (3), Autosomal dominant
chr19	PIAS4	605989.0 | PIAS4, PIASY | Protein inhibitor of activated STAT4 | 51588.0 | ENSG00000105229 | nan | nan
chr19	ZBTB7A	605878.0 | ZBTB7A, FBI1, LRF, MNDLFH | Zinc finger and BTB domain containing 7A | 51341.0 | ENSG00000178951 | nan | Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin, 619769 (3), Autosomal dominant
chr19	MAP2K2	601263.0 | MAP2K2, PRKMK2, MEK2, MKK2, CFC4 | Mitogen-activated protein kinase kinase 2 | 5605.0 | ENSG00000126934 | previously assigned to 7q32 | Cardiofaciocutaneous syndrome 4, 615280 (3), Autosomal dominant
chr19	CREB3L3	611998.0 | CREB3L3, CREBH, HYTG2 | cAMP responsive element-binding protein 3-like 3 | 84699.0 | ENSG00000060566 | nan | Hypertriglyceridemia 2, 619324 (3), Autosomal dominant
chr19	SIRT6	606211.0 | SIRT6, SIR2L6 | Sirtuin 6 | 51548.0 | ENSG00000077463 | nan | nan
chr19	ANKRD24	620234.0 | ANKRD24, KIAA1981 | Ankyrin repeat domain-containing protein 24 | 170961.0 | ENSG00000089847 | nan | nan
chr19	EBI3	605816.0 | EBI3 | Epstein-Barr virus-induced gene 3 | 10148.0 | ENSG00000105246 | nan | nan
chr19	SHD	610481.0 | SHD | SH2 domain-containing protein D | 56961.0 | ENSG00000105251 | nan | nan
chr19	TMIGD2	614715.0 | TMIGD2, IGPR1 | Transmembrane and immunoglobulin domains-containing protein 2 | 126259.0 | ENSG00000167664 | nan | nan
chr19	FSD1	609828.0 | FSD1, GLFND | Fibronectin type 3 and SPRY domains-containing protein 1 | 79187.0 | ENSG00000105255 | nan | nan
chr19	STAP2	607881.0 | STAP2, BKS | Signal-transducing adaptor protein 2 | 55620.0 | ENSG00000178078 | nan | nan
chr19	SH3GL1	601768.0 | SH3GL1, EEN | SH3 domain GRB2-like 1 (Extra 11-19 leukemia fusion gene) | 6455.0 | ENSG00000141985 | nan | Leukemia, acute myeloid, 601626 (1), Somatic mutation, Autosomal dominant
chr19	CHAF1A	601246.0 | CHAF1A, CAF1B, CAF1P150 | Chromatin assembly factor I, subunit A | 10036.0 | ENSG00000167670 | nan | nan
chr19	UBXN6	611946.0 | UBXN6, UBXD1 | UBX domain protein 6 | 80700.0 | ENSG00000167671 | nan | nan
chr19	HDGFL2	617884.0 | HDGFL2, HDGFRP2 | Hepatoma-derived growth factor-like protein 2 | 84717.0 | ENSG00000167674 | nan | nan
chr19	PLIN4	613247.0 | PLIN4, KIAA1881, MRUPAV | Perilipin 4 | 729359.0 | ENSG00000167676 | nan | Myopathy with rimmed ubiquitin-positive autophagic vacuolation, autosomal dominant, 601846 (3), Autosomal dominant
chr19	PLIN5	613248.0 | PLIN5, LSDP5 | Perilipin 5 | 440503.0 | ENSG00000214456 | nan | nan
chr19	LRG1	611289.0 | LRG1, LRG | Leucine-rich alpha-2-glycoprotein 1 | 116844.0 | ENSG00000171236 | nan | nan
chr19	SEMA6B	608873.0 | SEMA6B, EPM11 | Semaphorin 6B | 10501.0 | ENSG00000167680 | nan | Epilepsy, progressive myoclonic, 11, 618876 (3), Autosomal dominant
chr19	TNFAIP8L1	615869.0 | TNFAIP8L1, TIPE1 | Tumor necrosis factor-alpha-induced protein 8-like 1 | 126282.0 | ENSG00000185361 | nan | nan
chr19	MYDGF	606746.0 | MYDGF, C19orf10, SF20, IL25 | Myeloid-derived growth factor | 56005.0 | ENSG00000074842 | nan | nan
chr19	DPP9	608258.0 | DPP9, DPRP2, HATIS, IMD111 | Dipeptidyl peptidase IX | 91039.0 | ENSG00000142002 | nan | Hatipoglu immunodeficiency syndrome, 620331 (3), Autosomal recessive
chr19	TRG-TCC1-1	615303.0 | TRG-TCC1-1, TRNAG3 | tRNA glycine (anticodon TCC) 1-1 | 7197.0 | nan | nan | nan
chr19	TRV-CAC3-1	615304.0 | TRNAV32 | Transfer RNA valine 32 | 100189416.0 | nan | nan | nan
chr19	FEM1A	613538.0 | FEM1A | Fem-1 homolog A | 55527.0 | ENSG00000141965 | nan | nan
chr19	TICAM1	607601.0 | TICAM1, TRIF, IIAE6 | TIR domain-containing adaptor molecule 1 | 148022.0 | ENSG00000127666 | nan | {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}, 614850 (3), Autosomal recessive, Autosomal dominant
chr19	PLIN3	602702.0 | PLIN3, M6PRBP1, TIP47 | Perilipin 3 | 10226.0 | ENSG00000105355 | nan | nan
chr19	ARRDC5	620944.0 | ARRDC5 | Arrestin domain-containing protein 5 | 645432.0 | ENSG00000205784 | nan | nan
chr19	UHRF1	607990.0 | UHRF1, ICBP90, NP95 | Ubiquitin-like protein containing PHD and RING finger domains 1 | 29128.0 | ENSG00000276043 | nan | nan
chr19	KDM4B	609765.0 | KDM4B, JMJD2B, KIAA0876, MRD65 | Lysine demethylase 4B | 23030.0 | ENSG00000127663 | nan | Intellectual developmental disorder, autosomal dominant 65, 619320 (3), Autosomal dominant
chr19	PTPRS	601576.0 | PTPRS | Protein tyrosine phosphatase, receptor type, sigma | 5802.0 | ENSG00000105426 | nan | nan
chr19	ZNRF4	612063.0 | ZNRF4, SPERIZIN | Zinc finger and ring finger protein 4 | 148066.0 | ENSG00000105428 | nan | nan
chr19	TINCR	615241.0 | TINCR | Terminal differentiation-induced noncoding RNA | 257000.0 | ENSG00000223573 | nan | nan
chr19	SAFB2	608066.0 | SAFB2, KIAA0138 | Scaffold attachment factor B2 | 9667.0 | ENSG00000130254 | nan | nan
chr19	SAFB	602895.0 | SAFB, HET | Scaffold attachment factor B | 6294.0 | ENSG00000160633 | nan | nan
chr19	MICOS13	616658.0 | MICOS13, C19orf70, MIC13, QIL1 | Mitochondrial contact site and cristae organizing system subunit 13 | 125988.0 | ENSG00000174917 | nan | Combined oxidative phosphorylation deficiency 37, 618329 (3), Autosomal recessive
chr19	RPL36	617893.0 | RPL36 | Ribosomal protein L36 | 25873.0 | ENSG00000130255 | nan | nan
chr19	LONP1	605490.0 | LONP1, PRSS15, LON, CODASS | lon peptidase 1, mitochondrial | 9361.0 | ENSG00000196365 | nan | CODAS syndrome, 600373 (3), Autosomal recessive
chr19	CATSPERD	617490.0 | CATSPERD, TMEM146 | Cation channel, sperm-associated, auxiliary subunit delta | 257062.0 | ENSG00000174898 | nan | nan
chr19	NRTN	602018.0 | NRTN, NTN | Neurturin | 4902.0 | ENSG00000171119 | nan | nan
chr19	FUT6	136836.0 | FUT6 | Fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | 2528.0 | ENSG00000156413 | in cluster with FUT3, FUT5 | [Fucosyltransferase 6 deficiency], 613852 (3)
chr19	FUT3	111100.0 | FUT3, LE | Fucosyltransferase 3 | 2525.0 | ENSG00000171124 | cen-FUT5-23kb-FUT3-14kb-FUT6-ter | [Blood group, Lewis], 618983 (3)
chr19	FUT5	136835.0 | FUT5 | Fucosyltransferase 5 (alpha (1,3) fucosyltransferase) | 2527.0 | ENSG00000130383 | cen-FUT5-FUT3-FUT6-ter | nan
chr19	NDUFA11	612638.0 | NDUFA11, MC1DN14 | NADH-ubiquinone oxidoreductase subunit A11 | 126328.0 | ENSG00000174886 | nan | Mitochondrial complex I deficiency, nuclear type 14, 618236 (3), Autosomal recessive
chr19	VMAC	617204.0 | VMAC | Vimentin-type intermediate filament-associated coiled-coil protein | 400673.0 | ENSG00000187650 | nan | nan
chr19	CAPS	114212.0 | CAPS | Calcyphosine | 828.0 | ENSG00000105519 | nan | nan
chr19	RANBP3	603327.0 | RANBP3 | RAN-binding protein-3 | 8498.0 | ENSG00000031823 | nan | nan
chr19	RFX2	142765.0 | RFX2 | Regulatory factor (trans-acting) 2 (influences HLA class II expression) | 5990.0 | ENSG00000087903 | nan | nan
chr19	ACSBG2	614363.0 | ACSBG2, BGR | Acyl-CoA synthetase, bubblegum family, member 2 | 81616.0 | ENSG00000130377 | nan | nan
chr19	MLLT1	159556.0 | MLLT1, ENL | MLLT1 super elongation complex subunit | 4298.0 | ENSG00000130382 | fuses with ALL1 | nan
chr19	ACER1	613491.0 | ACER1 | Alkaline ceraminidase 1 | 125981.0 | ENSG00000167769 | nan | nan
chr19	CLPP	601119.0 | CLPP, PRLTS3, DFNB81 | ATP-dependent protease ClpAP, E. coli, proteolytic subunit, homolog of | 8192.0 | ENSG00000125656 | nan | Perrault syndrome 3, 614129 (3), Autosomal recessive
chr19	ALKBH7	613305.0 | ALKBH7, ABH7 | AlkB homolog 7 | 84266.0 | ENSG00000125652 | nan | nan
chr19	PSPN	602921.0 | PSPN | Persephin | 5623.0 | ENSG00000125650 | nan | nan
chr19	GTF2F1	189968.0 | GTF2F1, RAP74 | General transcription factor IIF, polypeptide 1 (74kD subunit) | 2962.0 | ENSG00000125651 | nan | nan
chr19	KHSRP	603445.0 | KHSRP, KSRP, FUBP2, FBP2 | KH-type splicing regulatory protein | 8570.0 | ENSG00000088247 | nan | nan
chr19	SLC25A41	610822.0 | SLC25A41 | Solute carrier family 25, member 41 | 284427.0 | ENSG00000181240 | nan | nan
chr19	SLC25A23	608746.0 | SLC25A23, SCAMC3 | Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 23 | 79085.0 | ENSG00000125648 | nan | nan
chr19	CRB3	609737.0 | CRB3 | Crumbs cell polarity complex component 3 | 92359.0 | ENSG00000130545 | nan | nan
chr19	DENND1C	613634.0 | DENND1C | DENN/MADD domain-containing protein 1C | 79958.0 | ENSG00000205744 | nan | nan
chr19	TUBB4A	602662.0 | TUBB4A, DYT4, HLD6 | Tubulin, beta-4A | 10382.0 | ENSG00000104833 | nan | Dystonia 4, torsion, autosomal dominant, 128101 (3), Autosomal dominant; Leukodystrophy, hypomyelinating, 6, 612438 (3), Autosomal dominant
chr19	TNFSF9	606182.0 | TNFSF9 | Tumor necrosis factor ligand superfamily, member 9 | 8744.0 | ENSG00000125657 | nan | nan
chr19	CD70	602840.0 | CD70, TNFSF7, CD27L, LPFS3 | CD70 molecule | 970.0 | ENSG00000125726 | nan | Lymphoproliferative syndrome 3, 618261 (3), Autosomal recessive
chr19	TNFSF14	604520.0 | TNFSF14, HVEML | Tumor necrosis factor ligand superfamily, member 14 | 8740.0 | ENSG00000125735 | nan | nan
chr19	C3	120700.0 | C3, ARMD9, AHUS5 | Complement component-3 | 718.0 | ENSG00000125730 | LE ~7cM in males vs. C3 RFLP | C3 deficiency, 613779 (3), Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3), Autosomal dominant; {Macular degeneration, age-related, 9}, 611378 (3)
chr19	GPR108	618491.0 | GPR108, LUSTR2 | G protein-coupled receptor 108 | 56927.0 | ENSG00000125734 | nan | nan
chr19	TRIP10	604504.0 | TRIP10, CIP4 | Thyroid hormone receptor interactor 10 | 9322.0 | ENSG00000125733 | nan | nan
chr19	SH2D3A	604721.0 | SH2D3A, NSP1 | SH2 domain-containing protein 3A | 10045.0 | ENSG00000125731 | nan | nan
chr19	VAV1	164875.0 | VAV1, VAV | VAV guanine nucleotide exchange factor 1 | 7409.0 | ENSG00000141968 | close to INSR | nan
chr19	ADGRE1	600493.0 | ADGRE1, EMR1 | Adhesion G protein-coupled receptor E1 | 2015.0 | ENSG00000174837 | nan | nan
chr19		164953.0 | LPSA, D19S381E | Oncogene liposarcoma (DNA segment, single copy, expressed, probes MC15, MC6) | 8177.0 | nan | nan | Liposarcoma (1)
chr19	NRCLP6	614223.0 | NRCLP6 | Narcolepsy 6 | 100689216.0 | nan | associated with rs2305795 | Narcolepsy 6, 614223 (2)
chr19	PAPA3	607324.0 | PAPA3 | Polydactyly, postaxial, type A3 | 338333.0 | nan | between D19S1165 and D19S929 | Polydactyly, postaxial, type A3, 607324 (2)
chr19	PCOS1	184700.0 | PCOS1, PCO1, PCO | Polycystic ovary syndrome 1 | 5120.0 | nan | max lod at D19S884 | Polycystic ovary syndrome 1, 184700 (2), Autosomal dominant
chr19	TCO	603386.0 | TCO | Thyroid carcinoma, nonmedullary, with cell oxyphilia | 50975.0 | nan | nan | Thyroid carcinoma, nonmedullary, with cell oxyphilia, 603386 (2)
chr19	ADGRE4P	612305.0 | ADGRE4P, EMR4, GPR127, EMR4P, FIRE | Adhesion G protein-coupled receptor E4, pseudogene | 326342.0 | nan | nan | nan
chr19	MBD3L2	607964.0 | MBD3L2 | Methyl-CpG binding domain protein 3-like 2 | 125997.0 | ENSG00000230522 | nan | nan
chr19	INSR	147670.0 | INSR, HHF5 | Insulin receptor | 3643.0 | ENSG00000171105 | 1 gene for alpha and beta subunits | Rabson-Mendenhall syndrome, 262190 (3), Autosomal recessive; Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3); Donohue syndrome, 246200 (3), Autosomal recessive; Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3), Autosomal dominant
chr19	ARHGEF18	616432.0 | ARHGEF18, KIAA0521, RP78 | Rho guanine nucleotide exchange factor 18 | 23370.0 | ENSG00000104880 | nan | Retinitis pigmentosa 78, 617433 (3), Autosomal recessive
chr19	PEX11G	607583.0 | PEX11G | Peroxisome biogenesis factor 11G | 92960.0 | ENSG00000104883 | nan | nan
chr19	ZNF358	619496.0 | ZNF358, ZFEND | Zinc finger protein 358 | 140467.0 | ENSG00000198816 | nan | nan
chr19	MCOLN1	605248.0 | MCOLN1, ML4, LECD | Mucolipin 1 | 57192.0 | ENSG00000090674 | nan | Lisch epithelial corneal dystrophy, 620763 (3), Autosomal dominant; Mucolipidosis IV, 252650 (3), Autosomal recessive
chr19	PNPLA6	603197.0 | PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS | Patatin-like phospholipase domain-containing protein 6 | 10908.0 | ENSG00000032444 | mutation identified in 1 LMNS family | Spastic paraplegia 39, autosomal recessive, 612020 (3), Autosomal recessive; Oliver-McFarlane syndrome, 275400 (3), Autosomal recessive; ?Laurence-Moon syndrome, 245800 (3), Autosomal recessive; Boucher-Neuhauser syndrome, 215470 (3), Autosomal recessive
chr19	CAMSAP3	612685.0 | CAMSAP3, NEZHA, KIAA1543 | Calmodulin-regulated spectrin-associated protein 3 | 57662.0 | ENSG00000076826 | nan | nan
chr19	XAB2	610850.0 | XAB2 | XPA-binding protein 2 | 56949.0 | ENSG00000076924 | nan | nan
chr19	PET100	614770.0 | PET100, C19orf79, MC4DN12 | PET100 cytochrome c oxidase chaperone | 100131801.0 | ENSG00000229833 | nan | Mitochondrial complex IV deficiency, nuclear type 12, 619055 (3), Autosomal recessive
chr19	STXBP2	601717.0 | STXBP2, UNC18B, FHL5 | Syntaxin binding protein 2 | 6813.0 | ENSG00000076944 | nan | Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease, 613101 (3), Autosomal recessive
chr19	PCP2	619344.0 | PCP2, PCD5 | Purkinje cell protein 2 | 126006.0 | ENSG00000174788 | nan | nan
chr19	RETN	605565.0 | RETN, RSTN, FIZZ3 | Resistin | 56729.0 | ENSG00000104918 | nan | {Hypertension, insulin resistance-related, susceptibility to}, 125853 (3), Autosomal dominant; {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant
chr19	MCEMP1	609565.0 | MCEMP1 | Mast cell-expressed membrane protein 1 | 199675.0 | ENSG00000183019 | nan | nan
chr19	FCER2	151445.0 | FCER2, FCE2, CD23, CLEC4J | Fc fragment of IgE, low affinity II, receptor for (CD23A) | 2208.0 | ENSG00000104921 | nan | nan
chr19	CLEC4G	616256.0 | CLEC4G, LSECTIN | C-type lectin domain family 4, member G | 339390.0 | ENSG00000182566 | nan | nan
chr19	CD209	604672.0 | CD209, CDSIGN | CD209 antigen | 30835.0 | ENSG00000090659 | nan | {HIV type 1, susceptibility to}, 609423 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3); {Dengue fever, protection against}, 614371 (3)
chr19	CLEC4M	605872.0 | CLEC4M, CD209L, LSIGN, DCSIGNR | C-type lectin domain family 4, member M | 10332.0 | ENSG00000104938 | nan | nan
chr19	LRRC8E	612891.0 | LRRC8E | Leucine-rich repeat-containing protein 8E | 80131.0 | ENSG00000171017 | nan | nan
chr19	MAP2K7	603014.0 | MAP2K7, PRKMK7, MKK7, JNKK2, MAPKK7 | Mitogen-activated protein kinase kinase 7 | 5609.0 | ENSG00000076984 | nan | nan
chr19	SNAPC2	605076.0 | SNAPC2, SNAP45 | Small nuclear RNA-activating protein complex, polypeptide 2 | 6618.0 | ENSG00000104976 | nan | nan
chr19	CTXN1	600135.0 | CTXN1, CTXN | Cortexin 1 | 404217.0 | ENSG00000178531 | nan | nan
chr19	TIMM44	605058.0 | TIMM44 | Translocase of inner mitochondrial membrane 44 | 10469.0 | ENSG00000104980 | nan | nan
chr19	ELAVL1	603466.0 | ELAVL1, HUR | ELAV-like RNA binding protein 1 | 1994.0 | ENSG00000066044 | nan | nan
chr19	CCL25	602565.0 | CCL25, SCYA25, TECK | Chemokine, C-C motif, ligand 25 | 6370.0 | ENSG00000131142 | nan | nan
chr19	FBN3	608529.0 | FBN3, KIAA1776 | Fibrillin 3 | 84467.0 | ENSG00000142449 | nan | nan
chr19	CERS4	615334.0 | CERS4, LASS4, TRH1 | Ceramide synthase 4 | 79603.0 | ENSG00000090661 | nan | nan
chr19	CD320	606475.0 | CD320, 8D6, 8D6A, TCBLR | CD320 molecule | 51293.0 | ENSG00000167775 | nan | Methylmalonic aciduria, transient, due to transcobalamin receptor defect, 613646 (3), Autosomal recessive
chr19	NDUFA7	602139.0 | NDUFA7 | NADH-ubiquinone oxidoreductase subunit A7 | 4701.0 | ENSG00000267855 | previously assigned to 20p13 | nan
chr19	RPS28	603685.0 | RPS28, DBA15 | Ribosomal protein S28 | 6234.0 | ENSG00000233927 | nan | Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3), Autosomal dominant
chr19	KANK3	614611.0 | KANK3 | KN motif- and ankyrin repeat domain-containing protein 3 | 256949.0 | ENSG00000186994 | nan | nan
chr19	ANGPTL4	605910.0 | ANGPTL4, PGAR, HFARP, FIAF, TGQTL | Angiopoietin-like 4 | 51129.0 | ENSG00000167772 | nan | Plasma triglyceride level QTL, low, 615881 (3), Autosomal dominant
chr19	RAB11B	604198.0 | RAB11B, NDAGSCW | Ras-associated protein RAB11B | 9230.0 | ENSG00000185236 | nan | Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter, 617807 (3), Autosomal dominant
chr19	MARCHF2	613332.0 | MARCH2 | Membrane-associated RING-CH finger protein 2 | 51257.0 | ENSG00000099785 | nan | nan
chr19	HNRNPM	160994.0 | HNRPM, HNRPM4, NAGR1 | Heterogeneous nuclear ribonucleoprotein M | 4670.0 | ENSG00000099783 | nan | nan
chr19	PRAM1	606466.0 | PRAM1 | PML-RARA target gene encoding an adaptor molecule 1 | 84106.0 | ENSG00000133246 | nan | nan
chr19	ZNF414	620980.0 | ZNF414 | Zinc finger protein 414 | 84330.0 | ENSG00000133250 | nan | nan
chr19	MYO1F	601480.0 | MYO1F | Myosin IF | 4542.0 | ENSG00000142347 | nan | nan
chr19	ADAMTS10	608990.0 | ADAMTS10, WMS1 | ADAM metallopeptidase domain with thrombospondin type 1 motif, 10 | 81794.0 | ENSG00000142303 | nan | Weill-Marchesani syndrome 1, recessive, 277600 (3), Autosomal recessive
chr19	ACTL9	619251.0 | ACTL9, SPGF53 | Actin-like 9 | 284382.0 | ENSG00000181786 | nan | Spermatogenic failure 53, 619258 (3), Autosomal recessive
chr19	MBD3L1	607963.0 | MBD3L1 | Methyl-CpG binding domain protein 3-like 1 | 85509.0 | ENSG00000170948 | nan | nan
chr19	MUC16	606154.0 | MUC16, CA125 | Mucin 16 | 94025.0 | ENSG00000181143 | nan | nan
chr19	ZNF317	613864.0 | ZNF317, KIAA1588 | Zinc finger protein 317 | 57693.0 | ENSG00000130803 | nan | nan
chr19	OR7D4	611538.0 | OR7D4, OR19B | Olfactory receptor, family 7, subfamily D, member 4 | 125958.0 | ENSG00000174667 | nan | nan
chr19	ZNF699	609571.0 | ZNF699, FLJ38144, DEGCAGS | Zinc finger protein 699 | 374879.0 | ENSG00000196110 | nan | DEGCAGS syndrome, 619488 (3), Autosomal recessive
chr19	ZNF177	601276.0 | ZNF177 | Zinc finger protein 177 | 7730.0 | ENSG00000188629 | nan | nan
chr19	ZNF266	604751.0 | ZNF266, HZF1 | Zinc finger protein-266 | 10781.0 | ENSG00000174652 | nan | nan
chr19	ZNF121	194628.0 | ZNF121, D19S204 | Zinc finger protein-121 (clone ZHC32) | 7675.0 | ENSG00000197961 | nan | nan
chr19	FBXL12	609079.0 | FBXL12, FBL12 | F-box and leucine-rich repeat protein 12 | 54850.0 | ENSG00000127452 | nan | nan
chr19	UBL5	606849.0 | UBL5, HUB1 | Ubiquitin-like 5 | 59286.0 | ENSG00000198258 | pseudogene on 17p11.2 | nan
chr19	PIN1	601052.0 | PIN1, DOD | Peptidyl-prolyl cis/trans isomerase, NIMA-interacting | 5300.0 | ENSG00000127445 | nan | nan
chr19	OLFM2	617492.0 | OLFM2, NOE2 | Olfactomedin 2 | 93145.0 | ENSG00000105088 | nan | nan
chr19	COL5A3	120216.0 | COL5A3 | Collagen, type V, alpha-3 polypeptide | 50509.0 | ENSG00000080573 | nan | nan
chr19	RDH8	608575.0 | RDH8, PRRDH | Retinol dehydrogenase 8 | 50700.0 | ENSG00000080511 | nan | nan
chr19	SHFL	616808.0 | SHFL, C19orf66, RYDEN | Shiftless antiviral inhibitor of ribosomal frameshifting | 55337.0 | ENSG00000130813 | nan | nan
chr19	ANGPTL6	609336.0 | ANGPTL6, AGF | Angiopoietin-like 6 | 83854.0 | ENSG00000130812 | nan | nan
chr19	PPAN	607793.0 | PPAN, SSF1 | Peter pan, Drosophila, homolog of | 56342.0 | ENSG00000130810 | fuses with P2RY11 | nan
chr19	P2RY11	602697.0 | P2RY11 | Purinergic receptor P2Y, G protein-coupled, 11 | 5032.0 | ENSG00000244165 | fuses with PPAN | nan
chr19	EIF3G	603913.0 | EIF3G, EIF3S4 | Eukaryotic translation initiation factor 3, subunit G | 8666.0 | ENSG00000130811 | nan | nan
chr19	DNMT1	126375.0 | DNMT1, MCMT, HSN1E, ADCADN | DNA methyltransferase 1 | 1786.0 | ENSG00000130816 | nan | Neuropathy, hereditary sensory, type IE, 614116 (3), Autosomal dominant; Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3), Autosomal dominant
chr19	S1PR2	605111.0 | S1PR2, EDG5, DFNB68 | Sphingosine-1-phosphate receptor 2 | 9294.0 | ENSG00000267534 | nan | Deafness, autosomal recessive 68, 610419 (3), Autosomal recessive
chr19	MRPL4	611823.0 | MRPL4 | Mitochondrial ribosomal protein L4 | 51073.0 | ENSG00000105364 | nan | nan
chr19	ICAM1	147840.0 | ICAM1 | Intercellular adhesion molecule-1 | 3383.0 | ENSG00000090339 | close to Ldlr in mouse | {Malaria, cerebral, susceptibility to}, 611162 (3)
chr19	ICAM4	614088.0 | ICAM4, CD242, LW | Intracellular adhesion molecule 4 | 3386.0 | ENSG00000105371 | close to C3, LU | [Blood group, Landsteiner-Wiener], 111250 (3)
chr19	ICAM5	601852.0 | ICAM5, TLCN, TLN | Intercellular adhesion molecule 5 (telencephalin) | 7087.0 | ENSG00000105376 | nan | nan
chr19	ZGLP1	611639.0 | ZGLP1, GLP1 | Zinc finger GATA-like protein 1 | 100125288.0 | ENSG00000220201 | nan | nan
chr19	FDX2	614585.0 | FDX2, FDX1L, MEOAL | Ferredoxin 2 | 112812.0 | ENSG00000267673 | nan | Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy, 251900 (3), Autosomal recessive
chr19	RAVER1	609950.0 | RAVER1, KIAA1978 | Ribonucleoprotein, PTB binding 1 | 125950.0 | ENSG00000161847 | nan | nan
chr19	ICAM3	146631.0 | ICAM3, CDW50 | Intercellular adhesion molecule-3 | 3385.0 | ENSG00000076662 | nan | nan
chr19	TYK2	176941.0 | TYK2, IMD35 | Tyrosine kinase 2 | 7297.0 | ENSG00000105397 | nan | Immunodeficiency 35, 611521 (3), Autosomal recessive
chr19	CDC37	605065.0 | CDC37 | Cell division cycle 37, HSP90 cochaperone | 11140.0 | ENSG00000105401 | nan | nan
chr19	PDE4A	600126.0 | PDE4A, DPDE2 | Phosphodiesterase-4A, cAMP-specific (dunce, Drosophila, homolog phosphodiesterase E2) | 5141.0 | ENSG00000065989 | nan | nan
chr19	KEAP1	606016.0 | KEAP1, KIAA0132 | Kelch-like ECH-associated protein 1 | 9817.0 | ENSG00000079999 | nan | nan
chr19	S1PR5	605146.0 | S1PR5, EDG8 | Sphingosine-1-phosphate receptor 5 | 53637.0 | ENSG00000180739 | nan | nan
chr19	ATG4D	611340.0 | ATG4D, APG4D, AUTL4 | Autophagy related 4D cysteine peptidase | 84971.0 | ENSG00000130734 | nan | nan
chr19	CDKN2D	600927.0 | CDKN2D | Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | 1032.0 | ENSG00000129355 | possible tumor suppressor | nan
chr19	AP1M2	607309.0 | AP1M2, MU1B | Adaptor-related protein complex 1, mu-2 subunit | 10053.0 | ENSG00000129354 | nan | nan
chr19	SLC44A2	606106.0 | SLC44A2, CTL2 | Solute carrier family 44, member 2 | 57153.0 | ENSG00000129353 | nan | nan
chr19	ILF3	603182.0 | ILF3, NF90, DRBP76, MPHOSPH4, NFAR | Interleukin enhancer-binding factor 3 | 3609.0 | ENSG00000129351 | nan | nan
chr19	QTRT1	609615.0 | QTRT1, TGT | Queuine tRNA-ribosyltransferase 1 | 81890.0 | ENSG00000213339 | nan | nan
chr19	DNM2	602378.0 | DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5 | Dynamin-2 | 1785.0 | ENSG00000079805 | 1 LCCS5 family identified with mutation | Centronuclear myopathy 1, 160150 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal type 2M, 606482 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3), Autosomal dominant; Lethal congenital contracture syndrome 5, 615368 (3), Autosomal recessive
chr19	MIR199A1	610719.0 | MIR199A1, MIRN199A1 | Micro RNA 199A1 | 406976.0 | ENSG00000207752 | nan | nan
chr19	TMED1	605395.0 | TMED1, IL1RL1LG | Transmembrane p24 trafficking protein 1 (interleukin-1 receptor-like 1 ligand) | 11018.0 | ENSG00000099203 | nan | nan
chr19	CARM1	603934.0 | CARM1, PRMT4 | Coactivator-associated arginine methyltransferase 1 | 10498.0 | ENSG00000142453 | nan | nan
chr19	YIPF2	617522.0 | YIPF2 | YIP1 domain family, member 2 | 78992.0 | ENSG00000130733 | nan | nan
chr19	TIMM29	617380.0 | TIMM29, C19orf52 | Translocase of inner mitochondrial membrane 29 | 90580.0 | ENSG00000142444 | nan | nan
chr19	SMARCA4	603254.0 | SMARCA4, BRG1, RTPS2, MRD16, CSS4, OTSC12 | SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4 | 6597.0 | ENSG00000127616 | mutation identified in 1 OTSC12 family | Coffin-Siris syndrome 4, 614609 (3), Autosomal dominant; {Rhabdoid tumor predisposition syndrome 2}, 613325 (3), Autosomal dominant; ?Otosclerosis 12, 620792 (3), Autosomal dominant
chr19	LDLR	606945.0 | LDLR, FHCL1, FHC, FH, LDLCQ2 | Low density lipoprotein receptor | 3949.0 | ENSG00000130164 | ~20cM distal to C3 | LDL cholesterol level QTL2, 143890 (3), Autosomal recessive, Autosomal dominant; Hypercholesterolemia, familial, 1, 143890 (3), Autosomal recessive, Autosomal dominant
chr19	SPC24	609394.0 | SPC24, SPBC24 | SPC24, NDC80 kinetochore complex component | 147841.0 | ENSG00000161888 | nan | nan
chr19	KANK2	614610.0 | KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16 | KN motif- and ankyrin repeat domain-containing protein 2 | 25959.0 | ENSG00000197256 | nan | Nephrotic syndrome, type 16, 617783 (3), Autosomal recessive; Palmoplantar keratoderma and woolly hair, 616099 (3), Autosomal recessive
chr19	DOCK6	614194.0 | DOCK6, KIAA1395, AOS2 | Dedicator of cytokinesis 6 | 57572.0 | ENSG00000130158 | nan | Adams-Oliver syndrome 2, 614219 (3), Autosomal recessive
chr19	ANGPTL8	616223.0 | ANGPTL8, C19orf80, LIPASIN | Angiopoietin-like protein 8 | 55908.0 | ENSG00000130173 | within intron of DOCK6 | nan
chr19	TSPAN16	617580.0 | TSPAN16, TM4SF16 | Tetraspanin 16 | 26526.0 | ENSG00000130167 | nan | nan
chr19	RAB3D	604350.0 | RAD3D, GOV | Ras family, member RAB3D | 9545.0 | ENSG00000105514 | nan | nan
chr19	TMEM205	613771.0 | TMEM205 | Transmembrane protein 205 | 374882.0 | ENSG00000105518 | nan | nan
chr19	PLPPR2	619591.0 | PLPPR2, PRG4 | Phospholipid phosphatase-related protein 2 | 64748.0 | ENSG00000105520 | nan | nan
chr19	SWSAP1	614536.0 | SWSAP1, ZSWIM7AP1, C19orf39 | SWIM-type zinc finger domain-containing protein 7-associated protein 1 | 126074.0 | ENSG00000173928 | nan | nan
chr19	EPOR	133171.0 | EPOR | Erythropoietin receptor | 2057.0 | ENSG00000187266 | nan | [Erythrocytosis, familial, 1], 133100 (3), Autosomal dominant
chr19	RGL3	616743.0 | RGL3 | Ral guanine nucleotide dissociation stimulator-like 3 | 57139.0 | ENSG00000205517 | nan | nan
chr19	ODAD3	615956.0 | ODAD2, CCDC151, CILD30 | Outer dynein arm docking complex subunit 3 | 115948.0 | ENSG00000198003 | nan | Ciliary dyskinesia, primary, 30, 616037 (3), Autosomal recessive
chr19	PRKCSH	177060.0 | PRKCSH, G19P1, PCLD1 | Protein kinase C substrate 80K-H | 5589.0 | ENSG00000130175 | nan | Polycystic liver disease 1, 174050 (3), Autosomal dominant
chr19	ELAVL3	603458.0 | ELAVL3, HUC, PLE21 | ELAV-like RNA binding protein 3 | 1995.0 | ENSG00000196361 | centromeric to ELAVL1 | nan
chr19	ZNF653	611371.0 | ZNF653, ZIP67 | Zinc finger protein 653 | 115950.0 | ENSG00000161914 | nan | nan
chr19	ECSIT	608388.0 | ECSIT, SITPEC | ECSIT signaling integrator | 51295.0 | ENSG00000130159 | nan | nan
chr19	CNN1	600806.0 | CNN1, SMCC | Calponin 1 | 1264.0 | ENSG00000130176 | nan | nan
chr19	ELOF1	619818.0 | ELOF1, ELF1 | Elongation factor 1 | 84337.0 | ENSG00000130165 | nan | nan
chr19	ACP5	171640.0 | ACP5, SPENCDI | Acid phosphatase 5, tartrate resistant | 54.0 | ENSG00000102575 | incorrectly assigned to 15 by A | Spondyloenchondrodysplasia with immune dysregulation, 607944 (3), Autosomal recessive
chr19	ZNF627	612248.0 | ZNF627 | Zinc finger protein 627 | 199692.0 | ENSG00000198551 | nan | nan
chr19	ZNF69	194543.0 | ZNF69 | Zinc finger protein-69 (Cos5) | 7620.0 | ENSG00000198429 | previously assigned to 22q11.2 | nan
chr19	ZNF20	194557.0 | ZNF20, KOX13 | Zinc finger protein-14 (KOX 6) | 7568.0 | ENSG00000132010 | nan | nan
chr19	ZNF136	604078.0 | ZNF136 | Zinc finger protein-136 | 7695.0 | ENSG00000196646 | nan | nan
chr19	ZNF44	194542.0 | ZNF44, KOX7 | Zinc finger protein-44 (KOX7) | 51710.0 | ENSG00000197857 | previously assigned to 16p11 | nan
chr19	ZNF799	619916.0 | ZNF799, HIT40 | Zinc finger protein 799 | 90576.0 | ENSG00000196466 | nan | nan
chr19	ZNF443	606697.0 | ZK1 | Zinc finger protein ZK1 | 10224.0 | ENSG00000180855 | nan | nan
chr19	ZNF490	620118.0 | ZNF490, KIAA1198 | Zinc finger protein 490 | 57474.0 | ENSG00000188033 | nan | nan
chr19		609753.0 | CELIAC4 | Celiac disease, susceptibility to, 4 | nan | nan | associated with rs2305764 | {Celiac disease, susceptibility to, 4}, 609753 (3), Multifactorial
chr19		613638.0 | DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13 | Chromosome 19p13.13 deletion syndrome (Chromosome 19p13.13 duplication syndrome) | nan | nan | contiguous gene syndrome | Chromosome 19p13.13 deletion syndrome, 613638 (4), Isolated cases; Chromosome 19p13.13 duplication syndrome, 613638 (4), Isolated cases
chr19		603992.0 | ZNF110 | Zinc finger protein-110 | nan | nan | nan | nan
chr19		603993.0 | ZNF111 | Zinc finger protein-111 | nan | nan | nan | nan
chr19		603995.0 | ZNF113 | Zinc finger protein-113 | nan | nan | ?13q21 | nan
chr19		603997.0 | ZNF118 | Zinc finger protein-118 | nan | nan | ?13q21 | nan
chr19		603998.0 | ZNF119 | Zinc finger protein-119 | nan | nan | nan | nan
chr19		603999.0 | ZNF120 | Zinc finger protein-120 | nan | nan | nan | nan
chr19		604000.0 | ZNF122 | Zinc finger protein-122 | nan | nan | nan | nan
chr19		603976.0 | ZNF94 | Zinc finger protein-94 | nan | nan | nan | nan
chr19	MAN2B1	609458.0 | MAN2B1, MANB | Mannosidase, alpha, class 2B, member 1 | 4125.0 | ENSG00000104774 | nan | Mannosidosis, alpha-, types I and II, 248500 (3), Autosomal recessive
chr19	WDR83	616850.0 | WDR83, MORG1 | WD repeat-containing protein 83 | 84292.0 | ENSG00000123154 | nan | nan
chr19	WDR83OS	618474.0 | WDR83OS, C19orf56, ASTERIX | WDR83 opposite strand | 51398.0 | ENSG00000105583 | nan | nan
chr19	DHPS	600944.0 | DHPS, NEDSSWI | Deoxyhypusine synthase | 1725.0 | ENSG00000095059 | nan | Neurodevelopmental disorder with seizures and speech and walking impairment, 618480 (3), Autosomal recessive
chr19	FBXW9	609074.0 | FBXW9, FBW9 | F-box and WD40 domain protein 9 | 84261.0 | ENSG00000132004 | nan | nan
chr19	TNPO2	603002.0 | TNPO2, TRN2, KPNB2B, IDDHISD | Transportin 2 | 30000.0 | ENSG00000105576 | nan | Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies, 619556 (3), Autosomal dominant
chr19	GET3	601913.0 | GET3, ASNA1, ARSA1, CMD2H | Guided entry of tail-anchored proteins factor 3, ATPase | 439.0 | ENSG00000198356 | mutation identified in 1 CMD2H family | ?Cardiomyopathy, dilated, 2H, 620203 (3), Autosomal recessive
chr19	BEST2	607335.0 | BEST2, VMD2L1 | Bestrophin 2 | 54831.0 | ENSG00000039987 | nan | nan
chr19	HOOK2	607824.0 | HOOK2, HK2 | Hook, Drosophila, homolog of, 2 | 29911.0 | ENSG00000095066 | nan | nan
chr19	JUNB	165161.0 | JUNB | Jun B protooncogene, AP-1 transcription factor subunit | 3726.0 | ENSG00000171223 | nan | nan
chr19	PRDX2	600538.0 | PRDX2, PRX2, TDPX1, PTX1, NKEFB | Peroxiredoxin 2 | 7001.0 | ENSG00000167815 | prev. mapped to chr.13 | nan
chr19	RNASEH2A	606034.0 | RNASEH2A, RNHIA, AGS4 | Ribonuclease H2, large subunit | 10535.0 | ENSG00000104889 | nan | Aicardi-Goutieres syndrome 4, 610333 (3), Autosomal recessive
chr19	RTBDN	609553.0 | RTBDN | Retbindin | 83546.0 | ENSG00000132026 | nan | nan
chr19	MAST1	612256.0 | MAST1, SAST, KIAA0973, MCCCHCM | Microtubule-associated serine/threonine kinase 1 | 22983.0 | ENSG00000105613 | nan | Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, 618273 (3), Autosomal dominant
chr19	DNASE2	126350.0 | DNASE2, DNL, AIPCS | Deoxyribonuclease II, lysosomal | 1777.0 | ENSG00000105612 | nan | Autoinflammatory-pancytopenia syndrome, 619858 (3), Autosomal recessive
chr19	KLF1	600599.0 | KLF1, EKLF, INLU, HBFQTL6, CDAN4A, CDAN4B | Kruppel-like factor 1, erythroid | 10661.0 | ENSG00000105610 | nan | Blood group--Lutheran inhibitor, 111150 (3), Autosomal dominant; [Hereditary persistence of fetal hemoglobin], 613566 (3), Autosomal dominant; Anemia, dyserythropoietic congenital, type IVa, 613673 (3), Autosomal dominant; Anemia, congenital dyserythropoietic, type IVb, 620969 (3), Autosomal recessive
chr19	GCDH	608801.0 | GCDH | Glutaryl-Coenzyme A dehydrogenase | 2639.0 | ENSG00000105607 | nan | Glutaricaciduria, type I, 231670 (3), Autosomal recessive
chr19	SYCE2	611487.0 | SYCE2, CESC1 | Synaptonemal complex central element protein 2 | 256126.0 | ENSG00000161860 | nan | nan
chr19	FARSA	602918.0 | FARSA, CML33, RILDBC2 | Phenylalanine-tRNA synthetase, alpha subunit | 2193.0 | ENSG00000179115 | mutation identified in 1 RILDBC2 | ?Rajab interstitial lung disease with brain calcifications 2, 619013 (3), Autosomal recessive
chr19	CALR	109091.0 | CALR, SSA | Sicca syndrome antigen A (autoantigen Ro; calreticulin) | 811.0 | ENSG00000179218 | distal to C3, near LDLR | Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic, 187950 (3)
chr19	RAD23A	600061.0 | RAD23A, HHR23A | RAD23 homolog A, nucleotide excision repair protein | 5886.0 | ENSG00000179262 | nan | nan
chr19	GADD45GIP1	605162.0 | GADD45GIP1, PRG6, CRIF1 | Growth arrest- and DNA damage-inducible DABB45G-interacting protein | 90480.0 | ENSG00000179271 | nan | nan
chr19	DAND5	609068.0 | DAND5, CER2, CERL2, DANTE, COCO | DAN domain family, member 5 | 199699.0 | ENSG00000179284 | nan | nan
chr19	NFIX	164005.0 | NFIX, NF1A, MALNS, MRSHSS | Nuclear factor I/X (CCAAT-binding transcription factor) | 4784.0 | ENSG00000008441 | nan | Marshall-Smith syndrome, 602535 (3), Autosomal dominant; Malan syndrome, 614753 (3), Autosomal dominant
chr19	LYL1	151440.0 | LYL1 | Lymphoblastic leukemia derived sequence-1 | 4066.0 | ENSG00000104903 | nan | Leukemia, T-cell acute lymphoblastoid, 151440 (2)
chr19	TRMT1	611669.0 | TRMT1, TRM1, MRT68 | tRNA methyltransferase 1 | 55621.0 | ENSG00000104907 | nan | Intellectual developmental disorder, autosomal recessive 68, 618302 (3), Autosomal recessive
chr19	NACC1	610672.0 | NACC1, BTBD14B, NECFM | Nucleus accumbens-associated protein 1, BEN and BTB/POZ domains-containing | 112939.0 | ENSG00000160877 | nan | Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination, 617393 (3), Autosomal dominant
chr19	STX10	603765.0 | STX10, SYN10 | Syntaxin 10 | 8677.0 | ENSG00000104915 | nan | nan
chr19	IER2	620036.0 | IER2, ETR101, CHX1 | Immediate-rearly response gene 2 | 9592.0 | ENSG00000160888 | nan | nan
chr19	CACNA1A	601011.0 | CACNA1A, CACNL1A4, SCA6, DEE42 | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 773.0 | ENSG00000141837 | nan | Spinocerebellar ataxia 6, 183086 (3), Autosomal dominant; Episodic ataxia, type 2, 108500 (3), Autosomal dominant; Developmental and epileptic encephalopathy 42, 617106 (3), Autosomal dominant; Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3), Autosomal dominant; Migraine, familial hemiplegic, 1, 141500 (3), Autosomal dominant
chr19	MRI1	615105.0 | MRI1, MRDI | Methylthioribose-1-phosphate isomerase, S. cerevisiae, homolog of | 84245.0 | ENSG00000037757 | nan | nan
chr19	C19orf53	620685.0 | C19orf53 | Chromosome 19 open reading frame 53 | 28974.0 | ENSG00000104979 | nan | nan
chr19	ZSWIM4	620539.0 | ZSWIM4, FLJ00044 | Zinc finger SWIM domain-containing protein 4 | 65249.0 | ENSG00000132003 | nan | nan
chr19	MIR24-2	610724.0 | MIR24-2, MIRN24-2 | Micro RNA 24-2 | 407013.0 | ENSG00000284387 | nan | nan
chr19	MIR27A	612153.0 | MIR27, MIRN27A | Micro RNA 27A | 407018.0 | ENSG00000207808 | nan | nan
chr19	MIR23A	607962.0 | MIR23A, MIRN23A | Micro RNA 23a | 407010.0 | ENSG00000207980 | nan | nan
chr19	NANOS3	608229.0 | NANOS3, NOS3 | NANOS C2HC-type zinc finger 3 | 342977.0 | ENSG00000187556 | nan | nan
chr19	MIR181C	612746.0 | MIR181C, MIRN181C | Micro RNA 181C | 406957.0 | ENSG00000207613 | nan | nan
chr19	BRME1	619276.0 | BRME1, C19orf57, MEIOK21 | Break repair meiotic recombinase recruitment factor 1 | 79173.0 | ENSG00000132016 | nan | nan
chr19	CC2D1A	610055.0 | CC2D1A, MRT3 | Coiled-coil and C2 domain-containing 1A | 54862.0 | ENSG00000132024 | nan | Intellectual developmental disorder, autosomal recessive 3, 608443 (3), Autosomal recessive
chr19	DCAF15	620109.0 | DCAF15 | DDB1- and CUL4-associated factor 15 | 90379.0 | ENSG00000132017 | nan | nan
chr19	RFX1	600006.0 | RFX1 | Regulatory factor (trans-acting) 1 (influences HLA class II expression) | 5989.0 | ENSG00000132005 | nan | nan
chr19	RLN3	606855.0 | RLN3, H3, RXN3 | Relaxin 3 | 117579.0 | ENSG00000171136 | nan | nan
chr19	IL27RA	605350.0 | TCCR, WSX1 | T-cell cytokine receptor | 9466.0 | ENSG00000104998 | nan | nan
chr19	SAMD1	620206.0 | SAMD1, ATHERIN | Sterile alpha motif-domain containing protein 1 | 90378.0 | ENSG00000141858 | nan | nan
chr19	PRKACA	601639.0 | PRKACA, CAFD1 | Protein kinase, cAMP-dependent, catalytic, alpha | 5566.0 | ENSG00000072062 | nan | Cushing syndrome, ACTH-independent adrenal, somatic, 615830 (3); Cardioacrofacial dysplasia 1, 619142 (3), Autosomal dominant
chr19	ASF1B	609190.0 | ASF1B | Anti-silencing function 1B histone chaperone | 55723.0 | ENSG00000105011 | nan | nan
chr19	ADGRL1	616416.0 | ADGRL1, LPHN1, CIRL1, CL1, LEC2, KIAA0821, DEDBANP | Adhesion G protein-coupled receptor L1 | 22859.0 | ENSG00000072071 | nan | Developmental delay, behavioral abnormalities, and neuropsychiatric disorders, 620065 (3), Autosomal dominant
chr19	ADGRE5	601211.0 | ADGRE5, CD97 | Adhesion G protein-coupled receptor E5 | 976.0 | ENSG00000123146 | nan | nan
chr19	DDX39A	619906.0 | DDX39A, URH49 | DExD-box helicase 39A | 10212.0 | ENSG00000123136 | nan | nan
chr19	PKN1	601032.0 | PKN1, PRKCL1, PRK1, PAK1 | Protein kinase N1 | 5585.0 | ENSG00000123143 | nan | nan
chr19	PTGER1	176802.0 | PTGER1 | Prostaglandin E receptor 1, EP1 subtype, 42kD | 5731.0 | ENSG00000160951 | nan | nan
chr19	GIPC1	605072.0 | GIPC1, RGS19IP1, C19orf3, OPDM2 | GIPC PDZ domain-containing family member 1 | 10755.0 | ENSG00000123159 | nan | Oculopharyngodistal myopathy 2, 618940 (3), Autosomal dominant
chr19	DNAJB1	604572.0 | DNAJB1, HSPF1 | DnaJ, E. coli, homolog of, subfamily B, member 1 (heat-shock 40kD protein 1) | 3337.0 | ENSG00000132002 | nan | nan
chr19	TECR	610057.0 | TECR, GPSN2, TER, SC2, MRT14 | Trans-2,3-enoyl-CoA reductase | 9524.0 | ENSG00000099797 | nan | Intellectual developmental disorder, autosomal recessive 14, 614020 (3), Autosomal recessive
chr19	NDUFB7	603842.0 | NDUFB7, MC1DN39 | NADH-ubiquinone oxidoreductase subunit B7 | 4713.0 | ENSG00000099795 | mutation identified in 1 MC1DN39 family | ?Mitochondrial complex I deficiency, nuclear type 39, 620135 (3), Autosomal recessive
chr19	CLEC17A	616838.0 | CLEC17A | C-type lectin domain family 17, member A | 388512.0 | ENSG00000187912 | nan | nan
chr19	ADGRE3	606101.0 | EMR3 | EGF-like module-containing, mucin-like hormone receptor 3 | 84658.0 | ENSG00000131355 | nan | nan
chr19	ZNF333	611811.0 | ZNF333, KIAA1806 | Zinc finger protein 333 | 84449.0 | ENSG00000160961 | nan | nan
chr19	ADGRE2	606100.0 | ADGRE2, EMR2, VBU | Adhesion G protein-coupled receptor E2 | 30817.0 | ENSG00000127507 | nan | Vibratory urticaria, 125630 (3), Autosomal dominant
chr19	SLC1A6	600637.0 | SLC1A6, EAAT4 | Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | 6511.0 | ENSG00000105143 | nan | nan
chr19	CASP14	605848.0 | CASP14, ARCI12 | Caspase 14, apoptosis-related cysteine protease | 23581.0 | ENSG00000105141 | nan | Ichthyosis, congenital, autosomal recessive 12, 617320 (3), Autosomal recessive
chr19	SYDE1	617377.0 | SYDE1 | Synapse defective Rho GTPase, C. elegans, homolog of, 1 | 85360.0 | ENSG00000105137 | nan | nan
chr19	ILVBL	605770.0 | ILVBL, AHAS | IlvB-like (acetolactate synthase, bacterial, homolog of) | 10994.0 | ENSG00000105135 | nan | nan
chr19	NOTCH3	600276.0 | NOTCH3, CADASIL1, CASIL, IMF2, LMNS | Notch, Drosophila, homolog of, 3 | 4854.0 | ENSG00000074181 | mutation identified in 1 IMF2 family | Lateral meningocele syndrome, 130720 (3), Autosomal dominant; ?Myofibromatosis, infantile 2, 615293 (3), Autosomal dominant; Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3), Autosomal dominant
chr19	EPHX3	617400.0 | EPHX3, ABHD9 | Epoxide hydrolase 3 | 79852.0 | ENSG00000105131 | nan | nan
chr19	BRD4	608749.0 | BRD4, CAP, HUNK1, CDLS6 | Bromodomain-containing protein 4 | 23476.0 | ENSG00000141867 | fused with NUT | Cornelia de Lange syndrome 6, 620568 (3), Autosomal dominant
chr19	AKAP8	604692.0 | AKAP8, AKAP95 | A-kinase anchor protein 8 | 10270.0 | ENSG00000105127 | nan | nan
chr19	AKAP8L	609475.0 | AKAP8L, HA95, NAKAP, HAP95 | A-kinase anchor protein 8-like protein | 26993.0 | ENSG00000011243 | nan | nan
chr19	WIZ	619715.0 | WIZ | WIZ zinc finger protein | 58525.0 | ENSG00000011451 | nan | nan
chr19	RASAL3	616561.0 | RASAL3 | Ras protein activator-like 3 | 64926.0 | ENSG00000105122 | nan | nan
chr19	PGLYRP2	608199.0 | PGRPL | Peptidoglycan recognition protein, long | 114770.0 | ENSG00000161031 | nan | nan
chr19	CYP4F22	611495.0 | CYP4F22, ARCI5, LI3 | Cytochrome P450, family 4, subfamily F, polypeptide 22 | 126410.0 | ENSG00000171954 | nan | Ichthyosis, congenital, autosomal recessive 5, 604777 (3), Autosomal recessive
chr19	CYP4F8	611545.0 | CYP4F8 | Cytochrome P450, family 4, subfamily F, polypeptide 8 | 11283.0 | ENSG00000186526 | nan | nan
chr19	CYP4F3	601270.0 | CYP4F3, LTB4H | Cytochrome P450, subfamily IVF, polypeptide 3 | 4051.0 | ENSG00000186529 | nan | nan
chr19	CYP4F12	611485.0 | CYP4F12 | Cytochrome P450, family 4, subfamily F, polypeptide 12 | 66002.0 | ENSG00000186204 | nan | nan
chr19	UCA1	617500.0 | UCA1, LINC00178, CUDR | Urothelial cancer-associated gene 1 | 652995.0 | ENSG00000214049 | nan | nan
chr19	CYP4F2	604426.0 | CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | 8529.0 | ENSG00000186115 | nan | nan
chr19	CYP4F11	611517.0 | CYP4F11 | Cytochrome P450, family 4, subfamily F, polypeptide 11 | 57834.0 | ENSG00000171903 | nan | nan
chr19	TPM4	600317.0 | TPM4, BDPLT25 | Tropomyosin 4 | 7171.0 | ENSG00000167460 | nan | Bleeding disorder, platelet-type, 25, 620486 (3), Autosomal dominant
chr19	RAB8A	165040.0 | RAB8A, MEL | Ras-associated protein RAB8A (oncogene MEL) | 4218.0 | ENSG00000167461 | nan | nan
chr19	HSH2D	608349.0 | HSH2D, ALX | Hemotopoietic SH2 domain-containing protein | 84941.0 | ENSG00000196684 | nan | nan
chr19	CIB3	610645.0 | CIB3, KIP3 | Calcium- and integrin-binding protein 3 | 117286.0 | ENSG00000141977 | nan | nan
chr19	FAM32A	614554.0 | FAM32A, OTAG12 | Family with sequence similarity 32, member A | 26017.0 | ENSG00000105058 | nan | nan
chr19	AP1M1	603535.0 | AP1M1, AP47, CLAPM2 | Adaptor-related protein complex 1, mu 1 subunit | 8907.0 | ENSG00000072958 | nan | nan
chr19	KLF2	602016.0 | KLF2, LKLF | Kruppel-like factor 2 | 10365.0 | ENSG00000127528 | nan | nan
chr19	EPS15L1	616826.0 | EPS15L1, EPS15R | EPS15-like protein 1 | 58513.0 | ENSG00000127527 | nan | nan
chr19	CALR3	611414.0 | CALR3, CRT2 | Calreticulin 3 | 125972.0 | ENSG00000269058 | nan | nan
chr19	CHERP	618539.0 | CHERP | Calcium homeostasis endoplasmic reticulum protein | 10523.0 | ENSG00000085872 | nan | nan
chr19	SLC35E1	620337.0 | SLC35E1 | Solute carrier family 35, member E1 | 79939.0 | ENSG00000127526 | nan | nan
chr19	MED26	605043.0 | MED26, CRSP7, CRSP70 | Mediator complex subunit 26 | 9441.0 | ENSG00000105085 | nan | nan
chr19	TMEM38A	611235.0 | TMEM38A, TRICA | Transmembrane protein 38A | 79041.0 | ENSG00000072954 | nan | nan
chr19	NWD1	616250.0 | NWD1 | NACHT domain- and WD repeat-containing protein 1 | 284434.0 | ENSG00000188039 | nan | nan
chr19	SIN3B	607777.0 | SIN3B, KIAA0700 | Sin3, yeast, homolog of, B | 23309.0 | ENSG00000127511 | nan | nan
chr19	F2RL3	602779.0 | F2RL3, PAR4 | Coagulation factor II, thrombin, receptor-like 3 (protease-activated receptor-4) | 9002.0 | ENSG00000127533 | nan | nan
chr19	CPAMD8	608841.0 | CPAMD8, KIAA1283, ASGD8 | Complement component 3- and pregnancy zone protein-like alpha-2-macroglobin domain-containing protein 8 | 27151.0 | ENSG00000160111 | nan | Anterior segment dysgenesis 8, 617319 (3), Autosomal recessive
chr19	HAUS8	613434.0 | HAUS8, DGT4, HICE1 | HAUS augmin-like complex, subunit 8 | 93323.0 | ENSG00000131351 | nan | nan
chr19	MYO9B	602129.0 | MYO9B, MYR5 | Myosin IXB | 4650.0 | ENSG00000099331 | nan | nan
chr19	USE1	610675.0 | USE1, MDS032 | Unconventional SNARE in the ER 1 | 55850.0 | ENSG00000053501 | nan | nan
chr19	NR2F6	132880.0 | NR2F6, ERBAL2, EAR2 | Nuclear receptor subfamily 2, group F, member 6 | 2063.0 | ENSG00000160113 | nan | nan
chr19	USHBP1	611810.0 | USHBP1, MCC2 | USH1C-binding protein 1 | 83878.0 | ENSG00000130307 | nan | nan
chr19	BABAM1	612766.0 | C10orf62, MERIT40, NBA1 | Chromosome 19 open reading frame 62 | 29086.0 | ENSG00000105393 | nan | nan
chr19	ANKLE1	619348.0 | ANKLE1, LEM3 | Ankyrin repeat- and LEM domain-containing protein 1 | 126549.0 | ENSG00000160117 | nan | nan
chr19	MRPL34	611840.0 | MRPL34 | Mitochondrial ribosomal protein L34 | 64981.0 | ENSG00000130312 | nan | nan
chr19	ANO8	610216.0 | TMEM16H, KIAA1623 | Transmembrane protein 16H | 57719.0 | ENSG00000074855 | nan | nan
chr19	GTPBP3	608536.0 | GTPBP3, MSS1, COXPD23 | GTP-binding protein 3 | 84705.0 | ENSG00000130299 | nan | Combined oxidative phosphorylation deficiency 23, 616198 (3), Autosomal recessive
chr19	PLVAP	607647.0 | PLVAP, PV1, DIAR10 | Plasmalemma vesicle-associated protein | 83483.0 | ENSG00000130300 | nan | Diarrhea 10, protein-losing enteropathy type, 618183 (3), Autosomal recessive
chr19	BST2	600534.0 | BST2 | Bone marrow stromal cell antigen | 684.0 | ENSG00000130303 | nan | nan
chr19	NXNL1	608791.0 | NXNL1, RDCVF, TXNL6, LOC115861 | Nucleoredoxin-like protein 1 | 115861.0 | ENSG00000171773 | nan | nan
chr19	SLC27A1	600691.0 | SLC27A1, FATP, FATP1 | Solute carrier family 27, member 1 | 376497.0 | ENSG00000130304 | nan | nan
chr19	PGLS	604951.0 | PGLS | 6-phosphogluconolactonase | 25796.0 | ENSG00000130313 | nan | nan
chr19	NIBAN3	609967.0 | BCNP1 | B-cell novel protein 1 | 199786.0 | ENSG00000167483 | nan | nan
chr19	COLGALT1	617531.0 | COLGALT1, GLT25D1, BSVD3 | Collagen beta(1-0)galactosyltransferase 1 | 79709.0 | ENSG00000130309 | nan | Brain small vessel disease 3, 618360 (3), Autosomal recessive
chr19	UNC13A	609894.0 | UNC13A, KIAA1032 | UNC13, C. elegans, homolog of, A | 23025.0 | ENSG00000130477 | nan | nan
chr19	MAP1S	607573.0 | MAP1S, BPY2IP1, VCY2IP1, C19orf5 | Microtubule-associated protein 1S | 55201.0 | ENSG00000130479 | nan | nan
chr19	FCHO1	613437.0 | FCHO1, IMD76 | FCH domain-only protein 1 | 23149.0 | ENSG00000130475 | nan | Immunodeficiency 76, 619164 (3), Autosomal recessive
chr19	B3GNT3	605863.0 | TMEM3, B3GNT3 | Transmembrane protein 3 (beta-1,3-N-acetylglucosaminyltransferase 3) | 10331.0 | ENSG00000179913 | nan | nan
chr19	INSL3	146738.0 | INSL3 | Insulin-like 3, Leydig cell | 3640.0 | ENSG00000248099 | nan | Cryptorchidism, 219050 (3), Autosomal dominant
chr19	JAK3	600173.0 | JAK3, JAKL | Janus kinase 3 (Janus kinase, leukocyte) | 3718.0 | ENSG00000105639 | nan | Severe combined immunodeficiency, autosomal recessive, T-negative/B-positive type, 600802 (3), Autosomal recessive
chr19	RPL18A	604178.0 | RPL18A | Ribosomal protein L18a | 6142.0 | ENSG00000105640 | nan | nan
chr19	SLC5A5	601843.0 | SLC5A5, NIS, TDH1 | Solute carrier family 5 (sodium iodide symporter), member-5 | 6528.0 | ENSG00000105641 | nan | Thyroid dyshormonogenesis 1, 274400 (3), Autosomal recessive
chr19	KCNN1	602982.0 | KCNN1 | Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 1 | 3780.0 | ENSG00000105642 | nan | nan
chr19	IL12RB1	601604.0 | IL12RB1, IMD30 | Interleukin-12 receptor, beta-1 | 3594.0 | ENSG00000096996 | nan | Immunodeficiency 30, 614891 (3), Autosomal recessive
chr19	MAST3	612258.0 | MAST3, KIAA0561, DEE108 | Microtubule-associated serine/threonine kinase 3 | 23031.0 | ENSG00000099308 | nan | Developmental and epileptic encephalopathy 108, 620115 (3), Autosomal dominant
chr19	PIK3R2	603157.0 | PIK3R2, MPPH1 | Phosphatidylinositol 3-kinase, regulatory subunit 2 | 5296.0 | ENSG00000105647 | nan | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3), Autosomal dominant
chr19	IFI30	604664.0 | IFI30, GILT | Interferon-gamma-inducible protein 30 | 10437.0 | ENSG00000216490 | nan | nan
chr19	MPV17L2	616133.0 | MPV17L2 | MPV17 mitochondrial inner membrane protein-like 2 | 84769.0 | ENSG00000254858 | nan | nan
chr19	RAB3A	179490.0 | RAB3A | RAS-associated protein RAB3A | 5864.0 | ENSG00000105649 | nan | nan
chr19	PDE4C	600128.0 | PDE4C, DPDE1 | Phosphodiesterase-4C, cAMP-specific (dunce, Drosophila, homolog phosphodiesterase E1) | 5143.0 | ENSG00000105650 | between JUND (proximal) and RAB3A (distal) | nan
chr19	IQCN	620160.0 | IQCN, SPGF78 | IQ motif-containing protein N | 80726.0 | ENSG00000130518 | nan | Spermatogenic failure 78, 620170 (3), Autosomal recessive
chr19	JUND	165162.0 | JUND | Jun D protooncogene, AP-1 transcription factor subunit | 3727.0 | ENSG00000130522 | nan | nan
chr19	LSM4	607284.0 | LSM4 | LSM4 protein | 25804.0 | ENSG00000130520 | nan | nan
chr19	PGPEP1	610694.0 | PGPEP1, PCP, PGP | Pyroglutamyl peptidase I | 54858.0 | ENSG00000130517 | nan | nan
chr19	GDF15	605312.0 | GDF15, PLAB, PDF, MIC1, HG | Growth/differentiation factor-15 (bone morphogenetic protein, placental) | 9518.0 | ENSG00000130513 | nan | {Hyperemesis gravidarum, susceptibility to}, 620730 (3), Autosomal dominant
chr19	LRRC25	607518.0 | LRRC25, MAPA | Leucine rich repeat containing 25 | 126364.0 | ENSG00000175489 | nan | nan
chr19	SSBP4	607391.0 | SSBP4 | Single-stranded DNA-binding protein 4 | 170463.0 | ENSG00000130511 | nan | nan
chr19	ISYNA1	611670.0 | ISYNA1, IPS | Myoinositol 1-phosphate synthase A1 | 51477.0 | ENSG00000105655 | pseudogene on 4p15 | nan
chr19	ELL	600284.0 | ELL | ELL gene (11-19 lysine-rich leukemia gene) | 8178.0 | ENSG00000105656 | nan | nan
chr19	FKBP8	604840.0 | FKBP8, FKBP38 | FK506-binding protein 8 | 23770.0 | ENSG00000105701 | pseudogene on 1q32 | nan
chr19	KXD1	615178.0 | KXD1, C10orf50 | KXDL motif-containing protein 1 | 79036.0 | ENSG00000105700 | nan | nan
chr19	UBA52	191321.0 | UBA52 | Ubiquitin A-52 residue ribosomal protein fusion product 1 | 7311.0 | ENSG00000221983 | nan | nan
chr19	CRLF1	604237.0 | CRLF1, CISS1 | Cytokine-like factor 1 | 9244.0 | ENSG00000006016 | nan | Cold-induced sweating syndrome 1, 272430 (3), Autosomal recessive
chr19	TMEM59L	617096.0 | TMEM59L, BSMAP | Transmembrane protein 59-like | 25789.0 | ENSG00000105696 | nan | nan
chr19	CRTC1	607536.0 | CRTC1, MECT1, KIAA0616, FLJ14027 | CREB-regulated transcription coactivator 1 | 23373.0 | ENSG00000105662 | t(11;19) | Mucoepidermoid salivary gland carcinoma (3)
chr19	COMP	600310.0 | COMP, EDM1, MED, PSACH, CTS2 | Cartilage oligomeric matrix protein | 1311.0 | ENSG00000105664 | nan | Pseudoachondroplasia, 177170 (3), Autosomal dominant; Carpal tunnel syndrome 2, 619161 (3), Autosomal dominant; Epiphyseal dysplasia, multiple, 1, 132400 (3), Autosomal dominant
chr19	UPF1	601430.0 | UPF1, RENT1, HUPF1 | UPF1 RNA helicase and ATPase | 5976.0 | ENSG00000005007 | nan | nan
chr19	CERS1	606919.0 | CERS1, LASS1, UOG1, EPM8 | Ceramide synthase 1 | 10715.0 | ENSG00000223802 | nan | Epilepsy, progressive myoclonic, 8, 616230 (3), Autosomal recessive
chr19	GDF1	602880.0 | GDF1, DTGA3, DORV, RAI, CHTD6 | Growth/differentiation factor 1 | 2657.0 | ENSG00000130283 | nan | Congenital heart defects, multiple types, 6, 613854 (3), Autosomal dominant; Right atrial isomerism (Ivemark), 208530 (3), Autosomal recessive
chr19	COPE	606942.0 | COPE | Cotamer protein complex, subunit epsilon | 11316.0 | ENSG00000105669 | nan | nan
chr19	HOMER3	604800.0 | HOMER3 | Homer scaffold protein 3 | 9454.0 | ENSG00000051128 | nan | nan
chr19	SUGP2	607993.0 | SUGP2, SRFS14, KIAA0365 | SURP and G-patch domains-containing protein 2 | 10147.0 | ENSG00000064607 | nan | nan
chr19	SLC25A42	610823.0 | SLC25A42, MECREN | Solute carrier family 25, member 42 | 284439.0 | ENSG00000181035 | nan | Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, 618416 (3), Autosomal recessive
chr19	TMEM161A	618966.0 | TMEM161A, AROS29 | Transmembrane protein 161A | 54929.0 | ENSG00000064545 | nan | nan
chr19	MEF2B	600661.0 | MEF2B | MADS box transcription enhancer factor 2, polypeptide B (myocyte enhancer factor 2B) | 100271849.0 | ENSG00000213999 | nan | nan
chr19	BORCS8	616601.0 | BORCS8, MEF2BNB, NDOABA | BLOC1-related complex, subunit 8 | 729991.0 | ENSG00000254901 | nan | Neurodegeneration, infantile-onset, with optic atrophy and brain abnormalities, 620987 (3), Autosomal recessive
chr19	RFXANK	603200.0 | RFXANK, MHC2D2 | Regulatory factor X, ankyrin repeat-containing | 8625.0 | ENSG00000064490 | nan | MHC class II deficiency 2, 620815 (3), Autosomal recessive
chr19	NR2C2AP	608719.0 | NR2C2AP, TRA16 | Nuclear receptor 2C2 associated protein | 126382.0 | ENSG00000184162 | nan | nan
chr19	NCAN	600826.0 | CSPG3, NCAN | Chondroitin sulfate proteoglycan 3 (neurocan) | 1463.0 | ENSG00000130287 | nan | nan
chr19	HAPLN4	619710.0 | HAPLN4, BRAL2, KIAA1926 | Hyaluronan and proteoglycan link protein 4 | 404037.0 | ENSG00000187664 | nan | nan
chr19	TM6SF2	606563.0 | TM6SF2, KIAA1926 | Transmembrane 6 superfamily, member 2 | 53345.0 | ENSG00000213996 | nan | nan
chr19	SUGP1	607992.0 | SUGP1, SF4 | SURP and G-patch domains-containing protein 1 | 57794.0 | ENSG00000105705 | nan | nan
chr19	MAU2	614560.0 | MAU2, SCC4, KIAA0892 | MAU2 chromatid cohesion factor | 23383.0 | ENSG00000129933 | nan | nan
chr19	GATAD2A	614997.0 | GATAD2A | GATA zinc finger domain-containing protein 2A | 54815.0 | ENSG00000167491 | nan | nan
chr19	TSSK6	610712.0 | TSSK6, SSTK, TSSK4 | Testis-specific serine/threonine kinase 6 | 83983.0 | ENSG00000178093 | nan | nan
chr19	NDUFA13	609435.0 | NDUFA13, GRIM19, MC1DN28 | NADH-ubiquinone oxidoreductase subunit A13 | 51079.0 | ENSG00000186010 | nan | {Thyroid carcinoma, Hurthle cell}, 607464 (3); Mitochondrial complex I deficiency, nuclear type 28, 618249 (3), Autosomal recessive
chr19	YJEFN3	618607.0 | YJEFN3 | Yjef N-terminal domain-containing protein 3 | 374887.0 | ENSG00000250067 | nan | nan
chr19	CILP2	612419.0 | CILP2 | Cartilage intermediate layer protein 2 | 148113.0 | ENSG00000160161 | nan | nan
chr19	PBX4	608127.0 | PBX4 | Pre-B-cell leukemia transcription factor 4 | 80714.0 | ENSG00000105717 | nan | nan
chr19	LPAR2	605110.0 | LPAR2, EDG4 | Lysophosphatidic acid receptor 2 | 9170.0 | ENSG00000064547 | nan | nan
chr19	GMIP	609694.0 | GMIP | GEM-interacting protein | 51291.0 | ENSG00000089639 | nan | nan
chr19	ATP13A1	619118.0 | ATP13A1 | ATPase 13A1 | 57130.0 | ENSG00000105726 | nan | nan
chr19	ZNF101	603983.0 | ZNF101 | Zinc finger protein-101 | 94039.0 | ENSG00000181896 | nan | nan
chr19	ZNF14	194556.0 | ZNF14, KOX6 | Zinc finger protein-14 (KOX 6) | 7561.0 | ENSG00000105708 | nan | nan
chr19	LINC00663	617117.0 | LINC00663 | Long intergenic noncoding RNA 663 | 284440.0 | nan | nan | nan
chr19	ZNF253	606954.0 | ZNF253 | Zinc finger protein 253 | 56242.0 | ENSG00000256771 | nan | nan
chr19	ZNF93	603975.0 | ZNF93 | Zinc finger protein-93 | 81931.0 | ENSG00000184635 | nan | nan
chr19	ZNF90	603973.0 | ZNF90 | Zinc finger protein-90 | 7643.0 | ENSG00000213988 | nan | nan
chr19	ZNF737	603984.0 | ZNF737, ZNF102 | Zinc finger protein-737 | 100129842.0 | ENSG00000237440 | nan | nan
chr19	ZNF85	603899.0 | ZNF85 | Zinc finger protein-85 | 7639.0 | ENSG00000105750 | nan | nan
chr19	ZNF431	619505.0 | ZNF431, ZFP932 | Zinc finger protein 431 | 170959.0 | ENSG00000196705 | nan | nan
chr19	ZNF100	603982.0 | ZNF100 | Zinc finger protein-100 | 163227.0 | ENSG00000197020 | nan | nan
chr19	ZNF43	603972.0 | ZNF43 | Zinc finger protein-43 | 7594.0 | ENSG00000198521 | nan | nan
chr19	ZNF208	603977.0 | ZNF208, ZNF95 | Zinc finger protein-208 | 7757.0 | ENSG00000160321 | nan | nan
chr19	ZNF257	606957.0 | ZNF257 | Zinc finger protein 257 | 113835.0 | ENSG00000197134 | nan | nan
chr19	ZNF98	603980.0 | ZNF98 | Zinc finger protein-98 | 148198.0 | ENSG00000197360 | nan | nan
chr19	ZNF492	620124.0 | ZNF492, KIAA1473 | Zinc finger protein 492 | 57615.0 | ENSG00000229676 | nan | nan
chr19	ZNF99	603981.0 | ZNF99 | Zinc finger protein-99 | 7652.0 | ENSG00000213973 | nan | nan
chr19	ZNF91	603971.0 | ZNF91 | Zinc finger protein-91 | 7644.0 | ENSG00000167232 | nan | nan
chr19	ZNF675	620090.0 | ZNF675, TIZ | Zinc finger protein 675 | 171392.0 | ENSG00000197372 | nan | nan
chr19	ZNF254	604768.0 | ZNF254, ZNF91L | Zinc finger protein-254 | 9534.0 | ENSG00000213096 | nan | nan
chr19	BFIS1	601764.0 | BFIS1, BFIC1 | Benign familial infantile seizures | 8181.0 | nan | nan | Seizures, benign familial infantile, 1, 601764 (2), Autosomal dominant
chr19	HPCQTL19	607592.0 | HPCQTL19 | Prostate cancer aggressiveness quantitative trait locus on chromosome 19 | 347747.0 | nan | D19S902 | {Prostate cancer aggressiveness QTL}, 607592 (2)
chr19	SLI2	606712.0 | SLI2 | Specific language impairment QTL, 2 | 171014.0 | nan | nan | Specific language impairment QTL, 2, 606712 (2), Multifactorial
chr19	HSCR7	606875.0 | HSCR7 | Hirschsprung disease, susceptibility to, 7 | 246322.0 | nan | nan | {Hirschsprung disease, susceptibility to, 7}, 606875 (2)
chr19	UQCRFS1	191327.0 | UQCRFS1, MC3DN10 | Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 | 7386.0 | ENSG00000169021 | nan | Mitochondrial complex III deficiency, nuclear type 10, 618775 (3), Autosomal recessive
chr19	POP4	606114.0 | POP4, RPP29 | POP4 homolog, ribonuclease P/MRP subunit | 10775.0 | ENSG00000105171 | nan | nan
chr19	PLEKHF1	615200.0 | PLEKHF1, LAPF, PHAFIN1 | Pleckstrin homolog domain-containing protein, family F, member 1 | 79156.0 | ENSG00000166289 | nan | nan
chr19	C19orf12	614297.0 | C19orf12, NBIA4, SPG43 | Chromosome 19 open reading frame 12 | 83636.0 | ENSG00000131943 | mutation identified in 1 SPG43 family | Neurodegeneration with brain iron accumulation 4, 614298 (3), Autosomal recessive, Autosomal dominant; ?Spastic paraplegia 43, autosomal recessive, 615043 (3), Autosomal recessive
chr19	CCNE1	123837.0 | CCNE1 | Cyclin E1 | 898.0 | ENSG00000105173 | nan | nan
chr19	URI1	603494.0 | URI1, NNX3, RMP | Prefoldin-like chaperone URI1 | 8725.0 | ENSG00000105176 | nan | nan
chr19	ZNF536	618037.0 | ZNF536, KIAA0390 | Zinc finger protein 536 | 9745.0 | ENSG00000198597 | nan | nan
chr19	TSHZ3	614119.0 | TSHZ3, KIAA1474 | Teashirt zinc finger homeobox 3 | 57616.0 | ENSG00000121297 | nan | nan
chr19	AAA1	100070.0 | AAA1, AAA | Aortic aneurysm, familial abdominal 1 | 100329167.0 | nan | near D19S416 | Aortic aneurysm, familial abdominal 1, 100070 (2), Autosomal dominant
chr19	ANIB2	608542.0 | ANIB2 | Aneurysm, intracranial berry, 2 | 449013.0 | nan | between D19S245 and D19S246 | Aneurysm, intracranial berry, 2, 608542 (2)
chr19	CTRCT35	609376.0 | CTRCT35, CATCN1 | Cataract 35 | 619404.0 | nan | max lod at D19S416 | Cataract 35, congenital nuclear, 609376 (2), Autosomal recessive
chr19		613026.0 | DEL19q13.11d, C19DELq13.11d | Chromosome 19q13.11 deletion syndrome, distal | nan | nan | contiguous gene syndrome | Chromosome 19q13.11 deletion syndrome, distal, 613026 (4), Autosomal dominant
chr19		617219.0 | DEL19q13.11p, C19DELq13.11p | Chromosome 19q13.11 deletion syndrome, proximal | nan | nan | nan | Chromosome 19q13.11 deletion syndrome, proximal, 617219 (4), Autosomal dominant
chr19	E11S	129150.0 | E11S | Echo 11 sensitivity | 1878.0 | nan | nan | nan
chr19	EA7	611907.0 | EA7 | Episodic ataxia, type 7 | 100188859.0 | nan | between rs1366444 and rs952108 | Episodic ataxia, type 7, 611907 (2), Autosomal dominant
chr19	OFC3	600757.0 | OFC3 | Orofacial cleft 3 | 4965.0 | nan | ?role of BCL3 | Orofacial cleft 3, 600757 (2), ?Autosomal dominant
chr19	PSS3	616265.0 | PSS3 | Peeling skin syndrome 3 | 134198642.0 | nan | between D19S414 and D19S412 | Peeling skin syndrome 3, 616265 (2), Autosomal recessive
chr19	UAQTL5	614746.0 | UAQTL5 | Uric acid concentration, serum, quantitative trait locus 5 | 100996934.0 | nan | associated with rs150414818 | [Uric acid concentration, serum, QTL5], 614746 (2)
chr19	ZNF507	620567.0 | ZNF507 | Zinc finger protein 507 | 22847.0 | ENSG00000168813 | nan | nan
chr19	DPY19L3	613894.0 | DPY19L3 | DPY19-like 3 | 147991.0 | ENSG00000178904 | nan | nan
chr19	PDCD5	604583.0 | PDCD5, TFAR19 | Programmed cell death 5 | 9141.0 | ENSG00000105185 | nan | nan
chr19	ANKRD27	618957.0 | ANKRD27, VARP | Ankyrin repeat domain-containing protein 27 | 84079.0 | ENSG00000105186 | nan | nan
chr19	RGS9BP	607814.0 | RGS9BP, R9AP, RGS9, PERRS2 | Regulator of G protein signaling 9-binding protein | 388531.0 | ENSG00000186326 | nan | Prolonged electroretinal response suppression 2, 620344 (3), Autosomal recessive
chr19	SLC7A9	604144.0 | SLC7A9, CSNU3 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 | 11136.0 | ENSG00000021488 | nan | Cystinuria, 220100 (3), Autosomal recessive, Autosomal dominant
chr19	CEP89	615470.0 | CEP89, CCDC123, CEP123, FLJ14640 | Centrosomal protein, 89kD | 84902.0 | ENSG00000121289 | nan | nan
chr19	FAAP24	610884.0 | FAAP24, C19orf40 | FA core complex-associated protein 24 | 91442.0 | ENSG00000131944 | nan | nan
chr19	RHPN2	617932.0 | RHPN2 | Rhophilin 2 | 85415.0 | ENSG00000131941 | nan | nan
chr19	LRP3	603159.0 | LRP3 | Low density lipoprotein receptor related protein 3 | 4037.0 | ENSG00000130881 | nan | nan
chr19	SLC7A10	607959.0 | SLC7A10, ASC1 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 10 | 56301.0 | ENSG00000130876 | nan | nan
chr19	CEBPA	116897.0 | CEBPA, CEBP | CCAAT/enhancer-binding protein (C/EBP), alpha | 1050.0 | ENSG00000245848 | germline mutation identified in 1 AML family | Leukemia, acute myeloid, somatic, 601626 (3); ?Leukemia, acute myeloid, 601626 (3), Somatic mutation, Autosomal dominant
chr19	CEBPA-DT	620560.0 | CEBPA-DT, ADINR, CEBPA-AS1, LOC80054 | CEBPA divergent transcript | 80054.0 | ENSG00000267296 | nan | nan
chr19	CEBPG	138972.0 | CEBPG, GPE1BP | CCAAT/enhancer-binding protein, gamma | 1054.0 | ENSG00000153879 | nan | nan
chr19	PEPD	613230.0 | PEPD | Peptidase D (prolidase) | 5184.0 | ENSG00000124299 | closely linked to APOC2 | Prolidase deficiency, 170100 (3), Autosomal recessive
chr19	CHST8	610190.0 | CHST8, GALNAC4ST1 | Carbohydrate sulfotransferase 8 | 64377.0 | ENSG00000124302 | mutation has been identified in 1 PSS3 family | nan
chr19	KCTD15	615240.0 | KCTD15 | Potassium channel tetramerization domain-containing protein 15 | 79047.0 | ENSG00000153885 | nan | nan
chr19	LSM14A	610677.0 | LSM14A, RAP55 | LSM14A protein | 26065.0 | ENSG00000257103 | nan | nan
chr19	GARRE1	619335.0 | GARRE1, KIAA0355 | Granule-associated RAC and RHOG effector 1 | 9710.0 | ENSG00000166398 | nan | nan
chr19	GPI	172400.0 | GPI, CNSHA4 | Glucose phosphate isomerase; neuroleukin | 2821.0 | ENSG00000105220 | nan | Anemia, congenital, nonspherocytic hemolytic, 4, glucose phosphate isomerase deficient, 613470 (3), Autosomal recessive
chr19	PDCD2L	615661.0 | PDCD2L, MGC13096 | Programmed cell death 2-like protein | 84306.0 | ENSG00000126249 | nan | nan
chr19	UBA2	613295.0 | UBA2, SAE2, ACCES | Ubiquitin-like modifier-activating enzyme 2 | 10054.0 | ENSG00000126261 | nan | ACCES syndrome, 619959 (3), Autosomal dominant
chr19	WTIP	614790.0 | WTIP | WT1-interacting protein | 126374.0 | ENSG00000142279 | nan | nan
chr19	SCGB2B2	615063.0 | SCGB2B2 | Secretoglobin, family 2B, member 2 | 284402.0 | ENSG00000205209 | nan | nan
chr19	ZNF181	606741.0 | ZNF181 | Zinc finger protein-181 | 339318.0 | ENSG00000197841 | nan | nan
chr19	GRAMD1A	620178.0 | GRAMD1A, KIAA1533 | GRAM domain-containing protein 1A | 57655.0 | ENSG00000089351 | nan | nan
chr19	SCN1B	600235.0 | SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52 | Sodium voltage-gated channel, beta subunit 1 | 6324.0 | ENSG00000105711 | nan | Generalized epilepsy with febrile seizures plus, type 1, 604233 (3), Autosomal dominant; Developmental and epileptic encephalopathy 52, 617350 (3), Autosomal recessive; Cardiac conduction defect, nonspecific, 612838 (3); Atrial fibrillation, familial, 13, 615377 (3), Autosomal dominant; Brugada syndrome 5, 612838 (3)
chr19	HPN	142440.0 | HPN | Hepsin | 3249.0 | ENSG00000105707 | nan | nan
chr19	FXYD3	604996.0 | FXYD3, PLML, MAT8 | FXYD domain-containing ion transport regulator 3 | 5349.0 | ENSG00000089356 | nan | nan
chr19	LGI4	608303.0 | LGI4, AMC1 | Leucine-rich gene, glioma-inactivated, 4 | 163175.0 | ENSG00000153902 | nan | Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect, 617468 (3), Autosomal recessive
chr19	FXYD1	602359.0 | FXYD1, PLM | FXYD domain-containing ion transport regulator 1 (phospholemman) | 5348.0 | ENSG00000266964 | nan | nan
chr19	FXYD7	606684.0 | FXYD7 | FXYD domain-containing ion transport regulator 7 | 53822.0 | ENSG00000221946 | nan | nan
chr19	FXYD5	606669.0 | FXYD5 | FXYD domain-containing ion transport regulator 5 | 53827.0 | ENSG00000089327 | nan | nan
chr19	LSR	616582.0 | LSR | Lipolysis-stimulated lipoprotein receptor | 51599.0 | ENSG00000105699 | nan | nan
chr19	USF2	600390.0 | USF2, FIP | Upstream transcription factor 2, c-fos interacting | 7392.0 | ENSG00000105698 | nan | nan
chr19	HAMP	606464.0 | HAMP, LEAP1, HEPC, HFE2B | Hepcidin antimicrobial peptide | 57817.0 | ENSG00000105697 | digenic form with HAMP and HFE mutations | Hemochromatosis, type 2B, 613313 (3), Autosomal recessive
chr19	MAG	159460.0 | MAG, GMA, SPG75 | Myelin-associated glycoprotein | 4099.0 | ENSG00000105695 | nan | Spastic paraplegia 75, autosomal recessive, 616680 (3), Autosomal recessive
chr19	CD22	107266.0 | CD22 | CD22 antigen | 933.0 | ENSG00000012124 | nan | nan
chr19	FFAR1	603820.0 | FFAR1, GPR40 | Free fatty acid receptor 1 | 2864.0 | ENSG00000126266 | nan | nan
chr19	FFAR3	603821.0 | FFAR3, GPR41 | Free fatty acid receptor 3 | 2865.0 | ENSG00000185897 | nan | nan
chr19	GPR42	603822.0 | GPR42 | G protein-coupled receptor-42 | 2866.0 | ENSG00000126251 | nan | nan
chr19	FFAR2	603823.0 | FFAR2, GPR43 | Free fatty acid receptor 2 | 2867.0 | ENSG00000126262 | nan | nan
chr19	KRTDAP	617212.0 | KDAP | Keratinocyte differentiation-associated protein | 388533.0 | ENSG00000188508 | nan | nan
chr19	DMKN	617211.0 | DMKN | Dermokine | 93099.0 | ENSG00000161249 | nan | nan
chr19	SBSN	609969.0 | SBSN | Suprabasin | 374897.0 | ENSG00000189001 | nan | nan
chr19	GAPDHS	609169.0 | GAPDHS, GAPD2 | Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic | 26330.0 | ENSG00000105679 | 9.5 Mbp prox. to APOE | nan
chr19	TMEM147	613585.0 | TMEM147, NEDFLPH | Transmembrane protein 147 | 10430.0 | ENSG00000105677 | nan | Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly, 620075 (3), Autosomal recessive
chr19	ATP4A	137216.0 | ATP4A, ATP6A | ATPase, H+, K+ transporting, alpha | 495.0 | ENSG00000105675 | nan | nan
chr19	HAUS5	613432.0 | HAUS5, DGT5, KIAA0841 | HAUS augmin-like complex, subunit 5 | 23354.0 | ENSG00000249115 | nan | nan
chr19	RBM42	613232.0 | RBM42 | RNA-binding motif protein 42 | 79171.0 | ENSG00000126254 | nan | nan
chr19	ETV2	609358.0 | ETV2, ETSRP71 | ETS variant transcription factor 2 | 2116.0 | ENSG00000105672 | nan | nan
chr19	COX6B1	124089.0 | COX6B1, MC4DN7 | Cytochrome c oxidase, subunit VIb polypeptide 1 (ubiquitous) | 1340.0 | ENSG00000126267 | nan | Mitochondrial complex IV deficiency, nuclear type 7, 619051 (3), Autosomal recessive
chr19	UPK1A	611557.0 | UPK1A, UPIA | Uroplakin 1A | 11045.0 | ENSG00000105668 | nan | nan
chr19	ZBTB32	605859.0 | ZBTB32, FAXF, TZFP, ROG | Zinc finger- and BTB domain-containing protein 32 | 27033.0 | ENSG00000011590 | nan | nan
chr19	KMT2B	606834.0 | KMT2B, MLL4, KIAA0304, DYT28, MRD68 | Lysine-specific methyltransferase 2B | 9757.0 | ENSG00000272333 | nan | Intellectual developmental disorder, autosomal dominant 68, 619934 (3), Autosomal dominant; Dystonia 28, childhood-onset, 617284 (3), Autosomal dominant
chr19	IGFLR1	614143.0 | IGFLR1, TMEM149 | IGF-like family receptor 1 | 79713.0 | ENSG00000126246 | nan | nan
chr19	U2AF1L4	601080.0 | U2AF1L4, U2AF1RS3 | U2 small nuclear RNA auxillary factor 1-like 4 | 199746.0 | ENSG00000161265 | nan | nan
chr19	PSENEN	607632.0 | PSENEN, PEN2, ACNINV2 | Presenilin enhancer, gamma-secretase subunit | 55851.0 | ENSG00000205155 | nan | Acne inversa, familial, 2, with or without Dowling-Degos disease, 613736 (3), Autosomal dominant
chr19	HSPB6	610695.0 | HSPB6, HSP20 | Heat-shock 27kD protein 6 | 126393.0 | ENSG00000004776 | nan | nan
chr19	ARHGAP33	614902.0 | ARHGAP33, TCGAP | Rho GTPase-activating protein 33 | 115703.0 | ENSG00000004777 | nan | nan
chr19	PRODH2	616377.0 | PRODH2, HYPDH | Proline dehydrogenase (oxidase) 2 | 58510.0 | ENSG00000250799 | nan | nan
chr19	NPHS1	602716.0 | NPHS1, NPHN | Nephrin | 4868.0 | ENSG00000161270 | nan | Nephrotic syndrome, type 1, 256300 (3), Autosomal recessive
chr19	KIRREL2	607762.0 | KIRREL2, NEPH3, NLG1, FILTRIN | Kirre-like nephrin family adhesion molecule 2 | 84063.0 | ENSG00000126259 | nan | nan
chr19	APLP1	104775.0 | APLP1, APLP | Amyloid beta (A4) precursor-like protein-1 | 333.0 | ENSG00000105290 | nan | nan
chr19	NFKBID	618887.0 | NFKBID, IKBNS | Nuclear factor kappa-B inhibitor, delta | 84807.0 | ENSG00000167604 | nan | nan
chr19	HCST	604089.0 | DAP10 | DNAX-activation protein 10 | 10870.0 | ENSG00000126264 | nan | nan
chr19	TYROBP	604142.0 | TYROBP, DAP12, PLOSL1 | TYRO protein tyrosine kinase-binding protein | 7305.0 | ENSG00000011600 | nan | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, 221770 (3), Autosomal recessive
chr19	LRFN3	612809.0 | LRFN3, SALM4 | Leucine-rich repeat and fibronectin type III domain-containing protein 3 | 79414.0 | ENSG00000126243 | nan | nan
chr19	SDHAF1	612848.0 | SDHAF1, MC2DN2 | Succinate dehydrogenase complex assembly factor 1 | 644096.0 | ENSG00000205138 | nan | Mitochondrial complex II deficiency, nuclear type 2, 619166 (3), Autosomal recessive
chr19	SYNE4	615535.0 | SYNE4, NESP4, C19orf46, DFNB76 | Spectrin repeat-containing nuclear envelope protein 4 | 163183.0 | ENSG00000181392 | nan | Deafness, autosomal recessive 76, 615540 (3), Autosomal recessive
chr19	ALKBH6	613304.0 | ALKBH6, ABH6 | AlkB homolog 6 | 84964.0 | ENSG00000239382 | nan | nan
chr19	CLIP3	607382.0 | CLIP3, CLIPR59 | CAP-GLY domain-containing linker protein 3 | 25999.0 | ENSG00000105270 | nan | nan
chr19	THAP8	612536.0 | THAP8 | THAP domain-containing protein 8 | 199745.0 | ENSG00000161277 | nan | nan
chr19	WDR62	613583.0 | WDR62, C19orf14, MCPH2 | WD repeat-containing protein 62 | 284403.0 | ENSG00000075702 | nan | Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3), Autosomal recessive
chr19	OVOL3	616442.0 | OVOL3 | ovo-like 3 | 728361.0 | ENSG00000105261 | nan | nan
chr19	POLR2I	180662.0 | POLR2I | Polymerase (RNA) II (DNA directed) polypeptide I, 14.5kD | 5438.0 | ENSG00000105258 | nan | nan
chr19	TBCB	601303.0 | CKAP1 | Cytoskeleton-associated protein 1 | 1155.0 | ENSG00000105254 | nan | nan
chr19	CAPNS1	114170.0 | CAPNS1, CAPN4, PPH6 | Calpain, small subunit 1 | 826.0 | ENSG00000126247 | nan | Pulmonary hypertension, primary, 6, 620777 (3), Autosomal recessive
chr19	COX7A1	123995.0 | COX7A1, COX7AM | Cytochrome c oxidase, subunit VIIa, polypeptide-1, muscle | 1346.0 | ENSG00000161281 | nan | nan
chr19	ZNF565	614275.0 | ZNF565 | Zinc finger protein 565 | 147929.0 | ENSG00000196357 | nan | nan
chr19	ZNF146	601505.0 | ZNF146, OZF | Zinc finger protein-146 | 7705.0 | ENSG00000167635 | nan | nan
chr19	ZFP14	620163.0 | ZFP14, ZNF531 | ZFP14 zinc finger protein | 57677.0 | ENSG00000142065 | nan | nan
chr19	ZNF260	613749.0 | ZNF260, PEX1 | Zinc finger protein 260 | 339324.0 | ENSG00000254004 | nan | nan
chr19	ZNF382	609516.0 | ZNF382, KS1 | Zinc finger protein 382 | 84911.0 | ENSG00000161298 | nan | nan
chr19	ZNF461	608640.0 | ZNF461, GIOT1 | Zinc finger protein-461 | 92283.0 | ENSG00000197808 | nan | nan
chr19	ZNF568	617566.0 | ZNF568, ZFP568 | Zinc finger protein 568 | 374900.0 | ENSG00000198453 | nan | nan
chr19	ZNF420	617216.0 | ZNF420, APAK | Zinc finger protein 420 | 147923.0 | ENSG00000197050 | nan | nan
chr19	ZNF383	619499.0 | ZNF383 | Zinc finger protein 383 | 163087.0 | ENSG00000188283 | nan | nan
chr19	ZNF875	165250.0 | ZNF875, HKR1 | Zinc finger protein 875 | 284459.0 | ENSG00000181666 | nan | nan
chr19	ZNF569	613904.0 | ZNF569 | Zinc finger protein 569 | 148266.0 | ENSG00000196437 | nan | nan
chr19	ZNF540	613903.0 | ZNF540 | Zinc finger protein 540 | 163255.0 | ENSG00000171817 | nan | nan
chr19	ZFP30	617317.0 | ZFP30, ZNF745, KIAA0961 | Zinc finger protein 30, mouse, homolog of | 22835.0 | ENSG00000120784 | nan | nan
chr19	WDR87	620274.0 | WDR87 | WD repeat-containing protein 87 | 83889.0 | ENSG00000171804 | nan | nan
chr19	SIPA1L3	616655.0 | SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45 | SIPA1-like protein 3 | 23094.0 | ENSG00000105738 | mutation identified in 1 CTRCT45 family | ?Cataract 45, 616851 (3), Autosomal recessive
chr19	CFM1	603855.0 | CFM1 | Cystic fibrosis modifier-1 | 10167.0 | nan | nan | {Meconium ileus in cystic fibrosis, susceptibility to}, 603855 (2)
chr19	MRT11	611097.0 | MRT11 | Intellectual developmental disorder, autosomal recessive 11 | 100101426.0 | nan | between rs2109075 and rs8101149 | Intellectual developmental disorder, autosomal recessive 11, 611097 (2), Autosomal recessive
chr19	TEC	227050.0 | TEC | Transient erythroblastopenia of childhood | 100124696.0 | nan | nan | Transient erythroblastopenia of childhood, 227050 (2), Autosomal recessive
chr19	DPF1	601670.0 | DPF1, NEUD4 | D4, zinc, and double PHD fingers family, member 1 | 8193.0 | ENSG00000011332 | nan | nan
chr19	PPP1R14A	608153.0 | PPP1R14A, CPI17 | Protein phosphatase 1, regulatory subunit 14A | 94274.0 | ENSG00000167641 | nan | nan
chr19	SPINT2	605124.0 | SPINT2, HAI2, DIAR3 | Serine protease inhibitor, Kunitz-type, 2 | 10653.0 | ENSG00000167642 | nan | Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3), Autosomal recessive
chr19	YIF1B	619109.0 | YIF1B, KABAMAS | YIP1-interacting factor homolog B, membrane-trafficking protein | 90522.0 | ENSG00000167645 | nan | Kaya-Barakat-Masson syndrome, 619125 (3), Autosomal recessive
chr19	C19orf33	619711.0 | C19orf33, H2RSP, IMUP | Chromosome 19 open reading frame 33 | 64073.0 | ENSG00000167644 | nan | nan
chr19	KCNK6	603939.0 | KCNK6, TWIK2, TOSS | Potassium channel, subfamily K, member 6 | 9424.0 | ENSG00000099337 | nan | nan
chr19	CATSPERG	613452.0 | CATSPERG | Cation channel, sperm-associated, gamma | 57828.0 | ENSG00000099338 | nan | nan
chr19	PSMD8	617844.0 | PSMD8 | Proteasome 26S subunit, non-ATPase, 8 | 5714.0 | ENSG00000099341 | nan | nan
chr19	GGN	609966.0 | GGN | Gametogenetin, mouse, homolog of | 199720.0 | ENSG00000179168 | nan | Spermatogenic failure 69, 619826 (3), Autosomal recessive
chr19	SPRED3	609293.0 | SPRED3 | Sprouty-related EVH1 domain-containing protein 3 | 399473.0 | ENSG00000188766 | nan | nan
chr19	RASGRP4	607320.0 | RASGRP4 | Ras guanyl nucleotide-releasing protein 4 | 115727.0 | ENSG00000171777 | nan | nan
chr19	RYR1	180901.0 | RYR1, MHS, KDS, CMYO1A, CMYO1B | Ryanodine receptor-1, skeletal | 6261.0 | ENSG00000196218 | nan | Congenital myopathy 1B, autosomal recessive, 255320 (3), Autosomal recessive; Congenital myopathy 1A, autosomal dominant, with susceptibility to malignant hyperthermia, 117000 (3), Autosomal dominant; King-Denborough syndrome, 619542 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 1}, 145600 (3), Autosomal dominant
chr19	MAP4K1	601983.0 | MAP4K1, HPK1 | Mitogen-activated protein kinase kinase kinase kinase 1 | 11184.0 | ENSG00000104814 | nan | nan
chr19	EIF3K	609596.0 | EIF3K, PLAC24, EIF3S12 | Eukaryotic translation initiation factor 3, subunit K | 27335.0 | ENSG00000178982 | nan | nan
chr19	ACTN4	604638.0 | ACTN4, FSGS1, FSGS | Actinin, alpha-4 | 81.0 | ENSG00000130402 | nan | Glomerulosclerosis, focal segmental, 1, 603278 (3), Autosomal dominant
chr19	CAPN12	608839.0 | CAPN12 | Calpain 12 | 147968.0 | ENSG00000182472 | nan | nan
chr19	LGALS7	600615.0 | LGALS7 | Lectin, galactoside-binding, soluble, 7 (galectin 7) | 3963.0 | ENSG00000205076 | nan | nan
chr19	LGALS7B	617139.0 | LGALS7B | Lectin, galactoside-binding, soluble, 7B | 653499.0 | ENSG00000178934 | nan | nan
chr19	LGALS4	602518.0 | LGALS4 | Lectin, galactoside-binding, soluble, 4 | 3960.0 | ENSG00000171747 | nan | nan
chr19	ECH1	600696.0 | ECH1 | Enoyl Coenzyme A hydratase 1, peroxisomal | 1891.0 | ENSG00000104823 | nan | nan
chr19	HNRNPL	603083.0 | HNRNPL, HNRPL | Heterogeneous nuclear riboprotein 1 | 3191.0 | ENSG00000104824 | nan | nan
chr19	RINL	620678.0 | RINL | Ras and Rab interactor-like protein | 126432.0 | ENSG00000187994 | nan | nan
chr19	SIRT2	604480.0 | SIRT2, SIR2L, SIR2L2 | Sirtuin 2 | 22933.0 | ENSG00000068903 | nan | nan
chr19	NFKBIB	604495.0 | NFKBIB, IKBB, TRIP9 | Nuclear factor of kappa-B inhibitor, beta | 4793.0 | ENSG00000104825 | nan | nan
chr19	CCER2	617634.0 | CCER2 | Coiled-coil glutamate-rich protein 2 | 643669.0 | ENSG00000262484 | nan | nan
chr19	SARS2	612804.0 | SARS2 | Seryl-tRNA synthetase 2 | 54938.0 | ENSG00000104835 | nan | Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3), Autosomal recessive
chr19	MRPS12	603021.0 | MRPS12, RPSM12 | Ribosomal protein, mitochondrial, S12 | 6183.0 | ENSG00000128626 | nan | nan
chr19	FBXO17	609094.0 | FBXO17, FBX17, FBX26, FBG4 | F-box only protein 17 | 115290.0 | ENSG00000269190 | nan | nan
chr19	FBXO27	609099.0 | FBXO27, FBX27, FBG5 | F-box only protein 27 | 126433.0 | ENSG00000161243 | nan | nan
chr19	ACP7	610490.0 | PAPL, FLJ16165 | Purple acid phosphatase, long form | 390928.0 | ENSG00000183760 | nan | nan
chr19	PAK4	605451.0 | PAK4 | p21-activated kinase 4 | 10298.0 | ENSG00000130669 | nan | nan
chr19	NCCRP1	615901.0 | NCCRP1, FBXO50 | Nonspecific cytotoxic cell receptor protein 1, zebrafish, homolog of | 342897.0 | ENSG00000188505 | nan | nan
chr19	SYCN	620140.0 | SYCN | Syncollin | 342898.0 | ENSG00000179751 | nan | nan
chr19	IFNL3	607402.0 | IFNL3, IL28B | Interferon, lambda 3 | 282617.0 | ENSG00000197110 | nan | {Hepatitis C virus infection, response to therapy of}, 609532 (3)
chr19	IFNL4	615090.0 | IFNL4 | Interferon, lambda-4 | 101180976.0 | ENSG00000272395 | nan | nan
chr19	IFNL2	607401.0 | IFNL2, IL28A | Interferon, lambda 2 | 282616.0 | ENSG00000183709 | nan | nan
chr19	IFNL1	607403.0 | IFNL1, IL29 | Interferon, lambda 1 | 282618.0 | ENSG00000182393 | nan | nan
chr19	LRFN1	612807.0 | LRFN1, SALM2, KIAA1484 | Leucine-rich repeat and fibronectin type III domain-containing protein 1 | 57622.0 | ENSG00000128011 | nan | nan
chr19	GMFG	604104.0 | GMFG | Glia maturation factor, gamma | 9535.0 | ENSG00000130755 | nan | nan
chr19	SAMD4B	619231.0 | SAMD4B | Sterile alpha motif domain-containing protein 4B | 55095.0 | ENSG00000179134 | nan | nan
chr19	PAF1	610506.0 | PAF1, PD2 | PAF1 RNA polymerase II-associated factor, S. cerevisiae, homolog of | 54623.0 | ENSG00000006712 | nan | nan
chr19	MED29	612914.0 | MED29, IXL | Mediator complex subunit 29 | 55588.0 | ENSG00000063322 | nan | nan
chr19	ZFP36	190700.0 | ZFP36, TTP | Zfp36, mouse, homolog of | 7538.0 | ENSG00000128016 | nan | nan
chr19	PLEKHG2	611893.0 | PLEKHG2, CLG, LDAMD | Pleckstrin homology domain- and RhoGEF domain-containing protein G2 | 64857.0 | ENSG00000090924 | nan | Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3), Autosomal recessive
chr19	RPS16	603675.0 | RPS16 | Ribosomal protein S16 | 6217.0 | ENSG00000105193 | nan | nan
chr19	SUPT5H	602102.0 | SUPT5H, SPT5 | SPT5 homolog, DSIF elongation factor subunit | 6829.0 | ENSG00000196235 | nan | nan
chr19	TIMM50	607381.0 | TIMM50, TIM50, MGCA9 | Translocase of inner mitochondrial membrane 50 | 92609.0 | ENSG00000105197 | nan | 3-methylglutaconic aciduria, type IX, 617698 (3), Autosomal recessive
chr19	DLL3	602768.0 | DLL3, SCDO1 | Delta-like canonical Notch ligand 3 | 10683.0 | ENSG00000090932 | nan | Spondylocostal dysostosis 1, autosomal recessive, 277300 (3), Autosomal recessive
chr19	SELENOV	607919.0 | SELENOV, SELV | Selenoprotein V | 348303.0 | ENSG00000186838 | nan | nan
chr19	EID2B	617355.0 | EID2B | EP300-interacting inhibitor of differentiation 2B | 126272.0 | ENSG00000176401 | nan | nan
chr19	EID2	609773.0 | EID2, CRI2 | EP300-interacting inhibitor of differentiation 2 | 163126.0 | ENSG00000176396 | nan | nan
chr19	LGALS13	608717.0 | LGALS13, GAL13, PP13 | Lectin, galactoside-binding, soluble, 13 | 29124.0 | ENSG00000105198 | nan | nan
chr19	LGALS14	607260.0 | PPL13 | Placental protein 13-like protein | 56891.0 | ENSG00000006659 | nan | nan
chr19	CLC	153310.0 | CLC | Charcot-Leyden crystal protein | 1178.0 | ENSG00000105205 | nan | nan
chr19	LEUTX	618701.0 | LEUTX | Leucine twenty homeobox | 342900.0 | ENSG00000213921 | nan | nan
chr19	DYRK1B	604556.0 | DYRK1B, MIRK, AOMS3 | Dual-specificity tyrosine phosphorylation-regulated kinase 1B | 9149.0 | ENSG00000105204 | nan | Abdominal obesity-metabolic syndrome 3, 615812 (3), Autosomal dominant
chr19	FBL	134795.0 | FBL | Fibrillarin | 2091.0 | ENSG00000105202 | nan | nan
chr19	FCGBP	617553.0 | FCGBP | Fc fragment of IgG-binding protein | 8857.0 | ENSG00000275395 | nan | nan
chr19	PSMC4	602707.0 | PSMC4, TBP7, S6 | Proteasome 26S subunit, ATPase, 4 | 5704.0 | ENSG00000013275 | nan | nan
chr19	MAP3K10	600137.0 | MAP3K10, MLK2, MST | Mitogen-activated protein kinase kinase kinase 10 | 4294.0 | ENSG00000130758 | nan | nan
chr19	CCNP	620396.0 | CCNP, CNTD2 | Cyclin P | 79935.0 | ENSG00000105219 | nan | nan
chr19	AKT2	164731.0 | AKT2, HIHGHH | AKT serine/threonine kinase 2 | 208.0 | ENSG00000105221 | nan | Diabetes mellitus, type II, 125853 (3), Autosomal dominant; Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3), Autosomal dominant
chr19	PLD3	615698.0 | PLD3, HUK4, SCA46 | Phospholipase D family, member 3 | 23646.0 | ENSG00000105223 | mutation identified in 1 SCA46 family | ?Spinocerebellar ataxia 46, 617770 (3), Autosomal dominant
chr19	HIPK4	611712.0 | HIPK4 | Homeodomain-interacting protein kinase 4 | 147746.0 | ENSG00000160396 | nan | nan
chr19	PRX	605725.0 | PRX, CMT4F | Periaxin | 57716.0 | ENSG00000105227 | nan | Charcot-Marie-Tooth disease, type 4F, 614895 (3), Autosomal recessive; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant
chr19	SERTAD1	617850.0 | SERTAD1, TRIPBR1 | SERTA domain-containing protein 1 | 29950.0 | ENSG00000197019 | nan | nan
chr19	SERTAD3	612125.0 | SERTAD3, RBT1 | SERTA domain-containing 3 | 29946.0 | ENSG00000167565 | nan | nan
chr19	BLVRB	600941.0 | BLVRB, BVRB, FLR | Biliverdin reductase B | 645.0 | ENSG00000090013 | nan | nan
chr19	SPTBN4	606214.0 | SPTBN4, QV, NEDHND, CMND | Spectrin, beta, nonerythrocytic, 4 (quivering, mouse, homolog of) | 57731.0 | ENSG00000160460 | nan | Neurodevelopmental disorder with hypotonia, neuropathy, and deafness, 617519 (3), Autosomal recessive
chr19	SHKBP1	617322.0 | SHKBP1, SB1 | SH3KBP1-binding protein 1 | 92799.0 | ENSG00000160410 | nan | nan
chr19	LTBP4	604710.0 | LTBP4, LTBP4S, LTBP4L, ARCL1C | Latent transforming growth factor-beta-binding protein 4 | 8425.0 | ENSG00000090006 | nan | Cutis laxa, autosomal recessive, type IC, 613177 (3), Autosomal recessive
chr19	NUMBL	604018.0 | NUMBL, NUMBR, NBL | Numb, Drosophila, homolog-like | 9253.0 | ENSG00000105245 | nan | nan
chr19	COQ8B	615567.0 | COQ8B, ADCK4, NPHS9 | Coenzyme Q8B | 79934.0 | ENSG00000123815 | nan | Nephrotic syndrome, type 9, 615573 (3), Autosomal recessive
chr19	ITPKC	606476.0 | ITPKC | Inositol 1,4,5-trisphosphate 3-kinase C | 80271.0 | ENSG00000086544 | nan | nan
chr19	ACTMAP	620093.0 | ACTMAP, C19orf54 | Actin maturation protease | 284325.0 | ENSG00000188493 | nan | nan
chr19	SNRPA	182285.0 | SNRPA | Small nuclear ribonucleoprotein polypeptide A | 6626.0 | ENSG00000077312 | nan | nan
chr19	MIA	601340.0 | MIA | MIA SH3 domain-containing protein | 8190.0 | ENSG00000261857 | nan | nan
chr19	RAB4B	612945.0 | RAB4B | Ras-associated protein RAB4B | 53916.0 | ENSG00000167578 | nan | nan
chr19	EGLN2	606424.0 | EGLN2, PHD1, HIFPH1 | egl-9 family hypoxia inducible factor 2 | 112398.0 | ENSG00000269858 | nan | nan
chr19	CYP2A6	122720.0 | CYP2A6, CYP2A3, CYP2A, P450C2A | Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6 | 1548.0 | ENSG00000255974 | nan | {Lung cancer, resistance to}, 211980 (3), Somatic mutation, Autosomal dominant; Coumarin resistance, 122700 (3), Autosomal dominant; {Nicotine addiction, protection from}, 188890 (3)
chr19	CYP2A7	608054.0 | CYP2A7 | Cytochrome P450, subfamily IIA, polypeptide 7 | 1549.0 | ENSG00000198077 | nan | nan
chr19	CYP2G1P	601133.0 | CYP2G1P, CYP2G1 | Cytochrome P450, family 2, subfamily G, member 1, pseudogene | 22952.0 | ENSG00000290611 | nan | nan
chr19	CYP2B6	123930.0 | CYP2B6, CYP2B, EFVM | Cytochrome P450, family 2, subfamily B, polypeptide 6 | 1555.0 | ENSG00000197408 | same NotI fragment as CYP2A | {Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3); Efavirenz, poor metabolism of, 614546 (3)
chr19	CYP2A13	608055.0 | CYP2A13 | Cytochrome P450, subfamily IIA, polypeptide 13 | 1553.0 | ENSG00000197838 | nan | nan
chr19	CYP2F1	124070.0 | CYP2F1 | Cytochrome P450, subfamily IIF, polypeptide 1 | 1572.0 | ENSG00000197446 | CYP2A, CYP2B, CYP2F1 in 240kb | nan
chr19	CYP2S1	611529.0 | CYP2S1 | Cytochrome P450, family 2, subfamily S, polypeptide 1 | 29785.0 | ENSG00000167600 | nan | nan
chr19	AXL	109135.0 | AXL | AXL transforming sequence (a receptor tyrosine kinase) | 558.0 | ENSG00000167601 | nan | nan
chr19	HNRNPUL1	605800.0 | HNRNPUL1, HNRPUL1, E1BAP5 | Heterogeneous nuclear ribonucleoprotein U-like 1 | 11100.0 | ENSG00000105323 | nan | nan
chr19	TGFB1	190180.0 | TGFB1, DPD1, CED, IBDIMDE | Transforming growth factor, beta-1 | 7040.0 | ENSG00000105329 | nan | Inflammatory bowel disease, immunodeficiency, and encephalopathy, 618213 (3), Autosomal recessive; Camurati-Engelmann disease, 131300 (3), Autosomal dominant; {Cystic fibrosis lung disease, modifier of}, 219700 (3), Autosomal recessive
chr19	B9D2	611951.0 | B9D2, MKS10, JBTS34 | B9 domain-containing protein 2 | 80776.0 | ENSG00000123810 | mutation identified in 1 MKS10 family | ?Meckel syndrome 10, 614175 (3), Autosomal recessive; Joubert syndrome 34, 614175 (3), Autosomal recessive
chr19	TMEM91	618294.0 | TMEM91, DSPC3 | Transmembrane protein 91 | 641649.0 | ENSG00000142046 | nan | nan
chr19	EXOSC5	606492.0 | EXOSC5, RRP46, CABAC | Exosome component 5 | 56915.0 | ENSG00000077348 | nan | Cerebellar ataxia, brain abnormalities, and cardiac conduction defects, 619576 (3), Autosomal recessive
chr19	BCKDHA	608348.0 | BCKDHA, MSUD1A | Branched chain keto acid dehydrogenase E1, alpha polypeptide | 593.0 | ENSG00000248098 | nan | Maple syrup urine disease, type Ia, 248600 (3), Autosomal recessive
chr19	B3GNT8	615357.0 | B3GNT8, BGALT15, B3GALT7 | Beta-1,3-galactosyltransferase 8 | 374907.0 | ENSG00000177191 | nan | nan
chr19	DMAC2	617262.0 | ATP5SL | ATP5S-like protein | 55101.0 | ENSG00000105341 | nan | nan
chr19	PCAT19	618192.0 | PCAT19, LINC01190 | Prostate cancer-associated transcript 19, noncoding | 100505495.0 | ENSG00000267107 | nan | nan
chr19	CEACAM21	618191.0 | CEACAM21 | CEA cell adhesion molecule 21 | 90273.0 | ENSG00000007129 | nan | nan
chr19	CEACAM4	619159.0 | CEACAM4 | CEA cell adhesion molecule 4 | 1089.0 | ENSG00000105352 | nan | nan
chr19	CEACAM7	619160.0 | CEACAM7, CGM2 | CEA cell adhesion molecule 7 | 1087.0 | ENSG00000007306 | nan | nan
chr19	CEACAM5	114890.0 | CEACAM5, CEA | CEA cell adhesion molecule 5 | 1048.0 | ENSG00000105388 | proximal to PSG cluster in 1.1-1.2Mb segment | nan
chr19	CEACAM6	163980.0 | CEACAM6, NCA | CEA cell adhesion molecule 6 | 4680.0 | ENSG00000086548 | in CEA cluster | nan
chr19	CEACAM3	609142.0 | CEACAM3, CGM1, CD66D | CEA cell adhesion molecule 3 | 1084.0 | ENSG00000170956 | nan | nan
chr19	DMRTC2	614806.0 | DMRTC2 | Doublesex- and MAB3-related transcription factor C2 | 63946.0 | ENSG00000142025 | nan | nan
chr19	RPS19	603474.0 | RPS19, DBA, DBA1 | Ribosomal protein S19 | 6223.0 | ENSG00000105372 | nan | Diamond-Blackfan anemia 1, 105650 (3), Autosomal dominant
chr19	CD79A	112205.0 | CD79A, IGA | CD79A antigen (immunoglobulin-associated alpha) | 973.0 | ENSG00000105369 | nan | Agammaglobulinemia 3, 613501 (3), Autosomal recessive
chr19	ARHGEF1	601855.0 | ARHGEF1, LBCL2, IMD62 | Rho guanine nucleotide exchange factor, 115-kD | 9138.0 | ENSG00000076928 | mutation identified in 1 IMD62 family | ?Immunodeficiency 62, 618459 (3), Autosomal recessive
chr19	RABAC1	604925.0 | PRA1 | Prenylated RAB acceptor 1 | 10567.0 | ENSG00000105404 | nan | nan
chr19	ATP1A3	182350.0 | ATP1A3, DYT12, RDP, AHC2, CAPOS, DEE99 | ATPase, Na+K+ transporting, alpha-3 polypeptide | 478.0 | ENSG00000105409 | nan | Alternating hemiplegia of childhood 2, 614820 (3), Autosomal dominant; Dystonia-12, 128235 (3), Autosomal dominant; CAPOS syndrome, 601338 (3), Autosomal dominant; Developmental and epileptic encephalopathy 99, 619606 (3), Autosomal dominant
chr19	GRIK5	600283.0 | GRIK5 | Glutamate receptor, ionotropic, kainate 5 | 2901.0 | ENSG00000105737 | nan | nan
chr19	POU2F2	164176.0 | POU2F2, OTF2, OCT2 | POU domain, class 2, transcription factor 2 | 5452.0 | ENSG00000028277 | nan | nan
chr19	DEDD2	617078.0 | DEDD2, FLAME3 | Death effector domain-containing protein 2 | 162989.0 | ENSG00000160570 | nan | nan
chr19	ZNF526	614387.0 | ZNF526, KIAA1951, DENNED | Zinc finger protein 526 | 116115.0 | ENSG00000167625 | nan | Dentici-Novelli neurodevelopmental syndrome, 619877 (3), Autosomal recessive
chr19	GSK3A	606784.0 | GSK3A | Glycogen synthase kinase 3-alpha | 2931.0 | ENSG00000105723 | nan | nan
chr19	ERF	611888.0 | ERF, PE2, CRS4, CHYTS | ETS2 repressor factor | 2077.0 | ENSG00000105722 | nan | Craniosynostosis 4, 600775 (3), Autosomal dominant; Chitayat syndrome, 617180 (3), Autosomal dominant
chr19	CIC	612082.0 | CIC, KIAA0306, MRD45 | Capicua transcriptional repressor | 23152.0 | ENSG00000079432 | nan | Intellectual developmental disorder, autosomal dominant 45, 617600 (3), Autosomal dominant
chr19	PAFAH1B3	603074.0 | PAFAH1B3 | Platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit | 5050.0 | ENSG00000079462 | nan | nan
chr19	MEGF8	604267.0 | MEGF8, EGFL4, CRPT2 | Multiple epidermal growth factor-like domains 8 | 1954.0 | ENSG00000105429 | nan | Carpenter syndrome 2, 614976 (3), Autosomal recessive
chr19	CNFN	611764.0 | CNFN | Cornifelin | 84518.0 | ENSG00000105427 | nan | nan
chr19	LIPE	151750.0 | LIPE, LHS, FPLD6 | Lipase E, hormone-sensitive | 3991.0 | ENSG00000079435 | nan | Lipodystrophy, familial partial, type 6, 615980 (3), Autosomal recessive
chr19	CXCL17	611387.0 | CXCL17, VCC1, DMC | Chemokine (C-X-C motif) ligand 17 | 284340.0 | ENSG00000189377 | nan | nan
chr19	CEACAM1	109770.0 | CEACAM1, BGP | CEA cell adhesion molecule 1 | 634.0 | ENSG00000079385 | in CEA cluster | nan
chr19	CEACAM8	615747.0 | CEACAM8, CD66B, CGM6 | CEA cell adhesion molecule 8 | 1088.0 | ENSG00000124469 | nan | nan
chr19	PSG3	176392.0 | PSG3 | Pregnancy-specific beta-1-glycoprotein-3 | 5671.0 | ENSG00000221826 | nan | nan
chr19	PSG8	176397.0 | PSG8 | Pregnancy-specific beta-1-glycoprotein-8 | 440533.0 | ENSG00000124467 | nan | nan
chr19	PSG10P	176399.0 | PSG10P, PSG10, PSG12 | Pregnancy-specific beta-1-glycoprotein 10, pseudogene | 653492.0 | ENSG00000291235 | nan | nan
chr19	PSG1	176390.0 | PSG1, PSBG1, B1G1, SP1 | Pregnancy-specific beta-1-glycoprotein-1 | 5669.0 | ENSG00000231924 | distal to CEA | nan
chr19	PSG6	176395.0 | PSG6 | Pregnancy-specific beta-1-glycoprotein-6 | 5675.0 | ENSG00000170848 | nan | nan
chr19	PSG7	176396.0 | PSG7 | Pregnancy-specific beta-1-glycoprotein-7 | 5676.0 | ENSG00000221878 | nan | nan
chr19	PSG11	176401.0 | PSG11, PSG13, PSG14 | Pregnancy-specific beta-1-glycoprotein-11 | 5680.0 | ENSG00000243130 | nan | nan
chr19	PSG2	176391.0 | PSG2, PSBG2 | Pregnancy-specific beta-1-glycoprotein-2 | 5670.0 | ENSG00000242221 | nan | nan
chr19	PSG5	176394.0 | PSG5 | Pregnancy-specific beta-1-glycoprotein-5 | 5673.0 | ENSG00000204941 | nan | nan
chr19	PSG4	176393.0 | PSG4 | Pregnancy-specific beta-1-glycoprotein-4 | 5672.0 | ENSG00000243137 | nan | nan
chr19	PSG9	176398.0 | PSG9, PSG11 | Pregnancy-specific beta-1-glycoprotein-9 | 5678.0 | ENSG00000183668 | nan | nan
chr19		605157.0 | PRG1 | p53-responsive gene 1 | 23574.0 | nan | nan | nan
chr19	CD177	162860.0 | NB1, PRV1, CD177, HNA2A | Neutrophil-specific antigen 1 | 57126.0 | ENSG00000204936 | nan | nan
chr19	TEX101	612665.0 | TEX101, SGRG, TES101RP | Testis-expressed gene 101 | 83639.0 | ENSG00000131126 | nan | nan
chr19	LYPD3	609484.0 | LYPD3 | LY6/PLAUR domain-containing protein 3 | 27076.0 | ENSG00000124466 | nan | nan
chr19	ETHE1	608451.0 | ETHE1, HSCO, D83198 | ETHE1 persulfide dioxygenase | 23474.0 | ENSG00000105755 | nan | Ethylmalonic encephalopathy, 602473 (3), Autosomal recessive
chr19	XRCC1	194360.0 | XRCC1, SCAR26 | X-ray repair cross complementing 1 | 7515.0 | ENSG00000073050 | mutation identified in 1 SCAR26 patient | ?Spinocerebellar ataxia, autosomal recessive 26, 617633 (3), Autosomal recessive
chr19	CADM4	609744.0 | CADM4, IGSF4C, TSLL2, NECL4, SYNCAM4 | Cell adhesion molecule 4 | 199731.0 | ENSG00000105767 | nan | nan
chr19	PLAUR	173391.0 | PLAUR, URKR | Plasminogen activator, urokinase, receptor | 5329.0 | ENSG00000011422 | nan | nan
chr19	IRGC	620634.0 | IRGC | Immunity-related GTPase cinema | 56269.0 | ENSG00000124449 | nan | nan
chr19	SMG9	613176.0 | SMG9, C19orf61, HBMS, NEDITPO | SMG9 nonsense mediated mRNA decay factor | 56006.0 | ENSG00000105771 | nan | Heart and brain malformation syndrome, 616920 (3), Autosomal recessive; Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies, 619995 (3), Autosomal recessive
chr19	KCNN4	602754.0 | KCNN4, KCA4, SK4, DHS2 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | 3783.0 | ENSG00000104783 | nan | Dehydrated hereditary stomatocytosis 2, 616689 (3), Autosomal dominant
chr19	LYPD5	619618.0 | LYPD5, HALDISIN | LY6/PLAUR domain-containing protein 5 | 284348.0 | ENSG00000159871 | nan | nan
chr19	ZNF45	194554.0 | ZNF45, ZNF13, KOX5 | Zinc finger protein-45 | 7596.0 | ENSG00000124459 | nan | nan
chr19	ZNF155	604086.0 | ZNF155 | Zinc finger protein-155 | 7711.0 | ENSG00000204920 | nan | nan
chr19	ZNF222	617357.0 | ZNF222 | Zinc finger protein 222 | 7673.0 | ENSG00000159885 | nan | nan
chr19	ZNF224	194555.0 | ZNF224, ZNF255, BMZF2, KOX22, ZNF27 | Zinc finger protein-224 | 7767.0 | ENSG00000267680 | nan | nan
chr19	ZNF234	604750.0 | ZNF234, ZNF269, HZF4 | Zinc finger protein 234 | 10780.0 | ENSG00000263002 | nan | nan
chr19	ZNF235	604749.0 | ZFP93, ANF270, HZF6 | Zinc finger protein 93, mouse, homolog of | 9310.0 | ENSG00000159917 | nan | nan
chr19	ZNF112	603994.0 | ZNF112 | Zinc finger protein-112 | 7771.0 | ENSG00000062370 | nan | nan
chr19	ZNF229	620827.0 | ZNF229 | Zinc finger protein 229 | 7772.0 | ENSG00000278318 | nan | nan
chr19	ZNF180	606740.0 | ZNF180 | Zinc finger protein-180 | 7733.0 | ENSG00000167384 | nan | nan
chr19	PVR	173850.0 | PVR, PVS | Polio virus receptor | 5817.0 | ENSG00000073008 | nan | nan
chr19	CEACAM19	606691.0 | CEACAM19, CEAL1 | CEA cell adhesion molecule 19 | 56971.0 | ENSG00000186567 | nan | nan
chr19	CEACAM16	614591.0 | CEACAM16, CEAL2, DFNA4B, DFNB113 | CEA cell adhesion molecule 16 | 388551.0 | ENSG00000213892 | nan | Deafness, autosomal dominant 4B, 614614 (3), Autosomal dominant; Deafness, autosomal recessive 113, 618410 (3), Autosomal recessive
chr19	BCL3	109560.0 | BCL3 | B-cell CLL/lymphoma-3 | 602.0 | ENSG00000069399 | nan | Leukemia/lymphoma, B-cell, 3, 109560 (2)
chr19	CBLC	608453.0 | CBLC | CAS-BR-M murine ecotropic retroviral transforming sequence C | 23624.0 | ENSG00000142273 | nan | nan
chr19	BCAM	612773.0 | LU, AU, BCAM | B-cell adhesion molecule | 4059.0 | ENSG00000187244 | linked to SE | [Blood group, Lutheran system], 111200 (3); [Blood group, Auberger system], 111200 (3); [Blood group, Lutheran null], 247420 (3), Autosomal recessive
chr19	NECTIN2	600798.0 | NECTIN2, PVRL2, HVEB, PVRR2, PRR2 | Nectin 2 | 5819.0 | ENSG00000130202 | nan | nan
chr19	TOMM40	608061.0 | TOMM40, TOM40, PEREC1 | Translocase of outer mitochondrial membrane 40 | 10452.0 | ENSG00000130204 | nan | nan
chr19	APOE	107741.0 | APOE, AD2, LPG, LDLCQ5 | Apolipoprotein E | 348.0 | ENSG00000130203 | mutation identified in 1 APOE3-Christchurch patient | Alzheimer disease 2, 104310 (3), Autosomal dominant; Sea-blue histiocyte disease, 269600 (3), Autosomal recessive; {?Alzheimer disease, protection against, due to APOE3-Christchurch}, 607822 (3), Autosomal dominant; {Coronary artery disease, severe, susceptibility to}, 617347 (3); Lipoprotein glomerulopathy, 611771 (3); {?Macular degeneration, age-related}, 603075 (3), Autosomal dominant; Hyperlipoproteinemia, type III, 617347 (3)
chr19	APOC1	107710.0 | APOC1 | Apolipoprotein C-I | 341.0 | ENSG00000130208 | nan | nan
chr19	APOC4	600745.0 | APOC4 | Apolipoprotein C-IV | 346.0 | ENSG00000267467 | 555bp upstream of APOC2 | nan
chr19	APOC2	608083.0 | APOC2 | Apolipoprotein C-II | 344.0 | ENSG00000234906 | nan | Hyperlipoproteinemia, type Ib, 207750 (3), Autosomal recessive
chr19	CLPTM1	604783.0 | CLPTM1 | Cleft lip and palate-associated transmembrane protein 1 | 1209.0 | ENSG00000104853 | nan | nan
chr19	RELB	604758.0 | RELB, IREL, IMD53 | v-rel avian reticuloendotheliosis viral oncogene homolog B | 5971.0 | ENSG00000104856 | mutation identified in 1 IMD53 family | ?Immunodeficiency 53, 617585 (3), Autosomal recessive
chr19	CLASRP	618532.0 | CLASRP, CLASP | CLK4-associating serine/arginine-rich protein | 11129.0 | ENSG00000104859 | nan | nan
chr19	ZNF296	613226.0 | ZNF296, ZFP296, ZNF342 | Zinc finger protein 296 | 162979.0 | ENSG00000170684 | nan | nan
chr19	GEMIN7	607419.0 | GEMIN7 | GEM-associated protein 7 | 79760.0 | ENSG00000142252 | nan | nan
chr19	TRAPPC6A	610396.0 | TRAPPC6A | Trafficking protein particle complex, subunit 6A | 79090.0 | ENSG00000007255 | nan | nan
chr19	BLOC1S3	609762.0 | BLOC1S3, BLOS3, HPS8 | Biogenesis of lysosome-related organelles complex 1, subunit 3 | 388552.0 | ENSG00000189114 | nan | Hermansky-Pudlak syndrome 8, 614077 (3), Autosomal recessive
chr19	EXOC3L2	616927.0 | EXOC3L2, XTP7, BMRS | Exocyst complex component 3-like 2 | 90332.0 | ENSG00000283632 | nan | Brain malformation renal syndrome, 620943 (3), Autosomal recessive
chr19	MARK4	606495.0 | MARK4, KIAA1860, MARKL1 | Map/microtubule affinity-regulating kinase-4 | 57787.0 | ENSG00000007047 | nan | nan
chr19	CKM	123310.0 | CKM, CKMM | Creatine kinase, muscle type | 1158.0 | ENSG00000104879 | nan | nan
chr19	KLC3	601334.0 | KLC3, KLC2L | Kinesin, light chain, 3 | 147700.0 | ENSG00000104892 | nan | nan
chr19	ERCC2	126340.0 | ERCC2, EM9, XPD, COFS2, TTD1 | ERCC excision repair 2, TFIIH core complex helicase subunit | 2068.0 | ENSG00000104884 | < 250kb from ERCC1; mutation identified in 1 COFS2 patient | Xeroderma pigmentosum, group D, 278730 (3), Autosomal recessive; Trichothiodystrophy 1, photosensitive, 601675 (3), Autosomal recessive; ?Cerebrooculofacioskeletal syndrome 2, 610756 (3), Autosomal recessive
chr19	PPP1R13L	607463.0 | PPP1R13L, RAI, IASPP, NKIP1, ARCME | Protein phosphatase 1, regulatory subunit 13-like | 10848.0 | ENSG00000104881 | nan | Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities, 620519 (3), Autosomal recessive
chr19	POLR1G	107325.0 | POLR1G, CD3EAP, ASE1, PAF49 | Polymerase I, RNA, subunit G | 10849.0 | ENSG00000117877 | nan | nan
chr19	ERCC1	126380.0 | ERCC1, UV20, COFS4 | ERCC excision repair 1, endonuclease non-catalytic subunit | 2067.0 | ENSG00000012061 | distal to CKM | Cerebrooculofacioskeletal syndrome 4, 610758 (3), Autosomal recessive
chr19	FOSB	164772.0 | FOSB | FOSB protooncogene, AP1 transcription factor subunit | 2354.0 | ENSG00000125740 | nan | nan
chr19	TRU-TCA1-1	165060.0 | TRU-TCA1-1, TRNAU1, TRSP, THMA3 | tRNA selenocysteine (anticodon TCA) 1-1 | 7234.0 | nan | pseudogene on 22 | Thyroid hormone metabolism, abnormal, 3, 620198 (3), Autosomal recessive
chr19	RTN2	603183.0 | RTN2, NSPL1, SPG12, HMNR11 | Reticulon-2 | 6253.0 | ENSG00000125744 | nan | Neuronopathy, distal hereditary motor, autosomal recessive 11, with spasticity, 620854 (3), Autosomal recessive; Spastic paraplegia 12, autosomal dominant, 604805 (3), Autosomal dominant
chr19	VASP	601703.0 | VASP | Vasodilator-stimulated phosphoprotein | 7408.0 | ENSG00000125753 | nan | nan
chr19	OPA3	606580.0 | OPA3, MGA3 | Outer mitochondrial membrane lipid metabolism regulator OPA3 | 80207.0 | ENSG00000125741 | nan | 3-methylglutaconic aciduria, type III, 258501 (3), Autosomal recessive; Optic atrophy 3 with cataract, 165300 (3), Autosomal dominant
chr19	GPR4	600551.0 | GPR4 | G protein-coupled receptor-4 | 2828.0 | ENSG00000177464 | nan | nan
chr19	EML2	617494.0 | EML2, EMAP2, ELP70 | Echinoderm microtubule-associated protein-like 2 | 24139.0 | ENSG00000125746 | nan | nan
chr19	GIPR	137241.0 | GIPR, PGQTL2 | Gastric inhibitory polypeptide receptor | 2696.0 | ENSG00000010310 | nan | nan
chr19	SNRPD2	601061.0 | SNRPD2 | Small nuclear ribonucleoprotein polypeptide D2 | 6633.0 | ENSG00000125743 | nan | nan
chr19	FBXO46	609117.0 | FBXO46, FBX46 | F-box only protein 46 | 23403.0 | ENSG00000177051 | nan | nan
chr19	SIX5	600963.0 | SIX5, DMAHP, BOR2 | SIX homeobox 5 | 147912.0 | ENSG00000177045 | nan | Branchiootorenal syndrome 2, 610896 (3)
chr19	DMPK	605377.0 | DMPK, DM, DMK | Dystrophia myotonica-protein kinase | 1760.0 | ENSG00000104936 | distal to APOLP2; distal to CKM | Myotonic dystrophy 1, 160900 (3), Autosomal dominant
chr19	DMWD	609857.0 | DMWD, DMRN9 | Dystrophia myotonica WD repeat-containing protein | 1762.0 | ENSG00000185800 | nan | nan
chr19	RSPH6A	607548.0 | RSPH6A, RSHL1 | Radial spoke head 6 homolog A | 81492.0 | ENSG00000104941 | nan | nan
chr19	SYMPK	602388.0 | SPK | Symplekin | 8189.0 | ENSG00000125755 | nan | nan
chr19	FOXA3	602295.0 | FOXA3, HNF3G | Forkhead box A3 (hepatocyte nuclear factor-3, gamma) | 3171.0 | ENSG00000170608 | nan | nan
chr19	IRF2BP1	615331.0 | IRF2BP1 | Interferon regulatory factor 2-binding protein 1 | 26145.0 | ENSG00000170604 | nan | nan
chr19	MYPOP	617861.0 | MYPOP | MYB-related transcription factor, partner of profilin | 339344.0 | ENSG00000176182 | nan | nan
chr19	NANOS2	608228.0 | NANOS2, NOS2 | NANOS C2HC-type zinc finger 2 | 339345.0 | ENSG00000188425 | nan | nan
chr19	NOVA2	601991.0 | NOVA2, ANOVA, NEDASB | NOVA alternative splicing regulator 2 | 4858.0 | ENSG00000104967 | nan | Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities, 618859 (3), Autosomal dominant
chr19	CCDC61	620676.0 | CCDC61, VFL3 | Coiled-coil domain-containing protein 61 | 729440.0 | ENSG00000104983 | nan | nan
chr19	PGLYRP1	604963.0 | PGRP, PGRPS | Peptidoglycan recognition protein | 8993.0 | ENSG00000008438 | nan | nan
chr19	IGFL4	610547.0 | IGFL4 | IGF-like family member 4 | 444882.0 | ENSG00000204869 | nan | nan
chr19	IGFL2	610545.0 | IGFL2 | IGF-like family member 2 | 147920.0 | ENSG00000204866 | nan | nan
chr19	IGFL3	610546.0 | IGFL3 | IGF-like family member 3 | 388555.0 | ENSG00000188624 | nan | nan
chr19	IGFL1	610544.0 | IGFL1 | IGF-like family member 1 | 374918.0 | ENSG00000188293 | nan | nan
chr19	HIF3A	609976.0 | HIF3A, IPAS | Hypoxia-inducible factor 3, alpha subunit | 64344.0 | ENSG00000124440 | nan | nan
chr19	PPP5C	600658.0 | PPP5C, PP5 | Protein phosphatase-5, catalytic subunit | 5536.0 | ENSG00000011485 | nan | nan
chr19	CCDC8	614145.0 | CCDC8, 3M3 | Coiled-coil domain-containing protein 8 | 83987.0 | ENSG00000169515 | nan | 3-M syndrome 3, 614205 (3), Autosomal recessive
chr19	PNMA8C	620934.0 | PNMA8C | PNMA family, member 8C | 110806277.0 | ENSG00000277531 | nan | nan
chr19	PNMA8A	620933.0 | PNMA8A, PNMAL1 | PNMA family, member 8A | 55228.0 | ENSG00000182013 | nan | nan
chr19	PNMA8B	620159.0 | PNMA8B | PNMA family, member 8B | 57469.0 | ENSG00000204851 | nan | nan
chr19	CALM3	114183.0 | CALM3, LQT16, CPVT6 | Calmodulin-3 | 808.0 | ENSG00000160014 | mutation identified in 1 CPVT6 family | Long QT syndrome 16, 618782 (3), Autosomal dominant; ?Ventricular tachycardia, catecholaminergic polymorphic 6, 618782 (3), Autosomal dominant
chr19	PTGIR	600022.0 | PTGIR | Prostaglandin I2 (prostacyclin) receptor (IP) | 5739.0 | ENSG00000160013 | nan | nan
chr19	DACT3	611112.0 | DACT3 | Dapper, antagonist of beta-catenin, 3 | 147906.0 | ENSG00000197380 | nan | nan
chr19	PRKD2	607074.0 | PRKD2, PKD2 | Protein kinase D2 | 25865.0 | ENSG00000105287 | nan | nan
chr19	STRN4	614767.0 | STRN4, ZIN | Striatin, calmodulin-binding protein 4 | 29888.0 | ENSG00000090372 | nan | nan
chr19	FKRP	606596.0 | FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5 | Fukutin-related protein | 79147.0 | ENSG00000181027 | nan | Muscular dystrophy-dystroglycanopathy (congenital with or without impaired intellectual development), type B, 5, 606612 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3), Autosomal recessive
chr19	SLC1A5	109190.0 | SLC1A5, RDRC, M7V1, M7VS1 | Solute carrier family 1 (neutral amino acid transporter), member 5 (receptor for RD114/simian type D retroviruses) | 6510.0 | ENSG00000105281 | nan | nan
chr19	AP2S1	602242.0 | AP2S1, CLAPS2, AP17, HHC3 | Adaptor-related protein complex 2, sigma 1 subunit | 1175.0 | ENSG00000042753 | nan | Hypocalciuric hypercalcemia, type III, 600740 (3), Autosomal dominant
chr19	ARHGAP35	605277.0 | ARHGAP35, GRLF1, P190A | Rho GTPase activating protein 35 | 2909.0 | ENSG00000160007 | nan | nan
chr19	NPAS1	603346.0 | NPAS1, MOP5 | Neuronal PAS domain protein 1 | 4861.0 | ENSG00000130751 | nan | nan
chr19	TMEM160	620258.0 | TMEM160 | Transmembrane protein 160 | 54958.0 | ENSG00000130748 | nan | nan
chr19	ZC3H4	619498.0 | ZC3H4, C19orf7 | Zinc finger CCCH domain-containing protein 4 | 23211.0 | ENSG00000130749 | nan | nan
chr19	SAE1	613294.0 | SAE1, SUA1, AOS1 | SUMO1-activating enzyme, subunit 1 | 10055.0 | ENSG00000142230 | nan | nan
chr19	BBC3	605854.0 | PUMA | p53-upregulated modulator of apoptosis | 27113.0 | ENSG00000105327 | nan | nan
chr19	C5AR1	113995.0 | C5AR1, C5R1, C5AR | Complement component 5a receptor 1 | 728.0 | ENSG00000197405 | nan | nan
chr19	C5AR2	609949.0 | C5AR2, GPF77, C5L2 | Complement component 5a receptor 2 | 27202.0 | ENSG00000134830 | nan | nan
chr19	DHX34	615475.0 | DHX34, KIAA0134 | DExH-box helicase 34 | 9704.0 | ENSG00000134815 | nan | nan
chr19	MEIS3	619443.0 | MEIS3, MRG2 | Meis homeobox 3 | 56917.0 | ENSG00000105419 | nan | nan
chr19	SLC8A2	601901.0 | SLC8A2, NCX2 | Solute carrier family 8, member 2 (sodium-calcium exchanger 2) | 6543.0 | ENSG00000118160 | nan | nan
chr19	KPTN	615620.0 | KPTN, 2E4, MRT41 | Kaptin | 11133.0 | ENSG00000118162 | nan | Intellectual developmental disorder, autosomal recessive 41, 615637 (3), Autosomal recessive
chr19	NAPA	603215.0 | NAPA, SNAPA | NSF attachment protein, alpha | 8775.0 | ENSG00000105402 | nan | nan
chr19	ZNF541	619942.0 | ZNF541, ZFP41 | Zinc finger protein 541 | 84215.0 | ENSG00000118156 | nan | nan
chr19	BICRA	605690.0 | BICRA, GLTSCR1, CSS12 | BRD4-interacting chromatin remodeling complex-associated protein | 29998.0 | ENSG00000063169 | nan | Coffin-Siris syndrome 12, 619325 (3), Autosomal dominant
chr19	EHD2	605890.0 | EHD2 | EH domain-containing 2 | 30846.0 | ENSG00000024422 | nan | nan
chr19	NOP53	605691.0 | NOP53, GLTSCR2 | NOP53 ribosome biogenesis factor | 29997.0 | ENSG00000105373 | nan | nan
chr19	SELENOW	603235.0 | SELENOW, SEPW1 | Selenoprotein W | 6415.0 | ENSG00000178980 | nan | nan
chr19	TPRX1	611166.0 | TPRX1 | Tetrapeptide repeat homeobox 1 | 284355.0 | ENSG00000178928 | nan | nan
chr19	CRX	602225.0 | CRX, CORD2, CRD, LCA7 | Cone-rod homeobox-containing gene | 1406.0 | ENSG00000105392 | nan | Leber congenital amaurosis 7, 613829 (3); Cone-rod retinal dystrophy-2, 120970 (3), Autosomal dominant
chr19	TPRX2	620360.0 | TPRX2 | Tetrapeptide repeat homeobox 2 | 503627.0 | ENSG00000259009 | nan | nan
chr19	SULT2A1	125263.0 | SULT2A1, STD | Sulfotransferase family 2A, dehydroepiandrosterone-preferring, member 1 (DHEA sulfotransferase) | 6822.0 | ENSG00000105398 | nan | nan
chr19	BSPH1	612213.0 | BSPH1 | Binder of sperm protein homolog 1 | 100131137.0 | ENSG00000188334 | nan | nan
chr19	ELSPBP1	607443.0 | ELSPBP1 | Epididymal sperm binding protein 1 | 64100.0 | ENSG00000169393 | nan | nan
chr19	CABP5	607315.0 | CABP5, CABP3 | Calcium-binding protein 5 | 56344.0 | ENSG00000105507 | nan | nan
chr19	PLA2G4C	603602.0 | PLA2G4C | Phospholipase A2, group IVC | 8605.0 | ENSG00000105499 | nan | nan
chr19	LIG1	126391.0 | LIG1, IMD96 | Ligase I, DNA, ATP-dependent | 3978.0 | ENSG00000105486 | nan | Immunodeficiency 96, 619774 (3), Autosomal recessive
chr19	CARD8	609051.0 | CARD8, TUCAN, KIAA0955, NDPP1, IBD30 | Caspase recruitment domain-containing protein 8 | 22900.0 | ENSG00000105483 | mutation identified in 1 IBD30 family | ?Inflammatory bowel disease (Crohn disease) 30, 619079 (3), Autosomal dominant
chr19	ZNF114	603996.0 | ZNF114 | Zinc finger protein-114 | 163071.0 | ENSG00000178150 | nan | nan
chr19	ODAD1	615038.0 | ODAD1, CCDC114, CILD20 | Outer dynein arm docking complex subunit 1 | 93233.0 | ENSG00000105479 | nan | Ciliary dyskinesia, primary, 20, 615067 (3), Autosomal recessive
chr19	EMP3	602335.0 | EMP3 | Epithelial membrane protein 3 | 2014.0 | ENSG00000142227 | nan | nan
chr19	SYNGR4	608373.0 | SYNGR4 | Synaptogyrin 4 | 23546.0 | ENSG00000105467 | nan | nan
chr19	KDELR1	131235.0 | KDELR1, ERD2, HDEL | KDEL endoplasmic reticulum protein retention receptor 1 | 10945.0 | ENSG00000105438 | nan | nan
chr19	GRIN2D	602717.0 | GRIN2D, NMDAR2D, DEE46 | Glutamate receptor, ionotropic, N-methyl-D-aspartate 2D | 2906.0 | ENSG00000105464 | nan | Developmental and epileptic encephalopathy 46, 617162 (3), Autosomal dominant
chr19	GRWD1	610597.0 | GRWD1, GRWD, KIAA1942 | Glutamate-rich WD repeat-containing protein 1 | 83743.0 | ENSG00000105447 | nan | nan
chr19	KCNJ14	603953.0 | KCNJ14 | Potassium inwardly-rectifying channel, subfamily J, member 14 | 3770.0 | ENSG00000182324 | nan | nan
chr19	CYTH2	602488.0 | CYTH2, PSCD2, ARNO, PSCD2L | Cytohesin 2 | 9266.0 | ENSG00000105443 | nan | nan
chr19	LMTK3	619624.0 | LMTK3 | Lemur tyrosine kinase 3 | 114783.0 | ENSG00000142235 | nan | nan
chr19	SULT2B1	604125.0 | SULT2B1, ARCI14 | Sulfotransferase family 2B, member 1 | 6820.0 | ENSG00000088002 | nan | Ichthyosis, congenital, autosomal recessive 14, 617571 (3), Autosomal recessive
chr19	SPACA4	609932.0 | SPACA4, SAMP14 | Sperm acrosome-associated protein 4 | 171169.0 | ENSG00000177202 | nan | nan
chr19	RPL18	604179.0 | RPL18, DBA18 | Ribosomal protein L18 | 6141.0 | ENSG00000063177 | mutation identified in 1 DBA18 family | ?Diamond-Blackfan anemia 18, 618310 (3), Autosomal dominant
chr19	SPHK2	607092.0 | SPHK2 | Sphingosine kinase 2 | 56848.0 | ENSG00000063176 | nan | nan
chr19	DBP	124097.0 | DBP | D site of albumin promoter binding protein | 1628.0 | ENSG00000105516 | nan | nan
chr19	CA11	604644.0 | CA11, CARP2 | Carbonic anhydrase XI | 770.0 | ENSG00000063180 | nan | nan
chr19	FUT2	182100.0 | FUT2, SE, B12QTL1 | Fucosyltransferase-2 (secretor) | 2524.0 | ENSG00000176920 | H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1 | {Norwalk virus infection, resistance to} (3); {Vitamin B12 plasma level QTL1}, 612542 (3); [Bombay phenotype, digenic], 616754 (3), Autosomal recessive
chr19	MAMSTR	610349.0 | MAMSTR, MASTR | MEF2-activating SAP transcriptional regulator | 284358.0 | ENSG00000176909 | nan | nan
chr19	RASIP1	609623.0 | RASIP1, RAIN | Ras-interacting protein 1 | 54922.0 | ENSG00000105538 | nan | nan
chr19	IZUMO1	609278.0 | IZUMO1, MGC34799 | Izumo sperm-egg fusion protein 1 | 284359.0 | ENSG00000182264 | nan | nan
chr19	FUT1	211100.0 | FUT1, H, HH | Fucosyltransferase-1 (Bombay phenotype) | 2523.0 | ENSG00000174951 | SE tightly linked | [Bombay phenotype], 616754 (3), Autosomal recessive
chr19	FGF21	609436.0 | FGF21 | Fibroblast growth factor 21 | 26291.0 | ENSG00000105550 | nan | nan
chr19	BCAT2	113530.0 | BCAT2, BCT2, HVLI, BCAT2 | Branched chain aminotransferase-2, mitochondrial | 587.0 | ENSG00000105552 | nan | Hypervalinemia and hyperleucine-isoleucinemia, 618850 (3), Autosomal recessive
chr19	HSD17B14	612832.0 | HSD17B14, DHRS10, RETSDR3 | 17-beta-hydroxysteroid dehydrogenase XIV | 51171.0 | ENSG00000087076 | nan | nan
chr19	PLEKHA4	607769.0 | PLEKHA4, PEPP1 | Pleckstrin homology domain-containing protein, family A, member 4 | 57664.0 | ENSG00000105559 | nan | nan
chr19	PPP1R15A	611048.0 | PPP1R15A, GADD34 | Protein phosphatase 1, regulatory subunit 15A | 23645.0 | ENSG00000087074 | nan | nan
chr19	TULP2	602309.0 | TULP2 | TUB-like protein 2 | 7288.0 | ENSG00000104804 | nan | nan
chr19	NUCB1	601323.0 | NUCB1 | Nucleobindin 1 | 4924.0 | ENSG00000104805 | nan | nan
chr19	DHDH	606377.0 | DHDH, HUM2DD | Dimeric dihydrodiol dehydrogenase | 27294.0 | ENSG00000104808 | nan | nan
chr19	BAX	600040.0 | BAX | BCL2-associated X protein | 581.0 | ENSG00000087088 | nan | Colorectal cancer, somatic, 114500 (3); T-cell acute lymphoblastic leukemia, somatic, 613065 (3)
chr19	FTL	134790.0 | FTL, NBIA3, LFTD | Ferritin, light chain | 2512.0 | ENSG00000087086 | nan | Hyperferritinemia-cataract syndrome, 600886 (3), Autosomal dominant; L-ferritin deficiency, dominant and recessive, 615604 (3), Autosomal recessive, Autosomal dominant; Neurodegeneration with brain iron accumulation 3, 606159 (3), Autosomal dominant
chr19	GYS1	138570.0 | GYS1, GYS | Glycogen synthase | 2997.0 | ENSG00000104812 | nan | Glycogen storage disease 0, muscle, 611556 (3), Autosomal recessive
chr19	RUVBL2	604788.0 | RUVBL2, TIP48, ECP51 | RUVB, E. coli, homolog-like 2 (TATA box-binding protein-interacting protein) | 10856.0 | ENSG00000183207 | nan | nan
chr19	LHB	152780.0 | LHB, HH23 | Luteinizing hormone, beta polypeptide | 3972.0 | ENSG00000104826 | beta chains of FSH, TSH on 11p, 1p, respectively | Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3), Autosomal recessive
chr19	CGB3	118860.0 | CGB | Chorionic gonadotropin, beta polypeptide | 1082.0 | ENSG00000104827 | at least 5 genes | nan
chr19	CGB2	608824.0 | CGB2 | Chorionic gonadotropin, beta polypeptide 2 | 114336.0 | ENSG00000104818 | nan | nan
chr19	CGB1	608823.0 | CGB1 | Chorionic gonadotropin, beta polypeptide 1 | 114335.0 | ENSG00000267631 | nan | nan
chr19	CGB5	608825.0 | CGB5 | Chorionic gonadotropin, beta polypeptide 5 | 93659.0 | ENSG00000189052 | nan | nan
chr19	CGB8	608827.0 | CGB8 | Chorionic gonadotropin, beta polypeptide 8 | 94115.0 | ENSG00000213030 | nan | nan
chr19	CGB7	608826.0 | CGB7, CGB6 | Chorionic gonadotropin, beta polypeptide 7 | 94027.0 | ENSG00000196337 | nan | nan
chr19	NTF4	162662.0 | NTF4 , NTF5, NT5, NT4, GLC1O | Neurotrophin-4 (neurotrophin-4/5) | 4909.0 | ENSG00000225950 | 3 genes, ? functional, also on 19 | Glaucoma 1, open angle, 1O, 613100 (3)
chr19	KCNA7	176268.0 | KCNA7 | Potassium voltage-gated channel, shaker-related subfamily, member 7 | 3743.0 | ENSG00000104848 | nan | nan
chr19	SNRNP70	180740.0 | SNRP70, U1RNP, RNPU1Z, RPU1 | Small nuclear ribonucleoprotein, U1 subunit, 70kD | 6625.0 | ENSG00000104852 | nan | nan
chr19	LIN7B	612331.0 | LIN7B, VELI2, MALS2 | Lin7 homolog B, crumbs cell polarity complex component | 64130.0 | ENSG00000104863 | nan | nan
chr19	PPFIA3	603144.0 | PPFIA3, LPNA3 | PTPRF-interacting protein alpha-3 | 8541.0 | ENSG00000177380 | nan | nan
chr19	HRC	142705.0 | HRC | Histidine-rich calcium-binding protein | 3270.0 | ENSG00000130528 | nan | nan
chr19	TRPM4	606936.0 | TRPM4, PFHB1B, EKVP6 | Transient receptor potential cation channel, subfamily M, member 4 | 54795.0 | ENSG00000130529 | nan | Progressive familial heart block, type IB, 604559 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 6, 618531 (3), Autosomal dominant
chr19	SLC6A16	607972.0 | SLC6A16, NT5 | Solute carrier family 6 (neurotransmitter transporter), member 16 | 28968.0 | ENSG00000063127 | nan | nan
chr19	CD37	151523.0 | CD37 | Leukocyte surface antigen CD37 | 951.0 | ENSG00000104894 | nan | nan
chr19	TEAD2	601729.0 | TEAD2, TEF4 | TEA domain family member 2 | 8463.0 | ENSG00000074219 | nan | nan
chr19	DKKL1	605418.0 | DKKL1, SGY1, SGY | Dickkopf-like 1 | 27120.0 | ENSG00000104901 | nan | nan
chr19	KASH5	618125.0 | KASH5, CCDC155, SPGF88, POF22 | KASH domain-containing protein 5 | 147872.0 | ENSG00000161609 | nan | Spermatogenic failure 88, 620547 (3), Autosomal recessive; Premature ovarian failure 22, 620548 (3)
chr19	PTH2	608386.0 | PTH2, TIP39 | Parathyroid hormone 2 | 113091.0 | ENSG00000142538 | nan | nan
chr19	GFY	618696.0 | GFY, GOOFY | Golgi-associated olfactory signaling regulator | 100507003.0 | ENSG00000261949 | nan | nan
chr19	SLC17A7	605208.0 | SLC17A7, BNPI, VGLUT1 | Solute carrier family 17, (sodium-dependent inorganic phosphate cotransporter), member 7 | 57030.0 | ENSG00000104888 | nan | nan
chr19	PIH1D1	611480.0 | PIH1D1, NOP17 | PIH1 domain-containing protein 1 | 55011.0 | ENSG00000104872 | nan | nan
chr19	ALDH16A1	613358.0 | ALDH16A1 | Aldehyde dehydrogenase 16 family, member A1 | 126133.0 | ENSG00000161618 | nan | nan
chr19	FLT3LG	600007.0 | FLT3LG, FLG3L, IMD125 | FMS-related tyrosine kinase 3 ligand | 2323.0 | ENSG00000090554 | mutation identified in 1 IMD125 family | ?Immunodeficiency 125, 620926 (3), Autosomal recessive
chr19	RPL13A	619225.0 | RPL13A | Ribosomal protein L13A | 23521.0 | ENSG00000142541 | nan | nan
chr19	RPS11	180471.0 | RPS11 | Ribosomal protein S11 | 6205.0 | ENSG00000142534 | nan | nan
chr19	MIR150	611114.0 | MIR150, MIRN150 | Micro RNA 150 | 406942.0 | ENSG00000207782 | nan | nan
chr19	FCGRT	601437.0 | FCGRT | Fc fragment of IgG receptor and transporter | 2217.0 | ENSG00000104870 | nan | nan
chr19	RCN3	619032.0 | RCN3 | Reticulocalbin 3 | 57333.0 | ENSG00000142552 | nan | nan
chr19	NOSIP	616759.0 | NOSIP | Nitric oxide synthase-interacting protein | 51070.0 | ENSG00000142546 | nan | nan
chr19	PRRG2	604429.0 | PRRG2, PRGP2 | Proline-rich gamma-carboxyglutamic acid protein 2 | 5639.0 | ENSG00000126460 | nan | nan
chr19	PRR12	616633.0 | PRR12, KIAA1205, NOC | Proline-rich protein 12 | 57479.0 | ENSG00000126464 | nan | Neuroocular syndrome, 619539 (3), Autosomal dominant
chr19	RRAS	165090.0 | RRAS | Oncogene RRAS | 6237.0 | ENSG00000126458 | nan | nan
chr19	SCAF1	617264.0 | SCAF1 | SR-related C-terminal domain-associated factor 1 | 58506.0 | ENSG00000126461 | nan | nan
chr19	IRF3	603734.0 | IRF3, IIAE7 | Interferon regulatory factor 3 | 3661.0 | ENSG00000126456 | nan | {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}, 616532 (3), Autosomal dominant
chr19	BCL2L12	610837.0 | BCL2L12 | BCL2-like 12 | 83596.0 | ENSG00000126453 | nan | nan
chr19	PRMT1	602950.0 | PRMT1, HRMT1L2, IR1B4 | Protein arginine methyltransferase 1 | 3276.0 | ENSG00000126457 | nan | nan
chr19	CPT1C	608846.0 | CPT1C, SPG73 | Carnitine palmitoyltransferase IC | 126129.0 | ENSG00000169169 | mutation identified in 1 SPG73 family | ?Spastic paraplegia 73, autosomal dominant, 616282 (3), Autosomal dominant
chr19	TSKS	608253.0 | TSKS | Testis-specific kinase substrate | 60385.0 | ENSG00000126467 | nan | nan
chr19	AP2A1	601026.0 | AP2A1, CLAPA1, ADTAA | Adaptor-related protein complex 2, alpha 1 subunit | 160.0 | ENSG00000196961 | match to PAC AC006942 | nan
chr19	FUZ	610622.0 | FUZ, NTD | Fuzzy planar cell polarity protein | 80199.0 | ENSG00000010361 | nan | {Neural tube defects, susceptibility to}, 182940 (3), Autosomal dominant
chr19	MED25	610197.0 | MED25, PTOV2, ARC92, BVSYS | Mediator of RNA polymerase II transcription, subunit 25, S. cerevisiae, homolog of | 81857.0 | ENSG00000104973 | nan | Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3), Autosomal recessive
chr19	PTOV1	610195.0 | PTOV1, ACID2 | PTOV1 extended AT-hook containg adaptor protein | 53635.0 | ENSG00000104960 | nan | nan
chr19	PNKP	605610.0 | PNKP, PNK, MCSZ, AOA4, CMT2B2 | Polynucleotide kinase 3' phosphatase | 11284.0 | ENSG00000039650 | mutation identified in 1 CMT2B2 family | ?Charcot-Marie-Tooth disease, type 2B2, 605589 (3), Autosomal recessive; Ataxia-oculomotor apraxia 4, 616267 (3), Autosomal recessive; Microcephaly, seizures, and developmental delay, 613402 (3), Autosomal recessive
chr19	AKT1S1	610221.0 | AKT1S1, PRAS40 | AKT1 substrate 1, proline-rich | 84335.0 | ENSG00000204673 | nan | nan
chr19	TBC1D17	616659.0 | TBC1D17 | TBC1 domain family, member 17 | 79735.0 | ENSG00000104946 | nan | nan
chr19	IL4I1	609742.0 | IL4I1, FIG1 | Interleukin 4-induced gene 1 | 259307.0 | ENSG00000104951 | nan | nan
chr19	NUP62	605815.0 | NUP62, SNDI, IBSN | Nucleoporin, 62-kD | 23636.0 | ENSG00000213024 | nan | Striatonigral degeneration, infantile, 271930 (3), Autosomal recessive
chr19	ATF5	606398.0 | ATF5, ATFX | Activating transcription factor 5 | 22809.0 | ENSG00000169136 | nan | nan
chr19	SIGLEC11	607157.0 | SIGLEC11 | Sialic acid-binding immunoglobulin-like lectin 11 | 114132.0 | ENSG00000161640 | pseudogene 8kb upstream | nan
chr19	VRK3	619771.0 | VRK3 | VRK serine/threonine kinase 3 | 51231.0 | ENSG00000105053 | nan | nan
chr19	ZNF473	617908.0 | ZNF473, ZFP100, KIAA1141 | Zinc finger protein 473 | 25888.0 | ENSG00000142528 | nan | nan
chr19	IZUMO2	618895.0 | IZUMO2 | IZUMO family, member 2 | 126123.0 | ENSG00000161652 | nan | nan
chr19	MYH14	608568.0 | MYH14, KIAA2034, DFNA4A, PNMHH | Myosin, heavy chain 14, nonmuscle | 79784.0 | ENSG00000105357 | mutation identified in 1 PNMHH family | ?Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3), Autosomal dominant; Deafness, autosomal dominant 4A, 600652 (3), Autosomal dominant
chr19	KCNC3	176264.0 | KCNC3, SCA13 | Potassium voltage-gated channel, Shaw-related subfamily, member 3 | 3748.0 | ENSG00000131398 | nan | Spinocerebellar ataxia 13, 605259 (3), Autosomal dominant
chr19	NAPSA	605631.0 | NAPA, NAP1, SNAPA | Napsin A | 9476.0 | ENSG00000131400 | nan | nan
chr19	NR1H2	600380.0 | NR1H2, UNR | Nuclear receptor subfamily 1, group H, member 2 (ubiquitously-expressed nuclear receptor) | 7376.0 | ENSG00000131408 | nan | nan
chr19	POLD1	174761.0 | POLD1, CRCS10, MDPL, IMD120 | Polymerase (DNA directed), delta 1, catalytic subunit | 5424.0 | ENSG00000062822 | nan | Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3), Autosomal dominant; Immunodeficiency 120, 620836 (3), Autosomal recessive; {Colorectal cancer, susceptibility to, 10}, 612591 (3), Autosomal dominant
chr19	SPIB	606802.0 | SPIB | SPIB transcription factor | 6689.0 | ENSG00000269404 | nan | nan
chr19	MYBPC2	160793.0 | MYBPC2, MYBPCF | Myosin-binding protein C, fast type | 4606.0 | ENSG00000086967 | nan | nan
chr19	GARIN5A	619890.0 | GARIN5A, GARIL5 | Golgi-associated Rab2 interactor 5A | 112703.0 | ENSG00000142530 | nan | nan
chr19	EMC10	614545.0 | EMC10, C19orf63, HSS1, HSM1, NEDDFAS | ER membrane protein complex subunit 10 | 284361.0 | ENSG00000161671 | nan | Neurodevelopmental disorder with dysmorphic facies and variable seizures, 619264 (3), Autosomal recessive
chr19	JOSD2	615324.0 | JOSD2 | Josephin domain-containing protein 2 | 126119.0 | ENSG00000161677 | nan | nan
chr19	SYT3	600327.0 | SYT3 | Synaptotagmin-3 | 84258.0 | ENSG00000213023 | nan | nan
chr19	SHANK1	604999.0 | SHANK1, SSTRIP | SH3 and multiple ankyrin repeat domains 1 | 50944.0 | ENSG00000161681 | nan | nan
chr19	CLEC11A	604713.0 | CLEC11A, SCGF, LSLCL | C-type lectin domain family 11, member A | 6320.0 | ENSG00000105472 | nan | nan
chr19	GPR32	603195.0 | GPR32 | G protein-coupled receptor-32 | 2854.0 | ENSG00000142511 | nan | nan
chr19	ACP4	606362.0 | ACP4, ACPT, AI1J | Acid phosphatase 4 | 93650.0 | ENSG00000142513 | nan | Amelogenesis imperfecta, type IJ, 617297 (3), Autosomal recessive
chr19	C19orf48P	618864.0 | C19orf48P, C19orf48 | Chromosome 19 open reading frame 48, pseudogene | 84798.0 | ENSG00000293495 | nan | nan
chr19	KLK1	147910.0 | KLK1, KLKR | Kallikrein 1 | 3816.0 | ENSG00000167748 | ~10cM distal to APOC2 | [Kallikrein, decreased urinary activity of], 615953 (3)
chr19	KLK15	610601.0 | KLK15 | Kallikrein-related peptidase 15 | 55554.0 | ENSG00000174562 | nan | nan
chr19	KLK3	176820.0 | KLK3, APS, PSA | Kallikrein-related peptidase 3 | 354.0 | ENSG00000142515 | probably with cluster KLK1, KLK2 | nan
chr19	KLK2	147960.0 | KLK2 | Kallikrein-related peptidase 2 | 3817.0 | ENSG00000167751 | 12kb from APS | nan
chr19	AAVS1	102699.0 | AAVS1 | Adeno-associated virus integration site-1 | 17.0 | nan | nan | nan
chr19	HPC15	611959.0 | HPC15 | Prostate cancer, hereditary, 15 | 100188868.0 | nan | associated with rs2735839 | {Prostate cancer, hereditary, 15}, 611959 (2)
chr19	KIR2DL2	604937.0 | KIR2DL2, NKAT6 | Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 | 3803.0 | nan | nan | nan
chr19	KIR2DL5B	615727.0 | KIR2DL5B | Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B | 553128.0 | nan | nan | nan
chr19	KIR2DS1	604952.0 | KIR2DS1 | Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1 | 3806.0 | nan | nan | nan
chr19	KIR2DS2	604953.0 | KIR2DS2, NKAT5 | Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2 | 100132285.0 | nan | nan | nan
chr19	KIR2DS3	604954.0 | KIR2DS3, NKAT7 | Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 | 3808.0 | nan | nan | nan
chr19	KIR2DS5	604956.0 | KIR2DS5, NKAT9, CD158G | Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5 | 3810.0 | nan | nan | nan
chr19	KIR3DS1	620778.0 | KIR3DS1, NKAT10, CD158E2 | Killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1 | 3813.0 | nan | nan | nan
chr19	LILRA3	604818.0 | LILRA3, LIR4, ILT6, HM43 | Leukocyte immunoglobulin-like receptor, subfamily A, member 3 | 11026.0 | nan | nan | nan
chr19	MENOQ2	612884.0 | MENOQ2 | Menopause, natural, age at, QTL2 | 100302517.0 | nan | associated with rs1172822, rs2384687, rs1551562, rs897798 | {Menopause, natural, age at, QTL2}, 612884 (2)
chr19	KLK4	603767.0 | KLK4, EMSP1, PRSS17, AI2A1 | Kallikrein-related peptidase 4 | 9622.0 | ENSG00000167749 | nan | Amelogenesis imperfecta, type IIA1, 204700 (3), Autosomal recessive
chr19	KLK5	605643.0 | KLK5, SCTE, KLKL2 | Kallikrein-related peptidase 5 | 25818.0 | ENSG00000167754 | nan | nan
chr19	KLK6	602652.0 | KLK6, PRSS9, ZYME | Kallikrein-related peptidase 6 | 5653.0 | ENSG00000167755 | nan | nan
chr19	KLK7	604438.0 | LKL7, PRSS6, SCCE | Kallikrein-related peptidase 7 | 5650.0 | ENSG00000169035 | nan | nan
chr19	KLK8	605644.0 | KLK8, TADG14, PRSS19 | Kallikrein-related peptidase 8 | 11202.0 | ENSG00000129455 | nan | nan
chr19	KLK9	605504.0 | KLK9, KLKL3 | Kallikrein-related peptidase 9 | 284366.0 | ENSG00000213022 | nan | nan
chr19	KLK10	602673.0 | KLK10, PRSSL1, NES1 | Kallikrein-related peptidase 10 | 5655.0 | ENSG00000129451 | nan | nan
chr19	KLK11	604434.0 | KLK11, PRSS20, TLSP, IEKD | Kallikrein-related peptidase 11 | 11012.0 | ENSG00000167757 | nan | Ichthyosis with erythrokeratoderma, 620507 (3), Autosomal dominant
chr19	KLK12	605539.0 | KLK12, KLKL5 | Kallikrein-related peptidase 12 | 43849.0 | ENSG00000186474 | nan | nan
chr19	KLK13	605505.0 | KLK13, KLKL4 | Kallikrein-related peptidase 13 | 26085.0 | ENSG00000167759 | nan | nan
chr19	KLK14	606135.0 | KLK14 | Kallikrein-related peptidase 14 | 43847.0 | ENSG00000129437 | nan | nan
chr19	CTU1	612694.0 | CTU1, ATPBD3 | Cytothiouridylase subunit 1 | 90353.0 | ENSG00000142544 | nan | nan
chr19	SIGLEC9	605640.0 | SIGLEC9 | Sialic acid-binding immunoglobulin-like lectin 9 | 27180.0 | ENSG00000129450 | nan | nan
chr19	SIGLEC7	604410.0 | SIGLEC7, AIRM1 | Sialic acid-binding immunoglobulin-like lectin 7 | 27036.0 | ENSG00000168995 | nan | nan
chr19	CD33	159590.0 | CD33 | CD33 antigen (gp67) | 945.0 | ENSG00000105383 | nan | nan
chr19	IGLON5	618861.0 | IGLON5 | IGLON family, member 5 | 402665.0 | ENSG00000142549 | nan | nan
chr19	VSIG10L	617740.0 | VSIG10L | V-set and immunoglobulin domains-containing protein 10-like | 147645.0 | ENSG00000186806 | nan | nan
chr19	ETFB	130410.0 | ETFB, MADD | Electron transfer flavoprotein, beta polypeptide | 2109.0 | ENSG00000105379 | nan | Glutaric acidemia IIB, 231680 (3), Autosomal recessive
chr19	NKG7	606008.0 | NKG7, GIG1 | Natural killer cell group 7 sequence | 4818.0 | ENSG00000105374 | nan | nan
chr19	LIM2	154045.0 | LIM2, MP19, CTRCT19 | Lens intrinsic protein 2, 19kD | 3982.0 | ENSG00000105370 | same cosmid as ETFB | Cataract 19, multiple types, 615277 (3), Autosomal recessive, Autosomal dominant
chr19	SIGLEC10	606091.0 | SIGLEC10 | Sialic acid-binding immunoglobulin-like lectin 10 | 89790.0 | ENSG00000142512 | nan | nan
chr19	SIGLEC8	605639.0 | SIGLEC8, SAF2, SIGLEC8L | Sialic acid-binding immunoglobulin-like lectin 8 | 27181.0 | ENSG00000105366 | nan | nan
chr19	SIGLEC12	606094.0 | SIGLEC12, SIGLECL1, S2V, SLG | Sialic acid-binding immunoglobulin-like lectin 12 | 89858.0 | ENSG00000254521 | nan | nan
chr19	SIGLEC6	604405.0 | SIGLEC6, CD33L, CD33L1, OBBP1 | Sialic acid-binding immunoglobulin-like lectin 6 | 946.0 | ENSG00000105492 | nan | nan
chr19	ZNF175	601139.0 | ZNF175, OTK18 | Zinc finger protein-175 | 7728.0 | ENSG00000105497 | nan | nan
chr19	SIGLEC5	604200.0 | SIGLEC5, CD33L2, OBBP2 | Sialic acid-binding Ig-like lectin 5 | 8778.0 | ENSG00000268500 | nan | nan
chr19	SIGLEC14	618132.0 | SIGLEC14 | Sialic acid-binding immunoglobulin-like lectin 14 | 100049587.0 | ENSG00000254415 | nan | nan
chr19	SPACA6	618945.0 | SPACA6 | Sperm acrosome-associated protein 6 | 147650.0 | ENSG00000182310 | nan | nan
chr19	MIR99B	614510.0 | MIR99B | Micro RNA 99B | 407056.0 | ENSG00000207550 | nan | nan
chr19	MIRLET7E	611250.0 | MIRLET7E, LET7E | Micro RNA Let7e | 406887.0 | ENSG00000198972 | nan | nan
chr19	MIR125A	611191.0 | MIR125A, MIRN125A | Micro RNA 125A | 406910.0 | ENSG00000208008 | nan | nan
chr19	HAS1	601463.0 | HAS1 | Hyaluronan synthase 1 | 3036.0 | ENSG00000105509 | nan | nan
chr19	FPR1	136537.0 | FPR1 | Formyl peptide receptor-1 | 2357.0 | ENSG00000171051 | nan | nan
chr19	FPR2	136538.0 | FPR2, FPRL1, FPRH1, LXA4R, HM63 | Formyl peptide receptor 2 | 2358.0 | ENSG00000171049 | nan | nan
chr19	FPR3	136539.0 | FPR3, FPRL2, FPRH2 | Formyl peptide receptor 3 | 2359.0 | ENSG00000187474 | nan | nan
chr19	ZNF649	611903.0 | ZNF649 | Zinc finger protein 649 | 65251.0 | ENSG00000198093 | nan | nan
chr19	ZNF350	605422.0 | ZNF350, ZBRK1 | Zinc finger protein 350 | 59348.0 | ENSG00000256683 | nan | nan
chr19	ZNF432	620554.0 | ZNF432 | Zinc finger protein 432 | 9668.0 | ENSG00000256087 | nan | nan
chr19	PPP2R1A	605983.0 | PPP2R1A, MRD36, HJS2 | Protein phosphatase 2, structural/regulatory subunit A, alpha | 5518.0 | ENSG00000105568 | nan | Houge-Janssens syndrome 2, 616362 (3), Autosomal dominant
chr19	ZNF480	613910.0 | ZNF480 | Zinc finger protein 480 | 147657.0 | ENSG00000198464 | nan | nan
chr19	ZNF528	615580.0 | ZNF528, KIAA1827 | Zinc finger protein 528 | 84436.0 | ENSG00000167555 | nan | nan
chr19	ZNF808	620970.0 | ZNF808, PAGEN3 | Zinc finger protein 808 | 388558.0 | ENSG00000198482 | nan | Pancreatic agenesis 3, 620991 (3), Autosomal recessive
chr19	ZNF137P	604079.0 | ZNF137 | Zinc finger protein-137 | 7696.0 | nan | nan | nan
chr19	ZNF83	194558.0 | ZNF83 | Zinc finger protein-83 | 55769.0 | ENSG00000167766 | nan | nan
chr19	ZNF28	620466.0 | ZNF28, KOX24 | Zinc finger protein 28 | 7576.0 | ENSG00000198538 | nan | nan
chr19	ZNF468	616841.0 | ZNF468 | Zinc finger protein 468 | 90333.0 | ENSG00000204604 | nan | nan
chr19	ZNF320	606427.0 | ZNF320 | Zinc finger protein 320 | 162967.0 | ENSG00000182986 | nan | nan
chr19	ZNF160	600398.0 | ZNF160 | Zinc finger protein-160 | 90338.0 | ENSG00000170949 | nan | nan
chr19	ZNF415	619506.0 | ZNF415 | Zinc finger protein 415 | 55786.0 | ENSG00000170954 | nan | nan
chr19	ZNF331	606043.0 | ZNF331, ZNF463 | Zinc finger protein-331 | 55422.0 | ENSG00000130844 | nan | nan
chr19	DPRX	611165.0 | DPRX | Divergent-paired related homeobox | 503834.0 | ENSG00000204595 | many pseudogenes | nan
chr19	MIR512-1	620571.0 | MIR512-1 | Micro RNA 512-1 | 574458.0 | ENSG00000207645 | in C19MC | nan
chr19	MIR512-2	620572.0 | MIR512-2 | Micro RNA 512-2 | 574459.0 | ENSG00000207644 | in C19MC | nan
chr19	MIR1323	620643.0 | MIR1323 | Micro RNA 1323 | 100302255.0 | ENSG00000221017 | in C19MC | nan
chr19	MIR498	620584.0 | MIR498 | Micro RNA 498 | 574460.0 | ENSG00000207869 | in C19MC | nan
chr19	MIR520E	620573.0 | MIR520E | Micro RNA 520E | 574461.0 | ENSG00000207599 | in C19MC | nan
chr19	MIR515-1	620574.0 | MIR515-1 | Micro RNA 515-1 | 574462.0 | ENSG00000207616 | in C19MC | nan
chr19	MIR519E	620575.0 | MIR519E | Micro RNA 519E | 574463.0 | ENSG00000207810 | in C19MC | nan
chr19	MIR520F	620585.0 | MIR520F | Micro RNA 520F | 574464.0 | ENSG00000283540 | in C19MC | nan
chr19	MIR515-2	620586.0 | MIR515-2 | Micro RNA 515-2 | 574465.0 | ENSG00000207615 | in C19MC | nan
chr19	MIR519C	620587.0 | MIR519C | Micro RNA 519C | 574466.0 | ENSG00000207788 | in C19MC | nan
chr19	MIR1283-1	620644.0 | MIR1283-1 | Micro RNA 1283-1 | 100302265.0 | ENSG00000221421 | nan | nan
chr19	MIR520A	620588.0 | MIR520A | Micro RNA 520A | 574467.0 | ENSG00000207594 | in C19MC | nan
chr19	MIR526B	620589.0 | MIR526B | Micro RNA 526B | 574468.0 | ENSG00000207580 | in C19MC | nan
chr19	MIR519B	620591.0 | MIR519B | Micro RNA 519B | 574469.0 | ENSG00000207825 | in C19MC | nan
chr19	MIR525	620592.0 | MIR525 | Micro RNA 525 | 574470.0 | ENSG00000207711 | in C19MC | nan
chr19	MIR523	620593.0 | MIR523 | Micro RNA 523 | 574471.0 | ENSG00000283455 | in C19MC | nan
chr19	MIR518F	620594.0 | MIR518F | Micro RNA 518F | 574472.0 | ENSG00000207706 | in C19MC | nan
chr19	MIR520B	620595.0 | MIR520B | Micro RNA 520B | 574473.0 | ENSG00000207722 | in C19MC | nan
chr19	MIR518B	620596.0 | MIR518B | Micro RNA 518B | 574474.0 | ENSG00000207862 | in C19MC | nan
chr19	MIR526A1	620597.0 | MIR526A1 | Micro RNA 526A1 | 574475.0 | ENSG00000207629 | in C19MC | nan
chr19	MIR520C	615908.0 | MIR520C | Micro RNA 520C | 574476.0 | ENSG00000207738 | nan | nan
chr19	MIR518C	620598.0 | MIR518C | Micro RNA 518C | 574477.0 | ENSG00000283490 | in C19MC | nan
chr19	MIR524	620599.0 | MIR524 | Micro RNA 524 | 574478.0 | ENSG00000283289 | nan | nan
chr19	MIR517A	620600.0 | MIR517A | MicroRNA 517A | 574479.0 | ENSG00000207734 | nan | nan
chr19	MIR519D	614247.0 | MIR519D, MIRN519D | Micro RNA 519D | 574480.0 | ENSG00000207981 | nan | nan
chr19	MIR521-2	620611.0 | MIR521-2 | Micro RNA 521-2 | 574481.0 | ENSG00000207549 | in C19MC | nan
chr19	MIR520D	620612.0 | MIR520D | Micro RNA 520D | 574482.0 | ENSG00000207735 | in C19MC | nan
chr19	MIR517B	620613.0 | MIR517B | Micro RNA 517B | 574483.0 | ENSG00000207837 | in C19MC | nan
chr19	MIR520G	616272.0 | MIR520G | Micro RNA 520G | 574484.0 | ENSG00000207799 | nan | nan
chr19	MIR516B2	620614.0 | MIR516B2 | Micro RNA 516B2 | 574485.0 | ENSG00000207925 | nan | nan
chr19	MIR526A2	620615.0 | MIR526A2 | Micro RNA 625A2 | 574486.0 | ENSG00000211532 | nan | nan
chr19	MIR518E	620616.0 | MIR518E | Micro RNA 518E | 574487.0 | ENSG00000207987 | in C19MC | nan
chr19	MIR518A1	620617.0 | MIR518A1 | Micro RNA 518A1 | 574488.0 | ENSG00000207803 | in C19MC | nan
chr19	MIR518D	620618.0 | MIR518D | Micro RNA 518D | 574489.0 | ENSG00000283330 | nan | nan
chr19	MIR516B1	620619.0 | MIR516B1 | Micro RNA 516B1 | 574490.0 | ENSG00000207946 | in C19MC | nan
chr19	MIR518A2	620620.0 | MIR518A2 | Micro RNA 518A2 | 574491.0 | ENSG00000207699 | in C19MC | nan
chr19	MIR517C	620621.0 | MIR517C | Micro RNA 517C | 574492.0 | ENSG00000207838 | nan | nan
chr19	MIR520H	614755.0 | MIR520H | Micro RNA 520H | 574493.0 | ENSG00000207861 | nan | nan
chr19	MIR521-1	620622.0 | MIR521-1 | Micro RNA 521-1 | 574494.0 | ENSG00000207634 | nan | nan
chr19	MIR522	620623.0 | MIR522 | Micro RNA 522 | 574495.0 | ENSG00000283685 | in C19MC | nan
chr19	MIR519A1	620624.0 | MIR519A1 | Micro RNA 519A1 | 574496.0 | ENSG00000207992 | in C19MC | nan
chr19	MIR527	620625.0 | MIR527 | Micro RNA 527 | 574497.0 | ENSG00000207979 | in C19MC | nan
chr19	MIR516A1	620626.0 | MIR516A1 | Micro RNA 516A1 | 574498.0 | ENSG00000207767 | nan | nan
chr19	MIR1283-2	620645.0 | MIR1283-2 | Micro RNA 1283-2 | 100302205.0 | ENSG00000221548 | nan | nan
chr19	MIR516A2	620627.0 | MIR516A2 | Micro RNA 516A2 | 574499.0 | ENSG00000207620 | in C19MC | nan
chr19	MIR519A2	620628.0 | MIR519A2 | Micro RNA 519A2 | 574500.0 | ENSG00000284362 | in C19MC | nan
chr19	MIR371A	612043.0 | MIR371A | Micro RNA 371A | 442916.0 | ENSG00000199031 | nan | nan
chr19	MIR372	612044.0 | MIR372, MIRN372 | Micro RNA 372 | 442917.0 | ENSG00000199095 | nan | nan
chr19	MIR373	611954.0 | MIR373, MIRN373 | Micro RNA 373 | 442918.0 | ENSG00000199143 | nan | nan
chr19	NLRP12	609648.0 | NLRP12, NALP12, PYPAF7, RNO, FCAS2 | NLR family, pyrin domain containing 12 | 91662.0 | ENSG00000142405 | nan | Familial cold autoinflammatory syndrome 2, 611762 (3), Autosomal dominant
chr19	MYADM	609959.0 | MYADM | Myeloid-associated differentiation marker | 91663.0 | ENSG00000179820 | nan | nan
chr19	PRKCG	176980.0 | PRKCG, PKCC, PKCG, SCA14 | Protein kinase C, gamma polypeptide | 5582.0 | ENSG00000126583 | nan | Spinocerebellar ataxia 14, 605361 (3), Autosomal dominant
chr19	CACNG7	606899.0 | CACNG7 | Calcium channel, voltage-dependent, gamma-7 subunit | 59284.0 | ENSG00000105605 | nan | nan
chr19	CACNG8	606900.0 | CACNG8 | Calcium channel, voltage-dependent, gamma-8 subunit | 59283.0 | ENSG00000142408 | nan | nan
chr19	CACNG6	606898.0 | CACNG6 | Calcium channel, voltage-dependent, gamma-6 subunit | 59285.0 | ENSG00000130433 | nan | nan
chr19	VSTM1	616804.0 | VSTM1, SIRL1 | V-SET and transmembrane domains-containing protein 1 | 284415.0 | ENSG00000189068 | nan | nan
chr19	TARM1	616802.0 | TARM1 | T cell-interacting activating receptor on myeloid cells 1 | 441864.0 | ENSG00000248385 | nan | nan
chr19	OSCAR	606862.0 | OSCAR | Osteoclast-associated receptor | 126014.0 | ENSG00000170909 | nan | nan
chr19	NDUFA3	603832.0 | NDUFA3 | NADH-ubiquinone oxidoreductase subunit A3 | 4696.0 | ENSG00000170906 | nan | nan
chr19	TFPT	609519.0 | TFPT, FB1 | TCF3 fusion partner | 29844.0 | ENSG00000105619 | nan | nan
chr19	PRPF31	606419.0 | PRPF31, PRP31, RP11 | Pre-mRNA processing factor 11 | 26121.0 | ENSG00000105618 | nan | Retinitis pigmentosa 11, 600138 (3), Autosomal dominant
chr19	CNOT3	604910.0 | CNOT3, NOT3, IDDSADF | CCR4-NOT transcription complex, subunit 3 | 4849.0 | ENSG00000088038 | nan | Intellectual developmental disorder with speech delay, autism, and dysmorphic facies, 618672 (3), Autosomal dominant
chr19	TMC4	617181.0 | TMC4 | Transmembrane channel-like protein 4 | 147798.0 | ENSG00000167608 | nan | nan
chr19	MBOAT7	606048.0 | MBOAT7, BB1, LENG4, MRT57 | Membrane bound O-acyltransferase domain containing 7 | 79143.0 | ENSG00000125505 | nan | Intellectual developmental disorder, autosomal recessive 57, 617188 (3), Autosomal recessive
chr19	TSEN34	608754.0 | TSEN34, PCH2C, LENG5, SEN34 | tRNA splicing endonuclease, subunit 34 | 79042.0 | ENSG00000170892 | mutation identified in 1 PCH2C patient | ?Pontocerebellar hypoplasia type 2C, 612390 (3), Autosomal recessive
chr19	RPS9	603631.0 | RPS9 | Ribosomal protein S9 | 6203.0 | ENSG00000170889 | nan | nan
chr19	LILRB3	604820.0 | LILRB3, LIR3, ILT5, HL9 | Leukocyte immunoglobulin-like receptor, subfamily B, member 3 | 11025.0 | ENSG00000204577 | nan | nan
chr19	LILRB5	604814.0 | LILRB5, LIR8 | Leukocyte immunoglobulin-like receptor, subfamily B, member 5 | 10990.0 | ENSG00000105609 | nan | nan
chr19	LILRB2	604815.0 | LILRB2, LIR2, ILT4, MIR10 | Leukocyte immunoglobulin-like receptor, subfamily B, member 2 | 10288.0 | ENSG00000131042 | nan | nan
chr19	LILRA5	606047.0 | LILRA9, ILT11, CD85F, LIR9 | Leukocyte immunoglobulin-like receptor, subfamily A, member 5 | 353514.0 | ENSG00000187116 | nan | nan
chr19	LILRA4	607517.0 | LILRA4, ILT7 | Leukocyte immunoglobulin-like receptor, subfamily A, member 4 | 23547.0 | ENSG00000239961 | nan | nan
chr19	LAIR1	602992.0 | LAIR1 | Leukocyte-associated immunoglobulin-like receptor 1 | 3903.0 | ENSG00000167613 | nan | nan
chr19	TTYH1	605784.0 | TTYH1 | Tweety family member 1 | 57348.0 | ENSG00000167614 | nan | nan
chr19	LENG8	616575.0 | LENG8, KIAA1932 | Leukocyte receptor cluster gene 8 | 114823.0 | ENSG00000167615 | nan | nan
chr19	CDC42EP5	609171.0 | CDC42EP5, CEP5, BORG3 | CDC42 effector protein 5 | 148170.0 | ENSG00000167617 | nan | nan
chr19	LAIR2	602993.0 | LIAR2, CD306 | Leukocyte-associated immunoglobulin-like receptor 2 | 3904.0 | ENSG00000167618 | nan | nan
chr19	LILRA2	604812.0 | LILRA2, LIR7, ILT1 | Leukocyte immunoglobulin-like receptor, subfamily A, member 2 | 11027.0 | ENSG00000239998 | nan | nan
chr19	LILRA1	604810.0 | LILRA1, LIR6 | Leukocyte immunoglobulin-like receptor, subfamily A, member 1 | 11024.0 | ENSG00000104974 | nan | nan
chr19	LILRB1	604811.0 | LILRB1, LIR1, ILT2, MIR7, CD85 | Leukocyte immunoglobulin-like receptor, subfamily B, member 1 | 10859.0 | ENSG00000104972 | nan | nan
chr19	LILRB4	604821.0 | LILRB4, LIR5, ILT3, HM18 | Leukocyte immunoglobulin-like receptor, subfamily B, member 4 | 11006.0 | ENSG00000186818 | nan | nan
chr19	KIR3DL3	610095.0 | KIR3KL3, KIRC1, KIR3DL7, KIR44 | Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3 | 115653.0 | ENSG00000242019 | nan | nan
chr19	KIR2DL3	604938.0 | KIR2DL3, NKAT2 | Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 | 3804.0 | ENSG00000243772 | nan | nan
chr19	KIR2DL1	604936.0 | KIR2DL1, NKAT1 | Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 | 3802.0 | ENSG00000125498 | nan | nan
chr19	KIR3DP1	610604.0 | KIR3DP1, CD158C, KIRX, KIR48, KIR2DS6 | Killer cell immunoglobulin-like receptor, three domains, pseudogene | 548594.0 | ENSG00000264257 | functional in some individuals | nan
chr19	KIR2DL4	604945.0 | KIR2DL4, KIR103AS | Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 | 3805.0 | ENSG00000189013 | nan | nan
chr19	KIR3DL1	604946.0 | KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1 | Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 | 3811.0 | ENSG00000167633 | nan | nan
chr19	KIR2DS4	604955.0 | KIR2DS4, NKAT8 | Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 | 3809.0 | ENSG00000221957 | nan | nan
chr19	KIR3DL2	604947.0 | KIR3DL2, NKAT4 | Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 | 3812.0 | ENSG00000240403 | nan | nan
chr19	FCAR	147045.0 | FCAR | Fc fragment of IgA, receptor for | 2204.0 | ENSG00000186431 | nan | nan
chr19	NCR1	604530.0 | NCR1, LY94, NKP46 | Natural cytotoxicity triggering receptor 1 (lymphocyte antigen 94, mouse, homolog of) | 9437.0 | ENSG00000189430 | nan | nan
chr19	NLRP7	609661.0 | NLRP7, NALP7, NOD12, PYPAF3, HYDM | NLR family pyrin-domain containing 7 | 199713.0 | ENSG00000167634 | nan | Hydatidiform mole, recurrent, 1, 231090 (3), Autosomal recessive
chr19	NLRP2	609364.0 | NLRP2, NALP2, PAN1, PYPAF2, OZEMA18 | NLR family pyrin-domain containing 2 | 55655.0 | ENSG00000022556 | nan | Oocyte/zygote/embryo maturation arrest 18, 620332 (3), Autosomal recessive
chr19	GP6	605546.0 | GP6, GPIV, BDPLT11 | Glycoprotein VI, platelet | 51206.0 | ENSG00000088053 | nan | Bleeding disorder, platelet-type, 11, 614201 (3), Autosomal recessive
chr19	EPS8L1	614987.0 | EPS8L1, EPS8R1 | EPS8-like protein 1 | 54869.0 | ENSG00000131037 | nan | nan
chr19	PPP1R12C	613245.0 | PPP1R12C, MBS85 | Protein phosphatase 1, regulatory subunit 12C | 54776.0 | ENSG00000125503 | nan | nan
chr19	TNNT1	191041.0 | TNNT1, ANM, NEM5 | Troponin-T1, skeletal, slow | 7138.0 | ENSG00000105048 | nan | Nemaline myopathy 5C, autosomal dominant, 620389 (3), Autosomal dominant; Nemaline myopathy 5A, autosomal recessive, severe infantile, 605355 (3), Autosomal recessive; Nemaline myopathy 5B, autosomal recessive, childhood-onset, 620386 (3), Autosomal recessive
chr19	TNNI3	191044.0 | TNNI3, CMH7, CMD2A, RCM1, CMD1FF | Troponin-I, cardiac | 7137.0 | ENSG00000129991 | mutation identified in 1 CMD2A family | ?Cardiomyopathy, dilated, 2A, 611880 (3), Autosomal recessive; Cardiomyopathy, hypertrophic, 7, 613690 (3), Autosomal dominant; Cardiomyopathy, familial restrictive, 1, 115210 (3), Autosomal dominant; Cardiomyopathy, dilated, 1FF, 613286 (3)
chr19	DNAAF3	614566.0 | DNAAF3, PF22, DAB1, CILD2 | Dynein, axonemal, assembly factor 3 | 352909.0 | ENSG00000167646 | nan | Ciliary dyskinesia, primary, 2, 606763 (3), Autosomal recessive
chr19	SYT5	600782.0 | SYT5 | Synaptotagmin-5 | 6861.0 | ENSG00000129990 | nan | nan
chr19	PTPRH	602510.0 | PTPRH | Protein tyrosine phosphatase, receptor type, H | 5794.0 | ENSG00000080031 | nan | nan
chr19	TMEM86B	617806.0 | TMEM86B | Transmembrane protein 86B | 255043.0 | ENSG00000180089 | nan | nan
chr19	PPP6R1	610875.0 | PPP6R1, SAPS1, PP6R1, KIAA1115 | Protein phosphatase 6, regulatory subunit 1 | 22870.0 | ENSG00000105063 | nan | nan
chr19	HSPBP1	612939.0 | HSPBP1 | Heat-shock 70kD protein-binding protein 1 | 23640.0 | ENSG00000133265 | nan | nan
chr19	BRSK1	609235.0 | BRSK1, KIAA1811 | BR serine/threonine kinase 1 | 84446.0 | ENSG00000160469 | nan | nan
chr19	TMEM150B	617291.0 | TMEM150B, DRAM3, TTN2, TMEM224 | Transmembrane protein 150B | 284417.0 | ENSG00000180061 | nan | nan
chr19	KMT5C	613198.0 | SUV420H2 | Suppressor of variegation 4-20, Drosophila, homolog of, 2 | 84787.0 | ENSG00000133247 | nan | nan
chr19	COX6B2	618127.0 | COX6B2, CT59 | Cytochrome c oxidase, subunit 6B2 | 125965.0 | ENSG00000160471 | nan | nan
chr19	IL11	147681.0 | IL11 | Interleukin-11 | 3589.0 | ENSG00000095752 | nan | nan
chr19	RPL28	603638.0 | RPL28 | Ribosomal protein L28 | 6158.0 | ENSG00000108107 | nan | nan
chr19	UBE2S	610309.0 | UBE2S, EPF5, E2EPF | Ubiquitin-conjugating enzyme E2 S | 27338.0 | ENSG00000108106 | nan | nan
chr19	SHISA7	617328.0 | SHISA7 | Shisa family, member 7 | 729956.0 | ENSG00000187902 | nan | nan
chr19	ISOC2	612928.0 | ISOC2 | Isochorismatase domain-containing 2 | 79763.0 | ENSG00000063241 | nan | nan
chr19	ZNF628	610671.0 | ZNF628, ZEC | Zinc finger protein 628 | 89887.0 | ENSG00000197483 | nan | nan
chr19	SSC5D	618194.0 | SSC5D | Scavenger receptor cysteine-rich family member with 5 domains | 284297.0 | ENSG00000179954 | nan | nan
chr19	SBK2	620414.0 | SBK2 | SH3 domain-binding kinase family, member 2 | 646643.0 | ENSG00000187550 | nan | nan
chr19	FIZ1	609133.0 | FIZ1, FLJ14768 | FLT3-interacting zinc finger protein 1 | 84922.0 | ENSG00000179943 | nan | nan
chr19	ZNF580	617888.0 | ZNF580 | Zinc finger protein 580 | 51157.0 | ENSG00000213015 | nan | nan
chr19	CCDC106	613478.0 | CCDC106 | Coiled-coil domain-containing protein 106 | 29903.0 | ENSG00000173581 | nan | nan
chr19	U2AF2	191318.0 | U2AF2, U2AF65, DEVDFB | U2 small nuclear RNA auxiliary factor 2 | 11338.0 | ENSG00000063244 | nan | Developmental delay, dysmorphic facies, and brain anomalies, 620535 (3), Autosomal dominant
chr19	EPN1	607262.0 | EPN1 | Epsin 1 | 29924.0 | ENSG00000063245 | nan | nan
chr19	NLRP9	609663.0 | NLRP9, NALP9, NOD6 | NLR family pyrin-domain containing 9 | 338321.0 | ENSG00000185792 | nan | nan
chr19	RFPL4A	612601.0 | RFPL4A, RNF210 | Ret finger protein-like 4A | 342931.0 | ENSG00000223638 | nan | nan
chr19	NLRP11	609664.0 | NLRP11, NALP11, PYPAF7, NOD17 | NLR family pyrin-domain containing 11 | 204801.0 | ENSG00000179873 | nan | nan
chr19	NLRP4	609645.0 | NLRP4, NALP4, PAN2, PYPAF4 | NLR family pyrin-domain containing 4 | 147945.0 | ENSG00000160505 | nan | nan
chr19	NLRP13	609660.0 | NLRP13, NALP13, NOD14 | NLR family pyrin-domain containing 13 | 126204.0 | ENSG00000173572 | nan | nan
chr19	NLRP8	609659.0 | NLRP8, NALP8, NOD16, PAN4 | NLR family pyrin-domain containing 8 | 126205.0 | ENSG00000179709 | nan | nan
chr19	NLRP5	609658.0 | NLRP5, NALP5, MATER, OZEMA19 | NLR family pyrin-domain containing 5 | 126206.0 | ENSG00000171487 | nan | Oocyte/zygote/embryo maturation arrest 19, 620333 (3), Autosomal recessive
chr19	ZNF444	607874.0 | ZNF444, EZF2 | Zinc finger protein 444 | 55311.0 | ENSG00000167685 | nan | nan
chr19	GALP	611178.0 | GALP, ALARIN | Galanin-like peptide (GALP precursor protein) | 85569.0 | ENSG00000197487 | nan | nan
chr19	ZSCAN5B	620918.0 | ZSCAN5B, ZNF495B | Zinc finger- and SCAN domain-containing protein 5B | 342933.0 | ENSG00000197213 | nan | nan
chr19	ZSCAN5A	620916.0 | ZSCAN5A, ZNF495 | Zinc finger- and SCAN domain-containing protein 5A | 79149.0 | ENSG00000131848 | nan | nan
chr19	ZNF582	615600.0 | ZNF582 | Zinc finger protein 582 | 147948.0 | ENSG00000018869 | nan | nan
chr19	ZNF667	611024.0 | ZNF667, MIPU1 | Zinc finger protein 667 | 63934.0 | ENSG00000198046 | nan | nan
chr19	ZNF471	620162.0 | ZNF471 | Zinc finger protein 471 | 57573.0 | ENSG00000196263 | nan | nan
chr19	ZFP28	616798.0 | ZFP28 | Zinc finger protein 28 | 140612.0 | ENSG00000196867 | nan | nan
chr19	ZNF470	620441.0 | ZNF470 | Zinc finger protein 470 | 388566.0 | ENSG00000197016 | nan | nan
chr19	ZNF71	194545.0 | ZNF71 | Zinc finger protein-71 (Cos26) | 58491.0 | ENSG00000197951 | previously assigned to 22q11.2 | nan
chr19	PEG3	601483.0 | PEG3 | Paternally expressed gene 3 | 5178.0 | ENSG00000198300 | nan | nan
chr19	MIMT1	620407.0 | MIMT1, LINC00067 | MER1 repeat-containing imprinted transcript 1, noncoding | 100073347.0 | ENSG00000268654 | nan | nan
chr19	USP29	609546.0 | USP29 | Ubiquitin-specific protease 29 | 57663.0 | ENSG00000131864 | nan | nan
chr19	DUXA	611168.0 | DUXA | Double homeobox A | 503835.0 | ENSG00000258873 | many pseudogenes | nan
chr19	ZNF264	604668.0 | ZNF264 | Zinc finger protein-264 | 9422.0 | ENSG00000083844 | nan | nan
chr19	AURKC	603495.0 | AURKC, STK13, AIE2, SPGF5 | Aurora kinase C | 6795.0 | ENSG00000105146 | nan | Spermatogenic failure 5, 243060 (3), Autosomal recessive
chr19	ZNF460	604755.0 | ZNF272, HZF8, ZNF460 | Zinc finger protein-272 | 10794.0 | ENSG00000197714 | nan | nan
chr19	ZNF543	616847.0 | ZNF543 | Zinc finger protein 543 | 125919.0 | ENSG00000178229 | nan | nan
chr19	ZNF304	613840.0 | ZNF304 | Zinc finger protein 304 | 57343.0 | ENSG00000131845 | nan | nan
chr19	TRAPPC2B	620472.0 | TRAPPC2B, MIP2A | Trafficking protein particle complex, subunit 2B | 10597.0 | ENSG00000256060 | nan | nan
chr19	ZNF17	619254.0 | ZNF17, KOX10, KIAA1947 | Zinc finger protein 17 | 7565.0 | ENSG00000186272 | nan | nan
chr19	VN1R1	605234.0 | VN1R1, V1RL1 | Vomeronasal 1 receptor 1 | 57191.0 | ENSG00000178201 | nan | nan
chr19	ZNF419	617410.0 | ZNF419 | Zinc finger protein 419 | 79744.0 | ENSG00000105136 | nan | nan
chr19	ZNF549	620720.0 | ZNF549 | Zinc finger protein 549 | 256051.0 | ENSG00000121406 | nan | nan
chr19	ZNF134	604076.0 | ZNF134 | Zinc finger protein-134 | 7693.0 | ENSG00000213762 | nan | nan
chr19	ZNF211	601856.0 | ZNFC25 | Zinc finger protein-C2H2-25 | 10520.0 | ENSG00000121417 | nan | nan
chr19	ZSCAN4	613419.0 | ZSCAN4, ZNF494 | Zinc finger- and SCAN domain-containing protein 4 | 201516.0 | ENSG00000180532 | nan | nan
chr19	ZNF154	604085.0 | ZNF154 | Zinc finger protein-154 | 7710.0 | ENSG00000179909 | nan | nan
chr19	ZNF418	619509.0 | ZNF418, ZFP418 | Zinc finger protein 418 | 147686.0 | ENSG00000196724 | nan | nan
chr19	ZNF256	606956.0 | ZNF256 | Zinc finger protein 256 | 10172.0 | ENSG00000152454 | nan | nan
chr19	ZNF606	613905.0 | ZNF606, ZNF328, KIAA1852 | Zinc finger protein 606 | 80095.0 | ENSG00000166704 | nan | nan
chr19	ZSCAN1	620026.0 | ZSCAN1 | Zinc finger- and SCAN domain-containing protein 1 | 284312.0 | ENSG00000152467 | nan | nan
chr19	ZNF135	604077.0 | ZNF135 | Zinc finger protein-135 | 7694.0 | ENSG00000176293 | nan | nan
chr19	ZNF274	605467.0 | ZNF274 | Zinc finger protein-274 | 10782.0 | ENSG00000171606 | nan | nan
chr19	ZNF8	194532.0 | ZNF8 | Zinc finger protein-8 | 7554.0 | ENSG00000278129 | previously assigned to 20q13 | nan
chr19	ZSCAN22	165260.0 | ZSCAN22, HKR2 | Zinc finger- and SCAN domain-containing protein 22 | 342945.0 | ENSG00000182318 | nan | nan
chr19	A1BG	138670.0 | A1BG | Glycoprotein, alpha-1B | 1.0 | ENSG00000121410 | order:  C3-SE-LU-A1BG | nan
chr19	RPS5	603630.0 | RPS5 | Ribosomal protein S5 | 6193.0 | ENSG00000083845 | nan | nan
chr19	ZNF132	604074.0 | ZNF132 | Zinc finger protein-132 | 7691.0 | ENSG00000131849 | nan | nan
chr19	ZNF324	617477.0 | ZNF324, ZF5128 | Zinc finger protein 324 | 25799.0 | ENSG00000083812 | nan | nan
chr19	SLC27A5	603314.0 | SLC27A5, FATP5, VLACSR, VLCSH2 | Solute carrier family 27 (fatty acid transporter), member 5 | 10998.0 | ENSG00000083807 | nan | nan
chr19	TRIM28	601742.0 | TRIM28, KAP1, TIF1B | Tripartite motif-containing protein 28 | 10155.0 | ENSG00000130726 | nan | nan
chr19	CHMP2A	610893.0 | CHMP2A, VPS2A, VPS2, BC2 | Charged multivesicular body protein 2A | 27243.0 | ENSG00000130724 | nan | nan
chr19	UBE2M	603173.0 | UBE2M, UBC12 | Ubiquitin-conjugating enzyme E2 M | 9040.0 | ENSG00000130725 | nan | nan
chr19	MZF1	194550.0 | MZF1, ZNF42 | Myeloid zinc finger 1 | 7593.0 | ENSG00000099326 | nan | nan
chr19		603979.0 | ZNF97 | Zinc finger protein-97 | nan | nan | nan | nan
chr20	AD8	607116.0 | AD8 | Alzheimer disease 8 | 353128.0 | nan | ?related to CST3 | Alzheimer disease 8, 607116 (2)
chr20	ALS7	608031.0 | ALS7 | Amyotrophic lateral sclerosis 7 | 406238.0 | nan | max lod at D20S103 | Amyotrophic lateral sclerosis 7, 608031 (2)
chr20	ATOD3	605804.0 | ATOD3 | Dermatitis, atopic, 3 | 117187.0 | nan | max lod at D20S115 | {Dermatitis, atopic, susceptibility to, 3}, 605804 (2)
chr20	BMIQ6	608559.0 | BMIQ6 | Body mass index quantitative trait locus 6 | 449017.0 | nan | near D20S482 and D20S851 | [Body mass index QTL6], 608559 (2)
chr20	RLS5	611242.0 | RLS5 | Restless legs syndrome, susceptibility to, 5 | 100188839.0 | nan | max lod at D20S849 | {Restless legs syndrome 5}, 611242 (2)
chr20	DEFB126	620131.0 | DEFB126 | Defensin, beta, 126 | 81623.0 | ENSG00000125788 | nan | nan
chr20	ZCCHC3	618326.0 | ZCCHC3 | Zinc finger CCHC domain-containing protein 3 | 85364.0 | ENSG00000247315 | nan | nan
chr20	SOX12	601947.0 | SOX12, SOX22 | SRY (sex-determining region Y)-box 12 | 6666.0 | ENSG00000177732 | nan | nan
chr20	NRSN2	610666.0 | NRSN2 | Neurensin 2 | 80023.0 | ENSG00000125841 | nan | nan
chr20	TRIB3	607898.0 | TRIB3, NIPK, SINK, C20orf97, SKIP3 | Tribbles pseudokinase 3 | 57761.0 | ENSG00000101255 | nan | nan
chr20	RBCK1	610924.0 | RBCK1, HOIL1, PGBM1, PBMEI, C20orf18 | RANBP-type and C3HC4-type zinc finger-containing 1 | 10616.0 | ENSG00000125826 | nan | Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3), Autosomal recessive
chr20	TBC1D20	611663.0 | TBC1D20, C20orf140, WARBM4 | TBC1 domain family, member 20 | 128637.0 | ENSG00000125875 | nan | Warburg micro syndrome 4, 615663 (3), Autosomal recessive
chr20	CSNK2A1	115440.0 | CSNK2A1, CK2A1, OCNDS | Casein kinase-2, alpha-1 polypeptide | 1457.0 | ENSG00000101266 | pseudogene on 11p15 | Okur-Chung neurodevelopmental syndrome, 617062 (3), Autosomal dominant
chr20	TCF15	601010.0 | TCF15 | Transcription factor-15 (basic helix-loop-helix) | 6939.0 | ENSG00000125878 | nan | nan
chr20	SRXN1	617583.0 | SRXN1, SRX | Sulfiredoxin 1 | 140809.0 | ENSG00000271303 | nan | nan
chr20	SLC52A3	613350.0 | SLC52A3, C20orf54, RFT2, BVVLS1 | Solute carrier family 52, riboflavin transporter, member 3 | 113278.0 | ENSG00000101276 | mutation identified in 1 FZLD family | ?Fazio-Londe disease, 211500 (3), Autosomal recessive; Brown-Vialetto-Van Laere syndrome 1, 211530 (3), Autosomal recessive
chr20	FAM110A	611393.0 | FAM110A, C20orf55 | Family with sequence similarity 110, member A | 83541.0 | ENSG00000125898 | nan | nan
chr20	ANGPT4	603705.0 | ANGPT4, ANG4 | Angiopoietin 4 | 51378.0 | ENSG00000101280 | no ANGT3 in human | nan
chr20	RSPO4	610573.0 | RSPO4, CRISTIN4 | R-spondin member 4 | 343637.0 | ENSG00000101282 | nan | Anonychia congenita, 206800 (3), Autosomal recessive
chr20	PSMF1	617858.0 | PSMF1, PI31 | Proteasome inhibitor subunit 1 | 9491.0 | ENSG00000125818 | nan | nan
chr20	RAD21L1	619533.0 | RAD21L1, RAD21L | RAD21 cohesin complex component-like 1 | 642636.0 | ENSG00000244588 | nan | nan
chr20	SNPH	604942.0 | SNPH | Syntaphilin | 9751.0 | ENSG00000101298 | nan | nan
chr20	SDCBP2	617358.0 | SDCBP2, SITAC, ST2, SITAC18 | Syndecan-binding protein 2 | 27111.0 | ENSG00000125775 | nan | nan
chr20	FKBP1A	186945.0 | FKBP1A, FKBP12 | FK506-binding protein-1A, 12kD | 2280.0 | ENSG00000088832 | nan | nan
chr20	NSFL1C	606610.0 | P47 | p47, rat, homolog of | 55968.0 | ENSG00000088833 | nan | nan
chr20	SIRPB1	603889.0 | SIRPB1 | Signal regulatory protein, beta-1 | 10326.0 | ENSG00000101307 | nan | nan
chr20	SIRPG	605466.0 | SIRPG, SIRPB2 | Signal regulatory protein, gamma | 55423.0 | ENSG00000089012 | nan | nan
chr20	SIRPA	602461.0 | SHPS1 | SHP substrate-1 | 140885.0 | ENSG00000198053 | nan | nan
chr20	PDYN	131340.0 | PDYN, SCA23 | Prodynorphin | 5173.0 | ENSG00000101327 | nan | Spinocerebellar ataxia 23, 610245 (3), Autosomal dominant
chr20	STK35	609370.0 | STK35, CLIK1 | Serine/threonine kinase 35 | 140901.0 | ENSG00000125834 | nan | nan
chr20	TGM3	600238.0 | TGM3, UHS2 | Transglutaminase-3 (E polypeptide, protein-glutamine-gamma-glutamyl transferase) | 7053.0 | ENSG00000125780 | mutation identified in 1 UHS2 patient | ?Uncombable hair syndrome 2, 617251 (3), Autosomal recessive
chr20	TGM6	613900.0 | TGM6, TG6, TGY, SCA35 | Transglutaminase 6 | 343641.0 | ENSG00000166948 | nan | Spinocerebellar ataxia 35, 613908 (3), Autosomal dominant
chr20	SNRPB	182282.0 | SNRPB, CCMS | Small nuclear ribonucleoprotein polypeptides B and B1 | 6628.0 | ENSG00000125835 | nan | Cerebrocostomandibular syndrome, 117650 (3), Autosomal dominant
chr20	TMC2	606707.0 | TMC2 | Transmembrane channel-like protein 2 | 117532.0 | ENSG00000149488 | nan | nan
chr20	NOP56	614154.0 | NOP56, SCA36 | Nop56, S. cerevisiae, homolog of | 10528.0 | ENSG00000101361 | nan | Spinocerebellar ataxia 36, 614153 (3), Autosomal dominant
chr20	MIR1292	614155.0 | MIR1292, MIRN1292 | Micro RNA 1292 | 100302138.0 | ENSG00000284481 | nan | nan
chr20	IDH3B	604526.0 | IDH3B, RP46 | Isocitrate dehydrogenase (NAD+) 3, noncatalytic, beta subunit | 3420.0 | ENSG00000101365 | nan | Retinitis pigmentosa 46, 612572 (3), Autosomal recessive
chr20	EBF4	609935.0 | EBF4, KIAA1442 | Early B-cell factor 4 | 57593.0 | ENSG00000088881 | nan | nan
chr20	CPXM1	609555.0 | CPXM1, CPX1 | Carboxypeptidase X, M14 family, member 1 | 56265.0 | ENSG00000088882 | nan | nan
chr20	VPS16	608550.0 | VPS16, DYT30 | VPS16 core subunit of CORVET and HOPS complexes | 64601.0 | ENSG00000215305 | nan | Dystonia 30, 619291 (3), Autosomal dominant
chr20	PTPRA	176884.0 | PTPRA, PTPA, PTPRL2, LRP | Protein tyrosine phosphatase, receptor type, alpha polypeptide | 5786.0 | ENSG00000132670 | nan | nan
chr20	GNRH2	602352.0 | GNRH2 | Gonadotropin-releasing hormone-2 | 2797.0 | ENSG00000125787 | nan | nan
chr20	MRPS26	611988.0 | MRPS26, MRPS13 | Mitochondrial ribosomal protein S26 | 64949.0 | ENSG00000125901 | nan | nan
chr20	OXT	167050.0 | OXT | Oxytocin-neurophysin I | 5020.0 | ENSG00000101405 | 12kb from ARVP | nan
chr20	AVP	192340.0 | AVP, AVRP, VP | Arginine vasopressin (neurophysin II, antidiuretic hormone) | 551.0 | ENSG00000101200 | distal 20p | Diabetes insipidus, neurohypophyseal, 125700 (3), Autosomal dominant
chr20	UBOX5	619675.0 | UBOX5, RNF37, UIP5 | U-box domain-containing protein 5 | 22888.0 | ENSG00000185019 | nan | nan
chr20	FASTKD5	614272.0 | FASTKD5 | Fast kinase domain-containing protein 5 | 60493.0 | ENSG00000215251 | nan | nan
chr20	LZTS3	610484.0 | PROSAPIP1, KIAA0552 | Proline-rich synapse-associated protein-interacting protein 1 | 9762.0 | ENSG00000088899 | nan | nan
chr20	DDRGK1	616177.0 | DDRGK1, UFBP1, C20orf116, SEMDSH | DDRGK domain-containing protein 1 | 65992.0 | ENSG00000198171 | nan | Spondyloepimetaphyseal dysplasia, Shohat type, 602557 (3), Autosomal recessive
chr20	ITPA	147520.0 | ITPA, DEE35 | Inosine triphosphatase-A | 3704.0 | ENSG00000125877 | nan | [Inosine triphosphatase deficiency], 613850 (3); Developmental and epileptic encephalopathy 35, 616647 (3), Autosomal recessive
chr20	SLC4A11	610206.0 | SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4 | Solute carrier family 4 (sodium borate cotransporter), member 11 | 83959.0 | ENSG00000088836 | nan | Corneal endothelial dystrophy, autosomal recessive, 217700 (3), Autosomal recessive; Corneal dystrophy, Fuchs endothelial, 4, 613268 (3); Corneal endothelial dystrophy and perceptive deafness, 217400 (3), Autosomal recessive
chr20	DNAAF9	614146.0 | DNAAF9, C20orf194 | Dynein, axonemal, assembly factor 9 | 25943.0 | ENSG00000088854 | nan | nan
chr20	ATRN	603130.0 | ATRN, MGCA | Attractin (mahogany, mouse, homolog of) | 8455.0 | ENSG00000088812 | nan | nan
chr20	GFRA4	618679.0 | GFRA4 | GDNF family receptor alpha-4 | 64096.0 | ENSG00000125861 | nan | nan
chr20	ADAM33	607114.0 | ADAM33 | ADAM metallopeptidase domain 33 | 80332.0 | ENSG00000149451 | nan | nan
chr20	SIGLEC1	600751.0 | SIGLEC1, SN, CD169 | Sialic acid-binding immunoglobulin-like lectin 1 (sialoadhesin) | 6614.0 | ENSG00000088827 | nan | nan
chr20	HSPA12B	610702.0 | HSPA12B | Heat-shock 70kD protein 12B | 116835.0 | ENSG00000132622 | nan | nan
chr20	ADISSP	620373.0 | ADISSP, C20orf27 | Adipose-secreted signaling protein | 54976.0 | ENSG00000101220 | nan | nan
chr20	SPEF1	610674.0 | C20orf28, CLAMP, SPEF1 | Sperm flagellar protein 1 | 25876.0 | ENSG00000101222 | nan | nan
chr20	CENPB	117140.0 | CENPB | Centromeric protein B | 1059.0 | ENSG00000125817 | nan | nan
chr20	CDC25B	116949.0 | CDC25B | Cell division cycle 25B | 994.0 | ENSG00000101224 | nan | nan
chr20	AP5S1	614824.0 | AP5S1, C20orf29 | Adaptor-related protein complex 5, sigma-1 subunit | 55317.0 | ENSG00000125843 | nan | nan
chr20	MAVS	609676.0 | MAVS, VISA, IPS1, CARDIF, KIAA1271 | Mitochondrial antiviral signaling protein | 57506.0 | ENSG00000088888 | nan | nan
chr20	PANK2	606157.0 | PANK2, NBIA1, PKAN | Pantothenate kinase 2 | 80025.0 | ENSG00000125779 | nan | Neurodegeneration with brain iron accumulation 1, 234200 (3), Autosomal recessive
chr20	MIR103A2	613188.0 | MIR103-2, MIRN103-2 | Micro RNA 103-2 | 406896.0 | ENSG00000199024 | nan | nan
chr20	RNF24	612489.0 | RNF24, G1L | Ring finger protein 24 | 11237.0 | ENSG00000101236 | nan | nan
chr20	SMOX	615854.0 | SMOX, SMO, PAO1, C20orf16, PAOH | Spermine oxidase | 54498.0 | ENSG00000088826 | nan | nan
chr20	ADRA1D	104219.0 | ADRA1D, ADRA1A | Adrenergic, alpha-1D-, receptor | 146.0 | ENSG00000171873 | incorrectly assigned to 5q | nan
chr20	PRNP	176640.0 | PRNP, PRIP, KURU, CJD | Prion protein | 5621.0 | ENSG00000171867 | pter-PRNP-SCG1-BMP2A-PAX1-cen | Spongiform encephalopathy with neuropsychiatric features, 606688 (3), Autosomal dominant; Gerstmann-Straussler disease, 137440 (3), Autosomal dominant; Huntington disease-like 1, 603218 (3), Autosomal dominant; Insomnia, fatal familial, 600072 (3), Autosomal dominant; {Kuru, susceptibility to}, 245300 (3); Cerebral amyloid angiopathy, PRNP-related, 137440 (3), Autosomal dominant; Creutzfeldt-Jakob disease, 123400 (3), Autosomal dominant
chr20	PRND	604263.0 | PRND, DPL | Prion-like protein doppel | 23627.0 | ENSG00000171864 | nan | nan
chr20	RASSF2	609492.0 | RASSF2, KIAA0168 | Ras association domain family protein 2 | 9770.0 | ENSG00000101265 | nan | nan
chr20	SLC23A2	603791.0 | SLC23A2, SVCT2 | Solute carrier family 23 (nucleobase transporters), member 2 (sodium-dependent vitamin C transporter 2) | 9962.0 | ENSG00000089057 | nan | nan
chr20	TMEM230	617019.0 | TMEM230, C20orf30 | Transmembrane protein 230 | 29058.0 | ENSG00000089063 | nan | nan
chr20	BMND7	611738.0 | BMND7 | Bone mineral density QTL 7 | 100188853.0 | nan | most significant association with haplotype C | {Osteoporosis}, 166710 (2), Autosomal dominant
chr20	CRCS11	612592.0 | CRCS11 | Colorectal cancer, susceptibility to, 11 | 100271692.0 | nan | associated with rs961253 | {Colorectal cancer, susceptibility to, 11}, 612592 (2)
chr20	GLC1K	608696.0 | GLC1K, JOAG3 | Glaucoma 1K, primary open angle, juvenile-onset | 574077.0 | nan | between D20S189 and D20S104 | Glaucoma 1K, primary open angle, juvenile-onset, 608696 (2)
chr20	SLEB7	610065.0 | SLEB7 | Systemic lupus erythematosus, susceptibility to, 7 | 100188803.0 | nan | nan | {Systemic lupus erythematosus, susceptibility to, 7}, 610065 (2)
chr20	PCNA	176740.0 | PCNA, ATLD2 | Proliferating cell nuclear antigen | 5111.0 | ENSG00000132646 | pseudogenes on X and 6; mutation identified in one ATLD2 family | ?Ataxia-telangiectasia-like disorder 2, 615919 (3), Autosomal recessive
chr20	CDS2	603549.0 | CDS2 | CDP-diacylglycerol synthase 2 | 8760.0 | ENSG00000101290 | nan | nan
chr20	PROKR2	607123.0 | PROKR2, PKR2, GPR73L1, HH3 | Prokineticin receptor 2 | 128674.0 | ENSG00000101292 | nan | Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3), Autosomal dominant
chr20	GPCPD1	614124.0 | GPCPD1, GDE5, KIAA1434 | Glycerophosphocholine phosphodiesterase 1 | 56261.0 | ENSG00000125772 | nan | nan
chr20	SHLD1	618028.0 | SHLD1, RINN3, C20orf196 | Shield complex, subunit 1 | 149840.0 | ENSG00000171984 | nan | nan
chr20	CHGB	118920.0 | CHGB, SCG1 | Chromogranin B (secretogranin B) | 1114.0 | ENSG00000089199 | nan | nan
chr20	TRMT6	620886.0 | TRMT6,, TRM6 | tRNA methyltransferase 6, noncatalytic subunit | 51605.0 | ENSG00000089195 | nan | nan
chr20	MCM8	608187.0 | MCM8, POF10 | Minichromosome maintenance complement component 8 | 84515.0 | ENSG00000125885 | mutation identified in 1 POF10 family | ?Premature ovarian failure 10, 612885 (3), Autosomal recessive
chr20	CRLS1	608188.0 | CRLS1, GCD10, C20orf155, COSPD57 | Cardiolipin synthase 1 | 54675.0 | ENSG00000088766 | nan | Combined oxidative phosphorylation deficiency 57, 620167 (3), Autosomal recessive
chr20	LRRN4	619706.0 | LRRN4 | Leucine-rich repeat neuronal protein 4 | 164312.0 | ENSG00000125872 | nan | nan
chr20	FERMT1	607900.0 | FERMT1, KIND1, URP1, C20orf42 | FERM domain-containing kindlin 1 | 55612.0 | ENSG00000101311 | nan | Kindler syndrome, 173650 (3), Autosomal recessive
chr20	BMP2	112261.0 | BMP2, BMP2A, BDA2, SSFSC1 | Bone morphogenetic protein-2 | 650.0 | ENSG00000125845 | nan | Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1, 617877 (3), Autosomal dominant; Brachydactyly, type A2, 112600 (3), Autosomal dominant; {HFE hemochromatosis, modifier of}, 235200 (3), Autosomal recessive
chr20	HAO1	605023.0 | HAO1, GOX1 | Hydroxyacid oxidase 1 | 54363.0 | ENSG00000101323 | nan | nan
chr20	TMX4	616766.0 | TMX4 | Thioredoxin-related transmembrane protein 4 | 56255.0 | ENSG00000125827 | nan | nan
chr20	PLCB1	607120.0 | PLCB1, KIAA0581, PLCB1A, PLCB1B, DEE12 | Phospholipase C, beta-1 | 23236.0 | ENSG00000182621 | nan | Developmental and epileptic encephalopathy 12, 613722 (3), Autosomal recessive
chr20	PLCB4	600810.0 | PLCB4, ARCND2A, ARCND2B | Phospholipase C, beta 4 | 5332.0 | ENSG00000101333 | nan | Auriculocondylar syndrome 2B, 620458 (3), Autosomal recessive; Auriculocondylar syndrome 2A, 614669 (3), Autosomal dominant
chr20	LAMP5	614641.0 | LAMP5, BADLAMP | Lysosome-associated membrane protein 5 | 24141.0 | ENSG00000125869 | nan | nan
chr20	PAK5	608038.0 | PAK5, PAK7, KIAA1264 | p21 (RAC1) activated kinase | 57144.0 | ENSG00000101349 | nan | nan
chr20	SNAP25	600322.0 | SNAP25, CMS18 | Synaptosomal-associated protein, 25kD | 6616.0 | ENSG00000132639 | mutation identified in 1 CMS18 patient | ?Myasthenic syndrome, congenital, 18, 616330 (3), Autosomal dominant
chr20	MKKS	604896.0 | MKKS, HMCS, KMS, MKS, BBS6 | McKusick-Kaufman syndrome gene | 8195.0 | ENSG00000125863 | nan | McKusick-Kaufman syndrome, 236700 (3), Autosomal recessive; Bardet-Biedl syndrome 6, 605231 (3), Autosomal recessive
chr20	SLX4IP	615958.0 | SLX4IP, C20orf94 | SLX4-interacting protein | 128710.0 | ENSG00000149346 | nan | nan
chr20	JAG1	601920.0 | JAG1, AGS1, AHD, DCHE, CMT2HH | Jagged 1 | 182.0 | ENSG00000101384 | mutation identified in 1 DCHE family | ?Deafness, congenital heart defects, and posterior embryotoxon, 617992 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2HH, 619574 (3), Autosomal dominant; Alagille syndrome 1, 118450 (3), Autosomal dominant; Tetralogy of Fallot, 187500 (3), Autosomal dominant
chr20	BTBD3	615566.0 | BTBD3, KIAA0952 | BTB/POZ domain-containing protein 3 | 22903.0 | ENSG00000132640 | nan | nan
chr20	SPTLC3	611120.0 | SPTLC3, SPTLC2L | Serine palmitoyltransferase, long-chain base subunit 3 | 55304.0 | ENSG00000172296 | nan | nan
chr20	TASP1	608270.0 | TASP1, C20orf13, SULEHS | Threonine aspartase 1 | 55617.0 | ENSG00000089123 | nan | Suleiman-El-Hattab syndrome, 618950 (3), Autosomal recessive
chr20	ISM1	615793.0 | ISM1, ISM | Isthmin 1, angiogenesis inhibitor | 140862.0 | ENSG00000101230 | nan | nan
chr20	ESF1	618765.0 | ESF1, ABTAP | ESF1 nucleolar pre-rRNA-processing protein | 51575.0 | ENSG00000089048 | nan | nan
chr20	NDUFAF5	612360.0 | NDUFAF5, C20orf7, MC1DN16 | NADH-ubiquinone oxidoreductase complex assembly factor 5 | 79133.0 | ENSG00000101247 | nan | Mitochondrial complex I deficiency, nuclear type 16, 618238 (3), Autosomal recessive
chr20	SEL1L2	614289.0 | SEL1L2 | SEL1L2 adaptor subunit of ERAD E3 ligase | 80343.0 | ENSG00000101251 | nan | nan
chr20	MACROD2	611567.0 | MACROD2, C2orf133 | Macro domain-containing 2 | 140733.0 | ENSG00000172264 | nan | nan
chr20	FLRT3	604808.0 | FLRT3, HH21 | Fibronectin-like domain-containing leucine-rich transmembrane protein-3 | 23767.0 | ENSG00000125848 | nan | Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3), Autosomal dominant
chr20	KIF16B	618171.0 | KIF16B | Kinesin family member 16B | 55614.0 | ENSG00000089177 | nan | nan
chr20	SNRPB2	603520.0 | SNRPB2 | Small nuclear ribonucleoprotein polypeptide B-double prime | 6629.0 | ENSG00000125870 | nan | nan
chr20	OTOR	606067.0 | OTOR | Otoraplin | 56914.0 | ENSG00000125879 | nan | nan
chr20	PCSK2	162151.0 | PCSK2, NEC2, PC2 | Proprotein convertase subtilisin/kexin type 2 | 5126.0 | ENSG00000125851 | nan | nan
chr20	BFSP1	603307.0 | BFSP1, CP115, CTRCT33 | Beaded filament structural protein-1 (filensin) | 631.0 | ENSG00000125864 | nan | Cataract 33, multiple types, 611391 (3), Autosomal recessive, Autosomal dominant
chr20	DSTN	609114.0 | DSTN, ADF | Destrin | 11034.0 | ENSG00000125868 | nan | nan
chr20	RRBP1	601418.0 | RRBP1, ES130 | Ribosome binding protein-1 | 6238.0 | ENSG00000125844 | nan | nan
chr20	DYT17	612406.0 | DYT17 | Dystonia-17, primary torsion | 100216344.0 | nan | between D20S472 and D20S911 | Dystonia-17, primary torsion, 612406 (2), Autosomal recessive
chr20	SNX5	605937.0 | SNX5 | Sorting nexin 5 | 27131.0 | ENSG00000089006 | nan | nan
chr20	MGME1	615076.0 | MGME1, C20orf72, MTDPS11 | Mitochondrial genome maintenance exonuclease 1 | 92667.0 | ENSG00000125871 | nan | Mitochondrial DNA depletion syndrome 11, 615084 (3), Autosomal recessive
chr20	OVOL2	616441.0 | OVOL2, ZNF339, PPCD1 | ovo-like 2 | 58495.0 | ENSG00000125850 | nan | Corneal dystrophy, posterior polymorphous, 1, 122000 (3), Autosomal dominant
chr20	KAT14	617501.0 | KAT14, CRP2BP, CSRP2BP, ATAC2 | Lysine acetyltransferase 14 | 57325.0 | ENSG00000149474 | nan | nan
chr20	PET117	614771.0 | PET117, MC4DN19 | PET117 cytochrome c oxidase chaperone | 100303755.0 | ENSG00000232838 | mutation identified in 1 MC4DN19 family | ?Mitochondrial complex IV deficiency, nuclear type 19, 619063 (3), Autosomal recessive
chr20	ZNF133	604075.0 | ZNF133 | Zinc finger protein-133 | 7692.0 | ENSG00000125846 | nan | nan
chr20	DZANK1	620905.0 | DZANK1 | Double zinc ribbon and ankyrin repeat domains 1 | 55184.0 | ENSG00000089091 | nan | nan
chr20	POLR3F	617455.0 | POLR3F, RPC39, RPC6, IMD101 | Polymerase III, RNA, subunit F | 10621.0 | ENSG00000132664 | mutation identified in 1 IMD101 family | ?Immunodeficiency 101 (varicella zoster virus-specific), 619872 (3), Autosomal dominant
chr20	RBBP9	602908.0 | RBBP9, BOG | Retinoma-binding protein 9 | 10741.0 | ENSG00000089050 | nan | nan
chr20	SEC23B	610512.0 | SEC23B, CDAN2, HEMPAS, CWS7 | SEC23 homolog B, coat complex II component | 10483.0 | ENSG00000101310 | mutation identified in 1 CWS7 family | ?Cowden syndrome 7, 616858 (3), Autosomal dominant; Dyserythropoietic anemia, congenital, type II, 224100 (3), Autosomal recessive
chr20	DTD1	610996.0 | DTD1, C20orf88 | D-aminoacyl-tRNA deacylase 1 | 92675.0 | ENSG00000125821 | nan | nan
chr20	SLC24A3	609839.0 | SLC24A3, NCKX3 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 | 57419.0 | ENSG00000185052 | nan | nan
chr20	RIN2	610222.0 | RIN2, MACS | RAS and RAB interactor 2 | 54453.0 | ENSG00000132669 | nan | Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3), Autosomal recessive
chr20	NAA20	610833.0 | NAA20, NAT5, NAT3, MRT73 | N-alpha-acetyltransferase 20, NatB catalytic subunit | 51126.0 | ENSG00000173418 | nan | Intellectual developmental disorder, autosomal recessive 73, 619717 (3), Autosomal recessive
chr20	CRNKL1	610952.0 | CRNKL1, CRN | Crooked neck pre-mRNA splicing factor-like 1 | 51340.0 | ENSG00000101343 | nan | nan
chr20	CFAP61	620381.0 | CFAP61, SPGF84 | Cilia- and flagella-associated protein 61 | 26074.0 | ENSG00000089101 | nan | Spermatogenic failure 84, 620409 (3), Autosomal recessive
chr20	INSM1	600010.0 | INSM1, IA1 | Insulinoma-associated 1 | 3642.0 | ENSG00000173404 | nan | nan
chr20	RALGAPA2	618836.0 | RALGAPA2, AS250, C20orf74 | Ral GTPase-activating protein, catalytic subunit alpha-2 | 57186.0 | ENSG00000188559 | nan | nan
chr20	LINC00237	614992.0 | LINC00237 | Long intergenic noncoding RNA 237 | 105372556.0 | ENSG00000225127 | nan | nan
chr20	KIZ	615757.0 | KIZ, KIZUNA, C20orf19, RP69 | Kizuna centrosomal protein | 55857.0 | ENSG00000088970 | nan | Retinitis pigmentosa 69, 615780 (3), Autosomal recessive
chr20	AGA3	612421.0 | AGA3 | Alopecia, androgenetic, 3 | 100217387.0 | nan | associated with rs1160312 | Alopecia, androgenetic, 3, 612421 (2)
chr20	XRN2	608851.0 | XRN2 | Exoribonuclease 2 | 22803.0 | ENSG00000088930 | nan | nan
chr20	NKX2-4	607808.0 | NKX2-4, NKX2D | NK2 homeobox 4 | 644524.0 | ENSG00000125816 | nan | nan
chr20	NKX2-2	604612.0 | NKX2-2, NKX2B | NK2, homeobox 2 | 4821.0 | ENSG00000125820 | nan | nan
chr20	PAX1	167411.0 | PAX1, OTFCS2 | Paired box homeotic gene-1 | 5075.0 | ENSG00000125813 | nan | Otofaciocervical syndrome 2 with T-cell deficiency, 615560 (3), Autosomal recessive
chr20	LINC00261	618518.0 | LINC00261, FALCOR, HCCDR1, DEANR1 | Long intergenic noncoding RNA 261 | 140828.0 | ENSG00000259974 | nan | nan
chr20	FOXA2	600288.0 | FOXA2, HNF3B | Forkhead box A2 (hepatic nuclear factor-3, beta) | 3170.0 | ENSG00000125798 | nan | nan
chr20	SSTR4	182454.0 | SSTR4 | Somatostatin receptor-4 | 6754.0 | ENSG00000132671 | nan | nan
chr20	THBD	188040.0 | THBD, THRM, AHUS6, THPH12 | Thrombomodulin | 7056.0 | ENSG00000178726 | nan | Thrombophilia 12 due to thrombomodulin defect, 614486 (3), Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3), Autosomal dominant
chr20	CD93	120577.0 | C1QR1, CD93, C1QR | Complement component 1, q subcomponent, receptor 1 | 22918.0 | ENSG00000125810 | nan | nan
chr20	NXT1	605811.0 | NXT1, MTR2 | NTF2-related export protein 1 | 29107.0 | ENSG00000132661 | nan | nan
chr20	GZF1	613842.0 | GZF1, ZNF336, JLSM | GDNF-inducible zinc finger protein 1 | 64412.0 | ENSG00000125812 | nan | Joint laxity, short stature, and myopia, 617662 (3), Autosomal recessive
chr20	NAPB	611270.0 | NAPB, SNAPB, DEE107 | NSF attachment protein, beta | 63908.0 | ENSG00000125814 | nan | Developmental and epileptic encephalopathy 107, 620033 (3), Autosomal recessive
chr20	CST11	609731.0 | CST11, CST8L | Cystatin 11 | 140880.0 | ENSG00000125831 | nan | nan
chr20	CST8	608683.0 | CST8, CRES | Cystatin 8 | 10047.0 | ENSG00000125815 | nan | nan
chr20	CST9L	616536.0 | CST9L | Cystatin 9-like | 128821.0 | ENSG00000101435 | nan | nan
chr20	CST9	616543.0 | CST9, CLM | Cystatin 9 | 128822.0 | ENSG00000173335 | nan | nan
chr20	CST3	604312.0 | CST3, ARMD11 | Cystatin C | 1471.0 | ENSG00000101439 | proximal to 20p11.2 | {Macular degeneration, age-related, 11}, 611953 (3); Cerebral amyloid angiopathy, 105150 (3), Autosomal dominant
chr20	CST4	123857.0 | CST4 | Cystatin S | 1472.0 | ENSG00000101441 | nan | nan
chr20	CST1	123855.0 | CST1 | Cystatin SN | 1469.0 | ENSG00000170373 | nan | nan
chr20	CST2	123856.0 | CST2 | Cystatin SA | 1470.0 | ENSG00000170369 | nan | nan
chr20	CST5	123858.0 | CST5 | Cystatin D | 1473.0 | ENSG00000170367 | nan | nan
chr20	GGTLC1	612338.0 | GGTLC1, GGTL6, GGTLA4 | Gamma-glutamyltransferase, light chain 1 | 92086.0 | ENSG00000149435 | nan | nan
chr20	WAKMAR1	618507.0 | WAKMAR1 | Wound- and keratinocyte migration-associated long noncoding RNA 1 | 105372576.0 | nan | nan | nan
chr20	SYNDIG1	614311.0 | SYNDIG1, TMEM90B | Synapse differentiation-induced gene 1 | 79953.0 | ENSG00000101463 | nan | nan
chr20	CST7	603253.0 | CST7, CMAP | Cystatin 7 | 8530.0 | ENSG00000077984 | nan | nan
chr20	APMAP	615884.0 | APMAP, C20orf3, BSCV | Adipocyte plasma membrane-associated protein | 57136.0 | ENSG00000101474 | nan | nan
chr20	ACSS1	614355.0 | ACSS1, ACECS1 | Acyl-CoA synthetase short-chain family, member 1 | 84532.0 | ENSG00000154930 | nan | nan
chr20	VSX1	605020.0 | VSX1, RINX, KTCN1, CAASDS | Visual system homeobox 1 | 30813.0 | ENSG00000100987 | mutation identified in 1 CAASDS family | ?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3), Autosomal dominant; Keratoconus 1, 148300 (3), Autosomal dominant
chr20	ENTPD6	603160.0 | ENTPD6, CD39L2 | Ectonucleoside triphosphate diphosphohydrolase 6 | 955.0 | ENSG00000197586 | nan | nan
chr20	PYGB	138550.0 | PYGB | Phosphorylase, glycogen, brain | 5834.0 | ENSG00000100994 | nan | nan
chr20	ABHD12	613599.0 | ABHD12, PHARC | Abhydrolase domain-containing protein 12, lysophospholipase | 26090.0 | ENSG00000100997 | nan | Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3), Autosomal recessive
chr20	GINS1	610608.0 | GINS1, PSF1, KIAA0186, IMD55 | GINS complex subunit 1 | 9837.0 | ENSG00000101003 | nan | Immunodeficiency 55, 617827 (3), Autosomal recessive
chr20	NINL	609580.0 | NINL, KIAA0980 | Ninein-like protein | 22981.0 | ENSG00000101004 | nan | nan
chr20	NANP	610763.0 | NANP, HDHD4 | N-acetylneuraminic acid phosphatase | 140838.0 | ENSG00000170191 | nan | nan
chr20	HYT5	610261.0 | HYT5 | Hypertension, essential, susceptibility to, 5 | 100188807.0 | nan | nan | {Hypertension, essential, susceptibility to, 5}, 145500 (2), Multifactorial
chr20		617352.0 | MBCS | Mulchandani-Bhoj-Conlin syndrome | nan | nan | maternal uniparental disomy of imprinted region | Mulchandani-Bhoj-Conlin syndrome, 617352 (3), Autosomal dominant
chr20		620195.0 | OBHP | Obesity and hypopigmentation | nan | nan | rearrangement disrupts normal expression of ASIP | Obesity and hypopigmentation, 620195 (4), Autosomal dominant
chr20	CLA3	608029.0 | SCAR6, CLA3 | Spinocerebellar ataxia, autosomal recessive 6 | 1167.0 | nan | between D20S471 and D20S119 | Spinocerebellar ataxia, autosomal recessive 6, 608029 (2), Autosomal recessive
chr20	CMM7	612263.0 | CMM7 | Melanoma, cutaneous malignant, susceptibility to, 7 | 100190932.0 | nan | between rs910873 and rs1885120 | {Melanoma, cutaneous malignant, 7}, 612263 (2)
chr20	MLRL	601308.0 | MLRL, MTS | Myeloid leukemia-related locus (myeloid tumor suppressor) | 8201.0 | nan | nan | nan
chr20	DEFB118	607650.0 | DEFB118, C20orf63, ESC42 | Defensin, beta, 118 | 117285.0 | ENSG00000131068 | nan | nan
chr20	DEFB119	615997.0 | DEFB119, DEFB120, DEFB20 | Defensin, beta, 119 | 245932.0 | ENSG00000180483 | nan | nan
chr20	DEFB121	616075.0 | DEFB121, DEFB21 | Defensin, beta, 121 | 245934.0 | ENSG00000204548 | nan | nan
chr20	DEFB122	616077.0 | DEFB122, DEFB22 | Defensin, beta, 122, pseudogene | 245935.0 | ENSG00000290996 | nan | nan
chr20	DEFB123	616076.0 | DEFB123, DEFB23 | Defensin, beta, 123 | 245936.0 | ENSG00000180424 | nan | nan
chr20	REM1	610388.0 | REM1, GES | RRAD- and GEM-like GTPase 1 | 28954.0 | ENSG00000088320 | nan | nan
chr20	HM13	607106.0 | HM13, SPP | Minor histocompatibility 13 (signal peptide peptidase) | 81502.0 | ENSG00000101294 | nan | nan
chr20	MCTS2	620406.0 | MCTS2 | MCTS family, member 2 | 100101490.0 | ENSG00000101898 | nan | nan
chr20	ID1	600349.0 | ID1 | Inhibitor of DNA binding 1, dominant negative | 3397.0 | ENSG00000125968 | nan | nan
chr20	COX4I2	607976.0 | COX4I2 | Cytochrome c oxidase, subunit IV, isoform 2 | 84701.0 | ENSG00000131055 | nan | Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3), Autosomal recessive
chr20	BCL2L1	600039.0 | BCL2L1, BCLX, BCLXL, BCLXS | BCL2-like 1 | 598.0 | ENSG00000171552 | nan | nan
chr20	TPX2	605917.0 | C20orf1, P100 | Proliferation-associated nuclear protein, 100kD | 22974.0 | ENSG00000088325 | nan | nan
chr20	MYLK2	606566.0 | MYLK2, MLCK | Myosin light chain kinase 2 | 85366.0 | ENSG00000101306 | nan | Cardiomyopathy, hypertrophic, 1, digenic, 192600 (3), Digenic dominant, Autosomal dominant
chr20	FOXS1	602939.0 | FOXS1, FKHL18, FREAC10 | Forkhead box S1 | 2307.0 | ENSG00000179772 | nan | nan
chr20	DUSP15	616776.0 | DUSP15, VHY | Dual-specificity phosphatase 15 | 128853.0 | ENSG00000149599 | nan | nan
chr20	TTLL9	619838.0 | TTLL9, C20orf125 | Tubulin tyrosine ligase-like 9 | 164395.0 | ENSG00000131044 | nan | nan
chr20	PDRG1	610789.0 | PDRG1, PDRG, C20orf126 | P53 and DNA damage-regulated 1 | 81572.0 | ENSG00000088356 | nan | nan
chr20	HCK	142370.0 | HCK, AIPCV | HCK protooncogene, Src family tyrosine kinase | 3055.0 | ENSG00000101336 | nan | Autoinflammation with pulmonary and cutaneous vasculitis, 620296 (3), Autosomal dominant
chr20	TM9SF4	617727.0 | TM9SF4, KIAA0255 | Transmembrane 9 superfamily, member 4 | 9777.0 | ENSG00000101337 | nan | nan
chr20	PLAGL2	604866.0 | PLAGL2 | PLAG1-like zinc finger 2 | 5326.0 | ENSG00000126003 | nan | nan
chr20	POFUT1	607491.0 | POFUT1, OFUCT1, KIAA0180, DDD2 | Protein O-fucosyltransferase 1 | 23509.0 | ENSG00000101346 | nan | Dowling-Degos disease 2, 615327 (3), Autosomal dominant
chr20	KIF3B	603754.0 | KIF3B, KIAA0359, RP89 | Kinesin family member 3B | 9371.0 | ENSG00000101350 | nan | Retinitis pigmentosa 89, 618955 (3), Autosomal dominant
chr20	ASXL1	612990.0 | ASXL1, KIAA0978, BOPS, MDS | ASXL transcriptional regulator 1 | 171023.0 | ENSG00000171456 | nan | Myelodysplastic syndrome, somatic, 614286 (3); Bohring-Opitz syndrome, 605039 (3), Autosomal dominant
chr20	NOL4L	618893.0 | NOL4L, C20orf112 | Nucleolar protein 4-like | 140688.0 | ENSG00000197183 | nan | nan
chr20	COMMD7	616703.0 | COMMD7 | COMM domain-containing protein 7 | 149951.0 | ENSG00000149600 | nan | nan
chr20	DNMT3B	602900.0 | DNMT3B, ICF1, FSHD4 | DNA methyltransferase 3B | 1789.0 | ENSG00000088305 | nan | Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3), Autosomal recessive; Facioscapulohumeral muscular dystrophy 4, digenic, 619478 (3), Digenic dominant
chr20	MAPRE1	603108.0 | MAPRE1, EB1 | Microtubule-associated protein, RP/EB family, member 1 | 22919.0 | ENSG00000101367 | nan | nan
chr20	SUN5	613942.0 | SUN5, TSARG4, SPAG4L, SPGF16 | Sad1 and Unc84 domain-containing protein 5 | 140732.0 | ENSG00000167098 | nan | Spermatogenic failure 16, 617187 (3), Autosomal recessive
chr20	BPIFB2	614108.0 | BPIFB2, BPIL1 | BPI fold-containing protein, family B, member 2 | 80341.0 | ENSG00000078898 | nan | nan
chr20	BPIFB6	614110.0 | BPIFB6, BPIL3 | BPI fold-containing protein, family B, member 6 | 128859.0 | ENSG00000167104 | nan | nan
chr20	BPIFB3	615717.0 | BPIFBP3, RYA3 | BPI fold-containing protein, family B, member 3 | 359710.0 | ENSG00000186190 | nan | nan
chr20	BPIFB4	615718.0 | BPIFB4, RY2G5 | BPI fold-containing protein, family B, member 4 | 149954.0 | ENSG00000186191 | nan | nan
chr20	BPIFA4P	607627.0 | BPIFA4P, BASE | BPI fold-containing protein, family A, member 4, pseudogene | 317716.0 | ENSG00000290942 | nan | nan
chr20	BPIFA1	607412.0 | BPIFA1, PLUNC, SPLUNC1 | BPI fold-containing protein, family A, member 1 | 51297.0 | ENSG00000198183 | nan | nan
chr20	CDK5RAP1	608200.0 | CDK5RAP1 | CDK5 regulatory subunit-associated protein 1 | 51654.0 | ENSG00000101391 | nan | nan
chr20	SNTA1	601017.0 | SNTA1, SNT1, TACIP1, LQT12 | Syntrophin, alpha-1 | 6640.0 | ENSG00000101400 | nan | Long QT syndrome 12, 612955 (3), Autosomal dominant
chr20	CBFA2T2	603672.0 | CBFA2T2, MTGR1, EHT | Core-binding factor, runt domain, alpha subunit 2, translocated to, 2 (ETO homolog on chromosome 20) | 9139.0 | ENSG00000078699 | nan | nan
chr20	STQTL14	612228.0 | STQTL14 | Stature quantitative trait locus 14 | 100270797.0 | nan | associated with rs6060373 | {Stature QTL 14}, 612228 (2)
chr20	NECAB3	612478.0 | NECAB3, EFCBP3, NIP1, APBA2BP, XB51, STIP3 | N-terminal EF-hand calcium-binding protein 3 | 63941.0 | ENSG00000125967 | nan | nan
chr20	E2F1	189971.0 | E2F1 | E2F transcription factor-1 | 1869.0 | ENSG00000101412 | nan | nan
chr20	PXMP4	616397.0 | PXMP4, PMP24 | Peroxisomal membrane protein 4 | 11264.0 | ENSG00000101417 | nan | nan
chr20	ZNF341	618269.0 | ZNF341, HIES3 | Zinc finger protein 341 | 84905.0 | ENSG00000131061 | nan | Hyper-IgE syndrome 3, autosomal recessive, with recurrent infections, 618282 (3), Autosomal recessive
chr20	CHMP4B	610897.0 | CHMP4B, SNF7, CTPP3, CTRCT31 | Charged multivesicular body protein 4B | 128866.0 | ENSG00000101421 | nan | Cataract 31, multiple types, 605387 (3), Autosomal dominant
chr20	RALY	614663.0 | RALY | RALY heterogeneous nuclear ribonuclear protein | 22913.0 | ENSG00000125970 | nan | nan
chr20	EIF2S2	603908.0 | EIF2S2 | Eukaryotic translation initiation factor 2, subunit 2 | 8894.0 | ENSG00000125977 | nan | nan
chr20	ASIP	600201.0 | ASIP, AGTIL, SHEP9 | Agouti, mouse, signaling protein | 434.0 | ENSG00000101440 | nan | [Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3); [Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3)
chr20	AHCY	180960.0 | AHCY, SAHH | S-adenosylhomocysteine hydrolase | 191.0 | ENSG00000101444 | nan | Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3), Autosomal recessive
chr20	ITCH	606409.0 | ITCH, AIP4, NAPP1, ADMFD | Itchy, mouse, homolog of | 83737.0 | ENSG00000078747 | nan | Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3), Autosomal recessive
chr20	DYNLRB1	607167.0 | DYNLRB1, DNCL2A, DNLC2A | Dynein, light chain, roadblock type, 1 | 83658.0 | ENSG00000125971 | nan | nan
chr20	MAP1LC3A	601242.0 | MAP1ALC3, MAP1BLC3 | Microtubule-associated proteins 1A and 1B, light chain 3 | 84557.0 | ENSG00000101460 | nan | nan
chr20	PIGU	608528.0 | PIGU, CDC91L1, GPIBD21, NEDBSS | Phosphatidylinositol glycan anchor biosynthesis class U protein | 128869.0 | ENSG00000101464 | nan | Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis, 618590 (3), Autosomal recessive
chr20	TP53INP2	617549.0 | TP53INP2, PIGU, DOR, C20orf110 | Tumor protein p53-inducible nuclear protein 2 | 58476.0 | ENSG00000078804 | nan | nan
chr20	NCOA6	605299.0 | NCOA6, ASC2, RAP250, NRC, PRIP | Nuclear receptor coactivator 6 | 23054.0 | ENSG00000198646 | nan | nan
chr20	GGT7	612342.0 | GGT7, GGTL3, GGTL5, GGT4 | Gamma-glutamyltransferase 7 | 2686.0 | ENSG00000131067 | nan | nan
chr20	ACSS2	605832.0 | ACSS2, ACS | Acetyl-CoA synthetase short-chain family member 2 | 55902.0 | ENSG00000131069 | nan | nan
chr20	GSS	601002.0 | GSS, GSHS, CNSHA6 | Glutathione synthetase | 2937.0 | ENSG00000100983 | nan | Anemia, congenital, nonspherocytic hemolytic, 6, glutatione synthetase deficient, 266130 (3), Autosomal recessive; Glutathione synthetase deficiency, 266130 (3), Autosomal recessive
chr20	MYH7B	609928.0 | MYH7B, MYH14, KIAA1512 | Myosin, heavy chain 7B, cardiac muscle, beta | 57644.0 | ENSG00000078814 | nan | nan
chr20	MIR499A	613614.0 | MIR499, MIRN499 | Micro RNA 499 | 574501.0 | ENSG00000207635 | nan | nan
chr20	TRPC4AP	608430.0 | TRPC4AP, TRUSS | TRPC4-associated protein | 26133.0 | ENSG00000100991 | nan | nan
chr20	EDEM2	610302.0 | EDEM2 | Endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 2 | 55741.0 | ENSG00000088298 | nan | nan
chr20	PROCR	600646.0 | PROCR, EPCR, CCCA, CCD41 | Protein C receptor | 10544.0 | ENSG00000101000 | nan | nan
chr20	MMP24	604871.0 | MMP25 | Matrix metalloproteinase 24 | 10893.0 | ENSG00000125966 | nan | nan
chr20	EIF6	602912.0 | EIF6, EIF3A, ITGB4BP | Eukaryotic translation initiation factor 6 | 3692.0 | ENSG00000242372 | nan | nan
chr20	UQCC1	611797.0 | UQCC, CBP3, BFZB, C20orf44 | Ubiquinol-cytochrome C reductase complex chaperone | 55245.0 | ENSG00000101019 | nan | nan
chr20	GDF5	601146.0 | GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS | Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1) | 8200.0 | ENSG00000125965 | mutation identified in 1 AMD2C family | Acromesomelic dysplasia 2A, 200700 (3), Autosomal recessive; Acromesomelic dysplasia 2B, 228900 (3), Autosomal recessive; Multiple synostoses syndrome 2, 610017 (3), Autosomal dominant; Symphalangism, proximal, 1B, 615298 (3), Autosomal dominant; Brachydactyly, type A2, 112600 (3), Autosomal dominant; ?Acromesomelic dysplasia 2C, Hunter-Thompson type, 201250 (3), Autosomal recessive; Brachydactyly, type C, 113100 (3), Autosomal dominant; {Osteoarthritis-5}, 612400 (3); Brachydactyly, type A1, C, 615072 (3), Autosomal recessive, Autosomal dominant
chr20	CEP250	609689.0 | CEP250, CEP2, CNAP1, CRDHL2 | Centrosomal protein, 250kD | 11190.0 | ENSG00000126001 | nan | Cone-rod dystrophy and hearing loss 2, 618358 (3), Autosomal recessive
chr20	ERGIC3	616971.0 | ERGIC3, C2orf47 | Endoplasmic reticulum-golgi intermediate compartment protein 3 | 51614.0 | ENSG00000125991 | nan | nan
chr20	SPAG4	603038.0 | SPAG4 | Sperm-associated antigen-4 | 6676.0 | ENSG00000061656 | nan | nan
chr20	CPNE1	604205.0 | CPNE1, CPN1 | Copine I | 8904.0 | ENSG00000214078 | nan | nan
chr20	RBM12	607179.0 | RBM12, KIAA0765, SCZD19 | RNA-binding motif protein 12 | 10137.0 | ENSG00000244462 | nan | {Schizophrenia 19, susceptibility to}, 617629 (3), Autosomal dominant
chr20	NFS1	603485.0 | NFS1, NIFS, COXPD52 | NFS1 cysteine desulfurase 1 | 9054.0 | ENSG00000244005 | nan | Combined oxidative phosphorylation deficiency 52, 619386 (3), Autosomal recessive
chr20	ROMO1	618894.0 | ROMO1, GLYRICHIN | Reactive oxygen species modulator 1 | 140823.0 | ENSG00000125995 | nan | nan
chr20	RBM39	604739.0 | RBM39, CAPER, RNPC2 | RNA binding motif protein 39 | 9584.0 | ENSG00000131051 | nan | nan
chr20	PHF20	610335.0 | PHF20, GLEA2, HCA58 | PHD finger protein 20 | 51230.0 | ENSG00000025293 | nan | nan
chr20	SCAND1	610416.0 | SCAND1, RAZ1, SDP1 | SCAN domain-containing 1 | 51282.0 | ENSG00000171222 | nan | nan
chr20	NORAD	617037.0 | NORAD, LINC00657 | Noncoding RNA activated by DNA damage | 647979.0 | ENSG00000260032 | nan | nan
chr20	EPB41L1	602879.0 | EPB41L1, MRD11 | Erythrocyte membrane protein band 4.1-like 1 | 2036.0 | ENSG00000088367 | mutation identified in 1 MRD11 patient | ?Intellectual developmental disorder, autosomal dominant 11, 614257 (3), Autosomal dominant
chr20	AAR2	617365.0 | AAR2, C20orf4 | AAR2 splicing factor | 25980.0 | ENSG00000131043 | nan | nan
chr20	DLGAP4	616191.0 | DLGAP4, SAPAP4, KIAA0964 | Discs LARGE-associated protein 4 | 22839.0 | ENSG00000080845 | noncoding RNAs transcribed from intron 1 are expressed in all tissues | nan
chr20	MYL9	609905.0 | MYL9, MLC2, MMIHS4 | Myosin light chain 9, regulatory | 10398.0 | ENSG00000101335 | mutation identified in 1 MMIHS4 patient | ?Megacystis-microcolon-intestinal hypoperistalsis syndrome 4, 619365 (3), Autosomal recessive
chr20	TGIF2	607294.0 | TGIF2 | Transforming growth factor-beta-induced factor 2 | 60436.0 | ENSG00000118707 | nan | nan
chr20	RAB5IF	619960.0 | RAB5IF, C20orf24, CFSMR2 | RAB5-interacting factor | 55969.0 | ENSG00000101084 | mutation identified in 1 CFSMR2 patient | ?Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 2, 616994 (3), Autosomal recessive
chr20	SLA2	606577.0 | SLA2, SLAP2 | SRC-like adaptor 2 | 84174.0 | ENSG00000101082 | nan | nan
chr20	NDRG3	605273.0 | NDRG3 | N-myc downstream-regulated gene 3 | 57446.0 | ENSG00000101079 | nan | nan
chr20	DSN1	609175.0 | DSN1, C20orf172 | DSN1 homolog, MIS12 kinetochore complex component | 79980.0 | ENSG00000149636 | nan | nan
chr20	MTCL2	620225.0 | SOGA1 | Suppressor glucose, autophagy-associated protein 1 | 140710.0 | ENSG00000149639 | nan | nan
chr20	SAMHD1	606754.0 | SAMHD1, AGS5, DCIP, CHBL2 | SAM domain- and HD domain-containing protein 1 | 25939.0 | ENSG00000101347 | mutation identified in 1 CHBL2 family | ?Chilblain lupus 2, 614415 (3), Autosomal dominant; Aicardi-Goutieres syndrome 5, 612952 (3), Autosomal recessive
chr20	RBL1	116957.0 | RBL1, CP107 | RB transcriptional corepressor-like 1 | 5933.0 | ENSG00000080839 | nan | nan
chr20	RPN2	180490.0 | RPN2 | Ribophorin II | 6185.0 | ENSG00000118705 | nan | nan
chr20	GHRH	139190.0 | GHRH, GHRF | Growth hormone releasing hormone (somatocrinin) | 2691.0 | ENSG00000118702 | nan | Gigantism due to GHRF hypersecretion (1); ?Isolated growth hormone deficiency due to defect in GHRF (1)
chr20	SRC	190090.0 | SRC, ASV, SRC1, THC6 | Protooncogene SRC, Rous sarcoma | 6714.0 | ENSG00000197122 | mutation identified in 1 THC6 family | ?Thrombocytopenia 6, 616937 (3), Autosomal dominant; Colon cancer, advanced, somatic, 114500 (3)
chr20	BLCAP	613110.0 | BLCAP, BC10 | Bladder cancer-associated protein | 10904.0 | ENSG00000166619 | nan | nan
chr20	NNAT	603106.0 | NNAT | Neuronatin | 4826.0 | ENSG00000053438 | nan | nan
chr20	CTNNBL1	611537.0 | CTNNBL1, NAP, IMD99 | Catenin, beta-like, 1 | 56259.0 | ENSG00000132792 | mutation identified in 1 IMD99 patient | ?Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias, 619846 (3), Autosomal recessive
chr20	VSTM2L	616537.0 | VSTM2L, C20orf102 | V-SET and transmembrane domains-containing protein 2-like | 128434.0 | ENSG00000132821 | nan | nan
chr20	TTI1	614425.0 | TTI1, KIAA0406, NEDMIM | TELO2-interacting protein 1 | 9675.0 | ENSG00000101407 | nan | Neurodevelopmental disorder with microcephaly and movement abnormalities, 620445 (3), Autosomal recessive
chr20	RPRD1B	614694.0 | RPRD1B, CREPT | Regulation of nuclear pre-mRNA domain-containing protein 1B | 58490.0 | ENSG00000101413 | nan | nan
chr20	TGM2	190196.0 | TGM2 | Transglutaminase-2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 7052.0 | ENSG00000198959 | nan | nan
chr20	BPI	109195.0 | BPI | Bactericidal/permeability-increasing protein | 671.0 | ENSG00000101425 | nan | nan
chr20	LBP	151990.0 | LBP | Lipopolysaccharide-binding protein | 3929.0 | ENSG00000129988 | nan | nan
chr20	SNHG17	620808.0 | SNHG17 | Small nucleolar RNA host gene 17 | 388796.0 | ENSG00000196756 | nan | nan
chr20	SNHG11	619494.0 | SNHG11, LINC00101 | Small nucleolar RNA host gene 11, noncoding | 128439.0 | ENSG00000174365 | nan | nan
chr20	RALGAPB	618833.0 | RALGAPB | Ral GTPase-activating protein, noncatalytic subunit beta | 57148.0 | ENSG00000170471 | nan | nan
chr20	ADIG	611396.0 | ADIG, SMAF1 | Adipogenin | 149685.0 | ENSG00000182035 | nan | nan
chr20	SLC32A1	616440.0 | SLC32A1, VGAT, VIAAT, GEFSP12, DEE114 | Solute carrier family 32 (GABA vesicular transporter), member 1 | 140679.0 | ENSG00000101438 | nan | Generalized epilepsy with febrile seizures plus, type 12, 620755 (3), Autosomal dominant; Developmental and epileptic encephalopathy 114, 620774 (3), Autosomal dominant
chr20	ACTR5	619730.0 | ACTR5, ARP5 | Actin-related protein 5 | 79913.0 | ENSG00000101442 | nan | nan
chr20	PPP1R16B	613275.0 | PPP1R16B, TIMAP, KIAA0823 | Protein phosphatase 1, regulatory subunit 16B | 26051.0 | ENSG00000101445 | nan | nan
chr20	FAM83D	618380.0 | FAM83D, CHICA | Family with sequence similarity 83, member D | 81610.0 | ENSG00000101447 | nan | nan
chr20	PSMNSW	613938.0 | PSMNSW | Parasomnia, sleepwalking type | 100653383.0 | nan | between 55.6 and 61.4 cM | Parasomnia, sleepwalking type, 613938 (2), Multifactorial, Autosomal dominant
chr20	NIDDM3	603694.0 | T2D3 | Type 2 diabetes mellitus 3 | 50982.0 | nan | nan | {Type 2 diabetes mellitus 3}, 603694 (2)
chr20	LINC01370	617038.0 | LINC01370, HILNC25 | Long intergenic noncoding RNA 1370 | 100505663.0 | ENSG00000237767 | nan | nan
chr20	MAFB	608968.0 | MAFB, KRML, MCTO, DURS3 | MAF bZIP transcription factor B | 9935.0 | ENSG00000204103 | nan | Duane retraction syndrome 3, 617041 (3), Autosomal dominant; Multicentric carpotarsal osteolysis syndrome, 166300 (3), Autosomal dominant
chr20	TOP1	126420.0 | TOP1 | Topoisomerase (DNA) I | 7150.0 | ENSG00000198900 | pseudogenes on chr.1 and 22 | DNA topoisomerase I, camptothecin-resistant (3)
chr20	PLCG1	172420.0 | PLCG1, PLC1, IDAA | Phospholipase C, gamma 1 (formerly subtype 148) | 5335.0 | ENSG00000124181 | mutation identified in 1 IDAA patient | ?Immune dysregulation, autoimmunity, and autoinflammation, 620514 (3), Autosomal dominant
chr20	ZHX3	609598.0 | ZHX3, KIAA0395 | Zinc finger and homeodomain protein-3 | 23051.0 | ENSG00000174306 | nan | nan
chr20	LPIN3	605520.0 | LPIN3 | Lipin 3 | 64900.0 | ENSG00000132793 | nan | nan
chr20	EMILIN3	608929.0 | EMILIN3 | Elastin microfibril interfacer 3 | 90187.0 | ENSG00000183798 | nan | nan
chr20	CHD6	616114.0 | CHD6, CHD5, RIGB | Chromodomain helicase DNA-binding protein 6 | 84181.0 | ENSG00000124177 | nan | nan
chr20	PTPRT	608712.0 | PTPRT, KIAA0283 | Protein-tyrosine phosphatase, receptor-type, T | 11122.0 | ENSG00000196090 | nan | nan
chr20	GEVQ2	608878.0 | GEVQ2 | Gene expression, variation in, quantitative trait locus on chromosome 20 | 474333.0 | nan | nan | {Gene expression, variation in, QTL}, 608878 (2)
chr20	GRD2	603388.0 | GRD2 | Graves disease, susceptibility to, 2 | 50976.0 | nan | nan | {Graves disease, susceptibility to, 2}, 603388 (2)
chr20	HPC3	608656.0 | HPC3 | Prostate cancer, hereditary, 3 | 408259.0 | nan | nan | {Prostate cancer, susceptibility to, 3}, 608656 (2)
chr20	IBD24	612566.0 | IBD24 | Inflammatory bowel disease 24 | 100270798.0 | nan | associated with rs2315008 and rs4809330 | {Inflammatory bowel disease 24}, 612566 (2)
chr20		612950.0 | PSORS12 | Psoriasis susceptibility 12 | nan | nan | associated with rs495337 | {Psoriasis susceptibility 12}, 612950 (2)
chr20	SLEB8	610066.0 | SLEB8 | Systemic lupus erythematosus, susceptibility to, 8 | 100188804.0 | nan | nan | {Systemic lupus erythematosus, susceptibility to, 8}, 610066 (2)
chr20	SRSF6	601944.0 | SRSF6, SFRS6, SRp55 | Splicing factor, serine/arginine-rich, 6 | 6431.0 | ENSG00000124193 | nan | nan
chr20	L3MBTL1	608802.0 | L3MBTL1, L3MBTL, KIAA0681 | L3MBTL histone methyl-lysine-binding protein 1 | 26013.0 | ENSG00000185513 | nan | nan
chr20	SGK2	607589.0 | SGK2 | Serum/glucocorticoid-regulated kinase 2 | 10110.0 | ENSG00000101049 | nan | nan
chr20	IFT52	617094.0 | IFT52 | Intraflagellar transport 52 | 51098.0 | ENSG00000101052 | nan | Short-rib thoracic dysplasia 16 with or without polydactyly, 617102 (3), Autosomal recessive
chr20	MYBL2	601415.0 | MYBL2, BMYB | v-myb avian myeloblastosis viral oncogene homolog-like 2 | 4605.0 | ENSG00000101057 | nan | nan
chr20	TOX2	611163.0 | TOX2, GCX1, C20orf100 | TOX high mobility group box family member 2 | 84969.0 | ENSG00000124191 | nan | nan
chr20	JPH2	605267.0 | JPH2, JP2, CMH17, CMD2E | Junctophilin 2 | 57158.0 | ENSG00000149596 | nan | Cardiomyopathy, dilated, 2E, 619492 (3), Autosomal recessive; Cardiomyopathy, hypertrophic, 17, 613873 (3), Autosomal dominant
chr20	FITM2	612029.0 | FIT2, C20orf142, SIDDIS | Fat-inducing transcript 2 | 128486.0 | ENSG00000197296 | nan | Siddiqi syndrome, 618635 (3), Autosomal recessive
chr20	HNF4A	600281.0 | HNF4A, TCF14, MODY1, FRTS4 | Hepatocyte nuclear factor 4, alpha (transcription factor-14) | 3172.0 | ENSG00000101076 | nan | Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3), Autosomal dominant; {Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant; MODY, type I, 125850 (3), Autosomal dominant
chr20	SERINC3	607165.0 | SERINC3, TDE1 | Serine incorporator 3 | 10955.0 | ENSG00000132824 | nan | nan
chr20	PKIG	604932.0 | PKIG | Protein kinase, cAMP-dependent catalytic, inhibitor gamma | 11142.0 | ENSG00000168734 | nan | nan
chr20	ADA	608958.0 | ADA | Adenosine deaminase | 100.0 | ENSG00000196839 | nan | Adenosine deaminase deficiency, partial, 102700 (3), Autosomal recessive, Somatic mosaicism; Severe combined immunodeficiency due to ADA deficiency, 102700 (3), Autosomal recessive, Somatic mosaicism
chr20	CCN5	603399.0 | CCN5, WISP2 | Cellular communication network factor 5 | 8839.0 | ENSG00000064205 | nan | nan
chr20	KCNK15	607368.0 | KCNK15, TASK5 | Potassium channel, subfamily K, member 15 | 60598.0 | ENSG00000124249 | nan | nan
chr20	RIMS4	611601.0 | RIMS4 | Protein regulating synaptic membrane exocytosis 4 | 140730.0 | ENSG00000101098 | nan | nan
chr20	YWHAB	601289.0 | YWHAB | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 7529.0 | ENSG00000166913 | nan | nan
chr20	TOMM34	616049.0 | TOMM34, TOM34 | Translocase of outer mitochondrial membrane 34 | 10953.0 | ENSG00000025772 | nan | nan
chr20	STK4	604965.0 | STK4, MST1, KRS2, TIIAC | Serine/threonine protein kinase 4 | 6789.0 | ENSG00000101109 | nan | T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3), Autosomal recessive
chr20	KCNS1	602905.0 | KCNS1, KV9.1 | Potassium channel, voltage-gated, delayed-rectifier, subfamily S, member 1 | 3787.0 | ENSG00000124134 | nan | nan
chr20	WFDC5	605161.0 | WFDC5, PRG5, WAP1 | WAP 4-disulfide core domain 5 | 149708.0 | ENSG00000175121 | nan | nan
chr20	WFDC12	609872.0 | WFDC12, WAP2, SWAM2 | Wap 4-disulfide core domain 12 | 128488.0 | ENSG00000168703 | nan | nan
chr20	PI3	182257.0 | PI3 | Protease inhibitor 3, skin derived (SKALP) | 5266.0 | ENSG00000124102 | nan | nan
chr20	SEMG1	182140.0 | SEMG1, SEMG | Semenogelin | 6406.0 | ENSG00000124233 | nan | nan
chr20	SEMG2	182141.0 | SEMG2 | Semenogelin II | 6407.0 | ENSG00000124157 | nan | nan
chr20	SLPI	107285.0 | SLPI, HUSI | Secretory leukocyte protease inhibitor | 6590.0 | ENSG00000124107 | nan | nan
chr20	MATN4	603897.0 | MATN4 | Matrilin 4 | 8785.0 | ENSG00000124159 | nan | nan
chr20	RBPJL	616104.0 | RBPJL, RBPL, SUHL | RBPJ-like protein | 11317.0 | ENSG00000124232 | nan | nan
chr20	SDC4	600017.0 | SDC4 | Syndecan 4 (amphiglycan, ryudocan) | 6385.0 | ENSG00000124145 | nan | nan
chr20	SYS1	612979.0 | SYS1 | SYS1 golgi trafficking protein | 90196.0 | ENSG00000204070 | nan | nan
chr20	TP53TG5	617316.0 | TP53TG5 | TP53 target gene 5 | 27296.0 | ENSG00000124251 | nan | nan
chr20	DBNDD2	611453.0 | DBNDD2, HSMNP1 | Dysbindin domain-containing 2 | 55861.0 | ENSG00000244274 | nan | nan
chr20	PIGT	610272.0 | PIGT, NDAP, PNH2, MCAHS3 | Phosphatidylinositol glycan, class T | 51604.0 | ENSG00000124155 | mutation identified in 1 PNH2 family | ?Paroxysmal nocturnal hemoglobinuria 2, 615399 (3), Somatic mutation, Autosomal dominant; Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3), Autosomal recessive
chr20	WFDC2	617548.0 | WFDC2, HE4, WAP5, BENP | WAP 4-disulfide core domain 2 | 10406.0 | ENSG00000101443 | nan | Bronchiectasis and nasal polyposis, 620984 (3), Autosomal recessive
chr20	SPINT3	613941.0 | SPINT3 | Serin protease inhibitor, Kunitz-type, 3 | 10816.0 | ENSG00000101446 | nan | nan
chr20	EPPIN	609031.0 | EPPIN, SPINLW1, EPPIN, WAP7 | Epididymal protease inhibitor | 57119.0 | ENSG00000101448 | nan | nan
chr20	SPINT4	619430.0 | SPINT4 | Serine peptidase inhibitor, Kunitz-type, 4 | 391253.0 | ENSG00000149651 | nan | nan
chr20	DNTTIP1	611388.0 | DNTTIP1, TDIF1, C20orf167 | Deoxynucleotidyltransferase, terminal, interacting protein 1 | 116092.0 | ENSG00000101457 | nan | nan
chr20	UBE2C	605574.0 | UBE2C, UBCH10 | Ubiquitin-conjugating enzyme E2 C | 11065.0 | ENSG00000175063 | nan | nan
chr20	TNNC2	191039.0 | TNNC2, CMYO15 | Troponin C2, fast | 7125.0 | ENSG00000101470 | nan | Congenital myopathy 15, 620161 (3), Autosomal dominant
chr20	SNX21	619200.0 | SNX21, SNXL | Sorting nexin family, member 21 | 90203.0 | ENSG00000124104 | nan | nan
chr20	ACOT8	608123.0 | ACOT8, PTE1 | Acyl-CoA thioesterase 8 | 10005.0 | ENSG00000101473 | nan | nan
chr20	ZSWIM3	620336.0 | ZSWIM3 | Zinc finger SWIM domain-containing protein 3 | 140831.0 | ENSG00000132801 | nan | nan
chr20	SPATA25	618936.0 | SPATA25, TSG23, C20orf165 | Spermatogenesis-associated protein 25 | 128497.0 | ENSG00000149634 | nan | nan
chr20	NEURL2	608597.0 | NEURL2, OZZ | Neuralized E3 ubiquitin protein ligase 2 | 140825.0 | ENSG00000124257 | nan | nan
chr20	CTSA	613111.0 | CTSA, PPGB, GSL, NGBE, GLB2 | Cathepsin A (protective protein for beta-galactosidase) | 5476.0 | ENSG00000064601 | nan | Galactosialidosis, 256540 (3), Autosomal recessive
chr20	PLTP	172425.0 | PLTP, HDLCQ9 | Phospholipid transfer protein | 5360.0 | ENSG00000100979 | nan | nan
chr20	PCIF1	618626.0 | PCIF1, CAPAM, PPP1R121, C20orf67 | phosphorylated C-terminal domain-interacting factor 1 | 63935.0 | ENSG00000100982 | nan | nan
chr20	ZNF335	610827.0 | ZNF335, NIF1, NIF2, MCPH10 | Zinc finger protein 335 | 63925.0 | ENSG00000198026 | nan | Microcephaly 10, primary, autosomal recessive, 615095 (3), Autosomal recessive
chr20	MMP9	120361.0 | MMP9, CLG4B, MANDP2 | Matrix metalloproteinase 9 (gelatinase B, 92kD type IV collagenase) | 4318.0 | ENSG00000100985 | nan | Metaphyseal anadysplasia 2, 613073 (3), Autosomal recessive
chr20	SLC12A5	606726.0 | SLC12A5, KCC2, KIAA1176, DEE34, EIG14 | Solute carrier family 12, (potassium-chloride transporter) member 5 | 57468.0 | ENSG00000124140 | nan | {Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3), Autosomal dominant; Developmental and epileptic encephalopathy 34, 616645 (3), Autosomal recessive
chr20	NCOA5	616825.0 | NCOA5, CIA | Nuclear receptor coactivator 5 | 57727.0 | ENSG00000124160 | nan | nan
chr20	CD40	109535.0 | CD40, TNFRSF5 | CD40 antigen | 958.0 | ENSG00000101017 | nan | Immunodeficiency with hyper-IgM, type 3, 606843 (3), Autosomal recessive
chr20	CDH22	609920.0 | CDH22 | Cadherin 22 | 64405.0 | ENSG00000149654 | nan | nan
chr20	SLC35C2	619530.0 | SLC35C2, OVCOV1 | Solute carrier family 35, member C2 | 51006.0 | ENSG00000080189 | nan | nan
chr20	ELMO2	606421.0 | ELMO2, CED12, VMPI | Engulfment and cell motility gene 2 | 63916.0 | ENSG00000062598 | nan | Vascular malformation, primary intraosseous, 606893 (3), Autosomal recessive
chr20	OCSTAMP	620432.0 | OCSTAMP | Osteoclast stimulatory transmembrane protein | 128506.0 | ENSG00000149635 | nan | nan
chr20	SLC13A3	606411.0 | SLC13A3, NADC3, ARLIAK | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | 64849.0 | ENSG00000158296 | nan | Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, 618384 (3), Autosomal recessive
chr20	TP53RK	608679.0 | TP53RK, PRPK, GAMOS4 | TP53-regulating kinase | 112858.0 | ENSG00000172315 | nan | Galloway-Mowat syndrome 4, 617730 (3), Autosomal recessive
chr20	SLC2A10	606145.0 | SLC2A10, GLUT10, ATORS | Solute carrier family 2 (facilitated glucose transporter), member 10 | 81031.0 | ENSG00000197496 | nan | Arterial tortuosity syndrome, 208050 (3), Autosomal recessive
chr20	EYA2	601654.0 | EYA2 | EYA transcriptional coactivator and phosphatase 2 | 2139.0 | ENSG00000064655 | nan | nan
chr20	ZMYND8	615713.0 | ZMYND8, PRKCBP1 | Zinc finger MYND domain-containing protein 8 | 23613.0 | ENSG00000101040 | nan | nan
chr20	NCOA3	601937.0 | NCOA3, AIB1, TNRC14 | Nuclear receptor coactivator 3 (amplified in breast cancer-1) | 8202.0 | ENSG00000124151 | nan | nan
chr20	SULF2	610013.0 | SULF2, KIAA1247 | Sulfatase 2 | 55959.0 | ENSG00000196562 | nan | nan
chr20	PREX1	606905.0 | PREX1, KIAA1415 | Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 | 57580.0 | ENSG00000124126 | nan | nan
chr20	ARFGEF2	605371.0 | ARFGEF2, BIG2, PVNH2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2, brefeldin A-inhibited | 10564.0 | ENSG00000124198 | nan | Periventricular heterotopia with microcephaly, 608097 (3), Autosomal recessive
chr20	CSE1L	601342.0 | CSE1L, CAS | Chromosome segregation-1, yeast, homolog of, like | 1434.0 | ENSG00000124207 | nan | nan
chr20	STAU1	601716.0 | STAU1, STAU | Staufen, Drosophila, homolog of, 1 | 6780.0 | ENSG00000124214 | nan | nan
chr20	DDX27	616621.0 | DDX27, RHLP | DEAD-box helicase 27 | 55661.0 | ENSG00000124228 | nan | nan
chr20	ZNFX1	618931.0 | ZNFX1, IMD91 | Zincfinger NFX1-type domain-containing protein 1 | 57169.0 | ENSG00000124201 | nan | Immunodeficiency 91 and hyperinflammation, 619644 (3), Autosomal recessive
chr20	KCNB1	600397.0 | KCNB1, DEE26 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | 3745.0 | ENSG00000158445 | nan | Developmental and epileptic encephalopathy 26, 616056 (3), Autosomal dominant
chr20	PTGIS	601699.0 | PTGIS, CYP8A1, PGIS, CYP8 | Prostaglandin I2 synthase | 5740.0 | ENSG00000124212 | nan | Hypertension, essential, 145500 (3), Multifactorial
chr20	B4GALT5	604016.0 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 9334.0 | ENSG00000158470 | previously mapped to chr.11 | nan
chr20	SLC9A8	612730.0 | SLC9A8, NHE8, KIAA0939 | Solute carrier family 9 (sodium/hydrogen exchanger), member 8 | 23315.0 | ENSG00000197818 | nan | nan
chr20	SPATA2	607662.0 | SPATA2, KIAA0757 | Spermatogenesis-associated protein 2 | 9825.0 | ENSG00000158480 | nan | nan
chr20	RNF114	612451.0 | RNF114, ZNF313 | Ring finger protein 114 | 55905.0 | ENSG00000124226 | nan | nan
chr20	SNAI1	604238.0 | SNAI1 | Snail family transcriptional repressor 1 | 6615.0 | ENSG00000124216 | pseudogene on 2q34 | nan
chr20	UBE2V1	602995.0 | UBE2V1, UEV1 | Ubiquitin-conjugating enzyme E2 V1 | 7335.0 | ENSG00000244687 | nan | nan
chr20	PEDS1	610994.0 | TMEM189, KUA | Transmembrane protein 189 | 387521.0 | ENSG00000240849 | nan | nan
chr20	CEBPB	189965.0 | CEBPB, TCF5 | CCAAT/enhancer-binding protein (C/EBP), beta (transcription factor-5) | 1051.0 | ENSG00000172216 | nan | nan
chr20	PTPN1	176885.0 | PTPN1, PTP1B | Protein tyrosine phosphatase, nonreceptor-type, 1 | 5770.0 | ENSG00000196396 | 20pter-q12 by REa | {Insulin resistance, susceptibility to}, 125853 (3), Autosomal dominant
chr20	PARD6B	608975.0 | PARD6B | PAR6 family cell polarity regulator beta | 84612.0 | ENSG00000124171 | nan | nan
chr20	BCAS4	607471.0 | BCAS4 | Breast carcinoma amplified sequence 4 | 55653.0 | ENSG00000124243 | nan | nan
chr20	ADNP	611386.0 | ADNP, ADNP1, KIAA0784, HVDAS, MRD28 | Activity-dependent neuroprotector homeobox | 23394.0 | ENSG00000101126 | nan | Helsmoortel-van der Aa syndrome, 615873 (3), Autosomal dominant
chr20	DPM1	603503.0 | DPM1, MPDS, CDGIE | Dolichyl-phosphate mannosyltransferase 1, catalytic subunit | 8813.0 | ENSG00000000419 | nan | Congenital disorder of glycosylation, type Ie, 608799 (3), Autosomal recessive
chr20	MOCS3	609277.0 | MOCS3 | Molybdenum cofactor synthesis 3 | 27304.0 | ENSG00000124217 | nan | nan
chr20	KCNG1	603788.0 | KCNG1, KH2 | Potassium voltage-gated channel, subfamily G, member 1 | 3755.0 | ENSG00000026559 | nan | nan
chr20	DFNB65	610248.0 | DFNB65 | Deafness, autosomal recessive 65 | 692219.0 | nan | max lod at D20S840 | Deafness, autosomal recessive 65, 610248 (2), Autosomal recessive
chr20	EEGV1	130180.0 | EEGV1, EEGL | Electroencephalographic variant pattern 1 | 1940.0 | nan | nan | Electroencephalographic variant pattern 1, 130180 (2), Autosomal dominant
chr20	NFATC2	600490.0 | NFATC2, NFATP, JCOSL | Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 2 | 4773.0 | ENSG00000101096 | mutation identified in 1 JCOSL patient | ?Joint contracture, osteochondromas, and B-cell lymphoma, 620232 (3), Autosomal recessive
chr20	ATP9A	609126.0 | ATP9A, KIAA0611, NEDGBA | ATPase, class II, type 9A | 10079.0 | ENSG00000054793 | nan | Neurodevelopmental disorder with poor growth and behavioral abnormalities, 620242 (3), Autosomal recessive
chr20	SALL4	607343.0 | SALL4, HSAL4, DRRS, IVIC | sal-like 4 | 57167.0 | ENSG00000101115 | mutation identified in 1 IVIC family | ?IVIC syndrome, 147750 (3), Autosomal dominant; Duane-radial ray syndrome, 607323 (3), Autosomal dominant
chr20	ZFP64	618111.0 | ZFP64, ZNF338 | Zinc finger protein 64 | 55734.0 | ENSG00000020256 | nan | nan
chr20	TSHZ2	614118.0 | TSHZ2 | Teashirt zinc finger homeobox 2 | 128553.0 | ENSG00000182463 | nan | nan
chr20	ZNF217	602967.0 | ZNF217 | Zinc finger protein-217 | 7764.0 | ENSG00000171940 | nan | nan
chr20	BCAS1	602968.0 | BCAS1, NABC1 | Brain-enriched myelin-associated protein 1 | 8537.0 | ENSG00000064787 | nan | nan
chr20	CYP24A1	126065.0 | CYP24A1, CYP24, HCINF1 | Cytochrome P450, family 24, subfamily A, polypeptide 1 (vitamin D 24-hydroxylase) | 1591.0 | ENSG00000019186 | nan | Hypercalcemia, infantile, 1, 143880 (3), Autosomal recessive
chr20	PFDN4	604898.0 | PFDN4, C1 | Prefoldin 4 | 5203.0 | ENSG00000101132 | nan | nan
chr20	DOK5	608334.0 | DOK5 | Docking protein 5 | 55816.0 | ENSG00000101134 | nan | nan
chr20	CBLN4	615029.0 | CBLN4 | Precerebellin 4 | 140689.0 | ENSG00000054803 | nan | nan
chr20	MC3R	155540.0 | MC3R, BMIQ9 | Melanocortin-3 receptor | 4159.0 | ENSG00000124089 | nan | {Obesity, severe, susceptibility to, BMIQ9}, 602025 (3)
chr20	FAM210B	618722.0 | FAM210B, C20orf108 | Family with sequence similarity 210, member B | 116151.0 | ENSG00000124098 | nan | nan
chr20	AURKA	603072.0 | AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK | Aurora kinase A | 6790.0 | ENSG00000087586 | nan | {Colon cancer, susceptibility to}, 114500 (3), Somatic mutation, Autosomal dominant
chr20	CSTF1	600369.0 | CSTF1 | Cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kD | 1477.0 | ENSG00000101138 | nan | nan
chr20	MTBS3	612929.0 | MTBS3 | Mycobacterium tuberculosis, susceptibility to, 3 | 100302686.0 | nan | associated with rs3827103 | {Mycobacterium tuberculosis, susceptibility to, 3}, 612929 (2)
chr20	CASS4	618888.0 | CASS4, HEPL, C20orf32 | CAS scaffold protein family, member 4 | 57091.0 | ENSG00000087589 | nan | nan
chr20	TFAP2C	601602.0 | TFAP2C | Transcription factor AP-2 gamma (activating enhancer-binding protein 2 gamma) | 7022.0 | ENSG00000087510 | nan | nan
chr20	BMP7	112267.0 | BMP7 | Bone morphogenetic protein-7 (osteogenic protein-1) | 655.0 | ENSG00000101144 | nan | nan
chr20	SPO11	605114.0 | SPO11 | Spo11, S. cerevisiae, homolog of | 23626.0 | ENSG00000054796 | nan | nan
chr20	RAE1	603343.0 | RAE1, MRNP41 | Ribonucleic acid export protein 1 | 8480.0 | ENSG00000101146 | nan | nan
chr20	RBM38	612428.0 | RBM38, RNPC1 | RNA-binding motif protein 38 | 55544.0 | ENSG00000132819 | nan | nan
chr20	CTCFL	607022.0 | CTCFL, BORIS | CCCTC-binding factor-like protein | 140690.0 | ENSG00000124092 | nan | nan
chr20	PCK1	614168.0 | PCK1, PCKDC | Phosphoenolpyruvate carboxykinase-1 (soluble) | 5105.0 | ENSG00000124253 | nan | Phosphoenolpyruvate carboxykinase deficiency, cytosolic, 261680 (3), Autosomal recessive
chr20	ZBP1	606750.0 | ZBP1, C20orf183, DLM1 | Z-DNA binding protein 1 (tumor stroma and activated macrophage protein DLM1) | 81030.0 | ENSG00000124256 | nan | nan
chr20	PMEPA1	606564.0 | PMEPA1, TMEPAI | Prostate transmembrane protein, androgen-induced | 56937.0 | ENSG00000124225 | nan | nan
chr20	CIMIP1	619277.0 | CIMIP1, C20orf85, LLC1 | Ciliary microtubule inner protein 1 | 128602.0 | ENSG00000124237 | nan | nan
chr20	RAB22A	612966.0 | RAB22A | Ras-associated protein RAB22A | 57403.0 | ENSG00000124209 | nan | nan
chr20	VAPB	605704.0 | VAPBC, VAPB, VAPC, ALS8 | VAMP-associated protein B and C | 9217.0 | ENSG00000124164 | nan | Spinal muscular atrophy, late-onset, Finkel type, 182980 (3), Autosomal dominant; Amyotrophic lateral sclerosis 8, 608627 (3), Autosomal dominant
chr20	STX16	603666.0 | STX16, SYN16 | Syntaxin 16 | 8675.0 | ENSG00000124222 | nan | Pseudohypoparathyroidism Ib, 603233 (3), Autosomal dominant
chr20	MIR296	610945.0 | MIR296, MIRN296 | Micro RNA 296 | 407022.0 | ENSG00000284040 | nan | nan
chr20	MIR298	614914.0 | MIR298 | Micro RNA 298 | 100126296.0 | ENSG00000216031 | nan | nan
chr20	GNAS-AS1	610540.0 | GNASAS1, GNASAS, SANG, NESPAS | GNAS antisense RNA 1 | 149775.0 | ENSG00000235590 | nan | Pseudohypoparathyroidism Ib, 603233 (3), Autosomal dominant
chr20	GNAS	139320.0 | GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3, AIMAH1 | GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1) | 2778.0 | ENSG00000087460 | nan | Pituitary adenoma 3, multiple types, somatic, 617686 (3); Pseudohypoparathyroidism Ic, 612462 (3), Autosomal dominant; Pseudohypoparathyroidism Ia, 103580 (3), Autosomal dominant; Osseous heteroplasia, progressive, 166350 (3), Autosomal dominant; Pseudohypoparathyroidism Ib, 603233 (3), Autosomal dominant; McCune-Albright syndrome, somatic, mosaic, 174800 (3); Pseudopseudohypoparathyroidism, 612463 (3), Autosomal dominant; ACTH-independent macronodular adrenal hyperplasia 1, somatic, 219080 (3)
chr20	NELFCD	605297.0 | NELFCD, TH1L, TH1 | Negative elongation factor complex member C/D | 51497.0 | ENSG00000101158 | nan | nan
chr20	CTSZ	603169.0 | CTSZ | Cathepsin Z | 1522.0 | ENSG00000101160 | nan | nan
chr20	TUBB1	612901.0 | TUBB1, MACTHC1 | Tubulin, beta-1 | 81027.0 | ENSG00000101162 | nan | Macrothrombocytopenia, isolated, 1, autosomal dominant, 613112 (3), Autosomal dominant
chr20	ATP5F1E	606153.0 | ATP5F1E, ATP5E, MC5DN3 | ATP synthase F1, subunit episilon | 514.0 | ENSG00000124172 | pseudogene on 4q25 | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3), Autosomal recessive
chr20	PRELID3B	620754.0 | PRELID3B, UPS2, SLMO2 | PRELI domain-containing protein 3B | 51012.0 | ENSG00000101166 | nan | nan
chr20	EDN3	131242.0 | EDN3, WS4B, HSCR4 | Endothelin-3 | 1908.0 | ENSG00000124205 | nan | Waardenburg syndrome, type 4B, 613265 (3), Autosomal recessive, Autosomal dominant; {Hirschsprung disease, susceptibility to, 4}, 613712 (3), Autosomal dominant
chr20	PHACTR3	608725.0 | PHACTR3, SCAPININ | Phosphatase and actin regulator 3 | 116154.0 | ENSG00000087495 | nan | nan
chr20	GLM6	613031.0 | GLM6 | Glioma susceptibility 6 | 100415895.0 | nan | associated with rs6010620 | {Glioma susceptibility 6}, 613031 (2)
chr20	SYCP2	604105.0 | SYCP2, SCP2, SPGF1 | Synaptonemal complex protein 2 | 10388.0 | ENSG00000196074 | nan | Spermatogenic failure 1, 258150 (3), Autosomal dominant
chr20	PPP1R3D	603326.0 | PPP1R3D, PPP1R6 | Protein phosphatase 1, regulatory subunit 3D | 5509.0 | ENSG00000132825 | nan | nan
chr20	CDH26	617685.0 | CDH26 | Cadherin 26 | 60437.0 | ENSG00000124215 | nan | nan
chr20	CDH4	603006.0 | CDH4 | Cadherin 4 | 1002.0 | ENSG00000179242 | nan | nan
chr20	TAF4	601796.0 | TAF4, TAF2C1, TAFII130, TAF2C, MRD73 | TAF4 RNA polymerase II, TATA box-binding protein-associated factor, 135kD | 6874.0 | ENSG00000130699 | nan | Intellectual developmental disorder, autosomal dominant 73, 620450 (3), Autosomal dominant
chr20	LSM14B	620689.0 | LSM14B, RAP55B | LSM family, member 14B | 149986.0 | ENSG00000149657 | nan | nan
chr20	PSMA7	606607.0 | PSMA7 | Proteasome subunit, alpha-type, 7 | 5688.0 | ENSG00000101182 | nan | nan
chr20	SS18L1	606472.0 | SS18L1, KIAA0693, CREST | SS18L1 subunit of BAF chromatin remodeling complex | 26039.0 | ENSG00000184402 | nan | nan
chr20	MTG2	610919.0 | GTPBP5, OBGH1 | GTP-binding protein 5 | 26164.0 | ENSG00000101181 | nan | nan
chr20	HRH3	604525.0 | HRH3, GPCR97 | Histamine receptor H3 | 11255.0 | ENSG00000101180 | nan | nan
chr20	OSBPL2	606731.0 | OSBPL2, ORP2, KIAA0772, DNFA67 | Oxysterol-binding protein-like protein 2 | 9885.0 | ENSG00000130703 | nan | Deafness, autosomal dominant 67, 616340 (3), Autosomal dominant
chr20	ADRM1	610650.0 | ADRM1, ARM1, RPN13 | Adhesion-regulating molecule 1 | 11047.0 | ENSG00000130706 | nan | nan
chr20	LAMA5	601033.0 | LAMA5, NPHS26, BBDS2 | Laminin, alpha-5 | 3911.0 | ENSG00000130702 | mutation identified in 1 BBDS2 family | Nephrotic syndrome, type 26, 620049 (3), Autosomal recessive; ?Bent bone dysplasia syndrome 2, 620076 (3), Autosomal recessive
chr20	RPS21	180477.0 | RPS21 | Ribosomal protein S21 | 6227.0 | ENSG00000171858 | nan | nan
chr20	CABLES2	618772.0 | CABLES2, C20orf150 | CDK5 and ABL enzyme substrate 3 | 81928.0 | ENSG00000149679 | nan | nan
chr20	GATA5	611496.0 | GATA5, CHTD5 | GATA-binding protein 5 | 140628.0 | ENSG00000130700 | nan | Congenital heart defects, multiple types, 5, 617912 (3), Autosomal recessive, Autosomal dominant
chr20	MIR1-1	609326.0 | MIR1-1 | Micro RNA 1-1 | 406904.0 | ENSG00000199017 | nan | nan
chr20	MIR133A2	610255.0 | MIR133A2 | Micro RNA 133A2 | 406923.0 | ENSG00000284508 | nan | nan
chr20	SLCO4A1	612436.0 | SLCO4A1, OATPE, OATP4A1 | Solute carrier organic anion transporter family, member 4A1 | 28231.0 | ENSG00000101187 | nan | nan
chr20	NTSR1	162651.0 | NTSR1 | Neurotensin receptor | 4923.0 | ENSG00000101188 | nan | nan
chr20	MRGBP	611157.0 | MRGBP, C20orf20 | MRG/MORF4L-binding protein | 55257.0 | ENSG00000101189 | nan | nan
chr20	OGFR	606459.0 | OGFR | Opioid growth factor receptor | 11054.0 | ENSG00000060491 | nan | nan
chr20	COL9A3	120270.0 | COL9A3, EDM3, IDD, STL6 | Collagen IX, alpha-3 polypeptide | 1299.0 | ENSG00000092758 | nan | {Intervertebral disc disease, susceptibility to}, 603932 (3); Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3), Autosomal dominant; Stickler syndrome, type VI, 620022 (3), Autosomal recessive
chr20	TCFL5	604745.0 | TCFL5 | Transcription factor-like 5 | 10732.0 | ENSG00000101190 | nan | nan
chr20	DIDO1	604140.0 | DATF1, DIO1 | Death-associated transcription factor 1 | 11083.0 | ENSG00000101191 | nan | nan
chr20	GID8	611625.0 | GID8, C20orf11, TWA1 | GID complex, subunit 8 | 54994.0 | ENSG00000101193 | nan | nan
chr20	SLC17A9	612107.0 | SLC17A9, C20orf59, POROK8 | Solute carrier family 17, member 9 | 63910.0 | ENSG00000101194 | nan | Porokeratosis 8, disseminated superficial actinic type, 616063 (3), Autosomal dominant
chr20	BHLHE23	609331.0 | BHLHE23, BHLHB4 | Basic helix-loop-helix family, member E23 | 128408.0 | ENSG00000125533 | nan | nan
chr20	HAR1B	610557.0 | HAR1B, HAR1R | Highly accelerated region gene 1B | 768097.0 | ENSG00000231133 | nan | nan
chr20	HAR1A	610556.0 | HAR1A, HAR1F | Highly accelerated region gene 1A | 768096.0 | nan | nan | nan
chr20	YTHDF1	616529.0 | YTHDF1 | YTH N6-methyladenosine RNA-binding protein 1 | 54915.0 | ENSG00000149658 | nan | nan
chr20	BIRC7	605737.0 | BIRC7, MLIAP, KIAP, LIVIN | Baculoviral IAP repeat-containing protein 7 | 79444.0 | ENSG00000101197 | nan | nan
chr20	NKAIN4	612873.0 | NKAIN4 | Na+/K+ transporting ATPase-interacting 4 | 128414.0 | ENSG00000101198 | nan | nan
chr20	ARFGAP1	608377.0 | ARFGAP1 | ADP-ribosylation factor GTPase-activating protein 1 | 55738.0 | ENSG00000101199 | nan | nan
chr20	COL20A1	619390.0 | COL20A1, KIAA1510 | Collagen, type XX, alpha-1 | 57642.0 | ENSG00000101203 | nan | nan
chr20	CHRNA4	118504.0 | CHRNA4, ENFL1 | Cholinergic receptor, nicotinic, alpha polypeptide-4 | 1137.0 | ENSG00000101204 | nan | {Nicotine addiction, susceptibility to}, 188890 (3); Epilepsy, nocturnal frontal lobe, 1, 600513 (3), Autosomal dominant
chr20	KCNQ2	602235.0 | KCNQ2, EBN1, DEE7, BFNS1 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | 3785.0 | ENSG00000075043 | nan | Developmental and epileptic encephalopathy 7, 613720 (3), Autosomal dominant; Seizures, benign neonatal, 1, 121200 (3), Autosomal dominant; Myokymia, 121200 (3), Autosomal dominant
chr20	EEF1A2	602959.0 | EEF1A2, DEE33, MRD38 | Eukaryotic translation elongation factor-1, alpha-2 | 1917.0 | ENSG00000101210 | nan | Developmental and epileptic encephalopathy 33, 616409 (3), Autosomal dominant; Intellectual developmental disorder, autosomal dominant 38, 616393 (3), Autosomal dominant
chr20	PTK6	602004.0 | PTK6, BRK | Protein-tyrosine kinase 6 | 5753.0 | ENSG00000101213 | nan | nan
chr20	SRMS	617797.0 | SRMS, C20orf148 | Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites | 6725.0 | ENSG00000125508 | nan | nan
chr20	HELZ2	611265.0 | PRIC285, PDIP1, KIAA1769 | Peroxisomal proliferator-activated receptor alpha-interacting cofactor complex, 285kD subunit | 85441.0 | ENSG00000130589 | nan | nan
chr20	GMEB2	607451.0 | GMEB2, KIAA1269 | Glucocorticoid modulatory element-binding protein 2 | 26205.0 | ENSG00000101216 | nan | nan
chr20	STMN3	608362.0 | STMN3, SCLIP | Stathmin-like 3 | 50861.0 | ENSG00000197457 | nan | nan
chr20	RTEL1	608833.0 | RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3 | Regulator of telomere elongation helicase 1 | 51750.0 | ENSG00000258366 | nan | Dyskeratosis congenita, autosomal dominant 4, 615190 (3), Autosomal recessive, Autosomal dominant; Dyskeratosis congenita, autosomal recessive 5, 615190 (3), Autosomal recessive, Autosomal dominant; Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 3, 616373 (3), Autosomal dominant
chr20	TNFRSF6B	603361.0 | TNFRSF6B, DCR3 | Tumor necrosis factor receptor superfamily, member 6b (decoy receptor 3) | 8771.0 | ENSG00000243509 | nan | nan
chr20	ARFRP1	604699.0 | ARFRP1, ARP | ADP-ribosylation factor-related protein 1 | 10139.0 | ENSG00000101246 | nan | nan
chr20	ZGPAT	619577.0 | ZGPAT, ZIP | Zinc finger CCCH domain- and G-patch domain-containing protein | 84619.0 | ENSG00000197114 | nan | nan
chr20	LIME1	609809.0 | LIME1, LIME | LCK-interacting transmembrane adaptor 1 | 54923.0 | ENSG00000203896 | nan | nan
chr20	SLC2A4RG	609493.0 | SLC2A4RG, GEF, HDBP1 | SLC2A4 regulator | 56731.0 | ENSG00000125520 | nan | nan
chr20	ZBTB46	614639.0 | ZBTB46, BZEL | Zinc finger- and BTB domain-containing protein 46 | 140685.0 | ENSG00000130584 | nan | nan
chr20	ABHD16B	620190.0 | ABHD16B, C20orf135 | Abhydrolase domain-containing protein 16B | 140701.0 | ENSG00000183260 | nan | nan
chr20	TPD52L2	603747.0 | TPD52L2 | Tumor protein D52-like 2 | 7165.0 | ENSG00000101150 | nan | nan
chr20	DNAJC5	611203.0 | DNAJC5, DNAJC5A, CSP, CLN4 | DNAJ/HSP40 homolog, subfamily C, member 5 | 80331.0 | ENSG00000101152 | nan | Ceroid lipofuscinosis, neuronal, 4 (Kufs type), autosomal dominant, 162350 (3), Autosomal dominant
chr20	UCKL1	610866.0 | UCKL1, UCK1L, URKL1 | Uridine/cytidine kinase-like 1 | 54963.0 | ENSG00000198276 | nan | nan
chr20	ZNF512B	617886.0 | ZNF512B, KIAA1196 | Zinc finger protein 512B | 57473.0 | ENSG00000196700 | nan | nan
chr20	PRPF6	613979.0 | PRPF6, PRP6, ANT1, TOM, C20orf14 | Pre-mRNA processing factor 6 | 24148.0 | ENSG00000101161 | nan | Retinitis pigmentosa 60, 613983 (3), Autosomal dominant
chr20	SOX18	601618.0 | SOX18, HLTS, HLTRS | SOX18, mouse, homolog of | 54345.0 | ENSG00000203883 | nan | Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3), Autosomal recessive; Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3), Autosomal dominant
chr20	TCEA2	604784.0 | TCEA2 | Transcription elongation factor A2 | 6919.0 | ENSG00000171703 | nan | nan
chr20	RGS19	605071.0 | RGS19, GAIP | Regulator of G protein signaling 19 | 10287.0 | ENSG00000171700 | nan | nan
chr20	OPRL1	602548.0 | OPRL1, NOP | Opioid receptor-like 1 | 4987.0 | ENSG00000125510 | nan | nan
chr20	NPBWR2	600731.0 | GPR8 | G protein-coupled receptor-8 | 2832.0 | ENSG00000125522 | related sequence on 14 | nan
chr20	MYT1	600379.0 | MYT1, PLPB1 | Myelin transcription factor 1 | 4661.0 | ENSG00000196132 | nan | nan
chr20	PCMTD2	620077.0 | PCMTD2, C20orf36 | Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain-containing protein 2 | 55251.0 | ENSG00000203880 | nan | nan
chr20	HTL	151310.0 | HTL, LEUT, HLT | Leucine transport, high | 3343.0 | nan | nan | nan
chr21	AUTS12	610838.0 | AUTS12 | Autism, susceptibility to, 12 | 100188314.0 | nan | max lod at D21S1437 | {Autism susceptibility 12}, 610838 (2)
chr21	RNR4	180453.0 | RNR4 | Ribosomal RNA-4 | 6055.0 | nan | nan | nan
chr21	BAGE	605167.0 | BAGE1, BAGE | BAGE family, member 1 | 574.0 | nan | previously assigned to chr.13 | nan
chr21	BAGE3	617777.0 | BAGE3 | BAGE family, member 3 | 85318.0 | nan | nan | nan
chr21	BAGE2	617776.0 | BAGE2 | BAGE family, member 2 | 85319.0 | nan | nan | nan
chr21	TPTE	604336.0 | TPTE | Transmembrane phosphatase with tensin homology | 7179.0 | ENSG00000274391 | nan | nan
chr21	NRCLP3	609039.0 | NRCLP3 | Narcolepsy 3 | 494446.0 | nan | max lod at D21S1245 | Narcolepsy 3, 609039 (2), Autosomal dominant
chr21	TAM	159595.0 | TAM, MST | Myeloproliferative syndrome, transient (transient abnormal myelopoiesis) | 8205.0 | nan | nan | Leukemia, transient, of Down syndrome, 159595 (2)
chr21	POTED	607549.0 | POTED, ANKRD21, POTE | POTE ankyrin domain family, member D | 317754.0 | ENSG00000166351 | nan | nan
chr21	LIPI	609252.0 | LIPI, LPDL, PRED5 | Lipase I | 149998.0 | ENSG00000188992 | nan | nan
chr21	RBM11	617937.0 | RBM11 | RNA-binding motif protein 11 | 54033.0 | ENSG00000185272 | nan | nan
chr21	ABCC13	608835.0 | ABCC13 | ATP-binding cassette, subfamily C, member 13 | 150000.0 | ENSG00000291052 | nan | nan
chr21	HSPA13	601100.0 | STCH | Stress 70 protein chaperone, microsome-associated, p60 | 6782.0 | ENSG00000155304 | nan | nan
chr21	SAMSN1	607978.0 | SAMSN1, HACS1 | SAM domain, SH3 domain, and nuclear localization signals 1 | 64092.0 | ENSG00000155307 | nan | nan
chr21	NRIP1	602490.0 | NRIP1, RIP140, CAKUT3 | Nuclear receptor interacting protein 1 (receptor interacting protein 140) | 8204.0 | ENSG00000180530 | mutation identified in 1 CAKUT3 family | ?Congenital anomalies of kidney and urinary tract 3, 618270 (3), Autosomal dominant
chr21	USH1E	602097.0 | USH1E | Usher syndrome-1E, autosomal recessive, severe | 7396.0 | nan | nan | Usher syndrome, type 1E, 602097 (2), Autosomal recessive
chr21	USP25	604736.0 | USP25, USP21 | Ubiquitin-specific protease 25 | 29761.0 | ENSG00000155313 | nan | nan
chr21	MIR99AHG	615964.0 | MIR99AHG, MONC, LINC00478 | MIR99A-LET7C cluster host gene, noncoding | 388815.0 | ENSG00000215386 | nan | nan
chr21	MIR99A	614509.0 | MIR99A | Micro RNA 99A | 407055.0 | ENSG00000207638 | nan | nan
chr21	MIRLET7C	612144.0 | MIRLET7C, MIRNLET7C, LET7C | Micro RNA Let7c | 406885.0 | ENSG00000199030 | nan | nan
chr21	MIR125B2	610105.0 | MIR125B2, MIRN125B2 | Micro RNA 125B-2 | 406912.0 | ENSG00000207863 | nan | nan
chr21	CXADR	602621.0 | CXADR, CAR | Coxsackie virus and adenovirus receptor | 1525.0 | ENSG00000154639 | pseudogenes on chr.15 and chr.18 | nan
chr21	BTG3	605674.0 | BTG3, ANA, TOB5 | BTG antiproliferation factor 3 | 10950.0 | ENSG00000154640 | nan | nan
chr21	CHODL	607247.0 | CHODL | Chondrolectin | 140578.0 | ENSG00000154645 | nan | nan
chr21	TMPRSS15	606635.0 | TMPRSS15, PRSS7, ENTK | Transmembrane protease, serine 15 | 5651.0 | ENSG00000154646 | nan | Enterokinase deficiency, 226200 (3), Autosomal recessive
chr21	NCAM2	602040.0 | NCAM2 | Cell adhesion molecule, neural, 2 | 4685.0 | ENSG00000154654 | nan | nan
chr21	MIR155	609337.0 | MIR155, BIC, MIRN155 | Micro RNA 155 | 406947.0 | ENSG00000283904 | nan | nan
chr21	MRPL39	611845.0 | MRPL39, MRPL5, COXPD59 | Mitochondrial ribosomal protein L39 | 54148.0 | ENSG00000154719 | nan | Combined oxidative phosphorylation deficiency 59, 620646 (3), Autosomal recessive
chr21	JAM2	606870.0 | JAM2, VEJAM, IBGC8 | Junctional adhesion molecule 2 | 58494.0 | ENSG00000154721 | nan | Basal ganglia calcification, idiopathic, 8, autosomal recessive, 618824 (3), Autosomal recessive
chr21	ATP5PF	603152.0 | ATP5PF, ATP5J, ATP5 | ATP synthase peripheral stalk, subunit F6 | 522.0 | ENSG00000154723 | nan | nan
chr21	GABPA	600609.0 | GABPA, E4TF1A | GA-binding protein transcription factor, alpha subunit, 60kD | 2551.0 | ENSG00000154727 | nan | nan
chr21	APP	104760.0 | APP, AAA, CVAP, AD1 | Amyloid beta (A4) precursor protein | 351.0 | ENSG00000142192 | proximal to SOD; very distal q21 or boundary with q22 | Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3), Autosomal dominant; Alzheimer disease 1, familial, 104300 (3), Autosomal dominant
chr21	CYYR1-AS1	616021.0 | CYYR1AS1, CYYR1-AS1 | CYRR1 antisense RNA 1 | 100996571.0 | ENSG00000197934 | nan | nan
chr21	CYYR1	616020.0 | CYYR1 | Cysteine/tyrosine-rich protein 1 | 116159.0 | ENSG00000166265 | nan | nan
chr21	ADAMTS1	605174.0 | ADAMTS1, METH1 | ADAM metallopeptidase domain with thrombospondin type 1 motif, 1 | 9510.0 | ENSG00000154734 | nan | nan
chr21	ADAMTS5	605007.0 | ADAMTS5, ADAMTS11 | ADAM metallopeptidase domain with thrombospondin type 1 motif, 5 (aggrecanase 2) | 11096.0 | ENSG00000154736 | nan | nan
chr21	N6AMT1	614553.0 | N6AMT1 | N6 adenine-specific DNA methyltransferase 1 | 29104.0 | ENSG00000156239 | nan | nan
chr21	LTN1	613083.0 | LTN1, RNF160, KIAA0714 | Listerin E3 ubiquitin protein ligase 1 | 26046.0 | ENSG00000198862 | nan | nan
chr21	RWDD2B	617843.0 | RWDD2B, C21orf6 | RWD domain-containing protein 2B | 10069.0 | ENSG00000156253 | nan | nan
chr21	USP16	604735.0 | USP16, UBPM | Ubiquitin-specific protease 16 | 10600.0 | ENSG00000156256 | nan | nan
chr21	CCT8	617786.0 | CCT8, KIAA0002 | Chaperonin containing T-complex polypeptide 1, subunit 8 | 10694.0 | ENSG00000156261 | nan | nan
chr21	MAP3K7CL	611110.0 | TAK1L, C21orf7 | TAK1-like | 56911.0 | ENSG00000156265 | nan | nan
chr21	BACH1	602751.0 | BACH1 | BTB and CNC homology 1 | 571.0 | ENSG00000156273 | nan | nan
chr21	GRIK1	138245.0 | GRIK1, GLUR5 | Glutamate receptor, ionotropic, kainate 1 | 2897.0 | ENSG00000171189 | nan | nan
chr21	CLDN17	617005.0 | CLDN17 | Claudin 17 | 26285.0 | ENSG00000156282 | nan | nan
chr21		619980.0 | BRDCS1, DEL21q22, C21DELq22 | Braddock-Carey syndrome 1 | nan | nan | 7.7 - 9.2 Mb deletion | Braddock-Carey syndrome 1, 619980 (4), Autosomal dominant
chr21	FEB7	611515.0 | FEB7 | Febrile seizures, familial, 7 | 100049160.0 | nan | max lod at D21S1910 | Febrile seizures, familial, 7, 611515 (2)
chr21	TUKLS	609428.0 | TUKLS | Tukel syndrome | 574049.0 | nan | max lod at D21S1259 | Tukel syndrome, 609428 (2), Autosomal recessive
chr21	CLDN8	611231.0 | CLDN8 | Claudin 8 | 9073.0 | ENSG00000156284 | nan | nan
chr21	KRTAP24-1	618927.0 | KRTAP24-1 | Keratin-associated protein 24-1 | 643803.0 | ENSG00000188694 | nan | nan
chr21	KRTAP13-1	608718.0 | KRTAP13-1 | Keratin-associated protein 13-1 | 140258.0 | ENSG00000198390 | nan | nan
chr21	KRTAP11-1	600064.0 | KRTAP11-1, HACL1 | Keratin-associated protein 11-1 | 337880.0 | ENSG00000182591 | nan | nan
chr21	TIAM1	600687.0 | TIAM1, NEDLDS | T-cell lymphoma invasion and metastasis 1 | 7074.0 | ENSG00000156299 | nan | Neurodevelopmental disorder with language delay and seizures, 619908 (3), Autosomal recessive
chr21	SOD1	147450.0 | SOD1, ALS1, STAHP | Superoxide dismutase-1, soluble | 6647.0 | ENSG00000142168 | mid q22.1 | Spastic tetraplegia and axial hypotonia, progressive, 618598 (3), Autosomal recessive; Amyotrophic lateral sclerosis 1, 105400 (3), Autosomal recessive, Autosomal dominant
chr21	SCAF4	616023.0 | SCAF4, KIAA1172, FZS | SR-related C-terminal domain-associated factor 4 | 57466.0 | ENSG00000156304 | nan | Fliedner-Zweier syndrome, 620511 (3), Autosomal dominant
chr21	HUNK	606532.0 | HUNK | Hormonally upregulated NEU-associated kinase | 30811.0 | ENSG00000142149 | nan | nan
chr21	MIS18A	618137.0 | MIS18A | Mis18 kinetochore protein A | 54069.0 | ENSG00000159055 | nan | nan
chr21	MRAP	609196.0 | MRAP, FALP, C21orf61, GCCD2, FGD2 | Melanocortin 2 receptor accessory protein | 56246.0 | ENSG00000170262 | nan | Glucocorticoid deficiency 2, 607398 (3), Autosomal recessive
chr21	URB1	608865.0 | URB1, NPA1, C21orf108, KIAA0539 | URB1 ribosome biogenesis 1 homolog (S. cerevisiae) | 9875.0 | ENSG00000142207 | nan | nan
chr21	TCP10L	608365.0 | TCP10L | T-complex protein 10-like | 140290.0 | ENSG00000242220 | nan | nan
chr21	CFAP298	615494.0 | CFAP298, C21orf59, CILD26 | Cilia- and flagella-associated protein 298 | 56683.0 | ENSG00000159079 | nan | Ciliary dyskinesia, primary, 26, 615500 (3), Autosomal recessive
chr21	SYNJ1	604297.0 | SYNJ1, PARK20, DEE53 | Synaptojanin 1 | 8867.0 | ENSG00000159082 | nan | Parkinson disease 20, early-onset, 615530 (3), Autosomal recessive; Developmental and epileptic encephalopathy 53, 617389 (3), Autosomal recessive
chr21	PAXBP1	617621.0 | PAXBP1, GCFC1, C21orf66 | PAX3- and PAX7-binding protein 1 | 94104.0 | ENSG00000159086 | nan | nan
chr21	OLIG2	606386.0 | OLIG2, PRKCBP2 | Oligodendrocyte lineage transcription factor 2 | 10215.0 | ENSG00000205927 | nan | nan
chr21	OLIG1	606385.0 | OLIG1 | Oligodendrocyte lineage transcription factor 1 | 116448.0 | ENSG00000184221 | nan | nan
chr21	IFNAR2	602376.0 | IFNAR2, IMD45 | Interferon, alpha, beta, and omega, receptor 2 | 3455.0 | ENSG00000159110 | nan | {Hepatitis B virus, susceptibility to}, 610424 (3); Immunodeficiency 45, 616669 (3), Autosomal recessive
chr21	IL10RB	123889.0 | IL10RB, CRFB4, IBD25 | Interleukin 10 receptor, beta | 3588.0 | ENSG00000243646 | 35kb distal to IFNAR; D21S58 | {Hepatitis B virus, susceptibility to}, 610424 (3); Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3), Autosomal recessive
chr21	IFNAR1	107450.0 | IFNAR1, IMD106 | Interferon, alpha, beta and omega, receptor 1 | 3454.0 | ENSG00000142166 | nan | Immunodeficiency 106, susceptibility to viral infections, 619935 (3), Autosomal recessive
chr21	IFNGR2	147569.0 | IFNGR2, IFNGT1, IFGR2, IMD28 | Interferon gamma receptor-2 (interferon gamma transducer 1) | 3460.0 | ENSG00000159128 | nan | Immunodeficiency 28, mycobacteriosis, 614889 (3), Autosomal recessive
chr21	TMEM50B	617894.0 | TMEM50B, C21orf4 | Transmembrane protein 50B | 757.0 | ENSG00000142188 | nan | nan
chr21	GART	138440.0 | GART, PRGS, PGFT | Phosphoribosylglycinamide formyltransferase (phosphoribosylglycinamide synthetase; phosphoribosylaminoimidazole synthetase) | 2618.0 | ENSG00000159131 | multifunctional protein: Ade(-)C, Ade(-)G, GART | nan
chr21	SON	182465.0 | SON, TOKIMS | SON DNA-binding protein | 6651.0 | ENSG00000159140 | nan | ZTTK syndrome, 617140 (3), Autosomal dominant
chr21	DONSON	611428.0 | DONSON, C21orf60, MISSLA, MIMIS | Downstream neighbor of SON | 29980.0 | ENSG00000159147 | nan | Microcephaly, short stature, and limb abnormalities, 617604 (3), Autosomal recessive; Microcephaly-micromelia syndrome, 251230 (3), Autosomal recessive
chr21	CRYZL1	603920.0 | CRYZL1 | Crystallin, zeta-like 1 | 9946.0 | ENSG00000205758 | nan | nan
chr21	ITSN1	602442.0 | ITSN1, SH3D1A, SH3P17 | Intersectin 1 (SH3 domain protein-1A) | 6453.0 | ENSG00000205726 | nan | nan
chr21	ATP5PO	600828.0 | ATP5PO, ATP5O, MC5DN7 | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein) | 539.0 | ENSG00000241837 | nan | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 7, 620359 (3), Autosomal recessive
chr21	MRPS6	611973.0 | MRPS6 | Mitochondrial ribosomal protein S6 | 64968.0 | ENSG00000243927 | nan | nan
chr21	SLC5A3	600444.0 | SLC5A3 | Solute carrier family 5 (inositol transporter), member 3 | 6526.0 | ENSG00000198743 | ?role in Down syndrome | nan
chr21	KCNE2	603796.0 | KCNE2, MIRP1, LQT6, ATFB4 | Potassium voltage-gated channel, Isk-related family, member 2 | 9992.0 | ENSG00000159197 | nan | Long QT syndrome 6, 613693 (3), Autosomal dominant; Atrial fibrillation, familial, 4, 611493 (3)
chr21	KCNE1	176261.0 | KCNE1, JLNS, LQT5, JLNS2 | Potassium voltage-gated channel, Isk-related subfamily, member 1 | 3753.0 | ENSG00000180509 | nan | Jervell and Lange-Nielsen syndrome 2, 612347 (3), Autosomal recessive; Long QT syndrome 5, 613695 (3), Autosomal dominant
chr21	RCAN1	602917.0 | RCAN1, DSCR1, MCIP1, CSP1 | Regulator of calcineurin 1 | 1827.0 | ENSG00000159200 | nan | nan
chr21	CLIC6	615321.0 | CLIC6, CLIC1L | Chloride intracellular channel 6 | 54102.0 | ENSG00000159212 | nan | nan
chr21	RUNX1	151385.0 | RUNX1, CBFA2, AML1 | Runt-related transcription factor 1 (aml1 oncogene) | 861.0 | ENSG00000159216 | nan | Platelet disorder, familial, with associated myeloid malignancy, 601399 (3), Autosomal dominant; Leukemia, acute myeloid, 601626 (3), Somatic mutation, Autosomal dominant
chr21	MIR802	616090.0 | MIR802 | Micro RNA 802 | 768219.0 | ENSG00000211590 | nan | nan
chr21	SETD4	620995.0 | SETD4 | SET domain-containing protein 4 | 54093.0 | ENSG00000185917 | nan | nan
chr21	CBR1	114830.0 | CBR1 | Carbonyl reductase 1 | 873.0 | ENSG00000159228 | nan | nan
chr21	CBR3	603608.0 | CBR3 | Carbonyl reductase 3 | 874.0 | ENSG00000159231 | nan | nan
chr21	DOP1B	604803.0 | DOP1B, DOPEY2, 21orf5, KIAA0933 | DOP1 leucine zipper-like protein B | 9980.0 | ENSG00000142197 | nan | nan
chr21	MORC3	610078.0 | MORC3, NXP2 | MORC family CW-type zinc finger 3 | 23515.0 | ENSG00000159256 | nan | nan
chr21	CHAF1B	601245.0 | CAF1A | Chromatin assembly factor I, p60 subunit | 8208.0 | ENSG00000159259 | nan | nan
chr21	BMND6	609876.0 | BMND6 | Bone mineral density QTL 6 | 100188797.0 | nan | max lod at D21S1446 | [Bone mineral density QTL 6], 609876 (2)
chr21	MAFD3	609633.0 | MAFD3, BPEO | Major affective disorder 3 | 100188792.0 | nan | max lod at D21S1252 | {Major affective disorder 3, early onset}, 609633 (2)
chr21	CLDN14	605608.0 | CLDN14, DFNB29 | Claudin 14 | 23562.0 | ENSG00000159261 | nan | Deafness, autosomal recessive 29, 614035 (3), Autosomal recessive
chr21	SIM2	600892.0 | SIM2 | Single-minded, Drosophila, homolog of, 2 | 6493.0 | ENSG00000159263 | nan | nan
chr21	HLCS	609018.0 | HLCS, HCS | Holocarboxylase synthetase | 3141.0 | ENSG00000159267 | nan | Holocarboxylase synthetase deficiency, 253270 (3), Autosomal recessive
chr21	RIPPLY3	609892.0 | RIPPLY3, DSCR6 | Ripply transcriptional repressor 3 | 53820.0 | ENSG00000183145 | nan | nan
chr21	PIGP	605938.0 | PIGP, DSCR5, DEE55 | Phosphatidylinositol glycan, class P | 51227.0 | ENSG00000185808 | nan | Developmental and epileptic encephalopathy 55, 617599 (3), Autosomal recessive
chr21	TTC3	602259.0 | TTC3, TPRD | Tetratricopeptide repeat domain 3 | 7267.0 | ENSG00000182670 | nan | nan
chr21	VPS26C	605298.0 | VPS26C, DSCR3, DSCRA | VPS26 endosomal protein sorting factor C | 10311.0 | ENSG00000157538 | nan | nan
chr21	DYRK1A	600855.0 | DYRK1A, MNBH, MNB, MRD7 | Dual specificity tyrosine phosphorylation regulated kinase-1A | 1859.0 | ENSG00000157540 | ?triplicate state responsible for mental defect in Down syndrome | Intellectual developmental disorder, autosomal dominant 7, 614104 (3), Autosomal dominant
chr21	KCNJ6	600877.0 | KCNJ6, GIRK2, KCNJ7, KPLBS | Potassium inwardly-rectifying channel, subfamily J, member 6 | 3763.0 | ENSG00000157542 | nan | Keppen-Lubinsky syndrome, 614098 (3), Autosomal dominant
chr21	DSCR4	604829.0 | DSCR4, DSCRB | Down syndrome critical region gene 4 | 10281.0 | ENSG00000184029 | nan | nan
chr21	DSCR8	613396.0 | DSCR8, MMA1 | Down syndrome critical region gene 8 | 84677.0 | ENSG00000198054 | nan | nan
chr21	KCNJ15	602106.0 | KCNJ15 | Potassium inwardly-rectifying channel, subfamily J, member 15 | 3772.0 | ENSG00000157551 | nan | nan
chr21	ERG	165080.0 | ERG, LMPHM14 | ETS transcription factor ERG | 2078.0 | ENSG00000157554 | fused with EWS in Ewing sarcoma, with FUS in leukemia | Lymphatic malformation 14, 620602 (3), Autosomal dominant
chr21	LINC00114	611723.0 | C21orf24 | Chromosome 21 open reading frame 24 | 400866.0 | ENSG00000223806 | nan | nan
chr21	ETS2	164740.0 | ETS2 | ETS protooncogene 2, transcription factor | 2114.0 | ENSG00000157557 | proximal q22.3 | nan
chr21	PSMG1	605296.0 | PSMG1, DSCR2, C21LRP | Proteasome (prosome, macropain) assembly chaperone 1 | 8624.0 | ENSG00000183527 | nan | nan
chr21	BRWD1	617824.0 | BRWD1, WRD9, C21orf107, CILD51 | Bromodomain and WD repeat domain-containing protein 1 | 54014.0 | ENSG00000185658 | nan | Ciliary dyskinesia, primary, 51, 620438 (3), Autosomal recessive
chr21	HMGN1	163920.0 | HMGN1, HMG14 | High-mobility group nucleosomal binding protein 1 | 3150.0 | ENSG00000205581 | nan | nan
chr21	GET1	602915.0 | GET1, WRB, CHD5 | Guided entry of tail-anchored proteins factor 1 | 7485.0 | ENSG00000182093 | nan | nan
chr21	SH3BGR	602230.0 | SH3GBR | SH3 domain binding glutamic acid-rich protein | 6450.0 | ENSG00000185437 | nan | nan
chr21	B3GALT5	604066.0 | B3GALT5, GLCT5 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5 | 10317.0 | ENSG00000183778 | nan | nan
chr21	IGSF5	610638.0 | IGSF5, JAM4 | Immunoglobulin superfamily, member 5 | 150084.0 | ENSG00000183067 | nan | nan
chr21	PCP4	601629.0 | PCP4 | Purkinje cell protein 4 | 5121.0 | ENSG00000183036 | nan | nan
chr21	DSCAM	602523.0 | DSCAM | DS cell adhesion molecule | 1826.0 | ENSG00000171587 | nan | nan
chr21	BACE2	605668.0 | BACE2, ALP56, DRAP | Beta-site amyloid beta A4 precursor protein-cleaving enzyme 2 (Down syndrome region aspartic protease) | 25825.0 | ENSG00000182240 | nan | nan
chr21	PLAC4	613770.0 | PLAC4 | Placenta-specific gene 4 | 191585.0 | nan | nan | nan
chr21		190685.0 | DCR, DSCR | Down syndrome chromosome region | nan | nan | many genes are involved in this phenotype | Down syndrome, 190685 (4), Isolated cases
chr21	HPE1	236100.0 | HPE1 | Holoprosencephaly-1, alobar | 3244.0 | nan | nan | Holoprosencephaly 1, 236100 (2), Isolated cases, Autosomal dominant
chr21	FAM3B	608617.0 | FAM3B | Family with sequence similarity 3, member B | 54097.0 | ENSG00000183844 | nan | nan
chr21	MX2	147890.0 | MX2 | MX dynamin-like GTPase 2 | 4600.0 | ENSG00000183486 | nan | nan
chr21	MX1	147150.0 | MX1, MX, IFI78 | MX dynamin-like GTPase 1 | 4599.0 | ENSG00000157601 | nan | nan
chr21	TMPRSS2	602060.0 | TMPRSS2 | Transmembrane protease, serine 2 | 7113.0 | ENSG00000184012 | nan | nan
chr21	RIPK4	605706.0 | RIPK4, NKRD3, DIK, PPS2, CHANDS | Receptor-interacting serine-threonine kinase 4 | 54101.0 | ENSG00000183421 | nan | CHAND syndrome, 214350 (3), Autosomal recessive; Popliteal pterygium syndrome, Bartsocas-Papas type 1, 263650 (3), Autosomal recessive
chr21	PRDM15	617692.0 | PRDM15, ZNF298 | PR domain-containing protein 15 | 63977.0 | ENSG00000141956 | nan | nan
chr21	C2CD2	617581.0 | C2CD2, TMEM24L, C21orf25 | C2 calcium-dependent domain-containing protein 2 | 25966.0 | ENSG00000157617 | nan | nan
chr21	ZBTB21	616485.0 | ZBTB21, ZNF295, KIAA1227 | Zinc finger- and BTB domain-containing protein 21 | 49854.0 | ENSG00000173276 | nan | nan
chr21	UMODL1	613859.0 | UMODL1 | Uromodulin-like 1 | 89766.0 | ENSG00000177398 | nan | nan
chr21	ABCG1	603076.0 | ABCG1, ABC8, WHITE1 | ATP-binding cassette, subfamily G, member 1 (white, Drosophila, homolog of) | 9619.0 | ENSG00000160179 | nan | nan
chr21	TFF3	600633.0 | TFF3, ITF | Trefoil factor 3 (intestinal) | 7033.0 | ENSG00000160180 | nan | nan
chr21	TFF2	182590.0 | TFF2, SML1 | Trefoil factor 2 (spasmolytic protein-1) | 7032.0 | ENSG00000160181 | within 230kb of BCEI | nan
chr21	TFF1	113710.0 | TFF1, BCEI | Trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in) | 7031.0 | ENSG00000160182 | nan | nan
chr21	TMPRSS3	605511.0 | TMPRSS3, ECHOS1, DFNB8, DFNB10 | Transmembrane protease, serine 3 | 64699.0 | ENSG00000160183 | nan | Deafness, autosomal recessive 8/10, 601072 (3), Autosomal recessive
chr21	UBASH3A	605736.0 | UBASH3A | Ubiquitin-associated and SH3 domain-containing protein A | 53347.0 | ENSG00000160185 | nan | nan
chr21	RSPH1	609314.0 | RSPH1, TSGA2, TSA2, CILD24 | Radial spoke head component 1 | 89765.0 | ENSG00000160188 | nan | Ciliary dyskinesia, primary, 24, 615481 (3), Autosomal recessive
chr21	SLC37A1	608094.0 | SLC37A1, G3PP | Solute carrier family 37 (glycerol-3-phosphate transporter), member 1 | 54020.0 | ENSG00000160190 | nan | nan
chr21	PDE9A	602973.0 | PDE9A, HSPDE9A2 | Phosphodiesterase 9A | 5152.0 | ENSG00000160191 | nan | nan
chr21	WDR4	605924.0 | WDR4, MIGSB, GAMOS6 | WD repeat-containing protein 4 | 10785.0 | ENSG00000160193 | nan | Galloway-Mowat syndrome 6, 618347 (3), Autosomal recessive; Microcephaly, growth deficiency, seizures, and brain malformations, 618346 (3), Autosomal recessive
chr21	NDUFV3	602184.0 | NDUFV3 | NADH-ubiquinone oxidoreductase subunit V3 | 4731.0 | ENSG00000160194 | nan | nan
chr21	PKNOX1	602100.0 | PKNOX1 | PBX/knotted 1 homeobox 1 | 5316.0 | ENSG00000160199 | nan | nan
chr21	CBS	613381.0 | CBS | Cystathionine beta-synthase | 875.0 | ENSG00000160200 | subtelomeric | Thrombosis, hyperhomocysteinemic, 236200 (3), Autosomal recessive; Homocystinuria, B6-responsive and nonresponsive types, 236200 (3), Autosomal recessive
chr21	U2AF1	191317.0 | U2AF1 | U2(RNU2) small nuclear RNA auxillary factor 1 | 7307.0 | ENSG00000160201 | nan | nan
chr21	CRYAA	123580.0 | CRYAA, CRYA1, CTRCT9 | Crystallin, alpha A | 1409.0 | ENSG00000160202 | nan | Cataract 9, multiple types, 604219 (3), Autosomal recessive, Autosomal dominant
chr21	SIK1	605705.0 | SIK1, SNF1LK, MSK, DEE30 | Salt-inducible kinase 1 | 150094.0 | ENSG00000142178 | nan | Developmental and epileptic encephalopathy 30, 616341 (3), Autosomal dominant
chr21	HSF2BP	604554.0 | HSF2BP, POF19 | Heat-shock transcription factor 2-binding protein | 11077.0 | ENSG00000160207 | nan | Premature ovarian failure 19, 619245 (3), Autosomal recessive
chr21	RRP1B	610654.0 | RRP1B, KIAA0179, NNP1L | Ribosomal RNA-processing protein 1, S. cerevisiae, homolog of, B | 23076.0 | ENSG00000160208 | nan | nan
chr21	PDXK	179020.0 | PDXK, PNK, PKH, HMSN6C | Pyridoxal kinase | 8566.0 | ENSG00000160209 | nan | Neuropathy, hereditary motor and sensory, type VIC, with optic atrophy, 618511 (3), Autosomal recessive
chr21	CSTB	601145.0 | CSTB, STFB, EPM1, PME, EPM1A, ULD | Cystatin B (stefin B) | 1476.0 | ENSG00000160213 | nan | Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3), Autosomal recessive
chr21	RRP1	610653.0 | RRP1, NOP52, NNP1 | Ribosomal RNA-processing 1 | 8568.0 | ENSG00000160214 | nan | nan
chr21	AGPAT3	614794.0 | AGPAT3, LPAAT3 | 1-acylglycerol-3-phosphate O-acyltransferase 3 | 56894.0 | ENSG00000160216 | nan | nan
chr21	TRAPPC10	602103.0 | TRAPPC10, TMEM1, EHOC1, NEDMISS | Trafficking protein particle complex, subunit 10 | 7109.0 | ENSG00000160218 | near PWP2H | Neurodevelopmental disorder with microcephaly, short stature, and speech delay, 620027 (3), Autosomal recessive
chr21	PWP2	601475.0 | PWP2H, PWP2 | PWP2 small subunit processome component | 5822.0 | ENSG00000241945 | nan | nan
chr21	GATD3	601659.0 | GATD3A, ES1, HES1, GT335, C21orf33 | Glutamine amidotransferase-like class 1 domain-containing protein 3A | 8209.0 | ENSG00000160221 | nan | nan
chr21	ICOSLG	605717.0 | ICOSLG, B7H2, GL50, B7RP1, IMD119 | Inducible T-cell co-stimulator ligand | 23308.0 | ENSG00000160223 | mutation identified in 1 IMD119 patient | ?Immunodeficiency 119, 620825 (3), Autosomal recessive
chr21	DNMT3L	606588.0 | DNMT3L | DNA methyltransferase 3-like protein | 29947.0 | ENSG00000142182 | nan | nan
chr21	AIRE	607358.0 | AIRE, APECED, APS1 | Autoimmune regulator | 326.0 | ENSG00000160224 | nan | Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3), Autosomal recessive, Autosomal dominant
chr21	PFKL	171860.0 | PFKL | Phosphofructokinase, liver type | 5211.0 | ENSG00000141959 | nan | Hemolytic anemia due to phosphofructokinase deficiency (1)
chr21	CFAP410	603191.0 | CFAP410, C21orf2, SMDAX, RDMS | Cilia and flagella-associated protein 410 | 755.0 | ENSG00000160226 | nan | Retinal dystrophy with macular staphyloma, 617547 (3), Autosomal recessive; Spondylometaphyseal dysplasia, axial, 602271 (3), Autosomal recessive
chr21	TRPM2	603749.0 | TRPM2, TRPC7, KNP3 | Transient receptor potential cation channel, subfamily M, member 2 | 7226.0 | ENSG00000142185 | nan | nan
chr21	LRRC3	617620.0 | LRRC3, C21orf102, C21orf30 | Leucine-rich repeat-containing protein 3 | 81543.0 | ENSG00000160233 | nan | nan
chr21	TSPEAR	612920.0 | TSPEAR, C21orf29, DFNB98, ECTD14, STHAG10 | Thrombospondin-type laminin G domain and EAR repeats | 54084.0 | ENSG00000175894 | mutation identified in 1 DFNB98 family | Tooth agenesis, selective, 10, 620173 (3), Autosomal recessive; ?Deafness, autosomal recessive 98, 614861 (3), Autosomal recessive; Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis, 618180 (3), Autosomal recessive
chr21	UBE2G2	603124.0 | UBE2G2, UBC7 | Ubiquitin-conjugating enzyme E2 G2 | 7327.0 | ENSG00000184787 | nan | nan
chr21	SUMO3	602231.0 | SUMO3, SMT3H1 | Small ubiquitin-like modifier 3 | 6612.0 | ENSG00000184900 | nan | nan
chr21	PTTG1IP	603784.0 | PTTG1IP, C21orf1, C21orf3, PBF | PPTG1-interacting protein | 754.0 | ENSG00000183255 | nan | nan
chr21	ITGB2	600065.0 | ITGB2, CD18, LCAMB, LAD | Integrin, beta-2 (antigen CD18 (p95), lymphocyte function-associated antigen-1; macrophage antigen, beta polypeptide) | 3689.0 | ENSG00000160255 | common subunit for CR3, LFA1, and P150,95 | Leukocyte adhesion deficiency, 116920 (3), Autosomal recessive
chr21	LINC00163	610259.0 | LINC00163, NCRNA00163, NLC1A | Long intergenic nonprotein coding RNA 163 | 727699.0 | ENSG00000234880 | nan | nan
chr21	PICSAR	617191.0 | PICSAR, LINC00162, NLC1C | p38-inhibited cutaneous squamous cell carcinoma-associated long intergenic noncoding RNA | 378825.0 | ENSG00000275874 | nan | nan
chr21	ADARB1	601218.0 | ADARB1, RED1, NEDHYMS | Adenosine deaminase, RNA-specific, B1 (RED1, rat, homolog of) | 104.0 | ENSG00000197381 | nan | Neurodevelopmental disorder with hypotonia, microcephaly, and seizures, 618862 (3), Autosomal recessive
chr21	POFUT2	610249.0 | POFUT2, C21Orf80, KIAA0958 | Protein O-fucosyltransferase 2 | 23275.0 | ENSG00000186866 | nan | nan
chr21	COL18A1	120328.0 | COL18A1, KNO1, GLCC | Collagen XVIII, alpha-1 polypeptide | 80781.0 | ENSG00000182871 | nan | Knobloch syndrome, type 1, 267750 (3), Autosomal recessive; Glaucoma, primary closed-angle, 618880 (3), Autosomal dominant
chr21	SLC19A1	600424.0 | SLC19A1, FOLT, MEGAF, IMD114 | Solute carrier family 19 (folate transporter), member 1 | 6573.0 | ENSG00000173638 | mutation identified in 1 MEGAF patient | Immunodeficiency 114, folate-responsive, 620603 (3), Autosomal recessive; ?Megaloblastic anemia, folate-responsive, 601775 (3), Autosomal recessive
chr21	PCBP3	608502.0 | PCBP3 | Poly(rC)-binding protein 3 | 54039.0 | ENSG00000183570 | nan | nan
chr21	COL6A1	120220.0 | COL6A1, BTHLM1A, UCHMD1A | Collagen VI, alpha-1 polypeptide | 1291.0 | ENSG00000142156 | nan | Ullrich congenital muscular dystrophy 1A, 254090 (3), Autosomal recessive, Autosomal dominant; Bethlem myopathy 1A, 158810 (3), Autosomal dominant
chr21	COL6A2	120240.0 | COL6A2, BTHLM1B, UCMD1B | Collagen VI, alpha-2 polypeptide | 1292.0 | ENSG00000142173 | mutation identified in 1 MYSCL family | ?Myosclerosis, congenital, 255600 (3), Autosomal recessive; Ullrich congenital muscular dystrophy 1B, 620727 (3), Autosomal recessive, Autosomal dominant; Bethlem myopathy 1B, 620725 (3), Autosomal recessive, Autosomal dominant
chr21	FTCD	606806.0 | FTCD | Formiminotransferase cyclodeminase | 10841.0 | ENSG00000160282 | nan | Glutamate formiminotransferase deficiency, 229100 (3), Autosomal recessive
chr21	SPATC1L	612412.0 | C21orf56 | Chromosome 21 open reading frame 56 | 84221.0 | ENSG00000160284 | nan | nan
chr21	LSS	600909.0 | LSS, OSC, CTRCT44, HYPT14, APMR4 | Lanosterol synthase | 4047.0 | ENSG00000160285 | nan | Hypotrichosis 14, 618275 (3), Autosomal recessive; Cataract 44, 616509 (3), Autosomal recessive; Alopecia-intellectual disability syndrome 4, 618840 (3), Autosomal recessive
chr21	MCM3AP	603294.0 | MCM3AP, MAP80, GANP, PNRIID | Minichromosome maintenance 3-associated protein, 80-kD | 8888.0 | ENSG00000160294 | nan | Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development, 618124 (3), Autosomal recessive
chr21	YBEY	617461.0 | YBEY, C21orf57 | YBEY metallopeptidase | 54059.0 | ENSG00000182362 | nan | nan
chr21	PCNT	605925.0 | PCNT, PCNT2, KEN, SCKL4, MOPD2 | Pericentrin | 5116.0 | ENSG00000160299 | nan | Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3), Autosomal recessive
chr21	DIP2A	607711.0 | DIP2A, KIAA0184 | Disco-interacting protein 2 homolog A | 23181.0 | ENSG00000160305 | previously mapped to Chr.2 | nan
chr21	S100B	176990.0 | S100B | S100 calcium-binding protein, beta (neural) | 6285.0 | ENSG00000160307 | nan | nan
chr21	PRMT2	601961.0 | HRMT1L1, PRMT2 | HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 1 | 3275.0 | ENSG00000160310 | nan | nan
chr22	RNR5	180454.0 | RNR5 | Ribosomal RNA-5 | 6056.0 | nan | nan | nan
chr22	ZNF73P	194547.0 | ZNF73 | Zinc finger protein-73 (Cos12) | 105379427.0 | ENSG00000288262 | nan | nan
chr22	ACF	125520.0 | ACF | Asymmetric crying facies (Cayler cardiofacial syndrome) | 387569.0 | nan | nan | Cayler cardiofacial syndrome, 125520 (2), Autosomal dominant
chr22		115470.0 | CECR, CES | Cat eye syndrome | nan | nan | partial tetrasomy of 22q11 | Cat eye syndrome, 115470 (4), Autosomal dominant
chr22		151626.0 | LRE1, L1.2 | Line-1.2 retrotransposable element | nan | nan | nan | nan
chr22	POTEH	608913.0 | POTEH, POTE22, ACTBL1 | POTE ankyrin domain family, member H | 23784.0 | ENSG00000198062 | nan | nan
chr22	ZNF72AP	194546.0 | ZNF72 | Zinc finger protein-72 (Cos8) | 100287084.0 | nan | nan | nan
chr22	XKR3	611674.0 | XKR3, XTES, XRG3 | X Kell blood group precursor-related family, member 3 | 150165.0 | ENSG00000172967 | nan | nan
chr22	IL17RA	605461.0 | IL17RA, IL17R, IMD51 | Interleukin 17 receptor A | 23765.0 | ENSG00000177663 | nan | Immunodeficiency 51, 613953 (3), Autosomal recessive
chr22	ADA2	607575.0 | ADA2, CECR1, VAIHS, SNEDS | Adenosine deaminase 2 | 51816.0 | ENSG00000093072 | nan | Sneddon syndrome, 182410 (3), Autosomal recessive; Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome, 615688 (3), Autosomal recessive
chr22	CECR2	607576.0 | CECR2, KIAA1740 | CECR2 histone acetyl-lysine reader | 27443.0 | ENSG00000099954 | nan | nan
chr22		611867.0 | DEL22q11.2, C22DELq11.2 | Chromosome 22q11.2 deletion syndrome, distal | nan | nan | nan | Chromosome 22q11.2 deletion syndrome, distal, 611867 (4), Autosomal dominant
chr22		609029.0 | DER22t11-22 | Emanuel syndrome (supernumerary der(22)t(11;22) syndrome) | nan | nan | nan | Emanuel syndrome, 609029 (4), Inherited chromosomal imbalance
chr22		613700.0 | DER22t8-22 | Supernumerary der(22)t(8;22) syndrome | nan | nan | nan | Supernumerary der(22)t(8-22) syndrome, 613700 (4)
chr22	DFNB40	608264.0 | DFNB40 | Deafness, autosomal recessive 40 | 379003.0 | nan | nan | Deafness, autosomal recessive 40, 608264 (2), Autosomal recessive
chr22		608363.0 | DUP22q11.2 | Chromosome 22q11.2 microduplication syndrome | nan | nan | contiguous gene microduplication syndrome | Chromosome 22q11.2 microduplication syndrome, 608363 (4), Isolated cases, Autosomal dominant
chr22	GSTT1	600436.0 | GSTT1 | Glutathione S-transferase, theta-1 | 2952.0 | nan | nan | nan
chr22		147230.0 | IGLJ@ | Immunoglobulin lambda light chain joining gene cluster | 8217.0 | nan | nine J-C duplexes | nan
chr22		147240.0 | IGLV@ | Immunoglobulin lambda light chain variable gene cluster | 3546.0 | nan | many genes | nan
chr22	SLC25A18	609303.0 | SLC25A18, GC2 | Solute carrier family 25 (mitochondrial carrier, glutamate), member 18 | 83733.0 | ENSG00000182902 | nan | nan
chr22	ATP6V1E1	108746.0 | ATP6V1E1, ATP6E, ARCL2C | ATPase, H+ transporting, V1 subunit E1 | 529.0 | ENSG00000131100 | nan | Cutis laxa, autosomal recessive, type IIC, 617402 (3), Autosomal recessive
chr22	BCL2L13	619822.0 | BCL2L13 | BCL2-like 13 | 23786.0 | ENSG00000099968 | nan | nan
chr22	BID	601997.0 | BID | BH3-interacting domain death agonist | 637.0 | ENSG00000015475 | nan | nan
chr22	MICAL3	608882.0 | MICAL3, KIAA1364 | Microtubule-associated monooxygenase, calponin and LIM domains-containing 3 | 57553.0 | ENSG00000243156 | nan | nan
chr22	MIR648	616205.0 | MIR648 | Micro RNA 648 | 693233.0 | ENSG00000207780 | in intron 1 of MICAL3 | nan
chr22	PEX26	608666.0 | PEX26, PBD7A, PBD7B | Peroxisome biogenesis factor 26 | 55670.0 | ENSG00000215193 | nan | Peroxisome biogenesis disorder 7B, 614873 (3), Autosomal recessive; Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3), Autosomal recessive
chr22	TUBA8	605742.0 | TUBA8, TUBAL2, MACTHC2 | Tubulin, alpha 8 | 51807.0 | ENSG00000183785 | nan | Macrothrombocytopenia, isolated, 2, autosomal dominant, 619840 (3), Autosomal dominant
chr22	USP18	607057.0 | USP18, UBP43, ISG43, PTORCH2 | Ubiquitin-specific protease 18 | 11274.0 | ENSG00000184979 | nan | Pseudo-TORCH syndrome 2, 617397 (3), Autosomal recessive
chr22	GGTLC3	612340.0 | GGTLC3 | Gamma-glutamyltransferase, light chain 3 | 728226.0 | ENSG00000274252 | nan | nan
chr22	RIMBP3	612699.0 | RIMBP3, RIMBP3A, KIAA1666 | RIMS-binding protein 3 | 85376.0 | ENSG00000275793 | nan | nan
chr22	DGCR6	601279.0 | DGCR6 | DiGeorge syndrome critical region 6 | 8214.0 | ENSG00000183628 | nan | nan
chr22	PRODH	606810.0 | PRODH, PRODH2, SCZD4 | Proline dehydrogenase (proline oxidase) | 5625.0 | ENSG00000100033 | nan | {Schizophrenia, susceptibility to, 4}, 600850 (3), Autosomal dominant; Hyperprolinemia, type I, 239500 (3), Autosomal recessive
chr22	DGCR5	618040.0 | DGCR5, LINC00037 | Digeorge syndrome critical region gene 5 | 26220.0 | ENSG00000273032 | nan | nan
chr22	DGCR2	600594.0 | DGCR2, IDD | DiGeorge critical region gene 2 (integral membrane protein deleted in DiGeorge syndrome) | 9993.0 | ENSG00000070413 | nan | nan
chr22	ESS2	601755.0 | ESS2, DGSI, DGCR14 | Ess2 splicing factor, Xenopus, homolog of | 8220.0 | ENSG00000100056 | nan | nan
chr22	TSSK2	610710.0 | TSSK2, STK22B | Testis-specific serine/threonine kinase 2 | 23617.0 | ENSG00000206203 | nan | nan
chr22	GSC2	601845.0 | GSC2, GSCL | Goosecoid homeobox 2 | 2928.0 | ENSG00000063515 | nan | nan
chr22	SLC25A1	190315.0 | SLC25A1, SLC20A3, CTP, D2L2AD, CMS23 | Solute carrier family 25 (mitochondrial citrate transporter), member 1 | 6576.0 | ENSG00000100075 | nan | Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3), Autosomal recessive; Myasthenic syndrome, congenital, 23, presynaptic, 618197 (3), Autosomal recessive
chr22	CLTCL1	601273.0 | CLTCL1, CLTD | Clathrin, heavy polypeptide-like 1 | 8218.0 | ENSG00000070371 | nan | nan
chr22	DVL1P1	601225.0 | DVL1P1, DVL, DVL1 | Dishevelled segment polarity protein 1, pseudogene 1 | 8215.0 | nan | nan | nan
chr22	HIRA	600237.0 | HIRA, TUPLE1 | Histone cell cycle regulator | 7290.0 | ENSG00000100084 | ?role in CATCH22 | nan
chr22	MRPL40	605089.0 | MRPL40, NLVCF, MRPL22 | Mitochondrial ribosomal protein L40 | 64976.0 | ENSG00000185608 | nan | nan
chr22	UFD1	601754.0 | UFD1L | Ubiquitin fusion degradation 1-like | 7353.0 | ENSG00000070010 | ?role in CATCH22 | nan
chr22	CDC45	603465.0 | CDC45, CDC45L, CDC45L2, MGORS7 | Cell division cycle 45 | 8318.0 | ENSG00000093009 | nan | Meier-Gorlin syndrome 7, 617063 (3), Autosomal recessive
chr22	CLDN5	602101.0 | CLDN5, TMVCF, AWAL | Claudin-5 (transmembrane protein deleted in velocardiofacial syndrome) | 7122.0 | ENSG00000184113 | nan | nan
chr22	SEPTIN5	602724.0 | SEPT5, PNUTL1, CDCREL | Septin 5 | 5413.0 | ENSG00000184702 | just 5' of GP1BB | nan
chr22	GP1BB	138720.0 | GP1BB, BS, BDPLT1 | Glycoprotein Ib, platelet, beta polypeptide | 2812.0 | ENSG00000203618 | nan | Giant platelet disorder, isolated, 231200 (3), Autosomal recessive; Bernard-Soulier syndrome, type B, 231200 (3), Autosomal recessive
chr22	TBX1	602054.0 | TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR | T-box 1 | 6899.0 | ENSG00000184058 | nan | Tetralogy of Fallot, 187500 (3), Autosomal dominant; DiGeorge syndrome, 188400 (3), Autosomal dominant; Conotruncal anomaly face syndrome, 217095 (3); Velocardiofacial syndrome, 192430 (3), Autosomal dominant
chr22	GNB1L	610778.0 | GNB1L, WDR14 | Guanine nucleotide-binding protein, beta-1-like | 54584.0 | ENSG00000185838 | nan | nan
chr22	RTL10	620751.0 | RTL10, C22orf29 | Retrotransposon GAG-like 10 | 79680.0 | ENSG00000215012 | nan | nan
chr22	TXNRD2	606448.0 | TXNRD2, TRXR2, SELZ, GCCD5 | Thioredoxin reductase 2 | 10587.0 | ENSG00000184470 | mutation identified in 1 GCCD5 family | ?Glucocorticoid deficiency 5, 617825 (3), Autosomal recessive
chr22	COMT	116790.0 | COMT | Catechol-O-methyltransferase | 1312.0 | ENSG00000093010 | nan | {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Panic disorder, susceptibility to}, 167870 (3), ?Autosomal dominant
chr22	ARVCF	602269.0 | ARVCF | ARVCF delta catenin family member | 421.0 | ENSG00000099889 | ?role in VCFS | nan
chr22	TANGO2	616830.0 | TANGO2, C22orf25, MECRCN | Transport and golgi organization 2 homolog | 128989.0 | ENSG00000183597 | nan | Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3), Autosomal recessive
chr22	MIR185	615576.0 | MIR185 | Micro RNA 185 | 406961.0 | ENSG00000208023 | within first intron of C22orf25 | nan
chr22	DGCR8	609030.0 | DGCR8 | DGCR8 microprocessor complex subunit | 54487.0 | ENSG00000128191 | nan | nan
chr22	TRMT2A	611151.0 | TRMT2A, HTF9C | tRNA methyltransferase 2 homolog A | 27037.0 | ENSG00000099899 | nan | nan
chr22	RANBP1	601180.0 | RANBP1, HTF9A | RAN-binding protein 1 | 5902.0 | ENSG00000099901 | nan | nan
chr22	ZDHHC8	608784.0 | ZDHHC8, ZNF378, KIAA1292 | Zinc finger DHHC domain-containing protein 8 | 29801.0 | ENSG00000099904 | nan | nan
chr22	RTN4R	605566.0 | RTN4R, NOGOR | NOGO receptor (reticulon 4 receptor) | 65078.0 | ENSG00000040608 | nan | {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant
chr22	DGCR6L	609459.0 | DGCR6L | DiGeorge syndrome critical region gene 6-like | 85359.0 | ENSG00000128185 | nan | nan
chr22	ZNF74	194548.0 | ZNF74 | Zinc finger protein-74 (Cos52) | 7625.0 | ENSG00000185252 | nan | nan
chr22	SCARF2	613619.0 | SCARF2, SREC2, VDEGS | Scavenger receptor class F, member 2 | 91179.0 | ENSG00000244486 | nan | Van den Ende-Gupta syndrome, 600920 (3), Autosomal recessive
chr22	KLHL22	618020.0 | KLHL22 | Kelch-like 22 | 84861.0 | ENSG00000099910 | nan | nan
chr22	MED15	607372.0 | MED15, PCQAP, TIG1, ARC105 | Mediator complex subunit 15 | 51586.0 | ENSG00000099917 | nan | nan
chr22	PI4KA	600286.0 | PI4KA, PIK4CA, PMGYCHA, SPG84, GIDID2 | Phosphatidylinositol 4-kinase, alpha | 5297.0 | ENSG00000241973 | nan | Spastic paraplegia 84, autosomal recessive, 619621 (3), Autosomal recessive; Gastrointestinal defects and immunodeficiency syndrome 2, 619708 (3), Autosomal recessive; Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3), Autosomal recessive
chr22	SERPIND1	142360.0 | HCF2, HC2, SERPIND1, THPH10 | Heparin cofactor II | 3053.0 | ENSG00000099937 | proximal to BCR | Thrombophilia 10 due to heparin cofactor II deficiency, 612356 (3), Autosomal dominant
chr22	SNAP29	604202.0 | SNAP29, CEDNIK | Synaptosomal-associated protein, 29kD | 9342.0 | ENSG00000099940 | nan | Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3), Autosomal recessive
chr22	CRKL	602007.0 | CRKL | v-crk avian sarcoma virus CT10 oncogene homolog-like | 1399.0 | ENSG00000099942 | nan | nan
chr22	AIFM3	617298.0 | AIFM3, AIFL | Apoptosis-inducing factor, mitochondria-associated, 3 | 150209.0 | ENSG00000183773 | nan | nan
chr22	LZTR1	600574.0 | LZTR1, SWNTS2, NS10, NS2 | Leucine-zipper-like regulator-1 | 8216.0 | ENSG00000099949 | nan | Noonan syndrome 2, 605275 (3), Autosomal recessive; Noonan syndrome 10, 616564 (3), Autosomal dominant; {Schwannomatosis-2, susceptibility to}, 615670 (3), Autosomal dominant
chr22	THAP7	609518.0 | THAP7 | THAP domain-containing protein 7 | 80764.0 | ENSG00000184436 | nan | nan
chr22	P2RX6	608077.0 | P2RXL1, P2XM, P2X6 | Purinergic receptor P2X-like 1 | 9127.0 | ENSG00000099957 | nan | nan
chr22	SLC7A4	603752.0 | SLC7A4, CAT4 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 4 | 6545.0 | ENSG00000099960 | nan | nan
chr22	GGT2P	137181.0 | GGT2 | Gamma-glutamyltransferase-2 | 728441.0 | nan | nan | [Gamma-glutamyltransferase, familial high serum], 137181 (2)
chr22	RIMBP3B	612700.0 | RIMBP3B | RIMS-binding protein 3B | 440804.0 | ENSG00000274600 | nan | nan
chr22	HIC2	607712.0 | HIC2, HRG22, KIAA1020 | Hypermethylated in cancer 2 | 23119.0 | ENSG00000169635 | nan | nan
chr22	RIMBP3C	612701.0 | RIMBP3C | RIMS-binding protein 3C | 150221.0 | ENSG00000183246 | nan | nan
chr22	UBE2L3	603721.0 | UBE2L3, UBCH7 | Ubiquitin-conjugating enzyme E2 L3 | 7332.0 | ENSG00000185651 | pseudogenes on 12q12 and 19q13.1-q13.2 | nan
chr22	YDJC	619770.0 | YDJC | YDJC chitooligosaccharide deacetylase homolog | 150223.0 | ENSG00000161179 | nan | nan
chr22	SDF2L1	607551.0 | SDF2L1 | Stromal cell-derived factor 2-like 1 | 23753.0 | ENSG00000128228 | nan | nan
chr22	MIR130B	613682.0 | MIR130B, MIRN130B | Micro RNA 130B | 406920.0 | ENSG00000283871 | nan | nan
chr22	PPIL2	607588.0 | PPIL2, CYP60 | Peptidyl-prolyl isomerase-like 2 | 23759.0 | ENSG00000100023 | nan | nan
chr22	YPEL1	608082.0 | YPEL1 | Yippee-like 1 | 29799.0 | ENSG00000100027 | pseudogene on 9p24.3 | nan
chr22	MAPK1	176948.0 | MAPK1, PRKM1, ERK2, NS13 | Mitogen-activated protein kinase 1 | 5594.0 | ENSG00000100030 | nan | Noonan syndrome 13, 619087 (3), Autosomal dominant
chr22	PPM1F	619309.0 | PPM1F, POPX2, CAMKP | Protein phosphatase, magnesium/manganese-dependent, 1F | 9647.0 | ENSG00000100034 | nan | nan
chr22	TOP3B	603582.0 | TOP3B | Topoisomerase, DNA, III, beta | 8940.0 | ENSG00000100038 | nan | nan
chr22	VPREB1	605141.0 | VPREB1, IGI, VPREB | Pre-B lymphocyte gene 1 | 7441.0 | ENSG00000169575 | nan | nan
chr22	PRAME	606021.0 | PRAME, MAPE, OIP4 | PRAME nuclear receptor transcriptional regulator | 23532.0 | ENSG00000185686 | nan | nan
chr22	GGTLC2	612339.0 | GGTLC2, GGTL4 | Gamma-glutamyltransferase, light chain 2 | 91227.0 | ENSG00000100121 | nan | nan
chr22	MIR650	615379.0 | MIR650 | Micro RNA 650 | 723778.0 | ENSG00000284049 | nan | nan
chr22	IGLC1	147220.0 | IGLC1, IGLC | Constant region of lambda light chains | 3537.0 | ENSG00000211675 | several genes | nan
chr22	RSPH14	605663.0 | RSPH14, RTDR1 | Radial spoke head 14 homolog | 27156.0 | ENSG00000100218 | nan | nan
chr22	GNAZ	139160.0 | GNAZ | Guanine nucleotide-binding protein (G protein), alpha z polypeptide | 2781.0 | ENSG00000128266 | nan | nan
chr22	RAB36	605662.0 | RAB36 | Ras family, member 36 | 9609.0 | ENSG00000100228 | nan | nan
chr22	BCR	151410.0 | BCR, CML, PHL, ALL | BCR activator of RhoGEF and GTPase | 613.0 | ENSG00000186716 | Ph1=t(9;22) (q34.1;q11.21); fused with ABL in CML | Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic, 608232 (4); Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic, 613065 (4)
chr22	IGLL1	146770.0 | IGLL1, IGO, IGL5, VPREB2, AGM2 | Immunoglobulin lambda-like polypeptide 1 (immunoglobulin omega peptide) | 3543.0 | ENSG00000128322 | between BCR2 and BCR4; distal to IGLC | Agammaglobulinemia 2, 613500 (3), Autosomal recessive
chr22	RGL4	612214.0 | RGL4, RGR | Ral guanine nucleotide dissociation stimulator-like 4 | 266747.0 | ENSG00000159496 | nan | nan
chr22	ZNF70	194544.0 | ZNF70 | Zinc finger protein-70 (Cos17) | 7621.0 | ENSG00000187792 | nan | nan
chr22	VPREB3	605017.0 | VPREB3 | Pre-B-lymphocyte gene 3 | 29802.0 | ENSG00000128218 | nan | nan
chr22	CHCHD10	615903.0 | CHCHD10, FTDALS2, SMAJ, IMMD | Coiled-coil-helix-coiled-coil-helix domain-containing protein 10 | 400916.0 | ENSG00000250479 | mutation identified in 1 IMMD family | ?Myopathy, isolated mitochondrial, autosomal dominant, 616209 (3), Autosomal dominant; Spinal muscular atrophy, Jokela type, 615048 (3), Autosomal dominant; Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3), Autosomal dominant
chr22	MMP11	185261.0 | MMP11, STMY3 | Matrix metalloproteinase 11 (stromelysin 3) | 4320.0 | ENSG00000099953 | nan | nan
chr22	SMARCB1	601607.0 | SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 6598.0 | ENSG00000099956 | nan | Rhabdoid tumors, somatic, 609322 (3); {Schwannomatosis-1, susceptibility to}, 162091 (3), Autosomal dominant; Coffin-Siris syndrome 3, 614608 (3), Autosomal dominant; {Rhabdoid tumor predisposition syndrome 1}, 609322 (3), Autosomal dominant
chr22	DERL3	610305.0 | DERL3 | DER1-like domain family, member 3 | 91319.0 | ENSG00000099958 | nan | nan
chr22	SLC2A11	610367.0 | SLC2A11, GLUT11 | Solute carrier family 2 (facilitated glucose transporter), member 11 | 66035.0 | ENSG00000133460 | nan | nan
chr22	MIF	153620.0 | MIF | Macrophage migration inhibitory factor | 4282.0 | ENSG00000240972 | previously assigned to chr.19 | {Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3)
chr22	DDT	602750.0 | DDT | D-dopachrome tautomerase | 1652.0 | ENSG00000099977 | nan | nan
chr22	GSTT2	600437.0 | GSTT2 | Glutathione S-transferase theta-2 | 2953.0 | ENSG00000099984 | nan | nan
chr22	CABIN1	604251.0 | CABIN1, CAIN | Calcineurin-binding protein 1 | 23523.0 | ENSG00000099991 | nan | nan
chr22	SUSD2	615825.0 | SUSD2 | Sushi domain-containing protein 2 | 56241.0 | ENSG00000099994 | nan | nan
chr22	GGT5	137168.0 | GGT5 | Gamma-glutamyltransferase 5 | 2687.0 | ENSG00000099998 | nan | nan
chr22	SPECC1L	614140.0 | SPECC1L, KIAA0376, OBLFC1, TBHS1 | Sperm antigen with calponin homology and coiled-coil domains 1-like | 23384.0 | ENSG00000100014 | mutation identified in 1 OBLFC1 patient | Teebi hypertelorism syndrome 1, 145420 (3), Autosomal dominant; ?Facial clefting, oblique, 1, 600251 (3), Autosomal dominant
chr22	ADORA2A	102776.0 | ADORA2A | Adenosine A2a receptor | 135.0 | ENSG00000128271 | incorrectly assigned to 11q | nan
chr22	UPB1	606673.0 | UPB1, BUP1 | Beta-ureidopropionase | 51733.0 | ENSG00000100024 | nan | Beta-ureidopropionase deficiency, 613161 (3), Autosomal recessive
chr22	GUCD1	619171.0 | GUCD1 | Guanylyl cyclase domain-containing protein 1 | 83606.0 | ENSG00000138867 | nan | nan
chr22	SNRPD3	601062.0 | SNRPD3 | Small nuclear ribonucleoprotein polypeptide D3 | 6634.0 | ENSG00000100028 | nan | nan
chr22	GGT1	612346.0 | GGT1, GGT, GGTD | Gamma-glutamyltransferase 1 | 2678.0 | ENSG00000100031 | mutation identified in 1 GGTD family | ?Glutathioninuria, 231950 (3), Autosomal recessive
chr22	PIWIL3	610314.0 | PIWIL3 | PIWI-like RNA-mediated gene silencing 3 | 440822.0 | ENSG00000184571 | nan | nan
chr22	SGSM1	611417.0 | SGSM1, KIAA1941 | Small G protein signaling modulator 1 | 129049.0 | ENSG00000167037 | nan | nan
chr22	CRYBB3	123630.0 | CRYBB3, CRYB3, CATCN2, CTRCT22 | Crystallin, beta-B3 | 1417.0 | ENSG00000100053 | nan | Cataract 22, 609741 (3), Autosomal recessive, Autosomal dominant
chr22	CRYBB2	123620.0 | CRYBB2, CRYB2, CTRCT3, CCA2 | Crystallin, beta-B2 | 1415.0 | ENSG00000244752 | 2nd CRYB2 gene in same region | Cataract 3, multiple types, 601547 (3), Autosomal dominant
chr22	BRV2	613106.0 | BRV2 | Vertigo, benign recurrent, 2 | 100313948.0 | nan | nan | Vertigo, benign recurrent, 2, 613106 (2)
chr22	HCHGQ3	613284.0 | HCHGQ3 | Hematocrit/hemoglobin quantitative trait locus 3 | 100381206.0 | nan | associated with rs855791 | [Hematocrit/hemoglobin quantitative trait locus 3], 613284 (2)
chr22		606960.0 | ITS | Insulinoma tumor suppressor gene locus | 282551.0 | nan | nan | Insulinoma (1)
chr22	KAZA1	608207.0 | KAZA1 | Kala-azar (visceral leishmaniasis), susceptibility to, 1 | 387582.0 | nan | nan | {Kala-azar, susceptibility to, 1}, 608207 (2)
chr22	SQTL2	611004.0 | SQTL2 | Smoking as a quantitative trait locus 2 | 100188828.0 | nan | max lod at D22S315 | {Smoking as a quantitative trait locus 2}, 611004 (2)
chr22	GRK3	109636.0 | ADRBK2, BARK2, GRK3 | Adrenergic, beta, receptor kinase-2 | 157.0 | ENSG00000100077 | nan | nan
chr22	MYO18B	607295.0 | MYO18B, KFS4 | Myosin XVIIIB | 84700.0 | ENSG00000133454 | nan | Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3), Autosomal recessive
chr22	SEZ6L	607021.0 | SEZ6L | Seizure-related 6-like | 23544.0 | ENSG00000100095 | nan | nan
chr22	HPS4	606682.0 | HPS4 | HPS4 biogenesis of lysosomal organelles complex 3 subunit 2 | 89781.0 | ENSG00000100099 | nan | Hermansky-Pudlak syndrome 4, 614073 (3), Autosomal recessive
chr22	SRRD	602254.0 | SRRD | SRR1 domain-containing protein | 402055.0 | ENSG00000100104 | nan | nan
chr22	TFIP11	612747.0 | TFIP11, TIP39, NTR1 | Tuftelin-interacting protein 11 | 24144.0 | ENSG00000100109 | nan | nan
chr22	TPST2	603126.0 | TPST2 | Tyrosylprotein phosphotransferase 2 | 8459.0 | ENSG00000128294 | nan | nan
chr22	CRYBA4	123631.0 | CRYBA4, CTRCT23 | Crystallin, beta polypeptide A4 | 1413.0 | ENSG00000196431 | nan | Cataract 23, 610425 (3), Autosomal dominant
chr22	CRYBB1	600929.0 | CRYBB1, CATCN3, CTRCT17 | Crystallin, beta B1 | 1414.0 | ENSG00000100122 | nan | Cataract 17, multiple types, 611544 (3), Autosomal recessive, Autosomal dominant
chr22	MIAT	611082.0 | MIAT, C22orf35 | MIAT gene | 440823.0 | ENSG00000225783 | nan | {Myocardial infarction, susceptibility to}, 608446 (3)
chr22	MN1	156100.0 | MN1, MGCR, CEBALID | MN1 protooncogene, transcriptional regulator | 4330.0 | ENSG00000169184 | fused with TEL in AML | CEBALID syndrome, 618774 (3), Autosomal dominant; Meningioma, 607174 (3), Autosomal dominant
chr22	PITPNB	606876.0 | PITPNB | Phosphatidylinositol transfer protein, beta | 23760.0 | ENSG00000180957 | nan | nan
chr22	TTC28	615098.0 | TTC28, TPRBK, KIAA1043 | Tetratricopeptide repeat domain-containing protein 28 | 23331.0 | ENSG00000100154 | nan | nan
chr22	CHEK2	604373.0 | CHEK2, RAD53, CHK2, CDS1, TPDS4 | Checkpoint kinase 2 | 11200.0 | ENSG00000183765 | nan | Prostate cancer, somatic, 176807 (3); Osteosarcoma, somatic, 259500 (3); Tumor predisposition syndrome 4, breast/prostate/colorectal, 609265 (3)
chr22	HSCB	608142.0 | HSC20, HSCB, JAC1, SIDBA5 | HSCB mitochondrial iron-sulfur cluster cochaperone | 150274.0 | ENSG00000100209 | mutation identified in 1 patient | ?Anemia, sideroblastic, 5, 619523 (3), Autosomal recessive
chr22	XBP1	194355.0 | XBP1, XBP2 | X-box-binding protein-1 | 7494.0 | ENSG00000100219 | pseudogene on chr.5 | {Major affective disorder-7, susceptibility to}, 612371 (3)
chr22	ZNRF3	612062.0 | ZNRF3, KIAA1133 | Zinc finger and ring finger protein 3 | 84133.0 | ENSG00000183579 | nan | nan
chr22	KREMEN1	609898.0 | KREMEN1, KRM1, ECTD13 | Kringle domain-containing transmembrane protein 1 | 83999.0 | ENSG00000183762 | nan | Ectodermal dysplasia 13, hair/tooth type, 617392 (3), Autosomal recessive
chr22	EMID1	608926.0 | EMID1, EMU1 | EMI domain-containing protein 1 | 129080.0 | ENSG00000186998 | nan | nan
chr22	EWSR1	133450.0 | EWSR1, EWS | EWS RNA-binding protein 1 | 2130.0 | ENSG00000182944 | t(11;22)(q24;q12); t(21;22)(q22;q12) | Neuroepithelioma, 612219 (3); Ewing sarcoma, 612219 (3)
chr22	GAS2L1	602128.0 | GAS2L1, GAR22 | Growth arrest-specific 2 like 1 | 10634.0 | ENSG00000185340 | nan | nan
chr22	RASL10A	602220.0 | RASL10A, RRP22 | Ras-like, family 10, member A | 10633.0 | ENSG00000100276 | nan | nan
chr22	AP1B1	600157.0 | AP1B1, ADTB1, BAM22, CLAPB2, KIDAR | Adaptor-related protein complex 1, beta 1 subunit (adaptin, beta) | 162.0 | ENSG00000100280 | nan | Keratitis-ichthyosis-deafness syndrome, autosomal recessive, 242150 (3), Autosomal recessive
chr22	RFPL1	605968.0 | RFPL1 | RET finger protein-like 1 | 5988.0 | ENSG00000128250 | nan | nan
chr22	RFPL1S	605972.0 | RFPL1S | Ret finger protein-like 1, antisense | 10740.0 | nan | nan | nan
chr22	NEFH	162230.0 | NEFH, CMT2CC | Neurofilament, heavy polypeptide | 4744.0 | ENSG00000100285 | mutation identified in 1 family with ALS susceptibility | Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3), Autosomal dominant; {?Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3), Autosomal recessive, Autosomal dominant
chr22	THOC5	612733.0 | THOC5, FMIP | THO complex 5 | 8563.0 | ENSG00000100296 | nan | nan
chr22	NIPSNAP1	603249.0 | NIPSNAP1 | Nipsnap homolog 1 | 8508.0 | ENSG00000184117 | nan | nan
chr22	NF2	607379.0 | NF2, SWNV | Neurofibromin 2 | 4771.0 | ENSG00000186575 | nan | Meningioma, NF2-related, somatic, 607174 (3); Schwannomatosis, vestibular, 101000 (3), Autosomal dominant; Schwannomatosis, somatic, 101000 (3)
chr22	CABP7	618759.0 | CABP7, CALN2 | Calcium-binding protein 7 | 164633.0 | ENSG00000100314 | nan | nan
chr22	ZMAT5	619741.0 | ZMAT5 | Zinc finger, matrin-type 5 | 55954.0 | ENSG00000100319 | nan | nan
chr22	UQCR10	610843.0 | UQCR10, UCRC | Ubiquinol-cytochrome C reductase, complex III subunit X | 29796.0 | ENSG00000184076 | nan | nan
chr22	ASCC2	614216.0 | ASCC2, p100 | Activating signal cointegrator 1 complex, subunit 2 | 84164.0 | ENSG00000100325 | nan | nan
chr22	MTMR3	603558.0 | MTMR3 | Myotubularin-related protein 3 | 8897.0 | ENSG00000100330 | nan | nan
chr22	HORMAD2	618842.0 | HORMAD2 | HORMA domain-containing protein 2 | 150280.0 | ENSG00000176635 | nan | nan
chr22	LIF	159540.0 | LIF, HILDA | Leukemia inhibitory factor (cholinergic differentiation factor) | 3976.0 | ENSG00000128342 | distal to ES | nan
chr22	OSM	165095.0 | OSM | Oncostatin M | 5008.0 | ENSG00000099985 | 10kb from LIF | nan
chr22	CASTOR1	617034.0 | CASTOR1, GATSL3 | Cytosolic arginine sensor for mTORC1 subunit 1 | 652968.0 | ENSG00000239282 | nan | nan
chr22	TBC1D10A	610020.0 | TBC1D10A, EPI64 | TBC1 domain family, member 10A | 83874.0 | ENSG00000099992 | nan | nan
chr22	SF3A1	605595.0 | SF3A1, SF3A120, SAP114, PRP21 | Splicing factor 3A, subunit 1 | 10291.0 | ENSG00000099995 | nan | nan
chr22	CCDC157	619391.0 | CCDC157 | Coiled-coil domain-containing protein 157 | 550631.0 | ENSG00000187860 | nan | nan
chr22	SEC14L2	607558.0 | SEC14L2, TAP, KIAA1186 | SEC14-like lipid-binding protein 2 | 23541.0 | ENSG00000100003 | nan | nan
chr22	MTFP1	610235.0 | MTFP1 | Mitochondrial fission process 1 | 51537.0 | ENSG00000242114 | nan | nan
chr22	SEC14L3	612824.0 | SEC14L3, TAP2 | SEC14-like lipid-binding protein 3 | 266629.0 | ENSG00000100012 | nan | nan
chr22	SEC14L4	612825.0 | SEC14L4, TAP3 | SEC14-like lipid-binding protein 4 | 284904.0 | ENSG00000133488 | nan | nan
chr22	GAL3ST1	602300.0 | GAL3ST1, CST | Galactose-3-O-sulfotransferase 1 | 9514.0 | ENSG00000128242 | nan | nan
chr22	PES1	605819.0 | PES1, PES | Pescadillo ribosomal biogenesis factor 1 | 23481.0 | ENSG00000100029 | nan | nan
chr22	TCN2	613441.0 | TCN2, TC2 | Transcobalamin II | 6948.0 | ENSG00000185339 | linked to P1 | Transcobalamin II deficiency, 275350 (3), Autosomal recessive
chr22	DUSP18	611446.0 | DUSP18 | Dual-specificity phosphatase 18 | 150290.0 | ENSG00000167065 | nan | nan
chr22	OSBP2	606729.0 | OSBP2, ORP4, KIAA1664 | Oxysterol-binding protein 2 | 23762.0 | ENSG00000184792 | nan | nan
chr22	MORC2	616661.0 | MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z, DIGFAN | MORC family CW-type zinc finger protein 2 | 22880.0 | ENSG00000133422 | nan | Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3), Autosomal dominant; Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy, 619090 (3), Autosomal dominant
chr22	TUG1	614971.0 | TUG1 | Taurine-upregulated gene 1, noncoding | 55000.0 | ENSG00000253352 | nan | nan
chr22	SMTN	602127.0 | SMTN | Smoothelin | 6525.0 | ENSG00000183963 | nan | nan
chr22	SELENOM	610918.0 | SELENOM, SELM, SEPM | Selenoprotein M | 140606.0 | ENSG00000198832 | nan | nan
chr22	INPP5J	606481.0 | INPP5J, PIB5PA, PIPP | Inositol polyphosphate-5-phosphatase J | 27124.0 | ENSG00000185133 | nan | nan
chr22	PLA2G3	611651.0 | PLA2G3, SPLA2III | Phospholipase A2, group III | 50487.0 | ENSG00000100078 | nan | nan
chr22	RNF185	620096.0 | RNF185 | RING finger protein 185 | 91445.0 | ENSG00000138942 | nan | nan
chr22	LIMK2	601988.0 | LIMK2 | LIM domain kinase 2 | 3985.0 | ENSG00000182541 | nan | nan
chr22	PIK3IP1	619158.0 | PIK3IP1 | Phosphatidylinositol 3-kinase-interacting protein 1 | 113791.0 | ENSG00000100100 | nan | nan
chr22	PATZ1	605165.0 | ZNF278, PATZ, MAZR | Zinc finger protein-278 | 23598.0 | ENSG00000100105 | nan | nan
chr22	DRG1	603952.0 | DRG1, NEDD3, TANALS | Developmentally regulated GTP-binding protein 1 | 4733.0 | ENSG00000185721 | nan | Tan-Almurshedi syndrome, 620641 (3), Autosomal recessive
chr22	EIF4ENIF1	607445.0 | EIF4ENIF1 | Eukaryotic translation initiation factor 4E nuclear import factor 1 | 56478.0 | ENSG00000184708 | nan | nan
chr22	SFI1	612765.0 | SFI1, KIAA0542 | SFI1 centrin-binding protein | 9814.0 | ENSG00000198089 | nan | nan
chr22	PISD	612770.0 | PISD, PSD, PSSC, LIBF | Phosphatidylserine decarboxylase | 23761.0 | ENSG00000241878 | nan | Liberfarb syndrome, 618889 (3), Autosomal recessive
chr22	DEPDC5	614191.0 | DEPDC5, KIAA0645, FFEVF1, DEE111 | DEP domain-containing protein 5 | 9681.0 | ENSG00000100150 | nan | Epilepsy, familial focal, with variable foci 1, 604364 (3), Autosomal dominant; Developmental and epileptic encephalopathy 111, 620504 (3), Autosomal recessive
chr22	HPC6	609558.0 | HPC6 | Prostate cancer, hereditary, 6 | 100188789.0 | nan | between D22S1265 and D22S277 | {Prostate cancer, susceptibility to}, 609558 (2)
chr22	MDNS	613689.0 | MDNS | Mammary-digital-nail syndrome | 100529148.0 | nan | max lod at D22S277, D22S1142, D22S683, D22S283 | Mammary-digital-nail syndrome, 613689 (2), Autosomal dominant
chr22	YWHAH	113508.0 | YWHAH, YWHA1 | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide 22 | 7533.0 | ENSG00000128245 | nan | nan
chr22	SLC5A1	182380.0 | SLC5A1, SGLT1 | Solute carrier family 5 (sodium/glucose transporter), member 1 | 6523.0 | ENSG00000100170 | nan | Glucose/galactose malabsorption, 606824 (3), Autosomal recessive
chr22	RFPL2	605969.0 | RFPL2 | RET finger protein-like 2 | 10739.0 | ENSG00000128253 | nan | nan
chr22	SLC5A4	618633.0 | SLC5A4 | Solute carrier family 5 (low-affinity glucose cotransporter), member 4 | 6527.0 | ENSG00000100191 | nan | nan
chr22	RFPL3	605970.0 | RFPL3 | RET finger protein-like 3 | 10738.0 | ENSG00000128276 | nan | nan
chr22	RFPL3S	605971.0 | RFPL3S | Ret finger protein-like 3, antisense | 10737.0 | ENSG00000205853 | nan | nan
chr22	RTCB	613901.0 | RTCB, C22orf28, HSPC117 | RNA 2-prime, 3-prime cyclic phosphate and 5-prime-OH ligase | 51493.0 | ENSG00000100220 | nan | nan
chr22	BPIFC	614109.0 | BPIFC, BPIL2 | BPI fold-containing protein, family C | 254240.0 | ENSG00000184459 | nan | nan
chr22	FBXO7	605648.0 | FBXO7, FBX7, FBX, PKPS, PARK15 | F-box only protein 7 | 25793.0 | ENSG00000100225 | nan | Parkinson disease 15, autosomal recessive, 260300 (3), Autosomal recessive
chr22	SYN3	602705.0 | SYN3 | Synapsin III | 8224.0 | ENSG00000185666 | ?relation to schizophrenia | nan
chr22	TIMP3	188826.0 | TIMP3, SFD | Tissue inhibitor of metalloproteinase-3 | 7078.0 | ENSG00000100234 | nan | Sorsby fundus dystrophy, 136900 (3), Autosomal dominant
chr22	LARGE1	603590.0 | LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6 | Acetylglucosaminyltransferase-like protein | 9215.0 | ENSG00000133424 | nan | Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6, 608840 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3), Autosomal recessive
chr22	ISX	612019.0 | ISX, RAXLX | Intestine-specific homeobox | 91464.0 | ENSG00000175329 | nan | nan
chr22	HMGXB4	604702.0 | HMGXB4, HMG2L1 | HMG box domain-containing 4 | 10042.0 | ENSG00000100281 | nan | nan
chr22	TOM1	604700.0 | TOM1, IMD85 | Target of MYB1 membrane trafficking protein | 10043.0 | ENSG00000100284 | mutation identified in 1 IMD85 family | ?Immunodeficiency 85 and autoimmunity, 619510 (3), Autosomal dominant
chr22	HMOX1	141250.0 | HMOX1, HMOX1D | Heme oxygenase 1 | 3162.0 | ENSG00000100292 | nan | Heme oxygenase-1 deficiency, 614034 (3), Autosomal recessive; {Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
chr22	MCM5	602696.0 | MCM5, CDC46, MGORS8 | Minichromosome maintenance complex component 5 | 4174.0 | ENSG00000100297 | mutation identified in 1 MGORS8 patient | ?Meier-Gorlin syndrome 8, 617564 (3), Autosomal recessive
chr22	RASD2	612842.0 | RASD2, RHES, TEM2 | RASD family, member 2 | 23551.0 | ENSG00000100302 | nan | nan
chr22	MB	160000.0 | MB, MYOSB | Myoglobin | 4151.0 | ENSG00000198125 | nan | Myopathy, sarcoplasmic body, 620286 (3), Autosomal dominant
chr22	APOL6	607256.0 | APOL6 | Apolipoprotein L6 | 80830.0 | ENSG00000221963 | nan | nan
chr22	APOL5	607255.0 | APOL5 | Apolipoprotein L5 | 80831.0 | ENSG00000128313 | nan | nan
chr22	RBFOX2	612149.0 | RBFOX2, RBM9, FOX2, RTA | RNA binding protein, fox-1 homolog 2 | 23543.0 | ENSG00000100320 | nan | nan
chr22	APOL3	607253.0 | APOL3 | Apolipoprotein L3 | 80833.0 | ENSG00000128284 | nan | nan
chr22	APOL4	607254.0 | APOL4 | Apolipoprotein L4 | 80832.0 | ENSG00000100336 | nan | {Schizophrenia}, 181500 (1), Autosomal dominant
chr22	APOL2	607252.0 | APOL2 | Apolipoprotein L2 | 23780.0 | ENSG00000128335 | nan | {Schizophrenia}, 181500 (1), Autosomal dominant
chr22	APOL1	603743.0 | APOL1, FSGS4 | Apolipoprotein L1 | 8542.0 | ENSG00000100342 | nan | {Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3), Autosomal dominant
chr22	MYH9	160775.0 | MYH9, MHA, FTNS, DFNA17, BDPLT6, MATINS | Myosin, heavy polypeptide-9, nonmuscle | 4627.0 | ENSG00000100345 | nan | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, 155100 (3), Autosomal dominant; Deafness, autosomal dominant 17, 603622 (3), Autosomal dominant
chr22	TXN2	609063.0 | TXN2, TRX2, MTRX, COXPD29 | Thioredoxin 2 | 25828.0 | ENSG00000100348 | mutation identified in 1 COXPD29 patient | ?Combined oxidative phosphorylation deficiency 29, 616811 (3), Autosomal recessive
chr22	FOXRED2	613777.0 | FOXRED2, ERFAD | FAD-dependent oxidoreductase domain-containing protein 2 | 80020.0 | ENSG00000100350 | nan | nan
chr22	EIF3D	603915.0 | EIF3D, EIF3S7 | Eukaryotic translation initiation factor 3, subunit D | 8664.0 | ENSG00000100353 | nan | nan
chr22	CACNG2	602911.0 | CACNG2, MRD10 | Calcium channel, voltage-dependent, gamma-2 subunit (stargazin) | 10369.0 | ENSG00000166862 | mutation identified one MRD10 patient | ?Intellectual developmental disorder, autosomal dominant 10, 614256 (3), Autosomal dominant
chr22	IFT27	615870.0 | IFT27, RABL4, BBS19 | Intraflagellar transport 27 | 11020.0 | ENSG00000100360 | nan | Bardet-Biedl syndrome 19, 615996 (3), Autosomal recessive
chr22	PVALB	168890.0 | PVALB | Parvalbumin | 5816.0 | ENSG00000100362 | ?role in DiGeorge syndrome | nan
chr22	NCF4	601488.0 | NCF4, P40PHOX, CGD3 | Neutrophil cytosolic factor-4 | 4689.0 | ENSG00000100365 | nan | Chronic granulomatous disease 3, autosomal recessive, 613960 (3), Autosomal recessive
chr22	CSF2RB	138981.0 | CSF2RB, SMDP5 | Colony-stimulating factor-2 receptor, beta, low-affinity | 1439.0 | ENSG00000100368 | nan | Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3), Autosomal recessive
chr22	CIMIP4	620945.0 | CIMIP4, TEX33 | Ciliary microtubule inner protein 4 | 339669.0 | ENSG00000185264 | nan | nan
chr22	TST	180370.0 | TST, RDS | Thiosulfate sulfurtransferase (Rhodanese) | 7263.0 | ENSG00000128311 | nan | nan
chr22	MPST	602496.0 | MPST | Mercaptopyruvate sulfurtransferase | 4357.0 | ENSG00000128309 | nan | nan
chr22	KCTD17	616386.0 | KCTD17 | Potassium channel tetramerization domain-containing protein 17 | 79734.0 | ENSG00000100379 | nan | Dystonia 26, myoclonic, 616398 (3), Autosomal dominant
chr22	TMPRSS6	609862.0 | TMPRSS6, IRIDA | Transmembrane protease, serine 6 (matriptase 2) | 164656.0 | ENSG00000187045 | nan | Iron-refractory iron deficiency anemia, 206200 (3), Autosomal recessive
chr22	IL2RB	146710.0 | IL2RB, IMD63 | Interleukin-2 receptor, beta polypeptide | 3560.0 | ENSG00000100385 | nan | Immunodeficiency 63 with lymphoproliferation and autoimmunity, 618495 (3), Autosomal recessive
chr22	C1QTNF6	614910.0 | C1QTNF6, CTFP6 | C1q- and tumor necrosis factor-related protein 6 | 114904.0 | ENSG00000133466 | nan | nan
chr22		615538.0 | DUP22q13, C22DUPq13 | Chromosome 22q13 duplication syndrome | nan | nan | nan | Chromosome 22q13 duplication syndrome, 615538 (4), Isolated cases
chr22	NAFLD1	613282.0 | FLD1, NAFLD1 | Fatty liver disease, susceptibility to, 1 | 100380876.0 | nan | associated with rs738409 | {Fatty liver disease, susceptibility to, 1}, 613282 (2), Multifactorial
chr22	MENAQ1	610873.0 | MENAQ1 | Menarche, age at, QTL 1 | 100188822.0 | nan | max lod at UT7136 | {Menarche, age at, QTL}, 610873 (2)
chr22	NRCLP4	612417.0 | NRCLP4 | Narcolepsy 4 | 100216484.0 | nan | associated with rs5770917 | {Narcolepsy 4}, 612417 (2)
chr22	SSTR3	182453.0 | SSTR3 | Somatostatin receptor-3 | 6753.0 | ENSG00000278195 | nan | nan
chr22	RAC2	602049.0 | RAC2, IMD73A, IMD73B, IMD73C | Rac family small GTPase 2 | 5880.0 | ENSG00000128340 | mutation identified in 1 IMD73C family | Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis, 608203 (3), Autosomal dominant; ?Immunodeficiency 73C with defective neutrophil chemotaxis and hypogammaglobulinemia, 618987 (3), Autosomal recessive; Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia, 618986 (3), Autosomal dominant
chr22	CYTH4	606514.0 | CYTH4, PSCD4, CYT4 | Cytohesin 4 | 27128.0 | ENSG00000100055 | nan | nan
chr22	ELFN2	620223.0 | ELFN2, LRRC62, PPP1R29 | Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2 | 114794.0 | ENSG00000166897 | nan | nan
chr22	MFNG	602577.0 | MFNG | Manic fringe | 4242.0 | ENSG00000100060 | nan | nan
chr22	CARD10	607209.0 | CARD10, CARMA3, BIMP1, IMD89 | Caspase recruitment domain-containing protein 10 | 29775.0 | ENSG00000100065 | mutation identifed in 1 IMD89 family | ?Immunodeficiency 89 and autoimmunity, 619632 (3), Autosomal recessive
chr22	CDC42EP1	606084.0 | CDC42EP1, MSE55, BORG5, CEP1 | CDC42 effector protein 1 | 11135.0 | ENSG00000128283 | nan | nan
chr22	LGALS2	150571.0 | LGALS2 | Lectin, galactoside-binding, soluble, 2 | 3957.0 | ENSG00000100079 | nan | {Myocardial infarction, susceptibility to}, 608446 (3)
chr22	GGA1	606004.0 | GGA1 | Golgi associated, gamma adaptin ear containing, ARF binding protein 1 | 26088.0 | ENSG00000100083 | nan | nan
chr22	SH3BP1	617368.0 | SH3BP1, ARHGAP43, BGIN | SH3 domain-binding protein 1 | 23616.0 | ENSG00000100092 | nan | nan
chr22	PDXP	609246.0 | PDXP, CIN | Pyridoxal phosphatase | 57026.0 | ENSG00000241360 | nan | nan
chr22	LGALS1	150570.0 | LGALS1 | Lectin, galactose-binding, soluble, 1 | 3956.0 | ENSG00000100097 | nan | nan
chr22	TRIOBP	609761.0 | TRIOBP, KIAA1662 | Trio- and F-actin-binding protein | 11078.0 | ENSG00000100106 | nan | Deafness, autosomal recessive 28, 609823 (3), Autosomal recessive
chr22	H1-0	142708.0 | H1F0, H1FV | H1 histone family, member 0 | 3005.0 | ENSG00000189060 | nan | nan
chr22	GCAT	607422.0 | GCAT, KBL | Glycine C-acetyltransferase | 23464.0 | ENSG00000100116 | nan | nan
chr22	GALR3	603692.0 | GALR3 | Galanin receptor 3 | 8484.0 | ENSG00000128310 | nan | nan
chr22	ANKRD54	613383.0 | ANKRD54, LIAR | Ankyrin repeat domain-containing protein 54 | 129138.0 | ENSG00000100124 | nan | nan
chr22	MIR659	613556.0 | MIR659 | Micro RNA 659 | 724029.0 | ENSG00000207696 | nan | nan
chr22	EIF3L	619197.0 | EIF3L, HSPC021 | Eukaryotic translation initiation factor 3, subunit L | 51386.0 | ENSG00000100129 | nan | nan
chr22	MICALL1	619563.0 | MICALL1 | MICAL-like protein 1 | 85377.0 | ENSG00000100139 | nan | nan
chr22	C22orf23	619678.0 | C22orf23 | Chromosome 22 open reading frame 23 | 84645.0 | ENSG00000128346 | nan | nan
chr22	POLR2F	604414.0 | POLR2F | Polymerase II, RNA, subunit F | 5435.0 | ENSG00000100142 | nan | nan
chr22	SOX10	602229.0 | SOX10, WS4, WS4C, PCWH | SRY (sex-determining region Y)-box-10 | 6663.0 | ENSG00000100146 | megacolon and spotting in mice | Waardenburg syndrome, type 4C, 613266 (3), Autosomal dominant; PCWH syndrome, 609136 (3), Autosomal dominant; Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3), Autosomal dominant
chr22	PICK1	605926.0 | PICK1, PRKCABP | Protein interacting with C kinase 1 | 9463.0 | ENSG00000100151 | nan | nan
chr22	SLC16A8	610409.0 | SLC16A8, MCT3 | Solute carrier family 16 (monocarboxylic acid transporter), member 8 | 23539.0 | ENSG00000100156 | nan | nan
chr22	BAIAP2L2	617536.0 | BAIAP2L2, PINKBAR | Bai1-associated protein 2-like 2 | 80115.0 | ENSG00000128298 | nan | nan
chr22	PLA2G6	603604.0 | PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14 | Phospholipase A2, group VI | 8398.0 | ENSG00000184381 | nan | Parkinson disease 14, autosomal recessive, 612953 (3), Autosomal recessive; Neurodegeneration with brain iron accumulation 2B, 610217 (3), Autosomal recessive; Infantile neuroaxonal dystrophy 1, 256600 (3), Autosomal recessive
chr22	MAFF	604877.0 | MAFF | MAF bZIP transcription factor F | 23764.0 | ENSG00000185022 | nan | nan
chr22	CSNK1E	600863.0 | CSNK1E | Casein kinase-1, epsilon | 1454.0 | ENSG00000213923 | nan | nan
chr22	KCNJ4	600504.0 | KCNJ4, HIR | Potassium inwardly-rectifying channel, subfamily J, member 4 | 3761.0 | ENSG00000168135 | nan | nan
chr22	KDELR3	619900.0 | KDELR3, ERD23 | KDEL endoplasmic reticulum protein retention receptor 3 | 11015.0 | ENSG00000100196 | nan | nan
chr22	DDX17	608469.0 | DDX17, RH70, P72 | DEAD-box helicase 17 | 10521.0 | ENSG00000100201 | nan | nan
chr22	DMC1	602721.0 | DMC1, LIM15 | DNA meiotic recombinase 1 | 11144.0 | ENSG00000100206 | nan | nan
chr22	CBY1	607757.0 | CBY1, C22orf2 | Chibby family, member 1 | 25776.0 | ENSG00000100211 | nan | nan
chr22	TOMM22	607046.0 | TOMM22, TOM22 | Translocase of outer mitochondrial membrane 22 | 56993.0 | ENSG00000100216 | nan | nan
chr22	JOSD1	615323.0 | JOSD1, KIAA0063 | Josephin domain-containing protein 1 | 9929.0 | ENSG00000100221 | nan | nan
chr22	GTPBP1	602245.0 | GTPBP1, GP1, NEDFET1 | GTP-binding protein 1 | 9567.0 | ENSG00000100226 | nan | Neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1, 620888 (3), Autosomal recessive
chr22	SUN2	613569.0 | SUN2, UNC84B, KIAA0668 | SAD1 and UNC84 domain-containing protein 2 | 25777.0 | ENSG00000100242 | nan | nan
chr22	DNAL4	610565.0 | DNAL4, MRMV3 | Dynein, axonemal, light chain 4 | 10126.0 | ENSG00000100246 | mutation identified in 1 MRMV3 family | ?Mirror movements 3, 616059 (3), Autosomal recessive
chr22	NPTXR	609474.0 | NPTXR | Neuronal pentrasin receptor | 23467.0 | ENSG00000221890 | nan | nan
chr22	CBX6	617438.0 | CBX6 | Chromobox 6 | 23466.0 | ENSG00000183741 | nan | nan
chr22	APOBEC3A	607109.0 | APOBEC3A, PHRBN | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A (phorbolin 1) | 200315.0 | ENSG00000128383 | nan | nan
chr22	APOBEC3B	607110.0 | APOBEC3B, PHRBNL | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B | 9582.0 | ENSG00000179750 | nan | nan
chr22	APOBEC3C	607750.0 | APOBEC3C | Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3C | 27350.0 | ENSG00000244509 | nan | nan
chr22	APOBEC3D	609900.0 | APOBEC3D | Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3D | 140564.0 | ENSG00000243811 | nan | nan
chr22	APOBEC3F	608993.0 | APOBEC3F | Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3F | 200316.0 | ENSG00000128394 | nan | nan
chr22	APOBEC3G	607113.0 | APOBEC3G, MDS019, CEM15, FLJ12740 | Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G | 60489.0 | ENSG00000239713 | nan | nan
chr22	APOBEC3H	610976.0 | APOBEC3H, ARP10 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H | 164668.0 | ENSG00000100298 | nan | nan
chr22	CBX7	608457.0 | CBX7 | Chromobox 7 | 23492.0 | ENSG00000100307 | nan | nan
chr22	PDGFB	190040.0 | PDGFB, SIS, IBGC5 | Platelet-derived growth factor, beta polypeptide (oncogene SIS) | 5155.0 | ENSG00000100311 | fused with COL1A1 in DFSP | Meningioma, SIS-related, 607174 (3), Autosomal dominant; Basal ganglia calcification, idiopathic, 5, 615483 (3), Autosomal dominant; Dermatofibrosarcoma protuberans, 607907 (3)
chr22	RPL3	604163.0 | RPL3 | Ribosomal protein L3 | 6122.0 | ENSG00000100316 | nan | nan
chr22	SNORD83B	611071.0 | SNORD83B, RNU83B | Small nucleolar RNA, C/D box, 83B | 116938.0 | ENSG00000209480 | nan | nan
chr22	SNORD83A	611070.0 | SNORD83A, RNU83A | Small nucleolar RNA, C/D box, 83A | 116937.0 | ENSG00000209482 | nan | nan
chr22	SNORD139	611069.0 | RNU86 | RNA, U86 small nucleolar | 116936.0 | nan | nan | nan
chr22	SNORD43	611068.0 | SNORD43, RNU43 | Small nucleolar RNA, C/D box, 43 | 26807.0 | ENSG00000263764 | nan | nan
chr22	SYNGR1	603925.0 | SYNGR1 | Synaptogyrin 1 | 9145.0 | ENSG00000100321 | nan | nan
chr22	TAB1	602615.0 | TAB1, MAP3K7IP1 | Tak1 (MAP3K7) binding protein 1 | 10454.0 | ENSG00000100324 | nan | nan
chr22	MGAT3	604621.0 | MGAT3, GNT3 | Beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase | 4248.0 | ENSG00000128268 | nan | nan
chr22	MIEF1	615497.0 | MIEF1, SMCR7L, MID51, OPA14 | Mitochondrial elongation factor 1 | 54471.0 | ENSG00000100335 | nan | Optic atrophy 14, 620550 (3), Autosomal dominant
chr22	ATF4	604064.0 | ATF4, CREB2, TAXREB67 | Activating transcription factor 4 | 468.0 | ENSG00000128272 | nan | nan
chr22	RPS19BP1	610225.0 | RPS19BP1, S19BP, MGC52010 | Ribosomal protein S19 binding protein 1 | 91582.0 | ENSG00000187051 | nan | nan
chr22	CACNA1I	608230.0 | CACNA1I, KIAA1120, NEDSIS | Calcium channel, voltage-dependent, T type, alpha-1I subunit | 8911.0 | ENSG00000100346 | nan | Neurodevelopmental disorder with speech impairment and with or without seizures, 620114 (3), Autosomal dominant
chr22	GRAP2	604518.0 | GRAP2, GRID | GRB2-related adaptor protein 2 | 9402.0 | ENSG00000100351 | nan | nan
chr22	TNRC6B	610740.0 | TNRC6B, KIAA1093, GDSBA | Trinucleotide repeat-containing gene 6B | 23112.0 | ENSG00000100354 | nan | Global developmental delay with speech and behavioral abnormalities, 619243 (3), Autosomal dominant
chr22	ADSL	608222.0 | ADSL | Adenylosuccinate lyase | 158.0 | ENSG00000239900 | ade(-)I; bifunctional | Adenylosuccinase deficiency, 103050 (3), Autosomal recessive
chr22	SGSM3	610440.0 | SGSM3, RUTBC3, MAP, RUSC3 | Small G protein signaling modulator 3 | 27352.0 | ENSG00000100359 | nan | nan
chr22	MRTFA	606078.0 | MKL1, AMKL, MAL | Megakaryoblastic leukemia 1 gene | 57591.0 | ENSG00000196588 | mutation identified in 1 IMD66 patient | ?Immunodeficiency 66, 618847 (3), Autosomal recessive
chr22	MCHR1	601751.0 | MCHR1, GPR24, SLC1 | Melanin-concentrating hormone receptor 1 | 2847.0 | ENSG00000128285 | nan | nan
chr22	SLC25A17	606795.0 | SLC25A17, PMP34 | Solute carrier family 25 (mitochondrial carrier), member 17 (peroxisomal membrane protein, 34kD) | 10478.0 | ENSG00000100372 | nan | nan
chr22	ST13	606796.0 | ST13, P48, HOP | Suppression of tumorigenicity 13 | 6767.0 | ENSG00000100380 | nan | nan
chr22	XPNPEP3	613553.0 | XPNPEP3, APP3, NPHPL1 | X-prolyl aminopeptidase 3 | 63929.0 | ENSG00000196236 | nan | Nephronophthisis-like nephropathy 1, 613159 (3), Autosomal recessive
chr22	DNAJB7	611336.0 | DNAJB7, DJ5, HSC3 | DNAJ/HSP40 homolog, subfamily B, member 7 | 150353.0 | ENSG00000172404 | nan | nan
chr22	RBX1	603814.0 | RBX1, ROC1 | RING-box 1 | 9978.0 | ENSG00000100387 | nan | nan
chr22	EP300	602700.0 | EP300, RSTS2, MKHK2 | E1A-binding protein, 300kD | 2033.0 | ENSG00000100393 | nan | Menke-Hennekam syndrome 2, 618333 (3), Autosomal dominant; Colorectal cancer, somatic, 114500 (3); Rubinstein-Taybi syndrome 2, 613684 (3), Autosomal dominant
chr22	L3MBTL2	611865.0 | L3MBTL2, L3MBT | L3MBTL histone methyl-lysine-binding protein 2 | 83746.0 | ENSG00000100395 | nan | nan
chr22	CHADL	616236.0 | CHADL | Chondroadherin-like | 150356.0 | ENSG00000100399 | nan | nan
chr22	RANGAP1	602362.0 | RANGAP1 | GTPase-activating protein, RAN, 1 | 5905.0 | ENSG00000100401 | nan | nan
chr22	ZC3H7B	618206.0 | ZC3H7B, ROXAN1, KIAA1031 | Zinc finger CCCH domain-containing protein 7B | 23264.0 | ENSG00000100403 | nan | nan
chr22	TEF	188595.0 | TEF | Thyrotroph embryonic factor | 7008.0 | ENSG00000167074 | nan | nan
chr22	TOB2	607396.0 | TOB2, KIAA1663 | Transducer of erbb2, 2 | 10766.0 | ENSG00000183864 | nan | nan
chr22	PHF5A	617846.0 | PHF5A, SF3B7, SF3B14B | PHD finger protein 5A | 84844.0 | ENSG00000100410 | nan | nan
chr22	ACO2	100850.0 | ACO2, ICRD, OPA9 | Aconitase 2 | 50.0 | ENSG00000100412 | distal to Ph1 break | Optic atrophy 9, 616289 (3), Autosomal recessive, Autosomal dominant; Infantile cerebellar-retinal degeneration, 614559 (3), Autosomal recessive
chr22	POLR3H	619801.0 | POLR3H, RPC8, KIAA1665 | RNA polymerase III, subunit H | 171568.0 | ENSG00000100413 | nan | nan
chr22	CSDC2	617689.0 | CSDC2, PIPPIN | Cold-shock domain-containing protein C2 | 27254.0 | ENSG00000172346 | nan | nan
chr22	PMM1	601786.0 | PMM1 | Phosphomannomutase 1 | 5372.0 | ENSG00000100417 | nan | nan
chr22	DESI1	614637.0 | DESI1, PPPDE2 | Desumoylating isopeptidase 1 | 27351.0 | ENSG00000100418 | nan | nan
chr22	XRCC6	152690.0 | XRCC6, G22P1, TLAA, Ku70 | X-ray repair cross complementing | 2547.0 | ENSG00000196419 | tight linkage to CYP2D | nan
chr22	SNU13	601304.0 | NHP2L1 | Non-histone chromosome protein 2, S. cerevisiae, like 1 | 4809.0 | ENSG00000100138 | previously assigned to 12q24.3 by FISH | nan
chr22	MEI1	608797.0 | MEI1, SPATA38, HYDM3 | Meiotic double-stranded break formation protein 1 | 150365.0 | ENSG00000167077 | nan | Hydatidiform mole, recurrent, 3, 618431 (3), Autosomal recessive
chr22	CCDC134	618788.0 | CCDC134, OI22 | Coiled-coil domain-containing protein 134 | 79879.0 | ENSG00000100147 | nan | Osteogenesis imperfecta, type XXII, 619795 (3), Autosomal recessive
chr22	SREBF2	600481.0 | SREBF2 | Sterol regulatory element binding transcription factor 2 | 6721.0 | ENSG00000198911 | nan | nan
chr22	MIR33A	612156.0 | MIR33A, MIRN33A | Micro RNA 33A | 407039.0 | ENSG00000207932 | nan | nan
chr22	SHISA8	617329.0 | SHISA8 | Shisa family, member 8 | 440829.0 | ENSG00000234965 | nan | nan
chr22	TNFRSF13C	606269.0 | TNFRSF13C, BAFFR, CVID4 | Tumor necrosis factor receptor superfamily, member 13C | 115650.0 | ENSG00000159958 | nan | Immunodeficiency, common variable, 4, 613494 (3), Autosomal recessive
chr22	CENPM	610152.0 | PANE1, C22orf18 | Proliferation-associated nuclear element 1 | 79019.0 | ENSG00000100162 | nan | nan
chr22	SEPTIN3	608314.0 | SEPT3, SEP3 | Septin 3 | 55964.0 | ENSG00000100167 | nan | nan
chr22	WBP2NL	610981.0 | WBP2NL, PAWP | WWBP2 N-terminal-like protein | 164684.0 | ENSG00000183066 | nan | nan
chr22	NAGA	104170.0 | NAGA | Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B) | 4668.0 | ENSG00000198951 | proximal to Ph1 break | Schindler disease, type I, 609241 (3), Autosomal recessive; Kanzaki disease, 609242 (3), Autosomal recessive; Schindler disease, type III, 609241 (3), Autosomal recessive
chr22	PHETA2	614240.0 | PHETA2, FAM109B, SES2, IPIP27B | PH domain-containing endocytic trafficking adaptor 2 | 150368.0 | ENSG00000177096 | nan | nan
chr22	SMDT1	615588.0 | SMDT1, EMRE, C22orf32 | Single-pass membrane protein with aspartate-rich tail 1 | 91689.0 | ENSG00000183172 | nan | nan
chr22	NDUFA6	602138.0 | NDUFA6, MC1DN33 | NADH-ubiquinone oxidoreductase subunit A6 | 4700.0 | ENSG00000184983 | nan | Mitochondrial complex I deficiency, nuclear type 33, 618253 (3), Autosomal recessive
chr22	CYP2D6	124030.0 | CYP2D6, CPD6, P450DB1 | Cytochrome P450, subfamily IID, polypeptide 6 | 1565.0 | ENSG00000100197 | nan | {Codeine sensitivity}, 608902 (3), Autosomal recessive; {Debrisoquine sensitivity}, 608902 (3), Autosomal recessive
chr22	TCF20	603107.0 | TCF20, SPBP, AR1, DDVIBA | Transcription factor 20 | 6942.0 | ENSG00000100207 | nan | Developmental delay with variable intellectual impairment and behavioral abnormalities, 618430 (3), Autosomal dominant
chr22	NFAM1	608740.0 | NFAM1, CNAIP | NFAT activating protein with ITAM motif 1 | 150372.0 | ENSG00000235568 | nan | nan
chr22	SERHL	607979.0 | SERHL | Serine hydrolase-like, pseudogene | 94009.0 | ENSG00000293485 | nan | nan
chr22	RRP7A	619449.0 | RRP7A, MCPH28 | Ribosomal RNA processing 7 homolog A | 27341.0 | ENSG00000189306 | mutation identified in 1 MCPH28 family | ?Microcephaly 28, primary, autosomal recessive, 619453 (3), Autosomal recessive
chr22	SERHL2	619045.0 | SERHL2 | Serine hydrolase-like 2 | 253190.0 | ENSG00000183569 | nan | nan
chr22	POLDIP3	611520.0 | POLDIP3, SKAR, PDIP46 | Polymerase delta-interacting protein 3 | 84271.0 | ENSG00000100227 | nan | nan
chr22	RNU12	620204.0 | RNU12, SCAR33, CDAGS | RNA, U12 small nuclear | 267010.0 | ENSG00000276027 | mutation identified in 1 SCAR33 family | CDAGS syndrome, 603116 (3), Autosomal recessive; ?Spinocerebellar ataxia, autosomal recessive 33, 620208 (3), Autosomal recessive
chr22	CYB5R3	613213.0 | CYB5R3, DIA1, B5R | Cytochrome b5 reductase 3 | 1727.0 | ENSG00000100243 | nan | Methemoglobinemia, type I, 250800 (3), Autosomal recessive; Methemoglobinemia, type II, 250800 (3), Autosomal recessive
chr22	A4GALT	607922.0 | A4GALT, P1PK | Alpha 1,4-galactosyltransferase | 53947.0 | ENSG00000128274 | nan | [Blood group, P1Pk system, P(2) phenotype], 111400 (3); NOR polyagglutination syndrome, 111400 (3); [Blood group, P1Pk system, p phenotype], 111400 (3)
chr22	ARFGAP3	612439.0 | ARFGAP3 | ADP-ribosylation factor GTPase-activating protein 3 | 26286.0 | ENSG00000242247 | nan | nan
chr22	PACSIN2	604960.0 | PACSIN2 | Protein kinase C and casein kinase substrate in neurons 2 | 11252.0 | ENSG00000100266 | nan | nan
chr22	TTLL1	608955.0 | TTLL1, KIAA0173 | Tubulin tyrosine ligase-like 1 | 25809.0 | ENSG00000100271 | nan | nan
chr22	BIK	603392.0 | BIK, NBK | Bcl2-interacting killer | 638.0 | ENSG00000100290 | nan | nan
chr22	MCAT	614479.0 | MCAT, OPA15 | Malonyl CoA:ACP acyltransferase, mitochondrial | 27349.0 | ENSG00000100294 | nan | Optic atrophy 15, 620583 (3), Autosomal recessive
chr22	TSPO	109610.0 | TSPO, BZRP, PBR, PBS, BPBS | Translocator protein, 18kD (benzodiazepine receptor, peripheral type) | 706.0 | ENSG00000100300 | nan | nan
chr22	TTLL12	619410.0 | TTLL12 | Tubulin tyrosine ligase-like 12 | 23170.0 | ENSG00000100304 | nan | nan
chr22	SCUBE1	611746.0 | SCUBE1 | Signal peptide-, CUB domain-, and EGF-like domains-containing protein 1 | 80274.0 | ENSG00000159307 | nan | nan
chr22	MPPED1	602112.0 | MPPED1, C22orf1, 239AB | Metallophosphoesterase domain-containing protein 1 | 758.0 | ENSG00000186732 | nan | nan
chr22	EFCAB6	619664.0 | EFCAB6, KIAA1672, DJBP | EF-hand calcium binding domain 6 | 64800.0 | ENSG00000186976 | nan | nan
chr22	SULT4A1	608359.0 | SULT4A1, BRSTL1 | Sulfotransferase family 4A, member 1 | 25830.0 | ENSG00000130540 | nan | nan
chr22	PNPLA5	611589.0 | PNPLA5, GS2L | Patatin-like phospholipase domain-containing 5 | 150379.0 | ENSG00000100341 | nan | nan
chr22	PNPLA3	609567.0 | PNPLA3, ADPN | Patatin-like phospholipase domain-containing protein 3 | 80339.0 | ENSG00000100344 | nan | nan
chr22	SAMM50	612058.0 | SAMM50, SAM50 | SAMM50 sorting ans assembly machinery component | 25813.0 | ENSG00000100347 | nan | nan
chr22	PARVB	608121.0 | PARVB | Parvin, beta | 29780.0 | ENSG00000188677 | nan | nan
chr22	PARVG	608122.0 | PARVG | Parvin, gamma | 64098.0 | ENSG00000138964 | nan | nan
chr22	SHISAL1	620220.0 | SHISAL1, KIAA1644 | Shisa-like 1 | 85352.0 | ENSG00000138944 | nan | nan
chr22	PRR5	609406.0 | PRR5, PP610 | Proline-rich protein 5 | 55615.0 | ENSG00000186654 | nan | nan
chr22	ARHGAP8	609405.0 | ARHGAP8, BPGAP1 | GTPase-activating protein, RHO, 8 | 23779.0 | ENSG00000241484 | nan | nan
chr22	PHF21B	616727.0 | PHF21B, PHF4, BHC80L | PHD finger protein 21B | 112885.0 | ENSG00000056487 | nan | nan
chr22	NUP50	604646.0 | NUP50, NPAP60L, NPAP60 | Nucleoporin, 50 kD | 10762.0 | ENSG00000093000 | nan | nan
chr22	KIAA0930	619709.0 | KIAA0930 | KIAA0930 gene | 23313.0 | ENSG00000100364 | nan | nan
chr22	UPK3A	611559.0 | UPK3A, UPK3, UPIII | Uroplakin 3A | 7380.0 | ENSG00000100373 | nan | nan
chr22	SMC1B	608685.0 | SMC1B, SMC1L2 | Structural maintenance of chromosome 1B | 27127.0 | ENSG00000077935 | nan | nan
chr22	FBLN1	135820.0 | FBLN1 | Fibulin 1 | 2192.0 | ENSG00000077942 | nan | Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (4), Autosomal dominant
chr22	ATXN10	611150.0 | ATXN10, SCA10 | Ataxin 10 | 25814.0 | ENSG00000130638 | ATTCTn repeat in intron 9 | Spinocerebellar ataxia 10, 603516 (3), Autosomal dominant
chr22	WNT7B	601967.0 | WNT7B | Wingless-type MMTV integration site family, member-7B | 7477.0 | ENSG00000188064 | nan | nan
chr22	MIRLET7BHG	618216.0 | MIRLET7BHG, LINC-PPARA | MIRLET7B host gene, noncoding | 400931.0 | ENSG00000197182 | nan | nan
chr22	MIRLET7A3	612143.0 | MIRLET7A3, LET7A3, MIRNLET7A3 | Micro RNA let7a3 | 406883.0 | ENSG00000283990 | nan | nan
chr22	MIRLET7B	611249.0 | MIRLET7B, LET7B, MIRNLET7B | Micro RNA Let7B | 406884.0 | ENSG00000284520 | nan | nan
chr22	PPARA	170998.0 | PPARA, PPAR | Peroxisome proliferator-activated receptor-alpha | 5465.0 | ENSG00000186951 | nan | nan
chr22	PKDREJ	604670.0 | PKDREJ | Polycystic kidney disease and sea urchin REJ homolog-like | 10343.0 | ENSG00000130943 | nan | nan
chr22	GTSE1	607477.0 | GTSE1 | G2 and S-phase expressed 1 | 51512.0 | ENSG00000075218 | nan | nan
chr22	TRMU	610230.0 | TRMU, MTO2 | tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase | 55687.0 | ENSG00000100416 | nan | {Deafness, mitochondrial, modifier of}, 580000 (3), Mitochondrial; Liver failure, transient infantile, 613070 (3), Autosomal recessive
chr22	CELSR1	604523.0 | CELSR1, LMPHM9 | Cadherin EGF LAG seven-pass G-type receptor 1 | 9620.0 | ENSG00000075275 | nan | Lymphatic malformation 9, 619319 (3), Autosomal dominant
chr22	GRAMD4	613691.0 | GRAMD4, KIAA0767, DIP | Gram domain-containing protein 4 | 23151.0 | ENSG00000075240 | nan | nan
chr22	CERK	610307.0 | CERK, KIAA1646 | Ceramide kinase | 64781.0 | ENSG00000100422 | nan | nan
chr22	TBC1D22A	616879.0 | TBC1D22A, C22orf4 | TBC1 domain family, member 22A | 25771.0 | ENSG00000054611 | nan | nan
chr22	TAFA5	617499.0 | FAM19A5, TAFA5 | Family with sequence similarity 19, member A5, CC motif chemokine-like | 25817.0 | ENSG00000219438 | nan | nan
chr22	BRD1	604589.0 | BRL | BR140-like gene | 23774.0 | ENSG00000100425 | nan | nan
chr22	ZBED4	612552.0 | ZBED4, KIAA0637 | Zinc finger BED domain-containing protein 4 | 9889.0 | ENSG00000100426 | nan | nan
chr22	ALG12	607144.0 | ALG12, CDG1G | ALG12 alpha-1,6-mannosyltransferase | 79087.0 | ENSG00000182858 | nan | Congenital disorder of glycosylation, type Ig, 607143 (3), Autosomal recessive
chr22	CRELD2	607171.0 | CRELD2 | Cysteine-rich protein with EGF-like domains 2 | 79174.0 | ENSG00000184164 | nan | nan
chr22	PIM3	610580.0 | PIM3 | Oncogene PIM3 | 415116.0 | ENSG00000198355 | nan | nan
chr22	IL17REL	613414.0 | IL17REL | Interleukin 17 receptor E-like | 400935.0 | ENSG00000188263 | nan | nan
chr22	TTLL8	619193.0 | TTLL8 | Tubulin tyrosine ligase-like 8 | 164714.0 | ENSG00000138892 | nan | nan
chr22	MLC1	605908.0 | MLC1, LVM, VL, MLC1 | Modulator of VRAC current 1 | 23209.0 | ENSG00000100427 | nan | Megalencephalic leukoencephalopathy with subcortical cysts 1, 604004 (3), Autosomal recessive
chr22	MOV10L1	605794.0 | MOV10L1, SPGF73 | MOV10-like RISC complex RNA helicase 1 | 54456.0 | ENSG00000073146 | mutation identified in 1 SPGF73 family | ?Spermatogenic failure 73, 619878 (3), Autosomal recessive
chr22	PANX2	608421.0 | PANX2, PX2 | Pannexin 2 | 56666.0 | ENSG00000073150 | nan | nan
chr22	SELENOO	607917.0 | SELENOO, SELO | Selenoprotein O | 83642.0 | ENSG00000073169 | nan | nan
chr22	TUBGCP6	610053.0 | TUBGCP6, GCP6, KIAA1669, MCCRP1 | Tubulin-gamma complex-associated protein 6 | 85378.0 | ENSG00000128159 | nan | Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3), Autosomal recessive
chr22	HDAC10	608544.0 | HDAC10 | Histone deacetylase 10 | 83933.0 | ENSG00000100429 | nan | nan
chr22	MAPK12	602399.0 | MAPK12, SAPK3, ERK3 | Mitogen-activated protein kinase 12 (Stress-activated protein kinase-3) | 6300.0 | ENSG00000188130 | nan | nan
chr22	MAPK11	602898.0 | MAPK11, PRKM11, SAPK2B | Mitogen-activated protein kinase 11 | 5600.0 | ENSG00000185386 | nan | nan
chr22	PLXNB2	604293.0 | PLXNB2, MM1 | Plexin B2 | 23654.0 | ENSG00000196576 | nan | nan
chr22	DENND6B	620562.0 | DENND6B, FAM116B | DENN domain-containing protein 6B | 414918.0 | ENSG00000205593 | nan | nan
chr22	PPP6R2	610877.0 | PPP6R2, SAPS2, PP6R2, KIAA0685 | Protein phosphatase 6, regulatory subunit 2 | 9701.0 | ENSG00000100239 | nan | nan
chr22	SBF1	603560.0 | SBF1, MTMR5, CMT4B3 | SET-binding factor 1 (myotubularin-related protein 5) | 6305.0 | ENSG00000100241 | nan | Charcot-Marie-Tooth disease, type 4B3, 615284 (3), Autosomal recessive
chr22	ADM2	608682.0 | ADM2 | Adrenomedullin 2 | 79924.0 | ENSG00000128165 | nan | nan
chr22	MIOX	606774.0 | MIOX, ALDRL6 | Myoinositol oxygenase | 55586.0 | ENSG00000100253 | nan | nan
chr22	NCAPH2	611230.0 | NCAPH2, CAPH2 | Non-SMC condensin II complex subunit H2 | 29781.0 | ENSG00000025770 | nan | nan
chr22	SCO2	604272.0 | SCO2, MC4DN2, MYP6 | SCO2 cytochrome c oxidase assembly protein | 9997.0 | ENSG00000284194 | nan | Myopia 6, 608908 (3), Autosomal dominant; Mitochondrial complex IV deficiency, nuclear type 2, 604377 (3), Autosomal recessive
chr22	TYMP	131222.0 | TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1 | Thymidine phosphorylase | 1890.0 | ENSG00000025708 | nan | Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3), Autosomal recessive
chr22	KLHDC7B	620521.0 | KLHDC7B | Kelch domain-containing protein 7B | 113730.0 | ENSG00000130487 | nan | nan
chr22	SYCE3	615775.0 | SYCE3 | Synaptonemal complex central element protein 3 | 644186.0 | ENSG00000217442 | nan | nan
chr22	CPT1B	601987.0 | CPT1B | Carnitine palmitoyltransferase I, muscle | 1375.0 | ENSG00000205560 | nan | nan
chr22	CHKB	612395.0 | CHKB, CHKL, CKEKB, EKB, MDCMC | Choline kinase, beta | 1120.0 | ENSG00000100288 | nan | Muscular dystrophy, congenital, megaconial type, 602541 (3), Autosomal recessive
chr22	MAPK8IP2	607755.0 | MAPK8IP2, JIP2, IB2 | Mitogen-activated protein kinase 8-interacting protein 2 | 23542.0 | ENSG00000008735 | nan | nan
chr22	ARSA	607574.0 | ARSA | Arylsulfatase A | 410.0 | ENSG00000100299 | nan | Metachromatic leukodystrophy, 250100 (3), Autosomal recessive
chr22	SHANK3	606230.0 | SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15 | SH3 and multiple ankyrin repeat domains 3 | 85358.0 | ENSG00000251322 | nan | Phelan-McDermid syndrome, 606232 (3), Autosomal dominant; {Schizophrenia 15}, 613950 (3), Autosomal dominant
chr22	ACR	102480.0 | ACR, SPGF87 | Acrosin | 49.0 | ENSG00000100312 | mutation identified in 1 SPGF87 family | ?Spermatogenic failure 87, 620500 (3), Autosomal recessive
chr22	RABL2B	605413.0 | RABL2B | RAB-like 2B | 11158.0 | ENSG00000079974 | nan | nan
chrX	AIC	304050.0 | AIC | Aicardi syndrome | 192.0 | nan | ?in p22.31 with FDH as contiguous gene syndrome | Aicardi syndrome, 304050 (2), X-linked dominant
chrX	ANIB5	300870.0 | ANIB5 | Aneurysm, intracranial berry, 5 | 137587484.0 | nan | nan | Aneurysm, intracranial berry, 5, 300870 (2)
chrX	ARSC2	301780.0 | ARSC2 | Arylsulfatase C, f form | 413.0 | nan | probably close to STS = ARSC1, or s form | nan
chrX	EMWX	300211.0 | EMWX | Episodic muscle weakness, X-linked | 10118.0 | nan | nan | Episodic muscle weakness, X-linked, 300211 (2)
chrX	FGS3	300406.0 | FGS3 | FG syndrome 3 | 93985.0 | nan | nan | FG syndrome 3, 300406 (2), X-linked
chrX	HDPA	300221.0 | HDPA | Hodgkin disease, susceptibility, pseudoautosomal | 50829.0 | nan | nan | {Hodgkin disease susceptibility, pseudoautosomal}, 300221 (2)
chrX	MNG2	300273.0 | MNG2 | Multinodular goiter-2 | 59081.0 | nan | nan | Goiter, multinodular, 2, 300273 (2), X-linked dominant
chrX	OASD	300650.0 | OASD | Ocular albinism and sensorineural deafness | 4941.0 | nan | ?allelic to OA1 | Ocular albinism with sensorineural deafness, 300650 (2), X-linked
chrX	VSPA	313000.0 | VSPA | Visuospatial/perceptual abilities | 59332.0 | nan | nan | [Visuospatial/perceptual abilities], 313000 (2), ?X-linked recessive; Turner syndrome-associated neurocognitive phenotype, 313000 (2), ?X-linked recessive
chrX		300428.0 | XLID2, MRX2 | Intellectual developmental disorder, X-linked 2 | nan | nan | nan | Intellectual developmental disorder, X-linked 2, 300428 (2), X-linked
chrX	PLCXD1	300974.0 | PLCXD1 | Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 1 | 55344.0 | ENSG00000182378 | in pseudoautosomal region | nan
chrX	GTPBP6	300124.0 | GTPBP6, PGPL | GTP-binding protein 6 | 8225.0 | ENSG00000178605 | nan | nan
chrX	PPP2R3B	300339.0 | PPP2R3B, PR48 | Protein phosphatase 2, regulatory subunit B-double prime, beta | 28227.0 | ENSG00000167393 | nan | nan
chrX	SHOX	312865.0 | SHOX, GCFX, SS, PHOG | Short stature homeobox | 6473.0 | ENSG00000185960 | pseudoautosomal; ?gene causing short stature in Turner syndrome | Short stature, idiopathic familial, 300582 (3); Leri-Weill dyschondrosteosis, 127300 (3), Pseudoautosomal dominant; Langer mesomelic dysplasia, 249700 (3), Pseudoautosomal recessive
chrX	CRLF2	300357.0 | CRLF2, CRL2 | Cytokine receptor-like factor 2 | 64109.0 | ENSG00000205755 | pseudoautosomal | nan
chrX	CSF2RA	306250.0 | CSF2RA, SMDP4 | Colony-stimulating factor-2 receptor, alpha, low-affinity, granulocyte-macrophage | 1438.0 | ENSG00000198223 | order in PAR: pter-CSF2RA-IL3RA-ANT3-ASMT-MIC2-cen | Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3), Pseudoautosomal recessive
chrX	IL3RA	308385.0 | IL3RA | Interleukin-3 receptor, alpha subunit | 3563.0 | ENSG00000185291 | same 190kb segment as CSF2RA | nan
chrX	SLC25A6	300151.0 | SLC25A6, ANT3 | Solute carrier family 25 (mitochondrial carrier), member 6 (adenine nucleotide translocator-3, liver) | 293.0 | ENSG00000169100 | 1st intron ~1.3Mb from Xqter; nonlyonized | nan
chrX	ASMTL	300162.0 | ASMTLX, ASTML | Acetylserotonin methyltransferase-like | 8623.0 | ENSG00000169093 | nan | nan
chrX	P2RY8	300525.0 | P2RY8, P2Y8 | Pyrimidinergic receptor P2Y, G protein-coupled, 8 | 286530.0 | ENSG00000182162 | nan | nan
chrX	AKAP17A	312095.0 | AKAP17A, SFRS17A, DXYS155E, XE7 | A kinase (PRKA) anchor protein 17A | 8227.0 | ENSG00000197976 | nonlyonizing | nan
chrX	ASMT	300015.0 | ASMT, HIOMT | Acetylserotonin methyltransferase | 438.0 | ENSG00000196433 | pseudoautosomal | nan
chrX	DHRSX	301034.0 | DHRSX | Dehydrogenase/reductase, X-linked | 207063.0 | ENSG00000169084 | nan | nan
chrX	ZBED1	300178.0 | ZBED1, ALTE, KIAA0785, TRAMP | Zinc finger BED domain-containing protein 1 | 9189.0 | ENSG00000214717 | nan | nan
chrX	CD99	313470.0 | CD99, MIC2, MIC2X | CD99 antigen (MIC2 (monoclonal antibody 12E7)) | 4267.0 | ENSG00000002586 | distal to STS | nan
chrX	XG	300879.0 | XG, PBDX | XG glycoprotein | 7499.0 | ENSG00000124343 | nonlyonizing; spans pseudoautosomal boundary | nan
chrX	GYG2	300198.0 | GYG2, GN2 | Glycogenin 2 | 8908.0 | ENSG00000056998 | nan | nan
chrX	ARSD	300002.0 | ARSD | Arylsulfatase D | 414.0 | ENSG00000006756 | nan | nan
chrX	ARSL	300180.0 | ARSL, CDPX1, CDPXR | Arylsulfatase L | 415.0 | ENSG00000157399 | CDPX1 in contiguous gene syndrome with STS | Chondrodysplasia punctata, X-linked recessive, 302950 (3), X-linked recessive
chrX	ARSH	300586.0 | ARSH | Arylsulfatase H | 347527.0 | ENSG00000205667 | nan | nan
chrX	ARSF	300003.0 | ARSF | Arylsulfatase F | 416.0 | ENSG00000062096 | nan | nan
chrX	MXRA5	300938.0 | MXRA5 | Matrix remodeling-associated protein 5 | 25878.0 | ENSG00000101825 | nan | nan
chrX	PRKX	300083.0 | PRKX | Protein kinase, X-linked | 5613.0 | ENSG00000183943 | nan | nan
chrX		314705.0 | XGR, XG | XG/MIC2 regulator | nan | nan | nan | [XG blood group system, Xg(a-) phenotype], 314700 (3)
chrX	NLGN4X	300427.0 | NLGN4X, NLGN4, KIAA1260, AUTSX2 | Neuroligin 4, X-linked | 57502.0 | ENSG00000146938 | nan | Intellectual developmental disorder, X-linked, 300495 (3), X-linked; {Autism susceptibility, X-linked 2}, 300495 (3), X-linked
chrX	VCX3A	300533.0 | VCX3A, VCX8R, VCXA | Variably charged, X chromosome, 3A | 51481.0 | ENSG00000169059 | nan | nan
chrX	PUDP	306480.0 | HDHD1A, DXF68S1E, GS1 | Haloacid dehalogenase-like hydrolase domain-containing 1A | 8226.0 | ENSG00000130021 | escapes X-inactivation; 100kb telomeric to STS | nan
chrX	STS	300747.0 | STS, ARSC1, ARSC, SSDD, XLI | Steroid sulfatase, microsomal (arylsulfatase C, isozyme S) | 412.0 | ENSG00000101846 | nonlyonizing | Ichthyosis, X-linked, 308100 (3), X-linked recessive
chrX	VCX	300229.0 | VCX, VCXB1, VCX10R | Variably charged, X chromosome | 26609.0 | ENSG00000182583 | nan | nan
chrX	PNPLA4	300102.0 | DXS1283E | GS2 gene | 8228.0 | ENSG00000006757 | nan | nan
chrX	VCX2	300532.0 | VCX2, VCX2R, VCXB | Variably charged, X chromosome, 2 | 51480.0 | ENSG00000177504 | nan | nan
chrX	VCX3B	300981.0 | VCS3B, VCXC | Variably charged, X chromosome, 3B | 425054.0 | ENSG00000205642 | nan | nan
chrX	ANOS1	300836.0 | ANOS1, KAL1, KMS, ADMLX, HH1 | Anosmin 1 | 3730.0 | ENSG00000011201 | with ichthyosis in probable microdeletion syndrome | Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3), X-linked recessive
chrX	FAM9A	300477.0 | FAM9A | Family with sequence similarity 9, member A | 171482.0 | ENSG00000183304 | pseudogene on Xq28, Yp11.31, 1p36.12, 8p11.1 | nan
chrX	FAM9B	300478.0 | FAM9B | Family with sequence similarity 9, member B | 171483.0 | ENSG00000177138 | nan | nan
chrX	TBL1X	300196.0 | TBL1X, TBL1, CHNG8 | Transducin-beta-like 1, X-linked | 6907.0 | ENSG00000101849 | nan | Hypothyroidism, congenital, nongoitrous, 8, 301033 (3), X-linked
chrX	CMTX2	302801.0 | CMTX2 | Charcot-Marie-Tooth disease, X-linked recessive, 2 | 1253.0 | nan | nan | Charcot-Marie-Tooth neuropathy, X-linked recessive, 2, 302801 (2), X-linked recessive
chrX	FCP1	305435.0 | HBFQTL3, FCP1, FCPX, FCP | Fetal hemoglobin quantitative trait locus 3 | 2221.0 | nan | nan | Fetal hemoglobin quantitative trait locus 3, 305435 (2), X-linked
chrX	MRX73	300355.0 | XLID73, MRX73 | Intellectual developmental disorder, X-linked 73 | 23694.0 | nan | between DXS8019 and DXS365 | Intellectual developmental disorder, X-linked 73, 300355 (2), X-linked recessive
chrX	GPR143	300808.0 | GPR143, OA1, NYS6 | G protein-coupled receptor 143 | 4935.0 | ENSG00000101850 | linked to XG | Ocular albinism, type I, Nettleship-Falls type, 300500 (3), X-linked; Nystagmus 6, congenital, X-linked, 300814 (3), X-linked recessive
chrX	SHROOM2	300103.0 | SHROOM2, APXL | Shroom family member 2 | 357.0 | ENSG00000146950 | nan | nan
chrX	WWC3	301089.0 | WWC3 | WWC family, member 3 | 55841.0 | ENSG00000047644 | nan | nan
chrX	CLCN4	302910.0 | CLCN4, MRX49, MRX15, MRXSRC | Chloride channel-4 | 1183.0 | ENSG00000073464 | nan | Raynaud-Claes syndrome, 300114 (3), X-linked dominant
chrX	MID1	300552.0 | MID1, OGS1, GBBB, FXY, OSX | Midline-1 | 4281.0 | ENSG00000101871 | type II defect on chr.22 | Opitz GBBB syndrome, 300000 (3), X-linked recessive
chrX	HCCS	300056.0 | HCCS, MCOPS7, LSDMCA1 | Holocytochrome c synthase (cytochrome c heme-lyase) | 3052.0 | ENSG00000004961 | nan | Linear skin defects with multiple congenital anomalies 1, 309801 (3), X-linked dominant
chrX	ARHGAP6	300118.0 | ARHGAP6 | Rho GTPase-activating protein-6 | 395.0 | ENSG00000047648 | nan | nan
chrX	AMELX	300391.0 | AMELX, AMG, AIH1, AMGX, AI1E | Amelogenin | 265.0 | ENSG00000125363 | also Y | Amelogenesis imperfecta, type 1E, 301200 (3), X-linked dominant
chrX	MSL3	300609.0 | MSL3, MSL3L1, MRXSBA | MSL complex subunit 3 | 10943.0 | ENSG00000005302 | nan | Basilicata-Akhtar syndrome, 301032 (3), X-linked dominant
chrX	FRMPD4	300838.0 | FRMPD4, PRESO, KIAA0316, XLID104 | FERM and PDZ domains-containing protein 4 | 9758.0 | ENSG00000169933 | nan | Intellectual developmental disorder, X-linked 104, 300983 (3), X-linked
chrX	PRPS2	311860.0 | PRPS2 | Phosphoribosyl pyrophosphate synthetase-2 | 5634.0 | ENSG00000101911 | between STS and ZFX | nan
chrX	TLR7	300365.0 | TLR7, IMD74, SLEB17 | Toll-like receptor 7 | 51284.0 | ENSG00000196664 | centromeric to TLR8 | Immunodeficiency 74, COVID19-related, X-linked, 301051 (3), X-linked recessive; Systemic lupus erythematosus 17, 301080 (3), X-linked dominant
chrX	TLR8	300366.0 | TLR8, IMD98 | Toll-like receptor 8 | 51311.0 | ENSG00000101916 | 16kb telomeric to TLR7 | Immunodeficiency 98 with autoinflammation, X-linked, 301078 (3), X-linked, Somatic mosaicism
chrX	TMSB4X	300159.0 | TMSB4X, TMSB4, TB4X, PTMB4 | Thymosin, beta-4, X chromosome | 7114.0 | ENSG00000205542 | nan | nan
chrX	FAM9C	300479.0 | FAM9C | Family with sequence similarity 9, member C | 171484.0 | ENSG00000187268 | nan | nan
chrX	ATXN3L	300920.0 | ATXN3L | Ataxin 3-like | 92552.0 | ENSG00000123594 | nan | nan
chrX	EGFL6	300239.0 | EGFL6 | Epidermal growth factor-like 6 | 25975.0 | ENSG00000198759 | nan | nan
chrX	TCEANC	301084.0 | TCEANC | Transcription elongation factor A N-terminal and central domain-containing protein | 170082.0 | ENSG00000176896 | nan | nan
chrX	RAB9A	300284.0 | RAB9 | RAS-associated protein RAB9 | 9367.0 | ENSG00000123595 | nan | nan
chrX	TRAPPC2	300202.0 | TRAPPC2, SEDL, SEDT | Trafficking protein particle complex 2 (sedlin) | 6399.0 | ENSG00000196459 | nan | Spondyloepiphyseal dysplasia tarda, 313400 (3), X-linked recessive
chrX	OFD1	300170.0 | OFD1, CXorf5, SGBS2, JBTS10, RP23 | OFD1 centriole and centriolar satellite protein | 8481.0 | ENSG00000046651 | mutation identified in 1 RP23 family | Simpson-Golabi-Behmel syndrome, type 2, 300209 (3), X-linked recessive; ?Retinitis pigmentosa 23, 300424 (3), X-linked recessive; Orofaciodigital syndrome I, 311200 (3), X-linked dominant; Joubert syndrome 10, 300804 (3), X-linked recessive
chrX	GPM6B	300051.0 | GPM6B, M6B | Glycoprotein M6B | 2824.0 | ENSG00000046653 | nan | nan
chrX	GEMIN8	300962.0 | GEMIN8, FAM51A1 | GEM nuclear organelle-associated protein 8 | 54960.0 | ENSG00000046647 | nan | nan
chrX	GLRA2	305990.0 | GLRA2, MRXSP | Glycine receptor, alpha-2 polypeptide | 2742.0 | ENSG00000101958 | nan | Intellectual developmental disorder, X-linked syndromic, Pilorge type, 301076 (3), X-linked
chrX	FANCB	300515.0 | FANCB, FAAP95, FAAP90, FLJ34064 | Fanconi anemia, complementation group B gene | 2187.0 | ENSG00000181544 | nan | Fanconi anemia, complementation group B, 300514 (3), X-linked recessive
chrX	MOSPD2	301086.0 | MOSPD2 | Motile sperm domain-containing protein 2 | 158747.0 | ENSG00000130150 | nan | nan
chrX	ASB9	300890.0 | ASB9 | Ankyrin repeat- and SOCS box-containing protein 9 | 140462.0 | ENSG00000102048 | nan | nan
chrX	ASB11	300626.0 | ASB11 | Ankyrin repeat- and SOCS box-containing protein 11 | 140456.0 | ENSG00000165192 | nan | nan
chrX	PIGA	311770.0 | PIGA, PNH1, MCAHS2, NEDEPH | Phosphatidylinositol glycan, class A | 5277.0 | ENSG00000165195 | pseudogene on chr.12 | Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3); Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3), X-linked recessive; Neurodevelopmental disorder with epilepsy and hemochromatosis, 301072 (3), X-linked recessive
chrX	VEGFD	300091.0 | FIGF, VEGFD | c-fos induced growth factor (vascular endothelial growth factor D) | 2277.0 | ENSG00000165197 | nan | nan
chrX	PIR	300931.0 | PIR | Pirin | 8544.0 | ENSG00000087842 | nan | nan
chrX	BMX	300101.0 | BMX | BMX non-receptor tyrosine kinase | 660.0 | ENSG00000102010 | nan | nan
chrX	ACE2	300335.0 | ACE2, ACEH | Angiotensin I converting enzyme 2 | 59272.0 | ENSG00000130234 | nan | nan
chrX	CLTRN	300631.0 | CLTRN, TMEM27, NX17 | Collectrin, amino acid transport regulator | 57393.0 | ENSG00000147003 | nan | nan
chrX	CA5B	300230.0 | CA5B | Carbonic anhydrase VB, mitochondrial | 11238.0 | ENSG00000169239 | nan | nan
chrX	INE2	300165.0 | INE2 | Inactivation escape 2 | 8551.0 | ENSG00000281371 | nan | nan
chrX	ZRSR2	300028.0 | ZRSR2, U2AF1RS2, OFD21 | Zinc finger-, CCCH domain-, and RNA-binding motif-containing serine/arginine-rich protein 2 | 8233.0 | ENSG00000169249 | nan | Orofaciodigital syndrome XXI, 301132 (3), X-linked recessive
chrX	AP1S2	300629.0 | AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS | Adaptor-related protein complex 1, sigma-2 subunit | 8905.0 | ENSG00000182287 | nan | Pettigrew syndrome, 304340 (3), X-linked recessive
chrX	GRPR	305670.0 | GRPR | Gastrin-releasing peptide receptor | 2925.0 | ENSG00000126010 | nan | nan
chrX	MAGEB17	300763.0 | MAGEB17 | Melanoma antigen, family B, 17 | 645864.0 | ENSG00000182798 | nan | nan
chrX	CTPS2	300380.0 | CTPS2 | Cytidine 5-prime triphosphate synthetase 2 | 56474.0 | ENSG00000047230 | nan | nan
chrX	S100G	302020.0 | CALB3, CABP9K | Calbindin 3 (vitamin D-dependent calcium-binding protein) | 795.0 | ENSG00000169906 | nan | nan
chrX	TXLNG	300677.0 | TXLNG, CXorf15, FIAT | Taxilin, gamma | 55787.0 | ENSG00000086712 | nan | nan
chrX	RBBP7	300825.0 | RBBP7 | Retinoblastoma-binding protein 7 | 5931.0 | ENSG00000102054 | nan | nan
chrX	REPS2	300317.0 | REPS2, POB1 | RALBP1-associated EPS domain-containing protein 2 | 9185.0 | ENSG00000169891 | nan | nan
chrX	NHS	300457.0 | NHS, CXN, CTRCT40 | NHS actin remodeling regulator | 4810.0 | ENSG00000188158 | nan | Cataract 40, X-linked, 302200 (3), X-linked; Nance-Horan syndrome, 302350 (3), X-linked dominant
chrX	SCML1	300227.0 | SCML1 | SCM polycomb group protein-like 1 | 6322.0 | ENSG00000047634 | nan | nan
chrX	RAI2	300217.0 | RAI2 | Retinoic acid-induced 2 | 10742.0 | ENSG00000131831 | nan | nan
chrX	SCML2	300208.0 | SCML2 | SCM polycomb group protein-like 2 | 10389.0 | ENSG00000102098 | nan | nan
chrX	CDKL5	300203.0 | CDKL5, STK9, ISSX, DEE2 | Cyclin-dependent kinase-like 5 (serine/threonine protein kinase 9) | 6792.0 | ENSG00000008086 | nan | Developmental and epileptic encephalopathy 2, 300672 (3), X-linked dominant
chrX	RS1	300839.0 | RS1, XLRS1 | Retinoschisin | 6247.0 | ENSG00000102104 | 25cM from XG | Retinoschisis, 312700 (3), X-linked recessive
chrX	PPEF1	300109.0 | PPEF1 | Protein phosphatase, EF hand calcium-binding domain 1 | 5475.0 | ENSG00000086717 | nan | nan
chrX	PHKA2	300798.0 | PHKA2, PHK, XLG, PYKL, GSD9A | Phosphorylase kinase, liver, alpha-2 subunit | 5256.0 | ENSG00000044446 | nan | Glycogen storage disease, type IXa2, 306000 (3), X-linked recessive; Glycogen storage disease, type IXa1, 306000 (3), X-linked recessive
chrX	ADGRG2	300572.0 | ADGRG2, GPR64, HE6, CBAVDX | Adhesion G protein-coupled receptor G2 | 10149.0 | ENSG00000173698 | nan | Congenital bilateral absence of vas deferens, X-linked, 300985 (3), X-linked
chrX	PDHA1	300502.0 | PDHA1, PHE1A, PDHAD | Pyruvate dehydrogenase E1, subunit alpha-1 | 5160.0 | ENSG00000131828 | nan | Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3), X-linked dominant
chrX	MAP3K15	300820.0 | MAP3K15, ASK3 | Mitogen-activated protein kinase kinase kinase 15 | 389840.0 | ENSG00000180815 | nan | nan
chrX	SH3KBP1	300374.0 | SH3KBP1, CIN85, IMD61, AGMX2 | SH3-domain kinase-binding protein 1 | 30011.0 | ENSG00000147010 | mutation identified in 1 IMD61 family | ?Immunodeficiency 61, 300310 (3), X-linked recessive
chrX	MAP7D2	301121.0 | MAP7D2 | MAP7 domain-containing protein 2 | 256714.0 | ENSG00000184368 | nan | nan
chrX	EIF1AX	300186.0 | EIF1A, EIF4C, EIF1AX | Eukaryotic translation initiation factor 1A | 1964.0 | ENSG00000173674 | nan | nan
chrX	RPS6KA3	300075.0 | RPS6KA3, RSK2, XLID19 | Ribosomal protein S6 kinase A3 | 6197.0 | ENSG00000177189 | nan | Intellectual developmental disorder, X-linked 19, 300844 (3), X-linked dominant; Coffin-Lowry syndrome, 303600 (3), X-linked dominant
chrX	CNKSR2	300724.0 | CNKSR2, CNK2, KIAA0902, MRXSHG | connector enhancer of KSR 2 | 22866.0 | ENSG00000149970 | nan | Intellectual developmental disorder, X-linked syndromic, Houge type, 301008 (3), X-linked
chrX	SMPX	300226.0 | SMPX, DFNX4, MPD7 | Small muscle protein, X-linked | 23676.0 | ENSG00000091482 | nan | Myopathy, distal, 7, adult-onset, X-linked, 301075 (3), X-linked recessive; Deafness, X-linked 4, 300066 (3), X-linked dominant
chrX	MBTPS2	300294.0 | MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19 | Membrane-bound transcription factor protease, site 2 | 51360.0 | ENSG00000012174 | mutation identified in 1 OLMSX family | Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3), X-linked recessive; Osteogenesis imperfecta, type XIX, 301014 (3), X-linked recessive; IFAP syndrome with or without BRESHECK syndrome, 308205 (3), X-linked recessive; ?Olmsted syndrome, X-linked, 300918 (3), X-linked recessive
chrX	YY2	300570.0 | YY2, ZNF631 | Transcription factor YY2 | 404281.0 | ENSG00000230797 | nan | nan
chrX	SMS	300105.0 | SMS, SRS, MRXSSR | Spermine synthase | 6611.0 | ENSG00000102172 | nan | Intellectual developmental disorder, X-linked syndromic, Snyder-Robinson type, 309583 (3), X-linked recessive
chrX	PHEX	300550.0 | PHEX, HYP, HPDR1, LXHR | Phosphate regulating endopeptidase homolog, X-linked | 5251.0 | ENSG00000102174 | nan | Hypophosphatemic rickets, X-linked dominant, 307800 (3), X-linked dominant
chrX	DDX53	301079.0 | DDX53, CAGE | DEAD-box helicase 53 | 168400.0 | ENSG00000184735 | nan | nan
chrX	PTCHD1	300828.0 | PTCHD1, AUTSX4 | Patched domain-containing protein 1 | 139411.0 | ENSG00000165186 | nan | {Autism, susceptibility to, X-linked 4}, 300830 (3), X-linked recessive
chrX	PRDX4	300927.0 | PRDX4, AOE372 | Peroxiredoxin 4 | 10549.0 | ENSG00000123131 | nan | nan
chrX	ACOT9	300862.0 | ACOT9, MTACT48 | Acyl-CoA thioesterase 9 | 23597.0 | ENSG00000123130 | nan | nan
chrX	SAT1	313020.0 | SAT1, SSAT | Spermidine/spermine N1-acetyltransferase 1 | 6303.0 | ENSG00000130066 | nan | nan
chrX	APOO	300753.0 | APOO, MYO25, FAM121B | Apolipoprotein O | 79135.0 | ENSG00000184831 | nan | nan
chrX	KLHL15	300980.0 | KLHL15, KIAA1677, XLID103 | Kelch-like 15 | 80311.0 | ENSG00000174010 | nan | Intellectual developmental disorder, X-linked 103, 300982 (3), X-linked recessive
chrX	EIF2S3	300161.0 | EIF2S3, EIF2G, MEHMO, MRXSBRK | Eukaryotic translation initiation factor 2, subunit 3 | 1968.0 | ENSG00000130741 | nan | MEHMO syndrome, 300148 (3), X-linked recessive
chrX	ZFX	314980.0 | ZFX, MRXS37 | Zinc finger protein, X-linked | 7543.0 | ENSG00000005889 | nonlyonizing | Intellectual developmental disorder, X-linked syndromic 37, 301118 (3), X-linked
chrX	PDK3	300906.0 | PDK3, CMTX6 | Pyruvate dehydrogenase kinase, isoenzyme 3 | 5165.0 | ENSG00000067992 | 1 family identified with mutation | ?Charcot-Marie-Tooth disease, X-linked dominant, 6, 300905 (3), X-linked dominant
chrX	PCYT1B	300948.0 | PCYT1B | Phosphate cytidylyltransferase 1, choline, beta isoform | 9468.0 | ENSG00000102230 | nan | nan
chrX	POLA1	312040.0 | POLA1, VEODS | Polymerase, DNA, alpha-1 | 5422.0 | ENSG00000101868 | nan | Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3), X-linked recessive; Van Esch-O'Driscoll syndrome, 301030 (3), X-linked recessive
chrX		300679.0 | DELXp21, CXDELp21 | Chromosome Xp21 deletion syndrome | nan | nan | contiguous gene deletion syndrome | Chromosome Xp21 deletion syndrome, 300679 (4)
chrX	MENOQ1	300488.0 | MENOQ1 | Menopause, natural, age at, QTL 1 | 494029.0 | nan | nan | {Menopause, natural, age at, QTL1}, 300488 (2), X-linked dominant
chrX	RP6	312612.0 | RP6 | Retinitis pigmentosa-6, X-linked recessive | 6104.0 | nan | nan | ?Retinitis pigmentosa, X-linked recessive, 6, 312612 (2), X-linked
chrX	ARX	300382.0 | ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32 | Aristaless-related homeobox, X-linked | 170302.0 | ENSG00000004848 | nan | Proud syndrome, 300004 (3), X-linked; Hydranencephaly with abnormal genitalia, 300215 (3), X-linked; Partington syndrome, 309510 (3), X-linked recessive; Developmental and epileptic encephalopathy 1, 308350 (3), X-linked recessive; Lissencephaly, X-linked 2, 300215 (3), X-linked; Intellectual developmental disorder, X-linked 29, 300419 (3), X-linked recessive
chrX	MAGEB18	301064.0 | MAGEB18 | Melanoma antigen, family B, 18 | 286514.0 | ENSG00000176774 | nan | nan
chrX	MAGEB6	300467.0 | MAGEB6 | Melanoma antigen, family B, 6 | 158809.0 | ENSG00000176746 | nan | nan
chrX	MAGEB5	300466.0 | MAGEB5 | Melanoma antigen, family B, 5 | 347541.0 | ENSG00000188408 | nan | nan
chrX	MAGEB10	300761.0 | MAGEB10 | Melanoma antigen, family B, 10 | 139422.0 | ENSG00000177689 | nan | nan
chrX	IL1RAPL1	300206.0 | IL1RAPL1, IL1R8, MRX21, MRX34 | Il-1 receptor accessory protein-like 1 | 11141.0 | ENSG00000169306 | nan | Intellectual developmental disorder, X-linked 21, 300143 (3), X-linked recessive
chrX	DFNX3	300030.0 | DFNX3, DFN4 | Deafness, X-linked 3 | 1680.0 | nan | ?same as DMD | Deafness, X-linked 3, 300030 (2), X-linked
chrX	XS	309050.0 | XS, LUXS | Lutheran suppressor, X-linked | 7523.0 | nan | nan | nan
chrX	MAGEB2	300098.0 | MAGEB2, DAM6 | Melanoma antigen, family B, 2 | 4113.0 | ENSG00000099399 | nan | nan
chrX	MAGEB3	300152.0 | MAGEB3 | Melanoma antigen, family B, 3 | 4114.0 | ENSG00000198798 | nan | nan
chrX	MAGEB4	300153.0 | MAGEB4 | Melanoma antigen, family B, 4 | 4115.0 | ENSG00000120289 | nan | nan
chrX	MAGEB1	300097.0 | MAGEB1, MAGEL1, DAM10 | Melanoma antigen, family B, 1 | 4112.0 | ENSG00000214107 | nan | nan
chrX	NR0B1	300473.0 | NR0B1, DAX1, AHC, AHX, SRXY2 | Nuclear receptor subfamily 0, group B, member 1 | 190.0 | ENSG00000169297 | distal to GK | Adrenal hypoplasia, congenital, 300200 (3), X-linked recessive; 46XY sex reversal 2, dosage-sensitive, 300018 (3), X-linked
chrX	TASL	301049.0 | TASL, CXorf21 | TLR adaptor interacting with endolysosomal SLC15A4 | 80231.0 | ENSG00000120280 | nan | nan
chrX	GK	300474.0 | GK | Glycerol kinase | 2710.0 | ENSG00000198814 | 2Mb distal to DMD; pseudogene on 4q32 | Glycerol kinase deficiency, 307030 (3), X-linked recessive
chrX	TAB3	300480.0 | TAB3 | Tak1 (MAP3K7) binding protein 3 | 257397.0 | ENSG00000157625 | nan | nan
chrX	FTHL17	300308.0 | FTHL17 | Ferritin heavy polypeptide-like 17 | 53940.0 | ENSG00000132446 | nan | nan
chrX	DMD	300377.0 | DMD, BMD, CMD3B | Dystrophin | 1756.0 | ENSG00000198947 | dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13 | Becker muscular dystrophy, 300376 (3), X-linked recessive; Cardiomyopathy, dilated, 3B, 302045 (3), X-linked; Duchenne muscular dystrophy, 310200 (3), X-linked recessive
chrX	MRXS17	300858.0 | MRXS17 | Intellectual developmental disorder, X-linked, syndromic 17 | 100739996.0 | nan | between rs2748314 and rs5906782 | Intellectual developmental disorder, X-linked syndromic 17, 300858 (2), X-linked recessive
chrX	TMEM47	300698.0 | TMEM47, BCMP1 | Transmembrane protein 47 | 83604.0 | ENSG00000147027 | nan | nan
chrX	MAGEB16	300762.0 | MAGEB16 | Melanoma antigen, family B, 16 | 139604.0 | ENSG00000189023 | nan | nan
chrX	CFAP47	301057.0 | CFAP47, CXorf22, SPGFX3 | Cilia- and flagella-associated protein 47 | 286464.0 | ENSG00000165164 | nan | Spermatogenic failure, X-linked 3, 301059 (3), X-linked recessive
chrX	FAM47C	301067.0 | FAM47C | Family with sequence similarity 47, member C | 442444.0 | ENSG00000198173 | nan | nan
chrX	PRRG1	300935.0 | PRRG1, PRGP1 | Proline-rich gamma-carboxyglutamic acid protein 1 | 5638.0 | ENSG00000130962 | nan | nan
chrX	XK	314850.0 | XK, MCLDS | Kell blood group precursor | 7504.0 | ENSG00000047597 | ~500kb distal to CGD | McLeod syndrome, 300842 (3), X-linked
chrX	CYBB	300481.0 | CYBB, CGDX, AMCBX2, IMD34 | Cytochrome b-245, beta polypeptide | 1536.0 | ENSG00000165168 | proximal to DMD | Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3), X-linked recessive; Chronic granulomatous disease, X-linked, 306400 (3), X-linked recessive
chrX	GAGE8	300638.0 | GAGE8 | G antigen 8 | 100101629.0 | nan | nan | nan
chrX	GRDX	300351.0 | GRDX, GD3 | Graves disease, susceptibility to, X-linked | 117189.0 | nan | nan | {Graves disease, susceptibility to, X-linked}, 300351 (2)
chrX	IDDMX	300136.0 | IDDMX | Diabetes mellitus, insulin-dependent, X-linked, susceptibility to | 8245.0 | nan | only with DR3 | {Diabetes mellitus, insulin-dependent, X-linked}, 300136 (2)
chrX	MRXS12	309545.0 | MRXS12 | Intellectual developmental disorder, X-linked, syndromic 12 | 8246.0 | nan | nan | ?Intellectual developmental disorder, X-linked syndromic 12, 309545 (2), X-linked
chrX	NYS5	300589.0 | NYS5 | Nystagmus 5, congenital, X-linked | 780901.0 | nan | max lod at DXS993 | Nystagmus 5, congenital, X-linked, 300589 (2), X-linked dominant
chrX	OPA2	311050.0 | OPA2 | Optic atrophy, X-linked | 4977.0 | nan | nan | Optic atrophy 2, X-linked, 311050 (2), X-linked
chrX	MRX20	300047.0 | XLID20, MRX20 | Intellectual developmental disorder, X-linked 20 | 4384.0 | nan | nan | Intellectual developmental disorder, X-linked 20, 300047 (2), X-linked
chrX	DYNLT3	300302.0 | DYNLT3, TCTE1L | Dynein light chain Tctex-type 3 | 6990.0 | ENSG00000165169 | nan | nan
chrX	SYTL5	301126.0 | SYTL5, SLP5 | Synaptotagmin-like 5 | 94122.0 | ENSG00000147041 | nan | nan
chrX	SRPX	300187.0 | SRPX, ETX1 | Sushi-repeat-containing protein, X chromosome | 8406.0 | ENSG00000101955 | probably between OTC and CGD | nan
chrX	RPGR	312610.0 | RPGR, RP3, CRD, RP15, COD1, CORDX1 | Retinitis pigmentosa GTPase regulator | 6103.0 | ENSG00000156313 | nan | Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3), X-linked; Cone-rod dystrophy, X-linked, 1, 304020 (3), X-linked recessive; Retinitis pigmentosa 3, 300029 (3), X-linked; Macular degeneration, X-linked atrophic, 300834 (3), X-linked recessive
chrX	OTC	300461.0 | OTC | Ornithine transcarbamylase | 5009.0 | ENSG00000036473 | proximal to DMD, CGD | Ornithine transcarbamylase deficiency, 311250 (3), X-linked
chrX	TSPAN7	300096.0 | TSPAN7, TM4SF2, MXS1, A15, XLID58 | Tetraspanin 7 | 7102.0 | ENSG00000156298 | nan | Intellectual developmental disorder, X-linked 58, 300210 (3), X-linked recessive
chrX	MID1IP1	300961.0 | MID1IP1, MIG12 | MID1-interacting protein 1 | 58526.0 | ENSG00000165175 | nan | nan
chrX	BCOR	300485.0 | BCOR, KIAA1575, MCOPS2, MAA2, ANOP2 | BCL6 corepressor | 54880.0 | ENSG00000183337 | nan | Microphthalmia, syndromic 2, 300166 (3), X-linked dominant
chrX	ATP6AP2	300556.0 | ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS, CDG2R | ATPase, H+ transporting, lysosomal, accessory protein 2 | 10159.0 | ENSG00000182220 | mutation identified in 1 XPDS family | Intellectual developmental disorder, X-linked syndromic, Hedera type, 300423 (3), X-linked recessive; ?Parkinsonism with spasticity, X-linked, 300911 (3), X-linked recessive; Congenital disorder of glycosylation, type IIr, 301045 (3), X-linked recessive
chrX	MPC1L	301103.0 | MPC1L | Mitochondrial pyruvate carrier 1-like protein | 347411.0 | ENSG00000238205 | nan | nan
chrX	CXorf38	301117.0 | CXorf38 | Chromosome X open reading frame 38 | 159013.0 | ENSG00000185753 | nan | nan
chrX	MED14	300182.0 | MED14, CRSP2, CXorf4, TRAP170, EXLM1 | Mediator complex subunit 14 | 9282.0 | ENSG00000180182 | nan | nan
chrX	USP9X	300072.0 | USP9X, DFFRX, XLID99, MRXS99F | Ubiquitin-specific protease-9, X chromosome (Drosophila fat facets related, X-linked) | 8239.0 | ENSG00000124486 | nan | Intellectual developmental disorder, X-linked 99, 300919 (3), X-linked recessive; Intellectual developmental disorder, X-linked 99, syndromic, female-restricted, 300968 (3), X-linked dominant
chrX	DDX3X	300160.0 | DDX3X, DDX3, DBX, MRX102, MRXSSB | DEAD-box helicase 3, X-linked | 1654.0 | ENSG00000215301 | nan | Intellectual developmental disorder, X-linked syndromic, Snijders Blok type, 300958 (3), X-linked dominant, X-linked recessive
chrX	NYX	300278.0 | NYX, CSNB1A, NBM1 | Nyctalopin | 60506.0 | ENSG00000188937 | nan | Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3), X-linked recessive
chrX	CASK	300172.0 | CASK, MICPCH, FGS4, CMG, MRXSNA | Calcium/calmodulin-dependent serine protein kinase | 8573.0 | ENSG00000147044 | nan | Intellectual developmental disorder, with or without nystagmus, 300422 (3), X-linked recessive; Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia, 300749 (3), X-linked; FG syndrome 4, 300422 (3), X-linked recessive
chrX	GPR34	300241.0 | GPR34 | G protein-coupled receptor 34 | 2857.0 | ENSG00000171659 | nan | nan
chrX	GPR82	300748.0 | GPR82 | G protein-coupled receptor 82 | 27197.0 | ENSG00000171657 | nan | nan
chrX	AGSPX	300652.0 | AGSPX | Angioma serptiginosum, X-linked | 100188767.0 | nan | between DXS8026 and DXS106 | Angio serpiginosum, 300652 (2), X-linked dominant
chrX		300578.0 | DELXp11.3, CXDELp11.3 | Chromosome Xp11.3 deletion syndrome | nan | nan | nan | Chromosome Xp11.3 deletion syndrome, 300578 (4), X-linked recessive
chrX	MRXS7	300218.0 | MRXS7 | Intellectual developmental disorder, X-linked, syndromic 7 | 4429.0 | nan | nan | Intellectual developmental disorder, X-linked syndromic 7, 300218 (2), X-linked
chrX	MRX14	300062.0 | XLID14, MRX14 | Intellectual developmental disorder, X-linked 14 | 4378.0 | nan | nan | Intellectual developmental disorder, X-linked 14, 300062 (2), X-linked
chrX		300498.0 | XLID45, MRX45 | Intellectual developmental disorder, X-linked 45 | nan | nan | nan | Intellectual developmental disorder, X-linked 45, 300498 (2), X-linked
chrX	MRX84	300505.0 | XLID84, MRX84 | Intellectual developmental disorder, X-linked 84 | 378882.0 | nan | 29 other MRX loci in same region | Intellectual developmental disorder, X-linked 84, 300505 (2), X-linked recessive
chrX		300848.0 | XLID89, MRX89 | Intellectual developmental disorder, X-linked 89 | nan | nan | t(X;7)(p11.3;q11.21) | Intellectual developmental disorder, X-linked 89, 300848 (2), X-linked dominant
chrX	MRX92	300851.0 | XLID92, MRX92 | Intellectual developmental disorder, X-linked 92 | 102775565.0 | nan | previously associated with ZNF674 | Intellectual developmental disorder, X-linked 92, 300851 (2), X-linked recessive
chrX	PPP1R2C	301017.0 | PPP1R2C | Protein phosphatase 1, regulatory subunit 2C | 80316.0 | ENSG00000102055 | nan | nan
chrX	MAOA	309850.0 | MAOA, BRNRS | Monoamine oxidase A | 4128.0 | ENSG00000189221 | NDP, MAOA, MAOB closely linked | Brunner syndrome, 300615 (3), X-linked recessive
chrX	MAOB	309860.0 | MAOB | Monoamine oxidase B | 4129.0 | ENSG00000069535 | nan | nan
chrX	NDP	300658.0 | NDP, ND, EVR2 | Norrin cystine knot growth factor | 4693.0 | ENSG00000124479 | nan | Exudative vitreoretinopathy 2, X-linked, 305390 (3), X-linked dominant, X-linked recessive; Norrie disease, 310600 (3), X-linked recessive
chrX	EFHC2	300817.0 | EFHC2 | EF-hand domain (C-terminal)-containing protein 2 | 80258.0 | ENSG00000183690 | nan | nan
chrX	FUNDC1	300871.0 | FUNDC1 | FUN14 domain-containing protein 1 | 139341.0 | ENSG00000069509 | nan | nan
chrX	DUSP21	300678.0 | DUSP21, LMWDSP21 | Dual-specificity phosphatase 21 | 63904.0 | ENSG00000189037 | nan | nan
chrX	KDM6A	300128.0 | KDM6A, UTX, KABUK2 | Lysine demethylase 6A | 7403.0 | ENSG00000147050 | UTY also in mouse and man; escapes inactivation | Kabuki syndrome 2, 300867 (3), X-linked dominant
chrX	DIPK2B	300959.0 | DIPK2B, CXorf36, DIA1R | Divergent protein kinase domain 2B | 79742.0 | ENSG00000147113 | nan | nan
chrX	MIR221	300568.0 | MIR221, MIRN221 | Micro RNA 221 | 407006.0 | ENSG00000207870 | near MIRN222 | nan
chrX	MIR222	300569.0 | MIR222, MIRN222 | Micro RNA 222 | 407007.0 | ENSG00000207725 | near MIRN221 | nan
chrX	KRBOX4	300585.0 | ZNF673, FLJ20344 | Zinc finger protein 673 | 55634.0 | ENSG00000147121 | nan | nan
chrX	ZNF674	300573.0 | ZNF674 | Zinc finger protein 674 | 641339.0 | ENSG00000251192 | nan | nan
chrX	CHST7	300375.0 | CHST7, C6ST2 | Carbohydrate sulfotransferase 7 | 56548.0 | ENSG00000147119 | nan | nan
chrX	SLC9A7	300368.0 | SLC9A7, NHE7, MRX108 | Solute carrier family 9 (sodium/hydrogen exchanger), member 7 | 84679.0 | ENSG00000065923 | nan | Intellectual developmental disorder, X-linked 108, 301024 (3), X-linked recessive
chrX	RP2	300757.0 | RP2 | RP2 activator of ARL3 GTPase | 6102.0 | ENSG00000102218 | nan | Retinitis pigmentosa 2, 312600 (3), X-linked
chrX	JADE3	300618.0 | PHF16, JADE3, KIAA0215 | PHD finger protein 16 | 9767.0 | ENSG00000102221 | nan | nan
chrX	RGN	300212.0 | RGN, SMP30 | Regucalcin | 9104.0 | ENSG00000130988 | nan | nan
chrX	NDUFB11	300403.0 | NDUFB11, LSDMCA3, MC1DN30 | NADH-ubiquinone oxidoreductase subunit B11 | 54539.0 | ENSG00000147123 | mutation identified in 1 MC1DN30 patient | Linear skin defects with multiple congenital anomalies 3, 300952 (3), X-linked dominant; ?Mitochondrial complex I deficiency, nuclear type 30, 301021 (3), X-linked
chrX	RBM10	300080.0 | RBM10, DXS8237E, KIAA0122, TARPS | RNA-binding motif protein 10 | 8241.0 | ENSG00000182872 | nan | TARP syndrome, 311900 (3), X-linked recessive
chrX	UBA1	314370.0 | UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1, VEXAS | Ubiquitin-like modifier activating enzyme 1 | 7317.0 | ENSG00000130985 | escapes inactivation | Spinal muscular atrophy, X-linked 2, infantile, 301830 (3), X-linked recessive; VEXAS syndrome, somatic, 301054 (3)
chrX	INE1	300164.0 | INE1 | Inactivation escape 1 | 8552.0 | ENSG00000224975 | nan | nan
chrX	CDK16	311550.0 | CDK16, PCTK1, PCTAIRE1 | Cyclin-dependent kinase 16 | 5127.0 | ENSG00000102225 | nan | nan
chrX	USP11	300050.0 | USP11, UHX1 | Ubiquitin-specific protease-11 (ubiquitin carboxyl-terminal hydrolase) | 8237.0 | ENSG00000102226 | nan | nan
chrX	ZNF157	300024.0 | ZNF157 | Zinc finger protein-157 (HZF22) | 7712.0 | ENSG00000147117 | nan | nan
chrX	ZNF41	314995.0 | ZNF41 | Zinc finger protein-41 | 7592.0 | ENSG00000147124 | nan | nan
chrX	ARAF	311010.0 | ARAF1, RAFA1, PKS2 | Oncogene ARAF1 | 369.0 | ENSG00000078061 | nan | nan
chrX	SYN1	313440.0 | SYN1, EPILX1, MRX50 | Synapsin I | 6853.0 | ENSG00000008056 | nan | Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders, 300491 (3), X-linked; Intellectual developmental disorder, X-linked 50, 300115 (3), X-linked
chrX	TIMP1	305370.0 | TIMP1, TIMP, EPA | Erythroid-potentiating activity (tissue inhibitor of metalloproteinases) | 7076.0 | ENSG00000102265 | in intron of SYN1 | nan
chrX		300801.0 | DUPXp11.23p11.22, CXDUPp11.23p11.22 | Chromosome Xp11.23-p11.22 duplication syndrome | nan | nan | nan | Chromosome Xp11.23-p11.22 duplication syndrome, 300801 (4), X-linked dominant
chrX	GAGE2B	300726.0 | GAGE2B | G antigen 2B | 645037.0 | nan | nan | nan
chrX	GAGE2C	300595.0 | GAGE2C, GAGE2 | G antigen 2C | 2574.0 | nan | nan | nan
chrX	GAGE2D	300735.0 | GAGE2D | G antigen 2D | 729408.0 | nan | nan | nan
chrX	GAGE2E	300736.0 | GAGE2E | G antigen 2E | 26749.0 | nan | nan | nan
chrX		300596.0 | GAGE3 | G antigen 3 | nan | nan | nan | nan
chrX	GAGE4	300597.0 | GAGE4 | G antigen 4 | 2576.0 | nan | nan | nan
chrX	GAGE5	300598.0 | GAGE5 | G antigen 5 | 2577.0 | nan | nan | nan
chrX	GAGE6	300599.0 | GAGE6 | G antigen 6 | 2578.0 | nan | nan | nan
chrX	GAGE7	300601.0 | GAGE7 | G antigen 7 | 2579.0 | nan | nan | nan
chrX	GAGE12I	300637.0 | GAGE7B | G antigen 7B | 26748.0 | nan | nan | nan
chrX		300434.0 | SDSX, MRXSDS | Intellectual developmental disorder, X-linked, syndromic, Stocco dos Santos type | nan | nan | nan | Intellectual developmental disorder, X-linked, syndromic, Stocco dos Santos type, 300434 (2), X-linked
chrX	MRX81	300433.0 | XLID81, MRX81 | Intellectual developmental disorder, X-linked 81 | 266678.0 | nan | between DXS1039 and DXS1216 | Intellectual developmental disorder, X-linked 81, 300433 (2), X-linked recessive
chrX	CFP	300383.0 | PFC, PFD | Properdin P factor, complement | 5199.0 | ENSG00000126759 | nan | Properdin deficiency, X-linked, 312060 (3), X-linked recessive
chrX	ELK1	311040.0 | ELK1 | ELK1, member of ETS oncogene family | 2002.0 | ENSG00000126767 | distal to OATL1 | nan
chrX	UXT	300234.0 | UXT | Ubiquitously expressed transcript | 8409.0 | ENSG00000126756 | nan | nan
chrX	ZNF81	314998.0 | ZNF81 | Zinc finger protein-81 (HFZ20) | 347344.0 | ENSG00000197779 | nan | nan
chrX	ZNF182	314993.0 | ZNF21 | Zinc finger protein-12 | 7569.0 | ENSG00000147118 | nan | nan
chrX	SPACA5	300593.0 | SPACA5, LOC389852 | Sperm acrosome associated 5 | 389852.0 | ENSG00000171489 | nan | nan
chrX	ZNF630	300819.0 | ZNF630 | Zinc finger protein 630 | 57232.0 | ENSG00000221994 | nan | nan
chrX	SSX6P	300541.0 | SSX6 | Synovial sarcoma, X breakpoint 6 | 280657.0 | nan | nan | nan
chrX	SSX5	300327.0 | SSX5 | Synovial sarcoma, X breakpoint 5 | 6758.0 | ENSG00000165583 | nan | nan
chrX	SSX1	312820.0 | SSX1, SSRC, SPGFX5 | Synovial sarcoma, X breakpoint 1 | 6756.0 | ENSG00000126752 | nan | Spermatogenic failure, X-linked, 5, 301099 (3), X-linked
chrX	SSX9P	300544.0 | SSX9 | Sarcoma, synovial, X breakpoint 9 | 280660.0 | ENSG00000290708 | nan | nan
chrX	SSX3	300325.0 | SSX3 | Synovial sarcoma, X breakpoint 3 | 10214.0 | ENSG00000165584 | nan | nan
chrX	SSX4	300326.0 | SSX4 | Synovial sarcoma, X breakpoint 4 | 6759.0 | ENSG00000268009 | nan | nan
chrX	SLC38A5	300649.0 | SLC38A5, SN2 | Solute carrier family 38 (amino acid transporter), member 5 | 92745.0 | ENSG00000017483 | nan | nan
chrX	FTSJ1	300499.0 | FTSJ1, JM23, SPB1, MRX44, MRX9, XLID9 | FTSJ RNA 2-prime-O-methyltransferase 1 | 24140.0 | ENSG00000068438 | nan | Intellectual developmental disorder, X-linked 9, 309549 (3), X-linked recessive
chrX	PORCN	300651.0 | PORCN, PORC, DHOF, FODH | Porcupine O-acyltransferase | 64840.0 | ENSG00000102312 | nan | Focal dermal hypoplasia, 305600 (3), X-linked dominant
chrX	EBP	300205.0 | EBP, CDPX2, CPXD, CPX, MEND | Emopamil-binding protein | 10682.0 | ENSG00000147155 | nan | MEND syndrome, 300960 (3), X-linked recessive; Chondrodysplasia punctata, X-linked dominant, 302960 (3), X-linked dominant
chrX	TBC1D25	311240.0 | TBC1D25, OATL1 | TBC1 domain family, member 25 | 4943.0 | ENSG00000068354 | nan | nan
chrX	RBM3	300027.0 | RBM3 | RNA binding motif protein 3 | 5935.0 | ENSG00000102317 | nan | nan
chrX	WDR13	300512.0 | WDR13 | WD repeat-containing protein 13 | 64743.0 | ENSG00000101940 | nan | nan
chrX	WAS	300392.0 | WAS, IMD2, THC1, SCNX | WASP actin nucleation promoting factor | 7454.0 | ENSG00000015285 | t(18;X)(q11.2;p11.2); distal to TIMP | Wiskott-Aldrich syndrome, 301000 (3), X-linked recessive; Neutropenia, severe congenital, X-linked, 300299 (3), X-linked recessive; Thrombocytopenia, X-linked, intermittent, 313900 (3), X-linked recessive; Thrombocytopenia, X-linked, 313900 (3), X-linked recessive
chrX	SUV39H1	300254.0 | SUV39H1 | Suppressor of variegation 3-9, Drosophila, homolog of, 1 | 6839.0 | ENSG00000101945 | nan | nan
chrX	GLOD5	301112.0 | GLOD5 | Glyoxalase domain-containing protein 5 | 392465.0 | ENSG00000171433 | nan | nan
chrX	GATA1	305371.0 | GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, CNSHA9 | GATA-binding protein-1 (globin transcription factor-1) | 2623.0 | ENSG00000102145 | nan | Anemia, congenital, nonspherocytic hemolytic, 9, 301083 (3), X-linked recessive; Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 159595 (3); Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3), X-linked recessive; Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3), X-linked recessive; Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3), X-linked recessive
chrX	HDAC6	300272.0 | HDAC6, CPBHM | Histone deacetylase 6 | 10013.0 | ENSG00000094631 | mutation identified in 1 CPBHM family | ?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 (3), X-linked dominant
chrX	ERAS	300437.0 | HRAS2, HRASP | v-Ha-ras harvey rat sarcoma viral oncogene homolog 2 | 3266.0 | ENSG00000187682 | nan | nan
chrX	PCSK1N	300399.0 | PCSK1N, PROSAAS | Proprotein convertase, subtilisin/kexin-type, 1, inhibitor of | 27344.0 | ENSG00000102109 | nan | nan
chrX	TIMM17B	300249.0 | TIMM17B, TIM17B | Translocase of inner mitochondrial membrane 17B | 10245.0 | ENSG00000126768 | nan | nan
chrX	PQBP1	300463.0 | PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8 | Polyglutamine-binding protein 1 | 10084.0 | ENSG00000102103 | nan | Renpenning syndrome, 309500 (3), X-linked recessive
chrX	SLC35A2	314375.0 | SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M | Solute carrier family 35 (UDP-galactose transporter), member 2 | 7355.0 | ENSG00000102100 | nan | Congenital disorder of glycosylation, type IIm, 300896 (3), X-linked dominant, Somatic mosaicism
chrX	PIM2	300295.0 | PIM2 | PIM2 protooncogene, serine/threonine kinase | 11040.0 | ENSG00000102096 | nan | nan
chrX	OTUD5	300713.0 | OTUD5, DUBA, MCAND | OTU domain-containing protein 5 | 55593.0 | ENSG00000068308 | nan | Multiple congenital anomalies-neurodevelopmental syndrome, X-linked, 301056 (3), X-linked recessive
chrX	KCND1	300281.0 | KCND1 | Potassium voltage-gated channel, SHAL-related subfamily, member 1 | 3750.0 | ENSG00000102057 | nan | nan
chrX	GRIPAP1	300408.0 | GRIPAP1, GRASP1, KIAA1167 | GRIP1-associated protein 1 | 56850.0 | ENSG00000068400 | nan | nan
chrX	TFE3	314310.0 | TFE3, RCCX1, MRXSPF | Transcription factor for IgH enhancer | 7030.0 | ENSG00000068323 | fuses with PRCC in RCCP | Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies, 301066 (3), X-linked; Renal cell carcinoma, papillary, 1, 300854 (3)
chrX	CCDC120	300947.0 | CCDC120 | Coiled-coil domain-containing protein 120 | 90060.0 | ENSG00000147144 | nan | nan
chrX	PRAF2	300840.0 | PRAF2, JM4 | PRA1 domain family, member 2 | 11230.0 | ENSG00000243279 | nan | nan
chrX	WDR45	300526.0 | WDR45, WIPI4, NBIA5 | WD repeat-containing protein 45 | 11152.0 | ENSG00000196998 | ?pseudogene on 4q31.3 | Neurodegeneration with brain iron accumulation 5, 300894 (3), X-linked dominant
chrX	GPKOW	301003.0 | GPKOW, GPATCH5 | G-patch domain and KO@ motifs | 27238.0 | ENSG00000068394 | nan | nan
chrX	PLP2	300112.0 | PLP2 | Proteolipid protein 2 | 5355.0 | ENSG00000102007 | nan | nan
chrX	PRICKLE3	300111.0 | PRICKLE3, LMO6, LOAM | Prickle, Drosophila, homolog of, 3 | 4007.0 | ENSG00000012211 | nan | {Leber hereditary optic neuropathy, modifier of}, 308905 (3), X-linked dominant
chrX	SYP	313475.0 | SYP, XLID96 | Synaptophysin | 6855.0 | ENSG00000102003 | nan | Intellectual developmental disorder, X-linked 96, 300802 (3), X-linked recessive
chrX	CACNA1F	300110.0 | CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2 | Calcium channel, voltage-dependent, alpha-1F subunit | 778.0 | ENSG00000102001 | nan | Cone-rod dystrophy, X-linked, 3, 300476 (3), X-linked recessive; Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3), X-linked; Aland Island eye disease, 300600 (3), X-linked
chrX	CCDC22	300859.0 | CCDC22, RTSC2 | Coiled-coil domain-containing protein 22 | 28952.0 | ENSG00000101997 | nan | Ritscher-Schinzel syndrome 2, 300963 (3), X-linked recessive
chrX	FOXP3	300292.0 | FOXP3, IPEX, AIID, XPID, PIDX | Forkhead box P3 (scurfin) | 50943.0 | ENSG00000049768 | nan | Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3), X-linked recessive
chrX	PPP1R3F	301104.0 | PPP1R3F, R3F | Protein phosphatase 1, regulatory subunit 3F | 89801.0 | ENSG00000049769 | nan | nan
chrX	GAGE10	300737.0 | GAGE10 | G antigen 10 | 102724473.0 | ENSG00000215274 | nan | nan
chrX	GAGE12J	300733.0 | GAGE12J | G antigen 12J | 729396.0 | ENSG00000224659 | nan | nan
chrX	GAGE13	300734.0 | GAGE13 | G antigen 13 | 645051.0 | ENSG00000274274 | nan | nan
chrX	GAGE12C	300727.0 | GAGE12C | G antigen 12C | 729422.0 | ENSG00000237671 | nan | nan
chrX	GAGE12D	300728.0 | GAGE12D | G antigen 12D | 100132399.0 | ENSG00000227488 | nan | nan
chrX	GAGE12E	300729.0 | GAGE12E | G antigen 12E | 729431.0 | ENSG00000216649 | nan | nan
chrX	GAGE12F	300730.0 | GAGE12F | G antigen 12F | 100008586.0 | ENSG00000236362 | nan | nan
chrX	GAGE12G	300731.0 | GAGE12G | G antigen 12G | 645073.0 | ENSG00000215269 | nan | nan
chrX	GAGE12H	300732.0 | GAGE12H | G antigen 12H | 729442.0 | ENSG00000224902 | nan | nan
chrX	GAGE2A	300720.0 | GAGE2A | G antigen 2A | 729447.0 | ENSG00000189064 | nan | nan
chrX	GAGE1	300594.0 | GAGE1 | G antigen 1 | 2543.0 | ENSG00000205777 | nan | nan
chrX	PAGE1	300288.0 | GAGEB1, PAGE1 | P antigen family, member 1 | 8712.0 | ENSG00000068985 | nan | nan
chrX	PAGE4	300287.0 | PAGE4, GAGEC1 | P antigen family, member 4 | 9506.0 | ENSG00000101951 | nan | nan
chrX	USP27X	300975.0 | USP27X, USP22L, XLID105 | Ubiquitin-specific protease 27, X-linked | 389856.0 | ENSG00000273820 | nan | Intellectual developmental disorder, X-linked 105, 300984 (3), X-linked recessive
chrX	CLCN5	300008.0 | CLCN5, CLCK2, NPHL2, DENT1, NPHL1 | Chloride channel-5 | 1184.0 | ENSG00000171365 | nan | Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3), X-linked recessive; Hypophosphatemic rickets, 300554 (3), X-linked recessive; Dent disease 1, 300009 (3), X-linked recessive; Nephrolithiasis, type I, 310468 (3), X-linked recessive
chrX	MIR532	301023.0 | MIR532 | Micro RNA 532 | 693124.0 | ENSG00000207758 | nan | nan
chrX	MIR502	300893.0 | MIR502 | Micro RNA 502 | 574504.0 | ENSG00000272080 | nan | nan
chrX		300705.0 | DUPXp11.22, MRX17, MRX31 | Xp11.22 microduplication syndrome | nan | nan | minimal duplicated region 228 kb overlapping HUWE1 and HSD17B10 | Xp11.22 microduplication syndrome, 300705 (4)
chrX	HPCX2	300704.0 | HPCX2 | Prostate cancer, hereditary, X-linked 2 | 100188769.0 | nan | associated with rs5945572 | {Prostate cancer, hereditary, X-linked 2}, 300704 (2)
chrX	HYSP4	300856.0 | HYSP4 | Hypospadias 4, X-linked, susceptibility to | 100689214.0 | nan | associated with rs1934179 and rs7063116 | {Hypospadias 4, X-linked, susceptibility to}, 300856 (2)
chrX	AKAP4	300185.0 | AKAP4, AKAP82, HI, FSC1 | A-kinase anchor protein 4, 82kD | 8852.0 | ENSG00000147081 | nan | nan
chrX	CCNB3	300456.0 | CCNB3 | Cyclin B3 | 85417.0 | ENSG00000147082 | nan | nan
chrX	DGKK	300837.0 | DGKK | Diacylglycerol kinase, kappa, 142kD | 139189.0 | ENSG00000274588 | nan | nan
chrX	SHROOM4	300579.0 | SHROOM4, KIAA1202 | Shroom family member 4 | 57477.0 | ENSG00000158352 | nan | nan
chrX	BMP15	300247.0 | BMP15, GDF9B, ODG2, POF4 | Bone morphogenetic protein 15 | 9210.0 | ENSG00000130385 | nan | Premature ovarian failure 4, 300510 (3), X-linked; Ovarian dysgenesis 2, 300510 (3), X-linked
chrX	NUDT10	300527.0 | NUDT10, DIPP3A, APS2 | Nudix hydrolase 10 | 170685.0 | ENSG00000122824 | nan | nan
chrX	EZHIP	301036.0 | EZHIP, CATACOMB, CXorf67 | EZH inhibitory protein | 340602.0 | ENSG00000187690 | nan | nan
chrX	NUDT11	300528.0 | NUDT11, DIPP3B, APS1 | Nudix hydrolase 11 | 55190.0 | ENSG00000196368 | nan | nan
chrX	GSPT2	300418.0 | GSPT2, GST2, ERF3B | G1- to S-phase transition 2 | 23708.0 | ENSG00000189369 | nan | nan
chrX	MAGED1	300224.0 | MAGED1 | Melanoma antigen, family D, 1 | 9500.0 | ENSG00000179222 | nan | nan
chrX	MAGED4B	300765.0 | MAGED4B | Melanoma antigen, family D, 4B | 81557.0 | ENSG00000187243 | nan | nan
chrX	MAGED4	300702.0 | MAGED4, MAGEE1, KIAA1859 | Melanoma antigen, family D, 4 | 728239.0 | ENSG00000154545 | nan | nan
chrX	XAGE2	300416.0 | XAGE2, GAGED3 | X antigen family, member 2 | 9502.0 | ENSG00000155622 | nan | nan
chrX	XAGE1A	300742.0 | XAGE1A, XAGE1B | X antigen family, member 1A | 653220.0 | ENSG00000204379 | nan | nan
chrX	XAGE1B	300289.0 | XAGE1B, XAGE1C, XAGE1D, XAGE1E | X antigen family, member 1B | 653067.0 | ENSG00000204382 | nan | nan
chrX	SSX8P	300543.0 | SSX8 | Sarcoma, synovial, X breakpoint 8 | 280659.0 | ENSG00000290686 | nan | nan
chrX	SSX7	300542.0 | SSX7 | Sarcoma, synovial, X breakpoint 7 | 280658.0 | ENSG00000187754 | nan | nan
chrX	SSX2	300192.0 | SSX2 | Sarcoma, synovial, X breakpoint 2 | 6757.0 | ENSG00000241476 | nan | ?Sarcoma, synovial, 300813 (3)
chrX	SPANXN5	300668.0 | SPANXN5 | SPANX family, member N5 | 494197.0 | ENSG00000204363 | nan | nan
chrX	XAGE5	301063.0 | XAGE5 | X antigen family, member 5 | 170627.0 | ENSG00000171405 | nan | nan
chrX	XAGE3	300740.0 | XAGE3, PLAC6 | X antigen family, member 3 | 170626.0 | ENSG00000171402 | nan | nan
chrX	GPR173	300253.0 | GPR173, SREB3 | G protein-coupled receptor 173 | 54328.0 | ENSG00000184194 | nan | nan
chrX	TSPYL2	300564.0 | TSPYL2, CDA1, DENTT, CINAP | TSPY-like 2 | 64061.0 | ENSG00000184205 | nan | nan
chrX	KANTR	301019.0 | KANTR, LINC01155 | KDM5C adjacent transcript, noncoding | 102723508.0 | ENSG00000232593 | nan | nan
chrX	KDM5C	314690.0 | KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ | Lysine demethylase 5C | 8242.0 | ENSG00000126012 | escapes inactivation | Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type, 300534 (3), X-linked recessive
chrX	IQSEC2	300522.0 | IQSEC2, KIAA0522, MRX1, MRX78, XLID1 | IQ motif- and Sec7 domain-containing protein 2 | 23096.0 | ENSG00000124313 | nan | Intellectual developmental disorder, X-linked 1, 309530 (3), X-linked dominant
chrX	SMC1A	300040.0 | SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2, DEE85 | Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; DXS423E; SB1.8) | 8243.0 | ENSG00000072501 | escapes lyonization | Cornelia de Lange syndrome 2, 300590 (3), X-linked dominant; Developmental and epileptic encephalopathy 85, with or without midline brain defects, 301044 (3), X-linked dominant
chrX	HSD17B10	300256.0 | HSD17B10, HADH2, ERAB, MRXS10, HSD10MD | 17-beta-hydroxysteroid dehydrogenase X | 3028.0 | ENSG00000072506 | nan | HSD10 mitochondrial disease, 300438 (3), X-linked dominant
chrX	HUWE1	300697.0 | HUWE1, UREB1, KIAA0312, LASU1, MRXST | HECT, UBA, and WWE domains-containing protein 1 | 10075.0 | ENSG00000086758 | nan | Intellectual developmental disorder, X-linked syndromic, Turner type, 309590 (3), X-linked
chrX	MIR98	300810.0 | MIR98, MIRN98 | Micro RNA 98 | 407054.0 | ENSG00000271886 | nan | nan
chrX	MIRLET7F2	300721.0 | MIRLET7F2, LET7F2, MIRNLET7F2 | Micro RNA Let7f2 | 406889.0 | ENSG00000208012 | nan | nan
chrX	PHF8	300560.0 | PHF8, ZNF422, KIAA1111, MRXSSD | PHD finger protein 8 | 23133.0 | ENSG00000172943 | nan | Intellectual developmental disorder, X-linked syndromic, Siderius type, 300263 (3), X-linked recessive
chrX	FAM120C	300741.0 | FAM120C, CXorf17 | Family with sequence similarity 120, member C | 54954.0 | ENSG00000184083 | nan | nan
chrX	WNK3	300358.0 | WNK3, PRKWNK3, KIAA1566, PRS | WNK lysine deficient protein kinase 3 | 65267.0 | ENSG00000196632 | nan | Prieto syndrome, 309610 (3), X-linked recessive
chrX	TSR2	300945.0 | TSR2, WGG1, DBA14 | TSR2, 20S rRNA accumulation, S. cerevisiae, homolog of | 90121.0 | ENSG00000158526 | mutation identified in 1 DBA14 family | ?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3), X-linked recessive
chrX	FGD1	300546.0 | FGD1, FGDY, AAS, MRXS16 | FYVE, RhoGEF, and PH domain-containing protein 1 | 2245.0 | ENSG00000102302 | nan | Intellectual developmental disorder, X-linked syndromic 16, 305400 (3), X-linked recessive; Aarskog-Scott syndrome, 305400 (3), X-linked recessive
chrX	GNL3L	300873.0 | GNL3L | Guanine nucleotide binding protein-like 3-like protein | 54552.0 | ENSG00000130119 | nan | nan
chrX	MAGED2	300470.0 | MAGED2, MAGED, BARTS5 | Melanoma antigen, family D, 2 | 10916.0 | ENSG00000102316 | nan | Bartter syndrome, type 5, antenatal, transient, 300971 (3), X-linked recessive
chrX	SNORA11	300662.0 | SNORA11 | Small nucleolar RNA, H/ACA box, 11 | 677799.0 | ENSG00000221716 | in intron 1 of MAGED2 | nan
chrX	TRO	300132.0 | TRO | Trophinin | 7216.0 | ENSG00000067445 | nan | nan
chrX	PFKFB1	311790.0 | PFKFB1, PFRX | Fructose-2,6-bisphosphatase | 5207.0 | ENSG00000158571 | ?Xq27-q25; ?Xcen-q13 | nan
chrX	APEX2	300773.0 | APEX2, APE2, XTH2, APEXL2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 | 27301.0 | ENSG00000169188 | nan | nan
chrX	ALAS2	301300.0 | ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1 | Aminolevulinate, delta-, synthase-2 | 212.0 | ENSG00000158578 | nan | Anemia, sideroblastic, 1, 300751 (3), X-linked recessive; Protoporphyria, erythropoietic, X-linked, 300752 (3), X-linked
chrX	PAGE2	300738.0 | PAGE2, GAGEC2 | P antigen family, member 2 | 203569.0 | ENSG00000234068 | nan | nan
chrX	PAGE5	301009.0 | PAGE5, CT16, GAGEE1 | P antigen family, member 5 | 90737.0 | ENSG00000158639 | nan | nan
chrX	PAGE3	300739.0 | PAGE3, GAGEC1 | P antigen family, member 3 | 139793.0 | ENSG00000204279 | nan | nan
chrX	MAGEH1	300548.0 | MAGEH1, MAGEH | Melanoma antigen, family H, 1 | 28986.0 | ENSG00000187601 | nan | nan
chrX	FOXR2	300949.0 | FOXR2, FOXN6 | Forkhead box R2 | 139628.0 | ENSG00000189299 | nan | nan
chrX	RRAGB	300725.0 | RRAGB, RAGB | Ras-related GTP-binding protein B | 10325.0 | ENSG00000083750 | nan | nan
chrX	KLF8	300286.0 | KLF8, ZNF741, BKLF3 | Kruppel-like factor 8 | 11279.0 | ENSG00000102349 | nan | nan
chrX	UBQLN2	300264.0 | UBQLN2, PLIC2, CHAP1, ALS15 | Ubiquilin 2 | 29978.0 | ENSG00000188021 | nan | Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3), X-linked dominant
chrX	NBDY	300992.0 | NBDY, LINC01420, NOBODY | Negative regulator of P-body association | 550643.0 | ENSG00000204272 | nan | nan
chrX	SPIN2B	300517.0 | SPIN2 | Spindlin family, member 2 | 474343.0 | ENSG00000186787 | nan | nan
chrX	FAAH2	300654.0 | FAAH2 | Fatty acid amide hydrolase 2 | 158584.0 | ENSG00000165591 | nan | nan
chrX	SPIN2A	300621.0 | DSF34 | DXF34 gene | 54466.0 | ENSG00000147059 | nan | nan
chrX	ZXDB	300236.0 | ZXDB | Zinc finger-encoding gene, X-linked, duplicated, B | 158586.0 | ENSG00000198455 | nan | nan
chrX	ZXDA	300235.0 | ZXDA | Zinc finger-encoding gene, X-linked, duplicated, A | 7789.0 | ENSG00000198205 | nan | nan
chrX	AGA2	300710.0 | AGA2 | Alopecia, androgenetic, 2 | 100188771.0 | nan | associated with rs6152 | Alopecia, androgenetic, 2, 300710 (2)
chrX	CGF1	300082.0 | CGF1 | Cognitive function-1, social | 1083.0 | nan | imprinted locus | [Social cognition], 300082 (2), X-linked
chrX		300010.0 | DXS435E, A11 | A-11 gene | nan | nan | nan | nan
chrX	MGR2	300125.0 | MGR2 | Migraine, familial typical, susceptibility to, 2 | 8249.0 | nan | nan | {Migraine, familial typical, susceptibility to, 2}, 300125 (2), X-linked
chrX	MTBSX	300259.0 | MTBSX | Mycobacterium tuberculosis, susceptibility to, X-linked | 57789.0 | nan | nan | {Mycobacterium tuberculosis, susceptibility, X-linked}, 300259 (2)
chrX	SPIN4	301113.0 | SPIN4, LJBS | Spindlin family, member 4 | 139886.0 | ENSG00000186767 | mutation identified in 1 LJBS family | ?Lui-Jee-Baron syndrome, 301114 (3), X-linked
chrX	ARHGEF9	300429.0 | ARHGEF9, PEM2, KIAA0424, DEE8 | Rho guanine nucleotide exchange factor 9 | 23229.0 | ENSG00000131089 | nan | Developmental and epileptic encephalopathy 8, 300607 (3), X-linked
chrX	SPG16	300266.0 | SPG16 | Spastic paraplegia 16, X-linked, complicated | 57760.0 | nan | nan | Spastic paraplegia 16, X-linked, complicated, 300266 (2), X-linked recessive
chrX	AMER1	300647.0 | AMER1, FAM123B, WTX, OSCS | APC membrane recruitment protein 1 | 139285.0 | ENSG00000184675 | nan | Osteopathia striata with cranial sclerosis, 300373 (3), X-linked dominant
chrX	ASB12	300891.0 | ASB12 | Ankyrin repeat- and SOCS box-containing protein 12 | 142689.0 | ENSG00000198881 | nan | nan
chrX	MTMR8	301061.0 | MTMR8 | Myotubularin-related protein 8 | 55613.0 | ENSG00000102043 | nan | nan
chrX	ZC4H2	300897.0 | ZC4H2, KIAA1166, WRWF, MRXS4, WRWFFR | Zinc finger C4H2 domain-containing protein | 55906.0 | ENSG00000126970 | nan | Wieacker-Wolff syndrome, 314580 (3), X-linked recessive; Wieacker-Wolff syndrome, female-restricted, 301041 (3), X-linked dominant
chrX	ZC3H12B	300889.0 | ZC3H12B, MCPIP2 | Zinc finger CCCH domain-containing protein 12B | 340554.0 | ENSG00000102053 | nan | nan
chrX		300709.0 | MRXS9 | Intellectual developmental disorder, X-linked, syndromic 9 | nan | nan | between DXS1111 and DXS1197 | Intellectual developmental disorder, X-linked syndromic 9, 300709 (2)
chrX	MRX77	300454.0 | XLID77, MRX77 | Intellectual developmental disorder, X-linked 77 | 93991.0 | nan | nan | Intellectual developmental disorder, X-linked 77, 300454 (2), X-linked recessive
chrX	LAS1L	300964.0 | LAS1L, MRXSWTS | Las1-like ribosome biogenesis factor | 81887.0 | ENSG00000001497 | nan | Wilson-Turner syndrome, 309585 (3), X-linked recessive
chrX	MSN	309845.0 | MSN, IMD50 | Moesin | 4478.0 | ENSG00000147065 | nan | Immunodeficiency 50, 300988 (3), X-linked recessive
chrX	MIR223	300694.0 | MIR223, MIRN223 | Micro RNA 223 | 407008.0 | ENSG00000284567 | nan | nan
chrX	VSIG4	300353.0 | Z39IG | Immunoglobulin superfamily protein Z39IG | 11326.0 | ENSG00000155659 | nan | nan
chrX	HEPH	300167.0 | HEPH | Hephaestin | 9843.0 | ENSG00000089472 | nan | nan
chrX	EDA2R	300276.0 | EDAR2, XEDAR, EDAA2R | Ectodysplasin A2 receptor | 60401.0 | ENSG00000131080 | nan | nan
chrX	AR	313700.0 | AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1 | Androgen receptor (dihydrotestosterone receptor) | 367.0 | ENSG00000169083 | nan | Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive; Spinal and bulbar muscular atrophy, X-linked 1, 313200 (3), X-linked recessive; {Prostate cancer, susceptibility to}, 301120 (3), X-linked; Androgen insensitivity, 300068 (3), X-linked recessive; Hypospadias 1, X-linked, 300633 (3), X-linked recessive
chrX	OPHN1	300127.0 | OPHN1, MRXSBL | Oligophrenin-1 | 4983.0 | ENSG00000079482 | nan | Intellectual developmental disorder, X-linked syndromic, Billuart type, 300486 (3), X-linked recessive
chrX	YIPF6	300996.0 | YIPF6 | YIP1 domain family, member 6 | 286451.0 | ENSG00000181704 | nan | nan
chrX	CFTDX	300580.0 | CFTDX | Myopathy, congenital, with fiber-type disproportion, X-linked | 100188765.0 | nan | between DXS8019 and DXS99 | Myopathy, congenital, with fiber-type disproportion, X-linked, 300580 (2), X-linked dominant
chrX	MRXSMP	300519.0 | MRXSMP | Martin-Probst syndrome | 574047.0 | nan | nan | Martin-Probst syndrome, 300519 (2), X-linked recessive
chrX	XCE	300074.0 | XCE, XITE | X chromosome-controlling element | 7497.0 | nan | nan | nan
chrX	STARD8	300689.0 | STARD8, DLC3, STARTGAP3, KIAA0189 | START domain-containing protein 8 | 9754.0 | ENSG00000130052 | nan | nan
chrX	EFNB1	300035.0 | EFNB1, EPLG2, CFNS, CFND | eph-related receptor tyrosine kinase ligand 2 (ephrin B1) | 1947.0 | ENSG00000090776 | ?CFNS also on Xp22 | Craniofrontonasal dysplasia, 304110 (3), X-linked dominant
chrX	PJA1	300420.0 | PJA1 | Praja RING finger ubiquitin ligase 1 | 64219.0 | ENSG00000181191 | nan | nan
chrX	EDA	300451.0 | EDA, ED1, ECTD1, HED1, STHAGX1 | Ectodysplasin A | 1896.0 | ENSG00000158813 | nan | Tooth agenesis, selective, X-linked 1, 313500 (3), X-linked dominant; Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3), X-linked recessive
chrX	AWAT2	300925.0 | AWAT2, DC4, MFAT | Acyl-CoA wax alcohol acyltransferase 2 | 158835.0 | ENSG00000147160 | nan | nan
chrX	OTUD6A	300714.0 | OTUD6A, DUBA2 | OTU domain-containing protein 6A | 139562.0 | ENSG00000189401 | nan | nan
chrX	IGBP1	300139.0 | IGBP1, MRXS28 | Immunoglobulin-binding protein 1 | 3476.0 | ENSG00000089289 | mutation identified in 1 MRXS28 family | ?Corpus callosum, agenesis of, with impaired intellectual development, ocular coloboma and micrognathia, 300472 (3), X-linked recessive
chrX	DGAT2L6	300926.0 | DGAT2L6, DC3 | Diacylglycerol O-acyltransferase 2-like 6 | 347516.0 | ENSG00000184210 | nan | nan
chrX	AWAT1	300924.0 | AWAT1, DGA2 | Acyl-CoA wax alcohol acyltransferase 1 | 158833.0 | ENSG00000204195 | nan | nan
chrX	P2RY4	300038.0 | P2RY4, NRU, P2Y4 | Pyrimidinergic receptor P2Y, G-protein coupled, 4 | 5030.0 | ENSG00000186912 | nan | nan
chrX	ARR3	301770.0 | ARR3, MYP26 | Arrestin 3, retinal | 407.0 | ENSG00000120500 | nan | Myopia 26, X-linked, female-limited, 301010 (3), X-linked
chrX	PDZD11	300632.0 | PDZD11, AIPP1, PISP | PDZ domain-containing 11 | 51248.0 | ENSG00000120509 | nan | nan
chrX	KIF4A	300521.0 | KIF4A, KIF4, XLID100, TMDI | Kinesin family member 4A | 24137.0 | ENSG00000090889 | nan | Taurodontism, microdontia, and dens invaginatus, 313490 (3), X-linked recessive; Intellectual developmental disorder, X-linked 100, 300923 (3), X-linked recessive
chrX	GDPD2	300940.0 | GDPD2, GDE3 | Glycerophosphodiester phosphodiesterase domain-containing protein 2 | 54857.0 | ENSG00000130055 | nan | nan
chrX	DLG3	300189.0 | DLG3, NEDLG, SAP102, XLID90 | Discs large MAGUK scaffold protein 3 | 1741.0 | ENSG00000082458 | nan | Intellectual developmental disorder, X-linked 90, 300850 (3), X-linked recessive
chrX	TEX11	300311.0 | TEX11, SPGFX2 | Testis-expressed gene 11 | 56159.0 | ENSG00000120498 | nan | Spermatogenic failure, X-linked 2, 309120 (3), X-linked recessive
chrX	SLC7A3	300443.0 | SLC7A3, CAT3 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 | 84889.0 | ENSG00000165349 | nan | nan
chrX	SNX12	300883.0 | SNX12 | Sorting nexin 12 | 29934.0 | ENSG00000147164 | nan | nan
chrX	FOXO4	300033.0 | FOXO4, MLLT7, AFX1 | Forkhead box O4 | 4303.0 | ENSG00000184481 | nan | nan
chrX	IL2RG	308380.0 | IL2RG, SCIDX1, SCIDX, IMD4 | Interleukin-2 receptor, gamma | 3561.0 | ENSG00000147168 | linked to DXS159 | Combined immunodeficiency, X-linked, moderate, 312863 (3), X-linked recessive; Severe combined immunodeficiency, X-linked, 300400 (3), X-linked recessive
chrX	MED12	300188.0 | MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX, HDKR | Mediator complex subunit 12 | 9968.0 | ENSG00000184634 | nan | Lujan-Fryns syndrome, 309520 (3), X-linked recessive; Ohdo syndrome, X-linked, 300895 (3), X-linked recessive; Hardikar syndrome, 301068 (3), X-linked dominant; Opitz-Kaveggia syndrome, 305450 (3), X-linked recessive
chrX	NLGN3	300336.0 | NLGN3, AUTSX1 | Neuroligin 3 | 54413.0 | ENSG00000196338 | nan | {Autism susceptibility, X-linked 1}, 300425 (3), X-linked
chrX	GJB1	304040.0 | GJB1, CX32, CMTX1 | Gap junction protein, beta-1, 32kD (connexin 32) | 2705.0 | ENSG00000169562 | nan | Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3), X-linked dominant
chrX	ZMYM3	300061.0 | ZMYM3, ZNF261, DXS6673E, XLID112 | Zinc finger, MYM-type 3 | 9203.0 | ENSG00000147130 | nan | Intellectual developmental disorder, X-linked 112, 301111 (3), X-linked recessive
chrX	NONO	300084.0 | NONO, NRB54, MRXS34 | Non-Pou domain-containing octamer (ATGCAAAT) binding protein (nuclear RNA-binding protein, 54-kD) | 4841.0 | ENSG00000147140 | 2Mb proximal to PHKA1 | Intellectual developmental disorder, X-linked syndromic 34, 300967 (3), X-linked
chrX	ITGB1BP2	300332.0 | ITGB1BP2 | Integrin, beta-1, binding protein of, 2 | 26548.0 | ENSG00000147166 | nan | nan
chrX	TAF1	313650.0 | TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33 | TATA-box binding protein-associated factor 1 | 6872.0 | ENSG00000147133 | SVA retrotransposon insertion | Intellectual developmental disorder, X-linked syndromic 33, 300966 (3), X-linked recessive; Dystonia-Parkinsonism, X-linked, 314250 (3), X-linked recessive
chrX	INGX	300452.0 | INGX, ING2 | Inhibitor of growth, X-linked | 27160.0 | ENSG00000293133 | nan | nan
chrX	OGT	300255.0 | OGT, XLID106 | O-linked N-acetylglucosamine transferase | 8473.0 | ENSG00000147162 | nan | Intellectual developmental disorder, X-linked 106, 300997 (3), X-linked recessive
chrX	GCNA	300369.0 | GCNA, ACRC, SPGFX4 | Germ cell nuclear acidic peptidase | 93953.0 | ENSG00000147174 | nan | Spermatogenic failure, X-linked, 4, 301077 (3), X-linked
chrX	CXCR3	300574.0 | CXCR3, GPR9, CD182 | Chemokine, C-X-C motif, receptor 3 (G protein-coupled receptor-9) | 2833.0 | ENSG00000186810 | previously assigned to chr.8 | nan
chrX	NHSL2	301093.0 | NHSL2 | NHS-like protein 2 | 340527.0 | ENSG00000204131 | nan | nan
chrX	PIN4	300252.0 | PIN4, PAR14, EPVH | Peptidyl-prolyl cis/trans isomerase, nima-interacting, 4 | 5303.0 | ENSG00000102309 | nan | nan
chrX	ERCC6L	300687.0 | ERCC6L, PICH | ERCC excision repair 6-like, spindle assembly checkpoint helicase | 54821.0 | ENSG00000186871 | nan | nan
chrX	RPS4X	312760.0 | RPS4X, CCG2, SCAR | Ribosomal protein S4, X-linked | 6191.0 | ENSG00000198034 | cen-RPS4X-PHKA1-XIST-qter in 2.6Mb | nan
chrX	CITED1	300149.0 | MSG1 | Melanocyte-specific gene 1 | 4435.0 | ENSG00000125931 | nan | nan
chrX	HDAC8	300269.0 | HDAC8, MRXS6, CDLS5 | Histone deacetylase 8 | 55869.0 | ENSG00000147099 | nan | Cornelia de Lange syndrome 5, 300882 (3), X-linked dominant
chrX	PHKA1	311870.0 | PHKA1 | Phosphorylase kinase, muscle, alpha polypeptide | 5255.0 | ENSG00000067177 | ?proximal and close to PGKA; | Muscle glycogenosis, 300559 (3), X-linked recessive
chrX	DMRTC1	300878.0 | DMRTC1 | Doublesex- and MAB3-related transcription factor C1 | 63947.0 | ENSG00000269502 | nan | nan
chrX		301069.0 | DUPXq13 | Chromosome Xq13 duplication syndrome | nan | nan | nan | Chromosome Xq13 duplication syndrome, 301069 (4), X-linked
chrX	MRXSAB	300262.0 | MRXSAB | Intellectual developmental disorder, X-linked, Abidi type | 57792.0 | nan | nan | Intellectual developmental disorder, X-linked syndromic, Abidi type, 300262 (2), X-linked
chrX	NAP1L2	300026.0 | NAP1L2, BPX | Nucleosome assembly protein 1-like 2 | 4674.0 | ENSG00000186462 | nan | nan
chrX	CDX4	300025.0 | CDX4 | Caudal type homeobox transcription factor 4 | 1046.0 | ENSG00000131264 | nan | nan
chrX	CHIC1	300922.0 | CHIC1, BRX | Cystein-rich hydrophobic domain protein 1 | 53344.0 | ENSG00000204116 | nan | nan
chrX	TSIX	300181.0 | TSIX | X-inactivation-specific transcript-antisense | 9383.0 | ENSG00000270641 | nan | nan
chrX	XIST	314670.0 | XIC, XCE, XIST, SXI1 | X chromosome controlling element (X-inactivation center) | 7503.0 | ENSG00000229807 | q13-q21; metaphase bend, or fold, at q13.3-q21.1 | X-inactivation, familial skewed, 300087 (3), X-linked
chrX	JPX	300832.0 | NCRNA00183, JPX, ENOX | Noncoding RNA 183 | 554203.0 | ENSG00000225470 | nan | nan
chrX	FTX	300936.0 | FTX, LINC00182 | FTX transcript, XIST regulator, noncoding | 100302692.0 | ENSG00000230590 | nan | nan
chrX	ZCCHC13	301125.0 | ZCCHC13, CNBP2 | Zinc finger domain-containing protein 13 | 389874.0 | ENSG00000187969 | nan | nan
chrX	SLC16A2	300095.0 | SLC16A2, DXS128, XPCT | Solute carrier family 16 (monocarboxylic acid transporters), member 2 | 6567.0 | ENSG00000147100 | nan | Allan-Herndon-Dudley syndrome, 300523 (3), X-linked
chrX	RLIM	300379.0 | RLIM, RNF12, TOKAS | RING finger protein, LIM domain-interacting | 51132.0 | ENSG00000131263 | nan | Tonne-Kalscheuer syndrome, 300978 (3), X-linked
chrX		300577.0 | XLID91, MRX91 | Intellectual developmental disorder, X-linked 91 | nan | nan | t(X;15)(q13.3;cen) | Intellectual developmental disorder, X-linked 91, 300577 (4), X-linked dominant
chrX	NEXMIF	300524.0 | NEXMIF, KIAA2022, XLID98 | Neurite extension and migration factor | 340533.0 | ENSG00000050030 | inv(X)(q13;p22) | Intellectual developmental disorder, X-linked 98, 300912 (3), X-linked dominant
chrX	ABCB7	300135.0 | ABCB7, ABC7, ASAT | ATP-binding cassette-7 | 22.0 | ENSG00000131269 | nan | Anemia, sideroblastic, with ataxia, 301310 (3), X-linked
chrX	UPRT	300656.0 | UPRT | Uracil phosphoribosyltransferase, S. cerevisiae, homolog of | 139596.0 | ENSG00000094841 | nan | nan
chrX	ZDHHC15	300576.0 | ZDHHC15 | Zinc finger DHHC domain-containing protein 15 | 158866.0 | ENSG00000102383 | nan | nan
chrX	BRAFP1	300956.0 | BRAFP1 | BRAF pseudogene 1 | 286494.0 | ENSG00000224775 | nan | nan
chrX	MAGEE2	300760.0 | MAGEE2 | Melanoma antigen, family E, 2 | 139599.0 | ENSG00000186675 | nan | nan
chrX	MAGEE1	300759.0 | MAGEE1, DAMAGE, KIAA1587 | Melanoma antigen, family E, 1 | 57692.0 | ENSG00000198934 | nan | nan
chrX		303110.0 | DELXq21, CXDELq21 | Chromosome Xq21 deletion syndrome | nan | nan | at least CHM and POU3F4 deleted | Xq21 deletion syndrome, 303110 (4), X-linked recessive
chrX	PARK12	300557.0 | PARK12 | Parkinson disease-12 | 677662.0 | nan | max lod with DXS1106, DXS8055, DXS1001 | {Parkinson disease 12}, 300557 (2)
chrX	FGF16	300827.0 | FGF16, MF4 | Fibroblast growth factor 16 | 8823.0 | ENSG00000196468 | previously mapped to 8q21.3 | Metacarpal 4-5 fusion, 309630 (3), X-linked recessive
chrX	ATRX	300032.0 | ATRX, XH2, XNP, SHS, SFM1, MRXHF1 | ATRX chromatin remodeler | 546.0 | ENSG00000085224 | nan | Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Intellectual disability-hypotonic facies syndrome, X-linked, 309580 (3), X-linked recessive; Alpha-thalassemia/impaired intellectual development syndrome, 301040 (3), X-linked dominant
chrX	MAGT1	300715.0 | MAGT1, IAP, XMEN, CDG1CC | Magnesium transporter 1 | 84061.0 | ENSG00000102158 | nan | Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3), X-linked recessive; Congenital disorder of glycosylation, type Icc, 301031 (3), X-linked recessive
chrX	COX7B	300885.0 | COX7B, LSDMCA2 | Cytochrome c oxidase, subunit VIIb | 1349.0 | ENSG00000131174 | nan | Linear skin defects with multiple congenital anomalies 2, 300887 (3), X-linked dominant
chrX	ATP7A	300011.0 | ATP7A, MNK, MK, OHS, HMNX | ATPase, Cu++ transporting, alpha polypeptide | 538.0 | ENSG00000165240 | probably Xq13.2-q13.3, ~150kb prox. to PGK1 | Occipital horn syndrome, 304150 (3), X-linked recessive; Neuronopathy, distal hereditary motor, X-linked, 300489 (3), X-linked recessive; Menkes disease, 309400 (3), X-linked recessive
chrX	PGAM4	300567.0 | PGAM4, PGAM3 | Phosphoglycerate mutase family member 4 | 441531.0 | ENSG00000226784 | nan | nan
chrX	PGK1	311800.0 | PGK1, PGKA | Phosphoglycerate kinase-1 | 5230.0 | ENSG00000102144 | ?Xq13.3; pseudogenes PGK1P1 on Xq, PGK1P2 on chr. 6 | Phosphoglycerate kinase 1 deficiency, 300653 (3), X-linked recessive
chrX	TAF9B	300754.0 | TAF9B, TAF9L, TAFII31L | TAF9B RNA polymerase II, TATA box-binding protein-associated factor, 31kD | 51616.0 | ENSG00000187325 | nan | nan
chrX	CYSLTR1	300201.0 | CYSLTR1, CYSLT1 | Cysteinyl leukotriene receptor 1 | 10800.0 | ENSG00000173198 | nan | nan
chrX	RTL3	301130.0 | RTL3 | Retrotransposon GAG-like 3 | 203430.0 | ENSG00000179300 | nan | nan
chrX	LPAR4	300086.0 | LPAR4, LPA4, P2RY9, P2Y9, GPR23 | Lysophosphatidic acid receptor 4 | 2846.0 | ENSG00000147145 | nan | nan
chrX	P2RY10	300529.0 | P2RY10, P2Y10 | Purinergic receptor P2Y, G protein-coupled, 10 | 27334.0 | ENSG00000078589 | nan | nan
chrX	GPR174	300903.0 | GPR174, GPCR17 | G protein-coupled receptor 174 | 84636.0 | ENSG00000147138 | nan | nan
chrX	ITM2A	300222.0 | ITM2A, E25A | Integral membrane protein 2A | 9452.0 | ENSG00000078596 | nan | nan
chrX	TBX22	300307.0 | TBX22, CPX, ABERS | T-box 22 | 50945.0 | ENSG00000122145 | 1 ABERS family identified with mutation | Cleft palate with ankyloglossia, 303400 (3), X-linked; ?Abruzzo-Erickson syndrome, 302905 (3), X-linked
chrX	TENT5D	300976.0 | FAM46D | Family with sequence similarity 46, member D | 169966.0 | ENSG00000174016 | nan | nan
chrX	BRWD3	300553.0 | BRWD3, MRX93, XLID93 | Bromodomain-and WD repeat-containing protein 3 | 254065.0 | ENSG00000165288 | nan | Intellectual developmental disorder, X-linked 93, 300659 (3), X-linked recessive
chrX	HMGN5	300385.0 | NSBP1 | Nucleosomal binding protein 1 | 79366.0 | ENSG00000198157 | nan | nan
chrX	SH3BGRL	300190.0 | SH3BGR | SH3-binding domain glutamic acid-rich protein-like | 6451.0 | ENSG00000131171 | nan | nan
chrX	POU3F4	300039.0 | POU3F4, DFN3, DFNX2 | POU domain, class 3, transcription factor 4 | 5456.0 | ENSG00000196767 | nan | Deafness, X-linked 2, 304400 (3), X-linked recessive
chrX	CYLC1	300768.0 | CYLC1, SPGFX8 | Cylicin 1 | 1538.0 | ENSG00000183035 | nan | {Spermatogenic failure, X-linked, 8, susceptibility to}, 301119 (3), X-linked
chrX	RPS6KA6	300303.0 | RPS6KA6, RSK4 | Ribosomal protein S6 kinase A6 | 27330.0 | ENSG00000072133 | nan | nan
chrX	HDX	300994.0 | HDX, CXorf43 | Highly divergent homeobox | 139324.0 | ENSG00000165259 | nan | nan
chrX	APOOL	300955.0 | APOOL, FAM121A, Cxorf33 | Apolipoprotein O-like | 139322.0 | ENSG00000155008 | nan | nan
chrX	SATL1	301129.0 | SATL1 | Spermidine/spermine N1-acetyltransferase-like 1 | 340562.0 | ENSG00000184788 | nan | nan
chrX	ZNF711	314990.0 | ZNF711, ZNF6, CMPX1, XLID97 | Zinc finger protein-711 | 7552.0 | ENSG00000147180 | nan | Intellectual developmental disorder, X-linked 97, 300803 (3), X-linked
chrX	POF1B	300603.0 | FLJ22792, POF1B, POF2B | FLJ22792 gene | 79983.0 | ENSG00000124429 | mutation identified in 1 POF2B family | ?Premature ovarian failure 2B, 300604 (3), X-linked recessive
chrX	CHM	300390.0 | CHM, TCD | CHM Rab escort protein | 1121.0 | ENSG00000188419 | nan | Choroideremia, 303100 (3), X-linked
chrX	DACH2	300608.0 | DACH2 | Dachshund family transcription factor 2 | 117154.0 | ENSG00000126733 | nan | nan
chrX	AD16	300756.0 | AD16 | Alzheimer disease 16 | 100271718.0 | nan | associated with rs5984894 | {Alzheimer disease 16}, 300756 (2)
chrX	KLHL4	300348.0 | KLHL4 | Kelch-like 4 | 56062.0 | ENSG00000102271 | nan | nan
chrX	CPXCR1	301055.0 | CPXCR1 | CPX chromosome region, candidate gene 1 | 53336.0 | ENSG00000147183 | nan | nan
chrX	TGIF2LX	300411.0 | TGIF2LX, TGIFLX | Transforming growth factor-beta-induced factor 2-like, X-linked | 90316.0 | ENSG00000153779 | nan | nan
chrX	PABPC5	300407.0 | PABPC5, PABP5 | Polyadenylate-binding protein, cytoplasmic, 5 | 140886.0 | ENSG00000174740 | nan | nan
chrX	PCDH11X	300246.0 | PCDH11X, PCDH11, PCDHX | Protocadherin 11, X-linked | 27328.0 | ENSG00000102290 | nan | nan
chrX	NAP1L3	300117.0 | NAP1L3 | Nucleosome assembly protein 1-like 3 | 4675.0 | ENSG00000186310 | nan | nan
chrX	MRXSCS	300861.0 | MRXSCS | Intellectual developmental disorder, X-linked, syndromic, Chudley-Schwartz type (2) | 100820761.0 | nan | max lod at DXS1120 | Intellectual developmental disorder, X-linked syndromic, Chudley-Schwartz type, 300861 (2), X-linked recessive
chrX	DIAPH2	300108.0 | DIAPH2, DIA, POF2A | diaphanous-related formin 2 | 1730.0 | ENSG00000147202 | mutation identified in 1 POF2A family | ?Premature ovarian failure 2A, 300511 (3), X-linked dominant
chrX	RPA4	300767.0 | RPA4 | Replication protein A4 | 29935.0 | ENSG00000204086 | nan | nan
chrX	DIAPH2-AS1	300347.0 | EPAG | Early lymphoid activation gene | 10824.0 | ENSG00000236256 | nan | nan
chrX	AIH3	301201.0 | AI1E2, AIH3 | Amelogenesis imperfecta, hypomaturation or hypoplastic type, X-linked 2 | 201.0 | nan | nan | ?Amelogenesis imperfecta, type IE, X-linked 2, 301201 (2), X-linked
chrX	PCDH19	300460.0 | PCDH19, KIAA1313, EFMR, DEE9 | Protocadherin 19 | 57526.0 | ENSG00000165194 | nan | Developmental and epileptic encephalopathy 9, 300088 (3), X-linked
chrX	TNMD	300459.0 | TNMD, TEM, CHM1L | Tenomodulin | 64102.0 | ENSG00000000005 | nan | nan
chrX	TSPAN6	300191.0 | TSPAN6, TM4SF6 | Tetraspanin 6 | 7105.0 | ENSG00000000003 | nan | nan
chrX	SRPX2	300642.0 | SRPX2, SRPUL, RESDX | SUSHI repeat-containing protein, X-linked, 2 | 27286.0 | ENSG00000102359 | mutation identified in 1 RESDX family | ?Rolandic epilepsy, impaired intellectual development, and speech dyspraxia, 300643 (3)
chrX	SYTL4	300723.0 | SYTL4 | Synaptotagmin-like 4 | 94121.0 | ENSG00000102362 | nan | nan
chrX	CSTF2	300907.0 | CSTF2, CSTF64, XLID113 | Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD | 1478.0 | ENSG00000101811 | mutation identified in 1 XLID113 family | ?Intellectual developmental disorder, X-linked 113, 301116 (3), X-linked recessive
chrX	NOX1	300225.0 | NOX1, MOX1, NOH1 | NADPH oxidase 1 | 27035.0 | ENSG00000007952 | nan | nan
chrX	XKRX	300684.0 | XKRX, XPLAC, XKR2, XRG2 | X Kell blood group precursor-related, X-linked | 402415.0 | ENSG00000182489 | nan | nan
chrX	TRMT2B	301128.0 | TRMT2B | tRNA methyltransferase 2 homolog B | 79979.0 | ENSG00000188917 | nan | nan
chrX	CENPI	300065.0 | FSHPRH1, LRPR1 | FSH primary response, rat, homolog of, 1 | 2491.0 | ENSG00000102384 | nan | nan
chrX	DRP2	300052.0 | DRP2 | Dystrophin-related protein 2 | 1821.0 | ENSG00000102385 | nan | nan
chrX	TAF7L	300314.0 | TAF7L, TAF2Q | TATA-box binding protein-associated factor 7-like | 54457.0 | ENSG00000102387 | nan | nan
chrX	TIMM8A	300356.0 | TIMM8A, DFN1, DDP, MTS, DDP1 | Translocase of inner mitochondrial membrane 8A | 1678.0 | ENSG00000126953 | nan | Mohr-Tranebjaerg syndrome, 304700 (3), X-linked recessive
chrX	BTK	300300.0 | BTK, AGMX1, IMD1, XLA, AT, IGHD3 | Bruton agammaglobulinemia tyrosine kinase | 695.0 | ENSG00000010671 | nan | Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive; Isolated growth hormone deficiency, type III, with agammaglobulinemia, 307200 (3), X-linked recessive
chrX	RPL36A	300902.0 | RPL36A, RPL44 | Ribosomal protein L36A | 6173.0 | ENSG00000241343 | nan | nan
chrX	GLA	300644.0 | GLA | Galactosidase, alpha | 2717.0 | ENSG00000102393 | nan | Fabry disease, cardiac variant, 301500 (3), X-linked; Fabry disease, 301500 (3), X-linked
chrX	HNRNPH2	300610.0 | HNRNPH2, NRPH2, MRXSB | Heterogeneous nuclear ribonucleoprotein H2 | 3188.0 | ENSG00000126945 | nan | Intellectual developmental disorder, X-linked syndromic, Bain type, 300986 (3), X-linked dominant
chrX	ARMCX4	301046.0 | ARMCX4 | Armadillo repeat-containing protein, X-linked 4 | 100131755.0 | ENSG00000196440 | nan | nan
chrX	ARMCX1	300362.0 | ARMCX1, ALEX1 | Armadillo repeat-containing protein, X-linked 1 | 51309.0 | ENSG00000126947 | nan | nan
chrX	ARMCX6	301048.0 | ARMCX | Armadillo repeat-containing protein, X-linked 6 | 54470.0 | ENSG00000198960 | nan | nan
chrX	ARMCX3	300364.0 | ARMCX3, ALEX3 | Armadillo repeat-containing protein, X-linked 3 | 51566.0 | ENSG00000102401 | nan | nan
chrX	ARMCX2	300363.0 | ARMCX2, ALEX2, KIAA0512 | Armadillo repeat-containing protein, X-linked 2 | 9823.0 | ENSG00000184867 | nan | nan
chrX	NXF5	300319.0 | NXF5 | Nuclear RNA export factor 5 | 55998.0 | ENSG00000290798 | nan | nan
chrX	ZMAT1	301007.0 | ZMAT1, KIAA1789 | Zinc finger, matrin-type 1 | 84460.0 | ENSG00000166432 | nan | nan
chrX	BEX5	300693.0 | BEX5, NGFRAP1L1 | BEX family member 5 | 340542.0 | ENSG00000184515 | nan | nan
chrX	NXF2	300315.0 | NXF2 | Nuclear RNA export factor 2 | 56001.0 | ENSG00000269405 | nan | nan
chrX	TMSB15A	300939.0 | TMSB15A, TMSB15, TMSNB | Thymosin, beta-15A | 11013.0 | ENSG00000158164 | nan | nan
chrX	NXF4	300318.0 | NXF4 | Nuclear RNA export factor 4 | 55999.0 | ENSG00000290811 | nan | nan
chrX	ARMCX5	301047.0 | ARMCX5 | Armadilla repeat-containing protein, X-linked 5 | 64860.0 | ENSG00000125962 | nan | nan
chrX	GPRASP1	300417.0 | GPRASP1, GASP, KIAA0443 | G protein-coupled receptor-associated sorting protein 1 | 9737.0 | ENSG00000198932 | conflicting assignment to chr.9 | nan
chrX	GPRASP2	300969.0 | GPRASP2, GASP2, DFNX7 | G protein-coupled receptor-associated sorting protein 2 | 114928.0 | ENSG00000158301 | mutation identified in 1 DFNX7 family | ?Deafness, X-linked 7, 301018 (3), X-linked recessive
chrX	GPRASP3	300921.0 | BHLHB9, P60TRP, KIAA1701 | Basic helix-loop-helix domain-containing protein, class B, 9 | 80823.0 | ENSG00000198908 | nan | nan
chrX	RAB40AL	300405.0 | RAB40AL, RLGP | Ras-associated protein, RAB40A-like | 282808.0 | ENSG00000102128 | nan | nan
chrX	BEX1	300690.0 | BEX1 | Brain-expressed X-linked gene 1 | 55859.0 | ENSG00000133169 | nan | nan
chrX	NXF3	300316.0 | NXF3 | Nuclear RNA export factor 3 | 56000.0 | ENSG00000147206 | nan | nan
chrX	BEX4	300692.0 | BEX4 | BEX family member 4 | 56271.0 | ENSG00000102409 | nan | nan
chrX	MRX53	300324.0 | XLID53, MRX53 | Intellectual developmental disorder, X-linked 53 | 4416.0 | nan | nan | Intellectual developmental disorder, X-linked 53, 300324 (2), X-linked recessive
chrX	BEX2	300691.0 | BEX2 | Brain-expressed X-linked gene 2 | 84707.0 | ENSG00000133134 | nan | nan
chrX	TCEAL7	300771.0 | TCEAL7 | Transcription elongation factor A-like 7 | 56849.0 | ENSG00000182916 | nan | nan
chrX	BEX3	300361.0 | NGFRAP1, BEX3, NADE, DXS6984E | Nerve growth factor receptor (TNFRSF16) associated protein 1 | 27018.0 | ENSG00000166681 | nan | nan
chrX	RAB40A	301065.0 | RAB40A | RAB40A, member Ras oncogene family | 142684.0 | ENSG00000172476 | nan | nan
chrX	TCEAL1	300237.0 | TCEAL1, P21, SIIR, HIJRS | Transcription elongation factor A-like 1 | 9338.0 | ENSG00000172465 | nan | Hijazi-Reis syndrome, 301094 (3), X-linked dominant
chrX	MORF4L2	300409.0 | MORFL2, MRGX, KIAA0026 | Mortality factor 4-like 2 | 9643.0 | ENSG00000123562 | nan | nan
chrX	TMEM31	301102.0 | TMEM31 | Transmembrane protein 31 | 203562.0 | ENSG00000179363 | nan | nan
chrX	RAB9B	300285.0 | RAB9B, RAB9L | RAS-associated protein RAB9B | 51209.0 | ENSG00000123570 | nan | nan
chrX	PLP1	300401.0 | PLP1, PMD, HLD1, SPG2 | Proteolipid protein 1 | 5354.0 | ENSG00000123560 | nan | Pelizaeus-Merzbacher disease, 312080 (3), X-linked recessive; Spastic paraplegia 2, X-linked, 312920 (3), X-linked recessive
chrX	TMSB15B	301011.0 | TMSB15B | Thymosin, beta-15B | 286527.0 | ENSG00000158427 | opposite strand relative to TMSB15A | nan
chrX	H2BW1	300507.0 | H2BW1, H2BFWT | H2B.W histone 1 | 158983.0 | ENSG00000123569 | nan | nan
chrX	SLC25A53	300941.0 | SLC25A53 | Solute carrier family 25, member 53 | 401612.0 | ENSG00000269743 | nan | nan
chrX	ZCCHC18	301122.0 | ZCCHC18, PNMA7B | Zinc finger CCHC domain-containing protein 18 | 644353.0 | ENSG00000166707 | nan | nan
chrX	ESX1	300154.0 | ESX1L, ESXR1 | ESX1-like protein | 80712.0 | ENSG00000123576 | nan | nan
chrX		300194.0 | AMMEC, DELXq22.3, CXDELq22.3 | Alport syndrome, impaired intellectual development, midface hypoplasia, and elliptocytosis complex | nan | nan | contiguous gene deletion syndrome | AMME complex, 300194 (4)
chrX	FGS5	300581.0 | FGS5 | FG syndrome 5 | 780900.0 | nan | nan | FG syndrome 5, 300581 (2), X-linked
chrX	IL1RAPL2	300277.0 | IL1RAPL2 | Interleukin 1 receptor accessory protein-like 2 | 26280.0 | ENSG00000189108 | nan | nan
chrX	TEX13A	300312.0 | TEX13A | Testis-expressed gene 13A | 56157.0 | ENSG00000268629 | nan | nan
chrX	NRK	300791.0 | NRK, NESK | NIK-related kinase | 203447.0 | ENSG00000123572 | nan | nan
chrX	SERPINA7	314200.0 | TBG, TBGQTL | Thyroxine-binding globulin | 6906.0 | ENSG00000123561 | nan | [Thyroxine-binding globulin QTL], 300932 (3), X-linked
chrX	RNF128	300439.0 | RNF128, GRAIL | Ring finger protein 128 | 79589.0 | ENSG00000133135 | nan | nan
chrX	TBC1D8B	301027.0 | TBC1D8B, NPHS20 | TBC1 domain family, member 8B | 54885.0 | ENSG00000133138 | nan | Nephrotic syndrome, type 20, 301028 (3), X-linked
chrX	RIPPLY1	300575.0 | RIPPLY1 | Ripply transcriptional repressor 1 | 92129.0 | ENSG00000147223 | nan | nan
chrX	CLDN2	300520.0 | CLDN2, OAZON | Claudin 2 | 9075.0 | ENSG00000165376 | mutation identified in 1 OAZON family | ?Azoospermia, obstructive, with nephrolithiasis, 301060 (3), X-linked recessive
chrX	MORC4	300970.0 | MORC4, ZCW4, ZCWCC2 | MORC family CW-type zinc finger protein 4 | 79710.0 | ENSG00000133131 | nan | nan
chrX	DNAAF6	300933.0 | PIH1D3, CILD36 | PIH1 domain-containing protein 3 | 139212.0 | ENSG00000080572 | nan | Ciliary dyskinesia, primary, 36, X-linked, 300991 (3), X-linked recessive
chrX	MYCLP1	310310.0 | MYCL2 | MYCL-related processed gene | 4611.0 | nan | pseudogene on Xq27.3 | nan
chrX	FRMPD3	301005.0 | FRMPD3, KIAA1817 | FERM- and PDZ domain-containing protein 3 | 84443.0 | ENSG00000147234 | nan | nan
chrX	PRPS1	311850.0 | PRPS1, CMTX5, DFNX1, DFN2 | Phosphoribosyl pyrophosphate synthetase-1 | 5631.0 | ENSG00000147224 | nan | Arts syndrome, 301835 (3), X-linked recessive; Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3), X-linked recessive; Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3), X-linked recessive; Deafness, X-linked 1, 304500 (3), X-linked; Gout, PRPS-related, 300661 (3), X-linked recessive
chrX	TSC22D3	300506.0 | TSC22D3, DSIPI, GILZ | TSC22 domain family, member 3 | 1831.0 | ENSG00000157514 | nan | nan
chrX	MID2	300204.0 | MID2, XLID101 | Midline 2 | 11043.0 | ENSG00000080561 | mutation identified in 1 XLID101 family | ?Intellectual developmental disorder, X-linked 101, 300928 (3), X-linked recessive
chrX	TEX13B	300313.0 | TEX13B | Testis-expressed gene 13B | 56156.0 | ENSG00000170925 | nan | nan
chrX	VSIG1	300620.0 | VSIG1, GPA34 | V-set and immunoglobulin domains-containing protein 1 | 340547.0 | ENSG00000101842 | nan | nan
chrX	PSMD10	300880.0 | PSMD10, p28 | Proteasome 26S subunit, non-ATPase, 10 | 5716.0 | ENSG00000101843 | nan | nan
chrX	ATG4A	300663.0 | ATG4A, APG4A, AUTL2 | Autophagy related 4A cysteine peptidase | 115201.0 | ENSG00000101844 | nan | nan
chrX	COL4A6	303631.0 | COL4A6, DELXq22.3, CXDELq22.3, DFNX6 | Collagen IV, alpha-6 polypeptide | 1288.0 | ENSG00000197565 | mutation identified in 1 DFNX6 family | ?Deafness, X-linked 6, 300914 (3), X-linked recessive
chrX	COL4A5	303630.0 | COL4A5, ATS1 | Collagen IV, alpha-5 polypeptide | 1287.0 | ENSG00000188153 | diffuse leiomyomatosis with Alport syndrome = contiguous gene syndrome with COL4A6 | Alport syndrome 1, X-linked, 301050 (3), X-linked dominant
chrX	IRS4	300904.0 | IRS4, CHNG9 | Insulin receptor substrate 4 | 8471.0 | ENSG00000133124 | nan | Hypothyroidism, congenital, nongoitrous, 9, 301035 (3), X-linked recessive
chrX	GUCY2F	300041.0 | GUCY2F, GUC2F | Guanylate cyclase 2F | 2986.0 | ENSG00000101890 | nan | nan
chrX	CHDS3	300464.0 | CHDS3 | Coronary heart disease, susceptibility to, 3 | 387573.0 | nan | nan | {Coronary heart disease, susceptibility to, 3}, 300464 (2)
chrX	IHPS4	300711.0 | IHPS4 | Pyloric stenosis, infantile hypertrophic, 4 | 100188772.0 | nan | max lod at rs3027802 | Pyloric stenosis, infantile hypertrophic, 4, 300711 (2)
chrX	MYP13	300613.0 | MYP13 | Myopia 13 | 677764.0 | nan | between DXS1210 and DXS1227 | Myopia 13, 300613 (2)
chrX	MRX23	300046.0 | XLID23, MRX23 | Intellectual developmental disorder, X-linked 23 | 4387.0 | nan | other MRX in same region MRX27, MRX30, MRX35, MRX47, MRX80 | Intellectual developmental disorder, X-linked 23, 300046 (2), X-linked
chrX	NXT2	300320.0 | NXT2 | NTF2-related export protein 2 | 55916.0 | ENSG00000101888 | nan | nan
chrX	KCNE5	300328.0 | KCNE1L | Potassium voltage-gated channel, Isk-related family, member 1-like | 23630.0 | ENSG00000176076 | nan | nan
chrX	ACSL4	300157.0 | ACSL4, FACL4, ACS4, XLID63 | Acyl-CoA synthetase long-chain family member 4 | 2182.0 | ENSG00000068366 | nan | Intellectual developmental disorder, X-linked 63, 300387 (3), X-linked dominant
chrX	AMMECR1	300195.0 | AMMECR1, MFHIEN | AMMECR nuclear protein 1 | 9949.0 | ENSG00000101935 | nan | Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, 300990 (3), X-linked recessive
chrX	RTL9	300965.0 | RTL9, RGAG1, MAR9, KIAA1318 | Retrotransposon GAG-like 9 | 57529.0 | ENSG00000243978 | nan | nan
chrX	CHRDL1	300350.0 | CHRDL1, VOPT, MGC1 | Chordin-like 1 | 91851.0 | ENSG00000101938 | nan | Megalocornea 1, X-linked, 309300 (3), X-linked recessive
chrX	PAK3	300142.0 | PAK3, MRX30, MRX47, XLID30 | p21-activated kinase-3 | 5063.0 | ENSG00000077264 | nan | Intellectual developmental disorder, X-linked 30, 300558 (3), X-linked recessive
chrX	CAPN6	300146.0 | CAPN6 | Calpain 6 | 827.0 | ENSG00000077274 | nan | nan
chrX	DCX	300121.0 | DCX, DBCN, LISX | Doublecortin | 1641.0 | ENSG00000077279 | nan | Subcortical laminal heterotopia, X-linked, 300067 (3), X-linked; Lissencephaly, X-linked, 300067 (3), X-linked
chrX	ALG13	300776.0 | ALG13, GLT28D1, CDG1S, DEE36 | ALG13 UDP-N-acetylglucosaminyltransferase subunit | 79868.0 | ENSG00000101901 | nan | Developmental and epileptic encephalopathy 36, 300884 (3), X-linked
chrX	TRPC5	300334.0 | TRPC5, TRP5 | Transient receptor potential channel 5 | 7224.0 | ENSG00000072315 | nan | nan
chrX	RTL4	301131.0 | RTL4, SIRH1, ZCCHC16 | Retrotransposon GAG-like 4 | 340595.0 | ENSG00000187823 | nan | nan
chrX	LHFPL1	300566.0 | LHFPL1 | LHFP tetraspan subfamily, member 1 | 340596.0 | ENSG00000182508 | nan | nan
chrX	AMOT	300410.0 | AMOT, KIAA1071 | Angiomotin | 154796.0 | ENSG00000126016 | nan | nan
chrX	XACT	300901.0 | XACT | Active X chromosome-coating transcript, noncoding | 105463123.0 | nan | nan | nan
chrX	HTR2C	312861.0 | HTR2C | 5-hydroxytryptamine (serotonin) receptor-2C | 3358.0 | ENSG00000147246 | formerly HTR1C | nan
chrX	MIR448	300686.0 | MIR448, MIRN448 | Micro RNA 448 | 554212.0 | ENSG00000199001 | nan | nan
chrX	IL13RA2	300130.0 | IL13RA2 | Interleukin-13 receptor, alpha-2 | 3598.0 | ENSG00000123496 | nan | nan
chrX	LUZP4	300616.0 | LUZP4 | Leucine zipper protein 4 | 51213.0 | ENSG00000102021 | nan | nan
chrX	PLS3	300131.0 | PLS3, BMND18, DIH5 | Plastin 3 | 5358.0 | ENSG00000102024 | nan | Bone mineral density QTL18, osteoporosis, 300910 (3), X-linked dominant; Diaphragmatic hernia 5, X-linked, 306950 (3), X-linked
chrX	DANT2	301004.0 | DANT2 | DXZ4-associated noncoding transcript 2, distal | 642776.0 | ENSG00000235244 | nan | nan
chrX	DANT1	301001.0 | DANT1 | DXZ4-associated noncoding transcript 1, proximal | 106029310.0 | nan | nan | nan
chrX	AGTR2	300034.0 | AGTR2 | Angiotensin receptor 2 | 186.0 | ENSG00000180772 | nan | nan
chrX	SLC6A14	300444.0 | SLC6A14 | Solute carrier family 6 (neurotransmitter transporter), member 14 | 11254.0 | ENSG00000268104 | nan | nan
chrX	CT83	300625.0 | CT83, KKLC1, CXorf61 | Cancer/testis antigen 83 | 203413.0 | ENSG00000204019 | nan | nan
chrX	ADFN	300700.0 | ADFN, ALDS | Albinism-deafness syndrome | 122.0 | nan | ~8cM proximal to F9 | Albinism-deafness syndrome, 300700 (2), X-linked
chrX		300306.0 | BMIQ11 | Body Mass Index quantitative trait locus 11 | nan | nan | nan | {Obesity, susceptibility to, BMIQ11}, 300306 (2)
chrX	CND	304730.0 | CND | Corneal dermoids | 8231.0 | nan | nan | Dermoids of cornea, 304730 (2), X-linked
chrX	PTOS2	300245.0 | PTOS2, PTOSX | Ptosis, hereditary congenital 2 | 54115.0 | nan | nan | Ptosis, hereditary congenital 2, 300245 (2), X-linked dominant
chrX	RRDX	300378.0 | RRDX | Radial ray deficiency | 266719.0 | nan | nan | Radial ray deficiency, 300378 (2)
chrX	SPG34	300750.0 | SPG34 | Spastic paraplegia 34, X-linked | 724110.0 | nan | max lod at DXS8057 | Spastic paraplegia 34, X-linked, 300750 (2), X-linked recessive
chrX	STQTL6	300591.0 | STQTL6 | Stature quantitative trait locus 6 | 100037264.0 | nan | max lod at DXS8067 | {Stature QTL 6}, 300591 (2)
chrX	MRX82	300518.0 | XLID82, MRX82 | Intellectual developmental disorder, X-linked 82 | 378484.0 | nan | between DXS6805 and DXS7346 | Intellectual developmental disorder, X-linked 82, 300518 (2), X-linked recessive
chrX	MRX88	300852.0 | XLID88, MRX88 | Intellectual developmental disorder, X-linked 88 | 105463129.0 | nan | nan | Intellectual developmental disorder, X-linked 88, 300852 (2), X-linked
chrX	KLHL13	300655.0 | KLHL13, KIAA1309 | Kelch-like 13 | 90293.0 | ENSG00000003096 | nan | nan
chrX	WDR44	301070.0 | WDR44, RAB11BP, RPH11 | WD repeat domain-containing protein 44 | 54521.0 | ENSG00000131725 | nan | nan
chrX	DOCK11	300681.0 | DOCK11, ACG, ZIZ2, ADMIDX | Dedicator of cytokinesis 11 | 139818.0 | ENSG00000147251 | nan | Autoinflammatory disease, multisystem, with immune dysregulation, X-linked, 301109 (3), X-linked recessive
chrX	IL13RA1	300119.0 | IL13RA1 | Interleukin-13 receptor, alpha-1 | 3597.0 | ENSG00000131724 | nan | nan
chrX	ZCCHC12	300701.0 | ZCCHC12, SIZN1 | Zinc finger CCHC domain-containing protein 12 | 170261.0 | ENSG00000174460 | nan | nan
chrX	KIAA1210	300995.0 | KIAA1210 | Kiaa1210 gene | 57481.0 | ENSG00000250423 | nan | nan
chrX	PGRMC1	300435.0 | PGRMC1 | Progesterone receptor membrane component 1 | 10857.0 | ENSG00000101856 | nan | nan
chrX	SLC25A43	300641.0 | SLC25A43 | Solute carrier family 25, member 43 | 203427.0 | ENSG00000077713 | nan | nan
chrX	SLC25A5	300150.0 | SLC25A5, ANT2, T3 | Solute carrier family 25 (mitochondrial carrier), member 5 (adenine nucleotide translocator-2, fibroblast) | 292.0 | ENSG00000005022 | nan | nan
chrX	STEEP1	301012.0 | STEEP1, CXorf56, XLID107 | STING1 ER exit protein 1 | 63932.0 | ENSG00000018610 | mutation identified in 1 XLID107 family | ?Intellectual developmental disorder, X-linked 107, 301013 (3), X-linked
chrX	UBE2A	312180.0 | UBE2A, RAD6A, MRXSN, MRXS30 | Ubiquitin-conjugating enzyme E2 A | 7319.0 | ENSG00000077721 | nan | Intellectual developmental disorder, X-linked syndromic, Nascimento type, 300860 (3), X-linked recessive
chrX	NKRF	300440.0 | NKRF, NRF | NFKB-repressing factor | 55922.0 | ENSG00000186416 | nan | nan
chrX	SEPTIN6	300683.0 | SEPT6, SEP2, KIAA0128 | Septin 6 | 23157.0 | ENSG00000125354 | nan | nan
chrX	MIR766	301062.0 | MIR766 | Micro RNA 766 | 768218.0 | ENSG00000211578 | located in intron of SEPT6 | nan
chrX	RPL39	300899.0 | RPL39 | Ribosomal protein L39 | 6170.0 | ENSG00000198918 | nan | nan
chrX	UPF3B	300298.0 | UPF3B, RENT3B, MRXS14 | UPF3B regulator of nonsense-mediated mRNA decay | 65109.0 | ENSG00000125351 | nan | Intellectual developmental disorder, X-linked syndromic 14, 300676 (3), X-linked recessive
chrX	RNF113A	300951.0 | RNF113A, ZNF183, TTD5 | RING finger protein 113A | 7737.0 | ENSG00000125352 | nan | Trichothiodystrophy 5, nonphotosensitive, 300953 (3), X-linked
chrX	NDUFA1	300078.0 | NDUFA1, MWFE, MC1DN12 | NADH-ubiquinone oxidoreductase subunit A1 | 4694.0 | ENSG00000125356 | nan | Mitochondrial complex I deficiency, nuclear type 12, 301020 (3), X-linked recessive
chrX	AKAP14	300462.0 | AKAP14, AKAP28 | A-kinase anchor protein 14 | 158798.0 | ENSG00000186471 | nan | nan
chrX	NKAP	300766.0 | NKAP, MRXSHD | NFKB-activating protein | 79576.0 | ENSG00000101882 | nan | Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type, 301039 (3), X-linked recessive
chrX	RHOXF1P1	300973.0 | RHOXF1P1 | RHOX homeobox family member 1, pseudogene 1 | 101928941.0 | ENSG00000291200 | nan | nan
chrX	RHOXF1	300446.0 | RHOXF1, OTEX, PEPP1 | RHOX homeobox family, member 1 | 158800.0 | ENSG00000101883 | nan | nan
chrX	RHOXF2	300447.0 | RHOXF2, PEPP2 | RHOX homeobox family, member 2 | 84528.0 | ENSG00000131721 | nan | nan
chrX	ZBTB33	300329.0 | ZBTB33, KAISO | Zinc finger- and BTB domain-containing protein 33 | 10009.0 | ENSG00000177485 | nan | nan
chrX	ATP1B4	301073.0 | ATP1B4 | ATPase, NA+/K+ transporting family, member beta-4 | 23439.0 | ENSG00000101892 | nan | nan
chrX	LAMP2	309060.0 | LAMP2, LAMPB, LGP110, DND | Lysosome-associated membrane protein-2 | 3920.0 | ENSG00000005893 | nan | Danon disease, 300257 (3), X-linked dominant
chrX	CUL4B	300304.0 | CUL4B, MRXSC, MRXHF2, SFM2, MRXS15 | Cullin-4B | 8450.0 | ENSG00000158290 | nan | Intellectual developmental disorder, X-linked syndromic, Cabezas type, 300354 (3), X-linked recessive
chrX	MCTS1	300587.0 | MCTS1, MCT1, IMD118 | Malignant T-cell amplified sequence 1 | 28985.0 | ENSG00000232119 | nan | Immunodeficiency 118, mycobacteriosis, 301115 (3), X-linked recessive
chrX	C1GALT1C1	300611.0 | C1GALT1C1, COSMC, C1GALT2, TNPS, AHUS8 | C1GALT1-specific chaperone 1 | 29071.0 | ENSG00000171155 | nan | Hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature, 301110 (3), X-linked recessive; Tn polyagglutination syndrome, somatic, 300622 (3)
chrX	CT47B1	300790.0 | CT47B1, CT47A13 | Cancer/testis antigen family 47, member B1 | 643311.0 | ENSG00000236446 | nan | nan
chrX	CT47A11	300592.0 | CT47A11, LOC255313 | Cancer/testis antigen family 47, member A11 | 255313.0 | ENSG00000226929 | nan | nan
chrX	CT47A10	300789.0 | CT47A10 | Cancer/testis antigen family 47, member A10 | 728036.0 | ENSG00000224089 | nan | nan
chrX	CT47A9	300788.0 | CT47A9 | Cancer/testis antigen family 47, member A9 | 728042.0 | ENSG00000226600 | nan | nan
chrX	CT47A8	300787.0 | CT47A8 | Cancer/testis antigen family 47, member A8 | 728049.0 | ENSG00000230347 | nan | nan
chrX	CT47A7	300786.0 | CT47A7 | Cancer/testis antigen family 47, member A7 | 653282.0 | ENSG00000228517 | nan | nan
chrX	CT47A6	300785.0 | CT47A6 | Cancer/testis antigen family 47, member A6 | 728062.0 | ENSG00000226023 | nan | nan
chrX	CT47A5	300784.0 | CT47A5 | Cancer/testis antigen family 47, member A5 | 728072.0 | ENSG00000237957 | nan | nan
chrX	CT47A4	300783.0 | CT47A4 | Cancer/testis antigen family 47, member A4 | 728075.0 | ENSG00000230594 | nan | nan
chrX	CT47A3	300782.0 | CT47A3 | Cancer/testis antigen family 47, member A3 | 728082.0 | ENSG00000236126 | nan | nan
chrX	CT47A2	300781.0 | CT47A2 | Cancer/testis antigen family 47, member A2 | 728090.0 | ENSG00000242362 | nan | nan
chrX	CT47A1	300780.0 | CT47A1 | Cancer/testis antigen family 45, member A1 | 728096.0 | ENSG00000236371 | nan | nan
chrX	GLUD2	300144.0 | GLUD2 | Glutamate dehydrogenase-2 | 2747.0 | ENSG00000182890 | nan | nan
chrX		300979.0 | DUPXq25 | Xq25 duplication syndrome | nan | nan | nan | Xq25 duplication syndrome, 300979 (4), X-linked
chrX	SCAX5	300703.0 | SCAX5 | Spinocerebellar ataxia, X-linked 5 | 100188768.0 | nan | between DXS1047 and DXS1227 | Spinocerebellar ataxia, X-linked 5, 300703 (2), X-linked recessive
chrX	SXI2	300179.0 | SXI2 | X inactivation, familial skewed, 2 | 117237.0 | nan | nan | X inactivation, familial skewed, 2, 300179 (2)
chrX	THAS	313850.0 | THAS, TAS | Thoracoabdominal syndrome | 7055.0 | nan | nan | Thoracoabdominal syndrome, 313850 (2), X-linked
chrX	XECD	300779.0 | XECD | Corneal dystrophy, endothelial, X-linked | 100302510.0 | nan | between DXS8057 and DXS1047 | Corneal dystrophy, endothelial, X-linked, 300779 (2), X-linked dominant
chrX		300436.0 | XLID46, MRX46 | Intellectual developmental disorder, X-linked 56 | nan | nan | between DXS8072 and DXS294 | Intellectual developmental disorder, X-linked 46, 300436 (2), X-linked recessive
chrX	GRIA3	305915.0 | GRIA3, GLUR3, MRXSW | Glutamate receptor, ionotropic, AMPA 3 | 2892.0 | ENSG00000125675 | nan | Intellectual developmental disorder, X-linked syndromic, Wu type, 300699 (3), X-linked recessive
chrX	THOC2	300395.0 | THOC2, THO2, XLID12, AMC7 | THO complex 2 | 57187.0 | ENSG00000125676 | nan | Arthrogryposis multiplex congenita 7, X-linked, 301127 (3), X-linked; Intellectual developmental disorder, X-linked syndromic, Kumar type, 300957 (3), X-linked
chrX	XIAP	300079.0 | XIAP, BIRC4, API3, XLP2 | Inhibitor of apoptosis, X-linked | 331.0 | ENSG00000101966 | nan | Lymphoproliferative syndrome, X-linked, 2, 300635 (3), X-linked recessive
chrX	STAG2	300826.0 | STAG2, SA2, MKMS, HPE13 | Stromal antigen 2 | 10735.0 | ENSG00000101972 | nan | Holoprosencephaly 13, X-linked, 301043 (3), X-linked dominant, X-linked recessive; Mullegama-Klein-Martinez syndrome, 301022 (3), X-linked
chrX	TEX13D	301124.0 | TEX13D | Testis-expressed gene 13D | 100132015.0 | ENSG00000282419 | nan | nan
chrX	SH2D1A	300490.0 | SH2D1A, LYP, IMD5, XLP, XLPD1 | SH2 domain protein 1A | 4068.0 | ENSG00000183918 | 1cM from DXS42; no recombination with DXS37 | Lymphoproliferative syndrome, X-linked, 1, 308240 (3), X-linked recessive
chrX	TENM1	300588.0 | TENM1, ODZ1, TNM1 | Teneurin transmembrane protein 1 | 10178.0 | ENSG00000009694 | nan | nan
chrX	TEX13C	301123.0 | TEX13C | Testis-expressed gene 13C | 100129520.0 | ENSG00000282815 | nan | nan
chrX	ACTRT1	300487.0 | ACTRT1, ARPT1 | Actin-related protein T1 | 139741.0 | ENSG00000123165 | nan | nan
chrX	SMARCA1	300012.0 | SMARCA1, SNF2L1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 | 6594.0 | ENSG00000102038 | nan | nan
chrX		301845.0 | BZX, BDCS | Bazex-Dupre-Christol syndrome | nan | nan | caused by microduplication in intergenic region | Bazex-Dupre-Christol syndrome, 301845 (4), X-linked dominant
chrX	CFSS	300712.0 | CFSS | Craniofacioskeletal syndrome | 100188773.0 | nan | nan | ?Craniofacioskeletal syndrome, 300712 (2), X-linked dominant, X-linked recessive
chrX		302802.0 | CMTX3 | Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 | nan | nan | genomic rearrangement between 8q24.3 and Xq27.1 | Charcot-Marie-Tooth neuropathy, X-linked recessive, 3, 302802 (4), X-linked recessive
chrX	INDX	300076.0 | INDX | Immunoneurologic syndrome X-linked, of Woods, Black, and Norbury | 8259.0 | nan | nan | Woods-Black-Norbury syndrome, 300076 (2), X-linked dominant
chrX	RP24	300155.0 | RP24 | Retinitis pigmentosa-24 | 6116.0 | nan | nan | Retinitis pigmentosa 24, 300155 (2)
chrX	SHFM2	313350.0 | SHFM2, SHFD2 | Split hand/foot malformation, type (ectrodactyly) 2 | 6463.0 | nan | nan | Split hand/foot malformation 2, 313350 (2), X-linked
chrX	MRX42	300372.0 | XLID42, MRX42 | Intellectual developmental disorder, X-linked 42 | 4406.0 | nan | ?pericentromeric region | Intellectual developmental disorder, X-linked 42, 300372 (2)
chrX	OCRL	300535.0 | OCRL, LOCR, OCRL1, NPHL2, DENT2 | OCRL inositol polyphosphate-5-phosphatase | 4952.0 | ENSG00000122126 | nan | Dent disease 2, 300555 (3), X-linked recessive; Lowe syndrome, 309000 (3), X-linked recessive
chrX	APLN	300297.0 | APLN | Apelin | 8862.0 | ENSG00000171388 | nan | nan
chrX	XPNPEP2	300145.0 | XPNPEP2, AEACEI | X-prolyl aminopeptidase 2 (aminopeptidase P) | 7512.0 | ENSG00000122121 | nan | {Angioedema induced by ACE inhibitors, susceptibility to}, 300909 (3)
chrX	SASH3	300441.0 | SASH3, HACS2, CXorf9, SLY, IMD102 | SAM and SH3 domain containing 3 | 54440.0 | ENSG00000122122 | nan | Immunodeficiency 102, 301082 (3), X-linked recessive
chrX	ZDHHC9	300646.0 | ZDHHC9, DHHC9, MRXSR | Zinc finger DHHC domain-containing protein 9 | 51114.0 | ENSG00000188706 | nan | Intellectual developmental disorder, X-linked syndromic, Raymond type, 300799 (3), X-linked
chrX	UTP14A	300508.0 | UTP14A | UTP14 small subunit processome component | 10813.0 | ENSG00000156697 | nan | nan
chrX	BCORL1	300688.0 | BCORL1, SHUVER | BCL6 corepressor-like 1 | 63035.0 | ENSG00000085185 | nan | Shukla-Vernon syndrome, 301029 (3), X-linked recessive
chrX	ELF4	300775.0 | ELF4, MEF, AIFBL2 | E74-like ETS transcription factor 4 | 2000.0 | ENSG00000102034 | nan | Autoinflammatory syndrome, familial, X-linked, Behcet-like 2, 301074 (3), X-linked recessive
chrX	AIFM1	300169.0 | AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5, SEMDHL | Apoptosis-inducing factor, mitochondrion-associated, 1 | 9131.0 | ENSG00000156709 | nan | Combined oxidative phosphorylation deficiency 6, 300816 (3), X-linked recessive; Cowchock syndrome, 310490 (3), X-linked recessive; Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy, 300232 (3), X-linked recessive; Deafness, X-linked 5, 300614 (3), X-linked recessive
chrX	RAB33A	300333.0 | RAB33A | Ras-associated protein RAB33A | 9363.0 | ENSG00000134594 | nan | nan
chrX	SLC25A14	300242.0 | SLC25A14, BMCP1 | Solute carrier family 25 (mitochondrial carrier), member 14 | 9016.0 | ENSG00000102078 | nan | nan
chrX	GPR119	300513.0 | GPR119, GPCR2 | G protein-coupled receptor 119 | 139760.0 | ENSG00000147262 | nan | nan
chrX	ENOX2	300282.0 | ENOX2 | ECTO-NOX disulfide-thiol exchanger 2 | 10495.0 | ENSG00000165675 | nan | nan
chrX	ARHGAP36	300937.0 | ARHGAP36 | Rho GTPase-activating protein 36 | 158763.0 | ENSG00000147256 | nan | nan
chrX	IGSF1	300137.0 | IGSF1, IGDC1, CHTE | Immunoglobulin superfamily, member 1 | 3547.0 | ENSG00000147255 | nan | Hypothyroidism, central, and testicular enlargement, 300888 (3), X-linked recessive
chrX	FIRRE	300999.0 | FIRRE, LINC01200 | Functional intergenic repeating RNA element | 286467.0 | ENSG00000213468 | nan | nan
chrX	STK26	300547.0 | STK26, MASK, MST4 | Serine/threonine kinase 26 | 51765.0 | ENSG00000134602 | nan | nan
chrX	FRMD7	300628.0 | FRMD7, NYS1, XIPAN | FERM domain-containing 7 | 90167.0 | ENSG00000165694 | nan | Nystagmus, infantile periodic alternating, X-linked, 310700 (3), X-linked; Nystagmus 1, congenital, X-linked, 310700 (3), X-linked
chrX	RAP2C	301016.0 | RAP2C | Ras-related protein 2C | 57826.0 | ENSG00000123728 | nan | nan
chrX	MBNL3	300413.0 | MBNL3, MBXL | Muscleblind-like protein 3 | 55796.0 | ENSG00000076770 | nan | nan
chrX	HS6ST2	300545.0 | HS6ST2, MRXSPM | Heparan sulfate 6-O-sulfotransferase 2 | 90161.0 | ENSG00000171004 | mutation identified in 1 MRXSPM family | ?Paganini-Miozzo syndrome, 301025 (3), X-linked recessive
chrX	USP26	300309.0 | USP26, SPGFX6 | Ubiquitin-specific protease 26 | 83844.0 | ENSG00000134588 | nan | Spermatogenic failure, X-linked, 6, 301101 (3), X-linked
chrX	TFDP3	300772.0 | TFDP3, HCA661, CT30, DP4 | Transcription factor DP family, member 3 | 51270.0 | ENSG00000183434 | nan | nan
chrX	GPC4	300168.0 | GPC4, KPTS | Glypican 4 | 2239.0 | ENSG00000076716 | centromeric to GPC3 | Keipert syndrome, 301026 (3), X-linked recessive
chrX	GPC3	300037.0 | GPC3, SDYS, SGBS1 | Glypican 3 | 2719.0 | ENSG00000147257 | nan | Wilms tumor, somatic, 194070 (3); Simpson-Golabi-Behmel syndrome, type 1, 312870 (3), X-linked recessive
chrX	MIR92A2	301092.0 | MIR92A2 | Micro RNA 92A2 | 407049.0 | ENSG00000284538 | nan | nan
chrX	MIR19B2	300722.0 | MIR19B2, MIRN19B2 | Micro RNA 19B2 | 406981.0 | ENSG00000284107 | nan | nan
chrX	MIR20B	300950.0 | MIR20B | Micro RNA 20B | 574032.0 | ENSG00000284043 | nan | nan
chrX	MIR106A	300792.0 | MIR106A, MIRN106A | Micro RNA 106A | 406899.0 | ENSG00000284157 | nan | nan
chrX	PHF6	300414.0 | PHF6, BFLS | PHD finger protein 6 | 84295.0 | ENSG00000156531 | nan | Borjeson-Forssman-Lehmann syndrome, 301900 (3), X-linked recessive
chrX	HPRT1	308000.0 | HPRT1, HPRT | Hypoxanthine phosphoribosyltransferase 1 | 3251.0 | ENSG00000165704 | nan | Hyperuricemia, HRPT-related, 300323 (3), X-linked recessive; Lesch-Nyhan syndrome, 300322 (3), X-linked recessive
chrX		300795.0 | CT45A4, CT45.4 | Cancer/testis antigen family 45, member A4 | nan | nan | nan | nan
chrX		300942.0 | CXDUPq26.3, DUPXq26.3, XLAG | Chromosome Xq26.3 duplication syndrome | nan | nan | nan | Chromosome Xq26.3 duplication syndrome, 300942 (4), X-linked dominant
chrX		300833.0 | SRXX3 | 46XX sex reversal 3 | nan | nan | due to deletion/duplication/rearrangement upstream of SOX3 | 46XX sex reversal 3, 300833 (4), X-linked dominant
chrX	MIR503	300865.0 | MIR503 | Micro RNA 503 | 574506.0 | ENSG00000208005 | nan | nan
chrX	MIR424	300682.0 | MIR424, MIRN424, MIR322 | Micro RNA 424 | 494336.0 | ENSG00000284231 | nan | nan
chrX	PLAC1	300296.0 | PLAC1 | Placenta-specific gene 1 | 10761.0 | ENSG00000170965 | nan | nan
chrX	MOSPD1	300674.0 | MOSPD1 | Motile sperm domain-containing protein 1 | 56180.0 | ENSG00000101928 | nan | nan
chrX	RTL8C	300213.0 | RTL8C, CXX1 | Retrotransposon GAG-like 8C | 8933.0 | ENSG00000134590 | nan | nan
chrX	CT55	301105.0 | CT55, SPGFX7 | Cancer/Testis antigen 55 | 54967.0 | ENSG00000169551 | mutation identified in 1 SPGFX7 family | ?Spermatogenic failure, X-linked, 7, 301106 (3), X-linked recessive
chrX	ZNF75D	314997.0 | ZNF75D, ZNF75 | Zinc finger protein-75D | 7626.0 | ENSG00000186376 | 1Mb distal to HPRT | nan
chrX	ZNF449	300627.0 | ZNF449, ZSCAN19 | Zinc finger protein 449 | 203523.0 | ENSG00000173275 | nan | nan
chrX	CT45A1	300648.0 | CT45A1, CT45 | Cancer/testis antigen family 45, member A1 | 541466.0 | ENSG00000268940 | nan | nan
chrX	CT45A3	300794.0 | CT45A3, CT45.3 | Cancer/testis antigen family 45, member A3 | 441519.0 | ENSG00000269096 | nan | nan
chrX	CT45A5	300796.0 | CT45A5, CT45.5 | Cancer/testis antigen family 45, member A5 | 441521.0 | ENSG00000228836 | nan | nan
chrX	CT45A6	300797.0 | CT45A6, CT45.6 | Cancer/testis antigen family 45, member A6 | 541465.0 | ENSG00000278289 | nan | nan
chrX	CT45A2	300793.0 | CT45A2, CT45.2 | Cancer/testis antigen family 45, member A2 | 728911.0 | ENSG00000271449 | nan | nan
chrX	SAGE1	300359.0 | SAGE | Sarcoma antigen | 55511.0 | ENSG00000181433 | nan | nan
chrX	MMGT1	301098.0 | MMGT1, EMC5 | Membrane magnesium transporter 1 | 93380.0 | ENSG00000169446 | nan | nan
chrX	SLC9A6	300231.0 | SLC9A6, NHE6, MRXSCH | Solute carrier family 9 (sodium/hydrogen exchanger), member 6 | 10479.0 | ENSG00000198689 | nan | Intellectual developmental disorder, X-linked syndromic, Christianson type, 300243 (3), X-linked
chrX	FHL1	300163.0 | FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU | Four-and-a-half LIM domains 1 | 2273.0 | ENSG00000022267 | mutation identified in 1 FCMSU family | Myopathy, X-linked, with postural muscle atrophy, 300696 (3), X-linked recessive; Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3), X-linked recessive; ?Uruguay faciocardiomusculoskeletal syndrome, 300280 (3), X-linked recessive; Scapuloperoneal myopathy, X-linked dominant, 300695 (3), X-linked dominant; Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3), X-linked; Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3), X-linked dominant
chrX	MAP7D3	300930.0 | MAP7D3, MDP3 | MAP7 domain-containing protein 3 | 79649.0 | ENSG00000129680 | nan | nan
chrX	ADGRG4	301085.0 | ADGRG4, GPR112 | Adhesion G protein-coupled receptor G4 | 139378.0 | ENSG00000156920 | nan | nan
chrX	BRS3	300107.0 | BRS3 | Bombesin-like receptor 3 | 680.0 | ENSG00000102239 | nan | nan
chrX	HTATSF1	300346.0 | HTATSF1, TATSF1 | HIV-1 TAT stimulatory factor 1 | 27336.0 | ENSG00000102241 | nan | nan
chrX	VGLL1	300583.0 | VGLL1, VGL1, TDU | Vestigial-like 1 | 51442.0 | ENSG00000102243 | nan | nan
chrX	CD40LG	300386.0 | TNFSF5, CD40LG, HIGM1, IGM | Tumor necrosis factor ligand superfamily, member 5 | 959.0 | ENSG00000102245 | Between DSX144E and DSX300 | Immunodeficiency, X-linked, with hyper-IgM, 308230 (3), X-linked recessive
chrX	ARHGEF6	300267.0 | ARHGEF6, COOL2 | Rho guanine nucleotide exchange factor-6 | 9459.0 | ENSG00000129675 | nan | nan
chrX	RBMX	300199.0 | RBMX, MRXS11, MRXSH, MRXSG | RNA-binding motif protein, X chromosome | 27316.0 | ENSG00000147274 | mutation identified in 1 MRXSSH family and 1 MRXSG family | ?Intellectual developmental disorder, X-linked syndromic, Gustavson type, 309555 (3), X-linked recessive; ?Intellectual developmental disorder, X-linked syndromic, Shashi type, 300238 (3), X-linked recessive
chrX	GPR101	300393.0 | GPR101, PAGH2, PITA2 | G protein-coupled receptor 101 | 83550.0 | ENSG00000165370 | nan | Pituitary adenoma 2, GH-secreting, 300943 (3), X-linked
chrX	ZIC3	300265.0 | ZIC3, HTX1, HTX, VACTERLX | Zic family, member 3 | 7547.0 | ENSG00000156925 | nan | Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3), X-linked recessive; Heterotaxy, visceral, 1, X-linked, 306955 (3), X-linked recessive; VACTERL association, X-linked, 314390 (3), X-linked recessive
chrX	FGF13	300070.0 | FGF13, FGF2, DEE90, XLID110 | Fibroblast growth factor-13 | 2258.0 | ENSG00000129682 | nan | Developmental and epileptic encephalopathy 90, 301058 (3), X-linked dominant, X-linked recessive; Intellectual developmental disorder, X-linked 110, 301095 (3), X-linked recessive
chrX	FGF13-AS1	301087.0 | FGF13AS1 | FGF13 antisense RNA 1, noncoding | 100129662.0 | ENSG00000226031 | nan | nan
chrX	BMND4	300536.0 | BMND4 | Bone mineral density QTL 4 | 554316.0 | nan | nan | [Bone mineral density QTL 4], 300536 (2)
chrX	CDR1	302650.0 | CDR1, CDR62A | Cerebellar degeneration-related protein-1, 34kD | 1038.0 | nan | between HPRT and F9 | nan
chrX	CDR1-AS	300898.0 | CDR1AS, CIRS7 | CD$1 antisense RNA | 103611090.0 | nan | nan | nan
chrX	COD2	300085.0 | COD2 | Cone dystrophy-2, X-linked | 1275.0 | nan | nan | Cone dystrophy, progressive X-linked, 2, 300085 (2), X-linked
chrX	HPCX	300147.0 | HPCX1 | Prostate cancer, hereditary, X-linked 1 | 9566.0 | nan | between D3S2390 and bG82i1.0 | {Prostate cancer, hereditary, X-linked 1}, 300147 (2)
chrX		307700.0 | HPT, HPTX, HYPX | Hypoparathyroidism | nan | nan | interstitial deletion/insertion on Xq27.1 | Hypoparathyroidism, X-linked, 307700 (4), X-linked
chrX		307150.0 | HTC2, HCG, CGH, CXINSq27.1 | Hypertrichosis, congenital generalized | nan | nan | palindrome-mediated interchromosomal insertion at Xq27.1 | Hypertrichosis, congenital generalized, 307150 (4), X-linked dominant
chrX	TGCT1	300228.0 | TGCT1 | Testicular germ cell tumor 1 | 50830.0 | nan | nan | Testicular germ cell tumor, 300228 (2)
chrX	F9	300746.0 | F9, HEMB, THPH8 | Coagulation factor IX (plasma thromboplastic component) | 2158.0 | ENSG00000101981 | distal to HPRT; proximal part of Xq27 | {Deep venous thrombosis, protection against}, 300807 (3), X-linked recessive; Hemophilia B, 306900 (3), X-linked recessive; Thrombophilia 8, X-linked, due to factor IX defect, 300807 (3), X-linked recessive; {Warfarin sensitivity}, 301052 (3), X-linked
chrX	MCF2	311030.0 | MCF2, DBL | Oncogene MCF2 (oncogene DBL) | 4168.0 | ENSG00000101977 | ~60kb telomeric to F9; 5' replacement by chr.15 segment | nan
chrX	ATP11C	300516.0 | ATP11C, ATPIQ, ATPIG, HACXL | ATPase, class VI, type 11C | 286410.0 | ENSG00000101974 | mutation identified in 1 HACXL patient | ?Hemolytic anemia, congenital, X-linked, 301015 (3), X-linked recessive
chrX	MIR505	301053.0 | MIR505 | Micro RNA 505 | 574508.0 | ENSG00000207633 | nan | nan
chrX	SOX3	313430.0 | SOX3, MRGH | SRY (sex determining region Y)-box 3 | 6658.0 | ENSG00000134595 | P mutant in BFLS | Intellectual developmental disorder, X-linked, with isolated growth hormone deficiency, 300123 (3); Panhypopituitarism, X-linked, 312000 (3), X-linked
chrX	SPANXB1	300669.0 | SPANXB1, SPANXB | SPANX family, member B1 | 728695.0 | ENSG00000227234 | nan | nan
chrX	LDOC1	300402.0 | LDOC1 | Leucine zipper downregulated in cancer 1 | 23641.0 | ENSG00000182195 | nan | nan
chrX		300388.0 | BPP, PMGX, CBPS | Polymicrogyria, bilateral perisylvian | nan | nan | possible genetic heterogeneity | Polymicrogyria, bilateral perisylvian, 300388 (2), X-linked dominant
chrX	SPANXC	300330.0 | SPANXC, CTP11 | Sperm protein associated with the nucleus, X chromosome, family member C | 64663.0 | ENSG00000198573 | nan | nan
chrX	SPANXA1	300305.0 | SPANXA1, SPANX | Sperm protein associated with the nucleus, X chromosome, family member A1 | 30014.0 | ENSG00000198021 | nan | nan
chrX	SPANXA2	300493.0 | SPANXA2 | Sperm protein associated with the nucleus, X chromosome, family member A2 | 728712.0 | ENSG00000203926 | nan | nan
chrX	SPANXD	300670.0 | SPANXD | SPANX family, member D | 64648.0 | ENSG00000196406 | nan | nan
chrX	MAGEC3	300469.0 | MAGEC3 | Melanoma antigen, family C, 3 | 139081.0 | ENSG00000165509 | nan | nan
chrX	MAGEC1	300223.0 | MAGEC1 | Melanoma antigen, family C, 1 | 9947.0 | ENSG00000155495 | nan | nan
chrX	MAGEC2	300468.0 | MAGEC2, MAGEE1, CT10, HCA587 | Melanoma antigen, family C, 2 | 51438.0 | ENSG00000046774 | nan | nan
chrX		300869.0 | DUPXq27.3q28, CXDUPq27.3q28 | Chromosome Xq27.3-q28 duplication syndrome | nan | nan | nan | Chromosome Xq27.3-q28 duplication syndrome, 300869 (4), X-linked recessive
chrX	DYX9	300509.0 | DYX9 | Dyslexia, susceptibility to, 9 | 474159.0 | nan | max lod at DXS8043 | {Dyslexia, susceptibility to, 9}, 300509 (2)
chrX	EBM	302000.0 | EBM | Epidermolysis bullosa, macular type | 1881.0 | nan | nan | nan
chrX	SPANXN4	300667.0 | SPANXN4 | SPANX family, member N4 | 441525.0 | ENSG00000189326 | nan | nan
chrX	SPANXN3	300666.0 | SPANXN3 | SPANX family, member N3 | 139067.0 | ENSG00000189252 | nan | nan
chrX	SLITRK4	300562.0 | SLITRK4 | SLIT- and NTRK-like family, member 4 | 139065.0 | ENSG00000179542 | nan | nan
chrX	SPANXN2	300665.0 | SPANXN2 | SPANX family, member N2 | 494119.0 | ENSG00000268988 | nan | nan
chrX	SPANXN1	300664.0 | SPANXN1 | SPANX family, member N1 | 494118.0 | ENSG00000203923 | nan | nan
chrX	SLITRK2	300561.0 | SLITRK2, KIAA1854, CXorf1, CXorf2, XLID111 | SLIT- and NTRK-like family, member 2 | 84631.0 | ENSG00000185985 | nan | Intellectual developmental disorder, X-linked 111, 301107 (3), X-linked
chrX	MIR506	300877.0 | MIR506 | Micro RNA 506 | 574511.0 | ENSG00000207731 | nan | nan
chrX	MIR508	300874.0 | MIR508 | Micro RNA 508 | 574513.0 | ENSG00000207589 | nan | nan
chrX	MIR509-3	300876.0 | MIR509-3 | Micro RNA 509-3 | 100126337.0 | ENSG00000212014 | nan | nan
chrX	MIR509-1	300875.0 | MIR509-1 | Micro RNA 509-2 | 574514.0 | ENSG00000208000 | nan | nan
chrX	MIR510	300866.0 | MIR510 | Micro RNA 510 | 574515.0 | ENSG00000207641 | nan | nan
chrX	FMR1-AS1	300805.0 | FMR1AS1, ASFMR1 | FMR1 antisense RNA 1 | 100126270.0 | ENSG00000268066 | nan | nan
chrX	FMR1	309550.0 | FMR1, FRAXA, POF1 | Fragile X messenger ribonucleoprotein 1 | 2332.0 | ENSG00000102081 | 8-8.7Mb from telomere | Fragile X tremor/ataxia syndrome, 300623 (3), X-linked dominant; Fragile X syndrome, 300624 (3), X-linked dominant; Premature ovarian failure 1, 311360 (3), X-linked
chrX	BED	300843.0 | BED | Bornholm eye disease | 100653365.0 | nan | linked to F8 | Bornholm eye disease, 300843 (2), X-linked recessive
chrX		300815.0 | DUPXq28, CXq28 | Chromosome Xq28 duplication syndrome | nan | nan | nan | Chromosome Xq28 duplication syndrome, 300815 (4)
chrX		305424.0 | F8B, DXS522E | Factor VIII F8B | nan | nan | alternative F8 transcript | nan
chrX		306995.0 | HMS1, GAY1 | Homosexuality, male | nan | nan | nan | [?Homosexuality, male], 306995 (2), X-linked
chrX	MAFD2	309200.0 | MAFD2, MDX | Major affective disorder 2 | 4096.0 | nan | linkage to G6PD,CB in non-Ashkenazi Jews | {?Major affective disorder 2}, 309200 (2), X-linked dominant
chrX	MRSD	309620.0 | MRSD, CHRS | Intellectual developmental disorder, X-linked, with skeletal dysplasia and abducens palsy | 4364.0 | nan | nan | Intellectual developmental disorder, X-linked, with skeletal dysplasia and abducens palsy, 309620 (2), X-linked
chrX		300845.0 | MYMY4, CXDELq38 | Moyamoya disease 4 with short stature, hypergonadotropic hypogonadism and facial dysmorphism | nan | nan | contiguous gene deletion syndrome (3.4kb) | Moyamoya disease 4, 300845 (4), X-linked recessive
chrX	MYP1	310460.0 | MYP1 | Myopia 1, X-linked | 4657.0 | nan | nan | Myopia-1, 310460 (2), X-linked recessive
chrX	RP34	300605.0 | RP34 | Retinitis pigmentosa 34 | 777642.0 | nan | nan | Retinitis pigmentosa 34, 300605 (2)
chrX	SLEB15	300809.0 | SLEB15 | Systemic lupus erythematosus, susceptibility to, 15 | 100379200.0 | nan | associated with rs17435 | {Systemic lupus erythematosus, susceptibility to, 15}, 300809 (2)
chrX	TKCR	314300.0 | TKCR, TKC | Torticollis, keloids, cryptorchidism and renal dysplasia | 7085.0 | nan | distal to G6PD | Goeminne TKCR syndrome, 314300 (2), X-linked
chrX	XM	314900.0 | XM | Xm | 7506.0 | nan | linked to DCB, PCB | nan
chrX	AFF2	300806.0 | AFF2, FMR2, FRAXE, XLID109 | AF4/FMR2 family, member 2 (fragile site, X-linked, E) | 2334.0 | ENSG00000155966 | nan | Intellectual developmental disorder, X-linked 109, 309548 (3), X-linked recessive
chrX	IDS	300823.0 | IDS, MPS2, SIDS | Iduronate 2-sulfatase (Hunter syndrome) | 3423.0 | ENSG00000010404 | telomeric IDS2 source of inversion in IDS | Mucopolysaccharidosis II, 309900 (3), X-linked recessive
chrX	EOLA1	300954.0 | EOLA1, CXorf40A | Endothelium- and lymphocyte-associated ASCH domain 1 | 91966.0 | ENSG00000197620 | nan | nan
chrX	MAGEA9B	300764.0 | MAGEA9B | Melanoma antigen, family A, 9B | 728269.0 | ENSG00000267978 | nan | nan
chrX	TMEM185A	300031.0 | FAM11A, FRAXF | Family with sequence similarity 11, member A | 84548.0 | ENSG00000269556 | nan | nan
chrX	MAGEA11	300344.0 | MAGEA11, MAGE11 | Melanoma antigen, family A, 11 | 4110.0 | ENSG00000185247 | nan | nan
chrX	MAGEA9	300342.0 | MAGEA9, MAGE9 | Melanoma antigen, family A, 9 | 4108.0 | ENSG00000123584 | nan | nan
chrX	LINC00850	300892.0 | LINC00850, KUCG1 | Long intergenic noncoding RNA 850 | 101241891.0 | ENSG00000280752 | nan | nan
chrX	MAGEA8	300341.0 | MAGEA8, MAGE8 | Melanoma antigen, family A, 8 | 4107.0 | ENSG00000156009 | nan | nan
chrX	MAMLD1	300120.0 | MAMLD1, CXorf6, F18, HYSP2 | Mastermind-like domain containing 1 | 10046.0 | ENSG00000013619 | near MTM1 in microdeletion | Hypospadias 2, X-linked, 300758 (3), X-linked recessive
chrX	MTM1	300415.0 | MTM1, MTMX, CNMX | Myotubularin | 4534.0 | ENSG00000171100 | close to F8 | Myopathy, centronuclear, X-linked, 310400 (3), X-linked recessive
chrX	MTMR1	300171.0 | MTMR1 | Myotubularin-related protein-1 | 8776.0 | ENSG00000063601 | nan | nan
chrX	CD99L2	300846.0 | CD99L2, CD99B | CD99 antigen-like 2 | 83692.0 | ENSG00000102181 | nan | nan
chrX	HMGB3	300193.0 | HMGB3, HMG4, HMG2A, MCOPS13 | High-mobility group box 3 (high mobility group protein 4) | 3149.0 | ENSG00000029993 | mutation identified in 1 MCOPS13 family | ?Microphthalmia, syndromic 13, 300915 (3), X-linked
chrX	GPR50	300207.0 | GPR50 | G protein-coupled receptor 50 | 9248.0 | ENSG00000102195 | nan | nan
chrX	VMA21	300913.0 | VMA21, XMEA | Vma21, S. cerevisiae, homolog of | 203547.0 | ENSG00000160131 | nan | Myopathy, X-linked, with excessive autophagy, 310440 (3), X-linked recessive
chrX	PASD1	300993.0 | PASD1, CT64, OXTES1 | PAS domain-containing repressor 1 | 139135.0 | ENSG00000166049 | nan | nan
chrX	PRRG3	300685.0 | PRRG3, PRGP3, TMG3 | Proline-rich gamma-carboxyglutamic acid protein 3 | 79057.0 | ENSG00000130032 | nan | nan
chrX	FATE1	300450.0 | FATE1 | Fetal and adult testis-expressed gene 1 | 89885.0 | ENSG00000147378 | nan | nan
chrX	CNGA2	300338.0 | CNGA2, CNG2, OCNC1 | Cyclic nucleotide-gated channel, alpha-2 | 1260.0 | ENSG00000183862 | nan | nan
chrX	MAGEA4	300175.0 | MAGEA4, MAGE4A, MAGE4B | Melanoma antigen, family A, 4 | 4103.0 | ENSG00000147381 | nan | nan
chrX	GABRE	300093.0 | GABRE | Gamma-aminobutyric acid (GABA) A receptor, epsilon | 2564.0 | ENSG00000102287 | nan | nan
chrX	MIR224	300769.0 | MIR224, MIRN224 | Micro RNA 224 | 407009.0 | ENSG00000284363 | nan | nan
chrX	MAGEA5P	300340.0 | MAGEA5, MAGE5 | Melanoma antigen, family A, 5 | 4104.0 | nan | nan | nan
chrX	MAGEA10	300343.0 | MAGEA10, MAGE10 | Melanoma antigen, family A, 10 | 4109.0 | ENSG00000124260 | nan | nan
chrX	GABRA3	305660.0 | GABRA3, EPILX2 | Gamma-aminobutyric acid (GABA) A receptor, alpha-3 | 2556.0 | ENSG00000011677 | 4Mb from telomere | Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features, 301091 (3), X-linked
chrX	MIR105-1	300811.0 | MIR105-1, MIRN105-1 | Micro RNA 105-1 | 406897.0 | ENSG00000207957 | nan | nan
chrX	MIR105-2	300812.0 | MIR105-2, MIRN105-2 | Micro RNA 105-2 | 406898.0 | ENSG00000207818 | nan | nan
chrX	GABRQ	300349.0 | GABRQ | Gamma-aminobutyric acid receptor, theta | 55879.0 | ENSG00000268089 | nan | nan
chrX	MAGEA3	300174.0 | MAGEA3, MAGE3 | Melanoma antigen, family A, 3 | 4102.0 | ENSG00000221867 | nan | nan
chrX	CSAG2	301096.0 | CSAG2, TRAG3 | CSAG family, member 2 | 102723547.0 | ENSG00000268902 | nan | nan
chrX	MAGEA2B	300549.0 | MAGEA2B | Melanoma antigen, family A, 2B | 266740.0 | ENSG00000183305 | nan | nan
chrX	CSAG1	300944.0 | CSAG1, CSAGE | CSAG family, member 1 ` | 158511.0 | ENSG00000198930 | nan | nan
chrX	MAGEA12	300177.0 | MAGEA12, MAGE12 | Melanoma antigen, family A, 12 | 4111.0 | ENSG00000213401 | nan | nan
chrX	MAGEA2	300173.0 | MAGEA2, MAGE2 | Melanoma antigen, family A, 2 | 4101.0 | ENSG00000268606 | nan | nan
chrX	CSAG3	301097.0 | CSAG3 | CSAG family, member 3 | 389903.0 | ENSG00000268916 | nan | nan
chrX	MAGEA6	300176.0 | MAGEA6, MAGE6 | Melanoma antigen, family A, 6 | 4105.0 | ENSG00000197172 | nan | nan
chrX	CETN2	300006.0 | CETN2, CALT | Centrin, EF-hand protein, 2 (caltractin) | 1069.0 | ENSG00000147400 | nan | nan
chrX	NSDHL	300275.0 | NSDHL | NAD(P)H steroid dehydrogenase-like protein | 50814.0 | ENSG00000147383 | nan | CK syndrome, 300831 (3), X-linked recessive; CHILD syndrome, 308050 (3), X-linked dominant
chrX	ZNF185	300381.0 | ZNF185 | Zinc finger protein 185 | 7739.0 | ENSG00000147394 | nan | nan
chrX	PNMA5	300916.0 | PNMA5, KIAA1934 | Paraneoplastic MA antigen family, member 5 | 114824.0 | ENSG00000198883 | nan | nan
chrX	PNMA3	300675.0 | PNMA3, MA3 | Paraneoplastic MA antigen 3 | 29944.0 | ENSG00000183837 | nan | nan
chrX	PNMA6A	300917.0 | PNMA6A, PNMA6 | Paraneoplastic MA antigen family, member 6A | 84968.0 | ENSG00000235961 | nan | nan
chrX	MAGEA1	300016.0 | MAGE1 | Melanoma antigen 1 (directs expression of antigen MZ2-E) | 4100.0 | ENSG00000198681 | cluster of 12 genes | nan
chrX	TREX2	300370.0 | TREX2 | 3-prime repair exonuclease 2 | 11219.0 | ENSG00000183479 | nan | nan
chrX	HAUS7	300540.0 | HAUS7, UCHL5IP, UIP1 | HAUS augmin-like complex, subunit 7 | 55559.0 | ENSG00000213397 | nan | nan
chrX	BGN	301870.0 | BGN, SEMDX, MRLS | Biglycan | 633.0 | ENSG00000182492 | proximal Xq28 | Meester-Loeys syndrome, 300989 (3), X-linked; Spondyloepimetaphyseal dysplasia, X-linked, 300106 (3), X-linked recessive
chrX	ATP2B3	300014.0 | ATP2B3, PMCA3, SCAX1 | ATPase, Ca++ transporting, plasma membrane, 3 | 492.0 | ENSG00000067842 | mutation identified in 1 family | ?Spinocerebellar ataxia, X-linked 1, 302500 (3), X-linked recessive
chrX	CCNQ	300708.0 | CCNQ, FAM58A, STAR | Cyclin Q | 92002.0 | ENSG00000262919 | nan | STAR syndrome, 300707 (3), X-linked dominant
chrX	DUSP9	300134.0 | DUSP9, MKP4 | Dual-specificity phosphatase 9 | 1852.0 | ENSG00000130829 | nan | nan
chrX	PNCK	300680.0 | PNCK, CAMK1B, BSTK3 | Pregnancy-upregulated, nonubiquitous, CAM kinase | 139728.0 | ENSG00000130822 | nan | nan
chrX	SLC6A8	300036.0 | SLC6A8, CRTR, CCDS1 | Solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | 6535.0 | ENSG00000130821 | distal to G6PD | Cerebral creatine deficiency syndrome 1, 300352 (3), X-linked recessive
chrX	BCAP31	300398.0 | BCAP31, BAP31, DXS1357E, DDCH | B-cell receptor-associated protein 31 | 10134.0 | ENSG00000185825 | nan | Deafness, dystonia, and cerebral hypomyelination, 300475 (3), X-linked recessive
chrX	ABCD1	300371.0 | ABCD1, ALD, AMN | ATP-binding cassette, subfamily D, member 1 | 215.0 | ENSG00000101986 | about 650kb from GCP/RCP | Adrenoleukodystrophy, 300100 (3), X-linked recessive; Adrenomyeloneuropathy, adult, 300100 (3), X-linked recessive
chrX	PLXNB3	300214.0 | PLXNB3, PLXN6 | Plexin B3 | 5365.0 | ENSG00000198753 | nan | nan
chrX	SRPK3	301002.0 | SRPK3, STK23, MSSK1 | SRSF protein kinase 3 | 26576.0 | ENSG00000184343 | nan | nan
chrX	IDH3G	300089.0 | IDH3G | Isocitrate dehydrogenase (NAD+) 3, noncatalytic, gamma subunit | 3421.0 | ENSG00000067829 | nan | nan
chrX	SSR4	300090.0 | SSR4, TRAPD, CDG1Y | Signal sequence receptor, delta | 6748.0 | ENSG00000180879 | nan | Congenital disorder of glycosylation, type Iy, 300934 (3), X-linked recessive
chrX	PDZD4	300634.0 | PDZD4, PDZK4, PDZRN4L, KIAA1444, LU1 | PDZ domain-containing 4 | 57595.0 | ENSG00000067840 | nan | nan
chrX	L1CAM	308840.0 | L1CAM, CAML1, HYCX, MASA, SPG1 | L1 cell adhesion molecule | 3897.0 | ENSG00000198910 | mutation identified in 1 PACCX family | MASA syndrome, 303350 (3), X-linked recessive; Hydrocephalus, congenital, X-linked, 307000 (3), X-linked recessive; ?Corpus callosum, partial agenesis of, 304100 (3), X-linked recessive
chrX	AVPR2	300538.0 | AVPR2, DIR, DI1, ADHR, NDI1 | Arginine vasopressin receptor-2 | 554.0 | ENSG00000126895 | nan | Diabetes insipidus, nephrogenic, 1, 304800 (3), X-linked recessive; Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3), X-linked recessive
chrX	ARHGAP4	300023.0 | RGC1 | Rho-GAP hematopoietic protein C1 | 393.0 | ENSG00000089820 | nan | nan
chrX	NAA10	300013.0 | NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1 | N-alpha-acetyltransferase 10, NatA catalytic subunit | 8260.0 | ENSG00000102030 | nan | Microphthalmia, syndromic 1, 309800 (3), X-linked; Ogden syndrome, 300855 (3), X-linked dominant, X-linked recessive
chrX	RENBP	312420.0 | RENBP | Renin-binding protein | 5973.0 | ENSG00000102032 | nan | nan
chrX	HCFC1	300019.0 | HCFC1, HCF1, MAHCX, XLID3 | Host cell factor C1 (VP16-accessory protein) | 3054.0 | ENSG00000172534 | 50kb distal to V2R | Methylmalonic aciduria and homocysteinemia, cblX type, 309541 (3), X-linked recessive
chrX	TMEM187	300059.0 | TMEM187, CXorf12, DXS9878E, ITBA1 gene | Transmembrane protein 187 | 8269.0 | ENSG00000177854 | nan | nan
chrX	IRAK1	300283.0 | IRAK1 | Interleukin 1 receptor-associated kinase 1 | 3654.0 | ENSG00000184216 | nan | nan
chrX	MIR718	300929.0 | MIR718 | Micro RNA 718 | 100313781.0 | ENSG00000284286 | nan | nan
chrX	MECP2	300005.0 | MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13 | Methyl-CpG-binding protein-2 | 4204.0 | ENSG00000169057 | 70kb centromeric of RCP/GCP | Rett syndrome, atypical, 312750 (3), X-linked dominant; Encephalopathy, neonatal severe, 300673 (3), X-linked recessive; Intellectual developmental disorder, X-linked syndromic, Lubs type, 300260 (3), X-linked recessive; {Autism susceptibility, X-linked 3}, 300496 (3), X-linked; Intellectual developmental disorder, X-linked syndromic 13, 300055 (3), X-linked recessive; Rett syndrome, 312750 (3), X-linked dominant; Rett syndrome, preserved speech variant, 312750 (3), X-linked dominant
chrX		300824.0 | OPN1C | OPN1LW and OPN1MW genes, controller of | 107604627.0 | nan | nan | nan
chrX	OPN1LW	300822.0 | OPN1LW, RCP, CBP, CBBM | Red cone pigment (opsin 1, long-wave-sensitive) | 5956.0 | ENSG00000102076 | 5' to CBD | Blue cone monochromacy, 303700 (3), X-linked recessive; Colorblindness, protan, 303900 (3), X-linked
chrX	OPN1MW	300821.0 | OPN1MW, GCP, CBD, CBBM | Green cone pigment (opsin 1, medium-wave-sensitive) | 2652.0 | ENSG00000268221 | linked to G6PD; multiple genes | Colorblindness, deutan, 303800 (3), X-linked; Blue cone monochromacy, 303700 (3), X-linked recessive
chrX	TEX28	300092.0 | TEX28 | Testis-expressed gene on Xq28 | 1527.0 | ENSG00000278057 | nan | nan
chrX	TKTL1	300044.0 | TKTL1, TKT2, TKR | Transketolase-like 1 | 8277.0 | ENSG00000007350 | between GCP and FLN1 | nan
chrX	FLNA	300017.0 | FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2 | Filamin A, alpha (actin-binding protein-280) | 2316.0 | ENSG00000196924 | mutation identified in 1 FGS2 patient | Otopalatodigital syndrome, type II, 304120 (3), X-linked dominant; Intestinal pseudoobstruction, neuronal, 300048 (3), X-linked recessive; Cardiac valvular dysplasia, X-linked, 314400 (3), X-linked; ?FG syndrome 2, 300321 (3), X-linked; Melnick-Needles syndrome, 309350 (3), X-linked dominant; Terminal osseous dysplasia, 300244 (3), X-linked dominant; Congenital short bowel syndrome, 300048 (3), X-linked recessive; Otopalatodigital syndrome, type I, 311300 (3), X-linked dominant; Heterotopia, periventricular, 1, 300049 (3), X-linked dominant; Frontometaphyseal dysplasia 1, 305620 (3), X-linked recessive
chrX	EMD	300384.0 | EMD, EDMD, STA | Emerin | 2010.0 | ENSG00000102119 | in distal Xq28 | Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3), X-linked recessive
chrX	RPL10	312173.0 | RPL10, DXS648, QM, AUTSX5, MRXS35 | Ribosomal protein L10 | 6134.0 | ENSG00000147403 | nan | {Autism, susceptibility to, X-linked 5}, 300847 (3); Intellectual developmental disorder, X-linked syndromic 35, 300998 (3), X-linked recessive
chrX	DNASE1L1	300081.0 | DNASE1L1, DNL1L | Deoxyribonuclease I-like 1 | 1774.0 | ENSG00000013563 | between QM and DXS1010E | nan
chrX	TAFAZZIN	300394.0 | TAFAZZIN, TAZ, EFE2, BTHS, CMD3A, LVNCX | Tafazzin | 6901.0 | ENSG00000102125 | nan | Barth syndrome, 302060 (3), X-linked recessive
chrX	ATP6AP1	300197.0 | ATP6AP1, ATP6IP1, ATP6S1, VATPS1 | ATPase, H+ transporting, lysosomal, accessory protein 1 | 537.0 | ENSG00000071553 | nan | Immunodeficiency 47, 300972 (3), X-linked recessive
chrX	GDI1	300104.0 | GDI1, RABGD1A, MRX41, MRX48, XLID41 | GDP dissociation inhibitor 1 | 2664.0 | ENSG00000203879 | nan | Intellectual developmental disorder, X-linked 41, 300849 (3), X-linked dominant
chrX	FAM50A	300453.0 | FAM50A, DXS9928E, HXC26, MRXSA | Family with sequence similarity 50, member A | 9130.0 | ENSG00000071859 | nan | Intellectual developmental disorder, X-linked syndromic, Armfield type, 300261 (3), X-linked recessive
chrX	PLXNA3	300022.0 | SEX | Sex chromosome X transmembrane protein of HGF receptor family 3 | 55558.0 | ENSG00000130827 | nan | nan
chrX	LAGE3	300060.0 | LAGE3, ITBA2, GAMOS2 | L antigen family member 3 | 8270.0 | ENSG00000196976 | nan | Galloway-Mowat syndrome 2, X-linked, 301006 (3), X-linked recessive
chrX	UBL4A	312070.0 | UBL4A, GDX, UBL4, DX254E | Ubiquitin-like 4A | 8266.0 | ENSG00000102178 | 40kb 3' to G6PD | nan
chrX	SLC10A3	312090.0 | SLC10A3, P3 | Solute carrier family 10 (sodium/bile acid cotransporter family) member 3 (protein p3) | 8273.0 | ENSG00000126903 | order: G6PD-3'-(7kb)-5'-P3-3'-(0.5kb)-5'-GDX | nan
chrX	FAM3A	300492.0 | FAM3A | Family with sequence similarity 3, member A | 60343.0 | ENSG00000071889 | nan | nan
chrX	G6PD	305900.0 | G6PD, G6PD1, CNSHA1 | Glucose-6-phosphate dehydrogenase | 2539.0 | ENSG00000160211 | nan | Anemia, congenital, nonspherocytic hemolytic, 1, G6PD deficient, 300908 (3), X-linked; {Resistance to malaria due to G6PD deficiency}, 611162 (3)
chrX	IKBKG	300248.0 | IKBKG, NEMO, FIP3, IP, EDAID1, IMD33, SAIDX | Inhibitor of nuclear factor kappa B kinase, regulatory subunit gamma | 8517.0 | ENSG00000269335 | nan | Incontinentia pigmenti, 308300 (3), X-linked dominant; Ectodermal dysplasia and immunodeficiency 1, 300291 (3), X-linked recessive; Immunodeficiency 33, 300636 (3), X-linked recessive; Autoinflammatory disease, systemic, X-linked, 301081 (3), X-linked
chrX	CTAG1A	300657.0 | CTAG1A, LAGE2A | Cancer/testis antigen 1A | 246100.0 | ENSG00000268651 | nan | nan
chrX	CTAG1B	300156.0 | CTAG1B, CTAG1 | Cancer/testis antigen 1B | 1485.0 | ENSG00000184033 | nan | nan
chrX	CTAG2	300396.0 | CTAG2, LAGE1, CAMEL | Cancer/testis antigen 2 | 30848.0 | ENSG00000126890 | nan | nan
chrX	GAB3	300482.0 | GAB3 | GRB2-associated binding protein 3 | 139716.0 | ENSG00000160219 | nan | nan
chrX	DKC1	300126.0 | DKC1, DKCX, CHINE1 | Dyskerin | 1736.0 | ENSG00000130826 | mutation identified in 1 CHINE1 family | ?Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 1, 301108 (3), X-linked dominant; Dyskeratosis congenita, X-linked, 305000 (3), X-linked recessive
chrX	MPP1	305360.0 | MPP1, PEMP, EMP55 | Membrane protein, palmitoylated-1, 55kD | 4354.0 | ENSG00000130830 | ~30kb 3' and centromeric to F8 | nan
chrX	F8	300841.0 | F8, F8C, HEMA, THPH13 | Coagulation factor VIII, procoagulant component | 2157.0 | ENSG00000185010 | cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomere | Thrombophilia 13, X-linked, due to factor VIII defect, 301071 (3); Hemophilia A, 306700 (3), X-linked recessive
chrX	H2AB1	301037.0 | H2AB1, H2AFB1 | H2A.B variant histone 1 | 474382.0 | ENSG00000274183 | nan | nan
chrX	F8A1	305423.0 | F8A1, DXS522E, HAP40 | Coagulation factor VIII associated 1 | 8263.0 | ENSG00000288722 | 3 copies, 1 in intron 22 of F8C | nan
chrX	FUNDC2	301042.0 | FUNDC2, HCBP6, HCC3 | FUN14 domain-containing protein 2 | 65991.0 | ENSG00000165775 | nan | nan
chrX	CMC4	301088.0 | CMC4, MTCP1NB | C-X9-C mitif-containing protein 4 | 100272147.0 | ENSG00000182712 | nan | nan
chrX	MTCP1	300116.0 | MTCP1 | Mature T-cell proliferation 1 | 4515.0 | ENSG00000214827 | nan | nan
chrX	BRCC3	300617.0 | BRCC3, BRCC36 | BRCA1/BRCA2-containing complex, subunit 3 | 79184.0 | ENSG00000185515 | nan | nan
chrX	VBP1	300133.0 | VBP1 | Von Hippel-Lindau binding protein-1 | 7411.0 | ENSG00000155959 | nan | nan
chrX	RAB39B	300774.0 | RAB39B, XLID72, WSMN, MRX72 | RAB39B, member Ras oncogene family | 116442.0 | ENSG00000155961 | nan | Intellectual developmental disorder, X-linked 72, 300271 (3), X-linked recessive; Waisman syndrome, 311510 (3), X-linked recessive
chrX	CLIC2	300138.0 | CLIC2, XAP121 | Chloride intracellular channel 2 | 1193.0 | ENSG00000155962 | nan | nan
chrX	H2AB2	301038.0 | H2AB2, H2AFB2 | H2A.B variant histone 2 | 474381.0 | ENSG00000277858 | nan | nan
chrX	H2AB3	300445.0 | H2AB3, H2AFB, H2ABBD | H2A.B variant histone 3 | 83740.0 | ENSG00000277745 | nan | nan
chrX	TMLHE	300777.0 | TMLHE, BBOX2, TMLH, TMLHED, AUTSX6 | Epsilon-trimethyllysine hydroxylase | 55217.0 | ENSG00000185973 | nan | {Autism, susceptibility to, X-linked 6}, 300872 (3), X-linked recessive
chrX	SPRY3	300531.0 | SPRY3 | Sprouty RTK signaling antagonist 3 | 10251.0 | ENSG00000168939 | in pseudoautosomal region PAR2 | nan
chrX	VAMP7	300053.0 | VAMP7, SYBL1, TIVAMP | Vesicle-associated membrane protein 7 | 6845.0 | ENSG00000124333 | nan | nan
chrX	IL9R	300007.0 | IL9R | Interleukin-9 receptor | 3581.0 | ENSG00000124334 | in PAR2 pseudoautosomal region | nan
chrX	CCCSX	300864.0 | CCCSX | Cerebral-cerebellar-coloboma syndrome, X-linked | 100820758.0 | nan | nan | Cerebral-cerebellar-coloboma syndrome, X-linked, 300864 (2), X-linked recessive
chrX	CVMRF	300471.0 | CVMRF | Cubitus valgus with impaired intellectual development and unusual facies | 494028.0 | nan | nan | Cubitus valgus with impaired intellectual development and unusual facies, 300471 (2), X-linked recessive
chrX	DFCTRPS	300719.0 | DFCTRPS | Deafness, cataract, retinitis pigmentosa, and sperm abnormalities | 100188774.0 | nan | nan | Deafness, cataract, retinitis pigmentosa, and sperm abnormalities, 300719 (2), X-linked recessive
chrX	MCOPCB1	300345.0 | MCOPCB1 | Microphthalmia, isolated, with coloboma 1 | 85503.0 | nan | nan | Microphthalmia with coloboma 1, 300345 (2)
chrX	MRXS32	300886.0 | MRXS32 | Intellectual developmental disorder, X-linked, syndromic 32 | 135933881.0 | nan | nan | Intellectual developmental disorder, X-linked, syndromic 32, 300886 (2), X-linked recessive
chrX		300484.0 | OFD8 | Orofaciodigital syndrome VIII | nan | nan | nan | Orofaciodigital syndrome VIII, 300484 (2), X-linked recessive
chrX	MRX95	300716.0 | XLID95, MRX95 | Intellectual developmental disorder, X-linked 95 | 102775568.0 | nan | nan | Intellectual developmental disorder, X-linked 95, 300716 (2), X-linked dominant
chrY		400046.0 | PLCXD1Y | Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 1 | nan | nan | in pseudoautosomal region | nan
chrY		489500.0 | XGR | XG regulator | nan | nan | in pseudoautosomal region | nan
chrY		400049.0 | DHRSY | Dehydrogenase/reductase, Y-linked | nan | nan | nan | nan
chrY	SHOX	400020.0 | SHOXY | Short stature homeobox, Y-linked | 6473.0 | ENSG00000185960 | pseudoautosomal | Short stature, idiopathic familial, 300582 (3); Langer mesomelic dysplasia, 249700 (3), Pseudoautosomal recessive; Leri-Weill dyschondrosteosis, 127300 (3), Pseudoautosomal dominant
chrY	CRLF2	400023.0 | CRLF2Y | Cytokine receptor-like factor 2, Y-linked | 64109.0 | ENSG00000205755 | pseudoautosomal | nan
chrY	CSF2RA	425000.0 | CSF2RY | Granulocyte-macrophage colony-stimulating factor receptor, alpha subunit (Y chromosome) | 1438.0 | ENSG00000198223 | 306250 = X homolog; distal to MIC2Y | nan
chrY	IL3RA	430000.0 | IL3RA, IL3RY, IL3RAY | Interleukin-3 receptor (Y chromosome) | 3563.0 | ENSG00000185291 | 308385 = X homolog; pseudoautosomal | nan
chrY	SLC25A6	403000.0 | ANT3Y | Adenine nucleotide translocator-3 (Y chromosome) | 293.0 | ENSG00000169100 | 300151 = X homolog; proximal to CSF2RY | nan
chrY	ASMTL	400011.0 | ASMTLY | Acetylserotonin methyltransferase-like, Y-linked | 8623.0 | ENSG00000169093 | nan | nan
chrY	AKAP17A	465000.0 | AKAP17A, SFRS17A, XE7Y | A kinase (PRKA) anchor protein 17A | 8227.0 | ENSG00000197976 | see 300015 locus | nan
chrY	ASMT	402500.0 | ASMTY | Acetylserotonin methyltransferase (Y chromosome) | 438.0 | ENSG00000196433 | pseudoautosomal | nan
chrY	CD99	450000.0 | MIC2Y | Antigen identified by monoclonal 12E7, Y homolog | 4267.0 | ENSG00000002586 | pseudoautosomal | nan
chrY	SRY	480000.0 | SRY, TDF, TDY, SRXX1, SRXY1 | Sex-determining region Y (testis determining factor) | 6736.0 | ENSG00000184895 | nan | 46XY sex reversal 1, 400044 (3), Y-linked; 46XX sex reversal 1, 400045 (4), X-linked dominant
chrY	RPS4Y1	470000.0 | RPS4Y1 | Ribosomal protein S4, Y-linked, 1 | 6192.0 | ENSG00000129824 | nan | nan
chrY	ZFY	490000.0 | ZFY | Zinc finger protein, Y-linked | 7544.0 | ENSG00000067646 | nan | nan
chrY	TGIF2LY	400025.0 | TGIF2LY, TGIFLY | Transforming growth factor-beta-induced factor 2-like, Y-linked | 90655.0 | ENSG00000176679 | nan | nan
chrY	PCDH11Y	400022.0 | PCDH11Y, PCDH22, PCDHY | Protocadherin 22 | 83259.0 | ENSG00000099715 | nan | nan
chrY	AMELY	410000.0 | AMELY, AMGL | Amelogenin (Y chromosome) | 266.0 | ENSG00000099721 | 301200 = X homolog | nan
chrY	TBL1Y	400033.0 | TBL1Y, DFNY2 | Transducin-beta-like 1, Y-linked | 90665.0 | ENSG00000092377 | mutation identified in 1 DFNY2 family | ?Deafness, Y-linked 2, 400047 (3), Y-linked
chrY	PRKY	400008.0 | PRKY | Protein kinase, Y-linked | 5616.0 | ENSG00000293442 | nan | nan
chrY	TSPY1	480100.0 | TSPY1, TSPY | Testis-specific protein, Y-linked, 1 | 7258.0 | ENSG00000258992 | nan | nan
chrY		400042.0 | DELYq11, CYDELq11, SPGFY1 | Chromosome Yq11 interstitial deletion syndrome | nan | nan | contiguous gene deletion syndrome | Spermatogenic failure, Y-linked, 1, 400042 (4), Y-linked
chrY	HEY	425500.0 | HEY | Hairy ears, Y-linked | 100188776.0 | nan | nan | ?Hairy ears, Y-linked, 425500 (2), Y-linked
chrY	USP9Y	400005.0 | USP9Y, DFFRY, SPGFY2 | Ubiquitin-specific protease-9, Y chromosome (Drosophila fat facets related, Y-linked) | 8287.0 | ENSG00000114374 | nan | Spermatogenic failure, Y-linked, 2, 415000 (3), Y-linked
chrY	DDX3Y	400010.0 | DDX3Y, DBY | DEAD-box helicase 3, Y-linked | 8653.0 | ENSG00000067048 | nan | nan
chrY	UTY	400009.0 | UTY | Ubiquitously transcribed TPR gene on Y chromosome | 7404.0 | ENSG00000183878 | nan | nan
chrY	TMSB4Y	400017.0 | TMSB4Y | Thymosin, beta-4, Y chromosome | 9087.0 | ENSG00000154620 | nan | nan
chrY	VCY	400012.0 | VCY, BPY1 | Variably charged, Y chromosome | 9084.0 | ENSG00000129864 | nan | nan
chrY	VCY1B	400050.0 | VCY1B, BPY1B | Variably charged, Y chromosome, 1B | 353513.0 | ENSG00000129862 | nan | nan
chrY	NLGN4Y	400028.0 | NLGN4Y, KIAA0951 | Neuroligin 4, Y-linked | 22829.0 | ENSG00000165246 | nan | nan
chrY	XKRY	400015.0 | XKRY | XK-related protein on Y chromosome | 9082.0 | ENSG00000290724 | nan | nan
chrY	CDY2A	400018.0 | CDY2 | Chromodomain protein, Y chromosome, 2 | 9426.0 | ENSG00000182415 | nan | nan
chrY	HSFY1	400029.0 | HSFY | Heat shock transcription factor, Y-linked | 86614.0 | ENSG00000172468 | nan | nan
chrY	TXLNGY	400031.0 | TXLNGY, CYorf15A, CYorf15B | Taxilin gamma pseudogene, Y-linked | 246126.0 | ENSG00000291033 | transcribed pseudogene | nan
chrY	KDM5D	426000.0 | KDM5D, JARID1D, SMCY, HYA | Lysine demethylase 5D | 8284.0 | ENSG00000012817 | encodes H-Y epitope in mouse | nan
chrY	EIF1AY	400014.0 | EIF1AY | Eukaryotic translation initiation factor 1A, Y isoform | 9086.0 | ENSG00000198692 | nan | nan
chrY	RPS4Y2	400030.0 | RPS4Y2 | Ribosomal protein S4, Y-linked | 140032.0 | ENSG00000280969 | nan | nan
chrY	RBMY1A1	400006.0 | RBMY1A1, RBM1, YRRM1, RBM2 | RNA binding motif protein, Y chromosome, family 1, member A1 | 5940.0 | ENSG00000234414 | nan | nan
chrY	PRY2	400041.0 | PRY2 | PTPBL-related gene on Y, 2 | 442862.0 | nan | nan | nan
chrY	TTTY5	400038.0 | TTTY5 | Testis-specific transcript, Y-linked, 5 | 83863.0 | ENSG00000215560 | nan | nan
chrY	TTTY6	400039.0 | TTTY6 | Testis-specific transcript, Y-linked, 6 | 84672.0 | nan | nan | nan
chrY	PRY	400019.0 | PRY | PTPN13-like, Y-linked | 9081.0 | ENSG00000169789 | nan | nan
chrY	TTTY17A	400040.0 | TTY17 | Testis-specific transcript, Y-linked, 17 | 252949.0 | ENSG00000228240 | nan | nan
chrY	TTTY4	400037.0 | TTTY4 | Testis-specific transcript, Y-linked, 4 | 114761.0 | ENSG00000226906 | nan | nan
chrY	BPY2	400013.0 | BPY2 | Basic protein on Y chromosome, 2 | 9083.0 | ENSG00000183753 | nan | nan
chrY	DAZ1	400003.0 | DAZ1 | Deleted in azoospermia 1 | 1617.0 | ENSG00000188120 | nan | nan
chrY	DAZ2	400026.0 | DAZ2 | Deleted in azoospermia 2 | 57055.0 | ENSG00000205944 | nan | nan
chrY	GOLGA2P2Y	400035.0 | GOLGA2P2Y, GOLGA2LY | GOLGA2 pseudogene 2, Y-linked | 84559.0 | ENSG00000291016 | nan | nan
chrY	DAZ3	400027.0 | DAZ3 | Deleted in azoospermia 3 | 57054.0 | ENSG00000187191 | nan | nan
chrY	DAZ4	400048.0 | DAZ4 | Deleted in azoospermia 4 | 57135.0 | ENSG00000205916 | nan | nan
chrY	CSPG4P1Y	400034.0 | CSPG4P1Y, CSPG4LY | Chondroitin sulfate proteoglycan 4 pseudogene 1, Y-linked | 114758.0 | ENSG00000240450 | nan | nan
chrY	CDY1	400016.0 | CDY1, CDY | Chromodomain protein, Y chromosome | 9085.0 | ENSG00000172288 | nan | nan
chrY	TTTY3	400036.0 | TTTY3 | Testis-specific transcript, Y-linked, 3 | 114760.0 | ENSG00000231141 | nan | nan
chrY	GCY	475000.0 | GCY, TSY, STA | Growth control, Y-chromosome influenced | 2656.0 | nan | nan | nan
chrY	DFNY1	400043.0 | DFNY1 | Deafness, Y-linked 1 | 724074.0 | nan | nan | Deafness, Y-linked 1, 400043 (2), Y-linked
chrY	RPY	400004.0 | RPY | Retinitis pigmentosa, Y-linked | 79051.0 | nan | nan | Retinitis pigmentosa, Y-linked, 400004 (2), Y-linked
#		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# Source of data in fields are as follows:		nan | nan | nan | nan | nan | nan | nan
# ----------------------------------------		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# Chromosome (NCBI)		nan | nan | nan | nan | nan | nan | nan
# Genomic position start * (NCBI)		nan | nan | nan | nan | nan | nan | nan
# Genomic position end (NCBI)		nan | nan | nan | nan | nan | nan | nan
# Cyto location (OMIM)		nan | nan | nan | nan | nan | nan | nan
# Computed cyto location (UCSC)		nan | nan | nan | nan | nan | nan | nan
# MIM Number for Gene/Locus (OMIM)		nan | nan | nan | nan | nan | nan | nan
# Gene symbols (OMIM)		nan | nan | nan | nan | nan | nan | nan
# Gene name (OMIM)		nan | nan | nan | nan | nan | nan | nan
# Approved gene symbol (HGNC)		nan | nan | nan | nan | nan | nan | nan
# Entrez gene ID (NCBI)		nan | nan | nan | nan | nan | nan | nan
# Ensembl gene ID (Ensembl)		nan | nan | nan | nan | nan | nan | nan
# Comments (OMIM)		nan | nan | nan | nan | nan | nan | nan
# Phenotype(s) (OMIM)		nan | nan | nan | nan | nan | nan | nan
# Mouse gene symbol & ID (MGI)		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# * for phenotypes with mapping key of (2) or genes not found in NCBI		nan | nan | nan | nan | nan | nan | nan
# data, genomic coordinates are derived from OMIM's cyto location mapped		nan | nan | nan | nan | nan | nan | nan
# to genomic using UCSC table.		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# OMIM Phenotype field is nested:		nan | nan | nan | nan | nan | nan | nan
# -------------------------------		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# Each Phenotype is followed by its MIM number, if different from		nan | nan | nan | nan | nan | nan | nan
# that of the locus, preceded by a comma		nan | nan | nan | nan | nan | nan | nan
# Phenotype mapping key in parentheses follows the phenotype MIM		nan | nan | nan | nan | nan | nan | nan
# number (explanation below).		nan | nan | nan | nan | nan | nan | nan
# Allelic disorders are separated by a semi-colon following the		nan | nan | nan | nan | nan | nan | nan
# phenotype mapping key.		nan | nan | nan | nan | nan | nan | nan
# Inheritance for the phenotype follows the phenotype mapping key		nan | nan | nan | nan | nan | nan | nan
# preceded by a ,<space>		nan | nan | nan | nan | nan | nan | nan
# Explanation of the symbols and question marks (?) in the Phenotype		nan | nan | nan | nan | nan | nan | nan
# field is given in OMIM FAQ 1.6)		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# Phenotype Mapping Method - Appears in parentheses after a disorder :		nan | nan | nan | nan | nan | nan | nan
# --------------------------------------------------------------------		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# 1 - the disorder is placed on the map based on its association with		nan | nan | nan | nan | nan | nan | nan
# a gene, but the underlying defect is not known.		nan | nan | nan | nan | nan | nan | nan
# 2 - the disorder has been placed on the map by linkage; no mutation has		nan | nan | nan | nan | nan | nan | nan
# been found.		nan | nan | nan | nan | nan | nan | nan
# 3 - the molecular basis for the disorder is known; a mutation has been		nan | nan | nan | nan | nan | nan | nan
# found in the gene.		nan | nan | nan | nan | nan | nan | nan
# 4 - a contiguous gene deletion or duplication syndrome, multiple genes		nan | nan | nan | nan | nan | nan | nan
# are deleted or duplicated causing the phenotype.		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# Genomic Coordinates - GRCh38 :		nan | nan | nan | nan | nan | nan | nan
# ------------------------------		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# The genomic coordinates for the genes are for GRCh38, if you need		nan | nan | nan | nan | nan | nan | nan
# coordinates for for GRCh37, you can get them from this file and use		nan | nan | nan | nan | nan | nan | nan
# the MIM number or the Entrez gene ID to map them:		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
#   https://ftp.ncbi.nlm.nih.gov/genomes/archive/old_refseq/H_sapiens/ARCHIVE/BUILD.37.3/GFF/ref_GRCh37.p5_top_level.gff3.gz		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# You can also get this script which will handle that for you:		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
#   https://github.com/OMIM-org/hg19-generator		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# Sample code to parse this file :		nan | nan | nan | nan | nan | nan | nan
# --------------------------------		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
# You can find sample code in Python to parse this file here:		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
#   https://github.com/OMIM-org/genemap2-parser		nan | nan | nan | nan | nan | nan | nan
#		nan | nan | nan | nan | nan | nan | nan
